Title,Authors,Year,Journal,URL,Keywords,Cleaned_Abstract
"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial.","Samir Jaber, Catherine Paugam, Emmanuel Futier, Jean-Yves Lefrant, Sigismond Lasocki, Thomas Lescot, Julien Pottecher, Alexandre Demoule, Martine Ferrandière, Karim Asehnoune, Jean Dellamonica, Lionel Velly, Paër-Sélim Abback, Audrey de Jong, Vincent Brunot, Fouad Belafia, Antoine Roquilly, Gérald Chanques, Laurent Muller, Jean-Michel Constantin, Helena Bertet, Kada Klouche, Nicolas Molinari, Boris Jung                              ;, BICAR-ICU Study Group, Marion Monnin, Jean-Marc Delay, Moussa Cissé, Marie Geniez, Matthieu Conseil, Bruno Souche, Jean Michel Constantin, Eric Noll, Elise Morawiec, Alexandre Robert, Thibaut Triglia, Malika Mechati, Jean-Michel Arnal, Jacques Durand-Gasselin, Didier Demoly, Sami Hraiech, Laurent Papazian, Vincent Gilles, Thomas Rimmelé, Béatrice Riu, Pierre Cougot, Olivier Fourcade, Philippe Seguin, Jonathan Charbit, Xavier Capdevila, Marc Leone, Laurent Zieleskiewicz, Carole Ichai, Jean Christophe Orban, Michael Darmon, Elie Azoulay, Virginie Lemiale, Lara Zafrani, Karim Debbat, Oliver Mimoz, Claude Guérin, Eric Kipnis, Samir Jaberet al.",2018 Jul 7,Lancet,https://pubmed.ncbi.nlm.nih.gov/29910040/,No keywords found,"['acute', 'acidaemia', 'frequently', 'observed', 'critical', 'illness', '.', 'sodium', 'bicarbonate', 'infusion', 'treatment', 'of', 'severe', 'metabolic', 'acidaemia', 'possible', 'treatment', 'option', 'remains', 'controversial', ',', 'no', 'study', 'to', 'date', 'examined', 'effect', 'clinical', 'outcome', '.', 'therefore', ',', 'aimed', 'to', 'evaluate', 'whether', 'sodium', 'bicarbonate', 'infusion', 'would', 'improve', 'outcome', 'in', 'critically', 'ill', 'patient', '.', 'method', 'multicentre', ',', 'open-label', ',', 'randomised', 'controlled', ',', 'phase', 'trial', '.', 'local', 'investigator', 'screened', 'eligible', 'patient', 'intensive', 'care', 'unit', '(', 'icu', ')', 'in', 'france', '.', 'included', 'adult', 'patient', '(', 'aged', 'year', ')', 'admitted', 'within', 'h', 'to', 'icu', 'with', 'severe', 'acidaemia', '(', 'ph', ',', 'paco', 'mm', 'hg', ',', 'and', 'sodium', 'bicarbonate', 'concentration', 'mmoll', ')', 'and', 'with', 'total', 'sequential', 'organ', 'failure', 'assessment', 'score', 'of', 'or', 'or', 'arterial', 'lactate', 'concentration', 'of', 'mmoll', 'or', '.', 'randomly', 'assigned', 'patient', '(', ')', ',', 'stratified', 'randomisation', 'with', 'minimisation', 'via', 'restricted', 'web', 'platform', ',', 'to', 'receive', 'either', 'no', 'sodium', 'bicarbonate', '(', 'control', 'group', ')', 'or', 'of', 'intravenous', 'sodium', 'bicarbonate', 'infusion', '(', 'bicarbonate', 'group', ')', 'to', 'maintain', 'arterial', 'ph', '.', 'protocol', 'recommended', 'volume', 'of', 'infusion', 'within', 'range', 'of', '-', 'ml', 'in', 'min', ',', 'with', 'maximum', 'of', 'ml', 'within', 'h', 'inclusion', '.', 'randomisation', 'criterion', 'stratified', 'among', 'three', 'prespecified', 'stratum', 'age', ',', 'sepsis', 'status', ',', 'and', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'score', '.', 'primary', 'outcome', 'composite', 'of', 'death', 'cause', 'day', 'and', 'presence', 'of', 'least', 'one', 'organ', 'failure', 'day', '.', 'analysis', 'done', 'data', 'intention-to-treat', 'population', ',', 'included', 'patient', 'underwent', 'randomisation', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'may', ',', ',', 'and', 'may', ',', ',', 'enrolled', 'patient', 'intention-to-treat', 'analysis', 'in', 'overall', 'population', '(', 'in', 'control', 'group', 'and', 'in', 'bicarbonate', 'group', ')', '.', 'primary', 'outcome', 'occurred', 'in', '(', ')', 'of', 'patient', 'in', 'control', 'group', 'and', '(', ')', 'of', 'in', 'bicarbonate', 'group', '(', 'absolute', 'difference', 'estimate', '-', ',', 'ci', '-', 'to', 'p', ')', '.', 'kaplan-meier', 'method', 'estimate', 'of', 'probability', 'of', 'survival', 'day', 'control', 'group', 'and', 'bicarbonate', 'group', 'not', 'significant', '(', 'ci', '-', 'v', '-', 'p.', 'in', 'prespecified', 'akin', 'stratum', 'of', 'patient', 'with', 'score', 'of', 'or', ',', 'kaplan-meier', 'method', 'estimate', 'of', 'survival', 'day', 'control', 'group', 'and', 'bicarbonate', 'group', 'significant', '(', 'ci', '-', 'v', '-', 'p', ')', '.', 'corrected', 'metabolic', 'alkalosis', ',', 'hypernatraemia', ',', 'and', 'hypocalcaemia', 'observed', 'frequently', 'in', 'bicarbonate', 'group', 'in', 'control', 'group', ',', 'with', 'no', 'life-threatening', 'complication', 'reported', '.', 'interpretation', 'in', 'patient', 'with', 'severe', 'metabolic', 'acidaemia', ',', 'sodium', 'bicarbonate', 'no', 'effect', 'primary', 'composite', 'outcome', '.', 'however', ',', 'sodium', 'bicarbonate', 'decreased', 'primary', 'composite', 'outcome', 'and', 'day', 'mortality', 'in', 'a-priori', 'defined', 'stratum', 'of', 'patient', 'with', 'acute', 'kidney', 'injury', '.', 'funding', 'french', 'ministry', 'of', 'health', 'and', 'socit', 'franaise', ""d'anesthsie"", 'ranimation', '.']"
Cardiovascular Safety of Testosterone-Replacement Therapy.,"A Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, Lisa M Mitchell, Shehzad Basaria, William E Boden, Glenn R Cunningham, Christopher B Granger, Mohit Khera, Ian M Thompson Jr, Qiuqing Wang, Kathy Wolski, Deborah Davey, Vidyasagar Kalahasti, Nader Khan, Michael G Miller, Michael C Snabes, Anna Chan, Elena Dubcenco, Xue Li, Tingting Yi, Bidan Huang, Karol M Pencina, Thomas G Travison, Steven E Nissen                              ;, TRAVERSE Study Investigators, A Michael Lincoffet al.",2023 Jul 13,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/37326322/,No keywords found,"['cardiovascular', 'safety', 'of', 'testosterone-replacement', 'therapy', 'in', 'middle-aged', 'and', 'older', 'men', 'with', 'hypogonadism', 'not', 'determined', '.', 'method', 'in', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'noninferiority', 'trial', ',', 'enrolled', 'men', 'to', 'year', 'of', 'age', 'preexisting', 'or', 'high', 'risk', 'of', 'cardiovascular', 'disease', 'and', 'reported', 'symptom', 'of', 'hypogonadism', 'and', 'two', 'fasting', 'testosterone', 'level', 'of', 'less', 'ng', 'per', 'deciliter', '.', 'patient', 'randomly', 'assigned', 'to', 'receive', 'daily', 'transdermal', '.', 'testosterone', 'gel', '(', 'dose', 'adjusted', 'to', 'maintain', 'testosterone', 'level', 'and', 'ng', 'per', 'deciliter', ')', 'or', 'placebo', 'gel', '.', 'primary', 'cardiovascular', 'safety', 'end', 'point', 'first', 'occurrence', 'of', 'component', 'of', 'composite', 'of', 'death', 'cardiovascular', 'cause', ',', 'nonfatal', 'myocardial', 'infarction', ',', 'or', 'nonfatal', 'stroke', ',', 'assessed', 'in', 'time-to-event', 'analysis', '.', 'secondary', 'cardiovascular', 'end', 'point', 'first', 'occurrence', 'of', 'component', 'of', 'composite', 'of', 'death', 'cardiovascular', 'cause', ',', 'nonfatal', 'myocardial', 'infarction', ',', 'nonfatal', 'stroke', ',', 'or', 'coronary', 'revascularization', ',', 'assessed', 'in', 'time-to-event', 'analysis', '.', 'noninferiority', 'required', 'upper', 'limit', 'of', 'less', '.', 'confidence', 'interval', 'of', 'hazard', 'ratio', 'among', 'patient', 'receiving', 'least', 'one', 'dose', 'of', 'testosterone', 'or', 'placebo', '.', 'result', 'mean', '(', 'sd', ')', 'duration', 'of', 'treatment', '..', 'month', ',', 'and', 'mean', 'follow-up', '..', 'month', '.', 'primary', 'cardiovascular', 'end-point', 'event', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'testosterone', 'group', 'and', 'in', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', 'p.', 'noninferiority', ')', '.', 'similar', 'finding', 'observed', 'in', 'sensitivity', 'analysis', 'in', 'data', 'event', 'censored', 'various', 'time', 'discontinuation', 'of', 'testosterone', 'or', 'placebo', '.', 'incidence', 'of', 'secondary', 'end-point', 'event', 'or', 'of', 'of', 'event', 'of', 'composite', 'primary', 'cardiovascular', 'end', 'point', 'appeared', 'to', 'similar', 'in', 'two', 'group', '.', 'higher', 'incidence', 'of', 'atrial', 'fibrillation', ',', 'of', 'acute', 'kidney', 'injury', ',', 'and', 'of', 'pulmonary', 'embolism', 'observed', 'in', 'testosterone', 'group', '.', 'conclusion', 'in', 'men', 'with', 'hypogonadism', 'and', 'preexisting', 'or', 'high', 'risk', 'of', 'cardiovascular', 'disease', ',', 'testosterone-replacement', 'therapy', 'noninferior', 'to', 'placebo', 'with', 'respect', 'to', 'incidence', 'of', 'major', 'adverse', 'cardiac', 'event', '.', '(', 'funded', 'abbvie', 'and', 'others', 'traverse', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).","Keith S Kaye, Andrew F Shorr, Richard G Wunderink, Bin Du, Gabrielle E Poirier, Khurram Rana, Alita Miller, Drew Lewis, John O'Donnell, Lan Chen, Harald Reinhart, Subasree Srinivasan, Robin Isaacs, David Altarac, Keith S Kayeet al.",2023 Sep,Lancet Infect Dis,https://pubmed.ncbi.nlm.nih.gov/37182534/,No keywords found,"['urgent', 'need', 'exists', 'antibiotic', 'to', 'treat', 'infection', 'caused', 'carbapenem-resistant', 'acinetobacter', 'baumannii-calcoaceticus', 'complex', '(', 'abc', ')', '.', 'sulbactam-durlobactam', '-lactam', '--', 'lactamase', 'inhibitor', 'combination', 'with', 'activity', 'acinetobacter', ',', 'including', 'multidrug-resistant', 'strain', '.', 'in', 'phase', ',', 'pathogen-specific', ',', 'randomised', 'controlled', 'trial', ',', 'compared', 'efficacy', 'and', 'safety', 'of', 'sulbactam-durlobactam', 'versus', 'colistin', ',', 'in', 'combination', 'with', 'imipenem-cilastatin', 'background', 'therapy', ',', 'in', 'patient', 'with', 'serious', 'infection', 'caused', 'carbapenem-resistant', 'abc', '.', 'method', 'attack', 'trial', 'done', 'clinical', 'site', 'in', 'country', '.', 'adult', 'aged', 'year', 'or', 'older', 'with', 'abc-confirmed', 'hospital-acquired', 'bacterial', 'pneumonia', ',', 'ventilator-associated', 'bacterial', 'pneumonia', ',', 'ventilated', 'pneumonia', ',', 'or', 'bloodstream', 'infection', 'randomised', 'using', 'block', 'size', 'of', 'four', 'to', 'sulbactam-durlobactam', '(', 'g', 'of', 'drug', 'in', 'combination', 'h', 'every', 'h', ')', 'or', 'colistin', '(', 'mgkg', 'min', 'every', 'h', ')', '-', 'day', '.', 'patient', 'received', 'imipenem-cilastatin', '(', 'g', 'of', 'drug', 'in', 'combination', 'h', 'every', 'h', ')', 'background', 'therapy', '.', 'primary', 'efficacy', 'endpoint', '-day', 'all-cause', 'mortality', 'in', 'patient', 'with', 'laboratory-confirmed', 'carbapenem-resistant', 'abc', '(', 'carbapenem-resistant', 'abc', 'microbiologically', 'modified', 'intention-to-treat', 'population', ')', '.', 'non-inferiority', 'concluded', 'upper', 'bound', 'of', 'ci', 'treatment', 'difference', 'less', '.', 'primary', 'safety', 'endpoint', 'incidence', 'of', 'nephrotoxicity', 'assessed', 'using', 'modified', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', ',', 'end-stage', 'renal', 'disease', 'criterion', 'measured', 'creatinine', 'level', 'or', 'glomerular', 'filtration', 'rate', 'day', '.', 'trial', 'registered', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'sep', ',', ',', 'and', 'july', ',', ',', 'patient', 'randomly', 'assigned', 'to', 'sulbactam-durlobactam', 'or', 'colistin', '(', 'hospital-acquired', 'bacterial', 'pneumonia', ',', 'ventilator-associated', 'bacterial', 'pneumonia', ',', 'or', 'ventilated', 'pneumonia', 'and', 'five', 'bloodstream', 'infection', ')', 'patient', 'with', 'laboratory-confirmed', 'carbapenem-resistant', 'abc', 'isolates', 'included', 'in', 'primary', 'efficacy', 'analysis', '.', '-day', 'all-cause', 'mortality', '(', ')', 'of', 'in', 'sulbactam-durlobactam', 'group', 'and', '(', ')', 'of', 'in', 'colistin', 'group', ',', 'difference', 'of', '-', '(', 'ci', '-', 'to', ')', ',', 'met', 'criterion', 'non-inferiority', '.', 'incidence', 'of', 'nephrotoxicity', 'significantly', '(', 'p', ')', 'lower', 'with', 'sulbactam-durlobactam', 'colistin', '(', 'of', 'v', 'of', ')', '.', 'serious', 'adverse', 'event', 'reported', 'in', '(', ')', 'of', 'patient', 'in', 'sulbactam-durlobactam', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'colistin', 'group', '.', 'treatment-related', 'adverse', 'event', 'leading', 'to', 'study', 'drug', 'discontinuation', 'reported', 'in', 'ten', '(', ')', 'of', 'patient', 'in', 'sulbactam-durlobactam', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'colistin', 'group', '.', 'interpretation', 'data', 'show', 'sulbactam-durlobactam', 'non-inferior', 'to', 'colistin', ',', 'agent', 'given', 'in', 'combination', 'with', 'imipenem-cilastatin', ',', 'primary', 'endpoint', 'of', '-day', 'all-cause', 'mortality', '.', 'sulbactam-durlobactam', 'well', 'tolerated', 'and', 'could', 'effective', 'intervention', 'to', 'reduce', 'mortality', 'serious', 'infection', 'caused', 'carbapenem-resistant', 'abc', ',', 'including', 'multidrug-resistant', 'strain', '.', 'funding', 'entasis', 'therapeutic', 'and', 'zai', 'lab', '.']"
Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults.,"Simon Finfer, Sharon Micallef, Naomi Hammond, Leanlove Navarra, Rinaldo Bellomo, Laurent Billot, Anthony Delaney, Martin Gallagher, David Gattas, Qiang Li, Diane Mackle, Jayanthi Mysore, Manoj Saxena, Colman Taylor, Paul Young, John Myburgh                              ;, PLUS Study Investigators and the Australian New Zealand Intensive Care Society Clinical Trials Group, Simon Finferet al.",2022 Mar 3,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/35041780/,No keywords found,"['whether', 'use', 'of', 'balanced', 'multielectrolyte', 'solution', '(', 'bmes', ')', 'in', 'preference', 'to', '.', 'sodium', 'chloride', 'solution', '(', 'saline', ')', 'in', 'critically', 'ill', 'patient', 'reduces', 'risk', 'of', 'acute', 'kidney', 'injury', 'or', 'death', 'uncertain', '.', 'method', 'in', 'double-blind', ',', 'randomized', ',', 'controlled', 'trial', ',', 'assigned', 'critically', 'ill', 'patient', 'to', 'receive', 'bmes', '(', 'plasma-lyte', ')', 'or', 'saline', 'fluid', 'therapy', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'day', '.', 'primary', 'outcome', 'death', 'cause', 'within', 'day', 'randomization', '.', 'secondary', 'outcome', 'receipt', 'of', 'new', 'renal-replacement', 'therapy', 'and', 'maximum', 'increase', 'in', 'creatinine', 'level', 'icu', 'stay', '.', 'result', 'total', 'of', 'patient', 'recruited', 'icu', 'in', 'australia', 'and', 'new', 'zealand', '-', 'patient', 'assigned', 'to', 'bmes', 'group', 'and', 'to', 'saline', 'group', '.', 'death', 'within', 'day', 'randomization', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'bmes', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'saline', 'group', ',', 'difference', 'of', '-', '.', 'percentage', 'point', '(', 'confidence', 'interval', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'new', 'renal-replacement', 'therapy', 'initiated', 'in', 'of', 'patient', '(', '.', ')', 'in', 'bmes', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'saline', 'group', ',', 'difference', 'of', '-', '.', 'percentage', 'point', '(', 'ci', ',', '-', '.', 'to', '.', ')', '.', 'mean', '(', 'sd', ')', 'maximum', 'increase', 'in', 'serum', 'creatinine', 'level', '..', 'mg', 'per', 'deciliter', '(', '..', 'mol', 'per', 'liter', ')', 'in', 'bmes', 'group', 'and', '..', 'mg', 'per', 'deciliter', '(', '..', 'mol', 'per', 'liter', ')', 'in', 'saline', 'group', ',', 'difference', 'of', '.', 'mg', 'per', 'deciliter', '(', 'ci', ',', '-', '.', 'to', '.', ')', '(', '.', 'mol', 'per', 'liter', 'ci', ',', '-', '.', 'to', '.', ')', '.', 'number', 'of', 'adverse', 'and', 'serious', 'adverse', 'event', 'not', 'differ', 'meaningfully', 'group', '.', 'conclusion', 'found', 'no', 'evidence', 'risk', 'of', 'death', 'or', 'acute', 'kidney', 'injury', 'among', 'critically', 'ill', 'adult', 'in', 'icu', 'lower', 'with', 'use', 'of', 'bmes', 'with', 'saline', '.', '(', 'funded', 'national', 'health', 'and', 'medical', 'research', 'council', 'of', 'australia', 'and', 'health', 'research', 'council', 'of', 'new', 'zealand', 'plus', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
A Randomized Trial of Intravenous Amino Acids for Kidney Protection.,"Giovanni Landoni, Fabrizio Monaco, Lian Kah Ti, Martina Baiardo Redaelli, Nikola Bradic, Marco Comis, Yuki Kotani, Claudio Brambillasca, Eugenio Garofalo, Anna Mara Scandroglio, Cristina Viscido, Gianluca Paternoster, Annalisa Franco, Sabrina Porta, Federica Ferrod, Maria Grazia Calabrò, Antonio Pisano, Igor Vendramin, Gaia Barucco, Francesco Federici, Luca Severi, Alessandro Belletti, Andrea Cortegiani, Andrea Bruni, Carola Galbiati, Angelo Covino, Ekaterina Baryshnikova, Giuseppe Giardina, Maria Venditto, Daniel Kroeller, Cristina Nakhnoukh, Lorenzo Mantovani, Simona Silvetti, Margherita Licheri, Fabio Guarracino, Rosetta Lobreglio, Ambra Licia Di Prima, Stefano Fresilli, Rosa Labanca, Marta Mucchetti, Rosalba Lembo, Rosario Losiggio, Tiziana Bove, Marco Ranucci, Evgeny Fominskiy, Federico Longhini, Alberto Zangrillo, Rinaldo Bellomo                              ;, PROTECTION Study Group, Rinaldo Bellomo, Alessandra Bonaccorso, Aurora Campugiani, Martina Crivellari, Filippo D'Amico, Jacopo D'Andria Ursoleo, Giovanna Frau, Carolina Fustini, Stefano Lazzari, Gaetano Lombardi, Nicolò Maimeri, Marco Manazza, Cristiano Marchetti, Marilena Marmiere, Matteo Marzaroli, Edoardo Mongardini, Giacomo Monti, Francesco Giuseppe Nisi, Federico Mattia Oliva, Enrica Piazza, Gioia Piersanti, Domenico Pontillo, Alessandro Pruna, Erica Ronca, Tommaso Scquizzato, Stefano Turi, Marta Veneziano, Simone Vietri, Luisa Zaraca, Angela Corea, Lucia Lentini, Giuseppe Neri, Palma Ferrante, Erica Rurali, Cristina Arangino, Luca Salvi, Martina Anguissola, Vittoria Mazzotta, Maria Teresa Tucciariello, Francesca Gallicchio, Luigi Verniero, Diana di Fraja, Fabio Castro, Sara Scapol, Francesco Meroi, Monica Rocco, Lucia Mastrangelo, Maria Rosaria Re, Cesira Palmeri Di Villalba, Giuseppe Crescenzi, Antonello Rago, Elena Tenti, Francesca Rapetti, Giulia Brizzi, Kollengode Ramanathan, Yang Jinghui, Andrea Costamagna, Dorela Haxhiademi, Vincenzo Francesco Tripodi, Jasminka Persec, Zdenko Povšić-Čevra, Nazar Bukamal, Lei Chong, Giuseppe Biondi-Zoccai, Fabrizio D'Ascenzo, Enrico Romagnoli, Evgeny Alessandro Belletti, Nikola Bradić, Giovanni Landoniet al.",2024 Aug 22,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/38865168/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'serious', 'and', 'common', 'complication', 'of', 'cardiac', 'surgery', ',', 'reduced', 'kidney', 'perfusion', 'key', 'contributing', 'factor', '.', 'intravenous', 'amino', 'acid', 'increase', 'kidney', 'perfusion', 'and', 'recruit', 'renal', 'functional', 'reserve', '.', 'however', ',', 'efficacy', 'of', 'amino', 'acid', 'in', 'reducing', 'occurrence', 'of', 'aki', 'cardiac', 'surgery', 'uncertain', '.', 'method', 'in', 'multinational', ',', 'double-blind', 'trial', ',', 'randomly', 'assigned', 'adult', 'patient', 'scheduled', 'to', 'undergo', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'to', 'receive', 'intravenous', 'infusion', 'of', 'either', 'balanced', 'mixture', 'of', 'amino', 'acid', ',', 'dose', 'of', 'g', 'per', 'kilogram', 'of', 'ideal', 'body', 'weight', 'per', 'day', ',', 'or', 'placebo', '(', 'ringer', ""'s"", 'solution', ')', 'to', 'day', '.', 'primary', 'outcome', 'occurrence', 'of', 'aki', ',', 'defined', 'according', 'to', 'kidney', 'disease', 'improving', 'global', 'outcome', 'creatinine', 'criterion', '.', 'secondary', 'outcome', 'included', 'severity', 'of', 'aki', ',', 'use', 'and', 'duration', 'of', 'kidney-replacement', 'therapy', ',', 'and', 'all-cause', '-day', 'mortality', '.', 'result', 'recruited', 'patient', 'center', 'in', 'three', 'country', 'and', 'assigned', 'patient', 'to', 'amino', 'acid', 'group', 'and', 'to', 'placebo', 'group', '.', 'aki', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'amino', 'acid', 'group', 'and', 'in', '(', '.', ')', 'in', 'placebo', 'group', '(', 'relative', 'risk', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'stage', 'aki', 'occurred', 'in', 'patient', '(', '.', ')', 'and', 'patient', '(', '.', ')', ',', 'respectively', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'kidney-replacement', 'therapy', 'used', 'in', 'patient', '(', '.', ')', 'in', 'amino', 'acid', 'group', 'and', 'in', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '.', 'no', 'substantial', 'difference', 'two', 'group', 'in', 'secondary', 'outcome', 'or', 'in', 'adverse', 'event', '.', 'conclusion', 'among', 'adult', 'patient', 'undergoing', 'cardiac', 'surgery', ',', 'infusion', 'of', 'amino', 'acid', 'reduced', 'occurrence', 'of', 'aki', '.', '(', 'funded', 'italian', 'ministry', 'of', 'health', 'protection', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Multiple Electrolytes Solution Versus Saline as Bolus Fluid for Resuscitation in Pediatric Septic Shock: A Multicenter Randomized Clinical Trial.,"Jhuma Sankar, Jayashree Muralidharan, A V Lalitha, Ramachandran Rameshkumar, Mona Pathak, Rashmi Ranjan Das, Vinay M Nadkarni, Javed Ismail, Mahadevan Subramanian, Karthi Nallasamy, Nishanth Dev, U Vijay Kumar, Kiran Kumar, Taniya Sharma, Kanika Jaravta, Neha Thakur, Praveen Aggarwal, Kana Ram Jat, S K Kabra, Rakesh Lodha, Jhuma Sankaret al.",2023 Nov 1,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/37294145/,No keywords found,"['to', 'determine', 'initial', 'fluid', 'resuscitation', 'with', 'balanced', 'crystalloid', '(', 'e.g.', ',', 'multiple', 'electrolyte', 'solution', 'me', ')', 'or', '.', 'saline', 'adversely', 'affect', 'kidney', 'function', 'in', 'child', 'with', 'septic', 'shock', '.', 'design', 'parallel-group', ',', 'blinded', 'multicenter', 'trial', '.', 'setting', 'picus', 'of', 'four', 'tertiary', 'care', 'center', 'in', 'india', 'to', '.', 'patient', 'child', 'to', 'year', 'of', 'age', 'with', 'septic', 'shock', '.', 'method', 'child', 'randomized', 'to', 'receive', 'fluid', 'bolus', 'of', 'either', 'me', '(', 'plasmalyte', ')', 'or', '.', 'saline', 'time', 'of', 'identification', 'of', 'shock', '.', 'child', 'managed', 'per', 'standard', 'protocol', 'and', 'monitored', 'dischargedeath', '.', 'primary', 'outcome', 'new', 'andor', 'progressive', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'time', 'within', 'first', 'day', 'of', 'fluid', 'resuscitation', '.', 'key', 'secondary', 'outcome', 'included', 'hyperchloremia', ',', 'adverse', 'event', '(', 'ae', ')', ',', ',', ',', 'and', 'hour', ',', 'and', 'all-cause', 'icu', 'mortality', '.', 'intervention', 'me', 'solution', '(', 'n', ')', 'versus', '.', 'saline', '(', 'n', ')', 'bolus', 'fluid', 'resuscitation', 'first', 'day', '.', 'measurement', 'and', 'main', 'result', 'median', 'age', 'year', '(', 'interquartile', 'range', ',', '.-', ')', '(', ')', 'girl', '.', 'relative', 'risk', '(', 'rr', ')', 'meeting', 'criterion', 'new', 'andor', 'progressive', 'aki', '.', '(', 'ci', ',', '.-', '.', 'p', '.', ')', ',', 'favoring', 'me', '(', ')', 'versus', 'saline', '(', ')', 'group', '.', 'proportion', 'of', 'child', 'with', 'hyperchloremia', 'lower', 'in', 'me', 'versus', 'saline', 'group', ',', ',', 'and', 'hour', '.', 'no', 'difference', 'in', 'icu', 'mortality', '(', 'in', 'me', 'v', 'in', 'saline', 'group', ')', '.', 'no', 'difference', 'with', 'regard', 'to', 'infusion-related', 'aes', 'fever', ',', 'thrombophlebitis', ',', 'or', 'fluid', 'overload', 'group', '.', 'conclusion', 'among', 'child', 'presenting', 'with', 'septic', 'shock', ',', 'fluid', 'resuscitation', 'with', 'me', '(', 'balanced', 'crystalloid', ')', 'compared', 'with', '.', 'saline', 'resulted', 'in', 'significantly', 'lower', 'incidence', 'of', 'new', 'andor', 'progressive', 'aki', 'first', 'day', 'of', 'hospitalization', '.']"
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA.,"Giovanni Palladini, Efstathios Kastritis, Mathew S Maurer, Jeffrey Zonder, Monique C Minnema, Ashutosh D Wechalekar, Arnaud Jaccard, Hans C Lee, Naresh Bumma, Jonathan L Kaufman, Eva Medvedova, Tibor Kovacsovics, Michael Rosenzweig, Vaishali Sanchorawala, Xiang Qin, Sandra Y Vasey, Brendan M Weiss, Jessica Vermeulen, Giampaolo Merlini, Raymond L Comenzo, Giovanni Palladiniet al.",2020 Jul 2,Blood,https://pubmed.ncbi.nlm.nih.gov/32244252/,No keywords found,"['although', 'no', 'therapy', 'approved', 'light', 'chain', '(', 'al', ')', 'amyloidosis', ',', 'cyclophosphamide', ',', 'bortezomib', ',', 'and', 'dexamethasone', '(', 'cybord', ')', 'considered', 'standard', 'of', 'care', '.', 'based', 'outcome', 'of', 'daratumumab', 'in', 'multiple', 'myeloma', '(', 'mm', ')', ',', 'phase', 'andromeda', 'study', '(', 'nct', ')', 'evaluating', 'daratumumab-cybord', 'v', 'cybord', 'in', 'newly', 'diagnosed', 'al', 'amyloidosis', '.', 'report', 'result', 'of', '-patient', 'safety', 'run-in', '.', 'patient', 'received', 'subcutaneous', 'daratumumab', '(', 'dara', 'sc', ')', 'weekly', 'in', 'cycle', 'to', ',', 'every', 'week', 'in', 'cycle', 'to', ',', 'and', 'every', 'week', 'thereafter', 'to', 'year', '.', 'cybord', 'given', 'weekly', 'cycle', '.', 'patient', 'median', 'of', 'involved', 'organ', '(', 'kidney', ',', 'cardiac', ',', ')', '.', 'patient', 'received', 'median', 'of', '(', 'range', ',', '-', ')', 'treatment', 'cycle', '.', 'treatment-emergent', 'adverse', 'event', 'consistent', 'with', 'dara', 'sc', 'in', 'mm', 'and', 'cybord', '.', 'infusion-related', 'reaction', 'occurred', 'in', 'patient', '(', 'grade', ')', '.', 'no', 'grade', 'treatment-emergent', 'adverse', 'event', 'occurred', 'patient', 'died', ',', 'including', 'transplant', '.', 'overall', 'hematologic', 'response', 'rate', ',', 'with', 'complete', 'hematologic', 'response', 'in', '(', ')', 'patient', 'least', 'partial', 'response', 'occurred', 'in', ',', ',', 'and', 'patient', ',', ',', 'and', 'month', ',', 'respectively', '.', 'renal', 'response', 'occurred', 'in', 'of', ',', 'of', ',', 'and', 'of', 'patient', ',', 'and', 'cardiac', 'response', 'occurred', 'in', 'of', ',', 'of', ',', 'and', 'of', 'patient', ',', ',', 'and', 'month', ',', 'respectively', '.', 'hepatic', 'response', 'occurred', 'in', 'of', 'patient', 'month', '.', 'daratumumab-cybord', 'well', 'tolerated', ',', 'with', 'no', 'new', 'safety', 'concern', 'versus', 'intravenous', 'formulation', ',', 'and', 'demonstrated', 'robust', 'hematologic', 'and', 'organ', 'response', '.', 'trial', 'registered', 'www.clinicaltrials.gov', 'nct', '.']"
Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery.,"Paul S Myles, Rinaldo Bellomo, Tomas Corcoran, Andrew Forbes, Philip Peyton, David Story, Chris Christophi, Kate Leslie, Shay McGuinness, Rachael Parke, Jonathan Serpell, Matthew T V Chan, Thomas Painter, Stuart McCluskey, Gary Minto, Sophie Wallace                              ;, Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group, M Mythen, R Gruen, J McNeil, G Ludbrook, K Lee, A Meehan, D McIlroy, M Shulman, D J Cooper, C Farrington, A Ditoro, W Galagher, M Pollock, A Neylan, S Sidiropoulos, S Baulch, A Carter, S Jacups, J L Reynolds, J Rowley, A J Neal, E J Bendall, J R Sutherland, R Bulach, A Wang, N L T Tan, C Osborne, A Marriott, K Ives, B Wakefield, A Quail, J Douglas, I Boden, D Blackford, A Chuan, I Seppelt, A Wu, B Rodriguez, L Siu, R Robinson, L Bulfin, A A Beck, V Wilkinson, B Riedel, A Melville, U Gurunathan, M Bennett, A Duggan, P Sivalingam, B Moser, T Bott, S Sawhney, M Duroux, M Chapman, J Moore, S Lang, J Hayer, R Koronis, N Terblanche, D Cooper, R Turner, R Seale, M Challis, K Gard, R Cotter, T D Phan, P Corcoran, Y Uda, V Nguyen, D Bramley, A M Southcott, J Grant, H Taylor, S Bates, M Towns, A Tippett, F Marshall, J van Vlymen, M Jaeger, D DuMerton Shore, H Sato, T Sato, V Chan, R Jin, N Ayach, M T V Chan, P W Y Chiu, W W K Wu, M Tsang, G Landoni, R Lembo, F Pugh, D McAllister, P Dalley, S Reddy, E Ridgeon, S Hurford, L Navarra, R Sol Cruz, S Harwood, A Patrick, A Pai, A Kaliappan, M Vertue, J Sonksen, R Gidda, A Chishti, C Scott, S Jakkampudi, P Watt, Z Milan, S Birch, G Kunst, D Martin, S James, M Pinto, R C F Sinclair, A Addei, S Cope, H Melsom, L Duncan, A Kurz, D Sessler, S Miller, M Brawley, K O Pryor, S C Marcott, L A Pharmer, Paul S Myleset al.",2018 Jun 14,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/29742967/,No keywords found,"['guideline', 'to', 'promote', 'early', 'recovery', 'of', 'patient', 'undergoing', 'major', 'surgery', 'recommend', 'restrictive', 'intravenous-fluid', 'strategy', 'abdominal', 'surgery', '.', 'however', ',', 'supporting', 'evidence', 'limited', ',', 'and', 'concern', 'impaired', 'organ', 'perfusion', '.', 'method', 'in', 'pragmatic', ',', 'international', 'trial', ',', 'randomly', 'assigned', 'patient', 'increased', 'risk', 'of', 'complication', 'undergoing', 'major', 'abdominal', 'surgery', 'to', 'receive', 'restrictive', 'or', 'liberal', 'intravenous-fluid', 'regimen', 'and', 'to', 'hour', 'surgery', '.', 'primary', 'outcome', 'disability-free', 'survival', 'year', '.', 'key', 'secondary', 'outcome', 'acute', 'kidney', 'injury', 'day', ',', 'renal-replacement', 'therapy', 'day', ',', 'and', 'composite', 'of', 'septic', 'complication', ',', 'surgical-site', 'infection', ',', 'or', 'death', '.', 'result', 'and', 'to', 'hour', 'surgery', ',', 'patient', 'in', 'restrictive', 'fluid', 'group', 'median', 'intravenous-fluid', 'intake', 'of', '.', 'liter', '(', 'interquartile', 'range', ',', '.', 'to', '.', ')', ',', 'compared', 'with', '.', 'liter', '(', 'interquartile', 'range', ',', '.', 'to', '.', ')', 'in', 'patient', 'in', 'liberal', 'fluid', 'group', '(', 'p.', ')', '.', 'rate', 'of', 'disability-free', 'survival', 'year', '.', 'in', 'restrictive', 'fluid', 'group', 'and', '.', 'in', 'liberal', 'fluid', 'group', '(', 'hazard', 'ratio', 'death', 'or', 'disability', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', 'p.', ')', '.', 'rate', 'of', 'acute', 'kidney', 'injury', '.', 'in', 'restrictive', 'fluid', 'group', 'and', '.', 'in', 'liberal', 'fluid', 'group', '(', 'p.', ')', '.', 'rate', 'of', 'septic', 'complication', 'or', 'death', '.', 'in', 'restrictive', 'fluid', 'group', 'and', '.', 'in', 'liberal', 'fluid', 'group', '(', 'p.', ')', 'rate', 'of', 'surgical-site', 'infection', '(', '.', 'v', '.', '.', ',', 'p.', ')', 'and', 'renal-replacement', 'therapy', '(', '.', 'v', '.', '.', ',', 'p.', ')', 'higher', 'in', 'restrictive', 'fluid', 'group', ',', 'between-group', 'difference', 'not', 'significant', 'adjustment', 'multiple', 'testing', '.', 'conclusion', 'among', 'patient', 'increased', 'risk', 'complication', 'major', 'abdominal', 'surgery', ',', 'restrictive', 'fluid', 'regimen', 'not', 'associated', 'with', 'higher', 'rate', 'of', 'disability-free', 'survival', 'liberal', 'fluid', 'regimen', 'and', 'associated', 'with', 'higher', 'rate', 'of', 'acute', 'kidney', 'injury', '.', '(', 'funded', 'australian', 'national', 'health', 'and', 'medical', 'research', 'council', 'and', 'others', 'relief', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.","Steven Y C Tong, David C Lye, Dafna Yahav, Archana Sud, J Owen Robinson, Jane Nelson, Sophia Archuleta, Matthew A Roberts, Alan Cass, David L Paterson, Hong Foo, Mical Paul, Stephen D Guy, Adrian R Tramontana, Genevieve B Walls, Stephen McBride, Narin Bak, Niladri Ghosh, Benjamin A Rogers, Anna P Ralph, Jane Davies, Patricia E Ferguson, Ravindra Dotel, Genevieve L McKew, Timothy J Gray, Natasha E Holmes, Simon Smith, Morgyn S Warner, Shirin Kalimuddin, Barnaby E Young, Naomi Runnegar, David N Andresen, Nicholas A Anagnostou, Sandra A Johnson, Mark D Chatfield, Allen C Cheng, Vance G Fowler Jr, Benjamin P Howden, Niamh Meagher, David J Price, Sebastiaan J van Hal, Matthew V N O'Sullivan, Joshua S Davis                                                            ;, Australasian Society for Infectious Diseases Clinical Research Network, Steven Y C Tonget al.",2020 Feb 11,JAMA,https://pubmed.ncbi.nlm.nih.gov/32044943/,No keywords found,"['methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', 'bacteremia', 'associated', 'with', 'mortality', 'of', '.', 'combining', 'standard', 'therapy', 'with', '-lactam', 'antibiotic', 'associated', 'with', 'reduced', 'mortality', ',', 'although', 'adequately', 'powered', 'randomized', 'clinical', 'trial', 'of', 'intervention', 'not', 'conducted', '.', 'objective', 'to', 'determine', 'whether', 'combining', 'antistaphylococcal', '-lactam', 'with', 'standard', 'therapy', 'effective', 'standard', 'therapy', 'alone', 'in', 'patient', 'with', 'mrsa', 'bacteremia', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'open-label', ',', 'randomized', 'clinical', 'trial', 'conducted', 'hospital', 'site', 'in', 'country', 'august', 'to', 'july', 'among', 'hospitalized', 'adult', 'with', 'mrsa', 'bacteremia', '.', 'follow-up', 'complete', 'october', ',', '.', 'intervention', 'participant', 'randomized', 'to', 'standard', 'therapy', '(', 'intravenous', 'vancomycin', 'or', 'daptomycin', ')', 'plus', 'antistaphylococcal', '-lactam', '(', 'intravenous', 'flucloxacillin', ',', 'cloxacillin', ',', 'or', 'cefazolin', ')', '(', 'n', ')', 'or', 'standard', 'therapy', 'alone', '(', 'n', ')', '.', 'total', 'duration', 'of', 'therapy', 'determined', 'treating', 'clinician', 'and', '-lactam', 'administered', 'day', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', '-day', 'composite', 'of', 'mortality', ',', 'persistent', 'bacteremia', 'day', ',', 'microbiological', 'relapse', ',', 'and', 'microbiological', 'treatment', 'failure', '.', 'secondary', 'outcome', 'included', 'mortality', 'day', ',', ',', 'and', 'persistent', 'bacteremia', 'day', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'microbiological', 'relapse', 'microbiological', 'treatment', 'failure', 'and', 'duration', 'of', 'intravenous', 'antibiotic', '.', 'result', 'data', 'and', 'safety', 'monitoring', 'board', 'recommended', 'early', 'termination', 'of', 'study', 'prior', 'to', 'enrollment', 'of', 'patient', 'of', 'safety', '.', 'among', 'patient', 'randomized', '(', 'mean', 'age', ',', '.', 'sd', ',', '.', 'year', 'woman', '.', ')', ',', '(', ')', 'completed', 'trial', '.', 'primary', 'end', 'point', 'met', '(', ')', 'with', 'combination', 'therapy', 'and', '(', ')', 'with', 'standard', 'therapy', '(', 'absolute', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', ')', '.', 'seven', 'of', 'prespecified', 'secondary', 'end', 'point', 'showed', 'no', 'significant', 'difference', '.', 'combination', 'therapy', 'v', 'standard', 'therapy', 'group', ',', 'all-cause', '-day', 'mortality', 'occurred', 'in', '(', ')', 'v', '(', ')', '(', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', ')', 'persistent', 'bacteremia', 'day', 'observed', 'in', 'of', '(', ')', 'v', 'of', '(', ')', '(', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', ')', 'and', ',', 'excluding', 'patient', 'receiving', 'dialysis', 'baseline', ',', 'aki', 'occurred', 'in', 'of', '(', ')', 'v', 'of', '(', ')', '(', 'difference', ',', '.', 'ci', ',', '.-.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'with', 'mrsa', 'bacteremia', ',', 'addition', 'of', 'antistaphylococcal', '-lactam', 'to', 'standard', 'antibiotic', 'therapy', 'with', 'vancomycin', 'or', 'daptomycin', 'not', 'result', 'in', 'significant', 'improvement', 'in', 'primary', 'composite', 'end', 'point', 'of', 'mortality', ',', 'persistent', 'bacteremia', ',', 'relapse', ',', 'or', 'treatment', 'failure', '.', 'early', 'trial', 'termination', 'safety', 'concern', 'and', 'possibility', 'study', 'underpowered', 'to', 'detect', 'clinically', 'important', 'difference', 'in', 'favor', 'of', 'intervention', 'considered', 'interpreting', 'finding', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
"Thiamine for Renal Protection in Septic Shock (TRPSS): A Randomized, Placebo-controlled, Clinical Trial.","Ari Moskowitz, Katherine M Berg, Anne V Grossestreuer, Lakshman Balaji, Xiaowen Liu, Michael N Cocchi, Maureen Chase, Michelle Ng Gong, Jonathan Gong, Samir M Parikh, Long Ngo, Noa Berlin, Michael W Donnino, Ari Moskowitzet al.",2023 Sep 1,Am J Respir Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/37364280/,"kidney injury, sepsis, shock, thiamine.","['kidney', 'injury', 'common', 'and', 'associated', 'with', 'worse', 'outcome', 'in', 'patient', 'with', 'septic', 'shock', '.', 'mitochondrial', 'resuscitation', 'with', 'thiamine', '(', 'vitamin', 'b', ')', 'may', 'attenuate', 'septic', 'kidney', 'injury', '.', 'objective', 'to', 'assess', 'whether', 'thiamine', 'supplementation', 'attenuates', 'kidney', 'injury', 'in', 'septic', 'shock', '.', 'method', 'trpss', '(', 'thiamine', 'renal', 'protection', 'in', 'septic', 'shock', ')', 'trial', 'multicenter', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'of', 'thiamine', 'versus', 'placebo', 'in', 'septic', 'shock', '.', 'primary', 'outcome', 'change', 'in', 'serum', 'creatinine', 'enrollment', 'and', 'hour', 'enrollment', '.', 'measurement', 'and', 'main', 'result', 'eighty-eight', 'patient', 'enrolled', '(', 'patient', 'received', 'intervention', ',', 'and', 'received', 'placebo', ')', '.', 'no', 'significant', 'between-groups', 'difference', 'in', 'creatinine', 'hour', '(', 'mean', 'difference', ',', '-', '.', 'mgdl', 'confidence', 'interval', ',', '-.', ',', '.', 'p', '.', ')', '.', 'no', 'difference', 'in', 'receipt', 'of', 'kidney', 'replacement', 'therapy', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', ',', 'acute', 'kidney', 'injury', '(', 'defined', 'stage', 'of', 'kidney', 'disease', 'improving', 'global', 'outcome', 'acute', 'kidney', 'injury', 'scale', '.', 'v', '.', '.', ',', 'p', '.', ')', ',', 'or', 'mortality', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', 'thiamine', 'and', 'placebo', 'group', '.', 'patient', 'received', 'thiamine', 'icu-free', 'day', '(', 'median', 'interquartile', 'range', '.', '.-', '.', 'vs.', '.', '.-.', ',', 'p', '.', ')', '.', 'in', 'thiamine-deficient', 'cohort', '(', '.', 'of', 'patient', ')', ',', 'no', 'difference', 'in', 'rate', 'of', 'kidney', 'failure', '(', '.', 'thiamine', 'vs.', '.', 'placebo', ')', 'or', 'in-hospital', 'mortality', '(', '.', 'v', '.', '.', ')', 'group', '.', 'conclusion', 'in', 'trpss', 'trial', ',', 'no', 'statistically', 'significant', 'difference', 'in', 'primary', 'outcome', 'of', 'change', 'in', 'creatinine', 'time', '.', 'patient', 'received', 'thiamine', 'icu-free', 'day', ',', 'no', 'difference', 'in', 'secondary', 'outcome', '.', 'clinical', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', '(', 'nct', ')', '.']"
Balanced Crystalloids versus Saline in Noncritically Ill Adults.,"Wesley H Self, Matthew W Semler, Jonathan P Wanderer, Li Wang, Daniel W Byrne, Sean P Collins, Corey M Slovis, Christopher J Lindsell, Jesse M Ehrenfeld, Edward D Siew, Andrew D Shaw, Gordon R Bernard, Todd W Rice                              ;, SALT-ED Investigators, I D Jones, S Russ, R M Brown, H J Domenico, L Atchison, M Felbinger, J L Stollings, M Knostman, Wesley H Selfet al.",2018 Mar 1,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/29485926/,No keywords found,"['comparative', 'clinical', 'effect', 'of', 'balanced', 'crystalloids', 'and', 'saline', 'uncertain', ',', 'particularly', 'in', 'noncritically', 'ill', 'patient', 'cared', 'outside', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'method', 'conducted', 'single-center', ',', 'pragmatic', ',', 'multiple-crossover', 'trial', 'comparing', 'balanced', 'crystalloids', '(', 'lactated', 'ringer', ""'s"", 'solution', 'or', 'plasma-lyte', ')', 'with', 'saline', 'among', 'adult', 'treated', 'with', 'intravenous', 'crystalloids', 'in', 'emergency', 'department', 'and', 'subsequently', 'hospitalized', 'outside', 'icu', '.', 'type', 'of', 'crystalloid', 'administered', 'in', 'emergency', 'department', 'assigned', 'to', 'patient', 'basis', 'of', 'calendar', 'month', ',', 'with', 'entire', 'emergency', 'department', 'crossing', 'balanced', 'crystalloids', 'and', 'saline', 'monthly', '-month', 'trial', '.', 'primary', 'outcome', 'hospital-free', 'day', '(', 'day', 'alive', 'discharge', 'day', ')', '.', 'secondary', 'outcome', 'included', 'major', 'adverse', 'kidney', 'event', 'within', 'day', '-', 'composite', 'of', 'death', 'cause', ',', 'new', 'renal-replacement', 'therapy', ',', 'or', 'persistent', 'renal', 'dysfunction', '(', 'defined', 'elevation', 'of', 'creatinine', 'level', 'to', 'of', 'baseline', ')', '-', 'censored', 'hospital', 'discharge', 'or', 'day', ',', 'whichever', 'occurred', 'first', '.', 'result', 'total', 'of', ',', 'patient', 'enrolled', ',', 'with', 'median', 'crystalloid', 'volume', 'administered', 'in', 'emergency', 'department', 'of', 'ml', 'and', '.', 'of', 'patient', 'exclusively', 'receiving', 'assigned', 'crystalloid', '.', 'number', 'of', 'hospital-free', 'day', 'not', 'differ', 'balanced-crystalloids', 'and', 'saline', 'group', '(', 'median', ',', 'day', 'in', 'group', 'adjusted', 'odds', 'ratio', 'with', 'balanced', 'crystalloids', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'balanced', 'crystalloids', 'resulted', 'in', 'lower', 'incidence', 'of', 'major', 'adverse', 'kidney', 'event', 'within', 'day', 'saline', '(', '.', 'vs.', '.', 'adjusted', 'odds', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'conclusion', 'among', 'noncritically', 'ill', 'adult', 'treated', 'with', 'intravenous', 'fluid', 'in', 'emergency', 'department', ',', 'no', 'difference', 'in', 'hospital-free', 'day', 'treatment', 'with', 'balanced', 'crystalloids', 'and', 'treatment', 'with', 'saline', '.', '(', 'funded', 'vanderbilt', 'institute', 'clinical', 'and', 'translational', 'research', 'and', 'others', 'salt-ed', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.","Kohei Shitara, Sun Young Rha, Lucjan S Wyrwicz, Takashi Oshima, Nina Karaseva, Mikhail Osipov, Hisateru Yasui, Hiroshi Yabusaki, Sergey Afanasyev, Young-Kyu Park, Salah-Eddin Al-Batran, Takaki Yoshikawa, Patricio Yanez, Maria Dib Bartolomeo, Sara Lonardi, Josep Tabernero, Eric Van Cutsem, Yelena Y Janjigian, Do-Youn Oh, Jianming Xu, Xiao Fang, Chie-Schin Shih, Pooja Bhagia, Yung-Jue Bang                              ;, KEYNOTE- investigators, Kohei Shitaraet al.",2024 Feb,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/38134948/,No keywords found,"['benefit', 'of', 'combination', 'neoadjuvant', 'and', 'adjuvant', 'chemotherapy', 'and', 'immune', 'checkpoint', 'inhibition', 'in', 'patient', 'with', 'locally', 'advanced', ',', 'resectable', 'gastric', 'or', 'gastro-oesophageal', 'adenocarcinoma', 'unknown', '.', 'assess', 'antitumor', 'activity', 'of', 'neoadjuvant', 'and', 'adjuvant', 'pembrolizumab', 'plus', 'chemotherapy', 'in', 'patient', 'with', 'locally', 'advanced', 'resectable', 'gastric', 'or', 'gastro-oesophageal', 'adenocarcinoma', '.', 'method', 'keynote-', 'study', 'multicentre', ',', 'randomised', ',', 'placebo-controlled', ',', 'double-blind', ',', 'phase', 'study', 'done', 'medical', 'centre', 'in', 'country', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', 'with', 'untreated', ',', 'locally', 'advanced', ',', 'resectable', 'gastric', 'or', 'gastro-oesophageal', 'adenocarcinoma', ',', 'and', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', '-', '.', 'patient', 'randomly', 'assigned', '(', ')', 'interactive', 'voice', 'response', 'system', 'and', 'integrated', 'web', 'response', 'system', 'to', 'neoadjuvant', 'pembrolizumab', 'mg', 'intravenously', 'or', 'placebo', '(', 'saline', ')', 'plus', 'cisplatin-based', 'doublet', 'chemotherapy', '(', 'main', 'cohort', ')', 'every', 'week', 'cycle', ',', 'followed', 'surgery', ',', 'adjuvant', 'pembrolizumab', 'or', 'placebo', 'plus', 'chemotherapy', 'cycle', ',', 'adjuvant', 'pembrolizumab', 'or', 'placebo', 'cycle', '.', 'small', 'cohort', 'also', 'randomly', 'assigned', '(', ')', 'to', 'pembrolizumab', 'or', 'placebo', 'plus', 'fluorouracil', ',', 'docetaxel', ',', 'and', 'oxaliplatin', '(', 'flot', ')', '-based', 'chemotherapy', '(', 'flot', 'cohort', ')', 'every', 'week', 'four', 'cycle', ',', 'followed', 'surgery', ',', 'adjuvant', 'pembrolizumab', ',', 'or', 'placebo', 'plus', 'flot', 'four', 'cycle', ',', 'adjuvant', 'pembrolizumab', 'or', 'placebo', 'cycle', '.', 'patient', 'stratified', 'geographic', 'region', ',', 'tumour', 'stage', ',', 'and', 'chemotherapy', 'backbone', '.', 'primary', 'endpoint', 'pathological', 'complete', 'response', '(', 'reviewed', 'centrally', ')', ',', 'event-free', 'survival', '(', 'reviewed', 'investigator', ')', ',', 'and', 'overall', 'survival', 'in', 'intention-to-treat', 'population', ',', 'and', 'safety', 'assessed', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '.', 'study', 'registered', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'closed', 'to', 'accrual', '.', 'finding', 'oct', ',', ',', 'and', 'jan', ',', ',', 'of', 'patient', 'screened', ',', 'randomly', 'assigned', 'to', 'main', 'cohort', ',', 'of', 'assigned', 'to', 'pembrolizumab', 'plus', 'cisplatin-based', 'chemotherapy', 'group', 'and', 'to', 'placebo', 'plus', 'cisplatin-based', 'chemotherapy', 'group', ',', 'and', 'to', 'flot', 'cohort', ',', 'of', 'assigned', 'to', 'pembrolizumab', 'plus', 'flot', 'group', 'and', 'to', 'placebo', 'plus', 'flot', 'group', '.', 'in', 'main', 'cohort', 'of', 'participant', ',', '(', ')', 'male', 'and', '(', ')', 'female', '.', 'in', 'main', 'cohort', ',', 'median', 'follow-up', 'of', 'month', '(', 'iqr', '-', ')', ',', 'pembrolizumab', 'superior', 'to', 'placebo', 'pathological', 'complete', 'response', '(', 'ci', '-', 'of', 'v', 'eight', '-', 'of', 'difference', ',', 'ci', 'to', 'p', ')', '.', 'median', 'event-free', 'survival', 'longer', 'with', 'pembrolizumab', 'versus', 'placebo', '(', 'month', ',', 'ci', 'to', 'not', 'reached', 'v', 'month', ',', 'to', 'hazard', 'ratio', 'hr', ',', 'ci', 'to', 'p', ')', 'not', 'meet', 'threshold', 'statistical', 'significance', '(', 'p', ')', '.', 'median', 'overall', 'survival', 'month', '(', 'ci', 'to', 'not', 'reached', ')', 'in', 'pembrolizumab', 'group', 'versus', 'month', '(', 'to', 'not', 'reached', ')', 'in', 'placebo', 'group', '(', 'hr', ',', 'ci', 'to', 'p', ')', '.', 'grade', 'or', 'worse', 'adverse', 'event', 'of', 'cause', 'occurred', 'in', '(', ')', 'of', 'patient', 'in', 'pembrolizumab', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'placebo', 'group', 'common', 'nausea', '(', 'v', ')', ',', 'anaemia', '(', 'v', ')', ',', 'and', 'decreased', 'appetite', '(', 'v', ')', '.', 'treatment-related', 'serious', 'adverse', 'event', 'reported', 'in', '(', ')', 'and', '(', ')', 'patient', '.', 'treatment-related', 'adverse', 'event', 'led', 'to', 'death', 'occurred', 'in', 'four', '(', ')', 'patient', 'in', 'pembrolizumab', 'group', '(', 'interstitial', 'ischaemia', ',', 'pneumonia', ',', 'decreased', 'appetite', ',', 'and', 'acute', 'kidney', 'injury', 'n', ')', 'and', 'two', '(', ')', 'patient', 'in', 'placebo', 'group', '(', 'neutropenic', 'sepsis', 'and', 'neutropenic', 'colitis', 'n', ')', '.', 'interpretation', 'although', 'neoadjuvant', 'and', 'adjuvant', 'pembrolizumab', 'versus', 'placebo', 'improved', 'pathological', 'complete', 'response', ',', 'not', 'translate', 'to', 'significant', 'improvement', 'in', 'event-free', 'survival', 'in', 'patient', 'with', 'untreated', ',', 'locally', 'advanced', 'resectable', 'gastric', 'or', 'gastro-oesophageal', 'cancer', '.', 'funding', 'merck', 'sharp', 'dohme', '.']"
"Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial.","Evan Y Yu, Daniel P Petrylak, Peter H O'Donnell, Jae-Lyun Lee, Michiel S van der Heijden, Yohann Loriot, Mark N Stein, Andrea Necchi, Takahiro Kojima, Michael R Harrison, Se Hoon Park, David I Quinn, Elisabeth I Heath, Jonathan E Rosenberg, Joyce Steinberg, Shang-Ying Liang, Janet Trowbridge, Mary Campbell, Bradley McGregor, Arjun V Balar, Evan Y Yuet al.",2021 Jun,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/33991512/,No keywords found,"['locally', 'advanced', 'or', 'metastatic', 'urothelial', 'carcinoma', 'generally', 'incurable', 'and', 'scarce', 'treatment', 'option', ',', 'especially', 'cisplatin-ineligible', 'patient', 'previously', 'treated', 'with', 'pd-', 'or', 'pd-l', 'therapy', '.', 'enfortumab', 'vedotin', 'antibody-drug', 'conjugate', 'directed', 'nectin-', ',', 'protein', 'highly', 'expressed', 'in', 'urothelial', 'carcinoma', '.', 'aimed', 'to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'enfortumab', 'vedotin', 'in', 'post-immunotherapy', 'setting', 'in', 'cisplatin-ineligible', 'patient', '.', 'method', 'ev-', 'multicentre', ',', 'single-arm', ',', 'phase', 'study', 'of', 'enfortumab', 'vedotin', 'in', 'patient', 'with', 'locally', 'advanced', 'or', 'metastatic', 'urothelial', 'carcinoma', 'previously', 'treated', 'with', 'pd-', 'or', 'pd-l', 'inhibitor', '.', 'cohort', 'included', 'adult', '(', 'aged', 'year', ')', 'with', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'score', 'of', 'or', 'less', 'considered', 'ineligible', 'cisplatin', 'enrolment', 'and', 'not', 'received', 'platinum-containing', 'chemotherapy', 'in', 'locally', 'advanced', 'or', 'metastatic', 'setting', '.', 'enfortumab', 'vedotin', 'given', 'intravenously', 'dose', 'of', 'mgkg', 'day', ',', ',', 'and', 'of', 'every', '-day', 'cycle', '.', 'primary', 'endpoint', 'confirmed', 'objective', 'response', 'rate', 'per', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumour', 'version', '.', 'assessed', 'blinded', 'independent', 'central', 'review', '.', 'efficacy', 'and', 'safety', 'analysed', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'enfortumab', 'vedotin', '.', 'ev-', 'ongoing', 'study', 'and', 'primary', 'analysis', 'complete', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'oct', ',', ',', 'and', 'feb', ',', ',', 'patient', 'enrolled', 'site', 'globally', ',', 'of', 'received', 'treatment', '.', 'median', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', 'data', 'cutoff', '(', 'sept', ',', ')', ',', 'confirmed', 'objective', 'response', 'rate', '(', 'of', 'patient', 'ci', '-', ')', ',', 'with', '(', ')', 'of', 'patient', 'achieving', 'complete', 'response', 'and', '(', ')', 'achieving', 'partial', 'response', '.', '(', ')', 'of', 'patient', 'grade', 'or', 'worse', 'treatment-related', 'adverse', 'event', '.', 'common', 'grade', 'or', 'treatment-related', 'adverse', 'event', 'neutropenia', '(', 'eight', 'patient', ')', ',', 'maculopapular', 'rash', '(', 'seven', 'patient', ')', ',', 'and', 'fatigue', '(', 'six', 'patient', ')', '.', 'treatment-related', 'serious', 'adverse', 'event', 'occurred', 'in', '(', ')', 'patient', '.', 'three', '(', ')', 'patient', 'died', 'due', 'to', 'acute', 'kidney', 'injury', ',', 'metabolic', 'acidosis', ',', 'and', 'multiple', 'organ', 'dysfunction', 'syndrome', '(', 'one', ')', 'within', 'day', 'of', 'first', 'dose', 'and', 'death', 'considered', 'investigator', 'to', 'related', 'to', 'treatment', 'fourth', 'death', 'pneumonitis', 'occurred', 'day', 'last', 'dose', 'and', 'also', 'considered', 'to', 'related', 'to', 'treatment', '.', 'interpretation', 'treatment', 'with', 'enfortumab', 'vedotin', 'tolerable', 'and', 'confirmed', 'response', 'seen', 'in', 'of', 'cisplatin-ineligible', 'patient', 'with', 'locally', 'advanced', 'or', 'metastatic', 'urothelial', 'carcinoma', 'previously', 'treated', 'with', 'pd-', 'or', 'pd-l', 'inhibitor', '.', 'patient', 'treatment', 'option', ',', 'and', 'enfortumab', 'vedotin', 'could', 'promising', 'new', 'therapy', 'patient', 'population', 'with', 'high', 'unmet', 'need', '.', 'funding', 'astellas', 'pharma', 'global', 'development', 'and', 'seagen', '.']"
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.,"Steven D Weisbord, Martin Gallagher, Hani Jneid, Santiago Garcia, Alan Cass, Soe-Soe Thwin, Todd A Conner, Glenn M Chertow, Deepak L Bhatt, Kendrick Shunk, Chirag R Parikh, Edward O McFalls, Mary Brophy, Ryan Ferguson, Hongsheng Wu, Maria Androsenko, John Myles, James Kaufman, Paul M Palevsky                              ;, PRESERVE Trial Group, Steven D Weisbordet al.",2018 Feb 15,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/29130810/,No keywords found,"['intravenous', 'sodium', 'bicarbonate', 'and', 'oral', 'acetylcysteine', 'widely', 'used', 'to', 'prevent', 'acute', 'kidney', 'injury', 'and', 'associated', 'adverse', 'outcome', 'angiography', 'without', 'definitive', 'evidence', 'of', 'efficacy', '.', 'method', 'using', '-by-', 'factorial', 'design', ',', 'randomly', 'assigned', 'patient', 'high', 'risk', 'renal', 'complication', 'scheduled', 'angiography', 'to', 'receive', 'intravenous', '.', 'sodium', 'bicarbonate', 'or', 'intravenous', '.', 'sodium', 'chloride', 'and', 'day', 'of', 'oral', 'acetylcysteine', 'or', 'oral', 'placebo', 'of', 'patient', ',', 'included', 'in', 'modified', 'intention-to-treat', 'analysis', '.', 'primary', 'end', 'point', 'composite', 'of', 'death', ',', 'need', 'dialysis', ',', 'or', 'persistent', 'increase', 'of', 'least', 'baseline', 'in', 'serum', 'creatinine', 'level', 'day', '.', 'contrast-associated', 'acute', 'kidney', 'injury', 'secondary', 'end', 'point', '.', 'result', 'sponsor', 'stopped', 'trial', 'prespecified', 'interim', 'analysis', '.', 'no', 'interaction', 'sodium', 'bicarbonate', 'and', 'acetylcysteine', 'with', 'respect', 'to', 'primary', 'end', 'point', '(', 'p.', ')', '.', 'primary', 'end', 'point', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'sodium', 'bicarbonate', 'group', 'compared', 'with', 'of', '(', '.', ')', 'in', 'sodium', 'chloride', 'group', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'acetylcysteine', 'group', 'compared', 'with', 'of', '(', '.', ')', 'in', 'placebo', 'group', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'no', 'significant', 'between-group', 'difference', 'in', 'rate', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', '.', 'conclusion', 'among', 'patient', 'high', 'risk', 'renal', 'complication', 'undergoing', 'angiography', ',', 'no', 'benefit', 'of', 'intravenous', 'sodium', 'bicarbonate', 'intravenous', 'sodium', 'chloride', 'or', 'of', 'oral', 'acetylcysteine', 'placebo', 'prevention', 'of', 'death', ',', 'need', 'dialysis', ',', 'or', 'persistent', 'decline', 'in', 'kidney', 'function', 'day', 'or', 'prevention', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', '.', '(', 'funded', 'u.s.', 'department', 'of', 'veteran', 'affair', 'office', 'of', 'research', 'and', 'development', 'and', 'national', 'health', 'and', 'medical', 'research', 'council', 'of', 'australia', 'preserve', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.","Angela Lamarca, Daniel H Palmer, Harpreet Singh Wasan, Paul J Ross, Yuk Ting Ma, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel, Alan Anthoney, Anthony Maraveyas, Tim Iveson, Justin S Waters, Claire Hobbs, Safia Barber, W David Ryder, John Ramage, Linda M Davies, John A Bridgewater, Juan W Valle                              ;, Advanced Biliary Cancer Working Group, Angela Lamarcaet al.",2021 May,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/33798493/,No keywords found,"['advanced', 'biliary', 'tract', 'cancer', 'poor', 'prognosis', '.', 'cisplatin', 'and', 'gemcitabine', 'standard', 'first-line', 'chemotherapy', 'regimen', ',', 'no', 'robust', 'evidence', 'available', 'second-line', 'chemotherapy', '.', 'aim', 'of', 'study', 'to', 'determine', 'benefit', 'derived', 'second-line', 'folfox', '(', 'folinic', 'acid', ',', 'fluorouracil', ',', 'and', 'oxaliplatin', ')', 'chemotherapy', 'in', 'advanced', 'biliary', 'tract', 'cancer', '.', 'method', 'abc-', 'clinical', 'trial', 'phase', ',', 'open-label', ',', 'randomised', 'trial', 'done', 'in', 'site', 'with', 'expertise', 'in', 'managing', 'biliary', 'tract', 'cancer', 'across', 'uk', '.', 'adult', 'patient', '(', 'aged', 'year', ')', 'histologically', 'or', 'cytologically', 'verified', 'locally', 'advanced', 'or', 'metastatic', 'biliary', 'tract', 'cancer', '(', 'including', 'cholangiocarcinoma', 'and', 'gallbladder', 'or', 'ampullary', 'carcinoma', ')', 'with', 'documented', 'radiological', 'disease', 'progression', 'to', 'first-line', 'cisplatin', 'and', 'gemcitabine', 'chemotherapy', 'and', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', '-', 'randomly', 'assigned', '(', ')', 'centrally', 'to', 'active', 'symptom', 'control', '(', 'asc', ')', 'and', 'folfox', 'or', 'asc', 'alone', '.', 'folfox', 'chemotherapy', 'administered', 'intravenously', 'every', 'week', 'maximum', 'of', 'cycle', '(', 'oxaliplatin', 'mgm', ',', 'l-folinic', 'acid', 'mg', 'or', 'folinic', 'acid', 'mg', ',', 'fluorouracil', 'mgm', 'bolus', ',', 'and', 'fluorouracil', 'mgm', '-h', 'continuous', 'intravenous', 'infusion', ')', '.', 'randomisation', 'done', 'following', 'minimisation', 'algorithm', 'using', 'platinum', 'sensitivity', ',', 'serum', 'albumin', 'concentration', ',', 'and', 'stage', 'stratification', 'factor', '.', 'primary', 'endpoint', 'overall', 'survival', ',', 'assessed', 'in', 'intention-to-treat', 'population', '.', 'safety', 'also', 'assessed', 'in', 'intention-to-treat', 'population', '.', 'study', 'complete', 'and', 'final', 'result', 'reported', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'eudract', ',', '--', '.', 'finding', 'march', ',', ',', 'and', 'jan', ',', ',', 'patient', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'asc', 'plus', 'folfox', '(', 'n', ')', 'or', 'asc', 'alone', '(', 'n', ')', '.', 'median', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', 'overall', 'survival', 'significantly', 'longer', 'in', 'asc', 'plus', 'folfox', 'group', 'in', 'asc', 'alone', 'group', ',', 'with', 'median', 'overall', 'survival', 'of', 'month', '(', 'ci', '-', ')', 'in', 'asc', 'plus', 'folfox', 'group', 'versus', 'month', '(', '-', ')', 'in', 'asc', 'alone', 'group', '(', 'adjusted', 'hazard', 'ratio', 'ci', '-', 'p', ')', '.', 'overall', 'survival', 'rate', 'in', 'asc', 'alone', 'group', '(', 'ci', '-', ')', 'month', 'and', '(', '-', ')', 'month', ',', 'compared', 'with', '(', '-', ')', 'month', 'and', '(', '-', ')', 'month', 'in', 'asc', 'plus', 'folfox', 'group', '.', 'grade', '-', 'adverse', 'event', 'reported', 'in', '(', ')', 'of', 'patient', 'in', 'asc', 'alone', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'asc', 'plus', 'folfox', 'group', ',', 'including', 'three', 'chemotherapy-related', 'death', '(', 'one', 'due', 'to', 'infection', ',', 'acute', 'kidney', 'injury', ',', 'and', 'febrile', 'neutropenia', ')', '.', 'frequently', 'reported', 'grade', '-', 'folfox-related', 'adverse', 'event', 'neutropenia', '(', 'ten', 'patient', ')', ',', 'fatigue', 'or', 'lethargy', '(', 'nine', 'patient', ')', ',', 'and', 'infection', '(', 'eight', 'patient', ')', '.', 'interpretation', 'addition', 'of', 'folfox', 'to', 'asc', 'improved', 'median', 'overall', 'survival', 'in', 'patient', 'with', 'advanced', 'biliary', 'tract', 'cancer', 'progression', 'cisplatin', 'and', 'gemcitabine', ',', 'with', 'clinically', 'meaningful', 'increase', 'in', '-month', 'and', '-month', 'overall', 'survival', 'rate', '.', 'to', 'knowledge', ',', 'trial', 'first', 'prospective', ',', 'randomised', 'study', 'providing', 'reliable', ',', 'high-quality', 'evidence', 'to', 'allow', 'informed', 'discussion', 'with', 'patient', 'of', 'potential', 'benefit', 'and', 'risk', 'second-line', 'folfox', 'chemotherapy', 'in', 'advanced', 'biliary', 'tract', 'cancer', '.', 'based', 'finding', ',', 'folfox', 'become', 'standard-of-care', 'chemotherapy', 'in', 'second-line', 'treatment', 'advanced', 'biliary', 'tract', 'cancer', 'and', 'reference', 'regimen', 'clinical', 'trial', '.', 'funding', 'cancer', 'research', 'uk', ',', 'standuptocancer', ',', 'ammf', '(', 'uk', 'cholangiocarcinoma', 'charity', ')', ',', 'and', 'christie', 'charity', ',', 'with', 'additional', 'funding', 'cholangiocarcinoma', 'foundation', 'and', 'conquer', 'cancer', 'foundation', 'young', 'investigator', 'award', 'translational', 'research', '.']"
Dosing guidance for intravenous colistin in critically-ill patients.,"Roger L Nation, Samira M Garonzik, Visanu Thamlikitkul, Evangelos J Giamarellos-Bourboulis, Alan Forrest, David L Paterson, Jian Li, Fernanda P Silveira, Roger L Nationet al.",2017 Mar 1,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/28011614/,No keywords found,"['intravenous', 'colistin', 'difficult', 'to', 'use', 'plasma', 'concentration', 'antibacterial', 'effect', 'overlap', 'causing', 'nephrotoxicity', ',', 'and', 'large', 'inter-patient', 'variability', 'in', 'pharmacokinetics', '.', 'aim', 'to', 'develop', 'dosing', 'algorithm', 'achievement', 'of', 'clinically', 'desirable', 'average', 'steady-state', 'plasma', 'colistin', 'concentration', '(', 'cs', ',', 'avg', ')', 'of', 'mgl', '.', 'method', 'plasma', 'concentration-time', 'data', 'adult', 'critically-ill', 'patient', '(', 'creatinine', 'clearance', '-mlmin', 'receiving', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', ')', 'subjected', 'to', 'population', 'pharmacokinetic', 'analysis', '.', 'development', 'of', 'algorithm', 'patient', 'not', 'receiving', 'rrt', 'based', 'upon', 'relationship', 'dose', 'of', 'colistimethate', 'would', 'needed', 'to', 'achieve', 'desired', 'cs', ',', 'avg', 'and', 'creatinine', 'clearance', '.', 'increase', 'in', 'colistin', 'clearance', 'patient', 'rrt', 'determined', 'population', 'analysis', 'and', 'guided', 'supplemental', 'dosing', 'needed', '.', 'to', 'balance', 'potential', 'antibacterial', 'benefit', 'risk', 'of', 'nephrotoxicity', 'algorithm', 'designed', 'to', 'achieve', 'target', 'attainment', 'rate', 'of', 'cs', ',', 'avg', 'and', 'of', 'patient', 'with', 'creatinine', 'clearance', 'with', 'proposed', 'supplemental', 'dosing', '.', 'in', 'category', 'of', 'patient', ',', 'of', 'patient', 'attained', 'cs', ',', 'avg', 'mgl', '.', 'conclusion', 'project', 'generated', 'clinician-friendly', 'dosing', 'algorithm', 'and', 'pointed', 'to', 'circumstance', 'intravenous', 'monotherapy', 'may', 'inadequate', '.']"
Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty.,"Trisha N Peel, Sarah Astbury, Allen C Cheng, David L Paterson, Kirsty L Buising, Tim Spelman, An Tran-Duy, Sam Adie, Glenn Boyce, Catherine McDougall, Robert Molnar, Jonathan Mulford, Peter Rehfisch, Michael Solomon, Ross Crawford, Tiffany Harris-Brown, Janine Roney, Jessica Wisniewski, Richard de Steiger                              ;, ASAP Trial Group, David Paterson, Richard de Steiger, Stasie Abela, Rhea Alcordo, Kerrie Amy, Zweena Badoordeen, Mellissa Bryant, Keisha Cabahug, Chen Cao, Kira Chamberlain, Wei Ju Chang, Amanda Collings, Shelley Davey, Anna Donaldson, Phillipa Gelgard, Laura Harris, Simon Holz, Anna Imbesi, Alexandra Ingram, Trent Li, Simone Lovison, Jason McMahon, Masiath Monjula, Erin Murray, Jane Niecamp, Monika O'Connor, Anton Peleg, Stephanie Pereira, Peta Piltz, Toufic Safi, Stephanie Spartalis, Lucinda Swan, India Thorogood, Angela Toohey, Nicholas van Rhijn, Jane Wickins, Iain Abbott, Paul Johnson, Rowan Walker, Andrew Stewardson, Susan Liew, Sue Lee, Jonathon Mulford, Masiath Monuja, Adam Meehan, Lexi Randall-L'Estrange, Trisha N Peelet al.",2023 Oct 19,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/37851875/,No keywords found,"['addition', 'of', 'vancomycin', 'to', 'beta-lactam', 'prophylaxis', 'in', 'arthroplasty', 'may', 'reduce', 'surgical-site', 'infection', 'however', ',', 'efficacy', 'and', 'safety', 'unclear', '.', 'method', 'in', 'multicenter', ',', 'double-blind', ',', 'superiority', ',', 'placebo-controlled', 'trial', ',', 'randomly', 'assigned', 'adult', 'patient', 'without', 'known', 'methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', 'colonization', 'undergoing', 'arthroplasty', 'to', 'receive', '.', 'g', 'of', 'vancomycin', 'or', 'normal', 'saline', 'placebo', ',', 'in', 'addition', 'to', 'cefazolin', 'prophylaxis', '.', 'primary', 'outcome', 'surgical-site', 'infection', 'within', 'day', 'surgery', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', '.', 'among', 'patient', 'in', 'modified', 'intention-to-treat', 'population', '(', 'undergoing', 'knee', 'arthroplasty', ',', 'undergoing', 'hip', 'arthroplasty', ',', 'and', 'undergoing', 'shoulder', 'arthroplasty', ')', ',', 'surgical-site', 'infection', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'vancomycin', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'relative', 'risk', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'among', 'patient', 'undergoing', 'knee', 'arthroplasty', ',', 'surgical-site', 'infection', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'vancomyin', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'among', 'patient', 'undergoing', 'hip', 'arthroplasty', ',', 'surgical-site', 'infection', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'vancomyin', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'adverse', 'event', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'vancomycin', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'placebo', 'group', ',', 'including', 'hypersensitivity', 'reaction', 'in', 'of', 'patient', '(', '.', ')', 'and', 'of', 'patient', '(', '.', ')', ',', 'respectively', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.', 'to', '.', ')', ',', 'and', 'acute', 'kidney', 'injury', 'in', 'of', 'patient', '(', '.', ')', 'and', 'of', 'patient', '(', '.', ')', ',', 'respectively', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'conclusion', 'addition', 'of', 'vancomycin', 'to', 'cefazolin', 'prophylaxis', 'not', 'superior', 'to', 'placebo', 'prevention', 'of', 'surgical-site', 'infection', 'in', 'arthroplasty', 'among', 'patient', 'without', 'known', 'mrsa', 'colonization', '.', '(', 'funded', 'australian', 'national', 'health', 'and', 'medical', 'research', 'council', 'australian', 'new', 'zealand', 'clinical', 'trial', 'registry', 'number', ',', 'actrn', '.', ')', '.']"
"Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.","Corey J Langer, Shirish M Gadgeel, Hossein Borghaei, Vassiliki A Papadimitrakopoulou, Amita Patnaik, Steven F Powell, Ryan D Gentzler, Renato G Martins, James P Stevenson, Shadia I Jalal, Amit Panwalkar, James Chih-Hsin Yang, Matthew Gubens, Lecia V Sequist, Mark M Awad, Joseph Fiore, Yang Ge, Harry Raftopoulos, Leena Gandhi                              ;, KEYNOTE- investigators, Corey J Langeret al.",2016 Nov,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/27745820/,No keywords found,"['limited', 'evidence', 'exists', 'to', 'show', 'adding', 'third', 'agent', 'to', 'platinum-doublet', 'chemotherapy', 'improves', 'efficacy', 'in', 'first-line', 'advanced', 'non-small-cell', 'lung', 'cancer', '(', 'nsclc', ')', 'setting', '.', 'anti-pd-', 'antibody', 'pembrolizumab', 'shown', 'efficacy', 'monotherapy', 'in', 'patient', 'with', 'advanced', 'nsclc', 'and', 'non-overlapping', 'toxicity', 'profile', 'with', 'chemotherapy', '.', 'assessed', 'whether', 'addition', 'of', 'pembrolizumab', 'to', 'platinum-doublet', 'chemotherapy', 'improves', 'efficacy', 'in', 'patient', 'with', 'advanced', 'non-squamous', 'nsclc', '.', 'method', 'in', 'randomised', ',', 'open-label', ',', 'phase', 'cohort', 'of', 'multicohort', 'study', '(', 'keynote-', ')', ',', 'patient', 'enrolled', 'medical', 'centre', 'in', 'usa', 'and', 'taiwan', '.', 'patient', 'with', 'chemotherapy-naive', ',', 'stage', 'iiib', 'or', 'iv', ',', 'non-squamous', 'nsclc', 'without', 'targetable', 'egfr', 'or', 'alk', 'genetic', 'aberration', 'randomly', 'assigned', '(', ')', 'in', 'block', 'of', 'four', 'stratified', 'pd-l', 'tumour', 'proportion', 'score', '(', 'v', ')', 'using', 'interactive', 'voice-response', 'system', 'to', 'cycle', 'of', 'pembrolizumab', 'mg', 'plus', 'carboplatin', 'area', 'curve', 'mgml', 'per', 'min', 'and', 'pemetrexed', 'mgm', 'every', 'week', 'followed', 'pembrolizumab', 'month', 'and', 'indefinite', 'pemetrexed', 'maintenance', 'therapy', 'or', 'to', 'cycle', 'of', 'carboplatin', 'and', 'pemetrexed', 'alone', 'followed', 'indefinite', 'pemetrexed', 'maintenance', 'therapy', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'achieved', 'objective', 'response', ',', 'defined', 'percentage', 'of', 'patient', 'with', 'radiologically', 'confirmed', 'complete', 'or', 'partial', 'response', 'according', 'to', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumor', 'version', '.', 'assessed', 'masked', ',', 'independent', 'central', 'review', ',', 'in', 'intention-to-treat', 'population', ',', 'defined', 'patient', 'allocated', 'to', 'study', 'treatment', '.', 'significance', 'threshold', 'p', '(', 'one', 'sided', ')', '.', 'safety', 'assessed', 'in', 'as-treated', 'population', ',', 'defined', 'patient', 'received', 'least', 'one', 'dose', 'of', 'assigned', 'study', 'treatment', '.', 'trial', ',', 'closed', 'enrolment', 'continuing', 'follow-up', ',', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'nov', ',', ',', 'and', 'jan', ',', ',', 'patient', 'enrolled', 'randomly', 'assigned', 'to', 'pembrolizumab', 'plus', 'chemotherapy', 'group', 'and', 'to', 'chemotherapy', 'alone', 'group', '.', '(', 'ci', '-', ')', 'of', 'patient', 'in', 'pembrolizumab', 'plus', 'chemotherapy', 'group', 'achieved', 'objective', 'response', 'compared', 'with', '(', '-', ')', 'of', 'patient', 'in', 'chemotherapy', 'alone', 'group', '(', 'estimated', 'treatment', 'difference', 'ci', '-', 'p', ')', '.', 'incidence', 'of', 'grade', 'or', 'worse', 'treatment-related', 'adverse', 'event', 'similar', 'group', '(', 'of', 'patient', 'in', 'pembrolizumab', 'plus', 'chemotherapy', 'group', 'and', 'of', 'in', 'chemotherapy', 'alone', 'group', ')', '.', 'common', 'grade', 'or', 'worse', 'treatment-related', 'adverse', 'event', 'in', 'pembrolizumab', 'plus', 'chemotherapy', 'group', 'anaemia', '(', 'seven', 'of', ')', 'and', 'decreased', 'neutrophil', 'count', '(', 'three', ')', 'additional', 'six', 'event', 'occurred', 'in', 'two', '(', ')', 'acute', 'kidney', 'injury', ',', 'decreased', 'lymphocyte', 'count', ',', 'fatigue', ',', 'neutropenia', ',', 'and', 'sepsis', ',', 'and', 'thrombocytopenia', '.', 'in', 'chemotherapy', 'alone', 'group', ',', 'common', 'grade', 'or', 'worse', 'event', 'anaemia', '(', 'nine', 'of', ')', 'and', 'decreased', 'neutrophil', 'count', ',', 'pancytopenia', ',', 'and', 'thrombocytopenia', '(', 'two', ')', '.', 'one', '(', ')', 'of', 'patient', 'in', 'pembrolizumab', 'plus', 'chemotherapy', 'group', 'experienced', 'treatment-related', 'death', 'of', 'sepsis', 'compared', 'with', 'two', '(', ')', 'of', 'patient', 'in', 'chemotherapy', 'group', 'one', 'of', 'sepsis', 'and', 'one', 'of', 'pancytopenia', '.', 'interpretation', 'combination', 'of', 'pembrolizumab', ',', 'carboplatin', ',', 'and', 'pemetrexed', 'could', 'effective', 'and', 'tolerable', 'first-line', 'treatment', 'option', 'patient', 'with', 'advanced', 'non-squamous', 'nsclc', '.', 'finding', 'explored', 'in', 'ongoing', 'international', ',', 'randomised', ',', 'double-blind', ',', 'phase', 'study', '.', 'funding', 'merck', 'co', '.']"
"Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.","John H Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew S Paulson, Joleen M Hubbard, Andrew L Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon M Kasi, Heinz-Josef Lenz, Kristen K Ciombor, Elena Elez, David L Bajor, Chiara Cremolini, Federico Sanchez, Michael Stecher, Wentao Feng, Tanios S Bekaii-Saab                              ;, MOUNTAINEER investigators, Marc Peeters, Marc Van den Evnde, Christophe Borg, Matthieu Sarabi, Francois Ghiringhelli, Benoist Chibaudel, Maria G Zampino, Susana R Keranen, Ramon Salazar, Pilar Alfonso, Tanios S Bekaii-Saab, Olumide Gbolahan, Patrick Boland, Daniel Berg, Timothy Goggins, Anwar Saeed, Howard Burris, Johanna Bendell, Darryl Outlaw, Isaac Tafur, Ardaman Shergill, Daniel Catenacci, Jun Gong, Ignacio Garrido-Laguna, Gene Finley, Benjamin Weinberg, Anthony Shields, Philip Philip, Anita Turk, Anthony Nguyen, Fadi Braiteh, Vijay Patel, William Harwin, Ian Anderson, Ajay Kundra, Christopher Chen, James Ford, Madappa Kundranda, Danny Nguyen, Suresh Ratnam, Donald Richards, Sujatha Nallapareddy, Sridhar Beeram, Scott McKenney, Spencer Shao, John H Strickleret al.",2023 May,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/37142372/,No keywords found,"['actionable', 'target', 'in', 'metastatic', 'colorectal', 'cancer', '.', 'assessed', 'activity', 'of', 'tucatinib', 'plus', 'trastuzumab', 'in', 'patient', 'with', 'chemotherapy-refractory', ',', 'her-positive', ',', 'ra', 'wild-type', 'unresectable', 'or', 'metastatic', 'colorectal', 'cancer', '.', 'method', 'mountaineer', 'global', ',', 'open-label', ',', 'phase', 'study', 'enrolled', 'patient', 'aged', 'year', 'and', 'older', 'with', 'chemotherapy-refractory', ',', 'her-positive', ',', 'ra', 'wild-type', 'unresectable', 'or', 'metastatic', 'colorectal', 'cancer', 'site', '(', 'clinic', 'and', 'hospital', ')', 'in', 'five', 'country', '(', 'belgium', ',', 'france', ',', 'italy', ',', 'spain', ',', 'and', 'usa', ')', '.', 'initially', ',', 'study', 'designed', 'single-cohort', 'study', ',', 'expanded', 'following', 'interim', 'analysis', 'to', 'include', 'patient', '.', 'initially', ',', 'patient', 'given', 'tucatinib', '(', 'mg', 'orally', 'twice', 'daily', ')', 'plus', 'intravenous', 'trastuzumab', '(', 'mgkg', 'initial', 'loading', 'dose', ',', 'mgkg', 'every', 'day', 'cohort', ')', 'duration', 'of', 'treatment', '(', 'progression', ')', ',', 'and', 'expansion', ',', 'patient', 'randomly', 'assigned', '(', ')', ',', 'using', 'interactive', 'web', 'response', 'system', 'and', 'stratified', 'primary', 'tumour', 'location', ',', 'to', 'either', 'tucatinib', 'plus', 'trastuzumab', '(', 'cohort', 'b', ')', 'or', 'tucatinib', 'monotherapy', '(', 'cohort', 'c', ')', '.', 'primary', 'endpoint', 'confirmed', 'objective', 'response', 'rate', 'per', 'blinded', 'independent', 'central', 'review', '(', 'bicr', ')', 'cohort', 'and', 'b', 'combined', 'and', 'assessed', 'in', 'patient', 'in', 'full', 'analysis', 'set', '(', 'ie', ',', 'patient', 'with', 'her-positive', 'disease', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', ')', '.', 'safety', 'assessed', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'ongoing', '.', 'finding', 'aug', ',', ',', 'and', 'sept', ',', ',', 'patient', 'enrolled', '(', 'in', 'cohort', ',', 'in', 'cohort', 'b', ',', 'and', 'in', 'cohort', 'c', ')', ',', 'of', 'patient', 'locally', 'assessed', 'her-positive', 'disease', 'and', 'received', 'treatment', '(', 'in', 'cohort', ',', 'in', 'cohort', 'b', ',', 'and', 'in', 'cohort', 'c', 'full', 'analysis', 'set', ')', ',', 'and', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '(', 'in', 'cohort', ',', 'in', 'cohort', 'b', ',', 'and', 'in', 'cohort', 'c', 'safety', 'population', ')', '.', 'in', 'full', 'analysis', 'set', ',', 'median', 'age', 'year', '(', 'iqr', '-', ')', ',', '(', ')', 'male', ',', '(', ')', 'female', ',', '(', ')', 'white', ',', 'and', 'six', '(', ')', 'black', 'or', 'african', 'american', '.', 'of', 'data', 'cutoff', '(', 'march', ',', ')', ',', 'in', 'patient', 'cohort', 'and', 'b', 'in', 'full', 'analysis', 'set', ',', 'confirmed', 'objective', 'response', 'rate', 'per', 'bicr', '(', 'ci', '-', 'three', 'patient', 'complete', 'response', 'and', 'partial', 'response', ')', '.', 'in', 'cohort', 'and', 'b', ',', 'common', 'adverse', 'event', 'diarrhoea', '(', 'of', ')', ',', 'common', 'grade', 'or', 'worse', 'adverse', 'event', 'hypertension', '(', 'six', 'of', ')', ',', 'and', 'three', '(', ')', 'patient', 'tucatinib-related', 'serious', 'adverse', 'event', '(', 'acute', 'kidney', 'injury', ',', 'colitis', ',', 'and', 'fatigue', ')', '.', 'in', 'cohort', 'c', ',', 'common', 'adverse', 'event', 'diarrhoea', '(', 'ten', 'of', ')', ',', 'common', 'grade', 'or', 'worse', 'adverse', 'event', 'increased', 'alanine', 'aminotransferase', 'and', 'aspartate', 'aminotransferase', '(', 'two', ')', ',', 'and', 'one', '(', ')', 'patient', 'tucatinib-related', 'serious', 'adverse', 'event', '(', 'overdose', ')', '.', 'no', 'death', 'attributed', 'to', 'adverse', 'event', '.', 'death', 'in', 'treated', 'patient', 'due', 'to', 'disease', 'progression', '.', 'interpretation', 'tucatinib', 'plus', 'trastuzumab', 'clinically', 'meaningful', 'anti-tumour', 'activity', 'and', 'favourable', 'tolerability', '.', 'treatment', 'first', 'u', 'food', 'and', 'drug', 'administration-approved', 'anti-her', 'regimen', 'metastatic', 'colorectal', 'cancer', 'and', 'important', 'new', 'treatment', 'option', 'chemotherapy-refractory', 'her-positive', 'metastatic', 'colorectal', 'cancer', '.', 'funding', 'seagen', 'and', 'merck', 'co', '.']"
"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.","Mical Paul, George L Daikos, Emanuele Durante-Mangoni, Dafna Yahav, Yehuda Carmeli, Yael Dishon Benattar, Anna Skiada, Roberto Andini, Noa Eliakim-Raz, Amir Nutman, Oren Zusman, Anastasia Antoniadou, Pia Clara Pafundi, Amos Adler, Yaakov Dickstein, Ioannis Pavleas, Rosa Zampino, Vered Daitch, Roni Bitterman, Hiba Zayyad, Fidi Koppel, Inbar Levi, Tanya Babich, Lena E Friberg, Johan W Mouton, Ursula Theuretzbacher, Leonard Leibovici, Mical Paulet al.",2018 Apr,Lancet Infect Dis,https://pubmed.ncbi.nlm.nih.gov/29456043/,No keywords found,"['colistin-carbapenem', 'combination', 'synergistic', 'in', 'vitro', 'carbapenem-resistant', 'gram-negative', 'bacteria', '.', 'aimed', 'to', 'test', 'whether', 'combination', 'therapy', 'improves', 'clinical', 'outcome', 'adult', 'with', 'infection', 'caused', 'carbapenem-resistant', 'or', 'carbapenemase-producing', 'gram-negative', 'bacteria', '.', 'method', 'randomised', 'controlled', 'superiority', 'trial', 'done', 'in', 'six', 'hospital', 'in', 'israel', ',', 'greece', ',', 'and', 'italy', '.', 'included', 'adult', 'with', 'bacteraemia', ',', 'ventilator-associated', 'pneumonia', ',', 'hospital-acquired', 'pneumonia', ',', 'or', 'urosepsis', 'caused', 'carbapenem-non-susceptible', 'gram-negative', 'bacteria', '.', 'patient', 'randomly', 'assigned', '(', ')', 'centrally', ',', 'computer-generated', 'permuted', 'block', 'stratified', 'centre', ',', 'to', 'intravenous', 'colistin', '(', '-million', 'unit', 'loading', 'dose', ',', 'followed', 'million', 'unit', 'twice', 'per', 'day', ')', 'or', 'colistin', 'with', 'meropenem', '(', '-g', 'prolonged', 'infusion', 'three', 'time', 'per', 'day', ')', '.', 'trial', 'open-label', ',', 'with', 'blinded', 'outcome', 'assessment', '.', 'treatment', 'success', 'defined', 'survival', ',', 'haemodynamic', 'stability', ',', 'improved', 'or', 'stable', 'sequential', 'organ', 'failure', 'assessment', 'score', ',', 'stable', 'or', 'improved', 'ratio', 'of', 'partial', 'pressure', 'of', 'arterial', 'oxygen', 'to', 'fraction', 'of', 'expired', 'oxygen', 'patient', 'with', 'pneumonia', ',', 'and', 'microbiological', 'cure', 'patient', 'with', 'bacteraemia', '.', 'primary', 'outcome', 'clinical', 'failure', ',', 'defined', 'not', 'meeting', 'success', 'criterion', 'intention-to-treat', 'analysis', ',', 'day', 'randomisation', '.', 'trial', 'registered', 'clinicaltrials.gov', ',', 'number', 'nct', ',', 'and', 'closed', 'to', 'accrual', '.', 'finding', 'oct', ',', ',', 'and', 'dec', ',', ',', 'randomly', 'assigned', 'patient', 'to', 'two', 'treatment', 'group', '.', 'patient', 'pneumonia', 'or', 'bacteraemia', '(', ',', ')', ',', 'and', 'infection', 'caused', 'acinetobacter', 'baumannii', '(', ',', ')', '.', 'no', 'significant', 'difference', 'colistin', 'monotherapy', '(', ',', ')', 'and', 'combination', 'therapy', '(', ',', ')', 'observed', 'clinical', 'failure', 'day', 'randomisation', '(', 'risk', 'difference', '-', ',', 'ci', '-', 'to', 'risk', 'ratio', 'rr', ',', 'ci', '-', ')', '.', 'result', 'similar', 'among', 'patient', 'with', 'baumannii', 'infection', '(', 'rr', ',', 'ci', '-', ')', '.', 'combination', 'therapy', 'increased', 'incidence', 'of', 'diarrhoea', '(', 'v', 'patient', ')', 'and', 'decreased', 'incidence', 'of', 'mild', 'renal', 'failure', '(', 'of', 'v', 'of', 'patient', 'risk', 'of', 'or', 'with', 'kidney', 'injury', ')', '.', 'interpretation', 'combination', 'therapy', 'not', 'superior', 'to', 'monotherapy', '.', 'addition', 'of', 'meropenem', 'to', 'colistin', 'not', 'improve', 'clinical', 'failure', 'in', 'severe', 'baumannii', 'infection', '.', 'trial', 'unpowered', 'to', 'specifically', 'address', 'bacteria', '.', 'funding', 'eu', 'aida', 'grant', 'health-f', '--', '.']"
Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.,"Justin M Belcher, Xavier Vela Parada, Douglas A Simonetto, Luis A Juncos, Nithin Karakala, Hani M Wadei, Pratima Sharma, Kevin R Regner, Mitra K Nadim, Guadalupe Garcia-Tsao, Juan Carlos Q Velez, Samir M Parikh, Raymond T Chung, Andrew S Allegretti                              ;, HRS-HARMONY Study Investigators, Justin M Belcheret al.",2022 May,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/34606933/,"Acute kidney injury (AKI), cirrhosis, drug approval, drug safety, hepatorenal syndrome (HRS), midodrine, norepinephrine, octreotide, renal perfusion, respiratory failure, terlipressin, vasoconstrictor, vasopressin analogue.","['hepatorenal', 'syndrome', '(', 'hr', ')', 'form', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'occurring', 'in', 'patient', 'with', 'advanced', 'cirrhosis', 'and', 'associated', 'with', 'significant', 'morbidity', 'and', 'mortality', '.', 'pathophysiology', 'underlying', 'hr', 'begin', 'with', 'increasing', 'portal', 'pressure', 'leading', 'to', 'release', 'of', 'vasodilatory', 'substance', 'result', 'in', 'pooling', 'blood', 'in', 'splanchnic', 'system', 'and', 'corresponding', 'reduction', 'in', 'effective', 'circulating', 'volume', '.', 'compensatory', 'activation', 'of', 'sympathetic', 'nervous', 'system', 'and', 'renin-angiotensin-aldosterone', 'system', 'and', 'release', 'of', 'arginine', 'vasopressin', 'serve', 'to', 'defend', 'mean', 'arterial', 'pressure', 'cost', 'of', 'severe', 'constriction', 'of', 'renal', 'vasculature', ',', 'leading', 'to', 'progressive', ',', 'often', 'fulminant', 'form', 'of', 'aki', '.', 'no', 'approved', 'treatment', 'hr', 'in', 'united', 'state', ',', 'multiple', 'country', ',', 'including', 'much', 'of', 'europe', ',', 'use', 'terlipressin', ',', 'synthetic', 'vasopressin', 'analogue', ',', 'first-line', 'therapy', '.', 'confirm', '(', 'multi-center', ',', 'randomized', ',', 'placebo', 'controlled', ',', 'double-blind', 'study', 'to', 'confirm', 'efficacy', 'and', 'safety', 'of', 'terlipressin', 'in', 'subject', 'with', 'hepatorenal', 'syndrome', 'type', ')', ',', 'third', 'randomized', 'trial', 'based', 'in', 'north', 'america', 'evaluating', 'terlipressin', ',', 'met', 'primary', 'end', 'point', 'of', 'showing', 'greater', 'rate', 'of', 'hr', 'reversal', 'in', 'terlipressin', 'arm', '.', 'however', ',', 'due', 'to', 'concern', 'apparent', 'increased', 'rate', 'of', 'respiratory', 'adverse', 'event', 'and', 'lack', 'of', 'evidence', 'mortality', 'benefit', ',', 'terlipressin', 'not', 'approved', 'food', 'and', 'drug', 'administration', '(', 'fda', ')', '.', 'explore', 'history', 'of', 'regulatory', 'approval', 'terlipressin', 'in', 'united', 'state', ',', 'examine', 'result', 'confirm', 'and', 'concern', 'raised', ',', 'and', 'consider', 'future', 'role', 'of', 'terlipressin', 'in', 'critical', 'clinical', 'area', 'of', 'continued', 'unmet', 'need', '.']"
Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.,"Vinod Arora, Rakhi Maiwall, Vijayaraghavan Rajan, Ankur Jindal, Saggere Muralikrishna Shasthry, Guresh Kumar, Priyanka Jain, Shiv Kumar Sarin, Vinod Aroraet al.",2020 Feb,Hepatology,https://pubmed.ncbi.nlm.nih.gov/30076614/,No keywords found,"['aki', 'in', 'aclf', 'carry', 'high', 'mortality', '.', 'infusion', 'of', 'terlipressin', 'give', 'earlier', 'and', 'higher', 'response', 'noradrenaline', ',', 'with', 'improved', 'survival', 'in', 'aclf', 'patient', 'with', 'hrs-aki', '.']"
Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical Trial.,"Eero Pesonen, Hanna Vlasov, Raili Suojaranta, Seppo Hiippala, Alexey Schramko, Erika Wilkman, Tiina Eränen, Kaapo Arvonen, Maxim Mazanikov, Ulla-Stina Salminen, Mihkel Meinberg, Tommi Vähäsilta, Liisa Petäjä, Peter Raivio, Tatu Juvonen, Ville Pettilä, Eero Pesonenet al.",2022 Jul 19,JAMA,https://pubmed.ncbi.nlm.nih.gov/35852528/,No keywords found,"['in', 'cardiac', 'surgery', ',', 'albumin', 'solution', 'may', 'maintain', 'hemodynamics', 'better', 'crystalloids', 'and', 'reduce', 'decrease', 'in', 'platelet', 'count', 'and', 'excessive', 'fluid', 'balance', ',', 'randomized', 'trial', 'needed', 'to', 'compare', 'effectiveness', 'of', 'approach', 'in', 'reducing', 'surgical', 'complication', '.', 'objective', 'to', 'assess', 'whether', 'albumin', 'solution', 'compared', 'with', 'ringer', 'acetate', 'cardiopulmonary', 'bypass', 'prime', 'and', 'perioperative', 'intravenous', 'volume', 'replacement', 'solution', 'reduces', 'incidence', 'of', 'major', 'perioperative', 'and', 'postoperative', 'complication', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'randomized', ',', 'double-blind', ',', 'single-center', 'clinical', 'trial', 'in', 'tertiary', 'university', 'hospital', '-', 'with', '-day', 'follow-up', 'postoperatively', 'involving', 'patient', 'undergoing', 'on-pump', 'coronary', 'artery', 'bypass', 'grafting', 'aortic', ',', 'mitral', ',', 'or', 'tricuspid', 'valve', 'surgery', 'ascending', 'aorta', 'surgery', 'without', 'hypothermic', 'circulatory', 'arrest', 'andor', 'maze', 'procedure', 'randomly', 'assigned', 'to', 'study', 'group', '(', 'last', 'follow-up', 'april', ',', ')', '.', 'intervention', 'patient', 'received', 'in', 'ratio', 'either', 'albumin', 'solution', '(', 'n', ')', 'or', 'ringer', 'acetate', 'solution', '(', 'n', ')', 'cardiopulmonary', 'bypass', 'priming', 'and', 'intravenous', 'volume', 'replacement', 'intraoperatively', 'and', 'to', 'hour', 'postoperatively', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'number', 'of', 'patient', 'with', 'least', 'major', 'adverse', 'event', 'death', ',', 'myocardial', 'injury', ',', 'acute', 'heart', 'failure', ',', 'resternotomy', ',', 'stroke', ',', 'arrhythmia', ',', 'bleeding', ',', 'infection', ',', 'or', 'acute', 'kidney', 'injury', '.', 'result', 'among', 'patient', 'randomized', ',', '(', 'mean', 'age', ',', '.', 'sd', ',', '.', 'year', 'men', 'woman', ')', 'completed', 'trial', '.', 'patient', 'received', 'median', 'of', 'ml', '(', 'iqr', ',', '-', 'ml', ')', 'of', 'study', 'fluid', 'in', 'albumin', 'group', 'and', 'ml', '(', 'iqr', ',', '-', 'ml', ')', 'in', 'ringer', 'group', '.', 'number', 'of', 'patient', 'with', 'least', 'major', 'adverse', 'event', 'of', 'patient', '(', '.', ')', 'in', 'albumin', 'group', 'and', 'of', 'patient', '(', '.', ')', 'in', 'ringer', 'group', '(', 'relative', 'risk', 'albuminringer', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', ',', 'absolute', 'difference', 'of', '.', 'percentage', 'point', '(', 'ci', ',', '-', '.', 'to', '.', ')', '.', 'common', 'serious', 'adverse', 'event', 'pulmonary', 'embolus', '(', '.', 'in', 'albumin', 'group', 'v', '.', 'in', 'ringer', 'group', ')', ',', 'postpericardiotomy', 'syndrome', '(', '.', 'in', 'group', ')', ',', 'and', 'pleural', 'effusion', 'with', 'intensive', 'care', 'unit', 'or', 'hospital', 'readmission', '(', '.', 'in', 'albumin', 'group', 'v', '.', 'in', 'ringer', 'group', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', ',', 'treatment', 'with', 'albumin', 'solution', 'priming', 'and', 'perioperative', 'intravenous', 'volume', 'replacement', 'solution', 'compared', 'with', 'ringer', 'acetate', 'not', 'significantly', 'reduce', 'risk', 'of', 'major', 'adverse', 'event', 'following', 'day', '.', 'finding', 'not', 'support', 'use', 'of', 'albumin', 'solution', 'in', 'setting', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Balanced Crystalloids versus Saline in the Intensive Care Unit. The SALT Randomized Trial.,"Matthew W Semler, Jonathan P Wanderer, Jesse M Ehrenfeld, Joanna L Stollings, Wesley H Self, Edward D Siew, Li Wang, Daniel W Byrne, Andrew D Shaw, Gordon R Bernard, Todd W Rice                              ;, SALT Investigators * and the Pragmatic Critical Care Research Group;, SALT Investigators, Michael J Noto, Todd W Rice, Henry J Domenico, Antonio Hernandez, Avinash B Kumar, Debra F Dunlap, Mark Sullivan, Molly Knostman, David P Mulherin, Fred R Hargrove, David R Janz, Seth Strawbridge, Matthew W Semleret al.",2017 May 15,Am J Respir Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/27749094/,No keywords found,"['saline', 'intravenous', 'fluid', 'commonly', 'administered', 'to', 'critically', 'ill', 'adult', ',', 'may', 'associated', 'with', 'acute', 'kidney', 'injury', 'and', 'death', '.', 'whether', 'use', 'of', 'balanced', 'crystalloids', 'rather', 'saline', 'affect', 'patient', 'outcome', 'remains', 'unknown', '.', 'objective', 'to', 'pilot', 'cluster-randomized', ',', 'multiple-crossover', 'trial', 'using', 'software', 'tool', 'within', 'electronic', 'health', 'record', 'to', 'compare', 'saline', 'to', 'balanced', 'crystalloids', '.', 'method', 'cluster-randomized', ',', 'multiple-crossover', 'trial', 'among', 'adult', 'admitted', 'to', 'tertiary', 'medical', 'intensive', 'care', 'unit', 'february', ',', 'to', 'may', ',', '.', 'intravenous', 'crystalloid', 'used', 'in', 'unit', 'alternated', 'monthly', 'saline', '(', '.', 'sodium', 'chloride', ')', 'and', 'balanced', 'crystalloids', '(', 'lactated', 'ringer', ""'s"", 'solution', 'or', 'plasma-lyte', ')', '.', 'enrollment', ',', 'fluid', 'delivery', ',', 'and', 'data', 'collection', 'performed', 'using', 'software', 'tool', 'within', 'electronic', 'health', 'record', '.', 'primary', 'outcome', 'difference', 'study', 'group', 'in', 'proportion', 'of', 'isotonic', 'crystalloid', 'administered', 'saline', '.', 'secondary', 'outcome', 'major', 'adverse', 'kidney', 'event', 'within', 'day', '(', 'make', ')', ',', 'composite', 'of', 'death', ',', 'dialysis', ',', 'or', 'persistent', 'renal', 'dysfunction', '.', 'measurement', 'and', 'main', 'result', 'patient', 'assigned', 'to', 'saline', '(', 'n', ')', 'and', 'balanced', 'crystalloids', '(', 'n', ')', 'similar', 'baseline', 'and', 'received', 'similar', 'volume', 'of', 'crystalloid', 'day', '(', 'median', 'interquartile', 'range', ',', 'ml', '-', ',', 'vs.', ',', 'ml', '-', ',', 'p', '.', ')', '.', 'saline', 'made', 'larger', 'proportion', 'of', 'isotonic', 'crystalloid', 'given', 'in', 'saline', 'group', 'in', 'balanced', 'crystalloid', 'group', '(', 'vs.', 'p', '.', ')', '.', 'make', 'not', 'differ', 'group', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'conclusion', 'electronic', 'health', 'record-embedded', ',', 'cluster-randomized', ',', 'multiple-crossover', 'trial', 'comparing', 'saline', 'with', 'balanced', 'crystalloids', 'produce', 'well-balanced', 'study', 'group', 'and', 'separation', 'in', 'crystalloid', 'receipt', '.', 'clinical', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', '(', 'nct', ')', '.']"
De novo NAD(+) biosynthetic impairment in acute kidney injury in humans.,"Ali Poyan Mehr, Mei T Tran, Kenneth M Ralto, David E Leaf, Vaughan Washco, Joseph Messmer, Adam Lerner, Ajay Kher, Steven H Kim, Charbel C Khoury, Shoshana J Herzig, Mary E Trovato, Noemie Simon-Tillaux, Matthew R Lynch, Ravi I Thadhani, Clary B Clish, Kamal R Khabbaz, Eugene P Rhee, Sushrut S Waikar, Anders H Berg, Samir M Parikh, Ali Poyan Mehret al.",2018 Sep,Nat Med,https://pubmed.ncbi.nlm.nih.gov/30127395/,No keywords found,"['nicotinamide', 'adenine', 'dinucleotide', '(', 'nad', ')', 'extends', 'longevity', 'in', 'experimental', 'organism', ',', 'raising', 'interest', 'in', 'impact', 'human', 'health', '.', 'de', 'novo', 'nad', 'biosynthesis', 'tryptophan', 'evolutionarily', 'conserved', 'yet', 'considered', 'supplanted', 'among', 'higher', 'specie', 'biosynthesis', 'nicotinamide', '(', 'nam', ')', '.', 'show', 'bottleneck', 'enzyme', 'in', 'de', 'novo', 'biosynthesis', ',', 'quinolinate', 'phosphoribosyltransferase', '(', 'qprt', ')', ',', 'defends', 'renal', 'nad', 'and', 'mediates', 'resistance', 'to', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'following', 'murine', 'aki', ',', 'renal', 'nad', 'fell', ',', 'quinolinate', 'rose', ',', 'and', 'qprt', 'declined', '.', 'qprt-', 'mouse', 'exhibited', 'higher', 'quinolinate', ',', 'lower', 'nad', ',', 'and', 'higher', 'aki', 'susceptibility', '.', 'metabolomics', 'suggested', 'elevated', 'urinary', 'quinolinatetryptophan', 'ratio', '(', 'uqt', ')', 'indicator', 'of', 'reduced', 'qprt', '.', 'elevated', 'uqt', 'predicted', 'aki', 'and', 'adverse', 'outcome', 'in', 'critically', 'ill', 'patient', '.', 'phase', 'placebo-controlled', 'study', 'of', 'oral', 'nam', 'demonstrated', 'dose-related', 'increase', 'in', 'circulating', 'nad', 'metabolite', '.', 'nam', 'well', 'tolerated', 'and', 'associated', 'with', 'less', 'aki', '.', 'therefore', ',', 'impaired', 'nad', 'biosynthesis', 'may', 'feature', 'of', 'high-risk', 'hospitalization', 'nad', 'augmentation', 'could', 'beneficial', '.']"
Inhaled Epoprostenol Compared With Nitric Oxide for Right Ventricular Support After Major Cardiac Surgery.,"Kamrouz Ghadimi, Jhaymie L Cappiello, Mary Cooter Wright, Jerrold H Levy, Benjamin S Bryner, Adam D DeVore, Jacob N Schroder, Chetan B Patel, Sudarshan Rajagopal, Svati H Shah, Carmelo A Milano                              ;, INSPIRE-FLO Investigators, Kamrouz Ghadimiet al.",2023 Oct 24,Circulation,https://pubmed.ncbi.nlm.nih.gov/37401479/,No keywords found,"['right', 'ventricular', 'failure', '(', 'rvf', ')', 'leading', 'driver', 'of', 'morbidity', 'and', 'death', 'major', 'cardiac', 'surgery', 'advanced', 'heart', 'failure', ',', 'including', 'orthotopic', 'heart', 'transplantation', 'and', 'left', 'ventricular', 'assist', 'device', 'implantation', '.', 'inhaled', 'pulmonary-selective', 'vasodilator', ',', 'inhaled', 'epoprostenol', '(', 'iepo', ')', 'and', 'nitric', 'oxide', '(', 'ino', ')', ',', 'essential', 'therapeutic', 'prevention', 'and', 'medical', 'management', 'of', 'postoperative', 'rvf', '.', 'however', ',', 'limited', 'evidence', 'clinical', 'trial', 'to', 'guide', 'agent', 'selection', 'despite', 'significant', 'cost', 'consideration', 'of', 'ino', 'therapy', '.', 'method', 'in', 'double-blind', 'trial', ',', 'participant', 'stratified', 'assigned', 'surgery', 'and', 'key', 'preoperative', 'prognostic', 'feature', ',', 'randomized', 'to', 'continuously', 'receive', 'either', 'iepo', 'or', 'ino', 'beginning', 'time', 'of', 'separation', 'cardiopulmonary', 'bypass', 'with', 'continuation', 'of', 'treatment', 'intensive', 'care', 'unit', 'stay', '.', 'primary', 'outcome', 'composite', 'rvf', 'rate', 'operation', ',', 'defined', 'transplantation', 'initiation', 'of', 'mechanical', 'circulatory', 'support', 'isolated', 'rvf', ',', 'and', 'defined', 'left', 'ventricular', 'assist', 'device', 'implantation', 'moderate', 'or', 'severe', 'right', 'heart', 'failure', 'according', 'to', 'criterion', 'interagency', 'registry', 'mechanically', 'assisted', 'circulatory', 'support', '.', 'equivalence', 'margin', 'of', 'percentage', 'point', 'prespecified', 'between-group', 'rvf', 'risk', 'difference', '.', 'secondary', 'postoperative', 'outcome', 'assessed', 'treatment', 'difference', 'and', 'included', 'mechanical', 'ventilation', 'duration', 'hospital', 'and', 'intensive', 'care', 'unit', 'length', 'of', 'stay', 'index', 'hospitalization', 'acute', 'kidney', 'injury', 'development', 'including', 'renal', 'replacement', 'therapy', 'initiation', 'and', 'death', 'day', ',', 'day', ',', 'and', 'year', 'surgery', '.', 'result', 'of', 'randomized', 'participant', 'met', 'eligibility', 'time', 'of', 'surgery', ',', 'received', 'iepo', ',', 'and', 'received', 'ino', '.', 'primary', 'outcome', 'occurred', 'in', 'participant', '(', '.', ')', 'in', 'iepo', 'group', 'and', 'participant', '(', '.', ')', 'in', 'ino', 'group', ',', 'risk', 'difference', 'of', '.', 'percentage', 'point', '(', 'two', 'one-sided', 'test', 'ci', ',', '-', '.', 'to', '.', ')', 'in', 'support', 'of', 'equivalence', '.', 'no', 'significant', 'between-group', 'difference', 'of', 'measured', 'postoperative', 'secondary', 'outcome', '.', 'conclusion', 'among', 'patient', 'undergoing', 'major', 'cardiac', 'surgery', 'advanced', 'heart', 'failure', ',', 'inhaled', 'pulmonary-selective', 'vasodilator', 'treatment', 'using', 'iepo', 'associated', 'with', 'similar', 'risk', 'rvf', 'development', 'and', 'development', 'of', 'postoperative', 'secondary', 'outcome', 'compared', 'with', 'treatment', 'using', 'ino', '.', 'registration', 'url', 'httpswww', '.', 'clinicaltrials', 'gov', 'unique', 'identifier', 'nct', '.']"
"RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.","Johann Motsch, Cláudia Murta de Oliveira, Viktor Stus, Iftihar Köksal, Olexiy Lyulko, Helen W Boucher, Keith S Kaye, Thomas M File, Michelle L Brown, Ireen Khan, Jiejun Du, Hee-Koung Joeng, Robert W Tipping, Angela Aggrey, Katherine Young, Nicholas A Kartsonis, Joan R Butterton, Amanda Paschke, Johann Motschet al.",2020 Apr 15,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/31400759/,No keywords found,"['-lactamase', 'inhibitor', 'relebactam', 'restore', 'imipenem', 'activity', 'imipenem-nonsusceptible', 'gram-negative', 'pathogen', '.', 'evaluated', 'imipenemrelebactam', 'treating', 'imipenem-nonsusceptible', 'infection', '.', 'method', 'randomized', ',', 'controlled', ',', 'double-blind', ',', 'phase', 'trial', '.', 'hospitalized', 'patient', 'with', 'hospital-acquiredventilator-associated', 'pneumonia', ',', 'complicated', 'intraabdominal', 'infection', ',', 'or', 'complicated', 'urinary', 'tract', 'infection', 'caused', 'imipenem-nonsusceptible', '(', 'colistin-', 'and', 'imipenemrelebactam-susceptible', ')', 'pathogen', 'randomized', 'to', '-', 'day', 'imipenemrelebactam', 'or', 'colistinimipenem', '.', 'primary', 'endpoint', 'favorable', 'overall', 'response', '(', 'defined', 'relevant', 'endpoint', 'infection', 'type', ')', 'in', 'modified', 'microbiologic', 'intent-to-treat', '(', 'mmitt', ')', 'population', '(', 'qualifying', 'baseline', 'pathogen', 'and', 'dose', 'study', 'treatment', ')', '.', 'secondary', 'endpoint', 'clinical', 'response', ',', 'all-cause', 'mortality', ',', 'and', 'treatment-emergent', 'nephrotoxicity', '.', 'safety', 'analysis', 'included', 'patient', 'with', 'dose', 'study', 'treatment', '.', 'result', 'thirty-one', 'patient', 'received', 'imipenemrelebactam', 'and', 'colistinimipenem', '.', 'among', 'mitt', 'patient', '(', 'n', 'imipenemrelebactam', ',', 'n', 'colistinimipenem', ')', ',', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', 'ii', 'score', ',', 'creatinine', 'clearance', 'mlmin', ',', 'and', 'aged', 'year', '.', 'qualifying', 'baseline', 'pathogen', 'pseudomonas', 'aeruginosa', '(', ')', ',', 'klebsiella', 'spp', '.', '(', ')', ',', 'enterobacteriaceae', '(', ')', '.', 'favorable', 'overall', 'response', 'observed', 'in', 'imipenemrelebactam', 'and', 'colistinimipenem', 'patient', '(', 'confidence', 'interval', 'ci', 'difference', ',', '-.', ',', '.', ')', ',', 'day', 'favorable', 'clinical', 'response', 'in', 'and', '(', 'ci', ',', '.', ',', '.', ')', ',', 'and', '-day', 'mortality', 'in', 'and', '(', 'ci', ',', '-.', ',', '.', ')', ',', 'respectively', '.', 'serious', 'adverse', 'event', '(', 'aes', ')', 'occurred', 'in', 'of', 'imipenemrelebactam', 'and', 'of', 'colistinimipenem', 'patient', ',', 'drug-related', 'aes', 'in', 'and', '(', 'no', 'drug-related', 'death', ')', ',', 'and', 'treatment-emergent', 'nephrotoxicity', 'in', 'and', '(', 'p', '.', ')', ',', 'respectively', '.', 'conclusion', 'imipenemrelebactam', 'efficacious', 'and', 'well-tolerated', 'treatment', 'option', 'carbapenem-nonsusceptible', 'infection', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Simplified Rapid Hydration Prevents Contrast-Associated Acute Kidney Injury Among CKD Patients Undergoing Coronary Angiography.,"Yong Liu, Ning Tan, Yong Huo, Shi-Qun Chen, Jin Liu, Yan Wang, Lang Li, Jian-Hong Tao, Xi Su, Li Zhang, Qing-Xian Li, Jin-Ying Zhang, Yan-Song Guo, Zhi-Min Du, Yin-Pin Zhou, Zhen-Fei Fang, Guang-Ma Xu, Yan Liang, Ling Tao, Hui Chen, Zheng Ji, Bing Han, Ping-Yan Chen, Jun-Bo Ge, Ya-Ling Han, Ji-Yan Chen, Yong Liuet al.",2023 Jun 26,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/37380233/,No keywords found,"['patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'undergoing', 'coronary', 'angiography', '(', 'cag', ')', 'high', 'risk', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', 'and', 'mortality', '.', 'therefore', ',', 'clinical', 'need', 'to', 'explore', 'safe', ',', 'convenient', ',', 'and', 'effective', 'strategy', 'preventing', 'ca-aki', '.', 'objective', 'study', 'sought', 'to', 'assess', 'whether', 'simplified', 'rapid', 'hydration', 'noninferior', 'to', 'standard', 'hydration', 'ca-aki', 'prevention', 'in', 'patient', 'with', 'ckd', '.', 'method', 'multicenter', ',', 'open-label', ',', 'randomized', 'controlled', 'study', 'conducted', 'across', 'teaching', 'hospital', 'and', 'included', ',', 'patient', 'with', 'ckd', '.', 'patient', 'randomized', 'to', 'either', 'simplified', 'hydration', '(', 'sh', ')', '(', 'sh', 'group', ',', 'with', 'normal', 'saline', 'hour', 'to', 'hour', 'cag', 'rate', 'of', 'mlkgh', ')', 'or', 'standard', 'hydration', '(', 'control', 'group', ',', 'with', 'normal', 'saline', 'hour', 'and', 'hour', 'cag', 'rate', 'of', 'mlkgh', ')', '.', 'primary', 'endpoint', 'of', 'ca-aki', 'or', '.-mgdl', 'rise', 'in', 'serum', 'creatinine', 'baseline', 'within', 'to', 'hour', '.', 'result', 'ca-aki', 'occurred', 'in', 'of', '(', '.', ')', 'patient', 'in', 'sh', 'group', 'and', 'in', 'of', '(', '.', ')', 'patient', 'in', 'control', 'group', '(', 'relative', 'risk', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'in', 'addition', ',', 'risk', 'of', 'acute', 'heart', 'failure', 'and', '-year', 'major', 'adverse', 'cardiovascular', 'event', 'not', 'differ', 'significantly', 'group', '.', 'however', ',', 'median', 'hydration', 'duration', 'significantly', 'shorter', 'in', 'sh', 'group', 'in', 'control', 'group', '(', 'v', 'hour', 'p', '.', ')', '.', 'conclusion', 'in', 'ckd', 'patient', 'undergoing', 'cag', ',', 'sh', 'noninferior', 'to', 'standard', 'hydration', 'in', 'preventing', 'ca-aki', 'with', 'shorter', 'hydration', 'duration', '.']"
Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.,"Ryan M Brown, Li Wang, Taylor D Coston, Nathan I Krishnan, Jonathan D Casey, Jonathan P Wanderer, Jesse M Ehrenfeld, Daniel W Byrne, Joanna L Stollings, Edward D Siew, Gordon R Bernard, Wesley H Self, Todd W Rice, Matthew W Semler, Ryan M Brownet al.",2019 Dec 15,Am J Respir Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/31454263/,"balanced crystalloids, lactated Ringer’s, saline, sepsis, septic shock.","['administration', 'of', 'intravenous', 'crystalloid', 'solution', 'fundamental', 'therapy', 'sepsis', ',', 'effect', 'of', 'crystalloid', 'composition', 'patient', 'outcome', 'remains', 'unknown.objectives', 'to', 'compare', 'effect', 'of', 'balanced', 'crystalloids', 'versus', 'saline', '-day', 'in-hospital', 'mortality', 'among', 'critically', 'ill', 'adult', 'with', 'sepsis.methods', 'secondary', 'analysis', 'of', 'patient', 'smart', '(', 'isotonic', 'solution', 'and', 'major', 'adverse', 'renal', 'event', 'trial', ')', 'admitted', 'to', 'medical', 'icu', 'with', 'international', 'classification', 'of', 'disease', ',', 'th', 'edition', ',', 'clinical', 'modification', 'system', 'code', 'sepsis', ',', 'using', 'multivariable', 'regression', 'to', 'control', 'potential', 'confounders.measurements', 'and', 'main', 'result', 'of', ',', 'patient', 'enrolled', 'in', 'smart', ',', ',', 'patient', 'admitted', 'to', 'medical', 'icu', 'with', 'diagnosis', 'of', 'sepsis', '.', 'total', 'of', 'patient', '(', '.', ')', 'in', 'balanced', 'crystalloids', 'group', 'experienced', '-day', 'in-hospital', 'morality', 'compared', 'with', 'patient', '(', '.', ')', 'in', 'saline', 'group', '(', 'adjusted', 'odds', 'ratio', 'aor', ',', '.', 'confidence', 'interval', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'patient', 'in', 'balanced', 'group', 'experienced', 'lower', 'incidence', 'of', 'major', 'adverse', 'kidney', 'event', 'within', 'day', '(', '.', 'vs.', '.', 'aor', ',', '.', 'ci', ',', '.-', '.', ')', 'and', 'greater', 'number', 'of', 'vasopressor-free', 'day', '(', 'vs.', 'aor', ',', '.', 'ci', ',', '.-', '.', ')', 'and', 'renal', 'replacement', 'therapy-free', 'day', '(', 'vs.', 'aor', ',', '.', 'ci', ',', '.-', '.', ')', 'compared', 'with', 'saline', 'group.conclusions', 'among', 'patient', 'with', 'sepsis', 'in', 'large', 'randomized', 'trial', ',', 'use', 'of', 'balanced', 'crystalloids', 'associated', 'with', 'lower', '-day', 'in-hospital', 'mortality', 'compared', 'with', 'use', 'of', 'saline.clinical', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', '(', 'nct', ')', '.']"
Combination of Vancomycin and beta-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.,"Joshua S Davis, Archana Sud, Matthew V N O'Sullivan, James O Robinson, Patricia E Ferguson, Hong Foo, Sebastiaan J van Hal, Anna P Ralph, Benjamin P Howden, Paula M Binks, Adrienne Kirby, Steven Y C Tong                                                            ;, Combination Antibiotics for MEthicillin Resistant                    Staphylococcus aureus (CAMERA) study group;, Steven Tong, Joshua Davis, Paula Binks, Suman Majumdar, Anna Ralph, Rob Baird, Claire Gordon, Cameron Jeremiah, Grace Leung, Anna Brischetto, Amy Crowe, Farshid Dakh, Kelly Whykes, Maria Kirkwood, Mahesh Menon, Lucy Somerville, Shrada Subedi, Shirley Owen, Matthew O'Sullivan, Eunice Liu, Fei Zhou, Owen Robinson, Geoffrey Coombs, Patrician Ferguson, Simon Pollet, Sebastian Van Hal, Rebecca Davis, Joshua S Daviset al.",2016 Jan 15,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/26349552/,No keywords found,"['in', 'vitro', 'laboratory', 'and', 'animal', 'study', 'demonstrate', 'synergistic', 'role', 'combination', 'of', 'vancomycin', 'and', 'antistaphylococcal', '-lactams', 'methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', 'bacteremia', '.', 'prospective', 'clinical', 'data', 'lacking', '.', 'method', 'in', 'open-label', ',', 'multicenter', ',', 'clinical', 'trial', ',', 'adult', 'with', 'mrsa', 'bacteremia', 'received', 'vancomycin', '.', 'g', 'intravenously', 'twice', 'daily', 'and', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'intravenous', 'flucloxacillin', 'g', 'every', 'hour', 'day', '(', 'combination', 'group', ')', 'or', 'no', 'additional', 'therapy', '(', 'standard', 'therapy', 'group', ')', '.', 'participant', 'stratified', 'hospital', 'and', 'randomized', 'in', 'permuted', 'block', 'of', 'variable', 'size', '.', 'randomization', 'code', 'kept', 'in', 'sealed', ',', 'sequentially', 'numbered', ',', 'opaque', 'envelope', '.', 'primary', 'outcome', 'duration', 'of', 'mrsa', 'bacteremia', 'in', 'day', '.', 'result', 'randomly', 'assigned', 'patient', 'to', 'receive', 'vancomycin', '(', 'n', ')', ',', 'or', 'vancomycin', 'plus', 'flucloxacillin', '(', 'n', ')', '.', 'mean', 'duration', 'of', 'bacteremia', '.', 'day', 'in', 'standard', 'therapy', 'group', 'and', '.', 'day', 'in', 'combination', 'group', '.', 'according', 'to', 'negative', 'binomial', 'model', ',', 'mean', 'time', 'to', 'resolution', 'of', 'bacteremia', 'in', 'combination', 'group', '(', 'confidence', 'interval', ',', '-', 'p', '.', ')', 'in', 'standard', 'therapy', 'group', '.', 'no', 'difference', 'in', 'secondary', 'end', 'point', 'of', '-', 'and', '-day', 'mortality', ',', 'metastatic', 'infection', ',', 'nephrotoxicity', ',', 'or', 'hepatotoxicity', '.', 'conclusion', 'combining', 'antistaphylococcal', '-lactam', 'with', 'vancomycin', 'may', 'shorten', 'duration', 'of', 'mrsa', 'bacteremia', '.', 'trial', 'with', 'larger', 'sample', 'size', 'and', 'objective', 'clinically', 'relevant', 'end', 'point', 'warranted', '.', 'australian', 'new', 'zealand', 'clinical', 'trial', 'registry', 'actrn', '(', 'www.anzctr.org.au', ')', '.']"
"Efficacy of Furosemide, Oral Sodium Chloride, and Fluid Restriction for Treatment of Syndrome of Inappropriate Antidiuresis (SIAD): An Open-label Randomized Controlled Study (The EFFUSE-FLUID Trial).","Pajaree Krisanapan, Surachet Vongsanim, Pathomporn Pin-On, Chidchanok Ruengorn, Kajohnsak Noppakun, Pajaree Krisanapanet al.",2020 Aug,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/32199708/,No keywords found,"['first-line', 'therapy', 'syndrome', 'of', 'inappropriate', 'antidiuresis', '(', 'siad', ')', 'fluid', 'restriction', '.', 'additional', 'treatment', 'patient', 'not', 'respond', 'to', 'fluid', 'restriction', 'water', 'restriction', 'with', 'furosemide', 'or', 'water', 'restriction', 'with', 'furosemide', 'and', 'salt', 'supplementation', '.', 'however', ',', 'efficacy', 'of', 'treatment', 'never', 'tested', 'in', 'randomized', 'controlled', 'study', '.', 'objective', 'of', 'study', 'to', 'investigate', 'whether', ',', 'combined', 'with', 'fluid', 'restriction', ',', 'furosemide', 'with', 'or', 'without', 'sodium', 'chloride', '(', 'nacl', ')', 'supplementation', 'effective', 'fluid', 'restriction', 'alone', 'in', 'treatment', 'of', 'hyponatremia', 'in', 'siad', '.', 'study', 'design', 'open-label', 'randomized', 'controlled', 'study', '.', 'setting', 'participant', 'patient', 'with', 'serum', 'sodium', 'concentration', '(', 'na', ')', 'mmoll', 'due', 'to', 'siad', '.', 'intervention', '(', ')', 'random', 'assignment', 'to', 'of', 'group', 'fluid', 'restriction', 'alone', '(', 'fr', ')', ',', 'fluid', 'restriction', 'and', 'furosemide', '(', 'frfm', ')', ',', 'or', 'fluid', 'restriction', ',', 'furosemide', ',', 'and', 'nacl', '(', 'frfmnacl', ')', '.', 'strictness', 'of', 'fluid', 'restriction', '(', ',', 'ormld', ')', 'guided', 'urine', 'to', 'serum', 'electrolyte', 'ratio', '.', 'furosemide', 'dosage', 'to', 'mgd', '.', 'nacl', 'supplement', 'gd', '.', 'treatment', 'continued', 'day', '.', 'outcome', 'primary', 'outcome', 'change', 'in', 'na', 'day', ',', ',', ',', 'and', 'randomization', '.', 'result', 'patient', 'recruited', '(', 'fr', ',', 'n', 'frfm', ',', 'n', 'frfmnacl', ',', 'n', ')', '.', 'baseline', 'na', 'mmoll', ',', 'and', 'no', 'significant', 'difference', 'group', '.', 'mean', 'na', 'day', 'in', 'treatment', 'group', 'significantly', 'increased', 'baseline', 'mmoll', '(', 'p.', ')', 'however', ',', 'change', 'in', 'na', 'not', 'significantly', 'different', 'across', 'group', '(', 'p.', ')', '.', 'no', 'significant', 'difference', 'in', 'percentage', 'of', 'patient', 'or', 'time', 'to', 'reach', 'na', 'ormmoll', 'across', 'group', '.', 'acute', 'kidney', 'injury', 'and', 'hypokalemia', '(', 'potassium.mmoll', ')', 'common', 'in', 'patient', 'receiving', 'furosemide', '.', 'limitation', 'open-label', 'treatment', '.', 'conclusion', 'in', 'patient', 'with', 'siad', ',', 'furosemide', 'with', 'nacl', 'supplement', 'in', 'combination', 'with', 'fluid', 'restriction', 'not', 'show', 'benefit', 'in', 'correction', 'of', 'na', 'compared', 'with', 'treatment', 'with', 'fluid', 'restriction', 'alone', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', 'and', 'hypokalemia', 'increased', 'in', 'patient', 'receiving', 'furosemide', '.', 'funding', 'none', '.', 'trial', 'registration', 'registered', 'thai', 'clinical', 'trial', 'registry', 'with', 'study', 'number', 'tctr', '.']"
Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial.,"Suvi T Vaara, Marlies Ostermann, Laurent Bitker, Antoine Schneider, Elettra Poli, Eric Hoste, Jan Fierens, Michael Joannidis, Alexander Zarbock, Frank van Haren, John Prowle, Tuomas Selander, Minna Bäcklund, Ville Pettilä, Rinaldo Bellomo                                                            ;, REVERSE-AKI study team, Rinaldo Bellomo, Suvi Vaara, Glenn Eastwood, Liam Byrne, Mary Nourse, Samantha Adam, Clare Robertson, Josie Russell-Brown, Shakira Spiller, Pieter Nepuydt, Daisy Vermeiren, Ingrid Herck, Druwe Patrick, Luc De Crop, Stephanie Bracke, Andy Retter, Sara Campos, Gill Arbane, Andrea Kelly, Neus Grau Novellas, Rosario Lim, Martina Marotti, Aneta Bociek, Tim Jones, Christopher Whitton, Andrew Slack, Luigi Camporota, Simon Sparkes, Duncan Wyncoll, Jonna Heinonen, Leena Pettilä, Sari Sutinen, Elina Lappi, Marco Altarelli, Michel Thibault, Philippe Eckert, Madeleine Schnorf, Ryan Haines, Richard Cashmore, Alex Fowler, Filipa Dos Santos, Amaia Garcia, Maria Fernandez, Tim Martin, Ruzena Uddin, Suvi T Vaaraet al.",2021 Jun,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/33961058/,No keywords found,"['compared', 'restrictive', 'fluid', 'management', 'strategy', 'to', 'usual', 'care', 'among', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'received', 'initial', 'fluid', 'resuscitation', '.', 'method', 'multicenter', 'feasibility', 'trial', 'randomized', 'aki', 'patient', 'in', 'seven', 'icu', 'in', 'europe', 'and', 'australia', '.', 'restrictive', 'fluid', 'management', 'included', 'targeting', 'negative', 'or', 'neutral', 'daily', 'fluid', 'balance', 'minimizing', 'fluid', 'input', 'andor', 'enhancing', 'urine', 'output', 'with', 'diuretic', 'administered', 'discretion', 'of', 'clinician', '.', 'fluid', 'bolus', 'administered', 'clinically', 'indicated', '.', 'primary', 'endpoint', 'cumulative', 'fluid', 'balance', 'h', 'randomization', '.', 'result', 'mean', '(', 'sd', ')', 'cumulative', 'fluid', 'balance', 'h', 'randomization', '-', 'ml', '(', 'ml', ')', 'in', 'restrictive', 'fluid', 'management', 'arm', 'and', 'ml', '(', 'ml', ')', 'in', 'usual', 'care', 'arm', ',', 'mean', 'difference', '(', 'ci', ')', '-', 'ml', '(', '-', 'to', '-', ')', 'ml', ',', 'p', '..', 'median', 'iqr', 'duration', 'of', 'aki', '-', 'and', '-', 'day', ',', 'respectively', '(', 'median', 'difference', '-', '.', '-', '.', 'to', '.', ',', 'p', '.', ')', '.', 'altogether', ',', 'of', '(', ')', 'patient', 'in', 'restrictive', 'fluid', 'management', 'arm', 'and', 'of', '(', ')', 'in', 'usual', 'care', 'arm', 'received', 'renal', 'replacement', 'therapy', '(', 'rr', '.', 'ci', '.-', '.', ')', ',', 'p', '..', 'cumulative', 'fluid', 'balance', 'h', 'and', 'day', 'lower', 'in', 'restrictive', 'fluid', 'management', 'arm', '.', 'dose', 'of', 'diuretic', 'not', 'different', 'group', '.', 'adverse', 'event', 'occurred', 'frequently', 'in', 'usual', 'care', 'arm', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'aki', ',', 'restrictive', 'fluid', 'management', 'regimen', 'resulted', 'in', 'lower', 'cumulative', 'fluid', 'balance', 'and', 'less', 'adverse', 'event', 'compared', 'to', 'usual', 'care', '.', 'larger', 'trial', 'of', 'intervention', 'justified', '.']"
Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.,"Jocelyn Fotso Soh, Susana G Torres-Platas, Serge Beaulieu, Outi Mantere, Robert Platt, Istvan Mucsi, Sybille Saury, Suzane Renaud, Andrea Levinson, Ana C Andreazza, Benoit H Mulsant, Daniel Müller, Ayal Schaffer, Annemiek Dols, Pablo Cervantes, Nancy Cp Low, Nathan Herrmann, Birgitte M Christensen, Francesco Trepiccione, Tarek Rajji, Soham Rej, Jocelyn Fotso Sohet al.",2018 Jul 16,BMC Psychiatry,https://pubmed.ncbi.nlm.nih.gov/30012135/,No keywords found,"['lithium', 'gold-standard', 'treatment', 'bipolar', 'disorder', ',', 'highly', 'effective', 'in', 'treating', 'major', 'depressive', 'disorder', ',', 'and', 'anti-suicidal', 'property', '.', 'however', ',', 'clinician', 'increasingly', 'avoiding', 'lithium', 'largely', 'due', 'to', 'fear', 'of', 'renal', 'toxicity', '.', 'nephrogenic', 'diabetes', 'insipidus', '(', 'ndi', ')', 'occurs', 'in', '-', 'of', 'lithium', 'user', 'and', 'predicts', '-', 'time', 'increased', 'risk', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'recently', 'found', 'use', 'of', 'statin', 'associated', 'with', 'lower', 'ndi', 'risk', 'in', 'cross-sectional', 'study', '.', 'in', 'current', 'paper', ',', 'describe', 'methodology', 'of', 'randomized', 'controlled', 'trial', '(', 'rct', ')', 'to', 'treat', 'lithium-induced', 'ndi', 'using', 'atorvastatin', '.', 'method', 'conduct', '-week', ',', 'double-blind', 'placebo-controlled', 'rct', 'of', 'atorvastatin', 'lithium-induced', 'ndi', 'mcgill', 'university', ',', 'montreal', ',', 'canada', '.', 'recruit', 'current', 'lithium', 'user', ',', 'aged', '-', ',', 'indicator', 'of', 'ndi', ',', 'defined', 'urine', 'osmolality', '(', 'uosm', ')', 'mosmkg', '-h', 'fluid', 'restriction', '.', 'randomize', 'patient', 'to', 'atorvastatin', '(', 'mgday', ')', 'or', 'placebo', 'week', '.', 'examine', 'whether', 'improves', 'measure', 'of', 'ndi', 'uosm', 'and', 'aquaporin', '(', 'aqp', ')', 'excretion', '-week', 'follow-up', ',', 'adjusted', 'baseline', '.', 'result', 'not', 'applicable', '.', 'conclusion', 'aim', 'of', 'clinical', 'trial', 'to', 'provide', 'preliminary', 'data', 'efficacy', 'of', 'atorvastatin', 'in', 'treating', 'ndi', '.', 'successful', ',', 'lithium', 'could', 'theoretically', 'used', 'safely', 'in', 'patient', 'with', 'reduced', 'subsequent', 'risk', 'of', 'ckd', ',', 'hypernatremia', ',', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'future', 'definitive', 'trial', 'confirm', ',', 'could', 'potentially', 'allow', 'patient', 'to', 'benefit', 'lithium', ',', 'minimizing', 'renal', 'risk', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'registered', 'in', 'february', '.']"
"Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.","Axel S Merseburger, Gerhardt Attard, Lennart Åström, Vsevolod B Matveev, Sergio Bracarda, Adil Esen, Susan Feyerabend, Elżbieta Senkus, Marta López-Brea Piqueras, Gunther Boysen, Georgia Gourgioti, Karla Martins, Simon Chowdhury, Axel S Merseburgeret al.",2022 Nov,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/36265504/,No keywords found,"['although', 'androgen', 'deprivation', 'therapy', 'typically', 'given', 'long-term', 'men', 'with', 'metastatic', 'prostate', 'cancer', ',', 'second-generation', 'hormone', 'therapy', 'generally', 'discontinued', 'subsequent', 'line', 'of', 'treatment', '.', 'aimed', 'to', 'evaluate', 'efficacy', 'of', 'continuing', 'enzalutamide', 'progression', 'in', 'controlling', 'metastatic', 'castration-resistant', 'prostate', 'cancer', '(', 'mcrpc', ')', 'treated', 'with', 'docetaxel', 'and', 'prednisolone', '.', 'method', 'preside', 'two-period', ',', 'multinational', ',', 'double-blind', ',', 'randomised', ',', 'placebo-controlled', ',', 'phase', 'b', 'study', 'done', 'site', 'in', 'europe', '(', 'in', 'austria', ',', 'belgium', ',', 'czech', 'republic', ',', 'france', ',', 'germany', ',', 'greece', ',', 'italy', ',', 'netherlands', ',', 'norway', ',', 'poland', ',', 'russia', ',', 'spain', ',', 'sweden', ',', 'switzerland', ',', 'turkey', ',', 'and', 'uk', ')', '.', 'patient', 'eligible', 'period', '(', 'p', ')', 'of', 'study', 'histologically', 'confirmed', 'prostate', 'adenocarcinoma', 'without', 'neuroendocrine', 'differentiation', 'or', 'small-cell', 'feature', ',', 'serum', 'testosterone', 'concentration', 'of', 'nmoll', 'or', 'less', ',', 'and', 'progressed', 'androgen', 'deprivation', 'therapy', 'with', 'luteinising', 'hormone-releasing', 'hormone', 'agonist', 'or', 'antagonist', 'or', 'bilateral', 'orchiectomy', '.', 'in', 'p', ',', 'patient', 'received', 'open-label', 'enzalutamide', 'mg', 'per', 'day', 'orally', '.', 'week', ',', 'patient', 'assessed', 'either', 'radiographic', 'or', 'prostate-specific', 'antigen', '(', 'psa', ')', 'progression', '(', 'or', 'increase', 'and', 'ngml', 'or', 'nadir', ')', '.', 'patient', 'showed', 'decline', 'in', 'psa', 'week', 'and', 'subsequently', 'progressed', '(', 'radiographic', 'progression', ',', 'psa', 'progression', ',', 'or', ')', 'screened', 'and', 'enrolled', 'in', 'period', '(', 'p', ')', ',', 'eligible', 'patient', 'treated', 'with', 'to', 'ten', 'cycle', 'of', 'intravenous', 'docetaxel', 'mgm', 'every', 'week', 'and', 'oral', 'prednisolone', 'mgday', ',', 'and', 'randomly', 'assigned', '(', ')', 'to', 'oral', 'enzalutamide', 'mgday', 'or', 'oral', 'placebo', '.', 'patient', 'stratified', 'type', 'of', 'disease', 'progression', '.', 'block', 'size', 'four', 'and', 'overall', 'number', 'of', 'block', '.', 'patient', ',', 'investigator', ',', 'and', 'study', 'organiser', 'masked', 'to', 'treatment', 'assignment', '.', 'primary', 'endpoint', 'progression-free', 'survival', 'analysed', 'in', 'patient', 'in', 'p.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'no', 'longer', 'recruiting', '.', 'finding', 'dec', ',', ',', 'and', 'feb', ',', ',', 'patient', 'screened', 'p', 'of', 'study', '.', 'patient', 'enrolled', 'in', 'p', 'and', 'received', 'open-label', 'enzalutamide', '.', 'in', 'p', ',', 'patient', 'randomly', 'assigned', 'site', 'to', 'receive', 'enzalutamide', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', '.', 'data', 'cutoff', 'analysis', 'april', ',', '.', 'median', 'progression-free', 'survival', 'with', 'enzalutamide', 'month', '(', 'ci', '-', ')', 'versus', 'month', '(', '-', ')', 'with', 'placebo', '(', 'hazard', 'ratio', 'ci', '-', 'p', ')', '.', 'common', 'grade', 'treatment-emergent', 'adverse', 'event', 'neutropenia', '(', 'of', 'patient', 'in', 'enzalutamide', 'group', 'v', 'of', 'patient', 'in', 'placebo', 'group', ')', 'and', 'asthenia', '(', 'ten', 'v', 'six', ')', '.', 'common', 'grade', 'treatment-emergent', 'adverse', 'event', 'in', 'p', 'neutropenia', '(', 'of', 'patient', 'in', 'enzalutamide', 'group', 'v', 'of', 'patient', 'in', 'placebo', 'group', ')', '.', 'serious', 'treatment-emergent', 'adverse', 'event', 'reported', 'in', '(', ')', 'of', 'patient', 'in', 'enzalutamide', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'placebo', 'group', '.', 'two', '(', ')', 'of', 'death', 'in', 'enzalutamide', 'group', '(', 'caused', 'septic', 'shock', 'and', 'haematuria', ')', 'and', 'one', '(', ')', 'of', 'seven', 'death', 'in', 'placebo', 'group', '(', 'caused', 'actue', 'kidney', 'injury', ')', 'associated', 'with', 'docetaxel', '.', 'interpretation', 'preside', 'met', 'primary', 'endpoint', 'and', 'showed', 'continuing', 'enzalutamide', 'with', 'docetaxel', 'plus', 'androgen', 'deprivation', 'therapy', 'delayed', 'time', 'to', 'progression', 'compared', 'with', 'docetaxel', 'plus', 'androgen', 'deprivation', 'therapy', 'alone', ',', 'supporting', 'hypothesis', 'enzalutamide', 'maintenance', 'could', 'control', 'persistent', 'androgen-dependent', 'clone', 'in', 'men', 'with', 'mcrpc', 'progress', 'treatment', 'with', 'enzalutamide', 'alone', '.', 'funding', 'astellas', 'pharma', 'and', 'pfizer', '.']"
Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis.,"Gustavo A Ospina-Tascón, Glenn Hernandez, Ingrid Alvarez, Luis E Calderón-Tapia, Ramiro Manzano-Nunez, Alvaro I Sánchez-Ortiz, Egardo Quiñones, Juan E Ruiz-Yucuma, José L Aldana, Jean-Louis Teboul, Alexandre Biasi Cavalcanti, Daniel De Backer, Jan Bakker, Gustavo A Ospina-Tascónet al.",2020 Feb 14,Crit Care,https://pubmed.ncbi.nlm.nih.gov/32059682/,No keywords found,"['optimal', 'timing', 'start', 'of', 'vasopressor', '(', 'vp', ')', 'in', 'septic', 'shock', 'not', 'widely', 'studied', 'since', 'assumed', 'fluid', 'must', 'administered', 'in', 'advance', '.', 'sought', 'to', 'evaluate', 'whether', 'early', 'start', 'of', 'vp', ',', 'even', 'without', 'completing', 'initial', 'fluid', 'loading', ',', 'might', 'impact', 'clinical', 'outcome', 'in', 'septic', 'shock', '.', 'method', 'total', 'of', 'patient', 'with', 'sepsis', 'requiring', 'vp', 'support', 'least', 'h', 'initially', 'selected', 'prospectively', 'collected', 'database', 'in', '-bed', 'mixed-icu', '-month', 'period', '.', 'classified', 'very-early', '(', 've-vps', ')', 'or', 'delayed', 'vasopressor', 'start', '(', 'd-vps', ')', 'category', 'according', 'to', 'whether', 'norepinephrine', 'initiated', 'or', 'not', 'withinbefore', 'next', 'hour', 'of', 'first', 'resuscitative', 'fluid', 'load', '.', ',', 've-vps', '(', 'n', ')', 'patient', 'propensity', 'matched', 'to', 'd-vps', '(', 'n', ')', 'based', 'age', 'source', 'of', 'admission', '(', 'emergency', 'room', ',', 'general', 'ward', ',', 'intensive', 'care', 'unit', ')', 'chronic', 'and', 'acute', 'comorbidities', 'and', 'lactate', ',', 'heart', 'rate', ',', 'systolic', ',', 'and', 'diastolic', 'pressure', 'vasopressor', 'start', '.', 'risk-adjusted', 'cox', 'proportional', 'hazard', 'model', 'fitted', 'to', 'assess', 'association', 've-vps', 'and', 'day', 'mortality', '.', 'finally', ',', 'sensitivity', 'analysis', 'performed', 'also', 'including', 'patient', 'requiring', 'vp', 'support', 'less', 'h.', 'result', 'patient', 'subjected', 'to', 've-vps', 'received', 'significantly', 'less', 'resuscitation', 'fluid', 'vasopressor', 'starting', '(', '-', 'vs.', '-', 'ml', ',', 'p', '.', ')', 'and', 'first', 'h', 'of', 'resuscitation', '(', '-', 'vs.', '-', 'ml', ',', 'p', '.', ')', ',', 'with', 'no', 'significant', 'increase', 'in', 'acute', 'renal', 'failure', 'andor', 'renal', 'replacement', 'therapy', 'requirement', '.', 've-vps', 'related', 'with', 'significant', 'lower', 'net', 'fluid', 'balance', 'and', 'h', 'vps', '.', 've-vps', 'also', 'associated', 'with', 'significant', 'reduction', 'in', 'risk', 'of', 'death', 'compared', 'to', 'd-vps', '(', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'day', '.', 'association', 'maintained', 'including', 'patient', 'receiving', 'vasopressor', 'h.', 'conclusion', 'early', 'start', 'of', 'vasopressor', 'support', 'seems', 'to', 'safe', ',', 'might', 'limit', 'amount', 'of', 'fluid', 'to', 'resuscitate', 'septic', 'shock', ',', 'and', 'could', 'lead', 'to', 'better', 'clinical', 'outcome', '.']"
"Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study.","Matthias Thielmann#, David Corteville#, Gabor Szabo, Madhav Swaminathan, Andre Lamy, Lukas J Lehner, Craig D Brown, Nicolas Noiseux, Mohamed G Atta, Elizabeth C Squiers, Shai Erlich, Daniel Rothenstein, Bruce Molitoris, C David Mazer#, Matthias Thielmannet al.",2021 Oct 5,Circulation,https://pubmed.ncbi.nlm.nih.gov/34474590/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'affect', 'to', 'of', 'patient', 'undergoing', 'cardiac', 'surgery', ',', 'leading', 'to', 'increased', 'in-hospital', 'and', 'long-term', 'morbidity', 'and', 'mortality', '.', 'teprasiran', 'novel', 'small', 'interfering', 'rna', 'temporarily', 'inhibits', 'p-mediated', 'cell', 'death', 'underlies', 'aki', '.', 'method', 'prospective', ',', 'multicenter', ',', 'double-blind', ',', 'randomized', ',', 'controlled', 'phase', 'trial', 'evaluated', 'efficacy', 'and', 'safety', 'of', 'single', 'mgkg', 'dose', 'of', 'teprasiran', 'versus', 'placebo', '(', ')', ',', 'in', 'reducing', 'incidence', ',', 'severity', ',', 'and', 'duration', 'of', 'aki', 'cardiac', 'surgery', 'in', 'high-risk', 'patient', '.', 'primary', 'end', 'point', 'proportion', 'of', 'patient', 'developed', 'aki', 'determined', 'serum', 'creatinine', 'postoperative', 'day', '.', 'end', 'point', 'included', 'aki', 'severity', 'and', 'duration', 'using', 'various', 'prespecified', 'criterion', '.', 'to', 'inform', 'future', 'clinical', 'development', ',', 'composite', 'end', 'point', 'of', 'major', 'adverse', 'kidney', 'event', 'day', ',', 'including', 'death', ',', 'renal', 'replacement', 'therapy', ',', 'and', 'reduction', 'of', 'estimated', 'glomerular', 'filtration', 'rate', 'assessed', '.', 'serum', 'creatinine', 'and', 'serum', 'cystatin-c', 'used', 'estimated', 'glomerular', 'filtration', 'rate', 'assessment', '.', 'result', 'total', 'of', 'patient', 'randomly', 'assigned', 'in', 'center', 'dosed', 'patient', '.', 'year', 'of', 'age', '(', 'meansd', ')', ',', 'men', ',', 'and', 'median', 'european', 'system', 'cardiac', 'operative', 'risk', 'evaluation', 'score', '..', 'demographic', 'and', 'surgical', 'parameter', 'similar', 'group', '.', 'aki', 'incidence', 'teprasiran-', 'versus', 'placebo-treated', 'patient', ',', '.', 'absolute', 'risk', 'reduction', ',', 'p.', 'odds', 'ratio', ',', '.', '(', 'ci', ',', '.-.', ')', '.', 'aki', 'severity', 'and', 'duration', 'also', 'improved', 'with', 'teprasiran', '.', 'of', 'teprasiran-', 'versus', '.', 'of', 'placebo-treated', 'patient', 'grade', 'aki', 'teprasiran-', 'versus', 'placebo-treated', 'patient', 'aki', 'lasting', 'day', '.', 'no', 'significant', 'difference', 'observed', 'major', 'adverse', 'kidney', 'event', 'day', 'composite', 'in', 'overall', 'population', '.', 'no', 'safety', 'issue', 'identified', 'with', 'teprasiran', 'treatment', '.', 'conclusion', 'incidence', ',', 'severity', ',', 'and', 'duration', 'of', 'early', 'aki', 'in', 'high-risk', 'patient', 'undergoing', 'cardiac', 'surgery', 'significantly', 'reduced', 'teprasiran', 'administration', '.', 'phase', 'study', 'with', 'major', 'adverse', 'kidney', 'event', 'day', 'primary', 'outcome', 'recently', 'completed', 'enrollment', 'designed', 'basis', 'of', 'finding', '(', 'nct', ')', '.', 'registration', 'url', 'httpswww.clinicaltrials.gov', 'unique', 'identifier', 'nct', '.']"
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).,"Peter Pickkers, Derek C Angus, Kristie Bass, Rinaldo Bellomo, Erik van den Berg, Juliane Bernholz, Morten H Bestle, Kent Doi, Chistopher J Doig, Ricard Ferrer, Bruno Francois, Henrik Gammelager, Ulf Goettrup Pedersen, Eric Hoste, Susanne Iversen, Michael Joannidis, John A Kellum, Kathleen Liu, Melanie Meersch, Ravindra Mehta, Scott Millington, Patrick T Murray, Alistair Nichol, Marlies Ostermann, Ville Pettilä, Christoffer Solling, Matthias Winkel, Paul J Young, Alexander Zarbock                              ;, REVIVAL investigators, Angus Carter, Dietmar Fries, Philip Eller, Ludovic Gérard, Nicolas DeSchryver, Elisabeth Diltoer, Vincent Huberlant, Isabelle Michaux, Patrick M Honore, Tom Fivez, Christopher Doig, Gordon Wood, John Boyd, Alexis Turgeon, Maj Kamper, Thomas Strøm, Sussanne Iversen, Hendrik Gammelager, Bodil Steen Rasmussen, Christoffer Grant Sølling, Morten Hyllander Mæller, Thorbjoern Groefte, Nilanjan Dey, Ulf Gøttrup Pedersen, Mila Valkonen, Panu Uusalo, Ville Jalkanen, Ferhat Meziani, Jermie Lemarie, Gaetan Plantefeve, Konstantimos Bachoumas, Jean Louis Dufour, Anne-Laure Fedou, Pierre Asfar, Xavier Monnet, Christophe Vinsonneau, Sebastien Gibot, Christophe Guitton, Jean-Pierre Quenot, Gregoire Muller, Jean Yves Lefrant, Emmanuelle Mercier, Alexandre Mebazaa, Andreas Kortgen, Sebastian Fichtner, Stefan Kluge, Gernot Marx, Ignatio Martin-Loeches, Bairbre McNicolas, Hidenobu Kamohara, Masahiro Harada, Takuo Nakagami, Shingo Adachi, Kohei Ota, Ryo Furuya, Ayumu Tsuruoka, Yasuaki Mizushima, Satoki Inoue, Pieter Tuinman, F Wim Roozendaal, Bert Beishuizen, Oscar Hoiting, Tom Dormans, Arthur Van Zanten, Paul Young, Anthony Williams, Colin McArthur, Pawel Twardowski, Shay McGuinness, Ricard Ferrer Roca, Carol Lorencio Cardenas, Anna Navas Perez, Fernando Martinez Sagasti, Ingeborg Welters, Matt Wise, Sam Waddy, Niall MacCallum, Raghaven Murugan, Hernando Gomez, Larry Busse, David Boldt, Andrew Bernard, Daniel Files, Benjamin Margolis, Jarrod Mosier, Jonathon Truwit, Felix Zamora, Danielle Davison, Matthew Exline, Nathan Nielsen, Duncan Hite, Peter Pickkerset al.",2024 Jan,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/38172296/,No keywords found,"['ilofotase', 'alfa', 'human', 'recombinant', 'alkaline', 'phosphatase', 'with', 'reno-protective', 'effect', 'showed', 'improved', 'survival', 'and', 'reduced', 'major', 'adverse', 'kidney', 'event', 'day', '(', 'make', ')', 'in', 'sepsis-associated', 'acute', 'kidney', 'injury', '(', 'sa-aki', ')', 'patient', '.', 'revival', ',', 'phase-', 'trial', 'conducted', 'to', 'confirm', 'efficacy', 'and', 'safety', '.', 'method', 'in', 'international', 'double-blinded', 'randomized-controlled', 'trial', ',', 'sa-aki', 'patient', 'enrolled', 'h', 'vasopressor', 'and', 'h', 'of', 'aki', '.', 'primary', 'endpoint', '-day', 'all-cause', 'mortality', '.', 'main', 'secondary', 'endpoint', 'make', ',', 'secondary', 'endpoint', '(', ')', 'day', 'alive', 'and', 'free', 'of', 'organ', 'support', 'day', ',', '(', 'ii', ')', 'day', 'alive', 'and', 'of', 'intensive', 'care', 'unit', '(', 'icu', ')', 'day', ',', 'and', '(', 'iii', ')', 'time', 'to', 'death', 'day', '.', 'prior', 'to', 'unblinding', ',', 'statistical', 'analysis', 'plan', 'amended', ',', 'including', 'updated', 'make', 'definition', '.', 'result', 'six', 'hundred', 'fifty', 'patient', 'treated', 'and', 'analyzed', 'safety', 'and', 'efficacy', 'data', '(', 'ilofotase', 'alfa', 'n', 'placebo', 'n', ')', '.', 'observed', 'mortality', 'rate', 'in', 'ilofotase', 'alfa', 'and', 'placebo', 'group', '.', 'and', '.', 'day', ',', 'and', '.', 'and', '.', 'day', '.', 'trial', 'stopped', 'futility', 'primary', 'endpoint', '.', 'observed', 'proportion', 'of', 'patient', 'with', 'makea', 'and', 'makeb', '.', 'and', '.', 'in', 'ilofotase', 'alfa', 'group', 'vs.', '.', 'and', '.', 'in', 'placebo', 'group', '.', 'median', 'interquartile', 'range', '(', 'iqr', ')', 'day', 'alive', 'and', 'free', 'of', 'organ', 'support', '-', 'and', '-', ',', 'number', 'of', 'day', 'alive', 'and', 'discharged', 'icu', 'day', '-', 'and', '-', 'in', 'ilofotase', 'alfa', 'and', 'placebo', 'group', ',', 'respectively', '.', 'adverse', 'event', 'reported', 'in', '.', 'and', 'patient', 'in', 'ilofotase', 'and', 'placebo', 'group', '.', 'conclusion', 'among', 'critically', 'ill', 'patient', 'with', 'sa-aki', ',', 'ilofotase', 'alfa', 'not', 'improve', 'day', 'survival', '.', 'may', ',', 'however', ',', 'reduced', 'make', 'event', '.', 'no', 'safety', 'concern', 'identified', '.']"
Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.,"Tariq Ahmad, Keyanna Jackson, Veena S Rao, W H Wilson Tang, Meredith A Brisco-Bacik, Horng H Chen, G Michael Felker, Adrian F Hernandez, Christopher M O'Connor, Venkata S Sabbisetti, Joseph V Bonventre, F Perry Wilson, Steven G Coca, Jeffrey M Testani, Tariq Ahmadet al.",2018 May 8,Circulation,https://pubmed.ncbi.nlm.nih.gov/29352071/,No keywords found,"['worsening', 'renal', 'function', '(', 'wrf', ')', 'in', 'setting', 'of', 'aggressive', 'diuresis', 'acute', 'heart', 'failure', 'treatment', 'may', 'reflect', 'renal', 'tubular', 'injury', 'or', 'simply', 'indicate', 'hemodynamic', 'or', 'functional', 'change', 'in', 'glomerular', 'filtration', '.', 'well-validated', 'tubular', 'injury', 'biomarkers', ',', 'n-acetyl', '--', 'd-glucosaminidase', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'and', 'kidney', 'injury', 'molecule', ',', 'available', 'quantify', 'degree', 'of', 'renal', 'tubular', 'injury', '.', 'rose-ahf', 'trial', '(', 'renal', 'optimization', 'strategy', 'evaluation-acute', 'heart', 'failure', ')', 'provides', 'experimental', 'platform', 'study', 'of', 'mechanism', 'of', 'wrf', 'aggressive', 'diuresis', 'acute', 'heart', 'failure', 'rose-ahf', 'protocol', 'dictated', 'high-dose', 'loop', 'diuretic', 'therapy', 'in', 'patient', '.', 'sought', 'to', 'determine', 'whether', 'tubular', 'injury', 'biomarkers', 'associated', 'with', 'wrf', 'in', 'setting', 'of', 'aggressive', 'diuresis', 'and', 'association', 'with', 'prognosis', '.', 'method', 'patient', 'in', 'multicenter', 'rose-ahf', 'trial', 'with', 'baseline', 'and', '-hour', 'urine', 'tubular', 'injury', 'biomarkers', 'analyzed', '(', 'n', ')', '.', 'wrf', 'defined', 'decrease', 'in', 'glomerular', 'filtration', 'rate', 'estimated', 'with', 'cystatin', 'c.', 'result', 'consistent', 'with', 'protocol-driven', 'aggressive', 'dosing', 'of', 'loop', 'diuretic', ',', 'participant', 'received', 'median', 'mg', 'iv', 'furosemide', 'equivalent', '(', 'interquartile', 'range', ',', '-', 'mg', ')', ',', 'induced', 'urine', 'output', 'of', 'ml', '(', 'interquartile', 'range', ',', '-', 'ml', ')', '-hour', 'intervention', 'period', '.', 'level', 'of', 'n-acetyl', '--', 'd-glucosaminidase', 'and', 'kidney', 'injury', 'molecule', 'not', 'change', 'with', 'aggressive', 'diuresis', '(', 'p.', ')', ',', 'whereas', 'level', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'decreased', 'slightly', '(', '-', '.', 'ngmg', 'interquartile', 'range', ',', '-', 'to', 'ngmg', 'p.', ')', '.', 'wrf', 'occurred', 'in', '.', 'of', 'population', 'and', 'not', 'associated', 'with', 'increase', 'in', 'marker', 'of', 'renal', 'tubular', 'injury', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'p.', ')', ',', 'n-acetyl', '--', 'd-glucosaminidase', '(', 'p.', ')', ',', 'or', 'kidney', 'injury', 'molecule', '(', 'p.', ')', '.', 'increase', 'in', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'n-acetyl', '--', 'd-glucosaminidase', ',', 'and', 'kidney', 'injury', 'molecule', 'paradoxically', 'associated', 'with', 'improved', 'survival', '(', 'adjusted', 'hazard', 'ratio', ',', '.', 'per', 'percentile', 'increase', 'confidence', 'interval', ',', '.-', '.', 'p.', ')', '.', 'conclusion', 'kidney', 'tubular', 'injury', 'not', 'appear', 'to', 'association', 'with', 'wrf', 'in', 'context', 'of', 'aggressive', 'diuresis', 'of', 'patient', 'with', 'acute', 'heart', 'failure', '.', 'finding', 'reinforce', 'notion', 'small', 'to', 'moderate', 'deterioration', 'in', 'renal', 'function', 'commonly', 'encountered', 'with', 'aggressive', 'diuresis', 'dissimilar', 'traditional', 'cause', 'of', 'acute', 'kidney', 'injury', '.']"
"Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial.","Luca F Roggeveen#, Tingjie Guo#, Lucas M Fleuren#, Ronald Driessen, Patrick Thoral, Reinier M van Hest, Ron A A Mathot, Eleonora L Swart, Harm-Jan de Grooth, Bas van den Bogaard, Armand R J Girbes, Rob J Bosman, Paul W G Elbers, Luca F Roggeveenet al.",2022 Sep 5,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36064438/,No keywords found,"['adequate', 'antibiotic', 'dosing', 'may', 'improve', 'outcome', 'in', 'critically', 'ill', 'patient', 'challenging', 'due', 'to', 'altered', 'and', 'variable', 'pharmacokinetics', '.', 'to', 'address', 'challenge', ',', 'autokinetics', 'developed', ',', 'decision', 'support', 'system', 'bedside', ',', 'real-time', ',', 'data-driven', 'and', 'personalised', 'antibiotic', 'dosing', '.', 'study', 'evaluates', 'feasibility', ',', 'safety', 'and', 'efficacy', 'of', 'clinical', 'implementation', '.', 'method', 'in', 'two-centre', 'randomised', 'clinical', 'trial', ',', 'critically', 'ill', 'patient', 'with', 'sepsis', 'or', 'septic', 'shock', 'randomised', 'to', 'autokinetics', 'dosing', 'or', 'standard', 'dosing', 'four', 'antibiotic', 'vancomycin', ',', 'ciprofloxacin', ',', 'meropenem', ',', 'and', 'ceftriaxone', '.', 'adult', 'patient', 'with', 'confirmed', 'or', 'suspected', 'infection', 'and', 'either', 'lactate', 'mmoll', 'or', 'vasopressor', 'requirement', 'eligible', 'inclusion', '.', 'primary', 'outcome', 'pharmacokinetic', 'target', 'attainment', 'in', 'first', 'h', 'randomisation', '.', 'clinical', 'endpoint', 'included', 'mortality', ',', 'icu', 'length', 'of', 'stay', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', '.', 'result', 'inclusion', 'of', 'patient', ',', 'study', 'stopped', 'early', 'due', 'to', 'covid-', 'pandemic', '.', 'in', 'ciprofloxacin', 'intervention', 'group', ',', 'primary', 'outcome', 'obtained', 'in', 'compared', 'to', 'in', 'control', 'group', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'furthermore', ',', 'target', 'attainment', 'faster', '(', 'h', ',', 'ci', '-', 'h', ',', 'p', '.', ')', 'and', 'better', '(', 'increase', ',', 'ci', '-', ',', 'p', '.', ')', '.', 'antibiotic', ',', 'autokinetics', 'dosing', 'not', 'improve', 'target', 'attainment', '.', 'clinical', 'endpoint', 'not', 'significantly', 'different', '.', 'importantly', ',', 'higher', 'dosing', 'not', 'lead', 'to', 'increased', 'mortality', 'or', 'renal', 'failure', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', ',', 'personalised', 'dosing', 'feasible', ',', 'safe', 'and', 'significantly', 'improved', 'target', 'attainment', 'ciprofloxacin', '.', 'trial', 'registration', 'trial', 'prospectively', 'registered', 'netherlands', 'trial', 'register', '(', 'ntr', ')', ',', 'nlntr', 'august', 'and', 'european', 'clinical', 'trial', 'database', '(', 'eudract', ')', ',', '--', 'november', '.']"
"Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial.","Matthieu Legrand, Rishi Kothari, Nicholas Fong, Nandini Palaniappa, David Boldt, Lee-Lynn Chen, Philip Kurien, Eilon Gabel, Jillene Sturgess-DaPrato, Michael O Harhay, Romain Pirracchio, Michael P Bokoch                              ;, VEGA- trial investigators, Matthieu Legrandet al.",2023 May,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/36925330/,No keywords found,"['intraoperative', 'hypotension', 'associated', 'with', 'postoperative', 'complication', '.', 'use', 'of', 'vasopressor', 'often', 'required', 'to', 'correct', 'hypotension', 'best', 'vasopressor', 'unknown', '.', 'method', 'multicentre', ',', 'cluster-randomised', ',', 'crossover', ',', 'feasibility', 'and', 'pilot', 'trial', 'conducted', 'across', 'five', 'hospital', 'in', 'california', '.', 'phenylephrine', '(', 'pe', ')', 'v', 'norepinephrine', '(', 'ne', ')', 'infusion', 'first-line', 'vasopressor', 'in', 'patient', 'general', 'anaesthesia', 'alternated', 'monthly', 'hospital', 'month', '.', 'primary', 'endpoint', 'first-line', 'vasopressor', 'administration', 'compliance', 'of', 'or', 'higher', '.', 'secondary', 'endpoint', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', '-day', 'mortality', ',', 'myocardial', 'injury', 'noncardiac', 'surgery', '(', 'min', ')', ',', 'hospital', 'length', 'of', 'stay', ',', 'and', 'rehospitalisation', 'within', 'day', '.', 'result', 'total', 'of', 'patient', 'enrolled', 'month', 'patient', 'randomised', 'in', 'ne', 'group', ',', 'in', 'pe', 'group', '.', 'overall', ',', '.', 'received', 'assigned', 'first-line', 'vasopressor', '.', 'no', 'drug', 'infiltration', 'requiring', 'treatment', 'reported', 'in', 'either', 'group', '.', 'patient', 'median', 'yr', 'old', ',', 'female', ',', 'and', 'white', '.', 'randomisation', 'in', 'ne', 'group', 'v', 'pe', 'group', 'not', 'reduce', 'readmission', 'within', 'day', '(', 'adjusted', 'odds', 'ratio', '.', 'confidence', 'interval', ',', '.-', '.', ')', ',', '-day', 'mortality', '(', '.', '.-', '.', ')', ',', 'aki', '(', '.', '.-', '.', ')', ',', 'or', 'min', '(', '.', '.-.', ')', '.', 'conclusion', 'large', 'and', 'diverse', 'population', 'undergoing', 'major', 'surgery', 'general', 'anaesthesia', 'successfully', 'enrolled', 'and', 'randomised', 'to', 'receive', 'ne', 'or', 'pe', 'infusion', '.', 'pilot', 'and', 'feasibility', 'trial', 'not', 'powered', 'adverse', 'postoperative', 'outcome', 'and', 'follow-up', 'multicentre', 'effectiveness', 'trial', 'planned', '.', 'clinical', 'trial', 'registration', 'nct', '(', 'clinicaltrials.gov', ')', '.']"
"Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.","Olivier Hermine, Eva Hoster, Jan Walewski, André Bosly, Stephan Stilgenbauer, Catherine Thieblemont, Michal Szymczyk, Reda Bouabdallah, Michael Kneba, Michael Hallek, Gilles Salles, Pierre Feugier, Vincent Ribrag, Josef Birkmann, Roswitha Forstpointner, Corinne Haioun, Mathias Hänel, René Olivier Casasnovas, Jürgen Finke, Norma Peter, Kamal Bouabdallah, Catherine Sebban, Thomas Fischer, Ulrich Dührsen, Bernd Metzner, Georg Maschmeyer, Lothar Kanz, Christian Schmidt, Richard Delarue, Nicole Brousse, Wolfram Klapper, Elizabeth Macintyre, Marie-Hélène Delfau-Larue, Christiane Pott, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling                              ;, European Mantle Cell Lymphoma Network, Olivier Hermineet al.",2016 Aug 6,Lancet,https://pubmed.ncbi.nlm.nih.gov/27313086/,No keywords found,"['mantle', 'cell', 'lymphoma', 'characterised', 'poor', 'long-term', 'prognosis', '.', 'european', 'mantle', 'cell', 'lymphoma', 'network', 'aimed', 'to', 'investigate', 'whether', 'introduction', 'of', 'high-dose', 'cytarabine', 'to', 'immunochemotherapy', 'autologous', 'stem-cell', 'transplantation', '(', 'asct', ')', 'improves', 'outcome', '.', 'method', 'randomised', ',', 'open-label', ',', 'parallel-group', ',', 'phase', 'trial', 'done', 'in', 'haemato-oncological', 'hospital', 'department', 'or', 'private', 'practice', 'in', 'germany', ',', 'france', ',', 'belgium', ',', 'and', 'poland', '.', 'patient', 'aged', 'year', 'or', 'younger', 'with', 'untreated', 'stage', 'ii-iv', 'mantle', 'cell', 'lymphoma', 'centrally', 'randomised', '(', ')', ',', 'with', 'computer-assisted', 'random', 'block', 'selection', ',', 'to', 'receive', 'either', 'six', 'course', 'of', 'r-chop', '(', 'rituximab', 'plus', 'cyclophosphamide', ',', 'doxorubicin', ',', 'vincristine', ',', 'and', 'prednisone', ')', 'followed', 'myeloablative', 'radiochemotherapy', 'and', 'asct', '(', 'control', 'group', ')', ',', 'or', 'six', 'course', 'of', 'alternating', 'r-chop', 'or', 'r-dhap', '(', 'rituximab', 'plus', 'dexamethasone', ',', 'high-dose', 'cytarabine', ',', 'and', 'cisplatin', ')', 'followed', 'high-dose', 'cytarabine-containing', 'conditioning', 'regimen', 'and', 'asct', '(', 'cytarabine', 'group', ')', '.', 'patient', 'stratified', 'study', 'group', 'and', 'international', 'prognostic', 'index', '.', 'primary', 'outcome', 'time', 'to', 'treatment', 'failure', 'randomisation', 'to', 'stable', 'disease', 'least', 'four', 'induction', 'cycle', ',', 'progression', ',', 'or', 'death', 'cause', '.', 'patient', 'with', 'stage', 'ii-iv', 'mantle', 'cell', 'lymphoma', 'included', 'in', 'primary', 'analysis', 'treatment', 'started', 'according', 'to', 'randomisation', '.', 'safety', 'analysis', ',', 'patient', 'assessed', 'according', 'to', 'treatment', 'actually', 'started', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'of', 'patient', '(', 'median', 'age', 'year', 'iqr', '-', ')', 'randomised', 'july', ',', ',', 'to', 'march', ',', ',', 'of', 'in', 'control', 'group', 'and', 'of', 'in', 'cytarabine', 'group', 'included', 'in', 'primary', 'analysis', '.', 'median', 'follow-up', 'of', '.', 'year', '(', 'ci', '.-', '.', ')', ',', 'time', 'to', 'treatment', 'failure', 'significantly', 'longer', 'in', 'cytarabine', 'group', '(', 'median', '.', 'year', 'ci', '.-not', 'reached', ',', 'year', 'rate', 'ci', '-', ')', 'in', 'control', 'group', '(', '.', 'year', '.-.', ',', '-', 'hazard', 'ratio', '.', 'p.', ')', '.', 'induction', 'immunochemotherapy', ',', 'patient', 'received', 'high-dose', 'cytarabine', 'increased', 'grade', 'or', 'haematological', 'toxicity', '(', 'haemoglobin', 'of', 'v', 'of', 'control', 'platelet', 'of', 'v', 'of', ')', ',', 'grade', 'or', 'febrile', 'neutropenia', '(', 'of', 'v', 'of', ')', ',', 'and', 'grade', 'or', 'renal', 'toxicity', '(', 'creatinine', 'of', 'v', 'of', ')', '.', 'number', 'of', 'asct-related', 'death', 'similar', '(', 'eight', '.', ')', 'in', 'group', '.', 'interpretation', 'immunochemotherapy', 'containing', 'high-dose', 'cytarabine', 'followed', 'asct', 'considered', 'standard', 'of', 'care', 'in', 'patient', 'aged', 'year', 'or', 'younger', 'with', 'mantle', 'cell', 'lymphoma', '.', 'funding', 'european', 'commission', ',', 'lymphoma', 'research', 'foundation', ',', 'and', 'roche', '.']"
A randomised-controlled trial (TARGET-C) of high vs. low target mean arterial pressure in patients with cirrhosis and septic shock.,"Rakhi Maiwall, Samba Siva Rao Pasupuleti, Ashini Kumar Hidam, Anupam Kumar, Harsh Vardhan Tevethia, Rajan Vijayaraghavan, Arpita Majumdar, Adarsh Prasher, Sherin Thomas, Rajendra Prasad Mathur, Guresh Kumar, Shiv Kumar Sarin, Rakhi Maiwallet al.",2023 Aug,J Hepatol,https://pubmed.ncbi.nlm.nih.gov/37088310/,No keywords found,"['high', 'mean', 'arterial', 'pressure', '(', 'map', ')', 'target', 'associated', 'with', 'improved', 'renal', 'outcome', 'in', 'patient', 'with', 'cirrhosis', ',', 'though', 'not', 'studied', 'in', 'critically', 'ill', 'patient', 'with', 'cirrhosis', 'and', 'septic', 'shock', '(', 'cics', ')', '.', 'compared', 'efficacy', 'of', 'high', '(', '-', 'mmhg', 'h-map', ')', 'vs.', 'low', '(', '-', 'l-map', ')', 'target', 'map', 'strategy', 'in', 'improving', '-day', 'mortality', 'in', 'cics', '.', 'method', 'performed', 'open-label', 'randomisation', 'of', 'cics', '(', 'h-map', 'l-map', ')', '.', 'primary', 'endpoint', '-day', 'mortality', 'and', 'secondary', 'endpoint', 'included', 'reversal', 'of', 'shock', ',', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'day', ',', 'incidence', 'of', 'intradialytic', 'hypotension', '(', 'idh', ')', ',', 'and', 'adverse', 'event', '.', 'endothelial', 'marker', 'analysed', 'in', 'subset', 'of', 'patient', '.', 'result', 'baseline', 'characteristic', 'comparable', '.', 'intention-to-treat', 'analysis', ',', '-day', 'mortality', '(', 'vs.', 'p', '.', ')', ',', 'reversal', 'of', 'shock', '(', 'vs.', 'p', '.', ')', 'and', 'aki', 'development', '(', 'vs.', 'p', '.', ')', 'not', 'different', 'h-map', 'and', 'l-map', 'group', ',', 'respectively', '.', 'lower', 'incidence', 'of', 'idh', '(', 'vs.', 'p', '.', ')', 'and', 'higher', 'adverse', 'event', 'necessitating', 'protocol', 'discontinuation', '(', 'vs.', 'p', '.', ')', 'noted', 'in', 'h-map', 'group', '.', 'per-protocol', 'analysis', '(', 'l-map', 'h-map', ')', ',', 'significantly', 'higher', 'reversal', 'of', 'aki', '(', 'vs.', 'p', '.', ')', 'and', 'lower', 'incidence', 'of', 'idh', '(', 'vs.', 'p', '.', ')', 'observed', 'in', 'h-map', 'group', '.', 'endothelial', 'repair', 'marker', 'adamts', '(', '.', '.', 'vs.', '.', '.', 'p', '.', ')', 'and', 'angiopoietin-', '(', '.', '.', 'vs.', '.', '.', 'p', '.', ')', 'higher', 'in', 'h-map', 'group', '.', 'conclusion', 'higher', 'map', 'strategy', 'not', 'confer', 'survival', 'benefit', 'in', 'cics', ',', 'improves', 'tolerance', 'to', 'dialysis', ',', 'lactate', 'clearance', 'and', 'renal', 'recovery', '.', 'higher', 'adverse', 'event', 'indicate', 'need', 'better', 'tool', 'to', 'evaluate', 'target', 'microcirculation', 'pressure', 'in', 'cics', '.', 'impact', 'and', 'implication', 'maintaining', 'appropriate', 'organ', 'perfusion', 'pressure', 'sepsis', 'ultimate', 'goal', 'of', 'haemodynamic', 'management', '.', 'higher', 'mean', 'arterial', 'pressure', '(', 'map', ')', 'improves', 'renal', 'outcome', 'in', 'patient', 'with', 'hepatorenal', 'syndrome', '.', 'patient', 'with', 'cirrhosis', 'and', 'septic', 'shock', 'severe', 'circulatory', 'disturbance', ',', 'low', 'map', ',', 'and', 'poor', 'tissue', 'perfusion', '.', 'in', 'patient', ',', 'targeting', 'higher', 'map', 'vs.', 'lower', 'map', 'not', 'confer', 'survival', 'benefit', 'associated', 'with', 'adverse', 'event', '.', 'higher', 'target', 'strategy', 'associated', 'with', 'better', 'tolerance', 'and', 'lesser', 'episode', 'of', 'hypotension', 'dialysis', '.', 'patient', 'could', 'achieve', 'higher', 'target', 'map', ',', 'without', 'development', 'of', 'adverse', 'event', ',', 'improved', 'renal', 'outcome', 'and', 'better', 'lactate', 'clearance', '.', 'higher', 'map', 'also', 'associated', 'with', 'improvement', 'in', 'marker', 'of', 'endothelial', 'function', '.', 'higher', 'target', 'map', 'strategy', ',', 'with', 'close', 'monitoring', 'of', 'adverse', 'event', ',', 'may', 'recommended', 'patient', 'with', 'cirrhosis', 'and', 'septic', 'shock', '.', 'clinical', 'trial', 'number', 'nct', '.']"
"Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial.","Robert H Jones, Angela Casbard, Margherita Carucci, Catrin Cox, Rachel Butler, Fouad Alchami, Tracie-Ann Madden, Catherine Bale, Pavel Bezecny, Johnathan Joffe, Sarah Moon, Chris Twelves, Ramachandran Venkitaraman, Simon Waters, Andrew Foxley, Sacha J Howell, Robert H Joneset al.",2020 Mar,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/32035020/,No keywords found,"['capivasertib', '(', 'azd', ')', 'potent', 'selective', 'oral', 'inhibitor', 'of', 'three', 'isoforms', 'of', 'serinethreonine', 'kinase', 'akt', '.', 'faktion', 'trial', 'investigated', 'whether', 'addition', 'of', 'capivasertib', 'to', 'fulvestrant', 'improved', 'progression-free', 'survival', 'in', 'patient', 'with', 'aromatase', 'inhibitor-resistant', 'advanced', 'breast', 'cancer', '.', 'method', 'in', 'randomised', ',', 'double-blind', ',', 'placebo-controlled', ',', 'phase', 'trial', ',', 'postmenopausal', 'woman', 'aged', 'least', 'year', 'with', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', '-', 'and', 'oestrogen', 'receptor-positive', ',', 'her-negative', ',', 'metastatic', 'or', 'locally', 'advanced', 'inoperable', 'breast', 'cancer', 'relapsed', 'or', 'progressed', 'aromatase', 'inhibitor', 'recruited', 'hospital', 'in', 'uk', '.', 'enrolled', 'participant', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'intramuscular', 'fulvestrant', 'mg', '(', 'day', ')', 'every', 'day', '(', 'plus', 'loading', 'dose', 'day', 'of', 'cycle', ')', 'with', 'either', 'capivasertib', 'mg', 'or', 'matching', 'placebo', ',', 'orally', 'twice', 'daily', 'intermittent', 'weekly', 'schedule', 'of', 'day', 'and', 'day', '(', 'starting', 'cycle', 'day', ')', 'disease', 'progression', ',', 'unacceptable', 'toxicity', ',', 'loss', 'to', 'follow-up', ',', 'or', 'withdrawal', 'of', 'consent', '.', 'treatment', 'allocation', 'done', 'using', 'interactive', 'web-response', 'system', 'using', 'minimisation', 'method', '(', 'with', 'random', 'element', ')', 'and', 'following', 'minimisation', 'factor', 'measurable', 'or', 'non-measurable', 'disease', ',', 'primary', 'or', 'secondary', 'aromatase', 'inhibitor', 'resistance', ',', 'pikca', 'status', ',', 'and', 'pten', 'status', '.', 'primary', 'endpoint', 'progression-free', 'survival', 'with', 'one-sided', 'alpha', 'of', '.', 'analysis', 'done', 'intention', 'to', 'treat', '.', 'recruitment', 'complete', ',', 'and', 'trial', 'in', 'follow-up', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'march', ',', ',', 'and', 'march', ',', ',', 'patient', 'screened', 'eligibility', ',', 'of', '(', ')', 'eligible', 'and', 'randomly', 'assigned', 'to', 'receive', 'fulvestrant', 'plus', 'capivasertib', '(', 'n', ')', 'or', 'fulvestrant', 'plus', 'placebo', '(', 'n', ')', '.', 'median', 'follow-up', 'progression-free', 'survival', 'month', '(', 'iqr', '-', ')', '.', 'time', 'of', 'primary', 'analysis', 'progression-free', 'survival', '(', 'jan', ',', ')', ',', 'progression-free', 'survival', 'event', 'occurred', ',', '(', ')', 'in', 'patient', 'in', 'capivasertib', 'group', 'compared', 'with', '(', ')', 'of', 'in', 'placebo', 'group', '.', 'median', 'progression-free', 'survival', 'month', '(', 'ci', '-', ')', 'in', 'capivasertib', 'group', 'versus', 'month', '(', '-', ')', 'in', 'placebo', 'group', ',', 'giving', 'unadjusted', 'hazard', 'ratio', '(', 'hr', ')', 'of', '(', 'ci', '-', ')', 'in', 'favour', 'of', 'capivasertib', 'group', '(', 'two-sided', 'p', 'one-sided', 'log', 'rank', 'test', 'p', ')', '.', 'common', 'grade', '-', 'adverse', 'event', 'hypertension', '(', 'of', 'patient', 'in', 'capivasertib', 'group', 'v', 'of', 'in', 'placebo', 'group', ')', ',', 'diarrhoea', '(', 'ten', 'v', 'three', ')', ',', 'rash', '(', 'v', ')', ',', 'infection', '(', 'four', 'v', 'two', ')', ',', 'and', 'fatigue', '(', 'one', 'v', 'three', ')', '.', 'serious', 'adverse', 'reaction', 'occurred', 'in', 'capivasertib', 'group', ',', 'and', 'acute', 'kidney', 'injury', '(', 'two', ')', ',', 'diarrhoea', '(', 'three', ')', ',', 'rash', '(', 'two', ')', ',', 'hyperglycaemia', '(', 'one', ')', ',', 'loss', 'of', 'consciousness', '(', 'one', ')', ',', 'sepsis', '(', 'one', ')', ',', 'and', 'vomiting', '(', 'one', ')', '.', 'one', 'death', ',', 'due', 'to', 'atypical', 'pulmonary', 'infection', ',', 'assessed', 'possibly', 'related', 'to', 'capivasertib', 'treatment', '.', 'one', 'death', 'in', 'capivasertib', 'group', 'unknown', 'cause', 'remaining', 'death', 'in', 'group', '(', 'in', 'capivasertib', 'group', 'and', 'in', 'placebo', 'group', ')', 'disease', 'related', '.', 'interpretation', 'progression-free', 'survival', 'significantly', 'longer', 'in', 'participant', 'received', 'capivasertib', 'in', 'received', 'placebo', '.', 'combination', 'of', 'capivasertib', 'and', 'fulvestrant', 'warrant', 'investigation', 'in', 'phase', 'trial', '.', 'funding', 'astrazeneca', 'and', 'cancer', 'research', 'uk', '.']"
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.,"Samer Gawrieh, Srinivasan Dasarathy, Wanzhu Tu, Patrick S Kamath, Naga P Chalasani, Craig J McClain, Ramon Bataller, Gyongyi Szabo, Qing Tang, Svetlana Radaeva, Bruce Barton, Laura E Nagy, Vijay H Shah, Arun J Sanyal, Mack C Mitchell                              ;, AlcHepNet Investigators, Naga Chalasani, Kavish R Patidar, Raj Vuppalanchi, Niha Samala, Lindsey Yoder, Lauren Nephew, Douglas A Simonetto, Patrick Kamath, Hugo E Vargas, Liu Yang, Nicole Welch, Annette Bellar, Amy Attaway, Jaividhya Dasarathy, Ashley Growley, David Streem, Mack C Mitchell, H Franklin Herlong, Thomas Kerr, Thomas Cotter, Arun Sanyal, Sara O'Connor, Velimir Luketic, Amon Asgharpour, Stephanie Taylor, Vatsalya Vatsalya, Loretta Jophlin, Matt Cave, Suman Kumar Jha, Luis Marsano, Ashutosh Barve, Jane Frimodig, Samhita Ravi, Jaideep Behari, Sharvari Shivanekar, Paula Novelli, Andres Duarte-Rojo, Naudia Jonassaint, Curry, Zhenghui G Jiang, Ushma Agarwal, Mia Hazel, Bernd Schnabl, Samer Gawriehet al.",2024 May,J Hepatol,https://pubmed.ncbi.nlm.nih.gov/38342441/,No keywords found,"['severe', 'alcohol-associated', 'hepatitis', '(', 'sah', ')', 'associated', 'with', 'high', '-day', 'mortality', '.', 'glucocorticoid', 'therapy', 'day', 'improves', '-', 'not', '-day', 'survival', '.', 'assessed', 'efficacy', 'and', 'safety', 'of', 'combination', 'of', 'anakinra', ',', 'il-', 'antagonist', ',', 'plus', 'zinc', '(', 'az', ')', 'compared', 'to', 'prednisone', 'using', 'day-', 'lille', 'score', 'stopping', 'rule', 'in', 'patient', 'with', 'sah', '.', 'method', 'in', 'phase', 'iib', 'double-blind', 'randomized', 'trial', 'in', 'adult', 'with', 'sah', 'and', 'meld', 'score', 'of', '-', ',', 'participant', 'randomized', 'to', 'receive', 'either', 'daily', 'anakinra', 'mg', 'subcutaneously', 'day', 'plus', 'daily', 'zinc', 'sulfate', 'mg', 'orally', 'day', ',', 'or', 'daily', 'prednisone', 'mg', 'orally', 'day', '.', 'prednisone', 'or', 'prednisone', 'placebo', 'stopped', 'day-', 'lille', 'score', '..', 'study', 'drug', 'stopped', 'uncontrolled', 'infection', 'or', 'point', 'increase', 'in', 'meld', 'score', '.', 'primary', 'endpoint', 'overall', 'survival', 'day', '.', 'result', 'seventy-three', 'participant', 'randomized', 'to', 'prednisone', 'and', 'to', 'az', '.', 'trial', 'stopped', 'early', 'prespecified', 'interim', 'analysis', 'showed', 'prednisone', 'associated', 'with', 'higher', '-day', 'overall', 'survival', '(', 'vs.', 'hazard', 'ratio', 'death', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'transplant-free', 'survival', '(', 'vs.', 'hazard', 'ratio', 'transplant', 'or', 'death', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'az', '.', 'acute', 'kidney', 'injury', 'frequent', 'with', 'az', '(', ')', 'prednisone', '(', ')', '(', 'p', '.', ')', ',', 'rate', 'of', 'infection', 'similar', '(', 'in', 'az', 'vs.', 'in', 'prednisone', ',', 'p', '.', ')', '.', 'conclusion', 'participant', 'with', 'sah', 'treated', 'with', 'prednisone', 'using', 'day-', 'lille', 'score', 'stopping', 'rule', 'significantly', 'higher', 'overall', 'and', 'transplant-free', '-day', 'survival', 'and', 'lower', 'incidence', 'of', 'acute', 'kidney', 'injury', 'treated', 'with', 'az', '.', 'impact', 'and', 'implication', 'no', 'approved', 'treatment', 'severe', 'alcohol-associated', 'hepatitis', '(', 'sah', ')', '.', 'in', 'double-blind', 'randomized', 'trial', ',', 'patient', 'with', 'sah', 'treated', 'with', 'prednisone', 'using', 'lille', 'stopping', 'rule', 'day', 'higher', '-day', 'overall', 'and', 'transplant-free', 'survival', 'and', 'lower', 'rate', 'of', 'acute', 'kidney', 'injury', 'compared', 'to', 'patient', 'treated', 'with', 'combination', 'of', 'anakinra', 'and', 'zinc', '.', 'data', 'support', 'continued', 'use', 'of', 'glucocorticoid', 'patient', 'with', 'sah', ',', 'with', 'treatment', 'discontinuation', 'with', 'lille', 'score', '.', 'day', '.', 'trial', 'registration', 'nct', '.']"
Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial.,"Paul Young, Michael Bailey, Richard Beasley, Seton Henderson, Diane Mackle, Colin McArthur, Shay McGuinness, Jan Mehrtens, John Myburgh, Alex Psirides, Sumeet Reddy, Rinaldo Bellomo                              ;, SPLIT Investigators;, ANZICS CTG, Anna Hunt, Sally Hurford, Leanlove Navarra, Adelaide Jason-Smith, Lynn Andrews, Louise Hitchings, David Closey, Kim Parker, Emmeline Minto, Anna Morris, Rachael McConnochie, Yan Chen, Lynette Newby, Rachael Parke, Lianne McCarthy, Eileen Gilder, Andrea Lammert, Stephanie Long, Keri-Anne Cowdrey, Paul Younget al.",2015 Oct 27,JAMA,https://pubmed.ncbi.nlm.nih.gov/26444692/,No keywords found,"['saline', '(', '.', 'sodium', 'chloride', ')', 'commonly', 'administered', 'intravenous', 'fluid', 'however', ',', 'use', 'may', 'associated', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'increased', 'mortality', '.', 'objective', 'to', 'determine', 'effect', 'of', 'buffered', 'crystalloid', 'compared', 'with', 'saline', 'renal', 'complication', 'in', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'design', 'and', 'setting', 'double-blind', ',', 'cluster', 'randomized', ',', 'double-crossover', 'trial', 'conducted', 'in', 'icu', 'in', 'new', 'zealand', 'april', 'october', '.', 'three', 'icu', 'general', 'medical', 'and', 'surgical', 'icu', 'icu', 'predominance', 'of', 'cardiothoracic', 'and', 'vascular', 'surgical', 'patient', '.', 'participant', 'patient', 'admitted', 'to', 'icu', 'requiring', 'crystalloid', 'fluid', 'therapy', 'eligible', 'inclusion', '.', 'patient', 'with', 'established', 'aki', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'excluded', '.', 'eligible', 'patient', 'enrolled', 'of', 'patient', '(', '.', ')', 'receiving', 'buffered', 'crystalloid', 'and', 'of', 'patient', '(', '.', ')', 'receiving', 'saline', 'analyzed', '.', 'intervention', 'participating', 'icu', 'assigned', 'masked', 'study', 'fluid', ',', 'either', 'saline', 'or', 'buffered', 'crystalloid', ',', 'alternating', '-week', 'treatment', 'block', '.', 'two', 'icu', 'commenced', 'using', 'fluid', 'and', 'commenced', 'using', 'alternative', 'fluid', '.', 'two', 'crossover', 'occurred', 'icu', 'used', 'fluid', 'twice', 'week', 'of', 'study', '.', 'treating', 'clinician', 'determined', 'rate', 'and', 'frequency', 'of', 'fluid', 'administration', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'proportion', 'of', 'patient', 'with', 'aki', '(', 'defined', 'rise', 'in', 'serum', 'creatinine', 'level', 'of', 'least', '-fold', 'or', 'serum', 'creatinine', 'level', 'of', '.', 'mgdl', 'with', 'increase', 'of', '.', 'mgdl', ')', 'main', 'secondary', 'outcome', 'incidence', 'of', 'rrt', 'use', 'and', 'in-hospital', 'mortality', '.', 'result', 'in', 'buffered', 'crystalloid', 'group', ',', 'of', 'patient', '(', '.', ')', 'developed', 'aki', 'within', 'day', 'enrollment', 'compared', 'with', 'of', 'patient', '(', '.', ')', 'in', 'saline', 'group', '(', 'absolute', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'relative', 'risk', 'rr', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'in', 'buffered', 'crystalloid', 'group', ',', 'rrt', 'used', 'in', 'of', 'patient', '(', '.', ')', 'compared', 'with', 'of', 'patient', '(', '.', ')', 'in', 'saline', 'group', '(', 'absolute', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'rr', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'overall', ',', 'of', 'patient', '(', '.', ')', 'in', 'buffered', 'crystalloid', 'group', 'and', 'of', 'patient', '(', '.', ')', 'in', 'saline', 'group', 'died', 'in', 'hospital', '(', 'absolute', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'rr', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'receiving', 'crystalloid', 'fluid', 'therapy', 'in', 'icu', ',', 'use', 'of', 'buffered', 'crystalloid', 'compared', 'with', 'saline', 'not', 'reduce', 'risk', 'of', 'aki', '.', 'large', 'randomized', 'clinical', 'trial', 'needed', 'to', 'assess', 'efficacy', 'in', 'higher-risk', 'population', 'and', 'to', 'measure', 'clinical', 'outcome', 'mortality', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'actrn', '.']"
"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.","Andrew X Zhu, Yoon-Koo Kang, Chia-Jui Yen, Richard S Finn, Peter R Galle, Josep M Llovet, Eric Assenat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim, Kun-Ming Rau, Kenta Motomura, Izumi Ohno, Philippe Merle, Bruno Daniele, Dong Bok Shin, Guido Gerken, Christophe Borg, Jean-Baptiste Hiriart, Takuji Okusaka, Manabu Morimoto, Yanzhi Hsu, Paolo B Abada, Masatoshi Kudo                              ;, REACH- study investigators, Andrew X Zhuet al.",2019 Feb,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/30665869/,No keywords found,"['patient', 'with', 'advanced', 'hepatocellular', 'carcinoma', 'and', 'increased', '-fetoprotein', 'concentration', 'poor', 'prognosis', '.', 'aimed', 'to', 'establish', 'efficacy', 'of', 'ramucirumab', 'in', 'patient', 'with', 'advanced', 'hepatocellular', 'carcinoma', 'and', '-fetoprotein', 'concentration', 'of', 'ngml', 'or', 'higher', '.', 'method', 'reach-', 'randomised', ',', 'double-blind', ',', 'placebo-controlled', ',', 'phase', 'trial', 'done', 'hospital', ',', 'clinic', ',', 'and', 'medical', 'centre', 'in', 'country', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', 'and', 'histologically', 'or', 'cytologically', 'confirmed', 'hepatocellular', 'carcinoma', ',', 'or', 'diagnosed', 'cirrhosis', 'and', 'hepatocellular', 'carcinoma', ',', 'barcelona', 'clinic', 'liver', 'cancer', 'stage', 'b', 'or', 'c', 'disease', ',', 'child-pugh', 'class', 'liver', 'disease', ',', 'eastern', 'cooperative', 'oncology', 'group', '(', 'ecog', ')', 'performance', 'status', 'of', 'or', ',', '-fetoprotein', 'concentration', 'of', 'ngml', 'or', 'greater', ',', 'and', 'previously', 'received', 'first-line', 'sorafenib', '.', 'participant', 'randomly', 'assigned', '(', ')', 'via', 'interactive', 'web', 'response', 'system', 'with', 'computer-generated', 'random', 'sequence', 'to', 'mgkg', 'intravenous', 'ramucirumab', 'every', 'week', 'or', 'placebo', '.', 'patient', 'received', 'best', 'supportive', 'care', '.', 'primary', 'endpoint', 'overall', 'survival', '.', 'secondary', 'endpoint', 'progression-free', 'survival', ',', 'proportion', 'of', 'patient', 'achieving', 'objective', 'response', ',', 'time', 'to', 'radiographic', 'progression', ',', 'safety', ',', 'time', 'to', 'deterioration', 'in', 'score', 'functional', 'assessment', 'of', 'cancer', 'therapy', 'hepatobiliary', 'symptom', 'index', '(', 'fhsi-', ')', ',', 'and', 'time', 'to', 'deterioration', 'in', 'ecog', 'performance', 'status', '.', 'also', 'pooled', 'individual', 'patient', 'data', 'reach-', 'with', 'data', 'reach', '(', 'nct', ')', 'patient', 'with', '-fetoprotein', 'concentration', 'of', 'ngml', 'or', 'greater', '.', 'efficacy', 'analysis', 'intention', 'to', 'treat', ',', 'whereas', 'safety', 'analysis', 'done', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'july', ',', ',', 'and', 'aug', ',', ',', 'patient', 'randomly', 'assigned', ',', 'to', 'ramucirumab', 'group', 'and', 'to', 'placebo', 'group', '.', 'median', 'follow-up', 'of', 'month', '(', 'iqr', '-', ')', ',', 'median', 'overall', 'survival', '(', 'month', 'ci', '-', 'v', 'month', '-', 'hazard', 'ratio', 'hr', 'ci', '-', 'p', ')', 'and', 'progression-free', 'survival', '(', 'month', '-', 'v', 'month', '-', '-', 'p', ')', 'significantly', 'improved', 'in', 'ramucirumab', 'group', 'compared', 'with', 'placebo', 'group', '.', 'proportion', 'of', 'patient', 'with', 'objective', 'response', 'not', 'differ', 'significantly', 'group', '(', 'nine', 'of', 'v', 'one', 'of', 'p', ')', '.', 'median', 'time', 'to', 'deterioration', 'in', 'fhsi-', 'total', 'score', '(', 'month', 'ci', '-', 'v', 'month', '-', 'hr', 'ci', '-', 'p', ')', 'and', 'ecog', 'performance', 'status', '(', 'hr', 'ci', '-', 'p', ')', 'not', 'differ', 'group', '.', 'grade', 'or', 'worse', 'treatment-emergent', 'adverse', 'event', 'occurred', 'in', 'least', 'of', 'patient', 'in', 'either', 'group', 'hypertension', '(', 'in', 'ramucirumab', 'group', 'v', 'five', 'in', 'placebo', 'group', ')', ',', 'hyponatraemia', '(', 'v', ')', 'and', 'increased', 'aspartate', 'aminotransferase', '(', 'six', 'v', 'five', ')', '.', 'serious', 'adverse', 'event', 'of', 'grade', 'and', 'cause', 'occurred', 'in', '(', ')', 'patient', 'in', 'ramucirumab', 'group', 'and', '(', ')', 'patient', 'in', 'placebo', 'group', '.', 'three', 'patient', 'in', 'ramucirumab', 'group', 'died', 'treatment-emergent', 'adverse', 'event', 'judged', 'to', 'related', 'to', 'study', 'treatment', '(', 'one', 'acute', 'kidney', 'injury', ',', 'one', 'hepatorenal', 'syndrome', ',', 'and', 'one', 'renal', 'failure', ')', '.', 'interpretation', 'reach-', 'met', 'primary', 'endpoint', ',', 'showing', 'improved', 'overall', 'survival', 'ramucirumab', 'compared', 'with', 'placebo', 'in', 'patient', 'with', 'hepatocellular', 'carcinoma', 'and', '-fetoprotein', 'concentration', 'of', 'least', 'ngml', 'previously', 'received', 'sorafenib', '.', 'ramucirumab', 'well', 'tolerated', ',', 'with', 'manageable', 'safety', 'profile', '.', 'to', 'knowledge', ',', 'reach-', 'first', 'positive', 'phase', 'trial', 'done', 'in', 'biomarker-selected', 'patient', 'population', 'with', 'hepatocellular', 'carcinoma', '.', 'funding', 'eli', 'lilly', '.']"
"Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.","Thomas Powles, Michiel S van der Heijden, Daniel Castellano, Matthew D Galsky, Yohann Loriot, Daniel P Petrylak, Osamu Ogawa, Se Hoon Park, Jae-Lyun Lee, Ugo De Giorgi, Martin Bögemann, Aristotelis Bamias, Bernhard J Eigl, Howard Gurney, Som D Mukherjee, Yves Fradet, Iwona Skoneczna, Marinos Tsiatas, Andrey Novikov, Cristina Suárez, André P Fay, Ignacio Duran, Andrea Necchi, Sophie Wildsmith, Philip He, Natasha Angra, Ashok K Gupta, Wendy Levin, Joaquim Bellmunt                              ;, DANUBE study investigators, Jae Lyun Lee, Cristina Suarez, Hans Westgeest, Aude Flechon, Yen-Chuan Ou, Inkeun Park, Vsevolod Matveev, Begoña Pérez-Valderrama, Susanna Cheng, Stephen Frank, Urbano Anido, Alketa Hamzaj, Margitta Retz, Srikala Sridhar, Giorgio Vittorio Scagliotti, Jens Voortman, Boris Alekseev, Anna Alyasova, Boris Komyakov, Herlinde Dumez, Michel Pavic, Go Kimura, Atsushi Mizokami, Susanne Osanto, Jose Angel Arranz, Djura Piersma, Sang Joon Shin, Oleg Karyakin, Ignacio Delgado, Jose Luis Gonzalez, See-Tong Pang, Anna Tran, Oleg Lipatov, Wen-Pin Su, Thomas Flaig, Ajjai Alva, Hwa Park Kyong, Evgeny Kopyltsov, Elena Almagro, Monserrat Domenech, Yen-Hwa Chang, Brieuc Sautois, Andre Ravaux, Gerasimos Aravantinos, Vasileios Georgoulias, Sasja Mulder, Yu Jung Kim, Fabio Kater, Christine Chevreau, Scott Tagawa, Pawel Zalewski, Florence Joly, Gencay Hatiboglu, Luca Gianni, Franco Morelli, Rosa Tambaro, Yasuhiro Hashimoto, Alexander Nosov, Albert Font, Alejo M Rodriguez-Vida, Robert Jones, Naveen Vasudev, Sandhya Srinivas, Jingsong Zhang, Thierry Gil, Daygen Finch, Marc-Oliver Grimm, Yu-Li Su, Simon Chowdhury, Christopher Hocking, Eugen Plas, Scott North, Niels Viggo Jensen, Christine Theodore, Florian Imkamp, Avivit Peer, Takashi Kobayashi, Hideki Sakai, Naoto Sassa, Kazuhiro Yoshimura, Maureen Aarts, Ana Ferreira Castro, Marlen Topuzov, Juan Francisco Rodriguez, Federico Jose Vazquez, Yu-Chieh Tsai, Simon Crabb, Syed Hussain, Johanna Bendell, Marine Gross-Goupil, Gravis Gwenaelle, Raanan Berger, Galina Statsenko, Linda Evans, Alexandra Drakaki, Bradley Somer, Ian Davis, James Lynam, Giuliano Borges, Aldo Dettino, Graziella Martins, Luis Eduardo Zucca, Mads Agerbaek, Haralambos Kalofonos, Eli Rosenbaum, Hideki Enokida, Hiroaki Kikukawa, Kazuo Nishimura, Satoshi Tamada, Motohide Uemura, Yamil Lopez, Jourik Gietema, Marcin Slojewski, Isabel Fernandes, Alexey Smolin, Danish Mazhar, Arash Rezazadeh Kalebasty, Bradley Carthon, Wolfgang Loidl, Fabio Franke, Gustavo Girotto, Nimira Alimohamed, Robyn Macfarlane, Helle Pappot, Guenter Niegisch, Dimitrios Mavroudis, Avishay Sella, Camillo Porta, Shin Ebara, Motonobu Nakamura, Wataru Obara, Norihiko Okuno, Nobuo Shinohara, Mikio Sugimoto, Akitaka Suzuki, Noriaki Tokuda, Hiroji Uemura, Akito Yamaguchi, Francisco Ramirez, Pawel Rozanowski, Pawel Wiechno, Bhumsuk Keam, Nikolay Kislov, Denis Plaksin, Irfan Cicin, Satish Kumar, Joseph Rosales, Ulka Vaishampayan, Stephane Culine, Christos Papandreou, Taketoshi Nara, Mustafa Erman, Laurence Kreiger, Juliana Janoski, Diogo Rosa, Mariana Siqueira, Christina Canil, Lisa Sengelov, Jean-Marc Tourani, Gaku Arai, Katsuyoshi Hashine, Mutsushi Kawakita, Noboru Nakaigawa, Hayahito Nomi, Hiroaki Shiina, Hiroyoshi Suzuki, Junji Yonese, Roberto Kuri, Eleazar Macedo, Samuel Rivera, Alberto Villalobos Prieto, Anna Polakiewicz-Gilowska, Renata Zaucha, Fabio Lopes, Roman Ponomarev, Mark Pomerantz, Shahrokh Shariat, Cynthia Luk, Krzysztof Lesniewski-Kmak, Thomas Powleset al.",2020 Dec,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/32971005/,No keywords found,"['survival', 'outcome', 'poor', 'patient', 'with', 'metastatic', 'urothelial', 'carcinoma', 'receive', 'standard', ',', 'first-line', ',', 'platinum-based', 'chemotherapy', '.', 'assessed', 'overall', 'survival', 'of', 'patient', 'received', 'durvalumab', '(', 'pd-l', 'inhibitor', ')', ',', 'with', 'or', 'without', 'tremelimumab', '(', 'ctla-', 'inhibitor', ')', ',', 'first-line', 'treatment', 'metastatic', 'urothelial', 'carcinoma', '.', 'method', 'danube', 'open-label', ',', 'randomised', ',', 'controlled', ',', 'phase', 'trial', 'in', 'patient', 'with', 'untreated', ',', 'unresectable', ',', 'locally', 'advanced', 'or', 'metastatic', 'urothelial', 'carcinoma', ',', 'conducted', 'academic', 'research', 'centre', ',', 'hospital', ',', 'and', 'oncology', 'clinic', 'in', 'country', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', 'with', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', 'or', '.', 'randomly', 'assigned', 'patient', '(', ')', 'to', 'receive', 'durvalumab', 'monotherapy', '(', 'mg', ')', 'administered', 'intravenously', 'every', 'week', 'durvalumab', '(', 'mg', ')', 'plus', 'tremelimumab', '(', 'mg', ')', 'administered', 'intravenously', 'every', 'week', 'to', 'four', 'dos', ',', 'followed', 'durvalumab', 'maintenance', '(', 'mg', ')', 'every', 'week', 'or', 'standard-of-care', 'chemotherapy', '(', 'gemcitabine', 'plus', 'cisplatin', 'or', 'gemcitabine', 'plus', 'carboplatin', ',', 'depending', 'cisplatin', 'eligibility', ')', 'administered', 'intravenously', 'to', 'six', 'cycle', '.', 'randomisation', 'done', 'interactive', 'voice-web', 'response', 'system', ',', 'with', 'stratification', 'cisplatin', 'eligibility', ',', 'pd-l', 'status', ',', 'and', 'presence', 'or', 'absence', 'of', 'liver', 'metastasis', ',', 'lung', 'metastasis', ',', 'or', '.', 'coprimary', 'endpoint', 'overall', 'survival', 'compared', 'durvalumab', 'monotherapy', 'versus', 'chemotherapy', 'group', 'in', 'population', 'of', 'patient', 'with', 'high', 'pd-l', 'expression', '(', 'high', 'pd-l', 'population', ')', 'and', 'durvalumab', 'plus', 'tremelimumab', 'versus', 'chemotherapy', 'group', 'in', 'intention-to-treat', 'population', '(', 'randomly', 'assigned', 'patient', ')', '.', 'study', 'completed', 'enrolment', 'and', 'final', 'analysis', 'of', 'overall', 'survival', 'reported', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'eu', 'clinical', 'trial', 'register', ',', 'eudract', 'number', '--', '.', 'finding', 'nov', ',', ',', 'and', 'march', ',', ',', 'randomly', 'assigned', 'patient', 'to', 'receive', 'durvalumab', '(', 'n', ')', ',', 'durvalumab', 'plus', 'tremelimumab', '(', 'n', ')', ',', 'or', 'chemotherapy', '(', 'n', ')', '.', 'data', 'cutoff', '(', 'jan', ',', ')', ',', 'median', 'follow-up', 'survival', 'month', '(', 'iqr', '-', ')', 'patient', '.', 'in', 'high', 'pd-l', 'population', ',', 'median', 'overall', 'survival', 'month', '(', 'ci', '-', ')', 'in', 'durvalumab', 'monotherapy', 'group', '(', 'n', ')', 'versus', 'month', '(', '-', ')', 'in', 'chemotherapy', 'group', '(', 'n', 'hazard', 'ratio', ',', 'ci', '-', 'p', ')', '.', 'in', 'intention-to-treat', 'population', ',', 'median', 'overall', 'survival', 'month', '(', '-', ')', 'in', 'durvalumab', 'plus', 'tremelimumab', 'group', 'versus', 'month', '(', '-', ')', 'in', 'chemotherapy', 'group', '(', ',', 'ci', '-', 'p', ')', '.', 'in', 'safety', 'population', ',', 'grade', 'or', 'treatment-related', 'adverse', 'event', 'occurred', 'in', '(', ')', 'of', 'patient', 'in', 'durvalumab', 'group', ',', '(', ')', 'of', 'patient', 'in', 'durvalumab', 'plus', 'tremelimumab', 'group', ',', 'and', 'in', '(', ')', 'of', 'patient', 'in', 'chemotherapy', 'group', '.', 'common', 'grade', 'or', 'treatment-related', 'adverse', 'event', 'increased', 'lipase', 'in', 'durvalumab', 'group', '(', 'seven', 'of', 'patient', ')', 'and', 'in', 'durvalumab', 'plus', 'tremelimumab', 'group', '(', 'of', 'patient', ')', ',', 'and', 'neutropenia', 'in', 'chemotherapy', 'group', '(', 'of', 'patient', ')', '.', 'serious', 'treatment-related', 'adverse', 'event', 'occurred', 'in', '(', ')', 'of', 'patient', 'in', 'durvalumab', 'group', ',', '(', ')', 'of', 'patient', 'in', 'durvalumab', 'plus', 'tremelimumab', 'group', ',', 'and', '(', ')', 'of', 'patient', 'in', 'chemotherapy', 'group', '.', 'death', 'due', 'to', 'study', 'drug', 'toxicity', 'reported', 'in', 'two', '(', ')', 'patient', 'in', 'durvalumab', 'group', '(', 'acute', 'hepatic', 'failure', 'and', 'hepatitis', ')', ',', 'two', '(', ')', 'patient', 'in', 'durvalumab', 'plus', 'tremelimumab', 'group', '(', 'septic', 'shock', 'and', 'pneumonitis', ')', ',', 'and', 'one', '(', ')', 'patient', 'in', 'chemotherapy', 'group', '(', 'acute', 'kidney', 'injury', ')', '.', 'interpretation', 'study', 'not', 'meet', 'either', 'of', 'coprimary', 'endpoint', '.', 'research', 'to', 'identify', 'patient', 'with', 'previously', 'untreated', 'metastatic', 'urothelial', 'carcinoma', 'benefit', 'treatment', 'with', 'immune', 'checkpoint', 'inhibitor', ',', 'either', 'alone', 'or', 'in', 'combination', 'regimen', ',', 'warranted', '.', 'funding', 'astrazeneca', '.']"
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.,"Frank Bridoux, Pierre-Louis Carron, Brigitte Pegourie, Eric Alamartine, Karine Augeul-Meunier, Alexandre Karras, Bertrand Joly, Marie-Noëlle Peraldi, Bertrand Arnulf, Cécile Vigneau, Thierry Lamy, Alain Wynckel, Brigitte Kolb, Bruno Royer, Nolwenn Rabot, Lotfi Benboubker, Christian Combe, Arnaud Jaccard, Bruno Moulin, Bertrand Knebelmann, Sylvie Chevret, Jean-Paul Fermand                              ;, MYRE Study Group, Frank Bridouxet al.",2017 Dec 5,JAMA,https://pubmed.ncbi.nlm.nih.gov/29209721/,No keywords found,"['cast', 'nephropathy', 'main', 'cause', 'of', 'acute', 'kidney', 'injury', 'in', 'multiple', 'myeloma', 'and', 'persistent', 'reduction', 'in', 'kidney', 'function', 'strongly', 'affect', 'prognosis', '.', 'strategy', 'to', 'rapidly', 'remove', 'nephrotoxic', 'serum-free', 'light', 'chain', 'combined', 'with', 'novel', 'antimyeloma', 'agent', 'not', 'evaluated', 'prospectively', '.', 'objective', 'to', 'compare', 'hemodialysis', 'independence', 'rate', 'among', 'patient', 'newly', 'diagnosed', 'with', 'myeloma', 'cast', 'nephropathy', 'treated', 'with', 'hemodialysis', 'using', 'high-cutoff', 'dialyzer', '(', 'with', 'large', 'membrane', 'pore', 'and', 'high', 'permeability', 'to', 'immunoglobulin', 'light', 'chain', ')', 'or', 'conventional', 'high-flux', 'dialyzer', '(', 'with', 'small', 'pore', 'and', 'lower', 'permeability', ')', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'randomized', 'clinical', 'trial', 'involving', 'patient', 'with', 'biopsy-proven', 'myeloma', 'cast', 'nephropathy', 'requiring', 'hemodialysis', 'treated', 'french', 'center', 'july', 'and', 'june', 'final', 'date', 'of', 'follow-up', 'june', ',', '.', 'intervention', 'intensive', 'hemodialysis', '(', 'eight', '-hour', 'session', 'day', ')', 'with', 'either', 'high-cutoff', 'dialyzer', '(', 'patient', ')', 'or', 'conventional', 'high-flux', 'dialyzer', '(', 'patient', ')', '.', 'patient', 'received', 'chemotherapy', 'regimen', 'of', 'bortezomib', 'and', 'dexamethasone', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', 'hemodialysis', 'independence', 'month', 'secondary', 'end', 'point', 'hemodialysis', 'independence', 'rate', 'and', 'month', ',', 'hemodialysis-', 'and', 'chemotherapy-related', 'adverse', 'event', ',', 'and', 'death', '.', 'result', 'among', 'randomized', 'patient', ',', '(', ')', '(', 'median', 'age', ',', '.', 'year', 'interquartile', 'range', ',', '.-', '.', 'year', 'woman', ')', 'included', 'in', 'modified', 'intent-to-treat', 'analysis', '.', 'hemodialysis', 'independence', 'rate', 'month', '.', '(', 'n', ')', 'in', 'high-cutoff', 'hemodialysis', 'group', 'v', '.', '(', 'n', ')', 'in', 'conventional', 'hemodialysis', 'group', '(', 'between-group', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', ',', 'p', '.', ')', 'month', ',', 'rate', '.', '(', 'n', ')', 'v', '.', '(', 'n', ')', ',', 'respectively', '(', 'between-group', 'difference', ',', '.', 'ci', ',', '.', 'to', '.', ',', 'p', '.', ')', 'and', 'month', ',', 'rate', '.', '(', 'n', ')', 'v', '.', '(', 'n', ')', '(', 'between-group', 'difference', ',', '.', 'ci', ',', '.', 'to', '.', ',', 'p', '.', ')', '.', 'incidence', 'of', 'hemodialysis-related', 'adverse', 'event', 'in', 'high-cutoff', 'hemodialysis', 'group', 'v', 'in', 'conventional', 'hemodialysis', 'group', 'chemotherapy-related', 'serious', 'adverse', 'event', ',', 'v', ',', 'respectively', 'and', 'month', ',', 'patient', 'v', 'patient', 'died', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'with', 'myeloma', 'cast', 'nephropathy', 'treated', 'with', 'bortezomib-based', 'chemotherapy', 'regimen', ',', 'use', 'of', 'high-cutoff', 'hemodialysis', 'compared', 'with', 'conventional', 'hemodialysis', 'not', 'result', 'in', 'statistically', 'significant', 'difference', 'in', 'hemodialysis', 'independence', 'month', '.', 'however', ',', 'study', 'may', 'underpowered', 'to', 'identify', 'early', 'clinically', 'important', 'difference', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.,"K V Charaya, D Yu Schekochikhin, T V Nikiforova, A S Dimchishina, T V Soboleva, A M Shkliarov, Z R Kusova, D F Mesitskaya, N A Novikova, D A Andreev, K V Charayaet al.",2023 Aug 31,Kardiologiia,https://pubmed.ncbi.nlm.nih.gov/37697958/,No keywords found,"['aim', 'to', 'determine', 'effect', 'of', 'sodium-glucose', 'cotransporter-', 'inhibitor', '(', 'sglti', ')', 'kidney', 'function', 'in', 'acute', 'decompensated', 'heart', 'failure', '(', 'adhf', ')', '.material', 'and', 'method', 'controlled', 'randomized', 'study', 'dapagliflozin', 'treatment', 'in', 'adhf', 'performed', '.', 'patient', 'randomized', 'to', 'main', 'group', '(', 'standard', 'therapy', 'supplemented', 'with', 'dapagliflozin', ')', 'or', 'control', 'group', '(', 'standard', 'therapy', 'adhf', ')', '.', 'primary', 'endpoint', 'development', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'patient', 'included', '(', 'mean', 'age', ',', 'year', 'men', ')', '.', 'of', 'patient', 'type', 'diabetes', 'mellitus', '(', 'dm', ')', '.', 'mean', 'left', 'ventricular', 'ejection', 'fraction', '(', 'lv', 'ef', ')', 'in', '.', 'of', 'patient', ',', 'lv', 'ef', 'less', '.', 'median', 'concentration', 'of', 'n-terminal', 'pro-brain', 'natriuretic', 'peptide', '(', 'nt-probnp', ')', 'pg', 'ml', ',', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'ml', 'min', '.', 'm.results', 'in-hospital', 'mortality', '..', 'analysis', 'of', 'dynamic', 'of', 'body', 'weight', 'loss', 'showed', 'significant', 'difference', '(', 'g', 'vs.', 'g', 'p.', ')', 'in', 'favor', 'of', 'dapagliflozin', 'group', '.', 'requirement', 'increasing', 'daily', 'dose', 'of', 'furosemide', 'and', 'adding', 'another', 'class', 'diuretic', '(', 'thiazide', 'or', 'acetazolamide', ')', 'not', 'differ', 'group', '.', 'however', ',', 'median', 'furosemide', 'dose', 'stay', 'in', 'hospital', 'lower', 'in', 'dapagliflozin', 'group', '(', 'mg', 'vs.', 'mg', 'p.', ')', '.', 'hour', 'randomization', ',', 'gfr', 'significantly', 'decreased', 'in', 'dapagliflozin', 'group', '(', '-', '.', '-', 'mlmin', '.', ')', 'compared', 'to', 'control', 'group', '(', '-', '.', '-', 'ml', 'min', '.', ',', '.', ')', '.', 'despite', ',', 'gfr', 'not', 'differ', 'group', 'discharge', '(', 'mlmin', '.', 'and', 'mlmin', '.', ',', 'respectively', 'p', '.', ')', '.', 'in', 'dapagliflozin', 'group', ',', 'frequency', 'of', 'aki', 'episode', 'not', 'increased', 'compared', 'to', 'control', 'group', '(', 'and', '.', ',', 'respectively', 'p', '.', ')', '.conclusion', 'dapagliflozin', 'treatment', 'in', 'adhf', 'associated', 'with', 'pronounced', 'body', 'weight', 'loss', 'and', 'lower', 'average', 'dos', 'of', 'loop', 'diuretic', 'period', 'of', 'stay', 'in', 'hospital', ',', 'with', 'no', 'associated', 'clinically', 'significant', 'impairment', 'of', 'renal', 'function', '.']"
"Probiotics in septic acute kidney injury, a double blind, randomized control trial.","Jonathan S Chávez-Íñiguez, Miguel Ibarra-Estrada, Alejandro Martínez Gallardo-González, Ari Cisneros-Hernández, Rolando Claure-Del Granado, Gael Chávez-Alonso, Eduardo M Hernández-Barajas, Alexia C Romero-Muñoz, Fidel Ramos-Avellaneda, Manuel L Prieto-Magallanes, Marcela Plascencia-Cruz, Jarumi A Tanaka-Gutiérrez, Cristina Pérez-Hernández, Guillermo Navarro-Blackaller, Ramón Medina-González, Luz Alcantar-Vallin, Karina Renoirte-López, Guillermo García-García, Jonathan S Chávez-Íñiguezet al.",2023,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/37724527/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'due', 'to', 'sepsis', ',', 'intestinal', 'microbiota', 'change', 'to', 'dysbiosis', ',', 'affect', 'kidney', 'function', 'recovery', '(', 'kfr', ')', 'and', 'amplifies', 'injury', '.', 'therefore', ',', 'administration', 'of', 'probiotic', 'could', 'improve', 'dysbiosis', 'and', 'thereby', 'increase', 'probability', 'of', 'kfr', '.', 'method', 'in', 'double-blind', 'clinical', 'trial', ',', 'patient', 'with', 'aki', 'associated', 'with', 'sepsis', 'randomized', '(', ')', 'to', 'receive', 'probiotic', 'or', 'placebo', 'consecutive', 'day', ',', 'with', 'objective', 'of', 'evaluate', 'effect', 'kfr', ',', 'mortality', ',', 'kidney', 'replacement', 'therapy', '(', 'krt', ')', ',', 'urea', ',', 'urine', 'volume', ',', 'serum', 'electrolyte', 'and', 'adverse', 'event', 'day', '.', 'result', 'february', 'to', 'march', ',', 'total', 'of', 'patient', 'randomized', ',', 'to', 'probiotic', 'and', 'to', 'placebo', 'group', '.', 'comparing', 'with', 'placebo', ',', 'in', 'probiotic', 'not', 'observe', 'higher', 'kfr', '(', 'hr', '.', ',', '.-.', ',', 'p', '.', ')', ',', 'benefit', 'in', 'mortality', 'month', '(', 'ci', '.-.', ',', 'p', '.', ')', '.', 'with', 'probiotic', ',', 'urea', 'value', 'decreased', 'significantly', ',', 'event', 'not', 'observed', 'with', 'placebo', '(', 'to', 'mgdl', ',', 'p', '.', 'and', 'to', 'mgdl', ',', 'p', '.', ',', 'respectively', ')', '.', 'urinary', 'volume', ',', 'need', 'krt', ',', 'electrolyte', 'abnormality', ',', 'and', 'adverse', 'event', 'similar', 'group', '.', '(', 'clinicaltrial.gov', 'nct', ')', '(', 'registered', ')', '.', 'conclusion', 'in', 'aki', 'related', 'to', 'sepsis', ',', 'probiotic', 'consecutive', 'day', 'not', 'increase', 'probability', 'of', 'kfr', ',', 'variable', 'related', 'to', 'clinical', 'improvement', ',', 'although', 'safe', '.']"
"Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.","Eve Rodler, Priyanka Sharma, William E Barlow, Julie R Gralow, Shannon L Puhalla, Carey K Anders, Lori Goldstein, Debu Tripathy, Ursa A Brown-Glaberman, Thu-Tam Huynh, Christopher S Szyarto, Andrew K Godwin, Harsh B Pathak, Elizabeth M Swisher, Marc R Radke, Kirsten M Timms, Danika L Lew, Jieling Miao, Lajos Pusztai, Daniel F Hayes, Gabriel N Hortobagyi, Eve Rodleret al.",2023 Feb,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/36623515/,No keywords found,"['poly', '(', 'adp-ribose', ')', 'polymerase', '(', 'parp', ')', 'inhibitor', 'effective', 'in', 'germline', 'brca', 'or', 'brca', '(', 'brca', ')', 'mutation-associated', 'metastatic', 'breast', 'cancer', '.', 'however', ',', 'study', 'evaluating', 'parp', 'inhibitor', 'plus', 'platinum-based', 'chemotherapy', 'in', 'germline', 'brca-wildtype', 'triple-negative', 'breast', 'cancer', 'scarce', '.', 'large', 'proportion', 'of', 'germline', 'brca-wildtype', 'triple-negative', 'breast', 'cancer', 'show', 'homologous', 'recombination', 'deficiency', '(', 'hrd', ')', ',', 'resulting', 'in', 'brca-like', 'phenotype', 'might', 'render', 'sensitivity', 'to', 'parp', 'inhibitor', '.', 'trial', 'assessed', 'efficacy', 'of', 'cisplatin', 'combined', 'with', 'parp', 'inhibitor', 'veliparib', 'in', 'three', 'predefined', 'group', 'of', 'metastatic', 'breast', 'cancer', 'germline', 'brca-mutated', ',', 'brca-like', ',', 'and', 'non-brca-like', '.', 'method', 'randomised', ',', 'double-blind', ',', 'placebo-controlled', ',', 'phase', 'trial', 'conducted', 'community', 'and', 'academic', 'clinical', 'site', 'across', 'usa', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', 'metastatic', 'or', 'recurrent', 'triple-negative', 'breast', 'cancer', 'or', 'germline', 'brca-associated', 'metastatic', 'or', 'recurrent', 'breast', 'cancer', ',', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', '-', ',', 'and', 'received', 'to', 'one', 'line', 'of', 'chemotherapy', 'metastatic', 'disease', '.', 'patient', 'randomly', 'assigned', '(', ')', 'via', 'national', 'clinical', 'trial', 'network', 'open', 'interactive', 'system', 'with', 'dynamic', 'balancing', 'number', 'of', 'previous', 'cytotoxic', 'regimen', 'metastatic', 'disease', 'to', 'receive', 'intravenous', 'cisplatin', '(', 'mgm', ',', 'day', ')', 'combined', 'with', 'either', 'veliparib', 'or', 'matching', 'placebo', '(', 'mg', 'orally', 'twice', 'day', ',', 'day', '-', ')', '-day', 'cycle', '.', 'investigator', ',', 'patient', ',', 'and', 'sponsor', 'masked', 'to', 'treatment', 'assignment', 'study', 'statistician', 'unmasked', '.', 'central', 'testing', 'ran', 'domisation', 'classified', 'patient', 'mutated', 'or', 'wildtype', 'germline', 'brca', '.', 'biomarker', 'panel', 'established', 'priori', 'used', 'to', 'classify', 'patient', 'with', 'wildtype', 'germline', 'brca', 'brca-like', 'and', 'non-brca-like', 'phenotype', 'group', ',', 'with', 'brca-like', 'status', 'based', 'least', 'one', 'of', 'biomarkers', 'genomic', 'instability', 'score', '(', ')', ',', 'somatic', 'brca', 'mutation', ',', 'brca', 'promoter', 'methylation', ',', 'or', 'non-brca', 'homologous', 'recombination', 'repair', 'germline', 'mutation', '.', 'primary', 'endpoint', 'investigator-assessed', 'progression-free', 'survival', ',', 'analysed', 'separately', 'three', 'predefined', 'biomarker', 'group', 'with', 'prespecified', 'value', 'analysis', '.', 'efficacy', 'analysis', 'done', 'intention', 'to', 'treat', 'and', 'included', 'eligible', 'patient', '.', 'safety', 'analysis', 'of', 'toxicity', 'attributed', 'to', 'treatment', 'included', 'patient', 'received', 'least', 'one', 'dose', 'of', 'veliparib', 'or', 'placebo', '.', 'study', 'ongoing', 'and', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'july', ',', ',', 'and', 'june', ',', ',', 'patient', 'enrolled', 'and', 'randomly', 'assigned', '.', 'patient', '(', 'n', 'to', 'cisplatin', 'plus', 'veliparib', ',', 'woman', 'and', 'n', 'to', 'cisplatin', 'plus', 'placebo', ',', 'woman', 'and', 'one', 'man', ')', 'eligible', 'efficacy', 'evaluation', '.', 'patient', 'classified', 'three', 'biomarker', 'group', 'germline', 'brca-mutated', '(', 'n', ')', ',', 'brca-like', '(', 'n', ')', ',', 'and', 'non-brca-like', '(', 'n', ')', '.', 'patient', 'could', 'not', 'classified', 'due', 'to', 'missing', 'biomarker', 'information', '.', 'median', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', 'in', 'germline', 'brca-mutated', 'group', ',', 'median', 'progression-free', 'survival', 'month', '(', 'ci', '-', ')', 'in', 'cisplatin', 'plus', 'veliparib', 'group', 'and', 'month', '(', '-', ')', 'in', 'cisplatin', 'plus', 'placebo', 'group', '(', 'hr', 'ci', '-', 'log-rank', 'p', ')', '.', 'in', 'brca-like', 'group', ',', 'median', 'progression-free', 'survival', 'month', '(', 'ci', '-', ')', 'in', 'cisplatin', 'plus', 'veliparib', 'group', 'versus', 'month', '(', '-', ')', 'in', 'cisplatin', 'plus', 'placebo', 'group', '(', 'hr', 'ci', '-', 'p', ')', '.', 'in', 'non-brca-like', 'group', ',', 'median', 'progression-free', 'survival', 'month', '(', 'ci', '-', ')', 'in', 'cisplatin', 'plus', 'veliparib', 'group', 'versus', 'month', '(', '-', ')', 'in', 'cisplatin', 'plus', 'placebo', 'group', '(', 'hr', 'ci', '-', 'p', ')', '.', 'common', 'grade', 'or', 'worse', 'adverse', 'event', 'attributed', 'to', 'treatment', 'neutropenia', '(', 'of', 'patient', 'in', 'cisplatin', 'plus', 'veliparib', 'group', 'v', 'of', 'in', 'cisplatin', 'plus', 'placebo', 'group', ')', ',', 'leukopenia', '(', 'v', ')', ',', 'anaemia', '(', 'v', ')', ',', 'and', 'thrombocytopenia', '(', 'v', 'four', ')', '.', 'serious', 'adverse', 'event', 'attributed', 'to', 'treatment', 'occurred', 'in', '(', ')', 'patient', 'in', 'cisplatin', 'plus', 'veliparib', 'group', 'and', '(', ')', 'patient', 'in', 'cisplatin', 'plus', 'placebo', 'group', '.', 'treatment-related', 'adverse', 'event', 'led', 'to', 'death', 'in', 'one', 'patient', 'in', 'cisplatin', 'plus', 'veliparib', 'group', '(', 'sepsis', ')', 'and', 'one', 'patient', 'in', 'cisplatin', 'plus', 'placebo', 'group', '(', 'acute', 'kidney', 'injury', 'due', 'to', 'cisplatin', 'plus', 'heart', 'failure', 'previous', 'doxorubicin', 'exposure', ')', '.', 'interpretation', 'addition', 'of', 'veliparib', 'to', 'cisplatin', 'significantly', 'improved', 'progression-free', 'survival', 'in', 'patient', 'with', 'brca-like', 'metastatic', 'triple-negative', 'breast', 'cancer', ',', 'not', 'in', 'patient', 'with', 'non-brca-like', 'metastatic', 'breast', 'cancer', '.', 'parp', 'inhibitor', 'combined', 'with', 'platinum-based', 'chemotherapy', 'explored', 'in', 'brca-like', 'triple-negative', 'breast', 'cancer', '.', 'funding', 'national', 'cancer', 'institute', 'and', 'national', 'institute', 'of', 'general', 'medical', 'science', '(', 'u', 'national', 'institute', 'of', 'health', ')', 'abbvie', 'myriad', 'genetics', 'biomarker', ',', 'imaging', ',', 'and', 'quality', 'of', 'life', 'study', 'funding', 'program', '(', 'awarded', 'national', 'cancer', 'institute', ')', 'and', 'university', 'of', 'kansa', 'cancer', 'center', '.']"
A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes.,"F Perry Wilson, Yu Yamamoto, Melissa Martin, Claudia Coronel-Moreno, Fan Li, Chao Cheng, Abinet Aklilu, Lama Ghazi, Jason H Greenberg, Stephen Latham, Hannah Melchinger, Sherry G Mansour, Dennis G Moledina, Chirag R Parikh, Caitlin Partridge, Jeffrey M Testani, Ugochukwu Ugwuowo, F Perry Wilsonet al.",2023 May 17,Nat Commun,https://pubmed.ncbi.nlm.nih.gov/37198160/,No keywords found,"['non-steroidal', 'anti-inflammatory', 'drug', ',', 'renin-angiotensin-aldosterone', 'system', 'inhibitor', ',', 'or', 'proton', 'pump', 'inhibitor', '.', 'within', 'hour', 'of', 'randomization', ',', 'medication', 'of', 'interest', 'discontinued', 'in', '.', 'of', 'alert', 'group', 'versus', '.', 'of', 'usual', 'care', 'group', '(', 'relative', 'risk', '.', ',', '.', '-', '.', ',', 'p', '.', ')', '.', 'primary', 'outcome', '-', 'composite', 'of', 'progression', 'of', 'acute', 'kidney', 'injury', ',', 'dialysis', ',', 'or', 'death', 'within', 'day', '-', 'occurred', 'in', '(', '.', ')', 'of', 'individual', 'in', 'alert', 'group', 'and', '(', '.', ')', 'of', 'patient', 'in', 'usual', 'care', 'group', '(', 'rr', '.', ',', '.', '-', '.', ',', 'p', '.', ')', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates.,"Sangeeta Hingorani, Robert H Schmicker, Patrick D Brophy, Patrick J Heagerty, Sandra E Juul, Stuart L Goldstein, David Askenazi                              ;, PENUT Investigators, Sangeeta Hingoraniet al.",2021 Jun,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/34117080/,No keywords found,"['aki', 'associated', 'with', 'poor', 'short-', 'and', 'long-term', 'outcome', '.', 'question', 'remain', 'frequency', 'and', 'timing', 'of', 'aki', ',', 'and', 'whether', 'aki', 'cause', 'of', 'death', 'in', 'extremely', 'low', 'gestational', 'age', 'neonate', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'recombinant', 'erythropoietin', 'protection', 'of', 'infant', 'kidney', 'disease', 'study', 'examines', 'kidney', 'outcome', 'of', 'extremely', 'low', 'gestational', 'age', 'neonate', 'enrolled', 'in', 'preterm', 'epo', 'neuroprotection', 'study', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'of', 'recombinant', 'human', 'erythropoietin', '.', 'included', 'of', 'patient', 'enrolled', 'in', 'preterm', 'epo', 'neuroprotection', '.', 'baseline', 'characteristic', 'compared', 'primary', 'exposure', '(', 'severe', 'aki', 'versus', 'nonestage', 'aki', ')', 'using', 'unadjusted', 'logistic', 'regression', 'model', '.', 'cox', 'regression', 'model', 'estimated', 'relationship', 'severe', 'aki', 'and', 'death', 'adjustment', 'potential', 'confounders', '.', 'time-dependent', 'aki', 'modeled', 'binary', 'outcome', 'and', 'categorical', 'variable', 'stage', 'of', 'aki', '.', 'fit', 'cox', 'model', 'using', 'time-dependent', 'aki', 'status', 'lagged', 'day', 'death', '.', 'landmark', 'analysis', 'examined', 'relationship', 'of', 'death', 'with', 'development', 'of', 'severe', 'aki', '.', 'result', 'severe', 'aki', 'occurred', 'in', 'of', '(', ',', 'confidence', 'interval', ',', 'to', ')', 'neonate', ',', 'and', 'stage', 'aki', 'occurred', 'in', '(', ',', 'confidence', 'interval', ',', 'to', ')', '.', 'stage', 'aki', 'occurring', 'day', 'death', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', ',', 'intraventricular', 'hemorrhage', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', 'and', 'sepsis', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', 'independently', 'associated', 'with', 'death', '.', 'severe', 'aki', 'occurring', 'day', 'death', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', 'associated', 'with', 'death', 'not', 'statistically', 'significant', '.', 'in', 'landmark', 'analysis', ',', 'adjusting', 'potential', 'confounders', ',', 'late', '(', 'day', 'and', 'day', ')', 'severe', 'aki', 'strongly', 'associated', 'with', 'higher', 'hazard', 'of', 'death', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'conclusion', 'severe', 'aki', 'occurs', 'frequently', 'in', 'extremely', 'low', 'gestational', 'age', 'neonate', '.', 'stage', 'aki', 'associated', 'with', 'mortality', ',', 'and', 'association', 'present', 'day', 'death', '.']"
The Relationship between Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography.,"Qandeel H Soomro, Sonia T Anand, Steven D Weisbord, Martin P Gallagher, Ryan E Ferguson, Paul M Palevsky, Deepak L Bhatt, Chirag R Parikh, James S Kaufman                                                            ;, PRESERVE Trial Investigators;, PRESERVE Trial Group, Qandeel H Soomroet al.",2022 Oct,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/36008352/,No keywords found,"['contrast-associated', 'aki', 'may', 'result', 'in', 'higher', 'morbidity', 'and', 'mortality', '.', 'intravenous', 'fluid', 'administration', 'remains', 'mainstay', 'prevention', '.', 'lack', 'of', 'consensus', 'optimal', 'administration', 'strategy', '.', 'studied', 'association', 'of', 'periprocedure', 'fluid', 'administration', 'with', 'contrast-associated', 'aki', ',', 'defined', 'increase', 'in', 'serum', 'creatinine', 'of', 'least', 'or', '.', 'mgdl', 'baseline', '-', 'day', 'angiography', ',', 'and', '-day', 'need', 'dialysis', ',', 'death', ',', 'or', 'increase', 'in', 'serum', 'creatinine', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'conducted', 'secondary', 'analysis', 'of', 'preserve', 'participant', 'underwent', 'angiographic', 'procedure', '.', 'although', 'fluid', 'type', 'randomized', ',', 'strategy', 'of', 'administration', 'discretion', 'of', 'clinician', '.', 'divided', 'study', 'cohort', 'quartile', 'total', 'fluid', 'volume', '.', 'performed', 'multivariable', 'logistic', 'regression', ',', 'adjusting', 'clinically', 'important', 'covariates', '.', 'tested', 'interaction', 'fluid', 'volume', 'and', 'duration', 'of', 'fluid', 'administration', ',', 'categorized', 'hour', '.', 'mean', 'fluid', 'volume', 'ml', 'may', 'associated', 'with', 'higher', 'risk', 'primary', 'outcome', ',', 'although', 'residual', 'confounding', 'not', 'excluded', '.']"
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.,"K V Charaya, D Itri Yu Schekochikhin, T V Nikiforova, A S Dimchishina, T V Soboleva, A M Shkliarov, Z R Kusova, D F Mesitskaya, N A Novikova, D A Andreev, K V Charayaet al.",2023 Aug 31,Kardiologiia,https://pubmed.ncbi.nlm.nih.gov/37691500/,No keywords found,"['aim', 'to', 'determine', 'effect', 'of', 'sodium-glucose', 'cotransporter-', 'inhibitor', '(', 'sglti', ')', 'kidney', 'function', 'in', 'acute', 'decompensated', 'heart', 'failure', '(', 'adhf', ')', '.material', 'and', 'method', 'controlled', 'randomized', 'study', 'dapagliflozin', 'treatment', 'in', 'adhf', 'performed', '.', 'patient', 'randomized', 'to', 'main', 'group', '(', 'standard', 'therapy', 'supplemented', 'with', 'dapagliflozin', ')', 'or', 'control', 'group', '(', 'standard', 'therapy', 'adhf', ')', '.', 'primary', 'endpoint', 'development', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'patient', 'included', '(', 'mean', 'age', ',', 'year', 'men', ')', '.', 'of', 'patient', 'type', 'diabetes', 'mellitus', '(', 'dm', ')', '.', 'mean', 'left', 'ventricular', 'ejection', 'fraction', '(', 'lv', 'ef', ')', 'in', '.', 'of', 'patient', ',', 'lv', 'ef', 'less', '.', 'median', 'concentration', 'of', 'n-terminal', 'pro-brain', 'natriuretic', 'peptide', '(', 'nt-probnp', ')', 'pg', 'ml', ',', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'ml', 'min', '.', 'm.results', 'in-hospital', 'mortality', '..', 'analysis', 'of', 'dynamic', 'of', 'body', 'weight', 'loss', 'showed', 'significant', 'difference', '(', 'g', 'vs.', 'g', 'p.', ')', 'in', 'favor', 'of', 'dapagliflozin', 'group', '.', 'requirement', 'increasing', 'daily', 'dose', 'of', 'furosemide', 'and', 'adding', 'another', 'class', 'diuretic', '(', 'thiazide', 'or', 'acetazolamide', ')', 'not', 'differ', 'group', '.', 'however', ',', 'median', 'furosemide', 'dose', 'stay', 'in', 'hospital', 'lower', 'in', 'dapagliflozin', 'group', '(', 'mg', 'vs.', 'mg', 'p.', ')', '.', 'hour', 'randomization', ',', 'gfr', 'significantly', 'decreased', 'in', 'dapagliflozin', 'group', '(', '-', '.', '-', 'mlmin', '.', ')', 'compared', 'to', 'control', 'group', '(', '-', '.', '-', 'ml', 'min', '.', ',', '.', ')', '.', 'despite', ',', 'gfr', 'not', 'differ', 'group', 'discharge', '(', 'mlmin', '.', 'and', 'mlmin', '.', ',', 'respectively', 'p', '.', ')', '.', 'in', 'dapagliflozin', 'group', ',', 'frequency', 'of', 'aki', 'episode', 'not', 'increased', 'compared', 'to', 'control', 'group', '(', 'and', '.', ',', 'respectively', 'p', '.', ')', '.conclusion', 'dapagliflozin', 'treatment', 'in', 'adhf', 'associated', 'with', 'pronounced', 'body', 'weight', 'loss', 'and', 'lower', 'average', 'dos', 'of', 'loop', 'diuretic', 'period', 'of', 'stay', 'in', 'hospital', ',', 'with', 'no', 'associated', 'clinically', 'significant', 'impairment', 'of', 'renal', 'function', '.']"
A Phase III open-label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine-rituximab in treatment-naïve follicular lymphoma.,"Sushant Kumar Paikaray, Ajay Gogia, Lalit Kumar, Atul Sharma, Ahit Agni Biswas, Sreeniwas Vishnubhatla, Soumya Mallick, Sushant Kumar Paikarayet al.",2023 Oct 1,Indian J Cancer,https://pubmed.ncbi.nlm.nih.gov/38185869/,No keywords found,"['bendamustine-rituximab', '(', 'br', ')', 'preferred', 'regimen', 'treatment', 'of', 'nave', 'follicular', 'lymphoma', '(', 'fl', ')', '.', 'recently', ',', 'lenalidomide-rituximab', '(', 'lr', ')', ',', 'chemotherapy-free', 'protocol', ',', 'shown', 'good', 'response', 'rate', 'in', 'advanced', 'fl', '.', 'regimen', 'never', 'compared', 'in', 'randomized', 'controlled', 'trial', 'treatment-nave', 'fl', 'in', 'indian', 'patient', '.', 'material', 'and', 'method', 'phase', 'iii', 'open-label', 'randomized', 'controlled', 'trial', 'conducted', 'to', 'compare', 'efficacy', 'and', 'safety', 'of', 'br', 'and', 'lr', '.', 'treatment-nave', 'patient', 'older', 'year', 'of', 'age', ',', 'ecog', 'p', '(', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', ')', ',', 'diagnosed', 'with', 'fl', '(', 'stage', 'ii-iv', ')', 'included', 'in', 'study', '.', 'patient', 'randomized', 'in', 'ratio', 'to', 'receive', 'six', 'cycle', 'of', 'br', '(', 'bendamustine', 'mgm', 'day', '-', 'and', 'rituximab', 'mgm', 'day', ')', 'every', 'week', 'or', 'lr', '(', 'lenalidomide', 'mg', 'day', '-', 'and', 'rituximab', 'mgm', ')', 'every', 'week', '.', 'primary', 'end', 'point', 'complete', 'response', '(', 'cr', ')', 'and', 'secondary', 'end', 'point', 'overall', 'response', 'rate', '(', 'orr', ')', 'and', 'toxicity', '.', 'result', 'enrolled', 'patient', ',', 'in', 'group', 'with', 'median', 'age', 'of', 'year', '.', 'cr', 'rate', 'and', 'in', 'br', 'and', 'lr', 'arm', ',', 'respectively', '(', 'p', '.', ')', 'however', ',', 'orr', '.', 'and', '.', 'in', 'br', 'and', 'lr', 'arm', ',', 'respectively', '(', 'p', '.', ')', '.', 'anemia', '(', 'versus', ')', ',', 'skin', 'rash', '(', 'versus', ')', ',', 'diarrhea', '(', 'versus', ')', ',', 'vomiting', '(', 'versus', ')', ',', 'nephrotoxicity', '(', 'versus', ')', ',', 'and', 'transaminitis', '(', 'versus', ')', 'in', 'lr', 'in', 'br', ',', 'and', 'thrombocytopenia', 'higher', 'in', 'br', 'in', 'lr', 'group', 'statistically', 'not', 'different', '.', 'grade', 'toxicity', 'seen', 'in', 'and', 'in', 'lr', 'and', 'br', ',', 'respectively', '(', 'p', '.', ')', ',', 'no', 'significant', 'difference', 'in', 'grade', 'or', 'toxicity', 'br', 'and', 'lr', 'regimen', '(', 'versus', ')', '.', 'conclusion', 'orr', 'similar', 'in', 'arm', 'however', ',', 'cr', 'rate', 'significantly', 'higher', 'in', 'br', 'arm', '.', 'br', 'better', 'tolerated', 'lr', '.', '(', 'ctri', ')', '.']"
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?,"Yasemin Ozsurekci, Pembe Derin Oygar, Sibel Laçinel Gürlevik, Selman Kesici, Seza Ozen, Eda Didem Kurt Sukur, Bora Gülhan, Rezan Topaloglu, Benan Bayrakci, Ali Bülent Cengiz, Yasemin Ozsurekciet al.",2021 Nov,Pediatr Nephrol,https://pubmed.ncbi.nlm.nih.gov/34021797/,No keywords found,"['rising', 'number', 'of', 'infection', 'due', 'to', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus-', '(', 'popularly', 'known', 'covid-', ')', 'brought', 'to', 'fore', 'new', 'antiviral', 'drug', 'possible', 'treatment', ',', 'including', 'favipiravir', '.', 'however', ',', 'currently', 'no', 'data', 'regarding', 'safety', 'of', 'drug', 'in', 'patient', 'with', 'kidney', 'impairment', '.', 'aim', 'of', 'paper', ',', 'therefore', ',', 'to', 'share', 'experience', 'of', 'use', 'of', 'favipiravir', 'in', 'pediatric', 'patient', 'affected', 'covid-', 'with', 'degree', 'of', 'kidney', 'impairment', '.', 'method', 'study', 'enrolled', 'pediatric', 'patient', 'aged', 'year', 'and', 'confirmed', 'suffering', 'covid-', 'and', 'multisystem', 'inflammatory', 'syndrome', 'in', 'child', '(', 'mis-c', ')', 'with', 'degree', 'of', 'kidney', 'injury', ',', 'treated', 'with', 'favipiravir', 'time', 'of', 'admission', '.', 'result', 'of', 'total', 'of', 'patient', ',', 'diagnosed', 'with', 'mis-c', 'and', 'with', 'severe', 'covid-', '.', 'median', 'age', 'of', 'case', '.', '(', '-', '.', ')', 'year', 'and', 'malefemale', 'ratio', '.', 'time', 'of', 'admission', ',', 'median', 'serum', 'creatinine', 'level', '.', 'mgdl', '.', 'nine', 'patient', 'treated', 'with', 'favipiravir', 'day', ',', 'and', 'patient', 'day', 'followed', 'remdesivir', '-', 'day', 'despite', 'kidney', 'injury', 'time', 'of', 'admission', '.', 'seven', 'patient', 'underwent', 'plasma', 'exchange', 'mis-c', 'severely', 'affected', 'case', 'underwent', 'continuous', 'kidney', 'replacement', 'therapy', '(', 'ckrt', ')', 'well', '.', 'one', 'severe', 'covid-', 'patient', 'received', 'plasma', 'exchange', 'well', 'ckrt', '.', 'serum', 'creatinine', 'value', 'returned', 'to', 'normal', 'in', 'mean', '.', 'day', '.', 'conclusion', 'favipiravir', 'seems', 'suitable', 'therapeutic', 'option', 'in', 'patient', 'affected', 'covid-', 'with', 'kidney', 'injury', 'without', 'need', 'dose', 'adjustment', '.']"
"ACETATE RINGER'S SOLUTION VERSUS NORMAL SALINE SOLUTION IN SEPSIS: A RANDOMIZED, CONTROLLED TRIAL.","Jing Zhang, Fang Liu, Ziyi Wu, Jun Jiang, Bingqing Wang, Yaoyao Qian, Jinmeng Suo, Yiming Li, Zhiyong Peng, Jing Zhanget al.",2024 Apr 1,Shock,https://pubmed.ncbi.nlm.nih.gov/38369528/,No keywords found,"['normal', 'saline', 'solution', '(', 'nss', ')', 'and', 'ringer', ""'s"", 'acetate', 'solution', '(', 'ra', ')', 'commonly', 'given', 'to', 'critically', 'ill', 'patient', 'fundamental', 'fluid', 'therapy', '.', 'however', ',', 'effect', 'of', 'ra', 'and', 'nss', 'sepsis', 'patient', 'outcome', 'remains', 'unknown', '.', 'method', 'conducted', 'single-center', 'prospective', 'open-label', 'parallel', 'controlled', 'trial', 'to', 'enroll', 'adult', 'patient', '(', 'year', 'old', ')', 'diagnosed', 'with', 'sepsis', '.', 'participant', 'received', 'either', 'ra', 'or', 'nss', 'intravenous', 'infusion', 'day', '.', 'primary', 'outcome', 'incidence', 'of', 'major', 'adverse', 'kidney', 'event', 'within', 'day', '(', 'make', ')', '.', 'secondary', 'outcome', 'included', '--', 'day', 'mortality', ',', 'acute', 'kidney', 'injury', ',', 'and', 'hyperchloremia', '.', 'patient', 'reclassified', 'nss-only', ',', 'ras-only', ',', 'and', 'ra', 'nss', 'group', 'according', 'to', 'type', 'of', 'fluid', 'received', 'enrollment', '.', 'thereafter', ',', 'secondary', 'post', 'hoc', 'analysis', 'performed', '.', 'result', 'two', 'hundred', 'fifty-five', 'septic', 'patient', 'screened', ',', 'and', 'patient', '(', '.', 'in', 'ra', 'group', 'and', '.', 'in', 'nss', 'group', ')', 'enrolled', 'in', 'study', '.', 'group', 'received', 'median', 'of', 'l', 'of', 'fluid', 'administration', 'five', 'interventional', 'day', '.', 'of', 'patient', ',', '.', 'received', 'ml', '(', '-', ',', 'ml', ')', 'of', 'balanced', 'salt', 'solution', '(', 'bsss', ')', 'intensive', 'care', 'unit', '(', 'icu', ')', 'admission', '.', 'no', 'statistical', 'difference', 'among', 'ra', 'and', 'nss', 'group', 'primary', 'outcome', 'make', 'in', 'initial', 'analysis', '(', '.', 'vs.', '.', 'or', ',', '.', '.', 'to', '.', 'p', '.', ')', '.', 'make', 'observed', 'in', '.', 'of', 'ras-only', 'versus', '.', 'of', 'nss-only', 'group', 'patient', '(', '.', '.-.', ',', 'p', '.', ')', 'in', 'secondary', 'post', 'hoc', 'analysis', '.', 'patient', 'in', 'nss-only', 'group', 'longer', 'invasive', 'mechanical', 'ventilation', 'day', 'and', 'trend', 'toward', 'accumulation', 'of', 'serum', 'chloride', '.', 'conclusion', 'study', 'observed', 'no', 'statistically', 'significant', 'difference', 'make', 'and', 'secondary', 'outcome', 'among', 'sepsis', 'patient', 'receiving', 'ra', 'and', 'nss', '.', 'however', ',', 'unclear', 'whether', 'large', 'amount', 'of', 'fluid', 'resuscitation', 'icu', 'admission', 'and', 'carrier', 'nss', 'narrowed', 'difference', 'bsss', 'and', 'nsss', '.']"
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.,"Ahmed Fayed, Ahmed A Hammad, Dina O Abdulazim, Hany Hammad, Mohamed Amin, Samir Elhadidy, Mona M Salem, Ibrahim M Abd ElAzim, Lajos Zsom, Eva Csongradi, Karim M Soliman, Usama A Sharaf El Din, Ahmed Fayedet al.",2023 Dec,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/36974638/,No keywords found,"['patient', 'with', 'diabetic', 'kidney', 'disease', '(', 'dkd', ')', 'increased', 'risk', 'to', 'develop', 'post-contrast', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'diabetic', 'patient', 'dipeptidyl', 'peptidase', 'inhibitor', '(', 'dppis', ')', 'experience', 'lower', 'propensity', 'to', 'develop', 'aki', '.', 'speculated', 'linagliptin', 'single', 'agent', 'or', 'in', 'combination', 'with', 'allopurinol', 'may', 'reduce', 'incidence', 'of', 'post-contrast', 'aki', 'in', 'stage', '-', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'patient', 'with', 'underlying', 'dkd', '.', 'method', 'of', 'dkd', 'patient', 'eligible', 'study', ',', 'accepted', 'to', 'sign', 'informed', 'consent', '.', 'randomly', 'allocated', 'to', 'equal', 'group', 'received', 'prophylaxis', 'day', 'and', 'radiocontrast', '.', 'first', 'control', 'group', 'received', 'n-acetyl', 'cysteine', 'and', 'saline', ',', 'nd', 'received', 'allopurinol', ',', 'rd', 'group', 'received', 'linagliptin', ',', 'and', 'th', 'received', 'allopurinol', 'and', 'linagliptin', '.', 'post-procedure', 'follow-up', 'kidney', 'function', 'conducted', 'week', 'in', 'patient', '.', 'result', ',', ',', ',', 'and', 'patient', 'developed', 'post-contrast', 'aki', 'in', 'group', ',', 'respectively', '.', 'neither', 'linagliptin', 'allopurinol', 'superior', 'to', 'n-acetyl', 'cysteine', 'and', 'saline', 'alone', '.', 'however', ',', 'combination', 'of', 'two', 'agent', 'provided', 'statistically', 'significant', 'renal', 'protection', 'post-contrast', 'aki', 'in', 'group', 'significantly', 'lower', 'in', 'group', 'and', '(', 'p', '.', 'and', '.', ',', 'respectively', ')', '.', 'none', 'of', 'post-contrast', 'aki', 'case', 'required', 'dialysis', '.', 'conclusion', 'linagliptin', 'and', 'allopurinol', 'in', 'combination', 'may', 'offer', 'protection', 'post-contrast', 'aki', 'in', 'dkd', 'exposed', 'to', 'radiocontrast', '.', 'study', 'needed', 'to', 'support', 'view', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Thiamine administration in septic shock: a post hoc analysis of two randomized trials.,"Jacob Vine#, John H Lee#, Max S Kravitz, Anne V Grossestreuer, Lakshman Balaji, Shannon B Leland, Noa Berlin, Ari Moskowitz#, Michael W Donnino#, Jacob Vineet al.",2024 Feb 6,Crit Care,https://pubmed.ncbi.nlm.nih.gov/38321529/,No keywords found,"['post', 'hoc', 'analysis', 'of', 'combined', 'cohort', 'two', 'previous', 'phase', 'ii', 'clinical', 'trial', 'to', 'assess', 'effect', 'of', 'thiamine', 'administration', 'kidney', 'protection', 'and', 'mortality', 'in', 'patient', 'with', 'septic', 'shock', '.', 'method', 'patient-level', 'data', 'thiamine', 'in', 'septic', 'shock', 'trial', '(', 'nct', ')', 'and', 'thiamine', 'renal', 'protection', 'in', 'septic', 'shock', 'trial', '(', 'nct', ')', 'combined', 'in', 'analysis', '.', 'primary', 'outcome', 'current', 'study', 'survival', 'without', 'receipt', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'analysis', 'performed', 'overall', 'cohort', 'and', 'thiamine-deficient', 'cohort', '(', 'thiamine', 'nmoll', ')', '.', 'result', 'totally', ',', 'patient', 'included', '.', 'overall', ',', 'thiamine', 'administration', 'associated', 'with', 'higher', 'odds', 'of', 'alive', 'and', 'rrt-free', '(', 'adjusted', 'odds', 'ratio', 'aor', '.', 'confidence', 'interval', '(', 'ci', ')', '.-', '.', ')', 'and', 'not', 'needing', 'rrt', '(', 'aor', '.', 'ci', '.-.', ')', '.', 'in', 'thiamine-deficient', 'group', ',', 'thiamine', 'administration', 'associated', 'with', 'higher', 'odds', 'of', 'alive', 'and', 'rrt-free', '(', 'aor', '.', 'ci', '.-', '.', ')', 'and', 'surviving', 'to', 'hospital', 'discharge', '(', 'aor', '.', 'ci', '.-.', ')', '.', 'significant', 'effect', 'modification', 'baseline', 'thiamine', 'deficiency', 'alive', 'and', 'rrt-free', '(', 'interaction', ',', 'p', '.', ')', 'and', 'surviving', 'to', 'hospital', 'discharge', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'combined', 'analysis', 'of', 'two', 'previous', 'randomized', 'trial', ',', 'thiamine', 'administration', 'associated', 'with', 'higher', 'odds', 'of', 'alive', 'and', 'rrt-free', 'hospital', 'discharge', 'in', 'patient', 'with', 'septic', 'shock', '.', 'signal', 'stronger', 'in', 'patient', 'with', 'thiamine', 'deficiency', '.']"
Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial.,"Markus B Skrifvars, Elizabeth Moore, Johan Mårtensson, Michael Bailey, Craig French, Jeffrey Presneill, Alistair Nichol, Lorraine Little, Jacques Duranteau, Olivier Huet, Samir Haddad, Yaseen Arabi, Colin McArthur, David J Cooper, Rinaldo Bellomo                                                            ;, EPO-TBI Investigators and the ANZICS Clinical Trials Group, Markus B Skrifvarset al.",2019 Feb,Acta Anaesthesiol Scand,https://pubmed.ncbi.nlm.nih.gov/30132785/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'traumatic', 'brain', 'injury', '(', 'tbi', ')', 'poorly', 'understood', 'and', 'unknown', 'attenuated', 'using', 'erythropoietin', '(', 'epo', ')', '.', 'method', 'pre-planned', 'analysis', 'of', 'patient', 'included', 'in', 'epo-tbi', '(', 'clinicaltrials.gov', 'nct', ')', 'trial', 'randomized', 'to', 'weekly', 'epo', '(', 'unit', ')', 'or', 'placebo', '(', '.', 'sodium', 'chloride', ')', 'subcutaneously', 'to', 'three', 'dos', 'or', 'intensive', 'care', 'unit', '(', 'icu', ')', 'discharge', '.', 'creatinine', 'level', 'and', 'urinary', 'output', '(', 'to', 'day', ')', 'categorized', 'according', 'to', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'classification', '.', 'severity', 'of', 'tbi', 'categorized', 'with', 'international', 'mission', 'prognosis', 'and', 'analysis', 'of', 'clinical', 'trial', 'in', 'tbi', '.', 'result', 'of', 'screened', 'patient', ',', 'randomized', 'and', 'analyzed', '.', 'of', ',', '(', ')', 'patient', 'developed', 'aki', 'according', 'to', 'kdigo', '(', 'with', 'kdigo', ',', 'patient', 'with', 'kdigo', ',', 'and', 'patient', 'with', 'kdigo', ')', '.', 'male', 'gender', '(', 'hazard', 'ratio', 'hr', '.', 'confidence', 'interval', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'severity', 'of', 'tbi', '(', 'hr', '.', 'ci', '.-.', ',', 'p', '.', 'increase', 'in', 'risk', 'of', 'poor', 'month', 'outcome', ')', 'predicted', 'time', 'to', 'aki', '.', 'kdigo', 'stage', '(', 'hr', '.', 'ci', '.-', ',', 'p', '.', ')', ',', 'kdigo', 'stage', '(', 'hr', '.', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'kdigo', 'stage', '(', 'hr', '.', 'ci', '.-.', ',', 'p', '.', ')', 'predicted', 'time', 'to', 'mortality', '.', 'epo', 'not', 'influence', 'time', 'to', 'aki', '(', 'hr', '.', 'ci', '.-.', ',', 'p', '.', ')', 'or', 'creatinine', 'level', 'icu', 'stay', '(', 'p', '.', ')', '.', 'conclusion', 'acute', 'kidney', 'injury', 'common', 'in', 'male', 'patient', 'and', 'with', 'severe', 'compared', 'to', 'moderate', 'tbi', 'and', 'appears', 'associated', 'with', 'worse', 'outcome', '.', 'epo', 'not', 'prevent', 'aki', 'tbi', '.']"
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.,"Betty K Hamilton, Lisa A Rybicki, Hong Li, Taylor Lucas, Donna Corrigan, Matt Kalaycio, Ronald Sobecks, Rabi Hanna, Seth J Rotz, Robert M Dean, Aaron T Gerds, Deepa Jagadeesh, Claudio Brunstein, Craig S Sauter, Edward A Copelan, Navneet S Majhail, Betty K Hamiltonet al.",2023 Aug 22,Blood Adv,https://pubmed.ncbi.nlm.nih.gov/37352262/,No keywords found,"['tacrolimus', '(', 'tac', ')', 'methotrexate', '(', 'mtx', ')', 'standard', 'graft-versus-host', 'disease', '(', 'gvhd', ')', 'prophylaxis', 'however', ',', 'associated', 'with', 'several', 'toxicity', '.', 'tac', ',', 'reduced-dose', 'mtx', '(', 'mini-mtx', ')', ',', 'and', 'mycophenolate', 'mofetil', '(', 'mmf', ')', 'used', 'never', 'compared', 'with', 'standard', 'mtx', '.', 'performed', 'randomized', 'trial', 'comparing', 'tacmtx', '(', 'full-mtx', ')', 'with', 'tacmini-mtxmmf', '(', 'mini-mtxmmf', ')', 'gvhd', 'prevention', 'allogeneic', 'hematopoietic', 'cell', 'transplantation', '(', 'hct', ')', '.', 'patient', '(', 'pt', ')', 'receiving', 'first', 'myeloablative', 'hct', 'using', 'hla-matched', 'donor', 'eligible', '.', 'primary', 'end', 'point', 'incidence', 'of', 'acute', 'gvhd', '(', 'agvhd', ')', ',', 'mucositis', ',', 'and', 'engraftment', '.', 'secondary', 'end', 'point', 'included', 'chronic', 'gvhd', '(', 'cgvhd', ')', ',', 'organ', 'toxicity', ',', 'infection', ',', 'relapse', ',', 'nonrelapse', 'mortality', '(', 'nrm', ')', ',', 'and', 'overall', 'survival', '(', 'o', ')', '.', 'ninety-six', 'pt', 'randomly', 'assigned', 'to', 'full-mtx', '(', 'n', ')', 'or', 'mini-mtx', '(', 'n', ')', '.', 'majority', '(', ')', 'used', 'bone', 'marrow', 'graft', '.', 'no', 'significant', 'difference', 'in', 'grade', '-', 'agvhd', '(', 'mini-mtxmmf', 'v', 'full-mtx', 'p', '.', ')', 'however', 'higher', 'incidence', 'of', 'grade', '-', 'agvhd', '(', 'v', 'p', '.', ')', 'with', 'mini-mtxmmf', '.', 'pt', 'receiving', 'mini-mtxmmf', 'lower', 'grade', 'or', 'mucositis', 'and', 'faster', 'engraftment', '.', 'no', 'difference', 'in', 'moderate-to-severe', 'cgvhd', 'year', 'or', 'infection', '.', 'pt', 'receiving', 'mini-mtxmmf', 'experienced', 'less', 'nephrotoxicity', 'and', 'respiratory', 'failure', '.', 'no', 'difference', 'in', '-year', 'relapse', '(', 'v', 'p', '.', ')', 'and', 'o', '(', 'v', 'p', '.', ')', ',', 'and', 'mini-mtxmmf', 'associated', 'with', 'lower', 'nonsignificant', 'nrm', '(', 'v', 'p', '.', ')', '.', 'compared', 'with', 'full-mtx', ',', 'mini-mtxmmf', 'associated', 'with', 'no', 'difference', 'in', 'grade', '-', 'agvhd', 'and', 'favorable', 'toxicity', 'profile', '.', 'higher', 'severe', 'agvhd', 'warrant', 'study', 'to', 'optimize', 'regimen', '.', 'trial', 'registered', 'www.clinicaltrials.gov', 'nct', '.']"
Effects of low-dose furosemide combined with aminophylline on the renal function in septic shock patients.,"Zhenhua Mai, Yaying Tan, Yang Zhu, Zilong Yang, Hongpeng Chen, Shuting Cai, Wangwang Hu, Xiaoyan Wang, Fenghua Ding, Liehua Deng, Zhenhua Maiet al.",2023 Dec,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/36856313/,No keywords found,"['to', 'investigate', 'effect', 'of', 'low-dose', 'furosemide', 'and', 'aminophylline', 'renal', 'function', 'in', 'patient', 'with', 'septic', 'shock', '.', 'method', 'and', 'result', 'total', 'of', 'eligible', 'septic', 'shock', 'patient', 'in', 'intensive', 'care', 'unit', 'randomly', 'divided', 'control', 'group', '(', 'n', ')', 'and', 'intervention', 'group', '(', 'n', ')', '.', 'control', 'group', 'received', 'normal', 'saline', ',', 'and', 'intervention', 'group', 'received', 'low-dose', 'furosemide', '(', '.', 'mgkg.h-', ')', 'with', 'aminophylline', '(', '.', 'mgkg.h-', ')', '.', 'primary', 'outcome', 'included', 'level', 'of', 'serum', 'creatinine', '(', 'scr', ')', ',', 'creatinine', 'clearance', 'rate', '(', 'ccr', ')', ',', 'blood', 'urea', 'nitrogen', '(', 'bun', ')', ',', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', ',', 'and', 'urine', 'output', 'admission', 'and', 'day', ',', 'and', '.', 'secondary', 'outcome', 'sequential', 'organ', 'failure', 'assessment', '(', 'sofa', ')', 'score', ',', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'time', 'and', 'intensive', 'care', 'unit', '(', 'icu', ')', 'mortality', ',', 'hospital', 'mortality', 'and', '-day', 'mortality', '.', 'no', 'significant', 'difference', 'in', 'level', 'of', 'scr', ',', 'ccr', ',', 'bun', ',', 'or', 'gfr', 'two', 'group', ',', 'urine', 'output', 'higher', 'in', 'intervention', 'group', 'day', ',', ',', 'and', '.', 'compared', 'with', 'control', 'group', ',', 'sofa', 'score', ',', 'icu', 'mortality', ',', 'hospital', 'mortality', 'and', '-day', 'mortality', 'significantly', 'lower', 'in', 'intervention', 'group', 'day', ',', ',', 'and', ',', 'crrt', 'time', 'shorter', ',', 'and', 'cumulative', 'fluid', 'balance', 'lower', 'day', 'and', 'in', 'intervention', 'group', '.', 'conclusion', 'although', 'low-dose', 'furosemide', 'and', 'aminophylline', 'fewer', 'protective', 'effect', 'renal', 'function', 'in', 'septic', 'shock', 'patient', ',', 'could', 'reduce', 'crrt', 'time', 'and', 'improve', 'prognosis', '.']"
Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.,"Claire C J Dekkers, Sergei Petrykiv, Gozewijn D Laverman, David Z Cherney, Ron T Gansevoort, Hiddo J L Heerspink, Claire C J Dekkerset al.",2018 Aug,Diabetes Obes Metab,https://pubmed.ncbi.nlm.nih.gov/29573529/,"KIM-1, MCP-1, SGLT-2, acute kidney injury, dapagliflozin, type 2 diabetes.","['mechanism', 'sglt-', 'inhibitor', 'lower', 'albuminuria', 'incompletely', 'understood', '.', 'assessed', 'in', 'post-hoc', 'analysis', 'of', 'cross-over', 'trial', 'effect', 'of', 'sglt', 'inhibitor', 'dapagliflozin', 'glomerular', 'marker', '(', 'igg', 'to', 'igg', 'and', 'igg', 'to', 'albumin', ')', ',', 'tubular', 'marker', '(', 'urinary', 'kim-', ',', 'ngal', 'and', 'lfabp', ')', 'and', 'inflammatory', 'marker', '(', 'urinary', 'mcp-', 'and', 'il-', ')', 'to', 'provide', 'insight', 'kidney', 'protective', 'effect', '.', 'dapagliflozin', 'decreased', 'albuminuria', '.', '(', 'ci', ',', '.-', '.', ')', 'and', 'egfr', '.', '(', '.-', '.', ')', 'mlmin.m', 'compared', 'to', 'placebo', '.', 'dapagliflozin', 'not', 'change', 'glomerular', 'charge', 'or', 'size', 'selectivity', 'index', 'compared', 'to', 'placebo', '.', 'dapagliflozin', 'decreased', 'urinary', 'kim-', 'excretion', '.', '(', '.-', '.', 'p', '.', ')', 'and', 'il-', 'excretion', '.', '(', '.-', '.', 'p', '.', ')', 'compared', 'to', 'placebo', ',', 'whereas', 'no', 'change', 'in', 'ngal', ',', 'lfabp', 'and', 'mcp-', 'observed', '.', 'dapagliflozin', 'treatment', ',', 'change', 'in', 'albuminuria', 'correlated', 'with', 'change', 'in', 'egfr', '(', 'r', '.', 'p', '.', ')', 'and', 'kim-', '(', 'r', '.', 'p', '.', ')', '.', 'in', 'conclusion', ',', 'albuminuria-lowering', 'effect', 'of', 'week', 'of', 'dapagliflozin', 'therapy', 'may', 'result', 'of', 'decreased', 'intraglomerular', 'pressure', 'or', 'reduced', 'tubular', 'cell', 'injury', '.']"
"Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study.","Maria Tholén, Sven-Erik Ricksten, Lukas Lannemyr, Maria Tholénet al.",2021 Jun 12,Crit Care,https://pubmed.ncbi.nlm.nih.gov/34118980/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'and', 'serious', 'complication', 'cardiac', 'surgery', ',', 'and', 'current', 'strategy', 'aimed', 'treating', 'aki', 'proven', 'ineffective', '.', 'levosimendan', ',', 'inodilatating', 'agent', ',', 'shown', 'to', 'increase', 'renal', 'blood', 'flow', 'and', 'glomerular', 'filtration', 'rate', 'in', 'uncomplicated', 'postoperative', 'patient', 'and', 'in', 'patient', 'with', 'cardiorenal', 'syndrome', '.', 'hypothesized', 'levosimendan', 'specific', 'effect', 'renal', 'vasculature', ',', 'preferential', 'vasodilating', 'effect', 'preglomerular', 'resistance', 'vessel', ',', 'could', 'improve', 'renal', 'function', 'in', 'aki-patients', 'with', 'not', 'clinical', 'indication', 'inotropic', 'support', '.', 'method', 'in', 'single-center', ',', 'double-blind', ',', 'randomized', 'controlled', 'study', ',', 'adult', 'patient', 'with', 'postoperative', 'aki', 'within', 'day', 'cardiac', 'surgery', ',', 'hemodynamically', 'stable', 'with', 'central', 'venous', 'oxygen', 'saturation', '(', 'scvo', ')', 'without', 'inotropic', 'support', 'eligible', 'inclusion', '.', 'randomization', ',', 'study', 'drug', 'infusion', ',', 'levosimendan', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'given', 'h.', 'bolus', 'infusion', 'of', 'levosimendan', '(', 'gkg', ')', ',', 'given', 'min', 'followed', '.', 'gkgmin', 'h.', 'renal', 'blood', 'flow', 'and', 'glomerular', 'filtration', 'rate', 'measured', 'using', 'infusion', 'clearance', 'of', 'para-aminohippuric', 'acid', 'and', 'filtration', 'marker', ',', 'respectively', '.', 'safety', 'issue', ',', 'norepinephrine', 'administered', 'to', 'maintain', 'mean', 'arterial', 'pressure', '-', 'mmhg', '.', 'intra-group', 'difference', 'tested', 'mann-whitney', 'u-tests', ',', 'and', 'linear', 'mixed', 'model', 'used', 'to', 'test', 'time', 'and', 'group', 'interaction', '.', 'result', 'twenty-nine', 'patient', 'completed', 'study', '.', 'inclusion', ',', 'mean', 'serum', 'creatinine', 'higher', 'in', 'patient', 'randomized', 'to', 'levosimendan', '(', 'v', 'moll', ',', 'p', '.', ')', ',', 'and', 'estimated', 'gfr', 'lower', '(', 'v', 'mlmin', '.', ',', 'p', '.', ')', '.', 'levosimendan', 'induced', 'significantly', '(', 'p', '.', ')', 'pronounced', 'increase', 'in', 'renal', 'blood', 'flow', '(', ')', 'compared', 'placebo', '(', ')', 'and', 'pronounced', 'decrease', 'in', 'renal', 'vascular', 'resistance', '(', '-', 'vs.', '-', ',', 'respectively', ',', 'p', '.', ')', '.', 'trend', 'minor', 'increase', 'in', 'glomerular', 'filtration', 'rate', 'with', 'levosimendan', '(', '.', ',', 'p', '.', ')', ',', 'differ', 'significantly', 'placebo', 'group', '(', 'p', '.', ')', '.', 'mean', 'norepinephrine', 'dose', 'increased', 'in', 'levosimedan', 'group', 'and', 'decreased', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'hemodynamically', 'stable', 'patient', 'with', 'aki', 'cardiac', 'surgery', ',', 'levosimendan', 'increase', 'renal', 'blood', 'flow', 'renal', 'vasodilatation', '.', 'trial', 'registration', 'nct', ',', 'prospectly', 'registered', '.', 'httpsclinicaltrials.govctshownctcondakicntryseagedrawrank', '.']"
Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure.,"Kirsten Thiele, Matthias Rau, Niels-Ulrik Korbinian Hartmann, Marcus Möller, Julia Möllmann, Joachim Jankowski, András P Keszei, Michael Böhm, Jürgen Floege, Nikolaus Marx, Michael Lehrke, Kirsten Thieleet al.",2022 Aug,ESC Heart Fail,https://pubmed.ncbi.nlm.nih.gov/35611683/,No keywords found,"['in', 'prospective', ',', 'placebo-controlled', ',', 'double-blind', ',', 'exploratory', 'study', ',', 'examined', 'early', 'and', 'delayed', 'effect', 'of', 'empagliflozin', 'treatment', 'haemodynamic', 'parameter', '(', 'primary', 'endpoint', 'cardiac', 'output', ')', 'and', 'kidney', 'function', 'including', 'parameter', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'with', 'acute', 'decompensated', 'heart', 'failure', '(', 'hf', ')', '.', 'method', 'and', 'result', 'patient', 'with', 'acute', 'decompensated', 'hf', 'with', 'or', 'without', 'diabetes', 'randomized', 'to', 'empagliflozin', 'mg', 'or', 'placebo', 'day', '.', 'haemodynamic', ',', 'laboratory', ',', 'and', 'urinary', 'parameter', 'assessed', 'h', ',', 'day', ',', 'day', ',', 'day', ',', 'and', 'day', 'of', 'treatment', '.', 'median', 'time', 'hospital', 'admission', 'and', 'randomization', 'h.', 'baseline', 'characteristic', 'not', 'different', 'in', 'empagliflozin', '(', 'n', ')', 'and', 'placebo', '(', 'n', ')', 'group', '.', 'empagliflozin', 'led', 'to', 'significant', 'increase', 'in', 'urinary', 'glucose', 'excretion', 'throughout', 'study', '(', 'baseline', 'mg', 'h', 'day', 'mg', 'h', 'p', '.', ')', '.', 'empagliflozin', 'not', 'affect', 'primary', 'endpoint', 'of', 'cardiac', 'index', 'or', 'systemic', 'vascular', 'resistance', 'index', 'time', 'point', '.', 'however', ',', 'empagliflozin', 'significantly', 'reduced', 'parameter', 'of', 'aki', '(', 'urinary', 'timp-', 'and', 'igfbp', 'nephrocheck', 'indicator', 'of', 'tubular', 'kidney', 'damage', ')', ',', 'became', 'significant', 'day', 'of', 'treatment', 'placebo', '.', '.', '(', 'ngml', ')', 'empagliflozin', '.', '.', '(', 'ngml', ')', 'p', '.', 'and', 'remained', 'significant', 'day', 'time', 'point', 'placebo', '.', '.', '(', 'ngml', ')', 'empagliflozin', '.', '.', '(', 'ngml', ')', 'p', '..', 'conclusion', 'in', 'study', ',', 'empagliflozin', 'treatment', 'not', 'affect', 'haemodynamic', 'parameter', 'significantly', 'reduced', 'marker', 'of', 'tubular', 'injury', 'in', 'patient', 'with', 'acute', 'decompensated', 'hf', '.']"
Liver and kidney function in patients with Covid-19 treated with remdesivir.,"Sylvia A van Laar, Mark G J de Boer, Kim B Gombert-Handoko, Henk-Jan Guchelaar, Juliette Zwaveling                              ;, LUMC-Covid- research group, Sylvia A van Laaret al.",2021 Nov,Br J Clin Pharmacol,https://pubmed.ncbi.nlm.nih.gov/33763917/,"Covid-19, adverse events, liver function, remdesivir, renal function.","['treatment', 'of', 'covid-', 'patient', 'with', 'remdesivir', ',', 'poor', 'renal', 'and', 'liver', 'function', 'exclusion', 'criterion', 'in', 'randomized', 'clinical', 'trial', 'and', 'contraindication', 'treatment', '.', 'also', ',', 'nephrotoxicity', 'and', 'hepatotoxicity', 'reported', 'adverse', 'event', '.', 'retrospectively', 'reviewed', 'renal', 'and', 'liver', 'function', 'of', 'covid-', 'patient', 'received', 'remdesivir', 'in', 'day', 'treatment', 'initiation', '.', 'approximately', 'of', 'patient', 'population', 'met', 'randomized', 'clinical', 'trial', 'exclusion', 'criterion', '.', 'in', 'total', ',', 'of', 'patient', 'decrease', 'in', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin.m', '.', 'also', ',', 'and', 'increased', 'alanine', 'transaminase', 'and', 'aspartate', 'transaminase', 'level', ',', 'respectively', '.', 'however', ',', 'serious', 'adverse', 'event', 'limited', '.', 'therefore', ',', 'based', 'preliminary', 'result', ',', 'contraindication', 'based', 'kidney', 'and', 'liver', 'function', 'not', 'absolute', 'remdesivir', 'treatment', 'in', 'patient', 'with', 'covid-', 'function', 'monitored', 'regularly', '.', 'larger', 'patient', 'cohort', 'warranted', 'to', 'confirm', 'result', '.']"
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.,"Cristina Ripoll, Stephanie Platzer, Philipp Franken, Rene Aschenbach, Andreas Wienke, Ulrike Schuhmacher, Ulf Teichgräber, Andreas Stallmach, Jörg Steighardt, Alexander Zipprich                              ;, Liver-HERO Study Group, Philipp Reuken, Marina Reljic, Florian Bürckenmeyer, Kathleen Lange, Robin Greinert, Marco Damm, Christian Lange, Paul Jamme, Max Seidensticker, Moritz Wildgruber, Dominik Bettinger, Michael Schultheiss, Marco Berning, Stefan Sulk, Jens-Peter Kühn, Ralf-Thorsten Hoffmann, Christoph Radosa, Thomas Hofmockel, Tony Bruns, Theresa Wirtz, Philipp Bruners, Karel Caca, Andreas Wannhoff, Benjamin Massoumy, Katja Deterding, Jan Hinrichs, Kerstin Port, Jonel Trebicka, Michael Praktiknjo, Cornelius Engelmann, Andreas Drolz, Cristina Ripollet al.",2023 Apr 5,Trials,https://pubmed.ncbi.nlm.nih.gov/37020315/,No keywords found,"['patient', 'with', 'cirrhosis', 'and', 'ascites', '(', 'and', 'portal', 'hypertension', ')', 'risk', 'of', 'developing', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'although', 'many', 'etiology', 'exist', ',', 'hepatorenal', 'aki', '(', 'hrs-aki', ')', 'remains', 'frequent', 'and', 'difficult-to-treat', 'cause', ',', 'with', 'high', 'mortality', 'left', 'untreated', '.', 'standard', 'of', 'care', 'use', 'of', 'terlipressin', 'and', 'albumin', '.', 'lead', 'to', 'reversal', 'of', 'aki', ',', 'associated', 'to', 'survival', '.', 'nevertheless', ',', 'approximately', 'half', 'of', 'patient', 'achieve', 'reversal', 'and', 'even', 'reversal', 'patient', 'remains', 'risk', 'new', 'episode', 'of', 'hrs-aki', '.', 'tip', 'accepted', 'use', 'in', 'patient', 'with', 'variceal', 'bleeding', 'and', 'refractory', 'ascites', ',', 'lead', 'to', 'reduction', 'in', 'portal', 'pressure', '.', 'although', 'preliminary', 'data', 'suggest', 'may', 'useful', 'in', 'hrs-aki', ',', 'use', 'in', 'setting', 'controversial', 'and', 'caution', 'recommended', 'given', 'fact', 'hrs-aki', 'associated', 'to', 'cardiac', 'alteration', 'and', 'acute-on-chronic', 'liver', 'failure', '(', 'aclf', ')', 'represent', 'relative', 'contraindication', 'transjugular', 'intrahepatic', 'portosystemic', 'shunt', '(', 'tip', ')', '.', 'in', 'last', 'decade', ',', 'with', 'new', 'definition', 'of', 'renal', 'failure', 'in', 'patient', 'with', 'cirrhosis', ',', 'patient', 'identified', 'earlier', 'stage', '.', 'patient', 'less', 'sick', 'and', 'therefore', 'likely', 'to', 'not', 'contraindication', 'tip', '.', 'hypothesize', 'tip', 'could', 'superior', 'to', 'standard', 'of', 'care', 'in', 'patient', 'with', 'hrs-aki', '.', 'method', 'study', 'prospective', ',', 'multicenter', ',', 'open', ',', '-randomized', ',', 'controlled', 'parallel-group', 'trial', '.', 'main', 'end-point', 'to', 'compare', '-month', 'liver', 'transplant-free', 'survival', 'in', 'patient', 'assigned', 'to', 'tip', 'compared', 'to', 'standard', 'of', 'care', '(', 'terlipressin', 'and', 'albumin', ')', '.', 'secondary', 'end-point', 'include', 'reversal', 'of', 'hrs-aki', ',', 'health-related', 'quality', 'of', 'life', '(', 'hrqol', ')', ',', 'and', 'incidence', 'of', 'decompensation', 'among', 'others', '.', 'patient', 'diagnosed', 'with', 'hrs-aki', ',', 'randomized', 'to', 'tip', 'or', 'standard', 'of', 'care', '(', 'soc', ')', '.', 'tip', 'placed', 'within', 'h.', 'tip', 'placement', ',', 'tip', 'patient', 'treated', 'with', 'terlipressin', 'and', 'albumin', '.', 'tip', 'placed', ',', 'terlipressin', 'and', 'albumin', 'weaned', 'according', 'to', 'attending', 'physician', '.', 'discussion', 'trial', 'to', 'show', 'survival', 'advantage', 'patient', 'undergo', 'tip', 'placement', ',', 'could', 'incorporated', 'in', 'routine', 'clinical', 'practice', 'in', 'management', 'of', 'patient', 'with', 'hrs-aki', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'released', 'to', 'public', 'april', '.']"
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.,"Despina Fotiou, Maria Roussou, Charikleia Gakiopoulou, Erasmia Psimenou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Ioanna Dialoupi, Evangelos Eleutherakis-Papaiakovou, Stavroula Giannouli, Christina Delavinia, Kostantinos Efstathiou, Sofoklis Kontogiannis, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis, Despina Fotiouet al.",2020 Nov 3,Blood Cancer J,https://pubmed.ncbi.nlm.nih.gov/33149167/,No keywords found,"['carfilzomib', '(', 'cfz', ')', 'non-reversible', 'proteasome', 'inhibitor', 'approved', 'treatment', 'of', 'patient', 'with', 'relapsed', 'and', 'refractory', 'myeloma', '(', 'rrmm', ')', '.', 'use', 'associated', 'with', 'cardiovascular', 'toxicity', 'although', 'recently', 'signal', 'of', 'clinically', 'significant', 'renal', 'complication', 'also', 'identified', ',', 'less', 'extensively', 'investigated', '.', 'analyzed', 'data', 'of', 'consecutive', 'patient', 'with', 'rrmm', 'received', 'cfz-based', 'regimen', '.', 'renal', 'complication', 'not', 'related', 'to', 'mm', 'progression', 'observed', 'in', '(', ')', 'patient', 'thrombotic', 'microangiopathy', '(', 'tma', ')', 'seen', 'in', '(', ')', 'patient', ',', 'albuminuria', 'grday', 'in', 'patient', '(', ')', 'and', 'least', 'grade', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'could', 'not', 'otherwise', 'explained', 'in', 'patient', '(', ')', '.', 'total', 'of', 'patient', 'discontinued', 'cfz', 'and', 'dosing', 'reinitiated', 'lower', 'level', 'in', 'one', 'patient', 'with', 'aki', '.', 'albuminuria', 'associated', 'with', 'focal', 'segmental', 'glomerulosclerosis', 'in', 'renal', 'biopsy', '(', 'performed', 'in', 'total', 'of', 'patient', ')', '.', 'renal', 'complication', 'cfz', 'therapy', 'common', ',', 'occur', 'mostly', 'early', 'and', 'unpredictable', '.', 'potential', 'effect', 'of', 'cfz', 'renal', 'endothelium', 'could', 'implicated', 'in', 'pathogenesis', 'of', 'complication', 'and', 'may', 'also', 'share', 'common', 'pathophysiology', 'with', 'cardiovascular', 'effect', 'of', 'cfz', '.']"
"The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury.","Kranti A Mapuskar, Casey F Pulliam, Ann Tomanek-Chalkley, Prerna Rastogi, Hsiang Wen, Sanjana Dayal, Benjamin R Griffin, Diana Zepeda-Orozco, Amy L Sindler, Carryn M Anderson, Robert Beardsley, Eugene P Kennedy, Douglas R Spitz, Bryan G Allen, Kranti A Mapuskaret al.",2024 Apr:70:103022.,Redox Biol,https://pubmed.ncbi.nlm.nih.gov/38215546/,No keywords found,"['cisplatin', 'contributes', 'to', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'occurs', 'with', 'greater', 'frequency', 'and', 'severity', 'in', 'older', 'patient', '.', 'age-associated', 'cisplatin', 'sensitivity', 'in', 'human', 'fibroblast', 'involves', 'increased', 'mitochondrial', 'superoxide', 'produced', 'older', 'donor', 'cell', '.', 'experimental', 'design', 'young', 'and', 'old', 'cbl', 'j', 'murine', 'model', 'of', 'cisplatin-induced', 'aki', 'and', 'ckd', 'treated', 'with', 'sod', 'mimetic', 'avasopasem', 'manganese', 'to', 'investigate', 'potential', 'antioxidant', 'and', 'anti-inflammatory', 'effect', '.', 'adverse', 'event', 'reporting', 'phase', 'and', 'phase', 'randomized', 'clinical', 'trial', '(', 'nct', 'and', 'nct', ')', 'conducted', 'in', 'patient', 'treated', 'with', 'cisplatin', 'and', 'ava', 'determined', 'to', 'established', 'incidence', 'and', 'severity', 'of', 'aki', '.', 'result', 'cisplatin-induced', 'aki', 'and', 'ckd', 'occurred', 'in', 'mouse', ',', 'however', ',', 'pronounced', 'in', 'older', 'mouse', '.', 'ava', 'reduced', 'cisplatin-induced', 'mortality', ',', 'aki', ',', 'and', 'ckd', ',', 'in', 'older', 'animal', '.', 'ava', 'also', 'alleviated', 'cisplatin-induced', 'alteration', 'in', 'mitochondrial', 'electron', 'transport', 'chain', '(', 'etc', ')', 'complex', 'activity', 'and', 'nadph', 'oxidase', '(', 'nox', ')', 'and', 'inhibited', 'increased', 'level', 'of', 'inflammation', 'marker', ',', 'tnf', ',', 'il', ',', 'icam-', ',', 'and', 'vcam-', '.', 'analysis', 'of', 'age-stratified', 'subject', 'treated', 'with', 'cisplatin', 'clinical', 'trial', '(', 'nct', ',', 'nct', ')', 'also', 'supported', 'incidence', 'of', 'aki', 'increased', 'with', 'age', 'and', 'ava', 'reduced', 'age-associated', 'therapy-induced', 'adverse', 'event', '(', 'ae', ')', ',', 'including', 'hypomagnesemia', ',', 'increased', 'creatinine', ',', 'and', 'aki', '.', 'conclusion', 'older', 'mouse', 'and', 'human', 'susceptible', 'to', 'cisplatin-induced', 'kidney', 'injury', ',', 'and', 'treatment', 'with', 'ava', 'mitigates', 'age-associated', 'damage', '.', 'mitochondrial', 'etc', 'and', 'nox', 'activity', 'represent', 'source', 'of', 'superoxide', 'production', 'contributing', 'to', 'cisplatin-induced', 'kidney', 'injury', ',', 'and', 'pro-inflammatory', 'cytokine', 'production', 'and', 'endothelial', 'dysfunction', 'may', 'also', 'increased', 'superoxide', 'formation', '.']"
Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial.,"Amit X Garg, Andrea Kurz, Daniel I Sessler, Meaghan Cuerden, Andrea Robinson, Marko Mrkobrada, Chirag R Parikh, Richard Mizera, Philip M Jones, Maria Tiboni, Adrià Font, Virginia Cegarra, Maria Fernanda Rojas Gomez, Christian S Meyhoff, Tomas VanHelder, Matthew T V Chan, David Torres, Joel Parlow, Miriam de Nadal Clanchet, Mohammed Amir, Seyed Javad Bidgoli, Laura Pasin, Kristian Martinsen, German Malaga, Paul Myles, Rey Acedillo, Pavel S Roshanov, Michael Walsh, George Dresser, Priya Kumar, Edith Fleischmann, Juan Carlos Villar, Thomas Painter, Bruce Biccard, Sergio Bergese, Sadeesh Srinathan, Juan P Cata, Vincent Chan, Bhupendra Mehra, Duminda N Wijeysundera, Kate Leslie, Patrice Forget, Richard Whitlock, Salim Yusuf, P J Devereaux                              ;, POISE- Investigators, A Alvarez, R Bulach, S Hannon, K Ives, A Jeffreys, S Lang, G Ludbrook, P Myles, C Osborne, T Painter, B Riedel, S Sawhney, P Sivalingam, E Fleischmann, B Kabon, F Luf, M Radonic, S Bidgoli, S De Hert, M De Kock, S Hublet, P Van der Linden, P Forget, R  R Bergo, O Berwanger, P Duarte, D Gualandro, S Abbas, R Allard, W Beattie, V Chan, D Chauret, K Chin, D Cook, W Dechert, E de Medicis, G Dresser, D Dumerton-Shore, H El Beheiry, A Garg, M Graham, K Gregus, M Gros, D Hornstein, P Jackson, P Jones, R Lavi, K Lawrence, P Li, J McCourt, S McMullen, R Mizera, R Moor, D Ong, J Parlow, M Raazi, O Regalado, T Schricker, V Schumann, J Shin, S Srinathan, M Tiboni, A Todd, T VanHelder, D Wijeysundera, X Jara, P Leon, D Torres, O Cortes, F Montes, G Parra, M Rojas, R Plata, F Romero, S Vasquez, J Villar, N Bauer, M Bøgeskov, R Dahl, M Madsen, K Martinsen, E Søndergaard, P Alfonsi, P Coriat, P Diemunsch, V Piriou, A Hoeft, U Kaisers, T Treschan, M Chan, G Choi, T Gin, P Chiu, V Abraham, K Agarwal, S Gaikwad, B Mehra, N Mohan, B Premendaran, G Sidhu, R Lembo, L Pasin, S Passarani, H Lee, K Jamieson, S Olliff, S Walker, M Amir, O Ishtiaq, J Safdar, A Acuna-Villaorduna, P Barrionuevo, A Castaneda-Guarderas, B Biccard, B Diedericks, L Drummond, P Naidoo, J Alvarez, M de Nadal, S  Garcia del Valle, R Gonzalez, S González-Suárez, A González-Tallada, M Maestre, E Mena, P Plou, B Tena, S Sabate, G Urrutia, P Balaji, N Hemmings, M Vizcaychipi, I Wrench, D Ai, H Arora, S Bergese, J Cata, R Coombs, H Honar, P Kumar, A Kurz, S Martinelli, R McKay, S Melibary, S Memtsoudis, S Miller, E Nemergut, A Podolyak, V Salmasi, D Sessler, A Uribe, Amit X Garget al.",2014 Dec 3,JAMA,https://pubmed.ncbi.nlm.nih.gov/25399007/,No keywords found,"['acute', 'kidney', 'injury', ',', 'common', 'complication', 'of', 'surgery', ',', 'associated', 'with', 'poor', 'outcome', 'and', 'high', 'health', 'care', 'cost', '.', 'study', 'suggest', 'aspirin', 'or', 'clonidine', 'administered', 'perioperative', 'period', 'reduces', 'risk', 'of', 'acute', 'kidney', 'injury', 'however', ',', 'effect', 'uncertain', 'and', 'intervention', 'potential', 'harm', '.', 'objective', 'to', 'determine', 'whether', 'aspirin', 'compared', 'with', 'placebo', ',', 'and', 'clonidine', 'compared', 'with', 'placebo', ',', 'alters', 'risk', 'of', 'perioperative', 'acute', 'kidney', 'injury', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'factorial', 'randomized', ',', 'blinded', ',', 'clinical', 'trial', 'of', 'patient', 'undergoing', 'noncardiac', 'surgery', 'center', 'in', 'country', 'with', 'consecutive', 'patient', 'enrolled', 'january', 'and', 'december', '.', 'intervention', 'patient', 'assigned', 'to', 'take', 'aspirin', '(', 'mg', ')', 'or', 'placebo', 'to', 'hour', 'surgery', 'and', 'aspirin', '(', 'mg', ')', 'or', 'placebo', 'daily', 'to', 'day', 'surgery', ',', 'and', 'assigned', 'to', 'take', 'oral', 'clonidine', '(', '.', 'mg', ')', 'or', 'placebo', 'to', 'hour', 'surgery', ',', 'and', 'transdermal', 'clonidine', 'patch', '(', 'provided', 'clonidine', '.', 'mgd', ')', 'or', 'placebo', 'patch', 'remained', 'hour', 'surgery', '.', 'main', 'outcome', 'and', 'measure', 'acute', 'kidney', 'injury', 'primarily', 'defined', 'increase', 'in', 'serum', 'creatinine', 'concentration', 'preoperative', 'concentration', 'either', 'increase', 'of', '.', 'mgdl', 'or', 'greater', '(', '.', 'moll', ')', 'within', 'hour', 'of', 'surgery', 'or', 'increase', 'of', 'or', 'greater', 'within', 'day', 'of', 'surgery', '.', 'result', 'aspirin', '(', 'n', ')', 'v', 'placebo', '(', 'n', ')', 'not', 'alter', 'risk', 'of', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', ',', 'respectively', 'adjusted', 'relative', 'risk', ',', '.', 'ci', ',', '.-.', ')', '.', 'clonidine', '(', 'n', ')', 'v', 'placebo', '(', 'n', ')', 'not', 'alter', 'risk', 'of', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', ',', 'respectively', 'adjusted', 'relative', 'risk', ',', '.', 'ci', ',', '.-.', ')', '.', 'aspirin', 'increased', 'risk', 'of', 'major', 'bleeding', '.', 'in', 'post', 'hoc', 'analysis', ',', 'major', 'bleeding', 'associated', 'with', 'greater', 'risk', 'of', 'subsequent', 'acute', 'kidney', 'injury', '(', '.', 'bleeding', 'present', 'v', '.', 'bleeding', 'absent', 'adjusted', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-.', ')', '.', 'similarly', ',', 'clonidine', 'increased', 'risk', 'of', 'clinically', 'important', 'hypotension', '.', 'in', 'post', 'hoc', 'analysis', ',', 'clinically', 'important', 'hypotension', 'associated', 'with', 'greater', 'risk', 'of', 'subsequent', 'acute', 'kidney', 'injury', '(', '.', 'hypotension', 'present', 'v', '.', 'hypotension', 'absent', 'adjusted', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'undergoing', 'major', 'noncardiac', 'surgery', ',', 'neither', 'aspirin', 'clonidine', 'administered', 'perioperatively', 'reduced', 'risk', 'of', 'acute', 'kidney', 'injury', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Effects of Dexmedetomidine on Patients Undergoing Laparoscopic Surgery for Colorectal Cancer.,"Wenqin Sun, Fengling Li, Xianxue Wang, Hongbo Liu, Hong Mo, Daobo Pan, Shihong Wen, Aiguo Zhou, Wenqin Sunet al.",2021 Nov:267:687-694.,J Surg Res,https://pubmed.ncbi.nlm.nih.gov/34274907/,No keywords found,"['pneumoperitoneum', 'laparoscopic', 'surgery', 'systemic', 'impact', 'renal', 'system', 'and', 'might', 'contribute', 'to', 'acute', 'kidney', 'injury', 'or', 'postoperative', 'renal', 'dysfunction', '.', 'however', ',', 'effective', 'preventive', 'strategy', 'still', 'lacking', '.', 'aimed', 'to', 'explore', 'effect', 'of', 'dexmedetomidine', '(', 'dex', ')', 'kidney', 'and', 'organ', 'function', 'in', 'patient', 'undergoing', 'elective', 'laparoscopic', 'surgery', 'colorectal', 'cancer', '.', 'material', 'and', 'method', 'fifty-six', 'patient', 'randomly', 'enrolled', 'control', 'or', 'dex', 'group', '.', 'dex', 'group', 'received', 'g', 'kg-', 'dex', 'intravenously', 'within', 'min', 'followed', 'maintenance', 'dose', 'of', '.', 'g', 'kg-', 'h-', 'infused', 'min', 'closing', 'peritoneum', '.', 'in', 'control', 'group', ',', '.', 'sodium', 'chloride', 'administered', 'placebo', '.', 'primary', 'outcome', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'level', 'reflecting', 'kidney', 'injury', '.', 'secondary', 'outcome', 'included', 'variable', 'reflecting', 'kidney', ',', 'intestinal', 'injury', 'and', 'systemic', 'inflammatory', 'response', '.', 'result', 'ngal', 'level', 'significantly', 'lower', 'in', 'dex', 'group', 'in', 'control', 'group', 'and', 'postoperatively', '(', '.', '.', 'ng', 'ml-versus', '.', '.', 'ng', 'ml-', '.', '.', 'ng', 'ml-versus', '.', '.', 'ng', 'ml-', ',', 'p', '.', ')', ',', 'bun', 'and', 'cr', 'level', 'showed', 'no', 'difference', 'group', '.', 'serum', 'dao', 'activity', 'significantly', 'lower', 'in', 'dex', 'group', 'patient', 'h', 'surgery', '.', 'moreover', ',', 'i-fabp', 'level', 'markedly', 'lower', 'h', 'and', 'h', 'postoperatively', 'in', 'dex', 'group', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'perioperative', 'dex', 'administration', 'may', 'potentially', 'confer', 'kidney', 'and', 'intestinal', 'protection', 'laparoscopic', 'surgery', 'colorectal', 'cancer', 'patient', '.']"
High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.,"Frederic T Billings th, Patricia A Hendricks, Jonathan S Schildcrout, Yaping Shi, Michael R Petracek, John G Byrne, Nancy J Brown, Frederic T Billings thet al.",2016 Mar 1,JAMA,https://pubmed.ncbi.nlm.nih.gov/26906014/,No keywords found,"['statin', 'affect', 'several', 'mechanism', 'underlying', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'objective', 'to', 'test', 'hypothesis', 'short-term', 'high-dose', 'perioperative', 'atorvastatin', 'would', 'reduce', 'aki', 'following', 'cardiac', 'surgery', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'double-blinded', ',', 'placebo-controlled', ',', 'randomized', 'clinical', 'trial', 'of', 'adult', 'cardiac', 'surgery', 'patient', 'conducted', 'november', 'to', 'october', 'vanderbilt', 'university', 'medical', 'center', '.', 'intervention', 'patient', 'naive', 'to', 'statin', 'treatment', '(', 'n', ')', 'randomly', 'assigned', 'mg', 'of', 'atorvastatin', 'day', 'surgery', ',', 'mg', 'of', 'atorvastatin', 'morning', 'of', 'surgery', ',', 'and', 'mg', 'of', 'atorvastatin', 'daily', 'following', 'surgery', '(', 'n', ')', 'or', 'matching', 'placebo', '(', 'n', ')', '.', 'patient', 'already', 'taking', 'statin', 'prior', 'to', 'study', 'enrollment', '(', 'n', ')', 'continued', 'taking', 'preenrollment', 'statin', 'day', 'of', 'surgery', ',', 'randomly', 'assigned', 'mg', 'of', 'atorvastatin', 'morning', 'of', 'surgery', 'and', 'mg', 'of', 'atorvastatin', 'morning', '(', 'n', ')', 'or', 'matching', 'placebo', '(', 'n', ')', ',', 'and', 'resumed', 'taking', 'previously', 'prescribed', 'statin', 'postoperative', 'day', '.', 'main', 'outcome', 'and', 'measure', 'acute', 'kidney', 'injury', 'defined', 'increase', 'of', '.', 'mgdl', 'in', 'serum', 'creatinine', 'concentration', 'within', 'hour', 'of', 'surgery', '(', 'acute', 'kidney', 'injury', 'network', 'criterion', ')', '.', 'result', 'data', 'and', 'safety', 'monitoring', 'board', 'recommended', 'stopping', 'group', 'naive', 'to', 'statin', 'treatment', 'due', 'to', 'increased', 'aki', 'among', 'participant', 'with', 'chronic', 'kidney', 'disease', '(', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin', '.', ')', 'receiving', 'atorvastatin', '.', 'board', 'later', 'recommended', 'stopping', 'futility', 'participant', '(', 'median', 'age', ',', 'year', '.', 'woman', '.', 'diabetes', ')', 'completed', 'study', '.', 'among', 'participant', '(', 'n', ')', ',', 'aki', 'occurred', 'in', 'of', '(', '.', ')', 'in', 'atorvastatin', 'group', 'v', 'of', '(', '.', ')', 'in', 'placebo', 'group', '(', 'relative', 'risk', 'rr', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'among', 'patient', 'naive', 'to', 'statin', 'treatment', '(', 'n', ')', ',', 'aki', 'occurred', 'in', 'of', '(', '.', ')', 'in', 'atorvastatin', 'group', 'v', 'of', '(', '.', ')', 'in', 'placebo', 'group', '(', 'rr', ',', '.', '.', 'to', '.', 'p', '.', ')', 'and', 'serum', 'creatinine', 'concentration', 'increased', 'median', 'of', '.', 'mgdl', '(', 'th-th', 'percentile', ',', '-', '.', 'to', '.', 'mgdl', ')', 'in', 'atorvastatin', 'group', 'v', 'median', 'of', '.', 'mgdl', '(', 'th-th', 'percentile', ',', '-', '.', 'to', '.', 'mgdl', ')', 'in', 'placebo', 'group', '(', 'mean', 'difference', ',', '.', 'mgdl', 'ci', ',', '.', 'to', '.', 'mgdl', 'p', '.', ')', '.', 'among', 'patient', 'already', 'taking', 'statin', '(', 'n', ')', ',', 'aki', 'occurred', 'in', 'of', '(', '.', ')', 'in', 'atorvastatin', 'group', 'v', 'of', '(', '.', ')', 'in', 'placebo', 'group', '(', 'rr', ',', '.', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'undergoing', 'cardiac', 'surgery', ',', 'high-dose', 'perioperative', 'atorvastatin', 'treatment', 'compared', 'with', 'placebo', 'not', 'reduce', 'risk', 'of', 'aki', 'overall', ',', 'among', 'patient', 'naive', 'to', 'treatment', 'with', 'statin', ',', 'or', 'in', 'patient', 'already', 'taking', 'statin', '.', 'result', 'not', 'support', 'initiation', 'of', 'statin', 'therapy', 'to', 'prevent', 'aki', 'following', 'cardiac', 'surgery', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.,"Chirag R Parikh, Caroline Liu, Maria K Mor, Paul M Palevsky, James S Kaufman, Heather Thiessen Philbrook, Steven D Weisbord, Chirag R Parikhet al.",2020 Feb,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/31547939/,No keywords found,"['preserve', 'trial', 'used', 'factorial', 'design', 'to', 'compare', 'intravenous', 'saline', 'solution', 'with', 'intravenous', 'sodium', 'bicarbonate', 'solution', 'and', 'oral', 'n-acetylcysteine', 'with', 'placebo', 'prevention', 'of', '-day', 'major', 'adverse', 'kidney', 'event', 'and', 'death', '(', 'make-d', ')', 'and', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', 'among', 'patient', 'with', 'chronic', 'kidney', 'disease', 'undergoing', 'angiography', '.', 'in', 'ancillary', 'study', ',', 'evaluated', 'predictive', 'capacity', 'of', 'preangiography', 'injury', 'and', 'repair', 'protein', 'in', 'urine', 'and', 'plasma', 'make-d', ',', 'ca-aki', ',', 'and', 'impact', 'trial', 'design', '.', 'study', 'design', 'longitudinal', 'analysis', '.', 'setting', 'participant', 'subset', 'of', 'participant', 'preserve', 'trial', '.', 'exposure', 'injury', '(', 'kim-', ',', 'ngal', ',', 'and', 'il-', ')', 'and', 'repair', '(', 'mcp-', ',', 'umod', ',', 'and', 'ykl-', ')', 'protein', 'in', 'urine', 'and', 'plasma', 'to', 'hour', 'preangiography', '.', 'outcome', 'make-d', 'and', 'ca-aki', '.', 'analytical', 'approach', 'analyzed', 'association', 'of', 'preangiography', 'biomarkers', 'with', 'make-d', 'and', 'with', 'ca-aki', '.', 'evaluated', 'whether', 'biomarker', 'level', 'could', 'enrich', 'make-d', 'event', 'rate', 'and', 'improve', 'future', 'clinical', 'trial', 'efficiency', 'online', 'biomarker', 'prognostic', 'enrichment', 'tool', 'available', 'prognosticenrichment.com', '.', 'result', 'measured', 'plasma', 'biomarkers', 'in', 'participant', 'and', 'urine', 'biomarkers', 'in', 'participant', '.', 'adjusting', 'urinary', 'albumin-creatinine', 'ratio', 'and', 'baseline', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'preangiography', 'level', 'of', 'plasma', '(', 'kim-', ',', 'ngal', ',', 'umod', ',', 'and', 'ykl-', ')', 'and', 'urine', '(', 'ngal', ',', 'il-', ',', 'and', 'ykl-', ')', 'biomarkers', 'associated', 'with', 'make-d.', 'plasma', 'kim-', 'level', 'significantly', 'associated', 'with', 'ca-aki', 'adjustment', '.', 'biomarker', 'level', 'provided', 'modest', 'discriminatory', 'capacity', 'make-d.', 'screening', 'patient', 'using', 'th', 'percentile', 'of', 'preangiography', 'plasma', 'kim-', 'or', 'ykl-', 'level', 'would', 'reduced', 'required', 'sample', 'size', '(', ',', 'participant', ')', '.', 'limitation', 'evaluation', 'of', 'prognostic', 'enrichment', 'not', 'account', 'changing', 'trial', 'cost', ',', 'time', 'needed', 'to', 'screen', 'patient', ',', 'or', 'loss', 'to', 'follow-up', '.', 'participant', 'male', ',', 'limiting', 'generalizability', 'of', 'finding', '.', 'conclusion', 'preangiography', 'level', 'of', 'injury', 'and', 'repair', 'biomarkers', 'modestly', 'predict', 'development', 'of', 'make-d', 'and', 'used', 'to', 'improve', 'efficiency', 'of', 'future', 'ca-aki', 'trial', '.']"
Serial Quantification of Urinary Protein Biomarkers to Predict Drug-induced Acute Kidney Injury.,"Yi Da, K Akalya, Tanusya Murali, Anantharaman Vathsala, Chuen-Seng Tan, Sanmay Low, Hui-Ning Lim, Boon-Wee Teo, Titus Lau, Lizhen Ong, Horng-Ruey Chua, Yi Daet al.",2019,Curr Drug Metab,https://pubmed.ncbi.nlm.nih.gov/31296157/,No keywords found,"['drug-induced', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'develops', 'in', '-', 'of', 'patient', 'receive', 'nephrotoxic', 'medication', '.', 'urinary', 'biomarkers', 'of', 'renal', 'tubular', 'dysfunction', 'may', 'detect', 'nephrotoxicity', 'early', 'and', 'predict', 'aki', '.', 'method', 'prospectively', 'studied', 'patient', 'received', 'aminoglycosides', ',', 'vancomycin', ',', 'amphotericin', ',', 'or', 'calcineurin', 'inhibitor', ',', 'and', 'collected', 'serial', 'urine', 'therapy', '.', 'patient', 'developed', 'drug-induced', 'aki', '(', 'fulfilling', 'kdigo', 'criterion', ')', 'matched', 'with', 'non-aki', 'control', 'in', 'ratio', '.', 'urine', 'sample', 'batch-analyzed', 'time-intervals', 'leading', 'to', 'aki', 'onset', 'latter', 'benchmarked', 'final', 'day', 'of', 'nephrotoxic', 'therapy', 'in', 'non-', 'aki', 'control', '.', 'biomarkers', 'examined', 'include', 'clusterin', ',', 'beta', '--', 'microglobulin', ',', 'kim', ',', 'mcp', ',', 'cystatin-c', ',', 'trefoil-factor-', ',', 'ngal', ',', 'interleukin-', ',', 'gst-pi', ',', 'calbindin', ',', 'and', 'osteopontin', 'biomarkers', 'normalized', 'with', 'corresponding', 'urine', 'creatinine', '.', 'result', 'nine', 'of', '(', ')', 'patient', 'developed', 'drug-induced', 'aki', '.', 'biomarkers', 'aki', 'case', 'with', 'pre-aki', 'sample', 'compared', 'with', 'non-aki', 'control', '.', 'corresponding', 'mean', 'age', '(', ')', 'and', '(', ')', 'year', 'baseline', 'egfr', '(', ')', 'and', '(', ')', 'mlmin.m', '(', 'pns', ')', '.', 'biomarker', 'level', 'peaked', 'onset', 'of', 'aki', '.', 'median', 'level', 'of', 'biomarkers', 'significantly', 'higher', 'in', 'aki', 'case', 'control', '-', 'day', 'aki', 'onset', '(', 'gmmol', ')', 'clusterin', '(', '-', ')', 'versus', '(', '-', ')', ',', 'beta', '--', 'microglobulin', '(', '-', ')', 'versus', '(', '-', ')', ',', 'kim', '.', '(', '.-', '.', ')', 'versus', '.', '(', '.-', '.', ')', ',', 'mcp', '.', '(', '.-', '.', ')', 'versus', '.', '(', '.-', '.', ')', ',', 'and', 'cystatin-c', '(', '-', ')', 'versus', '(', '-', ')', ',', 'p.', '(', 'confidence', 'interval', '.', ')', ',', 'with', 'average', 'accuracy', 'highest', 'clusterin', '(', ')', ',', 'followed', 'beta', '--', 'microglobulin', ',', 'cystatin-c', ',', 'mcp', ',', 'and', 'kim', '(', ')', 'cross-validation', '.', 'conclusion', 'serial', 'surveillance', 'of', 'biomarkers', 'could', 'improve', 'lead', 'time', 'nephrotoxicity', 'detection', 'day', '.']"
Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis.,"Thomas L Nickolas, Jonathan Barasch, Kenneth K Mugwanya, Andrea D Branch, Renee Heffron, Valentine Wanga, Nelly R Mugo, Allan Ronald, Connie Celum, Deborah Donnell, Jared M Baeten, Christina M Wyatt                              ;, Partners PrEP Study Team, Thomas L Nickolaset al.",2021 Jun 1,AIDS,https://pubmed.ncbi.nlm.nih.gov/33710023/,No keywords found,"['previously', 'reported', 'higher', 'incidence', 'of', 'non-albumin', 'proteinuria', 'and', 'small', 'significant', 'decline', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'among', 'hiv-negative', 'adult', 'randomized', 'to', 'emtricitabinetenofovir', 'disoproxil', 'fumarate', 'preexposure', 'prophylaxis', '(', 'ftctdf', 'prep', ')', 'versus', 'placebo', '.', 'in', 'nested', 'case', '--', 'control', 'study', 'among', 'participant', 'randomized', 'to', 'ftctdf', 'prep', ',', 'established', 'kidney', 'injury', 'biomarkers', 'measured', 'month', 'not', 'significantly', 'different', 'participant', 'subsequently', 'experienced', 'one', 'of', 'kidney', 'endpoint', 'and', 'randomly', 'selected', 'control', 'not', '.']"
Angiotensin blockade in late autosomal dominant polycystic kidney disease.,"Vicente E Torres, Kaleab Z Abebe, Arlene B Chapman, Robert W Schrier, William E Braun, Theodore I Steinman, Franz T Winklhofer, Godela Brosnahan, Peter G Czarnecki, Marie C Hogan, Dana C Miskulin, Frederic F Rahbari-Oskoui, Jared J Grantham, Peter C Harris, Michael F Flessner, Charity G Moore, Ronald D Perrone;, HALT-PKD Trial Investigators, Theodore Steinman, Jesse Wei, Peter Czarnecki, Ivan Pedrosa, William Braun, Saul Nurko, Erick Remer, Arlene Chapman, Diego Martin, Frederic Rahbari-Oskoui, Pardeep Mittal, Vicente Torres, Ziad El-Zoghby, Peter Harris, James Glockner, Bernard King Jr, Ronald Perrone, Neil Halin, Dana Miskulin, Robert Schrier, Berenice Gitomer, Cass Kelleher, Amirali Masoumi, Nayana Patel, Franz Winklhofer, Jared Grantham, Alan Yu, Connie Wang, Louis Wetzel, James E Bost, Kyongtae Bae, J  Philip Miller, Paul A Thompson, Josephine Briggs, Michael Flessner, Catherine M Meyers, Robert Star, James Shayman, William Henrich, Tom Greene, Mary Leonard, Peter McCullough, Sharon Moe, Michael Rocco, David Wendler, Vicente E Torreset al.",2014 Dec 11,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/25399731/,No keywords found,"['hypertension', 'develops', 'early', 'in', 'patient', 'with', 'autosomal', 'dominant', 'polycystic', 'kidney', 'disease', '(', 'adpkd', ')', 'and', 'associated', 'with', 'disease', 'progression', '.', 'renin-angiotensin-aldosterone', 'system', '(', 'raas', ')', 'implicated', 'in', 'pathogenesis', 'of', 'hypertension', 'in', 'patient', 'with', 'adpkd', '.', 'dual', 'blockade', 'of', 'raas', 'may', 'circumvent', 'compensatory', 'mechanism', 'limit', 'efficacy', 'of', 'monotherapy', 'with', 'angiotensin-converting-enzyme', '(', 'ace', ')', 'inhibitor', 'or', 'angiotensin', 'ii-receptor', 'blocker', '(', 'arb', ')', '.', 'method', 'in', 'double-blind', ',', 'placebo-controlled', 'trial', ',', 'randomly', 'assigned', 'patient', ',', 'to', 'year', 'of', 'age', ',', 'with', 'adpkd', '(', 'estimated', 'glomerular', 'filtration', 'rate', 'gfr', ',', 'to', 'ml', 'per', 'minute', 'per', '.', '(', ')', 'of', 'body-surface', 'area', ')', 'to', 'receive', 'ace', 'inhibitor', '(', 'lisinopril', ')', 'and', 'placebo', 'or', 'lisinopril', 'and', 'arb', '(', 'telmisartan', ')', ',', 'with', 'dos', 'adjusted', 'to', 'achieve', 'blood', 'pressure', 'of', 'to', 'mm', 'hg', '.', 'composite', 'primary', 'outcome', 'time', 'to', 'death', ',', 'end-stage', 'renal', 'disease', ',', 'or', 'reduction', 'baseline', 'estimated', 'gfr', '.', 'secondary', 'outcome', 'included', 'rate', 'of', 'change', 'in', 'urinary', 'aldosterone', 'and', 'albumin', 'excretion', ',', 'frequency', 'of', 'hospitalization', 'cause', 'and', 'cardiovascular', 'cause', ',', 'incidence', 'of', 'pain', ',', 'frequency', 'of', 'adpkd-related', 'symptom', ',', 'quality', 'of', 'life', ',', 'and', 'adverse', 'study-medication', 'effect', '.', 'patient', 'followed', 'to', 'year', '.', 'result', 'no', 'significant', 'difference', 'study', 'group', 'in', 'incidence', 'of', 'composite', 'primary', 'outcome', '(', 'hazard', 'ratio', 'with', 'lisinopril-telmisartan', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'two', 'treatment', 'controlled', 'blood', 'pressure', 'and', 'lowered', 'urinary', 'aldosterone', 'excretion', 'similarly', '.', 'rate', 'of', 'decline', 'in', 'estimated', 'gfr', ',', 'urinary', 'albumin', 'excretion', ',', 'and', 'secondary', 'outcome', 'and', 'adverse', 'event', ',', 'including', 'hyperkalemia', 'and', 'acute', 'kidney', 'injury', ',', 'also', 'similar', 'in', 'two', 'group', '.', 'conclusion', 'monotherapy', 'with', 'ace', 'inhibitor', 'associated', 'with', 'blood-pressure', 'control', 'in', 'patient', 'with', 'adpkd', 'and', 'stage', 'chronic', 'kidney', 'disease', '.', 'addition', 'of', 'arb', 'not', 'alter', 'decline', 'in', 'estimated', 'gfr', '.', '(', 'funded', 'national', 'institute', 'of', 'diabetes', 'and', 'digestive', 'and', 'kidney', 'disease', 'and', 'others', 'halt-pkd', 'study', 'b', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans.,"Somila Mateza, Yuki Bradford, Gary Maartens, Simiso Sokhela, Nomathemba C Chandiwana, Willem D F Venter, Frank A Post, Marylyn D Ritchie, David W Haas, Phumla Sinxadi, Somila Matezaet al.",2023 Jul 1,Pharmacogenet Genomics,https://pubmed.ncbi.nlm.nih.gov/37099271/,No keywords found,"['renal', 'toxicity', 'common', 'with', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', 'with', 'tenofovir', 'alafenamide', 'fumarate', '(', 'taf', ')', '.', 'investigated', 'whether', 'polymorphism', 'in', 'gene', 'relevant', 'to', 'tenofovir', 'disposition', 'affect', 'renal', 'toxicity', 'among', 'hiv-positive', 'southern', 'african', '.', 'method', 'genetic', 'sub-study', 'of', 'adult', 'randomized', 'to', 'initiate', 'taf', 'or', 'tdf', 'together', 'with', 'dolutegravir', 'and', 'emtricitabine', 'conducted', '.', 'outcome', 'change', 'week', 'to', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'and', 'baseline', 'to', 'week', 'in', 'urine', 'retinol-binding', 'protein', 'and', 'urine', '-microglobulin', 'adjusted', 'urinary', 'creatinine', '(', 'urbpcr', 'and', 'ubmcr', ')', '.', 'primary', 'analysis', 'prioritized', 'polymorphism', 'previously', 'reported', 'to', 'associated', 'with', 'tenofovir', 'disposition', 'or', 'renal', 'outcome', ',', 'and', 'polymorphism', 'in', 'selected', 'gene', '.', 'also', 'explored', 'genome-wide', 'association', '.', 'result', 'participant', 'enrolled', '.', 'among', 'polymorphism', 'of', 'primary', 'interest', ',', 'lowest', 'p', 'value', 'change', 'in', 'egfr', ',', 'urbpcr', ',', 'and', 'ubmcr', 'abcc', 'r', '(', 'p', '.', ')', ',', 'abcc', 'r', '(', 'p', '.', ')', ',', 'and', 'abcc', 'r', '(', 'p', '.', ')', 'and', 'in', 'gene', 'of', 'interest', ',', 'lowest', 'p', 'value', 'abcc', 'r', '(', 'p', '.', ')', ',', 'r', '(', 'p', '.', ')', ',', 'and', 'pkd', 'r', '(', 'p', '.', ')', '.', 'however', ',', 'none', 'of', 'polymorphism', 'withstood', 'correction', 'multiple', 'testing', '.', 'genome-wide', ',', 'lowest', 'p', 'value', 'cola', 'r', '(', 'p', '.', '-', ')', ',', 'cdh', 'r', '(', 'p', '.', '-', ')', ',', 'and', 'itga', 'r', '(', 'p', '.', '-', ')', '.', 'conclusion', 'two', 'abcc', 'polymorphism', ',', 'r', 'and', 'r', ',', 'nominally', 'associated', 'with', 'change', 'in', 'egfr', 'and', 'ubmcr', ',', 'respectively', ',', 'albeit', 'in', 'opposite', 'direction', 'of', 'previous', 'report', '.', 'cola', 'polymorphism', 'genome-wide', 'significantly', 'associated', 'with', 'change', 'in', 'egfr', '.']"
Effect of a Combined Drug Approach on the Severity of Ischemia-Reperfusion Injury During Liver Transplant: A Randomized Clinical Trial.,"Nicolas Meurisse, Markoen Mertens, Steffen Fieuws, Nicholas Gilbo, Ina Jochmans, Jacques Pirenne, Diethard Monbaliu, Nicolas Meurisseet al.",2023 Feb 1,JAMA Netw Open,https://pubmed.ncbi.nlm.nih.gov/36853611/,No keywords found,"['in', 'porcine', 'model', 'of', 'liver', 'transplant', ',', 'combined', 'drug', 'approach', 'targeted', 'donor', 'graft', 'and', 'graft', 'recipient', 'reduced', 'ischemia-reperfusion', 'injury', ',', 'major', 'hurdle', 'to', 'success', 'of', 'liver', 'transplant', '.', 'objective', 'to', 'assess', 'effect', 'of', 'clinical', 'form', 'of', 'perioperative', 'combined', 'drug', 'approach', 'delivered', 'immediately', 'implantation', 'to', 'procured', 'liver', 'and', 'to', 'liver', 'recipient', 'degree', 'of', 'ischemia-reperfusion', 'injury', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'unicentric', ',', 'investigator-driven', ',', 'open-label', 'randomized', 'clinical', 'trial', 'with', 'parallel', 'arm', 'conducted', 'in', 'belgium', 'september', 'february', ',', 'with', '-year', 'follow-up', '.', 'adult', 'wait-listed', 'first', 'solitary', 'full-size', 'liver', 'transplant', 'screened', 'eligibility', '.', 'exclusion', 'criterion', 'acute', 'liver', 'failure', ',', 'kidney', 'failure', ',', 'contraindication', 'to', 'treatment', ',', 'participation', 'in', 'another', 'trial', ',', 'refusal', ',', 'technical', 'issue', ',', 'and', 'death', 'awaiting', 'transplant', '.', 'included', 'patient', 'enrolled', 'and', 'randomized', 'time', 'of', 'liver', 'offer', '.', 'data', 'analyzed', 'may', ',', ',', 'to', 'may', ',', '.', 'intervention', 'participant', 'randomized', 'to', 'combined', 'drug', 'approach', 'with', 'standard', 'of', 'care', '(', 'static', 'cold', 'storage', ')', 'or', 'standard', 'of', 'care', '(', 'control', 'group', ')', '.', 'in', 'combined', 'drug', 'approach', 'group', ',', 'following', 'static', 'cold', 'preservation', ',', 'donor', 'liver', 'infused', 'with', 'epoprostenol', '(', 'ex', 'situ', ',', 'portal', 'vein', ')', 'recipient', 'given', 'oral', '-tocopherol', 'and', 'melatonin', 'prior', 'to', 'anesthesia', 'and', 'intravenous', 'antithrombin', 'iii', ',', 'infliximab', ',', 'apotransferrin', ',', 'recombinant', 'erythropoietin-', ',', 'c-inhibitor', ',', 'and', 'glutathione', 'anhepatic', 'and', 'reperfusion', 'phase', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'posttransplant', 'peak', 'serum', 'aspartate', 'aminotransferase', '(', 'ast', ')', 'level', 'within', 'first', 'hour', '.', 'secondary', 'end', 'point', 'frequency', 'of', 'postreperfusion', 'syndrome', ',', 'ischemia-reperfusion', 'injury', 'score', ',', 'early', 'allograft', 'dysfunction', ',', 'surgical', 'complication', ',', 'ischemic', 'cholangiopathy', ',', 'acute', 'kidney', 'injury', ',', 'acute', 'cellular', 'rejection', ',', 'and', 'graft', 'and', 'patient', 'survival', '.', 'result', 'of', 'randomized', 'patient', ',', 'excluded', ',', 'resulting', 'in', 'patient', '(', 'per', 'study', 'arm', ')', 'in', 'per', 'protocol', 'analysis', '(', 'median', 'recipient', 'age', ',', 'year', 'iqr', ',', '.-', '.', 'year', '.', 'men', ')', '.', 'peak', 'ast', 'serum', 'level', 'not', 'different', 'in', 'combined', 'drug', 'approach', 'and', 'control', 'group', '(', 'geometric', 'mean', ',', '.', 'ul', 'ci', ',', '.-', '.', 'ul', 'v', '.', 'ul', 'ci', ',', '.-', '.', 'ul', 'geometric', 'mean', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '(', 'to', 'convert', 'ast', 'to', 'katl', ',', 'multiply', '.', ')', '.', 'also', 'no', 'significant', 'difference', 'in', 'secondary', 'end', 'point', 'group', '.', 'conclusion', 'and', 'relevance', 'in', 'randomized', 'clinical', 'trial', ',', 'combined', 'drug', 'approach', 'targeting', 'post-cold', 'storage', 'graft', 'and', 'recipient', 'not', 'decrease', 'ischemic-reperfusion', 'injury', '.', 'finding', 'suggest', 'in', 'addition', 'to', 'downstream', 'strategy', 'target', 'preimplantation', 'liver', 'graft', 'and', 'graft', 'recipient', ',', 'clinically', 'effective', 'combined', 'drug', 'approach', 'may', 'need', 'to', 'include', 'upstream', 'strategy', 'target', 'donor', 'graft', 'preservation', '.', 'dynamic', 'preservation', 'strategy', 'may', 'provide', 'appropriate', 'delivery', 'platform', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease.,"Kam Wa Chan, J David Smeijer, Meir Schechter, Niels Jongs, Priya Vart, Donald E Kohan, Ron T Gansevoort, Adrian Liew, Sydney C W Tang, Christoph Wanner, Dick de Zeeuw, Hiddo J L Heerspink, Kam Wa Chanet al.",2023 Dec,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/37657768/,No keywords found,"['pain', 'prevalent', 'among', 'patient', 'with', 'diabetes', 'and', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'management', 'of', 'chronic', 'pain', 'in', 'patient', 'limited', 'nephrotoxicity', 'of', 'commonly', 'used', 'drug', 'including', 'non-steroidal', 'anti-inflammatory', 'drug', '(', 'nsaid', ')', 'and', 'opioids', '.', 'since', 'previous', 'study', 'implicated', 'endothelin-', 'in', 'pain', 'nociception', ',', 'post', 'hoc', 'analysis', 'of', 'sonar', 'trial', 'assessed', 'association', 'endothelin', 'receptor', 'antagonist', 'atrasentan', 'and', 'pain', 'and', 'prescription', 'of', 'analgesic', '.', 'sonar', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'clinical', 'trial', 'recruited', 'participant', 'with', 'type', 'diabetes', 'and', 'ckd', '(', 'estimated', 'glomerular', 'filtration', 'rate', '-', 'mlmin', '.', 'urinary', 'albumin-to-creatinine', 'ratio', '-', 'mgg', ')', '.', 'participant', 'randomized', 'to', 'receive', 'atrasentan', 'or', 'placebo', '(', 'arm', ')', '.', 'main', 'outcome', 'pain-related', 'adverse', 'event', '(', 'aes', ')', 'reported', 'investigator', '.', 'applied', 'cox', 'regression', 'to', 'assess', 'effect', 'of', 'atrasentan', 'compared', 'to', 'placebo', 'risk', 'of', 'first', 'reported', 'pain-related', 'ae', 'and', ',', 'secondly', ',', 'first', 'prescription', 'of', 'analgesic', '.', 'used', 'anderson-gill', 'method', 'to', 'assess', 'effect', '(', 'first', 'and', 'subsequent', ')', 'pain-related', 'aes', '.', '.-year', 'median', 'follow-up', ',', 'pain-related', 'aes', 'occurred', '.', 'rate', 'first', 'pain-related', 'event', '.', 'and', '.', 'per', 'person-years', 'in', 'atrasentan', 'and', 'placebo', 'group', 'respectively', '(', 'hazard', 'ratio', '.', 'confidence', 'interval', '.-.', ')', '.', 'atrasentan', 'also', 'reduced', 'rate', 'of', '(', 'first', 'and', 'subsequent', ')', 'pain-related', 'aes', '(', 'rate', 'ratio', '.', '.-.', ')', '.', 'finding', 'similar', 'accounting', 'competing', 'risk', 'of', 'death', '(', 'sub-hazard', 'ratio', '.', '.-.', ')', '.', 'patient', 'treated', 'with', 'atrasentan', 'initiated', 'fewer', 'analgesic', 'including', 'nsaid', 'and', 'opioids', 'compared', 'to', 'placebo', 'follow-up', '(', 'hazard', 'ratio', '.', '.-.', ')', '.', 'thus', ',', 'atrasentan', 'associated', 'with', 'reduced', 'pain-related', 'event', 'and', 'pain-related', 'use', 'of', 'analgesic', 'in', 'carefully', 'selected', 'patient', 'with', 'type', 'diabetes', 'and', 'ckd', '.']"
Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.,"Amber B Clemmons, Christine F Bech, Jeremy Pantin, Imran Ahmad, Amber B Clemmonset al.",2018 Apr,Biol Blood Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/29292056/,"Acute kidney injury, Antimicrobial, Cefepime, Hematopoietic cell transplantation, Piperacillin/tazobactam, Vancomycin.","['empiric', 'antimicrobial', 'frequently', 'utilized', 'in', 'pre-engraftment', 'phase', 'hematopoietic', 'cell', 'transplantation', '(', 'hct', ')', '.', 'recent', 'evidence', 'suggests', 'increased', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'combination', 'of', 'vancomycin', 'with', 'piperacillintazobactam', 'however', ',', 'not', 'specifically', 'evaluated', 'in', 'hct', 'population', '.', 'single-center', ',', 'retrospective', 'review', 'conducted', 'to', 'autologous', 'and', 'allogeneic', 'hct', 'patient', 'with', 'primary', 'objective', 'of', 'comparing', 'incidence', 'of', 'aki', 'received', 'vancomycin', 'with', 'piperacillintazobactam', 'versus', 'vancomycin', 'with', 'cefepime', 'in', 'pre-engraftment', 'phase', '.', 'demographic', 'and', 'outcome', 'compared', 'patient', 'received', 'vancomycin', 'with', 'piperacillintazobactam', 'versus', 'vancomycin', 'with', 'cefepime', 'well', 'within', 'autologous', 'and', 'allogeneic', 'subgroup', '.', 'primary', 'endpoint', 'of', 'incidence', 'of', 'aki', ',', 'defined', 'increase', 'in', 'serum', 'creatinine', '.', 'mgdl', 'or', 'baseline', '(', 'whichever', 'larger', ')', ',', 'significantly', 'higher', 'received', 'vancomycin', 'with', 'piperacillintazobactam', 'versus', 'cefepime', 'overall', 'cohort', '(', 'versus', 'p', '.', ')', 'resulting', 'in', 'odds', 'ratio', '(', 'or', ')', 'of', '.', '(', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', 'adjusting', 'hypotension', '.', 'result', 'similar', 'within', 'autologous', '(', 'versus', 'p', '.', 'or', ',', '.', 'ci', ',', '.', 'to', '.', ')', 'and', 'allogeneic', '(', 'versus', 'p', '.', 'or', ',', '.', 'ci', ',', '.', 'to', '.', ')', 'subgroup', '.', 'within', 'overall', 'cohort', 'received', 'vancomycin', 'with', 'piperacillintazobactam', 'versus', 'cefepime', 'time', 'to', 'onset', 'of', 'aki', 'commonly', 'within', 'hour', 'of', 'concomitant', 'antimicrobial', 'use', '(', 'versus', 'p', '.', ')', ',', 'whereas', 'resolution', 'of', 'aki', 'discharge', 'date', 'not', 'different', '(', 'versus', 'p', '.', ')', '.', 'no', 'difference', 'in', 'percentage', 'of', 'patient', 'requiring', 'least', 'session', 'of', 'dialysis', ',', 'duration', 'of', 'hospital', 'stay', ',', 'or', '-day', 'mortality', 'found', 'overall', 'cohort', '.', 'study', 'of', 'hct', 'patient', 'warranted', 'to', 'fully', 'elucidate', 'risk', 'of', 'various', 'combination', 'antimicrobial', 'regimen', 'renal', 'outcome', '.']"
Preloading magnesium attenuates cisplatin-associated nephrotoxicity: pilot randomized controlled trial (PRAGMATIC study).,"S Suppadungsuk, W Phitakwatchara, T Reungwetwattana, A Pathumarak, B Phakdeekitcharoen, C Kitiyakara, P Srisuwarn, A Davenport, A Nongnuch, S Suppadungsuket al.",2022 Feb,ESMO Open,https://pubmed.ncbi.nlm.nih.gov/34953401/,No keywords found,"['cisplatin', 'one', 'of', 'potent', 'chemotherapeutic', 'drug', 'used', 'in', 'head', 'and', 'neck', 'cancer', 'treatment', 'however', ',', 'nephrotoxicity', 'major', 'side-effect', 'limiting', 'usage', '.', 'magnesium', 'supplementation', 'reported', 'to', 'reduce', 'risk', 'in', 'non-controlled', 'study', '.', 'investigated', 'whether', 'preloading', 'with', 'magnesium', 'prevents', 'nephrotoxicity', 'with', 'low-dose', 'weekly', 'cisplatin', 'regimen', '.', 'method', 'carried', 'prospective', 'pilot', ',', 'single-blinded', ',', 'randomized', 'controlled', 'trial', 'to', 'compare', 'cisplatin-associated', 'acute', 'kidney', 'injury', '(', 'cis-aki', ')', 'and', 'acute', 'kidney', 'disease', '(', 'cis-akd', ')', 'two', 'group', 'intravenous', '.', 'nacl', 'ml', 'kcl', 'meq', 'h', 'pre-cisplatin', 'mgm', 'weekly', '-', 'week', '(', 'control', 'group', ')', 'compared', 'with', 'additional', 'meq', 'magnesium', 'added', 'to', 'saline', 'infusion', '(', 'mg', 'group', ')', 'in', 'head', 'and', 'neck', 'cancer', 'patient', '.', 'cis-aki', 'defined', 'increased', 'serum', 'creatinine', '(', 'scr', ')', '.', 'mgdl', 'within', 'day', 'and', 'cis-akd', 'increased', 'scr', '.', 'mgdl', 'last', 'scr', 'and', 'baseline', 'pre-chemotherapy', 'scr', '.', 'result', 'overall', 'cisplatin', 'tumor', 'response', 'rate', 'and', 'survival', 'comparable', 'group', '.', 'baseline', 'characteristic', 'comparable', 'group', ',', 'although', 'scr', 'lower', 'in', 'control', '(', '.', '.', 'versus', '.', '.', 'mgdl', ',', 'p', '.', ')', '.', 'incidence', 'of', 'cis-aki', 'similar', '(', '.', 'versus', '.', ')', 'however', ',', 'incidence', 'of', 'cis-akd', 'higher', 'control', 'group', '(', '.', 'versus', '.', ',', 'hazard', 'ratio', '.', ',', 'confidence', 'interval', '.-.', ',', 'p', '.', ')', '.', 'time', 'to', 'develop', 'cis-akd', 'significantly', 'shorter', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'magnesium-preloading', 'regimen', 'safe', 'and', 'significantly', 'showed', 'decreased', 'incidence', 'of', 'cis-akd', '.', 'encouraging', 'result', 'of', 'pilot', 'study', 'need', 'to', 'confirmed', 'in', 'large-scale', 'randomized', 'controlled', 'trial', '.']"
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.,"E Durante-Mangoni, R Andini, S Signoriello, G Cavezza, P Murino, S Buono, M De Cristofaro, C Taglialatela, M Bassetti, P Malacarne, N Petrosillo, A Corcione, C Viscoli, R Utili, C Gallo, E Durante-Mangoniet al.",2016 Dec,Clin Microbiol Infect,https://pubmed.ncbi.nlm.nih.gov/27545697/,"Acinetobacter baumannii, Colistin, Extensively-drug-resistant, Nephrotoxicity, Nosocomial infection, Risk factors.","['study', 'aimed', 'to', 'prospectively', 'assess', 'incidence', 'and', 'risk', 'factor', 'colistin-associated', 'nephrotoxicity', '.', 'secondary', 'analysis', 'of', 'multicentre', ',', 'randomized', 'clinical', 'trial', ',', 'comparing', 'efficacy', 'and', 'safety', 'of', 'colistin', 'versus', 'combination', 'of', 'colistin', 'plus', 'rifampicin', 'in', 'severe', 'infection', 'due', 'to', 'extensively', 'drug-resistant', '(', 'xdr', ')', 'acinetobacter', 'baumannii', '.', 'primary', 'end', 'point', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'colistin', 'treatment', ',', 'assessed', 'using', 'aki', 'network', 'criterion', ',', 'and', 'considering', 'death', 'competing', 'risk', '.', 'total', 'of', 'adult', 'patient', 'without', 'baseline', 'kidney', 'disease', 'renal', 'replacement', 'therapy', 'studied', '.', 'life-threatening', 'infection', 'due', 'to', 'colistin-susceptible', 'xdr', 'a.', 'baumannii', '.', 'patient', 'received', 'colistin', 'intravenously', 'initial', 'dose', '(', 'million', 'international', 'unit', '(', 'miu', ')', 'every', 'h', ')', 'with', 'predefined', 'dose', 'adjustment', 'according', 'to', 'actual', 'renal', 'function', '.', 'serum', 'creatinine', 'measured', 'baseline', 'and', 'day', ',', ',', ',', 'and', '(', 'or', 'last', 'day', 'of', 'therapy', 'discontinued', 'earlier', ')', '.', 'outcome', 'assessed', ""'time"", 'to', 'kidney', 'injury', ""'"", '(', 'aki', 'stage', '-', ')', 'and', ""'time"", 'to', 'severe', 'kidney', 'injury', ""'"", '(', 'considering', 'aki', 'stage', '-', 'event', ')', '.', 'evaluating', 'overall', 'mortality', ',', 'aki', 'occurrence', 'modelled', 'time-dependent', 'variable', '.', 'aki', 'observed', 'in', 'patient', '(', '.', ',', 'stage', 'in', '.', ')', ',', 'with', 'incidence', 'rate', 'of', 'person-days', '(', 'ci', '-.', ')', '.', 'risk', 'estimate', 'of', 'aki', 'and', 'day', '.', 'and', '..', 'age', 'and', 'previous', 'chronic', 'kidney', 'disease', 'significantly', 'associated', 'with', 'aki', 'in', 'multivariable', 'analysis', '.', 'neither', ""'any"", ""'"", ""'severe"", 'aki', ""'"", 'associated', 'with', 'on-treatment', 'mortality', '(', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', '.', 'aki', 'occurs', 'in', 'one-third', 'to', 'one-half', 'of', 'colistin-treated', 'patient', 'and', 'likely', 'in', 'elderly', 'patient', 'and', 'in', 'patient', 'with', 'kidney', 'disease', '.', 'no', 'impact', 'of', 'colistin-associated', 'aki', 'mortality', 'found', ',', 'adverse', 'event', 'not', 'represent', 'reason', 'withholding', 'colistin', 'therapy', ',', 'whenever', 'indicated', '.']"
Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.,"Jean-Philippe Bertocchio, Coralie Barbe, Sylvie Lavaud, Olivier Toupance, Pierre Nazeyrollas, Frederic Jaisser, Philippe Rieu, Jean-Philippe Bertocchioet al.",2016 Apr 18,PLoS One,https://pubmed.ncbi.nlm.nih.gov/27088859/,No keywords found,"['animal', 'study', 'highlighted', 'role', 'of', 'vascular', 'mineralocorticoid', 'receptor', 'cyclosporine', 'a-induced', 'nephrotoxicity', '.', 'mineralocorticoid', 'receptor', 'antagonist', 'could', 'improve', 'kidney', 'survival', 'not', 'commonly', 'used', 'renal', 'impairment', 'and', 'in', 'association', 'with', 'several', 'immunosuppressive', 'drug', 'due', 'to', 'supposed', 'higher', 'risk', 'of', 'adverse', 'event', '.', 'tested', 'tolerance', 'of', 'eplerenone', 'according', 'to', 'expected', 'adverse', 'event', 'hyperkalemia', ',', 'metabolic', 'acidosis', ',', 'hypotension', ',', 'acute', 'kidney', 'failure', ',', 'or', 'adverse', 'event', '.', 'method', 'conducted', 'single-center', ',', 'prospective', ',', 'open-label', 'study', 'in', 'kidney-transplant', 'recipient', 'with', 'impaired', 'renal', 'function', '(', 'and', 'mlmin', '.', ')', 'and', 'receiving', 'cyclosporine', 'a.', 'patient', 'received', 'eplerenone', 'mgd', 'week', '.', 'serum', 'potassium', ',', 'renal', 'function', 'and', 'expected', 'adverse', 'event', 'closely', 'monitored', '.', 'result', 'eight', 'patient', 'experienced', 'mild', 'hyperkalemia', '(', 'mmoll', ')', ',', 'one', 'moderate', 'hyperkalemia', '(', '.', 'mmoll', ')', 'and', 'to', 'receive', 'potassium-exchange', 'resin', '.', 'no', 'severe', 'hyperkalemia', '(', 'mmoll', ')', 'occurred', '.', 'one', 'acute', 'kidney', 'failure', 'observed', ',', 'secondary', 'to', 'diarrhea', '.', 'basal', 'serum', 'potassium', 'and', 'bicarbonate', 'independently', 'associated', 'with', 'higher', 'risk', 'of', 'developing', 'mild', 'hyperkalemia', '(', 'mmoll', ')', 'treatment', '(', 'or', '.', ',', 'p', '.', 'and', '.', ',', 'p', '.', ',', 'respectively', ')', '.', 'cut-off', 'value', 'of', '.', 'mmoll', 'basal', 'serum', 'potassium', 'best', 'factor', 'to', 'predict', 'risk', 'of', 'developing', 'mild', 'hyperkalemia', '(', 'mmoll', ')', '.', 'conclusion', 'egfr', 'fall', 'to', 'mlmin', '.', ',', 'eplerenone', 'could', 'safely', 'given', 'to', 'kidney-transplant', 'recipient', 'receiving', 'cyclosporine', ',', 'kalemia', 'closely', 'monitored', '.', 'renal', 'function', 'impaired', 'and', 'basal', 'kalemia', '.', 'mmoll', ',', 'clinician', 'properly', 'balance', 'risk', 'and', 'benefit', 'of', 'eplerenone', 'use', 'and', 'offer', 'dietary', 'advice', '.', 'adequately', 'powered', 'prospective', 'randomized', 'study', 'needed', 'to', 'test', 'efficiency', '(', 'and', 'safety', ')', 'in', 'population', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial.,"Mabel Aoun, Ghassan Sleilaty, Celine Boueri, Eliane Younes, Kim Gabriel, Reine-Marie Kahwaji, Najla Hilal, Jenny Hawi, Rita Araman, Dania Chelala, Chadia Beaini, Mabel Aounet al.",2022 Mar 13,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/35279078/,No keywords found,"['treatment', 'with', 'erythropoietin', 'well', 'established', 'anemia', 'in', 'chronic', 'kidney', 'disease', 'patient', 'not', 'well', 'studied', 'in', 'acute', 'kidney', 'injury', '.', 'method', 'multicenter', ',', 'randomized', ',', 'pragmatic', 'controlled', 'clinical', 'trial', '.', 'included', 'hospitalized', 'patient', 'with', 'anemia', 'defined', 'hemoglobin', 'gdl', 'and', 'acute', 'kidney', 'injury', 'defined', 'increase', 'of', 'serum', 'creatinine', 'of', '.', 'mgdl', 'within', 'h', 'or', '.', 'time', 'baseline', '.', 'one', 'arm', 'received', 'recombinant', 'human', 'erythropoietin', 'ui', 'subcutaneously', 'every', 'day', '(', 'intervention', 'n', ')', 'and', 'second', 'received', 'standard', 'of', 'care', '(', 'control', 'n', ')', 'hospitalization', 'discharge', 'or', 'death', '.', 'primary', 'outcome', 'need', 'transfusion', 'secondary', 'outcome', 'death', ',', 'renal', 'recovery', ',', 'need', 'dialysis', '.', 'result', 'no', 'statistically', 'significant', 'difference', 'in', 'transfusion', 'need', '(', 'rr', '.', ',', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'in', 'renal', 'recovery', 'full', 'or', 'partial', '(', 'rr', '.', ',', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'in', 'need', 'dialysis', '(', 'rr', '.', ',', 'ci', '.', ',', '.', 'p', '.', ')', 'or', 'in', 'death', '(', 'rr', '.', ',', 'ci', '.', ',', '.', 'p', '.', ')', 'erythropoietin', 'and', 'control', 'group', '.', 'conclusion', 'erythropoietin', 'treatment', 'no', 'impact', 'transfusion', ',', 'renal', 'recovery', 'or', 'mortality', 'in', 'acute', 'kidney', 'injury', 'patient', 'with', 'anemia', '.', 'trial', 'registered', 'clinicaltrials.gov', '(', 'nct', ',', ')', '.']"
"Incidence, Characteristics and Risk Factors of Acute Kidney Injury among Dengue Patients: A Retrospective Analysis.","Tauqeer Hussain Mallhi, Amer Hayat Khan, Azreen Syazril Adnan, Azmi Sarriff, Yusra Habib Khan, Fauziah Jummaat, Tauqeer Hussain Mallhiet al.",2015 Sep 30,PLoS One,https://pubmed.ncbi.nlm.nih.gov/26421839/,No keywords found,"['dengue', 'induced', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'imposes', 'heavy', 'burden', 'of', 'illness', 'in', 'term', 'of', 'morbidity', 'and', 'mortality', '.', 'retrospective', 'study', 'conducted', 'to', 'investigate', 'incidence', ',', 'characteristic', ',', 'risk', 'factor', 'and', 'clinical', 'outcome', 'of', 'aki', 'among', 'dengue', 'patient', '.', 'methodology', 'total', 'dengue', 'patient', '(', '-', ')', 'retrospectively', 'evaluated', 'and', 'stratified', 'aki', 'and', 'non-aki', 'group', 'using', 'akin', 'criterion', '.', 'two', 'group', 'compared', 'using', 'appropriate', 'statistical', 'method', '.', 'result', 'patient', '(', '.', ')', 'aki', ',', 'with', 'akin-i', ',', 'akin-ii', 'and', 'akin-iii', 'in', '.', ',', '.', 'and', '.', 'patient', ',', 'respectively', '.', 'significant', 'difference', '(', 'pdays', ')', 'also', 'observed', 'among', 'aki', 'patient', '(', 'or', '.', ',', 'p', '.', ')', 'corrected.additionally', ',', '.', 'aki', 'patient', 'renal', 'insufficiency', 'discharge', 'signicantly', 'associated', 'with', 'severe', 'dengue', ',', 'secondary', 'infection', 'and', 'diabetes', 'mellitus', '.', 'overall', 'mortality', '.', 'and', 'fatal', 'case', 'aki', '.', 'conclusion', 'incidence', 'of', 'aki', 'high', '.', 'among', 'dengue', 'patient', ',', 'and', 'with', 'aki', 'portended', 'significant', 'morbidity', ',', 'mortality', ',', 'longer', 'hospital', 'stay', 'and', 'poor', 'renal', 'outcome', '.', 'finding', 'suggest', 'aki', 'in', 'dengue', 'likely', 'to', 'increase', 'healthcare', 'burden', 'underscore', 'need', 'of', 'clinician', ""'"", 'alertness', 'to', 'highly', 'morbid', 'and', 'potentially', 'fatal', 'complication', 'optimal', 'prevention', 'and', 'management', '.']"
Evaluation of Renal Toxicity of Colistin Therapy With Neutrophil Gelatinase-associated Lipocalin: a Biomarker of Renal Tubular Damage.,"Atefeh Ordooei Javan, Jamshid Salamzadeh, Shervin Shokouhi, Zahra Sahraei, Atefeh Ordooei Javanet al.",2017 Nov,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/29190605/,No keywords found,"['nephrotoxicity', 'concern', 'with', 'new', 'dosing', 'regimen', 'of', 'colistin', '.', 'study', 'designed', 'to', 'compare', 'nephrotoxicity', 'of', 'high', 'dose', 'and', 'conventional', 'dose', 'of', 'colistin', 'and', 'ability', 'of', 'detecting', 'using', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', '.', 'material', 'and', 'method', 'randomized', 'clinical', 'trial', 'carried', 'patient', 'with', 'multidrug-resistant', 'gram-negative', 'infection', 'assigned', 'group', 'to', 'receive', 'high', 'and', 'conventional', 'dos', 'of', 'colistin', '.', 'blood', 'sample', 'taken', 'time', 'measuring', 'serum', 'ngal', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', 'also', 'evaluated', 'based', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', ',', 'end-stage', 'renal', 'disease', '(', 'rifle', ')', 'criterion', '.', 'result', 'baseline', 'level', 'of', 'ngal', 'not', 'significantly', 'different', 'patient', 'high', 'dose', 'and', 'conventional', 'dose', 'of', 'colistin', '.', 'mean', 'ngal', 'level', 'day', '.', '.', 'pgml', 'and', '.', '.', 'pgml', ',', 'respectively', '.', 'however', ',', 'between-group', 'analysis', 'not', 'show', 'significant', 'difference', 'in', 'ngal', 'level', '.', 'prevalence', 'of', 'acute', 'kidney', 'injury', 'and', 'based', 'rifle', 'criterion', ',', 'in', 'high-dose', 'and', 'conventional-dose', 'group', ',', 'respectively', '(', 'p', '.', ')', '.', 'conclusion', 'although', 'colistin-induced', 'nephrotoxicity', 'not', 'confirmed', 'with', 'ngal', 'level', ',', 'finding', ',', 'however', ',', 'showed', 'higher', 'incidence', 'of', 'acute', 'kidney', 'injury', 'associated', 'with', 'high-dose', 'colistin', ',', 'defined', 'rifle', 'criterion', '.', 'higher', 'level', 'of', 'ngal', 'in', 'acute', 'kidney', 'injury', 'patient', 'associated', 'with', 'high-dose', 'regimen', 'of', 'colistin', '.']"
Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.,"Hong-Liang Xiong, Meng Peng, Xiong-Jing Jiang, Hui Dong, Wu-Qiang Che, Yang Chen, Yu-Bao Zou, Bo Xu, Yue-Jin Yang, Run-Lin Gao, Hong-Liang Xionget al.",2018 Oct,Int Urol Nephrol,https://pubmed.ncbi.nlm.nih.gov/29948863/,No keywords found,"['to', 'compare', 'nephrotoxic', 'effect', 'of', 'iodixanol', 'and', 'iopamidol', 'in', 'patient', 'undergoing', 'peripheral', 'angiography', '.', 'method', 'patient', 'scheduled', 'peripheral', 'angiography', 'randomly', 'assigned', 'to', 'iodixanol', 'group', '(', 'n', ')', 'and', 'iopamidol', 'group', '(', 'n', ')', '.', 'primary', 'endpoint', 'incidence', 'of', 'contrast', 'associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', ',', 'defined', 'increase', 'or', '.', 'moll', '(', '.', 'mgdl', ')', 'in', 'serum', 'creatinine', '(', 'scr', ')', 'baseline', 'within', 'h', 'receiving', 'contrast', 'medium', '(', 'cm', ')', '.', 'secondary', 'endpoint', 'mean', 'peak', 'scr', 'increase', 'within', 'h', 'receiving', 'cm', 'and', 'major', 'adverse', 'renal', 'event', '(', 'scr', 'increased', 'two', 'time', 'day', ',', 'need', 'dialysis', 'treatment', ',', 'rehospitalization', 'acute', 'renal', 'failure', ',', 'or', 'kidney-related', 'death', ')', 'hospitalization', 'and', 'within', 'day', 'postdischarge', '.', 'result', 'incidence', 'of', 'ca-aki', 'not', 'differ', 'significantly', 'iodixanol', 'group', 'and', 'iopamidol', 'group', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'mean', 'peak', 'scr', 'increase', 'iodixanol', 'group', 'and', 'iopamidol', 'group', '(', '.', '.', 'vs.', '.', '.', 'moll', ',', 'p', '.', ')', '.', 'four', 'patient', '(', '.', ')', 'patient', 'in', 'iodixanol', 'group', 'and', '(', '.', ')', 'patient', 'in', 'iopamidol', 'group', ',', 'p', '.', 'with', 'doubling', 'of', 'scr', 'no', 'adverse', 'renal', 'event', 'observed', '.', 'conclusion', 'data', 'showed', 'nephrotoxicity', 'of', 'iodixanol', 'comparable', 'with', 'of', 'iopamidol', 'in', 'patient', 'undergoing', 'peripheral', 'angiography', '.']"
"Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: A Multicenter, Observational Study.","Alexandre Boyer, Jean-François Timsit, Kada Klouche, Emmanuel Canet, Thuy-Nga Phan, Julien Bohé, Sebastien Rubin, Arthur Orieux, Alexandre Lautrette, Didier Gruson, Bertrand Souweine, Alexandre Boyeret al.",2021 Jun,Clin Ther,https://pubmed.ncbi.nlm.nih.gov/34039478/,No keywords found,"['data', 'aminoglycoside', 'stewardship', 'in', 'critically', 'ill', 'septic', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'needing', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'scarce', '.', 'objective', 'of', 'study', 'to', 'determine', ',', 'crrt', ',', 'time', 'window', 'with', 'low', 'likelihood', 'safe', 'reinjection', 'and', 'proportion', 'of', 'inappropriate', 'reinjection', '.', 'method', 'post', 'hoc', 'observational', 'analysis', 'of', 'multicenter', 'randomized', 'trial', 'comparing', 'risk', 'of', 'hemodialysis', 'catheter', 'infection', 'with', 'ethanol', 'lock', 'v', 'placebo', 'in', 'critically', 'ill', 'patient', 'with', 'aki', 'conducted', '.', 'eligible', 'patient', 'adult', 'in', 'intensive', 'care', 'unit', 'french', 'hospital', '.', 'patient', 'with', 'aki', 'needing', 'crrt', 'and', 'receiving', 'antimicrobial', 'therapy', 'septic', 'episode', 'occurring', '(', 'hour', ')', 'or', 'crrt', 'included', '.', 'aminoglycoside', 'order', 'left', 'to', 'physician', ""'"", 'discretion', ',', 'high', 'dose', 'daily', 'schedule', 'of', 'aminoglycoside', 'administration', '.', 'finding', 'total', 'of', 'septic', 'episode', 'treated', 'aminoglycosides', 'analyzed', 'in', 'patient', 'receiving', 'crrt', '.', 'mean', '(', 'sd', ')', 'of', '.', '(', '.', ')', 'amikacin', 'and', '.', '(', '.', ')', 'gentamicin', 'administration', 'per', 'patient', 'observed', '.', 'crrt', ',', 'cmax', '.', 'mgl', '(', 'interquartile', 'range', ',', '.-', '.', 'mgl', ')', 'gentamicin', 'and', 'mgl', '(', 'interquartile', 'range', ',', '.-', '.', 'mgl', ')', 'amikacin', '.', 'plasma', 'drug', 'concentration', 'hour', '(', 'ch', ')', '.', 'mgl', '(', 'interquartile', 'range', ',', '.-', '.', 'mgl', ')', 'gentamicin', 'and', '.', '(', 'interquartile', 'range', ',', '.-', '.', 'mgl', ')', 'amikacin', '.', 'sixty-five', 'cmin', 'dosage', 'remained', 'reinjection', 'threshold', '.', 'inappropriate', 'reinjection', 'observed', 'in', 'of', 'episode', '(', ')', '.', 'inappropriate', 'reinjection', '(', 'defined', ',', 'reinjection', 'time', ',', 'cmin', 'dosage', 'threshold', 'ie', ',', 'cmin', 'mgl', 'gentamicin', 'and', 'mgl', 'amikacin', ')', 'observed', 'in', 'of', 'analyzed', 'episode', '.', 'patient', 'not', 'need', 'reinjection', 'approximately', 'hour', 'initial', 'administration', '.', 'implication', 'crrt', ',', 'indicated', 'ch', 'value', ',', 'higher', 'recommended', 'threshold', ',', 'interval', 'to', 'obtain', 'cmin', 'low', 'enough', 'to', 'allow', 'redosing', 'aminoglycosides', 'significantly', 'longer', 'hour', '.', 'interval', 'not', 'always', 'respected', 'and', 'lead', 'to', 'of', 'inappropriate', 'reinjection', 'rate', 'of', '.', 'clinicaltrials.gov', 'identifier', 'isrctnct', '.']"
A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.,"Elizabeth Fox, Christine Busch, Alexander DeBernardo, Blair Segers, Joseph Gottschalk, Richard Womer, Naomi Balamuth, Rochelle Bagatell, Frank Balis, Elizabeth Foxet al.",2021 Jun,Cancer Chemother Pharmacol,https://pubmed.ncbi.nlm.nih.gov/33677616/,No keywords found,"['high', 'dose', 'methotrexate', '(', 'hdmtx', ')', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'result', 'in', 'prolonged', 'hospitalization', 'and', 'treatment', 'delay', '.', 'using', 'pharmacologically-based', 'approach', ',', 'hdmtx', 'administered', 'with', 'standard', 'combination', 'therapy', 'to', 'patient', 'with', 'osteosarcoma', 'nephrotoxicity', 'assessed', '.', 'method', 'patient', 'randomized', 'cycle', 'to', 'h', 'or', 'h', 'hdmtx', '(', 'gm', ')', 'infusion', 'administered', 'with', 'hydration', ',', 'alkalization', 'and', 'leucovorin', 'rescue', '.', 'urinalysis', ',', 'aki', 'biomarkers', ',', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'using', 'serum', 'creatinine', 'or', 'cystatin', 'c', '(', 'gfrcr', 'or', 'gfrcysc', ')', 'obtained', '.', 'serum', 'and', 'urine', 'methotrexate', 'concentration', 'mtx', 'measured', '.', 'result', 'patient', '(', 'n', ')', ',', 'median', '(', 'range', ')', 'age', '.', '(', '.-', '.', ')', 'year', 'enrolled', 'mtx', 'infusion', 'analyzed', '.', 'median', '(', 'confidence', 'interval', ')', 'serum', 'and', 'urine', 'mtx', '(', ',', ')', 'and', '.', '(', '.', ',', '.', ')', 'mm', 'end', 'of', 'h', 'infusion', 'and', '(', ',', ')', 'and', '.', '(', '.', ',', '.', ')', 'mm', 'end', 'of', 'h', 'infusion', '.', 'time', 'to', 'serum', 'mtx', '.', 'conclusion', 'reducing', 'peak', 'serum', 'and', 'urine', 'mtx', 'concentration', 'prolonging', 'infusion', 'duration', 'not', 'alter', 'risk', 'of', 'acute', 'kidney', 'injury', '.', 'gfrcysc', 'decreased', 'end', 'of', 'therapy', '.', 'proteinuria', 'and', 'elevation', 'in', 'aki', 'biomarkers', 'indicate', 'direct', 'tubular', 'damage', 'contributes', 'to', 'hdmtx', 'nephrotoxicity', '.', 'clinical', 'trial', 'nct', '.']"
Comparing The Efficacy And Safety Of Pregabalin Vs Gabapentin In Uremic Pruritus In Patients Of Chronic Kidney Injury Undergoing Haemodialysis.,"Nudrat Jehangir Khan                              ;, Wahaj                              ;, Sara Haider, Haider Gilani, Neelam Iqbal, Syed Affan Ali, Mohammad Arshad Abbasi, Nudrat Jehangir Khanet al.",2022 Jul-Sep,J Ayub Med Coll Abbottabad,https://pubmed.ncbi.nlm.nih.gov/36377169/,No keywords found,"['world', 'facing', 'epidemic', 'of', 'non-communicable', 'disease', 'including', 'heart', ',', 'metabolic', 'and', 'renal', 'disease', '.', 'renal', 'disease', 'commonly', 'diagnosed', 'and', 'managed', 'in', 'low-', 'and', 'middle-income', 'country', '.', 'objective', 'to', 'compare', 'efficacy', 'and', 'safety', 'of', 'pregabalin', 'and', 'gabapentin', 'in', 'uremic', 'pruritus', 'among', 'patient', 'of', 'chronic', 'kidney', 'injury', 'undergoing', 'haemodialysis', '.', 'comparative', 'cross-sectional', 'study', ',', 'conducted', 'department', 'of', 'nephrology', 'abbottabad', 'international', 'medical', 'institute', '.', 'february', 'to', 'january', '.', 'method', 'total', 'of', 'case', 'included', 'in', 'study', ',', 'diagnosed', 'chronic', 'kidney', 'disease', 'stage', 'undergoing', 'haemodialysis', 'and', 'presented', 'with', 'pruritus', '.', 'pruritus', 'gauged', 'numeric', 'rating', 'scale', 'and', 'patient', 'score', 'of', 'included', '.', 'patient', 'randomly', 'divided', 'two', 'group', 'via', 'lottery', 'method', '.', 'group', 'received', 'pregabalin', 'group', 'b', 'received', 'gabapentin', '.', 'efficacy', 'and', 'safety', 'assessed', 'in', 'group', 'end', 'of', 'six', 'month', '.', 'result', 'of', 'dialysis', 'dependent', 'chronic', 'kidney', 'disease', 'patient', 'with', 'significant', 'pruritus', 'included', 'in', 'study', ',', '(', '.', ')', 'patient', 'male', 'and', '(', '.', ')', 'female', '.', 'end', 'of', 'week', ',', 'found', '(', '.', ')', 'no', 'pruritus', ',', '(', '.', ')', 'mild', ',', '(', '.', ')', 'moderate', '(', '.', ')', 'severe', 'pruritus', '.', 'applying', 'chi-square', 'test', 'found', 'pregablin', 'statistically', 'significantly', 'efficacious', 'gabapentin', '(', 'p-value-.', ')', '.', 'sedation', ',', 'nausea', 'and', 'blurred', 'vision', 'found', 'in', 'patient', 'took', 'pregabalin', '(', 'p-value.', ')', '.', 'conclusion', 'pregablin', 'emerged', 'to', 'efficacious', 'with', 'regard', 'to', 'reducing', 'pruritus', 'of', 'two', 'medication', 'compared', 'in', 'study', 'population', 'patient', 'took', 'gabapentin', 'experience', 'significantly', 'smaller', 'number', 'of', 'side', 'effect', 'compared', 'to', 'patient', 'given', 'pregabalin', '.']"
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.,"Haruka Shinke, Satohiro Masuda, Yousuke Togashi, Yasuaki Ikemi, Aiko Ozawa, Tomoko Sato, Young Hak Kim, Michiaki Mishima, Takaharu Ichimura, Joseph V Bonventre, Kazuo Matsubara, Haruka Shinkeet al.",2015 Nov,Cancer Chemother Pharmacol,https://pubmed.ncbi.nlm.nih.gov/26407820/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'and', 'serious', 'adverse', 'effect', 'of', 'cisplatin-based', 'chemotherapy', '.', 'however', ',', 'traditional', 'marker', 'of', 'kidney', 'function', ',', 'serum', 'creatinine', ',', 'suboptimal', ',', 'not', 'sensitive', 'measure', 'of', 'proximal', 'tubular', 'injury', '.', 'aimed', 'to', 'determine', 'whether', 'new', 'urinary', 'biomarkers', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', ',', 'monocyte', 'chemotactic', 'protein-', '(', 'mcp-', ')', ',', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'could', 'detect', 'cisplatin-induced', 'aki', 'in', 'lung', 'cancer', 'patient', 'in', 'comparison', 'with', 'conventional', 'urinary', 'protein', 'n-acetyl', '--', 'd-glucosaminidase', '(', 'nag', ')', 'and', '-microglobulin', '.', 'method', 'measured', 'kim-', ',', 'mcp-', ',', 'ngal', ',', 'nag', ',', 'and', '-microglobulin', 'concentration', 'in', 'urine', 'sample', 'lung', 'cancer', 'patient', ',', 'collected', 'day', 'cisplatin', 'administration', 'and', 'day', ',', ',', 'and', '.', 'subsequently', ',', 'evaluated', 'biomarkers', 'comparing', 'concentration', 'in', 'aki', 'positive', '(', ')', 'and', 'aki', 'negative', '(', '-', ')', 'sample', 'and', 'performing', 'receiver', 'operating', 'characteristic', '(', 'roc', ')', 'curve', 'analysis', '.', 'result', 'urinary', 'level', 'normalized', 'with', 'urine', 'creatinine', 'of', 'kim-', 'and', 'mcp-', ',', 'not', 'ngal', ',', 'nag', ',', 'and', '-microglobulin', 'in', 'aki', '(', ')', 'sample', 'significantly', 'higher', 'in', 'aki', '(', '-', ')', 'sample', '.', 'in', 'addition', ',', 'roc', 'curve', 'analysis', 'revealed', 'kim-', 'and', 'mcp-', ',', 'not', 'ngal', ',', 'could', 'detect', 'aki', 'with', 'high', 'accuracy', '(', 'area', 'curve', 'auc', '.', ',', '.', ',', 'and', '.', ',', 'respectively', ')', '.', 'combination', 'of', 'kim-', 'and', 'mcp-', 'outperformed', 'either', 'biomarker', 'alone', '(', 'auc', '.', ')', '.', 'conclusion', 'urinary', 'kim-', 'and', 'mcp-', ',', 'either', 'alone', 'or', 'in', 'combination', ',', 'may', 'represent', 'biomarkers', 'of', 'cisplatin-induced', 'aki', 'in', 'lung', 'cancer', 'patient', '.']"
Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer.,"Michael T Spiotto, Hongyuan Cao, Loren Mell, F Gary Toback, Michael T Spiottoet al.",2015 Mar,Anticancer Drugs,https://pubmed.ncbi.nlm.nih.gov/25486599/,No keywords found,"['head', 'and', 'neck', 'cancer', 'patient', 'undergoing', 'chemoradiation', 'experience', 'considerable', 'toxicity', 'including', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'however', ',', 'remains', 'unclear', 'factor', 'predispose', 'patient', 'to', 'renal', 'toxicity', 'treatment', '.', ',', 'assessed', 'predictor', 'and', 'outcome', 'of', 'patient', 'experiencing', 'aki', 'chemoradiation', '.', 'carried', 'retrospective', 'cohort', 'study', 'to', 'assess', 'maximum', 'change', 'in', 'serum', 'creatinine', '(', 'cr', ')', 'in', 'patient', 'with', 'stage', 'iii-iv', 'head', 'and', 'neck', 'cancer', 'treated', 'with', 'chemoradiation', 'and', '.', 'defined', 'aki', 'cr', 'increase', '.', 'moll', 'or', 'pretreatment', 'baseline', '.', 'aki', 'associated', 'with', 'angiotensin-converting', 'enzyme', 'inhibitor', '(', 'acei', ')', 'use', '(', '.', 'vs.', '.', 'p.', ')', ',', 'no', 'medication', 'or', 'comorbidities', '.', 'multivariate', 'analysis', ',', 'acei', 'use', ',', 'weight', 'loss', 'or', 'of', 'body', 'weight', ',', 'and', 'performance', 'status', 'or', 'predicted', 'cr', 'increment', '.', 'moll', 'or', ',', 'whereas', 'acei', 'use', 'predicted', 'cr', 'increment', 'of', '.', 'moll', 'or', 'greater', '.', 'furthermore', ',', 'multivariate', 'analysis', ',', 'aki', 'predicted', 'intervention', 'radiotherapy', 'including', 'intravenous', 'fluid', 'use', '(', 'p.', ')', 'and', 'hospitalization', '(', 'p.', ')', ',', 'well', 'long-term', 'renal', 'dysfunction', '(', 'p.', ')', '.', 'renal', 'toxicity', 'not', 'associated', 'with', 'worse', 'locoregional', 'control', ',', 'progression-free', 'survival', ',', 'or', 'overall', 'survival', '.', 'renal', 'toxicity', 'chemoradiation', 'associated', 'with', 'acei', 'use', 'alone', 'or', 'coupled', 'with', 'weight', 'loss', 'or', 'of', 'body', 'weight', 'therapy', '.', 'result', 'suggest', 'actively', 'managing', 'acei', 'use', 'and', 'intravascular', 'volume', 'status', 'chemoradiation', 'may', 'avoid', 'aki', ',', 'minimize', 'subsequent', 'intervention', ',', 'and', 'reduce', 'risk', 'long-term', 'renal', 'dysfunction', '.']"
Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients.,"K A Mapuskar, G Vasquez Martinez, C F Pulliam, M S Petronek, E J Steinbach, V Monga, M Furqan, J G Jetton, D P Saunders, A Pearce, S Davidson, L Pitre, N E Dunlap, R Fairbanks, C M Lee, S L Mott, K L Bodeker, Huang Cl, J M Buatti, C M Anderson, R A Beardsley, J T Holmlund, D Zepeda-Orozco, D R Spitz, B G Allen, K A Mapuskaret al.",2023 Apr:60:102599.,Redox Biol,https://pubmed.ncbi.nlm.nih.gov/36640725/,"Acute kidney disease, Avasopasem manganese, Chronic kidney disease, Cisplatin, Epithelial growth factor, GC4419, Iron, Kidney injury, Radiation, Superoxide dismutase mimetic, eGFR.","['head', 'and', 'neck', 'squamous', 'cell', 'carcinoma', '(', 'hnscc', ')', 'patient', 'treated', 'with', 'high-dose', 'cisplatin', 'concurrently', 'with', 'radiotherapy', '(', 'hdcis-rt', ')', 'commonly', 'suffer', 'kidney', 'injury', 'leading', 'to', 'acute', 'and', 'chronic', 'kidney', 'disease', '(', 'akd', 'and', 'ckd', ',', 'respectively', ')', '.', 'conducted', 'retrospective', 'analysis', 'of', 'renal', 'function', 'and', 'kidney', 'injury-related', 'plasma', 'biomarkers', 'in', 'subset', 'of', 'hnscc', 'subject', 'receiving', 'hdcis-rt', 'in', 'double-blinded', ',', 'placebo-controlled', 'clinical', 'trial', '(', 'nct', ')', 'evaluating', 'superoxide', 'dismutase', 'mimetic', ',', 'avasopasem', 'manganese', '(', 'ava', ')', ',', 'investigational', 'new', 'drug', '.', 'found', 'mg', 'ava', 'treatment', 'prevented', 'significant', 'reduction', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'three', 'month', 'well', 'six', 'and', 'twelve', 'month', 'treatment', 'compared', 'to', 'mg', 'ava', 'and', 'placebo', '.', 'moreover', ',', 'ava', 'treatment', 'may', 'allowed', 'renal', 'repair', 'in', 'first', 'day', 'following', 'cisplatin', 'treatment', 'evidenced', 'increase', 'in', 'epithelial', 'growth', 'factor', '(', 'egf', ')', ',', 'known', 'to', 'aid', 'in', 'renal', 'recovery', '.', 'upward', 'trend', 'also', 'observed', 'in', 'plasma', 'iron', 'homeostasis', 'protein', 'including', 'total', 'iron', '(', 'fe-blood', ')', 'and', 'iron', 'saturation', '(', 'fe-saturation', ')', 'in', 'mg', 'ava', 'group', 'versus', 'placebo', '.', 'data', 'support', 'hypothesis', 'treatment', 'with', 'mg', 'ava', 'mitigates', 'cisplatin-induced', 'ckd', 'inhibiting', 'hdcis-induced', 'renal', 'change', 'and', 'promoting', 'renal', 'recovery', '.']"
0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.,"Vijai Williams, Muralidharan Jayashree, Karthi Nallasamy, Devi Dayal, Amit Rawat, Vijai Williamset al.",2020 Jan 2,Crit Care,https://pubmed.ncbi.nlm.nih.gov/31898531/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'important', 'complication', 'encountered', 'course', 'of', 'diabetic', 'ketoacidosis', '(', 'dka', ')', '.', 'plasma-lyte', 'with', 'lower', 'chloride', 'concentration', 'saline', 'shown', 'to', 'associated', 'with', 'reduced', 'incidence', 'of', 'aki', 'in', 'adult', 'with', 'septic', 'shock', '.', 'no', 'study', 'compared', 'in', 'dka', '.', 'method', 'double-blind', ',', 'parallel-arm', ',', 'investigator-initiated', ',', 'randomized', 'controlled', 'trial', 'compared', '.', 'saline', 'with', 'plasma-lyte-a', 'initial', 'fluid', 'in', 'pediatric', 'dka', '.', 'study', 'done', 'in', 'tertiary', 'care', ',', 'teaching', ',', 'and', 'referral', 'hospital', 'in', 'india', 'in', 'child', '(', 'month-', 'year', ')', 'with', 'dka', 'defined', 'ispad', '.', 'child', 'with', 'cerebral', 'edema', 'or', 'known', 'chronic', 'kidneyliver', 'disease', 'or', 'received', 'pre-referral', 'fluid', 'andor', 'insulin', 'excluded', '.', 'sixty-six', 'child', 'randomized', 'to', 'receive', 'either', 'plasma-lyte', '(', 'n', ')', 'or', '.', 'saline', '(', 'n', ')', '.', 'main', 'outcome', 'primary', 'outcome', 'incidence', 'of', 'new', 'or', 'progressive', 'aki', ',', 'defined', 'composite', 'outcome', 'of', 'change', 'in', 'creatinine', '(', 'defined', 'kdigo', ')', ',', 'estimated', 'creatinine', 'clearance', '(', 'defined', 'p-rifle', ')', ',', 'and', 'ngal', 'level', '.', 'secondary', 'outcome', 'resolution', 'of', 'aki', ',', 'time', 'to', 'resolution', 'of', 'dka', '(', 'ph', '.', ',', 'bicarbonate', 'meql', 'normal', 'sensorium', ')', ',', 'change', 'in', 'chloride', ',', 'ph', 'and', 'bicarbonate', 'level', ',', 'proportion', 'of', 'in-hospital', 'all-cause', 'mortality', ',', 'need', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', ',', 'and', 'length', 'of', 'icu', 'and', 'hospital', 'stay', '.', 'result', 'baseline', 'characteristic', 'similar', 'in', 'group', '.', 'incidence', 'of', 'new', 'or', 'progressive', 'aki', 'similar', 'in', 'plasma-lyte', '(', '.', ')', 'versus', '.', 'saline', '(', '.', ')', 'adjusted', 'or', '.', 'ci', '.-.', ',', 'p', '..', 'median', '(', 'iqr', ')', 'time', 'to', 'resolution', 'of', 'dka', 'in', 'plasma-lyte-a', 'and', '.', 'saline', '.', '(', 'to', ')', 'and', '(', 'to', ')', 'h', 'respectively', '.', 'time', 'to', 'resolution', 'of', 'aki', 'similar', 'in', 'plasma-lyte', '.', 'versus', '.', 'saline', '.', 'h', '(', 'adjusted', 'hr', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'length', 'of', 'hospital', 'stay', 'also', 'similar', 'in', 'plasma-lyte', '(', 'to', ')', 'versus', '.', 'saline', '(', '.', 'to', ')', 'day', 'p', '..', 'conclusion', 'incidence', 'of', 'new', 'or', 'progressive', 'aki', 'and', 'resolution', 'of', 'aki', 'similar', 'in', 'group', '.', 'plasma-lyte-a', 'similar', 'to', '.', 'saline', 'in', 'time', 'to', 'resolution', 'of', 'dka', ',', 'need', 'rrt', ',', 'mortality', ',', 'and', 'length', 'of', 'picu', 'and', 'hospital', 'stay', '.', 'trial', 'registration', 'clinical', 'trial', 'registry', 'of', 'india', ',', 'ctri', '(', 'ctri.nic.in', ')', '(', 'retrospectively', 'registered', ')', '.']"
Intravenous amino acid therapy for kidney protection in cardiac surgery patients: A pilot randomized controlled trial.,"Hong Pu, Gordon S Doig, Philippa T Heighes, Matilde J Allingstrup, Andy Wang, John Brereton, Carol Pollock, Douglas Chesher, Rinaldo Bellomo, Hong Puet al.",2019 Jun,J Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/30685166/,No keywords found,"['to', 'determine', 'whether', 'continuous', 'intravenous', 'infusion', 'of', 'standard', 'amino', 'acid', 'could', 'preserve', 'kidney', 'function', 'on-pump', 'cardiac', 'surgery', '.', 'method', 'adult', 'patient', 'scheduled', 'to', 'receive', 'cardiac', 'surgery', 'lasting', 'longer', 'hour', 'on-pump', 'randomized', 'to', 'standard', 'care', '(', 'n', ')', 'or', 'infusion', 'of', 'amino', 'acid', 'initiated', 'immediately', 'induction', 'of', 'anesthesia', '(', 'n', ')', '.', 'study', ""'s"", 'primary', 'outcome', 'measurement', 'assessed', 'renal', 'function', '.', 'assessment', 'included', 'duration', 'of', 'renal', 'dysfunction', ',', 'duration', 'and', 'severity', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'time', ',', 'urine', 'output', ',', 'and', 'use', 'of', 'renal-replacement', 'therapy', '.', 'complication', 'and', 'measure', 'of', 'morbidity', 'also', 'assessed', '.', 'result', 'sixty-nine', 'patient', '(', 'mean', 'age', '.', 'standard', 'deviation', '.', 'year', 'of', 'woman', ')', 'enrolled', 'and', 'randomized', '.', 'patient', 'received', 'coronary', 'artery', 'bypass', 'graft', 'surgery', '(', ')', ',', 'valve', 'surgery', '(', ')', ',', 'coronary', 'artery', 'bypass', 'graft', 'and', 'valve', 'surgery', '(', ')', ',', 'or', 'procedure', '(', ')', '.', 'mean', 'on-pump', 'time', 'standard', 'deviation', 'minute', '.', 'duration', 'of', 'renal', 'dysfunction', 'not', 'differ', 'group', '(', 'relative', 'risk', ',', '.', 'confidence', 'interval', 'ci', ',', '.-.', ',', 'p', '.', ')', '.', 'however', ',', 'patient', 'received', 'amino', 'acid', 'infusion', 'reduced', 'duration', 'of', 'aki', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.-.', ',', 'p', '.', ')', 'and', 'greater', 'egfr', '(', '.', 'ci', ',', '.-.', ',', 'p', '.', ')', '.', 'daily', 'mean', 'urine', 'output', 'also', 'significantly', 'greater', 'in', 'patient', 'received', 'amino', 'acid', 'infusion', '(', '.', '.', 'v', '.', '.', 'ld', 'p', '.', ')', '.', 'conclusion', 'commencing', 'infusion', 'of', 'standard', 'amino', 'acid', 'immediately', 'induction', 'of', 'anesthesia', 'not', 'alter', 'duration', 'of', 'renal', 'dysfunction', 'however', ',', 'key', 'measure', 'of', 'renal', 'function', '(', 'duration', 'of', 'aki', ',', 'egfr', 'and', 'urine', 'output', ')', 'significantly', 'improved', '.', 'result', 'warrant', 'replication', 'in', 'multicenter', 'clinical', 'trial', '.']"
"Combined BRAF, MEK, and heat-shock protein 90 inhibition in advanced BRAF V600-mutant melanoma.","Zeynep Eroglu, Y Ann Chen, Inna Smalley, Jiannong Li, Joseph K Markowitz, Andrew S Brohl, Leticia Tetteh, Hayley Taylor, Vernon K Sondak, Nikhil I Khushalani, Keiran S M Smalley, Zeynep Erogluet al.",2024 Jan,Cancer,https://pubmed.ncbi.nlm.nih.gov/37776537/,No keywords found,"['resistance', 'to', 'braf', 'and', 'mek', 'inhibitor', 'in', 'braf', 'v-mutant', 'melanoma', 'common', '.', 'multiple', 'resistance', 'mechanism', 'involve', 'heat-shock', 'protein', '(', 'hsp', ')', 'client', ',', 'and', 'phase', 'study', 'of', 'vemurafenib', 'with', 'hsp', 'inhibitor', 'xl', 'in', 'patient', 'with', 'advanced', 'melanoma', 'showed', 'activity', 'equivalent', 'to', 'of', 'braf', 'and', 'mek', 'inhibitor', '.', 'method', 'vemurafenib', '(', 'mg', 'orally', 'twice', 'daily', ')', 'and', 'cobimetinib', '(', 'mg', 'orally', 'daily', 'of', 'day', ')', 'with', 'escalating', 'dose', 'cohort', 'of', 'xl', '(', ',', ',', ',', 'or', 'mg', 'orally', 'twice', 'weekly', ')', 'investigated', 'in', 'phase', 'trial', 'of', 'advanced', 'melanoma', ',', 'with', 'modified', 'ji', 'dose-escalation', 'design', '.', 'result', 'twenty-five', 'patient', 'enrolled', '.', 'two', 'dose-limiting', 'toxicity', '(', 'dlts', ')', '(', 'rash', 'and', 'acute', 'kidney', 'injury', ')', 'in', 'first', 'cohort', ',', 'lower', 'dos', 'of', 'vemurafenib', '(', 'mg', ')', 'and', 'cobimetinib', '(', 'mg', ')', 'investigated', 'with', 'xl', 'dos', '.', 'three', 'dlts', '(', 'rash', ')', 'observed', 'in', 'patient', 'in', 'xl', '-mg', 'cohort', ',', 'and', 'determined', 'maximum', 'tolerated', 'dose', '.', 'objective', 'response', 'observed', 'in', 'patient', '(', ')', ',', 'and', 'median', 'progression-free', 'survival', '.', 'month', ',', 'with', '-year', 'progression-free', 'survival', 'rate', 'of', '.', 'median', 'overall', 'survival', '.', 'month', ',', 'with', '-year', 'overall', 'survival', 'rate', 'of', '.', 'single-cell', 'rna', 'sequencing', 'performed', 'baseline', 'and', 'on-treatment', 'biopsy', 'treatment', 'associated', 'with', 'increased', 'immune', 'cell', 'influx', '(', 'cd-positive', 'and', 'cd-positive', 'cell', ')', 'and', 'decreased', 'melanoma', 'cell', '.', 'conclusion', 'combined', 'vemurafenib', 'and', 'cobimetinib', 'plus', 'xl', 'significant', 'toxicity', ',', 'requiring', 'frequent', 'dose', 'reduction', ',', 'may', 'contributed', 'to', 'relatively', 'low', 'progression-free', 'survival', 'despite', 'high', 'tumor', 'response', 'rate', '.', 'given', 'overlapping', 'toxicity', ',', 'caution', 'must', 'used', 'combining', 'hsp', 'inhibitor', 'with', 'braf', 'and', 'mek', 'inhibitor', '.']"
The Effect of Curcumin on Renal Ischemia/Reperfusion Injury in Diabetic Rats.,"Douglas Ikedo Machado, Eloiza de Oliveira Silva, Sara Ventura, Maria de Fatima Fernandes Vattimo, Douglas Ikedo Machadoet al.",2022 Jul 7,Nutrients,https://pubmed.ncbi.nlm.nih.gov/35889755/,"curcumin, diabetes, ischemia/reperfusion.","['citrate', '(', 'citrate', 'buffer', ',', 'i.v.', ',', 'single', 'dose', ',', 'day', 'of', 'protocol', ')', 'dm', '(', 'streptozotocin', '(', 'stz', ')', ',', 'mgk', ',', 'single', 'dose', ',', 'i.v.', ',', 'day', ')', 'dm', 'ir', '(', 'dm', 'rat', ',', 'day', ',', 'renal', 'pedicle', 'clamped', 'min', 'side', ')', 'dm', 'ir', 'curcumin', '(', 'dm', 'ir', 'rat', 'submitted', 'to', 'curcumin', 'treatment', ')', '.', 'result', 'showed', 'ir', 'worsened', 'renal', 'function', 'and', 'oxidative', 'stress', 'in', 'dm', 'rat', ',', 'dm', 'ir', 'curcumin', 'group', 'showed', 'increase', 'in', 'inulin', 'clearance', 'and', 'decrease', 'in', 'serum', 'creatinine', 'and', 'in', 'ngal', ',', 'in', 'addition', 'to', 'improvement', 'in', 'renal', 'hemodynamics', '.', 'effect', 'accompanied', 'reduction', 'in', 'oxidative', 'and', 'nitrosative', 'metabolite', 'and', 'increase', 'in', 'thiol', 'antioxidant', 'reserve', 'curcumin', 'administered', 'to', 'dm', 'ir', 'group', '.']"
"Effects of Monomeric and Oligomeric Flavanols on Kidney Function, Inflammation and Oxidative Stress in Runners: A Randomized Double-Blind Pilot Study.","Khrystyna O Semen, Antje R Weseler, Marcel J W Janssen, Marie-José Drittij-Reijnders, Jos L M L le Noble, Aalt Bast, Khrystyna O Semenet al.",2020 Jun 1,Nutrients,https://pubmed.ncbi.nlm.nih.gov/32492913/,"exercise, flavanols, ibuprofen, inflammation, kidney function, neutrophil gelatinase-associated lipocalin.","['nonsteroidal', 'anti-inflammatory', 'drug', 'frequently', 'used', 'athlete', 'in', 'order', 'to', 'prevent', 'musculoskeletal', 'pain', 'and', 'improve', 'performance', '.', 'in', 'combination', 'with', 'strenuous', 'exercise', ',', 'contribute', 'to', 'reduction', 'of', 'renal', 'blood', 'flow', 'and', 'promote', 'development', 'of', 'kidney', 'damage', '.', 'aimed', 'to', 'investigate', 'whether', 'monomeric', 'and', 'oligomeric', 'flavanols', '(', 'mof', ')', 'could', 'reduce', 'severity', 'of', 'kidney', 'injury', 'associated', 'with', 'intake', 'of', '-mg', 'ibuprofen', 'followed', 'completion', 'of', 'half-marathon', 'in', 'recreational', 'athlete', '.', 'in', 'double-blind', ',', 'randomized', 'study', ',', 'original', 'mof', 'blend', 'of', 'extract', 'grape', 'seed', '(', 'vitis', 'vinifera', 'l.', ')', 'and', 'pine', 'bark', '(', 'pinus', 'pinaster', 'l.', ')', 'or', 'placebo', 'taken', 'day', 'preceding', 'ibuprofenhalf-marathon', '.', 'urine', 'sample', 'collected', 'and', 'ibuprofenhalf-marathon', ',', 'and', 'biomarkers', 'of', 'kidney', 'injury', ',', 'inflammation', 'and', 'oxidative', 'stress', 'assessed', '.', 'intake', 'of', 'mof', 'significantly', 'reduced', 'incidence', 'of', 'post-race', 'hematuria', '(', 'p', '.', ')', 'and', 'lowered', 'concentration', 'of', 'interleukin', '(', 'il', ')', '-', 'in', 'urine', '(', 'p', '.', ')', '.', 'urinary', 'neutrophil-associated', 'lipocalin', ',', 'creatine', ',', 'albumin', ',', 'il-', 'and', 'malondialdehyde', 'tended', 'to', 'decrease', '.', 'supplementation', 'with', 'mof', 'in', 'recreational', 'runner', 'appears', 'to', 'safely', 'preserve', 'kidney', 'function', ',', 'reduce', 'inflammation', 'and', 'promote', 'antioxidant', 'defense', 'strenuous', 'exercise', 'and', 'intake', 'of', 'single', 'dose', 'of', 'ibuprofen', '.']"
"Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.","Enrique Grande, José Á Arranz, Maria De Santis, Aristotelis Bamias, Eiji Kikuchi, Xavier Garcia Del Muro, Se Hoon Park, Ugo De Giorgi, Boris Alekseev, Marina Mencinger, Kouji Izumi, Fabio A Schutz, Javier Puente, Jian-Ri Li, Peter H O'Donnell, Arash Rezazadeh Kalebasty, Dingwei Ye, Sanjeev Mariathasan, FabioIa Bene-Tchaleu, Sandrine Bernhard, Chooi Lee, Ian D Davis, Matthew D Galsky, Enrique Grandeet al.",2024 Jan,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/38101433/,No keywords found,"['imvigor', 'demonstrated', 'statistically', 'significant', 'investigator-assessed', 'progression-free', 'survival', 'benefit', 'with', 'first-line', 'atezolizumab', 'plus', 'platinum-based', 'chemotherapy', '(', 'group', ')', 'versus', 'placebo', 'plus', 'platinum-based', 'chemotherapy', '(', 'group', 'c', ')', 'in', 'patient', 'with', 'locally', 'advanced', 'or', 'metastatic', 'urothelial', 'carcinoma', '.', 'overall', 'survival', 'not', 'improved', 'in', 'interim', 'analysis', '.', 'report', 'final', 'overall', 'analysis', 'group', 'versus', 'group', 'c.', 'method', 'in', 'global', ',', 'partially', 'blinded', ',', 'randomised', ',', 'controlled', ',', 'phase', 'study', ',', 'patient', '(', 'aged', 'year', ')', 'with', 'previously', 'untreated', 'locally', 'advanced', 'or', 'metastatic', 'urothelial', 'cancer', 'and', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', '-', 'enrolled', 'hospital', 'and', 'oncology', 'centre', 'in', 'country', '.', 'patient', 'randomly', 'assigned', '(', ')', ',', 'with', 'permuted', 'block', 'method', '(', 'block', 'size', 'of', 'six', ')', 'and', 'interactive', 'voice', 'and', 'web', 'response', 'system', ',', 'stratified', 'pd-l', 'status', ',', 'bajorin', 'risk', 'factor', 'score', ',', 'and', 'investigator', ""'s"", 'choice', 'of', 'platinum-based', 'chemotherapy', ',', 'to', 'receive', 'atezolizumab', 'plus', 'platinum-based', 'chemotherapy', '(', 'group', ')', ',', 'atezolizumab', 'monotherapy', '(', 'group', 'b', ')', ',', 'or', 'placebo', 'plus', 'platinum-based', 'chemotherapy', '(', 'group', 'c', ')', '.', 'sponsor', ',', 'investigator', ',', 'and', 'patient', 'masked', 'to', 'assignment', 'to', 'atezolizumab', 'or', 'placebo', '(', 'ie', ',', 'group', 'and', 'group', 'c', ')', 'and', 'atezolizumab', 'monotherapy', '(', 'group', 'b', ')', 'open', 'label', '.', 'group', 'and', 'c', ',', 'patient', 'received', 'gemcitabine', '(', 'mgm', 'intravenously', 'day', 'and', 'day', 'of', '-day', 'cycle', ')', ',', 'plus', 'investigator', ""'s"", 'choice', 'of', 'carboplatin', '(', 'area', 'curve', 'mgml', 'per', 'min', 'or', 'mgml', 'per', 'min', 'intravenously', ')', 'or', 'cisplatin', '(', 'mgm', 'intravenously', ')', ',', 'plus', 'either', 'atezolizumab', '(', 'mg', 'intravenously', ')', 'or', 'placebo', 'day', 'of', 'cycle', '.', 'co-primary', 'endpoint', 'of', 'study', 'investigator-assessed', 'progression-free', 'survival', 'and', 'overall', 'survival', 'group', 'versus', 'group', 'c', 'in', 'intention-to-treat', '(', 'itt', ')', 'population', '(', 'ie', ',', 'randomised', 'patient', ')', ',', 'and', 'overall', 'survival', 'group', 'b', 'versus', 'group', 'c', ',', 'tested', 'hierarchically', '.', 'final', 'overall', 'survival', 'and', 'updated', 'safety', 'outcome', '(', 'safety', 'population', 'patient', 'received', 'amount', 'of', 'study', 'treatment', 'component', ')', 'group', 'versus', 'group', 'c', 'reported', '.', 'final', 'prespecified', 'boundary', 'significance', 'of', 'overall', 'survival', 'analysis', 'one-sided', 'p.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'active', 'no', 'longer', 'recruiting', '.', 'finding', 'july', ',', ',', 'and', 'july', ',', ',', 'patient', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'treatment', ',', 'of', 'assigned', 'to', 'group', '(', 'n', ')', 'and', 'group', 'c', '(', 'n', ')', '.', '(', ')', 'patient', 'in', 'group', 'and', '(', ')', 'in', 'group', 'c', 'male', ',', '(', ')', 'in', 'group', 'and', '(', ')', 'in', 'group', 'c', 'female', ',', 'and', '(', ')', 'in', 'group', 'and', '(', ')', 'in', 'group', 'c', 'white', '.', 'data', 'cutoff', '(', 'aug', ',', ')', ',', 'median', 'follow', 'of', 'month', '(', 'iqr', '-', ')', ',', 'median', 'overall', 'survival', 'month', '(', 'ci', '-', 'death', ')', 'in', 'group', 'versus', 'month', '(', '-', 'death', ')', 'in', 'group', 'c', '(', 'stratified', 'hazard', 'ratio', 'ci', '-', 'one-sided', 'p', ')', '.', 'common', 'grade', '-', 'treatment-related', 'adverse', 'event', 'anaemia', '(', 'of', 'patient', 'received', 'atezolizumab', 'plus', 'chemotherapy', 'v', 'of', 'received', 'placebo', 'plus', 'chemotherapy', ')', ',', 'neutropenia', '(', 'v', ')', ',', 'decreased', 'neutrophil', 'count', '(', 'v', ')', ',', 'thrombocytopenia', '(', 'v', ')', ',', 'and', 'decreased', 'platelet', 'count', '(', 'v', ')', '.', 'serious', 'adverse', 'event', 'occurred', 'in', '(', ')', 'patient', 'received', 'atezolizumab', 'plus', 'chemotherapy', 'and', '(', ')', 'patient', 'received', 'placebo', 'plus', 'chemotherapy', '.', 'treatment-related', 'death', 'occurred', 'in', 'nine', '(', 'acute', 'kidney', 'injury', ',', 'dyspnoea', ',', 'hepatic', 'failure', ',', 'hepatitis', ',', 'neutropenia', ',', 'pneumonitis', ',', 'respiratory', 'failure', ',', 'sepsis', ',', 'and', 'thrombocytopenia', 'n', ')', 'patient', 'received', 'atezolizumab', 'plus', 'chemotherapy', 'and', 'four', '(', 'unexplained', 'death', ',', 'diarrhoea', ',', 'febrile', 'neutropenia', ',', 'and', 'toxic', 'hepatitis', 'n', ')', 'received', 'placebo', 'plus', 'chemotherapy', '.', 'interpretation', 'progression-free', 'survival', 'benefit', 'with', 'first-line', 'combination', 'of', 'atezolizumab', 'plus', 'platinum-based', 'chemotherapy', 'not', 'translate', 'significant', 'improvement', 'in', 'overall', 'survival', 'in', 'itt', 'population', 'of', 'imvigor', '.', 'research', 'needed', 'to', 'understand', 'patient', 'might', 'benefit', 'first-line', 'combination', 'treatment', '.', 'no', 'new', 'safety', 'signal', 'observed', '.', 'funding', 'f', 'hoffmann-la', 'roche', '.']"
Tight vs liberal control of mild postpartum hypertension: a randomized controlled trial.,"Oluyemi A Aderibigbe, David N Hackney, Angela C Ranzini, Justin R Lappen, Oluyemi A Aderibigbeet al.",2023 Feb,Am J Obstet Gynecol MFM,https://pubmed.ncbi.nlm.nih.gov/36402355/,No keywords found,"['high-quality', 'evidence', 'to', 'inform', 'management', 'of', 'postpartum', 'hypertension', ',', 'including', 'optimal', 'blood', 'pressure', 'threshold', 'to', 'initiate', 'therapy', ',', 'lacking', '.', 'randomized', 'trial', 'conducted', 'in', 'pregnancy', ',', 'no', 'published', 'trial', 'to', 'guide', 'management', 'in', 'postpartum', 'period', '.', 'objective', 'study', 'aimed', 'to', 'test', 'hypothesis', 'initiating', 'antihypertensive', 'therapy', 'in', 'postpartum', 'period', 'threshold', 'of', 'mm', 'hg', 'would', 'result', 'in', 'less', 'maternal', 'morbidity', 'initiating', 'therapy', 'threshold', 'of', 'mm', 'hg', '.', 'study', 'design', 'performed', 'pragmatic', 'multicenter', 'randomized', 'controlled', 'trial', 'of', 'patient', 'aged', 'to', 'year', 'with', 'postpartum', 'hypertension', '.', 'patient', 'with', 'chronic', 'hypertension', ',', 'gestational', 'hypertension', ',', 'and', 'preeclampsia', 'without', 'severe', 'feature', 'randomized', 'to', 'of', 'blood', 'pressure', 'threshold', 'to', 'initiate', 'treatment', 'persistent', 'blood', 'pressure', 'of', 'mm', 'hg', '(', 'institutional', 'standard', 'or', '``', 'liberal', 'control', ""''"", 'group', ')', 'or', 'mm', 'hg', '(', 'intervention', 'or', '``', 'tight', 'control', ""''"", 'group', ')', '.', 'primary', 'outcome', 'composite', 'maternal', 'morbidity', 'defined', 'severe', 'hypertension', '(', 'blood', 'pressure', 'mm', 'hg', ')', 'or', 'preeclampsia', 'with', 'severe', 'feature', ',', 'need', 'second', 'antihypertensive', 'agent', ',', 'postpartum', 'hospitalization', 'day', ',', 'and', 'maternal', 'adverse', 'outcome', 'secondary', 'to', 'hypertension', 'evidenced', 'pulmonary', 'edema', ',', 'acute', 'kidney', 'injury', '(', 'creatinine', 'level', '.', 'mgdl', ')', ',', 'cardiac', 'dysfunction', '(', 'eg', ',', 'elevated', 'brain', 'natriuretic', 'peptide', 'level', ')', 'or', 'cardiomyopathy', ',', 'posterior', 'reversible', 'encephalopathy', 'syndrome', ',', 'cerebrovascular', 'accident', ',', 'or', 'admission', 'to', 'intensive', 'care', 'unit', '.', 'secondary', 'outcome', 'included', 'hospital', 'readmission', 'hypertension', ',', 'persistence', 'of', 'hypertension', 'beyond', 'day', ',', 'medication', 'side', 'effect', ',', 'and', 'time', 'to', 'blood', 'pressure', 'control', '.', 'calculated', 'woman', 'would', 'provide', 'power', 'to', 'detect', 'relative', 'reduction', 'in', 'primary', 'outcome', 'in', 'standard', 'blood', 'pressure', 'threshold', 'group', 'to', ',', 'with', '-sided', 'alpha', 'set', '.', 'significance', '.', 'data', 'analyzed', 'using', 'r', 'statistical', 'software', '.', 'result', 'total', 'of', 'patient', 'randomized', ',', 'including', 'to', '``', 'tight', 'control', ""''"", 'group', '(', 'mm', 'hg', ')', 'and', 'to', '``', 'liberal', 'control', ""''"", 'group', '(', 'mm', 'hg', ')', '.', 'patient', 'in', '``', 'tight', 'control', ""''"", 'group', 'higher', 'body', 'mass', 'index', 'delivery', '(', '..', 'v', '..', 'p.', ')', 'demographic', 'and', 'obstetrical', 'characteristic', 'similar', 'group', '.', 'rate', 'of', 'primary', 'outcome', 'similar', 'group', '(', '.', 'v', '.', 'p.', 'relative', 'risk', ',', '.', 'confidence', 'interval', ',', '.-.', ')', '.', 'rate', 'of', 'secondary', 'outcome', 'and', 'individual', 'component', 'of', 'primary', 'and', 'secondary', 'outcome', 'measure', 'also', 'similar', 'group', '.', 'conclusion', 'in', 'postpartum', 'period', ',', 'initiation', 'of', 'antihypertensive', 'therapy', 'lower', 'blood', 'pressure', 'threshold', 'of', 'mm', 'hg', 'not', 'decrease', 'maternal', 'morbidity', 'or', 'improve', 'outcome', 'compared', 'with', 'threshold', 'of', 'mm', 'hg', '.']"
Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial.,"Brad P Dieter, Kenn B Daratha, Sterling M McPherson, Robert Short, Radica Z Alicic, Katherine R Tuttle, Brad P Dieteret al.",2019,Am J Nephrol,https://pubmed.ncbi.nlm.nih.gov/30939480/,No keywords found,"['in', 'systolic', 'blood', 'pressure', 'intervention', 'trial', ',', 'possible', 'relationship', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'risk', 'of', 'major', 'cardiovascular', 'event', 'and', 'death', 'not', 'known', '.', 'study', 'design', 'post', 'hoc', 'analysis', 'of', 'multicenter', ',', 'randomized', ',', 'controlled', ',', 'open-label', 'clinical', 'trial', '.', 'setting', 'and', 'participant', 'hypertensive', 'adult', 'without', 'diabetes', 'year', 'of', 'age', 'with', 'prior', 'cardiovascular', 'disease', ',', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', ',', '-year', 'framingham', 'risk', 'score', ',', 'or', 'age', 'year', 'assigned', 'to', 'systolic', 'blood', 'pressure', 'target', 'of', 'mm', 'hg', '(', 'intensive', ')', 'or', 'mm', 'hg', '(', 'standard', ')', '.', 'predictor', 'aki', 'episode', '.', 'outcome', 'primary', 'outcome', 'composite', 'of', 'myocardial', 'infarction', ',', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'decompensated', 'heart', 'failure', ',', 'or', 'cardiovascular', 'death', '.', 'secondary', 'outcome', 'death', 'cause', '.', 'analytical', 'approach', 'aki', 'defined', 'using', 'kidney', 'disease', 'improving', 'global', 'outcome', 'modified', 'criterion', 'based', 'solely', 'upon', 'serum', 'creatinine', '.', 'aki', 'episode', 'identified', 'serious', 'adverse', 'event', 'or', 'emergency', 'room', 'visit', '.', 'cox', 'proportional', 'hazard', 'model', 'assessed', 'risk', 'primary', 'and', 'secondary', 'outcome', 'aki', 'status', '.', 'result', 'participant', 'year', 'of', 'age', ',', 'woman', '(', ',', ',', ')', ',', 'and', 'black', 'race', '(', ',', ',', ')', ',', 'and', '(', ',', ',', ')', 'with', 'cardiovascular', 'disease', '.', 'systolic', 'blood', 'pressure', 'mm', 'hg', 'study', 'entry', '.', 'aki', 'occurred', 'in', '.', '(', ',', ')', 'and', '.', '(', ',', ')', 'in', 'intensive', 'and', 'standard', 'treatment', 'group', 'respectively', '(', 'p', '.', ')', '.', 'experienced', 'aki', 'higher', 'risk', 'of', 'cardiovascular', 'event', '(', 'hazard', 'ratio', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'death', 'cause', '(', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'controlling', 'age', ',', 'sex', ',', 'race', ',', 'baseline', 'systolic', 'blood', 'pressure', ',', 'body', 'mass', 'index', ',', 'number', 'of', 'antihypertensive', 'medication', ',', 'cardiovascular', 'disease', 'and', 'ckd', 'status', ',', 'hypotensive', 'episode', ',', 'and', 'treatment', 'assignment', '.', 'limitation', 'study', 'not', 'prospectively', 'designed', 'to', 'determine', 'relationship', 'aki', ',', 'cardiovascular', 'event', ',', 'and', 'death', '.', 'conclusion', 'among', 'older', 'adult', 'with', 'hypertension', 'high', 'cardiovascular', 'risk', ',', 'intensive', 'treatment', 'of', 'blood', 'pressure', 'independently', 'increased', 'risk', 'of', 'aki', ',', 'substantially', 'raised', 'risk', 'of', 'major', 'cardiovascular', 'event', 'and', 'death', '.']"
Midodrine reduces new-onset acute kidney injury and hyponatremia in children with cirrhosis and ascites awaiting liver transplantation: Results from an open-label RCT.,"A Ashritha, Bikrant B Lal, Rajeev Khanna, Vikrant Sood, Arun K Sood, Seema Alam, A Ashrithaet al.",2024 Feb,J Pediatr Gastroenterol Nutr,https://pubmed.ncbi.nlm.nih.gov/38374552/,No keywords found,"['midodrine', ',', 'oral', '--', 'adrenergic', 'receptor', 'agonist', ',', 'counter', 'arterial', 'hypovolemia', 'and', 'reduces', 'complication', 'in', 'adult', 'patient', 'with', 'cirrhosis', '.', 'randomized', 'controlled', 'trial', '(', 'rct', ')', 'aimed', 'to', 'assess', 'efficacy', 'and', 'safety', 'of', 'midodrine', 'in', 'preventing', 'complication', 'and', 'improving', 'survival', 'in', 'child', 'with', 'cirrhosis', 'and', 'ascites', 'awaiting', 'liver', 'transplantation', '(', 'lt', ')', '.', 'method', 'open-label', 'rct', 'conducted', 'january', 'to', 'may', 'included', 'child', 'year', 'with', 'cirrhosis', 'and', 'ascites', '.', 'patient', 'randomized', 'to', 'receive', 'either', 'midodrine', 'plus', 'standard', 'medical', 'therapy', '(', 'smts', ')', 'or', 'smt', 'alone', '.', 'primary', 'outcome', 'measure', 'incidence', 'of', 'cirrhosis-related', 'complication', 'within', 'month', '.', 'result', 'thirty-five', 'subject', 'enrolled', 'and', 'randomized', '.', 'patient', 'in', 'midodrine', 'arm', 'lower', 'incidence', 'of', 'new-onset', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'compared', 'with', 'smt', 'arm', '(', '.', 'v', '.', '.', ')', '.', 'patient', 'in', 'midodrine', 'arm', 'showed', 'decline', 'in', 'serum', 'creatinine', 'and', 'improvement', 'in', 'glomerular', 'filtration', 'rate', ',', 'whereas', 'no', 'change', 'observed', 'in', 'smt', 'arm', '.', 'lower', 'incidence', 'of', 'new-onset', 'hyponatremia', 'in', 'midodrine', 'arm', '(', 'vs.', ')', '.', 'midodrine', 'led', 'to', 'reduction', 'in', 'plasma', 'rennin', 'activity', '(', 'pra', ')', 'and', 'improvement', 'in', 'systemic', 'hemodynamics', '.', 'no', 'difference', 'in', 'rate', 'of', 'resolution', 'of', 'ascites', ',', 'recurrence', 'of', 'ascites', ',', 'requirement', 'of', 'therapeutic', 'paracentesis', ',', 'cumulative', 'albumin', 'infusion', 'requirement', ',', 'episode', 'of', 'spontaneous', 'bacterial', 'peritonitis', ',', 'and', 'hepatic', 'encephalopathy', 'two', 'arm', '.', 'conclusion', 'midodrine', ',', 'added', 'to', 'smt', ',', 'effective', 'in', 'reducing', 'incidence', 'of', 'new-onset', 'aki', 'and', 'hyponatremia', 'in', 'pediatric', 'cirrhotics', 'awaiting', 'lt.', 'also', 'improved', 'systemic', 'hemodynamics', 'and', 'showed', 'trend', 'towards', 'reducing', 'pra', '.']"
Exploring therapeutic mechanisms of Chuan Huang Fang-II in the treatment of acute kidney injury on chronic kidney disease patients from the perspective of lipidomics.,"Ling Chen, Qian Wang, Tonglu Li, Lejia Li, Chen Wang, Bing Xu, Xuezhong Gong, Ling Chenet al.",2024 Dec,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/38785301/,No keywords found,"['study', 'aim', 'to', 'assess', 'clinical', 'efficacy', 'and', 'safety', 'of', 'chf-ii', 'in', 'combination', 'with', 'rg', 'treating', 'aki', 'ckd', '(', 'c', ')', ',', 'and', 'to', 'explore', 'potential', 'therapeutic', 'mechanism', 'lipidomics', 'analysis', '.', 'method', 'patient', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'rg', 'or', 'rg', 'chf', 'group', '.', 'group', 'received', 'rg', 'therapy', ',', 'with', 'rg', 'chf', 'group', 'additionally', 'receiving', 'chf-ii', 'treatment', 'duration', 'of', 'two', 'week', '.', 'evaluation', 'endpoint', 'included', 'change', 'in', 'renal', 'function', ',', 'blood', 'lipid', 'profile', ',', 'urinary', 'aki', 'biomarkers', ',', 'and', 'tcm', 'symptom', 'and', 'treatment', '.', 'serum', 'sample', 'collected', 'lipid', 'metabolite', 'analysis', '.', 'result', 'total', 'clinical', 'effective', 'rate', 'in', 'rg', 'chf', 'group', '.', ',', 'and', 'of', 'rg', 'group', '..', 'tcm', 'syndrome', 'score', 'in', 'rg', 'chf', 'group', 'showed', 'pronounced', 'decrease', '(', 'p', '.', ')', '.', 'scr', ',', 'bun', ',', 'and', 'ua', 'level', 'decreased', 'egfr', 'level', 'increased', 'in', 'group', '(', 'p', '.', ')', ',', 'with', 'greater', 'magnitude', 'of', 'change', 'observed', 'in', 'rg', 'chf', 'group', '.', 'urinary', 'aki', 'biomarkers', 'decreased', 'in', 'rg', 'chf', 'group', '(', 'p', '.', ')', '.', 'no', 'serious', 'adverse', 'event', 'occurred', 'trial', '.', 'different', 'lipid', 'metabolite', 'and', 'lipid', 'biomarkers', 'identified', '.', 'according', 'to', 'kegg', 'database', ',', 'possible', 'metabolic', 'pathway', 'involved', 'triglyceride', 'metabolic', 'pathway', 'and', 'fat', 'digestion', 'and', 'absorption', 'metabolic', 'pathway', '.', 'conclusion', 'chf-ii', 'effectively', 'alleviated', 'kidney', 'injury', 'and', 'improved', 'tcm', 'syndrome', 'score', 'in', 'patient', 'with', 'c.', 'lipid', 'differential', 'metabolite', 'could', 'serve', 'diagnostic', 'indicator', 'aki', 'in', 'patient', 'with', 'ckd', '.', 'possible', 'metabolic', 'pathway', 'might', 'implicated', 'in', 'therapeutic', 'action', 'of', 'chf-ii', 'in', 'prevention', 'and', 'treatment', 'of', 'patient', 'with', 'c', '.']"
"Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.","Cullen M Taniguchi, Jessica M Frakes, Todd A Aguilera, Manisha Palta, Brian Czito, Manoop S Bhutani, Lauren E Colbert, Joseph Abi Jaoude, Vincent Bernard, Shubham Pant, Ching-Wei D Tzeng, Dae Won Kim, Mokenge Malafa, James Costello, Geena Mathew, Neal Rebueno, Eugene J Koay, Prajnan Das, Ethan B Ludmir, Matthew H G Katz, Robert A Wolff, Sam Beddar, Gabriel O Sawakuchi, Shalini Moningi, Rebecca S Slack Tidwell, Ying Yuan, Peter F Thall, Robert A Beardsley, Jon Holmlund, Joseph M Herman, Sarah E Hoffe, Cullen M Taniguchiet al.",2023 Dec,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/38039992/,No keywords found,"['stereotactic', 'body', 'radiotherapy', '(', 'sbrt', ')', 'potential', 'to', 'ablate', 'localised', 'pancreatic', 'ductal', 'adenocarcinoma', '.', 'selective', 'dismutase', 'mimetics', 'sensitise', 'tumour', 'reducing', 'normal', 'tissue', 'toxicity', '.', 'trial', 'designed', 'to', 'establish', 'efficacy', 'and', 'toxicity', 'afforded', 'selective', 'dismutase', 'mimetic', 'avasopasem', 'manganese', 'combined', 'with', 'ablative', 'sbrt', 'localised', 'pancreatic', 'ductal', 'adenocarcinoma', '.', 'method', 'in', 'adaptive', ',', 'randomised', ',', 'double-blind', ',', 'placebo-controlled', ',', 'phase', 'b', 'trial', ',', 'patient', 'aged', 'year', 'or', 'older', 'with', 'borderline', 'resectable', 'or', 'locally', 'advanced', 'pancreatic', 'cancer', 'received', 'least', 'month', 'of', 'chemotherapy', 'and', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', '-', 'enrolled', 'six', 'academic', 'site', 'in', 'usa', '.', 'eligible', 'patient', 'randomly', 'assigned', '(', ')', ',', 'with', 'block', 'randomisation', '(', 'block', 'size', 'of', '-', ')', 'with', 'maximum', 'of', 'patient', 'per', 'group', ',', 'to', 'receive', 'daily', 'avasopasem', '(', 'mg', ')', 'or', 'placebo', 'intravenously', 'directly', '(', 'ie', ',', 'within', 'min', ')', 'sbrt', '(', ',', ',', 'or', 'gy', 'in', 'five', 'fraction', ',', 'adaptively', 'assigned', 'in', 'real', 'time', 'bayesian', 'estimate', 'of', '-day', 'safety', 'and', 'efficacy', ')', '.', 'patient', 'and', 'physician', 'masked', 'to', 'treatment', 'group', 'allocation', ',', 'not', 'to', 'sbrt', 'dose', '.', 'primary', 'objective', 'to', 'find', 'optimal', 'dose', 'of', 'sbrt', 'with', 'avasopasem', 'or', 'placebo', 'determined', 'late', 'onset', 'efftox', 'method', '.', 'analysis', 'done', 'intention-to-treat', 'basis', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'complete', '.', 'finding', 'jan', ',', ',', 'and', 'april', ',', ',', 'patient', 'screened', ',', 'of', 'enrolled', '(', 'median', 'age', 'year', 'iqr', '-', ',', 'male', ',', 'female', ',', 'white', ',', 'three', 'black', ',', 'and', 'one', 'unknown', 'or', 'race', ')', 'and', 'randomly', 'assigned', 'to', 'avasopasem', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'placebo', 'group', 'terminated', 'early', 'failing', 'to', 'meet', 'prespecified', 'efficacy', 'parameter', '.', 'data', 'cutoff', '(', 'june', ',', ')', ',', 'avasopasem', 'group', 'satisfied', 'boundary', 'efficacy', 'and', 'toxicity', '.', 'late', 'onset', 'efftox', 'efficacy', 'response', 'observed', 'in', '(', ')', 'of', 'patient', 'gy', 'and', 'six', '(', ')', 'of', 'six', 'patient', 'gy', 'in', 'avasopasem', 'group', ',', 'and', 'observed', 'in', 'three', '(', ')', 'of', 'six', 'patient', 'gy', 'and', 'nine', '(', ')', 'of', 'patient', 'gy', 'in', 'placebo', 'group', ',', 'and', 'bayesian', 'model', 'recommended', 'gy', 'or', 'gy', 'in', 'five', 'fraction', 'with', 'avasopasem', 'study', '.', 'serious', 'adverse', 'event', 'of', 'cause', 'reported', 'in', 'three', '(', ')', 'of', 'patient', 'in', 'placebo', 'group', 'and', 'six', '(', ')', 'of', 'in', 'avasopasem', 'group', '.', 'in', 'placebo', 'group', ',', 'grade', 'adverse', 'event', 'within', 'day', 'of', 'sbrt', 'abdominal', 'pain', ',', 'acute', 'cholangitis', ',', 'pyrexia', ',', 'increased', 'blood', 'lactic', 'acid', ',', 'and', 'increased', 'lipase', '(', 'one', ')', 'no', 'grade', 'event', 'occurred', '.', 'in', 'avasopasem', 'group', ',', 'grade', '-', 'adverse', 'event', 'within', 'day', 'of', 'sbrt', 'acute', 'kidney', 'injury', ',', 'increased', 'blood', 'alkaline', 'phosphatase', ',', 'haematoma', ',', 'colitis', ',', 'gastric', 'obstruction', ',', 'lung', 'infection', ',', 'abdominal', 'abscess', ',', 'post-surgical', 'atrial', 'fibrillation', ',', 'and', 'pneumonia', 'leading', 'to', 'respiratory', 'failure', '(', 'one', ')', '.there', 'no', 'treatment-related', 'death', 'one', 'late', 'death', 'in', 'avasopasem', 'group', 'due', 'to', 'sepsis', 'in', 'setting', 'of', 'duodenal', 'obstruction', 'off-study', 'treatment', 'reported', 'potentially', 'related', 'to', 'sbrt', '.', 'interpretation', 'sbrt', 'us', 'or', 'gy', 'in', 'five', 'fraction', 'considered', 'patient', 'with', 'localised', 'pancreatic', 'ductal', 'adenocarcinoma', '.', 'addition', 'of', 'avasopasem', 'might', 'enhance', 'disease', 'outcome', '.', 'larger', 'phase', 'trial', '(', 'greco-', ',', 'nct', ')', 'underway', 'to', 'validate', 'result', '.', 'funding', 'galera', 'therapeutic', '.']"
"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.","Roxanne Cofiell, Anjli Kukreja, Krystin Bedard, Yan Yan, Angela P Mickle, Masayo Ogawa, Camille L Bedrosian, Susan J Faas, Roxanne Cofiellet al.",2015 May 21,Blood,https://pubmed.ncbi.nlm.nih.gov/25833956/,No keywords found,"['atypical', 'hemolytic', 'uremic', 'syndrome', '(', 'ahus', ')', 'genetic', ',', 'life-threatening', 'disease', 'characterized', 'uncontrolled', 'complement', 'activation', ',', 'systemic', 'thrombotic', 'microangiopathy', '(', 'tma', ')', ',', 'and', 'vital', 'organ', 'damage', '.', 'evaluated', 'effect', 'of', 'terminal', 'complement', 'blockade', 'with', 'anti-c', 'monoclonal', 'antibody', 'eculizumab', 'biomarkers', 'of', 'cellular', 'process', 'involved', 'in', 'tma', 'in', 'patient', 'with', 'ahus', 'longitudinally', ',', 'to', 'year', 'of', 'treatment', ',', 'compared', 'with', 'in', 'healthy', 'volunteer', '.', 'biomarker', 'level', 'elevated', 'baseline', 'in', 'patient', ',', 'regardless', 'of', 'mutational', 'status', ',', 'plasma', 'exchangeinfusion', 'use', ',', 'platelet', 'count', ',', 'or', 'lactate', 'dehydrogenase', 'or', 'haptoglobin', 'level', '.', 'eculizumab', 'reduced', 'terminal', 'complement', 'activation', '(', 'ca', 'and', 'scb-', ')', 'and', 'renal', 'injury', 'marker', '(', 'clusterin', ',', 'cystatin-c', ',', '-microglobulin', ',', 'and', 'liver', 'fatty', 'acid', 'binding', 'protein-', ')', 'to', 'healthy', 'volunteer', 'level', 'and', 'reduced', 'inflammation', '(', 'soluble', 'tumor', 'necrosis', 'factor', 'receptor-', ')', ',', 'coagulation', '(', 'prothrombin', 'fragment', 'f', 'and', 'd-dimer', ')', ',', 'and', 'endothelial', 'damage', '(', 'thrombomodulin', ')', 'marker', 'to', 'near-normal', 'level', '.', 'alternative', 'pathway', 'activation', '(', 'ba', ')', 'and', 'endothelial', 'activation', 'marker', '(', 'soluble', 'vascular', 'cell', 'adhesion', 'molecule-', ')', 'decreased', 'remained', 'elevated', ',', 'reflecting', 'ongoing', 'complement', 'activation', 'in', 'ahus', 'despite', 'complete', 'terminal', 'complement', 'blockade', '.', 'result', 'highlight', 'link', 'terminal', 'complement', 'activation', 'and', 'inflammation', ',', 'endothelial', 'damage', ',', 'thrombosis', ',', 'and', 'renal', 'injury', 'and', 'underscore', 'ongoing', 'risk', 'systemic', 'tma', 'and', 'progression', 'to', 'organ', 'damage', '.', 'research', 'regarding', 'underlying', 'complement', 'dysregulation', 'warranted', '.', 'trial', 'registered', 'www.clinicaltrials.gov', 'nct', '.']"
Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics.,"Radica Z Alicic, Robert A Short, Cynthia L Corbett, Joshua J Neumiller, Brian J Gates, Kenn B Daratha, Celestina Barbosa-Leiker, Sterling McPherson, Naomi S Chaytor, Brad P Dieter, Stephen M Setter, Katherine R Tuttle, Radica Z Alicicet al.",2016,Am J Nephrol,https://pubmed.ncbi.nlm.nih.gov/27487357/,No keywords found,"['hospital', 'readmission', 'rate', 'in', 'population', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'high', 'and', 'strategy', 'to', 'reduce', 'risk', 'urgently', 'needed', '.', 'method', 'ckd-medication', 'intervention', 'trial', '(', 'ckd-mit', 'www.clinicaltrials.gov', 'ncto', ')', 'single-blind', '(', 'investigator', ')', ',', 'randomized', ',', 'clinical', 'trial', 'conducted', 'providence', 'health', 'care', 'in', 'spokane', ',', 'washington', '.', 'study', 'participant', 'hospitalized', 'patient', 'with', 'ckd', 'stage', '-', '(', 'not', 'treated', 'with', 'kidney', 'replacement', 'therapy', ')', 'and', 'acute', 'illness', '.', 'study', 'intervention', 'pharmacist-led', ',', 'home-based', ',', 'medication', 'management', 'intervention', 'delivered', 'within', 'day', 'hospital', 'discharge', '.', 'primary', 'outcome', 'composite', 'of', 'hospital', 'readmission', 'and', 'visit', 'to', 'emergency', 'department', 'and', 'urgent', 'care', 'center', 'day', 'following', 'hospital', 'discharge', '.', 'secondary', 'outcome', 'achievement', 'of', 'guideline-based', 'target', 'ckd', 'risk', 'factor', 'and', 'complication', '.', 'result', 'enrollment', 'began', 'in', 'february', 'and', 'ended', 'in', 'may', '.', 'baseline', ',', 'age', 'of', 'participant', 'year', '(', 'mean', 'sd', ')', ',', '(', 'of', ')', 'woman', ',', '(', 'of', ')', 'hypertension', 'and', '(', 'of', ')', 'diabetes', '.', 'baseline', ',', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin', '.', 'and', 'urine', 'albumin-to-creatinine', 'ratio', 'mgg', '(', 'interquartile', 'range', '-', 'mgg', ')', '.', 'frequent', 'diagnosis', 'category', 'index', 'hospital', 'admission', 'cardiovascular', 'disease', '(', 'of', ')', ',', 'common', 'single', 'diagnosis', 'admission', 'community-acquired', 'acute', 'kidney', 'injury', '(', 'of', ')', '.', 'conclusion', 'participant', 'in', 'ckd-mit', 'typical', 'of', 'acutely', 'ill', 'hospitalized', 'patient', 'with', 'ckd', '.', 'medication', 'management', 'intervention', 'hospital', 'discharge', 'study', 'to', 'reduce', 'post-hospitalization', 'acute', 'care', 'utilization', 'and', 'to', 'improve', 'ckd', 'management', '.']"
Prospective comparison of the effects of intraoperative goal-directed fluid therapy and restrictive fluid therapy on complications in thoracoscopic lobectomy.,"Min Li, Mingqing Peng, Min Liet al.",2021 Dec,J Int Med Res,https://pubmed.ncbi.nlm.nih.gov/34918965/,No keywords found,"['restrictive', 'fluid', 'therapy', 'recommended', 'in', 'thoracoscopic', 'lobectomy', 'to', 'reduce', 'postoperative', 'pulmonary', 'complication', ',', 'may', 'contribute', 'to', 'hypovolemia', '.', 'goal-directed', 'fluid', 'therapy', '(', 'gdft', ')', 'regulates', 'fluid', 'infusion', 'to', 'amount', 'required', 'to', 'avoid', 'dehydration', '.', 'compared', 'effect', 'of', 'gdft', 'versus', 'restrictive', 'fluid', 'therapy', 'postoperative', 'complication', 'thoracoscopic', 'lobectomy', '.', 'method', 'in', 'total', ',', 'patient', 'underwent', 'thoracoscopic', 'lobectomy', 'randomized', 'gdft', 'group', '(', 'group', 'g', ',', 'n', ')', 'or', 'restrictive', 'fluid', 'therapy', 'group', '(', 'group', 'r', ',', 'n', ')', '.', 'fluid', 'volume', 'and', 'postoperative', 'complication', 'within', 'day', 'of', 'surgery', 'recorded', '.', 'result', 'total', 'fluid', 'volume', 'in', 'group', 'g', 'and', 'r', 'and', 'ml', ',', 'respectively', '.', 'group', 'r', 'received', 'smaller', 'colloid', 'fluid', 'volume', '(', 'vs.', 'ml', ')', ',', 'smaller', 'urine', 'output', '(', 'vs.', 'ml', ')', ',', 'and', 'received', 'norepinephrine', '(', 'vs.', 'g', ')', 'group', 'g.', 'however', ',', 'no', 'significant', 'difference', 'in', 'postoperative', 'pulmonary', 'complication', ',', 'acute', 'kidney', 'injury', ',', 'length', 'of', 'hospital', 'stay', ',', 'or', 'in-hospital', 'mortality', 'two', 'group', '.', 'conclusion', 'restrictive', 'fluid', 'therapy', 'performs', 'similarly', 'to', 'gdft', 'in', 'thoracoscopic', 'lobectomy', 'simpler', 'fluid', 'strategy', 'gdft.trial', 'registration', 'study', 'registered', 'chinese', 'clinical', 'trial', 'registry', '(', 'chictr', ')', '(', 'httpwww.chictr.org.cnindex.aspx', ')', '.']"
Conservative Fluid Management After Sepsis Resuscitation: A Pilot Randomized Trial.,"Matthew W Semler, David R Janz, Jonathan D Casey, Wesley H Self, Todd W Rice, Matthew W Semleret al.",2020 Dec,J Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/30630380/,No keywords found,"['feasibility', 'and', 'clinical', 'outcome', 'of', 'conservative', 'fluid', 'management', 'sepsis', 'resuscitation', 'remain', 'unknown', '.', 'objective', 'to', 'evaluate', 'effect', 'of', 'conservative', 'fluid', 'management', 'protocol', 'fluid', 'balance', 'and', 'intensive', 'care', 'unit', '(', 'icu', ')', '-free', 'day', 'among', 'patient', 'with', 'sepsis', '.', 'method', 'in', 'single-center', 'phase', 'iiiii', 'randomized', 'trial', ',', 'enrolled', 'adult', 'with', 'suspected', 'infection', ',', 'systemic', 'inflammatory', 'response', 'syndrome', 'criterion', ',', 'and', 'either', 'shock', '(', 'mean', 'arterial', 'pressure', 'mm', 'hg', 'or', 'vasopressor', ')', 'or', 'respiratory', 'insufficiency', '(', 'mechanical', 'ventilation', 'or', 'oxygen', 'saturation', 'and', 'fraction', 'of', 'inspired', 'oxygen', '.', ')', '.', 'patient', 'randomized', 'to', 'usual', 'care', 'or', 'conservative', 'fluid', 'management', 'protocol', '.', 'protocol', 'restricted', 'intravenous', 'fluid', 'administration', 'shock', 'to', 'treatment', 'of', 'oliguria', 'or', 'increasing', 'vasopressor', 'requirement', '.', 'in', 'absence', 'of', 'shock', ',', 'loop', 'diuretic', 'infusion', 'targeted', 'equal', 'fluid', 'input', 'and', 'output', 'study', 'day', '.', 'primary', 'outcome', 'mean', 'daily', 'fluid', 'balance', '(', 'phase', 'ii', ')', 'and', 'icu-free', 'day', '(', 'phase', 'iii', ')', '.', 'result', 'completion', 'of', 'phase', 'ii', '(', 'n', ')', ',', 'difference', 'in', 'mean', 'daily', 'fluid', 'balance', 'group', '(', '-', 'ml', ')', 'less', 'prespecified', 'threshold', '(', '-', 'ml', ')', 'and', 'trial', 'stopped', '.', 'patient', 'in', 'conservative', 'fluid', 'management', '(', 'n', ')', 'and', 'usual', 'care', '(', 'n', ')', 'group', 'experienced', 'similar', 'cumulative', 'fluid', 'input', '(', 'ml', 'v', 'ml', 'p', '.', ')', 'of', 'intravenous', 'crystalloid', 'or', 'colloid', '.', 'loop', 'diuretic', 'infusion', 'occurred', 'frequently', 'in', 'conservative', 'fluid', 'management', 'group', '(', 'v', 'p', '.', ')', ',', 'and', 'cumulative', 'fluid', 'output', 'ml', 'in', 'conservative', 'fluid', 'management', 'group', 'compared', 'to', 'ml', 'in', 'usual', 'care', 'group', '(', 'p', '.', ')', '.', 'hemodynamic', ',', 'respiratory', ',', 'and', 'renal', 'function', 'not', 'differ', 'group', '.', 'conclusion', 'in', 'phase', 'ii', 'trial', ',', 'conservative', 'fluid', 'management', 'protocol', 'not', 'decrease', 'mean', 'daily', 'fluid', 'balance', 'ml', 'among', 'patient', 'with', 'sepsis', '.', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE): a randomized multicentre feasibility trial.,"Anja Lindén, M Spångfors, M H Olsen, J Fisher, G Lilja, F Sjövall, M Jungner, M Lengquist, T Kander, L Samuelsson, J Johansson, E Palmnäs, J Undén, J Oras, M Cronhjort, M Chew, A Linder, M Lipcsey, N Nielsen, J C Jakobsen, P Bentzer                                                            ;, REDUSE Trial Group, Jane Fisher, Maria Nelderup, Lisa Hassel, Eva Johnsson, Camilla Claesson, Anna Lybeck, Susann Schrey, Linda K Andersson, Sandra Holmström, Marina Larsson, Katarina Bramell, Karin Aspholm, Karin Olne, Hanna Larsson, Miklos Lipscey, Region Skåne, Niklas Nielsen, Anja Lindénet al.",2024 May 17,Crit Care,https://pubmed.ncbi.nlm.nih.gov/38760833/,No keywords found,"['non-resuscitation', 'fluid', 'constitute', 'majority', 'of', 'fluid', 'administered', 'septic', 'shock', 'patient', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'multicentre', ',', 'randomized', ',', 'feasibility', 'trial', 'conducted', 'to', 'test', 'hypothesis', 'restrictive', 'protocol', 'targeting', 'non-resuscitation', 'fluid', 'reduces', 'overall', 'volume', 'administered', 'compared', 'with', 'usual', 'care', '.', 'method', 'adult', 'with', 'septic', 'shock', 'in', 'six', 'swedish', 'icu', 'randomized', 'within', 'h', 'of', 'icu', 'admission', 'to', 'receive', 'either', 'protocolized', 'reduction', 'of', 'non-resuscitation', 'fluid', 'or', 'usual', 'care', '.', 'primary', 'outcome', 'total', 'volume', 'of', 'fluid', 'administered', 'within', 'three', 'day', 'of', 'inclusion', '.', 'result', 'median', '(', 'iqr', ')', 'total', 'volume', 'of', 'fluid', 'in', 'first', 'three', 'day', ',', 'ml', '(', 'interquartile', 'range', 'iqr', '-', ')', 'in', 'restrictive', 'fluid', 'group', '(', 'n', ')', ',', 'and', 'ml', '(', 'iqr', '-', ',', ')', 'in', 'control', 'group', '(', 'n', ')', 'corresponding', 'to', 'hodges-lehmann', 'median', 'difference', 'of', 'ml', 'confidence', 'interval', '-', 'p', '.', ')', '.', 'outcome', 'data', 'all-cause', 'mortality', ',', 'day', 'alive', 'and', 'free', 'of', 'mechanical', 'ventilation', 'and', 'acute', 'kidney', 'injury', 'or', 'ischemic', 'event', 'in', 'icu', 'within', 'day', 'of', 'inclusion', 'recorded', 'in', '(', ')', ',', '(', ')', 'and', '(', ')', 'of', 'participant', 'respectively', '.', 'cognition', 'and', 'health-related', 'quality', 'of', 'life', 'six', 'month', 'recorded', 'in', '(', ')', 'and', '(', ')', 'of', 'surviving', 'participant', ',', 'respectively', '.', 'ninety', 'of', 'patient', '(', ')', 'of', 'eligible', 'patient', 'randomized', ',', 'and', '(', ')', 'of', 'participant', 'experienced', 'least', 'one', 'protocol', 'violation', '.', 'conclusion', 'protocolized', 'reduction', 'of', 'non-resuscitation', 'fluid', 'in', 'patient', 'with', 'septic', 'shock', 'resulted', 'in', 'large', 'decrease', 'in', 'fluid', 'administration', 'compared', 'with', 'usual', 'care', '.', 'trial', 'using', 'design', 'to', 'test', 'reducing', 'non-resuscitation', 'fluid', 'improves', 'outcome', 'feasible', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'nct', ',', 'february', '.', 'httpsclinicaltrials.govctshownct', '.']"
Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat.,"Chaoliang Tang, Yida Hu, Jie Gao, Jiazhen Jiang, Si Shi, Jiawu Wang, Qingtian Geng, Xinghan Liang, Xiaoqing Chai, Chaoliang Tanget al.",2020 Sep 15:257:118004.,Life Sci,https://pubmed.ncbi.nlm.nih.gov/32621918/,No keywords found,"['patient', 'undergoing', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'often', 'develop', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'caused', 'myocardial', 'ischemia', 'reperfusion', '(', 'mir', ')', ',', 'and', 'renal', 'injury', 'resolved', 'notably', 'dexmedetomidine', '.', 'endoplasmic', 'reticulum', '(', 'er', ')', 'stress', 'reported', 'to', 'get', 'involved', 'in', 'organ', 'injury', 'including', 'aki', '.', 'objective', 'current', 'study', 'aimed', 'to', 'address', 'correlation', 'mir', 'induced', 'aki', 'with', 'er', 'stress', 'and', 'to', 'assess', 'effect', 'of', 'dexmedetomidine', 'pretreatment', 'aki', 'protection', '.', 'method', 'patient', 'selected', 'heart', 'valve', 'replacement', 'surgery', 'randomly', 'assigned', 'to', 'n', 'group', '(', 'pre-anesthesia', 'with', '.', 'nacl', ')', 'and', 'dex', 'group', '(', 'pre-anesthesia', 'with', 'dexmedetomidine', ')', '.', 'rat', 'mir', 'model', 'induced', 'occluding', 'coronary', 'artery', 'min', 'followed', '-hour', 'reperfusion', '.', 'rat', 'randomized', 'sham', '(', '.', 'nacl', ')', ',', 'ir', '(', 'mir', '.', 'nacl', ')', 'and', 'ir', 'dex', '(', 'mir', 'dexmedetomidine', ')', '.', 'organ', 'function', 'and', 'er', 'stress', 'condition', 'evaluated', 'blood', 'chemistry', ',', 'pathology', ',', 'and', 'molecular', 'test', '.', 'result', 'clinical', 'data', 'indicated', 'dexmedetomidine', 'pretreatment', 'attenuated', 'aki', 'and', 'oxidative', 'stress', 'well', 'postischemic', 'myocardial', 'injury', 'in', 'patient', '.', 'accordingly', 'animal', 'result', 'suggested', 'dexmedetomidine', 'reduced', 'cellular', 'injury', 'and', 'improved', 'postischemic', 'myocardial', 'and', 'renal', 'function', '.', 'dexmedetomidine', 'also', 'reduced', 'myocardial', 'and', 'renal', 'cell', 'apoptosis', 'and', 'down-regulated', 'er', 'stress', '.', 'conclusion', 'result', 'suggested', 'dexmedetomidine', 'pretreatment', 'attenuates', 'mir', 'injury-induced', 'aki', 'relieving', 'er', 'stress', '.']"
"Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial.","Elizabeth O'Donnell, Clifton Mo, Andrew J Yee, Omar Nadeem, Jacob Laubach, Jacalyn Rosenblatt, Nikhil Munshi, Shonali Midha, Diana Cirstea, Pavlina Chrysafi, Nora Horick, Paul G Richardson, Noopur Raje, Elizabeth O'Donnellet al.",2024 Jun,Lancet Haematol,https://pubmed.ncbi.nlm.nih.gov/38677302/,No keywords found,"['isatuximab', 'cd', 'monoclonal', 'antibody', 'approved', 'relapsed', 'or', 'refractory', 'multiple', 'myeloma', '.', 'aimed', 'to', 'evaluate', 'addition', 'of', 'isatuximab', 'to', 'weekly', 'carfilzomib', '(', 'k', ')', ',', 'lenalidomide', '(', 'r', ')', ',', 'and', 'dexamethasone', '(', 'isa-krd', ')', 'in', 'transplant-eligible', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', 'and', 'stratified', 'maintenance', 'cytogenetic', 'risk', '.', 'method', 'single-arm', 'phase', 'trial', 'done', 'three', 'cancer', 'centre', '(', 'two', 'hospital', 'and', 'cancer', 'institute', ')', 'in', 'boston', '(', ',', 'usa', ')', '.', 'eligible', 'patient', 'aged', 'least', 'year', 'and', 'transplant-eligible', 'newly', 'diagnosed', 'multiple', 'myeloma', 'and', 'ecog', 'performance', 'status', 'of', 'or', 'less', '.', 'patient', 'received', 'four', '-day', 'cycle', 'of', 'isa-krd', ',', 'including', 'isatuximab', 'mgkg', 'intravenously', 'weekly', 'week', ',', 'every', 'week', 'week', ',', 'and', 'every', 'week', 'thereafter', 'carfilzomib', 'mgm', 'intravenously', 'day', ',', ',', 'and', '(', 'mgm', 'cycle', 'day', ')', 'lenalidomide', 'mg', 'orally', 'day', '-', 'and', 'dexamethasone', 'mg', 'orally', 'day', 'of', 'and', 'day', 'dos', 'of', 'carfilzomib', 'and', 'isatuximab', '.', 'consolidation', 'involved', 'either', 'upfront', 'haematopoietic', 'stem-cell', 'transplantation', '(', 'hsct', ')', 'with', 'two', 'additional', 'cycle', 'or', 'deferred', 'hsct', 'with', 'four', 'additional', 'cycle', 'of', 'treatment', '.', 'primary', 'endpoint', 'complete', 'response', 'four', 'cycle', 'of', 'treatment', '.', 'analysis', 'intention-to-treat', '.', 'patient', 'received', 'one', 'dose', 'of', 'study', 'drug', 'included', 'in', 'safety', 'analysis', '.', 'study', 'registered', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'completed', 'enrolment', '.', 'finding', 'july', ',', 'and', 'jan', ',', ',', 'patient', 'enrolled', '.', 'median', 'age', 'year', '(', 'range', '-', ')', ',', '(', 'of', 'patient', ')', 'male', ',', 'and', '(', ')', 'white', '.', '(', 'of', ')', 'of', 'patient', 'high-risk', 'cytogenetics', '.', 'median', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', '(', 'of', 'patient', ')', 'achieved', 'complete', 'response', 'four', 'cycle', '.', 'overall', 'response', 'rate', '(', 'orr', ')', '(', 'patient', ')', 'and', '(', 'patient', ')', 'achieved', 'good', 'partial', 'response', '(', 'vgpr', ')', 'or', 'better', '.', 'completion', 'of', 'consolidation', ',', '(', 'patient', ')', 'achieved', 'complete', 'response', 'orr', '(', 'patient', ')', 'and', '(', 'patient', ')', 'achieved', 'vgpr', 'or', 'better', '.', 'common', 'grade', 'or', 'side-effects', '(', 'two', 'patient', ')', 'included', 'neutropenia', '(', 'of', 'patient', ')', ',', 'elevated', 'alanine', 'aminotransferase', '(', 'six', 'patient', ')', ',', 'fatigue', '(', 'three', 'patient', ')', ',', 'thrombocytopenia', '(', 'three', 'patient', ')', ',', 'acute', 'kidney', 'injury', '(', 'two', 'patient', ')', ',', 'anaemia', '(', 'two', 'patient', ')', ',', 'and', 'febrile', 'neutropenia', '(', 'two', 'patient', ')', '.', 'grade', '-', 'infusion-related', 'reaction', 'seen', 'in', '(', 'ten', 'patient', ')', ',', 'with', 'none', 'grade', '.', 'grade', '-', 'hypertension', 'seen', 'in', '(', 'seven', 'patient', ')', 'with', 'one', 'grade', '(', 'one', 'patient', ')', '.', 'two', 'death', 'assessed', 'unrelated', 'to', 'treatment', '.', 'interpretation', 'although', 'study', 'not', 'achieve', 'prespecified', 'complete', 'response', 'threshold', ',', 'isa-krd', 'induced', 'deep', 'and', 'durable', 'response', 'in', 'transplant-eligible', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', '.', 'treatment', 'proved', 'safe', 'and', 'consistent', 'with', 'similar', 'regimen', 'in', 'setting', '.', 'funding', 'amgen', ',', 'sanofi', ',', 'and', 'adaptive', '.']"
Impact of Tolvaptan Combined with Low-Dose Dopamine in Heart Failure Patients with Acute Kidney Injury.,"Lingchao Yang, Jian Wang, Ying Yu, Yanyan Li, Song Zhang, Lingchao Yanget al.",2024,Int Heart J,https://pubmed.ncbi.nlm.nih.gov/38825491/,"Cardiac insufficiency, Cardiorenal serological index, Congestion.","['fashion', 'dopamine', 'combined', 'with', 'tolvaptan', 'group', '(', 'dtg', ')', ',', 'tolvaptan', 'group', '(', 'tg', ')', ',', 'and', 'control', 'group', '(', 'cg', ')', '.', 'according', 'to', 'standard', 'of', 'care', ',', 'tg', 'received', 'tolvaptan', 'mg', 'orally', 'daily', 'week', '.', 'dtg', 'received', 'combination', 'treatment', ',', 'including', 'consecutive', 'day', 'of', 'dopamine', 'infusion', '(', 'gkgminutes', ')', 'and', 'oral', 'tolvaptan', 'mg.', 'venous', 'blood', 'and', 'urine', 'sample', 'taken', 'and', 'therapy', '.', 'primary', 'endpoint', 'cardiorenal', 'serological', 'index', 'day', 'of', 'treatment.sixty-five', 'patient', 'chosen', 'randomly', 'dtg', '(', 'patient', ')', ',', 'tg', '(', 'patient', ')', ',', 'and', 'cg', '(', 'patient', ')', ',', 'similar', 'treatment', '.', 'serum', 'index', 'related', 'to', 'cardiac', 'function', '(', 'n-terminal', 'probrain', 'natriuretic', 'peptide', 'and', 'cardiac', 'troponin', ')', 'in', 'dtg', 'decreased', ',', 'compared', 'with', 'tg', 'and', 'cg', '(', 'p', '.', ')', '.', 'furthermore', ',', 'serological', 'marker', 'of', 'renal', 'function', '(', 'serum', 'cystatin', 'c', ',', 'serum', 'creatinine', ',', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', ')', 'in', 'dtg', 'lower', 'in', 'tg', 'and', 'cg', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'incidence', 'of', 'adverse', 'reaction', 'among', 'groups.low-dose', 'dopamine', 'combined', 'with', 'tolvaptan', 'markedly', 'improve', 'patient', ""'"", 'cardiac', 'and', 'renal', 'function', '.', 'may', 'considered', 'new', 'therapeutic', 'method', 'hf', 'patient', 'with', 'aki', '.']"
HYDration and Bicarbonate to Prevent Acute Renal Injury After Endovascular Aneurysm Repair With Suprarenal Fixation: Pilot/Feasibility Randomised Controlled Study (HYDRA Pilot Trial).,"Athanasios Saratzis, Virginia Chiocchia, Ahmad Jiffry, Neelam Hassanali, Surjeet Singh, Christopher H Imray, Matthew J Bown, Asif Mahmood, Athanasios Saratziset al.",2018 May,Eur J Vasc Endovasc Surg,https://pubmed.ncbi.nlm.nih.gov/29482973/,No keywords found,"['to', 'of', 'patient', 'undergoing', 'elective', 'endovascular', 'aneurysm', 'repair', '(', 'evar', ')', 'develop', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'associated', 'with', 'short', 'and', 'long-term', 'morbidity', 'and', 'mortality', '.', 'no', 'high', 'quality', 'randomised', 'evidence', 'regarding', 'prevention', 'of', 'evar', 'related', 'aki', '.', 'method', 'novel', 'aki', 'prevention', 'strategy', 'evar', 'devised', ',', 'based', 'best', 'evidence', 'and', 'expert', 'consensus', 'group', '.', 'included', 'bolus', 'of', 'high', 'dose', 'sodium', 'bicarbonate', '(', 'nahco', ')', 'immediately', 'evar', '(', 'mlkg', 'of', '.', 'nahco', ')', 'and', 'standardised', 'crystalloid', 'based', 'hydration', 'pre-', 'and', 'post-evar', '.', 'pilotfeasibility', 'randomised', 'controlled', 'trial', '(', 'rct', ')', 'performed', 'in', 'two', 'centre', 'to', 'assess', 'safety', 'of', 'intervention', ',', 'potential', 'impact', 'aki', 'prevention', ',', 'and', 'feasibility', 'of', 'national', 'rct', 'primary', 'end', 'point', 'proportion', 'of', 'eligible', 'patient', 'recruited', 'study', '.', 'aki', 'defined', 'using', '``', 'kidney', 'disease', 'improving', 'global', 'outcome', ""''"", 'and', '``', 'acute', 'kidney', 'injury', 'network', ""''"", 'criterion', 'based', 'national', 'institute', 'health', 'and', 'clinical', 'excellence', 'aki', 'recommendation', ',', 'using', 'serum', 'creatinine', 'and', 'hourly', 'urine', 'output', '.', 'result', 'fifty-eight', 'patient', '(', 'of', 'screened', 'median', 'age', 'year', 'range', '-', 'year', ',', 'female', ')', 'randomised', 'to', 'receive', 'standardised', 'intravenous', 'hydration', 'with', '(', 'intervention', ')', 'or', 'without', '(', 'control', ')', 'nahco', '.', 'group', 'comparable', 'in', 'term', 'of', 'aki', 'risk', 'factor', 'of', 'participant', 'device', 'with', 'suprarenal', 'fixation', '.', 'overall', ',', 'of', 'patient', 'in', 'control', 'arm', 'developed', 'aki', 'versus', 'in', 'intervention', 'arm', '(', 'treated', 'analysis', ')', '.', 'none', 'of', 'patient', 'receiving', 'nahco', 'developed', 'serious', 'intervention', 'related', 'adverse', 'event', 'five', 'patient', 'not', 'attend', 'day', 'follow-up', '.', 'conclusion', 'bolus', 'high', 'dose', 'nahco', 'and', 'hydration', 'promising', 'evar', 'related', 'aki', 'prevention', 'method', '.', 'trial', 'confirmed', 'feasibility', 'of', 'delivering', 'definitive', 'large', 'rct', 'to', 'confirm', 'efficacy', 'of', 'novel', 'intervention', ',', 'in', 'preventing', 'evar', 'related', 'aki', '.']"
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.,"Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Hiroshi Nishino, Yukinori Asada, Hiroki Mitani, Shigemichi Iwae, Naoki Nishio, Yusuke Onozawa, Nobuhiro Hanai, Akira Ohkoshi, Hiroki Hara, Nobuya Monden, Masato Nagaoka, Shujiro Minami, Ryo Kitabayashi, Keita Sasaki, Akihiro Homma                              ;, Head, Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG), Yoshinori Imamuraet al.",2024 Jul:154:106868.,Oral Oncol,https://pubmed.ncbi.nlm.nih.gov/38820889/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'represents', 'major', 'toxicity', 'associated', 'with', 'cisplatin', '.', 'developed', 'risk', 'prediction', 'model', 'cisplatin-induced', 'aki', 'in', 'patient', 'with', 'postoperative', 'high-risk', 'head', 'and', 'neck', 'cancer', 'received', 'chemoradiotherapy', 'randomized', 'phase', 'iiiii', 'trial', ',', 'jcog', '.', 'material', 'and', 'method', 'two', 'hundred', 'and', 'fifty-one', 'patient', 'received', 'radiotherapy', 'with', 'weekly', 'cisplatin', 'mgm', '(', 'weekly', 'arm', ')', 'or', '-weekly', 'cisplatin', 'mgm', '(', '-weekly', 'arm', ')', '.', 'aki', 'defined', 'using', 'aki', 'network', 'classificationstaging', 'system', 'increased', 'serum', 'creatinine', 'of', '.', 'mgdl', 'or', '.-fold', 'increase', 'baseline', 'day', 'completing', 'chemoradiotherapy', '.', 'akaike', 'information', 'criterion', 'used', 'to', 'explore', 'optimal', 'model', 'combining', 'explanatory', 'variable', 'registration', '.', 'result', 'among', 'patient', '(', 'men', 'and', 'woman', '(', 'median', 'age', 'year', ')', ')', ',', '(', '.', ')', 'developed', 'cisplatin-induced', 'aki', '.', 'optimal', 'cisplatin-induced', 'aki', 'risk', 'prediction', 'model', 'comprised', 'four', 'factor', ',', 'including', 'primary', 'site', 'of', 'hypopharynxlarynx', '(', 'vs.', 'oral', 'cavityoropharynx', ')', ',', '-weekly', 'arm', '(', 'vs.', 'weekly', 'arm', ')', ',', 'serum', 'albumin', 'of', '.', 'gdl', '(', 'vs.', '.', 'gdl', ')', 'and', 'creatinine', 'clearance', '(', 'ccr', ')', 'of', 'mlmin', '(', 'vs.', 'mlmin', ')', '.', 'incidence', 'of', 'cisplatin-induced', 'aki', 'rose', 'with', 'cumulative', 'count', 'of', 'four', 'factor', '.', 'cumulative', 'count', ',', 'positive', 'predictive', 'value', 'cisplatin-induced', 'aki', '.', '.', 'conclusion', 'developed', 'risk', 'prediction', 'model', 'cisplatin-induced', 'aki', 'in', 'patient', 'with', 'head', 'and', 'neck', 'cancer', 'received', 'postoperative', 'chemoradiotherapy', 'using', 'primary', 'site', ',', 'cisplatin', 'administration', 'method', ',', 'serum', 'albumin', ',', 'and', 'ccr', '.', 'patient', 'with', 'risk', 'factor', 'unrelated', 'to', 'cisplatin', 'administration', 'method', 'adopt', 'weekly', 'cisplatin', 'regimen', '.']"
Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study).,"Chris Anthony, Muhammad Imran, Jim Pouliopoulos, Sam Emmanuel, James W Iliff, Kirsten J Moffat, Joanne Ross, Robert M Graham, Eugene Kotlyar, Kavitha Muthiah, Anne M Keogh, Christopher S Hayward, Peter Macdonald, Andrew Jabbour, Chris Anthonyet al.",2021 Apr,JACC Heart Fail,https://pubmed.ncbi.nlm.nih.gov/33795116/,No keywords found,"['study', 'aimed', 'to', 'determine', 'safety', 'and', 'efficacy', 'of', 'combined', 'low-dose', 'everolimus', 'and', 'low-dose', 'tacrolimus', 'compared', 'with', 'standard-dose', 'tacrolimus', 'in', 'attenuating', 'left', 'ventricular', 'hypertrophy', '(', 'lvh', ')', 'orthotopic', 'heart', 'transplantation', '(', 'oht', ')', '.', 'background', 'calcineurin', 'inhibitor', '(', 'cnis', ')', 'tactrolimus', 'important', 'in', 'preventing', 'cardiac', 'allograft', 'rejection', 'and', 'reducing', 'mortality', 'oht', '.', 'however', 'cnis', 'causatively', 'linked', 'to', 'development', 'of', 'lvh', ',', 'and', 'associated', 'with', 'nephrotoxicity', 'and', 'vasculopathy', '.', 'cni-sparing', 'agent', 'everolimus', 'hypothesized', 'to', 'inhibit', 'adverse', 'effect', 'of', 'cnis', '.', 'method', 'in', 'prospective', ',', 'randomized', ',', 'open-label', 'study', ',', 'oht', 'recipient', 'randomized', 'week', 'oht', 'to', 'combination', 'of', 'low-dose', 'everolimus', 'and', 'tacrolimus', '(', 'radtac', 'group', ')', 'or', 'standard-dose', 'tacrolimus', '(', 'tac', 'group', ')', ',', 'with', 'group', 'coadministered', 'mycophenolate', 'and', 'prednisolone', '.', 'primary', 'endpoint', 'lvh', 'indexed', 'change', 'in', 'left', 'ventricular', 'mass', '(', 'lvm', ')', 'cardiovascular', 'magnetic', 'resonance', '(', 'cmr', ')', 'imaging', 'to', 'week', '.', 'secondary', 'endpoint', 'included', 'cmr-based', 'myocardial', 'performance', ',', 'fibrosis', 'mapping', ',', 'blood', 'pressure', ',', 'and', 'renal', 'function', '.', 'safety', 'endpoint', 'included', 'episode', 'of', 'allograft', 'rejection', 'and', 'infection', '.', 'result', 'forty', 'stable', 'oht', 'recipient', 'randomized', '.', 'recipient', 'in', 'radtac', 'group', 'significantly', 'lower', 'tacrolimus', 'level', 'compared', 'with', 'tac', 'group', '(', '.', '.', 'gl', 'vs.', '.', '.', 'gl', 'p', '.', ')', '.', 'mean', 'everolimus', 'level', 'in', 'radtac', 'group', '.', '.', 'gl', '.', 'significant', 'reduction', 'in', 'lvm', 'observed', 'in', 'radtac', 'group', 'compared', 'with', 'increase', 'in', 'lvm', 'in', 'tac', 'group', '(', 'lvm', '-', '.', '.', 'g', 'vs.', '.', '.', 'g', 'p', '.', ')', '.', 'significant', 'difference', 'also', 'noted', 'in', 'secondary', 'endpoint', 'measuring', 'function', 'and', 'fibrosis', '(', 'circumferential', 'strain', '-', '.', '.', 'vs.', '.', '.', 'p', '.', 'mapping', 'value', '-', '.', '.', 'm', 'vs.', '.', '.', 'm', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'observed', 'in', 'blood', 'pressure', '(', 'mean', 'arterial', 'pressure', '.', '.', 'mm', 'hg', 'vs.', '.', '.', 'mm', 'hg', 'p', '.', ')', ',', 'renal', 'function', '(', 'creatinine', '.', '.', 'moll', 'vs.', '.', 'moll', 'p', '.', ')', ',', 'frequency', 'of', 'rejection', 'episode', '(', 'p', '.', ')', ',', 'or', 'frequency', 'of', 'infection', '(', 'p', '.', ')', 'group', '.', 'conclusion', 'combination', 'of', 'low-dose', 'everolimus', 'and', 'tacrolimus', 'compared', 'with', 'standard-dose', 'tacrolimus', 'safely', 'attenuates', 'lvh', 'in', 'first', 'year', 'cardiac', 'transplantation', 'with', 'observed', 'reduction', 'in', 'cmr-measured', 'fibrosis', 'and', 'improvement', 'in', 'myocardial', 'strain', '.']"
Phenotype-specific therapeutic efficacy of ilofotase alfa in patients with sepsis-associated acute kidney injury.,"Niklas Bruse, Katerina Pardali, Maarten Kraan, Matthijs Kox, Peter Pickkers                              ;, REVIVAL investigators, Niklas Bruseet al.",2024 Feb 19,Crit Care,https://pubmed.ncbi.nlm.nih.gov/38373981/,No keywords found,"['no', 'effective', 'treatment', 'sepsis-associated', 'acute', 'kidney', 'injury', '(', 'sa-aki', ')', '.', 'ilofotase', 'alfa', '(', 'human', 'recombinant', 'alkaline', 'phosphatase', ')', 'shown', 'to', 'exert', 'reno-protective', 'property', ',', 'although', 'remains', 'unclear', 'patient', 'might', 'likely', 'to', 'benefit', '.', 'aimed', 'to', 'identify', 'clinical', 'phenotype', 'associated', 'with', 'ilofotase', 'alfa', ""'s"", 'therapeutic', 'efficacy', '.', 'method', 'data', 'of', 'patient', 'enrolled', 'in', 'revival', 'trial', 'used', 'in', 'stepwise', 'machine', 'learning', 'approach', '.', 'first', ',', 'clinical', 'variable', 'with', 'increasing', 'or', 'decreasing', 'risk', 'ratio', 'ilofotase', 'alfa', 'treatment', 'across', 'quartile', 'main', 'secondary', 'endpoint', ',', 'major', 'adverse', 'kidney', 'event', 'to', 'day', '(', 'make', ')', ',', 'selected', '.', 'second', ',', 'linear', 'regression', 'analysis', 'used', 'to', 'determine', 'therapeutic', 'effect', 'size', '.', 'finally', ',', 'top-', 'variable', 'used', 'in', 'different', 'clustering', 'analysis', 'with', 'consensus', 'assessment', '.', 'result', 'optimal', 'clustering', 'model', 'comprised', 'two', 'phenotype', '.', 'phenotype', 'displayed', 'relatively', 'lower', 'disease', 'severity', 'score', ',', 'and', 'less', 'pronounced', 'renal', 'and', 'pulmonary', 'dysfunction', '.', 'phenotype', 'exhibited', 'higher', 'severity', 'score', 'and', 'creatinine', ',', 'with', 'lower', 'egfr', 'and', 'bicarbonate', 'level', '.', 'compared', 'with', 'placebo', 'treatment', ',', 'ilofotase', 'alfa', 'significantly', 'reduced', 'make', 'event', 'phenotype', 'patient', '(', 'vs.', ',', 'p', '.', ')', ',', 'not', 'phenotype', 'patient', '(', 'vs.', ',', 'p', '.', ')', '.', 'conclusion', 'identified', 'clinical', 'phenotype', 'comprising', 'severely', 'ill', 'patient', 'with', 'underlying', 'kidney', 'disease', 'benefitted', 'ilofotase', 'alfa', 'treatment', '.', 'yield', 'insight', 'therapeutic', 'potential', 'of', 'novel', 'treatment', 'in', 'homogeneous', 'patient', 'group', 'and', 'could', 'guide', 'patient', 'selection', 'in', 'future', 'trial', ',', 'showing', 'promise', 'personalized', 'medicine', 'in', 'sa-aki', 'and', 'complex', 'condition', '.']"
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.,"Amy Legg, Niamh Meagher, Sandra A Johnson, Matthew A Roberts, Alan Cass, Marc H Scheetz, Jane Davies, Jason A Roberts, Joshua S Davis, Steven Y C Tong, Amy Legget al.",2023 Jan,Clin Drug Investig,https://pubmed.ncbi.nlm.nih.gov/36217068/,No keywords found,"['clinical', 'risk', 'factor', 'nephrotoxicity', 'in', 'staphylococcus', 'aureus', 'bacteraemia', 'remain', 'largely', 'undetermined', ',', 'despite', 'common', 'occurrence', 'and', 'clinical', 'significance', '.', 'in', 'international', ',', 'multicentre', ',', 'prospective', 'clinical', 'trial', '(', 'camera', ')', ',', 'compared', 'standard', 'therapy', '(', 'vancomycin', 'monotherapy', ')', 'to', 'combination', 'therapy', '(', 'adding', 'anti-staphylococcal', 'beta-lactam', ')', 'methicillin-resistant', 's.', 'aureus', 'bacteraemia', ',', 'significantly', 'people', 'in', 'combination', 'therapy', 'arm', 'experienced', 'acute', 'kidney', 'injury', 'compared', 'with', 'in', 'monotherapy', 'arm', '(', 'v', ')', '.', 'objective', 'aim', 'of', 'post', 'hoc', 'analysis', 'to', 'explore', 'in', 'greater', 'depth', 'risk', 'factor', 'acute', 'kidney', 'injury', 'camera', 'trial', '.', 'method', 'among', 'participant', 'of', 'camera', 'trial', ',', 'demographic-related', ',', 'infection-related', 'and', 'treatment-related', 'risk', 'factor', 'assessed', 'relationship', 'with', 'acute', 'kidney', 'injury', 'univariable', 'and', 'multivariable', 'logistic', 'regression', '.', 'acute', 'kidney', 'injury', 'defined', 'modified-kdigo', '(', 'kidney', 'disease', 'improving', 'global', 'outcome', ')', 'criterion', '(', 'not', 'including', 'urinary', 'output', ')', '.', 'result', 'of', 'participant', 'included', ',', 'age', '(', 'p', '.', ')', ',', 'randomisation', 'to', 'combination', 'therapy', '(', 'p', '.', ')', ',', 'vancomycin', 'area', 'concentration-time', 'curve', '(', 'p', '.', ')', 'and', 'receipt', 'of', '(', 'flu', ')', 'cloxacillin', 'companion', 'beta-lactam', '(', 'p', '.', ')', 'significantly', 'associated', 'with', 'acute', 'kidney', 'injury', '.', 'multivariable', 'analysis', ',', 'concurrent', 'use', 'of', '(', 'flu', ')', 'cloxacillin', 'increased', 'risk', 'of', 'acute', 'kidney', 'injury', 'four', 'time', 'compared', 'with', 'use', 'of', 'cefazolin', 'or', 'no', 'beta-lactam', '.', 'association', 'of', 'vancomycin', 'area', 'concentration-time', 'curve', 'with', 'acute', 'kidney', 'injury', 'also', 'persisted', 'in', 'multivariable', 'model', '.', 'conclusion', 'participant', 'receiving', 'vancomycin', 's.', 'aureus', 'bacteraemia', ',', 'use', 'of', '(', 'flu', ')', 'cloxacillin', 'and', 'increased', 'vancomycin', 'area', 'concentration-time', 'curve', 'risk', 'factor', 'acute', 'kidney', 'injury', '.', 'represent', 'potentially', 'modifiable', 'risk', 'factor', 'nephrotoxicity', 'and', 'highlight', 'importance', 'of', 'avoiding', 'use', 'of', 'concurrent', 'nephrotoxin', '.']"
Hypertonic Mannitol for the Prevention of Intradialytic Hypotension: A Randomized Controlled Trial.,"Finnian R Mc Causland, Brian Claggett, Venkata S Sabbisetti, Petr Jarolim, Sushrut S Waikar, Finnian R Mc Causlandet al.",2019 Oct,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/31040088/,No keywords found,"['intradialytic', 'hypotension', '(', 'idh', ')', 'common', 'complication', 'initiation', 'of', 'hemodialysis', '(', 'hd', ')', 'therapy', ',', 'associated', 'with', 'greater', 'mortality', ',', 'and', 'may', 'related', 'to', 'relatively', 'rapid', 'shift', 'in', 'plasma', 'osmolality', '.', 'study', 'sought', 'to', 'evaluate', 'effect', 'of', 'intervention', 'to', 'minimize', 'intradialytic', 'change', 'in', 'plasma', 'osmolality', 'occurrence', 'of', 'idh', '.', 'study', 'design', 'double-blind', ',', 'single-center', ',', 'randomized', ',', 'controlled', 'trial', '.', 'setting', 'participant', 'individual', 'requiring', 'initiation', 'of', 'hd', 'acute', 'or', 'chronic', 'kidney', 'disease', '.', 'intervention', 'mannitol', ',', '.gkgh', ',', 'versus', 'similar', 'volume', 'of', '.', 'saline', 'solution', 'first', 'hd', 'session', '.', 'outcome', 'primary', 'end', 'point', 'average', 'decline', 'in', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', '.', 'secondary', 'end', 'point', 'proportion', 'of', 'total', 'session', 'complicated', 'idh', '(', 'defined', 'decrease', 'mm', 'hg', 'pre-hd', 'sbp', ')', '.', 'exploratory', 'end', 'point', 'included', 'biomarkers', 'of', 'cardiac', 'and', 'kidney', 'injury', '.', 'result', 'patient', 'randomly', 'assigned', 'and', 'contributed', 'to', 'study', 'visit', '.', 'no', 'significant', 'difference', 'in', 'average', 'sbp', 'decline', 'mannitol', 'and', 'placebo', 'group', '(', 'v', 'mm', 'hg', 'p', '.', ')', '.', 'proportion', 'of', 'total', 'session', 'complicated', 'idh', 'lower', 'in', 'mannitol', 'group', 'compared', 'to', 'placebo', '(', 'v', ')', ',', 'with', 'nominally', 'lower', 'risk', 'developing', 'episode', 'of', 'idh', '(', 'or', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'though', 'finding', 'of', 'borderline', 'statistical', 'significance', '(', 'p', '.', ')', '.', 'no', 'consistent', 'difference', 'in', 'cardiac', 'and', 'kidney', 'injury', 'biomarker', 'level', 'treatment', 'group', '.', 'limitation', 'modest', 'sample', 'size', 'and', 'number', 'of', 'event', '.', 'conclusion', 'in', 'pilot', 'randomized', 'controlled', 'trial', 'studying', 'patient', 'requiring', 'initiation', 'of', 'hd', ',', 'found', 'no', 'difference', 'in', 'absolute', 'sbp', 'decline', 'received', 'mannitol', 'and', 'received', 'saline', 'solution', '.', 'however', ',', 'fewer', 'overall', 'idh', 'event', 'and', 'nominally', 'lower', 'risk', 'dialysis', 'session', 'complicated', 'idh', 'in', 'mannitol', 'group', '.', 'larger', 'multicenter', 'randomized', 'controlled', 'trial', 'warranted', '.', 'funding', 'government', 'funding', 'to', 'author', '(', 'dr', 'mc', 'causland', 'supported', 'national', 'institute', 'of', 'diabetes', 'and', 'digestive', 'and', 'kidney', 'disease', 'grant', 'kdk', ')', '.', 'trial', 'registration', 'registered', 'clinicaltrials.gov', 'with', 'study', 'number', 'nct', '.']"
Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial.,"Santiago Garcia, Deepak L Bhatt, Martin Gallagher, Hani Jneid, James Kaufman, Paul M Palevsky, Hongsheng Wu, Steven D Weisbord                              ;, PRESERVE Trial Group, Santiago Garciaet al.",2018 Nov 26,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/30466822/,No keywords found,"['aim', 'of', 'study', 'to', 'compare', 'intravenous', '(', 'iv', ')', 'sodium', 'bicarbonate', 'with', 'iv', 'sodium', 'chloride', 'and', 'oral', 'acetylcysteine', 'with', 'placebo', 'prevention', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'caaki', ')', 'and', 'intermediate-term', 'adverse', 'outcome', '.', 'background', 'data', 'conflicting', 'optimal', 'strategy', 'to', 'reduce', 'caaki', 'and', 'related', 'complication', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', '.', 'method', 'preserve', '(', 'prevention', 'of', 'serious', 'adverse', 'event', 'following', 'angiography', ')', 'trial', 'used', 'factorial', 'design', 'to', 'randomize', ',', 'patient', 'with', 'stage', 'iii', 'or', 'iv', 'chronic', 'kidney', 'disease', 'undergoing', 'angiography', 'to', 'iv', '.', 'sodium', 'bicarbonate', 'or', 'iv', '.', 'sodium', 'chloride', 'and', 'day', 'of', 'oral', 'acetylcysteine', 'or', 'placebo', '.', 'subgroup', 'analysis', 'conducted', 'of', 'efficacy', 'of', 'intervention', 'in', 'patient', 'underwent', 'pci', 'study', 'angiographic', 'examination', '.', 'primary', 'endpoint', 'composite', 'of', 'death', ',', 'need', 'dialysis', ',', 'or', 'persistent', 'kidney', 'impairment', 'day', 'caaki', 'secondary', 'endpoint', '.', 'result', 'total', 'of', ',', 'preserve', 'patient', '(', 'mean', 'age', 'year', ')', 'underwent', 'pci', '.', 'median', 'estimated', 'glomerular', 'filtration', 'rate', '.', 'mlmin', '.', '(', 'interquartile', 'range', '.', 'to', '.', 'mlmin', '.', ')', ',', 'and', 'patient', '(', ')', 'diabetes', 'mellitus', '.', 'primary', 'endpoint', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'iv', 'sodium', 'bicarbonate', 'group', 'and', 'of', 'patient', '(', '.', ')', 'in', 'iv', 'sodium', 'chloride', 'group', '(', 'odds', 'ratio', '.', 'confidence', 'interval', '.', 'to', '.', 'p', 'interaction', '.', ')', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'acetylcysteine', 'group', 'and', 'of', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'odds', 'ratio', '.', 'confidence', 'interval', '.', 'to', '.', 'p', 'interaction', '.', ')', '.', 'no', 'significant', 'between-group', 'difference', 'in', 'rate', 'of', 'caaki', '.', 'conclusion', 'among', 'patient', 'with', 'ckd', 'undergoing', 'pci', ',', 'no', 'benefit', 'of', 'iv', 'sodium', 'bicarbonate', 'iv', 'sodium', 'chloride', 'or', 'of', 'acetylcysteine', 'placebo', 'prevention', 'of', 'caaki', 'or', 'intermediate-term', 'adverse', 'outcome', '.']"
Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.,"Lindsay N Helget, Anne Davis-Karim, James R O'Dell, Ted R Mikuls, Jeff A Newcomb, Maria Androsenko, Mary T Brophy, Bryant R England, Ryan Ferguson, Michael H Pillinger, Tuhina Neogi, Hongsheng Wu, Paul M Palevsky, Lindsay N Helgetet al.",2024 Nov,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/38906504/,No keywords found,"['conducted', 'prespecified', 'examination', 'of', 'efficacy', 'and', 'safety', 'of', 'allopurinol', 'and', 'febuxostat', 'administered', 'using', 'treat-to-target', 'strategy', 'in', 'trial', 'participant', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'study', 'design', 'prespecified', 'subcohort', 'analysis', 'of', 'randomized', 'controlled', 'trial', '.', 'setting', 'participant', 'substudy', 'of', 'stop', 'gout', 'trial', 'in', 'participant', 'with', 'ckd', '.', 'ckd', 'defined', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', '-mlmin.m', 'baseline', '.', 'exposure', 'trial', 'participant', 'with', 'ckd', 'and', 'gout', 'and', 'serum', 'urate', '(', 'sua', ')', 'concentration', 'of.mgdl', 'randomized', 'to', 'receive', 'allopurinol', 'or', 'febuxostat', '.', 'urate-lowering', 'therapy', '(', 'ult', ')', 'titrated', 'week', '-', 'to', 'achieve', 'goal', 'sua', 'of.mgdl', '(', '.mgdl', 'with', 'tophus', ')', '(', 'phase', ')', 'and', 'maintained', 'week', '-', '(', 'phase', ')', '.', 'gout', 'flare', 'assessed', 'week', '-', '(', 'phase', ')', '.', 'outcome', 'gout', 'flare', 'week', '-', '(', 'phase', ')', 'primary', 'outcome', '.', 'secondary', 'outcome', 'included', 'sua', 'goal', 'achievement', 'and', 'ult', 'dosing', 'end', 'of', 'phase', ',', 'and', 'serious', 'adverse', 'event', '.', 'analytical', 'approach', 'outcome', 'treatment', 'group', 'compared', 'using', 'logistic', 'regression', 'model', 'binary', 'outcome', ',', 'and', 'poisson', 'regression', 'flare', 'rate', '.', 'multivariable', 'model', 'subsequently', 'used', ',', 'adjusting', 'factor', 'identified', 'to', 'imbalanced', 'treatment', 'arm', '.', 'result', 'ckd', 'present', 'in', 'of', 'participant', 'assessed', 'primary', 'outcome', '.', 'fewer', 'patient', 'randomized', 'to', 'allopurinol', 'flare', 'phase', '(', 'v', 'p.', ')', 'despite', 'similar', 'attainment', 'of', 'sua', 'goal', '(', 'v', 'p.', ')', 'end', 'of', 'phase', '.', 'acute', 'kidney', 'injury', 'common', 'in', 'participant', 'with', 'stage', 'ckd', 'randomized', 'to', 'allopurinol', 'compared', 'with', 'febuxostat', '.', 'limitation', 'limited', 'power', 'to', 'assess', 'infrequent', 'safety', 'event', ',', 'largely', 'male', ',', 'older', 'population', '.', 'conclusion', 'allopurinol', 'and', 'febuxostat', 'similarly', 'efficacious', 'and', 'well-tolerated', 'in', 'treatment', 'of', 'gout', 'in', 'people', 'with', 'ckd', 'used', 'in', 'treat-to-target', 'regimen', 'with', 'lower', 'incidence', 'of', 'gout', 'flare', 'in', 'participant', 'randomized', 'to', 'allopurinol', '.', 'plain-language', 'summary', 'stop', 'gout', 'trial', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'noninferiority', ',', 'comparative', 'effectiveness', 'trial', ',', 'found', 'allopurinol', 'noninferior', 'to', 'febuxostat', 'in', 'gout', 'flare', 'prevention', 'and', 'medication', 'similarly', 'efficacious', 'in', 'reaching', 'serum', 'urate', 'goal', 'used', 'part', 'of', 'treat-to-target', 'approach', '.', 'significant', 'proportion', 'of', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'afflicted', 'gout', ',', 'yet', 'lack', 'of', 'high-quality', 'comparative', 'effectiveness', 'data', 'comparing', 'allopurinol', 'and', 'febuxostat', 'in', 'patient', '.', 'evaluated', 'efficacy', 'and', 'safety', 'of', 'allopurinol', 'and', 'febuxostat', 'in', 'subgroup', 'of', 'stop', 'gout', 'trial', 'participant', 'with', 'stage', 'ckd', 'and', 'found', 'allopurinol', 'and', 'febuxostat', 'similarly', 'efficacious', 'and', 'well-tolerated', 'in', 'treatment', 'of', 'gout', 'in', 'people', 'with', 'ckd', 'used', 'in', 'treat-to-target', 'regimen', ',', 'with', 'lower', 'incidence', 'of', 'gout', 'flare', 'in', 'participant', 'randomized', 'to', 'allopurinol', '.']"
Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis.,"Kevin J Downes, Neha R Patil, Marepalli B Rao, Rajesh Koralkar, William T Harris, John P Clancy, Stuart L Goldstein, David J Askenazi, Kevin J Downeset al.",2015 Oct,Pediatr Nephrol,https://pubmed.ncbi.nlm.nih.gov/25912993/,No keywords found,"['aminoglycoside', '(', 'ag', ')', 'therapy', 'common', 'cause', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'cystic', 'fibrosis', '(', 'cf', ')', 'patient', '.', 'aim', 'of', 'study', 'to', 'identify', 'factor', 'associated', 'with', 'aki', 'intravenous', 'ag', 'course', 'in', 'population', '.', 'method', 'matched', 'case-control', 'study', 'utilizing', 'two', 'independent', 'cohort', 'of', 'hospitalized', 'cf', 'patient', 'receiving', 'day', 'of', 'intravenous', 'ag', 'cincinnati', 'child', ""'s"", 'hospital', 'medical', 'center', 'and', 'child', ""'s"", 'of', 'alabama', '.', 'admission', 'with', 'aki', '(', 'case', ',', 'n', ')', 'matched', 'to', 'two', 'randomly', 'selected', 'admission', 'without', 'aki', '(', 'control', ',', 'n', ')', 'center', ',', 'gender', ',', 'and', 'age', 'year', 'of', 'case', '.', 'aki', 'defined', '.-fold', 'increase', 'in', 'baseline', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'or', 'increase', 'in', 'scr', 'level', 'of', '.', 'mgdl', 'within', 'h.', 'admission', 'with', 'aki', 'day', 'or', 'without', 'least', 'weekly', 'scr', 'monitoring', 'excluded', 'analysis', '.', 'factor', 'compared', 'case', 'and', 'control', 'using', 'simple', 'and', 'multiple', 'conditional', 'logistic', 'regression', '.', 'result', 'multivariable', 'analysis', 'identified', 'receipt', 'of', 'ag', 'within', 'day', 'prior', 'to', 'admission', ',', 'longer', 'duration', 'of', 'ag', 'therapy', ',', 'low', 'serum', 'albumin', ',', 'and', 'receipt', 'of', 'trimethoprimsulfamethoxazole', 'independent', 'risk', 'factor', 'developing', 'aki', '.', 'infection', 'with', 'staphylococcus', 'aureus', 'diminished', 'odds', 'of', 'developing', 'aki', '.', 'conclusion', 'study', 'identifies', 'risk', 'factor', 'contributing', 'to', 'ag-associated', 'aki', 'in', 'cf', 'patient', '.', 'finding', 'used', 'to', 'anticipate', 'high-risk', 'scenario', 'and', 'limit', 'aki', 'in', 'cf', 'patient', 'clinical', 'care', '.']"
Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime.,"Henry T Quach, Adam J Esbenshade, Zhiguo Zhao, Ritu Banerjee, Henry T Quachet al.",2019 Jul,Pediatr Blood Cancer,https://pubmed.ncbi.nlm.nih.gov/30989780/,"acute kidney injury, cefepime, hematology/oncology, infections, piperacillin/tazobactam, vancomycin.","['mounting', 'evidence', 'combination', 'of', 'antibiotic', 'therapy', 'with', 'vancomycin', 'and', 'piperacillintazobactam', '(', 'piptazo', ')', 'associated', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'to', 'determine', 'whether', 'vancomycin', 'plus', 'piptazo', 'associated', 'with', 'higher', 'rate', 'of', 'aki', 'compared', 'to', 'vancomycin', 'plus', 'cefepime', 'among', 'pediatric', 'hematologyoncology', '(', 'hemeonc', ')', 'patient', ',', 'examined', 'hemeonc', 'patient', 'receiving', 'least', 'two', 'consecutive', 'day', 'of', 'therapy', 'with', 'vancomycin', 'and', 'either', 'piptazo', 'or', 'cefepime', '.', 'rate', 'of', 'aki', 'higher', 'in', 'piptazo', 'cefepime', 'group', '(', '.', 'v', '.', ',', 'p', '.', ')', '.']"
Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure.,"Wendy McCallum, Hocine Tighiouart, Jeffrey M Testani, Matthew Griffin, Marvin A Konstam, James E Udelson, Mark J Sarnak, Wendy McCallumet al.",2020 Jul,JACC Heart Fail,https://pubmed.ncbi.nlm.nih.gov/32535124/,No keywords found,"['study', 'aimed', 'to', 'examine', 'whether', 'incorporation', 'of', 'comprehensive', 'set', 'of', 'measure', 'of', 'decongestion', 'modifies', 'association', 'of', 'acute', 'decline', 'in', 'kidney', 'function', 'with', 'outcome', '.', 'background', 'in-hospital', 'acute', 'decline', 'in', 'kidney', 'function', 'occur', 'in', 'approximately', 'to', 'of', 'patient', 'admitted', 'with', 'acute', 'decompensated', 'heart', 'failure', '(', 'adhf', ')', 'and', 'may', 'associated', 'with', 'adverse', 'outcome', '.', 'method', 'using', 'data', 'everest', '(', 'efficacy', 'of', 'vasopressin', 'antagonism', 'in', 'heart', 'failure', 'outcome', 'study', 'with', 'tolvaptan', ')', ',', 'used', 'multivariable', 'cox', 'regression', 'model', 'to', 'evaluate', 'association', 'in-hospital', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'with', 'death', 'and', 'composite', 'outcome', 'of', 'cardiovascular', 'death', 'and', 'hospitalization', 'heart', 'failure', '.', 'evaluated', 'egfr', 'decline', 'within', 'context', 'of', 'change', 'in', 'marker', 'of', 'volume', 'overload', 'including', 'b-type', 'natriuretic', 'peptide', '(', 'bnp', ')', ',', 'n-terminal', 'prohormone', 'of', 'b-type', 'natriuretic', 'peptide', '(', 'nt-probnp', ')', ',', 'and', 'weight', ',', 'well', 'change', 'in', 'measure', 'of', 'hemoconcentration', 'including', 'hematocrit', ',', 'albumin', ',', 'and', 'total', 'protein', '.', 'result', 'among', ',', 'patient', 'median', 'follow-up', 'of', '.', 'month', ',', 'every', 'decline', 'in', 'egfr', 'associated', 'with', 'higher', 'risk', 'of', 'death', '(', 'hazard', 'ratio', 'hr', '.', 'confidence', 'interval', 'ci', '.', 'to', '.', ')', 'and', 'composite', 'outcome', '(', 'hr', '.', 'ci', '.', 'to', '.', ')', 'in', 'adjusted', 'model', '.', 'acute', 'decline', 'in', 'egfr', 'no', 'longer', 'associated', 'with', 'higher', 'risk', 'of', 'either', 'outcome', 'long', 'evidence', 'of', 'decongestion', ',', 'either', 'decline', 'in', 'bnp', ',', 'nt-probnp', ',', 'or', 'weight', 'or', 'increase', 'in', 'hematocrit', ',', 'albumin', 'or', 'total', 'protein', '.', 'interaction', 'testing', 'decline', 'in', 'egfr', 'and', 'change', 'in', 'hematocrit', ',', 'albumin', ',', 'and', 'total', 'protein', 'statistically', 'significant', '(', 'p', 'interaction', 'of', '.', 'death', 'and', 'p', 'interaction', 'of', '.', 'composite', 'biomarkers', ')', '.', 'interaction', 'change', 'in', 'egfr', 'and', 'change', 'in', 'bnp', '(', 'p', 'interaction', '.', 'death', 'p', 'interaction', '.', 'composite', ')', ',', 'nt-probnp', '(', 'p', 'interaction', '.', 'death', 'p', 'interaction', '.', 'composite', ')', 'and', 'weight', '(', 'p', 'interaction', '.', 'death', 'p', 'interaction', '.', 'composite', ')', 'not', 'meet', 'statistical', 'significance', '.', 'conclusion', 'overall', ',', 'acute', 'decline', 'in', 'egfr', 'associated', 'with', 'adverse', 'outcome', ',', 'with', 'evidence', 'of', 'modification', 'change', 'in', 'marker', 'of', 'decongestion', ',', 'suggesting', 'no', 'longer', 'associated', 'with', 'adverse', 'outcome', 'marker', 'concomitantly', 'improving', '.']"
The effect of dapagliflozin on renal function in patients with type 2 diabetes.,"Donald Elliott Kohan, Paola Fioretto, Kristina Johnsson, Shamik Parikh, Agata Ptaszynska, Lisa Ying, Donald Elliott Kohanet al.",2016 Jun,J Nephrol,https://pubmed.ncbi.nlm.nih.gov/26894924/,No keywords found,"['dapagliflozin', ""'s"", 'antihyperglycemic', 'effect', 'mediated', 'inhibition', 'of', 'renal', 'sodium-glucose', 'cotransporter-', 'therefore', ',', 'renal', 'safety', 'of', 'dapagliflozin', 'assessed', '.', 'method', 'twelve', 'double-blind', ',', 'placebo-controlled', ',', 'randomized', 'clinical', 'trial', 'analyzed', 'to', 'week', '(', 'n', ')', '.', 'six', 'of', 'study', 'included', 'long-term', 'data', 'to', 'week', '(', 'n', ')', '.', 'patient', 'with', 'type', 'diabetes', 'with', 'normal', 'or', 'mildly', 'impaired', 'renal', 'function', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'to', 'mlmin', '.', '(', ')', 'treated', 'with', 'dapagliflozin', '(', '.', ',', ',', 'or', 'mgday', ')', 'or', 'placebo', '.', 'renal', 'adverse', 'event', '(', 'aes', ')', 'assessed', '.', 'result', 'mean', 'egfr', 'showed', 'small', 'transient', 'reduction', 'with', 'dapagliflozin', 'week', ',', 'returned', 'to', 'near', 'baseline', 'value', 'week', 'and', 'remained', 'stable', 'to', 'week', '.', 'mean', 'egfr', 'change', 'not', 'different', 'dapagliflozin', '.', ',', 'and', 'mg', 'versus', 'placebo', 'week', '-.', ',', '.', 'and', '.', 'versus', '.', 'mlmin', '.', '(', ')', ',', 'respectively', '.', 'renal', 'aes', 'similar', 'in', 'frequency', 'to', 'placebo', 'week', '(', '.', ',', '.', ',', '.', ',', 'and', '.', ',', 'respectively', ')', 'and', 'week', '(', '.', ',', '.', ',', '.', 'and', '.', ',', 'respectively', ')', '.', 'serious', '(', '.', ',', '.', ',', 'and', '.', ',', 'respectively', ',', 'week', ')', '.', 'common', 'renal', 'event', 'serum', 'creatinine', 'increase', '.', 'in', 'sub-group', 'analysis', 'in', 'patient', 'year', 'of', 'age', 'or', 'with', 'moderate', 'renal', 'impairment', '(', 'egfr', 'to', 'mlmin', '.', '(', ')', ')', ',', 'renal', 'aes', 'occurred', 'frequently', 'with', 'dapagliflozin', 'placebo', '.', 'no', 'event', 'of', 'acute', 'tubular', 'necrosis', 'reported', '.', 'conclusion', 'in', 'patient', 'with', 'normal', 'or', 'mildly', 'impaired', 'renal', 'function', ',', 'dapagliflozin', 'not', 'associated', 'with', 'increased', 'risk', 'of', 'acute', 'renal', 'toxicity', 'or', 'deterioration', 'of', 'renal', 'function', '.', 'trial', 'included', 'in', 'analysis', 'registered', 'clinicaltrials.gov', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', ',', 'nct', '.']"
Protocol and statistical analysis plan for the REstricted fluid therapy VERsus Standard trEatment in Acute Kidney Injury-REVERSE-AKI randomized controlled pilot trial.,"Suvi T Vaara, Marlies Ostermann, Tuomas Selander, Laurent Bitker, Antoine Schneider, Elettra Poli, Eric Hoste, Michael Joannidis, Alexander Zarbock, Frank van Haren, John Prowle, Ville Pettilä, Rinaldo Bellomo, Suvi T Vaaraet al.",2020 Jul,Acta Anaesthesiol Scand,https://pubmed.ncbi.nlm.nih.gov/32022904/,No keywords found,"['fluid', 'accumulation', 'frequently', 'coexists', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'associated', 'with', 'increased', 'risk', 'aki', 'progression', 'and', 'mortality', '.', 'among', 'septic', 'shock', 'patient', ',', 'restricted', 'use', 'of', 'resuscitation', 'fluid', 'reported', 'to', 'reduce', 'risk', 'of', 'worsening', 'of', 'aki', '.', 'restrictive', 'fluid', 'therapy', ',', 'however', ',', 'not', 'studied', 'in', 'setting', 'of', 'established', 'aki', '.', ',', 'present', 'protocol', 'and', 'statistical', 'analysis', 'plan', 'of', 'restricted', 'fluid', 'therapy', 'versus', 'standard', 'treatment', 'in', 'acute', 'kidney', 'injury-the', 'reverse-aki', 'trial', 'compare', 'restrictive', 'fluid', 'therapy', 'regimen', 'to', 'standard', 'therapy', 'in', 'critically', 'ill', 'patient', 'with', 'aki', '.', 'method', 'reverse-aki', 'investigator-initiated', ',', 'multinational', ',', 'open-label', ',', 'randomized', ',', 'controlled', ',', 'feasibility', 'pilot', 'trial', 'conducted', 'in', 'seven', 'icu', 'in', 'five', 'country', '.', 'aim', 'to', 'randomize', 'critically', 'ill', 'patient', 'with', 'aki', 'to', 'restrictive', 'fluid', 'treatment', 'regimen', 'v', 'standard', 'management', '.', 'in', 'restrictive', 'fluid', 'therapy', 'regimen', ',', 'daily', 'fluid', 'balance', 'target', 'neutral', 'or', 'negative', '.', 'primary', 'outcome', 'cumulative', 'fluid', 'balance', 'assessed', 'hour', 'randomization', '.', 'secondary', 'outcome', 'include', 'safety', ',', 'feasibility', ',', 'duration', ',', 'and', 'severity', 'of', 'aki', ',', 'and', 'outcome', 'day', '(', 'mortality', 'and', 'dialysis', 'dependence', ')', '.', 'conclusion', 'first', 'multinational', 'trial', 'investigating', 'feasibility', 'and', 'safety', 'of', 'restrictive', 'fluid', 'therapy', 'regimen', 'in', 'critically', 'ill', 'patient', 'with', 'aki', '.', 'trial', 'registration', 'clinical.trials.gov', 'nct', '.']"
A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops.,"Ronald G Victor, Kathleen Lynch, Ning Li, Ciantel Blyler, Eric Muhammad, Joel Handler, Jeffrey Brettler, Mohamad Rashid, Brent Hsu, Davontae Foxx-Drew, Norma Moy, Anthony E Reid, Robert M Elashoff, Ronald G Victoret al.",2018 Apr 5,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/29527973/,No keywords found,"['uncontrolled', 'hypertension', 'major', 'problem', 'among', 'non-hispanic', 'black', 'men', ',', 'underrepresented', 'in', 'pharmacist', 'intervention', 'trial', 'in', 'traditional', 'health', 'care', 'setting', '.', 'method', 'enrolled', 'cohort', 'of', 'black', 'male', 'patron', 'with', 'systolic', 'blood', 'pressure', 'of', 'mm', 'hg', 'or', 'black-owned', 'barbershop', '(', 'nontraditional', 'health', 'care', 'setting', ')', 'in', 'cluster-randomized', 'trial', 'in', 'barbershop', 'assigned', 'to', 'pharmacist-led', 'intervention', '(', 'in', 'barber', 'encouraged', 'meeting', 'in', 'barbershop', 'with', 'specialty-trained', 'pharmacist', 'prescribed', 'drug', 'therapy', 'collaborative', 'practice', 'agreement', 'with', 'participant', 'doctor', ')', 'or', 'to', 'active', 'control', 'approach', '(', 'in', 'barber', 'encouraged', 'lifestyle', 'modification', 'and', 'doctor', 'appointment', ')', '.', 'primary', 'outcome', 'reduction', 'in', 'systolic', 'blood', 'pressure', 'month', '.', 'result', 'baseline', ',', 'mean', 'systolic', 'blood', 'pressure', '.', 'mm', 'hg', 'in', 'intervention', 'group', 'and', '.', 'mm', 'hg', 'in', 'control', 'group', '.', 'month', ',', 'mean', 'systolic', 'blood', 'pressure', 'fell', '.', 'mm', 'hg', '(', 'to', '.', 'mm', 'hg', ')', 'in', 'intervention', 'group', 'and', '.', 'mm', 'hg', '(', 'to', '.', 'mm', 'hg', ')', 'in', 'control', 'group', 'mean', 'reduction', '.', 'mm', 'hg', 'greater', 'with', 'intervention', '(', 'confidence', 'interval', ',', '.', 'to', '.', 'p.', ')', '.', 'blood-pressure', 'level', 'of', 'less', 'mm', 'hg', 'achieved', 'among', '.', 'of', 'participant', 'in', 'intervention', 'group', 'versus', '.', 'of', 'participant', 'in', 'control', 'group', '(', 'p.', ')', '.', 'in', 'intervention', 'group', ',', 'rate', 'of', 'cohort', 'retention', ',', 'and', 'adverse', 'event', '(', 'three', 'case', 'of', 'acute', 'kidney', 'injury', ')', '.', 'conclusion', 'among', 'black', 'male', 'barbershop', 'patron', 'with', 'uncontrolled', 'hypertension', ',', 'health', 'promotion', 'barber', 'resulted', 'in', 'larger', 'blood-pressure', 'reduction', 'coupled', 'with', 'medication', 'management', 'in', 'barbershop', 'specialty-trained', 'pharmacist', '.', '(', 'funded', 'national', 'heart', ',', 'lung', ',', 'and', 'blood', 'institute', 'and', 'others', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Safer Prescribing--A Trial of Education, Informatics, and Financial Incentives.","Tobias Dreischulte, Peter Donnan, Aileen Grant, Adrian Hapca, Colin McCowan, Bruce Guthrie, Tobias Dreischulteet al.",2016 Mar 17,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/26981935/,No keywords found,"['high-risk', 'prescribing', 'and', 'preventable', 'drug-related', 'complication', 'common', 'in', 'primary', 'care', '.', 'evaluated', 'whether', 'rate', 'of', 'high-risk', 'prescribing', 'primary', 'care', 'clinician', 'and', 'related', 'clinical', 'outcome', 'would', 'reduced', 'complex', 'intervention', '.', 'method', 'in', 'cluster-randomized', ',', 'stepped-wedge', 'trial', 'conducted', 'in', 'tayside', ',', 'scotland', ',', 'randomly', 'assigned', 'participating', 'primary', 'care', 'practice', 'to', 'various', 'start', 'date', '-week', 'intervention', 'comprising', 'professional', 'education', ',', 'informatics', 'to', 'facilitate', 'review', ',', 'and', 'financial', 'incentive', 'practice', 'to', 'review', 'patient', ""'"", 'chart', 'to', 'assess', 'appropriateness', '.', 'primary', 'outcome', 'patient-level', 'exposure', 'to', 'of', 'nine', 'measure', 'of', 'high-risk', 'prescribing', 'of', 'nonsteroidal', 'antiinflammatory', 'drug', '(', 'nsaid', ')', 'or', 'selected', 'antiplatelet', 'agent', '(', 'e.g.', ',', 'nsaid', 'prescription', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', 'or', 'coprescription', 'of', 'nsaid', 'and', 'oral', 'anticoagulant', 'without', 'gastroprotection', ')', '.', 'prespecified', 'secondary', 'outcome', 'included', 'incidence', 'of', 'related', 'hospital', 'admission', '.', 'analysis', 'performed', 'according', 'to', 'intention-to-treat', 'principle', ',', 'with', 'use', 'of', 'mixed-effect', 'model', 'to', 'account', 'clustering', 'in', 'data', '.', 'result', 'total', 'of', 'practice', 'underwent', 'randomization', ',', 'of', 'completed', 'study', '.', 'data', 'analyzed', ',', 'patient', 'risk', 'one', 'or', 'point', 'in', 'preintervention', 'period', 'and', ',', 'risk', 'one', 'or', 'point', 'in', 'intervention', 'period', '.', 'targeted', 'high-risk', 'prescribing', 'significantly', 'reduced', ',', 'rate', 'of', '.', '(', 'of', ',', 'patient', 'risk', ')', 'immediately', 'intervention', 'to', '.', '(', 'of', ',', ')', 'end', 'of', 'intervention', '(', 'adjusted', 'odds', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'rate', 'of', 'hospital', 'admission', 'gastrointestinal', 'ulcer', 'or', 'bleeding', 'significantly', 'reduced', 'preintervention', 'period', 'to', 'intervention', 'period', '(', '.', 'to', '.', 'admission', 'per', ',', 'person-years', 'rate', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', ',', 'rate', 'of', 'admission', 'heart', 'failure', '(', '.', 'to', '.', 'admission', 'per', ',', 'person-years', 'rate', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', ',', 'admission', 'acute', 'kidney', 'injury', 'not', '(', '.', 'and', '.', 'admission', 'per', ',', 'person-years', ',', 'respectively', 'rate', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'conclusion', 'complex', 'intervention', 'combining', 'professional', 'education', ',', 'informatics', ',', 'and', 'financial', 'incentive', 'reduced', 'rate', 'of', 'high-risk', 'prescribing', 'of', 'antiplatelet', 'medication', 'and', 'nsaid', 'and', 'may', 'improved', 'clinical', 'outcome', '.', '(', 'funded', 'scottish', 'government', 'chief', 'scientist', 'office', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.,"Rosemary N Senguttuvan, Nicole Lugo Santiago, Ernest S Han, Byrne Lee, Stephen Lee, Wei-Chien Lin, Mehdi Kebria, Amy Hakim, Jeff F Lin, Mark T Wakabayashi, Nora Ruel, Raechelle Tinsley, Melissa Eng, Daphne B Stewart, Edward W Wang, Benjamin I Paz, Xiwei Wu, Hyejin Cho, Winnie S Liang, Lorna Rodriguez-Rodriguez, Mihaela C Cristea, Mustafa Raoof, Thanh H Dellinger, Rosemary N Senguttuvanet al.",2023 Dec,Ann Surg Oncol,https://pubmed.ncbi.nlm.nih.gov/37710139/,No keywords found,"['hyperthermic', 'intraperitoneal', 'chemotherapy', '(', 'hipec', ')', 'with', 'cisplatin', 'confers', 'survival', 'benefit', 'in', 'epithelial', 'ovarian', 'cancer', '(', 'eoc', ')', 'associated', 'with', 'renal', 'toxicity', '.', 'sodium', 'thiosulfate', '(', 'st', ')', 'used', 'nephroprotection', 'hipec', 'with', 'cisplatin', ',', 'standard', 'hipec', 'practice', 'vary', '.', 'method', 'prospective', ',', 'nonrandomized', ',', 'clinical', 'trial', 'evaluated', 'safety', 'outcome', 'of', 'hipec', 'with', 'cisplatin', 'mgm', 'cytoreductive', 'surgery', '(', 'cr', ')', 'in', 'patient', 'with', 'eoc', '(', 'n', ')', 'and', 'endometrial', 'cancer', '(', 'n', ')', '.', 'twenty-one', 'patient', 'received', 'no', 'st', '(', 'nst', ')', ',', 'and', 'received', 'st.', 'adverse', 'event', '(', 'aes', ')', 'reported', 'according', 'to', 'ctcae', 'v', '...', 'serum', 'creatinine', '(', 'cr', ')', 'collected', 'preoperatively', 'and', 'postoperatively', '(', 'day', '-', ')', '.', 'progression-free', 'survival', '(', 'pfs', ')', 'followed', '.', 'normal', 'peritoneum', 'biopsied', 'and', 'hipec', 'whole', 'transcriptomic', 'sequencing', 'to', 'identify', 'rnaseq', 'signature', 'correlating', 'with', 'aes', '.', 'result', 'forty', 'patient', 'hipec', 'time', 'of', 'interval', 'or', 'secondary', 'cr', '.', 'renal', 'toxicity', 'in', 'nst', 'group', 'grade', 'ae', 'and', 'grade', 'aes', '.', 'st', 'group', 'demonstrated', 'no', 'renal', 'aes', '.', 'median', 'postoperative', 'cr', 'in', 'nst', 'group', '.', 'mgdl', 'and', '.', 'mgdl', 'in', 'st', 'group', '(', 'p', '.', ')', '.', 'median', 'change', 'in', 'cr', 'preoperative', 'to', 'postoperative', 'level', '(', 'nst', ')', 'compared', 'with', '-', '.', '(', 'st', ')', '(', 'p', '.', ')', '.', 'pfs', 'not', 'differ', 'st', 'and', 'nst', 'group', 'in', 'primary', 'or', 'recurrent', 'eoc', 'patient', '.', 'renal', 'aes', 'associated', 'with', 'downregulation', 'of', 'metabolic', 'pathway', 'and', 'upregulation', 'of', 'immune', 'pathway', '.', 'conclusion', 'st', 'significantly', 'reduces', 'acute', 'renal', 'toxicity', 'associated', 'with', 'hipec', 'with', 'cisplatin', 'in', 'ovarian', 'cancer', 'patient', '.', 'nephrotoxicity', 'high', 'in', 'hipec', 'with', 'cisplatin', ',', 'nephroprotective', 'agent', 'considered', '.']"
Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement.,"Marcus Broman, Bengt Klarin, Karin Sandin, Ola Carlsson, Anders Wieslander, Jan Sternby, Gabriela Godaly, Marcus Bromanet al.",2015 Jul-Aug,ASAIO J,https://pubmed.ncbi.nlm.nih.gov/25851312/,No keywords found,"['since', ',', 'citrate', 'anticoagulation', 'recommended', 'anticoagulation', 'strategy', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '.', 'main', 'drawback', 'using', 'citrate', 'anticoagulant', 'compared', 'with', 'heparin', 'need', 'calcium', 'replacement', 'and', 'rigorous', 'control', 'of', 'calcium', 'level', '.', 'study', 'investigated', 'possibility', 'to', 'achieve', 'anticoagulation', 'eliminating', 'need', 'calcium', 'replacement', '.', 'successfully', 'achieved', 'including', 'citrate', 'and', 'calcium', 'in', 'crrt', 'solution', '.', 'thereby', 'total', 'calcium', 'concentration', 'kept', 'constant', 'throughout', 'extracorporeal', 'circuit', ',', 'whereas', 'ionized', 'calcium', 'kept', 'low', 'level', 'enough', 'to', 'avoid', 'clotting', '.', 'completely', 'new', 'concept', ',', 'five', 'patient', 'with', 'acute', 'renal', 'failure', 'included', 'in', 'short', ',', 'prospective', ',', 'intensely', 'supervised', 'nonrandomized', 'pilot', 'study', '.', 'systemic', 'electrolyte', 'level', 'and', 'acid-base', 'parameter', 'stable', 'and', 'remained', 'within', 'physiologic', 'level', '.', 'ionized', 'calcium', 'level', 'declined', 'slightly', 'initially', 'stabilized', '.', 'mmoll', '.', 'plasma', 'citrate', 'concentration', 'stabilized', 'approximately', '.', 'mmoll', '.', 'postfilter', 'ionized', 'calcium', 'level', '.', 'mmoll', ',', ',', 'anticoagulation', 'effect', 'reached', '.', 'filter', 'pressure', 'normal', 'indicating', 'no', 'clotting', 'problem', ',', 'and', 'no', 'visible', 'clotting', 'observed', '.', 'no', 'calcium', 'replacement', 'needed', '.', 'pilot', 'study', 'suggests', 'possible', 'to', 'perform', 'regional', 'citrate', 'anticoagulation', 'without', 'need', 'separate', 'calcium', 'infusion', 'crrt', '.']"
Scintigraphic evaluation of renal functional damage in volatile substance abusers.,"Derya Cayir, Koray Demirel, Meliha Korkmaz, Mine Araz, Gokhan Koca, Derya Cayiret al.",2016 Jun,Nucl Med Commun,https://pubmed.ncbi.nlm.nih.gov/26881973/,No keywords found,"['volatile', 'organic', 'compound', 'maintained', 'easily', 'and', 'cause', 'dependency', '.', 'volatile', 'substance', 'abuse', 'may', 'cause', 'damage', 'affecting', 'several', 'system', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'renal', 'functional', 'damage', 'in', 'volatile', 'substance', 'abuser', 'diuretic', 'renogram', '.', 'method', 'twenty', 'nine', 'volatile', 'substance', 'abuser', 'and', 'young', 'healthy', 'voluntary', 'young', 'men', 'included', 'in', 'study', '.', 'technetium-m', 'mertiatide', 'diuretic', 'renogram', 'used', 'to', 'evaluate', 'renal', 'function', 'and', 'collective', 'system', 'urodynamics', 'to', 'investigate', 'progress', 'of', 'renal', 'functional', 'damage', '.', 'image', 'evaluated', 'visually', 'and', 'quantitatively', '.', 'split', 'renal', 'function', 'of', 'kidney', ',', 'time', 'to', 'peak', 'activity', '(', 'tmax', ')', ',', 'and', 'half-time', 'radiopharmaceutical', 'clearance', 'pelvicalyceal', 'system', '(', ')', ',', 'ratio', 'of', 'cortical', 'and', 'whole-kidney', 'count', '-', 'min', ',', 'and', 'maximum', 'count', '(', 'and', 'tmax', ')', 'compared', 'in', 'two', 'group', '.', 'result', 'in', 'study', 'group', ',', 'time', 'to', 'reach', 'peak', 'activity', 'statistically', 'prolonged', 'compared', 'with', 'healthy', 'volunteer', '.', 'in', 'volatile', 'substance', 'abuser', 'group', ',', 'average', 'tmax', 'value', ',', 'average', 'value', ',', 'cortical', 'and', 'whole-kidney', ',', 'and', 'tmax', 'value', 'found', 'to', 'prolonged', 'compared', 'with', 'control', 'group', 'in', 'diuretic', 'renogram', '.', 'no', 'significant', 'difference', 'in', 'split', 'renal', 'function', 'ratio', 'two', 'group', '.', 'conclusion', 'in', 'study', ',', 'possible', 'renal', 'functional', 'damage', 'evaluated', 'in', 'volatile', 'substance', 'abuser', 'diuretic', 'renogram', '.', 'in', 'conclusion', ',', 'diuretic', 'renogram', 'useful', 'in', 'evaluation', 'of', 'renal', 'functional', 'damage', 'blood', 'renal', 'function', 'test', 'affected', 'and', 'could', 'used', 'in', 'follow-up', 'of', 'disease', 'in', 'volatile', 'substance', 'abuser', '.', 'result', 'of', 'pilot', 'study', 'country', ',', 'of', 'course', ',', 'supported', 'clinical', 'study', '.']"
Effect of N-acetylcysteine against Vancomycin-Induced Nephrotoxicity: A Randomized Controlled Clinical Trial.,"Shirinsadat Badri, Rasool Soltani, Mina Sayadi, Farzin Khorvash, Mohsen Meidani, Shahram Taheri, Shirinsadat Badriet al.",2020 Jun 1,Arch Iran Med,https://pubmed.ncbi.nlm.nih.gov/32536177/,No keywords found,"['proposed', 'mechanism', 'of', 'vancomycin-induced', 'nephrotoxicity', '(', 'vin', ')', 'indirect', 'production', 'of', 'reactive', 'oxygen', 'specie', 'in', 'kidney', 'tissue', '.', 'study', 'aimed', 'to', 'investigate', 'effectiveness', 'of', 'n-acetylcysteine', '(', 'nac', ')', ',', 'anti-oxidant', 'agent', ',', 'in', 'prevention', 'of', 'vin', '.', 'method', 'patient', 'received', 'vancomycin', 'indication', 'randomly', 'divided', 'to', 'drug', '(', 'nac', ')', 'and', 'control', 'group', '.', 'patient', 'in', 'drug', 'group', 'received', 'oral', 'nac', 'mg', 'every', 'hour', 'day', ',', 'starting', 'concurrently', 'with', 'vancomycin', '.', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'and', 'blood', 'urea', 'nitrogen', '(', 'bun', ')', 'well', 'creatinine', 'clearance', '(', 'crcl', ')', 'and', '-hour', 'urine', 'volume', 'recorded', 'baseline', ',', 'every', 'day', 'study', ',', 'and', 'hour', 'last', 'dose', 'of', 'vancomycin', 'th', 'day', '.', 'furthermore', ',', 'case', 'of', 'acute', 'kidney', 'injury', '(', 'aki', '.', 'mgdl', 'or', 'least', 'increase', 'in', 'serum', 'creatinine', 'baseline', ')', 'recorded', 'in', 'two', 'group', '.', 'result', 'study', 'period', ',', 'and', 'patient', 'completed', 'study', 'in', 'drug', 'and', 'control', 'group', ',', 'respectively', '.', 'scr', 'and', 'crcl', 'significantly', 'lower', 'and', 'higher', ',', 'respectively', ',', 'all-time', 'point', '(', 'except', 'baseline', ')', 'in', 'nac', 'compared', 'to', 'control', 'group', '.', 'furthermore', ',', 'although', 'not', 'statistically', 'significant', ',', 'case', 'of', 'vancomycin-induced', 'aki', 'observed', 'in', 'control', 'group', '(', '.', ')', ',', 'case', '(', '.', ')', 'reported', 'drug', 'group', '(', 'p', '.', 'relative', 'risk', 'rr', '.', ',', 'ci', '.-.', ')', '.', 'conclusion', 'nac', 'potential', 'reduction', 'of', 'vin', '.', 'however', ',', 'study', 'necessary', 'to', 'confirm', 'effect', '.']"
Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy - the prospective-randomized MAYDAY-trial.,"Alexandra M Anker, Marc Ruewe, Lukas Prantl, Magnus Baringer, Michael T Pawlik, Florian Zeman, Ivan Goecze, Silvan M Klein, Alexandra M Ankeret al.",2024 Jul 24,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/39048691/,"Acute kidney injury, Breast neoplasms/surgery, Breast reconstruction, Fluid therapy, Intraoperative fluid management, Urinary biomarkers.","['acute', 'kidney', 'injury', '(', 'aki', ')', 'prevalence', 'in', 'surgical', 'patient', 'high', ',', 'emphasizing', 'need', 'preventative', 'measure', '.', 'study', 'address', 'insufficient', 'evidence', 'nephroprotective', 'intraoperative', 'fluid', 'resuscitation', 'and', 'highlight', 'drawback', 'of', 'relying', 'solely', 'serum', 'creatinineurine', 'output', 'to', 'monitor', 'kidney', 'function', '.', 'study', 'assessed', 'impact', 'of', 'intraoperative', 'fluid', 'management', 'aki', 'in', 'female', 'breast', 'cancer', 'patient', 'undergoing', 'autologous', 'breast', 'reconstruction', ',', 'utilizing', 'novel', 'urinary', 'biomarkers', '(', 'timp-', 'and', 'igfbp-', ')', '.', 'in', 'monocentric', 'prospective', 'randomized', 'controlled', 'trial', 'involving', 'patient', ',', 'liberal', '(', 'lfa', ')', 'and', 'restrictive', '(', 'frv', ')', 'fluid', 'management', 'strategy', 'compared', '.', 'timp-', 'and', 'igfbp-', 'biomarker', 'level', 'assessed', 'using', 'nephrocheck', '(', 'biomerieux', ',', 'france', ')', 'test', 'kit', 'preoperative', ',', 'immediate', 'postoperative', ',', 'and', '-h', 'postoperative', 'stage', '.', 'frv', 'showed', 'significantly', 'higher', 'immediate', 'postoperative', 'biomarker', 'level', ',', 'indicating', 'renal', 'tubular', 'stress', '.', 'frv', 'patient', '(', ')', 'experiencing', 'aki', 'compared', 'to', '(', ')', 'in', 'lfa', 'group', 'according', 'to', 'kdigo', 'criterion', '(', 'p', '.', ')', '.', 'restrictive', 'fluid', 'resuscitation', 'increase', 'risk', 'of', 'aki', 'in', 'surgical', 'patient', 'significantly', ',', 'emphasizing', 'necessity', 'individualized', 'hemodynamic', 'management', '.', 'finding', 'underscore', 'importance', 'of', 'urinary', 'biomarkers', 'in', 'early', 'aki', 'detection', '.']"
Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study.,"Jinlong Wang, Mengjuan Shi, Lili Huang, Qing Li, Shanshan Meng, Jingyuan Xu, Ming Xue, Jianfeng Xie, Songqiao Liu, Yingzi Huang, Jinlong Wanget al.",2022 Dec,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/35856162/,No keywords found,"['terlipressin', 'improves', 'renal', 'function', 'in', 'patient', 'with', 'septic', 'shock', '.', 'however', ',', 'mechanism', 'remains', 'unclear', '.', ',', 'aimed', 'to', 'evaluate', 'effect', 'of', 'terlipressin', 'renal', 'perfusion', 'in', 'patient', 'with', 'septic', 'shock', '.', 'material', 'and', 'method', 'pilot', 'study', 'enrolled', 'patient', 'with', 'septic', 'shock', 'in', 'intensive', 'care', 'unit', 'of', 'tertiary', 'hospital', 'september', 'to', 'may', '.', 'randomly', 'assigned', 'patient', 'to', 'terlipressin', 'and', 'usual', 'care', 'group', 'using', 'ratio', '.', 'terlipressin', 'intravenously', 'pumped', 'rate', 'of', '.', 'gkghour', 'h.', 'monitored', 'renal', 'perfusion', 'using', 'renal', 'contrast-enhanced', 'ultrasound', '(', 'ceus', ')', '.', 'primary', 'outcome', 'peak', 'sonographic', 'signal', 'intensity', '(', 'renal', 'perfusion', 'parameter', 'monitored', 'ceus', ')', 'h', 'enrollment', '.', 'result', 'patient', 'enrolled', 'in', 'study', 'with', 'in', 'terlipressin', 'group', 'and', 'in', 'usual', 'care', 'group', '.', 'baseline', 'characteristic', 'of', 'patient', 'two', 'group', 'comparable', '.', 'peak', 'sonographic', 'signal', 'intensity', 'h', 'enrollment', 'in', 'terlipressin', 'group', '(', '.', '.', 'db', ')', 'significantly', 'higher', 'in', 'usual', 'care', 'group', '(', '.', '.', 'db', 'mean', 'difference', ',', '.', 'db', 'ci', ',', '.-', '.', 'adjusted', 'p', '.', ')', '.', 'patient', 'in', 'terlipressin', 'group', 'lower', 'time', 'to', 'peak', ',', 'heart', 'rate', ',', 'norepinephrine', 'dose', ',', 'and', 'higher', 'stroke', 'volume', 'h', 'enrollment', '.', 'no', 'significant', 'difference', 'in', 'urine', 'output', 'within', 'h', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', 'within', 'day', 'found', 'two', 'group', '.', 'conclusion', 'terlipressin', 'improves', 'renal', 'perfusion', ',', 'increase', 'stroke', 'volume', ',', 'and', 'decrease', 'norepinephrine', 'dose', 'and', 'heart', 'rate', 'in', 'patient', 'with', 'septic', 'shock', '.']"
Saline versus Lactated Ringer's Solution: The Saline or Lactated Ringer's (SOLAR) Trial.,"Kamal Maheshwari, Alparslan Turan, Natalya Makarova, Chao Ma, Wael Ali Sakr Esa, Kurt Ruetzler, Sabri Barsoum, Alan G Kuhel, Michael R Ritchey, Carlos Higuera-Rueda, Tatyana Kopyeva, Luca Stocchi, Hani Essber, Barak Cohen, Iman Suleiman, Gausan R Bajracharya, David Chelnick, Edward J Mascha, Andrea Kurz, Daniel I Sessler, Kamal Maheshwariet al.",2020 Apr,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/31977517/,No keywords found,"['saline', 'and', 'lactated', 'ringer', ""'s"", 'solution', 'commonly', 'given', 'to', 'surgical', 'patient', '.', 'however', ',', 'hyperchloremic', 'acidosis', 'consequent', 'to', 'saline', 'administration', 'may', 'provoke', 'complication', '.', 'author', 'therefore', 'tested', 'primary', 'hypothesis', 'composite', 'of', 'in-hospital', 'mortality', 'and', 'major', 'postoperative', 'complication', 'less', 'common', 'in', 'patient', 'given', 'lactated', 'ringer', ""'s"", 'solution', 'normal', 'saline', '.', 'method', 'author', 'conducted', 'alternating', 'cohort', 'controlled', 'trial', 'in', 'adult', 'colorectal', 'and', 'orthopedic', 'surgery', 'given', 'either', 'lactated', 'ringer', ""'s"", 'solution', 'or', 'normal', 'saline', 'in', '-week', 'block', 'september', 'and', 'august', '.', 'primary', 'outcome', 'composite', 'of', 'in-hospital', 'mortality', 'and', 'major', 'postoperative', 'renal', ',', 'respiratory', ',', 'infectious', ',', 'and', 'hemorrhagic', 'complication', '.', 'secondary', 'outcome', 'postoperative', 'acute', 'kidney', 'injury', '.', 'result', 'among', ',', 'qualifying', 'patient', ',', ',', '(', ')', 'assigned', 'to', 'lactated', 'ringer', ""'s"", 'solution', ',', 'and', ',', '(', ')', 'assigned', 'to', 'saline', '.', 'group', 'received', 'median', '.', 'l', 'of', 'fluid', '.', 'primary', 'composite', 'of', 'major', 'complication', 'observed', 'in', '.', 'of', 'lactated', 'ringer', ""'s"", 'versus', '.', 'of', 'normal', 'saline', 'patient', ',', 'with', 'estimated', 'average', 'relative', 'risk', 'across', 'component', 'of', 'composite', 'of', '.', '(', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'secondary', 'outcome', ',', 'postoperative', 'acute', 'kidney', 'injury', ',', 'acute', 'kidney', 'injury', 'network', 'stage', 'i-iii', 'versus', ',', 'occurred', 'in', '.', 'of', 'lactated', 'ringer', ""'s"", 'patient', 'versus', '.', 'of', 'normal', 'saline', 'patient', ',', 'with', 'estimated', 'relative', 'risk', 'of', '.', '(', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ',', 'significance', 'criterion', 'of', '.', ')', '.', 'absolute', 'difference', 'treatment', 'group', 'outcome', 'less', '.', ',', 'amount', 'not', 'clinically', 'meaningful', '.', 'conclusion', 'in', 'elective', 'orthopedic', 'and', 'colorectal', 'surgery', 'patient', ',', 'no', 'clinically', 'meaningful', 'difference', 'in', 'postoperative', 'complication', 'with', 'lactated', 'ringer', ""'s"", 'or', 'saline', 'volume', 'replacement', '.', 'clinician', 'reasonably', 'use', 'either', 'solution', 'intraoperatively', '.']"
Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery.,"Tomoyuki Mizuno, Katja M Gist, Zhiqian Gao, Michael F Wempe, Jeffrey Alten, David S Cooper, Stuart L Goldstein, Alexander A Vinks, Tomoyuki Mizunoet al.",2019 Jun,Clin Pharmacokinet,https://pubmed.ncbi.nlm.nih.gov/30607889/,No keywords found,"['milrinone', 'used', 'prevention', 'of', 'low', 'cardiac', 'output', 'syndrome', 'in', 'pediatric', 'patient', 'cardiac', 'surgery', '.', 'milrinone', 'mainly', 'eliminated', 'kidney', 'however', ',', 'limited', 'information', 'milrinone', 'pharmacokinetics', 'in', 'infant', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'aim', 'of', 'study', 'to', 'develop', 'milrinone', 'population', 'pharmacokinetic', 'model', 'in', 'neonate', 'and', 'infant', 'with', 'or', 'without', 'aki', '.', 'developed', 'milrinone', 'pharmacokinetic', 'model', 'utilized', 'monte', 'carlo', 'simulation', 'analysis', 'to', 'identify', 'age-appropriate', 'dosing', 'regimen', 'in', 'neonate', 'and', 'infant', '.', 'method', 'population', 'pharmacokinetic', 'analysis', 'performed', 'with', 'total', 'of', 'serum', 'milrinone', 'concentration', 'obtained', 'infant', 'part', 'of', 'prospective', 'clinical', 'study', 'in', 'neonate', 'and', 'infant', 'following', 'cardiac', 'surgery', '(', 'clinicaltrials.gov', 'identifier', 'nct', ')', '.', 'aki', 'stage', 'determined', 'based', 'kidney', 'injury', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'clinical', 'practice', 'guideline', 'within', 'first', 'three', 'postoperative', 'day', '.', 'result', 'two-compartment', 'model', 'found', 'to', 'adequately', 'describe', 'pharmacokinetic', 'data', '.', 'allometrically', 'scaled', 'body', 'weight', ',', 'aki', 'stage', ',', 'and', 'maturation', 'function', 'identified', 'significant', 'predictor', 'of', 'milrinone', 'clearance', '.', 'proposed', 'dosing', 'regimen', 'milrinone', 'continuous', 'infusion', 'determined', 'based', 'target', 'concentration', 'attainment', 'of', 'simulated', 'steady-state', 'concentration', 'and', 'covered', 'three', 'age', 'group', 'across', '-', 'month', 'of', 'age', 'aki', 'stage', '.', 'conclusion', 'study', 'provides', 'milrinone', 'population', 'pharmacokinetic', 'model', 'in', 'neonate', 'and', 'infant', 'and', 'capture', 'developmental', 'change', 'in', 'clearance', '.', 'age-appropriate', 'dosing', 'regimen', 'determined', 'based', 'simulation', 'analysis', 'with', 'developed', 'pharmacokinetic', 'model', '.', 'finding', 'facilitate', 'model-informed', 'precision', 'dosing', 'of', 'milrinone', 'in', 'infant', 'with', 'or', 'without', 'aki', '.']"
Oral hydration compared to intravenous hydration in the prevention of post-contrast acute kidney injury in patients with chronic kidney disease stage IIIb: A phase III non-inferiority study (NICIR study).,"Carmen Sebastià, Alfredo Páez-Carpio, Elena Guillen, Blanca Paño, David Garcia-Cinca, Esteban Poch, Laura Oleaga, Carlos Nicolau, Carmen Sebastiàet al.",2021 Mar:136:109509.,Eur J Radiol,https://pubmed.ncbi.nlm.nih.gov/33516141/,No keywords found,"['to', 'evaluate', 'non-inferiority', 'of', 'oral', 'hydration', 'compared', 'to', 'intravenous', '(', 'i.v', '.', ')', 'hydration', 'in', 'prevention', 'of', 'post-contrast', 'acute', 'kidney', 'injury', '(', 'pc-aki', ')', 'in', 'patient', 'with', 'stage', 'iiib', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'referred', 'elective', 'contrast-enhanced', 'computed', 'tomography', '(', 'ce-ct', ')', '.', 'material', 'and', 'method', 'prospective', ',', 'randomized', ',', 'phase', ',', 'parallel-group', ',', 'open-label', ',', 'non-inferiority', 'trial', '.', 'patient', 'randomly', 'assigned', 'to', 'receive', 'prophylaxis', 'pc-aki', 'either', 'with', 'oral', 'hydration', 'ml', 'of', 'water', 'two', 'hour', 'and', 'ml', 'h', 'performing', 'ce-ct', 'or', 'i.v', '.', 'hydration', 'sodium', 'bicarbonate', '(', 'mmoll', ')', 'mlkgh', 'starting', 'one', 'hour', 'and', 'sodium', 'bicarbonate', '(', 'mmoll', ')', 'mlkgh', 'first', 'hour', 'ce-ct.', 'ml', 'of', 'non-ionic', 'iodinated', 'contrast', 'administered', 'in', 'case', '.', 'primary', 'outcome', 'proportion', 'of', 'pc-aki', 'in', 'first', '-', 'h', 'ce-ct.', 'secondary', 'outcome', 'persistent', 'pc-aki', ',', 'need', 'hemodialysis', ',', 'and', 'occurrence', 'of', 'adverse', 'event', 'related', 'to', 'prophylaxis', '.', 'result', 'of', 'patient', 'randomized', 'january', 'and', 'january', ',', 'received', 'oral', 'hydration', ',', 'and', 'received', 'i.v', '.', 'hydration', 'and', 'evaluable', '.', 'no', 'significant', 'difference', 'found', '(', 'p', '.', ')', 'arm', 'in', 'clinical', 'characteristic', 'or', 'risk', 'factor', '.', 'pc-aki', 'rate', '.', '(', 'ci', '.-', '.', ')', 'in', 'oral', 'hydration', 'arm', 'and', '.', '(', 'ci', '.-', '.', ')', 'in', 'i.v', '.', 'hydration', 'arm', '.', 'persistent', 'pc-aki', 'rate', '.', '(', 'ci', '.-', '.', ')', 'in', 'arm', '.', 'no', 'patient', 'required', 'dialysis', 'first', 'month', 'ce-ct', 'or', 'adverse', 'effect', 'related', 'to', 'hydration', 'regime', '.', 'conclusion', 'in', 'with', 'stage', 'iiib', 'ckd', 'referred', 'elective', 'ce-ct', ',', 'provide', 'evidence', 'of', 'non-inferiority', 'of', 'oral', 'hydration', 'compared', 'to', 'i.v', '.', 'hydration', 'in', 'prevention', 'of', 'pc-aki', '.']"
Candidate Kidney Protective Strategies for Patients Undergoing Major Abdominal Surgery: A Secondary Analysis of the RELIEF Trial Cohort.,"David R McIlroy, Xiaoke Feng, Matthew Shotwell, Sophia Wallace, Rinaldo Bellomo, Amit X Garg, Kate Leslie, Philip Peyton, David Story, Paul S Myles, David R McIlroyet al.",2024 Jun 1,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/38381960/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'major', 'abdominal', 'surgery', '.', 'selection', 'of', 'candidate', 'kidney', 'protective', 'strategy', 'testing', 'in', 'large', 'trial', 'based', 'robust', 'preliminary', 'evidence', '.', 'method', 'secondary', 'analysis', 'of', 'restrictive', 'versus', 'liberal', 'fluid', 'therapy', 'in', 'major', 'abdominal', 'surgery', '(', 'relief', ')', 'trial', 'conducted', 'in', 'adult', 'patient', 'undergoing', 'major', 'abdominal', 'surgery', 'and', 'randomly', 'assigned', 'to', 'restrictive', 'or', 'liberal', 'perioperative', 'fluid', 'regimen', '.', 'primary', 'outcome', 'maximum', 'aki', 'stage', 'hospital', 'discharge', '.', 'two', 'multivariable', 'ordinal', 'regression', 'model', 'developed', 'to', 'test', 'primary', 'hypothesis', 'modifiable', 'risk', 'factor', 'associated', 'with', 'increased', 'maximum', 'stage', 'of', 'postoperative', 'aki', 'could', 'identified', '.', 'model', 'used', 'separate', 'approach', 'to', 'variable', 'selection', 'to', 'assess', 'sensitivity', 'of', 'finding', 'to', 'modeling', 'approach', '.', 'model', ',', 'variable', 'selection', 'informed', 'investigator', 'opinion', 'model', ',', 'least', 'absolute', 'shrinkage', 'and', 'selection', 'operator', '(', 'lasso', ')', 'technique', 'used', 'to', 'develop', 'data-driven', 'model', 'available', 'variable', '.', 'result', 'of', ',', 'patient', 'analyzed', ',', 'stage', ',', ',', 'and', 'aki', 'occurred', 'in', '(', '.', ')', ',', '(', '.', ')', ',', 'and', '(', '.', ')', 'patient', ',', 'respectively', '.', 'in', 'multivariable', 'modeling', 'model', ',', 'administration', 'of', 'nonsteroidal', 'anti-inflammatory', 'drug', 'or', 'cyclooxygenase-', 'inhibitor', ',', 'intraoperatively', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', ',', 'and', 'preoperative', 'day-of-surgery', 'administration', 'of', 'angiotensin-converting', 'enzyme', 'inhibitor', 'or', 'angiotensin', 'receptor', 'blocker', 'compared', 'to', 'no', 'regular', 'use', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', 'associated', 'with', 'increased', 'odds', 'greater', 'maximum', 'stage', 'aki', '.', 'result', 'unchanged', 'in', 'model', ',', 'with', 'additional', 'finding', 'of', 'inverse', 'association', 'nadir', 'hemoglobin', 'concentration', 'postoperative', 'day', 'and', 'greater', 'maximum', 'stage', 'aki', '.', 'conclusion', 'avoiding', 'intraoperative', 'nonsteroidal', 'anti-inflammatory', 'drug', 'or', 'cyclooxygenase-', 'inhibitor', 'potential', 'strategy', 'to', 'mitigate', 'risk', 'postoperative', 'aki', '.', 'finding', 'strengthen', 'rationale', 'clinical', 'trial', 'comprehensively', 'testing', 'risk-benefit', 'ratio', 'of', 'drug', 'in', 'perioperative', 'period', '.']"
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.,"Kazuma Oyama, Itamar Raz, Avivit Cahn, Erica L Goodrich, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Ingrid A M Gause-Nilsson, Ofri Mosenzon, Marc S Sabatine, Stephen D Wiviott, Kazuma Oyamaet al.",2022 Sep 1,JAMA Cardiol,https://pubmed.ncbi.nlm.nih.gov/35857296/,No keywords found,"['dapagliflozin', 'shown', 'to', 'reduce', 'cardiovascular', '(', 'cv', ')', 'and', 'kidney', 'outcome', 'in', 'patient', 'with', 'type', 'diabetes', '.', 'however', ',', 'data', 'limited', 'relationship', 'of', 'effect', 'and', 'safety', 'with', 'concurrent', 'use', 'of', 'cv', 'medication', 'in', 'patient', 'with', 'type', 'diabetes', '.', 'objective', 'to', 'assess', 'whether', 'cardiorenal', 'efficacy', 'and', 'safety', 'of', 'dapagliflozin', 'consistent', 'with', 'and', 'without', 'background', 'use', 'of', 'cv', 'medication', 'commonly', 'used', 'heart', 'failure', '(', 'hf', ')', 'and', 'kidney', 'disease', 'in', 'patient', 'with', 'type', 'diabetes', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'study', 'prespecified', 'secondary', 'analysis', 'of', 'declare-timi', ',', 'randomized', 'trial', 'of', 'dapagliflozin', 'v', 'placebo', 'in', 'patient', 'with', 'type', 'diabetes', 'and', 'either', 'atherosclerotic', 'disease', 'or', 'multiple', 'risk', 'factor', 'cv', 'disease', '.', 'patient', 'stratified', 'baseline', 'use', 'of', 'following', 'cv', 'medication', 'angiotensin-converting', 'enzyme', 'inhibitor', 'or', 'angiotensin-receptor', 'blocker', '(', 'aceiarbs', ')', ',', '-blockers', ',', 'diuretic', ',', 'and', 'mineralocorticoid', 'receptor', 'antagonist', '(', 'mras', ')', '.', 'study', 'conducted', 'may', 'to', 'september', ',', 'and', 'data', 'evaluated', 'analysis', 'february', 'to', 'may', '.', 'intervention', 'dapagliflozin', 'or', 'placebo', '.', 'main', 'outcome', 'and', 'measure', 'outcome', 'of', 'interest', 'composite', 'of', 'cv', 'death', 'or', 'hospitalization', 'hf', '(', 'hhf', ')', ',', 'hhf', 'alone', ',', 'and', 'kidney-specific', 'composite', 'outcome', '(', 'persistent', 'decrease', 'in', 'estimated', 'glomerular', 'filtration', 'rate', 'egfr', ',', 'end-stage', 'kidney', 'disease', ',', 'or', 'kidney-related', 'death', ')', '.', 'result', 'among', 'patient', ',', '(', ')', 'used', 'aceiarbs', ',', '(', ')', 'used', '-blockers', ',', '(', ')', 'used', 'diuretic', ',', 'and', '(', ')', 'used', 'mras', 'baseline', '.', 'change', 'in', 'blood', 'pressure', 'and', 'egfr', 'month', 'with', 'dapagliflozin', 'compared', 'with', 'placebo', 'not', 'differ', 'regardless', 'of', 'concurrent', 'therapy', '(', 'placebo-corrected', 'change', ',', '-', '.', 'mm', 'hg', 'ci', ',', '-', '.', 'to', '.', 'to', '-', '.', 'mm', 'hg', 'ci', ',', '-', '.', 'to', '-', '.', 'p', '.', 'interaction', ')', '.', 'dapagliflozin', 'consistently', 'reduced', 'risk', 'of', 'cv', 'deathhhf', ',', 'hhf', 'alone', ',', 'and', 'kidney-specific', 'composite', 'outcome', 'regardless', 'of', 'background', 'use', 'of', 'selected', 'medication', '(', 'hazard', 'ratio', 'hr', 'range', 'hr', ',', '.', 'ci', ',', '.-', '.', 'to', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p', '.', 'interaction', ')', '.', 'in', 'patient', 'receiving', 'aceiarbs', '-blockers', 'diuretic', '(', 'n', ')', ',', 'dapagliflozin', 'reduced', 'risk', 'of', 'cv', 'deathhhf', 'and', 'of', 'kidney-specific', 'outcome', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', 'and', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'respectively', '.', 'no', 'significant', 'treatment', 'interaction', 'with', 'concomitant', 'cv', 'medication', 'adverse', 'event', 'of', 'volume', 'depletion', ',', 'acute', 'kidney', 'injury', ',', 'or', 'hyperkalemia', '(', 'range', 'hr', ',', '.', 'ci', ',', '.-', '.', 'to', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p', '.', 'interaction', ')', '.', 'conclusion', 'and', 'relevance', 'dapagliflozin', 'consistently', 'reduced', 'risk', 'of', 'cv', 'and', 'kidney', 'outcome', 'irrespective', 'of', 'background', 'use', 'of', 'various', 'cv', 'medication', 'without', 'treatment', 'interaction', 'key', 'safety', 'event', '.', 'data', 'show', 'clinical', 'benefit', 'and', 'safety', 'of', 'dapagliflozin', 'in', 'broad', 'range', 'of', 'patient', 'with', 'type', 'diabetes', 'regardless', 'of', 'background', 'therapy', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
"Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study.","Giuseppe Curigliano, Miguel Martin, Komal Jhaveri, J T Beck, Giampaolo Tortora, Nicola Fazio, Michela Maur, Richard A Hubner, Harald Lahner, Valerie Donnet, Olga Ajipa, Zheng Li, Lars Blumenstein, Fabrice Andre, Giuseppe Curiglianoet al.",2021 Jul:151:49-62.,Eur J Cancer,https://pubmed.ncbi.nlm.nih.gov/33964572/,No keywords found,"['combined', 'mtorc', 'inhibition', 'with', 'everolimus', '(', 'eve', ')', 'and', 'phosphatidylinositol', '-kinase', 'catalytic', 'subunit', 'p', 'blockade', 'with', 'alpelisib', '(', 'alp', ')', 'demonstrated', 'synergistic', 'efficacy', 'in', 'preclinical', 'model', 'and', 'support', 'testing', 'combination', 'of', 'alp', 'and', 'eve', 'in', 'clinical', 'setting', '.', 'primary', 'objective', 'to', 'determine', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'recommended', 'dose', 'expansion', '(', 'rde', ')', 'of', 'alp', 'in', 'combination', 'with', 'eve', 'and', 'in', 'combination', 'with', 'eve', 'and', 'exemestane', '(', 'exe', ')', 'and', 'subsequently', 'assess', 'safety', ',', 'preliminary', 'efficacy', 'and', 'effect', 'of', 'alp', 'pharmacokinetics', 'of', 'eve', 'and', 'determine', 'magnitude', 'of', 'drug-drug', 'interaction', '.', 'patient', 'and', 'method', 'dose', 'escalation', 'phase', 'conducted', 'in', 'patient', 'with', 'advanced', 'solid', 'tumour', 'and', 'in', 'postmenopausal', 'woman', 'with', 'hormone', 'receptor-positive', '(', 'hr', ')', ',', 'human', 'epidermal', 'growth', 'factor', 'receptor', '-negative', '(', 'her-', ')', 'advanced', 'breast', 'cancer', '(', 'abc', ')', '.', 'dose', 'expansion', 'phase', 'conducted', 'in', 'patient', 'with', 'pancreatic', 'neuroendocrine', 'tumour', 'and', 'renal', 'cell', 'carcinoma', '(', 'rcc', ')', '(', 'mechanistic', 'target', 'of', 'rapamycin', 'inhibitor', 'mtori-naive', ')', ',', 'in', 'patient', 'with', 'mtori-pretreated', 'solid', 'tumour', 'and', 'in', 'postmenopausal', 'woman', 'with', 'hr', ',', 'her-', 'abc', '.', 'result', 'doublet', 'escalation', 'phase', ',', 'dose-limiting', 'toxicity', '(', 'dlts', ')', 'reported', 'in', 'of', '(', ')', 'patient', 'one', 'patient', 'grade', '(', 'gr', ')', 'hyperglycemia', 'and', 'one', 'patient', 'gr', 'diarrhoea', 'in', 'mg', 'dose', 'group', ',', 'one', 'patient', 'gr', 'hyperglycemia', 'and', 'one', 'patient', 'gr', 'hypocalcaemia', 'in', 'mg', 'dose', 'group', ',', 'and', 'one', 'patient', 'in', 'mg', 'dose', 'group', 'gr', 'diarrhoea', 'and', 'gr', 'stomatitis', '.', 'combination', 'of', 'alp', 'mg', 'eve', '.', 'mg', 'declared', 'mtdrde', 'in', 'subject', 'with', 'advanced', 'solid', 'tumour', '.', 'in', 'triplet', 'escalation', 'phase', ',', 'one', 'patient', 'received', 'alp', 'mg', 'eve', '.', 'mg', 'exe', 'mg', 'dlt', 'of', 'gr', 'acute', 'kidney', 'injury', '.', 'dose', 'combination', 'declared', 'mtd', 'and', 'rde', 'in', 'subject', 'with', 'advanced', 'hr-positive', 'her-negative', 'bc', '.', 'common', 'adverse', 'event', '(', 'patient', ')', ',', 'occurring', 'across', 'phase', ',', 'hyperglycaemia', ',', 'stomatitis', ',', 'diarrhoea', ',', 'nausea', ',', 'asthenia', ',', 'decreased', 'appetite', 'and', 'fatigue', '.', 'sixteen-week', 'progression-free', 'survival', 'rate', '.', '(', 'confidence', 'interval', 'ci', '.', ',', '.', ')', 'in', 'rcc', 'cohort', ',', '.', '(', 'ci', '.', ',', '.', ')', 'in', 'prior', 'pnet', 'cohort', 'and', '.', '(', 'ci', '.', ',', '.', ')', 'in', 'prior', 'mtori', 'cohort', '.', 'pharmacokinetics', 'of', '.', 'mg', 'of', 'eve', 'largely', 'unchanged', 'in', 'presence', 'of', 'alp', ',', 'independent', 'of', 'dose', '(', 'mg', 'or', 'mg', ')', '.', 'no', 'clinically', 'relevant', 'drug-drug', 'interaction', 'observed', 'alp', 'and', 'eve', '.', 'conclusion', 'overall', 'safety', 'profile', 'of', 'alp', 'with', 'eve', 'and', 'exe', 'manageable', 'and', 'reversible', 'no', 'unexpected', 'safety', 'signal', 'noted', 'compared', 'with', 'individual', 'safety', 'profile', '.', 'pharmacokinetics', 'of', 'alp', ',', 'eve', 'and', 'exe', 'largely', 'unchanged', 'in', 'combination', 'with', '.']"
Theophylline Population Pharmacokinetics and Dosing in Children Following Congenital Heart Surgery With Cardiopulmonary Bypass.,"Adam Frymoyer, Felice Su, Paul C Grimm, Scott M Sutherland, David M Axelrod, Adam Frymoyeret al.",2016 Sep,J Clin Pharmacol,https://pubmed.ncbi.nlm.nih.gov/26712558/,"acute kidney injury, aminophylline, congenital heart defect, pediatric, pharmacokinetics.","['child', 'undergoing', 'cardiac', 'surgery', 'requiring', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'frequently', 'develop', 'acute', 'kidney', 'injury', 'due', 'to', 'renal', 'ischemia', '.', 'theophylline', ',', 'improves', 'renal', 'perfusion', 'via', 'adenosine', 'receptor', 'inhibition', ',', 'potential', 'targeted', 'therapy', '.', 'however', ',', 'child', 'undergoing', 'cardiac', 'surgery', 'and', 'cpb', 'commonly', 'alteration', 'in', 'drug', 'pharmacokinetics', '.', 'to', 'help', 'understand', 'optimal', 'aminophylline', '(', 'salt', 'formulation', 'of', 'theophylline', ')', 'dosing', 'strategy', 'in', 'population', ',', 'population-based', 'pharmacokinetic', 'model', 'developed', 'using', 'nonlinear', 'mixed-effects', 'modeling', '(', 'nonmem', ')', 'child', '(', 'median', 'age', 'month', 'range', 'week', 'to', 'year', ')', 'underwent', 'cardiac', 'surgery', 'requiring', 'cpb', 'and', 'received', 'aminophylline', 'part', 'of', 'previous', 'randomized', 'controlled', 'trial', '.', '-compartment', 'model', 'with', 'linear', 'elimination', 'adequately', 'described', 'pharmacokinetics', 'of', 'theophylline', '.', 'weight', 'scaled', 'via', 'allometry', 'significant', 'predictor', 'of', 'clearance', 'and', 'volume', '.', 'in', 'addition', ',', 'allometric', 'scaled', 'clearance', 'increased', 'with', 'age', 'implemented', 'power', 'maturation', 'function', '.', 'compared', 'to', 'prior', 'report', 'in', 'noncardiac', 'child', ',', 'theophylline', 'clearance', 'markedly', 'reduced', 'across', 'age', '.', 'in', 'final', 'population', 'pharmacokinetic', 'model', ',', 'optimized', 'empiric', 'dosing', 'regimen', 'developed', 'via', 'monte', 'carlo', 'simulation', '.', 'dos', 'to', 'lower', 'recommended', 'in', 'noncardiac', 'child', 'needed', 'to', 'achieve', 'target', 'serum', 'concentration', 'of', 'to', 'mgl', '.']"
Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial.,"Gaerolwe Masheto, Sean S Brummel, Lauren Ziemba, John Shepherd, Tapiwa Mbengeranwa, Laarni Igawa, Anne Coletti, Dorinda Mukura, Lindie Rossouw, Gerhard Theron, Chelsea Krotje, Patrick Jean-Philippe, Nahida Chakhtoura, Haseena Cassim, Sisinyana Ruth Mathiba, Joel Maena, William Murtaugh, Lee Fairlie, Judith Currier, Risa Hoffman, Lameck Chinula, Paul E Sax, Lynda Stranix-Chibanda, Shahin Lockman                                                                                                                        ;, IMPAACT /VESTED Study Team and Investigators, Gaerolwe Mashetoet al.",2024 Oct 1,J Acquir Immune Defic Syndr,https://pubmed.ncbi.nlm.nih.gov/39250651/,No keywords found,"['safety', 'data', 'randomized', 'trial', 'of', 'antiretrovirals', 'in', 'pregnancy', 'scarce', '.', 'evaluated', 'maternal', 'bone', 'and', 'renal', 'data', 'international', 'maternal', 'pediatric', 'adolescent', 'aid', 'clinical', 'trial', 'network', 'trial', ',', 'compared', 'safety', 'and', 'efficacy', 'of', 'antiretroviral', 'therapy', 'regimen', 'started', 'in', 'pregnancy', 'dolutegravir', 'emtricitabinetenofovir', 'alafenamide', '(', 'dtg', 'ftctaf', ')', ',', 'dolutegravir', 'emtricitabinetenofovir', 'disoproxil', 'fumarate', '(', 'dtg', 'ftctdf', ')', ',', 'and', 'efavirenzemtricitabinetenofovir', 'disoproxil', 'fumarate', '(', 'efvftctdf', ')', '.', 'method', 'subset', 'of', 'participant', 'underwent', 'dual-energy', 'x-ray', 'absorptiometry', 'scan', 'postpartum', 'week', '.', 'maternal', 'bone', 'mineral', 'density', '(', 'bmd', ')', 'z-scores', 'compared', 'arm', '.', 'maternal', 'creatinine', 'measured', 'enrolment', 'and', 'periodically', 'week', 'postpartum', ',', 'and', 'by-arm', 'difference', 'in', 'average', 'weekly', 'change', 'in', 'estimated', 'creatinine', 'clearance', 'compared', '.', 'result', 'six', 'hundred', 'forty-three', 'participant', 'randomized', 'to', 'dtg', 'ftctaf', '(', 'n', ')', 'or', 'dtg', 'ftctdf', '(', 'n', ')', 'or', 'efvftctdf', '(', 'n', ')', '.', 'median', 'age', 'year', '(', 'iqr', ',', ')', ',', 'median', 'cd', 'count', 'cellsmm', '(', 'iqr', ',', ')', '(', ')', 'woman', 'enrolled', 'in', 'africa', 'and', '(', ')', 'breastfed', '.', 'week', 'postpartum', 'dual-energy', 'x-ray', 'absorptiometry', 'result', 'woman', 'included', 'in', 'analysis', '.', 'hip', 'and', 'spine', 'bmd', 'average', 'higher', 'in', 'woman', 'in', 'dtg', 'ftctaf', 'and', 'lower', 'in', 'dtg', 'ftctdf', 'and', 'efvftctdf', 'arm', ',', 'no', 'significant', 'difference', 'in', 'bmd', 'z-scores', 'observed', 'treatment', 'group', '.', 'weekly', 'rate', 'of', 'change', 'in', 'estimated', 'creatinine', 'clearance', 'differed', 'among', 'treatment', 'group', 'antepartum', 'period', ',', 'not', 'full', 'study', 'follow-up', '.', 'conclusion', 'marker', 'of', 'bone', 'and', 'renal', 'toxicity', 'not', 'differ', 'significantly', 'week', 'postpartum', 'among', 'woman', 'randomized', 'to', 'start', 'dtg', 'ftctaf', 'or', 'dtg', 'ftctdf', 'or', 'efvftctdf', 'in', 'pregnancy', '.']"
Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.,"Jigar V Desai#, Amanda Urban#, Doris Z Swaim, Benjamin Colton, Lilian W Kibathi, Elise M N Ferrè, Pamela Stratton, Melissa A Merideth, Sally Hunsberger, Theresa Matkovits, Raphael Mannino, Steven M Holland, Edmund Tramont, Michail S Lionakis#, Alexandra F Freeman#, Jigar V Desaiet al.",2022 Jul 19,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/35699443/,"amphotericin B, chronic mucocutaneous candidiasis, cochleated, mouse model, mucosal candidiasis, phase 2 trial.","['candida', 'albicans', 'cause', 'debilitating', ',', 'often', 'azole-resistant', ',', 'infection', 'in', 'patient', 'with', 'chronic', 'mucocutaneous', 'candidiasis', '(', 'cmc', ')', '.', 'amphotericin', 'b', '(', 'amb', ')', 'resistance', 'rare', ',', 'amb', 'use', 'limited', 'parenteral', 'administration', 'and', 'nephrotoxicity', '.', 'in', 'study', ',', 'evaluated', 'cochleated', 'amb', '(', 'camb', ')', ',', 'new', 'oral', 'amb', 'formulation', ',', 'in', 'mouse', 'model', 'of', 'oropharyngeal', 'candidiasis', '(', 'opc', ')', 'and', 'vulvovaginal', 'candidiasis', '(', 'vvc', ')', 'and', 'in', 'patient', 'with', 'azole-resistant', 'cmc', '.', 'opc', 'and', 'vvc', 'modeled', 'in', 'act', '--', 'mouse', ',', 'and', 'mucosal', 'tissue', 'fungal', 'burden', 'assessed', 'once-daily', 'treatment', 'with', 'camb', ',', 'vehicle', ',', 'or', 'amb-deoxycholate', '(', 'amb-d', ')', '.', 'four', 'patient', 'with', 'azole-resistant', 'cmc', 'enrolled', 'in', 'phase', 'camb', 'dose-escalation', 'study', '.', 'primary', 'endpoint', 'clinical', 'improvement', 'week', 'followed', 'optional', 'extension', 'long-term', 'cmc', 'suppression', 'to', 'assess', 'safety', 'and', 'efficacy', '.', 'camb-treated', 'mouse', 'significantly', 'reduced', 'tongue', 'and', 'vaginal', 'fungal', 'burden', 'compared', 'to', 'vehicle-treated', 'mouse', 'and', 'exhibited', 'comparable', 'fungal', 'burden', 'reduction', 'relative', 'to', 'amb-d-treated', 'mouse', '.', 'camb-treated', 'patient', 'reached', 'clinical', 'efficacy', 'week', ',', 'three', 'mg', 'twice', 'daily', 'and', 'one', 'mg', 'twice-daily', 'dosing', '.', 'patient', 'continued', 'to', 'extension', 'phase', ',', 'with', 'three', 'sustained', 'clinical', 'improvement', 'of', 'opc', 'and', 'esophageal', 'candidiasis', '(', 'ec', ')', 'to', 'month', '.', 'one', 'patient', 'relapse', 'of', 'esophageal', 'symptom', 'week', 'and', 'withdrawn', 'study', '.', 'clinical', 'response', 'not', 'seen', 'onychomycosis', 'or', 'vvc', '.', 'camb', 'safe', 'and', 'well-tolerated', ',', 'without', 'evidence', 'of', 'nephrotoxicity', '.', 'in', 'summary', ',', 'oral', 'camb', 'reduced', 'tongue', 'and', 'vaginal', 'fungal', 'burden', 'murine', 'candidiasis', '.', 'proof-of-concept', 'clinical', 'trial', 'in', 'human', 'cmc', 'showed', 'efficacy', 'with', 'good', 'tolerability', 'and', 'safety', '.', 'study', 'registered', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery.,"Jin Sun Cho, Jae-Kwang Shim, Sara Soh, Min Kyung Kim, Young-Lan Kwak, Jin Sun Choet al.",2016 Mar,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/26444030/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'following', 'cardiac', 'surgery', 'closely', 'interrelated', 'with', 'hemodynamic', 'instability', 'and', 'sympathetic', 'activity', ',', 'and', 'adversely', 'influence', 'prognosis', '.', ',', 'investigated', 'in', 'randomized', 'placebo-controlled', 'trial', 'whether', 'dexmedetomidine', ',', 'adrenoreceptor', 'agonist', ',', 'could', 'prevent', 'aki', 'valvular', 'heart', 'surgery', '.', 'two', 'hundred', 'patient', 'undergoing', 'valvular', 'heart', 'surgery', 'randomly', 'assigned', 'to', 'equal', 'placebo', 'or', 'treatment', 'group', '.', 'dexmedetomidine', 'infused', 'rate', 'of', '.', 'gkgh', 'starting', 'immediately', 'anesthetic', 'induction', 'and', 'continuing', 'h', 'surgery', '.', 'assessed', 'incidence', 'of', 'aki', 'first', 'postoperative', 'hour', ',', 'hemodynamic', 'variable', ',', 'and', 'composite', 'of', 'major', 'morbidity', 'end', 'point', '.', 'incidence', 'of', 'aki', ',', 'based', 'acute', 'kidney', 'injury', 'network', 'criterion', ',', 'significantly', 'lower', 'in', 'treatment', 'group', 'compared', 'with', 'control', 'group', '(', 'vs.', ')', '.', 'dexmedetomidine', 'group', 'exhibited', 'significantly', 'lower', 'incidence', 'of', 'composite', 'of', 'major', 'morbidity', 'end', 'point', '(', 'vs.', ')', 'and', 'significantly', 'shorter', 'length', 'of', 'intensive', 'care', 'unit', 'stay', '(', ',', 'day', 'vs.', ',', 'day', ')', 'compared', 'with', 'control', 'group', '.', 'thus', ',', 'perioperative', 'infusion', 'of', 'dexmedetomidine', 'effectively', 'reduced', 'incidence', 'and', 'severity', 'of', 'aki', ',', 'and', 'improved', 'outcome', 'in', 'patient', 'undergoing', 'valvular', 'heart', 'surgery', 'without', 'untoward', 'hemodynamic', 'side', 'effect', '.']"
Effect of Saline vs Gluconate/Acetate-Buffered Solution vs Lactate-Buffered Solution on Serum Chloride Among Children in the Pediatric Intensive Care Unit: The SPLYT-P Randomized Clinical Trial.,"Sainath Raman, Kristen S Gibbons, Adrian Mattke, Andreas Schibler, Peter Trnka, Melanie Kennedy, Renate Le Marsney, Luregn J Schlapbach, Sainath Ramanet al.",2023 Feb 1,JAMA Pediatr,https://pubmed.ncbi.nlm.nih.gov/36534387/,No keywords found,"['child', 'admitted', 'to', 'pediatric', 'intensive', 'care', 'unit', '(', 'picus', ')', 'receive', 'intravenous', 'fluid', '.', 'recent', 'systematic', 'review', 'suggested', 'mortality', 'benefit', 'in', 'critically', 'ill', 'adult', 'treated', 'with', 'balanced', 'solution', 'compared', 'with', 'sodium', 'chloride', ',', '.', '(', 'saline', ')', '.', 'lack', 'of', 'clinically', 'directive', 'data', 'optimal', 'fluid', 'choice', 'in', 'critically', 'ill', 'child', '.', 'objective', 'to', 'determine', 'balanced', 'solution', 'decrease', 'rise', 'of', 'plasma', 'chloride', 'compared', 'with', 'saline', ',', '.', ',', 'in', 'critically', 'ill', 'child', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'single-center', ',', '-arm', ',', 'open-label', 'randomized', 'clinical', 'trial', 'took', 'place', 'in', '-bed', 'picu', '.', 'child', 'younger', 'year', 'admitted', 'to', 'picu', 'and', 'considered', 'to', 'require', 'intravenous', 'fluid', 'therapy', 'treating', 'clinician', 'eligible', '.', 'child', 'screened', 'november', 'to', 'april', '.', 'intervention', 'enrolled', 'child', 'allocated', 'to', 'gluconateacetate-buffered', 'solution', ',', 'lactate-buffered', 'solution', ',', 'or', 'saline', 'intravenous', 'fluid', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'increase', 'in', 'serum', 'chloride', 'of', 'meql', 'or', 'within', 'hour', 'randomization', '.', 'new-onset', 'acute', 'kidney', 'injury', ',', 'length', 'of', 'hospital', 'and', 'intensive', 'care', 'stay', ',', 'and', 'intensive', 'care-free', 'survival', 'secondary', 'outcome', '.', 'result', 'total', 'of', 'patient', 'with', 'median', '(', 'iqr', ')', 'age', 'of', '.', '(', '.-', '.', ')', 'year', 'randomized', 'with', ',', ',', 'and', 'allocated', 'to', 'gluconateacetate-buffered', 'solution', ',', 'lactate-buffered', 'solution', ',', 'and', 'saline', ',', 'respectively', '.', 'serum', 'chloride', 'level', 'increased', 'meql', 'or', 'in', 'patient', '(', '.', ')', ',', 'patient', '(', '.', ')', ',', 'and', 'patient', '(', '.', ')', 'in', 'gluconateacetate-buffered', 'solution', ',', 'lactate-buffered', 'solution', ',', 'and', 'saline', 'group', '.', 'odds', 'of', 'rise', 'in', 'plasma', 'chloride', 'meql', 'or', 'halved', 'with', 'use', 'of', 'gluconateacetate-buffered', 'solution', 'compared', 'with', 'saline', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', 'and', 'with', 'use', 'of', 'lactate-buffered', 'solution', 'compared', 'with', 'saline', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'new-onset', 'acute', 'kidney', 'injury', 'observed', 'in', 'patient', '(', '.', ')', ',', 'patient', '(', '.', ')', ',', 'and', 'patient', '(', '.', ')', 'in', 'gluconateacetate-buffered', 'solution', ',', 'lactate-buffered', 'solution', ',', 'and', 'saline', 'group', ',', 'respectively', '.', 'conclusion', 'and', 'relevance', 'balanced', 'solution', '(', 'gluconateacetate-buffered', 'solution', 'and', 'lactate-buffered', 'solution', ')', 'administered', 'intravenous', 'fluid', 'therapy', 'reduced', 'incidence', 'of', 'rise', 'in', 'plasma', 'chloride', 'compared', 'with', 'saline', 'in', 'child', 'in', 'picu', '.', 'trial', 'registration', 'anzctr.org.au', 'identifier', 'actrn', '.']"
Intratumor cisplatin nephrotoxicity in combined laser-induced thermal therapy for cancer treatment.,"Marcel N Palumbo, Onivaldo Cervantes, Cecilia Eugênio, Flávia T P Hortense, João C Ribeiro, Ana Amélia P Paolini, Antônio C Tedesco, Joel A Sercarz, Marcos B Paiva, Marcel N Palumboet al.",2017 Oct,Lasers Surg Med,https://pubmed.ncbi.nlm.nih.gov/28598516/,No keywords found,"['thermal', 'ablation', 'of', 'tumor', 'ndyag', 'laser', 'growing', 'multidisciplinary', 'subspecialty', 'defined', 'laser-induced', 'thermal', 'therapy', '(', 'litt', ')', ',', 'and', 'increasingly', 'accepted', 'minimally', 'invasive', 'method', 'palliation', 'of', 'advanced', 'or', 'recurrent', 'cancer', '.', 'previous', 'study', 'shown', 'adjuvant', 'chemotherapy', 'potentiate', 'laser', 'thermal', 'ablation', 'of', 'tumor', 'leading', 'to', 'improved', 'palliation', 'in', 'advanced', 'cancer', 'patient', '.', 'objective', 'evaluate', 'nephrotoxicity', 'early', 'marker', 'of', 'renal', 'function', 'in', 'treating', 'head', 'and', 'neck', 'cancer', 'using', 'intra-tumor', 'injection', 'of', 'cisplatin', 'combined', 'with', 'laser-induced', 'thermal', 'therapy', '(', 'cddp-litt', ')', '.', 'method', 'nine', 'patient', 'with', 'recurrent', 'head', 'and', 'neck', 'tumor', 'treated', 'cddp-litt', 'in', 'order', 'to', 'determine', 'nephrotoxicity', 'related', 'to', 'synergistic', 'association', '.', 'among', 'test', 'requested', 'to', 'detect', 'early', 'creatinine', ',', 'magnesium', ',', 'creatinine', 'clearance', ',', 'serum', 'urea-bun', ',', 'type', 'urine', ',', 'and', 'proteinuria', 'hour', '.', 'result', 'twelve', 'recurrent', 'tumor', 'in', 'nine', 'patient', 'treated', 'cddp-litt', '.', 'pain', 'major', 'complaint', '(', 'four', 'patient', ')', ',', 'symptom', 'included', 'dysphagia', ',', 'dyspnea', ',', 'bleeding', ',', 'and', 'difficulty', 'in', 'chewing', '.', 'fifteen', 'laser', 'procedure', 'performed', 'and', 'maximal', 'cddp', 'dose', 'mg.', 'none', 'of', 'marker', 'nephrotoxicity', 'showed', 'change', 'level', 'of', 'cddp', 'intra-tumor', 'injection', '.', 'conclusion', 'initial', 'experience', 'with', '(', 'cddp-litt', ')', 'indicates', 'safety', 'and', 'therapeutic', 'potential', 'palliation', 'of', 'advanced', 'head', 'and', 'neck', 'cancer', '.', 'however', ',', 'safety', 'and', 'feasibility', 'must', 'confirmed', 'longer', 'follow-up', 'and', 'escalation', 'of', 'cddp', 'dos', 'in', 'phase', 'study', 'to', 'determine', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'and', 'demonstrate', 'tangible', 'benefit', 'patient', '.', 'laser', 'surg', '.', 'med', '.', '-', ',', '.', 'wiley', 'periodical', ',', 'inc', '.']"
"Efficacy and safety of Yiqi Peiyuan granules for improving the short-term prognosis of patients with acute kidney injury: A multicenter, double-blind, placebo-controlled, randomized trial.","Jia-Jia Wu, Tian-Yi Zhang, Ying-Hui Qi, Min-Yan Zhu, Yan Fang, Chao-Jun Qi, Li-Ou Cao, Ji-Fang Lu, Bo-Han Lu, Lu-Min Tang, Jian-Xiao Shen, Shan Mou, Jia-Jia Wuet al.",2024 May,J Integr Med,https://pubmed.ncbi.nlm.nih.gov/38688809/,No keywords found,"['yiqi', 'peiyuan', '(', 'yqpy', ')', 'prescription', ',', 'composite', 'prescription', 'of', 'traditional', 'chinese', 'medicine', ',', 'used', 'to', 'prevent', 'or', 'delay', 'continued', 'deterioration', 'of', 'renal', 'function', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'institution', 'and', 'shown', 'considerable', 'efficacy', '.', 'objective', 'first', 'randomized', 'controlled', 'trial', 'to', 'assess', 'efficacy', 'and', 'safety', 'of', 'yqpy', 'improving', 'short-term', 'prognosis', 'in', 'adult', 'patient', 'with', 'aki', '.', 'design', ',', 'setting', ',', 'participant', 'and', 'intervention', 'prospective', ',', 'double-blind', ',', 'multicenter', ',', 'randomized', ',', 'and', 'placebo-controlled', 'clinical', 'trial', '.', 'total', 'of', 'enrolled', 'participant', 'randomly', 'allocated', 'to', 'two', 'group', 'according', 'to', 'randomization', 'schedule', '.', 'participant', ',', 'caregiver', 'and', 'investigator', 'assessing', 'outcome', 'blinded', 'to', 'group', 'assignment', '.', 'patient', 'in', 'yqpy', 'group', 'received', 'g', 'yqpy', 'granule', 'twice', 'day', 'day', '.', 'patient', 'in', 'placebo', 'group', 'received', 'placebo', 'in', 'dose', 'yqpy', 'granule', '.', 'main', 'outcome', 'measure', 'primary', 'outcome', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'baseline', 'and', 'and', 'week', 'of', 'treatment', '.', 'secondary', 'outcome', 'change', 'of', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'baseline', 'and', 'treatment', ',', 'and', 'incidence', 'of', 'endpoint', 'event', ',', 'defined', 'egfr', 'increasing', 'baseline', ',', 'egfr', 'mlmin', 'per', '.', 'or', 'composite', 'endpoint', ',', 'defined', 'sum', 'of', 'patient', 'meeting', 'either', 'of', 'criterion', '.', 'result', 'data', 'total', 'of', 'patient', '(', 'in', 'yqpy', 'group', 'and', 'in', 'control', 'group', ')', 'analyzed', '.', 'mean', 'change', 'in', 'egfr', 'and', 'scr', 'in', 'week', 'and', 'no', 'difference', 'two', 'group', '.', 'in', 'subgroup', 'analysis', '(', 'in', 'yqpy', 'group', 'and', 'in', 'control', 'group', ')', ',', 'mean', 'change', 'in', 'egfr', 'treatment', 'week', '.', 'mlmin', 'per', '.', 'in', 'yqpy', 'group', 'and', '.', 'mlmin', 'per', '.', 'in', 'placebo', 'group', ',', 'and', 'mean', 'difference', 'group', '.', 'mlmin', 'per', '.', '(', 'p', '.', ')', '.', 'thirteen', '(', '.', ')', 'patient', 'in', 'yqpy', 'group', 'and', '(', '.', ')', 'in', 'placebo', 'group', 'reached', 'composite', 'endpoint', '(', 'p', '.', ')', '.', 'intervention', ',', 'and', 'severe', 'adverse', 'event', 'reported', 'in', 'yqpy', 'and', 'placebo', 'group', ',', 'respectively', '.', 'conclusion', 'yqpy', 'granule', 'effectively', 'improve', 'renal', 'function', 'of', 'patient', 'week', 'onset', 'of', 'aki', ',', 'indicating', 'good', 'efficacy', 'improving', 'short-term', 'renal', 'outcome', 'in', 'patient', 'with', 'aki', '.', 'yqpy', 'granule', 'may', 'promising', 'therapy', 'adult', 'with', 'aki', '.', 'trial', 'registration', 'chinese', 'clinical', 'trial', 'registry', 'chictr', '.', 'please', 'cite', 'article', 'wu', 'jj', ',', 'zhang', 'ty', ',', 'qi', 'yh', ',', 'zhu', ',', 'fang', ',', 'qi', 'cj', ',', 'cao', 'lo', ',', 'lu', 'jf', ',', 'lu', 'bh', ',', 'tang', 'lm', ',', 'shen', 'jx', ',', 'mou', 's.', 'efficacy', 'and', 'safety', 'of', 'yiqi', 'peiyuan', 'granule', 'improving', 'short-term', 'prognosis', 'of', 'patient', 'with', 'acute', 'kidney', 'injury', 'multicenter', ',', 'double-blind', ',', 'placebo-controlled', ',', 'randomized', 'trial', '.', 'j', 'integr', 'med', '.', '(', ')', '-', '.']"
"Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin.","Elizabeth Fox, Kristin Levin, Yan Zhu, Blair Segers, Naomi Balamuth, Richard Womer, Rochelle Bagatell, Frank Balis, Elizabeth Foxet al.",2018 Jul,Oncologist,https://pubmed.ncbi.nlm.nih.gov/29445029/,No keywords found,"['using', 'randomized', 'crossover', 'design', 'and', 'continuous', 'variable', 'change', 'in', 'hearing', 'threshold', 'and', 'biomarkers', 'of', 'acute', 'renal', 'injury', 'short-term', 'endpoint', ',', 'determined', 'pantoprazole', ',', 'organic', 'cation', 'transporter', 'inhibitor', ',', 'not', 'ameliorate', 'cisplatin-associated', 'nephrotoxicity', 'or', 'ototoxicity.cystatin', 'c', 'robust', 'method', 'to', 'estimate', 'glomerular', 'filtration', 'rate', 'in', 'patient', 'with', 'cancer', '.', 'using', 'patient-reported', 'outcome', 'survey', ',', 'patient', 'identified', 'tinnitus', 'and', 'subjective', 'hearing', 'loss', 'occurring', '``', 'least', 'rarely', ""''"", 'cycle', ',', 'prior', 'to', 'objective', 'high-frequency', 'hearing', 'loss', 'measured', 'audiograms.new', 'therapy', 'improve', 'outcome', 'with', 'less', 'acute', 'and', 'long-term', 'toxicity', 'needed', '.', 'background', 'organic', 'cation', 'transporter', '(', 'oct', ')', ',', 'cisplatin', 'uptake', 'transporter', 'expressed', 'renal', 'tubule', 'and', 'cochlear', 'hair', 'cell', 'not', 'osteosarcoma', 'cell', ',', 'mediates', 'cisplatin', 'uptake', '.', 'pantoprazole', 'inhibits', 'oct', 'and', 'could', 'ameliorate', 'cisplatin', 'ototoxicity', 'and', 'nephrotoxicity', '.', 'using', 'randomized', 'crossover', 'design', ',', 'evaluated', 'audiogram', ',', 'urinary', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'biomarkers', ',', 'and', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'estimated', 'cystatin', 'c', '(', 'gfrcysc', ')', 'in', 'patient', 'receiving', 'cisplatin', 'with', 'and', 'without', 'pantoprazole', '.', 'material', 'and', 'method', 'cisplatin', '(', 'mgm', 'day', 'per', 'cycle', ')', 'administered', 'concurrently', 'with', 'pantoprazole', '(', 'intravenous', 'iv', ',', '.', 'mgkg', 'hour', ')', 'cycle', 'and', 'or', 'cycle', 'and', 'in', 'patient', 'with', 'osteosarcoma', '(', 'o', ')', 'with', 'median', '(', 'range', ')', 'age', 'of', '.', '(', '.-', ')', 'year', '.', 'audiogram', ',', 'urinary', 'aki', 'biomarkers', ',', 'and', 'serum', 'cystatin', 'c', 'monitored', 'cycle', '.', 'result', 'pantoprazole', 'no', 'impact', 'decrement', 'in', 'hearing', 'threshold', '-', 'khz', ',', 'post-treatment', 'elevation', 'of', 'urinary', 'aki', 'biomarkers', ',', 'or', 'gfrcysc', '(', 'fig', '.', ',', 'table', ')', '.', 'histological', 'response', '(', 'percent', 'necrosis', ')', 'two', 'cycle', 'similar', 'with', 'or', 'without', 'pantoprazole', '.', 'eight', 'patient', 'with', 'localized', 'o', 'diagnosis', 'alive', 'and', 'in', 'remission', 'three', 'of', 'four', 'patient', 'with', 'metastasis', 'diagnosis', 'died', '.', 'conclusion', 'pantoprazole', 'not', 'ameliorate', 'cisplatin', 'ototoxicity', 'or', 'nephrotoxicity', '.', 'decrease', 'in', 'gfrcysc', 'and', 'increase', 'in', 'n-acetyl', '--', 'glucosaminidase', '(', 'nag', ')', 'and', 'creatinine', 'demonstrate', 'biomarkers', 'quantify', 'cisplatin', 'glomerular', 'and', 'proximal', 'tubular', 'toxicity', '.', 'oct', 'inhibition', 'pantoprazole', 'not', 'appear', 'to', 'alter', 'antitumor', 'response', 'or', 'survival', '.']"
Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency.,"Edit Dósa, Krisztina Heltai, Tamás Radovits, Gabriella Molnár, Judit Kapocsi, Béla Merkely, Rongwei Fu, Nancy D Doolittle, Gerda B Tóth, Zachary Urdang, Edward A Neuwelt, Edit Dósaet al.",2017 Oct 3,Fluids Barriers CNS,https://pubmed.ncbi.nlm.nih.gov/28974245/,No keywords found,"['cisplatin', 'neuro-', ',', 'oto-', ',', 'and', 'nephrotoxicity', 'major', 'problem', 'in', 'child', 'with', 'malignant', 'tumor', ',', 'including', 'medulloblastoma', ',', 'negatively', 'impacting', 'educational', 'achievement', ',', 'socioemotional', 'development', ',', 'and', 'overall', 'quality', 'of', 'life', '.', 'blood-labyrinth', 'barrier', 'somewhat', 'permeable', 'to', 'cisplatin', ',', 'and', 'sensory', 'hair', 'cell', 'and', 'cochlear', 'supporting', 'cell', 'highly', 'sensitive', 'to', 'toxic', 'drug', '.', 'several', 'chemoprotective', 'agent', 'n-acetylcysteine', '(', 'nac', ')', 'utilized', 'experimentally', 'to', 'avoid', 'potentially', 'serious', 'and', 'life-long', 'side', 'effect', ',', 'although', 'no', 'clinical', 'phase', 'trial', 'performed', '.', 'purpose', 'of', 'study', 'to', 'establish', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'and', 'pharmacokinetics', 'of', 'intravenous', '(', 'iv', ')', 'and', 'intra-arterial', '(', 'ia', ')', 'nac', 'in', 'adult', 'with', 'chronic', 'kidney', 'disease', 'to', 'used', 'in', 'trial', 'oto-', 'and', 'nephroprotection', 'in', 'pediatric', 'patient', 'receiving', 'platinum', 'therapy', '.', 'method', 'due', 'to', 'ethical', 'consideration', 'in', 'pediatric', 'tumor', 'patient', ',', 'used', 'clinical', 'population', 'of', 'adult', 'with', 'non-neoplastic', 'disease', '.', 'subject', 'with', 'stage', 'three', 'or', 'worse', 'renal', 'failure', 'endovascular', 'procedure', 'enrolled', 'in', 'prospective', ',', 'non-randomized', ',', 'single', 'center', 'trial', 'to', 'determine', 'mtd', 'nac', '.', 'initially', 'aimed', 'to', 'evaluate', 'three', 'patient', ',', ',', ',', ',', 'and', 'mgkg', 'nac', '.', 'mtd', 'defined', 'one', 'dose', 'level', 'dose', 'producing', 'grade', 'or', 'toxicity', '.', 'serum', 'nac', 'level', 'assessed', ',', 'and', 'min', 'post', 'nac', '.', 'twenty-eight', 'subject', '(', 'men', 'mean', 'age', '.', '.', 'year', ')', 'received', 'nac', 'iv', '(', 'n', ')', 'or', 'ia', '(', 'n', ')', '.', 'result', 'first', 'participant', 'to', 'experience', 'grade', 'toxicity', 'mgkg', 'iv', 'dose', ',', 'time', 'protocol', 'modified', 'to', 'add', 'additional', 'dose', 'level', 'of', 'mgkg', 'nac', '.', 'subsequently', ',', 'no', 'severe', 'nac-related', 'toxicity', 'arose', 'and', 'mgkg', 'nac', 'found', 'to', 'mtd', 'in', 'iv', 'and', 'ia', 'group', '.', 'blood', 'level', 'of', 'nac', 'showed', 'linear', 'dose', 'response', '(', 'p', '.', ')', '.', 'five', 'min', 'either', 'iv', 'or', 'ia', 'nac', 'mtd', 'dose', 'administration', ',', 'serum', 'nac', 'level', 'reached', '-', 'mm', 'concentration', 'seemed', 'to', 'nephroprotective', 'in', 'previous', 'preclinical', 'study', '.', 'conclusion', 'in', 'adult', 'with', 'kidney', 'impairment', ',', 'nac', 'safely', 'given', 'iv', 'and', 'ia', 'dose', 'of', 'mgkg', '.', 'additional', 'study', 'needed', 'to', 'confirm', 'oto-', 'and', 'nephroprotective', 'property', 'in', 'setting', 'of', 'cisplatin', 'treatment', '.', 'clinical', 'trial', 'registration', 'url', 'httpseudract.ema.europa.eu', '.', 'unique', 'identifier', '--', '.']"
Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury.,"Rita Garcia-Martinez, Lorette Noiret, Sambit Sen, Rajeshwar Mookerjee, Rajiv Jalan, Rita Garcia-Martinezet al.",2015 Feb,Liver Int,https://pubmed.ncbi.nlm.nih.gov/24620819/,No keywords found,"['in', 'cirrhotic', 'patient', 'with', 'renal', 'failure', ',', 'renal', 'blood', 'flow', 'autoregulation', 'curve', 'shifted', 'to', 'right', ',', 'consequent', 'upon', 'sympathetic', 'nervous', 'system', 'activation', 'and', 'endothelial', 'dysfunction', '.', 'albumin', 'infusion', 'improves', 'renal', 'function', 'in', 'cirrhosis', 'mechanism', 'incompletely', 'understood', '.', 'aimed', 'to', 'determine', 'effect', 'of', 'albumin', 'infusion', 'systemic', 'haemodynamics', ',', 'renal', 'blood', 'flow', ',', 'renal', 'function', 'and', 'endothelial', 'function', 'in', 'patient', 'with', 'acute', 'decompensation', 'of', 'cirrhosis', 'and', 'acute', 'kidney', 'injury', '.', 'method', 'twelve', 'patient', 'with', 'refractory', 'ascites', 'and', 'patient', 'with', 'acute', 'decompensation', 'of', 'cirrhosis', 'and', 'acute', 'kidney', 'injury', 'studied', '.', 'group', 'treated', 'with', 'intravenous', 'albumin', 'infusion', ',', '-', 'gdays', '-', 'day', '.', 'cardiac', 'and', 'renal', 'haemodynamics', 'measured', '.', 'endothelial', 'activationdysfunction', 'assessed', 'using', 'von', 'willebrand', 'factor', 'and', 'serum', 'nitrite', 'level', '.', 'f', 'isoprostanes', ',', 'resting', 'neutrophil', 'burst', 'and', 'noradrenaline', 'level', 'quantified', 'marker', 'of', 'oxidative', 'stress', ',', 'endotoxemia', 'and', 'sympathetic', 'activation', 'respectively', '.', 'result', 'albumin', 'infusion', 'lead', 'to', 'shift', 'in', 'renal', 'blood', 'flow', 'autoregulation', 'curve', 'towards', 'normalization', ',', 'resulted', 'in', 'significant', 'increase', 'in', 'renal', 'blood', 'flow', '.', 'accordingly', ',', 'improvement', 'of', 'renal', 'function', 'observed', '.', 'in', 'parallel', ',', 'significant', 'decrease', 'in', 'sympathetic', 'activation', ',', 'inflammationoxidative', 'stress', 'and', 'endothelial', 'activationdysfunction', 'documented', '.', 'improvement', 'of', 'renal', 'blood', 'flow', 'correlated', 'with', 'improvement', 'in', 'endothelial', 'activation', '(', 'r', '.', ',', 'p', '.', ')', '.', 'conclusion', 'data', 'suggest', 'albumin', 'infusion', 'improves', 'renal', 'function', 'in', 'acutely', 'decompensated', 'cirrhotic', 'patient', 'with', 'acute', 'kidney', 'injury', 'impacting', 'renal', 'blood', 'flow', 'autoregulation', '.', 'possibly', 'achieved', 'endothelial', 'stabilization', 'and', 'reduction', 'in', 'sympathetic', 'tone', ',', 'endotoxemia', 'and', 'oxidative', 'stress', '.']"
Forced fluid removal in intensive care patients with acute kidney injury: The randomised FFAKI feasibility trial.,"R E Berthelsen, A Perner, A K Jensen, B S Rasmussen, J U Jensen, J Wiis, M T Behzadi, M H Bestle, R E Berthelsenet al.",2018 Aug,Acta Anaesthesiol Scand,https://pubmed.ncbi.nlm.nih.gov/29664109/,No keywords found,"['accumulation', 'of', 'fluid', 'frequent', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'patient', 'with', 'acute', 'kidney', 'injury', 'and', 'may', 'associated', 'with', 'increased', 'mortality', 'and', 'decreased', 'renal', 'recovery', '.', 'present', 'result', 'of', 'pilot', 'trial', 'assessing', 'feasibility', 'of', 'forced', 'fluid', 'removal', 'in', 'icu', 'patient', 'with', 'acute', 'kidney', 'injury', 'and', 'fluid', 'accumulation', 'of', 'ideal', 'bodyweight', '.', 'method', 'ffaki-trial', 'pilot', 'trial', 'of', 'forced', 'fluid', 'removal', 'v', 'standard', 'care', 'in', 'adult', 'icu', 'patient', 'with', 'moderate', 'to', 'high', 'risk', 'acute', 'kidney', 'injury', 'and', 'fluid', 'accumulation', '.', 'fluid', 'removal', 'done', 'with', 'furosemide', 'andor', 'continuous', 'renal', 'replacement', 'therapy', 'aiming', 'net', 'negative', 'fluid', 'balance', 'mlkg', 'ideal', 'body', 'weighthour', 'cumulative', 'fluid', 'balance', 'calculated', 'icu', 'admission', 'reached', 'less', 'ml', '.', 'result', 'month', ',', 'stopped', 'trial', 'prematurely', 'due', 'to', 'low', 'inclusion', 'rate', 'with', '(', ')', 'included', 'patient', 'of', 'screened', '.', 'despite', 'reduced', 'sample', 'size', ',', 'observed', 'marked', 'reduction', 'in', 'cumulative', 'fluid', 'balance', 'day', 'randomisation', '(', 'mean', 'difference', '-', 'ml', ',', 'ci', '-', 'to', '-', ',', 'p', '.', ')', 'with', 'forced', 'fluid', 'removal', 'compared', 'to', 'standard', 'care', '.', 'trial', 'underpowered', 'clinical', 'endpoint', ',', 'no', 'point', 'estimate', 'suggested', 'harm', 'forced', 'fluid', 'removal', '.', 'conclusion', 'forced', 'fluid', 'removal', 'aiming', 'mlkg', 'ideal', 'body', 'weighthour', 'may', 'effective', 'treatment', 'of', 'fluid', 'accumulation', 'in', 'icu', 'patient', 'with', 'acute', 'kidney', 'injury', '.', 'definitive', 'trial', 'using', 'inclusion', 'criterion', 'seems', 'less', 'feasible', 'based', 'inclusion', 'rate', 'of', '.']"
Systemic Absorption and Nephrotoxicity Associated With Topical Vancomycin Powder for Fracture Surgery.,"Robert V O'Toole, Yasmin Degani, Anthony R Carlini, Renan C Castillo, Nathan N O'Hara, Manjari Joshi                              ;, and METRC, Robert V O'Tooleet al.",2021 Jan 1,J Orthop Trauma,https://pubmed.ncbi.nlm.nih.gov/32569068/,No keywords found,"['to', 'determine', 'whether', 'using', 'topical', 'vancomycin', 'powder', 'in', 'fracture', 'surgery', 'may', 'result', 'in', 'low', 'level', 'of', 'vancomycin', 'in', 'serum', 'and', 'not', 'result', 'in', 'nephrotoxicity', '.', 'design', 'prospective', 'observational', 'single', 'site', 'substudy', 'of', 'vanco', 'trial', '.', 'setting', 'single', ',', 'large', 'urban', 'level', 'trauma', 'center', '.', 'patientsparticipants', 'fifty-eight', 'patient', 'with', 'tibial', 'plateau', 'and', 'pilon', 'fracture', 'randomized', 'to', 'treatment', 'arm', 'principal', 'investigator', ""'s"", 'site', '.', 'intervention', 'topical', 'vancomycin', 'powder', '(', 'mg', ')', 'applied', 'directly', 'in', 'wound', 'metal', 'implant', 'time', 'of', 'wound', 'closure', '.', 'main', 'outcome', 'measurement', 'serum', 'vancomycin', 'level', 'hour', 'and', '-', 'hour', 'surgery', '.', 'secondary', 'outcome', 'included', 'serum', 'creatinine', 'surgery', ',', 'day', 'surgery', ',', 'and', 'week', 'postoperatively', 'and', 'complete', 'blood', 'count', 'week', 'postoperatively', '.', 'result', 'except', 'in', 'patient', 'also', 'received', 'intravenous', 'vancomycin', ',', 'none', 'of', 'study', 'patient', 'detectable', '(', 'gml', ')', 'serum', 'vancomycin', 'level', 'hour', 'and', '-', 'hour', 'surgery', '.', 'one', 'patient', 'with', 'history', 'of', 'elevation', 'of', 'serum', 'creatinine', 'minor', 'increase', 'of', 'serum', 'creatinine', 'undetectable', 'vancomycin', 'level', '.', 'none', 'of', 'patient', 'clinically', 'significant', 'increase', 'in', 'creatinine', 'level', '.', 'conclusion', 'despite', 'relatively', 'widespread', 'usage', ',', 'little', 'data', 'exist', 'regarding', 'systemic', 'level', 'and', 'nephrotoxicity', 'associated', 'with', 'topical', 'use', 'of', 'vancomycin', 'powder', 'in', 'orthopaedic', 'fracture', 'surgery', '.', 'prospective', 'data', 'indicate', 'seems', 'to', 'little', 'clinical', 'concern', 'regarding', 'toxicity', 'associated', 'with', 'systemic', 'absorption', 'of', 'vancomycin', 'powder', 'in', 'specific', 'clinical', 'application', '.', 'level', 'of', 'evidence', 'therapeutic', 'level', 'iv', '.', 'see', 'instruction', 'author', 'complete', 'description', 'of', 'level', 'of', 'evidence', '.']"
"Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.","Stefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, Ludovic Evesque, Denis Smith, Nicolas Badet, Emmanuelle Samalin, Daniel Lopez-Trabada Ataz, Aurelie Parzy, Jérôme Desramé, Nabil Baba Hamed, Bruno Buecher, David Tougeron, Olivier Bouché, Laetitia Dahan, Benoist Chibaudel, Farid El Hajbi, Laurent Mineur, Olivier Dubreuil, Meher Ben Abdelghani, Solange Pecout, Frederic Bibeau, Michael Herfs, Marie-Line Garcia, Aurelia Meurisse, Dewi Vernerey, Julien Taïeb, Christophe Borg, Stefano Kimet al.",2024 Apr,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/38547895/,No keywords found,"['modified', 'docetaxel', ',', 'cisplatin', ',', 'and', 'fluorouracil', '(', 'mdcf', ')', 'regimen', 'shown', 'efficacy', 'and', 'safety', 'first-line', 'treatment', 'advanced', 'squamous', 'cell', 'carcinoma', 'of', 'anus', ',', 'making', 'standard', 'regimen', '.', 'inhibitor', 'of', 'programmed', 'cell', 'death', 'protein', 'and', 'ligand', ',', 'pembrolizumab', ',', 'nivolumab', ',', 'retifanlimab', ',', 'avelumab', ',', 'and', 'atezolizumab', ',', 'shown', 'antitumour', 'activity', 'monotherapy', 'in', 'advanced', 'squamous', 'cell', 'carcinoma', 'of', 'anus', 'refractory', 'to', 'chemotherapy', '.', 'phase', 'study', 'evaluated', 'combination', 'of', 'mdcf', 'and', 'atezolizumab', 'first-line', 'treatment', 'in', 'advanced', 'squamous', 'cell', 'carcinoma', 'of', 'anus', '.', 'method', 'in', 'randomised', ',', 'open-label', ',', 'non-comparative', ',', 'phase', 'study', ',', 'participant', 'centre', '(', 'academic', ',', 'private', ',', 'and', 'community', 'hospital', 'and', 'cancer', 'research', 'centre', ')', 'across', 'france', 'with', 'chemo-naive', ',', 'metastatic', ',', 'or', 'unresectable', 'locally', 'advanced', 'recurrent', 'squamous', 'cell', 'carcinoma', 'of', 'anus', ',', 'aged', 'year', 'or', 'older', ',', 'and', 'with', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', 'or', ',', 'randomly', 'allocated', '(', ')', 'to', 'receive', 'either', 'atezolizumab', '(', 'mg', 'intravenously', 'every', 'week', 'to', 'year', ')', 'plus', 'mdcf', '(', 'eight', 'cycle', 'of', 'mg', 'per', 'docetaxel', 'and', 'mg', 'per', 'cisplatin', 'day', 'and', 'mg', 'per', 'per', 'day', 'of', 'fluorouracil', 'day', ',', 'every', 'week', 'intravenously', 'group', ')', 'or', 'mdcf', 'alone', '(', 'group', 'b', ')', '.', 'randomisation', 'done', 'centrally', 'using', 'minimisation', 'technique', 'and', 'stratified', 'age', '(', 'year', 'v', 'year', ')', 'and', 'disease', 'status', '.', 'primary', 'endpoint', 'investigator-assessed', '-month', 'progression-free', 'survival', 'in', 'modified', 'intention-to-treat', 'population', 'in', 'group', '(', 'null', 'hypothesis', 'and', 'alternative', 'hypothesis', ')', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'closed', 'to', 'new', 'participant', '.', 'finding', 'evaluable', 'participant', '(', 'in', 'group', 'and', 'in', 'group', 'b', ')', 'enrolled', 'july', ',', ',', 'and', 'aug', ',', '.', 'median', 'follow-up', 'month', '(', 'ci', '-', ')', '.', 'median', 'age', 'of', 'participant', 'year', '(', 'iqr', '-', ')', ',', 'and', '(', ')', 'female', '.', '-month', 'progression-free', 'survival', '(', 'ci', '-', ')', 'in', 'group', 'and', '(', '-', ')', 'in', 'group', 'b.', 'in', 'participant', 'with', 'pd-l', 'combined', 'positive', 'score', 'of', 'or', 'greater', ',', '-month', 'progression-free', 'survival', '(', 'ci', '-', ')', 'in', 'group', 'and', '(', '-', ')', 'in', 'group', 'b', '(', 'interaction', 'p', ')', 'group', 'showed', 'high', 'compliance', '.', 'adverse', 'event', 'of', 'grade', 'or', 'higher', 'observed', 'in', '(', ')', 'participant', 'in', 'group', 'and', '(', ')', 'in', 'group', 'b.', 'common', 'grade', '-', 'adverse', 'event', 'neutropenia', '(', 'nine', 'participant', 'in', 'group', 'v', 'five', 'in', 'group', 'b', ')', ',', 'anaemia', '(', 'nine', 'v', 'one', ')', ',', 'fatigue', '(', 'three', 'v', 'four', ')', ',', 'and', 'diarrhoea', '(', 'seven', 'v', 'one', ')', '.', 'serious', 'adverse', 'event', 'occurred', 'in', '(', ')', 'participant', 'in', 'group', 'and', 'four', '(', ')', 'in', 'group', 'b', ',', 'and', 'mdcf-related', 'in', 'seven', '(', ')', 'participant', 'in', 'group', 'and', 'four', '(', ')', 'in', 'group', 'b.', 'atezolizumab-related', 'serious', 'adverse', 'event', 'occurred', 'in', 'nine', '(', ')', 'participant', 'in', 'group', ',', 'including', 'grade', 'infusion-related', 'reaction', 'in', 'three', '(', ')', ',', 'grade', 'infection', 'in', 'two', '(', ')', ',', 'and', 'grade', 'colitis', ',', 'grade', 'acute', 'kidney', 'injury', ',', 'grade', 'sarcoidosis', ',', 'and', 'grade', 'platelet', 'count', 'decrease', 'in', 'one', 'participant', '(', ')', '.', 'no', 'treatment-related', 'death', '.', 'interpretation', 'despite', 'higher', 'incidence', 'of', 'adverse', 'event', ',', 'combining', 'atezolizumab', 'with', 'mdcf', 'feasible', ',', 'with', 'similar', 'dose', 'intensity', 'in', 'group', ',', 'although', 'primary', 'efficacy', 'endpoint', 'not', 'met', '.', 'predictive', 'value', 'of', 'pd-l', 'combined', 'positive', 'score', 'of', 'or', 'greater', 'need', 'to', 'confirmed', 'in', 'future', 'study', '.', 'funding', 'gercor', ',', 'roche', '.']"
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial.,"Do Seon Song, Won Kim, Sang Hoon Ahn, Hyung Joon Yim, Jae Young Jang, Young Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Young Kul Jung, Joo Hyun Sohn, Jin-Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Kim, Seung Kew Yoon, Moon Young Kim, Kwan Sik Lee, Young Suk Lim, Wan Sik Lee, Jin Mo Yang, Kyun-Hwan Kim, Kwang-Hyub Han, Soon Ho Um, Do Seon Songet al.",2021 Apr,Clin Mol Hepatol,https://pubmed.ncbi.nlm.nih.gov/33493393/,No keywords found,"['besifovir', 'dipivoxil', 'maleate', '(', 'bsv', ')', ',', 'acyclic', 'nucleotide', 'phosphonate', ',', 'show', 'potent', 'antiviral', 'activity', 'hepatitis', 'b', 'virus', '.', 'previous', '-week', 'trial', 'revealed', 'bsv', 'comparable', 'antiviral', 'efficacy', 'to', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', 'and', 'better', 'safety', 'profile', 'in', 'term', 'of', 'improved', 'renal', 'and', 'bone', 'safety', '.', 'extension', 'study', 'evaluated', 'prolonged', 'efficacy', 'and', 'safety', 'of', 'bsv', 'in', 'treatment-naive', 'chronic', 'hepatitis', 'b', 'patient', '.', 'method', 'patient', 'continued', 'to', 'participate', 'in', 'open-label', 'bsv', 'study', 'initial', '-week', 'double-blind', 'comparison', 'of', 'bsv', 'and', 'tdf', 'treatment', '.', 'antiviral', 'efficacy', 'and', 'drug', 'safety', 'evaluated', 'to', 'week', 'in', 'two', 'group', 'patient', 'continuing', 'bsv', 'treatment', '(', 'bsv-bsv', ')', 'and', 'patient', 'switching', 'tdf', 'to', 'bsv', 'week', '(', 'tdf-bsv', ')', '.', 'result', 'among', 'patient', 'receiving', 'randomized', 'treatment', ',', '(', ')', 'entered', 'open-label', 'phase', 'and', '(', ')', 'entered', '-week', 'extension', 'study', '.', 'virological', 'response', 'rate', 'week', '.', 'and', '.', 'in', 'bsv-bsv', 'and', 'tdf-bsv', 'group', ',', 'respectively', '(', 'p.', ')', '.', 'hepatitis', 'b', 'envelop', 'antigen', 'seroconversion', 'and', 'alanine', 'aminotransferase', 'normalization', 'rate', 'similar', 'group', '(', 'p.', 'and', 'p.', ',', 'respectively', ')', '.', 'no', 'drug-resistant', 'mutation', 'to', 'bsv', '.', 'bone', 'mineral', 'density', 'and', 'renal', 'function', 'well', 'preserved', 'in', 'bsv-bsv', 'group', ',', 'whereas', 'initially', 'worsened', 'recovered', 'switching', 'therapy', 'in', 'tdf-bsv', 'group', '.', 'conclusion', 'bsv', 'maintained', 'potent', 'antiviral', 'efficacy', 'week', 'and', 'showed', 'no', 'evidence', 'of', 'drug', 'resistance', '.', 'bsv', 'safe', ',', 'well', 'tolerated', ',', 'and', 'effective', 'in', 'patient', 'switched', 'tdf', 'to', 'bsv', '.', 'trial', 'registration', 'number', 'nct', '(', 'date', 'sep', ')', '.']"
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.,"J E Megías-Vericat, P Montesinos, M J Herrero, F Moscardó, V Bosó, L Rojas, D Martínez-Cuadrón, R Rodríguez-Veiga, L Sendra, J Cervera, J L Poveda, M Á Sanz, S F Aliño, J E Megías-Vericatet al.",2018 Apr,Pharmacogenomics J,https://pubmed.ncbi.nlm.nih.gov/28485375/,No keywords found,"['r', ',', 'ncfrs', ',', 'racrs', ')', 'evaluated', 'in', 'adult', 'de', 'novo', 'aml', 'patient', '.', 'variant', 'allele', 'of', 'ncf', 'and', 'rac', 'related', 'to', 'higher', 'complete', 'remission', '(', 'p.', ',', 'p.', ')', ',', 'and', 'cyba', 'homozygous', 'variant', 'showed', 'lower', 'overall', 'survival', 'with', 'recessive', 'model', '(', 'p.', ')', '.', 'anthracycline-induced', 'cardiotoxicity', 'associated', 'to', 'ncf', 'homozygous', 'variant', '(', 'p.', ')', 'and', 'cyba', 'heterozygous', 'genotype', '(', 'p.', ')', '.', 'novel', 'association', 'found', 'variant', 'allele', 'of', 'cyba', 'and', 'lower', 'lung', 'and', 'gastrointestinal', 'toxicity', ',', 'and', 'protective', 'effect', 'in', 'nephrotoxicity', 'and', 'rac', 'homozygous', 'variant', '.', 'moreover', ',', 'rac', 'homozygous', 'variant', 'related', 'to', 'delayed', 'thrombocytopenia', 'recovery', '.', 'study', 'support', 'interest', 'of', 'nadph', 'oxidase', 'polymorphism', 'regarding', 'efficacy', 'and', 'toxicity', 'of', 'aml', 'induction', 'therapy', ',', 'in', 'coherent', 'integrated', 'manner', '.']"
Propranolol vs. band ligation for primary prophylaxis of variceal hemorrhage in cirrhotic patients with ascites: a randomized controlled trial.,"Virendra Singh#, Pramod Kumar#, Nipun Verma, Rajesh Vijayvergiya, Akash Singh, Ashish Bhalla, Virendra Singhet al.",2022 Aug,Hepatol Int,https://pubmed.ncbi.nlm.nih.gov/35672572/,No keywords found,"['recent', 'study', 'debated', 'utility', 'of', 'beta-blockers', 'to', 'prevent', 'variceal', 'hemorrhage', '(', 'v.h', '.', ')', 'in', 'cirrhosis', 'patient', 'with', 'ascites', '.', 'aimed', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'propranolol', '(', 'ppl', ')', 'compared', 'to', 'endoscopic', 'variceal', 'ligation', '(', 'evl', ')', 'v.h', '.', 'primary', 'prevention', 'in', 'patient', 'with', 'ascites', '.', 'method', 'cirrhosis', 'patient', 'with', 'grade', 'ascites', 'and', 'varix', 'needing', 'primary', 'prophylaxis', 'randomly', 'assigned', 'to', 'receive', 'either', 'ppl', '(', 'n', ')', 'or', 'evl', '(', 'n', ')', '.', 'patient', 'followed', 'monthly', 'month', 'or', 'transplant', 'or', 'death', '.', 'primary', 'endpoint', '-month', 'transplant-free-survival', '(', 'tfs', ')', '.', 'secondary', 'endpoint', 'incidence', 'of', 'v.h.', ',', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'and', 'control', 'of', 'ascites', '.', 'result', 'baseline', 'characteristic', 'similar', 'group', '.', 'ppl-group', 'lower', '-month', 'tfs', '(', '.', 'vs.', '.', 'p', '.', ')', 'compared', 'with', 'evl-group', '.', 'mean', 'arterial', 'pressure', 'mmhg', 'and', 'meld-sodium', 'independent', 'predictor', 'of', 'mortality', '.', 'incidence', 'of', 'vh', 'comparable', 'ppl', 'and', 'evl-groups', '(', '.', ')', 'v', '.', '(', '.', ')', ',', 'p', '..', 'in', 'ppl', 'vs.', 'evl-group', ',', 'patient', 'worsening', 'of', 'ascites', '(', 'vs.', 'p', '.', ')', ',', 'developed', 'refractory', 'ascites', '(', '.', 'v', '..', 'p', '.', ')', ',', 'relapse', 'of', 'ascites', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', ',', 'and', 'aki', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'side', 'effect', 'comparable', 'two', 'group', '.', 'conclusion', 'primary', 'vh-prophylaxis', 'with', 'ppl', 'associated', 'with', 'lower', 'survival', ',', 'poor', 'control', 'of', 'ascites', ',', 'and', 'increased', 'risk', 'of', 'aki', 'in', 'cirrhosis', 'patient', 'with', 'grade', 'ascites', '.', 'ppl', 'and', 'evl', 'equally', 'effective', 'in', 'preventing', 'v.h', '.', 'serial', 'monitoring', 'of', 'blood', 'pressure', 'and', 'renal', 'function', 'needed', 'in', 'cirrhosis', 'patient', 'with', 'ascites', 'ppl', '(', 'nct', ')', '.']"
"Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).","M Moehler, A Maderer, P C Thuss-Patience, B Brenner, J Meiler, T J Ettrich, R-D Hofheinz, S E Al-Batran, A Vogel, L Mueller, M P Lutz, F Lordick, M Alsina, K Borchert, R Greil, W Eisterer, A Schad, J Slotta-Huspenina, E Van Cutsem, S Lorenzen, M Moehleret al.",2020 Feb,Ann Oncol,https://pubmed.ncbi.nlm.nih.gov/31959339/,No keywords found,"['palliative', 'chemotherapy', 'of', 'advanced', 'oesophageal', 'squamous', 'cell', 'cancer', '(', 'escc', ')', 'consists', 'of', 'cisplatin-fluorouracil', '(', 'cf', ')', 'to', 'target', 'epidermal', 'growth', 'factor', 'receptor', '(', 'egfr', ')', 'with', 'panitumumab', '(', 'p', ')', 'chemotherapy', 'enhanced', 'overall', 'survival', '(', 'o', ')', 'in', 'advanced', 'colorectal', 'or', 'squamous', 'cell', 'head', 'and', 'neck', 'cancer', '.', 'with', 'prospective', 'serum', 'and', 'tumour', 'biomarkers', ',', 'tested', 'p', 'added', 'to', 'cf', '(', 'cfp', ')', 'improved', 'o', 'in', 'advanced', 'escc', '.', 'patient', 'and', 'method', 'eligible', 'patient', 'with', 'confirmed', 'escc', 'not', 'curatively', 'resectable', 'or', 'not', 'qualify', 'definitive', 'radiochemotherapy', ',', 'randomised', 'to', 'receive', 'cf', 'cisplatin', '(', 'c', ')', 'mgm', 'i.v.', ',', 'day', '-fluorouracil', '(', 'f', ')', 'mgm', 'i.v.', ',', 'day', '-', 'or', 'cf', 'plus', 'p', '(', 'mgkg', ',', 'i.v.', ',', 'day', ',', 'q-week', 'cycle', ')', 'progressive', 'disease', 'or', 'unacceptable', 'toxicity', '.', 'safety', 'reviewed', 'data', 'safety', 'monitoring', 'board', ',', 'and', 'patient', 'completed', 'least', 'one', 'cycle', '.', 'enrolled', 'patient', ',', 'cisplatin', 'reduced', 'mgm', 'to', 'mgm', '.', 'result', 'trial', 'stopped', 'early', 'based', 'interim', 'efficacy', 'result', 'triggered', 'third', 'safety', 'analysis', 'median', 'o', '(', 'mo', ')', 'favoured', 'cf', 'cfp', ',', 'regardless', 'of', 'cisplatin', 'dose', 'hazard', 'ratio', '(', 'hr', ')', '.', ',', 'confidence', 'interval', '(', 'ci', ')', '.-', '.', 'p', '..', 'in', 'final', 'analysis', ',', 'mo', '.', 'versus', '.', 'month', 'cf', 'versus', 'cfp', ',', 'respectively', '(', 'hr', '.', ',', 'ci', '.-', '.', 'p', '.', ')', '.', 'one', 'hundred', '(', '.', ')', 'of', 'patient', 'in', 'safety', 'population', 'died', ',', '(', '.', ')', 'with', 'cfp', '.', 'death', 'related', 'to', 'disease', 'progression', '(', ')', 'death', 'in', 'cf', 'versus', '(', ')', 'death', 'in', 'cfp', 'objective', 'response', '(', '.', ')', 'identical', '.', 'common', 'serious', 'adverse', 'event', 'kidney', 'injury', '(', '.', ')', 'versus', '(', '.', ')', ',', 'general', 'health', 'deterioration', '(', '.', ')', 'versus', '(', '.', ')', 'and', 'dysphagia', '(', '.', ')', 'versus', '(', '.', ')', 'in', 'cf', 'versus', 'cfp', ',', 'respectively', '.', 'three', '(', '.', ')', 'and', '(', '.', ')', 'common', 'terminology', 'criterion', 'adverse', 'event', '(', 'ctcae', ')', 'grade', 'event', 'in', 'cf', 'versus', 'cfp', ',', 'respectively', '.', 'low', 'soluble', '(', ')', 'egfr', 'level', 'associated', 'with', 'better', 'progression-free', 'survival', 'segfr', 'induced', 'cfp', '.', 'conclusion', 'egfr', 'inhibition', 'added', 'to', 'cf', 'not', 'improve', 'survival', 'in', 'unselected', 'advanced', 'escc', 'patient', '.', 'result', 'support', 'liquid', 'biopsy', 'study', '.', 'trial', 'registration', 'clinicaltrials.gov', '(', 'nct', ')', 'and', 'eudract', '(', '--', ')', '.']"
Effect of a 3% gelatin solution on urinary KIM-1 levels in patients after thyroidectomy: a preliminary randomized controlled trial.,"Patrycja Leśnik, Ewa Woźnica-Niesobska#, Jarosław Janc#, Magdalena Mierzchała-Pasierb, Lidia Łysenko#, Patrycja Leśniket al.",2021 Dec 8,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/34880372/,No keywords found,"['httpswww.isrctn.comisrctn', ')', '.']"
A Pilot Study Evaluating the Effect of Cooler Dialysate Temperature on Hemodynamic Stability During Prolonged Intermittent Renal Replacement Therapy in Acute Kidney Injury.,"Fahad Y Edrees, Sreelatha Katari, Jack D Baty, Anitha Vijayan, Fahad Y Edreeset al.",2019 Feb,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/30394919/,No keywords found,"['acute', 'kidney', 'injury', 'requiring', 'renal', 'replacement', 'therapy', 'associated', 'with', 'high', 'morbidity', 'and', 'mortality', '.', 'complication', 'of', 'renal', 'replacement', 'therapy', 'include', 'hemodynamic', 'instability', 'with', 'ensuing', 'shortened', 'treatment', ',', 'inadequate', 'ultrafiltration', ',', 'and', 'delay', 'in', 'renal', 'recovery', '.', 'study', 'shown', 'lowering', 'dialysate', 'temperature', 'in', 'patient', 'with', 'end-stage', 'renal', 'disease', 'associated', 'with', 'decrease', 'in', 'frequency', 'of', 'intradialytic', 'hypotension', '.', 'however', ',', 'data', 'regarding', 'mitigation', 'of', 'hypotension', 'lowering', 'dialysate', 'temperature', 'in', 'patient', 'with', 'acute', 'kidney', 'injury', 'scarce', '.', 'conducted', 'prospective', ',', 'randomized', ',', 'cross-over', 'pilot', 'study', 'to', 'evaluate', 'effect', 'of', 'lower', 'dialysate', 'temperature', 'hemodynamic', 'status', 'of', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', 'prolonged', 'intermittent', 'renal', 'replacement', 'therapy', '.', 'design', 'single-center', 'prospective', ',', 'randomized', ',', 'cross-over', 'study', '.', 'setting', 'icu', 'and', 'step', 'unit', 'in', 'tertiary', 'referral', 'center', '.', 'patient', 'acute', 'kidney', 'injury', 'patient', 'undergoing', 'prolonged', 'intermittent', 'renal', 'replacement', 'therapy', '.', 'intervention', 'participant', 'randomized', 'to', 'start', 'prolonged', 'intermittent', 'renal', 'replacement', 'therapy', 'with', 'dialysate', 'temperature', 'of', 'c', 'or', 'dialysate', 'temperature', 'of', 'c.', 'measurement', 'and', 'main', 'result', 'primary', 'endpoint', 'number', 'of', 'hypotensive', 'event', ',', 'defined', 'of', 'following', 'decrease', 'in', 'systolic', 'blood', 'pressure', 'greater', 'or', 'equal', 'to', 'mm', 'hg', ',', 'decrease', 'in', 'mean', 'arterial', 'pressure', 'greater', 'or', 'equal', 'to', 'mm', 'hg', ',', 'decrease', 'in', 'ultrafiltration', ',', 'or', 'increase', 'in', 'vasopressor', 'requirement', '.', 'number', 'of', 'event', 'analyzed', 'poisson', 'regression', 'and', 'outcome', 'with', 'repeated-measures', 'analysis', 'of', 'variance', '.', 'twenty-one', 'patient', 'underwent', 'total', 'of', 'prolonged', 'intermittent', 'renal', 'replacement', 'therapy', 'session', ',', 'in', 'arm', '.', 'number', 'of', 'hypotensive', 'event', 'twice', 'high', 'treatment', 'with', 'dialysate', 'temperature', 'of', 'c', ',', 'compared', 'with', 'treatment', 'with', 'cooler', 'dialysate', '(', '.', '.', 'v', '.', '.', 'incidence', 'rate', 'ratio', ',', '.', 'p', '.', ')', '.', 'treatment', 'session', 'with', 'cooler', 'dialysate', 'likely', 'to', 'reach', 'prescribed', 'ultrafiltration', 'target', '.', 'conclusion', 'patient', 'with', 'acute', 'kidney', 'injury', 'undergoing', 'prolonged', 'intermittent', 'renal', 'replacement', 'therapy', 'with', 'cooler', 'dialysate', 'experienced', 'significantly', 'less', 'hypotension', 'treatment', '.', 'prevention', 'of', 'hemodynamic', 'instability', 'renal', 'replacement', 'therapy', 'helped', 'to', 'achieve', 'ultrafiltration', 'goal', 'and', 'may', 'help', 'to', 'prevent', 'volume', 'overload', 'in', 'critically', 'ill', 'patient', '.']"
Assessment of antiviral and antibiotic combination treatment in influenza-A H1N1 induced acute kidney injury among hospitalized patients.,"Azfar Athar Ishaqui, Amer Hayat Khan, Syed Azhar Syed Sulaiman, Mohammed Taher Alsultan, Irfanullah Khan, Hamad Al Nami, Azfar Athar Ishaquiet al.",2019 May,Pak J Pharm Sci,https://pubmed.ncbi.nlm.nih.gov/31303595/,No keywords found,"['group', ',', 'received', 'antiviral', '(', 'oseltamivir', ')', 'drug', 'alone', 'and', 'group', ',', 'received', 'antiviral', '(', 'oseltamivir', ')', 'in', 'combination', 'with', 'empirically', 'prescribed', 'antibiotic', '.', 'patient', 'of', 'group', 'assessed', 'incidence', 'of', 'aki', 'two', 'criterion', 'i.e', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'and', 'rifle', '.', 'total', 'of', 'patient', '(', 'group', 'and', 'group', ')', 'enrolled', '.', 'according', 'to', 'rifle', 'criterion', ',', '(', ')', 'of', 'group', 'and', '(', ')', 'patient', 'of', 'group', 'suffered', 'aki', 'with', 'statistically', 'significant', 'difference', '(', 'p.', ')', '.', 'also', 'per', 'akin', 'criterion', ',', 'incidence', 'of', 'aki', 'statistically', 'significantly', 'difference', '(', 'p.', ')', 'group', 'with', '(', ')', 'patient', 'and', '(', ')', 'patient', 'of', 'group', 'and', 'respectively', '.', 'length', 'of', 'hospitalization', 'statistically', 'less', '(', 'p.', ')', 'in', 'group', 'patient', '.', 'incidence', 'of', 'aki', 'in', 'influenza-a', 'hn', 'treated', 'with', 'antiviral', 'and', 'antibiotic', 'combination', 'statistically', 'less', 'compared', 'to', 'patient', 'given', 'antiviral', 'alone', 'treatment', 'of', 'influenza', 'infection', '.']"
Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.,"F H Mose, A N Jörgensen, M H Vrist, N P Ekelöf, E B Pedersen, J N Bech, F H Moseet al.",2019 Jun 3,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/31159750/,No keywords found,"['chloride', 'speculated', 'to', 'nephrotoxic', 'property', '.', 'in', 'healthy', 'subject', 'tested', 'hypothesis', 'acute', 'chloride', 'loading', 'with', 'saline', 'would', 'induce', 'kidney', 'injury', ',', 'could', 'prevented', 'with', 'loop-diuretic', 'furosemide', '.', 'method', 'study', 'designed', 'randomized', ',', 'placebo-controlled', ',', 'crossover', 'study', '.', 'subject', 'given', 'saline', 'accompanied', 'either', 'placebo', 'or', 'furosemide', '.', ',', 'and', 'infusion', 'of', 'saline', 'measured', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', ',', 'fractional', 'excretion', 'of', 'sodium', '(', 'fena', ')', ',', 'urinary', 'chloride', 'excretion', '(', 'u-cl', ')', ',', 'urinary', 'excretion', 'of', 'aquaporin-', '(', 'u-aqp', ')', 'and', 'epithelial', 'sodium', 'channel', '(', 'u-enac', ')', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'u-ngal', ')', 'and', 'kidney', 'injury', 'molecule-', '(', 'u-kim-', ')', 'marker', 'of', 'kidney', 'injury', 'and', 'vasoactive', 'hormone', 'renin', '(', 'prc', ')', ',', 'angiotensin', 'ii', '(', 'p-angii', ')', ',', 'aldosterone', '(', 'p-aldo', ')', 'and', 'arginine', 'vasopressin', '(', 'p-avp', ')', '.', 'four', 'day', 'prior', 'to', 'of', 'two', 'examination', 'subject', 'given', 'standardized', 'fluid', 'and', 'diet', 'intake', '.', 'result', 'saline', 'infusion', 'u-ngal', 'and', 'kim-', 'excretion', 'increased', 'slightly', '(', 'u-ngal', 'placebo', 'vs.', '-', 'ngmin', 'furosemide', ',', 'p', '.', ',', 'u-kim-', '.', '.', 'v', '-', '.', '.', 'ngml', ',', 'p', '.', ')', '.', 'increase', 'in', 'u-ngal', 'absent', 'furosemide', 'given', 'simultaneously', ',', 'and', 'response', 'in', 'u-ngal', 'not', 'significantly', 'different', 'placebo', 'control', '.', 'furosemide', 'changed', 'response', 'in', 'u-kim-', 'delayed', 'increase', 'observed', '.', 'gfr', 'increased', 'saline', 'decreased', 'furosemide', 'accompanied', 'infusion', '.', 'u-na', ',', 'fena', ',', 'u-cl', ',', 'and', 'u-osmolality', 'increased', 'in', 'response', 'to', 'saline', ',', 'and', 'increase', 'markedly', 'pronounced', 'furosemide', 'added', '.', 'fek', 'decreased', 'slightly', 'saline', 'infusion', ',', 'simultaneously', 'furosemide', 'increased', 'fek', '.', 'u-aqp', 'increased', 'saline', 'and', 'placebo', ',', 'and', 'response', 'increased', 'furosemide', '.', 'u-enac', 'decreased', 'to', 'extent', 'saline', 'infusion', 'in', 'two', 'group', '.', 'saline', 'significantly', 'reduced', 'prc', ',', 'p-angii', 'and', 'p-aldo', ',', 'and', 'response', 'attenuated', 'furosemide', '.', 'p-avp', 'increased', 'saline', ',', 'with', 'larger', 'increase', 'furosemide', '.', 'conclusion', 'study', 'show', 'minor', 'increase', 'in', 'marker', 'of', 'kidney', 'injury', 'saline', 'infusion', 'furosemide', 'abolished', 'increase', 'in', 'ngal', 'and', 'postponed', 'increase', 'in', 'u-kim-', '.', 'clinical', 'importance', 'of', 'finding', 'need', 'investigation', '.', 'trial', 'registration', '(', 'eu', 'clinical', 'trial', 'register', 'number', '--', ',', 'registered', 'th', 'november', ')', '.']"
Bioimpedance-Guided Hydration for the Prevention of Contrast-Induced Kidney Injury: The HYDRA Study.,"Mauro Maioli, Anna Toso, Mario Leoncini, Nicola Musilli, Gabriele Grippo, Claudio Ronco, Peter A McCullough, Francesco Bellandi, Mauro Maioliet al.",2018 Jun 26,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/29929610/,No keywords found,"['intravascular', 'volume', 'expansion', 'play', 'major', 'role', 'in', 'prevention', 'of', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', '.', 'recommended', 'standard', 'amount', 'of', 'fluid', 'infusion', 'procedure', 'not', 'produce', 'homogeneous', 'response', 'in', 'subject', 'with', 'different', 'initial', 'hydration', 'status', '.', 'objective', 'goal', 'of', 'study', 'to', 'compare', 'effect', 'of', 'standard', 'and', 'double', 'intravenous', '(', 'iv', ')', 'infusion', 'volume', 'in', 'patient', 'with', 'low', 'body', 'fluid', 'level', ',', 'assessed', 'using', 'bioimpedance', 'vector', 'analysis', '(', 'biva', ')', ',', 'incidence', 'of', 'ci-aki', 'elective', 'coronary', 'angiographic', 'procedure', '.', 'method', 'total', 'of', 'patient', 'with', 'low', 'biva', 'level', 'admission', 'randomized', 'to', 'receive', 'standard', 'volume', 'saline', '(', 'mlkgh', 'h', 'and', 'procedure', ')', 'or', 'double', 'volume', 'saline', '(', 'mlkgh', ')', '.', 'patient', '(', 'n', ')', 'with', 'optimal', 'biva', 'level', 'received', 'standard', 'volume', 'saline', 'and', 'included', 'in', 'prospective', 'registry', '.', 'saline', 'infusion', 'halved', 'in', 'patient', 'with', 'ejection', 'fraction', '.', 'biva', 'repeated', 'immediately', 'angiographic', 'procedure', 'in', 'patient', '.', 'ci-aki', 'defined', 'increase', 'in', 'level', 'of', 'cystatin', 'c', 'baseline', 'h', 'contrast', 'administration', '.', 'result', 'incidence', 'of', 'ci-aki', 'significantly', 'lower', '(', '.', 'vs.', '.', 'p', '.', ')', 'in', 'patient', 'receiving', 'double', 'volume', 'saline', 'in', 'receiving', 'standard', 'volume', 'saline', ',', 'respectively', '.', 'angiographic', 'procedure', ',', 'of', 'double', 'volume', 'patient', 'achieved', 'optimal', 'biva', 'level', 'compared', 'with', '.', 'in', 'standard', 'group', '(', 'p', '.', ')', '.', 'finding', 'consistent', 'in', 'pre-specified', 'subgroup', 'excluding', 'patient', 'with', 'left', 'ventricular', 'ejection', 'fraction', '(', 'p', 'interaction', '.', ')', '.', 'conclusion', 'evaluation', 'of', 'biva', 'level', 'admission', 'in', 'patient', 'with', 'stable', 'coronary', 'artery', 'disease', 'allows', 'adjustment', 'of', 'intravascular', 'volume', 'expansion', ',', 'resulting', 'in', 'lower', 'ci-aki', 'occurrence', 'angiographic', 'procedure', '.', '(', 'personalized', 'versus', 'standard', 'hydration', 'prevention', 'of', 'ci-aki', 'randomized', 'trial', 'with', 'bioimpedance', 'analysis', 'nct', ')', '.']"
A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer.,"Neal Shore, Begoña Mellado, Satish Shah, Ralph Hauke, Dan Costin, Nabil Adra, Marie Cullberg, Carlos Fernandez Teruel, Thomas Morris, Neal Shoreet al.",2023 Apr,Clin Genitourin Cancer,https://pubmed.ncbi.nlm.nih.gov/36572571/,No keywords found,"['although', 'androgen', 'receptor-targeted', 'agent', 'prolong', 'life', 'of', 'patient', 'with', 'metastatic', 'prostate', 'cancer', ',', 'patient', 'develop', 'therapy', 'resistance', 'and', 'ultimately', 'succumb', 'to', 'disease', '.', 'pikaktpten', 'pathway', 'associated', 'with', 'development', 'of', 'resistance', ',', 'raising', 'possibility', 'pathway', 'inhibitor', 'may', 'produce', 'clinical', 'benefit', '.', 'open-label', 'phase', 'ib', 'study', 'examined', 'safety', ',', 'tolerability', ',', 'pharmacokinetics', '(', 'pk', ')', 'and', 'preliminary', 'clinical', 'activity', 'of', 'adding', 'capivasertib', '-', 'potent', ',', 'selective', 'inhibitor', 'of', 'akt', '-', 'to', 'approved', 'abiraterone', 'acetate', 'therapy', '.', 'method', 'twenty-seven', 'patient', 'with', 'metastatic', 'castration-resistant', 'prostate', 'cancer', 'undergone', 'least', 'prior', 'line', 'of', 'systemic', 'therapy', 'received', 'abiraterone', 'acetate', 'mg', '(', 'orally', 'administered', 'daily', ')', ',', 'plus', 'oral', 'prednisone', 'mg', '(', 'twice', 'daily', ')', 'with', 'capivasertib', 'mg', '(', 'orally', ',', 'twice', 'daily', ',', 'with', 'intermittent', 'schedule', 'of', 'day', ',', 'day', ')', '.', 'result', 'no', 'dose-limiting', 'toxicity', 'observed', '.', 'frequent', 'adverse', 'event', '(', 'grade', ')', 'diarrhea', '(', ')', ',', 'anemia', '(', ')', ',', 'asthenia', '(', ')', ',', 'and', 'nausea', '(', ')', '.', 'frequent', 'grade', 'or', 'higher', 'adverse', 'event', 'acute', 'kidney', 'injury', '(', ')', ',', 'hyperglycemia', '(', ')', ',', 'rash', '(', ')', ',', 'abdominal', 'pain', '(', ')', ',', 'and', 'asthenia', '(', ')', '.', 'capivasertib', 'and', 'abiraterone', 'pk', 'consistent', 'with', 'previously', 'reported', 'result', 'monotherapy', 'dosing', '.', 'nine', 'participant', '(', ')', 'showed', 'or', 'greater', 'decrease', 'in', 'prostate-specific', 'antigen', 'study', 'treatment', '.', 'conclusion', 'combination', 'of', 'capivasertib', 'and', 'abiraterone', 'acetate', 'acceptable', 'tolerability', 'profile', 'consistent', 'with', 'known', 'profile', 'of', 'agent', '.', 'data', 'support', 'evaluation', 'of', 'capivasertib', 'and', 'abiraterone', 'acetate', 'in', 'patient', 'with', 'advanced', 'prostate', 'cancer', '.']"
Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma.,"Hung C Tran, Araz Marachelian, Rajkumar Venkatramani, Rima F Jubran, Leo Mascarenhas, Hung C Tranet al.",2015 Feb,Pediatr Hematol Oncol,https://pubmed.ncbi.nlm.nih.gov/25551355/,"Chemotherapy, doxorubicin, neuroblastoma, oxaliplatin, pediatric oncology.","['patient', 'with', 'relapsed', 'or', 'refractory', 'neuroblastoma', 'poor', 'long-term', 'survival', '.', 'new', 'therapeutic', 'regimen', 'needed', '.', 'doxorubicin', 'and', 'cisplatin', 'commonly', 'used', 'in', 'treatment', 'of', 'high-risk', 'neuroblastoma', '.', 'oxaliplatin', ',', 'platinum', 'compound', 'with', ',', '-diaminocyclohexan', 'carrier', 'ligand', ',', 'potent', 'cisplatin', 'with', 'less', 'nephrotoxicity', 'and', 'ototoxicity', '.', 'treated', 'seven', 'relapsedrefractory', 'neuroblastoma', 'patient', 'using', 'oxaliplatin', '(', '-', 'mgm', '(', ')', ')', 'and', 'doxorubicin', '(', '-', 'mgm', '(', ')', ')', 'together', 'with', 'dexrazoxane', '(', 'mgmg', 'of', 'doxorubicin', ')', 'administered', 'intravenously', 'every', 'three', 'week', '.', 'prolonged', 'thrombocytopenia', 'causing', 'treatment', 'delay', 'observed', 'oxaliplatin', 'administered', 'mgm', '(', ')', '.', 'reduced', 'dose', 'of', 'oxaliplatin', 'mgm', '(', ')', 'day', 'with', 'doxorubicin', 'mgm', '(', ')', 'dose', 'day', '-', 'well', 'tolerated', '.', 'sensory', 'neuropathy', 'mild', 'and', 'transient', '.', 'no', 'cardiotoxicity', 'noted', 'despite', 'patient', 'history', 'of', 'prior', 'anthracycline', 'exposure', '.', 'best', 'response', 'included', 'complete', 'response', ',', 'partial', 'response', ',', 'mixed', 'response', ',', 'stable', 'disease', '.', 'in', 'cohort', 'of', 'heavily', 'pretreated', 'relapsed', 'and', 'refractory', 'neuroblastoma', 'patient', ',', 'combination', 'of', 'oxaliplatin', 'and', 'doxorubicin', 'demonstrated', 'anti-tumor', 'activity', 'and', 'merit', 'investigation', '.']"
Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.,"Kanta Tanaka, Masatoshi Koga, Mayumi Fukuda-Doi, Adnan I Qureshi, Haruko Yamamoto, Kaori Miwa, Masafumi Ihara, Kazunori Toyoda                              ;, ATACH- Trial Investigators, Kanta Tanakaet al.",2022 Jun,Stroke,https://pubmed.ncbi.nlm.nih.gov/35400202/,No keywords found,"['to', 'highlight', 'heterogeneity', 'of', 'acute', 'temporal', 'blood', 'pressure', '(', 'bp', ')', 'change', 'in', 'atach-', 'trial', '(', 'antihypertensive', 'treatment', 'of', 'acute', 'cerebral', 'hemorrhage-', ')', 'and', 'association', 'with', 'outcome', 'of', 'intracerebral', 'hemorrhage', '.', 'method', 'one', 'thousand', 'patient', 'with', 'acute', 'intracerebral', 'hemorrhage', ',', 'randomized', 'to', 'intensive', '(', '-', 'mm', 'hg', ')', 'or', 'standard', '(', '-', 'mm', 'hg', ')', 'systolic', 'bp', '(', 'sbp', ')', 'lowering', 'with', 'intravenous', 'nicardipine', 'in', 'atach-', 'to', ',', 'analyzed', 'temporal', 'change', 'in', 'hourly', 'maximum', 'sbp', 'to', 'hour', 'randomization', 'using', 'group-based', 'trajectory', 'modeling', '.', 'outcome', 'included', 'death', 'or', 'disability', '(', 'modified', 'rankin', 'scale', 'score', '-', ')', 'month', ',', 'neurological', 'deterioration', 'within', 'hour', '(', '-point', 'decrease', 'in', 'glasgow', 'coma', 'scale', 'score', 'or', '-point', 'increase', 'in', 'national', 'institute', 'of', 'health', 'stroke', 'scale', 'score', ')', ',', 'and', 'acute', 'kidney', 'injury', '(', '.', 'mgdl', 'within', 'hour', 'or', '.-fold', 'increase', 'in', 'serum', 'creatinine', ')', 'within', 'day', 'onset', '.', 'result', 'group-based', 'trajectory', 'modeling', 'revealed', 'sbp', 'trajectory', 'group', 'moderate', 'sbp', '(', 'mm', 'hg', 'hospital', 'arrival', 'to', '-', 'mm', 'hg', 'randomization', 'n', ')', ',', 'moderate-to-low', 'sbp', '(', 'mm', 'hg', 'to', 'mm', 'hg', 'to', 'mm', 'hg', 'to', '-', 'mm', 'hg', 'n', ')', '.', 'patient', 'with', 'intensive', 'treatment', 'accounted', '.', ',', '.', ',', '.', ',', 'and', '.', 'of', 'group', ',', 'respectively', '.', 'compared', 'with', 'moderate-to-low', 'sbp', 'group', ',', 'high-to-low', 'sbp', 'group', 'showed', 'increased', 'risk', 'of', 'death', 'or', 'disability', 'month', '(', 'adjusted', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', 'and', 'acute', 'kidney', 'injury', '(', 'adjusted', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'no', 'increase', 'in', 'neurological', 'deterioration', 'seen', 'in', 'group', '(', 'adjusted', 'odds', 'ratio', ',', '.', 'ci', ',', '.-.', ')', '.', 'moderate', 'sbp', 'and', 'high', 'sbp', 'group', 'showed', 'no', 'significant', 'risk', 'difference', 'outcome', '.', 'conclusion', 'data-driven', 'observation', 'using', 'group-based', 'trajectory', 'modeling', 'approach', 'may', 'useful', 'to', 'clarify', 'relationship', 'antihypertensive', 'treatment', ',', 'temporal', 'sbp', 'change', ',', 'and', 'outcome', 'in', 'acute', 'intracerebral', 'hemorrhage', '.', 'registration', 'url', 'httpswww', '.', 'clinicaltrials', 'gov', 'unique', 'identifier', 'nct', '.']"
Lung ultrasound-guided fluid resuscitation in neonatal septic shock: A randomized controlled trial.,"Dabin Huang, Chuming You, Xiaowei Mai, Lin Li, Qiong Meng, Zhenyu Liang, Dabin Huanget al.",2024 Mar,Eur J Pediatr,https://pubmed.ncbi.nlm.nih.gov/38095714/,No keywords found,"['lung', 'ultrasound', 'noninvasive', 'and', 'convenient', 'tool', 'predicting', 'fluid', 'overload', 'in', 'neonatal', 'septic', 'shock', '.', 'fluid', 'resuscitation', 'guided', 'lung', 'ultrasound', 'shorten', 'length', 'of', 'hospital', 'and', 'nicu', 'stay', ',', 'reduce', 'amount', 'of', 'fluid', 'used', 'in', 'first', 'h', ',', 'and', 'reduce', 'risk', 'of', 'acute', 'kidney', 'injury', 'and', 'intracranial', 'hemorrhage', '.', 'trial', 'registration', 'registered', 'in', 'guangdong', 'second', 'provincial', 'general', 'hospital', '-iit', '--', 'ek', ',', 'date', 'of', 'registration', 'november', ',', '.', 'and', 'clinicaltrials.gov', 'nct', '(', 'retrospectively', 'registered', ')', '.', 'known', 'excessive', 'fluid', 'resuscitation', 'in', 'neonate', 'with', 'septic', 'shock', 'worse', 'outcome', '.', 'new', 'lung', 'ultrasound', 'routinely', 'used', 'to', 'guide', 'fluid', 'resuscitation', 'in', 'neonatal', 'septic', 'shock', '.']"
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis.,"Tihana Bicanic, Christian Bottomley, Angela Loyse, Annemarie E Brouwer, Conrad Muzoora, Kabanda Taseera, Arthur Jackson, Jacob Phulusa, Mina C Hosseinipour, Charles van der Horst, Direk Limmathurotsakul, Nicholas J White, Douglas Wilson, Robin Wood, Graeme Meintjes, Thomas S Harrison, Joseph N Jarvis, Tihana Bicanicet al.",2015 Dec,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/26349818/,No keywords found,"['amphotericin', 'b', 'deoxycholate', '(', 'ambd', ')', 'recommended', 'induction', 'treatment', 'hiv-associated', 'cryptococcal', 'meningitis', '(', 'cm', ')', '.', 'use', 'hampered', 'toxicity', 'include', 'electrolyte', 'abnormality', ',', 'nephrotoxicity', ',', 'and', 'anemia', '.', 'protocol', 'to', 'minimize', 'toxicity', 'applied', 'inconsistently', '.', 'in', 'clinical', 'trial', 'cohort', 'of', 'ambd-based', 'cm', 'induction', 'treatment', ',', 'standardized', 'protocol', 'of', 'preemptive', 'hydration', 'and', 'electrolyte', 'supplementation', 'applied', '.', 'change', 'in', 'blood', 'count', ',', 'electrolyte', 'level', ',', 'and', 'creatinine', 'level', 'day', 'analyzed', 'in', 'relation', 'to', 'ambd', 'dose', ',', 'treatment', 'duration', '(', 'short', 'course', 'of', 'to', 'day', 'or', 'standard', 'course', 'of', 'day', ')', ',', 'addition', 'of', 'flucytosine', '(', 'fc', ')', ',', 'and', 'outcome', '.', 'in', 'patient', 'studied', ',', 'hemoglobin', 'level', 'dropped', 'mean', 'of', '.', 'gdl', '(', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'gdl', ')', 'following', 'day', 'of', 'ambd', 'and', 'mean', 'of', '.', 'gdl', '(', 'ci', ',', '.', 'to', '.', 'gdl', ')', 'day', '.', 'serum', 'creatinine', 'level', 'increased', 'molliter', '(', 'ci', ',', 'to', 'molliter', ')', 'day', 'and', 'molliter', '(', 'ci', ',', 'to', 'molliter', ')', 'day', 'of', 'ambd', 'treatment', '.', 'overall', ',', 'of', 'patient', 'developed', 'grade', 'iiiiv', 'anemia', ',', '.', 'developed', 'grade', 'iii', 'hypokalemia', ',', '.', 'creatinine', 'level', 'exceeded', 'mol', ',', 'and', 'discontinued', 'ambd', 'prematurely', '.', 'addition', 'of', 'fc', 'associated', 'with', 'slight', 'increase', 'in', 'anemia', 'not', 'neutropenia', '.', 'laboratory', 'abnormality', 'stabilized', 'or', 'reversed', 'second', 'week', 'in', 'patient', 'short-course', 'induction', '.', 'grade', 'iiiiv', 'anemia', '(', 'adjusted', 'odds', 'ratio', 'aor', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', 'and', 'nephrotoxicity', '(', 'aor', ',', '.', 'ci', ',', '.', 'to', 'p', '.', ')', 'risk', 'factor', '-week', 'mortality', '.', 'in', 'summary', ',', 'routine', 'intravenous', 'saline', 'hydration', 'and', 'preemptive', 'electrolyte', 'replacement', 'ambd-based', 'induction', 'regimen', 'hiv-associated', 'cm', 'minimized', 'incidence', 'of', 'hypokalemia', 'and', 'nephrotoxicity', '.', 'anemia', 'remained', 'concerning', 'adverse', 'effect', '.', 'addition', 'of', 'flucytosine', 'not', 'associated', 'with', 'increased', 'neutropenia', '.', 'shorter', 'ambd', 'course', 'less', 'toxic', ',', 'with', 'rapid', 'reversibility', '.']"
The CARDINAL Trial of Bardoxolone Methyl in Alport Syndrome: When Marketing Interests Prevail over Patients Clinical Needs.,"Piero Ruggenenti, Piero Ruggenenti.",2023,Nephron,https://pubmed.ncbi.nlm.nih.gov/36731435/,"Alport syndrome, Bardoxolone, CARDINAL trial, Heart failure, Liver toxicity, Nephrotoxicity.","['evidence', 'accompanied', 'glomerular', 'and', 'tubular', 'inflammatory', 'change', 'and', 'bardoxolone', 'methyl', 'exerts', 'anti-inflammatory', 'effect', 'suppression', 'of', 'nf-kb', 'and', 'activation', 'of', 'transcription', 'of', 'antioxidant', 'and', 'anti-inflammatory', 'gene', ',', 'provided', 'justification', 'cardinal', 'study', ',', 'prospective', ',', 'randomized', 'controlled', 'trial', 'testing', 'potential', 'renoprotective', 'effect', 'of', 'bardoxolone', 'methyl', 'in', 'adolescent', 'or', 'adult', 'patient', 'with', '.', 'author', 'concluded', 'bardoxolone', 'methyl', 'preserved', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'relative', 'to', 'placebo', 'and', 'week', 'randomization', '.', 'however', ',', 'exactly', 'number', 'of', 'patient', '(', 'n', ')', 'in', 'group', 'developed', 'kidney', 'failure', '.', 'second', 'opinion', 'despite', 'alarming', 'safety', 'signal', 'previous', 'trial', 'in', 'type', 'diabetic', 'with', 'ckd', '(', 'increased', 'hospitalization', 'heart', 'failure', ',', 'fatal', 'and', 'nonfatal', 'cardiovascular', 'event', ',', 'liver', 'toxicity', ',', 'and', 'increased', 'blood', 'pressure', 'and', 'albuminuria', ')', ',', 'major', 'marketing', 'interest', 'encouraged', 'drug', 'manufacturer', 'to', 'pursue', 'line', 'of', 'research', '.', 'finding', 'type', 'iv', 'collagen', 'gene', 'mutation', 'account', 'nearly', 'one-third', 'of', 'case', 'of', 'hereditary', 'glomerulopathies', 'implies', 'population', 'of', 'potential', 'target-patients', 'could', 'probably', 'much', 'larger', 'estimated', '.', 'moreover', ',', 'new', 'medication', 'approved', 'might', 'receive', 'orphan', 'drug', 'designation', 'might', 'associated', 'with', 'shortened', 'time', 'to', 'approval', ',', 'monetary', 'benefit', ',', 'and', 'period', 'of', 'market', 'exclusivity', '.', 'in', 'actual', 'fact', ',', 'cardinal', 'failed', 'to', 'demonstrate', 'nephro-protective', 'effect', 'of', 'bardoxolone', 'methyl', 'and', 'found', 'increase', 'in', 'liver', 'enzyme', 'in', 'of', '(', '.', ')', 'bardoxolone-treated', 'patient', 'consistent', 'with', 'chronic', 'liver', 'toxicity', '.', 'indeed', ',', 'in', 'zucker', 'diabetic', 'fatty', 'rat', 'treated', 'with', 'analog', 'of', 'bardoxolone', 'methyl', ',', 'elevation', 'of', 'liver', 'aminotransferase', 'associated', 'with', 'enhanced', 'liver', 'weight', ',', 'severe', 'and', 'diffuse', 'hepatocyte', 'vacuolization', ',', 'swelling', ',', 'and', 'degeneration', '.', 'moreover', ',', 'bardoxolone-induced', 'increase', 'in', 'egfr', 'associated', 'with', 'concomitant', 'increase', 'in', 'geometric', 'mean', 'urinary', 'albumincreatinine', 'ratio', ',', 'finding', 'consistent', 'with', 'worsening', 'glomerular', 'hyperfiltration', '.', 'considering', 'also', 'consequent', 'increase', 'in', 'biomechanical', 'strain', 'fragile', 'alport', 'glomerular', 'basement', 'membrane', ',', 'hemodynamic', 'effect', 'expected', 'to', 'translate', 'accelerated', 'renal', 'disease', 'progression', '(', 'consistently', 'with', 'evidence', 'bardoxolone', 'methyl', 'analog', 'worsened', 'proteinuria', ',', 'glomerulosclerosis', ',', 'and', 'tubular', 'damage', 'in', 'zucker', 'diabetic', 'fatty', 'rat', ')', '.', 'concern', 'induced', 'food', 'and', 'drug', 'administration', 'to', 'reject', 'new', 'drug', 'application', 'bardoxolone', 'methyl', 'submitted', 'reata', 'pharmaceutical', ',', 'inc.', 'with', 'proposed', 'indication', 'to', 'slow', 'ckd', 'progression', 'in', 'patient', 'year', 'of', 'age', 'and', 'older', '.', 'thus', ',', 'bardoxolone', 'methyl', 'devoid', 'of', 'nephro-protective', 'effect', 'and', 'associated', 'with', 'significant', 'heart', ',', 'liver', ',', 'and', 'renal', 'toxicity', 'in', 'patient', 'with', 'ckd', ',', 'including', 'with', '.', 'of', 'safety', 'signal', ',', 'not', 'used', 'in', 'clinical', 'context', '.', 'research', 'program', 'could', 'explore', 'potential', 'clinical', 'application', ',', 'even', 'outside', 'kidney', 'field', ',', 'of', 'novel', 'nf', 'erythroid', '-like', 'modulators', 'devoid', 'of', 'bardoxolone', 'methyl', 'toxicity', '.']"
"Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.","Marie José Kersten, Julia Driessen, Josée M Zijlstra, Wouter J Plattel, Franck Morschhauser, Pieternella J Lugtenburg, Pauline Brice, Martin Hutchings, Thomas Gastinne, Roberto Liu, Coreline N Burggraaff, Marcel Nijland, Sanne H Tonino, Anne I J Arens, Roelf Valkema, Harm van Tinteren, Marta Lopez-Yurda, Arjan Diepstra, Daphne De Jong, Anton Hagenbeek, Marie José Kerstenet al.",2021 Apr 1,Haematologica,https://pubmed.ncbi.nlm.nih.gov/32273476/,No keywords found,"['-', ')', 'achieved', 'mcr', 'hdcauto-pbsct', ',', 'five', 'mpr', 'and', 'five', 'progressive', 'disease', '(', 'three', 'not', 'evaluable', ')', '.', 'hdcauto-pbsct', ',', 'four', 'patient', 'with', 'mpr', 'converted', 'to', 'mcr', '.', '-year', 'pfs', 'ci', '-', ',', 'and', 'overall', 'survival', 'ci', '-', '.', 'toxicity', 'manageable', 'and', 'mainly', 'consisted', 'of', 'grade', 'hematological', 'toxicity', ',', 'fever', ',', 'nephrotoxicity', ',', 'ototoxicity', '(', 'grade', ')', 'and', 'transiently', 'elevated', 'liver', 'enzyme', 'bv-dhap', '.', 'eighteen', 'patient', 'developed', 'new', 'onset', 'peripheral', 'neuropathy', '(', 'maximum', 'grade', ')', 'and', 'recovered', '.', 'in', 'conclusion', ',', 'bv-dhap', 'effective', 'salvage', 'regimen', 'in', 'rr', 'chl', 'patient', ',', 'patient', 'monitored', 'closely', 'toxicity', '.', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial.,"Jung Tak Park, Hajeong Lee, Youn Kyung Kee, Seokwoo Park, Hyung Jung Oh, Seung Hyeok Han, Kwon Wook Joo, Chun-Soo Lim, Yon Su Kim, Shin-Wook Kang, Tae-Hyun Yoo, Dong Ki Kim                              ;, HICORES Investigators, Hyung Ah Jo, Miyeun Han, Sunhwa Lee, Eun Young Kim, Ji-Soo Yang, Mi Jung Lee, Young Eun Kwon, Kyoung Sook Park, Seung Gyu Han, In Mee Han, Chang Yun Yoon, Geun Woo Ryu, Jong Hyun Jhee, Hyung Woo Kim, Seohyun Park, Su-Young Jung, Eun Kyoung Kim, Min Hee Kim, Yeon Ji Kim, Yoon Hee Jang, Mi Rae Kim, Kwnag Ju Song, Mi Ae Kim, Ju Young Hyun, Byeol Na Choi, Jung Tak Parket al.",2016 Oct,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/27084247/,No keywords found,"['soluble', 'inflammatory', 'mediator', 'known', 'to', 'exacerbate', 'sepsis-induced', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'suggested', 'to', 'play', 'part', 'in', 'immunomodulation', 'cytokine', 'removal', '.', 'however', ',', 'effect', 'of', 'continuous', 'venovenous', 'hemodiafiltration', '(', 'cvvhdf', ')', 'dose', 'inflammatory', 'cytokine', 'removal', 'and', 'influence', 'patient', 'outcome', 'not', 'yet', 'clear', '.', 'study', 'design', 'prospective', ',', 'randomized', ',', 'controlled', ',', 'open-label', 'trial', '.', 'setting', 'participant', 'septic', 'patient', 'with', 'aki', 'receiving', 'cvvhdf', 'aki', '.', 'intervention', 'conventional', '(', 'mlkgh', ')', 'and', 'high', '(', 'mlkgh', ')', 'dos', 'of', 'cvvhdf', 'duration', 'of', 'crrt', '.', 'outcome', 'patient', 'and', 'kidney', 'survival', 'and', 'day', ',', 'circulating', 'cytokine', 'level', '.', 'result', 'patient', 'randomly', 'assigned', 'group', '.', 'mean', 'age', '.', 'year', ',', 'and', '(', '.', ')', 'men', '.', 'mean', 'intervention', 'duration', '.', 'and', '.', 'day', 'conventional-', 'and', 'high-dose', 'group', ',', 'respectively', '.', 'no', 'difference', 'in', '-day', 'mortality', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', 'or', '-day', 'kidney', 'survival', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', 'group', '.', 'high-dose', 'cvvhdf', ',', 'not', 'conventional', 'dose', ',', 'significantly', 'reduced', 'interleukin', '(', 'il-', ')', ',', 'il-', ',', 'il-b', ',', 'and', 'il-', 'level', '.', 'no', 'difference', 'in', 'development', 'of', 'electrolyte', 'disturbance', 'conventional-', 'and', 'high-dose', 'group', '.', 'limitation', 'small', 'sample', 'size', '.', 'predilution', 'cvvhdf', 'method', 'used', 'and', 'initiation', 'criterion', 'not', 'controlled', '.', 'conclusion', 'high', 'cvvhdf', 'dose', 'not', 'improve', 'patient', 'outcome', 'despite', 'significant', 'influence', 'inflammatory', 'cytokine', 'removal', '.', 'crrt-induced', 'immunomodulation', 'may', 'not', 'sufficient', 'to', 'influence', 'clinical', 'end', 'point', '.']"
"Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.","Arndt Vogel, Anna Saborowski, Patrick Wenzel, Henning Wege, Gunnar Folprecht, Albrecht Kretzschmar, Philipp Schütt, Lutz Jacobasch, Nicolas Ziegenhagen, Stefan Boeck, Danmei Zhang, Stephan Kanzler, Sebastian Belle, Johannes Mohm, Eray Gökkurt, Christian Lerchenmüller, Ullrich Graeven, Daniel Pink, Thorsten Götze, Martha M Kirstein, Arndt Vogelet al.",2024 Aug,Lancet Gastroenterol Hepatol,https://pubmed.ncbi.nlm.nih.gov/38870977/,No keywords found,"['unmet', 'need', 'effective', 'therapy', 'in', 'pretreated', 'advanced', 'biliary', 'tract', 'cancer', '.', 'aimed', 'to', 'evaluate', 'efficacy', 'of', 'nanoliposomal', 'irinotecan', 'and', 'fluorouracil', 'plus', 'leucovorin', 'compared', 'with', 'fluorouracil', 'plus', 'leucovorin', 'second-line', 'treatment', 'biliary', 'tract', 'cancer', '.', 'method', 'naliricc', 'multicentre', ',', 'open-label', ',', 'randomised', ',', 'phase', 'trial', 'done', 'in', 'german', 'centre', 'patient', 'aged', 'year', 'or', 'older', ',', 'with', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', '-', ',', 'metastatic', 'biliary', 'tract', 'cancer', ',', 'and', 'progression', 'gemcitabine-based', 'therapy', '.', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'intravenous', 'infusion', 'of', 'nanoliposomal', 'irinotecan', '(', 'mgm', ')', ',', 'fluorouracil', '(', 'mgm', ')', ',', 'and', 'leucovorin', '(', 'mgm', ')', 'every', 'week', '(', 'nanoliposomal', 'irinotecan', 'group', ')', 'or', 'fluorouracil', '(', 'mgm', ')', 'plus', 'leucovorin', '(', 'mgm', ')', 'every', 'week', '(', 'control', 'group', ')', '.', 'randomisation', 'permutated', 'block', 'randomisation', 'in', 'block', 'size', 'of', 'four', ',', 'stratified', 'primary', 'tumour', 'site', '.', 'investigator-assessed', 'progression-free', 'survival', 'primary', 'endpoint', ',', 'evaluated', 'in', 'randomly', 'assigned', 'patient', '.', 'secondary', 'efficacy', 'outcome', 'overall', 'survival', ',', 'objective', 'response', 'rate', ',', 'and', 'quality', 'of', 'life', '.', 'safety', 'assessed', 'in', 'randomly', 'assigned', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '.', 'enrolment', 'trial', 'completed', ',', 'and', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'dec', ',', ',', 'and', 'aug', ',', ',', 'patient', 'randomly', 'assigned', 'to', 'nanoliposomal', 'irinotecan', 'group', 'and', 'patient', 'to', 'control', 'group', '.', 'median', 'age', 'year', '(', 'iqr', '-', ')', '(', ')', 'of', 'patient', 'female', '.', 'median', 'progression-free', 'survival', 'month', '(', 'ci', '-', ')', 'in', 'nanoliposomal', 'irinotecan', 'group', 'and', 'month', '(', '-', ')', 'in', 'control', 'group', '(', 'hazard', 'ratio', 'hr', '-', ')', '.', 'median', 'overall', 'survival', 'month', '(', 'ci', '-', ')', 'in', 'nanoliposomal', 'irinotecan', 'group', 'and', 'month', '(', '-', ')', 'in', 'control', 'group', '(', 'hr', '-', ')', '.', 'objective', 'response', 'rate', '(', 'ci', '-', 'seven', 'patient', ')', 'in', 'nanoliposomal', 'irinotecan', 'group', 'and', '(', '-', 'two', 'patient', ')', 'in', 'control', 'group', '.', 'common', 'grade', 'or', 'worse', 'adverse', 'event', 'in', 'nanoliposomal', 'irinotecan', 'group', 'neutropenia', '(', 'eight', 'of', 'v', 'none', 'in', 'control', 'group', ')', ',', 'diarrhoea', '(', 'seven', 'v', 'one', ')', ',', 'and', 'nausea', '(', 'four', 'v', 'none', ')', '.', 'in', 'control', 'group', ',', 'common', 'grade', 'or', 'worse', 'adverse', 'event', 'cholangitis', '(', 'four', 'patient', 'v', 'none', 'in', 'nanoliposomal', 'irinotecan', 'group', ')', 'and', 'bile', 'duct', 'stenosis', '(', 'four', 'v', 'three', ')', '.', 'treatment-related', 'serious', 'adverse', 'event', 'occurred', 'in', '(', ')', 'patient', 'in', 'nanoliposomal', 'irinotecan', 'group', '(', 'grade', '-', 'diarrhoea', 'in', 'five', 'patient', 'one', 'case', 'of', 'abdominal', 'infection', ',', 'acute', 'kidney', 'injury', ',', 'pancytopenia', ',', 'increased', 'blood', 'bilirubin', ',', 'colitis', ',', 'dehydration', ',', 'dyspnoea', ',', 'infectious', 'enterocolitis', ',', 'ileus', ',', 'oral', 'mucositis', ',', 'and', 'nausea', ')', '.', 'one', '(', ')', 'treatment-related', 'serious', 'adverse', 'event', 'occurred', 'in', 'control', 'group', '(', 'worsening', 'of', 'general', 'condition', ')', '.', 'median', 'duration', 'deterioration', 'of', 'global', 'health', 'status', ',', 'characterised', 'time', 'randomisation', 'to', 'initial', 'observation', 'of', 'score', 'decline', 'exceeding', 'point', ',', 'month', '(', 'ci', '-not', 'reached', ')', 'in', 'nanoliposomal', 'irinotecan', 'group', 'and', 'month', '(', '-not', 'reached', ')', 'in', 'control', 'group', '.', 'interpretation', 'addition', 'of', 'nanoliposomal', 'irinotecan', 'to', 'fluorouracil', 'plus', 'leucovorin', 'not', 'improve', 'progression-free', 'survival', 'or', 'overall', 'survival', 'and', 'associated', 'with', 'higher', 'toxicity', 'compared', 'with', 'fluorouracil', 'plus', 'leucovorin', '.', 'research', 'necessary', 'to', 'define', 'role', 'of', 'irinotecan-based', 'combination', 'in', 'second-line', 'treatment', 'of', 'biliary', 'tract', 'cancer', '.', 'funding', 'servier', 'and', 'aio-studien', '.']"
Remote ischemic preconditioning to reduce contrast-induced acute kidney injury in chronic kidney disease: a randomized controlled trial.,"Ali Ghaemian, Jamshid Yazdani, Soheil Azizi, Ali A Farsavian, Maryam Nabati, Alireza Malekrah, Mozhdeh Dabirian, Fatemeh Espahbodi, Bahareh Mirjani, Hossein Mohsenipouya, Javad Heshmatian, Ali Ghaemianet al.",2018 Dec 22,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/30577785/,No keywords found,"['impact', 'of', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'patient', 'with', 'chronic', 'renal', 'disease', 'well-known', '.', 'remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'non-invasive', 'method', 'reduce', 'risk', 'of', 'ci-aki', ',', 'study', 'ripc', 'different', 'result', '.', 'aim', 'of', 'present', 'study', 'to', 'assess', 'potential', 'impact', 'of', 'ripc', 'ci-aki', '.', 'method', 'in', 'randomized', ',', 'double', 'blinded', ',', 'controlled', 'trial', ',', 'patient', 'with', 'chronic', 'renal', 'dysfunction', '(', 'glomerular', 'filtration', 'rate', 'mlminm', ')', 'underwent', 'coronary', 'angiography', 'or', 'angioplasty', 'received', 'adequate', 'hydration', '.', 'ripc', 'performed', 'in', 'patient', 'applying', 'upper', 'arm', 'blood', 'pressure', 'cuff', '.', 'cuff', 'inflated', 'four', 'time', 'min', 'to', 'mmhg', 'systolic', 'blood', 'pressure', ',', 'followed', 'deflation', 'min', '.', 'in', 'control', 'group', ',', 'blood', 'pressure', 'cuff', 'inflated', 'to', 'mmhg', 'patient', ""'s"", 'diastolic', 'blood', 'pressure', '.', 'primary', 'endpoint', 'increase', 'in', 'serum', 'cystatin', 'c', 'baseline', 'to', '-', 'h', 'exposure', 'to', 'contrast', '.', 'result', 'primary', 'endpoint', 'achieved', 'in', '(', '.', ')', 'patient', '(', 'in', 'group', ')', '.', 'ripc', 'not', 'show', 'significant', 'effect', 'occurrence', 'of', 'primary', 'endpoint', '(', 'p', ')', '.', 'in', 'addition', ',', 'result', 'analyzed', 'based', 'mehran', 'risk', 'score', 'subgroup', 'of', 'patient', ',', 'ripc', 'not', 'reduce', 'occurrence', 'of', 'primary', 'endpoint', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'patient', 'moderate-to-high', 'risk', 'of', 'developing', 'ci-aki', 'adequate', 'hydration', 'protocol', 'performed', ',', 'ripc', 'not', 'additive', 'effect', 'to', 'prevent', 'occurrence', 'of', 'ci-aki', '.', 'trial', 'registration', 'clinical', 'trial', 'registered', '(', 'identification', 'number', 'irctn', ',', 'december', ',', 'retrospective', 'irct', ')', '.']"
Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT.,"Aswath Venkitaraman#, Arka De, Nipun Verma, Sunita Kumari, Bidyalaxmi Leishangthem, Ratti Ram Sharma, Naveen Kalra, Sandeep Grover, Virendra Singh#, Aswath Venkitaramanet al.",2022 Oct,Hepatol Int,https://pubmed.ncbi.nlm.nih.gov/35322373/,No keywords found,"['liver', 'transplant', ',', 'definitive', 'treatment', 'of', 'decompensated', 'cirrhosis', '(', 'dc', ')', ',', 'constrained', 'donor', 'shortage', 'and', 'long-term', 'complication', '.', 'granulocyte', 'colony-stimulating', 'factor', '(', 'g-csf', ')', 'explored', 'alternative', 'option', 'in', 'open-label', 'study', '.', 'double-blind', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'designed', 'to', 'elucidate', 'efficacy', 'of', 'g-csf', 'in', 'dc', '.', 'method', 'seventy', 'patient', 'randomized', 'to', 'either', 'g-csf', 'plus', 'standard', 'medical', 'therapy', '(', 'group', ',', 'n', ')', 'or', 'placebo', 'plus', 'standard', 'medical', 'therapy', '(', 'group', 'b', ',', 'n', ')', '.', 'primary', 'outcome', '-month', 'overall', 'survival', 'in', 'patient', 'received', 'least', 'one', 'cycle', 'of', 'intervention', '.', 'secondary', 'outcome', 'mobilization', 'of', 'cd', 'cell', 'day', ',', 'improvement', 'in', 'child-turcotte-pugh', '(', 'ctp', ')', ',', 'and', 'model', 'end-stage', 'liver', 'disease', '(', 'meld', ')', ',', 'liver', 'stiffness', 'measurement', ',', 'quality', 'of', 'life', ',', 'nutrition', ',', 'hepatic', 'decompensation', ',', 'infection', ',', 'hospitalization', ',', 'and', 'acute', 'kidney', 'injury', '.', 'result', 'survival', 'in', 'group', 'higher', 'in', 'group', 'b', 'although', 'difference', 'not', 'statistically', 'significant', '(', '.', 'v', '.', 'p', '.', ')', '.', 'cd', 'cell', 'day', 'significantly', 'higher', 'in', 'group', 'compared', 'to', 'baseline', '(', 'p', '.', ')', '.', 'ascites', 'control', '(', 'p', '.', ')', 'and', 'ctp', 'score', 'improvement', '(', 'p', '.', ')', 'better', 'in', 'group', '-months', '.', 'encephalopathy', 'episode', '(', 'p', '.', ')', ',', 'infection', '(', 'p', '.', ')', 'fewer', 'in', 'group', 'group', 'b', 'month', '.', 'secondary', 'outcome', 'not', 'improve', 'post-therapy', '.', 'no', 'treatment-related', 'discontinuation', 'or', 'severe', 'adverse', 'event', '.', 'conclusion', 'g-csf', 'therapy', 'safe', '.', 'improvement', 'in', 'survival', 'month', 'not', 'statistically', 'significant', '.', 'better', 'control', 'of', 'ascites', ',', 'improvement', 'of', 'ctp', 'score', ',', 'fewer', 'encephalopathy', 'episode', 'and', 'decreased', 'rate', 'of', 'infection', 'observed', 'with', 'g-csf', 'therapy', '(', 'nct', ')', '.', 'trial', 'registration', 'nct', '.']"
Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy.,"Frank Bridoux, Bertrand Arnulf, Lionel Karlin, Nicolas Blin, Nolwenn Rabot, Margaret Macro, Vincent Audard, Karim Belhadj, Brigitte Pegourie, Pierre Gobert, Emilie Cornec Le Gall, Bertrand Joly, Alexandre Karras, Arnaud Jaccard, Karine Augeul-Meunier, Salomon Manier, Bruno Royer, Denis Caillot, Mourad Tiab, Sébastien Delbes, Felipe Suarez, Cécile Vigneau, Sophie Caillard, Nina Arakelyan-Laboure, Damien Roos-Weil, Sylvie Chevret, Jean Paul Fermand                              ;, MYRE study group, Frank Bridouxet al.",2020 Aug 10,J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/32574117/,No keywords found,"['report', 'multicenter', 'controlled', 'trial', 'comparing', 'renal', 'recovery', 'and', 'tolerance', 'profile', 'of', 'doublet', 'versus', 'triplet', 'bortezomib-based', 'regimen', 'in', 'patient', 'with', 'initial', 'myeloma', 'cast', 'nephropathy', '(', 'cn', ')', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'without', 'need', 'dialysis', '.', 'method', 'symptomatic', 'measure', 'and', 'high-dose', 'dexamethasone', ',', 'patient', 'randomly', 'assigned', 'to', 'receive', 'bortezomib', 'plus', 'dexamethasone', '(', 'bd', ')', ',', 'or', 'bd', 'plus', 'cyclophosphamide', '(', 'c-bd', ')', '.', 'in', 'patient', 'with', 'reduction', 'of', 'serum', 'free', 'light', 'chain', '(', 'sflcs', ')', 'cycle', ',', 'chemotherapy', 'reinforced', 'with', 'either', 'cyclophosphamide', '(', 'bd', 'group', ')', 'or', 'thalidomide', '(', 'c-bd', 'group', ')', '.', 'result', 'ninety-two', 'patient', 'enrolled', 'in', 'group', '.', 'random', 'assignment', ',', 'characteristic', 'of', 'group', 'similar', ',', 'including', 'median', 'age', '(', 'year', ')', 'and', 'serum', 'creatinine', 'level', '(', '.', 'and', '.', 'moll', 'in', 'bd', 'and', 'c-bd', 'group', ',', 'respectively', ')', '.', 'month', ',', 'renal', 'response', 'rate', '(', 'primary', 'end', 'point', ')', 'not', 'different', '(', 'v', 'responder', 'in', 'bd', 'and', 'c-bd', 'group', ',', 'respectively', 'relative', 'risk', 'rr', ',', '.', 'p', '.', ')', '.', 'good', 'partial', 'response', '(', 'free', 'light', 'chain', 'reduction', ')', 'or', 'achieved', 'in', 'and', 'patient', ',', 'respectively', '(', 'rr', ',', '.', 'p', '.', ')', '.', 'cycle', 'of', 'chemotherapy', ',', 'in', 'bd', 'group', 'and', 'patient', 'in', 'c-bd', 'group', 'achieved', 'sflc', 'level', 'mgl', '.', 'serious', 'adverse', 'event', 'recorded', 'in', 'and', 'patient', ',', 'respectively', '.', 'month', ',', 'patient', 'died', '(', 'in', 'bd', 'group', 'v', 'in', 'c-bd', 'group', ')', ',', 'including', '(', 'in', 'bd', 'group', 'and', 'in', 'c-bd', 'group', ')', 'myeloma', 'progression', 'and', '(', 'in', 'bd', 'group', 'and', 'in', 'c-bd', 'group', ')', 'infection', '.', 'within', 'median', 'follow-up', 'of', 'month', ',', 'and', 'patient', 'switched', 'to', 'new', 'therapy', ',', 'respectively', '.', 'overall', ',', 'patient', '(', 'in', 'bd', 'group', 'and', 'in', 'c-bd', 'group', ')', 'died', '.', 'conclusion', 'randomized', 'study', 'not', 'show', 'benefit', 'of', 'c-bd', 'compared', 'with', 'bd', 'renal', 'recovery', 'of', 'patient', 'with', 'initial', 'cn', 'not', 'requiring', 'dialysis', '.', 'adding', 'cyclophosphamide', 'not', 'sufficiently', 'improve', 'efficacy-toxicity', 'balance', '.', 'patient', 'with', 'myeloma', 'with', 'aki', 'fragile', ',', 'and', 'indication', 'doublet', 'or', 'triplet', 'regimen', 'adapted', 'to', 'frailty', '.']"
Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.,"Heinz Ludwig, Elisabeth Rauch, Thomas Kuehr, Zdeněk Adam, Adalbert Weißmann, Hedwig Kasparu, Eva-Maria Autzinger, Daniel Heintel, Richard Greil, Wolfram Poenisch, Ercan Müldür, Niklas Zojer, Heinz Ludwiget al.",2015 Mar,Haematologica,https://pubmed.ncbi.nlm.nih.gov/25398836/,No keywords found,"['five', '(', '.', ')', 'achieved', 'complete', ',', 'four', '(', '.', ')', 'partial', 'and', 'seven', '(', ')', 'minor', 'renal', 'response', '.', 'five', 'of', 'patient', 'dialysis', 'dependent', 'baseline', 'became', 'dialysis', 'independent', '.', 'median', 'time', 'to', 'myeloma', 'and', 'to', 'renal', 'response', 'day', 'parameter', ',', 'median', 'time', 'to', 'best', 'myeloma', 'and', 'best', 'renal', 'response', 'and', 'day', ',', 'respectively', '.', 'median', 'estimated', 'glomerular', 'filtration', 'rate', 'increased', 'significantly', 'in', 'patient', 'with', 'partial', 'response', 'or', 'better', '.', 'mlmin', 'baseline', 'to', '.', 'mlmin', 'best', 'response', '(', 'p.', ')', '.', 'median', 'progression-free', 'and', 'overall', 'survival', '.', 'and', '.', 'month', ',', 'respectively', ',', 'in', 'intent-to-treat', 'population', 'and', '.', 'and', '.', 'month', ',', 'respectively', ',', 'in', 'per-protocol', 'group', '.', 'infection', ',', 'cardiotoxicity', ',', 'anemia', 'and', 'thrombocytopenia', 'frequent', 'toxicity', '.', 'in', 'conclusion', ',', 'lenalidomide-dexamethasone', 'regimen', 'achieved', 'rapid', 'and', 'substantial', 'myeloma', 'and', 'renal', 'response', '.', 'trial', 'registered', 'eudract', 'number', '--', '.']"
Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin.,"Yoshihiro Yamamoto, Kazushi Watanabe, Ikuto Tsukiyama, Hiroshi Matsushita, Hiromitsu Yabushita, Katsuhiko Matsuura, Akihiko Wakatsuki, Yoshihiro Yamamotoet al.",2015 Apr,Anticancer Res,https://pubmed.ncbi.nlm.nih.gov/25862878/,No keywords found,"['present', 'study', 'aimed', 'to', 'assess', 'efficacy', 'of', 'meq', 'magnesium', 'supplied', 'part', 'of', 'prehydration', 'regimen', 'in', 'preventing', 'cisplatin-induced', 'nephrotoxicity', 'in', 'patient', 'undergoing', 'therapy', 'with', 'cisplatin-alone', '(', 'mgm', '(', ')', 'week', ')', 'cervical', 'cancer', '.', 'patient', 'and', 'method', 'studied', 'patient', 'with', 'cervical', 'cancer', '.', 'prospective', 'cohort', 'study', 'compared', 'nephrotoxicity', 'in', 'patient', 'received', 'hydration', 'with', 'and', 'without', 'magnesium', 'sulfate', '(', 'mg-hydration', 'group', ',', 'n', 'non-mg-hydration', 'group', ',', 'n', ')', '.', 'result', 'baseline', 'characteristic', ',', 'stage', 'of', 'cervical', 'cancer', ',', 'cisplatin', 'dose', 'and', 'renal', 'function', 'not', 'differ', 'significantly', 'two', 'group', '.', 'serum', 'creatinine', 'level', 'significantly', 'increased', '.', 'to', '.', 'mgdl', ',', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'significantly', 'decreased', '.', 'to', '.', 'mlmin', 'chemotherapy', 'in', 'non-mg-hydration', 'group', '.', 'in', 'contrast', ',', 'level', 'not', 'change', 'significantly', 'in', 'mg-hydration', 'group', '.', 'conclusion', 'magnesium', 'dose', 'of', 'meq', 'found', 'to', 'provide', 'nephroprotective', 'effect', 'among', 'patient', 'with', 'cervical', 'cancer', 'undergoing', 'chemotherapy', 'with', 'cisplatin', 'alone', '.']"
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.,"Annegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, Michael J Ross, Shweta Sharma, Steven Coca, Amit Achhra, Elaine Cornell, Russell Tracy, Andrew Phillips, Marta Montero Alonso, Giota Toulomi, Brian K Agan, Nicholas Medland, Christina M Wyatt                              ;, INSIGHT START Study Group, Annegret Pelchen-Matthewset al.",2024 Jul,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/38697479/,"APOL1, albuminuria, chronic kidney disease, glomerular filtration rate, nephrotoxicity.","['people', 'with', 'human', 'immunodeficiency', 'virus', '(', 'hiv', ')', 'risk', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'due', 'to', 'hiv', 'and', 'antiretroviral', 'therapy', '(', 'art', ')', 'nephrotoxicity', '.', 'immediate', 'art', 'initiation', 'reduces', 'mortality', 'and', 'standard', 'of', 'care', ',', 'long-term', 'impact', 'of', 'prolonged', 'art', 'exposure', 'ckd', 'unknown', '.', 'to', 'evaluate', ',', 'strategic', 'timing', 'of', 'antiretroviral', 'treatment', '(', 'start', ')', 'trial', 'randomized', ',', 'art-nave', 'adult', 'with', 'cd', 'cell', 'count', 'cellsmm', 'to', 'immediate', 'versus', 'deferred', 'art', '.', 'previously', 'reported', 'small', 'statistically', 'significantly', 'greater', 'decline', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'median', 'of', '.', 'year', 'in', 'participant', 'randomized', 'to', 'deferred', 'versus', 'immediate', 'art', '.', ',', 'compare', 'incidence', 'of', 'ckd', 'event', 'and', 'change', 'in', 'egfr', 'and', 'urine', 'albumincreatinine', 'ratio', '(', 'uacr', ')', 'in', 'participant', 'randomized', 'to', 'immediate', 'versus', 'deferred', 'art', 'extended', 'follow-up', '.', 'median', 'of', '.', 'year', ',', 'eight', 'participant', 'experienced', 'kidney', 'failure', 'or', 'kidney-related', 'death', ',', 'three', 'in', 'immediate', 'and', 'five', 'in', 'deferred', 'art', 'arm', ',', 'respectively', '.', 'median', 'of', 'five', 'year', 'of', 'comprehensive', 'follow-up', ',', 'annual', 'rate', 'of', 'egfr', 'decline', '.', 'mlmin.myear', ',', 'with', 'no', 'significant', 'difference', 'treatment', 'arm', '(', 'difference', 'deferred', '-', 'immediate', 'arm', '.', 'confidence', 'interval', '-.', ',', '.', 'mlmin.m', ')', '.', 'result', 'similar', 'in', 'model', 'adjusted', 'baseline', 'covariates', 'associated', 'with', 'ckd', ',', 'including', 'uacr', 'and', 'apol', 'genotype', '.', 'similarly', ',', 'no', 'significant', 'difference', 'treatment', 'arm', 'in', 'incidence', 'of', 'confirmed', 'uacr', 'mgg', 'or', '(', 'odds', 'ratio', '.', 'confidence', 'interval', '.', ',', '.', ')', '.', 'thus', ',', 'finding', 'provide', 'definitive', 'evidence', 'to', 'date', 'in', 'support', 'of', 'long-term', 'safety', 'of', 'early', 'art', 'with', 'respect', 'to', 'kidney', 'health', '.']"
Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial.,"Rohit J Timal, Judith Kooiman, Yvo W J Sijpkens, Jean-Paul P M de Vries, Iris J A M Verberk-Jonkers, Harald F H Brulez, Marjolijn van Buren, Aart J van der Molen, Suzanne C Cannegieter, Hein Putter, Wilbert B van den Hout, J Wouter Jukema, Ton J Rabelink, Menno V Huisman, Rohit J Timalet al.",2020 Apr 1,JAMA Intern Med,https://pubmed.ncbi.nlm.nih.gov/32065601/,No keywords found,"['prevention', 'of', 'postcontrast', 'acute', 'kidney', 'injury', 'in', 'patient', 'with', 'stage', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'mean', 'of', 'prehydration', 'standard', 'care', 'year', '.', 'however', ',', 'evidence', 'need', 'prehydration', 'in', 'group', 'limited', '.', 'objective', 'to', 'assess', 'renal', 'safety', 'of', 'omitting', 'prophylactic', 'prehydration', 'prior', 'to', 'iodine-based', 'contrast', 'medium', 'administration', 'in', 'patient', 'with', 'stage', 'ckd', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'kompas', 'trial', 'multicenter', ',', 'noninferiority', ',', 'randomized', 'clinical', 'trial', 'conducted', 'hospital', 'in', 'netherlands', 'in', 'patient', 'with', 'stage', 'ckd', 'randomized', 'in', 'ratio', 'to', 'receive', 'no', 'prehydration', 'or', 'prehydration', 'with', 'ml', 'of', '.', 'sodium', 'bicarbonate', 'administered', 'in', '-hour', 'infusion', 'undergoing', 'elective', 'contrast-enhanced', 'computed', 'tomography', 'april', 'september', '.', 'final', 'follow-up', 'completed', 'in', 'september', '.', 'data', 'analyzed', 'january', 'to', 'june', '.', 'intervention', 'in', 'total', ',', 'patient', 'allocated', 'to', 'no', 'prehydration', 'group', 'and', 'allocated', 'to', 'receive', 'prehydration', '.', 'analysis', 'primary', 'end', 'point', 'available', 'in', 'patient', '(', '.', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', 'mean', 'relative', 'increase', 'in', 'serum', 'creatinine', 'level', 'to', 'day', 'contrast', 'administration', 'compared', 'with', 'baseline', '(', 'noninferiority', 'margin', 'of', 'less', 'increase', 'in', 'serum', 'creatinine', 'level', ')', '.', 'secondary', 'outcome', 'included', 'incidence', 'of', 'postcontrast', 'acute', 'kidney', 'injury', 'to', 'day', 'contrast', 'administration', ',', 'mean', 'relative', 'increase', 'in', 'creatinine', 'level', 'to', 'day', 'contrast', 'administration', ',', 'incidence', 'of', 'acute', 'heart', 'failure', 'and', 'renal', 'failure', 'requiring', 'dialysis', ',', 'and', 'health', 'care', 'cost', '.', 'result', 'of', 'patient', 'randomized', ',', 'included', 'in', 'intention-to-treat', 'analysis', '.', 'median', '(', 'interquartile', 'range', ')', 'age', '(', '-', ')', 'year', '(', '.', ')', 'men', 'and', '(', '.', ')', 'woman', '.', 'mean', '(', 'sd', ')', 'relative', 'increase', 'in', 'creatinine', 'level', 'to', 'day', 'contrast', 'administration', 'compared', 'with', 'baseline', '.', '(', '.', ')', 'in', 'no', 'prehydration', 'group', 'v', '.', '(', '.', ')', 'in', 'prehydration', 'group', '(', 'mean', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', 'noninferiority', ')', '.', 'postcontrast', 'acute', 'kidney', 'injury', 'occurred', 'in', 'patient', '(', '.', ')', ',', 'including', 'of', '(', '.', ')', 'in', 'no', 'prehydration', 'group', 'and', 'of', '(', '.', ')', 'in', 'prehydration', 'group', ',', 'resulted', 'in', 'relative', 'risk', 'of', '.', '(', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'none', 'of', 'patient', 'required', 'dialysis', 'or', 'developed', 'acute', 'heart', 'failure', '.', 'subgroup', 'analysis', 'showed', 'no', 'evidence', 'of', 'statistical', 'interaction', 'treatment', 'arm', 'and', 'predefined', 'subgroup', '.', 'mean', 'hydration', 'cost', '(', 'u', '.', ')', 'per', 'patient', 'in', 'prehydration', 'group', 'compared', 'with', '(', 'u', ')', 'in', 'no', 'prehydration', 'group', '(', 'p', '.', ')', '.', 'health', 'care', 'cost', 'similar', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'with', 'stage', 'ckd', 'undergoing', 'contrast-enhanced', 'computed', 'tomography', ',', 'withholding', 'prehydration', 'not', 'compromise', 'patient', 'safety', '.', 'finding', 'of', 'study', 'support', 'option', 'of', 'not', 'giving', 'prehydration', 'safe', 'and', 'cost-efficient', 'measure', '.', 'trial', 'registration', 'netherlands', 'trial', 'register', 'identifier', 'ntr', '.']"
Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial.,"Mohamed A Kandil, Khalid M Abouelenain, Ayman Alsebaey, Hanaa S Rashed, Mohamed H Afifi, Mohamed A Mahmoud, Khaled A Yassen, Mohamed A Kandilet al.",2017 Aug,Clin Transplant,https://pubmed.ncbi.nlm.nih.gov/28564127/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'with', 'liver', 'transplantation', '(', 'lt', ')', 'not', 'uncommon', '.', 'impact', 'of', 'terlipressin', 'infusion', 'aki', ',', 'hemodynamics', ',', 'and', 'plasma', 'concentration', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'studied', '.', 'method', 'patient', '(', 'n', ')', 'randomized', '(', 'nct', ',', 'usa', ')', 'two', 'equal', 'group', 'terlipressin', 'v', 'control', '.', 'terlipressin', '(', '-', 'gkgh', ')', 'administrated', 'day', '.', 'intraoperative', 'transesophageal', 'doppler', 'hemodynamic', 'management', '.', 'renal', 'function', ',', 'peak', 'portal', 'vein', 'blood', 'flow', 'velocity', '(', 'ppv', ')', ',', 'and', 'hepatic', 'artery', 'resistive', 'index', '(', 'hari', ')', 'recorded', '.', 'plasma', 'ngal', '(', 'pngal', ')', 'measured', 'baseline', ',', 'and', 'hour', 'postreperfusion', '.', 'result', 'hepatitis', 'c', 'virus', '(', 'hcv', ')', 'main', 'etiology', '.', 'age', ',', 'sex', ',', 'model', 'of', 'end-stage', 'liver', 'disease', '(', 'meld', ')', ',', 'and', 'renal', 'function', 'comparable', '.', 'postoperative', 'aki', 'incidence', 'and', 'ngal', 'concentration', 'comparable', '(', 'p.', ')', 'terlipressin', 'and', 'control', 'group', '(', 'v', 'and', '.', 'v', '.', 'ngml', ')', ',', 'respectively', ',', 'intraoperative', 'ngal', 'in', 'group', 'increased', 'significantly', 'hour', 'postreperfusion', '(', 'p.', ')', 'aki', '(', 'n', ')', 'and', 'non-aki', 'developer', '(', 'n', ')', '.', 'mean', 'arterial', 'blood', 'pressure', '(', 'map', ')', 'maintained', 'in', 'group', 'with', 'less', 'systemic', 'vascular', 'resistance', '(', 'svr', ')', 'fluctuation', 'with', 'terlipressin', '.', 'median', 'norepinephrine', 'consumption', 'lower', 'in', 'terlipressin', 'v', 'control', '(', 'v', 'mg', 'p.', ')', '.', 'ppv', 'and', 'hari', 'not', 'affected', 'terlipressin', 'stage', '(', 'p.', ')', '.', 'conclusion', 'postliver', 'transplant', 'aki', 'not', 'prevented', 'terlipressin', 'use', 'predicted', 'ngal', 'level', '.']"
Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189.,"Edward B Garon, Joachim Aerts, Jong Seok Kim, Catherine E Muehlenbein, Patrick Peterson, Maria Teresa Rizzo, Shirish M Gadgeel, Edward B Garonet al.",2021 May:155:53-60.,Lung Cancer,https://pubmed.ncbi.nlm.nih.gov/33730652/,No keywords found,"['post', 'hoc', 'analysis', 'assessed', 'safety', 'of', 'pemetrexed', 'and', 'platinum', 'in', 'combination', 'with', 'pembrolizumab', ',', 'including', 'time-to-onset', 'and', 'time-to-resolution', 'of', 'all-cause', 'any-grade', 'and', 'grade', 'adverse', 'event', '(', 'aes', ')', 'and', 'renal', 'aes', '.', 'material', 'and', 'method', 'patient-level', 'data', 'keynote-', 'analyzed', 'in', 'all-subjects-as-treated', 'population', '(', 'pembrolizumab', 'arm', ',', 'n', 'placebo', 'arm', ',', 'n', ')', ',', 'and', 'among', 'patient', 'received', 'cycle', 'of', 'pemetrexed', '(', 'pemetrexedpembrolizumabplatinum', 'arm', ',', 'n', 'pemetrexedplaceboplatinum', 'arm', ',', 'n', ')', '.', 'all-cause', 'aes', 'selected', 'based', 'incidence', 'previously', 'reported', 'keynote-', 'data', 'and', 'included', 'neutropenia', ',', 'febrile', 'neutropenia', ',', 'anemia', ',', 'thrombocytopenia', ',', 'asthenia', ',', 'fatigue', ',', 'dyspnea', ',', 'diarrhea', ',', 'nausea', ',', 'vomiting', ',', 'pneumonitis', ',', 'and', 'renal', 'event', '.', 'descriptive', 'statistic', 'summarized', 'all-cause', 'aes', '.', 'median', 'and', 'interquartile', 'range', 'used', 'to', 'examine', 'time-to-onset', 'and', 'time-to-resolution', '.', 'data', 'cutoff', 'november', ',', '.', 'result', 'in', 'treatment', 'arm', ',', 'non-hematologic', '(', 'nausea', ',', 'vomiting', ',', 'diarrhea', ',', 'and', 'asthenia', ')', ',', 'and', 'hematologic', '(', 'febrile', 'neutropenia', ',', 'thrombocytopenia', ',', 'and', 'neutropenia', ')', 'grade', 'aes', 'with', 'incidence', 'median', 'time-to-onset', 'within', 'first', 'cycle', ',', 'and', 'median', 'time-to-resolution', 'of', 'within', 'week', 'onset', '.', 'small', 'number', 'of', 'aes', 'longer', 'median', 'time-to-onset', '(', 'pneumonitis', 'and', 'fatigue', ')', 'and', 'median', 'time-to-resolution', '(', 'pneumonitis', ',', 'fatigue', ',', 'acute', 'kidney', 'injury', ',', 'and', 'anemia', ')', '.', 'among', 'patient', 'received', 'cycle', 'of', 'pemetrexed', ',', 'incidence', 'of', 'any-grade', 'renal', 'toxicity', 'in', 'pemetrexedpembrolizumabplatinum', 'arm', '.', 'in', 'cycle', '-', ',', '.', 'in', 'cycle', '-', ',', '.', 'in', 'cycle', '-', ',', 'and', '.', 'in', 'cycle', 'and', ',', 'in', 'pemetrexedplaceboplatinum', 'arm', ',', '.', 'in', 'cycle', '-', ',', '.', 'in', 'cycle', '-', ',', '.', 'in', 'cycle', '-', ',', 'and', '.', 'in', 'cycle', '.', 'conclusion', 'pemetrexedpembrolizumabplatinum', 'manageable', 'toxicity', 'with', 'longer', 'duration', 'of', 'treatment', '.', 'incidence', 'of', 'renal', 'toxicity', 'slightly', 'higher', 'in', 'pembrolizumab', 'combination', 'compared', 'to', 'pemetrexed', ',', 'incidence', 'not', 'increase', 'in', 'later', 'treatment', 'cycle', '.', 'result', 'support', 'safe', 'use', 'of', 'keynote-', 'regimen', 'in', 'clinical', 'practice', '.', 'clinical', 'trial', 'registration', 'number', 'nct', '(', 'clinicaltrials.gov', ')', '.']"
"Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.","Saleh Sandoughdaran, Abolfazl Razzaghdoust, Ali Tabibi, Abbas Basiri, Nasser Simforoosh, Bahram Mofid, Saleh Sandoughdaranet al.",2021 Apr 11,Urol J,https://pubmed.ncbi.nlm.nih.gov/32350847/,No keywords found,"['to', 'evaluate', 'feasibility', 'and', 'potential', 'efficacy', 'of', 'nanocurcumin', 'supplementation', 'in', 'patient', 'with', 'localized', 'muscle-invasive', 'bladder', 'cancer', '(', 'mibc', ')', 'undergoing', 'induction', 'chemotherapy', '.', 'material', 'and', 'method', 'in', 'double-blind', ',', 'placebo-controlled', 'trial', ',', 'mibc', 'patient', 'randomized', 'to', 'receive', 'either', 'nanocurcumin', '(', 'mgday', ')', 'or', 'placebo', 'course', 'of', 'chemotherapy', '.', 'patient', 'followed', 'to', 'four', 'week', 'end', 'of', 'treatment', 'to', 'assess', 'complete', 'clinical', 'response', 'to', 'chemotherapy', 'primary', 'endpoint', '.', 'secondary', 'endpoint', 'comparison', 'of', 'chemotherapy-induced', 'nephrotoxicity', ',', 'hematologic', 'nadir', ',', 'and', 'toxicity', 'two', 'group', '.', 'hematologic', 'nadir', 'and', 'toxicity', 'assessed', 'treatment', '.', 'result', 'nanocurcumin', 'well', 'tolerated', '.', 'complete', 'clinical', 'response', 'rate', '.', 'and', 'in', 'placebo', 'and', 'nanocurcumin', 'group', ',', 'respectively', '.', 'although', 'nanocurcumin', 'shown', 'to', 'superior', 'to', 'placebo', 'with', 'respect', 'to', 'complete', 'clinical', 'response', 'rate', 'primary', 'endpoint', ',', 'no', 'significant', 'difference', 'group', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'also', 'found', 'two', 'group', 'with', 'regard', 'to', 'grade', 'renal', 'and', 'hematologic', 'toxicity', 'well', 'hematologic', 'nadir', '.', 'conclusion', 'preliminary', 'data', 'indicate', 'feasibility', 'of', 'nanocurcumin', 'supplementation', 'complementary', 'therapy', 'in', 'mibc', 'patient', 'and', 'support', 'larger', 'study', '.', 'moreover', ',', 'substantial', 'translational', 'insight', 'to', 'fill', 'gap', 'experiment', 'and', 'clinical', 'practice', 'in', 'field', 'provided', '.']"
Fluid resuscitation and standard drug treatment strategies in heatstroke Chinese patients.,"K Hongjun, S Qing, Z Yan, P Liang, L Hui, Z Feihu, K Hongjunet al.",2015 Jan,Drug Res (Stuttg),https://pubmed.ncbi.nlm.nih.gov/24668574/,No keywords found,"['objective', 'of', 'present', 'study', 'to', 'evaluate', 'different', 'stage', 'fluid', 'and', 'standard', 'drug', 'treatment', 'strategy', 'in', 'heatstroke', 'patient', '.', 'adult', 'with', 'heatstroke', 'received', 'fluid', 'resuscitation', 'treatment', 'guided', 'transpulmonary', 'thermodilution', '(', 'picco', ')', 'in', 'intensive', 'care', 'unit', '.', 'systemic', 'hemodynamics', ',', 'microvascular', 'index', 'and', 'measure', 'of', 'acidosis', ',', 'renal', 'function', ',', 'and', 'pulmonary', 'edema', 'followed', 'prospectively', '.', 'speed', 'of', 'recovery', 'and', 'component', 'change', 'compared', 'h', ',', 'h', 'and', 'h', 'stage', 'fluid', 'therapy', '.', 'patient', 'hyperpyrexia', '(', 'core', 'temperaturec', ')', ',', 'and', 'ventilation', 'enrolled', 'in', 'icu', '.', 'patient', 'received', '.', '(', '.', ')', 'mlkgh', 'of', 'crystal', 'fluid', 'and', '.', '(', '.', ')', 'mlkgh', 'of', 'colloidal', 'fluid', 'in', 'first', 'h', '(', '..', ')', 'mlkgh', 'crystal', 'fluid', 'along', 'with', '.', '(', '.', ')', 'mlkgh', 'colloidal', 'fluid', 'in', 'first', 'h', '.', '(', '.', ')', 'mlkgh', 'crystal', 'fluid', 'along', 'with', '.', '(', '.', ')', 'mlkgh', 'colloidal', 'fluid', 'in', 'next', 'h.', 'with', 'resuscitation', ',', 'acid-base', 'status', 'deteriorated', 'in', 'of', 'patient', '(', '.', ')', ',', 'extravascular', 'lung', 'water', 'increased', 'in', 'of', 'resuscitated', 'patient', '(', ')', 'of', 'patient', 'developed', 'pulmonary', 'edema', 'though', 'guided', 'transpulmonary', 'thermodilution', ',', '(', '.', ')', 'patient', 'survived', '.', 'patient', 'with', 'pulmonary', 'edema', 'study', 'hypovolemic', 'or', 'euvolemic', 'time', 'pulmonary', 'edema', 'developed', '.', 'plasma', 'lactate', 'lower', 'in', 'hypovolemic', 'patient', '(', 'p.', ')', 'and', '(', 'p.', ')', 'resuscitation', '.', 'acute', 'kidney', 'injury', 'evident', 'in', 'of', 'patient', '(', ')', 'h', 'enrollment', '.', 'in', 'conclusion', ',', 'study', 'revealed', 'fluid', 'resuscitation', 'post', 'heatstroke', 'adjusted', 'according', 'to', 'different', 'stage', '.']"
Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008.,"Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Hiroshi Nishino, Yukinori Asada, Hiroki Mitani, Shigemichi Iwae, Naoki Nishio, Yusuke Onozawa, Nobuhiro Hanai, Akira Ohkoshi, Hiroki Hara, Nobuya Monden, Masato Nagaoka, Shujiro Minami, Ryo Kitabayashi, Keita Sasaki, Akihiro Homma                              ;, Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG‐HNCSG), Yoshinori Imamuraet al.",2024 Sep,Cancer Med,https://pubmed.ncbi.nlm.nih.gov/39348265/,No keywords found,"['in', 'randomized', 'phase', 'iiiii', 'trial', '(', 'jcog', ')', ',', 'weekly', 'cisplatin', '(', 'mgm', ')', 'non-inferior', 'to', '-weekly', 'cisplatin', '(', 'mgm', ')', 'postoperative', 'high-risk', 'head', 'and', 'neck', 'cancer', '.', 'investigated', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'major', 'dose-limiting', 'toxicity', 'effect', 'of', 'cisplatin', ',', 'affect', 'overall', 'survival', '(', 'o', ')', '.', 'method', 'analyzed', 'patient', 'jcog', 'receiving', 'chemoradiotherapy', '.', 'aki', 'defined', 'based', 'aki', 'network', 'criterion', '(', 'serum', 'creatinine', 'increase', 'of', '.', 'mgdl', 'or', '.-fold', 'stage', ')', 'within', 'day', 'completing', 'chemoradiotherapy', '.', 'o', 'in', 'two', 'arm', 'compared', 'according', 'to', 'aki', 'development', 'using', 'log-rank', 'test', '.', 'result', 'total', 'incidence', 'of', 'aki', 'lower', 'in', 'weekly', 'arm', 'in', '-weekly', 'arm', '(', '.', 'v', '.', '.', ')', '.', 'additionally', ',', 'stage', 'iiiii', 'aki', 'occurred', 'less', 'frequently', 'in', 'weekly', 'arm', 'in', '-weekly', 'arm', '(', '.', 'v', '.', '.', ')', '.', 'cisplatin', 'dos', 'similar', 'in', 'weekly', 'arm', 'patient', 'with', 'and', 'without', 'aki', '(', 'median', ',', '.', 'mgm', 'vs.', '.', 'mgm', 'p', '.', ')', ',', 'lower', 'in', '-weekly', 'arm', 'developed', 'aki', '(', 'median', ',', '.', 'mgm', 'vs.', '.', 'mgm', 'p', '.', ')', '.', 'in', 'weekly', 'arm', ',', 'no', 'difference', 'in', 'o', 'patient', 'with', 'and', 'without', 'aki', '(', 'hazard', 'ratio', 'hr', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', '.', 'however', ',', 'in', '-weekly', 'arm', ',', 'patient', 'with', 'aki', 'poorer', 'o', 'without', 'aki', '(', 'hr', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'conclusion', 'in', 'supplementary', 'analysis', 'of', 'jcog', 'data', ',', 'aki', 'impacted', 'o', 'of', 'patient', 'with', 'head', 'and', 'neck', 'cancer', 'undergoing', 'postoperative', 'chemoradiotherapy', 'in', '-weekly', 'arm', 'not', 'in', 'weekly', 'arm', '.', 'result', 'endorse', 'utilization', 'of', 'weekly', 'cisplatin', 'mgm', 'in', 'setting', '.']"
"Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy.","Maya Sterling, Zubaida Al-Ismaili, Kelly R McMahon, Melissa Piccioni, Michael Pizzi, Theresa Mottes, Larry C Lands, Sharon Abish, Adam J Fleming, Michael R Bennett, Ana Palijan, Prasad Devarajan, Stuart L Goldstein, Maureen M O'Brien, Michael Zappitelli, Maya Sterlinget al.",2017 Oct,Pediatr Blood Cancer,https://pubmed.ncbi.nlm.nih.gov/28417544/,No keywords found,"['cisplatin', '(', 'ci', ')', ',', 'carboplatin', '(', 'carb', ')', ',', 'and', 'ifosfamide', '(', 'ifos', ')', 'common', 'nephrotoxic', 'chemotherapy', '.', 'biomarkers', 'of', 'tubular', 'injury', 'may', 'allow', 'early', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'diagnosis', '.', 'procedure', 'performed', 'two-center', '(', 'canada', ',', 'united', 'state', ')', 'pilot', 'study', 'to', 'prospectively', 'measure', 'serum', 'creatinine', '(', 'scr', ')', ',', 'urine', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'and', 'interleukin-', '(', 'il-', ')', 'in', 'child', 'receiving', 'ciscarb', '(', 'episode', ')', ',', 'ifos', '(', 'episode', ')', ',', 'and', 'in', 'hospitalized', ',', 'nonchemotherapy', 'patient', '.', 'defined', 'aki', 'using', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'definition', '.', 'compared', 'postchemotherapy', 'infusion', 'ngal', 'and', 'il-', 'concentration', '(', 'immediate', 'postdose', 'to', 'day', 'later', ')', 'to', 'pre-infusion', 'concentration', '.', 'calculated', 'area', 'receiver', 'operating', 'characteristic', 'curve', '(', 'auc', ')', 'postinfusion', 'biomarkers', 'to', 'discriminate', 'aki', '.', 'result', 'prechemotherapy', 'infusion', 'ngal', 'and', 'il-', 'concentration', 'not', 'higher', 'nonchemotherapy', 'control', 'concentration', '.', 'increasing', 'chemotherapy', 'dose', 'associated', 'with', 'increasing', 'postinfusion', '(', '-', 'hr', 'infusion', ')', 'ngal', '(', 'p', '.', ')', '.', 'ngal', 'and', 'il-', 'measured', 'immediately', 'ifos', 'infusion', 'discriminated', 'aki', 'with', 'auc', '.', '(', 'standard', 'error', '.', ')', 'and', '.', '(', 'standard', 'error', '.', ')', ',', 'respectively', '.', 'ngal', 'and', 'il-', 'not', 'diagnostic', 'of', 'cis-carb-associated', 'aki', '.', 'auc', 'adjusted', 'age', ',', 'biomarker', 'auc', '(', 'cis-carb', 'and', 'ifos', ')', 'improved', '.', 'conclusion', 'urine', 'ngal', 'and', 'il-', 'show', 'promise', 'early', 'aki', 'diagnostic', 'test', 'in', 'child', 'treated', 'with', 'ifosfamide', 'and', 'may', 'potential', 'role', 'in', 'drug', 'toxicity', 'monitoring', '.']"
Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.,"Stefan Haneder, Johannes Michael Budjan, Stefan Oswald Schoenberg, Simon Konstandin, Lothar Rudi Schad, Ralf Dieter Hofheinz, Veronika Gramlich, Frederik Wenz, Frank Lohr, Judit Boda-Heggemann, Stefan Hanederet al.",2015 Apr,Strahlenther Onkol,https://pubmed.ncbi.nlm.nih.gov/25445156/,No keywords found,"['combined', 'radiochemotherapy', '(', 'rct', ')', 'gastric', 'cancer', 'with', 'three-dimensional', 'conformal', 'radiotherapy', '(', 'd-crt', ')', 'result', 'in', 'ablative', 'dos', 'to', 'upper', 'left', 'kidney', ',', 'image-guided', 'intensity-modulated', 'radiotherapy', '(', 'ig-imrt', ')', 'allows', 'kidney', 'sparing', 'despite', 'improved', 'target', 'coverage', '.', 'renal', 'function', 'in', 'long-term', 'gastric', 'cancer', 'survivor', 'evaluated', 'with', 'functional', 'magnetic', 'resonance', 'imaging', '(', 'mri', ')', 'including', 'diffusion-weighted', 'imaging', '(', 'dwi', ')', 'and', '(', ')', 'na', 'imaging', '.', 'patient', 'and', 'method', 'five', 'healthy', 'volunteer', 'and', 'patient', 'radiotherapy', 'included', 'ig-imrt', 'd-crt', '``', 'positive', 'control', ""''"", 'with', 'stereotactic', 'body', 'radiotherapy', '(', 'sbrt', ')', 'of', 'metastasis', 'spleenleft', 'kidney', '.', 'radiation', 'dos', 'documented', 'uppermiddlelower', 'kidney', 'subvolumes', '.', 'late', 'toxicity', 'evaluated', 'based', 'ctc', 'criterion', ',', 'questionnaire', ',', 'and', 'creatinine', 'value', '.', 'morphological', 'sequence', ',', 'dwi', 'image', ',', 'and', '(', ')', 'na', 'image', 'acquired', 'using', '(', ')', 'h', '(', ')', 'na-tuned', 'body-coil', 'beforeafter', 'intravenous', 'water', 'load', '(', 'wl', ')', '.', 'statistic', '(', ')', 'na', '(', 'concentration', ')', 'and', 'apparent', 'diffusion', 'coefficient', '(', 'adc', ')', 'value', 'calculated', 'uppermiddlelower', 'renal', 'subvolumes', '.', 'corticomedullary', '(', ')', 'na', 'gradient', 'and', '(', ')', 'na', 'difference', 'wl', 'determined', '.', 'result', 'no', 'major', 'morphological', 'alteration', 'detected', 'in', 'patient', '.', 'minor', 'scar', 'observed', 'in', 'cranial', 'subvolume', 'of', 'left', 'kidney', 'of', 'd-crt', 'and', 'whole', 'kidney', 'of', 'control', 'sbrt', 'patient', '.', 'participant', 'presented', 'corticomedullary', '(', ')', 'na', 'gradient', '.', 'wl', ',', 'significant', 'physiological', '(', ')', 'na', 'gradient', 'decrease', '(', 'p', 'gy', 'in', '.-', 'gy', 'fraction', 'clearly', 'result', 'in', 'impairment', '.']"
Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trial.,"Andrea Cortegiani, Giacomo Grasselli, Jennifer Meessen, Alessandra Moscarelli, Mariachiara Ippolito, Fabrizio Turvani, Chiara Maria Bonenti, Stefano Romagnoli, Carlo Alberto Volta, Giacomo Bellani, Antonino Giarratano, Roberto Latini, Antonio Pesenti, Pietro Caironi, Andrea Cortegianiet al.",2021 Jun:63:83-91.,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/33636427/,No keywords found,"['best', 'fluid', 'replacement', 'strategy', 'and', 'role', 'of', 'albumin', 'in', 'immunocompromised', 'patient', 'with', 'sepsis', 'unclear', '.', 'method', 'performed', 'secondary', 'analysis', 'of', 'immunocompromised', 'patient', 'enrolled', 'in', 'albios', 'trial', 'randomized', 'patient', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', 'to', 'receive', 'either', 'albumin', '(', 'target', 'g', 'per', 'liter', 'or', ')', 'and', 'crystalloid', 'or', 'crystalloid', 'alone', 'icu', 'stay', '.', 'result', 'of', 'patient', 'originally', 'enrolled', ',', '(', '.', ')', 'immunocompromised', '.', 'one-hundred-thirty-nine', '(', '.', ')', 'patient', 'randomized', 'in', 'albumin', '(', '.', ')', 'in', 'crystalloid', 'group', '.', 'day', ',', '(', '.', ')', 'in', 'albumin', 'group', 'and', '(', '.', ')', 'in', 'crystalloids', 'group', 'died', '(', 'hazard', 'ratio', '-', 'hr', '-', '.', 'ci', '.-.', ')', '.', 'no', 'difference', 'observed', 'with', 'regard', 'to', '-day', 'mortality', ',', 'sofa', 'score', '(', 'and', 'sub-scores', ')', ',', 'length', 'of', 'stay', 'in', 'icu', 'and', 'in', 'hospital', ',', 'proportion', 'of', 'patient', 'developed', 'acute', 'kidney', 'injury', 'or', 'received', 'renal', 'replacement', 'therapy', ',', 'duration', 'of', 'mechanical', 'ventilation', '.', 'albumin', 'not', 'independently', 'associated', 'with', 'higher', 'or', 'lower', '-day', 'mortality', '(', 'hr', '.', ',', 'ci', '.-', '.', ')', 'compared', 'to', 'crystalloid', '.', 'conclusion', 'albumin', 'replacement', 'icu', 'stay', ',', 'compared', 'with', 'crystalloids', 'alone', ',', 'not', 'affect', 'clinical', 'outcome', 'in', 'cohort', 'of', 'immunocompromised', 'patient', 'with', 'sepsis', '.']"
Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.,"R B Müller, N Haase, T Lange, J Wetterslev, A Perner, R B Mülleret al.",2015 Mar,Acta Anaesthesiol Scand,https://pubmed.ncbi.nlm.nih.gov/25524831/,No keywords found,"['aimed', 'to', 'detail', 'effect', 'of', 'hydroxyethyl', 'starch', '(', 'he', ')', 'vs.', 'ringer', ""'s"", 'kidney', 'function', 'including', 'interaction', 'with', 'mortality', 'in', 'post-hoc', 'analysis', 'resuscitation', 'with', 'he', '.', 'increased', 'mortality', 'in', 'scandinavian', 'starch', 'severe', 'sepsisseptic', 'shock', '(', ')', 'trial', '.', 'method', 'in', 'randomised', 'patient', ',', 'assessed', 'incidence', 'and', 'effect', 'mortality', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'he', 'vs.', 'ringer', ""'s"", 'acetate', 'group', 'using', 'kidney', 'disease', 'improving', 'global', 'outcome', 'criterion', '.', 'also', 'assessed', 'intervention', 'effect', 'time', 'to', 'and', 'duration', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'result', 'baseline', ',', 'intervention', 'group', 'similar', '.', 'maximal', 'aki', 'stage', 'higher', 'in', 'he', 'vs.', 'ringer', ""'s"", 'group', 'within', 'first', 'day', 'randomisation', '(', 'p', '.', ')', ',', 'average', 'difference', '.', 'point', '(', 'p', '.', ')', '.', 'increase', 'in', 'aki', 'stage', 'associated', 'with', 'mortality', '(', 'hazard', 'ratio', '(', 'hr', ')', '.', 'ci', '.', 'to', '.', 'p', '.', ')', '.', 'significantly', ',', 'patient', 'in', 'he', 'group', 'received', 'rrt', 'within', 'first', 'day', '(', 'p', '.', ')', ',', 'and', 'time', 'to', 'initiation', 'of', 'rrt', 'also', 'shorter', 'compared', 'with', 'ringer', ""'s"", 'group', '(', 'hr', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'intervention', 'effect', 'of', 'he', 'mortality', 'reduced', 'adjusting', 'aki', 'stage', 'time-dependent', 'covariate', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'patient', 'with', 'severe', 'sepsis', ',', 'he', 'appeared', 'to', 'increase', 'rate', 'of', 'severe', 'aki', 'and', 'use', 'of', 'rrt', 'within', 'first', 'day', '.', 'increased', 'mortality', 'observed', 'with', 'he', 'may', 'partly', 'mediated', 'acute', 'kidney', 'impairment', '.']"
Left Ventricular End-Diastolic Pressure Versus Urine Flow Rate-Guided Hydration in Preventing Contrast-Associated Acute Kidney Injury.,"Carlo Briguori, Carmen D'Amore, Francesca De Micco, Nicola Signore, Giovanni Esposito, Gabriella Visconti, Flavio Airoldi, Giuseppe Signoriello, Amelia Focaccio, Carlo Briguoriet al.",2020 Sep 14,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/32912462/,No keywords found,"['study', 'compared', 'left', 'ventricular', 'end-diastolic', 'pressure', '(', 'lvedp', ')', '-guided', 'and', 'urine', 'flow', 'rate', '(', 'ufr', ')', '-guided', 'hydration', '.', 'background', 'tailored', 'hydration', 'regimen', 'improve', 'prevention', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', '.', 'method', 'july', ',', ',', 'and', 'june', ',', ',', 'patient', 'high', 'risk', 'ca-aki', 'scheduled', 'coronary', 'and', 'peripheral', 'procedure', 'randomized', 'to', 'group', ')', 'normal', 'saline', 'infusion', 'rate', 'adjusted', 'according', 'to', 'lvedp', '(', 'lvedp-guided', 'group', ')', 'and', ')', 'hydration', 'controlled', 'renalguard', 'system', 'in', 'order', 'to', 'reach', 'ufr', 'mlh', '(', 'ufr-guided', 'group', ')', '.', 'primary', 'endpoint', 'composite', 'of', 'ca-aki', '(', 'i.e.', ',', 'serum', 'creatinine', 'increase', 'or', '.', 'mgdl', 'h', ')', 'and', 'acute', 'pulmonary', 'edema', '(', 'pe', ')', '.', 'major', 'adverse', 'event', '(', 'all-cause', 'death', ',', 'renal', 'failure', 'requiring', 'dialysis', ',', 'pe', ',', 'and', 'sustained', 'kidney', 'injury', ')', 'month', 'assessed', '.', 'result', 'primary', 'endpoint', 'occurred', 'in', 'of', '(', '.', ')', 'patient', 'in', 'ufr-guided', 'group', 'and', 'in', 'of', '(', '.', ')', 'patient', 'in', 'lvedp-guided', 'group', '(', 'relative', 'risk', 'rr', '.', 'confidence', 'interval', 'ci', '.', 'to', '.', 'p', '.', ')', '.', 'ca-aki', 'and', 'pe', 'rate', 'in', 'ufr-guided', 'group', 'and', 'lvedp-guided', 'group', '.', 'and', '.', '(', 'rr', '.', 'ci', '.', 'to', '.', 'p', '.', ')', ',', 'and', ',', 'respectively', ',', '.', 'and', '.', '(', 'rr', '.', 'ci', '.', 'to', '.', 'p', '.', ')', '.', 'three', 'patient', 'in', 'ufr-guided', 'group', 'experienced', 'complication', 'related', 'to', 'foley', 'catheter', '.', 'hypokalemia', 'rate', '.', 'in', 'ufr-guided', 'group', 'and', '.', 'in', 'lvedp-guided', 'group', '(', 'p', '.', ')', '.', '-month', 'major', 'adverse', 'event', 'rate', '.', 'in', 'ufr-guided', 'group', 'and', '.', 'in', 'lvedp-guided', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'study', 'demonstrates', 'ufr-guided', 'hydration', 'superior', 'to', 'lvedp-guided', 'hydration', 'to', 'prevent', 'composite', 'of', 'ca-aki', 'and', 'pe', '.']"
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study.,"Delphine Sculier, Angèle Gayet-Ageron, Manuel Battegay, Matthias Cavassini, Jan Fehr, Cedric Hirzel, Patrick Schmid, Enos Bernasconi, Alexandra Calmy                              ;, Swiss HIV Cohort Study, Delphine Sculieret al.",2017 Jul 6,BMC Infect Dis,https://pubmed.ncbi.nlm.nih.gov/28683720/,No keywords found,"['rilpivirine', 'safe', 'and', 'effective', 'in', 'hiv-nave', 'patient', 'with', 'low', 'baseline', 'hiv-rna', 'or', 'in', 'switch', 'strategy', '.', 'offer', 'advantage', 'of', 'drug-drug', 'interaction', 'and', 'favourable', 'toxicity', 'profile', '.', 'aimed', 'to', 'determine', 'reason', 'prescribing', 'rilpivirine', '(', 'rpv', ')', 'tenofovir', 'disoproxil', '(', 'tdf', ')', 'emtricitabine', '(', 'ftc', ')', 'co-formulation', 'within', 'swiss', 'hiv', 'cohort', 'study', 'and', 'to', 'assess', 'effectiveness', 'and', 'safety', 'month', 'period', '.', 'method', 'individual', 'enrolled', 'in', 'swiss', 'hiv', 'cohort', 'study', 'initiated', 'rpvtdfftc', 'co-formulation', 'april', 'and', 'march', 'included', '.', 'primary', 'outcome', 'hiv-rna', 'viral', 'load', '(', 'copiesml', ')', 'and', 'cd', 'cell', 'count', '(', 'cellsmm', ')', ',', 'and', 'month', '.', 'reason', 'switch', 'to', 'rpvtdfftc', 'evaluated', 'standardized', 'questionnaire', '.', 'also', 'assessed', 'discontinuation', 'and', 'reason', 'discontinuation', 'of', 'rpvtdfftc', 'october', ',', '.', 'result', 'of', 'individual', 'started', 'rpvtdfftc', 'co-formulation', ',', '.', 'treatment-nave', '.', 'month', ',', 'viral', 'suppression', '(', 'hiv-rna', 'copiesml', ')', 'achieved', 'in', 'and', '.', 'of', 'cart-nave', 'and', 'cart-experienced', 'patient', 'respectively', '.', 'switch', 'to', 'rpv', 'mainly', 'done', 'simplification', '(', '.', ')', 'and', 'to', 'overcome', 'central', 'nervous', 'system', 'toxicity', 'symptom', 'due', 'to', 'efavirenz', '(', ')', '.', 'six', 'month', 'switch', ',', '.', 'of', 'patient', 'reported', 'improvement', 'of', 'psycho-neurological', 'symptom', 'with', 'continued', 'improvement', 'month', 'almost', '.', 'however', ',', 'one', 'quarter', 'of', 'patient', 'reported', 'discontinuation', 'of', 'rpvtdfftc', 'october', ',', 'median', 'time', 'of', '.', 'month', '.', 'reason', 'discontinuation', 'included', 'physician', 'decision', '(', '.', ')', 'and', 'side-effects', '(', '.', ')', 'mainly', 'related', 'to', 'central', 'nervous', 'system', 'and', 'to', 'renal', 'toxicity', '.', 'conclusion', 'rpvtdfftc', 'co-formulation', 'safe', 'and', 'effective', 'throughout', 'month', 'of', 'follow-up', 'barely', 'prescribed', 'hiv-nave', 'patient', '.', 'despite', 'excellent', 'virological', 'suppression', 'among', 'treatment-nave', 'and', '-experienced', 'patient', ',', 'observed', 'high', 'rate', 'of', 'treatment', 'discontinuation', '.']"
PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy.,"Feifan Xie, Jan Van Bocxlaer, Pieter Colin, Charlotte Carlier, Olivier Van Kerschaver, Joseph Weerts, Hannelore Denys, Philippe Tummers, Wouter Willaert, Wim Ceelen, An Vermeulen, Feifan Xieet al.",2020 Jul 24,AAPS J,https://pubmed.ncbi.nlm.nih.gov/32710204/,"HIPEC, NONMEM, PKPD, cisplatin, ovarian cancer.","['intraperitoneal', 'chemoperfusion', '(', 'ipec', ')', 'of', 'cisplatin', 'popular', 'treatment', 'advanced', 'ovarian', 'cancer', ',', 'typically', 'hyperthermia', '(', 'hipec', ')', '.', 'use', 'of', 'cisplatin', '(', 'h', ')', 'ipec', 'off-label', ',', 'and', 'role', 'of', 'hyperthermia', 'unknown', '.', 'aim', 'of', 'study', 'to', 'characterize', 'pharmacokineticpharmacodynamic', '(', 'pkpd', ')', 'property', 'of', 'cisplatin', '(', 'h', ')', 'ipec', 'and', 'to', 'predict', 'optimal', 'treatment', 'regimen', '.', 'using', 'randomized', 'design', ',', 'data', 'intact', 'cisplatin', 'perfusate', 'and', 'plasma', 'concentration', ',', 'leukocyte', 'counts-a', 'hematotoxicity', 'marker-and', 'serum', 'creatinine-a', 'nephrotoxicity', 'marker-were', 'collected', 'patient', 'treated', 'with', 'combination', 'of', 'cytoreductive', 'surgery', '(', 'cr', ')', 'and', 'either', 'normothermic', 'or', 'hyperthermic', 'ipec', 'of', 'cisplatin', 'dosed', ',', ',', 'and', 'mgm', '.', 'non-linear', 'mixed', 'effect', 'modeling', 'technique', 'used', 'to', 'construct', 'pkpd', 'model', '.', 'pk', 'of', 'intact', 'cisplatin', 'characterized', 'two-compartment', 'model', '.', 'semi-physiological', 'myelosuppression', 'model', 'leukopenia', 'modified', 'to', 'account', 'crs-induced', 'leukocytosis', 'and', 'residual', 'myelosuppression', 'effect', 'of', 'neoadjuvant', 'chemotherapy', '.', 'incidence', 'and', 'severity', 'of', 'nephrotoxicity', 'described', 'discrete-time', 'markov', 'model', '.', 'hyperthermia', 'increased', 'absorption', 'rate', 'of', 'cisplatin', '.', 'not', 'show', 'clinically', 'relevant', 'impact', 'investigated', 'toxicity', 'compared', 'with', 'normothermia', '.', 'leukopenia', 'not', 'severe', ',', 'nephrotoxicity', 'become', 'severe', 'or', 'life-threatening', 'and', 'affected', 'dose', 'and', 'ipec', 'duration', '.', 'model', 'predicted', 'nephrotoxicity', 'minimal', 'cisplatin', 'dose', 'of', 'mgm', 'with', 'ipec', 'duration', 'of', '-', 'h', 'and', '-h', 'duration', 'favored', 'dos', 'and', 'mgm', '.', 'graphical', 'abstract', '.']"
Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy.,"Till Markowiak, Nadine Kerner, Reiner Neu, Tobias Potzger, Christian Großer, Florian Zeman, Hans-Stefan Hofmann, Michael Ried, Till Markowiaket al.",2019 Dec,J Surg Oncol,https://pubmed.ncbi.nlm.nih.gov/31602673/,No keywords found,"['hyperthermic', 'intrathoracic', 'chemotherapy', '(', 'hitoc', ')', 'used', 'treatment', 'of', 'malignant', 'pleural', 'tumor', '.', 'although', 'hitoc', 'proved', 'to', 'safe', ',', 'postoperative', 'renal', 'failure', 'due', 'to', 'nephrotoxicity', 'of', 'intrapleural', 'cisplatin', 'remains', 'concern', '.', 'method', 'single-center', 'study', 'performed', 'retrospectively', 'in', 'patient', 'underwent', 'pleural', 'tumor', 'resection', 'and', 'hitoc', 'september', 'and', 'december', '.', 'result', 'total', 'of', 'patient', '(', 'female', 'n', '.', ')', 'with', 'malignant', 'pleural', 'tumor', 'underwent', 'surgical', 'cytoreduction', 'with', 'subsequent', 'hitoc', '(', 'minute', 'c', ')', '.', 'study', 'period', ',', 'gradually', 'increased', 'dosage', 'of', 'cisplatin', '(', '-', 'mgm', 'bsa', 'n', 'mgm', 'bsa', 'n', ')', 'and', 'finally', 'added', 'doxorubicin', '(', 'cisplatin', 'mgm', 'bsadoxorubicin', 'mg', 'n', ')', '.', 'patient', 'perioperative', 'fluid', 'balancing', '.', 'last', '(', '.', ')', 'patient', 'also', 'received', 'perioperative', 'cytoprotection', '.', 'overall', 'patient', '(', '.', ')', 'experienced', 'renal', 'insufficiency', '.', 'despite', 'higher', 'cisplatin', 'concentration', ',', 'patient', 'with', 'cytoprotection', 'showed', 'significantly', 'lower', 'postoperative', 'serum', 'creatinine', 'level', 'week', '(', 'p', '.', ')', 'and', 'discharge', '(', 'p', '.', ')', '.', 'also', ',', 'showed', 'less', 'intermediate', 'and', 'severe', 'renal', 'insufficiency', '(', '.', 'v', '.', ')', '.', 'conclusion', 'adequate', 'perioperative', 'fluid', 'management', 'and', 'cytoprotection', 'seem', 'to', 'effective', 'in', 'protecting', 'renal', 'function', '.', 'allows', 'administration', 'of', 'higher', 'intracavitary', 'cisplatin', 'dos', 'without', 'raising', 'rate', 'of', 'renal', 'insufficiency', '.']"
"Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.","Piero Ferolla, Maria Pia Brizzi, Tim Meyer, Wasat Mansoor, Julien Mazieres, Christine Do Cao, Hervé Léna, Alfredo Berruti, Vincenzo Damiano, Wieneke Buikhuisen, Henning Grønbæk, Catherine Lombard-Bohas, Christian Grohé, Vincenzo Minotti, Marcello Tiseo, Javier De Castro, Nicholas Reed, Gabriella Gislimberti, Neha Singh, Miona Stankovic, Kjell Öberg, Eric Baudin, Piero Ferollaet al.",2017 Dec,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/29074099/,No keywords found,"['no', 'data', 'prospective', 'study', 'focused', 'exclusively', 'patient', 'with', 'advanced', 'lung', 'and', 'thymic', 'carcinoid', '.', 'aimed', 'to', 'assess', 'efficacy', 'and', 'safety', 'of', 'long-acting', 'pasireotide', 'and', 'everolimus', ',', 'administered', 'alone', 'or', 'in', 'combination', ',', 'in', 'patient', 'with', 'advanced', 'carcinoid', 'of', 'lung', 'or', 'thymus', '.', 'method', 'luna', 'prospective', ',', 'multicentre', ',', 'randomised', ',', 'open-label', ',', 'phase', 'trial', 'of', 'adult', 'patient', '(', 'aged', 'year', ')', 'with', 'advanced', '(', 'unresectable', 'or', 'metastatic', ')', ',', 'well', 'differentiated', 'carcinoid', 'tumour', 'of', 'lung', 'or', 'thymus', ',', 'with', 'radiological', 'progression', 'within', 'month', 'randomisation', ',', 'and', 'performance', 'status', 'of', '-', '.', 'centre', ',', 'investigator', 'or', 'designee', 'registered', 'patient', 'using', 'interactive', 'voice', 'recognition', 'system', 'one', 'of', 'three', 'treatment', 'group', '.', 'randomisation', 'allocation', 'sequence', 'generated', 'external', 'company', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'treatment', 'with', 'long-acting', 'pasireotide', '(', 'mg', 'intramuscularly', 'every', 'day', ')', ',', 'everolimus', '(', 'mg', 'orally', 'daily', ')', ',', 'or', 'in', 'combination', ',', 'core', '-month', 'treatment', 'period', '.', 'patient', 'stratified', 'carcinoid', 'type', '(', 'typical', 'v', 'atypical', ')', 'and', 'line', 'of', 'study', 'treatment', '(', 'first', 'line', 'v', 'others', ')', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'progression-free', 'month', ',', 'defined', 'proportion', 'of', 'patient', 'with', 'overall', 'lesion', 'assessment', 'month', 'showing', 'complete', 'response', ',', 'partial', 'response', ',', 'or', 'stable', 'disease', 'according', 'to', 'local', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumor', ',', 'version', '.', ',', 'assessed', 'in', 'intention-to-treat', 'population', '.', 'safety', 'assessed', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', 'and', 'least', 'one', 'post-baseline', 'safety', 'assessment', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'extension', 'phase', 'of', 'study', 'ongoing', '.', 'finding', 'aug', ',', ',', 'and', 'sept', ',', ',', 'patient', 'enrolled', 'centre', 'in', 'nine', 'country', 'allocated', 'to', 'long-acting', 'pasireotide', 'group', ',', 'to', 'everolimus', 'group', ',', 'and', 'to', 'combination', 'group', '.', 'month', ',', 'proportion', 'of', 'patient', 'with', 'overall', 'lesion', 'assessment', 'of', 'complete', 'response', ',', 'partial', 'response', ',', 'or', 'stable', 'disease', 'of', 'patient', '(', ',', 'ci', '-', ')', 'in', 'long-acting', 'pasireotide', 'group', ',', 'of', 'patient', '(', ',', '-', ')', 'in', 'everolimus', 'group', ',', 'and', 'of', 'patient', '(', ',', '-', ')', 'in', 'combination', 'group', '.', 'common', 'grade', '-', 'adverse', 'event', 'with', 'suspected', 'association', 'with', 'long-acting', 'pasireotide', 'monotherapy', 'diarrhoea', '(', 'of', ')', ',', 'hyperglycaemia', '(', ')', ',', 'and', 'weight', 'loss', '(', ')', 'with', 'suspected', 'association', 'with', 'everolimus', 'monotherapy', 'stomatitis', '(', 'of', ')', 'and', 'diarrhoea', '(', ')', 'and', 'suspected', 'to', 'associated', 'with', 'combination', 'treatment', 'hyperglycaemia', '(', 'of', ')', ',', 'diarrhoea', '(', ')', ',', 'and', 'asthenia', '(', ')', '.', 'common', 'grade', '-', 'adverse', 'event', 'with', 'suspected', 'association', 'with', 'long-acting', 'pasireotide', 'monotherapy', '-glutamyltransferase', 'increased', '(', 'four', 'of', 'patient', ')', ',', 'diarrhoea', '(', 'three', ')', ',', 'and', 'hyperglycaemia', '(', 'three', ')', 'everolimus', 'hyperglycaemia', '(', 'seven', 'of', 'patient', ')', ',', 'stomatitis', '(', 'four', ')', ',', 'and', 'diarrhoea', '(', 'three', ')', 'combination', 'treatment', 'hyperglycaemia', '(', 'nine', 'of', 'patient', ')', 'and', 'diarrhoea', '(', 'four', ')', '.', 'patient', 'died', 'core', '-month', 'treatment', 'phase', 'or', 'to', 'day', 'last', 'study', 'treatment', 'exposure', 'date', 'two', '(', ')', 'of', 'in', 'long-acting', 'pasireotide', 'group', ',', 'six', '(', ')', 'of', 'in', 'everolimus', 'group', ',', 'and', 'three', '(', ')', 'of', 'in', 'combination', 'group', '.', 'no', 'death', 'suspected', 'to', 'related', 'to', 'long-acting', 'pasireotide', 'treatment', '.', 'one', 'death', 'in', 'everolimus', 'group', '(', 'acute', 'kidney', 'injury', 'associated', 'with', 'diarrhoea', ')', ',', 'and', 'two', 'death', 'in', 'combination', 'group', '(', 'diarrhoea', 'and', 'urinary', 'sepsis', 'in', 'one', 'patient', ',', 'and', 'acute', 'renal', 'failure', 'and', 'respiratory', 'failure', 'in', 'one', 'patient', ')', 'suspected', 'to', 'related', 'to', 'everolimus', 'treatment', '.', 'in', 'latter', 'patient', ',', 'acute', 'renal', 'failure', 'not', 'suspected', 'to', 'related', 'to', 'everolimus', 'treatment', ',', 'respiratory', 'failure', 'suspected', 'to', 'related', '.', 'interpretation', 'study', 'met', 'primary', 'endpoint', 'in', 'three', 'treatment', 'group', '.', 'safety', 'profile', 'consistent', 'with', 'known', 'safety', 'profile', 'of', 'agent', '.', 'study', 'needed', 'to', 'confirm', 'antitumour', 'efficacy', 'of', 'combination', 'of', 'somatostatin', 'analogue', 'with', 'everolimus', 'in', 'lung', 'and', 'thymic', 'carcinoid', '.', 'funding', 'novartis', 'pharma', 'ag', '.']"
Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies.,"Irina Amitai, Uri Rozovski, Reem El-Saleh, Shai Shimony, Daniel Shepshelovich, Benaya Rozen-Zvi, Pia Raanani, Anat Gafter-Gvili, Ronit Gurion, Irina Amitaiet al.",2020 Oct,Hematol Oncol,https://pubmed.ncbi.nlm.nih.gov/32506594/,"acute kidney injury, albumin, lactic dehydrogenase, methotrexate, survival.","['primary', 'central', 'nervous', 'system', '(', 'cns', ')', 'lymphoma', ',', 'cns', 'prophylaxis', 'in', 'lymphoma', 'type', ',', 'acute', 'lymphatic', 'leukemia', 'and', 'others', '.', 'median', 'age', 'diagnosis', 'year', '(', 'range', ',', '-', ')', ',', 'male', ',', 'median', 'mtx', 'dose', 'mgm', '(', 'range', ',', '-', ')', 'and', 'aki', 'developed', 'in', 'of', 'drug', 'administration', '(', 'n', ')', '.', 'in', 'univariate', 'analysis', 'age', ',', 'ldh', 'unitsl', ',', 'egfr', 'unitsl', '(', 'or', '.', ',', 'confidence', 'interval', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'albumin', 'level', 'unitsl', 'and', 'albumin', '.', 'gdl', 'strongest', 'factor', 'associated', 'with', 'aki', 'in', 'patient', 'receiving', 'hdmtx', '.', 'although', 'rise', 'in', 'creatinine', 'level', 'almost', 'uniformly', 'reversible', ',', 'aki', 'associated', 'with', 'increased', 'mortality', 'rate', '.']"
Optimal blood pressure decreases acute kidney injury after gastrointestinal surgery in elderly hypertensive patients: A randomized study: Optimal blood pressure reduces acute kidney injury.,"Xiujuan Wu, Zongming Jiang, Jing Ying, Yangyang Han, Zhonghua Chen, Xiujuan Wuet al.",2017 Dec:43:77-83.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/29055803/,No keywords found,"['to', 'determine', 'appropriate', 'mean', 'arterial', 'pressure', '(', 'map', ')', 'control', 'level', 'elderly', 'patient', 'with', 'hypertension', 'perioperative', 'period', '.', 'design', 'prospective', ',', 'randomized', 'study', '.', 'setting', 'three', 'teaching', 'hospital', 'in', 'china', '.', 'patient', 'six', 'hundred', 'seventy-eight', 'elderly', 'patient', 'with', 'chronic', 'hypertension', 'undergoing', 'major', 'gastrointestinal', 'surgery', '.', 'intervention', 'patient', 'randomly', 'allocated', 'to', 'three', 'group', 'and', 'target', 'map', 'level', 'strictly', 'controlled', 'to', 'one', 'of', 'three', 'level', 'level', '(', '-mmhg', ')', ',', 'level', 'ii', '(', '-mmhg', ')', ',', 'or', 'level', 'iii', '(', '-mmhg', ')', '.', 'measurement', 'primary', 'outcome', 'acute', 'kidney', 'injury', '(', 'aki', ')', '(', 'or', '.mgdl-increase', 'in', 'creatinine', 'level', ')', 'first', 'postoperative', 'day', '.', 'secondary', 'outcome', 'perioperative', 'adverse', 'complication', '.', 'moreover', ',', 'vasoactive', 'agent', 'observed', 'surgery', '.', 'main', 'result', 'overall', 'incidence', 'of', 'postoperative', 'aki', '.', '(', ')', '.', 'aki', 'occurred', 'significantly', 'less', 'often', 'in', 'patient', 'with', 'level', 'ii', 'map', 'control', '(', '.', ')', 'in', 'patient', 'with', 'level', '(', '.', ')', 'and', 'level', 'iii', '(', '.', ')', '(', 'p.', ')', 'map', 'control', '.', 'level', 'ii', 'associated', 'with', 'lower', 'incidence', 'of', 'hospital-acquired', 'pneumonia', '(', '.', 'p.', ')', 'and', 'admission', 'to', 'intensive', 'care', 'unit', '(', 'icu', ')', '(', '.', 'p.', ')', 'and', 'with', 'shorter', 'length', 'of', 'stay', 'in', 'icu', '(', 'p.', ')', 'compared', 'with', 'level', 'and', 'level', 'iii', '.', 'use', 'of', 'norepinephrine', ',', 'phenylephrine', ',', 'and', 'nitroglycerin', 'significantly', 'higher', 'patient', 'with', 'level', 'iii', 'map', 'control', 'patient', 'with', 'level', 'and', 'level', 'ii', 'map', 'control', '(', 'p.', ')', '.', 'conclusion', 'elderly', 'hypertensive', 'patient', ',', 'controlling', 'intraoperative', 'map', 'level', 'to', 'to', 'mmhg', 'reduce', 'postoperative', 'aki', 'major', 'abdominal', 'surgery', '.']"
Effect of dexmedetomidine on perioperative hemodynamics and organ protection in children with congenital heart disease: A randomized controlled trial.,"Shaopeng Ming, Yongguo Xie, Xueke Du, Haiqing Huang, Yue Fan, Qingxuan Liang, Yubo Xie, Shaopeng Minget al.",2021 Jan 8,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/33429762/,No keywords found,"['study', 'aimed', 'to', 'investigate', 'effect', 'of', 'dexmedetomidine', '(', 'dex', ')', 'hemodynamics', 'and', 'organ', 'protection', 'in', 'congenital', 'heart', 'disease', '(', 'chd', ')', 'child', 'underwent', 'open-heart', 'surgery', 'cryogenic', 'cardiopulmonary', 'bypass', '.', 'method', 'ninety', 'child', 'randomly', 'allocated', 'to', 'group', 'c', '(', '.', 'saline', '.', 'gkghour', ')', ',', 'group', '(', 'dex', '.', 'gkghour', ')', ',', 'and', 'group', '(', 'dex', '.', 'gkghour', ')', '(', 'n', 'per', 'group', ')', '.', 'participant', 'received', 'fentanyl', ',', 'propofol', 'and', 'sevoflurane', 'anesthesia', 'induction', '.', 'hemodynamic', 'data', 'measured', '(', 'induction', ')', 'to', '(', 'minute', 'extubation', ')', '.', 'difference', 'of', 'arterial', 'internal', 'jugular', 'vein', 'bulbar', 'oxygen', 'difference', 'and', 'cerebral', 'oxygen', 'extraction', 'ratio', 'calculated', 'according', 'to', 'fick', 'formula', '.', 'enzyme-linked', 'immunosorbent', 'assay', 'performed', 'to', 'detect', 'serum', 'myocardial', ',', 'brain', 'and', 'kidney', 'injury', 'marker', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'calculated', 'serum', 'creatinine', 'level', '.', 'tracheal', 'extubation', 'time', ',', 'postoperative', 'pain', 'score', 'and', 'emergence', 'agitation', 'score', 'also', 'recorded', '.', 'result', 'compared', 'with', 'group', 'c', ',', 'group', ',', 'and', 'exhibited', 'reduction', 'in', 'hemodynamic', 'parameter', ',', 'myocardial', 'and', 'brain', 'injury', 'indicator', ',', 'and', 'tracheal', 'extubation', 'time', '.', 'no', 'significant', 'difference', 'in', 'blood', 'urea', 'nitrogen', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'or', 'incidence', 'of', 'aki', 'among', 'group', '.', 'besides', ',', 'incidence', 'of', 'tachycardia', ',', 'nausea', ',', 'vomiting', 'and', 'moderate', 'agitation', ',', 'and', 'flacc', 'scale', 'in', 'group', 'and', 'lower', 'in', 'group', 'c.', 'moreover', ',', 'dex', '.', 'gkghour', 'could', 'reduce', 'dosage', 'of', 'fentanyl', 'and', 'dopamine', 'compared', 'with', 'dex', '.', 'gkghour', '.', 'conclusion', 'dex', 'anesthesia', 'effectively', 'maintain', 'hemodynamic', 'stability', 'and', 'diminish', 'organ', 'injury', 'in', 'chd', 'child', '.']"
"The safety and efficacy of Chinese herbal medicine for pneumonia prevention in high-risk elder residents in the nursing home: A randomized, double-blind clinical trial.","Yun-Tai Chen, Pei-Hsin Chen, Fang-Yu Chou, Sheng-Hao Lin, Sung-Yen Huang, Ming-Chung Lee, Yu-Jun Chang, Po-Chi Hsu, Lun-Chien Lo, Yun-Tai Chenet al.",2024 Jan 10,J Ethnopharmacol,https://pubmed.ncbi.nlm.nih.gov/37562462/,No keywords found,"['nursing', 'home-associated', 'pneumonia', '(', 'nhap', ')', 'common', 'type', 'of', 'infection', 'among', 'long-term', 'care', 'resident', '.', 'moreover', ',', 'mortality', 'of', 'nhap', 'also', 'higher', 'community-acquired', 'pneumonia', '(', 'cap', ')', '.', 'in', 'traditional', 'chinese', 'medicine', '(', 'tcm', ')', ',', 'decoction', 'of', 'banxia', 'houpo', 'tang', '(', 'bht', ')', 'and', 'ding', 'chuan', 'tang', '(', 'dct', ')', 'two', 'formula', 'supporting', 'lung', ""'"", 'natural', 'defense', 'system', ',', 'help', 'to', 'expel', 'mucus', 'and', 'promote', 'detoxification', '.', 'aim', 'of', 'study', 'designed', 'concentrated', 'chinese', 'herbal', 'extract', 'formula', 'called', 'bdt', ',', 'combine', 'compound', 'of', 'bht', 'and', 'dct', '.', 'in', 'study', ',', 'evaluated', 'safety', 'and', 'efficacy', 'of', 'bdt', 'nhap', 'prevention', 'in', 'high-risk', 'older', 'resident', 'in', 'nursing', 'home', '.', 'material', 'and', 'method', 'in', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trial', ',', 'participant', 'aged', 'year', 'old', 'living', 'in', 'nursing', 'home', 'randomly', 'assigned', 'to', 'bdt', 'and', 'placebo', 'group', '.', 'besides', 'regular', 'medicine', ',', 'participant', 'received', 'either', 'bdt', 'or', 'placebo', 'consecutive', 'week', '.', 'primary', 'outcome', 'hospitalization', 'rate', 'pneumonia', 'in', 'intervention', 'period', 'and', 'half-year', 'follow-up', '.', 'microscopic', 'examination', 'of', 'gram-stained', 'sputum', 'also', 'evaluated', 'and', 'trial', '.', 'data', 'analyzed', 'using', 'chi-square', 'test', 'and', 'wilcoxon', 'signed', 'rank', 'test', 'with', 'spss', '.', 'result', 'total', 'of', 'participant', 'enrolled', 'two', 'study', 'group', 'in', 'study', ',', 'completed', 'with', 'participant', 'analyzed', ',', 'including', 'subject', 'in', 'bdt', 'group', 'and', 'subject', 'in', 'placebo', 'group', '.', '-week', 'medical', 'treatment', ',', 'hospitalization', 'rate', 'pneumonia', '.', 'and', '.', 'in', 'bdt', 'and', 'placebo', 'group', 'respectively', '.', 'risk', 'of', 'pneumonia', 'in', 'half', 'year', 'lower', 'in', 'bdt', 'group', '(', 'adjusted', 'hazard', 'ratio', '.', ',', 'ci', '.-.', ')', '.', 'compared', 'to', 'placebo', 'group', ',', 'level', 'of', 'gram-negative', 'bacillus', 'in', 'bdt', 'group', 'significantly', 'declined', 'in', 'sputum', 'sample', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'conclusion', ',', 'cumulative', 'incidence', 'of', 'pneumonia', 'and', 'related-hospitalization', 'rate', 'declined', 'significantly', '-weeks', 'of', 'bdt', 'treatment', '.', 'besides', ',', 'chinese', 'herbal', 'medicine', 'bdt', 'safe', 'therapy', 'without', 'hepatotoxicity', 'or', 'nephrotoxicity', '.']"
"Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial.","Oliver K Jawitz, Amanda S Stebbins, Vignesh Raman, Brooke Alhanti, Sean van Diepen, Matthias Heringlake, Stephen Fremes, Richard Whitlock, Steven R Meyer, Rajendra H Mehta, Mark Stafford-Smith, Shaun G Goodman, John H Alexander, Renato D Lopes, Oliver K Jawitzet al.",2021 Jan:231:18-24.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/33127531/,No keywords found,"['aimed', 'to', 'evaluate', 'association', 'levosimendan', 'treatment', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'well', 'assess', 'clinical', 'sequela', 'of', 'aki', 'in', 'cardiac', 'surgery', 'patient', 'with', 'depressed', 'left', 'ventricular', 'function', '(', 'ejection', 'fraction', ')', '.', 'method', 'patient', 'in', 'levo-cts', 'trial', 'undergoing', 'on-pump', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', ',', 'valve', ',', 'or', 'cabgvalve', 'surgery', 'stratified', 'occurrence', 'and', 'severity', 'of', 'postoperative', 'aki', 'using', 'akin', 'classification', '.', 'association', 'levosimendan', 'infusion', 'and', 'aki', 'modeled', 'using', 'multivariable', 'regression', '.', 'result', 'among', 'levo-cts', 'patient', ',', '(', '.', ')', 'experienced', 'postoperative', 'aki', ',', 'including', '(', '.', ')', 'with', 'stage', ',', '(', '.', ')', 'with', 'stage', ',', 'and', '(', '.', ')', 'with', 'stage', 'aki', '.', 'rate', 'of', 'aki', 'similar', 'patient', 'receiving', 'levosimendan', 'or', 'placebo', '.', 'odds', 'of', '-day', 'mortality', 'significantly', 'increased', 'aki', 'stage', 'compared', 'to', 'without', 'aki', '(', 'stage', 'adjusted', 'odds', 'ratio', 'aor', '.', ',', 'confidence', 'interval', 'ci', '.-', '.', 'stage', 'aor', '.', ',', 'ci', '.-', '.', 'stage', 'aor', '.', ',', 'ci', '.-.', ')', '.', 'no', 'association', 'observed', 'levosimendan', ',', 'aki', 'stage', ',', 'and', 'odds', 'of', '-day', 'mortality', '(', 'interaction', 'p', '.', ')', '.', 'factor', 'independently', 'associated', 'with', 'aki', 'included', 'increasing', 'age', ',', 'body', 'mass', 'index', ',', 'diabetes', ',', 'and', 'increasing', 'baseline', 'systolic', 'blood', 'pressure', '.', 'increasing', 'baseline', 'egfr', 'and', 'aldosterone', 'antagonist', 'use', 'associated', 'with', 'lower', 'risk', 'of', 'aki', '.', 'conclusion', 'postoperative', 'aki', 'common', 'among', 'high-risk', 'patient', 'undergoing', 'cardiac', 'surgery', 'and', 'associated', 'with', 'significantly', 'increased', 'risk', 'of', '-day', 'death', 'or', 'dialysis', '.', 'levosimendan', 'not', 'associated', 'with', 'risk', 'of', 'aki', '.']"
"A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).","Shamir N Kalaria, Michael Armahizer, Paul McCarthy, Neeraj Badjatia, Jogarao V Gobburu, Mathangi Gopalakrishnan, Shamir N Kalariaet al.",2020 Sep,Clin Transl Sci,https://pubmed.ncbi.nlm.nih.gov/32223067/,No keywords found,"['limited', 'data', 'exist', 'effect', 'of', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'method', 'anti-epileptic', 'drug', 'pharmacokinetics', '(', 'pk', ')', '.', 'prospective', 'practice-based', 'pk', 'study', 'aim', 'to', 'assess', 'impact', 'of', 'continuous', 'venovenous', 'hemofiltration', '(', 'cvvh', ')', ',', 'modality', 'of', 'crrt', ',', 'levetiracetam', 'pk', 'in', 'critically', 'ill', 'patient', 'and', 'to', 'derive', 'individualized', 'dosing', 'recommendation', '.', 'eleven', 'patient', 'receiving', 'oral', 'or', 'intravenous', 'levetiracetam', 'and', 'cvvh', 'in', 'various', 'intensive', 'care', 'unit', 'large', 'academic', 'medical', 'center', 'enrolled', 'to', 'investigate', 'need', 'dosing', 'adjustment', '.', 'prefilter', ',', 'postfilter', ',', 'and', 'ultrafiltrate', 'sample', 'obtained', 'dosing', ',', 'completion', 'of', 'infusion', 'or', '-hour', 'postoral', 'dose', ',', 'and', 'to', 'additional', 'time', 'point', 'postinfusion', 'or', 'postoral', 'administration', '.', 'patient-specific', 'blood', 'and', 'ultrafiltrate', 'flow', 'rate', 'and', 'laboratory', 'value', 'also', 'collected', 'time', 'of', 'sampling', '.', 'average', 'sieving', 'coefficient', '(', 'sc', ')', 'levetiracetam', '.', '.', ',', 'indicating', 'high', 'filter', 'efficiency', '.', 'six', 'of', 'patient', 'experienced', 'concentration', 'outside', 'reported', 'therapeutic', 'range', '(', '-', 'mgl', ')', '.', 'average', 'volume', 'of', 'distribution', '.', 'lkg', '.', 'cvvh', 'clearance', 'contributes', 'major', 'fraction', 'of', 'total', 'levetiracetam', 'clearance', '(', '-', ')', 'in', 'neurocritically', 'ill', 'patient', '.', 'average', 'bias', 'and', 'precision', 'of', 'estimated', 'vs.', 'observed', 'total', 'clearance', 'value', '.', 'and', '..', 'major', 'dose', 'determinant', 'identified', 'to', 'sc', 'and', 'effluent', 'flow', 'rate', '.', 'patient', 'with', 'higher', 'ultrafiltrate', 'rate', 'increased', 'drug', 'clearance', 'and', ',', 'therefore', ',', 'require', 'higher', 'dos', 'in', 'order', 'to', 'match', 'exposure', 'seen', 'in', 'patient', 'with', 'normal', 'renal', 'function', '.']"
Ibuprofen versus placebo effect on acute kidney injury in ultramarathons: a randomised controlled trial.,"Grant S Lipman, Kate Shea, Mark Christensen, Caleb Phillips, Patrick Burns, Rebecca Higbee, Viktoria Koskenoja, Kurt Eifling, Brian J Krabak, Grant S Lipmanet al.",2017 Oct,Emerg Med J,https://pubmed.ncbi.nlm.nih.gov/28679502/,No keywords found,"['despite', 'concern', 'non-steroidal', 'anti-inflammatory', 'drug', '(', 'nsaid', ')', 'contribute', 'to', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'to', 'of', 'ultramarathon', 'runner', 'ingest', 'competition', '.', 'effect', 'of', 'nsaid', 'aki', 'incidence', 'in', 'ultramarathon', 'runner', 'unclear', '.', 'method', 'multisite', 'randomised', 'double-blind', 'placebo-controlled', 'trial', 'in', 'gobi', ',', 'atacama', ',', 'ecuador', 'and', 'sri', 'lankan', 'desert', 'to', 'determine', 'whether', 'ibuprofen', '(', 'mg', 'every', 'hour', ')', 'would', 'non-inferior', 'to', 'placebo', '-mile', '(', 'km', ')', 'foot', 'race', '.', 'primary', 'outcome', 'incidence', 'of', 'aki', 'defined', 'severity', 'category', 'of', ""'risk"", ""'"", 'of', 'injury', 'of', '.', 'baseline', 'creatinine', '(', 'cr', ')', 'or', ""'injury"", ""'"", 'cr', ',', 'combined', 'to', 'calculate', 'total', 'incidence', 'finish', 'line', '.', 'non-inferiority', 'margin', 'difference', 'in', 'aki', 'rate', 'defined', '.', 'result', 'eighty-nine', 'participant', '(', 'ibuprofen', 'and', 'placebo', ')', 'enrolled', 'with', 'similar', 'demographic', 'group', '.', 'overall', 'incidence', 'of', 'aki', '.', 'intent-to-treat', 'analysis', 'found', '(', ')', 'ibuprofen', 'versus', '(', ')', 'placebo', 'user', 'developed', 'aki', '(', 'difference', ',', 'ci', '-', 'to', 'or', '.', ',', 'ci', '.', 'to', '.', ')', 'with', 'number', 'needed', 'to', 'harm', 'of', '..', 'greater', 'severity', 'of', 'aki', 'seen', 'with', 'ibuprofen', 'compared', 'with', 'placebo', '(', 'risk', 'v', 'ci', '-', 'to', 'injury', 'v', 'ci', '-', 'to', ')', '.', 'slower', 'finisher', 'less', 'likely', 'to', 'encounter', 'aki', '(', 'or', '.', ',', 'ci', '.', 'to', '.', ')', 'and', 'greater', 'weight', 'loss', '(', '-', '.', ')', 'increased', 'aki', '(', 'or', '.', ',', 'ci', '.', 'to', '.', ')', '.', 'conclusion', 'increased', 'rate', 'of', 'aki', 'in', 'took', 'ibuprofen', ',', 'and', 'although', 'not', 'statistically', 'inferior', 'to', 'placebo', 'small', 'margin', ',', 'number', 'needed', 'to', 'harm', 'of', '.', 'people', 'to', 'cause', 'case', 'of', 'aki', '.', 'consideration', 'therefore', 'taken', 'ingesting', 'nsaid', 'endurance', 'running', 'could', 'exacerbate', 'renal', 'injury', '.', 'trial', 'registration', 'number', 'nct', '.']"
Renal dysfunction within 90 days of FluBu4 predicts early and late mortality.,"Karen Sweiss, Gregory S Calip, Annie L Oh, Damiano Rondelli, Pritesh R Patel, Karen Sweisset al.",2019 Jul,Bone Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/30604772/,No keywords found,"['myeloablative', 'conditioning', 'regimen', 'with', 'significant', 'extramedullary', 'toxicity', 'result', 'in', 'high', 'rate', 'of', 'renal', 'dysfunction', 'including', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'examine', 'incidence', 'and', 'impact', 'of', 'reduced', 'creatinine', 'clearance', '(', 'mlmin', ')', 'day', '(', 'early', 'renal', 'dysfunction', ',', 'erd', ')', 'in', 'patient', 'receiving', 'reduced', 'toxicity', 'fludarabinei.v', '.', 'busulfan', '(', 'flubu', ')', 'regimen', 'prior', 'to', 'allogeneic', 'transplant', '.', 'of', 'patient', 'receiving', 'flubu', ',', '(', ')', 'developed', 'erd', '.', 'erd', 'resulted', 'in', 'worse', 'overall', 'survival', '(', 'o', ',', '.', 'year', 'versus', 'median', 'not', 'reached', ',', 'p', '.', ')', 'and', 'progression-free', 'survival', '(', 'pfs', ',', '.', 'year', 'versus', 'median', 'not', 'reached', ',', 'p', '.', ')', '.', 'due', 'to', 'higher', 'relapse', 'rate', '(', 'versus', ',', 'p', '.', ')', 'in', 'erd', 'group', '.', 'in', 'time-dependent', 'cox', 'proportional', 'hazard', 'model', 'adjusted', 'age', ',', 'erd', 'associated', 'with', 'worse', 'o', '(', 'hazard', 'ratio', 'hr', '.', ',', 'confidence', 'interval', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'pfs', '(', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'patient', 'with', 'erd', 'surviving', 'year', 'increased', 'risk', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ',', 'or', 'ci', '.-.', ',', 'p', '.', ')', ',', 'associated', 'with', 'worse', 'survival', '(', '.', 'year', 'versus', 'median', 'not', 'reached', ',', 'p', '.', ')', '.', 'erd', 'flubu', 'therefore', 'poor', 'prognostic', 'sign', 'resulting', 'in', 'increased', 'relapse', ',', 'worse', 'o', ',', 'and', 'high', 'risk', 'of', 'ckd', 'year', '.']"
No Differences in Renal Function between Balanced 6% Hydroxyethyl Starch (130/0.4) and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy: A Randomized Controlled Trial.,"Tobias Kammerer, Florian Brettner, Sebastian Hilferink, Nikolai Hulde, Florian Klug, Judith-Irina Pagel, Alexander Karl, Alexander Crispin, Klaus Hofmann-Kiefer, Peter Conzen, Markus Rehm, Tobias Kammereret al.",2018 Jan,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/29064872/,No keywords found,"['use', 'of', 'artificial', 'colloid', 'declined', 'in', 'critical', 'care', ',', 'whereas', 'still', 'used', 'in', 'perioperative', 'medicine', '.', 'little', 'known', 'nephrotoxic', 'potential', 'in', 'noncritically', 'ill', 'patient', 'routine', 'surgery', '.', 'objective', 'of', 'trial', 'to', 'evaluate', 'influence', 'of', 'albumin', 'and', 'balanced', 'hydroxyethyl', 'starch', '(', '.', ')', 'renal', 'function', 'and', 'kidney', 'injury', '.', 'method', 'one', 'hundred', 'urologic', 'patient', 'undergoing', 'elective', 'cystectomy', 'randomly', 'assigned', 'prospective', ',', 'single-blinded', ',', 'controlled', 'study', 'with', 'two', 'parallel', 'group', 'to', 'receive', 'either', 'albumin', 'or', 'balanced', 'hydroxyethyl', 'starch', '(', '.', ')', 'perioperative', 'colloid', '.', 'primary', 'endpoint', 'ratio', 'of', 'serum', 'cystatin', 'c', 'last', 'visit', 'day', 'and', 'first', 'preoperative', 'visit', '.', 'secondary', 'endpoint', 'estimated', 'glomerular', 'filtration', 'rate', 'and', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'third', 'postoperative', 'day', 'and', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', ',', 'and', 'end-stage', 'renal', 'disease', 'criterion', 'postoperative', 'day', 'and', '.', 'result', 'median', 'cystatin', 'c', 'ratio', '.', '(', 'interquartile', 'range', ',', '.', 'to', '.', ')', 'in', 'albumin', 'and', '.', '(', 'interquartile', 'range', ',', '.', 'to', '.', ')', 'in', 'hydroxyethyl', 'starch', 'group', '(', 'median', 'difference', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'also', ',', 'no', 'significant', 'difference', 'concerning', 'serum', 'cystatin', 'c', 'concentration', 'estimated', 'glomerular', 'filtration', 'rate', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', ',', 'and', 'end-stage', 'renal', 'disease', 'criterion', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', '.', 'infusion', 'requirement', ',', 'transfusion', 'rate', ',', 'and', 'perioperative', 'hemodynamics', 'similar', 'in', 'group', '.', 'conclusion', 'with', 'respect', 'to', 'renal', 'function', 'and', 'kidney', 'injury', ',', 'study', 'indicates', 'albumin', 'and', 'balanced', 'hydroxyethyl', 'starch', 'comparable', 'safety', 'profile', 'in', 'noncritically', 'ill', 'patient', 'undergoing', 'major', 'surgery', '.']"
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.,"Nienke M A Idzerda, Frederik Persson, Michelle J Pena, Barry M Brenner, Patrick Brunel, Nish Chaturvedi, John J McMurray, Hans-Henrik Parving, Dick de Zeeuw, Hiddo J L Heerspink, Nienke M A Idzerdaet al.",2018 Dec,Diabetes Obes Metab,https://pubmed.ncbi.nlm.nih.gov/29987919/,"cardiovascular disease, clinical trial, diabetes complications, type 2 diabetes.","['sodium', 'retention', 'and', 'volume', 'overload', 'main', 'determinant', 'of', 'poor', 'response', 'to', 'renin-angiotensin-aldosterone', 'system', '(', 'raas', ')', 'inhibition', 'in', 'patient', 'with', 'diabetes', '.', 'volume', 'excess', 'exist', 'without', 'symptom', ',', 'biomarkers', 'needed', 'to', 'identify', 'priori', 'patient', 'volume', 'overloaded', 'and', 'may', 'experience', 'less', 'benefit', 'raas', 'inhibition', '.', 'n-terminal', 'pro-brain', 'natriuretic', 'peptide', '(', 'nt-probnp', ')', 'released', 'in', 'setting', 'of', 'increased', 'cardiac', 'wall', 'stress', 'and', 'volume', 'overload', '.', 'conducted', 'post', 'hoc', 'analysis', 'among', 'patient', 'with', 'type', 'diabetes', 'mellitus', 'participating', 'in', 'altitude', 'trial', 'to', 'investigate', 'whether', 'ntprobnp', 'predict', 'effect', 'of', 'additional', 'therapy', 'with', 'aliskiren', 'cardio-renal', 'endpoint', '.', 'aliskiren', 'compared', 'to', 'placebo', 'reduced', 'risk', 'of', 'primary', 'cardio-renal', 'endpoint', 'event', '(', 'confidence', 'interval', 'ci', 'to', ')', 'and', '(', 'ci', '-', 'to', ')', 'in', 'two', 'lowest', 'nt-probnp', 'tertiles', ',', 'and', 'increased', 'risk', '(', 'ci', '-', 'to', ')', 'in', 'highest', 'nt-probnp', 'tertile', '(', 'p', 'value', 'trend', '.', ')', '.', 'similar', 'trend', 'observed', 'cardiovascular', 'and', 'end-stage', 'renal', 'disease', 'endpoint', '.', 'effect', 'of', 'aliskiren', 'compared', 'to', 'placebo', 'safety', 'outcome', '(', 'hyperkalaemia', 'and', 'hospitalization', 'acute', 'kidney', 'injury', ')', 'independent', 'of', 'nt-probnp', '.', 'in', 'conclusion', ',', 'baseline', 'nt-probnp', 'may', 'used', 'marker', 'to', 'predict', 'response', 'to', 'aliskiren', 'with', 'regard', 'to', 'cardio-renal', 'outcome', 'added', 'to', 'standard', 'therapy', 'with', 'raas', 'inhibition', '.']"
Is ciprofloxacin safe in patients with solitary kidney and upper urinary tract infection?,"Gheorghe Gluhovschi, Florica Gadalean, Cristina Gluhovschi, Silvia Velciov, Ligia Petrica, Flaviu Bob, Gheorghe Bozdog, Adriana Kaycsa, Gheorghe Gluhovschiet al.",2016 Dec:84:366-372.,Biomed Pharmacother,https://pubmed.ncbi.nlm.nih.gov/27668536/,"Biomarkers, Ciprofloxacin, Glomerular filtration rate, Nephrotoxicity, Solitary kidney.","['solitary', 'kidney', '(', 'sk', ')', 'undergoes', 'adaptive', 'phenomenon', 'of', 'hyperfunction', 'and', 'hyperfiltration', '.', 'secondary', 'adaptive', 'phenomenon', 'make', 'vulnerable', 'to', 'potentially', 'nephrotoxic', 'therapy', '.', 'adverse', 'reaction', 'of', 'kidney', 'to', 'ciprofloxacin', 'rare', ',', 'sometimes', 'severe', '.', 'therefore', ',', 'study', 'sought', 'to', 'assess', 'reaction', 'to', 'ciprofloxacin', 'of', 'patient', 'with', 'solitary', 'kidney', '(', 'sk', ')', 'and', 'urinary', 'tract', 'infection', '(', 'uti', ')', 'mean', 'of', 'urinary', 'biomarkers', '.', 'studied', 'patient', 'with', 'sk', 'and', 'urinary', 'tract', 'infection', '(', 'uti', ')', 'administered', '-day', 'treatment', 'with', 'intravenous', 'ciprofloxacin', '.', 'urinary', 'n-acetyl-beta-d-glucosaminidase', ',', 'alpha', '-microglobulin', ',', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'of', 'patient', 'measured', 'initiation', 'and', 'end', 'of', 'treatment', '.', 'in', '.', 'patient', 'nag', 'diminished', 'ciprofloxacin', 'treatment', '.', 'observation', 'significance', 'of', 'favourable', 'evolution', 'of', 'tubulointerstitial', 'lesion', 'caused', 'uti', 'and', 'lack', 'of', 'nephrotoxic', 'effect', '.', 'case', 'presented', 'increase', 'of', 'urinary', 'nag', ',', 'fact', 'suggests', 'nephrotoxic', 'effect', 'of', 'ciprofloxacin', '.', 'evolution', 'of', 'urinary', 'alpha', '-microglobulin', 'similar', 'to', 'one', 'of', 'urinary', 'nag', '.', 'one', 'of', 'three', 'case', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'stage', 'presented', 'acute', 'kidney', 'injury', ',', 'associated', 'with', 'increase', 'in', 'tubular', 'marker', '.', 'in', 'spite', 'of', 'high', 'variability', 'of', 'urinary', 'biomarkers', ',', 'uti', 'evolved', 'favourably', 'in', 'case', 'egfr', 'increased', 'in', 'of', 'patient', ',', 'fact', 'indicative', 'of', 'good', 'outcome', 'of', 'renal', 'function', ',', 'even', 'in', 'patient', 'with', 'elevated', 'level', 'of', 'tubular', 'damage', 'biomarkers', '.', 'observation', 'support', 'hypothesis', 'egfr', 'may', 'dissociated', 'biomarkers', 'assess', 'tubular', 'injury', '.', 'in', 'sk', 'patient', 'occurrence', 'of', 'aki', 'not', 'frequent', ',', 'although', 'urinary', 'biomarkers', 'rise', 'in', 'patient', 'treated', 'with', 'ciprofloxacin', '.', 'related', 'not', 'to', 'nephrotoxic', 'effect', 'of', 'drug', ',', 'probably', 'to', 'association', 'of', 'factor', '(', 'allergy', ',', 'individual', 'susceptibility', ')', '.', 'in', 'sk', 'patient', ',', 'renal', 'tubular', 'biomarkers', ',', 'especially', 'nag', ',', 'allow', 'monitoring', 'of', 'tubular', 'injury', 'and', 'impose', 'caution', 'in', 'prescribing', 'ciprofloxacin', 'treatment', ',', 'mainly', 'to', 'patient', 'risk', '.', 'ciprofloxacin', 'relatively', 'safe', 'regarding', 'nephrotoxicity', ',', 'caution', 'required', 'in', 'vulnerable', 'patient', '.']"
Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): a study protocol for a randomized controlled trial.,"Hyung Ah Jo, Sehoon Park, Chan-Duck Kim, Hee-Yeon Jung, Jang-Hee Cho, Ran-Hui Cha, Ea Wha Kang, Tae Ik Chang, Sejoong Kim, Hyung-Jong Kim, Byung Ha Chung, Jung Pyo Lee, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Dong-Ryeol Ryu, Sung Jin Moon, Jae Hyun Chang, Dong Ki Kim, Kwon Wook Joo, Hyung Ah Joet al.",2017 Oct 5,Trials,https://pubmed.ncbi.nlm.nih.gov/28982378/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'one', 'of', 'common', 'cause', 'of', 'iatrogenic', 'kidney', 'injury', 'and', ',', 'therefore', ',', 'prevention', 'important', 'issue', '.', 'however', ',', 'whether', 'administration', 'of', '.', 'saline', 'optimal', 'prophylaxis', 'method', 'remains', 'uncertain', 'due', 'to', 'supra-physiologic', 'chloride', 'component', '.', 'in', 'particular', ',', 'recent', 'study', 'suggest', 'chloride-restricted', 'solution', 'showed', 'superiority', '.', 'saline', 'in', 'several', 'clinical', 'setting', '.', 'methodsdesign', 'investigator', 'designed', 'multicenter', 'randomized', 'controlled', 'trial', 'to', 'compare', 'efficacy', 'of', 'balanced', 'salt', 'solution', 'and', '.', 'saline', 'in', 'ci-aki', 'prophylaxis', '.', 'study', 'recruit', 'patient', 'scheduled', 'contrast-enhanced', 'computed', 'tomography', '(', 'ct', ')', 'scan', 'with', 'ci-aki', 'prophylaxis', '.', 'in', 'study', ',', 'participant', 'randomized', 'two', 'study', 'arm', 'study', 'group', 'receive', 'balanced', 'salt', 'solution', ',', 'and', 'control', 'group', 'receive', '.', 'saline', '.', 'fluid', 'administered', 'designated', 'in', 'protocol', 'and', 'ct', 'scan', ',', 'and', 'evaluation', 'of', 'baseline', 'clinical', 'status', 'performed', 'obtaining', 'blood', 'and', 'urine', 'sample', '.', 'follow-up', 'visit', ',', 'incidence', 'of', 'ci-aki', 'and', 'long-term', 'outcome', ',', 'including', 'start', 'of', 'renal', 'replacement', 'therapy', 'or', 'all-cause', 'mortality', ',', 'assessed', '.', 'discussion', 'to', 'knowledge', ',', 'study', 'first', 'study', 'assessing', 'preventive', 'value', 'of', 'balanced', 'salt', 'solution', '.', 'saline', 'ci-aki', '.', 'trial', 'show', 'balanced', 'salt', 'solution', 'effective', 'ci-aki', 'prophylaxis', '.', 'saline', ',', 'use', 'of', 'balanced', 'salt', 'solution', 'could', 'promoted', 'due', 'to', 'reduced', 'possibility', 'of', 'consequent', 'metabolic', 'acidosis', 'compared', 'to', '.', 'saline', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'id', 'nct', '.', 'registered', 'june', '.']"
Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay.,"L Cuñetti, L Manzo, R Peyraube, J Arnaiz, L Curi, S Orihuela, L Cuñettiet al.",2018 Mar,Transplant Proc,https://pubmed.ncbi.nlm.nih.gov/29579828/,No keywords found,"['chronic', 'pain', 'major', 'therapeutic', 'problem', 'in', 'kidney', 'transplant', 'patient', 'owing', 'to', 'nephrotoxicity', 'associated', 'with', 'nonsteroidal', 'antiiflammatory', 'drug', '.', 'benefit', 'in', 'chronic', 'pain', 'treatment', 'with', 'cannabidiol', '(', 'cbd', ')', 'reported', '.', 'study', 'assesses', 'effect', ',', 'safety', ',', 'and', 'possible', 'drug', 'interaction', 'in', 'kidney', 'transplant', 'patient', 'treated', 'with', 'cbd', 'chronic', 'pain', '.', 'method', 'assessed', 'patient', 'asked', 'to', 'receive', 'cbd', 'pain', 'treatment', '.', 'dos', 'increased', 'to', 'mg', 'twice', 'day', 'week', '.', 'creatinine', ',', 'blood', 'count', ',', 'liver', 'function', ',', 'liver', 'enzyme', ',', 'and', 'drug', 'level', 'determined', 'every', 'hour', 'first', 'week', 'and', 'week', 'thereafter', '.', 'result', 'assessed', 'patient', 'with', 'mean', 'age', 'of', '.', 'year', '(', 'range', ',', '-', 'year', ')', '.', 'cbd', 'initial', 'dose', 'mgd', ',', 'cbd', 'dose', 'reduction', 'to', 'mgd', 'done', 'day', 'to', 'patient', 'persistent', 'nausea', '.', 'tacrolimus', 'dose', 'reduction', 'in', 'patient', 'undertaken', 'day', ',', ',', 'and', 'owing', 'to', 'persisting', 'elevated', 'level', '(', 'even', 'cbd', ')', 'and', 'itching', ',', 'and', 'day', 'in', 'patient', '.', 'tacrolimus', 'level', 'decreased', 'in', 'patient', 'normal', 'in', 'control', 'week', 'later', '.', 'patient', 'cyclosporine', 'stable', '.', 'adverse', 'effect', 'nausea', ',', 'dry', 'mouth', ',', 'dizziness', ',', 'drowsiness', ',', 'and', 'intermittent', 'episode', 'of', 'heat', '.', 'cbd', 'dose', 'decrease', 'required', 'in', 'patient', '.', 'two', 'patient', 'total', 'pain', 'improvement', ',', 'partial', 'response', 'in', 'first', 'day', ',', 'and', 'in', 'no', 'change', '.', 'conclusion', 'follow-up', ',', 'cbd', 'well-tolerated', ',', 'and', 'no', 'severe', 'adverse', 'effect', '.', 'plasma', 'level', 'of', 'tacrolimus', 'variable', '.', 'therefore', ',', 'longer', 'follow-up', 'required', '.']"
"Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with beta-Lactam Antibiotics in Healthy Subjects.","Paul B Eckburg, Troy Lister, Susannah Walpole, Tim Keutzer, Luke Utley, John Tomayko, Ellen Kopp, Nicholas Farinola, Scott Coleman, Paul B Eckburget al.",2019 Aug 23,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/31262767/,"SPR741, drug interaction, pharmacokinetics, potentiator.","['spr', 'novel', 'polymyxin', 'b', 'derivative', ',', 'with', 'minimal', 'intrinsic', 'antibacterial', 'activity', 'and', 'reduced', 'nonclinical', 'nephrotoxicity', 'compared', 'to', 'level', 'with', 'polymyxin', 'b', ',', 'interacts', 'with', 'outer', 'membrane', 'of', 'gram-negative', 'bacteria', ',', 'enhancing', 'penetration', 'of', 'coadministered', 'antibiotic', '.', 'safety', ',', 'tolerability', ',', 'and', 'pharmacokinetics', '(', 'pk', ')', 'of', 'spr', 'evaluated', 'in', 'two', 'study', ',', 'single', 'and', 'multiple', 'intravenous', '(', 'i.v', '.', ')', 'dos', 'in', 'healthy', 'adult', 'subject', 'and', 'coadministration', 'with', 'partner', 'antibiotic', '.', 'in', 'single', 'and', 'multiple', 'ascending-dose', 'study', ',', 'spr', 'or', 'placebo', 'administered', '-h', 'infusion', 'single', 'dos', 'of', 'to', 'mg', 'and', 'in', 'multiple', 'dos', 'of', 'to', 'mg', 'every', 'h', '(', 'qh', ')', 'day', '.', 'in', 'drug-drug', 'interaction', 'study', ',', 'single', '-mg', 'i.v', '.', 'dose', 'of', 'spr', 'administered', 'alone', 'and', 'in', 'combination', 'with', 'piperacillin-tazobactam', ',', 'ceftazidime', ',', 'and', 'aztreonam', '.', 'pk', 'parameter', 'spr', 'and', 'partner', 'antibiotic', 'determined', 'using', 'noncompartmental', 'analysis', '.', 'single', 'dos', ',', 'dose-linear', 'and', 'proportional', 'increase', 'in', 'mean', 'maximum', 'concentration', 'in', 'plasma', '(', 'cmax', ')', 'and', 'area', 'concentration-time', 'curve', '(', 'auc', ')', 'observed', '.', 'dos', 'of', 'to', 'mg', ',', 'of', 'dose', 'excreted', 'in', 'urine', 'in', 'first', 'h', 'postdose', '.', 'multiple', 'dos', ',', 'mean', 'half-life', '.', 'h', 'day', 'and', 'to', '.', 'h', 'day', ',', 'with', 'no', 'evidence', 'of', 'accumulation', 'day', 'of', 'dosing', 'to', 'mg.', 'pk', 'profile', 'of', 'spr', 'and', 'partner', 'antibiotic', 'unchanged', 'with', 'coadministration', '.', 'spr', 'generally', 'well', 'tolerated', 'dos', 'to', ',', 'mgday', '.', 'data', 'support', 'clinical', 'development', 'of', 'spr', 'treating', 'serious', 'infection', 'due', 'to', 'resistant', 'bacteria', '.', '(', 'study', 'registered', 'clinicaltrials.gov', 'identifier', 'nct', 'and', 'nct', '.', ')', '.']"
Pharmacokinetics of initial full and subsequent reduced doses of S-1 in patients with locally advanced head and neck cancer-effect of renal insufficiency.,"Tomoko Yamazaki, Makoto Tahara, Tomohiro Enokida, Tetsuro Wakasugi, Satoko Arahira, Sadamoto Zenda, Atsushi Motegi, Tetsuo Akimoto, Kunihiro Yoshisue, Tomoko Yamazakiet al.",2017 May 1,Jpn J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/28159957/,No keywords found,"['s-', 'combination', 'of', 'tegafur', 'metabolized', 'to', '-fluorouracil', '(', '-fu', ')', 'with', 'modulators', 'gimeracil', '(', '-chloro-', ',', '-dihydroxypyridine', ')', 'and', 'oteracil', 'potassium', '.', '-chloro-', ',', '-dihydroxypyridine', 'maintains', 'plasma', '-fu', 'concentration', 'inhibiting', 'dihydropyrimidine', 'dehydrogenase', ',', 'pyrimidine', 'catabolism', 'enzyme', 'degrades', '-fu', '.', 'of', '-chloro-', ',', '-dihydroxypyridine', 'excreted', 'in', 'urine', ',', 'renal', 'insufficiency', 'may', 'increase', 'blood', 'level', ',', 'increasing', '-fu', 'concentration', '.', 'investigated', 'whether', 'special', 'dose', 'modification', 'needed', 'in', 'presence', 'of', 'renal', 'insufficiency', '.', 'objective', 'compared', 'steady', 'state', 'pharmacokinetics', 'of', '-fu', 'initial', 's-', 'dose', 'and', 'reduced', 'dos', 'in', 'patient', 'with', 'head', 'and', 'neck', 'cancer', 'requiring', 'dose', 'reduction', 'due', 'to', 'renal', 'and', 'non-renal', 'toxicity', '.', 'method', 'chemoradiotherapy', 'with', 's-', 'and', 'cisplatin', 'administered', 'every', 'week', 'two', 'course', 'with', 'radiation', 'dose', 'totaling', 'gy', '-', 'fraction', '.', 'two', 'additional', 'course', 'of', 'adjuvant', 'chemotherapy', 'administered', 'in', 'case', 'of', 'objective', 'response', '.', 's-', 'andor', 'cisplatin', 'dose', 'reduced', 'in', 'response', 'to', 'renal', ',', 'hematologic', 'or', 'toxicity', '.', 'primary', 'endpoint', 'change', 'in', 'area', 'plasma', 'concentration-versus-time', 'curve', 'time', '-', 'hour', '(', '-fu', 'aucss', '-', ')', 'initial', 'and', 'reduced', 's-', 'dos', '.', 'result', 'although', 'mean', '-fu', 'level', 'in', 'patient', 'with', 'non-renal', 'toxicity', 'significantly', 'decreased', 'full', 'and', 'reduced', 'dose', ',', 'full-dose', 'and', 'reduced-dose', 'mean', 'maximum', '-fu', 'plasma', 'concentration', 'steady', 'state', '(', 'cs', 'max', ')', 'and', 'aucss', '-', 'in', 'patient', 'with', 'renal', 'insufficiency', 'similar', '.', 'conclusion', 'standard', 's-', 'dose', 'reduction', 'renal', 'toxicity', 'not', 'result', 'in', 'significant', 'decrease', 'in', '-fu', 'level', 'steady', 'state', '.', 'greater', 'reduction', 'to', 'lower', 'plasma', '-chloro-', ',', '-dihydroxypyridine', 'may', 'necessary', 'in', 'patient', 'with', 'renal', 'insufficiency', '.']"
Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial.,"Laurence Weinberg, Jeremy Broad, Param Pillai, Guangjun Chen, Micheline Nguyen, Glenn M Eastwood, Nick Scurrah, Mehrdad Nikfarjam, David Story, Larry McNicol, Rinaldo Bellomo, Laurence Weinberget al.",2016 May,Clin Transplant,https://pubmed.ncbi.nlm.nih.gov/26915026/,No keywords found,"['liver', 'transplantation-associated', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'carry', 'significant', 'morbidity', 'and', 'mortality', '.', 'hypothesized', 'sodium', 'bicarbonate', 'would', 'reduce', 'incidence', 'andor', 'severity', 'of', 'liver', 'transplantation-associated', 'aki', '.', 'method', 'in', 'double-blinded', 'pilot', 'rct', ',', 'adult', 'patient', 'undergoing', 'orthotopic', 'liver', 'transplantation', 'randomized', 'to', 'infusion', 'of', 'either', '.', 'sodium', 'bicarbonate', '(', '.', 'meqkgh', 'first', 'hour', '.', 'meqkgh', 'completion', 'of', 'surgery', ')', '(', 'n', ')', 'or', '.', 'sodium', 'chloride', '(', 'n', ')', '.', 'primary', 'outcome', 'aki', 'within', 'first', 'h', 'post-operatively', '.', 'result', 'no', 'significant', 'difference', 'two', 'treatment', 'group', 'with', 'regard', 'to', 'baseline', 'characteristic', ',', 'model', 'end-stage', 'liver', 'disease', 'and', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', '(', 'apache', ')', 'ii', 'score', ',', 'and', 'pre-transplantation', 'renal', 'function', '.', 'intra-operative', 'factor', 'similar', 'duration', 'of', 'surgery', ',', 'blood', 'product', 'requirement', ',', 'crystalloid', 'and', 'colloid', 'volume', 'infused', 'and', 'requirement', 'vasoactive', 'therapy', '.', 'eleven', 'patient', '(', ')', 'in', 'bicarbonate', 'group', 'and', 'patient', '(', ')', 'in', 'sodium', 'chloride', 'group', 'developed', 'post-operative', 'aki', '(', 'p', '.', ')', '.', 'bicarbonate', 'infusion', 'attenuated', 'degree', 'of', 'immediate', 'post-operative', 'metabolic', 'acidosis', 'however', ',', 'effect', 'dissipated', 'h.', 'no', 'significant', 'difference', 'in', 'ventilation', 'hour', ',', 'icu', 'or', 'hospital', 'length', 'of', 'stay', ',', 'or', 'mortality', '.', 'conclusion', 'intra-operative', 'infusion', 'of', 'sodium', 'bicarbonate', 'not', 'decrease', 'incidence', 'of', 'aki', 'in', 'patient', 'following', 'orthotopic', 'liver', 'transplantation', '.']"
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study.,"Camilla Thellenberg-Karlsson, Claes Nyman, Sten Nilsson, René Blom, Marcela Márquez, Enrique Castellanos, Anders R Holmberg, Camilla Thellenberg-Karlssonet al.",2016 Dec,Anticancer Res,https://pubmed.ncbi.nlm.nih.gov/27919973/,No keywords found,"['osteodex', '(', 'odx', ')', 'cytotoxic', 'bone-targeting', 'polybisphosphonate', ',', 'intended', 'treatment', 'of', 'bone', 'metastasis', 'castration-resistant', 'prostate', 'cancer', '(', 'crpc', ')', '.', 'primary', 'objective', 'of', 'study', 'to', 'describe', 'tolerability', 'and', 'toxicity', 'of', 'treatment', 'defining', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'and', 'dose-limiting', 'toxicity', '(', 'dlt', ')', '.', 'patient', 'and', 'method', 'twenty-eight', 'patient', 'with', 'castration-resistant', 'prostate', 'cancer', 'and', 'confirmed', 'bone', 'metastasis', 'assigned', 'to', 'seven', 'infusion', 'of', 'odx', 'every', 'third', 'week', ',', 'divided', 'in', 'seven', 'ascending', 'dose', 'cohort', '.', 'result', 'no', 'dlt', ""'s"", 'observed', 'and', 'pre-specified', ',', 'highest', 'dose', 'administered', 'defined', 'mtd', '.', 'in', 'total', ',', 'adverse', 'event', '(', 'ae', ')', 'recorded', 'and', ',', 'classified', 'treatment-related', ',', 'none', 'serious', 'or', 'severe', '(', 'sae', ')', '.', 'no', 'cumulative', 'toxicity', 'and', 'no', 'renal', 'toxicity', 'recorded', '.', 'conclusion', 'odx', 'well', 'tolerated', ',', 'with', 'and', 'mild', 'side-effects', 'and', 'with', 'apparent', 'treatment', 'efficacy', 'in', 'highest', 'dose', 'cohort', '.', 'clinical', 'development', 'currently', 'in', 'progress', '.']"
Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.,"Paloma L Martin-Moreno, Nerea Varo, Eduardo Martínez-Ansó, Nerea Martin-Calvo, Carmen Sayón-Orea, Jose I Bilbao, Nuria Garcia-Fernandez, Paloma L Martin-Morenoet al.",2015,Nephron,https://pubmed.ncbi.nlm.nih.gov/26336919/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'common', 'cause', 'of', 'renal', 'failure', '.', 'evaluated', 'effectiveness', 'of', 'oral', 'sodium', 'citrate', 'versus', 'intravenous', '(', 'iv', ')', 'sodium', 'bicarbonate', 'ci-aki', 'prophylaxis', 'well', 'influence', 'kidney', 'injury', 'biomarkers', '.', 'material', 'and', 'method', 'randomized', ',', 'controlled', ',', 'single-center', 'study', 'including', 'hospitalized', 'patient', '(', '.', 'men', ')', ',', 'randomized', 'to', 'receive', 'sodium', 'bicarbonate', '(', 'men', ',', 'mlkgh', 'h', 'n', ')', ',', 'oral', 'sodium', 'citrate', '(', 'ml', 'kg', 'divided', 'dos', 'n', ')', 'or', 'nonspecific', 'hydration', '(', 'n', ')', 'contrast', 'administration', ',', 'conducted', '.', 'serum', 'creatinine', 'and', 'kidney', 'injury', 'biomarkers', '(', 'cystatin', 'c', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'interleukin-', ',', 'f-isoprostanes', 'and', 'cardiotrophin-', 'ct-', ')', 'assessed', '.', 'result', 'incidence', 'of', 'ci-aki', '.', 'with', 'no', 'difference', 'found', 'hydration', 'group', '.', 'in', 'sodium', 'bicarbonate', 'group', ',', '.', 'in', 'oral', 'sodium', 'citrate', 'group', 'and', '.', 'in', 'nonspecific', 'hydration', 'group', '.', 'urinary', 'creatinine', 'and', 'urinary', 'ct-creatinine', 'ratio', 'decreased', 'h', 'contrast', 'infusion', '(', 'p', '.', ')', ',', 'none', 'of', 'biomarkers', 'assessed', 'affected', 'treatment', '.', 'conclusion', 'no', 'difference', 'in', 'hydration', 'with', 'oral', 'sodium', 'citrate', 'and', 'iv', 'sodium', 'bicarbonate', 'prophylaxis', 'of', 'ci-aki', '.', 'therefore', ',', 'oral', 'hydration', 'represents', 'safe', ',', 'inexpensive', 'and', 'practical', 'method', 'preventing', 'ci-aki', 'in', 'low-risk', 'patient', '.', 'no', 'effect', 'biomarkers', 'kidney', 'injury', 'could', 'demonstrated', '.']"
"The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.","Parisa Golriz Khatami, Alireza Soleimani, Nasrin Sharifi, Esmat Aghadavod, Zatollah Asemi, Parisa Golriz Khatamiet al.",2016 Jul-Aug,J Clin Lipidol,https://pubmed.ncbi.nlm.nih.gov/27578124/,No keywords found,"['limited', 'data', 'available', 'evaluated', 'effect', 'of', 'high-dose', 'vitamin', 'e', 'supplementation', 'biomarkers', 'of', 'kidney', 'injury', ',', 'inflammation', ',', 'and', 'oxidative', 'stress', 'in', 'patient', 'with', 'diabetic', 'nephropathy', '(', 'dn', ')', '.', 'objective', 'study', 'conducted', 'to', 'evaluate', 'effect', 'of', 'high-dose', 'vitamin', 'e', 'supplementation', 'biomarkers', 'of', 'kidney', 'injury', ',', 'inflammation', ',', 'and', 'oxidative', 'stress', 'in', 'patient', 'with', 'dn', '.', 'method', 'randomized', 'double-blind', 'placebo-controlled', 'clinical', 'trial', 'carried', 'among', 'patient', 'with', 'dn', '.', 'patient', 'randomly', 'allocated', 'two', 'group', 'to', 'take', 'either', 'iud', 'of', 'vitamin', 'e', 'supplement', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'week', '.', 'fasting', 'blood', 'sample', 'obtained', 'onset', 'of', 'study', 'and', '-week', 'intervention', 'to', 'assess', 'biomarkers', 'of', 'kidney', 'injury', ',', 'inflammation', ',', 'and', 'oxidative', 'stress', '.', 'result', 'week', 'of', 'intervention', ',', 'compared', 'with', 'placebo', ',', 'vitamin', 'e', 'supplementation', 'resulted', 'in', 'significant', 'increase', 'in', 'serum', 'vitamin', 'e', 'level', '(', '.', '.', 'v', '-', '.', '.', 'nmolml', ',', 'p', '.', ')', 'and', 'significant', 'decrease', 'in', 'urine', 'protein', '(', '-', '.', '.', 'v', '-', '.', '.', 'mgdl', ',', 'p', '.', ')', 'and', 'protein-to-creatinine', 'ratio', '(', '-', '.', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'in', 'addition', ',', 'significant', 'reduction', 'in', 'serum', 'tumor', 'necrosis', 'factor-', '(', '-', '.', '.', 'v', '.', '.', 'ngl', ',', 'p', '.', ')', ',', 'matrix', 'metalloproteinase-', '(', '-', '.', '.', 'v', '.', '.', 'ngml', ',', 'p', '.', ')', ',', 'matrix', 'metalloproteinase-', '(', '-', '.', '.', 'v', '.', '.', 'ngl', ',', 'p', '.', ')', ',', 'malondialdehyde', '(', '-', '.', '.', 'v', '.', '.', 'moll', ',', 'p', '.', ')', ',', 'advanced', 'glycation', 'end', 'product', '(', '-', '.', '.', 'v', '.', '.', 'arbitrary', 'unit', ',', 'p', '.', ')', ',', 'and', 'insulin', 'concentration', '(', '-', '.', '.', 'v', '.', '.', 'iuml', ',', 'p', '.', ')', 'seen', 'administration', 'of', 'vitamin', 'e', 'supplement', 'compared', 'with', 'placebo', '.', 'supplementation', 'with', 'vitamin', 'e', 'no', 'significant', 'effect', 'biomarkers', 'of', 'kidney', 'injury', ',', 'fasting', 'plasma', 'glucose', ',', 'and', 'insulin', 'resistance', 'compared', 'with', 'placebo', '.', 'conclusion', 'overall', ',', 'study', 'demonstrated', 'oral', 'high-dose', 'vitamin', 'e', 'supplementation', 'week', 'among', 'dn', 'patient', 'favorable', 'effect', 'biomarkers', 'of', 'kidney', 'injury', ',', 'inflammation', ',', 'and', 'oxidative', 'stress', '.']"
eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?,"Véronique Loustaud-Ratti, Annick Rousseau, Paul Carrier, Chanlina Vong, Tristan Chambaraud, Jérémie Jacques, Marilyne Debette-Gratien, Denis Sautereau, Marie Essig, Véronique Loustaud-Rattiet al.",2015 Jan,Liver Int,https://pubmed.ncbi.nlm.nih.gov/25039814/,No keywords found,"['renal', 'toxicity', 'of', 'first', 'generation', 'protease', 'inhibitor', '(', 'pi', ')', 'not', 'safety', 'signal', 'in', 'phase', 'iii', 'clinical', 'trial', ',', 'recently', 'reported', 'in', 'recent', 'study', '.', 'appeared', 'important', 'to', 'determine', 'clinical', 'significance', 'of', 'finding', '.', 'method', 'retrospectively', 'analysed', 'hcv', 'patient', 'receiving', 'triple', 'therapy', 'with', 'telaprevir', '(', 'n', ')', 'or', 'boceprevir', '(', 'n', ')', 'or', 'double', 'therapy', '(', 'n', ')', 'with', 'peginterferon', 'and', 'ribavirin', 'and', 'close', 'monitoring', 'of', 'egfr', '(', 'mdrd', 'formula', ')', 'and', 'treatment', '.', 'egfr', 'decline', 'time', 'assessed', 'linear', 'mixed-effects', 'model', '(', 'lmem', ')', 'with', 'search', 'possible', 'explanatory', 'covariates', '.', 'result', 'patient', 'treated', 'with', 'telaprevir', 'presented', 'significant', 'decrease', 'of', 'egfr', 'with', 'kinetics', 'initial', 'decrease', 'w', '(', 'week', ')', ',', 'nadir', 'w', '(', 'mean', 'decrease', '.', '.', 'mlmin', '.', '(', ')', ')', 'and', 'return', 'to', 'baseline', 'w.', 'w', 'egfr', 'correlated', 'with', 'egfr', '(', 'r', '(', ')', '.', ')', '.', 'lmem', 'showed', 'interindividual', 'variability', 'in', 'slope', 'of', 'egfr', 'v', 'time', 'and', 'w', 'non-significant', 'and', 'egfr', 'nadir', 'could', 'predicted', 'egfr', 'obtained', 'd.', 'in', 'multivariate', 'analysis', ',', 'egfr', 'intercept', '(', 'i.e', '.', 'baseline', 'value', ')', 'associated', 'with', 'older', 'age', 'and', 'male', 'sex', '.', 'conclusion', 'egfr', 'significantly', 'varied', 'in', 'telaprevir', 'group', '.', 'model', 'showed', 'egfr', 'nadir', 'mainly', 'depended', 'initial', 'egfr', '.', 'telaprevir', 'shown', 'to', 'inhibit', 'mostly', 'drug', 'transporter', 'oct', 'interacts', 'with', 'creatinine', 'transport', ',', 'early', 'decrease', 'of', 'egfr', 'observed', 'could', 'benign', 'phenomenon', '.', 'however', ',', 'unpredictable', 'true', 'renal', 'toxicity', 'may', 'occur', 'therapy', ',', 'recommend', 'thorough', 'follow-up', 'of', 'egfr', '.']"
Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities.,"Louise Schilder, S Azam Nurmohamed, Pieter M ter Wee, Nanne J Paauw, Armand R J Girbes, Albertus Beishuizen, Robert H J Beelen, A B Johan Groeneveld, Louise Schilderet al.",2015 Oct 30:16:178.,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/26519056/,No keywords found,"['novel', 'putative', 'mediator', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'include', 'immune-cell', 'derived', 'tumour', 'necrosis', 'factor-like', 'weak', 'inducer', 'of', 'apoptosis', '(', 'tweak', ')', ',', 'angiopoietin-', '(', 'ang-', ')', 'and', 'protein', 'pentraxin-', '(', 'ptx', ')', '.', 'effect', 'of', 'continuous', 'venovenous', 'hemofiltration', '(', 'cvvh', ')', 'and', 'different', 'anticoagulation', 'regimen', 'plasma', 'level', 'studied', '.', 'method', ',', ',', ',', 'and', 'min', 'of', 'cvvh', ',', 'sample', 'collected', 'pre-', 'and', 'postfilter', 'blood', 'and', 'ultrafiltrate', '.', 'no', 'anticoagulation', '(', 'n', ')', ',', 'unfractionated', 'heparin', '(', 'n', ')', 'or', 'trisodium', 'citrate', '(', 'n', ')', 'compared', '.', 'result', 'concentration', 'of', 'tweak', ',', 'ang-', 'and', 'ptx', 'hardly', 'affected', 'cvvh', 'since', 'mediator', 'not', '(', 'tweak', ',', 'ptx', ')', 'or', 'hardly', '(', 'ang-', ')', 'detectable', 'in', 'ultrafiltrate', ',', 'indicating', 'negligible', 'clearance', 'filter', 'in', 'spite', 'of', 'molecular', 'size', '(', 'tweak', ',', 'ptx', ')', 'or', 'cutoff', 'of', 'membrane', '.', 'heparin', 'use', ',', 'however', ',', 'associated', 'with', 'increase', 'in', 'in-', 'and', 'outlet', 'plasma', 'tweak', '.', 'conclusion', 'novel', 'aki', 'mediator', 'not', 'cleared', 'produced', 'cvvh', '.', 'however', ',', 'heparin', 'anticoagulation', 'increased', 'tweak', 'level', 'in', 'patient', ""'s"", 'plasma', 'whereas', 'citrate', 'not', ',', 'favouring', 'latter', 'anticoagulant', 'in', 'cvvh', 'aki', '.']"
A comparison of the effects of oral vs. intravenous hydration on subclinical acute kidney injury in living kidney donors: a protocol of a randomised controlled trial.,"Shona Mackinnon, Emma Aitken, Ryan Ghita, Marc Clancy, Shona Mackinnonet al.",2017 Jan 19,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/28103829/,No keywords found,"['optimal', 'treatment', 'established', 'renal', 'failure', 'living', 'donor', 'kidney', 'transplantation', '.', 'however', 'pathway', 'expose', 'healthy', 'individual', 'to', 'significant', 'reduction', 'in', 'nephron', 'mass', 'via', 'major', 'surgical', 'procedure', '.', 'laparoscopic', 'donor', 'nephrectomy', 'common', 'method', 'live', 'donor', 'transplantation', ',', 'reducing', 'donor', 'post-operative', 'pain', 'and', 'recovery', 'time', '.', 'however', 'procedure', 'expose', 'kidney', 'to', 'additional', 'haemodynamic', 'stress', '.', 'suggested', 'donor', 'hydration-particularly', 'use', 'of', 'preoperative', 'intravenous', 'fluids-may', 'counteract', 'stress', ',', 'reducing', 'subclinical', 'acute', 'kidney', 'injury', 'and', 'ultimately', 'improving', 'long-term', 'renal', 'function', '.', 'may', 'important', 'in', 'preservation', 'of', 'donor', 'renal', 'function', 'and', 'recipient', 'graft', 'longevity', '.', 'methodsdesign', 'prospective', 'single-centre', 'single-blinded', 'randomized', 'controlled', 'trial', 'carried', 'to', 'determine', 'effect', 'of', 'donor', 'preoperative', 'intravenous', 'fluid', '.', 'primary', 'outcome', 'donor', 'subclinical', 'acute', 'kidney', 'injury', '(', 'defined', 'plasma', 'ngal', ',', 'ngml', ')', 'day', 'postoperatively', '.', 'secondary', 'outcome', 'include', 'intraoperative', 'haemodynamics', ',', 'recipient', 'subclinical', 'acute', 'kidney', 'injury', ',', 'perioperative', 'complication', 'and', 'donor', 'sleep', 'quality', '.', 'donor', 'randomised', 'two', 'group', 'intervention', 'group', 'receive', 'active', 'pre-hydration', 'consisting', 'of', 'three', 'litre', 'of', 'intravenous', 'hartmann', ""'s"", 'solution', 'midnight', 'and', 'morning', 'kidney', 'donation', ',', 'control', 'group', 'not', 'receive', '.', 'group', 'receive', 'unlimited', 'oral', 'fluid', 'midnight', ',', 'routine', '.', 'plasma', 'ngal', 'measured', 'pre-specified', 'perioperative', 'time', 'point', ',', 'intraoperative', 'haemodynamic', 'data', 'collected', 'using', 'non-invasive', 'cardiac', 'output', 'monitoring', 'and', 'clinical', 'note', 'used', 'to', 'obtain', 'demographic', 'and', 'clinical', 'data', '.', 'researcher', 'blinded', 'to', 'donor', 'fluid', 'hydration', 'status', '.', 'blinded', 'statistical', 'analysis', 'performed', 'intention-to-treat', 'basis', '.', 'prospective', 'power', 'calculation', 'estimate', 'required', 'sample', 'size', 'of', 'patient', '.', 'discussion', 'study', 'provide', 'important', 'data', ',', 'currently', 'little', 'evidence', 'use', 'of', 'donor', 'preoperative', 'fluid', 'in', 'laparoscopic', 'nephrectomy', '.', 'hoped', 'result', 'obtained', 'guide', 'future', 'clinical', 'practice', '.', 'trial', 'registration', 'study', 'approved', 'west', 'of', 'scotland', 'research', 'ethic', 'committee', '(', 'reference', 'no', '.', 'w', ',', 'january', ')', 'and', 'registered', 'with', 'international', 'standard', 'randomised', 'controlled', 'trial', 'number', 'register', '(', 'reference', 'no', '.', 'isrctn', ',', 'april', ')', '.']"
When is it safe to start venous thromboembolism prophylaxis after blunt solid organ injury? A prospective American Association for the Surgery of Trauma multi-institutional trial.,"Morgan Schellenberg, Natthida Owattanapanich, Brent Emigh, Jan-Michael Van Gent, Tanya Egodage, Patrick B Murphy, Chad G Ball, Audrey L Spencer, Kelly N Vogt, Jessica A Keeley, Stephanie Doris, Marissa Beiling, Megan Donnelly, Mira Ghneim, Thomas Schroeppel, James Bradford, Connor S Breinholt, Raul Coimbra, Allison E Berndtson, Catherine Anding, Michael S Charles, William Rieger, Kenji Inaba;, AAST VTE Prophylaxis Study Group, Bryan Cotton, Olivia Coburn-Flynn, Courtney Pokrzywa, Annie Ritter, Andrew M Nunn, Laura Allen, Maria Valadez, M Chance Spalding, Martin Schreiber, Jeffry Nahmias, Patrick Walker, Jennifer Rodriquez, Marc D Trust, James M Bardes, Lauren Arbetman, Todd Costantini, Brittany K Bankhead, Morgan Schellenberget al.",2024 Feb 1,J Trauma Acute Care Surg,https://pubmed.ncbi.nlm.nih.gov/37872669/,No keywords found,"['optimal', 'time', 'to', 'initiate', 'venous', 'thromboembolism', '(', 'vte', ')', 'chemoprophylaxis', '(', 'vtep', ')', 'blunt', 'solid', 'organ', 'injury', 'remains', 'controversial', ',', 'vte', 'mitigation', 'must', 'balanced', 'bleeding', 'promulgation', '.', 'evidence', 'primarily', 'small', ',', 'retrospective', ',', 'single-center', 'work', 'suggests', 'vtep', 'hour', 'safe', 'and', 'effective', '.', 'study', 'undertaken', 'to', 'validate', 'clinical', 'practice', '.', 'method', 'blunt', 'trauma', 'patient', 'presenting', 'to', 'participating', 'trauma', 'center', 'in', 'north', 'america', 'screened', '-year', 'study', 'period', 'beginning', 'august', 'and', 'october', ',', '.', 'inclusion', 'age', 'older', 'year', 'liver', ',', 'spleen', ',', 'or', 'kidney', 'injury', 'and', 'initial', 'nonoperative', 'management', '.', 'exclusion', 'transfer', ',', 'emergency', 'department', 'death', ',', 'pregnancy', ',', 'and', 'concomitant', 'bleeding', 'disorderanticoagulationantiplatelet', 'medication', '.', 'priori', 'power', 'calculation', 'stipulated', 'need', ',', 'patient', '.', 'time', 'of', 'vtep', 'initiation', 'defined', 'study', 'group', 'early', '(', 'hour', 'of', 'admission', ')', 'versus', 'late', '(', 'hour', ')', '.', 'bivariate', 'and', 'multivariable', 'analysis', 'compared', 'outcome', '.', 'result', 'in', 'total', ',', ',', 'patient', 'satisfied', 'study', 'criterion', 'with', 'liver', '(', ')', ',', 'spleen', '(', ')', ',', 'and', 'kidney', 'injury', '(', ')', '.', 'median', 'patient', 'age', 'year', '(', 'interquartile', 'range', ',', '-', 'year', ')', ',', 'and', '(', 'n', ')', 'male', '.', 'median', 'injury', 'severity', 'score', '(', 'interquartile', 'range', ',', '-', ')', 'with', 'abbreviated', 'injury', 'scale', 'abdomen', 'score', 'of', '(', 'interquartile', 'range', ',', '-', ')', ',', 'and', 'median', 'american', 'association', 'surgery', 'of', 'trauma', 'grade', 'of', 'solid', 'organ', 'injury', '(', 'interquartile', 'range', ',', '-', ')', '.', 'early', 'vtep', 'patient', '(', 'n', ')', 'significantly', 'lower', 'rate', 'of', 'vte', '(', 'n', 'vs.', 'n', ',', 'p', '.', ')', ',', 'comparable', 'rate', 'of', 'nonoperative', 'management', 'failure', '(', 'n', 'vs.', 'n', ',', 'p', '.', ')', ',', 'and', 'lower', 'rate', 'of', 'post-vtep', 'blood', 'transfusion', '(', 'n', 'vs.', 'n', ',', 'p', '.', ')', 'compared', 'with', 'late', 'vtep', 'patient', '(', 'n', ')', '.', 'late', 'vtep', 'independently', 'associated', 'with', 'vte', '(', 'odd', 'ratio', ',', '.', 'p', '.', ')', '.', 'conclusion', 'early', 'initiation', 'of', 'vtep', 'associated', 'with', 'significantly', 'reduced', 'rate', 'of', 'vte', 'with', 'no', 'increase', 'in', 'bleeding', 'complication', '.', 'venous', 'thromboembolism', 'chemoprophylaxis', 'initiation', 'hour', 'therefore', 'safe', 'and', 'effective', 'and', 'standard', 'of', 'care', 'patient', 'with', 'blunt', 'solid', 'organ', 'injury', '.', 'level', 'of', 'evidence', 'therapeutic', 'and', 'care', 'management', 'level', 'iii', '.']"
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.,"Fabien Stucker, Belen Ponte, James Tataw, Pierre-Yves Martin, Hannah Wozniak, Jérome Pugin, Patrick Saudan, Fabien Stuckeret al.",2015 Mar 18,Crit Care,https://pubmed.ncbi.nlm.nih.gov/25881975/,No keywords found,"['systemic', 'anticoagulation', 'often', 'required', 'to', 'prevent', 'circuit', 'and', 'filter', 'clotting', 'in', 'icu', 'patient', 'undergoing', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '.', 'regional', 'citrate-based', 'anticoagulation', '(', 'rca', ')', 'not', 'induce', 'systemic', 'anticoagulation', 'and', 'prolongs', 'filter', 'lifespan', ',', 'metabolic', 'side-effects', 'associated', 'with', 'therapy', '.', 'conducted', 'randomized', 'controlled', 'trial', 'with', 'patient', 'requiring', 'crrt', 'to', 'determine', 'whether', 'rca', 'using', 'balanced', 'predilution', 'replacement', 'fluid', 'effective', 'heparin', 'in', 'term', 'of', 'renal', 'replacement', 'delivered', 'dose', 'and', 'safety', 'profile', '.', 'method', 'one', 'hundred', 'and', 'three', 'patient', 'with', 'aki', 'requiring', 'crrt', 'included', '.', 'patient', 'randomized', 'to', 'either', 'crrt', 'with', 'rca', 'or', 'heparin', 'anticoagulation', '.', 'primary', 'endpoint', 'effective', 'daily', 'delivered', 'rrt', 'dose', 'first', 'day', 'of', 'crrt', 'and', 'filter', 'lifespan', '.', 'secondary', 'endpoint', '-day', 'and', '-day', 'survival', 'and', 'severe', 'metabolic', 'complication', 'and', 'bleeding', 'disorder', '.', 'result', 'median', 'crrt', 'duration', '.', '(', '-', ')', 'day', '.', 'effective', 'delivered', 'daily', 'rrt', 'dos', 'and', 'mlkghr', 'in', 'rca', 'and', 'heparin', 'group', ',', 'respectively', '(', 'p', '.', ')', '.', 'filter', 'lifespan', 'versus', 'hr', 'in', 'rca', 'and', 'heparin', 'group', '(', 'p', '.', ')', '.', 'survival', 'rate', 'and', 'day', '-', 'in', 'rca', 'and', '-', 'in', 'heparin', 'group', '.', 'electrolyte', 'and', 'acid-base', 'disturbance', 'uncommon', 'and', 'transient', 'in', 'patient', 'treated', 'with', 'rca', '.', 'conclusion', 'result', 'show', 'rca', 'superior', 'to', 'heparin-based', 'anticoagulation', 'in', 'term', 'of', 'delivered', 'rrt', 'dose', 'and', 'filter', 'life', 'span', 'and', 'safe', 'and', 'feasible', 'method', '.', 'not', 'translate', 'improvement', 'in', 'short', 'term', 'survival', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'registered', 'rd', 'january', '.']"
Electrolytes-Enriched Hemodiafiltration Solutions for Continuous Renal Replacement Therapy in Acute Kidney Injury: A Crossover Study.,"Noemie Besnard, Marianne Serveaux, Sonia Machado, Delphine Daubin, Vincent Brunot, Laurent Amigues, Liliane Landreau, Olivier Jonquet, Kada Klouche, Noemie Besnardet al.",2016,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/26949936/,No keywords found,"['to', 'evaluate', 'capability', 'of', 'electrolytes-enriched', 'solution', 'to', 'prevent', 'metabolic', 'disorder', 'continuous', 'veno-venous', 'hemodiafiltration', '(', 'cvvhdf', ')', '.', 'method', 'serum', 'biochemistry', 'and', 'clinical', 'tolerance', 'compared', 'cvvhdf', 'treatment', 'with', 'electrolyte-enriched', '(', 'phoxilium', ')', 'or', 'standard', 'solution', 'in', 'acute', 'renal', 'failure', 'patient', '.', 'result', 'compared', 'to', 'standard', 'fluid', ',', 'serum', 'potassium', 'and', 'phosphate', 'level', 'maintained', 'in', 'normal', 'range', 'with', 'phoxilium', 'without', 'supplementation', 'total', 'serum', 'calcium', 'level', 'significantly', 'lower', '.', 'bicarbonatemia', 'slightly', 'higher', '(', '-', 'vs.', '.-', '.', 'mmoll', ',', 'p', '.', ')', '.', 'despite', 'absence', 'of', 'glucose', 'in', 'phoxilium', 'solution', ',', 'blood', 'glucose', 'level', 'and', 'glucose', 'supplementation', 'similar', 'treatment', '.', 'clinical', 'tolerance', 'and', 'efficiency', 'of', 'cvvhdf', 'session', 'comparable', '.', 'conclusion', 'phoxilium', 'effectively', 'prevented', 'hypophosphatemia', 'and', 'hypokalemia', 'cvvhdf', '.', ',', 'however', ',', 'associated', 'with', 'slight', 'metabolic', 'acidosis', 'and', 'hypocalcemia', 'compared', 'with', 'conventional', 'solution', '.']"
Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649.,"Pinky Dua, Rachel Gurrell, Simon Kirby, Maria Sudworth, Peter T Loudon, Pinky Duaet al.",2016 Aug,Clin Rheumatol,https://pubmed.ncbi.nlm.nih.gov/27094945/,"Acute kidney injury, Gout, URAT1, Xanthine oxidase.","['objective', 'of', 'clinical', 'study', 'to', 'assess', 'safety', 'and', 'urate', 'lowering', 'activity', 'of', 'novel', 'urate', 'transporter', '(', 'urat', ')', 'xanthine', 'oxidase', '(', 'xo', ')', 'inhibitor', 'pf-', 'in', 'healthy', 'subject', 'and', 'gout', 'patient', '.', 'escalating', 'dos', 'of', 'pf-', 'or', 'placebo', 'given', 'to', 'healthy', 'young', 'subject', ',', 'healthy', 'elderly', 'subject', 'and', 'gout', 'patient', '.', 'serum', 'uric', 'acid', '(', 'sua', ')', 'and', 'urinary', 'pharmacodynamic', 'marker', 'assayed', ',', 'and', 'safety', 'assessed', 'collection', 'of', 'adverse', 'event', 'and', 'assessment', 'of', 'safety', 'lab', ',', 'ecg', 'and', 'vital', 'sign', '.', 'administration', 'of', 'pf-', 'led', 'to', 'rapid', 'decrease', 'in', 'sua', 'in', 'cohort', 'in', 'gout', 'patient', ',', 'change', 'baseline', 'of', 'observed', 'mg', 'dose', '.', 'urinary', 'and', 'serum', 'biomarkers', 'consistent', 'with', 'inhibition', 'of', 'urat', 'and', 'xo', '.', 'although', 'dosing', 'otherwise', 'well', 'tolerated', ',', 'two', 'subject', 'experienced', 'serious', 'adverse', 'event', 'of', 'acute', 'kidney', 'injury', '.', 'subject', 'exhibited', 'increased', 'serum', 'creatinine', 'and', 'blood', 'urea', 'nitrogen', 'in', 'first', 'day', 'post', 'first', 'dose', 'and', 'hospitalised', '.', 'one', 'subject', 'exhibited', 'oliguria', 'first', 'h.', 'subject', 'made', 'complete', 'recovery', 'with', 'minimal', 'intervention', '.', 'pf-', 'effective', 'rapidly', 'lowering', 'sua', ',', 'development', 'terminated', 'identified', 'renal', 'safety', 'risk', '.']"
Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial.,"Kevin L Winthrop, Patrick A Flume, Rachel Thomson, Kevin C Mange, Dayton W Yuen, Monika Ciesielska, Kozo Morimoto, Stephen J Ruoss, Luigi R Codecasa, Jae-Joon Yim, Theodore K Marras, Jakko van Ingen, Richard J Wallace Jr, Barbara A Brown-Elliott, Chris Coulter, David E Griffith, Kevin L Winthropet al.",2021 Jul,Ann Am Thorac Soc,https://pubmed.ncbi.nlm.nih.gov/33326356/,"ALIS, Mycobacterium avium, amikacin liposome inhalation suspension, culture conversion, nontuberculous mycobacteria.","['patient', 'with', 'refractory', 'mycobacterium', 'avium', 'complex', '(', 'mac', ')', 'lung', 'disease', 'limited', 'treatment', 'option', '.', 'in', 'convert', 'study', ',', 'amikacin', 'liposome', 'inhalation', 'suspension', '(', 'ali', ')', 'added', 'to', 'guideline-based', 'therapy', '(', 'gbt', ')', 'increased', 'culture', 'conversion', 'rate', 'versus', 'gbt', 'alone', 'month', '.', 'limited', 'data', 'available', 'regarding', '-month', 'treatment', 'in', 'refractory', 'population.objectives', 'evaluate', '-month', 'safety', ',', 'tolerability', ',', 'and', 'efficacy', 'of', 'alisgbt.methods', 'adult', 'with', 'refractory', 'mac', 'lung', 'disease', 'not', 'achieving', 'culture', 'conversion', 'convert', 'month', 'could', 'enroll', 'in', 'open-label', 'extension', '(', 'ins-', ')', 'to', 'receive', 'mg', 'once-daily', 'alisgbt', 'month', '.', 'two', 'cohort', 'enrolled', '``', 'alis-naive', ""''"", 'cohort', 'included', 'patient', 'randomized', 'to', 'gbt', 'alone', 'in', 'convert', ',', 'and', '``', 'prior-alis', ""''"", 'cohort', 'included', 'randomized', 'to', 'alisgbt', 'in', 'convert', '.', 'safety', 'and', 'tolerability', 'of', 'ali', 'month', '(', 'primary', 'endpoint', ')', 'and', 'culture', 'conversion', 'month', 'and', 'assessed.results', 'in', 'alis-naive', 'cohort', ',', '.', 'of', 'patient', '(', 'n', ')', 'experienced', 'respiratory', 'treatment-emergent', 'adverse', 'event', '(', 'teaes', ')', ',', 'and', '.', '(', 'n', ')', 'serious', 'teaes', '.', '(', 'n', ')', 'achieved', 'culture', 'conversion', 'month', 'and', '.', '(', 'n', ')', 'month', '.', 'in', 'prior-alis', 'cohort', ',', '.', 'of', 'patient', '(', 'n', ')', 'experienced', 'respiratory', 'teaes', ',', 'and', '.', '(', 'n', ')', 'serious', 'teaes', '.', '(', 'n', ')', 'achieved', 'culture', 'conversion', 'month', '(', 'mo', 'ali', 'exposure', ')', 'and', '.', '(', 'n', ')', 'month', '(', 'mo', 'ali', 'exposure', ')', '.', 'nephrotoxicity-related', 'teaes', 'and', 'measured', 'hearing', 'decline', 'infrequent', 'in', 'cohorts.conclusions', 'in', 'to', 'month', 'of', 'ali', 'use', ',', 'respiratory', 'teaes', 'common', ',', 'nephrotoxicity', 'and', 'hearing', 'decline', 'infrequent', ',', 'and', 'culture', 'conversion', 'continued', 'beyond', 'month', 'of', 'therapy.clinical', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', '(', 'nct', ')', '.']"
High incidence of acute kidney injury during chemotherapy for childhood acute myeloid leukemia.,"Liezl Du Plessis, Shahrad Rod Rassekh, Cherry Mammen, Liezl Du Plessiset al.",2018 Apr,Pediatr Blood Cancer,https://pubmed.ncbi.nlm.nih.gov/29286559/,No keywords found,"['childhood', 'acute', 'myeloid', 'leukemia', '(', 'aml', ')', 'rare', 'and', 'heterogeneous', 'disease', '.', 'pediatric', 'data', 'epidemiology', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'aml', 'limited', '.', 'report', 'incidence', 'of', 'aki', 'in', 'childhood', 'aml', 'and', 'risk', 'factor', 'associated', 'with', 'aki', 'episode', '.', 'method', 'retrospective', 'cohort', 'of', 'patient', '(', 'year', ')', ',', 'with', 'de', 'novo', 'aml', ',', 'receiving', 'chemotherapy', '-year', 'period', '.', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'therapy-related', 'hospitalization', 'assessed', 'to', 'stage', 'aki', 'episode', 'per', 'kidney', 'disease', 'improving', 'global', 'outcome', 'criterion', '.', 'severe', 'aki', 'defined', 'aki', 'stage', 'or', 'and', 'urine', 'output', 'criterion', 'not', 'used', '.', 'aki', 'risk', 'factor', 'assessed', 'independently', 'in', 'cycle', 'alone', 'and', 'combining', 'chemotherapy', 'cycle', '.', 'result', 'aki', 'developed', 'in', 'patient', '(', ')', 'with', 'multiple', 'aki', 'episode', 'in', 'patient', '(', 'total', 'episode', ')', '.', 'twenty-four', 'severe', 'aki', 'episode', 'occurred', 'in', 'patient', '(', '.', ')', 'with', 'mean', 'duration', 'of', '.', 'day', '(', 'sd', '.', ')', '.', 'in', 'cycle', ',', 'hyperleukocytosis', 'not', 'predictive', 'of', 'aki', ',', 'severe', 'sepsis', 'independent', 'risk', 'factor', 'of', 'severe', 'aki', '(', 'odds', 'ratio', 'or', '.', 'ci', '.-.', ')', '.', 'with', 'cycle', 'combined', ',', 'subject', 'with', 'aki', 'severe', 'sepsis', 'and', 'older', 'age', '(', 'year', ')', 'associated', 'with', 'severe', 'aki', '(', 'or', '.', 'ci', '.-.', ')', '.', 'conclusion', 'high', 'incidence', 'of', 'aki', 'in', 'aml', 'cohort', 'with', 'strong', 'association', 'with', 'older', 'age', '(', 'year', ')', 'and', 'severe', 'sepsis', '.', 'larger', 'prospective', 'study', 'needed', 'to', 'confirm', 'high', 'burden', 'of', 'aki', 'and', 'risk', 'factor', 'in', 'susceptible', 'population', '.']"
A LC/MS/MS method for determination of tenofovir in human plasma and its application to toxicity monitoring.,"Narit Wiriyakosol, Apichaya Puangpetch, Weerawut Manosuthi, Sasinapha Tomongkon, Chonlaphat Sukasem, Darawan Pinthong, Narit Wiriyakosolet al.",2018 May 15:1085:89-95.,J Chromatogr B Analyt Technol Biomed Life Sci,https://pubmed.ncbi.nlm.nih.gov/29635209/,"HIV-1, Kidney injury, LC/MS/MS, Tenofovir, Tenofovir plasma concentration.","[',', 'vv', ')', '.', 'detection', 'achieved', 'multiple', 'reaction', 'monitoring', 'using', 'positive', 'ionization', 'mode', 'triple', 'quadrupole', 'mass', 'spectrometer', 'with', 'run', 'time', 'of', 'min', '.', 'monitoring', 'transition', 'set', 'mz', '.', '.', 'and', '.', 'tenofovir', 'and', 'mz', '.', '.', 'acyclovir', '(', 'internal', 'standard', ')', '.', 'standard', 'curve', 'linear', 'to', 'ngml', ',', 'with', 'lower', 'limit', 'of', 'quantification', 'of', 'ngml', '.', 'inter-', 'and', 'intra-day', 'precision', 'result', 'less', '.', 'and', 'accuracy', 'within', 'acceptable', 'range', 'of', '.-', '..', 'validated', 'method', 'successfully', 'applied', 'to', 'study', 'of', 'tenofovir', 'induced', 'kidney', 'injury', 'in', 'hiv-', 'infected', 'patient', 'taking', 'mg', 'daily', 'week', '.']"
Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial.,"Vittoria Arslan-Carlon, Kay See Tan, Guido Dalbagni, Alessia C Pedoto, Harry W Herr, Bernard H Bochner, Eugene K Cha, Timothy F Donahue, Mary Fischer, S Machele Donat, Vittoria Arslan-Carlonet al.",2020 Aug,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/32472804/,No keywords found,"['postoperative', 'ileus', 'common', 'complication', 'of', 'intraabdominal', 'surgery', ',', 'including', 'radical', 'cystectomy', 'with', 'reported', 'rate', 'high', '.', 'perioperative', 'fluid', 'administration', 'associated', 'with', 'improvement', 'in', 'postoperative', 'ileus', 'rate', ',', 'difficult', 'to', 'generalize', 'earlier', 'study', 'lacked', 'standardized', 'definition', 'of', 'postoperative', 'ileus', 'and', 'relevant', 'outcome', '.', 'hypothesis', 'targeted', 'individualized', 'perioperative', 'fluid', 'management', 'would', 'improve', 'postoperative', 'ileus', 'in', 'patient', 'receiving', 'radical', 'cystectomy', '.', 'method', 'parallel-arm', ',', 'double-blinded', ',', 'single-center', 'randomized', 'trial', 'of', 'goal-directed', 'fluid', 'therapy', 'versus', 'standard', 'fluid', 'therapy', 'patient', 'undergoing', 'open', 'radical', 'cystectomy', '.', 'primary', 'outcome', 'postoperative', 'ileus', ',', 'and', 'secondary', 'outcome', 'complication', 'within', 'day', 'post-surgery', '.', 'participant', 'least', 'yr', 'old', ',', 'maximum', 'body', 'mass', 'index', 'of', 'kgm', 'and', 'no', 'active', 'atrial', 'fibrillation', '.', 'intervention', 'in', 'goal-directed', 'therapy', 'arm', 'combined', 'preoperative', 'and', 'postoperative', 'stroke', 'volume', 'optimization', 'and', 'intraoperative', 'stroke', 'volume', 'variation', 'minimization', 'to', 'guide', 'fluid', 'administration', ',', 'using', 'advanced', 'hemodynamic', 'monitoring', '.', 'result', 'august', 'and', 'april', ',', 'radical', 'cystectomy', 'patient', '(', 'goal-directed', 'fluid', 'therapy', 'and', 'standard', 'fluid', 'therapy', ')', 'included', 'in', 'analysis', '.', 'postoperative', 'ileus', 'occurred', 'in', '(', 'of', ')', 'of', 'patient', 'in', 'goal-directed', 'fluid', 'therapy', 'arm', 'and', '(', 'of', ')', 'of', 'patient', 'in', 'standard', 'arm', '(', 'difference', 'in', 'proportion', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'no', 'difference', 'in', 'incidence', 'of', 'high-grade', 'complication', 'two', 'arm', '(', 'of', 'vs.', 'of', 'difference', 'in', 'proportion', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', ',', 'with', 'exception', 'of', 'acute', 'kidney', 'injury', ',', 'frequent', 'in', 'goal-directed', 'fluid', 'therapy', 'arm', '(', 'of', 'vs.', 'of', 'in', 'standard', 'arm', 'difference', 'in', 'proportion', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', 'p', '.', 'adjustment', 'multiple', 'testing', ')', '.', 'conclusion', 'goal-directed', 'fluid', 'therapy', 'may', 'not', 'effective', 'strategy', 'lowering', 'risk', 'of', 'postoperative', 'ileus', 'in', 'patient', 'undergoing', 'open', 'radical', 'cystectomy', '.']"
The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.,"Xuemei Huang, Mechelle M Lewis, Lauren Jodi Van Scoy, Sol De Jesus, Paul J Eslinger, Amy C Arnold, Amanda J Miller, Julio Fernandez-Mendoza, Bethany Snyder, William Harrington, Lan Kong, Xi Wang, Dongxiao Sun, Marielle Delnomdedieu, Sridhar Duvvuri, Susan E Mahoney, David L Gray, Richard B Mailman, Xuemei Huanget al.",2020,J Parkinsons Dis,https://pubmed.ncbi.nlm.nih.gov/32986682/,No keywords found,"['current', 'drug', 'treatment', 'little', 'efficacy', 'in', 'advanced-to-end-stage', 'parkinson', ""'s"", 'disease', '(', 'advpd', ')', ',', 'yet', 'no', 'report', 'of', 'interventional', 'trial', 'in', 'advpd', '.', 'dopamine', 'agonist', 'potential', 'to', 'provide', 'benefit', '.', 'objective', 'to', 'determine', 'feasibility', 'and', 'safety', 'of', 'selective', 'dd', 'dopamine', 'partial', 'agonist', 'pf', 'in', 'advpd', '.', 'method', 'two-week', ',', 'randomized', ',', 'double', 'blind', ',', 'crossover', 'phase', 'ib', 'study', 'in', 'advpd', 'patient', 'compared', 'standard-of-care', '(', 'soc', ')', 'carbidopalevodopa', 'with', 'pf', '.', 'week', ',', 'day', 'baseline', 'evaluation', 'with', 'overnight', 'levodopa', 'washout', ',', 'treatment', 'day', 'and', 'with', 'either', 'soc', 'or', 'pf-', '(', 'split', 'dose', 'mg', ')', ',', 'followed', 'discharge', 'day', '.', 'primary', 'endpoint', 'safety', 'and', 'tolerability', '.', 'secondary', 'endpoint', 'global', 'clinical', 'impression', 'of', 'change', '(', 'gci-c', ')', 'rated', 'clinician', 'and', 'caregiver', '.', 'result', 'eight', 'advpd', 'patient', 'and', 'caregiver', 'consented', 'to', 'participate', 'and', 'six', 'randomized', '(', 'average', 'disease', 'duration', ')', '.', 'none', 'withdrew', 'voluntarily', '.', 'one', 'participant', 'with', 'baseline', 'day', 'dehydration', ',', 'pre-renal', 'kidney', 'injury', ',', 'and', 'autonomic', 'dysfunction', 'experienced', 'symptomatic', 'and', 'serious', 'hypotension', 'receiving', 'pf-', 'in', 'week', 'and', 'discontinued', 'study', '.', 'adverse', 'event', 'rated', 'mild', '(', 'pf-', 'n', ',', 'soc', 'n', ')', ',', 'moderate', '(', 'pf-', 'n', ',', 'soc', 'n', ')', ',', 'or', 'severe', 'non-serious', '(', 'pf-', 'n', ',', 'soc', 'n', ')', '.', 'no', 'clinically', 'meaningful', 'laboratory', 'change', 'observed', '.', 'among', 'five', 'participant', 'completed', 'study', ',', 'gci-c', 'favored', 'pf-', 'in', 'two', 'per', 'clinician', ""'"", 'and', 'four', 'participant', 'per', 'caregiver', ""'"", 'rating', '.', 'conclusion', 'pf-', 'tolerated', 'in', 'advpd', 'patient', '.', 'study', 'provides', 'feasibility', 'future', 'safety', 'and', 'efficacy', 'study', 'in', 'population', 'with', 'unmet', 'need', '.']"
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.,"Katsuhiro Miura, Masaru Nakagawa, Hiromichi Takahashi, Yoshihito Uchino, Hitomi Kodaira, Noriyoshi Iriyama, Masashi Sakagami, Shimon Ohtake, Sumiko Kobayashi, Atsuko Hojo, Daisuke Kurita, Yujin Kobayashi, Machiko Kusuda, Yukio Hirabayashi, Yoshihiro Hatta, Masami Takei, Katsuhiro Miuraet al.",2016 Mar,Int J Hematol,https://pubmed.ncbi.nlm.nih.gov/26715149/,"Arbekacin, Coagulase-negative Staphylococci, Febrile neutropenia, Methicillin-resistant Staphylococcus aureus, Therapeutic drug monitoring, Vancomycin.","['performed', 'clinical', 'trial', 'to', 'investigate', 'efficacy', 'and', 'safety', 'of', 'arbekacin', '(', 'abk', ')', ',', 'unique', 'aminoglycoside', 'with', 'activity', 'methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', ',', 'in', 'patient', 'with', 'hematological', 'malignancy', 'complicated', 'high-risk', 'infection', '.', 'abk', 'administered', 'intravenously', 'dose', 'of', 'approximately', 'mgkg', 'with', 'various', 'broad-spectrum', '-lactams', ',', 'followed', 'therapeutic', 'drug', 'monitoring', '(', 'tdm', ')', '.', 'total', 'of', 'febrile', 'or', 'infectious', 'episode', 'registered', ',', 'and', 'tdm', 'performed', 'in', '(', ')', 'case', '.', 'absolute', 'neutrophil', 'count', 'l', 'in', '(', ')', 'case', ',', 'and', 'cytotoxic', 'chemotherapy', 'administered', 'in', '(', ')', 'case', '.', 'initiation', 'of', 'abk', ',', '(', ')', 'patient', 'received', 'fluoroquinolones', '(', 'n', ')', 'andor', 'broad-spectrum', '-lactams', '(', 'n', ')', '.', 'case', 'of', 'documented', 'infection', 'including', 'one', 'of', 'mrsa', 'pneumonia', ',', 'and', 'case', 'of', 'febrile', 'neutropenia', '.', 'efficacy', 'end', 'of', 'treatment', 'patient', ',', 'and', 'efficacy', 'significantly', 'higher', 'in', 'patient', 'attaining', 'maximum', 'concentration', 'gml', 'or', 'receiving', 'tdm-guided', 'dose-adjustment', 'of', 'abk', '(', 'n', ',', 'vs.', ',', 'p', '.', ')', '.', 'renal', 'toxicity', 'observed', 'in', 'six', 'case', '(', ')', 'generally', 'acceptable', '.', 'study', 'demonstrated', 'tdm-guided', 'abk', 'administration', 'may', 'applicable', 'limited', 'condition', 'patient', 'with', 'hematological', 'malignancy', '.']"
Renin-Angiotensin-Aldosterone System Optimization for Acute Decompensated Heart Failure Patients (ROAD-HF): Rationale and Design.,"Bhagwan Dass, Michelle Dimza, Girish Singhania, Cody Schwartz, Jerin George, Avni Bhatt, Nila Radhakrishnan, Asha Bansari, Shahab Bozorgmehri, Rajesh Mohandas, Bhagwan Dasset al.",2020 Aug,Am J Cardiovasc Drugs,https://pubmed.ncbi.nlm.nih.gov/31797310/,No keywords found,"['long-term', 'benefit', 'of', 'angiotensin-converting', 'enzyme', 'inhibitor', '(', 'aceis', ')', 'and', 'angiotensin', 'receptor', 'blocker', '(', 'arb', ')', 'outcome', 'in', 'patient', 'with', 'chronic', 'congestive', 'heart', 'failure', 'well-known', ',', 'making', 'one', 'of', 'widely', 'prescribed', 'medication', '.', 'however', ',', 'administration', 'of', 'aceisarbs', 'in', 'acute', 'decompensated', 'heart', 'failure', '(', 'adhf', ')', 'increase', 'risk', 'of', 'morbidity', 'and', 'mortality', 'secondary', 'to', 'worsening', 'renal', 'function', '(', 'wrf', ')', '.', 'decrease', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'treatment', 'of', 'adhf', 'associated', 'with', 'increase', 'in', 'mortality', 'proportional', 'to', 'degree', 'of', 'wrf', '.', 'aim', 'aim', 'of', 'study', 'to', 'determine', 'whether', 'withholding', 'aceisarbs', 'initial', 'h', 'of', 'admission', 'in', 'patient', 'with', 'adhf', 'prevent', 'wrf', 'and', 'allow', 'effective', 'diuresis', '.', 'method', 'four', 'hundred', 'and', 'thirty', 'patient', 'randomized', 'to', 'intervention', '(', 'withholding', 'aceisarbs', ')', 'or', 'control', '(', 'continuestart', 'aceisarbs', ')', 'arm', 'h.', 'primary', 'outcome', 'include', 'rate', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'patient', 'global', 'assessment', ',', 'and', 'change', 'in', 'kinetic', 'egfr', 'h', ',', 'secondary', 'outcome', 'include', 'change', 'in', 'weight', ',', 'fluid', 'balance', ',', 'change', 'in', 'sign', 'and', 'symptom', 'of', 'congestion', ',', 'change', 'in', 'renal', 'function', ',', 'change', 'in', 'urinary', 'biomarkers', '(', 'tissue', 'inhibitor', 'of', 'metalloproteinases', 'timp-', 'insulin-like', 'growth', 'factor-binding', 'protein', 'igfbp', ')', ',', 'patient', 'experiencing', 'treatment', 'failure', ',', 'hospital', 'length', 'of', 'stay', '(', 'los', ')', ',', 'cost', 'analysis', ',', 'mortality', 'within', 'day', ',', 'and', 'hospital', 'readmission', 'day', 'and', 'year', '.', 'conclusion', 'prospective', 'clinical', 'trial', 'prove', 'withholding', 'aceisarbs', 'prevent', 'aki', 'in', 'adhf', '.', 'help', 'u', 'understand', 'complex', 'interaction', 'heart', 'and', 'kidney', ',', 'and', 'delineate', 'best', 'treatment', 'strategy', 'adhf', '.', 'holding', 'aceisarbs', 'might', 'help', 'preserve', 'renal', 'function', ',', 'and', 'decrease', 'hospital', 'los', ',', 'readmission', 'rate', ',', 'and', 'cost', 'of', 'care', 'in', 'adhf', '.', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment.,"Saptarshi Ghosh, Pamidimukkala Brahmananda Rao, P Ravindra Kumar, Surendra Manam, Saptarshi Ghoshet al.",2015,Asian Pac J Cancer Prev,https://pubmed.ncbi.nlm.nih.gov/26514533/,No keywords found,"['concurrent', 'chemoradiation', 'with', 'three', 'weekly', 'high', 'dose', 'cisplatin', 'non-surgical', 'standard', 'of', 'care', 'treatment', 'of', 'locally', 'advanced', 'head', 'and', 'neck', 'cancer', '.', 'although', 'treatment', 'regime', 'efficacious', ',', 'high', 'acute', 'toxicity', ',', 'lead', 'not', 'to', 'increased', 'treatment', 'cost', ',', 'also', 'to', 'increased', 'overall', 'treatment', 'time', '.', 'hence', ',', 'current', 'study', 'undertaken', 'to', 'evaluate', 'acute', 'toxicity', 'and', 'tumor', 'response', 'in', 'head', 'and', 'neck', 'cancer', 'patient', 'treated', 'with', 'concurrent', 'chemoradiation', 'using', 'mgm', 'weekly', 'cisplatin', ',', 'institutional', 'practice', '.', 'material', 'and', 'method', 'single', 'institution', 'retrospective', 'study', 'included', 'data', 'head', 'and', 'neck', 'cancer', 'patient', 'treated', 'with', 'concurrent', 'chemoradiation', 'to', '.', 'result', 'mean', 'age', 'of', 'patient', '.', 'year', '.', 'common', 'site', 'of', 'involvement', 'oral', 'cavity', '.', 'of', 'study', 'patient', 'presented', 'with', 'advanced', 'stage', 'disease', '.', 'mean', 'overall', 'treatment', 'time', '.', 'day', '.', '.', 'overall', 'complete', 'response', 'to', 'treatment', 'documented', 'till', 'day', 'start', 'of', 'treatment', '.', 'according', 'to', 'radiation', 'therapy', 'oncology', 'group', '(', 'rtog', ')', 'acute', 'radiation', 'morbidity', 'scoring', 'criterion', ',', 'mucositis', 'seen', 'in', '.', 'of', 'patient', '.', 'dermatitis', 'and', 'emesis', 'observed', 'in', '.', 'and', '.', ',', 'respectively', '.', 'regarding', 'haematological', 'toxicity', ',', '.', 'and', '.', 'suffered', 'anaemia', 'and', 'leukopenia', ',', 'respectively', ',', 'treatment', '.', 'acute', 'kidney', 'injury', 'assessed', 'using', 'common', 'terminology', 'criterion', 'adverse', 'event', '(', 'ctcae', ')', ',', 'and', 'found', 'in', '.', 'of', 'patient', '.', 'conclusion', 'concurrent', 'chemoradiotherapy', 'with', 'weekly', 'cisplatin', 'effective', 'treatment', 'regime', 'head', 'and', 'neck', 'cancer', 'with', 'reasonable', 'toxicity', 'used', 'in', 'developing', 'country', ',', 'cost', 'of', 'treatment', 'important', '.']"
"Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Intermittent Hemodialysis: A Multicenter, Observational Study.","Alexandre Boyer, Jean-François Timsit, Kada Klouche, Emmanuel Canet, Thuy-Nga Phan, Julien Bohé, Sebastien Rubin, Arthur Orieux, Alexandre Lautrette, Didier Gruson, Bertrand Souweine, Alexandre Boyeret al.",2021 Jun,Clin Ther,https://pubmed.ncbi.nlm.nih.gov/34108081/,No keywords found,"['data', 'aminoglycoside', 'stewardship', 'in', 'critically', 'ill', 'septic', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'needing', 'intermittent', 'hemodialysis', '(', 'ih', ')', 'scarce', '.', 'first', 'objective', 'of', 'study', 'to', 'evaluate', 'whether', 'aminoglycoside', 'administration', 'occurs', 'v', 'ih', 'in', 'real-life', 'management', 'of', 'critically', 'ill', 'septic', 'patient', 'with', 'aki', 'needing', 'ih', '.', 'second', 'objective', 'to', 'assess', 'delay', 'in', 'achieving', 'potential', 'reinjection', 'window', 'second', 'dose', 'of', 'aminoglycoside', ',', 'obtained', 'with', 'postdialysis', 'v', 'predialysis', 'regimen', '.', 'method', 'post', 'hoc', 'observational', 'analysis', 'of', 'multicenter', 'randomized', 'trial', 'of', 'critically', 'ill', 'patient', 'with', 'aki', 'needing', 'renal', 'replacement', 'therapy', 'conducted', '.', 'inclusion', 'criterion', 'consisted', 'of', 'patient', 'receiving', 'ih', 'aki', 'antimicrobial', 'therapy', 'septic', 'episode', '.', 'finding', 'among', 'of', 'septic', 'patient', '(', ')', 'receiving', 'aminoglycosides', ',', 'underwent', 'ih', '(', 'with', 'previous', 'continuous', 'renal', 'replacement', 'therapy', 'and', 'without', ')', '.', 'amikacin', 'and', 'gentamicin', 'administered', 'mean', '(', 'sd', ')', 'of', '.', '(', '.', ')', 'and', '.', '(', '.', ')', 'day', 'with', 'mean', '(', 'sd', ')', 'dos', 'of', '.', '(', '.', ')', 'and', '.', '(', '.', ')', 'mgkg', ',', 'respectively', '.', 'in', 'patient', 'undergoing', 'exclusive', 'ih', ',', 'aminoglycosides', 'administered', 'in', 'predialysis', 'in', 'of', 'episode', 'versus', 'in', 'postdialysis', 'schedule', '.', 'first', 'cmin', 'target', 'obtained', 'earlier', 'with', 'predialysis', 'v', 'postdialysis', 'schedule', '(', '.', '.', 'hour', 'v', '.', '.', 'hour', ',', 'p', '.', ')', '.', 'implication', 'despite', 'less', 'frequently', 'used', 'predialysis', 'schedule', ',', 'postdialysis', 'administration', 'of', 'aminoglycosides', 'remains', 'regular', 'practice', 'in', 'intensive', 'care', 'unit', '.', 'predialysis', 'schedule', 'of', 'administration', 'in', 'ih', 'reduces', 'interval', 'time', 'to', 'tolerable', 'aminoglycoside', 'redosing', '.']"
Renal perfusion with histidine-tryptophan-ketoglutarate compared with Ringer's solution in patients undergoing thoracoabdominal aortic open repair.,"Andrea Kahlberg, Yamume Tshomba, Domenico Baccellieri, Luca Bertoglio, Enrico Rinaldi, Vincenzo Ardita, Elisa Colombo, Umberto Moscato, Germano Melissano, Roberto Chiesa                              ;, CURITIBA Investigators, Luca Apruzzi, Samuele Bossi, Renata Castellano, Barbara Catenaccio, Roberto Chiesa, Angela Maria Ferrante, Giovanni Landoni, Rosalba Lembo, Pasquale Nardelli, Laura Pasin, Elisa Simonini, Massimo Venturini, Andrea Kahlberget al.",2023 Feb,J Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/33820636/,No keywords found,"['objective', 'of', 'study', 'to', 'compare', 'efficacy', 'of', 'renal', 'perfusion', 'with', 'custodiol', '(', 'dr', 'franz-kohler', 'chemie', 'gmbh', ',', 'bensheim', ',', 'germany', ')', 'versus', 'enriched', 'ringer', ""'s"", 'solution', 'renal', 'protection', 'in', 'patient', 'undergoing', 'open', 'thoracoabdominal', 'aortic', 'aneurysm', '(', 'taaa', ')', 'repair', '.', 'method', 'ninety', 'consecutive', 'patient', 'scheduled', 'elective', 'open', 'taaa', 'repair', 'enrolled', 'and', 'in', 'single-center', ',', 'phase', 'iv', ',', 'prospective', ',', 'parallel', ',', 'randomized', ',', 'double-blind', 'trial', '(', 'custodiol', 'versus', 'ringer', 'best', 'agent', 'curitiba', 'trial', ')', ',', 'and', 'randomized', 'to', 'renal', 'artery', 'perfusion', 'with', 'c', 'custodiol', '(', 'dr', 'franz-kohler', 'chemie', 'gmbh', ',', 'bensheim', ',', 'germany', 'n', ')', 'or', 'c', 'lactated', 'ringer', ""'s"", 'solution', '(', 'n', ')', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'undergoing', 'taaa', 'open', 'surgery', 'using', 'custodiol', 'renal', 'perfusion', 'versus', 'enriched', 'ringer', ""'s"", 'solution', 'primary', 'end', 'point', '.', 'result', 'ninety', 'patient', 'completed', 'study', '(', 'patient', 'in', 'group', ')', '.', 'incidence', 'of', 'postoperative', 'aki', 'significantly', 'lower', 'in', 'custodiol', 'group', '(', '.', 'v', '.', 'p', '.', ')', '.', 'in', 'multivariable', 'model', ',', 'use', 'of', 'custodiol', 'solution', 'resulted', 'protective', 'occurrence', 'of', 'aki', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', ',', 'whereas', 'taaa', 'type', 'ii', 'extent', 'associated', 'with', 'development', 'of', 'severe', 'aki', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', '.', '-year', 'follow-up', ',', 'serum', 'creatinine', 'not', 'significantly', 'different', 'preoperative', 'value', 'in', 'group', '.', 'conclusion', 'use', 'of', 'custodiol', 'open', 'taaa', 'repair', 'safe', 'and', 'resulted', 'in', 'significantly', 'lower', 'rate', 'of', 'postoperative', 'aki', 'compared', 'with', 'ringer', ""'s"", 'solution', '.', 'finding', 'support', 'safety', 'and', 'efficacy', 'of', 'custodiol', 'in', 'specific', 'setting', ',', 'currently', 'off-label', '.']"
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.,"Wanda L Salzer, Michael J Burke, Meenakshi Devidas, Si Chen, Lia Gore, Eric C Larsen, Michael Borowitz, Brent Wood, Nyla A Heerema, Andrew J Carroll, Joanne M Hilden, Mignon L Loh, Elizabeth A Raetz, Naomi J Winick, William L Carroll, Stephen P Hunger, Wanda L Salzeret al.",2018 Mar 15,Cancer,https://pubmed.ncbi.nlm.nih.gov/29266189/,No keywords found,"['child', ',', 'adolescent', ',', 'and', 'young', 'adult', 'with', 'high-risk', '(', 'vhr', ')', 'b', 'acute', 'lymphoblastic', 'leukemia', '(', 'b-all', ')', 'poor', 'outcome', ',', 'and', 'novel', 'therapy', 'needed', 'subgroup', '.', 'aall', 'study', 'evaluated', 'postinduction', 'therapy', 'using', 'cyclophosphamide', '(', 'cpm', ')', ',', 'etoposide', '(', 'etop', ')', ',', 'and', 'clofarabine', '(', 'clof', ')', 'patient', 'with', 'vhr', 'b-all', '.', 'method', 'patient', 'to', 'year', 'old', 'and', 'vhr', 'b-all', 'received', 'modified', 'berlin-frankfurt-mnster', 'therapy', 'induction', 'and', 'randomized', 'to', ')', 'cpm', ',', 'cytarabine', ',', 'mercaptopurine', ',', 'vincristine', '(', 'vcr', ')', ',', 'and', 'pegaspargase', '(', 'control', 'arm', ')', ',', ')', 'cpm', ',', 'etop', ',', 'vcr', ',', 'and', 'pegaspargase', '(', 'experimental', 'arm', ')', ',', 'or', ')', 'cpm', ',', 'etop', ',', 'clof', '(', 'mgm', ')', ',', 'vcr', ',', 'and', 'pegaspargase', '(', 'experimental', 'arm', ')', 'second', 'half', 'of', 'consolidation', 'and', 'delayed', 'intensification', '.', 'result', 'rate', 'of', 'grade', 'infection', 'and', 'grade', 'pancreatitis', 'significantly', 'increased', 'in', 'experimental', 'arm', '.', 'dose', 'of', 'clof', ',', 'therefore', ',', 'reduced', 'to', 'mgm', ',', 'and', 'myeloid', 'growth', 'factor', 'required', 'clof', 'administration', '.', 'despite', 'change', ',', 'of', 'patient', '(', '.', ')', 'developed', 'grade', 'infection', ',', 'with', 'of', 'patient', 'developing', 'grade', 'acute', 'kidney', 'injury', 'attributed', 'to', 'clof', ',', 'whereas', 'of', 'patient', '(', '.', ')', 'in', 'experimental', 'arm', 'developed', 'grade', 'infection', ',', 'and', 'no', 'grade', 'infection', 'in', 'control', 'arm', '(', 'n', ')', '.', 'four', 'patient', 'in', 'experimental', 'arm', 'prolonged', 'cytopenia', 'day', ',', 'whereas', 'none', 'in', 'control', 'arm', 'or', 'experimental', 'arm', '.', 'count', 'failed', 'to', 'recover', 'of', 'patient', ',', 'one', 'grade', 'acute', 'kidney', 'injury', 'and', 'removed', 'protocol', 'therapy', 'event', 'occurred', 'day', 'start', 'of', 'consolidation', 'part', '.', 'conclusion', 'in', 'aall', ',', 'clof', ',', 'administered', 'with', 'cpm', 'and', 'etop', ',', 'associated', 'with', 'unacceptable', 'toxicity', '.', 'cancer', '-', '.', 'american', 'cancer', 'society', '.']"
Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.,"Roxana Mehran, Michela Faggioni, Jaya Chandrasekhar, Dominick J Angiolillo, Barry Bertolet, Robert Lee Jobe, Bassam Al-Joundi, Somjot Brar, George Dangas, Wayne Batchelor, Anand Prasad, Hitinder S Gurm, James Tumlin, Gregg W Stone, Roxana Mehranet al.",2018 Aug 27,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/30139467/,No keywords found,"['aim', 'of', 'avert', '(', 'avert', 'clinical', 'trial', 'contrast', 'medium', 'volume', 'reduction', 'and', 'incidence', 'of', 'cin', ')', 'trial', 'to', 'test', 'efficacy', 'of', 'avert', 'system', 'to', 'reduce', 'contrast', 'medium', 'volume', '(', 'cmv', ')', 'used', 'coronary', 'angiographic', 'procedure', 'without', 'impairing', 'image', 'quality', 'and', 'to', 'prevent', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'in', 'patient', 'risk', 'ci-aki', '.', 'background', 'ci-aki', 'common', 'complication', 'of', 'percutaneous', 'coronary', 'procedure', ',', 'associated', 'with', 'increased', 'morbidity', 'and', 'mortality', '.', 'avert', 'system', 'alters', 'coronary', 'injection', 'pressure', 'profile', 'diverting', 'contrast', 'away', 'patient', 'coronary', 'injection', '.', 'method', 'avert', 'trial', 'prospective', ',', 'multicenter', ',', 'randomized', 'clinical', 'trial', 'in', 'subject', 'with', 'either', 'baseline', 'estimated', 'glomerular', 'filtration', 'rate', 'to', 'mlmin', '.', 'or', 'estimated', 'glomerular', 'filtration', 'rate', 'to', 'mlmin', '.', 'and', 'least', 'additional', 'risk', 'factor', 'ci-aki', '.', 'patient', 'undergoing', 'coronary', 'angiography', 'with', 'planned', 'or', 'possible', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'randomized', 'to', 'hydration', 'plus', 'avert', 'system', '(', 'n', ')', 'or', 'hydration', '(', 'n', ')', '.', 'primary', 'effectiveness', 'endpoint', ')', 'total', 'cmv', 'used', 'and', ')', 'incidence', 'of', 'ci-aki', ',', 'defined', '.', 'mgdl', 'increase', 'in', 'serum', 'creatinine', 'within', 'day', 'post-procedure', '.', 'result', 'patient', 'demographic', 'well', 'balanced', 'group', ',', 'with', 'mean', 'baseline', 'serum', 'creatinine', 'of', '.', '.', 'mgdl', 'and', '.', 'patient', 'with', 'diabetes', 'mellitus', '.', 'pci', 'performed', 'in', '.', 'of', 'procedure', ',', 'with', 'coronary', 'angiography', 'in', 'remainder', '.', 'use', 'of', 'avert', 'resulted', 'in', '.', 'relative', 'reduction', 'in', 'cmv', 'overall', '(', '.', '.', 'ml', 'vs.', '.', '.', 'ml', 'p', '.', ')', 'and', '.', 'relative', 'reduction', 'in', 'cmv', 'among', 'pci', 'patient', '(', 'ml', 'vs.', 'ml', 'p', '.', ')', '.', 'maximum', 'relative', 'reduction', 'in', 'cmv', '(', 'ml', 'vs.', 'ml', 'p', '.', ')', 'lesion', 'treated', '.', 'no', 'difference', 'in', 'rate', 'of', 'ci-aki', '(', '.', 'vs.', '.', 'p', '.', ')', 'study', 'group', '.', 'conclusion', 'use', 'of', 'avert', 'system', 'feasible', 'and', 'safe', ',', 'with', 'acceptable', 'image', 'quality', 'coronary', 'angiography', 'and', 'pci', '.', 'avert', 'significantly', 'reduced', 'cmv', ',', 'with', 'extent', 'of', 'cmv', 'reduction', 'correlating', 'with', 'procedural', 'complexity', '.', 'no', 'significant', 'difference', 'in', 'ci-aki', 'observed', 'with', 'avert', 'in', 'trial', '.', '(', 'avert', 'clinical', 'trial', 'contrast', 'medium', 'volume', 'reduction', 'and', 'incidence', 'of', 'cin', 'avert', 'nct', ')', '.']"
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.,"Florence Wong, Thomas D Boyer, Arun J Sanyal, Stephen C Pappas, Shannon Escalante, Khurram Jamil, Florence Wonget al.",2020 Sep 1,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/30887050/,No keywords found,"['hepatorenal', 'syndrome', 'type', '(', 'hrs-', ')', ',', 'form', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'cirrhosis', ',', 'median', 'survival', 'of', 'day', 'to', 'week', 'untreated', '.', 'impact', 'of', 'reduction', 'in', 'aki', 'stage', 'overall', 'survival', 'in', 'cirrhosis', ',', 'independent', 'of', 'hr', 'reversal', ',', 'unclear', '.', 'method', 'randomized', ',', 'placebo-controlled', ',', 'double-blind', 'study', 'to', 'confirm', 'reversal', 'of', 'hrs-', 'with', 'terlipressin', 'study', 'assessed', 'terlipressin', 'versus', 'placebo', ',', 'with', 'albumin', ',', 'treatment', 'hrs-', 'day', '.', 'renal', 'dysfunction', 'severity', 'categorized', 'aki', 'stage', 'enrollment', '.', 'baseline', 'patient', 'characteristic', 'evaluated', 'predictor', 'of', 'aki', 'improvement', 'using', 'multivariate', 'model', 'association', 'aki', 'stage', 'reduction', 'and', '-day', 'survival', 'assessed', 'using', 'linear', 'regression', '.', 'result', 'total', 'of', 'patient', '(', 'terlipressin', 'n', 'placebo', 'n', ')', 'with', 'similar', 'number', 'in', 'aki', 'stage', '-', '(', 'terlipressinplacebo', ',', 'stage', 'n', 'stage', 'n', 'stage', 'n', ')', 'included', '.', 'predictor', 'of', 'aki', 'improvement', 'absence', 'of', 'alcoholic', 'hepatitis', ',', 'baseline', 'serum', 'creatinine', 'and', 'male', 'gender', '.', 'overall', 'survival', 'not', 'significantly', 'different', 'across', 'aki', 'stage', '(', 'range', '-', ')', '.', 'in', 'patient', 'with', 'no', 'aki', 'worsening', ',', '-day', 'survival', 'consistently', 'better', 'aki', 'improved', 'independent', 'of', 'hr', 'reversal', ',', 'regardless', 'of', 'initial', 'aki', 'stage', ',', 'with', 'patient', 'with', 'stage', 'initial', 'diagnosis', 'achieving', 'greatest', 'clinical', 'benefit', '.', 'significant', 'association', 'observed', 'aki', 'reduction', 'and', 'overall', '-day', 'survival', '(', 'p', '.', ')', '.', 'conclusion', 'reduction', 'in', 'aki', 'stage', ',', 'independent', 'of', 'hr', 'reversal', ',', 'sufficient', 'to', 'improve', 'overall', 'survival', 'in', 'patient', 'with', 'hrs-', '.', 'goal', 'hrs-', 'treatment', 'less', 'stringent', 'absolute', 'hr', 'reversal', '.']"
Continuing versus withholding angiotensin receptor blocker (ARB)/calcium channel blocker (CCB) combination tablets during perioperative periods in patients undergoing minor surgery: a single-blinded randomized controlled trial.,"Kazuyo Takeuchi, Masakazu Hayashida, Osamu Kudoh, Naoko Niimi, Kumi Kataoka, Maho Kakemizu-Watanabe, Makiko Yamamoto, Atsuko Hara, Izumi Kawagoe, Keisuke Yamaguchi, Kazuyo Takeuchiet al.",2022 Jun,J Anesth,https://pubmed.ncbi.nlm.nih.gov/35247102/,No keywords found,"['trial', 'conducted', 'to', 'compare', 'effect', 'of', 'continuing', 'versus', 'withholding', 'single-pill', 'combination', 'tablet', 'consisting', 'of', 'angiotensin', 'receptor', 'blocker', '(', 'arb', ')', 'and', 'calcium', 'channel', 'blocker', '(', 'ccbs', ')', 'perioperative', 'hemodynamics', 'and', 'clinical', 'outcome', '.', 'method', 'patient', 'undergoing', 'minor', 'abdominal', 'or', 'urological', 'surgery', '(', 'n', ')', 'randomly', 'assigned', 'to', 'group', 'c', ',', 'in', 'arbccb', 'combination', 'tablet', 'continued', 'surgery', ',', 'or', 'group', 'w', ',', 'in', 'withheld', 'within', 'h', 'of', 'surgery', '.', 'perioperative', 'hemodynamics', 'and', 'clinical', 'outcome', 'compared', 'group', '.', 'result', 'incidence', 'of', 'hypotension', 'anesthesia', 'requiring', 'repeated', 'treatment', 'with', 'vasoconstrictor', 'higher', 'in', 'group', 'c', 'group', 'w', '(', 'p', '.', ')', '.', 'blood', 'pressure', 'anesthesia', 'generally', 'lower', 'in', 'group', 'c', 'group', 'w', '(', 'p', '.', ')', 'despite', 'significantly', 'dos', 'of', 'ephedrine', 'and', 'phenylephrine', 'administrated', 'in', 'group', 'c', '(', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', '.', 'incidence', 'of', 'postoperative', 'hypertension', 'not', 'differ', 'group', '(', 'p', '.', ')', '.', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'preoperative', 'day', 'not', 'differ', 'group', '(', 'p', '.', ')', ',', 'egfr', 'slightly', 'lower', 'in', 'group', 'c', 'group', 'w', 'first', 'and', 'third', 'postoperative', 'day', '(', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', ',', 'although', 'clinically', 'relevant', 'acute', 'kidney', 'injury', 'not', 'develop', '.', 'conclusion', 'continuing', 'arbccb', 'combination', 'tablet', 'preoperatively', 'in', 'patient', 'undergoing', 'minor', 'surgery', 'increased', 'incidence', 'of', 'hypotension', 'anesthesia', ',', 'increased', 'requirement', 'of', 'vasoconstrictor', 'to', 'treat', 'hypotension', ',', 'and', 'might', 'deteriorate', 'postoperative', 'renal', 'function', ',', 'albeit', 'slightly', '.', 'result', 'suggest', 'withholding', 'arbccb', 'tablet', 'preoperatively', 'preferable', 'to', 'continuing', '.', 'clinical', 'trial', 'registration', 'trial', 'registered', 'with', 'japan', 'registry', 'of', 'clinical', 'trial', '(', 'jrct', ')', 'japanese', 'ministry', 'of', 'health', ',', 'labour', ',', 'and', 'welfare', '(', 'trial', 'id', 'jrct', ')', '.']"
Combination of terlipressin and noradrenaline versus terlipressin in hepatorenal syndrome with early non-response to terlipressin infusion:  A randomized trial.,"Virendra Singh, Akshaya Jayachandran, Arka De, Akash Singh, Shivani Chandel, Navneet Sharma, Virendra Singhet al.",2023 Jun,Indian J Gastroenterol,https://pubmed.ncbi.nlm.nih.gov/37145232/,No keywords found,"['terlipressin', 'and', 'noradrenaline', 'effective', 'in', 'management', 'of', 'hepatorenal', 'syndrome', '(', 'hr', ')', '.', 'no', 'report', 'combination', 'of', 'vasoconstrictor', 'in', 'type-', 'hr', '.', 'aim', 'to', 'evaluate', 'terlipressin', 'with', 'or', 'without', 'noradrenaline', 'in', 'type-', 'hr', 'not', 'responding', 'to', 'terlipressin', 'hour', '.', 'method', 'sixty', 'patient', 'randomized', 'to', 'receive', 'either', 'terlipressin', '(', 'group', 'n', ')', 'or', 'combination', 'of', 'terlipressin', 'and', 'noradrenaline', 'infusion', '(', 'group', 'b', 'n', ')', '.', 'in', 'group', ',', 'terlipressin', 'infusion', 'started', 'mgday', 'and', 'increased', 'mgday', '(', 'maximum', 'mgday', ')', '.', 'in', 'group', 'b', ',', 'terlipressin', 'given', 'constant', 'dose', 'of', 'mgday', '.', 'noradrenaline', 'infusion', 'started', '.', 'mgh', 'baseline', 'and', 'increased', 'to', 'mgh', 'in', 'stepwise', 'manner', '.', 'primary', 'outcome', 'treatment', 'response', 'day', '.', 'secondary', 'outcome', '-day', 'survival', ',', 'cost-benefit', 'analysis', 'and', 'adverse', 'event', '.', 'result', 'no', 'significant', 'difference', 'in', 'response', 'rate', 'group', '(', 'v', '.', '.', ',', 'p', '.', ')', 'and', '-day', 'survival', 'similar', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'treatment', 'expensive', 'in', 'group', '(', 'usd', 'vs.', ',', 'p', '.', ')', '.', 'adverse', 'event', 'frequent', 'in', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'conclusion', 'combination', 'of', 'noradrenaline', 'and', 'terlipressin', 'infusion', 'result', 'in', 'non-significantly', 'higher', 'rate', 'of', 'hr', 'resolution', 'with', 'significantly', 'fewer', 'adverse', 'effect', 'in', 'hr', 'patient', 'not', 'respond', 'to', 'terlipressin', 'within', 'hour', '.', 'clinicaltrials', 'gov', '(', 'nct', ')', '.']"
Lack of difference in acute nephrotoxicity of intravenous bisphosphonates zoledronic acid and ibandronate in women with breast cancer and bone metastases.,"Dörte W Luedders, Jürgen Steinhoff, Marc Thill, Achim Rody, Michael K Bohlmann, Dörte W Luedderset al.",2015 Mar,Anticancer Res,https://pubmed.ncbi.nlm.nih.gov/25750345/,No keywords found,"['of', 'patient', 'with', 'advanced', 'breast', 'cancer', 'develop', 'bone', 'metastasis', 'may', 'lead', 'to', 'multiple', 'complication', 'pathological', 'fracture', ',', 'bone', 'pain', 'or', 'hypercalcaemia', '.', 'standard', 'treatment', ',', 'besides', 'endocrine', ',', 'targeted-therapy', 'or', 'chemotherapy', ',', 'use', 'of', 'bisphosphonates', '.', 'however', ',', 'one', 'of', 'main', 'adverse', 'side-effects', 'bisphosphonate-induced', 'nephrotoxicity', '.', 'mechanism', 'latter', 'occurs', 'not', 'well-understood', ',', 'although', 'emerging', 'evidence', 'suggests', 'effect', 'of', 'bisphosphonates', 'kidney', 'may', 'differ', 'agent', '.', 'patient', 'and', 'method', 'aim', 'of', 'evaluation', 'to', 'compare', 'renal', 'toxicity', 'of', 'mg', 'ibandronate', 'i.v', '.', 'versus', 'mg', 'zoledronic', 'acid', 'i.v', '.', 'period', 'of', 'six', 'month', 'in', 'woman', 'with', 'breast', 'cancer', 'and', 'bone', 'metastasis', '.', 'prospective', 'randomized', 'trial', 'carried', 'to', 'examine', 'specific', 'kidney', 'and', 'parameter', '(', '-', 'and', '-microglobulin', ',', 'albumin', ',', '-macroglobulin', ',', 'igg', 'and', 'c-reactive', 'protein', '(', 'crp', ')', 'generated', 'spontaneous', 'urine', 'sample', 'patient', 'of', 'group', '.', 'result', 'unable', 'to', 'find', 'significant', 'difference', 'two', 'treatment', 'group', 'with', 'regard', 'to', 'renal', 'toxicity', '.', 'patient', ',', 'independently', 'of', 'applied', 'bisphosphonate', ',', 'experienced', 'temporary', 'renal', 'dysfunction', 'without', 'evidence', 'of', 'irreversible', 'damage', 'in', 'term', 'of', 'acute', 'nephrotoxicity', 'study', 'period', '.', '-microglobulin', ',', 'marker', 'proximal', 'tubular', 'damage', ',', 'in', 'particular', ',', 'not', 'differently', 'elevated', 'in', 'either', 'group', '.', 'conclusion', 'applied', 'bisphosphonates', 'found', 'to', 'well-tolerated', 'and', 'safe', 'with', 'regard', 'to', 'renal', 'toxicity', 'six-month', 'treatment', 'period', 'in', 'patient', 'with', 'otherwise', 'healthy', 'kidney', 'advanced', 'breast', 'cancer', 'and', 'bone', 'metastasis', '.']"
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.,"R Brian Stevens, Kirk W Foster, Clifford D Miles, Andre C Kalil, Diana F Florescu, John P Sandoz, Theodore H Rigley, Tamer Malik, Lucile E Wrenshall, R Brian Stevenset al.",2015 Oct 14,PLoS One,https://pubmed.ncbi.nlm.nih.gov/26465152/,No keywords found,"['two', 'significant', 'impediment', 'to', 'renal', 'allograft', 'survival', 'rejection', 'and', 'direct', 'nephrotoxicity', 'of', 'immunosuppressant', 'drug', 'required', 'to', 'prevent', '.', 'calcineurin', 'inhibitor', '(', 'cni', ')', ',', 'mainstay', 'of', 'immunosuppression', 'regimen', ',', 'particularly', 'nephrotoxic', '.', 'less', 'toxic', 'antirejection', 'agent', 'become', 'available', ',', 'option', 'to', 'optimize', 'use', 'of', 'hand', '.', 'aim', 'to', 'determine', 'whether', 'intensive', 'rabbit', 'anti-thymocyte', 'globulin', '(', 'ratg', ')', 'induction', 'followed', 'cni', 'withdrawal', 'would', 'individually', 'or', 'combined', 'improve', 'graft', 'function', 'and', 'reduce', 'graft', 'chronic', 'histopathology-surrogates', 'graft', 'and', ',', 'therefore', ',', 'patient', 'survival', '.', 'previously', 'reported', ',', 'single', 'large', 'ratg', 'dose', 'hour', 'well-tolerated', 'and', 'associated', 'with', 'better', 'renal', 'function', ',', 'fewer', 'infection', ',', 'and', 'improved', 'patient', 'survival', '.', 'report', 'testing', 'whether', 'complete', 'cni', 'discontinuation', 'would', 'improve', 'renal', 'function', 'and', 'decrease', 'graft', 'pathology', '.', 'method', 'april', ',', 'and', '--', 'conducted', 'prospective', ',', 'randomized', ',', 'non-blinded', 'renal', 'transplantation', 'trial', 'of', 'two', 'ratg', 'dosing', 'protocol', '(', 'single', 'dose', ',', 'mgkg', 'vs.', 'divided', 'dos', ',', '.', 'mgkg', 'every', 'day', 'x', 'target', 'enrollment', ')', '.', 'subsequent', 'maintenance', 'immunosuppression', 'consisted', 'of', 'tacrolimus', ',', 'cni', ',', 'and', 'sirolimus', ',', 'mammalian', 'target', 'of', 'rapamycin', 'inhibitor', '.', 'report', 'outcome', 'of', 'converting', 'patient', 'six', 'month', 'either', 'to', 'minimized', 'tacrolimussirolimus', 'or', 'mycophenolate', 'mofetilsirolimus', '.', 'primary', 'endpoint', 'graft', 'function', 'and', 'chronic', 'histopathology', 'protocol', 'kidney', 'biopsy', 'and', 'month', '.', 'result', 'cni', 'withdrawal', '(', 'on-treatment', 'analysis', ')', 'associated', 'with', 'better', 'graft', 'function', '(', 'p', '.', ')', 'and', 'lower', 'chronic', 'histopathology', 'composite', 'score', 'in', 'protocol', 'biopsy', '(', 'p', '.', ')', 'and', '(', 'p', '.', ')', 'month', ',', 'without', 'affecting', 'patient', '(', 'p', '.', ')', 'or', 'graft', '(', 'p', '.', ')', 'survival', ',', 'or', 'rejection', 'rate', '(', 'p', '.', ')', '.', 'conclusion', 'cni', '(', 'tacrolimus', ')', 'withdrawal', 'six', 'month', 'may', 'provide', 'strategy', 'decreased', 'nephrotoxicity', 'and', 'improved', 'long-term', 'function', 'in', 'steroid-free', 'low', 'immunological', 'risk', 'renal', 'transplant', 'patient', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.,"Gregory D Huhn, Moti Ramgopal, Mamta K Jain, Federico Hinestrosa, David M Asmuth, Jihad Slim, Deborah Goldstein, Shauna Applin, Julie H Ryu, Shuping Jiang, Stephanie Cox, Moupali Das, Thai Nguyen-Cleary, David Piontkowsky, Bill Guyer, Lorenzo Rossaro, Richard H Haubrich, Gregory D Huhnet al.",2020 Jan 29,PLoS One,https://pubmed.ncbi.nlm.nih.gov/31995556/,No keywords found,"['guideline', 'advocate', 'treatment', 'of', 'hcv', 'in', 'hivhcv', 'co-infected', 'individual', '.', 'aim', 'of', 'randomized', ',', 'open-label', 'study', '(', 'clinicaltrials.gov', 'identifier', 'nct', 'httpsclinicaltrials.govctshownct', ')', 'to', 'evaluate', 'safetyefficacy', 'of', 'ledipasvirsofosbuvir', '(', 'ldvsof', ')', 'co-administered', 'with', 'elvitegravircobicistatemtricitabinetenofovir', 'alafenamide', '(', 'ecftaf', ')', 'or', 'rilpivirineftaf', '(', 'rftaf', ')', 'in', 'hiv-hcv', 'co-infected', 'participant', '.', 'method', 'participant', 'with', 'hiv-', 'rna', 'copiesml', 'and', 'chronic', 'hcv-genotype', '(', 'gt', ')', '(', 'hcv', 'treatment-nave', 'compensated', 'cirrhosis', 'or', 'hcv', 'treatment-experienced', 'non-cirrhotic', ')', 'randomized', 'to', 'switch', 'to', 'ecftaf', 'or', 'rftaf', '.', 'hiv', 'suppression', 'maintained', 'week', ',', 'participant', 'received', 'week', 'of', 'ldvsof', '.', 'primary', 'endpoint', 'sustained', 'hcv', 'virologic', 'response', 'week', 'ldvsof', 'completion', '(', 'svr', ')', '.', 'result', 'of', 'participant', ',', 'received', 'dose', 'of', 'hiv', 'study', 'drug', 'and', 'received', 'ldvsof', '(', 'in', 'ftaf', 'group', 'gta', ',', 'hcv', 'treatment-nave', ',', 'cirrhotic', ')', '.', 'overall', ',', 'svr', '(', 'confidence', 'interval', '-', ')', '.', 'black', 'race', 'not', 'affect', 'svr', '.', 'of', 'four', 'participant', 'not', 'achieving', 'svr', ',', 'one', 'hcv', 'relapse', ',', 'one', 'hcv', 'virologic', 'non-response', 'due', 'to', 'non-adherence', ',', 'and', 'two', 'missed', 'post-hcv', 'week', 'visit', '.', 'of', 'participant', ',', 'receiving', 'ecftaf', 'and', 'receiving', 'rftaf', 'maintained', 'hiv', 'suppression', 'week', 'no', 'hiv', 'resistance', 'detected', '.', 'no', 'participant', 'discontinued', 'ldvsof', 'or', 'ecftaf', 'due', 'to', 'adverse', 'event', 'one', 'participant', 'discontinued', 'rftaf', 'due', 'to', 'worsening', 'of', 'pre-existing', 'hypercholesterolemia', '.', 'renal', 'toxicity', 'not', 'observed', 'in', 'either', 'ftaf', 'regimen', 'ldvsof', 'co-administration', '.', 'in', 'conclusion', ',', 'high', 'rate', 'of', 'hcv', 'svr', 'and', 'maintenance', 'of', 'hiv', 'suppression', 'achieved', 'with', 'ldvsof', 'and', 'ftaf-based', 'regimen', '.', 'conclusion', 'study', 'support', 'ldvsof', 'co-administered', 'with', 'ftaf-based', 'regimen', 'in', 'hiv-hcv-gt', 'co-infected', 'patient', '.']"
RENAL PROTECTIVE EFFECT AND CLINICAL ANALYSIS OF VITAMIN B 6 IN PATIENTS WITH SEPSIS.,"Yao Wang, Wen-Long Lu, Wen-Ming Feng, Wei Xu, Li-Hua Liu, Li-Min He, Yao Wanget al.",2024 Jun 1,Shock,https://pubmed.ncbi.nlm.nih.gov/38691102/,No keywords found,"['to', 'investigate', 'protective', 'effect', 'and', 'possible', 'mechanism', 'of', 'vitamin', 'b', 'renal', 'injury', 'in', 'patient', 'with', 'sepsis', '.', 'method', 'total', 'of', 'patient', 'with', 'sepsis', 'met', 'entry', 'criterion', 'in', 'multiple', 'center', 'randomly', 'divided', 'experimental', '(', 'intravenous', 'vitamin', 'b', 'therapy', ')', 'and', 'control', '(', 'intravenous', '.', 'sodium', 'chloride', 'therapy', ')', 'group', 'based', 'usual', 'care', '.', 'clinical', 'data', ',', 'inflammatory', 'response', 'indicator', 'interleukin', '(', 'il-', ')', ',', 'interleukin', '(', 'il-', ')', ',', 'tumor', 'necrosis', 'factor', '(', 'tnf-', ')', ',', 'and', 'endothelin-', '(', 'et-', ')', ',', 'oxidative', 'stress', 'response', 'indicator', 'superoxide', 'dismutase', ',', 'glutathione', 'and', 'malondialdehyde', ',', 'and', 'renal', 'function', '(', 'assessed', 'blood', 'urea', 'nitrogen', ',', 'serum', 'creatinine', ',', 'and', 'renal', 'resistance', 'index', 'monitored', 'ultrasound', ')', 'compared', 'two', 'group', '.', 'result', 'of', 'treatment', ',', 'il-', ',', 'il-', ',', 'tnf-', ',', 'and', 'et-', 'level', 'in', 'experimental', 'group', 'significantly', 'lower', 'in', 'control', 'group', ',', 'oxidative', 'stress', 'response', 'indicator', 'significantly', 'improved', 'in', 'experimental', 'group', 'and', 'blood', 'urea', 'nitrogen', ',', 'serum', 'creatinine', ',', 'and', 'renal', 'resistance', 'index', 'value', 'in', 'experimental', 'group', 'significantly', 'lower', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'however', ',', 'intensive', 'care', 'unit', 'length', 'of', 'stay', 'and', 'total', 'hospitalization', 'expense', 'in', 'experimental', 'group', 'significantly', 'lower', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'administration', 'of', 'vitamin', 'b', 'in', 'treatment', 'of', 'patient', 'with', 'sepsis', 'attenuates', 'renal', 'injury', ',', 'and', 'mechanism', 'may', 'related', 'to', 'pyridoxine', 'decreasing', 'level', 'of', 'inflammatory', 'mediator', 'and', 'regulation', 'redox', 'stress', '.']"
Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial.,"Eva Schönenberger, Peter Martus, Maria Bosserdt, Elke Zimmermann, Rudolf Tauber, Michael Laule, Marc Dewey, Eva Schönenbergeret al.",2019 Sep,Radiology,https://pubmed.ncbi.nlm.nih.gov/31264950/,No keywords found,"['nct', ')', 'involved', 'randomizing', 'participant', 'with', 'atypical', 'chest', 'pain', 'and', 'suspected', 'coronary', 'artery', 'disease', '(', 'cad', ')', 'february', 'and', 'august', 'to', 'undergo', 'coronary', 'ct', 'angiography', 'with', 'intravenous', 'contrast', 'agent', 'administration', 'or', 'cardiac', 'catheterization', 'angiography', 'with', 'intra-arterial', 'contrast', 'agent', 'administration', '.', 'prespecified', 'secondary', 'analysis', 'compared', 'aki', '(', 'serum', 'creatinine', 'increase', 'of', 'or', '.', 'mgdl', '-', 'or', '-', 'hour', ')', 'determined', 'blinded', 'investigator', 'using', 'absolute', 'difference', 'and', 'relative', 'risk', ',', 'including', 'two-sided', 'confidence', 'interval', '(', 'ci', ')', '.', 'result', 'total', 'of', 'participant', '(', '.', 'woman', 'mean', 'age', ',', 'year', ')', 'included', '.', 'baseline', 'egfr', 'not', 'differ', 'ct', 'angiography', 'group', '(', '.', 'mlmin', '.', '.', ')', 'and', 'catheterization', 'group', '(', '.', 'mlmin', '.', '.', ')', '(', 'p', '.', ')', '.', 'aki', 'occurred', 'in', 'nine', 'of', 'participant', 'in', 'ct', 'angiography', 'group', '(', '.', 'ci', ',', ')', 'and', 'in', 'of', 'participant', 'in', 'catheterization', 'group', '(', '.', 'ci', ',', ')', '(', 'relative', 'risk', ',', '.', 'ci', '.', ',', '.', 'p', '.', ')', '.', 'also', 'in', 'subgroup', 'of', 'participant', 'without', 'obstructive', 'cad', ',', 'in', 'not', 'requiring', 'coronary', 'intervention', ',', 'aki', 'common', 'in', 'catheterization', 'group', '(', '.', 'ci', ',', ')', 'in', 'ct', 'angiography', 'group', '(', '.', 'ci', ',', 'difference', ',', '.', 'ci', '.', ',', '.', 'relative', 'risk', ',', '.', 'ci', '.', ',', '.', 'p', '.', ')', '.', 'obstructive', 'cad', '(', 'odds', 'ratio', 'or', '.', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'femoral', 'catheter', 'access', '(', 'or', '.', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'and', 'cine', 'ventriculography', 'associated', 'with', 'aki', '(', 'or', '.', 'ci', '.', ',', '.', 'p', '.', ')', '.', 'in', 'multivariable', 'analysis', ',', 'presence', 'of', 'postcontrast', 'aki', 'associated', 'with', 'chronic', 'kidney', 'disease', '(', 'hazard', 'ratio', '.', 'ci', '.', ',', '.', 'p', '.', ')', '.', 'conclusion', 'acute', 'kidney', 'injury', 'common', 'cardiac', 'catheterization', 'ct', 'angiography', 'in', 'prospective', 'randomized', 'study', 'of', 'patient', 'suspected', 'of', 'coronary', 'artery', 'disease', '.', 'rsna', ',', 'online', 'supplemental', 'material', 'available', 'article', '.', 'see', 'also', 'editorial', 'einstein', 'and', 'newhouse', 'in', 'issue', '.']"
"Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.","Foroud Shahbazi, Sanambar Sadighi, Simin Dashti-Khavidaki, Farhad Shahi, Mehrzad Mirzania, Alireza Abdollahi, Mohammad-Hossein Ghahremani, Foroud Shahbaziet al.",2015 Jul,Phytother Res,https://pubmed.ncbi.nlm.nih.gov/25857366/,"cisplatin, milk thistle, nephrotoxicity, silymarin.","['despite', 'several', 'introduced', 'preventive', 'modality', ',', 'cisplatin', 'nephrotoxicity', 'remains', 'clinical', 'problem', '.', 'in', 'vitro', 'and', 'in', 'vivo', 'study', 'addressed', 'protective', 'effect', 'of', 'silymarin', 'cisplatin', 'nephrotoxicity', '.', 'study', 'evaluated', 'effect', 'of', 'silymarin', 'administration', 'cisplatin', 'nephrotoxicity', 'first', 'human', 'study', '.', 'pilot', ',', 'randomized', ',', 'double-blinded', ',', 'placebo-controlled', 'clinical', 'trial', ',', 'effect', 'of', 'oral', 'silymarin', 'mg', 'daily', 'in', 'three', 'divided', 'dos', 'starting', '-', 'h', 'initiation', 'of', 'cisplatin', 'infusion', 'and', 'continuing', 'to', 'end', 'of', 'three', '-day', 'cisplatin-containing', 'chemotherapy', 'course', 'cisplatin-induced', 'renal', 'electrolyte', 'wasting', 'and', 'kidney', 'function', 'assessed', '.', 'cisplatin-associated', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'occurred', 'in', 'of', 'patient', '.', 'urine', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'to', 'urine', 'creatinine', 'ratio', '(', 'ngalcr', ')', 'and', 'urinary', 'magnesium', 'and', 'potassium', 'wasting', 'increased', 'significantly', 'cisplatin', 'infusion', 'in', 'group', '.', 'significant', 'positive', 'correlation', 'found', 'cumulative', 'dose', 'of', 'cisplatin', 'and', 'urine', 'ngalcr', 'three', 'course', 'of', 'cisplatin', 'infusion', '.', 'incidence', 'of', 'aki', 'and', 'magnitude', 'of', 'urinary', 'magnesium', 'and', 'potassium', 'wasting', 'not', 'differ', 'silymarin', 'and', 'placebo', 'group', '.', 'no', 'adverse', 'reaction', 'reported', 'silymarin', 'administration', '.', 'prophylactic', 'administration', 'of', 'conventional', 'form', 'of', 'silymarin', 'tablet', 'could', 'not', 'prevent', 'cisplatin-induced', 'urine', 'electrolyte', 'wasting', 'or', 'renal', 'function', 'impairment', '.']"
"Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial.","Matthew W Semler, Wesley H Self, Li Wang, Daniel W Byrne, Jonathan P Wanderer, Jesse M Ehrenfeld, Joanna L Stollings, Avinash B Kumar, Antonio Hernandez, Oscar D Guillamondegui, Addison K May, Edward D Siew, Andrew D Shaw, Gordon R Bernard, Todd W Rice                              ;, Isotonic Solutions and Major Adverse Renal Events Trial (SMART) Investigators;, Pragmatic Critical Care Research Group, Jonathan D Casey, Michael J Noto, Todd W Rice, Henry J Domenico, Christopher G Hughes, Emily Holcombe, Jayme Gibson, Lisa Weavind, Mias Pretorius, William T Costello, Debra F Dunlap, Kelli A Rumbaugh, Leanne Atchison, Mark Sullivan, Matthew Felbinger, Molly Knostman, Susan E Hamblin, Jason B Young, Julie Y Valenzuela, David P Mulherin, Fred R Hargrove, Seth Strawbridge, Matthew W Semleret al.",2017 Mar 16,Trials,https://pubmed.ncbi.nlm.nih.gov/28302179/,No keywords found,"['saline', ',', 'intravenous', 'fluid', 'commonly', 'administered', 'to', 'critically', 'ill', 'adult', ',', 'contains', 'high', 'chloride', 'content', ',', 'may', 'associated', 'with', 'acute', 'kidney', 'injury', 'and', 'death', '.', 'whether', 'using', 'balanced', 'crystalloids', 'rather', 'saline', 'decrease', 'risk', 'of', 'acute', 'kidney', 'injury', 'and', 'death', 'among', 'critically', 'ill', 'adult', 'remains', 'unknown', '.', 'method', 'isotonic', 'solution', 'and', 'major', 'adverse', 'renal', 'event', 'trial', '(', 'smart', ')', 'pragmatic', ',', 'cluster-level', 'allocation', ',', 'cluster-level', 'crossover', 'trial', 'conducted', 'june', 'and', 'april', 'in', 'five', 'intensive', 'care', 'unit', 'vanderbilt', 'university', 'medical', 'center', 'in', 'nashville', ',', 'tn', ',', 'usa', '.', 'smart', 'compare', 'saline', '(', '.', 'sodium', 'chloride', ')', 'with', 'balanced', 'crystalloids', '(', 'clinician', ""'s"", 'choice', 'of', 'lactated', 'ringer', ""'s"", 'solution', 'or', 'plasma-lyte', ')', '.', 'intensive', 'care', 'unit', 'assigned', 'to', 'provide', 'either', 'saline', 'or', 'balanced', 'crystalloids', 'month', ',', 'with', 'assigned', 'crystalloid', 'alternating', 'monthly', 'course', 'of', 'trial', '.', 'adult', 'admitted', 'to', 'participating', 'intensive', 'care', 'unit', 'study', 'period', 'enrolled', 'and', 'followed', 'hospital', 'discharge', 'or', 'day', 'enrollment', '.', 'anticipated', 'enrollment', 'approximately', ',', 'patient', '.', 'primary', 'outcome', 'major', 'adverse', 'kidney', 'event', 'within', 'days-the', 'composite', 'of', 'in-hospital', 'death', ',', 'receipt', 'of', 'new', 'renal', 'replacement', 'therapy', ',', 'or', 'persistent', 'renal', 'dysfunction', '(', 'discharge', 'creatinine', 'of', 'baseline', 'creatinine', ')', '.', 'secondary', 'clinical', 'outcome', 'include', 'in-hospital', 'mortality', ',', 'intensive', 'care', 'unit-free', 'day', ',', 'ventilator-free', 'day', ',', 'vasopressor-free', 'day', ',', 'and', 'renal', 'replacement', 'therapy-free', 'day', '.', 'secondary', 'renal', 'outcome', 'include', 'new', 'renal', 'replacement', 'therapy', 'receipt', ',', 'persistent', 'renal', 'dysfunction', ',', 'and', 'incidence', 'of', 'stage', 'or', 'higher', 'acute', 'kidney', 'injury', '.', 'discussion', 'ongoing', 'pragmatic', 'trial', 'provide', 'largest', 'and', 'comprehensive', 'comparison', 'to', 'date', 'of', 'clinical', 'outcome', 'with', 'saline', 'versus', 'balanced', 'crystalloids', 'among', 'critically', 'ill', 'adult', '.', 'trial', 'registration', 'logistical', 'reason', ',', 'smart', 'prospectively', 'registered', 'separately', 'medical', 'icu', '(', 'smart-med', 'clinicaltrials.gov', 'identifier', 'nct', 'registered', 'may', 'date', 'of', 'first', 'patient', 'enrollment', 'june', ')', 'and', 'nonmedical', 'icu', '(', 'smart-surg', 'clinicaltrials.gov', 'identifier', 'nct', 'registered', 'september', 'date', 'of', 'first', 'patient', 'enrollment', 'october', ')', '.']"
Histopathologic impacts of everolimus introduction on kidney transplant recipients.,"T Nakamura, H Ushigome, T Takata, T Nakao, S Harada, K Koshino, T Suzuki, T Ito, S Nobori, N Yoshimura, T Nakamuraet al.",2015 Apr,Transplant Proc,https://pubmed.ncbi.nlm.nih.gov/25891700/,No keywords found,"['introduction', 'of', 'everolimus', '(', 'rad', ')', 'established', 'new', 'immunosuppressive', 'medication', 'kidney', 'transplant', '(', 'kt', ')', 'recipient', '.', 'administration', 'of', 'rad', 'capable', 'of', 'reducing', 'dosage', 'of', 'coadministrated', 'calcineurin', 'inhibitor', '(', 'cni', ')', '.', 'however', ',', 'histological', 'investigation', 'rarely', 'performed', '.', 'method', 'to', 'clarify', 'histopathologic', 'effect', 'of', 'rad', ',', 'total', 'of', 'adult', 'kt', 'recipient', 'enrolled', '(', 'rad', 'group', ',', 'n', 'mycophenolate', 'mofetil', '(', 'mmf', ')', 'group', ',', 'n', ')', '.', 'renal', 'graft', 'biopsy', 'performed', 'week', 'and', 'year', 'following', 'kt', '.', 'result', 'no', 'difference', 'in', '-', ',', '-', ',', 'and', '-year', 'graft', 'survival', 'rate', '(', 'rad', 'group', ',', ',', 'and', ',', 'respectively', 'mmf', 'group', ',', ',', 'and', ',', 'respectively', ')', ',', 'and', 'patient', 'survival', 'group', '(', 'no', 'death', 'year', 'post-transplantation', ')', '.', 'interestingly', ',', 'although', 'patient', 'in', 'rad', 'group', 'developed', 'cni', 'nephrotoxicity', 'clinically', ',', 'renal', 'biopsy', 'proven', 'no', 'cni-related', 'lesion', 'year', 'later', ',', 'might', 'due', 'to', 'reduction', 'in', 'cni', '.', 'hand', ',', 'patient', ',', 'in', 'mmf', 'group', ',', 'diagnosed', 'histologically', 'with', 'new-onset', 'cni', 'nephrotoxicity', 'year', 'following', 'kt', '.', 'importantly', ',', 'frequency', 'and', 'mean', 'arteriolar', 'hyalinosis', '(', 'ah', ')', 'score', ',', 'reflect', 'cni', 'nephrotoxicity', ',', 'significantly', 'higher', 'in', 'mmf', 'group', '-year', 'biopsy', '(', 'p', '.', ',', 'p', '.', ')', '.', 'two', 'patient', 'in', 'rad', 'group', 'improved', 'ah', 'score', 'week', 'and', 'year', '.', 'conclusion', 'pathological', 'finding', 'revealed', 'reversible', 'cni', 'nephrotoxicity', 'improved', 'rad', 'with', 'reduced', 'cni', 'maintenance', 'therapy', '.', 'reasonable', 'to', 'believe', ',', 'therefore', ',', 'introduction', 'of', 'rad', 'useful', 'patient', 'diagnosed', 'with', 'cni', 'nephrotoxicity', '.']"
Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin.,"Omary M S Minzi, Tatu E Lyimo, Francis F Furia, Alphonce I Marealle, Manase Kilonzi, George M Bwire, Christina Malichewe, Omary M S Minziet al.",2020 Sep 23,BMC Pharmacol Toxicol,https://pubmed.ncbi.nlm.nih.gov/32967726/,No keywords found,"['cisplatin', 'important', 'drug', 'in', 'treatment', 'of', 'various', 'cancer', '.', 'however', ',', 'drug', 'cause', 'nephrotoxicity', 'linked', 'to', 'electrolyte', 'derangement', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'effect', 'of', 'electrolyte', 'supplementation', 'in', 'reducing', 'kidney', 'injury', 'in', 'patient', 'receiving', 'cisplatin-based', 'regimen', '.', 'method', 'non-randomized', 'interventional', 'study', 'conducted', 'ocean', 'road', 'cancer', 'institute', '(', 'orci', ')', 'among', 'patient', 'with', 'confirmed', 'solid', 'tumor', '.', 'patient', 'received', 'cisplatin-based', 'chemotherapy', 'dose', 'of', 'mg', 'with', 'intravenous', 'normal', 'saline', 'supplemented', 'with', 'magnesium', ',', 'calcium', 'and', 'potassium', '(', 'triple', 'electrolyte', 'supplementation', ')', 'compared', 'with', 'received', 'cisplatin-based', 'chemotherapy', 'with', 'normal', 'saline', 'alone', '.', 'patient', 'followed', 'week', 'and', 'serum', 'creatinine', 'measured', 'every', 'visit', '.', 'nephrotoxicity', 'defined', 'serum', 'creatinine', 'elevation', '.', 'time', 'baseline', '.', 'result', 'total', 'of', 'patient', 'recruited', ',', 'whereby', 'patient', '(', '.', ')', 'received', 'electrolyte', 'supplementation', '(', 'treatment', 'group', ')', 'and', 'patient', '(', '.', ')', 'not', 'receive', 'electrolyte', 'supplementation', '(', 'control', 'group', ')', '.', 'incidence', 'risk', 'of', 'nephrotoxicity', '.', '(', 'n', ')', 'in', 'treatment', 'group', 'and', '(', 'n', ')', 'in', 'control', 'group', '.', 'patient', 'in', 'control', 'group', '.', 'time', 'likely', 'to', 'experience', 'nephrotoxicity', 'compared', 'to', 'treatment', 'group', 'relative', 'risk', '(', 'rr', ')', '.', ',', 'ci', '.-.', ',', 'p', '..', 'common', 'malignancy', 'cervical', 'cancer', ',', 'n', '(', '.', ')', 'in', 'treatment', 'group', 'and', 'n', '(', '.', ')', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'kaplan-meier', 'analysis', 'and', 'log-rank', 'test', 'revealed', 'electrolyte', 'supplementation', 'associated', 'with', 'extended', 'survival', 'with', 'less', 'nephrotoxicity', 'incidence', 'p', '.', 'hazard', 'ratio', '(', 'hr', ')', '.', 'ci', '.', 'to', '..', 'conclusion', 'electrolyte', 'supplementation', 'decrease', 'risk', 'of', 'nephrotoxicity', 'chemotherapy', 'with', 'cisplatin', '.', 'randomized', 'controlled', 'trial', 'with', 'larger', 'sample', 'size', 'recommended', 'to', 'evaluate', 'robustness', 'of', 'finding', '.']"
Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials.,"Tiziana Bove, Alessandro Belletti, Alessandro Putzu, Simone Pappacena, Giuseppe Denaro, Giovanni Landoni, Sean M Bagshaw, Alberto Zangrillo, Tiziana Boveet al.",2018 Apr 24,PLoS One,https://pubmed.ncbi.nlm.nih.gov/29689116/,No keywords found,"['furosemide', 'common', 'loop', 'diuretic', 'used', 'worldwide', '.', 'off-label', 'administration', 'of', 'furosemide', 'bolus', '(', 'e', ')', 'prevention', 'or', 'to', 'reverse', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'widespread', 'not', 'supported', 'available', 'evidence', '.', 'conducted', 'meta-analysis', 'of', 'randomized', 'trial', '(', 'rcts', ')', 'to', 'investigate', 'whether', 'bolus', 'furosemide', 'to', 'prevent', 'or', 'treat', 'aki', 'detrimental', 'patient', ""'"", 'survival', '.', 'method', 'electronic', 'database', 'searched', 'october', 'rcts', 'comparing', 'bolus', 'furosemide', 'administration', 'versus', 'comparator', 'in', 'patient', 'with', 'or', 'risk', 'aki', '.', 'primary', 'endpoint', 'all-cause', 'longest', 'follow-up', 'mortality', '.', 'secondary', 'endpoint', 'included', 'new', 'or', 'worsening', 'aki', ',', 'receipt', 'of', 'renal', 'replacement', 'therapy', ',', 'length', 'of', 'hospital', 'stay', ',', 'and', 'peak', 'serum', 'creatinine', 'randomization', '.', 'result', 'total', 'of', 'study', 'randomizing', ',', 'patient', 'included', 'in', 'analysis', '.', 'found', 'no', 'difference', 'in', 'mortality', 'two', 'group', '(', 'in', 'furosemide', 'group', 'versus', 'in', 'control', 'group', 'odds', 'ratio', 'or', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'secondary', 'outcome', 'found', '.', 'significant', 'improvement', 'in', 'survival', 'found', 'in', 'subgroup', 'of', 'patient', 'receiving', 'furosemide', 'bolus', '(', 'e', ')', 'preventive', 'measure', '(', '.', 'versus', '.', ',', 'or', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'intermittent', 'furosemide', 'administration', 'not', 'associated', 'with', 'increased', 'mortality', 'in', 'patient', 'with', 'or', 'risk', 'aki', ',', 'although', 'may', 'reduce', 'mortality', 'used', 'preventive', 'measure', '.', 'future', 'high-quality', 'rcts', 'needed', 'to', 'define', 'role', 'of', 'loop', 'diuretic', 'in', 'aki', 'prevention', 'and', 'management', '.', 'trial', 'registration', 'study', 'protocol', 'registered', 'prospero', 'database', 'systematic', 'review', '(', 'registration', 'no', '.', 'crd', '-', 'httpwww.crd.york.ac.ukprosperodisplayrecord.phpidcrd', ')', '.']"
"Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.","Mohamed Farouk Ahmed Abdelsalam, Maged Salah Abdalla, Hanan Salah El-Din El-Abhar, Mohamed Farouk Ahmed Abdelsalamet al.",2018 Dec:15:127-135.,J Glob Antimicrob Resist,https://pubmed.ncbi.nlm.nih.gov/30010061/,No keywords found,"['in', 'clinical', 'practice', ',', 'colistin', 'used', 'combination', 'therapy', 'to', 'improve', 'antibacterial', 'activity', ',', 'despite', 'consequent', 'increase', 'in', 'toxicity', '.', 'prospective', ',', 'comparative', 'study', 'evaluated', 'effectiveness', 'and', 'adverse', 'effect', 'of', 'using', 'colistin', 'alone', 'loading', 'dose', 'of', 'million', 'international', 'unit', '(', 'miu', ')', 'followed', 'miu', 'every', 'h', '(', 'qh', ')', 'versus', 'colistinmeropenem', 'g', 'qh', 'in', 'treating', 'multidrug-resistant', '(', 'mdr', ')', 'klebsiella', 'pneumoniae-induced', 'hospital-acquired', 'pneumonia', '(', 'hap', ')', 'or', 'ventilator-associated', 'pneumonia', '(', 'vap', ')', '.', 'primary', 'outcome', 'measure', 'in-hospital', 'mortality', '.', 'secondary', 'measure', 'occurrence', 'of', 'colistin', 'toxicity', '.', 'method', 'total', 'of', 'patient', 'divided', 'two', 'group', '(', 'patient', ')', 'first', 'group', 'received', 'intravenous', 'colistin', 'mean', 'daily', 'dose', 'of', '.', 'miu', 'and', 'second', 'group', 'received', 'colistin', '.', 'miu', 'combined', 'with', 'meropenem', '(', 'mean', 'daily', 'dose', 'of', '.g', 'day', ')', '.', 'result', 'colistin-meropenem', 'combination', 'group', 'showed', 'significant', 'decrease', 'in', 'mortality', 'versus', 'colistin', 'alone', '.', '(', ')', 'vs.', '.', '(', ')', 'p', '..', 'improved', 'clinical', 'response', 'mediated', 'combination', 'therapy', 'not', 'associated', 'with', 'significant', 'nephrotoxicity', ',', 'hepatotoxicity', 'or', 'neurotoxicity', '.', 'moreover', ',', 'surviving', 'patient', 'showed', 'normal', 'procalcitonin', 'value', 'associated', 'with', 'decrease', 'in', 'sofa', 'score', ',', 'whilst', 'of', 'showed', 'significantly', 'elevated', 'c-reactive', 'protein', '(', 'crp', ')', '(', 'p.', ')', '.', 'conclusion', 'study', 'revealed', 'superiority', 'of', 'colistin-meropenem', 'combination', 'therapy', 'colistin', 'monotherapy', 'in', 'treatment', 'of', 'mdr', 'k.', 'pneumoniae-induced', 'hap', 'or', 'vap', 'and', 'highlight', 'advantage', 'of', 'procalcitonin', 'crp', 'marker', 'eradication', 'of', 'sepsis', 'and', 'suspension', 'of', 'therapy', '.']"
A norepinephrine weaning strategy using dynamic arterial elastance is associated with reduction of acute kidney injury in patients with vasoplegia after cardiac surgery: A post-hoc analysis of the randomized SNEAD study.,"Pierre-Grégoire Guinot, Pierre Huette, Belaid Bouhemad, Osama Abou-Arab, Maxime Nguyen, Pierre-Grégoire Guinotet al.",2023 Sep:88:111124.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/37099874/,No keywords found,"['to', 'evaluate', 'impact', 'of', 'dynamic', 'arterial', 'elastance', 'guided', 'norepinephrine', 'weaning', 'strategy', 'occurrence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'with', 'vasoplegia', 'cardiac', 'surgery', '.', 'design', 'post-hoc', 'analysis', 'of', 'monocentric', 'randomized', 'controlled', 'trial', '.', 'setting', 'tertiary', 'care', 'hospital', 'in', 'france', '.', 'participant', 'vasoplegic', 'cardiac', 'surgical', 'patient', 'treated', 'with', 'norepinephrine', '.', 'intervention', 'patient', 'randomized', 'to', 'algorithm-based', 'norepinephrine', 'weaning', 'intervention', '(', 'dynamic', 'arterial', 'elastance', ')', 'group', 'or', 'control', 'group', '.', 'measurement', 'primary', 'endpoint', 'number', 'of', 'patient', 'with', 'aki', 'defined', 'according', 'to', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'criterion', '.', 'secondary', 'endpoint', 'major', 'adverse', 'cardiac', 'post-operative', 'event', '(', 'new', 'onset', 'of', 'atrial', 'fibrillation', 'or', 'flutter', ',', 'low', 'cardiac', 'output', 'syndrome', ',', 'and', 'in-hospital', 'death', ')', '.', 'end', 'point', 'evaluated', 'first', 'seven', 'post-operative', 'day', '.', 'result', 'patient', 'analyzed', '.', 'in', 'overall', 'study', 'population', ',', 'mean', 'age', '(', '-', ')', 'year', ',', 'male', 'and', 'median', 'euroscore', '(', '-', ')', '.', 'overall', ',', '(', ')', 'patient', 'developed', 'aki', '(', 'kdigo', ',', 'kdigo', ',', 'kdigo', ')', ',', 'and', 'patient', 'required', 'renal', 'replacement', 'therapy', '.', 'incidence', 'of', 'aki', 'significantly', 'lower', 'in', 'intervention', 'group', 'in', 'control', 'group', '(', 'patient', '(', ')', 'v', 'patient', '(', ')', ',', 'p', '.', ')', '.', 'higher', 'dose', 'and', 'longer', 'duration', 'of', 'norepinephrine', 'associated', 'with', 'aki', 'severity', '.', 'conclusion', 'decreasing', 'norepinephrine', 'exposure', 'using', 'dynamic', 'arterial', 'elastance', 'guided', 'norepinephrine', 'weaning', 'strategy', 'associated', 'with', 'reduced', 'incidence', 'of', 'acute', 'kidney', 'injury', 'in', 'patient', 'with', 'vasoplegia', 'cardiac', 'surgery', '.', 'prospective', 'multicentric', 'study', 'needed', 'to', 'confirm', 'result', '.']"
Protective effect of dexmedetomidine on kidney injury of parturients with preeclampsia undergoing cesarean section: a randomized controlled study.,"Qing-Lin Zhang, Lei Wang, Ming-Jun Xu, Tian-Long Wang, Qing-Lin Zhanget al.",2019 May 3,Biosci Rep,https://pubmed.ncbi.nlm.nih.gov/30962264/,"Dexmedetomidine, SpO2, kidney injury, preeclampsia, urine protein, β2-MG.","['present', 'study', 'aimed', 'to', 'elucidate', 'effect', 'of', 'dexmedetomidine', 'kidney', 'injury', 'of', 'parturients', 'with', 'preeclampsia', '(', 'pe', ')', 'undergoing', 'cesarean', 'section', '.', 'total', 'cesarean', 'delivery', 'woman', 'with', 'pe', 'randomly', 'divided', 'intervention', 'group', '(', 'ig', ')', 'and', 'control', 'group', '(', 'cg', ')', '.', 'group', 'underwent', 'combined', 'spinal', 'and', 'epidural', 'anesthesia', '(', 'csea', ')', ',', 'ig', 'treated', 'with', '.', 'g', '(', 'kgmin', ')', 'dexmedetomidine', 'min', 'surgery', '.', 'cg', 'treated', 'with', 'equivalent', 'saline', '.', 'heart', 'rate', '(', 'hr', ')', ',', 'blood', 'pressure', ',', 'oxygen', 'saturation', '(', 'spo', ')', 'of', 'two', 'group', 'measured', 'different', 'time', 'point', 'administration', '.', 'level', 'of', 'inflammatory', 'factor', 'detected', 'enzyme-linked', 'immunosorbent', 'assay', '(', 'elisa', ')', '.', 'visual', 'analogue', 'score', '(', 'va', ')', ',', 'ramsay', 'sedation', 'score', '(', 'rss', ')', ',', 'and', 'kidney', 'injury', 'related', 'index', 'evaluated', 'different', 'time', 'point', '.', 'plasma-drug', 'concentration', 'of', 'patient', 'determined', 'high', 'performance', 'liquid', 'chromatography', '(', 'hplc', ')', 'method', '.', 'compared', 'with', 'cg', ',', 'hr', ',', 'pe', ',', 'and', 'diastolic', 'blood', 'pressure', '(', 'dbp', ')', 'showed', 'lower', 'level', 'spo', 'showed', 'higher', 'level', 'in', 'ig', '.', 'furthermore', ',', 'expression', 'of', 'tumor', 'necrosis', 'factor', '(', 'tnf-', ')', ',', 'interleukin-', '(', 'il-', ')', ',', 'and', 'il-', 'in', 'ig', 'decreased', 'drug', 'administration', ',', 'content', 'of', '-mg', ',', 'kim-', 'and', 'urine', 'protein', 'also', 'decreased', 'in', 'contrast', 'to', 'cg', '(', 'p.', ')', '.', 'besides', ',', 'va', 'score', 'decreased', 'ramsay', 'score', 'increased', 'in', 'ig', '(', 'p.', ')', '.', 'result', 'of', 'hplc', 'showed', 'half', 'life', 'of', 'dexmedetomidine', 'min', 'and', 'speculated', 'drug', 'quickly', 'metabolized', 'within', 'h.', 'dexmedetomidine', 'exerted', 'protective', 'effect', 'kidney', 'injury', 'of', 'parturients', 'with', 'pe', 'undergoing', 'cesarean', 'section', '.']"
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.,"David T Woodley, Michelle Hao, Andrew Kwong, Brandon Levian, Jon Cogan, Yingping Hou, Daniel Mosallaei, Elana Kleinman, Kate Zheng, Claire Chung, Gene Kim, David Peng, Mei Chen, David T Woodleyet al.",2024 Jul 16,Br J Dermatol,https://pubmed.ncbi.nlm.nih.gov/38366625/,No keywords found,"['recessive', 'dystrophic', 'epidermolysis', 'bullosa', '(', 'rdeb', ')', 'incurable', 'widespread', 'blistering', 'skin', 'disorder', 'caused', 'mutation', 'in', 'gene', 'encoding', 'type', 'vii', 'collagen', '(', 'c', ')', ',', 'major', 'component', 'of', 'anchoring', 'fibril', '.', 'objective', 'to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'intravenous', '(', 'iv', ')', 'gentamicin', 'readthrough', 'therapy', 'in', 'patient', 'with', 'rdeb', 'harbouring', 'nonsense', 'mutation', '.', 'primary', 'outcome', 'increased', 'expression', 'of', 'c', 'in', 'patient', ""'"", 'skin', 'and', 'safety', 'assessment', '(', 'ototoxicity', ',', 'nephrotoxicity', ',', 'autoimmune', 'response', ')', 'secondary', 'outcome', 'included', 'measuring', 'wound', 'healing', 'in', 'target', 'wound', 'and', 'assessment', 'validated', 'epidermolysis', 'bullosa', 'disease', 'activity', 'and', 'scarring', 'index', '(', 'ebdasi', ')', 'scoring', 'system', '.', 'method', 'open-label', 'pilot', 'trial', 'to', 'assess', 'two', 'different', 'iv', 'gentamicin', 'regimen', 'august', 'and', 'march', 'with', 'follow-up', 'to', 'day', 'post-treatment', 'carried', '.', 'three', 'patient', 'with', 'rdeb', 'with', 'confirmed', 'nonsense', 'mutation', 'in', 'cola', 'in', 'either', 'one', 'or', 'two', 'allele', 'and', 'decreased', 'baseline', 'expression', 'of', 'c', 'dermal-epidermal', 'junction', '(', 'dej', ')', 'of', 'skin', 'participated', 'in', 'study', '.', 'three', 'patient', 'received', 'gentamicin', '.', 'mg', 'kg-', 'daily', 'day', 'and', 'two', 'of', 'three', 'patient', 'received', '.', 'mg', 'kg-', 'iv', 'gentamicin', 'twice', 'weekly', 'week', '.', 'patient', 'pre-existing', 'auditory', 'or', 'renal', 'impairment', ',', 'currently', 'using', 'ototoxic', 'or', 'nephrotoxic', 'medication', ',', 'or', 'allergy', 'to', 'aminoglycosides', 'or', 'sulfate', 'compound', 'excluded', '.', 'result', 'gentamicin', 'treatment', ',', 'skin', 'biopsy', 'three', 'patient', '(', 'age', 'range', '-', 'year', ')', 'exhibited', 'increased', 'c', 'in', 'dej', '.', 'with', 'regimen', ',', 'new', 'c', 'persisted', 'least', 'month', 'post-treatment', '.', 'and', 'month', 'post-treatment', ',', 'of', 'monitored', 'wound', 'exhibited', 'closure', '.', 'iv', 'gentamicin', 'infusion', 'regimen', 'decreased', 'ebdasi', 'total', 'activity', 'score', '.', 'of', 'patient', 'assessed', 'with', 'ebdasi', ',', 'exhibited', 'decreased', 'total', 'activity', 'score', 'month', 'post-treatment', '.', 'three', 'patient', 'completed', 'study', 'no', 'adverse', 'effect', 'or', 'anti-c', 'antibody', 'detected', '.', 'conclusion', 'iv', 'gentamicin', 'induced', 'readthrough', 'of', 'nonsense', 'mutation', 'in', 'patient', 'with', 'rdeb', 'and', 'restored', 'functional', 'c', 'in', 'skin', ',', 'enhanced', 'wound', 'healing', 'and', 'improved', 'clinical', 'parameter', '.', 'iv', 'gentamicin', 'may', 'safe', ',', 'efficacious', ',', 'low-cost', 'and', 'readily', 'available', 'treatment', 'population', 'of', 'patient', 'with', 'rdeb', '.']"
Isotonic balanced fluid versus 0.9% saline in patients with moderate to severe traumatic brain injury: A double-blinded randomised controlled trial.,"Khadijah Poh, Aida Bustam, Mohd Shahnaz Hasan, Nor'azim Mohd Yunos, Chun Yoong Cham, Fang Jen Lim, Ahmad Zulkarnain Ahmad Zahedi, Aliyah Zambri, Muhaimin Noor Azhar, Khadijah Pohet al.",2024 Mar:77:106-114.,Am J Emerg Med,https://pubmed.ncbi.nlm.nih.gov/38118385/,No keywords found,"['traumatic', 'brain', 'injury', '(', 'tbi', ')', 'global', 'health', 'concern', 'with', 'significant', 'economic', 'impact', '.', 'optimal', 'fluid', 'therapy', 'aim', 'to', 'restore', 'intravascular', 'volume', ',', 'maintain', 'cerebral', 'perfusion', 'pressure', 'and', 'blood', 'flow', ',', 'thus', 'preventing', 'secondary', 'brain', 'injury', '.', '.', 'saline', '(', 'n', ')', 'commonly', 'used', ',', 'concern', 'acid-base', 'and', 'electrolyte', 'imbalance', 'and', 'development', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'lead', 'to', 'consideration', 'of', 'balanced', 'fluid', 'alternative', '.', 'objective', 'study', 'aimed', 'to', 'compare', 'outcome', 'of', 'patient', 'with', 'moderate', 'to', 'severe', 'tbi', 'treated', 'with', 'sterofundin', '(', 'sf', ')', 'versus', 'n', '.', 'design', ',', 'setting', 'and', 'participant', 'double-blinded', 'randomised', 'controlled', 'trial', 'of', 'patient', 'aged', 'to', 'year', 'with', 'tbi', 'conducted', 'university', 'malaya', 'medical', 'centre', 'february', 'to', 'november', '.', 'intervention', 'or', 'exposure', 'patient', 'randomly', 'assigned', 'to', 'receive', 'either', 'n', 'or', 'sf', '.', 'study', 'fluid', 'administered', 'h', 'continuous', 'infusion', 'or', 'bolus', '.', 'participant', ',', 'investigator', ',', 'and', 'staff', 'blinded', 'to', 'fluid', 'type', '.', 'outcome', 'measure', 'and', 'analysis', 'primary', 'outcome', 'in-hospital', 'mortality', '.', 'relative', 'risk', '(', 'rr', ')', 'with', 'confidence', 'interval', '(', 'ci', ')', 'calculated', '.', 'main', 'result', 'total', 'of', 'patient', 'included', 'in', 'analysis', ',', 'with', 'in', 'n', 'group', 'and', 'in', 'sf', 'group', '.', 'in-hospital', 'mortality', 'rate', '(', '.', ')', 'in', 'n', 'group', 'v', '.', '(', '.', ')', 'in', 'sf', 'group', ',', 'rr', '.', '(', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'no', 'patient', 'developed', 'aki', 'and', 'required', 'renal', 'replacement', 'therapy', '.', 'icp', 'day', 'significantly', 'higher', 'in', 'sf', 'group', '(', '.', '.', ')', 'compared', 'to', '.', '.', 'in', 'n', 'group', ',', '(', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', '-day', 'biochemical', 'parameter', 'and', 'cerebral', 'perfusion', 'pressure', ',', 'ventilator-free', 'day', ',', 'length', 'of', 'icu', 'stay', ',', 'or', 'glasgow', 'outcome', 'scale-extended', '(', 'gos-e', ')', 'score', 'month', '.', 'conclusion', 'in', 'patient', 'with', 'moderate', 'to', 'severe', 'tbi', ',', 'use', 'of', 'sf', 'not', 'associated', 'with', 'reduced', 'in-hospital', 'mortality', ',', 'development', 'of', 'aki', ',', 'or', 'improved', '-month', 'gos-e', 'compared', 'to', 'n', '.']"
Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study.,"Julien Taieb, Sara Lonardi, Jayesh Desai, Gunnar Folprecht, Claire Gallois, Eduardo Polo Marques, Sadya Khan, Claire Castagné, Harpreet Wasan, Julien Taiebet al.",2023 Mar,Clin Colorectal Cancer,https://pubmed.ncbi.nlm.nih.gov/36653241/,No keywords found,"['braf', 'inhibitor', 'encorafenib', 'in', 'combination', 'with', 'cetuximab', 'recently', 'approved', 'patient', 'with', 'brafve-mutated', '(', 'brafvemut', ')', 'metastatic', 'colorectal', 'cancer', '(', 'mcrc', ')', '.', 'approval', 'based', 'positive', 'result', 'phase', 'beacon', 'crc', 'study', 'in', 'brafvemut', 'mcrc', 'patient', 'progressed', '-', 'previous', 'regimen', '.', 'analysis', 'provides', 'detailed', 'examination', 'of', 'adverse', 'event', '(', 'aes', ')', 'of', 'interest', '(', 'aeis', ')', 'with', 'encorafenibcetuximab', 'in', 'beacon', 'study', 'to', 'aid', 'gastrointestinal', 'oncologist', ',', 'given', 'limited', 'experience', 'with', 'combination', '.', 'material', 'and', 'method', 'aeis', ',', 'including', 'dermatological', 'aes', ',', 'arthralgiamyalgia', ',', 'nauseavomiting', ',', 'diarrhea', ',', 'abdominal', 'pain', ',', 'fatigueasthenia', 'and', 'nephrotoxicity', ',', 'examined', 'in', 'doublet', 'therapy', 'group', '.', 'clinical', 'characteristic', 'associated', 'with', 'aes', ',', 'ae', 'grade', ',', 'time', 'to', 'onset', 'and', 'time', 'to', 'resolution', 'also', 'studied', '.', 'result', 'safety', 'analysis', 'included', 'patient', 'randomized', 'to', 'doublet', 'therapy', '.', 'commonly', 'occurring', 'aei', 'dermatological', 'toxicity', '(', '.', ')', ',', 'followed', 'arthralgiamyalgia', '(', '.', ')', 'and', 'fatigueasthenia', '(', '.', ')', '.', 'nephrotoxicity', '(', 'patient', 'with', 'grade', 'or', ')', ',', 'aes', 'grade', 'or', '.', 'aes', 'common', 'in', 'woman', 'men', '(', 'nauseavomiting', ',', 'diarrhea', ',', 'abdominal', 'pain', ',', 'dermatological', 'aes', ',', 'and', 'arthralgiamyalgia', ')', '.', 'nauseavomiting', ',', 'abdominal', 'pain', 'and', 'fatigueasthenia', 'common', 'in', 'patient', 'aged', 'year', '.', 'aes', 'developed', 'early', ',', 'within', 'first', '-', 'month', 'of', 'treatment', ',', 'and', 'resolved', 'within', '-', 'week', '.', 'in', 'addition', ',', 'survival', 'outcome', 'better', 'in', 'patient', 'experiencing', 'arthralgiamyalgia', 'or', 'dermatological', 'toxicity', '.', 'conclusion', 'analysis', 'indicated', ',', 'except', 'rare', 'case', 'of', 'nephrotoxicity', ',', 'encorafenibcetuximab', 'well', 'tolerated', 'in', 'patient', ',', 'with', 'aeis', 'mild-to-moderate', 'in', 'severity', ',', 'occurring', 'early', 'and', 'resolving', 'rapidly', '.', 'clinical', 'trial', 'registration', 'beacon', 'study', '(', 'clinicaltrials.gov', ',', 'nct', 'eudract', ',', '--', ')', '.']"
"Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.","Anthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, Giovanni DiPerri, Jan Van Lunzen, Ellen Koenig, Richard Elion, Matthias Cavassini, Jose Valdez Madruga, Jason Brunetta, David Shamblaw, Edwin DeJesus, Chloe Orkin, David A Wohl, Indira Brar, Jeffrey L Stephens, Pierre-Marie Girard, Gregory Huhn, Andrew Plummer, Ya-Pei Liu, Andrew K Cheng, Scott McCallister                              ;, GS-US-- team, Anthony Millset al.",2016 Jan,Lancet Infect Dis,https://pubmed.ncbi.nlm.nih.gov/26538525/,No keywords found,"['antiretroviral', 'regimen', 'containing', 'tenofovir', 'disoproxil', 'fumarate', 'associated', 'with', 'renal', 'toxicity', 'and', 'reduced', 'bone', 'mineral', 'density', '.', 'tenofovir', 'alafenamide', 'novel', 'tenofovir', 'prodrug', 'reduces', 'tenofovir', 'plasma', 'concentration', ',', 'thereby', 'decreasing', 'off-target', 'side-effects', '.', 'aimed', 'to', 'assess', 'whether', 'efficacy', ',', 'safety', ',', 'and', 'tolerability', 'non-inferior', 'in', 'patient', 'switched', 'to', 'regimen', 'containing', 'tenofovir', 'alafenamide', 'versus', 'in', 'remaining', 'one', 'containing', 'tenofovir', 'disoproxil', 'fumarate', '.', 'method', 'in', 'randomised', ',', 'actively', 'controlled', ',', 'multicentre', ',', 'open-label', ',', 'non-inferiority', 'trial', ',', 'recruited', 'hiv', '--', 'infected', 'adult', 'gilead', 'clinical', 'study', 'site', 'in', 'country', '.', 'patient', 'virologically', 'suppressed', '(', 'hiv-', 'rna', 'copy', 'per', 'ml', ')', 'with', 'estimated', 'glomerular', 'filtration', 'rate', 'of', 'ml', 'per', 'min', 'or', 'greater', ',', 'and', 'taking', 'one', 'of', 'four', 'tenofovir', 'disoproxil', 'fumarate-containing', 'regimen', 'least', 'week', 'enrolment', '.', 'with', 'use', 'of', 'third-party', 'computer-generated', 'sequence', ',', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'once-a-day', 'single-tablet', 'containing', 'elvitegravir', 'mg', ',', 'cobicistat', 'mg', ',', 'emtricitabine', 'mg', ',', 'and', 'tenofovir', 'alafenamide', 'mg', '(', 'tenofovir', 'alafenamide', 'group', ')', 'or', 'to', 'carry', 'taking', 'one', 'of', 'four', 'previous', 'tenofovir', 'disoproxil', 'fumarate-containing', 'regimen', '(', 'tenofovir', 'disoproxil', 'fumarate', 'group', ')', 'week', '.', 'randomisation', 'stratified', 'previous', 'treatment', 'regimen', 'in', 'block', 'of', 'six', '.', 'patient', 'and', 'treating', 'physician', 'not', 'masked', 'to', 'assigned', 'study', 'regimen', 'outcome', 'assessor', 'masked', 'database', 'lock', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', 'undetectable', 'viral', 'load', '(', 'hiv-', 'rna', 'copy', 'per', 'ml', ')', 'week', '.', 'non-inferiority', 'margin', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'april', ',', 'and', 'april', ',', ',', 'enrolled', 'patient', '.', 'patient', 'randomly', 'assigned', 'to', 'tenofovir', 'alafenamide', 'group', 'and', 'to', 'tenofovir', 'disoproxil', 'fumarate', 'group', '.', 'viral', 'suppression', 'week', 'noted', 'in', '(', ')', 'patient', 'assigned', 'to', 'tenofovir', 'alafenamide', 'group', 'and', 'in', '(', ')', 'assigned', 'to', 'tenofovir', 'disoproxil', 'fumarate', 'group', '(', 'adjusted', 'difference', ',', 'ci', '-', ')', ',', 'with', 'virological', 'failure', 'noted', 'in', 'ten', 'and', 'six', 'patient', ',', 'respectively', '.', 'number', 'of', 'adverse', 'event', 'similar', 'two', 'group', ',', 'study', 'drug-related', 'adverse', 'event', 'common', 'in', 'tenofovir', 'alafenamide', 'group', '(', 'patient', 'v', ')', '.', 'hip', 'and', 'spine', 'bone', 'mineral', 'density', 'and', 'glomerular', 'filtration', 'significantly', 'improved', 'in', 'patient', 'in', 'tenofovir', 'alafenamide', 'group', 'compared', 'with', 'in', 'tenofovir', 'disoproxil', 'fumarate', 'group', '.', 'interpretation', 'switching', 'to', 'tenofovir', 'alafenamide-containing', 'regimen', 'one', 'containing', 'tenofovir', 'disoproxil', 'fumarate', 'non-inferior', 'maintenance', 'of', 'viral', 'suppression', 'and', 'led', 'to', 'improved', 'bone', 'mineral', 'density', 'and', 'renal', 'function', '.', 'longer', 'term', 'follow-up', 'needed', 'to', 'better', 'understand', 'clinical', 'impact', 'of', 'change', '.', 'funding', 'gilead', 'science', '.']"
Chronic pain and analgesic use in CKD: implications for patient safety.,"Juliana Wu, Jennifer S Ginsberg, Min Zhan, Clarissa J Diamantidis, Jingjing Chen, Corinne Woods, Jeffrey C Fink, Juliana Wuet al.",2015 Mar 6,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/25710806/,No keywords found,"['chronic', 'pain', 'in', 'predialysis', 'ckd', 'not', 'fully', 'understood', '.', 'study', 'examined', 'chronic', 'pain', 'in', 'ckd', 'and', 'relationship', 'with', 'analgesic', 'usage', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'data', 'include', 'baseline', 'visit', 'patient', 'with', 'ckd', 'enrolled', 'and', 'in', 'safe', 'kidney', 'care', 'cohort', 'study', 'in', 'baltimore', ',', 'maryland', '.', 'wong-baker', 'face', 'pain', 'rating', 'scale', 'measured', 'chronic', 'pain', 'severity', '.', 'analgesic', 'prescription', 'and', 'over-the-counter', 'purchase', 'recorded', 'to', 'day', 'visit', ',', 'and', 'classified', 'drug-related', 'problem', '(', 'drp', ')', 'based', 'analgesic', ""'s"", 'nephrotoxicity', 'and', 'dose', 'appropriateness', 'participant', ""'"", 'egfr', '.', 'participant', 'sorted', 'pain', 'frequency', 'and', 'severity', 'and', 'categorized', 'ordinal', 'group', '.', 'analgesic', 'use', 'and', 'rate', 'of', 'analgesic', 'with', 'drp', 'reported', 'across', 'pain', 'group', '.', 'multivariate', 'regression', 'determined', 'factor', 'associated', 'with', 'chronic', 'pain', 'and', 'assessed', 'relationship', 'chronic', 'pain', 'and', 'analgesic', 'usage', '.', 'result', '(', '.', ')', 'participant', 'reported', 'chronic', 'pain', '.', 'factor', 'associated', 'with', 'pain', 'severity', 'included', 'arthritis', ',', 'taking', 'medication', ',', 'and', 'lower', 'physical', 'function', '.', 'use', 'of', 'nonsteroidal', 'anti-inflammatory', 'drug', 'reported', 'seven', 'participant', '(', '.', ')', 'with', 'no', 'chronic', 'pain', '.', 'mild', 'and', 'severe', 'chronic', 'pain', 'associated', 'with', 'analgesic', 'with', 'drp', ',', 'with', 'odds', 'ratio', 'of', '.', '(', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', 'and', '.', '(', 'ci', ',', '.', 'to', '.', ')', ',', 'respectively', '.', 'adjusted', 'rate', 'of', 'analgesic', 'with', 'drp', 'per', 'participant', 'increased', 'group', 'with', 'none', 'to', 'severe', 'chronic', 'pain', ',', 'with', 'rate', 'of', '.', '(', 'ci', ',', '.', 'to', '.', ')', ',', '.', '(', 'ci', ',', '.', 'to', '.', ')', 'and', '.', '(', 'ci', ',', '.', 'to', '.', ')', ',', 'respectively', '.', 'conclusion', 'chronic', 'pain', 'common', 'in', 'ckd', 'with', 'significant', 'relationship', 'severity', 'of', 'pain', 'and', 'proper', 'and', 'improper', 'analgesic', 'usage', '.', 'screening', 'chronic', 'pain', 'may', 'help', 'in', 'understanding', 'role', 'of', 'drps', 'in', 'delivery', 'of', 'safe', 'ckd', 'care', '.']"
Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial.,"Manoj Kumar, Sumit Kainth, Ashok Choudhury, Rakhi Maiwall, Lalita G Mitra, Vandana Saluja, Prashant Mohan Agarwal, Saggere Muralikrishna Shasthry, Ankur Jindal, Ankit Bhardwaj, Guresh Kumar, Shiv K Sarin, Manoj Kumaret al.",2019 Nov,Hepatol Int,https://pubmed.ncbi.nlm.nih.gov/31541422/,No keywords found,"['in', 'addition', 'to', 'portal', 'pressure', 'reducing', 'effect', ',', 'non-selective', 'beta', 'blocker', '(', 'nsbbs', ')', 'possible', 'immunomodulatory', 'and', 'effect', 'in', 'reducing', 'bacterial', 'translocation', '.', 'recently', ',', 'shown', 'patient', 'already', 'nsbbs', 'continued', '(', 'feasible', ')', ',', 'acute-on-chronic', 'liver', 'failure', '(', 'aclf', ')', 'develops', '.', ',', 'however', ',', 'remains', 'unknown', 'patient', 'with', 'aclf', 'and', 'no', 'or', 'small', 'esophageal', 'varix', 'presentation', 'benefit', 'use', 'of', 'nsbbs', '.', 'studied', 'efficacy', 'and', 'safety', 'of', 'carvedilol', 'in', 'patient', 'with', 'aclf', 'in', 'reducing', 'mortality', ',', 'variceal', 'bleeding', 'and', 'non-bleeding', 'complication', '.', 'method', 'patient', 'with', 'aclf', '(', 'with', 'no', 'or', 'small', 'esophageal', 'varix', 'and', 'hvpg', 'mmhg', ')', 'randomized', 'to', 'either', 'carvedilol', '(', 'n', ')', 'or', 'placebo', 'arm', '(', 'n', ')', '.', 'result', 'within', 'day', ',', '(', '.', ')', 'of', 'patient', 'in', 'carvedilol', 'group', 'and', '(', '.', ')', 'of', 'in', 'placebo', 'group', 'died', '(', 'p', '.', ')', '.', 'fewer', 'patient', 'in', 'carvedilol', 'compared', 'to', 'placebo', 'group', 'developed', 'acute', 'kidney', 'injury', '(', 'aki', ')', '(', '.', 'v', '.', ',', 'p', '.', 'and', 'spontaneous', 'bacterial', 'peritonitis', '(', 'sbp', ')', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'significantly', ',', 'patient', 'in', 'placebo', 'group', 'increase', 'in', 'apasl', 'aclf', 'research', 'consortium-aclf', 'grade', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', '-day', 'transplant-free', 'survival', 'rate', 'and', 'development', 'of', 'aki', ',', 'sbp', ',', 'non-sbp', 'infection', '(', 'including', 'pneumonia', ')', 'and', 'variceal', 'bleed', 'within', 'day', ',', 'two', 'group', '.', 'conclusion', 'in', 'aclf', 'patient', 'with', 'either', 'no', 'or', 'small', 'esophageal', 'varix', 'and', 'hvpg', 'mmhg', ',', 'carvedilol', 'lead', 'to', 'improved', 'survival', 'and', 'fewer', 'aki', 'and', 'sbp', 'event', 'to', 'day', '.', 'clinicaltrials', '.', 'gov', 'identifier', 'number', 'nct', '.']"
Effect of N-acetyl cysteine and vitamin C on kidney allograft function biomarkers interleukin-18 and neutrophil gelatinase-associated lipocalin.,"Zahra Sahraei, Jamshid Salamzadeh, Mohsen Nafar, Zahra Sahraeiet al.",2015 Jan,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/25599738/,No keywords found,"['delayed', 'graft', 'function', '(', 'dgf', ')', 'consequence', 'of', 'ischemia-reperfusion', 'injury', 'in', 'kidney', 'allograft', ',', 'no', 'definite', 'treatment', 'available', '.', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'interleukin-', '(', 'il-', ')', 'introduced', 'promising', 'urine', 'biomarkers', 'to', 'detect', 'dgf', '.', 'n-acetylcysteine', '(', 'nac', ')', 'and', 'vitamin', 'c', ',', 'well-known', 'potent', 'antioxidant', 'scavenge', 'free', 'radical', ',', 'may', 'alleviate', 'kidney', 'injury', '.', 'study', 'investigated', 'protective', 'effect', 'of', 'nac', 'alone', 'and', 'in', 'combination', 'with', 'vitamin', 'c', 'dgf', ',', 'measuring', 'il-', 'and', 'ngal', 'in', 'living', 'donor', 'kidney', 'transplantation', '.', 'material', 'and', 'method', 'patient', 'transplanted', 'january', 'and', 'february', 'randomly', 'divided', 'group', 'to', 'receive', 'routine', 'anti-rejection', 'medication', '(', 'n', ')', ',', 'nac', 'plus', 'routine', 'immunosuppressive', 'regimen', '(', 'nac', 'group', 'n', ')', ',', 'and', 'nac', 'and', 'vitamin', 'c', 'plus', 'routine', 'regimen', '(', 'nac', 'and', 'vitamin', 'c', 'group', 'n', ')', '.', 'urine', 'sample', 'taken', 'hour', 'and', 'hour', 'transplantation', '.', 'enzyme-linked', 'immunosorbent', 'assay', 'kit', 'utilized', 'measuring', 'urine', 'ngal', 'and', 'il-', '.', 'result', 'no', 'significant', 'difference', 'in', 'dgf', 'prevalence', 'and', 'duration', 'study', 'arm', '.', 'although', 'level', 'of', 'ngal', 'and', 'il-', 'decreased', 'in', 'nac', 'and', 'nac', 'and', 'vitamin', 'c', 'group', ',', 'reduction', 'not', 'significant', '.', 'glomerular', 'filtration', 'rate', 'and', 'day', 'transplantation', 'not', 'significantly', 'different', 'study', 'group', ',', 'either', '.', 'conclusion', 'result', 'showed', 'nac', 'safe', 'drug', 'without', 'significant', 'adverse', 'effect', 'in', 'kidney', 'transplant', 'recipient', 'however', ',', 'potential', 'useful', 'effect', 'urinary', 'biomarkers', 'of', 'dgf', 'not', 'illustrated', 'in', 'present', 'study', '.']"
"The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial.","Jonathan S Chávez-Iñiguez, Miguel Ibarra-Estrada, Sergio Sánchez-Villaseca, Gregorio Romero-González, Jorge J Font-Yañez, Andrés De la Torre-Quiroga, Andrés Aranda-G de Quevedo, Alexia Romero-Muñóz, Pablo Maggiani-Aguilera, Gael Chávez-Alonso, Juan Gómez-Fregoso, Guillermo García-García, Jonathan S Chávez-Iñiguezet al.",2022 Jan 3,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/34979962/,No keywords found,"['main', 'treatment', 'strategy', 'in', 'type', 'cardiorenal', 'syndrome', '(', 'cr', ')', 'vascular', 'decongestion', '.', 'probable', 'sequential', 'blockage', 'of', 'renal', 'tubule', 'with', 'combined', 'diuretic', '(', 'cd', ')', 'obtain', 'similar', 'benefit', 'compared', 'with', 'stepped-dose', 'furosemide', '(', 'sf', ')', '.', 'method', 'in', 'pilot', 'double-blind', 'randomized', 'controlled', 'trial', 'of', 'cr', 'patient', 'allocated', 'in', 'fashion', 'to', 'sf', 'or', 'cd', '.', 'sf', 'group', 'received', 'continuous', 'infusion', 'of', 'furosemide', 'mg', 'first', 'day', ',', 'with', 'daily', 'incremental', 'dos', 'to', 'mg', ',', 'mg', 'and', 'mg.', 'cd', 'group', 'received', 'combination', 'of', 'diuretic', ',', 'including', 'consecutive', 'day', 'of', 'oral', 'chlorthalidone', 'mg', ',', 'spironolactone', 'mg', 'and', 'infusion', 'of', 'furosemide', 'mg.', 'objective', 'to', 'assess', 'renal', 'function', 'recovery', 'and', 'variable', 'associated', 'with', 'vascular', 'decongestion', '.', 'result', 'july', 'to', 'february', ',', 'patient', 'randomized', ',', 'to', 'sf', 'and', 'to', 'cd', 'group', '.', 'group', 'similar', 'baseline', 'and', 'several', 'high-risk', 'feature', '.', 'mean', 'age', '.', 'year', ',', 'men', '(', '.', ')', '.', 'primary', 'endpoint', 'occurred', 'in', 'of', 'sf', 'group', 'and', '.', 'of', 'dc', 'group', '(', 'p', '.', ')', '.', 'secondary', 'and', 'exploratory', 'endpoint', 'similar', 'group', '.', 'adverse', 'event', 'occurred', 'frequently', '(', ')', 'with', 'no', 'difference', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'patient', 'with', 'cr', 'and', 'high', 'risk', 'of', 'resistance', 'to', 'diuretic', ',', 'use', 'of', 'cd', 'compared', 'to', 'sf', 'offer', 'result', 'in', 'renal', 'recovery', ',', 'diuresis', ',', 'vascular', 'decongestion', 'and', 'adverse', 'event', ',', 'and', 'considered', 'alternative', 'treatment', '.', 'clinicaltrials.gov', 'with', 'number', 'nct', 'retrospectively', 'registered', '.']"
Analysis of the clinical characteristics of pediatric patients who experience ifosfamide-induced encephalopathy.,"Yuichiro Ide, Ryu Yanagisawa, Noriko Kubota, Kazuo Sakashita, Minoru Tozuka, Tomohiko Nakamura, Takayuki Honda, Yuichiro Ideet al.",2019 Dec,Pediatr Blood Cancer,https://pubmed.ncbi.nlm.nih.gov/31535455/,No keywords found,"['several', 'kind', 'of', 'pediatric', 'hematological', 'andor', 'malignant', 'disease', 'treated', 'with', 'chemotherapy', 'regimen', 'including', 'ifosfamide', '(', 'ifo', ')', '.', 'ifo-induced', 'encephalopathy', '(', 'iie', ')', 'one', 'of', 'serious', 'side', 'effect', ',', 'not', 'enough', 'evidence', 'regarding', 'clinical', 'feature', 'of', 'iie', 'in', 'child', '.', 'procedure', 'performed', 'retrospective', 'study', 'pediatric', 'patient', 'treated', 'with', 'chemotherapy', 'regimen', ',', 'including', 'ifo', ',', 'single', 'center', '.', 'recorded', 'clinical', 'characteristic', 'of', 'patient', 'compared', 'clinical', 'characteristic', 'patient', 'developed', 'iie', 'and', 'not', '.', 'result', 'in', 'total', ',', 'patient', 'received', 'chemotherapy', 'regimen', 'including', 'ifo', '.', 'iie', 'developed', 'in', 'seven', 'patient', '(', '.', ')', '.', 'median', 'age', 'of', 'patient', 'time', 'of', 'iie', 'development', '.', '(', 'range', '.-', '.', ')', 'year', 'in', 'younger', 'population', '.', 'six', 'of', 'seven', 'patient', 'with', 'iie', 'improved', 'with', 'supportive', 'therapy', 'however', ',', 'one', 'patient', 'died', 'due', 'to', 'heart', 'failure', '.', 'overall', 'survival', 'not', 'different', 'two', 'group', '.', 'multivariable', 'analysis', 'revealed', 'co-administration', 'of', 'cisplatin', '(', 'cddp', ')', 'or', 'carboplatin', '(', 'cbdca', ')', 'significant', 'risk', 'factor', 'associated', 'with', 'iie', '.', 'although', 'no', 'significant', 'difference', 'in', 'laboratory', 'data', 'group', 'chemotherapy', ',', 'patient', 'developed', 'iie', 'showed', 'exacerbation', 'in', 'several', 'laboratory', 'test', ',', 'including', 'renal', 'and', 'liver', 'function', '.', 'conclusion', 'renal', 'dysfunction', 'caused', 'combination', 'of', 'nephrotoxic', 'agent', '(', 'ifo', 'and', 'cddpcbdca', ')', 'seems', 'to', 'important', 'development', 'of', 'pediatric', 'iie', '.', 'thought', 'to', 'difficult', 'to', 'predict', 'iie', 'onset', 'based', 'laboratory', 'data', 'initiation', 'of', 'chemotherapy', 'regimen', 'however', ',', 'careful', 'observation', 'of', 'laboratory', 'data', 'ifo', 'chemotherapy', 'regimen', 'may', 'help', 'predict', 'iie', 'onset', 'and', 'facilitate', 'early', 'treatment', '.']"
The effects of vitamin E on colistin-induced nephrotoxicity in treatment of drug-resistant gram-negative bacterial infections: A randomized clinical trial.,"Maryam Samsami, Minoosh Shabani, Mohammadreza Hajiesmaeili, Maria Tavakoli-Ardakani, Seyed Hossein Ardehali, Alireza Fatemi, Saghar Barati, Omid Moradi, Zahra Sahraei, Maryam Samsamiet al.",2021 Aug,J Infect Chemother,https://pubmed.ncbi.nlm.nih.gov/33863635/,No keywords found,"['nephrotoxicity', 'remains', 'major', 'long-standing', 'concern', 'colistin', ',', 'and', 'critical', 'to', 'find', 'agent', 'prevent', '.', 'present', 'study', 'aim', 'to', 'investigate', 'effect', 'of', 'vitamin', 'e', 'prevention', 'of', 'colistin-induced', 'nephrotoxicity', 'based', 'antioxidant', 'and', 'free', 'radical', 'scavenging', 'property', '.', 'method', 'randomized', 'clinical', 'trial', 'designed', 'patient', 'taking', 'colistin', '.', 'patient', 'categorized', 'two', 'group', 'of', 'equal', 'size', ',', 'receiving', 'colistin', 'or', 'colistin', 'plus', 'vitamin', 'e', '(', '-tocopherol', ')', '.', 'vitamin', 'e', 'with', 'dos', 'of', 'unit', 'administrated', 'daily', 'either', 'orally', 'or', 'nasogastric', 'tube', 'needed', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'duration', 'recorded', 'based', 'rifle', 'criterion', '.', 'result', 'incidence', 'of', 'aki', 'based', 'rifle', 'criterion', '.', 'and', '.', 'in', 'intervention', 'and', 'control', 'group', ',', 'respectively', '.', 'analysis', 'showed', 'no', 'significant', 'difference', 'in', 'prevalence', 'of', 'aki', 'two', 'group', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'duration', 'of', 'aki', 'neither', '(', 'p', '.', ')', '.', 'conclusion', 'although', 'vitamin', 'e', 'powerful', 'biological', 'antioxidant', ',', 'effect', 'of', 'vitamin', 'e', 'prophylaxis', 'colistin-induced', 'nephrotoxicity', 'not', 'taken', 'consideration', 'in', 'study', '.']"
In-line filtration of intravenous infusion may reduce organ dysfunction of adult critical patients.,"Elke Schmitt, Patrick Meybohm, Eva Herrmann, Karin Ammersbach, Raphaela Endres, Simone Lindau, Philipp Helmer, Kai Zacharowski, Holger Neb, Elke Schmittet al.",2019 Nov 22,Crit Care,https://pubmed.ncbi.nlm.nih.gov/31757216/,No keywords found,"['potential', 'harmful', 'effect', 'of', 'particle-contaminated', 'infusion', 'critically', 'ill', 'adult', 'patient', 'yet', 'unclear', '.', 'far', ',', 'significant', 'improved', 'outcome', 'in', 'critically', 'ill', 'child', 'and', 'new-borns', 'demonstrated', 'using', 'in-line', 'filter', ',', 'adult', 'patient', ',', 'evidence', 'still', 'missing', '.', 'method', 'single-centre', ',', 'retrospective', 'controlled', 'cohort', 'study', 'assessed', 'effect', 'of', 'in-line', 'filtration', 'of', 'intravenous', 'fluid', 'with', 'finer', '.', 'or', '.', 'v', '.', 'filter', 'in', 'critically', 'ill', 'adult', 'patient', '.', 'total', 'of', 'n', 'adult', 'patient', ',', 'n', 'patient', 'selected', 'propensity', 'score', 'matching', '(', 'adjusting', 'sex', ',', 'age', ',', 'and', 'surgery', 'group', ')', 'and', 'assigned', 'to', 'either', 'fine', 'filter', 'cohort', '(', 'with', '..', 'filter', ',', 'n', ',', 'time', 'period', 'february', 'to', 'january', ')', 'or', 'control', 'filter', 'cohort', '(', 'with', '.', 'filter', ',', 'n', ',', 'time', 'period', 'april', 'to', 'march', ')', '.', 'cohort', 'compared', 'regarding', 'occurrence', 'of', 'severe', 'vasoplegia', ',', 'organ', 'dysfunction', '(', 'lung', ',', 'kidney', ',', 'and', 'brain', ')', ',', 'inflammation', ',', 'in-hospital', 'complication', '(', 'myocardial', 'infarction', ',', 'ischemic', 'stroke', ',', 'pneumonia', ',', 'and', 'sepsis', ')', ',', 'in-hospital', 'mortality', ',', 'and', 'length', 'of', 'icu', 'and', 'hospital', 'stay', '.', 'result', 'comparing', 'fine', 'filter', 'v', 'control', 'filter', 'cohort', ',', 'respiratory', 'dysfunction', '(', 'horowitz', 'index', '(', '-', ')', 'v', '(', '.-', ')', 'p', '.', ')', ',', 'pneumonia', '(', '.', 'v', '.', 'p', '.', ')', ',', 'sepsis', '(', '.', 'v', '.', 'p', '.', ')', ',', 'interleukin-', '(', '.', '(', '.-', '.', ')', 'ngl', 'v', '.', '(', '.-', '.', ')', 'ngl', 'p', '.', ')', ',', 'and', 'length', 'of', 'icu', '(', '.', '(', '.-', '.', ')', 'v', '.', '(', '.-', '.', ')', 'day', 'p', '.', ')', 'and', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', 'p', '.', ')', 'not', 'significantly', 'different', 'cohort', '.', 'conclusion', 'in-line', 'filtration', 'with', 'finer', '.', 'and', '.', 'filter', 'may', 'associated', 'with', 'less', 'organ', 'dysfunction', 'and', 'less', 'inflammation', 'in', 'critically', 'ill', 'adult', 'patient', '.', 'trial', 'registration', 'study', 'registered', 'clinicaltrials.gov', '(', 'number', 'nct', ')', '.']"
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison.,"A P Prayle, K Jain, D J Touw, B C P Koch, A J Knox, A Watson, A R Smyth, A P Prayleet al.",2016 Jul,J Cyst Fibros,https://pubmed.ncbi.nlm.nih.gov/26282839/,No keywords found,"['circadian', 'variation', 'in', 'renal', 'toxicity', 'of', 'aminoglycosides', 'demonstrated', 'in', 'animal', 'and', 'human', 'study', '.', 'people', 'with', 'cf', 'frequently', 'prescribed', 'aminoglycosides', '.', 'altered', 'pharmacokinetics', 'of', 'aminoglycosides', 'predictive', 'of', 'toxicity', '.', 'aim', 'to', 'investigate', 'whether', 'time', 'of', 'day', 'of', 'aminoglycoside', 'administration', 'modulates', 'renal', 'excretion', 'of', 'tobramycin', 'and', 'toxicity', 'in', 'child', 'with', 'cf', '.', 'to', 'determine', 'whether', 'circadian', 'rhythm', 'disrupted', 'in', 'child', 'with', 'cf', 'hospital', 'admission', '.', 'method', 'child', '(', 'age', '-years', ')', 'with', 'cf', 'scheduled', 'tobramycin', 'therapy', 'randomly', 'allocated', 'to', 'receive', 'tobramycin', 'or', 'h.', 'serum', 'tobramycin', 'level', 'drawn', 'h', 'and', '.', 'and', 'h', 'post-infusion', 'day', 'and', 'of', 'therapy', '.', 'melatonin', 'level', 'measured', 'serially', 'interval', 'h', 'in', 'evening', 'h', 'next', 'day', '.', 'circadian', 'rhythm', 'categorised', 'normal', 'dim', 'light', 'melatonin', 'onset', 'demonstrated', 'and', 'h', 'andor', 'peak', 'melatonin', 'level', 'observed', 'night', '.', 'weight', 'and', 'spirometry', 'measured', 'start', 'and', 'end', 'of', 'therapy', '.', 'urinary', 'biomarkers', 'of', 'kidney', 'toxicity', '(', 'kim', ',', 'nag', ',', 'ngal', ',', 'il-', 'and', 'cysc', ')', 'assayed', 'start', 'and', 'end', 'of', 'course', 'of', 'tobramycin', '.', 'result', 'eighteen', 'child', 'recruited', 'to', 'study', '.', 'no', 'difference', 'in', 'renal', 'clearance', 'morning', 'and', 'evening', 'group', '.', 'increase', 'in', 'urinary', 'kim-', 'greater', 'in', 'evening', 'dosage', 'group', 'compared', 'to', 'morning', 'group', '(', 'mean', 'difference', ',', '.ngmg', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'no', 'difference', 'in', 'urinary', 'biomarkers', '.', 'normal', 'circadian', 'rhythm', 'in', 'participant', '(', ')', '.', 'conclusion', 'renal', 'elimination', 'of', 'tobramycin', 'not', 'affected', 'time', 'of', 'day', 'of', 'administration', '.', 'urinary', 'kim-', 'raise', 'possibility', 'of', 'greater', 'nephrotoxicity', 'with', 'evening', 'administration', '.', 'four', 'child', 'showed', 'disturbed', 'circadian', 'rhythm', 'and', 'high', 'melatonin', 'level', '(', 'clinicaltrials.gov', 'nct', ')', '.']"
"Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial.","Marcelo Augusto Duarte Silveira, David De Jong, Andresa Aparecida Berretta, Erica Batista Dos Santos Galvão, Juliana Caldas Ribeiro, Thiago Cerqueira-Silva, Thais Chaves Amorim, Luis Filipe Miranda Rebelo da Conceição, Marcel Miranda Dantas Gomes, Maurício Brito Teixeira, Sergio Pinto de Souza, Marcele Helena Celestino Alves Dos Santos, Raissa Lanna Araújo San Martin, Márcio de Oliveira Silva, Monique Lírio, Lis Moreno, Julio Cezar Miranda Sampaio, Renata Mendonça, Silviana Salles Ultchak, Fabio Santos Amorim, João Gabriel Rosa Ramos, Paulo Benigno Pena Batista, Suzete Nascimento Farias da Guarda, Ana Verena Almeida Mendes, Rogerio da Hora Passos                              ;, BeeCovid Team, Marcelo Augusto Duarte Silveiraet al.",2021 Jun:138:111526.,Biomed Pharmacother,https://pubmed.ncbi.nlm.nih.gov/34311528/,No keywords found,"['severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '(', 'sars-cov-', ')', 'promotes', 'challenging', 'immune', 'and', 'inflammatory', 'phenomenon', '.', 'though', 'various', 'therapeutic', 'possibility', 'tested', 'coronavirus', 'disease', '(', 'covid-', ')', ',', 'adequate', 'treatment', 'not', 'yet', 'established', '.', 'propolis', 'natural', 'product', 'with', 'considerable', 'evidence', 'of', 'immunoregulatory', 'and', 'anti-inflammatory', 'activity', ',', 'and', 'experimental', 'data', 'point', 'to', 'potential', 'viral', 'target', '.', 'hypothesized', 'propolis', 'reduce', 'negative', 'effect', 'of', 'covid-', '.', 'method', 'in', 'randomized', ',', 'controlled', ',', 'open-label', ',', 'single-center', 'trial', ',', 'hospitalized', 'adult', 'covid-', 'patient', 'treated', 'with', 'standardized', 'green', 'propolis', 'extract', '(', 'epp-af', ')', 'adjunct', 'therapy', '.', 'patient', 'allocated', 'to', 'receive', 'standard', 'care', 'plus', 'oral', 'dose', 'of', 'mg', 'or', 'mgday', 'of', 'green', 'propolis', 'seven', 'day', ',', 'or', 'standard', 'care', 'alone', '.', 'standard', 'care', 'included', 'necessary', 'intervention', ',', 'determined', 'attending', 'physician', '.', 'primary', 'end', 'point', 'time', 'to', 'clinical', 'improvement', ',', 'defined', 'length', 'of', 'hospital', 'stay', 'or', 'oxygen', 'therapy', 'dependency', 'duration', '.', 'secondary', 'outcome', 'included', 'acute', 'kidney', 'injury', 'and', 'need', 'intensive', 'care', 'or', 'vasoactive', 'drug', '.', 'patient', 'followed', 'day', 'admission', '.', 'result', 'enrolled', 'patient', 'assigned', 'to', 'epp-af', 'mgday', ',', 'to', 'epp-af', 'mgday', ',', 'and', 'to', 'control', 'group', '.', 'length', 'of', 'hospital', 'stay', 'post-intervention', 'shorter', 'in', 'propolis', 'group', 'in', 'control', 'group', 'lower', 'dose', ',', 'median', 'day', 'versus', 'day', '(', 'confidence', 'interval', 'ci', '-', '.', 'to', '-', '.', 'p', '.', ')', 'and', 'higher', 'dose', ',', 'median', 'day', 'versus', 'day', '(', 'ci', '-', '.', 'to', '-', '.', 'p', '.', ')', '.', 'propolis', 'not', 'significantly', 'affect', 'need', 'oxygen', 'supplementation', '.', 'in', 'high', 'dose', 'propolis', 'group', ',', 'lower', 'rate', 'of', 'acute', 'kidney', 'injury', 'in', 'control', '(', '.', 'v', '.', ')', ',', '(', 'odds', 'ratio', 'or', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'no', 'patient', 'propolis', 'treatment', 'discontinued', 'due', 'to', 'adverse', 'event', '.', 'conclusion', 'addition', 'of', 'propolis', 'to', 'standard', 'care', 'procedure', 'resulted', 'in', 'clinical', 'benefit', 'hospitalized', 'covid-', 'patient', ',', 'especially', 'evidenced', 'reduction', 'in', 'length', 'of', 'hospital', 'stay', '.', 'consequently', ',', 'conclude', 'propolis', 'reduce', 'impact', 'of', 'covid-', '.']"
Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium-Containing Solutions: A Randomized Controlled Trial.,"Shan Huang, Guangfeng Sun, Penglong Wu, LinJing Wu, Hongfei Jiang, Xixing Wang, Liyuan Li, Lingling Gao, Fanqi Meng, Shan Huanget al.",2024 May-Jun,Semin Dial,https://pubmed.ncbi.nlm.nih.gov/38439685/,No keywords found,"['calcium-free', '(', 'ca-free', ')', 'solution', 'theoretically', 'ideal', 'regional', 'citrate', 'anticoagulation', '(', 'rca', ')', 'in', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '.', 'however', ',', 'majority', 'of', 'medical', 'center', 'in', 'china', 'to', 'make', 'compromise', 'of', 'using', 'commercially', 'available', 'calcium-containing', '(', 'ca-containing', ')', 'solution', 'instead', 'of', 'ca-free', 'one', 'due', 'to', 'scarcity', '.', 'study', 'designed', 'to', 'probe', 'potential', 'of', 'ca-containing', 'solution', 'secure', 'and', 'efficient', 'substitution', 'ca-free', 'solution', '.', 'method', 'in', 'prospective', ',', 'randomized', 'single-center', 'trial', ',', 'patient', 'scheduled', 'crrt', 'randomly', 'assigned', 'in', 'ratio', 'to', 'one', 'of', 'three', 'treatment', 'group', 'continuous', 'veno-venous', 'hemodialysis', 'ca-free', 'dialysate', '(', 'cvvhd', 'ca-free', ')', 'group', ',', 'continuous', 'veno-venous', 'hemodiafiltration', 'calcium-free', 'dialysate', '(', 'cvvhdf', 'ca-free', ')', 'group', ',', 'and', 'continuous', 'veno-venous', 'hemodiafiltration', 'ca-containing', 'dialysate', '(', 'cvvhdf', 'ca-containing', ')', 'group', 'cardiac', 'intensive', 'care', 'unit', '(', 'cicu', ')', '.', 'primary', 'endpoint', 'incidence', 'of', 'metabolic', 'complication', '.', 'secondary', 'endpoint', 'included', 'premature', 'termination', 'of', 'treatment', ',', 'thrombus', 'of', 'filter', ',', 'and', 'bubble', 'trap', 'process', '.', 'result', 'incidence', 'of', 'citrate', 'accumulation', '(', '.', 'vs.', '.', 'v', '.', '.', ')', 'and', 'metabolic', 'alkalosis', '(', '.', 'vs.', 'v', '.', '.', ')', 'not', 'significantly', 'differ', 'among', 'three', 'group', '(', 'p', '.', ')', '.', 'incidence', 'of', 'premature', 'termination', 'comparable', 'among', 'group', '(', '.', 'vs.', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'thrombus', 'level', 'of', 'filter', 'and', 'bubble', 'trap', 'similar', 'in', 'three', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'rca-crrt', 'cicu', 'population', ',', 'rca-cvvhdf', 'with', 'ca-containing', 'solution', 'and', 'traditional', 'rca', 'with', 'ca-free', 'solution', 'comparable', 'safety', 'and', 'feasibility', '.', 'trial', 'registration', 'chictr', 'in', 'chinese', 'clinical', 'trial', 'registry', '.']"
A minimal impact of long-term S-flurbiprofen plaster application on kidney function in osteoarthritis patients.,"Noboru Otsuka, Ikuko Yataba, Isao Matsushita, Hideo Matsumoto, Yuichi Hoshino, Yoshio Terada, Noboru Otsukaet al.",2017 Dec,Clin Exp Nephrol,https://pubmed.ncbi.nlm.nih.gov/28378068/,No keywords found,"['number', 'of', 'kidney', 'injury', 'due', 'to', 'nonsteroidal', 'anti-inflammatory', 'drug', '(', 'nsaid', ')', 'largest', 'among', 'drug-induced', 'kidney', 'disease', '.', 'newly', 'developed', 'nsaid', 'plaster', 'containing', 's-flurbiprofen', '(', 'sfp', ')', 'show', 'innovative', 'percutaneous', 'absorption', '.', 'however', ',', 'systemic', 'exposure', 'to', 'sfp', 'following', 'repeated', 'application', 'of', 'mgday', 'estimated', 'comparable', 'to', 'of', 'oral', 'mgday', 'flurbiprofen', 'and', 'prolonged', 'use', 'of', 'topical', 'nsaid', 'common', 'in', 'clinical', 'practice', '.', 'thus', ',', 'report', 'safety', 'focusing', 'kidney', 'function', 'long-term', 'application', 'of', 'sfp', 'plaster', '(', 'sfpp', ')', '.', 'method', 'total', 'of', 'osteoarthritis', 'patient', '(', 'mean', 'age', '.', ',', 'female', ',', 'mean', 'estimated', 'glomerular', 'filtration', 'rate', '.', 'mlmin', '.', 'mm', ')', 'applied', 'or', 'mg', 'sfpp', 'week', ',', 'and', 'kidney', 'function', 'examined', 'blood', 'urea', 'nitrogen', '(', 'bun', ')', ',', 'serum', 'creatinine', '(', 'scr', ')', ',', 'egfr', ',', 'and', 'urinalysis', '.', 'result', '(', '.', ')', 'patient', 'completed', '-week', 'application', '.', 'in', 'group', 'of', 'and', 'mg', ',', 'small', 'statistically', 'significant', 'increase', 'observed', 'in', 'bun', '(', 'mean', '.', 'and', '.', 'mgdl', ',', 'p', '.', ')', 'and', 'scr', '(', 'mean', '.', 'and', '.', 'mgdl', ',', 'p', '.', ')', '.', 'although', 'abnormal', 'change', 'in', 'laboratory', 'test', 'renal', 'function', 'observed', 'in', 'seven', 'patient', ',', 'change', 'small', 'and', 'subclinical', '.', 'acute', 'kidney', 'injury', 'observed', 'in', 'two', 'patient', '.', 'meanwhile', ',', 'investigator', 'denied', 'relevance', 'of', 'sfpp', 'according', 'to', 'clinical', 'course', '.', 'conclusion', 'toward', 'end', 'of', '-week', 'application', ',', 'statistically', 'significant', 'increase', 'in', 'scr', 'observed', 'in', 'and', 'mg', ',', 'increment', 'small', 'and', 'subclinical', '.', 'attention', 'paid', 'to', 'kidney', 'function', 'applying', 'sfpp', 'to', 'patient', 'with', 'multiple', 'risk', 'factor', '.']"
Heparin-Binding Protein (HBP): A Causative Marker and Potential Target for Heparin Treatment of Human Sepsis-Induced Acute Kidney Injury.,"Jane Fisher, James A Russell, Peter Bentzer, Devyn Parsons, Stefano Secchia, Matthias Mörgelin, Keith R Walley, John H Boyd, Adam Linder, Jane Fisheret al.",2017 Sep,Shock,https://pubmed.ncbi.nlm.nih.gov/28319494/,No keywords found,"['sepsis-induced', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'condition', 'with', 'high', 'morbidity', 'and', 'mortality', '.', 'neutrophil-derived', 'heparin-binding', 'protein', '(', 'hbp', ')', 'induces', 'vascular', 'leakage', 'and', 'promising', 'biomarker', 'of', 'sepsis-induced', 'organ', 'dysfunction', '.', 'remains', 'unknown', 'hbp', 'prognostic', 'of', 'aki', 'in', 'septic', 'shock', 'and', 'hbp', 'could', 'play', 'role', 'in', 'pathophysiology', 'of', 'sepsis-induced', 'aki', '.', 'objective', 'to', 'determine', 'association', 'of', 'plasma', 'hbp', 'level', 'with', 'development', 'of', 'aki', ',', 'investigate', 'role', 'of', 'hbp', 'in', 'pathophysiology', 'of', 'sepsis-induced', 'aki', ',', 'and', 'test', 'effect', 'of', 'blocking', 'hbp', 'using', 'heparin', 'derivative', '.', 'method', 'in', 'septic', 'shock', 'patient', 'randomized', 'multicenter', 'vasopressin', 'and', 'septic', 'shock', 'trial', '(', 'vasst', ')', 'plasma', 'hbp', 'level', 'associated', 'with', 'development', 'of', 'aki', 'and', 'need', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'human', 'renal', 'tubular', 'cell', 'exposed', 'to', 'recombinant', 'hbp', 'to', 'evaluate', 'inflammation', 'and', 'heparin', 'derivative', 'used', 'to', 'abrogate', 'effect', '.', 'finally', ',', 'mouse', 'exposed', 'to', 'hbp', 'with', 'and', 'without', 'heparin', 'derivative', 'and', 'kidney', 'examined', 'sign', 'of', 'inflammation', '.', 'finding', 'plasma', 'hbp', 'level', 'significantly', 'higher', 'in', 'patient', 'with', 'aki', 'and', 'requiring', 'rrt', '.', 'hbp', 'level', 'identified', 'patient', 'with', 'moderate', 'aki', 'with', 'area', 'curve', '(', 'auc', ')', 'of', '..', 'hbp', 'increased', 'il-', 'production', 'in', 'renal', 'tubular', 'epithelial', 'cell', '.', 'different', 'heparin', 'derivative', 'abrogated', 'hbp-induced', 'increased', 'inflammatory', 'response', 'in', 'vitro', 'and', 'in', 'vivo', '.', 'conclusion', 'elevated', 'plasma', 'hbp', 'associated', 'with', 'development', 'of', 'sepsis-induced', 'aki', 'and', 'hbp', 'involved', 'in', 'pathophysiology', '.', 'study', 'suggest', 'heparin', '(', ')', 'could', 'tested', 'efficacy', 'and', 'safety', 'of', 'prevention', 'of', 'sepsis-induced', 'aki', '.']"
The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation.,"Martijn P Lolkema#, Hilde H Bohets#, Hendrik-Tobias Arkenau, Ann Lampo, Erio Barale, Maja J A de Jonge, Leni van Doorn, Peter Hellemans, Johann S de Bono, Ferry A L M Eskens, Martijn P Lolkemaet al.",2015 May 15,Clin Cancer Res,https://pubmed.ncbi.nlm.nih.gov/25745036/,No keywords found,"['receptor', 'tyrosine', 'kinase', 'c-met', 'play', 'important', 'role', 'in', 'tumorigenesis', 'and', 'novel', 'target', 'anticancer', 'treatment', '.', 'phase', ',', 'first-in-human', 'trial', ',', 'explored', 'safety', ',', 'pharmacokinetics', ',', 'pharmacodynamics', ',', 'and', 'initial', 'antitumor', 'activity', 'of', 'jnj-', ',', 'potent', 'and', 'selective', 'c-met', 'inhibitor', '.', 'experimental', 'design', 'performed', 'phase', 'dose-escalation', 'study', 'according', 'to', 'standard', 'design', '.', 'result', 'even', 'subtherapeutic', 'dos', ',', 'mild', 'though', 'recurrent', 'renal', 'toxicity', 'observed', 'in', 'virtually', 'patient', '.', 'renal', 'toxicity', 'not', 'observed', 'in', 'preclinical', 'study', 'in', 'rat', 'and', 'dog', '.', 'additional', 'preclinical', 'study', 'pointed', 'toward', 'rabbit', 'suitable', 'toxicology', 'model', ',', 'formation', 'of', 'metabolite', 'of', 'jnj-', 'specifically', 'occurred', 'in', 'rabbit', 'and', 'human', '.', 'additional', 'toxicology', 'study', 'in', 'rabbit', 'clearly', 'demonstrated', 'jnj-', 'induced', 'species-specific', 'renal', 'toxicity', '.', 'histopathological', 'evaluation', 'in', 'rabbit', 'revealed', 'renal', 'crystal', 'formation', 'with', 'degenerative', 'and', 'inflammatory', 'change', '.', 'identification', 'of', 'component', 'of', 'renal', 'crystal', 'revealed', 'and', 'metabolite', '.', 'accordingly', ',', 'found', 'human', 'and', 'rabbit', 'showed', 'significantly', 'increased', 'systemic', 'exposure', 'to', 'metabolite', 'relative', 'to', 'specie', '.', 'main', 'culprit', 'insoluble', 'metabolite', 'generated', 'aldehyde', 'oxidase', 'activity', '.', 'alternative', 'dosing', 'schedule', 'of', 'jnj-', 'and', 'concomitant', 'probenecid', 'administration', 'in', 'rabbit', 'failed', 'to', 'prevent', 'renal', 'toxicity', 'dose', 'level', 'could', 'pharmacologically', 'active', '.', 'conclusion', 'combined', 'clinical', 'and', 'correlative', 'preclinical', 'study', 'suggest', 'renal', 'toxicity', 'of', 'jnj-', 'caused', 'formation', 'of', 'species-specific', 'insoluble', 'metabolite', '.', 'observation', 'preclude', 'clinical', 'development', 'of', 'jnj-', '.']"
A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia.,"Margaret T Kasner, Molly B Halloran, Jonathan Pan, Ellen K Ritchie, Gerald J Fetterly, Douglas Kramer, David G Hangauer, James E Thompson, Margaret T Kasneret al.",2022 Aug,Invest New Drugs,https://pubmed.ncbi.nlm.nih.gov/35579731/,"Acute Myeloid Leukemia, KX01, KX2-391, Phase I, Src Kinase, Tirbanibulin.","['mg', '(', 'n', ')', ',', 'mg', '(', 'n', ')', ',', 'mg', '(', 'n', ')', ',', 'mg', '(', 'n', ')', ',', 'and', 'mg', '(', 'n', ')', '.', 'seven', 'patient', 'treated', 'day', 'or', 'less', ',', 'nine', '-', 'day', ',', 'five', '-', 'day', ',', 'and', 'three', '-', 'day', '.', 'one', 'patient', 'receiving', 'mg', 'day', 'reduced', 'splenomegaly', 'and', 'survived', 'day', '.', 'another', 'no', 'evidence', 'of', 'disease', 'progression', 'day', '.', 'one', 'patient', 'receiving', 'mg', 'day', 'remained', 'treatment-free', 'month', '.', 'dose-limiting', 'toxicity', 'occurred', 'in', 'eight', 'patient', 'mg', '(', 'transaminitis', ',', 'hyperbilirubinemia', ')', ',', 'mg', '(', 'mucositis', ',', 'allergic', 'reaction', ',', 'transaminitis', ',', 'acute', 'kidney', 'injury', ')', ',', 'and', 'mg', '(', 'mucositis', ')', '.', 'maximum', 'tolerated', 'dose', 'kx-', 'mg', 'daily', '.', 'kx-', 'bone', 'marrow', 'concentration', 'approximately', 'similar', 'to', 'plasma', 'concentration', '.', 'first', 'study', 'to', 'evaluate', 'safety', 'of', 'kx-', 'in', 'elderly', 'patient', 'with', 'aml', '.', 'study', 'warranted', ',', 'including', 'alternative', 'dosing', 'phase', 'trial', 'evaluating', 'shorter', 'course', 'higher', 'dos', 'and', 'phase', 'ii', 'trial', '.', '(', 'clinical', 'trial', 'registrationthe', 'study', 'registered', 'clinicaltrials.gov', 'nct', '(', 'july', ',', ')', ')', '.']"
Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.,"Amy E Caruso Brown, Mindy N Cohen, Suhong Tong, Rebecca S Braverman, James F Rooney, Roger Giller, Myron J Levin, Amy E Caruso Brownet al.",2015 Jul,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/25733509/,No keywords found,"['child', 'undergoing', 'hematopoietic', 'stem', 'cell', 'transplantation', '(', 'hsct', ')', 'risk', 'life-threatening', 'viral', 'infection', '.', 'cidofovir', 'often', 'used', 'first-line', 'agent', 'adenovirus', 'infection', ',', 'despite', 'absence', 'of', 'randomized', 'controlled', 'trial', 'with', 'hsct', 'patient', ',', 'and', 'second-line', 'agent', 'resistant', 'herpesvirus', 'infection', '.', 'frequency', 'and', 'severity', 'of', 'adverse', 'effect', ',', 'particularly', 'nephrotoxicity', ',', 'in', 'pediatric', 'hsct', 'recipient', 'unclear', ',', 'and', 'pharmacokinetics', '(', 'pk', ')', 'of', 'cidofovir', 'in', 'child', 'not', 'previously', 'reported', '.', 'study', 'open-label', ',', 'nonrandomized', ',', 'single-dose', 'pilot', 'study', 'to', 'determine', 'safety', 'and', 'pk', 'of', 'cidofovir', 'in', 'pediatric', 'hsct', 'recipient', 'with', 'symptomatic', 'adenovirus', ',', 'nucleoside-resistant', 'cytomegalovirus', '(', 'cmv', ')', 'or', 'herpes', 'simplex', 'virus', '(', 'hsv', ')', ',', 'andor', 'human', 'papovavirus', 'infection', '.', 'subsequent', 'dosing', 'and', 'frequency', 'determined', 'clinical', 'response', 'and', 'side', 'effect', ',', 'assessed', 'treating', 'physician', '.', 'blood', 'and', 'urine', 'sample', 'obtained', 'patient', 'pk', 'study', 'and', 'assessment', 'of', 'toxicity', 'and', 'virologic', 'response', '.', 'twelve', 'patient', 'enrolled', '(', 'median', 'age', ',', 'year', '.', 'day', 'posttransplantation', ')', '.', 'four', 'of', 'seven', 'patient', 'with', 'adenovirus', 'infection', 'successfully', 'treated', 'and', 'eventually', 'cleared', 'infection', '.', 'four', 'of', 'twelve', 'patient', 'died', 'of', 'disseminated', 'viral', 'disease', 'and', 'multiorgan', 'failure', '.', 'two', 'of', 'twelve', 'patient', 'evidence', 'of', 'acute', 'kidney', 'injury', 'first', 'dose', ',', 'and', 'one', 'of', 'patient', 'developed', 'chronic', 'kidney', 'disease', 'two', 'patient', 'developed', 'late', 'nephrotoxicity', '.', 'mean', 'drug', 'half-life', '.', 'h.', 'no', 'correlation', 'nephrotoxicity', 'and', 'plasma', 'maximum', 'concentration', ',', 'clearance', ',', 'or', 'half-life', '.', 'pk', 'similar', 'to', 'reported', 'adult', ',', 'although', 'drug', 'half-life', 'significantly', 'longer', 'adult', '.', 'cidofovir', 'well', 'tolerated', 'in', 'majority', 'of', 'patient', '.', 'however', ',', 'effective', 'therapeutic', 'strategy', 'urgently', 'needed', 'to', 'support', 'patient', 'immune', 'reconstitution', 'achieved', '.']"
Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer.,"Ahmad Ameri, Shokoufe Norouzi, Ainaz Sourati, Samira Azghandi, Kambiz Novin, Farzad Taghizadeh-Hesary, Ahmad Ameriet al.",2022 Jan,Cancer Rep (Hoboken),https://pubmed.ncbi.nlm.nih.gov/34101389/,No keywords found,"['current', 'first-line', 'treatment', 'of', 'locally', 'advanced', 'head', 'and', 'neck', 'carcinoma', '(', 'lahnc', ')', 'concurrent', 'chemoradiation', 'with', 'three-weekly', 'cisplatin', 'mgm', '.', 'however', ',', 'prescribing', 'cisplatin', 'dose', 'increase', 'treatment', 'toxicity', ',', 'may', 'compromise', 'treatment', 'result', '.', 'alternative', 'schedule', 'weekly', 'mgm', 'cisplatin', '.', 'aim', 'to', 'compare', 'acute', 'hematologic', 'and', 'renal', 'toxicity', 'of', 'two', 'regimen', '.', 'method', 'randomized', 'clinical', 'trial', 'included', 'lahnc', 'patient', 'allocated', 'to', 'high', 'dose', '(', 'mgm', 'every', 'week', ')', 'or', 'low', 'dose', '(', 'mgm', 'weekly', ')', 'cisplatin', 'group', 'concurrent', 'with', 'radiotherapy', '.', 'hematologic', 'and', 'renal', 'index', 'measured', 'weekly', 'chemoradiation', '.', 'result', 'average', 'age', 'of', 'patient', '.', 'year', '.', 'overall', ',', '.', 'of', 'patient', 'treated', 'in', 'definitive', 'setting', '.', 'incidence', 'of', 'severe', 'hematologic', 'event', 'not', 'significantly', 'different', '.', 'however', ',', 'average', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'significantly', 'greater', 'in', 'three-weekly', 'group', '(', '.', 'vs.', '.', 'mlmin', 'per', '.', 'p-value', '.', ')', '.', 'cumulative', 'cisplatin', 'dose', 'of', 'mgm', 'significantly', 'greater', 'in', 'weekly', 'group', '.', 'totally', ',', 'treatment', 'break', 'occurred', 'in', '.', 'of', 'patient', 'due', 'to', 'treatment', 'toxicity', '.', 'treatment', 'interruption', 'primarily', 'due', 'to', 'neutropenia', 'in', 'three-weekly', 'and', 'renal', 'dysfunction', 'and', 'thrombocytopenia', 'in', 'weekly', 'group', '.', 'conclusion', 'severe', 'acute', 'hematologic', 'toxicity', 'comparable', 'three-weekly', 'and', 'weekly', 'group', '.', 'decrease', 'in', 'egfr', 'treatment', 'significant', 'with', 'weekly', 'cisplatin', '.', 'follow-up', ',', 'however', ',', 'needed', 'to', 'confirm', 'impact', 'delayed', 'renal', 'function', '.']"
Protein loss and glucose absorption in children with AKI treated with peritoneal dialysis.,"Peter Nourse, Mignon McCulloch, Ashton Coetzee, Tim Bunchman, Stefano Picca, Jody Rusch, Andre Brooks, Hilton Heydenrych, Brenda Morrow, Peter Nourseet al.",2024 Mar,Perit Dial Int,https://pubmed.ncbi.nlm.nih.gov/37970810/,No keywords found,"['protein', 'loss', 'and', 'glucose', 'absorption', 'in', 'child', 'acute', 'peritoneal', 'dialysis', '(', 'pd', ')', 'important', 'to', 'inform', 'dietary', 'prescription', ',', 'yet', 'data', 'lacking', 'in', 'regard', '.', 'study', 'secondary', 'analysis', 'of', 'previously', 'published', 'crossover', 'randomised', 'controlled', 'trial', ',', 'aiming', 'to', 'describe', 'glucose', 'uptake', 'and', 'protein', 'loss', 'dialysate', 'among', 'child', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'receiving', 'pd', '.', 'method', 'secondary', 'analysis', 'described', 'and', 'compared', 'dialysate', 'albumin', 'loss', 'and', 'glucose', 'absorption', 'in', 'child', 'with', 'aki', 'receiving', 'pd', 'or', 'continuous', 'flow', 'peritoneal', 'dialysis', '(', 'cfpd', ')', '.', 'in', 'addition', ',', 'correlation', 'albumin', 'loss', ',', 'glucose', 'absorption', 'and', 'patient', 'and', 'dialysis', 'factor', 'analysed', '.', 'result', 'median', '(', 'range', ')', 'age', 'and', 'weight', 'of', 'participant', '.', '(', '.-', ')', 'month', 'and', '.', '(', '.-', '.', ')', 'kg', ',', 'respectively', '.', 'patient', 'received', 'approximately', 'h', 'of', 'dialysis', 'modality', 'however', ',', 'result', 'extrapolated', 'and', 'expressed', 'per', 'day', '.', 'mean', 'sd', 'albumin', 'loss', 'conventional', 'pd', 'and', 'cfpd', '.', '.', 'gkgday', 'and', '.', '.', 'gkgday', ',', 'respectively', ',', 'and', 'mean', 'sd', 'glucose', 'absorption', '.', '.', 'gkgday', 'and', '.', '.', 'gkgday', ',', 'respectively', '.', 'moderate', 'correlation', 'ultrafiltration', 'and', 'albumin', 'loss', 'cfpd', '(', 'pearson', ""'s"", 'r', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'pd', 'and', 'cfpd', 'either', 'glucose', 'absorption', 'or', 'albumin', 'loss', 'however', ',', 'study', 'not', 'powered', 'outcome', '.', 'conclusion', 'protein', 'loss', 'and', 'glucose', 'absorption', 'in', 'child', 'pd', 'with', 'aki', 'significant', 'and', 'considered', 'prescribing', 'nutritional', 'content', '.', 'protein', 'loss', 'cfpd', 'twice', 'high', 'conventional', 'pd', '.']"
MODIFIED TREATMENT OF HEPATORENAL SYNDROME TYPE I DEPENDING ON THE STAGE OF ACUTE KIDNEY INJURY.,"N Slyvka, I Rusnak, L Zub, Y Kulachek, V Kulachek, M Al Salama, O Rovinskyi, N Slyvkaet al.",2021 May:(314):125-128.,Georgian Med News,https://pubmed.ncbi.nlm.nih.gov/34248041/,No keywords found,"['improving', 'global', 'outcome', '(', 'kdigo', ')', 'clinical', 'practice', 'guideline', 'acute', 'kidney', 'injury', ',', '.', 'risk', 'of', 'short', 'term', 'mortality', '(', 'within', 'first', 'day', ')', 'prognosed', 'model', 'end-stage', 'liver', 'disease', '(', 'meld', ')', 'score', '.', 'kidney', 'function', 'improved', 'better', 'in', 'person', 'with', 'modified', 'dose', 'of', 'terlipressin', 'complete', 'response', 'rate', 'in', '..', 'response', 'rate', 'in', 'received', 'standard', 'treatment', ',', '.', '(', 'p.', ')', '.', 'found', 'effective', 'dosage', 'of', 'terlipressin', 'mg', 'aki', 'stage', 'mg', '-', 'aki', 'stage', 'ii', 'mg', '-', 'aki', 'stage', 'iii', '.', 'relapse', 'of', 'disease', 'occurred', 'in', '.', 'patient', 'with', 'modified', 'treatment', '.', 'in', 'control', 'group', '(', 'p.', ')', '.', 'short', 'term', 'survival', 'also', 'significantly', 'higher', 'in', 'study', 'group', '-', '.', ',', 'in', 'control', 'group', '(', 'p.', ')', '.', 'thus', ',', 'correction', 'of', 'terlipressin', 'dosage', 'could', 'improve', 'result', 'of', 'treatment', 'and', 'reduce', 'mortality', 'in', 'patient', 'with', 'hepatorenal', 'syndrome', 'type', '.']"
A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis.,"Ankur Jindal, Manoj Kumar, Ajeet S Bhadoria, Rakhi Maiwall, Shiv K Sarin, Ankur Jindalet al.",2016 May,Liver Int,https://pubmed.ncbi.nlm.nih.gov/26474358/,No keywords found,"['spontaneous', 'bacterial', 'peritonitis', '(', 'sbp', ')', ',', 'in', 'presence', 'of', 'bacterial', 'resistance', 'or', 'failure', 'of', 'third', 'generation', 'cephalosporin', '(', 'rd', 'gc', ')', 'poor', 'outcome', '.', 'empirical', 'antibiotic', '(', ')', 'option', 'limited', 'in', 'scenario', '.', 'method', 'consecutive', 'cirrhotics', 'with', 'sbp', 'of', 'hospital', 'acquired', 'sbp', '(', 'h', 'of', 'admission', ')', ',', 'microbial', 'resistance', 'or', 'non-response', '(', 'no', 'resolution', 'of', 'sbp', 'h', ')', 'randomized', 'to', 'cefepime', '(', 'n', ')', 'or', 'imipenem', '(', 'n', ')', 'plus', 'standard', 'medical', 'therapy', '.', 'assessed', ""'response"", 'h', ""'"", '(', 'reduction', 'in', 'ascitic', 'fluid', 'absolute', 'neutrophil', 'count', '(', 'anc', ')', 'h', ')', ',', 'resolution', 'of', 'sbp', '(', 'cumm', 'anc', 'day', ')', 'and', 'clinical', 'outcome', '.', 'result', 'of', 'paracentesis', 'in', 'hospitalized', 'cirrhotics', ',', '(', '.', ')', 'sbp', 'and', '(', '.', ')', 'randomized', '.', 'baseline', 'parameter', 'comparable', 'in', 'two', 'group', '.', 'response', 'h', '(', '.', 'vs.', '.', 'p', '.', ')', 'and', 'resolution', 'of', 'sbp', 'in', 'with', 'response', 'h', 'comparable', 'with', 'no', 'difference', 'in', 'mortality', 'week', ',', 'month', 'and', '.', 'patient', 'with', ""'no"", 'response', 'h', ""'"", 'higher', 'mortality', 'compared', 'with', 'responder', '(', '.', 'vs.', 'p', '.', ')', '.', 'resolution', 'of', 'sbp', 'associated', 'with', ""'response"", 'h', ""'"", 'and', 'septic', 'shock', ',', 'latter', 'main', 'pre-terminal', 'event', '.', 'aki', 'enrolment', 'hazard', 'ratio', '(', 'hr', ')', ',', '.', ',', 'pneumonia', 'hr', ',', '.', ',', 'septic', 'shock', 'hr', ',', '.', 'and', 'response', 'h', 'hr', ',', '.', 'predicted', 'poor', 'outcome', '.', 'conclusion', 'in', 'hospitalized', 'cirrhotics', 'with', 'sbp', 'and', 'risk', 'factor', 'treatment', 'failure', ',', 'cefepime', 'showed', 'comparable', 'efficacy', 'and', 'survival', 'to', 'imipenem', '.', 'non-response', 'to', 'therapy', 'h', 'reliable', 'predictor', 'of', 'treatment', 'failure', 'and', 'mortality', '.', 'antibiotic', 'combination', 'and', 'novel', 'option', 'needed', 'patient', '.']"
"Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study.","Annelies J van Velzen, Joris W F Uges, Harry G M Heijerman, Bert G M Arets, Marianne Nuijsink, Els C van der Wiel-Kooij, Erik M van Maarseveen, Gijsbert A van Zanten, Bas Pullens, Daan J Touw, Hettie M Janssens, Annelies J van Velzenet al.",2019 Sep,Br J Clin Pharmacol,https://pubmed.ncbi.nlm.nih.gov/31112621/,No keywords found,"['aimed', 'to', 'compare', 'pharmacokinetics', '(', 'pk', ')', 'and', 'safety', 'profile', 'of', 'tobramycin', 'inhalation', 'solution', '(', 'ti', ')', 'using', 'i-neb', 'device', 'to', 'standard', 'pari-lc', 'plus', 'nebulizer', 'in', 'child', 'with', 'cystic', 'fibrosis', '.', 'method', 'randomized', ',', 'open-label', ',', 'crossover', 'study', 'performed', '.', 'in', 'separate', 'study', 'visit', ',', 'blood', 'sample', 'child', 'collected', 'following', 'ti', 'nebulization', 'with', 'i-neb', '(', 'mg', ')', 'and', 'pari-lc', 'plus', '(', 'mg', ')', '.', 'study', 'visit', 'separated', 'month', ',', 'in', 'of', 'study', 'nebulizer', 'used', 'twice', 'daily', '.', 'tobramycin', 'pk', 'nebulizer', 'established', 'using', 'measured', 'tobramycin', 'concentration', 'and', 'bayesian', 'pk', 'modelling', 'software', '.', 'hearing', 'and', 'renal', 'function', 'test', 'performed', 'to', 'test', 'aminoglycoside', 'associated', 'toxicity', '.', 'in', 'addition', 'to', 'standard', 'estimated', 'glomerular', 'filtration', 'rate', 'value', ',', 'biomarkers', 'tubular', 'injury', '(', 'kim-', 'and', 'nag', ')', 'measured', '.', 'patient', 'and', 'nebulizer', 'satisfaction', 'assessed', '.', 'result', 'inhalation', 'well', 'tolerated', 'and', 'serum', 'trough', 'concentration', 'predefined', 'toxic', 'limit', 'reached', 'with', 'no', 'significant', 'difference', 'in', 'pk', 'parameter', 'nebulizer', '.', 'result', 'of', 'audiometry', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'revealed', 'no', 'abnormality', '.', 'however', ',', 'increased', 'urinary', 'nagcreatinine', 'ratio', 'visit', 'nebulizer', 'suggest', 'tis-induced', 'subclinical', 'tubular', 'kidney', 'injury', '.', 'nebulization', 'time', 'shorter', 'and', 'patient', 'satisfaction', 'significantly', 'higher', 'with', 'i-neb', '.', 'conclusion', 'nebulization', 'of', 'mg', 'ti', 'with', 'i-neb', 'in', 'child', 'with', 'cystic', 'fibrosis', 'resulted', 'in', 'comparable', 'systemic', 'exposure', 'to', 'mg', 'ti', 'with', 'pari-lc', 'plus', 'and', 'well', 'tolerated', 'and', 'preferred', 'pari-lc', 'plus', '.', 'long-term', 'safety', 'of', 'ti', 'nebulization', 'monitored', 'clinically', ',', 'especially', 'regarding', 'effect', 'tubular', 'kidney', 'injury', '.']"
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil.,"Opas Traitanon, James M Mathew, Aneesha Shetty, Sai Vineela Bontha, Daniel G Maluf, Yvonne El Kassis, Sook H Park, Jing Han, M Javeed Ansari, Joseph R Leventhal, Valeria Mas, Lorenzo Gallon, Opas Traitanonet al.",2019 May 28,PLoS One,https://pubmed.ncbi.nlm.nih.gov/31136582/,No keywords found,"['calcineurin', 'inhibitor', '(', 'cni', ')', ',', 'cornerstone', 'of', 'immunosuppression', 'transplantation', 'implicated', 'in', 'nephrotoxicity', 'and', 'allograft', 'dysfunction', '.', 'hypothesized', 'combined', 'low', 'dos', 'of', 'cni', 'and', 'everolimus', '(', 'evr', ')', 'may', 'result', 'in', 'better', 'graft', 'outcome', 'and', 'greater', 'tolerogenic', 'milieu', '.', 'forty', 'adult', 'renal', 'transplant', 'recipient', 'prospectively', 'randomized', 'to', '(', 'steroid', 'free', ')', 'low', 'dose', 'tacrolimus', '(', 'tac', ')', 'and', 'evr', 'or', 'standard', 'dose', 'tac', 'and', 'mycophenolate', '(', 'mmf', ')', 'alemtuzumab', 'induction', '.', 'baseline', 'characteristic', 'statistically', 'similar', '.', 'evr', 'level', 'maintained', '-', 'ngml', '.', 'tac', 'level', '..', 'and', '..', 'ngml', 'in', 'tacevr', 'and', 'tacmmf', 'group', 'respectively', '.', 'follow', 'and', 'month', 'respectively', 'and', 'included', 'protocol', 'kidney', 'biopsy', 'and', 'month', 'post-transplantation', '.', 'rejection-rate', 'lower', 'in', 'tacevr', 'group', '.', 'however', 'patient', 'and', 'overall', 'graft', 'survival', ',', 'egfr', 'and', 'incidence', 'of', 'adverse', 'event', 'similar', '.', 'tacevr', 'induced', 'expansion', 'of', 'cdcdhifoxp', 'regulatory', 'cell', 'early', 'month', 'and', 'expansion', 'of', 'ifn-cdcdhifoxp', 'regulatory', 'cell', 'month', 'post-transplant', '.', 'gene', 'expression', 'profile', 'showed', 'trend', 'toward', 'decreased', 'inflammation', ',', 'angiogenesis', 'and', 'connective', 'tissue', 'growth', 'in', 'tacevr', 'group', '.', 'thus', ',', 'greater', 'tolerogenic', 'mechanism', 'found', 'to', 'operating', 'in', 'patient', 'with', 'low', 'dose', 'tacevr', 'and', 'might', 'responsible', 'lower', 'rejection-rate', 'in', 'patient', 'standard', 'dose', 'tacmmf', '.', 'however', ',', 'study', 'with', 'longer', 'follow', 'and', 'evaluating', 'impact', 'regulatory', 'cell', 'warranted', '.']"
"A double-blinded, placebo-controlled, multicenter clinical trial of N-acetylcysteine for preventing amphotericin B-induced nephrotoxicity.","Iman Karimzadeh, Hossein Khalili, Mohammad Mahdi Sagheb, Shadi Farsaei, Iman Karimzadehet al.",2015,Expert Opin Drug Metab Toxicol,https://pubmed.ncbi.nlm.nih.gov/26050706/,No keywords found,"['to', 'evaluate', 'effectiveness', 'of', 'oral', 'n-acetylcysteine', '(', 'nac', ')', 'co-treatment', 'in', 'preventing', 'amphotericin', 'b', '(', 'amb', ')', '-induced', 'nephrotoxicity', '(', ')', ',', 'including', 'creatinine', 'clearance', 'and', 'biomarkers', 'of', 'renal', 'function', '(', 'cystatin', 'c', 'cys', 'c', 'and', 'kidney', 'injury', 'molecule-', 'kim-', ')', '.', 'method', 'either', 'placebo', 'or', 'mg', 'oral', 'nac', 'given', 'twice', 'daily', 'treatment', 'course', 'of', 'amb', '.', 'renal', 'function', 'test', ',', 'serum', 'well', 'urinary', 'level', 'of', 'cys', 'c', 'and', 'urinary', 'kim-', 'determined', '.', 'result', 'among', 'study', 'population', '(', 'n', ')', ',', '(', '.', ')', 'patient', 'developed', 'amb', 'nephrotoxicity', 'treatment', 'course', '.', 'nac', 'co-treatment', 'significantly', 'associated', 'with', 'mitigating', 'amb', 'nephrotoxicity', '(', 'or', '.', ',', 'ci', '.', '-', '.', 'p', '.', ')', '.', 'no', 'statistically', 'significant', 'difference', 'regarding', 'accuracy', 'of', 'measured', 'biomarkers', 'including', 'serum', 'creatinine', ',', 'serum', 'and', 'urine', 'cys', 'c', 'and', 'urine', 'kim-', 'day', 'and', 'of', 'treatment', 'in', 'predicting', 'and', 'detecting', 'amb', 'nephrotoxicity', 'identified', '.', 'change', 'in', 'mean', 'serum', 'and', 'urine', 'cys', 'c', 'and', 'urine', 'kim', 'amb', 'treatment', 'within', 'and', 'treatment', 'group', 'not', 'statistically', 'significant', '.', 'conclusion', 'co-treatment', 'with', 'mg', 'oral', 'nac', 'twice', 'day', 'amb', 'treatment', ',', 'adjusting', 'multiple', 'variable', ',', 'associated', 'with', 'prevention', 'of', '.', 'however', ',', 'significantly', 'higher', 'adverse', 'reaction', 'developed', 'in', 'patient', 'treated', 'with', 'nac', '.']"
Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function.,"Bettina M Buchholz, James W Ferguson, Andreas A Schnitzbauer, Peter Nightingale, Hans J Schlitt, Edward K Geissler, Darius F Mirza                                                            ;, International SiLVER study group, Bettina M Buchholzet al.",2020 May,Transplantation,https://pubmed.ncbi.nlm.nih.gov/31577671/,No keywords found,"['long-term', 'use', 'of', 'calcineurin', 'inhibitor', '(', 'cnis', ')', 'liver', 'transplantation', '(', 'lt', ')', 'associated', 'with', 'nephrotoxicity', '.', 'method', 'five-year', 'follow-up', 'data', 'retrieved', 'randomized', 'controlled', 'multicenter', 'silver', 'trial', '.', 'standard', 'cni-based', 'mammalian', 'target', 'of', 'rapamycin-free', 'immunosuppression', '(', 'group', ',', 'n', ')', 'compared', 'with', 'reduction', 'of', 'cni', 'and', 'introduction', 'of', 'mammalian', 'target', 'of', 'rapamycin', 'inhibitor', 'sirolimus', '(', 'sir', ')', 'within', '-', 'week', 'lt', '(', 'group', 'b', ',', 'n', ')', '.', 'result', 'median', 'meld', 'lt', 'low', 'with', '(', '-', ')', '(', 'group', ')', 'and', '(', '-', ')', '(', 'group', 'b', ')', 'in', 'intention-to-treat', 'approach', '.', 'cni', 'dose', 'and', 'cni', 'trough', 'reduced', 'and', '(', 'group', ')', 'versus', 'and', '(', 'group', 'b', ')', 'month', 'posttransplantation', '.', 'renal', 'function', 'preserved', 'month', 'lt', 'in', 'sir', 'arm', '(', 'estimated', 'glomerular', 'filtration', 'rate', '-', 'versus', '-', 'mlmin.m', 'p', '.', ')', 'similarly', 'impaired', 'thereafter', 'compared', 'with', 'group', 'a.', 'per', 'protocol', 'analysis', 'identified', 'lt', 'recipient', 'in', 'group', 'b', 'with', 'concomitant', 'early', 'cni', 'minimization', 'and', 'sir', 'treatment', 'year', 'with', 'significantly', 'superior', 'estimated', 'glomerular', 'filtration', 'rate', 'and', 'lowest', 'rate', 'of', 'chronic', 'kidney', 'disease', '(', 'stage', ')', 'year', 'onwards', 'study', 'end', '.', 'competing', 'risk', 'factor', 'renal', 'disease', '(', 'arterial', 'hypertension', ',', 'fat', 'metabolism', 'disorder', ',', 'and', 'hyperglycemia', ')', 'not', 'associated', 'with', 'worse', 'kidney', 'function', '.', 'conclusion', 'prevention', 'of', 'cni', 'nephrotoxicity', 'sir-based', 'early', 'cni', 'minimization', 'protects', 'renal', 'function', 'short-term', 'lt', 'in', 'intention-to-treat', 'analysis', 'of', 'low', 'meld', 'cohort', '.', 'yet', ',', 'selected', 'lt', 'recipient', 'compliant', 'with', 'early', 'cni', 'minimization', 'and', 'sir', 'maintenance', 'achieved', 'better', 'long-term', 'renal', 'outcome', 'compared', 'with', 'real-world', 'practice', '.']"
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial.,"George Bakris, Megumi Oshima, Kenneth W Mahaffey, Rajiv Agarwal, Christopher P Cannon, George Capuano, David M Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J L Heerspink, Adeera Levin, Bruce Neal, Richard Oh, Carol Pollock, Norman Rosenthal, David C Wheeler, Hong Zhang, Bernard Zinman, Meg J Jardine, Vlado Perkovic, George Bakriset al.",2020 Dec 7,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/33214158/,No keywords found,"['canagliflozin', 'and', 'renal', 'event', 'in', 'diabetes', 'with', 'established', 'nephropathy', 'clinical', 'evaluation', '(', 'credence', ')', 'trial', 'demonstrated', 'sodium', 'glucose', 'cotransporter', '(', 'sglt', ')', 'inhibitor', 'canagliflozin', 'reduced', 'risk', 'of', 'kidney', 'failure', 'and', 'cardiovascular', 'event', 'in', 'participant', 'with', 'type', 'diabetes', 'mellitus', 'and', 'ckd', '.', 'little', 'known', 'use', 'of', 'sglt', 'inhibitor', 'in', 'patient', 'with', 'egfr', '-', 'mgg', ',', 'and', 'egfr', 'of', 'to', '.', ')', '.', 'estimate', 'kidney', 'failure', 'in', 'participant', 'with', 'egfr', '.', ')', '.', 'conclusion', 'post', 'hoc', 'analysis', 'suggests', 'canagliflozin', 'slowed', 'progression', 'of', 'kidney', 'disease', ',', 'without', 'increasing', 'aki', ',', 'even', 'in', 'participant', 'with', 'egfr', 'mlmin', 'per', '.', '.']"
A randomized double-blinded placebo-controlled clinical trial on protective effects of pentoxifylline on gentamicin nephrotoxicity in infectious patients.,"Seyed Ruhollah Mousavinasab, Zohreh Akhoundi-Meybodi, Laleh Mahmoudi, Iman Karimzadeh, Seyed Ruhollah Mousavinasabet al.",2021 Aug,Clin Exp Nephrol,https://pubmed.ncbi.nlm.nih.gov/33792832/,No keywords found,"['renal', 'toxicity', 'limited', 'gentamicin', 'use', 'in', 'clinical', 'practice', '.', 'aim', 'of', 'present', 'clinical', 'trial', 'to', 'assess', 'possible', 'nephroprotective', 'effect', 'of', 'pentoxifylline', '(', 'ptx', ')', 'gentamicin', 'nephrotoxicity', '.', 'material', 'and', 'method', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'clinical', 'trial', 'conducted', 'patient', 'indication', 'systemic', 'gentamicin', 'least', 'day', '.', 'sixty', 'people', 'selected', 'and', 'randomly', 'assigned', '.', 'patient', 'in', 'intervention', 'and', 'control', 'group', ',', 'mg', 'ptx', 'sustained', 'release', 'tablet', 'and', 'placebo', 'given', 'orally', 'three', 'time', 'daily', ',', 'respectively', '.', 'demographic', ',', 'clinical', ',', 'laboratory', ',', 'and', 'therapeutic', 'information', 'of', 'patient', 'recorded', '.', 'malondialdehyde', '(', 'mda', ')', 'and', 'tumor', 'necrosis', 'factor-alpha', '(', 'tnf-', ')', 'level', 'in', 'serum', 'measured', 'day', 'and', '.', 'result', 'incidence', 'of', 'nephrotoxicity', 'in', 'placebo', 'group', '.', 'time', 'higher', 'in', 'ptx', 'group', '(', 'or', '.', ',', 'ci', '.-', '.', 'p', 'value', '.', ')', '.', 'mean', 'sd', 'time', 'onset', 'of', 'atn', '.', '.', 'and', '.', '.', 'day', 'in', 'ptx', 'and', 'placebo', 'recipient', ',', 'respectively', '(', 'p', 'value', '.', ')', '.', 'no', 'significant', 'difference', 'observed', 'hypokalemia', ',', 'hypomagnesemia', ',', 'potassium', 'and', 'magnesium', 'wasting', 'two', 'group', '.', 'mean', 'sd', 'level', 'of', 'serum', 'mda', 'and', 'tnf-', 'day', 'significantly', 'lower', 'in', 'ptx', 'compared', 'to', 'in', 'placebo', 'group', '(', 'p', 'value', '.', 'index', ')', '.', 'conclusion', 'co-administration', 'of', 'mg', 'ptx', 'orally', 'three', 'time', 'daily', 'along', 'with', 'gentamicin', 'well-tolerated', 'and', 'effective', 'in', 'preventing', 'nephrotoxicity', 'of', 'gentamicin', 'in', 'patient', 'with', 'different', 'infectious', 'disease', '.']"
Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study.,"Benjamin I Silbert, Kwok M Ho, Jeffrey Lipman, Jason A Roberts, Tomas B Corcoran, David J Morgan, Warren Pavey, Emilie Mas, Anne E Barden, Trevor A Mori, Benjamin I Silbertet al.",2016 Oct,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/27183025/,No keywords found,"['study', 'assessed', 'determinant', 'of', 'urinary', 'output', 'response', 'to', 'furosemide', 'in', 'acute', 'kidney', 'injury', 'specifically', ',', 'whether', 'response', 'related', 'to', 'altered', 'pharmacokinetics', 'or', 'pharmacodynamics', '.', 'design', 'prospective', 'cohort', '.', 'setting', 'tertiary', 'icu', '.', 'patient', 'thirty', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', 'without', 'preexisting', 'renal', 'impairment', 'or', 'recent', 'diuretic', 'exposure', '.', 'intervention', 'single', 'dose', 'of', 'iv', 'furosemide', '.', 'measurement', 'and', 'main', 'result', 'baseline', 'marker', 'of', 'intravascular', 'volume', 'status', 'obtained', 'prior', 'to', 'administering', 'furosemide', '.', 'six-hour', 'creatinine', 'clearance', ',', 'hourly', 'plasmaurinary', 'furosemide', 'concentration', ',', 'and', 'hourly', 'urinary', 'output', 'used', 'to', 'assess', 'furosemide', 'pharmacokineticspharmacodynamics', 'parameter', '.', 'of', 'patient', 'enrolled', ',', 'stage-', '(', ')', ',', 'nine', 'stage-', '(', ')', ',', 'and', 'stage-', '(', ')', 'acute', 'kidney', 'injury', 'network', 'acute', 'kidney', 'injury', '.', 'seventy-three', 'percent', 'septic', ',', 'required', 'norepinephrine', ',', 'and', 'mechanically', 'ventilated', '.', 'urinary', 'output', 'doubled', 'in', 'patient', '(', ')', 'following', 'iv', 'furosemide', '.', 'measured', 'creatinine', 'clearance', 'strongly', 'associated', 'with', 'amount', 'of', 'urinary', 'furosemide', 'excreted', 'and', 'reliable', 'predictor', 'of', 'urinary', 'output', 'furosemide', '(', 'area', 'receiver-operating-characteristic', 'curve', ',', '.', 'ci', ',', '.-.', ')', '.', 'in', 'addition', 'to', 'altered', 'pharmacokinetics', '(', 'p', '.', ')', ',', 'reduced', 'pharmacodynamics', 'response', 'to', 'furosemide', 'also', 'became', 'important', 'creatinine', 'clearance', 'reduced', 'to', 'less', 'mlmin', '.', '(', 'p', '.', ')', '.', 'acute', 'kidney', 'injury', 'staging', 'and', 'marker', 'of', 'intravascular', 'volume', ',', 'including', 'central', 'venous', 'pressure', ',', 'brain-natriuretic-peptide', 'concentration', ',', 'and', 'fractional', 'urinary', 'sodium', 'excretion', 'not', 'predictive', 'of', 'urinary', 'output', 'response', 'to', 'furosemide', '.', 'conclusion', 'severity', 'of', 'acute', 'kidney', 'injury', ',', 'reflected', 'measured', 'creatinine', 'clearance', ',', 'alters', 'pharmacokinetics', 'and', 'pharmacodynamics', 'of', 'furosemide', 'in', 'acute', 'kidney', 'injury', ',', 'and', 'reliable', 'predictor', 'of', 'urinary', 'output', 'response', 'to', 'furosemide', 'in', 'acute', 'kidney', 'injury', '.']"
Efficacy and safety of 20% albumin fluid loading in healthy subjects: a comparison of four resuscitation fluids.,"Shailesh Bihari, Ubbo F Wiersema, Rebecca Perry, David Schembri, Tara Bouchier, Dani Dixon, Teresa Wong, Andrew D Bersten, Shailesh Bihariet al.",2019 Jun 1,J Appl Physiol (1985),https://pubmed.ncbi.nlm.nih.gov/30998121/,"0.9% saline, stroke volume, 20% albumin, 4% albumin, Hartmann's solution, echocardiography, healthy volunteers, pulmonary function test, stroke work.","['recently', ',', 'buffered', 'salt', 'solution', 'and', 'albumin', '(', 'small', 'volume', 'resuscitation', ')', 'advocated', 'alternative', 'fluid', 'intravenous', 'resuscitation', '.', 'relative', 'comparative', 'efficacy', 'and', 'potential', 'adverse', 'effect', 'of', 'solution', 'not', 'evaluated', '.', 'in', 'randomized', ',', 'double', 'blind', ',', 'cross-over', 'study', 'of', 'six', 'healthy', 'male', 'subject', 'compared', 'pulmonary', 'and', 'hemodynamic', 'effect', 'of', 'intravenous', 'administration', 'of', 'mlkg', 'of', '.', 'saline', ',', 'hartmann', ""'s"", 'solution', 'and', 'albumin', ',', 'and', 'mlkg', 'of', 'albumin', '(', 'albumin', 'dose', 'equivalent', ')', '.', 'lung', 'test', '(', 'spirometry', ',', 'ultrasound', ',', 'impulse', 'oscillometry', ',', 'diffusion', 'capacity', ',', 'and', 'plethysmography', ')', ',', 'two-', 'to', 'three-dimensional', 'doppler', 'echocardiography', ',', 'carotid', 'applanation', 'tonometry', ',', 'blood', 'gas', ',', 'serumurine', 'marker', 'of', 'endothelial', ',', 'and', 'kidney', 'injury', 'measured', 'and', 'fluid', 'bolus', '.', 'data', 'analyzed', 'with', 'repeated', 'measure', 'anova', 'with', 'effect', 'of', 'fluid', 'type', 'examined', 'interaction', '.', 'crystalloids', 'caused', 'lung', 'edema', 'increase', 'in', 'ultrasound', 'b', 'line', '(', 'p', '.', ')', 'and', 'airway', 'resistance', '(', 'p', '.', ')', ',', 'evidence', 'of', 'lung', 'injury', 'increased', 'angiopoietin-', '(', 'p', '.', ')', 'and', 'glycocalyx', 'injury', 'increased', 'syndecan', '(', 'p', '.', ')', 'observed', 'with', '.', 'saline', '.', 'colloid', 'caused', 'greater', 'left', 'atrial', 'stretch', ',', 'decrease', 'in', 'lung', 'volume', ',', 'and', 'increase', 'in', 'diffusion', 'capacity', 'crystalloids', ',', 'without', 'pulmonary', 'edema', '.', 'stroke', 'work', 'increased', 'proportionally', 'to', 'increase', 'in', 'preload', 'with', 'four', 'fluid', '(', 'r', '.', ')', '.', 'greater', 'increase', 'in', 'cardiac', 'output', 'and', 'stroke', 'volume', 'colloid', 'administration', ',', 'associated', 'with', 'reduction', 'in', 'afterload', '.', 'hartmann', ""'s"", 'solution', 'not', 'significantly', 'alter', 'ventricular', 'performance', '.', 'marker', 'of', 'kidney', 'injury', 'not', 'affected', 'of', 'fluid', 'administrated', '.', 'bolus', 'administration', 'of', 'albumin', 'effective', 'and', 'safe', 'in', 'healthy', 'subject', '.', 'new', 'noteworthy', 'bolus', 'administration', 'of', 'albumin', 'effective', 'and', 'safe', 'in', 'healthy', 'subject', 'compared', 'with', 'commonly', 'available', 'crystalloids', 'and', 'colloidal', 'solution', '.']"
Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial.,"Dominique M Bovée, Lodi C W Roksnoer, Cornelis van Kooten, Joris I Rotmans, Liffert Vogt, Martin H de Borst, Robert Zietse, A H Jan Danser, Ewout J Hoorn, Dominique M Bovéeet al.",2021 Oct,J Nephrol,https://pubmed.ncbi.nlm.nih.gov/33382448/,No keywords found,"['acidosis-induced', 'kidney', 'injury', 'mediated', 'intrarenal', 'renin-angiotensin', 'system', ',', 'urinary', 'renin', 'potential', 'marker', '.', 'therefore', ',', 'hypothesized', 'sodium', 'bicarbonate', 'supplementation', 'reduces', 'urinary', 'renin', 'excretion', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'and', 'metabolic', 'acidosis', '.', 'method', 'patient', 'with', 'ckd', 'stage', 'g', 'and', 'plasma', 'bicarbonate', '-', 'mmoll', 'randomized', 'to', 'receive', 'sodium', 'bicarbonate', '(', 'mgday', ',', '.', 'meqkg', ')', ',', 'sodium', 'chloride', '(', ',', 'mgday', ')', ',', 'or', 'no', 'treatment', 'week', '(', 'n', 'arm', ')', '.', 'effect', 'urinary', 'renin', 'excretion', '(', 'primary', 'outcome', ')', ',', 'plasma', 'and', 'urine', 'parameter', 'of', 'renin-angiotensin', 'system', ',', 'endothelin-', ',', 'and', 'proteinuria', 'analyzed', '.', 'result', 'forty-five', 'patient', 'included', '(', 'year', ',', 'egfr', 'mlmin.m', ',', 'plasma', 'bicarbonate', '.', '.', 'mmoll', ')', '.', 'sodium', 'bicarbonate', 'supplementation', 'increased', 'plasma', 'bicarbonate', '(', '.', 'to', '.', 'mmoll', ')', 'and', 'reduced', 'urinary', 'ammonium', 'excretion', '(', 'to', 'mmolday', ',', 'p', '.', ')', '.', 'furthermore', ',', 'trend', 'towards', 'lower', 'plasma', 'aldosterone', '(', 'to', 'ngl', ',', 'p', '.', ')', 'and', 'potassium', '(', '.', 'to', '.', 'mmoll', ',', 'p', '.', ')', 'observed', 'in', 'patient', 'receiving', 'sodium', 'bicarbonate', '.', 'sodium', 'bicarbonate', 'not', 'significantly', 'change', 'urinary', 'excretion', 'of', 'renin', ',', 'angiotensinogen', ',', 'aldosterone', ',', 'endothelin-', ',', 'albumin', ',', 'or', '-microglobulin', '.', 'sodium', 'chloride', 'supplementation', 'reduced', 'plasma', 'renin', '(', 'to', 'ngl', ')', ',', 'and', 'increased', 'urinary', 'excretion', 'of', 'angiotensinogen', ',', 'albumin', ',', 'and', '-microglobulin', '(', 'p', '.', ')', '.', 'conclusion', 'despite', 'correction', 'of', 'acidosis', 'and', 'reduction', 'in', 'urinary', 'ammonium', 'excretion', ',', 'sodium', 'bicarbonate', 'supplementation', 'not', 'improve', 'urinary', 'marker', 'of', 'renin-angiotensin', 'system', ',', 'endothelin-', ',', 'or', 'proteinuria', '.', 'possible', 'explanation', 'include', 'bicarbonate', 'dose', ',', 'short', 'treatment', 'time', ',', 'or', 'inability', 'of', 'urinary', 'renin', 'to', 'reflect', 'intrarenal', 'renin-angiotensin', 'system', 'activity', '.']"
Prophylactic preoperative levosimendan for off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: Single-centered randomized prospective study.,"Pushkar Mahendra Desai, Manjula S Sarkar, Sanjeeta R Umbarkar, Pushkar Mahendra Desaiet al.",2018 Apr-Jun,Ann Card Anaesth,https://pubmed.ncbi.nlm.nih.gov/29652271/,No keywords found,"['off-pump', 'coronary', 'artery', 'bypass', 'surgery', '(', 'opcab', ')', 'often', 'complicated', 'hemodynamic', 'instability', ',', 'especially', 'in', 'patient', 'with', 'prior', 'left', 'ventricular', '(', 'lv', ')', 'dysfunction', 'and', 'appropriate', 'choice', 'of', 'inotrope', 'play', 'vital', 'role', 'in', 'perioperative', 'management', 'of', 'patient', '.', 'aim', 'and', 'objective', 'to', 'study', 'hemodynamic', 'effect', 'and', 'immediate', 'outcome', 'of', 'prophylactic', 'infusion', 'of', 'levosimendan', 'in', 'patient', 'with', 'lv', 'dysfunction', 'undergoing', 'opcab', 'surgery', 'and', 'whether', 'strategy', 'help', 'in', 'successful', 'conduct', 'of', 'opcab', 'surgery', '.', 'material', 'and', 'method', 'institutional', 'ethic', 'committee', 'approval', ',', 'patient', 'posted', 'elective', 'opcab', 'surgery', 'randomly', 'divided', 'two', 'group', '(', 'n', ')', '.', 'patient', 'with', 'lv', 'ejection', 'fraction', 'mmhg', '.', 'chi-squarefisher', ""'s"", 'exactmid', 'p', 'exact', 'test', 'and', 'student', ""'s"", 't-tests', 'applied', 'categorical', 'and', 'continuous', 'data', '.', 'result', 'ci', 'greater', 'and', 'pcwp', 'reduced', 'significantly', 'in', 'group', 'l', 'intraoperative', 'and', 'early', 'postoperative', 'period', '.', 'serum', 'lactate', 'concentration', 'lower', 'in', 'patient', 'pretreated', 'with', 'levosimendan', '.', 'incidence', 'of', 'postoperative', 'atrial', 'fibrillation', '(', 'poaf', ')', '(', '.', 'vs.', '.', 'p', '.', ')', ',', 'low', 'cardiac', 'output', 'syndrome', '(', 'lcos', ')', '(', 'vs.', 'p', '.', ')', ',', 'and', 'acute', 'kidney', 'injury', '(', '.', 'vs.', '.', 'p', '.', ')', 'less', 'in', 'group', 'l.', 'three', 'patient', '(', ')', 'in', 'control', 'group', 'required', 'conversion', 'to', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'compared', 'to', 'none', 'in', 'study', 'group', '.', 'no', 'difference', 'regarding', 'icu', 'or', 'hospital', 'stay', 'and', 'mortality', 'in', 'group', '.', 'conclusion', 'preoperative', 'levosimendan', 'help', 'in', 'successful', 'conduct', 'of', 'opcab', 'and', 'reduces', 'incidence', 'of', 'lcos', ',', 'poaf', ',', 'conversion', 'to', 'cpb', ',', 'and', 'requirement', 'of', 'intra-aortic', 'balloon', 'pump', '.']"
Effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy: a randomized trial.,"Bora Lee, Sook Young Lee, Na Young Kim, Koon Ho Rha, Young Deuk Choi, Sujung Park, So Yeon Kim, Bora Leeet al.",2017 Sep,Surg Endosc,https://pubmed.ncbi.nlm.nih.gov/28593413/,No keywords found,"['robot-assisted', 'laparoscopic', 'partial', 'nephrectomy', '(', 'rlpn', ')', 'emerging', 'technique', 'treating', 'small', 'renal', 'mass', '.', 'although', 'rlpn', 'many', 'advantage', ',', 'ischemic', 'kidney', 'injury', 'inevitable', 'renal', 'artery', 'clamping', '.', 'overall', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'partial', 'nephrectomy', 'reported', 'to', 'to', '.', 'moreover', ',', 'effective', 'pharmacological', 'protection', 'aki', 'partial', 'nephrectomy', 'not', 'yet', 'demonstrated', '.', 'ulinastatin', 'shown', 'to', 'protect', 'kidney', 'ischemiareperfusion', 'injury', 'via', 'anti-inflammatory', 'and', 'anti-oxidant', 'activity', '.', 'therefore', ',', 'study', 'aimed', 'to', 'evaluate', 'effect', 'of', 'ulinastatin', 'postoperative', 'kidney', 'function', 'in', 'patient', 'undergoing', 'rlpn', '.', 'method', 'in', 'randomized', ',', 'double-blinded', ',', 'placebo-controlled', 'study', ',', 'patient', 'undergoing', 'rlpn', 'received', 'either', 'intravenous', 'ulinastatin', '(', ',', 'unit', 'kg', 'ulinastatin', 'group', ',', 'n', ')', 'or', 'volume', 'of', 'normal', 'saline', '(', 'control', 'group', ',', 'n', ')', 'h', 'starting', 'min', 'renal', 'artery', 'clamping', '.', 'primary', 'outcome', 'incidence', 'of', 'postoperative', 'aki', '.', 'secondary', 'outcome', 'level', 'of', 'serum', 'creatinine', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', ',', 'cystatin', 'c', ',', 'and', 'inflammatory', 'marker', 'and', 'measured', 'operation', 'and', ',', ',', ',', 'and', 'h', 'postoperatively', '.', 'result', 'incidence', 'of', 'postoperative', 'aki', 'in', 'ulinastatin', 'group', ',', 'whereas', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'postoperative', 'change', 'of', 'serum', 'creatinine', ',', 'egfr', ',', 'or', 'cystatin', 'c', 'observed', 'two', 'group', '.', 'postoperative', 'inflammatory', 'marker', 'including', 'c-reactive', 'protein', ',', 'white', 'blood', 'cell', 'count', ',', 'and', 'neutrophil', 'percentage', 'significantly', 'increased', 'h', 'operation', 'compared', 'to', 'preoperative', 'value', 'in', 'group', ',', 'with', 'no', 'significant', 'difference', 'group', '.', 'conclusion', 'administration', 'of', 'ulinastatin', '(', ',', 'unit', 'kg', ')', 'warm', 'ischemia', 'and', 'reperfusion', 'period', 'not', 'show', 'beneficial', 'effect', 'postoperative', 'kidney', 'function', 'or', 'inflammatory', 'response', 'in', 'patient', 'undergoing', 'rlpn', '.']"
EPILAT-IRA Study: A contribution to the understanding of the epidemiology of acute kidney injury in Latin America.,"Raúl Lombardi, Alejandro Ferreiro, Rolando Claure-Del Granado, Emmanuel A Burdmann, Guillermo Rosa-Diez, Luis Yu, Mauricio Younes-Ibrahim, Cristina Carlino, Jonathan S Chávez-Iñiguez, Mariana B Pereira, Carlos F Varela, Welder Zamoner, Diego Janiques, Soledad Lecueder, Víctor Cerrón-Millán, Alfonso Cueto-Manzano                              ;, EPILAT-ITA Study Group, Raúl Lombardiet al.",2019 Nov 14,PLoS One,https://pubmed.ncbi.nlm.nih.gov/31725746/,No keywords found,"['epidemiology', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'highly', 'dependent', 'patient', 'characteristic', ',', 'context', 'and', 'geography', '.', 'considering', 'limited', 'information', 'in', 'latin', 'america', 'and', 'caribbean', ',', 'performed', 'study', 'with', 'aim', 'to', 'contribute', 'to', 'improve', 'better', 'understanding', '.', 'method', 'observational', ',', 'prospective', ',', 'longitudinal', ',', 'multinational', 'cohort', 'study', 'addressed', 'to', 'determine', 'risk', 'factor', ',', 'clinical', 'profile', ',', 'process', 'of', 'care', 'and', 'outcome', 'of', 'aki', 'in', 'region', '.', 'patient', 'meeting', 'kdigo', 'aki', 'definition', 'included', '-month', 'period', 'and', 'designated', 'community', 'or', 'hospital-acquired', '.', 'de-identified', 'clinical', 'and', 'lab', 'data', 'entered', 'in', 'specifically', 'designed', 'on-line', 'platform', '.', 'co-variables', 'potentially', 'linked', 'to', 'aki', 'onset', ',', 'in-hospital', 'and', '-days', 'mortality', ',', 'recorded', 'and', 'correlated', 'using', 'multiple', 'logistic', 'regression', 'model', '.', 'result', 'fifty-seven', 'physician', 'country', 'provided', 'data', 'patient', ',', 'with', 'acceptable', 'basic', 'need', 'coverage', '.', 'median', 'age', '(', '-', ')', 'yr', 'of', 'male', '(', ')', 'and', 'mestizo', '(', ')', '.', 'comorbidities', 'present', 'in', '.', 'aki', 'community-acquired', 'in', '.', 'dehydration', ',', 'shock', 'and', 'nephrotoxic', 'drug', 'commonest', 'cause', '.', 'process', 'of', 'care', ',', 'of', 'patient', 'assessed', 'nephrologists', '.', 'kidney', 'replacement', 'therapy', '(', 'krt', ')', 'performed', 'in', 'of', 'case', '.', 'in-hospital', 'mortality', '.', 'and', 'independently', 'associated', 'to', 'older', 'age', ',', 'chronic', 'liver', 'disease', ',', 'hypotension', ',', 'shock', ',', 'cardiac', 'disturbance', ',', 'hospital-acquired', 'sepsis', ',', 'krt', 'and', 'mechanical', 'ventilation', '.', '-days', 'follow', 'partial', 'or', 'complete', 'renal', 'recovery', 'and', 'mortality', '.', 'conclusion', 'aki', 'mainly', 'community-acquired', ',', 'in', 'patient', 'with', 'comorbidities', 'and', 'linked', 'to', 'fluid', 'loss', 'and', 'nephrotoxic', 'drug', '.', 'mortality', 'high', 'and', 'long-term', 'follow', 'poor', '.', 'notwithstanding', ',', 'study', 'show', 'partially', 'situation', 'in', 'participant', 'country', 'rather', 'actual', 'epidemiology', 'of', 'aki', 'in', 'latin', 'america', 'and', 'caribbean', ',', 'pending', 'and', 'needed', 'task', '.']"
Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis: A Randomized Controlled Trial.,"Abd Elazeez Shabaan, Islam Nour, Heba Elsayed Eldegla, Nehad Nasef, Basma Shouman, Hesham Abdel-Hady, Abd Elazeez Shabaanet al.",2017 Apr,Pediatr Infect Dis J,https://pubmed.ncbi.nlm.nih.gov/27918382/,No keywords found,"['gram-negative', 'bacteria', 'associated', 'with', 'significant', 'morbidity', 'and', 'mortality', 'in', 'preterm', 'and', 'term', 'newborn', '.', 'meropenem', 'widespread', 'efficacy', 'and', 'often', 'allows', 'monotherapy', 'in', 'group', '.', 'prolonged', 'infusion', 'instead', 'of', 'infusion', 'minute', 'suggested', 'to', 'result', 'in', 'higher', 'microbiologic', 'efficacy', '.', 'objective', 'to', 'compare', 'clinical', 'and', 'microbiologic', 'efficacy', 'and', 'safety', 'of', 'prolonged', 'infusion', 'versus', 'conventional', 'dosing', 'of', 'meropenem', 'in', 'neonate', 'with', 'gram-negative', 'late-onset', 'sepsis', '(', 'gn-los', ')', '.', 'method', 'prospective', ',', 'randomized', 'clinical', 'trial', 'conducted', 'in', 'neonate', 'with', 'gn-los', 'admitted', 'to', 'neonatal', 'intensive', 'care', 'unit', '(', 'nicu', ')', ',', 'mansoura', 'university', 'child', ""'s"", 'hospital', ',', 'august', 'and', 'june', '.', 'patient', 'randomly', 'assigned', 'to', 'receive', 'either', 'intravenous', 'infusion', 'of', 'meropenem', 'hour', '(', 'infusion', 'group', ')', 'or', 'minute', '(', 'conventional', 'group', ')', 'dosing', 'regimen', 'of', 'mgkgdose', 'every', 'hour', 'and', 'mgkgdose', 'every', 'hour', 'in', 'meningitis', 'and', 'pseudomonas', 'infection', '.', 'clinical', 'and', 'microbiologic', 'success', 'in', 'eradication', 'of', 'infection', 'primary', 'outcome', '.', 'neonatal', 'mortality', ',', 'meropenem-related', '(', 'mr', ')', 'duration', 'of', 'mechanical', 'ventilation', ',', 'mr', 'length', 'of', 'nicu', 'stay', ',', 'total', 'length', 'of', 'nicu', 'stay', ',', 'duration', 'of', 'respiratory', 'support', '(', 'r', ')', ',', 'duration', 'of', 'mechanical', 'ventilation', ',', 'mr', 'duration', 'of', 'inotropes', 'and', 'adverse', 'effect', 'secondary', 'outcome', '.', 'result', 'total', 'of', 'infant', '(', 'in', 'group', ')', 'recruited', '.', 'infusion', 'group', 'demonstrated', 'significantly', 'higher', 'rate', 'of', 'clinical', 'improvement', 'and', 'microbiologic', 'eradication', 'day', 'starting', 'meropenem', 'therapy', 'compared', 'with', 'conventional', 'group', '.', 'mortality', 'and', 'duration', 'of', 'r', 'significantly', 'less', 'in', 'infusion', 'group', 'compared', 'with', 'conventional', 'group', '.', 'acute', 'kidney', 'injury', 'meropenem', 'treatment', 'significantly', 'less', 'in', 'infusion', 'group', 'compared', 'with', 'conventional', 'group', '.', 'conclusion', 'prolonged', 'infusion', 'of', 'meropenem', 'in', 'neonate', 'with', 'gn-los', 'associated', 'with', 'higher', 'clinical', 'improvement', ',', 'microbiologic', 'eradication', ',', 'less', 'neonatal', 'mortality', ',', 'shorter', 'duration', 'of', 'r', 'and', 'less', 'acute', 'kidney', 'injury', 'compared', 'with', 'conventional', 'strategy', '.']"
Effect of Intraoperative Goal-directed Balanced Crystalloid versus Colloid Administration on Major Postoperative Morbidity: A Randomized Trial.,"Barbara Kabon, Daniel I Sessler, Andrea Kurz;, Crystalloid–Colloid Study Team, Kamal Maheshwari, Rovnat Babazade, Alexa Fiffick, Ignacia Gazmuri, Michael Ghobrial, Hooman Honar, Michael Kot, Tatyana Kopyeva, Onur Koyuncu, Ian Lavery, Edward J Mascha, Amanda Naylor, Attila Podolyak, Eric Reville, Joseph Saxon, Iman Suleiman, Dongsheng Yang, Jing You, David W Dietz, Edith Fleischmann, Christian Reiterer, Oliver M Zotti, Anton Stift, Thomas Gruenberger, Mina Obradovic, Florian Luf, Jakob Muehlbacher, Samir Sljivic, Ahmed Bayoumi, Corinna Marschalek, Alexander Kaserer, Jasmin Rahimi, Klaus Eredics, Benedict Krischer, Erol Erdik, Jonas Rech, Sergio Bergese, Barbara Kabonet al.",2019 May,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/30882476/,No keywords found,"['crystalloid', 'solution', 'leave', 'circulation', 'quickly', ',', 'whereas', 'colloid', 'remain', 'hour', ',', 'thus', 'promoting', 'hemodynamic', 'stability', '.', 'however', ',', 'colloid', 'expensive', 'and', 'promote', 'renal', 'toxicity', 'in', 'critical', 'care', 'patient', '.', 'study', 'tested', 'hypothesis', 'goal-directed', 'colloid', 'administration', 'elective', 'abdominal', 'surgery', 'decrease', '-day', 'major', 'complication', 'goal-directed', 'crystalloid', 'administration', '.', 'method', 'in', 'parallel-arm', 'double-blinded', 'multicenter', 'randomized', 'trial', ',', 'adult', 'moderate-', 'to', 'high-risk', 'open', 'and', 'laparoscopically', 'assisted', 'abdominal', 'surgery', 'with', 'general', 'anesthesia', 'randomly', 'assigned', 'to', 'doppler-guided', 'intraoperative', 'volume', 'replacement', 'with', 'hydroxyethyl', 'starch', '.', '(', 'n', ')', 'or', 'lactated', 'ringer', ""'s"", 'solution', '(', 'n', ')', '.', 'primary', 'outcome', 'composite', 'of', 'serious', 'postoperative', 'cardiac', ',', 'pulmonary', ',', 'infectious', ',', 'gastrointestinal', ',', 'renal', ',', 'and', 'coagulation', 'complication', 'assessed', 'with', 'generalized', 'estimating', 'equation', 'multivariate', 'model', '.', 'primary', 'safety', 'outcome', 'change', 'in', 'serum', 'creatinine', 'concentration', 'to', 'month', 'postoperatively', ',', 'compared', 'to', 'baseline', 'concentration', '.', 'result', 'total', 'of', ',', 'patient', 'included', 'in', 'analysis', '.', 'patient', 'assigned', 'to', 'crystalloid', 'received', 'median', 'quartile', ',', 'quartile', 'amount', 'of', '.', 'l', '.', ',', '.', 'of', 'crystalloid', ',', 'and', 'patient', 'assigned', 'to', 'colloid', 'received', '.', 'l', '.', ',', '.', 'of', 'colloid', 'and', '.', 'l', '.', ',', '.', 'of', 'crystalloid', '.', 'estimated', 'intention-to-treat', 'common', 'effect', 'relative', 'risk', 'primary', 'composite', '.', 'colloid', 'versus', 'crystalloids', '(', 'ci', '.', 'to', '.', ',', 'p', '.', ')', ',', 'and', '(', 'of', ')', 'of', 'colloid', 'patient', 'and', '(', 'of', ')', 'of', 'crystalloid', 'patient', 'incurred', 'least', 'one', 'component', 'of', 'primary', 'outcome', 'composite', '.', 'no', 'evidence', 'of', 'renal', 'toxicity', 'time', '.', 'conclusion', 'doppler-guided', 'intraoperative', 'hydroxyethyl', 'starch', 'administration', 'not', 'significantly', 'reduce', 'composite', 'of', 'serious', 'complication', '.', 'however', ',', 'also', 'no', 'indication', 'of', 'renal', 'or', 'toxicity', '.']"
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.,"Noboru Asada, Jun Ando, Satoru Takada, Chikashi Yoshida, Kensuke Usuki, Atsushi Shinagawa, Kenichi Ishizawa, Toshihiro Miyamoto, Hiroatsu Iida, Nobuaki Dobashi, Sumiko Okubo, Hideyuki Honda, Tomomi Soshin, Yasuko Nishimura, Atsuko Tsutsui, Harumi Mukai, Kazuhito Yamamoto, Noboru Asadaet al.",2023 Jun 29,Jpn J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/37017320/,No keywords found,"['in', 'phase', 'international', 'clinical', 'trial', '(', 'viale-c', ')', ',', 'venetoclax', 'plus', 'low-dose', 'cytarabine', 'improved', 'response', 'rate', 'and', 'overall', 'survival', 'versus', 'placebo', 'plus', 'low-dose', 'cytarabine', 'in', 'patient', 'with', 'newly', 'diagnosed', 'acute', 'myeloid', 'leukemia', 'ineligible', 'intensive', 'chemotherapy', '.', 'enrollment', 'period', 'of', 'viale-c', 'ended', ',', 'conducted', 'expanded', 'access', 'study', 'to', 'provide', 'preapproval', 'access', 'to', 'venetoclax', 'in', 'combination', 'with', 'low-dose', 'cytarabine', 'in', 'japan', '.', 'method', 'previously', ',', 'untreated', 'patient', 'with', 'acute', 'myeloid', 'leukemia', 'ineligible', 'intensive', 'chemotherapy', 'enrolled', 'according', 'to', 'viale-c', 'criterion', '.', 'patient', 'received', 'venetoclax', '(', 'mg', ',', 'day', '-', ',', '-day', 'ramp-up', 'in', 'cycle', ')', 'in', '-day', 'cycle', 'and', 'low-dose', 'cytarabine', '(', 'mgm', ',', 'day', '-', ')', '.', 'patient', 'took', 'tumor', 'lysis', 'syndrome', 'prophylactic', 'agent', 'and', 'hydration', '.', 'safety', 'endpoint', 'assessed', '.', 'result', 'fourteen', 'patient', 'enrolled', 'in', 'study', '.', 'median', 'age', '.', 'year', '(', 'range', '-', ')', ',', 'with', '.', 'year', 'old', '.', 'common', 'grade', 'treatment-emergent', 'adverse', 'event', 'neutropenia', '(', '.', ')', '.', 'febrile', 'neutropenia', 'frequent', 'serious', 'adverse', 'event', '(', '.', ')', '.', 'one', 'patient', 'developed', 'treatment-related', 'acute', 'kidney', 'injury', ',', 'leading', 'to', 'discontinuation', 'of', 'treatment', '.', 'two', 'patient', 'died', 'of', 'cardiac', 'failure', 'and', 'disease', 'progression', 'judged', 'not', 'related', 'to', 'study', 'treatment', '.', 'no', 'patient', 'developed', 'tumor', 'lysis', 'syndrome', '.', 'conclusion', 'safety', 'outcome', 'similar', 'to', 'in', 'viale-c', 'without', 'new', 'safety', 'signal', 'and', 'well', 'managed', 'with', 'standard', 'medical', 'care', '.', 'in', 'clinical', 'practice', ',', 'patient', 'with', 'severe', 'background', 'disease', 'expected', ',', 'in', 'comparison', 'with', 'in', 'viale-c', ',', 'suggesting', 'important', 'to', 'carefully', 'manage', 'and', 'prevent', 'adverse', 'event', '.']"
Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.,"Terence T Sio, Pamela J Atherton, Levi D Pederson, W Ken Zhen, Robert W Mutter, Yolanda I Garces, Daniel J Ma, James L Leenstra, Jean-Claude M Rwigema, Shaker Dakhil, James D Bearden, Sonja J van der Veen, Apar K Ganti, Steven E Schild, Robert C Miller, Terence T Sioet al.",2019 Mar 1,Int J Radiat Oncol Biol Phys,https://pubmed.ncbi.nlm.nih.gov/30395904/,No keywords found,"['chemoradiation', '(', 'crt', ')', 'integral', 'treatment', 'modality', 'patient', 'with', 'locally', 'advanced', 'lung', 'cancer', '.', 'hypothesized', 'current', 'use', 'of', 'angiotensin-converting', 'enzyme', 'inhibitor', 'crt', 'may', 'protective', 'treatment-related', 'lung', 'damage', 'and', 'pneumonitis', '.', 'method', 'and', 'material', 'conducted', 'pilot', ',', 'double-blind', ',', 'placebo-controlled', ',', 'randomized', 'trial', '.', 'study-eligible', 'patient', 'receiving', 'curative', 'thoracic', 'radiation', 'therapy', '(', 'rt', ')', 'randomly', 'assigned', 'to', 'mg', 'of', 'lisinopril', 'or', 'placebo', 'daily', 'and', 'to', 'month', 'rt', '.', 'patient', 'received', 'concurrent', 'chemotherapy', '.', 'primary', 'endpoint', 'adverse', 'event', 'profiling', '.', 'multiple', 'patient-reported', 'outcome', '(', 'pro', ')', 'survey', ',', 'including', 'lung', 'cancer', 'symptom', 'scale', ',', 'function', 'assessment', 'of', 'cancer', 'therapy-lung', ',', 'and', 'european', 'organisation', 'research', 'and', 'treatment', 'of', 'cancer', 'lung', 'cancer', 'questionnaire', ',', 'applied', 'with', 'symptom', 'experience', 'questionnaire', '.', 'exploratory', 'comparative', 'statistic', 'used', 'to', 'detect', 'difference', 'arm', 'with', 'and', 'kruskal-wallis', 'testing', '.', 'result', 'five', 'institution', 'enrolled', 'patient', '.', 'however', ',', 'accrual', 'less', 'expected', '.', 'eleven', 'and', 'patient', 'in', 'placebo', 'and', 'lisinopril', 'arm', ',', 'respectively', '(', 'mean', 'age', ',', '.', 'year', 'male', ',', ')', '.', 'baseline', 'characteristic', 'balanced', '.', 'eighteen', 'patient', '(', ')', 'former', 'or', 'current', 'smoker', '.', 'primary', 'endpoint', 'met', 'neither', 'arm', 'grade', 'or', 'higher', 'hypotension', ',', 'acute', 'kidney', 'injury', ',', 'allergic', 'reaction', '(', 'medication-induced', 'cough', ')', ',', 'or', 'anaphylaxis', '(', 'medication-related', 'angioedema', ')', '.', 'pro', 'measure', 'suggested', 'compared', 'with', 'placebo', 'arm', ',', 'patient', 'receiving', 'lisinopril', 'less', 'cough', ',', 'less', 'shortness', 'of', 'breath', ',', 'fewer', 'symptom', 'lung', 'cancer', ',', 'less', 'dyspnea', 'with', 'walking', 'and', 'climbing', 'stair', ',', 'and', 'better', 'overall', 'quality', 'of', 'life', '(', ',', 'p', '.', ')', '.', 'conclusion', 'although', 'underpowered', 'of', 'low', 'accrual', ',', 'result', 'suggest', 'clinical', 'signal', 'safety-and', 'possibly', 'beneficial', 'limited', 'pro', 'measures-in', 'concurrently', 'administering', 'lisinopril', 'thoracic', 'crt', 'to', 'mitigate', 'or', 'prevent', 'rt-induced', 'pulmonary', 'distress', '.', 'result', 'showed', 'definitive', ',', 'larger-scale', ',', 'randomized', 'phase', 'trial', 'needed', 'in', 'future', '.']"
"Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS): a study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept study.","Per Ederoth, Edgars Grins, Alain Dardashti, Björn Brondén, Carsten Metzsch, André Erdling, Shahab Nozohoor, Arash Mokhtari, Magnus J Hansson, Eskil Elmér, Lars Algotsson, Stefan Jovinge, Henrik Bjursten, Per Ederothet al.",2016 Dec 15,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/27979834/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', 'common', 'and', 'result', 'in', 'increased', 'morbidity', 'and', 'mortality', '.', 'one', 'possible', 'mechanism', 'aki', 'ischaemia-reperfusion', 'injury', 'caused', 'extracorporeal', 'circulation', '(', 'ecc', ')', ',', 'resulting', 'in', 'opening', 'of', 'mitochondrial', 'permeability', 'transition', 'pore', '(', 'mptp', ')', 'in', 'kidney', ',', 'lead', 'to', 'cell', 'injury', 'or', 'cell', 'death', '.', 'ciclosporin', 'may', 'block', 'opening', 'of', 'mptp', 'administered', 'ischaemia-reperfusion', 'injury', '.', 'hypothesised', 'ciclosporin', 'given', 'start', 'of', 'ecc', 'in', 'cardiac', 'surgery', 'decrease', 'degree', 'of', 'aki', '.', 'method', 'and', 'analysis', 'ciclosporin', 'to', 'protect', 'renal', 'function', 'in', 'cardiac', 'surgery', '(', 'ciprics', ')', 'study', 'investigator-initiated', 'double-blind', ',', 'randomised', ',', 'placebo-controlled', ',', 'parallel', 'design', ',', 'single-centre', 'study', 'performed', 'tertiary', 'university', 'hospital', '.', 'primary', 'objective', 'to', 'assess', 'safety', 'and', 'efficacy', 'of', 'ciclosporin', 'to', 'limit', 'degree', 'of', 'aki', 'in', 'patient', 'undergoing', 'coronary', 'artery', 'bypass', 'grafting', 'surgery', '.', 'aim', 'to', 'evaluate', 'patient', 'with', 'preoperative', 'estimated', 'glomerular', 'filtration', 'rate', 'of', '-', 'mlmin', '.', 'm.', 'study', 'patient', 'randomised', 'in', 'ratio', 'to', 'receive', 'study', 'drug', '.', 'mgkg', 'ciclosporin', 'or', 'placebo', 'intravenous', 'injection', 'anaesthesia', 'induction', 'start', 'of', 'surgery', '.', 'primary', 'end', 'point', 'consists', 'of', 'relative', 'p-cystatin', 'c', 'change', 'preoperative', 'day', 'to', 'postoperative', 'day', '.', 'primary', 'variable', 'tested', 'using', 'analysis', 'of', 'covariance', 'method', '.', 'secondary', 'end', 'point', 'include', 'evaluation', 'of', 'p-creatinine', 'and', 'biomarkers', 'of', 'kidney', ',', 'heart', 'and', 'brain', 'injury', '.', 'ethic', 'and', 'dissemination', 'trial', 'conducted', 'in', 'compliance', 'with', 'current', 'version', 'of', 'declaration', 'of', 'helsinki', 'and', 'international', 'council', 'harmonisation', '(', 'ich', ')', 'good', 'clinical', 'practice', 'guideline', 'e', '(', 'r', ')', 'and', 'approved', 'regional', 'ethical', 'review', 'board', ',', 'lund', 'and', 'swedish', 'medical', 'product', 'agency', '(', 'mpa', ')', '.', 'written', 'and', 'oral', 'informed', 'consent', 'obtained', 'enrolment', 'study', '.', 'trial', 'registration', 'number', 'nct', 'pre-results', '.']"
Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.,"Ana Villegas, Ramiro Núñez, Anna Gaya, María Victoria Cuevas-Ruiz, José Miguel Bosch, Anna Carral, Beatriz Arrizabalaga, María Isabel Gómez-Roncero, Asunción Mora, Pilar Bravo, Esperanza Lavilla, Carmen Monteserín, Belén Hernández, Pilar Martínez-Barranco, Isidro Jarque, María Anunciación Urquía, Gloria García-Donas, Salut Brunet, Fernando Ataulfo González, Álvaro Urbano, Ana Villegaset al.",2017 Oct,Ann Hematol,https://pubmed.ncbi.nlm.nih.gov/28748287/,"Acute and chronic renal failure, Eculizumab, Glomerular filtration rate, Paroxysmal nocturnal hemoglobinuria (PNH), Renal function status.","['paroxysmal', 'nocturnal', 'hemoglobinuria', '(', 'pnh', ')', 'rare', ',', 'life-threatening', 'blood', 'disease', '.', 'with', 'advent', 'of', 'eculizumab', 'treatment', ',', 'renal', 'function', 'substantially', 'improved', ',', 'although', 'no', 'data', 'real-world', 'clinical', 'practice', 'available', '.', 'observational', ',', 'retrospective', ',', 'multicenter', 'study', 'conducted', 'in', 'spain', 'clinical', 'data', 'obtained', 'outpatient', 'visit', 'of', 'patient', 'with', 'pnh', '(', 'spanish', 'pnh', 'registry', ')', 'experienced', 'acute', '(', 'arf', ')', 'or', 'chronic', '(', 'crf', ')', 'renal', 'failure', '.', 'of', 'patient', 'registered', '(', 'april', ')', ',', 'diagnosed', 'with', 'classic', 'pnh', '.', 'twenty-seven', '(', '.', ')', 'patient', 'with', 'mean', 'age', 'of', '.', '(', '.', ')', 'year', 'renal', 'failure', ',', 'arf', 'or', 'crf', ',', 'and', 'included', 'in', 'study', '.', 'near', 'half', 'of', 'patient', '(', 'n', '.', ')', 'presented', 'with', 'arf', 'alone', ',', '.', '(', 'n', ')', 'crf', 'with', 'episode', 'of', 'arf', ',', '.', '(', 'n', ')', 'diagnosed', 'with', 'crf', 'alone', '.', 'patient', 'with', 'diagnosis', 'of', 'pnh', 'and', 'renal', 'failure', '(', 'n', ')', ',', 'median', 'time', 'to', 'first', 'arf', 'episode', '.', '(', 'ci', '.', ',', '.', ')', 'year', ',', 'whereas', 'median', 'to', 'diagnosis', 'of', 'crf', '.', '(', 'ci', '.', ',', '.', ')', 'year', 'diagnosis', 'of', 'pnh', '.', 'patient', 'with', 'arf', '(', 'n', ')', 'treated', 'with', 'eculizumab', 'and', 'not', 'experience', 'new', 'episode', 'of', 'arf', ',', 'except', 'one', 'patient', 'with', 'sepsis', '.', 'of', 'patient', 'with', 'crf', ',', 'two', 'received', 'treatment', 'without', 'experiencing', 'episode', 'of', 'arf', '.', 'sixteen', 'patient', 'completed', 'treatment', '(', 'with', 'arf', 'and', 'with', 'arf', 'crf', ')', 'recovered', 'episode', 'of', 'arf', 'or', 'crf', '.', 'of', 'remaining', 'patient', 'treated', 'with', 'eculizumab', ',', 'one', 'patient', 'improved', 'stage', 'iii', 'to', 'ii', ',', 'three', 'patient', 'stabilized', 'without', 'showing', 'disease', 'progression', ',', 'and', 'one', 'patient', 'progressed', 'stage', 'iii', 'to', 'iv', '.', 'treatment', 'with', 'eculizumab', 'in', 'pnh', 'patient', 'beneficial', 'effect', 'renal', 'function', ',', 'preventing', 'arf', 'and', 'progression', 'to', 'crf', '.']"
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial.,"Eman Ghonaim, Sahar El-Haggar, Suzy Gohar, Eman Ghonaimet al.",2021 Aug 6,Med Oncol,https://pubmed.ncbi.nlm.nih.gov/34357466/,"Cisplatin, KIM-1, NGAL, Pantoprazole, Soluble FasL.","['patient', 'in', '.', 'group', '(', 'control', 'group', ')', 'received', 'cisplatin', 'without', 'pantoprazole', ',', 'group', 'ii', 'and', 'iii', 'received', 'pantoprazole', 'mg', 'and', 'mg', ',', 'respectively', ',', 'concurrently', 'with', 'cisplatin', '.', 'blood', 'and', 'urine', 'sample', 'collected', 'baseline', ',', 'and', 'h', 'first', 'and', 'third', 'cycle', 'of', 'cisplatin', 'administration', '.', 'assessment', 'of', 'serum', 'creatinine', 'and', 'soluble', 'fasl', '(', 'sfasl', ')', ',', 'well', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'performed', '.', 'nephrotoxicity', 'detected', 'in', 'patient', 'in', 'group', ',', 'none', 'in', 'group', 'ii', 'and', 'patient', 'in', 'group', 'iii', '.', 'serum', 'creatinine', 'significantly', 'increased', 'end', 'of', 'treatment', 'in', 'group', 'compared', 'to', 'group', 'ii', 'and', 'iii', '.', 'group', 'also', 'significantly', 'higher', 'urinary', 'kim-', 'and', 'ngal', 'and', 'serum', 'sfasl', 'compared', 'to', 'group', 'ii', 'and', 'iii', 'first', 'and', 'third', 'cycle', '.', 'contrary', ',', 'no', 'significant', 'difference', 'group', 'ii', 'and', 'iii', '.', 'pantoprazole', 'prevented', 'increase', 'in', 'acute', 'kidney', 'injury', 'biomarkers', 'in', 'cisplatin-treated', 'patient', '.', 'therefore', ',', 'promising', 'agent', 'in', 'reducing', 'cisplatin-induced', 'nephrotoxicity.trial', 'registration', 'clinical', 'trials.gov', 'identifier', 'nct', ',', 'registered', 'in', 'january', '``', 'retrospectively', 'registered', ""''"", '.']"
Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial.,"Motohiro Matsui, Atsushi Makimoto, Motoaki Chin, Katsuyoshi Koh, Masako Tomotsune, Tetsuji Kaneko, Yoshihiko Morikawa, Riku Hamada, Yuki Yuza, Motohiro Matsuiet al.",2024 May,Int J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/38564107/,No keywords found,"['present', 'study', 'aimed', 'to', 'examine', 'effect', 'of', 'magnesium', '(', 'mg', ')', 'supplementation', 'cisplatin-induced', 'nephrotoxicity', '(', 'cin', ')', 'in', 'pediatric', 'cancer', 'patient', '.', 'method', 'present', 'phase-', ',', 'open-label', ',', 'multicenter', ',', 'randomized', 'controlled', 'trial', 'enrolled', 'patient', 'aged', 'less', 'year', 'scheduled', 'to', 'receive', 'cisplatin-containing', 'chemotherapy', 'and', 'randomly', 'allocated', 'ratio', 'of', 'to', 'mg', 'supplementation', 'arm', 'with', 'even-numbered', 'chemotherapy', 'course', '(', 'arm', 'ab', ')', 'or', 'another', 'arm', 'with', 'odd-numbered', 'course', '(', 'arm', 'ba', ')', '.', 'analysis', 'object', 'reconstructed', 'two', 'group', 'depending', 'whether', 'chemotherapy', 'course', 'mg', 'supplementation', '(', 'group', 'b', ')', 'or', 'not', '(', 'group', ')', '.', 'primary', 'outcome', 'proportion', 'of', 'chemotherapy', 'course', 'resulting', 'in', 'elevated', 'serum', 'creatinine', 'per', 'chemotherapy', 'course', '.', 'secondary', 'outcome', 'included', 'efficacy', 'evaluated', 'using', 'biomarkers', 'and', 'safety', 'of', 'mg', 'supplementation', '.', 'result', 'twenty-eight', 'patient', 'randomly', 'allocated', 'to', 'either', 'group', '(', 'to', 'arm', 'ab', 'and', 'to', 'arm', 'ba', ')', '.', 'baseline', 'characteristic', 'of', 'group', 'similar', '.', 'no', 'significant', 'difference', 'in', 'proportion', 'of', 'course', 'with', 'increased', 'serum', 'creatinine', 'group', '(', 'group', 'vs.', 'group', 'b', 'p', '.', ')', 'significant', 'difference', 'observed', 'in', 'biomarkers', 'chemotherapy', 'course', '.', 'mg', 'value', 'chemotherapy', 'significantly', 'higher', 'in', 'group', 'b', 'in', 'group', 'a.', 'no', 'adverse', 'event', 'related', 'to', 'magnesium', 'administration', 'observed', '.', 'conclusion', 'study', 'design', ',', 'treated', 'single', 'chemotherapy', 'course', 'study', 'object', ',', 'failed', 'to', 'detect', 'statistically', 'significant', 'benefit', 'of', 'mg', 'supplementation', 'preventing', 'cin', 'in', 'pediatric', 'cancer', 'patient', '.', 'trial', 'registration', 'jrct', '(', 'httpsjrct.niph.go.jp', ')', 'identifier', 'umin', 'jrcts', '.', 'umin-ctr', '(', 'httpwww.umin.ac.jpicdrindex.html', ')', 'identifier', 'umin', '.']"
Impact of continuous hypertonic (NaCl 20%) saline solution on renal outcomes after traumatic brain injury (TBI): a post hoc analysis of the COBI trial.,"Olivier Huet#, Xavier Chapalain#, Véronique Vermeersch, Jean-Denis Moyer, Sigismond Lasocki, Benjamin Cohen, Claire Dahyot-Fizelier, Kevin Chalard, P Seguin, Y Hourmant, Karim Asehnoune, Antoine Roquilly                              ;, Atlanrea Study Group and the Société Française d’Anesthésie Réanimation (SFAR) Research Network, Olivier Huetet al.",2023 Jan 27,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36707841/,No keywords found,"['to', 'evaluate', 'increase', 'in', 'chloride', 'intake', 'continuous', 'infusion', 'of', 'hypertonic', 'saline', 'solution', '(', 'hs', ')', 'associated', 'with', 'increase', 'in', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'compared', 'to', 'standard', 'of', 'care', 'in', 'traumatic', 'brain', 'injury', 'patient', '.', 'method', 'in', 'post', 'hoc', 'analysis', 'of', 'cobi', 'trial', ',', 'patient', 'admitted', 'moderate-to-severe', 'tbi', 'in', 'participating', 'icu', 'enrolled', '.', 'intervention', 'consisted', 'in', 'continuous', 'infusion', 'of', 'hs', 'to', 'maintain', 'blood', 'sodium', 'level', 'and', 'mmoll', 'least', 'h.', 'patient', 'enrolled', 'in', 'control', 'arm', 'treated', 'recommended', 'latest', 'brain', 'trauma', 'foundation', 'guideline', '.', 'primary', 'outcome', 'of', 'study', 'occurrence', 'of', 'aki', 'within', 'day', 'enrollment', '.', 'aki', 'defined', 'stage', 'or', 'according', 'to', 'kdigo', 'criterion', '.', 'result', 'exclusion', 'of', 'missing', 'data', ',', 'patient', 'included', 'in', 'post', 'hoc', 'analysis', '.', 'patient', 'randomized', 'in', 'intervention', 'arm', 'received', 'significantly', 'higher', 'amount', 'of', 'chloride', 'first', 'day', '(', 'intervention', 'group', '.', '.', 'g', 'vs.', 'control', 'group', '.', '.', 'g', 'p', '.', ')', 'and', 'higher', 'blood', 'chloride', 'level', 'day', '(', '.', '.', 'mmoll', 'vs.', '.', 'mmoll', ',', 'respectively', ',', 'p', '.', ')', '.', 'incidence', 'of', 'aki', 'not', 'statistically', 'different', 'intervention', 'and', 'control', 'group', '(', '.', 'v', '.', '.', ',', 'respectively', 'p', '.', ')', '.', 'conclusion', 'despite', 'significant', 'increase', 'in', 'chloride', 'intake', ',', 'continuous', 'infusion', 'of', 'hs', 'not', 'associated', 'with', 'aki', 'in', 'moderate-to-severe', 'tbi', 'patient', '.', 'study', 'not', 'confirm', 'potentially', 'detrimental', 'effect', 'of', 'chloride', 'load', 'kidney', 'function', 'in', 'icu', 'patient', '.', 'trial', 'registration', 'cobi', 'trial', 'registered', 'clinicaltrial.gov', '(', 'trial', 'registration', 'number', 'nct', ',', 'date', 'of', 'registration', 'may', ')', '.']"
Preoperative VolumE Replacement therapy in DIabetic patients undergoing coronary artery bypass grafting surgery: results from an open parallel group randomized Controlled Trial (VeRDiCT).,"Kunal Sarkar, Rosie A Harris, Sian Wells, Tracy Harris, Madeleine Clout, Jodi Taylor, Lucy Culliford, Gianni D Angelini, Katie Pike, Kate Ashton, Pradeep Narayan, Barney Reeves, James Hillier, Chris A Rogers, Raimondo Ascione, Kunal Sarkaret al.",2020 Jan 1,Interact Cardiovasc Thorac Surg,https://pubmed.ncbi.nlm.nih.gov/31539025/,No keywords found,"['to', 'investigate', 'effect', 'of', 'preoperative', 'volume', 'replacement', 'therapy', '(', 'vrt', ')', 'renal', 'function', ',', 'health', 'outcome', 'and', 'time', 'to', 'fitness', 'discharge', 'in', 'diabetic', 'patient', 'undergoing', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', '.', 'method', 'in', 'parallel', 'randomized', 'controlled', 'trial', ',', 'diabetic', 'patient', 'allocated', 'to', 'preoperative', 'vrt', '(', 'mlkgh', 'of', 'hartmann', ""'s"", 'solution', 'h', ')', 'or', 'usual', 'care', '.', 'primary', 'outcome', 'time', 'to', 'fitness', 'discharge', '.', 'secondary', 'outcome', 'included', 'acute', 'kidney', 'injury', ',', 'postoperative', 'complication', ',', 'patient-reported', 'quality', 'of', 'life', '(', 'qol', ')', ',', 'hospital', 'resource', 'use', 'and', 'marker', 'of', 'renal', ',', 'cardiac', 'and', 'inflammatory', 'injury', '.', 'result', 'in', 'total', ',', 'patient', 'randomized', '(', 'vrt', ',', 'usual', 'care', 'mean', 'age', 'year', 'male', ')', '.', 'time', 'to', 'fitness', 'discharge', 'similar', 'group', 'median', 'day', 'interquartile', 'range', '.-', '.', 'in', 'group', 'hazard', 'ratio', '.', ',', 'confidence', 'interval', '(', 'ci', ')', '.-', '.', 'p', '..', 'postoperative', 'acute', 'kidney', 'injury', 'not', 'statistically', 'different', '(', 'vrt', '.', 'v', 'usual', 'care', '.', ',', 'odds', 'ratio', '.', ',', 'ci', '.-', '.', 'p', '.', ')', '.', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'mean', 'difference', '-.', ',', 'ci', '-', '.', 'to', '.', 'p', '.', ')', ',', 'microalbumincreatinine', 'ratio', 'geometric', 'mean', 'ratio', '(', 'gmr', ')', '.', ',', 'ci', '.-', '.', 'p', '.', ',', 'n-acetyl-beta-d-glucosaminidase', '(', 'gmr', '.', ',', 'ci', '.-', '.', 'p', '.', ')', ',', 'c-reactive', 'protein', '(', 'gmr', '.', ',', 'ci', '.-', '.', 'p', '.', ')', ',', 'troponin', '(', 'trop-t', 'gmr', '.', ',', 'ci', '.-', '.', 'p', '.', ')', 'and', 'secondary', 'health', 'outcome', 'similar', 'group', '.', 'qol', 'improved', 'in', 'group', 'month', 'with', 'no', 'difference', 'observed', '.', 'conclusion', 'use', 'of', 'preoperative', 'vrt', 'not', 'superior', 'to', 'usual', 'care', 'in', 'diabetic', 'patient', 'undergoing', 'cabg', '.', 'clinical', 'trial', 'registration', 'number', 'isrctn', '.']"
Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity.,"Rujipas Sirijatuphat, Samornrod Limmahakhun, Vorapan Sirivatanauksorn, Roger L Nation, Jian Li, Visanu Thamlikitkul, Rujipas Sirijatuphatet al.",2015,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/25801556/,No keywords found,"['nephrotoxicity', 'dose-limiting', 'factor', 'of', 'colistin', ',', 'last-line', 'therapy', 'multidrug-resistant', 'gram-negative', 'bacterial', 'infection', '.', 'earlier', 'animal', 'study', 'revealed', 'protective', 'effect', 'of', 'ascorbic', 'acid', 'colistin-induced', 'nephrotoxicity', '.', 'present', 'randomized', 'controlled', 'study', 'conducted', 'in', 'patient', 'and', 'aimed', 'to', 'investigate', 'potential', 'nephroprotective', 'effect', 'of', 'intravenous', 'ascorbic', 'acid', '(', 'g', 'every', 'h', ')', 'colistin-associated', 'nephrotoxicity', 'in', 'patient', 'requiring', 'intravenous', 'colistin', '.', 'thirteen', 'patient', 'received', 'colistin', 'plus', 'ascorbic', 'acid', ',', 'whereas', 'received', 'colistin', 'alone', '.', 'nephrotoxicity', 'defined', 'rifle', 'classification', 'system', '.', 'additionally', ',', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'n-acetyl-beta-d-glucosaminidase', '(', 'nag', ')', 'measured', 'marker', 'of', 'renal', 'damage', ',', 'and', 'plasma', 'colistin', 'concentration', 'quantified', '.', 'baseline', 'characteristic', ',', 'clinical', 'feature', ',', 'and', 'concomitant', 'treatment', 'of', 'patient', 'in', 'two', 'group', 'comparable', '.', 'incidence', 'of', 'nephrotoxicity', '.', '(', ')', 'and', '.', '(', ')', 'in', 'colistin-ascorbic', 'acid', 'group', 'and', 'colistin', 'group', ',', 'respectively', '(', 'p', '.', 'relative', 'risk', 'rr', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'in', 'group', ',', 'urinary', 'excretion', 'rate', 'of', 'ngal', 'and', 'nag', 'day', 'or', 'of', 'colistin', 'treatment', 'and', 'end', 'of', 'colistin', 'treatment', 'significantly', 'higher', 'respective', 'baseline', '(', 'p', '.', ')', '.', 'plasma', 'colistin', 'concentration', 'in', 'two', 'group', 'not', 'significantly', 'different', '(', 'p', '.', ')', '.', 'clinical', 'and', 'microbiological', 'outcome', 'and', 'mortality', 'of', 'patient', 'in', 'two', 'group', 'not', 'significantly', 'different', '.', 'preliminary', 'study', 'suggests', 'ascorbic', 'acid', 'not', 'offer', 'nephroprotective', 'effect', 'patient', 'receiving', 'intravenous', 'colistin', '.', '(', 'study', 'registered', 'clinicaltrials.gov', 'registration', 'no', '.', 'nct', '.', ')', '.']"
Perioperative intravenous acetaminophen attenuates lipid peroxidation in adults undergoing cardiopulmonary bypass: a randomized clinical trial.,"Frederic T Billings th, Michael R Petracek, L Jackson Roberts nd, Mias Pretorius, Frederic T Billings thet al.",2015 Feb 23,PLoS One,https://pubmed.ncbi.nlm.nih.gov/25705899/,No keywords found,"['cardiopulmonary', 'bypass', '(', 'cpb', ')', 'lysis', 'erythrocyte', 'and', 'induces', 'lipid', 'peroxidation', ',', 'indicated', 'increasing', 'plasma', 'concentration', 'of', 'free', 'hemoglobin', ',', 'f-isoprostanes', ',', 'and', 'isofurans', '.', 'acetaminophen', 'attenuates', 'hemeprotein-mediated', 'lipid', 'peroxidation', ',', 'reduces', 'plasma', 'and', 'urine', 'concentration', 'of', 'f-isoprostanes', ',', 'and', 'preserve', 'kidney', 'function', 'in', 'animal', 'model', 'of', 'rhabdomyolysis', '.', 'acetaminophen', 'also', 'attenuates', 'plasma', 'concentration', 'of', 'isofurans', 'in', 'child', 'undergoing', 'cpb', '.', 'effect', 'of', 'acetaminophen', 'lipid', 'peroxidation', 'in', 'adult', 'not', 'studied', '.', 'pilot', 'study', 'designed', 'to', 'test', 'hypothesis', 'acetaminophen', 'attenuates', 'lipid', 'peroxidation', 'in', 'adult', 'undergoing', 'cpb', 'and', 'to', 'generate', 'data', 'clinical', 'trial', 'aimed', 'to', 'reduce', 'acute', 'kidney', 'injury', 'following', 'cardiac', 'surgery', '.', 'method', 'and', 'result', 'in', 'prospective', 'double-blind', 'placebo-controlled', 'clinical', 'trial', ',', 'sixty', 'adult', 'patient', 'randomized', 'to', 'receive', 'intravenous', 'acetaminophen', 'or', 'placebo', 'starting', 'prior', 'to', 'initiation', 'of', 'cpb', 'and', 'every', 'hour', 'dos', '.', 'acetaminophen', 'concentration', 'measured', 'min', 'cpb', 'and', 'post-cpb', '.', '.', 'gml', '(', '.', '.', ')', 'and', '.', '.', 'gml', '(', '.', '.', ')', ',', 'respectively', '.', 'plasma', 'free', 'hemoglobin', 'increased', '-fold', 'cpb', ',', 'and', 'haptoglobin', 'decreased', ',', 'indicating', 'hemolysis', '.', 'plasma', 'and', 'urinary', 'marker', 'of', 'lipid', 'peroxidation', 'also', 'increased', 'cpb', 'returned', 'to', 'baseline', 'first', 'postoperative', 'day', '.', 'acetaminophen', 'reduced', 'plasma', 'isofuran', 'concentration', 'duration', 'of', 'study', '(', 'p', '.', ')', ',', 'and', 'intraoperative', 'plasma', 'isofuran', 'concentration', 'corresponded', 'to', 'peak', 'hemolysis', 'attenuated', 'in', 'subject', 'randomized', 'to', 'acetaminophen', '(', 'p', '.', ')', '.', 'perioperative', 'acetaminophen', 'not', 'affect', 'plasma', 'concentration', 'of', 'f-isoprostanes', 'or', 'urinary', 'marker', 'of', 'lipid', 'peroxidation', '.', 'conclusion', 'intravenous', 'acetaminophen', 'attenuates', 'increase', 'in', 'intraoperative', 'plasma', 'isofuran', 'concentration', 'occurs', 'cpb', ',', 'urinary', 'marker', 'unaffected', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial.,"Mads Israelsen, Emilie Kristine Dahl, Bjørn Stæhr Madsen, Signe Wiese, Flemming Bendtsen, Søren Møller, Annette Dam Fialla, Boye L Jensen, Aleksander Krag, Mads Israelsenet al.",2020 Feb 1,Am J Physiol Gastrointest Liver Physiol,https://pubmed.ncbi.nlm.nih.gov/31841026/,"AKI, HRS, acute kidney injury, hepatorenal, portal hypertension.","[')', 'group', 'received', 'terlipressin', 'followed', 'addition', 'of', 'dobutamine', 'group', 'b', 'received', 'dobutamine', 'and', 'terlipressin', 'monotherapies', 'and', 'group', 'c', 'received', 'placebo', '.', 'renal', 'and', 'cardiac', 'function', 'assessed', 'clearance', 'period', 'of', 'min', ',', 'and', 'concentration', 'of', 'vasoactive', 'hormone', 'measured', '.', 'dobutamine', 'monotherapy', 'increased', 'co', '(', '.', 'lmin', ',', 'p', '.', ')', 'no', 'significant', 'effect', 'gfr', '.', 'renin', '(', 'p', '.', ')', ',', 'angiotensin', 'ii', '(', 'p', '.', ')', ',', 'and', 'aldosterone', '(', 'p', '.', ')', 'increased', 'dobutamine', 'infusion', '.', 'terlipressin', 'monotherapy', 'improved', 'gfr', '(', '.', 'mlmin-m-', ',', 'p', '.', ')', 'and', 'mean', 'arterial', 'pressure', '(', 'map', ')', '(', 'mmhg', ',', 'p', '.', ')', 'reduced', 'co', '(', '-', '.', 'lmin', ',', 'p', '.', ')', 'and', 'renin', '(', 'p', '.', ')', '.', 'combined', 'treatment', 'of', 'dobutamine', 'and', 'terlipressin', 'positive', 'effect', 'co', '(', '.', 'lmin', ',', 'p', '.', ')', 'and', 'increased', 'renin', '(', 'p', '.', ')', ',', 'angiotensin', 'ii', '(', 'p', '.', ')', ',', 'and', 'aldosterone', '(', 'p', '.', ')', ',', 'no', 'significant', 'effect', 'map', 'or', 'gfr', '.', 'dobutamine', 'reversed', 'cardio-suppressive', 'effect', 'of', 'terlipressin', 'in', 'cirrhosis', ',', 'ascites', ',', 'and', 'impaired', 'renal', 'function', '.', 'however', ',', 'dobutamine', 'reduced', 'peripheral', 'vascular', 'resistance', ',', 'activated', 'renin-angiotensin-aldosterone', 'system', ',', 'and', 'not', 'improve', 'gfr', 'compared', 'with', 'terlipressin', 'monotherapy', '.', 'therefore', ',', 'dobutamine', 'not', 'recommended', 'in', 'cirrhosis', 'and', 'ascites.new', 'noteworthy', 'study', 'show', 'cardio-suppressive', 'effect', 'of', 'vasopressin', 'receptor', 'agonist', 'terlipressin', 'reversed', 'dobutamine', '.', 'novel', 'observation', 'in', 'patient', 'with', 'decompensated', 'cirrhosis', '.', 'furthermore', ',', 'show', 'dobutamine', 'reduced', 'peripheral', 'vascular', 'resistance', 'and', 'activated', 'renin-angiotensin', 'system', ',', 'whereas', 'renal', 'function', 'not', 'improved', 'terlipressin', 'alone', '.']"
Effects of Xuebijing Injection for Patients With Sepsis-induced Acute Kidney Injury After Wenchuan Earthquake.,"Qin Yuxi, Hanlai Zhang, Yu Baili, Shihua Shi, Qin Yuxiet al.",2017 Mar,Altern Ther Health Med,https://pubmed.ncbi.nlm.nih.gov/28323627/,No keywords found,"['context', 'earthquake', 'devastating', 'disaster', 'claimed', 'countless', 'life', 'in', 'past', ',', 'partially', 'owing', 'to', 'danger', 'of', 'direct', 'and', 'indirect', 'injury', 'to', 'vital', 'organ', '.', 'in', 'deadly', 'earthquake', 'occurred', 'in', 'sichuan', 'province', 'of', 'china', 'may', ',', ',', 'victim', 'suffered', 'severe', 'damage', 'to', 'multiple', 'organ', 'and', 'tissue', 'and', 'developed', 'sepsis', ',', 'systematic', 'inflammatory', 'reaction', 'resulting', 'infection', 'and', 'trauma', '.', 'xuebijing', 'injection', '(', 'ccxg', ')', 'could', 'beneficial', 'improvement', 'of', 'clinical', 'symptom', 'in', 'patient', ',', 'no', 'research', 'yet', 'examined', 'potential', '.', 'objective', 'study', 'intended', 'to', 'investigate', 'whether', 'combination', 'of', 'conventional', 'treatment', 'and', 'ccxg', 'superior', 'to', 'conventional', 'treatment', 'alone', ',', 'or', 'control', 'group', '(', 'cg', ')', ',', 'in', 'treatment', 'of', 'clinical', 'symptom', 'in', 'patient', 'with', 'sepsis-induced', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'design', 'study', 'retrospectively', 'analyzed', 'medical', 'record', 'of', 'individual', 'injured', 'in', 'earthquake', 'occurred', 'in', 'sichuan', 'province', 'of', 'china', 'may', ',', ',', 'and', 'developed', 'aki', '.', 'setting', 'study', 'took', 'place', 'in', 'hospital', 'associated', 'with', 'chengdu', 'university', 'of', 'traditional', 'chinese', 'medicine', '(', 'chengdu', ',', 'sichuan', ',', 'china', ')', '.', 'participant', 'participant', 'injured', 'individual', 'treated', 'hospital', '.', 'cg', 'included', 'patient', 'and', 'ccxg', 'group', 'included', 'patient', '.', 'intervention', 'intervention', 'group', '(', 'ccxg', 'group', ')', 'and', 'cg', 'received', 'conventional', 'treatment', '.', 'ccxg', 'group', 'also', 'given', 'intravenous', 'drip', 'containing', 'ml', 'of', 'ccxg', '.', 'cg', 'given', 'ml', 'of', 'normal', 'saline', 'injection', 'in', 'addition', 'to', 'conventional', 'treatment', '.', 'received', 'treatment', 'within', 'to', 'min', ',', 'd.', 'outcome', 'measure', 'blood', 'urea', 'nitrogen', '(', 'bun', ')', ',', 'creatine', 'phosphate', 'kinase', '(', 'cpk', ')', ',', 'serum', 'creatinine', '(', 'cr', ')', ',', 'interleukin', '(', 'il-', ')', ',', 'and', 'interleukin', '(', 'il-', ')', 'measured', 'treatment', 'and', 'day', ',', ',', 'and', 'treatment', '.', 'result', 'level', 'of', 'cpk', ',', 'bun', ',', 'cr', ',', 'and', 'il-', 'group', 'significantly', 'lower', 'baseline', 'day', ',', ',', 'and', 'treatment', '(', 'p', '.', ')', '.', 'level', 'of', 'ccxg', 'group', 'significantly', 'lower', 'of', 'cg', 'group', 'day', ',', ',', 'and', '(', 'p', '.', ')', '.', 'conclusion', 'supplement', ',', 'ccxg', 'effective', 'method', 'of', 'improving', 'clinical', 'symptom', 'of', 'sepsis-induced', 'aki', '.']"
Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial.,"Amit X Garg, Matthew T V Chan, Meaghan S Cuerden, P J Devereaux, Seyed Hesameddin Abbasi, Ainslie Hildebrand, François Lamontagne, Andre Lamy, Nicolas Noiseux, Chirag R Parikh, Vlado Perkovic, Mackenzie Quantz, Antoine Rochon, Alistair Royse, Daniel I Sessler, Pallav J Shah, Jessica M Sontrop, Georgios I Tagarakis, Kevin H Teoh, Jessica Vincent, Michael Walsh, Jean-Pierre Yared, Salim Yusuf, Richard P Whitlock                              ;, SIRS Investigators, Amit X Garget al.",2019 Mar 4,CMAJ,https://pubmed.ncbi.nlm.nih.gov/30833491/,No keywords found,"['perioperative', 'corticosteroid', 'use', 'may', 'reduce', 'acute', 'kidney', 'injury', '.', 'sought', 'to', 'test', 'whether', 'methylprednisolone', 'reduces', 'risk', 'of', 'acute', 'kidney', 'injury', 'cardiac', 'surgery', '.', 'method', 'conducted', 'prespecified', 'substudy', 'of', 'randomized', 'controlled', 'trial', 'involving', 'patient', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', '-', ')', 'patient', 'recruited', 'centre', 'in', 'country', '.', 'eligibility', 'criterion', 'included', 'moderate-to-high', 'risk', 'of', 'perioperative', 'death', 'based', 'preoperative', 'score', 'of', 'or', 'greater', 'european', 'system', 'cardiac', 'operative', 'risk', 'evaluation', 'i.', 'patient', '(', 'n', ')', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'intravenous', 'methylprednisolone', '(', 'mg', 'anesthetic', 'induction', 'and', 'mg', 'initiation', 'of', 'cardiopulmonary', 'bypass', ')', 'or', 'placebo', '.', 'patient', ',', 'caregiver', ',', 'data', 'collector', 'and', 'outcome', 'adjudicator', 'unaware', 'of', 'assigned', 'intervention', '.', 'primary', 'outcome', 'postoperative', 'acute', 'kidney', 'injury', ',', 'defined', 'increase', 'in', 'serum', 'creatinine', 'concentration', '(', 'preoperative', 'value', ')', 'of', '.', 'mgdl', 'or', 'greater', '(', '.', 'moll', ')', 'or', 'or', 'greater', 'in', '-day', 'period', 'surgery', ',', 'or', 'use', 'of', 'dialysis', 'within', 'day', 'surgery', '.', 'result', 'acute', 'kidney', 'injury', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'methylprednisolone', 'group', 'and', 'in', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'adjusted', 'relative', 'risk', '.', ',', 'confidence', 'interval', '.', 'to', '.', ')', '.', 'result', 'consistent', 'across', 'several', 'definition', 'of', 'acute', 'kidney', 'injury', 'and', 'in', 'patient', 'with', 'preoperative', 'chronic', 'kidney', 'disease', '.', 'interpretation', 'intraoperative', 'corticosteroid', 'use', 'not', 'reduce', 'risk', 'of', 'acute', 'kidney', 'injury', 'in', 'patient', 'with', 'moderate-to-high', 'risk', 'of', 'perioperative', 'death', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '.', 'result', 'not', 'support', 'prophylactic', 'use', 'of', 'steroid', 'cardiopulmonary', 'bypass', 'surgery', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'no', '.', 'nct', '.']"
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.,"Takaya Yamashita, Naohito Fujishima, Masatomo Miura, Takenori Niioka, Maiko Abumiya, Yoshinori Shinohara, Kumi Ubukawa, Miho Nara, Masumi Fujishima, Yoshihiro Kameoka, Hiroyuki Tagawa, Makoto Hirokawa, Naoto Takahashi, Takaya Yamashitaet al.",2016 Jul,Cancer Chemother Pharmacol,https://pubmed.ncbi.nlm.nih.gov/27217047/,No keywords found,"['tacrolimus', 'metabolized', 'cytochrome', 'p', '(', 'cyp', ')', 'and', 'a.', 'investigated', 'influence', 'of', 'cypa', 'polymorphism', 'and', 'concurrent', 'use', 'of', 'azole', 'antifungal', 'agent', '(', 'az', ')', 'pharmacokinetics', 'of', 'once-daily', 'modified-release', 'tacrolimus', 'formulation', '(', 'tac-qd', ')', 'in', 'patient', 'hematopoietic', 'stem', 'cell', 'transplantation', '(', 'hsct', ')', '.', 'design', 'and', 'method', 'twenty-four', 'patient', 'receiving', 'allogeneic', 'hsct', 'enrolled', '.', 'genotyping', 'cypa', 'done', 'pcr-restriction', 'fragment', 'length', 'polymorphism', 'method', '.', 'trough', 'blood', 'concentration', '(', 'c', ')', 'of', 'tacrolimus', 'measured', 'chemiluminescence', 'magnetic', 'microparticle', 'immunoassay', '.', 'continuous', 'infusion', 'of', 'tacrolimus', 'administered', 'day', 'transplantation', 'and', 'switched', 'to', 'tac-qd', 'adequate', 'oral', 'intake', '.', 'result', 'thirteen', 'patient', 'cypa', 'genotype', ',', 'and', 'patient', 'cypa', 'or', 'genotype', '.', 'no', 'significant', 'difference', 'observed', 'in', 'daily', 'dosage', 'and', 'c', 'of', 'tacrolimus', 'two', 'genotype', 'group', 'without', 'az', '.', 'however', ',', 'in', 'patient', 'co-administered', 'az', ',', 'c', 'value', 'of', 'tacrolimus', 'higher', 'in', 'patient', 'with', 'cypa', 'allele', 'with', 'cypa', 'allele', '(', 'p', '.', ')', ',', 'although', 'daily', 'dos', 'of', 'tac-qd', 'in', 'patient', 'with', 'cypa', 'significantly', 'lower', 'with', 'cypa', 'allele', '(', 'p', '.', ')', '.', 'cumulative', 'incidence', 'of', 'acute', 'kidney', 'injury', 'higher', 'in', 'patient', 'with', 'cypa', 'with', 'cypa', 'allele', 'az', 'co-administered', '.', 'decrement', 'daily', 'dosage', 'of', 'tac-qd', 'significantly', 'greater', 'in', 'patient', 'expressing', 'cypa', 'cypa', 'allele', '.', 'conclusion', 'cypa', 'genotyping', 'may', 'useful', 'safe', 'and', 'effective', 'immunosuppressive', 'therapy', 'with', 'tac-qd', 'in', 'hsct', 'patient', 'in', 'use', 'of', 'az', 'anticipated', '.']"
Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.,"Athanasios Karampeazis, Lambros Vamvakas, Nikolaos Kentepozidis, Aris Polyzos, Vassilis Chandrinos, Georgios Rigas, Charalambos Christofyllakis, Athanasios Kotsakis, Dora Hatzidaki, Athanasios G Pallis, Vassilis Georgoulias, Athanasios Karampeaziset al.",2016 Nov,Clin Lung Cancer,https://pubmed.ncbi.nlm.nih.gov/27397849/,No keywords found,"['present', 'study', 'phase', 'iii', 'study', 'to', 'determine', 'maximum', 'tolerated', 'dos', '(', 'mtds', ')', 'and', 'dose-limiting', 'toxicity', 'of', 'biweekly', 'carboplatingemcitabine', 'combination', 'and', 'evaluate', 'safety', 'and', 'efficacy', 'in', 'patient', 'aged', 'year', 'with', 'advanced', 'squamous', 'non-small-cell', 'lung', 'cancer', '(', 'nsclc', ')', '.', 'patient', 'and', 'method', 'patient', 'aged', 'year', 'with', 'advanced', 'or', 'metastatic', 'squamous', 'nsclc', 'received', 'escalated', 'dos', 'of', 'carboplatin', '(', 'area', 'curve', 'auc', '-', '.', 'intravenously', ')', 'and', 'gemcitabine', '(', '-', 'mgm', 'intravenously', ')', 'every', 'week', '(', 'phase', ')', '.', 'in', 'phase', 'ii', ',', 'drug', 'administered', 'previously', 'defined', 'mtds', '(', 'carboplatin', ',', 'auc', '.', 'gemcitabine', ',', 'mgm', ')', '.', 'primary', 'endpoint', 'overall', 'response', 'rate', '.', 'result', 'total', 'of', 'patient', 'enrolled', '(', 'phase', ',', 'n', ')', '.', 'median', 'age', 'year', '(', 'range', ',', '-', 'year', ')', 'patient', 'stage', 'iv', 'disease', ',', 'and', 'and', 'patient', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', 'to', 'and', ',', 'respectively', '.', 'mtds', 'could', 'not', 'reached', 'predefined', 'last', 'dose', 'level', '.', 'dose-limiting', 'toxicity', 'grade', 'renal', 'toxicity', 'and', 'grade', 'thrombocytopenia', '.', 'in', 'phase', 'ii', 'study', ',', 'overall', 'response', 'rate', '.', '(', 'confidence', 'interval', 'ci', ',', '.-.', ')', '.', 'in', 'intention-to-treat', 'analysis', ',', 'median', 'progression-free', 'survival', '.', 'month', '(', 'ci', ',', '.-', '.', 'month', ')', ',', 'and', 'median', 'overall', 'survival', '.', 'month', '(', 'ci', ',', '.-', '.', 'month', ')', '.', 'grade', 'or', 'neutropenia', 'observed', 'in', 'patient', '(', '.', ')', ',', 'grade', 'or', 'thrombocytopenia', 'in', 'patient', '(', '.', ')', ',', 'and', 'grade', 'or', 'fatigue', 'in', 'patient', '(', '.', ')', '.', 'one', 'toxic', 'death', 'occurred', 'in', 'phase', 'of', 'study', '.', 'conclusion', 'biweekly', 'regimen', 'of', 'gemcitabine', 'and', 'carboplatin', 'showed', 'satisfactory', 'efficacy', 'and', 'favorable', 'toxicity', 'profile', 'in', 'elderly', 'patient', 'with', 'advanced', 'or', 'metastatic', 'squamous', 'cell', 'nsclc', '.']"
Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).,"Justin L Grodin, Antonio L Perez, Yuping Wu, Adrian F Hernandez, Javed Butler, Marco Metra, G Michael Felker, Adriaan A Voors, John J McMurray, Paul W Armstrong, Robert M Califf, Randall C Starling, Christopher M O'Connor, W H Wilson Tang, Justin L Grodinet al.",2015 Oct,JACC Heart Fail,https://pubmed.ncbi.nlm.nih.gov/26449997/,No keywords found,"['study', 'sought', 'to', 'determine', 'relationship', 'of', 'kim-', 'level', 'with', 'adverse', 'clinical', 'outcome', 'in', 'acute', 'decompensated', 'heart', 'failure', '(', 'adhf', ')', '.', 'background', 'kidney', 'injury', 'molecule', '(', 'kim', ')', '-', 'biomarker', 'expressed', 'nephron', 'in', 'acute', 'tubular', 'injury', ',', 'and', 'sensitive', 'and', 'specific', 'marker', 'early', 'acute', 'kidney', 'injury', '.', 'although', 'commonly', 'measured', 'in', 'urine', ',', 'kim-', 'level', 'also', 'detectable', 'in', 'plasma', ',', 'clinical', 'and', 'prognostic', 'utility', 'in', 'adhf', 'unknown', '.', 'method', 'baseline', ',', '-', 'to', '-h', ',', 'and', '-day', 'kim-', 'plasma', 'level', 'measured', 'in', 'subject', 'in', 'ascend-hf', '(', 'acute', 'study', 'of', 'clinical', 'effectiveness', 'of', 'nesiritide', 'in', 'decompensated', 'heart', 'failure', ')', 'trial', '.', 'multivariable', 'logistic', 'and', 'cox', 'model', 'used', 'to', 'assess', 'relationship', 'kim-', 'level', 'and', 'outcome', 'and', 'adhf', '.', 'result', 'median', 'circulating', 'kim-', 'level', 'baseline', '.', 'pgml', '(', 'interquartile', 'range', 'iqr', '.', 'to', '.', 'pgml', ')', ',', 'to', 'h', '.', 'pgml', '(', 'iqr', '.', 'to', '.', 'pgml', ')', ',', 'and', 'day', '.', 'pgml', '(', 'iqr', '.', 'to', '.', 'pgml', ')', '.', 'no', 'association', 'kim-', 'level', 'and', '-day', 'outcome', '.', 'in', 'univariable', 'analysis', ',', 'baseline', 'and', 'follow-up', 'kim-', 'associated', 'with', 'greater', '-day', 'mortality', 'risk', '.', 'however', ',', 'adjusting', 'blood', 'urea', 'nitrogen', 'or', 'creatinine', 'in', 'addition', 'to', 'established', 'risk', 'predictor', 'ascend-hf', ',', 'higher', 'kim-', 'time', 'point', 'hospitalization', 'not', 'associated', 'with', 'in-hospital', 'or', 'post-discharge', 'outcome', '(', 'p', '.', ')', ',', 'kim-', 'level', 'measured', 'day', 'associated', 'independently', 'with', '-day', 'mortality', '(', 'hazard', 'ratio', '.', 'p', '.', ')', '.', 'conclusion', 'in', 'study', 'cohort', ',', 'circulating', 'kim-', 'baseline', 'and', 'hospitalization', 'not', 'associated', 'with', 'adverse', 'clinical', 'outcome', 'in', 'adhf', 'adjusting', 'standard', 'index', 'of', 'kidney', 'function', '.']"
Effect of Aminophylline in Preventing Renal Dysfunction among Neonates with Prenatal Asphyxia: A Clinical Trial.,"Maryam Saboute, Javad Balasi, Saleheh Tajalli, Mahmoud Hajipour, Shaghayegh Heshmat, Nasrin Khalesi, Leila Allahqoli, Maryam Sabouteet al.",2020 May 1,Arch Iran Med,https://pubmed.ncbi.nlm.nih.gov/32383615/,No keywords found,"['different', 'view', 'effect', 'of', 'aminophylline', 'neonatal', 'renal', 'function', ',', 'intended', 'to', 'observe', 'effect', 'of', 'aminophylline', 'renal', 'dysfunction', 'in', 'neonate', 'with', 'prenatal', 'asphyxia', '.', 'method', 'randomized', 'trial', 'conducted', 'in', 'obstetrics', 'and', 'gynecology', 'hospital', ',', 'tehran', ',', 'iran', ',', 'june', 'to', 'may', ',', 'in', 'neonate', 'with', 'moderate', 'to', 'severe', 'asphyxia', 'birth', '.', 'fifty-six', 'neonate', 'divided', 'randomly', 'two', 'group', '.', 'intervention', 'group', 'received', 'one', 'dose', 'of', 'mgkg', 'slow', 'intravenous', 'aminophylline', 'injection', 'and', 'placebo', 'group', 'received', 'mlkg', 'of', 'intravenous', 'solution', 'of', 'dextrose', 'saline', 'first', 'hour', 'of', 'life', '.', 'monitored', 'and', 'compared', 'renal', 'functional', 'index', ',', 'electrolyte', ',', 'and', 'complication', 'of', 'asphyxia', 'three', 'day', 'of', 'life', '.', 'result', 'mean', 'of', 'cr', '(', '.', '.', 'v', '.', '.', 'and', '.', '.', 'v', '.', '.', 'moll', ')', ',', 'gfr', '(', '.', '.', 'v', '.', '.', 'and', '.', '.', 'v', '.', '.', 'mlminute', '.', ')', ',', 'na', '(', '.', '.', 'vs.', '.', 'and', '.', '.', 'v', '.', '.', 'meql', ')', ',', 'and', 'urine', 'output', '(', '.', 'v', '.', 'and', '.', 'v', '.', 'cc', ')', 'in', 'aminophylline', 'treated', 'and', 'placebo', 'group', 'st', 'and', 'rd', 'day', ',', 'respectively', '.', 'mean', 'difference', 'of', 'cr', '(', '-', '.', '(', '-', '.', '-', '.', ')', 'moll', ')', '(', 'p', '.', ')', ',', 'gfr', '(', '.', '(', '.', '.', ')', 'mlminute', '.', ')', '(', 'p', '.', ')', ',', 'na', '(', '-', '.', '(', '-', '.', '-', '.', ')', 'meql', ')', '(', 'p', '.', ')', ',', 'and', 'urine', 'volume', '(', '.', '(', '.', '.', ')', 'cc', ')', '(', 'p', '.', ')', 'presented', 'statistically', 'significant', 'difference', 'third', 'day', 'intervention', 'and', 'placebo', 'group', '.', 'conclusion', 'aminophylline', 'effective', 'in', 'preventing', 'renal', 'dysfunction', 'in', 'neonate', 'with', 'asphyxia', '.', 'neonate', 'received', 'aminophylline', 'indicated', 'significant', 'improvement', 'in', 'gfr', 'and', 'urine', 'output', 'first', 'day', 'of', 'life', '.']"
Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).,"Ankur Jindal, Hitesh Singh, Guresh Kumar, Vinod Arora, Manoj Kumar Sharma, Rakhi Maiwall, V Rajan, Harsh Vardhan Tewathia, Chitranshu Vasishtha, Shiv Kumar Sarin, Ankur Jindalet al.",2024 Jun,Dig Dis Sci,https://pubmed.ncbi.nlm.nih.gov/38637454/,No keywords found,"['terlipressin', 'infusion', 'effective', 'in', 'hepatorenal', 'syndrome', '(', 'hrs-aki', ')', '.', 'however', ',', 'efficacy', 'hrs-aki', 'resolution', 'in', 'acute-on-chronic', 'liver', 'failure', '(', 'aclf', ')', 'patient', 'suboptimal', '.', 'progression', 'of', 'aki', 'rapid', 'in', 'aclf', '.', 'investigated', 'whether', 'early', 'initiation', 'of', 'terlipressin', '(', 'eterli', ')', 'improve', 'response', 'rate', '.', 'method', 'consecutive', 'aclf', 'patient', 'with', 'stage', 'iiiii', 'aki', 'despite', 'albumin', 'resuscitation', '(', 'g', ')', 'randomized', 'to', 'receive', 'terlipressin', 'mg', 'h', 'plus', 'albumin', 'h', '(', 'et', ',', 'n', ')', 'or', 'h', 'standard', 'therapy', '(', 'st', ',', 'n', ')', '.', '(', 'june', ',', 'to', 'june', ',', ')', '.', 'primary', 'end-point', 'aki', 'reversal', 'day', '.', 'result', 'baseline', 'parameter', 'including', 'aki', 'stage', 'and', 'aclf-aarc', 'score', 'in', 'two', 'arm', 'comparable', '.', 'full', 'aki', 'response', 'day', 'higher', 'in', 'et', '(', '.', ')', 'st', 'arm', '(', '.', 'p', '..', 'day', 'aki', 'response', 'also', 'higher', 'in', 'et', 'arm', '(', '.', ')', 'v', '.', '(', '.', ')', ',', 'p', '..', 'using', 'st', 'compared', 'to', 'et', 'hr', '.', 'p', '.', 'and', 'day', 'serum', 'creatinine', '.', 'mgdl', 'hr', '.', 'auroc-', '.', 'p', '.', 'predicted', 'hrs-aki', 'non-response', 'day', '.', 'et', 'patient', 'showed', 'greater', 'improvement', 'in', 'aclf', 'grade', ',', 'mean', 'arterial', 'pressure', ',', 'and', 'urine', 'output', 'day', ',', 'and', 'required', 'lower', 'albumin', 'within', 'day', 'et', 'arm', '(', '.', '.', 'g', 'vs.', '.', '.', 'g', ',', 'p', '.', ')', 'and', 'lower', '-day', 'mortality', 'v', '.', '.', ',', 'p', '..', 'early', 'use', 'of', 'terlipressin', 'st', 'hr', '.', 'p', '.', ',', 'baseline', 'hr', '.', 'p', '.', ',', 'and', 'aki', 'persistence', 'day', 'hr', '.', 'p', '.', 'predicted', '-day', 'mortality', '.', 'fifteen', '(', '.', ')', 'patient', 'treatment', 'related', 'adverse', 'effect', ',', 'none', 'life', 'threatening', '.', 'conclusion', 'in', 'aclf', 'patient', ',', 'early', 'initiation', 'of', 'terlipressin', 'aki', 'persisting', 'h', 'of', 'volume', 'expansion', 'with', 'albumin', 'help', 'in', 'reduced', 'short-term', 'mortality', 'and', 'early', 'aki', 'reversal', 'with', 'regression', 'of', 'aclf', 'stage', '.', 'result', 'indicate', 'need', 'change', 'in', 'current', 'practice', 'terlipressin', 'usage', 'in', 'hrs-aki', '.']"
Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.,"Raja Ramachandran, Harsha Kumar Hn, Vinod Kumar, Ritambhra Nada, Ashok Kumar Yadav, Ajay Goyal, Vivek Kumar, Manish Rathi, Vivekanand Jha, Krishan Lal Gupta, Vinay Sakhuja, Harbir Singh Kohli, Raja Ramachandranet al.",2016 Feb,Nephrology (Carlton),https://pubmed.ncbi.nlm.nih.gov/26205759/,No keywords found,"['study', 'comparing', 'cyclophosphamide', '(', 'ctx', ')', 'and', 'calcineurin', 'inhibitor', 'based', 'regimen', 'in', 'management', 'of', 'non-immunosuppressive', 'symptomatic', 'therapy', '(', 'nist', ')', 'resistant', 'idiopathic', 'membranous', 'nephropathy', '(', 'imn', ')', '.', 'present', 'study', 'aimed', 'comparing', 'efficacy', 'and', 'safety', 'of', 'tacrolimus', '(', 'tac', ')', 'steroid', 'with', 'cyclical', 'ctxsteroids', '(', 'modified', 'ponticelli', 'regimen', '(', 'mpr', ')', ')', 'in', 'patient', 'with', 'imn', '.', 'method', 'idiopathic', 'membranous', 'nephropathy', 'patient', '(', 'n', ')', 'with', 'persistent', 'nephrotic', 'syndrome', 'least', 'month', 'of', 'antiproteinuric', 'therapy', 'or', 'with', 'complication', 'of', 'nephrotic', 'syndrome', 'equally', 'randomized', 'to', 'receive', 'tac', 'with', 'oral', 'prednisolone', '(', 'tac', ')', 'or', 'mpr', '.', 'antibody', 'm-type', 'phospholipase', 'receptor', '(', 'plar', 'ab', ')', 'tested', 'baseline', 'and', ',', 'and', 'month', 'start', 'of', 'therapy', '.', 'primary', 'end', 'point', 'achievement', 'of', 'remission', 'and', 'secondary', 'objective', 'adverse', 'effect', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'in', 'study', 'group', '.', 'result', 'intention-to-treat', 'analysis', 'showed', 'remission', 'end', 'of', '(', 'with', 'tac', 'vs.', 'with', 'mpr', 'p', '.', ')', 'and', 'month', '(', 'with', 'tac', 'vs.', 'with', 'mpr', 'p', '.', ')', 'comparable', '.', 'plar', 'ab', 'titre', 'month', 'correlated', 'with', 'urine', 'protein', '(', 'r', '..', ')', 'and', 'serum', 'albumin', '(', 'r', '-.-', '.', ')', 'end', 'of', 'therapy', '.', 'patient', 'ctx', 'significantly', 'higher', 'risk', 'of', 'amenorrhea', 'and', 'tac', 'greater', 'risk', 'of', 'reversible', 'nephrotoxicity', '.', 'conclusion', 'in', 'nist', 'refractory', 'imn', ',', 'tac', 'and', 'mpr', 'comparable', ',', 'with', 'different', 'adverse', 'effect', 'profile', '.', 'pla', 'r', 'ab', 'good', 'association', 'with', 'proteinuria', ',', 'and', 'regularly', 'monitored', 'clinical', 'follow-up', '.']"
Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors.,"Vivek Subbiah, Juneko E Grilley-Olson, Austin J Combest, Neelesh Sharma, Richard H Tran, Iulian Bobe, Atsushi Osada, Kazuhiro Takahashi, Jaikrishna Balkissoon, Aaron Camp, Atsuhiro Masada, Dirk J Reitsma, Lyudmila A Bazhenova, Vivek Subbiahet al.",2018 Jan 1,Clin Cancer Res,https://pubmed.ncbi.nlm.nih.gov/29030354/,No keywords found,"['nc-', ',', 'novel', 'cisplatin', 'nanoparticle', 'developed', 'using', 'micellar', 'technology', 'exhibit', 'sustained', 'release', 'of', 'cisplatin', 'and', 'selective', 'distribution', 'to', 'tumor', '.', 'preclinical', 'data', 'demonstrated', 'favorable', 'tolerability', 'profile', 'and', 'preserved', 'or', 'improved', 'antitumor', 'activity', 'compared', 'with', 'cisplatin', 'across', 'animal', 'model', '.', 'evaluated', 'safety', 'and', 'tolerability', 'of', 'nc-', 'and', 'gemcitabine', 'using', 'bayesian', 'continual', 'reassessment', 'model', '(', 'n-crm', ')', 'to', 'determine', 'optimal', 'dose.experimental', 'design', 'patient', 'with', 'advanced', 'solid', 'tumor', 'received', 'nc-', 'to', 'mgm', 'day', 'and', 'gemcitabine', ',', 'mgm', 'day', 'and', 'every', 'week', '.', 'dose', 'escalation', 'of', 'nc-', 'began', 'with', 'single', 'patient', 'run-in', 'dose-limiting', 'toxicity', 'occurred', 'mgm', 'cohort', 'of', 'four', 'patient', 'enrolled', 'dos', 'predicted', 'n-crm', '.', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'defined', 'greatest', 'probability', 'of', 'target', 'toxicity', '.', 'quality', 'of', 'life', 'assessed', 'using', 'eortc-qlq-c.results', 'among', 'patient', ',', 'common', 'grade', 'iiiiv', 'hematologic', 'adverse', 'event', 'leukopenia', '(', ')', 'and', 'thrombocytopenia', '(', ')', '.', 'of', 'pretreated', 'patient', 'evaluable', 'response', ',', 'half', 'previously', 'exposed', 'to', 'platinum', 'agent', '.', 'mtd', 'mgm', 'nine', 'patient', 'treated', 'mtd', 'with', 'median', 'treatment', 'duration', 'of', 'week', '(', 'range', ',', '-', ')', '.', 'tumor', 'shrinkage', 'occurred', 'in', '(', ')', ',', 'partial', 'response', 'in', '(', ')', ',', 'and', 'stable', 'disease', 'in', '(', ')', '.', 'patient', 'reported', 'stable', 'or', 'improved', 'eortc', 'qlq-c', 'scores.conclusions', 'greater', 'cisplatin', 'equivalent', 'dos', 'achieved', 'with', 'no', 'clinically', 'significant', 'neuro-', ',', 'oto-', ',', 'or', 'nephrotoxicity', '.', 'data', 'demonstrate', 'tolerability', 'and', 'promising', 'activity', 'of', 'nc-', 'in', 'combination', 'with', 'gemcitabine', '.', 'clin', 'cancer', 're', '(', ')', '-', '.', 'aacr', '.']"
Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways.,"Meng Wang, Huzi Xu, Octavia Li-Sien Chong Lee Shin, Li Li, Hui Gao, Zhi Zhao, Fan Zhu, Han Zhu, Wangqun Liang, Kun Qian, Chunxiu Zhang, Rui Zeng, Hanjing Zhou, Ying Yao, Meng Wanget al.",2019 Apr 11,J Transl Med,https://pubmed.ncbi.nlm.nih.gov/30975176/,No keywords found,"['keto-analogues', 'administration', 'play', 'important', 'role', 'in', 'clinical', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'adjunctive', 'therapy', ',', 'however', 'previous', 'study', 'reno-protective', 'effect', 'mainly', 'focused', 'kidney', 'pathological', 'change', 'induced', 'nephrectomy', '.', 'study', 'designed', 'to', 'explore', 'currently', 'understudied', 'alternative', 'mechanism', 'compound', '-ketoacid', 'tablet', '(', 'ka', ')', 'influenced', 'ischemia-reperfusion', '(', 'ir', ')', 'induced', 'murine', 'renal', 'injury', ',', 'and', 'to', 'probe', 'current', 'status', 'of', 'ka', 'administration', 'staving', 'ckd', 'progression', 'in', 'chinese', 'ckd', 'patient', 'different', 'stage', '.', 'method', 'in', 'animal', 'experiment', ',', 'ir', 'surgery', 'performed', 'to', 'mimic', 'progressive', 'chronic', 'kidney', 'injury', ',', 'ka', 'administrated', 'orally', '.', 'clinical', 'research', ',', 'retrospective', 'cohort', 'study', 'conducted', 'to', 'delineate', 'usage', 'and', 'effect', 'of', 'ka', 'attenuating', 'ckd', 'exacerbation', '.', 'end-point', 'ckd', 'event', 'defined', 'reduction', 'of', 'initial', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', '.', 'kaplan-meier', 'analysis', 'and', 'cox', 'proportional', 'hazard', 'regression', 'model', 'adopted', 'to', 'calculate', 'cumulative', 'probability', 'to', 'reach', 'end-point', 'and', 'hazard', 'ratio', 'of', 'renal', 'function', 'deterioration', '.', 'result', 'in', 'animal', 'study', ',', 'ka', 'presented', 'protective', 'effect', 'ir', 'induced', 'renal', 'injury', 'and', 'fibrosis', 'attenuating', 'inflammatory', 'infiltration', 'and', 'apoptosis', 'via', 'inhibition', 'of', 'nuclear', 'factor-kappa', 'b', '(', 'nf-b', ')', 'and', 'mitogen-activated', 'protein', 'kinase', '(', 'mapk', ')', 'pathway', '.', 'in', 'clinical', 'research', ',', 'adjusting', 'basic', 'demographic', 'factor', ',', 'patient', 'stage', 'and', 'in', 'ka', 'group', 'presented', 'much', 'delayed', 'and', 'slower', 'incidence', 'of', 'egfr', 'decrease', 'compared', 'to', 'in', 'no-ka', 'group', '(', 'hazard', 'ratio', '(', 'hr', ')', '.', ',', 'confidence', 'interval', '(', 'ci', ')', '.-.', ',', 'p', '.', ')', ',', 'demonstrating', 'positive', 'effect', 'of', 'ka', 'staving', 'ckd', 'progression', '.', 'conclusion', 'ka', 'improved', 'ir', 'induced', 'chronic', 'renal', 'injury', 'and', 'fibrosis', ',', 'and', 'seemed', 'to', 'prospective', 'protective', 'factor', 'in', 'end', 'stage', 'renal', 'disease', '.']"
"Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors.","Catherine G Lam, Wayne L Furman, Chong Wang, Sheri L Spunt, Jianrong Wu, Percy Ivy, Victor M Santana, Lisa M McGregor, Catherine G Lamet al.",2015 Jan,J Pediatr Hematol Oncol,https://pubmed.ncbi.nlm.nih.gov/24942022/,No keywords found,"['day', ',', 'oxaliplatin', 'mgm', '(', 'consistent', 'dose', ')', 'day', 'to', ',', 'ifosfamide', 'mgmd', '(', 'level', ')', 'or', 'mgmd', '(', 'level', 'and', ')', 'and', 'etoposide', 'mgmd', '(', 'level', 'and', ')', 'or', 'mgmd', '(', 'level', ')', '.', 'course', 'filgrastimpegfilgrastim', 'permitted', 'initial', 'dlt', 'determination', ',', 'neutropenia', 'dose', 'limiting', '.', 'seventeen', 'patient', 'received', 'course', '.', 'without', 'filgrastim', '(', 'n', ')', ',', 'dlt', 'neutropenia', 'in', 'patient', 'dose', 'level', '.', 'no', 'dlt', 'observed', 'adding', 'filgrastim', '(', 'n', ')', '.', 'no', 'ototoxicity', ',', 'nephrotoxicity', 'grade', ',', 'or', 'neurotoxicity', 'grade', '.', 'one', 'patient', 'experienced', 'partial', 'response', 'and', 'stable', 'disease', 'course', '.', 'in', 'conclusion', ',', 'ioe', 'regimen', 'well', 'tolerated', '.', 'without', 'filgrastim', ',', 'neutropenia', 'dose', 'limiting', 'with', 'mtd', 'ifosfamide', 'mgmd', 'and', 'etoposide', 'mgmd', '.', 'mtd', 'with', 'filgrastim', 'not', 'defined', 'due', 'to', 'early', 'study', 'closure', '.', 'filgrastim', 'allowed', 'ifosfamide', 'and', 'etoposide', 'dose', 'escalation', 'and', 'included', 'in', 'future', 'study', '.']"
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.,"Jyoti Malhotra, Petros Nikolinakos, Ticiana Leal, Jonathan Lehman, Daniel Morgensztern, Jyoti D Patel, John M Wrangle, Giuseppe Curigliano, Laurent Greillier, Melissa L Johnson, Neal Ready, Gilles Robinet, Satwant Lally, David Maag, Ricardo Valenzuela, Vincent Blot, Benjamin Besse, Jyoti Malhotraet al.",2021 Sep,J Thorac Oncol,https://pubmed.ncbi.nlm.nih.gov/33652156/,No keywords found,"['open-label', ',', 'phase', '-', 'study', 'evaluated', 'safety', 'and', 'efficacy', 'of', 'rovalpituzumab', 'tesirine', '(', 'rova-t', ')', ',', 'antibody-drug', 'conjugate', 'targeting', 'dll', ',', 'plus', 'immune', 'checkpoint', 'inhibitor', 'nivolumab', 'plus', 'or', 'minus', 'ipilimumab', 'in', 'previously', 'treated', 'extensive-stage', 'sclc', '(', 'e', 'sclc', ')', '.', 'method', 'patient', 'with', 'histologically', 'or', 'cytologically', 'confirmed', ',', 'previously', 'treated', '(', 'two', 'or', 'line', 'of', 'therapy', ')', 'e', 'sclc', 'enrolled', 'two', 'cohort', '.', 'cohort', 'received', '.', 'mgkg', 'rova-t', '(', 'every', 'wk', 'two', 'cycle', ')', 'plus', 'mg', 'nivolumab', '(', 'two', '-wk', 'cycle', 'beginning', 'week', ')', '.', 'cohort', 'received', 'dosage', 'of', 'rova-t', 'cohort', 'plus', 'mgkg', 'nivolumab', '(', 'four', '-wk', 'cycle', ')', 'and', 'mgkg', 'ipilimumab', '(', 'beginning', 'week', ')', '.', 'cohort', 'received', 'mg', 'nivolumab', 'every', 'week', 'starting', 'week', '.', 'key', 'objective', 'to', 'evaluate', 'safety', 'and', 'tolerability', 'and', 'efficacy', '(', 'per', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumor', 'version', '.', ')', '.', 'response-related', 'result', 'based', 'centrally', 'read', 'data', '.', 'result', 'total', 'of', 'patient', 'received', 'therapy', 'cohort', ',', 'n', 'cohort', ',', 'n', '.', 'overall', ',', 'received', 'two', 'or', 'previous', 'line', 'of', 'therapy', '.', 'patient', 'experienced', 'one', 'or', 'treatment-emergent', 'adverse', 'event', '(', 'teae', ')', 'patient', 'reported', 'aes', 'considered', 'related', 'to', 'study', 'drug', 'investigator', '.', 'frequent', 'teae', 'pleural', 'effusion', '(', 'n', ',', ')', 'common', 'grade', 'greater', 'or', 'equal', 'to', 'anemia', '(', 'n', ',', ')', '.', 'three', 'grade', 'teaes', 'considered', 'related', 'to', 'study', 'drug', 'reported', '(', 'cohort', ')', 'pneumonitis', '(', 'n', ')', ',', 'acute', 'kidney', 'injury', '(', 'n', ')', '.', 'objective', 'response', 'rate', '(', 'of', ')', 'cohort', ',', '.', '(', 'of', ')', 'cohort', ',', '.', '(', 'of', ')', 'partial', 'response', '.', 'conclusion', 'despite', 'encouraging', 'antitumor', 'activity', 'in', 'previously', 'treated', 'e', 'sclc', ',', 'combination', 'therapy', 'with', 'rova-t', 'and', 'nivolumab', 'plus', 'or', 'minus', 'ipilimumab', 'not', 'well', 'tolerated', 'dose', 'level', 'and', 'administration', 'schedule', 'evaluated', '.']"
"Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection.","Hong Zhang, Min Wu, Xiaoxue Zhu, Cuiyun Li, Xiaojiao Li, Weili Jin, Dengke Zhang, Hong Chen, Chengjiao Liu, Yanhua Ding, Junqi Niu, Jingrui Liu, Hong Zhanget al.",2020 Feb:174:104693.,Antiviral Res,https://pubmed.ncbi.nlm.nih.gov/31838002/,No keywords found,"['pradefovir', 'liver', 'targeted', 'novel', 'prodrug', 'of', 'adefovir', '(', 'pmea', ')', 'developed', 'to', 'provide', 'higher', 'antiviral', 'activity', 'with', 'reduced', 'systemic', 'toxicity', '.', 'study', 'evaluated', 'tolerability', ',', 'pharmacokinetics', ',', 'and', 'antiviral', 'activity', 'of', 'pradefovir', 'in', 'patient', 'with', 'chronic', 'hepatitis', 'b', '(', 'chb', ')', 'virus', 'infection', '.', 'method', 'non-cirrhotic', ',', 'treatment-nave', 'subject', 'with', 'chb', 'divided', 'five', 'group', '(', 'patient', ')', 'and', 'randomized', 'within', 'group', 'in', 'ratio', 'of', 'to', 'receive', 'ascending', 'dose', 'of', ',', ',', ',', ',', 'or', 'mg', 'pradefovir', ',', 'mg', 'adefovir', 'dipivoxil', '(', 'adv', ')', ',', 'or', 'mg', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', 'day', 'day', '.', 'result', 'total', 'of', 'subject', 'randomized', 'and', 'subject', 'completed', 'study', '.', 'group', 'well', 'matched', 'and', 'included', 'male', ',', 'of', 'hepatitis', 'b', 'e-antigen-negative', 'with', 'mean', 'hepatitis', 'b', 'virus', '(', 'hbv', ')', 'dna', 'level', 'of', '.-', '.', 'log', 'iuml', '.', 'no', 'subject', 'experienced', 'serious', 'adverse', 'event', 'or', 'nephrotoxicity', '.', 'frequently', 'reported', 'adverse', 'event', 'asymptomatic', 'reduction', 'in', 'blood', 'cholinesterase', 'level', 'in', 'pradefovir', 'group', 'recovered', 'without', 'treatment', 'day', 'drug', 'discontinuation', '.', 'adverse', 'event', 'not', 'observed', 'in', 'adv', 'and', 'tdf', 'group', '.', 'mean', 'change', 'in', 'serum', 'hbv', 'dna', '-.', ',', '-.', ',', '-.', ',', '-.', ',', '-.', ',', '-.', ',', 'and', '-', '.', 'log', 'iuml', ',', ',', ',', ',', 'and', 'mg', 'pradefovir', ',', 'mg', 'adv', 'and', 'mg', 'tdf', ',', 'respectively', ',', 'with', 'plateau', 'level', 'reached', 'with', 'mg', 'pradefovir', '.', 'pradefovir', 'and', 'metabolite', 'pmea', 'showed', 'linear', 'pharmacokinetics', 'proportional', 'to', 'dose', '.', 'half-life', 'of', 'pmea', 'in', 'pradefovir', 'group', '.-', '.', 'h.', 'conclusion', 'short-term', 'use', 'of', 'pradefovir', 'well', 'tolerated', '.', 'decline', 'in', 'hbv', 'dna', 'level', 'superior', 'to', 'tdf', 'higher', 'dos', 'of', 'pradefovir', '.', '-', 'mg', 'pradefovir', 'recommended', 'chb', 'treatment', '.', 'clinical', 'trial', 'number', 'ctr', '.']"
"The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial).","Line Aas Mortensen, Helle C Thiesson, Birgitte Tougaard, Martin Egfjord, Anne Sophie Lind Fischer, Claus Bistrup, Line Aas Mortensenet al.",2018 May 3,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/29724188/,No keywords found,"['calcineurin', 'inhibitor', 'induced', 'nephrotoxicity', 'contributes', 'to', 'late', 'allograft', 'failure', 'in', 'kidney', 'transplant', 'patient', '.', 'evidence', 'point', 'towards', 'aldosterone', 'to', 'play', 'role', 'in', 'development', 'of', 'fibrosis', 'in', 'multiple', 'organ', '.', 'animal', 'study', 'indicated', 'beneficial', 'effect', 'of', 'mineralocorticoid', 'receptor', 'antagonist', 'preventing', 'calcineurin', 'inhibitor', 'induced', 'nephrotoxicity', '.', 'study', 'explored', 'effect', 'in', 'human', '.', 'objective', 'of', 'study', 'to', 'evaluate', 'effect', 'of', 'spironolactone', 'glomerular', 'filtration', 'rate', 'and', 'fibrosis', 'in', 'kidney', 'transplant', 'patient', '.', 'method', 'prospective', ',', 'double-blind', ',', 'randomized', ',', 'clinical', 'trial', 'including', 'prevalent', 'kidney', 'transplant', 'patient', '.', 'patient', 'randomized', 'to', 'spironolactone', '-', 'mgday', 'or', 'placebo', 'three', 'year', '.', 'primary', 'outcome', 'glomerular', 'filtration', 'rate', 'evaluated', 'chrome-edta', 'clearance', '.', 'secondary', 'outcome', '-h', 'protein', 'excretion', ',', 'amount', 'of', 'interstitial', 'fibrosis', 'in', 'renal', 'allograft', 'biopsy', ',', 'and', 'cardiovascular', 'event', '.', 'exploratory', 'outcome', ',', 'aim', 'to', 'identify', 'marker', 'of', 'fibrosis', 'in', 'blood', 'and', 'urine', '.', 'discussion', 'long', 'term', 'allograft', 'survival', 'remains', 'key', 'issue', 'in', 'renal', 'transplantation', ',', 'partly', 'due', 'to', 'calcineurin', 'inhibitor', 'induced', 'nephrotoxicity', '.', 'evidence', 'animal-', 'and', 'small', 'human', 'study', 'indicate', 'beneficial', 'effect', 'of', 'mineralocorticoid', 'receptor', 'antagonism', 'renal', 'function', 'and', 'fibrosis', '.', 'study', 'aim', 'to', 'test', 'hypothesis', 'in', 'sufficiently', 'powered', 'randomized', 'clinical', 'trial', '.', 'result', 'might', 'influence', 'future', 'management', 'of', 'long', 'term', 'allograft', 'survival', 'in', 'renal', 'transplantation', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', '(', ')', 'nct', '.', 'eudract', 'number', '(', ')', '--', '.']"
Effect of post-operative goal-directed fluid therapy (GDFT) on organ function after orthotopic liver transplantation: Secondary outcome analysis of the COLT randomised control trial.,"Farid Froghi, Vignesh Gopalan, Zachos Anastasiou, Rahul Koti, Kurinchi Gurusamy, Christine Eastgate, Margaret McNeil, Helder Filipe, Manuel Pinto, Jeshika Singh, Louise Longworth, Susan Mallett, Nick Schofield, Douglas Thorburn, Daniel Martin, Brian R Davidson;, COLT Study Group, Farid Froghiet al.",2022 Mar:99:106265.,Int J Surg,https://pubmed.ncbi.nlm.nih.gov/35181556/,No keywords found,"['goal-directed', 'fluid', 'therapy', '(', 'gdft', ')', 'shown', 'to', 'reduce', 'complication', 'following', 'variety', 'of', 'major', 'surgical', 'procedure', ',', 'possibly', 'mediated', 'improved', 'organ', 'perfusion', 'and', 'function', '.', 'shown', 'feasible', 'to', 'randomise', 'patient', 'to', 'gdft', 'or', 'standard', 'fluid', 'management', 'following', 'liver', 'transplant', 'in', 'cardiac-output', 'optimisation', 'following', 'liver', 'transplantation', '(', 'colt', ')', 'trial', '.', 'current', 'study', 'compare', 'end', 'organ', 'function', 'in', 'patient', 'colt', 'trial', 'received', 'gdft', 'in', 'comparison', 'to', 'receiving', 'standard', 'care', '(', 'sc', ')', 'following', 'liver', 'transplant', '.', 'method', 'adult', 'patient', 'with', 'liver', 'cirrhosis', 'undergoing', 'liver', 'transplantation', 'randomised', 'to', 'gdft', 'or', 'sc', 'first', 'h', 'following', 'surgery', 'detailed', 'in', 'published', 'trial', 'protocol', '.', 'gdft', 'protocol', 'based', 'stroke', 'volume', '(', 'sv', ')', 'optimisation', 'using', 'ml', 'crystalloid', 'bolus', '.', 'total', 'fluid', 'administration', 'and', 'time', 'to', 'extubation', 'recorded', '.', 'hourly', 'sv', 'and', 'cardiac', 'output', '(', 'co', ')', 'reading', 'recorded', 'non-invasive', 'cardiac', 'output', 'monitoring', '(', 'nicom', ')', 'device', 'in', 'group', '.', 'pulmonary', 'function', 'assessed', 'arterial', 'blood', 'gas', '(', 'abg', ')', 'and', 'ventilatory', 'parameter', '.', 'lung', 'injury', 'assessed', 'using', 'paofio', 'ratio', 'and', 'calculated', 'pulmonary', 'compliance', '.', 'kdigo', 'score', 'used', 'determining', 'acute', 'kidney', 'injury', '.', 'renal', 'and', 'liver', 'graft', 'function', 'assessed', 'post-operative', 'period', 'and', 'month', 'and', '-year', '.', 'result', 'patient', 'randomised', 'to', 'gdft', '(', 'n', ')', 'or', 'sc', '(', 'n', ')', '.', 'patient', 'completed', 'h', 'intervention', 'period', '.', 'gdft', 'group', 'received', 'significantly', 'higher', 'total', 'volume', 'of', 'fluid', 'h', 'trial', 'intervention', 'period', '(', 'gdft', '(', ')', 'vs.', 'sc', '(', ')', 'ml', ',', 'p', '.', ')', 'in', 'particular', 'crystalloids', '(', 'gdft', '(', ')', 'vs.', 'sc', '(', ')', 'ml', ',', 'p', '.', ')', '.', 'no', 'evidence', 'of', 'significant', 'difference', 'group', 'in', 'sv', 'or', 'co', 'assessment', 'period', '.', 'time', 'to', 'extubation', ',', 'pao', 'fio', 'ratio', ',', 'pulmonary', 'compliance', ',', 'ventilatory', 'or', 'blood', 'gas', 'measurement', 'similar', 'in', 'group', '.', 'significant', 'rise', 'in', 'serum', 'creatinine', 'baseline', '(', 'moll', ')', 'compared', 'to', 'first', '(', 'moll', ',', 'p', '.', ')', 'and', 'second', '(', 'moll', ',', 'p', '.', ')', 'post-operative', 'day', '.', 'no', 'difference', 'gdft', 'and', 'sc', 'in', 'highest', 'kdigo', 'score', 'first', 'day', 'post-lt.', '-year', 'follow-up', ',', 'no', 'difference', 'in', 'need', 'renal', 'replacement', 'therapy', 'or', 'graft', 'function', '.', 'conclusion', 'in', 'randomised', 'trial', 'of', 'fluid', 'therapy', 'post', 'liver', 'transplant', ',', 'gdft', 'associated', 'with', 'increased', 'volume', 'of', 'crystalloids', 'administered', 'not', 'alter', 'early', 'post-operative', 'pulmonary', 'or', 'renal', 'function', 'compared', 'with', 'standard', 'care', '.']"
"Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial.","Øyvind S Svendsen, Marit Farstad, Arve Mongstad, Rune Haaverstad, Paul Husby, Venny L Kvalheim, Øyvind S Svendsenet al.",2018 Sep,Perfusion,https://pubmed.ncbi.nlm.nih.gov/29199540/,No keywords found,"['use', 'of', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'lead', 'to', 'increased', 'fluid', 'filtration', 'and', 'edema', '.', 'use', 'of', 'artificial', 'colloid', 'to', 'counteract', 'fluid', 'extravasation', 'cardiac', 'surgery', 'controversial', '.', 'beneficial', 'effect', 'global', 'fluid', 'loading', ',', 'leading', 'to', 'better', 'cardiac', 'performance', 'and', 'hemodynamics', ',', 'claimed', '.', 'however', ',', 'renal', 'function', 'and', 'coagulation', 'may', 'adversely', 'affected', ',', 'with', 'unfavorable', 'impact', 'outcome', 'following', 'cardiac', 'surgery', '.', 'method', 'forty', 'patient', 'randomly', 'allocated', 'to', 'study', 'group', 'receiving', 'either', 'acetated', 'ringer', ""'s"", 'solution', '(', 'ct', 'group', ')', 'or', 'hydroxyethyl', 'starch', '(', 'he', 'group', ',', 'tetraspan', ')', 'cpb', 'priming', 'solution', '.', 'fluid', 'balance', ',', 'bleeding', 'and', 'hemodynamics', ',', 'including', 'cardiac', 'output', ',', 'followed', 'postoperatively', '.', 'occurrence', 'of', 'acute', 'kidney', 'injury', 'closely', 'registered', '.', 'result', 'two', 'patient', 'excluded', 'analyzes', 'due', 'to', 'surgical', 'complication', '.', 'fluid', 'accumulation', 'attenuated', 'in', 'he', 'group', '(', '(', ')', 'ml', ')', 'compared', 'with', 'ct', 'group', '(', '(', ')', 'ml', ')', '(', 'p.', ')', '.', 'reduced', 'perioperative', 'fluid', 'accumulation', 'accompanied', 'increased', 'cardiac', 'index', 'immediately', 'surgery', '(', '.', '(', '.', ')', 'lminm', 'in', 'he', 'group', 'and', '.', '(', '.', ')', 'lminm', 'in', 'ct', 'group', '(', 'p.', ')', ')', '.', 'no', 'increase', 'in', 'bleeding', 'could', 'demonstrated', 'in', 'he', 'group', '.', 'three', 'patient', ',', 'of', 'in', 'he', 'group', ',', 'experienced', 'acute', 'kidney', 'injury', 'postoperatively', '.', 'conclusion', 'cpb', 'priming', 'with', 'he', 'solution', 'lower', 'fluid', 'loading', 'bypass', 'and', 'improves', 'cardiac', 'function', 'in', 'early', 'postoperative', 'period', '.', 'manifestation', 'of', 'acute', 'kidney', 'injury', 'exclusively', 'in', 'he', 'group', 'of', 'patient', 'raise', 'doubt', 'use', 'of', 'he', 'product', 'in', 'conjunction', 'with', 'cardiac', 'surgery', '.', '(', 'httpsclinicaltrials.govctshownct', ')', '.']"
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis.,"Toshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara, Satoru Iwasa, Yasuhiro Shimada, Mitsunori Harada, Kenichiro Naito, Naoto Hayashi, Atsuhiro Masada, Atsushi Ohtsu, Toshihiko Doiet al.",2017 Mar,Cancer Chemother Pharmacol,https://pubmed.ncbi.nlm.nih.gov/28224231/,No keywords found,"['study', 'open-label', 'phase', 'study', 'to', 'confirm', 'safety', 'and', 'tolerability', 'of', 'nc-', 'in', 'combination', 'with', 'gemcitabine', 'in', 'japanese', 'patient', 'with', 'advanced', 'solid', 'tumor', 'and', 'to', 'assess', 'pk', 'effect', 'of', 'nc-', 'monotherapy', '.', 'method', 'phase', 'study', 'used', 'design', 'to', 'determine', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'and', 'recommended', 'dose', 'of', 'nc-', 'combined', 'with', 'gemcitabine', '.', 'safety', 'and', 'pharmacokinetics', 'assessed', '.', 'administration', 'of', 'nc-', 'alone', 'started', 'mgm', 'every', 'treatment', 'cycle', '(', 'day', 'per', 'cycle', ')', '.', 'second', 'eighth', 'cycle', ',', 'patient', 'received', 'nc-', 'in', 'combination', 'with', 'mgm', 'of', 'gemcitabine', 'administered', 'day', 'and', 'day', 'of', 'cycle', ',', 'except', 'first', 'treatment', 'cycle', '.', 'result', 'twelve', 'patient', 'with', 'advanced', 'solid', 'tumor', 'received', 'or', 'mgm', 'nc-', '.', 'mtd', 'and', 'rd', 'determined', 'to', 'mgm', '.', 'common', 'drug-related', 'adverse', 'event', 'neutrophil', 'decrease', '(', '.', ')', 'and', 'white', 'blood', 'cell', 'count', 'decrease', '(', '.', ')', '.', 'population', 'pharmacokinetic', '(', 'pk', ')', 'analysis', 'revealed', 'nc-', 'pk', 'profile', 'in', 'japanese', 'study', 'not', 'significantly', 'different', 'in', 'previous', 'caucasian', 'study', '.', 'conclusion', 'mtd', 'and', 'rd', 'of', 'nc-', 'determined', 'to', 'mgm', '.', 'pharmacodynamic', '(', 'pd', ')', 'model', 'well', 'explained', 'time', 'course', 'of', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'and', 'amplitude', 'of', 'decrease', 'in', 'egfr', '.', 'decrease', 'in', 'egfr', 'appeared', 'to', 'reach', 'saturation', 'mgm', 'with', 'nc-', '.', 'estimated', 'probability', 'of', 'acute', 'kidney', 'injury', 'pkpd', 'simulation', 'with', 'nc-', 'and', 'with', 'cisplatin', ',', 'may', 'better', 'explain', 'renal', 'toxicity', 'profile', '.']"
"Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial.","Richard R Watkins, Bin Du, Robin Isaacs, David Altarac, Richard R Watkinset al.",2023 May 1,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/37125468/,"ATTACK trial, antibiotics, antimicrobial resistance, sulbactam-durlobactam.","['crucial', 'need', 'novel', 'antibiotic', 'to', 'stem', 'tide', 'of', 'antimicrobial', 'resistance', ',', 'particularly', 'difficult', 'to', 'treat', 'gram-negative', 'pathogen', 'like', 'acinetobacter', 'baumannii-calcoaceticus', 'complex', '(', 'abc', ')', '.', 'innovative', 'approach', 'to', 'addressing', 'antimicrobial', 'resistance', 'may', 'pathogen-targeted', 'development', 'program', '.', 'sulbactam-durlobactam', '(', 'sul-dur', ')', '-lactam-lactamase', 'inhibitor', 'combination', 'antibiotic', 'developed', 'to', 'specifically', 'target', 'drug-resistant', 'abc', '.', 'development', 'of', 'sul-dur', 'culminated', 'with', 'acinetobacter', 'treatment', 'trial', 'colistin', '(', 'attack', ')', 'trial', ',', 'global', ',', 'randomized', ',', 'active-controlled', 'phase', 'clinical', 'trial', 'compared', 'sul-dur', 'with', 'colistin', 'treating', 'serious', 'infection', 'due', 'to', 'carbapenem-resistant', 'abc', '.', 'sul-dur', 'met', 'primary', 'noninferiority', 'endpoint', 'of', '-day', 'all-cause', 'mortality', '.', 'furthermore', ',', 'sul-dur', 'favorable', 'safety', 'profile', 'with', 'statistically', 'significant', 'lower', 'incidence', 'of', 'nephrotoxicity', 'compared', 'with', 'colistin', '.', 'approved', ',', 'sul-dur', 'could', 'important', 'treatment', 'option', 'infection', 'caused', 'abc', ',', 'including', 'carbapenem-resistant', 'and', 'multidrug-resistant', 'strain', '.', 'development', 'program', 'and', 'attack', 'trial', 'highlight', 'potential', 'pathogen-targeted', 'development', 'program', 'to', 'address', 'challenge', 'of', 'antimicrobial', 'resistance', '.']"
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.,"Thomas D Boyer, Arun J Sanyal, Florence Wong, R Todd Frederick, John R Lake, Jacqueline G O'Leary, Daniel Ganger, Khurram Jamil, Stephen Chris Pappas                              ;, REVERSE Study Investigators, Samuel H Sigal, Santiago J Munoz, Vishal Patel, Paul Y Kwo, Jasmohan S Bajaj, Tarek I Hassanein, Kirti Shetty, Rohit Satoskar, K Rajender Reddy, Marlyn Mayo, Victor Araya, Nikroo Hashemi, Eyob Feyssa, Lorenzo Rossaro, David Kravetz, Priya Grewal, Ram Subramanian, Kevin Korenblat, Yuri Stepanovich Genyk, Fredric Regenstein, Joseph F Buell, Nathan J Shores, Sukru H Emre, Andrea Duchini, Atif Zaman, Marco Antonio Olivera-Martinez, Michael K Porayko, Alex S Befeler, K Gautham Reddy, Maria Del Pilar Hernandez, Stephen D Zucker, Hugo E Vargas, Michael Curry, Adnan Said, Kris V Kowdley, Terry Box, David Shields Barnes, Marie Noëlle Pépin, Madhavi Rudraraju, Paul Angulo, Howard P Monsour, David Wolf, Charles Howell, Fredric G Regenstein, Antonio Sanchez, Hany Elbeshbeshy, Michael B Fallon, Colin Swales, David A Sass, Eva Urtasun Sotil, Brendan McGuire, Richard K Gilroy, Juan A Guerrero, Mark N Wong, Obaid Shaikh, Stevan Gonzalez, Zeid Kayali, Thomas D Boyeret al.",2016 Jun,Gastroenterology,https://pubmed.ncbi.nlm.nih.gov/26896734/,No keywords found,"['hepatorenal', 'syndrome', 'type', '(', 'hrs-', ')', 'in', 'patient', 'with', 'cirrhosis', 'and', 'ascites', 'functional', ',', 'potentially', 'reversible', ',', 'form', 'of', 'acute', 'kidney', 'injury', 'characterized', 'rapid', '(', 'wk', ')', 'and', 'progressive', 'deterioration', 'of', 'renal', 'function', '.', 'terlipressin', 'synthetic', 'vasopressin', 'analogue', 'act', ',', 'via', 'vascular', 'vasopressin', 'v', 'receptor', ',', 'systemic', 'vasoconstrictor', '.', 'performed', 'phase', 'study', 'to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'intravenous', 'terlipressin', 'plus', 'albumin', 'v', 'placebo', 'plus', 'albumin', 'in', 'patient', 'with', 'hrs-', '.', 'method', 'adult', 'patient', 'with', 'cirrhosis', ',', 'ascites', ',', 'and', 'hrs-', '(', 'based', 'international', 'club', 'of', 'ascites', 'criterion', 'of', 'rapidly', 'deteriorating', 'renal', 'function', ')', 'assigned', 'randomly', 'to', 'group', 'given', 'intravenous', 'terlipressin', '(', 'mg', ',', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'every', 'hour', 'with', 'concomitant', 'albumin', '.', 'treatment', 'continued', 'day', 'unless', 'following', 'occurred', 'confirmed', 'hr', 'reversal', '(', 'chrsr', ',', 'defined', 'serum', 'creatinine', 'scr', 'value', '.', 'mgdl', ',', 'least', 'hour', 'apart', ',', 'treatment', 'without', 'renal', 'replacement', 'therapy', 'or', 'liver', 'transplantation', ')', 'or', 'scr', 'or', 'baseline', 'day', '.', 'primary', 'end', 'point', 'percentage', 'of', 'patient', 'with', 'confirmed', 'chrsr', '.', 'secondary', 'end', 'point', 'included', 'incidence', 'of', 'hr', 'reversal', '(', 'defined', 'least', 'scr', 'value', '.', 'mgdl', 'treatment', ')', ',', 'transplant-free', 'survival', ',', 'and', 'overall', 'survival', '.', 'study', 'performed', 'investigational', 'site', 'in', 'united', 'state', 'and', 'in', 'canada', ',', 'october', 'february', '.', 'result', 'baseline', 'demographicclinical', 'characteristic', 'similar', 'group', '.', 'chrsr', 'observed', 'in', 'of', 'patient', '(', '.', ')', 'receiving', 'terlipressin', 'v', 'of', 'patient', '(', '.', ')', 'receiving', 'placebo', '(', 'p', '.', ')', '.', 'hr', 'reversal', 'achieved', 'in', 'of', '(', '.', ')', 'patient', 'receiving', 'terlipressin', 'v', 'of', '(', '.', ')', 'receiving', 'placebo', '(', 'p', '.', ')', '.', 'scr', 'decreased', '.', 'mgdl', 'in', 'patient', 'receiving', 'terlipressin', 'and', '.', 'mgdl', 'in', 'patient', 'receiving', 'placebo', '(', 'p', '.', ')', '.', 'decrease', 'in', 'scr', 'and', 'survival', 'correlated', '(', 'r', '(', ')', '.', 'p', '.', ')', '.', 'transplant-free', 'and', 'overall', 'survival', 'similar', 'group', '.', 'significantly', 'greater', 'proportion', 'of', 'patient', 'with', 'chrsr', 'received', 'terlipressin', 'survived', 'day', 'patient', 'not', 'chrsr', 'receiving', 'terlipressin', '(', 'p', '.', ')', 'difference', 'not', 'observed', 'in', 'patient', 'v', 'not', 'chrsr', 'receiving', 'placebo', '(', 'p', '.', ')', '.', 'similar', 'number', 'of', 'adverse', 'event', 'in', 'group', ',', 'patient', 'in', 'terlipressin', 'group', 'ischemic', 'event', '.', 'conclusion', 'terlipressin', 'plus', 'albumin', 'associated', 'with', 'greater', 'improvement', 'in', 'renal', 'function', 'v', 'albumin', 'alone', 'in', 'patient', 'with', 'cirrhosis', 'and', 'hrs-', '.', 'patient', 'similar', 'rate', 'of', 'hr', 'reversal', 'with', 'terlipressin', 'with', 'albumin', '.', 'clinicaltrials.gov', 'no', 'nct', '.']"
The effect of N-acetyl cysteine injection on renal function after coronary artery bypass graft surgery: a randomized double blind clinical trial.,"Fatemeh Javaherforooshzadeh, Zahra Shaker, Mahboobeh Rashidi, Reza Akhondzadeh, Fatemeh Hayati, Fatemeh Javaherforooshzadehet al.",2021 Jun 5,J Cardiothorac Surg,https://pubmed.ncbi.nlm.nih.gov/34090464/,No keywords found,"['study', 'aimed', 'to', 'compare', 'effect', 'of', 'n-acetyl', 'cysteine', 'renal', 'function', 'coronary', 'artery', 'bypass', 'graft', 'surgery', '.', 'method', 'in', 'randomized', 'clinical', 'trial', 'conducted', 'in', 'golestan', 'hospital', ',', 'ahvaz', ',', 'iran', ',', 'candidate', 'coronary', 'artery', 'bypass', 'graft', 'surgery', 'selected', 'and', 'divided', 'two', 'n-acetyl', 'cysteine', 'and', 'control', 'group', '(', 'people', ')', '.', 'patient', 'received', '(', 'intraoperative', 'and', 'postoperative', ')', 'dos', 'of', 'iv', 'n-acetyl', 'cysteine', '(', 'mgkg', ')', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'h.', 'prescription', 'time', 'follows', 'induction', 'of', 'anesthesia', ',', 'in', 'next', 'h', ',', 'and', 'in', 'h', '.', 'primary', 'outcome', 'serum', 'level', 'of', 'bun', 'and', 'cr', ',', 'baseline', ',', 'and', 'h', 'surgery', '.', 'and', 'also', 'need', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'secondary', 'outcome', 'included', 'hemodynamic', 'variable', ',', 'blood', 'product', 'transfusion', '.', 'result', 'significant', 'difference', 'in', 'bun', 'group', 'h', '(', 'p', '.', ')', 'and', 'h', 'surgery', '(', 'p', '.', ')', 'significant', 'difference', 'in', 'cr', 'level', 'group', 'h', '(', 'p', '.', ')', 'and', 'h', 'surgery', '(', 'p', '.', ')', '.', 'map', 'different', 'time', '(', 'h', 'p', '.', 'and', 'h', 'surgery', 'p', '.', ')', 'significantly', 'different', 'two', 'group', '.', 'significant', 'difference', 'two', 'group', 'in', 'term', 'of', 'unit', 'of', 'packed', 'cell', 'transfusion', '(', 'p', '.', ')', 'and', 'ffp', 'transfusion', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'present', 'study', ',', 'found', 'administration', 'of', 'n-acetyl', 'cysteine', 'reduce', 'incidence', 'of', 'acute', 'kidney', 'injury', 'in', 'patient', 'undergoing', 'coronary', 'artery', 'bypass', 'graft', 'surgery', 'and', 'improved', 'kidney', 'function', '.', 'trial', 'registry', 'irctn', 'registered', '...']"
Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial.,"Fernando G Zampieri, Luciano C P Azevedo, Thiago D Corrêa, Maicon Falavigna, Flavia R Machado, Murillo S C de Assunção, Suzana M A Lobo, Letícia K Dourado, Otavio Berwanger, John A Kellum, Nilton Brandão, Alexandre B Cavalcanti                              ;, BaSICS Investigators and the BRICNet, Fernando G Zampieriet al.",2017 Jun,Crit Care Resusc,https://pubmed.ncbi.nlm.nih.gov/28651514/,No keywords found,"['effectiveness', 'and', 'safety', 'of', 'balanced', 'crystalloid', 'fluid', 'compared', 'with', 'saline', '(', '.', 'sodium', 'chloride', ')', 'fluid', 'of', 'choice', 'in', 'critically', 'ill', 'patient', 'remain', 'unclear', '.', 'effect', 'of', 'different', 'fluid', 'infusion', 'rate', 'outcome', 'also', 'unknown', '.', 'objective', 'to', 'test', 'hypothesis', 'balanced', 'crystalloid', 'solution', ',', 'compared', 'with', 'saline', ',', 'decrease', '-day', 'all-cause', 'mortality', 'among', 'critically', 'ill', 'patient', 'and', 'to', 'test', 'hypothesis', 'slow', ',', 'compared', 'with', 'rapid', ',', 'infusion', 'rate', 'decrease', '-day', 'mortality', 'in', 'population', 'of', 'patient', '.', 'method', 'balanced', 'solution', 'versus', 'saline', 'in', 'intensive', 'care', 'study', '(', 'basic', ')', 'pragmatic', ',', 'factorial', ',', 'randomised', 'controlled', 'trial', '.', 'total', 'of', 'patient', 'recruited', 'least', 'brazilian', 'intensive', 'care', 'unit', '.', 'patient', 'randomised', 'to', 'receive', 'plasma-lyte', 'or', 'saline', ',', 'and', 'to', 'rapid', 'infusion', '(', 'mlh', ')', 'or', 'slow', 'infusion', '(', 'mlh', ')', '.', 'study', 'fluid', 'used', 'resuscitation', 'episode', '(', 'rapid', 'or', 'slow', 'infusion', 'rate', ')', ',', 'dilution', 'of', 'compatible', 'medication', 'and', 'maintenance', 'solution', '.', 'patient', ',', 'health', 'care', 'provider', 'and', 'investigator', 'blinded', 'to', 'solution', 'tested', '.', 'rate', 'of', 'bolus', 'infusion', 'not', 'blinded', '.', 'outcome', 'primary', 'outcome', '-day', 'all-cause', 'mortality', '.', 'secondary', 'outcome', 'incidence', 'of', 'renal', 'failure', 'requiring', 'renal', 'replacement', 'therapy', 'within', 'day', ',', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'kidney', 'disease', 'improving', 'global', 'outcome', 'stage', 'and', ')', ',', 'incidence', 'of', 'non-renal', 'organ', 'dysfunction', 'assessed', 'sepsis-related', 'organ', 'failure', 'assessment', 'score', 'day', 'and', ',', 'and', 'number', 'of', 'mechanical', 'ventilationfree', 'day', 'within', 'first', 'day', 'randomisation', '.', 'result', 'and', 'conclusion', 'basic', 'trial', 'provide', 'robust', 'evidence', 'whether', 'balanced', 'crystalloid', ',', 'compared', 'with', 'saline', ',', 'improves', 'important', 'patient', 'outcome', 'in', 'critically', 'ill', 'patient', '.', 'basic', 'also', 'provide', 'relevant', 'information', 'whether', 'bolus', 'infusion', 'rate', 'affect', 'outcome', 'in', 'population', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.,"Okay Abaci, Alev Arat Ozkan, Cuneyt Kocas, Gokhan Cetinkal, Osman Sukru Karaca, Onur Baydar, Aysem Kaya, Tevfik Gurmen, Okay Abaciet al.",2015 Apr 1,Am J Cardiol,https://pubmed.ncbi.nlm.nih.gov/25670636/,No keywords found,"['although', 'statin', 'shown', 'to', 'prevent', 'contrast-induced', 'acute', 'kidney', 'injury', 'in', 'patient', 'with', 'acute', 'coronary', 'syndrome', ',', 'benefit', 'of', 'statin', 'not', 'known', 'patient', 'high', 'risk', 'nephropathy', 'undergo', 'elective', 'coronary', 'angiography', '.', 'two', 'hundred', 'twenty', 'consecutive', 'statin-naive', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin', '.', '(', ')', ')', 'underwent', 'elective', 'coronary', 'or', 'peripheral', 'angiography', 'randomly', 'assigned', 'to', 'receive', 'rosuvastatin', '(', 'mg', 'admission', ',', 'followed', 'mgday', 'n', ')', 'or', 'no', 'statin', 'treatment', '(', 'control', 'group', ',', 'n', ')', '.', 'contrast-induced', 'acute', 'kidney', 'injury', 'defined', 'absolute', 'increase', 'in', 'serum', 'creatinine', 'of', '.', 'mgdl', 'or', 'relative', 'increase', 'of', 'measured', 'or', 'hour', 'procedure', '.', 'contrast-induced', 'acute', 'kidney', 'injury', 'occurred', 'in', 'patient', '(', '.', ')', ',', '(', '.', ')', 'in', 'control', 'group', 'and', '(', '.', ')', 'in', 'rosuvastatin', 'group', '(', 'p', '.', ')', '.', 'incidence', 'of', 'adverse', 'cardiovascular', 'and', 'renal', 'event', '(', 'death', ',', 'dialysis', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'or', 'persistent', 'renal', 'damage', ')', 'similar', 'two', 'group', 'follow-up', '.', 'in', 'conclusion', ',', 'rosuvastatin', 'not', 'reduce', 'risk', 'contrast-induced', 'acute', 'kidney', 'injury', 'or', 'clinically', 'relevant', 'outcome', 'in', 'at-risk', 'patient', 'underwent', 'coronary', 'and', 'peripheral', 'vascular', 'angiography', '.']"
"A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).","James I Geller, Elizabeth Fox, Brian K Turpin, Stuart L Goldstein, Xiaowei Liu, Charles G Minard, Rachel A Kudgus, Joel M Reid, Stacey L Berg, Brenda J Weigel, James I Gelleret al.",2018 Dec 1,Cancer,https://pubmed.ncbi.nlm.nih.gov/30394521/,No keywords found,"['axitinib', 'oral', 'small', 'molecule', 'inhibits', 'receptor', 'tyrosine', 'kinase', 'vascular', 'endothelial', 'growth', 'factor', 'receptor', 'to', '.', 'phase', 'and', 'pharmacokinetic', '(', 'pk', ')', 'trial', 'evaluating', 'axitinib', 'conducted', 'in', 'child', 'with', 'refractory', 'solid', 'tumor', '.', 'method', 'axitinib', 'administered', 'orally', 'twice', 'daily', 'in', 'continuous', '-day', 'cycle', '.', 'dose', 'level', '(', '.', 'mgm', 'dose', 'and', '.', 'mgm', 'dose', ')', 'evaluated', 'using', 'rolling', 'design', '.', 'serial', 'pks', '(', 'cycle', ',', 'day', 'and', ')', 'and', 'exploratory', 'biomarkers', 'analyzed', '.', 'result', 'total', 'of', 'patient', 'enrolled', 'patient', 'ineligible', 'due', 'to', 'inadequate', 'time', 'elapsed', 'prior', 'therapy', '.', 'median', 'age', 'of', 'patient', '.', 'year', '(', 'range', ',', '-', 'year', ')', '.', 'two', 'of', 'patient', 'treated', 'dose', 'level', 'experienced', 'dose-limiting', 'toxicity', '(', 'palmar-plantar', 'erythryodysesthesia', 'syndrome', 'in', 'patient', 'and', 'intratumoral', 'hemorrhage', 'in', 'patient', ')', '.', 'frequent', '(', ')', 'grade', 'to', 'toxicity', 'cycle', 'included', 'anemia', ',', 'anorexia', ',', 'fatigue', ',', 'diarrhea', ',', 'nausea', ',', 'and', 'hypertension', '.', 'nonhematological', 'toxicity', 'of', 'grade', 'in', 'subsequent', 'cycle', 'included', 'hypertension', 'and', 'elevated', 'serum', 'lipase', '.', 'pk', 'analysis', 'demonstrated', 'variability', 'in', 'axitinib', 'exposure', ',', 'median', 'time', 'to', 'peak', 'plasma', 'concentration', 'hour', ',', 'and', 'half-life', 'ranged', '.', 'to', '.', 'hour', '.', 'exposure', 'and', 'dose', 'not', 'found', 'to', 'significantly', 'associated', 'with', 'hypertension', '.', 'five', 'patient', 'achieved', 'stable', 'disease', 'cycle', 'best', 'response', ',', 'including', 'patient', 'with', 'malignant', 'peripheral', 'nerve', 'sheath', 'tumor', '(', 'patient', ')', ',', 'ewing', 'sarcoma', '(', 'patient', ')', ',', 'hepatocellular', 'carcinoma', '(', 'patient', ')', ',', 'and', 'osteosarcoma', '(', 'patient', ')', '.', 'one', 'patient', 'with', 'alveolar', 'soft', 'part', 'sarcoma', 'achieved', 'partial', 'response', '.', 'kidney', 'injury', 'biomarkers', 'found', 'to', 'elevated', 'baseline', 'no', 'trend', 'identified', '.', 'conclusion', 'in', 'child', 'with', 'refractory', 'solid', 'tumor', ',', 'maximum', 'tolerated', 'and', 'recommended', 'dose', 'of', 'axitinib', 'appears', 'to', '.', 'mgm', 'dose', ',', 'provides', 'pk', 'exposure', 'similar', 'to', 'of', 'adult', '.']"
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.,"Henk van den Berg, Michael Paulussen, Gwénaël Le Teuff, Ian Judson, Hans Gelderblom, Uta Dirksen, Bernadette Brennan, Jeremy Whelan, Ruth Lydia Ladenstein, Perrine Marec-Berard, Jarmila Kruseova, Lars Hjorth, Thomas Kühne, Benedicte Brichard, Keith Wheatley, Alan Craft, Heribert Juergens, Nathalie Gaspar, Marie-Cécile Le Deley                              ;, Euro-EWING Group, Ch Urban, B Meister, F M Fink, R Kerbl, O Stollinger, K Schmitt, G Ebetsberger, N Jones, R Ladenstein, H Gadner, P Maes, B Brichard, F Mazzeo, T Gil, C Dhooge, J B Vermorken, A Klein, J Kruseova, A Krarup-Hansen, O Nielsen, M Capra, B Pautard, X Rialland, P Maillart, E Plouvier, C Vérité, B Bui N'guyen, P Boutard, C Delcambre, J O Bay, F Demeocq, G Couillault, N Isambert, D Plantaz, A S Desfachelles, C Piguet, P Marec-Bérard, J Y Blay, J C Gentet, F Duffaud, F Bertucci, N Sirvent, C Schmitt, M Rios, N Corradini, F Rolland, A Deville, A Thyss, J Michon, M D Tabone, J Y Pierga, F Millot, M Munzer, C Edan, J P Vannier, C Guillemet, E Brun, C Berger, M P Castex, H Roche, O Lejars, C Linassier, O Oberlin, A Le Cesne, S Bauer, P Ebeling, M Flasshove, J T Hartmann, P Reichardt, R Mertens, R Osieka, A Gnekow, G Schlimok, G Henze, P Thuss-Patience, L Wickmann, J Potenberg, U Bode, I G M Schmidt-Wolf, W Eberl, Th Wolff, A Pekrun, A Hofmann, W Andler, D Schneider, I Lauterbach, P Zickler, U Göbel, A Borkhardt, A Sauerbrey, W Holter, A Eggert, T Klingebiel, C Niemeyer, J Heinz, A Reiter, M Rummel, V Runde, M Lakomek, L Trümper, J Beck, G Dölken, H-W Lindemann, D Körholz, H-J Schmoll, R Schneppenheim, D K Hossfeld, C Bokemeyer, H Keles, K Welte, C Klein, A Kulozik, G Egerer, J Cyran, D Strumberg, W Freier, N Graf, M Pfreundschuh, B Gruhn, A Leipold, M Bentz, H Wehinger, M Schrappe, H Nolte, F Berthold, J Wolf, W Sternschulte, S Voelpel, T Frieling, J Moessner, D Selle, D Bucsky, H Bartels, M Mohren, Th Fischer, U Kluba, P Gutjahr, M Dittrich, S Reiter, M Dürken, A Neubauer, J Beyer, H Christiansen, B Erdlenbruch, S Burdach, I Schmid, C Meyer zum Büschenfelde, C Peschel, F Oduncu, H Jürgens, W Berdel, H Held, G Hofmann-Wackersreuther, H Müller, O Peters, R Andreesen, S Krause, F Heits, R Geib-König, M Kasbohm, D Bürger, R Burghard, R Dickerhoff, S Bielack, I Feddersen, M R Clemens, R Handgretinger, K-M Debatin, R Mayer-Steinacker, A Schoengen, P Schlegel, V Lee, K-W Chik, H van den Berg, S Rodenhuis, A J Gelderblom, P Hoogerbrugge, J P M Bökkerink, R Pieters, R Corbett, G Österlundh, M Behrendtz, B-M Holmqvist, L Hjorth, C Petersen, Å Jakobson, U Hjalmars, G Ljungman, R Angst, T Kühne, M Paulussen, S Leyvraz, J Rischewski, A Feldges, J Greiner, U Hess, G U Exner, F Niggli, A Knuth, D King, A McCarthy, P Henry, B Morland, H Rees, J Nicholson, H Traunecker, H Wallace, M Ronghe, E Simpson, F Cowie, J White, S Picton, I Lewis, M Leahy, D Stark, P J Selby, D Heney, B Pizer, H McDowell, A Michalski, J Whelan, J Chisholm, K Pritchard-Jones, I Judson, B Brennan, J Hale, M Verrill, D Walker, M Sokal, K Wheeler, M Gerrard, P Woll, P Lorigan, M Robinson, J Kohler, Henk van den Berget al.",2015 Nov,Eur J Cancer,https://pubmed.ncbi.nlm.nih.gov/26271204/,No keywords found,"['based', 'randomised', 'euro-ewing-r', 'trial', ',', 'vincristine', ',', 'adriamycin', ',', 'cyclophosphamide', '(', 'vac', ')', 'may', 'able', 'to', 'replace', 'vincristine', ',', 'adriamycin', ',', 'ifosfamide', '(', 'vai', ')', 'in', 'treatment', 'of', 'standard-risk', 'ewing', 'sarcoma', '.', 'however', 'heterogeneity', 'of', 'treatment', 'effect', 'gender', 'observed', '.', 'current', 'exploratory', 'study', 'aimed', 'investigating', 'influence', 'of', 'gender', 'treatment', 'efficacy', 'and', 'acute', 'toxicity', '.', 'patient', 'and', 'method', 'impact', 'of', 'gender', 'event-free', 'survival', '(', 'efs', ')', ',', 'acute', 'toxicity', 'course', ',', 'switch', 'treatment', 'arm', 'and', 'cumulative', 'dose', 'of', 'alkylating', 'agent', 'evaluated', 'in', 'multivariable', 'model', 'adjusted', 'age', 'including', 'term', 'to', 'test', 'heterogeneity', 'of', 'treatment', 'effect', 'gender', '.', 'analysis', 'of', 'efs', 'performed', 'intention-to-treat', 'population', '.', 'result', 'efs', 'not', 'significantly', 'differ', 'male', 'and', 'female', '(', 'p.', ')', ',', 'interaction', 'in', 'term', 'of', 'efficacy', 'suspected', 'treatment', 'and', 'gender', '(', 'p.', ')', 'vac', 'associated', 'with', 'poorer', 'efs', 'vai', 'in', 'male', ',', 'hazard', 'ratio', '(', 'hr', ')', '(', 'vacvai', ')', '.', 'confidence', 'interval', '(', 'ci', ')', ',', '.-.', ',', 'contrasting', 'with', 'hr', '.', 'ci', ',', '.-', '.', 'in', 'female', '.', 'severe', 'toxicity', 'frequent', 'in', 'female', ',', 'whatever', 'toxicity', 'type', '.', 'thirty', 'patient', 'switched', 'vai', 'to', 'vac', '(', 'male', ',', ',', 'and', 'female', ',', ')', 'mostly', 'due', 'to', 'renal', 'toxicity', ',', 'and', 'three', 'vac', 'to', 'vai', '(', 'male', ',', '.', ',', 'and', 'female', ',', '.', ')', '.', 'reduction', 'of', 'alkylating', 'agent', 'cumulative', 'dose', 'frequent', 'in', 'female', '(', 'versus', ',', 'p.', ')', ',', 'with', 'no', 'major', 'difference', 'vac', 'and', 'vai', '(', 'versus', ',', 'p.', ')', '.', 'conclusion', 'difference', 'of', 'acute', 'toxicity', 'rate', 'and', 'cumulative', 'dos', 'of', 'alkylating', 'agent', 'could', 'not', 'explain', 'marginal', 'interaction', 'observed', 'in', 'euro-ewing-r', 'trial', 'data', '.', 'effect', 'of', 'gender-dependent', 'polymorphismactivity', 'of', 'metabolic', 'enzyme', '(', 'e.g', '.', 'known', 'cypb', ')', 'of', 'ifosfamide', 'versus', 'cyclophosphamide', 'explored', '.', 'external', 'data', 'required', 'to', 'evaluate', 'whether', 'heterogeneity', 'of', 'alkylating', 'agent', 'effect', 'gender', '.', 'trial', 'number', 'nct', 'and', 'eudract', '--', '.']"
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia.,"Pankit Vachhani, Jeffrey Baron, Craig W Freyer, Austin Miller, Meir Wetzler, James E Thompson, Elizabeth A Griffiths, Eunice S Wang, Pankit Vachhaniet al.",2021 Aug:107:106588.,Leuk Res,https://pubmed.ncbi.nlm.nih.gov/33957371/,No keywords found,"['rasburicase', 'markedly', 'and', 'rapidly', 'decrease', 'uric', 'acid', '(', 'ua', ')', 'level', ',', 'thereby', 'preventing', 'and', 'treating', 'tumor', 'lysis', 'syndrome', '.', 'however', ',', 'rasburicase', 'expensive', ',', 'especially', 'used', 'per', 'manufacturer', ""'s"", 'recommended', 'dosage', 'of', '.', 'mgkgday', 'to', 'day', '.', 'numerous', 'report', 'shown', 'lower', ',', 'and', 'even', 'single', 'dos', 'effective', 'in', 'lowering', 'ua', 'level', 'prospective', 'randomized', 'study', 'comparing', 'low', 'dos', 'not', 'performed', '.', 'objective', 'to', 'prospectively', 'determine', 'efficacy', 'and', 'safety', 'of', 'two', 'single', 'low', 'dos', 'of', 'rasburicase', 'in', 'adult', 'patient', '(', 'pt', ')', 'with', 'acute', 'leukemia', 'and', 'elevated', 'plasma', 'ua', '.', 'method', 'eligible', 'pt', 'aged', 'year', 'old', 'with', 'acute', 'leukemia', 'and', 'ua', '.', 'mgdl', 'randomized', 'to', 'receive', 'initial', 'single', 'dose', 'of', 'rasburicase', '.', 'mg', '(', 'arm', ')', 'or', 'mg', '(', 'arm', 'b', ')', 'day', 'in', 'unblinded', 'fashion', '.', 'pt', 'received', 'allopurinol', 'mg', 'daily', 'day', '-', '.', 'result', 'twenty-four', 'pt', '(', 'median', 'age', 'year', 'male', 'and', 'female', ')', 'enrolled', 'in', 'phase', 'study', '(', 'arm', ')', '.', 'twenty', 'pt', 'acute', 'myeloid', 'leukemia', 'acute', 'lymphoblastic', 'leukemia', ',', 'and', 'acute', 'promyelocytic', 'leukemia', '.', 'median', 'initial', 'ua', 'level', '.', 'mgdl', '.', 'eighty-three', 'percent', 'of', 'pt', 'in', 'arm', 'achieved', 'ua', '.', 'mgdl', 'h', 'therapy', '.', 'five', 'pt', '(', 'arm', 'and', 'arm', 'b', ')', 'required', 'additional', 'dos', 'of', 'rasburicase', '.', 'majority', '(', ')', 'of', 'pt', 'achieved', 'ua', 'goal', '-', 'dos', 'of', 'rasburicase', '.', 'none', 'worsening', 'renal', 'function', '.', 'dos', 'well', 'tolerated', ',', 'and', 'no', 'treatment', 'related', 'adverse', 'event', 'reported', '.', 'conclusion', 'single', 'dos', 'of', 'rasburicase', '(', 'low', '.-', 'mg', ')', 'used', 'in', 'addition', 'to', 'allopurinol', 'well', 'tolerated', 'and', 'highly', 'efficacious', '(', 'response', 'rate', ')', 'in', 'decreasing', 'ua', 'level', 'within', 'h', 'of', 'administration', 'in', 'adult', 'acute', 'leukemia', 'pt', 'with', 'hyperuricemia', '.']"
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).,"Michael V Rocco, Kaycee M Sink, Laura C Lovato, Dawn F Wolfgram, Thomas B Wiegmann, Barry M Wall, Kausik Umanath, Frederic Rahbari-Oskoui, Anna C Porter, Roberto Pisoni, Cora E Lewis, Julia B Lewis, James P Lash, Lois A Katz, Amret T Hawfield, William E Haley, Barry I Freedman, Jamie P Dwyer, Paul E Drawz, Mirela Dobre, Alfred K Cheung, Ruth C Campbell, Udayan Bhatt, Srinivasan Beddhu, Paul L Kimmel, David M Reboussin, Glenn M Chertow                              ;, SPRINT Research Group, Michael V Roccoet al.",2018 Mar,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/29162340/,No keywords found,"['treating', 'to', 'lower', 'blood', 'pressure', '(', 'bp', ')', 'may', 'increase', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'event', '.', 'study', 'design', 'data', 'aki', 'resulting', 'in', 'or', 'hospitalization', 'or', 'emergency', 'department', 'visit', 'collected', 'part', 'of', 'serious', 'adverse', 'event', 'reporting', 'process', 'of', 'systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', ')', '.', 'setting', 'participant', ',', 'participant', 'year', 'or', 'older', 'with', 'or', 'risk', 'factor', 'cardiovascular', 'disease', '.', 'intervention', 'participant', 'randomly', 'assigned', 'to', 'systolic', 'bp', 'target', 'of', '(', 'intensive', 'arm', ')', 'or', 'mmhg', '(', 'standard', 'arm', ')', '.', 'outcome', 'measurement', 'primary', 'outcome', 'number', 'of', 'adjudicated', 'aki', 'event', '.', 'secondary', 'outcome', 'included', 'severity', 'of', 'aki', 'and', 'degree', 'of', 'recovery', 'of', 'kidney', 'function', 'aki', 'event', '.', 'baseline', 'creatinine', 'concentration', 'defined', 'recent', 'sprint', 'outpatient', 'creatinine', 'value', 'date', 'of', 'aki', 'event', '.', 'result', 'participant', 'with', 'aki', 'event', 'in', 'intensive', 'arm', 'and', 'in', 'standard', 'arm', '(', '.', 'v', '.', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', '.', 'of', 'participant', 'with', 'aki', 'event', ',', '(', '.', ')', 'single', 'aki', 'event', 'trial', '.', 'based', 'modified', 'kdigo', '(', 'kidney', 'disease', 'improving', 'global', 'outcome', ')', 'criterion', 'severity', 'of', 'aki', ',', 'number', 'of', 'aki', 'event', 'in', 'intensive', 'versus', 'standard', 'arm', 'kdigo', 'stage', '(', '.', ')', 'versus', '(', '.', ')', 'aki', 'stage', ',', '(', '.', ')', 'versus', '(', '.', ')', 'aki', 'stage', ',', 'and', '(', '.', ')', 'versus', '(', '.', ')', 'aki', 'stage', '(', 'p.', ')', '.', 'participant', 'with', 'sufficient', 'data', ',', 'complete', 'or', 'partial', 'resolution', 'of', 'aki', 'seen', '(', '.', ')', 'and', '(', '.', ')', 'of', 'aki', 'event', 'in', 'intensive', 'arm', 'and', '(', '.', ')', 'and', '(', '.', ')', 'of', 'aki', 'event', 'in', 'standard', 'arm', ',', 'respectively', '.', 'limitation', 'trial', 'result', 'not', 'generalizable', 'to', 'patient', 'with', 'diabetes', 'mellitus', 'or', 'without', 'risk', 'factor', 'cardiovascular', 'disease', '.', 'conclusion', 'intensive', 'bp', 'lowering', 'resulted', 'in', 'frequent', 'episode', 'of', 'aki', '.', 'case', 'mild', 'and', 'participant', 'complete', 'recovery', 'of', 'kidney', 'function', '.', 'trial', 'registration', 'registered', 'clinicaltrials.gov', 'with', 'study', 'number', 'nct', '.']"
"The Effect of Regularly Dosed Acetaminophen vs No Acetaminophen on Renal Function in Plasmodium knowlesi Malaria (PACKNOW): A Randomized, Controlled Trial.","Daniel J Cooper, Matthew J Grigg, Katherine Plewes, Giri S Rajahram, Kim A Piera, Timothy William, Jayaram Menon, Glenn Koleth, Michael D Edstein, Geoffrey W Birrell, Thanaporn Wattanakul, Joel Tarning, Aatish Patel, Tsin Wen Yeo, Arjen M Dondorp, Nicholas M Anstey, Bridget E Barber, Daniel J Cooperet al.",2022 Oct 12,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/35180298/,No keywords found,"['acetaminophen', 'inhibits', 'cell-free', 'hemoglobin-induced', 'lipid', 'peroxidation', 'and', 'improves', 'renal', 'function', 'in', 'severe', 'falciparum', 'malaria', 'not', 'evaluated', 'in', 'infection', 'with', 'prominent', 'hemolysis', ',', 'including', 'plasmodium', 'knowlesi', 'malaria', '.', 'method', 'packnow', 'open-label', ',', 'randomized', ',', 'controlled', 'trial', 'of', 'acetaminophen', '(', 'mg', 'or', 'mg', 'every', 'hour', 'hour', ')', 'v', 'no', 'acetaminophen', 'in', 'malaysian', 'patient', 'aged', 'year', 'with', 'knowlesi', 'malaria', 'of', 'severity', '.', 'primary', 'end', 'point', 'change', 'in', 'creatinine', 'hour', '.', 'secondary', 'end', 'point', 'included', 'longitudinal', 'change', 'in', 'creatinine', 'in', 'patient', 'with', 'severe', 'malaria', 'or', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'stratified', 'hemolysis', '.', 'result', '-', ',', 'patient', '(', 'aged', '-', 'year', ')', 'randomized', 'to', 'acetaminophen', '(', 'n', ')', 'or', 'no', 'acetaminophen', '(', 'n', ')', '.', 'overall', ',', 'creatinine', 'fell', 'mean', '(', 'standard', 'deviation', ')', '.', '(', '.', ')', 'in', 'acetaminophen', 'arm', 'v', '.', '(', '.', ')', 'in', 'control', 'arm', '(', 'p', '.', ')', '.', 'in', 'severe', 'disease', ',', 'creatinine', 'fell', '.', '(', '.', ')', 'in', 'acetaminophen', 'arm', 'v', '.', '(', '.', ')', 'in', 'control', 'arm', '(', 'p', '.', ')', ',', 'and', 'in', 'with', 'hemolysis', '.', '(', '.', ')', 'and', '(', '.', ')', ',', 'respectively', '(', 'p', '.', ')', '.', 'no', 'difference', 'seen', 'overall', 'in', 'patient', 'with', 'aki', 'however', ',', 'in', 'with', 'aki', 'and', 'hemolysis', ',', 'creatinine', 'fell', '.', '(', '.', ')', 'in', 'acetaminophen', 'arm', 'v', '.', '(', '.', ')', 'in', 'control', 'arm', '(', 'p', '.', ')', '.', 'mixed-effects', 'modeling', 'demonstrated', 'benefit', 'of', 'acetaminophen', 'hour', '(', 'p', '.', ')', 'and', 'week', '(', 'p', '.', ')', 'in', 'patient', 'with', 'severe', 'malaria', 'and', 'with', 'aki', 'and', 'hemolysis', '(', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', '.', 'conclusion', 'acetaminophen', 'not', 'improve', 'creatinine', 'among', 'entire', 'cohort', 'may', 'improve', 'renal', 'function', 'in', 'patient', 'with', 'severe', 'knowlesi', 'malaria', 'and', 'in', 'with', 'aki', 'and', 'hemolysis', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
"Saline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial.","Wesley H Self, Matthew W Semler, Jonathan P Wanderer, Jesse M Ehrenfeld, Daniel W Byrne, Li Wang, Leanne Atchison, Matthew Felbinger, Ian D Jones, Stephan Russ, Andrew D Shaw, Gordon R Bernard, Todd W Rice, Wesley H Selfet al.",2017 Apr 13,Trials,https://pubmed.ncbi.nlm.nih.gov/28407811/,No keywords found,"['prior', 'study', 'in', 'critically', 'ill', 'patient', 'suggest', 'supra-physiologic', 'chloride', 'concentration', 'of', '.', '(', '``', 'normal', ""''"", ')', 'saline', 'may', 'associated', 'with', 'higher', 'risk', 'of', 'renal', 'failure', 'and', 'death', 'compared', 'to', 'physiologically', 'balanced', 'crystalloids', '.', 'however', ',', 'comparative', 'effect', 'of', '.', 'saline', 'and', 'balanced', 'fluid', 'largely', 'unexamined', 'among', 'patient', 'outside', 'intensive', 'care', 'unit', ',', 'represent', 'vast', 'majority', 'of', 'patient', 'treated', 'with', 'intravenous', 'fluid', '.', 'methodsdesign', 'study', ',', 'entitled', 'saline', 'lactated', 'ringer', ""'s"", 'or', 'plasma-lyte', 'in', 'emergency', 'department', '(', 'salt-ed', ')', ',', 'pragmatic', ',', 'cluster', ',', 'multiple-crossover', 'trial', 'single', 'institution', 'evaluating', 'clinical', 'outcome', 'of', 'adult', 'treated', 'with', '.', 'saline', 'versus', 'balanced', 'crystalloids', 'intravenous', 'fluid', 'resuscitation', 'in', 'emergency', 'department', '.', 'adult', 'treated', 'in', 'study', 'emergency', 'department', 'receiving', 'least', 'ml', 'of', 'isotonic', 'crystalloid', 'solution', 'usual', 'clinical', 'care', 'and', 'subsequently', 'hospitalized', 'outside', 'intensive', 'care', 'unit', 'included', '.', 'treatment', 'allocation', 'of', '.', 'saline', 'versus', 'balanced', 'crystalloids', 'assigned', 'calendar', 'month', ',', 'with', 'study', 'patient', 'treated', 'month', 'assigned', 'to', 'fluid', 'type', '.', 'first', 'month', '(', 'january', ')', 'randomly', 'assigned', 'to', 'balanced', 'crystalloids', ',', 'with', 'subsequent', 'month', 'alternating', '.', 'saline', 'and', 'balanced', 'crystalloids', '.', 'balanced', 'crystalloid', 'treatment', ',', 'clinician', 'choose', 'either', 'lactated', 'ringer', ""'s"", 'or', 'plasma-lyte', 'a.', 'study', 'period', 'set', 'month', ',', 'result', 'in', 'anticipated', 'estimated', 'sample', 'size', 'of', ',', 'patient', '.', 'primary', 'outcome', 'hospital-free', 'day', 'to', 'day', ',', 'defined', 'number', 'of', 'day', 'alive', 'and', 'of', 'hospital', 'index', 'emergency', 'department', 'visit', 'day', 'later', '.', 'major', 'secondary', 'outcome', 'include', 'proportion', 'of', 'patient', 'develop', 'acute', 'kidney', 'injury', 'creatinine', 'measurement', 'major', 'adverse', 'kidney', 'event', 'hospital', 'discharge', 'or', 'day', '(', 'make', ')', ',', 'composite', 'outcome', 'of', 'death', ',', 'new', 'renal', 'replacement', 'therapy', ',', 'and', 'persistent', 'creatinine', 'elevation', 'of', 'baseline', 'and', 'in-hospital', 'mortality', '.', 'discussion', 'ongoing', 'pragmatic', 'trial', 'provide', 'comprehensive', 'evaluation', 'to', 'date', 'of', 'clinical', 'outcome', 'associated', 'with', '.', 'saline', 'compared', 'to', 'physiologically', 'balanced', 'fluid', 'in', 'patient', 'outside', 'intensive', 'care', 'unit', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'nct', '.', 'registered', 'november', '.']"
"Gravity-assisted continuous flow peritoneal dialysis technique use in acute kidney injury in children: a randomized, crossover clinical trial.","Peter Nourse, Mignon McCulloch, Ashton Coetzee, Tim Bunchman, Stefano Picca, Jody Rusch, Andre Brooks, Hilton Heydenrych, Brenda Morrow, Peter Nourseet al.",2023 Aug,Pediatr Nephrol,https://pubmed.ncbi.nlm.nih.gov/36929384/,No keywords found,"['previously', 'demonstrated', 'continuous', 'flow', 'peritoneal', 'dialysis', '(', 'cfpd', ')', 'technique', 'in', 'child', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'although', 'effective', ',', 'manpower', 'heavy', 'and', 'expensive', 'due', 'to', 'high-volume', 'pump', 'required', '.', 'aim', 'of', 'study', 'to', 'develop', 'and', 'test', 'novel', 'gravity-driven', 'cfpd', 'technique', 'in', 'child', 'using', 'readily', 'available', ',', 'inexpensive', 'equipment', 'and', 'to', 'compare', 'technique', 'to', 'conventional', 'pd', '.', 'method', 'development', 'and', 'initial', 'in', 'vitro', 'testing', ',', 'randomised', 'crossover', 'clinical', 'trial', 'conducted', 'in', 'child', 'with', 'aki', 'requiring', 'dialysis', '.', 'patient', 'received', 'conventional', 'pd', 'and', 'cfpd', 'sequentially', ',', 'in', 'random', 'order', '.', 'primary', 'outcome', 'measure', 'of', 'feasibility', ',', 'clearance', 'and', 'ultrafiltration', '(', 'uf', ')', '.', 'secondary', 'outcome', 'complication', 'and', 'mass', 'transfer', 'coefficient', '(', 'mtc', ')', '.', 'paired', 't-tests', 'used', 'to', 'compare', 'pd', 'and', 'cfpd', 'outcome', '.', 'result', 'median', '(', 'range', ')', 'age', 'and', 'weight', 'of', 'participant', '.', '(', '.-', ')', 'month', 'and', '.', '(', '.-', '.', ')', 'kg', ',', 'respectively', '.', 'cfpd', 'system', 'easily', 'and', 'rapidly', 'assembled', '.', 'no', 'serious', 'adverse', 'event', 'attributed', 'to', 'cfpd', '.', 'mean', 'sd', 'uf', 'significantly', 'higher', 'cfpd', 'compared', 'to', 'conventional', 'pd', '(', '.', '.', 'mlkgh', 'vs.', '.', '.', 'mlkgh', 'p', '.', ')', '.', 'clearance', 'urea', ',', 'creatinine', 'and', 'phosphate', 'child', 'cfpd', '.', '.', 'mlmin', '.', ',', '.', '.', 'mlmin', '.', 'and', '.', '.', 'mlmin', '.', 'compared', 'to', 'conventional', 'pd', 'with', 'value', 'of', '.', '.', 'mlmin', '.', ',', '.', '.', 'mlmin', '.', 'and', '.', '.', 'mlmin', '.', ',', 'respectively', '(', 'p', '.', ')', '.', 'conclusion', 'gravity-assisted', 'cfpd', 'appears', 'to', 'feasible', 'and', 'effective', 'way', 'to', 'augment', 'ultrafiltration', 'and', 'clearance', 'in', 'child', 'with', 'aki', '.', 'assembled', 'readily', 'available', 'non-expensive', 'equipment', '.', 'higher', 'resolution', 'version', 'of', 'graphical', 'abstract', 'available', 'supplementary', 'information', '.']"
Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms - a prospective randomized clinical trial.,"Bharathi Balachander, Nivedita Mondal, Vishnu Bhat, Bethou Adhisivam, Mahesh Kumar, Santhosh Satheesh, Mahalakshmi Thulasingam, Bharathi Balachanderet al.",2020 May,J Matern Fetal Neonatal Med,https://pubmed.ncbi.nlm.nih.gov/30227731/,"Ductus, PDA, ibuprofen, paracetamol, preterm.","['currently', 'nonselective', 'cyclooxygenase', '(', 'cox', ')', 'inhibitor', ',', 'ibuprofen', 'and', 'indomethacin', ',', 'approved', 'drug', 'closure', 'of', 'patent', 'ductus', 'arteriosus', 'potential', 'toxicity', '.', 'report', 'of', 'effectiveness', 'of', 'paracetamol', 'in', 'ductal', 'closure', '.', 'however', ',', 'paucity', 'of', 'data', 'comparing', 'paracetamol', 'to', 'ibuprofen', 'or', 'indomethacin', 'in', 'relation', 'to', 'efficacy', 'and', 'safety', 'profile.methods', 'randomized', 'clinical', 'trial', 'done', 'in', 'tertiary', 'care', 'neonatal', 'unit', 'october', 'to', 'january', 'clearance', 'ethical', 'committee', '.', 'registered', 'with', 'clinical', 'trial', 'registry', 'of', 'india', '(', 'ctri', ')', 'and', 'drug', 'controller', 'general', 'of', 'india', '(', 'ctdrugs', ')', '.', 'preterm', 'neonate', 'with', 'clinical', 'suspicion', 'of', 'hemodynamically', 'significant', 'pda', 'echo', 'confirmation', 'included', 'in', 'study', '.', 'randomization', 'done', 'stratified', 'randomization', 'sealed', 'opaque', 'envelope', '.', 'sample', 'size', 'of', 'estimated', 'with', 'expected', 'difference', 'in', 'success', 'of', 'closure', 'treatment', 'group', 'level', 'of', 'significance', 'and', 'power', '.', 'echocardiography', 'done', 'hour', 'completion', 'of', 'treatment', 'cardiologist', 'blinded', 'to', 'treatment.results', 'baseline', 'parameter', 'comparable', 'two', 'group', '.', 'one', 'hundred', 'and', 'forty-six', 'baby', 'hs-pda', ',', 'of', 'baby', 'randomized', '.', 'no', 'significant', 'difference', 'found', 'two', 'group', 'with', 'respect', 'to', 'pda', 'closure', '(', 'rr', '.', ',', 'ci', '.-.', ',', 'p', ')', ',', 'mortality', 'or', 'cardio-respiratory', 'morbidity', '.', 'baby', 'received', 'ibuprofen', 'higher', 'occurrence', 'of', 'acute', 'kidney', 'injury', '(', 'rr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.conclusions', 'paracetamol', 'effective', 'ibuprofen', 'pda', 'closure', 'in', 'preterm', 'neonate', '.', 'ibuprofen', 'used', 'pda', 'closure', 'in', 'preterms', 'pose', 'increased', 'risk', 'acute', 'kidney', 'injury', 'compared', 'to', 'paracetamol', '.']"
High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.,"Shruti Gupta, Sophia L Wells, Arunima M Jose, Robert H Seitter, Lea Feghali, Nishant Devaraj, Philip M Hartigan, Stephanie Yacoubian, David J Kwiatkowski, Donna M Burke, Julianne Barlow, Raphael Bueno, David E Leaf, Shruti Guptaet al.",2023 Dec,J Surg Oncol,https://pubmed.ncbi.nlm.nih.gov/37702402/,No keywords found,"['hyperthermic', 'intraoperative', 'cisplatin', '(', 'hioc', ')', 'associated', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'administration', 'of', 'high-dose', 'magnesium', 'attenuates', 'cisplatin-induced', 'aki', '(', 'cp-aki', ')', 'in', 'animal', 'model', 'not', 'rigorously', 'examined', 'in', 'human', '.', 'method', 'tested', 'feasibility', 'and', 'safety', 'of', 'different', 'dos', 'of', 'magnesium', 'in', 'mesothelioma', 'patient', 'receiving', 'hioc', '.', 'in', 'pilot', 'study', ',', 'administered', '-h', 'continuous', 'infusion', 'of', 'magnesium', '.', 'gh', ',', 'targeting', 'serum', 'magnesium', 'level', 'and', '.', 'mgdl', '.', 'in', 'pilot', 'study', ',', 'administered', 'g', 'bolus', 'followed', 'infusion', 'starting', 'gh', ',', 'titrated', 'to', 'achieve', 'level', 'and', 'mgdl', '.', 'eliminated', 'bolus', 'in', 'pilot', 'study', 'b.', 'result', 'in', 'pilot', 'study', ',', 'five', 'patient', 'enrolled', 'completed', 'study', 'however', ',', 'median', 'postoperative', 'mg', 'level', '.', 'mgdl', '.', 'in', 'pilot', 'study', ',', 'two', 'of', 'four', 'patient', '(', ')', 'withdrawn', 'due', 'to', 'bradycardia', 'bolus', '.', 'in', 'pilot', 'study', 'b', ',', 'two', 'patient', 'completed', 'study', 'whereas', 'two', 'developed', 'postoperative', 'bradycardia', 'attributed', 'to', 'magnesium', '.', 'conclusion', '.', 'gh', 'infusion', 'h', 'not', 'achieve', 'therapeutic', 'magnesium', 'level', ',', 'infusion', 'gh', 'associated', 'with', 'bradycardia', '.', 'study', 'informed', 'design', 'of', 'randomized', 'clinical', 'trial', 'testing', 'whether', 'intravenously', 'mg', 'attenuates', 'hioc-associated', 'aki', '.']"
Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT.,"Kenechukwu Mezue, Abhinav Goyal, Gregg S Pressman, Roy Matthew, Jay C Horrow, Janani Rangaswami, Kenechukwu Mezueet al.",2018 Sep,J Clin Hypertens (Greenwich),https://pubmed.ncbi.nlm.nih.gov/29984884/,"blood pressure variability, cardiovascular outcomes, hypertension.","['sprint', '(', 'systolic', 'blood', 'pressure', 'intervention', 'trial', ')', 'highlighted', 'benefit', 'of', 'intensive', 'targeted', 'antihypertensive', 'therapy', 'resulted', 'in', 'higher', 'rate', 'of', 'treatment-related', 'adverse', 'event', '.', 'blood', 'pressure', '(', 'bp', ')', 'variability', 'emerged', 'significant', 'predictor', 'of', 'outcome', 'and', 'level', 'of', 'bp', '.', 'using', 'sprint', 'data', 'set', ',', 'aimed', 'to', 'determine', 'relationship', 'of', 'bp', 'variability', 'with', 'cardiovascular', 'outcome', 'and', 'side', 'effect', 'of', 'antihypertensive', 'therapy', '.', 'analysis', 'included', 'participant', 'randomized', 'in', 'sprint', 'reached', 'target', 'systolic', 'bp', '(', 'sbp', ')', 'respective', 'group', '(', 'intensive', 'mm', 'hg', 'standard', 'mm', 'hg', ')', '.', 'coefficient', 'of', 'variation', '(', 'cv', ')', 'sbp', ',', 'diastolic', 'bp', '(', 'dbp', ')', ',', 'and', 'pp', 'patient', 'characterized', 'variability', '.', 'student', 'test', 'used', 'to', 'compare', 'treatment', 'arm', 'cv', 'metric', '.', 'cox', 'proportional', 'hazard', 'regression', 'used', 'to', 'identify', 'independent', 'predictor', 'of', 'sprint', 'primary', 'outcome', 'and', 'adverse', 'event', '.', 'p', '.', 'univariate', 'analysis', 'required', 'to', 'enter', 'model', 'and', 'p', '.', 'to', 'remain', 'in', '.', 'total', 'of', 'patient', '(', 'standard', 'group', 'intensive', 'group', ')', 'met', 'inclusion', 'criterion', '.', 'dbp', 'cv', 'differed', 'group', '(', '.', '.', 'standard', 'group', '.', '.', 'intensive', 'group', 'p', '.', ')', '.', 'dbp', 'cv', 'predicted', 'greater', 'hazard', 'primary', 'outcome', '(', 'hazard', 'ratio', 'hr', ',', '.', ')', 'in', 'overall', 'model', 'well', 'separate', 'analysis', 'treatment', 'arm', '(', 'standard', 'group', 'hr', ',', '.', 'intensive', 'group', 'hr', ',', '.', ')', ',', 'p', '..', 'dbp', 'cv', 'also', 'independently', 'predicted', 'greater', 'hazard', 'acute', 'kidney', 'injury', '(', 'hr', ',', '.', ')', 'and', 'hypotensive', 'event', '(', 'hr', ',', '.', ')', '.', 'visit-to-visit', 'dbp', 'variability', 'independently', 'predicted', 'worse', 'cardiovascular', 'outcome', 'and', 'hypoperfusion-related', 'adverse', 'event', 'in', 'sprint', '.']"
Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial.,"Taha Sen, Akihiko Koshino, Bruce Neal, Maarten J Bijlsma, Clare Arnott, Jingwei Li, Michael K Hansen, Joachim H Ix, Hiddo J L Heerspink, Taha Senet al.",2022 Oct,Diabetes Obes Metab,https://pubmed.ncbi.nlm.nih.gov/35635326/,No keywords found,"['to', 'test', 'hypothesis', 'reduction', 'in', 'urinary', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'observed', 'with', 'sodium-glucose', 'cotransporter-', '(', 'sglt', ')', 'inhibitor', 'canagliflozin', 'mediated', 'effect', 'urine', 'albumin', 'to', 'creatinine', 'ratio', '(', 'uacr', ')', 'and', 'monocyte', 'chemoattractant', 'protein-', '(', 'mcp-', ')', 'assessing', 'proportion', 'of', 'effect', 'of', 'canagliflozin', 'kim-', 'mediated', 'effect', 'mcp-', 'and', 'uacr', 'in', 'patient', 'with', 'type', 'diabetes', 'and', 'albuminuric', 'kidney', 'disease', '.', 'material', 'and', 'method', 'measured', 'kim-', 'and', 'mcp-', 'level', 'in', 'urine', 'sample', 'canvas', 'trial', 'baseline', 'and', 'week', 'with', 'mesoscale', 'quickplex', 'sq', 'platform', '.', 'kim-', 'and', 'mcp-', 'standardized', 'urinary', 'creatinine', '(', 'cr', ')', '.', 'proportion', 'of', 'effect', 'of', 'canagliflozin', 'mediated', 'uacr', 'and', 'mcp-cr', 'kim-cr', 'estimated', 'with', 'g-computation', '.', 'result', 'in', 'total', ',', 'patient', 'with', 'micro-', 'or', 'macroalbuminuria', '(', '.', 'of', 'total', 'cohort', ')', 'included', '.', 'baseline', 'characteristic', 'well', 'balanced', 'canagliflozin', 'and', 'placebo', 'group', '.', 'year', ',', 'canagliflozin', 'compared', 'to', 'placebo', 'reduced', 'uacr', ',', 'mcp-cr', 'and', 'kim-cr', '.', '(', 'ci', '.', ',', '.', ')', ',', '.', '(', 'ci', '.', ',', '.', ')', 'and', '.', '(', 'ci', '.', ',', '.', ')', ',', 'respectively', '.', 'proportion', 'of', 'effect', 'of', 'canagliflozin', 'kim-cr', 'mediated', 'effect', 'uacr', 'and', 'in', 'turn', 'mcp-cr', '.', '(', 'ci', '.', ',', '.', ')', '.', 'conclusion', 'canagliflozin', 'reduces', 'urinary', 'kim-', ',', 'suggesting', 'decreased', 'tubular', 'damage', '.', 'effect', 'partly', 'mediated', 'reduction', 'in', 'mcp-', ',', 'indicative', 'of', 'reduced', 'tubular', 'inflammation', ',', 'in', 'turn', 'mediated', 'reduction', 'in', 'uacr', '.', 'post', 'hoc', 'analysis', 'suggests', 'urinary', 'albumin', 'leakage', 'may', 'lead', 'to', 'tubular', 'inflammation', 'and', 'induction', 'of', 'injury', ',', 'and', 'provide', 'mechanistic', 'insight', 'canagliflozin', 'may', 'ameliorate', 'tubular', 'damage', ',', 'research', 'required', 'to', 'confirm', 'finding', '.']"
Efficacy of allogeneic mesenchymal stem cell administration in a model of acute ischemic kidney injury in cats.,"Desiree D Rosselli, Jennifer L Mumaw, Vanna Dickerson, Cathy A Brown, Scott A Brown, Chad W Schmiedt, Desiree D Rosselliet al.",2016 Oct:108:18-24.,Res Vet Sci,https://pubmed.ncbi.nlm.nih.gov/27663365/,No keywords found,"['to', 'evaluate', 'effect', 'of', 'allogeneic', 'mesenchymal', 'stem', 'cell', '(', 'msc', ')', 'in', 'model', 'of', 'ischemic', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'study', 'design', 'randomized', 'controlled', 'trial', '.', 'animal', 'adult', ',', 'purpose-bred', 'research', 'cat', '(', 'n', ')', 'and', 'historical', 'reference', 'group', '(', 'n', ')', '.', 'method', 'cat', 'underwent', 'unilateral', ',', 'in', 'vivo', ',', 'warm', 'renal', 'ischemia', ',', 'intravenous', 'administration', 'of', 'million', 'adipose-derived', 'msc', ',', 'bone', 'marrow-derived', 'msc', ',', 'or', 'fibroblast', '(', 'ntreatment', ')', 'h', 'reperfusion', '.', 'serum', 'creatinine', 'and', 'blood', 'urea', 'nitrogen', 'concentration', 'measured', 'baseline', 'and', 'day', 'and', '.', 'urine', 'specific', 'gravity', ',', 'urine', 'protein', 'to', 'urine', 'creatinine', 'ratio', ',', 'and', 'glomerular', 'filtration', 'rate', 'measured', 'baseline', 'and', 'day', '.', 'kidney', 'harvested', 'day', 'histopathology', 'described', 'and', 'scored', 'and', 'smooth', 'muscle', 'actin', 'quantified', 'with', 'histomorphometry', '.', '-way', 'anova', 'used', 'to', 'compare', 'time', 'and', 'treatment', '.', 'chi', 'square', 'analysis', 'used', 'to', 'determine', 'of', 'cat', 'with', 'least', 'international', 'renal', 'interest', 'society', '(', 'iris', ')', 'grade', 'aki', '.', 'result', 'time', ',', 'not', 'treatment', ',', 'significant', 'effect', 'renal', 'function', '.', 'no', 'difference', 'noted', 'in', 'of', 'cat', 'with', 'iris', 'aki', '.', 'significantly', 'fewer', 'mitotic', 'figure', 'observed', 'in', 'ischemic', 'kidney', 'received', 'bone-marrow', 'derived', 'msc', 'vs.', 'fibroblast', '.', 'no', 'difference', 'in', 'smooth', 'muscle', 'actin', 'staining', 'noted', '.', 'conclusion', 'study', 'not', 'support', 'use', 'of', 'allogeneic', 'msc', 'in', 'aki', 'in', 'regimen', 'described', '.', 'type', 'of', 'renal', 'injury', ',', 'msc', 'dose', ',', 'allogenicity', ',', 'duration', ',', 'and', 'route', 'or', 'timing', 'of', 'administration', 'could', 'influence', 'efficacy', 'msc', '.']"
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.,"Anne-Marie Chaftari, Ray Hachem, Mary Jordan, Kumait Garoge, Zainab Al Hamal, Aline El Zakhem, George M Viola, Bruno Granwehr, Victor Mulanovich, Andrew Gagel, Ruth Reitzel, Ammar Yousif, Ying Jiang, Issam Raad, Anne-Marie Chaftariet al.",2015 Oct 19,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/26482312/,No keywords found,"['gram-positive', 'bacterial', 'infection', 'important', 'cause', 'of', 'morbidity', 'and', 'death', 'among', 'cancer', 'patient', ',', 'despite', 'current', 'therapy', '.', 'in', 'case-control', 'study', ',', 'evaluated', 'clinical', 'outcome', 'and', 'safety', 'of', 'telavancin', 'in', 'cancer', 'patient', 'with', 'uncomplicated', 'gram-positive', 'bloodstream', 'infection', '(', 'bsis', ')', '.', 'march', 'and', 'may', ',', 'enrolled', 'cancer', 'patient', 'with', 'uncomplicated', 'gram-positive', 'bsis', 'to', 'receive', 'intravenous', 'telavancin', 'therapy', 'least', 'day', 'staphylococcus', 'aureus', 'and', 'day', 'gram-positive', 'cocci', '.', 'patient', 'with', 'baseline', 'creatinine', 'clearance', '(', 'clcr', ')', 'value', 'of', 'mlmin', 'received', 'mgkgday', 'of', 'telavancin', ',', 'and', 'with', 'clcr', 'value', 'and', 'mlmin', 'received', '.', 'mgkgday', '.', 'patient', 'compared', 'with', 'retrospective', 'cohort', 'of', 'historical', 'patient', 'with', 'gram-positive', 'bsis', ',', 'matched', 'underlying', 'malignancy', ',', 'infecting', 'organism', ',', 'and', 'neutropenia', 'status', ',', 'treated', 'with', 'vancomycin', '.', 'total', 'of', 'patient', 'analyzed', ',', 'with', 'in', 'group', '.', 'common', 'pathogen', 'causing', 'bsis', 's.', 'aureus', '(', ')', ',', 'followed', 'alpha-hemolytic', 'streptococci', '(', ')', ',', 'enterococcus', 'spp', '.', '(', ')', ',', 'coagulase-negative', 'staphylococci', '(', ')', ',', 'and', 'beta-hemolytic', 'streptococci', '(', ')', '.', 'sixty-two', 'percent', 'of', 'patient', 'hematological', 'malignancy', ',', 'and', 'solid', 'tumor', 'of', 'patient', 'neutropenic', '.', 'overall', 'response', 'rate', 'determined', 'clinical', 'outcome', 'and', 'microbiological', 'eradication', 'h', 'following', 'initiation', 'of', 'therapy', ',', 'in', 'absence', 'of', 'relapse', ',', 'deep-seated', 'infection', ',', 'andor', 'infection-related', 'death', ',', 'better', 'with', 'telavancin', 'with', 'vancomycin', '(', 'versus', 'p', '.', ')', '.', 'rate', 'of', 'drug-related', 'adverse', 'event', 'similar', 'in', 'two', 'group', '(', 'telavancin', ',', 'vancomycin', ',', 'p', '.', ')', ',', 'with', 'similar', 'rate', 'of', 'renal', 'adverse', 'event', '.', 'telavancin', 'may', 'provide', 'useful', 'alternative', 'to', 'standard', 'vancomycin', 'therapy', 'gram-positive', 'bsis', 'in', 'cancer', 'patient', '.', '(', 'study', 'registered', 'clinicaltrials.gov', 'registration', 'no', '.', 'nct', '.', ')', '.']"
Effect of high-dose sodium selenite in cardiac surgery patients: A randomized controlled bi-center trial.,"Tanja Schmidt, Hans Pargger, Esther Seeberger, Friedemann Eckhart, Stefanie von Felten, Christoph Haberthür, Tanja Schmidtet al.",2018 Aug,Clin Nutr,https://pubmed.ncbi.nlm.nih.gov/28502744/,No keywords found,"['cardiac', 'surgery', 'accompanied', 'oxidative', 'stress', 'and', 'systemic', 'inflammatory', 'response', ',', 'may', 'associated', 'with', 'organ', 'dysfunction', 'and', 'increased', 'mortality', '.', 'selenium', 'and', 'selenoenzymes', 'important', 'constituent', 'of', 'anti-oxidative', 'defense', '.', 'hypothesized', 'high-dose', 'sodium', 'selenite', 'supplementation', 'attenuate', 'postoperative', 'inflammation', 'and', 'might', ',', 'therefore', ',', 'improve', 'clinical', 'outcome', '.', 'method', 'randomized', ',', 'placebo-controlled', ',', 'double-blinded', ',', 'bi-center', 'study', 'adult', 'patient', 'undergoing', 'elective', 'cardiac', 'surgery', '.', 'patient', 'received', 'intravenous', 'bolus', 'of', 'g', 'selenium', '(', 'in', 'form', 'of', 'sodium', 'selenite', ')', 'or', 'placebo', 'induction', 'of', 'anesthesia', 'and', 'gd', 'selenium', 'or', 'placebo', 'intensive', 'care', 'unit', '(', 'icu', ')', 'stay', '.', 'primary', 'outcome', 'measure', 'sequential', 'organ', 'failure', 'assessment', '(', 'sofa', ')', 'score', 'second', 'postoperative', 'day', '.', 'secondary', 'endpoint', 'included', 'change', 'in', 'perioperative', 'selenium', 'level', ',', 'change', 'of', 'inflammatory', 'and', 'cardiac', 'marker', ',', 'use', 'of', 'vasoactive', 'medication', ',', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'icu', 'and', 'hospital', 'length', 'of', 'stay', ',', 'and', 'mortality', '.', 'result', 'perioperative', 'administration', 'of', 'high-dose', 'sodium', 'selenite', 'prevented', 'postoperative', 'drop', 'of', 'blood', 'and', 'serum', 'selenium', 'level', ',', 'reduced', 'number', 'of', 'patient', 'depending', 'postoperative', 'vasoactive', 'support', 'failed', 'to', 'reduce', 'postoperative', 'sofa', 'score', 'and', 'related', 'organ-specific', 'score', 'compared', 'to', 'placebo', '.', 'except', 'increase', 'of', 'postoperative', 'procalcitonin', 'and', 'bilirubin', 'level', 'in', 'sodium', 'selenite', 'group', ',', 'inflammatory', 'marker', ',', 'organ', 'function', 'variable', 'and', 'clinical', 'endpoint', 'remained', 'unchanged', '.', 'conclusion', 'perioperative', 'administration', 'of', 'high-dose', 'sodium', 'selenite', 'in', 'cardiac', 'surgery', 'patient', 'prevented', 'postoperative', 'fall', 'of', 'blood', 'selenium', 'level', 'and', 'reduced', 'need', 'postoperative', 'vasoactive', 'support', 'yet', 'unknown', 'mechanism', '.', 'trial', 'registration', 'registered', 'clinicaltrials.gov', 'identifier', 'no', '.', 'nct', '.']"
Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer.,"Shuchi Gulati, Janki Desai, Sarah M Palackdharry, John C Morris, Zheng Zhu, Roman Jandarov, Muhammad K Riaz, Vinita Takiar, Michelle Mierzwa, J Silvio Gutkind, Alfredo Molinolo, Pankaj B Desai, Nooshin Hashemi Sadraei, Trisha M Wise-Draper, Shuchi Gulatiet al.",2020 Jan 15,Cancer,https://pubmed.ncbi.nlm.nih.gov/31626727/,No keywords found,"['-year', 'overall', 'survival', '(', 'o', ')', 'rate', 'remains', 'patient', 'with', 'locally', 'advanced', 'head', 'and', 'neck', 'squamous', 'cell', 'carcinoma', '(', 'lahnscc', ')', ',', 'thereby', 'underscoring', 'need', 'improved', 'treatment', '.', 'antidiabetic', 'agent', ',', 'metformin', ',', 'found', 'in', 'retrospective', 'study', 'to', 'improve', 'survival', 'in', 'patient', 'with', 'hnscc', '.', 'therefore', ',', 'author', 'conducted', 'phase', 'dose', 'escalation', 'study', 'combining', 'metformin', 'with', 'chemoradiotherapy', 'in', 'patient', 'with', 'lahnscc', '.', 'method', 'nondiabetic', 'patient', 'with', 'lahnscc', 'enrolled', 'in', 'current', 'study', 'to', 'receive', 'escalating', 'dos', 'of', 'metformin', 'and', 'crt', 'based', 'modified', 'toxicity', 'probability', 'interval', 'design', '.', 'metformin', 'cohort', 'dos', 'included', 'mg', ',', 'mg', ',', 'and', 'mg', 'daily', 'in', 'divided', 'dos', 'in', 'addition', 'to', 'cisplatin', '(', 'dose', 'of', 'mgm', 'day', ',', ',', 'and', ')', 'and', 'standard', 'radiotherapy', '(', 'gray', ')', '.', 'adverse', 'event', 'categorized', 'per', 'national', 'cancer', 'institute', 'common', 'terminology', 'criterion', 'adverse', 'event', '(', 'version', '.', ')', '.', 'result', 'twenty', 'patient', 'enrolled', ',', 'of', 'withdrew', 'consent', '.', 'median', 'age', 'of', 'patient', 'year', 'and', 'majority', 'male', '(', ')', ',', 'white', '(', ')', ',', 'p-positive', 'disease', '(', ')', ',', 'and', 'tobacco', 'user', '(', ')', '.', 'median', 'length', 'of', 'metformin', 'exposure', '.', 'day', '.', 'common', 'grade', 'toxicity', 'nausea', '(', ')', ',', 'vomiting', '(', ')', ',', 'mucositis', '(', ')', ',', 'acute', 'kidney', 'injury', '(', ')', ',', 'anemia', '(', ')', ',', 'and', 'leukopenia', '(', ')', '.', 'dose-limiting', 'toxicity', 'included', 'diarrhea', 'and', 'acute', 'kidney', 'injury', '.', 'median', 'follow-up', 'of', 'month', ',', '-year', 'overall', 'survival', 'and', 'progression-free', 'survival', 'rate', 'and', ',', 'respectively', '.', 'no', 'hypoglycemia', 'event', 'or', 'lactic', 'acidosis', 'observed', '.', 'cisplatin', 'administration', 'not', 'appear', 'to', 'affect', 'metformin', 'pharmacokinetics', '.', 'maximum', 'tolerated', 'dose', 'metformin', 'could', 'not', 'determined', 'given', 'limited', 'number', 'of', 'patient', 'tolerated', 'metformin', 'chemoradiotherapy', '.', 'conclusion', 'to', 'author', ""'"", 'knowledge', ',', 'current', 'study', 'first', 'phase', 'trial', 'combining', 'metformin', 'with', 'chemoradiotherapy', '.', 'rate', 'of', 'overall', 'survival', 'and', 'progression-free', 'survival', 'encouraging', 'in', 'limited', 'patient', 'population', ',', 'and', 'warrant', 'investigation', 'in', 'phase', 'trial', '.']"
A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy.,"Yosuke Suzuki, Issei Tokimatsu, Yuko Morinaga, Yuhki Sato, Kuniko Takano, Kazuhiro Kohno, Masao Ogata, Kazufumi Hiramatsu, Hiroki Itoh, Jun-ichi Kadota, Yosuke Suzukiet al.",2015 Feb 2:440:183-7.,Clin Chim Acta,https://pubmed.ncbi.nlm.nih.gov/25476135/,No keywords found,"['target', 'trough', 'concentration', 'of', 'vancomycin', 'in', 'patient', 'with', 'febrile', 'neutropenia', 'not', 'reported', '.', 'aim', 'of', 'study', 'to', 'estimate', 'target', 'trough', 'concentration', 'febrile', 'neutropenia', 'in', 'patient', 'with', 'hematological', 'malignancy', '.', 'method', 'in', 'retrospective', ',', 'single-center', ',', 'observational', 'cohort', 'study', ',', 'hospitalized', 'patient', 'with', 'hematological', 'malignancy', 'treated', 'with', 'vancomycin', 'febrile', 'neutropenia', 'due', 'to', 'bacteriologically', 'documented', 'or', 'presumptive', 'gram-positive', 'infection', 'analyzed', '.', 'result', 'significant', 'difference', 'in', 'first', 'trough', 'concentration', 'of', 'vancomycin', 'observed', 'response', 'and', 'non-response', 'group', ',', 'and', 'nephrotoxicity', 'and', 'non-nephrotoxicity', 'group', '.', 'multiple', 'logistic', 'regression', 'analysis', 'identified', 'first', 'trough', 'concentration', 'independent', 'variable', 'associated', 'with', 'clinical', 'efficacy', 'and', 'nephrotoxicity', 'of', 'vancomycin', '.', 'area', 'roc', 'curve', '.', 'and', '.', 'clinical', 'efficacy', 'and', 'nephrotoxicity', ',', 'respectively', '.', 'cut-off', 'value', 'of', 'first', 'trough', 'concentration', '.', 'gml', 'clinical', 'efficacy', '(', 'sensitivity', ',', 'specificity', ')', 'and', '.', 'gml', 'nephrotoxicity', '(', 'sensitivity', ',', 'specificity', ')', '.', 'conclusion', 'result', 'suggest', 'relationship', 'of', 'trough', 'vancomycin', 'concentration', 'with', 'clinical', 'efficacy', 'and', 'incidence', 'of', 'nephrotoxicity', '.', 'propose', 'target', 'trough', 'vancomycin', 'concentration', 'of', 'around', '.', 'gml', 'febrile', 'neutropenia', 'in', 'patient', 'with', 'hematological', 'malignancy', '.']"
Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury: A multicenter randomized controlled trial.,"Chieko Mitaka, Tetsu Ohnuma, Takanori Murayama, Fumio Kunimoto, Michio Nagashima, Tetsuhiro Takei, Naoya Iguchi, Makoto Tomita                              ;, JAPAN Investigators, Chieko Mitakaet al.",2017 Apr:38:253-258.,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/27997877/,No keywords found,"['to', 'evaluate', 'effect', 'of', 'atrial', 'natriuretic', 'peptide', '(', 'anp', ')', 'renal', 'function', 'and', 'medical', 'cost', 'in', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'associated', 'with', 'cardiac', 'surgery', '.', 'material', 'and', 'method', 'japanese', 'trial', 'aki', 'in', 'post-cardiovascular', 'surgery', 'patient', 'anp', '(', 'japan', ')', 'prospective', ',', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'study', 'conducted', 'in', 'hospital', 'in', 'japan', '.', 'acute', 'kidney', 'injury', 'defined', 'increase', 'in', 'serum', 'creatinine', 'of', 'least', '.', 'mgdl', 'within', 'hour', '.', 'patient', 'randomly', 'assigned', 'to', 'receive', 'anp', '(', '.', 'g', 'kg-', 'min-', ')', 'or', 'placebo', '.', 'primary', 'end', 'point', 'change', 'in', 'renal', 'function', '.', 'secondary', 'end', 'point', 'need', 'renal', 'replacement', 'therapy', ',', 'length', 'of', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', ',', 'and', 'medical', 'cost', 'incurred', '-day', 'follow-up', '.', 'result', 'of', 'randomized', 'patient', ',', 'in', 'anp', 'group', 'and', 'in', 'placebo', 'group', '.', 'although', 'anp', 'significantly', '(', 'p', '.', ')', 'increased', 'urine', 'output', ',', 'not', 'significantly', 'improve', 'renal', 'function', 'compared', 'with', 'placebo', '.', 'no', 'significant', 'difference', 'group', 'in', 'renal', 'replacement', 'therapy', 'rate', ',', 'length', 'of', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', ',', 'or', 'medical', 'cost', '.', 'conclusion', 'atrial', 'natriuretic', 'peptide', 'infusion', 'not', 'show', 'renoprotective', 'effect', 'or', 'cost-saving', 'effect', 'in', 'treatment', 'of', 'cardiac', 'surgery-associated', 'aki', '.']"
Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.,"Iain C Macdougall, Andreas H Bock, Fernando Carrera, Kai-Uwe Eckardt, Carlo Gaillard, David Van Wyck, Yvonne Meier, Sylvain Larroque, Simon D Roger                              ;, FIND-CKD Study investigators, Simon D Roger, Alastair Gilles, Randall Faull, Nigel D Toussaint, Lawrence McMahon, Michael Suranyi, David Mudge, Brian Hutchison, Ashley Irish, Peter Kerr, Hemant Kulkarni, Grahame Elder, Margaret Jardine, Karl Lhotta, Gert Mayer, Raymond Vanholder, Bart Dirk Maes, Pieter Evenepoel, Frédéric Debelle, Michel Jadoul, Max Dratwa, Igor Macel, Milan Dunaj, Milan Kvapil, Petr Bucek, Jitka Rehorova, Ales Hruby, Václava Honová, Lada Malanova, Martin Lucak, Dalibor Lecian, Martin Jirovec, Jiri Vlasak, Ivan Rychlik, Stanislav Surel, Anne-Lise Kamper, Ove Ostergaard, Gudrun K Steffensen, Leila Chenine, Gabrial Choukroun, Philippe Zaoui, Christoph Wanner, Wolfgang Backs, Uwe Kraatz, Frank Dellanna, Klaus Busch, Tobias Marsen, Wolfgang Seeger, Rainer Woitas, Nicholas Obermueller, Thomas Haak, Stephan Lueders, Frank Pistrosch, Eckhard Mueller, Peter R Mertens, Werner Sutermer, Scott-Oliver Grebe, Syrus Hafezi-Rachti, Silke Roeser, Dimitrios Tsakiris, Dimitrios Memmos, Demetrios Vlachakos, Vassilis Vargemezis, Ioannis Stefanidis, Christos Syrganis, Polichronis Alivanis, Ioannis Papadakis, Nickolaos Papagalanis, Aimilios Andrikos, Dimitrios Goumenos, Kostas Siamopoulos, Charikelia Gouva, Gabriel Papadakis, Ioannis Boletis, Myrsini Tsimnadi-Spanoudaki, Dimitrios Stamatiades, Kyriaki Stamatelou, Spyridon Moutafis, Francesco Locatelli, Antonio Santoro, Francesco Quarello, Giuseppe Remuzzi, Salvatore Coppola, Rosella Ferraro Mortellaro, Andrea Icardi, Giacomo Colussi, Franco Della Grotta, Luigi Lombardi, Maurizio Gallieni, Giuseppe Villa, Giuseppe Grandaliano, Sebastiaan Huisman, Jos Barendregt, Peter J H Smak Gregoor, Cecilia Oien, Boleslaw Rutkowski, Robert Malecki, Michal Nowicki, Przemyslaw Rutkowski, Kryzsztof Marczewski, Michal Mysliwiec, Antoni Sydor, Jacek Rysz, Andrzej Rydzewski, Marian Klinger, Rafal Wnuk, Piotr Kozminski, Anna Nocon, Kazimierz Ciechanowski, Pedro Correia, Fernando Neves, José Barata, Gabriel Mircescu, Mihai Voiculescu, Gheorghe Gluhovschi, Eugen Mota, Angel Luís Martín De Francisco, Alberto Torre, Alba Herreros, José Luño, E Gruss, Judith Martins, Marti Vallés, Julio Pascual, Peter Bárány, Patrice M Ambuehl, Sehsuvar Erturk, Mustafa Arici, Saime Paydas, Zeki Soypacaci, Taner Camsari, Sedat Ustundag, Mark E Thomas, Richard J D'Souza, Jo E Taylor, Nicholas R Pritchard, Robin Jeffery, Stephen G Riley, Deepak Bhatnagar, Sunil Bhandari, David Reaich, Paul E Stevens, Mohsen El Kossi, Simon Roe, Brian Camilleri, Aimun Ahmed, Arif Khwaja, Barbara Thompson, Debasish Banerjee, Johann Nicholas, Alistair Hutchison, Richard Borrows, Iain C Macdougallet al.",2017 Jan 17,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/28095881/,No keywords found,"['preclinical', 'study', 'demonstrate', 'renal', 'proximal', 'tubular', 'injury', 'administration', 'of', 'intravenous', 'iron', 'preparation', 'clinical', 'data', 'renal', 'effect', 'of', 'intravenous', 'iron', 'sparse', '.', 'method', 'find-ckd', '-week', ',', 'randomized', ',', 'open-label', ',', 'multicenter', 'study', 'in', 'patient', 'with', 'non-dialysis', 'dependent', 'chronic', 'kidney', 'disease', '(', 'nd-ckd', ')', ',', 'anemia', 'and', 'iron', 'deficiency', 'without', 'erythropoiesis-stimulating', 'agent', 'therapy', 'received', 'intravenous', 'ferric', 'carboxymaltose', '(', 'fcm', ')', ',', 'targeting', 'either', 'higher', '(', '-', 'gl', ')', 'or', 'lower', '(', '-', 'gl', ')', 'ferritin', 'value', ',', 'or', 'oral', 'iron', '.', 'result', 'mean', '(', 'sd', ')', 'egfr', 'baseline', '.', '(', '.', ')', ',', '.', '(', '.', ')', 'and', '.', '(', '.', ')', 'mlmin', '.', 'in', 'high', 'ferritin', 'fcm', '(', 'n', ')', ',', 'low', 'ferritin', 'fcm', '(', 'n', ')', 'and', 'oral', 'iron', '(', 'n', ')', 'group', ',', 'respectively', '.', 'corresponding', 'value', 'month', '.', '(', '.', ')', ',', '.', '(', '.', ')', 'and', '.', '(', '.', ')', 'mlmin', '.', 'm.', 'pre-specified', 'endpoint', 'of', 'mean', '(', 'se', ')', 'change', 'in', 'egfr', 'baseline', 'to', 'month', '.', '(', '.', ')', 'mlmin', '.', 'with', 'high', 'ferritin', 'fcm', '(', 'p', '.', 'versus', 'oral', 'iron', ')', ',', '-', '.', '(', '.', ')', 'mlmin', '.', 'with', 'low', 'ferritin', 'fcm', '(', 'p', '.', 'versus', 'oral', 'iron', ')', 'and', '-', '.', '(', '.', ')', 'mlmin', '.', 'with', 'oral', 'iron', '.', 'no', 'significant', 'association', 'detected', 'quartile', 'of', 'fcm', 'dose', ',', 'change', 'in', 'ferritin', 'or', 'change', 'in', 'tsat', 'versus', 'change', 'in', 'egfr', '.', 'dialysis', 'initiation', 'similar', 'group', '.', 'renal', 'adverse', 'event', 'rare', ',', 'with', 'no', 'indication', 'of', 'between-group', 'difference', '.', 'conclusion', 'intravenous', 'fcm', 'dos', 'maintained', 'ferritin', 'level', 'of', '-', 'gl', 'or', '-', 'gl', 'not', 'negatively', 'impact', 'renal', 'function', '(', 'egfr', ')', 'in', 'patient', 'with', 'nd-ckd', 'month', 'versus', 'oral', 'iron', ',', 'and', 'egfr', 'remained', 'stable', '.', 'finding', 'show', 'no', 'evidence', 'of', 'renal', 'toxicity', 'following', 'intravenous', 'fcm', '-year', 'period', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '(', 'first', 'registration', 'october', ')', '.']"
Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial.,"Atul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, V Sreenivas, Ranjit Kumar Sahoo, Nootan Kumar Shukla, Sanjay Thulkar, Sujoy Pal, Surya V Deo, Sushmita Pathy, Nihar Ranjan Dash, Sunil Kumar, Sushma Bhatnagar, Rakesh Kumar, Seema Mishra, Peush Sahni, Venkateswaran K Iyer, Vinod Raina, Atul Sharmaet al.",2019 Dec:123:162-170.,Eur J Cancer,https://pubmed.ncbi.nlm.nih.gov/31707181/,No keywords found,"['to', 'determine', 'equivalence', 'of', 'modified', 'gemcitabine', 'and', 'oxaliplatin', 'compared', 'with', 'gemcitabine', 'and', 'cisplatin', 'in', 'unresectable', 'gallbladder', 'cancer', '(', 'gbc', ')', '.', 'primary', 'end-point', 'overall', 'survival', '(', 'o', ')', '.', 'method', 'open', 'label', ',', 'prospective', ',', 'randomised', 'phase', 'iii', 'equivalence', 'study', '.', 'inclusion', 'criterion', 'included', 'histologically', 'proven', 'unresectable', 'gbc', ',', 'year', 'or', 'older', ',', 'adequate', 'organ', 'function', 'and', 'eastern', 'cooperative', 'oncology', 'group', '.', 'sample', 'size', 'patient', 'required', 'in', 'arm', 'to', 'equivalence', 'margin', 'of', 'month', 'with', 'power', 'of', '.', 'treatment', 'modified', 'gemcitabine', 'and', 'oxaliplatin', '(', 'mgemox', ')', '-gemcitabine', 'mgm', ',', 'oxaliplatin', 'mgm', ',', 'maximum', 'cycle', 'gemcitabine', 'cisplatin', '(', 'cisgem', ')', '-gemcitabine', 'mgm', ',', 'cisplatin', 'mgm', ',', 'maximum', 'cycle', ',', 'day', 'and', 'every', 'week', '.', 'result', 'two', 'hundred', 'sixty', 'subject', 'recruited', 'february', 'and', 'july', '.', 'two', 'hundred', 'forty-three', 'patient', '(', ',', 'mgemox', 'and', ',', 'cisgem', ')', 'received', 'least', 'dose', 'and', 'analysed', 'safety', 'and', 'efficacy', '(', 'modified', 'intention', 'to', 'treat', ')', '.', 'median', 'o', 'month', 'whole', 'group', '(', 'confidence', 'interval', 'ci', '-', ')', '.', 'median', 'o', 'in', 'mgemox', 'month', 'and', 'month', 'in', 'cisgem', 'p', '(', 'hazard', 'ratio', 'ci', '-', ')', '.', 'restricted', 'mean', 'o', 'follow-up', 'limited', 'to', 'month', 'month', '(', 'ci', '-', ')', 'in', 'mgemox', 'and', 'month', '(', 'ci', '-', ')', 'in', 'cisgem', '.', 'difference', 'of', 'mean', 'month', 'with', 'ci', ',', 'exceeding', 'month', '(', '-', 'to', ')', ',', 'hence', 'rejecting', 'equivalence', '.', 'peripheral', 'neuropathy', ',', 'thrombocytopaenia', 'in', 'mgemox', 'and', 'nephrotoxicity', 'higher', 'with', 'cisgem', '.', 'conclusion', 'trial', 'failed', 'to', 'show', 'equivalence', 'of', 'eight', 'cycle', 'of', 'cisgem', 'to', 'six', 'cycle', 'of', 'mgemox', '.', 'numerically', 'o', 'better', 'with', 'mgemox', '.', 'toxicity', 'different', '.', 'trial', 'not', 'powered', 'to', 'answer', 'superiority', '.', 'clinical', 'trial', 'registration', 'ctri', '.']"
"Effect of perioperative sodium bicarbonate administration on renal function following cardiac surgery for infective endocarditis: a randomized, placebo-controlled trial.","Jin Sun Cho, Sarah Soh, Jae-Kwang Shim, Sanghwa Kang, Haegi Choi, Young-Lan Kwak, Jin Sun Choet al.",2017 Jan 5,Crit Care,https://pubmed.ncbi.nlm.nih.gov/28057030/,No keywords found,"['patient', 'with', 'infective', 'endocarditis', '(', 'ie', ')', 'elevated', 'risk', 'of', 'renal', 'dysfunction', 'of', 'extensive', 'systemic', 'inflammation', 'and', 'use', 'of', 'nephrotoxic', 'antibiotic', '.', 'in', 'randomized', ',', 'placebo-controlled', 'trial', ',', 'investigated', 'whether', 'perioperative', 'sodium', 'bicarbonate', 'administration', 'could', 'attenuate', 'postoperative', 'renal', 'dysfunction', 'in', 'patient', 'with', 'ie', 'undergoing', 'cardiac', 'surgery', '.', 'method', 'seventy', 'patient', 'randomly', 'received', 'sodium', 'chloride', '(', 'n', ')', 'or', 'sodium', 'bicarbonate', '(', 'n', ')', '.', 'sodium', 'bicarbonate', 'administered', '.', 'mmolkg', 'loading', 'dose', 'h', 'commencing', 'with', 'anesthetic', 'induction', ',', 'followed', '.', 'mmolkgh', 'infusion', 'h.', 'primary', 'outcome', 'peak', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'first', 'h', 'postoperatively', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'scr', 'level', ',', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'and', 'major', 'morbidity', 'endpoint', 'assessed', 'postoperatively', '.', 'result', 'peak', 'scr', 'first', 'h', 'postoperatively', '(', 'bicarbonate', 'vs.', 'control', '.', '(', '.', ',', '.', ')', 'mgdl', 'vs.', '.', '(', '.', ',', '.', ')', 'mgdl', ',', 'p', '.', ')', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'bicarbonate', 'vs.', 'control', 'vs.', ',', 'p', '.', ')', 'similar', 'in', 'group', '.', 'postoperative', 'increase', 'in', 'scr', 'baseline', 'greater', 'in', 'bicarbonate', 'group', 'in', 'control', 'group', 'postoperative', 'day', '(', '.', '(', '.', ',', '.', ')', 'mgdl', 'vs.', '.', '(', '.', ',', '.', ')', 'mgdl', ',', 'p', '.', ')', 'and', 'postoperative', 'day', '(', '.', '(', '.', ',', '.', ')', 'mgdl', 'vs.', '.', '(', '.', ',', '.', ')', 'mgdl', ',', 'p', '.', ')', '.', 'conclusion', 'perioperative', 'sodium', 'bicarbonate', 'administration', 'no', 'favorable', 'impact', 'postoperative', 'renal', 'function', 'and', 'outcome', 'in', 'patient', 'with', 'ie', 'undergoing', 'cardiac', 'surgery', '.', 'instead', ',', 'associated', 'with', 'possibly', 'harmful', 'renal', 'effect', ',', 'illustrated', 'greater', 'increase', 'in', 'scr', 'postoperatively', ',', 'compared', 'to', 'control', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'nct', '.', 'registered', 'july', '.']"
"Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study.","Pietro Lampertico, Maria Buti, Scott Fung, Sang Hoon Ahn, Wan-Long Chuang, Won Young Tak, Alnoor Ramji, Chi-Yi Chen, Edward Tam, Ho Bae, Xiaoli Ma, John F Flaherty, Anuj Gaggar, Audrey Lau, Yang Liu, George Wu, Vithika Suri, Susanna K Tan, G Mani Subramanian, Huy Trinh, Seung-Kew Yoon, Kosh Agarwal, Young-Suk Lim, Henry L Y Chan, Pietro Lamperticoet al.",2020 May,Lancet Gastroenterol Hepatol,https://pubmed.ncbi.nlm.nih.gov/32087795/,No keywords found,"['treatment', 'with', 'tenofovir', 'disoproxil', 'fumarate', 'associated', 'with', 'renal', 'toxicity', 'or', 'reduction', 'in', 'bone', 'mineral', 'density', ',', 'or', ',', 'in', 'patient', 'with', 'chronic', 'hepatitis', 'b', 'virus', '(', 'hbv', ')', 'infection', '.', 'tenofovir', 'alafenamide', 'tenofovir', 'prodrug', 'with', 'high', 'intrahepatic', 'concentration', 'of', 'active', 'drug', 'and', 'reduced', 'systemic', 'tenofovir', 'exposure', 'compared', 'with', 'tenofovir', 'disoproxil', 'fumarate', '.', 'in', 'patient', 'with', 'chronic', 'hbv', ',', 'tenofovir', 'alafenamide', 'shown', 'efficacy', 'non-inferior', 'to', 'of', 'tenofovir', 'disoproxil', 'fumarate', 'with', 'improved', 'renal', 'and', 'bone', 'safety', '.', 'with', 'non-inferiority', 'study', ',', 'aimed', 'to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'tenofovir', 'alafenamide', 'in', 'patient', 'with', 'hbv', 'infection', 'switching', 'tenofovir', 'disoproxil', 'fumarate', 'virally', 'suppressed', '.', 'method', 'patient', 'with', 'chronic', 'hbv', 'infection', 'receiving', 'tenofovir', 'disoproxil', 'fumarate', 'week', 'or', 'and', 'hbv', 'dna', 'less', 'lower', 'limit', 'of', 'quantification', '(', 'lloq', ')', 'least', 'week', 'recruited', 'to', 'randomised', ',', 'multicentre', ',', 'double-blind', ',', 'phase', 'non-inferiority', 'study', '.', 'patient', 'randomly', 'assigned', 'in', 'ratio', 'to', 'receive', 'tenofovir', 'alafenamide', 'mg', 'day', 'or', 'to', 'continue', 'tenofovir', 'disoproxil', 'fumarate', 'mg', 'day', '.', 'primary', 'efficacy', 'endpoint', 'loss', 'of', 'virological', 'control', ',', 'defined', 'proportion', 'of', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', 'hbv', 'dna', 'of', 'least', 'iuml', 'week', 'modified', 'u', 'food', 'and', 'drug', 'administration', '(', 'fda', ')', 'snapshot', 'algorithm', '.', 'key', 'safety', 'endpoint', 'change', 'in', 'hip', 'and', 'spine', 'bone', 'mineral', 'density', ',', 'estimated', 'creatinine', 'clearance', 'cockcroft-gault', ',', 'and', 'marker', 'of', 'bone', 'turnover', 'and', 'renal', 'tubular', 'function', '.', 'study', 'powered', 'non-inferiority', 'in', 'efficacy', 'of', 'tenofovir', 'alafenamide', 'versus', 'tenofovir', 'disoproxil', 'fumarate', 'with', 'margin', '.', 'investigator', 'and', 'patient', 'unaware', 'of', 'treatment', 'allocation', 'and', 'on-treatment', 'result', '.', 'trial', 'ongoing', 'and', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'participant', 'in', 'study', 'enrolled', 'dec', ',', ',', 'and', 'oct', ',', '.', 'patient', 'screened', 'and', 'patient', 'randomly', 'assigned', 'to', 'switch', 'to', 'tenofovir', 'alafenamide', 'or', 'to', 'stay', 'tenofovir', 'disoproxil', 'fumarate', '.', 'two', 'patient', 'assigned', 'to', 'receive', 'tenofovir', 'alafenamide', 'not', 'receive', 'treatment', 'thus', 'full', 'analysis', 'set', 'efficacy', 'and', 'safety', 'analysis', 'consisted', 'of', 'patient', 'in', 'tenofovir', 'alafenamide', 'group', 'and', 'in', 'tenofovir', 'disoproxil', 'fumarate', 'group', '.', 'week', ',', 'one', 'patient', 'treatment', 'group', '(', ')', 'hbv', 'dna', 'of', 'least', 'iuml', '(', 'difference', 'in', 'proportion', ',', 'ci', '-', 'to', ')', ',', 'thereby', 'showing', 'non-inferior', 'efficacy', 'of', 'tenofovir', 'alafenamide', 'to', 'tenofovir', 'disoproxil', 'fumarate', '.', 'patient', 'received', 'tenofovir', 'alafenamide', 'significantly', 'increased', 'bone', 'mineral', 'density', 'hip', '(', 'mean', 'change', 'sd', 'v', '-', 'sd', 'difference', 'in', 'least', 'square', 'mean', 'ci', 'to', 'p', ')', 'and', 'spine', '(', 'mean', 'change', 'v', '-', 'difference', 'in', 'least', 'square', 'mean', 'to', 'p', ')', ',', 'creatinine', 'clearance', 'cockcroft-gault', 'relative', 'to', 'tenofovir', 'disoproxil', 'fumarate', '(', 'median', 'change', 'mlmin', 'iqr', '-', 'to', 'v', '-', 'mlmin', '-', 'to', 'p', ')', ',', 'and', 'improved', 'marker', 'of', 'bone', 'turnover', 'and', 'tubular', 'function', 'week', '.', 'common', 'treatment-emergent', 'adverse', 'event', 'upper', 'respiratory', 'tract', 'infection', '(', 'of', 'patient', 'in', 'tenofovir', 'alafenamide', 'group', 'and', 'of', 'patient', 'in', 'tenofovir', 'disoproxil', 'fumarate', 'group', ')', 'and', 'nasopharyngitis', '(', 'of', 'patient', 'in', 'tenofovir', 'alafenamide', 'group', 'and', 'of', 'patient', 'in', 'tenofovir', 'disoproxil', 'fumarate', 'group', ')', '.', 'incidence', 'of', 'grade', 'and', 'adverse', 'event', 'and', 'serious', 'adverse', 'event', 'low', 'and', 'similar', 'group', '.', 'no', 'viral', 'resistance', 'observed', 'in', 'patient', 'qualified', 'viral', 'sequencing', '.', 'interpretation', 'finding', 'suggest', 'tenofovir', 'alafenamide', 'substituted', 'tenofovir', 'disoproxil', 'fumarate', 'in', 'patient', 'with', 'hbv', 'infection', 'improved', 'safety', 'without', 'loss', 'of', 'efficacy', '.', 'funding', 'gilead', 'science', '.']"
Impact of Isolyte Versus 0.9% Saline on Postoperative Event of Acute Kidney Injury Assayed by Urinary [TIMP-2] [IGFBP7] in Patients Undergoing Cardiac Surgery.,"Nathan M Lee, Lev Deriy, Timothy R Petersen, Vallabh O Shah, Michael P Hutchens, Neal S Gerstein, Nathan M Leeet al.",2019 Feb,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/30181085/,No keywords found,"['administration', 'of', 'excess', 'chloride', 'in', '.', 'normal', 'saline', '(', 'n', ')', 'decrease', 'renal', 'perfusion', 'and', 'glomerular', 'filtration', 'rate', ',', 'thereby', 'increasing', 'risk', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'in', 'study', ',', 'effect', 'of', 'n', 'versus', 'isolyte', 'use', 'cardiac', 'surgery', 'urinary', 'level', 'of', 'tissue', 'inhibitor', 'of', 'metalloproteinase', 'and', 'insulin-like', 'growth', 'factor-binding', 'protein', 'timp-', 'igfbp', 'and', 'postoperative', 'risk', 'of', 'aki', 'examined', '.', 'design', 'prospective', ',', 'randomized', ',', 'and', 'single-blinded', 'trial', '.', 'setting', 'single', 'university', 'medical', 'center', '.', 'participant', 'thirty', 'patient', 'year', 'without', 'chronic', 'renal', 'insufficiency', 'or', 'recent', 'aki', 'undergoing', 'elective', 'cardiac', 'surgery', '.', 'intervention', 'subject', 'randomized', 'to', 'receive', 'either', 'n', 'or', 'isolyte', 'intraoperative', 'period', '.', 'measurement', 'and', 'main', 'result', 'primary', 'outcome', 'change', 'in', 'urinary', 'level', 'of', 'timp', 'igfbp', 'surgery', 'to', 'hour', 'postoperatively', '.', 'secondary', 'outcome', 'included', 'serum', 'creatinine', 'pre-', 'and', 'postoperatively', 'and', 'hour', ',', 'serum', 'chloride', 'pre-', 'and', 'postoperatively', 'and', 'hour', ',', 'need', 'dialysis', 'prior', 'to', 'discharge', ',', 'and', 'arterial', 'ph', 'measured', 'hour', 'postoperatively', '.', 'sixteen', 'patient', 'received', 'n', 'and', 'patient', 'received', 'isolyte', '.', 'three', 'patient', 'developed', 'aki', 'within', 'first', 'postoperative', 'day', ',', 'in', 'n', 'group', '.', 'author', 'found', 'increase', 'in', 'timp-', 'igfbp', 'in', 'group', '.', 'however', ',', 'difference', 'in', 'increase', 'study', 'arm', 'not', 'significant', '(', 'p', '.', '-', '.', 'to', '.', ')', '.', 'conclusion', 'author', 'observed', 'no', 'change', 'in', 'urinary', 'timp-', 'igfbp', 'level', 'in', 'patient', 'receiving', 'n', 'versus', 'isolyte', 'cardiac', 'surgery', '.', 'future', 'larger', 'study', 'in', 'patient', 'higher', 'risk', 'aki', 'recommended', 'to', 'evaluate', 'impact', 'of', 'high-', 'versus', 'lower-chloride', 'solution', 'risk', 'of', 'postoperative', 'aki', 'cardiac', 'surgery', '.']"
Negligible Systemic Uptake of Suprafascial Vancomycin Powder Following Instrumented Posterior Spinal Fusion-Preliminary Results From A Randomized Clinical Trial (VANCO Trial).,"Ralph T Schär, C Marvin Jesse, Matteo Montalbetti, Nicole Söll, Katharina Lutz, Valentin Steinsiepe, Mattia Branca, Andreas Raabe, Stefan Zimmerli, Ralph T Schäret al.",2021 Nov 18,Neurosurgery,https://pubmed.ncbi.nlm.nih.gov/34528089/,No keywords found,"['intrawound', 'vancomycin', 'powder', 'emerging', 'strategy', 'to', 'reduce', 'surgical', 'site', 'infection', '(', 'ssis', ')', 'in', 'spine', 'surgery', '.', 'however', ',', 'concern', 'relating', 'to', 'safety', 'profile', 'and', 'toxicity', '.', 'data', 'systemic', 'uptake', 'of', 'suprafascially', 'administered', 'vancomycin', 'powder', 'following', 'instrumented', 'spinal', 'fusion', 'lacking', '.', 'objective', 'to', 'study', 'systemic', 'uptake', 'and', 'safety', 'of', 'suprafascially', 'administered', 'vancomycin', 'powder', 'in', 'early', 'postoperative', 'phase', 'following', 'open', 'instrumented', 'posterior', 'spinal', 'fusion', '.', 'method', 'substudy', 'of', 'ongoing', 'randomized', 'clinical', 'trial', '.', 'eligible', 'adult', 'patient', 'randomized', 'to', 'either', 'receive', 'suprafascial', 'vancomycin', 'powder', 'wound', 'closure', 'or', 'not', 'to', 'receive', 'vancomycin', 'powder', '.', 'serum', 'vancomycin', 'level', 'assessed', 'postoperative', 'day', 'and', ',', 'serum', 'creatinine', 'level', 'measured', 'pre-', 'and', 'post-operatively', '.', 'adverse', 'event', 'to', 'wk', 'following', 'surgery', 'recorded', '.', 'result', 'among', 'randomized', 'patient', '(', 'mean', 'age', 'yr', ',', 'range', '-', 'yr', 'woman', ')', ',', 'received', 'vancomycin', 'powder', '.', 'no', 'detectable', 'serum', 'vancomycin', 'level', '(', '.', 'mgl', ')', 'found', '.', 'proportion', 'of', 'adverse', 'event', 'per', 'patient', 'in', 'vancomycin', 'and', 'control', 'group', ',', 'respectively', ',', '.', '(', ')', 'v', '.', '(', ')', '(', 'or', '.', 'ci', ',', '.', '.', 'p', '.', ')', '.', 'no', 'patient', 'nephrotoxicity', 'or', 'ototoxicity', 'in', 'either', 'group', '.', 'conclusion', 'suprafascial', 'vancomycin', 'powder', 'in', 'open', 'instrumented', 'spinal', 'fusion', 'surgery', 'safe', 'and', 'result', 'in', 'negligible', 'systemic', 'uptake', '.', 'final', 'result', 'of', 'vanco', 'trial', 'need', 'to', 'awaited', 'conclusive', 'data', 'efficacy', 'of', 'vancomycin', 'ssi', 'prevention', 'and', 'impact', 'wound', 'healing', '.']"
"Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial.","Hossein Khalili, Hamid Rahmani, Mostafa Mohammadi, Mohamadreza Salehi, Zahra Mostafavi, Hossein Khaliliet al.",2021 Dec,Daru,https://pubmed.ncbi.nlm.nih.gov/34463929/,No keywords found,"['recent', 'study', 'shown', 'increased', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'induced', 'vancomycin', 'piperacillin-tazobactam', '(', 'vpt', ')', 'combination', '.', 'in', 'study', ',', 'efficacy', 'of', 'intravenous', 'magnesium', 'sulfate', 'in', 'prevention', 'of', 'vpt', 'induced', 'aki', 'in', 'critically', 'ill', 'patient', 'admitted', 'to', 'icu', 'evaluated', '.', 'method', 'in', 'open-label', ',', 'placebo-controlled', ',', 'randomized', 'clinical', 'trial', ',', 'adult', '(', 'year', 'old', ')', 'indication', 'to', 'receive', 'vpt', 'empiric', 'therapy', 'assigned', 'to', 'magnesium', 'or', 'control', 'group', 'in', 'ratio', '.', 'concomitant', 'with', 'vpt', ',', 'intravenous', 'infusion', 'of', 'magnesium', 'sulfate', 'started', 'patient', 'in', 'magnesium', 'group', '.', 'target', 'serum', 'level', 'of', 'magnesium', 'defined', 'mgdl', '.', 'patient', 'in', 'control', 'group', 'received', 'normal', 'saline', 'placebo', '.', 'target', 'serum', 'level', 'of', 'magnesium', 'defined', '.', 'mgdl', 'in', 'group', '.', 'study', ""'s"", 'primary', 'outcome', 'incidence', 'of', 'aki', 'and', 'to', 'h', 'treatment', 'course', '.', 'escalation', 'and', 'de-escalation', 'of', 'vpt', 'regimen', ',', 'duration', 'of', 'hospitalization', ',', 'length', 'of', 'icu', 'stay', 'and', '-day', 'mortality', 'secondary', 'outcome', '.', 'result', 'thirty', 'patient', 'in', 'group', 'completed', 'examination', '.', 'five', 'patient', 'in', 'magnesium', 'group', 'and', 'patient', 'in', 'control', 'group', 'experienced', 'aki', '(', 'p', '.', ')', '.', 'de-escalation', 'of', 'vpt', 'regimen', 'done', 'approximately', 'in', 'of', 'patient', '.', 'duration', 'of', 'hospitalization', 'and', 'length', 'of', 'icu', 'stay', 'not', 'statistically', 'different', 'group', '.', 'finally', ',', '-day', 'mortality', '.', 'in', 'group', '.', 'although', 'incidence', 'of', 'aki', 'not', 'statistically', 'different', 'group', 'in', 'unadjusted', 'logistic', 'regression', 'model', ',', 'became', 'significant', 'adjusting', 'confounding', 'factor', 'unadjusted', 'model', '(', 'or', '.', 'ci', '.-.', ',', 'p', '.', ')', ',', 'adjusted', 'model', '(', 'or', '.', 'ci', '.-.', ',', 'p', '.', ')', '.', 'conclusion', 'administration', 'of', 'magnesium', 'sulfate', 'with', 'target', 'serum', 'level', 'around', 'mgdl', 'reduced', 'incidence', 'of', 'aki', 'in', 'critically', 'ill', 'patient', 'receiving', 'vpt', 'empric', 'therapy', '.']"
Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions.,"Jiangfeng Wang, Qiang Zhao, Lei Cai, Jianqiang Li, Sheng Chen, Jiangfeng Wanget al.",2022 Apr 18:2022:2317181.,Biomed Res Int,https://pubmed.ncbi.nlm.nih.gov/35480138/,No keywords found,"['to', 'evaluate', 'efficacy', 'of', 'bevacizumab', 'and', 'gemcitabine', 'in', 'combination', 'with', 'cisplatin', 'in', 'treatment', 'of', 'esophageal', 'cancer', 'and', 'effect', 'incidence', 'of', 'adverse', 'reaction', '.', 'method', 'total', 'of', 'esophageal', 'cancer', 'patient', 'admitted', 'to', 'hospital', 'march', 'to', 'march', 'identified', 'research', 'subject', 'and', 'randomized', 'control', 'group', 'and', 'study', 'group', ',', 'with', 'case', 'in', 'group', '.', 'control', 'group', 'treated', 'with', 'gemcitabine', 'combined', 'with', 'cisplatin', ',', 'and', 'study', 'group', 'treated', 'with', 'triple', 'therapy', 'of', 'bevacizumab', ',', 'gemcitabine', ',', 'and', 'cisplatin', '.', 'treatment', 'efficiency', 'and', 'incidence', 'of', 'adverse', 'reaction', 'compared', 'two', 'group', 'of', 'patient', '.', 'result', 'total', 'treatment', 'efficiency', 'in', 'study', 'group', ',', 'significantly', 'higher', 'of', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'survival', 'rate', 'of', 'patient', 'in', 'study', 'group', 'and', 'and', 'year', 'treatment', ',', 'significantly', 'higher', 'of', 'and', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'clinical', 'efficiency', 'of', 'bevacizumab', 'and', 'gemcitabine', 'combined', 'with', 'cisplatin', 'in', 'treatment', 'of', 'esophageal', 'cancer', 'remarkable', ',', 'improves', 'survival', 'of', 'patient', ',', 'and', 'worthy', 'of', 'clinical', 'promotion', 'and', 'application', '.']"
Restrictive versus Liberal Fluid Therapy for Post-Cesarean Acute Kidney Injury in Severe Preeclampsia: a Pilot Randomized Clinical Trial.,"Wallace Andrino da Silva, Carlo Victor A Varela, Aline Macedo Pinheiro, Paula Castro Scherer, Rossana P V Francisco, Marcelo Luis Abramides Torres, Maria José C Carmona, Fernando Bliacheriene, Lúcia C Andrade, Paolo Pelosi, Luiz Marcelo S Malbouisson, Wallace Andrino da Silvaet al.",2020:75:e1797.,Clinics (Sao Paulo),https://pubmed.ncbi.nlm.nih.gov/32725073/,No keywords found,"['aim', 'of', 'study', 'to', 'determine', 'whether', 'restrictive', 'compared', 'to', 'liberal', 'fluid', 'therapy', 'increase', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'with', 'severe', 'preeclampsia', '.', 'method', 'total', 'of', 'patient', '(', 'mean', 'age', ',', 'year', 'standard', 'deviation', ',', '.', 'year', ')', 'with', 'severe', 'preeclampsia', 'randomized', 'to', 'liberal', '(', 'ml', 'of', 'lactated', 'ringer', ""'s"", ',', 'n', ')', 'or', 'restrictive', '(', 'ml', 'of', 'lactated', 'ringer', ""'s"", ',', 'n', ')', 'intravenous', 'fluid', 'regimen', 'cesarean', 'section', '.', 'primary', 'outcome', 'development', 'of', 'postoperative', 'renal', 'dysfunction', 'defined', 'aki', 'network', 'stage', '.', 'serum', 'cystatin', 'c', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'evaluated', 'postoperative', 'day', 'and', '.', 'clinicaltrials.gov', 'nct', '.', 'result', 'rate', 'of', 'postoperative', 'aki', '.', 'in', 'liberal', 'fluid', 'group', 'and', '.', 'in', 'restrictive', 'fluid', 'group', '(', 'p.', ')', '.', 'intraoperative', 'urine', 'output', 'higher', 'in', 'liberal', '(', 'mlh', ',', 'iqr', '-', ')', 'in', 'restrictive', 'fluid', 'group', '(', 'mlh', ',', 'iqr', '-', ',', 'p.', ')', '.', 'in', 'group', ',', 'serum', 'cystatin', 'c', 'not', 'change', 'postoperative', 'day', 'compared', 'to', 'preoperative', 'period', 'and', 'significantly', 'decreased', 'postoperative', 'day', 'compared', 'to', 'postoperative', 'day', '(', 'p.', ')', '.', 'in', 'restrictive', 'fluid', 'group', ',', 'ngal', 'level', 'increased', 'postoperative', 'day', 'compared', 'to', 'preoperative', 'period', '(', 'p.', ')', 'and', 'decreased', 'postoperative', 'day', 'compared', 'to', 'postoperative', 'day', '(', 'p.', ')', '.', 'conclusion', 'among', 'patient', 'with', 'severe', 'preeclampsia', ',', 'restrictive', 'fluid', 'regimen', 'cesarean', 'section', 'not', 'associated', 'with', 'increased', 'postoperative', 'aki', '.']"
"Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial.","Jin Ha Park, Jae-Kwang Shim, Jong-Wook Song, Sarah Soh, Young-Lan Kwak, Jin Ha Parket al.",2016 Sep,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/27120082/,No keywords found,"['statin', ',', '-hydroxy', '--', 'methylglutaryl', 'coenzyme', '(', 'hmg-coa', ')', 'reductase', 'inhibitor', 'potential', 'to', 'reduce', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', 'pleiotropic', 'property', '.', 'studied', 'preventive', 'effect', 'of', 'atorvastatin', 'aki', 'valvular', 'heart', 'surgery', '.', 'method', 'two-hundred', 'statin-nave', 'patient', 'randomly', 'allocated', 'to', 'receive', 'either', 'statin', 'or', 'placebo', '.', 'atorvastatin', 'administered', 'orally', 'to', 'statin', 'group', 'according', 'to', 'dosage', 'schedule', '(', 'mg', 'single', 'dose', 'evening', 'prior', 'to', 'surgery', 'mg', 'morning', 'of', 'surgery', 'three', 'dos', 'of', 'mg', 'evening', 'of', 'postoperative', 'day', ',', ',', 'and', ')', '.', 'aki', 'incidence', 'assessed', 'first', 'postoperative', 'hour', 'basis', 'of', 'acute', 'kidney', 'injury', 'network', 'criterion', '.', 'result', 'incidence', 'of', 'aki', 'similar', 'in', 'statin', 'and', 'control', 'group', '(', 'vs.', ',', 'respectively', ',', 'p', '.', ')', '.', 'biomarkers', 'of', 'renal', 'injury', 'including', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'and', 'interleukin-', 'also', 'similar', 'group', '.', 'statin', 'group', 'required', 'significantly', 'less', 'norepinephrine', 'and', 'vasopressin', 'surgery', ',', 'and', 'fewer', 'patient', 'in', 'statin', 'group', 'required', 'vasopressin', '.', 'no', 'significant', 'difference', 'in', 'postoperative', 'outcome', '.', 'conclusion', 'acute', 'perioperative', 'statin', 'treatment', 'not', 'associated', 'with', 'lower', 'incidence', 'of', 'aki', 'or', 'improved', 'clinical', 'outcome', 'in', 'patient', 'undergoing', 'valvular', 'heart', 'surgery', '.', '(', 'clinicaltrials.gov', 'nct', ')', '.']"
"Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area.","Esther van Meerten, Martine Franckena, Erik Wiemer, Lena van Doorn, Jaco Kraan, Anneke Westermann, Stefan Sleijfer, Esther van Meertenet al.",2015 Mar,Oncologist,https://pubmed.ncbi.nlm.nih.gov/25660155/,No keywords found,"['patient', 'with', 'recurrent', 'cervical', 'cancer', 'in', 'previously', 'irradiated', 'area', 'might', 'benefit', 'cisplatin', 'combined', 'with', 'hyperthermia', '.', 'lapatinib', 'inhibits', 'intracellular', 'tyrosine', 'kinase', 'domain', 'of', 'epidermal', 'growth', 'factor', 'receptor', '(', 'egfr', ')', 'and', '.', 'overexpression', 'of', 'egfr', 'and', 'frequently', 'seen', 'in', 'patient', 'with', 'cervical', 'cancer', 'and', 'potentially', 'involved', 'in', 'chemotherapy', 'resistance', '.', 'in', 'addition', ',', 'preclinical', 'data', 'suggest', 'synergistic', 'effect', 'of', 'combining', 'cisplatin', 'and', 'lapatinib', '.', 'consequently', ',', 'phase', 'dose-escalation', 'study', 'performed', 'to', 'determine', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'of', 'lapatinib', 'added', 'to', 'fixed', 'dos', 'of', 'cisplatin', 'and', 'hyperthermia', '.', 'method', 'eight', 'patient', 'with', 'previously', 'irradiated', 'recurrent', 'cervical', 'carcinoma', 'enrolled', 'and', 'scheduled', 'weekly', 'administration', 'of', 'mgm', '(', ')', 'cisplatin', 'combined', 'with', 'locoregional', 'hyperthermia', '.', 'hyperthermia', 'consisted', 'of', 'achievement', 'of', 'intraluminal', 'temperature', 'of', '-c', 'homogeneously', 'possible', 'minute', '.', 'daily', 'lapatinib', 'added', 'day', '-', ',', 'starting', 'with', 'dose', 'level', 'of', ',', 'mg.', 'mtd', 'defined', 'highest', 'dose', 'of', 'patient', 'experienced', 'dose-limiting', 'toxicity', '(', 'dlt', ')', '.', 'dlt', 'defined', 'grade', 'neutropenia', 'lasting', 'day', ',', 'febrile', 'neutropenia', 'grade', ',', 'grade', 'thrombocytopenia', ',', 'grade', 'renal', 'toxicity', ',', 'postponement', 'of', 'cisplatin', 'and', 'hyperthermia', 'week', ',', 'or', 'grade', 'nonhematologic', 'adverse', 'event', 'except', 'nausea', 'or', 'vomiting', ',', 'diarrhea', ',', 'or', 'skin', 'toxicity', ',', 'following', 'dlt', 'definition', 'applied', 'grade', 'persistent', 'nausea', 'or', 'vomiting', 'or', 'diarrhea', 'despite', 'optimal', 'medical', 'treatment', 'or', 'grade', 'skin', 'toxicity', '.', 'safety', ',', 'pharmacodynamics', ',', 'and', 'response', 'assessed', '.', 'result', 'first', 'two', 'patient', 'of', ',', '-', 'and', '-mg', 'dose', 'level', 'experienced', 'dlts', '.', 'of', 'four', 'patient', 'treated', 'dose', 'level', '-', '(', 'mg', ')', ',', 'one', 'patient', 'able', 'to', 'complete', 'treatment', 'planned', ',', 'two', 'patient', 'experienced', 'dlt', ',', 'and', 'one', 'patient', 'not', 'evaluable', 'of', 'early', 'progressive', 'disease', '.', 'in', 'evaluable', 'patient', ',', 'one', 'patient', 'with', 'progressive', 'disease', ',', 'four', 'patient', 'with', 'stable', 'disease', ',', 'and', 'two', 'patient', 'with', 'partial', 'response', 'observed', '.', 'one', 'patient', 'with', 'partial', 'response', 'resection', 'of', 'local', 'recurrence', '.', 'pathological', 'analysis', 'showed', 'complete', 'pathological', 'response', '.', 'enumeration', 'of', 'circulating', 'endothelial', 'cell', 'measured', 'baseline', 'and', 'therapy', 'not', 'show', 'consistent', 'result', '.', 'applied', 'pharmacodynamic', 'effect', 'ki-', ',', 'pkip', ',', 'and', 'egfr', 'in', 'pretreatment', 'and', 'on-therapy', 'skin', 'biopsy', '.', 'conclusion', 'not', 'feasible', 'to', 'combine', 'lapatinib', 'with', 'fixed', 'dos', 'of', 'cisplatin', 'and', 'hyperthermia', 'in', 'patient', 'with', 'recurrent', 'cervical', 'carcinoma', 'in', 'previously', 'irradiated', 'area', 'mainly', 'of', 'increased', 'cisplatin-related', 'toxicity', '.', 'observed', 'complete', 'pathological', 'response', 'intriguing', 'and', 'warrant', 'investigation', 'of', 'combination', 'consisting', 'of', 'blockade', 'and', 'cisplatin', 'plus', 'hyperthermia', '.']"
"The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial.","Panot Sainamthip, Siriwimon Saichaemchan, Bancha Satirapoj, Naiyarat Prasongsook, Panot Sainamthipet al.",2022 Mar:8:e2100275.,JCO Glob Oncol,https://pubmed.ncbi.nlm.nih.gov/35436142/,No keywords found,"['nephrotoxicity', 'major', 'dose-limiting', 'toxicity', 'among', 'patient', 'with', 'cancer', 'treated', 'with', 'cisplatin', '.', 'although', 'no', 'standard', 'approach', 'available', 'to', 'prevent', 'cisplatin-induced', 'nephrotoxicity', ',', 'administering', 'intravenous', 'isotonic', 'saline', 'recommended', '.', 'additionally', ',', 'mannitol', 'combined', 'with', 'hydration', 'evaluated', ',', 'none', 'of', 'established', '.', 'study', 'aimed', 'to', 'determine', 'efficacy', 'of', 'mannitol', 'combined', 'hydration', 'to', 'prevent', 'cisplatin-induced', 'nephrotoxicity', '.', 'patient', 'and', 'method', 'study', 'phase', 'ii', ',', 'randomized', ',', 'placebo-controlled', 'design', '.', 'patient', 'with', 'solid', 'cancer', 'treated', 'with', 'cisplatin', '(', 'n', ')', 'randomly', 'assigned', 'to', 'receive', 'either', 'placebo', '(', 'n', ')', 'or', 'g', 'of', 'mannitol', '(', 'n', ')', 'completing', 'l', 'of', 'prehydration', 'and', 'receiving', 'cisplatin', '.', 'serum', 'creatinine', ',', 'blood', 'urea', 'nitrogen', ',', 'electrolyte', ',', 'and', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'measured', 'baseline', 'and', 'day', 'and', '.', 'moreover', ',', 'gfr', 'calculated', 'based', '-hour', 'urine', 'creatinine', 'clearance', 'rate', 'to', 'assess', 'renal', 'function', 'baseline', 'and', 'hour', 'receiving', 'cisplatin', '.', 'severity', 'of', 'nausea', 'and', 'vomiting', 'evaluated', 'using', 'common', 'terminology', 'criterion', 'adverse', 'event', '.', 'result', 'no', 'difference', 'found', 'regarding', 'baseline', 'characteristic', 'two', 'group', '.', 'seven', 'of', 'patient', '(', '.', ')', 'in', 'mannitol', 'group', 'and', 'of', 'patient', '(', ')', 'in', 'placebo', 'group', 'increased', 'serum', 'creatinine', 'level', '.', 'mgdl', 'hour', 'intervention', '(', 'p', 'value', '.', ')', '.', 'patient', 'receiving', 'mannitol', 'exhibited', 'significantly', 'lower', 'incidence', 'of', '-hour', 'urine', 'gfr', 'mlmin', '.', 'in', 'placebo', 'group', '(', '.', 'v', '.', 'in', 'placebo', 'group', 'p', 'value', '.', ')', '.', 'univariate', 'analysis', 'showed', 'greatest', 'benefit', 'administering', 'mannitol', 'among', 'patient', 'receiving', 'cisplatin', 'mgm', ',', 'or', 'patient', 'receiving', 'concomitant', 'radiation', '.', 'conclusion', 'mannitol', 'combined', 'with', 'hydration', 'significantly', 'prevented', 'cisplatin-induced', 'nephrotoxicity', '.', 'additionally', ',', 'mannitol', 'particularly', 'considered', 'among', 'patient', 'with', 'cancer', ',', 'treated', 'with', 'cisplatin', 'mgm', ',', 'or', 'patient', 'receiving', 'concomitant', 'radiation', '.']"
Protocol of a randomised controlled trial in cardiac surgical patients with endothelial dysfunction aimed to prevent postoperative acute kidney injury by administering nitric oxide gas.,"Francesco Marrazzo, Stefano Spina, Francesco Zadek, Tenzing Lama, Changhan Xu, Grant Larson, Emanuele Rezoagli, Rajeev Malhotra, Hui Zheng, Edward A Bittner, Kenneth Shelton, Serguei Melnitchouk, Nathalie Roy, Thoralf M Sundt, William D Riley, Purris Williams, Daniel Fisher, Robert M Kacmarek, Taylor B Thompson, Joseph Bonventre, Warren Zapol, Fumito Ichinose, Lorenzo Berra, Francesco Marrazzoet al.",2019 Jul 4,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/31278097/,No keywords found,"['postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'in', 'cardiac', 'surgery', '.', 'level', 'of', 'intravascular', 'haemolysis', 'strongly', 'associated', 'with', 'postoperative', 'aki', 'and', 'with', 'prolonged', '(', 'min', ')', 'use', 'of', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'ferrous', 'plasma', 'haemoglobin', 'released', 'circulation', 'act', 'scavenger', 'of', 'nitric', 'oxide', '(', 'no', ')', 'produced', 'endothelial', 'cell', '.', 'consequently', ',', 'vascular', 'bioavailability', 'of', 'no', 'reduced', ',', 'leading', 'to', 'vasoconstriction', 'and', 'impaired', 'renal', 'function', '.', 'in', 'patient', 'with', 'cardiovascular', 'risk', 'factor', ',', 'endothelium', 'dysfunctional', 'and', 'not', 'replenish', 'no', 'deficit', '.', 'previous', 'clinical', 'study', 'in', 'young', 'cardiac', 'surgical', 'patient', 'with', 'rheumatic', 'fever', ',', 'without', 'evidence', 'of', 'endothelial', 'dysfunction', ',', 'showed', 'supplementation', 'of', 'no', 'gas', 'decrease', 'aki', 'converting', 'ferrous', 'plasma', 'haemoglobin', 'to', 'ferric', 'methaemoglobin', ',', 'thus', 'preserving', 'vascular', 'no', '.', 'in', 'current', 'trial', ',', 'hypothesised', 'hour', 'administration', 'of', 'no', 'gas', 'reduce', 'aki', 'following', 'cpb', 'in', 'patient', 'with', 'endothelial', 'dysfunction', '.', 'method', 'single-centre', ',', 'randomised', '(', ')', 'controlled', ',', 'parallel-arm', 'superiority', 'trial', 'includes', 'patient', 'with', 'endothelial', 'dysfunction', ',', 'stable', 'kidney', 'function', 'and', 'undergoing', 'cardiac', 'surgery', 'procedure', 'with', 'expected', 'cpb', 'duration', 'min', '.', 'randomisation', ',', 'part', 'per', 'million', '(', 'ppm', ')', 'no', '(', 'intervention', 'group', ')', 'or', 'ppm', 'nitrogen', '(', 'n', ',', 'control', 'group', ')', 'added', 'to', 'gas', 'mixture', '.', 'test', 'gas', '(', 'n', 'or', 'no', ')', 'delivered', 'cpb', 'and', 'hour', 'surgery', '.', 'primary', 'study', 'outcome', 'occurrence', 'of', 'aki', 'among', 'study', 'group', '.', 'key', 'secondary', 'outcome', 'include', 'aki', 'severity', ',', 'occurrence', 'of', 'renal', 'replacement', 'therapy', ',', 'major', 'adverse', 'kidney', 'event', 'week', 'surgery', 'and', 'mortality', '.', 'recruiting', 'patient', ',', 'allowing', 'detection', 'of', 'aki', 'relative', 'risk', 'reduction', ',', 'assuming', 'two-sided', 'error', 'of', '..', 'ethic', 'and', 'dissemination', 'partner', 'human', 'research', 'committee', 'approved', 'trial', '.', 'recruitment', 'began', 'in', 'february', '.', 'dissemination', 'plan', 'include', 'presentation', 'scientific', 'conference', ',', 'scientific', 'publication', 'and', 'advertising', 'flyer', 'and', 'poster', 'massachusetts', 'general', 'hospital', '.', 'trial', 'registration', 'number', 'nct', '.']"
The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.,"Elin M Thorlacius, Pertti K Suominen, Håkan Wåhlander, Juho Keski-Nisula, Maria Vistnes, Sven-Erik Ricksten, Mats Synnergren, Birgitta S Romlin, Albert Castellheim, Elin M Thorlaciuset al.",2019 Oct,Pediatr Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/31274775/,No keywords found,"['shown', ',', 'in', 'contrast', 'to', 'inotropic', 'agent', ',', 'levosimendan', 'improves', 'glomerular', 'filtration', 'rate', 'adult', 'cardiac', 'surgery', '.', 'aim', 'of', 'study', 'to', 'investigate', 'efficacy', 'of', 'levosimendan', ',', 'compared', 'with', 'milrinone', ',', 'in', 'preventing', 'acute', 'kidney', 'dysfunction', 'in', 'infant', 'open-heart', 'surgery', 'with', 'cardiopulmonary', 'bypass', '.', 'design', 'two-center', ',', 'double-blinded', ',', 'prospective', ',', 'randomized', 'clinical', 'trial', '.', 'setting', 'study', 'performed', 'in', 'two', 'tertiary', 'pediatric', 'center', ',', 'one', 'in', 'sweden', '(', 'gothenburg', ')', 'and', 'one', 'in', 'finland', '(', 'helsinki', ')', '.', 'patient', 'infant', 'and', 'month', 'old', ',', 'diagnosed', 'with', 'tetralogy', 'of', 'fallot', ',', 'complete', 'atrioventricular', 'septal', 'defect', 'or', 'nonrestrictive', 'ventricular', 'septal', 'defect', ',', 'undergoing', 'total', 'corrective', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '.', 'intervention', 'seventy-two', 'infant', 'randomized', 'to', 'receive', 'perioperative', 'infusion', 'of', 'levosimendan', '(', '.', 'gkgmin', ')', 'or', 'milrinone', '(', '.', 'gkgmin', ')', '.', 'infusion', 'initiated', 'start', 'of', 'cardiopulmonary', 'bypass', 'and', 'continued', 'hour', '.', 'measurement', 'and', 'main', 'result', 'primary', 'outcome', 'variable', 'absolute', 'value', 'of', 'serum', 'creatinine', 'data', 'postoperative', 'day', '.', 'secondary', 'outcome', 'included', 'following', ')', 'acute', 'kidney', 'injury', 'according', 'to', 'serum', 'creatinine', 'criterion', 'of', 'kidney', 'disease', 'improving', 'global', 'outcome', ')', 'acute', 'kidney', 'injury', 'with', 'serum', 'creatinine', 'corrected', 'fluid', 'balance', ')', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', ')', 'cystatin', 'c', ')', 'urea', ')', 'lactate', ')', 'hemodynamic', 'variable', ')', 'use', 'of', 'diuretic', 'in', 'picu', ')', 'need', 'of', 'dialysis', ')', 'length', 'of', 'ventilator', 'therapy', 'and', ')', 'length', 'of', 'picu', 'stay', '.', 'no', 'significant', 'difference', 'in', 'postoperative', 'serum', 'creatinine', 'treatment', 'group', 'time', '(', 'p', '.', ')', '.', 'occurrence', 'rate', 'of', 'acute', 'kidney', 'injury', 'within', 'hour', '.', 'in', 'levosimendan', 'group', 'and', '.', 'in', 'milrinone', 'group', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'secondary', 'outcome', 'variable', 'group', '.', 'conclusion', 'levosimendan', 'compared', 'with', 'milrinone', 'not', 'reduce', 'occurrence', 'rate', 'of', 'acute', 'kidney', 'injury', 'in', 'infant', 'total', 'corrective', 'heart', 'surgery', 'atrioventricular', 'septal', 'defect', ',', 'ventricular', 'septal', 'defect', ',', 'or', 'tetralogy', 'of', 'fallot', '.']"
Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial.,"Yeoungjee Cho, David W Johnson, David A Vesey, Carmel M Hawley, Margaret Clarke, Nicholas Topley                              ;, balANZ Trial Investigators, G Rangan, L Liew, H Kulkarni, U Steinwandel, B Jones, L Garvey, John Hunter, M G Suranyi, M Gilbert, F G Brown, I Abraham, J Nandkumar, A Coburn, V Bali, S McDonald, S Frasca, M Hockley, C Russ, T J Elias, K Bannister, K Pirone, D Ranganathan, L Williams, K Warr, G Smith, N Boudville, S Pellicano, R Langham, E O'Flaherty, J Schollum, L Reed, L Anderson, D Voss, B Jagannathan, P Nicholls, M W Y Foo, C K Tam, R Lee, Tang Tock Seng, S H Tan, Yeoungjee Choet al.",2015 Mar-Apr,Perit Dial Int,https://pubmed.ncbi.nlm.nih.gov/24711637/,No keywords found,"['ability', 'of', 'urinary', 'biomarkers', 'to', 'predict', 'residual', 'renal', 'function', '(', 'rrf', ')', 'decline', 'in', 'peritoneal', 'dialysis', '(', 'pd', ')', 'patient', 'not', 'defined', '.', 'present', 'study', 'aimed', 'to', 'explore', 'utility', 'of', 'established', 'biomarkers', 'kidney', 'injury', 'model', 'predicting', 'loss', 'of', 'rrf', 'in', 'incident', 'pd', 'patient', ',', 'and', 'to', 'evaluate', 'impact', 'rrf', 'of', 'using', 'neutral-ph', 'pd', 'solution', 'low', 'in', 'glucose', 'degradation', 'product', '.', 'method', 'study', 'included', 'randomly', 'selected', 'participant', 'balanz', 'trial', 'completed', 'month', 'of', 'follow-up', '.', 'change', 'in', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'used', 'primary', 'clinical', 'outcome', 'measure', '.', 'in', 'mixed-effects', 'general', 'linear', 'model', ',', 'baseline', 'measurement', 'of', 'novel', 'urinary', 'biomarkers', 'and', 'albumin', 'used', 'to', 'predict', 'gfr', 'change', '.', 'model', 'used', 'to', 'evaluate', 'impact', 'of', 'biocompatible', 'pd', 'solution', 'rrf', ',', 'adjusted', 'biomarker', '.', 'result', 'baseline', 'albuminuria', 'not', 'useful', 'predictor', 'of', 'change', 'in', 'rrf', 'in', 'pd', 'patient', '(', 'p', '.', ')', '.', 'clusterin', 'significant', 'predictor', 'of', 'gfr', 'decline', 'in', 'whole', 'population', '(', 'p', '.', ',', 'adjusted', 'baseline', 'gfr', 'and', 'albuminuria', ')', '.', 'however', ',', 'relationship', 'no', 'longer', 'apparent', 'albuminuria', 'removed', 'model', '(', 'p', '.', ')', '.', 'effect', 'of', 'administered', 'pd', 'solution', 'examined', 'using', 'model', 'adjusted', 'pd', 'solution', 'type', ',', 'baseline', 'albuminuria', ',', 'and', 'gfr', ',', 'higher', 'baseline', 'urinary', 'concentration', 'of', 'trefoil', 'factor', '(', 'tff', ',', 'p', '.', ')', ',', 'kidney', 'injury', 'molecule', '(', 'kim-', ',', 'p', '.', ')', ',', 'and', 'interferon', '-induced', 'protein', '(', 'ip-', ',', 'p', '.', ')', 'associated', 'with', 'rapid', 'decline', 'of', 'rrf', 'in', 'patient', 'receiving', 'conventional', 'pd', 'solution', 'compared', 'with', 'biocompatible', 'pd', 'solution', '.', 'conclusion', 'higher', 'urinary', 'level', 'of', 'kidney', 'injury', 'biomarkers', '(', 'tff', ',', 'kim-', ',', 'ip-', ')', 'baseline', 'predicted', 'significantly', 'slower', 'rrf', 'decline', 'in', 'patient', 'receiving', 'biocompatible', 'pd', 'solution', '.', 'finding', 'present', 'investigation', 'help', 'to', 'guide', 'future', 'study', 'to', 'validate', 'utility', 'of', 'urinary', 'biomarkers', 'tool', 'to', 'predict', 'rrf', 'decline', 'in', 'pd', 'patient', '.']"
Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.,"Hyeong Su Kim, Ho Young Kim, Dae Young Zang, Ho Suk Oh, Jang Yong Jeon, Ji Woong Cho, Choong Kee Park, Jong Hyeok Kim, Min-Jeong Kim, Hong Il Ha, Jung Han Kim, Boram Han, Hunho Song, Jung Hye Kwon, Dae Ro Choi, Joo Young Jung, Hyeong Su Kimet al.",2015 Apr,Cancer Chemother Pharmacol,https://pubmed.ncbi.nlm.nih.gov/25630414/,No keywords found,"['phase', 'ii', 'study', 'conducted', 'to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'gemcitabine', 'and', 's-', 'combination', 'chemotherapy', 'in', 'patient', 'with', 'metastatic', 'biliary', 'tract', 'cancer', '(', 'btc', ')', '.', 'method', 'patient', 'with', 'pathologically', 'confirmed', ',', 'unresectable', ',', 'recurrent', ',', 'or', 'metastatic', 'adenocarcinoma', 'originated', 'intrahepatic', 'or', 'extrahepatic', 'biliary', 'duct', 'or', 'gallbladder', 'assessed', 'eligibility', '.', 'primary', 'end', 'point', 'overall', 'response', 'rate', '(', 'orr', ')', '.', 'treatment', 'consisted', 'of', ',', 'mgm', '(', ')', 'intravenous', 'gemcitabine', 'administered', 'min', 'day', 'and', ',', 'and', 'mgm', '(', ')', 'oral', 's-', 'day', '-', 'of', 'cycle', '.', 'treatment', 'repeated', 'every', 'week', '.', 'result', 'thirty-eight', 'patient', 'enrolled', 'november', 'and', '.', 'patient', 'metastatic', 'disease', ',', 'and', 'primary', 'site', 'of', 'cancer', 'follows', 'gallbladder', 'in', '(', '.', ')', ',', 'intrahepatic', 'and', 'extrahepatic', 'bile', 'duct', 'in', '(', '.', ')', ',', 'and', 'ampulla', 'of', 'vater', 'in', '(', '.', ')', 'patient', '.', 'one', 'patient', 'achieved', 'complete', 'response', ',', 'and', 'six', 'experienced', 'partial', 'response', '.', 'orr', '.', '(', 'ci', '.-', '.', 'in', 'per-protocol', '(', 'pp', ')', 'population', ',', 'and', '.', '(', 'ci', '.-', '.', ')', 'in', 'intention-to-treat', '(', 'itt', ')', 'population', 'median', 'response', 'duration', '.', 'month', '.', 'nineteen', 'patient', 'stable', 'disease', ',', 'and', 'disease', 'control', 'rate', '.', '(', 'ci', '.-', '.', ')', 'in', 'pp', 'population', '.', 'median', 'progression-free', 'survival', '.', 'month', '(', 'ci', '.-', '.', ')', ',', 'and', 'median', 'overall', 'survival', '.', 'month', '(', 'ci', '.-', '.', ')', 'with', '-year', 'survival', 'rate', 'of', '.', '(', 'ci', '.-', '.', ')', 'in', 'itt', 'population', '.', 'grade', 'hematologic', 'toxicity', ',', 'neutropenia', ',', 'anemia', ',', 'and', 'thrombocytopenia', 'observed', 'in', '(', '.', ')', ',', '(', '.', ')', ',', '(', '.', ')', ',', 'and', '(', '.', ')', 'patient', ',', 'respectively', '.', 'one', 'patient', 'experienced', 'grade', 'febrile', 'neutropenia', 'without', 'documented', 'infection', '.', 'grade', 'non-hematologic', 'toxicity', 'hepatic', 'toxicity', '(', '.', ')', ',', 'anorexia', '(', '.', ')', ',', 'and', 'renal', 'toxicity', '(', '.', ')', '.', 'conclusion', 'gemcitabine', 'and', 's-', 'combination', 'chemotherapy', 'showed', 'acceptable', 'efficacy', 'and', 'favorable', 'toxicity', 'profile', '.', 'therefore', ',', 'might', 'offer', 'alternative', 'therapeutic', 'strategy', 'in', 'patient', 'with', 'btc', '.']"
Utility of N-acetylcysteine in ischemic hepatitis in cirrhotics with acute variceal bleed: a randomized controlled trial.,"Rakhi Maiwall, Awinash Kumar, Ajeet Singh Bhadoria, Ankur Jindal, Guresh Kumar, Ankit Bhardwaj, Jaswinder Singh Maras, Manoj Kumar Sharma, Barjesh Chandra Sharma, Shiv Kumar Sarin, Rakhi Maiwallet al.",2020 Jul,Hepatol Int,https://pubmed.ncbi.nlm.nih.gov/32048131/,No keywords found,"['ischemic', 'hepatitis', '(', 'ih', ')', 'following', 'acute', 'variceal', 'bleed', '(', 'avb', ')', 'carry', 'ominous', 'prognosis', '.', 'n-acetylcysteine', '(', 'nac', ')', ',', 'potent', 'anti-oxidant', ',', 'may', 'prevent', 'ih', 'improving', 'tissue', 'oxygen', 'delivery', 'and', 'improving', 'hepatic', 'hypoxia', '.', 'method', 'consecutive', 'cirrhotics', 'with', 'avb', 'prospectively', 'randomized', 'to', 'receive', 'either', 'standard', 'of', 'care', '(', 'soc', ')', 'plus', 'nac', 'intravenously', 'h', '(', 'mgkgh', 'h', 'followed', '.', 'mgkgh', 'h', ',', 'followed', '.', 'mgkg', 'h', ')', '(', 'group', ',', 'n', ')', 'or', 'soc', 'alone', '(', 'group', 'b', ',', 'n', ')', '.', 'result', 'baseline', 'characteristic', 'comparable', '.', 'ih', 'developed', 'frequently', 'in', 'gr.b', '(', ')', 'a-', '(', ')', 'p', '.', ')', '.', 'incidence', 'of', 'ih', 'increased', 'with', 'severity', 'of', 'liver', 'disease', '.', 'binary', 'logistic', 'regression', 'analysis', 'showed', 'reduced', 'incidence', 'of', 'ih', 'in', 'gr.a', 'b', 'odds', 'ratio', '(', 'or', ')', '.', ',', '.-', '.', 'patient', 'controlling', 'significant', 'factor', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'also', 'reduced', 'in', 'gr.a', 'or', '.', ',', '.-', '..', 'development', 'of', 'ih', 'significantly', 'associated', 'with', 'increased', 'death', 'due', 'to', 'liver', 'failure', 'week', 'subdistribution', 'hazard', 'ratio', '(', 'shr', ')', '.', ',', '.-', '..', 'multivariate', 'competing', 'risk', 'analysis', ',', 'significantly', 'lower', 'death', 'due', 'to', 'liver', 'failure', '(', 'shr', '.', ',', '.-', '.', ')', 'noted', 'in', 'gr.a', 'b.', 'conclusion', 'one', 'in', 'five', 'patient', 'with', 'acute', 'variceal', 'bleed', 'develops', 'ischemic', 'hepatitis', 'associated', 'with', 'worse', 'outcome', '.', 'nac', 'therapy', 'averts', 'death', 'due', 'to', 'liver', 'failure', 'preventing', 'ih', 'and', 'reduces', 'aki', 'and', ',', 'therefore', ',', 'recommended', 'cirrhotics', 'with', 'acute', 'variceal', 'bleed', '.', 'trial', 'registration', 'clinicaltrials.gov', 'no', 'nct', '.']"
Does Scheduled Low-Dose Short-Term NSAID (Ketorolac) Modulate Cytokine Levels After Orthopaedic Polytrauma? A Secondary Analysis of a Randomized Clinical Trial.,"Jeffrey A Foster, Gregory S Hawk, David C Landy, Jarod T Griffin, Andrew C Bernard, Douglas R Oyler, Wyatt G S Southall, Maaz Muhammad, Carlos R Sierra-Arce, Samuel D Mounce, Jacob S Borgida, Lusha Xiang, Arun Aneja, Jeffrey A Fosteret al.",2024 Jul 1,J Orthop Trauma,https://pubmed.ncbi.nlm.nih.gov/38506517/,No keywords found,"['to', 'determine', 'whether', 'scheduled', 'low-dose', ',', 'short-term', 'ketorolac', 'modulates', 'cytokine', 'concentration', 'in', 'orthopaedic', 'polytrauma', 'patient', '.', 'design', 'secondary', 'analysis', 'of', 'double-blinded', ',', 'randomized', 'controlled', 'trial', '.', 'setting', 'single', 'level', 'trauma', 'center', 'august', 'to', 'october', '.', 'patient', 'selection', 'criterion', 'orthopaedic', 'polytrauma', 'patient', 'and', 'year', 'with', 'new', 'injury', 'severity', 'score', 'greater', 'enrolled', '.', 'participant', 'randomized', 'to', 'receive', 'mg', 'of', 'intravenous', 'ketorolac', 'every', 'hour', 'to', 'inpatient', 'day', 'or', 'ml', 'of', 'intravenous', 'saline', 'similarly', '.', 'outcome', 'measure', 'and', 'comparison', 'daily', 'concentration', 'of', 'prostaglandin', 'e', 'and', 'interleukin', '(', 'il', ')', '-a', ',', 'il-b', ',', 'il-', ',', 'and', 'il-', '.', 'clinical', 'outcome', 'included', 'hospital', 'and', 'intensive', 'care', 'unit', 'length', 'of', 'stay', ',', 'pulmonary', 'complication', ',', 'and', 'acute', 'kidney', 'injury', '.', 'result', 'seventy', 'orthopaedic', 'polytrauma', 'patient', 'enrolled', ',', 'with', 'participant', 'randomized', 'to', 'ketorolac', 'group', 'and', 'to', 'placebo', 'group', '.', 'overall', 'il-', 'trend', 'time', 'significantly', 'different', 'in', 'ketorolac', 'group', '(', 'p', '.', ')', '.', 'il-', '.', 'higher', 'enrollment', 'compared', 'to', 'day', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'clinical', 'outcome', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'scheduled', 'low-dose', ',', 'short-term', ',', 'intravenous', 'ketorolac', 'associated', 'with', 'significantly', 'different', 'mean', 'trend', 'in', 'il-', 'concentration', 'in', 'orthopaedic', 'polytrauma', 'patient', 'with', 'no', 'significant', 'difference', 'in', 'prostaglandin', 'e', ',', 'il-a', ',', 'il-b', ',', 'or', 'il-', 'level', 'group', '.', 'treatment', 'not', 'impact', 'clinical', 'outcome', 'of', 'hospital', 'or', 'intensive', 'care', 'unit', 'length', 'of', 'stay', ',', 'pulmonary', 'complication', ',', 'or', 'acute', 'kidney', 'injury', '.', 'level', 'of', 'evidence', 'therapeutic', 'level', 'ii', '.', 'see', 'instruction', 'author', 'complete', 'description', 'of', 'level', 'of', 'evidence', '.']"
Kidney-protective Effect of Magnesium Supplementation in Cisplatin-containing Chemotherapy for Pediatric Cancer: A Retrospective Study.,"Motohiro Matsui, Yuya Saito, Shoko Yamaoka, Yuichi Yokokawa, Yoshihiko Morikawa, Atsushi Makimoto, Yuki Yuza, Motohiro Matsuiet al.",2018 Jul,J Pediatr Hematol Oncol,https://pubmed.ncbi.nlm.nih.gov/29683958/,No keywords found,"['course', ')', 'or', 'not', '(', 'mg-', 'course', ')', '.', 'renal', 'impairment', 'defined', 'grade', 'or', 'higher', 'creatinine', 'elevation', '(', 'ce', ')', 'chemotherapy', 'course', '.', 'incidence', 'of', 'ce', 'in', 'mg', 'significantly', 'lower', 'in', 'mg-', '(', '.', 'vs.', '.', 'p.', ')', '.', 'multivariate', 'analysis', 'revealed', 'mg', 'supplementation', 'significantly', 'reduced', 'incidence', 'of', 'ce', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-.', ')', '.', 'in', 'pediatric', 'patient', ',', 'mg', 'supplementation', 'cisplatin-containing', 'chemotherapy', 'associated', 'with', 'less', 'cisplatin-induced', 'nephrotoxicity', 'to', 'prevent', 'cisplatin-induced', 'nephrotoxicity', '.']"
"LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.","Afshin Dowlati, R Donald Harvey, Richard D Carvajal, Omid Hamid, Samuel J Klempner, John Sae Wook Kauh, Daniel A Peterson, Danni Yu, Sonya C Chapman, Anna M Szpurka, Michelle Carlsen, Tonya Quinlan, Robert Wesolowski, Afshin Dowlatiet al.",2021 Aug,Invest New Drugs,https://pubmed.ncbi.nlm.nih.gov/33624233/,"Advanced solid tumor, CSF-1, CSF-1R inhibitor, IL-34, Immunotherapy, LY3022855, Tumor -associated macrophages.","['weight-based', '(', 'part', ')', 'and', 'non-weight-based', '(', 'part', 'b', ')', '.', 'part', 'patient', 'assigned', 'to', 'intravenous', '(', 'iv', ')', 'dose-escalation', 'cohort', '.', 'mgkg', 'per', 'week', '(', 'qw', ')', ',', '.', 'mgkg', 'qw', ',', '.', 'mgkg', 'qw', ',', '.', 'mgkg', 'every', 'week', '(', 'qw', ')', 'and', '.', 'mgkg', 'qw', 'dos', 'of', 'ly', '.', 'non-weight-based', 'dos', 'in', 'part', 'b', 'mg', 'and', 'mg', 'iv', 'qw', '.', 'result', 'fifty-two', 'patient', '(', 'mean', 'age', '.', '.', 'year', ')', 'treated', 'with', 'dose', 'of', 'ly', '(', 'range', '-', ')', '.', 'five', 'dose-limiting', 'toxicity', '(', 'left', 'ventricular', 'dysfunction', ',', 'anemia', ',', 'pancreatitis', ',', 'rhabdomyolysis', ',', 'and', 'acute', 'kidney', 'injury', ')', 'occurred', 'in', 'patient', '.', 'non-weight-based', 'mg', 'qw', 'dose', 'established', 'rpd', '.', 'common', 'treatment-emergent', 'adverse', 'event', 'increase', 'in', 'liver', 'function', 'variable', ',', 'fatigue', ',', 'nausea', ',', 'vomiting', ',', 'diarrhea', ',', 'anorexia', ',', 'pyrexia', ',', 'increased', 'lipase', ',', 'amylase', ',', 'and', 'lactate', 'dehydrogenase', '.', 'clearance', 'decreased', 'with', 'increasing', 'dose', 'and', 'weight-based', 'dosing', 'minimal', 'effect', 'pharmacokinetics', '.', 'serum', 'csf-', ',', 'and', 'il-', 'level', 'increased', 'higher', 'dos', 'and', 'frequent', 'dosing', ',', 'whereas', 'tam', 'and', 'cddimcdbright', 'level', 'decreased', '.', 'three', 'patient', 'achieved', 'stable', 'disease', '.', 'no', 'response', 'seen', '.', 'conclusion', 'ly', 'well', 'tolerated', 'and', 'showed', 'dose-dependent', 'pharmacokinetics-pharmacodynamics', 'and', 'limited', 'clinical', 'activity', 'in', 'heterogenous', 'solid', 'tumor', 'population', '.', 'clinicaltrials.gov', 'id', 'nct', '(', 'registration', 'date', 'may', ',', ')', '.']"
Evaluation of the effectiveness of caspofungin against febrile neutropenia and the factors related to the alteration in its plasma concentration.,"Yuhei Shibata, Yuri Miyahara, Yuna Sadaka, Mika Yasue, Minami Fujimura, Midori Soda, Miho Yamamoto, Hiroko Kato, Akio Suzuki, Katsura Tsukamoto, Takeshi Hara, Hisashi Tsurumi, Kiyoyuki Kitaichi, Yuhei Shibataet al.",2019 Oct,J Infect Chemother,https://pubmed.ncbi.nlm.nih.gov/31047782/,"Caspofungin, Febrile neutropenia, Japanese patients, Pharmacokinetics.","['caspofungin', '(', 'cpfg', ')', 'echinocandin', 'antifungal', 'agent', 'inhibits', 'synthesis', 'of', '-', ',', '-d-glucan', ',', 'critical', 'component', 'of', 'cell', 'wall', 'of', 'target', 'fungi', '.', 'several', 'clinical', 'study', 'confirmed', 'efficacy', 'and', 'safety', 'of', 'cpfg', 'in', 'patient', 'with', 'febrile', 'neutropenia', '(', 'fn', ')', 'however', ',', 'no', 'report', 'available', 'in', 'japanese', 'patient', 'with', 'fn', '.', 'therefore', ',', 'investigated', 'therapeutic', 'efficacy', 'and', 'pharmacokinetics', 'of', 'cpfg', 'empirical', 'therapy', 'in', 'japanese', 'hospital', '.', 'twenty-four', 'japanese', 'patient', ',', 'diagnosed', 'with', 'fn', 'gifu', 'university', 'hospital', 'february', 'to', 'august', ',', 'enrolled', '.', 'blood', 'sample', 'collected', 'end', 'of', 'cpfg', 'dosing', '(', '.', 'h', 'infusion', ')', 'day', 'and', 'immediately', 'prior', 'to', 'next', 'infusion', 'day', ',', ',', 'and', '.', 'concentration', 'of', 'cpfg', 'in', 'plasma', 'measured', 'high-performance', 'liquid', 'chromatography', '.', 'efficacy', 'assessed', 'five', 'of', 'component', 'endpoint', ',', 'and', 'safety', 'monitored', 'according', 'to', 'common', 'terminology', 'criterion', 'adverse', 'event', '.', 'cpfg', 'showed', 'excellent', 'effect', 'fn', '(', ',', ')', ',', 'without', 'serious', 'hepatic', 'or', 'renal', 'toxicity', '.', 'regarding', 'pharmacokinetics', ',', 'plasma', 'concentration', 'of', 'cpfg', 'significantly', 'correlated', 'with', 'body', 'weight', 'although', ',', 'no', 'correlation', 'observed', 'plasma', 'concentration', 'of', 'cpfg', 'and', 'factor', 'investigated', ',', 'gender', 'or', 'laboratory', 'result', '.', 'result', 'suggest', 'high', 'efficacy', ',', 'safety', ',', 'and', 'tolerability', 'of', 'cpfg', 'empirical', 'antifungal', 'therapy', 'japanese', 'patient', 'with', 'fn', '.']"
Different Doses of Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction.,"Zhengyang Hao, Yanzhou Zhang, Zhengyang Haoet al.",2022 Sep 30,Int Heart J,https://pubmed.ncbi.nlm.nih.gov/36104235/,"Cardiac function, High dose, SGLT2i.","['unclear', 'whether', 'discrepancy', 'among', 'efficacy', 'and', 'safety', 'of', 'different', 'dos', 'of', 'empagliflozin', 'in', 'patient', 'with', 'heart', 'failure', 'with', 'reduced', 'ejection', 'fraction', '(', 'hfref', ')', '.', 'aim', 'of', 'study', 'to', 'compare', 'efficacy', 'and', 'safety', 'of', 'mg', 'and', 'mg', 'of', 'empagliflozin', 'in', 'hfref', 'patients.in', '-month', ',', 'single-center', ',', 'open-label', ',', 'randomized', ',', 'positive-controlled', ',', 'parallel-group', 'study', ',', 'patient', 'with', 'hfref', 'divided', 'two', 'group', ',', 'namely', ',', 'group', '(', 'n', ')', 'and', 'b', '(', 'n', ')', ',', 'given', 'mgday', 'and', 'mgday', 'of', 'empagliflozin', ',', 'respectively', '.', 'cardiac', 'function', 'index', 'baseline', 'and', 'end', 'of', 'third', 'month', 'compared', 'two', 'group', ',', 'well', 'adverse', 'event', '-month', 'follow-up', 'period', '.', 'primary', 'outcome', 'of', 'study', 'change', 'in', 'left', 'ventricular', 'ejection', 'fraction', '(', 'lvef', ')', ',', 'and', 'secondary', 'outcome', 'change', 'in', 'left', 'ventricular', 'end-diastolic', 'diameter', '(', 'lvedd', ')', 'and', 'incidence', 'of', 'hypotension', ',', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'and', 'genitourinary', 'infections.at', 'end', 'of', 'third', 'month', ',', 'change', 'in', 'lvef', 'and', 'lvedd', 'greater', 'in', 'group', 'in', 'group', 'b', '(', 'p', '.', ')', '.the', 'result', 'study', 'suggested', 'mg', 'of', 'empagliflozin', 'might', 'better', 'mg', 'in', 'improving', 'heart', 'function', 'in', 'hfref', 'patient', ',', 'and', 'safety', 'profile', 'of', 'mg', 'and', 'mg', 'of', 'empagliflozin', 'comparable', '.', 'study', 'expected', 'to', 'substantiate', 'speculation', '.']"
A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury.,"Rafidah Atan, Leah Peck, John Prowle, Elisa Licari, Glenn M Eastwood, Markus Storr, Hermann Goehl, Rinaldo Bellomo, Rafidah Atanet al.",2018 Oct,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/30074491/,No keywords found,"['in', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', 'receiving', 'vasopressor', ',', 'high', 'cytokine', 'level', 'may', 'sustain', 'shock', 'state', '.', 'high', 'cutoff', 'hemofiltration', 'achieves', 'greater', 'cytokine', 'removal', 'in', 'ex', 'vivo', 'and', 'in', 'animal', 'model', 'and', 'may', 'reduce', 'duration', 'of', 'shock', 'may', 'also', 'increase', 'albumin', 'loss', '.', 'design', 'single-center', 'double-blind', 'randomized', 'controlled', 'trial', 'comparing', 'continuous', 'venovenous', 'hemofiltration-high', 'cutoff', 'to', 'continuous', 'venovenous', 'hemofiltration-standard', '.', 'setting', 'tertiary', 'care', 'hospital', 'in', 'australia', '.', 'patient', 'vasopressor-dependent', 'patient', 'in', 'acute', 'kidney', 'injury', 'admitted', 'to', 'icu', '.', 'intervention', 'norepinephrine-free', 'time', 'calculated', 'in', 'critically', 'ill', 'vasopressor-dependent', 'patient', 'in', 'acute', 'kidney', 'injury', ',', 'randomized', 'to', 'either', 'continuous', 'venovenous', 'hemofiltration-high', 'cutoff', 'or', 'continuous', 'venovenous', 'hemofiltration-standard', '.', 'measurement', 'and', 'main', 'result', 'total', 'of', 'patient', 'randomized', 'with', 'following', 'characteristic', '(', 'continuous', 'venovenous', 'hemofiltration-high', 'cutoff', 'v', 'continuous', 'venovenous', 'hemofiltration-standard', ')', 'median', 'age', 'of', 'versus', 'year', ',', 'percentage', 'of', 'male', 'versus', ',', 'and', 'median', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', 'score', 'of', 'versus', '..', 'median', 'hour', 'of', 'norepinephrine-free', 'time', 'day', '(', '-', '.', ')', 'continuous', 'venovenous', 'hemofiltration-high', 'cutoff', 'and', 'hour', '(', '-', '.', 'hr', ')', '(', 'p', '.', ')', 'continuous', 'venovenous', 'hemofiltration-standard', '.', 'inhospital', 'mortality', '.', 'with', 'continuous', 'venovenous', 'hemofiltration-high', 'cutoff', 'versus', '.', 'with', 'continuous', 'venovenous', 'hemofiltration-standard', '(', 'adjusted', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'time', 'to', 'cessation', 'of', 'norepinephrine', '(', 'p', '.', ')', ',', 'time', 'to', 'cessation', 'of', 'hemofiltration', '(', 'p', '.', ')', ',', 'and', 'filter', 'life', '(', 'p', '.', ')', '.', 'serum', 'albumin', 'level', '(', 'p', '.', ')', 'similar', 'and', 'median', 'dose', 'of', 'iv', 'albumin', 'given', 'gram', '(', '-', 'g', ')', 'continuous', 'venovenous', 'hemofiltration-high', 'cutoff', 'and', 'gram', '(', '-', 'g', ')', 'continuous', 'venovenous', 'hemofiltration-standard', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', ',', 'continuous', 'venovenous', 'hemofiltration-high', 'cutoff', 'not', 'reduce', 'duration', 'of', 'vasopressor', 'support', 'or', 'mortality', 'or', 'change', 'albumin', 'level', 'compared', 'with', 'continuous', 'venovenous', 'hemofiltration-standard', '.']"
Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.,"Tobias Kammerer, Florian Klug, Michaela Schwarz, Sebastian Hilferink, Bernhard Zwissler, Vera von Dossow, Alexander Karl, Hans-Helge Müller, Markus Rehm, Tobias Kammereret al.",2015 Aug 28:16:384.,Trials,https://pubmed.ncbi.nlm.nih.gov/26314293/,No keywords found,"['use', 'of', 'artificial', 'colloid', 'currently', 'controversial', ',', 'especially', 'in', 'central', 'europe', 'several', 'study', 'demonstrated', 'worse', 'outcome', 'in', 'intensive', 'care', 'unit', 'patient', 'with', 'use', 'of', 'hydroxyethyl', 'starch', '.', 'recently', 'even', 'led', 'to', 'drug', 'warning', 'use', 'of', 'hydroxyethyl', 'starch', 'product', 'in', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', '.', 'data', 'hydroxyethyl', 'starch', 'in', 'non-critically', 'ill', 'patient', 'insufficient', 'to', 'support', 'perioperative', 'use', '.', 'methodsdesign', 'conducting', 'single-center', ',', 'open-label', ',', 'randomized', ',', 'comparative', 'trial', 'with', 'two', 'parallel', 'patient', 'group', 'to', 'compare', 'human', 'albumin', '(', 'test', 'drug', ')', 'with', 'hydroxyethyl', 'starch', '.', '(', 'comparator', ')', '.', 'primary', 'endpoint', 'cystatin', 'c', 'ratio', ',', 'calculated', 'ratio', 'of', 'cystatin', 'value', 'day', 'surgery', 'relative', 'to', 'preoperative', 'value', '.', 'secondary', 'objective', 'inter', 'alia', 'evaluation', 'of', 'influence', 'of', 'human', 'albumin', 'and', 'hydroxyethyl', 'starch', 'laboratory', 'chemical', 'and', 'clinical', 'parameter', ',', 'glycocalyx', 'shedding', ',', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', 'and', 'acute', 'kidney', 'injury', 'defined', 'rifle', 'criterion', '(', 'risk', 'of', 'renal', 'dysfunction', ',', 'injury', 'to', 'kidney', ',', 'failure', 'of', 'kidney', 'function', ',', 'loss', 'of', 'kidney', 'function', ',', 'and', 'end-stage', 'kidney', 'disease', ')', 'criterion', '.', 'discussion', 'general', 'lack', 'of', 'evidence', 'relative', 'safety', 'and', 'effect', 'of', 'hydroxyethyl', 'starch', 'compared', 'with', 'human', 'albumin', 'volume', 'replacement', 'in', 'perioperative', 'setting', '.', 'previously', 'conducted', 'study', 'of', 'surgical', 'patient', 'in', 'researcher', 'compared', 'different', 'hydroxyethyl', 'starch', 'product', 'included', 'patient', 'to', 'properly', 'evaluate', 'clinical', 'important', 'outcome', 'renal', 'function', '.', 'in', 'present', 'study', 'in', 'high-risk', 'patient', 'population', 'undergoing', 'major', 'surgical', 'intervention', ',', 'determine', 'perioperative', 'fluid', 'replacement', 'with', 'human', 'albumin', 'long-term', 'advantage', 'third-generation', 'hydroxyethyl', 'starch', '.', 'progression', 'of', 'renal', 'dysfunction', 'day', 'surgery', '.', 'trial', 'registration', 'eudract', 'number', '--', '.', 'registered', 'january', '.']"
"Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial.","Bjorn Nashan, Peter Schemmer, Felix Braun, Markus Dworak, Peter Wimmer, Hans Schlitt, Bjorn Nashanet al.",2015 Mar 26:16:118.,Trials,https://pubmed.ncbi.nlm.nih.gov/25873064/,No keywords found,"['introduction', 'of', 'calcineurin', 'inhibitor', 'led', 'to', 'improved', 'survival', 'rate', 'in', 'liver', 'transplant', 'recipient', '.', 'however', ',', 'long-term', 'use', 'of', 'calcineurin', 'inhibitor', 'associated', 'with', 'higher', 'risk', 'of', 'chronic', 'renal', 'failure', ',', 'neurotoxicity', ',', 'de', 'novo', 'malignancy', ',', 'recurrence', 'of', 'hepatitis', 'c', 'viral', '(', 'hcv', ')', 'infection', 'and', 'hepatocellular', 'carcinoma', '.', 'several', 'study', 'shown', 'everolimus', 'potential', 'to', 'provide', 'protection', 'viral', 'replication', ',', 'malignancy', ',', 'and', 'progression', 'of', 'fibrosis', ',', 'well', 'preventing', 'nephrotoxicity', 'facilitating', 'calcineurin', 'inhibitor', 'reduction', 'without', 'compromising', 'efficacy', '.', 'hephaistos', 'study', 'evaluates', 'beneficial', 'effect', 'of', 'early', 'initiation', 'of', 'everolimus', 'in', 'de', 'novo', 'liver', 'transplant', 'recipient', '.', 'methodsdesign', 'hephaistos', 'ongoing', '-month', ',', 'multi-center', ',', 'open-label', ',', 'controlled', 'study', 'aiming', 'to', 'enroll', 'de', 'novo', 'liver', 'transplant', 'recipient', 'center', 'across', 'germany', '.', 'patient', 'randomized', 'in', 'ratio', '(', '-', 'day', 'post-transplantation', ')', 'to', 'receive', 'everolimus', '(', 'trough', 'level', '-', 'ngml', ')', 'with', 'reduced', 'tacrolimus', '(', 'trough', 'level', 'ngml', ')', ',', 'or', 'standard', 'tacrolimus', '(', 'trough', 'level', '-', 'ngml', ')', 'entering', 'run-in', 'period', '(', '-', 'day', 'post-transplantation', ')', '.', 'in', 'run-in', 'period', ',', 'patient', 'treated', 'with', 'induction', 'therapy', ',', 'mycophenolate', 'mofetil', ',', 'tacrolimus', ',', 'and', 'corticosteroid', 'according', 'to', 'local', 'practice', '.', 'randomization', 'stratified', 'hcv', 'status', 'and', 'model', 'of', 'end-stage', 'liver', 'disease', 'score', 'transplantation', '.', 'primary', 'objective', 'of', 'study', 'to', 'exhibit', 'superior', 'renal', 'function', '(', 'estimated', 'glomerular', 'filtration', 'rate', 'assessed', 'modification', 'of', 'diet', 'in', 'renal', 'disease', '(', 'mdrd', ')', '-', 'formula', ')', 'with', 'everolimus', 'plus', 'reduced', 'tacrolimus', 'compared', 'to', 'standard', 'tacrolimus', 'month', '.', 'objective', 'to', 'assess', 'incidence', 'of', 'treated', 'biopsy-proven', 'acute', 'rejection', ',', 'graft', 'loss', ',', 'or', 'death', 'incidence', 'of', 'component', 'of', 'composite', 'efficacy', 'endpoint', 'renal', 'function', 'via', 'estimated', 'glomerular', 'filtration', 'rate', 'using', 'various', 'formula', '(', 'mdrd-', ',', 'nankivell', ',', 'cockcroft-gault', ',', 'chronic', 'kidney', 'disease', 'epidemiology', 'collaboration', 'and', 'hoek', 'formula', ')', 'incidence', 'of', 'proteinuria', 'incidence', 'of', 'adverse', 'event', 'and', 'serious', 'adverse', 'event', 'incidence', 'and', 'severity', 'of', 'cytomegalovirus', 'and', 'hcv', 'infection', 'and', 'hcv-related', 'fibrosis', '.', 'discussion', 'study', 'aim', 'to', 'demonstrate', 'superior', 'renal', 'function', ',', 'comparable', 'efficacy', ',', 'and', 'safety', 'in', 'de', 'novo', 'liver', 'transplant', 'recipient', 'receiving', 'everolimus', 'with', 'reduced', 'tacrolimus', 'compared', 'with', 'standard', 'tacrolimus', '.', 'study', 'also', 'evaluates', 'antiviral', 'benefit', 'early', 'initiation', 'of', 'everolimus', '.', 'trial', 'registration', 'nct', '.']"
Conventional- versus high-dose vancomycin regimen in patients with acute bacterial meningitis: a randomized clinical trial.,"Sepideh Elyasi, Hossein Khalili, Simin Dashti-Khavidaki, Hamid Emadi-Koochak, Sepideh Elyasiet al.",2015 Feb,Expert Opin Pharmacother,https://pubmed.ncbi.nlm.nih.gov/25547064/,No keywords found,"['efficacy', 'of', 'conventional-', 'versus', 'high-dose', 'vancomycin', 'regimen', 'in', 'patient', 'with', 'acute', 'bacterial', 'meningitis', 'compared', '.', 'method', 'in', 'randomized', 'clinical', 'trial', 'patient', 'with', 'acute', 'bacterial', 'meningitis', 'randomly', 'assigned', 'to', 'conventional-', 'or', 'high-dose', 'vancomycin', 'group', '.', 'clinical', 'and', 'laboratory', 'parameter', 'used', 'evaluation', 'of', 'response', 'to', 'treatment', 'regimen', '.', 'result', 'in', 'high-dose', 'group', ',', 'leukocytosis', 'and', 'fever', 'resolved', 'significantly', 'faster', 'in', 'conventional', 'group', '.', 'furthermore', ',', 'length', 'of', 'hospitalization', 'shorter', 'and', 'glasgow', 'coma', 'scale', 'end', 'of', 'th', 'day', 'significantly', 'lower', 'in', 'high', 'dose', 'compared', 'to', 'conventional', 'group', '.', 'trend', 'of', 'creatinine', 'clearance', 'change', 'not', 'differ', 'significantly', 'two', 'group', '.', 'conclusion', 'in', 'comparison', 'to', 'conventional-dose', 'regimen', ',', 'high-dose', 'vancomycin', 'regimen', 'associated', 'with', 'significantly', 'favorable', 'clinical', 'response', 'without', 'increase', 'in', 'incidence', 'of', 'nephrotoxicity', 'in', 'patient', 'with', 'acute', 'bacterial', 'meningitis', '.']"
"A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial of Aminophylline to Prevent Acute Kidney Injury in Children Following Congenital Heart Surgery With Cardiopulmonary Bypass.","David M Axelrod, Scott M Sutherland, Andrew Anglemyer, Paul C Grimm, Stephen J Roth, David M Axelrodet al.",2016 Feb,Pediatr Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/26669642/,No keywords found,"['acute', 'kidney', 'injury', 'occurs', 'commonly', 'in', 'child', 'following', 'congenital', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'and', 'associated', 'with', 'increased', 'morbidity', 'and', 'mortality', '.', 'aminophylline', ',', 'methylxanthine', 'nonselective', 'adenosine', 'receptor', 'antagonist', ',', 'effective', 'in', 'management', 'of', 'acute', 'kidney', 'injury', 'in', 'certain', 'population', '.', 'study', 'sought', 'to', 'determine', 'whether', 'postoperative', 'administration', 'of', 'aminophylline', 'attenuates', 'acute', 'kidney', 'injury', 'in', 'child', 'undergoing', 'congenital', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '.', 'design', 'single-center', ',', 'double-blinded', ',', 'placebo-controlled', ',', 'randomized', 'clinical', 'trial', '.', 'setting', 'tertiary', 'center', ',', 'pediatric', 'cardiovascular', 'icu', '.', 'patient', 'total', 'of', 'child', 'congenital', 'heart', 'surgery', 'with', 'cardiopulmonary', 'bypass', '.', 'intervention', 'seventy-two', 'patient', 'randomized', 'to', 'receive', 'aminophylline', 'and', 'patient', 'received', 'placebo', '.', 'study', 'drug', 'administered', 'every', 'hour', 'hour', '.', 'measurement', 'and', 'main', 'result', 'primary', 'outcome', 'variable', 'development', 'of', 'acute', 'kidney', 'injury', ',', 'defined', 'serum', 'creatinine', 'criterion', 'of', 'kidney', 'disease', 'improving', 'global', 'outcome', '.', 'secondary', 'outcome', 'included', 'development', 'of', 'severe', 'acute', 'kidney', 'injury', ',', 'time', 'cardiovascular', 'icu', 'admission', 'and', 'first', 'successful', 'extubation', ',', 'percent', 'fluid', 'overload', ',', 'total', 'fluid', 'balance', ',', 'urine', 'output', ',', 'bioelectrical', 'impedance', ',', 'and', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', '.', 'unadjusted', 'rate', 'and', 'severity', 'of', 'acute', 'kidney', 'injury', 'not', 'different', 'group', 'of', '(', ')', 'of', 'treatment', 'group', 'and', 'of', '(', ')', 'of', 'placebo', 'group', 'developed', 'acute', 'kidney', 'injury', '(', 'p', '.', ')', '.', 'stage', 'acute', 'kidney', 'injury', 'occurred', 'in', 'of', '(', ')', 'of', 'treatment', 'group', 'and', 'of', '(', ')', 'of', 'placebo', 'group', '(', 'p', '.', ')', '.', 'secondary', 'outcome', 'measure', 'also', 'demonstrated', 'no', 'significant', 'difference', 'treatment', 'and', 'placebo', 'group', '.', 'aminophylline', 'administration', 'safe', 'no', 'death', 'occurred', 'in', 'either', 'group', ',', 'and', 'rate', 'of', 'adverse', 'event', 'similar', '(', 'in', 'treatment', 'group', 'v', 'in', 'placebo', 'group', 'p', '.', ')', '.', 'conclusion', 'in', 'placebo-controlled', 'randomized', 'clinical', 'trial', ',', 'found', 'no', 'effect', 'of', 'aminophylline', 'to', 'prevent', 'acute', 'kidney', 'injury', 'in', 'child', 'recovering', 'cardiac', 'surgery', 'performed', 'with', 'cardiopulmonary', 'bypass', '.', 'future', 'study', 'of', 'preoperative', 'aminophylline', 'administration', 'to', 'prevent', 'acute', 'kidney', 'injury', 'may', 'warranted', '.']"
"A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.","Clemens B Tempfer, Urs Giger-Pabst, Veronika Seebacher, Miriam Petersen, Askin Dogan, Günther A Rezniczek, Clemens B Tempferet al.",2018 Jul,Gynecol Oncol,https://pubmed.ncbi.nlm.nih.gov/29743140/,No keywords found,"['performed', 'phase', ',', 'single-arm', ',', 'non-randomized', ',', 'open-label', ',', 'dose-escalation', 'trial', 'to', 'determine', 'dose-limiting', 'toxicity', 'of', 'intraperitoneal', 'cisplatin', 'and', 'doxorubicin', 'applied', 'pressurized', 'intraperitoneal', 'aerosol', 'chemotherapy', '(', 'pipac', ')', 'in', 'woman', 'with', 'recurrent', 'ovarian', 'cancer', '.', 'method', 'used', 'standard', 'dose-escalation', 'design', 'with', 'doxorubicin', '.', 'mgm', ',', 'cisplatin', '.', 'mgm', 'q', 'to', 'week', 'cycle', 'and', 'subsequent', 'dose', 'escalation', 'step', '(', 'increment', 'per', 'step', ')', 'in', 'patient', 'with', 'recurrent', 'ovarian', 'cancer', 'and', 'peritoneal', 'carcinomatosis', '.', 'toxicity', 'and', 'clinical', 'efficacy', 'monitored', '.', 'primary', 'endpoint', 'maximum-tolerable', 'dose', '.', 'secondary', 'endpoint', 'included', 'histologic', 'tumor', 'regression', 'and', 'serum', 'parameter', '.', 'result', 'evaluable', 'patient', '(', ',', ',', 'and', 'in', 'cohort', ',', ',', 'and', ',', 'respectively', ')', 'average', 'received', '.', 'pipac', 'cycle', '.', 'no', 'dose', 'limiting', 'toxicity', 'found', '.', 'adverse', 'side', 'effect', 'grade', 'event', '(', 'colon', 'perforation', ')', 'and', 'grade', 'event', 'including', 'fatigue', '(', 'n', ')', ',', 'abdominal', 'pain', '(', 'n', ')', ',', 'nauseavomiting', '(', 'n', ')', ',', 'sleep', 'disorder', '(', 'n', ')', ',', 'diarrhea', '(', 'n', ')', ',', 'and', 'fever', '(', 'n', ')', '.', 'liver', 'and', 'renal', 'toxicity', 'not', 'observed', 'in', 'of', 'cohort', '(', 'ast', '.', '.', ',', '.', '.', ',', 'and', '.', '.', 'iul', ',', 'respectively', 'alt', '.', '.', ',', '.', '.', ',', 'and', '.', '.', 'iul', ',', 'respectively', 'ggt', '.', '.', ',', '.', '.', ',', 'and', '.', '.', 'iul', ',', 'respectively', 'serum', 'creatinine', '.', '.', ',', '.', '.', ',', 'and', '.', '.', 'mgdl', ',', 'respectively', ')', '.', 'no', 'systemic', 'hematologic', 'toxicity', ',', 'alopecia', ',', 'or', 'neurotoxicity', 'noted', '.', 'maximum', 'tolerable', 'dose', 'not', 'reached', '.', 'histologic', 'tumor', 'regression', 'observed', 'in', '(', ')', 'patient', 'underwent', 'pipac', 'cycle', '.', 'conclusion', 'pipac', 'with', 'cisplatin', 'and', 'doxorubicin', 'may', 'safely', 'used', 'intraperitoneal', 'dose', 'of', '.', 'mgm', 'and', '.', 'mgm', ',', 'respectively', '.', 'systemic', 'toxicity', 'of', 'therapy', 'low', '.']"
Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT).,"Joseph J Carreno, Rachel M Kenney, George Divine, Jose A Vazquez, Susan L Davis, Joseph J Carrenoet al.",2017 Mar,Ann Pharmacother,https://pubmed.ncbi.nlm.nih.gov/27838680/,No keywords found,"['use', 'of', 'alternative', 'antimicrobial', 'to', 'vancomycin', 'potential', 'strategy', 'to', 'reduce', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'high-risk', 'patient', ',', 'current', 'data', 'not', 'support', 'widespread', 'adoption', 'of', 'practice', '.', 'objective', 'to', 'determine', 'efficacy', 'of', 'early', 'switch', 'to', 'nonnephrotoxic', 'alternative', 'prevention', 'of', 'aki', 'in', 'high-risk', 'patient', 'receive', 'vancomycin', '.', 'method', 'irb-approved', ',', 'prospective', 'randomized', 'controlled', 'trial', 'in', 'single', ',', 'tertiary', 'care', 'academic', 'medical', 'center', '.', 'patient', 'initially', 'prescribed', 'vancomycin', 'october', 'to', 'april', 'with', 'least', 'risk', 'factor', 'aki', 'included', '.', 'treatment', 'randomization', 'stratified', 'indication', 'therapy', '.', 'patient', 'randomized', 'to', 'continuation', 'of', 'dose-optimized', 'vancomycin', 'or', 'early', 'switch', 'to', 'alternative', 'antimicrobial', 'agent', '.', 'primary', 'end', 'point', 'nephrotoxicity', 'consensus', 'guideline', 'definition', 'adjudicated', 'blinded', 'review', 'secondary', 'end', 'point', 'aki', 'network-defined', 'aki', '.', 'result', 'total', 'of', 'patient', 'randomized', 'included', 'in', 'modified', 'intent-to-treat', 'population', ',', 'in', 'vancomycin', 'group', 'and', 'in', 'alternative', 'group', '.', 'incidence', 'of', 'nephrotoxicity', '.', 'in', 'alternative', 'therapy', 'arm', 'and', '.', 'in', 'vancomycin', 'group', '(', 'p', '.', ')', '.', 'incidence', 'of', 'aki', '.', 'in', 'alternative', 'therapy', 'group', 'and', '.', 'in', 'vancomycin', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'no', 'significant', 'difference', 'in', 'nephrotoxicity', 'or', 'aki', 'detected', 'among', 'patient', 'treated', 'with', 'alternative', 'antimicrobial', 'compared', 'with', 'vancomycin', '.', 'use', 'of', 'alternative', 'antimicrobial', 'therapy', 'instead', 'of', 'vancomycin', 'solely', 'purpose', 'of', 'preventing', 'aki', 'in', 'high-risk', 'patient', 'not', 'appear', 'to', 'warranted', '.']"
Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease.,"Gilbert Lefèvre, Francesca Callegari, Sandro Gsteiger, Yuan Xiong, Gilbert Lefèvreet al.",2016 Oct,Drugs Aging,https://pubmed.ncbi.nlm.nih.gov/27681702/,No keywords found,"['glomerular', 'filtration', 'rate', '(', 'gfr', ')', ',', 'measure', 'of', 'renal', 'function', ',', 'decrease', 'approximately', 'mlmin', 'every', 'year', 'age', 'of', 'year', ',', 'could', 'lead', 'to', 'accumulation', 'of', 'drug', 'andor', 'renal', 'toxicity', '.', 'pharmacokinetic', 'study', 'of', 'drug', 'excreted', 'renally', 'and', 'non-renally', 'desirable', 'in', 'patient', 'with', 'impaired', 'renal', 'function', ',', 'defined', 'parameter', 'including', 'estimated', 'gfr', '(', 'egfr', ')', 'and', 'creatinine', 'clearance', '(', 'clcr', ')', '.', 'objective', 'describe', 'population', 'pharmacokinetic', 'analysis', 'of', 'possible', 'effect', 'of', 'renal', 'impairment', 'steady-state', 'plasma', 'concentration', 'of', 'rivastigmine', 'and', 'metabolite', 'nap-', 'rivastigmine', 'patch', '(', 'cm', '.', 'mg', 'h', ',', 'cm', '.', 'mg', 'h', ',', 'cm', '.', 'mg', 'h', ',', 'and', 'cm', '.', 'mg', 'h', ')', 'and', 'capsule', '(', '.', ',', ',', '.', ',', 'and', 'mg', 'h', ')', 'treatment', 'in', 'patient', 'with', 'alzheimer', ""'s"", 'disease', '.', 'method', 'data', 'used', 'to', 'conduct', 'current', 'pharmacokinetic', 'analysis', 'obtained', 'pivotal', 'phase', 'iii', ',', '-week', ',', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'placebo-', 'and', 'active-controlled', ',', 'parallel-group', 'study', '(', 'ideal', ')', '.', 'one', 'blood', 'sample', 'collected', 'patient', 'steady-state', 'to', 'measure', 'plasma', 'concentration', 'of', 'rivastigmine', 'and', 'nap-', 'using', 'liquid', 'chromatography-tandem', 'mass', 'spectrometry', '(', 'lc-msms', ')', 'method', '.', 'steady-state', 'plasma', 'concentration', 'of', 'rivastigmine', 'and', 'nap-', 'plotted', 'clcr', 'and', 'egfr', 'data', ',', 'and', 'boxplots', 'constructed', 'stratification', 'renal', 'function', '.', 'result', 'two', 'group', '(', 'mildno', 'renal', 'impairment', 'vs.', 'moderatesevereend-stage', 'renal', 'impairment', ')', 'showed', 'comparable', 'demographic', 'covariates', 'patch', 'size', 'and', 'capsule', 'dos', '.', 'no', 'correlation', 'observed', 'clcr', 'or', 'egfr', 'and', 'plasma', 'concentration', 'of', 'rivastigmine', 'or', 'nap-', '.', 'boxplots', 'of', 'concentration', 'of', 'rivastigmine', 'or', 'nap-', 'dose', 'largely', 'overlapped', 'patch', 'and', 'capsule', '.', 'additionally', ',', 'model-based', 'estimate', 'of', 'plasma', 'concentration', 'adjusted', 'body', 'weight', 'yielded', 'similar', 'result', '.', 'conclusion', 'result', 'of', 'study', 'show', 'renal', 'function', 'not', 'affect', 'rivastigmine', 'or', 'nap-', 'steady-state', 'plasma', 'concentration', ',', 'and', 'no', 'dose', 'adjustment', 'in', 'patient', 'with', 'renal', 'impairment', 'required', '.', 'clinicaltrials.gov', 'nct', '.']"
Influence of 6% Hydroxyethyl Starch 130/0.4 Versus Crystalloid Solution on Structural Renal Damage Markers After Coronary Artery Bypass Grafting: A Post Hoc Subgroup Analysis of a Prospective Trial.,"Thomas Datzmann, Markus Hoenicka, Helmut Reinelt, Andreas Liebold, Hagen Gorki, Thomas Datzmannet al.",2018 Feb,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/29221978/,No keywords found,"['restriction', 'of', 'hydroxyethyl', 'starch', '(', 'he', ')', 'mandated', 'change', 'in', 'volume', 'management', 'based', 'data', 'of', 'critically', 'ill', 'patient', '.', 'reliable', 'data', 'of', 'structural', 'renal', 'damage', 'he', 'treatment', 'in', 'cardiac', 'surgical', 'patient', 'lacking', '.', 'influence', 'of', 'he', '.', 'investigated', 'in', 'study', '.', 'design', 'exploratory', 'post', 'hoc', 'subgroup', 'analysis', 'of', 'prospective', 'trial', 'performed', '.', 'setting', 'study', 'carried', 'university', 'hospital', '.', 'participant', 'forty-four', 'low-risk', 'cardiac', 'surgical', 'patient', 'examined', '.', 'intervention', 'twenty-two', 'patient', 'received', 'crystalloid', 'solution', ',', 'and', 'treated', 'with', 'balanced', 'he', '..', 'measurement', 'and', 'main', 'result', 'functional', 'renal', 'parameter', 'and', 'structural', 'biomarkers', '-glutathione', 's-transferase', ',', 'kidney', 'injury', 'molecule-', ',', 'liver', 'fatty', 'acid-binding', 'protein', ',', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'investigated', '.', 'volume', 'balance', ',', 'vasopressor', 'dosage', ',', 'blood', 'loss', ',', 'and', 'coagulation', 'parameter', 'compared', '.', 'functional', 'and', 'structural', 'renal', 'parameter', 'not', 'differ', 'group', '(', 'serum', 'creatinine', 'p', '.', ')', '.', 'liver', 'fatty', 'acid-binding', 'protein', 'transiently', 'higher', 'in', 'he', 'group', 'hour', 'postoperatively', '(', 'p', '.', ')', '.', 'no', 'difference', 'in', 'mortality', ',', 'acute', 'kidney', 'injury', ',', 'and', 'need', 'renal', 'replacement', 'therapy', 'observed', '.', 'blood', 'coagulation', 'significantly', 'compromised', 'in', 'he', 'group', 'intensive', 'care', 'unit', 'arrival', '(', 'factor', 'ii', ',', 'p', '.', 'factor', 'x', ',', 'p', '.', 'thrombocyte', ',', 'p', '.', ')', '.', 'blood', 'loss', ',', 'and', 'vasopressor', 'dosage', 'tended', 'to', 'higher', 'in', 'hes-treated', 'patient', 'without', 'significance', '.', 'conclusion', 'overall', ',', 'value', 'and', 'time', 'course', 'of', 'biomarkers', 'used', 'not', 'indicate', 'evidence', 'of', 'mechanism', 'tubular', 'injury', 'caused', 'he', '.']"
Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.,"Ji-Hee Hwang, Ju-Hyung Lee, Jeong-Hwan Hwang, Kyung Min Chung, Eun-Jung Lee, Yong-Joo Yoon, Mi-Kyoung Moon, Ju-Sin Kim, Kyoung-Suk Won, Chang-Seop Lee, Ji-Hee Hwanget al.",2015 Jun,J Korean Med Sci,https://pubmed.ncbi.nlm.nih.gov/26028918/,"Arbekacin, Methicillin-resistant Staphylococcus aureus, Otitis Media, Vancomycin.","['.', 'v', '.', '.', ')', 'and', 'improved', 'clinical', 'efficacy', '(', 'arbekacin', 'vs.', 'vancomycin', '.', 'v', '.', '.', ')', 'not', 'different', 'two', 'group', '.', 'however', ',', 'rate', 'of', 'complication', 'higher', 'in', 'vancomycin', 'group', '(', '.', ')', 'in', 'arbekacin', 'group', '(', '.', ')', '(', 'p.', ')', '.', 'in', 'addition', ',', 'total', 'of', 'adverse', 'reaction', 'observed', 'in', 'vancomycin', 'group', 'two', 'hepatotoxicity', ',', 'one', 'nephrotoxicity', ',', 'eight', 'leukopenia', ',', 'two', 'skin', 'rash', ',', 'and', 'one', 'drug', 'fever', '.', 'suggested', 'arbekacin', 'good', 'alternative', 'drug', 'to', 'vancomycin', 'in', 'treatment', 'of', 'csom', 'caused', 'mrsa', '.']"
Treating perinatal asphyxia with theophylline at birth helps to reduce the severity of renal dysfunction in term neonates.,"Alok Raina, Aakash Pandita, Rekha Harish, Monika Yachha, Ashu Jamwal, Alok Rainaet al.",2016 Oct,Acta Paediatr,https://pubmed.ncbi.nlm.nih.gov/27173369/,No keywords found,"['perinatal', 'asphyxia', 'common', 'neonatal', 'problem', 'and', 'contributes', 'significantly', 'to', 'neonatal', 'morbidity', 'and', 'mortality', '.', 'study', 'designed', 'to', 'determine', 'whether', 'theophylline', 'could', 'prevent', 'or', 'ameliorate', 'renal', 'dysfunction', 'in', 'term', 'neonate', 'with', 'perinatal', 'asphyxia', '.', 'method', 'randomised', 'severely', 'asphyxiated', 'term', 'newborn', 'to', 'receive', 'single', 'dose', 'of', 'mgkg', 'intravenous', 'theophylline', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'first', 'hour', 'of', 'life', '.', 'infant', ""'s"", '-hour', 'fluid', 'intake', ',', 'urine', 'volume', ',', 'serum', 'creatinine', ',', 'creatinine', 'clearance', 'and', 'sodium', 'excretion', 'recorded', 'day', 'one', ',', 'three', 'and', 'five', 'of', 'life', ',', 'starting', 'hour', 'theophylline', 'or', 'placebo', 'infusion', '.', 'result', 'neonate', 'in', 'theophylline', 'group', 'lower', 'serum', 'creatinine', 'level', '(', '.', '.', 'versus', '.', '.', 'p', '.', ')', 'and', 'higher', 'endogenous', 'creatinine', 'clearance', '(', '.', '.', 'versus', '.', '.', 'p', '.', ')', 'placebo', 'group', '.', 'severe', 'renal', 'dysfunction', ',', 'namely', 'acute', 'kidney', 'injury', ',', 'present', 'in', '(', ')', 'of', 'neonate', 'in', 'theophylline', 'group', 'versus', '(', ')', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'single', 'dose', 'of', 'intravenous', 'theophylline', 'administered', 'to', 'term', 'neonate', 'with', 'perinatal', 'asphyxia', 'within', 'first', 'hour', 'of', 'life', 'significantly', 'decreased', 'serum', 'creatinine', 'level', 'and', 'significantly', 'increased', 'creatinine', 'clearance', '.']"
Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.,"Armin Marashizadeh, Hamid Reza Sanati, Parham Sadeghipour, Mohamad Mehdi Peighambari, Jamal Moosavi, Omid Shafe, Ata Firouzi, Ali Zahedmehr, Mohsen Maadani, Farshad Shakerian, Reza Kiani, Bahram Mohebbi, Mohammad Javad Alemzadeh-Ansari, Reza Tahvili, Batoul Naghavi, Armin Marashizadehet al.",2019 Oct,Int Urol Nephrol,https://pubmed.ncbi.nlm.nih.gov/31332700/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'serious', 'complication', 'in', 'patient', 'undergoing', 'diagnostic', 'cardiac', 'angiography', 'or', 'percutaneous', 'coronary', 'intervention', '.', 'aimed', 'to', 'evaluate', 'preventive', 'effect', 'of', 'left', 'ventricular', 'end-diastolic', 'pressure', '(', 'lvedp', ')', '-guided', 'hydration', 'prevention', 'of', 'ci-aki', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', 'undergoing', 'cardiac', 'catheterization', '.', 'method', 'prospective', 'randomized', 'single-blind', 'clinical', 'trial', 'enrolled', 'eligible', 'patient', 'with', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'of', 'egfr', 'mlmin', '.', 'according', 'to', 'level-modified', 'modification', 'of', 'diet', 'in', 'renal', 'disease', 'formula', '(', 'mdrd', ')', 'and', 'stable', 'ischemic', 'heart', 'disease', 'undergoing', 'coronary', 'procedure', '.', 'patient', 'randomly', 'allocated', 'lvedp-guided', 'hydration', 'group', '(', 'n', ')', 'or', 'standard', 'hydration', 'group', '(', 'n', ')', '.', 'ci-aki', 'defined', 'greater', 'or', 'greater', '.', 'mgdl', '(', '.', 'mmoll', ')', 'increase', 'in', 'serum', 'creatinine', 'concentration', 'compared', 'with', 'baseline', 'value', '.', 'hydration', 'with', '.', 'sodium', 'chloride', 'rate', 'of', 'mlkgh', '(', '.', 'mlkgh', 'left', 'ventricular', 'ejection', 'fraction', ')', 'within', 'h', 'given', 'to', 'patient', 'in', 'group', 'procedure', '.', 'in', 'lvedp-guided', 'group', ',', 'hydration', 'infusion', 'rate', 'adjusted', 'according', 'to', 'lvedp', 'level', 'and', 'procedure', '.', 'result', 'incidence', 'of', 'ci-aki', '.', '(', ')', 'in', 'lvedp-guided', 'group', 'v', '.', '(', ')', 'in', 'standard', 'hydration', 'group', '(', 'summary', 'odds', 'ratio', '.', ',', 'ci', '.-', '.', 'p', '.', ')', '.', 'major', 'adverse', 'cardiac', 'event', ',', 'hemodialysis', ',', 'or', 'related', 'death', 'occurred', 'in', 'neither', 'of', 'group', 'hospitalization', 'or', '-day', 'follow-up', '.', 'conclusion', 'in', 'present', 'study', ',', 'lvedp-guided', 'fluid', 'administration', ',', 'comparison', 'with', 'standard', 'hydration', ',', 'failed', 'to', 'offer', 'protection', 'risk', 'of', 'ci-aki', 'in', 'patient', 'with', 'renal', 'insufficiency', 'undergoing', 'coronary', 'angiography', 'with', 'or', 'without', 'percutaneous', 'coronary', 'intervention', '.']"
The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.,"Laurence Weinberg, Michael Hua-Gen Li, Leonid Churilov, Christopher Macgregor, Kent Garrett, Jade Eyles, Rinaldo Bellomo, Laurence Weinberget al.",2021 May 19,PLoS One,https://pubmed.ncbi.nlm.nih.gov/34010324/,No keywords found,"['saline', 'and', 'plasma-lyte', 'different', 'physiochemical', 'content', 'consequently', ',', 'may', 'differently', 'affect', 'patient', ""'"", 'renal', 'function', '.', 'compared', 'effect', 'of', 'fluid', 'therapy', 'with', '.', 'saline', 'and', 'with', 'plasma-lyte', 'renal', 'function', 'assessed', 'creatinine', 'concentration', 'among', 'patient', 'undergoing', 'major', 'surgery', '.', 'method', 'conducted', 'prospective', ',', 'double-blinded', 'cluster', 'crossover', 'trial', 'comparing', 'effect', 'of', 'two', 'fluid', 'major', 'surgery', 'patient', '.', 'primary', 'aim', 'to', 'establish', 'pilot', 'feasibility', ',', 'safety', 'and', 'preliminary', 'efficacy', 'evidence', 'base', 'large', 'interventional', 'trial', 'to', 'establish', 'whether', 'saline', 'or', 'plasma-lyte', 'preferred', 'crystalloid', 'fluid', 'managing', 'major', 'surgery', 'patient', '.', 'primary', 'efficacy', 'outcome', 'proportion', 'of', 'patient', 'with', 'change', 'in', 'renal', 'function', 'assessed', 'creatinine', 'concentration', 'index', 'hospital', 'admission', '.', 'used', 'change', 'in', 'creatinine', 'to', 'define', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'according', 'to', 'rifle', 'criterion', '.', 'result', 'study', 'feasible', 'with', 'patient', 'and', 'clinician', 'acceptance', '.', 'no', 'deviation', 'trial', 'protocol', '.', 'screening', ',', 'allocated', 'patient', 'to', 'saline', 'and', 'to', 'plasma-lyte', '.', 'median', '(', 'iqr', ')', 'volume', 'of', 'intraoperative', 'fluid', 'received', 'ml', '(', ')', 'in', 'group', '.', 'forty-nine', 'saline', 'patient', '(', '.', ')', 'and', 'plasma-lyte', 'patient', '(', '.', ')', 'developed', 'postoperative', 'aki', '(', 'adjusted', 'incidence', 'rate', 'ratio', 'airr', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'no', 'difference', 'observed', 'in', 'development', 'of', 'postoperative', 'complication', '(', 'airr', '.', 'ci', '.-', '.', ')', 'or', 'severity', 'of', 'worst', 'complication', '(', 'airr', '.', 'ci', '.-.', ')', '.', 'median', '(', 'iqr', ')', 'length', 'of', 'hospital', 'stay', 'six', 'day', '(', ')', 'saline', 'group', 'and', 'five', 'day', '(', ')', 'plasma-lyte', 'group', '(', 'airr', '.', 'ci', '.-.', ')', '.', 'no', 'serious', 'adverse', 'event', 'relating', 'to', 'trial', 'fluid', ',', 'fluid', 'crossover', 'or', 'contamination', 'event', '.', 'conclusion', 'study', 'design', 'feasible', 'to', 'support', 'future', 'follow-up', 'larger', 'clinical', 'trial', '.', 'patient', 'treated', 'with', 'saline', 'not', 'demonstrate', 'increased', 'incidence', 'of', 'postoperative', 'aki', '(', 'defined', 'change', 'in', 'creatinine', ')', 'compared', 'to', 'treated', 'with', 'plasma-lyte', '.', 'finding', 'imply', 'clinician', 'reasonably', 'use', 'either', 'solution', 'intraoperatively', 'adult', 'patient', 'undergoing', 'major', 'surgery', '.', 'trial', 'registration', 'registry', 'australian', 'new', 'zealand', 'clinical', 'trial', 'registry', 'actrn', 'url', 'httpswww.anzctr.org.autrialregistrationtrialreview.aspxid', '.']"
"The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.","C Michael Gibson, Mathieu Kerneis, Megan K Yee, Yazan Daaboul, Serge Korjian, Ali Poyan Mehr, Pierluigi Tricoci, John H Alexander, John J P Kastelein, Roxana Mehran, Christoph Bode, Basil S Lewis, Ravindra Mehta, Danielle Duffy, John Feaster, Majdi Halabi, Dominick J Angiolillo, Daniel Duerschmied, Ton Oude Ophuis, Bela Merkely, C Michael Gibsonet al.",2019 Feb:208:81-90.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/30580130/,No keywords found,"['csl', '(', 'apolipoprotein', 'a-i', 'human', ')', 'plasma-derived', 'apolipoprotein', 'a-i', 'developed', 'early', 'reduction', 'of', 'cardiovascular', 'risk', 'following', 'acute', 'myocardial', 'infarction', '(', 'ami', ')', '.', 'safety', 'of', 'csl', 'among', 'ami', 'subject', 'with', 'moderate', ',', 'stage', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'unknown', '.', 'method', 'csl', ',', 'multicenter', ',', 'placebo-controlled', ',', 'parallel-group', ',', 'double-blind', ',', 'randomized', 'phase', 'trial', ',', 'enrolled', 'patient', 'with', 'moderate', 'ckd', 'within', 'day', 'following', 'ami', '.', 'enrollment', 'stratified', 'basis', 'of', 'estimated', 'glomerular', 'filtration', 'rate', 'and', 'presence', 'of', 'diabetes', 'requiring', 'treatment', '.', 'patient', 'randomized', 'in', 'ratio', 'to', 'receive', 'weekly', 'infusion', 'of', 'csl', 'g', 'or', 'placebo', '.', 'co-primary', 'safety', 'end', 'point', 'renal', 'serious', 'adverse', 'event', '(', 'saes', ')', 'and', 'acute', 'kidney', 'injury', ',', 'defined', 'increase', '.', 'moll', 'in', 'baseline', 'serum', 'creatinine', 'hour', ',', 'treatment', 'period', '.', 'result', 'total', 'of', 'patient', 'randomized', '(', 'csl', 'v', 'placebo', ')', '.', 'no', 'increase', 'in', 'renal', 'saes', 'observed', 'in', 'csl', 'group', 'compared', 'with', 'placebo', '(', 'csl', '.', ',', 'placebo', '.', ')', '.', 'similarly', ',', 'no', 'increase', 'in', 'acute', 'kidney', 'injury', 'event', 'observed', '(', 'csl', '.', ',', 'placebo', '.', ')', '.', 'rate', 'of', 'saes', 'similar', 'group', '.', 'csl', 'administration', 'resulted', 'in', 'increase', 'in', 'apoa-i', 'and', 'cholesterol', 'efflux', 'similar', 'to', 'observed', 'in', 'patient', 'with', 'ami', 'and', 'normal', 'renal', 'function', 'or', 'stage', 'ckd', 'enrolled', 'in', 'apoa-i', 'event', 'reducing', 'in', 'ischemic', 'syndrome', 'trial', '.', 'conclusion', 'result', 'demonstrate', 'acceptable', 'safety', 'of', '-g', 'dose', 'of', 'csl', 'among', 'ami', 'subject', 'with', 'moderate', 'stage', 'ckd', 'and', 'support', 'inclusion', 'of', 'patient', 'in', 'phase', 'cardiovascular', 'outcome', 'trial', 'powered', 'to', 'assess', 'efficacy', '.']"
Effects of probucol on contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.,"Yong Wang, Yun Shi, Xuesheng Xu, Wenkun Ge, Shuo Yang, Chengzhi Lu, Yong Wanget al.",2019 Jun,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/31232940/,No keywords found,"['study', 'performed', 'to', 'explore', 'effect', 'of', 'probucol', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ciaki', ')', 'in', 'patient', 'with', 'coronary', 'heart', 'disease', 'undergoing', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', '.', 'method', 'in', 'total', ',', 'patient', 'undergoing', 'pci', 'randomly', 'assigned', 'to', 'either', 'control', 'group', '(', 'hydration', 'hour', 'to', 'hour', 'contrast', 'administration', 'n', ')', 'or', 'probucol', 'group', '(', 'hydration', 'plus', 'probucol', 'mg', 'twice', 'daily', 'day', 'and', 'day', 'operation', 'n', ')', '.', 'primary', 'endpoint', 'occurrence', 'of', 'serum', 'creatinine', '(', 'scr', ')', '-based', 'ciaki', ',', 'defined', 'absolute', 'increase', 'in', 'scr', '.', 'mgdl', '(', '.', 'moll', ')', 'or', 'relative', 'increase', 'baseline', 'within', 'to', 'hour', 'exposure', 'to', 'contrast', 'medium', '.', 'secondary', 'outcome', 'composite', 'variation', 'in', 'scr', ',', 'blood', 'urea', 'nitrogen', '(', 'bun', ')', ',', 'creatinine', 'clearance', 'rate', '(', 'ccr', ')', 'within', 'to', 'hour', ',', 'and', 'major', 'adverse', 'event', 'hospitalization', 'or', '-day', 'follow-up', 'period', 'pci', '.', 'result', 'overall', 'incidence', 'of', 'scr-based', 'ciaki', '.', '(', ')', '.', '(', ')', 'in', 'control', 'group', 'and', '.', '(', ')', 'in', 'probucol', 'group', '(', '.', ',', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'occurrence', 'rate', 'of', 'major', 'adverse', 'event', 'hospitalization', 'or', '-day', 'follow-up', 'period', 'pci', 'group', '.', 'multivariate', 'logistic', 'regression', 'analysis', 'showed', 'probucol', 'not', 'independent', 'protective', 'factor', 'ciaki', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', '.', 'however', ',', 'hydration', 'independent', 'protective', 'factor', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'probucol', 'not', 'effectively', 'reduce', 'incidence', 'of', 'ciaki', 'anti-inflammatory', 'and', 'antioxidative', 'stress', 'effect', '.']"
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant.,"Prashant Hiwarkar, Persis Amrolia, Ponni Sivaprakasam, Su Han Lum, Hemalatha Doss, Ciara O'Rafferty, Toni Petterson, Katharine Patrick, Juliana Silva, Mary Slatter, Sarah Lawson, Kanchan Rao, Colin Steward, Adam Gassas, Paul Veys, Robert Wynn                              ;, United Kingdom Paediatric Bone Marrow Transplant Group, Prashant Hiwarkaret al.",2017 Apr 6,Blood,https://pubmed.ncbi.nlm.nih.gov/28153824/,No keywords found,"['cidofovir', 'preemptively', 'used', 'controlling', 'adenoviremia', 'and', 'preventing', 'disseminated', 'viral', 'disease', 'in', 'hematopoietic', 'cell', 'transplant', '(', 'hct', ')', 'recipient', 'not', 'lead', 'to', 'resolution', 'of', 'viremia', 'without', 't-cell', 'immune-reconstitution', '.', 'lipid-conjugated', 'prodrug', 'of', 'cidofovir', ',', 'brincidofovir', ',', 'improved', 'oral', 'bioavailability', 'and', 'achieves', 'higher', 'intracellular', 'concentration', 'of', 'active', 'drug', '.', 'present', 'retrospective', 'multicenter', 'data', 'comparing', 'kinetics', 'of', 'viremia', 'and', 'toxicity', 'following', 'preemptive', 'treatment', 'with', 'and', 'brincidofovir', 'in', 'child', 'and', 'adolescent', 'diagnosed', 'with', 'hct-related', 'adenoviremia', '.', 'forty-one', 'episode', '(', 'brincidofovir', 'cidofovir', ')', 'of', 'antiviral', 'therapy', 'observed', 'in', 'patient', '.', 'group', 'comparable', 'immune-reconstitution', 'and', 'viral', 'burden', '.', 'major', '(', 'log-reduction', 'in', 'week', 'n', ')', 'and', 'minor', '(', 'to', 'log-reduction', 'in', 'week', 'n', ')', 'virological', 'response', 'observed', 'in', '(', ')', 'brincidofovir', 'episode', 'compared', 'to', '(', ')', 'major', 'virological', 'response', 'with', 'cidofovir', '(', 'p', '.', ')', '.', 'brincidofovir', 'mediated', 'major', 'response', 'in', 'of', 'cidofovir-unresponsive', 'patient', 'and', 'resulted', 'in', 'complete', 'response', '(', 'cr', ')', 'despite', 'significant', 'lymphopenia', '(', 'brincidofovir', 'v', 'cidofovir', 'cr', '(', ')', 'v', '(', ')', 'median', 'lymphocyte', 'count', 'l', 'v', 'l', 'p', '.', ')', '.', 'one', 'patient', 'experienced', 'abdominal', 'cramp', 'and', 'diarrhea', 'necessitating', 'interruption', 'of', 'brincidofovir', 'and', 'none', 'developed', 'nephrotoxicity', 'with', 'brincidofovir', '.', 'thus', ',', 'brincidofovir', 'well-tolerated', 'and', 'highly', 'efficacious', 'in', 'controlling', 'adenoviremia', 'lymphopenic', 'phase', 'of', 'hct', '.']"
A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer.,"Kodai Kawamura, Hidekazu Matsushima, Hiroshi Sakai, Akira Iwashima, Sukeyuki Nakamura, Tohru Kojima, Shinichi Sasaki, Takehiko Shigenaga, Ichiro Natsume, Takaaki Sasaki, Yoshinobu Ohsaki, Kentaro Iwanaga, Koichi Nishi, Yoichiro Mitsuishi, Hirokazu Taniguchi, Kazuhiro Sato, Mitsugu Yamauchi, Motowo Nakajima, Kazuhisa Takahashi, Kodai Kawamuraet al.",2022,Oncology,https://pubmed.ncbi.nlm.nih.gov/36099876/,No keywords found,"['cisplatin-based', 'chemotherapy', 'established', 'in', ',', 'and', 'improved', 'development', 'of', 'short', 'hydration', 'protocol', 'in', 'lung', 'cancer', 'therapy', '.', 'however', ',', 'cisplatin-based', 'chemotherapy', 'still', 'associated', 'with', 'renal', 'toxicity', '.', '-aminolevulinic', 'acid', '(', '-ala', ')', 'with', 'sodium', 'ferrous', 'citrate', '(', 'sfc', ')', 'known', 'to', 'mitochondrial', 'activator', 'and', 'heme', 'oxygenase-', '(', 'ho-', ')', 'inducer', ',', '-ala', 'with', 'sfc', 'speculated', 'to', 'mitigate', 'cisplatin-induced', 'renal', 'inflammation', '.', 'method', 'investigated', 'effect', 'of', 'oral', 'administration', 'of', '-ala', 'with', 'sfc', 'preventing', 'cisplatin-based', 'nephrotoxicity', 'in', 'patient', 'with', 'lung', 'cancer', 'and', 'evaluated', 'benefit', 'patient', 'received', 'cisplatin-based', 'chemotherapy', '.', 'primary', 'endpoint', 'significance', 'of', 'difference', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'of', 'patient', 'administered', '-ala', 'with', 'sfc', 'and', 'given', 'placebo', 'course', 'of', 'chemotherapy', '.', 'difference', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'two', 'group', 'also', 'evaluated', 'secondary', 'endpoint', '.', 'result', 'double-blind', ',', 'randomized', 'two-arm', 'study', 'conducted', 'medical', 'facility', 'in', 'japan', 'male', 'and', 'female', 'patient', 'with', 'lung', 'cancer', 'received', 'cisplatin-based', 'chemotherapy', 'age', 'of', 'and', 'year', 'included', 'in', 'study', '.', 'compliance', 'rate', 'greater', 'in', 'primary', 'assessment', 'and', 'subsequent', 'drug', 'administration', 'period', '.', 'enrolled', 'patient', 'completed', 'four', 'cycle', 'of', 'cisplatin-based', 'chemotherapy', 'with', 'short', 'hydration', '.', 'average', 'level', 'of', 'scr', 'day', 'of', 'course', '.', 'mgdl', 'in', 'group', 'treated', 'with', '-ala', 'and', 'sfc', 'and', '.', 'mgdl', 'in', 'placebo', 'group', ',', 'respectively', ',', 'and', 'scr', 'in', 'test', 'group', 'significantly', 'lower', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'in', 'addition', ',', 'egfr', 'significantly', 'higher', 'in', 'spp-', 'group', 'in', 'placebo', 'group', 'to', 'day', 'of', 'course', '(', '.', 'and', '.', 'mlmin', '.', ',', 'respectively', ',', 'p', '.', ')', 'and', 'kept', 'better', 'even', 'last', 'administration', 'of', 'study', 'drug', '(', '.', 'and', '.', 'mlmin', '.', ',', 'respectively', ',', 'p', '.', ')', '.', 'conclusion', 'oral', 'administration', 'of', '-ala', 'with', 'sfc', 'beneficial', 'to', 'patient', 'undergoing', 'cisplatin-based', 'chemotherapy', 'lung', 'cancer', 'with', 'short', 'hydration', '.']"
The efficacy of theophylline in preventing cisplatin-related nephrotoxicity in patients with cancer.,"Lutfiye Derya Karademir, Fatma Dogruel, Ismail Kocyigit, Cevat Yazici, Aydin Unal, Murat Hayri Sipahioglu, Oktay Oymak, Bulent Tokgoz, Lutfiye Derya Karademiret al.",2016 Jun,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/27049176/,No keywords found,"['cisplatin', 'potent', 'antineoplastic', 'agent', 'used', 'and', 'major', 'limiting', 'side', 'effect', 'nephrotoxicity', '.', 'aim', 'of', 'study', 'early', 'detection', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'with', 'biomarkers', 'and', 'investigation', 'of', 'potential', 'nephron-protective', 'effect', 'of', 'theophylline', '.', 'method', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'cystatin', 'c', 'measured', 'th', 'day', 'of', 'treatment', 'in', 'of', 'patient', '.', 'in', 'addition', ',', 'parameter', 'measured', 'repeatedly', 'administration', 'of', 'cisplatin', ',', 'nd', 'hour', ',', 'th', 'and', 'th', 'day', '.', 'patient', 'sixty', 'patient', 'planned', 'to', 'receive', 'cisplatin', 'first', 'time', 'included', 'in', 'study', '.', 'patient', 'divided', 'two', 'group', 'group', '(', 'n', ')', '(', 'standard', 'treatment', 'arm', ')', 'and', 'group', 'ii', '(', 'n', ')', '(', 'theophylline', 'arm', ')', '.', 'result', 'in', 'group', 'administration', 'of', 'cisplatin', ',', 'gfr', 'showed', 'significant', 'decrease', 'within', 'time', '(', 'p', '.', ')', '.', 'urine', 'ngal', 'level', 'significantly', 'high', 'h', 'of', 'cisplatin', 'administration', '(', 'p', '.', ')', ',', 'no', 'significant', 'difference', 'observed', 'group', '.', 'however', ',', 'timegroup', 'effect', 'considered', 'together', ',', 'higher', 'ngal', 'level', 'detected', 'in', 'group', 'not', 'receiving', 'theophylline', '(', 'p', '.', ')', '.', 'day', 'of', 'cisplatin', 'administration', ',', 'urine', 'protein', 'level', 'significantly', 'higher', 'in', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'result', 'showed', 'urine', 'ngal', 'level', 'superior', 'biomarker', 'compared', 'to', 'serum', 'creatinine', 'and', 'serum', 'cystatin', 'c', 'in', 'detection', 'of', 'early', 'aki', '.', 'theophylline', 'found', 'not', 'to', 'bring', 'complete', 'protection', 'kidney', ',', 'less', 'nephrotoxicity', 'developed', 'compared', 'to', 'group', 'not', 'receiving', 'theophylline', '.']"
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.,"Ho Namkoong, Kozo Morimoto, Tomoyasu Nishimura, Hiromu Tanaka, Hiroaki Sugiura, Yoshitake Yamada, Atsuko Kurosaki, Takanori Asakura, Shoji Suzuki, Hiroshi Fujiwara, Kazuma Yagi, Makoto Ishii, Sadatomo Tasaka, Tomoko Betsuyaku, Yoshihiko Hoshino, Atsuyuki Kurashima, Naoki Hasegawa, Ho Namkoonget al.",2016 Aug 9:16:396.,BMC Infect Dis,https://pubmed.ncbi.nlm.nih.gov/27506679/,No keywords found,"['mycobacterium', 'abscessus', '(', 'm.', 'abscessus', ')', 'pulmonary', 'disease', 'refractory', 'chronic', 'infectious', 'disease', '.', 'option', 'treating', 'm.', 'abscessus', 'pulmonary', 'disease', 'limited', ',', 'especially', 'in', 'outpatient', 'setting', '.', 'among', 'parenteral', 'antibiotic', 'm.', 'abscessus', ',', 'intravenous', 'amikacin', '(', 'amk', ')', 'expected', 'to', 'effective', 'outpatient', 'antimicrobial', 'therapy', '.', 'study', 'evaluated', 'clinical', 'efficacy', 'and', 'safety', 'of', 'intravenous', 'amk', 'therapy', 'in', 'outpatient', 'with', 'm.', 'abscessus', 'pulmonary', 'disease', '.', 'method', 'retrospective', 'chart', 'review', 'of', 'case', 'of', 'm.', 'abscessus', 'pulmonary', 'disease', 'evaluated', 'patient', 'background', 'data', ',', 'amk', 'dosage', 'and', 'duration', ',', 'sputum', 'conversion', ',', 'clinical', 'symptom', 'radiological', 'finding', ',', 'and', 'adverse', 'event', '.', 'm.', 'massiliense', 'excluded', 'basis', 'of', 'multiplex', 'pcr', 'assay', '.', 'result', 'thirteen', 'patient', '(', 'men', 'and', 'woman', ')', 'with', 'm.', 'abscessus', 'pulmonary', 'disease', 'enrolled', 'hospital', '.', 'median', 'age', 'initiation', 'of', 'intravenous', 'amk', 'treatment', 'year', '(', 'range', '-', 'year', ')', '.', 'patient', 'received', 'median', 'amk', 'dose', 'of', '.', 'mgkg', '(', 'range', '.-', '.', 'mgkg', ')', 'median', 'duration', 'of', 'month', '(', 'range', '-', 'month', ')', '.', 'addition', 'of', 'intravenous', 'amk', 'led', 'to', 'sputum', 'conversion', 'in', 'of', 'patient', ',', 'and', 'patient', 'continued', 'to', 'negative', 'sputum', 'status', 'year', 'treatment', '.', 'approximately', 'half', 'of', 'patient', 'showed', 'improvement', 'chest', 'high-resolution', 'computed', 'tomography', '.', 'no', 'severe', 'adverse', 'event', 'ototoxicity', ',', 'vestibular', 'toxicity', ',', 'and', 'renal', 'toxicity', '.', 'conclusion', 'thrice', 'weekly', 'intravenous', 'amk', 'administration', 'in', 'outpatient', 'setting', 'effective', 'and', 'safe', 'patient', 'with', 'm.', 'abscessus', 'pulmonary', 'disease', '.']"
"Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction.","C Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, John H Alexander, Philippe G Steg, A Michael Lincoff, John J P Kastelein, Roxana Mehran, Denise D'Andrea, Bela Merkely, Maciej Zarebinski, Ton Oude Ophius, Robert A Harrington, C Michael Gibsonet al.",2016 Oct:180:22-8.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/27659879/,No keywords found,"['despite', 'aggressive', 'pharmacotherapy', 'and', 'stenting', ',', 'residual', 'risk', 'of', 'major', 'adverse', 'cardiovascular', 'event', 'among', 'patient', 'with', 'acute', 'coronary', 'syndrome', '.', 'high-density', 'lipoprotein', '(', 'hdl', ')', 'major', 'target', 'secondary', 'acute', 'coronary', 'syndrome', 'prevention', 'however', ',', 'better', 'understanding', 'of', 'physiologic', 'function', 'of', 'hdl', 'demonstrated', 'high', 'cholesterol', 'efflux', 'capacity', ',', 'rather', 'high', 'hdl', 'concentration', 'alone', ',', 'may', 'critical', 'to', 'improving', 'outcome', '.', 'csl', ',', 'reconstituted', ',', 'infusible', 'human', 'apolipoprotein', 'a-i', ',', 'demonstrated', 'to', 'increase', 'cholesterol', 'efflux', 'capacity', 'and', 'to', 'protective', 'effect', 'in', 'experimental', 'model', 'of', 'atherosclerotic', 'cardiovascular', 'disease', '.', 'design', 'aegis-i', 'trial', '(', 'clinicaltrials.govnct', ')', 'phase', 'b', ',', 'multicenter', ',', 'randomized', ',', 'placebo-controlled', ',', 'dose-ranging', 'clinical', 'trial', 'to', 'evaluate', 'hepatic', 'and', 'renal', 'safety', 'of', 'multiple', 'administration', 'of', 'dos', 'of', 'csl', 'among', 'subject', 'with', 'acute', 'myocardial', 'infarction', '(', 'ami', ')', '.', 'approximately', ',', 'subject', '(', 'per', 'treatment', 'group', ')', 'with', 'either', 'normal', 'renal', 'function', 'or', 'mild', 'renal', 'impairment', 'enrolled', 'to', 'day', 'ami', 'and', 'stratified', 'renal', 'function', 'and', 'randomized', 'in', 'ratio', 'to', 'either', 'of', 'dos', 'of', 'csl', '(', 'either', 'g', 'or', 'g', ')', 'or', 'placebo', 'weekly', '-hour', 'infusion', 'course', 'of', 'consecutive', 'week', '.', 'coprimary', 'safety', 'endpoint', 'incidence', 'of', 'hepatic', 'and', 'renal', 'toxicity', ',', 'defined', 'either', 'confirmed', 'alt', 'uln', ',', 'total', 'bilirubin', 'uln', ',', 'serum', 'creatinine', '.baseline', 'value', ',', 'or', 'new', 'requirement', 'renal', 'replacement', 'therapy', 'end', 'of', 'active', 'treatment', 'period', '.', 'summary', 'aegis-i', 'trial', 'characterize', 'safety', 'profile', 'of', 'csl', ',', 'reconstituted', 'formulation', 'of', 'apolipoprotein', 'a-i', ',', 'and', 'assess', 'administration', 'to', 'patient', 'with', 'recent', 'ami', 'associated', 'with', 'clinically', 'significant', 'alteration', 'in', 'either', 'liver', 'or', 'kidney', 'function', 'compared', 'with', 'placebo', '.']"
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.,"Josep-Maria Ribera, Olga García, Albert Oriol, Cristina Gil, Pau Montesinos, Teresa Bernal, José González-Campos, Esperanza Lavilla, Jordi Ribera, Salut Brunet, María-Pilar Martínez, Mar Tormo, Eulàlia Genescà, Pere Barba, Josep Sarrà, María-Carmen Monteserín, Beatriz Soria, Mercedes Colorado, Antònia Cladera, Antoni García-Guiñón, María Calbacho, Alfons Serrano, Xavier Ortín, María Pedreño, Maria-Luz Amigo, Lourdes Escoda, Evarist Feliu                              ;, PETHEMA Group, Spanish Society of Hematology, Josep-Maria Riberaet al.",2016 Feb:41:12-20.,Leuk Res,https://pubmed.ncbi.nlm.nih.gov/26686475/,No keywords found,"['prognosis', 'of', 'acute', 'lymphoblastic', 'leukemia', '(', ')', 'poor', 'in', 'older', 'adult', 'and', 'elderly', 'patient', ',', 'and', 'subtype-oriented', 'prospective', 'trial', 'scarce', 'in', 'patient', '.', 'present', 'result', 'of', 'three', 'prospective', 'parallel', 'subtype-oriented', 'protocol', 'in', 'fit', 'patient', 'older', 'year', '.', 'patient', 'and', 'method', 'in', ',', 'three', 'prospective', 'phase', 'ii', 'trial', 'in', 'patient', 'older', 'year', 'activated', 'allold', 'philadephia', '(', 'ph', ')', 'chromosome-negative', ',', 'alloph', 'ph-positive', ',', 'and', 'burkimab', 'mature', 'b-all', '.', 'early', 'death', '(', 'ed', ')', ',', 'complete', 'remission', '(', 'cr', ')', ',', 'disease-free', 'survival', '(', 'dfs', ')', ',', 'overall', 'survival', '(', 'o', ')', 'and', 'toxicity', 'analyzed', '.', 'result', ',', 'and', 'patient', 'allold', ',', 'alloph', 'and', 'burkimab', 'trial', ',', 'respectively', ',', 'evaluable', '.', 'cr', ',', 'and', ',', 'with', 'ed', 'rate', 'of', ',', 'and', ',', 'respectively', '.', 'median', 'of', 'dfs', 'and', 'month', 'allold', 'and', 'alloph', 'protocol', ',', 'not', 'achieved', 'in', 'burkimab', 'trial', '(', 'p.', ')', ',', 'and', 'median', 'o', ',', 'and', 'month', ',', 'respectively', '(', 'p.', ')', '.', 'neutropenia', ',', 'thrombocytopenia', 'and', 'infection', 'less', 'frequent', 'in', 'alloph', 'trial', 'vs.', 'allold', 'and', 'burkimab', 'trial', ',', 'and', 'renal', 'toxicity', 'and', 'mucositis', 'frequent', 'in', 'burkimab', 'trial', 'vs.', 'allold', 'and', 'alloph', 'trial', '.', 'ecog', 'score', 'and', 'wbc', 'count', 'prognostic', 'significance', 'o', 'in', 'alloph', 'and', 'burkimab', 'trial', ',', 'whereas', 'no', 'prognostic', 'factor', 'identified', 'in', 'allold', 'protocol', '.', 'conclusion', 'subtype-oriented', 'treatment', 'impact', 'in', 'outcome', 'of', 'older', 'adult', 'with', '.', 'poorest', 'outcome', 'observed', 'in', 'ph-negative', 'non-mature', 'b-cell', 'patient', ',', 'improvement', 'in', 'therapy', 'clearly', 'needed', '.']"
Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study.,"Sanjeev Khera, Deepti Mahajan, Kapil Barbind, Sandeep Dhingra, Sanjeev Kheraet al.",2023 Apr,Cancer Chemother Pharmacol,https://pubmed.ncbi.nlm.nih.gov/36951972/,No keywords found,"['hydration', 'starting', 'high-dose', 'methotrexate', '(', 'hd-mtx', ')', 'ensures', 'good', 'renal', 'perfusion', 'and', 'alkaline', 'urinary', 'ph', '.', 'duration', 'of', 'pre-hydration', 'not', 'uniform', 'across', 'protocol', '.', 'compared', '-h', 'versus', '-h', 'of', 'pre-hydration', 'hd-mtx', 'therapy', 'in', 'childhood', 'acute', 'lymphoblastic', 'leukaemia', '(', ')', 'centre', 'serial', 'mtx', 'level', 'monitoring', 'not', 'feasible', '.', 'method', 'randomised', 'cross-over', 'study', 'consecutively', 'enrolled', 'child', 'year', 'with', 'receiving', 'hd-mtx', '.', 'child', 'with', 'pre-existing', 'renal', 'disease', 'or', 'exposed', 'to', 'nephrotoxic', 'drug', 'excluded', '.', 'two', 'group', 'receiving', '-h', 'versus', '-h', 'pre-hydration', 'alternate', 'basis', 'in', 'patient', '(', 'exposed', 'to', 'four', 'cycle', 'of', '-', 'gm', 'of', 'hd-mtx', ')', 'compared', 'hd-mtx', 'induced', 'nephrotoxicity', '(', 'primary', 'outcome', ')', 'and', 'hd-mtx', 'toxicity', '(', 'hmt', ')', 'per', 'common', 'terminology', 'criterion', 'adverse', 'event', '(', 'ctcae-.', ')', '.', 'hd-mtx', 'administered', 'h', 'per', 'bfm-protocol-', '.', 'solitary', 'mtx', 'level', '-h', '(', 'mtx', ')', 'outsourced', 'and', 'leucovorin', '(', 'lv', ')', 'started', 'h', 'mgmdose', '-', 'dos', '-hourly', 'depending', 'mtx', '.', 'hydration', 'fluid', 'dextrose', 'normal', 'saline', 'with', 'sodium-bicarbonate', 'and', 'administered', 'till', 'last', 'lv', 'dose', '.', 'result', 'total', 'hd-mtx', 'cycle', 'in', 'patient', '(', 'age', 'range', '-', 'month', ')', 'evaluated', '.', 'nephrotoxicity', '(', '.', ')', 'in', '-h', 'versus', '(', '.', ')', 'in', '-h', 'and', 'hmt', 'incidence', 'comparable', 'in', 'two', 'pre-hydration', 'group', '.', 'median', 'mtx', 'level', 'not', 'affected', 'duration', 'of', 'hydration', 'irrespective', 'of', 'administered', 'dose', 'of', 'hd-mtx', '.', 'median', 'serum', 'creatinine', 'baseline', ',', 'post-pre-hydration', 'and', '-h', 'post', 'start', 'of', 'hd-mtx', 'comparable', '.', 'conclusion', 'reduction', 'of', 'pre-hydration', 'duration', 'not', 'affect', 'hd-mtx', 'induced', 'nephrotoxicity', 'and', 'mtx', 'level', 'in', 'child', 'year', '.']"
"Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.","Ping Liu, Blair Capitano, Amy Stein, Ali A El-Solh, Ping Liuet al.",2017 May 22,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/28532398/,No keywords found,"['primary', 'objective', 'of', 'study', 'to', 'assess', 'whether', 'baseline', 'renal', 'function', 'impact', 'treatment', 'outcome', 'of', 'linezolid', 'and', 'vancomycin', '(', 'with', 'dose-optimized', 'regimen', ')', 'methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', 'pneumonia', '.', 'method', 'conducted', 'retrospective', 'cohort', 'analysis', 'of', 'data', 'generated', 'prospective', ',', 'randomized', ',', 'controlled', 'clinical', 'trial', '(', 'nct', ')', '.', 'analysis', 'included', 'patient', 'with', 'culture-proven', 'mrsa', 'pneumonia', '.', 'baseline', 'renal', 'function', 'stratified', 'based', 'creatinine', 'clearance', '.', 'clinical', 'and', 'microbiological', 'success', 'rate', 'and', 'presence', 'of', 'nephrotoxicity', 'assessed', 'end', 'of', 'treatment', '(', 'eot', ')', 'and', 'end', 'of', 'study', '(', 'eos', ')', '.', 'multivariate', 'logistic', 'regression', 'analysis', 'of', 'baseline', 'patient', 'characteristic', ',', 'including', 'treatment', ',', 'performed', 'to', 'identify', 'independent', 'predictor', 'of', 'efficacy', '.', 'vancomycin', 'concentration', 'analyzed', 'using', 'nonlinear', 'mixed-effects', 'modeling', 'approach', '.', 'relationship', 'vancomycin', 'exposure', ',', 'pharmacokinetic-pharmacodynamic', 'index', '(', 'trough', 'concentration', ',', 'area', 'curve', '-h', 'interval', 'auc-', ',', 'and', 'auc-mic', ')', 'and', 'efficacynephrotoxicity', 'assessed', 'in', 'mrsa', 'pneumonia', 'patient', 'using', 'univariate', 'logistic', 'regression', 'or', 'cox', 'proportional', 'hazard', 'regression', 'analysis', 'approach', '.', 'result', 'controlling', 'use', 'of', 'vasoactive', 'agent', ',', 'choice', 'of', 'antibiotic', 'therapy', 'and', 'bacteremia', ',', 'baseline', 'renal', 'function', 'not', 'correlated', 'with', 'clinical', 'and', 'microbiological', 'success', 'in', 'mrsa', 'pneumonia', 'either', 'end', 'of', 'treatment', 'or', 'end', 'of', 'study', 'treatment', 'group', '.', 'no', 'positive', 'association', 'identified', 'vancomycin', 'exposure', 'and', 'efficacy', 'in', 'patient', '.', 'higher', 'vancomycin', 'exposure', 'correlated', 'with', 'increased', 'risk', 'of', 'nephrotoxicity', '(', 'e.g.', ',', 'hazard', 'ratio', 'confidence', 'interval', 'gml', 'increase', 'in', 'trough', 'concentration', '.', '.', ',', '.', ')', '.', 'conclusion', 'in', 'non-dialysis', 'patient', ',', 'baseline', 'renal', 'function', 'not', 'impact', 'difference', 'in', 'efficacy', 'or', 'nephrotoxicity', 'with', 'treatment', 'of', 'linezolid', 'versus', 'vancomycin', 'in', 'mrsa', 'pneumonia', '.']"
Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy.,"Harleen Walia, Parul Sharma, Navneet Singh, Siddharth Sharma, Harleen Waliaet al.",2022 Mar,Xenobiotica,https://pubmed.ncbi.nlm.nih.gov/35445643/,"Phase II enzymes, lung cancer, polymorphism, risk, toxicity.","['genetic', 'polymorphism', 'of', 'drug-metabolising', 'enzyme', 'nqo', ',', 'sulta', ',', 'ephx', ',', 'and', 'nat', 'alters', 'activity', 'hamper', 'detoxification', 'and', 'disposal', 'of', 'chemotherapeutic', 'compound', '.', 'thus', ',', 'in', 'present', 'study', ',', 'comprehensively', 'investigated', 'association', 'snp', 'of', 'phase', 'ii', 'detoxifying', 'gene', 'and', 'relationship', 'towards', 'platinum-induced', 'toxicity', 'of', 'lung', 'cancer', 'patients.nqo', '(', 'c', ')', ',', 'sulta', '(', 'arg', ')', ',', 'ephx', '(', 'tyrhis', ',', 'hisarg', ')', ',', 'and', 'nat', '(', 'c', ',', 'g', ',', 'g', ',', 'g', ')', 'evaluated', 'in', 'study', 'associated', 'adverse', 'event', 'caused', 'due', 'to', 'administration', 'of', 'platinum-based', 'chemotherapy', 'to', 'lung', 'cancer', 'patients.for', 'nqo', 'c', 'polymorphism', ',', 'tt', 'genotype', 'showed', 'reduced', 'risk', 'of', 'constipation', '(', 'or', '.', ',', 'p', '.', ')', 'and', 'anorexia', '(', 'or', '.', ',', 'p', '.', ')', '.', 'sulta', 'arghis', ',', 'heterozygous', 'genotype', '(', 'arghis', ')', '(', 'aor', '.', ',', 'p', '.', ')', 'and', 'combined', 'genotype', '(', 'arghis', 'hishis', ')', 'not', 'associated', 'with', 'increased', 'risk', 'of', 'nephrotoxicity', '(', 'aor', '.', ',', 'p', '.', ')', '.', 'nat', ',', 'heterozygous', '(', 'nat', ')', 'and', 'combined', 'genotype', '(', 'nat', ')', 'nat', 'polymorphism', 'exhibit', '.', 'fold', '(', 'p', '.', ')', ',', 'and', 'two-folds', '(', 'p', '.', ')', 'increased', 'risk', 'of', 'hematological', 'toxicity', '.', 'heterozygous', '(', 'aor', '.', ',', 'p', '.', ')', 'and', 'variant', 'genotype', '(', 'aor', '.', ',', 'p', '.', ')', 'natc', 'decreased', 'risk', 'hematological', 'toxicity', '.', 'heterozygous', 'genotype', 'nat', 'polymorphism', 'showed', 'two-fold', 'increased', 'risk', 'developing', 'thrombocytopenia.this', 'study', 'provides', 'association', 'of', 'nat', 'polymorphic', 'variant', 'in', 'predicting', 'haematological', 'toxicity', '.']"
"Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.","Marquita Camilleri, Maria Cuadrado, Elizabeth Phillips, William Wilson, Richard Jenner, Gavin Pang, Sumaiya Kamora, Matthew Streetly, Rakesh Popat, Ceri Bygrave, Roger Owen, James Cavenagh, Mike Chapman, Jonathan Sive, Lydia Eccersley, Michael Sheaff, Reuben Benjamin, Karthik Ramasamy, Gordon Cook, Andres Virchis, Selina J Chavda, Laura Clifton-Hadley, Marie Anne Scully, Kwee Yong, Marquita Camilleriet al.",2021 May,Br J Haematol,https://pubmed.ncbi.nlm.nih.gov/33650100/,"carfilzomib, clinical trials, myeloma, thrombocytopenia, thrombotic haemolytic anaemias.","['aggressive', 'hypertension', 'management', ',', 'carfilzomib', 'step-up', 'dosing', '(', 'mgm', 'day', ')', 'start', 'of', 'maintenance', 'dose', 'escalation', 'to', 'mgm', 'maximum', ',', 'and', 'adding', 'mg', 'dexamethasone', 'premedication', 'to', 'maintenance', 'carfilzomib', 'infusion', '.', 'no', 'tma', 'event', 'occurred', 'maintenance', 'following', 'amendment', 'and', 'tma', 'incidence', 'reduced', 'to', 'per', 'patient', 'cycle', '.']"
Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (50 mg/m2) Combination Chemotherapy.,"Yoshihiro Yamamoto, Kazushi Watanabe, Ikuto Tsukiyama, Hiromitsu Yabushita, Katsuhiko Matsuura, Akihiko Wakatsuki, Yoshihiro Yamamotoet al.",2016 Apr,Anticancer Res,https://pubmed.ncbi.nlm.nih.gov/27069173/,No keywords found,"['aimed', 'to', 'assess', 'whether', 'efficacy', 'of', 'pre-hydration', 'with', 'meq', 'magnesium', 'prevents', 'cisplatin-induced', 'nephrotoxicity', 'in', 'cisplatin', 'regimen', '(', 'dosage', 'mgm', '(', ')', 'or', ')', 'gynecological', 'cancer', '.', 'patient', 'and', 'method', 'historical', ',', 'prospective', 'cohort', 'study', 'compared', 'nephrotoxicity', 'in', 'patient', 'received', 'pre-hydration', 'with', 'or', 'without', 'magnesium', 'sulfate', '(', 'mg-hydration', 'group', ',', 'n', 'non-mg-hydration', 'group', ',', 'n', ')', '.', 'used', 'serum', 'creatinine', '(', 'scr', ')', ',', 'creatinine', 'clearance', '(', 'ccr', ')', 'and', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', 'of', 'kidney', 'function', 'and', 'end-stage', 'kidney', 'disease', '(', 'rifle', ')', 'criterion', '.', 'result', 'change', 'of', 'scr', 'and', 'ccr', 'in', 'mg-hydration', 'group', 'higher', 'in', 'non-mg-hydration', 'group', '.', 'based', 'rifle', 'criterion', ',', 'number', 'of', 'moderate', 'renal', 'dysfunction', 'patient', 'classified', '``', 'risk', ""''"", 'in', 'mg-hydration', 'group', 'significantly', 'lower', 'in', 'non-mg-hydration', 'group', '(', 'mg-hydration', 'group', '.', 'non-mg-hydration', 'group', '.', 'p.', ')', '.', 'serum', 'magnesium', 'level', 'in', 'mg-hydration', 'group', 'significantly', 'declined', 'chemotherapy', '(', 'p.', ')', '.', 'conclusion', 'found', 'meq', 'magnesium', 'pre-hydration', 'provided', 'nephroprotective', 'effect', 'in', 'patient', 'receiving', 'cisplatin', 'regimen', '.', 'future', 'research', 'involve', 'finding', 'appropriate', 'magnesium', 'dos', '.']"
Comparison of two Anti Snake Venom protocols in hemotoxic snake bite: A randomized trial.,"Pramod Sagar, Chanaveerappa Bammigatti, Tamilarasu Kadhiravan, K T Harichandrakumar, Rathinam Palamalai Swaminathan, Mahendra M Reddy, Pramod Sagaret al.",2020 Jul:73:101996.,J Forensic Leg Med,https://pubmed.ncbi.nlm.nih.gov/32658754/,"Anti snake venom, Dosing protocol, Efficacy, Hemotoxic, Snake bite.","['initial', 'dose', 'of', 'ml', 'followed', 'ml', 'th', 'hourly', 'till', '-min', 'whole', 'blood', 'clotting', 'time', '(', 'wbct', ')', 'negative', 'or', 'ml', 'of', 'asv', 'given', ',', 'whichever', 'earlier', '.', 'group', 'b', 'received', 'ml', 'followed', 'ml', 'every', 'th', 'hourly', 'two', 'consecutive', 'wbct', 'negative', '.', 'no', 'statistical', 'difference', 'in', 'amount', 'of', 'asv', 'required', 'in', 'group', '.', 'mortality', 'and', 'acute', 'kidney', 'injury', 'higher', 'in', 'group', '(', 'statistically', 'not', 'significant', ')', ',', 'probably', 'due', 'to', 'sicker', 'patient', 'in', 'group', '.', 'no', 'relapse', 'of', 'clotting', 'time', 'abnormality', 'in', 'group', '.', 'in', 'significant', 'number', 'of', 'patient', '(', ')', ',', 'clotting', 'time', 'persistently', 'prolonged', 'till', 'death', '.', 'found', 'use', 'of', 'national', 'asv', 'dosing', 'protocol', 'not', 'decrease', 'mortality', 'and', 'morbidity', '.']"
High clinical and morphologic response using (90)Y-DOTA-octreotate sequenced with (177)Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.,"Grace Kong, Jason Callahan, Michael S Hofman, David A Pattison, Tim Akhurst, Michael Michael, Peter Eu, Rodney J Hicks, Grace Konget al.",2017 Mar,Eur J Nucl Med Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/27678267/,No keywords found,"['bulky', 'disease', 'adverse', 'prognostic', 'factor', 'lu-dota-octreotate', '(', 'lu-dotatate', ')', 'peptide', 'receptor', 'radionuclide', 'therapy', '(', 'prrt', ')', '.', 'y-dota-octreotate', '(', 'y-dotatate', ')', 'theoretical', 'advantage', 'in', 'setting', 'may', 'less', 'effectively', 'treat', 'co-existent', 'smaller', 'deposit', 'and', 'higher', 'toxicity', 'lu-dotatate', '.', 'aim', 'of', 'study', 'to', 'assess', 'efficacy', 'and', 'safety', 'of', 'using', 'agent', 'sequentially', '.', 'method', 'reviewed', 'patient', '(', 'pt', ')', 'with', 'least', 'one', 'lesion', 'of', 'transaxial', 'diameter', 'cm', 'completed', '-', 'cycle', 'of', 'y-dotatate', 'followed', '-', 'cycle', 'of', 'lu-dotatate', ',', 'with', 'treatment', 'empirically', 'adapted', 'to', 'disease', 'size', 'and', 'burden', 'in', 'individual', 'patient', '.', 'data', 'collected', 'included', 'morphological', 'and', 'molecular', 'imaging', 'response', ',', 'toxicity', ',', 'and', 'progression-free', 'and', 'overall', 'survival', '.', 'result', 'twenty-six', 'pt', '(', 'men', 'aged', '-', 'year', ')', 'received', 'median', 'cumulative', 'activity', 'of', '.', 'gbq', 'y-dotatate', ',', 'and', 'gbq', 'lu-dotatate', '.', 'one', 'received', 'radiosensitising', 'chemotherapy', '.', 'adverse', 'prognostic', 'factor', 'included', 'enets', 'grade', 'or', 'in', ',', 'and', 'fdg-avid', 'disease', 'in', '.', 'nineteen', 'pt', 'treated', 'progressive', 'disease', 'stabilisation', '(', ')', 'or', 'regression', 'ct', '(', 'partial', 'response', ',', 'minor', 'response', ')', ',', 'with', 'mean', '(', '-', ')', 'reduction', 'in', 'disease', 'burden', '.', 'seven', 'pt', 'treated', 'uncontrolled', 'symptom', 'reported', 'improvement', 'prrt', 'with', 'complete', 'symptom', 'resolution', 'month', '.', 'eight', 'patient', 'grade', 'lymphopaenia', ',', 'and', 'two', 'patient', 'grade', 'thrombocytopaenia', 'without', 'significant', 'hepatic', 'or', 'renal', 'toxicity', '.', 'median', 'survival', 'not', 'reached', 'median', 'follow-up', 'of', 'month', '.', 'median', 'progression-free', 'survival', 'month', '.', 'conclusion', 'prcrt', 'with', '-dotatate', 'followed', 'lu-dotatate', 'in', 'individualised', 'regimen', 'achieved', 'high', 'clinical', 'and', 'morphological', 'response', 'in', 'patient', 'with', 'bulky', 'tumour', '.', 'despite', 'lack', 'of', 'control', 'arm', ',', 'efficacy', 'of', 'treatment', 'approach', 'appears', 'higher', 'reported', 'result', 'with', 'either', 'agent', 'used', 'alone', 'or', 'approved', 'treatment', ',', 'particularly', 'given', 'adverse', 'prognostic', 'feature', 'of', 'cohort', '.']"
Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.,"Lisa T Hong, Tiffany A Goolsby, Deborah S Sherman, Scott W Mueller, Paul Reynolds, Luis Cava, Robert Neumann, Tyree H Kiser, Lisa T Honget al.",2015 Oct,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/26239323/,No keywords found,"['target', 'plasma', 'level', 'achievement', 'remained', 'challenge', 'in', 'neurosurgical', 'intensive', 'care', 'unit', 'patient', 'receiving', 'intravenous', 'vancomycin', '.', 'evaluated', 'continuous', 'infusion', '(', 'ci', ')', 'and', 'intermittent', 'vancomycin', 'dosing', 'strategy', 'in', 'patient', '.', 'method', 'retrospective', 'cohort', 'compared', 'ci', 'vancomycin', '(', 'target', 'random', 'level', ',', '-', 'mgl', ')', 'to', 'intermittent', 'vancomycin', '(', 'target', 'trough', ',', '-', 'mgl', ')', 'in', 'regard', 'to', 'achievement', 'of', 'target', 'plasma', 'level', ',', 'nephrotoxicity', ',', 'pharmacodynamic', 'target', 'attainment', ',', 'and', 'cost', 'saving', 'in', 'patient', '.', 'result', 'continuous', 'infusion', 'resulted', 'in', 'greater', 'achievement', 'of', 'goal', 'plasma', 'concentration', 'first', 'steady-state', 'level', '(', 'v', '.', ',', 'p', '.', ')', ',', 'rapid', 'achievement', 'of', 'goal', 'plasma', 'concentration', '(', '.', 'v', '.', 'day', ',', 'p', '.', ')', ',', 'and', 'increased', 'time', 'within', 'therapeutic', 'range', '(', 'v', ',', 'p', '.', ')', 'no', 'significant', 'difference', 'in', 'nephrotoxicity', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'continuous', 'infusion', 'improved', 'pharmacodynamic', 'target', 'attainment', '(', '.', 'v', '.', ',', 'p', '.', ')', 'and', 'also', 'reduced', 'level', 'drawn', '(', '.', 'v', '.', ',', 'p', '.', ')', ',', 'dose', 'adjustment', '(', '.', 'v', '.', ',', 'p', '.', ')', ',', 'day', 'of', 'therapy', '(', '.', 'v', '.', ',', 'p', '.', ')', ',', 'and', 'mean', 'total', 'daily', 'dose', 'requirement', '(', 'v', '.', 'mgkg', ',', 'p', '.', ')', 'per', 'patient', '.', 'conclusion', 'continuous', 'infusion', 'appears', 'beneficial', 'improving', 'attainment', 'of', 'target', 'plasma', 'concentration', ',', 'pharmacodynamic', 'goal', ',', 'and', 'financial', 'burden', ',', 'without', 'increasing', 'risk', 'of', 'acute', 'kidney', 'injury', '.']"
"Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.","Grant Waterer, John Lord, Thomas Hofmann, Taneli Jouhikainen, Grant Watereret al.",2020 Feb 21,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/31964790/,"MRSA, cystic fibrosis, inhaled, vancomycin.","['methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', 'become', 'significant', 'acute', 'and', 'chronic', 'respiratory', 'pathogen', '.', 'vancomycin', 'effective', 'mrsa', ',', 'relatively', 'poor', 'penetration', 'lung', 'secretion', 'and', 'dose-limiting', 'renal', 'toxicity', 'make', 'less', 'effective', 'in', 'respiratory', 'setting', '.', 'inhaled', 'administration', 'of', 'vancomycin', 'would', 'overcome', 'limitation', ',', 'developed', 'dry', 'powder', 'formulation', 'suitable', 'inhalation', '(', 'aerovanc', ')', '.', ',', 'report', 'phase', ',', 'single-dose', ',', 'dose-escalating', 'study', 'aimed', 'demonstrating', 'safety', 'and', 'tolerability', 'of', 'aerovanc', '.', 'in', 'part', ',', 'healthy', 'subject', 'received', 'single', 'dose', 'of', 'mg', ',', 'mg', ',', 'or', 'mg', 'of', 'aerovanc', '.', 'two', 'subject', 'also', 'received', '-mg', 'dose', 'of', 'intravenous', 'vancomycin', '.', 'in', 'part', 'of', 'study', ',', 'mg', 'and', 'mg', 'aerovanc', 'administered', 'to', 'subject', 'with', 'cystic', 'fibrosis', 'single', 'dos', '.', 'no', 'serious', 'side', 'effect', '.', 'small', 'drop', 'in', 'forced', 'expiratory', 'volume', 'in', '(', 'fev', ')', 'observed', 'in', 'subject', 'with', 'cystic', 'fibrosis', ',', 'one', 'of', 'required', 'salbutamol', '.', 'vancomycin', 'rapidly', 'absorbed', 'inhalation', '.', 'peak', 'and', 'mean', 'plasma', 'concentration', 'of', 'vancomycin', 'dose', 'proportional', '.', 'average', 'minimum', 'concentration', 'of', 'vancomycin', 'in', 'sputum', 'remained', 'usual', 'mic', 'value', 'mrsa', 'to', 'h', '(', 'minimum', 'sputum', 'concentration', 'cmin', ',', '-mg', 'dose', '.', 'gml', ',', '-mg', 'dose', '.', 'gml', ')', '.', 'in', 'conclusion', ',', 'aerovanc', 'well', 'tolerated', 'and', 'achieved', 'high', 'level', 'in', 'sputum', 'with', 'mean', 'systemic', 'absorption', 'of', ',', 'making', 'potential', 'therapeutic', 'strategy', 'respiratory', 'infection', 'with', 'mrsa', '.']"
Non-interventional follow-up versus fluid bolus in RESPONSE to oliguria in hemodynamically stable critically ill patients: a randomized controlled pilot trial.,"Nina Inkinen, Ville Pettilä, Miia Valkonen, Maija Serlo, Minna Bäcklund, Johanna Hästbacka, Anni Pulkkinen, Tuomas Selander, Suvi T Vaara, Nina Inkinenet al.",2022 Dec 22,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36550559/,No keywords found,"['fluid', 'bolus', 'therapy', 'common', 'intervention', 'to', 'improve', 'urine', 'output', '.', 'data', 'concerning', 'effect', 'of', 'fluid', 'bolus', 'oliguria', 'originate', 'mainly', 'observational', 'study', 'and', 'remain', 'controversial', 'regarding', 'actual', 'benefit', 'of', 'therapy', '.', 'compared', 'effect', 'of', 'follow-up', 'approach', 'without', 'fluid', 'bolus', 'to', 'ml', 'fluid', 'bolus', 'urine', 'output', 'in', 'hemodynamically', 'stable', 'critically', 'ill', 'patient', 'with', 'oliguria', 'least', 'h', '(', 'urine', 'output', '.', 'mlkgh', ')', 'in', 'randomized', 'setting', '.', 'method', 'randomized', 'patient', 'in', 'fashion', 'to', 'receive', 'either', '(', ')', 'non-interventional', 'follow-up', '(', 'fu', ')', 'h', 'or', '(', ')', 'ml', 'crystalloid', 'fluid', 'bolus', '(', 'fb', ')', 'administered', 'min', '.', 'primary', 'outcome', 'proportion', 'of', 'patient', 'doubled', 'urine', 'output', ',', 'defined', '-h', 'urine', 'output', 'post-randomization', 'divided', 'urine', 'output', 'h', 'pre-randomization', '.', 'outcome', 'adjusted', 'stratification', 'variable', '(', 'presence', 'of', 'sepsis', 'or', 'aki', ')', 'using', 'two-tailed', 'regression', '.', 'obtained', 'odds', 'ratio', 'converted', 'to', 'risk', 'ratio', '(', 'rr', ')', 'with', 'confidence', 'interval', '(', 'ci', ')', '.', 'between-group', 'difference', 'in', 'continuous', 'variable', 'compared', 'using', 'mean', 'or', 'median', 'regression', 'and', 'expressed', 'with', 'ci', '.', 'result', 'altogether', '(', '.', ')', 'of', 'patient', 'in', 'fu', 'group', 'and', '(', '.', ')', 'of', 'patient', 'in', 'fb', 'group', 'doubled', 'urine', 'output', '-h', 'period', ',', 'rr', '(', 'ci', ')', '.', '(', '.-', '.', ')', ',', 'p', '..', 'median', 'iqr', 'change', 'in', 'individual', 'urine', 'output', 'h', 'post-randomization', 'compared', 'to', 'h', 'pre-randomization', '-', '-', 'to', 'ml', 'in', 'fu', 'group', 'and', '-', 'ml', 'in', 'fb', 'group', ',', 'median', 'difference', '(', 'ci', ')', '-', '(', '-', 'to', '-', ')', 'ml', ',', 'p', '..', 'median', 'iqr', 'duration', 'of', 'oliguria', 'in', 'fu', 'group', '-', 'h', 'and', 'in', 'fb', 'group', '-', 'h', ',', 'median', 'difference', '(', 'ci', ')', '(', '-', ')', 'h', ',', 'p', '..', 'median', 'iqr', 'cumulative', 'fluid', 'balance', 'study', 'day', 'lower', 'in', 'fu', 'group', 'compared', 'to', 'fb', 'group', ',', '-', 'ml', 'versus', '-', 'ml', ',', 'respectively', ',', 'median', 'difference', '(', 'ci', ')', '-', '(', '-', 'to', '-', ')', 'ml', ',', 'p', '..', 'conclusion', 'follow-up', 'approach', 'to', 'oliguria', 'compared', 'to', 'administering', 'fluid', 'bolus', 'of', 'ml', 'crystalloid', 'in', 'oliguric', 'patient', 'improved', 'urine', 'output', 'less', 'frequently', 'lead', 'to', 'lower', 'cumulative', 'fluid', 'balance', '.', 'trial', 'registration', 'clinical', '.', 'trial', 'gov', ',', 'nct', '.', 'registered', 'august', '.']"
Noninterventional follow-up vs fluid bolus in RESPONSE to oliguria-The RESPONSE trial protocol and statistical analysis plan.,"Nina Inkinen, Tuomas Selander, Ville Pettilä, Miia Valkonen, Minna Bäcklund, Johanna Wennervirta, Anni Pulkkinen, Johanna Hästbacka, Suvi T Vaara, Nina Inkinenet al.",2020 Sep,Acta Anaesthesiol Scand,https://pubmed.ncbi.nlm.nih.gov/32270496/,No keywords found,"['oliguria', 'frequent', 'trigger', 'administering', 'fluid', 'bolus', ',', 'effect', 'of', 'fluid', 'bolus', 'in', 'improving', 'urine', 'output', 'inadequately', 'demonstrated', '.', ',', 'summarize', 'protocol', 'and', 'detailed', 'statistical', 'analysis', 'plan', 'of', 'randomized', ',', 'controlled', 'response', 'trial', 'comparing', 'follow-up', 'experimental', 'group', 'and', 'ml', 'crystalloid', 'fluid', 'bolus', 'control', 'group', 'oliguria', 'in', 'critically', 'ill', 'oliguric', 'patient', '.', 'method', 'trial', 'investigator-initiated', ',', 'randomized', ',', 'controlled', ',', 'pilot', 'trial', 'conducted', 'in', 'three', 'icu', 'in', 'two', 'center', '.', 'aim', 'to', 'randomize', 'altogether', 'hemodynamically', 'stable', 'oliguric', 'patient', 'either', 'to', '-hour', 'follow-up', 'without', 'intervention', 'or', 'to', 'receive', 'crystalloid', 'bolus', 'of', 'ml', 'minute', '.', 'primary', 'outcome', 'change', 'in', 'individual', 'urine', 'output', '-hour', 'period', 'compared', 'to', 'hour', 'preceding', 'randomization', '.', 'doubling', 'of', 'urine', 'output', 'considered', 'clinically', 'significant', '.', 'additionally', ',', 'record', 'duration', 'of', 'oliguria', ',', 'physiological', 'and', 'biochemical', 'variable', ',', 'adverse', 'event', ',', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', 'and', 'renal', 'replacement', 'therapy', '.', 'conclusion', 'oliguria', 'frequent', 'trigger', 'potentially', 'harmful', 'fluid', 'loading', '.', 'therefore', ',', 'response', 'trial', 'give', 'information', 'of', 'potential', 'effect', 'of', 'fluid', 'bolus', 'oliguria', 'in', 'critically', 'ill', 'patient', '.', 'trial', 'registration', 'clinical.trials.gov', ',', 'nct', '.']"
A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.,"Ryo Kasahara, Takashi Kawahara, Shinji Ohtake, Yoko Saitoh, Sohgo Tsutsumi, Jun-Ichi Teranishi, Yasuhide Miyoshi, Noboru Nakaigawa, Masahiro Yao, Kazuki Kobayashi, Hiroji Uemura, Ryo Kasaharaet al.",2017:2017:7981549.,Biomed Res Int,https://pubmed.ncbi.nlm.nih.gov/28497065/,No keywords found,"['right', 'psoas', 'muscle', 'area', '(', 'cm', ')', 'square', 'of', 'body', 'height', '(', ')', '.', 'overall', 'survival', '(', 'o', ')', 'of', 'high', 'pmi', 'group', '(', 'male', '.', ',', 'female', '.', ')', 'and', 'low', 'pmi', 'group', '(', 'male', '.', ',', 'female', '.', ')', 'compared', '.', 'result', '.', 'kaplan-meier', 'survival', 'curve', 'and', 'log-rank', 'test', 'revealed', 'high', 'pmi', 'group', 'significantly', 'better', 'o', 'low', 'pmi', 'group', '(', 'p', '.', ')', '.', 'mean', 'survival', 'of', 'high', 'and', 'low', 'pmi', 'group', 'day', 'and', 'day', ',', 'respectively', '.', 'conclusion', '.', 'in', 'present', 'study', ',', 'revealed', 'sarcopenia', '(', 'low', 'psoas', 'muscle', 'volume', ')', 'might', 'predictive', 'factor', 'poorer', 'overall', 'survival', 'in', 'patient', 'with', 'advanced', 'urothelial', 'carcinoma', 'undergoing', 'gn', 'chemotherapy', '.']"
Modification of the effects of intensive systolic blood pressure control on kidney outcomes by baseline body mass index.,"Adhish Agarwal, Guo Wei, Robert Boucher, Faris Ahmed, Srinivasan Beddhu, Adhish Agarwalet al.",2021 Apr,Nephrology (Carlton),https://pubmed.ncbi.nlm.nih.gov/33538091/,No keywords found,"['obesity', 'and', 'intensive', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'control', 'independently', 'associated', 'with', 'greater', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'incident', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'examined', 'whether', 'baseline', 'body', 'mass', 'index', '(', 'bmi', ')', 'modifies', 'effect', 'of', 'intensive', 'sbp', 'lowering', 'aki', 'or', 'incident', 'ckd', '.', 'method', 'systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', ')', 'randomized', 'participant', 'with', 'high', 'blood', 'pressure', 'to', 'sbp', 'target', 'of', 'either', 'mm', 'hg', 'or', 'mm', 'hg', '.', 'in', 'secondary', 'analysis', 'of', 'sprint', 'participant', 'with', 'baseline', 'bmi', 'of', '.', 'and', 'kgm', ',', 'examined', 'interaction', 'of', 'baseline', 'bmi', 'and', 'sprint', 'sbp', 'intervention', 'subsequent', 'aki', 'and', 'incident', 'ckd', '.', 'result', 'kgm', 'increase', 'in', 'baseline', 'bmi', 'associated', 'with', 'higher', 'risk', 'of', 'aki', '(', 'hazard', 'ratio', 'hr', '.', ',', 'confidence', 'interval', 'ci', '.', 'to', '.', ')', 'and', 'incident', 'ckd', '(', 'hr', '.', ',', 'ci', '.', 'to', '.', ')', '.', 'intensive', 'sbp', 'control', 'increased', 'risk', 'of', 'aki', '(', 'hr', '.', ',', 'ci', '.-', '.', ')', 'and', 'incident', 'ckd', '(', 'hr', '.', ',', 'ci', '.-.', ')', '.', 'increased', 'risk', 'of', 'aki', 'with', 'intensive', 'sbp', 'control', 'consistent', 'across', 'baseline', 'bmi', 'spectrum', '(', 'linear', 'interaction', 'p', '.', ')', 'however', ',', 'risk', 'of', 'incident', 'ckd', 'with', 'sprint', 'intervention', 'increased', 'with', 'higher', 'bmi', '(', 'linear', 'interaction', 'p', '.', ')', '.', 'conclusion', 'increased', 'risk', 'of', 'adverse', 'kidney', 'event', 'seen', 'with', 'intensive', 'sbp', 'control', 'in', 'sprint', 'persisted', 'across', 'baseline', 'bmi', 'spectrum', '.', 'higher', 'baseline', 'bmi', 'associated', 'with', 'augmented', 'risk', 'of', 'incident', 'ckd', 'with', 'intensive', 'sbp', 'control', '.']"
"Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial.","Cristina Esposito, Cristina Santarcangelo, Raffaello Masselli, Giuseppe Buonomo, Giovanna Nicotra, Violetta Insolia, Maria D'Avino, Giuseppe Caruso, Antonio Riccardo Buonomo, Roberto Sacchi, Eduardo Sommella, Pietro Campiglia, Gian Carlo Tenore, Maria Daglia, Cristina Espositoet al.",2021 Jun:138:111414.,Biomed Pharmacother,https://pubmed.ncbi.nlm.nih.gov/33765581/,"Benign prostatic hyperplasia, Epilobium angustifolium L. extract, LC-MS metabolic profile, Oenothein B, Randomized double-blind placebo-controlled clinical trial.","['benign', 'prostatic', 'hyperplasia', '(', 'bph', ')', 'common', 'condition', 'in', 'adult', 'men', '.', 'especially', 'in', 'europe', ',', 'increasing', 'attention', 'focused', 'e.', 'angustifolium', 'extract', '(', 'eaes', ')', ',', 'widely', 'used', 'positive', 'effect', 'symptom', 'of', 'bph', ',', 'although', 'human', 'clinical', 'trial', 'limited', '.', 'aim', 'of', 'monocentric', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'clinical', 'trial', 'to', 'evaluate', 'daily', 'intake', 'of', 'hard', ',', 'gastric-resistant', 'capsule', 'containing', 'chemically', 'characterized', 'eae', '(', 'mg', ')', 'month', 'may', 'allow', 'significant', 'improvement', 'in', 'symptom', 'in', 'subject', 'with', 'bph', '.', 'study', 'conducted', 'in', 'adult', 'men', ',', 'randomly', 'assigned', 'to', 'receive', 'either', 'eae', 'food', 'supplement', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', ',', 'underwent', 'four', 'visit', '(', 'baseline', ',', 'day', ',', 'month', 'and', 'month', ')', 'in', 'outpatient', 'setting', 'to', 'evaluate', 'post-void', 'residual', '(', 'pvr', ')', 'and', 'prostate', 'volume', '(', 'pv', ')', 'mean', 'of', 'prostate', 'ultrasound', ',', 'prostate-specific', 'antigen', '(', 'psa', ')', 'and', 'neutrofilelymphocyte', 'ratio', '(', 'nl', ')', ',', 'nocturia', 'clinical', 'visit', 'and', 'international', 'prostate', 'specific', 'score', '(', 'ipss', ')', 'registered', 'physician', '.', 'eae', 'food', 'supplement', 'induced', 'significant', 'decrease', 'in', 'pvr', 'and', 'consequently', 'nocturia', 'improving', 'quality', 'of', 'life', 'suggested', 'decrease', 'of', 'ipss', '.', 'no', 'subject', 'reported', 'adverse', 'effect', 'related', 'to', 'oral', 'intake', 'of', 'eae', 'food', 'supplement', '.', 'moreover', ',', 'eae', 'food', 'supplement', 'not', 'show', 'hepatic', 'or', 'renal', 'toxicity', '.', 'in', 'conclusion', ',', 'eae', 'food', 'supplement', 'used', 'in', 'subject', 'with', 'bph', ',', 'to', 'improve', 'quality', 'of', 'life', 'and', 'general', 'renal', 'function', '.']"
Fluid loading in abdominal surgery - saline versus hydroxyethyl starch (FLASH Trial): study protocol for a randomized controlled trial.,"Emmanuel Futier, Matthieu Biais, Thomas Godet, Lise Bernard, Christine Rolhion, Justine Bourdier, Dominique Morand, Bruno Pereira, Samir Jaber                              ;, FLASH trial management committee, Emmanuel Futieret al.",2015 Dec 21:16:582.,Trials,https://pubmed.ncbi.nlm.nih.gov/26690683/,No keywords found,"['inappropriate', 'fluid', 'therapy', 'surgery', 'associated', 'with', 'significant', 'morbidity', 'and', 'mortality', '.', 'study', 'examined', 'effect', 'of', 'particular', 'type', 'of', 'fluid', '(', 'crystalloid', 'or', 'colloid', 'solution', ')', 'in', 'surgical', 'patient', ',', 'especially', 'with', 'goal', 'of', 'hemodynamic', 'optimization', '.', 'isotonic', 'saline', 'commonly', 'used', 'fluid', 'worldwide', 'may', 'associated', 'with', 'potential', 'nephrotoxicity', '.', 'hydroxyethyl', 'starch', '(', 'he', ')', 'solution', 'widely', 'used', 'in', 'surgical', 'patient', 'component', 'of', 'goal-directed', 'fluid', 'optimization', 'strategy', ',', 'several', 'large', 'multicenter', 'study', 'suggested', 'increased', 'rate', 'of', 'acute', 'kidney', 'injury', 'and', 'adverse', 'event', 'with', 'use', 'of', 'he', 'in', 'icu', 'patient', '.', 'despite', 'may', 'inferred', 'physiological', 'study', ',', 'benefit', 'and', 'harm', 'of', '.', 'saline', 'and', 'he', 'hemodynamic', 'therapy', 'not', 'clearly', 'established', 'in', 'surgical', 'patient', '.', 'methodsdesign', 'flash', 'trial', 'investigator-initiated', ',', 'prospective', ',', 'multicenter', ',', 'randomized', ',', 'double-blinded', ',', 'two-arm', 'trial', ',', 'randomizing', 'patient', 'with', 'moderate-to-high', 'risk', 'of', 'postoperative', 'complication', 'to', 'receive', 'he', '.', 'or', '.', 'saline', 'individualized', 'goal-directed', 'fluid', 'optimization', '.', 'primary', 'outcome', 'measure', 'composite', 'of', 'death', 'or', 'major', 'postoperative', 'complication', 'within', 'day', 'following', 'surgery', '.', 'sample', 'size', 'allow', 'detection', 'of', 'absolute', 'between-group', 'difference', 'in', 'primary', 'outcome', 'measure', 'with', 'type', 'error', 'rate', 'of', 'and', 'power', 'of', ',', 'assuming', 'mortality', 'rate', 'and', 'morbidity', '(', 'thus', 'composite', 'endpoint', ')', '.', 'discussion', 'flash', 'trial', 'may', 'provide', 'important', 'data', 'efficacy', 'and', 'safety', 'of', 'commonly', 'used', 'fluid', 'solution', 'and', 'could', 'significant', 'impact', 'future', 'treatment', 'of', 'surgical', 'patient', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.', 'registered', 'june', '.']"
"A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.","Sara Ataei, Molouk Hadjibabaie, Amirhossein Moslehi, Maryam Taghizadeh-Ghehi, Asieh Ashouri, Elham Amini, Kheirollah Gholami, Alireza Hayatshahi, Mohammad Vaezi, Ardeshir Ghavamzadeh, Sara Ataeiet al.",2015 Jun,Hematol Oncol,https://pubmed.ncbi.nlm.nih.gov/24711000/,"N-acetylcysteine, acute kidney injury, hematopoietic stem cell transplantation, randomized controlled trial, urine neutrophil gelatinase-associated lipocalin.","['patient', 'and', 'placebo', 'patient', ')', '.', 'participant', 'of', 'group', 'not', 'different', 'considering', 'baseline', 'characteristic', '.', 'aki', 'observed', 'in', 'of', 'nac', 'recipient', 'and', 'of', 'placebo', 'group', 'patient', ',', 'and', 'occurrence', 'pattern', 'not', 'significantly', 'different', '(', 'p', '.', ')', '.', 'moreover', ',', 'no', 'significant', 'difference', 'observed', 'group', 'ungal', 'measure', '(', 'p', '.', ')', '.', 'transplant-related', 'outcome', 'similar', 'group', ',', 'and', 'patient', 'successful', 'engraftment', '.', 'three', 'patient', 'not', 'tolerate', 'nac', 'of', 'abdominal', 'pain', ',', 'shortness', 'of', 'breath', 'and', 'rash', 'with', 'pruritus', 'and', 'dropped', 'intervention', 'group', 'transplantation', '.', 'however', ',', 'frequency', 'of', 'adverse', 'reaction', 'not', 'significantly', 'different', 'group', '.', 'in', 'conclusion', ',', 'finding', 'could', 'not', 'show', 'clinical', 'benefit', 'high-dose', 'nac', 'particularly', 'aki', 'prevention', 'in', 'allogeneic', 'hematopoietic', 'stem', 'cell', 'transplantation', 'patient', '.']"
Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by Cisplatin-based Chemotherapy with Short-term Low-volume Hydration in Advanced Non-small Cell Lung Cancer: The OLCSG1406 Study Protocol.,"Go Makimoto, Eiki Ichihara, Katsuyuki Hotta, Kiichiro Ninomiya, Isao Oze, Daisuke Minami, Takashi Ninomiya, Toshio Kubo, Kadoaki Ohashi, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura, Go Makimotoet al.",2018 Jun,Acta Med Okayama,https://pubmed.ncbi.nlm.nih.gov/29926012/,"cisplatin, furosemide, hydration, lung cancer, mannitol, non-small cell lung cancer.","['although', 'cisplatin-based', 'chemotherapy', 'show', 'survival', 'advantage', 'compared', 'to', 'carboplatin', 'treating', 'advanced', 'non-small', 'cell', 'lung', 'cancer', ',', 'high-volume', 'hydration', 'and', 'long', 'infusion', 'time', 'necessary', 'to', 'avoid', 'nephrotoxicity', ',', 'and', 'cisplatin-based', 'chemotherapy', 'difficult', 'to', 'administer', 'in', 'outpatient', 'setting', '.', 'low-volume', 'hydration', 'method', 'using', 'mannitol', 'or', 'furosemide', 'forced', 'diuresis', 'recently', 'introduced', ',', 'no', 'clear', 'conclusion', 'regarding', 'agent', 'used', '.', 'describe', 'ongoing', 'randomized', 'phase', 'ii', 'trial', '(', 'olcsg', 'study', ')', 'evaluating', 'efficacy', 'of', 'forced', 'diuresis', '.', 'study', 'clarify', 'whether', 'mannitol', 'or', 'furosemide', 'suitable', 'in', 'cisplatin-based', 'chemotherapy', 'with', 'low-volume', 'hydration', '.']"
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis.,"Sriram Ravichandran, Andrew Hall, Matthew Jenner, Mamta Garg, Bhuvan Kishore, Helen Lachmann, Julian Gillmore, Alexandra Pitchford, Jamie B Oughton, Shameem Mahmood, Sajitha Sachchithantham, Philip Hawkins, Sarah Brown, Ashutosh Wechalekar, Sriram Ravichandranet al.",2023 Sep,Amyloid,https://pubmed.ncbi.nlm.nih.gov/37216268/,No keywords found,"['proteasome', 'inhibitor', 'backbone', 'of', 'al', 'amyloidosis', 'treatment', '-', 'bortezomib', 'widely', 'used', '.', 'carfilzomib', 'proteasome', 'inhibitor', 'licenced', 'to', 'treat', 'multiple', 'myeloma', 'autonomic', 'and', 'peripheral', 'neuropathy', 'uncommon', 'toxicity', 'with', 'carfilzomib', '.', 'limited', 'data', 'use', 'of', 'carfilzomib', 'in', 'al', 'amyloidosis', '.', ',', 'report', 'result', 'of', 'phase', 'ib', 'dose-escalation', 'study', 'of', 'carfilzomib-thalidomide-dexamethasone', '(', 'ktd', ')', 'in', 'relapsedrefractory', 'al', 'amyloidosis', '.', 'result', 'trial', 'registered', 'patient', 'uk', 'centre', 'september', 'to', 'january', 'patient', 'received', 'least', 'one', 'dose', 'of', 'trial', 'treatment', '.', 'adverse', 'event', 'reported', 'patient', 'in', 'st', 'three', 'cycle', '.', 'one', 'patient', 'experienced', 'dose-limiting', 'toxicity', '(', 'acute', 'kidney', 'injury', ')', 'dose', 'of', 'mgm', ',', 'and', 'another', 'patient', 'sar', '(', 'fever', ')', '.', 'five', 'patient', 'experienced', 'ae', 'grade', '.', 'no', 'haematologic', ',', 'infectious', ',', 'or', 'cardiac', 'ae', 'grade', '.', 'overall', 'haematological', 'response', 'rate', '(', 'orr', ')', 'end', 'of', 'three', 'cycle', 'of', 'treatment', '.', 'conclusion', 'carfilzomib', 'mgm', 'weekly', 'safely', 'given', 'with', 'thalidomide', 'and', 'dexamethasone', '.', 'efficacy', 'and', 'tolerability', 'profile', 'appears', 'comparable', 'to', 'agent', 'in', 'relapsed', 'al', 'amyloidosis', '.', 'data', 'provide', 'framework', 'study', 'of', 'carfilzomib', 'combination', 'in', 'al', 'amyloidosis', '.']"
"A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors.","Taofeek K Owonikoko, R Donald Harvey, Bradley Carthon, Zhengjia Chen, Colleen Lewis, Hanna Collins, Chao Zhang, David H Lawson, Olatunji B Alese, Mehmet Asim Bilen, Gabriel L Sica, Conor E Steuer, Walid L Shaib, Christina Wu, Wayne B Harris, Mehmet Akce, Ragini R Kudchagkar, Bassel F El-Rayes, Sagar Lonial, Suresh S Ramalingam, Fadlo Raja Khuri, Taofeek K Owonikokoet al.",2020 Jun 1,Clin Cancer Res,https://pubmed.ncbi.nlm.nih.gov/32005746/,No keywords found,"['concurrent', 'inhibition', 'of', 'mtor', 'and', 'pik', 'led', 'to', 'improved', 'efficacy', 'in', 'preclinical', 'model', 'and', 'provided', 'rationale', 'phase', 'study', 'of', 'everolimus', 'and', 'buparlisib', '(', 'bkm', ')', 'in', 'patient', 'with', 'advanced', 'solid', 'tumor', '.', 'patient', 'and', 'method', 'used', 'bayesian', 'escalation', 'with', 'overdose', 'control', 'design', 'to', 'test', 'escalating', 'dos', 'of', 'everolimus', '(', 'or', 'mg', ')', 'and', 'buparlisib', '(', ',', ',', ',', ',', 'and', 'mg', ')', 'in', 'eligible', 'patient', '.', 'pharmacokinetic', 'assessment', 'conducted', 'using', 'blood', 'sample', 'collected', 'cycle', ',', 'day', 'and', '.', 'pharmacodynamic', 'impact', 'mtorpik', 'pathway', 'modulation', 'evaluated', 'in', 'paired', 'skin', 'biopsy', 'collected', 'baseline', 'and', 'end', 'of', 'cycle', '.', 'result', 'enrolled', 'patient', ',', 'median', 'age', 'of', '(', 'range', ',', '-', ')', 'year', '(', '.', ')', 'female', ',', '(', '.', ')', 'caucasian', ',', 'and', '(', '.', ')', 'black', '.', 'frequent', 'toxicity', 'hyperglycemia', ',', 'diarrhea', ',', 'nausea', ',', 'fatigue', ',', 'and', 'aspartate', 'aminotransferase', 'elevation', '.', 'dose-limiting', 'toxicity', 'observed', 'in', 'patient', 'fatigue', '(', ')', ',', 'hyperglycemia', '(', ')', ',', 'mucositis', '(', ')', ',', 'acute', 'kidney', 'injury', '(', ')', ',', 'and', 'urinary', 'tract', 'infection', '(', ')', '.', 'recommended', 'phase', 'ii', 'dose', '(', 'rpd', ')', 'combination', 'established', 'everolimus', '(', 'mg', ')', 'and', 'buparlisib', '(', 'mg', ')', '.', 'best', 'response', 'in', 'evaluable', 'patient', 'progressive', 'disease', 'and', 'stable', 'disease', 'in', '(', ')', 'and', '(', ')', ',', 'respectively', '.', 'median', 'progression-free', 'survival', 'and', 'overall', 'survival', '.', '(', '.-', '.', ')', 'and', '(', '.-', '.', ')', 'month', '.', 'steady-state', 'pharmacokinetic', 'analysis', 'showed', 'dose-normalized', 'maximum', 'concentration', 'and', 'auc', 'value', 'everolimus', 'and', 'buparlisib', 'in', 'combination', 'to', 'comparable', 'with', 'single-agent', 'pharmacokinetic', '.', 'conclusion', 'combination', 'of', 'everolimus', 'and', 'buparlisib', 'safe', 'and', 'well-tolerated', 'rpd', 'of', 'and', 'mg', 'continuous', 'daily', 'schedule', '.']"
"A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).","Ralph V Boccia, Alberto Bessudo, Richy Agajanian, Paul Conkling, Wael Harb, Hui Yang, Dawn Pinchasik, Amy S Kimball, James R Berenson, Ralph V Bocciaet al.",2017 Jul,Clin Lymphoma Myeloma Leuk,https://pubmed.ncbi.nlm.nih.gov/28576443/,No keywords found,"['phase', 'b', 'study', 'evaluated', 'safety', 'and', 'efficacy', 'of', 'dose', 'level', 'of', 'carfilzomib', 'provided', 'with', 'fixed', 'dose', 'oral', 'cyclophosphamide', 'and', 'dexamethasone', '(', 'kcyd', ')', 'in', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', '(', 'mm', ')', '.', 'patient', 'and', 'method', 'champion-', 'multicenter', 'single-arm', 'study', '.', 'patient', 'with', 'newly', 'diagnosed', 'secretory', 'mm', 'enrolled', 'and', 'received', 'kcyd', 'treatment', 'to', 'cycle', '.', 'dose', 'escalation', 'scheme', 'used', 'to', 'evaluate', 'twice-weekly', 'carfilzomib', ',', ',', 'and', 'mgm', 'dose', 'level', ',', 'followed', 'dose', 'expansion', '.', 'result', 'no', 'dose-limiting', 'toxicity', 'observed', 'in', 'of', 'dose', 'evaluation', 'cohort', '.', 'kcyd', 'regimen', 'included', 'maximum', 'planned', 'carfilzomib', 'dose', 'of', 'mgm', 'twice', 'weekly', 'brought', 'forward', 'dose', 'expansion', '.', 'total', 'of', 'patient', 'treated', 'dose', 'level', '.', 'mgm', 'overall', 'response', 'rate', '.', '(', 'confidence', 'interval', ',', '.-', '.', ')', ',', 'and', 'median', 'time', 'to', 'response', 'of', 'patient', 'whose', 'disease', 'responded', 'to', 'therapy', 'month', '.', 'dose', 'level', ',', 'common', 'adverse', 'event', 'of', 'grade', 'or', 'higher', 'anemia', '(', '.', ')', ',', 'neutropenia', '(', '.', ')', ',', 'acute', 'kidney', 'injury', '(', '.', ')', ',', 'and', 'decreased', 'white', 'blood', 'cell', 'count', '(', '.', ')', '.', 'ten', 'of', 'patient', 'received', 'carfilzomib', 'mgm', 'completed', 'cycle', ',', 'patient', 'discontinued', 'study', 'therapy', 'cycle', 'result', 'of', 'adverse', 'event', ',', 'and', 'patient', 'discontinued', 'therapy', 'result', 'of', 'progressive', 'disease', '.', 'conclusion', 'carfilzomib', 'in', 'combination', 'with', 'cyclophosphamide', 'and', 'dexamethasone', 'effective', 'and', 'manageable', 'toxicity', 'patient', 'with', 'newly', 'diagnosed', 'mm', '.']"
A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study.,"Sumeet K Reddy, Michael J Bailey, Richard W Beasley, Rinaldo Bellomo, Seton J Henderson, Diane M Mackle, Colin J McArthur, Jan E Mehrtens, John A Myburgh, Shay P McGuinness, Alex J Psirides, Paul J Young, Sumeet K Reddyet al.",2014 Dec,Crit Care Resusc,https://pubmed.ncbi.nlm.nih.gov/25437221/,No keywords found,"['.', 'saline', 'commonly', 'used', 'intravenous', '(', 'iv', ')', 'fluid', 'in', 'world', '.', 'however', ',', 'recent', 'data', 'raise', 'possibility', ',', 'compared', 'with', 'buffered', 'crystalloid', 'fluid', 'plasma-lyte', ',', 'administration', 'of', '.', 'saline', 'to', 'intensive', 'care', 'unit', 'patient', 'might', 'increase', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'objective', 'to', 'describe', 'protocol', '.', 'saline', 'v', 'plasma-lyte', 'icu', 'fluid', 'therapy', '(', 'split', ')', 'study', '.', 'method', 'multicentre', ',', 'cluster-randomised', ',', 'double', 'crossover', 'feasibility', 'study', 'to', 'conducted', 'in', 'four', 'new', 'zealand', 'tertiary', 'icu', '-week', 'period', 'and', 'enroll', 'participant', '.', 'icu', 'patient', 'need', 'crystalloid', 'iv', 'fluid', 'therapy', '(', 'except', 'with', 'established', 'renal', 'failure', 'needing', 'dialysis', 'and', 'admitted', 'to', 'icu', 'palliative', 'care', ')', 'enrolled', '.', 'participating', 'icu', 'randomly', 'assigned', 'to', '.', 'saline', 'or', 'plasma-lyte', 'routine', 'crystalloid', 'iv', 'fluid', ',', 'in', 'blinded', 'fashion', ',', 'in', 'four', 'alternating', '-week', 'block', '.', 'main', 'outcome', 'measure', 'primary', 'outcome', 'proportion', 'of', 'patient', 'develop', 'aki', 'in', 'icu', '.', 'secondary', 'outcome', 'include', 'difference', 'recent', 'serum', 'creatinine', 'level', 'measured', 'study', 'enrollment', 'and', 'peak', 'serum', 'creatinine', 'level', 'in', 'icu', 'use', 'of', 'renal', 'replacement', 'therapy', 'and', 'icu', 'and', 'in', 'hospital', 'mortality', '.', 'analysis', 'conducted', 'intention-to-treat', 'basis', '.', 'result', 'and', 'conclusion', 'split', 'study', 'started', 'april', 'and', 'provide', 'preliminary', 'data', 'comparative', 'effectiveness', 'of', 'using', '.', 'saline', 'v', 'plasma-', 'lyte', 'routine', 'iv', 'fluid', 'therapy', 'in', 'icu', 'patient', '.']"
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.,"Stefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, Alessandra Longhi, Gerlinde Egerer, Kirsten Sundby Hall, Davide Donati, Matthias Kevric, Otte Brosjö, Alessandro Comandone, Mathias Werner, Odd Monge, Emanuela Palmerini, Wolfgang E Berdel, Bodil Bjerkehagen, Anna Paioli, Sylvie Lorenzen, Mikael Eriksson, Marco Gambarotti, Per-Ulf Tunn, Nina L Jebsen, Marilena Cesari, Thekla von Kalle, Virginia Ferraresi, Rudolf Schwarz, Rossella Bertulli, Anne-Katrin Kasparek, Giovanni Grignani, Fatime Krasniqi, Benjamin Sorg, Stefanie Hecker-Nolting, Piero Picci, Peter Reichardt, Stefano Ferrariet al.",2018 Jan-Feb,Tumori,https://pubmed.ncbi.nlm.nih.gov/29218692/,No keywords found,"['european', 'bone', 'sarcoma', 'study', '(', 'euro-b.o.s.s', '.', ')', 'first', 'prospective', 'international', 'study', 'patient', '-', 'year', 'old', 'with', 'high-grade', 'bone', 'sarcoma', 'treated', 'with', 'intensive', 'chemotherapy', 'regimen', 'derived', 'protocol', 'younger', 'patient', 'with', 'high-grade', 'skeletal', 'osteosarcoma', '.', 'method', 'chemotherapy', 'based', 'doxorubicin', ',', 'cisplatin', ',', 'ifosfamide', ',', 'and', 'methotrexate', 'suggested', ',', 'patient', 'treated', 'with', 'regimen', 'investigator', ""'"", 'choice', 'also', 'eligible', 'study', '.', 'result', 'present', 'report', 'focus', 'subgroup', 'of', 'patient', 'with', 'primary', 'high-grade', 'osteosarcoma', '.', 'with', 'median', 'follow-up', 'of', 'month', ',', '-year', 'probability', 'of', 'overall', 'survival', '(', 'o', ')', 'in', 'patient', 'with', 'localized', 'disease', 'and', 'in', 'case', 'of', 'synchronous', 'metastasis', '.', '-year', 'o', 'in', 'patient', 'with', 'localized', 'disease', 'in', 'pelvic', 'tumor', ',', 'and', 'and', 'extremity', 'or', 'craniofacial', 'location', ',', 'respectively', '.', 'in', 'primary', 'chemotherapy', ',', 'tumor', 'necrosis', 'reported', 'in', 'of', 'patient', '.', 'no', 'toxic', 'death', 'however', ',', 'hematological', 'toxicity', 'considerable', 'with', 'of', 'patient', 'experiencing', 'or', 'episode', 'of', 'neutropenic', 'fever', '.', 'incidence', 'of', 'nephrotoxicity', 'and', 'neurotoxicity', '(', 'mainly', 'peripheral', ')', 'and', ',', 'respectively', '.', 'methotrexate', ',', 'of', 'patient', 'experienced', 'delayed', 'excretion', ',', 'in', 'case', 'with', 'nephrotoxicity', '.', 'conclusion', 'in', 'patient', 'year', 'of', 'age', 'with', 'primary', 'high-grade', 'osteosarcoma', ',', 'aggressive', 'approach', 'with', 'chemotherapy', 'and', 'surgery', 'offer', 'probability', 'of', 'survival', 'similar', 'to', 'achieved', 'in', 'younger', 'patient', '.', 'chemotherapy-related', 'toxicity', 'significant', 'and', 'generally', 'higher', 'reported', 'in', 'younger', 'cohort', 'of', 'osteosarcoma', 'patient', 'treated', 'with', 'intensive', 'regimen', '.']"
Postoperative Hydrocortisone Infusion Reduces the Prevalence of Low Cardiac Output Syndrome After Neonatal Cardiopulmonary Bypass.,"Stephen M Robert, Santiago Borasino, Robert J Dabal, David C Cleveland, Kristal M Hock, Jeffrey A Alten, Stephen M Robertet al.",2015 Sep,Pediatr Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/25901540/,No keywords found,"['neonatal', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'often', 'complicated', 'morbidity', 'associated', 'with', 'inflammation', 'and', 'low', 'cardiac', 'output', 'syndrome', '.', 'hydrocortisone', '``', 'stress', 'dosing', ""''"", 'reported', 'to', 'provide', 'hemodynamic', 'benefit', 'in', 'patient', 'with', 'refractory', 'shock', '.', 'development', 'of', 'cardiopulmonary', 'bypass-induced', 'adrenal', 'insufficiency', 'may', 'provide', 'rationale', 'postoperative', 'hydrocortisone', 'administration', '.', 'sought', 'to', 'determine', 'whether', 'prophylactic', ',', 'postoperative', 'hydrocortisone', 'infusion', 'could', 'decrease', 'prevalence', 'of', 'low', 'cardiac', 'output', 'syndrome', 'neonatal', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '.', 'design', 'double-blind', ',', 'randomized', 'control', 'trial', '.', 'setting', 'pediatric', 'cardiac', 'icu', 'and', 'operating', 'room', 'in', 'tertiary', 'care', 'center', '.', 'patient', 'forty', 'neonate', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'randomized', '(', 'hydrocortisone', 'and', 'placebo', ')', '.', 'demographic', 'and', 'known', 'risk', 'factor', 'similar', 'group', '.', 'intervention', 'cardiopulmonary', 'bypass', 'separation', ',', 'bolus', 'hydrocortisone', '(', 'mgm', ')', 'or', 'placebo', 'administered', ',', 'followed', 'continuous', 'hydrocortisone', 'infusion', '(', 'mgmd', ')', 'or', 'placebo', 'tapered', 'day', '.', 'adrenocorticotropic', 'hormone', 'stimulation', 'testing', '(', 'g', ')', 'performed', 'and', 'cardiopulmonary', 'bypass', ',', 'prior', 'to', 'steroid', 'administration', '.', 'blood', 'collected', 'cytokine', 'analysis', 'and', 'cardiopulmonary', 'bypass', '.', 'measurement', 'and', 'main', 'result', 'subject', 'receiving', 'hydrocortisone', 'less', 'likely', 'to', 'develop', 'low', 'cardiac', 'output', 'syndrome', '(', ',', 'v', ',', 'p', '.', ')', '.', 'hydrocortisone', 'group', 'negative', 'net', 'fluid', 'balance', 'hour', '(', '-', 'v', '-', 'mlkg', 'p', '.', ')', 'and', 'greater', 'urine', 'output', '-', 'hour', '(', '.', 'v', '.', 'mlkghr', 'p', '.', ')', '.', 'hydrocortisone', 'group', 'weaned', 'catecholamine', 'and', 'vasopressin', 'sooner', 'placebo', ',', 'with', 'difference', 'in', 'inotrope-free', 'subject', 'apparent', 'hour', '(', 'p', '.', ')', '.', 'five', 'placebo', 'subject', '(', ')', 'compared', 'with', 'no', 'hydrocortisone', 'subject', 'required', 'rescue', 'steroid', '(', 'p', '.', ')', '.', 'thirteen', '(', '.', ')', 'adrenal', 'insufficiency', 'cardiopulmonary', 'bypass', '.', 'patient', 'with', 'adrenal', 'insufficiency', 'randomized', 'to', 'receive', 'hydrocortisone', 'lower', 'prevalence', 'of', 'low', 'cardiac', 'output', 'syndrome', 'compared', 'with', 'patient', 'with', 'adrenal', 'insufficiency', 'randomized', 'to', 'placebo', '(', 'v', ',', 'respectively', 'p', '.', ')', '.', 'hydrocortisone', 'significantly', 'reduced', 'proinflammatory', 'cytokine', '.', 'ventilator-free', 'day', ',', 'hospital', 'length', 'of', 'stay', ',', 'and', 'kidney', 'injury', 'similar', '.', 'conclusion', 'prophylactic', ',', 'postoperative', 'hydrocortisone', 'reduces', 'low', 'cardiac', 'output', 'syndrome', ',', 'improves', 'fluid', 'balance', 'and', 'urine', 'output', ',', 'and', 'attenuates', 'inflammation', 'neonatal', 'cardiopulmonary', 'bypass', 'surgery', '.', 'study', 'necessary', 'to', 'show', 'benefit', 'lead', 'to', 'improvement', 'in', 'important', 'clinical', 'outcome', '.']"
A randomised feasibility study to assess a novel strategy to rationalise fluid in patients after cardiac surgery.,"R L Parke, S P McGuinness, E Gilder, L W McCarthy, K-A L Cowdrey, R L Parkeet al.",2015 Jul,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/25991758/,No keywords found,"['cardiac', 'surgery', ',', 'patient', 'receive', 'large', 'amount', 'of', 'fluid', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'plan', 'to', 'conduct', 'multi-centre', 'randomised', 'controlled', 'trial', ',', 'of', 'conservative', 'fluid', 'regime', ',', 'in', 'patient', 'cardiac', 'surgery', ',', 'and', 'reported', 'result', 'of', 'feasibility', 'study', 'evaluated', 'efficacy', 'and', 'safety', 'of', 'proposed', 'regime', '.', 'method', 'ethical', 'approval', ',', 'single-centre', ',', 'prospectively', 'randomised', 'interventional', 'study', 'undertaken', '.', 'participant', 'randomised', 'to', 'either', 'usual', 'care', ',', 'or', 'to', 'protocolised', 'algorithm', ',', 'utilising', 'stroke', 'volume', 'variation', ',', 'to', 'guide', 'fluid', 'administration', 'to', 'patient', 'deemed', 'to', 'inadequate', 'cardiac', 'output', 'and', 'likely', 'to', 'volume', 'responsive', '.', 'study', 'protocol', 'lasted', 'icu', 'admission', 'to', 'de-sedation', 'or', 'h', ',', 'whichever', 'occurred', 'first', '.', 'result', 'randomised', 'subject', 'month', '.', 'less', 'bolus', 'fluid', 'and', 'less', 'total', 'overall', 'fluid', 'volume', 'administered', 'in', 'intervention', 'group', '(', 'median', '(', 'iqr', ')', 'ml', '(', '-', ')', 'and', 'ml', '(', '-', 'p.', ')', ',', 'compared', 'with', 'usual', 'care', 'group', '(', 'ml', '(', '-', ')', 'and', 'ml', '(', '-', 'p.', ')', ',', 'icu', 'admission', 'to', 'extubation', '.', 'no', 'significant', 'difference', 'in', 'incidence', 'of', 'acute', 'kidney', 'injury', 'or', 'average', 'amount', 'of', 'fluid', 'administered', 'to', 'usual', 'care', 'group', 'beginning', 'compared', 'with', 'end', 'of', 'study', '.', 'conclusion', 'possible', 'and', 'safe', 'to', 'achieve', 'significant', 'reduction', 'in', 'amount', 'of', 'fluid', 'administered', 'to', 'patient', ',', 'allocated', 'to', 'conservative', 'fluid', 'protocol', '.', 'result', 'suggest', 'planned', 'multi-centre', 'study', 'justified', 'and', 'feasible', '.', 'clinical', 'trial', 'registration', 'australia', 'new', 'zealand', 'clinical', 'trial', 'registry', 'www.anzctr.org.au', '(', 'actrn', ')', '.']"
Intensive Blood Pressure Control and Cardiovascular Outcomes in Elderly Patients: A Secondary Analysis of SPRINT Study Based on a 60-Year Age Cutoff.,"Manal F Cheema, Zeeshan Butt, Samreen Gilani, Sidra Shafiq, Shafiq Cheema, Manash K Das, Manal F Cheemaet al.",2023 Aug 5,Am J Hypertens,https://pubmed.ncbi.nlm.nih.gov/37105717/,No keywords found,"['in', 'original', 'sprint', 'article', ',', 'age', 'categorized', 'year', ',', 'contrary', 'to', 'many', 'previous', 'clinical', 'trial', 'year', '.', 'method', 'sprint', 'trial', 'randomized', ',', 'hypertensive', 'patient', 'to', 'target', 'blood', 'pressure', 'of', 'vs.', 'mm', 'hg', '(', 'intensive', 'vs.', 'standard', 'treatment', ',', 'respectively', ')', '.', 'age', 're-categorized', 'and', 'year', 'and', 'hazard', 'ratio', '(', 'hr', ')', 'calculated', 'with', 'confidence', 'interval', '(', 'ci', ')', 'outcome', 'and', 'adverse', 'event', '.', 'result', 'intensive', 'treatment', 'reduced', 'primary', 'outcome', 'significantly', 'in', 'and', 'year', 'of', 'age', 'subgroup', 'with', 'relative', 'risk', 'reduction', '(', 'rrr', ')', 'of', 'and', ',', 'respectively', ',', 'and', 'hr', 'of', '.', 'ci', ',', '.-', '.', 'and', '.', 'ci', ',', '.-.', ',', 'respectively', '.', 'although', 'intensive', 'treatment', 'rendered', 'no', 'effect', 'myocardial', 'infarction', '(', 'mi', ')', 'in', 'overall', 'comparison', ',', 'significantly', 'reduced', 'mi', 'in', 'patient', 'year', 'of', 'age', 'with', 'rrr', 'of', 'and', 'hr', 'of', '.', 'ci', ',', '.-', '..', 'in', '-year', 'age', 'subgroup', ',', 'reduced', 'heart', 'failure', 'incidence', 'noted', 'intensive', 'treatment', ',', 'including', 'death', 'cardiovascular', 'cause', 'however', ',', 'not', 'observed', 'in', '-year', 'age', 'subgroup', '.', 'intensive', 'treatment', 'resulted', 'in', 'significant', 'hypotension', ',', 'syncope', ',', 'acute', 'renal', 'failure', ',', 'or', 'acute', 'kidney', 'injury', 'in', '-year', 'age', 'group', 'conversely', ',', 'risk', 'of', 'adverse', 'effect', 'in', 'patient', 'year', 'of', 'age', 'not', 'increase', '.', 'conclusion', 'intensive', 'blood', 'pressure', 'control', 'beneficial', 'elderly', 'patient', '(', 'age', 'year', ')', ',', 'albeit', 'with', 'increased', 'risk', 'of', 'adverse', 'event', '.']"
Diuretic response to colloid and crystalloid fluid loading in critically ill patients.,"Annemieke Smorenberg, A B Johan Groeneveld, Annemieke Smorenberget al.",2015 Feb,J Nephrol,https://pubmed.ncbi.nlm.nih.gov/24828327/,No keywords found,"['in', 'critically', 'ill', 'patient', ',', 'fluid', 'loading', 'commonly', 'done', 'to', 'stabilise', 'hemodynamics', 'and', 'increase', 'diuresis', ',', 'whereas', 'absence', 'of', 'diuresis', 'may', 'predispose', 'to', 'harmful', 'overloading', '.', 'goal', 'of', 'current', 'study', 'to', 'evaluate', 'diuretic', 'response', 'and', 'determinant', 'thereof', 'upon', 'crystalloid', 'and', 'colloid', 'fluid', 'loading', '.', 'subject', 'and', 'method', 'substudy', 'clinically', 'hypovolemic', ',', 'septic', 'or', 'non-septic', 'patient', 'without', 'acute', 'kidney', 'injury', ',', 'randomly', 'assigned', ',', 'stratification', 'sepsis', ',', 'to', '-min', 'fluid', 'loading', 'protocol', 'with', 'either', '.', 'saline', 'or', 'colloid', 'solution', '(', 'gelatin', ',', 'hydroxyethyl', 'starch', '.', 'or', 'albumin', ')', '.', 'hemodynamics', ',', 'biochemical', 'parameter', 'and', 'diuresis', 'recorded', '.', 'response', 'defined', 'increase', 'in', 'diuresis', 'of', 'fluid', 'loading', '.', 'result', 'diuresis', 'increased', 'saline', 'colloid', 'infusion', ',', 'together', 'with', 'decline', 'in', 'colloid', 'osmotic', 'pressure', '(', 'cop', ')', 'of', 'plasma', 'and', 'less', 'increase', 'in', 'plasma', 'volume', 'and', 'global', 'hemodynamics', 'with', 'saline', ',', 'similar', 'fluid', 'balance', '.', 'nine', 'patient', '(', ')', 'receiving', 'saline', 'diuretic', 'response', ',', 'compared', 'to', 'patient', '(', ')', 'receiving', 'colloid', '(', 'p', '.', ')', ',', 'and', 'response', 'not', 'predicted', 'underlying', 'condition', ',', 'global', 'hemodynamics', ',', 'volume', 'of', 'fluid', 'infused', 'and', 'cop', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'clinical', 'hypovolemia', ',', 'diuresis', 'increase', 'saline', 'colloid', 'fluid', 'loading', ',', 'partly', 'dependent', 'of', 'fall', 'in', 'plasma', 'cop', '.']"
Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer.,"Dora Niedersüss-Beke, Thomas Puntus, Thomas Kunit, Birgit Grünberger, Michael Lamche, Wolfgang Loidl, Reinhard Böhm, Nicole Kraischits, Stefan Kudlacek, Paul Schramek, Johannes G Meran, Dora Niedersüss-Bekeet al.",2017,Oncology,https://pubmed.ncbi.nlm.nih.gov/28399521/,No keywords found,"['neoadjuvant', 'chemotherapy', 'with', 'methotrexate-vinblastine-doxorubicin-cisplatin', '(', 'mvac', ')', 'standard', 'of', 'care', 'muscle-invasive', 'urothelial', 'bladder', 'cancer', '.', 'gemcitabine', 'plus', 'cisplatin', '(', 'gc', ')', 'show', 'similar', 'efficacy', 'with', 'less', 'toxicity', 'in', 'metastatic', 'setting', 'and', 'therefore', 'often', 'used', 'interchangeably', 'with', 'mvac', '.', 'report', 'efficacy', 'and', 'safety', 'of', 'neoadjuvant', 'gc', 'in', 'patient', 'with', 'locally', 'advanced', 'urothelial', 'cancer', '.', 'material', 'and', 'method', 'prospectively', 'evaluated', 'patient', 'in', 'center', '.', 'median', 'age', 'year', '.', 'treatment', 'consisted', 'of', 'gc', 'prior', 'to', 'radical', 'cystectomy', '.', 'primary', 'endpoint', 'pathologic', 'response', '.', 'secondary', 'endpoint', 'safety', ',', 'progression-free', 'survival', '(', 'pfs', ')', ',', 'and', 'overall', 'survival', '(', 'o', ')', '.', 'result', 'in', ',', 'patient', 'finished', 'chemotherapy', 'patient', 'evaluable', 'primary', 'endpoint', '.', 'pathologic', 'complete', 'response', '(', 'pcr', ')', 'achieved', 'in', '.', 'and', 'near', 'pcr', 'seen', 'in', '.', 'of', 'patient', '.', '-year', 'pfs', 'rate', '.', 'among', 'patient', 'achieving', 'pt', 'versus', 'among', 'patient', 'achieving', 'pcr', 'or', 'near', 'pcr', '(', 'p', '.', ')', '.', 'five-year', 'o', '.', '(', 'ci', '.', 'to', 'na', ')', '.', 'gc', 'well', 'tolerated', '.', 'grade', 'toxicity', 'occurred', 'in', 'of', 'patient', '.', 'no', 'grade', 'renal', 'toxicity', ',', 'febrile', 'neutropenia', ',', 'or', 'death', '.', 'conclusion', 'neoadjuvant', 'gc', 'well-tolerated', 'regimen', '.', 'although', 'pathologic', 'response', 'lower', 'reported', 'with', 'mvac', ',', 'data', 'support', 'gc', 'feasible', 'option', 'in', 'absence', 'of', 'prospective', 'randomized', 'comparison', ',', 'particularly', 'older', 'patient', ',', 'since', 'toxicity', 'lower', 'of', 'mvac', '.']"
A randomized double blinded placebo controlled trial of sildenafil for renoprotection prior to hilar clamping in patients undergoing robotic assisted laparoscopic partial nephrectomy.,"Louis S Krane, Charles C Peyton, Michael A Olympio, Ashok K Hemal, Louis S Kraneet al.",2016 Dec,J Surg Oncol,https://pubmed.ncbi.nlm.nih.gov/27613357/,No keywords found,"['to', 'perform', 'randomized', 'control', 'trial', '(', 'rct', ')', 'assessing', 'effect', 'of', 'phosphodiesterase', 'inhibitor', '(', 'pdei', ')', 'used', 'prior', 'to', 'hilar', 'clamping', 'robot', 'assisted', 'partial', 'nephrectomy', '(', 'rapn', ')', 'renoprotection', '.', 'material', 'and', 'method', 'performed', 'institutional', 'review', 'board', 'approved', ',', 'placebo', 'controlled', ',', 'double', 'blinded', 'rct', 'evaluating', 'single', 'mg', 'oral', 'dose', 'of', 'sildenafil', 'immediately', 'prior', 'to', 'rapn', '.', 'primary', 'end', 'point', 'accrual', ',', 'participation', 'and', 'retention', 'of', 'patient', 'with', 'secondary', 'endpoint', 'assessing', 'post-operative', 'renal', 'functional', 'outcome', 'and', 'safety', '.', 'exclusion', 'criterion', 'included', 'history', 'of', 'coronary', 'artery', 'disease', ',', 'solitary', 'kidney', ',', 'suspected', 'benign', 'pathology', ',', 'pdei', 'intolerance', 'or', 'pregnant', 'female', '.', 'result', 'of', 'eligible', 'consecutive', 'patient', 'undergoing', 'rpn', 'and', ',', '(', ')', 'randomized', 'to', 'treatment', 'and', 'participation', 'and', 'retention', '.', 'group', 'well', 'matched', 'measured', 'comorbidities', '.', 'intraoperative', 'outcome', 'including', 'warm', 'ischemia', 'time', '(', 'median', 'vs.', '.', 'min', ',', 'p', '.', ')', 'similar', '.', 'change', 'in', 'egfr', 'demonstrated', 'similar', 'decrease', 'sildenafil', 'versus', 'placebo', 'day', '(', '-', 'vs.', '-', ',', 'p', '.', ')', ',', 'day', '(', '-', 'vs.', '-', ',', 'p', '.', ')', ',', 'and', 'month', '(', '-', 'vs.', '-', ',', 'p', '.', ')', 'following', 'rapn', '.', 'intermediate', 'follow', '(', 'median', 'day', ')', 'demonstrated', 'similar', 'result', '(', '-', 'vs.', '-', ',', 'p', '.', ')', 'two', 'cohort', '.', 'safety', 'profile', 'similar', 'two', 'cohort', 'without', 'adverse', 'reaction', 'to', 'sildenafil', '.', 'conclusion', 'successful', 'retention', 'of', 'patient', 'achieved', 'in', 'rct', '.', 'secondary', 'outcome', 'of', 'renoprotection', 'not', 'identified', '.', 'j.', 'surg', '.', 'oncol', '.', '-', '.', 'wiley', 'periodical', ',', 'inc', '.']"
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.,"Liang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, Xin-Jun Huang, Jing Yang, Ya-Hui Yu, Hu Liang, Guo-Ying Liu, Yan-Fang Ye, Yan-Qun Xiang, Xiang Guo, Xing Lv, Liang-Ru Keet al.",2017 Feb 15,BMC Cancer,https://pubmed.ncbi.nlm.nih.gov/28202000/,No keywords found,"['due', 'to', 'improvement', 'in', 'imaging', 'and', 'radiological', 'technique', 'well', 'use', 'of', 'chemotherapy', ',', 'distant', 'metastasis', 'become', 'predominant', 'mode', 'of', 'treatment', 'failure', 'in', 'patient', 'with', 'locally', 'advanced', 'nasopharyngeal', 'carcinoma', '(', 'la-npc', ')', '.', 'platinum-based', 'systemic', 'chemotherapy', 'shown', 'survival', 'benefit', 'and', 'standard', 'strategy', 'systemic', 'therapy', 'in', 'patient', 'with', 'la-npc', '.', 'notably', ',', 'third-generation', 'platinum', 'reagent', 'lobaplatin', 'shown', 'anti-tumor', 'effect', 'in', 'several', 'solid', 'tumor', 'with', 'lower', 'incidence', 'of', 'gastrointestinal', ',', 'hepatic', 'and', 'renal', 'toxicity', 'relative', 'to', 'platinum', 'drug', '.', 'however', ',', 'safety', 'and', 'efficacy', 'of', 'lobaplatin', 'first-line', 'regimen', 'in', 'patient', 'with', 'la-npc', 'undetermined', '.', 'method', 'patient', 'with', 'stage', 'iii-iva-b', 'npc', 'received', 'lobaplatin', 'dose', 'of', 'mgm', 'day', 'and', 'combined', 'with', 'continuous', '-h', 'intravenous', 'injection', 'of', '-fluorouracil', 'dose', 'of', 'gm', 'followed', 'lobaplatin', 'dose', 'of', 'mgm', 'day', 'and', 'concomitant', 'with', 'intensity-modulated', 'radiation', 'therapy', '.', 'objective', 'response', 'rate', 'and', 'acute', 'toxicity', 'assessed', 'based', 'recist', '(', '.', ')', 'and', 'ctcae', 'v', '..', ',', 'respectively', '.', 'kaplan-meier', 'analysis', 'used', 'to', 'calculate', 'survival', 'rate', '.', 'result', 'fifty-nine', 'patient', 'enrolled', ',', 'and', 'patient', '(', '.', ')', 'received', 'allocated', 'cycle', 'of', 'chemotherapy', '.', 'objective', 'response', 'rate', '.', '(', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', 'and', 'induction', 'chemotherapy', '(', 'ict', ')', 'and', 'concurrent', 'chemoradiotherapy', '(', 'crt', ')', ',', 'respectively', '.', 'with', 'median', 'follow-up', 'period', 'of', 'month', ',', '-year', 'estimated', 'progression-free', 'survival', 'and', 'overall', 'survival', '.', '(', 'ci', ',', '.', 'to', '.', ')', 'and', '.', '(', 'ci', ',', '.', 'to', ')', ',', 'respectively', '.', 'common', 'grade', '-', 'toxicity', 'neutropenia', '(', '.', ')', 'and', 'thrombocytopenia', '(', '.', ')', 'ict', 'and', 'crt', ',', 'respectively', '.', 'conclusion', 'lobaplatin', 'combined', 'with', '-fluorouracil', 'followed', 'lobaplatin-rt', 'treatment', 'showed', 'encouraging', 'anti-tumor', 'effect', 'with', 'tolerable', 'toxicity', 'in', 'patient', 'with', 'la-npc', '.', 'randomized', 'controlled', 'trial', 'of', 'lobaplatin', 'in', 'patient', 'with', 'la-npc', 'warranted', '.', 'trial', 'registration', 'trial', 'registered', 'with', 'chinese', 'clinical', 'trial', 'registry', 'and', 'approved', 'march', 'st', ',', ',', 'number', 'chictr-onc-', '.']"
Effects of aminophylline on the levels of neutrophil gelatinase-associated lipocalin (NGAL) in asphyxiated term neonates.,"Nazanin Maleki-Sadeghi, Parisa Rahmani, Ziba Aghsaeifard, Ghobad Heidari, Nazanin Maleki-Sadeghiet al.",2022 Aug,Arch Physiol Biochem,https://pubmed.ncbi.nlm.nih.gov/32299251/,No keywords found,"['study', 'evaluates', 'effect', 'of', 'aminophylline', 'in', 'reduction', 'of', 'ngal', 'level', 'in', 'perinatal', 'asphyxia', '.', 'method', 'term', 'neonate', 'with', 'hypoxic', 'ischaemic', 'encephalopathy', 'divided', 'two', 'group', ',', 'treatment', 'and', 'placebo', '.', 'urine', 'ngal', 'level', 'measured', 'day', 'one', 'and', 'four', 'of', 'treatment', 'using', 'bioporto', 'kit', 'in', 'group', '.', 'result', 'day', 'ngal', 'level', 'not', 'statistically', 'different', 'in', 'either', 'group', 'irrespective', 'of', 'age', ',', 'gender', 'and', 'mode', 'of', 'delivery', '.', 'th', 'day', ',', 'ngal', 'in', 'treatment', 'group', 'significantly', 'decreased', 'compared', 'to', 'day', 'level', 'and', 'placebo', 'day-', 'level', '.', 'significant', 'difference', 'seen', 'first', 'and', 'fourth', 'day', 'ngal', 'level', 'among', 'child', 'with', 'normal', 'and', 'caesarean', 'birth', 'and', 'among', 'female', 'and', 'male', 'neonate', '.', 'conclusion', 'following', 'treatment', 'with', 'aminophylline', ',', 'ngal', 'level', 'in', 'asphyxiated', 'neonate', 'likely', 'to', 'reduce', '.', 'study', 'based', 'kidney', 'dysfunction', 'parameter', 'lead', 'to', 'better', 'and', 'accurate', 'conclusion', '.']"
Effect of Hydroxyethyl Starch vs Saline for Volume Replacement Therapy on Death or Postoperative Complications Among High-Risk Patients Undergoing Major Abdominal Surgery: The FLASH Randomized Clinical Trial.,"Emmanuel Futier, Matthias Garot, Thomas Godet, Matthieu Biais, Daniel Verzilli, Alexandre Ouattara, Olivier Huet, Thomas Lescot, Gilles Lebuffe, Antoine Dewitte, Anna Cadic, Aymeric Restoux, Karim Asehnoune, Catherine Paugam-Burtz, Philippe Cuvillon, Marion Faucher, Camille Vaisse, Younes El Amine, Hélène Beloeil, Marc Leone, Eric Noll, Vincent Piriou, Sigismond Lasocki, Jean-Etienne Bazin, Bruno Pereira, Samir Jaber                              ;, FLASH Trial Group;, Christophe Jacob, Ioana Feitita, Elsa Deloge, Mylène Defaye, Olivier Joannes-Boyau, Pauline Carles, Guya Napolitano, Simon Monziols, Marie Vignaud, Solène Paul, Karim Gahbiche, Julie Fayon, Erwan Laroche, Antoine Brandely, Charlene Le Moal, Samir Jaber, Gérald Chanques, Audrey De Jong, Alice Millot, Anna Castagnoli, Bruno Pastene, Caroline Castelli, Sophie Medam, Lionel Velly, Esther Samba, Antoine Roquilly, Marguerite Le Penndu, Jean Yves Lefrant, Olivier Wira, Elisabeth Dubout, Willy-Serge Mfam, Emilie Begneu, Julien Burey, Teodora Cirilovic, Guillaume Allo, Julien Pottecher, Benjamin Lebas, Clementine Venot, Jean Pierre Rameau, Florin Dimache, Pierre Saint Léger, Emmanuel Futieret al.",2020 Jan 21,JAMA,https://pubmed.ncbi.nlm.nih.gov/31961418/,No keywords found,"['not', 'known', 'use', 'of', 'colloid', 'solution', 'containing', 'hydroxyethyl', 'starch', '(', 'he', ')', 'to', 'correct', 'intravascular', 'deficit', 'in', 'high-risk', 'surgical', 'patient', 'either', 'effective', 'or', 'safe', '.', 'objective', 'to', 'evaluate', 'effect', 'of', 'he', '.', 'compared', 'with', '.', 'saline', 'intravascular', 'volume', 'expansion', 'mortality', 'and', 'postoperative', 'complication', 'major', 'abdominal', 'surgery', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'multicenter', ',', 'double-blind', ',', 'parallel-group', ',', 'randomized', 'clinical', 'trial', 'of', 'adult', 'patient', 'increased', 'risk', 'of', 'postoperative', 'kidney', 'injury', 'undergoing', 'major', 'abdominal', 'surgery', 'university', 'hospital', 'in', 'france', 'february', 'to', 'july', 'final', 'follow-up', 'in', 'october', '.', 'intervention', 'patient', 'randomized', 'to', 'receive', 'fluid', 'containing', 'either', 'he', '.', 'diluted', 'in', '.', 'saline', '(', 'n', ')', 'or', '.', 'saline', 'alone', '(', 'n', ')', 'in', '-ml', 'bolus', 'using', 'individualized', 'hemodynamic', 'algorithm', 'surgery', 'and', 'to', 'hour', 'first', 'postoperative', 'day', ',', 'defined', 'ending', 'following', 'day', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'composite', 'of', 'death', 'or', 'major', 'postoperative', 'complication', 'day', 'surgery', '.', 'secondary', 'outcome', 'included', 'predefined', 'postoperative', 'complication', 'within', 'day', 'surgery', ',', 'duration', 'of', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', ',', 'and', 'all-cause', 'mortality', 'postoperative', 'day', 'and', '.', 'result', 'among', 'patient', 'enrolled', '(', 'mean', 'age', ',', 'sd', ',', 'year', 'woman', ')', ',', '(', ')', 'completed', 'trial', '.', 'primary', 'outcome', 'occurred', 'in', 'of', 'patient', '(', ')', 'in', 'he', 'group', 'and', 'of', 'patient', '(', ')', 'in', 'saline', 'group', '(', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'relative', 'risk', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'among', 'prespecified', 'secondary', 'outcome', 'reported', ',', 'showed', 'no', 'significant', 'difference', ',', 'statistically', 'significant', 'difference', 'found', 'in', 'median', 'volume', 'of', 'study', 'fluid', 'administered', 'day', 'ml', '(', 'interquartile', 'range', ',', '-', 'ml', ')', 'in', 'he', 'group', 'and', 'ml', '(', 'interquartile', 'range', ',', '-', 'ml', ')', 'in', 'saline', 'group', '(', 'median', 'difference', ',', 'ml', 'ci', ',', '-', 'ml', 'p', '.', ')', '.', 'day', 'surgery', ',', '.', 'and', '.', 'of', 'patient', 'died', 'in', 'he', 'and', 'saline', 'group', ',', 'respectively', '(', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'relative', 'risk', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'risk', 'of', 'postoperative', 'kidney', 'injury', 'undergoing', 'major', 'abdominal', 'surgery', ',', 'use', 'of', 'he', 'volume', 'replacement', 'therapy', 'compared', 'with', '.', 'saline', 'resulted', 'in', 'no', 'significant', 'difference', 'in', 'composite', 'outcome', 'of', 'death', 'or', 'major', 'postoperative', 'complication', 'within', 'day', 'surgery', '.', 'finding', 'not', 'support', 'use', 'of', 'he', 'volume', 'replacement', 'therapy', 'in', 'patient', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.,"Usama Shalaby, Usama Shalaby.",2017 Mar,Jpn J Ophthalmol,https://pubmed.ncbi.nlm.nih.gov/27943089/,No keywords found,"['to', 'investigate', 'effect', 'of', 'diltiazem', 'co-treatment', 'with', 'microemulsified', 'cyclosporine-a', '(', 'csa', ')', 'dosage', ',', 'blood', 'concentration', 'of', 'csa', ',', 'well', 'therapeutic', 'and', 'side', 'effect', 'in', 'patient', 'with', 'sight-threatening', 'non-infectious', 'intraocular', 'inflammation', '.', 'method', 'prospective', ',', 'randomized', ',', 'placebo-controlled', ',', 'open-label', 'trial', 'of', 'patient', 'with', 'sight-threatening', 'non-infectious', 'intraocular', 'inflammation', '.', 'change', 'in', 'visual', 'acuity', '(', 'logmar', ')', ',', 'grade', 'of', 'inflammatory', 'activity', ',', 'therapeutic', 'concentration', 'of', 'csa', 'in', 'blood', 'and', 'systemic', 'and', 'renal', 'toxicity', 'determined', 'comparing', 'two', 'group', ',', 'one', 'treated', 'with', 'csa', 'and', 'diltiazem', '(', 'treatment', 'group', ')', ',', 'and', 'without', 'diltiazem', '(', 'control', 'group', ')', '.', 'result', 'compared', 'with', 'control', 'group', ',', 'concentration', 'of', 'csa', 'in', 'blood', 'of', 'treatment', 'group', 'significantly', 'increased', '(', 'p', '.', ')', 'requiring', 'reduction', 'in', 'dosage', 'of', 'csa', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'patient', 'with', 'severe', 'intraocular', 'inflammation', 'treated', 'with', 'csa', 'and', 'diltiazem', ',', 'blood', 'concentration', 'of', 'csa', 'increased', 'dosage', 'decreased', '.', 'efficient', 'combination', 'therapy', 'reduced', 'patient', ""'s"", 'economic', 'burden', ',', 'time', 'decreasing', 'systemic', 'and', 'renal', 'toxicity', 'in', 'turn', 'may', 'promote', 'use', 'of', 'csa', 'longer', 'period', '.']"
Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF.,"C Ding, W Xue, P Tian, X Ding, X Pan, H Yan, H Xiang, X Feng, J Hou, X Tian, Y Li, J Zheng, C Dinget al.",2015 May:(183):8-15.,Int J Clin Pract Suppl,https://pubmed.ncbi.nlm.nih.gov/26176940/,No keywords found,"['lower', 'limit', 'of', 'exposure', 'to', 'cyclosporine', '(', 'csa', ')', 'not', 'yet', 'established', 'in', 'donation', 'cardiac', 'death', '(', 'dcd', ')', 'renal', 'transplantation', 'recipient', 'with', 'delayed', 'graft', 'function', '(', 'dgf', ')', 'receiving', 'enteric-coated', 'mycophenolate', 'sodium', '(', 'ec-mps', ')', 'therapy', '.', 'stable', 'and', 'adequate', 'mycophenolic', 'acid', '(', 'mpa', ')', 'dosing', 'may', 'facilitate', 'lower', 'csa', 'exposure', 'dcd', 'renal', 'transplantation', 'in', 'recipient', 'with', 'dgf', 'without', 'compromising', 'safety', '.', 'method', '-month', ',', 'single-centre', 'open-label', 'prospective', 'trial', 'performed', 'in', 'centre', '.', 'according', 'to', 'dgf', 'risk', 'index', 'using', 'previous', 'dgf', 'prediction', 'model', ',', 'divided', 'patient', 'oral', 'csa', 'either', 'dgf', 'group', '(', 'n', ')', 'and', 'no', 'dgf', 'group', '(', 'n', ')', '.', 'of', 'patient', 'initially', 'received', 'standard', 'ec-mps', 'dosing', '(', 'mgday', ')', '.', 'initial', 'dose', 'of', 'csa', 'in', 'low', 'risk', 'of', 'dgf', 'group', '.', 'mgkgday', 'and', 'in', 'high', 'risk', 'of', 'dgf', 'group', '.', 'mgkgday', '.', 'efficacy', 'parameter', ',', 'safety', 'and', 'tolerability', 'assessed', '-month', 'study', 'period', '.', 'result', 'incidence', 'of', 'dgf', '.', 'in', 'dcd', 'recipient', '.', 'dgf', 'group', 'and', 'no', 'dgf', 'group', ',', '-year', 'patient', 'survival', 'and', 'graft', 'survival', 'not', 'significantly', 'different', '.', 'incidence', 'of', 'bpar', 'higher', 'in', 'dgf', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'patient', 'in', 'dgf', 'group', 'recovery', 'of', 'renal', 'function', 'month', '.', 'adverse', 'event', 'two', 'group', 'not', 'significantly', 'different', '.', 'daily', 'ec-mps', 'dos', 'of', 'dgf', 'group', 'significantly', 'higher', 'no', 'dgf', 'group', '-month', 'follow-up', 'period', '.', 'no', 'significant', 'difference', 'two', 'group', 'regarding', 'mean', 'auc', 'level', 'follow-up', 'period', '.', 'conclusion', 'result', 'show', 'low', 'expose', 'csa', 'with', 'standard', 'dosing', 'of', 'ec-mps', 'and', 'thymoglobulin', 'efficacious', ',', 'safe', 'and', 'well-tolerated', 'in', 'dcd', 'renal', 'transplant', 'recipient', 'with', 'dgf', 'in', 'china', '.', 'furthermore', ',', 'stable', 'and', 'adequate', 'mpa', 'exposure', 'helped', 'to', 'reduce', 'dose', 'of', 'and', 'exposure', 'to', 'csa', '.', 'thus', ',', 'may', 'lead', 'to', 'less-induced', 'nephrotoxicity', 'and', 'better', 'renal', 'function', 'recovery', '.']"
Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib.,"Yanina J Jansen, Peter Janssens, Anne Hoorens, Max S Schreuer, Teofila Seremet, Sofie Wilgenhof, Bart Neyns, Yanina J Jansenet al.",2015 Dec,Melanoma Res,https://pubmed.ncbi.nlm.nih.gov/26512791/,No keywords found,"['-year-old', 'man', 'diagnosed', 'with', 'stage', 'iiib', 'braf', 'mutant', 'melanoma', 'in', 'october', '.', 'treated', 'with', 'combination', 'therapy', 'of', 'dabrafenib', 'and', 'trametinib', '.', 'remained', 'in', 'complete', 'remission', 'month', 'and', 'treatment', 'well', 'tolerated', 'dose', 'reduction', 'of', 'pyrexia', '.', 'in', 'march', ',', 'developed', 'bilateral', 'pitting', 'edema', 'of', 'leg', 'with', 'erythematous', ',', 'slightly', 'infiltrated', 'rash', 'back', 'and', 'upper', 'arm', '.', 'face', 'edematous', ',', 'with', 'heliotrope', 'rash-like', 'aspect', '.', 'eye', 'examination', 'showed', 'bilateral', 'blepharitis', '.', 'additional', 'blood', 'test', 'showed', 'inflammation', 'and', 'acute', 'kidney', 'injury', 'rifle', 'category', 'failure', '.', 'skin', 'and', 'kidney', 'biopsy', 'indicated', 'granulomatous', 'inflammation', '.', 'complete', 'workup', 'cause', 'of', 'granulomatous', 'inflammation', 'negative', '.', 'treatment', 'with', 'dabrafenib', 'and', 'trametinib', 'stopped', 'and', 'corticosteroid', 'initiated', ',', 'with', 'rapid', 'beneficial', 'effect', 'kidney', 'function', 'and', 'skin', 'rash', '.', 'corticosteroid', 'halted', 'month', ',', 'rapid', 'decline', 'in', 'kidney', 'function', 'observed', '.', 'reintroduction', 'of', 'corticosteroid', ',', 'kidney', 'function', 'normalized', 'and', 'steroid', 'could', 'tapered', 'gradually', 'month', '.', 'to', 'knowledge', ',', 'interstitial', 'nephritis', 'not', 'described', 'in', 'patient', 'braf-targeted', 'mek-targeted', 'therapy', 'melanoma', ',', 'although', 'described', 'in', 'melanoma', 'patient', 'treated', 'with', 'immune', 'checkpoint', 'inhibitor', ',', 'ipilimumab', '.', 'currently', ',', 'patient', 'no', 'sign', 'of', 'local', 'or', 'distal', 'recurrence', 'of', 'melanoma', ',', 'notwithstanding', 'treatment', 'with', 'dabrafenib', 'and', 'trametinib', 'stopped', 'month', 'and', 'no', 'antimelanoma', 'therapy', 'initiated', '.']"
Phase I study of combined indomethacin and platinum-based chemotherapy to reduce platinum-induced fatty acids.,"Daphne L van der Velden, Geert A Cirkel, Julia M Houthuijzen, E van Werkhoven, Jeanine M L Roodhart, Laura G M Daenen, Sovann Kaing, Johan Gerrits, Nanda M Verhoeven-Duif, Cecile Grootscholten, Henk Boot, Cristisiana Sessa, Haiko J Bloemendal, Filip Y De Vos, Emile E Voest, Daphne L van der Veldenet al.",2018 May,Cancer Chemother Pharmacol,https://pubmed.ncbi.nlm.nih.gov/29574584/,No keywords found,"['chemotherapy-resistance', 'remains', 'major', 'obstacle', 'to', 'effective', 'anti-cancer', 'treatment', '.', 'previously', 'showed', 'platinum', 'analog', 'cause', 'release', 'of', 'two', 'fatty', 'acid', '.', 'platinum-induced', 'fatty', 'acid', '(', 'pifas', ')', 'induced', 'complete', 'chemoresistance', 'in', 'mouse', ',', 'whereas', 'co-administration', 'of', 'cox-', 'inhibitor', ',', 'indomethacin', ',', 'prevented', 'pifa', 'release', 'and', 'significantly', 'enhanced', 'chemosensitivity', '.', 'to', 'assess', 'safety', 'of', 'combining', 'indomethacin', 'with', 'platinum-based', 'chemotherapy', ',', 'and', 'to', 'explore', 'efficacy', 'and', 'associated', 'pifa', 'level', ',', 'multi-center', 'phase', 'trial', 'conducted', '.', 'method', 'study', 'comprised', 'of', 'two', 'arm', 'oxaliplatin', 'plus', 'capecitabine', '(', 'capox', ',', 'arm', ')', 'and', 'cisplatin', 'plus', 'gemcitabine', ',', 'capecitabine', 'or', 'fu', '(', 'arm', 'ii', ')', 'in', 'patient', 'regimen', 'indicated', 'standard', 'care', '.', 'indomethacin', 'escalated', 'to', 'mg', 'tid', ',', 'using', 'standard', 'design', 'per', 'arm', ',', 'and', 'administered', 'orally', 'day', 'around', 'chemo-infusion', 'cycle', 'two', 'onwards', '.', 'pifa', 'level', 'measured', 'and', 'treatment', 'initiation', ',', 'with', 'and', 'without', 'indomethacin', '.', 'result', 'thirteen', 'patient', 'enrolled', ',', 'of', 'ten', 'evaluable', 'safety', 'analysis', '.', 'in', 'arm', ',', 'no', 'dose-limiting', 'toxicity', 'observed', ',', 'and', 'indomethacin', 'dose', 'level', 'well-tolerated', '.', 'partial', 'response', 'observed', 'in', 'three', 'patient', '(', ')', '.', 'indomethacin', 'lowered', 'plasma', 'level', 'of', '-s-hydroxy-', ',', ',-heptadecatrienoic', 'acid', '(', '-s-hht', ')', ',', 'whereas', ',', ',', ',', '-hexadecatetraenoic', 'acid', '(', '(', 'n-', ')', ')', 'level', 'not', 'affected', '.', 'one', 'patient', 'included', 'in', 'arm', 'ii', 'renal', 'toxicity', 'led', 'to', 'closure', 'of', 'cohort', '.', 'conclusion', 'combined', 'indomethacin', 'and', 'capox', 'treatment', 'safe', 'and', 'reduces', 'concentration', 'of', '-s-hht', ',', 'may', 'associated', 'with', 'improved', 'chemosensitivity', '.', 'recommended', 'phase', 'ii', 'dose', 'mg', 'indomethacin', 'tid', 'given', 'day', 'surrounding', 'standard', 'dosed', 'capox', '.']"
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy.,"Silvia Chiesa, Stefan Hohaus, Lorenzo Falcinelli, Francesco D'Alò, Massimo Fabrizio Martelli, Stefania Manfrida, Francesco Beghella Bartoli, Cesare Colosimo, Vincenzo Valentini, Cynthia Aristei, Mario Balducci, Silvia Chiesaet al.",2020 Oct,Ann Hematol,https://pubmed.ncbi.nlm.nih.gov/32816079/,"CNS lymphoma, Chemoradiotherapy, Phase I study, Temozolomide.","['study', 'aimed', 'to', 'define', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'of', 'temozolomide', '(', 'tmz', ')', 'concurrent', 'with', 'radiotherapy', '(', 'rt', ')', 'high-dose', 'methotrexate', '(', 'hd-mtx', ')', 'newly', 'diagnosed', 'primary', 'central', 'nervous', 'system', 'lymphoma', '(', 'pcnsl', ')', '.', 'adult', 'patient', 'with', 'pcnsl', 'treated', 'according', 'to', 'response-adapted', 'strategy', '.', 'hd-mtx', '(', '.', 'gm', ')', 'followed', 'concomitant', 'rt', 'and', 'escalating', 'tmz', '(', '--', 'mgmday', ',', 'daysweek', ')', '.', 'total', 'radiation', 'dose', 'modulated', 'according', 'to', 'patient', ""'s"", 'response', 'to', 'hd-mtx', '.', 'patient', 'received', 'gy', 'to', 'whole', 'brain', 'plus', 'leptomeninges', 'to', 'c', ',', 'including', 'third', 'posterior', 'of', 'orbital', 'cavity', '(', 'clinical', 'target', 'volume', 'ctv', ')', ',', 'plus', ',', ',', 'or', 'gy', 'to', 'primary', 'site', ',', 'including', 'residual', 'mass', '(', 'ctv', ')', ',', 'complete', 'response', '(', 'cr', ')', ',', 'partial', 'response', '(', 'pr', ')', 'stable', 'disease', '(', 'sd', ')', ',', 'or', 'progressive', 'disease', '(', 'pd', ')', 'observed', ',', 'respectively', '.', 'acute', 'toxicity', 'graded', 'according', 'to', 'rtog-eortc', 'criterion', '.', 'dose-limiting', 'toxicity', '(', 'dlt', ')', 'defined', 'grade', 'hematological', 'toxicity', 'or', 'grade', '-', 'hepatic', 'toxicity', ',', 'although', 'mgmday', 'maximum', 'dose', 'regardless', 'of', 'dlt', '.', 'neurocognitive', 'function', 'evaluated', 'using', 'mini-mental', 'state', 'examination', '.', 'three', 'patient', 'enrolled', 'tmz', 'dose', 'level', '(', 'total', 'patient', ')', '.', 'twelve', 'lesion', 'treated', '.', 'six', 'patient', 'received', 'cycle', 'of', 'hd-mtx', ',', 'received', 'cycle', 'of', 'hepatic', 'or', 'renal', 'toxicity', '.', 'patient', 'completed', 'chemoradiotherapy', 'without', 'interruption', '.', 'no', 'dlt', 'event', 'recorded', '.', 'tmz', 'appears', 'to', 'tolerable', 'dose', 'of', 'mgmday', 'administered', 'concomitantly', 'with', 'radiotherapy', 'and', 'hd-mtx', '.']"
Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial.,"Michael T Hawkes, Andrea L Conroy, Robert O Opoka, Laura Hermann, Kevin E Thorpe, Chloe McDonald, Hani Kim, Sarah Higgins, Sophie Namasopo, Chandy John, Chris Miller, W Conrad Liles, Kevin C Kain, Michael T Hawkeset al.",2015 Oct 29:14:421.,Malar J,https://pubmed.ncbi.nlm.nih.gov/26510464/,No keywords found,"['severe', 'malaria', 'remains', 'major', 'cause', 'of', 'childhood', 'mortality', 'globally', '.', 'decreased', 'endothelial', 'nitric', 'oxide', 'associated', 'with', 'severe', 'and', 'fatal', 'malaria', '.', 'hypothesis', 'adjunctive', 'inhaled', 'nitric', 'oxide', '(', 'ino', ')', 'would', 'improve', 'outcome', 'in', 'african', 'child', 'with', 'severe', 'malaria', '.', 'method', 'randomized', ',', 'blinded', ',', 'placebo-controlled', 'trial', 'of', 'ino', 'ppm', 'non-rebreather', 'mask', 'versus', 'room', 'air', 'placebo', 'adjunctive', 'treatment', 'to', 'artesunate', 'in', 'child', 'with', 'severe', 'malaria', 'conducted', '.', 'primary', 'outcome', 'longitudinal', 'course', 'of', 'angiopoietin-', '(', 'ang-', ')', ',', 'endothelial', 'biomarker', 'of', 'malaria', 'severity', 'and', 'clinical', 'outcome', '.', 'result', 'one', 'hundred', 'and', 'eighty', 'child', 'enrolled', 'assigned', 'to', 'ino', 'and', 'to', 'placebo', '(', 'received', 'iv', 'artesunate', ')', '.', 'ang-', 'level', 'measured', 'first', 'h', 'of', 'hospitalization', 'not', 'significantly', 'different', 'group', '.', 'mortality', 'h', 'similar', 'group', '(', '.', ')', 'in', 'ino', 'group', 'v', '(', '.', ')', 'in', 'placebo', 'group', 'or', '.', ',', 'ci', '.-', '.', 'p', '..', 'clinical', 'recovery', 'time', 'and', 'parasite', 'clearance', 'kinetics', 'similar', '(', 'p', '.', ')', '.', 'methaemoglobinaemia', 'occurred', 'in', 'of', 'patient', 'receiving', 'ino', 'and', 'resolved', 'without', 'sequela', '.', 'incidence', 'of', 'neurologic', 'deficit', '(', '.', ')', '.', 'conclusion', 'ino', 'ppm', 'administered', 'non-rebreather', 'mask', 'safe', 'not', 'affect', 'circulating', 'level', 'of', 'ang-', '.', 'alternative', 'method', 'of', 'enhancing', 'endothelial', 'no', 'bioavailability', 'may', 'necessary', 'to', 'achieve', 'biological', 'effect', 'and', 'improve', 'clinical', 'outcome', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial.,"F J Bemelman, J W de Fijter, J Kers, C Meyer, H Peters-Sengers, E F de Maar, K A M I van der Pant, A P J de Vries, J-S Sanders, A Zwinderman, M M Idu, S Berger, M E J Reinders, C Krikke, I M Bajema, M C van Dijk, I J M Ten Berge, J Ringers, J Lardy, D Roelen, D-J Moes, S Florquin, J J Homan van der Heide, F J Bemelmanet al.",2017 Apr,Am J Transplant,https://pubmed.ncbi.nlm.nih.gov/27639190/,"calcineurin inhibitor (CNI), clinical research/practice, clinical trial, immunosuppressant, immunosuppression/immune modulation, kidney transplantation/nephrology.","['in', 'renal', 'transplantation', ',', 'use', 'of', 'calcineurin', 'inhibitor', '(', 'cnis', ')', 'associated', 'with', 'nephrotoxicity', 'and', 'immunosuppression', 'with', 'malignancy', 'and', 'infection', '.', 'trial', 'aimed', 'to', 'minimize', 'cni', 'exposure', 'and', 'total', 'immunosuppression', 'maintaining', 'efficacy', '.', 'performed', 'randomized', 'controlled', ',', 'open-label', 'multicenter', 'trial', 'with', 'early', 'cyclosporine', '(', 'csa', ')', 'elimination', '.', 'patient', 'started', 'with', 'basiliximab', ',', 'prednisolone', '(', 'p', ')', ',', 'mycophenolate', 'sodium', '(', 'mp', ')', ',', 'and', 'csa', '.', 'month', ',', 'immunosuppression', 'tapered', 'to', 'pcsa', ',', 'pmps', ',', 'or', 'peverolimus', '(', 'evl', ')', '.', 'primary', 'outcome', 'renal', 'fibrosis', 'and', 'inflammation', '.', 'secondary', 'outcome', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'and', 'incidence', 'of', 'rejection', 'month', '.', 'pmps', 'arm', 'prematurely', 'halted', '.', 'trial', 'continued', 'with', 'pcsa', '(', 'n', ')', 'and', 'pevl', '(', 'n', ')', '.', 'interstitial', 'fibrosis', 'and', 'inflammation', 'significantly', 'decreased', 'and', 'egfr', 'significantly', 'higher', 'in', 'pevl', 'arm', '.', 'cumulative', 'rejection', 'rate', '(', 'pevl', ')', 'and', '(', 'pcsa', ')', ',', '(', 'p', '.', ')', '.', 'post', 'hoc', 'analysis', 'of', 'hla', 'and', 'donor-specific', 'antibody', 'year', 'transplantation', 'revealed', 'no', 'difference', '.', 'individualized', 'immunosuppressive', 'strategy', 'of', 'early', 'cni', 'elimination', 'to', 'dual', 'therapy', 'with', 'everolimus', 'associated', 'with', 'decreased', 'allograft', 'fibrosis', ',', 'preserved', 'allograft', 'function', ',', 'and', 'good', 'efficacy', ',', 'also', 'with', 'serious', 'adverse', 'event', 'and', 'discontinuation', '.', 'valuable', 'alternative', 'regimen', 'in', 'patient', 'suffering', 'cni', 'toxicity', '.']"
High-Dose Antibiotic Cement Spacers Independently Increase the Risk of Acute Kidney Injury in Revision for Periprosthetic Joint Infection: A Prospective Randomized Controlled Clinical Trial.,"Michael M Valenzuela, Susan M Odum, William L Griffin, Bryan D Springer, Thomas K Fehring, Jesse E Otero, Michael M Valenzuelaet al.",2022 Jun,J Arthroplasty,https://pubmed.ncbi.nlm.nih.gov/35210153/,No keywords found,"['standard', 'treatment', 'periprosthetic', 'joint', 'infection', '(', 'pji', ')', 'involves', '-stage', 'exchange', 'with', 'placement', 'of', 'antibiotic-impregnated', 'cement', 'spacer', '(', 'ac', ')', '.', 'conflicting', 'evidence', 'exists', 'role', 'of', 'ac', 'in', 'development', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'first-stage', 'surgery', '.', 'in', 'randomized', 'clinical', 'trial', ',', 'aimed', 'to', 'compare', 'incidence', 'of', 'aki', 'first-stage', 'of', 'planned', '-stage', 'exchange', 'v', '-stage', 'exchange', '.', 'study', 'design', 'isolates', 'effect', 'of', 'ac', 'in', 'otherwise', 'identical', 'treatment', 'group', '.', 'method', 'primary', 'outcome', 'variable', 'aki', ',', 'defined', 'creatinine', '.', 'time', 'baseline', 'or', 'increase', 'of', '.', 'mgdl', '.', 'risk', 'factor', 'aki', 'evaluated', 'using', 'bivariate', 'statistical', 'test', 'and', 'multivariable', 'logistic', 'regression', '.', 'result', 'patient', 'underwent', 'first', 'stage', 'of', 'planned', '-stage', 'exchange', 'significantly', 'likely', 'to', 'develop', 'aki', 'compared', 'with', '-stage', 'exchange', 'group', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'multivariable', 'regression', 'analysis', ',', 'ac', 'placement', '(', 'odds', 'ratio', '.', ',', 'confidence', 'limit', '.-', '.', ')', 'and', 'chronic', 'kidney', 'disease', '(', 'odds', 'ratio', '.', ',', 'confidence', 'limit', '.-', '.', ')', 'independent', 'risk', 'factor', 'aki', '.', 'conclusion', 'study', 'provides', 'evidence', 'high-dose', 'antibiotic', 'cement', 'spacers', 'treatment', 'of', 'pji', 'independent', 'risk', 'factor', 'aki', '.', 'therefore', ',', 'effort', 'to', 'minimize', 'nephrotoxicity', 'employed', 'in', 'revision', 'pji', 'possible', '.']"
Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation.,"Jonathan S Bromberg, Matthew R Weir, A Osama Gaber, Michael A Yamin, Itzhak D Goldberg, Tracy J Mayne, Weizhong Cal, Matthew Cooper, Jonathan S Bromberget al.",2021 Feb 1,Transplantation,https://pubmed.ncbi.nlm.nih.gov/32265417/,No keywords found,"['patient', '(', '-', ')', 'undergoing', 'renal', 'transplantation', 'experience', 'acute', 'kidney', 'injury', 'resulting', 'in', 'delayed', 'graft', 'function', '.', 'ang-', 'hepatocyte', 'growth', 'factor', 'mimetic', 'bind', 'to', 'c-met', 'receptor', '.', 'in', 'animal', 'model', ',', 'ang-', 'decrease', 'apoptosis', ',', 'increase', 'proliferation', ',', 'and', 'promotes', 'organ', 'repair', 'and', 'function', '.', 'method', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'phase', 'trial', 'of', 'patient', 'undergoing', 'renal', 'transplantation', 'with', 'cch', 'urine', 'output', 'consecutive', 'hour', 'first', 'hour', 'posttransplantation', ',', 'or', 'creatinine', 'reduction', 'ratio', 'pretransplantation', 'to', 'hour', 'posttransplantation', '.', 'subject', 'randomized', 'to', ',', 'once-daily', 'iv', 'infusion', 'of', 'ang-', ',', 'mgkg', '(', 'n', ')', ',', 'or', 'placebo', '(', 'n', ')', '.', 'primary', 'endpoint', 'time', 'in', 'day', 'to', 'achieve', 'cc', 'urine', 'hour', '.', 'result', 'patient', 'treated', 'with', 'ang-', 'likely', 'to', 'achieve', 'primary', 'endpoint', 'of', 'cc', 'urine', 'hour', 'day', 'posttransplantation', '(', '.', 'versus', 'placebo', 'log-rank', 'test', '.', ',', 'p', '.', ')', '.', 'compared', 'with', 'placebo', ',', 'patient', 'in', 'ang-', 'arm', 'larger', 'increase', 'in', 'urine', 'output', 'lower', 'serum', 'creatinine', 'greater', 'reduction', 'in', 'c-reactive', 'protein', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'fewer', 'dialysis', 'session', 'and', 'shorter', 'duration', 'of', 'dialysis', 'fewer', 'hospital', 'day', 'significantly', 'less', 'graft', 'failure', 'and', 'higher', 'estimated', 'glomerular', 'filtration', 'rate', '.', 'adverse', 'event', 'occurred', 'in', 'similar', 'percentage', 'of', 'subject', 'in', 'arm', '.', 'event', 'per', 'subject', 'twice', 'high', 'in', 'placebo', 'arm', '.', 'conclusion', 'efficacy', 'signal', 'improved', 'renal', 'function', 'in', 'subject', 'treated', 'with', 'ang-', 'relative', 'to', 'placebo', ',', 'with', 'good', 'safety', 'profile', '.']"
Long-term safety of withholding standard prophylaxis in patients with moderate chronic kidney disease.,"E C Nijssen, P J Nelemans, R J Rennenberg, G V van Ommen, J E Wildberger, E C Nijssenet al.",2023 Jan,Eur Radiol,https://pubmed.ncbi.nlm.nih.gov/35763097/,"Acute kidney injury, Chronic kidney disease, Clinical practice guidelines, Contrast media, Prophylaxis.","['in', 'latest', 'version', 'of', 'esur', 'clinical', 'practice', 'guideline', 'safe', 'use', 'of', 'contrast', 'medium', ',', 'standard', 'prophylaxis', 'no', 'longer', 'recommended', 'patient', 'with', 'moderate', 'chronic', 'kidney', 'disease', '.', 'benefit', 'of', 'change', 'in', 'recommendation', 'patient', 'and', 'hospital', 'burden', 'numerated', '.', 'current', 'report', 'provides', 'data', 'long-term', 'safety', 'amacing', 'randomised', 'controlled', 'trial', '.', 'no', 'disadvantage', 'of', 'withholding', 'prophylaxis', 'could', 'discerned', '.', 'result', 'suggest', ',', 'in', 'population', ',', 'underlying', 'disease', 'relevant', 'survival', 'and', 'prognosis', 'contrast', 'administration', '.']"
De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.,"E Dannhorn, M Cheung, S Rodrigues, H Cooper, D Thorburn, D Patch, A K Burroughs, J O'Beirne, E Dannhornet al.",2014 Dec,Clin Transplant,https://pubmed.ncbi.nlm.nih.gov/25142496/,No keywords found,"['patient', 'studied', 'and', 'programmatic', 'change', 'de', 'novo', 'with', 'prograf', 'to', 'adoport', '.', 'outcome', ',', 'tacrolimus', 'level', ',', 'dos', ',', 'and', 'cost', 'compared', 'first-yr', 'post-lt.', 'result', 'ninety-four', 'patient', 'studied', ',', 'prograf', ',', 'adoport', '.', 'no', 'significant', 'difference', 'in', 'rejection', ',', 'cytomegalovirus', 'infection', ',', 'acute', 'kidney', 'injury', ',', 'sepsis', ',', 'or', 'graft', 'loss', 'observed', 'group', '.', 'tacrolimus', 'cost', 'significantly', 'reduced', 'with', 'de', 'novo', 'use', 'of', 'adoport', '.', 'day', 'dose', 'normalized', 'level', 'in', 'adoport', 'patient', 'showed', 'significant', 'variation', 'day', 'and', 'one', 'yr', ',', 'no', 'significant', 'difference', 'in', 'dos', 'or', 'level', 'of', 'tacrolimus', 'group', '.', 'conclusion', 'adoport', 'safe', 'and', 'effective', 'compared', 'to', 'prograf', 'used', 'de', 'novo', 'in', 'lt', 'patient', '.', 'tacrolimus', 'cost', 'significantly', 'reduced', 'use', 'of', 'adoport', '.']"
Intravenous magnesium sulfate: new method in prevention of contrast-induced nephropathy in primary percutaneous coronary intervention.,"Ata Firouzi, Mohsen Maadani, Reza Kiani, Farshad Shakerian, Hamid Reza Sanati, Ali Zahedmehr, Seyedabbas Nabavi, Mona Heidarali, Ata Firouziet al.",2015 Mar,Int Urol Nephrol,https://pubmed.ncbi.nlm.nih.gov/25475196/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'adverse', 'consequence', 'of', 'percutaneous', 'coronary', 'intervention', 'result', 'in', 'significant', 'morbidity', 'and', 'mortality', 'and', 'add', 'to', 'cost', 'of', 'diagnostic', 'and', 'interventional', 'cardiology', 'procedure', '.', 'various', 'pathophysiological', 'mechanism', 'proposed', 'ci-aki', 'and', 'various', 'agent', 'tested', 'prevention', '.', 'currently', 'general', 'agreement', 'adequate', 'pre-procedural', 'hydration', 'constitutes', 'cornerstone', 'of', 'prevention', ',', 'yet', 'report', 'of', 'use', 'of', 'agent', 'with', 'various', 'efficacy', '.', 'prospectively', 'tested', 'iv', 'magnesium', 'sulfate', '(', 'mg', ')', 'ci-aki', 'prevention', '.', 'method', 'and', 'design', 'study', 'prospective', ',', 'randomized', ',', 'open-labeled', ',', 'single-center', 'clinical', 'trial', '.', 'randomly', 'assigned', 'consecutive', 'patient', 'to', 'two', 'group', '.', 'first', 'group', 'control', 'group', 'with', 'routine', 'treatment', '(', 'n', ')', ',', 'and', 'second', 'group', 'study', 'group', 'with', 'routine', 'treatment', 'plus', 'iv', 'magnesium', 'sulfate', 'g', 'procedure', '(', 'n', ')', '.', 'serum', 'creatinine', 'measured', 'procedure', 'and', 'day', 'procedure', '.', 'primary', 'end', 'point', 'occurrence', 'of', 'ci-aki', 'within', 'h.', 'ci-aki', 'defined', '.', 'mgdl', 'or', 'increase', 'in', 'serum', 'creatinine', 'or', 'or', 'increase', 'baseline', 'serum', 'creatinine', '.', 'no', 'difference', 'in', 'definition', 'of', 'parameter', 'present', '.', 'result', 'control', 'and', 'study', 'group', 'comparable', 'in', 'overall', 'predicted', 'risk', 'of', 'ci-aki', '.', 'also', ',', 'type', 'and', 'volume', 'of', 'contrast', 'not', 'significantly', 'different', 'two', 'group', '.', 'following', 'angioplasty', ',', 'ci-aki', 'occurred', 'in', '(', '.', ')', 'patient', 'in', 'control', 'group', 'and', 'nine', '(', '.', ')', 'patient', 'in', 'study', 'group', 'significant', 'reduction', 'in', 'ci-aki', 'in', 'study', 'group', '(', 'p', '.', ')', '.', 'additionally', ',', 'no', 'mortality', 'or', 'need', 'hemodialysis', 'in', 'either', 'group', '.', 'conclusion', 'in', 'primary', 'pci', 'patient', ',', 'prophylactic', 'use', 'of', 'intravenous', 'mg', 'recommended', 'to', 'added', 'to', 'traditional', 'hydration', 'ci-aki', 'prevention', '.']"
Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatients: SHORTCIS Trial.,"Chaichana Chantharakhit, Nantapa Sujaritvanichpong, Chaichana Chantharakhitet al.",2022 Oct 1,Asian Pac J Cancer Prev,https://pubmed.ncbi.nlm.nih.gov/36308355/,No keywords found,"['supporting', 'data', 'exists', 'concerning', 'short', 'hydration', 'to', 'prevent', 'cisplatin-induced', 'nephrotoxicity', '.', 'however', ',', 'study', 'exist', '.', ',', 'data', 'remains', 'limited', ',', 'comprising', 'mostly', 'retrospective', 'data', '.', 'therefore', ',', 'study', 'would', 'like', 'to', 'evaluate', 'efficacy', 'of', 'short', 'hydration', 'using', 'prospective', 'cohort', 'study', '.', 'material', 'and', 'method', 'prospective', 'cohort', 'non-randomized', 'controlled', 'study', 'in', 'patient', 'receiving', 'intermediate', 'to', 'high', 'dos', 'of', 'cisplatin', '.', 'short', 'hydration', 'set', 'intervention', 'arm', ',', 'conventional', 'hydration', 'set', 'controlled', 'arm', '.', 'consecutive', 'estimate', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'compared', 'baseline', ',', 'week', ',', 'week', ',', 'week', ',', 'week', ',', 'and', 'week', 'group', 'using', 'multilevel', 'regression', 'analysis', 'with', 'random-effects', 'model', 'with', 'double', 'adjustment', '(', 'propensity', 'score', 'and', 'confounding', 'adjustment', ')', 'used', '.', 'trial', 'registered', 'with', 'thai', 'registry', 'of', 'clinical', 'trial', ',', 'shortcis', 'thaiclinicaltrials.org', ',', 'number', 'tctr', '.', 'result', 'patient', 'registered', '.', 'assigned', 'to', 'short', 'hydration', 'group', ',', 'assigned', 'to', 'conventional', 'hydration', 'group', '.', 'level', 'of', 'consecutive', 'egfr', 'of', 'group', 'receiving', 'short', 'hydration', 'stable', '(', 'regression', 'coefficient', '.', ')', ',', 'level', 'of', 'consecutive', 'egfr', 'of', 'group', 'receiving', 'conventional', 'hydration', 'declined', '(', 'regression', 'coefficient', '-.', ')', '.', 'multilevel', 'regression', 'analysis', 'of', 'consecutive', 'egfr', 'conventional', 'group', 'and', 'short', 'hydration', 'group', 'adjusted', 'random-effects', 'parameter', 'and', 'double', 'adjustment', 'significantly', 'different', '(', 'p-value', '.', ')', '.', 'analyzing', 'relationship', 'of', 'received', 'short', 'hydration', ',', 'could', 'significantly', 'reduce', 'risk', 'of', 'nephrotoxicity', 'well', ',', 'i.e', '.', 'acute', 'kidney', 'injury', '(', 'odds', 'ratio', '.', ',', 'ci', '.', ',', '.', ',', 'p-value', '.', ')', '.', 'conclusion', 'short', 'hydration', 'efficient', 'preventing', 'nephrotoxicity', 'conventional', 'hydration', 'protocol', 'in', 'patient', 'receiving', 'intermediate', 'to', 'high', 'dos', 'of', 'cisplatin', '.']"
Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors.,"Izumi Komoto, Norihiro Kokudo, Taku Aoki, Chigusa Morizane, Tetsuhide Ito, Takuya Hashimoto, Wataru Kimura, Naoya Inoue, Kiyoshi Hasegawa, Shunsuke Kondo, Hideki Ueno, Hisato Igarashi, Takamasa Oono, Masatoshi Makuuchi, Takeshi Takamoto, Ichiro Hirai, Akiko Takeshita, Masayuki Imamura, Izumi Komotoet al.",2022 Jul 8,Jpn J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/35411926/,No keywords found,"['phase', 'iii', 'study', 'conducted', 'to', 'evaluate', 'efficacy', ',', 'safety', 'and', 'pharmacokinetics', 'of', 'streptozocin', '(', 'stz', ')', 'in', 'japanese', 'patient', 'with', 'unresectable', 'or', 'metastatic', 'gastroenteropancreatic', 'neuroendocrine', 'tumor', '.', 'method', 'twenty-two', 'patient', 'received', 'to', 'cycle', 'of', 'intravenous', 'stz', 'either', 'mgm', 'daily', 'consecutive', 'day', 'every', 'week', '(', 'daily', 'regimen', ')', 'or', '-', 'mgm', 'weekly', 'week', '(', 'weekly', 'regimen', ')', '.', 'tumor', 'response', 'evaluated', 'using', 'modified', 'recist', 'criterion', 'ver', '.', '.', ',', 'and', 'adverse', 'event', 'assessed', 'grade', 'according', 'to', 'national', 'cancer', 'institute', 'ctcae', '(', 'ver', '.', '.', ')', '.', 'result', 'fourteen', '(', '.', ')', 'patient', 'completed', 'study', 'protocol', '.', 'no', 'patient', 'complete', 'response', 'partial', 'response', 'in', '(', '.', ')', ',', 'stable', 'disease', 'in', '(', '.', ')', ',', 'non-complete', 'responsenon-progressive', 'disease', 'in', '(', '.', ')', 'and', '(', '.', ')', 'non-evaluable', 'disease', '.', 'excluding', 'latter', ',', 'response', 'rate', 'in', 'daily', 'and', 'weekly', 'regimen', '.', '(', ')', 'and', '.', '(', ')', ',', 'respectively', ',', 'with', 'overall', 'response', 'rate', 'of', '.', '(', ')', '.', 'however', ',', 'best', 'overall', 'response', 'in', 'patient', 'showed', 'disease', 'control', 'rate', '.adverse', 'event', 'occurred', 'in', 'patient', ',', 'including', 'grade', 'adverse', 'event', 'in', 'patient', 'however', ',', 'no', 'grade', 'or', 'adverse', 'event', 'reported', '.', 'prophylactic', 'hydration', 'and', 'antiemetic', 'treatment', 'reduced', 'severity', 'and', 'incidence', 'of', 'nephrotoxicity', ',', 'nausea', 'and', 'vomiting', '.', 'plasma', 'stz', 'concentration', 'decreased', 'rapidly', 'termination', 'of', 'infusion', ',', 'with', 'half-life', 'of', '-', 'min', '.', 'neither', 'repeated', 'administration', 'dose', 'increase', 'affected', 'pharmacokinetic', 'parameter', '.', 'conclusion', 'stz', 'may', 'useful', 'option', 'japanese', 'patient', 'with', 'unresectable', 'or', 'metastatic', 'gastroenteropancreatic', 'neuroendocrine', 'tumor', '.']"
A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales.,"Tomefa E Asempa, Joseph L Kuti, Julie D Seroogy, Allison S Komirenko, David P Nicolau, Tomefa E Asempaet al.",2019 Aug,Clin Ther,https://pubmed.ncbi.nlm.nih.gov/31248681/,No keywords found,"['in', 'phase', 'iii', 'study', 'of', 'plazomicin', 'compared', 'with', 'colistin', 'in', 'patient', 'with', 'infection', 'due', 'to', 'carbapenem-resistant', 'enterobacteriaceae', '(', 'care', ')', ',', 'plazomicin', 'studied', 'treatment', 'of', 'critically', 'ill', 'patient', 'with', 'infection', 'caused', 'carbapenem-resistant', 'enterobacterales', '.', 'initial', 'plazomicin', 'dosing', 'guided', 'creatinine', 'clearance', '(', 'crcl', ')', 'and', 'subsequent', 'dos', 'adjusted', 'therapeutic', 'drug', 'monitoring', 'to', 'achieve', 'auc-', 'exposure', 'within', 'target', 'range', '(', '-', 'mghl', ')', '.', 'applied', 'hartford', 'nomogram', 'to', 'evaluate', 'whether', 'clinical', 'tool', 'could', 'reduce', 'plazomicin', 'trough', 'level', 'and', 'increase', 'proportion', 'of', 'patient', 'within', 'target', 'auc', 'range', '.', 'method', 'thirty-seven', 'patient', 'enrolled', 'in', 'cohort', 'or', 'of', 'care', 'eligible', 'analysis', '.', 'observed', '-hour', 'concentration', 'initial', 'dose', 'plotted', 'hartford', 'nomogram', 'to', 'determine', 'eligible', 'dosing', 'interval', 'group', '(', 'qh', ',', 'qh', 'or', 'qh', ')', '.', 'basis', 'of', 'baseline', 'crcl', ',', '-', 'or', '-mgkg', 'dose', 'simulated', 'with', 'nomogram-recommended', 'dosing', 'interval', '.', 'proportion', 'of', 'patient', 'in', 'dosing', 'interval', 'group', 'with', 'trough', 'mgl', '(', 'trough', 'threshold', 'associated', 'with', 'serum', 'creatinine', 'increase', '.', 'mgdl', 'in', 'product', 'label', ')', 'quantified', '.', 'simulated', 'interval-normalized', 'auc-', 'compared', 'with', 'target', 'auc', 'range', '.', 'finding', 'among', 'patient', 'with', 'crcl', 'mlmin', ',', 'nomogram', 'recommended', 'every', '--', 'hour', 'dosing', 'in', 'and', 'extended-interval', '(', 'qh', 'or', 'qh', ')', 'in', 'of', 'patient', '.', 'patient', 'with', 'crcl', '-', 'mlmin', '(', 'n', ')', ',', 'nomogram', 'recommended', 'every', '--', 'hour', 'dosing', 'and', 'extended-interval', 'in', 'and', 'of', 'patient', ',', 'respectively', '.', 'among', 'renal', 'function', 'cohort', ',', 'exposure', 'simulation', 'with', 'nomogram', 'significantly', 'reduced', 'proportion', 'of', 'patient', 'with', 'trough', 'concentration', 'mgl', '(', 'crcl', 'mlmin', 'cohort', 'v', ',', 'p', '.', 'crcl', '-', 'mlmin', 'cohort', ',', 'v', ',', 'p', '.', ')', '.', 'relative', 'to', 'observed', 'mean', '(', 'sd', ')', 'auc-', 'of', 'mghml', '(', 'mghml', ')', ',', 'simulation', 'of', 'extended', 'interval', 'resulted', 'in', 'mean', 'interval-normalized', 'auc-', 'of', 'mghml', '(', 'mghml', ')', 'in', 'patient', 'eligible', 'extended', 'interval', ',', 'resulting', 'in', 'similar', 'proportion', '(', 'v', ')', 'of', 'patient', 'within', 'target', 'auc-', 'range', 'first', 'dose', '.', 'implication', 'application', 'of', 'hartford', 'nomogram', 'successfully', 'reduced', 'likelihood', 'of', 'elevated', 'plazomicin', 'trough', 'concentration', 'improving', 'auc', 'exposure', 'in', 'patient', 'with', 'carbapenem-resistant', 'enterobacterales', 'infection', '.']"
"Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial.","Hyun-Sook Kim, Won-Ho Choi, Bo Young Kim, Sung Soo Kim, Sang-Il Lee, Sang-Hyon Kim, Sung Jae Choi, Geun-Tae Kim, Jin-Wuk Hur, Myeung-Su Lee, Yun Sung Kim, Seung-Jae Hong, Hyun-Sook Kimet al.",2020 Jun,J Int Med Res,https://pubmed.ncbi.nlm.nih.gov/32589073/,No keywords found,"['celecoxib', 'selective', 'cyclooxygenase', '(', 'cox', ')', '-', 'inhibitor', 'commonly', 'used', 'to', 'reduce', 'incidence', 'of', 'gastrointestinal', '(', 'gi', ')', 'complication', 'in', 'patient', 'with', 'rheumatoid', 'arthritis', '(', 'ra', ')', '.', 'celbesta', 'generic', 'equivalent', 'to', 'celebrex', ',', 'celecoxib', 'preparation', '.', 'study', 'compared', 'efficacy', 'and', 'safety', 'of', 'celbesta', 'and', 'celebrex', 'in', 'patient', 'with', 'ra', '.', 'method', 'multicenter', ',', 'double-blind', ',', 'double-dummy', ',', 'active-controlled', ',', 'randomized', ',', 'parallel-group', ',', 'non-inferiority', 'clinical', 'trial', '.', 'primary', 'endpoint', 'change', 'baseline', 'in', 'self-assessed', 'pain', 'intensity', 'determined', 'using', '-mm', 'visual', 'analog', 'scale', 'week', 'of', 'treatment', '.', 'result', 'washout', 'period', ',', 'eligible', 'subject', 'randomized', 'to', 'one', 'of', 'two', 'group', '(', 'celbesta', 'group', ',', 'n', 'celebrex', 'group', ',', 'n', ')', '.', 'celbesta', 'not', 'inferior', 'to', 'celebrex', 'upper', 'limit', 'of', 'two-sided', 'confidence', 'interval', '(', 'ci', ')', 'difference', 'two', 'group', '(', 'difference', 'in', 'least', 'square', 'l', 'mean', ',', '-', '.', 'mm', 'two-sided', 'ci', '-', '.', 'mm', 'to', '-', '.', 'mm', ')', 'less', 'non-inferiority', 'margin', '(', 'mm', ')', '.', 'no', 'significant', 'difference', 'in', 'gi', 'complication', 'and', 'renal', 'toxicity', '.', 'conclusion', 'celbesta', 'not', 'inferior', 'to', 'celebrex', 'with', 'regard', 'to', 'pain', 'relief', 'efficacy', 'in', 'ra', 'patient', ',', 'and', 'tolerability', 'and', 'safety', 'profile', 'excellent', 'and', 'similar', 'level', 'preparation', '.']"
Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.,"Joseph Scarpa, Emilie Bruzelius, Patrick Doupe, Matthew Le, James Faghmous, Aaron Baum, Joseph Scarpaet al.",2019 Mar 1,JAMA Netw Open,https://pubmed.ncbi.nlm.nih.gov/30848803/,No keywords found,"['randomized', 'systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', ')', 'showed', 'lowering', 'systolic', 'blood', 'pressure', 'target', 'adult', 'with', 'hypertension', 'reduces', 'cardiovascular', 'morbidity', 'and', 'mortality', 'in', 'general', '.', 'however', ',', 'whether', 'overall', 'benefit', 'intensive', 'blood', 'pressure', 'control', 'mask', 'important', 'heterogeneity', 'in', 'risk', 'unknown', '.', 'objective', 'to', 'test', 'hypothesis', 'overall', 'benefit', 'observed', 'in', 'sprint', 'masked', 'important', 'heterogeneity', 'in', 'risk', 'intensive', 'blood', 'pressure', 'control', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'in', 'exploratory', ',', 'hypothesis-generating', ',', 'ad', 'hoc', ',', 'secondary', 'analysis', 'of', 'data', 'obtained', 'participant', 'in', 'sprint', ',', 'random', 'forest-based', 'analysis', 'used', 'to', 'identify', 'potential', 'heterogeneous', 'treatment', 'effect', 'using', 'half', 'of', 'trial', 'data', '.', 'cox', 'proportional', 'hazard', 'regression', 'model', 'applied', 'to', 'test', 'potential', 'heterogeneous', 'treatment', 'effect', 'remaining', 'data', '.', 'original', 'trial', 'conducted', 'site', 'in', 'united', 'state', 'november', 'and', 'march', '.', 'analysis', 'conducted', 'november', 'and', 'august', '.', 'intervention', 'participant', 'assigned', 'systolic', 'blood', 'pressure', 'target', 'of', 'less', 'mm', 'hg', '(', 'intervention', 'treatment', ')', 'or', 'of', 'less', 'mm', 'hg', '(', 'standard', 'treatment', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'composite', 'cardiovascular', 'outcome', 'myocardial', 'infarction', ',', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'heart', 'failure', ',', 'or', 'death', 'cardiovascular', 'cause', '.', 'result', 'of', 'participant', 'in', 'sprint', ',', 'participant', '(', '.', ')', 'current', 'smoker', 'with', 'systolic', 'blood', 'pressure', 'greater', 'mm', 'hg', 'baseline', ',', 'with', 'participant', '(', '.', ')', 'randomized', 'to', 'training', 'data', 'set', 'and', 'participant', '(', '.', ')', 'randomized', 'to', 'testing', 'data', 'set', 'participant', '(', '.', ')', 'male', ',', 'and', 'mean', '(', 'sd', ')', 'age', '.', '(', '.', ')', 'year', '.', 'combination', 'of', 'covariates', '(', 'ie', ',', 'baseline', 'smoking', 'status', 'and', 'systolic', 'blood', 'pressure', ')', 'distinguished', 'participant', 'differentially', 'affected', 'intervention', '.', 'in', 'testing', 'data', ',', 'cox', 'proportional', 'hazard', 'model', 'primary', 'outcome', 'revealed', 'number', 'needed', 'to', 'harm', 'of', '.', 'to', 'cause', 'event', 'across', '.', 'year', 'among', 'participant', ',', 'baseline', ',', 'current', 'smoker', 'with', 'systolic', 'blood', 'pressure', 'greater', 'mm', 'hg', '(', '.', 'of', 'of', 'primary', 'outcome', 'event', 'intervention', 'treatment', 'v', '.', 'of', 'standard', 'treatment', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'subgroup', 'also', 'associated', 'with', 'higher', 'likelihood', 'to', 'experience', 'acute', 'kidney', 'injury', 'intensive', 'blood', 'pressure', 'control', '(', 'with', 'frequency', 'of', '.', 'of', 'of', 'acute', 'kidney', 'injury', 'event', 'intervention', 'treatment', 'v', '.', 'of', 'standard', 'treatment', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'in', 'secondary', 'analysis', 'of', 'sprint', 'data', ',', 'current', 'smoker', 'with', 'baseline', 'systolic', 'blood', 'pressure', 'greater', 'mm', 'hg', 'higher', 'rate', 'of', 'cardiovascular', 'event', 'in', 'intensive', 'treatment', 'group', 'v', 'standard', 'treatment', 'group', '.', 'research', 'needed', 'to', 'evaluate', 'potential', 'tradeoff', 'of', 'intensive', 'blood', 'pressure', 'control', 'in', 'hypertensive', 'smoker', '.']"
Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study.,"A A Khalafallah, M Slancar, W Cosolo, E Abdi, B Chern, R J Woodfield, M C Copeman, A A Khalafallahet al.",2018 Mar,Eur J Cancer Care (Engl),https://pubmed.ncbi.nlm.nih.gov/28134499/,"bone metastasis, long-term safety, osteonecrosis of the jaw, renal impairment, zoledronic acid.","['.-.', ')', '.', 'although', 'of', 'patient', 'reported', 'serious', 'adverse', 'event', ',', 'two', 'case', 'suspected', 'zol', 'related', '.', 'no', 'patient', 'confirmed', 'onj', '.', 'observed', 'incidence', 'of', 'new', 'renal', 'impairment', '(', 'none', 'due', 'to', 'zol', ')', '.', 'study', 'confirms', 'benefit', 'risk', 'of', 'continuing', 'monthly', 'zol', 'least', 'year', 'in', 'patient', 'with', 'advanced', 'cancer', 'involving', 'bone', '.']"
"A prospective, randomized, comparison study on effect of perioperative use of chloride liberal intravenous fluids versus chloride restricted intravenous fluids on postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass grafting surgeries.","K Bhaskaran, Ganapathy Arumugam, P V Vinay Kumar, K Bhaskaranet al.",2018 Oct-Dec,Ann Card Anaesth,https://pubmed.ncbi.nlm.nih.gov/30333337/,No keywords found,"['off-pump', 'coronary', 'artery', 'bypass', 'graft', '(', 'opcabg', ')', 'form', 'of', 'cabg', 'surgery', '.', 'performed', 'without', 'use', 'of', 'cardiopulmonary', 'bypass', 'machine', 'surgical', 'treatment', 'coronary', 'heart', 'disease', '.', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'one', 'of', 'common', 'postoperative', 'complication', 'of', 'opcabg', '.', 'previous', 'study', 'suggest', 'important', 'difference', 'related', 'to', 'intravenous', 'fluid', '(', 'ivf', ')', 'chloride', 'content', 'and', 'renal', 'function', '.', 'hypothesize', 'perioperative', 'use', 'of', 'chloride', 'restricted', 'ivfs', 'may', 'decrease', 'incidence', 'and', 'severity', 'of', 'postoperative', 'aki', 'in', 'patient', 'undergoing', 'opcabg', '.', 'method', 'six', 'hundred', 'patient', 'randomly', 'divided', 'two', 'group', 'of', '.', 'in', 'group', '(', 'n', ')', ',', 'chloride', 'liberal', 'ivfs', ',', 'namely', ',', 'hydroxyethyl', 'starch', '(', '.', ')', 'in', '.', 'normal', 'saline', '(', 'voluven', ')', ',', '.', 'normal', 'saline', ',', 'and', 'ringer', ""'s"", 'lactate', 'used', 'perioperative', 'fluid', 'management', '.', 'in', 'group', 'b', '(', 'n', ')', ',', 'chloride-restricted', 'ivfs', ',', 'namely', ',', 'hydroxyethyl', 'starch', '(', '.', ')', 'in', 'balanced', 'colloid', 'solution', '(', 'volulyte', ')', 'and', 'balanced', 'salt', 'crystalloid', 'solution', '(', 'plasmalyte', ')', ',', 'used', 'perioperative', 'fluid', 'management', '.', 'serum', 'creatinine', 'value', 'taken', 'preoperatively', ',', 'postoperatively', 'h', 'and', 'h.', 'postoperative', 'aki', 'determined', 'aki', 'network', '(', 'akin', ')', 'criterion', '.', 'result', 'in', 'group', ',', '.', 'patient', 'and', 'in', 'group', 'b', '.', 'patient', 'developed', 'stage-i', 'aki', 'determined', 'akin', 'criterion', 'statistically', 'significant', '(', 'p', '.', ')', '.', 'conclusion', 'perioperative', 'use', 'of', 'chloride', 'restricted', 'ivf', 'found', 'to', 'decrease', 'incidence', 'of', 'postoperative', 'aki', '.', 'use', 'of', 'chloride', 'liberal', 'ivf', 'associated', 'with', 'hyperchloremic', 'metabolic', 'acidosis', '.']"
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.,"Erin Frazee, Andrew D Rule, John C Lieske, Kianoush B Kashani, Jason N Barreto, Abinash Virk, Philip J Kuper, Ross A Dierkhising, Nelson Leung, Erin Frazeeet al.",2017 May,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/28131530/,No keywords found,"['aim', 'of', 'study', 'to', 'determine', 'whether', 'vancomycin', 'dosing', 'algorithm', 'based', 'estimated', 'glomerular', 'filtration', 'rate', 'creatinine', 'and', 'cystatin', 'c', 'level', '(', 'egfrcr-cys', ')', 'improves', 'target', 'trough', 'concentration', 'achievement', 'compared', 'to', 'algorithm', 'based', 'estimated', 'creatinine', 'clearance', '(', 'eclcr', ')', 'in', 'critically', 'ill', 'patient', '.', 'study', 'design', 'prospective', 'quality', 'improvement', 'project', 'evaluated', 'intensive', 'care', 'unit', '(', 'icu', ')', 'patient', 'started', 'intravenous', 'vancomycin', 'using', 'one', 'of', 'different', 'strategy', '.', 'dosing', 'regimen', 'selected', 'and', 'implemented', 'individualized', 'goal', 'trough', 'range', 'established', '(', '-', 'or', '-mgl', ')', '.', 'steady-state', 'goal', 'trough', 'achievement', 'compared', 'treatment', 'arm', 'with', 'and', 'without', 'adjustment', 'potential', 'confounders', '.', 'setting', 'participant', 'medical', 'and', 'surgical', 'icu', 'single', 'tertiary', 'medical', 'center', '.', 'quality', 'improvement', 'plan', 'january', 'to', 'october', ',', 'vancomycin', 'dosed', 'according', 'to', 'eclcr', 'using', 'cockcroft-gault', 'formula', '(', 'control', 'arm', ')', '.', 'december', 'to', 'may', ',', 'multidisciplinary', 'quality', 'improvement', 'team', 'implemented', 'novel', 'vancomycin', 'dosing', 'algorithm', 'according', 'to', 'egfrcr-cys', 'using', 'ckd-epi', 'equation', '(', 'intervention', 'arm', ')', '.', 'outcome', 'steady-state', 'initial', 'goal', 'vancomycin', 'trough', 'concentration', 'achievement', '.', 'measurement', 'result', 'patient', 'in', 'intervention', 'arm', '(', 'of', ')', 'achieved', 'therapeutic', 'trough', 'vancomycin', 'level', 'in', 'control', 'arm', '(', 'of', 'or', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', '.', 'improved', 'trough', 'achievement', 'maintained', 'even', 'adjustment', 'age', ',', 'sex', ',', 'apache', '(', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', ')', 'iii', 'score', ',', 'fluid', 'balance', ',', 'baseline', 'clcr', ',', 'surgical', 'admission', 'diagnosis', ',', 'presence', 'of', 'sepsis', ',', 'and', 'goal', 'trough', 'concentration', 'range', '(', 'adjusted', 'or', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', '.', 'clinical', 'outcome', 'similar', 'group', '.', 'limitation', 'nonrandomized', ',', 'incomplete', 'algorithm', 'compliance', '.', 'conclusion', 'vancomycin', 'dosing', 'nomogram', 'based', 'egfrcr-cys', 'significantly', 'improved', 'goal', 'trough', 'achievement', 'compared', 'to', 'eclcr', 'among', 'icu', 'patient', 'with', 'stable', 'kidney', 'function', '.', 'study', 'warranted', 'to', 'characterize', 'relationship', 'use', 'of', 'cystatin', 'c-guided', 'dosing', 'and', 'clinical', 'outcome', '.']"
"Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation.","Allan R Glanville, Christina Aboyoun, Walter Klepetko, Hermann Reichenspurner, Hendrik Treede, Erik A Verschuuren, Annette Boehler, Christian Benden, Peter Hopkins, Paul A Corris                              ;, European and Australian Investigators in Lung Transplantation, Allan R Glanvilleet al.",2015 Jan,J Heart Lung Transplant,https://pubmed.ncbi.nlm.nih.gov/25049068/,No keywords found,"['chronic', 'lung', 'allograft', 'dysfunction', '(', 'clad', ')', ',', 'predominantly', 'manifest', 'bronchiolitis', 'obliterans', 'syndrome', '(', 'bos', ')', ',', 'primary', 'cause', 'of', 'morbidity', 'and', 'death', 'lung', 'transplantation', '.', 'assessed', 'efficacy', 'and', 'safety', 'of', 'de', 'novo', 'immunosuppression', 'protocol', 'to', 'prevent', 'bos', '.', 'method', 'multicenter', ',', 'prospective', ',', 'international', ',', 'randomized', '(', ')', 'open-label', 'superiority', 'study', 'of', 'de', 'novo', 'enteric-coated', 'mycophenolate', 'sodium', '(', 'mp', ')', 'v', 'delayed-onset', 'everolimus', '(', 'rad', ')', ',', 'arm', 'in', 'combination', 'with', 'cyclosporine', '(', 'csa', ')', 'monitored', '-hour', 'post-dose', '(', 'c', ')', 'level', ',', 'and', 'corticosteroid', '.', 'target', 'c', 'level', 'lower', 'in', 'rad', 'group', 'rad', 'known', 'to', 'potentiate', 'csa', 'nephrotoxicity', '.', 'cytolytic', 'induction', 'therapy', 'not', 'used', '.', 'patient', 'stratified', 'entry', 'cystic', 'fibrosis', '.', 'confirmation', 'of', 'anastomotic', 'healing', 'required', 'randomization', '.', 'primary', 'efficacy', 'freedom', 'bos', 'grade', 'intention-to-treat', '(', 'itt', ')', 'analysis', '.', 'secondary', 'efficacy', 'parameter', 'patient', 'and', 'graft', 'survival', 'and', 'severity', 'of', 'rejection', '.', 'treatment', 'failure', 'defined', 'graft', 'loss', ',', 'patient', 'death', ',', 'drug', 'cessation', ',', 'or', 'need', 'therapy', '.', 'result', '-year', 'freedom', 'bos', 'grade', 'mp', '(', 'n', ')', 'v', 'rad', '(', 'n', 'p', '.', 'log-rank', ')', 'in', 'itt', 'lower', 'in', 'rad', 'arm', 'of', 'per-protocol', 'population', '(', 'p', '.', ')', '.', '-year', 'survival', '(', 'mp', ')', 'v', '(', 'rad', 'p', '.', 'log-rank', ')', '.', 'thirteen', 'patient', 'switched', 'mp', 'v', 'rad', '(', 'p', '.', ')', '.', 'day', 'mp', 'greater', 'day', 'rad', '(', 'p', '.', ')', '.', 'rejection', 'event', 'proven', 'biopsy', 'specimen', 'common', 'mp', '(', 'p', '.', ')', ',', 'leucopenia', '(', 'p', '.', ')', ',', 'diarrhea', '(', 'p', '.', ')', ',', 'and', 'cytomegalovirus', 'infection', '(', 'p', '.', ')', '.', 'venous', 'thromboembolism', 'frequent', 'rad', '(', 'p', '.', ')', '.', 'creatinine', 'year', 'moliter', 'in', 'mp', 'patient', 'v', 'moliter', 'in', 'rad', 'patient', '(', 'p', '.', ')', '.', 'conclusion', '-year', 'itt', 'analysis', 'found', 'no', 'significant', 'difference', 'arm', 'underpowered', 'to', 'accept', 'null', 'hypothesis', 'rad', 'and', 'mp', 'equivalent', 'efficacy', 'in', 'preventing', 'bos', 'or', 'death', 'lung', 'transplantation', '.']"
"Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.","Jong Wook Song, Jae Kwang Shim, Sarah Soh, Jaewon Jang, Young Lan Kwak, Jong Wook Songet al.",2015 Feb,Nephrology (Carlton),https://pubmed.ncbi.nlm.nih.gov/25384603/,No keywords found,"['aim', 'of', 'study', 'to', 'investigate', 'influence', 'of', 'perioperative', 'n-acetylcysteine', '(', 'nac', ')', 'administration', ',', 'known', 'antioxidant', ',', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'off-pump', 'coronary', 'bypass', 'surgery', '(', 'opcab', ')', 'in', 'patient', 'with', 'known', 'risk', 'factor', 'of', 'aki', '.', 'method', 'one', 'hundred', 'and', 'seventeen', 'patient', 'with', 'of', 'following', 'risk', 'factor', 'of', 'aki', 'randomized', 'either', 'control', '(', 'n', ')', 'or', 'nac', '(', 'n', ')', 'group', '(', ')', 'preoperative', 'serum', 'creatinine', '.', 'mgdl', '(', 'ii', ')', 'left', 'ventricular', 'ejection', 'fraction', 'year', '(', 'iv', ')', 'diabetes', 'or', '(', 'v', ')', 're-operation', '.', 'patient', 'in', 'nac', 'group', 'received', 'mgkg', 'of', 'nac', 'iv', 'bolus', 'anaesthetic', 'induction', 'followed', 'continuous', 'infusion', 'mgkg', 'per', 'day', 'h.', 'aki', 'diagnosed', 'based', 'acute', 'kidney', 'injury', 'network', 'criterion', 'h', 'postoperatively', '.', 'result', 'incidence', 'of', 'aki', '(', ')', 'and', '(', ')', 'in', 'control', 'and', 'nac', 'group', ',', 'respectively', '(', 'p', '.', ')', '.', 'serum', 'concentration', 'of', 'creatinine', 'and', 'cystatin', 'c', 'similar', 'group', 'throughout', 'study', 'period', '.', 'fluid', 'balance', 'including', 'amount', 'of', 'blood', 'loss', 'and', 'transfusion', 'requirement', 'similar', 'group', 'except', 'amount', 'of', 'postoperative', 'urine', 'output', ',', 'higher', 'in', 'control', 'group', 'compared', 'with', 'nac', 'group', '(', 'ml', 'vs.', 'ml', ',', 'control', 'vs.', 'nac', ',', 'p', '.', ')', '.', 'conclusion', 'perioperative', 'administration', 'of', 'nac', 'not', 'prevent', 'development', 'of', 'postoperative', 'aki', 'opcab', 'in', 'highly', 'susceptible', 'patient', 'to', 'aki', '.']"
"N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.","Cassiana Mazon Fraga, Cristiane Damiani Tomasi, Danusa de Castro Damasio, Francieli Vuolo, Cristiane Ritter, Felipe Dal-Pizzol, Cassiana Mazon Fragaet al.",2016 Oct 17,Crit Care,https://pubmed.ncbi.nlm.nih.gov/27745551/,No keywords found,"['aim', 'to', 'test', 'primary', 'hypothesis', 'in', 'patient', 'suffering', 'shock', ',', 'treatment', 'with', 'n-acetylcysteine', '(', 'nac', ')', 'plus', 'deferoxamine', '(', 'dfx', ')', 'decrease', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'method', 'double-blind', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'conducted', 'in', 'general', 'intensive', 'care', 'unit', 'in', 'academic', 'hospital', '.', 'patient', 'included', 'new-onset', 'hypotension', ',', 'defined', 'mean', 'arterial', 'blood', 'pressure', 'mmhg', 'or', 'requirement', 'vasopressor', 'medication', '.', 'loading', 'dose', 'of', 'nac', 'or', 'placebo', 'of', 'mgkg', 'in', 'h', 'administered', 'intravenously', '.', 'loading', 'dose', ',', 'patient', 'received', 'mgkgday', 'next', 'h.', 'dfx', 'or', 'placebo', 'administered', 'mg', 'rate', 'of', 'mgkgh', '.', 'primary', 'outcome', 'incidence', 'of', 'aki', '.', 'result', 'total', 'of', 'patient', 'enrolled', 'in', 'study', '.', 'incidence', 'of', 'aki', 'in', 'placebo', 'arm', 'and', 'in', 'treatment', 'group', '(', 'relative', 'risk', '(', 'rr', ')', '.', '(', '.-.', ')', ')', '.', 'furthermore', ',', 'nac', 'plus', 'dfx', 'effective', 'in', 'decreasing', 'severity', 'and', 'duration', 'of', 'aki', ',', 'and', 'patient', 'in', 'treatment', 'group', 'lower', 'serum', 'creatinine', 'level', 'discharge', '.', 'no', 'severe', 'adverse', 'event', 'associated', 'with', 'treatment', 'reported', '.', 'effect', 'of', 'nac', 'plus', 'dfx', 'could', 'secondary', 'to', 'attenuation', 'of', 'early', 'inflammatory', 'response', 'and', 'oxidative', 'damage', '.', 'conclusion', 'administration', 'of', 'nac', 'plus', 'dfx', 'to', 'critically', 'ill', 'patient', 'new', 'episode', 'of', 'hypotension', 'not', 'decrease', 'incidence', 'of', 'aki', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '(', 'registered', 'march', '.', ')', '.']"
Guidewire exchange vs new site placement for temporary dialysis catheter insertion in ICU patients: is there a greater risk of colonization or dysfunction?,"Elisabeth Coupez, Jean-François Timsit, Stéphane Ruckly, Carole Schwebel, Didier Gruson, Emmanuel Canet, Kada Klouche, Laurent Argaud, Julien Bohe, Maïté Garrouste-Orgeas, Christophe Mariat, François Vincent, Sophie Cayot, Olivier Cointault, Alain Lepape, Michael Darmon, Alexandre Boyer, Elie Azoulay, Lila Bouadma, Alexandre Lautrette, Bertrand Souweine, Elisabeth Coupezet al.",2016 Jul 30,Crit Care,https://pubmed.ncbi.nlm.nih.gov/27473868/,No keywords found,"['intensive', 'care', 'unit', '(', 'icu', ')', 'patient', 'require', 'dialysis', 'catheter', '(', 'dc', ')', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'carry', 'high', 'risk', 'of', 'developing', 'end-stage', 'renal', 'disease', ',', 'and', 'therefore', 'vascular', 'access', 'must', 'preserved', '.', 'guidewire', 'exchange', '(', 'gwe', ')', 'often', 'used', 'to', 'avoid', 'venipuncture', 'insertion', '(', 'vpi', ')', 'new', 'site', '.', 'however', ',', 'impact', 'of', 'gwe', 'infection', 'and', 'dysfunction', 'of', 'dc', 'in', 'icu', 'unknown', '.', 'aim', 'to', 'compare', 'effect', 'of', 'gwe', 'and', 'vpi', 'dc', 'colonization', 'and', 'dysfunction', 'in', 'icu', 'patient', '.', 'method', 'using', 'data', 'elvis', 'randomized', 'controlled', 'trial', '(', 'rct', ')', '(', 'icu', 'adult', 'requiring', 'dc', 'rrt', 'or', 'plasma', 'exchange', ')', 'performed', 'matched-cohort', 'analysis', '.', 'case', 'dc', 'inserted', 'gwe', '(', 'n', ')', '.', 'matched', 'with', 'dc', 'inserted', 'vpi', '.', 'matching', 'criterion', 'participating', 'centre', ',', 'simplified', 'acute', 'physiology', 'score', '(', 'sap', ')', 'ii', '-', ',', 'insertion', 'site', '(', 'jugular', 'or', 'femoral', ')', ',', 'side', 'jugular', 'site', ',', 'and', 'length', 'of', 'icu', 'stay', 'dc', 'placement', '.', 'used', 'marginal', 'cox', 'model', 'to', 'estimate', 'effect', 'of', 'dc', 'insertion', '(', 'gwe', 'vs.', 'vpi', ')', 'dc', 'colonization', 'and', 'dysfunction', '.', 'result', 'dc', 'colonization', 'rate', 'not', 'different', 'gwe-dcs', 'and', 'vpi-dcs', '(', '(', '.', ')', 'group', ')', 'dc', 'dysfunction', 'frequent', 'with', 'gwe-dcs', '(', '(', '.', ')', 'vs.', '(', '.', ')', 'hazard', 'ratio', '(', 'hr', ')', ',', '.', '(', '.-', '.', ')', 'p', '.', ')', '.', 'result', 'similar', 'analysis', 'restricted', 'to', 'dc', 'changed', 'dysfunction', '.', 'conclusion', 'gwe', 'dc', 'in', 'icu', 'patient', ',', 'compared', 'with', 'vpi', 'not', 'contribute', 'to', 'dc', 'colonization', 'or', 'infection', 'associated', 'with', 'twofold', 'increase', 'in', 'dc', 'dysfunction', '.', 'trial', 'registration', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'registered', 'april', '.']"
"Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.","Shannon N Westin, Michael W Sill, Robert L Coleman, Steven Waggoner, Kathleen N Moore, Cara A Mathews, Lainie P Martin, Susan C Modesitt, Sanghoon Lee, Zhenlin Ju, Gordon B Mills, Russell J Schilder, Paula M Fracasso, Michael J Birrer, Carol Aghajanian, Shannon N Westinet al.",2019 Dec,Gynecol Oncol,https://pubmed.ncbi.nlm.nih.gov/31623857/,No keywords found,"['sought', 'to', 'determine', 'safety', 'and', 'efficacy', 'of', 'akt', 'inhibitor', ',', 'gsk', ',', 'combined', 'with', 'mek', 'inhibitor', ',', 'trametinib', ',', 'in', 'endometrial', 'cancer', '.', 'method', 'patient', 'with', 'measurable', 'recurrent', 'endometrial', 'cancer', 'eligible', '.', 'one', 'to', 'two', 'prior', 'cytotoxic', 'regimen', 'allowed', 'prior', 'use', 'of', 'mek', 'or', 'pik', 'pathway', 'inhibitor', 'excluded', '.', 'initial', 'trial', 'design', 'consisted', 'of', 'kras', 'mutation', 'stratified', 'randomized', 'phase', 'ii', 'with', 'safety', 'lead-in', 'evaluating', 'combination', '.', 'safety', 'lead', 'in', ',', 'previously', 'recommended', 'phase', 'dose', '(', 'rpd', 'trametinib', '.', 'mg', ',', 'gsk', 'mg', ')', 'chosen', 'dose', 'level', '(', 'dl', ')', '.', 'result', 'of', 'enrolled', 'patient', ',', 'treated', 'dl', 'and', 'treated', 'dl-', '(', 'trametinib', '.', 'mg', ',', 'gsk', 'mg', ')', '.', 'common', 'histology', 'endometrioid', '(', ')', 'and', 'serous', '(', ')', '.', 'four', 'of', '(', ')', 'patient', 'kras', 'mutant', '.', 'dose', 'limiting', 'toxicity', '(', 'dlts', ')', 'assessed', 'cycle', '.', 'dl', 'dlts', '(', 'hypertension', '(', 'n', ')', ',', 'mucositis', '(', ')', ',', 'rash', '(', ')', ',', 'dehydration', ',', 'strokeacute', 'kidney', 'injury', ')', '.', 'dl', 'deemed', 'non-tolerable', 'dl-', 'explored', '.', 'dl-', 'no', 'dlts', '.', 'sixty-five', 'percent', 'of', 'patient', 'grade', 'toxicity', '.', 'no', 'response', 'in', 'dl', '(', ',', 'ci', '-', ')', 'and', 'response', 'in', 'dl-', '(', '.', ',', 'ci', '.-.', ')', '.', 'proportion', 'pfs', 'month', 'dl', ',', 'and', 'dl-', '.', 'conclusion', 'combination', 'of', 'trametinib', 'and', 'gsk', 'high', 'level', 'of', 'toxicity', 'in', 'endometrial', 'cancer', 'previously', 'rpd', 'tolerable', 'reduced', 'dose', '.', 'due', 'to', 'insufficient', 'preliminary', 'efficacy', 'tolerable', 'dose', ',', 'phase', 'ii', 'study', 'not', 'initiated', '.']"
Clinical Study of Standard- vs Reduced-Dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Kidney Transplantation: A Prospective Randomized Trial.,"Jun Bae Bang, Chang-Kwon Oh, Man Ki Ju, Sung Joo Kim, Hee Chul Yu, Su Hyung Lee, Jun Bae Banget al.",2020 Jan-Feb,Transplant Proc,https://pubmed.ncbi.nlm.nih.gov/31898939/,No keywords found,"['lowering', 'of', 'calcineurin', 'inhibitor', 'exposure', 'possibly', 'considered', 'proper', 'strategy', 'to', 'prevent', 'calcineurin', 'inhibitor-induced', 'nephrotoxicity', 'in', 'kidney', 'transplant', '.', 'clinical', 'study', 'designed', 'to', 'compare', 'efficacy', 'and', 'tolerability', 'of', 'reduced-dose', 'tacrolimus', 'with', 'standard-dose', 'mycophenolate', 'mofetil', '(', 'mmf', ')', 'v', 'standard-dose', 'tacrolimus', 'with', 'reduced-dose', 'mmf', '.', 'method', 'prospective', ',', 'multicenter', ',', 'open-label', ',', 'randomized', ',', 'and', 'parallel-group', 'clinical', 'trial', 'conducted', 'transplant', 'center', 'in', 'korea', '.', 'total', 'sample', 'size', ',', 'and', 'eligible', 'patient', 'randomly', 'assigned', 'in', 'ratio', 'to', 'either', 'reduced-dose', 'tacrolimus', 'with', 'standard-dose', 'mmf', '(', 'study', 'group', ')', 'or', 'standard-dose', 'tacrolimus', 'with', 'reduced-dose', 'mmf', '(', 'control', 'group', ')', 'month', 'in', 'de', 'novo', 'kidney', 'transplant', 'recipient', '.', 'graft', 'function', ',', 'incidence', 'of', 'efficacy', 'failure', ',', 'and', 'adverse', 'event', 'compared', '.', 'result', 'mean', 'estimated', 'glomerular', 'filtration', 'rate', 'month', 'post-transplantation', '.', '.', 'mlmin', '.', 'in', 'study', 'group', 'and', '.', '.', 'mlmin', '.', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'overall', 'incidence', 'of', 'biopsy-proven', 'acute', 'rejection', '.', '(', 'n', ')', 'in', 'study', 'group', ',', 'compared', 'to', '.', '(', 'n', ')', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'no', 'graft', 'loss', ',', 'death', ',', 'or', 'loss', 'of', 'follow-up', 'in', 'either', 'group', '.', 'conclusion', 'in', 'conclusion', ',', 'result', 'suggest', 'tacrolimus', 'minimization', 'with', 'standard-dose', 'mmf', 'provides', 'adequate', 'immunosuppression', 'with', 'proper', 'renal', 'function', 'and', 'similar', 'rate', 'of', 'incidence', 'of', 'acute', 'rejection', 'compared', 'with', 'regimen', 'including', 'standard-dose', 'tacrolimus', 'with', 'reduced-dose', 'mmf', '.']"
Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.,"Eric H Decloedt, Maia Lesosky, Gary Maartens, John A Joska, Eric H Decloedtet al.",2017 Feb 4,AIDS Res Ther,https://pubmed.ncbi.nlm.nih.gov/28160772/,No keywords found,"['prevalence', 'of', 'bipolar', 'disorder', 'in', 'hiv-infected', 'patient', 'higher', 'general', 'population', '.', 'lithium', 'effective', 'mood', 'stabiliser', ',', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', 'frequently', 'used', 'part', 'of', 'combination', 'antiretroviral', 'therapy', '(', 'art', ')', '.', 'tdf', 'and', 'lithium', 'associated', 'with', 'renal', 'tubular', 'toxicity', ',', 'could', 'additive', ',', 'or', 'pharmacokinetic', 'interaction', 'may', 'occur', 'renal', 'transporter', 'with', 'decrease', 'in', 'tdf', 'elimination', '.', 'objective', 'report', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'using', 'modification', 'of', 'diet', 'in', 'renal', 'disease', 'formula', 'in', 'participant', 'received', 'art', 'including', 'tdf', 'and', 'enrolled', 'in', 'week', 'randomised', 'trial', 'of', 'lithium', 'versus', 'placebo', 'in', 'patient', 'with', 'hiv-associated', 'neurocognitive', 'impairment', '.', 'method', 'included', 'hiv-infected', 'adult', 'with', 'cognitive', 'impairment', 'established', 'art', 'least', 'month', 'with', 'suppressed', 'viral', 'load', 'attending', 'public', 'sector', 'art', 'clinic', 'in', 'cape', 'town', ',', 'south', 'africa', '.', 'excluded', 'participant', 'with', 'egfr', 'mlmin', 'and', 'treated', 'with', 'medication', 'predisposing', 'to', 'lithium', 'toxicity', '.', 'reviewed', 'participant', 'weekly', 'first', 'month', 'adverse', 'event', 'followed', 'weekly', 'visit', 'renal', 'function', 'assessment', ',', 'adverse', 'event', 'monitoring', 'and', 'adherence', '.', 'lithium', 'dose', 'titrated', 'to', 'achieve', 'maintenance', 'target', 'plasma', 'concentration', 'of', '.', 'and', '.', 'mmoll', '.', 'sham', 'lithium', 'concentration', 'generated', 'participant', 'receiving', 'placebo', '.', 'result', 'included', 'participant', 'allocated', 'to', 'lithium', 'arm', 'and', 'participant', 'allocated', 'to', 'placebo', 'arm', '.', 'baseline', 'characteristic', 'not', 'statistically', 'different', 'with', 'mean', 'age', 'of', '.', 'and', '.', 'year', ',', 'median', 'time', 'art', 'of', 'and', 'month', 'and', 'egfr', 'of', '.', 'and', '.', 'mlmin', 'in', 'lithium', 'and', 'placebo', 'arm', 'respectively', '.', 'no', 'statistical', 'significant', 'difference', 'in', 'reduction', 'in', 'egfr', 'or', 'increase', 'in', 'potassium', 'two', 'arm', 'week', '.', 'conclusion', 'found', '-week', 'treatment', 'of', 'hiv-infected', 'patient', 'with', 'lithium', 'and', 'tdf', 'not', 'result', 'in', 'increased', 'nephrotoxicity', '.', 'trial', 'registration', 'study', 'registered', 'pan', 'african', 'clinical', 'trial', 'registry', '(', 'pactr', ')', 'with', 'identifier', 'number', 'pactr', '.', 'registered', 'october', 'first', 'participant', 'enrolled', '.']"
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.,"Stephen J McWilliam, Anna Rosala-Hallas, Ashley P Jones, Victoria Shaw, William Greenhalf, Thomas Jaki, Alan R Smyth, Rosalind L Smyth, Munir Pirmohamed, Stephen J McWilliamet al.",2020 Feb 4,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/32020028/,No keywords found,"['protekt', 'study', 'tested', 'hypothesis', 'rosuvastatin', 'inhibit', 'aminoglycoside-induced', 'nephrotoxicity', 'in', 'child', 'with', 'cystic', 'fibrosis', '(', 'cf', ')', '.', 'open', 'label', ',', 'parallel', 'group', ',', 'randomised', 'controlled', 'trial', 'recruited', 'child', 'and', 'young', 'people', 'aged', 'to', 'year', 'with', 'cf', 'paediatric', 'cf', 'treatment', 'centre', 'in', 'uk', '.', 'participant', 'randomised', 'equally', 'to', 'either', 'receive', 'oral', 'rosuvastatin', '(', 'mg', 'daily', ')', 'or', 'no', 'intervention', '(', 'control', ')', 'throughout', 'clinically', 'indicated', 'treatment', 'with', 'intravenous', 'tobramycin', '.', 'primary', 'outcome', 'difference', 'group', 'in', 'mean', 'fold-change', 'in', 'urinary', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', '.', 'fifty', '(', 'rosuvastatin', 'n', ',', 'control', 'n', ')', 'participant', 'recruited', 'may', 'and', 'january', '.', 'primary', 'outcome', 'data', 'available', '(', 'rosuvastatin', 'n', ',', 'control', 'n', ')', '.', 'estimated', 'mean', 'treatment', 'difference', 'in', 'geometric', 'mean-fold', 'change', 'of', 'normalised', 'kim-', '.', '(', 'ci', '.-.', ',', 'p', '.', ')', '.', 'in', 'total', 'adverse', 'reaction', ',', 'mild', ',', 'reported', 'five', 'participant', 'randomised', 'to', 'rosuvastatin', ',', 'and', 'one', 'serious', 'adverse', 'event', 'in', 'group', '.', 'whilst', 'no', 'protective', 'effect', 'of', 'rosuvastatin', 'seen', ',', 'lower', 'expected', 'level', 'of', 'nephrotoxicity', 'in', 'cohort', '.', 'therefore', ',', 'neither', 'confirm', 'refute', 'hypothesis', 'rosuvastatin', 'protects', 'aminoglycoside', 'nephrotoxicity', '.']"
Comparison of postoperative ascites replacement strategies on time to first flatus after living donor liver transplantation: Albumin vs. lactated Ringer's solution.,"Seung-Young Oh, Hye-Young Woo, Leerang Lim, Hyunjae Im, Hannah Lee, Jeong-Moo Lee, Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Ho Geol Ryu, Seung-Young Ohet al.",2024 Jan,Clin Transplant,https://pubmed.ncbi.nlm.nih.gov/38289882/,No keywords found,"['insufficient', 'evidence', 'regarding', 'optimal', 'regimen', 'ascites', 'replacement', 'living', 'donor', 'liver', 'transplantation', '(', 'lt', ')', 'and', 'effectiveness', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'impact', 'of', 'replacing', 'postoperative', 'ascites', 'lt', 'with', 'albumin', 'time', 'to', 'first', 'flatus', 'recovery', 'with', 'early', 'ambulation', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'method', 'adult', 'patient', 'underwent', 'elective', 'living', 'donor', 'lt', 'seoul', 'national', 'university', 'hospital', 'to', 'randomly', 'assigned', 'to', 'either', 'albumin', 'group', 'or', 'lactated', 'ringer', ""'s"", 'group', ',', 'based', 'ascites', 'replacement', 'regimen', '.', 'replacement', 'of', 'postoperative', 'ascites', 'performed', 'patient', 'every', 'h', 'lt', 'patient', 'transferred', 'to', 'general', 'ward', '.', 'seventy', 'percent', 'of', 'ascites', 'drained', 'previous', 'h', 'replaced', 'next', 'h', 'with', 'continuous', 'infusion', 'of', 'fluid', 'with', 'prescribed', 'regimen', 'according', 'to', 'assigned', 'group', '.', 'in', 'albumin', 'group', ',', 'of', 'total', 'of', 'of', 'drained', 'ascites', 'replaced', 'with', 'albumin', 'solution', ',', 'and', 'remnant', 'replaced', 'with', 'lactated', 'ringer', ""'s"", 'solution', '.', 'in', 'lactated', 'ringer', ""'s"", 'group', ',', 'of', 'drained', 'ascites', 'replaced', 'with', 'lactated', 'ringer', ""'s"", 'solution', '.', 'primary', 'outcome', 'time', 'to', 'first', 'flatus', 'end', 'of', 'lt', 'and', 'secondary', 'outcome', 'incidence', 'of', 'aki', 'to', 'postoperative', 'day', '.', 'result', 'among', 'patient', 'screened', 'eligibility', ',', 'patient', 'enrolled', '.', 'mean', 'age', '.', 'year', ',', 'and', '.', '(', ')', 'male', '.', 'time', 'to', 'first', 'flatus', 'similar', 'two', 'group', '(', '.', '.', 'h', 'vs.', '.', '.', 'h', ',', 'p', '.', ')', '.', 'albumin', 'group', 'showed', 'higher', 'glomerular', 'filtration', 'rate', 'and', 'lower', 'incidence', 'of', 'aki', 'postoperative', 'day', ',', 'compared', 'to', 'lactated', 'ringer', ""'s"", 'group', '.', 'conclusion', 'using', 'lactated', 'ringer', ""'s"", 'solution', 'alone', 'replacement', 'of', 'ascites', 'living', 'donor', 'lt', 'not', 'reduce', 'time', 'to', 'first', 'flatus', 'and', 'associated', 'with', 'increased', 'risk', 'of', 'aki', '.', 'research', 'optimal', 'ascites', 'replacement', 'regimen', 'and', 'target', 'serum', 'albumin', 'level', 'corrected', 'lt', 'required', '.']"
Combination Therapy Use and Associated Events in Clinical Practice Following Dissemination of Trial Findings: A De-Implementation Study Using Interrupted Time Series Analysis.,"Heather M Campbell, Allison E Murata, Adam M Henrie, Todd A Conner, Heather M Campbellet al.",2024 Jan,Clin Ther,https://pubmed.ncbi.nlm.nih.gov/37953077/,No keywords found,"['take', 'year', ',', 'average', ',', 'trial', 'result', 'to', 'implemented', 'practice', '.', 'using', 'data', 'department', 'of', 'veteran', 'affair', '(', 'va', ')', ',', 'study', 'assessed', 'potential', 'impact', 'clinical', 'practice', 'of', 'dissemination', 'of', 'finding', 'randomized', ',', 'controlled', 'trial', 'reporting', 'harm', 'with', 'use', 'of', 'combination', 'therapy', '.', 'communication', 'research', 'and', 'va', 'pharmacy', 'benefit', 'management', 'service', '(', 'pbm', ')', 'provided', 'impetus', 'communication', 'pbm', 'finding', 'of', 'trial', 'in', 'accordance', 'with', 'policy', '.', 'method', 'in', 'de-implementation', 'study', ',', 'interrupted', 'time', 'series', 'analysis', 'used', 'assessing', 'prescribing', 'pattern', 'and', 'adverse', 'clinical', 'event', 'and', 'dissemination', 'of', 'trial', 'finding', '.', 'de-implementation', 'strategy', 'multicomponent', 'and', 'multilevel', '.', 'strategy', 'aligned', 'with', 'category', 'outlined', 'in', 'expert', 'recommendation', 'implementing', 'change', 'train', 'and', 'educate', 'stakeholder', ',', 'use', 'evaluative', 'and', 'iterative', 'strategy', ',', 'develop', 'stakeholder', 'inter-relationships', ',', 'change', 'infrastructure', ',', 'provide', 'interactive', 'assistance', ',', 'and', 'engage', 'consumer', '.', 'va', 'patient', 'with', 'type', 'diabetes', 'mellitus', ',', 'chronic', 'kidney', 'disease', 'stage', 'to', ',', 'and', 'moderate', 'or', 'severe', 'albuminuria', 'received', 'care', 'july', 'and', 'november', 'included', '.', 'patient', 'subgrouped', 'according', 'to', 'treatment', 'with', 'angiotensin-converting', 'enzyme', 'inhibitor', 'angiotensin', 'receptor', 'blocker', '.', 'primary', 'end', 'point', 'prevalence', 'of', 'combination', 'therapy', 'use', '.', 'secondary', 'end', 'point', 'incidence', 'of', 'acute', 'kidney', 'injury', 'and', 'hyperkalemia', '.', 'finding', 'study', 'followed', ',', 'patient', ',', 'of', 'used', 'combination', 'therapy', '.', 'data', 'available', ',', 'and', ',', 'patient', 'pre-', 'and', 'post-intervention', ',', 'respectively', 'among', ',', 'and', 'patient', 'used', 'combination', 'therapy', ',', 'median', 'age', 'and', 'year', ',', 'and', '.', 'and', '.', 'men', '.', 'one', 'month', 'following', 'communication', 'pbm', ',', 'reduction', 'in', 'combination', 'therapy', 'user', ',', 'acute', 'kidney', 'injury', 'event', ',', 'and', 'hyperkalemia', '.', '(', 'ci', ',', '.-', '.', ')', ',', '.', '(', 'ci', ',', '.-', '.', ')', ',', 'and', '.', '(', 'ci', ',', '.-', '.', ')', 'per', ',', 'patient', 'per', 'month', ',', 'respectively', '(', ',', 'p', '.', ')', ',', 'whereas', 'communication', ',', 'change', '.', '(', 'ci', ',', '.-', '.', ')', ',', '-', '.', '(', 'ci', ',', '.-', '.', ')', ',', 'and', '-', '.', '(', 'ci', ',', '.-', '.', ')', '(', ',', 'p', '.', ')', '.', 'implication', 'apparent', 'speed', 'and', 'impact', 'of', 'implementation', 'of', 'change', 'resulting', 'dissemination', 'of', 'trial', 'finding', 'va', 'clinical', 'practice', 'encouraging', '.', 'speed', 'of', 'implementation', 'much', 'faster', 'average', 'health', 'care', 'provider', 'in', 'united', 'state', '.', 'established', 'communication', 'research', 'and', 'clinical', 'practice', ',', 'well', 'established', 'policy', 'and', 'communication', 'pbm', 'and', 'clinical', 'practice', ',', 'may', 'model', 'health', 'care', 'organization', '.']"
Effects of Balanced Versus Saline-based Solutions on Acute Kidney Injury in Off-pump Coronary Artery Bypass Surgery: A Randomized Controlled Trial.,"Jae-Sik Nam, Wook-Jong Kim, Wan-Woo Seo, Sang-Wook Lee, Kyung-Woon Joung, Ji-Hyun Chin, Dae-Kee Choi, In-Cheol Choi, Jae-Sik Namet al.",2024 Sep,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/38960803/,No keywords found,"['to', 'determine', 'whether', 'balanced', 'solution', 'reduce', 'incidence', 'of', 'acute', 'kidney', 'injury', 'off-pump', 'coronary', 'artery', 'bypass', 'surgery', 'compared', 'with', 'saline', '.', 'design', 'randomized', 'controlled', 'trial', '.', 'setting', 'single', 'tertiary', 'care', 'center', '.', 'participant', 'patient', 'underwent', 'off-pump', 'coronary', 'artery', 'bypass', 'surgery', 'june', 'and', 'july', '.', 'intervention', 'balanced', 'solution-based', 'chloride-restrictive', 'intravenous', 'fluid', 'strategy', '.', 'measurement', 'and', 'main', 'result', 'primary', 'outcome', 'acute', 'kidney', 'injury', 'within', 'postoperative', 'day', ',', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', 'clinical', 'practice', 'guideline', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', '.', '(', ')', 'in', 'balanced', 'group', 'and', '.', '(', ')', 'in', 'saline', 'group', '.', 'difference', 'not', 'statistically', 'significant', '(', 'risk', 'difference', ',', '-', '.', 'confidence', 'interval', 'ci', ',', '-', '.', 'to', '.', 'risk', 'ratio', ',', '.', ',', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'compared', 'with', 'balanced', 'group', ',', 'saline', 'group', 'higher', 'level', 'of', 'intraoperative', 'serum', 'chloride', 'and', 'lower', 'base', 'excess', ',', 'resulted', 'in', 'lower', 'ph', '.', 'conclusion', 'in', 'patient', 'undergoing', 'off-pump', 'bypass', 'surgery', 'with', 'normal', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'intraoperative', 'balanced', 'solution-based', 'chloride-restrictive', 'intravenous', 'fluid', 'administration', 'strategy', 'not', 'decrease', 'rate', 'of', 'postoperative', 'acute', 'kidney', 'injury', 'compared', 'with', 'saline-based', 'chloride-liberal', 'intravenous', 'fluid', 'administration', 'strategy', '.']"
Effect of Albumin Addition to Cardiopulmonary Bypass Prime on Outcomes in Children Undergoing Open-Heart Surgery (EACPO Study)-A Randomized Controlled Trial.,"Abdul Rauf, Reena K Joshi, Neeraj Aggarwal, Mridul Agarwal, Manendra Kumar, Veronique Dinand, Raja Joshi, Abdul Raufet al.",2021 Jan,World J Pediatr Congenit Heart Surg,https://pubmed.ncbi.nlm.nih.gov/33078664/,No keywords found,"['paucity', 'of', 'literature', 'regarding', 'association', 'of', 'high', 'oncotic', 'priming', 'solution', 'pediatric', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'and', 'outcome', ',', 'and', 'no', 'consensus', 'exists', 'regarding', 'composition', 'of', 'optimal', 'cpb', 'priming', 'solution', '.', 'study', 'aimed', 'to', 'examine', 'impact', 'of', 'high', 'oncotic', 'pressure', 'priming', 'addition', 'of', 'human', 'albumin', 'outcome', '.', 'method', 'double-blinded', ',', 'randomized', 'controlled', 'study', 'done', 'in', 'pediatric', 'cardiac', 'intensive', 'care', 'unit', 'of', 'tertiary', 'care', 'hospital', '.', 'consecutive', 'child', 'with', 'congenital', 'heart', 'disease', 'admitted', 'open-heart', 'surgery', 'randomized', 'two', 'group', ',', 'study', 'group', 'received', 'additional', 'albumin', 'to', 'conventional', 'blood', 'prime', 'cpb', 'initiation', '.', 'result', 'enrolled', 'child', 'in', 'high', 'oncotic', 'prime', '(', 'added', 'albumin', ')', 'group', 'and', 'child', 'in', 'conventional', 'prime', 'group', '.', 'in', 'first', '-hour', 'postoperative', 'period', ',', 'child', 'in', 'albumin', 'group', 'significantly', 'lower', 'occurrence', 'of', 'hypotension', '(', '.', 'v', ',', 'p', '.', ')', ',', 'requirement', 'of', 'fluid', 'bolus', '(', '.', 'v', ',', 'p', '.', ')', ',', 'and', 'lactate', 'clearance', 'time', '(', 'v', 'hour', ',', 'p', '.', ')', '.', 'albumin', 'group', 'also', 'significantly', 'higher', 'platelet', 'count', '(', 'l', ')', 'hour', '(', 'v', ',', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'intra-cpb', 'hemodynamic', 'parameter', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', '.', 'in', 'subgroup', 'analysis', 'based', 'risk', 'category', ',', 'significantly', 'decreased', 'intensive', 'care', 'unit', 'stay', '(', 'v', 'day', ',', 'p', '.', ')', 'and', 'hospital', 'stay', '(', 'v', 'day', ',', 'p', '.', ')', 'found', 'in', 'albumin', 'group', 'in', 'low-risk', 'category', '.', 'conclusion', 'high', 'oncotic', 'pressure', 'cpb', 'prime', 'using', 'albumin', 'addition', 'might', 'beneficial', 'conventional', 'blood', 'prime', ',', 'and', 'study', 'provide', 'rationale', 'study', '.']"
The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients.,"Maryam Hami, Amir Bigdeli, Ramin Khameneh Bagheri, Omid Rajabi, Maryam Salehi, Farnaz Zahedi Avval, Maryam Hamiet al.",2019 Sep,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/31705746/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'common', 'cause', 'of', 'iatrogenic', 'acute', 'kidney', 'injury', '.', 'happened', 'commonly', 'in', 'patient', 'with', 'underlying', 'kidney', 'disease', '.', 'appeared', 'oxidative', 'stress', 'main', 'mechanism', 'of', 'contrast', 'nephropathy', '.', 'curcumin', 'suggested', 'herbal', 'antioxidant', 'agent', ',', 'decided', 'to', 'assess', 'effect', 'of', 'curcumin', 'in', 'preventing', 'of', 'complication', 'in', 'patient', 'with', 'underlying', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'need', 'coronary', 'angiography', '.', 'method', 'and', 'material', 'conducted', 'double', 'blind', ',', 'placebo-controlled', 'clinical', 'trial', 'in', 'moderate', 'to', 'severe', 'ckd', 'patient', 'underwent', 'coronary', 'angiography', 'or', 'angioplasty', '.', 'adjusted', 'dose', 'of', 'iodixanol', 'used', 'contrast', 'agent', 'in', 'of', '.', 'curcumin', 'or', 'placebo', 'administered', 'orally', ',', '.', 'g', 'daily', 'day', 'procedure', 'to', 'day', '.', 'cin', 'defined', 'increased', 'serum', 'creatinine', 'level.mgdl', 'or', 'increase', 'to', '.', 'time', 'of', 'baseline', 'within', 'hour', 'procedure', '.', 'urinary', 'ngal', 'test', 'also', 'done', 'next', 'day', 'angiography', '.', 'result', 'cin', 'occurred', 'in', '(', ')', 'of', 'patient', ',', '(', '.', ')', 'in', 'curcumin', 'group', 'and', '(', '.', ')', 'in', 'placebo', 'group', '(', 'odds', 'ratio', 'or', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'serum', 'creatinine', 'increased', 'hour', 'of', 'intervention', '..', 'mgdl', 'to', '..', 'mgdl', 'in', 'curcumin', 'group', 'and', '..', 'mgdl', 'to', '..', 'in', 'placebo', 'group', '.', 'no', 'significant', 'difference', 'mean', 'increase', 'in', 'serum', 'creatinine', 'concentration', 'in', 'placebo', 'group', 'and', 'curcumin', 'group', '(', 'difference', 'of', '.', 'mgdl', 'ci', ',', '-', '.', 'to', '.', 'p.', ')', '.', 'urinary', 'ngal', 'test', 'significantly', 'higher', 'in', 'patient', 'with', 'aki', '(', 'p.', ')', ',', ""n't"", 'difference', 'in', 'level', 'in', 'two', 'group', '(', 'p.', ')', 'conclusion', 'appeared', 'prophylactic', 'oral', 'curcumin', ""n't"", 'protective', 'effect', 'cin', 'in', 'high', 'risk', 'patient', 'undergone', 'coronary', 'procedure', '.']"
Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial.,"Nehal A Hassan, Faten Farid Awdallah, Maggie M Abbassi, Nirmeen A Sabry, Nehal A Hassanet al.",2018 Jan,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/28857848/,No keywords found,"['nebulized', 'antibiotic', 'offer', 'high', 'efficacy', 'due', 'to', 'significant', 'local', 'concentration', 'and', 'safety', 'with', 'minimal', 'blood', 'level', '.', 'study', 'evaluates', 'efficacy', 'and', 'nephrotoxicity', 'of', 'nebulized', 'versus', 'iv', 'amikacin', 'in', 'postcardiothoracic', 'surgical', 'patient', 'with', 'nosocomial', 'pneumonia', 'caused', 'multidrug-resistant', 'gram-', 'negative', 'bacillus', '.', 'design', 'prospective', ',', 'randomized', ',', 'controlled', 'study', 'surgical', 'patient', 'divided', 'two', 'group', '.', 'setting', 'postcardiac', 'surgery', 'icu', '.', 'intervention', 'first', 'gtroup', 'administered', 'iv', 'amikacin', 'mgkg', 'daily', '.', 'second', 'group', 'prescribed', 'amikacin', 'nebulizer', 'mg', 'twice', 'daily', '.', 'group', 'co-administered', 'iv', 'piperacillintazobactam', 'empirically', '.', 'patient', 'recruited', 'patient', 'diagnosed', 'either', 'hospital-acquired', 'pneumonia', 'or', 'ventilator-associated', 'pneumonia', '(', '.', ')', 'patient', 'diagnosed', 'with', 'hospital-acquired', 'pneumonia', ',', '(', '.', ')', 'patient', 'diagnosed', 'with', 'early', 'ventilator-associated', 'pneumonia', ',', 'and', '(', '.', ')', 'patient', 'with', 'late', 'ventilator-associated', 'pneumonia', '.', 'measurement', 'and', 'main', 'result', 'clinical', 'cure', 'in', 'group', 'assessed', 'day', 'of', 'treatment', 'primary', 'outcome', '.', 'efficacy', 'additionally', 'evaluated', 'assessing', 'length', 'of', 'hospital', 'stay', ',', 'icu', 'stay', ',', 'day', 'amikacin', ',', 'day', 'mechanical', 'ventilator', ',', 'mechanical', 'ventilator-free', 'day', ',', 'day', 'to', 'reach', 'clinical', 'cure', ',', 'and', 'mortality', 'rate', '.', 'lower', 'nephrotoxicity', 'in', 'nebulized', 'group', 'observed', 'significant', 'preservation', 'of', 'kidney', 'function', '(', 'p', '.', ')', '.', 'although', 'group', 'comparable', 'regarding', 'length', 'of', 'hospital', 'stay', ',', 'nebulizer', 'group', 'showed', 'shorter', 'icu', 'stay', '(', 'p', '.', ')', ',', 'lower', 'number', 'of', 'day', 'to', 'reach', 'complete', 'clinical', 'cure', '(', 'p', '.', ')', ',', 'fewer', 'day', 'mechanical', 'ventilator', '(', 'p', '.', ')', ',', 'and', 'fewer', 'day', 'amikacin', 'treatment', '(', 'p', '.', ')', '.', 'conclusion', 'nebulized', 'amikacin', 'showed', 'better', 'clinical', 'cure', 'rate', ',', 'less', 'icu', 'stay', ',', 'and', 'fewer', 'day', 'to', 'reach', 'complete', 'recovery', 'compared', 'to', 'iv', 'amikacin', 'surgical', 'patient', 'with', 'nosocomial', 'pneumonia', '.', 'also', 'less', 'nephrotoxic', 'option', 'associated', 'with', 'less', 'deterioration', 'in', 'kidney', 'function', '.']"
"Normal saline, the known but least-examined fluid therapy method for preventing heme-induced nephropathy in children with glucose 6 phosphate dehydrogenase deficiency: a randomized controlled clinical trial.","Afshin Safaei-Asl, Saba Emami, Adel Baghersalimi, Bahram Darbandi, Afagh Hassanzadeh Rad, Hamidreza Badeli, Afshin Safaei-Aslet al.",2023 Feb,Pediatr Nephrol,https://pubmed.ncbi.nlm.nih.gov/35507141/,No keywords found,"['glucose', 'phosphate', 'dehydrogenase', 'deficiency', '(', 'gpdd', ')', 'common', 'enzyme', 'deficiency', 'in', 'human', '.', 'randomized', 'clinical', 'trial', 'comparing', 'efficacy', 'of', 'different', 'type', 'of', 'fluid', 'therapy', 'prevention', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'following', 'hemolysis', 'in', 'patient', 'with', 'gpdd', 'lacking', '.', 'present', 'study', 'aimed', 'to', 'compare', 'efficacy', 'of', 'three', 'different', 'type', 'of', 'fluid', 'administration', ',', 'isotonic', 'saline', 'with', 'or', 'without', 'acetazolamide', 'versus', 'bicarbonate', 'solution', 'in', 'prevention', 'of', 'aki', 'among', 'child', 'with', 'acute', 'hemolysis', 'due', 'to', 'gpdd', '.', 'method', 'in', 'double-blind', 'randomized', 'controlled', 'clinical', 'trial', ',', 'infant', 'and', 'child', 'with', 'acute', 'hemolysis', 'due', 'to', 'gpdd', 'randomly', 'divided', 'three', 'group', 'consisting', 'of', 'participant', 'in', 'group', '.', 'group', 'received', 'normal', 'saline', '.', 'group', 'b', 'received', 'normal', 'saline', 'plus', 'oral', 'acetazolamide', 'dose', 'of', 'mgkgday', ',', 'and', 'group', 'c', 'received', 'half', 'saline', 'plus', 'meql', 'sodium', 'bicarbonate', '.', 'primary', 'outcome', 'of', 'study', 'frequency', 'of', 'aki', 'among', 'different', 'type', 'of', 'fluid', 'administration', '.', 'result', 'in', 'study', ',', '(', ')', 'patient', 'boy', 'with', 'mean', 'age', 'and', 'length', 'of', 'hospital', 'stay', 'of', '.', '.', 'year', 'and', '.', '.', 'h', ',', 'respectively', '.', 'aki', 'primary', 'outcome', 'of', 'study', 'occurred', 'in', 'one', 'patient', 'in', 'group', 'c', 'and', 'rate', 'of', 'aki', 'not', 'differ', 'significantly', 'among', 'patient', 'receiving', 'different', 'type', 'of', 'fluid', 'resuscitation', '(', 'p', '.', ')', '.', 'conclusion', 'normal', 'saline', 'equivalent', 'to', 'fluid', 'containing', 'alkalinizing', 'agent', 'in', 'preventing', 'heme-induced', 'nephropathy', 'in', 'patient', 'with', 'gpdd', '.', 'higher', 'resolution', 'version', 'of', 'graphical', 'abstract', 'available', 'supplementary', 'information', '.']"
A multicentre randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients.,"Brij Verma, Nora Luethi, Luca Cioccari, Patryck Lloyd-Donald, Marco Crisman, Glenn Eastwood, Neil Orford, Craig French, Rinaldo Bellomo, Johan Martensson, Brij Vermaet al.",2016 Sep,Crit Care Resusc,https://pubmed.ncbi.nlm.nih.gov/27604335/,No keywords found,"['normal', 'saline', '(', 'n', ')', 'commonly', 'used', 'crystalloid', 'solution', 'worldwide', 'contains', 'excess', 'of', 'chloride', 'and', 'may', 'cause', 'metabolic', 'acidosis', 'and', 'hyperchloraemia', '.', 'abnormality', 'may', 'attenuated', 'use', 'of', 'balanced', 'solution', 'plasma-lyte', '(', 'pl-', ')', '.', 'objective', 'to', 'assess', 'feasibility', ',', 'safety', 'and', 'biochemical', 'and', 'physiological', 'effect', 'of', 'resuscitation', 'with', 'n', 'versus', 'pl-', 'in', 'critically', 'ill', 'patient', '.', 'design', ',', 'setting', 'and', 'participant', 'exploratory', ',', 'multicentre', ',', 'doubleblind', ',', 'randomised', 'controlled', 'trial', 'involving', 'patient', 'aged', 'ge', 'year', 'prescribed', 'crystalloid', 'fluid', 'resuscitation', 'treating', 'clinician', 'july', 'and', 'october', ',', 'in', 'three', 'multidisciplinary', 'intensive', 'care', 'unit', 'in', 'melbourne', ',', 'victoria', ',', 'australia', '.', 'method', 'random', 'allocation', 'of', 'n', 'or', 'pl-', 'concealed', ',', 'and', 'fluid', 'delivered', 'in', 'indistinguishable', 'bag', '.', 'intervention', 'n', 'or', 'pl-', 'administered', 'fluid', 'resuscitation', 'and', 'subsequent', 'crystalloid', 'fluid', 'therapy', 'day', 'of', 'icu', 'admission', '.', 'treating', 'intensivist', 'determined', 'rate', 'and', 'frequency', 'of', 'fluid', 'administration', '.', 'main', 'outcome', 'measure', 'primary', 'outcome', 'daily', 'base', 'excess', '(', ')', '.', 'relevant', 'secondary', 'outcome', 'included', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'change', 'in', 'serum', 'creatinine', 'and', 'serum', 'chloride', 'level', ',', 'and', 'mortality', '.', 'result', 'seventy', 'patient', 'recruited', ',', 'with', 'in', 'n', 'group', 'and', 'in', 'pl-', 'group', 'available', 'analysis', '.', 'baseline', 'characteristic', 'of', 'study', 'patient', 'well', 'balanced', 'mean', 'age', 'and', 'year', ',', 'respectively', ',', 'and', 'nearly', 'two-thirds', 'of', 'patient', 'in', 'group', 'men', '.', 'median', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', 'iii', 'score', 'n', 'group', '(', 'interquartile', 'range', 'iqr', ',', '-', ')', 'and', 'pl-', 'group', '(', 'iqr', ',', '-', ')', '.', 'treatment', ',', 'no', 'significant', 'difference', 'in', 'worst', '(', 'negative', ')', 'median', 'n', 'and', 'pl-', 'group', '(', '-', 'meql', 'iqr', ',', '-', 'to', '-', 'meql', 'v', '-', 'meql', 'iqr', ',', '-', 'to', 'meql', 'p', '.', ')', '.', 'chloride', 'level', 'significantly', 'higher', 'with', 'n', 'therapy', '(', 'median', ',', 'mmoll', 'iqr', ',', '-', 'mmoll', 'v', 'mmoll', 'iqr', ',', '-', 'mmoll', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'incidence', 'of', 'aki', '(', 'p', '.', ')', ',', 'peak', 'creatinine', 'level', '(', 'p', '.', ')', 'or', 'icu', 'or', 'hospital', 'mortality', 'two', 'group', '.', 'conclusion', 'in', 'exploratory', ',', 'double-blind', ',', 'randomised', 'controlled', 'trial', ',', 'compared', 'with', 'n', ',', 'pl-', 'not', 'significantly', 'increase', 'value', 'in', 'critically', 'ill', 'patient', 'requiring', 'fluid', 'resuscitation', ',', 'decreased', 'peak', 'chloride', 'concentration', '.']"
Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial.,"Y Obi, K Kalantar-Zadeh, A Shintani, C P Kovesdy, T Hamano, Y Obiet al.",2018 Mar,J Intern Med,https://pubmed.ncbi.nlm.nih.gov/29044764/,No keywords found,"['systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', 'clinicaltrials.gov', ',', 'nct', ')', 'reported', 'reduced', 'cardiovascular', 'event', 'intensive', 'blood', 'pressure', '(', 'bp', ')', 'control', 'amongst', 'hypertensive', 'patient', 'without', 'diabetes', '.', 'however', ',', 'risk-benefit', 'profile', 'of', 'intensive', 'bp', 'control', 'may', 'differ', 'across', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'level', '.', 'method', 'post', 'hoc', 'analysis', 'of', 'sprint', '.', 'nondiabetic', 'hypertensive', 'adult', '(', 'n', ')', 'with', 'egfr', 'ml', 'per', 'min', 'per', '.', 'enrolled', 'u', 'facility', 'november', 'and', 'march', 'and', 'followed', 'august', '(', 'median', 'follow-up', ',', '.', 'year', ')', '.', 'patient', 'randomly', 'assigned', 'to', 'either', 'systolic', 'bp', 'target', 'of', 'or', 'mmhg', '(', 'intensive', 'or', 'standard', 'treatment', ',', 'respectively', ')', '.', 'outcome', 'of', 'interest', 'development', 'of', '(', ')', 'fatal', 'and', 'nonfatal', 'major', 'cardiovascular', 'event', 'and', '(', 'ii', ')', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'result', 'cardiovascular', 'benefit', 'intensive', 'treatment', 'attenuated', 'with', 'lower', 'egfr', '(', 'pinteraction', '.', ')', ',', 'whereas', 'egfr', 'not', 'modify', 'adverse', 'effect', 'aki', '(', 'pinteraction', '.', ')', '.', 'amongst', 'participant', 'with', 'egfr', 'ml', 'per', 'min', 'per', '.', ',', 'intensive', 'treatment', 'not', 'reduce', 'cardiovascular', 'outcome', '(', 'vs.', 'event', 'in', 'standard', 'group', ',', 'respectively', 'hazard', 'ratio', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', 'with', 'absolute', 'rate', 'difference', '(', 'ard', ')', 'of', '-', '.', '(', 'ci', ',', '-', '.', 'to', '.', ')', 'per', 'patient-years', ',', 'whereas', 'increased', 'aki', '(', 'vs.', 'event', 'in', 'standard', 'group', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', 'with', 'ard', 'of', '.', '(', 'ci', ',', '.', 'to', '.', ')', 'per', 'patient-years', '.', 'conclusion', 'intensive', 'bp', 'control', 'may', 'provide', 'little', 'or', 'no', 'benefit', 'and', 'even', 'harmful', 'patient', 'with', 'moderate-to-advanced', 'chronic', 'kidney', 'disease', '.']"
Safety and Efficacy of Low-Volume Preparation in the Elderly: Oral Sulfate Solution on the Day before and Split-Dose Regimens (SEE SAFE) Study.,"Min Seob Kwak, Jae Myung Cha, Hyo-Joon Yang, Dong Il Park, Kyeong Ok Kim, Jun Lee, Jeong Eun Shin, Young-Eun Joo, Jongha Park, Jeong-Sik Byeon, Hyun Gun Kim, Min Seob Kwaket al.",2019 Mar 15,Gut Liver,https://pubmed.ncbi.nlm.nih.gov/30400725/,No keywords found,"['use', 'of', 'low-volume', 'bowel', 'cleansing', 'agent', 'associated', 'with', 'greater', 'willingness', 'to', 'undergo', 'repeat', 'colonoscopy', '.', 'oral', 'sulfate', 'solution', '(', 'os', ')', 'recently', 'approved', 'low-volume', 'agent', 'however', ',', 'efficacy', 'and', 'safety', 'in', 'elderly', 'population', 'remain', 'unclear', '.', 'aimed', 'to', 'evaluate', 'efficacy', ',', 'safety', ',', 'and', 'acceptability', 'of', 'os', 'preparation', ',', 'in', 'comparison', 'to', 'of', 'standard', 'polyethylene', 'glycol', '(', 'peg', 'l', ')', 'preparation', ',', 'in', 'elderly', 'patient', '.', 'method', 'multicenter', ',', 'randomized', ',', 'investigator-blinded', 'study', 'conducted', '.', 'participant', 'randomized', 'to', 'receive', 'os', 'or', '-l', 'peg', 'with', 'split-dose', 'regimen', '.', 'bowel', 'cleansing', 'efficacy', 'assessed', 'using', 'boston', 'bowel', 'preparation', 'scale', '(', 'bbps', ')', '.', 'acceptance', ',', 'satisfaction', ',', 'and', 'preparation-related', 'symptom', 'recorded', '.', 'additionally', ',', 'blood', 'parameter', 'analyzed', 'electrolyte', 'abnormality', 'and', 'nephrotoxicity', '.', 'result', 'total', 'of', 'patient', 'analyzed', '.', 'no', 'group', 'difference', 'in', 'overall', 'bowel', 'cleansing', 'efficacy', 'observed', ',', 'with', '``', 'adequate', ""''"", 'preparation', 'achieved', 'in', '.', '(', ')', 'and', '.', '(', ')', 'of', 'patient', 'in', 'os', 'and', 'l', 'peg', 'group', ',', 'respectively', '(', 'p.', ')', '.', 'however', ',', 'mean', 'bbps', 'score', 'entire', '(', 'p.', ')', 'and', 'right', 'colon', '(', 'p.', ')', 'significantly', 'higher', 'in', 'os', 'group', 'in', '-l', 'peg', 'group', '.', 'severity', 'of', 'clinical', 'adverse', 'event', 'and', 'frequency', 'of', 'acute', 'kidney', 'injury', 'similarly', 'low', ',', 'and', 'no', 'clinically', 'meaningful', 'electrolyte', 'change', 'identified', '.', 'self-reported', 'score', 'regarding', 'amount', '(', 'p.', ')', 'and', 'feeling', '(', 'p.', ')', ',', 'well', 'overall', 'satisfaction', '(', 'p.', ')', 'and', 'willingness', 'to', 'repeat', 'preparation', '(', '.', 'v', '.', ',', 'p.', ')', ',', 'significantly', 'better', 'in', 'os', 'group', 'in', '-l', 'peg', 'group', '.', 'conclusion', 'in', 'elderly', 'individual', ',', 'os', 'with', 'split-dose', 'regimen', 'greater', 'acceptability', 'and', 'comparable', 'efficacy', 'in', 'bowel', 'cleansing', 'compared', 'to', '-l', 'peg', '.', '(', 'clinical', 'trial', 'registration', 'number', 'nct', ')', '.']"
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.,"Lilach Shema-Didi, Batya Kristal, Sarit Eizenberg, Nabil Marzuq, Majdy Sussan, Yulie Feldman-Idov, Pnina Ofir, Shaul Atar, Lilach Shema-Didiet al.",2016 Apr,Nephrology (Carlton),https://pubmed.ncbi.nlm.nih.gov/26370061/,No keywords found,"['contrast-induced-nephropathy', '(', 'cin', ')', 'associated', 'with', 'poor', 'outcome', ',', 'thus', 'prevention', 'of', 'cin', 'may', 'of', 'clinical', 'value', '.', 'erythropoietin', '(', 'epo', ')', 'shown', 'to', 'elicit', 'tissue-protective', 'effect', 'in', 'experimental', 'model', 'and', 'in', 'clinical', 'study', 'of', 'acute', 'kidney', 'injury', '.', 'therefore', 'evaluated', 'effectiveness', 'prevention', 'of', 'cin', 'coronary', 'angiography', '(', 'ca', ')', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'in', 'diabetic', 'patient', 'with', 'chronic', 'kidney', 'disease', '.', 'method', 'prospective', ',', 'randomized', ',', 'controlled', 'trial', 'carried', 'in', 'diabetic', 'patient', 'with', 'egfr', 'mlmin', 'underwent', 'non-urgent', 'ca', 'pci', '.', 'patient', 'received', 'normal', 'saline', 'and', 'n-acetyl', 'cysteine', 'ca', ',', 'with', 'or', 'without', ',', 'u', 'of', 'epo', 'administered', 'min', 'prior', 'to', 'ca', '.', 'cin', 'defined', 'increase', 'in', 'serum', 'creatinine', 'of', 'least', '.', 'mgdl', 'first', 'day', 'exposure', 'to', 'contrast', 'medium', '.', 'primary', 'outcome', 'incidence', 'of', 'cin', '.', 'secondary', 'outcome', 'sensitivity', 'and', 'positive', 'predictive', 'value', '(', 'ppv', ')', 'of', 'cystatin', 'c', '(', 'cc', ')', 'and', 'neutrophil-gelatinase-associated-lipocalin', '(', 'ngal', ')', 'diagnosis', 'of', 'cin', '.', 'result', 'observed', 'incidence', 'of', 'cin', '.', ',', 'significantly', 'lower', 'expected', 'high-risk', 'population', '.', 'administration', 'of', 'epo', 'prior', 'to', 'ca', 'not', 'reduce', 'incidence', 'of', 'cin', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'cc', 'and', 'ngal', 'demonstrated', 'low', 'sensitivity', '(', '.', ')', 'and', 'low', 'ppv', '(', '.', 'and', '.', ',', 'respectively', ')', 'detecting', 'cin', '.', 'conclusion', 'administration', 'of', 'epo', 'prior', 'to', 'ca', 'not', 'reduce', 'incidence', 'of', 'cin', '.', 'additional', 'prospective', 'research', 'with', 'larger', 'sample', 'size', 'and', 'in', 'patient', 'category', 'essential', 'to', 'define', 'potential', 'protective', 'effect', 'of', 'epo', 'prevention', 'of', 'cin', '.']"
Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.,"Chang-Kwon Oh, Kyu Ha Huh, Jongwon Ha, Yeong Hoon Kim, Yong-Lim Kim, Yu Seun Kim, Chang-Kwon Ohet al.",2015 Jan,Transplantation,https://pubmed.ncbi.nlm.nih.gov/24983307/,No keywords found,"['everolimus', 'and', 'cyclosporine', '(', 'csa', ')', 'exhibit', 'synergistic', 'immunosuppressive', 'activity', 'used', 'in', 'combination', '.', 'examined', 'safety', 'and', 'efficacy', 'of', 'use', 'of', 'everolimus', 'with', 'cyclosporine-sparing', 'strategy', 'in', 'de', 'novo', 'renal', 'transplant', 'recipient', '.', 'method', 'comparative', ',', 'parallel', ',', 'randomized', ',', 'open-label', '-year', 'study', 'performed', 'in', 'patient', 'five', 'transplant', 'center', 'to', 'compare', 'efficacy', 'and', 'tolerability', 'of', 'everolimus', 'and', 'reduced', 'exposure', 'csa', '(', 'investigational', 'group', ')', 'or', 'enteric-coated', 'mycophenolate', 'sodium', 'and', 'standard-exposure', 'csa', '(', 'control', 'group', ')', 'in', 'combination', 'with', 'basiliximab', 'and', 'steroid', '.', 'eligible', 'subject', 'randomly', 'assigned', 'month', 'transplantation', '.', 'efficacy', 'failure', '(', 'biopsy-proven', 'acute', 'rejection', ',', 'death', ',', 'graft', 'loss', ',', 'or', 'loss', 'to', 'follow-up', ')', ',', 'safety', ',', 'and', 'renal', 'function', 'evaluated', '.', 'result', 'one', 'graft', 'loss', 'reported', 'in', 'control', 'group', 'and', 'no', 'patient', 'death', 'reported', 'in', 'either', 'group', '.', 'incidence', 'of', 'biopsy-proven', 'acute', 'rejection', 'month', 'transplantation', 'of', 'investigational', 'group', '.', ',', 'compared', 'to', '.', 'of', 'control', 'group', '(', 'p.', ')', '.', 'mean', 'estimated', 'glomerular', 'filtration', 'rate', 'of', 'investigational', 'group', 'month', 'transplantation', 'significantly', 'higher', '(', '.', '.', 'mlmin', '.', '(', ')', ')', 'of', 'control', 'group', '(', '.', '.', 'mlmin', '.', '(', ')', 'p.', ')', '.', 'no', 'significant', 'difference', '(', 'p.', ')', 'in', 'incidence', 'of', 'discontinuation', 'and', 'serious', 'adverse', 'event', 'group', '.', 'conclusion', 'result', 'of', 'study', 'provide', 'evidence', '(', ')', 'calcineurin', 'inhibitor', '(', 'cni', ')', 'minimization', 'introduction', 'of', 'everolimus', '-month', 'posttransplantation', 'keep', 'incidence', 'of', 'acute', 'rejection', 'and', 'additional', 'risk', 'low', 'conventional', 'immunosuppression', '(', ')', 'allows', 'minimizing', 'cni', 'exposure', ',', 'consequently', 'reducing', 'cni', 'nephrotoxicity', 'and', 'preserving', 'renal', 'function', '.']"
Randomized study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in non-small cell lung cancer: The OLCSG1406 trial.,"Go Makimoto, Katsuyuki Hotta, Isao Oze, Kiichiro Ninomiya, Masamoto Nakanishi, Naofumi Hara, Hirohisa Kano, Hiromi Watanabe, Yusuke Hata, Kazuya Nishii, Takamasa Nakasuka, Junko Itano, Takashi Ninomiya, Toshio Kubo, Kadoaki Ohashi, Eiki Ichihara, Daisuke Minami, Akiko Sato, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura, Go Makimotoet al.",2021 Feb,Asia Pac J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/32885583/,No keywords found,"['evidence', 'lacking', 'best', 'standard', 'method', 'forced', 'diuresis', 'to', 'prevent', 'cisplatin-induced', 'nephrotoxicity', '.', 'compared', 'cisplatin-induced', 'nephrotoxicity', 'prevention', 'effect', 'of', 'furosemide', 'or', 'mannitol', 'in', 'patient', 'with', 'advanced', 'non-small', 'cell', 'lung', 'cancer', '.', 'method', 'patient', 'with', 'advanced', 'non-small', 'cell', 'lung', 'cancer', 'suitable', 'to', 'receive', 'cisplatin-containing', 'regimen', 'randomly', 'assigned', 'to', 'receive', 'furosemide', 'or', 'mannitol', 'with', 'appropriate', 'hydration', '.', 'primary', 'endpoint', 'proportion', 'of', 'grade', 'serum', 'creatinine', 'elevation', 'in', 'first', 'cycle', '.', 'result', 'trial', 'terminated', 'early', 'with', '(', 'per', 'arm', ')', 'of', 'planned', 'patient', 'of', 'slow', 'accrual', '.', 'patient', ""'"", 'characteristic', 'well', 'balanced', 'with', 'median', 'baseline', 'creatinine', 'clearance', 'of', '.', 'and', '.', 'mlmin', 'in', 'furosemide', 'and', 'mannitol', 'arm', ',', 'respectively', '.', 'in', 'first', 'cycle', ',', 'two', '(', ')', 'and', 'four', '(', ')', 'patient', 'developed', 'grade', 'creatinine', 'elevation', '(', 'p', '.', ')', ',', 'respectively', ',', 'despite', 'no', 'grade', 'toxicity', '.', 'median', 'time', 'to', 'develop', 'worst', 'creatinine', 'score', 'and', 'day', ',', 'respectively', '.', 'cycle', ',', 'median', 'time', 'to', 'recover', 'to', 'grade', 'and', 'day', ',', 'respectively', '.', 'furosemide', 'arm', 'characterized', 'relatively', 'high', 'urine', 'output', 'cisplatin', 'administration', '(', 'v', 'mlh', ')', ',', 'low', 'frequency', 'of', 'unplanned', 'additional', 'hydration', '(', 'v', ')', ',', 'and', 'high', 'incidence', 'of', 'hyponatremia', '(', 'and', ')', 'compared', 'with', 'mannitol', 'arm', '.', 'arm', 'showed', 'similar', 'progression-free', 'survival', 'and', 'overall', 'survival', '.', 'conclusion', 'preventive', 'effect', 'of', 'two', 'forced', 'diuretic', 'cisplatin-induced', 'nephrotoxicity', 'not', 'significantly', 'different', '.', 'however', ',', 'two', 'diuretic', 'distinct', 'type', 'of', 'clinical', 'presentation', '.']"
Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients - the BISHOP study.,"Gustavo Gomes Resende, Ricardo da Cruz Lage, Samara Quadros Lobê, Amanda Fonseca Medeiros, Alessandra Dias Costa E Silva, Antônio Tolentino Nogueira Sá, Argenil José de Assis Oliveira, Denise Sousa, Henrique Cerqueira Guimarães, Isabella Coelho Gomes, Renan Pedra Souza, Renato Santana Aguiar, Roberto Tunala, Francisco Forestiero, Julio Silvio Souza Bueno Filho, Mauro Martins Teixeira, Gustavo Gomes Resendeet al.",2022 Aug,Infect Dis (Lond),https://pubmed.ncbi.nlm.nih.gov/35485381/,No keywords found,"['patient', 'with', 'severe', 'covid-', 'seem', 'to', 'evolve', 'with', 'compromised', 'antiviral', 'response', 'and', 'hyperinflammation', '.', 'neutrophil', 'critical', 'player', 'in', 'covid-', '.', 'il-a', 'play', 'major', 'role', 'in', 'protection', 'extracellular', 'pathogen', 'and', 'neutrophil', 'attractionactivation', '.', 'hypothesized', 'secukinumab', ',', 'anti-ila', 'monoclonal', 'antibody', ',', 'could', 'prevent', 'deleterious', 'hyperinflammation', 'in', 'covid-', '.', 'method', 'bishop', 'randomized', ',', 'open-label', ',', 'single-centre', ',', 'phase-ii', 'controlled', 'trial', '.', 'fifty', 'adult', 'patient', 'hospitalized', 'with', 'pcr-positive', 'covid-', ',', 'randomized', 'to', 'receive', 'mg', 'of', 'secukinumab', 'subcutaneously', 'day-', 'plus', 'standard', 'of', 'care', '(', 'group', ')', 'or', 'standard', 'of', 'care', 'alone', '(', 'group', 'b', ')', '.', 'second', 'dose', 'of', 'mg', 'of', 'secukinumab', 'could', 'administered', 'day-', ',', 'according', 'to', 'staff', 'judgement', '.', 'primary', 'endpoint', 'ventilator-free', 'day', 'day-', '(', 'vfd-', ')', '.', 'secondary', 'efficacy', 'and', 'safety', 'outcome', 'also', 'explored', '.', 'result', 'intention-to-treat', 'analysis', 'showed', 'no', 'difference', 'in', 'vfd-', '.', '(', 'ci', '.-', '.', ')', 'in', 'group', 'vs.', '.', '(', '.-', '.', ')', 'in', 'group', 'b', ',', 'p', '.', 'also', 'no', 'difference', 'in', 'hospitalization', 'time', ',', 'intensive', 'care', 'unit', 'demand', 'and', 'incidence', 'of', 'circulatory', 'shock', ',', 'acute', 'kidney', 'injury', ',', 'fungal', 'or', 'bacterial', 'co-infections', '.', 'no', 'difference', 'in', 'incidence', 'of', 'severe', 'adverse', 'event', '.', 'pulmonary', 'thromboembolism', 'occurred', 'in', 'male', 'and', 'less', 'frequent', 'in', 'secukinumab-treated', 'patient', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'one', 'death', 'in', 'group', '.', 'upper', 'airway', 'viral', 'clearance', 'also', 'similar', 'in', 'group', '.', 'conclusion', 'efficacy', 'of', 'secukinumab', 'in', 'treatment', 'of', 'covid', 'not', 'demonstrated', '.', 'secukinumab', 'decreased', 'pulmonary', 'embolism', 'in', 'male', 'patient', '.', 'no', 'difference', 'group', 'in', 'adverse', 'event', 'and', 'no', 'unexpected', 'event', 'observed', '.']"
Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial.,"Miao-Fang Wu, Xiao-Yu Cheng, Dong-Yan Wang, Yu-Ting Lai, Hui Li, Yan-Fang Ye, Yong-Pai Peng, Qing Chen, Bing-Zhong Zhang, Zhong-Qiu Lin, Jing Li, Miao-Fang Wuet al.",2024 Feb:181:125-132.,Gynecol Oncol,https://pubmed.ncbi.nlm.nih.gov/38159362/,No keywords found,"['to', 'determine', 'maximum', 'tolerated', 'dose', '(', 'mtd', ')', 'of', 'paclitaxel', 'combined', 'with', 'fixed', 'dose', 'of', 'cisplatin', '(', 'mgm', ')', 'delivered', 'via', 'hyperthermic', 'intraperitoneal', 'chemotherapy', '(', 'hipec', ')', 'to', 'patient', 'with', 'ovarian', 'cancer', '.', 'method', 'multicenter', 'phase', 'trial', 'employed', 'bayesian', 'optimal', 'interval', '(', 'boin', ')', 'design', '.', 'mtd', 'determined', 'to', 'target', 'dose-limiting', 'toxicity', '(', 'dlt', ')', 'rate', 'of', '.', 'starting', 'dose', 'mgm', '.', 'data', 'and', 'safety', 'monitoring', 'board', 'made', 'decision', 'regarding', 'dose', 'escalation', 'or', 'de-escalation', 'in', 'increment', 'of', 'mgm', 'subsequent', 'patient', 'cohort', ',', 'to', 'maximum', 'sample', 'size', 'of', 'or', 'patient', 'treated', 'given', 'dose', '.', 'result', 'twenty-one', 'patient', 'participated', 'in', 'study', '.', 'among', 'three', 'evaluable', 'patient', 'received', 'mgm', 'paclitaxel', ',', 'no', 'dlts', 'observed', '.', 'among', 'evaluable', 'patient', 'received', 'mgm', 'paclitaxel', ',', 'two', 'reported', 'dlts', 'one', 'grade', 'neutropenia', 'and', 'one', 'grade', 'anemia', ',', 'neutropenia', ',', 'and', 'leukopenia', '.', 'four', 'of', 'six', 'evaluable', 'patient', 'received', 'mgm', 'paclitaxel', 'reported', 'dlts', 'one', 'patient', 'grade', 'diarrhea', ',', 'one', 'grade', 'kidney', 'injury', ',', 'and', 'two', 'grade', 'anemia', '.', 'isotonic', 'estimate', 'of', 'dlt', 'rate', 'in', 'mgm', 'dose', 'group', '.', '(', 'confidence', 'interval', ',', '.-', '.', ')', ',', 'and', 'dose', 'selected', 'mtd', '.', 'conclusion', 'paclitaxel', ',', 'combined', 'with', 'fixed', 'dose', 'of', 'cisplatin', '(', 'mgm', ')', ',', 'safely', 'administered', 'intraperitoneally', 'dose', 'of', 'mgm', 'in', 'patient', 'with', 'ovarian', 'cancer', 'received', 'hipec', '(', 'c', ',', 'min', ')', 'following', 'cytoreductive', 'surgery', '.']"
Goal-directed fluid therapy during post-resection phase in low central venous pressure assisted laparoscopic hepatectomy: a randomized controlled superiority trial.,"Shichao Li#, Yue Yin#, Pei Wang, Long Jiang, Huan Yan, Jing Cang, Shichao Liet al.",2024 Feb,J Anesth,https://pubmed.ncbi.nlm.nih.gov/38091035/,No keywords found,"['purpose', 'of', 'prospective', 'single', 'blinded', 'randomized', 'controlled', 'trial', 'to', 'find', 'whether', 'goal-directed', 'fluid', 'therapy', '(', 'gdft', ')', 'strategy', 'in', 'post-transection', 'period', 'in', 'low', 'central', 'venous', 'pressure', '(', 'cvp', ')', 'assisted', 'laparoscopic', 'hepatectomy', '(', 'lh', ')', 'benefit', 'traditional', 'fluid', 'strategy', '.', 'method', 'april', 'and', 'dec', ',', 'patient', 'scheduled', 'laparoscopic', 'liver', 'resection', 'surgery', 'eligible', 'to', 'participate', 'in', 'study', '.', 'patient', 'randomly', 'divided', 'two', 'group', 'control', 'group', 'received', 'traditional', 'fluid', 'strategy', 'in', 'post-transection', 'period', 'in', 'low', 'cvp', 'assisted', 'laparoscopic', 'hepatectomy', 'and', 'gdft', 'strategy', 'group', 'received', 'gdft', 'strategy', 'in', 'post-transection', 'period', '.', 'primary', 'outcome', 'parameter', 'incidence', 'of', 'postoperative', 'complication', '.', 'secondary', 'outcome', 'parameter', 'include', 'perioperative', 'clinical', 'outcome', ',', 'postoperative', 'clinical', 'outcome', ',', 'length', 'of', 'hospital', 'stay', 'surgery', ',', 'postoperative', 'lactic', 'acid', ',', 'fluid', 'and', 'vasoactive', 'medication', 'operation', '.', 'result', 'total', 'of', 'patient', 'in', 'control', 'group', 'and', 'patient', 'in', 'gdft', 'included', '.', 'two', 'group', 'no', 'significant', 'difference', 'in', 'incidence', 'of', 'postoperative', 'complication', 'including', 'pneumonia', '(', 'p', '.', ')', ',', 'acute', 'kidney', 'injury', '(', 'p', '.', ')', ',', 'hepatic', 'insufficiency', '(', 'p', '.', ')', ',', 'pleural', 'effusion', '(', 'p', '.', ')', 'and', 'seroperitoneum', '(', 'p', '.', ')', ',', 'respectively', '.', 'amount', 'of', 'perioperative', 'urine', 'output', 'fewer', 'in', 'gdft', 'group', 'in', 'control', 'group', '(', 'p', '.', ')', ',', 'perioperative', 'variable', 'and', 'postoperative', 'variable', 'comparable', 'two', 'group', '.', 'conclusion', 'result', 'show', 'implementation', 'of', 'gdft', 'strategy', 'not', 'associated', 'with', 'fewer', 'postoperative', 'complication', '.', 'gdft', 'strategy', 'not', 'result', 'in', 'improved', 'outcome', 'in', 'low', 'cvp-assisted', 'laparoscopic', 'hepatectomy', '.']"
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).,"Marco Barbanti, Simona Gulino, Piera Capranzano, Sebastiano Immè, Carmelo Sgroi, Claudia Tamburino, Yohei Ohno, Guilherme F Attizzani, Martina Patanè, Rita Sicuso, Gerlando Pilato, Alessio Di Landro, Denise Todaro, Emanuela Di Simone, Andrea Picci, Giuliana Giannetto, Giuliano Costa, Wanda Deste, Daniela Giannazzo, Carmelo Grasso, Davide Capodanno, Corrado Tamburino, Marco Barbantiet al.",2015 Oct,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/26386766/,No keywords found,"['purpose', 'of', 'study', 'to', 'investigate', 'effect', 'of', 'renalguard', 'system', '(', 'plc', 'medical', 'system', ',', 'milford', ',', 'massachusetts', ')', 'prevention', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'undergoing', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', '.', 'background', 'tavr', 'associated', 'with', 'varying', 'degree', 'of', 'post-procedural', 'aki', '.', 'renalguard', 'system', 'dedicated', 'device', 'designed', 'contrast-induced', 'aki', 'prevention', '.', 'whether', 'device', 'also', 'effective', 'in', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'undergoing', 'tavr', 'unexplored', '.', 'method', 'present', 'investigator-driven', ',', 'single-center', ',', 'prospective', ',', 'open-label', ',', 'registry-based', 'randomized', 'study', 'used', 'tavr', 'institutional', 'registry', 'of', 'ferrarotto', 'hospital', 'in', 'catania', ',', 'italy', ',', 'platform', 'randomization', ',', 'data', 'collection', ',', 'and', 'follow-up', 'assessment', '.', 'total', 'of', 'consecutive', 'patient', 'undergoing', 'tavr', 'randomly', 'assigned', 'to', 'hydration', 'with', 'normal', 'saline', 'solution', 'controlled', 'renalguard', 'system', 'and', 'furosemide', '(', 'renalguard', 'group', ')', 'or', 'normal', 'saline', 'solution', '(', 'control', 'group', ')', '.', 'primary', 'endpoint', 'incidence', 'of', 'valve', 'academic', 'research', 'consortium-defined', 'aki', 'in', 'first', 'h', 'procedure', '.', 'result', 'aki', 'rate', 'lower', 'in', 'renalguard', 'group', 'in', 'control', 'group', '(', 'n', '.', 'vs.', 'n', '.', ',', 'respectively', ',', 'p', '.', ')', '.', 'majority', 'of', 'patient', '(', '.', 'v', '.', '.', ')', 'developed', 'mild', 'aki', '(', 'stage', ')', 'severe', 'damage', '(', 'stage', ')', 'occurred', 'in', 'patient', 'in', 'control', 'group', '(', '.', 'v', '.', '.', ')', '.', 'no', 'case', 'of', 'in-hospital', 'renal', 'failure', 'requiring', 'dialysis', 'reported', '.', 'no', 'significant', 'difference', 'in', 'term', 'of', 'mortality', ',', 'cerebrovascular', 'event', ',', 'bleeding', ',', 'and', 'hospitalization', 'heart', 'failure', 'noted', 'in', 'group', 'day', '.', 'conclusion', 'furosemide-induced', 'diuresis', 'with', 'matched', 'isotonic', 'intravenous', 'hydration', 'using', 'renalguard', 'system', 'effective', 'therapeutic', 'tool', 'to', 'reduce', 'occurrence', 'of', 'aki', 'in', 'patient', 'undergoing', 'tavr', '.']"
Role of aminophylline in prevention of acute kidney injury in term neonates with severe perinatal asphyxia: a randomized open-label controlled trial.,"Dinesh Munian, Sukanta Dutta, Arindam Ghosh, Ripan Saha, Dinesh Munianet al.",2024 Oct 4,J Trop Pediatr,https://pubmed.ncbi.nlm.nih.gov/39390900/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'one', 'of', 'frequently', 'observed', 'complication', 'in', 'neonate', 'with', 'severe', 'perinatal', 'asphyxia', '.', 'efficacy', 'of', 'aminophylline', 'in', 'preventing', 'or', 'alleviating', 'renal', 'dysfunction', 'in', 'neonate', 'remains', 'controversial', '.', 'current', 'study', 'aimed', 'to', 'explore', 'whether', 'treatment', 'with', 'aminophylline', 'adjunctive', 'therapy', 'superior', 'to', 'standard', 'care', 'alone', 'in', 'preventing', 'aki', 'in', 'severely', 'asphyxiated', 'term', 'neonate', 'and', 'to', 'delineate', 'change', 'in', 'renal', 'parameter', '.', 'in', 'open-label', 'randomized', 'clinical', 'trial', ',', 'term', 'neonate', 'with', 'severe', 'asphyxia', '(', 'n', ')', 'received', 'mgkg', 'intravenous', 'dose', 'of', 'aminophylline', 'within', 'first', 'hour', 'birth', ',', 'in', 'addition', 'to', 'standard', 'care', 'birth', 'asphyxia', '.', 'control', 'group', '(', 'n', ')', 'received', 'standard', 'care', 'alone', '.', 'daily', 'urine', 'output', ',', 'weight', ',', 'serum', 'creatinine', ',', 'renal', 'functional', 'status', ',', 'and', 'complication', 'first', 'day', 'of', 'life', 'monitored', 'and', 'compared', '.', 'statistical', 'package', 'social', 'science', 'version', 'used', 'analysis', '.', 'approximately', '.', 'of', 'neonate', 'in', 'aminophylline', 'group', 'developed', 'aki', ',', 'compared', 'to', '.', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'although', 'urine', 'output', 'generally', 'higher', 'in', 'aminophylline-treated', 'newborn', 'in', 'control', 'group', ',', 'increase', 'not', 'statistically', 'significant', '(', 'p', '.', ')', ',', 'with', 'notable', 'difference', 'observed', 'second', 'and', 'third', 'postnatal', 'day', '.', 'also', ',', 'change', 'in', 'plasma', 'creatinine', 'level', 'two', 'group', 'time', 'not', 'statistically', 'significant', '.', 'administering', 'single', 'dose', 'of', 'aminophylline', '(', 'mgkg', ')', 'within', 'first', 'hour', 'of', 'life', 'to', 'severely', 'asphyxiated', 'term', 'neonate', 'might', 'temporarily', 'enhance', 'urine', 'output', ',', 'not', 'reduce', 'overall', 'incidence', 'of', 'aki', '.']"
Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study.,"Takeshi Osonoi, Maki Gouda, Mamiko Kubo, Kenji Arakawa, Toshio Hashimoto, Masanori Abe, Takeshi Osonoiet al.",2018 Oct,Diabetes Technol Ther,https://pubmed.ncbi.nlm.nih.gov/30096243/,No keywords found,"['albuminuria', 'characterizes', 'progression', 'of', 'kidney', 'injury', '.', 'effect', 'of', 'canagliflozin', 'excretion', 'of', 'microalbumin', 'assessed', 'investigating', 'renoprotective', 'potential', 'in', 'japanese', 'patient', 'with', 'type', 'diabetes', 'mellitus', '(', 'tdm', ')', '.', 'patient', 'and', 'method', 'twenty', 'japanese', 'patient', 'with', 'tdm', 'and', 'microalbuminuria', 'enrolled', 'and', 'administered', 'with', 'mg', 'of', 'canagliflozin', 'day', 'week', '.', 'subject', 'admitted', 'to', 'clinic', 'start', 'and', 'end', 'of', 'treatment', 'period', '-h', 'urine', 'collection', '.', 'primary', 'endpoint', 'percentage', 'change', 'in', 'geometric', 'mean', '-h', 'urinary', 'albumin', 'excretion', 'baseline', 'to', 'week', '.', 'result', 'urinary', 'albumin', 'level', 'decreased', '.', '(', 'confidence', 'interval', '.-', '.', 'p', '.', ')', 'week', 'of', 'canagliflozin', 'treatment', '.', 'number', 'of', 'blood', 'and', 'urinary', 'parameter', 'also', 'significantly', 'decreased', ',', 'including', 'hemoglobin', 'ac', ',', 'fasting', 'plasma', 'glucose', ',', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'and', 'creatinine', 'clearance', ',', 'hematocrit', 'elevated', '.', 'among', 'biomarkers', 'associated', 'with', 'kidney', 'injury', 'and', 'inflammation', ',', 'urinary', 'level', 'of', 'oxidative', 'stress', 'marker', ""-hydroxy-'-deoxyguanosine"", 'also', 'decreased', '.', 'no', 'meaningful', 'correlation', 'noted', 'change', 'in', 'urinary', 'albumin', 'excretion', 'and', 'parametersbiomarkers', '.', 'no', 'severe', 'adverse', 'event', 'reported', '-week', 'treatment', 'period', '.', 'conclusion', 'result', 'of', 'study', 'indicate', 'canagliflozin', 'decrease', 'microalbuminuria', 'in', 'japanese', 'patient', 'with', 'tdm', '.', 'albuminuria', 'could', 'reduced', 'result', 'of', 'change', 'in', 'various', 'physiological', 'pathway', 'therefore', ',', 'imperative', 'future', ',', 'large-scale', ',', 'study', 'attempt', 'to', 'determine', 'detailed', 'mechanism', 'involved', '.', 'canagliflozin', 'may', 'offer', 'novel', 'therapeutic', 'option', 'japanese', 'patient', 'with', 'tdm', 'and', 'incipient', 'nephropathy', '.']"
"Forced diuresis with matched hydration during transcatheter aortic valve implantation for Reducing Acute Kidney Injury: a randomized, sham-controlled study (REDUCE-AKI).","Yaron Arbel, Eyal Ben-Assa, Daniela Puzhevsky, Batia Litmanowicz, Naama Galli, Ehud Chorin, Amir Halkin, Ben Sadeh, Maayan Konigstein, Orit Kliuk-Ben Bassat, Arie Steinvil, Samuel Bazan, Shmuel Banai, Ariel Finkelstein, Yaron Arbelet al.",2019 Oct 7,Eur Heart J,https://pubmed.ncbi.nlm.nih.gov/31120108/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'following', 'transcatheter', 'aortic', 'valve', 'implantation', '(', 'tavi', ')', 'and', 'associated', 'with', 'increased', 'risk', 'short-', 'and', 'long-term', 'mortality', '.', 'in', 'patient', 'undergoing', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', ',', 'forced', 'diuresis', 'with', 'matched', 'hydration', 'shown', 'to', 'reduce', 'incidence', 'of', 'aki', '.', 'aim', 'of', 'present', 'study', 'to', 'evaluate', 'whether', 'forced', 'diuresis', 'with', 'matched', 'intravenous', 'hydration', 'reduces', 'aki', 'in', 'patient', 'undergoing', 'tavi', '.', 'method', 'and', 'result', 'reducing', 'acute', 'kidney', 'injury', '(', 'reduce-aki', ')', 'single-centre', ',', 'prospective', ',', 'randomized', ',', 'double-blind', 'sham-controlled', 'clinical', 'trial', ',', 'designed', 'to', 'examine', 'effect', 'of', 'automated', 'matched', 'saline', 'infusion', 'with', 'urine', 'output', 'prevention', 'of', 'aki', 'in', 'patient', 'undergoing', 'tavi', '.', 'total', 'of', 'tavi', 'patient', 'randomized', ',', 'in', 'group', '.', 'mean', 'age', '.', 'year', 'and', '.', 'male', '.', 'no', 'difference', 'in', 'baseline', 'characteristic', 'two', 'group', '.', 'rate', 'of', 'aki', 'not', 'statistically', 'different', 'group', '(', 'in', 'active', 'group', 'vs.', '.', 'in', 'sham', 'group', ',', 'p', '.', ')', '.', 'significant', 'increase', 'in', 'long-term', 'mortality', 'in', 'active', 'group', '(', '.', 'vs.', '.', 'hr', '.', ',', 'ci', '.-', '.', 'p', '.', ')', '.', 'study', 'terminated', 'prematurely', 'data', 'safety', 'monitoring', 'board', 'futility', 'and', 'possible', 'signal', 'of', 'harm', '.', 'conclusion', 'unlike', 'in', 'pci', ',', 'forced', 'diuresis', 'with', 'matched', 'hydration', 'not', 'prevent', 'aki', 'in', 'patient', 'undergoing', 'tavi', ',', 'and', 'might', 'associated', 'with', 'increased', 'long-term', 'mortality', '.', 'future', 'study', 'focus', 'understanding', 'mechanism', 'behind', 'finding', '.', 'clinicaltrials.gov', 'registration', 'nct', ',', 'april', '.']"
"Nicotinamide riboside with pterostilbene (NRPT) increases NAD(+) in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI.","Petra Simic, Xavier Fernando Vela Parada, Samir M Parikh, Ryan Dellinger, Leonard P Guarente, Eugene P Rhee, Petra Simicet al.",2020 Aug 13,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/32791973/,No keywords found,"['preclinical', 'study', 'identified', 'nad', 'and', 'sirtuin', 'augmentation', 'potential', 'strategy', 'prevention', 'and', 'treatment', 'of', 'aki', '.', 'nicotinamide', 'riboside', '(', 'nr', ')', 'nad', 'precursor', 'vitamin', 'and', 'pterostilbene', '(', 'pt', ')', 'potent', 'sirtuin', 'activator', 'found', 'in', 'blueberry', '.', ',', 'tested', 'effect', 'of', 'combined', 'nr', 'and', 'pt', '(', 'nrpt', ')', 'whole', 'blood', 'nad', 'level', 'and', 'safety', 'parameter', 'in', 'patient', 'with', 'aki', '.', 'method', 'conducted', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'study', 'of', 'escalating', 'dos', 'of', 'nrpt', 'in', 'hospitalized', 'patient', 'with', 'aki', '.', 'study', 'comprised', 'of', 'four', 'step', 'nrpt', '(', 'subject', ')', 'or', 'placebo', '(', 'subject', ')', 'given', 'twice', 'day', 'day', '.', 'nrpt', 'dosing', 'increased', 'in', 'step', 'step', 'mg', ',', 'step', 'mg', ',', 'step', 'mg', 'and', 'step', ',', 'mg.', 'blood', 'nad', 'level', 'measured', 'liquid', 'chromatography-mass', 'spectrometry', 'and', 'safety', 'assessed', 'history', ',', 'physical', 'exam', ',', 'and', 'clinical', 'laboratory', 'testing', '.', 'result', 'aki', 'resulted', 'in', 'reduction', 'in', 'whole', 'blood', 'nad', 'level', 'h', 'compared', 'to', 'h', 'in', 'patient', 'receiving', 'placebo', '(', 'p', '.', ')', '.', 'trend', 'increase', 'in', 'nad', 'level', 'in', 'nrpt', 'step', 'individually', 'h', 'compared', 'to', 'h', ',', 'change', 'in', 'step', 'reached', 'statistical', 'significance', '(', ',', 'p', '.', ')', ',', 'and', 'considerable', 'interindividual', 'variability', 'in', 'nad', 'response', 'to', 'treatment', '.', 'considering', 'step', 'together', ',', 'nrpt', 'treatment', 'increased', 'nad', 'level', 'h', 'compared', 'to', 'h', '(', 'p', '.', ')', '.', 'safety', 'laboratory', 'test', 'unchanged', 'nrpt', 'treatment', ',', 'including', 'creatinine', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', ',', 'electrolyte', ',', 'liver', 'function', 'test', ',', 'and', 'blood', 'count', '.', 'three', 'of', 'patient', 'receiving', 'nrpt', 'reported', 'minor', 'gastrointestinal', 'side', 'effect', '.', 'conclusion', 'nrpt', 'increase', 'whole', 'blood', 'nad', 'level', 'in', 'hospitalized', 'patient', 'with', 'aki', '.', 'in', 'addition', ',', 'nrpt', 'to', 'dose', 'of', 'mg', 'mg', 'twice', 'day', 'day', 'safe', 'and', 'well', 'tolerated', 'in', 'patient', '.', 'study', 'to', 'assess', 'potential', 'therapeutic', 'benefit', 'of', 'nrpt', 'in', 'aki', 'warranted', '.', 'trial', 'registration', 'nct', ',', 'date', 'of', 'registration', 'june', 'th', ',', '.']"
Mannitol Is Comparable to Hypertonic Saline for Raised Intracranial Pressure in Acute Liver Failure (MAHAL Study): A Randomized Controlled Trial.,"Chetan Ramesh Kalal, Rakhi Maiwall, Ashok Choudhary, Madhumita Premkumar, Guresh Kumar, Ashish Kumar Vyas, Shiv Kumar Sarin, Chetan Ramesh Kalalet al.",2022,Dig Dis,https://pubmed.ncbi.nlm.nih.gov/34763338/,No keywords found,"['raised', 'intracranial', 'pressure', '(', 'icp', ')', 'due', 'to', 'cerebral', 'edema', '(', 'ce', ')', 'central', 'to', 'development', 'of', 'hepatic', 'encephalopathy', 'in', 'acute', 'liver', 'failure', '(', 'alf', ')', '.', 'mannitol', '(', 'mt', ')', 'and', 'hypertonic', 'saline', '(', 'h', ')', 'shown', 'to', 'improve', 'ce', '.', 'compared', 'efficacy', 'and', 'safety', 'of', 'modality', '.', 'method', 'alf', 'with', 'ce', 'prospectively', 'randomized', 'in', 'open', 'study', 'to', 'receive', 'either', 'mlkg', 'of', 'either', 'h', ',', 'continuous', 'infusion', 'titrated', 'every', 'hourly', 'to', 'achieve', 'serum', 'sodium', 'of', '.', 'vs.', ')', '.', 'overall', ',', '.', 'patient', 'in', 'h', 'and', 'in', 'mn', 'group', 'showed', 'reduction', 'in', 'icp', 'h', '(', 'p', '.', ')', '.', 'rebound', 'increase', 'in', 'icp', 'index', 'noted', 'in', '(', ')', 'patient', 'in', 'mt', 'and', 'none', 'in', 'h', '(', 'p', '.', ')', 'group', '.', 'new', 'onset', 'acute', 'kidney', 'injury', 'common', 'in', 'mt', 'group', 'in', 'h', 'group', '.', 'icu', 'stay', 'and', '-day', 'transplant-free', 'survival', 'not', 'different', 'group', '.', 'conclusion', 'agent', 'comparable', 'efficacy', 'in', 'reducing', 'icp', 'and', 'mortality', 'in', 'alf', 'patient', 'comparable', ',', 'h', 'significantly', 'better', 'in', 'preventing', 'reducing', 'rebound', 'ce', 'with', 'lower', 'renal', 'dysfunction', '.']"
"Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial.","Mehrdad Hasibi, Sirous Jafari, Seyyed Ali Manshadi, Marjan Asadollahi, Mohammadreza Salehi, Varasteh Vakili Zarch, Ali Kouhi, Mehrdad Hasibiet al.",2017 Feb,Ear Nose Throat J,https://pubmed.ncbi.nlm.nih.gov/28231371/,No keywords found,"['intervention', 'group', '(', 'n', ')', 'and', 'control', 'group', '(', 'patient', ')', '.', 'no', 'statistically', 'significant', 'difference', 'two', 'group', 'in', 'demographic', 'or', 'clinical', 'variable', '.', 'patient', 'received', 'mgkgday', 'of', 'abd', 'in', 'dextrose', '.', 'in', 'addition', ',', 'patient', 'in', 'intervention', 'arm', 'received', 'intralipid', ',', 'started', 'soon', 'possible', 'within', 'hour', 'infusion', 'of', 'abd', '.', 'abd-associated', 'nephrotoxicity', 'defined', 'minimum', 'increase', 'in', 'baseline', 'serum', 'creatinine', 'to', 'minimum', 'of', 'mgdl', '.', 'also', 'measured', 'daily', 'serum', 'creatinine', 'change', 'first', 'week', 'of', 'treatment', ',', 'and', 'compared', 'relevant', 'index', 'of', 'renal', 'function', ',', 'well', 'abd-related', 'hypokalemia', '.', 'found', 'no', 'statistically', 'significant', 'difference', 'two', 'treatment', 'in', 'term', 'of', 'abd-associated', 'nephrotoxicity', 'or', 'of', 'index', '.', 'conclude', 'administration', 'of', 'intralipid', 'early', 'infusion', 'of', 'abd', 'in', 'dextrose', 'not', 'effect', 'in', 'decreasing', 'abd-associated', 'nephrotoxicity', 'or', 'hypokalemia', '.']"
De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.,"Sonja Guethoff, Katja Stroeh, Carola Grinninger, Matthias A Koenig, Eike C Kleinert, Anna Rieger, Tanja Mayr, Franz von Ziegler, Bruno Reichart, Christian Hagl, René Schramm, Ingo Kaczmarek, Bruno M Meiser, Sonja Guethoffet al.",2015 May,J Heart Lung Transplant,https://pubmed.ncbi.nlm.nih.gov/25701373/,No keywords found,"['although', 'acute', 'cellular', 'rejection', 'heart', 'transplantation', '(', 'htx', ')', 'controlled', 'full-dose', 'calcineurin', 'inhibitor', '(', 'cni', ')', '-based', 'immunosuppressive', 'regimen', ',', 'cardiac', 'allograft', 'vasculopathy', '(', 'cav', ')', ',', 'nephrotoxicity', ',', 'and', 'malignancy', 'remain', 'ongoing', 'problem', '.', 'to', 'evaluate', 'potential', 'beneficial', 'effect', 'of', 'sirolimus', 'and', 'cni', 'reduction', ',', 'compared', 'de', 'novo', 'low-dose', 'tacrolimus', 'and', 'sirolimus', 'with', 'standard', 'tacrolimus', 'and', 'mycophenolate', 'mofetil', '(', 'mmf', ')', '-based', 'immunosuppression', 'htx', '.', 'method', 'analyzed', 'long-term', 'follow-up', 'cohort', 'of', 'patient', 'underwent', 'htx', 'period', '-', 'and', 'received', 'either', 'de', 'novo', 'low-dose', 'tacrolimussirolimus', '(', 'lowtacsir', 'n', ')', 'or', 'full-dose', 'tacrolimusmmf', '(', 'tacmmf', 'n', ')', '.', 'result', 'freedom', 'treatment', 'switch', 'less', 'in', 'low', 'tacsir', 'group', 'in', 'tacmmf', 'group', '(', '.', 'v', '.', ',', 'p', '.', ')', 'year', 'htx', '.', 'freedom', 'acute', 'rejection', '.', 'in', 'low', 'tacsir', 'group', 'v', '.', 'in', 'tacmmf', 'group', '(', 'p', '.', ')', '.', 'no', 'difference', 'in', 'freedom', 'international', 'society', 'heart', 'and', 'lung', 'transplantation', 'cav', 'grade', '(', '.', 'v', '.', ',', 'p', '.', ')', ',', 'time', 'cav', 'diagnosis', '(', '.', '.', 'year', 'v', '.', '.', 'year', ',', 'p', '.', ')', ',', 'and', 'cav', 'severity', '(', 'p', '.', ')', '.', 'benefit', 'of', 'reduced', 'early', 'maximum', 'creatinine', 'low', 'tacsir', 'treatment', '(', '.', '.', 'mgdl', 'v', '.', '.', 'mgdl', 'in', 'tacmmf', 'group', ',', 'p', '.', ')', 'not', 'continue', 'year', 'and', 'year', 'htx', '(', '.', '.', 'mgdl', 'v', '.', '.', 'mgdl', ',', 'p', '.', ',', 'and', '.', '.', 'mgdl', 'v', '.', '.', 'mgdl', ',', 'p', '.', ')', '.', 'trend', 'superior', 'survival', 'year', 'with', 'low', 'tacsir', 'treatment', '(', '.', 'v', '.', 'in', 'tacmmf', 'group', ',', 'p', '.', ')', 'could', 'not', 'confirmed', 'year', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'multivariate', 'analysis', 'year', 'not', 'reveal', 'benefit', 'of', 'low', 'tacsir', 'treatment', '.', 'conclusion', 'reduction', 'of', 'de', 'novo', 'cni', 'not', 'result', 'in', 'superior', 'long-term', 'renal', 'function', '.', 'low-dose', 'mechanistic', 'target', 'of', 'rapamycin', 'inhibition', 'not', 'achieve', 'benefit', 'in', 'cav', 'prevention', 'compared', 'with', 'full-dose', 'tacmmf', 'htx', '.']"
"Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patients.","Yang Han, Yijia Li, Jing Xie, Zhifeng Qiu, Yanling Li, Xiaojing Song, Ting Zhu, Taisheng Li, Yang Hanet al.",2015 Mar 30,PLoS One,https://pubmed.ncbi.nlm.nih.gov/25821963/,No keywords found,"['tenofovir', '(', 'tdf', ')', 'and', 'ritonavir-boosted', 'lopinavir', '(', 'lpvr', ')', 'not', 'introduced', 'to', 'china', 'second-line', 'medication', '.', 'efficacy', 'and', 'safety', 'of', 'tdftclpvr', 'based', 'second-line', 'regimen', 'not', 'evaluated', 'in', 'chinese', 'hiv', 'patient', 'failed', 'first-line', 'regimen', '.', 'method', 'multicenter', 'cohort', 'study', 'recruiting', 'patient', 'beijing', ',', 'shanghai', ',', 'guangdong', ',', 'and', 'henan', 'province', 'november', 'and', 'january', '.', 'eighty', 'hiv', 'infected', 'patient', 'failing', 'first-line', 'regimen', 'with', 'serum', 'creatinine', 'lower', '.', 'time', 'upper', 'limit', 'of', 'normal', 'received', 'tdf', 'lamivudine', '(', 'tc', ')', 'lpvr', 'followed', 'week', '.', 'cd', 'cell', 'count', ',', 'viral', 'load', ',', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'monitored', 'visit', '.', 'result', 'baseline', ',', '.', 'and', '.', 'of', 'patient', 'moderatehigh-level', 'resistance', 'to', 'tdf', 'and', 'tc', ',', 'respectively', '.', 'of', 'patient', 'low-level', 'resistance', 'to', 'lpvr', '.', 'week', 'of', 'follow-up', ',', 'virological', 'suppression', 'rate', 'reached', '(', 'copiesml', ')', 'and', '(', 'copiesml', ')', ',', 'and', 'median', 'cd', 'cell', 'count', 'increased', 'cellsl', 'baseline', 'to', 'cellsl', 'week', '.', 'baseline', 'drug-resistance', 'mutation', 'no', 'impact', 'efficacy', 'of', 'second-line', 'antiretroviral', 'therapy', '.', 'median', 'egfr', 'dropped', '.', 'mlmin.m', 'baseline', 'to', '.', 'mlmin.m', 'week', 'and', 'recovered', 'week', '.', 'conclusion', 'study', 'first', 'time', 'demonstrated', 'tdf', 'tc', 'lpvr', 'efficacious', 'second-line', 'regimen', 'with', 'acceptable', 'nephrotoxicity', 'profile', 'in', 'patient', 'failed', 'zidovudine', 'or', 'stavudine', 'based', 'first-line', 'regimen', 'in', 'china', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Effect of periprocedural furosemide-induced diuresis with matched isotonic intravenous hydration in patients with chronic kidney disease undergoing transcatheter aortic valve implantation.,"Lisa Voigtländer-Buschmann, Sarina Schäfer, Christian Schmidt-Lauber, Jessica Weimann, Mina Shenas, Julian Giraldo Cortes, Piotr Mariusz Kuta, Tanja Zeller, Raphael Twerenbold, Moritz Seiffert, Niklas Schofer, Yvonne Schneeberger, Andreas Schäfer, Johannes Schirmer, Hermann Reichenspurner, Stefan Blankenberg, Lenard Conradi, Ulrich Schäfer, Lisa Voigtländer-Buschmannet al.",2024 Jun,Clin Res Cardiol,https://pubmed.ncbi.nlm.nih.gov/37264143/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'transcatheter', 'aortic', 'valve', 'implantation', '(', 'tavi', ')', 'serious', 'complication', 'associated', 'with', 'increased', 'mortality', '.', 'renalguard', 'system', 'developed', 'to', 'reduce', 'risk', 'of', 'aki', 'contrast', 'medium', 'exposition', 'furosemide-induced', 'diuresis', 'with', 'matched', 'isotonic', 'intravenous', 'hydration', '.', 'aim', 'of', 'study', 'to', 'examine', 'effect', 'of', 'renalguard', 'system', 'occurrence', 'of', 'aki', 'tavi', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '.', 'method', 'present', 'study', 'single-center', 'randomized', 'trial', 'including', 'patient', 'with', 'severe', 'aortic', 'valve', 'stenosis', 'undergoing', 'tavi', '.', 'overall', ',', 'total', 'of', 'patient', 'treated', 'tavi', 'january', 'and', 'august', 'randomly', 'assigned', 'to', 'periprocedural', 'treatment', 'with', 'renalguard', 'system', 'or', 'standard', 'treatment', 'pre-', 'and', 'postprocedural', 'intravenous', 'hydration', '.', 'primary', 'endpoint', 'occurrence', 'of', 'aki', 'tavi', ',', 'and', 'secondary', 'endpoint', 'assessed', 'according', 'to', 'valve', 'academic', 'research', 'consortium', 'criterion', '.', 'result', 'overall', ',', 'prevalence', 'of', 'aki', '.', '(', 'n', ')', '.', 'majority', 'of', 'patient', 'developed', 'mild', 'aki', 'according', 'to', 'stage', '.', 'comparing', 'renalguard', 'to', 'standard', 'therapy', ',', 'no', 'significant', 'difference', 'observed', 'in', 'occurrence', 'of', 'aki', '(', 'renalguard', '.', 'control', 'group', '.', 'p', '.', ')', '.', 'in', 'addition', ',', 'no', 'difference', 'group', 'with', 'regard', 'to', '-day', 'and', '-month', 'mortality', 'and', 'procedure-associated', 'complication', 'rate', '.', 'conclusion', 'in', 'randomized', 'trial', ',', 'not', 'detect', 'reduction', 'in', 'aki', 'tavi', 'using', 'renalguard', 'system', '.', 'substantial', 'number', 'of', 'patient', 'with', 'chronic', 'kidney', 'disease', 'developed', 'aki', 'tavi', ',', 'whereas', 'majority', 'presented', 'with', 'mild', 'aki', 'according', 'to', 'stage', '(', 'clinicaltrials.gov', 'number', 'nct', ')', '.']"
Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805).,"Wenxin Xu, Mäneka Puligandla, Brian Halbert, Naomi B Haas, Keith T Flaherty, Robert G Uzzo, Janice P Dutcher, Robert S DiPaola, Venkata Sabbisetti, Rupal S Bhatt, Wenxin Xuet al.",2021 Jun 15,Clin Cancer Res,https://pubmed.ncbi.nlm.nih.gov/33832947/,No keywords found,"['no', 'circulating', 'biomarkers', 'currently', 'available', 'to', 'identify', 'patient', 'highest', 'risk', 'of', 'recurrence', 'nephrectomy', 'renal', 'cell', 'carcinoma', '(', 'rcc', ')', '.', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'overexpressed', 'in', 'rcc', 'and', 'ectodomain', 'circulates', 'in', 'plasma', '.', 'investigated', 'whether', 'plasma', 'kim-', 'prognostic', 'biomarker', 'in', 'patient', 'with', 'localized', 'rcc', 'nephrectomy', '.', 'experimental', 'design', 'ecog-acrin', 'e', '(', 'assure', ')', 'trial', 'evaluated', 'adjuvant', 'sunitinib', ',', 'sorafenib', ',', 'or', 'placebo', 'in', 'resected', 'high-risk', 'rcc', '.', 'kim-', 'level', 'measured', 'banked', 'plasma', 'trial', 'enrollment', '-', 'week', 'nephrectomy', '.', 'lognormal', 'accelerated', 'failure', 'time', 'model', 'used', 'to', 'test', 'association', 'kim-', 'and', 'disease-free', 'survival', '(', 'dfs', ')', 'well', 'overall', 'survival', '(', 'o', ')', '.', 'result', 'plasma', 'patient', 'analyzed', '.', 'higher', 'post-nephrectomy', 'kim-', 'associated', 'with', 'worse', 'dfs', 'across', 'study', 'arm', 'adjustment', 'fuhrman', 'grade', ',', 'stage', ',', 'n', 'stage', ',', 'and', 'tumor', 'histology', 'survival', 'time', 'ratio', '.', 'th', 'vs.', 'th', 'percentile', 'of', 'kim-', 'confidence', 'interval', '(', 'ci', ')', ',', '.-', '.', 'p', '..', 'association', 'kim-', 'and', 'dfs', 'stronger', 'among', 'patient', 'with', 'pathologic', 'nodal', 'involvement', '(', 'p', 'interaction', '.', ')', '.', 'addition', 'of', 'post-nephrectomy', 'kim-', 'improved', 'concordance', 'of', 'clinical', 'prognostic', 'model', 'stage', ',', 'size', ',', 'grade', ',', 'and', 'necrosis', '(', 'ssign', ')', 'concordance', '.', 'v', '.', '.', ',', 'p', '.', 'ucla', 'international', 'staging', 'system', '(', 'uiss', ')', 'concordance', '.', 'v', '.', '.', ',', 'p', '..', 'higher', 'post-nephrectomy', 'kim-', 'also', 'associated', 'with', 'worse', 'o', 'multivariable', 'adjustment', '(', 'survival', 'time', 'ratio', '.', 'th', 'vs.', 'th', 'percentile', 'of', 'kim-', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'post-nephrectomy', 'plasma', 'kim-', 'associated', 'with', 'dfs', 'and', 'o', 'in', 'rcc', ',', 'and', 'may', 'biomarker', 'microscopic', 'residual', 'disease', '.']"
"Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.","Katherine Plewes, Hugh W F Kingston, Aniruddha Ghose, Thanaporn Wattanakul, Md Mahtab Uddin Hassan, Md Shafiul Haider, Prodip K Dutta, Md Akhterul Islam, Shamsul Alam, Selim Md Jahangir, A S M Zahed, Md Abdus Sattar, M A Hassan Chowdhury, M Trent Herdman, Stije J Leopold, Haruhiko Ishioka, Kim A Piera, Prakaykaew Charunwatthana, Kamolrat Silamut, Tsin W Yeo, Sue J Lee, Mavuto Mukaka, Richard J Maude, Gareth D H Turner, Md Abul Faiz, Joel Tarning, John A Oates, Nicholas M Anstey, Nicholas J White, Nicholas P J Day, Md Amir Hossain, L Jackson Roberts Ii, Arjen M Dondorp, Katherine Pleweset al.",2018 Sep 14,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/29538635/,No keywords found,"['acute', 'kidney', 'injury', 'independently', 'predicts', 'mortality', 'in', 'falciparum', 'malaria', '.', 'unknown', 'whether', 'acetaminophen', ""'s"", 'capacity', 'to', 'inhibit', 'plasma', 'hemoglobin-mediated', 'oxidation', 'renoprotective', 'in', 'severe', 'malaria', '.', 'method', 'phase', ',', 'open-label', ',', 'randomized', 'controlled', 'trial', 'conducted', 'two', 'hospital', 'in', 'bangladesh', 'assessed', 'effect', 'renal', 'function', ',', 'safety', ',', 'pharmacokinetic', '(', 'pk', ')', 'property', 'and', 'pharmacodynamic', '(', 'pd', ')', 'effect', 'of', 'acetaminophen', '.', 'febrile', 'patient', '(', 'year', ')', 'with', 'severe', 'falciparum', 'malaria', 'randomly', 'assigned', 'to', 'receive', 'acetaminophen', '(', 'g', '-hourly', 'hour', ')', 'or', 'no', 'acetaminophen', ',', 'in', 'addition', 'to', 'intravenous', 'artesunate', '.', 'primary', 'outcome', 'proportional', 'change', 'in', 'creatinine', 'hour', 'stratified', 'median', 'plasma', 'hemoglobin', '.', 'result', 'and', ',', 'patient', 'randomly', 'assigned', 'to', 'receive', 'acetaminophen', '(', 'n', ')', 'or', 'no', 'acetaminophen', '(', 'n', ')', '.', 'median', '(', 'interquartile', 'range', ')', 'reduction', 'in', 'creatinine', 'hour', '(', 'to', ')', 'in', 'patient', 'assigned', 'to', 'acetaminophen', ',', 'versus', '(', 'to', ')', 'in', 'patient', 'assigned', 'to', 'no', 'acetaminophen', '(', 'p', '.', ')', '.', 'difference', 'in', 'reduction', '(', 'to', ')', 'versus', '(', 'to', '-', ')', 'in', 'patient', 'with', 'hemoglobin', 'ngml', '(', 'p', '.', ')', '.', 'proportion', 'with', 'progressing', 'kidney', 'injury', 'higher', 'among', 'control', '(', 'subdistribution', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', 'p', '.', ')', '.', 'pk-pd', 'analysis', 'showed', 'higher', 'exposure', 'to', 'acetaminophen', 'increased', 'probability', 'of', 'creatinine', 'improvement', '.', 'no', 'patient', 'fulfilled', 'hy', ""'s"", 'law', 'hepatotoxicity', '.', 'conclusion', 'in', 'proof-of-principle', 'study', ',', 'acetaminophen', 'showed', 'renoprotection', 'without', 'evidence', 'of', 'safety', 'concern', 'in', 'patient', 'with', 'severe', 'falciparum', 'malaria', ',', 'particularly', 'in', 'with', 'prominent', 'intravascular', 'hemolysis', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
"Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.","Moshe Mittelman, Uwe Platzbecker, Boris Afanasyev, Sebastian Grosicki, Raymond S M Wong, Achilles Anagnostopoulos, Benjamin Brenner, Claudio Denzlinger, Giuseppe Rossi, Arnon Nagler, Regina Garcia-Delgado, Maria Socorro O Portella, Zewen Zhu, Dominik Selleslag, Moshe Mittelmanet al.",2018 Jan,Lancet Haematol,https://pubmed.ncbi.nlm.nih.gov/29241762/,No keywords found,"['thrombocytopenia', 'life-threatening', 'complication', 'in', 'patient', 'with', 'advanced', 'myelodysplastic', 'syndrome', '(', 'md', ')', 'and', 'acute', 'myeloid', 'leukaemia', '(', 'aml', ')', '.', 'in', 'study', '(', 'aspire', ')', ',', 'aimed', 'to', 'assess', 'eltrombopag', ',', 'oral', 'thrombopoietin', 'receptor', 'agonist', ',', 'thrombocytopenia', '(', 'grade', ')', 'treatment', 'in', 'adult', 'patient', 'with', 'advanced', 'md', 'or', 'aml', '.', 'method', 'aspire', 'consisted', 'of', 'open-label', ',', 'double-blind', 'phase', 'week', 'and', 'randomised', ',', 'double-blind', 'phase', '(', 'part', 'and', ',', 'reported', ')', 'week', ',', 'and', 'open-label', 'extension', '(', 'part', ')', '.', 'eligible', 'patient', 'men', 'and', 'woman', 'aged', 'year', 'or', 'older', ',', 'with', 'intermediate-', 'or', 'high-risk', 'md', 'or', 'aml', ',', 'with', 'bone', 'marrow', 'blast', 'of', 'or', 'less', ',', 'and', 'either', 'grade', 'thrombocytopenia', 'due', 'to', 'bone', 'marrow', 'insufficiency', '(', 'platelet', 'count', 'per', 'l', ')', 'or', 'grade', 'thrombocytopenia', 'platelet', 'transfusion', ',', 'with', 'platelet', 'per', 'l', 'or', 'greater', 'transfusion', '.', 'additionally', ',', 'eligible', 'patient', 'least', 'one', 'of', 'following', 'within', 'screening', 'period', 'of', 'week', 'platelet', 'transfusion', ',', 'symptomatic', 'bleeding', ',', 'or', 'platelet', 'count', 'of', 'less', 'per', 'l.', 'part', ',', 'patient', 'received', 'eltrombopag', ',', 'and', 'dose-escalation', 'criterion', 'part', 'determined', '.', 'in', 'part', ',', 'randomly', 'allocated', 'patient', 'using', 'interactive', 'voice-response', 'system', 'to', 'eltrombopag', 'or', 'placebo', ',', 'stratified', 'baseline', 'platelet', 'count', '(', 'platelet', 'per', 'l', 'v', 'platelet', 'per', 'l', ')', 'and', 'disease', '(', 'md', 'v', 'aml', ')', '.', 'in', 'part', 'and', ',', 'patient', 'received', 'supportive', 'standard', 'of', 'care', 'and', 'initiated', 'eltrombopag', 'or', 'placebo', 'mg', 'per', 'day', '(', 'mg', 'per', 'day', 'patient', 'of', 'east-asian', 'heritage', ')', 'to', 'maximum', 'of', 'mg', 'per', 'day', '(', 'mg', 'per', 'day', 'patient', 'of', 'east-asian', 'heritage', ')', '.', 'part', 'primary', 'objective', 'assessed', 'composite', 'primary', 'endpoint', 'of', 'clinically', 'relevant', 'thrombocytopenic', 'event', '(', 'crte', ')', 'week', '-', ',', 'defined', 'one', 'of', 'following', 'event', ',', 'either', 'alone', 'or', 'in', 'combination', 'grade', 'or', 'worse', 'haemorrhagic', 'adverse', 'event', 'platelet', 'count', 'of', 'less', 'per', 'l', 'or', 'platelet', 'transfusion', '.', 'efficacy', 'analysis', 'based', 'intention', 'to', 'treat', 'clinically', 'meaningful', 'efficacy', 'defined', 'absolute', 'difference', 'group', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'in', 'part', ',', 'patient', 'received', 'eltrombopag', 'and', 'patient', 'completed', 'treatment', 'four', 'experienced', 'significantly', 'increased', 'platelet', 'count', ',', 'and', 'ten', 'reduced', 'platelet', 'transfusion', 'requirement', '.', 'in', 'part', 'randomly', 'allocated', 'patient', 'to', 'receive', 'supportive', 'care', 'plus', 'eltrombopag', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'similar', 'proportion', 'md', '(', 'patient', 'to', 'eltrombopag', ',', '(', ')', 'patient', 'to', 'placebo', ')', 'or', 'aml', '(', 'patient', 'to', 'eltrombopag', ',', 'patient', 'to', 'placebo', ')', '.', 'average', 'weekly', 'crte', 'proportion', 'week', '-', 'significantly', 'lower', 'with', 'eltrombopag', '(', 'ci', '-', ')', 'with', 'placebo', '(', '-', ',', 'odds', 'ratio', 'or', ',', 'ci', '-', 'p', ')', 'although', 'difference', 'treatment', 'group', 'less', '.', 'common', 'grade', 'and', 'grade', 'adverse', 'event', 'fatigue', '(', 'six', 'in', 'eltrombopag', 'group', 'and', 'one', 'in', 'placebo', 'group', ')', ',', 'hypokalaemia', '(', 'six', 'and', 'two', ')', ',', 'pneumonia', '(', 'five', 'and', 'five', ')', ',', 'and', 'febrile', 'neutropenia', '(', 'five', 'and', 'six', ')', '.', 'serious', 'adverse', 'event', 'reported', 'in', '(', ')', 'eltrombopag-treated', 'patient', 'and', '(', ')', 'placebo-treated', 'patient', '.', 'seven', 'eltrombopag', 'recipient', 'and', 'two', 'placebo', 'recipient', 'serious', 'adverse', 'event', 'suspected', 'to', 'study', 'drug-related', '(', 'eltrombopag', 'acute', 'kidney', 'injury', ',', 'arterial', 'thrombosis', ',', 'bone', 'pain', ',', 'diarrhoea', ',', 'myocardial', 'infarction', ',', 'pyrexia', ',', 'retinal', 'vein', 'occlusion', ',', 'n', 'placebo', 'vomiting', ',', 'white', 'blood', 'cell', 'count', 'increased', ',', 'n', ')', '.', 'two', 'eltrombopag', 'recipient', '(', 'arterial', 'thrombosis', 'n', 'myocardial', 'infarction', 'n', ')', 'and', 'no', 'placebo', 'recipient', 'experienced', 'fatal', 'serious', 'adverse', 'event', 'suspected', 'to', 'study', 'drug-related', '.', 'interpretation', 'no', 'new', 'safety', 'concern', 'noted', 'with', 'eltrombopag', 'and', 'trial', 'met', 'primary', 'objective', 'of', 'reduction', 'in', 'crtes', 'eltrombopag', 'might', 'treatment', 'option', 'thrombocytopenic', 'patient', 'with', 'aml', 'or', 'md', 'ineligible', 'treatment', 'and', 'not', 'receiving', 'disease-modifying', 'treatment', '.', 'funding', 'novartis', 'pharma', 'ag', '.']"
Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.,"Noppadol Wacharachaisurapol, Chayapa Phasomsap, Warumphon Sukkummee, Weeraya Phaisal, Ankanee Chanakul, Supeecha Wittayalertpanya, Pajaree Chariyavilaskul, Thanyawee Puthanakit, Noppadol Wacharachaisurapolet al.",2020 Jun,Int J Antimicrob Agents,https://pubmed.ncbi.nlm.nih.gov/32179149/,"Colistin, Multidrug-resistant bacteria, Paediatrics, Pharmacodynamics, Pharmacokinetics.","['cmax', ',', '.', '(', '.', ')', 'vs.', '.', '(', '.', ')', 'mgl', 'auc-t', ',', '.', '(', '.', ')', 'vs.', '.', '(', '.', ')', 'mglh', 'vd', ',', '.', '(', '.', ')', 'vs.', '.', '(', '.', ')', 'lkg', 'and', ',', '.', '(', '.', ')', 'vs.', '.', '(', '.', ')', 'h.', 'no', 'patient', 'developed', 'aki', 'serum', 'creatinine', 'criterion', '.', 'cm', 'loading', 'dose', 'beneficial', 'improvement', 'of', 'colistin', 'exposure', 'without', 'increased', 'aki', '.', 'higher', 'daily', 'dose', 'of', 'cm', 'considered', ',', 'especially', 'mdr-gnb', 'treatment', '.']"
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06).,"Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, Kazuhiro Nishikawa, Chikara Kunisaki, Satoshi Matsusaka, Yoshihiko Segawa, Masato Nakamura, Kinro Sasaki, Narutoshi Nagao, Yukimasa Hatachi, Yasuhiro Yuasa, Shinya Asami, Masahiro Takeuchi, Hiroshi Furukawa, Toshifusa Nakajima                              ;, JACCRO GC- Study Group, Tomono Kawase, Ryohei Kawabata, Tetsuya Etou, Hirochika Makino, Hidetaka Ono, Yusuke Izumisawa, Junji Kawada, Ken Shimada, Yu Sunakawa, Hitoshi Satomura, Katsuyuki Kunieda, Akihito Tsuji, Hironaga Satake, Hisashi Ishikura, Hiroshi Okitsu, Takahiro Ito, Kentaro Moriichi, Masazumi Takahashi, Yasutaka Takinishi, Takashi Sekikawa, Naoki Okumura, Shigemitsu Ueyama, Noriyuki Yamamura, Dai Manaka, Sachiko Oouchi, Ryuichiro Ohashi, Tomohiko Mannami, Kazuaki Tanabe, Takeshi Shiraishi, Yutaka Kimuraet al.",2018 May,Gastric Cancer,https://pubmed.ncbi.nlm.nih.gov/28936560/,No keywords found,"['s-', 'plus', 'cisplatin', 'standard', 'regimen', 'advanced', 'gastric', 'cancer', '(', 'agc', ')', 'in', 'asia', '.', 'toga', 'trial', 'established', 'fluoropyrimidine', 'plus', 'cisplatin', 'and', 'trastuzumab', 'standard', 'treatment', 'human', 'epidermal', 'growth', 'factor', 'receptor', '(', ')', '-positive', 'agc', '.', 'in', 'herbis-', 'trial', ',', 'trastuzumab', 'combined', 'with', 's-', 'plus', 'cisplatin', 'showed', 'promising', 'antitumor', 'activity', 'in', 'patient', 'with', 'her-positive', 'agc', '.', 'however', ',', 'cisplatin', 'several', 'important', 'drawback', ',', 'including', 'vomiting', 'and', 'renal', 'toxicity', '.', 'disadvantage', 'of', 'cisplatin', 'prominent', 'in', 'elderly', 'patient', '.', 'therefore', ',', 'conducted', 'prospective', 'phase', 'ii', 'study', 'of', 'trastuzumab', 'plus', 's-', 'without', 'cisplatin', 'in', 'elderly', 'patient', 'with', 'her-positive', 'agc', '.', 'method', 'patient', 'year', 'or', 'older', 'her-positive', 'agc', 'received', 's-', 'orally', 'day', '-', 'of', '-day', 'cycle', 'and', 'trastuzumab', 'intravenously', 'day', 'of', '-day', 'cycle', '.', 'result', 'total', 'of', 'patient', 'enrolled', '.', 'two', 'patient', 'ineligible', '.', 'full', 'analysis', 'set', 'thus', 'comprised', 'patient', '.', 'median', 'age', 'year', '(', 'range', '-', ')', '.', 'confirmed', 'response', 'rate', '.', '(', 'ci', '.-', '.', ')', ',', 'and', 'null', 'hypothesis', 'rejected', '.', 'median', 'follow-up', 'period', '.', 'month', '.', 'median', 'overall', 'survival', '.', 'month', '.', 'median', 'progression-free', 'survival', '.', 'month', ',', 'and', 'time', 'to', 'treatment', 'failure', '.', 'month', '.', 'major', 'grade', 'or', 'adverse', 'event', 'included', 'neutropenia', '(', '.', ')', ',', 'anemia', '(', '.', ')', ',', 'diarrhea', '(', '.', ')', ',', 'and', 'anorexia', '(', '.', ')', '.', 'one', 'treatment-related', 'death', '.', 'conclusion', 'trastuzumab', 'in', 'combination', 'with', 's-', 'alone', 'demonstrated', 'promising', 'antitumor', 'activity', 'and', 'manageable', 'toxic', 'effect', 'well', 'promising', 'survival', 'result', 'in', 'elderly', 'patient', 'with', 'her-positive', 'agc', '.', 'clinical', 'trial', 'registration', 'umin', '.']"
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.,"Alberto Zangrillo, Gabriele Alvaro, Antonio Pisano, Fabio Guarracino, Rosetta Lobreglio, Nikola Bradic, Rosalba Lembo, Stefano Gianni, Maria Grazia Calabrò, Valery Likhvantsev, Evgeny Grigoryev, Giuseppe Buscaglia, Giovanni Pala, Elisabetta Auci, Bruno Amantea, Fabrizio Monaco, Giovanni De Vuono, Antonio Corcione, Nicola Galdieri, Claudia Cariello, Tiziana Bove, Evgeny Fominskiy, Stefano Auriemma, Massimo Baiocchi, Alessandro Bianchi, Mario Frontini, Gianluca Paternoster, Fabio Sangalli, Chew-Yin Wang, Maria Chiara Zucchetti, Giuseppe Biondi-Zoccai, Marco Gemma, Michael J Lipinski, Vladimir V Lomivorotov, Giovanni Landoni, Alberto Zangrilloet al.",2016 Jul:177:66-73.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/27297851/,No keywords found,"['patient', 'undergoing', 'cardiac', 'surgery', 'risk', 'of', 'perioperative', 'low', 'cardiac', 'output', 'syndrome', 'due', 'to', 'postoperative', 'myocardial', 'dysfunction', '.', 'myocardial', 'dysfunction', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', 'potential', 'indication', 'use', 'of', 'levosimendan', ',', 'calcium', 'sensitizer', 'with', 'beneficial', 'cardiovascular', 'effect', '(', 'inotropic', ',', 'vasodilatory', ',', 'and', 'anti-inflammatory', ')', ',', 'appears', 'effective', 'in', 'improving', 'clinically', 'relevant', 'outcome', '.', 'design', 'double-blind', ',', 'placebo-controlled', ',', 'multicenter', 'randomized', 'trial', '.', 'setting', 'tertiary', 'care', 'hospital', '.', 'intervention', 'cardiac', 'surgery', 'patient', '(', 'n', ',', ')', 'with', 'postoperative', 'myocardial', 'dysfunction', '(', 'defined', 'patient', 'with', 'intraaortic', 'balloon', 'pump', 'andor', 'high-dose', 'standard', 'inotropic', 'support', ')', 'randomized', 'to', 'receive', 'continuous', 'infusion', 'of', 'either', 'levosimendan', '(', '.-', '.', 'gkg', 'min', ')', 'or', 'placebo', '-', 'hour', '.', 'measurement', 'and', 'main', 'result', 'primary', 'end', 'point', '-day', 'mortality', '.', 'secondary', 'end', 'point', 'mortality', 'year', ',', 'time', 'mechanical', 'ventilation', ',', 'acute', 'kidney', 'injury', ',', 'decision', 'to', 'stop', 'study', 'drug', 'due', 'to', 'adverse', 'event', 'or', 'to', 'start', 'open-label', 'levosimendan', ',', 'and', 'length', 'of', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', '.', 'test', 'hypothesis', 'levosimendan', 'reduces', '-day', 'mortality', 'in', 'cardiac', 'surgery', 'patient', 'with', 'postoperative', 'myocardial', 'dysfunction', '.', 'conclusion', 'trial', 'planned', 'to', 'determine', 'whether', 'levosimendan', 'could', 'improve', 'survival', 'in', 'patient', 'with', 'postoperative', 'low', 'cardiac', 'output', 'syndrome', '.', 'result', 'of', 'double-blind', ',', 'placebo-controlled', 'randomized', 'trial', 'may', 'provide', 'important', 'insight', 'management', 'of', 'low', 'cardiac', 'output', 'in', 'cardiac', 'surgery', '.']"
Clinical Evaluation of a Vancomycin Dosage Strategy Based on a Serum Trough Concentration Model in Elderly Patients with Severe Pneumonia.,"Wei Yan, Xiao Yan Sun, Meng Wang, Fei Fan Zhao, Qing Tao Zhou, Wei Yanet al.",2023 May 20,Biomed Environ Sci,https://pubmed.ncbi.nlm.nih.gov/37253666/,No keywords found,"['study', 'aimed', 'to', 'evaluate', 'clinical', 'benefit', 'of', 'vancomycin', 'dosage', 'strategy', 'based', 'serum', 'trough', 'concentration', 'model', 'in', 'elderly', 'patient', '.', 'method', 'prospective', 'single-center', ',', 'open-label', ',', 'randomized', 'controlled', 'trial', 'categorized', 'elderly', 'patient', 'with', 'severe', 'pneumonia', 'study', 'and', 'control', 'group', '.', 'control', 'group', 'received', 'vancomycin', 'using', 'regimen', 'decided', 'attending', 'physician', '.', 'meanwhile', ',', 'study', 'group', 'received', 'individualized', 'vancomycin', 'therapy', 'with', 'dosing', 'strategy', 'based', 'serum', 'trough', 'concentration', 'model', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'with', 'serum', 'trough', 'concentration', 'reaching', 'target', 'value', '.', 'secondary', 'endpoint', 'clinical', 'response', ',', 'vancomycin', 'treatment', 'duration', ',', 'and', 'vancomycin-associated', 'acute', 'kidney', 'injury', '(', 'va-aki', ')', 'occurrence', '.', 'result', 'patient', 'least', 'year', 'old', '(', 'median', 'age', 'year', ')', '.', 'proportion', 'of', 'patient', 'with', 'target', 'trough', 'concentration', 'achievement', '(', 'mgl', ')', 'with', 'initial', 'vancomycin', 'regimen', 'significantly', 'higher', 'in', 'study', 'group', 'compared', 'to', 'control', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'forty-five', 'patient', '(', '.', ')', 'achieved', 'clinical', 'success', ',', 'median', 'duration', 'of', 'vancomycin', 'therapy', '.', 'day', ',', 'and', 'va-aki', 'occurred', 'in', 'eight', 'patient', '(', '.', ')', '.', 'however', ',', 'no', 'significant', 'difference', 'in', 'parameter', 'two', 'group', '.', 'model', 'predicting', 'vancomycin', 'trough', 'concentration', 'upgraded', 'to', 'serum', 'trough', 'concentration', '(', 'mgl', ')', '.', '-', '.', 'creatinine', 'clearance', 'rate', '(', 'mlmin', ')', '.', 'vancomycin', 'daily', 'dose', '(', 'mg', '(', 'kgd', ')', '.', 'conclusion', 'vancomycin', 'dosage', 'strategy', 'based', 'serum', 'trough', 'concentration', 'model', 'improve', 'proportion', 'of', 'patient', 'achieving', 'target', 'trough', 'concentration', 'in', 'elderly', 'patient', 'with', 'severe', 'pneumonia', '.']"
Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin.,"Kalthi Vaishnavi, Deepak Bansal, Amita Trehan, Richa Jain, Savita Verma Attri, Kalthi Vaishnaviet al.",2018 Dec,Pediatr Blood Cancer,https://pubmed.ncbi.nlm.nih.gov/29768710/,No keywords found,"['lack', 'of', 'access', 'to', 'methotrexate', 'level', 'common', 'in', 'low-', 'and', 'middle-income', 'country', '(', 'lmic', ')', ',', 'relevant', 'of', 'child', 'with', 'cancer', 'worldwide', '.', 'evaluated', 'whether', 'high-dose', 'methotrexate', '(', 'hd-mtx', ')', 'administered', 'safely', 'with', 'extended', 'hydration', 'and', 'leucovorin', 'rescue', ',', 'with', 'monitoring', 'of', 'serum', 'creatinine', 'and', 'urine', 'ph', '.', 'method', 'prospective', 'study', 'conducted', 'single', 'centre', 'in', 'chandigarh', ',', 'india', 'in', '.', 'patient', 'with', 'b-cell', 'acute', 'lymphoblastic', 'leukemia', '(', ')', 'or', 'with', 't-cell', 'or', 'non-hodgkin', 'lymphoma', '(', 't-nhl', ')', 'administered', 'and', 'gmm', 'of', 'mtx', '(', 'hr', 'infusion', ')', ',', 'respectively', '.', 'six', 'dos', 'of', 'leucovorin', '(', 'mgm', 'dose', ')', ',', 'instead', 'of', 'recommended', 'three', '(', 'optimally', 'reduced', 'level', ')', 'standard', 'timing', '(', 'hr', 'start', 'of', 'hd-mtx', ')', 'administered', '.', 'hydration', '(', 'mlm', 'hr', ')', 'continued', 'hr', ',', 'instead', 'of', 'recommended', 'hr', '.', 'hydration', 'fluid', 'consisted', 'of', '.', 'sodium', 'chloride', ',', 'dextrose', ',', '.', 'sodium', 'bicarbonate', '(', 'mmoll', ')', 'and', 'potassium', 'chloride', '(', 'mmoll', ')', '.', 'serum', 'creatinine', 'and', 'urine', 'ph', 'measured', 'baseline', ',', 'and', 'hr', '.', 'volume', 'of', 'hydration', 'increased', '(', 'mlm', 'hr', ')', 'serum', 'creatinine', '.', 'time', 'baseline', '.', 'result', 'study', 'included', 'cycle', 'of', 'hd-mtx', 'in', 'patient', 'b-all', 'patient', '(', 'cycle', ')', ',', 't-all', 'patient', '(', 'cycle', ')', ',', 't-nhl', 'patient', '(', 'cycle', ')', ',', 'and', 'relapsed', 'patient', '(', 'cycle', ')', '.', 'mean', 'age', '.', '.', 'year', '.', 'patient', 'underweight', 'in', '(', ')', 'cycle', '.', 'patient', 'in', 'of', 'cycle', 'rise', 'in', 'creatinine', 'to', '.', 'time', 'baseline', '.', 'toxicity', '(', 'nci', 'ctcae', 'v.', ')', 'included', 'mucositis', '(', ')', ',', 'diarrhoea', '(', ')', ',', 'and', 'febrile', 'neutropenia', '(', ')', '.', 'one', 'patient', 'died', 'dengue', 'shock', 'syndrome', '.', 'conclusion', 'safe', 'to', 'administer', 'or', 'gmm', 'of', 'mtx', '(', 'hr', 'infusion', ')', 'without', 'measuring', 'mtx', 'level', ',', 'with', 'extended', 'hydration', ',', 'additional', 'dos', 'of', 'leucovorin', ',', 'and', 'monitoring', 'of', 'serum', 'creatinine', 'and', 'urine', 'ph', '.']"
Is oral nano-curcumin formulation a safe and effective measure for preventing cisplatin-induced nephrotoxicity in cancer patients?,"Sare Hosseini, Sara Rahsepar, Sara Naghipour, Sepideh Elyasi, Sare Hosseiniet al.",2024 Oct 1,Anticancer Drugs,https://pubmed.ncbi.nlm.nih.gov/39017207/,No keywords found,"['nephrotoxicity', 'one', 'of', 'important', 'complication', 'in', 'cancer', 'patient', 'treatment', 'with', 'cisplatin-containing', 'regimen', '.', 'curcumin', ',', 'important', 'active', 'component', 'of', 'curcuma', 'longa', ',', 'antioxidant', 'and', 'anti-inflammatory', 'compound', '.', 'in', 'clinical', 'trial', ',', 'assessed', 'preventive', 'effect', 'of', 'nano-curcumin', 'oral', 'formulation', 'cisplatin-induced', 'nephrotoxicity', 'in', 'cancer', 'patient', '.', 'in', 'triple-blind', 'clinical', 'trial', 'cancer', 'patient', 'cisplatin', 'randomly', 'included', 'in', 'treatment', 'group', ',', 'receiving', 'nano-curcumin', 'mg', 'capsule', '(', 'n', ')', 'or', 'placebo', 'group', '(', 'n', ')', 'twice', 'day', 'four', 'chemotherapy', 'course', '.', 'kidney', 'function', 'measured', 'beginning', 'of', 'study', 'and', 'end', 'of', 'course', 'of', 'chemotherapy', '.', 'no', 'significant', 'difference', 'in', 'acute', 'kidney', 'injury', 'occurrence', 'rate', 'and', 'creatinine', 'and', 'blood', 'urine', 'nitrogen', 'serum', 'level', 'treatment', 'and', 'placebo', 'group', 'end', 'of', 'chemotherapy', 'course', '(', 'p', 'value', '.', ')', '.', 'end', 'of', 'first', 'course', ',', 'difference', 'close', 'to', 'significant', '(', 'p', '.', ')', '.', 'also', 'found', 'no', 'difference', 'in', 'mortality', 'and', 'recurrence', 'rate', 'in', 'average', '-month', 'follow-up', '.', 'nano-curcumin', 'in', 'prescribed', 'dose', 'and', 'duration', 'not', 'effective', 'in', 'preventing', 'cisplatin-induced', 'nephrotoxicity', 'in', 'cancer', 'patient', 'in', 'comparison', 'with', 'placebo', '.', 'study', 'with', 'larger', 'sample', 'size', 'using', 'different', 'dos', 'and', 'duration', 'of', 'nano-curcumin', 'recommended', '.']"
Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.,"Geng Qian, Zhenhong Fu, Jun Guo, Feng Cao, Yundai Chen, Geng Qianet al.",2016 Jan 11,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/26685074/,No keywords found,"['study', 'aimed', 'to', 'explore', 'hemodynamic', 'index-guided', 'hydration', 'method', 'patient', 'with', 'congestive', 'heart', 'failure', '(', 'chf', ')', 'and', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'to', 'reduce', 'risk', 'of', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'and', 'time', 'to', 'avoid', 'acute', 'heart', 'failure', '.', 'background', 'patient', 'moderate', 'or', 'high', 'risk', 'cin', 'receive', 'sufficient', 'hydration', 'contrast', 'application', '.', 'method', 'prospective', ',', 'randomized', ',', 'double-blind', ',', 'comparative', 'clinical', 'trial', 'enrolled', 'consecutive', 'patient', 'with', 'ckd', 'and', 'chf', 'undergoing', 'coronary', 'procedure', '.', 'patient', 'randomly', 'assigned', 'to', 'either', 'central', 'venous', 'pressure', '(', 'cvp', ')', '-guided', 'hydration', 'group', '(', 'n', ')', 'or', 'standard', 'hydration', 'group', '(', 'n', ')', '.', 'in', 'cvp-guided', 'group', ',', 'hydration', 'infusion', 'rate', 'dynamically', 'adjusted', 'according', 'to', 'cvp', 'level', 'every', 'hour', '.', 'cin', 'defined', 'absolute', 'increase', 'in', 'serum', 'creatinine', '(', 'scr', ')', '.', 'mgdl', '(', '.', 'moll', ')', 'or', 'relative', 'increase', 'compared', 'with', 'baseline', 'scr', '.', 'result', 'baseline', 'characteristic', 'well-matched', 'group', '.', 'total', 'mean', 'volume', 'of', 'isotonic', 'saline', 'administered', 'in', 'cvp-guided', 'hydration', 'group', 'significantly', 'higher', 'control', 'group', '(', ',', 'ml', 'vs.', ',', 'ml', 'p', '.', ')', '.', 'cin', 'occurred', 'less', 'frequently', 'in', 'cvp-guided', 'hydration', 'group', 'control', 'group', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'incidence', 'of', 'acute', 'heart', 'failure', 'hydration', 'not', 'differ', 'group', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'conclusion', 'cvp-guided', 'fluid', 'administration', 'safely', 'and', 'effectively', 'reduce', 'risk', 'of', 'cin', 'in', 'patient', 'with', 'ckd', 'and', 'chf', '.', '(', 'central', 'venous', 'pressure', 'guided', 'hydration', 'prevention', 'contrast-induced', 'nephropathy', 'nct', ')', '.']"
"Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial.","Peter B Hjortrup, Nicolai Haase, Helle Bundgaard, Simon L Thomsen, Robert Winding, Ville Pettilä, Anne Aaen, David Lodahl, Rasmus E Berthelsen, Henrik Christensen, Martin B Madsen, Per Winkel, Jørn Wetterslev, Anders Perner                                                            ;, CLASSIC Trial Group;, Scandinavian Critical Care Trials Group, Peter B Hjortrupet al.",2016 Nov,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/27686349/,No keywords found,"['assessed', 'effect', 'of', 'protocol', 'restricting', 'resuscitation', 'fluid', 'vs.', 'standard', 'care', 'protocol', 'initial', 'resuscitation', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'patient', 'with', 'septic', 'shock', '.', 'method', 'randomised', 'adult', 'patient', 'with', 'septic', 'shock', 'received', 'initial', 'fluid', 'resuscitation', 'in', 'nine', 'scandinavian', 'icu', '.', 'in', 'fluid', 'restriction', 'group', 'fluid', 'bolus', 'permitted', 'sign', 'of', 'severe', 'hypoperfusion', 'occurred', ',', 'in', 'standard', 'care', 'group', 'fluid', 'bolus', 'permitted', 'long', 'circulation', 'continued', 'to', 'improve', '.', 'result', 'co-primary', 'outcome', 'measure', ',', 'resuscitation', 'fluid', 'volume', 'day', 'and', 'icu', 'stay', ',', 'lower', 'in', 'fluid', 'restriction', 'group', 'in', 'standard', 'care', 'group', 'mean', 'difference', '-', '.', 'l', '(', 'confidence', 'interval', '-', '.', 'to', '-', '.', ')', 'p', '.', 'and', '-', '.', 'l', '(', '-', '.', 'to', '-', '.', ')', 'respectively', 'p', '..', 'neither', 'total', 'fluid', 'input', 'and', 'balance', 'serious', 'adverse', 'reaction', 'differed', 'statistically', 'significantly', 'group', '.', 'major', 'protocol', 'violation', 'occurred', 'in', 'patient', 'in', 'fluid', 'restriction', 'group', '.', 'ischaemic', 'event', 'occurred', 'in', 'in', 'fluid', 'restriction', 'group', 'vs.', 'in', 'standard', 'care', 'group', '(', 'odds', 'ratio', '.', '.-', '.', 'p', '.', ')', ',', 'worsening', 'of', 'acute', 'kidney', 'injury', 'in', 'vs.', '(', '.', '.-', '.', 'p', '.', ')', ',', 'and', 'death', 'day', 'in', 'vs.', '(', '.', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'protocol', 'restricting', 'resuscitation', 'fluid', 'successfully', 'reduced', 'volume', 'of', 'resuscitation', 'fluid', 'compared', 'with', 'standard', 'care', 'protocol', 'in', 'adult', 'icu', 'patient', 'with', 'septic', 'shock', '.', 'patient-centred', 'outcome', 'pointed', 'towards', 'benefit', 'with', 'fluid', 'restriction', ',', 'trial', 'not', 'powered', 'to', 'show', 'difference', 'in', 'exploratory', 'outcome', '.', 'trial', 'registration', 'nct', '.']"
Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration.,"Buyun Wu, Kaiyue Zhang, Bin Xu, Daxi Ji, Zhihong Liu, Dehua Gong, Buyun Wuet al.",2015,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/26022434/,No keywords found,"['to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'regional', 'citrate', 'anticoagulation', '(', 'rca', ')', 'plus', 'low-dose', 'dalteparin', 'in', 'patient', 'receiving', 'continuous', 'veno-venous', 'hemofiltration', '(', 'cvvh', ')', '.', 'method', 'patient', 'requiring', 'pre-dilution', 'cvvh', 'lh', 'randomly', 'assigned', 'to', 'group', '(', 'rca', ')', ',', 'group', 'b', '(', 'normal-dose', 'dalteparin', 'anticoagulation', ')', 'or', 'group', 'c', '(', 'rca', 'plus', 'low-dose', 'dalteparin', ')', '.', 'primary', 'endpoint', 'filter', 'runtime', 'and', 'secondary', 'endpoint', 'premature', 'clotting', 'of', 'filter', 'and', 'anticoagulation-related', 'side', 'effect', '.', 'result', 'fifty-three', 'patient', 'completed', 'study', '.', 'mean', 'filter', 'runtime', 'significantly', 'longer', 'in', 'group', 'c', '(', '.', '.', 'h', ')', 'in', 'group', '(', '.', '.', 'h', ',', 'p', '.', ')', 'and', 'group', 'b', '(', '.', '.', 'h', ',', 'p', '.', ')', '.', 'rate', 'of', 'premature', 'clotting', ',', 'new', 'onset', 'of', 'bleeding', ',', 'hypocalcemia', 'and', 'metabolic', 'acidosis', 'not', 'differ', 'significantly', 'in', 'three', 'group', '.', 'conclusion', 'rca', 'plus', 'low-dose', 'dalteparin', 'prolonged', 'filter', 'runtime', 'compared', 'with', 'rca', 'or', 'normal-dose', 'dalteparin', 'without', 'increasing', 'incidence', 'of', 'anticoagulation-related', 'complication', '.']"
"Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.","Martin B Madsen, Peter B Hjortrup, Marco B Hansen, Theis Lange, Anna Norrby-Teglund, Ole Hyldegaard, Anders Perner, Martin B Madsenet al.",2017 Nov,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/28421246/,No keywords found,"['aim', 'of', 'instinct', 'trial', 'to', 'assess', 'effect', 'of', 'intravenous', 'polyspecific', 'immunoglobulin', 'g', '(', 'ivig', ')', 'compared', 'with', 'placebo', 'self-reported', 'physical', 'function', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'patient', 'with', 'necrotising', 'soft', 'tissue', 'infection', '(', 'nsti', ')', '.', 'method', 'randomised', 'patient', 'with', 'nsti', 'to', 'masked', 'infusion', 'of', 'g', 'of', 'ivig', '(', 'privigen', ',', 'csl', 'behring', ')', 'or', 'equal', 'volume', 'of', '.', 'saline', 'daily', 'first', 'day', 'of', 'icu', 'admission', '.', 'primary', 'outcome', 'physical', 'component', 'summary', '(', 'pc', ')', 'score', 'of', '-item', 'short', 'form', 'health', 'survey', '(', 'sf-', ')', 'month', 'randomisation', 'patient', 'died', 'given', 'lowest', 'possible', 'score', '(', 'zero', ')', '.', 'result', 'of', 'patient', 'randomised', ',', 'included', 'in', 'intention-to-treat', 'analysis', 'of', 'pc', 'score', ',', 'patient', '(', ')', 'in', 'ivig', 'group', 'and', 'patient', '(', ')', 'in', 'placebo', 'group', '.', 'two', 'intervention', 'group', 'similar', 'baseline', 'characteristic', 'with', 'exception', 'of', 'ivig', 'use', 'randomisation', '(', 'dose', 'allowed', ')', 'and', 'rate', 'of', 'acute', 'kidney', 'injury', '.', 'median', 'pc', 'score', '(', 'interquartile', 'range', '-', ')', 'in', 'group', 'assigned', 'to', 'ivig', 'and', '(', '-', ')', 'in', 'group', 'assigned', 'to', 'placebo', '(', 'mean', 'adjusted', 'difference', '(', 'confidence', 'interval', '-', 'to', ')', ',', 'p', '.', ')', '.', 'result', 'supported', 'analysis', 'adjusted', 'baseline', 'prognostic', ',', 'in', 'per', 'protocol', 'population', ',', 'in', 'subgroup', '(', 'site', 'of', 'nsti', ')', 'and', 'done', 'post', 'hoc', 'adjusted', 'ivig', 'use', 'randomisation', '.', 'conclusion', 'in', 'icu', 'patient', 'with', 'nsti', ',', 'observed', 'no', 'apparent', 'effect', 'of', 'adjuvant', 'ivig', 'self-reported', 'physical', 'functioning', 'month', '.', 'trial', 'registration', 'nct', '.']"
Electronic health record intervention to increase use of NSAIDs as analgesia for hospitalised patients: a cluster randomised controlled study.,"Tasce Bongiovanni, Mark J Pletcher, Andrew Robinson, Elizabeth Lancaster, Li Zhang, Matthias Behrends, Elizabeth Wick, Andrew Auerbach, Tasce Bongiovanniet al.",2023 Dec 30,BMJ Health Care Inform,https://pubmed.ncbi.nlm.nih.gov/38159932/,No keywords found,"['prescribing', 'non-opioid', 'pain', 'medication', ',', 'non-steroidal', 'anti-inflammatory', '(', 'nsaid', ')', 'medication', ',', 'shown', 'to', 'reduce', 'pain', 'and', 'decrease', 'opioid', 'use', ',', 'unclear', 'to', 'effectively', 'encourage', 'multimodal', 'pain', 'medication', 'prescribing', 'hospitalised', 'patient', '.', 'therefore', ',', 'aim', 'of', 'study', 'to', 'evaluate', 'effect', 'of', 'prechecking', 'non-opioid', 'pain', 'medication', 'order', 'clinician', 'prescribing', 'of', 'nsaid', 'among', 'hospitalised', 'adult', '.', 'method', 'cluster', 'randomised', 'controlled', 'trial', 'of', 'adult', '(', 'year', ')', 'hospitalised', 'patient', 'admitted', 'to', 'three', 'hospital', 'site', 'one', 'quaternary', 'hospital', 'system', 'in', 'usa', 'march', 'to', 'march', '.', 'multimodal', 'pain', 'order', 'panel', 'embedded', 'in', 'admission', 'order', 'set', ',', 'with', 'nsaid', 'prechecked', 'in', 'intervention', 'group', '.', 'intervention', 'group', 'could', 'uncheck', 'nsaid', 'order', '.', 'control', 'group', 'access', 'to', 'nsaid', 'order', '.', 'primary', 'outcome', 'increase', 'in', 'nsaid', 'ordering', '.', 'secondary', 'outcome', 'include', 'nsaid', 'administration', ',', 'inpatient', 'pain', 'score', 'and', 'opioid', 'use', 'and', 'prescribing', 'and', 'relevant', 'clinical', 'harm', 'including', 'acute', 'kidney', 'injury', ',', 'new', 'gastrointestinal', 'bleed', 'and', 'in-hospital', 'death', '.', 'result', 'overall', ',', 'clinician', 'randomised', '.', 'study', 'included', 'patient', 'total', 'of', 'encounter', '.', 'nsaid', 'ordering', '(', 'v', ',', 'p.', ')', 'and', 'administering', '(', 'v', ',', 'p.', ')', 'end', 'of', 'first', 'full', 'hospital', 'day', 'higher', 'in', 'intervention', '(', 'prechecked', ')', 'group', '.', 'no', 'statistically', 'significant', 'difference', 'in', 'opioid', 'outcome', 'hospitalisation', 'and', 'discharge', '.', 'statistically', 'perhaps', 'not', 'clinically', 'significant', 'difference', 'in', 'pain', 'score', 'first', 'and', 'last', 'full', 'hospital', 'day', '.', 'conclusion', 'cluster', 'randomised', 'controlled', 'trial', 'showed', 'prechecking', 'order', 'nsaid', 'to', 'promote', 'multimodal', 'pain', 'management', 'in', 'admission', 'order', 'set', 'increased', 'nsaid', 'ordering', 'and', 'administration', ',', 'although', 'no', 'change', 'to', 'pain', 'score', 'or', 'opioid', 'use', '.', 'prechecking', 'order', 'important', 'way', 'to', 'increase', 'adoption', ',', 'safety', 'check', 'in', 'place', '.']"
"Efficacy and safety of ""unboosting"" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DF.","Marianne Harris, Bruce Ganase, Birgit Watson, Mark W Hull, Silvia A Guillemi, Wendy Zhang, Ramesh Saeedi, P Richard Harrigan, Marianne Harriset al.",2017 Jan,HIV Clin Trials,https://pubmed.ncbi.nlm.nih.gov/28067119/,No keywords found,"['to', 'assess', 'safety', 'and', 'efficacy', 'of', 'switch', 'to', 'unboosted', 'atazanavir', '(', 'atv', ')', 'among', 'hiv-infected', 'adult', 'receiving', 'atvritonavir', '(', 'r', ')', 'and', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', '.', 'method', 'hiv-infected', 'adult', 'with', 'viral', 'load', '(', 'vl', ')', 'copiesml', 'twice', 'consecutively', ')', 'week', '.', 'result', 'fifty', 'participant', '(', 'male', ',', 'median', 'age', 'year', ')', 'randomized', ',', 'to', 'arm', '.', 'week', ',', 'treatment', 'success', 'occurred', 'in', 'in', 'control', 'arm', 'and', 'in', 'switch', 'arm', '(', 'itt', ',', 'p', '.', ')', '.', 'atv', 'trough', 'level', 'week', 'higher', 'in', 'control', '(', 'median', 'ngml', ')', 'in', 'switch', 'arm', '(', 'median', 'ngml', ')', '(', 'p', '.', ')', ',', 'total', 'bilirubin', 'week', '(', 'median', 'moll', 'and', 'moll', ',', 'respectively', 'p', '.', ')', '.', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'decreased', 'in', 'control', 'arm', '(', 'p', '.', ')', ',', 'not', 'change', 'in', 'switch', 'arm', '.', 'week', ',', 'egfr', 'higher', 'in', 'switch', 'arm', '(', 'median', 'mlmin', ')', 'in', 'control', 'arm', '(', 'median', 'mlmin', ')', '(', 'p', '.', ')', ',', 'arm', 'similar', 'with', 'respect', 'to', 'fasting', 'glucose', ',', 'c-reactive', 'protein', ',', 'and', 'lipid', 'parameter', '.', 'conclusion', 'switching', 'atvr', 'to', 'unboosted', 'atv', 'appears', 'to', 'safe', 'and', 'effective', 'in', 'selected', 'virologically', 'suppressed', 'patient', 'receiving', 'tdf-containing', 'regimen', ',', 'and', 'may', 'favorable', 'effect', 'bilirubin', 'and', 'renal', 'function', '.']"
Nonaggressive Versus Aggressive Intravenous Fluid Therapy in Acute Pancreatitis With More Than 24 Hours From Disease Onset: A Randomized Controlled Trial.,"Jesús Eduardo Cuéllar-Monterrubio, Roberto Monreal-Robles, Emmanuel I González-Moreno, Omar D Borjas-Almaguer, José Luis Herrera-Elizondo, Diego García-Compean, Héctor J Maldonado-Garza, José Alberto González-González, Jesús Eduardo Cuéllar-Monterrubioet al.",2020 Apr,Pancreas,https://pubmed.ncbi.nlm.nih.gov/32282773/,No keywords found,"['study', 'aimed', 'to', 'compare', '``', 'nonaggressive', ""''"", 'hydration', 'versus', '``', 'aggressive', ""''"", 'hydration', 'using', 'hartmann', ""'s"", 'solution', 'in', 'patient', 'with', 'acute', 'pancreatitis', '(', 'ap', ')', 'with', 'hour', 'disease', 'onset', '.', 'method', 'included', 'patient', 'with', 'ap', 'with', 'hour', 'disease', 'onset', ',', 'and', 'randomized', 'group', '.', 'group', '(', 'n', ')', 'received', 'nonaggressive', 'hydration', '(', 'hartmann', ""'s"", 'solution', '.', 'ml', 'kg', 'h', 'first', 'hour', 'and', 'ml', 'kg', 'next', 'hour', ')', ',', 'and', 'group', 'ii', '(', 'n', ')', 'received', 'aggressive', 'hydration', '(', 'bolus', 'of', 'hartmann', ""'s"", 'solution', 'ml', 'kg', ',', 'followed', 'infusion', 'of', 'ml', 'kg', 'h', 'first', 'hour', 'and', 'ml', 'kg', 'next', 'hour', ')', '.', 'result', 'mean', 'volume', 'of', 'fluid', 'administered', 'greater', 'in', 'group', 'ii', '(', 'p', '.', ')', '.', 'not', 'find', 'difference', 'comparing', 'group', 'in', 'reference', 'to', 'persistent', 'systemic', 'inflammatory', 'response', 'syndrome', '(', 'p', '.', ')', ',', 'pancreatic', 'necrosis', '(', 'p', '.', ')', ',', 'respiratory', 'complication', '(', 'p', '.', ')', ',', 'acute', 'kidney', 'injury', '(', 'p', '.', ')', ',', 'or', 'length', 'of', 'hospital', 'stay', '(', 'p', '.', ')', '.', 'conclusion', 'study', 'suggests', 'clinical', 'evolution', 'of', 'patient', 'with', 'ap', 'with', 'hour', 'disease', 'onset', 'similar', 'using', 'aggressive', 'or', 'nonaggressive', 'hydration', '.']"
Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.,"Soo Hwan Park, Myung Ho Jeong, In Hyae Park, Jin Soo Choi, Jung Ae Rhee, In Soo Kim, Min Cheol Kim, Jae Yeong Cho, Doo Sun Sim, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang, Soo Hwan Parket al.",2016 Jun 1:212:100-6.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/27045874/,No keywords found,"['acute', 'myocardial', 'infarction', '(', 'ami', ')', 'risk', 'factor', 'contrast-induced', 'nephropathy', '(', 'cin', ')', '.', 'investigated', 'whether', 'pretreatment', 'with', 'statin', ',', 'n-acetylcysteine', '(', 'nac', ')', 'and', 'sodium', 'bicarbonate', '(', 'nahco', ')', 'reduces', 'risk', 'of', 'cin', '.', 'method', 'conducted', 'prospective', 'trial', 'and', 'enrolled', 'total', 'of', 'st-segment', 'elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'patient', '.', 'patient', 'divided', 'four', 'group', 'group', '(', 'statin', 'mg', ')', ',', 'group', 'ii', '(', 'statin', 'mg', ')', ',', 'group', 'iii', '(', 'statin', 'mg', 'plus', 'nac', 'mg', ')', 'and', 'group', 'iv', '(', 'regimen', 'of', 'group', 'iii', 'plus', 'nahco', 'meql', ')', '.', 'cin', 'defined', 'or', '.mgdl', 'increase', 'in', 'serum', 'creatinine', 'baseline', 'within', 'h', 'pci', '.', 'result', 'cin', 'occurred', 'in', '(', '.', ')', 'patient', '.', 'incidence', 'of', 'cin', 'lowest', 'in', 'group', 'iii', '(', '.', ')', ',', 'and', 'multivariate', 'analysis', 'showed', 'lower', 'incidence', 'of', 'cin', 'in', 'group', 'iii', 'compared', 'to', 'group', 'odds', 'ratio', '(', 'or', ')', '.', ',', 'confidence', 'interval', '(', 'ci', ')', '.-.', ',', 'p', '..', 'admission', 'hyperglycemia', '(', 'ahg', ')', 'mgdl', '(', 'or', '.', ',', 'cl', '.-.', ',', 'p.', ')', 'and', 'use', 'of', 'intra-aortic', 'balloon', 'pump', '(', 'iabp', ')', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p.', ')', 'independent', 'predictor', 'cin', '.', 'cin', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p.', ')', 'independent', 'predictor', 'in-hospital', 'mortality', '.', 'conclusion', 'combination', 'of', 'high-dose', 'statin', 'plus', 'nac', 'associated', 'with', 'lower', 'incidence', 'of', 'cin', 'in', 'patient', 'with', 'stemi', 'underwent', 'primary', 'pci', 'compared', 'to', 'statin', '.']"
"The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial.","Anne Sophie Pinholt Kancir, Joergen Kühlwein Johansen, Niels Peter Ekeloef, Erling Bjerregaard Pedersen, Anne Sophie Pinholt Kanciret al.",2015 Mar,Anesth Analg,https://pubmed.ncbi.nlm.nih.gov/25627076/,No keywords found,"['although', 'hydroxyethyl', 'starch', '(', 'he', ')', 'commonly', 'used', 'intravascular', 'volume', 'expander', 'in', 'surgical', 'patient', ',', 'recent', 'study', 'suggest', 'may', 'increase', 'risk', 'of', 'renal', 'failure', 'in', 'critically', 'ill', 'patient', '.', 'hypothesized', 'patient', 'undergoing', 'radical', 'prostatectomy', 'and', 'receiving', 'he', 'would', 'likely', 'to', 'develop', 'marker', 'of', 'renal', 'failure', ',', 'increasing', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'u-ngal', ')', ',', 'creatinine', 'clearance', '(', 'c', '(', 'crea', ')', ')', ',', 'and', 'decreasing', 'urine', 'output', '(', 'uo', ')', '.', 'method', 'in', 'randomized', ',', 'double-blinded', ',', 'placebo-controlled', 'study', ',', 'patient', 'referred', 'radical', 'prostatectomy', 'received', 'either', 'he', '.', 'or', 'saline', '.', '.', 'mlkg', 'first', 'hour', 'of', 'surgery', 'and', 'mlkg', 'in', 'following', 'hour', 'u-ngal', ',', 'urine', 'albumin', ',', 'c', '(', 'crea', ')', ',', 'uo', ',', 'arterial', 'blood', 'pressure', ',', 'and', 'plasma', 'concentration', 'of', 'creatinine', ',', 'renin', ',', 'angiotensin', 'ii', ',', 'aldosterone', ',', 'and', 'vasopressin', 'measured', ',', ',', 'and', 'surgery', '.', 'result', 'thirty-six', 'patient', 'completed', 'study', '.', 'u-ngal', ',', 'c', '(', 'crea', ')', ',', 'uo', ',', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'p-creatinine', ',', 'urine', 'albumin', ',', 'and', 'arterial', 'blood', 'pressure', 'in', 'group', '.', 'blood', 'loss', 'higher', 'in', 'he', 'group', '(', 'he', 'v', 'saline', 'ml', ')', ',', 'p-albumin', 'reduced', 'to', 'significantly', 'lower', 'level', '.', 'p-renin', 'and', 'p-angiotensin-ii', 'increased', 'in', 'group', ',', 'whereas', 'p-aldosterone', 'and', 'p-vasopressin', 'increased', 'significantly', 'in', 'saline', 'group', '.', 'conclusion', 'found', 'no', 'evidence', 'of', 'nephrotoxicity', 'infusion', 'of', 'he', '.', 'in', 'patient', 'undergoing', 'prostatectomy', 'with', 'normal', 'preoperative', 'renal', 'function', '.', 'hemodynamic', 'stability', 'and', 'infused', 'fluid', 'volume', 'in', 'group', '.', 'observed', 'increased', 'blood', 'loss', 'in', 'group', 'given', 'he', '..']"
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.,"Michael S Grimley, Roy F Chemaly, Janet A Englund, Joanne Kurtzberg, Gregory Chittick, Thomas M Brundage, Andrew Bae, Marion E Morrison, Vinod K Prasad, Michael S Grimleyet al.",2017 Mar,Biol Blood Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/28063938/,"Adenoviruses, Antiviral, BCV, Brincidofovir, CMX001, Stem cell transplantation, Treatment.","['to', 'receive', 'oral', 'bcv', 'mg', '(', 'mgkg', 'kg', ')', 'twice', 'weekly', '(', 'biw', ')', ',', 'bcv', 'mg', '(', 'mgkg', 'kg', ')', 'weekly', '(', 'qw', ')', ',', 'or', 'placebo', 'to', 'week', ',', 'followed', 'week', 'of', 'post-treatment', 'follow-up', '.', 'randomization', ',', 'subject', 'stratified', 'screening', 'absolute', 'lymphocyte', 'count', '(', 'cellsmm', 'versus', 'cellsmm', ')', '.', 'assignment', 'to', 'bcv', 'or', 'placebo', 'double', 'blinded', 'dose', 'frequency', 'unblinded', '.', 'primary', 'endpoint', 'proportion', 'of', 'subject', 'experiencing', 'treatment', 'failure', ',', 'defined', 'either', 'progression', 'to', 'probable', 'or', 'definitive', 'adenovirus', 'disease', 'or', 'confirmed', 'increasing', 'adenovirus', 'viremia', '(', 'log', 'copiesml', ')', 'randomized', 'therapy', '.', 'june', 'and', 'december', ',', 'subject', 'randomized', 'to', 'bcv', 'biw', '(', 'n', ')', ',', 'bcv', 'qw', '(', 'n', ')', ',', 'or', 'placebo', '(', 'n', ')', 'group', '.', 'proportion', 'of', 'subject', 'with', 'treatment', 'failure', 'in', 'bcv', 'biw', 'group', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', ',', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ',', 'p', '.', ')', 'in', 'bcv', 'qw', 'group', ',', 'and', 'in', 'placebo', 'group', '.', 'all-cause', 'mortality', 'lower', 'in', 'bcv', 'biw', '(', ')', 'and', 'bcv', 'qw', 'group', '(', ')', 'relative', 'to', 'placebo', 'group', '(', ')', ',', 'difference', 'not', 'statistically', 'significant', '.', 'week', 'of', 'therapy', ',', 'of', 'subject', '(', ')', 'randomized', 'to', 'bcv', 'biw', 'undetectable', 'adenovirus', 'viremia', '(', 'copiesml', ')', ',', 'compared', 'with', 'of', 'subject', '(', ')', 'randomized', 'to', 'bcv', 'qw', 'and', 'of', 'subject', '(', ')', 'randomized', 'to', 'placebo', '.', 'in', 'post', 'hoc', 'analysis', 'of', 'subject', 'with', 'viremia', 'copiesml', 'baseline', ',', 'of', 'bcv', 'biw', 'subject', '(', ')', 'achieved', 'undetectable', 'viremia', 'compared', 'with', 'of', 'placebo', 'subject', '(', 'p', '.', ')', '.', 'early', 'treatment', 'discontinuation', 'of', 'adverse', 'event', 'common', 'in', 'subject', 'treated', 'with', 'bcv', 'with', 'placebo', '.', 'diarrhea', 'common', 'event', 'in', 'group', '(', 'bcv', 'biw', ',', 'bcv', 'qw', ',', 'placebo', ')', ',', 'led', 'to', 'treatment', 'discontinuation', 'in', 'subject', 'receiving', 'bcv', 'qw', '.', 'event', 'diagnosed', 'acute', 'graft-versus-host', 'disease', ',', 'primarily', 'of', 'gastrointestinal', 'tract', ',', 'frequent', 'in', 'bcv', 'biw', 'group', '(', ')', 'in', 'bcv', 'qw', '(', ')', 'and', 'placebo', '(', ')', 'group', '.', 'no', 'evidence', 'of', 'myelotoxicity', 'or', 'nephrotoxicity', 'in', 'bcv-treated', 'subject', '.', 'result', 'of', 'trial', 'confirm', 'antiviral', 'activity', 'of', 'bcv', 'adenovirus', '.', 'investigation', 'ongoing', 'to', 'define', 'optimal', 'treatment', 'strategy', 'hct', 'recipient', 'with', 'serious', 'adenovirus', 'infection', 'and', 'disease', '.']"
Low vs. high haemoglobin trigger for transfusion in vascular surgery: protocol for a randomised trial.,"A Møller, H B Nielsen, J Wetterslev, O B Pedersen, D Hellemann, S Shahidi, A Mølleret al.",2017 Sep,Acta Anaesthesiol Scand,https://pubmed.ncbi.nlm.nih.gov/28782109/,No keywords found,"['in', 'patient', 'with', 'cardiovascular', 'disease', ',', 'guideline', 'administration', 'of', 'red', 'blood', 'cell', '(', 'rbc', ')', 'mainly', 'based', 'study', 'outside', 'vascular', 'surgical', 'setting', 'with', 'recommendation', 'to', 'use', 'haemoglobin', '(', 'hb', ')', 'trigger-level', 'lower', 'guideline', 'european', 'society', 'vascular', 'surgery', '.', 'restricting', 'rbc', 'transfusion', 'may', 'affect', 'blood', 'transport', 'with', 'risk', 'development', 'of', 'tissue', 'ischaemia', 'and', 'postoperative', 'complication', '.', 'method', 'in', 'single-centre', ',', 'open-label', ',', 'assessor', 'blinded', 'trial', ',', 'vascular', 'surgical', 'patient', '(', 'year', 'of', 'age', ')', 'awaiting', 'open', 'surgery', 'of', 'infrarenal', 'aorta', 'or', 'infrainguinal', 'arterial', 'bypass', 'surgery', 'undergo', 'web-based', 'randomisation', 'to', 'one', 'of', 'two', 'group', 'perioperative', 'rbc', 'transfusion', 'triggered', 'hb', 'gdl', 'or', 'hb', '.', 'gdl', '.', 'administration', 'of', 'fluid', 'follows', 'individualised', 'strategy', 'optimising', 'cardiac', 'stroke', 'volume', 'and', 'near-infrared', 'spectroscopy', 'determines', 'tissue', 'oxygenation', '.', 'serious', 'adverse', 'event', 'rate', 'myocardial', 'injury', '(', 'troponin-i', 'ngl', 'or', 'ischaemic', 'electrocardiographic', 'finding', 'day', ')', ',', 'acute', 'kidney', 'injury', ',', 'death', ',', 'stroke', 'and', 'severe', 'transfusion', 'reaction', '.', 'follow-up', 'visit', 'take', 'place', 'day', 'surgery', 'and', 'follow-up', 'of', 'serious', 'adverse', 'event', 'in', 'danish', 'national', 'patient', 'register', 'within', 'day', 'pending', '.', 'discussion', 'trial', 'expected', 'to', 'determine', 'whether', 'rbc', 'transfusion', 'triggered', 'hb', '.', 'gdl', 'compared', 'with', 'hb', 'gdl', 'result', 'in', 'adequate', 'separation', 'of', 'postoperative', 'hb', 'level', ',', 'transfusion', 'of', 'rbc', 'unit', 'and', 'maintains', 'higher', 'tissue', 'oxygenation', '.', 'result', 'inform', 'design', 'of', 'multicentre', 'trial', 'evaluation', 'of', 'important', 'postoperative', 'outcome', '.']"
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.,"Suzanne Leijen, Sjaak A Burgers, Paul Baas, Dick Pluim, Matthijs Tibben, Erik van Werkhoven, Enzo Alessio, Gianni Sava, Jos H Beijnen, Jan H M Schellens, Suzanne Leijenet al.",2015 Feb,Invest New Drugs,https://pubmed.ncbi.nlm.nih.gov/25344453/,No keywords found,"['phase', 'iii', 'study', 'determined', 'maximal', 'tolerable', 'dose', ',', 'dose', 'limiting', 'toxicity', ',', 'antitumor', 'activity', ',', 'pharmacokinetics', 'and', 'pharmacodynamics', 'of', 'ruthenium', 'compound', 'nami-a', 'in', 'combination', 'with', 'gemcitabine', 'in', 'non-small', 'cell', 'lung', 'cancer', 'patient', 'first', 'line', 'treatment', '.', 'method', 'initial', 'dose', 'escalation', 'of', 'nami-a', 'performed', 'in', 'day', 'cycle', 'nami-a', 'h', 'infusion', 'port-a-cath', 'starting', 'dose', 'of', 'mgm', '(', ')', 'day', ',', 'and', ',', 'in', 'combination', 'with', 'gemcitabine', ',', 'mgm', '(', ')', 'day', ',', 'and', '.', 'subsequently', ',', 'dose', 'escalation', 'of', 'nami-a', 'in', 'day', 'schedule', 'explored', '.', 'maximal', 'tolerable', 'dose', 'level', 'of', 'schedule', 'expansion', 'group', 'enrolled', 'of', 'patient', 'evaluable', 'response', '.', 'result', 'due', 'to', 'frequent', 'neutropenic', 'dose', 'interruption', 'in', 'third', 'week', ',', 'day', 'schedule', 'amended', 'day', 'schedule', '.', 'maximal', 'tolerable', 'dose', 'and', 'mgm', '(', ')', 'of', 'nami-a', '(', 'day', 'schedule', ')', '.', 'main', 'adverse', 'event', 'consisted', 'of', 'neutropenia', ',', 'anemia', ',', 'elevated', 'liver', 'enzyme', ',', 'transient', 'creatinine', 'elevation', ',', 'nausea', ',', 'vomiting', ',', 'constipation', ',', 'diarrhea', ',', 'fatigue', ',', 'and', 'renal', 'toxicity', '.', 'conclusion', 'nami-a', 'administered', 'in', 'combination', 'with', 'gemcitabine', 'moderately', 'tolerated', 'and', 'less', 'active', 'in', 'nsclc', 'patient', 'first', 'line', 'treatment', 'gemcitabine', 'alone', '.']"
Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection.,"Tomefa E Asempa, Joseph L Kuti, Julie D Seroogy, Allison S Komirenko, David P Nicolau, Tomefa E Asempaet al.",2019 Sep 23,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/31358580/,"aminoglycoside, dosing, nephrotoxicity, pharmacokinetics.","['plazomicin', 'new', 'fda-approved', 'aminoglycoside', 'antibiotic', 'complicated', 'urinary', 'tract', 'infection', '(', 'cuti', ')', '.', 'in', 'product', 'labeling', ',', 'trough-based', 'therapeutic', 'drug', 'management', '(', 'tdm', ')', 'recommended', 'cuti', 'patient', 'with', 'renal', 'impairment', 'to', 'prevent', 'elevated', 'trough', 'concentration', 'associated', 'with', 'serum', 'creatinine', 'increase', 'of', '.', 'mgdl', 'baseline', '.', 'herein', ',', 'utility', 'of', 'hartford', 'nomogram', 'to', 'prevent', 'plazomicin', 'trough', 'concentration', 'exceeding', 'tdm', 'trough', 'of', 'gml', 'and', 'optimize', 'area', 'curve', '(', 'auc', ')', 'assessed', '.', 'auc', 'reference', 'range', 'defined', 'th', 'to', 'th', 'percentile', 'auc', 'observed', 'in', 'phase', 'cuti', 'trial', '(', 'epic', ')', '(', 'to', 'g', 'hml', ')', '.', 'observed', '-h', 'plazomicin', 'concentration', 'patient', 'in', 'epic', '(', 'n', ')', 'plotted', 'nomogram', 'to', 'determine', 'eligible', 'dosing', 'interval', '(', 'every', 'h', 'qh', ',', 'qh', ',', 'qh', ')', '.', 'based', 'creatinine', 'clearance', '(', 'clcr', ')', ',', '-', 'or', '-mgkg', 'of', 'body', 'weight', 'dose', 'simulated', 'with', 'nomogram-derived', 'interval', '.', 'nomogram', 'recommended', 'extended', 'interval', '(', 'qh', 'and', 'qh', ')', 'in', 'of', 'patient', '.', 'compared', 'with', 'mgkg', 'qh', 'regimen', 'received', 'patient', 'with', 'clcr', 'of', 'mlmin', 'in', 'epic', ',', 'nomogram-derived', 'interval', 'reduced', 'proportion', 'of', 'patient', 'with', 'trough', 'of', 'gml', '(', 'qh', ',', 'versus', ',', 'p', '.', 'qh', ',', 'versus', ',', 'p', '.', ')', 'significantly', 'increasing', 'number', 'of', 'patient', 'within', 'auc', 'range', '.', 'compared', 'with', 'to', 'mgkg', 'qh', 'regimen', '(', 'received', 'patient', 'with', 'clcr', 'of', 'to', 'mlmin', 'in', 'epic', ')', ',', 'nomogram-derived', 'interval', 'significantly', 'reduced', 'proportion', 'of', 'trough', 'of', 'gml', 'in', 'qh', 'cohort', '(', 'versus', ',', 'p', '.', ')', 'maintaining', 'similar', 'proportion', 'of', 'patient', 'in', 'auc', 'range', '.', 'simulated', 'application', 'of', 'hartford', 'nomogram', 'optimized', 'plazomicin', 'exposure', 'in', 'patient', 'with', 'cuti', 'reducing', 'trough', 'to', 'gml', '.']"
Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention.,"Weiwei Ling, Zichao Jiang, Ke Liu, Han Zhang, Yongan Qian, Jinwen Tian, Zhao Zhang, Yundai Chen, Geng Qian, Weiwei Linget al.",2023 May 15:195:77-82.,Am J Cardiol,https://pubmed.ncbi.nlm.nih.gov/37018968/,No keywords found,"[')', 'to', 'receive', 'either', 'aggressive', 'hydration', 'guided', 'vigileoflotrac', 'system', '(', 'intervention', 'group', ')', 'or', 'general', 'hydration', '(', 'control', 'group', ')', '.', 'patient', 'with', 'ami', 'in', 'intervention', 'group', 'received', 'loading', 'dose', 'of', 'saline', ',', 'and', 'hydration', 'speed', 'adjusted', 'according', 'to', 'change', 'of', 'vigileoflotrac', 'index', '.', 'primary', 'end', 'point', 'cin', ',', 'defined', 'or', '.', 'mg', 'ml', 'increase', 'in', 'serum', 'creatinine', 'compared', 'with', 'baseline', 'first', 'hour', 'urgent', 'pci', '.', 'trial', 'registered', 'in', 'clinicaltrials.gov', '(', 'nct', ')', '.', 'total', 'of', 'patient', 'with', 'ami', 'enrolled', 'and', 'randomized', 'in', 'trial', ',', 'and', 'baseline', 'characteristic', ',', 'including', 'risk', 'factor', 'of', 'cin', ',', 'of', 'vigileoflotrac-guided', 'hydration', 'group', '(', 'n', ')', 'and', 'control', 'group', '(', 'n', ')', 'well', 'balanced', '(', 'p', '.', ')', '.', 'total', 'hydration', 'volume', 'in', 'vigileoflotrac-guided', 'hydration', 'group', 'significantly', 'much', 'control', 'group', '(', ',', 'v', 'ml', ',', 'p', '.', ')', '.', 'incidence', 'of', 'cin', 'in', 'vigileoflotrac-guided', 'hydration', 'group', 'significantly', 'decreased', 'in', 'control', 'group', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'not', 'significantly', 'different', 'in', 'incidence', 'of', 'acute', 'heart', 'failure', 'pci', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'incidence', 'of', 'main', 'adverse', 'cardiovascular', 'event', 'in', 'vigileoflotrac-guided', 'hydration', 'group', 'lower', 'in', 'control', 'group', 'without', 'statistically', 'difference', '(', 'event', '.', 'v', 'event', '.', ',', 'p', '.', ')', '.', 'in', 'conclusion', ',', 'vigileoflotrac', 'system-guided', 'aggressive', 'hydration', 'could', 'effectively', 'decrease', 'risk', 'of', 'cin', 'patient', 'with', 'ami', 'undergoing', 'urgent', 'pci', 'and', 'avoid', 'attack', 'of', 'acute', 'heart', 'failure', 'time', '.']"
The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.,"Eleni Palli, Demosthenes Makris, John Papanikolaou, Grigorios Garoufalis, Irini Tsilioni, Paris Zygoulis, Epaminondas Zakynthinos, Eleni Palliet al.",2017 Oct 31,Crit Care,https://pubmed.ncbi.nlm.nih.gov/29089038/,No keywords found,"['aim', 'to', 'investigate', 'whether', 'use', 'of', 'n-acetylcysteine', 'and', 'ascorbic', 'acid', 'reduce', 'contrast-induced', 'nephropathy', 'incidence', 'in', 'critical', 'care', 'patient', '.', 'method', 'one-center', ',', 'two-arm', ',', 'prospective', ',', 'randomized', ',', 'open-label', ',', 'controlled', 'trial', 'in', 'intensive', 'care', 'unit', 'of', 'university', 'hospital', 'of', 'larissa', ',', 'greece', '.', 'patient', 'with', 'stable', 'renal', 'function', ',', 'underwent', 'non', 'urgent', 'contrast-enhanced', 'computed', 'tomography', 'diagnostic', 'purpose', ',', 'included', 'in', 'study', '.', 'patient', 'in', 'treatment', 'group', '(', 'naca', ',', 'n', ')', 'received', 'intravenously', 'n-acetylcysteine', '(', 'mg', ')', 'and', 'ascorbic', 'acid', '(', 'g', ')', 'dissolved', 'separately', 'in', 'ml', 'of', 'normal', 'saline', 'hour', ',', 'and', 'hour', 'and', 'hour', 'following', 'infusion', 'of', 'contrast', 'agent', ',', 'control', 'group', 'patient', '(', 'cg', ',', 'n', ')', 'received', 'normal', 'saline', '.', 'patient', 'received', 'additional', 'hydration', '.', 'contrast-induced', 'nephropathy', 'defined', 'relative', 'increase', 'of', 'baseline', 'value', 'of', 'serum', 'creatinine', '.', 'result', 'contrast-induced', 'nephropathy', 'in', 'naca', 'and', 'cg', '.', 'and', '.', ',', 'respectively', '(', 'p', '.', ')', '.', 'percentage', 'change', 'median', '(', 'interquartile', 'range', '(', 'ir', ')', ')', 'of', 'serum', 'cystatin-c', '(', 'mgl', ')', 'baseline', 'in', 'patient', 'underwent', 'contrast-induced', 'tomography', ',', '.', '(', '.', ')', 'and', '.', '(', '.', ')', 'in', 'naca', 'and', 'in', 'cg', ',', 'respectively', '(', 'p', '.', ')', '.', '-isoprostane', 'serum', 'level', 'in', 'naca', 'significantly', 'lower', 'compared', 'to', 'cg', 'hour', '(', 'p', '.', ')', 'and', 'hour', '(', 'p', '.', ')', 'following', 'radiocontrast', 'infusion', '.', 'multivariate', 'analysis', 'revealed', 'contrast-induced', 'nephropathy', 'independently', 'associated', 'with', 'higher', 'baseline', 'ratio', 'of', 'serum', 'ureacreatinine', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', 'and', 'with', 'use', 'of', 'nephrotoxic', 'medication', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-.', ')', '.', 'conclusion', 'intravenous', 'administration', 'of', 'n-acetylcysteine', 'and', 'ascorbic', 'acid', 'failed', 'to', 'reduce', 'contrast-induced', 'nephropathy', 'in', 'critically', 'ill', 'patient', 'underwent', 'contrast-enhanced', 'computed', 'tomography', ',', 'despite', 'significant', 'reduction', 'of', '-isoprostane', 'level', 'in', 'treated', 'patient', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'nct', '.', 'registered', 'november', '.']"
Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.,"Ville Pettilä, Tobias Merz, Erika Wilkman, Anders Perner, Sari Karlsson, Theis Lange, Johanna Hästbacka, Peter Buhl Hjortrup, Anne Kuitunen, Stephan M Jakob, Jukka Takala, Ville Pettiläet al.",2016 Aug 2:17:384.,Trials,https://pubmed.ncbi.nlm.nih.gov/27484695/,No keywords found,"['septic', 'shock', '-day', 'mortality', 'risk', 'of', 'to', '.', 'hemodynamic', 'target', ',', 'including', 'mean', 'arterial', 'pressure', '(', 'map', ')', 'not', 'based', 'robust', 'clinical', 'data', '.', 'severe', 'hypotension', 'and', 'high', 'dos', 'of', 'vasopressor', 'may', 'harmful', '.', 'hence', ',', 're-evaluation', 'of', 'hemodynamic', 'target', 'in', 'septic', 'shock', 'relevant', '.', 'methodsdesign', 'targeted', 'tissue', 'perfusion', 'versus', 'macrocirculation-guided', 'standard', 'care', 'in', 'patient', 'with', 'septic', 'shock', '(', 'tartare-s', ')', 'trial', 'prospective', ',', 'two-parallel-group', ',', 'randomized', ',', 'open-label', ',', 'multicenter', 'trial', 'with', 'assessor-blinded', 'outcome', 'evaluation', '.', 'randomize', 'least', 'patient', 'with', 'septic', 'shock', 'in', 'four', 'european', 'intensive', 'care', 'unit', '(', 'icu', ')', 'to', 'test', 'whether', 'tissue', 'perfusion-guided', 'treatment', 'strategy', 'based', 'capillary', 'refill', 'time', ',', 'peripheral', 'temperature', ',', 'arterial', 'lactate', 'concentration', ',', 'and', 'accepting', 'lower', 'map', 'level', ',', 'lead', 'to', 'faster', 'resolution', 'of', 'shock', 'macrocirculation', 'target-guided', 'standard', 'care', '.', 'primary', 'outcome', 'measure', 'day', 'alive', 'in', 'day', 'with', 'normal', 'arterial', 'blood', 'lactate', '(', 'first', 'value', 'of', 'mmoll', ')', 'and', 'without', 'inotropic', 'or', 'vasopressor', 'agent', '.', 'secondary', 'outcome', 'include', 'individual', 'component', 'of', 'primary', 'outcome', ',', 'day', 'alive', 'without', 'renal', 'replacement', ',', 'day', 'alive', 'without', 'mechanical', 'ventilation', 'in', 'day', ',', 'and', 'new', 'acute', 'kidney', 'injury', '.', 'sample', 'size', 'enables', 'detection', 'of', '.-h', 'difference', 'in', 'primary', 'outcome', 'with', 'type', 'error', 'of', 'and', 'power', 'of', ',', 'assuming', 'mortality', 'and', 'mean', 'of', 'h', '(', 'sd', ')', 'among', '-day', 'survivor', '.', 'included', 'patient', 'statistician', 'masked', 'allocation', 'group', 'recalculate', 'sample', 'size', 'potentially', 'increasing', 'sample', 'to', '.', 'data', 'safety', 'and', 'monitoring', 'board', '(', 'dsmb', ')', 'review', 'safety', 'data', 'patient', '.', 'discussion', 'tartare-s', 'trial', 'provide', 'important', 'clinical', 'data', 'treatment', 'target', 'in', 'septic', 'shock', ',', 'evaluating', 'impact', 'of', 'clinical', 'tissue', 'perfusion-guided', 'hemodynamic', 'treatment', 'surrogate', 'outcome', 'combining', 'resolution', 'of', 'shock', '(', 'hyperlactatemia', 'and', 'vasopressorsinotropes', ')', ',', 'and', '-day', 'mortality', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'registered', 'october', '.']"
Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.,"Tetsunari Hase, Masayuki Miyazaki, Kazuya Ichikawa, Naoyuki Yogo, Naoya Ozawa, Takahiro Hatta, Masahiko Ando, Mitsuo Sato, Masashi Kondo, Kiyofumi Yamada, Yoshinori Hasegawa, Tetsunari Haseet al.",2020 Nov,Int J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/32740717/,No keywords found,"['intravenous', 'administration', 'of', 'magnesium', 'with', 'short', 'hydration', 'regimen', 'recommended', 'patient', 'receiving', 'high-dose', 'cisplatin', 'to', 'protect', 'cisplatin-induced', 'nephrotoxicity', '.', 'however', ',', 'optimal', 'dose', 'of', 'magnesium', 'supplementation', 'not', 'clarified', '.', 'aim', 'of', 'trial', 'to', 'investigate', 'safety', 'and', 'efficacy', 'of', 'short', 'hydration', 'regimen', 'with', 'meq', 'of', 'magnesium', 'supplementation', 'lung', 'cancer', 'patient', 'receiving', 'cisplatin-based', 'chemotherapy', '.', 'method', 'key', 'eligibility', 'criterion', 'included', 'cytologically', 'or', 'histologically', 'diagnosed', 'lung', 'cancer', ',', 'candidacy', 'cisplatin-based', '(', 'mgm', ')', 'chemotherapy', 'or', 'chemoradiotherapy', ',', 'no', 'prior', 'chemotherapy', ',', 'aged', '-', 'year', ',', 'and', 'adequate', 'renal', 'function', '.', 'cisplatin', 'administered', 'with', 'pre-hydration', 'with', 'meq', 'of', 'magnesium', 'sulfate', '.', 'mannitol', 'administered', 'cisplatin', 'infusion', 'to', 'enforce', 'diuresis', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'underwent', 'cisplatin-based', 'chemotherapy', 'with', 'short', 'hydration', 'regimen', 'with', 'meq', 'of', 'magnesium', 'supplementation', 'without', 'grade', 'or', 'higher', 'elevation', 'in', 'creatinine', '.', 'result', 'forty', 'patient', 'with', 'median', 'age', 'of', 'year', '(', 'range', '-', ')', 'prospectively', 'enrolled', '.', 'median', 'baseline', 'creatinine', '.', 'mgdl', '.', 'median', 'dose', 'of', 'cisplatin', 'in', 'first', 'cycle', 'mgm', '.', 'in', 'first', 'cycle', ',', 'no', 'patient', 'developed', 'grade', 'creatinine', 'toxicity', '.', 'treatment', 'period', ',', 'one', 'patient', 'developed', 'grade', 'creatinine', 'elevation', 'thus', ',', 'proportion', 'of', 'patient', 'without', 'grade', 'or', 'higher', 'elevation', 'in', 'creatinine', '.', '(', 'confidence', 'interval', '.-.', ')', '.', 'conclusion', 'short', 'hydration', 'regimen', 'with', 'meq', 'of', 'magnesium', 'supplementation', 'safe', 'and', 'feasible', 'patient', 'with', 'lung', 'cancer', 'receiving', 'cisplatin-based', 'chemotherapy', '.']"
Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure.,"Geng Qian, Chang-Fu Liu, Jun Guo, Wei Dong, Jin Wang, Yundai Chen, Geng Qianet al.",2019 Jan,Clin Cardiol,https://pubmed.ncbi.nlm.nih.gov/30054906/,No keywords found,"['adequate', 'hydration', 'remains', 'mainstay', 'of', 'contrast-induced', 'nephropathy', 'prevention', ',', 'and', 'nitrate', 'could', 'reduce', 'cardiac', 'preload', '.', 'hypothesis', 'study', 'aimed', 'to', 'explore', 'adequate', 'hydration', 'with', 'nitrate', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'and', 'congestive', 'heart', 'failure', '(', 'chf', ')', 'to', 'reduce', 'risk', 'of', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'and', 'time', 'avoid', 'acute', 'heart', 'failure', '.', 'method', 'three', 'hundred', 'and', 'ninty-four', 'consecutive', 'patient', 'with', 'ckd', 'and', 'chf', 'undergoing', 'coronary', 'procedure', 'randomized', 'to', 'either', 'adequate', 'hydration', 'with', 'nitrate', '(', 'n', ')', 'or', 'to', 'routine', 'hydration', '(', 'control', 'group', 'n', ')', '.', 'adequate', 'hydration', 'group', 'received', 'continuous', 'intravenous', 'infusion', 'of', 'isosorbide', 'dinitrate', 'combined', 'with', 'intravenous', 'infusion', 'of', 'isotonic', 'saline', 'rate', 'of', '.', 'mlkgh', 'perioperative', 'period', '.', 'definition', 'of', 'cin', 'or', '.', 'mgdl', 'rise', 'in', 'serum', 'creatinine', 'baseline', '.', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', ',', 'number', 'nct', '.', 'result', 'baseline', 'characteristic', 'well-matched', 'two', 'group', '.', 'cin', 'occurred', 'less', 'frequently', 'in', 'adequate', 'hydration', 'group', 'control', 'group', '(', '.', 'v', '.', 'p', '.', ')', '.', 'incidence', 'of', 'acute', 'heart', 'failure', 'not', 'differ', 'two', 'group', '(', '.', 'v', '.', 'p', '.', ')', '.', 'cumulative', 'major', 'adverse', 'event', '(', 'death', ',', 'myocardial', 'infarction', ',', 'stoke', ',', 'hospitalization', 'acute', 'heart', 'failure', ')', '-day', 'follow-up', 'lower', 'in', 'adequate', 'hydration', 'with', 'nitrate', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'adequate', 'hydration', 'with', 'nitrate', 'safely', 'and', 'effectively', 'reduce', 'risk', 'of', 'cin', 'in', 'patient', 'with', 'ckd', 'and', 'chf', '.']"
Does sodium bicarbonate infusion really have no effect on the incidence of acute kidney injury after cardiac surgery? A prospective observational trial.,"Anna J Wetz, Anselm Bräuer, Michael Quintel, Daniel Heise, Anna J Wetzet al.",2015 Apr 22,Crit Care,https://pubmed.ncbi.nlm.nih.gov/25899029/,No keywords found,"['postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'frequently', 'observed', 'phenomenon', 'cardiac', 'surgery', 'with', 'cardio-pulmonary', 'bypass', '(', 'cpb', ')', 'severe', 'complication', 'associated', 'with', 'adverse', 'patient', 'outcome', '.', 'multiple', 'mechanism', 'involved', 'in', 'aki', 'cardiac', 'surgery', ',', 'including', 'cpb-dependent', 'hemolysis', '.', 'iv', 'infusion', 'of', 'sodium', 'bicarbonate', ',', 'lead', 'to', 'urine', 'alkalization', ',', 'may', 'play', 'role', 'in', 'preventing', 'aki', '.', 'recently', ',', 'several', 'trial', 'investigated', 'effect', 'of', 'sodium', 'bicarbonate', 'and', 'reported', 'controversial', 'result', '.', 'purpose', 'of', 'investigation', 'to', 'investigate', 'following', 'question', '.', 'circumstance', 'sodium', 'bicarbonate', 'prevent', 'postoperative', 'aki', 'method', 'analyzed', 'data', 'patient', 'undergoing', 'cpb', 'surgery', 'university', 'hospital', 'goettingen', ',', 'germany', '.', 'total', 'of', 'patient', 'received', 'preemptive', 'dose', 'of', 'sodium', 'bicarbonate', '.', 'directly', 'induction', 'of', 'anesthesia', ',', 'continuous', 'infusion', 'of', '.', 'mmolkg', 'body', 'weighth', 'started', 'and', 'continued', 'pm', 'first', 'postoperative', 'day', '.', 'patient', 'not', 'treated', 'with', 'sodium', 'bicarbonate', 'formed', 'control', 'group', '(', 'n', ')', '.', 'to', 'verify', 'aki', 'risk', 'configuration', 'of', 'group', ',', 'surveyed', 'risk', 'factor', 'and', 'determined', 'commonly', 'used', 'clinical', 'predictive', 'score', 'according', 'to', 'thakar', 'and', 'colleague', '.', 'recorded', 'concentration', 'of', 'free', 'hemoglobin', '(', 'fhb', ')', 'to', 'estimate', 'amount', 'of', 'cpb-dependent', 'hemolysis', '.', 'definition', 'of', 'aki', 'acquired', 'applying', 'aki-network', '(', 'akin', ')', 'classification', 'course', 'of', 'five', 'postoperative', 'day', '.', 'result', 'patient', 'received', 'sodium', 'bicarbonate', 'infusion', 'showed', 'significantly', 'lower', 'incidence', '(', '.', 'vs.', ')', 'of', 'aki', 'of', 'patient', 'not', 'receive', 'infusion', '(', 'p', '.', ')', '.', 'akin', 'level', 'and', 'also', 'frequent', 'sodium', 'bicarbonate', 'not', 'administered', '.', 'particularly', ',', 'in', 'low-risk', 'cohort', '(', 'thakar', 'point', ')', ',', 'incidence', 'of', 'aki', 'significantly', 'reduced', '(', 'vs.', ')', 'patient', 'received', 'sodium', 'bicarbonate', '(', 'p', '.', ')', ',', 'whereas', 'in', 'high-risk', 'patient', ',', 'no', 'significant', 'reduction', 'observed', '.', 'conclusion', 'in', 'study', ',', 'observed', 'low-risk', 'patient', 'particularly', 'benefited', 'preventive', 'treatment', 'with', 'sodium', 'bicarbonate', '.', 'incidence', 'of', 'aki', 'significantly', 'reduced', 'in', 'low-risk', 'patient', 'no', 'statistically', 'significant', 'difference', 'in', 'high-risk', 'patient', 'cohort', '.', 'trial', 'registration', 'drks', ',', 'registered', 'december', '.']"
Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.,"Leili Iranirad, Seyed Fakhreddin Hejazi, Mohammad Saleh Sadeghi, Shahram Arsang Jang, Leili Iraniradet al.",2017,Cardiol J,https://pubmed.ncbi.nlm.nih.gov/28281738/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'remains', 'to', 'potentially', 'serious', 'complication', 'of', 'radiographic', 'procedure', 'and', 'third', 'leading', 'cause', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'among', 'hospitalized', 'patient', '.', 'clinical', 'trial', 'performed', 'to', 'assess', 'preventive', 'effect', 'of', 'oral', 'nicorandil', 'cin', 'in', 'high-risk', 'patient', 'undergoing', 'cardiac', 'catheterization', '.', 'method', 'in', 'prospective', ',', 'randomized', ',', 'controlled', 'trial', ',', 'patient', 'with', 'least', 'two', 'risk', 'factor', 'cin', 'undergoing', 'elective', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'randomly', 'assigned', 'to', 'either', 'nicorandil', 'group', 'or', 'control', 'group', '.', 'patient', 'in', 'nicorandil', 'group', '(', 'n', ')', 'received', 'mg', 'nicorandil', ',', 'daily', 'min', 'and', 'to', 'day', 'procedure', 'and', 'intravenous', 'hydration', 'h', 'and', 'h', 'procedure', ',', 'whereas', 'patient', 'in', 'control', 'group', '(', 'n', ')', 'received', 'intravenous', 'hydration', '.', 'serum', 'creatinine', '(', 'scr', ')', 'measured', 'contrast', 'exposure', 'and', 'h.', 'cin', 'defined', 'increase', 'of', 'in', 'scr', 'or', '.', 'mgdl', 'h', 'contrast', 'administration', '.', 'result', 'contrast-induced', 'nephropathy', 'occurred', 'in', 'of', '(', '.', ')', 'patient', 'in', 'control', 'group', 'and', 'in', 'of', '(', '.', ')', 'patient', 'in', 'nicorandil', 'group', '.', 'significant', 'difference', 'in', 'incidence', 'of', 'cin', 'two', 'group', 'h', 'administering', 'radiocontrast', 'agent', '(', 'p', '.', ')', '.', 'moreover', ',', 'significant', 'difference', 'two', 'group', 'in', 'scr', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'h', 'radiocontrast', 'administration', '(', 'p', '.', ')', '.', 'conclusion', 'finding', 'revealed', 'oral', 'nicorandil', 'substantial', 'efficacy', 'hydration', 'protocol', 'development', 'of', 'cin', 'in', 'high-risk', 'patient', 'undergoing', 'cardiac', 'catheterization', '.']"
Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.,"Chih-Lang Lin, Rong-Nan Chien, Charisse Yeh, Chao-Wei Hsu, Ming-Ling Chang, Yi-Cheng Chen, Chau-Ting Yeh, Chih-Lang Linet al.",2014 Dec,Scand J Gastroenterol,https://pubmed.ncbi.nlm.nih.gov/25283499/,No keywords found,"['cisplatin', 'known', 'nephrotoxic', 'agent', 'requiring', 'vigorous', 'hydration', 'use', '.', 'however', ',', 'aggressive', 'hydration', 'could', 'life-threatening', '.', 'therefore', ',', 'in', 'cirrhotic', 'patient', 'with', 'advanced', 'hepatocellular', 'carcinoma', '(', 'hcc', ')', 'cisplatin-based', 'chemotherapy', ',', 'risk', 'of', 'nephrotoxicity', 'increased', '.', 'previous', 'study', 'showed', 'long-term', 'telbivudine', 'treatment', 'improved', 'renal', 'function', 'in', 'chronic', 'hepatitis', 'b', 'virus', '(', 'hbv', ')', 'infected', 'patient', ',', 'conducted', 'case-control', 'study', 'to', 'evaluate', 'clinical', 'outcome', 'of', 'telbivudine', 'preemptive', 'therapy', 'in', 'hbv-related', 'advanced', 'hcc', 'patient', 'treated', 'combination', 'chemotherapy', 'comprising', '-fluorouracil', ',', 'mitoxantrone', 'and', 'cisplatin', '(', 'fmp', ')', '.', 'material', 'and', 'method', 'june', 'to', 'march', ',', 'patient', 'with', 'hbv-related', 'advanced', 'hcc', ',', 'receiving', 'fmp', 'chemotherapy', 'protocol', ',', 'enrolled', '.', 'of', ',', 'not', 'receive', 'antiviral', 'therapy', ',', 'whereas', 'remaining', 'patient', '(', 'sex', 'and', 'age', 'matched', ')', 'received', 'telbivudine', 'preemptive', 'therapy', '.', 'result', 'progressive', 'decrease', 'of', 'aminotransferase', 'level', '(', 'p', 'mlmin', '(', 'n', ')', ',', 'median', 'overall', 'survival', 'significantly', 'longer', 'in', 'telbivudine-treated', 'group', '(', '.', 'vs.', '.', 'month', 'p', '.', ')', '.', 'conclusion', 'preemptive', 'use', 'of', 'telbivudine', 'significantly', 'prevented', 'egfr', 'deterioration', 'caused', 'cisplatin-based', 'chemotherapy', 'in', 'hbv-related', 'advanced', 'hcc', '.', 'in', 'patient', 'with', 'initially', 'sufficient', 'egfr', 'level', ',', 'telbivudine', 'treatment', 'associated', 'with', 'longer', 'overall', 'survival', '.']"
A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers.,"Jeffrey S Zaltzman, Vesta Lai, Miklos Z Schulz, Kyung-Hee Moon, David Z Cherney, Jeffrey S Zaltzmanet al.",2014 Dec,Transpl Int,https://pubmed.ncbi.nlm.nih.gov/25160518/,"nephrotoxicity, renal physiology, tacrolimus.","['nct', ')', '.']"
Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.,"Kenneth Mugwanya, Jared Baeten, Connie Celum, Deborah Donnell, Thomas Nickolas, Nelly Mugo, Andrea Branch, Jordan Tappero, James Kiarie, Allan Ronald, Michael Yin, Christina Wyatt                              ;, Partners PrEP Study Team, Jared M Baeten, Robert W Coombs, Lisa Frenkel, Craig W Hendrix, Jairam R Lingappa, M Juliana McElrath, Eldoret Kenya, Kenneth H Fife, Edwin Were, Elioda Tumwesigye, Patrick Ndase, Elly Katabira, Elizabeth Bukusi, Craig R Cohen, Jonathan Wangisi, James D Campbell, Jordan W Tappero, Carey Farquhar, Grace John-Stewart, Nelly R Mugo, Kenneth Mugwanyaet al.",2016 Oct 1,J Infect Dis,https://pubmed.ncbi.nlm.nih.gov/27029778/,No keywords found,"['tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', 'associated', 'with', 'proximal', 'tubular', 'dysfunction', '(', 'tubulopathy', ')', 'used', 'in', 'treatment', 'of', 'human', 'immunodeficiency', 'virus', '(', 'hiv', ')', 'infection', '.', 'evaluated', 'whether', 'tdf', 'cause', 'tubulopathy', 'used', 'hiv', 'preexposure', 'prophylaxis', '(', 'prep', ')', 'and', 'whether', 'tubulopathy', 'predicts', 'clinically', 'relevant', 'decline', '(', ')', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', '.', 'method', 'subgroup', 'analysis', 'of', 'partner', 'prep', 'study', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'of', 'daily', 'oral', 'tdf', ',', 'alone', 'or', 'with', 'emtricitabine', '(', 'ftc', ')', ',', 'in', 'hiv-uninfected', 'african', 'men', 'and', 'woman', '(', 'clinicaltrials.gov', 'nct', ')', '.', 'tubulopathy', 'assessed', 'in', 'concurrently', 'obtained', 'urine', 'and', 'serum', 'sample', '-month', 'or', 'last', 'on-treatment', 'visit', ',', 'predefined', 'of', 'following', 'tubular', 'proteinuria', ',', 'euglycemic', 'glycosuria', ',', 'increased', 'urinary', 'phosphate', ',', 'and', 'uric', 'acid', 'excretion', '.', 'result', 'of', 'person', 'studied', '(', 'receiving', 'ftc-tdf', ',', 'receiving', 'placebo', ')', ',', 'male', ',', 'and', 'median', 'age', 'year', '.', 'median', 'month', 'of', 'study-drug', 'exposure', ',', 'frequency', 'of', 'tubulopathy', '.', 'ftc-tdf', 'versus', '.', 'placebo', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', 'tubulopathy', 'occurred', 'in', 'of', 'person', '(', '.', ')', 'with', 'versus', 'of', '(', '.', ')', 'without', 'egfr', 'decline', '(', 'adjusted', 'odds', 'ratio', ',', '.', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'daily', 'oral', 'ftc-tdf', 'prep', 'not', 'significantly', 'associated', 'with', 'tubulopathy', 'course', 'of', 'month', ',', 'tubulopathy', 'predict', 'clinically', 'relevant', 'egfr', 'decline', '.']"
"Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU).","Thomas E Witzig, Patrick B Johnston, Betsy R LaPlant, Paul J Kurtin, Levi D Pederson, Dennis F Moore Jr, Nassim H Nabbout, Daniel A Nikcevich, Kendrith M Rowland, Axel Grothey, Thomas E Witziget al.",2017 Oct,Am J Hematol,https://pubmed.ncbi.nlm.nih.gov/28614905/,No keywords found,"['.', 'mos-not', 'reached', ')', 'and', 'median', 'progression-free', 'survival', 'mo', '(', 'ci', '-', 'mo', ')', '.', 'no', 'grade', 'nephrotoxicity', 'rate', 'of', 'grade', 'neuropathy', '.', 'forty-two', 'percent', 'of', 'patient', 'and', 'of', 'patient', 'transplanted', 'remain', 'alive', 'year', '.', 'road', 'represents', 'acceptable', 'salvage', 'therapeutic', 'option', 'patient', 'with', 'relapsed', 'aggressive', 'nhl', '.']"
Comparison of normal saline and balanced crystalloid (plasmalyte) in patients undergoing elective craniotomy for supratentorial brain tumors: A randomized controlled trial.,"Ankita Dey, S Adinarayanan, Prasanna Udupi Bidkar, Rakesh K Bangera, V Balasubramaniyan, Ankita Deyet al.",2018 Sep-Oct,Neurol India,https://pubmed.ncbi.nlm.nih.gov/30233000/,No keywords found,"['choice', 'of', 'fluid', 'important', 'in', 'neurosurgical', 'patient', ',', 'may', 'dehydrated', 'due', 'to', 'administration', 'of', 'diuretic', 'in', 'order', 'to', 'reduce', 'cerebral', 'edema', '.', 'normal', 'saline', ',', 'infused', 'fluid', 'routinely', 'used', 'in', 'neurosurgical', 'patient', ',', 'cause', 'hyperchloremic', 'metabolic', 'acidosis', '.', 'balanced', 'crystalloid', '(', 'bc', ')', 'may', 'help', 'to', 'maintain', 'metabolic', 'status', 'favorably', 'in', 'patient', ',', 'without', 'adversely', 'affecting', 'brain', 'relaxation', '.', 'method', 'conducted', 'prospective', ',', 'randomized', 'controlled', 'trial', 'patient', 'undergoing', 'elective', 'craniotomy', 'supratentorial', 'tumor', 'resection', 'general', 'anesthesia', '.', 'patient', 'randomly', 'allocated', 'two', 'group', 'of', 'to', 'receive', 'either', 'normal', 'saline', 'or', 'bc', '(', 'plasmalyte', ')', 'maintenance', 'fluid', ',', 'intra-operatively', '.', 'metabolic', 'parameter', 'and', 'osmolality', 'measured', 'regular', 'interval', '.', 'brain', 'relaxation', 'score', 'assessed', 'operating', 'surgeon', '.', 'patient', 'monitored', 'with', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'blood', 'urea', 'and', 'serum', 'creatinine', 'assessing', 'degree', 'of', 'acute', 'kidney', 'injury', '.', 'result', 'metabolic', 'profile', 'better', 'maintained', 'with', 'bc', '.', 'brain', 'relaxation', 'score', 'comparable', 'two', 'group', '.', 'postoperative', 'ngal', ',', 'urea', 'and', 'creatinine', 'value', 'significantly', 'higher', 'in', 'normal', 'saline', 'group', 'compared', 'to', 'bc', 'group', '.', 'conclusion', 'balanced', 'crystalloid', 'maintains', 'metabolic', 'status', 'favorably', 'normal', 'saline', 'in', 'neurosurgical', 'patient', '.', 'hyperchloremic', 'metabolic', 'acidosis', ',', 'and', 'problem', 'occur', 'consequence', 'of', 'normal', 'saline', 'infusion', 'may', 'circumvented', 'choosing', 'balanced', 'crystalloid', 'electrolyte', 'solution', '.', 'neither', 'of', 'crystalloids', 'appeared', 'to', 'adverse', 'effect', 'brain', 'relaxation', '.']"
To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).,"Vidya Nand Rabi Das, Niyamat Ali Siddiqui, Biplab Pal, Chandra Shekhar Lal, Neena Verma, Ashish Kumar, Rakesh Bihari Verma, Dhirendra Kumar, Pradeep Das, Krishna Pandey, Vidya Nand Rabi Daset al.",2017 Mar 29,PLoS One,https://pubmed.ncbi.nlm.nih.gov/28355259/,No keywords found,"['post', 'kala-azar', 'dermal', 'leishmaniasis', '(', 'pkdl', ')', 'skin', 'disorder', 'usually', 'occurs', 'among', 'patient', 'with', 'past', 'history', 'of', 'visceral', 'leishmaniasis', '(', 'vl', ')', '.', 'case', 'also', 'reported', 'without', 'history', 'of', 'vl', '.', 'no', 'satisfactory', 'treatment', 'regimen', 'available', 'present', '.', 'aimed', 'to', 'compare', 'efficacy', 'and', 'safety', 'of', 'amphotericin', 'b', 'in', 'two', 'different', 'dos', '(', '.mgkg', 'v', 'mgkg', ')', 'in', 'prospective', 'randomized', 'trial', 'in', 'pkdl', 'patient', '.', 'method', 'in', 'open', 'label', 'study', 'patient', 'with', 'pkdl', ',', 'aged', '-', 'year', 'randomized', 'in', 'two', 'group', '.', 'group', 'received', 'amphotericin', 'b', 'in', 'dose', 'of', '.', 'mgkg', 'in', 'dextrose', ',', 'daily', 'infusion', 'course', 'interval', 'of', 'day', 'course', 'and', 'group', 'b', 'received', 'amphotericin', 'b', 'in', 'dose', 'of', 'mgkg', 'in', 'dextrose', 'alternate', 'day', ',', 'infusion', 'course', 'interval', 'of', 'day', 'course', 'and', 'followed', 'one', 'year', '.', 'result', 'total', 'of', 'patient', 'enrolled', ',', 'in', 'of', 'group', 'and', 'group', 'b.', 'two', 'patient', 'lost', 'to', 'follow', 'and', 'three', 'patient', 'withdrew', 'consent', 'due', 'to', 'adverse', 'event', '.', 'initial', 'cure', 'rate', 'in', 'group', 'and', 'in', 'group', 'b', 'intention', 'to', 'treat', 'analysis', 'and', 'final', 'cure', 'rate', 'per', 'protocol', 'analysis', '.', 'and', '.', 'in', 'group', 'and', 'group', 'b', 'respectively', '.', 'two', 'patient', 'either', 'group', 'relapsed', '.', 'nephrotoxicity', 'common', 'adverse', 'event', 'occurring', 'in', 'group', '.', 'conclusion', 'lower', 'dose', 'appears', 'to', 'fewer', 'adverse', 'event', 'however', ',', 'nephrotoxicity', 'remains', 'problem', 'in', 'regimen', '.', '.mgkg', 'regimen', 'may', 'considered', 'instead', 'of', 'higher', 'dosage', 'however', 'safer', 'treatment', 'remain', 'critical', 'pkdl', 'treatment', '.']"
"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.","Salvatore Piano, Silvano Fasolato, Freddy Salinas, Antonietta Romano, Marta Tonon, Filippo Morando, Marta Cavallin, Elisabetta Gola, Antonietta Sticca, Arianna Loregian, Giorgio Palù, Giacomo Zanus, Marco Senzolo, Patrizia Burra, Umberto Cillo, Paolo Angeli, Salvatore Pianoet al.",2016 Apr,Hepatology,https://pubmed.ncbi.nlm.nih.gov/26084406/,No keywords found,"['.', 'p', '.', ')', ',', 'development', 'of', 'acute', 'kidney', 'injury', 'hospitalization', '(', 'hr', '.', 'p', '.', ')', ',', 'and', 'baseline', 'mean', 'arterial', 'pressure', '(', 'hr', '.', 'p', '.', ')', 'found', 'to', 'independent', 'predictor', 'of', '-day', 'tfs', '.', 'conclusion', 'combination', 'of', 'meropenem', 'plus', 'daptomycin', 'effective', 'ceftazidime', 'empirical', 'antibiotic', 'treatment', 'of', 'nosocomial', 'sbp', '.', 'efficacy', 'of', 'empirical', 'antibiotic', 'treatment', 'strong', 'predictor', 'of', '-day', 'survival', 'in', 'patient', 'with', 'nosocomial', 'sbp', '.']"
Balanced 10% hydroxyethyl starch compared with balanced 6% hydroxyethyl starch and balanced crystalloid using a goal-directed hemodynamic algorithm in pancreatic surgery: A randomized clinical trial.,"Julia Werner, Oliver Hunsicker, Anja Schneider, Henryk Stein, Christian von Heymann, Adrian Freitag, Aarne Feldheiser, Klaus-Dieter Wernecke, Claudia Spies, Julia Werneret al.",2018 Apr,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/29703051/,No keywords found,"['hydroxyethyl', 'starch', '(', 'he', ')', 'solution', 'not', 'recommended', 'longer', 'in', 'critically', 'ill', 'patient', ',', 'data', 'efficacy', 'and', 'safety', 'surgery', 'still', 'limited', '.', 'method', 'in', 'randomized', 'controlled', 'trial', 'patient', 'assigned', 'to', 'receive', 'he', '(', '.', ')', ',', 'he', '(', '.', ')', ',', 'or', 'crystalloid', 'within', 'goal-directed', 'hemodynamic', 'algorithm', 'pancreatic', 'surgery', '.', 'primary', 'endpoint', 'intraoperative', 'volume', 'of', 'he', 'and', 'time', 'fully', 'oral', 'diet', '.', 'result', 'trial', 'terminated', 'early', 'upon', 'recommendation', 'of', 'independent', 'data', 'monitoring', 'committee', 'due', 'to', 'futility', 'efficacy', 'planned', 'interim', 'analysis', '.', 'intraoperative', 'volume', 'of', 'he', 'not', 'different', 'and', 'he', 'group', '(', 'v', 'ml', ',', 'p.', ')', '.', 'however', ',', 'considering', 'inhomogeneity', 'of', 'patient', ""'s"", 'body', 'weight', 'he', 'group', ',', 'significant', 'difference', 'in', 'intraoperative', 'volume', 'of', 'he', 'and', 'group', 'adjusting', 'patient', ""'s"", 'body', 'weight', '(', '.', '.', '.', 'v', '.', '.', '.', 'ml', 'kg', 'bw', ',', 'p', '.', ')', '.', 'patient', 'in', 'he', 'group', 'required', 'less', 'additional', 'fluid', 'dose', 'limit', 'in', 'crystalloid', 'group', ',', 'resulting', 'in', 'lower', 'intraoperative', 'net', 'balance', '.', 'time', 'fully', 'oral', 'diet', 'not', 'different', 'study', 'group', '.', 'applying', 'kdigo', 'oliguria', 'criterion', ',', 'patient', 'receiving', 'he', 'aki', 'compared', 'to', 'patient', 'receiving', 'crystalloids', '(', '.', 'v', '.', ',', 'p', '.', ')', ',', 'whereas', 'receiving', 'he', 'and', 'crystalloids', 'not', 'differ', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'explorative', 'analysis', 'using', 'gray-zone', 'approach', 'indicated', 'patient', 'receiving', 'he', '.', 'ml', 'kg', 'not', 'experience', 'aki', 'with', 'near', 'certainty', '.', 'conclusion', 'adjusting', 'patient', ""'s"", 'body', 'weight', ',', 'patient', 'receiving', 'he', 'required', 'volume', 'of', 'he', 'patient', 'receiving', 'he', '.', 'relation', 'of', 'represents', 'well', 'volume', 'effect', 'of', 'hyperoncotic', 'he', 'solution', '.', 'nonetheless', ',', 'he', 'solution', 'similarly', 'effective', 'in', 'reducing', 'intraoperative', 'fluid', 'administration', 'compared', 'with', 'crystalloid', ',', 'not', 'result', 'difference', 'in', 'gastrointestinal', 'outcome', '.', 'patient', 'receiving', 'he', 'showed', 'increased', 'rate', 'of', 'aki', ',', 'whereas', 'receiving', 'he', 'and', 'crystalloid', 'not', 'differ', '.', 'however', ',', 'he', 'not', 'applied', 'beyond', 'ml', 'kg', 'surgery', '.']"
Evaluation the Effects of Alpha-tocopherol in Comparison with N-acetylcystein for Prevention of Contrast Induced Nephropathy (CIN) in CKD Patients.,"Katayoon Samadi, Massih Naghibi, Mahmood Shabestari, Farzaneh Sharifipour, Mohammad Khajeh Dalooee, Vajehallah Raeesi, Sara Moosavi Nik, Mohammad Samadi, Katayoon Samadiet al.",2020 Jan,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/32156838/,No keywords found,"['contrast', 'induced', 'nephropathy', '(', 'cin', ')', ',', 'well-known', 'complication', 'of', 'using', 'radio', 'contrast', 'medium', ',', 'dramatically', 'increase', 'likelihood', 'of', 'patient', 'morbidity', 'and', 'mortality', 'following', 'coronary', 'angiography', '.', 'no', 'specific', 'treatment', 'cin', ',', 'prevention', 'could', 'best', 'strategy', 'to', 'address', 'issue', '.', 'since', ',', 'approved', 'preventing', 'strategy', 'hydration', 'with', 'normal', 'saline', 'antioxidant', 'agent', 'new', 'yet', 'unapproved', 'remedy', 'purpose', 'could', 'applied', '.the', 'present', 'study', 'conducted', 'to', 'examine', 'effect', 'of', 'alpha', 'tocopherol', 'in', 'cin', 'prevention', '.', 'method', 'prospective', 'controlled', 'trial', 'carried', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'egfr', 'ccmin', ')', 'underwent', 'coronary', 'angiography', '.', 'assigned', 'three', 'group', 'of', 'ckd', 'patient', 'patient', 'received', 'prophylaxis', 'administration', 'with', 'isotonic', 'saline', '(', 'group', ')', ',', 'patient', 'with', 'isotonic', 'saline', 'plus', 'n-acetylcysteine', '(', 'mg', 'twice', 'day', ')', 'day', '(', 'group', 'b', ')', 'and', 'patient', 'received', 'isotonic', 'saline', 'plus', 'daily', 'alpha', 'tocopherol', '(', 'iu', 'daily', 'one', 'day', 'till', 'day', 'angiography', ')', 'day', '(', 'group', 'c', ')', '.', 'contrast', 'medium', 'in', 'three', 'group', 'nonionic', 'iso-osmolal', 'agent', ',', 'visipaque', '.', 'result', 'even', 'though', 'cin', ""n't"", 'developed', 'in', 'of', 'three', 'aforementioned', 'group', 'statistically', 'significant', 'reduction', 'in', 'egfr', 'baseline', 'in', 'three', 'group', '(', 'p', '.', ')', '.', 'moreover', ',', 'found', 'no', 'statistically', 'significant', 'difference', 'in', 'gfr', 'reduction', 'three', 'studied', 'group', '.', 'conclusion', 'administration', 'of', 'alpha', 'tocopherol', 'no', 'additive', 'beneficial', 'effect', 'isotonic', 'saline', 'in', 'cin', 'prevention', 'in', 'ckd', 'patient', '.']"
CONIFER - Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload.,"Harald-Robert Bruch, Yves Dencausse, Jörg Heßling, Gerlinde Michl, Rudolf Schlag, Alexandra Skorupa, Cornelia Schneider-Schranz, Sebastian Wolf, Clemens Schulte, Hans Tesch, Harald-Robert Bruchet al.",2016,Oncol Res Treat,https://pubmed.ncbi.nlm.nih.gov/27486873/,No keywords found,"['non-interventional', 'study', 'conifer', 'designed', 'to', 'assess', 'safety', 'and', 'clinical', 'practicability', 'of', 'deferasirox', 'treatment', 'of', 'transfusional', 'iron', 'overload', 'in', 'myelodysplastic', 'syndrome', '(', 'md', ')', 'patient', '.', 'method', 'patient', 'included', 'in', 'study', 'diagnosed', 'with', 'md', 'and', 'received', 'least', 'treatment', 'with', 'deferasirox', '.', 'observation', 'period', 'covered', 'time', 'initial', 'visit', 'last', 'follow-up', '.', 'result', 'data', 'of', 'patient', 'with', 'md', 'scored', 'mainly', 'international', 'prognostic', 'scoring', 'system', '(', 'ipss', ')', 'low', 'and', 'intermediate', 'evaluated', '.', 'mean', 'age', 'of', 'participant', 'year', 'and', 'of', 'patient', 'male', '.', 'iron', 'overload', 'assessed', 'serum', 'ferritin', 'level', '(', 'mean', 'baseline', 'serum', 'ferritin', ',', ',', 'gl', ')', '.', 'patient', 'treated', 'mean', 'duration', 'of', 'month', '(', 'mean', 'daily', 'dose', 'baseline', '.', '.', 'mgkg', ')', '.', 'stratification', 'of', 'serum', 'ferritin', 'level', 'deferasirox', 'dose', 'showed', 'reduction', 'higher', 'no', 'reduction', 'lower', 'dose', '(', 'mgkg', 'vs.', 'mgkg', 'and', 'mgkg', 'vs.', 'mgkg', ')', '.', 'majority', 'of', 'patient', '(', ')', 'affected', 'least', 'adverse', 'event', ',', 'with', 'decreased', 'renal', 'creatinine', 'clearance', 'frequent', '.', 'conclusion', 'higher', 'dos', '(', 'mgkg', ')', 'of', 'deferasirox', 'effectively', 'and', 'safely', 'reduced', 'serum', 'ferritin', 'level', 'in', 'md', 'patient', 'with', 'transfusional', 'iron', 'overload', '.']"
Effect of continuous intraoperative infusion of methoxamine on renal function in elderly patients undergoing gastrointestinal tumor surgery: a randomized controlled trial.,"Xiaowei Guo, Jie Hu, Hanbing Xiao, Tianyu Liu, Zheng Niu, Min Wang, Dunyi Qi, Xiaowei Guoet al.",2020 Jun 13,BMC Anesthesiol,https://pubmed.ncbi.nlm.nih.gov/32534584/,No keywords found,"['acute', 'renal', 'injury', '(', 'aki', ')', 'caused', 'hypotension', 'often', 'occurs', 'in', 'elderly', 'patient', 'gastrointestinal', 'tumor', 'surgery', '.', 'although', 'vasoactive', 'drug', 'increase', 'effective', 'filtration', 'pressure', ',', 'may', 'increase', 'renal', 'vascular', 'resistance', 'and', 'reduce', 'renal', 'blood', 'flow', '.', 'effect', 'of', 'methoxamine', 'renal', 'function', 'not', 'clear', '.', 'method', 'obtaining', 'written', 'informed', 'consent', ',', 'elderly', 'patient', 'undergoing', 'elective', 'gastrointestinal', 'tumor', 'surgery', 'randomly', 'allocated', 'two', 'group', 'group', '(', 'continuous', 'infusion', 'of', 'methoxamine', 'gkgmin', ')', 'and', 'n', 'group', '(', 'continuous', 'infusion', 'of', 'normal', 'saline', ')', '.', 'patient', ""'"", 'mean', 'arterial', 'pressure', 'maintained', 'within', 'of', 'baseline', 'continuous', 'infusion', 'of', 'methoxamine', 'or', 'normal', 'saline', '.', 'maintenance', 'fluid', 'kept', 'mlkgh', '.', 'according', 'to', 'kidney', 'disease', 'improve', 'global', 'outcome', '(', 'kdigo', ')', 'guideline', ',', 'creatinine', 'measured', ',', 'and', 'day', 'operation', ',', 'and', 'urine', 'volume', ',', 'and', 'h', 'operation', 'measured', 'to', 'evaluate', 'occurrence', 'of', 'aki', '.', 'patient', 'included', 'in', 'final', 'data', 'analysis', '.', 'result', 'significant', 'difference', 'in', 'incidence', 'of', 'postoperative', 'acute', 'kidney', 'injury', '(', 'group', '.', 'n', 'group', '.', 'p', '.', ')', ',', 'frequency', 'of', 'hypotension', '(', 'group', '-', 'n', 'group', '-', 'p', '.', ')', ',', 'and', 'duration', 'of', 'intraoperative', 'hypotension', '(', 'group', '-', 'n', 'group', '-', 'p', '.', ')', 'identified', 'group', '.', 'multivariate', 'logistic', 'regression', 'analysis', 'demonstrated', 'preoperative', 'creatinine', 'and', 'frequency', 'of', 'intraoperative', 'hypotension', 'common', 'factor', 'leading', 'to', 'occurrence', 'of', 'postoperative', 'aki', '.', 'result', 'of', 'cox', 'multivariate', 'analysis', 'showed', 'age', 'and', 'aki', 'independent', 'risk', 'factor', '-day', 'death', '.', 'conclusion', 'compared', 'with', 'intraoperative', 'continuous', 'infusion', 'of', 'placebo', 'and', 'methoxamine', ',', 'continuous', 'infusion', 'of', 'gkgmin', 'methoxamine', 'reduced', 'incidence', 'of', 'postoperative', 'aki', 'and', 'clinical', 'complication', 'in', 'elderly', 'patient', 'undergoing', 'gastrointestinal', 'surgery', 'raising', 'blood', 'pressure', 'and', 'improved', 'prognosis', 'of', 'patient', '.', 'trial', 'registration', 'trial', 'registration', 'chinese', 'clinical', 'trial', 'registry', ',', 'chictr', ',', 'registered', 'january', ',', '.']"
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 study.,"Avivit Cahn, Itamar Raz, Marc Bonaca, Ofri Mosenzon, Sabina A Murphy, Ilan Yanuv, Aliza Rozenberg, John P H Wilding, Deepak L Bhatt, Darren K McGuire, Ingrid A M Gause-Nilsson, Martin Fredriksson, Peter A Johansson, Gyorgy Jermendy, Samy Hadjadj, Anna Maria Langkilde, Marc S Sabatine, Stephen D Wiviott, Lawrence A Leiter, Avivit Cahnet al.",2020 Aug,Diabetes Obes Metab,https://pubmed.ncbi.nlm.nih.gov/32239659/,No keywords found,"['to', 'evaluate', 'comprehensively', 'safety', 'of', 'dapagliflozin', 'in', 'patient', 'with', 'type', 'diabetes', '(', 'tdm', ')', ',', 'with', 'emphasis', 'placed', 'potential', 'safety', 'concern', 'related', 'to', 'sodium-glucose', 'co-transporter-', 'inhibitor', 'class', '.', 'method', 'in', 'dapagliflozin', 'effect', 'cardiovascular', 'event', '-', 'thrombolysis', 'in', 'myocardial', 'infarction', '(', 'declare-timi', ')', 'study', ',', 'patient', 'with', 'tdm', 'randomized', 'to', 'dapagliflozin', 'or', 'placebo', 'and', 'followed', 'median', 'of', '.', 'year', '.', 'safety', 'evaluated', 'in', 'patient', 'receiving', 'least', 'one', 'dose', 'of', 'study', 'drug', '.', 'result', 'acute', 'kidney', 'injury', 'occurred', 'less', 'frequently', 'with', 'dapagliflozin', ',', 'and', 'adverse', 'event', 'suggestive', 'of', 'volume', 'depletion', 'balanced', 'treatment', 'group', ',', 'irrespective', 'of', 'baseline', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'blood', 'pressure', ',', 'diuretic', 'or', 'loop', 'diuretic', 'use', '(', 'interaction', 'p', 'value', '.', ')', '.', 'fracture', 'and', 'malignancy', 'balanced', 'group', ',', 'irrespective', 'of', 'sex', ',', 'diabetes', 'duration', 'or', 'smoking', '(', 'interaction', 'p', 'value', '.', ')', 'and', 'fewer', 'case', 'of', 'bladder', 'cancer', 'occurred', 'in', 'dapagliflozin', 'versus', 'placebo', 'group', '.', 'diabetic', 'ketoacidosis', 'rare', ',', 'frequent', 'with', 'dapagliflozin', 'versus', 'placebo', '(', 'vs.', 'patient', 'with', 'event', 'p', '.', ')', ',', 'yet', 'sign', ',', 'symptom', 'and', 'contributing', 'factor', 'similar', 'in', 'two', 'group', '.', 'major', 'hypoglycaemia', 'occurred', 'less', 'frequently', 'with', 'dapagliflozin', 'versus', 'placebo', ',', 'regardless', 'of', 'baseline', 'use', 'of', 'either', 'insulin', 'or', 'sulphonylureas', '(', 'interaction', 'p', 'value', '.', ')', '.', 'adverse', 'event', 'of', 'genital', 'infection', 'leading', 'to', 'discontinuation', 'of', 'study', 'drug', 'in', 'dapagliflozin', 'versus', 'placebo', 'group', ',', 'serious', 'genital', 'infection', 'and', 'balanced', 'treatment', 'group', '.', 'urinary', 'tract', 'infection', ',', 'acute', 'pyelonephritis', 'and', 'urosepsis', 'also', 'balanced', 'treatment', 'group', '.', 'conclusion', 'dapagliflozin', 'well', 'tolerated', '.', 'long', 'duration', 'and', 'large', 'number', 'of', 'patient-years', 'in', 'declare-timi', 'comprehensively', 'addressed', 'previous', 'safety', 'question', ',', 'confirming', 'robust', 'safety', 'profile', 'of', 'dapagliflozin', '.']"
"Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial.","Sara M Tolaney, Andrew M Wardley, Stefania Zambelli, John F Hilton, Tiffany A Troso-Sandoval, Francesco Ricci, Seock-Ah Im, Sung-Bae Kim, Stephen Rd Johnston, Arlene Chan, Shom Goel, Kristen Catron, Sonya C Chapman, Gregory L Price, Zhengyu Yang, M Corona Gainford, Fabrice André, Sara M Tolaneyet al.",2020 Jun,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/32353342/,No keywords found,"['patient', 'with', 'her-positive', 'breast', 'cancer', 'received', 'two', 'or', 'previous', 'therapy', 'advanced', 'disease', 'effective', 'treatment', 'option', '.', 'monarcher', 'trial', 'aimed', 'to', 'compare', 'efficacy', 'of', 'abemaciclib', 'plus', 'trastuzumab', 'with', 'or', 'without', 'fulvestrant', 'with', 'standard-of-care', 'chemotherapy', 'of', 'physician', ""'s"", 'choice', 'plus', 'trastuzumab', 'in', 'woman', 'with', 'advanced', 'breast', 'cancer', '.', 'method', 'phase', ',', 'three-group', ',', 'open-label', 'trial', 'done', 'across', 'hospital', ',', 'clinic', ',', 'and', 'medical', 'centre', 'in', 'country', '.', 'eligible', 'patient', 'woman', 'aged', 'year', 'or', 'older', ',', 'hormone', 'receptor-positive', ',', 'her-positive', 'advanced', 'breast', 'cancer', 'with', 'unresectable', ',', 'locally', 'advanced', ',', 'recurrent', 'or', 'metastatic', 'disease', ',', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', 'or', ',', 'and', 'previously', 'received', 'least', 'two', 'her-targeted', 'therapy', 'advanced', 'disease', '.', 'patient', 'randomly', 'assigned', 'to', 'abemaciclib', ',', 'trastuzumab', ',', 'and', 'fulvestrant', '(', 'group', ')', ',', 'abemaciclib', 'and', 'trastuzumab', '(', 'group', 'b', ')', ',', 'or', 'standard-of-care', 'chemotherapy', 'and', 'trastuzumab', '(', 'group', 'c', ')', '.', 'oral', 'abemaciclib', 'mg', 'hourly', 'administered', 'day', '-', 'of', '-day', 'cycle', ',', 'intravenous', 'trastuzumab', 'mgkg', 'cycle', 'day', ',', 'followed', 'mgkg', 'day', 'of', 'subsequent', '-day', 'cycle', ',', 'and', 'intramuscular', 'fulvestrant', 'mg', 'day', ',', ',', 'and', 'and', 'every', 'week', 'thereafter', '.', 'standard-of-care', 'chemotherapy', 'administered', 'specified', 'product', 'label', '.', 'randomisation', 'computer-generated', 'random', 'sequence', 'mean', 'of', 'interactive', 'web-response', 'system', 'and', 'stratified', 'number', 'of', 'previous', 'systemic', 'therapy', 'advanced', 'breast', 'cancer', 'and', 'measurable', 'versus', 'non-measurable', 'disease', '.', 'primary', 'endpoint', 'investigator-assessed', 'progression-free', 'survival', 'in', 'intention-to-treat', 'population', ',', 'first', 'testing', 'group', 'versus', 'group', 'c', 'and', ',', 'result', 'significant', ',', 'group', 'b', 'versus', 'group', 'c.', 'safety', 'assessed', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '.', 'trial', 'registered', 'clinicaltrials.gov', '(', 'nct', ')', 'and', 'ongoing', 'long-term', 'survival', 'follow-up', '.', 'finding', 'may', ',', ',', 'and', 'feb', ',', ',', 'patient', 'screened', ',', 'of', 'eligible', 'patient', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'group', '(', 'n', ')', ',', 'b', '(', 'n', ')', ',', 'and', 'c', '(', 'n', ')', '.', 'median', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', 'study', 'met', 'primary', 'endpoint', ',', 'showing', 'significant', 'difference', 'prespecified', 'two-sided', 'of', 'in', 'median', 'progression-free', 'survival', 'group', '(', 'month', ',', 'ci', '-', ')', 'and', 'group', 'c', '(', 'month', ',', '-', 'hr', 'ci', '-', 'p', ')', '.', 'no', 'difference', 'observed', 'median', 'progression-free', 'survival', 'in', 'group', 'b', '(', 'month', ',', 'ci', '-', ')', 'and', 'group', 'c', '(', 'hr', '-', 'p', ')', '.', 'common', 'grade', '-', 'treatment-emergent', 'adverse', 'event', 'in', 'group', ',', 'b', ',', 'and', 'c', 'neutropenia', '(', 'of', 'patient', ',', 'of', ',', 'and', 'of', ')', '.', 'common', 'serious', 'adverse', 'event', 'in', 'group', ',', 'pyrexia', '(', 'three', ')', ',', 'diarrhoea', '(', 'two', ')', ',', 'urinary', 'tract', 'infection', '(', 'two', ')', ',', 'and', 'acute', 'kidney', 'injury', '(', 'two', ')', 'in', 'group', 'b', ',', 'diarrhoea', '(', 'two', ')', 'and', 'pneumonitis', '(', 'two', ')', 'and', 'in', 'group', 'c', ',', 'neutropenia', '(', 'four', ')', 'and', 'pleural', 'effusion', '(', 'two', ')', '.', 'two', 'death', 'attributed', 'to', 'treatment', 'one', 'due', 'to', 'pulmonary', 'fibrosis', 'in', 'group', 'b', 'and', 'one', 'due', 'to', 'febrile', 'neutropenia', 'in', 'group', 'c.', 'interpretation', 'combination', 'of', 'abemaciclib', ',', 'fulvestrant', ',', 'and', 'trastuzumab', 'significantly', 'improved', 'progression-free', 'survival', 'versus', 'standard-of-care', 'chemotherapy', 'plus', 'trastuzumab', 'showing', 'tolerable', 'safety', 'profile', '.', 'result', 'suggest', 'chemotherapy-free', 'regimen', 'might', 'potentially', 'alternative', 'treatment', 'option', 'patient', 'with', 'hormone', 'receptor-positive', ',', 'her-positive', 'advanced', 'breast', 'cancer', '.', 'funding', 'eli', 'lilly', 'and', 'company', '.']"
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.,"Bita Shakoory, Joseph A Carcillo, W Winn Chatham, Richard L Amdur, Huaqing Zhao, Charles A Dinarello, Randall Q Cron, Steven M Opal, Bita Shakooryet al.",2016 Feb,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/26584195/,No keywords found,"['to', 'determine', 'efficacy', 'of', 'anakinra', '(', 'recombinant', 'interleukin-', 'receptor', 'antagonist', ')', 'in', 'improving', '-day', 'survival', 'in', 'sepsis', 'patient', 'with', 'feature', 'of', 'macrophage', 'activation', 'syndrome', '.', 'despite', 'equivocal', 'result', 'in', 'sepsis', 'trial', ',', 'anakinra', 'effective', 'in', 'treating', 'macrophage', 'activation', 'syndrome', ',', 'similar', 'entity', 'with', 'fever', ',', 'disseminated', 'intravascular', 'coagulation', ',', 'hepatobiliary', 'dysfunction', ',', 'cytopenia', ',', 'and', 'hyperferritinemia', '.', 'hence', ',', 'sepsis', 'patient', 'with', 'macrophage', 'activation', 'syndrome', 'feature', 'may', 'benefit', 'interleukin-', 'receptor', 'blockade', '.', 'design', 'reanalysis', 'of', 'deidentified', 'data', 'phase', 'iii', 'randomized', 'interleukin-', 'receptor', 'antagonist', 'trial', 'in', 'severe', 'sepsis', '.', 'setting', 'multicenter', 'study', 'recruiting', 'center', 'country', 'in', 'europe', 'and', 'north', 'america', '.', 'patient', 'sepsis', 'patient', 'with', 'multiorgan', 'dysfunction', 'syndrome', 'andor', 'shock', '(', 'original', 'study', ')', 'regrouped', 'based', 'presence', 'or', 'absence', 'of', 'concurrent', 'hepatobiliary', 'dysfunction', 'and', 'disseminated', 'intravascular', 'coagulation', 'feature', 'of', 'macrophage', 'activation', 'syndrome', '.', 'non-hepatobiliary', 'dysfunctiondisseminated', 'intravascular', 'coagulation', 'group', 'included', 'patient', 'with', 'hepatobiliary', 'dysfunction', ',', 'disseminated', 'intravascular', 'coagulation', ',', 'or', 'neither', '.', 'intervention', 'treatment', 'with', 'anakinra', 'or', 'placebo', '.', 'measurement', 'and', 'main', 'result', 'main', 'outcome', '-day', 'mortality', '.', 'descriptive', 'and', 'comparative', 'statistic', 'performed', '.', 'data', 'available', 'adult', 'original', 'study', 'cohort', ',', 'randomized', 'to', 'receive', 'either', 'anakinra', 'or', 'placebo', '.', 'concurrent', 'hepatobiliary', 'dysfunctiondisseminated', 'intravascular', 'coagulation', 'noted', 'in', 'patient', '(', '.', 'of', 'total', '-', 'year', 'old', 'woman', ')', '.', '-day', 'survival', 'similar', 'in', 'anakinra', 'and', 'placebo-treated', 'non-hepatobiliary', 'dysfunctiondisseminated', 'intravascular', 'coagulation', 'patient', '(', '.', 'v', '.', 'p', '.', ')', '.', 'treatment', 'with', 'anakinra', 'associated', 'with', 'significant', 'improvement', 'in', '-day', 'survival', 'rate', 'in', 'hepatobiliary', 'dysfunctiondisseminated', 'intravascular', 'coagulation', 'patient', '(', '.', 'anakinra', 'v', '.', 'placebo', ')', ',', 'with', 'hazard', 'ratio', 'death', '.', '(', '.-', '.', 'p', '.', ')', 'treatment', 'group', 'in', 'cox', 'regression', '.', 'conclusion', 'in', 'subgroup', 'analysis', ',', 'interleukin-', 'receptor', 'blockade', 'associated', 'with', 'significant', 'improvement', 'in', 'survival', 'of', 'patient', 'with', 'sepsis', 'and', 'concurrent', 'hepatobiliary', 'dysfunctiondisseminated', 'intravascular', 'coagulation', '.', 'prospective', 'randomized', 'trial', 'using', 'feature', 'of', 'macrophage', 'activation', 'syndrome', 'mortality', 'risk', 'stratification', 'undertaken', 'to', 'confirm', 'role', 'of', 'interleukin-', 'blockage', '.']"
Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome.,"Jutta Gellermann, Franz Schaefer, Uwe Querfeld, Jutta Gellermannet al.",2014 Dec,Pediatr Nephrol,https://pubmed.ncbi.nlm.nih.gov/25129204/,No keywords found,"['soluble', 'urokinase-type', 'plasminogen', 'activator', 'receptor', '(', 'supar', ')', 'could', 'causative', 'factor', 'in', 'idiopathic', 'focal', 'segmental', 'glomerulosclerosis', '(', 'fsgs', ')', '.', 'currently', 'unknown', 'to', 'extent', 'supar', 'level', 'could', 'affected', 'treatment', 'with', 'immunosuppressive', 'drug', 'cyclosporin', '(', 'csa', ')', 'and', 'mycophenolate', 'mofetil', '(', 'mmf', ')', '.', 'treatment', 'with', 'csa', ',', 'not', 'mmf', ',', 'accompanied', 'nephrotoxicity', ',', 'and', 'since', 'supar', 'level', 'correlate', 'with', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', ',', 'treatment', 'with', 'drug', 'could', 'indirectly', 'modulate', 'supar', 'level', 'effect', 'renal', 'function', '.', 'method', 'measured', 'supar', 'level', 'in', 'recent', 'prospective', 'multicenter', 'crossover', 'trial', 'comparing', 'efficacy', 'of', 'mmf', 'and', 'csa', 'in', 'pediatric', 'patient', 'with', 'minimal', 'change', 'disease', '(', 'mcd', ')', 'and', 'frequently', 'relapsing', 'steroid-sensitive', 'nephrotic', 'syndrome', '(', 'fr-ssns', ')', '.', 'patient', 'biopsy-proven', 'mcd', 'and', 'normal', 'renal', 'function', 'treated', 'with', 'drug', 'year', 'in', 'crossover', 'study', 'design', '.', 'serum', 'supar', 'level', 'measured', 'and', 'year', 'of', 'therapy', 'with', 'mmf', '(', 'n', ')', 'and', 'csa', '(', 'n', ')', '.', 'result', 'supar', 'level', 'decreased', 'year', 'of', 'treatment', 'with', 'mmf', '(', 'p', '.', ')', '.', 'conversely', ',', 'supar', 'level', 'increased', 'year', 'of', 'treatment', 'with', 'csa', 'in', 'patient', '(', 'p', '.', ')', '.', 'change', 'in', 'supar', 'level', 'not', 'correlated', 'to', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'or', 'change', 'in', 'gfr', '.', 'conclusion', 'data', 'prospective', 'randomized', 'trial', 'suggest', 'treatment', 'with', 'mmf', 'and', 'csa', 'associated', 'with', 'different', 'effect', 'supar', 'level', 'in', 'child', 'with', 'mcd', 'and', 'independent', 'of', 'effect', 'gfr', '.']"
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.,"Colin A Hutchison, Paul Cockwell, Veronica Moroz, Arthur R Bradwell, Lesley Fifer, Julian D Gillmore, Mark D Jesky, Markus Storr, Julie Wessels, Christopher G Winearls, Katja Weisel, Nils Heyne, Mark Cook, Colin A Hutchisonet al.",2019 Apr,Lancet Haematol,https://pubmed.ncbi.nlm.nih.gov/30872075/,No keywords found,"['in', 'multiple', 'myeloma', ',', 'severe', 'acute', 'kidney', 'injury', 'due', 'to', 'myeloma', 'cast', 'nephropathy', 'caused', 'pathogenic', 'free', 'light', 'chain', 'immunoglobulin', 'in', 'serum', '.', 'high', 'cutoff', 'haemodialysis', '(', 'hco-hd', ')', 'remove', 'large', 'quantity', 'of', 'free', 'light', 'chain', 'immunoglobulin', 'serum', ',', 'effect', 'clinical', 'outcome', 'uncertain', '.', 'therefore', 'aimed', 'to', 'assess', 'whether', 'hco-hd', 'could', 'increase', 'frequency', 'of', 'renal', 'recovery', 'in', 'patient', 'with', 'de', 'novo', 'multiple', 'myeloma', ',', 'severe', 'acute', 'kidney', 'injury', ',', 'and', 'myeloma', 'cast', 'nephropathy', 'relative', 'to', 'treatment', 'with', 'standard', 'high-flux', 'haemodialysis', '(', 'hf-hd', ')', '.', 'method', 'in', 'open-label', ',', 'phase', ',', 'multicentre', ',', 'randomised', 'controlled', 'trial', '(', 'eulite', ')', ',', 'recruited', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', ',', 'biopsy-confirmed', 'cast', 'nephropathy', ',', 'and', 'acute', 'kidney', 'injury', 'required', 'dialysis', 'renal', 'service', 'in', 'hospital', 'in', 'uk', 'and', 'germany', '.', 'patient', 'randomly', 'assigned', '(', ')', 'random', 'number', 'generation', 'to', 'receive', 'intensive', 'hco-hd', '(', 'in', 'session', 'lasting', '-', 'h', ')', 'or', 'standard', 'hf-hd', 'and', 'stratified', 'age', 'and', 'centre', '.', 'patient', 'and', 'medical', 'staff', 'treating', 'not', 'masked', 'to', 'treatment', 'allocation', '.', 'patient', 'received', 'bortezomib', ',', 'doxorubicin', ',', 'and', 'dexamethasone', 'chemotherapy', ',', 'and', 'followed', 'year', '.', 'primary', 'outcome', 'independence', 'dialysis', 'day', 'random', 'allocation', 'to', 'group', ',', 'assessed', 'in', 'intention-to-treat', 'population', '.', 'trial', 'completed', 'follow-up', ',', 'and', 'registered', 'isrctn', 'registry', ',', 'number', 'isrctn', '.', 'finding', 'june', ',', ',', 'and', 'sept', ',', ',', 'recruited', 'patient', ',', 'of', '(', ')', 'randomly', 'assigned', 'to', 'receive', 'hco-hd', 'and', '(', ')', 'randomly', 'assigned', 'to', 'receive', 'hf-hd', '.', 'patient', 'included', 'in', 'analysis', 'of', 'primary', 'outcome', '.', 'one', '(', ')', 'patient', 'hf-hd', 'group', 'withdrew', 'consent', 'receiving', 'treatment', '.', 'treatment', ',', 'nine', '(', ')', 'patient', 'hco-hd', 'group', 'and', 'two', '(', ')', 'patient', 'in', 'hf-hd', 'group', 'discontinued', 'trial', 'treatment', '.', 'day', ',', '(', ')', 'patient', 'in', 'hco-hd', 'group', 'and', '(', ')', 'patient', 'in', 'hf-hd', 'group', 'independent', 'dialysis', '(', 'relative', 'risk', ',', 'ci', '-', 'p', ')', '.', '-year', 'follow-up', ',', 'serious', 'adverse', 'event', 'reported', 'in', 'hco-hd', 'group', 'and', 'serious', 'adverse', 'event', 'reported', 'in', 'hf-hd', 'group', '.', 'common', 'serious', 'adverse', 'event', 'infection', 'and', 'adverse', 'event', 'related', 'to', 'cardiovascular', 'and', 'thrombotic', 'and', 'musculoskeletal', 'system', '.', 'first', 'day', ',', 'infection', 'reported', 'in', 'hco-hd', 'group', 'and', 'infection', 'reported', 'in', 'hf-hd', 'group', ',', 'including', 'lung', 'infection', 'in', 'hco-hd', 'group', 'and', 'three', 'lung', 'infection', 'in', 'hf-hd', 'group', '.', 'interpretation', 'in', 'phase', 'study', ',', 'hco-hd', 'not', 'improve', 'clinical', 'outcome', 'patient', 'with', 'de', 'novo', 'multiple', 'myeloma', 'and', 'myeloma', 'cast', 'nephropathy', 'required', 'haemodialysis', 'acute', 'kidney', 'injury', 'and', 'received', 'bortezomib-based', 'chemotherapy', 'regimen', 'relative', 'to', 'receiving', 'hf-hd', '.', 'result', 'not', 'support', 'proceeding', 'to', 'phase', 'study', 'hco-hd', 'in', 'patient', '.', 'funding', 'gambro', ',', 'janssen', ',', 'and', 'binding', 'site', '.']"
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.,"Alexander L Bullen, Ronit Katz, Alexandra K Lee, Cheryl A M Anderson, Alfred K Cheung, Pranav S Garimella, Vasantha Jotwani, William E Haley, Areef Ishani, James P Lash, Javier A Neyra, Henry Punzi, Anjay Rastogi, Erik Riessen, Rakesh Malhotra, Chirag R Parikh, Michael V Rocco, Barry M Wall, Udayan Y Bhatt, Michael G Shlipak, Joachim H Ix, Michelle M Estrella, Alexander L Bullenet al.",2019 Aug,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/31262489/,"acute kidney injury, alpha-1 microglobulin, beta-2 microglobulin, chitinase-3-like protein, interleukin-18, kidney injury molecule-1, monocyte chemoattractant protein-1, neutrophil gelatinase-associated lipocalin, uromodulin.","['urine', 'marker', 'quantify', 'tubular', 'function', 'including', 'reabsorption', '(', '-', 'microglobulin', ')', 'and', '--', 'microglobulin', ')', 'and', 'protein', 'synthesis', '(', 'uromodulin', ')', '.', 'individual', 'with', 'tubular', 'dysfunction', 'may', 'less', 'able', 'to', 'compensate', 'to', 'insult', 'without', ',', 'despite', 'similar', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'and', 'albuminuria', '.', 'among', 'systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', ')', 'participant', 'with', 'egfr', 'mlmin.m', ',', 'measured', 'urine', 'marker', 'of', 'tubular', 'function', 'and', 'injury', '(', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'ngal', ',', 'kidney', 'injury', 'molecule-', 'kim-', ',', 'interleukin-', 'il-', ',', 'monocyte', 'chemoattractant', 'protein-', ',', 'and', 'chitinase', '--', 'like', 'protein', 'ykl-', ')', 'baseline', '.', 'cox', 'model', 'evaluated', 'association', 'with', 'subsequent', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'risk', ',', 'adjusting', 'clinical', 'risk', 'factor', ',', 'baseline', 'egfr', 'and', 'albuminuria', ',', 'and', 'tubular', 'function', 'and', 'injury', 'marker', '.', 'in', 'random', 'subset', ',', 'remeasured', 'biomarkers', 'four', 'year', ',', 'and', 'compared', 'change', 'in', 'biomarkers', 'in', 'with', 'and', 'without', 'intervening', 'aki', '.', 'among', 'participant', ',', 'experienced', 'aki', '.', 'year', 'mean', 'follow-up', '.', 'lower', 'uromodulin', '(', 'hazard', 'ratio', 'per', 'two-fold', 'higher', '(', '.', ',', 'confidence', 'interval', '.', ',', '.', ')', 'and', 'higher', '(', '.', '.', ',', '.', ')', 'associated', 'with', 'subsequent', 'aki', ',', 'independent', 'of', 'egfr', 'and', 'albuminuria', '.', 'none', 'of', 'five', 'injury', 'marker', 'associated', 'with', 'eventual', 'aki', '.', 'in', 'random', 'subset', 'of', 'patient', 'with', 'repeated', 'measurement', ',', 'patient', 'with', 'intervening', 'aki', 'versus', 'without', 'longitudinal', 'increase', 'in', 'urine', 'ngal', ',', 'il-', ',', 'and', 'ykl-', 'and', 'marker', 'of', 'tubule', 'function', '(', ')', '.', 'thus', ',', 'joint', 'evaluation', 'of', 'tubule', 'function', 'and', 'injury', 'provided', 'novel', 'insight', 'to', 'factor', 'predisposing', 'to', 'aki', ',', 'and', 'response', 'to', 'kidney', 'injury', '.']"
Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial.,"Bettina J Kraus, Matthew R Weir, George L Bakris, Michaela Mattheus, David Z I Cherney, Naveed Sattar, Hiddo J L Heerspink, Ivana Ritter, Maximilian von Eynatten, Bernard Zinman, Silvio E Inzucchi, Christoph Wanner, Audrey Koitka-Weber, Bettina J Krauset al.",2021 Mar,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/33181154/,"acute kidney injury, cardiovascular disease, diabetes, estimated glomerular filtration rate, sodium-glucose co-transporter-2 inhibition.","['treatment', 'with', 'sodium-glucose', 'co-transporter-', 'inhibitor', 'induces', 'initial', '-', 'mlmin', '.', 'decline', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', '.', 'although', 'considered', 'to', 'of', 'hemodynamic', 'origin', 'and', 'largely', 'reversible', ',', ""'egfr"", 'dip', ""'"", 'may', 'cause', 'concern', 'in', 'clinical', 'practice', ',', 'highlight', 'need', 'to', 'better', 'understand', 'incidence', 'and', 'clinical', 'implication', '.', 'in', 'post', 'hoc', 'analysis', 'of', 'empa-reg', 'outcome', 'trial', ',', ',', 'participant', 'randomized', 'to', 'empagliflozin', 'mg', ',', 'mg', 'or', 'placebo', 'with', 'egfr', 'available', 'baseline', 'and', 'week', 'four', 'categorized', 'initial', 'egfr', 'change', 'three', 'group', 'decline', '(', ""'egfr"", 'dipper', ""'"", ')', ',', 'and', 'to', 'decline', '(', ""'egfr"", 'intermediate', ""'"", ')', ',', 'no', 'egfr', 'decline', '(', ""'egfr"", 'non-dipper', ""'"", ')', '.', 'baseline', 'characteristic', 'of', ""'egfr"", 'intermediate', ""'"", 'and', ""'egfr"", 'non-dipper', ""'"", 'generally', 'comparable', '.', 'initial', ""'egfr"", 'dip', ""'"", 'observed', 'in', '.', 'of', 'empagliflozin', 'versus', '.', 'of', 'placebo-treated', 'participant', 'odds', 'ratio', '.', 'confidence', 'interval', '.-', '..', 'in', 'multivariate', 'logistic', 'regression', ',', 'diuretic', 'use', 'and', 'higher', 'kdigo', 'risk', 'category', 'baseline', 'independently', 'predictive', 'of', ""'egfr"", 'dip', ""'"", 'in', 'empagliflozin', 'versus', 'placebo', '.', 'safety', 'and', 'beneficial', 'treatment', 'effect', 'with', 'empagliflozin', 'cardiovascular', 'and', 'kidney', 'outcome', 'consistent', 'across', 'subgroup', 'based', 'predictive', 'factor', '.', 'initial', ""'egfr"", 'dip', ""'"", 'not', 'major', 'impact', 'treatment', 'effect', 'of', 'empagliflozin', 'subsequent', 'cardiovascular', 'death', ',', 'hospitalization', 'heart', 'failure', ',', 'and', 'incident', 'or', 'worsening', 'kidney', 'disease', '.', 'thus', ',', 'patient', 'with', 'type', 'diabetes', 'with', 'advanced', 'kidney', 'disease', 'andor', 'diuretic', 'therapy', 'likely', 'to', 'experience', ""'egfr"", 'dip', ""'"", 'of', 'with', 'empagliflozin', ',', 'reduction', 'in', 'cardiovascular', 'and', 'kidney', 'outcome', 'not', 'relevantly', 'modified', ""'egfr"", 'dip', '.', ""'""]"
Effect of standard dose paracetamol versus placebo as antipyretic therapy on liver injury in adult dengue infection: a multicentre randomised controlled trial.,"Vasin Vasikasin, Thanawith Rojdumrongrattana, Worayon Chuerboonchai, Thanawhan Siriwiwattana, Wittaya Thongtaeparak, Suchada Niyasom, Nawarat Lertliewtrakool, Sitawee Jitsiri, Dhitiwat Changpradub, Vasin Vasikasinet al.",2019 May,Lancet Glob Health,https://pubmed.ncbi.nlm.nih.gov/31000133/,No keywords found,"['dengue', 'common', 'cause', 'of', 'acute', 'liver', 'failure', 'in', 'tropical', 'country', '.', 'paracetamol', 'recommended', 'antipyretic', 'dengue', '.', 'related', 'observational', 'study', 'in', 'dengue', 'suggested', 'excessive', 'paracetamol', 'intake', 'related', 'to', 'hepatic', 'injury', '.', 'aimed', 'to', 'evaluate', 'whether', 'standard', 'dose', 'paracetamol', 'antipyretic', 'in', 'dengue', 'infection', 'caused', 'transaminase', 'elevation', ',', 'and', 'to', 'evaluate', 'efficacy', 'of', 'paracetamol', '.', 'method', 'in', 'randomised', ',', 'double-blind', ',', 'placebo-controlled', 'trial', ',', 'adult', 'participant', '(', 'aged', 'year', ')', 'with', 'dengue', ',', 'confirmed', 'either', 'positive', 'n', 'antigen', ',', 'positive', 'dengue', 'igm', 'antigen', 'with', 'thrombocytopenia', ',', 'or', 'positive', 'pcr', 'test', ',', 'enrolled', 'three', 'royal', 'thai', 'army', 'hospital', 'in', 'thailand', '.', 'key', 'exclusion', 'criterion', 'baseline', 'ast', 'or', 'alt', 'concentration', 'of', 'time', 'upper', 'limit', 'of', 'normal', ',', 'cirrhosis', ',', 'indication', 'of', 'paracetamol', 'dengue', 'infection', ',', 'concurrent', 'diagnosis', 'of', 'cause', 'of', 'fever', ',', 'or', 'pregnancy', '.', 'patient', 'randomly', 'assigned', '(', ')', ',', 'computer-generated', 'block', 'randomisation', 'procedure', '(', 'block', 'size', 'of', 'six', ')', ',', 'to', 'receive', 'either', 'paracetamol', '(', 'mg', ')', 'or', 'placebo', '(', 'mg', ')', 'every', 'h', 'body', 'temperature', 'exceeded', 'c', 'hospitalisation', '.', 'participant', 'and', 'investigator', 'masked', 'to', 'treatment', 'assignment', '.', 'primary', 'outcome', 'proportion', 'of', 'participant', 'with', 'transaminase', 'elevation', ',', 'defined', 'serum', 'aspartate', 'transaminase', '(', 'ast', ')', 'and', 'alanine', 'transaminase', '(', 'alt', ')', 'concentration', 'of', 'time', 'upper', 'limit', 'of', 'normal', 'recovery', 'day', ',', 'in', 'intention-to-treat', 'population', '.', 'prespecified', 'interim', 'analysis', 'safety', 'and', 'efficacy', 'performed', 'with', 'group', 'sequential', 'stopping', 'boundary', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'sept', ',', ',', 'and', 'dec', ',', ',', 'participant', 'randomly', 'assigned', 'to', 'receive', 'either', 'paracetamol', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', '.', 'participant', 'included', 'in', 'intention-to-treat', 'population', '.', 'median', 'daily', 'dose', 'of', 'study', 'medication', 'g', '(', 'iqr', '-', ')', '.', 'study', 'terminated', 'early', 'owing', 'to', 'higher', 'rate', 'of', 'transaminase', 'elevation', 'in', 'paracetamol', 'group', 'in', 'placebo', 'group', '(', 'v', 'incidence', 'rate', 'ratio', ',', 'ci', '-', ',', 'p', ')', '.', 'change', 'of', 'ast', 'and', 'alt', 'concentration', 'in', 'paracetamol', 'group', 'higher', 'in', 'placebo', 'group', '(', 'mean', 'difference', 'ul', 'per', 'day', ',', '-', ',', 'p', 'ast', 'ul', 'per', 'day', ',', 'ci', '-', ',', 'p', 'alt', ')', '.', 'three', 'participant', 'in', 'paracetamol', 'group', 'severe', 'dengue', 'two', 'upper', 'gastric', 'haemorrhage', 'and', 'one', 'acute', 'kidney', 'injury', '.', 'no', 'patient', 'died', 'or', 'liver', 'failure', '.', 'interpretation', 'use', 'of', 'standard', 'dose', 'paracetamol', 'in', 'dengue', 'infection', 'increased', 'incidence', 'of', 'transaminase', 'elevation', ',', 'and', 'also', 'overall', 'transaminase', 'concentration', 'in', 'absence', 'of', 'counterbalancing', 'reduced', 'fever', 'or', 'pain', 'score', '.', 'funding', 'phramongkutklao', 'college', 'of', 'medicine', '.']"
A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function.,"E Wlodek, R B Kirkpatrick, S Andrews, R Noble, R Schroyer, J Scott, C J E Watson, M Clatworthy, E M Harrison, S J Wigmore, K Stevenson, D Kingsmore, N S Sheerin, O Bestard, H A Stirnadel-Farrant, L Abberley, M Busz, S DeWall, M Birchler, D Krull, K S Thorneloe, A Weber, L Devey, E Wlodeket al.",2021 Mar 8,PLoS One,https://pubmed.ncbi.nlm.nih.gov/33684160/,No keywords found,"['delayed', 'graft', 'function', '(', 'dgf', ')', 'following', 'renal', 'transplantation', 'manifestation', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'leading', 'to', 'poor', 'long-term', 'outcome', '.', 'current', 'treatment', 'limited', 'effectiveness', 'in', 'preventing', 'dgf', '.', 'interleukin-', '(', 'il', ')', ',', 'biomarker', 'of', 'aki', ',', 'induces', 'interferon-', 'expression', 'and', 'immune', 'activation', '.', 'gsk', ',', 'anti-il', 'monoclonal', 'antibody', ',', 'neutralizes', 'activated', '(', 'mature', ')', 'il', 'released', 'damaged', 'cell', 'following', 'inflammasome', 'activation', '.', 'phase', 'iia', ',', 'single-arm', 'trial', 'assessed', 'effect', 'of', 'single', 'dose', 'of', 'gsk', 'dgf', 'occurrence', 'post', 'donation', 'circulatory', 'death', '(', 'dcd', ')', 'kidney', 'transplantation', '.', 'method', 'mgkg', 'intravenous', 'dose', 'selected', 'based', 'prior', 'study', 'and', 'physiologically', 'based', 'pharmacokinetic', '(', 'pbpk', ')', 'modeling', ',', 'indicating', 'high', 'likelihood', 'of', 'rapid', 'and', 'high', 'level', 'of', 'il', 'target', 'engagement', 'administered', 'prior', 'to', 'kidney', 'allograft', 'reperfusion', '.', 'utilization', 'of', 'bayesian', 'sequential', 'design', 'with', 'background', 'standard-of-care', 'dgf', 'rate', 'of', 'based', 'literature', ',', 'and', 'confirmed', 'via', 'extensive', 'registry', 'data', 'analysis', ',', 'enabled', 'statistical', 'efficacy', 'assessment', 'with', 'minimal', 'sample', 'size', '.', 'primary', 'endpoint', 'dgf', 'frequency', ',', 'defined', 'dialysis', 'requirement', 'day', 'post', 'transplantation', '(', 'except', 'hyperkalemia', ')', '.', 'secondary', 'endpoint', 'included', 'safety', ',', 'pharmacokinetics', 'and', 'pharmacodynamic', 'biomarkers', '.', 'result', 'gsk', 'administration', 'associated', 'with', 'il-gsk', 'complex', 'detection', 'and', 'increased', 'total', 'serum', 'il', 'level', 'due', 'to', 'il', 'half-life', 'prolongation', 'induced', 'gsk', 'binding', '.', 'interferon', '--', 'induced', 'chemokine', 'level', 'declined', 'or', 'remained', 'unchanged', 'in', 'patient', '.', 'although', 'study', 'concluded', 'prior', 'to', 'bayesian-defined', 'stopping', 'point', ',', 'enrolled', 'patient', '(', ')', 'dgf', ',', 'exceeding', 'standard-of-care', 'rate', ',', 'and', 'additional', 'two', 'patient', ',', 'although', 'not', 'reaching', 'protocol-defined', 'dgf', 'definition', ',', 'demonstrated', 'poor', 'graft', 'function', '.', 'six', 'of', 'seven', 'patient', 'experienced', 'serious', 'adverse', 'event', '(', 'saes', ')', ',', 'including', 'two', 'treatment-related', 'saes', '.', 'conclusion', 'overall', ',', 'using', 'bayesian', 'design', 'and', 'extensive', 'pbpk', 'dose', 'modeling', 'with', 'small', 'sample', 'size', ',', 'deemed', 'unlikely', 'gsk', 'would', 'efficacious', 'in', 'preventing', 'dgf', 'in', 'enrolled', 'dcd', 'transplant', 'population', '.', 'trial', 'registration', 'nct', '.']"
"Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers.","Esther Peters, Jules A A C Heuberger, Renger Tiessen, Andrea van Elsas, Rosalinde Masereeuw, Jacques Arend, Jasper Stevens, Peter Pickkers, Esther Peterset al.",2016 Oct,Clin Pharmacokinet,https://pubmed.ncbi.nlm.nih.gov/27147514/,No keywords found,"['previous', 'clinical', 'trial', 'suggested', 'bovine', 'intestinal', 'alkaline', 'phosphatase', 'renal', 'protective', 'effect', 'in', 'patient', 'with', 'sepsis-associated', 'acute', 'kidney', 'injury', '.', 'conducted', 'first-in-human', 'study', 'to', 'investigate', 'pharmacokinetics', ',', 'safety', 'and', 'tolerability', 'of', 'novel', 'human', 'recombinant', 'alkaline', 'phosphatase', '(', 'recap', ')', ',', 'and', 'developed', 'population', 'pharmacokinetic', 'model', 'to', 'support', 'dose', 'selection', 'future', 'patient', 'study', '.', 'method', 'in', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'phase', 'trial', ',', 'healthy', 'volunteer', 'received', 'single', 'dose', 'of', 'recap', '(', ',', ',', 'or', 'ukg', 'n', 'ratio', ')', 'or', 'multiple', 'dos', 'of', 'recap', '(', 'or', 'ukg', 'n', 'ratio', ')', 'via', '-h', 'intravenous', 'infusion', 'three', 'consecutive', 'day', '.', 'serum', 'recap', 'concentration', ',', 'alkaline', 'phosphatase', '(', 'ap', ')', 'activity', 'level', 'and', 'anti-drug', 'antibody', 'measured', ',', 'and', 'safety', 'parameter', 'monitored', '.', 'population', 'pharmacokinetic', 'model', 'developed', ',', 'and', 'simulation', 'performed', 'to', 'guide', 'dose', 'selection', 'phase', 'iiab', 'trial', '.', 'result', 'peak', 'concentration', 'of', 'recap', 'and', 'peak', 'ap', 'activity', 'reached', 'end', 'of', '-h', 'infusion', 'and', 'showed', 'rapid', 'decline', ',', 'with', 'of', 'maximum', 'concentration', 'remaining', 'h', 'and', 'less', 'remaining', 'h', 'post-start', '.', 'recap', 'treatment', 'generally', 'well', 'tolerated', ',', 'and', 'anti-drug', 'antibody', 'could', 'not', 'detected', 'in', 'serum', 'to', 'week', 'post-injection', 'single', 'dose', ',', 'or', 'to', 'week', 'post-injection', 'multiple', 'dos', '.', 'four-compartment', 'model', 'best', 'described', 'pharmacokinetics', 'of', 'recap', 'administration', ',', 'with', 'moderate', 'inter-individual', 'variability', 'central', 'volume', 'of', 'distribution', 'and', 'elimination', 'rate', 'constant', '.', 'simulation', 'showed', '-h', 'intravenous', 'infusion', 'of', ',', 'and', 'ukg', 'recap', 'every', 'h', 'three', 'consecutive', 'day', 'constituted', 'dosing', 'regimen', 'best', 'met', 'criterion', 'dose', 'selection', 'in', 'patient', 'study', '.', 'conclusion', 'recap', 'not', 'raise', 'safety', 'concern', 'administered', 'to', 'healthy', 'volunteer', '.', 'population', 'pharmacokinetic', 'model', 'developed', 'to', 'support', 'dose', 'selection', 'patient', 'study', '.', 'trial', 'registration', '--', '(', 'eudract', ')', '.']"
"Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.","Danilo Fliser, Frank Dellanna, Michael Koch, Alfons Wiggenhauser                              ;, PRIMAVERA study group, Danilo Fliseret al.",2017 Feb 1,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/28186540/,No keywords found,"['unknown', 'whether', 'early', 'intervention', 'with', 'low-dose', 'erythropoiesis-stimulating', 'agent', '(', 'esas', ')', 'in', 'non-anaemic', 'patient', 'delay', 'progression', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'method', 'in', 'single-blind', ',', '-month', 'trial', ',', 'adult', 'with', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'mlmin', '.', 'and', 'either', 'type', 'diabetes', 'mellitus', 'or', 'previous', 'kidney', 'transplantation', 'randomized', 'to', 'low-dose', 'continuous', 'erythropoiesis', 'receptor', 'activator', '(', 'cera', 'monthly', 'dose', 'g', 'n', ')', 'or', 'placebo', '(', 'n', ')', '.', 'primary', 'endpoint', 'annual', 'change', 'in', 'egfr', '(', 'abbreviated', 'modification', 'of', 'diet', 'in', 'renal', 'disease', 'formula', ')', '.', 'result', 'mean', '(', 'standard', 'deviation', ')', 'egfr', '.', '(', '.', ')', 'mlmin', '.', 'versus', '.', '(', '.', ')', 'mlmin', '.', 'baseline', 'cera', 'and', 'placebo', ',', 'respectively', ',', 'and', '.', '(', '.', ')', 'gdl', 'versus', '.', '(', '.', ')', 'gdl', 'final', 'visit', '.', 'median', '(', 'interquartile', 'range', ')', 'annual', 'reduction', 'in', 'egfr', '.', '(', '.', ',', '.', ')', 'mlmin', '.', 'with', 'cera', 'versus', '.', '(', '.', ',', '.', ')', 'mlmin', '.', 'with', 'placebo', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'annual', 'change', 'in', 'egfr', 'observed', 'treatment', 'group', 'in', 'subpopulation', 'with', 'type', 'diabetes', 'or', 'kidney', 'transplant', '.', 'adverse', 'event', 'with', 'suspected', 'relation', 'to', 'study', 'drug', 'occurred', 'in', '.', 'and', '.', 'of', 'patient', 'randomized', 'to', 'cera', 'or', 'placebo', ',', 'respectively', ',', 'and', 'adverse', 'event', 'led', 'to', 'study', 'drug', 'discontinuation', 'in', '.', 'and', '.', 'of', 'patient', '.', 'conclusion', 'patient', 'with', 'moderate', 'ckd', 'and', 'type', 'diabetes', 'or', 'previous', 'kidney', 'transplantation', 'showed', 'stable', 'renal', 'function', 'unaffected', 'administration', 'of', 'low-dose', 'esa', '.', 'in', 'addition', ',', 'no', 'clinically', 'meaningful', 'effect', 'of', '-year', 'low-dose', 'esa', 'treatment', 'albuminuria', ',', 'important', 'surrogate', 'marker', 'of', 'kidney', 'injury', '.']"
"Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial.","Willem Daniel Francois Venter, Andrew Kambugu, Matthew F Chersich, Stephen Becker, Andrew Hill, Natasha Arulappan, Michelle Moorhouse, Mohammed Majam, Godspower Akpomiemie, Simiso Sokhela, Selvamuthu Poongulali, Charles Feldman, Chris Duncombe, David H Brown Ripin, Alinda Vos, Nagalingeswaran Kumarasamy, Willem Daniel Francois Venteret al.",2019 Feb 1,J Acquir Immune Defic Syndr,https://pubmed.ncbi.nlm.nih.gov/30640204/,No keywords found,"['reducing', 'dos', 'of', 'antiretroviral', 'drug', ',', 'including', 'stavudine', '(', 'dt', ')', ',', 'may', 'lower', 'toxicity', ',', 'preserving', 'efficacy', '.', 'substantial', 'concern', 'renal', 'and', 'bone', 'toxicity', 'of', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', '.', 'setting', 'hiv', '--', 'infected', 'treatment-naive', 'adult', 'in', 'india', ',', 'south', 'africa', ',', 'and', 'uganda', '.', 'method', 'phase-', ',', '-week', ',', 'randomized', ',', 'double-blind', ',', 'noninferiority', 'trial', 'compared', 'dt', 'mg', 'twice', 'daily', 'and', 'tdf', ',', 'taken', 'in', 'combination', 'with', 'lamivudine', '(', 'tc', ')', 'and', 'efavirenz', '(', 'efv', ')', '.', 'primary', 'endpoint', 'proportion', 'of', 'participant', 'with', 'hiv-', 'rna', 'copy', 'per', 'milliliter', 'week', '.', 'adverse', 'event', 'assessment', 'included', 'measure', 'of', 'bone', 'density', 'and', 'body', 'fat', '.', 'trial', 'registered', 'clinicaltrials.gov', '(', 'nct', ')', '.', 'result', 'and', ',', 'participant', 'recruited', 'per', 'arm', '.', 'week', ',', 'trial', 'completion', 'rate', '.', 'with', 'dttcefv', '(', 'n', ')', 'and', '.', 'with', 'tdftcefv', '(', 'n', ',', 'p', '.', ')', '.', 'noncompletion', 'largely', 'due', 'to', 'virological', 'failure', '.', '(', ')', 'with', 'dttcefv', 'versus', '.', '(', ')', 'with', 'tdftcefv', 'p', '..', 'primary', 'endpoint', ',', 'dttcefv', 'noninferior', 'to', 'tdftcefv', '(', '.', ',', 'versus', '.', 'difference', '-.', ',', 'ci', '-', '.', 'to', '.', 'p', '.', ')', '.', 'drug-related', 'adverse', 'event', 'discontinuation', 'higher', 'with', 'dt', '(', '.', ',', ')', ',', 'tdf', '(', '.', ',', 'p', '.', ')', '.', 'lipodystrophy', 'common', 'with', 'dt', '(', '.', ',', ')', 'tdf', '(', '.', ',', 'p', '.', ')', '.', 'creatinine', 'clearance', 'increased', 'in', 'arm', ',', '.', 'mlmin', 'in', 'dt', 'arm', 'and', '.', 'mlmin', 'with', 'tdf', '(', 'p', '.', ')', '.', 'hip', 'bone', 'density', 'measure', ',', 'however', ',', 'showed', 'greater', 'loss', 'with', 'tdf', '.', 'conclusion', 'low-dose', 'dt', 'combined', 'with', 'tcefv', 'demonstrated', 'noninferior', 'virological', 'efficacy', 'compared', 'with', 'tdftcefv', ',', 'mitochondrial', 'toxicity', 'remained', 'high', '.', 'little', 'renal', 'toxicity', 'occurred', 'in', 'either', 'arm', '.', 'implication', 'of', 'bone', 'mineral', 'density', 'change', 'with', 'tdf', 'warrant', 'investigation', '.']"
"Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.","Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, Maurilio Ponzoni, Martina Deckert, Letterio S Politi, Valter Torri, Christopher P Fox, Paul La Rosée, Elisabeth Schorb, Achille Ambrosetti, Alexander Roth, Claire Hemmaway, Angela Ferrari, Kim M Linton, Roberta Rudà, Mascha Binder, Tobias Pukrop, Monica Balzarotti, Alberto Fabbri, Peter Johnson, Jette Sønderskov Gørløv, Georg Hess, Jens Panse, Francesco Pisani, Alessandra Tucci, Stephan Stilgenbauer, Bernd Hertenstein, Ulrich Keller, Stefan W Krause, Alessandro Levis, Hans J Schmoll, Franco Cavalli, Jürgen Finke, Michele Reni, Emanuele Zucca, Gerald Illerhaus                              ;, International Extranodal Lymphoma Study Group (IELSG), Andrés J M Ferreriet al.",2016 May,Lancet Haematol,https://pubmed.ncbi.nlm.nih.gov/27132696/,No keywords found,"['standard', 'treatment', 'patient', 'with', 'primary', 'cns', 'lymphoma', 'remains', 'to', 'defined', '.', 'active', 'therapy', 'often', 'associated', 'with', 'increased', 'risk', 'of', 'haematological', 'or', 'neurological', 'toxicity', '.', 'in', 'trial', ',', 'addressed', 'tolerability', 'and', 'efficacy', 'of', 'adding', 'rituximab', 'with', 'or', 'without', 'thiotepa', 'to', 'methotrexate-cytarabine', 'combination', 'therapy', '(', 'matrix', 'regimen', ')', ',', 'followed', 'second', 'randomisation', 'comparing', 'consolidation', 'with', 'whole-brain', 'radiotherapy', 'or', 'autologous', 'stem', 'cell', 'transplantation', 'in', 'patient', 'with', 'primary', 'cns', 'lymphoma', '.', 'report', 'result', 'of', 'first', 'randomisation', 'in', 'article', '.', 'method', 'international', 'randomised', 'phase', 'international', 'extranodal', 'lymphoma', 'study', 'group-', '(', 'ielsg', ')', 'trial', ',', 'hiv-negative', 'patient', '(', 'aged', '-', 'year', ')', 'with', 'newly', 'diagnosed', 'primary', 'cns', 'lymphoma', 'and', 'measurable', 'disease', 'enrolled', 'cancer', 'centre', 'in', 'five', 'european', 'country', '(', 'denmark', ',', 'germany', ',', 'italy', ',', 'switzerland', ',', 'and', 'uk', ')', 'and', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'four', 'course', 'of', 'methotrexate', 'gm', '(', ')', 'day', 'plus', 'cytarabine', 'gm', '(', ')', 'twice', 'daily', 'day', 'and', '(', 'group', ')', 'or', 'combination', 'plus', 'two', 'dos', 'of', 'rituximab', 'mgm', '(', ')', 'day', '-', 'and', '(', 'group', 'b', ')', 'or', 'methotrexate-cytarabine-rituximab', 'combination', 'plus', 'thiotepa', 'mgm', '(', ')', 'day', '(', 'group', 'c', ')', ',', 'with', 'three', 'group', 'repeating', 'treatment', 'every', 'week', '.', 'patient', 'with', 'responsive', 'or', 'stable', 'disease', 'first', 'stage', 'randomly', 'allocated', 'whole-brain', 'radiotherapy', 'and', 'autologous', 'stem', 'cell', 'transplantation', '.', 'permuted', 'block', 'randomised', 'design', '(', 'block', 'size', 'four', ')', 'used', 'randomisation', ',', 'and', 'computer-generated', 'randomisation', 'list', 'used', 'within', 'stratum', 'to', 'preserve', 'allocation', 'concealment', '.', 'randomisation', 'stratified', 'ielsg', 'risk', 'score', '(', 'low', 'v', 'intermediate', 'v', 'high', ')', '.', 'no', 'masking', 'assignment', 'to', 'intervention', 'used', '.', 'primary', 'endpoint', 'of', 'first', 'randomisation', 'complete', 'remission', 'rate', ',', 'analysed', 'modified', 'intention', 'to', 'treat', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'feb', ',', ',', 'and', 'aug', ',', ',', 'eligible', 'patient', 'recruited', '.', 'of', 'enrolled', 'patient', 'assessable', '.', 'median', 'follow-up', 'of', 'month', '(', 'iqr', '-', ')', ',', 'patient', 'treated', 'with', 'rituximab', 'and', 'thiotepa', 'complete', 'remission', 'rate', 'of', '(', 'ci', '-', ')', ',', 'compared', 'with', '(', '-', ')', 'of', 'treated', 'with', 'methotrexate-cytarabine', 'alone', '(', 'hazard', 'ratio', ',', 'ci', '-', ')', 'and', '(', '-', ')', 'of', 'treated', 'with', 'methotrexate-cytarabine', 'plus', 'rituximab', '(', ',', '-', ')', '.', 'grade', 'haematological', 'toxicity', 'frequent', 'in', 'patient', 'treated', 'with', 'methotrexate-cytarabine', 'plus', 'rituximab', 'and', 'thiotepa', ',', 'infective', 'complication', 'similar', 'in', 'three', 'group', '.', 'common', 'grade', '-', 'adverse', 'event', 'in', 'three', 'group', 'neutropenia', ',', 'thrombocytopenia', ',', 'anaemia', ',', 'and', 'febrile', 'neutropenia', 'or', 'infection', '.', '(', ')', 'patient', 'died', 'of', 'toxicity', '.', 'interpretation', 'with', 'limitation', 'of', 'randomised', 'phase', 'study', 'design', ',', 'ielsg', 'trial', 'provides', 'high', 'level', 'of', 'evidence', 'supporting', 'use', 'of', 'matrix', 'combination', 'new', 'standard', 'chemoimmunotherapy', 'patient', 'aged', 'to', 'year', 'with', 'newly', 'diagnosed', 'primary', 'cns', 'lymphoma', 'and', 'control', 'group', 'future', 'randomised', 'trial', '.', 'funding', 'associazione', 'italiana', 'del', 'farmaco', ',', 'cancer', 'research', 'uk', ',', 'oncosuisse', ',', 'and', 'swiss', 'national', 'foundation', '.']"
"Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206.","Jon Bruss, Troy Lister, Vipul K Gupta, Emily Stone, Lisa Morelli, Yang Lei, David Melnick, Jon Brusset al.",2021 Sep 17,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/34339267/,"antimicrobial safety, pharmacokinetics, polymyxins.","['carbapenem-resistant', 'acinetobacter', 'baumannii', 'and', 'enterobacterales', 'identified', 'urgent', 'threat', ',', 'and', 'multidrug-resistant', '(', 'mdr', ')', 'pseudomonas', 'aeruginosa', 'and', 'extended-spectrum', 'beta-lactamase', '(', 'esbl', ')', '-producing', 'pathogen', 'identified', 'serious', 'threat', 'center', 'disease', 'control', 'and', 'prevention', '(', 'cdc', ')', '.', 'spr', 'novel', 'polymyxin', 'derivative', 'with', 'potent', 'in', 'vitro', 'and', 'in', 'vivo', 'activity', 'a.', 'baumannii', ',', 'p.', 'aeruginosa', ',', 'and', 'multiple', 'clinically', 'important', 'specie', 'of', 'enterobacterales', ',', 'including', 'multidrug-', 'and', 'extensively', 'drug-resistant', 'strain', '.', 'first-in-human', '(', 'fih', ')', 'double-blind', ',', 'placebo-controlled', ',', 'single-', ',', 'and', 'multiple-ascending-dose', 'study', 'of', 'safety', ',', 'tolerability', ',', 'and', 'pharmacokinetics', '(', 'pk', ')', 'of', 'spr', 'in', 'healthy', 'subject', '.', 'following', 'intravenous', '(', 'i.v', '.', ')', 'administration', '(', '-h', 'infusion', ')', 'single', 'dos', 'of', 'mg', 'to', 'mg', 'and', 'multiple', 'dos', 'of', 'mg', 'to', 'mg', 'every', 'h', '(', 'qh', ')', 'day', 'and', 'mg', 'qh', 'day', ',', 'spr', 'generally', 'safe', 'and', 'generally', 'well', 'tolerated', '.', 'incidence', 'of', 'adverse', 'event', 'increased', 'with', 'dose', ',', 'of', 'mild', 'severity', '.', 'systemic', 'exposure', '(', 'maximum', 'concentration', 'of', 'drug', 'in', 'serum', 'cmax', 'and', 'area', 'concentration-time', 'curve', 'auc', ')', 'to', 'spr', 'approximately', 'dose', 'proportional', ',', 'time', 'to', 'peak', 'concentration', 'ranged', '.', 'to', '.', 'h', ',', 'and', 'half-life', 'ranged', '.', 'to', '.', 'h.', 'no', 'appreciable', 'accumulation', 'occurred', 'with', 'repeated', 'dosing', 'of', 'spr', ',', 'and', 'trough', 'concentration', 'suggest', 'steady', 'state', 'achieved', 'day', '.', 'urinary', 'excretion', 'of', 'unchanged', 'spr', 'dose', 'dependent', 'across', 'single-', '(', 'sad', ')', 'and', 'multiple-ascending-dose', '(', 'mad', ')', 'cohort', ',', 'and', 'percentage', 'of', 'dose', 'excreted', 'spr', 'to', '.', 'importantly', ',', 'no', 'evidence', 'of', 'nephrotoxicity', 'observed', 'day', 'of', 'mg', 'qh', 'dosing', 'of', 'spr', 'dosing', 'regimen', 'anticipated', 'to', 'exceed', 'requirement', 'clinical', 'efficacy', '.', '(', 'study', 'registered', 'clinicaltrials.gov', 'identifier', 'nct', '.', ')', '.']"
The Effect of IV Amino Acid Supplementation on Mortality in ICU Patients May Be Dependent on Kidney Function: Post Hoc Subgroup Analyses of a Multicenter Randomized Trial.,"Ran Zhu, Matilde J Allingstrup, Anders Perner, Gordon S Doig                              ;, Nephro-Protective Trial Investigators Group, Gordon Doig, Fiona Simpson, Elizabeth Sweetman, Phillipa Heighes, Rinaldo Bellomo, Carol Pollock, Douglas Chesher, Michael Reade, Andrew Davies, Peter Harrigan, John Botha, Jennifer L Hannam, Christopher Doig, Shay McGuiness, Rachael Parke, Eileen Gilder, Lianne McCarthy, Jodi Brown, Anna Whitley, Glenn Eastwood, Leah Peck, Helen Young, Kalpesh Gandhi, Treena Sara, Kiran Nand, Sachin Gupta, Sharon Allsop, David Lewis, Neil Orford, Claire Cattigan, Allison Bone, Tania Elderkin, Tania Salerno, Melissa Fraser, Rob Cameron, Sheridan Hatter, Miranda Hardie, Emma Pollock, Paul Carless, Katrina Ellem, Alan Rashid, Irene Bailey, Tony Williams, Judy Tai, Anna Tilsley, Rima Song, Laura Rust, Chantal Hogan, Marilyn Beggs, Ian Seppelt, Leonie Weisbrodt, Maria Nikas, Rebecca Gresham, Phoebe Palejs, Anne Ritchie, Sarah Whereat, Graeme Duke, Tanya Gilliver, Amy Sutherland, Emily Dynon, Liz Hickson, Gwen Hickey, Kirilee Matters, Deirdre Mathai, Theresa Jacques, Deborah Inskip, Rebecca Sidoli, John Santamaria, Jenny Holmes, Roger Smith, Espedito Farone, Priya Nair, Claire Reynolds, Serena Knowles, Karen Storer, Michael Davis, Martin Sterba, Johnson Johnson, Wenli Geng, Ran Zhuet al.",2018 Aug,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/29771700/,No keywords found,"['investigated', 'whether', 'preexisting', 'kidney', 'function', 'determines', 'icu', 'patient', 'may', 'benefit', 'increased', '(', '.', 'gkgd', ')', 'protein', 'intake', '.', 'design', 'post', 'hoc', ',', 'hypothesis-generating', ',', 'subgroup', 'analysis', 'of', 'multicenter', ',', 'phase', ',', 'randomized', 'clinical', 'trial', '.', 'analysis', 'conducted', 'intention', 'to', 'treat', 'and', 'maintained', 'group', 'allocation', '.', 'ninety-day', 'mortality', 'primary', 'outcome', '.', 'setting', 'icu', 'of', 'hospital', 'throughout', 'australia', 'and', 'new', 'zealand', '.', 'patient', 'adult', 'critically', 'ill', 'patient', 'expected', 'to', 'remain', 'in', 'study', 'icu', 'longer', 'day', '.', 'intervention', 'random', 'allocation', 'to', 'receive', 'daily', 'supplement', 'of', 'to', 'g', 'of', 'iv', 'amino', 'acid', 'to', 'achieve', 'total', 'protein', 'intake', 'of', '.', 'gkgd', 'or', 'standard', 'nutrition', 'care', '.', 'measurement', 'and', 'main', 'result', 'total', 'of', 'patient', 'randomized', 'to', 'standard', 'care', 'and', 'to', 'iv', 'amino', 'acid', 'supplementation', '.', 'statistically', 'significant', 'interaction', 'baseline', 'kidney', 'function', 'and', 'supplementation', 'with', 'study', 'amino', 'acid', '(', 'p', 'value', 'interaction', '.', ')', '.', 'within', 'subgroup', 'of', 'patient', 'with', 'normal', 'kidney', 'function', 'randomization', ',', 'patient', 'allocated', 'to', 'receive', 'study', 'amino', 'acid', 'supplement', 'less', 'likely', 'to', 'die', 'study', 'day', '(', 'covariate-adjusted', 'risk', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'p', '.', ')', '.', 'furthermore', ',', 'amino', 'acid', 'supplementation', 'significantly', 'increased', 'estimated', 'glomerular', 'filtration', 'rate', 'in', 'patient', '(', 'repeated-measures', 'treatment', 'time', 'interaction', 'p', '.', ')', '.', 'within', 'subgroup', 'of', 'patient', 'with', 'baseline', 'kidney', 'dysfunction', 'andor', 'risk', 'of', 'progression', 'of', 'acute', 'kidney', 'injury', ',', 'significant', 'effect', 'of', 'study', 'intervention', 'mortality', 'not', 'found', '(', 'covariate-adjusted', 'risk', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'in', 'post', 'hoc', ',', 'hypothesis-generating', ',', 'subgroup', 'analysis', ',', 'observed', 'reduced', 'mortality', 'and', 'improved', 'estimated', 'glomerular', 'filtration', 'rate', 'in', 'icu', 'patient', 'with', 'normal', 'kidney', 'function', 'randomly', 'allocated', 'to', 'receive', 'increased', 'protein', 'intake', '(', 'to', '.', 'gkgd', ')', '.', 'strongly', 'recommend', 'confirmation', 'of', 'result', 'in', 'trial', 'with', 'low', 'risk', 'of', 'bias', 'treatment', 'recommended', 'routine', 'care', '.']"
Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose.,"Rinaldo Bellomo, Johan Mårtensson, Serigne Lo, Kirsi-Maija Kaukonen, Alan Cass, Martin Gallagher;, RENAL study investigators;, Australian and New Zealand Intensive Care Clinical Trials Group, Louise Cole, Simon Finfer, Martin Gallagher, Serigne N Lo, Shay McGuinness, Colin McArthur, John Myburgh, Robyn Norton, Carlos Scheinkestel, Steve Su, David Ali, Donna Goldsmith, Joanne Lee, Ashoke Banerjee Deepak Bhonagiri, David Blythe, John Botha, John Cade, Geoff Dobb, John Eddington, Arthas Flabouris, Craig French, Peter Garrett, Seton Henderson, Benno Ihle, Chris Joyce, Michael Kalkoff, Jeff Lipman, David Milliss, Imogen Mitchell, John Morgan, Priya Nair, Neil Orford, Asif Raza, Yahya Shehabi, Antony Tobin, Richard Totaro, Andrew Turner, Christopher Wright, Lorraine Little, Alana Morrison, Giovanna Regaglia, Ravi Shukla, Colin Baigent, Jonathan Emberson, David Wheeler, Duncan Young, Laurent Billot, Severine Bompoint, Stephane Heritier, Avinesh Pillai, Sameer Pandey, Suzanne Ryan, Manuela Schmidt, Gemma Starzec, Bala Vijayan, Rebecca Ashley, Jelena Gissane, Katya Malchukova, Jamie Ranse, Kiran Nand, Treena Sara, David Millis, Jeff Tan, Helen Wong, Peter Harrigan, Elise Crowfoot, Miranda Hardie, Deepak Bhonagiri, Sharon Micallef, Jorge Brieva, Melissa Lintott, Rebecca Gresham, Maria Nikas, Leonie Weisbrodt, Frances Bass, Michelle Campbell, Victoria Stockdale, Susan Ankers, Julie Potter, Dorrilyn Rajbhandari, Vanessa Dhiacou, Alina Jovanovska, Francesca Munster, Jeff Breeding, Claire Burns, Ashoke Banerjee, Maridy Morrison, Caroline Pfeffercorn, Anne Ritchie, Heidi Buhr, Michelle Eccleston, Rachael Parke, Jeanette Bell, Lynette Newby, Cathy West, Lorraine Rudder, Joanne Sutton, Nicole Groves, Shona McDonald, Jennifer Palmer, Meg Harwood, Jean Helyar, Benjamin Mackie, Robert Boots, Claire Bertenshaw, Renae Deans, Cheryl Fourie, Melissa Lassig-Smith, Jason Edwards, Stephanie O'Connor, Justine Rivett, Tanya Field, Kathryn Marsden, Claire Mathlin, Inga Mercer, John Edington, Catherine Boschert, Julie Smith, Michael Graan, Samuel Ho, Nina Fowler, Jodi McInness, Naomi Pratt, Tania Elderkin, Melissa Fraser, Anne Kinmonth, Sue Burton, Carly Culhane, Pauline Galt, Rebecca Rutzou, Megan Roberston, Deborah Barge, Tania Caf, Belinda Howe, Jennifer Holmes, Roger Smith, Andrew Davies, Lynne Murray, Rachael Nevill, Shirley Vallance, Sue Varley, Vickie White, Heike Raunow, Anna Palermo, Melanie Boardman, Jenny Chamberlain, Andree Gould, Geraldine McEntaggart, Samantha Perryman, Linda Thomas, Rinaldo Bellomoet al.",2016,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/26485539/,No keywords found,"['study', 'aim', 'to', 'describe', 'use', 'of', 'dialysis', 'catheter', 'in', 'critically', 'ill', 'patient', 'treated', 'with', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'and', 'to', 'study', 'impact', 'of', 'femoral', 'versus', 'non-femoral', 'access', 'crrt', 'dose', '.', 'method', 'statistical', 'analysis', 'and', 'predictive', 'modelling', 'of', 'data', 'randomized', 'evaluation', 'of', 'normal', 'vs.', 'augmented', 'level', 'renal', 'replacement', 'therapy', 'trial', '.', 'result', 'femoral', 'vein', 'first', 'access', 'site', 'in', '(', ')', 'of', ',', 'patient', '.', 'patient', 'higher', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', 'and', 'sequential', 'organ', 'failure', 'assessment', 'score', '(', 'p', '.', ')', 'and', 'lower', 'ph', '(', 'p', '.', ')', 'similar', 'mortality', 'to', 'patient', 'with', 'non-femoral', 'access', '(', 'vs.', 'p', '.', ')', '.', 'lower', 'body', 'weight', 'independently', 'associated', 'with', 'femoral', 'access', 'placement', '(', 'or', '.', ',', 'ci', '.-.', ')', '.', 'femoral', 'access', 'associated', 'with', '.', 'lower', 'crrt', 'dose', '(', 'p', '.', ')', ',', '.', 'higher', 'dose', 'achieved', 'with', '.', 'fr', 'catheter', '(', 'p', '.', ')', '.', 'conclusion', 'femoral', 'access', 'preferred', 'in', 'lighter', 'and', 'sicker', 'patient', '.', 'catheter', 'gauge', 'greater', 'impact', 'catheter', 'site', 'in', 'crrt', 'dose', 'delivery', '.', 'video', 'journal', 'club', '``', 'cappuccino', 'with', 'claudio', 'ronco', ""''"", 'httpwww.karger.comdoi', '.']"
Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.,"Atsushi Komoto, Takayoshi Maiguma, Daisuke Teshima, Tetsuhiro Sugiyama, Yuto Haruki, Atsushi Komotoet al.",2018 Sep 6,PLoS One,https://pubmed.ncbi.nlm.nih.gov/30188918/,No keywords found,"['conducted', 'retrospective', 'study', 'based', 'composite', 'endpoint', 'treatment', 'failure', 'to', 'evaluate', 'effect', 'of', 'pharmacist-led', 'vcm', 'initial', 'dose', 'planning', 'methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', 'bacteremia', 'patient', '.', 'method', 'retrospective', 'cohort', 'study', 'performed', 'pharmacist', 'intervention', 'and', 'non-intervention', 'group', '.', 'in', 'study', ',', 'four', 'type', 'of', 'failure', 'defined', 'composite', 'endpoint', '.', 'one', 'of', 'following', 'failure', 'occurred', ')', 'death', 'within', 'day', 'start', 'of', 'vcm', 'therapy', ',', ')', 'positive', 'blood', 'culture', 'day', 'start', 'of', 'vcm', 'therapy', ',', ')', 'change', 'of', 'vcm', 'to', 'another', 'anti-mrsa', 'agent', ',', 'and', ')', 'development', 'of', 'nephrotoxicity', ',', 'considered', 'vcm', 'treatment', 'failed', '.', 'survival', 'time', 'analysis', 'conducted', 'with', 'kaplan-meier', 'method', 'and', 'cox', ""'s"", 'proportional', 'hazard', 'model', 'included', 'seven', 'predefined', 'parameter', 'pharmacist', 'intervention', ',', 'age', ',', 'sex', ',', 'weight', ',', 'baseline', 'vcm', 'trough', 'concentration', ',', 'charlson', 'comorbidity', 'index', '(', 'cci', ')', ',', 'and', 'pitt', 'bacteremia', 'score', '(', 'pb', ')', '.', 'effect', 'of', 'pharmacist', 'intervention', 'studied', 'survival', 'probability', 'estimated', 'period', 'of', 'time', 'start', 'of', 'vcm', 'administration', 'to', 'earliest', 'failure', '.', 'result', 'survival', 'rate', 'day', 'starting', 'vcm', 'therapy', ',', 'end', 'of', 'follow-up', ',', '.', 'and', '.', 'in', 'non-intervention', 'and', 'intervention', 'group', ',', 'respectively', '.', 'significant', 'survival', 'time', 'prolongation', 'noted', 'in', 'intervention', 'group', '(', 'p', '.', ',', 'log', 'rank', 'test', ')', '.', 'among', 'seven', 'parameter', ',', 'pharmacist', 'intervention', 'significantly', 'different', 'and', 'hazard', 'ratio', '.', '(', 'p', '.', ')', '.', 'survival', 'probability', 'of', 'intervention', 'group', 'higher', 'of', 'non-intervention', 'group', 'time', 'to', 'failure', '.', 'in', 'subgroup', 'analysis', ',', 'significant', 'difference', 'noted', 'in', 'male', 'patient', 'intervention', 'and', 'non-intervention', 'group', '(', 'p', '.', ')', '.', 'age', 'categorized', 'and', 'year', 'old', '.', 'year', 'old', ',', 'significant', 'difference', 'shown', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'to', 'knowledge', ',', 'first', 'study', 'to', 'evaluate', 'failure', 'of', 'vcm', 'treatment', 'based', 'composite', 'endpoint', '.', 'pharmacist', 'intervention', 'initial', 'vcm', 'dose', 'planning', 'could', 'maintain', 'balance', 'efficacy', 'and', 'safety', 'of', 'vcm', 'treatment', 'and', 'might', 'avoid', 'treatment', 'failure', 'patient', 'with', 'mrsa', 'bacteremia', '.', 'investigation', 'with', 'large', 'sample', 'size', 'required', 'to', 'confirm', 'finding', '.']"
Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial.,"Seon Ha Baek, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Ki Young Na, Seon Ha Baeket al.",2015 May 29:16:239.,Trials,https://pubmed.ncbi.nlm.nih.gov/26021829/,No keywords found,"['cisplatin', 'potent', 'chemotherapeutic', 'agent', ',', 'nephrotoxicity', ',', 'result', 'in', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'often', 'limit', 'clinical', 'application', '.', 'although', 'many', 'study', 'attempted', 'to', 'target', 'mechanism', 'responsible', 'nephrotoxicity', ',', 'no', 'method', 'demonstrated', 'to', 'effective', 'in', 'clinical', 'trial', '.', 'recently', ',', 'dipeptidyl', 'peptidase-', '(', 'dpp', ')', 'inhibitor', 'reported', 'to', 'renoprotective', 'effect', 'in', 'mouse', 'model', 'of', 'cisplatin-induced', 'aki', '.', 'therefore', ',', 'evaluate', 'whether', 'dpp', 'inhibitor', 'protects', 'kidney', 'cisplatin-induced', 'injury', 'in', 'human', '.', 'methodsdesign', 'single-center', ',', 'prospective', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trial', '.', 'total', 'of', 'participant', 'scheduled', 'cisplatin', 'treatment', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'receive', 'either', 'dpp', 'inhibitor', '(', 'gemigliptin', ')', 'or', 'placebo', '.', 'participant', 'take', 'study', 'drug', 'day', 'starting', 'day', 'cisplatin', 'treatment', '.', 'primary', 'outcome', 'of', 'interest', 'incidence', 'of', 'aki', 'day', 'finishing', 'treatment', 'with', 'cisplatin', '.', 'secondary', 'outcome', 'include', 'change', 'in', 'serum', 'creatinine', 'level', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'baseline', 'to', 'day', 'cisplatin', 'treatment', '.', 'discussion', 'first', 'clinical', 'trial', 'to', 'investigate', 'effect', 'of', 'dpp', 'inhibitor', 'cisplatin-induced', 'aki', '.', 'trial', 'registration', 'clinicaltrials.gov', 'number', 'nct', ',', 'december', ',', '.']"
Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease.,"Tobias Breidthardt, Cedric Jaeger, Andreas Christ, Theresia Klima, Tamina Mosimann, Raphael Twerenbold, Jasper Boeddinghaus, Thomas Nestelberger, Patrick Badertscher, Joachim Struck, Andreas Bergmann, Oliver Hartmann, Stefan Kalbermatter, Giancarlo Marenzi, Christian Mueller, Tobias Breidthardtet al.",2018 Oct,Eur J Clin Invest,https://pubmed.ncbi.nlm.nih.gov/30009473/,No keywords found,"['early', 'detection', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'unmet', 'clinical', 'need', '.', 'proenkephalin', '(', 'penk', ')', 'might', 'improve', 'early', 'detection', 'of', 'aki', '.', 'method', 'one', 'hundred', 'and', 'eleven', 'hospitalized', 'ckd', 'patient', 'undergoing', 'radiographic', 'contrast', 'procedure', 'enrolled', '.', 'penk', 'measured', 'in', 'blinded', 'fashion', 'baseline', '(', 'contrast', 'medium', 'administration', ')', 'and', 'day', '(', 'contrast', 'medium', 'administration', ')', '.', 'potential', 'of', 'penk', 'level', 'to', 'predict', 'contrast-induced', 'aki', 'primary', 'endpoint', '.', 'result', 'baseline', 'creatinine', 'and', 'baseline', 'penk', 'similar', 'in', 'aki', 'and', 'no-aki', 'patient', '.', 'in', 'aki', 'patient', ',', 'day', 'penk', '(', 'pmoll', 'v', 'pmoll', ',', 'p', '.', ')', 'significantly', 'higher', 'compared', 'to', 'no-aki', 'patient', '.', 'area', 'curve', '(', 'auc', ')', 'prediction', 'of', 'aki', 'day', 'penk', '.', ',', 'ci', '.-.', ',', 'similar', 'to', 'serum', 'creatinine', '.', ',', 'ci', '.-', '..', 'delta', 'penk', 'significantly', 'higher', 'in', 'aki', 'compared', 'to', 'no-aki', 'patient', '(', 'pmoll', 'v', 'pmoll', ',', 'p', '.', ')', '.', 'auc', 'prediction', 'of', 'aki', 'delta', 'penk', 'high', '(', '.', ',', 'ci', '.-', '.', ')', 'and', 'remained', 'high', 'creatinine-blind', 'aki', '(', '.', ',', 'ci', '.-.', ')', '.', 'conclusion', 'delta', 'penk', 'level', 'improve', 'early', 'detection', 'of', 'contrast-induced', 'aki', 'in', 'ckd', 'patient', 'serial', 'creatinine', 'sampling', '.', 'delta', 'penk', 'accelerates', 'detection', 'of', 'creatinine-blind', 'aki', 'hour', '.']"
Sodium Bicarbonate Versus Sodium Chloride for Preventing Contrast-Associated Acute Kidney Injury in Critically Ill Patients: A Randomized Controlled Trial.,"Xavier Valette, Isabelle Desmeulles, Benoit Savary, Romain Masson, Amélie Seguin, Bertrand Sauneuf, Jennifer Brunet, Pierre Verrier, Véronique Pottier, Marie Orabona, Désiré Samba, Gérald Viquesnel, Mathilde Lermuzeaux, Pascal Hazera, Jean-Jacques Dutheil, Jean-Luc Hanouz, Jean-Jacques Parienti, Damien du Cheyron, Xavier Valetteet al.",2017 Apr,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/28181941/,No keywords found,"['to', 'test', 'whether', 'hydration', 'with', 'bicarbonate', 'rather', 'isotonic', 'sodium', 'chloride', 'reduces', 'risk', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', 'in', 'critically', 'ill', 'patient', '.', 'design', 'prospective', ',', 'double-blind', ',', 'multicenter', ',', 'randomized', 'controlled', 'study', '.', 'setting', 'three', 'french', 'icu', '.', 'patient', 'critically', 'ill', 'patient', 'with', 'stable', 'renal', 'function', '(', 'n', ')', 'received', 'intravascular', 'contrast', 'medium', '.', 'intervention', 'hydration', 'with', '.', 'sodium', 'chloride', 'or', '.', 'sodium', 'bicarbonate', 'administered', 'with', 'infusion', 'protocol', 'mlkg', 'hour', 'and', 'mlkghr', 'hour', 'contrast', 'medium', 'exposure', '.', 'measurement', 'and', 'main', 'result', 'primary', 'endpoint', 'development', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', ',', 'defined', 'acute', 'kidney', 'injury', 'network', 'criterion', ',', 'hour', 'contrast', 'exposure', '.', 'patient', 'randomized', 'to', 'bicarbonate', 'group', '(', 'n', ')', 'showed', 'higher', 'urinary', 'ph', 'end', 'of', 'infusion', 'patient', 'randomized', 'to', 'saline', 'group', '(', 'n', ')', '(', '.', '.', 'v', '.', '.', ',', 'respectively', 'p', '.', ')', 'also', 'similar', 'saline', 'and', 'bicarbonate', 'group', ',', 'respectively', '.', 'conclusion', 'except', 'urinary', 'ph', ',', 'none', 'of', 'outcome', 'differed', 'two', 'group', '.', 'among', 'icu', 'patient', 'with', 'stable', 'renal', 'function', ',', 'benefit', 'of', 'using', 'sodium', 'bicarbonate', 'rather', 'isotonic', 'sodium', 'chloride', 'preventing', 'contrast-associated', 'acute', 'kidney', 'injury', 'marginal', ',', '.']"
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.,"A Vogel, V Sahai, A Hollebecque, G M Vaccaro, D Melisi, R M Al Rajabi, A S Paulson, M J Borad, D Gallinson, A G Murphy, D-Y Oh, E Dotan, D V Catenacci, E Van Cutsem, C F Lihou, H Zhen, M L Veronese, G K Abou-Alfa, A Vogelet al.",2024 Jun,ESMO Open,https://pubmed.ncbi.nlm.nih.gov/38838500/,No keywords found,"['fibroblast', 'growth', 'factor', 'receptor', '(', 'fgfr', ')', 'fusion', 'and', 'rearrangement', 'clinically', 'actionable', 'genomic', 'alteration', 'in', 'cholangiocarcinoma', '(', 'cca', ')', '.', 'pemigatinib', 'selective', ',', 'potent', ',', 'oral', 'inhibitor', 'of', 'fgfr-', 'and', 'demonstrated', 'efficacy', 'in', 'patient', 'with', 'previously', 'treated', ',', 'advancedmetastatic', 'cca', 'with', 'fgfr', 'alteration', 'in', 'fight-', '(', 'nct', ')', '.', 'report', 'final', 'outcome', 'extended', 'follow-up', 'period', '.', 'patient', 'and', 'method', 'multicenter', ',', 'open-label', ',', 'single-arm', ',', 'phase', 'ii', 'fight-', 'study', 'enrolled', 'patient', 'year', 'old', 'with', 'previously', 'treated', 'advancedmetastatic', 'cca', 'with', 'fgfr', 'fusion', 'or', 'rearrangement', '(', 'cohort', ')', ',', 'fgffgfr', 'alteration', '(', 'cohort', 'b', ')', ',', 'or', 'no', 'fgffgfr', 'alteration', '(', 'cohort', 'c', ')', '.', 'patient', 'received', 'once-daily', 'oral', 'pemigatinib', '.', 'mg', 'in', '-day', 'cycle', '(', 'week', ',', 'week', ')', 'disease', 'progression', 'or', 'unacceptable', 'toxicity', '.', 'primary', 'endpoint', 'objective', 'response', 'rate', '(', 'orr', ')', 'in', 'cohort', 'assessed', 'per', 'recist', 'v.', 'independent', 'review', 'committee', 'secondary', 'endpoint', 'included', 'duration', 'of', 'response', '(', 'dor', ')', ',', 'progression-free', 'survival', '(', 'pfs', ')', ',', 'overall', 'survival', '(', 'o', ')', ',', 'and', 'safety', '.', 'result', 'fight-', 'enrolled', 'patient', '(', 'cohort', ',', 'cohort', 'b', ',', 'cohort', 'c', ',', 'unconfirmed', 'fgffgfr', 'alteration', ',', ')', '.', 'final', 'analysis', ',', '(', '.', ')', 'discontinued', 'treatment', 'due', 'to', 'progressive', 'disease', '(', '.', ')', ',', 'withdrawal', 'patient', '(', '.', ')', ',', 'or', 'adverse', 'event', '(', 'aes', '.', ')', '.', 'median', 'follow-up', '.', 'month', '.', 'orr', 'in', 'cohort', '.', '(', 'confidence', 'interval', '.', 'to', '.', ')', 'complete', 'and', 'partial', 'response', 'observed', 'in', 'and', 'patient', ',', 'respectively', '.', 'median', 'dor', '.', '(', '.-', '.', ')', 'month', 'median', 'pfs', 'and', 'o', '.', '(', '.-', '.', ')', 'month', 'and', '.', '(', '.-', '.', ')', 'month', ',', 'respectively', '.', 'common', 'treatment-emergent', 'aes', '(', 'teaes', ')', 'hyperphosphatemia', '(', '.', ')', ',', 'alopecia', '(', '.', ')', ',', 'and', 'diarrhea', '(', '.', ')', '.', 'overall', ',', '(', '.', ')', 'patient', 'experienced', 'teaes', 'leading', 'to', 'pemigatinib', 'discontinuation', 'intestinal', 'obstruction', 'and', 'acute', 'kidney', 'injury', '(', 'n', ')', 'occurred', 'frequently', '.', 'conclusion', 'pemigatinib', 'demonstrated', 'durable', 'response', 'and', 'prolonged', 'o', 'with', 'manageable', 'aes', 'in', 'patient', 'with', 'previously', 'treated', ',', 'advancedmetastatic', 'cca', 'with', 'fgfr', 'alteration', 'in', 'extended', 'follow-up', 'period', 'of', 'fight-', '.']"
"Efficacy of FurosapTM, a novel Trigonella foenum-graecum seed extract, in Enhancing Testosterone Level and Improving Sperm Profile in Male Volunteers.","Anuj Maheshwari, Narsingh Verma, Anand Swaroop, Manashi Bagchi, Harry G Preuss, Kiran Tiwari, Debasis Bagchi, Anuj Maheshwariet al.",2017 Jan 10,Int J Med Sci,https://pubmed.ncbi.nlm.nih.gov/28138310/,"Cardiovascular health, Fenugreeks seed extract (FurosapTM), Mental alertness, Mood, Protodioscin, Safety, Sperm profile, Testosterone.","['dietary', 'fiber', 'rich', 'fenugreek', '(', 'trigonella', 'foenum-graecum', ')', 'seed', 'exhibited', 'cardioprotective', ',', 'hypolipidemic', 'and', 'health', 'benefit', '.', 'furosap', '(', 'f', ')', ',', 'innovative', ',', 'patented', ',', 'protodioscin-enriched', 'extract', 'developed', 'in', 'laboratory', 'fenugreek', 'seed', '.', 'study', 'examined', 'free', 'and', 'total', 'testosterone', 'level', ',', 'sperm', 'profile', 'and', 'morphology', ',', 'sexual', 'health', ',', 'mood', 'and', 'mental', 'alertness', ',', 'and', 'broad', 'spectrum', 'safety', 'parameter', 'of', 'f', 'in', 'male', 'volunteer', 'following', 'supplementation', 'period', 'of', 'week', '.', 'method', 'institutional', 'review', 'board', '(', 'irb', ')', 'and', 'regulatory', 'approval', 'obtained', 'study', '.', 'one-arm', ',', 'open-labelled', ',', 'multi-center', 'study', 'conducted', 'in', 'male', 'volunteer', '(', 'age', 'to', 'year', ')', 'period', 'of', 'week', 'to', 'determine', 'efficacy', 'of', 'f', '(', 'mgdaysubject', ')', 'free', 'and', 'total', 'testosterone', 'level', ',', 'sperm', 'profile', ',', 'sperm', 'morphology', ',', 'libido', 'and', 'sexual', 'health', ',', 'mood', 'and', 'mental', 'alertness', ',', 'and', 'broad', 'spectrum', 'safety', 'parameter', '.', 'result', 'free', 'testosterone', 'level', 'improved', 'to', 'in', 'of', 'study', 'population', '.', '.', 'of', 'study', 'population', 'showed', 'improvement', 'in', 'sperm', 'count', '.', 'sperm', 'morphology', 'improved', 'in', '.', 'of', 'volunteer', '.', 'majority', 'of', 'subject', 'enrolled', 'in', 'study', 'demonstrated', 'improvement', 'in', 'mental', 'alertness', 'and', 'mood', '.', 'furthermore', ',', 'cardiovascular', 'health', 'and', 'libido', 'significantly', 'improved', '.', 'extensive', 'safety', 'parameter', 'evaluated', 'included', 'blood', 'chemistry', 'data', '.', 'no', 'significant', 'change', 'observed', 'in', 'serum', 'lipid', 'function', ',', 'cholesterol', ',', 'triglyceride', ',', 'hdl', 'and', 'ldl', 'level', ',', 'hemogram', '(', 'cbc', ')', ',', 'hepatotoxicity', 'and', 'nephrotoxicity', '.', 'conclusion', 'overall', ',', 'result', 'demonstrate', 'f', ',', 'enriched', 'in', 'protodioscin', ',', 'safe', 'and', 'effective', 'in', 'attenuating', 'testosterone', 'level', ',', 'healthy', 'sperm', 'profile', ',', 'mental', 'alertness', ',', 'cardiovascular', 'health', 'and', 'overall', 'performance', 'in', 'human', 'subject', '.']"
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.,"Spinello Antinori, Maria Vittoria Cossu, Anna Lisa Ridolfo, Roberto Rech, Cecilia Bonazzetti, Gabriele Pagani, Guido Gubertini, Massimo Coen, Carlo Magni, Antonio Castelli, Beatrice Borghi, Riccardo Colombo, Riccardo Giorgi, Elena Angeli, Davide Mileto, Laura Milazzo, Stefania Vimercati, Martina Pellicciotta, Mario Corbellino, Alessandro Torre, Stefano Rusconi, Letizia Oreni, Maria Rita Gismondo, Andrea Giacomelli, Luca Meroni, Giuliano Rizzardini, Massimo Galli, Spinello Antinoriet al.",2020 Aug:158:104899.,Pharmacol Res,https://pubmed.ncbi.nlm.nih.gov/32407959/,"COVID-19, Remdesivir, SARS-CoV-2.","['sars-cov-', 'causing', 'increasing', 'number', 'of', 'death', 'worldwide', 'no', 'effective', 'treatment', 'currently', 'available', '.', 'remdesivir', 'shown', 'in', 'vitro', 'activity', 'coronaviruses', 'and', 'possible', 'antiviral', 'treatment', 'sars-cov-', 'infection', '.', 'prospective', '(', 'compassionate', ')', ',', 'open-label', 'study', 'of', 'remdesivir', ',', 'conducted', 'luigi', 'sacco', 'hospital', ',', 'milan', ',', 'italy', ',', 'february', 'and', 'march', ',', ',', 'involved', 'patient', 'with', 'sars-cov-', 'pneumonia', 'aged', 'year', 'undergoing', 'mechanical', 'ventilation', 'or', 'with', 'oxygen', 'saturation', 'level', 'of', 'in', 'air', 'or', 'national', 'early', 'warning', 'score', 'of', '.', 'primary', 'outcome', 'change', 'in', 'clinical', 'status', 'based', '-category', 'ordinal', 'scale', '(', 'not', 'hospitalised', ',', 'resuming', 'normal', 'daily', 'activity', 'deceased', ')', '.', 'patient', 'enrolled', 'february', 'to', 'march', ',', ',', 'included', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', ',', 'and', 'in', 'infectious', 'disease', 'ward', '(', 'idw', ')', '.', '-day', 'course', 'of', 'remdesivir', 'completed', 'patient', '(', ')', 'and', 'discontinued', ',', 'of', 'eight', '(', '.', ')', 'discontinued', 'of', 'adverse', 'event', '.', 'median', 'follow-up', 'day', '(', 'iqr', '-', ')', '.', 'day', ',', '(', '.', ')', 'patient', 'idw', 'discharged', ',', 'two', 'still', 'hospitalized', 'and', 'one', 'died', '(', '.', ')', ',', 'whereas', 'in', 'icu', '(', '.', ')', 'discharged', ',', '(', '.', ')', 'patient', 'died', ',', 'three', '(', '.', ')', 'still', 'mechanically', 'ventilated', 'and', 'one', '(', '.', ')', 'improved', 'still', 'hospitalized', '.', 'hypertransaminasemia', 'and', 'acute', 'kidney', 'injury', 'frequent', 'severe', 'adverse', 'event', 'observed', '(', '.', 'and', '.', 'of', 'case', ',', 'respectively', ')', '.', 'data', 'suggest', 'remdesivir', 'benefit', 'patient', 'with', 'sars-cov-', 'pneumonia', 'hospitalised', 'outside', 'icu', 'clinical', 'outcome', 'better', 'and', 'adverse', 'event', 'less', 'frequently', 'observed', '.', 'ongoing', 'randomised', 'controlled', 'trial', 'clarify', 'real', 'efficacy', 'and', 'safety', ',', 'to', 'treat', ',', 'and', '.']"
"Effects of Chios Mastiha essential oil on cholesterol levels of healthy volunteers: A prospective, randomized, placebo-controlled study (MASTIHA-OIL).","Athanasios Kartalis, Dimitrios Afendoulis, Matthaios Didagelos, Michail Ampeliotis, Maria Moutafi, Petros Voutas, Nikolaos Smyrnioudis, Nikolaos Papagiannis, Stefanos Garoufalis, Eirini Boula, Ilias Smyrnioudis, Charalambos Vlachopoulos, Athanasios Kartaliset al.",2024 May-Jun:77:63-69.,Hellenic J Cardiol,https://pubmed.ncbi.nlm.nih.gov/37634870/,No keywords found,"['chios', 'mastiha', 'essential', 'oil', '(', 'cmo', ')', 'natural', 'product', 'extracted', 'resin', 'of', 'mastiha', ',', 'possessing', 'antioxidant', ',', 'anti-microbial', ',', 'anti-ulcer', ',', 'anti-neoplastic', ',', 'and', 'cholesterol-lowering', 'capability', 'in', 'vitro', ',', 'and', 'hypolipidemic', 'effect', 'confirmed', 'in', 'animal', 'study', '.', 'yet', ',', 'no', 'randomized', ',', 'placebo-controlled', 'clinical', 'study', 'in', 'literature', 'regarding', 'cmo', ""'s"", 'hypolipidemic', 'effect', 'in', 'human', '.', 'prospective', ',', 'randomized', ',', 'placebo-controlled', 'study', 'designed', 'to', 'study', 'hypolipidemic', 'effect', 'of', 'cmo', 'capsule', 'healthy', 'volunteer', 'with', 'elevated', 'cholesterol', '.', 'method', 'healthy', 'volunteer', 'screened', 'and', 'of', 'with', 'total', 'cholesterol', 'mgdl', 'participated', 'in', 'study', '.', 'randomized', 'with', 'ratio', 'of', 'receiving', 'cmo', 'capsule', '(', 'mg', 'mastiha-oilcapsule', ')', 'and', 'placebo', 'week', 'respectively', '.', 'patient', 'received', 'cmo', 'and', 'randomized', 'in', 'control', 'group', ',', 'and', 'of', 'completed', 'follow-up', 'period', '.', 'result', 'week', 'of', 'cmo', 'administration', ',', 'total', 'and', 'ldl', 'cholesterol', 'significantly', 'lower', 'in', 'cmo', 'compared', 'to', 'placebo', 'group', '.', '.', 'v', '.', '.', 'mgdl', '(', 'p', '.', ')', 'and', '.', '.', 'v', '.', '.', 'mgdl', '(', 'p', '.', ')', 'respectively', '.', 'no', 'gastrointestinal', 'adverse', 'event', 'or', 'liver', 'or', 'renal', 'toxicity', 'reported', '.', 'additionally', ',', 'in', 'cmo', 'group', 'total', 'cholesterol', 'significantly', 'decreased', '.', 'mgdl', '(', ')', ',', 'ldl', '.', 'mgdl', '(', ')', ',', 'triglyceride', '.', 'mgdl', '(', ')', ',', 'and', 'glucose', '.', 'mgdl', '(', ')', 'and', 'hdl', 'increased', '.', 'mgdl', '(', ')', ',', 'compared', 'to', 'baseline', 'value', '.', 'conclusion', 'mastiha-oil', 'study', 'showed', 'efficacy', 'and', 'safety', 'of', 'cmo', 'in', 'reduction', 'of', 'total', 'and', 'ldl', 'cholesterol', 'week', 'of', 'administration', 'in', 'healthy', 'volunteer', 'with', 'elevated', 'cholesterol', 'level', '.']"
Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).,"Ling Zhang, Xiuting Sun, Lizhen Liao, Shaozhao Zhang, Huimin Zhou, Xiangbin Zhong, Xiaodong Zhuang, Xinxue Liao, Ling Zhanget al.",2019 Dec,J Clin Hypertens (Greenwich),https://pubmed.ncbi.nlm.nih.gov/31670874/,"Framingham risk score, Systolic Blood Pressure Intervention Trial (SPRINT), cardiovascular disease, intensive blood pressure treatment.","['.-.', ',', 'p', '.', ')', 'in', 'high-risk', 'arm', '.', 'and', ',', 'all-cause', 'mortality', ',', 'hazard', 'ratio', 'with', 'intensive', 'sbp', 'treatment', '.', '(', 'ci', '.-', '.', ')', ',', '.', '(', 'ci', '.-', '.', ')', ',', 'and', '.', '(', 'ci', '.-', '.', ')', 'in', 'three', 'arm', '(', 'p', 'value', 'interaction', '.', ')', '.', 'effect', 'of', 'intensive', 'versus', 'standard', 'sbp', 'control', 'serious', 'adverse', 'event', 'similar', 'among', 'patient', 'with', 'different', 'fr', '.', 'result', 'suggested', 'regardless', 'of', 'fr', 'level', ',', 'intensive', 'blood', 'pressure', 'control', 'beneficial', '.']"
"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.","Sarah B Goldberg, Scott N Gettinger, Amit Mahajan, Anne C Chiang, Roy S Herbst, Mario Sznol, Apostolos John Tsiouris, Justine Cohen, Alexander Vortmeyer, Lucia Jilaveanu, James Yu, Upendra Hegde, Stephanie Speaker, Matthew Madura, Amanda Ralabate, Angel Rivera, Elin Rowen, Heather Gerrish, Xiaopan Yao, Veronica Chiang, Harriet M Kluger, Sarah B Goldberget al.",2016 Jul,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/27267608/,No keywords found,"['immunotherapy', 'targeting', 'pd-', 'axis', 'activity', 'in', 'several', 'tumour', 'type', '.', 'aimed', 'to', 'establish', 'activity', 'and', 'safety', 'of', 'pd-', 'inhibitor', 'pembrolizumab', 'in', 'patient', 'with', 'untreated', 'brain', 'metastasis', 'melanoma', 'or', 'non-small-cell', 'lung', 'cancer', '(', 'nsclc', ')', '.', 'method', 'in', 'non-randomised', ',', 'open-label', ',', 'phase', 'trial', ',', 'enrolled', 'patient', 'aged', 'year', 'or', 'older', 'with', 'melanoma', 'or', 'nsclc', 'with', 'untreated', 'brain', 'metastasis', 'yale', 'cancer', 'center', '.', 'patient', 'least', 'one', 'untreated', 'or', 'progressive', 'brain', 'metastasis', 'and', 'mm', 'in', 'diameter', 'without', 'associated', 'neurological', 'symptom', 'or', 'need', 'corticosteroid', '.', 'patient', 'with', 'nsclc', 'tumour', 'tissue', 'positive', 'pd-l', 'expression', 'not', 'required', 'patient', 'with', 'melanoma', '.', 'patient', 'given', 'mgkg', 'pembrolizumab', 'every', 'week', 'progression', '.', 'primary', 'endpoint', 'brain', 'metastasis', 'response', 'assessed', 'in', 'treated', 'patient', '.', 'trial', 'ongoing', 'and', 'present', 'early', 'analysis', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'march', ',', ',', 'and', 'may', ',', ',', 'screened', 'patient', 'with', 'untreated', 'or', 'progressive', 'brain', 'metastasis', '(', 'with', 'melanoma', ',', 'with', 'nsclc', ')', ',', 'and', 'enrolled', '(', 'with', 'melanoma', ',', 'with', 'nsclc', ')', '.', 'brain', 'metastasis', 'response', 'achieved', 'in', 'four', '(', 'ci', '-', ')', 'of', 'patient', 'with', 'melanoma', 'and', 'six', '(', '-', ')', 'of', 'patient', 'with', 'nsclc', '.', 'response', 'durable', ',', 'with', 'one', 'patient', 'with', 'nsclc', 'responded', 'showing', 'ongoing', 'response', 'time', 'of', 'data', 'analysis', 'june', ',', '.', 'treatment-related', 'serious', 'and', 'grade', '-', 'adverse', 'event', 'grade', 'elevated', 'aminotransferase', '(', 'n', ')', 'in', 'melanoma', 'cohort', ',', 'and', 'grade', 'colitis', '(', 'n', ')', ',', 'grade', 'pneumonitis', '(', 'n', ')', ',', 'grade', 'fatigue', '(', 'n', ')', ',', 'grade', 'hyperkalemia', '(', 'n', ')', ',', 'and', 'grade', 'acute', 'kidney', 'injury', '(', 'n', ')', 'in', 'nsclc', 'cohort', '.', 'clinically', 'significant', 'neurological', 'adverse', 'event', 'included', 'transient', 'grade', 'cognitive', 'dysfunction', 'and', 'grade', '-', 'seizure', '(', 'n', ')', 'in', 'melanoma', 'cohort', '.', 'interpretation', 'pembrolizumab', 'show', 'activity', 'in', 'brain', 'metastasis', 'in', 'patient', 'with', 'melanoma', 'or', 'nsclc', 'with', 'acceptable', 'safety', 'profile', ',', 'suggests', 'might', 'role', 'systemic', 'immunotherapy', 'in', 'patient', 'with', 'untreated', 'or', 'progressive', 'brain', 'metastasis', '.', 'funding', 'merck', 'and', 'yale', 'cancer', 'center', '.']"
Prevention of Contrast-induced Nephropathy With Oxygen Supplementation: a Randomized Controlled Trial.,"Farzanehsadat Minoo, Mahboob Lessan-Pezeshki, Ata Firouzi, Salman Nikfarjam, Seyed Mansoor Gatmiri, Elham Ramezanzade, Farzanehsadat Minooet al.",2016 Sep,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/27721227/,No keywords found,"['aim', 'of', 'study', 'to', 'investigate', 'efficacy', 'of', 'nasal', 'oxygen', 'supplementation', 'to', 'hydration', 'therapy', 'in', 'reducing', 'risk', 'of', 'developing', 'contrast-induced', 'nephropathy', '(', 'cin', ')', '.', 'material', 'and', 'method', 'in', 'randomized', 'controlled', 'trial', ',', 'patient', 'scheduled', 'to', 'undergo', 'elective', 'coronary', 'angiography', 'randomly', 'allocated', 'to', 'standard', 'hydration', 'plus', 'lmin', 'to', 'lmin', 'nasal', 'oxygen', '(', 'minute', 'procedure', 'end', 'of', 'procedure', ')', '(', 'n', ')', 'or', 'standard', 'hydration', 'alone', '(', 'n', ')', '.', 'primary', 'outcome', 'measure', 'development', 'of', 'cin', 'defined', 'either', 'increase', 'of', 'or', 'in', 'serum', 'creatinine', 'concentration', 'or', 'increment', 'of', 'least', '.', 'mgdl', 'in', 'serum', 'creatinine', 'concentration', 'hour', 'catheterization', '.', 'result', 'of', 'patient', 'completed', 'study', ',', 'developed', 'cin', '(', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'diagnosis', 'of', 'cin', 'made', 'in', '(', '.', ')', 'and', '(', '.', ')', 'patient', 'in', 'nasal', 'oxygen', 'and', 'control', 'arm', ',', 'respectively', '(', 'p', '.', ')', '.', 'in', 'intervention', 'arm', ',', 'creatinine', 'concentration', 'postcontrast', 'remained', 'relatively', 'constant', '(', 'average', 'change', ',', '.', ')', ',', 'whereas', 'significant', 'increase', 'of', '.', 'recorded', 'in', 'control', 'arm', '(', 'p', '.', 'effect', 'size', ',', '.', ')', '.', 'conclusion', 'supplementation', 'with', 'nasal', 'oxygen', 'in', 'addition', 'to', 'standard', 'hydration', 'appears', 'to', 'effective', 'strategy', 'in', 'reducing', 'cin', '.', 'effect', 'size', 'intervention', 'seems', 'to', 'moderate', '.']"
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.,"Antonio Landi, Mattia Branca, Giuseppe Andò, Filippo Russo, Enrico Frigoli, Giuseppe Gargiulo, Carlo Briguori, Pascal Vranckx, Sergio Leonardi, Felice Gragnano, Paolo Calabrò, Gianluca Campo, Giuseppe Ambrosio, Andrea Santucci, Ferdinando Varbella, Tiziana Zaro, Dik Heg, Stephan Windecker, Peter Jüni, Giovanni Pedrazzini, Marco Valgimigli                                                            ;, MATRIX Investigators, Antonio Landiet al.",2021 Dec 18,Eur Heart J Acute Cardiovasc Care,https://pubmed.ncbi.nlm.nih.gov/34491323/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'critical', 'complication', 'among', 'patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'undergoing', 'invasive', 'management', '.', 'value', 'of', 'adjunctive', 'antithrombotic', 'strategy', ',', 'bivalirudin', 'or', 'unfractionated', 'heparin', '(', 'ufh', ')', 'risk', 'of', 'aki', 'unclear', '.', 'method', 'and', 'result', 'among', 'patient', 'enrolled', 'in', 'matrix-antithrombin', 'and', 'treatment', 'duration', 'study', ',', 'subject', 'excluded', 'due', 'to', 'incomplete', 'information', 'serum', 'creatinine', '(', 'scr', ')', 'or', 'end-stage', 'renal', 'disease', 'dialysis', 'treatment', '.', 'primary', 'endpoint', 'aki', 'defined', 'absolute', '(', '.', 'mgdl', ')', 'or', 'relative', '(', ')', 'increase', 'in', 'scr', '.', 'aki', 'occurred', 'in', 'patient', '(', '.', ')', 'treated', 'with', 'bivalirudin', 'and', 'patient', '(', '.', ')', 'treated', 'with', 'ufh', 'odds', 'ratio', '(', 'or', ')', '.', 'confidence', 'interval', '(', 'ci', ')', '.-', '.', 'p', '..', 'scr', 'increase', 'observed', 'in', 'patient', '(', '.', ')', 'with', 'bivalirudin', 'and', 'patient', '(', '.', ')', 'with', 'ufh', '(', 'or', '.', 'ci', '.-', '.', 'p', '.', ')', ',', 'whereas', '.', 'mgdl', 'absolute', 'scr', 'increase', 'occurred', 'in', 'patient', '(', '.', ')', 'with', 'bivalirudin', 'vs.', 'patient', '(', '.', ')', 'with', 'ufh', '(', 'or', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'implementing', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'criterion', ',', 'risk', 'of', 'aki', 'not', 'significantly', 'different', 'bivalirudin', 'and', 'ufh', 'group', '(', 'or', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'subgroup', 'analysis', 'of', 'primary', 'endpoint', 'suggested', 'benefit', 'with', 'bivalirudin', 'in', 'patient', 'randomized', 'to', 'femoral', 'access', '.', 'conclusion', 'among', 'ac', 'patient', 'undergoing', 'invasive', 'management', ',', 'risk', 'of', 'aki', 'not', 'significantly', 'lower', 'with', 'bivalirudin', 'compared', 'with', 'ufh', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Effects of Remote Ischemic Pre-Conditioning to Prevent Contrast-Induced Nephropathy after Intravenous Contrast Medium Injection: A Randomized Controlled Trial.,"Dihia Belabbas, Caroline Koch, Ségolène Chaudru, Mathieu Lederlin, Bruno Laviolle, Estelle Le Pabic, Dominique Boulmier, Jean François Heautot, Guillaume Mahe, Dihia Belabbaset al.",2020 Nov,Korean J Radiol,https://pubmed.ncbi.nlm.nih.gov/32729273/,No keywords found,"['aimed', 'to', 'assess', 'effect', 'of', 'remote', 'ischemic', 'pre-conditioning', '(', 'ripc', ')', 'incidence', 'of', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'intravenous', '(', 'iv', ')', 'or', 'intra-arterial', 'injection', 'of', 'contrast', 'medium', '(', 'cm', ')', 'in', 'patient', 'and', 'control', 'group', '.', 'material', 'and', 'method', 'prospective', ',', 'randomized', ',', 'single-blinded', ',', 'controlled', 'trial', 'included', 'patient', 'hospitalized', 'evaluation', 'of', 'feasibility', 'of', 'transcatheter', 'aortic', 'valve', 'implantation', 'and', 'underwent', 'investigation', 'including', 'contrast-enhanced', 'computed', 'tomography', '(', 'ct', ')', ',', 'with', 'mehran', 'risk', 'score', 'greater', 'or', 'equal', 'to', 'six', '.', 'patient', 'underwent', 'four', 'cycle', 'of', 'five', 'minute-blood', 'pressure', 'cuff', 'inflation', 'followed', 'five', 'minute', 'of', 'total', 'deflation', '.', 'in', 'ripc', 'group', '(', 'n', ')', ',', 'cuff', 'inflated', 'to', 'mm', 'hg', 'patient', ""'s"", 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'in', 'control', 'group', '(', 'n', ')', ',', 'inflated', 'to', 'mm', 'hg', 'patient', ""'s"", 'sbp', '.', 'primary', 'endpoint', 'occurrence', 'of', 'cin', '.', 'additionally', ',', 'variation', 'in', 'serum', 'level', 'of', 'cystatin', 'c', 'assessed', '.', 'result', 'one', 'case', 'of', 'cin', 'observed', 'in', 'control', 'group', ',', 'whereas', 'no', 'case', 'detected', 'in', 'ripc', 'group', '(', 'p', '.', ',', 'analysis', 'of', 'patient', ')', '.', 'mean', 'creatinine', 'value', 'baseline', ',', 'hour', 'injection', 'of', 'cm', ',', 'and', 'hour', 'injection', 'of', 'cm', 'moll', ',', 'moll', 'and', 'moll', ',', 'respectively', '(', 'p', '.', ')', 'in', 'ripc', 'group', ',', 'whereas', 'in', 'control', 'group', ',', 'moll', ',', 'moll', ',', 'and', 'moll', ',', 'respectively', '(', 'p', '.', ')', '.', 'cystatin', 'c', 'value', '(', 'median', 'q', ',', 'q', ')', 'baseline', ',', 'hour', 'injection', 'of', 'cm', ',', 'and', 'hour', 'injection', 'of', 'cm', '.', '.', ',', '.', 'mgl', ',', '.', '.', ',', '.', 'mgl', ',', 'and', '.', '.', ',', '.', 'mgl', ',', 'respectively', '(', 'p', '.', ')', 'in', 'ripc', 'group', ',', 'whereas', '.', '.', ',', '.', 'mgl', ',', '.', '.', ',', '.', 'mgl', ',', 'and', '.', '.', ',', '.', 'mgl', ',', 'respectively', '(', 'p', '.', ')', ',', 'in', 'control', 'group', '.', 'conclusion', 'risk', 'of', 'cin', 'iv', 'injection', 'of', 'cm', 'low', 'in', 'patient', 'with', 'mehran', 'risk', 'score', 'greater', 'or', 'equal', 'to', 'six', 'and', 'even', 'in', 'patient', 'unable', 'to', 'receive', 'preventive', 'hyperhydration', '.', 'hence', ',', 'mehran', 'risk', 'score', 'may', 'not', 'appropriate', 'method', 'estimation', 'of', 'risk', 'of', 'cin', 'iv', 'cm', 'injection', '.']"
Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial.,"Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Sarah Abdelaal Mohamed, Nancy Samir Elbarbaryet al.",2023 Dec,Clin Nutr,https://pubmed.ncbi.nlm.nih.gov/37862823/,No keywords found,"['numerous', 'study', 'evaluated', 'beneficial', 'effect', 'of', 'omega-', 'fatty', 'acid', 'inflammatory', ',', 'autoimmune', 'and', 'renal', 'disease', '.', 'however', ',', 'data', 'effect', 'of', 'omega-', 'fatty', 'acid', 'diabetic', 'kidney', 'disease', 'in', 'type', 'diabetes', 'mellitus', '(', 'tdm', ')', 'lacking', '.', 'objective', 'randomized-controlled', 'trial', 'assessed', 'effect', 'of', 'oral', 'omega-', 'supplementation', 'glycemic', 'control', ',', 'lipid', 'profile', ',', 'albuminuria', 'level', ',', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'and', 'carotid', 'intima', 'medium', 'thickness', '(', 'cimt', ')', 'in', 'pediatric', 'patient', 'with', 'tdm', 'and', 'diabetic', 'nephropathy', '.', 'method', 'seventy', 'tdm', 'patient', 'and', 'diabetic', 'nephropathy', 'enrolled', 'with', 'mean', 'age', '.', '.', 'year', 'and', 'median', 'disease', 'duration', 'year', '.', 'patient', 'randomly', 'assigned', 'two', 'group', 'intervention', 'group', 'received', 'oral', 'omega-', 'fatty', 'acid', 'capsule', '(', 'g', 'daily', ')', '.', 'group', 'received', 'matching', 'placebo', 'and', 'served', 'control', 'group', '.', 'group', 'followed-up', 'month', 'with', 'assessment', 'of', 'fasting', 'blood', 'glucose', '(', 'fbg', ')', ',', 'hbac', ',', 'fasting', 'lipid', ',', 'urinary', 'albumin', 'creatinine', 'ratio', '(', 'uacr', ')', ',', 'kim-', 'and', 'cimt', '.', 'result', 'month', ',', 'omega-', 'fatty', 'acid', 'adjuvant', 'therapy', 'intervention', 'group', 'resulted', 'in', 'significant', 'decrease', 'in', 'fbg', ',', 'hbac', ',', 'triglyceride', ',', 'total', 'cholesterol', ',', 'ldl-cholesterol', ',', 'uacr', ',', 'kim-', 'and', 'cimt', ',', 'whereas', ',', 'hdl-cholesterol', 'significantly', 'higher', 'post-therapy', 'compared', 'with', 'baseline', 'level', 'and', 'compared', 'with', 'control', 'group', '(', 'p', '.', ')', '.', 'baseline', 'kim-', 'level', 'positively', 'correlated', 'to', 'hbac', ',', 'uacr', 'and', 'cimt', '.', 'supplementation', 'with', 'omega-', 'fatty', 'acid', 'safe', 'and', 'well-tolerated', '.', 'conclusion', 'omega-', 'fatty', 'acid', 'adjuvant', 'therapy', 'in', 'pediatric', 'tdm', 'patient', 'with', 'diabetic', 'nephropathy', 'improved', 'glycemic', 'control', ',', 'dyslipidemia', 'and', 'delayed', 'disease', 'progression', 'and', 'subclinical', 'atherosclerosis', 'among', 'patient', '.', 'trial', 'registered', 'clinicaltrials.gov', 'identifier', 'no', '.', 'nct', '.']"
"Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.","Zhongjun Xia#, Yun Leng#, Baijun Fang#, Yang Liang, Wei Li, Chengcheng Fu, Linhua Yang, Xiaoyan Ke, Hua Jiang, Jianyu Weng, Li Liu, Yaozhong Zhao, Xuejun Zhang, Zhongxia Huang, Aichun Liu, Qingzhi Shi, Yuhuan Gao, Xiequn Chen, Ling Pan, Zhen Cai, Zhao Wang, Yafei Wang, Yaqun Fan, Ming Hou, Yigai Ma, Jianda Hu, Jing Liu, Jianfeng Zhou, Xiaohong Zhang, Haitao Meng, Xuzhang Lu, Fei Li, Hanyun Ren, Bintao Huang, Zonghong Shao, Hebing Zhou, Yu Hu, Shifang Yang, Xiangjun Zheng, Peng Wei, Hongyan Pang, Wei Yu, Yuzhang Liu, Sujun Gao, Lingzhi Yan, Yanping Ma, Hongmei Jing, Juan Du, Wei Ling, Jingyi Zhang, Weiwei Sui, Fuxu Wang, Xin Li, Wenming Chen, Zhongjun Xiaet al.",2023 Oct 14,BMC Cancer,https://pubmed.ncbi.nlm.nih.gov/37838670/,No keywords found,"['aponermin', ',', 'circularly', 'permuted', 'tumor', 'necrosis', 'factor-related', 'apoptosis-inducing', 'ligand', ',', 'potential', 'death', 'receptor', '-targeted', 'antitumour', 'candidate', '.', 'previous', 'phase', 'study', 'demonstrated', 'efficacy', 'of', 'aponermin', 'in', 'patient', 'with', 'relapsed', 'or', 'refractory', 'multiple', 'myeloma', '(', 'rrmm', ')', '.', 'to', 'confirm', 'superiority', 'of', 'aponermin', 'plus', 'thalidomide', 'and', 'dexamethasone', '(', 'aponermin', 'group', ')', 'placebo', 'plus', 'thalidomide', 'and', 'dexamethasone', '(', 'placebo', 'group', ')', 'in', 'rrmm', ',', 'randomized', ',', 'double-blinded', ',', 'placebo', 'controlled', 'phase', 'trial', 'performed', '.', 'method', 'four', 'hundred', 'seventeen', 'patient', 'with', 'rrmm', 'previously', 'received', 'least', 'two', 'regimen', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'aponermin', ',', 'thalidomide', ',', 'and', 'dexamethasone', 'or', 'placebo', ',', 'thalidomide', ',', 'and', 'dexamethasone', '.', 'primary', 'endpoint', 'progression-free', 'survival', '(', 'pfs', ')', '.', 'key', 'secondary', 'endpoint', 'included', 'overall', 'survival', '(', 'o', ')', 'and', 'overall', 'response', 'rate', '(', 'orr', ')', '.', 'result', 'total', 'of', 'patient', 'received', 'least', 'one', 'dose', 'of', 'trial', 'treatment', '(', 'vs.', ')', '.', 'median', 'pfs', '.', 'month', 'in', 'aponermin', 'group', 'and', '.', 'month', 'in', 'placebo', 'group', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'median', 'o', '.', 'month', 'aponermin', 'group', 'and', '.', 'month', 'placebo', 'group', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'significantly', 'higher', 'rate', 'of', 'orr', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', 'and', 'good', 'partial', 'response', 'or', 'better', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', 'achieved', 'in', 'aponermin', 'group', 'in', 'placebo', 'group', '.', 'treatment', 'with', 'aponermin', 'caused', 'hepatotoxicity', 'in', 'patient', ',', 'indicated', 'elevated', 'alanine', 'transaminase', ',', 'aspartate', 'transaminase', ',', 'or', 'lactate', 'dehydrogenase', 'level', '(', '.', 'v', '.', '.', ',', '.', 'vs.', '.', 'and', '.', 'v', '.', '.', ',', 'respectively', ')', ',', 'mostly', 'grade', ',', 'transient', 'and', 'reversible', '.', 'main', 'grade', 'adverse', 'event', 'included', 'neutropenia', ',', 'pneumonia', 'and', 'hyperglycemia', '.', 'incidence', 'of', 'serious', 'adverse', 'event', 'similar', 'two', 'group', '(', '.', 'v', '.', '.', ')', '.', 'no', 'evidence', 'aponermin', 'lead', 'to', 'hematological', 'toxicity', ',', 'nephrotoxicity', ',', 'cardiotoxicity', ',', 'or', 'secondary', 'tumor', '.', 'conclusion', 'aponermin', 'plus', 'thalidomide', 'and', 'dexamethasone', 'significantly', 'improved', 'pfs', ',', 'o', 'and', 'orr', 'with', 'manageable', 'side', 'effect', 'in', 'rrmm', 'patient', 'received', 'least', 'two', 'prior', 'therapy', '.', 'result', 'support', 'use', 'of', 'aponermin', ',', 'thalidomide', ',', 'and', 'dexamethasone', 'treatment', 'option', 'rrmm', 'patient', '.', 'trial', 'registration', 'trial', 'registered', 'httpwww.chictr.org.cn', 'chictr-ipr-', ',', '.']"
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.,"Remo H M Furtado, Itamar Raz, Erica L Goodrich, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Philip Aylward, Anthony J Dalby, Mikael Dellborg, Doina Dimulescu, José C Nicolau, Anthonius J M Oude Ophuis, Avivit Cahn, Ofri Mosenzon, Ingrid Gause-Nilsson, Anna Maria Langkilde, Marc S Sabatine, Stephen D Wiviott, Remo H M Furtadoet al.",2022 May 24,Circulation,https://pubmed.ncbi.nlm.nih.gov/35510542/,No keywords found,"['dapagliflozin', 'improved', 'heart', 'failure', 'and', 'kidney', 'outcome', 'in', 'patient', 'with', 'type', 'diabetes', '(', 'tdm', ')', 'with', 'or', 'high', 'risk', 'atherosclerotic', 'cardiovascular', 'disease', 'in', 'declare-timi', 'trial', '(', 'dapagliflozin', 'effect', 'cardiovascular', 'event', '-', 'thrombolysis', 'in', 'myocardial', 'infarction', ')', '.', ',', 'aim', 'to', 'analyze', 'efficacy', 'and', 'safety', 'of', 'dapagliflozin', 'stratified', 'according', 'to', 'baseline', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', '.', 'method', 'declare-timi', 'trial', 'randomly', 'assigned', 'patient', 'with', 'tdm', 'and', 'either', 'previous', 'atherosclerotic', 'cardiovascular', 'disease', 'or', 'atherosclerotic', 'cardiovascular', 'disease', 'risk', 'factor', 'to', 'dapagliflozin', 'or', 'placebo', '.', 'patient', 'categorized', 'baseline', 'sbp', 'level', ',', 'to', ',', 'to', ',', 'to', ',', 'and', 'mm', 'hg', '(', 'normal', ',', 'elevated', ',', 'stage', ',', 'stage', ',', 'and', 'severe', 'hypertension', ',', 'respectively', ')', '.', 'efficacy', 'outcome', 'of', 'interest', 'hospitalization', 'heart', 'failure', 'and', 'renal-specific', 'composite', 'outcome', '(', 'sustained', 'decrease', 'in', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'progression', 'to', 'end-stage', 'renal', 'disease', ',', 'or', 'renal', 'death', ')', '.', 'safety', 'outcome', 'included', 'symptom', 'of', 'volume', 'depletion', ',', 'lower', 'extremity', 'amputation', ',', 'and', 'acute', 'kidney', 'injury', '.', 'result', 'trial', 'comprised', 'patient', 'mean', 'age', ',', '..', 'year', '.', 'woman', 'median', 'duration', 'of', 'tdm', ',', 'year', '.', 'with', 'prevalent', 'cardiovascular', 'disease', '.', 'overall', ',', 'dapagliflozin', 'reduced', 'sbp', '.', 'mm', 'hg', '(', 'ci', ',', '.-', '.', 'p.', ')', 'compared', 'with', 'placebo', 'month', '.', 'beneficial', 'effect', 'of', 'dapagliflozin', 'hospitalization', 'heart', 'failure', 'and', 'renal', 'outcome', 'consistent', 'across', 'baseline', 'sbp', 'category', ',', 'with', 'no', 'evidence', 'of', 'modification', 'of', 'treatment', 'effect', '(', 'pinteractions', '.', 'and', '.', ',', 'respectively', ')', '.', 'among', 'normotensive', 'patient', ',', 'hazard', 'ratio', '.', '(', 'ci', ',', '.-', '.', ')', 'and', '.', '(', 'ci', ',', '.-', '.', ')', ',', 'respectively', ',', 'hospitalization', 'heart', 'failure', 'and', 'renal-specific', 'outcome', '.', 'event', 'of', 'volume', 'depletion', ',', 'amputation', ',', 'and', 'acute', 'kidney', 'injury', 'not', 'differ', 'with', 'dapagliflozin', 'overall', 'or', 'within', 'baseline', 'sbp', 'group', '.', 'conclusion', 'in', 'patient', 'with', 'tdm', 'with', 'or', 'high', 'atherosclerotic', 'cardiovascular', 'disease', 'risk', ',', 'dapagliflozin', 'reduced', 'risk', 'hospitalization', 'heart', 'failure', 'and', 'renal', 'outcome', 'regardless', 'of', 'baseline', 'sbp', ',', 'with', 'no', 'difference', 'in', 'adverse', 'event', 'of', 'interest', 'level', 'of', 'baseline', 'sbp', '.', 'result', 'indicate', 'dapagliflozin', 'provides', 'cardiorenal', 'benefit', 'in', 'patient', 'with', 'tdm', 'high', 'atherosclerotic', 'cardiovascular', 'disease', 'risk', 'independent', 'of', 'baseline', 'blood', 'pressure', '.', 'registration', 'url', 'httpswww', '.', 'clinicaltrials', 'gov', 'unique', 'identifier', 'nct', '.']"
A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients.,"Etienne Macedo, Bethany Karl, Euyhyun Lee, Ravindra L Mehta, Etienne Macedoet al.",2021 Jan 6,Crit Care,https://pubmed.ncbi.nlm.nih.gov/33407747/,No keywords found,"['intradialytic', 'hypotension', '(', 'idh', ')', 'frequent', 'complication', 'of', 'intermittent', 'hemodialysis', '(', 'ihd', ')', ',', 'occurring', 'to', 'of', 'ambulatory', 'session', ',', 'and', 'frequent', 'among', 'hospitalized', 'patient', 'with', 'hypoalbuminemia', '.', 'idh', 'limit', 'adequate', 'fluid', 'removal', 'and', 'increase', 'risk', 'vascular', 'access', 'thrombosis', ',', 'early', 'hemodialysis', '(', 'hd', ')', 'termination', ',', 'and', 'mortality', '.', 'albumin', 'infusion', 'and', 'therapy', 'used', 'treating', 'idh', 'with', 'varying', 'result', '.', 'evaluated', 'efficacy', 'of', 'albumin', 'infusion', 'in', 'preventing', 'idh', 'ihd', 'in', 'hypoalbuminemic', 'inpatient', '.', 'method', 'randomized', ',', 'crossover', 'trial', 'performed', 'in', 'aki', 'or', 'eskd', 'patient', 'with', 'hypoalbuminemia', '(', 'albumin', 'gdl', ')', 'required', 'hd', 'hospitalization', '.', 'patient', 'randomized', 'to', 'receive', 'ml', 'of', 'either', '.sodium', 'chloride', 'or', 'albumin', 'intravenously', 'initiation', 'of', 'dialysis', '.', 'two', 'solution', 'alternated', 'to', 'six', 'session', '.', 'patient', ""'"", 'vital', 'sign', 'and', 'ultrafiltration', 'removal', 'rate', 'recorded', 'every', 'to', 'min', 'dialysis', '.', 'idh', 'assessed', 'different', 'definition', 'reported', 'in', 'literature', '.', 'symptom', 'associated', 'with', 'noted', 'hypotensive', 'event', 'well', 'intervention', 'dialysis', 'recorded', '.', 'result', 'sixty-five', 'patient', 'submitted', 'to', 'session', 'mean', 'age', '(', 'formula', 'see', 'text', ')', ',', 'and', '(', ')', 'male', 'with', 'mean', 'weight', 'of', '(', 'formula', 'see', 'text', ')', 'kg', '.', 'presence', 'of', 'idh', 'lower', 'albumin', 'session', 'based', 'definition', '.', 'hypotension', 'risk', 'significantly', 'decreased', 'based', 'kidney', 'disease', 'outcome', 'quality', 'initiative', 'definition', '(', 'with', 'n', 'vs.', 'with', 'albumin', ',', 'p', '.', ')', '.', 'lowest', 'intradialytic', 'sbp', 'significantly', 'worse', 'in', 'patient', 'received', '.', 'sodium', 'chloride', 'albumin', '(', 'n', 'vs.', 'albumin', 'mmhg', ',', 'p', '.', ')', '.', 'overall', 'ultrafiltration', 'rate', 'significantly', 'higher', 'in', 'albumin', 'therapy', 'n', '-', '.', 'mlkgh', '(', '-', '.', '.', ')', 'vs.', '.', 'mlkgh', '(', '-', '.', 'to', '.', ')', 'with', 'albumin', ',', 'p', '..', 'conclusion', 'in', 'hypoalbuminemic', 'patient', 'need', 'hd', ',', 'albumin', 'administration', 'dialysis', 'result', 'in', 'fewer', 'episode', 'of', 'hypotension', 'and', 'improves', 'fluid', 'removal', '.', 'albumin', 'infusion', 'may', 'of', 'benefit', 'to', 'improve', 'safety', 'of', 'hd', 'and', 'achievement', 'of', 'fluid', 'balance', 'in', 'high-risk', 'patient', '.', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
"Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies.","Rosario Pivonello, Giovanna Muscogiuri, Geoffrey Holder, Michaela Paul, Severine Sarp, Anastasia Lesogor, Pierre Jordaan, Johannes Eisinger, Annamaria Colao, Rosario Pivonelloet al.",2018 Apr,Endocrine,https://pubmed.ncbi.nlm.nih.gov/29116540/,No keywords found,"['octreotide', '(', 'oct', ')', 'successfully', 'used', 'treatment', 'of', 'acromegaly', 'and', 'neuroendocrine', 'tumor', 'year', '.', 'however', ',', 'long-term', 'safety', 'of', 'oct', 'not', 'documented', 'in', 'placebo-controlled', 'setting', '.', 'present', 'analysis', 'pooled', 'safety', 'data', 'two', 'similarly-designed', ',', 'randomized', ',', 'and', 'placebo-controlled', 'study', 'to', 'evaluate', 'long-term', 'safety', 'of', 'long-acting', 'oct', '(', ',', 'mg', ')', 'targeted', 'post-hoc', 'analyzes', 'focused', 'cardiac', ',', 'hepatic', ',', 'and', 'renal', 'safety', '.', 'method', 'two', 'study', '(', 'nct', ',', 'nct', ')', 'conducted', 'in', 'patient', 'with', 'diabetic', 'retinopathy', '(', 'oct', ',', 'oct', ',', 'placebo', ')', '.', 'in', 'analysis', ',', 'patient', 'stratified', 'based', 'baseline', 'glomerular', 'filtration', 'rate', '.', 'hepatic', ',', 'cardiac', ',', 'and', 'renal', 'adverse', 'event', '(', 'aes', ')', 'identified', 'standardized', 'meddra', 'query', '.', 'result', 'median', 'duration', 'of', 'exposure', '.', 'year', '.', 'common', 'aes', 'reported', 'with', 'oct', 'diarrhea', ',', 'cholelithiasis', ',', 'hypoglycemia', ',', 'nasopharyngitis', ',', 'and', 'hypertension', '.', 'incidence', 'of', 'cardiac', 'event', '(', 'qt', 'prolongation', 'and', 'arrhythmia', ')', 'with', 'oct', 'and', 'oct', 'comparable', 'to', 'placebo', '(', 'oct', ',', 'rr', '.', 'ci', ',', '.-', '.', 'oct', ',', 'rr', '.', 'ci', ',', '.-.', ')', '.', 'ecg', 'finding', ',', 'change', 'in', 'qtcf', 'similar', 'in', 'treatment', 'group', ',', 'and', 'outlier', 'not', 'exceed', 'ms.', 'incidence', 'of', 'cardiac', 'ischemia', 'lower', 'with', 'oct', 'placebo', '(', 'oct', '.', ',', 'oct', '.', ',', 'placebo', '.', ')', '.', 'incidence', 'of', 'liver-related', 'aes', 'higher', 'with', 'oct', 'placebo', '(', 'rr', '.', 'ci', ',', '.-', '.', ')', 'incidence', 'comparable', 'with', 'oct', 'and', 'placebo', '(', 'rr', '.', 'ci', ',', '.-.', ')', '.', 'overall', 'incidence', 'of', 'renal', 'aes', 'comparable', 'treatment', 'group', '(', 'oct', '.', 'oct', '.', 'placebo', '.', ')', '.', 'drug-related', 'saes', 'reported', 'frequently', 'with', 'oct', '(', 'oct', '.', 'oct', '.', 'placebo', '.', ')', 'predominantly', 'gallbladder-related', ',', 'gi-related', ',', 'and', 'hypoglycemia', '.', 'conclusion', 'result', 'long-term', 'placebo-controlled', 'study', 'confirm', 'established', 'safety', 'profile', 'of', 'long-acting', 'oct', ',', 'in', 'particular', 'low', 'risk', 'of', 'cardiac', ',', 'hepatic', 'and', 'renal', 'toxicity', 'in', 'high-risk', 'population', '.']"
"Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.","Yong Liu, Ji-Yan Chen, Yong Huo, Jun-Bo Ge, Ying Xian, Chong-Yang Duan, Shi-Qun Chen, Wei Jiang, Ping-Yan Chen, Ning Tan                              ;, RESCIND group, Yong Liuet al.",2016 Feb:172:88-95.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/26856220/,No keywords found,"[')', 'to', 'receive', 'either', 'periprocedural', 'general', 'hydration', '(', 'control', 'group', ')', 'or', 'aggressive', 'hydration', '(', 'treatment', 'group', ')', '.', 'patient', 'in', 'control', 'group', 'receive', 'periprocedural', 'general', 'hydration', 'with', 'ml', 'normal', 'saline', '(', 'within', 'hour', ')', 'normal', 'rate', '(', '.', 'or', 'mlkg', 'h', ')', '.', 'patient', 'in', 'treatment', 'group', 'receive', 'preprocedural', 'loading', 'dose', '(', 'ml', ')', 'of', 'normal', 'saline', 'within', 'minute', 'and', 'intravenous', 'hydration', 'normal', 'rate', 'lvedp', 'available', ',', 'followed', 'postprocedural', 'aggressive', 'hydration', 'guided', 'lvedp', 'hour', 'and', 'continuous', 'intravascular', 'hydration', 'normal', 'rate', 'hour', 'pci', '.', 'primary', 'end', 'point', 'cin', ',', 'defined', 'or', '.-mgdl', 'increase', 'in', 'serum', 'creatinine', 'baseline', 'first', 'to', 'hour', 'procedure', '.', 'attempt', 'study', 'potential', 'to', 'identify', 'optimal', 'hydration', 'regimen', 'stemi', 'patient', 'undergoing', 'pci', '.']"
Effect of hyperglycemia and empagliflozin on markers of cardiorenal injury and inflammation in patients with type 1 diabetes.,"Luxcia Kugathasan, Vikas S Sridhar, Yuliya Lytvyn, Leif Erik Lovblom, Bruce A Perkins, Andrew Advani, David Z I Cherney, Luxcia Kugathasanet al.",2024 Jul:213:111764.,Diabetes Res Clin Pract,https://pubmed.ncbi.nlm.nih.gov/38960044/,No keywords found,"['to', 'investigate', 'effect', 'of', 'hyperglycemia', 'and', 'empagliflozin', 'cardiorenal', 'injury', 'and', 'inflammation', 'in', 'patient', 'with', 'uncomplicated', 'type', 'diabetes', '(', 'td', ')', '.', 'method', 'serum', 'cardiac', '(', 'sst', ',', 'gal-', ',', 'ctnt', ')', ',', 'kidney', 'injury', '(', 'kim-', ',', 'ngal', ')', ',', 'inflammatory', '(', 'stnfr', ',', 'stnfr', ')', ',', 'and', 'hemodynamic', '(', 'nt-probnp', ',', 'epo', ')', 'marker', 'assessed', 'post-hoc', 'in', 'two', 'separate', 'td', 'cohort', '.', 'glycemic', 'clamp', 'trial', '(', 'nct', ')', 'evaluated', 'adult', 'with', 'td', 'and', 'control', 'euglycemic', 'and', 'acute', 'hyperglycemic', 'condition', '.', 'crossover', 'trial', '(', 'nct', ')', 'investigated', 'empagliflozin', 'mg', 'plus', 'ramipril', 'week', 'compared', 'to', 'placebo-ramipril', 'week', 'in', 'adult', 'with', 'td', '.', 'result', 'in', 'glycemic', 'clamp', 'study', ',', 'hyperglycemia', 'acutely', 'increased', 'level', 'of', 'nt-probnp', '(', 'p', '.', ')', 'and', 'stnfr', '(', 'p', '.', ')', '.', 'participant', 'treated', 'with', 'empagliflozin', 'exhibited', 'paradoxical', 'subacute', 'rise', 'in', 'nt-probnp', '(', 'p', '.', ')', 'compared', 'to', 'placebo', ',', 'independent', 'of', 'hematocrit', '.', 'individual', 'with', 'higher', 'baseline', 'level', 'of', 'sst', 'and', 'stnfr', 'greater', 'empagliflozin-associated', 'reduction', 'in', 'systolic', 'blood', 'pressure', 'and', 'greater', 'activation', 'of', 'renin-angiotensin-aldosterone', 'system', '(', 'raas', ')', 'mediator', ',', 'whereas', 'with', 'higher', 'baseline', 'level', 'of', 'kim-', 'and', 'stnfr', 'greater', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'dip', '.', 'conclusion', 'protective', 'mechanism', 'of', 'sglt', 'inhibition', 'blood', 'pressure', ',', 'raas', 'activation', ',', 'and', 'renal', 'hemodynamics', 'apparent', 'in', 'subset', 'of', 'people', 'with', 'uncomplicated', 'td', 'with', 'adverse', 'cardiorenal', 'and', 'inflammatory', 'marker', '.']"
Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial.,"Daniel H Solomon, Ming Shao, Kathy Wolski, Steven Nissen, M Elaine Husni, Nina Paynter, Daniel H Solomonet al.",2019 Aug,Arthritis Rheumatol,https://pubmed.ncbi.nlm.nih.gov/30801994/,No keywords found,"['nonsteroidal', 'antiinflammatory', 'drug', '(', 'nsaid', ')', 'commonly', 'used', 'in', 'rheumatology', ',', 'cause', 'major', 'toxicity', '.', 'improving', 'riskbenefit', 'ratio', 'requires', 'precise', 'understanding', 'of', 'risk', '.', 'study', 'undertaken', 'to', 'derive', 'and', 'validate', 'risk', 'score', 'major', 'toxicity', 'among', 'nsaid', 'user', 'enrolled', 'in', 'randomized', 'controlled', 'trial', '.', 'method', 'patient', 'enrolled', 'in', 'randomized', 'controlled', 'trial', 'known', 'cardiovascular', 'disease', 'or', 'risk', 'factor', 'well', 'osteoarthritis', 'or', 'rheumatoid', 'arthritis', 'divided', 'derivation', 'and', 'validation', 'cohort', '.', 'patient', 'randomized', 'to', 'receive', 'celecoxib', ',', 'naproxen', ',', 'or', 'ibuprofen', 'typical', 'dosage', '.', 'risk', 'score', 'designed', 'to', 'predict', '-year', 'occurrence', 'of', 'major', 'toxicity', 'among', 'nsaid', 'user', ',', 'including', 'major', 'adverse', 'cardiovascular', 'event', ',', 'acute', 'kidney', 'injury', ',', 'significant', 'gastrointestinal', 'event', ',', 'and', 'mortality', '.', 'variable', 'significantly', 'associated', 'with', 'major', 'toxicity', 'candidate', 'inclusion', 'in', 'final', 'regression', 'model', '.', 'derived', 'model', 'found', 'to', 'similar', 'model', 'fit', 'in', 'validation', 'set', ',', 'cohort', 'combined', ',', 'allowing', 'calculation', 'of', 'risk', 'score', '.', 'result', 'in', 'derivation', 'cohort', ',', 'significant', 'variable', 'included', 'age', ',', 'male', 'sex', ',', 'history', 'of', 'cardiovascular', 'disease', ',', 'hypertension', ',', 'diabetes', 'mellitus', ',', 'tobacco', 'use', ',', 'statin', 'use', ',', 'elevated', 'serum', 'creatinine', 'level', ',', 'hematocrit', 'level', ',', 'and', 'type', 'of', 'arthritis', '.', 'c-index', '.', 'in', 'validation', 'cohort', 'and', '.', 'in', 'total', 'cohort', 'model', 'well', 'calibrated', '.', 'of', 'total', 'population', 'with', 'complete', 'data', '(', 'n', ',', ')', ',', ',', 'participant', '(', '.', ')', 'predicted', '-year', 'risk', 'of', 'major', 'toxicity', 'of', '.', 'conclusion', 'risk', 'score', 'accurately', 'categorizes', '-year', 'risk', 'of', 'major', 'toxicity', 'among', 'nsaid', 'user', 'and', 'may', 'useful', 'in', 'identifying', 'patient', 'safely', 'use', 'agent', '.']"
Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial.,"Thananda Trakarnvanich, Bancha Satirapoj, Swangjit Suraamornkul, Thanit Chirananthavat, Anoma Sanpatchayapong, Torpong Claimon, Thananda Trakarnvanichet al.",2021 Oct 16:2021:7382620.,J Diabetes Res,https://pubmed.ncbi.nlm.nih.gov/34697593/,No keywords found,"['dipeptidyl', 'peptidase-', '(', 'dpp-', ')', 'inhibitor', 'improve', 'glycemic', 'control', 'and', 'pleiotropic', 'effect', 'kidney', 'injury', ',', 'albuminuria', ',', 'and', 'vascular', 'inflammation', ',', 'especially', 'in', 'animal', 'model', '.', 'evaluated', 'effect', 'of', 'potent', 'dpp', 'inhibitor', '(', 'gemigliptin', ')', 'process', 'among', 'patient', 'with', 'diabetic', 'kidney', 'disease', '(', 'dkd', ')', '.', 'method', 'study', 'employed', 'multicenter', ',', 'prospective', ',', 'randomized', ',', 'placebo-controlled', 'design', '.', 'total', 'of', 'participant', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'one', 'of', 'two', 'group', ',', 'one', 'received', 'treatment', 'with', 'mg', 'gemigliptin', 'daily', 'along', 'with', 'standard', 'care', 'diabetes', 'mellitus', 'month', '.', 'change', 'in', 'coronary', 'calcium', 'score', '(', 'cac', 'score', ')', ',', 'cardio-ankle', 'vascular', 'index', '(', 'cavi', ')', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', ',', 'vascular', 'calcification', 'level', ',', 'and', 'tubular', 'renal', 'injury', 'marker', 'expression', 'evaluated', 'baseline', 'and', 'month', '.', 'result', 'in', 'total', ',', 'patient', 'completed', 'study', '.', 'significant', 'reduction', 'in', 'hemoglobin', 'ac', 'level', 'observed', 'in', 'group', '.', 'change', 'in', 'cac', 'score', ',', 'cavi', ',', 'egfr', ',', 'and', 'level', 'of', 'proteinuria', 'month', 'of', 'study', 'not', 'significantly', 'differ', 'gemigliptin', 'and', 'control', 'group', '.', 'however', ',', 'biomarkers', 'of', 'vascular', 'calcification', ',', 'including', 'serum', 'bone', 'alkaline', 'phosphatase', 'and', 'kidney', 'injury', ',', 'including', 'urine', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'cr', 'and', 'urine', 'liver', 'fatty', 'acid-binding', 'protein', '(', 'l-fabp', ')', 'cr', ',', 'improved', 'significantly', 'in', 'gemigliptin', 'treatment', 'group', 'compared', 'with', 'control', 'group', '.', 'no', 'serious', 'adverse', 'event', 'observed', 'study', '.', 'conclusion', 'study', 'showed', 'gemigliptin', 'significantly', 'improved', 'expression', 'of', 'renal', 'tubular', 'injury', 'biomarkers', 'and', 'vascular', 'calcification', 'level', 'among', 'patient', 'with', 'dkd', 'however', ',', 'gemigliptin', 'not', 'affect', 'renal', 'function', 'or', 'coronary', 'calcification', 'compared', 'with', 'observed', 'in', 'control', '.', 'larger', 'study', 'with', 'longer', 'follow-up', 'essential', 'to', 'verify', 'beneficial', 'effect', '.', 'clinical', 'trial', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial.,"Bancha Satirapoj, Wisit Kaewput, Ouppatham Supasyndh, Prajej Ruangkanchanasetr, Bancha Satirapojet al.",2015:2015:172038.,J Diabetes Res,https://pubmed.ncbi.nlm.nih.gov/25918727/,No keywords found,"['glycosaminoglycans', 'or', 'sulodexide', 'shown', 'benefit', 'in', 'early', 'experimental', 'diabetic', 'nephropathy', '(', 'dn', ')', 'model', ',', 'efficacy', 'in', 'patient', 'with', 'early', 'stage', 'of', 'dn', 'unknown', '.', 'method', '.', 'twenty', 'patient', 'randomly', 'assigned', 'to', 'placebo', 'group', 'and', 'another', 'patient', 'randomly', 'assigned', 'to', 'receive', 'sulodexide', 'mgday', 'week', '.', 'primary', 'outcome', 'change', 'of', 'urinary', 'tgf-beta', ',', 'albuminuria', ',', 'and', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', '.', 'patient', 'stable', 'metabolic', 'profile', 'least', 'day', 'randomization', '.', 'result', '.', 'urinary', 'tgf-beta', 'increased', 'significantly', 'in', 'placebo', 'group', 'not', 'change', 'significantly', 'in', 'sulodexide', 'group', '.', 'additionally', ',', 'mean', 'change', 'of', 'urine', 'tgf-beta', 'in', 'placebo', 'group', 'significantly', 'higher', 'in', 'sulodexide', 'group', '(', '.', '.', 'versus', '.', '.', 'pgmg', 'cr', ',', 'p', '.', ')', '.', 'mean', 'change', 'of', 'urinary', 'albumin', '.', '.', 'gmg', 'cr', '(', 'p', '.', ')', 'in', 'placebo', 'group', 'and', '.', '.', 'gmg', 'cr', '(', 'p', '.', ')', 'in', 'sulodexide', 'group', '.', 'no', 'consistent', 'pattern', 'of', 'side', 'effect', 'observed', '.', 'conclusion', '.', 'in', '-week', 'trial', ',', 'benefit', 'of', 'sulodexide', 'in', 'preventing', 'increase', 'of', 'urinary', 'tgf-beta', 'observed', 'in', 'patient', 'with', 'normoalbuminuric', 'type', 'diabetes', '.', 'study', 'suggests', 'sulodexide', 'treatment', 'may', 'provide', 'additional', 'renoprotection', 'in', 'early', 'stage', 'dn', '.', 'trial', 'registered', 'with', 'tctr', '.']"
The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.,"Hai-Feng Wang, Jie-Qing Lv, Hai-Feng Wanget al.",2015 Jul,Cell Biochem Biophys,https://pubmed.ncbi.nlm.nih.gov/25618173/,"Advanced cardiac carcinoma, DDP, THP, Tegafur gimeracil oteracil.","['aim', 'of', 'study', 'to', 'explore', 'clinical', 'effect', 'of', 'tegafur', 'gimeracil', 'oteracil', 'combined', 'with', 'pirarubicin', 'hydrochloride', '(', 'thp', ')', 'and', 'diamminedichloroplatinum', '(', 'ddp', ')', 'second-line', 'treatment', 'of', 'advanced', 'cardiac', 'carcinoma', ',', 'and', 'find', 'effective', 'method', 'to', 'improve', 'survival', 'rate', 'and', 'decrease', 'adverse', 'reaction', '.', 'patient', 'with', 'advanced', 'cardiac', 'carcinoma', 'admitted', 'february', '-march', 'selected', 'and', 'divided', 'two', 'group', 'with', 'case', 'in', 'group', '.', 'patient', 'treated', 'with', 'thp', 'and', 'ddp', ',', 'and', 'tegafur', 'gimeracil', 'oteracil', 'added', 'to', 'observation', 'group', '.', 'difference', 'of', 'effective', 'rate', ',', 'life', 'quality', ',', 'and', 'adverse', 'reaction', 'treatment', 'in', 'observational', 'group', 'observed', '.', 'result', 'of', 'total', 'curative', 'effect', 'indicated', 'occurrence', 'rate', 'of', 'complete', 'remission', 'partial', 'remission', '(', 'cr', 'pr', ')', 'in', 'control', 'group', '.', ',', 'total', 'effective', 'rate', '.', ',', 'occurrence', 'rate', 'of', 'cr', 'pr', 'in', 'observational', 'group', '.', ',', 'and', 'total', 'effective', 'rate', '.', 'no', 'statistical', 'difference', 'two', 'group', '(', 'p', '.', ')', '.', 'result', 'of', 'kp', 'scoring', 'indicated', 'improvement', 'rate', 'in', 'control', 'group', '.', ',', 'total', 'effective', 'rate', '.', ',', 'improvement', 'rate', 'in', 'observational', 'group', '.', ',', 'and', 'total', 'effective', 'rate', 'statistical', 'difference', 'two', 'group', '(', 'p', '.', ')', 'occurrence', 'rate', 'of', 'adverse', 'reaction', 'including', 'leukocyte', 'decrease', ',', 'thrombocytopenia', ',', 'anemia', ',', 'nausea', 'and', 'vomiting', ',', 'constipation', ',', 'peripheral', 'neurovirulence', ',', 'hepatotoxicity', ',', 'and', 'renal', 'toxicity', 'statistically', 'different', '(', 'p', '.', ')', '.', 'tegafur', 'gimeracil', 'oteracil', 'combined', 'with', 'thp', 'and', 'ddp', 'in', 'treating', 'advanced', 'cardiac', 'carcinoma', 'improve', 'life', 'quality', 'and', 'decrease', 'adverse', 'reaction', '.']"
"FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk.","M Spina, Z Nagy, J M Ribera, M Federico, I Aurer, K Jordan, G Borsaru, A S Pristupa, A Bosi, S Grosicki, N L Glushko, D Ristic, J Jakucs, P Montesinos, J Mayer, E M Rego, S Baldini, S Scartoni, A Capriati, C A Maggi, C Simonelli                              ;, FLORENCE Study Group, M Spinaet al.",2015 Oct,Ann Oncol,https://pubmed.ncbi.nlm.nih.gov/26216382/,No keywords found,"['serum', 'uric', 'acid', '(', 'sua', ')', 'control', 'of', 'key', 'relevance', 'in', 'tumor', 'lysis', 'syndrome', '(', 'tl', ')', 'prevention', 'correlate', 'with', 'tl', 'and', 'renal', 'event', 'risk', '.', 'sought', 'to', 'determine', 'whether', 'febuxostat', 'fixed', 'dose', 'achieves', 'better', 'sua', 'control', 'allopurinol', 'preserving', 'renal', 'function', 'in', 'tl', 'prevention', '.', 'patient', 'and', 'method', 'patient', 'with', 'hematologic', 'malignancy', 'intermediate', 'to', 'high', 'tl', 'risk', 'grade', 'randomized', 'to', 'receive', 'febuxostat', 'or', 'allopurinol', ',', 'starting', 'day', 'induction', 'chemotherapy', ',', '-', 'day', '.', 'study', 'treatment', 'blinded', ',', 'whereas', 'daily', 'dose', '(', 'lowstandardhigh', 'containing', 'allopurinol', 'mg', ',', 'respectively', ',', 'or', 'fixed', 'febuxostat', 'mg', ')', 'depended', 'investigator', ""'s"", 'choice', '.', 'co-primary', 'end', 'point', ',', 'sua', 'area', 'curve', '(', 'auc', 'sua-', ')', 'and', 'serum', 'creatinine', 'change', ',', 'assessed', 'baseline', 'to', 'day', 'and', 'analyzed', 'analysis', 'of', 'covariance', 'with', 'two-sided', 'overall', 'significance', 'level', 'of', '.', 'secondary', 'end', 'point', 'included', 'treatment', 'responder', 'rate', ',', 'laboratory', 'and', 'clinical', 'tl', 'incidence', 'and', 'safety', '.', 'result', 'total', 'of', 'patient', '(', '.', 'intermediate', 'tl', 'risk', '.', 'assigned', 'to', 'standard', 'dose', ')', 'randomized', '.', 'mean', 'auc', 'sua-', '.', '.', 'versus', '.', '.', 'mgxhdl', '(', 'p', '.', ')', 'in', 'favor', 'of', 'febuxostat', '.', 'mean', 'serum', 'creatinine', 'change', '-', '.', '.', 'and', '-', '.', '.', 'febuxostat', 'and', 'allopurinol', ',', 'respectively', '(', 'p', '.', ')', '.', 'no', 'difference', 'among', 'secondary', 'efficacy', 'end', 'point', 'detected', '.', 'drug-related', 'adverse', 'event', 'occurred', 'in', '.', 'of', 'patient', 'in', 'arm', '.', 'conclusion', 'in', 'largest', 'adult', 'trial', 'carried', 'in', 'tl', 'prevention', ',', 'febuxostat', 'achieved', 'significant', 'superior', 'sua', 'control', 'with', 'one', 'fixed', 'dose', 'in', 'comparison', 'to', 'allopurinol', 'with', 'comparable', 'renal', 'function', 'preservation', 'and', 'safety', 'profile', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Aminoglycosides in Immunocompromised Critically Ill Patients With Bacterial Pneumonia and Septic Shock: A Post-Hoc Analysis of a Prospective Multicenter Multinational Cohort.,"René Lopez, Jordi Rello, Fabio Silvio Taccone, Omar Ben Hadj Salem, Philippe R Bauer, Amélie Séguin, Andry van de Louw, Victoria Metaxa, Kada Klouche, Ignacio Martin Loeches, Luca Montini, Sangeeta Mehta, Fabrice Bruneel, T Lisboa, William Viana, Peter Pickkers, Lene Russell, Katerina Rusinova, Achille Kouatchet, François Barbier, Djamel Mokart, Elie Azoulay, Michael Darmon, René Lopezet al.",2020 Dec,Shock,https://pubmed.ncbi.nlm.nih.gov/32496415/,No keywords found,"['routine', 'use', 'of', 'empiric', 'combination', 'therapy', 'with', 'aminoglycosides', 'critical', 'illness', 'associated', 'with', 'uncertain', 'benefit', 'and', 'increased', 'risk', 'of', 'acute', 'kidney', 'injury', '.', 'study', 'aimed', 'to', 'assess', 'benefit', 'of', 'aminoglycosides', 'in', 'immunocompromised', 'patient', 'with', 'suspected', 'bacterial', 'pneumonia', 'and', 'sepsis', '.', 'method', 'secondary', 'analysis', 'of', 'prospective', 'multicenter', 'study', '.', 'adult', 'immunocompromised', 'patient', 'with', 'suspected', 'bacterial', 'pneumonia', 'and', 'sepsis', 'or', 'septic', 'shock', 'included', '.', 'primary', 'outcome', 'hospital', 'mortality', '.', 'secondary', 'outcome', 'needed', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'mortality', 'also', 'assessed', 'in', 'neutropenic', 'patient', 'and', 'in', 'with', 'confirmed', 'bacterial', 'pneumonia', '.', 'result', 'analyzed', 'in', 'cohort', 'matched', 'risk', 'of', 'receiving', 'aminoglycosides', 'combination', '.', 'result', 'five', 'hundred', 'thirty-five', 'patient', 'included', 'in', 'analysis', ',', 'of', '(', ')', 'received', 'aminoglycosides', 'in', 'addition', 'to', 'another', 'antibiotic', 'effective', 'gram-negative', 'bacteria', '.', 'overall', 'hospital', 'mortality', '.', '(', '.', 'vs.', '.', 'in', 'patient', 'receiving', 'and', 'not', 'receiving', 'combination', 'therapy', 'p', '.', ')', '.', 'lack', 'of', 'association', 'mortality', 'and', 'aminoglycosides', 'confirmed', 'adjustment', 'confounders', 'and', 'center', 'effect', '(', 'adjusted', 'or', '.', '.-', '.', ')', 'and', 'in', 'propensity', 'matched', 'cohort', '(', 'adjusted', 'or', '.', '.-.', ')', '.', 'no', 'association', 'found', 'aminoglycosides', 'and', 'need', 'rrt', '(', 'adjusted', 'or', '.', '.-.', ',', 'p', '.', ')', ',', 'aminoglycoside', 'use', 'and', 'outcome', 'in', 'neutropenic', 'patient', 'or', 'in', 'patient', 'with', 'confirmed', 'bacterial', 'pneumonia', '(', 'adjusted', 'or', '.', '.-', '.', 'and', '.', '.-.', ',', 'respectively', ')', '.', 'conclusion', 'aminoglycoside', 'combination', 'therapy', 'not', 'associated', 'with', 'hospital', 'mortality', 'or', 'need', 'renal', 'replacement', 'therapy', 'in', 'immunocompromised', 'patient', 'with', 'pulmonary', 'sepsis', '.']"
Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients.,"Maryam Taghizadeh-Ghehi, Amir Sarayani, Asieh Ashouri, Sara Ataei, Amirhossein Moslehi, Molouk Hadjibabaie, Maryam Taghizadeh-Ghehiet al.",2015 Jul,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/25945602/,"Acute kidney injury, hemtopoietic stem cell transplantation, nephrotoxicity, neutrophil gelatinase associated lipocalin, receiver-operating characteristic curve.","['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'in', 'hematopoietic', 'stem', 'cell', 'transplantation', '(', 'hsct', ')', 'patient', 'with', 'incidence', 'of', '-', '.', 'prevention', 'and', 'early', 'diagnosis', 'reduces', 'frequency', 'and', 'severity', 'of', 'complication', '.', 'predictive', 'biomarkers', 'of', 'major', 'importance', 'to', 'timely', 'diagnosis', '.', 'neutrophil', 'gelatinase', 'associated', 'lipocalin', '(', 'ngal', ')', 'widely', 'investigated', 'novel', 'biomarker', 'early', 'diagnosis', 'of', 'aki', '.', 'however', ',', 'no', 'study', 'assessed', 'ngal', 'aki', 'diagnosis', 'in', 'hsct', 'patient', '.', 'performed', 'analysis', 'gathered', 'data', 'recent', 'trial', 'to', 'evaluate', 'performance', 'of', 'urine', 'ngal', '(', 'ungal', ')', 'indicator', 'of', 'aki', 'in', 'allogeneic', 'hsct', 'patient', '.', 'aki', 'diagnosis', 'and', 'severity', 'assessed', 'using', 'risk-injury-failure-loss-end-stage', 'renal', 'disease', 'and', 'aki', 'network', 'criterion', '.', 'assessed', 'ungal', 'day', '-', ',', '-', ',', ',', 'and', '.', 'time-dependent', 'cox', 'regression', 'analysis', 'revealed', 'statistically', 'significant', 'relationship', 'ungal', 'and', 'aki', 'occurrence', '.', '(', 'hr', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', '.', 'relation', 'ungal', 'day', 'to', 'baseline', 'ratio', 'and', 'incidence', 'of', 'aki', '(', 'unadjusted', 'hr', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', '.', 'area', 'receiver-operating', 'characteristic', 'curve', 'day', 'to', 'baseline', 'ratio', '.', '(', '.-.', ',', 'p', '.', ')', 'and', 'cut-off', 'value', 'of', '.', 'sensitive', 'and', 'specific', 'in', 'predicting', 'aki', '.', 'result', 'indicated', 'increase', 'in', 'ungal', 'augmented', 'risk', 'of', 'aki', 'and', 'change', 'of', 'day', 'ungal', 'concentration', 'baseline', 'could', 'of', 'value', 'predicting', 'aki', 'in', 'hsct', 'patient', '.', 'additionally', 'ungal', 'change', 'preceded', 'serum', 'cr', 'raise', 'nearly', 'day', '.']"
Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.,"Melanie Meersch, Christoph Schmidt, Andreas Hoffmeier, Hugo Van Aken, Carola Wempe, Joachim Gerss, Alexander Zarbock, Melanie Meerschet al.",2017 Nov,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/28110412/,No keywords found,"['care', 'bundle', 'recommended', 'in', 'patient', 'high', 'risk', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'although', 'not', 'proven', 'to', 'improve', 'outcome', '.', 'sought', 'to', 'establish', 'efficacy', 'of', 'implementation', 'of', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'guideline', 'to', 'prevent', 'cardiac', 'surgery-associated', 'aki', 'in', 'high', 'risk', 'patient', 'defined', 'renal', 'biomarkers', '.', 'method', 'in', 'single-center', 'trial', ',', 'examined', 'effect', 'of', '``', 'kdigo', 'bundle', ""''"", 'consisting', 'of', 'optimization', 'of', 'volume', 'status', 'and', 'hemodynamics', ',', 'avoidance', 'of', 'nephrotoxic', 'drug', ',', 'and', 'preventing', 'hyperglycemia', 'in', 'high', 'risk', 'patient', 'defined', 'urinary', 'timp-igfbp', '.', 'undergoing', 'cardiac', 'surgery', '.', 'primary', 'endpoint', 'rate', 'of', 'aki', 'defined', 'kdigo', 'criterion', 'within', 'first', 'h', 'surgery', '.', 'secondary', 'endpoint', 'included', 'aki', 'severity', ',', 'need', 'dialysis', ',', 'length', 'of', 'stay', ',', 'and', 'major', 'adverse', 'kidney', 'event', '(', 'make', ')', 'day', ',', ',', 'and', '.', 'result', 'aki', 'significantly', 'reduced', 'with', 'intervention', 'compared', 'to', 'control', '.', 'vs.', '.', 'arr', '.', '(', 'ci', '.-', '.', ')', 'p', '..', 'implementation', 'of', 'bundle', 'resulted', 'in', 'significantly', 'improved', 'hemodynamic', 'parameter', 'different', 'time', 'point', '(', 'p', '.', ')', ',', 'less', 'hyperglycemia', '(', 'p', '.', ')', 'and', 'use', 'of', 'aceiarbs', '(', 'p', '.', ')', 'compared', 'to', 'control', '.', 'rate', 'of', 'moderate', 'to', 'severe', 'aki', 'also', 'significantly', 'reduced', 'intervention', 'compared', 'to', 'control', '.', 'no', 'significant', 'effect', 'secondary', 'outcome', '.', 'conclusion', 'implementation', 'of', 'kdigo', 'guideline', 'compared', 'with', 'standard', 'care', 'reduced', 'frequency', 'and', 'severity', 'of', 'aki', 'cardiac', 'surgery', 'in', 'high', 'risk', 'patient', '.', 'adequately', 'powered', 'multicenter', 'trial', 'warranted', 'to', 'examine', 'mortality', 'and', 'long-term', 'renal', 'outcome', '.']"
"Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection.","Hong Zhang, Yue Hu, Min Wu, Jingrui Liu, Xiaoxue Zhu, Xiaojiao Li, Hong Chen, Cuiyun Li, Chengjiao Liu, Junqi Niu, Yanhua Ding, Hong Zhanget al.",2021 Jan,Aliment Pharmacol Ther,https://pubmed.ncbi.nlm.nih.gov/33249630/,No keywords found,"['hs-', 'novel', 'prodrug', 'of', 'tenofovir', 'developed', 'to', 'increase', 'anti-viral', 'potency', 'and', 'to', 'reduce', 'systemic', 'toxicity', '.', 'aim', 'to', 'evaluate', 'tolerability', ',', 'pharmacokinetics', 'and', 'anti-viral', 'efficacy', 'of', 'hs-', 'in', 'patient', 'with', 'chronic', 'hepatitis', 'b', '(', 'chb', ')', 'infection', 'method', 'treatment-nave', 'subject', 'with', 'non-cirrhotic', 'chb', 'divided', 'three', 'group', '(', 'n', 'group', ')', 'and', 'randomised', 'within', 'group', 'to', 'receive', ',', 'or', 'mg', 'of', 'hs-', ',', 'or', 'mg', 'of', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', 'day', 'day', '.', 'result', 'among', 'enrolled', 'subject', ',', '.', 'hepatitis', 'b', 'e', 'antigen-negative', 'with', 'mean', 'hepatitis', 'b', 'virus', '(', 'hbv', ')', 'dna', 'level', 'of', '.-', '.', 'log', 'iuml', '.', 'nephrotoxicity', 'and', 'serious', 'adverse', 'event', 'not', 'observed', 'adverse', 'event', 'mild', 'or', 'moderate', 'and', 'non-specific', '.', 'mean', 'reduction', 'in', 'serum', 'hbv', 'dna', 'day', '-.', ',', '-.', ',', '-', '.', 'and', '-', '.', 'log', 'iuml', 'treatment', 'with', ',', 'or', 'mg', 'hs-', ',', 'and', 'mg', 'tdf', ',', 'respectively', '.', 'hs-', 'and', 'metabolite', 'tfv', 'showed', 'linear', ',', 'dose-proportional', 'pharmacokinetics', '.', 'concentration', 'of', 'active', 'tfv-dp', 'in', 'peripheral', 'blood', 'mononuclear', 'cell', 'higher', '(', 'approximately', '-', 'to', '-fold', 'increase', ')', 'and', 'tfv', 'in', 'plasma', 'lower', '(', 'approximately', '.-', 'to', '-fold', 'reduction', ')', 'in', 'subject', 'taking', 'hs-', 'in', 'tdf', 'group', '.', 'conclusion', 'hs-', 'well', 'tolerated', '-week', 'course', '.', 'tdf', 'and', 'hs-', 'comparable', 'potency', 'in', 'inhibiting', 'hbv', 'replication', '.', 'daily', 'dose', 'of', '-', 'mg', 'of', 'hs-', 'recommended', 'chb', 'treatment', '.', '(', 'chinese', 'drug', 'trial', 'identifier', 'ctr', ')', '.']"
Effect of mannitol plus hypertonic saline combination versus hypertonic saline monotherapy on acute kidney injury after traumatic brain injury.,"Sujita W Narayan, Ronald Castelino, Naomi Hammond, Asad E Patanwala, Sujita W Narayanet al.",2020 Jun:57:220-224.,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/32220771/,No keywords found,"['to', 'compare', 'effect', 'of', 'mannitol', 'plus', 'hypertonic', 'saline', 'combination', '(', 'mhs', ')', 'versus', 'hypertonic', 'saline', 'monotherapy', '(', 'h', ')', 'renal', 'function', 'in', 'patient', 'with', 'traumatic', 'brain', 'injury', '(', 'tbi', ')', '.', 'material', 'and', 'method', 'secondary', 'analysis', 'of', 'data', 'resuscitation', 'outcome', 'consortium', 'hypertonic', 'saline', 'trial', 'shock', 'study', 'and', 'traumatic', 'brain', 'injury', 'study', '.', 'study', 'cohort', 'included', 'propensity', 'matched', 'subset', 'of', 'patient', 'with', 'tbi', 'received', 'mhs', 'or', 'h', '.', 'primary', 'outcome', 'measure', 'maximum', 'serum', 'creatinine', 'value', 'critical', 'illness', '.', 'result', 'cohort', 'consisted', 'of', 'patient', 'in', 'mhs', 'group', 'and', 'patient', 'in', 'h', 'group', '(', 'n', ')', '.', 'maximum', 'serum', 'creatinine', 'value', 'hospitalization', 'moll', '(', '.', '.', 'mgdl', ')', 'in', 'mhs', 'group', 'and', 'moll', '(', '.', '.', 'mgdl', ')', 'in', 'h', 'group', '(', 'difference', '-', 'moll', ',', 'ci', '-', 'to', 'moll', ',', 'p', '.', ')', '.', 'lowest', 'egfr', 'hospitalization', 'mlmin', 'in', 'mhs', 'group', 'and', 'mlmin', 'in', 'h', 'group', '(', 'difference', '-', 'mlmin', ',', 'ci', '-', 'to', 'mlmin', ',', 'p', '.', ')', '.', 'conclusion', 'addition', 'of', 'mannitol', 'to', 'h', 'not', 'increase', 'risk', 'of', 'renal', 'dysfunction', 'compared', 'to', 'h', 'alone', 'in', 'patient', 'with', 'tbi', '.']"
Hypertension during Diabetic Ketoacidosis in Children.,"Andrew DePiero, Nathan Kuppermann, Kathleen M Brown, Jeff E Schunk, Julie K McManemy, Arleta Rewers, Michael J Stoner, Leah Tzimenatos, Aris Garro, Sage R Myers, Kimberly S Quayle, Jennifer L Trainor, Maria Y Kwok, Lise E Nigrovic, Cody S Olsen, T Charles Casper, Simona Ghetti, Nicole S Glaser                              ;, Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group, Andrew DePieroet al.",2020 Aug:223:156-163.e5.,J Pediatr,https://pubmed.ncbi.nlm.nih.gov/32387716/,No keywords found,"['to', 'characterize', 'hemodynamic', 'alteration', 'occurring', 'diabetic', 'ketoacidosis', '(', 'dka', ')', 'in', 'large', 'cohort', 'of', 'child', 'and', 'to', 'identify', 'clinical', 'and', 'biochemical', 'factor', 'associated', 'with', 'hypertension', '.', 'study', 'design', 'planned', 'secondary', 'analysis', 'of', 'data', 'pediatric', 'emergency', 'care', 'applied', 'research', 'network', 'fluid', 'therapy', 'investigation', 'in', 'dka', 'study', ',', 'randomized', 'clinical', 'trial', 'of', 'fluid', 'resuscitation', 'protocol', 'child', 'in', 'dka', '.', 'hemodynamic', 'data', '(', 'heart', 'rate', ',', 'blood', 'pressure', ')', 'child', 'with', 'dka', 'assessed', 'in', 'comparison', 'with', 'normal', 'value', 'age', 'and', 'sex', '.', 'multivariable', 'statistical', 'modeling', 'used', 'to', 'explore', 'clinical', 'and', 'laboratory', 'predictor', 'of', 'hypertension', '.', 'result', 'among', 'dka', 'episode', ',', 'hypertension', 'documented', 'presentation', 'in', '(', '.', ')', 'and', 'developed', 'dka', 'treatment', 'in', 'additional', '(', '.', ')', ',', 'resulting', 'in', 'total', 'of', 'dka', 'episode', '(', '.', ')', 'in', 'hypertension', 'occurred', 'time', '.', 'factor', 'associated', 'with', 'hypertension', 'presentation', 'included', 'severe', 'acidosis', ',', '(', 'lower', 'ph', 'and', 'lower', 'pco', ')', ',', 'and', 'stage', 'or', 'acute', 'kidney', 'injury', '.', 'severe', 'acidosis', 'and', 'lower', 'glasgow', 'coma', 'scale', 'score', 'associated', 'with', 'hypertension', 'occurring', 'time', 'dka', 'treatment', '.', 'conclusion', 'despite', 'dehydration', ',', 'hypertension', 'occurs', 'in', 'substantial', 'number', 'of', 'child', 'with', 'dka', '.', 'factor', 'associated', 'with', 'hypertension', 'include', 'greater', 'severity', 'of', 'acidosis', ',', 'lower', 'pco', ',', 'and', 'lower', 'glasgow', 'coma', 'scale', 'score', 'dka', 'treatment', ',', 'suggesting', 'hypertension', 'might', 'centrally', 'mediated', '.']"
Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12).,"Aslam Amod, John B Buse, Darren K McGuire, Thomas R Pieber, Rodica Pop-Busui, Richard E Pratley, Bernard Zinman, Marco Bo Hansen, Ting Jia, Thomas Mark, Neil R Poulter                              ;, DEVOTE Study Group, Aslam Amodet al.",2020 Nov-Dec,Diab Vasc Dis Res,https://pubmed.ncbi.nlm.nih.gov/33280425/,No keywords found,"['to', 'investigate', 'risk', 'factor', 'associated', 'with', 'kidney', 'disorder', 'in', 'patient', 'with', 'type', 'diabetes', '(', 'td', ')', 'high', 'cardiovascular', '(', 'cv', ')', 'risk', '.', 'method', 'in', 'devote', ',', 'cardiovascular', 'outcome', 'trial', ',', 'patient', 'randomised', 'to', 'insulin', 'degludec', '(', 'degludec', ')', 'or', 'insulin', 'glargine', 'unitsml', '(', 'glargine', 'u', ')', ',', 'with', 'standard', 'of', 'care', '.', 'in', 'exploratory', 'post', 'hoc', 'analysis', ',', 'serious', 'adverse', 'event', 'report', 'searched', 'using', 'standardised', 'meddra', 'query', 'related', 'to', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'or', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'baseline', 'predictor', 'of', 'ckd', ',', 'aki', 'and', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'identified', 'using', 'stepwise', 'selection', 'and', 'cox', 'or', 'linear', 'regression', '.', 'result', 'year', ',', 'egfr', '(', 'mlmin', '.', ')', 'decline', 'small', 'and', 'similar', 'treatment', '(', 'degludec', '.', 'glargine', 'u', '.', ')', '.', 'overall', ',', 'and', 'patient', 'experienced', 'ckd', 'and', 'aki', 'event', ',', 'respectively', '.', 'history', 'of', 'heart', 'failure', 'risk', 'factor', 'ckd', '(', 'hazard', 'ratio', 'hr', '.', 'confidence', 'interval', 'ci', '.', '.', ')', 'and', 'aki', '(', 'hr', '.', 'ci', '.', '.', ')', '.', 'history', 'of', 'hepatic', 'impairment', 'significant', 'predictor', 'of', 'ckd', '(', 'hr', '.', 'ci', '.', '.', ')', 'and', 'change', 'in', 'egfr', '(', 'estimate', '-', '.', 'ci', '-', '.', '-.', ')', '.', 'conclusion', 'finding', 'indicate', 'traditional', ',', 'non-modifiable', 'risk', 'factor', 'kidney', 'disorder', 'apply', 'to', 'insulin-treated', 'patient', 'with', 'td', 'high', 'cv', 'risk', '.', 'trial', 'registration', 'nct', '(', 'clinicaltrials.gov', ')', '.']"
"Melatonin for prevention of acute kidney injury in patients treated with intravenous polymyxin B: a double-blind, placebo-controlled randomized clinical trial.","Maria H Rigatto, Pedro Bergo, Giulia Baldissera, Eduarda Beck, Leonardo David, Lucas Santoro, Andressa Barros, Rafael Zanin, João I Budelon Gonçalves, Diego Falci, Wolnei Caumo, Alexandre P Zavascki, Maria H Rigattoet al.",2023 May,Clin Microbiol Infect,https://pubmed.ncbi.nlm.nih.gov/36586514/,No keywords found,"['to', 'evaluate', 'effect', 'of', 'melatonin', 'versus', 'placebo', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'treated', 'with', 'polymyxin', 'b.', 'method', 'performed', 'single-centre', ',', 'double-blind', ',', 'randomized', 'clinical', 'trial', '(', 'nct', ')', 'of', '-mg', 'oral', 'melatonin', 'versus', 'placebo', 'patient', 'treated', 'with', 'intravenous', 'polymyxin', 'b.', 'patient', 'aged', 'year', 'receiving', 'polymyxin', 'b', 'hour', 'eligible', '.', 'melatonin', 'or', 'placebo', 'pill', 'administered', 'end', 'of', 'polymyxin', 'b', 'treatment', 'or', 'maximum', 'of', 'day', '.', 'main', 'outcome', 'level', 'of', 'aki', '.', 'result', 'eighty-eight', 'patient', 'randomized', 'in', 'melatonin', 'group', 'and', 'in', 'placebo', 'group', '.', 'study', 'ended', 'prematurely', 'of', 'polymyxin', 'b', 'shortage', 'covid-', 'pandemic', '.', 'patient', ""'"", 'mean', 'age', '.', '.', 'year', ',', 'and', '.', 'of', 'patient', 'men', '.', 'forty-six', '(', '.', ',', 'in', 'group', ')', 'patient', 'developed', 'aki', 'follow-up', 'period', '.', 'incidence', 'rate', 'of', 'aki', '.', 'and', '.', 'patient', 'per', 'day', 'in', 'melatonin', 'and', 'placebo', 'group', ',', 'respectively', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'renal', 'failure', 'and', '-day', 'mortality', 'similar', 'group', '.', 'moreover', ',', 'incidence', 'of', 'aki', 'not', 'different', 'in', 'pre-specified', 'sub-groups', '.', 'discussion', 'melatonin', 'initiated', 'in', 'first', 'hour', 'of', 'therapy', 'not', 'reduce', 'incidence', 'of', 'aki', 'in', 'patient', 'treated', 'with', 'polymyxin', 'b', '.']"
Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study.,"Hongmei Zhang, Bin Zhu, Liyang Chang, Xingxing Ye, Rongrong Tian, Luchen He, Dongrong Yu, Hongyu Chen, Yongjun Wang, Hongmei Zhanget al.",2022 Mar 5,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/35247964/,No keywords found,"['excessive', 'salt', 'intake', 'associated', 'with', 'deterioration', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'aldosterone', 'also', 'known', 'independent', 'risk', 'factor', 'kidney', 'injury', '.', 'dietary', 'sodium', 'intake', 'act', 'main', 'stimulator', 'in', 'aldosterone-mediated', 'kidney', 'injury', '.', 'hence', ',', 'study', 'aimed', 'to', 'investigate', 'renal', 'protective', 'effect', 'and', 'safety', 'of', 'low-sodium', 'diet', 'in', 'combination', 'with', 'spironolactone', '(', 'spl', ')', 'in', 'stage', '-a', 'ckd', '.', 'method', 'single-center', ',', 'spl-blinded', 'randomized', 'controlled', 'trial', 'recruited', 'patient', 'with', 'stage', '-a', 'ckd', ',', 'randomized', 'three', 'group', ',', 'low-sodium', '(', 'gd', 'salt', ')', 'placebo', ',', 'medium-sodium', '(', 'gd', 'salt', ')', 'spl', ',', 'and', 'low-sodium', '(', 'gd', 'salt', ')', 'spl', '.', 'patient', 'received', 'week', 'of', 'intervention', '.', 'primary', 'and', 'secondary', 'endpoint', '-h', 'urine', 'protein', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'end', 'of', 'intervention', ',', 'respectively', '.', 'result', 'total', 'of', 'patient', 'analyzed', 'eventually', '.', 'significantly', 'decreased', '-h', 'urine', 'protein', 'found', 'in', 'three', 'group', ',', '.', 'to', '.', 'gd', '(', 'p', '.', ')', 'in', 'low-sodiumplacebo', 'group', ',', '.', 'to', '.', 'gd', '(', 'p', '.', ')', 'in', 'medium-sodiumspl', 'group', ',', 'and', '.', 'to', '.', 'gd', '(', 'p', '.', ')', 'in', 'low-sodium', 'spl', 'group', '.', 'no', 'significant', 'difference', 'among', 'three', 'group', 'in', '-h', 'urine', 'protein', 'amount', 'change', 'intervention', 'pre-treatment', 'value', '(', 'p', '.', ',', 'itt', 'set', ')', '.', 'result', 'of', '-h', 'urine', 'protein', 'using', 'pp', 'set', 'analysis', 'similar', 'to', 'itt', 'set', '.', 'no', 'significant', 'difference', 'in', 'egfr', ',', 'nutritional', ',', 'metabolic', ',', 'inflammatory', ',', 'and', 'biomarkers', 'observed', 'across', 'three', 'group', '(', 'p', '.', ')', '.', 'no', 'safety', 'signal', 'observed', '.', 'conclusion', 'no', 'additional', 'benefit', 'observed', 'spl', 'prescribed', 'to', 'patient', 'already', 'low-sodium', 'diet', '(', '.', 'gd', ')', '.', 'still', ',', 'small', 'dos', 'of', 'spl', 'may', 'benefit', 'patient', 'with', 'poor', 'sodium', 'restriction', '.', 'combination', 'of', 'short-term', 'low-dose', 'spl', 'and', 'arb', 'safe', 'patient', 'with', 'stage', '-a', 'ckd', ',', 'blood', 'potassium', 'must', 'regularly', 'monitored', '.', 'trial', 'registration', 'name', 'of', 'registry', 'chinese', 'clinical', 'trial', 'registry', '.', 'trial', 'registration', 'number', 'chictr', '.', 'date', 'of', 'registration', 'retrospectively', 'registered', 'october', '.', 'url', 'of', 'trial', 'registry', 'record', 'httpwww.chictr.org.cnsearchproj.aspxtitleofficialnamesubjectidsecondaryidapplierstudyleadericalcommitteesanctionspo', '.']"
"Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.","Madhumita Premkumar, Devaraja Rangegowda, Tanmay Vyas, Jelen S Khumuckham, Saggere M Shasthry, Sherin S Thomas, Ritu Goyal, Guresh Kumar, Shiv K Sarin, Madhumita Premkumaret al.",2020 Jul,J Clin Gastroenterol,https://pubmed.ncbi.nlm.nih.gov/31305281/,No keywords found,"['left', 'ventricular', 'diastolic', 'dysfunction', '(', 'lvdd', ')', 'refers', 'to', 'impaired', 'cardiac', 'diastolic', 'relaxation', 'and', 'may', 'improved', 'targeted', 'heart', 'rate', 'reduction', '(', 'thr', ')', '.', 'author', 'evaluated', 'whether', 'combination', 'of', 'carvedilol', 'and', 'ivabradine', ',', 'channel', 'blocker', 'reduces', 'heart', 'rate', 'without', 'affecting', 'blood', 'pressure', ',', 'could', 'improve', 'lvdd', 'and', 'outcome', 'in', 'cirrhosis', '.', 'patient', 'and', 'method', 'thr', 'defined', 'heart', 'rate', 'reduction', 'to', 'to', 'beat', 'per', 'minute', '.', 'of', 'patient', 'with', 'cirrhosis', ',', '(', ')', 'with', 'lvdd', 'randomized', 'to', 'thr', 'group', '(', 'gr', '.', ')', 'n', 'carvedilolivabradine', ')', 'or', 'standard', 'care', '(', 'gr.b', 'n', 'no', '-blockers', ')', 'and', 'followed', 'month', '.', 'result', 'in', 'gr.a', ',', 'thr', 'achieved', 'week', 'in', '(', ')', 'patient', '(', 'responder', ',', 'r', ')', '(', '.', ')', 'with', 'carvedilol', 'alone', 'and', '(', '.', ')', 'of', 'patient', 'with', 'additional', 'ivabradine', '.', 'in', 'gr.a', ',', 'lvdd', 'reversed', 'in', '(', '.', ')', 'and', 'improved', 'grade', 'to', 'in', '(', '.', ')', ',', 'whereas', 'in', 'gr.b', ',', 'progressed', 'grade', 'to', 'in', '(', '.', ')', 'patient', '.', 'month', ',', '(', '.', ')', 'patient', 'died', ',', '(', ')', 'in', 'gr.a', 'and', '(', ')', 'in', 'gr.b', '(', 'p.', ')', ',', 'no', 'mortality', 'seen', 'in', 'persistent', 'thr', 'year', '(', 'n', 'p.', ')', '.', 'in', 'multivariate', 'analysis', ',', 'model', 'end-stage', 'liver', 'disease', 'hazard', 'ratio', '(', 'hr', ')', ',', '.', 'confidence', 'interval', '(', 'ci', ')', ',', '.-', '.', 'p.', 'and', 'e-wave', 'transmitralearly', 'diastolic', 'mitral', 'annular', 'velocity', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', 'predicted', '-year', 'mortality', '.', 'nonresponders', 'increased', 'mortality', 'risk', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', 'independent', 'of', 'age', ',', 'gender', ',', 'and', 'baseline', 'model', 'end-stage', 'liver', 'disease', '.', 'level', 'of', 'norepinephrine', ',', 'n', 'terminal', 'brain', 'natriuretic', 'peptide', ',', 'plasma', 'renin', 'activity', ',', 'and', 'aldosterone', 'reduced', '(', 'p.', ')', 'in', 'responder', '.', 'patient', 'in', 'gr.b', 'developed', 'acute', 'kidney', 'injury', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', 'and', 'encephalopathy', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', '.', 'conclusion', 'ivabradine', 'combined', 'with', 'carvedilol', 'improves', 'lvdd', ',', 'achieves', 'thr', 'often', 'and', 'reduces', 'risk', 'of', 'encephalopathy', ',', 'acute', 'kidney', 'injury', 'with', 'improved', 'survival', 'in', 'patient', 'with', 'cirrhosis', '.']"
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.,"Yousef Rezaei, Kamal Khademvatani, Behzad Rahimi, Mehran Khoshfetrat, Nasim Arjmand, Mir-Hossein Seyyed-Mohammadzad, Yousef Rezaeiet al.",2016 Mar 15,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/27068631/,No keywords found,"['contrast', 'medium-induced', 'acute', 'kidney', 'injury', '(', 'ciaki', ')', 'leading', 'cause', 'of', 'acquired', 'renal', 'impairment', '.', 'effect', 'of', 'antioxidant', 'conflicting', 'regarding', 'prevention', 'of', 'ciaki', '.', 'performed', 'study', 'of', 'vitamin', 'e', 'use', 'to', 'decrease', 'ciaki', 'in', 'patient', 'undergoing', 'elective', 'coronary', 'angiography', '.', 'method', 'and', 'result', 'in', 'placebo-controlled', 'randomized', 'trial', 'center', 'in', 'iran', ',', 'patient', 'with', 'chronic', 'kidney', 'disease-defined', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin', 'per', '.', '(', ')', '-were', 'randomized', 'to', 'receive', '.', 'saline', 'infusion', 'hour', 'prior', 'to', 'and', 'intervention', 'combined', 'with', 'mg', 'vitamin', 'e', 'hour', 'plus', 'mg', 'vitamin', 'e', 'hour', 'coronary', 'angiography', 'or', 'to', 'receive', 'placebo', '.', 'primary', 'end', 'point', 'development', 'of', 'ciaki', ',', 'defined', 'increase', '.', 'mgdl', 'or', 'in', 'serum', 'creatinine', 'peaked', 'within', 'hour', '.', 'based', 'intention-to-treat', 'analysis', ',', 'ciaki', 'developed', 'in', '(', '.', ')', 'and', '(', '.', ')', 'patient', 'in', 'vitamin', 'e', 'and', 'placebo', 'group', ',', 'respectively', '(', 'p.', ')', '.', 'change', 'in', 'white', 'blood', 'cell', 'count', 'baseline', 'to', 'peak', 'value', 'greater', 'in', 'vitamin', 'e', 'group', 'compared', 'with', 'placebo', 'group', '(', '-', '-', 'to', 'versus', '-', 'to', '(', ')', 'ml', ',', 'p.', ')', '.', 'in', 'multivariate', 'analysis', ',', 'vitamin', 'e', '(', 'odds', 'ratio', '.', ',', 'ci', '.-.', ',', 'p.', ')', 'and', 'baseline', 'mehran', 'score', '(', 'odds', 'ratio', '.', ',', 'ci', '.-', '.', 'p.', ')', 'predicted', 'ciaki', '.', 'conclusion', 'prophylactic', 'short-term', 'high-dose', 'vitamin', 'e', 'combined', 'with', '.', 'saline', 'infusion', 'superior', 'to', 'placebo', 'prevention', 'of', 'ciaki', 'in', 'patient', 'undergoing', 'elective', 'coronary', 'angiography', '.', 'clinical', 'trial', 'registration', 'url', 'httpswww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.,"Silvia Nicolini#, Lisa Bodei#, Alberto Bongiovanni, Maddalena Sansovini, Ilaria Grassi, Toni Ibrahim, Manuela Monti, Paola Caroli, Anna Sarnelli, Danila Diano, Valentina Di Iorio, Chiara Maria Grana, Corrado Cittanti, Federica Pieri, Stefano Severi, Giovanni Paganelli, Silvia Nicoliniet al.",2021 Sep,Eur J Nucl Med Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/33604690/,No keywords found,"['fdg-positive', 'neuroendocrine', 'tumor', '(', 'net', ')', 'poorer', 'prognosis', 'and', 'exhibit', 'shorter', 'response', 'duration', 'to', 'peptide', 'receptor', 'radionuclide', 'therapy', '(', 'prrt', ')', '.', 'aim', 'of', 'prospective', 'phase', 'ii', 'study', 'to', 'evaluate', 'efficacy', 'and', 'toxicity', 'of', 'prrt', 'with', 'lu-dotatate', 'associated', 'with', 'metronomic', 'capecitabine', 'radiosensitizer', 'agent', 'in', 'patient', 'with', 'advanced', 'progressive', 'fdg-positive', 'gastro-entero-pancreatic', '(', 'gep', ')', 'net', '.', 'patient', 'and', 'method', 'patient', 'with', 'advanced', 'somatostatin', 'receptor-', 'and', 'fdg-positive', 'g-g', 'gep-nets', '(', 'ki', ')', 'net', '.', 'grade', '(', 'g', ')', 'or', '(', 'g', ')', 'hematological', 'toxicity', 'occurred', 'in', '.', 'of', 'patient', '.', 'g-g', 'adverse', 'event', 'diarrhea', 'in', '.', 'of', 'case', 'and', 'asthenia', 'in', '..', 'no', 'renal', 'toxicity', 'observed', 'duration', 'of', 'follow-up', '.', 'in', 'patient', ',', 'evaluable', 'response', '.', 'objective', 'response', 'included', 'partial', 'response', '(', 'pr', ')', 'in', 'patient', '(', ')', 'and', 'stable', 'disease', '(', 'sd', ')', 'in', 'patient', '(', ')', ',', 'with', 'dcr', 'of', '.', 'median', 'follow-up', 'month', '(', 'range', '.-', '.', 'month', ')', '.', 'median', 'pfs', '.', 'month', '(', '.-', '.', ')', ',', 'and', 'mo', 'not', 'reached', '.', 'conclusion', 'study', 'demonstrated', 'combination', 'of', 'prrt', 'with', 'lu-dotatate', 'and', 'metronomic', 'capecitabine', 'active', 'and', 'well', 'tolerated', 'in', 'patient', 'with', 'aggressive', 'fdg-positive', 'g-g', 'gep-nets', '.', 'data', 'constitute', 'basis', 'randomized', 'study', 'of', 'pprt', 'alone', 'vs.', 'prrt', 'plus', 'metronomic', 'capecitabine', '.']"
"Intravenous sildenafil citrate and post-cardiac surgery acute kidney injury: a double-blind, randomised, placebo-controlled trial.","Tracy Kumar, Hardeep Aujla, Marcin Woźniak, Will Dott, Nikol Sullo, Lathishia Joel-David, Paolo Pais, Dawn Smallwood, Douglas Miller, Bryony Eagle-Hemming, Ana Suazo Di Paola, Shaun Barber, Cassandra Brookes, Nigel J Brunskill, Gavin J Murphy, Tracy Kumaret al.",2020 Jun,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/32245569/,No keywords found,"['study', 'assessed', 'whether', 'i.v', '.', 'sildenafil', 'citrate', 'prevented', 'acute', 'kidney', 'injury', 'in', 'at-risk', 'patient', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '.', 'method', 'in', 'double-blind', 'rct', ',', 'adult', 'increased', 'risk', 'of', 'acute', 'kidney', 'injury', 'undergoing', 'cardiac', 'surgery', 'in', 'single', 'uk', 'tertiary', 'centre', 'randomised', 'to', 'receive', 'sildenafil', 'citrate', '.', 'mg', 'kg-', 'i.v', '.', 'min', 'or', 'dextrose', 'commencement', 'of', 'surgery', '.', 'primary', 'outcome', 'serum', 'creatinine', 'measured', 'six', 'post-randomisation', 'time', 'point', '.', 'primary', 'analysis', 'used', 'linear', 'mixed-effects', 'model', 'adjusted', 'stratification', 'variable', ',', 'baseline', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'and', 'surgical', 'procedure', '.', 'secondary', 'outcome', 'considered', 'clinical', 'event', 'and', 'potential', 'disease', 'mechanism', '.', 'effect', 'estimate', 'expressed', 'mean', 'difference', '(', 'md', ')', 'or', 'odds', 'ratio', 'with', 'confidence', 'interval', '.', 'result', 'analysis', 'population', 'comprised', 'eligible', 'randomised', 'patient', 'underwent', 'valve', 'surgery', 'or', 'combined', 'coronary', 'artery', 'bypass', 'graft', 'and', 'valve', 'surgery', ',', 'with', 'cardiopulmonary', 'bypass', ',', 'may', 'and', 'june', '.', 'subject', 'in', 'sildenafil', 'group', 'and', 'in', 'placebo', 'control', 'group', '.', 'difference', 'group', 'in', 'creatinine', 'concentration', 'not', 'statistically', 'significant', '(', 'md', '.', 'mol', 'l-', '-.', ',', '.', ')', '.', 'statistically', 'significant', 'increase', 'in', 'multiple', 'organ', 'dysfunction', 'score', 'in', 'sildenafil', 'group', '(', 'md', '.', '.', ',', '.', 'p.', ')', '.', 'secondary', 'outcome', ',', 'and', 'biomarkers', 'of', 'kidney', 'injury', ',', 'endothelial', 'function', ',', 'and', 'inflammatory', 'cell', 'activation', ',', 'not', 'significantly', 'different', 'group', '.', 'conclusion', 'result', 'not', 'support', 'use', 'of', 'i.v', '.', 'sildenafil', 'citrate', 'kidney', 'protection', 'in', 'adult', 'cardiac', 'surgery', '.', 'clinical', 'trial', 'registration', 'isrctn', '.']"
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study.,"Fredrik Uhlin, Wladimir Szpirt, Andreas Kronbichler, Annette Bruchfeld, Inga Soveri, Lionel Rostaing, Eric Daugas, Arnaud Lionet, Nassim Kamar, Cédric Rafat, Marek Mysliveček, Vladimír Tesař, Anders Fernström, Christian Kjellman, Charlotte Elfving, Stephen McAdoo, Johan Mölne, Ingeborg Bajema, Elisabeth Sonesson, Mårten Segelmark, Fredrik Uhlinet al.",2022 Apr,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/35260419/,No keywords found,"['prognosis', 'kidney', 'survival', 'poor', 'in', 'patient', 'presenting', 'with', 'circulating', 'anti-glomerular', 'basement', 'membrane', '(', 'gbm', ')', 'antibody', 'and', 'severe', 'kidney', 'injury', '.', 'unknown', 'treatment', 'with', 'endopeptidase', 'cleaves', 'circulating', 'and', 'kidney', 'bound', 'igg', 'alter', 'prognosis', '.', 'method', 'investigator-driven', 'phase', 'one-arm', 'study', '(', 'eudract', '--', ')', 'performed', 'in', 'hospital', 'in', 'five', 'european', 'country', '.', 'single', 'dose', 'of', '.', 'mgkg', 'of', 'imlifidase', 'given', 'to', 'adult', 'with', 'circulating', 'anti-gbm', 'antibody', 'and', 'egfr', 'mlmin', 'per', '.m', '.', 'patient', 'received', 'standard', 'treatment', 'with', 'cyclophosphamide', 'and', 'corticosteroid', ',', 'plasma', 'exchange', 'autoantibody', 'rebounded', '.', 'primary', 'outcome', 'safety', 'and', 'dialysis', 'independency', 'month', '.', 'result', 'inclusion', ',', 'ten', 'patient', 'dialysis', 'dependent', 'and', 'five', 'egfr', 'level', 'and', 'mlmin', 'per', '.m', '.', 'median', 'age', 'year', '(', 'range', '-', ')', ',', 'six', 'woman', ',', 'and', 'six', 'also', 'positive', 'anti-neutrophil', 'cytoplasmic', 'antibody', '.', 'hour', 'imlifidase', 'infusion', ',', 'patient', 'anti-gbm', 'antibody', 'level', 'reference', 'range', 'of', 'prespecified', 'assay', '.', 'month', '(', 'ten', 'of', ')', 'dialysis', 'independent', '.', 'significantly', 'higher', 'compared', 'with', '(', 'nine', 'of', ')', 'in', 'historical', 'control', 'cohort', '(', 'p.', ',', 'fisher', ""'s"", 'exact', 'test', ')', '.', 'eight', 'serious', 'adverse', 'event', '(', 'including', 'one', 'death', ')', 'reported', ',', 'none', 'assessed', 'probably', 'or', 'possibly', 'related', 'to', 'study', 'drug', '.', 'conclusion', 'in', 'pilot', 'study', ',', 'use', 'of', 'imlifidase', 'associated', 'with', 'better', 'outcome', 'compared', 'with', 'earlier', 'publication', ',', 'without', 'major', 'safety', 'issue', ',', 'finding', 'need', 'to', 'confirmed', 'in', 'randomized', 'controlled', 'trial.clinical', 'trial', 'registration', 'number', 'eudract', '--', 'httpswww.clinicaltrialsregister.euctr-searchtrial', '--', 'result', '.']"
Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial.,"Shaohua Liu#, Ying Wu#, Shaoyan Qi, Huanzhang Shao, Min Feng, Lihua Xing, Hongmei Liu, Yanqiu Gao, Zhiqiang Zhu, Shuguang Zhang, Yuming Du, Yibin Lu, Jing Yang, Pingyan Chen, Tongwen Sun, Shaohua Liuet al.",2023 Jun 13,Crit Care,https://pubmed.ncbi.nlm.nih.gov/37312218/,No keywords found,"['appropriate', 'administration', 'regimen', 'of', 'polymyxin', 'b', 'yet', 'controversial', '.', 'present', 'study', 'aimed', 'to', 'explore', 'optimal', 'dose', 'of', 'polymyxin', 'b', 'therapeutic', 'drug', 'monitoring', '(', 'tdm', ')', 'guidance', '.', 'method', 'in', 'china', ""'s"", 'henan', 'province', ',', 'hospital', 'participated', 'in', 'randomized', 'controlled', 'trial', '.', 'included', 'patient', 'with', 'sepsis', 'caused', 'carbapenem-resistant', 'gram-negative', 'bacteria', '(', 'cr-gnb', ')', 'susceptible', 'to', 'polymyxin', 'b.', 'patient', 'randomly', 'divided', 'high-dose', '(', 'hd', ')', 'group', 'or', 'low-dose', '(', 'ld', ')', 'group', 'and', 'received', 'mg', 'loading', 'dose', ',', 'mg', 'every', 'h', 'and', 'mg', 'loading', 'dose', ',', 'mg', 'every', 'h', ',', 'respectively', '.', 'tdm', 'employed', 'to', 'determine', 'dose', 'of', 'polymyxin', 'b', 'need', 'adjustment', 'based', 'area', 'concentration-time', 'curve', 'across', 'h', 'steady', 'state', '(', 'ssauc-', ')', 'of', '-', 'mg', 'hl', '.', 'primary', 'outcome', '-day', 'clinical', 'response', ',', 'and', 'secondary', 'outcome', 'included', '-', 'and', '-day', 'mortality', '.', 'result', 'trial', 'included', 'patient', ',', 'with', 'assigned', 'to', 'hd', 'group', 'and', 'assigned', 'to', 'ld', 'group', '.', 'intention-to-treat', 'analysis', 'showed', '-day', 'clinical', 'response', 'non-significant', '(', 'p', '.', ')', '(', '.', ')', 'in', 'hd', 'group', 'and', '(', '.', ')', 'in', 'ld', 'group', '.', 'kaplan-meier', ""'s"", '-day', 'survival', 'curve', 'showed', 'survival', 'advantage', 'in', 'hd', 'group', 'in', 'ld', 'group', '(', 'p', '.', ')', '.', 'patient', 'achieved', 'target', 'ssauc-', 'in', 'hd', 'in', 'ld', 'group', '(', '.', 'vs.', '.', 'p', '.', ')', 'and', 'in', 'septic', 'shock', 'subgroup', 'compared', 'to', 'subject', '(', 'hd', 'group', '.', 'v', '.', '.', ',', 'p', '.', 'ld', 'group', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'also', ',', 'target', 'auc', 'compliance', 'not', 'correlated', 'with', 'clinical', 'outcome', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', '(', 'p', '.', ')', '.', 'adverse', 'event', 'not', 'differ', 'hd', 'and', 'ld', 'group', '.', 'conclusion', 'fixed', 'polymyxin', 'b', 'loading', 'dose', 'of', 'mg', 'and', 'maintenance', 'dose', 'of', 'mg', 'every', 'h', 'safe', 'patient', 'with', 'sepsis', 'caused', 'cr-gnb', 'and', 'improves', 'long-term', 'survival', '.', 'increased', 'auc', 'associated', 'with', 'increased', 'incidence', 'of', 'aki', ',', 'and', 'tdm', 'result', 'valued', 'to', 'prevent', 'aki', '.', 'trial', 'registration', 'trial', 'registration', 'clinicaltrials.gov', 'chictr', ',', 'registration', 'date', 'january', ',', '.']"
"Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study.","Shuichi Ito, Yuya Nishiyama, Kenkichi Sugiura, Kazuaki Enya, Shuichi Itoet al.",2022 Apr,Clin Exp Nephrol,https://pubmed.ncbi.nlm.nih.gov/34837606/,No keywords found,"['azilsartan', 'angiotensin', 'ii', 'receptor', 'blocker', 'indicated', 'treatment', 'of', 'adult', 'hypertension', '.', 'previous', 'single-dose', 'study', 'suggested', 'azilsartan', 'may', 'also', 'promising', 'agent', 'paediatric', 'hypertension', '.', 'however', ',', 'long-term', 'safety', 'and', 'efficacy', 'of', 'azilsartan', 'in', 'child', 'not', 'established', '.', 'method', 'conducted', 'phase', ',', 'single-arm', ',', 'open-label', ',', 'prospective', 'study', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'azilsartan', 'in', 'pediatric', 'patient', 'with', 'hypertension', '.', 'twenty-seven', 'patient', 'aged', '-', 'year', 'treated', 'with', 'once-daily', 'azilsartan', 'week', '.', 'starting', 'dose', '.', 'mg', 'patient', 'weighing', 'kg', '(', 'n', ')', 'and', 'mg', 'patient', 'weighing', 'kg', '(', 'n', ')', ',', 'with', 'dos', 'titrated', 'to', 'maximum', 'of', 'and', 'mg', ',', 'respectively', '.', 'result', 'azilsartan', 'showed', 'acceptable', 'tolerability', 'dos', 'to', 'mg', 'in', 'patient', 'weighing', 'kg', 'and', 'mg', 'in', 'weighing', 'kg', '.', 'drug-related', 'adverse', 'event', '(', 'aes', ')', 'mild', ',', 'with', 'one', 'patient', '(', '.', ')', 'experiencing', 'severe', 'and', 'serious', 'drug-related', 'ae', '(', 'acute', 'kidney', 'injury', ')', '.', 'one', 'patient', '(', '.', ')', 'mild', 'increase', 'in', 'serum', 'creatinine', 'level', ',', 'resolved', 'treatment', 'discontinuation', '.', 'blood', 'pressure-lowering', 'effect', 'of', 'azilsartan', 'observed', 'early', 'week', '.', 'overall', ',', 'approximately', 'half', 'of', 'patient', 'achieved', 'target', 'blood', 'pressure', 'end', 'of', 'azilsartan', 'treatment', '.', 'conclusion', 'study', 'suggests', 'azilsartan', 'acceptable', 'safety', 'profile', 'in', 'hypertensive', 'patient', 'aged', '-', 'year', '.', 'azilsartan', 'may', 'promising', 'agent', 'treating', 'paediatric', 'hypertension', '.']"
Could Omega 3 fatty acids reduce the risk of contrast-induced nephropathy in patients undergoing coronary angiography? A randomized controlled trial.,"Fadel A Alrowaie, Khalid I Almatham, Faisal Alsamadi, Muhammad Salman Bashir, Humariya H Munshi, Fadel A Alrowaieet al.",2021 Mar-Apr,Saudi J Kidney Dis Transpl,https://pubmed.ncbi.nlm.nih.gov/35017325/,No keywords found,"['patient', 'assigned', 'to', 'n-acetylcysteine', '(', 'nac', 'mg', ')', 'and', 'patient', 'assigned', 'to', 'omega', 'fatty', 'acid', '(', 'g', ')', '.', 'drug', 'administered', 'orally', 'twice', 'per', 'day', 'one', 'day', 'and', 'day', 'of', 'contrast', 'administration', '.', 'of', 'patient', 'enrolled', 'in', 'study', ',', '(', '.', ')', 'experienced', 'increase', 'of', 'least', '.', 'mgdl', '(', 'moll', ')', 'in', 'serum', 'creatinine', 'level', 'h', 'administration', 'of', 'contrast', 'agent', 'including', 'of', 'patient', 'in', 'nac', 'group', '(', '.', ')', 'and', 'of', 'patient', 'in', 'omega', 'fatty', 'acid', 'group', '(', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'need', 'renal', 'replacement', 'therapy', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', 'or', 'in', 'mortality', 'rate', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', 'two', 'group', '.', 'short-term', 'prophylactic', 'omega', 'fatty', 'acid', 'treatment', 'with', 'hydration', 'not', 'reduce', 'risk', 'of', 'cin', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', 'undergoing', 'coronary', 'angiography', '.']"
Goal-directed Fluid Therapy Versus Conventional Fluid Therapy During Craniotomy and Clipping of Cerebral Aneurysm: A Prospective Randomized Controlled Trial.,"Summit D Bloria, Nidhi B Panda, Kiran Jangra, Hemant Bhagat, Banashree Mandal, Ketan Kataria, Rajeev Chauhan, Ankur Luthra, Shiv Lal Soni, Narender Kaloria, Shalvi Mahajan, Shamik Kr Paul, Shailesh Gupta, Sanket Agrawal, Navneet Singla, Summit D Bloriaet al.",2022 Oct 1,J Neurosurg Anesthesiol,https://pubmed.ncbi.nlm.nih.gov/33835084/,No keywords found,"['fluid', 'imbalance', 'common', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'and', 'negatively', 'impact', 'clinical', 'outcome', '.', 'compared', 'intraoperative', 'goal-directed', 'fluid', 'therapy', '(', 'gdft', ')', 'using', 'left', 'ventricular', 'outflow', 'tract', 'velocity', 'time', 'integral', '(', 'lvot-vti', ')', 'measured', 'transesophageal', 'echocardiography', 'with', 'central', 'venous', 'pressure', '(', 'cvp', ')', '-guided', 'fluid', 'therapy', 'aneurysm', 'clipping', 'in', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'patient', '.', 'method', 'fifty', 'adult', 'scheduled', 'urgent', 'craniotomy', 'aneurysm', 'clipping', 'randomly', 'allocated', 'to', 'group', 'group', 'g', '(', 'n', ')', 'received', 'gdft', 'guided', 'lvot-vti', 'and', 'group', 'c', '(', 'n', ')', 'received', 'cvp-guided', 'fluid', 'management', '.', 'primary', 'outcome', 'intraoperative', 'mean', 'arterial', 'pressure', '(', 'map', ')', '.', 'secondary', 'outcome', 'included', 'volume', 'of', 'fluid', 'administered', 'and', 'several', 'intraoperative', 'and', 'postoperative', 'variable', ',', 'including', 'neurological', 'outcome', 'hospital', 'discharge', 'and', 'and', 'day', '.', 'result', 'no', 'difference', 'in', 'map', 'group', 'despite', 'patient', 'in', 'group', 'g', 'receiving', 'lower', 'volume', 'of', 'fluid', 'compared', 'with', 'patient', 'in', 'group', 'c', '(', '..', 'vs.', '..', 'ml', ',', 'respectively', 'p', '.', ')', '.', 'heart', 'rate', 'and', 'diastolic', 'blood', 'pressure', 'also', 'comparable', 'group', ',', 'whereas', 'systolic', 'blood', 'pressure', 'higher', 'in', 'group', 'g', 'in', 'group', 'c', 'several', 'intraoperative', 'time', 'point', '.', 'intraoperative', 'variable', ',', 'including', 'blood', 'loss', ',', 'urine', 'output', ',', 'and', 'lactate', 'level', 'not', 'different', 'group', '.', 'postoperative', 'variable', ',', 'including', 'creatinine', ',', 'duration', 'of', 'postoperative', 'mechanical', 'ventilation', ',', 'length', 'of', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', ',', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'pneumonitis', ',', 'and', 'vasospasm', 'also', 'comparable', 'group', '.', 'no', 'difference', 'in', 'neurological', 'outcome', 'hospital', 'discharge', '(', 'modified', 'rankin', 'scale', ')', 'and', 'and', 'day', '(', 'extended', 'glasgow', 'outcome', 'scale', ')', 'group', '.', 'conclusion', 'compared', 'with', 'cvp-guided', 'fluid', 'therapy', ',', 'transesophageal', 'echocardiography-guided', 'gdft', 'maintains', 'map', 'with', 'lower', 'volume', 'of', 'intravenous', 'fluid', 'in', 'patient', 'undergoing', 'clipping', 'of', 'intracranial', 'aneurysm', 'with', 'no', 'adverse', 'impact', 'postoperative', 'complication', '.']"
"Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.","Andreas Tiede, Christina Hart, Paul Knöbl, Richard Greil, Johannes Oldenburg, Ulrich J Sachs, Wolfgang Miesbach, Christian Pfrepper, Karolin Trautmann-Grill, Katharina Holstein, Jan Pilch, Patrick Möhnle, Christoph Schindler, Carmen Weigt, Dorothea Schipp, Marcus May, Christiane Dobbelstein, Fabius J Pelzer, Sonja Werwitzke, Robert Klamroth, Andreas Tiedeet al.",2023 Nov,Lancet Haematol,https://pubmed.ncbi.nlm.nih.gov/37858328/,No keywords found,"['acquired', 'haemophilia', 'caused', 'neutralising', 'autoantibody', 'coagulation', 'factor', 'viii', ',', 'leading', 'to', 'severe', 'bleeding', '.', 'standard', 'treatment', 'involves', 'immunosuppressive', 'therapy', ',', 'associated', 'with', 'adverse', 'event', 'and', 'mortality', 'in', 'frail', 'population', 'of', 'patient', 'with', 'acquired', 'haemophilia', 'a.', 'study', 'investigated', 'whether', 'emicizumab', ',', 'factor', 'viiia', 'mimetic', 'antibody', ',', 'protects', 'patient', 'with', 'acquired', 'haemophilia', 'bleeding', 'and', 'allows', 'deferral', 'of', 'immunosuppression', 'first', 'week', 'diagnosis', '.', 'method', 'report', 'final', 'result', 'of', 'open-label', ',', 'single-arm', ',', 'phase', 'clinical', 'trial', '.', 'adult', 'patient', 'with', 'acquired', 'haemophilia', 'haemophilia', 'treatment', 'centre', 'in', 'germany', 'and', 'austria', 'eligible', 'not', 'previously', 'received', 'immunosuppression', '.', 'patient', 'received', 'emicizumab', 'subcutaneously', '(', 'and', 'mgkg', 'day', 'and', ',', 'mgkg', 'weekly', 'week', ')', ',', 'no', 'immunosuppression', '.', 'follow-up', 'week', '.', 'primary', 'endpoint', 'number', 'of', 'clinically', 'relevant', 'bleeds', 'per', 'patient-week', 'week', '.', 'emicizumab', 'considered', 'effective', 'mean', 'bleeding', 'rate', 'significantly', 'bleeds', 'per', 'patient-week', ',', 'rate', 'observed', 'in', 'previous', 'study', 'of', 'patient', 'with', 'acquired', 'haemophilia', 'treated', 'with', 'bypassing', 'agent', 'and', 'immunosuppression', 'no', 'emicizumab', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', 'and', 'complete', '.', 'finding', 'of', 'patient', 'screened', 'march', ',', ',', 'to', 'june', ',', ',', 'enrolled', '(', 'woman', ',', 'men', ')', '.', 'median', 'age', 'year', '(', 'iqr', '-', ')', ',', '(', ')', 'of', 'patient', 'white', ',', 'median', 'factor', 'viii', 'activity', 'iudl', '(', '-', ')', ',', 'and', 'median', 'inhibitor', 'concentration', 'bethesda', 'unit', 'per', 'ml', '(', '-', ')', '.', 'mean', 'breakthrough', 'bleeding', 'rate', 'bleeds', 'per', 'patient-week', '(', 'upper', 'ci', ')', '.', '(', ')', 'of', 'patient', 'no', 'bleeding', 'event', ',', 'seven', 'patient', '(', ')', 'one', 'bleed', ',', 'six', 'patient', '(', ')', 'two', 'bleeds', ',', 'and', 'one', 'patient', '(', ')', 'three', 'bleeds', '.', 'adverse', 'event', 'of', 'grade', 'or', 'worse', 'included', 'covid-', '(', 'n', ')', ',', 'acute', 'kidney', 'injury', '(', 'n', ')', ',', 'and', 'stroke', '(', 'n', ')', '.', 'four', 'of', 'patient', 'died', ',', 'including', 'two', 'death', 'related', 'to', 'bleeding', ',', 'one', 'covid-', ',', 'and', 'one', 'cardiac', 'arrest', '(', 'none', 'judged', 'related', 'to', 'emicizumab', ')', '.', 'interpretation', 'study', 'suggests', 'emicizumab', 'prophylaxis', 'prevents', 'bleeding', 'in', 'patient', 'with', 'acquired', 'haemophilia', 'and', 'immunosuppressive', 'therapy', 'deferred', 'patient', 'receiving', 'treatment', '.', 'low', 'number', 'of', 'thromboembolic', 'event', ',', 'severe', 'infection', ',', 'and', 'fatality', 'observed', 'in', 'study', 'promising', '.', 'funding', 'study', 'supported', 'funding', 'hoffman-la', 'roche', '.']"
Safety of PSMA-Targeted Molecular Radioligand Therapy with (177)Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312).,"Jeremie Calais, Johannes Czernin, Pan Thin, Jeannine Gartmann, Kathleen Nguyen, Wesley R Armstrong, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, Magnus Dahlbom, Beilei He, Rouzbeh Esfandiari, David Ranganathan, Ken Herrmann, Matthias Eiber, Wolfgang P Fendler, Ebrahim Delpassand, Jeremie Calaiset al.",2021 Oct,J Nucl Med,https://pubmed.ncbi.nlm.nih.gov/34272322/,"177Lu, RESIST-PC, metastatic castration-resistant prostate cancer, molecular radiotherapy, prospective randomized phase 2 trial, prostate-specific membrane antigen, radionuclide therapy, safety, theranostics.","['resist-pc', 'prospective', 'multicenter', 'phase', 'trial', '.', 'patient', 'with', 'progressive', 'metastatic', 'castration-resistant', 'prostate', 'cancer', 'novel', 'androgen-axis', 'drug', ',', 'either', 'chemotherapy', 'nave', 'or', 'postchemotherapy', ',', 'with', 'sufficient', 'bone', 'marrow', 'reserve', ',', 'normal', 'kidney', 'function', ',', 'sufficient', 'psma', 'expression', 'psma', 'pet', ',', 'and', 'no', 'psma-negative', 'soft-tissue', 'lesion', 'eligible', '.', 'patient', 'randomized', '(', ')', 'activity', 'group', '(', '.', 'or', '.', 'gbq', 'per', 'cycle', ')', 'and', 'received', 'to', 'cycle', 'every', 'wk', '.', 'primary', 'safety', 'endpoint', 'assessed', 'collecting', 'and', 'grading', 'adverse', 'event', 'using', 'common', 'terminology', 'criterion', 'adverse', 'event', '.', 'patient', 'followed', 'disease', 'progression', ',', 'death', ',', 'serious', 'or', 'intolerable', 'adverse', 'event', ',', 'study', 'termination', 'sponsor', ',', 'patient', 'withdrawal', ',', 'lost', 'to', 'follow-up', ',', 'or', 'mo', 'first', 'cycle', '.', 'result', 'study', 'closed', 'enrollment', 'of', 'of', 'planned', 'patient', 'of', 'sponsorship', 'transfer', '.', 'total', 'of', '(', '.', ')', 'patient', 'received', 'least', 'cycle', 'of', 'lu-psma-', '(', ')', 'in', 'arm', '(', '.', 'gbq', ')', 'and', '(', ')', 'in', 'arm', '(', '.', 'gbq', ')', '.', '(', '.', ')', ',', '(', '.', ')', ',', 'and', '(', '.', ')', 'patient', 'completed', 'cycle', 'of', 'lu-psma-', 'in', '.-gbq', 'arm', ',', '.-gbq', 'arm', ',', 'and', 'overall', ',', 'respectively', '.', 'common', 'treatment-emergent', 'adverse', 'event', '(', 'teaes', ')', 'of', 'grade', 'in', '.-gbq', 'arm', ',', '.-gbq', 'arm', 'and', 'overall', ',', 'dry', 'mouth', '(', '.', '.', '.', ',', 'respectively', ')', ',', 'fatigue', '(', '.', '.', '.', ',', 'respectively', ')', ',', 'nausea', '(', '.', '.', '.', ',', 'respectively', ')', ',', 'and', 'diarrhea', '(', '.', '.', '.', ',', 'respectively', ')', '.', 'frequency', 'of', 'teaes', 'comparable', 'among', 'group', '(', 'within', 'difference', ')', '.', 'serious', 'possibly', 'drug-related', 'teaes', 'reported', '(', '.', ')', 'patient', 'overall', '(', 'none', 'considered', 'probably', 'or', 'definitely', 'related', 'to', 'treatment', ')', 'subdural', 'hematoma', 'grade', ',', 'anemia', 'grade', ',', 'thrombocytopenia', 'grade', ',', 'gastrointestinal', 'hemorrhage', 'grade', ',', 'and', 'acute', 'kidney', 'injury', 'grade', '.', 'no', 'clinically', 'significant', 'change', 'in', 'vital', 'sign', 'in', 'electrocardiogram', 'in', 'treatment', 'group', '.', 'no', 'trend', 'to', 'creatinine', 'increase', 'or', 'increasing', 'frequency', 'of', 'shift', 'normal', 'to', 'abnormal', 'time', 'hematologic', 'parameter', 'noted', '.', 'conclusionlu-psma-', 'safe', 'and', 'well-tolerated', '.', 'and', '.', 'gbq', 'per', 'cycle', 'given', '-wk', 'interval', 'with', 'side', 'effect', 'easily', 'managed', 'with', 'standard', 'medical', 'support', '.', 'with', 'established', 'safety', ',', 'clinical', 'trial', 'applying', 'individualized', 'dosimetry', 'and', 'testing', 'different', 'lu-psma-', 'administration', 'scheme', '(', 'activity', 'level', ',', 'time', 'interval', ')', 'needed', 'to', 'optimize', 'tumor', 'dose', 'delivery', 'and', 'treatment', 'efficacy', '.']"
"Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report.","Tanya M Trippett, Cindy L Schwartz, R Paul Guillerman, Alan S Gamis, Sharon Gardner, Shirley Hogan, Wendy B London, Lu Chen, Pedro de Alarcon, Tanya M Trippettet al.",2015 Jan,Pediatr Blood Cancer,https://pubmed.ncbi.nlm.nih.gov/25308760/,No keywords found,"['assessed', 'safety', 'and', 'efficacy', 'of', 'ifosfamide', 'and', 'vinorelbine', '(', 'iv', ')', 'less', 'toxic', 'and', 'effective', 'reinduction', 'regimen', 'pediatric', 'patient', 'with', 'relapsed', 'or', 'refractory', 'hodgkin', 'lymphoma', '.', 'procedure', 'multi-center', 'child', ""'s"", 'oncology', 'group', 'phase', 'ii', 'pilot', 'study', 'enrolled', 'patient', 'year', 'of', 'age', 'with', 'biopsy-proven', 'hodgkin', 'lymphoma', 'in', 'relapse', 'or', 'refractory', 'disease', 'front-line', 'therapy', '.', 'treatment', 'consisted', 'of', 'ifosfamide', ',', 'mgm', '(', ')', 'intravenous', 'infusion', 'hr', 'day', '-', 'and', 'vinorelbine', 'mgm', '(', ')', 'dose', 'intravenous', 'push', 'day', 'and', 'of', 'day', 'cycle', 'with', 'cytokine', 'support', '.', 'study', 'endpoint', 'included', 'estimation', 'of', 'key', 'toxicity', '(', 'cardiac', ',', 'hepatic', ',', 'or', 'renal', 'toxicity', 'or', 'toxic', 'death', ')', ',', 'rate', 'of', 'successful', 'peripheral', 'stem', 'cell', 'harvesting', ',', 'and', 'response', 'two', 'cycle', 'of', 'therapy', '.', 'result', 'sixty-six', 'patient', 'received', 'median', 'of', 'two', 'cycle', 'of', 'iv', '.', 'sixty-four', 'of', 'heavily', 'pretreated', ',', 'refractory', 'disease', ',', 'male', 'and', 'nodular', 'sclerosis', 'hl', '.', 'primary', 'toxicity', 'hematologic', '.', 'harvested', 'peripheral', 'stem', 'cell', 'sufficient', 'autologous', 'transplantation', 'in', 'of', 'patient', 'stem', 'cell', 'collection', 'attempted', '.', 'overall', 'response', 'rate', '(', 'ci', '-', ')', 'permitted', 'majority', 'of', 'patient', 'to', 'undergo', 'subsequent', 'stem', 'cell', 'transplantation', '.', 'conclusion', 'iv', 'safe', 'and', 'effective', 're-induction', 'regimen', 'salvage', 'of', 'pediatric', 'patient', 'with', 'relapsed', 'or', 'refractory', 'hodgkin', 'lymphoma', 'with', 'excellent', 'response', 'rate', 'and', 'success', 'of', 'post', 'chemotherapy', 'stem', 'cell', 'harvest', '.', 'avoids', 'use', 'of', 'etoposide', ',', 'agent', 'associated', 'with', 'secondary', 'malignancy', 'stem', 'cell', 'transplantation', '.']"
Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial.,"Marina Urena, Maria Del Trigo, Omar Abdul-Jawad Altisent, Francisco Campelo-Prada, Ander Regueiro, Robert DeLarochellière, Daniel Doyle, Siamak Mohammadi, Jean-Michel Paradis, François Dagenais, Eric Dumont, Rishi Puri, Vincent Laroche, Josep Rodés-Cabau, Marina Urenaet al.",2017 May 15,EuroIntervention,https://pubmed.ncbi.nlm.nih.gov/28067195/,No keywords found,"['aim', 'of', 'study', 'to', 'evaluate', ',', 'in', 'anaemic', 'patient', ',', 'efficacy', 'of', 'erythropoietin', '(', 'epo', ')', 'in', 'reducing', 'red', 'cell', '(', 'rc', ')', 'transfusion', 'rate', 'post', 'tavi', '.', 'method', 'and', 'result', 'randomised', 'double-blind', 'trial', '.', 'patient', 'with', 'severe', 'symptomatic', 'aortic', 'stenosis', 'and', 'concomitant', 'anaemia', 'with', 'indication', 'tavi', 'randomised', '(', ')', 'to', 'receive', 'two', 'weight-based', 'dos', 'of', 'epo', '(', 'darbepoetin', 'alfa', ')', 'iron', 'or', 'placebo', 'day', '(', 'day', ')', 'and', '(', 'day', ')', 'pre', 'tavi', '.', 'primary', 'outcome', 'rate', 'of', 'rc', 'transfusion', 'day', '.', 'total', 'of', 'patient', '(', 'mean', 'age', 'year', ',', 'male', ')', 'included', 'patient', 'received', 'epo', '(', 'iron', ')', 'and', 'patient', 'received', 'placebo', '.', 'baseline', 'characteristic', 'and', 'procedural', 'finding', 'well', 'balanced', 'group', 'except', 'baseline', 'haemoglobin', 'level', ',', 'lower', 'in', 'patient', 'receiving', 'epo', '(', '..', 'vs.', '..', 'gdl', ',', 'p.', ')', '.', 'rate', 'of', '-day', 'rc', 'transfusion', 'similar', 'in', 'group', '(', '.', 'vs.', '.', 'in', 'epo', 'and', 'placebo', 'group', ',', 'respectively', 'adjusted', 'odds', 'ratio', '.', ',', 'ci', '.-.', ',', 'p.', ')', ',', 'and', 'no', 'difference', 'observed', 'in', 'number', 'of', 'rc', 'unit', 'per', 'transfused', 'patient', '(', '-', 'vs.', '-', 'in', 'epo', 'and', 'placebo', 'group', ',', 'respectively', ',', 'adjusted', 'p.', ')', '.', 'rate', 'of', '-day', 'mortality', ',', 'stroke', ',', 'new-onset', 'atrial', 'fibrillation', ',', 'acute', 'kidney', 'injury', ',', 'and', 'troponin', 'peak', 'also', 'similar', 'group', '(', 'p.', ')', '.', 'conclusion', 'epo', '(', 'iron', ')', 'administration', 'failed', 'to', 'reduce', 'rc', 'transfusion', 'rate', 'or', 'per-patient', 'number', 'of', 'transfusion', 'unit', 'in', 'anaemic', 'patient', 'undergoing', 'tavi', '.']"
Annexin A1 is a Potential Novel Biomarker of Congestion in Acute Heart Failure.,"Fadi W Adel, Aruna Rikhi, Siu-Hin Wan, Seethalakshmi R Iyer, Hrishikesh Chakraborty, Steven McNulty, W H Wilson Tang, G Michael Felker, Michael M Givertz, Horng H Chen, Fadi W Adelet al.",2020 Aug,J Card Fail,https://pubmed.ncbi.nlm.nih.gov/32473378/,No keywords found,"['study', 'sought', 'to', 'identify', 'role', 'of', 'annexin', '(', 'anxa', ')', 'congestion', 'marker', 'in', 'acute', 'heart', 'failure', '(', 'ahf', ')', 'and', 'to', 'identify', 'putative', 'role', 'in', 'predicting', 'clinical', 'outcome', '.', 'background', 'anxa', 'protein', 'inhibits', 'inflammation', 'following', 'ischemia-reperfusion', 'injury', 'in', 'cardiorenal', 'tissue', '.', 'ahf', 'state', 'of', 'tissue', 'hypoperfusion', ',', 'hypothesized', 'plasma', 'anxa', 'level', 'altered', 'in', 'ahf', '.', 'method', 'in', 'renal', 'optimization', 'strategy', 'evaluation', '(', 'rose', ')', 'trial', ',', 'patient', 'hospitalized', 'ahf', 'with', 'kidney', 'injury', 'randomized', 'to', 'receive', 'dopamine', ',', 'nesiritide', ',', 'or', 'placebo', 'hour', 'in', 'addition', 'to', 'diuresis', '.', 'in', 'subanalysis', ',', 'plasma', 'anxa', 'level', 'measured', 'baseline', 'and', 'hour', 'in', 'patient', '.', 'participant', 'divided', 'tertiles', 'based', 'baseline', 'anxa', 'level', '.', 'result', 'prevalence', 'of', 'peripheral', 'edema', 'increased', 'with', 'increasing', 'anxa', 'level', '(', 'p', '.', ')', '.', 'cystatin', 'c', ',', 'blood', 'urea', 'nitrogen', ',', 'and', 'kidney', 'injury', 'molecule-', 'plasma', 'level', 'higher', 'among', 'participant', 'in', 'tertile', 'v', 'tertiles', 'or', '(', 'p', '.', ')', '.', 'patient', 'with', 'congestion', 'score', 'of', 'mean', 'baseline', 'anxa', 'level', '.', 'unit', 'higher', 'with', 'congestion', 'score', 'of', '(', 'p', '.', ')', '.', 'patient', 'in', 'tertiles', 'and', 'twice', 'likely', 'to', 'experience', 'creatinine', 'elevation', 'patient', 'in', 'tertile', '(', 'p', '.', ')', '.', 'patient', 'in', 'tertiles', 'and', 'higher', 'risk', 'of', '-day', 'all-cause', 'mortality', 'or', 'heart', 'failure', 'hospitalization', 'and', '-day', 'all-cause', 'mortality', '(', 'p', '.', ')', '.', 'conclusion', 'among', 'patient', 'hospitalized', 'ahf', 'with', 'impaired', 'kidney', 'function', ',', 'elevated', 'anxa', 'level', 'associated', 'with', 'worse', 'congestion', ',', 'higher', 'risk', 'creatinine', 'elevation', ',', 'and', 'higher', 'rate', 'of', '-day', 'morbidity', 'or', 'all-cause', 'mortality', 'and', '-day', 'all-cause', 'mortality', '.', 'clinical', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Perioperative multi-system optimization protocol in elderly hip fracture patients: a randomized-controlled trial.,"Sebastian Schmid, Manfred Blobner, Brigitte Haas, Martin Lucke, Markus Neumaier, Aida Anetsberger, Bettina Jungwirth, Sebastian Schmidet al.",2019 Dec,Can J Anaesth,https://pubmed.ncbi.nlm.nih.gov/31531828/,No keywords found,"['hip', 'fracture', 'in', 'elderly', 'patient', 'associated', 'with', 'increased', 'postoperative', 'morbidity', 'and', 'mortality', '.', 'evaluated', 'whether', 'perioperative', 'multi-system', 'optimization', 'protocol', 'reduce', 'postoperative', 'complication', 'in', 'patient', '.', 'method', 'immediately', 'diagnosis', 'of', 'hip', 'fracture', ',', 'patient', 'yr', 'randomized', 'to', 'intervention', 'or', 'control', 'group', '.', 'patient', 'in', 'intervention', 'group', 'admitted', 'to', 'postanesthesia', 'care', 'unit', 'treated', 'with', 'goal-directed', 'hemodynamic', 'management', ',', 'optimized', 'pain', 'therapy', ',', 'oxygen', 'therapy', ',', 'and', 'optimized', 'nutrition', '.', 'patient', 'in', 'control', 'group', 'managed', 'according', 'to', 'usual', 'standard', 'of', 'care', 'regular', 'ward', '.', 'postoperative', 'complication', 'hospital', 'stay', 'included', 'pre-determined', 'cardiovascular', ',', 'respiratory', ',', 'neurologic', ',', 'renal', ',', 'or', 'surgical', 'event', '.', 'result', 'incidence', 'of', 'least', 'one', 'postoperative', 'complication', '(', 'primary', 'outcome', ')', 'seen', 'in', 'of', '(', ')', 'control', 'compared', 'with', 'of', '(', ')', 'in', 'intervention', 'group', '(', 'relative', 'risk', 'rr', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'secondary', 'unadjusted', 'outcome', 'showed', 'patient', 'in', 'intervention', 'group', 'received', 'ringer', ""'s"", 'acetate', 'compared', 'with', 'control', '(', 'median', 'difference', ',', '.', 'l', 'ci', ',', '.', 'to', '.', 'l', 'p', 'mmhg', '(', 'control', 'v', 'intervention', 'median', 'percentage', 'difference', ',', 'ci', ',', 'to', 'p', '.', ')', ',', 'better', 'pain', 'control', '(', 'numeric', 'rating', 'scale', 'postoperative', 'measurement', 'control', 'v', 'intervention', 'rr', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', ',', 'and', 'possibly', 'lower', 'incidence', 'of', 'acute', 'renal', 'failure', '(', 'rr', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'implementation', 'of', 'perioperative', 'multi-system', 'optimization', 'protocol', 'algorithm', 'not', 'significantly', 'reduce', 'risk', 'of', 'postoperative', 'complication', '.', 'nevertheless', ',', 'likely', 'over-estimated', 'potential', 'treatment', 'effect', 'in', 'study', 'design', 'and', 'thus', 'under-powered', 'to', 'show', 'effect', '.', 'trial', 'registration', 'clinicaltrials.gov', '(', 'nct', ')', '.', 'registered', 'august', ',', '.']"
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.,"Victoria K Snowdon, Neil J Lachlan, Anna M Hoy, Patrick W F Hadoke, Scott I Semple, Dilip Patel, Will Mungall, Timothy J Kendall, Adrian Thomson, Ross J Lennen, Maurits A Jansen, Carmel M Moran, Antonella Pellicoro, Prakash Ramachandran, Isaac Shaw, Rebecca L Aucott, Thomas Severin, Rajnish Saini, Judy Pak, Denise Yates, Neelesh Dongre, Jeremy S Duffield, David J Webb, John P Iredale, Peter C Hayes, Jonathan A Fallowfield, Victoria K Snowdonet al.",2017 Feb 28,PLoS Med,https://pubmed.ncbi.nlm.nih.gov/28245243/,No keywords found,"['chronic', 'liver', 'scarring', 'cause', 'lead', 'to', 'cirrhosis', ',', 'portal', 'hypertension', ',', 'and', 'progressive', 'decline', 'in', 'renal', 'blood', 'flow', 'and', 'renal', 'function', '.', 'extreme', 'renal', 'vasoconstriction', 'characterizes', 'hepatorenal', 'syndrome', ',', 'functional', 'and', 'potentially', 'reversible', 'form', 'of', 'acute', 'kidney', 'injury', 'in', 'patient', 'with', 'advanced', 'cirrhosis', ',', 'current', 'therapy', 'with', 'systemic', 'vasoconstrictor', 'ineffective', 'in', 'substantial', 'proportion', 'of', 'patient', 'and', 'limited', 'ischemic', 'adverse', 'event', '.', 'serelaxin', '(', 'recombinant', 'human', 'relaxin-', ')', 'peptide', 'molecule', 'with', 'anti-fibrotic', 'and', 'vasoprotective', 'property', 'bind', 'to', 'relaxin', 'family', 'peptide', 'receptor-', '(', 'rxfp', ')', 'and', 'shown', 'to', 'increase', 'renal', 'perfusion', 'in', 'healthy', 'human', 'volunteer', '.', 'hypothesized', 'serelaxin', 'could', 'ameliorate', 'renal', 'vasoconstriction', 'and', 'renal', 'dysfunction', 'in', 'patient', 'with', 'cirrhosis', 'and', 'portal', 'hypertension', '.', 'method', 'and', 'finding', 'to', 'establish', 'preclinical', 'proof', 'of', 'concept', ',', 'developed', 'two', 'independent', 'rat', 'model', 'of', 'cirrhosis', 'characterized', 'progressive', 'reduction', 'in', 'renal', 'blood', 'flow', 'and', 'glomerular', 'filtration', 'rate', 'and', 'showed', 'evidence', 'of', 'renal', 'endothelial', 'dysfunction', '.', 'set', 'to', 'explore', 'and', 'validate', 'hypothesis', 'in', 'phase', 'randomized', 'open-label', 'parallel-group', 'study', 'in', 'male', 'and', 'female', 'patient', 'with', 'alcohol-related', 'cirrhosis', 'and', 'portal', 'hypertension', '.', 'forty', 'patient', 'randomized', 'to', 'treatment', 'with', 'serelaxin', 'intravenous', '(', 'i.v', '.', ')', 'infusion', '(', 'min', 'gkgd', 'and', 'min', 'gkgd', ')', 'or', 'terlipressin', '(', 'single', '-mg', 'i.v', '.', 'bolus', ')', ',', 'and', 'regional', 'hemodynamic', 'effect', 'quantified', 'phase', 'contrast', 'magnetic', 'resonance', 'angiography', 'baseline', 'and', 'min', '.', 'primary', 'endpoint', 'change', 'baseline', 'in', 'total', 'renal', 'artery', 'blood', 'flow', '.', 'therapeutic', 'targeting', 'of', 'renal', 'vasoconstriction', 'with', 'serelaxin', 'in', 'rat', 'model', 'increased', 'kidney', 'perfusion', ',', 'oxygenation', ',', 'and', 'function', 'reduction', 'in', 'renal', 'vascular', 'resistance', ',', 'reversal', 'of', 'endothelial', 'dysfunction', ',', 'and', 'increased', 'activation', 'of', 'aktenosno', 'signaling', 'pathway', 'in', 'kidney', '.', 'in', 'randomized', 'clinical', 'study', ',', 'infusion', 'of', 'serelaxin', 'min', 'increased', 'total', 'renal', 'arterial', 'blood', 'flow', '(', 'ci', ',', 'p', '.', ')', 'baseline', '.', 'administration', 'of', 'serelaxin', 'safe', 'and', 'well', 'tolerated', ',', 'with', 'no', 'detrimental', 'effect', 'systemic', 'blood', 'pressure', 'or', 'hepatic', 'perfusion', '.', 'clinical', 'study', ""'s"", 'main', 'limitation', 'relatively', 'small', 'sample', 'size', 'and', 'stable', ',', 'well-compensated', 'population', '.', 'conclusion', 'mechanistic', 'finding', 'in', 'rat', 'model', 'and', 'exploratory', 'study', 'in', 'human', 'cirrhosis', 'suggest', 'therapeutic', 'potential', 'of', 'selective', 'renal', 'vasodilation', 'using', 'serelaxin', 'new', 'treatment', 'renal', 'dysfunction', 'in', 'cirrhosis', ',', 'although', 'validation', 'in', 'patient', 'with', 'advanced', 'cirrhosis', 'and', 'renal', 'dysfunction', 'required', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.,"Sang Hoon Ahn, Won Kim, Young Kul Jung, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Soon Ho Um, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Kim, Seung Kew Yoon, Moon Young Kim, Hyung Joon Yim, Kwan Sik Lee, Young Suk Lim, Wan Sik Lee, Neung Hwa Park, So Young Jin, Kyun-Hwan Kim, Won Choi, Kwang-Hyub Han, Sang Hoon Ahnet al.",2019 Aug,Clin Gastroenterol Hepatol,https://pubmed.ncbi.nlm.nih.gov/30448598/,No keywords found,"['besifovir', 'dipivoxil', 'maleate', '(', 'bsv', ')', 'activity', 'hepatitis', 'b', 'virus', '(', 'hbv', ')', '.', 'performed', 'phase', 'study', 'to', 'compare', 'antiviral', 'efficacy', 'and', 'safety', 'of', 'bsv', 'v', 'tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', 'in', 'patient', 'with', 'chronic', 'hbv', 'infection', 'in', 'korea', '.', 'method', 'conducted', 'double-blind', ',', 'non-inferiority', 'trial', 'of', 'patient', 'with', 'chronic', 'hbv', 'infection', 'site', 'in', 'south', 'korea', ',', 'november', 'february', '.', 'patient', 'randomly', 'assigned', 'to', 'group', 'given', 'bsv', '(', 'mg', ',', 'n', ')', 'or', 'tdf', '(', 'mg', ',', 'n', ')', 'week', '.', 'evaluated', 'virologic', 'response', 'to', 'therapy', '(', 'hbv', 'dna', 'iuml', 'or', 'copiesml', ')', ',', 'bone', 'mineral', 'density', '(', 'bmd', ')', ',', 'and', 'renal', 'outcome', 'safety', 'analysis', '.', 'main', 'efficacy', 'endpoint', 'proportion', 'of', 'patient', 'with', 'virologic', 'response', 'week', '.', 'week', ',', 'tdf', 'switched', 'to', 'bsv', '(', 'mg', ')', 'additional', 'week', '.', 'result', 'week', 'of', 'treatment', ',', '.', 'of', 'patient', 'given', 'bsv', 'and', '.', 'of', 'patient', 'given', 'tdf', 'met', 'efficacy', 'endpoint', ',', 'indicating', 'non-inferiority', 'of', 'bsv', 'to', 'tdf', '.', 'week', ',', '.', 'of', 'patient', 'in', 'bsv-bsv', 'and', '.', 'of', 'patient', 'in', 'tdf-bsv', 'virologic', 'response', '.', 'week', ',', 'change', 'in', 'hip', 'and', 'spine', 'bmd', 'differed', 'significantly', 'bsv', 'and', 'tdf', 'group', ',', 'whereas', 'estimated', 'glomerular', 'filtration', 'rate', 'in', 'tdf', 'group', 'significantly', 'lower', 'in', 'bsv', 'group', '.', 'however', ',', 'week', ',', 'no', 'significant', 'difference', 'in', 'bmd', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'bsv-bsv', 'and', 'tdf-bsv', 'group', '.', 'conclusion', 'bsv', 'antiviral', 'efficacy', 'comparable', 'to', 'of', 'tdf', 'week', 'of', 'treatment', ',', 'with', 'durable', 'effect', 'week', '.', 'bsv', 'better', 'safety', 'profile', 'tdf', ',', 'in', 'term', 'of', 'bone', 'and', 'renal', 'outcome', '.', 'clinicaltrials.gov', 'no', 'nct', '.']"
Heparin calcium treated Henoch-Schönlein purpura nephritis in children through inhibiting hyperfibrinolysis.,"Ming Tian, Cuihua Liu, Ming Tianet al.",2015 Aug,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/26133741/,No keywords found,"['to', 'explore', 'underlying', 'mechanism', 'of', 'low-molecular-weight', 'heparin', 'calcium', 'therapy', 'henoch-schnlein', 'purpura', 'nephritis', '(', 'hspn', ')', '.', 'method', 'eighty-nine', 'child', 'with', 'severe', 'hspn', 'randomized', 'control', 'group', '(', 'treated', 'with', 'conventional', 'therapy', ',', 'n', ')', 'and', 'treatment', 'group', '(', 'treated', 'with', 'conventional', 'therapy', 'plus', 'low-molecular-weight', 'heparin', 'calcium', ',', 'n', ')', '.', 'concentration', 'of', 'plasma', 'fibrinogen', '(', 'fg', ')', ',', 'd-dimer', 'and', 'fibrin', 'degradation', 'product', '(', 'fdps', ')', 'detected', 'and', 'treatment', '.', 'urinary', 'red', 'blood', 'cell', '(', 'rbc', ')', 'and', 'h', 'proteinuria', 'determined', 'weekly', 'assessing', 'child', ""'s"", 'kidney', 'function', '.', 'result', 'two', 'group', 'well-matched', 'baseline', '.', 'week', 'of', 'treatment', ',', 'clinical', 'outcome', 'of', 'hspn', 'and', 'outcome', 'of', 'proteinuria', 'of', 'treatment', 'group', 'better', 'control', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'fibrinolytic', 'system', 'may', 'participate', 'in', 'kidney', 'injury', 'of', 'hspn', 'child', 'and', 'low-molecular-weight', 'heparin', 'calcium', 'could', 'correct', 'blood', 'hypercoagulability', 'inhibiting', 'hyperfibrinolysis', ',', 'and', 'thus', 'improving', 'blood', 'supply', 'of', 'kidney', '.']"
"Effects of remote ischemic conditioning on kidney injury in at-risk patients undergoing elective coronary angiography (PREPARE study): a multicenter, randomized clinical trial.","François Roubille, Jean-Christophe Macia, Fabrice Ivanes, Denis Angoulvant, Victor Mateus, Loïc Belle, Meyer Elbaz, Olivier Morel, Alain Furber, Loïc Bière, Fabrice Prunier, François Roubilleet al.",2019 Aug 19,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/31427688/,No keywords found,"['ability', 'of', 'remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'to', 'prevent', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'following', 'percutaneous', 'coronary', 'angiography', 'in', 'at-risk', 'patient', 'controversial', '.', 'no', 'evidence', 'exists', 'regarding', 'potential', 'ripc', 'positive', 'effect', 'renal', 'function', 'and', 'clinical', 'outcome', 'in', 'long-term', '.', 'prepare', 'study', 'randomized', ',', 'prospective', ',', 'multicenter', ',', 'and', 'double-blinded', 'trial', '.', 'total', 'of', 'patient', 'scheduled', 'coronary', 'angiography', 'andor', 'percutaneous', 'transluminal', 'coronary', 'angioplasty', 'with', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'mlmin', '.', ',', 'or', 'egfr', 'and', 'mlmin', '.', 'and', 'two', 'risk', 'factor', 'allocated', 'to', 'ripc', 'or', 'control', 'group', '.', 'preventive', 'measure', 'applied', 'to', 'patient', ',', 'including', 'continuous', 'intravenous', 'saline', 'infusion', ',', 'withdrawal', 'of', 'nephrotoxic', 'drug', ',', 'and', 'limited', 'volume', 'of', 'contrast', 'medium', '.', 'primary', 'endpoint', ',', 'namely', 'incidence', 'of', 'cin', ',', '.', 'in', 'control', 'group', 'and', '.', 'in', 'ripc', 'group', '(', 'p', '.', ')', '.', 'secondary', 'endpoint', ',', 'i.e.', ',', 'change', 'in', 'serum', 'creatinine', 'and', 'egfr', 'level', 'baseline', 'to', 'hour', 'and', 'baseline', 'to', 'month', 'following', 'contrast', 'medium', 'exposure', ',', 'not', 'differ', 'group', '.', 'incidence', 'of', 'major', 'clinical', 'event', 'month', 'similar', 'in', 'group', '.', 'in', 'population', 'risk', 'of', 'cin', ',', 'preventive', 'strategy', 'associated', 'with', 'low', 'cin', 'incidence', '.', 'ripc', 'impacted', 'neither', 'cin', 'incidence', 'renal', 'function', 'and', 'clinical', 'outcome', '-year', 'follow-up', '.']"
Forced fluid removal versus usual care in intensive care patients with high-risk acute kidney injury and severe fluid overload (FFAKI): study protocol for a randomised controlled pilot trial.,"Rasmus E Berthelsen, Theis Itenov, Anders Perner, Jens-Ulrik Jensen, Michael Ibsen, Andreas Emil Kryger Jensen, Morten Bestle, Rasmus E Berthelsenet al.",2017 Apr 24,Trials,https://pubmed.ncbi.nlm.nih.gov/28438182/,No keywords found,"['intravenous', 'administration', 'of', 'fluid', 'essential', 'part', 'of', 'critical', 'care', '.', 'fluid', 'administration', 'likely', 'beneficial', ',', 'increasing', 'observational', 'evidence', 'development', 'of', 'fluid', 'overload', 'associated', 'with', 'increased', 'mortality', '.', 'no', 'randomised', 'trial', 'to', 'confirm', 'association', 'in', 'patient', 'with', 'acute', 'kidney', 'injury', '.', 'aim', 'to', 'perform', 'pilot', 'trial', 'to', 'test', 'feasibility', 'of', 'forced', 'fluid', 'removal', 'compared', 'to', 'standard', 'care', 'in', 'patient', 'with', 'acute', 'kidney', 'injury', 'and', 'severe', 'fluid', 'overload', ',', 'ffaki', 'trial', '.', 'method', 'ffaki', 'trial', 'pilot', ',', 'multicentre', ',', 'randomised', 'clinical', 'trial', 'recruiting', 'adult', 'intensive', 'care', 'patient', 'with', 'acute', 'kidney', 'injury', 'and', 'fluid', 'overload', ',', 'defined', 'of', 'ideal', 'bodyweight', '.', 'patient', 'randomised', 'with', 'concealed', 'allocation', 'to', 'either', 'standard', 'care', 'or', 'forced', 'fluid', 'removal', 'with', 'therapeutic', 'target', 'of', 'negative', 'net', 'fluid', 'balance', 'mlkgh', '.', 'safety', 'of', 'fluid', 'removal', 'continually', 'evaluated', 'according', 'to', 'predefined', 'criterion', 'of', 'hypoperfusion', 'lactate', 'mmoll', ',', 'mean', 'arterial', 'pressure', 'mmhg', 'or', 'mottling', 'beyond', 'edge', 'of', 'kneecap', '.', 'patient', 'fulfil', 'one', 'of', 'criterion', ',', 'fluid', 'removal', 'suspended', 'hypoperfusion', 'resolved', '.', 'primary', 'outcome', 'measure', 'fluid', 'balance', 'day', 'randomisation', 'and', 'secondary', 'outcome', 'include', 'mean', 'daily', 'fluid', 'balance', ',', 'fluid', 'balance', 'discharge', 'intensive', 'care', 'unit', ',', 'time', 'to', 'neutral', 'fluid', 'balance', ',', 'number', 'of', 'serious', 'adverse', 'reaction', 'and', 'number', 'of', 'protocol', 'violation', '.', 'patient', 'followed', 'day', '.', 'discussion', 'ffaki', 'trial', 'started', 'in', 'october', 'and', ',', 'completed', ',', 'provide', 'data', 'to', 'evaluate', 'whether', 'large', 'trial', 'of', 'forced', 'fluid', 'removal', 'in', 'critically', 'ill', 'patient', 'feasible', '.', 'primary', 'outcome', 'show', 'experimental', 'intervention', 'lead', 'to', 'clinically', 'relevant', 'difference', 'in', 'fluid', 'balance', ',', 'could', 'prove', 'beneficial', 'in', 'intensive', 'care', 'patient', 'with', 'acute', 'kidney', 'injury', '.', 'trial', 'registration', 'eudract', ',', 'identifier', '--', '.', 'registered', 'september', 'clinicaltrials.gov', ',', 'identifier', 'nct', '.', 'registered', 'may', 'danish', 'ethic', 'committee', ',', 'identifier', 'h-h.', 'registered', 'september', 'danish', 'health', 'and', 'medicine', 'authority', ',', 'identifier', '.', 'registered', 'august', '.']"
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.,"Damian Wild, Henning Grønbæk, Shaunak Navalkissoor, Alexander Haug, Guillaume P Nicolas, Ben Pais, Catherine Ansquer, Jean-Mathieu Beauregard, Alexander McEwan, Michael Lassmann, Daniele Pennestri, Magali Volteau, Nat P Lenzo, Rodney J Hicks, Damian Wildet al.",2023 Dec,Eur J Nucl Med Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/37721581/,No keywords found,"['present', 'result', 'of', 'open-label', ',', 'phase', 'iii', 'study', 'evaluating', 'safety', 'and', 'efficacy', 'of', 'novel', 'somatostatin', 'receptor', '(', 'sstr', ')', 'antagonist', 'lulu-satoreotide', 'tetraxetan', 'in', 'patient', 'with', 'previously', 'treated', ',', 'progressive', 'neuroendocrine', 'tumour', '(', 'net', ')', ',', 'in', 'dosimetry', 'used', 'to', 'guide', 'maximum', 'administered', 'activity', '.', 'method', 'study', 'conducted', 'in', 'two', 'part', '.', 'part', 'consisted', 'of', 'patient', 'completed', 'three', 'cycle', 'of', 'lulu-satoreotide', 'tetraxetan', 'fixed', 'administered', 'activity', 'and', 'peptide', 'amount', 'per', 'cycle', '(', '.', 'gbq', 'g', ')', '.', 'part', 'b', ',', 'included', 'patient', 'received', 'one', 'to', 'five', 'cycle', 'of', 'lulu-satoreotide', 'tetraxetan', ',', 'evaluated', 'different', 'administered', 'activity', '(', '.', 'or', '.', 'gbqcycle', ')', 'and', 'peptide', 'amount', '(', ',', ',', 'or', 'gcycle', ')', ',', 'limited', 'to', 'cumulative', 'absorbed', 'radiation', 'dose', 'of', 'gy', 'to', 'kidney', 'and', '.', 'gy', 'to', 'bone', 'marrow', '.', 'result', 'median', 'cumulative', 'administered', 'activity', 'of', 'lulu-satoreotide', 'tetraxetan', '.', 'gbq', 'three', 'cycle', '(', '.', 'gbq', 'in', 'part', 'and', '.', 'gbq', 'in', 'part', 'b', ')', '.', 'overall', ',', '(', '.', ')', 'patient', 'experienced', 'grade', 'treatmentrelated', 'adverse', 'event', 'common', 'lymphopenia', ',', 'thrombocytopenia', ',', 'and', 'neutropenia', '.', 'no', 'grade', 'nephrotoxicity', 'observed', '.', 'two', 'patient', 'developed', 'myeloid', 'neoplasm', 'considered', 'treatment', 'related', 'investigator', '.', 'disease', 'control', 'rate', 'part', 'and', 'part', 'b', '.', '(', 'confidence', 'interval', 'ci', '.-', '.', ')', ',', 'and', 'overall', 'response', 'rate', '.', '(', 'ci', '.-.', ')', '.', 'conclusion', 'lulu-satoreotide', 'tetraxetan', ',', 'administered', 'median', 'cumulative', 'activity', 'of', '.', 'gbq', 'three', 'cycle', ',', 'acceptable', 'safety', 'profile', 'with', 'promising', 'clinical', 'response', 'in', 'patient', 'with', 'progressive', ',', 'sstr-positive', 'net', '.', '-year', 'long-term', 'follow-up', 'study', 'ongoing', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'nct', '.', 'registered', 'october', ',', '.']"
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.,"Peter Pickkers, Ravindra L Mehta, Patrick T Murray, Michael Joannidis, Bruce A Molitoris, John A Kellum, Mirjam Bachler, Eric A J Hoste, Oscar Hoiting, Kenneth Krell, Marlies Ostermann, Wim Rozendaal, Miia Valkonen, David Brealey, Albertus Beishuizen, Ferhat Meziani, Raghavan Murugan, Hilde de Geus, Didier Payen, Erik van den Berg, Jacques Arend                              ;, STOP-AKI Investigators, Jacques Arend, Eric Hoste, John Kellum, Ravindra Mehta, Bruce Molitoris, Raghaven Murugan, Antonio Artigas Raventos, Frederic Bellec, Antoni Betbese Roig, Azra Bihorac, Thierry Boulain, Edward Cordasco, Dianna Cruz, Jacques Devriendt, Alain Dive, Joseph Eustace, Lui G. Forni, Kevin Finkel, Bruno Francois, Rita Galeiras, Herwig Gerlach, Richard Gerritsen, Matthias Gründling, Luis Jauregui-Peredo, Olivier Joannes-Boyau, Luis Juncos, Sari Karlsson, Kallirroi Kefale, Andreas Kortgen, Giacomo Monti, Raili Laru-Sompa, Pierre-Francois Laterre, Jean-Yves Lefrant, Nicolas Lerolle, Bruno Levy, Andrew Lewington, Jose Lorente, Rafael Manez Mendiluce, Laurent Martin-Lefevre, Martin Matejovic, Andreas Meier-Hellmann, Emmanuelle Mercier, Martin Novacek, Axel Nierhaus, Ronald Pearl, Enrique Piacentini, Michaël Piagnerelli, Gaetan Plantefève, John R. Prowle, Jean-Pierre Quenot, Anjay Rastogi, Jean Reignier, Rene Robert, Ricard Ferrer Roca, Monica Rocco, Alejandro Rodriguez Oviedo, Ignacio Saez de la Fuente, Fernando Martinez Sagasti, Martin Sauer, Fenna J. Schoonderbeek, Matthew Sims, Herbert Spapen, Peter E Spronk, Vladimir Sramek, Thomas Staudinger, Jay Steingrub, Charuhas V Thakar, Robert Thompson, Ashita J Tolwani, Teresa Maria Tomasa Irriguible, Pieter R. Tuinman, Ari Uusaro, Benoît Veber, Jean-Louis Vincent, Jacques Creteur, Anitha Vijayan, Norbert Weiler, James Welker, Tobias Welte, Jason Wilson, Kai Zacharowski, Pleun Hemelaar, Rob ten Pas, Willem Raaben, Annelies Resink, Alistair Nichol, Peter Pickkerset al.",2018 Nov 20,JAMA,https://pubmed.ncbi.nlm.nih.gov/30357272/,No keywords found,"['sepsis-associated', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'adversely', 'affect', 'long-term', 'kidney', 'outcome', 'and', 'survival', '.', 'administration', 'of', 'detoxifying', 'enzyme', 'alkaline', 'phosphatase', 'may', 'improve', 'kidney', 'function', 'and', 'survival', '.', 'objective', 'to', 'determine', 'optimal', 'therapeutic', 'dose', ',', 'effect', 'kidney', 'function', ',', 'and', 'adverse', 'effect', 'of', 'human', 'recombinant', 'alkaline', 'phosphatase', 'in', 'patient', 'critically', 'ill', 'with', 'sepsis-associated', 'aki', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'stop-aki', 'trial', 'international', '(', 'recruiting', 'site', ')', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'dose-finding', ',', 'adaptive', 'phase', 'ab', 'study', 'in', 'adult', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', 'with', 'diagnosis', 'of', 'sepsis', 'and', 'aki', '.', 'patient', 'enrolled', 'december', 'and', 'may', ',', 'and', 'follow-up', 'conducted', 'day', '.', 'final', 'date', 'of', 'follow-up', 'august', ',', '.', 'intervention', 'in', 'intention-to-treat', 'analysis', ',', 'in', 'part', 'of', 'trial', ',', 'patient', 'randomized', 'to', 'receive', 'recombinant', 'alkaline', 'phosphatase', 'in', 'dosage', 'of', '.', 'mgkg', '(', 'n', ')', ',', '.', 'mgkg', '(', 'n', ')', ',', 'or', '.', 'mgkg', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', ',', 'daily', 'day', ',', 'to', 'establish', 'optimal', 'dose', '.', 'optimal', 'dose', 'identified', '.', 'mgkg', 'based', 'modeling', 'approach', 'and', 'adverse', 'event', '.', 'in', 'part', ',', '.', 'mgkg', '(', 'n', ')', 'compared', 'with', 'placebo', '(', 'n', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', 'time-corrected', 'area', 'curve', 'of', 'endogenous', 'creatinine', 'clearance', 'day', ',', 'divided', 'to', 'provide', 'mean', 'daily', 'creatinine', 'clearance', '(', 'auc-', 'ecc', ')', '.', 'incidence', 'of', 'fatal', 'and', 'nonfatal', '(', 'serious', ')', 'adverse', 'event', '(', 'saes', ')', 'also', 'determined', '.', 'result', 'overall', ',', 'patient', 'enrolled', '(', 'men', ',', '.', 'median', 'age', ',', 'year', 'interquartile', 'range', 'iqr', ',', '-', ')', '.', 'day', 'to', 'day', ',', 'median', 'ecc', 'increased', '.', 'mlmin', '(', 'iqr', ',', '.', 'to', '.', ')', 'to', '.', 'mlmin', '(', 'iqr', ',', '.', 'to', '.', ')', 'in', 'recombinant', 'alkaline', 'phosphatase', '.-mgkg', 'group', 'v', '.', 'mlmin', '(', 'iqr', ',', '.', 'to', '.', ')', 'to', '.', 'mlmin', '(', 'iqr', ',', '.', 'to', '.', ')', 'in', 'placebo', 'group', '(', 'absolute', 'difference', ',', '.', 'mlmin', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'fatal', 'adverse', 'event', 'occurred', 'in', '.', 'of', 'patient', 'in', '.-mgkg', 'recombinant', 'alkaline', 'phosphatase', 'group', '.', 'in', '.-mgkg', 'group', ',', '.', 'in', '.-mgkg', 'group', ',', 'and', '.', 'in', 'placebo', 'group', '.', 'rate', 'of', 'nonfatal', 'saes', '.', '.-mgkg', 'recombinant', 'alkaline', 'phosphatase', 'group', ',', '.', '.-mgkg', 'group', ',', '.', '.-mgkg', 'group', ',', 'and', '.', 'placebo', 'group', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'critically', 'ill', 'with', 'sepsis-associated', 'acute', 'kidney', 'injury', ',', 'human', 'recombinant', 'alkaline', 'phosphatase', 'compared', 'with', 'placebo', 'not', 'significantly', 'improve', 'short-term', 'kidney', 'function', '.', 'research', 'necessary', 'to', 'assess', 'clinical', 'outcome', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
PEAR1 is not a human hypertension-susceptibility gene.,"Laura Olivi, Christophe Vandenbriele, Yu-Mei Gu, Erika Salvi, Simona Delli Carpini, Yan-Ping Liu, Lotte Jacobs, Yu Jin, Lutgarde Thijs, Lorena Citterio, Daniele Cusi, Peter Verhamme, Jan A Staessen, Laura Oliviet al.",2015 Feb,Blood Press,https://pubmed.ncbi.nlm.nih.gov/25541647/,No keywords found,"['platelet', 'endothelial', 'aggregation', 'receptor', '(', 'pear', ')', 'membrane', 'protein', 'involved', 'in', 'platelet', 'contact-induced', 'activation', 'and', 'sustained', 'platelet', 'aggregation', '.', 'experimental', 'study', 'identified', 'pear', ',', 'candidate', 'gene', 'may', 'linked', 'to', 'blood-pressure', 'driven', 'kidney', 'injury', 'in', 'salt-sensitive', 'dahl', 'rat', '.', 'aim', 'in', 'family-based', 'european', 'population', 'study', '(', 'mean', 'age', '.', 'year', '.', 'woman', ')', ',', 'searched', 'association', 'of', 'change', 'in', 'blood', 'pressure', 'or', 'incidence', 'of', 'hypertension', 'with', 'genetic', 'variation', 'in', 'pear', '.', 'method', 'among', 'randomly', 'recruited', 'people', ',', 'genotyped', 'pear', ',', 'measured', 'blood', 'pressure', 'baseline', 'and', 'follow-up', '.', 'result', 'median', 'follow-up', '.', 'year', '.', 'accounting', 'family', 'cluster', 'and', 'blood', 'pressure', 'baseline', 'and', 'with', 'adjustment', 'applied', 'sex', ',', 'age', ',', 'body', 'mass', 'index', ',', 'smoking', 'and', 'drinking', ',', 'total', 'cholesterol', ',', 'and', 'antihypertensive', 'drug', 'treatment', ',', 'association', 'of', 'systolic', 'and', 'diastolic', 'blood', 'pressure', 'change', 'with', 'nine', 'single', 'nucleotide', 'polymorphism', '(', 'snp', ')', 'in', 'pear', 'non-significant', '(', 'p', '.', ')', '.', 'with', 'similar', 'adjustment', ',', 'incidence', 'of', 'hypertension', '(', 'case', 'among', 'participant', 'normotensive', 'baseline', '.', ')', 'not', 'related', 'to', 'snp', 'in', 'pear', '(', 'hazard', 'ratio', '.', 'p', '.', ')', '.', 'conclusion', 'study', 'suggests', 'pear', 'not', 'hypertension', 'susceptibility', 'gene', 'in', 'human', '.']"
Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia.,"Xi-Ting Liu, Yan-Xia Zhao, Guang-Wei Jia, Fan Yang, Chuan-Zhou Zhang, Bing Han, Jian-Hua Dai, Yue-Qin Han, Bo-Hao Tang, Xin-Mei Yang, Hai-Yan Shi, Yue Zhou, Zhong-Guo Sui, Jian-Zhong Chen, Johannes N van den Anker, Wei Zhao, Xi-Ting Liuet al.",2021 Aug,Br J Clin Pharmacol,https://pubmed.ncbi.nlm.nih.gov/33506975/,No keywords found,"['open-label', ',', 'phase', 'study', 'evaluated', 'pharmacokinetics', 'and', 'safety', 'of', 'pegylated', 'recombinant', 'human', 'granulocyte', 'colony-stimulating', 'factor', '(', 'peg-rhg-csf', ')', 'treatment', 'of', 'chemotherapy-induced', 'neutropenia', 'in', 'child', 'with', 'acute', 'leukaemia', '.', 'method', 'peg-rhg-csf', 'administered', 'single', 'mcgkg', '(', 'mg', 'maximum', 'dose', ')', 'subcutaneous', 'injection', 'end', 'of', 'chemotherapy', 'period', 'neutropenia', 'occurred', '.', 'blood', 'sample', 'obtained', 'patient', 'treated', 'with', 'peg-rhg-csf', '.', 'peg-rhg-csf', 'serum', 'concentration', 'determined', 'enzyme-linked', 'immunosorbent', 'assay', '.', 'population', 'pharmacokinetic', '(', 'ppk', ')', 'analysis', 'implemented', 'using', 'nonlinear', 'mixed-effects', 'model', '.', 'short-term', 'safety', 'evaluated', 'adverse', 'event', 'collection', '(', 'registered', 'clinicaltrials.gov', 'identifier', ')', '.', 'result', 'total', 'of', 'acute', 'leukaemia', 'patient', '(', '.-', '.', 'year', ')', 'included', ',', 'of', 'two', '(', '.', ')', 'grade', 'neutropenia', ',', 'six', '(', '.', ')', 'grade', 'neutropenia', ',', 'and', 'eight', '(', '.', ')', 'severe', 'neutropenia', '.', 'ppk', 'modelling', ',', 'peg-rhg-csf', 'serum', 'concentration', 'obtainable', '.', 'one-compartment', 'model', 'with', 'first-order', 'elimination', 'used', 'pharmacokinetic', 'data', 'modelling', '.', 'current', 'weight', 'significant', 'covariate', '.', 'median', '(', 'range', ')', 'of', 'clearance', '(', 'cl', ')', 'and', 'area', 'serum', 'concentration-time', 'curve', '(', 'auc', ')', '.', '(', '.-', '.', ')', 'mlhkg', 'and', '.', '(', '.-', '.', ')', 'nghml', ',', 'respectively', '.', 'bone', 'pain', ',', 'pyrexia', ',', 'anaphylaxis', 'and', 'nephrotoxicity', 'not', 'observed', '.', 'one', 'patient', 'died', 'day', 'administration', ',', 'and', 'objective', 'assessment', 'of', 'causality', 'association', 'with', 'peg-rhg-csf', '``', 'possible', ""''"", '.', 'conclusion', 'auc', 'of', 'peg-rhg-csf', '(', 'mcgkg', ',', 'mg', 'maximum', 'dose', ')', 'in', 'paediatric', 'patient', 'with', 'acute', 'leukaemia', 'similar', 'to', 'of', 'peg-rhg-csf', '(', 'mcgkg', ')', 'in', 'child', 'with', 'sarcoma', '.', 'peg-rhg-csf', 'safe', ',', 'representing', 'important', 'therapeutic', 'option', 'chemotherapy-induced', 'neutropenia', 'in', 'paediatric', 'patient', 'with', 'acute', 'leukaemia', '.']"
"Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia.","Eveline P van Poelgeest, Marlous R Dillingh, Marieke de Kam, Karen E Malone, Marleen Kemper, Erik S G Stroes, Jacobus Burggraaf, Matthijs Moerland, Eveline P van Poelgeestet al.",2018 Jan-Feb:89:39-46.,J Pharmacol Toxicol Methods,https://pubmed.ncbi.nlm.nih.gov/29056520/,No keywords found,"['although', 'effect', 'of', 'relatively', 'high', 'concentration', 'of', 'endotoxin', 'endothelial', 'activationdysfunction', 'and', 'kidney', 'marker', 'described', 'in', 'literature', ',', 'detailed', 'insight', 'in', 'lp', 'concentration-effect', 'relationship', ',', 'magnitude', ',', 'variability', 'and', 'timing', 'of', 'response', ',', 'and', 'potential', 'effect', 'of', 'endotoxemia', 'kidney', 'lacking', '.', 'study', 'performed', 'to', 'assess', 'effect', 'of', 'low-', 'to', 'moderate', 'dose', '(', '.', ',', 'or', 'ngkg', ')', 'endotoxemia', 'endothelium', 'and', 'kidney', 'measured', 'panel', 'of', 'novel', 'highly', 'sensitive', 'kidney', 'injury', 'marker', '.', 'method', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'study', 'with', 'single', 'ascending', 'dos', 'of', 'lp', '(', '.', ',', 'or', 'ngkg', ')', 'administered', 'to', 'healthy', 'male', 'volunteer', '(', 'cohort', 'of', 'subject', ',', 'lpsplacebo', ')', '.', 'endothelial', 'measure', 'included', 'selectins', ',', 'cell', 'adhesion', 'molecule', ',', 'and', 'thrombomodulin', '.', 'renal', 'measure', 'included', 'novel', ',', 'sensitive', 'and', 'specific', 'biomarkers', 'of', 'acute', 'kidney', 'injury', '.', 'result', 'endotoxin', 'exposure', 'resulted', 'in', 'consistent', 'lp', 'dose-dependent', 'response', 'in', 'inflammatory', 'marker', ',', 'e-', 'and', 'p-', 'selectin', ',', 'vcam', ',', 'icam', ',', 'and', 'thrombomodulin', '.', 'observed', 'biological', 'response', 'transient', ',', 'reaching', 'level', 'of', 'significance', 'of', 'least', '.', 'in', 'highest', 'dose', 'group', 'and', 'with', 'effect', 'size', 'dependent', 'administered', 'lp', 'dose', '.', 'lps-induced', 'inflammatory', 'and', 'endothelial', 'effect', 'not', 'translate', 'change', 'in', 'renal', 'damage', 'biomarkers', ',', 'although', 'ngkg', 'lp', ',', 'subtle', 'and', 'transient', 'biomarker', 'change', 'observed', 'may', 'relate', 'to', '(', 'subclinical', ')', 'tubular', 'damage', '.', 'discussion', 'demonstrated', 'administration', 'of', 'single', 'lp', 'dose', 'of', 'ngkg', 'to', 'healthy', 'volunteer', 'result', 'in', 'significant', 'inflammatory', 'and', 'endothelial', 'response', ',', 'without', 'inducing', 'clinically', 'relevant', 'sign', 'of', 'kidney', 'injury', '.', 'finding', 'support', 'application', 'of', 'human', 'endotoxemia', 'model', 'in', 'future', 'clinical', 'pharmacology', 'study', '.']"
LUDT-ADHF trial: Lung ultrasound-guided diuretic therapy for hospitalized patients with acute decompensated heart failure: An open-label clinical trial.,"Masoud Kashoob, Salim Al-Busaidi, Juhaina Salim Al-Maqbali, Amira Al-Badi, Aya Aalhamad, Zubaida Al Falahi, Aisha Al Huraizi, Hatem Al Farhan, Khalfan Al Zeedy, Abdul Hakeem Al Hashim, Mohammed H Al-Ghailani, Muhammad Shoaib, Haitham El Bingawi, Abdullah M Al Alawi, Masoud Kashoobet al.",2025 Jan-Feb:69:155-162.,Heart Lung,https://pubmed.ncbi.nlm.nih.gov/39437536/,"90-day readmissions, Acute decompensated heart failure, All-cause readmissions, B-line, Hospitalization, Lung ultrasound, Mortality.","['control', 'and', 'lu', '.', 'median', 'age', 'of', 'patient', 'year', ',', 'with', 'woman', 'slightly', 'outnumbering', 'men', '(', '.', ',', 'n', ')', '.', 'prevalent', 'comorbidities', 'hypertension', '(', '.', ',', 'n', ')', ',', 'diabetes', 'mellitus', '(', '.', ',', 'n', ')', ',', 'and', 'chronic', 'kidney', 'disease', '(', '.', ',', 'n', ')', '.', 'lu', 'group', 'shorter', 'los', ',', 'though', 'not', 'statistically', 'significant', '(', 'v', 'five', 'day', ',', 'p', '.', ')', '.', 'patient', 'in', 'lu', 'group', 'significantly', 'fewer', '-day', 'adhf', 'readmission', 'compared', 'to', 'control', 'group', '(', '.', 'vs.', '.', 'p.', ')', '.', 'survival', 'analysis', 'demonstrated', 'lu', 'group', 'longer', 'time', 'to', '-day', 'adhf', 'readmission', ',', 'with', 'hazard', 'ratio', '(', 'hr', ')', 'of', '.', '(', 'ci', '.-.', ',', 'p.', ')', '.', '-day', 'all-cause', 'readmission', ',', 'lu', 'group', 'also', 'showed', 'longer', 'time', 'to', 'readmission', 'compared', 'to', 'control', ',', 'with', 'hr', 'of', '.', '(', 'ci', '.-.', ',', 'p.', ')', '.', 'safety', 'measure', ',', 'no', 'significant', 'difference', 'in', 'incidence', 'of', 'adverse', 'event', ',', 'including', 'acute', 'kidney', 'injury', ',', 'hypokalaemia', ',', 'or', 'hypotension', ',', 'lu', 'and', 'control', 'group', '.', 'conclusion', 'lu', 'might', 'reduce', 'in-hospital', 'mortality', 'and', 'readmission', 'among', 'adult', 'with', 'acute', 'decompensated', 'hf', '.', 'however', ',', 'double-blinded', 'randomized', 'clinical', 'trial', 'needed', 'to', 'confirm', 'preliminary', 'result', '.']"
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).,"John K Chan, William Brady, Bradley J Monk, Jubilee Brown, Mark S Shahin, Peter G Rose, Jae-Hoon Kim, Angeles Alvarez Secord, Joan L Walker, David M Gershenson, John K Chanet al.",2018 Aug,Gynecol Oncol,https://pubmed.ncbi.nlm.nih.gov/29921512/,No keywords found,"['to', 'determine', 'efficacy', 'and', 'tolerability', 'of', 'sunitinib', 'in', 'recurrent', 'or', 'persistent', 'clear', 'cell', 'ovarian', 'cancer', 'patient', '.', 'method', 'patient', 'one', 'or', 'two', 'prior', 'regimen', 'with', 'measurable', 'disease', '.', 'tumor', 'least', 'clear', 'cell', 'histomorphology', 'and', 'negative', 'wt-', 'antigen', 'and', 'estrogen', 'receptor', 'expression', 'immunohistochemistry', '.', 'sunitinib', 'mg', 'per', 'day', 'week', 'administered', 'in', 'repeated', '-week', 'cycle', 'disease', 'progression', 'or', 'prohibitive', 'toxicity', '.', 'primary', 'end', 'point', 'progression-free', 'survival', '(', 'pfs', ')', 'month', 'and', 'clinical', 'response', '.', 'study', 'designed', 'to', 'determine', 'drug', 'response', 'rate', 'of', 'least', 'or', '-month', 'pfs', 'of', 'least', '.', 'result', 'of', 'patient', 'enrolled', ',', 'treated', 'and', 'eligible', '(', 'median', 'age', ',', 'range', '-', ')', '.', 'twenty-five', '(', ')', 'white', ',', '(', ')', 'asian', ',', 'and', '(', ')', 'unknown', '.', 'majority', '(', ')', 'patient', ',', 'underwent', '(', ')', 'course', 'of', 'study', 'therapy', '.', 'five', '(', '.', ')', 'patient', 'pfs', 'month', '(', 'ci', '.-.', ')', '.', 'two', '(', '.', ')', 'patient', 'partial', 'or', 'complete', 'response', '(', 'ci', '.-.', ')', '.', 'median', 'pfs', '.', 'month', '.', 'median', 'overall', 'survival', '.', 'month', '.', 'common', 'grade', 'adverse', 'event', 'fatigue', '(', ')', ',', 'hypertension', '(', ')', ',', 'neutropenia', '(', ')', ',', 'anemia', '(', ')', ',', 'abdominal', 'pain', '(', ')', ',', 'and', 'leukopenia', '(', ')', '.', 'grade', '-', 'adverse', 'event', 'included', 'thrombocytopenia', '(', ')', ',', 'anemia', '(', ')', ',', 'acute', 'kidney', 'injury', '(', ')', ',', 'stroke', '(', ')', ',', 'and', 'allergic', 'reaction', '(', ')', '.', 'conclusion', 'sunitinib', 'demonstrated', 'minimal', 'activity', 'in', 'second-', 'and', 'third-line', 'treatment', 'of', 'persistent', 'or', 'recurrent', 'clear', 'cell', 'ovarian', 'carcinoma', '.', 'clinicaltrials.gov', 'number', ',', 'nct', '.']"
"Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial.","José M Cisneros, Clara María Rosso-Fernández, Cristina Roca-Oporto, Gennaro De Pascale, Silvia Jiménez-Jorge, Esteban Fernández-Hinojosa, Dimitrios K Matthaiou, Paula Ramírez, Ramón Ortiz Díaz-Miguel, Angel Estella, Massimo Antonelli, George Dimopoulos, José Garnacho-Montero                              ;, Magic Bullet Working Group WP, V Di Gravio, G Bello, V González, R Leal, A Puppo, J A Lepe, A Gutiérrez-Pizarraya, E Villarreal, M C Espinosa, M J Polanco, M D López, M E Herrera-Gutiérrez, G Seller, S Zakinthinos, S Malachias, A Komnos, T Zafeiridis, R Sierra, A González, E Zakynthinos, L Alvárez-Rocha, M Victoria de la Torre, P J Domínguez, M Bitsan, A Koutsoukou, R Zaragoza, E De Roberts, J M Allegue, J Carlos Pozo, G Nakos, R Ferrer, I Pneumatikos, P Vidal, José Garnacho-Montero, José M Cisneroset al.",2019 Nov 28,Crit Care,https://pubmed.ncbi.nlm.nih.gov/31779711/,No keywords found,"['colistin', 'recommended', 'in', 'empirical', 'treatment', 'of', 'ventilator-associated', 'pneumonia', '(', 'vap', ')', 'with', 'high', 'prevalence', 'of', 'carbapenem-resistant', 'gram-negative', 'bacillus', '(', 'cr-gnb', ')', '.', 'however', ',', 'efficacy', 'and', 'safety', 'of', 'colistin', 'not', 'well', 'defined', '.', 'method', 'multicenter', 'prospective', 'randomized', 'trial', 'conducted', 'in', 'european', 'center', 'compared', 'efficacy', 'and', 'safety', 'of', 'colistin', '(', '.', 'million', 'unit', 'loading', 'dose', 'followed', 'maintenance', 'dose', 'of', 'million', 'unit', 'every', 'h', ')', 'versus', 'meropenem', '(', 'g', 'every', 'h', ')', ',', 'in', 'combination', 'with', 'levofloxacin', '(', 'mg', 'every', 'h', ')', '-', 'day', 'in', 'patient', 'with', 'late', 'vap', '.', 'may', 'and', 'october', ',', 'patient', 'randomly', 'assigned', 'to', 'treatment', 'group', '.', 'primary', 'endpoint', 'mortality', 'day', 'randomization', 'in', 'microbiologically', 'modified', 'intention-to-treat', '(', 'mmitt', ')', 'population', '.', 'secondary', 'outcome', 'included', 'clinical', 'and', 'microbiological', 'cure', ',', 'renal', 'function', 'end', 'of', 'treatment', ',', 'and', 'serious', 'adverse', 'event', '.', 'study', 'interrupted', 'interim', 'analysis', 'due', 'to', 'excessive', 'nephrotoxicity', 'in', 'colistin', 'group', 'therefore', ',', 'sample', 'size', 'not', 'achieved', '.', 'result', 'total', 'of', '(', '.', ')', 'patient', 'included', 'in', 'mmitt', 'population', ',', 'of', '(', '.', ')', 'vap', 'caused', 'cr-gnb', '.', 'in', 'mmitt', 'population', ',', 'no', 'significant', 'difference', 'in', 'mortality', 'colistin', 'group', '(', ',', '.', ')', 'and', 'meropenem', 'group', '(', ',', '.', ')', 'observed', ',', 'with', 'risk', 'difference', 'of', '-', '.', '(', '-', '.', 'to', '.', ',', 'p', '.', ')', 'noninferiority', 'of', 'colistin', 'not', 'demonstrated', 'due', 'to', 'early', 'termination', 'and', 'limited', 'number', 'of', 'patient', 'infected', 'carbapenem-resistant', 'pathogen', '.', 'colistin', 'plus', 'levofloxacin', 'increased', 'incidence', 'of', 'renal', 'failure', '(', ',', '.', ',', 'versus', ',', '.', 'p', '.', ')', 'and', 'renal', 'replacement', 'therapy', '(', ',', '.', ',', 'versus', ',', '.', 'p', '.', ')', '.', 'conclusion', 'study', 'not', 'demonstrate', 'noninferiority', 'of', 'colistin', 'compared', 'with', 'meropenem', ',', 'combined', 'with', 'levofloxacin', ',', 'in', 'term', 'of', 'efficacy', 'in', 'empirical', 'treatment', 'of', 'late', 'vap', 'demonstrated', 'greater', 'nephrotoxicity', 'of', 'colistin', '.', 'finding', 'not', 'support', 'empirical', 'use', 'of', 'colistin', 'treatment', 'of', 'late', 'vap', 'due', 'to', 'early', 'termination', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'nct', '.', 'registered', 'february', '.']"
Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.,"Wen-Jun Yin, Yi-Hu Yi, Xiao-Feng Guan, Ling-Yun Zhou, Jiang-Lin Wang, Dai-Yang Li, Xiao-Cong Zuo, Wen-Jun Yinet al.",2017 Feb 3,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/28159819/,No keywords found,"['several', 'model', 'developed', 'prediction', 'of', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'however', ',', 'contain', 'patient', 'receiving', 'intra-arterial', 'contrast', 'medium', 'coronary', 'angiographic', 'procedure', ',', 'represent', 'small', 'proportion', 'of', 'contrast', 'procedure', '.', 'in', 'addition', ',', 'of', 'evaluate', 'radiological', 'interventional', 'procedure-related', 'variable', '.', 'necessary', 'u', 'to', 'develop', 'model', 'prediction', 'of', 'cin', 'radiological', 'procedure', 'among', 'patient', 'administered', 'contrast', 'medium', '.', 'method', 'and', 'result', 'total', 'of', 'patient', 'undergoing', 'contrast', 'administration', 'randomly', 'assigned', 'in', 'ratio', 'to', 'development', 'and', 'validation', 'data', 'set', '.', 'cin', 'defined', 'increase', 'of', 'andor', '.', 'mgdl', 'in', 'serum', 'creatinine', 'within', 'hour', 'baseline', 'value', '.', 'preprocedural', 'clinical', 'variable', 'used', 'to', 'develop', 'prediction', 'model', 'training', 'data', 'set', 'machine', 'learning', 'method', 'of', 'random', 'forest', ',', 'and', '-fold', 'cross-validation', 'used', 'to', 'evaluate', 'prediction', 'accuracy', 'of', 'model', '.', 'finally', 'tested', 'model', 'in', 'validation', 'data', 'set', '.', 'incidence', 'of', 'cin', '..', 'built', 'prediction', 'model', 'with', 'preprocedural', 'variable', 'selected', 'variable', '.', 'model', 'obtained', 'area', 'receiver-operating', 'characteristic', '(', 'roc', ')', 'curve', '(', 'auc', ')', 'of', '.', 'and', 'gave', 'prediction', 'accuracy', 'of', '.', ',', 'sensitivity', 'of', '.', ',', 'specificity', 'of', '.', ',', 'and', 'matthew', 'correlation', 'coefficient', 'of', '..', 'first', 'time', ',', 'new', 'factor', 'included', 'in', 'model', 'decreased', 'sodium', 'concentration', ',', 'inr', 'value', ',', 'and', 'preprocedural', 'glucose', 'level', '.', 'conclusion', 'newly', 'established', 'model', 'show', 'excellent', 'predictive', 'ability', 'of', 'cin', 'development', 'and', 'thereby', 'provides', 'preventative', 'measure', 'cin', '.']"
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.,"Peter Rossing, Geoffrey A Block, Melanie P Chin, Angie Goldsberry, Hiddo J L Heerspink, Peter A McCullough, Colin J Meyer, David Packham, Pablo E Pergola, Bruce Spinowitz, Stuart M Sprague, David G Warnock, Glenn M Chertow, Peter Rossinget al.",2019 Oct,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/31377056/,"albuminuria, chronic kidney disease, diabetic nephropathy, oxidative stress.","['-', '.', 'confidence', 'interval', '-', '.', 'to', '-.', ')', '.', 'thus', ',', 'among', 'patient', 'with', 'type', 'diabetes', 'mellitus', 'and', 'stage', 'chronic', 'kidney', 'disease', 'treated', 'with', 'bardoxolone', 'methyl', ',', 'change', 'in', 'albuminuria', 'directly', 'related', 'to', 'change', 'in', 'egfr', ',', 'challenging', 'conventional', 'construct', 'increase', 'in', 'albuminuria', 'universally', 'reflect', 'kidney', 'injury', 'and', 'denote', 'harm', '.']"
Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients.,"Chien-Yu Cheng, Shu-Yin Chang, Mei-Hui Lin, Shin-Yen Ku, Na-Lee Sun, Shu-Hsing Cheng, Chien-Yu Chenget al.",2016 Nov,J Infect Chemother,https://pubmed.ncbi.nlm.nih.gov/27613487/,No keywords found,"['tenofovir', 'disoproxil', 'fumarate', '(', 'tdf', ')', '-containing', 'regimen', 'associated', 'with', 'nephrotoxicity', 'and', 'hypophosphatemia', 'in', 'hiv-infected', 'patient', '.', 'objective', 'of', 'study', 'to', 'assess', 'possible', 'risk', 'factor', 'hypophosphatemia', 'and', 'evaluate', 'relationship', 'fractional', 'excretion', 'of', 'filtered', 'phosphate', '(', 'fepi', ')', 'and', 'hypophosphatemia', 'in', 'tdf', 'user', '.', 'patient', 'and', 'method', 'patient', 'enrolled', 'in', 'prospective', 'cohort', 'study', 'january', 'and', 'december', '.', 'classified', 'experienced', 'hiv-infected', 'patient', '(', 'individual', 'maintained', 'antiretroviral', 'therapy', '(', 'art', ')', 'month', 'or', ')', 'and', 'nave', 'patient', 'treatment', 'group', 'tdf-containing', 'art', '(', 'group', ')', ',', 'non-tdf-containing', 'art', '(', 'never', 'received', 'tdf', 'or', 'not', 'received', 'tdf', 'in', 'past', 'month', 'group', ')', 'and', 'naive', 'to', 'antiretroviral', 'therapy', '(', 'group', ')', '.', 'specimen', 'individual', 'assessed', 'serum', 'phosphate', ',', 'serum', 'creatinine', ',', 'urine', 'phosphate', ',', 'and', 'urine', 'creatinine', '.', 'multivariable', 'logistic', 'regression', 'performed', 'to', 'control', 'following', 'variable', 'measured', 'baseline', 'egfr', ',', 'age', ',', 'sex', ',', 'sexual', 'orientation', ',', 'injection', 'drug', 'use', '(', 'idus', ')', ',', 'hiv-rna', 'viral', 'load', ',', 'and', 'cd', 'cell', 'count', '.', 'result', 'frequency', 'of', 'hypophosphatemia', 'in', 'group', ',', ',', 'and', '.', ',', '.', ',', 'and', '.', ',', 'respectively', '(', 'p', '.', ')', '.', 'fepi', 'also', 'significantly', 'associated', 'with', 'hypophosphatemia', '(', 'p', '.', 'adjusted', 'odds', 'ratio', '.', ')', '.', 'patient', 'with', 'elevated', 'cd', 'cell', 'count', '(', 'cellsl', ')', 'exhibited', 'lower', 'risk', 'of', 'hypophosphatemia', '(', 'p', '.', 'adjusted', 'odds', 'ratio', '.', ')', '.', 'conclusion', 'hypophosphatemia', 'multifactorial', 'etiology', 'fepi', 'confirmed', 'suggested', 'method', 'to', 'predict', 'risk', 'of', 'hypophosphatemia', 'in', 'tdf', 'user', '.', 'clinical', 'trial', 'number', 'tygh', '.']"
Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial.,"Kamrouz Ghadimi, Jhaymie Cappiello, Mary Cooter-Wright, John C Haney, John M Reynolds, Brandi A Bottiger, Jacob A Klapper, Jerrold H Levy, Matthew G Hartwig                              ;, INSPIRE-FLO Investigators, Angelito Agbo, Terry Ainsworth, Hakim A Ali, Samuel Belgique, Tiffany Bisanar, Michael Blank, Desiree Bonadonna, Jason Boyle, Carla Bremenour, Jessica Burroughs, Rachel Byelene, Anne Cherry, Carl Clark, Kristen Collins, Taryn Cooper, Kelsey Decker, Jose M Del Rio, Shruti Desai, Sebastian Diaz, Jill Engel, William Fulkerson Jr, Loreta Grecu, Nazish Hashmi, Teresa Hoskins, Ehimemen Iboaya, Carrie Johnson, Mandisa-Maia Jones, Jorn Karhausen, Joel Kester, Rebecca Klinger, Casi Larish, Trevor Lee, Jessica Lumbard, Yasmin Maisonave, Negmeldeen Mamoun, Michael Manning, Joseph Mathew, Sharon McCartney, Lynn McGugan, Beth McLendon-Arvik, Amber Mcvey, Omar Mohamedaly, Margaret A Murphy, Alina Nicoara, Thomas Owens, Scott Palmer, Jhana Parikh, Matthew Pipeling, Mihai Podgoreanu, Angela Pollak, Dayana Ramos, Claudette Ramsey, Jake Ribet, Erick Saldivar, Amy Shing, Laurie Snyder, Kevin Sowers, Amanda Spiritos, Mark Stafford-Smith, Fabian Stone, Madhav Swaminathan, Annemarie Thompson, Jamie Todd, Dean Van Hart, Eleanor Vega, Cameron Wells, Ian Welsby, Meredith Whitacre, Jordan Whitson, Barbara Wiernek, Genevieve Wroblewski, Vincent Yeboah, Lorenzo Zaffiri, Kamrouz Ghadimiet al.",2022 Jan 1,JAMA Surg,https://pubmed.ncbi.nlm.nih.gov/34787647/,No keywords found,"['inhaled', 'nitric', 'oxide', '(', 'ino', ')', 'commonly', 'administered', 'selectively', 'inhaled', 'pulmonary', 'vasodilation', 'and', 'prevention', 'of', 'oxidative', 'injury', 'lung', 'transplant', '(', 'lt', ')', '.', 'inhaled', 'epoprostenol', '(', 'iepo', ')', 'introduced', 'worldwide', 'cost-saving', 'alternative', 'to', 'ino', 'without', 'high-grade', 'evidence', 'indication', '.', 'objective', 'to', 'investigate', 'whether', 'use', 'of', 'iepo', 'lead', 'to', 'similar', 'rate', 'of', 'severegrade', 'primary', 'graft', 'dysfunction', '(', 'pgd-', ')', 'adult', 'lt', 'compared', 'with', 'use', 'of', 'ino', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'health', 'system-funded', ',', 'randomized', ',', 'blinded', '(', 'to', 'participant', ',', 'clinician', ',', 'data', 'manager', ',', 'and', 'statistician', ')', ',', 'parallel-designed', ',', 'equivalence', 'clinical', 'trial', 'included', 'adult', 'patient', 'underwent', 'single', 'or', 'bilateral', 'lt', 'may', ',', ',', 'and', 'march', ',', '.', 'patient', 'grouped', 'stratum', 'according', 'to', 'key', 'prognostic', 'clinical', 'feature', 'and', 'randomized', 'per', 'stratum', 'to', 'receive', 'either', 'ino', 'or', 'iepo', 'time', 'of', 'lt', 'via', 'treatment', 'allocation', '.', 'intervention', 'treatment', 'with', 'ino', 'or', 'iepo', 'initiated', 'in', 'operating', 'room', 'lung', 'allograft', 'reperfusion', 'and', 'administered', 'continously', 'cessation', 'criterion', 'met', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'pgd-', 'development', ',', ',', 'or', 'hour', 'lt.', 'primary', 'analysis', 'equivalence', 'using', 'two', 'one-sided', 'test', '(', 'tost', ')', 'procedure', '(', 'ci', ')', 'with', 'margin', 'of', 'between-group', 'pgd-', 'risk', 'difference', '.', 'secondary', 'outcome', 'included', 'duration', 'of', 'mechanical', 'ventilation', ',', 'hospital', 'and', 'icu', 'length', 'of', 'stay', ',', 'incidence', 'and', 'severity', 'of', 'acute', 'kidney', 'injury', ',', 'postoperative', 'tracheostomy', 'placement', ',', 'and', 'in-hospital', ',', '-day', ',', 'and', '-day', 'mortality', 'rate', '.', 'intention-to-treat', 'analysis', 'performed', 'primary', 'and', 'secondary', 'outcome', ',', 'supplemented', 'per-protocol', 'analysis', 'primary', 'outcome', '.', 'result', 'total', 'of', 'randomized', 'patient', 'met', 'eligibility', 'criterion', 'time', 'of', 'lt', '(', 'men', '.', ')', '.', 'in', 'intention-to-treat', 'population', ',', 'patient', 'received', 'iepo', 'and', 'received', 'ino', '.', 'primary', 'outcome', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'iepo', 'group', 'and', 'of', '(', '.', ')', 'in', 'ino', 'group', ',', 'leading', 'to', 'risk', 'difference', 'of', '.', '(', 'tost', 'ci', ',', '-', '.', 'to', '.', 'p', '.', 'equivalence', ')', '.', 'no', 'significant', 'between-group', 'difference', 'secondary', 'outcome', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'undergoing', 'lt', ',', 'use', 'of', 'iepo', 'associated', 'with', 'similar', 'risk', 'pgd-', 'development', 'and', 'postoperative', 'outcome', 'compared', 'with', 'use', 'of', 'ino', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trial.,"Abhinav Sharma, João Pedro Ferreira, Faiez Zannad, Stuart J Pocock, Gerasimos Filippatos, Egon Pfarr, Michaela Petrini, Bettina J Kraus, Christoph Wanner, Milton Packer, Javed Butler, Stefan D Anker, Abhinav Sharmaet al.",2023 Aug,Eur J Heart Fail,https://pubmed.ncbi.nlm.nih.gov/37062851/,No keywords found,"['in', 'emperor-preserved', 'trial', ',', 'empagliflozin', 'improved', 'clinical', 'outcome', 'of', 'patient', 'with', 'heart', 'failure', '(', 'hf', ')', 'with', 'preserved', 'ejection', 'fraction', '.', 'in', 'pre-specified', 'analysis', ',', 'aim', 'to', 'study', 'effect', 'of', 'empagliflozin', 'cardiovascular', 'and', 'kidney', 'outcome', 'across', 'spectrum', 'of', 'kidney', 'function', '.', 'method', 'and', 'result', 'patient', 'categorized', 'presence', 'or', 'absence', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'baseline', '(', 'ckd', 'defined', 'estimated', 'glomerular', 'filtration', 'rate', 'egfr', 'mgg', ')', '.', 'primary', 'and', 'key', 'secondary', 'outcome', '(', ')', 'composite', 'of', 'cardiovascular', 'death', 'or', 'first', 'hf', 'hospitalization', '(', 'primary', 'outcome', ')', '(', 'ii', ')', 'total', 'number', 'of', 'hf', 'hospitalization', ',', '(', 'iii', ')', 'egfr', 'slope', 'and', 'pre-specified', 'exploratory', 'composite', 'kidney', 'outcome', 'including', 'sustained', 'decline', 'in', 'egfr', ',', 'chronic', 'dialysis', 'or', 'renal', 'transplant', '.', 'median', 'follow-up', '.', 'month', '.', 'total', 'of', 'patient', 'randomized', 'to', 'empagliflozin', 'or', 'placebo', ',', 'of', '(', '.', ')', 'ckd', '.', 'irrespective', 'of', 'ckd', 'status', ',', 'empagliflozin', 'reduced', 'primary', 'outcome', '(', 'with', 'ckd', 'hazard', 'ratio', 'hr', '.', ',', 'confidence', 'interval', 'ci', '.-', '.', 'without', 'ckd', 'hr', '.', ',', 'ci', '.-', '.', 'interaction', 'p', '.', ')', 'and', 'total', '(', 'first', 'and', 'recurrent', ')', 'hospitalization', 'hf', '(', 'with', 'ckd', 'hr', '.', ',', 'ci', '.-', '.', 'without', 'ckd', 'hr', '.', ',', 'ci', '.-', '.', 'interaction', 'p', '.', ')', '.', 'empagliflozin', 'slowed', 'slope', 'of', 'egfr', 'decline', '.', '(', '.-', '.', ')', 'mlmin', '.', 'year', 'in', 'patient', 'with', 'ckd', 'and', '.', '(', '.-', '.', ')', 'mlmin', '.', 'year', 'in', 'patient', 'without', 'ckd', '(', 'interaction', 'p', '.', ')', '.', 'empagliflozin', 'not', 'reduce', 'pre-specified', 'kidney', 'outcome', 'in', 'patient', 'with', 'or', 'without', 'ckd', '(', 'with', 'ckd', 'hr', '.', ',', 'ci', '.-', '.', 'without', 'ckd', 'hr', '.', ',', 'ci', '.-', '.', 'interaction', 'p', '.', ')', 'slowed', 'progression', 'to', 'macroalbuminuria', 'and', 'reduced', 'risk', 'of', 'acute', 'kidney', 'injury', '.', 'effect', 'of', 'empagliflozin', 'primary', 'composite', 'outcome', 'and', 'key', 'secondary', 'outcome', 'consistent', 'across', 'five', 'baseline', 'egfr', 'category', '(', 'interaction', 'p', '.', ')', '.', 'empagliflozin', 'well', 'tolerated', 'independent', 'of', 'ckd', 'status', '.', 'conclusion', 'in', 'emperor-preserved', ',', 'empagliflozin', 'beneficial', 'effect', 'key', 'efficacy', 'outcome', 'in', 'patient', 'with', 'and', 'without', 'ckd', '.', 'overall', ',', 'benefit', 'and', 'safety', 'of', 'empagliflozin', 'consistent', 'across', 'wide', 'range', 'of', 'kidney', 'function', 'spectrum', ',', 'to', 'baseline', 'egfr', 'of', 'mlmin', '.', '.']"
Rationale and design of COLchicine On-admission to Reduce inflammation in Acute Coronary Syndrome (COLOR-ACS) study.,"Anna Toso, Mario Leoncini, Gaia Magnaghi, Francesco Biagini, Olimpia Martini, Mauro Maioli, Simona Villani, Marco Comeglio, Francesco Bellandi, Anna Tosoet al.",2023 Jan 1,J Cardiovasc Med (Hagerstown),https://pubmed.ncbi.nlm.nih.gov/36473121/,No keywords found,"['aim', 'of', 'colchicine', 'on-admission', 'to', 'reduce', 'inflammation', 'in', 'acute', 'coronary', 'syndrome', '(', 'color-acs', ')', 'study', 'to', 'evaluate', 'effect', 'of', 'addition', 'of', 'short-term', ',', 'low-dose', 'colchicine', 'to', 'high-dose', 'atorvastatin', 'in', 'limiting', 'level', 'of', 'inflammatory', 'marker', ',', 'high-sensitivity', 'c-reactive', 'protein', '(', 'hs-crp', ')', ',', 'in', 'patient', 'with', 'non-st-elevation', 'acute', 'coronary', 'syndrome', '(', 'nste-acs', ')', '.', 'method', 'color-acs', 'study', 'multicenter', ',', 'randomized', ',', 'open-label', ',', 'two-arm', 'trial', '.', 'statin-naive', 'patient', 'with', 'nste-acs', ',', 'scheduled', 'early', 'invasive', 'strategy', ',', 'randomized', 'admission', 'to', 'receive', 'standard', 'treatment', 'of', 'atorvastatin', 'mg', 'or', 'standard', 'treatment', 'plus', 'colchicine', '(', 'mg', 'loading', 'dose', 'followed', '.', 'mgday', 'discharge', ')', '.', 'main', 'exclusion', 'criterion', 'prior', 'statin', 'andor', 'colchicine', 'treatment', ',', 'current', 'treatment', 'with', 'potent', 'inhibitor', 'of', 'cypa', ',', 'p-glycoprotein', 'or', 'immunosuppressive', 'drug', ',', 'known', 'active', 'malignancy', ',', 'severe', 'kidney', ',', 'cardiac', ',', 'liver', 'disease', '.', 'clinical', 'and', 'biochemical', 'follow-up', 'day', 'discharge', 'and', 'telephone', 'interview', 'month', '.', 'primary', 'end', 'point', 'change', 'in', 'hs-crp', 'admission', 'to', 'discharge', '.', 'secondary', 'end', 'point', 'include', 'incidence', 'of', 'acute', 'kidney', 'injury', 'mb', 'fraction', 'of', 'creatine', 'kinase', 'peak', 'value', 'glomerular', 'filtration', 'rate', 'change', 'baseline', 'to', 'day', 'persistence', 'of', 'hs-crp', 'mgdl', 'day', 'adverse', 'clinical', 'event', 'within', 'day', 'tolerance', 'to', 'colchicine', '.', 'conclusion', 'color-acs', 'study', 'provide', 'evidence', 'efficacy', 'of', 'early', 'short-term', 'treatment', 'with', 'colchicine', 'in', 'addition', 'to', 'high-dose', 'atorvastatin', 'compared', 'to', 'atorvastatin', 'alone', 'in', 'ac', 'patient', '.', 'potential', 'anti-inflammatory', 'action', 'of', 'colchicine', 'plus', 'atorvastatin', 'expected', 'to', 'limit', 'hs-crp', 'increase', 'with', 'resultant', 'clinical', 'benefit', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
A novel 12-hour versus 24-hour magnesium sulfate regimen in the management of eclampsia and preeclampsia in Ghana (MOPEP Study): A randomized controlled trial.,"Titus K Beyuo, Emma R Lawrence, Emily K Kobernik, Samuel A Oppong, Titus K Beyuoet al.",2022 Nov,Int J Gynaecol Obstet,https://pubmed.ncbi.nlm.nih.gov/35304745/,No keywords found,"['compared', 'efficacy', 'of', '-h', 'versus', '-h', 'regimen', 'of', 'intramuscular', 'magnesium', 'sulfate', 'in', 'management', 'of', 'eclampsia', 'and', 'preeclampsia', '.', 'method', 'open-labeled', 'parallel', 'randomized', 'controlled', 'trial', 'conducted', 'in', 'accra', ',', 'ghana', 'november', 'to', 'november', '.', 'participant', 'adult', 'pregnant', 'woman', 'admitted', 'to', 'korle', 'bu', 'teaching', 'hospital', '(', 'kbth', ')', 'with', 'diagnosis', 'of', 'antepartum', ',', 'intrapartum', ',', 'or', 'postpartum', 'eclampsia', 'or', 'preeclampsia', 'with', 'severe', 'feature', ',', 'received', 'no', 'loading', 'dose', 'of', 'magnesium', 'sulfate', 'prior', 'to', 'admission', 'kbth', '.', 'participant', 'in', 'standard', '-h', 'group', 'received', 'loading', 'dose', 'of', 'magnesium', 'sulfate', 'g', 'intravenous', 'and', 'g', 'intramuscular', '(', 'g', 'in', 'buttock', ')', 'followed', 'six', ',', 'g', 'intramuscular', 'maintenance', 'dos', 'h.', 'participant', 'in', '-h', 'intervention', 'group', 'received', 'loading', 'dose', 'followed', 'three', ',', 'g', 'intramuscular', 'maintenance', 'dos', 'h.', 'primary', 'outcome', 'occurrence', 'of', 'seizure', 'completion', 'of', 'assigned', 'magnesium', 'sulfate', 'regimen', '.', 'secondary', 'outcome', 'magnesium', 'sulfate', 'toxicity', ',', 'magnesium', 'sulfate', 'side', 'effect', ',', 'maternal', 'outcome', '(', 'mode', 'of', 'delivery', ',', 'duration', 'of', 'inpatient', 'admission', ',', 'duration', 'of', 'urethral', 'catheterization', ')', ',', 'maternal', 'complication', '(', 'pulmonary', 'edema', ',', 'acute', 'kidney', 'injury', ',', 'intensive', 'care', 'unit', 'admission', ',', 'death', ')', ',', 'and', 'neonatal', 'outcome', '.', 'result', 'among', 'total', 'participant', ',', 'found', 'no', 'difference', 'in', 'occurrence', 'of', 'seizure', 'completion', 'of', 'assigned', 'regimen', 'in', '-h', 'group', '(', 'n', ',', '.', ')', 'versus', '-h', 'group', '(', 'n', ',', '.', ')', ',', 'p', '.', 'rr', '.', ',', 'ci', '.', ',', '.', ')', ',', 'or', 'in', 'occurrence', 'of', 'seizure', 'time', 'enrollment', '(', 'n', ',', '.', 'vs.', 'n', ',', '.', ',', 'p', '.', ',', 'rr', '.', ',', 'ci', '.-.', ')', '.', 'participant', 'in', '-h', 'group', 'shorter', 'duration', 'of', 'inpatient', 'admission', '(', '.', '.', 'vs.', '.', '.', 'day', ',', 'p', '.', ')', 'and', 'urethral', 'catheterization', '(', '.', '.', 'vs.', '.', '.', 'day', ',', 'p', '.', ')', '.', 'rate', 'of', 'side', 'effect', 'magnesium', 'sulfate', 'lower', 'in', '-h', 'group', 'pain', 'injection', 'site', '(', '.', '(', 'n', ')', 'vs.', '.', '(', 'n', ')', ',', 'p', '.', ')', ',', 'inflammation', '(', '.', '(', 'n', ')', 'vs.', '.', '(', 'n', ')', ',', 'p', '.', ')', ',', 'and', 'bleeding', 'or', 'bruising', 'injection', 'site', '(', '.', '(', 'n', ')', 'vs.', '.', '(', 'n', ')', ',', 'p', '.', ')', '.', 'conclusion', 'compared', 'with', 'h', ',', 'h', 'of', 'intramuscular', 'magnesium', 'sulfate', 'showed', 'similar', 'rate', 'of', 'seizure', ',', 'with', 'fewer', 'side', 'effect', 'and', 'shorter', 'inpatient', 'admission', '.', 'trial', 'registration', 'prospective', 'registration', 'with', 'pan', 'african', 'clinical', 'trial', 'registry', '(', 'pactr', ')', 'httpspactr.samrc.ac.zatrialdisplay.aspxtrialid', '.']"
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).,"Kandai Nozu, Mayumi Sako, Seiji Tanaka, Yuji Kano, Yoko Ohwada, Tamaki Morohashi, Riku Hamada, Yasufumi Ohtsuka, Masafumi Oka, Koichi Kamei, Aya Inaba, Shuichi Ito, Tomoyuki Sakai, Hiroshi Kaito, Yuko Shima, Kenji Ishikura, Hidefumi Nakamura, Koichi Nakanishi, Tomoko Horinouchi, Akihide Konishi, Takashi Omori, Kazumoto Iijima, Kandai Nozuet al.",2024 Apr,Clin Exp Nephrol,https://pubmed.ncbi.nlm.nih.gov/38010466/,No keywords found,"['of', 'child', 'with', 'idiopathic', 'nephrotic', 'syndrome', 'respond', 'well', 'to', 'glucocorticoid', 'therapy', '.', 'multidrug-resistant', 'nephrotic', 'syndrome', '(', 'mrns', ')', 'associated', 'with', 'poor', 'kidney', 'prognosis', '.', 'several', 'retrospective', 'study', 'identified', 'rituximab', 'effective', 'treatment', 'mrns', 'however', ',', 'prospective', 'study', 'required', 'to', 'assess', 'efficacy', 'and', 'safety', '.', 'method', 'conducted', 'multicenter', ',', 'non-blinded', ',', 'single-arm', 'trial', 'to', 'investigate', 'efficacy', 'and', 'safety', 'of', 'rituximab', 'in', 'patient', 'with', 'childhood-onset', 'mrns', 'resistant', 'to', 'cyclosporine', 'and', 'three', 'course', 'of', 'steroid', 'pulse', 'therapy', '.', 'enrolled', 'patient', 'received', 'four', 'mgm', 'dos', 'of', 'rituximab', 'in', 'combination', 'with', 'baseline', 'cyclosporine', 'and', 'steroid', 'pulse', 'therapy', '.', 'primary', 'endpoint', 'reduction', 'in', 'urinary', 'proteincreatinine', 'ratio', 'baseline', 'day', '.', 'complete', 'and', 'partial', 'remission', 'also', 'evaluated', '.', 'result', 'six', 'patient', 'with', 'childhood-onset', 'mrns', 'enrolled', '.', 'patient', 'negative', 'pathogenic', 'variant', 'of', 'podocyte-related', 'gene', '.', 'day', ',', 'five', 'patient', '(', '.', ')', 'showed', 'reduction', 'in', 'urinary', 'proteincreatinine', 'ratio', ',', 'two', 'patient', 'showed', 'partial', 'remission', ',', 'and', 'two', 'patient', 'showed', 'complete', 'remission', '.', 'no', 'death', 'occurred', 'and', 'severe', 'adverse', 'event', 'occurred', 'in', 'two', 'patient', '(', 'infection', 'in', 'one', 'patient', 'and', 'acute', 'kidney', 'injury', 'in', 'one', 'patient', ')', '.', 'three', 'patient', 'needed', 'treatment', 'moderate-to-severe', 'infection', '.', 'conclusion', 'study', 'treatment', 'effectively', 'reduced', 'urinary', 'proteincreatinine', 'ratio', 'in', 'patient', 'with', 'childhood-onset', 'mrns', '.', 'adverse', 'event', 'in', 'study', 'within', 'expected', 'range', 'however', ',', 'attention', 'paid', 'to', 'occurrence', 'of', 'infection', '.']"
Pharmacokinetics and safety of colistin sulfate after single and multiple intravenous doses in healthy Chinese subjects.,"Xiaolan Huang, Xiaofen Liu, Yaxin Fan, Yu Wang, Beining Guo, Jingjing Wang, Jicheng Yu, Qiong Wei, Xiaojie Wu, Haihui Huang, Jing Zhang, Xiaolan Huanget al.",2024 Nov,Int J Antimicrob Agents,https://pubmed.ncbi.nlm.nih.gov/39276945/,No keywords found,"['increasing', 'antimicrobial', 'resistance', 'led', 'to', 'revival', 'of', 'polymyxin', 'last-resort', 'therapeutic', 'option', 'multidrug-resistant', 'gram-negative', 'bacterial', 'infection', '.', 'parenteral', 'formulation', 'of', 'colistin', 'sulfate', 'available', 'solely', 'in', 'china', '.', 'onset', 'of', 'action', 'of', 'iv', 'colistin', 'may', 'occur', 'faster', 'with', 'prodrug', 'cm', ',', 'pharmacokinetic', '(', 'pk', ')', 'profile', 'remains', 'unclear', '.', 'method', 'single-centre', ',', 'open-label', ',', 'single-', 'and', 'multi-dose', ',', 'phase', 'trial', 'examined', 'pks', 'and', 'safety', 'of', 'colistin', 'sulfate', 'in', 'healthy', 'chinese', 'adult', '.', 'participant', 'received', 'single', ',', 'unitskg', '(', 'equivalent', 'to', '.', 'mgkg', ')', 'dose', 'of', 'colistin', 'sulfate', '(', 'single-dose', 'group', ',', 'n', ')', 'or', 'dose', 'qh', 'day', '(', 'multi-dose', 'group', ',', 'n', ')', 'via', '-h', 'iv', 'infusion', '.', 'colistin', 'concentration', 'in', 'plasma', 'and', 'urine', 'determined', 'using', 'lc-msms', ',', 'and', 'pk', 'parameter', 'calculated', 'using', 'non-compartmental', 'analysis', '.', 'result', 'single', 'dose', 'peak', 'concentration', '(', 'cmax', ')', ',', 'area', 'curve', 'to', 'h', '(', 'auc-h', ')', ',', 'terminal', 'half-life', '(', ')', ',', 'volume', 'of', 'distribution', '(', 'vd', ')', ',', 'and', 'total', 'body', 'clearance', '(', 'cl', ')', 'of', 'colistin', '.', '.', 'mgl', ',', '.', '.', 'hmgl', ',', '.', '.', 'h', ',', '.', '.', 'l', ',', 'and', '.', '.', 'lh', ',', 'respectively', '.', 'no', 'accumulation', 'of', 'colistin', 'observed', 'multiple', 'dos', '.', 'cumulative', 'urinary', 'recovery', 'of', 'colistin', '.', '.', 'within', 'h', 'multi-dose', 'administration', '.', 'no', 'nephrotoxicity', 'reported', '.', 'conclusion', 'study', 'first', 'to', 'report', 'colistin', 'pks', 'in', 'healthy', 'chinese', 'subject', 'single', 'and', 'multiple', 'dos', 'of', 'colistin', 'sulfate', '.', 'pk', 'and', 'safety', 'data', 'required', 'optimal', 'dose', 'selection', 'in', 'clinical', 'practice', '.']"
Safety and Efficacy of Human Chorionic Gonadotropin Hormone-Derivative EA-230 in Cardiac Surgery Patients: A Randomized Double-Blind Placebo-Controlled Study.,"Roger van Groenendael, Remi Beunders, Pleun Hemelaar, Jan Hofland, Wim J Morshuis, Johannes G van der Hoeven, Jelle Gerretsen, Gert Wensvoort, Emma J Kooistra, Wout J Claassen, Denise Waanders, Maud G A Lamberts, Leonie S E Buijsse, Matthijs Kox, Lucas T van Eijk, Peter Pickkers, Roger van Groenendaelet al.",2021 May 1,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/33591006/,No keywords found,"['to', 'determine', 'safety', 'and', 'efficacy', 'of', 'human', 'chorionic', 'gonadotropin', 'hormone-derivative', 'ea-', 'in', 'cardiac', 'surgery', 'patient', '.', 'cardiac', 'surgery', 'induces', 'systemic', 'inflammation', 'and', 'may', 'impair', 'renal', 'function', ',', 'affecting', 'patient', 'outcome', '.', 'ea-', 'exerted', 'immunomodulatory', 'and', 'renoprotective', 'effect', 'in', 'preclinical', 'model', 'and', 'safe', 'and', 'showed', 'efficacy', 'in', 'phase', 'and', 'ii', 'human', 'study', '.', 'design', 'double-blinded', ',', 'placebo-controlled', ',', 'randomized', 'study', '.', 'setting', 'collaboration', 'of', 'cardiothoracic', 'surgery', ',', 'anesthesiology', ',', 'and', 'intensive', 'care', 'department', 'of', 'tertiary', 'hospital', 'in', 'netherlands', '.', 'patient', 'one', 'hundred', 'eighty', 'patient', 'undergoing', 'on-pump', 'coronary', 'artery', 'bypass', 'procedure', 'with', 'or', 'without', 'concomitant', 'valve', 'surgery', '.', 'intervention', 'ninety', 'mgkghr', 'ea-', 'or', 'placebo', 'administered', 'surgery', '.', 'measurement', 'and', 'main', 'result', 'study', ',', 'no', 'safety', 'concern', 'emerged', '.', 'ea-', 'not', 'modulate', 'interleukin-', 'plasma', 'concentration', '(', 'area', 'curve', ',', 'pgml', 'hr', ',', '-', ',', 'v', ',', 'pgml', 'hr', ',', '-', ',', 'ea-', 'and', 'placebo', 'group', ',', 'respectively', 'p', '.', ')', '.', 'glomerular', 'filtration', 'rate', 'increased', 'following', 'surgery', '(', 'mean', 'sem', 'increase', 'in', 'ea-', 'v', 'placebo', 'group', 'glomerular', 'filtration', 'rateiohexol', 'measured', 'using', 'iohexol', 'plasma', 'clearance', 'v', 'mlmin', '.', 'p', '.', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'with', 'modification', 'of', 'diet', 'in', 'renal', 'disease', 'equation', 'using', 'creatinine', 'v', 'mlmin', '.', 'p', '.', ')', '.', '``', 'injury', ""''"", 'stage', 'of', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', 'of', 'kidney', 'function', ',', 'and', 'end-stage', 'kidney', 'disease', 'criterion', 'acute', 'kidney', 'injury', 'in', 'ea-', 'group', 'versus', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'in', 'addition', ',', 'ea', '--', 'treated', 'patient', 'less', 'positive', 'fluid', 'balance', 'compared', 'with', 'placebo-treated', 'patient', '(', 'v', 'ml', 'p', '.', ')', ',', 'use', 'of', 'vasoactive', 'agent', 'similar', 'in', 'group', '(', 'p', '.', ')', '.', 'finally', ',', 'hospital', 'length', 'of', 'stay', 'shorter', 'in', 'ea-', 'treated', 'patient', '(', '-', 'v', '-', 'p', '.', ')', '.', 'efficacy', 'result', 'pronounced', 'in', 'patient', 'longer', 'duration', 'of', 'surgery', 'and', 'thus', 'longer', 'duration', 'of', 'study', 'drug', 'infusion', '.', 'conclusion', 'ea-', 'safe', 'in', 'patient', 'undergoing', 'on-pump', 'cardiac', 'surgery', '.', 'not', 'modulate', 'interleukin-', 'plasma', 'concentration', 'appeared', 'to', 'exert', 'beneficial', 'renal', 'and', 'cardiovascular', 'effect', 'and', 'shortened', 'in-hospital', 'length', 'of', 'stay', '.']"
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial.,"Hiddo J L Heerspink, Megumi Oshima, Hong Zhang, Jingwei Li, Rajiv Agarwal, George Capuano, David M Charytan, Jagriti Craig, Dick de Zeeuw, Gian Luca Di Tanna, Adeera Levin, Bruce Neal, Vlado Perkovic, David C Wheeler, Yshai Yavin, Meg J Jardine, Hiddo J L Heerspinket al.",2022 Feb,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/34029680/,No keywords found,"['canagliflozin', 'reduced', 'risk', 'of', 'kidney', 'failure', 'and', 'related', 'outcome', 'in', 'patient', 'with', 'type', 'diabetes', 'mellitus', '(', 'tdm', ')', 'and', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'in', 'credence', '(', 'canagliflozin', 'and', 'renal', 'event', 'in', 'diabetes', 'with', 'established', 'nephropathy', 'clinical', 'evaluation', ')', 'trial', '.', 'analysis', 'of', 'credence', 'trial', 'data', 'examines', 'effect', 'of', 'canagliflozin', 'incidence', 'of', 'kidney-related', 'adverse', 'event', '(', 'aes', ')', '.', 'study', 'design', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'multicenter', 'international', 'trial', '.', 'setting', 'participant', ',', 'trial', 'participant', 'with', 'tdm', ',', 'ckd', ',', 'and', 'urinary', 'albumin-creatinine', 'ratio', '-', ',', 'mgg', '.', 'intervention', 'participant', 'randomly', 'assigned', 'to', 'receive', 'canagliflozin', 'mgd', 'or', 'placebo', '.', 'outcome', 'rate', 'of', 'kidney-related', 'aes', 'analyzed', 'using', 'on-treatment', 'approach', ',', 'overall', 'and', 'screening', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'stratum', '(', '-', ',', '-', ',', 'and', '-', 'mlmin', '.', ')', '.', 'result', 'canagliflozin', 'associated', 'with', 'reduction', 'in', 'overall', 'incidence', 'rate', 'of', 'kidney-related', 'aes', '(', '.', 'v', '.', 'per', ',', 'patient-years', 'hazard', 'ratio', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', ',', 'with', 'consistent', 'result', 'serious', 'kidney-related', 'aes', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', 'and', 'acute', 'kidney', 'injury', '(', 'aki', 'hr', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'rate', 'of', 'kidney-related', 'aes', 'lower', 'with', 'canagliflozin', 'relative', 'to', 'placebo', 'across', 'egfr', 'stratum', '(', 'hr', 'of', '.', ',', '.', ',', 'and', '.', 'egfr', '-', ',', '-', ',', 'and', '-', 'mlmin', '.', ',', 'respectively', 'p', '.', 'interaction', ')', ',', 'with', 'similar', 'result', 'aki', '(', 'p', '.', 'interaction', ')', '.', 'full', 'recovery', 'of', 'kidney', 'function', 'within', 'day', 'aki', 'event', 'occurred', 'frequently', 'with', 'canagliflozin', 'versus', 'placebo', '(', '.', 'v', '.', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'limitation', 'kidney-related', 'aes', 'including', 'aki', 'investigator-reported', 'and', 'collected', 'without', 'central', 'adjudication', '.', 'biomarkers', 'of', 'aki', 'and', 'structural', 'tubular', 'damage', 'not', 'measured', ',', 'and', 'creatinine', 'data', 'aki', 'event', 'not', 'available', 'participant', '.', 'conclusion', 'compared', 'with', 'placebo', ',', 'canagliflozin', 'associated', 'with', 'reduced', 'incidence', 'of', 'serious', 'and', 'nonserious', 'kidney-related', 'aes', 'in', 'patient', 'with', 'tdm', 'and', 'ckd', '.', 'result', 'highlight', 'safety', 'of', 'canagliflozin', 'with', 'regard', 'to', 'adverse', 'kidney-related', 'aes', '.', 'funding', 'credence', 'trial', 'and', 'analysis', 'funded', 'janssen', 'research', 'development', ',', 'llc', ',', 'and', 'conducted', 'collaboration', 'funder', ',', 'academic', 'steering', 'committee', ',', 'and', 'academic', 'research', 'organization', ',', 'george', 'clinical', '.', 'trial', 'registration', 'credence', 'trial', 'registered', 'clinicaltrials.gov', 'with', 'identifier', 'number', 'nct', '.']"
Urinary Neutrophil Gelatinase-Associated Lipocalin/Hepcidin-25 Ratio for Early Identification of Patients at Risk for Renal Replacement Therapy After Cardiac Surgery: A Substudy of the BICARBONATE Trial.,"Saban Elitok, Hermann Kuppe, Prasad Devarajan, Rinaldo Bellomo, Berend Isermann, Sabine Westphal, Johanna Kube, Christian Albert, Martin Ernst, Siegfried Kropf, Anja Haase-Fielitz, Michael Haase, Saban Elitoket al.",2021 Dec 1,Anesth Analg,https://pubmed.ncbi.nlm.nih.gov/34543256/,No keywords found,"['acute', 'kidney', 'injury', 'requiring', 'renal', 'replacement', 'therapy', '(', 'aki-rrt', ')', 'strongly', 'associated', 'with', 'mortality', 'cardiac', 'surgery', 'however', ',', 'option', 'early', 'identification', 'of', 'patient', 'high', 'risk', 'aki-rrt', 'extremely', 'limited', '.', 'early', 'cardiac', 'surgery', ',', 'predictive', 'ability', 'aki-rrt', 'even', 'of', 'one', 'of', 'extensively', 'evaluated', 'novel', 'urinary', 'biomarkers', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'appears', 'to', 'moderate', '.', 'aimed', 'to', 'determine', 'whether', 'ngalhepcidin-', 'ratio', '(', 'urinary', 'concentration', 'of', 'ngal', 'divided', 'of', 'hepcidin-', ')', 'early', 'surgery', 'may', 'compare', 'favorably', 'to', 'ngal', 'identification', 'of', 'high-risk', 'patient', 'cardiac', 'surgery', '.', 'method', 'prospective', 'substudy', 'of', 'bicarbonate', 'trial', ',', 'multicenter', 'parallel-randomized', 'controlled', 'trial', 'comparing', 'perioperative', 'bicarbonate', 'infusion', 'aki', 'prevention', 'to', 'usual', 'patient', 'care', '.', 'tertiary', 'referral', 'center', ',', 'patient', 'increased', 'kidney', 'risk', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'included', 'present', 'study', '.', 'primary', 'outcome', 'measure', 'defined', 'aki-rrt', '.', 'secondary', 'outcome', 'in-hospital', 'mortality', 'and', 'long-term', 'mortality', '.', 'compared', 'area', 'curve', 'of', 'receiver', 'operating', 'characteristic', '(', 'auc-roc', ')', 'of', 'urinary', 'ngal', 'with', 'of', 'urinary', 'ngalhepcidin-', 'ratio', 'within', 'minute', 'end', 'of', 'surgery', '.', 'compared', 'adjusted', 'auc', 'and', 'performed', 'cross-validated', 'reclassification', 'statistic', 'of', '(', 'logarithmic', ')', 'urinary', 'ngalhepcidin-', 'ratio', 'adjusted', 'to', 'cleveland', 'risk', 'scoreeuroscore', ',', 'cross-clamp', 'time', ',', 'age', ',', 'volume', 'of', 'packed', 'red', 'blood', 'cell', ',', 'and', '(', 'logarithmic', ')', 'urinary', 'ngal', 'concentration', '.', 'association', 'of', 'ngalhepcidin-', 'ratio', 'with', 'long-term', 'patient', 'survival', 'assessed', 'using', 'cox', 'proportional', 'hazard', 'regression', 'analysis', 'adjusting', 'euroscore', ',', 'aortic', 'cross-clamp', 'time', ',', 'packed', 'red', 'blood', 'cell', 'and', 'urinary', 'ngal', '.', 'result', 'patient', 'with', 'aki-rrt', '(', 'n', ')', '.-times', 'higher', 'ngal', 'and', '.-times', 'lower', 'hepcidin-', 'concentration', 'resulting', 'in', '.-times', 'higher', 'ngalhepcidin-', 'ratio', 'early', 'surgery', 'compared', 'to', 'patient', 'without', 'aki-rrt', '.', 'ngalhepcidin-', 'ratio', 'higher', 'auc-roc', 'compared', 'with', 'ngal', 'risk', 'of', 'aki-rrt', 'and', 'in-hospital', 'mortality', '(', 'unadjusted', 'auc-roc', 'difference', '.', ',', 'confidence', 'interval', 'ci', ',', '.-.', ',', 'p', '.', '.', ',', 'ci', ',', '.-.', ',', 'p', '.', ')', '.', 'aki-rrt', ',', 'ngalhepcidin-', 'ratio', 'increased', 'adjusted', 'category-free', 'net', 'reclassification', 'improvement', '(', 'cfnri', '.', ',', 'ci', ',', '.-', '.', 'p', '.', ')', 'and', 'integrated', 'discrimination', 'improvement', '(', 'idi', '.', ',', 'ci', ',', '.-', '.', 'p', '.', ')', 'not', 'auc', 'difference', '.', 'in-hospital', 'mortality', ',', 'ratio', 'improved', 'auc', 'of', 'reference', 'model', '(', 'auc', 'difference', '.', ',', 'ci', ',', '.-', '.', 'p', '.', ')', 'and', 'cfnri', 'not', 'idi', '.', 'urinary', 'ngalhepcidin-', 'ratio', 'remained', 'significantly', 'associated', 'with', 'long-term', 'mortality', 'adjusting', 'model', 'covariates', '.', 'conclusion', 'urinary', 'ngalhepcidin-', 'ratio', 'appears', 'to', 'early', 'identify', 'high-risk', 'patient', 'and', 'outperform', 'ngal', 'cardiac', 'surgery', '.', 'confirmation', 'of', 'finding', 'in', 'cardiac', 'surgery', 'center', 'needed', '.']"
Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure.,"Alberto Palazzuoli, Gaetano Ruocco, Marco Pellegrini, Matteo Beltrami, Nicola Giordano, Ranuccio Nuti, Peter A McCullough, Alberto Palazzuoliet al.",2016 May 15,Am J Cardiol,https://pubmed.ncbi.nlm.nih.gov/27040576/,No keywords found,"['serum', 'uric', 'acid', '(', 'ua', ')', 'associated', 'with', 'death', 'and', 'hospitalization', 'in', 'chronic', 'heart', 'failure', '(', 'hf', ')', '.', 'however', ',', 'ua', 'in', 'acute', 'hf', 'not', 'well', 'studied', 'with', 'respect', 'to', 'relation', 'to', 'renal', 'dysfunction', 'and', 'vascular', 'congestion', '.', 'measured', 'admission', 'serum', 'ua', 'along', 'with', 'baseline', 'variable', 'in', 'patient', 'with', 'acute', 'hf', 'screened', 'loop', 'diuretic', 'administration', 'and', 'acute', 'heart', 'failure', '(', 'diur-hf', ')', 'trial', '.', 'hyperuricemia', 'defined', 'serum', 'ua', 'mgdl', 'in', 'men', 'and', 'mgdl', 'in', 'woman', '.', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'defined', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin', '.', '(', ')', 'hospital', 'admission', '.', 'death', 'or', 'hf', 'hospitalization', 'month', 'primary', 'outcome', '.', 'mean', 'ua', 'concentration', '.', '.', 'mgdl', ',', 'and', 'patient', '(', '.', ')', 'classified', 'hyperuricemic', '.', 'ua', 'value', 'significantly', 'increased', 'in', 'patient', 'with', 'ckd', 'compared', 'to', 'patient', 'without', 'ckd', '(', '.', '.', 'v', '.', '.', 'mgdl', 'p', '.', ')', 'however', ',', 'ua', 'not', 'associated', 'with', 'development', 'of', 'acute', 'kidney', 'injury', '.', 'patient', 'with', 'hyperuricemia', 'greater', 'degree', 'of', 'pulmonary', 'and', 'systemic', 'congestion', 'normouricemic', 'patient', '(', 'congestion', 'score', '.', 'v', '.', ',', 'p', '.', ')', '.', 'hyperuricemia', 'associated', 'with', 'higher', 'risk', 'of', 'death', 'or', 'hf', 'rehospitalization', '(', 'univariate', 'hazard', 'ratio', '.', '.', 'to', '.', 'p', '.', ',', 'multivariate', 'hazard', 'ratio', '.', '.', 'to', '.', 'p', '.', ')', '.', 'in', 'conclusion', ',', 'hospitalized', 'patient', 'with', 'acute', 'hf', ',', 'elevated', 'ua', 'level', 'associated', 'with', 'ckd', 'and', 'pulmonary', 'congestion', '.', 'controlling', 'potential', 'confounders', ',', 'hyperuricemia', 'associated', 'with', 'rehospitalization', 'and', 'death', 'month', '.']"
Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus.,"Geoffroy Liegeon, Nicole Ngo-Giang-Huong, Nicolas Salvadori, Piyawan Bunpo, Ratchada Cressey, Jullapong Achalapong, Prateep Kanjanavikai, Orada Patamasingh Na Ayudhaya, Sinart Prommas, Thitiporn Siriwachirachai, Prapan Sabsanong, Jean Yves Mary, Gonzague Jourdain, Geoffroy Liegeonet al.",2022 Mar 31,J Antimicrob Chemother,https://pubmed.ncbi.nlm.nih.gov/35045168/,No keywords found,"['data', 'evaluating', 'risk', 'of', 'proximal', 'tubular', 'dysfunction', 'in', 'woman', 'receiving', 'tenofovir', 'disoproxil', 'fumarate', 'prevention', 'of', 'mother-to-child', 'transmission', '(', 'pmtct', ')', 'of', 'hbv', 'scarce', '.', 'objective', 'to', 'assess', 'risk', 'of', 'proximal', 'tubulopathy', 'in', 'pregnant', 'woman', 'receiving', 'tenofovir', 'disoproxil', 'fumarate', 'pmtct', 'of', 'hbv', '.', 'patient', 'and', 'method', 'used', 'urine', 'sample', 'collected', 'hbv', 'monoinfected', 'pregnant', 'woman', 'participated', 'in', 'phase', 'iii', ',', 'multicentre', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'clinical', 'trial', 'assessing', 'tenofovir', 'disoproxil', 'fumarate', 'short', 'course', 'week', 'gestational', 'age', '(', '-wk-ga', ')', 'to', 'month', 'post-partum', '(', '-months-pp', ')', 'pmtct', 'of', 'hbv', 'in', 'thailand', '.', 'marker', 'of', 'tubular', 'dysfunction', ',', 'including', 'retinol', 'binding', 'protein', ',', 'kidney', 'injury', 'molecule-', ',', '-microglobuin', 'and', '-microglobulin', ',', 'assayed', '-', 'and', '-wk-ga', 'and', '-months-pp', 'visit', '.', 'proximal', 'tubulopathy', 'defined', 'presence', 'of', 'of', 'following', 'tubular', 'proteinuria', ',', 'euglycaemic', 'glycosuria', 'and', 'increased', 'urinary', 'phosphate', '.', 'result', 'total', 'of', 'woman', 'participated', 'in', 'study', '.', 'no', 'kidney-related', 'adverse', 'event', 'severe', ',', 'and', 'none', 'led', 'to', 'tenofovir', 'disoproxil', 'fumarate', 'discontinuation', '.', '-months-pp', ',', 'of', '(', ')', 'evaluated', 'woman', 'in', 'tenofovir', 'disoproxil', 'fumarate', 'group', 'experienced', 'proximal', 'tubulopathy', 'versus', 'of', '(', ')', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'none', 'of', 'six', 'woman', 'met', 'criterion', 'proximal', 'tubulopathy', '-months-pp', 'proteinuria', 'persisted', 'in', 'three', 'of', '.', 'no', 'growth', 'abnormality', 'found', 'year', 'of', 'age', 'in', 'infant', 'born', 'to', 'mother', 'with', 'proximal', 'tubulopathy', '-months-pp', '.', 'conclusion', 'in', 'hbv-infected', 'pregnant', 'and', 'breastfeeding', 'woman', ',', 'tenofovir', 'disoproxil', 'fumarate', 'administered', '-wk-ga', 'to', '-months-pp', 'not', 'associated', 'with', 'higher', 'risk', 'of', 'proximal', 'tubulopathy', '.']"
Colchicine in acute myocardial infarction: cardiovascular events at 1-year follow up.,"Claire Bouleti, Simon Viscogliosi, Didier Bresson, Simon Leboube, Thomas Bochaton, Naoual El-Jonhy, Camille Amaz, Fabrice Prunier, Gabriel Bidaux, Francois Roubille, Denis Angoulvant, Nathan Mewton, Claire Bouletiet al.",2024 Jan 17,Open Heart,https://pubmed.ncbi.nlm.nih.gov/38233042/,No keywords found,"['in', 'covert-mi', 'randomised', 'placebo-controlled', 'trial', ',', 'oral', 'administration', 'of', 'high-dose', 'colchicine', 'time', 'of', 'reperfusion', 'and', 'day', 'in', 'acute', 'st-elevated', 'myocardial', 'infarction', 'not', 'reduce', 'infarct', 'size', 'associated', 'with', 'significant', 'increase', 'in', 'left', 'ventricular', 'thrombus', '(', 'lvt', ')', 'in', 'comparison', 'to', 'placebo', '.', 'aimed', 'to', 'assess', '-year', 'clinical', 'outcome', 'of', 'study', 'population', '.', 'method', 'study', 'follow-up', 'analysis', 'of', 'covert-mi', 'study', 'prespecified', 'secondary', 'clinical', 'endpoint', 'year', '.', 'primary', 'endpoint', 'of', 'study', 'composite', 'of', 'major', 'adverse', 'cardiovascular', 'event', '(', 'mace', ')', ',', 'including', 'all-cause', 'death', ',', 'acute', 'coronary', 'syndrome', ',', 'heart', 'failure', 'event', ',', 'ischaemic', 'stroke', ',', 'sustained', 'ventricular', 'arrhythmia', 'and', 'acute', 'kidney', 'injury', '-year', 'follow-up', '.', 'quality', 'of', 'life', '(', 'qol', ')', 'and', 'drug', 'therapy', 'prescription', 'also', 'assessed', '.', 'result', 'year', ',', 'patient', '(', 'patient', 'in', 'colchicine', 'group', ',', 'in', 'placebo', 'group', ')', 'followed', '.', 'seventy-six', '(', '.', ')', 'mace', 'reported', 'in', 'study', 'population', '.', 'no', 'significant', 'difference', 'regarding', 'number', 'of', 'mace', 'group', '(', '.', ')', 'in', 'colchicine', 'group', 'and', '(', '.', ')', 'in', 'placebo', 'group', '(', 'p.', ')', '.', 'no', 'difference', 'in', 'occurrence', 'of', 'ischaemic', 'stroke', 'colchicine', 'group', 'and', 'control', 'group', '(', '(', ')', 'v', '(', '.', ')', ',', 'respectively', ',', 'p.', ')', '.', 'trend', 'towards', 'fewer', 'heart', 'failure', 'event', 'in', 'colchicine', 'group', 'compared', 'with', 'placebo', 'group', '(', '(', '.', ')', 'v', '(', '.', ')', ',', 'p.', ')', '.', 'no', 'significant', 'difference', 'in', 'qol', 'score', 'year', '(', '..', 'v', '..', 'respectively', ',', 'p.', ')', '.', 'conclusion', 'no', 'significant', 'difference', 'colchicine', 'and', 'placebo', 'group', 'year', 'regarding', 'mace', ',', 'especially', 'concerning', 'death', 'or', 'ischaemic', 'stroke', '.', 'no', 'excess', 'of', 'ischaemic', 'adverse', 'event', 'observed', 'despite', 'initial', 'increase', 'in', 'lvt', 'in', 'colchicine', 'group', '.', 'trial', 'registration', 'number', 'nct', '.']"
The effect of dexmedetomidine on renal function in patients undergoing cardiac valve replacement under cardiopulmonary bypass: A double-blind randomized controlled trial.,"Mingyu Zhai, Fang Kang, Mingming Han, Xiang Huang, Juan Li, Mingyu Zhaiet al.",2017 Aug:40:33-38.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/28625442/,No keywords found,"['attempted', 'to', 'explore', 'effect', 'of', 'dex', 'renal', 'function', 'in', 'patient', 'with', 'cardiac', 'valve', 'replacement', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'design', 'designed', 'prospective', ',', 'randomized', ',', 'placebo-controlled', ',', 'single-center', ',', 'parallel-arm', 'double-blind', 'trial', '.', 'setting', 'operating', 'room', '.', 'patient', 'seven-two', 'eligible', 'patient', 'randomly', 'divided', 'dex', 'group', 'and', 'placebo', 'group', '.', 'intervention', 'dexmedetomidine', '(', 'dex', ')', '(', '.gkg-', ')', 'administered', 'in', 'patient', 'of', 'dex', 'group', 'min', 'anesthesia', 'induction', ',', 'followed', 'treatment', 'of', '.gkg-h-', 'dex', 'end', 'of', 'operation', '.', 'patient', 'in', 'placebo', 'group', 'treated', 'with', 'normal', 'saline', 'equally', '.', 'measurement', 'level', 'of', 'serum', 'urea', 'nitrogen', '(', 'bun', ')', ',', 'creatinine', '(', 'cr', ')', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'urine', 'interleukin-', '(', 'il-', ')', 'and', 'superoxide', 'dismutase', '(', 'sod', ')', 'activity', 'tested', 'anesthesia', 'induction', '(', ')', 'and', 'operation', ',', 'h', ',', 'h', 'and', 'h', '(', 't-', ')', '.', 'urine', 'output', 'operation', 'and', 'post-operative', 'complication', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'recorded', '.', 'main', 'result', 'level', 'of', 'bun', 'and', 'cr', 'significantly', 'increased', ',', 'and', 'similar', 'finding', 'found', 'in', 'level', 'of', 'ngal', 'and', 'urine', 'il-', 'and', 't.', 'sod', 'activity', 'significantly', 'declined', 'and', 'in', 'two', 'group', '.', 'level', 'of', 'bun', 'and', 'cr', 'and', 'ngal', 'level', 'and', 'significantly', 'lower', 'in', 'dex', 'group', ',', 'comparable', 'to', 'placebo', 'group', '.', 'intraoperative', 'urine', 'output', 'significantly', 'increased', 'and', 'postoperative', 'incidence', 'of', 'aki', 'significantly', 'lower', 'in', 'dex', 'group', '.', 'conclusion', 'dex', 'may', 'attenuate', 'renal', 'injury', 'and', 'decrease', 'incidence', 'of', 'aki', 'in', 'patient', 'undergoing', 'cardiac', 'valve', 'replacement', 'cpb', '.']"
"Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.","Sok Cin Tye, Niels Jongs, Steven G Coca, Johan Sundström, Clare Arnott, Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Priya Vart, Hiddo J L Heerspink, Sok Cin Tyeet al.",2022 Sep 23,Cardiovasc Diabetol,https://pubmed.ncbi.nlm.nih.gov/36151557/,No keywords found,"['sodium', 'glucose', 'co-transporter-', '(', 'sglt', ')', 'inhibitor', 'reduce', 'risk', 'of', 'kidney', 'and', 'heart', 'failure', 'event', 'independent', 'of', 'glycemic', 'effect', '.', 'assessed', 'whether', 'initiation', 'of', 'sglt', 'inhibitor', 'canagliflozin', 'guided', 'multivariable', 'predicted', 'risk', 'based', 'clinical', 'characteristic', 'and', 'novel', 'biomarkers', 'efficient', 'to', 'prevent', 'clinical', 'outcome', 'compared', 'to', 'strategy', 'guided', 'hbac', 'or', 'urinary-albumin-creatinine', 'ratio', '(', 'uacr', ')', 'alone', '.', 'method', 'performed', 'post-hoc', 'analysis', 'of', 'canvas', 'trial', 'including', 'patient', 'with', 'available', 'biomarker', 'measurement', '.', 'compared', 'number', 'of', 'composite', 'kidney', '(', 'defined', 'sustained', 'decline', 'in', 'egfr', ',', 'chronic', 'dialysis', ',', 'kidney', 'transplantation', ',', 'or', 'kidney', 'death', ')', 'and', 'composite', 'heart', 'failure', 'outcome', '(', 'defined', 'heart', 'failure', 'hospitalization', 'or', 'cardiovascular', '(', 'cv', ')', 'death', ')', 'prevented', 'per', 'patient', 'treated', 'year', 'canagliflozin', 'initiated', 'in', 'patient', 'according', 'to', 'hbac', '.', ',', 'uacr', ',', 'or', 'multivariable', 'risk', 'model', 'consisting', 'of', '(', ')', 'clinical', 'characteristic', ',', 'or', '(', ')', 'clinical', 'characteristic', 'and', 'novel', 'biomarkers', '.', 'difference', 'in', 'rate', 'of', 'event', 'prevented', 'strategy', 'tested', 'chi-statistic', '.', 'result', 'median', 'follow-up', 'of', '.', 'year', ',', 'kidney', 'event', 'recorded', '.', 'final', 'clinical', 'model', 'included', 'age', ',', 'previous', 'history', 'of', 'cv', 'disease', ',', 'systolic', 'blood', 'pressure', ',', 'uacr', ',', 'hemoglobin', ',', 'body', 'weight', ',', 'albumin', ',', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'and', 'randomized', 'treatment', 'assignment', '.', 'combined', 'biomarkers', 'model', 'included', 'clinical', 'characteristic', ',', 'tumor', 'necrosis', 'factor', 'receptor-', ',', 'kidney', 'injury', 'molecule-', ',', 'matrix', 'metallopeptidase-', 'and', 'interleukin-', '.', 'treating', 'patient', 'with', 'hbac', '.', '(', 'n', ')', 'would', 'prevent', '.', '(', 'ci', '.', 'to', '.', ')', 'kidney', 'event', 'rate', 'of', '.', '(', 'ci', '.', 'to', '.', ')', 'event', 'prevented', 'per', 'patient', 'treated', 'year', '.', 'corresponding', 'rate', '.', '(', 'ci', '.', 'to', '.', ')', ',', '.', '(', 'ci', '.', 'to', '.', ')', '(', 'p', '.', 'versus', 'hbac', 'or', 'uacr', 'approach', ')', ',', 'and', '.', '(', 'ci', '.', 'to', '.', ')', '(', 'p', '.', 'versus', 'hbac', 'or', 'uacr', 'approach', 'p', '.', 'versus', 'clinical', 'model', ')', '.', 'finding', 'similar', 'heart', 'failure', 'outcome', '.', 'conclusion', 'initiation', 'of', 'canagliflozin', 'based', 'estimated', 'risk-based', 'approach', 'prevented', 'kidney', 'and', 'heart', 'failure', 'outcome', 'compared', 'to', 'strategy', 'based', 'hbac', 'or', 'uacr', 'alone', '.', 'no', 'apparent', 'gain', 'adding', 'novel', 'biomarkers', 'to', 'clinical', 'risk', 'model', '.', 'finding', 'support', 'use', 'of', 'risk-based', 'assessment', 'using', 'clinical', 'marker', 'to', 'guide', 'initiation', 'of', 'sglt', 'inhibitor', 'in', 'patient', 'with', 'type', 'diabetes', '.']"
Importance of intraoperative oliguria during major abdominal surgery: findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial.,"Paul S Myles, David R McIlroy, Rinaldo Bellomo, Sophie Wallace, Paul S Myleset al.",2019 Jun,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/30916001/,No keywords found,"['association', 'intraoperative', 'oliguria', 'major', 'abdominal', 'surgery', 'and', 'subsequent', 'development', 'of', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'remains', 'poorly', 'defined', '.', 'hypothesised', ',', 'in', 'patient', ',', 'intraoperative', 'oliguria', 'would', 'independent', 'predictor', 'of', 'subsequent', 'aki', '.', 'method', 'performed', 'post', 'hoc', 'analysis', 'of', 'data', 'restrictive', 'versus', 'liberal', 'fluid', 'therapy', 'in', 'major', 'abdominal', 'surgery', '(', 'relief', ')', 'trial', 'of', 'conservative', 'v', 'liberal', 'fluid', 'therapy', 'and', 'major', 'abdominal', 'surgery', '.', 'used', ',', 'logistic', 'regression', ',', 'and', 'fractional', 'polynomial', 'to', 'study', 'association', 'intraoperative', 'oliguria', 'defined', 'urinary', 'output', '.', 'ml', 'kg-', 'h-', 'and', 'development', 'of', 'postoperative', 'aki', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', 'consensus', 'criterion', '.', 'result', 'included', 'of', 'patient', 'relief', 'trial', 'in', 'study', '.', 'total', 'of', 'patient', '(', ')', 'met', 'oliguric', 'criterion', 'intraoperatively', '.', 'oliguria', 'occurred', 'in', 'of', 'without', 'aki', ',', 'and', ',', ',', 'and', 'of', 'developed', 'postoperative', 'aki', 'stage', '-', ',', 'respectively', '(', 'p.', 'trend', ')', '.', 'intraoperative', 'oliguria', 'associated', 'with', 'increased', 'risk', 'of', 'aki', ',', 'risk', 'ratio', '.', '(', 'confidence', 'interval', '.-', '.', 'p.', ')', ',', 'greater', 'intensity', 'of', 'oliguria', '(', 'urine', 'output', '.', 'ml', 'kg-', 'h-', ')', 'not', 'increase', 'risk', '.', 'patient', 'with', 'oliguria', 'not', 'develop', 'aki', 'positive', 'predictive', 'value', 'of', 'oliguria', '.', ',', 'and', 'negative', 'predictive', 'value', '..', 'conclusion', 'intraoperative', 'oliguria', ',', 'defined', 'urine', 'output', '.', 'ml', 'kg-', 'h-', ',', 'relatively', 'common', 'and', 'associated', 'with', 'postoperative', 'aki', '.', 'however', ',', 'predictive', 'utility', 'of', 'oliguria', 'aki', 'low', ',', 'whilst', 'absence', 'good', 'predictive', 'value', 'aki-free', 'postoperative', 'course', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial.,"Bart J Kramers, Iris W Koorevaar, Maatje D A van Gastel, Harry van Goor, Kenneth R Hallows, Hiddo L Heerspink, Hui Li, Wouter N Leonhard, Dorien J M Peters, Jiedong Qiu, Daan J Touw, Ron T Gansevoort, Esther Meijer, Bart J Kramerset al.",2022 Apr,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/35314480/,No keywords found,"['vasopressin', 'v', 'receptor', 'antagonist', 'tolvaptan', 'drug', 'proven', 'to', 'nephroprotective', 'in', 'autosomal', 'dominant', 'polycystic', 'kidney', 'disease', '(', 'adpkd', ')', '.', 'tolvaptan', 'also', 'cause', 'polyuria', ',', 'limiting', 'tolerability', '.', 'hypothesized', 'cotreatment', 'with', 'hydrochlorothiazide', 'or', 'metformin', 'may', 'ameliorate', 'side', 'effect', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'performed', 'clinical', 'study', 'and', 'animal', 'study', '.', 'in', 'randomized', ',', 'controlled', ',', 'double-blind', ',', 'crossover', 'trial', ',', 'included', 'tolvaptan-treated', 'patient', 'with', 'adpkd', '.', 'patient', 'treated', 'three', '-week', 'period', 'with', 'hydrochlorothiazide', ',', 'metformin', ',', 'or', 'placebo', 'in', 'random', 'order', '.', 'primary', 'outcome', 'change', 'in', '-hour', 'urine', 'volume', '.', 'also', 'measured', 'gfr', 'and', 'range', 'of', 'metabolic', 'and', 'kidney', 'injury', 'marker', '.', 'result', 'patient', '(', 'age', 'year', ',', 'woman', ',', 'measured', 'gfr', 'of', 'mlmin', 'per', '.', ')', 'baseline', 'urine', 'volume', 'tolvaptan', 'of', '..', 'l', 'h.', 'urine', 'volume', 'decreased', 'to', '.', 'l', 'h', '(', 'p.', ')', 'with', 'hydrochlorothiazide', 'and', 'to', '.', 'l', 'h', '(', 'p.', ')', 'metformin', '.', 'hydrochlorothiazide', 'treatment', ',', 'plasma', 'copeptin', '(', 'surrogate', 'vasopressin', ')', 'decreased', ',', 'quality', 'of', 'life', 'improved', ',', 'and', 'several', 'marker', 'of', 'kidney', 'damage', 'and', 'glucose', 'metabolism', 'improved', '.', 'metformin', 'not', 'induce', 'change', 'in', 'marker', 'or', 'in', 'quality', 'of', 'life', '.', 'given', 'result', ',', 'effect', 'of', 'adding', 'hydrochlorothiazide', 'to', 'tolvaptan', 'investigated', 'long-term', 'kidney', 'outcome', 'in', 'animal', 'experiment', '.', 'water', 'intake', 'in', 'tolvaptan-hydrochlorothiazide', 'cotreated', 'mouse', 'lower', 'in', 'mouse', 'treated', 'with', 'tolvaptan', '.', 'combination', 'treatment', 'superior', 'to', '``', 'no', 'treatment', ""''"", 'marker', 'of', 'disease', 'progression', '(', 'kidney', 'weight', ',', 'p.', 'and', 'cystic', 'index', ',', 'p.', ')', 'and', 'superior', 'or', 'equal', 'to', 'tolvaptan', 'alone', '.', 'conclusion', 'metformin', 'and', 'hydrochlorothiazide', 'reduced', 'tolvaptan-caused', 'polyuria', 'in', 'short-term', 'study', '.', 'hydrochlorothiazide', 'also', 'reduced', 'polyuria', 'in', 'long-term', 'animal', 'model', 'without', 'negatively', 'affecting', 'nephroprotection', '.', 'podcast', 'article', 'contains', 'podcast', 'httpswww.asn-online.orgmediapodcastcjasncjn.mp', '.']"
Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal Function.,"Shingo Matsumoto, Alasdair D Henderson, Li Shen, Mingming Yang, Karl Swedberg, Muthiah Vaduganathan, Dirk J van Veldhuisen, Scott D Solomon, Bertram Pitt, Faiez Zannad, Pardeep S Jhund, John J V McMurray, Shingo Matsumotoet al.",2024 Jun 18,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/38739064/,No keywords found,"['kidney', 'dysfunction', 'often', 'lead', 'to', 'reluctance', 'to', 'start', 'or', 'continue', 'life-saving', 'heart', 'failure', '(', 'hf', ')', 'therapy', '.', 'objective', 'study', 'sought', 'to', 'examine', 'efficacy', 'and', 'safety', 'of', 'mineralocorticoid', 'receptor', 'antagonist', '(', 'mras', ')', 'in', 'patient', 'with', 'hf', 'with', 'reduced', 'ejection', 'fraction', 'experiencing', 'significant', 'kidney', 'dysfunction', '.', 'method', 'pooled', 'individual', 'patient', 'data', 'rale', '(', 'randomized', 'aldactone', 'evaluation', 'study', ')', 'and', 'emphasis-hf', '(', 'eplerenone', 'in', 'mild', 'patient', 'hospitalization', 'and', 'survival', 'study', 'in', 'heart', 'failure', ')', 'trial', '.', 'association', 'mra', 'treatment', 'and', 'outcome', 'assessed', 'according', 'to', 'whether', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'declined', 'to', '.', 'mmoll', ')', '.', 'conclusion', 'patient', 'experiencing', 'decrease', 'in', 'egfr', 'to', 'mlmin', '.', 'high', 'risk', ',', 'absolute', 'risk', 'reduction', 'with', 'mra', 'in', 'patient', 'large', 'and', 'decline', 'in', 'egfr', 'not', 'automatically', 'lead', 'to', 'treatment', 'discontinuation', '.']"
Effects of dexmedetomidine on renal function after cardiac surgery for infective endocarditis: An interim analysis of a randomized controlled trial.,"Sung Yeon Ham, Jae-Kwang Shim, Sak Lee, Seo Hee Ko, Sarah Soh, Young-Lan Kwak, Sung Yeon Hamet al.",2024 Oct,Asian J Surg,https://pubmed.ncbi.nlm.nih.gov/38658274/,No keywords found,"['patient', 'undergoing', 'cardiac', 'surgery', 'infective', 'endocarditis', '(', 'ie', ')', 'high', 'risk', 'of', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'owing', 'to', 'heightened', 'systemic', 'inflammation', '.', 'therefore', ',', 'aimed', 'to', 'investigate', 'effect', 'of', 'dexmedetomidine', 'postoperative', 'aki', 'in', 'patient', 'underwent', 'cardiac', 'surgery', 'ie', '.', 'method', 'total', 'of', 'patient', 'underwent', 'cardiac', 'surgery', 'ie', 'randomly', 'assigned', 'to', 'receive', 'either', 'intravenous', 'dexmedetomidine', 'infusion', 'of', '.', 'g', 'kg-', 'h-', '(', 'dex', 'group', ')', 'or', 'normal', 'saline', 'infusion', '(', 'control', 'group', ')', 'h', 'induction', 'of', 'anesthesia', '.', 'occurrence', 'of', 'aki', 'within', 'seven', 'day', 'postoperation', ',', 'epinephrine', ',', 'norepinephrine', ',', 'and', 'interleukin-', 'level', ',', 'well', 'postoperative', 'morbidity', ',', 'assessed', '.', 'intertrim', 'analysis', 'conducted', 'using', 'pocock', ""'s"", 'alpha', 'spending', 'function', '.', 'and', '..', 'result', 'trial', 'early', 'terminated', 'according', 'to', 'result', 'of', 'interim', 'analysis', 'performed', 'of', 'pre-set', 'number', 'of', 'patient', 'collected', '.', 'incidence', 'of', 'aki', 'significantly', 'lower', 'in', 'dex', 'group', 'in', 'control', 'group', '(', '.', 'vs.', '.', ',', 'p', '.', ')', '.', 'patient', 'in', 'dex', 'group', 'significantly', 'lower', 'epinephrine', 'level', 'in', 'control', 'group', ',', 'whereas', 'norepinephrine', 'and', 'interleukin-', 'level', 'similar', '.', 'perioperative', 'mean', 'arterial', 'pressure', 'or', 'heart', 'rate', 'not', 'differ', 'group', '.', 'conclusion', 'dexmedetomidine', 'administration', 'h', 'starting', 'induction', 'of', 'anesthesia', 'significantly', 'reduced', 'incidence', 'of', 'postoperative', 'aki', 'cardiac', 'surgery', 'ie', '(', 'vs.', 'control', ')', 'without', 'hemodynamic', 'side', 'effect', '.', 'accompanied', 'significant', 'attenuation', 'of', 'postoperative', 'increase', 'in', 'serum', 'epinephrine', 'level', '.']"
"Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial.","Konstantinos C Koskinas, Stephan Windecker, Aliki Buhayer, Baris Gencer, Giovanni Pedrazzini, Christian Mueller, Stephan Cook, Olivier Muller, Christian M Matter, Lorenz Räber, Dik Heg, François Mach                              ;, EVOPACS Investigators, Konstantinos C Koskinaset al.",2018 Dec,Clin Cardiol,https://pubmed.ncbi.nlm.nih.gov/30421481/,"PCSK9 inhibitor, acute coronary syndrome, lipidology.","['statin', 'lower', 'low-density', 'lipoprotein', 'cholesterol', '(', 'ldl-c', ')', 'and', 'improve', 'clinical', 'outcome', 'in', 'patient', 'with', 'atherosclerotic', 'cardiovascular', 'disease', '(', 'cvd', ')', '.', 'patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'often', 'not', 'achieve', 'ldl-c', 'target', 'despite', 'potent', 'statin', 'treatment', ',', 'and', 'particularly', 'high', 'risk', 'of', 'early', 'recurrent', 'event', '.', 'evolocumab', ',', 'proprotein', 'convertase', 'subtilisinkexin', 'type', '(', 'pcsk', ')', '-inhibitor', 'resulting', 'in', 'rapid', ',', 'marked', 'ldl-c', 'reduction', ',', 'studied', 'in', 'hypercholesterolemic', 'subject', 'without', 'cvd', 'and', 'stabilized', 'patient', 'with', 'cvd', 'feasibility', ',', 'safety', ',', 'and', 'efficacy', 'of', 'treatment', 'initiated', 'in', 'acute', 'phase', 'of', 'ac', 'remain', 'unknown', '.', 'report', 'design', 'of', 'evolocumab', 'early', 'reduction', 'of', 'ldl-cholesterol', 'level', 'in', 'patient', 'with', 'ac', '(', 'evopacs', ')', ',', 'phase-', ',', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trial', 'to', 'assess', 'feasibility', ',', 'safety', ',', 'and', 'ldl-c-lowering', 'efficacy', 'of', 'evolocumab', 'top', 'of', 'atorvastatin', 'mg', 'in', 'patient', 'with', 'ac', '.', 'primary', 'endpoint', 'percent', 'change', 'in', 'ldl-c', 'baseline', 'to', 'week', '.', 'secondary', 'endpoint', 'adverse', 'event', 'and', 'serious', 'adverse', 'event', '.', 'background', 'of', 'beneficial', 'cardiovascular', 'effect', 'of', 'statin', 'beyond', 'ldl-c', 'lowering', 'and', 'in', 'view', 'of', 'preclinical', 'evidence', 'of', 'similar', 'effect', 'of', 'pcsk', 'inhibition', ',', 'study', 'also', 'address', 'variety', 'of', 'exploratory', 'endpoint', 'including', 'change', 'in', 'c-reactive', 'protein', 'and', 'inflammatory', 'biomarkers', 'platelet', 'reactivity', 'and', 'occurrence', 'of', 'contrast-induced', 'acute', 'kidney', 'injury', 'and', 'myocardial', 'injury', 'in', 'patient', 'undergoing', 'cardiac', 'catheterization', '.', 'intracoronary', 'imaging', 'sub-study', 'investigate', 'change', 'baseline', 'in', 'lipid', 'core', 'burden', 'index', 'in', 'non-culprit', 'lesion', ',', 'assessed', 'serial', 'near-infrared', 'spectroscopy', '.', 'recruitment', 'began', 'in', 'january', 'and', 'enrollment', 'of', 'patient', 'planned', '.']"
Effect of YH0618 soup on chemotherapy-induced toxicity in patients with cancer who have completed chemotherapy: study protocol for a randomized controlled trial.,"Jie-Shu You, Jian-Ping Chen, Jessie S M Chan, Ho-Fun Lee, Mei-Kuen Wong, Wing-Fai Yeung, Li-Xing Lao, Jie-Shu Youet al.",2016 Jul 26,Trials,https://pubmed.ncbi.nlm.nih.gov/27457560/,No keywords found,"['incidence', 'of', 'cancer', 'staying', 'high', 'level', 'worldwide', 'in', 'recent', 'year', '.', 'with', 'advance', 'in', 'cancer', 'diagnosis', 'and', 'therapy', 'strategy', ',', 'survival', 'rate', 'of', 'patient', 'with', 'cancer', 'increasing', ',', 'side', 'effect', 'of', 'treatment', ',', 'especially', 'chemotherapy', ',', 'obvious', 'even', 'chemotherapy', 'cease', '.', 'yh', ',', 'prescription', ',', 'showed', 'efficacy', 'in', 'reducing', 'chemotherapy-induced', 'toxicity', 'long', 'clinical', 'practice', '.', 'however', ',', 'no', 'scientific', 'research', 'exploring', 'effect', 'of', 'yh', 'in', 'patient', 'with', 'cancer', '.', 'therefore', ',', 'using', 'randomized', 'controlled', 'trial', ',', 'study', 'explore', 'efficacy', 'of', 'yh', 'ameliorating', 'chemotherapy-induced', 'toxicity', 'including', 'dermatologic', 'toxicity', ',', 'myelosuppression', ',', 'hepatotoxicity', 'and', 'nephrotoxicity', 'and', 'improving', 'fatigue', 'in', 'cancer', 'patient', 'completed', 'chemotherapy', '.', 'methodsdesign', 'prospective', 'assessor-blinded', ',', 'parallel', ',', 'randomized', 'controlled', 'trial', '.', 'patient', 'with', 'cancer', 'stage', 'completed', 'chemotherapy', 'within', 'two', 'week', 'randomly', 'divided', 'group', '(', 'yh', ')', 'and', 'group', 'b', '(', 'wait-list', ')', 'using', 'allocation', 'ratio', '.', 'chemotherapeutic', 'agent', 'include', 'taxanes', 'or', 'anthracyclines', '.', 'subject', 'assigned', 'to', 'group', 'receive', 'yh', 'soup', 'day', 'week', 'week', 'and', 'uncontrolled', 'follow-up', 'week', ',', 'group', 'b', 'required', 'to', 'wait', 'week', 'receiving', 'yh', 'intervention', '.', 'primary', 'outcome', 'of', 'study', 'incidence', 'of', 'protocol-specified', 'grade', 'dermatologic', 'toxicity', 'graded', 'nci', 'ctcae', 'chinese', 'version', '.', 'and', 'change', 'of', 'fingernail', 'color', ',', 'face', 'skin', 'color', 'and', 'tongue', 'color', 'evaluated', 'lab', 'system', 'within', 'week', '.', 'secondary', 'outcome', 'associated', 'with', 'dermatologic', 'toxicity', 'including', 'fatigue', 'and', 'clinical', 'objective', 'examination', '.', 'discussion', 'scientific', 'and', 'safe', 'method', 'in', 'ameliorating', 'chemotherapy-induced', 'toxicity', '.', 'proposed', 'study', 'may', 'provide', 'direct', 'and', 'convincing', 'evidence', 'to', 'support', 'yh', 'adjuvant', 'treatment', 'reducing', 'chemotherapy-induced', 'toxicity', ',', 'could', 'introduced', 'clinical', 'setting', '.', 'trial', 'registration', 'chinese', 'clinical', 'trial', 'registry', 'chictr-ior-', '.', 'registered', 'may', '.']"
AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes.,"Tullio Usmiani, Alessandro Andreis, Carlo Budano, Pierluigi Sbarra, Monica Andriani, Paolo Garrone, Anna Laura Fanelli, Chiara Calcagnile, Laura Bergamasco, Luigi Biancone, Sebastiano Marra, Tullio Usmianiet al.",2016 Jul,J Cardiovasc Med (Hagerstown),https://pubmed.ncbi.nlm.nih.gov/26702595/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ciaki', ')', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', 'undergoing', 'coronary', 'angiography', 'or', 'percutaneous', 'coronary', 'intervention', 'common', 'iatrogenic', 'complication', 'associated', 'with', 'increased', 'morbidity', 'and', 'mortality', '.', 'study', 'compare', 'sodium', 'bicarbonateisotonic', 'salinen-acetylcysteinevitamin', 'c', 'prophylaxis', '(', 'bs-nac', ')', 'high-volume', 'forced', 'diuresis', 'with', 'matched', 'hydration', 'in', 'ciaki', 'prevention', '.', 'method', 'one-hundred', 'and', 'thirty-three', 'consecutive', 'patient', 'undergoing', 'coronary', 'angiography', 'or', 'percutaneous', 'coronary', 'intervention', 'with', 'estimated', 'glomerular', 'filtration', 'rate', 'less', 'mlmin.m', 'randomized', 'to', 'study', 'group', 'receiving', 'matched', 'hydration', '(', 'mhg', ')', 'or', 'to', 'control', 'group', 'receiving', 'bs-nac', '.', 'mhg', 'received', 'in', 'vein', '(', 'i.v', '.', ')', 'ml', 'isotonic', 'saline', 'bolus', ',', 'followed', '.', 'mgkg', 'furosemide', 'i.v', '.', 'bolus', 'to', 'forced', 'diuresis', '.', 'dedicated', 'device', 'automatically', 'matched', 'isotonic', 'saline', 'i.v', '.', 'infusion', 'rate', 'to', 'urinary', 'output', 'h', ',', 'and', 'h', 'procedure', '.', 'result', 'mhg', 'lowest', 'incidence', 'of', 'ciaki', '(', 'vs.', ',', 'p', '.', ')', ',', 'major', 'adverse', 'cardiac', 'and', 'cerebrovascular', 'event', 'year', '(', 'vs.', ',', 'p', '.', ')', 'and', 'readmission', 'to', 'cardiologynephrology', 'department', '(', 'vs.', ',', 'p', '.', 'hospitalization', 'day', '.', '.', 'vs.', '.', '.', ',', 'p', '.', ')', '.', 'three', 'month', 'procedure', 'decrease', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '.', 'mhg', 'versus', 'control', 'group', '.', 'conclusion', 'matched', 'hydration', 'effective', 'bs-nac', 'in', 'ciaki', 'prevention', '.', 'one-year', 'follow-up', 'showed', 'matched', 'hydration', 'associated', 'also', 'with', 'limited', 'chronic', 'kidney', 'disease', 'progression', ',', 'major', 'adverse', 'cardiac', 'and', 'cerebrovascular', 'event', 'and', 'hospitalization', '.']"
"The NRF2 stimulating agent, tin protoporphyrin, activates protective cytokine pathways in healthy human subjects and in patients with chronic kidney disease.","Richard A Zager, Ali C M Johnson, Richard A Zageret al.",2020 Sep,Physiol Rep,https://pubmed.ncbi.nlm.nih.gov/32940965/,No keywords found,"['tin', 'protoporphyrin', '(', 'snpp', ')', ',', 'heme', 'oxygenase', '(', 'ho-', ')', 'inhibitor', ',', 'trigger', 'adaptive', 'tissue', 'response', 'confer', 'potent', 'protection', 'acute', 'renal-', 'and', 'extra-renal', 'tissue', 'injury', '.', 'effect', 'mediated', ',', 'in', 'part', ',', 'via', 'snpp-induced', 'activation', 'of', 'cytoprotective', 'nrf', 'pathway', '.', 'however', ',', 'remains', 'unclear', 'to', 'whether', 'snpp', 'also', 'upregulate', 'humoral', 'cytokine', 'defense', ',', 'either', 'in', 'healthy', 'human', 'subject', 'or', 'in', 'patient', 'with', 'ckd', '.', ',', 'systemically', 'derived', 'cytokine', 'could', 'contribute', 'snpp-induced', 'tissue', 'protection', '.', 'method', 'snpp', '(', 'mg', 'iv', ')', 'administered', 'hr', 'to', 'six', 'healthy', 'human', 'volunteer', '(', 'hvs', ')', 'and', 'subject', 'with', 'stage', '-', 'ckd', '.', 'plasma', 'sample', 'obtained', 'baseline', 'upto', 'hr', 'post', 'injection', '.', 'two', 'representative', 'anti-inflammatory', 'cytokine', '(', 'il-', ',', 'tgf', ')', ',', 'and', 'pro-inflammatory', 'cytokine', '(', 'tnf-', ')', ',', 'assayed', '.', 'il-', 'shown', 'to', 'induce', 'tissue', 'preconditioning', ',', 'plasma', 'concentration', 'also', 'assessed', '.', 'in', 'complementary', 'mouse', 'experiment', ',', 'snpp', 'effect', 'renal', ',', 'splenic', ',', 'and', 'hepatic', 'il-', ',', 'il-', ',', 'tgf', ',', 'and', 'tnf-', 'production', '(', 'gauged', 'mrna', ')', 'tested', '.', 'tissue', 'ho-', 'mrna', 'served', 'nrf', 'activation', 'marker', '.', 'result', 'snpp', 'induced', 'marked', '(', '-x', ')', 'increase', 'in', 'plasma', 'il-', 'and', 'il-', 'concentration', 'within', '-', 'hr', ',', 'and', 'to', 'equal', 'degree', 'in', 'hvs', 'and', 'ckd', 'patient', '.', 'snpp', 'modestly', 'raised', 'plasma', 'tgf', 'without', 'impacting', 'plasma', 'tnf-', 'level', '.', 'in', 'mouse', 'experiment', ',', 'snpp', 'not', 'affect', 'il-', ',', 'il-', ',', 'tnf-', ',', 'or', 'tgf', 'mrna', 'in', 'kidney', 'despite', 'marked', 'renal', 'nrf', 'activation', '.', 'conversely', ',', 'snpp', 'increased', 'splenic', 'il-', 'and', 'hepatic', 'il-tgf', 'mrna', 'level', ',', 'suggesting', 'organ', 'site', 'of', 'extra-renal', 'cytokine', 'generation', '.', 'conclusion', 'snpp', 'trigger', 'cytoprotective', 'cytokine', 'production', ',', 'likely', 'in', 'extra-renal', 'tissue', '.', 'with', 'ready', 'glomerular', 'cytokine', 'filtration', ',', 'extra-renalrenal', '``', 'organ', 'cross', 'talk', ""''"", 'result', '.', 'thus', ',', 'humoral', 'factor', 'seemingly', 'contribute', 'to', 'snpp', ""'s"", 'cytoprotective', 'effect', '.']"
Low Versus Standard Urine Output Targets in Patients Undergoing Major Abdominal Surgery: A Randomized Noninferiority Trial.,"Jevon R Puckett, John W Pickering, Suetonia C Palmer, John L McCall, Michal T Kluger, Janak De Zoysa, Zoltan H Endre, Mattias Soop, Jevon R Puckettet al.",2017 May,Ann Surg,https://pubmed.ncbi.nlm.nih.gov/27763895/,No keywords found,"['to', 'determine', 'whether', 'low', 'perioperative', 'minimum', 'urine', 'output', 'target', 'safe', 'and', 'fluid', 'sparing', 'compared', 'with', 'standard', 'target', '.', 'background', 'minimum', 'hourly', 'urine', 'output', 'of', '.', 'mlkg', 'key', 'target', 'guiding', 'perioperative', 'fluid', 'therapy', '.', 'data', 'support', 'standard', 'practice', ',', 'may', 'contribute', 'to', 'perioperative', 'fluid', 'overloading', '.', 'method', 'randomized', 'patient', 'without', 'significant', 'risk', 'factor', 'acute', 'kidney', 'injury', 'undergoing', 'elective', 'colectomy', 'to', 'minimum', 'urine', 'output', 'target', 'of', '.', 'mlkgh', '(', 'low', 'group', ')', 'or', '.', 'mlkgh', '(', 'standard', 'group', ')', 'induction', 'of', 'anesthesia', 'day', 'surgery', '.', 'maintenance', 'fluid', 'standardized', 'and', 'additional', 'fluid', 'administered', 'to', 'achieve', 'target', '.', 'primary', 'outcome', 'noninferiority', 'urine', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'day', 'surgery', '.', 'result', 'november', ',', 'and', 'july', ',', ',', 'participant', 'completed', 'study', '.', 'low', 'group', 'received', 'ml', '(', 'confidence', 'interval', '-', ')', 'intravenous', 'fluid', 'versus', 'ml', '(', 'confidence', 'interval', '-', ')', 'in', 'standard', 'group', '(', 'p', '.', ')', ',', 'and', 'noninferior', 'neutrophil', 'gelatinase-associated', 'lipocalin', '.', 'gl', '(', 'interquartile', 'range', '.-', '.', ')', 'v', '.', 'gl', '(', 'interquartile', 'range', '.-', '.', ')', 'pnoninferiority', '.', ',', 'serum', 'cystatin', 'c', '(', 'pnoninferiority', '.', ')', ',', 'serum', 'creatinine', '(', 'pnoninferiority', '.', ')', ',', 'and', 'measured', 'glomerular', 'filtration', '(', 'pnoninferiority', '.', ')', '.', 'effective', 'renal', 'plasma', 'flow', 'increased', 'in', 'group', 'surgery', ',', 'and', 'in', 'standard', 'group', '(', 'pnoninferiority', '.', ')', '.', 'conclusion', 'perioperative', 'urine', 'output', 'target', 'of', '.', 'mlkgh', 'noninferior', 'to', 'standard', 'target', 'of', '.', 'mlkgh', 'and', 'result', 'in', 'large', 'intravenous', 'fluid', 'sparing', '.', 'target', 'adopted', 'in', 'surgical', 'patient', 'without', 'significant', 'kidney', 'injury', 'risk', 'factor', '.']"
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.,"Guillermo Umpierrez, Saumeth Cardona, Francisco Pasquel, Sol Jacobs, Limin Peng, Michael Unigwe, Christopher A Newton, Dawn Smiley-Byrd, Priyathama Vellanki, Michael Halkos, John D Puskas, Robert A Guyton, Vinod H Thourani, Guillermo Umpierrezet al.",2015 Sep,Diabetes Care,https://pubmed.ncbi.nlm.nih.gov/26180108/,No keywords found,"['optimal', 'level', 'of', 'glycemic', 'control', 'needed', 'to', 'improve', 'outcome', 'in', 'cardiac', 'surgery', 'patient', 'remains', 'controversial', '.', 'research', 'design', 'and', 'method', 'randomized', 'patient', 'with', 'diabetes', '(', 'n', ')', 'and', 'without', 'diabetes', '(', 'n', ')', 'with', 'hyperglycemia', 'to', 'intensive', 'glucose', 'target', 'of', '-', 'mgdl', '(', 'n', ')', 'or', 'to', 'conservative', 'target', 'of', '-', 'mgdl', '(', 'n', ')', 'coronary', 'artery', 'bypass', 'surgery', '(', 'cabg', ')', 'surgery', '.', 'intensive', 'care', 'unit', '(', 'icu', ')', ',', 'patient', 'received', 'single', 'treatment', 'regimen', 'in', 'hospital', 'and', 'day', 'postdischarge', '.', 'primary', 'outcome', 'difference', 'in', 'composite', 'of', 'complication', ',', 'including', 'mortality', ',', 'wound', 'infection', ',', 'pneumonia', ',', 'bacteremia', ',', 'respiratory', 'failure', ',', 'acute', 'kidney', 'injury', ',', 'and', 'major', 'cardiovascular', 'event', '.', 'result', 'mean', 'glucose', 'in', 'icu', 'mgdl', '(', 'interquartile', 'range', 'iqr', '-', ')', 'in', 'intensive', 'and', 'mgdl', '(', 'iqr', '-', ')', 'in', 'conservative', 'group', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'composite', 'of', 'complication', 'intensive', 'and', 'conservative', 'group', '(', 'vs.', ',', 'p', '.', ')', '.', 'observed', 'heterogeneity', 'in', 'treatment', 'effect', 'according', 'to', 'diabetes', 'status', ',', 'with', 'no', 'difference', 'in', 'complication', 'among', 'patient', 'with', 'diabetes', 'treated', 'with', 'intensive', 'or', 'conservative', 'regimen', '(', 'vs.', ',', 'p', '.', ')', ',', 'significant', 'lower', 'rate', 'of', 'complication', 'in', 'patient', 'without', 'diabetes', 'treated', 'with', 'intensive', 'compared', 'with', 'conservative', 'treatment', 'regimen', '(', 'vs.', ',', 'p', '.', ')', '.', 'conclusion', 'intensive', 'insulin', 'therapy', 'to', 'target', 'glucose', 'of', 'and', 'mgdl', 'in', 'icu', 'not', 'significantly', 'reduce', 'perioperative', 'complication', 'compared', 'with', 'target', 'glucose', 'of', 'and', 'mgdl', 'cabg', 'surgery', '.', 'subgroup', 'analysis', 'showed', 'lower', 'number', 'of', 'complication', 'in', 'patient', 'without', 'diabetes', ',', 'not', 'in', 'patient', 'with', 'diabetes', 'treated', 'with', 'intensive', 'regimen', '.', 'large', 'prospective', 'randomized', 'study', 'needed', 'to', 'confirm', 'finding', '.']"
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.,"Kirk E Cahill, Yasmin H Karimi, Theodore G Karrison, Nitin Jain, Margaret Green, Howard Weiner, Noreen Fulton, Sabah Kadri, Lucy A Godley, Andrew S Artz, Hongtao Liu, Michael J Thirman, Michelle M Le Beau, Megan E McNerney, Jeremy Segal, Richard A Larson, Wendy Stock, Olatoyosi Odenike, Kirk E Cahillet al.",2020 Feb 25,Blood Adv,https://pubmed.ncbi.nlm.nih.gov/32074275/,No keywords found,"['acute', 'liver', 'failure', 'and', 'kidney', 'injury', 'mgm', 'dose', '.', '-day', 'induction', 'death', 'rate', '.', '(', 'of', ')', '.', 'overall', 'response', 'rate', ',', 'including', 'complete', 'remission', 'and', 'complete', 'remission', 'with', 'incomplete', 'count', 'recovery', ',', '(', 'of', ')', '.', 'previously', 'untreated', 'patient', 'aged', 'year', 'with', 'therapy-related', 'aml', 'and', 'de', 'novo', 'aml', 'likely', 'to', 'respond', 'untreated', 'patient', 'with', 'aml', 'progressing', 'antecedent', 'hematologic', 'disorder', '(', 'myelodysplastic', 'syndrome', 'and', 'chronic', 'myelomonocytic', 'leukemia', ')', '.', 'patient', 'with', 'favorable', 'european', 'leukemia', 'network', 'risk', '(', 'p', '.', ')', ',', 'npm', 'mutation', '(', 'p', '.', ')', ',', 'or', 'idh', 'mutation', '(', 'p', '.', ')', 'likely', 'to', 'respond', ',', 'and', 'with', 'tp', 'mutation', '(', 'p', '.', ')', 'less', 'likely', 'to', 'respond', '.', 'recommended', 'phase', 'dose', 'of', 'aza', 'mgm', 'per', 'day', 'day', 'to', 'followed', 'hidac', '(', 'mgm', ')', 'and', 'mitoxantrone', '(', 'mgm', ')', 'day', 'and', '.', 'trial', 'registered', 'www.clinicaltrials.gov', 'nct', '.']"
"Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement - a randomized trial.","A M Østergaard, A N Jørgensen, S Bøvling, N P Ekeløf, F H Mose, J N Bech, A M Østergaardet al.",2021 Mar 26,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/33771116/,No keywords found,"['isotonic', 'saline', '(', ')', 'widely', 'used', 'to', 'secure', 'perioperative', 'cardiovascular', 'stability', '.', 'however', ',', 'high', 'amount', 'of', 'chloride', 'in', 'induce', 'hyperchloremic', 'acidosis', '.', 'therefore', ',', 'suspected', 'to', 'increase', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'biomarkers', 'may', 'potential', 'indicator', '.', 'method', 'in', 'double-blinded', ',', 'placebo-controlled', 'study', ',', 'patient', 'undergoing', 'primary', 'uncemented', 'hip', 'replacement', 'randomized', 'to', 'or', 'plasmalyte', '(', 'pl', ')', '.', 'infusion', 'given', 'surgery', 'mlkg', 'first', 'hour', 'and', 'mlkg', 'following', 'two', 'hour', '.', 'urinary', 'sample', 'collected', 'upon', 'admission', 'and', 'day', 'surgery', '.', 'surgery', 'initiated', ',', 'urine', 'collected', 'course', 'of', 'h.', 'hereafter', ',', 'another', 'urine', 'collection', 'proceeded', 'morning', '.', 'urine', 'analyzed', 'marker', 'of', 'aki', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', '.', 'arterious', 'and', 'venous', 'blood', 'sample', 'measurement', 'of', 'ph', 'and', 'plasma', 'electrolyte', 'including', 'chloride', '(', 'p-cl', ')', 'collected', 'surgery', 'initiated', ',', 'end', 'of', 'surgery', 'and', 'following', 'morning', '.', 'result', 'induced', 'increase', 'in', 'p-cl', '(', 'mmoll', 'and', 'pl', ',', 'p', '.', ')', 'and', 'decrease', 'in', 'ph', '(', '.', '.', 'and', '.', '.', 'pl', ',', 'p', '.', ')', '.', 'urinary', 'ngal', 'excretion', 'increased', 'in', 'group', '(', 'ngal', '.', '.', '.', 'gmmol', 'creatinine', 'p', '.', 'vs.', '.', '..', 'gmmol', 'creatinine', 'pl', ',', 'p', '.', ')', '.', 'no', 'difference', 'found', 'group', '(', 'p', '.', ')', '.', 'similarly', ',', 'urinary', 'kim-', 'excretion', 'increased', 'in', 'group', '(', 'kim-', '.', '.', '.', 'ngmmol', 'creatinine', ',', 'p', '.', 'vs.', 'pl', '.', '.', '.', 'ngmmol', 'creatinine', ',', 'p', '.', ')', '.', 'no', 'difference', 'group', '(', 'p', '.', ')', '.', 'fena', 'increased', '(', '.', '.', 'and', '.', '.', 'pl', ',', 'p', '.', ')', '.', 'enac', 'excretion', 'different', 'within', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'significantly', 'higher', 'plasma', 'chloride', 'and', 'lower', 'ph', 'present', 'in', 'group', 'receiving', 'isotonic', 'saline', '.', 'however', ',', 'u-ngal', 'and', 'u-kim-', 'increased', 'significantly', 'in', 'group', 'surgery', 'despite', 'absence', 'of', 'change', 'in', 'creatinine', '.', 'result', 'indicate', 'surgery', 'induced', 'subclinical', 'kidney', 'injury', '.', 'also', ',', 'group', 'delayed', 'sodium', 'excretion', 'compared', 'to', 'pl', 'group', 'may', 'indicate', 'affect', 'renal', 'sodium', 'excretion', 'differently', 'pl', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', ',', '.']"
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.,"Hiddo J L Heerspink, David Cherney, Douwe Postmus, Bergur V Stefánsson, Glenn M Chertow, Jamie P Dwyer, Tom Greene, Mikhail Kosiborod, Anna Maria Langkilde, John J V McMurray, Ricardo Correa-Rotter, Peter Rossing, C David Sjöström, Robert D Toto, David C Wheeler                              ;, DAPA-CKD Trial Committees and Investigators, Hiddo J L Heerspinket al.",2022 Jan,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/34560136/,"SGLT2 inhibitors, acute kidney injury, chronic kidney disease, dapagliflozin.","['pre-specified', 'analysis', 'of', 'dapa-ckd', 'assessed', 'impact', 'of', 'sodium-glucose', 'cotransporter', 'inhibition', 'abrupt', 'decline', 'in', 'kidney', 'function', 'in', 'high-risk', 'patient', 'based', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'and', 'substantial', 'albuminuria', '.', 'dapa-ckd', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trial', 'median', 'follow-up', 'of', '.', 'year', '.', 'adult', 'with', 'ckd', '(', 'urinary', 'albumin-to-creatinine', 'ratio', '-', 'mgg', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '-', 'mlmin.m', ')', 'randomized', 'to', 'dapagliflozin', 'mgday', 'matched', 'to', 'placebo', '(', 'individual', ')', '.', 'abrupt', 'decline', 'in', 'kidney', 'function', 'defined', 'pre-specified', 'endpoint', 'of', 'doubling', 'of', 'serum', 'creatinine', 'two', 'subsequent', 'study', 'visit', '.', 'also', 'assessed', 'post-hoc', 'analysis', 'of', 'investigator-reported', 'acute', 'kidney', 'injury-related', 'serious', 'adverse', 'event', '.', 'doubling', 'of', 'serum', 'creatinine', 'two', 'subsequent', 'visit', '(', 'median', 'time-interval', 'day', ')', 'occurred', 'in', '(', '.', ')', 'and', '(', '.', ')', 'participant', 'in', 'dapagliflozin', 'and', 'placebo', 'group', ',', 'respectively', '(', 'hazard', 'ratio', '.', 'confidence', 'interval', '.', ',', '.', ')', '.', 'accounting', 'competing', 'risk', 'of', 'mortality', 'not', 'alter', 'finding', '.', 'no', 'heterogeneity', 'in', 'effect', 'of', 'dapagliflozin', 'abrupt', 'decline', 'in', 'kidney', 'function', 'based', 'baseline', 'subgroup', '.', 'acute', 'kidney', 'injury-related', 'serious', 'adverse', 'event', 'not', 'significantly', 'different', 'and', 'occurred', 'in', '(', '.', ')', 'and', '(', '.', ')', 'participant', 'in', 'dapagliflozin', 'and', 'placebo', 'group', ',', 'respectively', '(', '.', '.', ',', '.', ')', '.', 'thus', ',', 'in', 'patient', 'with', 'ckd', 'and', 'substantial', 'albuminuria', ',', 'dapagliflozin', 'reduced', 'risk', 'of', 'abrupt', 'decline', 'in', 'kidney', 'function', '.']"
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study.,"Martin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, Alejandro Navarro, Ross A Soo, Heike Richly, Philippe Alexandre Cassier, David Tai, Nicolas Penel, Lucia Nogova, Se Hoon Park, Martin Schostak, Pablo Gajate, Richard Cathomas, Prabhu Rajagopalan, Joachim Grevel, Sebastian Bender, Oliver Boix, Hendrik Nogai, Matthias Ocker, Peter Ellinghaus, Markus Joerger, Martin Schuleret al.",2019 Oct,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/31405822/,No keywords found,"['clinical', 'activity', 'of', 'fibroblast', 'growth', 'factor', 'receptor', '(', 'fgfr', ')', 'inhibitor', 'seems', 'restricted', 'to', 'cancer', 'harbouring', 'rare', 'fgfr', 'genetic', 'aberration', '.', 'in', 'preclinical', 'study', ',', 'high', 'tumour', 'fgfr', 'mrna', 'expression', 'predicted', 'response', 'to', 'rogaratinib', ',', 'oral', 'pan-fgfr', 'inhibitor', '.', 'aimed', 'to', 'assess', 'safety', ',', 'maximum', 'tolerated', 'dose', ',', 'recommended', 'phase', 'dose', ',', 'pharmacokinetics', ',', 'and', 'preliminary', 'clinical', 'activity', 'of', 'rogaratinib', '.', 'method', 'phase', 'dose-escalation', 'and', 'dose-expansion', 'study', 'of', 'rogaratinib', 'in', 'adult', 'with', 'advanced', 'cancer', 'site', 'in', 'germany', ',', 'switzerland', ',', 'south', 'korea', ',', 'singapore', ',', 'spain', ',', 'and', 'france', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', ',', 'and', 'ineligible', 'standard', 'therapy', ',', 'with', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', '-', ',', 'life', 'expectancy', 'of', 'least', 'month', ',', 'and', 'least', 'one', 'measurable', 'or', 'evaluable', 'lesion', 'according', 'to', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumor', '(', 'recist', ')', 'version', '..', 'dose', 'escalation', ',', 'rogaratinib', 'administered', 'orally', 'twice', 'daily', '-', 'mg', 'in', 'continuous', '-day', 'cycle', 'using', 'model-based', 'dose-response', 'analysis', '(', 'continuous', 'reassessment', 'method', ')', '.', 'in', 'dose-expansion', 'phase', ',', 'patient', 'provided', 'archival', 'formalin-fixed', 'paraffin-embedded', '(', 'ffpe', ')', 'tumour', 'biopsy', 'or', 'consented', 'to', 'new', 'biopsy', 'screening', 'analysis', 'of', 'fgfr-', 'mrna', 'expression', '.', 'in', 'dose-expansion', 'phase', ',', 'rogaratinib', 'given', 'recommended', 'dose', 'expansion', 'to', 'patient', 'in', 'four', 'cohort', 'urothelial', 'carcinoma', ',', 'head', 'and', 'neck', 'squamous-cell', 'cancer', '(', 'hnscc', ')', ',', 'non-small-cell', 'lung', 'cancer', '(', 'nsclc', ')', ',', 'and', 'solid', 'tumour', 'type', '.', 'primary', 'endpoint', 'safety', 'and', 'tolerability', ',', 'determination', 'of', 'maximum', 'tolerated', 'dose', 'including', 'dose-limiting', 'toxicity', 'and', 'determination', 'of', 'recommended', 'phase', 'dose', ',', 'and', 'pharmacokinetics', 'of', 'rogaratinib', '.', 'safety', 'analysis', 'reported', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'rogaratinib', '.', 'patient', 'completed', 'cycle', 'or', 'discontinued', 'cycle', 'due', 'to', 'adverse', 'event', 'or', 'dose-limiting', 'toxicity', 'included', 'in', 'evaluation', 'of', 'recommended', 'phase', 'dose', '.', 'efficacy', 'analysis', 'reported', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', 'and', 'available', 'post-baseline', 'efficacy', 'data', '.', 'ongoing', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', ',', 'and', 'fully', 'recruited', '.', 'finding', 'dec', ',', ',', 'and', 'july', ',', ',', 'patient', 'screened', 'fgfr', 'mrna', 'expression', ',', 'of', 'patient', 'treated', '(', 'fgfr', 'mrna-unselected', 'patient', 'in', 'dose-escalation', 'phase', 'and', 'patient', 'with', 'fgfr', 'mrna-overexpressing', 'tumour', 'patient', 'with', 'urothelial', 'carcinoma', ',', 'eight', 'patient', 'with', 'hnscc', ',', 'patient', 'with', 'nsclc', ',', 'and', 'patient', 'with', 'tumour', 'type', 'in', 'dose-expansion', 'phase', ')', '.', 'no', 'dose-limiting', 'toxicity', 'reported', 'and', 'maximum', 'tolerated', 'dose', 'not', 'reached', 'mg', 'twice', 'daily', 'established', 'recommended', 'phase', 'dose', 'and', 'selected', 'dose-expansion', 'phase', '.', 'common', 'adverse', 'event', 'of', 'grade', 'hyperphosphataemia', '(', 'in', 'of', 'patient', ')', ',', 'diarrhoea', '(', 'in', ')', ',', 'and', 'decreased', 'appetite', '(', 'in', ')', 'and', 'common', 'grade', '-', 'adverse', 'event', 'fatigue', '(', 'in', 'of', 'patient', ')', 'and', 'asymptomatic', 'increased', 'lipase', '(', 'in', ')', '.', 'serious', 'treatment-related', 'adverse', 'event', 'reported', 'in', 'five', 'patient', '(', 'decreased', 'appetite', 'and', 'diarrhoea', 'in', 'one', 'patient', 'with', 'urothelial', 'carcinoma', ',', 'and', 'acute', 'kidney', 'injury', 'nsclc', ',', 'hypoglycaemia', 'solid', 'tumour', ',', 'retinopathy', 'urothelial', 'carcinoma', ',', 'and', 'vomiting', 'urothelial', 'carcinoma', 'in', 'one', 'patient', ')', 'no', 'treatment-related', 'death', 'occurred', '.', 'median', 'follow-up', 'cessation', 'of', 'treatment', 'day', '(', 'iqr', '-', 'day', ')', '.', 'in', 'expansion', 'cohort', ',', '(', 'ci', '-', ')', 'of', 'evaluable', 'patient', 'achieved', 'objective', 'response', ',', 'with', 'response', 'recorded', 'in', 'four', 'expansion', 'cohort', '(', 'in', 'urothelial', 'carcinoma', 'cohort', 'and', 'one', 'in', 'of', 'three', 'cohort', ')', ',', 'and', 'in', 'ten', '(', ')', 'of', 'fgfr', 'mrna-overexpressing', 'tumour', 'without', 'apparent', 'fgfr', 'genetic', 'aberration', '.', 'interpretation', 'rogaratinib', 'well', 'tolerated', 'and', 'clinically', 'active', 'several', 'type', 'of', 'cancer', '.', 'selection', 'fgfr', 'mrna', 'expression', 'could', 'useful', 'additional', 'biomarker', 'to', 'identify', 'broader', 'patient', 'population', 'could', 'eligible', 'fgfr', 'inhibitor', 'treatment', '.', 'funding', 'bayer', 'ag', '.']"
A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.,"Shirin Kalimuddin, Yvonne F Z Chan, Rachel Phillips, Siew Pei Ong, Sophia Archuleta, David Chien Lye, Thuan Tong Tan, Jenny G H Low, Shirin Kalimuddinet al.",2018 Jun 1,Trials,https://pubmed.ncbi.nlm.nih.gov/29859132/,No keywords found,"['study', 'suggested', 'reduced', 'effectiveness', 'of', 'vancomycin', 'methicillin-resistant', 'staphylococcus', 'aureus', '(', 'mrsa', ')', 'bloodstream', 'infection', 'with', 'high', 'vancomycin', 'minimum', 'inhibitory', 'concentration', '.', 'alternative', 'agent', 'daptomycin', 'may', 'considered', '.', 'conducted', 'randomized', 'controlled', 'study', 'comparing', 'daptomycin', 'vancomycin', 'in', 'treatment', 'of', 'mrsa', 'bloodstream', 'infection', 'with', 'high', 'vancomycin', 'minimum', 'inhibitory', 'concentration', '.', 'method', 'patient', 'randomized', 'to', 'receive', 'vancomycin', 'or', 'daptomycin', 'minimum', 'of', 'day', '.', 'primary', 'end', 'point', 'rate', 'of', 'all-cause', 'mortality', 'day', '.', 'result', 'total', 'of', 'patient', 'randomized', 'in', 'study', ',', 'with', 'patient', 'in', 'treatment', 'arm', '.', 'study', 'terminated', 'early', 'due', 'to', 'slow', 'patient', 'accrual', '.', 'day', ',', 'one', 'death', 'in', 'vancomycin', 'arm', 'and', 'none', 'in', 'daptomycin', 'arm', '.', 'median', 'time', 'to', 'microbiological', 'clearance', 'day', 'in', 'arm', '(', 'iqr', '-', 'day', 'in', 'vancomycin', 'arm', 'and', '-', 'day', 'in', 'daptomycin', 'arm', ')', '.', 'one', 'patient', 'in', 'vancomycin', 'arm', 'recurrence', 'of', 'bacteremia', '.', 'rate', 'of', 'adverse', 'event', 'similar', 'in', 'arm', '.', 'one', 'case', 'of', 'musculoskeletal', 'toxicity', 'and', 'one', 'case', 'of', 'drug-related', 'nephrotoxicity', '-', 'event', 'occurred', 'in', 'daptomycin', 'arm', '.', 'none', 'of', 'patient', 'in', 'either', 'treatment', 'arm', 'required', 'cessation', 'of', 'study', 'treatment', 'or', 'addition', 'of', 'second', 'anti-mrsa', 'agent', 'of', 'worsening', 'infection', '.', 'conclusion', 'based', 'limited', 'number', 'of', 'patient', 'evaluated', 'in', 'study', ',', 'remains', 'unclear', 'alternative', ',', 'expensive', 'agent', 'daptomycin', 'superior', 'to', 'vancomycin', 'in', 'treatment', 'of', 'high', 'vancomycin', 'minimum', 'inhibitory', 'concentration', 'mrsa', 'bloodstream', 'infection', '.', 'study', 'urgently', 'needed', 'investigator', 'may', 'wish', 'to', 'consider', 'employing', 'novel', ',', 'alternative', 'trial', 'methodology', 'to', 'ensure', 'greater', 'chance', 'of', 'success', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'nct', '.', 'registered', 'november', '.']"
Efficacy of Intrawound Vancomycin in Prevention of Periprosthetic Joint Infection After Primary Total Knee Arthroplasty: A Prospective Double-Blinded Randomized Control Trial.,"Praharsha Mulpur, Tarun Jayakumar, Ramakanth R Yakkanti, Aditya Apte, Kushal Hippalgaonkar, Adarsh Annapareddy, A B Suhas Masilamani, A V Gurava Reddy, Praharsha Mulpuret al.",2024 Jun,J Arthroplasty,https://pubmed.ncbi.nlm.nih.gov/38749600/,No keywords found,"['periprosthetic', 'joint', 'infection', '(', 'pji', ')', 'total', 'knee', 'arthroplasty', '(', 'tka', ')', 'devastating', 'complication', '.', 'intrawound', 'vancomycin', 'powder', 'shown', 'to', 'reduce', 'infection', 'rate', 'in', 'spine', 'surgery', ',', 'role', 'in', 'arthroplasty', 'remains', 'controversial', '.', 'prospective', 'randomized', 'control', 'trial', 'aimed', 'to', 'evaluate', 'efficacy', 'of', 'intrawound', 'vancomycin', 'in', 'preventing', 'pji', 'primary', 'tka', '.', 'method', 'total', 'of', ',', 'patient', 'randomized', 'to', 'study', 'group', '(', 'n', ',', 'received', 'gram', 'intrawound', 'vancomycin', 'powder', 'arthrotomy', 'closure', ')', 'or', 'to', 'control', 'group', '(', 'n', ',', 'no', 'local', 'vancomycin', ')', 'with', 'minimum', 'follow-up', 'of', '-months', '.', 'primary', 'outcome', 'incidence', 'of', 'pji', 'or', 'surgical', 'site', 'infection', '(', 'ssi', ')', '.', 'secondary', 'outcome', 'included', 'associated', 'minor', 'complication', 'stitch', 'abscess', ',', 'persistent', 'wound', 'drainage', ',', 'and', 'delayed', 'stitch', 'removal', '.', 'parameter', 'evaluated', 'include', 'reoperation', 'rate', 'and', 'incidence', 'of', 'nephrotoxicity', '.', 'result', 'overall', 'infection', 'rate', 'in', ',', 'patient', '..', 'no', 'significant', 'difference', 'in', 'pji', 'rate', 'in', 'study', 'group', '(', 'n', '.', ')', 'versus', 'control', 'group', '(', 'n', '.', ')', ',', 'p', '..', 'reoperation', 'rate', 'in', 'study', 'group', '(', 'n', '.', ')', 'and', 'control', '(', 'n', '.', ')', ',', 'and', 'ssi', 'rate', 'in', 'study', '(', 'n', '.', ')', 'and', 'control', 'group', '(', 'n', '.', ')', 'comparable', '.', 'vancomycin', 'cohort', ',', 'however', ',', 'demonstrated', 'significantly', 'higher', 'number', 'of', 'minor', 'wound', 'complication', '(', 'n', '.', ')', 'compared', 'to', 'control', 'group', '(', 'n', '.', ',', 'p', '.', ')', '.', 'subgroup', 'analysis', 'showed', 'diabetic', 'in', 'study', 'group', 'to', 'also', 'higher', 'incidence', 'of', 'minor', 'wound', 'complication', '(', '.', 'versus', '.', 'p', '.', 'multivariate', 'analysis', 'found', 'vancomycin', 'use', '(', 'odds', 'ratio', '.', ')', 'and', 'smoking', '(', 'odds', 'ratio', '.', ')', 'associated', 'with', 'increased', 'risk', 'of', 'developing', 'minor', 'wound', 'complication', '.', 'no', 'case', 'of', 'nephrotoxicity', 'reported', '.', 'conclusion', 'intrawound', 'vancomycin', 'powder', 'not', 'appear', 'to', 'reduce', 'pjissi', 'rate', 'in', 'primary', 'total', 'knee', 'arthroplasty', ',', 'including', 'high-risk', 'group', '.', 'although', 'safe', 'renal', 'perspective', ',', 'intrawound', 'vancomycin', 'associated', 'with', 'increase', 'in', 'postoperative', 'aseptic', 'wound', 'complication', '.', 'intrawound', 'vancomycin', 'may', 'not', 'effective', 'in', 'reducing', 'rate', 'of', 'pji', 'in', 'primary', 'tka', '.']"
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.,"Sanjay Basu, Jeremy B Sussman, Joseph Rigdon, Lauren Steimle, Brian T Denton, Rodney A Hayward, Sanjay Basuet al.",2017 Oct 17,PLoS Med,https://pubmed.ncbi.nlm.nih.gov/29040268/,No keywords found,"['intensive', 'blood', 'pressure', '(', 'bp', ')', 'treatment', 'avert', 'cardiovascular', 'disease', '(', 'cvd', ')', 'event', 'cause', 'serious', 'adverse', 'event', '.', 'sought', 'to', 'develop', 'and', 'validate', 'risk', 'model', 'predicting', 'absolute', 'risk', 'difference', '(', 'increased', 'risk', 'or', 'decreased', 'risk', ')', 'cvd', 'event', 'and', 'serious', 'adverse', 'event', 'intensive', 'bp', 'therapy', '.', 'secondary', 'aim', 'to', 'test', 'statistical', 'method', 'of', 'elastic', 'net', 'regularization', 'would', 'improve', 'estimation', 'of', 'risk', 'model', 'predicting', 'absolute', 'risk', 'difference', ',', 'compared', 'to', 'traditional', 'backwards', 'variable', 'selection', 'approach', '.', 'method', 'and', 'finding', 'cox', 'model', 'derived', 'sprint', 'trial', 'data', 'and', 'validated', 'accord-bp', 'trial', 'data', 'to', 'estimate', 'risk', 'of', 'cvd', 'event', 'and', 'serious', 'adverse', 'event', 'model', 'included', 'term', 'intensive', 'bp', 'treatment', 'and', 'heterogeneous', 'response', 'to', 'intensive', 'treatment', '.', 'cox', 'model', 'used', 'to', 'estimate', 'absolute', 'reduction', 'in', 'probability', 'of', 'cvd', 'event', '(', 'benefit', ')', 'and', 'absolute', 'increase', 'in', 'probability', 'of', 'serious', 'adverse', 'event', '(', 'harm', ')', 'individual', 'intensive', 'treatment', '.', 'compared', 'method', 'of', 'elastic', 'net', 'regularization', ',', 'us', 'repeated', 'internal', 'cross-validation', 'to', 'select', 'variable', 'and', 'estimate', 'coefficient', 'in', 'presence', 'of', 'collinearity', ',', 'to', 'traditional', 'backwards', 'variable', 'selection', 'approach', '.', 'data', ',', 'sprint', 'participant', 'with', 'complete', 'data', 'covariates', 'utilized', 'model', 'development', ',', 'and', 'data', ',', 'accord-bp', 'participant', 'with', 'complete', 'data', 'utilized', 'model', 'validation', '.', 'participant', 'exposed', 'to', 'intensive', '(', 'goal', 'systolic', 'pressure', 'mm', 'hg', ')', 'versus', 'standard', '(', 'mm', 'hg', ')', 'treatment', '.', 'two', 'composite', 'primary', 'outcome', 'measure', 'evaluated', '(', ')', 'cvd', 'eventsdeaths', '(', 'myocardial', 'infarction', ',', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'congestive', 'heart', 'failure', ',', 'or', 'cvd', 'death', ')', ',', 'and', '(', 'ii', ')', 'serious', 'adverse', 'event', '(', 'hypotension', ',', 'syncope', ',', 'electrolyte', 'abnormality', ',', 'bradycardia', ',', 'or', 'acute', 'kidney', 'injuryfailure', ')', '.', 'model', 'cvd', 'chosen', 'elastic', 'net', 'regularization', 'included', 'interaction', 'term', 'suggesting', 'older', 'age', ',', 'black', 'race', ',', 'higher', 'diastolic', 'bp', ',', 'and', 'higher', 'lipid', 'associated', 'with', 'greater', 'cvd', 'risk', 'reduction', 'benefit', 'intensive', 'treatment', ',', 'current', 'smoking', 'associated', 'with', 'fewer', 'benefit', '.', 'model', 'serious', 'adverse', 'event', 'chosen', 'elastic', 'net', 'regularization', 'suggested', 'male', 'sex', ',', 'current', 'smoking', ',', 'statin', 'use', ',', 'elevated', 'creatinine', ',', 'and', 'higher', 'lipid', 'associated', 'with', 'greater', 'risk', 'of', 'serious', 'adverse', 'event', 'intensive', 'treatment', '.', 'sprint', 'participant', 'in', 'highest', 'predicted', 'benefit', 'subgroup', 'number', 'needed', 'to', 'treat', '(', 'nnt', ')', 'of', 'to', 'prevent', 'cvd', 'eventdeath', 'year', '(', 'absolute', 'risk', 'reduction', 'arr', '.', ',', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'in', 'middle', 'predicted', 'benefit', 'subgroup', 'nnt', 'of', '(', 'arr', '.', ',', 'ci', '-.', ',', '.', 'p', '.', ')', ',', 'and', 'in', 'lowest', 'subgroup', 'no', 'significant', 'risk', 'reduction', '(', 'arr', '.', ',', 'ci', '-.', ',', '.', 'p', '.', ')', '.', 'in', 'highest', 'predicted', 'harm', 'subgroup', 'number', 'needed', 'to', 'harm', '(', 'nnh', ')', 'of', 'to', 'induce', 'serious', 'adverse', 'event', '(', 'absolute', 'risk', 'increase', 'ari', '.', ',', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'in', 'middle', 'predicted', 'harm', 'subgroup', 'nnh', 'of', '(', 'ari', '.', ',', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'and', 'in', 'lowest', 'subgroup', 'no', 'significant', 'risk', 'increase', '(', 'ari', '-.', ',', 'ci', '-.', ',', '.', 'p', '.', ')', '.', 'in', 'accord-bp', ',', 'participant', 'in', 'highest', 'subgroup', 'of', 'predicted', 'benefit', 'significant', 'absolute', 'cvd', 'risk', 'reduction', ',', 'overall', 'accord-bp', 'participant', 'sample', 'skewed', 'towards', 'participant', 'with', 'less', 'predicted', 'benefit', 'and', 'predicted', 'risk', 'in', 'sprint', '.', 'model', 'chosen', 'traditional', 'backwards', 'selection', 'similar', 'ability', 'to', 'identify', 'absolute', 'risk', 'difference', 'cvd', 'elastic', 'net', 'model', ',', 'poorer', 'ability', 'to', 'correctly', 'identify', 'absolute', 'risk', 'difference', 'serious', 'adverse', 'event', '.', 'key', 'limitation', 'of', 'analysis', 'limited', 'sample', 'size', 'of', 'accord-bp', 'trial', ',', 'expanded', 'confidence', 'interval', 'ari', 'among', 'person', 'with', 'type', 'diabetes', '.', 'additionally', ',', 'not', 'possible', 'to', 'mechanistically', 'explain', 'physiological', 'relationship', 'explaining', 'heterogeneous', 'treatment', 'effect', 'captured', 'model', ',', 'since', 'study', 'observational', 'secondary', 'data', 'analysis', '.', 'conclusion', 'found', 'predictive', 'model', 'could', 'help', 'identify', 'subgroup', 'of', 'participant', 'in', 'sprint', 'and', 'accord-bp', 'lower', 'versus', 'higher', 'arrs', 'in', 'cvd', 'eventsdeaths', 'with', 'intensive', 'bp', 'treatment', ',', 'and', 'participant', 'lower', 'versus', 'higher', 'aris', 'in', 'serious', 'adverse', 'event', '.']"
Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial.,"Emmanuel Futier, Jean-Yves Lefrant, Pierre-Gregoire Guinot, Thomas Godet, Emmanuel Lorne, Philippe Cuvillon, Sebastien Bertran, Marc Leone, Bruno Pastene, Vincent Piriou, Serge Molliex, Jacques Albanese, Jean-Michel Julia, Benoit Tavernier, Etienne Imhoff, Jean-Etienne Bazin, Jean-Michel Constantin, Bruno Pereira, Samir Jaber                              ;, INPRESS Study Group, Emmanuel Futieret al.",2017 Oct 10,JAMA,https://pubmed.ncbi.nlm.nih.gov/28973220/,No keywords found,"['perioperative', 'hypotension', 'associated', 'with', 'increase', 'in', 'postoperative', 'morbidity', 'and', 'mortality', ',', 'appropriate', 'management', 'strategy', 'remains', 'uncertain', '.', 'objective', 'to', 'evaluate', 'whether', 'individualized', 'blood', 'pressure', 'management', 'strategy', 'tailored', 'to', 'individual', 'patient', 'physiology', 'could', 'reduce', 'postoperative', 'organ', 'dysfunction', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'intraoperative', 'norepinephrine', 'to', 'control', 'arterial', 'pressure', '(', 'inpress', ')', 'study', 'multicenter', ',', 'randomized', ',', 'parallel-group', 'clinical', 'trial', 'conducted', 'in', 'french', 'university', 'and', 'nonuniversity', 'hospital', '.', 'adult', 'patient', '(', 'n', ')', 'increased', 'risk', 'of', 'postoperative', 'complication', 'with', 'preoperative', 'acute', 'kidney', 'injury', 'risk', 'index', 'of', 'class', 'iii', 'or', 'higher', '(', 'indicating', 'moderate', 'to', 'high', 'risk', 'of', 'postoperative', 'kidney', 'injury', ')', 'undergoing', 'major', 'surgery', 'lasting', 'hour', 'or', 'longer', 'general', 'anesthesia', 'enrolled', 'december', ',', ',', 'august', ',', '(', 'last', 'follow-up', ',', 'september', ',', ')', '.', 'intervention', 'individualized', 'management', 'strategy', 'aimed', 'achieving', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'within', 'of', 'reference', 'value', '(', 'ie', ',', 'patient', ""'s"", 'resting', 'sbp', ')', 'or', 'standard', 'management', 'strategy', 'of', 'treating', 'sbp', 'less', 'mm', 'hg', 'or', 'lower', 'reference', 'value', 'and', 'hour', 'following', 'surgery', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'composite', 'of', 'systemic', 'inflammatory', 'response', 'syndrome', 'and', 'dysfunction', 'of', 'least', 'organ', 'system', 'of', 'renal', ',', 'respiratory', ',', 'cardiovascular', ',', 'coagulation', ',', 'and', 'neurologic', 'system', 'day', 'surgery', '.', 'secondary', 'outcome', 'included', 'individual', 'component', 'of', 'primary', 'outcome', ',', 'duration', 'of', 'icu', 'and', 'hospital', 'stay', ',', 'adverse', 'event', ',', 'and', 'all-cause', 'mortality', 'day', 'surgery', '.', 'result', 'among', 'patient', 'randomized', ',', 'patient', 'completed', 'trial', '(', 'mean', 'sd', 'age', ',', 'year', '.', 'woman', ')', 'and', 'included', 'in', 'modified', 'intention-to-treat', 'analysis', '.', 'primary', 'outcome', 'event', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'assigned', 'to', 'individualized', 'treatment', 'strategy', 'v', 'of', 'patient', '(', '.', ')', 'assigned', 'to', 'standard', 'treatment', 'strategy', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', 'absolute', 'risk', 'difference', ',', '-', ',', 'ci', ',', '-', 'to', '-', ')', '.', 'sixty-eight', 'patient', '(', '.', ')', 'in', 'individualized', 'treatment', 'group', 'and', '(', '.', ')', 'in', 'standard', 'treatment', 'group', 'postoperative', 'organ', 'dysfunction', 'day', '(', 'adjusted', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'no', 'significant', 'between-group', 'difference', 'in', 'severe', 'adverse', 'event', 'or', '-day', 'mortality', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'predominantly', 'undergoing', 'abdominal', 'surgery', 'increased', 'postoperative', 'risk', ',', 'management', 'targeting', 'individualized', 'systolic', 'blood', 'pressure', ',', 'compared', 'with', 'standard', 'management', ',', 'reduced', 'risk', 'of', 'postoperative', 'organ', 'dysfunction', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome.,"Xiaozhi Du, Zhiyong Ma, Li Li, Xuezhen Zhong, Xiaozhi Duet al.",2021 Sep 29,J Cardiovasc Pharmacol,https://pubmed.ncbi.nlm.nih.gov/34738551/,No keywords found,"['cardiorenal', 'syndrome', '(', 'cr', ')', 'group', 'of', 'disorder', 'in', 'heart', 'or', 'kidney', 'dysfunction', 'worsens', '.', 'study', 'aimed', 'to', 'explore', 'improvement', 'effect', 'of', 'nicorandil', 'cardiorenal', 'injury', 'in', 'patient', 'with', 'type', 'cr', '.', 'patient', 'with', 'coronary', 'heart', 'disease', 'complicated', 'with', 'type', 'cr', 'enrolled', '.', 'based', 'conventional', 'treatment', ',', 'patient', 'prospectively', 'randomized', 'conventional', 'treatment', 'group', 'and', 'nicorandil', 'group', ',', 'treated', 'with', 'mgd', 'nicorandil', 'intravenously', 'week', '.', 'fasting', 'peripheral', 'venous', 'blood', 'serum', 'and', 'urine', 'collected', 'and', 'end', 'of', 'treatment', '.', 'automatic', 'biochemical', 'analyzer', 'and', 'enzyme', 'linked', 'immunosorbent', 'assay', 'used', 'to', 'detect', 'b-type', 'brain', 'natriuretic', 'peptide', '(', 'bnp', ')', ',', 'serum', 'creatinine', '(', 'scr', ')', 'and', 'cystatin', 'c', '(', 'cys-c', ')', ',', 'renal', 'injury', 'index-kidney', 'injury', 'molecule-', '(', 'kim-', ')', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'and', 'interleukin-', '(', 'il-', ')', 'level', '.', 'left', 'ventricular', 'ejection', 'fraction', 'measured', 'echocardiography', '.', 'measurement', 'not', 'significantly', 'different', 'nicorandil', 'and', 'conventional', 'treatment', 'group', 'treatment', '(', 'p', '.', ')', ',', 'and', 'bnp', ',', 'scr', ',', 'cys-c', ',', 'ngal', ',', 'kim-', ',', 'and', 'il-', 'decreased', 'in', 'group', 'end', 'of', 'treatment', '(', 'p', '.', ')', '.', 'compared', 'with', 'conventional', 'treatment', 'group', ',', 'bnp', ',', 'scr', ',', 'cys-c', ',', 'ngal', ',', 'kim-', ',', 'and', 'il-', 'significantly', 'decreased', 'in', 'nicorandil', 'group', '(', 'p', '.', ')', 'and', 'left', 'ventricular', 'ejection', 'fraction', 'significantly', 'increased', '(', 'p', '.', ')', '.', 'therefore', ',', 'nicorandil', 'could', 'significantly', 'improve', 'cardiac', 'and', 'renal', 'function', 'of', 'patient', 'with', 'type', 'cr', '.', 'may', 'prove', 'to', 'new', 'therapeutic', 'tool', 'improving', 'prognosis', 'and', 'rehabilitation', 'of', 'type', 'cr', '.']"
"Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.","Shang-Yi Huang, Sung-Soo Yoon, Kazuyuki Shimizu, Wee Joo Chng, Cheng-Shyong Chang, Raymond Siu-Ming Wong, Seasea Gao, Yang Wang, Steve W Gordon, Anthony Glennane, Chang-Ki Min, Shang-Yi Huanget al.",2020 Jul,Adv Ther,https://pubmed.ncbi.nlm.nih.gov/32524500/,No keywords found,"['primary', 'analysis', 'of', 'global', 'phase', 'study', 'evaluated', 'efficacy', 'and', 'safety', 'of', 'denosumab', 'versus', 'zoledronic', 'acid', 'preventing', 'skeletal-related', 'event', '(', 'sres', ')', 'in', 'adult', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', '(', 'mm', ')', 'indicated', 'denosumab', 'noninferior', 'to', 'zoledronic', 'acid', 'time', 'to', 'first', 'on-study', 'sres', '.', 'present', 'subgroup', 'analysis', 'to', 'evaluate', 'efficacy', 'and', 'safety', 'in', 'asian', 'patient', '.', 'method', 'patient', 'randomized', 'to', 'receive', 'denosumab', 'mg', 'subcutaneously', 'or', 'zoledronic', 'acid', 'intravenously', 'mg', 'every', 'week', 'in', 'double-blind', ',', 'double-dummy', 'fashion', '.', 'patient', 'received', 'standard-of-care', 'first-line', 'antimyeloma', 'treatment', '.', 'patient', 'received', 'either', 'study', 'drug', 'estimated', 'patient', 'experienced', 'least', 'one', 'on-study', 'sre', 'and', 'primary', 'efficacy', 'and', 'safety', 'analysis', 'completed', '.', 'result', 'of', 'total', 'enrolled', 'patient', ',', 'asian', 'patient', '(', 'denosumab', ',', 'n', 'zoledronic', 'acid', ',', 'n', ')', 'included', 'in', 'subgroup', 'analysis', '.', 'fewer', 'patient', 'in', 'denosumab', 'group', 'developed', 'first', 'on-study', 'sre', 'compared', 'with', 'zoledronic', 'acid', 'group', 'crude', 'incidence', 'of', 'sres', 'primary', 'analysis', 'cutoff', '.', 'and', '.', ',', 'respectively', '(', 'hr', 'ci', ',', '.', '.-.', ')', '.', 'patient', 'receiving', 'least', 'one', 'dose', 'of', 'study', 'drug', 'experienced', 'least', 'one', 'treatment-emergent', 'ae', '.', 'common', 'aes', 'reported', 'in', 'either', 'group', '(', 'denosumab', ',', 'zoledronic', 'acid', ')', 'diarrhea', '(', '.', ',', '.', ')', ',', 'nausea', '(', '.', ',', '.', ')', ',', 'and', 'pyrexia', '(', '.', ',', '.', ')', '.', 'treatment-emergent', 'renal', 'toxicity', 'occurred', 'in', '(', '.', ')', 'and', '(', '.', ')', 'patient', ',', 'respectively', '.', 'similar', 'rate', 'of', 'positively', 'adjudicated', 'osteonecrosis', 'of', 'jaw', '(', '.', 'v', '.', ')', 'and', 'treatment-emergent', 'hypocalcemia', '(', '.', 'v', '.', ')', 'reported', 'in', 'denosumab', 'and', 'zoledronic', 'acid', 'group', ',', 'respectively', '.', 'conclusion', 'efficacy', 'and', 'safety', 'outcome', 'asian', 'subgroup', 'comparable', 'to', 'of', 'full', 'study', 'population', '.', 'overall', ',', 'analysis', 'support', 'denosumab', 'additional', 'treatment', 'option', 'standard', 'of', 'care', 'asian', 'patient', 'with', 'newly', 'diagnosed', 'mm', 'with', 'lytic', 'bone', 'lesion', '.', 'clinical', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes.,"Adrian V Hernandez, George Bradley, Mohammad Khan, Andrew Fratoni, Anna Gasparini, Yuani M Roman, Thomas J Bunz, Daniel Eriksson, Anna-Katharina Meinecke, Craig I Coleman, Adrian V Hernandezet al.",2020 Oct 1,Eur Heart J Qual Care Clin Outcomes,https://pubmed.ncbi.nlm.nih.gov/31432074/,No keywords found,"['vascular', 'calcification', 'common', 'in', 'diabetic', 'patient', '.', 'warfarin', 'associated', 'with', 'renovascular', 'calcification', 'and', 'worsening', 'renal', 'function', 'rivaroxaban', 'may', 'provide', 'renopreservation', 'decreasing', 'vascular', 'inflammation', '.', 'compared', 'impact', 'of', 'rivaroxaban', 'and', 'warfarin', 'renal', 'outcome', 'in', 'diabetic', 'patient', 'with', 'non-valvular', 'atrial', 'fibrillation', '(', 'nvaf', ')', '.', 'method', 'and', 'result', 'using', 'united', 'state', 'ibm', 'marketscan', 'data', 'january', 'to', 'december', ',', 'identified', 'adult', 'with', 'nvaf', 'and', 'diabetes', ',', 'newly-initiated', 'rivaroxaban', 'or', 'warfarin', 'with', '-month', 'insurance', 'coverage', 'prior', 'to', 'anticoagulation', 'initiation', '.', 'patient', 'with', 'stage', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'or', 'undergoing', 'haemodialysis', 'baseline', 'excluded', '.', 'difference', 'in', 'baseline', 'covariates', 'cohort', 'adjusted', 'using', 'inverse', 'probability-of-treatment', 'weighting', '(', 'iptw', ')', 'based', 'propensity', 'score', '(', 'absolute', 'standardized', 'difference', '.', 'achieved', 'adjustment', ')', '.', 'outcome', 'included', 'incidence', 'rate', 'of', 'emergency', 'departmenthospital', 'admission', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'composite', 'of', 'development', 'of', 'stage', 'ckd', 'or', 'need', 'haemodialysis', '.', 'patient', 'followed', 'event', ',', 'index', 'anticoagulant', 'discontinuationswitch', ',', 'insurance', 'disenrollment', ',', 'or', 'end-of-data', 'availability', '.', 'hazard', 'ratio', '(', 'hr', ')', 'with', 'confidence', 'interval', '(', 'ci', ')', 'estimated', 'using', 'cox', 'regression', '.', 'assessed', 'rivaroxaban', '(', '.', 'received', 'reduced', 'dose', ')', 'and', 'warfarin', 'user', '.', 'in', 'comparison', 'to', 'warfarin', ',', 'rivaroxaban', 'associated', 'with', 'lower', 'risk', 'of', 'aki', '(', 'hr', '.', ',', 'ci', '.-', '.', ')', 'and', 'development', 'of', 'stage', 'ckd', 'or', 'need', 'haemodialysis', '(', 'hr', '.', ',', 'ci', '.-.', ')', '.', 'sensitivity', 'and', 'subgroup', 'analysis', 'similar', 'effect', 'base-case', 'analysis', '.', 'conclusion', 'rivaroxaban', 'appears', 'to', 'associated', 'with', 'lower', 'risk', 'of', 'undesirable', 'renal', 'outcome', 'vs.', 'warfarin', 'in', 'diabetic', 'nvaf', 'patient', '.']"
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.,"Oliver Zivanovic, Alina Abramian, Maximilian Kullmann, Christine Fuhrmann, Christoph Coch, Tobias Hoeller, Hauke Ruehs, Mignon Denise Keyver-Paik, Christian Rudlowski, Stefan Weber, Nicholas Kiefer, Martin L Poelcher, Thore Thiesler, Babak Rostamzadeh, Michael Mallmann, Nico Schaefer, Maryse Permantier, Sandra Latten, Joerg Kalff, Juergen Thomale, Ulrich Jaehde, Walther C Kuhn, Oliver Zivanovicet al.",2015 Feb 1,Int J Cancer,https://pubmed.ncbi.nlm.nih.gov/24895230/,"HIPEC, chemotherapy, cisplatin, hyperthermic intraoperative intraperitoneal chemoperfusion, ovarian cancer, phase I.","['phase', 'study', 'tested', 'safety', ',', 'feasibility', ',', 'pharmacokinetics', 'and', 'pharmacodynamics', 'of', 'cisplatin', 'administered', 'hyperthermic', 'intraoperative', 'intraperitoneal', 'chemoperfusion', '(', 'hipec', ')', 'in', 'patient', 'with', 'platinum-sensitive', 'recurrent', 'epithelial', 'ovarian', 'cancer', '(', 'eoc', ')', 'undergoing', 'secondary', 'cytoreductive', 'surgery', 'followed', 'postoperative', 'platinum-based', 'intravenous', 'chemotherapy', '.', 'twelve', 'patient', 'with', 'operable', ',', 'recurrent', 'platinum-sensitive', 'eoc', '(', 'recurrence', 'month', 'first-line', 'therapy', ')', 'included', 'according', 'to', 'classical', 'dose-escalation', 'design', 'three', 'dose', 'levels-', ',', 'and', 'mgm', '(', ')', '.', 'surgical', 'cytoreduction', ',', 'single', 'dose', 'of', 'cisplatin', 'administered', 'via', 'hipec', 'min', '-c.', 'postoperatively', ',', 'patient', 'treated', 'with', 'standard', 'intravenous', 'platinum-based', 'combination', 'chemotherapy', '.', 'one', 'of', 'six', 'patient', 'experienced', 'dose-limiting', 'toxicity', '(', 'grade', 'renal', 'toxicity', ')', 'dose', 'of', 'mgm', '(', ')', '.', 'remaining', 'five', 'patient', 'treated', 'with', 'mgm', '(', ')', 'tolerated', 'treatment', 'well', '.', 'recommended', 'phase', 'ii', 'dose', 'established', 'mgm', '(', ')', '.', 'mean', 'peritoneal-to-plasma', 'auc', 'ratio', 'highest', 'dose', 'level', '.', 'cisplatin-induced', 'dna', 'adduct', 'confirmed', 'in', 'tumor', 'sample', '.', 'common', 'postoperative', 'grade', '-', 'toxicity', 'included', 'fatigue', ',', 'postoperative', 'pain', ',', 'nausea', ',', 'and', 'surgical', 'site', 'infection', '.', 'ability', 'to', 'administer', 'standard', 'intravenous', 'platinum-based', 'chemotherapy', 'hipec', 'uncompromised', '.', 'cisplatin', 'administered', 'hipec', 'dose', 'of', 'mgm', '(', ')', 'acceptable', 'safety', 'profile', 'in', 'selected', 'patient', 'undergoing', 'secondary', 'cytoreductive', 'surgery', 'platinum-sensitive', 'recurrent', 'eoc', '.', 'favorable', 'pharmacokinetic', 'and', 'pharmacodynamic', 'property', 'of', 'hipec', 'with', 'cisplatin', 'confirmed', 'dose', 'level', ',', 'especially', 'mgm', '(', ')', '.', 'result', 'encouraging', 'to', 'determine', 'efficacy', 'of', 'hipec', 'complementary', 'treatment', 'in', 'patient', 'with', 'eoc', '.']"
"The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.","Ozan Onur Balkanay, Deniz Goksedef, Suat Nail Omeroglu, Gokhan Ipek, Ozan Onur Balkanayet al.",2015 Feb,Interact Cardiovasc Thorac Surg,https://pubmed.ncbi.nlm.nih.gov/25392341/,No keywords found,"['acute', 'kidney', 'failure', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', 'serious', 'complication', 'increase', 'morbidity', 'and', 'mortality', 'rate', '.', 'early', 'detection', 'and', 'prevention', 'of', 'complication', 'important', '.', 'novel', 'biomarker', 'named', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'play', 'important', 'role', 'in', 'early', 'diagnosis', 'of', 'acute', 'kidney', 'injury', '.', 'recent', 'study', 'favourable', 'effect', 'of', 'dexmedetomidine', 'cardiac', 'surgery', 'published', '.', 'aim', 'of', 'study', 'to', 'investigate', 'whether', 'dose-dependent', 'positive', 'effect', 'of', 'dexmedetomidine', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'and', 'renal', 'function', 'used', 'cabg', '.', 'method', 'randomized', ',', 'triple-blinded', ',', 'placebo-controlled', 'study', 'conducted', 'among', 'patient', 'scheduled', 'cabg', 'surgery', 'august', 'and', 'march', 'in', 'tertiary', 'cardiac', 'and', 'vascular', 'surgery', 'clinic', '.', 'total', 'of', 'consecutive', 'patient', 'met', 'inclusion', 'criterion', 'randomized', 'and', 'divided', 'three', 'group', '.', 'first', 'group', 'received', 'placebo', '.', 'second', 'and', 'third', 'group', 'received', 'and', 'gcc', 'concentration', 'of', 'dexmedetomidine', 'infusion', ',', 'respectively', '.', 'infusion', 'rate', 'regulated', 'to', 'obtain', 'sedation', 'with', 'ramsey', 'sedation', 'score', 'of', 'or', '.', 'patient', 'regrouped', 'according', 'to', 'total', 'dexmedetomidine', 'dose', '.', 'statistical', 'analysis', 'of', 'variable', 'including', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'value', 'and', 'conventional', 'renal', 'function', 'test', 'made', 'six', 'possibility', 'blind', 'broken', '.', 'result', 'result', 'of', 'conventional', 'renal', 'function', 'test', 'not', 'significantly', 'different', '.', 'however', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'first', 'postoperative', 'day', 'placebo', ',', 'low-dose', 'and', 'high-dose', 'dexmedetomidine', 'group', '.', '.', ',', '.', '.', 'and', '.', '.', 'ngml', ',', 'respectively', '.', 'value', 'significantly', 'different', 'among', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'study', ',', 'found', 'dexmedetomidine', 'infusion', 'sedation', 'cabg', 'cardiopulmonary', 'bypass', 'useful', 'in', 'prevention', 'of', 'kidney', 'injury', '.', 'conventional', 'renal', 'function', 'test', ',', 'including', 'blood', 'urea', 'nitrogen', ',', 'serum', 'creatinine', ',', 'urine', 'output', 'and', 'creatinine', 'clearance', 'rate', 'measurement', 'typically', 'may', 'not', 'detect', 'development', 'of', 'acute', 'kidney', 'dysfunction', 'in', 'first', '-h', 'postoperative', 'period', '.', 'difference', 'detected', 'in', 'renal', 'function', 'in', 'early', 'postoperative', 'period', 'and', 'development', 'of', 'acute', 'kidney', 'injury', ',', 'determined', 'measurement', 'of', 'blood', 'ngal', 'level', ',', 'significant', 'and', 'dose-dependent', '.']"
Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation.,"James M Kidd, Colleen M Sakon, Louise-Marie Oleksiuk, Jeffrey J Cies, Rebecca S Pettit, David P Nicolau, Joseph L Kuti, James M Kiddet al.",2019 Dec 20,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/31685468/,"Monte Carlo simulation, acute pulmonary exacerbation, cystic fibrosis, dose, glycopeptides, pharmacokinetics, probability of target attainment, telavancin.","['v', ',', '.', '.', 'liter', 'kg-', 'clnr', ',', '.', '.', 'liter', 'h-', 'cl', ',', '.', '-', '.', '-', 'vp', '(', 'volume', 'of', 'peripheral', 'compartment', ')', ',', '.', '.', 'liter', 'q', '(', 'intercompartmental', 'clearance', ')', ',', '.', '.', 'liter', 'h-', 'free', 'area', 'concentration-time', 'curve', '(', 'fauc', ')', 'value', '.', 'and', 'mgkg', '.', 'and', 'mg', 'hliter', ',', 'respectively', '.', 'dos', 'of', '.', 'mgkg', 'and', 'mgkg', 'achieved', '.', 'and', 'probability', 'of', 'target', 'attainment', '(', 'pta', ')', 'faucmic', 'threshold', 'of', ',', 'respectively', ',', 'mic', 'of', '.', 'mgliter', '.', 'probability', 'of', 'reaching', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'threshold', 'auc', '(', 'mg', 'h', 'liter-', ')', 'dos', 'and', '.', ',', 'respectively', '.', 'no', 'serious', 'adverse', 'event', 'occurred', '.', 'telavancin', 'mgkg', 'yielded', 'optimal', 'pta', 'and', 'minimal', 'risk', 'of', 'aki', ',', 'suggesting', 'fda-approved', 'dose', 'appropriate', 'to', 'treat', 'acute', 'pulmonary', 'exacerbation', 'in', 'cf', 'adult', '.', '(', 'clinical', 'trial', 'discussed', 'in', 'study', 'registered', 'clinicaltrials.gov', 'identifier', 'nct', '.', ')', '.']"
Administration of HES in elderly patients undergoing hip arthroplasty under spinal anesthesia is not associated with an increase in renal injury.,"Yuanyuan Zhang, Yonghao Yu, Junya Jia, Wenli Yu, Rubin Xu, Licheng Geng, Ying Wei, Yuanyuan Zhanget al.",2017 Feb 21,BMC Anesthesiol,https://pubmed.ncbi.nlm.nih.gov/28222674/,No keywords found,"['hydroxyethyl', 'starch', '(', 'he', ')', 'applied', 'to', 'achieve', 'volume', 'expansion', 'surgery', 'however', ',', 'nephrotoxicity', 'may', 'induced', 'in', 'patient', 'with', 'sepsis', '.', 'simultaneously', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'il-', 'illustrated', 'pivotal', 'indicator', 'to', 'diagnose', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'early', '.', 'multi-center', ',', 'randomized', ',', 'double-blinded', ',', 'placebo-controlled', 'study', 'aimed', 'to', 'investigate', 'whether', 'he', '.', 'administration', 'caused', 'postoperative', 'aki', ',', 'revealed', 'urinary', 'and', 'plasma', 'ngal', 'and', 'il-', 'estimation', 'in', 'elderly', 'patient', 'with', 'normal', 'renal', 'function', 'undergoing', 'hip', 'arthroplasty', 'spinal', 'anesthesia', '.', 'method', 'asa', 'i-iii', ',', 'patient', 'aged', 'undergoing', 'hip', 'arthroplasty', 'spinal', 'anesthesia', 'randomly', 'received', 'he', '.', 'or', 'sodium', 'lactate', 'ringer', ""'s"", 'solution', '.', 'mlkg', 'first', 'hour', 'of', 'surgery', '.', 'patient', 'completed', 'study', '.', 'blood', 'pressure', ',', 'ngal', 'concentration', ',', 'il', ',', 'micro-albumin', 'and', 'albumin', 'in', 'urine', 'and', 'creatinine', ',', 'ngal', 'and', 'il-', 'in', 'plasma', 'repeatedly', 'measured', ',', ',', 'and', 'surgery', '.', 'result', 'group', 'balanced', 'in', 'mean', 'arterial', 'pressure', ',', 'urine', 'and', 'plasma', 'ngal', ',', 'plasma', 'il-', 'and', 'creatinine', ',', 'urine', 'microalbumin', 'and', 'albumin', '(', 'p', '.', ')', '.', 'urine', 'il-', 'dramatically', 'elevated', 'in', 'group', 'surgery', '(', 'p', '.', ')', '.', 'conclusion', 'elderly', 'patient', 'undergoing', 'surgery', 'spinal', 'anesthesia', 'high-risk', 'population', 'in', 'aki', '.', 'patient', 'with', 'normal', 'renal', 'function', 'receiving', 'spinal', 'anesthesia', 'short', 'duration', 'surgery', 'would', 'not', 'develop', 'aki', 'ml', '(', 'small', 'volume', ')', 'he', 'infused', '.', 'trial', 'registration', 'identifier', 'nct', '.', 'registration', 'date', 'february', '.']"
Avoiding the emergence of contrast-induced acute kidney injury in acute coronary syndrome: routine hydration treatment.,"Sukru Arslan, Ahmet Yildiz, Yalcin Dalgic, Servet Batit, Onur Kilicarslan, Ozgur Selim Ser, Sadiye Nur Dalgic, Cuneyt Kocas, Okay Abaci, Sukru Arslanet al.",2021 Aug 1,Coron Artery Dis,https://pubmed.ncbi.nlm.nih.gov/33060531/,No keywords found,"['patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'three-fold', 'risk', 'developing', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', '.', 'investigating', 'study', 'routine', 'hydration', 'therapy', 'frequently', 'included', 'patient', 'with', 'stable', 'coronary', 'artery', 'disease', 'and', 'high', 'risk', 'of', 'ci-aki', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'mlmin', '.', 'however', ',', 'data', 'routine', 'hydration', 'treatment', 'in', 'non-st', 'segment', 'elevation', 'myocardial', 'infarction', '(', 'nstemi', ')', 'patient', 'with', 'egfr', 'mlmin', 'insufficient', '.', 'aimed', 'to', 'investigate', 'association', 'routine', 'hydration', 'therapy', 'and', 'ci-aki', 'development', 'in', 'nstemi', 'patient', 'low', 'risk', 'nephropathy', '.', 'method', 'and', 'result', 'randomly', 'assigned', 'total', 'of', 'nstemi', 'patient', 'to', 'two', 'group', 'routine', 'hydration', 'group', '(', 'patient', ')', 'and', 'nonhydration', 'group', '(', 'control', 'group', ')', '(', 'patient', ')', '.', 'intravenous', 'hydration', 'with', 'isotonic', 'saline', '(', 'mlkgh', ',', '.', 'sodium', 'chloride', ')', 'given', '-', 'h', 'and', 'h', 'contrast', 'exposure', 'to', 'hydration', 'group', '.', 'ci-aki', 'defined', 'increase', 'in', 'serum', 'creatinine', 'value', '.', 'mgdl', 'or', 'and', 'h', 'invasive', 'procedure', '.', 'in', 'study', ',', 'incidence', 'of', 'ci-aki', 'development', 'in', 'routine', 'hydration', 'group', '(', '.', ')', 'significantly', 'lower', 'in', 'nonhydration', 'group', '(', '.', ')', '(', 'p', '.', ')', '.', 'study', 'revealed', 'older', 'age', ',', 'amount', 'of', 'contrast', 'medium', ',', 'and', 'routine', 'hydration', 'independent', 'risk', 'factor', 'developing', 'ci-aki', '(', 'p', '.', ',', 'p', '.', ',', 'p', '.', ',', 'respectively', ')', '.', 'conclusion', 'found', 'preprocedural', 'and', 'postprocedural', 'intravenous', 'hydration', 'therapy', 'reduces', 'development', 'of', 'ci-aki', 'in', 'patient', 'with', 'nstemi', 'low', 'risk', 'ci-aki', '.', 'suggest', 'administering', 'routine', 'hydration', 'therapy', 'in', 'ac', 'patient', 'regardless', 'of', 'egfr', 'value', '.']"
Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials.,"Wei Wang, Zhiying You, Cortney N Steele, Berenice Gitomer, Michel Chonchol, Kristen L Nowak, Wei Wanget al.",2024 Jun 25,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/38918734/,No keywords found,"['tubular', 'biomarkers', ',', 'reflect', 'tubular', 'dysfunction', 'or', 'injury', ',', 'associated', 'with', 'incident', 'chronic', 'kidney', 'disease', 'and', 'kidney', 'function', 'decline', '.', 'several', 'tubular', 'biomarkers', 'also', 'implicated', 'in', 'progression', 'of', 'autosomal', 'dominant', 'polycystic', 'kidney', 'disease', '(', 'adpkd', ')', '.', 'evaluated', 'change', 'in', 'multiple', 'tubular', 'biomarkers', 'in', 'four', 'group', 'of', 'patient', 'with', 'adpkd', 'participated', 'in', 'one', 'of', 'two', 'clinical', 'trial', '(', 'metformin', 'therapy', 'and', 'diet-induced', 'weight', 'loss', ')', ',', 'based', 'evidence', 'suggesting', 'intervention', 'could', 'reduce', 'tubule', 'injury', '.', 'method', 'participant', '(', 'f', ')', 'with', 'adpkd', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'mlmin.m', 'participated', 'in', 'either', 'metformin', 'clinical', 'trial', '(', 'n', 'metformin', 'n', 'placebo', ')', 'or', 'dietary', 'weight', 'loss', 'study', '(', 'n', 'daily', 'caloric', 'restriction', 'dcr', 'n', 'intermittent', 'fasting', 'imf', ')', 'included', 'in', 'assessment', 'of', 'urinary', 'tubular', 'biomarkers', '(', 'kidney', 'injury', 'molecule-', 'kim-', ',', 'fatty-acid', 'binding', 'protein', 'fabp', ',', 'interleukin-', 'il-', ',', 'monocyte', 'chemoattractant', 'protein-', 'mcp-', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'ngal', ',', 'clusterin', ',', 'and', 'human', 'cartilage', 'glycoprotein-', 'ykl-', 'normalized', 'to', 'urine', 'creatinine', ')', ',', 'baseline', 'and', 'month', '.', 'association', 'of', 'baseline', 'tubular', 'biomarkers', 'with', 'baseline', 'and', 'change', 'in', 'height-adjusted', 'total', 'kidney', 'volume', '(', 'httkv', 'percent', 'change', 'baseline', 'to', 'month', ')', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', 'absolute', 'change', 'month', 'vs.', 'baseline', ')', ',', 'with', 'covariate', 'adjustment', ',', 'also', 'assessed', 'using', 'multiple', 'linear', 'regression', '.', 'result', 'mean', 's.d', '.', 'age', 'year', ',', 'egfr', 'mlmin.m', ',', 'and', 'baseline', 'bmi', '.', '.', 'kgm', '.', 'none', 'of', 'tubular', 'biomarkers', 'changed', 'with', 'intervention', 'compared', 'to', 'placebo', '.', 'additionally', ',', 'baseline', 'tubular', 'biomarkers', 'not', 'associated', 'with', 'either', 'baseline', 'or', 'change', 'in', 'egfr', 'or', 'httkv', 'month', ',', 'adjustment', 'demographic', ',', 'group', 'assignment', ',', 'and', 'clinical', 'characteristic', '.', 'conclusion', 'tubular', 'biomarkers', 'not', 'change', 'with', 'dietary-induced', 'weight', 'loss', 'or', 'metformin', ',', 'associate', 'with', 'kidney', 'disease', 'progression', ',', 'in', 'cohort', 'of', 'patient', 'with', 'adpkd', '.']"
"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.","Noopur Raje, Evangelos Terpos, Wolfgang Willenbacher, Kazuyuki Shimizu, Ramón García-Sanz, Brian Durie, Wojciech Legieć, Marta Krejčí, Kamel Laribi, Li Zhu, Paul Cheng, Douglas Warner, G David Roodman, Noopur Rajeet al.",2018 Mar,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/29429912/,No keywords found,"['multiple', 'myeloma', 'characterised', 'monoclonal', 'paraprotein', 'production', 'and', 'osteolytic', 'lesion', ',', 'commonly', 'leading', 'to', 'skeletal-related', 'event', '(', 'spinal', 'cord', 'compression', ',', 'pathological', 'fracture', ',', 'or', 'surgery', 'or', 'radiotherapy', 'to', 'affected', 'bone', ')', '.', 'denosumab', ',', 'monoclonal', 'antibody', 'targeting', 'rankl', ',', 'reduces', 'skeletal-related', 'event', 'associated', 'with', 'bone', 'lesion', 'or', 'metastasis', 'in', 'patient', 'with', 'advanced', 'solid', 'tumour', '.', 'study', 'aimed', 'to', 'assess', 'efficacy', 'and', 'safety', 'of', 'denosumab', 'compared', 'with', 'zoledronic', 'acid', 'prevention', 'of', 'skeletal-related', 'event', 'in', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', '.', 'method', 'in', 'international', ',', 'double-blind', ',', 'double-dummy', ',', 'randomised', ',', 'active-controlled', ',', 'phase', 'study', ',', 'patient', 'in', 'centre', 'and', 'country', 'aged', 'year', 'or', 'older', 'with', 'symptomatic', 'newly', 'diagnosed', 'multiple', 'myeloma', 'least', 'one', 'documented', 'lytic', 'bone', 'lesion', 'randomly', 'assigned', '(', 'centrally', ',', 'interactive', 'voice', 'response', 'system', 'using', 'fixed', 'stratified', 'permuted', 'block', 'randomisation', 'list', 'with', 'block', 'size', 'of', 'four', ')', 'to', 'subcutaneous', 'denosumab', 'mg', 'plus', 'intravenous', 'placebo', 'every', 'week', 'or', 'intravenous', 'zoledronic', 'acid', 'mg', 'plus', 'subcutaneous', 'placebo', 'every', 'week', '(', 'group', 'also', 'received', 'investigator', ""'"", 'choice', 'of', 'first-line', 'antimyeloma', 'therapy', ')', '.', 'stratification', 'intent', 'to', 'undergo', 'autologous', 'transplantation', ',', 'antimyeloma', 'therapy', ',', 'international', 'staging', 'system', 'stage', ',', 'previous', 'skeletal-related', 'event', ',', 'and', 'region', '.', 'clinical', 'study', 'team', 'and', 'patient', 'masked', 'to', 'treatment', 'assignment', '.', 'primary', 'endpoint', 'non-inferiority', 'of', 'denosumab', 'to', 'zoledronic', 'acid', 'with', 'respect', 'to', 'time', 'to', 'first', 'skeletal-related', 'event', 'in', 'full', 'analysis', 'set', '(', 'randomly', 'assigned', 'patient', ')', '.', 'safety', 'endpoint', 'analysed', 'in', 'safety', 'analysis', 'set', ',', 'includes', 'randomly', 'assigned', 'patient', 'received', 'least', 'one', 'dose', 'of', 'active', 'study', 'drug', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'may', ',', ',', 'to', 'march', ',', ',', 'enrolled', 'patient', 'and', 'randomly', 'assigned', 'to', 'treatment', 'group', '.', 'study', 'met', 'primary', 'endpoint', 'denosumab', 'non-inferior', 'to', 'zoledronic', 'acid', 'time', 'to', 'first', 'skeletal-related', 'event', '(', 'hazard', 'ratio', ',', 'ci', '-', 'pnon-inferiority', ')', '.', 'patient', 'received', 'least', 'one', 'dose', 'of', 'investigational', 'drug', 'and', 'included', 'in', 'safety', 'analysis', '(', 'patient', 'receiving', 'denosumab', 'and', 'receiving', 'zoledronic', 'acid', ')', '.', 'common', 'grade', 'or', 'worse', 'treatment-emergent', 'adverse', 'event', 'denosumab', 'and', 'zoledronic', 'acid', 'neutropenia', '(', 'v', ')', ',', 'thrombocytopenia', '(', 'v', ')', ',', 'anaemia', '(', 'v', ')', ',', 'febrile', 'neutropenia', '(', 'v', ')', ',', 'and', 'pneumonia', '(', 'v', ')', '.', 'renal', 'toxicity', 'reported', 'in', '(', ')', 'patient', 'in', 'denosumab', 'group', 'versus', '(', ')', 'in', 'zoledronic', 'acid', 'group', 'hypocalcaemia', 'adverse', 'event', 'reported', 'in', '(', ')', 'versus', '(', ')', '.', 'incidence', 'of', 'osteonecrosis', 'of', 'jaw', 'not', 'significantly', 'different', 'denosumab', 'and', 'zoledronic', 'acid', 'group', '(', 'v', 'p', ')', '.', 'common', 'serious', 'adverse', 'event', 'treatment', 'group', 'pneumonia', '(', 'v', ')', '.', 'one', 'patient', 'in', 'zoledronic', 'acid', 'group', 'died', 'of', 'cardiac', 'arrest', 'deemed', 'treatment-related', '.', 'interpretation', 'in', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', ',', 'denosumab', 'non-inferior', 'to', 'zoledronic', 'acid', 'time', 'to', 'skeletal-related', 'event', '.', 'result', 'study', 'suggest', 'denosumab', 'could', 'additional', 'option', 'standard', 'of', 'care', 'patient', 'with', 'multiple', 'myeloma', 'with', 'bone', 'disease', '.', 'funding', 'amgen', '.']"
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.,"Faiez Zannad, João Pedro Ferreira, Javed Butler, Gerasimos Filippatos, James L Januzzi, Mikhail Sumin, Matthias Zwick, Maral Saadati, Stuart J Pocock, Naveed Sattar, Stefan D Anker, Milton Packer, Faiez Zannadet al.",2022 Dec 21,Eur Heart J,https://pubmed.ncbi.nlm.nih.gov/36017745/,No keywords found,"['sodium-glucose', 'co-transporter', '(', 'sglt', ')', 'inhibitor', 'improve', 'cardiovascular', 'outcome', 'in', 'diverse', 'patient', 'population', ',', 'mechanism', 'of', 'action', 'requires', 'study', '.', 'aim', 'to', 'explore', 'effect', 'of', 'empagliflozin', 'circulating', 'level', 'of', 'intracellular', 'protein', 'in', 'patient', 'with', 'heart', 'failure', ',', 'using', 'large-scale', 'proteomics', '.', 'method', 'and', 'result', 'circulating', 'protein', 'measured', 'baseline', ',', 'week', ',', 'and', 'week', 'in', 'patient', 'emperor-reduced', 'and', 'emperor-preserved', ',', 'using', 'olink', 'explore', 'platform', '.', 'statistical', 'and', 'bioinformatical', 'analysis', 'identified', 'differentially', 'expressed', 'protein', '(', 'empagliflozin', 'vs.', 'placebo', ')', ',', 'linked', 'to', 'demonstrated', 'biological', 'action', 'in', 'heart', 'and', 'kidney', '.', 'week', ',', 'of', 'protein', 'fulfilled', 'threshold', 'differentially', 'expressed', ',', 'i.e', '.', 'level', 'changed', 'with', 'false', 'discovery', 'rate', '(', 'empagliflozin', 'vs.', 'placebo', ')', '.', 'among', ',', 'nine', 'protein', 'demonstrated', 'largest', 'treatment', 'effect', 'of', 'empagliflozin', 'insulin-like', 'growth', 'factor-binding', 'protein', ',', 'transferrin', 'receptor', 'protein', ',', 'carbonic', 'anhydrase', ',', 'erythropoietin', ',', 'protein-glutamine', 'gamma-glutamyltransferase', ',', 'thymosin', 'beta-', ',', 'u-type', 'mitochondrial', 'creatine', 'kinase', ',', 'insulin-like', 'growth', 'factor-binding', 'protein', ',', 'and', 'adipocyte', 'fatty', 'acid-binding', 'protein', '.', 'change', 'of', 'protein', 'baseline', 'to', 'week', 'generally', 'concordant', 'with', 'change', 'baseline', 'to', 'week', ',', 'except', 'empagliflozin', 'reduced', 'level', 'of', 'kidney', 'injury', 'molecule-', 'week', ',', 'not', 'week', '.', 'common', 'biological', 'action', 'of', 'differentially', 'expressed', 'protein', 'appeared', 'to', 'promotion', 'of', 'autophagic', 'flux', 'in', 'heart', ',', 'kidney', 'or', 'endothelium', ',', 'feature', 'of', 'protein', '.', 'effect', 'of', 'differentially', 'expressed', 'protein', 'heart', 'included', 'reduction', 'of', 'oxidative', 'stress', ',', 'inhibition', 'of', 'inflammation', 'and', 'fibrosis', ',', 'and', 'enhancement', 'of', 'mitochondrial', 'health', 'and', 'energy', ',', 'repair', ',', 'and', 'regenerative', 'capacity', '.', 'action', 'of', 'differentially', 'expressed', 'protein', 'in', 'kidney', 'involved', 'promotion', 'of', 'autophagy', ',', 'integrity', 'and', 'regeneration', ',', 'suppression', 'of', 'renal', 'inflammation', 'and', 'fibrosis', ',', 'and', 'modulation', 'of', 'renal', 'tubular', 'sodium', 'reabsorption', '.', 'conclusion', 'change', 'in', 'circulating', 'protein', 'level', 'in', 'patient', 'with', 'heart', 'failure', 'consistent', 'with', 'finding', 'of', 'experimental', 'study', 'shown', 'effect', 'of', 'sglt', 'inhibitor', 'likely', 'related', 'to', 'action', 'heart', 'and', 'kidney', 'to', 'promote', 'autophagic', 'flux', ',', 'nutrient', 'deprivation', 'signalling', 'and', 'transmembrane', 'sodium', 'transport', '.']"
Effect of Dongchongxiacao (Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography.,"Zhao Kai, Li Yongjian, Gao Sheng, Lin Yu, Zhao Kaiet al.",2015 Aug,J Tradit Chin Med,https://pubmed.ncbi.nlm.nih.gov/26427112/,No keywords found,"['to', 'study', 'protective', 'effect', 'of', 'dongchongxiacao', '(', 'cordyceps', ')', '(', 'dcxc', ')', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'in', 'patient', 'with', 'type', 'diabetes', 'and', 'renal', 'insufficiency', 'undergoing', 'coronary', 'angiography', '.', 'method', 'total', 'of', 'patient', 'with', 'type', 'diabetes', 'whose', 'estimated', 'glomerular', 'filtration', 'rater', '(', 'egfr', ')', 'mlmin', '.', 'in', ',', 'divided', 'randomly', 'three', 'group', ',', 'basic', 'treatment', 'group', '(', 'n', ')', ',', 'standard', 'dcxc', 'therapy', 'group', '(', 'n', ',', '-g', 'corbrin', 'capsule', ',', 'timesd', ',', 'day', 'and', 'angiography', ')', ',', 'and', 'intensive', 'dcxc', 'therapy', 'group', '(', 'n', ',', '-g', 'corbrin', 'capsule', ',', 'timesd', ',', 'day', 'and', 'angiography', ')', '.', 'serum', 'creatinine', '(', 'cr', ')', 'and', 'egfr', 'assessed', 'time', 'of', 'admission', 'to', 'hospital', ',', 'and', 'day', ',', 'and', 'angiography', '.', 'urine', 'neutrophil-gelatinase-associated-lipo-', 'calin', '(', 'ngal', ')', ',', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'and', 'interleukin-', '(', 'il-', ')', 'measured', 'angiography', 'and', 'day', 'angiography', 'patient', '.', 'primary', 'end', 'point', 'prevalence', 'of', 'cin', '.', 'secondary', 'end', 'point', 'or', 'greater', 'reduction', 'in', 'egfr', '.', 'result', 'cin', 'occurred', 'in', 'of', 'patient', '(', '.', ')', '.', 'prevalence', 'of', 'cin', 'lower', 'in', 'dcxc', 'treatment', 'group', 'in', 'basic', 'treatment', 'group', '(', 'p', '.', ')', ',', 'with', 'significant', 'decrease', 'in', 'prevalence', 'of', 'cin', 'in', 'intensive', 'dcxc', 'therapy', 'group', '(', 'p', '.', ')', '.', 'compared', 'with', 'basic', 'treatment', 'group', ',', 'lower', 'proportion', 'of', 'patient', 'in', 'dcxc', 'treatment', 'group', 'egfr', 'decrease', 'of', 'or', 'greater', '(', 'p', '.', ')', 'patient', 'with', 'egfr', 'decrease', 'of', 'or', 'greater', 'accounted', 'even', 'lower', 'proportion', 'in', 'intensive', 'dcxc', 'therapy', 'group', '(', 'p', '.', ')', '.', 'within', 'day', 'of', 'procedure', ',', 'urine', 'level', 'of', 'kim-', ',', 'ngal', 'and', 'il-', 'in', 'patient', 'in', 'intensive', 'dcxc', 'therapy', 'group', 'lower', 'in', 'basic', 'treatment', 'group', 'and', 'standard', 'therapy', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'dcxc', 'treatment', 'may', 'protect', 'cin', 'in', 'patient', 'with', 'type', 'diabetes', 'and', 'renal', 'insufficiency', 'undergoing', 'coronary', 'angiography', ',', 'with', 'intensive', 'dcxc', 'therapy', 'effective', '.']"
Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.,"Christian Ott, Agnes Bosch, Nicole Winzer, Stephanie Friedrich, Reinhard Schinzel, Frank Tegtmeier, Roland E Schmieder, Christian Ottet al.",2019 May,Br J Clin Pharmacol,https://pubmed.ncbi.nlm.nih.gov/30666700/,No keywords found,"['reduced', 'nitric', 'oxide', '(', 'no', ')', 'availability', 'may', 'adversely', 'affect', 'renal', 'perfusion', 'and', 'glomerular', 'filtration', '.', 'aim', 'of', 'present', 'study', 'to', 'characterize', 'in', 'detail', 'pharmacological', 'effect', 'of', 'va', ',', 'inhibitor', 'of', 'no', 'synthase', ',', 'renal', 'haemodynamics', 'in', 'human', '.', 'method', 'double-blind', ',', 'randomized', ',', 'placebo-controlled', ',', 'cross-over', 'phase-i-study', 'comprised', 'healthy', 'men', '.', 'renal', 'haemodynamics', 'assessed', 'with', 'constant-infusion', 'input-clearance', 'technique', 'with', 'p-aminohippurate', 'and', 'inulin', 'renal', 'plasma', 'flow', '(', 'rpf', ')', 'and', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', ',', 'respectively', '.', 'baseline', 'measurement', ',', 'constant', 'infusion', 'of', 'tetrahydrobiopterin', 'analogue', 'ronopterin', '(', 'va', ',', 'total', 'mgkg', 'body', 'weight', ')', 'or', 'placebo', 'administered', 'random', 'order', 'hour', 'additionally', '.', 'wash-out', 'phase', 'of', 'day', ',', 'second', 'course', 'applied', '.', 'in', 'parallel', ',', 'marker', 'of', 'early', 'kidney', 'injury', 'and', 'renal', 'function', 'assessed', 'repeatedly', 'to', 'hour', 'starting', 'vasplacebo-infusion', '.', 'result', 'vas-infusion', 'resulted', 'in', 'significant', 'decrease', 'of', 'rpf', '(', 'p', '.', ')', 'observed', '.', 'conclusion', 'phase-i-study', 'in', 'healthy', 'human', 'indicates', 'va', '(', 'mgkg', 'body', 'weight', ')', 'reduces', 'renal', 'perfusion', 'and', 'glomerular', 'function', 'within', 'physiological', 'range', 'mainly', 'due', 'to', 'vasoconstriction', 'preglomerular', 'site', '.']"
"First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.","Samuel L Cytryn, Ryan H Moy, Darren Cowzer, Ronak H Shah, Joanne F Chou, Smita S Joshi, Geoffrey Y Ku, Steven B Maron, Avni Desai, Jessica Yang, Ryan Sugarman, Devika Rao, Zoe Goldberg, Carmelina Charalambous, Maria Lapshina, Ariel Antoine, Fiona Socolow, Nikhil Trivedi, Marinela Capanu, Hans Gerdes, Mark A Schattner, Marc Simmons, Mario E Lacouture, Viktoriya Paroder, Laura H Tang, Jinru Shia, David H Ilson, David B Solit, Michael F Berger, Yelena Y Janjigian, Samuel L Cytrynet al.",2023 Oct,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/37666264/,No keywords found,"['addition', 'of', 'nivolumab', 'to', 'chemotherapy', 'improves', 'survival', 'in', 'patient', 'with', 'advanced', 'oesophagogastric', '(', 'oesophageal', ',', 'gastric', ',', 'or', 'gastro-oesophageal', 'junction', ')', 'adenocarcinoma', 'however', ',', 'outcome', 'remain', 'poor', '.', 'assessed', 'safety', 'and', 'activity', 'of', 'regorafenib', 'in', 'combination', 'with', 'nivolumab', 'and', 'chemotherapy', 'in', 'first-line', 'treatment', 'of', 'advanced', 'oesophagogastric', 'adenocarcinoma', '.', 'method', 'investigator-initiated', ',', 'single-arm', ',', 'phase', 'trial', 'in', 'adult', 'patient', '(', 'aged', 'year', ')', 'with', 'previously', 'untreated', ',', 'her-negative', ',', 'metastatic', 'oesophagogastric', 'adenocarcinoma', 'done', 'memorial', 'sloan', 'kettering', 'cancer', 'center', '(', 'new', 'york', ',', 'ny', ',', 'usa', ')', '.', 'eligible', 'patient', 'measurable', 'disease', 'or', 'non-measurable', 'disease', 'evaluable', '(', 'defined', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumour', 'recist', 'version', '.', ')', 'and', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', 'or', '.', 'patient', 'received', 'folfox', 'chemotherapy', '(', 'fluorouracil', 'mgm', 'bolus', 'followed', 'mgm', 'h', ',', 'leucovorin', 'mgm', ',', 'and', 'oxaliplatin', 'mgm', ')', 'and', 'nivolumab', '(', 'mg', ')', 'intravenously', 'day', 'and', ',', 'and', 'oral', 'regorafenib', '(', 'mg', ')', 'day', '-', 'of', '-day', 'cycle', '.', 'treatment', 'continued', 'disease', 'progression', '(', 'defined', 'recist', 'version', '.', ')', ',', 'unacceptable', 'toxicity', ',', 'or', 'withdrawal', 'of', 'consent', '.', 'primary', 'endpoint', '-month', 'progression-free', 'survival', 'in', 'per-protocol', 'population', '(', 'ie', ',', 'participant', 'received', 'dose', 'of', 'study', 'treatment', ')', '.', 'regimen', 'would', 'considered', 'worthy', 'of', 'investigation', 'least', 'of', 'patient', 'progression', 'free', 'month', '.', 'safety', 'assessed', 'in', 'participant', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'complete', '.', 'finding', 'feb', ',', ',', 'and', 'may', ',', ',', 'patient', 'enrolled', ',', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', ',', 'and', 'included', 'in', 'safety', 'analysis', '.', 'patient', 'evaluable', '-month', 'progression-free', 'survival', '.', 'median', 'age', 'year', '(', 'iqr', '-', ')', ',', 'nine', '(', ')', 'patient', 'woman', ',', '(', ')', 'men', ',', '(', ')', 'white', ',', 'and', 'seven', '(', ')', 'asian', '.', 'data', 'cutoff', '(', 'march', ',', ')', ',', 'median', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', 'primary', 'endpoint', 'reached', ',', 'with', '(', 'ci', '-', ')', 'of', 'patient', 'progression', 'free', 'month', '.', 'nine', '(', ')', 'of', 'patient', 'disease', 'progression', 'and', 'one', '(', ')', 'patient', 'died', 'death', 'unrelated', 'to', 'treatment', '.', 'common', 'adverse', 'event', 'of', 'grade', 'fatigue', '(', 'of', ')', '.', 'common', 'grade', 'or', 'adverse', 'event', 'decreased', 'neutrophil', 'count', '(', ')', ',', 'hypertension', '(', 'six', ')', ',', 'dry', 'skin', ',', 'pruritus', ',', 'or', 'rash', '(', 'five', ')', ',', 'and', 'anaemia', '(', 'four', ')', '.', 'serious', 'treatment-related', 'adverse', 'event', 'occurred', 'in', 'ten', '(', ')', 'patient', ',', 'acute', 'kidney', 'injury', '(', 'three', ')', ',', 'hepatotoxicity', '(', 'two', ')', ',', 'sepsis', '(', 'two', ')', ',', 'dry', 'skin', ',', 'pruritus', ',', 'or', 'rash', '(', 'one', ')', ',', 'nausea', '(', 'one', ')', ',', 'and', 'gastric', 'perforation', '(', 'one', ')', '.', 'no', 'treatment-related', 'death', '.', 'interpretation', 'regorafenib', 'safely', 'combined', 'with', 'nivolumab', 'and', 'chemotherapy', 'and', 'showed', 'promising', 'activity', 'in', 'her-negative', 'metastatic', 'oesophagogastric', 'cancer', '.', 'randomised', ',', 'phase', 'clinical', 'trial', 'planned', '.', 'funding', 'bristol', 'myers', 'squibb', ',', 'bayer', 'and', 'national', 'institute', 'of', 'healthnational', 'cancer', 'institute', '.']"
Clinical outcomes of liver transplantation in human immunodeficiency virus/hepatitis B virus coinfected patients in China.,"Jianxin Tang#, Ruihui Weng#, Taishi Fang, Kangjun Zhang, Xu Yan, Xin Jin, Linjie Xie, Dong Zhao, Jianxin Tanget al.",2024 Apr 8,BMC Infect Dis,https://pubmed.ncbi.nlm.nih.gov/38589801/,No keywords found,"['highly', 'active', 'antiretroviral', 'therapy', '(', 'haart', ')', 'able', 'to', 'improve', 'immune', 'system', 'function', 'and', 'survival', 'of', 'human', 'immunodeficiency', 'virus', '(', 'hiv', ')', 'patient', '.', 'however', ',', 'patient', 'coinfected', 'with', 'hiv', 'and', 'hepatitis', 'b', 'virus', '(', 'hbv', ')', 'likely', 'to', 'develop', 'end-stage', 'liver', 'disease', '(', 'esld', ')', 'infected', 'with', 'hbv', 'alone', '.', 'consequently', ',', 'liver', 'transplantation', 'often', 'required', 'patient', '.', 'study', 'evaluates', 'outcome', 'of', 'orthotopic', 'liver', 'transplantation', '(', 'olt', ')', 'of', 'hiv-hbv', 'coinfected', 'patient', 'in', 'china', '.', 'method', 'conducted', 'retrospective', 'analysis', 'hiv-hbv', 'coinfected', 'patient', 'underwent', 'olt', 'april', ',', 'to', 'december', ',', 'and', 'outcome', 'compared', 'to', 'hbv', 'monoinfected', 'patient', 'undergoing', 'olt', 'period', '.', 'patient', 'outcome', 'determined', ',', 'including', 'cumulative', 'survival', ',', 'viral', 'load', ',', 'cd', 't-cell', 'count', 'and', 'postoperative', 'complication', '.', 'result', 'median', 'follow-up', 'of', 'hiv', 'recipient', 'month', 'olt', '(', 'interquartile', 'range', '-', 'month', ')', '.', 'almost', 'patient', 'stable', 'cd', 't-cell', 'count', '(', 'copiesul', ')', ',', 'undetectable', 'hbv', 'dna', 'level', ',', 'and', 'undetectable', 'hiv', 'rna', 'load', 'follow-up', '.', '-', ',', '-', ',', 'and', '-year', 'posttransplant', 'survival', 'rate', '.', 'hiv', 'group', '(', 'unchanged', 'to', 'year', ')', 'versus', '.', ',', '.', ',', 'and', '.', 'non-hiv', 'group', '.', 'cumulative', 'survival', 'among', 'hiv-hbv', 'coinfected', 'recipient', 'not', 'significantly', 'different', 'hbv', 'monoinfected', 'recipient', '(', 'log-rank', 'test', 'p', '.', ')', '.', 'percentage', 'of', 'death', 'attributed', 'to', 'infection', 'comparable', 'hiv', 'and', 'non-hiv', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'post', 'olt', ',', 'no', 'significant', 'difference', 'in', 'acute', 'rejection', ',', 'cytomegalovirus', 'infection', ',', 'bacteremia', ',', 'pulmonary', 'infection', ',', 'acute', 'kidney', 'injury', ',', 'de', 'novo', 'tumor', 'and', 'vascular', 'and', 'biliary', 'complication', '.', 'conclusion', 'liver', 'transplantation', 'in', 'patient', 'with', 'hiv-hbv', 'coinfection', 'yield', 'excellent', 'outcome', 'in', 'term', 'of', 'intermediate-', 'or', 'long-term', 'survival', 'rate', 'and', 'low', 'incidence', 'of', 'postoperative', 'complication', 'in', 'china', '.', 'finding', 'suggest', 'olt', 'safe', 'and', 'feasible', 'hiv-hbv', 'coinfected', 'patient', 'with', 'esld', '.', 'trial', 'registration', 'chinese', 'clinical', 'trial', 'registry', '(', 'chictr', ')', ',', 'registered', 'january', '.']"
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.,"Marie V Nelson, AeRang Kim, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Brent D Coffey, Joel M Reid, Jin Piao, Lauren Saguilig, Todd A Alonzo, Stacey L Berg, Nilsa C Ramirez, Alok Jaju, Elizabeth Fox, Brenda J Weigel, Douglas S Hawkins, Margaret M Mooney, Naoko Takebe, James V Tricoli, Katherine A Janeway, Nita L Seibel, D Williams Parsons, Marie V Nelsonet al.",2024 Aug 5,Oncologist,https://pubmed.ncbi.nlm.nih.gov/38873934/,No keywords found,"['phase', 'ii', 'subprotocol', 'of', 'nci-cog', 'pediatric', 'match', 'study', 'evaluating', 'vemurafenib', ',', 'selective', 'oral', 'inhibitor', 'of', 'braf', 'v', 'mutated', 'kinase', ',', 'in', 'patient', 'with', 'relapsed', 'or', 'refractory', 'solid', 'tumor', 'harboring', 'braf', 'v', 'mutation', '.', 'method', 'patient', 'received', 'vemurafenib', 'mgm', '(', 'maximum', 'mgdose', ')', 'orally', 'twice', 'daily', '-day', 'cycle', 'progression', 'or', 'intolerable', 'toxicity', '.', 'primary', 'aim', 'to', 'determine', 'objective', 'response', 'rate', 'and', 'secondary', 'objective', 'included', 'estimating', 'progression-free', 'survival', 'and', 'assessing', 'tolerability', 'of', 'vemurafenib', '.', 'result', 'twenty-two', 'patient', 'matched', 'to', 'subprotocol', 'and', 'patient', '(', ')', 'enrolled', '.', 'primary', 'reason', 'non-enrollment', 'ineligibility', 'due', 'to', 'exclusion', 'of', 'low-grade', 'glioma', '(', 'n', ')', 'and', 'prior', 'braf', 'inhibitor', 'therapy', '(', 'n', ')', '.', 'enrolled', 'diagnosis', 'one', 'of', 'histiocytosis', ',', 'ameloblastoma', ',', 'ewing', 'sarcoma', ',', 'and', 'high-grade', 'glioma', ',', 'with', 'braf', 'mutation', '.', 'treatment', 'overall', 'tolerable', 'with', 'mostly', 'expected', 'grade', 'adverse', 'event', '(', 'ae', ')', '.', 'grade', 'or', 'ae', 'treatment', 'acute', 'kidney', 'injury', ',', 'hyperglycemia', ',', 'and', 'maculopapular', 'rash', '.', 'one', 'patient', 'came', 'therapy', 'due', 'to', 'ae', '.', 'one', 'patient', '(', 'glioma', ')', 'objective', 'partial', 'response', 'and', 'remained', 'protocol', 'therapy', 'cycle', '.', 'conclusion', 'low', 'accrual', 'rate', 'match', 'subprotocol', ',', 'with', 'of', 'matched', 'with', 'brafv', 'mutation', 'enrolling', ',', 'resulting', 'in', 'early', 'termination', ',', 'and', 'limiting', 'study', 'result', '(', 'clinicaltrials.gov', 'identifier', 'nct', ')', '.']"
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.,"Robin K Avery, Sophie Alain, Barbara D Alexander, Emily A Blumberg, Roy F Chemaly, Catherine Cordonnier, Rafael F Duarte, Diana F Florescu, Nassim Kamar, Deepali Kumar, Johan Maertens, Francisco M Marty, Genovefa A Papanicolaou, Fernanda P Silveira, Oliver Witzke, Jingyang Wu, Aimee K Sundberg, Martha Fournier                              ;, SOLSTICE Trial Investigators, Robin K Averyet al.",2022 Sep 10,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/34864943/,No keywords found,"['therapy', 'refractory', 'cytomegalovirus', 'infection', '(', 'with', 'or', 'without', 'resistance', 'rr', ')', 'in', 'transplant', 'recipient', 'limited', 'toxicity', '.', 'maribavir', 'multimodal', 'anti-cytomegalovirus', 'activity', 'inhibition', 'of', 'ul', 'protein', 'kinase', '.', 'method', 'in', 'phase', ',', 'open-label', 'study', ',', 'hematopoietic-cell', 'and', 'solid-organ', 'transplant', 'recipient', 'with', 'rr', 'cytomegalovirus', 'randomized', 'to', 'maribavir', 'mg', 'twice', 'daily', 'or', 'investigator-assigned', 'therapy', '(', 'iat', 'valganciclovirganciclovir', ',', 'foscarnet', ',', 'or', 'cidofovir', ')', 'week', ',', 'with', 'week', 'of', 'follow-up', '.', 'primary', 'endpoint', 'confirmed', 'cytomegalovirus', 'clearance', 'end', 'of', 'week', '.', 'key', 'secondary', 'endpoint', 'achievement', 'of', 'cytomegalovirus', 'clearance', 'and', 'symptom', 'control', 'end', 'of', 'week', ',', 'maintained', 'week', '.', 'result', 'patient', 'randomized', '(', 'maribavir', 'iat', ')', '.', 'significantly', 'patient', 'in', 'maribavir', 'versus', 'iat', 'group', 'achieved', 'primary', 'endpoint', '(', '.', 'v', '.', 'adjusted', 'difference', 'confidence', 'interval', '(', 'ci', ')', '.', '.-', '.', 'p', '.', ')', 'and', 'key', 'secondary', 'endpoint', '(', '.', 'v', '.', 'adjusted', 'difference', 'ci', '.', '.-', '.', 'p', '.', ')', '.', 'rate', 'of', 'treatment-emergent', 'adverse', 'event', '(', 'teaes', ')', 'similar', 'group', '(', 'maribavir', ',', '.', 'iat', ',', '.', ')', '.', 'maribavir', 'associated', 'with', 'less', 'acute', 'kidney', 'injury', 'versus', 'foscarnet', '(', '.', 'v', '.', ')', 'and', 'neutropenia', 'versus', 'valganciclovirganciclovir', '(', '.', 'v', '.', ')', '.', 'fewer', 'patient', 'discontinued', 'treatment', 'due', 'to', 'teaes', 'with', 'maribavir', '(', '.', ')', 'iat', '(', '.', ')', '.', 'one', 'patient', 'per', 'group', 'fatal', 'treatment-related', 'teaes', '.', 'conclusion', 'maribavir', 'superior', 'to', 'iat', 'cytomegalovirus', 'viremia', 'clearance', 'and', 'viremia', 'clearance', 'plus', 'symptom', 'control', 'maintained', 'post-therapy', 'in', 'transplant', 'recipient', 'with', 'rr', 'cytomegalovirus', '.', 'maribavir', 'fewer', 'treatment', 'discontinuation', 'due', 'to', 'teaes', 'iat', '.', 'clinical', 'trial', 'registration', '.', 'nct', '(', 'solstice', ')', '.']"
"Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.","Jean-Yves Blay, César Serrano, Michael C Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L Jones, Steven Attia, Gina D'Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz-Soto, Suzanne George, Margaret von Mehren, Jean-Yves Blayet al.",2020 Jul,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/32511981/,No keywords found,"['resistance', 'to', 'approved', 'inhibitor', 'of', 'kit', 'proto-oncogene', ',', 'receptor', 'tyrosine', 'kinase', '(', 'kit', ')', ',', 'and', 'platelet-derived', 'growth', 'factor', 'receptor', '(', 'pdgfra', ')', 'clinical', 'challenge', 'patient', 'with', 'advanced', 'gastrointestinal', 'stromal', 'tumour', '.', 'compared', 'efficacy', 'and', 'safety', 'of', 'ripretinib', ',', 'switch-control', 'tyrosine', 'kinase', 'inhibitor', 'active', 'broad', 'spectrum', 'of', 'kit', 'and', 'pdgfra', 'mutation', ',', 'with', 'placebo', 'in', 'patient', 'with', 'previously', 'treated', ',', 'advanced', 'gastrointestinal', 'stromal', 'tumour', '.', 'method', 'in', 'double-blind', ',', 'randomised', ',', 'placebo-controlled', ',', 'phase', 'study', ',', 'enrolled', 'adult', 'patient', 'in', 'specialised', 'hospital', 'in', 'country', '.', 'included', 'patient', 'aged', 'year', 'or', 'older', 'advanced', 'gastrointestinal', 'stromal', 'tumour', 'with', 'progression', 'least', 'imatinib', ',', 'sunitinib', ',', 'and', 'regorafenib', 'or', 'documented', 'intolerance', 'to', 'of', 'treatment', 'despite', 'dose', 'modification', ',', 'and', 'eastern', 'cooperative', 'oncology', 'group', '(', 'ecog', ')', 'performance', 'status', 'of', '-', '.', 'eligible', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'either', 'oral', 'ripretinib', 'mg', 'daily', '(', 'ripretenib', 'group', ')', 'or', 'placebo', 'daily', '(', 'placebo', 'group', ')', '.', 'randomisation', 'done', 'via', 'interactive', 'response', 'system', 'using', 'randomly', 'permuted', 'block', 'size', 'of', 'six', 'and', 'stratified', 'according', 'to', 'number', 'of', 'previous', 'therapy', 'and', 'ecog', 'performance', 'status', '.', 'patient', ',', 'investigator', ',', 'research', 'staff', ',', 'and', 'sponsor', 'study', 'team', 'masked', 'to', 'patient', ""'s"", 'treatment', 'allocation', 'blinded', 'independent', 'central', 'review', '(', 'bicr', ')', 'showed', 'progressive', 'disease', 'patient', '.', 'primary', 'endpoint', 'progression-free', 'survival', ',', 'assessed', 'bicr', '.', 'primary', 'analysis', 'done', 'in', 'intention-to-treat', 'population', 'and', 'safety', 'assessed', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', '.', 'patient', 'randomly', 'assigned', 'to', 'placebo', 'permitted', 'to', 'cross', 'to', 'ripretinib', 'mg', 'time', 'of', 'disease', 'progression', '.', 'invictus', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', ',', 'and', 'with', 'international', 'clinical', 'trial', 'registry', 'platform', ',', 'number', 'euctr', '--', '-es', 'follow-up', 'ongoing', '.', 'finding', 'feb', ',', ',', 'and', 'nov', ',', ',', 'of', 'assessed', 'patient', 'randomly', 'assigned', 'to', 'receive', 'either', 'ripretinib', '(', 'n', ')', 'or', 'placebo', '(', 'n', ')', '.', 'data', 'cutoff', '(', 'may', ',', ')', ',', 'median', 'follow-up', 'of', 'month', '(', 'iqr', '-', ')', 'in', 'ripretinib', 'group', 'and', 'month', '(', '-', ')', 'in', 'placebo', 'group', ',', 'patient', 'in', 'ripretinib', 'group', 'and', 'in', 'placebo', 'group', 'progression-free', 'survival', 'event', '.', 'in', 'double-blind', 'period', ',', 'median', 'progression-free', 'survival', 'month', '(', 'ci', '-', ')', 'with', 'ripretinib', 'compared', 'with', 'month', '(', '-', ')', 'with', 'placebo', '(', 'hazard', 'ratio', ',', 'ci', '-', 'p', ')', 'grade', 'or', 'treatment-related', 'treatment-emergent', 'adverse', 'event', 'in', 'ripretinib', 'group', '(', 'n', ')', 'included', 'lipase', 'increase', '(', 'four', ')', ',', 'hypertension', '(', 'three', ')', ',', 'fatigue', '(', 'two', ')', ',', 'and', 'hypophosphataemia', '(', 'two', '(', ')', 'in', 'placebo', 'group', '(', 'n', ')', ',', 'common', '(', ')', 'grade', 'or', 'treatment-related', 'treatment-emergent', 'adverse', 'event', 'anaemia', '(', 'three', ')', ',', 'fatigue', '(', 'one', ')', ',', 'diarrhoea', '(', 'one', ')', ',', 'decreased', 'appetite', '(', 'one', ')', ',', 'dehydration', '(', 'one', ')', ',', 'hyperkalaemia', '(', 'one', ')', ',', 'acute', 'kidney', 'injury', '(', 'one', ')', ',', 'and', 'pulmonary', 'oedema', '(', 'one', ')', '.', 'treatment-related', 'serious', 'adverse', 'event', 'reported', 'in', 'eight', '(', ')', 'of', 'patient', 'received', 'ripretinib', 'and', 'three', '(', ')', 'of', 'patient', 'received', 'placebo', '.', 'treatment-related', 'death', 'occurred', 'in', 'one', 'patient', 'in', 'placebo', 'group', '(', 'septic', 'shock', 'and', 'pulmonary', 'oedema', ')', 'and', 'one', 'patient', 'in', 'ripretinib', 'group', '(', 'cause', 'of', 'death', 'unknown', 'patient', 'died', 'sleep', ')', '.', 'interpretation', 'ripretinib', 'significantly', 'improved', 'median', 'progression-free', 'survival', 'compared', 'with', 'placebo', 'and', 'acceptable', 'safety', 'profile', 'in', 'patient', 'with', 'advanced', 'gastrointestinal', 'stromal', 'tumour', 'resistant', 'to', 'approved', 'treatment', '.', 'funding', 'deciphera', 'pharmaceutical', '.']"
Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial.,"Alexander Zarbock, Mira Küllmar, Marlies Ostermann, Gianluca Lucchese, Kamran Baig, Armando Cennamo, Ronak Rajani, Stuart McCorkell, Christian Arndt, Hinnerk Wulf, Marc Irqsusi, Fabrizio Monaco, Ambra Licia Di Prima, Mercedes García Alvarez, Stefano Italiano, Jordi Miralles Bagan, Gudrun Kunst, Shrijit Nair, Camilla L'Acqua, Eric Hoste, Wim Vandenberghe, Patrick M Honore, John A Kellum, Lui G Forni, Philippe Grieshaber, Christina Massoth, Raphael Weiss, Joachim Gerss, Carola Wempe, Melanie Meersch, Alexander Zarbocket al.",2021 Aug 1,Anesth Analg,https://pubmed.ncbi.nlm.nih.gov/33684086/,No keywords found,"['prospective', ',', 'single-center', 'trial', 'shown', 'implementation', 'of', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'recommendation', 'in', 'high-risk', 'patient', 'significantly', 'reduced', 'development', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'surgery', '.', 'sought', 'to', 'evaluate', 'feasibility', 'of', 'implementing', 'bundle', 'of', 'supportive', 'measure', 'based', 'kdigo', 'guideline', 'in', 'high-risk', 'patient', 'undergoing', 'cardiac', 'surgery', 'in', 'multicenter', 'setting', 'in', 'preparation', 'large', 'definitive', 'trial', '.', 'method', 'in', 'multicenter', ',', 'multinational', ',', 'randomized', 'controlled', 'trial', ',', 'examined', 'adherence', 'to', 'kdigo', 'bundle', 'consisting', 'of', 'optimization', 'of', 'volume', 'status', 'and', 'hemodynamics', ',', 'functional', 'hemodynamic', 'monitoring', ',', 'avoidance', 'of', 'nephrotoxic', 'drug', ',', 'and', 'prevention', 'of', 'hyperglycemia', 'in', 'high-risk', 'patient', 'identified', 'urinary', 'biomarkers', 'tissue', 'inhibitor', 'of', 'metalloproteinases-', 'timp-', 'and', 'insulin', 'growth', 'factor-binding', 'protein', 'igfbp', 'cardiac', 'surgery', '.', 'primary', 'end', 'point', 'adherence', 'to', 'bundle', 'protocol', 'and', 'evaluated', 'percentage', 'of', 'compliant', 'patient', 'with', 'confidence', 'interval', '(', 'ci', ')', 'according', 'to', 'clopper-pearson', '.', 'secondary', 'end', 'point', 'included', 'development', 'and', 'severity', 'of', 'aki', '.', 'result', 'in', 'total', ',', 'patient', 'included', 'in', 'final', 'analysis', '.', 'in', 'intervention', 'group', ',', '.', 'of', 'patient', 'received', 'complete', 'bundle', 'compared', 'to', '.', 'in', 'control', 'group', '(', 'absolute', 'risk', 'reduction', 'arr', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'aki', 'rate', 'statistically', 'not', 'different', 'in', 'group', '(', '.', 'intervention', 'versus', '.', 'control', 'group', 'arr', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'however', ',', 'occurrence', 'of', 'moderate', 'and', 'severe', 'aki', 'significantly', 'lower', 'in', 'intervention', 'group', 'compared', 'to', 'control', 'group', '(', '.', 'v', '.', 'arr', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'no', 'significant', 'effect', 'specified', 'secondary', 'outcome', '.', 'conclusion', 'implementation', 'of', 'kdigo-derived', 'treatment', 'bundle', 'feasible', 'in', 'multinational', 'setting', '.', 'furthermore', ',', 'moderate', 'to', 'severe', 'aki', 'significantly', 'reduced', 'in', 'intervention', 'group', '.']"
The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study.,"Yong Chen, Ganlin Wu, Meirong Xu, Yong Chenet al.",2018 Jan,Int Urol Nephrol,https://pubmed.ncbi.nlm.nih.gov/29196928/,No keywords found,"['to', 'study', 'oxidative', 'stress', 'status', 'of', 'early', 'type', 'diabetic', 'nephropathy', '(', 'dn', ')', 'patient', 'with', 'subclinical', 'hypothyroidism', '(', 'sch', ')', 'and', 'to', 'assess', 'effect', 'of', 'l-thyroxine', 'therapy', 'oxidative', 'stress', 'in', 'patient', '.', 'method', 'randomized', 'double-blind', 'and', 'placebo-controlled', 'trial', '.', 'total', 'of', 'patient', 'with', 'early', 'type', 'dn', 'included', 'euthyroid', 'group', ',', 'and', 'early', 'type', 'dn', 'with', 'sch', 'selected', 'and', 'randomly', 'assigned', 'to', 'l-thyroxine', 'treatment', 'group', '(', 'lt', 'group', ')', 'and', 'placebo', 'group', '(', 'sch', 'group', ')', '.', 'change', 'in', 'urinary', 'albumin', 'excretion', 'rate', '(', 'uaer', ')', ',', 'serum', 'malondialdehyde', '(', 'mda', ')', ',', 'superoxide', 'dismutase', '(', 'sod', ')', 'activity', ',', 'urine', '-hydroxyl', 'deoxyguanosine', '(', '-ohdg', ')', ',', 'serum', 'creatinine', ',', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'and', 'lipid', 'profile', 'and', 'week', 'of', 'follow-up', 'examined', 'and', 'compared', '.', 'result', 'level', 'of', 'uaer', ',', 'mda', ',', '-ohdg', 'higher', ',', 'sod', 'activity', 'lower', 'in', 'dn', 'patient', 'with', 'sch', 'in', 'dn', 'patient', '(', 'p', '.', ')', '.', 'in', 'lt', 'group', ',', 'level', 'of', 'uaer', ',', 'mda', ',', '-ohdg', 'decreased', 'significantly', '(', 'p', '.', ')', 'to', 'level', 'no', 'longer', 'different', 'euthyroid', 'group', '.', 'sod', 'activity', 'increased', 'significantly', '.', 'in', 'sch', 'group', ',', 'level', 'of', 'malb', ',', 'mda', ',', '-ohdg', 'greater', 'week', 'of', 'follow-up', 'and', 'greater', 'patient', 'in', 'euthyroid', 'group', '.', 'sod', 'activity', 'decreased', 'significantly', 'week', 'in', 'sch', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'oxidative', 'stress', 'greater', 'in', 'dn', 'patient', 'with', 'sch', ',', 'and', 'sch', 'may', 'exacerbate', 'kidney', 'injury', 'in', 'early', 'dn', 'patient', '.', 'lt', 'treatment', 'may', 'decrease', 'oxidative', 'stress', 'and', 'attenuate', 'renal', 'injury', 'in', 'dn', 'patient', 'with', 'sch', '.']"
Randomized Trial of Carnitine for the Prevention of Perioperative Atrial Fibrillation.,"Farzaneh Dastan, Azita Hajhossein Talasaz, Mojtaba Mojtahedzadeh, Abbassali Karimi, Abbas Salehiomran, Payvand Bina, Arash Jalali, Farzaneh Dastanet al.",2018 Spring,Semin Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/28982550/,"L-carnitine, atrial fibrillation, coronary artery bypass grafting.","['atrial', 'fibrillation', '(', 'af', ')', 'one', 'of', 'common', 'complication', 'in', 'patient', 'undergo', 'coronary', 'artery', 'bypass', 'graft', 'surgery', '(', 'cabg', ')', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'effect', 'of', 'l-carnitine', 'administration', 'postoperative', 'af', 'and', 'level', 'of', 'c-reactive', 'protein', '(', 'crp', ')', 'following', 'cabg', '.', 'effect', 'of', 'l-carnitine', 'incidence', 'of', 'acute', 'kidney', 'injury', 'cabg', 'also', 'assessed', '.', 'one', 'hundred', 'thirty-four', 'patient', 'undergoing', 'elective', 'cabg', ',', 'without', 'history', 'of', 'af', 'or', 'previous', 'l-carnitine', 'treatment', ',', 'randomly', 'assigned', 'to', 'l-carnitine', 'group', '(', 'mgd', 'l-carnitine', ')', 'or', 'control', 'group', '.', 'crp', 'level', ',', 'biomarker', 'of', 'inflammation', ',', 'assessed', 'in', 'patient', 'surgery', 'baseline', 'level', 'and', 'hour', 'postoperatively', '.', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'kidney', 'biomarker', ',', 'also', 'measured', 'in', 'patient', 'surgery', 'and', 'hour', 'thereafter', '.', 'incidence', 'of', 'af', '.', 'in', 'population', '.', 'incidence', 'of', 'af', 'decreased', 'in', 'l-carnitine', 'group', '(', '.', 'in', 'l-carnitine', 'group', 'v', '.', 'in', 'control', 'group', 'p', '.', ')', 'and', 'postoperative', 'crp', 'level', '(', '.', '.', 'in', 'l-carnitine', 'group', ',', 'and', '.', '.', 'in', 'control', 'group', 'p', '.', ')', '.', 'postoperative', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'concentration', 'demonstrated', 'no', 'significant', 'rise', 'surgery', 'compared', 'with', 'preoperative', 'concentration', '(', '.', '.', 'in', 'l-carnitine', 'group', 'v', '.', '.', 'in', 'placebo', 'group', 'p', '.', ')', '.', 'study', 'showed', 'l-carnitine', 'administration', 'cabg', 'might', 'inhibit', 'and', 'reduce', 'incidence', 'of', 'af', 'cabg', '.', 'seems', 'rise', 'in', 'crp', 'level', ',', 'inflammation', 'marker', ',', 'may', 'associated', 'with', 'incidence', 'of', 'af', '.', 'inflammation', 'measured', 'crp', 'also', 'reduced', 'in', 'carnitine', 'group', ',', 'compared', 'with', 'control', 'group', '.']"
Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial.,"Marcelo Augusto Duarte Silveira, Matheus de Alencar Menezes, Sergio Pinto de Souza, Erica Batista Dos Santos Galvão, Andresa Aparecida Berretta, Juliana Caldas, Maurício Brito Teixeira, Marcel Miranda Dantas Gomes, Lucas Petri Damiani, Bruno Andrade Bahiense, Julia Barros Cabral, Cicero Wandson Luiz Macedo De Oliveira, Talita Rocha Mascarenhas, Priscila Carvalho Guedes Pinheiro, Milena Souza Alves, Rodrigo Morel Vieira de Melo, Flávia Mendes Leite, Carolina Kymie Vasques Nonaka, Bruno Solano de Freitas Souza, Nathália Ursoli Baptista, Flávio Teles, Suzete Farias da Guarda, Ana Verena Almeida Mendes, Rogério da Hora Passos, Marcelo Augusto Duarte Silveiraet al.",2023 Oct 27,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/37891178/,No keywords found,"['sars-cov-', 'and', 'different', 'variant', 'caused', '``', 'wave', 'and', 'wave', ""''"", 'pandemic', 'pattern', '.', 'first', 'wave', 'demonstrated', 'standardized', 'brazilian', 'green', 'propolis', 'extract', '(', 'epp-af', ')', 'reduces', 'length', 'of', 'hospital', 'stay', 'in', 'adult', 'patient', 'with', 'covid-', '.', 'afterwards', ',', 'decided', 'to', 'evaluate', 'impact', 'of', 'epp-af', 'in', 'hospitalized', 'patient', 'third', 'wave', 'of', 'pandemic', '.', 'beecovid', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'clinical', 'trial', 'in', 'hospitalized', 'covid-', 'adult', 'patient', '.', 'patient', 'allocated', 'to', 'receive', 'oral', 'dose', 'of', 'mgday', 'of', 'epp-af', 'or', 'placebo', 'day', '.', 'primary', 'outcome', 'length', 'of', 'hospital', 'stay', '.', 'secondary', 'outcome', 'included', 'safety', ',', 'secondary', 'infection', 'rate', ',', 'duration', 'of', 'oxygen', 'therapy', 'dependency', ',', 'acute', 'kidney', 'injury', 'and', 'need', 'intensive', 'care', '.', 'patient', 'followed', 'day', 'admission', '.', 'enrolled', 'patient', 'assigned', 'to', 'propolis', 'group', 'and', 'to', 'placebo', 'group', '.', 'post-intervention', 'length', 'of', 'hospital', 'stay', 'of', '.', '.', 'day', 'in', 'propolis', 'group', 'versus', '.', '.', 'day', 'in', 'control', 'group', '(', 'ci', '-', '.', '-', '.', 'to', '.', 'p', '.', ')', '.', 'propolis', 'not', 'significant', 'impact', 'need', 'oxygen', 'supplementation', 'or', 'frequency', 'of', 'aki', '.', 'significant', 'difference', 'in', 'incidence', 'of', 'secondary', 'infection', 'group', ',', 'with', '.', 'in', 'propolis', 'group', 'versus', '.', 'in', 'control', 'group', '(', 'ci', '-', '.', '.-.', ',', 'p', '.', ')', '.', 'use', 'of', 'epp-af', 'considered', 'safe', 'and', 'associated', 'with', 'decrease', 'in', 'secondary', 'infection', '.', 'drug', 'not', 'associated', 'with', 'significant', 'reduction', 'in', 'length', 'of', 'hospital', 'stay', '.', 'clinicaltrials.gov', '(', 'nct', ')', '.']"
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study.,"Avivit Cahn, Ofri Mosenzon, Stephen D Wiviott, Aliza Rozenberg, Ilan Yanuv, Erica L Goodrich, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Ingrid A M Gause-Nilsson, Martin Fredriksson, Peter A Johansson, Anna Maria Langkilde, Marc S Sabatine, Itamar Raz, Avivit Cahnet al.",2020 Feb,Diabetes Care,https://pubmed.ncbi.nlm.nih.gov/31843945/,No keywords found,"['data', 'regarding', 'effect', 'of', 'sodium-glucose', 'cotransporter', 'inhibitor', 'in', 'elderly', '(', 'age', 'year', ')', 'and', 'elderly', '(', 'age', 'year', ')', 'limited', '.', 'research', 'design', 'and', 'method', 'dapagliflozin', 'effect', 'cardiovascular', 'event', '(', 'declare', ')', '-timi', 'assessed', 'cardiac', 'and', 'renal', 'outcome', 'of', 'dapagliflozin', 'versus', 'placebo', 'in', 'patient', 'with', 'type', 'diabetes', '.', 'efficacy', 'and', 'safety', 'outcome', 'studied', 'within', 'age', 'subgroup', 'treatment', 'effect', 'and', 'age-based', 'treatment', 'interaction', '.', 'result', 'of', ',', 'patient', ',', ',', 'year', 'of', 'age', ',', ',', 'to', 'year', ',', 'and', ',', 'year', '.', 'dapagliflozin', 'reduced', 'composite', 'of', 'cardiovascular', 'death', 'or', 'hospitalization', 'heart', 'failure', 'consistently', ',', 'with', 'hazard', 'ratio', '(', 'hr', ')', 'of', '.', '(', 'ci', '.', ',', '.', ')', ',', '.', '(', '.', ',', '.', ')', ',', 'and', '.', '(', '.', ',', '.', ')', 'in', 'age-groups', ',', 'to', ',', 'and', 'year', ',', 'respectively', '(', 'interaction', 'p', 'value', '.', ')', '.', 'overall', ',', 'dapagliflozin', 'not', 'significantly', 'decrease', 'rate', 'of', 'major', 'adverse', 'cardiovascular', 'event', ',', 'with', 'hr', '.', '(', 'ci', '.', ',', '.', ')', ',', '.', '(', '.', ',', '.', ')', ',', 'and', '.', '(', '.', ',', '.', ')', 'in', 'age-groups', ',', 'to', ',', 'and', 'year', ',', 'respectively', '(', 'interaction', 'p', 'value', '.', ')', '.', 'relative', 'risk', 'reduction', 'secondary', 'prespecified', 'cardiorenal', 'composite', 'outcome', 'ranged', 'to', 'in', 'different', 'age-groups', 'with', 'no', 'heterogeneity', '.', 'major', 'hypoglycemia', 'less', 'frequent', 'with', 'dapagliflozin', 'versus', 'placebo', ',', 'with', 'hr', '.', '(', 'ci', '.', ',', '.', ')', ',', '.', '(', '.', ',', '.', ')', ',', 'and', '.', '(', '.', ',', '.', ')', 'in', 'age-groups', ',', 'to', ',', 'and', 'year', ',', 'respectively', '(', 'interaction', 'p', 'value', '.', ')', '.', 'safety', 'outcome', ',', 'including', 'fracture', ',', 'volume', 'depletion', ',', 'cancer', ',', 'urinary', 'tract', 'infection', ',', 'and', 'amputation', 'balanced', 'with', 'dapagliflozin', 'versus', 'placebo', ',', 'and', 'acute', 'kidney', 'injury', 'reduced', ',', 'regardless', 'of', 'age', '.', 'genital', 'infection', 'serious', 'or', 'led', 'to', 'discontinuation', 'of', 'study', 'drug', 'and', 'diabetic', 'ketoacidosis', 'uncommon', ',', 'yet', 'frequent', 'with', 'dapagliflozin', 'versus', 'placebo', ',', 'without', 'heterogeneity', '(', 'interaction', 'p', 'value', '.', 'and', '.', ',', 'respectively', ')', '.', 'conclusion', 'overall', 'efficacy', 'and', 'safety', 'of', 'dapagliflozin', 'consistent', 'regardless', 'of', 'age', '.']"
Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial.,"Zhiyan Zhang, Hiddo J L Heerspink, Glenn M Chertow, Ricardo Correa-Rotter, Antonio Gasparrini, Niels Jongs, Anna Maria Langkilde, John J V McMurray, Malcolm N Mistry, Peter Rossing, Robert D Toto, Priya Vart, Dorothea Nitsch, David C Wheeler, Ben Caplin, Zhiyan Zhanget al.",2024 Apr,Lancet Planet Health,https://pubmed.ncbi.nlm.nih.gov/38580424/,No keywords found,"['higher', 'temperature', 'associated', 'with', 'higher', 'rate', 'of', 'hospital', 'admission', 'nephrolithiasis', 'and', 'acute', 'kidney', 'injury', '.', 'occupational', 'heat', 'stress', 'also', 'risk', 'factor', 'kidney', 'dysfunction', 'in', 'resource-poor', 'setting', '.', 'unclear', 'whether', 'ambient', 'heat', 'exposure', 'associated', 'with', 'loss', 'of', 'kidney', 'function', 'in', 'patient', 'with', 'established', 'chronic', 'kidney', 'disease', '.', 'assessed', 'association', 'heat', 'index', 'and', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'in', 'participant', 'dapa-ckd', 'trial', 'in', 'post-hoc', 'analysis', '.', 'method', 'dapa-ckd', 'randomised', 'controlled', 'trial', 'of', 'oral', 'dapagliflozin', 'mg', 'daily', 'or', 'placebo', 'enrolled', 'participant', 'aged', 'year', 'or', 'older', ',', 'with', 'or', 'without', 'type', 'diabetes', ',', 'with', 'urinary', 'albumin-to-creatinine', 'ratio', 'of', '-', 'mgg', ',', 'and', 'egfr', 'of', '-', 'mlmin', 'per', 'm.', 'in', 'post-hoc', 'analysis', ',', 'explored', 'association', 'time-varying', 'daily', 'centre-level', 'heat', 'index', '(', 'era', 'dataset', ')', 'and', 'individual-level', 'change', 'in', 'egfr', 'in', 'trial', 'participant', 'using', 'linear', 'mixed', 'effect', 'model', 'and', 'case-time', 'series', '.', 'dapa-ckd', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'climate', 'and', 'egfr', 'data', 'available', '(', ')', 'of', 'participant', 'in', 'country', '(', 'mean', 'age', 'year', 'mean', 'egfr', 'ml', 'per', 'median', 'month', 'follow-up', ')', '.', 'across', 'centre', ',', 'heat', 'index', 'of', 'c', 'occurred', 'median', 'of', 'of', 'day', '.', 'in', 'adjusted', 'linear', 'mixed', 'effect', 'model', ',', 'within', '-day', 'window', ',', 'day', ""'"", 'heat', 'index', 'of', 'c', 'associated', 'with', '-', '(', 'ci', '-', 'to', '-', ')', 'change', 'in', 'egfr', '.', 'similar', 'estimate', 'obtained', 'using', 'case-time', 'series', '.', 'additional', 'analysis', 'longer', 'time-windows', 'showed', 'association', 'consistent', 'with', 'haemodynamic', 'or', 'seasonal', 'variability', ',', 'or', ',', 'overall', 'estimate', 'corresponded', 'to', 'additional', 'ml', 'per', '(', 'ci', 'to', ')', 'loss', 'of', 'egfr', 'per', 'year', 'in', 'patient', 'with', 'egfr', 'of', 'ml', 'per', 'located', 'in', 'hot', 'versus', 'temperate', 'environment', '.', 'interpretation', 'higher', 'ambient', 'heat', 'exposure', 'associated', 'with', 'rapid', 'egfr', 'decline', 'in', 'with', 'established', 'chronic', 'kidney', 'disease', '.', 'effort', 'to', 'mitigate', 'heat', 'exposure', 'tested', 'part', 'of', 'strategy', 'to', 'attenuate', 'chronic', 'kidney', 'disease', 'progression', '.', 'funding', 'none', '.']"
"Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study.","Adrian Vlad, Mihaela Vlad, Ligia Petrica, Sorin Ursoniu, Florica Gadalean, Roxana Popescu, Daliborca Vlad, Victor Dumitrascu, Gheorghe Gluhovschi, Cristina Gluhovschi, Silvia Velciov, Flaviu Bob, Petru Matusz, Alina Secara, Anca Simulescu, Dragos Catalin Jianu, Adrian Vladet al.",2017 Nov,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/27841047/,No keywords found,"['diabetic', 'nephropathy', 'severe', 'complication', 'of', 'type', 'diabetes', '.', 'tubular', 'lesion', 'may', 'play', 'important', 'role', 'in', 'early', 'stage', '.', 'aim', 'of', 'study', 'to', 'determine', 'atorvastatin', 'protects', 'podocytes', 'and', 'proximal', 'tubule', 'in', 'patient', 'with', 'type', 'diabetes', '.', 'method', 'total', 'of', 'patient', 'with', 'type', 'diabetes', 'completed', '-months', 'prospective', 'pilot', 'study', '.', 'randomized', 'to', 'continue', 'rosuvastatin', 'therapy', '(', 'control', 'group', ')', 'or', 'to', 'administered', 'equipotent', 'dose', 'of', 'atorvastatin', '(', 'intervention', 'group', ')', ',', 'and', 'assessed', 'regarding', 'urinary', 'podocytes', ',', 'podocyte-associated', 'molecule', ',', 'and', 'biomarkers', 'of', 'proximal', 'tubule', 'dysfunction', '.', 'result', 'patient', 'intervention', 'group', 'presented', 'significant', 'reduction', 'in', 'podocyturia', '(', '.', 'to', '.', 'cellsml', ',', 'p', '.', ')', ',', 'urinary', 'nephrin', '(', '.', 'to', '.', 'mgg', ',', 'p', '.', ')', ',', 'urinary', 'vascular', 'endothelial', 'growth', 'factor', '(', '.', 'to', '.', ',', 'p', '.', ')', ',', 'urinary', 'alpha-microglobulin', '(', '.', 'to', '.', 'mgg', ',', 'p', '.', ')', ',', 'urinary', 'kidney', 'injury', 'molecule-', '(', '.', 'to', '.', 'ngg', ',', 'p', '.', ')', ',', 'and', 'urinary', 'advanced', 'glycation', 'end-products', '(', '.', 'to', '.', 'pgml', ',', 'p', '.', ')', '.', 'podocyturia', 'correlated', 'directly', 'with', 'podocyte', 'damage', 'biomarkers', ',', 'proximal', 'tubule', 'dysfunction', 'biomarkers', ',', 'albumin', 'to', 'creatinine', 'ratio', ',', 'and', 'advanced', 'glycation', 'end-products', ',', 'and', 'inversely', 'with', 'glomerular', 'filtration', 'rate', '.', 'conclusion', 'in', 'patient', 'with', 'type', 'diabetes', ',', 'atorvastatin', 'exerts', 'favorable', 'effect', 'kidney', '.', 'correlation', 'evolution', 'of', 'podocytes', 'and', 'of', 'proximal', 'tubule', 'biomarkers', ',', 'supporting', 'hypothesis', 'glomerular', 'change', 'parallel', 'proximal', 'tubule', 'dysfunction', 'in', 'early', 'stage', 'of', 'diabetic', 'nephropathy', '.']"
A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients.,"Thaninee Prasoppokakorn, Jakapat Vanichanan, Roongruedee Chaiteerakij, Kamonwan Jutivorakool, Suwasin Udomkarnjananun, Krit Pongpirul, Wipusit Taesombat, Salin Wattanatorn, Yingyos Avihingsanon, Kriang Tungsanga, Somchai Eiam-Ong, Kearkiat Praditpornsilpa, Natavudh Townamchai, Thaninee Prasoppokakornet al.",2021 Jan 8,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/33420114/,No keywords found,"['allocation', 'ratio', 'conducted', 'august', 'to', 'december', '.', 'study', 'compared', 'seroconversion', 'rate', 'receiving', '-', 'or', '-dose', 'regimen', 'of', 'hepatitis', 'vaccine', ',', 'and', ',', ',', 'month', ',', 'respectively', ',', 'in', 'non-immune', 'kidney', 'transplant', 'recipient', '.', 'total', 'of', 'adult', 'kidney', 'transplant', 'recipient', 'screened', 'anti-hav', 'igg', 'and', 'subject', 'positive', 'result', 'seroprevalence', '..', 'of', 'seronegative', 'recipient', ',', '(', '.', ')', 'completed', 'vaccination', 'and', 'participant', 'completed', '-', 'and', '-dose', 'vaccination', ',', 'respectively', '.', 'baseline', 'characteristic', 'comparable', 'group', '.', 'seroconversion', 'rate', 'month', 'vaccination', '.', 'in', 'standard', '-dose', 'regimen', 'and', '.', 'in', '-dose', 'regimen', '(', 'p', '.', ')', '.', 'overall', ',', 'seroconversion', 'rate', 'appeared', 'to', 'associated', 'with', 'high', 'estimated', 'glomerular', 'infiltration', 'rate', ',', 'high', 'serum', 'albumin', ',', 'and', 'low', 'intensity', 'immunosuppressive', 'regimen', '.', 'seroconversion', 'rate', 'hepatitis', 'vaccination', 'in', 'kidney', 'transplant', 'recipient', 'less', 'favorable', 'healthy', 'population', '.', 'three-dose', 'regimen', 'not', 'show', 'superior', 'benefit', 'standard', '-dose', 'regimen', '.', 'strategy', 'of', 'immunization', 'may', 'increase', 'immunogenicity', 'among', 'kidney', 'transplant', 'recipient', '.']"
"Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial.","Gary Middleton, Kristian Brock, Joshua Savage, Rhys Mant, Yvonne Summers, John Connibear, Riyaz Shah, Christian Ottensmeier, Paul Shaw, Siow-Ming Lee, Sanjay Popat, Colin Barrie, Gloria Barone, Lucinda Billingham, Gary Middletonet al.",2020 Sep,Lancet Respir Med,https://pubmed.ncbi.nlm.nih.gov/32199466/,No keywords found,"['therapeutic', 'blockade', 'of', 'axis', 'of', 'programmed', 'cell', 'death', '(', 'pd-', ')', 'and', 'ligand', '(', 'pd-l', ')', 'transformed', 'management', 'of', 'non-small-cell', 'lung', 'cancer', '(', 'nsclc', ')', '.', 'clinical', 'trial', 'with', 'pembrolizumab', 'enrolled', 'patient', 'with', 'performance', 'status', '(', 'p', ')', '-', '.', 'however', ',', 'around', 'of', 'patient', 'with', 'nsclc', 'p', ',', 'and', 'activity', 'and', 'safety', 'of', 'pembrolizumab', 'in', 'patient', 'unclear', '.', 'aimed', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'pembrolizumab', 'in', 'patient', '.', 'method', 'multicentre', ',', 'single-arm', ',', 'open-label', ',', 'phase', 'trial', '(', 'pep', ')', 'in', 'ten', 'hospital', 'in', 'uk', ',', 'in', 'patient', 'with', 'nsclc', 'and', 'rigorous', 'ascription', 'of', 'p', 'given', 'pembrolizumab', 'mg', 'every', 'week', '.', 'no', 'masking', 'used', 'in', 'trial', '.', 'stratified', 'treatment', 'evaluation', 'tumour', 'proportion', 'score', '(', 'tps', ')', 'and', 'line', 'of', 'therapy', '.', 'co-primary', 'outcome', '(', ')', 'durable', 'clinical', 'benefit', '(', 'dcb', ')', ',', 'defined', 'occurrence', 'of', 'complete', 'response', ',', 'partial', 'response', ',', 'or', 'stable', 'disease', 'continues', 'least', 'second', 'ct', 'scan', 'scheduled', 'week', 'and', '(', ')', 'toxicity', ',', 'defined', 'occurrence', 'time', 'of', 'treatment-related', 'dose', 'delay', 'or', 'treatment', 'discontinuation', 'due', 'to', 'adverse', 'event', '.', 'analysis', 'included', 'patient', 'received', 'pembrolizumab', '.', 'well', 'reporting', 'simple', 'observed', 'incidence', 'co-primary', 'outcome', ',', 'dcb', 'and', 'toxicity', ',', 'also', 'estimated', 'incidence', 'using', 'model-based', 'method', 'correlated', 'binary', 'outcome', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', 'eudract', ',', '--', 'and', 'isrctn', ',', '.', 'finding', 'jan', ',', ',', 'and', 'feb', ',', ',', 'of', 'patient', 'assessed', 'eligibility', ',', 'recruited', 'patient', '.', 'patient', 'evaluable', 'co-primary', 'outcome', '.', 'median', 'age', 'year', '(', 'iqr', '-', ')', '(', ')', 'of', 'participant', 'male', 'and', '(', ')', 'female', '.', 'observed', 'incidence', 'dcb', '(', 'ci', '-', ')', 'in', 'first-line', 'patient', '(', 'n', ')', 'and', '(', '-', ')', 'in', 'subsequent-line', 'patient', '(', 'n', ')', 'dcb', '(', '-', ')', 'in', 'patient', 'with', 'tps', 'less', '(', 'n', ')', ',', '(', '-', ')', 'in', 'patient', 'with', 'tps', 'of', '-', '(', 'n', ')', ',', 'and', '(', '-', ')', 'in', 'patient', 'with', 'tps', 'of', 'or', 'greater', '(', 'n', ')', '.', 'increase', 'in', 'dcb', 'incidence', 'with', 'tps', 'also', 'shown', 'in', 'model-based', 'estimate', '.', 'toxicity', 'observed', 'in', '(', 'ci', '-', ')', 'of', 'patient', ',', '(', ')', 'of', 'due', 'to', 'dose', 'delay', 'and', '(', ')', 'of', 'due', 'to', 'drug', 'discontinuation', '.', 'no', 'grade', 'treatment-related', 'adverse', 'event', 'observed', 'and', 'no', 'early', 'death', 'attributed', 'to', 'hyperprogression', '.', 'common', 'grade', '-', 'adverse', 'event', 'dyspnoea', '(', 'n', ')', ',', 'hyponatraemia', '(', 'n', ')', ',', 'and', 'anorexia', '(', 'n', ')', '.', 'ten', 'serious', 'adverse', 'event', 'considered', 'to', 'related', 'to', 'treatment', ',', 'comprising', 'diarrhoea', '(', 'n', ')', 'and', 'acute', 'kidney', 'injury', ',', 'adrenal', 'insufficiency', ',', 'hyperbilirubinaemia', ',', 'oral', 'mucositis', ',', 'rash', ',', 'urinary', 'tract', 'infection', ',', 'and', 'vomiting', '(', 'n', ')', '.', 'interpretation', 'patient', 'with', 'nsclc', 'of', 'p', 'group', 'of', 'patient', 'of', 'unmet', 'therapeutic', 'need', '.', 'pep', 'trial', 'show', 'pembrolizumab', 'safely', 'administered', 'to', 'patient', ',', 'with', 'no', 'increase', 'in', 'risk', 'of', 'immune-related', 'or', 'toxicity', '.', 'efficacy', 'outcome', 'least', 'good', 'in', 'patient', 'with', 'ps-', 'and', 'data', 'provides', 'clinician', 'with', 'confidence', 'to', 'incorporate', 'pembrolizumab', 'treatment', 'pathway', 'of', 'patient', 'with', 'nsclc', 'of', 'p', '.', 'funding', 'merck', ',', 'sharp', 'dohme', '.']"
Predicting acute kidney injury at hospital re-entry using high-dimensional electronic health record data.,"Samuel J Weisenthal, Caroline Quill, Samir Farooq, Henry Kautz, Martin S Zand, Samuel J Weisenthalet al.",2018 Nov 20,PLoS One,https://pubmed.ncbi.nlm.nih.gov/30458044/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'sudden', 'decline', 'in', 'kidney', 'function', ',', 'associated', 'with', 'increased', 'mortality', ',', 'morbidity', ',', 'length', 'of', 'stay', ',', 'and', 'hospital', 'cost', '.', 'since', 'aki', 'sometimes', 'preventable', ',', 'great', 'interest', 'in', 'prediction', '.', 'existing', 'study', 'consider', 'patient', 'and', 'therefore', 'restrict', 'to', 'feature', 'available', 'in', 'first', 'hour', 'of', 'hospitalization', '.', ',', 'focus', 'instead', 'rehospitalized', 'patient', ',', 'cohort', 'in', 'rich', 'longitudinal', 'feature', 'prior', 'hospitalization', 'analyzed', '.', 'objective', 'to', 'provide', 'risk', 'score', 'directly', 'hospital', 're-entry', '.', 'gradient', 'boosting', ',', 'penalized', 'logistic', 'regression', '(', 'with', 'and', 'without', 'stability', 'selection', ')', ',', 'and', 'recurrent', 'neural', 'network', 'trained', 'two', 'year', 'of', 'adult', 'inpatient', 'ehr', 'data', '(', ',', 'attribute', ',', 'patient', 'generated', ',', 'training', 'sample', 'with', ',', 'case', 'and', ',', 'control', ')', '.', 'prediction', 'internally', 'evaluated', 'with', 'iteration', 'of', '-fold', 'grouped', 'cross-validation', 'with', 'special', 'emphasis', 'calibration', ',', 'analysis', 'of', 'performed', 'patient', 'well', 'hospitalization', 'level', '.', 'error', 'assessed', 'with', 'respect', 'to', 'diagnosis', ',', 'race', ',', 'age', ',', 'gender', ',', 'aki', 'identification', 'method', ',', 'and', 'hospital', 'utilization', '.', 'in', 'additional', 'experiment', ',', 'regularization', 'penalty', 'severely', 'increased', 'to', 'induce', 'parsimony', 'and', 'interpretability', '.', 'predictor', 'identified', 'rehospitalized', 'patient', 'also', 'reported', 'with', 'special', 'analysis', 'of', 'medication', 'might', 'modifiable', 'risk', 'factor', '.', 'insight', 'study', 'might', 'used', 'to', 'construct', 'predictive', 'tool', 'aki', 'in', 'rehospitalized', 'patient', '.', 'accurate', 'estimate', 'of', 'aki', 'risk', 'hospital', 'entry', 'might', 'serve', 'prior', 'admitting', 'provider', 'or', 'another', 'predictive', 'algorithm', '.']"
Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes.,"Elamin Abdelgadir, Fauzia Rashid, Alaaeldin Bashier, Maryam Al Saeed, Azza Khalifa, Fatheya Alawadi, Mohamed Hassanein, Elamin Abdelgadiret al.",2019 Sep-Oct,Diabetes Metab Syndr,https://pubmed.ncbi.nlm.nih.gov/31425958/,No keywords found,"['risk', 'of', 'hypoglycemia', ',', 'dehydration', 'and', 'kidney', 'injury', 'may', 'theoretically', 'aggravated', 'people', 'with', 'type', 'diabetes', 'treated', 'with', 'insulin', 'and', 'sglt', 'inhibitor', 'ramadan', '.', 'data', 'safety', 'and', 'efficacy', 'of', 'sglt-i', 'in', 'people', 'with', 'type', 'diabetes', 'treated', 'with', 'insulin', 'scanty', '.', 'aimed', 'to', 'assess', 'impact', 'of', 'sglt', 'inhibitor', 'ramadan', 'in', 'high-risk', 'patient', 'with', 'type', 'diabetes', 'treated', 'with', 'insulin', ',', 'hypoglycemia', ',', 'glycemic', 'control', 'and', 'kidney', 'function', '.', 'method', 'prospective', 'interventional', 'study', 'high-risk', 'diabetes', 'patient', 'insisted', 'fasting', '.', 'patient', 'treated', 'with', 'insulin', 'sglti', '.', 'patient', 'received', 'fgms', 'and', 'ramadan', 'focused', 'education', '.', 'patient', 'attended', 'clinic', 'and', 'post', 'ramadan', 'advised', 'treatment', 'modification', 'well', 'biometric', 'and', 'biochemical', 'measurement', '.', 'result', 'patient', 'enrolled', 'in', 'study', 'and', 'of', 'sglti', '.', 'no', 'significant', 'change', 'in', 'creatinine', 'in', 'group', '.', 'fgms', 'showed', 'improvement', 'in', 'sensor-calculated', 'hbac', '.', '.', 'to', '.', '.', 'and', '.', 'to', '.', '.', 'in', 'sglt', 'group', 'and', 'non-sgti', 'group', ',', 'respectively', '.', 'hypoglycemia', 'predominantly', 'reported', 'ramadan', 'to', 'h', ',', 'in', 'pre-ramadan', 'reading', '-', 'and', '-', 'slot', '.', 'conclusion', 'first', 'study', 'assesses', 'use', 'of', 'sglti', 'along', 'with', 'insulin', 'ramadan', ',', 'using', 'fgms', 'in', 'high-risk', 'patient', 'with', 'type', 'diabetes', 'optimal', 'care', '.', 'minimal', 'interruption', 'of', 'fasting', ',', 'significant', 'improvement', 'in', 'glycemic', 'control', ',', 'and', 'no', 'significant', 'change', 'in', 'kidney', 'function', 'ramadan', '.']"
Tranexamic acid is not inferior to placebo with respect to adverse events in suspected traumatic brain injury patients not in shock with a normal head computed tomography scan: A retrospective study of a randomized trial.,"Jordan W Harmer, Elizabeth N Dewey, Eric N Meier, Susan E Rowell, Martin A Schreiber, Jordan W Harmeret al.",2022 Jul 1,J Trauma Acute Care Surg,https://pubmed.ncbi.nlm.nih.gov/35358154/,No keywords found,"['-g', 'bolus', 'of', 'tranexamic', 'acid', '(', 'txa', ')', 'shown', 'to', 'reduce', '-day', 'mortality', 'in', 'randomized', 'controlled', 'trial', '.', 'study', 'investigates', 'whether', 'out-of-hospital', 'txa', 'use', 'associated', 'with', 'adverse', 'event', 'or', 'unfavorable', 'outcome', 'in', 'suspected', 'traumatic', 'brain', 'injury', '(', 'tbi', ')', 'intracranial', 'hemorrhage', '(', 'ich', ')', 'absent', 'initial', 'computed', 'tomography', '.', 'method', 'study', 'used', 'data', 'to', ',', 'multicenter', ',', 'randomized', 'trial', 'studying', 'effect', 'of', 'following', 'txa', 'dos', 'moderate', 'to', 'severe', 'tbi', '-g', 'bolus', ',', '-g', 'bolus', 'plus', '-g', 'infusion', 'hour', ',', 'and', 'placebo', 'bolus', 'with', 'placebo', 'infusion', '.', 'of', 'participant', 'enrolled', ',', 'with', 'initial', 'computed', 'tomography', 'negative', 'ich', 'included', 'in', 'analysis', '.', 'fifteen', 'adverse', 'event', '(', '-day', 'incidence', ')', 'studied', 'myocardial', 'infarction', ',', 'deep', 'vein', 'thrombosis', ',', 'seizure', ',', 'pulmonary', 'embolism', ',', 'acute', 'respiratory', 'distress', 'syndrome', ',', 'cardiac', 'failure', ',', 'liver', 'failure', ',', 'renal', 'failure', ',', 'cerebrovascular', 'accident', ',', 'cardiac', 'arrest', ',', 'cerebral', 'vasospasm', ',', '``', 'thromboembolism', ',', ""''"", 'hypernatremia', ',', 'acute', 'kidney', 'injury', ',', 'and', 'infection', '.', 'unfavorable', 'outcome', 'analyzed', 'include', 'mortality', 'day', 'and', 'month', ',', 'glasgow', 'outcome', 'scale-extended', 'score', 'of', 'discharge', 'and', 'month', ',', 'intensive', 'care', 'unit-free', 'day', ',', 'ventilator-free', 'day', ',', 'hospital-free', 'day', ',', 'and', 'combined', 'unfavorable', 'outcome', '.', 'in', 'study', 'drug', 'group', ',', 'incidence', 'of', 'dichotomous', 'outcome', 'and', 'quantity', 'of', 'ordinal', 'outcome', 'compared', 'with', 'placebo', '.', 'result', 'no', 'statistically', 'significant', 'increase', 'in', 'adverse', 'event', 'or', 'unfavorable', 'outcome', 'found', 'either', 'txa', 'dosing', 'regimen', 'and', 'placebo', '.', 'demographic', 'and', 'injury', 'score', 'not', 'statistically', 'different', 'two', 'method', 'of', 'injury', ',', 'overrepresented', 'in', '-g', 'txa', 'bolus', 'plus', '-g', 'txa', 'infusion', '.', 'conclusion', 'administration', 'of', 'either', '-g', 'txa', 'bolus', 'or', '-g', 'txa', 'bolus', 'plus', '-g', 'txa', '-hour', 'infusion', 'in', 'suspected', 'tbis', 'without', 'ich', 'not', 'associated', 'with', 'increased', 'adverse', 'event', 'or', 'unfavorable', 'outcome', '.', 'out-of-hospital', '-g', 'bolus', 'associated', 'with', 'mortality', 'benefit', ',', 'administered', 'in', 'suspected', 'tbi', '.', 'level', 'of', 'evidence', 'therapeuticcare', 'management', 'level', 'ii', '.']"
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial.,"Kanwal P Raghav, Bettzy Stephen, Daniel D Karp, Sarina A Piha-Paul, David S Hong, Dipti Jain, Dilichukwu O Chudy Onwugaje, Abdulrahman Abonofal, Anneleis F Willett, Michael Overman, Brandon Smaglo, Ryan W Huey, Funda Meric-Bernstam, Gauri R Varadhachary, Aung Naing, Kanwal P Raghavet al.",2022 May,J Immunother Cancer,https://pubmed.ncbi.nlm.nih.gov/35618285/,No keywords found,"['cancer', 'of', 'unknown', 'primary', '(', 'cup', ')', 'aggressive', 'rare', 'malignancy', 'with', 'limited', 'treatment', 'option', '.', 'data', 'regarding', 'clinical', 'activity', 'of', 'immune', 'checkpoint', 'inhibitor', 'in', 'cup', 'lacking', '.', 'therefore', ',', 'evaluated', 'efficacy', 'of', 'pembrolizumab', ',', 'programmed', 'cell', 'death-', 'inhibitor', ',', 'in', 'patient', 'with', 'cup', '.', 'method', 'study', 'designed', 'phase', 'basket', 'trial', 'independent', 'rare', 'tumor', 'cohort', 'including', 'cup', '.', 'adult', 'patient', 'with', 'cup', 'progressed', 'previous', 'systemic', 'therapy', ',', 'performance', 'status', 'and', 'measurable', 'disease', 'per', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumor', '(', 'recist', 'v', '..', ')', 'eligible', '.', 'patient', 'received', 'pembrolizumab', '(', 'mg', ')', 'intravenously', 'every', 'day', '.', 'twenty-nine', 'patient', 'enrolled', 'and', 'treated', 'august', 'and', 'june', '.', 'primary', 'endpoint', 'non-progression', 'rate', '(', 'npr', ')', 'week', '(', 'npr-', ')', 'per', 'immune-related', 'recist', '.', 'key', 'prespecified', 'secondary', 'endpoint', 'confirmed', 'objective', 'response', 'rate', '(', 'orr', ')', ',', 'safety', ',', 'duration', 'of', 'response', '(', 'dor', ')', ',', 'progression-free', 'survival', '(', 'pfs', ')', 'and', 'overall', 'survival', '(', 'o', ')', '.', 'pretreatment', 'biopsy', 'examined', 'biomarkers', 'of', 'response', '(', 'programmed', 'cell', 'death', 'ligand-', '(', 'pd-l', ')', 'expression', 'and', 'tumor', 'infiltrating', 'lymphocyte', '(', 'tils', ')', ')', '.', 'result', 'among', '(', 'of', 'enrolled', ')', 'eligible', 'and', 'evaluable', 'patient', ',', '(', ')', 'poorly', 'differentiated', 'carcinoma', '.', 'patient', 'received', 'median', 'of', 'two', 'line', 'of', 'therapy', 'prior', 'to', 'enrollment', '.', 'median', 'follow-up', '.', 'month', '.', 'npr-', 'observed', 'in', 'seven', 'patient', '(', '.', '(', 'ci', '.', 'to', '.', ')', ')', '.', 'orr', '.', '(', 'ci', '.', 'to', '.', ')', 'with', 'five', 'patient', 'achieving', 'immune-related', 'partial', 'response', 'with', 'median', 'dor', 'of', '.', 'month', '(', 'ci', '.', 'to', '.', ')', '.', 'median', 'pfs', 'and', 'o', '.', '(', 'ci', '.', 'to', '.', ')', 'and', '.', '(', 'ci', '.', 'to', '.', ')', 'month', ',', 'respectively', '.', 'treatment-related', 'adverse', 'event', 'of', 'and', 'grade', 'seen', 'in', '(', ')', 'and', '(', ')', 'patient', ',', 'respectively', '.', 'one', '(', ')', 'patient', 'grade', 'immune-related', 'acute', 'kidney', 'injury', 'requiring', 'treatment', 'discontinuation', '.', 'neither', 'pd-l', 'tils', 'associated', 'with', 'npr-', '.', 'positive', 'pd-l', 'staining', '(', '.', 'v', '.', 'p.', ')', 'and', 'intense', 'til', 'infiltration', '(', '.', 'v', '.', 'p.', ')', 'associated', 'with', 'response', '.', 'conclusion', 'pembrolizumab', 'showed', 'encouraging', 'efficacy', 'in', 'patient', 'with', 'cup', 'with', 'acceptable', 'safety', 'profile', '.', 'trial', 'registration', 'number', 'nct', '.']"
Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients.,"Stefanie W Benoit, Stuart L Goldstein, Devesh S Dahale, David B Haslam, Adam Nelson, Kori Truono, Stella M Davies, Stefanie W Benoitet al.",2019 Aug,Biol Blood Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/31048085/,"Acute kidney injury, Hematopoietic stem cell transplantation, Nephrotoxin, Pediatric, Quality improvement.","['exposure', 'to', 'nephrotoxic', 'medication', 'common', 'risk', 'factor', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'pediatric', 'stem', 'cell', 'transplantation', '(', 'sct', ')', '.', 'hypothesized', 'reducing', 'nephrotoxic', 'antimicrobial', 'exposure', 'sct', 'patient', 'would', 'associated', 'with', 'lower', 'nephrotoxin-associated', 'aki', '(', 'ntmx-aki', ')', 'rate', 'and', 'no', 'increase', 'in', 'infection', 'treatment', 'failure', '.', 'conducted', 'prospective', 'cohort', 'analysis', 'of', 'inpatient', 'sct', 'patient', 'cincinnati', 'child', ""'s"", 'hospital', 'medical', 'center', 'january', 'and', 'december', '.', 'in', 'january', ',', 'first', 'line', 'fever', 'coverage', 'changed', 'piperacillin-tazobactam', 'to', 'cefepime', ',', 'acknowledging', 'change', 'resulted', 'in', 'loss', 'of', 'enterococcal', 'coverage', ',', 'and', 'duration', 'of', 'antimicrobial', 'exposure', 'limited', ',', 'specifically', 'including', 'vancomycin', '.', 'collected', 'data', 'using', 'prospective', 'ntmx-aki', 'and', 'antimicrobial', 'utilization', 'monitoring', 'platform', 'within', 'electronic', 'health', 'record', '.', 'aki', 'day', 'and', 'severity', 'extracted', 'patient', 'exposed', 'to', 'nephrotoxin', ',', 'day', 'of', 'iv', 'aminoglycosides', ',', 'or', 'day', 'of', 'iv', 'vancomycin', '.', 'aki', 'identified', 'using', 'kdigo', 'serum', 'creatinine', 'criterion', '.', 'assessed', 'rate', 'of', 'nephrotoxin', 'exposure', 'and', 'ntmx-aki', 'in', 'sct', 'inpatient', 'year', 'pre-', 'and', 'post-intervention', '.', 'data', 'grouped', 'and', 'analyzed', 'calendar', 'month', ',', 'normalized', 'to', 'denominator', 'of', 'patient-days', '.', 'statistical', 'process', 'control', 'method', 'used', 'to', 'monitor', 'adherence', 'to', 'intervention', 'and', 'identify', 'change', 'in', 'mean', 'rate', 'of', 'nephrotoxin', 'exposure', 'and', 'ntmx-aki', '.', 'infection', 'rate', ',', 'alternate', 'antimicrobial', 'usage', 'rate', ',', 'and', 'fraction', 'of', 'repeat', 'positive', 'culture', 'used', 'to', 'identify', 'treatment', 'failure', '.', 'ptz', 'usage', 'decreased', 'to', 'day', 'patient', 'day', ',', 'cefepime', 'usage', 'increased', 'to', 'day', 'patient', 'day', ',', 'and', 'vancomycin', 'usage', 'decreased', 'to', 'day', 'patient', 'day', '.', 'high', 'nephrotoxin', 'exposure', 'decreased', '(', 'to', 'day', 'patient', 'day', ')', ',', 'and', 'ntmx-aki', 'decreased', '(', 'to', 'day', 'patient', 'day', ')', '.', 'rate', 'of', 'kdigo', 'stage', 'of', 'ntmx-aki', 'decreased', 'intervention', '.', 'stage', ',', 'severe', ',', 'decreased', '.', 'fraction', 'of', 'repeat', 'positive', 'culture', 'remained', 'stable', 'two', 'era', '.', '(', 'standard', 'deviation', '.', ')', 'and', '.', '(', 'standard', 'deviation', '.', ')', ',', 'respectively', '.', 'no', 'increase', 'in', 'infection', 'rate', ',', 'alternate', 'antimicrobial', 'usage', 'rate', ',', 'or', 'treatment', 'failure', '.', 'reduction', 'of', 'nephrotoxic', 'antimicrobial', 'exposure', 'decrease', 'amount', 'and', 'severity', 'of', 'ntmx-aki', 'in', 'sct', 'patient', 'without', 'increase', 'in', 'treatment', 'failure', '.']"
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.,"Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios A Dimopoulos, Evangelos Terposet al.",2024 Mar,Am J Hematol,https://pubmed.ncbi.nlm.nih.gov/38298023/,No keywords found,"['use', 'of', 'lenalidomide', 'in', 'frontline', 'therapy', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', '(', 'mm', ')', 'increased', 'number', 'of', 'become', 'refractory', 'to', 'lenalidomide', 'second', 'line', '.', 'in', 'context', ',', 'assessed', 'efficacy', 'of', 'daratumumab', 'in', 'combination', 'with', 'ixazomib', 'and', 'dexamethasone', '(', 'dara-ixa-dex', ')', 'in', 'prospective', 'phase', 'study', 'daria', '.', 'eligible', 'patient', 'relapsedrefractory', 'mm', '(', 'rrmm', ')', 'one', 'prior', 'line', 'with', 'lenalidomide-based', 'regimen', '.', 'primary', 'endpoint', 'overall', 'response', 'rate', '(', 'orr', ')', '.', 'secondary', 'endpoint', 'included', 'survival', 'outcome', ',', 'safety', 'and', 'change', 'in', 'biomarkers', 'of', 'bone', 'metabolism', '.', 'overall', ',', 'patient', 'enrolled', '(', 'median', 'age', 'year', ',', 'male', ')', '.', '(', ')', 'patient', 'refractory', 'to', 'lenalidomide', ',', 'and', '(', ')', 'undergone', 'autologous', 'transplant', '.', 'orr', '(', 'n', ')', 'whereas', '(', ')', 'good', 'partial', 'response', 'or', 'better', '.', 'median', 'time', 'to', 'first', 'response', '.', 'month', '.', 'median', 'follow-up', 'of', '.', 'month', ',', 'median', 'pfs', 'and', 'o', '.', 'and', '.', 'month', ',', 'respectively', '.', 'furthermore', ',', 'significant', 'change', 'in', 'marker', 'of', 'bone', 'metabolism', 'became', 'evident', 'early', 'month', 'treatment', '.', 'regarding', 'safety', ',', '(', ')', 'patient', 'grade', 'adverse', 'event', '(', 'ae', ')', 'common', 'thrombocytopenia', '(', 'n', ',', ')', '.', '(', ')', 'patient', 'serious', 'ae', '(', 'sae', ')', ',', 'common', 'acute', 'kidney', 'injury', 'and', 'pneumonia', '(', 'n', ',', ')', '.', 'four', 'patient', 'died', 'due', 'to', 'infection', '.', 'in', 'conclusion', ',', 'second-line', 'treatment', 'with', 'dara-ixa-dex', 'in', 'patient', 'with', 'rrmm', 'pre-treated', 'with', 'lenalidomide-based', 'regimen', 'resulted', 'in', 'rapid', 'response', 'along', 'with', 'favorable', 'effect', 'bone', 'metabolism', '.']"
Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization.,"Kyo Won Lee, Jae Berm Park, Hyojun Park, Yeongbeen Kwon, Ji Soo Lee, Kyeong Sik Kim, Young Jae Chung, Jin Soo Rhu, Sooin Choi, Ghee Young Kwon, Hee Jin Kim, Eun-Suk Kang, Chul Won Jung, Eui-Cheol Shin, Tatsuo Kawai, Sung Joo Kim, Jae-Won Joh, Kyo Won Leeet al.",2020 Jul,Transplantation,https://pubmed.ncbi.nlm.nih.gov/31634324/,No keywords found,"['tolerance', 'induction', 'important', 'goal', 'in', 'field', 'of', 'organ', 'transplantation', '.', 'sequentially', 'modified', 'conditioning', 'regimen', 'induction', 'of', 'donor-specific', 'tolerance', 'in', 'recipient', 'of', 'major', 'histocompatibility', 'complex-mismatched', 'combined', 'kidney', 'and', 'bone', 'marrow', 'transplantation', '(', 'ckbmt', ')', '.', 'method', 'december', 'to', 'may', ',', 'major', 'histocompatibility', 'complex-mismatched', 'patient', 'received', 'ckbmt', '.', 'initial', 'conditioning', 'regimen', '(', 'protocol', ')', 'consisted', 'of', 'cyclophosphamide', '(', 'cp', ')', ',', 'rituximab', ',', 'rabbit', 'antithymocyte', 'globulin', ',', 'and', 'thymic', 'irradiation', '.', 'tacrolimus', 'and', 'steroid', 'used', 'maintenance', 'of', 'immunosuppression', '(', ')', '.', 'result', 'regimen', 'complicated', 'transient', 'acute', 'kidney', 'injury', ',', 'major', 'clinical', 'feature', 'of', 'engraftment', 'syndrome', 'and', 'side', 'effect', 'of', 'cp', ',', 'although', 'one', 'of', 'subject', 'successfully', 'discontinued', 'month', '.', 'conditioning', 'regimen', 'modified', 'reducing', 'cp', 'dose', 'and', 'adding', 'fludarabine', '(', 'protocol', ')', '.', 'final', 'modification', 'reducing', 'fludarabine', 'and', 'rabbit', 'antithymocyte', 'globulin', 'dos', '(', 'protocol', ')', '.', 'mixed', 'chimerism', ',', 'detected', 'short', 'tandem', 'repeat', 'method', ',', 'achieved', 'transiently', 'in', 'subject', '-', 'week', '.', 'among', 'subject', 'treated', 'with', 'protocol', ',', 'successfully', 'discontinued', 'month', 'in', 'one', 'subject', ',', 'subject', 'suffered', 'severe', 'bk', 'virus-associated', 'nephritis', '.', 'subject', 'treated', 'with', 'protocol', 'tolerated', 'protocol', 'well', 'and', 'successfully', 'discontinued', '-', 'month', '.', 'interestingly', ',', 'de', 'novo', 'donor-specific', 'antibody', 'not', 'detected', 'in', 'subject', 'follow-up', 'period', '.', 'conclusion', 'clinical', 'trial', 'shown', 'long-term', 'renal', 'allograft', 'survival', 'without', 'maintenance', 'achieved', 'induction', 'of', 'mixed', 'chimerism', 'following', 'ckbmt', '.']"
Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients.,"Ibrahim Tawhari, Patrick Hallak, Sofia Bin, Fatmah Yamani, Maria Safar-Boueri, Aazib Irshad, Joseph Leventhal, Mohammed Javeed Ansari, Paolo Cravedi, Lorenzo Gallon, Ibrahim Tawhariet al.",2022 Dec 19:13:1096881.,Front Immunol,https://pubmed.ncbi.nlm.nih.gov/36601111/,No keywords found,"['belatacept', '(', 'bela', ')', 'developed', 'to', 'reduce', 'nephrotoxicity', 'and', 'cardiovascular', 'risk', 'associated', 'with', 'chronic', 'use', 'of', 'calcineurin', 'inhibitor', '(', 'cnis', ')', 'in', 'kidney', 'transplant', 'recipient', '.', 'use', 'of', 'bela', 'with', 'early', 'steroid', 'withdrawal', '(', 'esw', ')', 'and', 'simultaneous', 'cni', 'avoidance', 'not', 'formally', 'evaluated', '.', 'method', 'month', 'post-transplant', ',', 'stable', 'kidney', 'transplant', 'recipient', 'with', 'esw', 'tacrolimus', '(', 'tac', ')', 'mycophenolate', '(', 'mpa', ')', 'randomized', 'to', ')', 'belampa', ',', ')', 'belalow-dose', 'tac', '(', 'trough', 'goal', 'ngml', ')', ',', 'or', ')', 'continue', 'tacmpa', '.', 'patient', 'underwent', 'surveillance', 'graft', 'biopsy', 'enrollment', 'and', ',', 'and', 'month', 'post-transplant', '.', 'twenty-seven', 'recipient', 'included', 'underwent', 'conversion', 'to', 'belampa', ',', 'to', 'belalow-dose', 'tac', 'and', 'continued', 'tacmpa', '.', 'serial', 'blood', 'sample', 'collected', 'immune', 'phenotyping', 'and', 'gene', 'expression', 'analysis', '.', 'result', 'belampa', 'arm', 'closed', 'early', 'due', 'to', 'high', 'rate', 'of', 'biopsy', 'proven', 'acute', 'rejection', '(', 'bpar', ')', '.', 'incidence', 'of', 'bpar', 'in', 'belampa', ',', 'in', 'belalow', 'dose', 'tac', 'and', 'in', 'tacmpa', ',', 'p', '..', 'belalow-dose', 'tac', 'regimen', 'associated', 'with', '.', 'mlmin', '.', 'increase', 'in', 'egfr', 'compared', 'to', '-', '.', 'mlmin', '.', 'in', 'tacmpa', ',', 'p', '..', 'one', 'graft', 'loss', 'occurred', 'in', 'belampa', 'group', '.', 'immunophenotyping', 'of', 'peripheral', 'blood', 'monocyte', 'count', '(', 'pbmc', ')', 'showed', 'cdcd', 'and', 'cdcd', 'cell', 'higher', 'in', 'belampa', 'patient', 'with', 'acute', 'rejection', 'compared', 'to', 'patient', 'without', 'rejection', ',', 'although', 'difference', 'not', 'reach', 'statistical', 'significance', '.', 'conclusion', 'data', 'indicate', ',', 'in', 'steroid', 'free', 'regimen', ',', 'low-dose', 'tac', 'maintenance', 'needed', 'to', 'prevent', 'rejection', 'patient', 'converted', 'to', 'bela', ',', 'least', 'maneuver', 'done', 'early', 'transplant', '.']"
The Acute Kidney Outreach to Prevent Deterioration and Death trial: a large pilot study for a cluster-randomized trial.,"Mark E Thomas, Tarek S Abdelaziz, Gavin D Perkins, Alice J Sitch, Jyoti Baharani, R Mark Temple, Mark E Thomaset al.",2021 Mar 29,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/31860096/,No keywords found,"['acute', 'kidney', 'outreach', 'to', 'reduce', 'deterioration', 'and', 'death', 'trial', 'large', 'pilot', 'study', 'cluster-randomized', 'trial', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'outreach', '.', 'method', 'observational', 'control', '(', ')', 'phase', 'conducted', 'in', 'two', 'teaching', 'hospital', '(', 'mile', 'apart', ')', 'and', 'respective', 'catchment', 'area', '.', 'in', 'intervention', '(', ')', 'phase', ',', 'working-hours', 'aki', 'outreach', 'service', 'operated', 'intervention', 'hospitalarea', 'week', ',', 'with', 'site', 'acting', 'control', '.', 'aki', 'alert', 'in', 'hospital', 'and', 'community', 'patient', 'screened', 'inclusion', '.', 'major', 'exclusion', 'criterion', 'patient', 'end', 'of', 'life', ',', 'unlikely', 'to', 'benefit', 'outreach', ',', 'lacking', 'mental', 'capacity', 'or', 'already', 'referred', 'to', 'renal', 'team', '.', 'intervention', 'arm', 'included', 'model', 'of', 'escalation', 'of', 'renal', 'care', 'to', 'aki', 'patient', ',', 'depending', 'aki', 'stage', '.', '-day', 'primary', 'outcome', 'combination', 'of', 'death', ',', 'or', 'deterioration', ',', 'shown', 'need', 'dialysis', 'or', 'progression', 'in', 'aki', 'stage', '.', 'total', 'of', 'adult', 'patient', 'recruited', 'intervention', 'site', 'phase', '.', 'result', 'median', 'of', '.', 'non-medication', 'recommendation', 'and', '.', 'medication-related', 'recommendation', 'per', 'patient', 'made', 'outreach', 'team', 'median', 'of', '.', 'h', 'aki', 'alert', '.', 'relatively', 'low', 'rate', 'of', 'primary', 'outcome', 'of', 'death', 'within', 'day', '(', '-', ')', 'or', 'requirement', 'dialysis', '(', '.-', '.', ')', 'seen', 'across', 'four', 'group', '.', 'in', 'exploratory', 'analysis', ',', 'intervention', 'hospital', 'phase', ',', 'odds', 'ratio', 'combined', 'primary', 'outcome', 'of', '.', '(', 'confidence', 'interval', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'aki', 'outreach', 'service', 'provide', 'standardized', 'specialist', 'care', 'to', 'with', 'aki', 'across', 'healthcare', 'economy', '.', 'trial', 'assessing', 'aki', 'outreach', 'may', 'benefit', 'focusing', 'patient', 'with', ""'mid-range"", ""'"", 'prognosis', ',', 'nephrological', 'intervention', 'could', 'impact', '.']"
Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.,"Joseph G Cernigliaro, William E Haley, Doug P Adolphson, Maria A Jepperson, Julia E Crook, Colleen S Thomas, Alexander S Parker, Joseph G Cernigliaroet al.",2016 Sep-Oct,Clin Imaging,https://pubmed.ncbi.nlm.nih.gov/27183138/,No keywords found,"['concern', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'may', 'result', 'in', 'administration', 'of', 'costly', 'agent', '.', 'prospectively', 'compared', 'outpatient', 'cin', 'incidence', 'of', 'iodixanol', 'to', 'iohexol', '.', 'method', 'patient', 'randomized', 'to', 'receive', 'ml', 'of', 'iohexol', '(', 'n', ')', 'or', 'iodixanol', '(', 'n', ')', '.', 'compared', 'patient', 'developed', 'cin', 'using', 'wilson', 'score', 'interval', 'and', 'also', 'calculated', 'odds', 'ratio', 'development', 'of', 'cin', '.', 'result', 'cin', 'rate', 'iohexol', 'compared', 'to', 'iodixanol', '.', 'receiving', 'iodixanol', 'almost', 'time', 'likely', 'to', 'experience', 'cin', '.', 'conclusion', 'result', 'not', 'suggest', 'benefit', 'of', 'iodixanol', 'iohexol', 'in', 'study', 'population', '.']"
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.,"Ana González-Cordón, Lambert Assoumou, Graeme Moyle, Laura Waters, Margaret Johnson, Pere Domingo, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Mar Masiá, Mark Gompels, Stephane De Wit, Eric Florence, Stefan Esser, François Raffi, Georg Behrens, Anton Pozniak, José M Gatell, Esteban Martínez                              ;, NEAT Study Group, Linos Vandekerckhove, Els Caluwé, Coca Necsoi, Maartje Van Frankenhuijsen, Clotilde Allavena, Véronique Reliquet, David Boutoille, Morane Cavellec, Elisabeth André-Garnier, Audrey Rodallec, Thierry Le Tourneau, Jérôme Connault, Jean-Michel Molina, Samuel Ferret, Miresta Previlon, Yazdan Yazdanpanah, Roland Landman, Véronique Joly, Adriana Pinto, Christine Katlama, Fabienne Caby, Nadine Ktorza, Luminita Schneider, Christoph Stephan, Timo Wolf, Gundolf Schüttfort, Juergen Rockstroh, Jan-Christian Wasmuth, Carolynne Schwarze-Zander, Christoph Boesecke, Hans-Jurgen Stellbrink, Christian Hoffmann, Michael Sabranski, Stephan Esser, Robert Jablonka, Heidi Wiehler, Matthias Stoll, Gerrit Ahrenstorf, Giulia Nardini, Barbara Beghetto, Antonella D'Arminio Montforte, Teresa Bini, Viola Cogliandro, Massimo Di Pietro, Francesco Maria Fusco, Massimo Galli, Stefano Rusconi, Andrea Giacomelli, Paola Meraviglia, Esteban Martinez, José Maria Gatell, Berta Torres, Gracia Mateo, Mar Gutierrez, Joaquin Portilla, Esperanza Merino, Sergio Reus, Vicente Boix, Mar Masia, Félix Gutiérrez, Sergio Padilla, Bonaventura Clotet, Eugenia Negredo, Anna Bonjoch, José L Casado, Sara Bañón-Escandell, Jose Saban, Africa Duque, Daniel Podzamczer, Maria Saumoy, Laura Acerete, Juan Gonzalez-Garcia, José Ignacio Bernardino, José Ramón Arribas, Victor Hontañón, Nicole Pagani, Margherita Bracchi, Jaime Vera, Amanda Clarke, Tanya Adams, Celia Richardson, Alan Winston, Borja Mora-Peris, Scott Mullaney, Nahum de Esteban, Ana Milinkovic, Sarah Pett, Juan Manuel Tiraboschi, Mike Youle, Chloe Orkin, Simon Rackstraw, James Hand, Louise Jennings, Jane Nicholls, Sarah Johnston, Ana González-Cordónet al.",2021 Aug 12,J Antimicrob Chemother,https://pubmed.ncbi.nlm.nih.gov/34120186/,No keywords found,"['switching', 'boosted', 'pi', 'to', 'dolutegravir', 'in', 'people', 'living', 'with', 'hiv', '(', 'plwh', ')', 'with', 'high', 'cardiovascular', 'risk', 'improved', 'plasma', 'lipid', 'week', 'in', 'neat', 'trial', '.', 'whether', 'strategy', 'may', 'impact', 'cardiovascular', 'biomarkers', 'unknown', '.', 'method', 'assessed', 'week', 'change', 'in', 'biomarkers', 'associated', 'with', 'inflammation', ',', 'endothelial', 'dysfunction', ',', 'monocyte', 'immune', 'activation', ',', 'oxidation', ',', 'insulin', 'resistance', ',', 'hypercoagulability', ',', 'heart', 'failure', ',', 'myocardial', 'injury', ',', 'and', 'glomerular', 'and', 'tubular', 'kidney', 'injury', '.', 'result', 'of', 'plwh', 'randomized', 'in', 'neat', 'study', ',', '(', '.', ')', 'remained', 'allocated', 'therapy', 'and', 'paired', 'sample', 'available', '.', 'soluble', 'cd', '(', '-', ',', 'p', '.', ')', 'and', 'adiponectin', '(', '-', ',', 'p', '.', ')', 'significantly', 'declined', 'and', 'high-sensitive', 'c-reactive', 'protein', '(', '-', ',', 'p', '.', ')', 'and', 'oxidized', 'ldl', '(', '-', ',', 'p', '.', ')', 'tended', 'to', 'decrease', 'with', 'dolutegravir', '.', 'switching', 'to', 'dolutegravir', 'remained', 'significantly', 'associated', 'with', 'soluble', 'cd', 'and', 'adiponectin', 'reduction', 'adjustment', 'baseline', 'variable', '.', 'inverse', 'correlation', 'soluble', 'cd', 'and', 'cd', 'count', 'change', '(', 'p', '.', ')', ',', 'and', 'adiponectin', 'and', 'bmi', 'change', '(', 'p', '.', ')', '.', 'conclusion', 'switching', 'boosted', 'pi', 'to', 'dolutegravir', 'in', 'plwh', 'with', 'high', 'cardiovascular', 'risk', 'led', 'to', 'soluble', 'cd', 'and', 'adiponectin', 'reduction', 'week', '.', 'decreasing', 'soluble', 'cd', 'may', 'entail', 'favourable', 'health', 'effect', 'in', 'plwh', ',', 'adiponectin', 'reduction', 'may', 'reflect', 'less', 'insulin', 'sensitivity', 'associated', 'with', 'weight', 'gain', '.']"
N-acetylcysteine decreases urinary level of neutrophil gelatinase-associated lipocalin in deceased-donor renal transplant recipients: a randomized clinical trial.,"Atieh Modarresi, Mohsen Nafar, Zahra Sahraei, Jamshid Salamzadeh, Samira Chaibakhsh, Shadi Ziaie, Mahmoud Parvin, Yunes Panahi, Behzad Einollahi, Atieh Modarresiet al.",2018 Sep,Biomarkers,https://pubmed.ncbi.nlm.nih.gov/29683755/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'kidney', 'transplantation', '(', 'kt', ')', ',', 'especially', 'in', 'recipient', 'deceased', 'donor', '.', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'u-ngal', ')', 'early', 'and', 'sensitive', 'marker', 'of', 'aki', 'transplantation', '.', 'objective', 'assessed', 'renoprotective', 'effect', 'of', 'n-acetylcysteine', '(', 'nac', ')', 'u-ngal', 'level', 'early', 'prognostic', 'marker', 'of', 'graft', 'function', 'immediately', 'transplantation', '.', 'material', 'and', 'method', 'double-blind', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'conducted', 'deceased-donor', 'kt', 'recipient', '(', 'www.irct.ir', ',', 'trial', 'registration', 'number', 'irctn', ')', '.', 'patient', 'received', 'mg', 'oral', 'nac', 'or', 'placebo', 'twice', 'daily', 'day', 'to', 'and', 'urine', 'sample', 'taken', ',', 'and', 'first', 'and', 'fifth', 'day', 'transplantation', '.', 'u-ngal', 'and', 'early', 'graft', 'function', 'compared', 'two', 'group', '.', 'result', 'nac', 'significantly', 'reduced', 'u-ngal', 'level', 'compared', 'to', 'placebo', '(', 'p', 'value', '.', ')', ',', 'improvement', 'in', 'early', 'graft', 'function', 'with', 'nac', 'not', 'reach', 'statistical', 'significance', '.', 'conclusion', 'study', 'showed', 'nac', 'administration', 'in', 'deceased-donor', 'kt', 'recipient', 'reduce', 'tubular', 'kidney', 'injury', ',', 'evidenced', 'u-ngal', 'measurement', '.', 'improvement', 'in', 'early', 'graft', 'function', 'need', 'larger', 'sample', 'size', 'to', 'reach', 'statistical', 'conclusion', '.']"
Development of real-time individualized risk prediction models for contrast associated acute kidney injury and 30-day dialysis after contrast enhanced computed tomography.,"Yen-Yu Chen, Chung-Feng Liu, Yu-Ting Shen, Yu-Ting Kuo, Ching-Chung Ko, Tai-Yuan Chen, Te-Chang Wu, Yun-Ju Shih, Yen-Yu Chenet al.",2023 Oct:167:111034.,Eur J Radiol,https://pubmed.ncbi.nlm.nih.gov/37591134/,No keywords found,"['study', 'aimed', 'to', 'develop', 'preprocedural', 'real-time', 'artificial', 'intelligence', '(', 'ai', ')', '-based', 'system', 'predicting', 'individualized', 'risk', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', 'and', 'dialysis', 'requirement', 'within', 'day', 'following', 'contrast-enhanced', 'computed', 'tomography', '(', 'cect', ')', '.', 'method', 'single-center', ',', 'retrospective', 'study', 'analyzed', 'adult', 'patient', 'emergency', 'or', 'in-patient', 'department', 'underwent', 'cect', ',', 'patient', 'included', 'excluding', 'already', 'dialysis', ',', 'stage', 'v', 'chronic', 'kidney', 'disease', ',', 'or', 'missing', 'data', 'regarding', 'serum', 'creatinine', 'level', 'within', 'day', 'and', 'cect', '.', 'clinical', 'parameter', ',', 'laboratory', 'data', ',', 'medication', 'exposure', ',', 'and', 'comorbid', 'disease', 'selected', 'predictive', 'feature', '.', 'patient', 'randomly', 'divided', 'model', 'training', 'and', 'testing', 'group', 'ratio', '.', 'logistic', 'regression', '(', 'lr', ')', 'and', 'random', 'forest', '(', 'rf', ')', 'employed', 'to', 'create', 'prediction', 'model', ',', 'evaluated', 'using', 'receiver', 'operating', 'characteristic', 'curve', '.', 'result', 'incidence', 'rate', 'of', 'ca-aki', 'and', 'dialysis', 'within', 'day', 'post-cect', '.', 'and', '.', ',', 'respectively', '.', 'ca-aki', 'prediction', ',', 'lr', 'and', 'rf', 'exhibited', 'similar', 'performance', ',', 'with', 'area', 'curve', '(', 'auc', ')', 'of', '.', 'and', '.', ',', 'respectively', '.', '-day', 'dialysis', 'prediction', ',', 'lr', '(', 'auc', ',', '.', ')', 'and', 'rf', '(', 'auc', ',', '.', ')', 'also', 'exhibited', 'similar', 'performance', '.', 'relative', 'to', 'egfr-alone', ',', 'lr', 'and', 'rf', 'model', 'produced', 'significantly', 'higher', 'auc', 'ca-aki', 'prediction', '(', 'lr', 'vs.', 'egfr', 'alone', ',', '.', 'v', '.', '.', ',', 'p', '.', ')', 'and', '-day', 'dialysis', 'prediction', '(', 'rf', 'vs.', 'egfr', 'alone', ',', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'conclusion', 'proposed', 'ai', 'prediction', 'model', 'significantly', 'outperformed', 'egfr-alone', 'predicting', 'ca-aki', 'and', '-day', 'dialysis', 'risk', 'of', 'emergency', 'department', 'and', 'hospitalized', 'patient', 'underwent', 'cect', '.']"
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.,"Vasantha K Jotwani, Alexandra K Lee, Michelle M Estrella, Ronit Katz, Pranav S Garimella, Rakesh Malhotra, Dena E Rifkin, Walter Ambrosius, Barry I Freedman, Alfred K Cheung, Kalani L Raphael, Paul Drawz, Javier A Neyra, Suzanne Oparil, Henry Punzi, Michael G Shlipak, Joachim H Ix                                                            ;, fortheSPRINTResearchGroup, Vasantha K Jotwaniet al.",2019,Am J Nephrol,https://pubmed.ncbi.nlm.nih.gov/30939472/,No keywords found,"['kidney', 'tubulointerstitial', 'fibrosis', 'biopsy', 'strong', 'predictor', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'progression', ',', 'and', 'ckd', 'associated', 'with', 'elevated', 'risk', 'of', 'cardiovascular', 'disease', '(', 'cvd', ')', '.', 'tubular', 'health', 'poorly', 'quantified', 'traditional', 'kidney', 'function', 'measure', ',', 'including', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'and', 'albuminuria', '.', 'hypothesized', 'urinary', 'biomarkers', 'of', 'tubular', 'injury', ',', 'inflammation', ',', 'and', 'repair', 'would', 'associated', 'with', 'higher', 'risk', 'of', 'cvd', 'and', 'mortality', 'in', 'person', 'with', 'ckd', '.', 'method', 'measured', 'urinary', 'concentration', 'of', 'interleukin-', '(', 'il-', ')', ',', 'kidney', 'injury', 'molecule-', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'monocyte', 'chemoattractant', 'protein-', ',', 'and', 'chitinase', '--', 'like', 'protein-', '(', 'ykl-', ')', 'baseline', 'among', ',', 'participant', 'of', 'systolic', 'blood', 'pressure', 'intervention', 'trial', 'egfr', 'mlmin', '.', 'm.', 'used', 'cox', 'proportional', 'hazard', 'model', 'to', 'evaluate', 'biomarker', 'association', 'with', 'cvd', 'event', 'and', 'all-cause', 'mortality', '.', 'result', 'baseline', ',', 'mean', 'age', 'of', 'participant', 'year', ',', 'and', 'egfr', 'mlmin', '.', 'm.', 'median', 'follow-up', 'of', '.', 'year', ',', 'cvd', 'event', '(', '.', 'per', 'year', ')', 'and', 'all-cause', 'death', '(', '.', 'per', 'year', ')', 'occurred', '.', 'multivariable', 'adjustment', 'including', 'egfr', ',', 'albuminuria', ',', 'and', 'urinary', 'creatinine', ',', 'none', 'of', 'biomarkers', 'showed', 'statistically', 'significant', 'association', 'with', 'cvd', 'risk', '.', 'urinary', 'il-', '(', 'hazard', 'ratio', 'hr', 'per', '-fold', 'higher', 'value', ',', '.', 'ci', '.-', '.', ')', 'and', 'ykl-', '(', 'hr', 'per', '-fold', 'higher', 'value', ',', '.', 'ci', '.-', '.', ')', 'concentration', 'incrementally', 'associated', 'with', 'higher', 'mortality', 'risk', '.', 'association', 'similar', 'stratified', 'randomized', 'blood', 'pressure', 'arm', '.', 'conclusion', 'among', 'hypertensive', 'trial', 'participant', 'with', 'ckd', ',', 'higher', 'urinary', 'il-', 'and', 'ykl-', 'associated', 'with', 'higher', 'risk', 'of', 'mortality', ',', 'not', 'cvd', '.']"
"Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.","Lennart Tonneijck, Mark M Smits, Marcel H A Muskiet, Trynke Hoekstra, Mark H H Kramer, A H Jan Danser, Piet M Ter Wee, Michaela Diamant, Jaap A Joles, Daniël H van Raalte, Lennart Tonneijcket al.",2016 Nov,Diabetes Care,https://pubmed.ncbi.nlm.nih.gov/27585605/,No keywords found,"['to', 'investigate', 'effect', 'of', 'dipeptidyl', 'peptidase-', 'inhibitor', '(', 'dpp-i', ')', 'sitagliptin', 'or', 'glucagon-like', 'peptide', '(', 'glp-', ')', 'receptor', 'agonist', 'liraglutide', 'treatment', 'renal', 'hemodynamics', ',', 'tubular', 'function', ',', 'and', 'marker', 'of', 'renal', 'damage', 'in', 'overweight', 'patient', 'with', 'type', 'diabetes', 'without', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'research', 'design', 'and', 'method', 'in', '-week', ',', 'randomized', ',', 'double-blind', 'trial', ',', 'insulin-nave', 'patient', 'with', 'type', 'diabetes', '(', 'mean', 'sem', 'age', 'year', ',', 'bmi', '.', '.', 'kgm', ',', 'glomerular', 'filtration', 'rate', 'gfr', 'mlmin', '.', 'median', 'interquartile', 'range', 'albumin-to-creatinine', 'ratio', '(', 'acr', ')', '.', 'mgmmol', '.-', '.', ')', 'received', 'sitagliptin', '(', 'mgday', ')', ',', 'liraglutide', '(', '.', 'mgday', ')', ',', 'or', 'matching', 'placebo', '.', 'gfr', '(', 'primary', 'end', 'point', ')', 'and', 'effective', 'renal', 'plasma', 'flow', '(', 'erpf', ')', 'determined', 'inulin', 'and', 'para-aminohippuric', 'acid', 'clearance', ',', 'respectively', '.', 'intrarenal', 'hemodynamic', 'variable', 'estimated', '.', 'absolute', 'and', 'fractional', 'excretion', 'of', 'sodium', '(', 'fena', ')', ',', 'potassium', ',', 'and', 'urea', '(', 'feu', ')', 'and', 'renal', 'damage', 'marker', '(', 'acr', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'ngal', ',', 'and', 'kidney', 'injury', 'molecule-', 'kim-', ')', 'measured', '.', 'plasma', 'renin', 'concentration', '(', 'prc', ')', 'and', 'glycated', 'hemoglobin', '(', 'hbac', ')', 'assessed', '.', 'week', 'and', ',', 'estimated', 'gfr', 'and', 'fractional', 'electrolyte', 'excretion', 'determined', '.', 'result', 'week', ',', 'gfr', 'not', 'affected', 'sitagliptin', '(', '-', 'mlmin', '.', 'ci', '-', 'to', ',', 'p', '.', ')', 'or', 'liraglutide', '(', 'mlmin', '.', '-', 'to', ',', 'p', '.', ')', ',', 'compared', 'with', 'placebo', '.', 'sitagliptin', 'modestly', 'reduced', 'estimated', 'glomerular', 'hydraulic', 'pressure', '(', 'pglo', 'p', '.', ')', '.', 'erpf', ',', 'intrarenal', 'hemodynamic', 'variable', ',', 'renal', 'damage', 'marker', ',', 'and', 'prc', 'not', 'change', 'treatment', '.', 'agent', 'reduced', 'hbac', '.', 'week', ',', 'sitagliptin', 'increased', 'fena', 'and', 'feu', '(', 'p', '.', ')', '.', 'conclusion', 'twelve-week', 'treatment', 'with', 'sitagliptin', 'or', 'liraglutide', 'not', 'affect', 'measured', 'renal', 'hemodynamics', '.', 'no', 'sustained', 'change', 'in', 'tubular', 'function', 'or', 'alteration', 'in', 'renal', 'damage', 'marker', 'observed', '.', 'validity', 'and', 'clinical', 'relevance', 'of', 'slight', 'sitagliptin-induced', 'pglo', 'reduction', 'remains', 'speculative', '.']"
"A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 study.","Arne Ring, Tom Morris, Marcin Wozniak, Nikol Sullo, William Dott, Veerle Verheyden, Tracy Kumar, Nigel Brunskill, Rakesh Vaja, Gavin J Murphy, Arne Ringet al.",2017 Apr,Br J Clin Pharmacol,https://pubmed.ncbi.nlm.nih.gov/27779776/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'and', 'severe', 'complication', 'of', 'cardiac', 'surgery', '.', 'no', 'effective', 'prevention', 'or', 'treatment', '.', 'sildenafil', 'citrate', '(', 'revatio', ',', 'pfizer', 'inc.', ')', ',', 'phosphodiesterase', 'type', 'inhibitor', ',', 'prevents', 'post', 'cardiac', 'surgery', 'aki', 'in', 'pre-clinical', 'study', ',', 'however', 'use', 'contraindicated', 'in', 'patient', 'with', 'symptomatic', 'cardiovascular', 'disease', '.', 'aim', 'of', 'study', 'to', 'assess', 'safety', 'and', 'pharmacokinetics', 'of', 'intravenous', 'sildenafil', 'in', 'cardiac', 'surgery', 'patient', '.', 'method', 'conducted', 'open', 'label', ',', 'dose', 'escalation', 'study', 'with', 'six', 'patient', 'per', 'dose', 'level', '.', 'six', 'dos', '.', 'mg', ',', 'mg', 'or', 'mg', 'bolus', ',', 'either', 'alone', 'or', 'followed', 'additional', 'h', 'infusion', 'of', '.', 'mg', 'sildenafil', '.', 'result', 'thirty-six', 'patient', 'entered', 'trial', ',', 'of', 'completed', '.', 'mean', 'age', '.', 'year', '.', 'one', 'patient', 'died', 'surgery', ',', 'two', 'others', 'removed', 'trial', 'dosing', '(', 'dose', 'level', 'mg', '.', 'mg', ')', '.', 'pharmacokinetic', 'profile', 'of', 'sildenafil', 'similar', 'to', 'previously', 'published', 'study', '.', 'dose', 'of', 'mg', 'administered', 'bolus', 'followed', '.', 'mg', 'administered', 'h', 'result', 'auc', 'ng', 'h', 'ml-', ',', 'cmax', '.', 'ng', 'ml-', 'and', '.', 'h.', 'drug', 'well', 'tolerated', 'with', 'no', 'serious', 'adverse', 'event', 'related', 'to', 'drug', 'administration', '.', 'higher', 'sildenafil', 'dos', 'stabilized', 'post-surgery', 'nitric', 'oxide', 'bioavailability', '.', 'conclusion', 'pharmacokinetics', 'of', 'sildenafil', 'cardiopulmonary', 'bypass', 'comparable', 'to', 'of', 'patient', 'group', '.', 'drug', 'well', 'tolerated', 'therapeutic', 'plasma', 'level', '.', 'result', 'support', 'evaluation', 'of', 'sildenafil', 'prevention', 'of', 'aki', 'in', 'cardiac', 'surgery', '.']"
"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.","Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara, Danny Rischin, Gustavo Alves, Iane Pinto Figueiredo Lima, Brett G M Hughes, Yoann Pointreau, Sercan Aksoy, Simon Laban, Richard Greil, Martin Burian, Marcin Hetnał, Jean-Pierre Delord, Ricard Mesía, Miren Taberna, John N Waldron, Christian Simon, Vincent Grégoire, Kevin J Harrington, Ramona F Swaby, Yayan Zhang, Burak Gumuscu, Behzad Bidadi, Lillian L Siu                              ;, KEYNOTE- Investigators, Brett Gm Hughes, Bo Gao, Margaret McGrath, Dietmar Thurnher, Thorsten Fuereder, Sylvie Rottey, Paul M Clement, Stéphanie Henry, Stéphanie Deheneffe, Gustavo Vasconcelos Alves, Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak, Andrea Juliana Pereira de Santana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Monica Luciana Agostinho Padoan, Ana Paula Victorina, Sergio Jobim de Azevedo, Lillian L Siu, Stephanie Brule, John Hilton, Chang Shu Wang, Nathaniel Bouganim, Marc Webster, John Walker, Neil Chua, Angela Regina Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Beran Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Xavier Zasadny, Lionnel Geoffrois, Rainer Fietkau, Marlen Haderlein, Andreas H Mueller, Ursula Schroeder, Barbara Wollenberg, Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Dror Limon, Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nole, Federica Bertolini, Lorenzo Livi, Maria Grazia Ghi, Ilaria Imarisio, Akihiro Homma, Tsutomu Ueda, Yukinori Asada, Tomoko Yamazaki, Koji Matsumoto, Takashi Fujii, Sadakatsu Ikeda, Shunji Takahashi, Takashi Kinoshita, Keita Sasaki, Akihito Tsuji, Myung-Ju Ahn, Byoung Chul Cho, Keun-Wook Lee, Ki Hyeong Lee, Moon Ki Choi, Hwan Jung Yun, Mathijs P Hendriks, Sjoukje F Oosting, Jan Buter, Esther Van Meerten, Jonathan Graham, Andrzej Kawecki, Izabella Debicka, Adam Maciejczyk, Maciej Pysz, Dorota Filarska, Piotr Koralewski, Andrzej Wygoda, Krzysztof Składowski, Małgorzata Talerczyk, Alfonso Berrocal Jaime, Pedro Pérez Segura, Irene Braña García, Neus Basté Rotllan, Ricard Mesía Nin, Miren Taberna Sanz, Lara Iglesias Docampo, Ainara Soria Rivas, Antonio Rueda Domínguez, José Manuel Trigo Pérez, Ruey-Long Hong, Shau-Hsuan Li, Hung-Ming Wang, Chia-Jui Yen, Muh-Hwa Yang, Yi-Fang Chang, Yi-Chun Liu, Jin-Ching Lin, Meltem Ekenel, Hakan Harputluoğlu, Özgür Özyilkan, Ahmet Bılıcı, Mehmet Alı Nahıt Şendur, Cagatay Arslan, Kevin Harrington, Shanmugasundaram Ramkumar, Dorothy Gujral, Simon Stewart, Melanie Powell, Amen Sibtain, Tom Roques, Kent Yip, Arafat Mirza, Muthiah Sivaramalingam, Neil D Belman, Sanjiv Agarwala, Ian Anderson, Arpan Patel, Ronald Maggiore, Megan Baumgart, Mary Jo Fidler, Varinder Kaur, Elizabeth Gaughan, Francis Worden, Cristina P Rodriguez, Ammar Sukari, Deborah Wong, Sue Yom, William V Walsh, Joseph A Fiorillo, Jeffrey T Yorio, Grzegorz S Obara, Jean-Pascal Machielset al.",2024 May,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/38561010/,No keywords found,"['despite', 'multimodal', 'therapy', ',', '-year', 'overall', 'survival', 'locally', 'advanced', 'head', 'and', 'neck', 'squamous', 'cell', 'carcinoma', '(', 'hnscc', ')', '.', 'assessed', 'addition', 'of', 'pembrolizumab', 'to', 'concurrent', 'chemoradiotherapy', 'locally', 'advanced', 'hnscc', '.', 'method', 'in', 'randomised', ',', 'double-blind', ',', 'phase', 'keynote-', 'trial', ',', 'participant', 'with', 'newly', 'diagnosed', ',', 'high-risk', ',', 'unresected', 'locally', 'advanced', 'hnscc', 'medical', 'centre', 'globally', 'randomly', 'assigned', '(', ')', 'to', 'pembrolizumab', '(', 'mg', ')', 'plus', 'chemoradiotherapy', 'or', 'placebo', 'plus', 'chemoradiotherapy', '.', 'randomisation', 'done', 'using', 'interactive', 'response', 'technology', 'system', 'and', 'stratified', 'investigator', ""'s"", 'choice', 'of', 'radiotherapy', 'regimen', ',', 'tumour', 'site', 'and', 'p', 'status', ',', 'and', 'disease', 'stage', ',', 'with', 'participant', 'randomly', 'assigned', 'in', 'block', 'of', 'four', 'per', 'stratum', '.', 'participant', ',', 'investigator', ',', 'and', 'sponsor', 'personnel', 'masked', 'to', 'treatment', 'assignment', '.', 'local', 'pharmacist', 'aware', 'of', 'assignment', 'to', 'support', 'treatment', 'preparation', '.', 'pembrolizumab', 'and', 'placebo', 'administered', 'intravenously', 'every', 'week', 'to', 'dos', '(', 'one', 'chemoradiotherapy', ',', 'two', 'chemoradiotherapy', ',', 'maintenance', 'therapy', ')', '.', 'chemoradiotherapy', 'included', 'cisplatin', '(', 'mgm', ')', 'administered', 'intravenously', 'every', 'week', 'two', 'or', 'three', 'dos', 'and', 'accelerated', 'or', 'standard', 'fractionation', 'radiotherapy', '(', 'gy', 'delivered', 'in', 'fraction', ')', '.', 'primary', 'endpoint', 'event-free', 'survival', 'analysed', 'in', 'randomly', 'assigned', 'participant', '.', 'safety', 'analysed', 'in', 'participant', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'active', 'not', 'recruiting', '.', 'finding', 'april', ',', ',', 'and', 'may', ',', ',', 'participant', 'randomly', 'assigned', 'to', 'pembrolizumab', 'group', '(', 'n', ')', 'or', 'placebo', 'group', '(', 'n', ')', '.', '(', ')', 'of', 'participant', 'male', ',', '(', ')', 'female', ',', 'and', '(', ')', 'white', '.', 'median', 'study', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', 'median', 'event-free', 'survival', 'not', 'reached', '(', 'ci', 'months-not', 'reached', ')', 'in', 'pembrolizumab', 'group', 'and', 'month', '(', '-not', 'reached', ')', 'in', 'placebo', 'group', '(', 'hazard', 'ratio', 'ci', '-', 'log-rank', 'p', 'significance', 'threshold', ',', 'p', ')', '.', '(', ')', 'of', 'participant', 'treated', 'in', 'pembrolizumab', 'group', 'and', '(', ')', 'of', 'participant', 'treated', 'in', 'placebo', 'group', 'grade', 'or', 'worse', 'adverse', 'event', '.', 'common', 'grade', 'or', 'worse', 'adverse', 'event', 'decreased', 'neutrophil', 'count', '(', 'of', 'participant', 'in', 'pembrolizumab', 'group', 'v', 'of', 'participant', 'in', 'placebo', 'group', ')', ',', 'stomatitis', '(', 'v', ')', ',', 'anaemia', '(', 'v', ')', ',', 'dysphagia', '(', 'v', ')', ',', 'and', 'decreased', 'lymphocyte', 'count', '(', 'v', ')', '.', 'serious', 'adverse', 'event', 'occurred', 'in', '(', ')', 'participant', 'in', 'pembrolizumab', 'group', 'versus', '(', ')', 'participant', 'in', 'placebo', 'group', ',', 'commonly', 'pneumonia', '(', 'v', ')', ',', 'acute', 'kidney', 'injury', '(', 'v', ')', ',', 'and', 'febrile', 'neutropenia', '(', 'v', 'seven', ')', '.', 'treatment-related', 'adverse', 'event', 'led', 'to', 'death', 'in', 'four', '(', ')', 'participant', 'in', 'pembrolizumab', 'group', '(', 'one', 'participant', 'aspiration', 'pneumonia', ',', 'end-stage', 'renal', 'disease', ',', 'pneumonia', ',', 'and', 'sclerosing', 'cholangitis', ')', 'and', 'six', '(', ')', 'participant', 'in', 'placebo', 'group', '(', 'three', 'participant', 'pharyngeal', 'haemorrhage', 'and', 'one', 'participant', 'mouth', 'haemorrhage', ',', 'post-procedural', 'haemorrhage', ',', 'and', 'sepsis', ')', '.', 'interpretation', 'pembrolizumab', 'plus', 'chemoradiotherapy', 'not', 'significantly', 'improve', 'event-free', 'survival', 'compared', 'with', 'chemoradiotherapy', 'alone', 'in', 'molecularly', 'unselected', ',', 'locally', 'advanced', 'hnscc', 'population', '.', 'no', 'new', 'safety', 'signal', 'seen', '.', 'locally', 'advanced', 'hnscc', 'remains', 'challenging', 'disease', 'requires', 'better', 'treatment', 'approach', '.', 'funding', 'merck', 'sharp', 'dohme', ',', 'subsidiary', 'of', 'merck', 'co', ',', 'rahway', ',', 'nj', ',', 'usa', '.']"
The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study.,"Richard Fisher, Katie Lei, Mike J Mitchell, Gary W Moore, Helen Dickie, Linda Tovey, Siobhan Crichton, Marlies Ostermann, Richard Fisheret al.",2017 Oct 2,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/28969597/,No keywords found,"['regional', 'anticoagulation', 'with', 'citrate', 'recommended', 'first', 'line', 'treatment', 'patient', 'receiving', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '.', 'wide', 'variability', 'in', 'filter', 'patency', 'may', 'due', 'to', 'difference', 'in', 'patient', 'characteristic', 'and', 'local', 'practice', '.', 'also', 'possible', 'citrate', 'effect', 'primary', 'and', 'secondary', 'haemostasis', ',', 'fibrinolysis', 'and', 'platelet', 'function', 'still', 'unknown', '.', 'primary', 'aim', 'of', 'study', 'to', 'describe', 'effect', 'of', 'citrate', 'coagulation', 'and', 'fibrinolysis', 'pathway', 'in', 'patient', 'and', 'haemodialysis', 'circuit', '.', 'method', 'study', 'recruit', 'adult', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', ',', 'requiring', 'crrt', 'with', 'regional', 'citrate', 'anticoagulation', 'acute', 'kidney', 'injury', '.', 'patient', 'with', 'pre-existing', 'thrombotic', 'or', 'bleeding', 'tendency', 'excluded', '.', 'thrombin', 'generation', ',', 'clot', 'lysis', 'and', 'platelet', 'function', 'measured', 'baseline', 'and', ',', ',', ',', 'and', 'h', 'commencing', 'crrt', '(', 'patient', 'and', 'circuit', ')', '.', 'describe', 'evolution', 'of', 'parameter', 'time', 'well', 'difference', 'in', 'parameter', 'patient', 'and', 'circuit', '.', 'discussion', 'study', 'provide', 'new', 'data', 'effect', 'of', 'citrate', 'continuous', 'renal', 'replacement', 'therapy', 'not', 'currently', 'available', '.', 'minimise', 'confounding', 'factor', 'use', 'of', 'tight', 'exclusion', 'criterion', 'and', 'accept', 'slow', 'recruitment', '.', 'depending', 'result', ',', 'hope', 'to', 'incorporate', 'finding', 'existing', 'clinical', 'guideline', 'and', 'clinical', 'practice', 'with', 'aim', 'to', 'prevent', 'premature', 'filter', 'clotting', 'and', 'interruption', 'in', 'treatment', '.', 'trial', 'registration', 'study', 'registered', 'with', 'clinicaltrials.gov', 'th', 'june', '(', 'nct', ')', '.']"
"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.","Toby M Maher, Ellen M van der Aar, Olivier Van de Steen, Lisa Allamassey, Julie Desrivot, Sonia Dupont, Liesbeth Fagard, Paul Ford, Ann Fieuw, Wim Wuyts, Toby M Maheret al.",2018 Aug,Lancet Respir Med,https://pubmed.ncbi.nlm.nih.gov/29792287/,No keywords found,"['idiopathic', 'pulmonary', 'fibrosis', '(', 'ipf', ')', 'cause', 'irreversible', 'loss', 'of', 'lung', 'function', '.', 'people', 'with', 'ipf', 'increased', 'concentration', 'of', 'autotaxin', 'in', 'lung', 'tissue', 'and', 'lysophosphatidic', 'acid', '(', 'lpa', ')', 'in', 'bronchoalveolar', 'lavage', 'fluid', 'and', 'exhaled', 'condensate', '.', 'glpg', '(', 'galapagos', ',', 'mechelen', ',', 'belgium', ')', 'novel', ',', 'potent', ',', 'selective', 'autotaxin', 'inhibitor', 'with', 'good', 'oral', 'exposure', '.', 'explored', 'effect', 'of', 'glpg', 'in', 'patient', 'with', 'ipf', '.', 'method', 'randomised', ',', 'double-blind', ',', 'placebo-controlled', 'phase', 'study', 'done', 'in', 'centre', 'in', 'italy', ',', 'ukraine', 'and', 'uk', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', ',', 'non-smokers', ',', 'not', 'taking', 'pirfenidone', 'or', 'nintedanib', ',', 'and', 'centrally', 'confirmed', 'diagnosis', 'of', 'ipf', '.', 'used', 'computer-generated', 'randomisation', 'schedule', 'to', 'assign', 'patient', 'to', 'receive', 'placebo', 'or', 'mg', 'oral', 'glpg', 'daily', 'week', '.', 'primary', 'outcome', 'safety', '(', 'adverse', 'event', ')', ',', 'tolerability', ',', 'pharmacokinetics', ',', 'and', 'pharmacodynamics', '.', 'spirometry', 'assessed', 'secondary', 'outcome', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'march', ',', ',', 'and', 'may', ',', ',', 'patient', 'screened.', ',', 'of', 'ineligible', 'and', 'enrolled', 'in', 'eight', 'centre', '(', 'six', 'in', 'ukraine', 'and', 'two', 'in', 'uk', ')', '.', 'six', 'patient', 'assigned', 'to', 'receive', 'placebo', 'and', 'to', 'receive', 'glpg', '.', 'patient', 'completed', 'study', 'one', 'in', 'group', 'discontinued', 'of', 'adverse', 'event', 'and', 'one', 'in', 'glpg', 'group', 'withdrew', 'consent', '.', 'four', '(', ')', 'patient', 'in', 'placebo', 'group', 'and', '(', ')', 'in', 'glpg', 'group', 'treatment-emergent', 'adverse', 'event', ',', 'of', 'mild', 'to', 'moderate', '.', 'frequent', 'event', 'in', 'glpg', 'group', 'infection', 'and', 'infestation', '(', 'ten', 'event', ')', 'and', 'respiratory', ',', 'thoracic', ',', 'and', 'mediastinal', 'disorder', '(', 'eight', 'event', ')', 'with', 'no', 'apparent', 'difference', 'placebo', 'group', '.', 'two', '(', ')', 'patient', 'in', 'glpg', 'group', 'event', 'judged', 'to', 'related', 'to', 'treatment', '.', 'serious', 'adverse', 'event', 'seen', 'in', 'two', 'patient', 'in', 'placebo', 'group', '(', 'one', 'urinary', 'tract', 'infection', ',', 'acute', 'kidney', 'injury', ',', 'and', 'lower', 'respiratory', 'tract', 'infection', 'and', 'atrioventricular', 'block', ',', 'second', 'degree', ')', 'and', 'one', 'in', 'glpg', 'group', '(', 'cholangiocarcinoma', 'resulted', 'in', 'discontinuation', 'of', 'treatment', ')', '.', 'no', 'patient', 'died', '.', 'pharmacokinetic', 'and', 'pharmacodynamic', 'profile', 'of', 'glpg', 'similar', 'to', 'previously', 'shown', 'in', 'healthy', 'control', '.', 'lpa', 'c', 'concentration', 'in', 'plasma', 'consistently', 'decreased', '.', 'mean', 'change', 'baseline', 'in', 'forced', 'vital', 'capacity', 'week', 'ml', '(', 'ci', '-', 'to', ')', 'glpg', 'and', '-', 'ml', '(', '-', 'to', 'ml', ')', 'placebo', '.', 'interpretation', 'finding', 'support', 'development', 'of', 'glpg', 'novel', 'treatment', 'ipf', '.', 'funding', 'galapagos', '.']"
Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.,"Mettu Srinivas Reddy, Ilankumaran Kaliamoorthy, Akila Rajakumar, Selvakumar Malleeshwaran, Ellango Appuswamy, Sukanya Lakshmi, Joy Varghese, Mohamed Rela, Mettu Srinivas Reddyet al.",2017 Aug,Liver Transpl,https://pubmed.ncbi.nlm.nih.gov/28294557/,No keywords found,"['perioperative', 'terlipressin', '(', 'tp', ')', 'living', 'donor', 'liver', 'transplantation', '(', 'ldlt', ')', 'shown', 'to', 'reduce', 'intraoperative', 'portal', 'pressure', 'and', 'improve', 'renal', 'function', '.', 'role', 'and', 'safety', 'profile', 'never', 'evaluated', 'in', 'double-blind', 'randomized', 'controlled', 'trial', '(', 'rct', ')', '.', 'aim', 'to', 'evaluate', 'hemodynamic', 'effect', ',', 'clinical', 'benefit', ',', 'and', 'safety', 'of', 'perioperative', 'tp', 'infusion', 'in', 'adult', 'ldlt', '.', 'single-center', 'double-blind', 'rct', '.', 'consenting', 'adult', 'with', 'chronic', 'liver', 'disease', 'and', 'low', 'risk', 'of', 'posttransplant', 'renal', 'dysfunction', 'undergoing', 'first', 'ldlt', 'randomized', '.', 'study', 'group', '(', 'terlipressin', 'group', 'tpg', ')', 'received', 'initial', 'bolus', 'of', 'tp', 'surgery', 'followed', 'tp', 'infusion', 'hour', 'in', 'postoperative', 'period', '.', 'placebo', 'group', '(', 'pbg', ')', 'received', 'saline', 'infusion', '.', 'primary', 'endpoint', 'portal', 'pressure', 'arterial', 'reperfusion', '.', 'multiple', 'intraoperative', 'and', 'postoperative', 'variable', 'served', 'secondary', 'endpoint', '.', 'total', 'of', 'patient', 'enrolled', 'in', 'trial', '(', 'tpg', ',', 'pbg', ',', ')', '.', 'no', 'significant', 'difference', 'in', 'intraoperative', 'portal', 'pressure', ',', 'blood', 'loss', ',', 'fluid', 'requirement', ',', 'vasopressor', 'requirement', ',', 'or', 'urine', 'output', '.', 'peak', 'intraoperative', 'and', 'end', 'of', 'surgery', 'lactate', 'level', 'significantly', 'higher', 'in', 'tp', 'group', '.', 'no', 'difference', 'in', 'postoperative', 'liver', 'function', 'test', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', 'assessed', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', ',', 'and', 'end-stage', 'kidney', 'disease', 'criterion', 'lower', 'in', 'tp', 'group', '(', 'versus', 'p', '.', ')', '.', 'tpg', 'less', 'postoperative', 'ascites', ',', 'lower', 'need', 'percutaneous', 'intervention', ',', 'and', 'shorter', 'hospital', 'stay', '.', 'incidence', 'of', 'bradycardia', 'requiring', 'pharmacological', 'intervention', 'and', 'withdrawal', 'study', 'significantly', 'higher', 'in', 'tpg', '.', 'in', 'conclusion', ',', 'study', 'not', 'demonstrated', 'reduction', 'in', 'postreperfusion', 'portal', 'pressure', 'with', 'tp', '.', 'however', ',', 'tp', 'infusion', 'reduced', 'postoperative', 'ascitic', 'drain', 'output', 'resulting', 'in', 'less', 'frequent', 'percutaneous', 'intervention', 'and', 'reduced', 'hospital', 'stay', '.', 'intraoperative', 'hyperlactatemia', 'and', 'symptomatic', 'bradycardia', 'major', 'concern', '.', 'use', 'restricted', 'to', 'patient', 'with', 'high-volume', 'ascites', ',', 'and', 'need', 'close', 'monitoring', 'drug', 'infusion', '.', 'liver', 'transplantation', '-', 'aasld', '.']"
"Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.","Fabrice Barlesi, Johan Vansteenkiste, David Spigel, Hidenobu Ishii, Marina Garassino, Filippo de Marinis, Mustafa Özgüroğlu, Aleksandra Szczesna, Andreas Polychronis, Ruchan Uslu, Maciej Krzakowski, Jong-Seok Lee, Luana Calabrò, Osvaldo Arén Frontera, Barbara Ellers-Lenz, Marcis Bajars, Mary Ruisi, Keunchil Park, Fabrice Barlesiet al.",2018 Nov,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/30262187/,No keywords found,"['antibody', 'targeting', 'immune', 'checkpoint', 'molecule', 'pd-', 'or', 'pd-l', 'demonstrated', 'clinical', 'efficacy', 'in', 'patient', 'with', 'metastatic', 'non-small-cell', 'lung', 'cancer', '(', 'nsclc', ')', '.', 'in', 'trial', 'investigated', 'efficacy', 'and', 'safety', 'of', 'avelumab', ',', 'anti-pd-l', 'antibody', ',', 'in', 'patient', 'with', 'nsclc', 'already', 'received', 'platinum-based', 'therapy', '.', 'method', 'javelin', 'lung', 'multicentre', ',', 'open-label', ',', 'randomised', ',', 'phase', 'trial', 'hospital', 'and', 'cancer', 'treatment', 'centre', 'in', 'country', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', 'and', 'stage', 'iiib', 'or', 'iv', 'or', 'recurrent', 'nsclc', 'and', 'disease', 'progression', 'treatment', 'with', 'platinum-containing', 'doublet', ',', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'score', 'of', 'or', ',', 'estimated', 'life', 'expectancy', 'of', 'week', ',', 'and', 'adequate', 'haematological', ',', 'renal', ',', 'and', 'hepatic', 'function', '.', 'participant', 'randomly', 'assigned', '(', ')', ',', 'via', 'interactive', 'voice-response', 'system', 'with', 'stratified', 'permuted', 'block', 'method', 'with', 'variable', 'block', 'length', ',', 'to', 'receive', 'either', 'avelumab', 'mgkg', 'every', 'week', 'or', 'docetaxel', 'mgm', 'every', 'week', '.', 'randomisation', 'stratified', 'pd-l', 'expression', '(', 'v', 'of', 'tumour', 'cell', ')', ',', 'measured', 'with', '-', 'assay', ',', 'and', 'histology', '(', 'squamous', 'v', 'non-squamous', ')', '.', 'primary', 'endpoint', 'overall', 'survival', ',', 'analysed', 'roughly', 'event', '(', 'death', ')', 'occurred', 'in', 'pd-l-positive', 'population', '.', 'efficacy', 'analysed', 'in', 'pd-l-positive', 'patient', '(', 'ie', ',', 'pd-l', 'expression', 'in', 'of', 'tumour', 'cell', ')', 'randomly', 'assigned', 'to', 'study', 'treatment', '(', 'primary', 'analysis', 'population', ')', 'and', 'in', 'randomly', 'assigned', 'patient', 'hierarchical', 'testing', 'procedure', '.', 'safety', 'analysed', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'study', 'treatment', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'enrolment', 'complete', ',', 'trial', 'ongoing', '.', 'finding', 'march', ',', ',', 'and', 'jan', ',', ',', 'patient', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'receive', 'avelumab', '(', 'n', ')', 'or', 'docetaxel', '(', 'n', ')', '.', 'participant', 'in', 'avelumab', 'group', 'and', 'in', 'docetaxel', 'group', 'pd-l-positive', 'tumour', '.', 'in', 'patient', 'with', 'pd-l-positive', 'tumour', ',', 'median', 'overall', 'survival', 'not', 'differ', 'significantly', 'avelumab', 'and', 'docetaxel', 'group', '(', 'month', 'ci', '-', 'v', 'month', '-', 'hazard', 'ratio', 'ci', '-', 'one-sided', 'p', ')', '.', 'treatment-related', 'adverse', 'event', 'occurred', 'in', '(', ')', 'of', 'avelumab-treated', 'patient', 'and', '(', ')', 'of', 'docetaxel-treated', 'patient', ',', 'including', 'grade', '-', 'event', 'in', '(', ')', 'and', '(', ')', 'patient', ',', 'respectively', '.', 'common', 'grade', '-', 'treatment-related', 'adverse', 'event', 'infusion-related', 'reaction', '(', 'six', 'patient', ')', 'and', 'increased', 'lipase', '(', 'four', ')', 'in', 'avelumab', 'group', 'and', 'neutropenia', '(', ')', ',', 'febrile', 'neutropenia', '(', ')', ',', 'and', 'decreased', 'neutrophil', 'count', '(', ')', 'in', 'docetaxel', 'group', '.', 'serious', 'treatment-related', 'adverse', 'event', 'occurred', 'in', '(', ')', 'patient', 'in', 'avelumab', 'group', 'and', '(', ')', 'in', 'docetaxel', 'group', '.', 'treatment-related', 'death', 'occurred', 'in', 'four', '(', ')', 'participant', 'in', 'avelumab', 'group', ',', 'two', 'due', 'to', 'interstitial', 'lung', 'disease', ',', 'one', 'due', 'to', 'acute', 'kidney', 'injury', ',', 'and', 'one', 'due', 'to', 'combination', 'of', 'autoimmune', 'myocarditis', ',', 'acute', 'cardiac', 'failure', ',', 'and', 'respiratory', 'failure', '.', 'treatment-related', 'death', 'occurred', 'in', '(', ')', 'patient', 'in', 'docetaxel', 'group', ',', 'three', 'due', 'to', 'pneumonia', ',', 'and', 'one', 'due', 'to', 'febrile', 'neutropenia', ',', 'septic', 'shock', ',', 'febrile', 'neutropenia', 'with', 'septic', 'shock', ',', 'acute', 'respiratory', 'failure', ',', 'cardiovascular', 'insufficiency', ',', 'renal', 'impairment', ',', 'leucopenia', 'with', 'mucosal', 'inflammation', 'and', 'pyrexia', ',', 'infection', ',', 'neutropenic', 'infection', ',', 'dehydration', ',', 'and', 'unknown', 'cause', '.', 'interpretation', 'compared', 'with', 'docetaxel', ',', 'avelumab', 'not', 'improve', 'overall', 'survival', 'in', 'patient', 'with', 'platinum-treated', 'pd-l-positive', 'nsclc', ',', 'favourable', 'safety', 'profile', '.', 'funding', 'merck', 'and', 'pfizer', '.']"
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.,"Adam P Bress, Tom Greene, Catherine G Derington, Jincheng Shen, Yizhe Xu, Yiyi Zhang, Jian Ying, Brandon K Bellows, William C Cushman, Paul K Whelton, Nicholas M Pajewski, David Reboussin, Srinivasan Beddu, Rachel Hess, Jennifer S Herrick, Zugui Zhang, Paul Kolm, Robert W Yeh, Sanjay Basu, William S Weintraub, Andrew E Moran                              ;, SPRINT Research Group, Adam P Bresset al.",2021 Apr 27,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/33888247/,No keywords found,"['intensive', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'treatment', 'prevents', 'cardiovascular', 'disease', '(', 'cvd', ')', 'event', 'in', 'patient', 'with', 'high', 'cvd', 'risk', 'average', ',', 'though', 'benefit', 'likely', 'vary', 'among', 'patient', '.', 'objective', 'aim', 'of', 'study', 'to', 'predict', 'magnitude', 'of', 'benefit', '(', 'reduced', 'cvd', 'and', 'all-cause', 'mortality', 'risk', ')', 'along', 'with', 'adverse', 'event', '(', 'ae', ')', 'risk', 'intensive', 'versus', 'standard', 'sbp', 'treatment', '.', 'method', 'secondary', 'analysis', 'of', 'sprint', '(', 'systolic', 'blood', 'pressure', 'intervention', 'trial', ')', '.', 'separate', 'benefit', 'outcome', 'first', 'occurrence', 'of', ')', 'cvd', 'composite', 'of', 'acute', 'myocardial', 'infarction', 'or', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'heart', 'failure', ',', 'or', 'cvd', 'death', 'and', ')', 'all-cause', 'mortality', '.', 'treatment-related', 'aes', 'of', 'interest', 'included', 'hypotension', ',', 'syncope', ',', 'bradycardia', ',', 'electrolyte', 'abnormality', ',', 'injurious', 'fall', ',', 'and', 'acute', 'kidney', 'injury', '.', 'modified', 'elastic', 'net', 'cox', 'regression', 'used', 'to', 'predict', 'absolute', 'risk', 'outcome', 'and', 'absolute', 'risk', 'difference', 'basis', 'of', 'baseline', 'variable', 'available', 'point', 'of', 'care', 'with', 'intensive', 'versus', 'standard', 'treatment', '.', 'result', 'among', ',', 'sprint', 'participant', '(', 'mean', 'age', '.', 'year', ',', 'woman', ')', ',', 'cvd', 'composite', 'event', ',', 'all-cause', 'death', ',', 'and', 'treatment-related', 'aes', 'occurred', 'median', 'follow-up', 'period', 'of', '.', 'year', '.', 'individual', 'participant', 'risk', 'predicted', 'cvd', 'composite', '(', 'c', 'index', '.', ')', ',', 'all-cause', 'mortality', '(', 'c', 'index', '.', ')', ',', 'and', 'treatment-related', 'aes', '(', 'c', 'index', '.', ')', '.', 'higher', 'baseline', 'cvd', 'risk', 'associated', 'with', 'greater', 'benefit', '(', 'i.e.', ',', 'larger', 'absolute', 'cvd', 'risk', 'reduction', ')', '.', 'predicted', 'cvd', 'benefit', 'and', 'predicted', 'increased', 'treatment-related', 'ae', 'risk', 'correlated', '(', 'spearman', 'correlation', 'coefficient', '-', '.', ')', ',', 'and', 'of', 'participant', 'fell', 'highest', 'tertile', 'of', 'predicted', 'benefit', 'also', 'high', 'or', 'moderate', 'predicted', 'increase', 'in', 'treatment-related', 'ae', 'risk', '.', 'predicted', 'high', 'benefit', 'with', 'low', 'ae', 'risk', '(', '.', ')', 'or', 'low', 'benefit', 'with', 'high', 'ae', 'risk', '(', '.', ')', '.', 'similar', 'result', 'obtained', 'all-cause', 'mortality', '.', 'conclusion', 'sprint', 'participant', 'with', 'higher', 'baseline', 'predicted', 'cvd', 'risk', 'gained', 'greater', 'absolute', 'benefit', 'intensive', 'treatment', '.', 'participant', 'with', 'high', 'predicted', 'benefit', 'also', 'likely', 'to', 'experience', 'treatment-related', 'aes', ',', 'aes', 'generally', 'mild', 'and', 'transient', '.', 'patient', 'prioritized', 'intensive', 'sbp', 'treatment', 'basis', 'of', 'higher', 'predicted', 'benefit', '.', '(', 'systolic', 'blood', 'pressure', 'intervention', 'trial', 'sprint', 'nct', ')', '.']"
Effect of Ascorbic Acid on Postoperative Acute Kidney Injury in Coronary Artery Bypass Graft Patients: A Pilot Study.,"Miha Antonic, Miha Antonic.",2017 Oct 24,Heart Surg Forum,https://pubmed.ncbi.nlm.nih.gov/29087285/,No keywords found,"['even', 'minor', 'postoperative', 'reduction', 'in', 'renal', 'function', 'influence', 'outcome', 'of', 'cardiac', 'surgery', '.', 'mechanism', 'of', 'postoperative', 'renal', 'injury', 'in', 'cardiac', 'surgery', 'multifactorial', 'and', 'include', 'ischemia-reperfusion', 'injury', '.', 'study', 'investigates', 'effect', 'of', 'antioxidant', 'ascorbic', 'acid', 'postoperative', 'acute', 'kidney', 'injury', 'elective', 'cabg', 'surgery', '.', 'method', 'prospective', 'randomized', 'single-center', 'trial', 'conducted', 'in', 'on-pump', 'coronary', 'artery', 'bypass', 'patient', '.', 'patient', 'in', 'ascorbic', 'acid', 'group', 'received', 'gram', 'of', 'ascorbic', 'acid', 'hour', 'and', 'hour', 'preoperatively', 'and', 'gram', 'twice', 'daily', 'five', 'day', 'surgery', '.', 'postoperatively', ',', 'subject', 'monitored', 'renal', 'dysfunction', 'and', 'complication', '.', 'result', 'patient', 'included', ',', 'with', 'patient', 'in', 'study', 'group', '.', 'group', 'well', 'matched', 'baseline', 'demographic', ',', 'preoperative', 'medication', ',', 'comorbidities', ',', 'and', 'similar', 'intraoperative', 'characteristic', '.', 'incidence', 'of', 'postoperative', 'acute', 'kidney', 'injury', 'in', 'ascorbic', 'acid', 'group', 'and', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'group', 'also', 'not', 'differ', 'in', 'peak', 'postoperative', 'serum', 'creatinine', '(', 'moll', 'versus', 'moll', 'p', '.', ')', ',', 'lowest', 'postoperative', 'creatinine', 'clearance', '(', '.', '.', 'mlmin', 'versus', '.', '.', 'mlmin', 'p', '.', ')', ',', 'and', 'time', 'surgery', 'to', 'onset', 'of', 'peak', 'postoperative', 'serum', 'creatinine', '(', '.', '.', 'day', 'versus', '.', '.', 'day', 'p', '.', ')', '.', 'no', 'dialysis', 'required', 'in', 'patient', '.', 'conclusion', 'result', 'of', 'study', 'not', 'demonstrate', 'significant', 'protective', 'effect', 'of', 'ascorbic', 'acid', 'incidence', 'of', 'postoperative', 'acute', 'renal', 'injury', 'in', 'elective', 'on-pump', 'cabg', 'patient', '.']"
Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial.,"Bram Rochwerg, Tina Millen, Peggy Austin, Michelle Zeller, Frédérick D'Aragon, Roman Jaeschke, Marie-Hélène Masse, Sangeeta Mehta, Francois Lamontagne, Maureen Meade, Gordon Guyatt, Deborah J Cook                                                            ;, Canadian Critical Care Trials Group, Bram Rochwerget al.",2017 Jul 20,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/28729329/,No keywords found,"['observational', 'evidence', 'suggests', 'physiological', 'benefit', 'and', 'lower', 'mortality', 'with', 'lower', 'chloride', 'solution', 'however', ',', '.', 'saline', 'remains', 'widely', 'used', 'fluid', 'worldwide', '.', 'given', 'uncertainty', 'regarding', 'association', 'of', 'lower', 'chloride', 'mortality', ',', 'unlikely', 'practice', 'change', 'without', 'direct', 'randomised', 'clinical', 'trial', '(', 'rct', ')', 'evidence', '.', 'pilot', 'rct', 'investigate', 'feasibility', 'of', 'large-scale', 'trial', 'directly', 'comparing', 'low', 'chloride', 'with', 'high', 'chloride', 'fluid', 'in', 'patient', 'with', 'septic', 'shock', '.', 'method', 'and', 'analysis', 'randomised', ',', 'concealed', ',', 'blinded', 'parallel-group', 'multicentre', 'pilot', 'trial', '.', 'include', 'adult', 'critically', 'ill', 'patient', 'with', 'septic', 'shock', ',', 'defined', 'ongoing', 'hypotension', 'despite', 'l', 'of', 'fluid', ',', 'or', 'serum', 'lactate', 'mmoll', ',', 'within', 'hour', 'of', 'hospital', 'presentation', 'or', 'rapid', 'response', 'team', 'activation', '.', 'exclude', 'patient', 'aetiology', 'of', 'shock', 'sepsis', ',', 'acute', 'burn', 'injury', ',', 'elevated', 'intracranial', 'pressure', ',', 'intent', 'to', 'withdraw', 'life', 'support', 'or', 'previous', 'enrolment', 'in', 'or', 'competing', 'trial', '.', 'following', 'informed', 'consent', ',', 'patient', 'randomised', 'to', 'low', 'chloride', 'fluid', 'strategy', 'or', 'high', 'chloride', 'fluid', 'strategy', 'duration', 'of', 'icu', 'stay', 'or', 'day', 'postrandomisation', '.', 'clinician', ',', 'patient', ',', 'family', 'and', 'research', 'staff', 'blinded', '.', 'primary', 'outcome', 'trial', 'feasibility', ',', 'assessed', 'consent', 'rate', ',', 'recruitment', 'success', 'and', 'protocol', 'adherence', '.', 'patient-important', 'clinical', 'outcome', 'include', 'mortality', ',', 'receipt', 'of', 'renal', 'replacement', 'therapy', ',', 'intensive', 'care', 'unit', 'and', 'hospital', 'length', 'of', 'stay', 'and', 'surrogate', 'outcome', 'of', 'incidence', 'of', 'acidosis', ',', 'hyperkalaemia', 'and', 'acute', 'kidney', 'injury', '.', 'ethic', 'and', 'dissemination', 'pilot', 'trial', 'test', 'feasibility', 'of', 'conducting', 'main', 'trial', ',', 'examine', 'effect', 'of', 'high', 'versus', 'low', 'chloride', 'fluid', 'in', 'patient', 'with', 'septic', 'shock', 'patient-important', 'outcome', '.', 'trial', 'registration', 'number', 'nct', ',', 'registered', 'april', '.', 'protocol', 'date', 'july', '.']"
The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study).,"Sean M Bagshaw, R T Noel Gibney, Peter Kruger, Imran Hassan, Finlay A McAlister, Rinaldo Bellomo, Sean M Bagshawet al.",2017 Dec:42:138-146.,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/28732314/,No keywords found,"['furosemide', 'commonly', 'prescribed', 'in', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'prior', 'study', 'found', 'conflicting', 'finding', 'whether', 'furosemide', 'modifies', 'course', 'and', 'outcome', 'of', 'aki', '.', 'method', 'pilot', 'multi-center', 'randomized', 'blinded', 'placebo-controlled', 'trial', 'in', 'adult', 'patient', 'with', 'aki', 'admitted', 'to', 'three', 'intensive', 'care', 'unit', '.', 'participant', 'randomly', 'allocated', 'to', 'furosemide', 'bolus', 'and', 'infusion', 'or', '.', 'saline', 'placebo', '.', 'primary', 'endpoint', 'worsening', 'aki', ',', 'defined', 'rifle', 'criterion', '.', 'secondary', 'endpoint', 'kidney', 'recovery', ',', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'and', 'adverse', 'event', '.', 'result', 'trial', 'terminated', 'enrollment', 'of', 'participant', '(', 'to', 'furosemide', 'and', 'to', 'placebo', ')', '.', 'mean', '(', 'sd', ')', 'age', '.', '(', '.', ')', ',', '.', 'medical', 'admission', ',', 'mean', '(', 'sd', ')', 'apache', 'ii', 'score', '.', '(', '.', ')', ',', '.', 'received', 'mechanical', 'ventilation', 'and', '.', 'received', 'vasoactives', '.', 'group', 'similar', 'baseline', '.', 'no', 'difference', 'found', 'in', 'proportion', 'with', 'worsening', 'aki', '(', '.', 'v', '.', '.', ',', 'p.', ')', ',', 'kidney', 'recovery', '(', '.', 'v', '.', '.', ',', 'p.', ')', ',', 'or', 'rrt', '(', '.', '.', '.', ',', 'p.', ')', '.', 'adverse', 'event', ',', 'mostly', 'electrolyte', 'abnormality', ',', 'common', 'in', 'furosemide-treated', 'patient', '(', 'p.', ')', '.', 'protocol', 'deviation', 'common', ',', 'due', 'often', 'to', 'supplementary', 'furosemide', '.', 'conclusion', 'in', 'pilot', 'trial', ',', 'furosemide', 'not', 'reduce', 'rate', 'of', 'worsening', 'aki', ',', 'improve', 'recovery', 'or', 'reduce', 'rrt', 'however', ',', 'associated', 'with', 'greater', 'electrolyte', 'abnormality', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', 'registered', 'september', ',', '.']"
Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.,"Takahide Nawa, Kazuhiko Nishigaki, Yujiro Kinomura, Toshiki Tanaka, Yoshihisa Yamada, Masanori Kawasaki, Shinya Minatoguchi, Takahide Nawaet al.",2015 Sep 15:195:228-34.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/26048382/,No keywords found,"['conducted', 'prospective', 'randomized', 'trial', 'to', 'assess', 'protective', 'effect', 'of', 'continuous', 'intravenous', 'infusion', 'of', 'nicorandil', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'in', 'patient', 'with', 'poor', 'renal', 'function', '.', 'method', 'and', 'result', 'randomly', 'assigned', 'patient', 'would', 'subsequently', 'undergo', 'elective', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'and', 'high', 'serum', 'cystatin', 'c', 'level', 'to', 'saline', 'group', '(', 'n', ')', 'or', 'nicorandil', 'group', '(', 'n', ',', 'nicorandil', 'infused', 'in', 'addition', 'to', 'saline', 'h', 'and', 'h', 'pci', ')', '.', 'no', 'significant', 'difference', 'in', 'baseline', 'characteristic', 'two', 'group', '.', 'however', ',', 'average', 'percent', 'increase', 'in', 'serum', 'creatinine', 'and', 'cystatin', 'c', 'following', 'pci', 'significantly', 'smaller', 'in', 'nicorandil', 'group', 'saline', 'group', '.', 'likewise', ',', 'average', 'percent', 'decline', 'in', 'estimated', 'glomerular', 'filtration', 'rate', 'smaller', 'in', 'nicorandil', 'group', '.', 'correspondingly', ',', 'incidence', 'of', 'cin', 'dramatically', 'lower', 'in', 'nicorandil', 'group', 'saline', 'group', '(', '.', 'v', '.', '.', ',', 'p.', ')', '.', 'univariate', 'regression', 'analysis', 'revealed', 'nicorandil', 'treatment', 'to', 'significant', 'predictor', 'of', 'cin', 'development', '(', 'odds', 'ratio', '.', ',', 'confidence', 'interval', '.-.', ',', 'p.', ')', '.', 'conclusion', 'nicorandil', 'strongly', 'prevents', 'cin', 'in', 'patient', 'with', 'poor', 'renal', 'function', 'undergoing', 'pci', '.']"
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.,"François Lamontagne, Alvin Richards-Belle, Karen Thomas, David A Harrison, M Zia Sadique, Richard D Grieve, Julie Camsooksai, Robert Darnell, Anthony C Gordon, Doreen Henry, Nicholas Hudson, Alexina J Mason, Michelle Saull, Chris Whitman, J Duncan Young, Kathryn M Rowan, Paul R Mouncey                              ;, trial investigators, François Lamontagneet al.",2020 Mar 10,JAMA,https://pubmed.ncbi.nlm.nih.gov/32049269/,No keywords found,"['vasopressor', 'commonly', 'administered', 'to', 'intensive', 'care', 'unit', '(', 'icu', ')', 'patient', 'to', 'raise', 'blood', 'pressure', '.', 'balancing', 'risk', 'and', 'benefit', 'of', 'vasopressor', 'challenge', ',', 'particularly', 'in', 'older', 'patient', '.', 'objective', 'to', 'determine', 'whether', 'reducing', 'exposure', 'to', 'vasopressor', 'permissive', 'hypotension', '(', 'mean', 'arterial', 'pressure', 'map', 'target', ',', '-', 'mm', 'hg', ')', 'reduces', 'mortality', 'day', 'in', 'icu', 'patient', 'aged', 'year', 'or', 'older', 'with', 'vasodilatory', 'hypotension', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'multicenter', ',', 'pragmatic', ',', 'randomized', 'clinical', 'trial', 'conducted', 'in', 'icu', 'in', 'united', 'kingdom', 'and', 'included', 'randomized', 'patient', 'aged', 'year', 'or', 'older', 'with', 'vasodilatory', 'hypotension', '(', 'assessed', 'treating', 'clinician', ')', '.', 'study', 'conducted', 'july', 'to', 'march', ',', 'and', 'follow-up', 'completed', 'in', 'august', '.', 'intervention', 'patient', 'randomized', 'to', 'vasopressor', 'guided', 'either', 'map', 'target', '(', '-', 'mm', 'hg', ',', 'permissive', 'hypotension', ')', '(', 'n', ')', 'or', 'according', 'to', 'usual', 'care', '(', 'discretion', 'of', 'treating', 'clinician', ')', '(', 'n', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'clinical', 'outcome', 'all-cause', 'mortality', 'day', '.', 'result', 'of', 'randomized', 'patient', ',', 'removal', 'of', 'declined', 'or', 'withdrawn', 'consent', ',', '(', ')', 'included', 'in', 'analysis', 'of', 'primary', 'outcome', '(', 'mean', 'sd', 'age', 'year', 'year', 'men', ')', '.', 'patient', 'randomized', 'to', 'permissive', 'hypotension', 'group', 'lower', 'exposure', 'to', 'vasopressor', 'compared', 'with', 'in', 'usual', 'care', 'group', '(', 'median', 'duration', 'hour', 'v', 'hour', 'difference', 'in', 'median', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'hour', 'total', 'dose', 'in', 'norepinephrine', 'equivalent', 'median', ',', '.', 'mg', 'v', '.', 'mg', 'difference', 'in', 'median', ',', '-', '.', 'mg', 'ci', ',', '-', '.', 'to', '-', '.', 'mg', ')', '.', 'day', ',', 'of', '(', '.', ')', 'in', 'permissive', 'hypotension', 'compared', 'with', 'of', '(', '.', ')', 'in', 'usual', 'care', 'group', 'died', '(', 'absolute', 'risk', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '(', 'unadjusted', 'relative', 'risk', ',', '.', 'ci', ',', '.-.', ')', '.', 'adjusted', 'prespecified', 'baseline', 'variable', ',', 'odds', 'ratio', '-day', 'mortality', '.', '(', 'ci', ',', '.', 'to', '.', ')', '.', 'serious', 'adverse', 'event', 'reported', 'patient', '(', '.', ')', 'in', 'permissive', 'care', 'group', 'and', 'patient', '(', '.', ')', 'in', 'usual', 'care', 'group', '.', 'common', 'serious', 'adverse', 'event', 'acute', 'renal', 'failure', '(', '.', 'v', '.', ')', 'and', 'supraventricular', 'cardiac', 'arrhythmia', '(', '.', 'v', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'year', 'or', 'older', 'receiving', 'vasopressor', 'vasodilatory', 'hypotension', ',', 'permissive', 'hypotension', 'compared', 'with', 'usual', 'care', 'not', 'result', 'in', 'statistically', 'significant', 'reduction', 'in', 'mortality', 'day', '.', 'however', ',', 'confidence', 'interval', 'around', 'point', 'estimate', 'primary', 'outcome', 'considered', 'interpreting', 'clinical', 'importance', 'of', 'study', '.', 'trial', 'registration', 'isrctn.org', 'identifier', 'isrctn', '.']"
"Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial.","Justin Z Chen, Holly L Hoang, Maryna Yaskina, Dima Kabbani, Karen E Doucette, Stephanie W Smith, Cecilia Lau, Jackson Stewart, Shahileen Remtulla, Karen Zurek, Morgan Schultz, Hiromi Koriyama-McKenzie, Carlos Cervera, Justin Z Chenet al.",2023 Jun,Lancet Infect Dis,https://pubmed.ncbi.nlm.nih.gov/36716763/,No keywords found,"['covid-', 'pandemic', 'associated', 'with', 'increased', 'antimicrobial', 'use', 'despite', 'low', 'rate', 'of', 'bacterial', 'co-infection', '.', 'prospective', 'audit', 'and', 'feedback', 'recommended', 'to', 'optimise', 'antibiotic', 'prescribing', ',', 'high-quality', 'evidence', 'supporting', 'use', 'covid-', 'absent', '.', 'aimed', 'to', 'study', 'efficacy', 'and', 'safety', 'of', 'prospective', 'audit', 'and', 'feedback', 'in', 'patient', 'admitted', 'to', 'hospital', 'treatment', 'of', 'covid-', '.', 'method', 'covasp', 'prospective', ',', 'pragmatic', ',', 'non-inferiority', ',', 'small-unit', ',', 'cluster-randomised', 'trial', 'comparing', 'prospective', 'audit', 'and', 'feedback', 'plus', 'standard', 'of', 'care', 'with', 'standard', 'of', 'care', 'alone', 'in', 'adult', 'admitted', 'to', 'three', 'hospital', 'in', 'edmonton', ',', 'ab', ',', 'canada', ',', 'with', 'covid-', 'pneumonia', '.', 'patient', 'aged', 'least', 'year', 'admitted', 'community', 'to', 'designated', 'study', 'bed', 'with', 'microbiologically', 'confirmed', 'sars-cov-', 'infection', 'in', 'preceding', 'day', 'included', 'oxygen', 'saturation', 'of', 'or', 'lower', 'room', 'air', ',', 'required', 'supplemental', 'oxygen', ',', 'or', 'chest-imaging', 'finding', 'compatible', 'with', 'covid-', 'pneumonia', '.', 'patient', 'excluded', 'transferred', 'in', 'another', 'acute', 'care', 'centre', ',', 'enrolled', 'in', 'another', 'clinical', 'trial', 'involved', 'antibiotic', 'therapy', ',', 'expected', 'to', 'progress', 'to', 'palliative', 'care', 'or', 'death', 'within', 'h', 'of', 'hospital', 'admission', ',', 'or', 'managed', 'member', 'of', 'research', 'team', 'within', 'day', 'of', 'enrolment', '.', 'covid-', 'unit', 'and', 'critical', 'care', 'unit', 'bed', 'stratified', 'and', 'randomly', 'assigned', '(', ')', 'to', 'prospective', 'audit', 'and', 'feedback', 'plus', 'standard', 'of', 'care', 'group', 'or', 'standard', 'of', 'care', 'group', '.', 'patient', 'masked', 'to', 'bed', 'assignment', 'attending', 'physician', 'and', 'study', 'team', 'not', '.', 'primary', 'outcome', 'clinical', 'status', 'postadmission', 'day', ',', 'measured', 'using', 'seven-point', 'ordinal', 'scale', '.', 'used', 'non-inferiority', 'margin', 'of', '.', 'analysis', 'intention', 'to', 'treat', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'closed', '.', 'finding', 'march', 'and', 'oct', ',', ',', 'patient', 'screened', 'and', 'enrolled', 'prospective', 'audit', 'and', 'feedback', 'plus', 'standard', 'of', 'care', 'group', ',', 'of', 'completed', 'study', ',', 'and', 'standard', 'of', 'care', 'group', ',', 'of', 'completed', 'study', '.', 'baseline', 'characteristic', 'similar', 'group', ',', 'with', 'overall', 'mean', 'age', 'of', 'year', '(', 'sd', ')', 'and', 'median', 'baseline', 'ordinal', 'scale', 'of', '(', 'iqr', '-', ')', '.', 'audit', 'and', 'feedback', 'event', 'recorded', 'in', 'intervention', 'group', 'and', 'recommendation', 'made', ',', 'of', '(', ')', 'accepted', '.', 'despite', 'lower', 'antibiotic', 'use', 'in', 'intervention', 'group', 'in', 'control', 'group', '(', 'length', 'of', 'therapy', 'v', 'day', 'per', 'patient', 'day', ')', ',', 'clinical', 'status', 'postadmission', 'day', 'non-inferior', '(', 'median', 'ordinal', 'score', 'iqr', '-', 'v', 'iqr', '-', 'p', ',', 'mann-whitney', 'u', 'test', ')', '.', 'neutropenia', 'uncommon', 'in', 'intervention', 'group', '(', 'of', 'patient', ')', 'and', 'control', 'group', '(', 'of', 'patient', ')', ',', 'and', 'acute', 'kidney', 'injury', 'occurred', 'similar', 'rate', 'in', 'group', '(', 'of', 'patient', 'in', 'intervention', 'group', 'and', 'of', 'patient', 'in', 'control', 'group', ')', '.', 'no', 'intervention-related', 'death', 'recorded', '.', 'interpretation', 'cluster-randomised', 'clinical', 'trial', 'show', 'prospective', 'audit', 'and', 'feedback', 'safe', 'and', 'effective', 'in', 'optimising', 'and', 'reducing', 'antibiotic', 'use', 'in', 'adult', 'admitted', 'to', 'hospital', 'with', 'covid-', '.', 'despite', 'many', 'competing', 'priority', 'covid-', 'pandemic', ',', 'antimicrobial', 'stewardship', 'remain', 'priority', 'to', 'mitigate', 'overuse', 'of', 'antibiotic', 'in', 'population', '.', 'funding', 'none', '.']"
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.,"William R Zhang, Timothy E Craven, Rakesh Malhotra, Alfred K Cheung, Michel Chonchol, Paul Drawz, Mark J Sarnak, Chirag R Parikh, Michael G Shlipak, Joachim H Ix                              ;, SPRINT Research Group, William R Zhanget al.",2018 Nov 6,Ann Intern Med,https://pubmed.ncbi.nlm.nih.gov/30357395/,No keywords found,"['whether', 'increased', 'incidence', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'intensive', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'lowering', 'accompanied', 'intrinsic', 'kidney', 'injury', 'unknown', '.', 'objective', 'to', 'compare', 'change', 'in', 'kidney', 'damage', 'biomarkers', 'incident', 'ckd', 'case', 'participant', 'and', 'matched', 'control', 'participant', 'well', 'case', 'participant', 'in', 'intensive', '(', 'mm', 'hg', ')', 'versus', 'standard', '(', 'mm', 'hg', ')', 'sbp', 'management', 'group', 'of', 'sprint', '(', 'systolic', 'blood', 'pressure', 'intervention', 'trial', ')', '.', 'design', 'nested', 'case-control', 'study', 'within', 'sprint', '.', 'setting', 'adult', 'with', 'hypertension', 'without', 'baseline', 'kidney', 'disease', '.', 'participant', 'case', 'participant', '(', 'n', ')', ',', 'developed', 'incident', 'ckd', 'trial', 'follow-up', '(', 'in', 'intensive', 'and', 'in', 'standard', 'group', ')', ',', 'and', 'control', 'participant', '(', 'n', ')', 'without', 'incident', 'ckd', ',', 'matched', 'age', ',', 'sex', ',', 'race', ',', 'baseline', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'and', 'randomization', 'group', '.', 'measurement', 'urinary', 'biomarkers', 'of', 'kidney', 'damage', 'measured', 'baseline', 'and', 'year', '.', 'linear', 'mixed-effects', 'model', 'used', 'to', 'estimate', '-year', 'biomarker', 'change', '.', 'result', 'higher', 'concentration', 'of', 'urinary', 'albumin', ',', 'kidney', 'injury', 'molecule-', ',', 'and', 'monocyte', 'chemoattractant', 'protein-', 'baseline', 'significantly', 'associated', 'with', 'greater', 'odds', 'of', 'incident', 'ckd', '(', 'adjusted', 'odds', 'ratio', 'per', 'doubling', '.', 'ci', ',', '.', 'to', '.', ',', '.', 'ci', ',', '.', 'to', '.', ',', 'and', '.', 'ci', ',', '.', 'to', '.', ',', 'respectively', ')', '.', 'year', 'of', 'blood', 'pressure', 'intervention', ',', 'incident', 'ckd', 'case', 'participant', 'in', 'intensive', 'group', 'significantly', 'greater', 'decrease', 'in', 'albumin-creatinine', 'ratio', '(', 'acr', ')', ',', 'interleukin-', ',', 'anti-chitinase', '--', 'like', 'protein', '(', 'ykl-', ')', ',', 'and', 'uromodulin', 'matched', 'control', 'participant', '.', 'compared', 'with', 'case', 'participant', 'in', 'standard', 'group', ',', 'in', 'intensive', 'group', 'significantly', 'greater', 'decrease', 'in', 'acr', ',', '-microglobulin', ',', '-microglobulin', ',', 'ykl-', ',', 'and', 'uromodulin', '.', 'limitation', 'biomarker', 'measurement', 'available', 'baseline', 'and', 'year', '.', 'conclusion', 'incident', 'ckd', 'in', 'setting', 'of', 'intensive', 'sbp', 'lowering', 'accompanied', 'decrease', ',', 'rather', 'elevation', ',', 'in', 'level', 'of', 'kidney', 'damage', 'biomarkers', 'and', 'thus', 'may', 'reflect', 'benign', 'change', 'in', 'renal', 'blood', 'flow', 'rather', 'intrinsic', 'injury', '.', 'primary', 'funding', 'source', 'national', 'institute', 'diabetes', 'and', 'digestive', 'and', 'kidney', 'disease', '.']"
"Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.","Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, Tae Won Kim, Pamela N Munster, John C Krauss, Gerald S Falchook, Sae-Won Han, Volker Heinemann, Kei Muro, John H Strickler, David S Hong, Crystal S Denlinger, Gustavo Girotto, Myung-Ah Lee, Haby Henary, Qui Tran, Joseph K Park, Gataree Ngarmchamnanrith, Hans Prenen, Timothy J Price, Marwan G Fakihet al.",2022 Jan,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/34919824/,No keywords found,"['sotorasib', ',', 'specific', ',', 'irreversible', 'krasgc', 'protein', 'inhibitor', ',', 'shown', 'monotherapy', 'clinical', 'activity', 'in', 'krasgc-mutated', 'solid', 'tumour', ',', 'including', 'colorectal', 'cancer', ',', 'in', 'codebreak', 'phase', 'trial', '.', 'aimed', 'to', 'investigate', 'activity', 'and', 'safety', 'of', 'sotorasib', 'in', 'phase', 'of', 'trial', '.', 'method', 'in', 'single-arm', ',', 'phase', 'trial', ',', 'adult', 'patient', 'with', 'krasgc-mutated', 'advanced', 'solid', 'tumour', 'enrolled', ',', 'medical', 'centre', 'in', 'country', ',', 'aged', 'year', 'or', 'older', ',', 'least', 'one', 'measurable', 'lesion', 'according', 'to', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumour', '(', 'recist', ')', 'version', '.', ',', 'and', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'of', 'or', 'lower', '.', 'data', 'patient', 'with', 'colorectal', 'cancer', ',', 'enrolled', 'medical', 'centre', 'in', 'nine', 'country', ',', 'presented', 'basket', 'trial', '.', 'to', 'enrolled', ',', 'patient', 'to', 'progressed', 'receiving', 'fluoropyrimidine', ',', 'oxaliplatin', ',', 'and', 'irinotecan', 'treatment', '.', 'patient', 'administered', 'mg', 'sotorasib', 'orally', 'per', 'day', 'disease', 'progression', ',', 'development', 'of', 'unacceptable', 'side-effects', ',', 'withdrawal', 'of', 'consent', ',', 'or', 'death', '.', 'primary', 'endpoint', 'objective', 'response', '(', 'complete', 'or', 'partial', 'response', ')', 'assessed', 'blinded', 'independent', 'central', 'review', '.', 'response', 'evaluated', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'sotorasib', 'and', 'least', 'one', 'measurable', 'lesion', 'baseline', 'safety', 'evaluated', 'in', 'patient', 'received', 'least', 'one', 'dose', 'of', 'sotorasib', '.', 'analysis', 'prespecified', 'analysis', 'triggered', 'phase', 'colorectal', 'cancer', 'cohort', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'active', 'no', 'longer', 'recruiting', '.', 'finding', 'march', ',', ',', 'data', 'cutoff', ',', 'patient', 'with', 'krasgc-mutant', 'colorectal', 'cancer', 'enrolled', 'aug', ',', ',', 'and', 'may', ',', ',', 'and', 'received', 'least', 'one', 'dose', 'of', 'sotorasib', 'monotherapy', '.', 'objective', 'response', 'observed', 'in', 'six', '(', ',', 'ci', '-', ')', 'of', 'patient', ',', 'with', 'partial', 'response', '.', 'treatment-related', 'adverse', 'event', 'grade', 'occurred', 'in', 'six', '(', ')', 'patient', ',', 'common', 'of', 'diarrhoea', '(', 'two', 'of', 'patient', ')', ',', 'and', 'grade', 'occurred', 'in', 'one', '(', ')', 'patient', '(', 'blood', 'creatine', 'phosphokinase', 'increase', ')', 'no', 'fatal', 'event', 'recorded', '.', 'serious', 'treatment-related', 'adverse', 'event', 'occurred', 'in', 'two', '(', ')', 'patient', '(', 'back', 'pain', 'and', 'acute', 'kidney', 'injury', ')', '.', 'interpretation', 'although', 'overall', 'response', 'rate', 'not', 'reach', 'benchmark', ',', 'oral', 'administration', 'of', 'sotorasib', 'per', 'day', 'showed', 'modest', 'anti-tumour', 'activity', 'and', 'manageable', 'safety', 'in', 'heavily', 'pretreated', 'chemorefractory', 'patient', '.', 'sotorasib', 'evaluation', 'in', 'combination', 'with', 'therapeutic', 'to', 'increase', 'potential', 'activity', 'and', 'overcome', 'potential', 'resistance', 'mechanism', '.', 'funding', 'amgen', '.']"
"A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma.","Beata Holkova, Adriana Zingone, Maciej Kmieciak, Prithviraj Bose, Ashraf Z Badros, Peter M Voorhees, Rachid Baz, Neha Korde, Hui-Yi Lin, Jin-Qiu Chen, Michelle Herrmann, Liqiang Xi, Mark Raffeld, Xiuhua Zhao, Wen Wan, Mary Beth Tombes, Ellen Shrader, Caryn Weir-Wiggins, Heidi Sankala, Kevin T Hogan, Austin Doyle, Christina M Annunziata, Martha Wellons, John D Roberts, Daniel Sullivan, Ola Landgren, Steven Grant, Beata Holkovaet al.",2016 Mar 1,Clin Cancer Res,https://pubmed.ncbi.nlm.nih.gov/26446942/,No keywords found,"['azd', 'mek', 'inhibitor', 'with', 'significant', 'preclinical', 'activity', 'in', 'multiple', 'myeloma', 'cell', '.', 'phase', 'ii', 'study', 'used', 'two-stage', 'simon', 'design', 'to', 'determine', 'azd', 'response', 'rate', 'in', 'patient', 'with', 'relapsed', 'or', 'refractory', 'multiple', 'myeloma', '.', 'experimental', 'design', 'azd', '(', 'mg', ')', 'administered', 'orally', ',', 'twice', 'day', ',', 'continuously', '-day', 'cycle', '.', 'response', 'evaluated', 'three', 'cycle', '.', 'result', 'thirty-six', 'patient', 'received', 'therapy', '.', 'median', 'age', 'year', '(', 'range', '-', ')', 'and', 'median', 'number', 'of', 'prior', 'therapy', '(', 'range', '-', ')', '.', 'common', 'grade', 'and', 'toxicity', 'included', 'anemia', ',', 'neutropenia', ',', 'thrombocytopenia', ',', 'diarrhea', ',', 'and', 'fatigue', '.', 'three', 'death', 'occurred', 'possibly', 'related', 'to', 'azd', '(', 'due', 'to', 'sepsis', ',', 'due', 'to', 'acute', 'kidney', 'injury', ')', '.', 'azd', 'discontinuation', ',', 'three', 'additional', 'death', 'occurred', 'due', 'to', 'disease', 'progression', '.', 'response', 'rate', '(', 'cr', 'pr', ')', '.', 'with', 'mean', 'duration', 'of', 'response', 'of', '.', 'month', 'and', 'median', 'progression-free', 'survival', 'time', 'of', '.', 'month', '.', 'one', 'patient', 'good', 'partial', 'response', '(', 'vgpr', ')', ',', 'patient', 'partial', 'response', ',', 'patient', 'stable', 'disease', ',', 'patient', 'progressive', 'disease', ',', 'and', 'patient', 'could', 'not', 'assessed', 'response', '.', 'pharmacodynamic', 'study', 'revealed', 'variable', 'effect', 'bone', 'marrow', 'cd', '(', ')', 'cell', 'mek', 'and', 'erk', 'phosphorylation', '.', 'best', 'clinical', 'response', ',', 'prolonged', 'vgpr', ',', 'occurred', 'in', 'patient', 'with', 'mmset', 'translocation', '.', 'conclusion', 'single-agent', 'azd', 'tolerable', 'and', 'minimal', 'activity', 'in', 'heavily', 'pretreated', 'population', '.']"
Comparison of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial.,"Sean van Diepen, Colleen M Norris, Yinggan Zheng, Jayan Nagendran, Michelle M Graham, Damaris Gaete Ortega, Derek R Townsend, Justin A Ezekowitz, Sean M Bagshaw, Sean van Diepenet al.",2018 Oct 16,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/30371293/,No keywords found,"['httpswww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Acute kidney injury after cardiac surgery: is minocycline protective?,"Ladan Golestaneh, Kathryn Lindsey, Pooja Malhotra, Faraj Kargoli, Emily Farkas, Hendrick Barner, Rizwan Qazi, Anna Schmidt, Michael Rauchman, Ziyad Al-Aly, Robert Johnson, Kevin Martin, Pierre Dagher, Allon Friedman, Tarek M El-Achkar, Ladan Golestanehet al.",2015 Apr,J Nephrol,https://pubmed.ncbi.nlm.nih.gov/25348221/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'bypass', 'surgery', '(', 'cabg', ')', 'common', 'and', 'carry', 'significant', 'association', 'with', 'morbidity', 'and', 'mortality', '.', 'since', 'minocycline', 'therapy', 'attenuates', 'kidney', 'injury', 'in', 'animal', 'model', 'of', 'aki', ',', 'tested', 'effect', 'in', 'patient', 'undergoing', 'cabg', '.', 'design', ',', 'setting', ',', 'participant', 'and', 'measurement', 'randomized', ',', 'double-blinded', ',', 'placebo-controlled', ',', 'multi-center', 'study', '.', 'screened', 'high', 'risk', 'patient', 'scheduled', 'to', 'undergo', 'cabg', 'in', 'two', 'medical', 'center', 'jan', 'and', 'june', '.', 'patient', 'randomized', 'and', 'patient', 'in', 'group', 'completed', 'study', '.', 'minocycline', 'prophylaxis', 'given', 'twice', 'daily', ',', 'least', 'four', 'dos', 'prior', 'to', 'cabg', '.', 'primary', 'outcome', 'defined', 'aki', '.', 'mgdl', 'increase', 'in', 'creatinine', '(', 'cr', ')', 'within', 'day', 'surgery', '.', 'daily', 'serum', 'cr', 'day', ',', 'various', 'clinical', 'and', 'hemodynamic', 'measure', 'and', 'length', 'of', 'stay', 'recorded', '.', 'result', 'two', 'group', 'similar', 'baseline', 'and', 'intra-operative', 'characteristic', '.', 'primary', 'outcome', 'occurred', 'in', '.', 'of', 'patient', 'in', 'minocycline', 'group', 'compared', 'to', '.', 'of', 'patient', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'peak', 'cr', '.', '.', 'vs.', '.', '.', 'mgdl', '(', 'p', '.', ')', 'in', 'minocycline', 'and', 'placebo', 'group', ',', 'respectively', '.', 'death', 'day', 'occurred', 'in', 'vs.', '.', 'in', 'minocycline', 'and', 'placebo', 'group', ',', 'respectively', '(', 'p', '.', ')', '.', 'no', 'difference', 'in', 'post-operative', 'length', 'of', 'stay', ',', 'and', 'cardiovascular', 'event', 'two', 'group', '.', 'trend', 'towards', 'lower', 'diastolic', 'pulmonary', 'artery', 'pressure', '.', '.', 'vs.', '.', '.', 'mmhg', '(', 'p', '.', ')', 'and', 'central', 'venous', 'pressure', '.', '.', 'vs.', '.', '.', 'mmhg', '(', 'p', '.', ')', 'in', 'minocycline', 'group', 'compared', 'to', 'placebo', 'first', 'day', 'surgery', '.', 'conclusion', 'minocycline', 'not', 'protect', 'aki', 'post-cabg', '.']"
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.,"Meghan E Sise, Jose Ramon Santos, Jason D Goldman, Katherine R Tuttle, J Pedro Teixeira, Allan F Seibert, Yiannis Koullias, Joe Llewellyn, Sean Regan, Yang Zhao, Hailin Huang, Robert H Hyland, Anu Osinusi, Helen Winter, Rita Humeniuk, Henry N Hulter, Robert L Gottlieb, Dahlene N Fusco, Rita Birne, Fernando F Stancampiano, Claudia R Libertin, Catherine B Small, Markus Plate, Mark J McPhail                              ;, REDPINE Investigators, Rosa Ballesteros, Luis Malheiro, Gil Silva, João Paulo Correia, Ana Vida, Andre Silva, Antonio Carujo, Moncef Belhassen Garcia, Jordi Carratala Fernandez, Gabriela Abelenda-Alonso, Josep M Cruzado, Alexander Rombauts, Diego A Sandoval, Miguel Garcia Deltoro, Fransesc Puchades Gimeno, Neus Gómez-Muñoz, Maria Martínez Roma, Juan Horcajada Gallego, Castañeda Pablo, Padilla Urrea Silvia, Rial Crestelo Sergio, Santos Fernandez David, Ramon Jose, Susanna Benet, Rosa Benítez, Carmen Bracke, Anna Chamorro, Sergio España, Fredzzia Graterol, Gemma LLadós, Cristina López, Lourdes Mateu, Roger Paredes, Boris Rebollo, Alba Romero, Laura Soldevila, Elena Abad, Alba San José, Alex Soriano Viladomiu, Mark McPhail, Nicholas Medjeral-Thomas, Suzana Margareth Ajeje Lobo, Igor Abolnik, Anjali Acharya, Leland Allen, Keith A Bellovich, Mary Jane Burton, Miriam Cameron, Gerard J Criner, Lii-Yoong H Criner, Joseph Lambert, Marium Rashid, Heidi Shore-Brown, George A Diaz, David Dougherty, Nathaniel B Erdmann, Dahlene Fusco, William Berrington, Christine Logar, Nidyanandh Vadivel, Allison Everett, Gonzalez Suarez Maria Lourdes, Mezgebe Berhe, Gates Colbert, Christopher Hebert, Ankit Mehta, Cedric W Spak, Lorie Estrada, Richard Vargas, Jennifer Choe, Alex Pham, L Maria Mason, Catherine Tallmadge, Ariana Braddom, Maldonado Nicholas, Aayla Jamil, Ashley McAllister, Christina Guerra, Teena Sam, Edilia Solis, Deepa Gotur, Munish Goyal, Farrukh Koraishy, Brett Laurence, Vinay Malhotra, Luis A Manrique, James A McKinnell, Blaithin McMahon, Ruth Campbell, Caryn Morse, Jesus Navarro, Luis Ostrosky, Bela Patel, Carolyn Grimes, Maria Hernandez, Mehriban Mammadova, Laura Nielsen, Virginia Umana, Tobias Pusch, Philip Robinson, Arun J Sanyal, Harry Schrager, Jason Mallada, Marc Siegel, Meghan Sise, Jihad Slim, Catherine Small, Peruvemba Sriram, Fernando Stancampiano, Joao Pedro Teixeira, Krystle D Apodaca, Michelle S Harkins, Amy G Cunningham, Meghan E Siseet al.",2024 Nov 22,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/38913574/,No keywords found,"['antiviral', 'therapy', 'studied', 'in', 'patient', 'with', 'coronavirus', 'disease', '(', 'covid-', ')', 'and', 'kidney', 'impairment', '.', 'herein', ',', 'efficacy', ',', 'safety', ',', 'and', 'pharmacokinetics', 'of', 'remdesivir', ',', 'metabolite', ',', 'and', 'sulfobutylether', '--', 'cyclodextrin', 'excipient', 'evaluated', 'in', 'hospitalized', 'patient', 'with', 'covid-', 'and', 'severe', 'kidney', 'impairment', '.', 'method', 'in', 'redpine', ',', 'phase', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'study', ',', 'participant', 'aged', 'year', 'hospitalized', 'covid-', 'pneumonia', 'with', 'acute', 'kidney', 'injury', ',', 'chronic', 'kidney', 'disease', ',', 'or', 'kidney', 'failure', 'randomized', 'to', 'receive', 'intravenous', 'remdesivir', '(', 'mg', 'day', 'mg', 'daily', 'to', 'day', ')', 'or', 'placebo', '(', 'enrollment', 'march', 'to', 'march', ')', '.', 'primary', 'efficacy', 'end', 'point', 'composite', 'of', 'all-cause', 'mortality', 'rate', 'or', 'invasive', 'mechanical', 'ventilation', 'rate', 'day', '.', 'safety', 'evaluated', 'day', '.', 'result', 'although', 'enrollment', 'concluded', 'early', ',', 'participant', 'enrolled', 'and', 'treated', '(', 'remdesivir', ',', 'n', 'placebo', ',', 'n', ')', '.', 'baseline', ',', 'participant', '(', '.', ')', 'acute', 'kidney', 'injury', '(', 'remdesivir', ',', 'n', 'placebo', ',', 'n', ')', ',', '(', '.', ')', 'chronic', 'kidney', 'disease', '(', 'remdesivir', ',', 'n', 'placebo', ',', 'n', ')', ',', 'and', '(', '.', ')', 'kidney', 'failure', '(', 'remdesivir', ',', 'n', 'placebo', ',', 'n', ')', 'and', '(', '.', ')', 'vaccinated', 'covid-', '.', 'composite', 'all-cause', 'mortality', 'or', 'invasive', 'mechanical', 'ventilation', 'rate', 'day', '.', 'and', '.', 'in', 'remdesivir', 'and', 'placebo', 'group', ',', 'respectively', '(', 'p', '.', ')', '.', 'treatment-emergent', 'adverse', 'event', 'reported', 'in', '.', 'remdesivir', 'versus', '.', 'placebo', ',', 'and', 'serious', 'adverse', 'event', 'in', '.', 'versus', '.', ',', 'respectively', '.', 'pharmacokinetic', 'plasma', 'exposure', 'to', 'remdesivir', 'not', 'affected', 'kidney', 'function', '.', 'conclusion', 'although', 'study', 'underpowered', ',', 'no', 'significant', 'difference', 'in', 'efficacy', 'observed', 'treatment', 'group', '.', 'redpine', 'demonstrated', 'remdesivir', 'safe', 'in', 'patient', 'with', 'covid-', 'and', 'severe', 'kidney', 'impairment', '.', 'clinical', 'trial', 'registration', 'eudract', '--', 'clinical', 'trials.gov', 'nct', '.']"
"Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.","Charlotte C van Ruiten, Annemarie B van der Aart-van der Beek, Richard G IJzerman, Max Nieuwdorp, Klaas Hoogenberg, Daniël H van Raalte, Hiddo J L Heerspink, Charlotte C van Ruitenet al.",2021 Aug,Diabetes Obes Metab,https://pubmed.ncbi.nlm.nih.gov/33908691/,No keywords found,"['to', 'evaluate', 'effect', 'of', 'separate', 'and', 'combined', 'use', 'of', 'sodium-glucose', 'cotransporter-', '(', 'sglt', ')', 'inhibitor', 'dapagliflozin', 'and', 'glucagon-like', 'peptide-', 'receptor', 'agonist', '(', 'glp-ra', ')', 'exenatide', 'measure', 'of', 'kidney', 'function', '.', 'method', 'in', 'prespecified', 'secondary', 'analysis', 'of', 'decrease', 'trial', ',', 'enrolled', 'obese', 'patient', 'with', 'type', 'diabetes', 'in', '-week', 'randomized', 'double-blind', 'placebo-controlled', 'clinical', 'trial', 'to', 'investigate', 'effect', 'of', 'dapagliflozin', 'and', 'exenatide', 'twice', 'daily', ',', 'alone', 'or', 'in', 'combination', ',', 'versus', 'placebo', '-hour', 'urinary', 'albumincreatinine', 'ratio', '(', 'uacr', ')', ',', 'creatinine', 'and', 'cystatin', 'c-estimated', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'and', 'kidney', 'injury', 'molecule-creatinine', 'ratio', '(', 'kim-cr', ')', '.', 'result', 'week', ',', 'mean', 'uacr', 'change', 'baseline', '-', '.', '(', 'confidence', 'interval', 'ci', '-.', ',', '-', '.', 'p', '.', ')', 'in', 'combined', 'exenatide-dapagliflozin', 'group', ',', '-', '.', '(', 'ci', '-.', ',', '.', 'p', '.', ')', 'in', 'dapagliflozin', 'group', ',', '-', '.', '(', 'ci', '-.', ',', '.', 'p', '.', ')', 'in', 'exenatide', 'group', 'and', '-', '.', '(', 'ci', '-.', ',', '.', 'p', '.', ')', 'in', 'placebo', 'group', '.', 'compared', 'to', 'placebo', ',', 'uacr', 'difference', 'week', 'in', 'exenatide-dapagliflozin', 'group', '-', '.', '(', 'ci', '-.', ',', '.', 'p', '.', ')', '.', 'effect', 'similar', 'in', 'participant', 'using', 'angiotensin-converting', 'enzyme', 'inhibitor', 'or', 'angiotensin', 'receptor', 'blocker', 'baseline', '.', 'compared', 'to', 'placebo', ',', 'in', 'exenatide-dapagliflozin', 'group', ',', 'acute', 'dip', 'in', 'estimated', 'gfr', 'observed', 'with', 'creatinine-estimated', 'gfr', '(', '-', '.', 'mlmin', '.', 'ci', '-.', ',', '.', 'p', '.', ')', 'and', 'cystatin', 'c-estimated', 'gfr', '(', '-', '.', 'mlmin', '.', 'ci', '-.', ',', '-', '.', 'p', '.', ')', '.', 'mean', 'kim-cr', 'difference', 'in', 'combined', 'treatment', 'arm', 'versus', 'placebo', '-', '.', '(', 'ci', '-.', ',', '.', 'p', '.', ')', '.', 'conclusion', 'prespecified', 'secondary', 'analysis', 'suggests', 'combined', 'therapy', 'with', 'exenatide', 'and', 'dapagliflozin', 'may', 'synergistic', 'effect', 'marker', 'of', 'kidney', 'function', 'compared', 'to', 'either', 'therapy', 'alone', 'or', 'placebo', 'in', 'obese', 'patient', 'with', 'type', 'diabetes', '.']"
"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.","Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, Amit Mahajan, Roy S Herbst, Anne C Chiang, Rogerio Lilenbaum, Frederick H Wilson, Sacit Bulent Omay, James B Yu, Lucia Jilaveanu, Thuy Tran, Kira Pavlik, Elin Rowen, Heather Gerrish, Annette Komlo, Richa Gupta, Hailey Wyatt, Matthew Ribeiro, Yuval Kluger, Geyu Zhou, Wei Wei, Veronica L Chiang, Harriet M Kluger, Sarah B Goldberget al.",2020 May,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/32251621/,No keywords found,"['phase', 'trial', 'of', 'pembrolizumab', 'in', 'patient', 'with', 'non-small-cell', 'lung', 'cancer', '(', 'nsclc', ')', 'or', 'melanoma', 'with', 'untreated', 'brain', 'metastasis', 'to', 'determine', 'activity', 'of', 'pd-', 'blockade', 'in', 'cns', '.', 'interim', 'result', 'previously', 'published', ',', 'and', 'report', 'updated', 'analysis', 'of', 'full', 'nsclc', 'cohort', '.', 'method', 'open-label', ',', 'phase', 'study', 'of', 'patient', 'yale', 'cancer', 'center', '(', 'ct', ',', 'usa', ')', '.', 'eligible', 'patient', 'least', 'year', 'of', 'age', 'with', 'stage', 'iv', 'nsclc', 'with', 'least', 'one', 'brain', 'metastasis', '-', 'mm', 'in', 'size', ',', 'not', 'previously', 'treated', 'or', 'progressing', 'previous', 'radiotherapy', ',', 'no', 'neurological', 'symptom', 'or', 'corticosteroid', 'requirement', ',', 'and', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', 'less', 'two', '.', 'modified', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumor', '(', 'mrecist', ')', 'criterion', 'used', 'to', 'evaluate', 'cns', 'disease', 'systemic', 'disease', 'not', 'required', 'participation', '.', 'patient', 'treated', 'with', 'pembrolizumab', 'mgkg', 'intravenously', 'every', 'week', '.', 'patient', 'in', 'two', 'cohort', 'cohort', 'with', 'pd-l', 'expression', 'of', 'least', 'and', 'cohort', 'patient', 'with', 'pd-l', 'less', 'or', 'unevaluable', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'achieving', 'brain', 'metastasis', 'response', '(', 'partial', 'response', 'or', 'complete', 'response', ',', 'according', 'to', 'mrecist', ')', '.', 'treated', 'patient', 'analysed', 'response', 'and', 'safety', 'endpoint', '.', 'study', 'closed', 'to', 'accrual', 'and', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'march', ',', ',', 'and', 'may', ',', ',', 'patient', 'treated', '.', 'median', 'follow-up', 'month', '(', 'iqr', '-', ')', '.', '(', 'ci', '-', ')', 'of', 'patient', 'in', 'cohort', 'brain', 'metastasis', 'response', '.', 'no', 'response', 'in', 'cohort', '.', 'grade', '-', 'adverse', 'event', 'related', 'to', 'treatment', 'included', 'two', 'patient', 'with', 'pneumonitis', ',', 'and', 'one', 'with', 'constitutional', 'symptom', ',', 'colitis', ',', 'adrenal', 'insufficiency', ',', 'hyperglycaemia', ',', 'and', 'hypokalaemia', '.', 'treatment-related', 'serious', 'adverse', 'event', 'occurred', 'in', 'six', '(', ')', 'of', 'patient', 'and', 'pneumonitis', '(', 'n', ')', ',', 'acute', 'kidney', 'injury', ',', 'colitis', ',', 'hypokalaemia', ',', 'and', 'adrenal', 'insufficiency', '(', 'n', ')', '.', 'no', 'treatment-related', 'death', '.', 'interpretation', 'pembrolizumab', 'activity', 'in', 'brain', 'metastasis', 'nsclc', 'with', 'pd-l', 'expression', 'least', 'and', 'safe', 'in', 'selected', 'patient', 'with', 'untreated', 'brain', 'metastasis', '.', 'investigation', 'of', 'immunotherapy', 'in', 'patient', 'with', 'cns', 'disease', 'nsclc', 'warranted', '.', 'funding', 'merck', 'and', 'yale', 'cancer', 'center', '.']"
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures.,"John Peabody, David Paculdo, Czarlota Valdenor, Peter A McCullough, Eisei Noiri, Takeshi Sugaya, Jeffrey R Dahlen, John Peabodyet al.",2022,Cardiorenal Med,https://pubmed.ncbi.nlm.nih.gov/35034025/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'major', 'clinical', 'complication', 'of', 'percutaneous', 'cardiovascular', 'procedure', 'requiring', 'iodinated', 'contrast', '.', 'despite', 'relative', 'frequency', ',', 'practicing', 'physician', 'unlikely', 'to', 'identify', 'or', 'treat', 'condition', '.', 'method', 'in', '-round', 'clinical', 'trial', 'of', 'simulated', 'patient', ',', 'examined', 'clinical', 'utility', 'of', 'urine-based', 'assay', 'measure', 'liver-type', 'fatty', 'acid-binding', 'protein', '(', 'l-fabp', ')', ',', 'novel', 'marker', 'of', 'ci-aki', '.', 'sought', 'to', 'determine', 'interventional', 'cardiologist', ""'"", 'ability', 'to', 'diagnose', 'and', 'treat', 'potential', 'ci-aki', 'improved', 'using', 'biomarker', 'assay', 'different', 'patient', 'type', 'pre-procedure', ',', 'peri-procedure', ',', 'and', 'post-procedure', 'patient', '.', 'result', 'participating', 'cardiologist', 'randomly', 'divided', 'either', 'control', 'or', 'intervention', '.', 'baseline', ',', 'found', 'no', 'difference', 'in', 'demographic', 'or', 'identified', 'and', 'treated', 'potential', 'complication', 'of', 'aki', ',', 'with', 'group', 'providing', 'less', 'half', 'necessary', 'care', 'to', 'patient', '(', '.', 'control', 'vs.', '.', 'intervention', ',', 'p', '.', ')', '.', 'introduction', 'of', 'l-fabp', 'patient', 'care', 'resulted', 'in', 'statistically', 'significant', 'improvement', 'of', '.', '(', 'p', '.', ')', '.', 'compared', 'to', 'control', ',', 'physician', 'receiving', 'l-fabp', 'result', '.', 'time', 'likely', 'to', 'correctly', 'identify', 'patient', ""'"", 'risk', 'aki', '(', 'ci', '.-', '.', ')', 'and', 'twice', 'likely', 'to', 'treat', 'aki', 'providing', 'volume', 'expansion', 'and', 'withholding', 'nephrotoxic', 'medication', '.', 'found', 'greatest', 'clinical', 'utility', 'in', 'pre-procedure', 'and', 'peri-procedure', 'setting', 'limited', 'value', 'in', 'post-procedure', 'setting', '.', 'conclusion', 'study', 'suggests', 'l-fabp', 'clinical', 'marker', 'assessing', 'risk', 'of', 'potential', 'ci-aki', ',', 'clinical', 'utility', ',', 'and', 'lead', 'to', 'accurate', 'diagnosis', 'and', 'treatment', '.']"
"Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.","Evan L Fogel, Glen A Lehman, Paul Tarnasky, Gregory A Cote, Suzette E Schmidt, Akbar K Waljee, Peter D R Higgins, James L Watkins, Stuart Sherman, Richard S Y Kwon, Grace H Elta, Jeffrey J Easler, Douglas K Pleskow, James M Scheiman, Ihab I El Hajj, Nalini M Guda, Mark A Gromski, Lee McHenry Jr, Seena Arol, Sheryl Korsnes, Alejandro L Suarez, Rebecca Spitzer, Marilyn Miller, Maria Hofbauer, B Joseph Elmunzer                              ;, US Cooperative for Outcomes Research in Endoscopy (USCORE), Evan L Fogelet al.",2020 Feb,Lancet Gastroenterol Hepatol,https://pubmed.ncbi.nlm.nih.gov/31780277/,No keywords found,"['although', 'rectal', 'indometacin', 'mg', 'effective', 'in', 'reducing', 'frequency', 'and', 'severity', 'of', 'pancreatitis', 'endoscopic', 'retrograde', 'cholangiopancreatography', '(', 'ercp', ')', 'in', 'high-risk', 'patient', ',', 'optimal', 'dose', 'unknown', ',', 'and', 'pancreatitis', 'incidence', 'remains', 'high', '.', 'aim', 'of', 'study', 'to', 'compare', 'efficacy', 'of', 'two', 'dose', 'regimen', 'of', 'rectal', 'indometacin', 'frequency', 'and', 'severity', 'of', 'pancreatitis', 'ercp', 'in', 'high-risk', 'patient', '.', 'method', 'in', 'randomised', ',', 'double-blind', ',', 'comparative', 'effectiveness', 'trial', ',', 'enrolled', 'patient', 'six', 'tertiary', 'medical', 'centre', 'in', 'usa', '.', 'eligible', 'patient', 'high', 'risk', 'development', 'of', 'pancreatitis', 'ercp', '.', 'randomly', 'assigned', 'eligible', 'patient', '(', ')', 'immediately', 'ercp', 'to', 'receive', 'either', 'two', 'mg', 'indometacin', 'suppository', 'and', 'placebo', 'suppository', '(', 'standard-dose', 'group', ')', 'or', 'three', 'mg', 'indometacin', 'suppository', '(', 'high-dose', 'group', ')', '.', 'h', 'procedure', ',', 'patient', 'assigned', 'to', 'high-dose', 'group', 'received', 'additional', 'mg', 'indometacin', 'suppository', ',', 'whereas', 'patient', 'in', 'standard-dose', 'group', 'received', 'additional', 'placebo', 'suppository', '.', 'randomisation', 'schedule', ',', 'stratified', 'according', 'to', 'study', 'centre', 'and', 'with', 'no', 'restriction', ',', 'computer', 'generated', 'investigator', 'uninvolved', 'in', 'clinical', 'care', 'of', 'participant', ',', 'distributed', 'to', 'site', ',', 'and', 'kept', 'personnel', 'not', 'directly', 'involved', 'with', 'study', '.', 'personnel', 'responsible', 'packaging', 'drug', 'and', 'placebo', 'in', 'opaque', 'envelope', '.', 'patient', ',', 'study', 'personnel', ',', 'and', 'treating', 'physician', 'masked', 'to', 'study', 'group', 'assignment', '.', 'primary', 'outcome', 'of', 'study', 'development', 'of', 'pancreatitis', 'ercp', '.', 'analysis', 'done', 'intention-to-treat', 'basis', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', ',', 'and', 'enrolment', 'complete', '.', 'finding', 'july', ',', ',', 'and', 'march', ',', ',', 'eligible', 'patient', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'receive', 'either', 'standard-dose', '(', 'n', ')', 'or', 'high-dose', 'indometacin', '(', 'n', ')', '.', 'pancreatitis', 'ercp', 'occurred', 'in', '(', ')', 'of', 'patients-', '(', ')', 'of', 'patient', 'in', 'standard-dose', 'indometacin', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'high-dose', 'indometacin', 'group', '(', 'risk', 'ratio', 'rr', ',', 'ci', '-', 'p', ')', '.', 'observed', 'adverse', 'event', 'potentially', 'attributable', 'to', 'study', 'drug', '.', 'clinically', 'significant', 'bleeding', 'occurred', 'in', '(', ')', 'of', 'patients-six', '(', ')', 'of', 'patient', 'in', 'standard-dose', 'indometacin', 'group', 'and', 'eight', '(', ')', 'of', 'patient', 'in', 'high-dose', 'indometacin', 'group', '(', 'p', ')', '.', 'three', '(', ')', 'of', 'patient', 'in', 'high-dose', 'indometacin', 'group', 'developed', 'acute', 'kidney', 'injury', 'versus', 'none', 'in', 'standard-dose', 'group', '(', 'p', ')', '.', 'non-st', 'elevation', 'myocardial', 'infarction', 'occurred', 'in', 'standard-dose', 'indometacin', 'group', 'day', 'ercp', '.', 'transient', 'ischaemic', 'attack', 'occurred', 'in', 'high-dose', 'indometacin', 'group', 'day', 'ercp', '.', 'adverse', 'event', ',', 'in', 'addition', 'to', 'patient', 'developed', 'pancreatitis', 'ercp', ',', 'considered', 'serious', 'required', 'admission', 'to', 'hospital', '.', 'observed', 'no', 'allergic', 'reaction', 'or', 'death', 'day', 'follow-up', '.', 'interpretation', 'dose', 'escalation', 'to', 'rectal', 'indometacin', 'mg', 'not', 'confer', 'advantage', 'compared', 'with', 'standard', 'mg', 'regimen', ',', 'with', 'pancreatitis', 'incidence', 'remaining', 'high', 'in', 'high-risk', 'patient', '.', 'current', 'practice', 'continue', 'unchanged', '.', 'research', 'consider', 'pharmacokinetics', 'of', 'non-steroidal', 'anti-inflammatory', 'drug', 'to', 'determine', 'optimal', 'timing', 'of', 'administration', 'to', 'prevent', 'pancreatitis', 'ercp', '.', 'funding', 'american', 'college', 'of', 'gastroenterology', '.']"
Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study.,"Renata Pasqualini, Randall E Millikan, Dawn R Christianson, Marina Cardó-Vila, Wouter H P Driessen, Ricardo J Giordano, Amin Hajitou, Anh G Hoang, Sijin Wen, Kirstin F Barnhart, Wallace B Baze, Valerie D Marcott, David H Hawke, Kim-Anh Do, Nora M Navone, Eleni Efstathiou, Patricia Troncoso, Roy R Lobb, Christopher J Logothetis, Wadih Arap, Renata Pasqualiniet al.",2015 Jul 15,Cancer,https://pubmed.ncbi.nlm.nih.gov/25832466/,No keywords found,"['receptor', 'in', 'tumor', 'blood', 'vessel', 'attractive', 'target', 'ligand-directed', 'drug', 'discovery', 'and', 'development', '.', 'author', 'worked', 'systematically', 'to', 'map', 'human', 'endothelial', 'receptor', '(', '``', 'vascular', 'zip', 'code', ""''"", ')', 'within', 'tumor', 'direct', 'peptide', 'library', 'selection', 'in', 'cancer', 'patient', '.', 'previously', ',', 'selected', 'ligand-binding', 'motif', 'to', 'interleukin-', 'receptor', 'alpha', '(', 'il-r', ')', 'in', 'human', 'vasculature', '.', 'method', 'author', 'generated', 'ligand-directed', ',', 'peptidomimetic', 'drug', '(', 'bone', 'metastasis-targeting', 'peptidomimetic-', 'bmtp-', ')', 'il-r-based', 'human', 'tumor', 'vascular', 'targeting', '.', 'preclinical', 'study', '(', 'efficacytoxicity', ')', 'included', 'evaluating', 'bmtp-', 'in', 'prostate', 'cancer', 'xenograft', 'model', ',', 'drug', 'localization', ',', 'targeted', 'apoptotic', 'effect', ',', 'pharmacokineticpharmacodynamic', 'analysis', ',', 'and', 'dose-range', 'determination', ',', 'including', 'formal', '(', 'good', 'laboratory', 'practice', ')', 'toxicity', 'across', 'rodent', 'and', 'nonhuman', 'primate', 'specie', '.', 'initial', 'bmtp-', 'clinical', 'development', 'also', 'reported', 'based', 'single-institution', ',', 'open-label', ',', 'first-in-class', ',', 'first-in-man', 'trial', '(', 'national', 'clinical', 'trial', 'number', 'nct', ')', 'in', 'patient', 'with', 'metastatic', ',', 'castrate-resistant', 'prostate', 'cancer', '.', 'result', 'bmtp-', 'preclinically', 'promising', 'and', ',', 'thus', ',', 'chosen', 'clinical', 'development', 'in', 'patient', '.', 'limited', 'number', 'of', 'patient', 'castrate-resistant', 'prostate', 'cancer', 'with', 'osteoblastic', 'bone', 'metastasis', 'enrolled', 'phase', 'trial', 'with', 'biology-driven', 'endpoint', '.', 'author', 'demonstrated', 'biopsy-verified', 'localization', 'of', 'bmtp-', 'to', 'tumor', 'in', 'bone', 'marrow', 'and', 'drug-induced', 'apoptosis', 'in', 'patient', '.', 'moreover', ',', 'maximum', 'tolerated', 'dose', 'identified', 'weekly', 'schedule', '(', '-', 'mgm', '(', ')', ')', '.', 'finally', ',', 'renal', 'dose-limiting', 'toxicity', 'determined', ',', 'namely', ',', 'dose-dependent', ',', 'reversible', 'nephrotoxicity', 'with', 'proteinuria', 'and', 'cast', 'involving', 'increased', 'serum', 'creatinine', '.', 'conclusion', 'biologic', 'endpoint', 'establish', 'bmtp-', 'targeted', 'drug', 'candidate', 'in', 'metastatic', ',', 'castrate-resistant', 'prostate', 'cancer', '.', 'within', 'larger', 'discovery', 'context', ',', 'current', 'finding', 'indicate', 'functional', 'tumor', 'vascular', 'ligand-receptor', 'targeting', 'system', 'may', 'identified', 'direct', 'combinatorial', 'selection', 'of', 'peptide', 'library', 'in', 'cancer', 'patient', '.']"
"Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial.","Magdy Mohammed Mahdy, Mostafa Samy Abbas, Emad Zarief Kamel, Mohamed Fathy Mostafa, Ragaa Herdan, Shimaa Abbas Hassan, Ramy Hassan, Ahmed M Taha, Tameem M Ibraheem, Bashir A Fadel, Mohammed Geddawy, Jehan Ahmed Sayed, Osama Ali Ibraheim, Magdy Mohammed Mahdyet al.",2019 Jun 15,BMC Anesthesiol,https://pubmed.ncbi.nlm.nih.gov/31200638/,No keywords found,"['terlipressin', ',', 'in', 'general', ',', 'vasopressor', 'act', 'via', 'v', 'receptor', '.', 'infusion', 'elevates', 'mean', 'blood', 'pressure', 'and', 'reduce', 'bleeding', 'splanchnic', 'origin', '.', 'primary', 'outcome', 'to', 'assess', 'impact', 'of', 'intraoperative', 'terlipressin', 'infusion', 'portal', 'venous', 'pressure', 'hepatobiliary', 'surgery', 'ry', 'outcome', 'included', 'effect', 'upon', 'systemic', 'hemodynamics', ',', 'estimated', 'blood', 'loss', ',', 'and', 'postoperative', 'renal', 'function', '.', 'method', 'prospective', 'randomized', 'study', 'involved', 'patient', 'undergoing', 'hepatobiliary', 'surgery', 'randomly', 'and', 'equally', 'allocated', 'terlipressin', 'group', ',', 'or', 'control', 'group', '.', 'terlipressin', 'group', 'received', 'initial', 'bolus', 'dose', 'of', '(', 'mg', 'min', ')', 'followed', 'continuous', 'infusion', 'of', 'gkgh', 'throughout', 'procedure', 'and', 'gradually', 'weaned', 'first', 'four', 'postoperative', 'hour', ',', 'whereas', 'control', 'group', 'received', 'volume', 'of', 'normal', 'saline', '.', 'portal', 'venous', 'pressure', 'change', 'measured', 'directly', 'portal', 'vein', 'angiocatheter', '.', 'result', 'portal', 'pressure', 'significantly', 'reduced', 'time', 'in', 'terlipressin', 'group', '(', '.', '.', 'to', '.', '.', 'mmhg', ',', 'p', '.', ')', '.', 'mean', 'arterial', 'blood', 'pressure', 'significantly', 'higher', 'in', 'terlipressin', 'group', '.', 'estimated', 'blood', 'loss', 'significantly', 'higher', 'in', 'control', 'group', 'terlipressin', 'group', '(', '.', 'versus', '.', 'ml', 'p', '.', ')', ',', 'and', 'unit', 'of', 'packed', 'rbc', 'transfused', 'significantly', 'higher', 'in', 'control', 'group', '(', '(', '-', ')', 'versus', '(', '-', ')', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'group', 'regard', 'incidence', 'of', 'acute', 'kidney', 'injury', '.', 'conclusion', 'intraoperative', 'infusion', 'of', 'terlipressin', 'hepatobiliary', 'surgery', 'shown', 'to', 'improve', 'intraoperative', 'portal', 'hemodynamics', 'with', 'subsequent', 'reduction', 'in', 'blood', 'loss', '.', 'trial', 'registration', 'clinical', 'trial', 'number', 'and', 'registry', 'url', 'trial', 'registration', 'number', 'nct', '.', 'name', 'of', 'registry', 'clinicaltrials.gov', '.', 'url', 'of', 'registry', 'httpsclinicaltrials.govctshownct', '.', 'date', 'of', 'registration', 'march', '.', 'date', 'of', 'enrolment', 'of', 'first', 'participant', 'to', 'trial', 'april', '.']"
Fluid Overload and Kidney Injury Score: A Multidimensional Real-Time Assessment of Renal Disease Burden in the Critically Ill Patient.,"Ayse Akcan-Arikan, Daniel J Gebhard, Megan A Arnold, Laura L Loftis, Curtis E Kennedy, Ayse Akcan-Arikanet al.",2017 Jun,Pediatr Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/28406863/,No keywords found,"['interruptive', 'acute', 'kidney', 'injury', 'alert', 'reported', 'to', 'decrease', 'acute', 'kidney', 'injury-related', 'mortality', 'in', 'adult', '.', 'critically', 'ill', 'child', 'multiple', 'acute', 'kidney', 'injury', 'risk', 'factor', 'although', 'recognition', 'improved', 'due', 'to', 'standardized', 'definition', ',', 'subtle', 'change', 'in', 'serum', 'creatinine', 'make', 'acute', 'kidney', 'injury', 'recognition', 'challenging', '.', 'age', 'and', 'body', 'habitus', 'variability', 'prevent', 'uniform', 'maximum', 'threshold', 'of', 'creatinine', '.', 'exposure', 'of', 'nephrotoxic', 'medication', 'common', 'not', 'accounted', 'in', 'kidney', 'injury', 'score', '.', 'current', 'severity', 'of', 'illness', 'measure', 'not', 'include', 'fluid', 'overload', ',', 'well-described', 'mortality', 'risk', 'factor', '.', 'hypothesized', 'multidimensional', 'measure', 'of', 'renal', 'status', 'would', 'better', 'characterize', 'renal', 'severity', 'of', 'illness', 'maintaining', 'or', 'improving', 'correlation', 'measure', 'with', 'adverse', 'outcome', ',', 'compared', 'with', 'traditional', 'acute', 'kidney', 'injury', 'staging', '.', 'design', 'novel', ',', 'real-time', ',', 'multidimensional', ',', 'renal', 'status', 'measure', ',', 'combining', 'acute', 'kidney', 'injury', ',', 'fluid', 'overload', 'greater', 'or', 'equal', 'to', ',', 'and', 'nephrotoxin', 'exposure', ',', 'developed', '(', 'fluid', 'overload', 'kidney', 'injury', 'score', ')', 'and', 'prospectively', 'applied', 'to', 'patient', 'encounter', '.', 'peak', 'fluid', 'overload', 'kidney', 'injury', 'score', 'value', 'prior', 'to', 'discharge', 'or', 'death', 'used', 'to', 'measure', 'correlation', 'with', 'outcome', '.', 'setting', 'quarternary', 'picu', 'of', 'freestanding', 'child', ""'s"", 'hospital', '.', 'patient', 'patient', 'admitted', 'month', '.', 'intervention', 'none', '.', 'result', 'peak', 'fluid', 'overload', 'kidney', 'injury', 'score', 'ranged', 'and', 'in', ',', 'picu', 'patient', '(', 'median', 'age', ',', '.', 'yr', 'interquartile', 'range', ',', '.-', '.', 'male', ')', ',', 'of', 'patient', 'fluid', 'overload', 'kidney', 'injury', 'score', 'greater', 'or', 'equal', 'to', '.', 'fluid', 'overload', 'kidney', 'injury', 'score', 'independently', 'associated', 'with', 'picu', 'mortality', 'and', 'picu', 'and', 'hospital', 'length', 'of', 'stay', 'controlled', 'age', ',', 'pediatric', 'risk', 'of', 'mortality-', ',', 'ventilator', ',', 'pressor', ',', 'and', 'renal', 'replacement', 'therapy', 'use', '(', 'p', '.', ')', '.', 'mortality', 'increased', '.', 'in', 'fluid', 'overload', 'kidney', 'injury', 'score', 'to', 'in', 'fluid', 'overload', 'kidney', 'injury', 'score', '.', 'urine', 'output', 'point', 'excluded', ',', 'fluid', 'overload', 'kidney', 'injury', 'score', 'strongly', 'correlated', 'with', 'mortality', 'fluid', 'overload', 'or', 'acute', 'kidney', 'injury', 'definition', 'alone', '.', 'conclusion', 'multidimensional', 'score', 'of', 'renal', 'disease', 'burden', 'significantly', 'associated', 'with', 'adverse', 'picu', 'outcome', '.', 'study', 'evaluate', 'fluid', 'overload', 'kidney', 'injury', 'score', 'warning', 'and', 'decision', 'support', 'tool', 'to', 'impact', 'patient-centered', 'outcome', '.']"
"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.","Francisco J Pasquel, Roma Gianchandani, Daniel J Rubin, Kathleen M Dungan, Isabel Anzola, Patricia C Gomez, Limin Peng, Israel Hodish, Tim Bodnar, David Wesorick, Vijay Balakrishnan, Kwame Osei, Guillermo E Umpierrez, Francisco J Pasquelet al.",2017 Feb,Lancet Diabetes Endocrinol,https://pubmed.ncbi.nlm.nih.gov/27964837/,No keywords found,"['role', 'of', 'incretin-based', 'drug', 'in', 'treatment', 'of', 'patient', 'with', 'type', 'diabetes', 'admitted', 'to', 'hospital', 'not', 'extensively', 'assessed', '.', 'in', 'study', ',', 'compared', 'safety', 'and', 'efficacy', 'of', 'dipeptidyl', 'peptidase-', 'inhibitor', '(', 'sitagliptin', ')', 'plus', 'basal', 'insulin', 'with', 'basal-bolus', 'insulin', 'regimen', 'management', 'of', 'patient', 'with', 'type', 'diabetes', 'in', 'general', 'medicine', 'and', 'surgery', 'in', 'hospital', '.', 'method', 'multicentre', ',', 'prospective', ',', 'open-label', ',', 'non-inferiority', 'randomised', 'clinical', 'trial', '(', 'sita-hospital', ')', 'in', 'five', 'hospital', 'in', 'usa', ',', 'enrolling', 'patient', 'aged', '-', 'year', 'with', 'type', 'diabetes', 'and', 'random', 'blood', 'glucose', 'concentration', 'of', '-', 'mmoll', 'treated', 'with', 'diet', 'or', 'oral', 'antidiabetic', 'drug', 'or', 'total', 'daily', 'insulin', 'dose', 'of', 'unit', 'per', 'kg', 'or', 'less', ',', 'admitted', 'to', 'general', 'medicine', 'and', 'surgery', 'service', '.', 'randomly', 'assigned', 'patient', '(', ')', 'to', 'receive', 'either', 'sitagliptin', 'plus', 'basal', 'glargine', 'daily', '(', 'sitagliptin-basal', 'group', ')', 'or', 'basal-bolus', 'regimen', 'with', 'glargine', 'daily', 'and', 'rapid-acting', 'insulin', 'lispro', 'or', 'aspart', 'meal', '(', 'basal-bolus', 'group', ')', 'hospital', 'stay', '.', 'antidiabetic', 'drug', 'discontinued', 'admission', '.', 'randomisation', 'achieved', 'computer-generated', 'table', 'with', 'block', 'stratification', 'according', 'to', 'randomisation', 'blood', 'glucose', 'concentration', '(', 'ie', ',', 'higher', 'or', 'lower', 'mmoll', ')', '.', 'primary', 'endpoint', 'of', 'trial', 'non-inferiority', 'in', 'mean', 'difference', 'group', 'in', 'daily', 'blood', 'glucose', 'concentration', 'first', 'day', 'of', 'therapy', '(', 'point-of-care', 'measurement', 'non-inferiority', 'deemed', 'difference', 'mmoll', ')', '.', 'safety', 'endpoint', 'included', 'hypoglycaemia', 'and', 'uncontrolled', 'hyperglycaemia', 'leading', 'to', 'treatment', 'failure', '.', 'participant', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', 'included', 'in', 'analysis', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'aug', ',', ',', 'and', 'july', ',', ',', 'recruited', 'patient', ',', 'and', 'randomly', 'assigned', 'to', 'treatment', 'to', 'sitagliptin-basal', 'and', 'to', 'basal-bolus', '.', 'length', 'of', 'stay', 'in', 'hospital', 'similar', 'group', '(', 'median', 'day', 'iqr', '-', 'v', '-', 'day', ',', 'p', ')', '.', 'mean', 'daily', 'blood', 'glucose', 'concentration', 'in', 'sitagliptin-basal', 'group', '(', 'mmoll', 'sd', ')', 'not', 'inferior', 'to', 'in', 'basal-bolus', 'group', 'mmoll', ')', 'with', 'mean', 'blood', 'glucose', 'difference', 'of', 'mmoll', '(', 'ci', '-', 'to', ')', '.', 'no', 'death', 'occurred', 'in', 'trial', '.', 'treatment', 'failure', 'occurred', 'in', 'patient', '(', ')', 'in', 'sitagliptin-basal', 'group', 'versus', '(', ')', 'in', 'basal-bolus', 'group', '(', 'p', ')', '.', 'hypoglycaemia', 'occurred', 'in', 'patient', '(', ')', 'in', 'sitagliptin-basal', 'group', 'and', 'in', '(', ')', 'in', 'basal-bolus', 'group', '(', 'p', ')', '.', 'no', 'difference', 'in', 'hospital', 'complication', 'noted', 'group', '.', 'seven', 'patient', '(', ')', 'developed', 'acute', 'kidney', 'injury', 'in', 'sitagliptin-basal', 'group', 'and', 'six', '(', ')', 'in', 'basal-bolus', 'group', '.', 'one', 'patient', '(', ')', 'developed', 'acute', 'pancreatitis', '(', 'in', 'basal-bolus', 'group', ')', '.', 'interpretation', 'trial', 'met', 'non-inferiority', 'threshold', 'primary', 'endpoint', ',', 'no', 'significant', 'difference', 'group', 'in', 'mean', 'daily', 'blood', 'glucose', 'concentration', '.', 'treatment', 'with', 'sitagliptin', 'plus', 'basal', 'insulin', 'effective', 'and', 'safe', ',', 'and', 'convenient', 'alternative', 'to', ',', 'labour-intensive', 'basal-bolus', 'insulin', 'regimen', 'management', 'of', 'hyperglycaemia', 'in', 'patient', 'with', 'type', 'diabetes', 'admitted', 'to', 'general', 'medicine', 'and', 'surgery', 'service', 'in', 'hospital', 'in', 'non-intensive-care', 'setting', '.', 'funding', 'merck', '.']"
Evaluation of pharmacokinetic and pharmacodynamic parameters of meropenem in critically ill patients with acute kidney disease.,"Rezvan Hassanpour, Shadi Ziaie, Farzad Kobarfard, Mehran Kouchek, Mirmohammad Miri, Azadeh Ahmadi Koomleh, Seyedpouzhia Shojaei, Sara Salarian, Elham Pourheidar, Fatemeh Nezarat, Mohammad Sistanizad, Rezvan Hassanpouret al.",2021 Jun,Eur J Clin Pharmacol,https://pubmed.ncbi.nlm.nih.gov/33409684/,No keywords found,"['no', 'study', 'evaluated', 'pharmacokinetic', '(', 'pk', ')', 'and', 'pharmacodynamic', '(', 'pd', ')', 'property', 'of', '-lactam', 'antibiotic', 'in', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'not', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'evaluated', 'time', 'plasma', 'concentration', 'remain', 'four', 'time', 'mic', '(', 'ft', 'mic', ')', 'and', 'pk', 'parameter', 'of', 'meropenem', 'in', 'population', '.', 'method', 'in', 'prospective', ',', 'randomized', 'clinical', 'trial', '(', 'rct', ')', ',', 'patient', 'received', 'standard', 'dose', '(', 'g', 'daily', ')', 'of', 'meropenem', 'h', ',', 'randomly', 'allocated', 'in', 'standard', 'or', 'adjusted', 'group', '.', 'standard', 'group', 'received', 'meropenem', 'without', 'dose', 'adjustment', '.', 'in', 'adjusted', 'group', ',', 'meropenem', 'dose', 'adjusted', 'based', 'cockcroft-gault', '(', 'c-g', ')', 'equation', '.', 'meropenem', 'concentration', 'measured', 'peak', 'and', 'trough', 'time', 'nd', 'and', 'th', 'day', 'of', 'study', '.', 'result', 'nd', 'day', 'of', 'study', ',', 'of', '(', ')', 'of', 'patient', 'attained', 'pd', 'target', '(', 'ft', 'mic', ')', '.', 'in', 'th', 'day', 'of', 'study', ',', 'pd', 'target', 'attained', 'in', 'of', '(', ')', 'and', 'of', '(', ')', 'of', 'patient', 'received', 'standard', 'and', 'adjusted', 'dos', 'of', 'meropenem', ',', 'respectively', '(', 'p', ')', '.', 'in', 'sample', ',', 'increased', 'volume', 'of', 'distribution', '(', 'vd', ')', '(', 'median', 'iqr', ')', '(', '.', '.-', '.', 'l', ')', ',', 'terminal', 'half-life', '(', ')', '(', '.', '.-', '.', 'h', ')', 'and', 'decreased', 'clearance', '(', '.', '.-', '.', 'lh', ')', 'shown', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'aki', ',', 'not', 'receive', 'rrt', ',', 'standard', 'dos', ',', 'and', 'adjusted', 'according', 'to', 'renal', 'function', 'of', 'meropenem', 'failed', 'to', 'achieve', 'pd', 'target', 'of', 'ft', 'mic', '.', 'higher', 'dos', 'required', 'target', '.', 'retrospectively', 'registered', 'study', 'protocol', 'with', 'registered', 'retrospectively', 'and', 'approved', 'january', ',', ',', 'with', 'number', 'of', 'irctn', '.']"
"Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial.","Claire N Harrison, Ruben Mesa, Moshe Talpaz, Haifa Kathrin Al-Ali, Blanca Xicoy, Francesco Passamonti, Francesca Palandri, Giulia Benevolo, Alessandro Maria Vannucchi, Clemence Mediavilla, Alessandra Iurlo, InHo Kim, Shelonitda Rose, Patrick Brown, Christopher Hernandez, Jia Wang, Jean-Jacques Kiladjian, Claire N Harrisonet al.",2024 Oct,Lancet Haematol,https://pubmed.ncbi.nlm.nih.gov/39265613/,No keywords found,"['patient', 'with', 'myelofibrosis', 'develop', 'ruxolitinib', 'intolerance', 'or', 'disease', 'relapsed', 'or', 'refractory', ',', 'and', 'survival', 'rate', 'ruxolitinib', 'discontinuation', 'poor', '.', 'aimed', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'fedratinib', 'versus', 'best', 'available', 'therapy', '(', 'bat', ')', 'in', 'patient', 'with', 'myelofibrosis', 'previously', 'treated', 'with', 'ruxolitinib', '.', 'method', 'freedom', 'multicentre', ',', 'open-label', ',', 'randomised', ',', 'controlled', ',', 'phase', 'trial', 'in', 'clinic', 'in', 'country', ',', 'in', 'patient', 'aged', 'least', 'year', 'with', 'intermediate-', 'or', 'high-risk', 'myelofibrosis', 'relapsed', 'or', 'refractory', 'or', 'intolerant', 'to', 'ruxolitinib', 'with', 'eastern', 'cooperative', 'oncology', 'group', 'performance', 'status', '-', 'stratified', 'spleen', 'size', 'palpation', ',', 'platelet', 'count', ',', 'and', 'previous', 'ruxolitinib', 'treatment', ',', 'and', 'randomly', 'assigned', 'interactive', 'response', 'technology', 'to', 'receive', 'fedratinib', 'mg', 'per', 'day', '(', 'mg', 'capsule', 'orally', 'daily', ',', 'open-label', ')', 'or', 'bat', '.', 'patient', 'received', 'prophylactic', 'antiemetic', 'and', 'thiamine', 'supplementation', ',', 'and', 'symptomatic', 'antidiarrhoeals', 'required', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'reaching', 'spleen', 'volume', 'reduction', '(', 'svr', ')', 'of', 'least', '(', 'svr', ')', 'end', 'of', 'cycle', 'in', 'intention-to-treat', 'population', '.', 'manuscript', 'report', 'primary', 'analysis', 'of', 'trial', 'follow-up', 'ongoing', '.', 'trial', 'registered', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'sept', ',', 'and', 'june', ',', ',', 'of', 'patient', 'screened', ',', 'randomly', 'assigned', 'and', 'treated', '(', 'to', 'fedratinib', ',', 'to', 'bat', 'including', 'receiving', 'ruxolitinib', ')', 'patient', 'bat', 'group', 'crossed', 'to', 'fedratinib', '.', 'approximately', 'half', 'of', 'enrolled', 'patient', 'male', '(', 'fedratinib', 'of', 'bat', 'of', ')', 'and', 'white', '(', 'fedratinib', 'of', 'bat', 'of', ')', '.', 'data', 'cutoff', '(', 'dec', ',', ')', ',', 'median', 'survival', 'follow-up', 'week', '(', 'iqr', '-', ')', '.', 'svr', 'end', 'of', 'cycle', 'seen', 'in', '(', ')', 'of', 'patient', 'receiving', 'fedratinib', 'versus', 'four', '(', ')', 'of', 'patient', 'receiving', 'bat', '(', 'difference', 'ci', '-', 'one-sided', 'p-value', ')', '.', 'first', 'six', 'cycle', '(', ')', 'of', 'patient', 'in', 'fedratinib', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'bat', 'group', 'grade', 'or', 'greater', 'treatment-related', 'adverse', 'event', ',', 'frequently', 'anaemia', '(', 'fedratinib', 'of', 'bat', 'of', ')', 'and', 'thrombocytopenia', '(', 'fedratinib', 'of', 'bat', 'of', ')', 'one', 'patient', 'in', 'fedratinib', 'group', 'died', 'acute', 'kidney', 'injury', 'suspected', 'to', 'related', 'to', 'study', 'drug', '(', 'no', 'treatment-related', 'death', 'in', 'bat', 'group', ')', '.', 'gastrointestinal', 'adverse', 'event', 'occurred', 'frequently', 'in', 'fedratinib', 'group', 'compared', 'with', 'bat', 'group', ',', 'mostly', 'grade', '-', 'in', 'severity', 'and', 'frequent', 'in', 'early', 'cycle', ',', 'and', 'less', 'frequent', 'in', 'prior', 'clinical', 'trial', '.', 'total', 'of', '(', ')', 'of', 'patient', 'in', 'fedratinib', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'bat', 'group', 'thiamine', 'level', 'lower', 'limit', 'of', 'normal', 'per', 'central', 'laboratory', 'assessment', ',', 'with', 'one', 'case', 'of', 'low', 'thiamine', 'in', 'fedratinib', 'arm', 'introduction', 'of', 'prophylactic', 'thiamine', 'supplementation', '.', 'interpretation', 'finding', 'freedom', 'support', 'fedratinib', 'second-line', 'janus', 'kinase', 'inhibitor', 'option', 'to', 'reduce', 'spleen', 'size', 'ruxolitinib', 'failure', 'or', 'intolerance', 'in', 'patient', 'with', 'myelofibrosis', ',', 'and', 'show', 'effective', 'strategy', 'management', 'of', 'gastrointestinal', 'adverse', 'event', 'and', 'low', 'thiamine', 'concentration', 'prophylaxis', ',', 'monitoring', ',', 'and', 'treatment', '.', 'funding', 'bristol', 'myers', 'squibb', '.']"
"Th1, Th2, Th17 cell subsets in two different immunosuppressive protocols in renal allograft recipients (Sirolimus vs mycophenolate mofetil): A cohort study.","Atefeh Eteghadi, Fatemeh Pak, Pedram Ahmadpoor, Saeideh Jamali, Mozhdeh Karimi, Mir Saeed Yekaninejad, Parviz Kokhaei, Mohsen Nafar, Ali Akbar Amirzargar, Atefeh Eteghadiet al.",2019 Feb:67:319-325.,Int Immunopharmacol,https://pubmed.ncbi.nlm.nih.gov/30576916/,"Kidney transplantation, Mycophenolate mofetil, Prednisolone, Sirolimus, Tacrolimus, Th1, Th17 cells, Th2.","['group', 'comprised', 'patient', 'received', 'tac', ',', 'mmf', 'and', 'perd', 'whereas', 'group', 'b', 'composed', 'of', 'patient', 'received', 'tac', ',', 'srl', 'and', 'perd', '.', 'frequency', 'of', 'th', ',', 'th', 'and', 'th', 'cell', 'in', 'peripheral', 'blood', 'mononuclear', 'cell', '(', 'pbmcs', ')', 'of', 'patient', 'analyzed', 'flow', 'cytometry', 'and', 'month', 'transplantation', '.', 'in', 'addition', ',', 'ifn-', ',', 'il-', 'and', 'il-a', 'concentration', 'in', 'pbmc', 'culture', 'supernatant', 'of', 'patient', 'and', 'month', 'transplantation', 'quantified', 'elisa', '.', 'result', 'of', 'study', 'showed', 'tac', ',', 'mmf', 'and', 'pred', 'protocol', 'not', 'diminish', 'frequency', 'of', 'th', 'cell', 'month', 'post-transplantation', '(', '.', ')', 'compared', 'with', 'pre-transplantation', '(', '.', 'p', '.', ')', '.', 'however', ',', 'th', '(', '.', '.', 'pre-transplantation', 'v', '.', '.', 'month', 'post-transplantation', 'p', '.', ')', ',', 'th', '(', '.', '.', 'pre-transplantation', 'v', '.', '.', 'month', 'post-transplantation', 'p', '.', ')', 'cell', 'subset', 'and', 'il-', 'concentration', '(', '.', 'pgml', 'pre-transplantation', 'v', '.', 'pgml', '.', 'month', 'post-transplantation', 'p', '.', ')', 'significantly', 'decreased', 'transplantation', 'in', 'patient', 'received', 'srl', ',', 'tac', 'and', 'pred', '.', 'in', 'conclusion', ',', 'data', 'of', 'current', 'study', 'suggest', 'using', 'reduced', 'dose', 'of', 'tac', 'in', 'srl', ',', 'tac', 'and', 'pred', 'protocol', 'in', 'favor', 'of', 'allograft', 'survival', 'however', 'cohort', 'study', 'with', 'larger', 'sample', 'size', 'needed', 'confirming', 'result', '.']"
"Nonsedation or Light Sedation in Critically Ill, Mechanically Ventilated Patients.","Hanne T Olsen, Helene K Nedergaard, Thomas Strøm, Jakob Oxlund, Karl-Andre Wian, Lars M Ytrebø, Bjørn A Kroken, Michelle Chew, Serkan Korkmaz, Jørgen T Lauridsen, Palle Toft, Hanne T Olsenet al.",2020 Mar 19,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/32068366/,No keywords found,"['in', 'critically', 'ill', ',', 'mechanically', 'ventilated', 'patient', ',', 'daily', 'interruption', 'of', 'sedation', 'shown', 'to', 'reduce', 'time', 'ventilation', 'and', 'length', 'of', 'stay', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'data', 'whether', 'plan', 'of', 'no', 'sedation', ',', 'compared', 'with', 'plan', 'of', 'light', 'sedation', ',', 'effect', 'mortality', 'lacking', '.', 'method', 'in', 'multicenter', ',', 'randomized', ',', 'controlled', 'trial', ',', 'assigned', ',', 'in', 'ratio', ',', 'mechanically', 'ventilated', 'icu', 'patient', 'to', 'plan', 'of', 'no', 'sedation', '(', 'nonsedation', 'group', ')', 'or', 'to', 'plan', 'of', 'light', 'sedation', '(', 'i.e.', ',', 'to', 'level', 'patient', 'arousable', ',', 'defined', 'score', 'of', '-', 'to', '-', 'richmond', 'agitation', 'and', 'sedation', 'scale', 'ras', ',', 'score', 'range', '-', 'unresponsive', 'to', 'combative', ')', '(', 'sedation', 'group', ')', 'with', 'daily', 'interruption', '.', 'primary', 'outcome', 'mortality', 'day', '.', 'secondary', 'outcome', 'number', 'of', 'major', 'thromboembolic', 'event', ',', 'number', 'of', 'day', 'free', 'coma', 'or', 'delirium', ',', 'acute', 'kidney', 'injury', 'according', 'to', 'severity', ',', 'number', 'of', 'icu-free', 'day', ',', 'and', 'number', 'of', 'ventilator-free', 'day', '.', 'between-group', 'difference', 'calculated', 'value', 'in', 'nonsedation', 'group', 'minus', 'value', 'in', 'sedation', 'group', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', ',', 'and', 'included', 'in', 'modified', 'intention-to-treat', 'analysis', '.', 'characteristic', 'of', 'patient', 'baseline', 'similar', 'in', 'two', 'trial', 'group', ',', 'except', 'score', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', '(', 'apache', ')', 'ii', ',', 'point', 'higher', 'in', 'nonsedation', 'group', 'in', 'sedation', 'group', ',', 'indicating', 'greater', 'chance', 'of', 'in-hospital', 'death', '.', 'mean', 'ras', 'score', 'in', 'nonsedation', 'group', 'increased', '-', '.', 'day', 'to', '-', '.', 'day', 'and', ',', 'in', 'sedation', 'group', ',', '-', '.', 'day', 'to', '-', '.', 'day', '.', 'mortality', 'day', '.', 'in', 'nonsedation', 'group', 'and', '.', 'in', 'sedated', 'group', '(', 'difference', ',', '.', 'percentage', 'point', 'confidence', 'interval', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'number', 'of', 'icu-free', 'day', 'and', 'of', 'ventilator-free', 'day', 'not', 'differ', 'significantly', 'trial', 'group', '.', 'patient', 'in', 'nonsedation', 'group', 'median', 'of', 'day', 'free', 'coma', 'or', 'delirium', ',', 'and', 'in', 'sedation', 'group', 'median', 'of', 'day', 'free', 'coma', 'or', 'delirium', '.', 'major', 'thromboembolic', 'event', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'nonsedation', 'group', 'and', 'in', 'patient', '(', '.', ')', 'in', 'sedation', 'group', '(', 'difference', ',', '-', '.', 'percentage', 'point', 'ci', ',', '-', '.', 'to', '-', '.', 'unadjusted', 'multiple', 'comparison', ')', '.', 'conclusion', 'among', 'mechanically', 'ventilated', 'icu', 'patient', ',', 'mortality', 'day', 'not', 'differ', 'significantly', 'assigned', 'to', 'plan', 'of', 'no', 'sedation', 'and', 'assigned', 'to', 'plan', 'of', 'light', 'sedation', 'with', 'daily', 'interruption', '.', '(', 'funded', 'danish', 'medical', 'research', 'council', 'and', 'others', 'nonseda', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial.,"Karen C Tran, Pierre Asfar, Matthew Cheng, Julien Demiselle, Joel Singer, Terry Lee, David Sweet, John Boyd, Keith Walley, Greg Haljan, Omar Sharif, Guillaume Geri, Johann Auchabie, Jean-Pierre Quenot, Todd C Lee, Jennifer Tsang, Ferhat Meziani, Francois Lamontagne, Vincent Dubee, Sigismond Lasocki, Daniel Ovakim, Gordon Wood, Alexis Turgeon, Yves Cohen, Eddy Lebas, Marine Goudelin, David Forrest, Alastair Teale, Jean-Paul Mira, Robert Fowler, Nick Daneman, Neill K J Adhikari, Marie Gousseff, Pierre Leroy, Gaetan Plantefeve, Patrick Rispal, Roxane Courtois, Brent Winston, Steve Reynolds, Peter Birks, Boris Bienvenu, Jean-Marc Tadie, Jean-Philippe Talarmin, Severine Ansart, James A Russell                              ;, ARBs CORONA II Team, J Russell, K Tran, M Cheng, P Asfar, J Demiselle, J Singer, P Mann, F Jain, K Donohoe, V Leung, T Lee, J Boyd, K Walley, D Sweet, G Haljan, O Sharif, D Ovakim, G Wood, D Forrest, A Teale, S Reynolds, P Birk, B Winston, R Fowler, N Dameman, N Adhikari, J Tsang, F Lamontagne, A Turgeon-Fournier, Asfar, Demiselle, D G Geri, J Auchabie, J P Quenot, F Meziani, V Dubee, S Lasocki, Y Cohen, E Lebas, M Goudelin, J P Mira, M Gousseff, P Leroy, G Plantefev, P Rispal, R Courtois, B Bievenue, J M Tadie, J P Talarmin, S Ansart, Tae Won Yi, Adeera Levin, Karen C Tranet al.",2024 Sep 26,Clin Infect Dis,https://pubmed.ncbi.nlm.nih.gov/39325643/,No keywords found,"['severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '(', 'sars-cov-', ')', 'down-regulates', 'angiotensin-converting', 'enzyme', ',', 'potentially', 'increasing', 'angiotensin', 'ii', '.', 'hypothesized', 'losartan', 'compared', 'to', 'usual', 'care', 'decrease', 'mortality', 'and', 'safe', 'in', 'patient', 'hospitalized', 'with', 'coronavirus', 'disease', '(', 'covid-', ')', '.', 'aimed', 'to', 'evaluate', 'effect', 'of', 'losartan', 'versus', 'usual', 'care', '-day', 'mortality', 'in', 'patient', 'hospitalized', 'acute', 'covid-', '.', 'method', 'eligibility', 'criterion', 'included', 'adult', 'admitted', 'acute', 'covid-', '.', 'exclusion', 'criterion', 'hypotension', ',', 'hyperkalemia', ',', 'acute', 'kidney', 'injury', ',', 'and', 'use', 'of', 'angiotensin', 'receptor', 'blocker', '(', 'arb', ')', 'or', 'angiotensin-converting', 'enzyme', 'inhibitor', 'within', 'day', '.', 'participant', 'randomized', 'to', 'losartan', '-', 'mgday', 'orally', 'hospital', 'duration', 'or', 'month', 'or', 'control', 'arm', '(', 'usual', 'care', ')', 'in', 'hospital', 'in', 'canada', 'and', 'france', '.', 'primary', 'outcome', '-day', 'mortality', '.', 'secondary', 'outcome', 'hospital', 'mortality', ',', 'organ', 'support', ',', 'and', 'serious', 'adverse', 'event', '(', 'saes', ')', '.', 'result', 'trial', 'stopped', 'early', 'of', 'serious', 'safety', 'concern', 'with', 'losartan', '.', 'in', 'patient', ',', 'sae', 'and', 'hypotension', 'significantly', 'higher', 'in', 'losartan', 'versus', 'usual', 'care', 'group', '(', 'sae', '.', 'v', '.', ',', 'respectively', ',', 'p', '.', 'hypotension', '.', 'v', '.', ',', 'respectively', ',', 'p', '.', ')', 'in', 'ward', 'and', 'intensive', 'care', 'patient', '.', '-day', 'mortality', 'not', 'differ', 'losartan', '(', '.', ')', 'versus', 'usual', 'care', '(', '.', ')', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', ',', 'organ', 'dysfunction', 'or', 'secondary', 'outcome', '.', 'conclusion', 'caution', 'needed', 'in', 'deciding', 'patient', 'to', 'start', 'or', 'continue', 'using', 'arb', 'in', 'patient', 'hospitalized', 'with', 'pneumonia', 'to', 'mitigate', 'risk', 'of', 'hypotension', ',', 'acute', 'kidney', 'injury', ',', 'and', 'side', 'effect', '.', 'arb', 'not', 'added', 'to', 'care', 'of', 'patient', 'hospitalized', 'acute', 'covid-', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
"Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.","Srdan Verstovsek, Aaron T Gerds, Alessandro M Vannucchi, Haifa Kathrin Al-Ali, David Lavie, Andrew T Kuykendall, Sebastian Grosicki, Alessandra Iurlo, Yeow Tee Goh, Mihaela C Lazaroiu, Miklos Egyed, Maria Laura Fox, Donal McLornan, Andrew Perkins, Sung-Soo Yoon, Vikas Gupta, Jean-Jacques Kiladjian, Nikki Granacher, Sung-Eun Lee, Luminita Ocroteala, Francesco Passamonti, Claire N Harrison, Barbara J Klencke, Sunhee Ro, Rafe Donahue, Jun Kawashima, Ruben Mesa                              ;, MOMENTUM Study Investigators, Adi Shacham Abulafia, Bjorn Andreasson, Anna Angona, Rosa Ayala, Soo-Mee Bang, Bruce Bank, Fiorenza Barraco, Eloise Beggiato, Fleur Samantha Benghiat, MassimiliaNo Bonifacio, Claire Bories, Gabriela Borsaru, Mette Brabrand, Andrei Braester, Andes Broliden, Veronika Buxhofer-Ausch, Nathalie Cambier, Marianna Caramella, Benjamin Carpentier, Nicola Cascavilla, Maria Giraldo Castellano, Hung Chang, Chih-Cheng Chen, June-Won Cheong, Yunsuk Choi, Philip Choi, Maria Teresa Corsetti, Isabel Montero Cuadrado, Julia Cunningham, Gandhi Laurent Damaj, Valerio De Stefano, Robert Delage, Regina Garcĺa Delgado, Jose Miguel Torregrosa Diaz, Péter Dombi, Viviane Dubruille, Miklós Egyed, Daniel El Fassi, Anna Elinder-Camburn, Elena Maria Elli, Martin Ellis, Carmen Fava, Salman Fazal, Angela Fleischman, Lynda Foltz, Laura Fox, Nashat Gabrail, Jose Valentĺn Garcĺa-Gutiérrez, Aaron Gerds, Stephane Girault, Heinz Gisslinger, Alexandru Gluvacov, Joachim Göthert, Evgeni Evgueniy Hadjiev Hadzhiev, Kaoutar Hafraoui, Aryan Hamed, Claire Harrison, Hans Hasselbalch, Hanns Hauser, Mark Heaney, Holger Hebart, Jesus Maria Hernandez Rivas, Victor Higuero Saavedra, Christopher Hillis, Hsin-An Hou, Jonathan How, Daniel Huang, Marek Hus, Arpad Illés, Alessandro Isidori, Vadim Ivanov, Peter Johansson, Chul Won Jung, Ilya Kirgner, Maya Koren-Michowitz, Steffen Koschmieder, Szabolcs Ors Kosztolanyi, Natalia Kreiniz, Andrew Kuykendall, Jonathan Lambert, Kamel Laribi, Axelle Lascaux, Noa Lavie, Mihaela Lazaroiu, Michael Leahy, Ewa Lech-Maranda, Won Sik Lee, Ollivier Legrand, Roberto Lemoli, James Liang, Sung-Nam Lim, Michael Loschi, Alessandro Lucchesi, Ioan Macarie, Jean-Pierre Marolleau, Maurizio Martelli, Jiri Mayer, James McCloskey, Christopher McDermott, Brandon McMahon, Priyanka Mehta, Ruben Mesa, Gábor Mikala, Dragana Milojkovic, Philippe Mineur, Elena Mishchenko, Joon Ho Moon, Zsolt Nagy, Srinivasan Narayanan, Casey O'Connell, Stephen Oh, Mario Ojeda-Uribe, Kiat Hoe Ong, Folashade Otegbeye, Jeanne Palmer, Fabrizio Pane, Andrea Patriarca, Giuseppe Pietrantuono, Mark Plander, Uwe Platzbecker, Ritam Prasad, Witold Prejzner, Tobias Rachow, Atanas Radinoff, László Rejtő, Ciro Rinaldi, Tadeusz Robak, Maria Angeles Fernandez Rodriguez, Aaron Ronson, David Ross, Tomasz Sacha, Parvis Sadjadian, Antonio Salar, Guillermo Sanz Santillana, Christof Scheid, Aline Schmidt, Marianne Tang Severinsen, Vera Stoeva, Paweł Szwedyk, Mario Tiribelli, Karolin Trautmann-Grill, Amy Trottier, Nikolay Tzvetkov, Janusz van Droogenbroeck, Alessandro Vannucchi, Nicola Vianelli, Nikolas von Bubnoff, Dominik Wolf, Dariusz Woszczyk, Tomasz Woźny, Tomasz Wróbel, Blanca Xicoy, Su-Peng Yeh, Srdan Verstovseket al.",2023 Jan 28,Lancet,https://pubmed.ncbi.nlm.nih.gov/36709073/,No keywords found,"['janus', 'kinase', '(', 'jak', ')', 'inhibitor', 'approved', 'myelofibrosis', 'provide', 'spleen', 'and', 'symptom', 'improvement', 'not', 'meaningfully', 'improve', 'anaemia', '.', 'momelotinib', ',', 'first-in-class', 'inhibitor', 'of', 'activin', 'receptor', 'type', 'well', 'jak', 'and', 'jak', ',', 'shown', 'symptom', ',', 'spleen', ',', 'and', 'anaemia', 'benefit', 'in', 'myelofibrosis', '.', 'aimed', 'to', 'confirm', 'differentiated', 'clinical', 'benefit', 'of', 'momelotinib', 'versus', 'active', 'comparator', 'danazol', 'in', 'jak-inhibitor-exposed', ',', 'symptomatic', 'patient', 'with', 'anaemia', 'and', 'intermediate-risk', 'or', 'high-risk', 'myelofibrosis', '.', 'method', 'momentum', 'international', ',', 'double-blind', ',', 'randomised', ',', 'controlled', ',', 'phase', 'study', 'enrolled', 'patient', 'site', 'across', 'country', 'worldwide', '.', 'eligible', 'patient', 'year', 'or', 'older', 'with', 'confirmed', 'diagnosis', 'of', 'primary', 'myelofibrosis', 'or', 'post-polycythaemia', 'vera', 'or', 'post-essential', 'thrombocythaemia', 'myelofibrosis', '.', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'momelotinib', '(', 'mg', 'orally', 'per', 'day', ')', 'plus', 'danazol', 'placebo', '(', 'ie', ',', 'momelotinib', 'group', ')', 'or', 'danazol', '(', 'mg', 'orally', 'twice', 'per', 'day', ')', 'plus', 'momelotinib', 'placebo', '(', 'ie', ',', 'danazol', 'group', ')', ',', 'stratified', 'total', 'symptom', 'score', '(', 'tss', 'v', ')', ',', 'spleen', 'size', '(', 'cm', 'v', 'cm', ')', ',', 'red', 'blood', 'cell', 'or', 'whole', 'blood', 'unit', 'transfused', 'in', 'week', 'randomisation', '(', 'unit', 'v', '-', 'unit', 'v', 'unit', ')', ',', 'and', 'study', 'site', '.', 'primary', 'endpoint', 'myelofibrosis', 'symptom', 'assessment', 'form', '(', 'mfsaf', ')', 'tss', 'response', 'rate', 'week', '(', 'defined', 'reduction', 'in', 'mean', 'mfsaf', 'tss', 'day', 'immediately', 'end', 'of', 'week', 'compared', 'with', 'baseline', ')', '.', 'momentum', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', ',', 'and', 'active', 'not', 'recruiting', '.', 'finding', 'patient', 'randomly', 'assigned', 'to', 'either', 'momelotinib', 'group', '(', ')', 'or', 'danazol', 'group', '(', ')', 'and', 'received', 'study', 'treatment', 'in', '-week', 'randomised', 'treatment', 'period', 'april', ',', ',', 'and', 'dec', ',', '.', 'significantly', 'greater', 'proportion', 'of', 'patient', 'in', 'momelotinib', 'group', 'reported', 'or', 'reduction', 'in', 'tss', 'in', 'danazol', 'group', '(', 'of', 'v', 'six', 'of', 'proportion', 'difference', 'ci', '-', ',', 'p', ')', '.', 'frequent', 'grade', 'or', 'higher', 'treatment-emergent', 'adverse', 'event', 'with', 'momelotinib', 'and', 'danazol', 'haematological', 'abnormality', 'laboratory', 'value', 'anaemia', '(', 'of', 'v', 'of', ')', 'and', 'thrombocytopenia', '(', 'v', ')', '.', 'frequent', 'non-haematological', 'grade', 'or', 'higher', 'treatment-emergent', 'adverse', 'event', 'with', 'momelotinib', 'and', 'danazol', 'acute', 'kidney', 'injury', '(', 'four', 'of', 'v', 'six', 'of', ')', 'and', 'pneumonia', '(', 'three', 'v', 'six', ')', '.', 'interpretation', 'treatment', 'with', 'momelotinib', ',', 'compared', 'with', 'danazol', ',', 'resulted', 'in', 'clinically', 'significant', 'improvement', 'in', 'myelofibrosis-associated', 'symptom', ',', 'anaemia', 'measure', ',', 'and', 'spleen', 'response', ',', 'with', 'favourable', 'safety', '.', 'finding', 'support', 'future', 'use', 'of', 'momelotinib', 'effective', 'treatment', 'in', 'patient', 'with', 'myelofibrosis', ',', 'especially', 'in', 'with', 'anaemia', '.', 'funding', 'sierra', 'oncology', '.']"
"Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.","Lin-Quan Tang, Dong-Ping Chen, Ling Guo, Hao-Yuan Mo, Ying Huang, Shan-Shan Guo, Bin Qi, Qing-Nan Tang, Pan Wang, Xiao-Yun Li, Ji-Bin Li, Qing Liu, Yuan-Hong Gao, Fang-Yun Xie, Li-Ting Liu, Yang Li, Sai-Lan Liu, Hao-Jun Xie, Yu-Jing Liang, Xue-Song Sun, Jin-Jie Yan, Yi-Shan Wu, Dong-Hua Luo, Pei-Yu Huang, Yan-Qun Xiang, Rui Sun, Ming-Yuan Chen, Xing Lv, Lin Wang, Wei-Xiong Xia, Chong Zhao, Ka-Jia Cao, Chao-Nan Qian, Xiang Guo, Ming-Huang Hong, Zhi-Qiang Nie, Qiu-Yan Chen, Hai-Qiang Mai, Lin-Quan Tanget al.",2018 Apr,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/29501366/,No keywords found,"['cisplatin-based', 'concurrent', 'chemoradiotherapy', 'currently', 'considered', 'to', 'standard', 'treatment', 'regimen', 'patient', 'with', 'advanced', 'nasopharyngeal', 'carcinoma', ',', 'well', 'known', 'side-effects', 'gastrointestinal', 'reaction', ',', 'nephrotoxicity', ',', 'and', 'ototoxicity', '.', 'nedaplatin', 'developed', 'to', 'decrease', 'toxic', 'effect', 'induced', 'cisplatin', ',', 'and', 'in', 'trial', 'assessed', 'whether', 'nedaplatin-based', 'concurrent', 'chemoradiotherapy', 'regimen', 'non-inferior', 'to', 'cisplatin-based', 'regimen', 'in', 'patient', 'with', 'locoregional', ',', 'stage', 'ii-ivb', 'nasopharyngeal', 'carcinoma', '.', 'method', 'open-label', ',', 'non-inferiority', ',', 'phase', ',', 'randomised', ',', 'controlled', 'trial', 'two', 'centre', 'in', 'china', '.', 'patient', 'aged', '-', 'year', 'with', 'non-keratinising', 'stage', 'ii-ivb', '(', 't-n-', 'or', 't-n', ')', 'nasopharyngeal', 'carcinoma', ',', 'karnofsky', 'score', 'of', 'least', ',', 'and', 'adequate', 'haematological', ',', 'renal', ',', 'and', 'hepatic', 'function', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'intravenously', 'either', 'nedaplatin', 'mgm', 'or', 'cisplatin', 'mgm', 'day', ',', ',', 'and', 'three', 'cycle', 'concurrently', 'with', 'intensity-modulated', 'radiotherapy', '.', 'randomisation', 'done', 'manually', 'using', 'computer-generated', 'random', 'number', 'code', 'and', 'patient', 'stratified', 'treatment', 'centre', 'and', 'clinical', 'stage', '.', 'patient', 'and', 'clinician', 'not', 'masked', 'to', 'treatment', 'allocation', '.', 'primary', 'endpoint', 'progression-free', 'survival', 'year', 'non-inferiority', 'shown', 'upper', 'limit', 'of', 'ci', 'difference', 'in', '-year', 'progression-free', 'survival', 'two', 'group', 'not', 'exceed', '.', 'analysis', 'intention', 'to', 'treat', 'and', 'per', 'protocol', ',', 'including', 'patient', 'received', 'least', 'one', 'complete', 'cycle', 'of', 'chemotherapy', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', ',', 'and', 'currently', 'in', 'follow-up', '.', 'finding', 'jan', ',', ',', 'and', 'july', ',', ',', 'randomly', 'assigned', 'patient', 'to', 'nedaplatin-based', '(', 'n', ')', 'or', 'cisplatin-based', '(', 'n', ')', 'concurrent', 'chemoradiotherapy', '.', 'in', 'intention-to-treat', 'population', ',', '-year', 'progression-free', 'survival', '(', 'ci', '-', ')', 'in', 'cisplatin', 'group', 'and', '(', '-', ')', 'in', 'nedaplatin', 'group', ',', 'with', 'difference', 'of', '(', 'ci', '-', 'to', 'pnon-inferiority', ')', '.', 'in', 'per-protocol', 'analysis', '(', 'cisplatin', 'group', ',', 'n', 'nedaplatin', 'group', ',', 'n', ')', ',', '-year', 'progression-free', 'survival', '(', 'ci', '-', ')', 'in', 'cisplatin', 'group', 'and', '(', '-', ')', 'in', 'nedaplatin', 'group', ',', 'with', 'difference', 'of', '(', 'ci', '-', 'to', 'pnon-inferiority', ')', '.', 'significantly', 'higher', 'frequency', 'of', 'grade', 'or', 'vomiting', '(', 'of', 'in', 'cisplatin', 'group', 'v', 'of', 'in', 'nedaplatin', 'group', ',', 'p', ')', ',', 'nausea', '(', 'v', 'four', ',', 'p', ')', ',', 'and', 'anorexia', '(', 'v', ',', 'p', ')', 'observed', 'in', 'cisplatin', 'group', 'compared', 'with', 'nedaplatin', 'group', '.', '(', ')', 'patient', 'in', 'nedaplatin', 'group', 'grade', 'or', 'thrombocytopenia', 'compared', 'with', 'four', '(', ')', 'in', 'cisplatin', 'group', '(', 'p', ')', '.', 'patient', 'in', 'cisplatin', 'group', 'higher', 'frequency', 'of', 'grade', 'or', 'grade', 'or', 'late', 'auditory', 'or', 'hearing', 'toxicity', 'patient', 'in', 'nedaplatin', 'group', '(', 'grade', 'or', 'three', 'in', 'nedaplatin', 'group', 'v', 'in', 'cisplatin', 'group', ',', 'p', ')', '.', 'no', 'patient', 'died', 'treatment-related', 'cause', '.', 'interpretation', 'finding', 'show', 'nedaplatin-based', 'concurrent', 'chemoradiotherapy', 'represents', 'alternative', 'doublet', 'treatment', 'strategy', 'to', 'cisplatin-based', 'concurrent', 'chemoradiotherapy', 'patient', 'with', 'locoregional', ',', 'advanced', 'nasopharyngeal', 'carcinoma', '.', 'investigation', 'needed', 'to', 'explore', 'potential', 'use', 'of', 'treatment', 'induction', 'or', 'adjuvant', 'chemotherapy', 'or', 'in', 'combination', 'with', 'agent', '.', 'funding', 'national', 'key', 'rd', 'program', 'of', 'china', ',', 'national', 'natural', 'science', 'foundation', 'of', 'china', ',', 'sun', 'yat-sen', 'university', 'clinical', 'research', 'program', ',', 'sci-tech', 'project', 'foundation', 'of', 'guangzhou', 'city', ',', 'national', 'key', 'basic', 'research', 'program', 'of', 'china', ',', 'special', 'support', 'plan', 'of', 'guangdong', 'province', ',', 'sci-tech', 'project', 'foundation', 'of', 'guangdong', 'province', ',', 'health', 'medical', 'collaborative', 'innovation', 'project', 'of', 'guangzhou', 'city', ',', 'national', 'science', 'technology', 'pillar', 'program', 'twelfth', 'five-year', 'plan', 'period', ',', 'phd', 'start-up', 'fund', 'of', 'natural', 'science', 'foundation', 'of', 'guangdong', 'province', ',', 'cultivation', 'foundation', 'junior', 'teacher', 'in', 'sun', 'yat-sen', 'university', ',', 'and', 'fundamental', 'research', 'fund', 'central', 'university', '.']"
"Comprehensive versus standard care in post-severe acute kidney injury survivors, a randomized controlled trial.","Peerapat Thanapongsatorn#, Kamolthip Chaikomon#, Nuttha Lumlertgul, Khanitha Yimsangyad, Akarathep Leewongworasingh, Win Kulvichit, Phatadon Sirivongrangson, Sadudee Peerapornratana, Weerachai Chaijamorn, Yingyos Avihingsanon, Nattachai Srisawat, Peerapat Thanapongsatornet al.",2021 Aug 31,Crit Care,https://pubmed.ncbi.nlm.nih.gov/34465357/,No keywords found,"['currently', ',', 'lack', 'of', 'evidence', 'to', 'guide', 'optimal', 'care', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'survivor', '.', 'therefore', ',', 'post-discharge', 'care', 'multidisciplinary', 'care', 'team', '(', 'mdct', ')', 'may', 'improve', 'outcome', '.', 'study', 'aimed', 'to', 'demonstrate', 'outcome', 'of', 'implementing', 'comprehensive', 'care', 'mdct', 'in', 'severe', 'aki', 'survivor', '.', 'method', 'study', 'randomized', 'controlled', 'trial', 'conducted', 'august', 'to', 'january', '.', 'patient', 'survived', 'severe', 'aki', 'stage', '-', 'enrolled', 'and', 'randomized', 'to', 'followed', 'with', 'either', 'comprehensive', 'or', 'standard', 'care', 'month', '.', 'comprehensive', 'post-aki', 'care', 'involved', 'mdct', '(', 'nephrologists', ',', 'nurse', ',', 'nutritionist', ',', 'and', 'pharmacist', ')', '.', 'primary', 'outcome', 'feasibility', 'outcome', 'comprising', 'of', 'rate', 'of', 'loss', 'to', 'follow', ',', '-d', 'dietary', 'record', ',', 'drug', 'reconciliation', ',', 'and', 'drug', 'alert', 'rate', 'month', '.', 'secondary', 'outcome', 'included', 'major', 'adverse', 'kidney', 'event', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', ',', 'and', 'amount', 'of', 'albuminuria', 'month', '.', 'result', 'ninety-eight', 'aki', 'stage', 'survivor', 'enrolled', 'and', 'randomized', 'comprehensive', 'care', 'and', 'standard', 'care', 'group', '(', 'patient', 'in', 'group', ')', '.', 'compared', 'to', 'standard', 'care', 'group', ',', 'comprehensive', 'care', 'group', 'significantly', 'better', 'feasibility', 'outcome', '-d', 'dietary', 'record', ',', 'drug', 'reconciliation', ',', 'and', 'drug', 'alert', '(', 'p', '.', ')', '.', 'mean', 'egfr', 'month', 'comparable', 'two', 'group', '(', '.', 'vs.', '.', 'mlmin', '.', ',', 'p', '.', ')', '.', 'urine', 'albumin', 'creatinine', 'ratio', '(', 'uacr', ')', 'significantly', 'lower', 'in', 'comprehensive', 'care', 'group', '(', '.', 'vs.', '.', 'mgg', ',', 'p', '.', ')', ',', 'blood', 'pressure', 'control', 'also', 'better', 'in', 'comprehensive', 'care', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'no', 'difference', 'in', 'renal', 'outcome', 'two', 'group', '.', 'conclusion', 'comprehensive', 'care', 'mdct', 'feasible', 'and', 'could', 'implemented', 'severe', 'aki', 'survivor', '.', 'mdct', 'involvement', 'also', 'yield', 'better', 'reduction', 'of', 'uacr', 'and', 'better', 'blood', 'pressure', 'control', '.', 'trial', 'registration', 'clinicaltrial.gov', 'nct', '(', 'first', 'registered', 'july', ',', ')', '.']"
Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.,"Vinod Arora, Rajan Vijayaraghavan, Rakhi Maiwall, Amrish Sahney, Sherin Sarah Thomas, Rehmat Ali, Priyanka Jain, Guresh Kumar, Shiv Kumar Sarin, Vinod Aroraet al.",2020 Sep,Hepatology,https://pubmed.ncbi.nlm.nih.gov/31849085/,No keywords found,"['paracentesis-induced', 'circulatory', 'dysfunction', '(', 'picd', ')', 'serious', 'complication', 'of', 'large-volume', '(', 'l', ')', 'paracentesis', 'in', 'cirrhosis', 'and', 'reduced', 'with', 'albumin', 'infusion', '.', 'lack', 'of', 'data', 'picd', 'in', 'acute-on-chronic', 'liver', 'failure', '(', 'aclf', ')', '.', 'aclf', 'patient', 'greater', 'hemodynamic', 'derangement', 'patient', 'with', 'decompensated', 'cirrhosis', ',', 'investigated', 'whether', 'picd', 'could', 'develop', 'with', 'modest-volume', 'paracentesis', '(', 'mvp', ')', 'and', 'role', 'of', 'albumin', 'infusion', '.', 'approach', 'and', 'result', 'total', 'of', 'aclf', 'patient', 'undergoing', 'l', 'paracentesis', 'randomized', 'to', 'receive', 'albumin', '(', 'gdl', 'of', 'ascitic', 'fluid', 'n', ')', 'or', 'no', 'albumin', '(', 'n', ')', 'and', 'serially', 'followed', 'to', 'detect', 'picd', '.', 'baseline', 'characteristic', 'comparable', 'group', ',', 'including', 'volume', 'of', 'ascitic', 'tap', '(', '.', '.', 'versus', '.', '.', 'l', 'p', '.', ')', 'and', 'plasma', 'renin', 'activity', '(', 'pra', '.', '.', 'versus', '.', '.', 'ngmlhour', 'p', '.', ')', '.', 'picd', 'frequent', 'in', 'no-albumin', 'group', 'albumin', 'group', '(', 'versus', 'p', '.', ')', ',', 'with', 'higher', 'incidence', 'of', 'hepatic', 'encephalopathy', '(', 'versus', '.', 'p', '.', ')', ',', 'hyponatremia', '(', '.', 'versus', '.', 'p', '.', ')', ',', 'acute', 'kidney', 'injury', '(', '.', 'versus', 'p', '.', ')', ',', 'and', 'in-house', 'mortality', '(', '.', 'versus', '.', 'p', '.', ')', '.', 'pra', 'of', '.', 'ngml', 'day', 'sensitivity', 'and', 'specificity', 'of', 'and', ',', 'respectively', ',', 'development', 'of', 'picd', 'day', '.', 'albumin', 'infusion', 'decreased', 'incidence', 'of', 'picd', 'day', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'picd', 'common', 'and', 'develops', 'even', 'with', 'mvp', 'in', 'aclf', 'patient', '.', 'albumin', 'infusion', 'decrease', 'incidence', 'of', 'picd', 'and', 'mortality', 'in', 'patient', 'with', 'aclf', '.', 'clinical', 'trial', 'identifier', 'nct', '.']"
"Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.","Taha Sen, Jingwei Li, Brendon L Neuen, Bruce Neal, Clare Arnott, Chirag R Parikh, Steven G Coca, Vlado Perkovic, Kenneth W Mahaffey, Yshai Yavin, Norman Rosenthal, Michael K Hansen, Hiddo J L Heerspink, Taha Senet al.",2021 Oct,Diabetologia,https://pubmed.ncbi.nlm.nih.gov/34415356/,No keywords found,"['higher', 'plasma', 'concentration', 'of', 'tumour', 'necrosis', 'factor', 'receptor', '(', 'tnfr', ')', '-', ',', 'tnfr-', 'and', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'found', 'to', 'associated', 'with', 'higher', 'risk', 'of', 'kidney', 'failure', 'in', 'individual', 'with', 'type', 'diabetes', 'in', 'previous', 'study', '.', 'whether', 'drug', 'reduce', 'biomarkers', 'not', 'well', 'established', '.', 'measured', 'biomarkers', 'in', 'sample', 'of', 'canvas', 'study', 'and', 'examined', 'effect', 'of', 'sodium-glucose', 'cotransporter', 'inhibitor', 'canagliflozin', 'biomarkers', 'and', 'assessed', 'whether', 'early', 'change', 'in', 'biomarkers', 'predict', 'cardiovascular', 'and', 'kidney', 'outcome', 'in', 'individual', 'with', 'type', 'diabetes', 'in', 'canagliflozin', 'cardiovascular', 'assessment', 'study', '(', 'canvas', ')', '.', 'method', 'biomarkers', 'measured', 'with', 'immunoassay', '(', 'proprietary', 'multiplex', 'assay', 'performed', 'renalytixai', ',', 'new', 'york', ',', 'ny', ',', 'usa', ')', 'baseline', 'and', 'year', ',', 'and', '.', 'mixed-effects', 'model', 'repeated', 'measure', 'assessed', 'effect', 'of', 'canagliflozin', 'v', 'placebo', 'biomarkers', '.', 'association', 'of', 'baseline', 'level', 'and', 'early', 'change', '(', 'baseline', 'to', 'year', ')', 'biomarker', 'with', 'kidney', 'outcome', 'assessed', 'using', 'multivariable-adjusted', 'cox', 'regression', '.', 'result', 'in', 'total', ',', '(', '.', ')', 'of', 'canvas', 'participant', 'available', 'sample', 'baseline', '.', 'doubling', 'in', 'baseline', 'tnfr-', ',', 'tnfr-', 'and', 'kim-', 'associated', 'with', 'higher', 'risk', 'of', 'kidney', 'outcome', ',', 'with', 'corresponding', 'hr', 'of', '.', '(', 'ci', '.', ',', '.', 'p', '.', ')', ',', '.', '(', 'ci', '.', ',', '.', 'p', '.', ')', 'and', '.', '(', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'respectively', '.', 'canagliflozin', 'reduced', 'level', 'of', 'plasma', 'biomarkers', 'with', 'difference', 'in', 'tnfr-', ',', 'tnfr-', 'and', 'kim-', 'canagliflozin', 'and', 'placebo', 'follow-up', 'of', '.', '(', 'ci', '.', ',', '.', 'p', '.', ')', ',', '.', '(', 'ci', '.', ',', '.', 'p', '.', ')', 'and', '.', '(', 'ci', '.', ',', '.', 'p', '.', ')', ',', 'respectively', '.', 'within', 'canagliflozin', 'treatment', 'group', ',', 'reduction', 'in', 'tnfr-', 'and', 'tnfr-', 'year', 'associated', 'with', 'lower', 'risk', 'of', 'kidney', 'outcome', '(', 'hr', '.', 'ci', '.', ',', '.', 'p', '.', 'and', '.', 'ci', '.', ',', '.', 'p', '.', 'respectively', ')', ',', 'independent', 'of', 'patient', 'characteristic', '.', 'baseline', 'and', 'year', 'change', 'in', 'biomarkers', 'not', 'associate', 'with', 'cardiovascular', 'or', 'heart', 'failure', 'outcome', '.', 'conclusionsinterpretation', 'canagliflozin', 'decreased', 'kim-', 'and', 'modestly', 'reduced', 'tnfr-', 'and', 'tnfr-', 'compared', 'with', 'placebo', 'in', 'individual', 'with', 'type', 'diabetes', 'in', 'canvas', '.', 'early', 'decrease', 'in', 'tnfr-', 'and', 'tnfr-', 'canagliflozin', 'treatment', 'independently', 'associated', 'with', 'lower', 'risk', 'of', 'kidney', 'disease', 'progression', ',', 'suggesting', 'tnfr-', 'and', 'tnfr-', 'potential', 'to', 'pharmacodynamic', 'marker', 'of', 'response', 'to', 'canagliflozin', '.']"
"Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.","Christophe Massard, Michael S Gordon, Sunil Sharma, Saeed Rafii, Zev A Wainberg, Jason Luke, Tyler J Curiel, Gerardo Colon-Otero, Omid Hamid, Rachel E Sanborn, Peter H O'Donnell, Alexandra Drakaki, Winston Tan, John F Kurland, Marlon C Rebelatto, Xiaoping Jin, John A Blake-Haskins, Ashok Gupta, Neil H Segal, Christophe Massardet al.",2016 Sep 10,J Clin Oncol,https://pubmed.ncbi.nlm.nih.gov/27269937/,No keywords found,"['to', 'investigate', 'safety', 'and', 'efficacy', 'of', 'durvalumab', ',', 'human', 'monoclonal', 'antibody', 'bind', 'programmed', 'cell', 'death', 'ligand-', '(', 'pd-l', ')', ',', 'and', 'role', 'of', 'pd-l', 'expression', 'clinical', 'response', 'in', 'patient', 'with', 'advanced', 'urothelial', 'bladder', 'cancer', '(', 'ubc', ')', '.', 'method', 'phase', 'multicenter', ',', 'open-label', 'study', 'conducted', 'in', 'patient', 'with', 'inoperable', 'or', 'metastatic', 'solid', 'tumor', '.', 'report', 'result', 'ubc', 'expansion', 'cohort', '.', 'durvalumab', '(', 'medi', ',', 'mgkg', 'every', 'week', ')', 'administered', 'intravenously', 'to', 'month', '.', 'primary', 'end', 'point', 'safety', ',', 'and', 'objective', 'response', 'rate', '(', 'orr', ',', 'confirmed', ')', 'key', 'secondary', 'end', 'point', '.', 'exploratory', 'analysis', 'of', 'pretreatment', 'tumor', 'biopsy', 'led', 'to', 'defining', 'pd-l-positive', 'of', 'tumor', 'cell', 'or', 'tumor-infiltrating', 'immune', 'cell', 'expressing', 'membrane', 'pd-l.', 'result', 'total', 'of', 'patient', '(', 'pd-l-positive', ',', 'pd-l-negative', ')', ',', '.', 'of', 'received', 'one', 'or', 'prior', 'therapy', 'advanced', 'disease', ',', 'treated', '(', 'median', 'duration', 'of', 'follow-up', ',', '.', 'month', ')', '.', 'common', 'treatment-related', 'adverse', 'event', '(', 'aes', ')', 'of', 'grade', 'fatigue', '(', '.', ')', ',', 'diarrhea', '(', '.', ')', ',', 'and', 'decreased', 'appetite', '(', '.', ')', '.', 'grade', 'treatment-related', 'aes', 'occurred', 'in', 'three', 'patient', '(', '.', ')', 'no', 'treatment-related', 'grade', 'or', 'aes', '.', 'one', 'treatment-related', 'ae', '(', 'acute', 'kidney', 'injury', ')', 'resulted', 'in', 'treatment', 'discontinuation', '.', 'orr', '.', '(', 'ci', ',', '.', 'to', '.', ')', 'in', 'response-evaluable', 'patient', ',', '.', '(', 'ci', ',', '.', 'to', '.', ')', 'in', 'pd-l-positive', 'subgroup', ',', 'and', '(', 'ci', ',', '.', 'to', '.', ')', 'in', 'pd-l-negative', 'subgroup', '.', 'response', 'ongoing', 'in', 'of', 'responding', 'patient', ',', 'with', 'median', 'duration', 'of', 'response', 'not', 'yet', 'reached', '(', 'range', ',', '.', 'to', '.', 'week', ')', '.', 'conclusion', 'durvalumab', 'demonstrated', 'manageable', 'safety', 'profile', 'and', 'evidence', 'of', 'meaningful', 'clinical', 'activity', 'in', 'pd-l-positive', 'patient', 'with', 'ubc', ',', 'many', 'of', 'heavily', 'pretreated', '.']"
"Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.","Charles S Fuchs, Kohei Shitara, Maria Di Bartolomeo, Sara Lonardi, Salah-Eddin Al-Batran, Eric Van Cutsem, David H Ilson, Maria Alsina, Ian Chau, Jill Lacy, Michel Ducreux, Guillermo Ariel Mendez, Alejandro Molina Alavez, Daisuke Takahari, Wasat Mansoor, Peter C Enzinger, Vera Gorbounova, Zev A Wainberg, Susanna Hegewisch-Becker, David Ferry, Ji Lin, Roberto Carlesi, Mayukh Das, Manish A Shah                              ;, RAINFALL Study Group, Alexander V Luft, Nina A Karaseva, Rubén Dario Kowalyszyn, Carlos Alberto Hernandez, Tibor Csoszi, Ferdinando De Vita, Per Pfeiffer, Naotoshi Sugimoto, Judit Kocsis, Andràs Csilla, Gyorgy Bodoky, Georgina Garnica Jaliffe, Svetlana Protsenko, Ayman Madi, Elzbieta Wojcik, Baruch Brenner, Gunnar Folprecht, Tomasz Sarosiek, Katriina Johanna Peltola, Peter Bono, Hubert Ayala, Giuseppe Aprile, Cardellino Giovanni Gerardo, Fidel David Huitzil Melendez, Alfredo Falcone, Francesco Di Costanzo, Moustapha Tehfe, Laurent Mineur, Pilar García Alfonso, Radka Obermannova, Hélène Senellart, Russell Petty, Leslie Samuel, Peter Istvan Acs, Maen Abdelkarim Hussein, Marina N Nechaeva, F L G Erdkamp, Elizabeth Won, Johanna Chock Bendell, Javier Gallego Plazas, Sylvie Lorenzen, Bohuslav Melichar, Miguel Angel Escudero, Denis Pezet, Jean-Marc Phelip, Diego Lucas Kaen, James A Jr Reeves, Federico Longo Muñoz, Srinivasan Madhusudan, Carlo Barone, Luis Enrique Fein, Angel Gomez Villanueva, Mohamed Hebbar, Jana Prausova, Laura Visa Turmo, Joana Vidal Barrull, Mette Karen Nytoft Yilmaz, Alex Beny, H M W Van Laarhoven, Brian Anthony DiCarlo, Taito Esaki, Kazumasa Fujitani, Karen Geboes, Ravit Geva, Shigenori Kadowaki, Stephen Leong, Nozomu Machida, Moses Sundar Raj, Francisco Javier Ramirez Godinez, Agnes Ruzsa, Hugo Ford, William E Lawler, Nicolas Robert Maisey, Jiri Petera, Einat Shacham-Shmueli, Isabelle Sinapi, Kensei Yamaguchi, Hiroki Hara, Joseph Thaddeus Beck, Maria Błasińska-Morawiec, Ricardo Villalobos Valencia, Thierry Alcindor, Madhuri Bajaj, Scott Berry, Christina Maria Gomez, Daniel Dammrich, Ravindranath Patel, Julien Taieb, A J Ten Tije, Ronald L Burkes, Fernando Cabanillas, Irfan Firdaus, Cynthia Coo Chua, Shuichi Hironaka, Ralf-Dieter Hofheinz, Howard J Lim, Marianne Nordsmark, Bela Piko, Udit Verma, Jonathan Wadsley, Seigo Yukisawa, Francisco Gutiérrez Delgado, Crystal S Denlinger, Raija Kallio, Joanna Pikiel, Joanna Wojcik-Tomaszewska, Christine Brezden-Masley, Raymond Woo-Jun Jang, Jana Pribylova, Daisuke Sakai, Maria Alejandra Bartoli, A Cats, M I Grootscholten, Robert Andrew Dichmann, Hugo Hool, Walid Shaib, Akihito Tsuji, Marc Van den Eynde, Hector Velez-Cortez, Timothy R Asmis, Charles S Fuchset al.",2019 Mar,Lancet Oncol,https://pubmed.ncbi.nlm.nih.gov/30718072/,No keywords found,"['vegf', 'and', 'vegf', 'receptor', '(', 'vegfr-', ')', '-mediated', 'signalling', 'and', 'angiogenesis', 'contribute', 'to', 'pathogenesis', 'and', 'progression', 'of', 'gastric', 'cancer', '.', 'aimed', 'to', 'assess', 'whether', 'addition', 'of', 'ramucirumab', ',', 'vegfr-', 'antagonist', 'monoclonal', 'antibody', ',', 'to', 'first-line', 'chemotherapy', 'improves', 'outcome', 'in', 'patient', 'with', 'metastatic', 'gastric', 'or', 'gastro-oesophageal', 'junction', 'adenocarcinoma', '.', 'method', 'double-blind', ',', 'randomised', ',', 'placebo-controlled', ',', 'phase', 'trial', 'done', 'centre', 'in', 'country', ',', 'recruited', 'patient', 'aged', 'year', 'or', 'older', 'with', 'metastatic', ',', 'her-negative', 'gastric', 'or', 'gastro-oesophageal', 'junction', 'adenocarcinoma', ',', 'eastern', 'cooperative', 'oncology', 'group', '(', 'ecog', ')', 'performance', 'status', 'of', 'or', ',', 'and', 'adequate', 'organ', 'function', '.', 'eligible', 'patient', 'randomly', 'assigned', '(', ')', 'with', 'interactive', 'web', 'response', 'system', 'to', 'receive', 'cisplatin', '(', 'mgm', ',', 'first', 'day', ')', 'plus', 'capecitabine', '(', 'mgm', ',', 'twice', 'daily', 'day', ')', ',', 'every', 'day', ',', 'and', 'either', 'ramucirumab', '(', 'mgkg', ')', 'or', 'placebo', 'day', 'and', ',', 'every', 'day', '.', '-fluorouracil', '(', 'mgm', 'intravenous', 'infusion', 'day', '-', ')', 'permitted', 'in', 'patient', 'unable', 'to', 'take', 'capecitabine', '.', 'primary', 'endpoint', 'investigator-assessed', 'progression-free', 'survival', ',', 'analysed', 'intention', 'to', 'treat', 'in', 'first', 'patient', '.', 'sensitivity', 'analysis', 'of', 'primary', 'endpoint', ',', 'including', 'central', 'review', 'of', 'ct', 'scan', '.', 'overall', 'survival', 'key', 'secondary', 'endpoint', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'jan', ',', ',', 'and', 'sept', ',', ',', 'patient', 'randomly', 'assigned', 'to', 'receive', 'ramucirumab', 'plus', 'fluoropyrimidine', 'and', 'cisplatin', '(', 'n', ')', 'or', 'placebo', 'plus', 'fluoropyrimidine', 'and', 'cisplatin', '(', 'n', ')', '.', 'investigator-assessed', 'progression-free', 'survival', 'significantly', 'longer', 'in', 'ramucirumab', 'group', 'placebo', 'group', '(', 'hazard', 'ratio', 'hr', ',', 'ci', '-', ',', 'p', 'median', 'progression-free', 'survival', 'month', '-', 'v', 'month', '-', ')', '.', 'sensitivity', 'analysis', 'based', 'central', 'independent', 'review', 'of', 'radiological', 'image', 'not', 'corroborate', 'investigator-assessed', 'difference', 'in', 'progression-free', 'survival', '(', 'hr', ',', 'ci', '-', ',', 'p', ')', '.', 'no', 'difference', 'in', 'overall', 'survival', 'group', '(', ',', '-', ',', 'p', 'median', 'overall', 'survival', 'month', '-', 'in', 'ramucirumab', 'group', 'v', 'month', '-', 'in', 'placebo', 'group', ')', '.', 'common', 'grade', '-', 'adverse', 'event', 'neutropenia', '(', 'of', 'patient', 'in', 'ramucirumab', 'group', 'v', 'of', 'in', 'placebo', 'group', ')', ',', 'anaemia', '(', 'v', ')', ',', 'and', 'hypertension', '(', 'v', ')', '.', 'incidence', 'of', 'any-grade', 'serious', 'adverse', 'event', '(', ')', 'of', 'patient', 'in', 'ramucirumab', 'group', 'and', '(', ')', 'of', 'patient', 'in', 'placebo', 'group', '.', 'common', 'serious', 'adverse', 'event', 'vomiting', '(', 'in', 'ramucirumab', 'group', 'v', 'in', 'placebo', 'group', ')', 'and', 'diarrhoea', '(', 'v', ')', '.', 'seven', 'death', 'in', 'group', ',', 'either', 'study', 'treatment', 'or', 'within', 'day', 'of', 'discontinuing', 'study', 'treatment', ',', 'result', 'of', 'treatment-related', 'adverse', 'event', '.', 'in', 'ramucirumab', 'group', ',', 'adverse', 'event', 'acute', 'kidney', 'injury', ',', 'cardiac', 'arrest', ',', 'gastric', 'haemorrhage', ',', 'peritonitis', ',', 'pneumothorax', ',', 'septic', 'shock', ',', 'and', 'sudden', 'death', '(', 'n', 'of', ')', '.', 'in', 'placebo', 'group', ',', 'adverse', 'event', 'cerebrovascular', 'accident', '(', 'n', ')', ',', 'multiple', 'organ', 'dysfunction', 'syndrome', '(', 'n', ')', ',', 'pulmonary', 'embolism', '(', 'n', ')', ',', 'sepsis', '(', 'n', ')', ',', 'and', 'small', 'intestine', 'perforation', '(', 'n', ')', '.', 'interpretation', 'although', 'primary', 'analysis', 'progression-free', 'survival', 'statistically', 'significant', ',', 'outcome', 'not', 'confirmed', 'in', 'sensitivity', 'analysis', 'of', 'progression-free', 'survival', 'central', 'independent', 'review', ',', 'and', 'not', 'improve', 'overall', 'survival', '.', 'therefore', ',', 'addition', 'of', 'ramucirumab', 'to', 'cisplatin', 'plus', 'fluoropyrimidine', 'chemotherapy', 'not', 'recommended', 'first-line', 'treatment', 'patient', 'population', '.', 'funding', 'eli', 'lilly', 'and', 'company', '.']"
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.,"Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra, Lars H Lund, Michel Komajda, Jeffrey M Testani, Christopher S Wilcox, Piotr Ponikowski, Renato D Lopes, Subodh Verma, Pablo Lapuerta, Bertram Pitt                              ;, SOLOIST-WHF Trial Investigators, Deepak L Bhattet al.",2021 Jan 14,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/33200892/,No keywords found,"['sodium-glucose', 'cotransporter', '(', 'sglt', ')', 'inhibitor', 'reduce', 'risk', 'of', 'hospitalization', 'heart', 'failure', 'or', 'death', 'cardiovascular', 'cause', 'among', 'patient', 'with', 'stable', 'heart', 'failure', '.', 'however', ',', 'safety', 'and', 'efficacy', 'of', 'sglt', 'inhibitor', 'initiated', 'soon', 'episode', 'of', 'decompensated', 'heart', 'failure', 'unknown', '.', 'method', 'performed', 'multicenter', ',', 'double-blind', 'trial', 'in', 'patient', 'with', 'type', 'diabetes', 'mellitus', 'recently', 'hospitalized', 'worsening', 'heart', 'failure', 'randomly', 'assigned', 'to', 'receive', 'sotagliflozin', 'or', 'placebo', '.', 'primary', 'end', 'point', 'total', 'number', 'of', 'death', 'cardiovascular', 'cause', 'and', 'hospitalization', 'and', 'urgent', 'visit', 'heart', 'failure', '(', 'first', 'and', 'subsequent', 'event', ')', '.', 'trial', 'ended', 'early', 'of', 'loss', 'of', 'funding', 'sponsor', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', '(', 'to', 'sotagliflozin', 'group', 'and', 'to', 'placebo', 'group', ')', 'and', 'followed', 'median', 'of', '.', 'month', 'first', 'dose', 'of', 'sotagliflozin', 'or', 'placebo', 'administered', 'discharge', 'in', '.', 'and', 'median', 'of', 'day', 'discharge', 'in', '..', 'among', 'patient', ',', 'primary', 'end-point', 'event', 'occurred', '(', 'in', 'sotagliflozin', 'group', 'and', 'in', 'placebo', 'group', ')', '.', 'rate', '(', 'number', 'of', 'event', 'per', 'patient-years', ')', 'of', 'primary', 'end-point', 'event', 'lower', 'in', 'sotagliflozin', 'group', 'in', 'placebo', 'group', '(', '.', 'vs.', '.', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'rate', 'of', 'death', 'cardiovascular', 'cause', '.', 'in', 'sotagliflozin', 'group', 'and', '.', 'in', 'placebo', 'group', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', 'rate', 'of', 'death', 'cause', '.', 'in', 'sotagliflozin', 'group', 'and', '.', 'in', 'placebo', 'group', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'diarrhea', 'common', 'with', 'sotagliflozin', 'with', 'placebo', '(', '.', 'v', '.', '.', ')', ',', 'severe', 'hypoglycemia', '(', '.', 'v', '.', '.', ')', '.', 'percentage', 'of', 'patient', 'with', 'hypotension', 'similar', 'in', 'sotagliflozin', 'group', 'and', 'placebo', 'group', '(', '.', 'and', '.', ',', 'respectively', ')', ',', 'percentage', 'with', 'acute', 'kidney', 'injury', '(', '.', 'and', '.', ',', 'respectively', ')', '.', 'benefit', 'of', 'sotagliflozin', 'consistent', 'in', 'prespecified', 'subgroup', 'of', 'patient', 'stratified', 'according', 'to', 'timing', 'of', 'first', 'dose', '.', 'conclusion', 'in', 'patient', 'with', 'diabetes', 'and', 'recent', 'worsening', 'heart', 'failure', ',', 'sotagliflozin', 'therapy', ',', 'initiated', 'or', 'shortly', 'discharge', ',', 'resulted', 'in', 'significantly', 'lower', 'total', 'number', 'of', 'death', 'cardiovascular', 'cause', 'and', 'hospitalization', 'and', 'urgent', 'visit', 'heart', 'failure', 'placebo', '.', '(', 'funded', 'sanofi', 'and', 'lexicon', 'pharmaceutical', 'soloist-whf', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial.","Viju Kumar Bharathan, Biju Chandran, Unnikrishnan Gopalakrishnan, Christi Titus Varghese, Ramachandran N Menon, Dinesh Balakrishnan, O V Sudheer, Puneet Dhar, Sudhindran Surendran, Viju Kumar Bharathanet al.",2016 Aug,Liver Transpl,https://pubmed.ncbi.nlm.nih.gov/27152759/,No keywords found,"['role', 'of', 'prostaglandin', 'e', '(', 'pge', ')', 'infusion', 'in', 'improving', 'early', 'graft', 'function', 'not', 'well', 'defined', ',', 'especially', 'in', 'scenario', 'of', 'living', 'donor', 'liver', 'transplantation', '(', 'ldlt', ')', '.', 'designed', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trial', 'to', 'evaluate', 'role', 'of', 'perioperative', 'pge', 'infusion', 'in', 'ldlt', '.', 'patient', 'in', 'study', 'arm', 'received', 'pge', '(', 'alprostadil', ')', 'rate', 'of', '.', 'gkghour', ',', 'starting', 'hour', 'portal', 'venous', 'reperfusion', ',', 'and', 'continued', 'hour', '.', 'primary', 'endpoint', 'early', 'allograft', 'dysfunction', '(', 'ead', ')', '.', 'analyzed', 'multiple', 'secondary', 'endpoint', 'including', 'postoperative', 'liver', 'function', 'and', 'renal', 'function', 'parameter', ',', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'hepatic', 'artery', 'thrombosis', '(', 'hat', ')', ',', 'postoperative', 'bleeding', ',', 'overall', 'mortality', ',', 'and', 'posttransplant', 'hospital', 'stay', '.', 'incidence', 'of', 'ead', 'lower', 'in', 'pge', 'arm', ',', 'although', 'difference', 'not', 'reach', 'statistical', 'significance', '(', '.', 'versus', 'p', '.', ')', '.', 'among', 'secondary', 'endpoint', ',', 'incidence', 'of', 'aki', 'significantly', 'lower', 'in', 'pge', 'arm', '(', '.', 'versus', 'p', '.', ')', ',', 'peak', 'and', 'mean', 'postoperative', 'creatinine', 'level', '.', 'need', 'renal', 'replacement', 'therapy', 'similar', 'group', '.', 'among', 'postoperative', 'graft', 'function', 'parameter', ',', 'postoperative', 'alanine', 'aminotransferase', 'level', 'significantly', 'lower', 'in', 'pge', 'arm', '(', 'p', '.', ')', ',', 'whereas', 'remaining', 'parameter', 'including', 'serum', 'bilirubin', ',', 'aspartate', 'aminotransferase', ',', 'and', 'international', 'normalized', 'ratio', 'similar', 'arm', '.', 'no', 'difference', 'in', 'incidence', 'of', 'hat', 'and', 'postoperative', 'bleeding', ',', 'in-hospital', 'mortality', ',', 'and', 'posttransplant', 'hospital', 'stay', 'arm', '.', 'perioperative', 'pge', 'infusion', 'reduces', 'incidence', 'of', 'posttransplant', 'renal', 'dysfunction', 'in', 'patient', 'undergoing', 'ldlt', '.', 'liver', 'transplantation', '-', 'aasld', '.']"
A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery.,"T G Coulson, L F Miles, A Serpa Neto, D Pilcher, L Weinberg, G Landoni, A Zarbock, R Bellomo, T G Coulsonet al.",2022 Sep,Anaesthesia,https://pubmed.ncbi.nlm.nih.gov/35915923/,"angiotensin-2, cardiac surgery, kidney injury, noradrenaline, norepinephrine, randomised controlled trial, renal dysfunction, renal failure.","['acute', 'kidney', 'injury', 'common', 'cardiac', 'surgery', '.', 'vasoplegic', 'hypotension', 'may', 'contribute', 'to', 'kidney', 'injury', ',', 'and', 'different', 'vasopressor', 'may', 'variable', 'effect', 'kidney', 'function', '.', 'conducted', 'double-blind', ',', 'randomised', 'feasibility', 'trial', 'comparing', 'peri-operative', 'angiotensin-', 'with', 'noradrenaline', '.', 'randomly', 'allocated', 'patient', 'two', 'centre', 'to', 'blinded', 'equipotent', 'angiotensin-', 'or', 'noradrenaline', 'infusion', 'intra-operatively', 'and', 'to', 'h', 'postoperatively', ',', 'titrated', 'to', 'mean', 'arterial', 'pressure', 'of', '-', 'mmhg', '.', 'primary', 'feasibility', 'outcome', 'included', 'consent', 'rate', ',', 'protocol', 'adherence', ',', 'infusion', 'duration', ',', 'mean', 'arterial', 'pressure', 'maintenance', 'in', 'target', 'range', 'and', 'major', 'adverse', 'outcome', '.', 'secondary', 'outcome', 'included', 'kidney', 'injury', 'rate', '.', 'consent', 'rate', '.', 'protocol', 'adherence', 'in', 'angiotensin-', 'group', 'and', 'in', 'noradrenaline', 'group', '.', 'study', 'drug', 'duration', 'median', '(', 'iqr', 'range', ')', '(', '-', '-', ')', 'vs.', '(', '-', '-', ')', 'min', '(', 'p', '.', ')', 'min', 'intra-operatively', ',', 'and', '(', '-', '-', ')', 'vs.', '.', '(', '.-', '-', ')', 'hour', '(', 'p', '.', ')', 'postoperatively', 'angiotensin-', 'and', 'noradrenaline', ',', 'respectively', '.', 'mean', 'arterial', 'pressure', 'target', 'achieved', 'postoperatively', 'in', 'of', '(', ')', 'of', 'angiotensin-', 'group', 'and', 'of', '(', ')', 'of', 'noradrenaline', 'group', '.', 'one', 'participant', 'stroke', ',', 'one', 'required', 'extracorporeal', 'support', 'and', 'three', 'required', 'renal', 'replacement', 'therapy', ',', 'in', 'noradrenaline', 'group', '(', 'p', '.', ',', 'p', '.', 'and', 'p', '.', ')', '.', 'acute', 'kidney', 'injury', 'occurred', 'in', 'of', 'in', 'angiotensin-', 'group', 'vs.', 'of', 'patient', 'in', 'noradrenaline', 'group', '(', 'p', '.', ')', '.', 'pilot', 'study', 'suggests', 'trial', 'comparing', 'angiotensin-', 'with', 'noradrenaline', 'feasible', '.', 'finding', 'justify', 'investigation', 'of', 'angiotensin-', 'in', 'cardiac', 'surgery', '.']"
"Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.","Ari Moskowitz, Lars W Andersen, Michael N Cocchi, Mathias Karlsson, Parth V Patel, Michael W Donnino, Ari Moskowitzet al.",2017 May,Ann Am Thorac Soc,https://pubmed.ncbi.nlm.nih.gov/28207287/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'in', 'patient', 'with', 'sepsis', 'and', 'associated', 'with', 'high', 'mortality', 'rate', '.', 'provision', 'of', 'thiamine', 'to', 'patient', 'with', 'sepsis', 'may', 'reduce', 'incidence', 'and', 'severity', 'of', 'sepsis-related', 'aki', 'and', 'thereby', 'prevent', 'renal', 'failure', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'objective', 'to', 'test', 'hypothesis', 'thiamine', 'supplementation', 'mitigates', 'kidney', 'injury', 'in', 'septic', 'shock', '.', 'method', 'secondary', 'analysis', 'of', 'single-center', ',', 'randomized', ',', 'double-blind', 'trial', 'comparing', 'thiamine', 'to', 'placebo', 'in', 'patient', 'with', 'septic', 'shock', '.', 'renal', 'function', ',', 'need', 'rrt', ',', 'timing', 'of', 'hemodialysis', 'catheter', 'placement', ',', 'and', 'timing', 'of', 'rrt', 'initiation', 'abstracted', '.', 'baseline', 'creatinine', 'and', 'worst', 'creatinine', 'value', 'and', 'hour', ',', 'and', 'hour', ',', 'and', 'and', 'hour', 'likewise', 'abstracted', '.', 'result', 'patient', 'eligible', 'analysis', 'excluding', 'patient', 'in', 'hemodialysis', 'initiated', 'study', 'drug', 'administration', '.', 'baseline', 'serum', 'creatinine', 'in', 'thiamine', 'group', '.', 'mgdl', '(', 'interquartile', 'range', ',', '.-', '.', ')', 'compared', 'with', '.', 'mgdl', '(', 'interquartile', 'range', ',', '.-', '.', ')', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'initiation', 'of', 'study', 'drug', ',', 'patient', 'in', 'placebo', 'group', 'in', 'thiamine', 'group', 'started', 'rrt', '(', 'eight', 'vs.', 'one', 'p', '.', ')', '.', 'in', 'repeated', 'measure', 'analysis', 'adjusting', 'baseline', 'creatinine', 'level', ',', 'worst', 'creatinine', 'level', 'higher', 'in', 'placebo', 'group', 'in', 'thiamine', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'post', 'hoc', 'analysis', 'of', 'randomized', 'controlled', 'trial', ',', 'patient', 'with', 'septic', 'shock', 'randomized', 'to', 'receive', 'thiamine', 'lower', 'serum', 'creatinine', 'level', 'and', 'lower', 'rate', 'of', 'progression', 'to', 'rrt', 'patient', 'randomized', 'to', 'placebo', '.', 'finding', 'considered', 'hypothesis', 'generating', 'and', 'used', 'foundation', ',', 'prospective', 'investigation', 'in', 'area', '.']"
"Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.","Nilufar Mohebbi, Alexander Ritter, Anna Wiegand, Nicole Graf, Suzan Dahdal, Daniel Sidler, Spyridon Arampatzis, Karine Hadaya, Thomas F Mueller, Carsten A Wagner, Rudolf P Wüthrich, Nilufar Mohebbiet al.",2023 Feb 18,Lancet,https://pubmed.ncbi.nlm.nih.gov/36708734/,No keywords found,"['metabolic', 'acidosis', 'common', 'in', 'kidney', 'transplant', 'recipient', 'and', 'associated', 'with', 'declining', 'graft', 'function', '.', 'sodium', 'bicarbonate', 'treatment', 'effectively', 'corrects', 'metabolic', 'acidosis', ',', 'no', 'prospective', 'study', 'examined', 'effect', 'graft', 'function', '.', 'therefore', ',', 'aimed', 'to', 'test', 'whether', 'sodium', 'bicarbonate', 'treatment', 'would', 'preserve', 'graft', 'function', 'and', 'slow', 'progression', 'of', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'decline', 'in', 'kidney', 'transplant', 'recipient', '.', 'method', 'preserve-transplant', 'study', 'multicentre', ',', 'randomised', ',', 'single-blind', ',', 'placebo-controlled', ',', 'phase', 'trial', 'three', 'university', 'hospital', 'in', 'switzerland', '(', 'zurich', ',', 'bern', ',', 'and', 'geneva', ')', ',', 'recruited', 'adult', '(', 'aged', 'year', ')', 'male', 'and', 'female', 'long-term', 'kidney', 'transplant', 'recipient', 'undergone', 'transplantation', 'year', 'ago', '.', 'key', 'inclusion', 'criterion', 'estimated', 'gfr', 'mlmin', 'per', 'and', 'mlmin', 'per', ',', 'stable', 'allograft', 'function', 'in', 'last', 'month', 'study', 'inclusion', '(', 'change', 'in', 'serum', 'creatinine', ')', ',', 'and', 'serum', 'bicarbonate', 'of', 'mmoll', 'or', 'less', '.', 'randomly', 'assigned', 'patient', '(', ')', 'to', 'either', 'oral', 'sodium', 'bicarbonate', '-', 'g', 'per', 'day', 'or', 'matching', 'placebo', 'using', 'web-based', 'data', 'management', 'software', '.', 'randomisation', 'stratified', 'study', 'centre', 'and', 'gender', 'using', 'permuted', 'block', 'design', 'to', 'guarantee', 'balanced', 'allocation', '.', 'multi-block', 'randomisation', 'with', 'variable', 'block', 'size', 'of', 'two', 'and', 'four', '.', 'treatment', 'duration', 'year', '.', 'acid-resistant', 'soft', 'gelatine', 'capsule', 'of', 'mg', 'sodium', 'bicarbonate', 'or', 'matching', 'mg', 'placebo', 'capsule', 'given', 'initial', 'dose', 'of', 'mg', '(', 'bodyweight', 'kg', ')', 'or', 'mg', '(', 'bodyweight', 'kg', ')', 'three', 'time', 'daily', '.', 'primary', 'endpoint', 'estimated', 'gfr', 'slope', '-month', 'treatment', 'phase', '.', 'primary', 'efficacy', 'analysis', 'applied', 'to', 'modified', 'intention-to-treat', 'population', 'comprised', 'randomly', 'assigned', 'participant', 'baseline', 'visit', '.', 'safety', 'population', 'comprised', 'participant', 'received', 'least', 'one', 'dose', 'of', 'study', 'drug', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'june', ',', ',', 'and', 'july', ',', ',', 'kidney', 'transplant', 'recipient', 'with', 'metabolic', 'acidosis', 'assessed', 'trial', 'eligibility', '.', 'patient', 'excluded', 'and', 'randomly', 'assigned', 'to', 'study', 'group', '(', 'to', 'placebo', 'group', 'and', 'to', 'sodium', 'bicarbonate', 'group', ')', '.', 'secondary', 'exclusion', 'of', 'two', 'patient', ',', 'patient', 'included', 'in', 'intention-to-treat', 'analysis', '.', 'calculated', 'yearly', 'estimated', 'gfr', 'slope', '-year', 'treatment', 'period', 'median', '-', 'mlmin', 'per', '(', 'iqr', '-', 'to', ')', 'and', 'mean', '-', 'mlmin', 'per', '(', 'sd', ')', 'per', 'year', 'in', 'placebo', 'group', 'versus', 'median', '-', 'mlmin', 'per', '(', 'iqr', '-', 'to', ')', 'and', 'mean', '-', 'mlmin', 'per', '(', 'sd', ')', 'per', 'year', 'in', 'sodium', 'bicarbonate', 'group', '(', 'wilcoxon', 'rank', 'sum', 'test', 'p', 'welch', 't-test', 'p', ')', '.', 'mean', 'difference', 'mlmin', 'per', 'per', 'year', '(', 'ci', '-', 'to', ')', '.', 'no', 'significant', 'difference', 'in', 'estimated', 'gfr', 'slope', 'in', 'subgroup', 'analysis', 'and', 'sensitivity', 'analysis', 'confirmed', 'primary', 'analysis', '.', 'although', 'estimated', 'gfr', 'slope', 'not', 'show', 'significant', 'difference', 'treatment', 'group', ',', 'treatment', 'with', 'sodium', 'bicarbonate', 'effectively', 'corrected', 'metabolic', 'acidosis', 'increasing', 'serum', 'bicarbonate', 'mmoll', '(', 'sd', ')', 'to', 'mmoll', '(', ')', 'and', 'blood', 'ph', '(', 'sd', ')', 'to', '(', ')', '-year', 'treatment', 'period', '.', 'adverse', 'event', 'and', 'serious', 'adverse', 'event', 'similar', 'in', 'group', '.', 'three', 'study', 'participant', 'died', '.', 'in', 'placebo', 'group', ',', 'one', '(', ')', 'patient', 'died', 'acute', 'respiratory', 'distress', 'syndrome', 'due', 'to', 'sars-cov-', 'and', 'one', '(', ')', 'cardiac', 'arrest', 'severe', 'dehydration', 'following', 'diarrhoea', 'with', 'hypotension', ',', 'acute', 'kidney', 'injury', ',', 'and', 'metabolic', 'acidosis', '.', 'in', 'sodium', 'bicarbonate', 'group', ',', 'one', '(', ')', 'patient', 'sudden', 'cardiac', 'death', '.', 'interpretation', 'in', 'adult', 'kidney', 'transplant', 'recipient', ',', 'correction', 'of', 'metabolic', 'acidosis', 'treatment', 'with', 'sodium', 'bicarbonate', 'year', 'not', 'affect', 'decline', 'in', 'estimated', 'gfr', '.', 'thus', ',', 'treatment', 'with', 'sodium', 'bicarbonate', 'not', 'generally', 'recommended', 'to', 'preserve', 'estimated', 'gfr', '(', 'surrogate', 'marker', 'graft', 'function', ')', 'in', 'kidney', 'transplant', 'recipient', 'with', 'chronic', 'kidney', 'disease', 'metabolic', 'acidosis', '.', 'funding', 'swiss', 'national', 'science', 'foundation', '.']"
The Risk of Oxygen during Cardiac Surgery (ROCS) trial: study protocol for a randomized clinical trial.,"Marcos G Lopez, Mias Pretorius, Matthew S Shotwell, Robert Deegan, Susan S Eagle, Jeremy M Bennett, Bantayehu Sileshi, Yafen Liang, Brian J Gelfand, Adam J Kingeter, Kara K Siegrist, Frederick W Lombard, Tiffany M Richburg, Dane A Fornero, Andrew D Shaw, Antonio Hernandez, Frederic T Billings th, Marcos G Lopezet al.",2017 Jun 26,Trials,https://pubmed.ncbi.nlm.nih.gov/28651648/,No keywords found,"['anesthesiologist', 'administer', 'excess', 'supplemental', 'oxygen', '(', 'hyper-oxygenation', ')', 'to', 'patient', 'surgery', 'to', 'avoid', 'hypoxia', '.', 'hyper-oxygenation', ',', 'however', ',', 'may', 'increase', 'generation', 'of', 'reactive', 'oxygen', 'specie', 'and', 'cause', 'oxidative', 'damage', '.', 'in', 'cardiac', 'surgery', ',', 'increased', 'oxidative', 'damage', 'associated', 'with', 'postoperative', 'kidney', 'and', 'brain', 'injury', '.', 'hypothesize', 'maintenance', 'of', 'normoxia', 'cardiac', 'surgery', '(', 'physiologic', 'oxygenation', ')', 'decrease', 'kidney', 'injury', 'and', 'oxidative', 'damage', 'compared', 'to', 'hyper-oxygenation', '.', 'methodsdesign', 'risk', 'of', 'oxygen', 'cardiac', 'surgery', '(', 'roc', ')', 'trial', 'randomly', 'assign', 'cardiac', 'surgery', 'patient', 'to', 'receive', 'physiologic', 'oxygenation', ',', 'defined', 'lowest', 'fraction', 'of', 'inspired', 'oxygen', '(', 'fio', ')', 'necessary', 'to', 'maintain', 'arterial', 'hemoglobin', 'saturation', 'of', 'to', ',', 'or', 'hyper-oxygenation', '(', 'fio', '.', ')', 'surgery', '.', 'primary', 'clinical', 'endpoint', 'serum', 'creatinine', 'change', 'baseline', 'to', 'postoperative', 'day', ',', 'and', 'primary', 'mechanism', 'endpoint', 'change', 'in', 'plasma', 'concentration', 'of', 'f-isoprostanes', 'and', 'isofurans', '.', 'secondary', 'endpoint', 'include', 'superoxide', 'production', ',', 'clinical', 'delirium', ',', 'myocardial', 'injury', ',', 'and', 'length', 'of', 'stay', '.', 'endothelial', 'function', 'substudy', 'examine', 'effect', 'of', 'oxygen', 'treatment', 'and', 'oxidative', 'stress', 'endothelial', 'function', ',', 'measured', 'using', 'flow', 'mediated', 'dilation', ',', 'peripheral', 'arterial', 'tonometry', ',', 'and', 'wire', 'tension', 'myography', 'of', 'epicardial', 'fat', 'arteriole', '.', 'discussion', 'roc', 'trial', 'test', 'hypothesis', 'intraoperative', 'physiologic', 'oxygenation', 'decrease', 'oxidative', 'damage', 'and', 'organ', 'injury', 'compared', 'to', 'hyper-oxygenation', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'id', 'nct', '.', 'registered', 'th', 'of', 'january', '.']"
Risk Factors for Acute Kidney Injury after Congenital Cardiac Surgery in Infants and Children: A Retrospective Observational Study.,"Sun-Kyung Park, Min Hur, Eunhee Kim, Won Ho Kim, Jung Bo Park, Youngwon Kim, Ji-Hyuk Yang, Tae-Gook Jun, Chung Su Kim, Sun-Kyung Parket al.",2016 Nov 10,PLoS One,https://pubmed.ncbi.nlm.nih.gov/27832187/,No keywords found,"['improving', 'global', 'outcome', '(', 'kdigo', ')', 'criterion', '.', 'ninety-two', 'patient', '(', '.', ')', 'developed', 'aki', 'and', '(', '.', ')', 'required', 'renal', 'replacement', 'therapy', 'within', 'first', 'postoperative', 'week', '.', 'among', 'patient', 'developed', 'aki', ',', 'patient', '(', '.', ')', 'kdigo', 'stage', ',', 'patient', '(', '.', ')', 'kdigo', 'stage', ',', 'and', 'eight', 'patient', '(', '.', ')', 'kdigo', 'stage', '.', 'rachs-', '(', 'risk-adjusted', 'classification', 'congenital', 'heart', 'surgery', ')', 'category', ',', 'perioperative', 'transfusion', 'and', 'fluid', 'administration', 'well', 'fluid', 'overload', 'compared', 'patient', 'with', 'and', 'without', 'aki', '.', 'multivariable', 'logistic', 'regression', 'analysis', 'determined', 'risk', 'factor', 'aki', '.', 'aki', 'associated', 'with', 'longer', 'hospital', 'stay', 'or', 'icu', 'stay', ',', 'and', 'frequent', 'sternal', 'wound', 'infection', '.', 'younger', 'age', '(', 'gdl', ')', 'preoperative', 'level', 'pod', 'entered', 'multivariable', 'analysis', ',', 'independently', 'associated', 'with', 'postoperative', 'aki', '(', 'or', ',', '.', 'ci', ',', '.-', '.', 'compared', 'with', 'no', 'increase', ')', '.', 'association', 'significant', 'adjustment', 'with', 'patient', 'demographic', ',', 'medication', 'history', 'and', 'rachs-', 'category', '(', 'hemoglobin', 'increase', 'gdl', 'vs.', 'no', 'increase', 'adjusted', 'or', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'regardless', 'of', 'different', 'age', 'group', 'and', 'cyanotic', 'or', 'non-cyanotic', 'heart', 'disease', '.', 'prospective', 'trial', 'required', 'to', 'evaluate', 'whether', 'correction', 'of', 'preoperative', 'anemia', 'and', 'prevention', 'of', 'hemoconcentration', 'may', 'ameliorate', 'postoperative', 'aki', 'in', 'patient', 'underwent', 'congenital', 'cardiac', 'surgery', '.']"
No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT.,"Judith Kooiman, Wilke R van de Peppel, Yvo W J Sijpkens, Harald F H Brulez, P M de Vries, Mioara A Nicolaie, H Putter, Menno V Huisman, W van der Kooij, Cees van Kooten, Ton J Rabelink, Judith Kooimanet al.",2015 Jul,Eur Radiol,https://pubmed.ncbi.nlm.nih.gov/25773936/,No keywords found,"['to', 'analyze', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'n-gal', ')', 'excretion', 'post-intravenous', 'contrast', 'enhanced-ct', '(', 'ce-ct', ')', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'method', 'patient', 'enrolled', 'in', 'trial', 'hydration', 'regime', 'to', 'prevent', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', '.', 'blood', 'and', 'urine', 'sample', 'taken', 'baseline', ',', '-', ',', 'and', '-', 'h', 'post', 'ce-ct.', 'urinary', 'kim-', 'and', 'n-gal', 'value', 'normalized', 'urinary', 'creatinine', 'level', ',', 'presented', 'median', 'with', '.', '-', '.', 'percentile', '.', 'result', 'of', 'enrolled', 'patient', ',', '(', ')', 'lost', 'to', 'follow-up', '.', 'ci-aki', 'occurred', 'in', '.', 'of', 'patient', '(', ')', '.', 'median', 'kim-', 'value', '.', '(', '.', '-', '.', ')', 'baseline', ',', '.', '(', '.', '-', '.', ')', '-', 'h', ',', 'and', '.', 'ngmg', '(', '.', '-', '.', ')', '-', 'h', 'post', 'ce-ct', '(', 'p', '.', ')', '.', 'median', 'n-gal', 'value', '.', '(', '.', '-', ',', '.', ')', ',', '.', '(', '.', '-', ',', '.', ')', ',', 'and', '.', 'gmg', '(', '.', '-', ',', '.', ')', ',', 'respectively', '(', 'p', '.', ')', '.', 'amount', 'of', 'kim-', 'and', 'n-gal', 'excretion', 'in', 'follow-up', 'similar', 'patient', 'with', 'and', 'without', 'ci-aki', '(', 'p-value', 'kim-', '.', ',', 'p-value', 'n-gal', '.', ')', '.', 'neither', 'patient', 'characteristic', 'baseline', 'including', 'severe', 'ckd', ',', 'medication', 'use', ',', 'contrast', 'dose', 'associated', 'with', 'increased', 'excretion', 'of', 'kim-', 'or', 'n-gal', 'follow-up', '.', 'conclusion', 'kim-', 'and', 'n-gal', 'excretion', 'unaffected', 'ce-ct', 'in', 'patient', 'with', 'and', 'without', 'ci-aki', ',', 'suggesting', 'ci-aki', 'not', 'accompanied', 'tubular', 'injury', '.', 'key', 'point', 'kim-', 'and', 'n-gal', 'excretion', 'unaffected', 'intravenous', 'contrast-enhanced', 'ct', '(', 'ce-ct', ')', '.', 'patient', 'or', 'procedure', 'characteristic', 'not', 'associated', 'with', 'increased', 'kim-', 'or', 'n-gal', 'excretion', '.', 'performance', 'of', 'ce-ct', 'in', 'ckd', 'patient', 'likely', 'to', 'safe', '.']"
Reliability of glomerular filtration rate estimating formulas compared to iohexol plasma clearance in critically ill children.,"Evelyn Dhont, Charlotte Windels, Evelien Snauwaert, Tatjana Van Der Heggen, Annick de Jaeger, Laura Dhondt, Joris Delanghe, Siska Croubels, Johan Vande Walle, Peter De Paepe, Pieter A De Cock, Evelyn Dhontet al.",2022 Nov,Eur J Pediatr,https://pubmed.ncbi.nlm.nih.gov/36053381/,No keywords found,"['in', 'proof-of-concept', 'study', ',', 'egfr', 'formula', 'found', 'to', 'largely', 'inaccurate', 'in', 'picu', 'population', '.', 'clinician', 'therefore', 'use', 'formula', 'with', 'caution', 'to', 'guide', 'drug', 'dosing', 'and', 'therapeutic', 'intervention', 'in', 'critically', 'ill', 'child', '.', 'research', 'in', 'subgroup', 'population', 'warranted', 'to', 'conclude', 'generalizability', 'of', 'study', 'finding', '.', 'clinicaltrials', 'gov', 'nct', ',', 'registered', 'retrospectively', 'january', ',', '.', 'known', 'acute', 'kidney', 'injury', 'and', 'augmented', 'renal', 'clearance', 'may', 'present', 'in', 'picu', 'patient', 'and', 'warrant', 'adaptation', 'of', 'therapy', ',', 'including', 'drug', 'dosing', '.', 'biomarker-based', 'egfr', 'formula', 'widely', 'used', 'gfr', 'assessment', 'in', 'critically', 'ill', 'child', ',', 'although', 'endogenous', 'filtration', 'biomarkers', 'important', 'limitation', 'in', 'picu', 'patient', 'and', 'egfr', 'formula', 'never', 'validated', 'measured', 'gfr', 'in', 'population', '.', 'new', 'egfr', 'formula', 'found', 'to', 'largely', 'inaccurate', 'in', 'picu', 'population', 'compared', 'to', 'measured', 'gfr', 'iohexol', 'clearance', '.', 'clinician', 'therefore', 'use', 'formula', 'with', 'caution', 'to', 'guide', 'drug', 'dosing', 'and', 'therapeutic', 'intervention', 'in', 'critically', 'ill', 'child', '.', 'iohexol', 'plasma', 'clearance', 'could', 'considered', 'alternative', 'accurate', 'gfr', 'assessment', 'in', 'picu', 'patient', '.']"
An Organizational-Level Program of Intervention for AKI: A Pragmatic Stepped Wedge Cluster Randomized Trial.,"Nicholas M Selby, Anna Casula, Laura Lamming, John Stoves, Yohan Samarasinghe, Andrew J Lewington, Russell Roberts, Nikunj Shah, Melanie Johnson, Natalie Jackson, Carol Jones, Erik Lenguerrand, Eileen McDonach, Richard J Fluck, Mohammed A Mohammed, Fergus J Caskey, Nicholas M Selbyet al.",2019 Mar,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/31058607/,No keywords found,"['variable', 'standard', 'of', 'care', 'may', 'contribute', 'to', 'poor', 'outcome', 'associated', 'with', 'aki', '.', 'evaluated', 'whether', 'multifaceted', 'intervention', '(', 'aki', 'e-alerts', ',', 'aki', 'care', 'bundle', ',', 'and', 'education', 'program', ')', 'would', 'improve', 'delivery', 'of', 'care', 'and', 'patient', 'outcome', 'organizational', 'level', '.', 'method', 'multicenter', ',', 'pragmatic', ',', 'stepped-wedge', 'cluster', 'randomized', 'trial', 'performed', 'in', 'five', 'uk', 'hospital', ',', 'involving', 'patient', 'with', 'aki', 'aged', 'year', '.', 'intervention', 'introduced', 'sequentially', 'across', 'fixed', 'three-month', 'period', 'according', 'to', 'randomly', 'determined', 'schedule', 'hospital', 'exposed', '.', 'primary', 'outcome', '-day', 'mortality', ',', 'with', 'pre-specified', 'secondary', 'endpoint', 'and', 'nested', 'evaluation', 'of', 'care', 'process', 'delivery', '.', 'nature', 'of', 'intervention', 'precluded', 'blinding', ',', 'data', 'collection', 'and', 'analysis', 'independent', 'of', 'project', 'delivery', 'team', '.', 'result', 'studied', ',', 'aki', 'episode', ',', 'finding', 'overall', '-day', 'mortality', 'of', '.', ',', 'with', 'no', 'difference', 'control', 'and', 'intervention', 'period', '.', 'hospital', 'length', 'of', 'stay', 'reduced', 'with', 'intervention', '(', 'decrease', 'of', '.', ',', '.', ',', 'and', '.', 'day', '.', ',', '.', ',', 'and', '.', 'quantiles', ',', 'respectively', ')', '.', 'aki', 'incidence', 'increased', 'and', 'mirrored', 'increase', 'in', 'proportion', 'of', 'patient', 'with', 'coded', 'diagnosis', 'of', 'aki', '.', 'assessment', 'of', 'process', 'measure', 'in', 'patient', 'showed', 'improvement', 'in', 'several', 'metric', 'including', 'aki', 'recognition', ',', 'medication', 'optimization', ',', 'and', 'fluid', 'assessment', '.', 'conclusion', 'complex', ',', 'hospital-wide', 'intervention', 'to', 'reduce', 'harm', 'associated', 'with', 'aki', 'not', 'reduce', '-day', 'aki', 'mortality', 'result', 'in', 'reduction', 'in', 'hospital', 'length', 'of', 'stay', ',', 'accompanied', 'improvement', 'in', 'in', 'quality', 'of', 'care', '.', 'increase', 'in', 'aki', 'incidence', 'likely', 'reflected', 'improved', 'recognition', '.']"
Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study.,"Ivan Göcze, Dominik Jauch, Markus Götz, Pascal Kennedy, Bettina Jung, Florian Zeman, Carsten Gnewuch, Bernhard M Graf, Wolfgang Gnann, Bernhard Banas, Thomas Bein, Hans J Schlitt, Tobias Bergler, Ivan Göczeet al.",2018 Jun,Ann Surg,https://pubmed.ncbi.nlm.nih.gov/28857811/,No keywords found,"['to', 'determine', 'impact', 'of', 'renal', 'biomarker-guided', 'implementation', 'of', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'care', 'bundle', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'major', 'noncardiac', 'surgery', 'in', 'single-center', 'unblinded', 'randomized', 'clinical', 'trial', '.', 'background', 'early', 'optimization', 'of', 'volume', 'status', 'and', 'discontinuation', 'of', 'nephrotoxic', 'medication', 'occurrence', 'of', 'aki', 'may', 'crucial', 'step', 'to', 'reduce', 'preventable', 'aki', '.', 'method', 'urinary', 'biomarker-triggered', 'kdigo', 'care', 'bundle', '(', 'early', 'optimization', 'of', 'fluid', 'status', ',', 'maintenance', 'of', 'perfusion', 'pressure', ',', 'discontinuation', 'of', 'nephrotoxic', 'agent', ')', 'compared', 'to', 'standard', 'intensive', 'care', 'unit', '(', 'icu', ')', 'care', 'in', 'patient', 'with', 'increased', 'aki', 'risk', 'major', 'abdominal', 'surgery', 'determined', 'urinary', 'biomarker', '(', 'inhibitor', 'of', 'metalloproteinase-', 'insulin-like', 'growth', 'factor-binding', 'protein', ')', '..', 'incidence', 'of', 'overall', 'aki', ',', 'severity', 'of', 'aki', ',', 'length', 'of', 'stay', ',', 'major', 'kidney', 'event', 'discharge', ',', 'and', 'cost', 'effectiveness', 'evaluated', '.', 'result', 'overall', 'stage', 'of', 'aki', 'not', 'statistically', 'different', 'group', ',', 'in', 'patient', 'with', 'inhibitor', 'of', 'metalloproteinase-', 'insulin-like', 'growth', 'factor-binding', 'protein', 'value', 'of', '.', 'to', '.', 'subgroup', 'analysis', 'demonstrated', 'significantly', 'reduced', 'incidence', 'of', 'aki', '(', '.', ')', 'in', 'intervention', 'group', 'compared', 'to', 'control', '(', '.', ',', 'p', '.', ')', '.', 'incidence', 'of', 'moderate', 'and', 'severe', 'aki', '(', 'p', '.', ')', ',', 'incidence', 'of', 'creatinine', 'increase', 'of', 'baseline', 'value', '(', 'p', '.', ')', ',', 'length', 'of', 'icu', ',', 'and', 'hospital', 'stay', '(', 'p', '.', ')', 'significantly', 'lower', 'in', 'intervention', 'group', '.', 'intervention', 'associated', 'with', 'cost', 'reduction', '.', 'no', 'significant', 'difference', 'regarding', 'renal', 'replacement', 'therapy', ',', 'in-hospital', 'mortality', ',', 'or', 'major', 'kidney', 'event', 'hospital', 'discharge', '.', 'conclusion', 'early', 'biomarker-based', 'prediction', 'of', 'imminent', 'aki', 'followed', 'implementation', 'of', 'kdigo', 'care', 'bundle', 'reduced', 'aki', 'severity', ',', 'postoperative', 'creatinine', 'increase', ',', 'length', 'of', 'icu', ',', 'and', 'hospital', 'stay', 'in', 'patient', 'major', 'noncardiac', 'surgery', '.']"
Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.,"Sai-Ping Jiang, Yan-Yan Xu, Ping-Yang, Wei-Fang Wu, Xing-Guo Zhang, Xiao-Yang Lu, Yong-Hong Xiao, Wei-Feng Liang, Jian Chen, Sai-Ping Jianget al.",2014 Dec,Eur J Intern Med,https://pubmed.ncbi.nlm.nih.gov/25153537/,No keywords found,"['appropriate', 'antimicrobial', 'dosing', 'patient', 'receiving', 'continuous', 'venovenous', 'hemofiltration', '(', 'cvvh', ')', 'complex', '.', 'pharmacist', 'participation', 'in', 'antimicrobial', 'dosing', 'adjustment', 'patient', 'receiving', 'cvvh', 'may', 'advantageous', '.', 'method', 'comparative', 'study', 'performed', 'in', 'china', 'hospital', 'intensive', 'care', 'unit', '(', 'icu', ')', '.patients', 'receiving', 'cvvh', 'in', 'intervention', 'group', 'received', 'antimicrobial', 'dosing', 'adjustment', 'service', 'pharmacist', 'january', 'to', 'june', ',', 'whereas', 'patient', 'in', 'control', 'group', 'received', 'routine', 'medical', 'care', 'july', 'and', 'december', '.', 'primary', 'outcome', 'including', 'patient', ""'"", 'length', 'of', 'icu', 'stay', ',', 'mortality', 'in', 'icu', ',', 'icu', 'hospitalization', 'cost', ',', 'and', 'occurrence', 'of', 'adverse', 'drug', 'event', '(', 'ade', ')', 'compared', '.', 'result', 'and', 'patient', 'included', 'in', 'control', 'and', 'intervention', 'group', '.', 'intervention', 'period', ',', 'pharmacist', 'made', 'antimicrobial', 'dosing', 'adjustment', 'recommendation', 'enrolled', 'patient', 'receiving', 'cvvh', ',', 'of', '(', '.', ')', 'recommendation', 'accepted', 'physician', '.', 'changing', 'in', 'cvvh-related', 'variable', '(', ',', '.', ')', 'common', 'risk', 'factor', 'dosing', 'error', ',', 'whereas', '-lactams', '(', ',', '.', ')', 'frequency', 'of', 'antimicrobial', 'associated', 'with', 'dosing', 'error', '.', 'compared', 'with', 'control', 'group', ',', 'pharmacist', 'dosing', 'adjustment', 'resulted', 'in', '.', 'cost', 'saving', 'per', 'patient', ',', 'and', '.', 'time', 'reduction', 'of', 'antimicrobial-related', 'adverse', 'drug', 'event', '(', 'ade', ')', '(', 'v', ',', 'p.', ')', ',', 'length', 'of', 'icu', 'stay', 'and', 'mortality', 'in', 'icu', 'showed', 'no', 'significant', 'difference', '(', 'p.', ')', '.', 'conclusion', 'involvement', 'of', 'pharmacist', 'to', 'participate', 'in', 'icu', 'team', 'round', 'patient', 'receiving', 'cvvh', 'associated', 'with', 'cost', 'saving', 'and', 'reduction', 'of', 'ade', '.', 'hospital', 'may', 'consider', 'employing', 'icu', 'pharmacist', '.']"
"Sodium Bicarbonate Supplementation and Urinary TGF-β1 in Nonacidotic Diabetic Kidney Disease: A Randomized, Controlled Trial.","Kalani L Raphael, Tom Greene, Guo Wei, Tristin Bullshoe, Kunani Tuttle, Alfred K Cheung, Srinivasan Beddhu, Kalani L Raphaelet al.",2020 Feb 7,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/31974286/,No keywords found,"['in', 'early-phase', 'study', 'of', 'individual', 'with', 'hypertensive', 'ckd', 'and', 'normal', 'serum', 'total', 'co', ',', 'sodium', 'bicarbonate', 'reduced', 'urinary', 'tgf-', 'level', 'and', 'preserved', 'kidney', 'function', '.', 'effect', 'of', 'sodium', 'bicarbonate', 'kidney', 'fibrosis', 'and', 'injury', 'marker', 'in', 'individual', 'with', 'diabetic', 'kidney', 'disease', 'and', 'normal', 'serum', 'total', 'co', 'unknown', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'conducted', 'randomized', ',', 'double-blinded', ',', 'placebo-controlled', 'study', 'in', 'united', 'state', 'veteran', 'with', 'type', 'or', 'diabetes', 'mellitus', ',', 'egfr', 'of', '-', 'mlmin', 'per', '.', ',', 'urinary', 'albumin-to-creatinine', 'ratio', '(', 'uacr', ')', 'mgg', ',', 'and', 'serum', 'total', 'co', 'of', '-', 'meql', '.', 'participant', 'received', 'oral', 'sodium', 'bicarbonate', '(', '.', 'meqkg', 'lean', 'body', 'wt', 'per', 'day', 'n', ')', 'or', 'placebo', '(', 'n', ')', 'month', '.', 'primary', 'outcome', 'change', 'in', 'urinary', 'tgf', '--', 'to-creatinine', 'baseline', 'to', 'month', 'and', '.', 'secondary', 'outcome', 'included', 'change', 'in', 'urinary', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', '-to-creatinine', ',', 'fibronectin-to-creatinine', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', '-to-creatinine', ',', 'and', 'uacr', 'baseline', 'to', 'month', 'and', '.', 'result', 'key', 'baseline', 'characteristic', 'age', 'year', ',', 'egfr', 'of', 'mlmin', 'per', '.', ',', 'and', 'serum', 'total', 'co', 'of', 'meql', '.', 'sodium', 'bicarbonate', 'treatment', 'increased', 'mean', 'total', 'co', '.', '(', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', 'meql', ',', 'increased', 'urinary', 'ph', '.', '(', 'ci', ',', '.', 'to', '.', ')', ',', 'and', 'decreased', 'urinary', 'ammonium', 'excretion', '(', 'ci', ',', 'to', ')', 'meqd', 'and', 'urinary', 'titratable', 'acid', 'excretion', '(', 'ci', ',', 'to', ')', 'meqd', '.', 'sodium', 'bicarbonate', 'not', 'significantly', 'change', 'urinary', 'tgf-creatinine', '(', 'difference', 'in', 'change', ',', ',', 'ci', ',', '-', 'to', 'change', 'within', 'sodium', 'bicarbonate', 'group', ',', ',', 'ci', ',', '-', 'to', 'change', 'within', 'placebo', 'group', ',', '-', ',', 'ci', ',', '-', 'to', ')', '.', 'similarly', ',', 'no', 'significant', 'effect', 'kim', '--', 'to-creatinine', '(', 'difference', 'in', 'change', ',', '-', ',', 'ci', ',', '-', 'to', ')', ',', 'fibronectin-to-creatinine', '(', ',', 'ci', ',', '-', 'to', ')', ',', 'ngal-to-creatinine', '(', '-', ',', 'ci', ',', '-', 'to', ')', ',', 'or', 'uacr', '(', ',', 'ci', ',', '-', 'to', ')', 'observed', '.', 'conclusion', 'in', 'nonacidotic', 'diabetic', 'kidney', 'disease', ',', 'sodium', 'bicarbonate', 'not', 'significantly', 'reduce', 'urinary', 'tgf-', ',', 'kim-', ',', 'fibronectin', ',', 'ngal', ',', 'or', 'uacr', 'month', '.']"
A Novel Method for Rapid Bedside Measurement of GFR.,"Dana V Rizk, Daniel Meier, Ruben M Sandoval, Teresa Chacana, Erinn S Reilly, Jesse C Seegmiller, Emmanuel DeNoia, James S Strickland, Joseph Muldoon, Bruce A Molitoris, Dana V Rizket al.",2018 Jun,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/29748326/,"Biomarker, FAST BioMedical, acute kidney injury, chronic kidney disease, fluorescent glomerular filtration rate measurement, kidney function.","['background', 'direct', 'quantitative', 'measurement', 'of', 'gfr', '(', 'mgfr', ')', 'remains', 'specialized', 'task', 'primarily', 'performed', 'in', 'research', 'setting', '.', 'multiple', 'formula', 'estimating', 'gfr', 'developed', 'use', 'readily', 'available', 'endogenous', 'biomarkers', 'creatinine', 'andor', 'cystatin', 'c.', 'however', ',', 'egfr', 'formula', 'limitation', ',', 'and', 'accurate', 'mgfr', 'necessary', 'in', 'clinical', 'situation', 'and', 'certain', 'patient', 'population', '.', 'conducted', 'prospective', ',', 'open-label', 'study', 'to', 'evaluate', 'novel', 'rapid', 'technique', 'determining', 'plasma', 'volume', 'and', 'mgfr.methods', 'developed', 'new', 'exogenous', 'biomarker', ',', 'visible', 'fluorescent', 'injectate', '(', 'vfi', ')', ',', 'consisting', 'of', 'large', '-kd', 'rhodamine', 'derivative', 'and', 'small', '-kd', 'fluorescein', 'carboxymethylated', 'dextrans', '.', 'single', 'intravenous', 'injection', 'of', 'vfi', ',', 'plasma', 'volume', 'and', 'mgfr', 'determined', 'basis', 'of', 'plasma', 'pharmacokinetics', 'of', 'rhodamine', 'derivative', 'and', 'fluorescein', 'carboxymethylated', 'dextrans', ',', 'respectively', '.', 'in', 'study', 'involving', 'adult', 'with', 'normal', 'kidney', 'function', '(', 'n', ')', ',', 'ckd', 'stage', '(', 'n', ')', ',', 'or', 'ckd', 'stage', '(', 'n', ')', ',', 'compared', 'vfi-based', 'mgfr', 'value', 'with', 'value', 'obtained', 'measuring', 'iohexol', 'plasma', 'disappearance', '.', 'vfi-based', 'mgfr', 'required', 'three', '.-ml', 'blood', 'draw', 'hour', 'iohexol-based', 'mgfr', 'required', 'five', 'sample', 'taken', 'hour', '.', 'eight', 'healthy', 'participant', 'received', 'repeat', 'vfi', 'injection', 'hours.results', 'vfi-based', 'mgfr', 'value', 'showed', 'close', 'linear', 'correlation', 'with', 'iohexol-based', 'mgfr', 'value', 'in', 'participant', '.', 'injection', 'well', 'tolerated', ',', 'including', 'given', 'consecutive', 'day', '.', 'no', 'serious', 'adverse', 'event', 'reported', '.', 'vfi-based', 'mgfr', 'highly', 'reproducible.conclusions', 'vfi-based', 'approach', 'allows', 'rapid', 'determination', 'of', 'mgfr', 'bedside', 'maintaining', 'patient', 'safety', 'and', 'measurement', 'accuracy', 'and', 'reproducibility', '.']"
Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.,"Tiziana Bove, Alberto Zangrillo, Fabio Guarracino, Gabriele Alvaro, Bruno Persi, Enivarco Maglioni, Nicola Galdieri, Marco Comis, Fabio Caramelli, Daniela C Pasero, Giovanni Pala, Massimo Renzini, Massimiliano Conte, Gianluca Paternoster, Blanca Martinez, Fulvio Pinelli, Mario Frontini, Maria C Zucchetti, Federico Pappalardo, Bruno Amantea, Annamaria Camata, Antonio Pisano, Claudio Verdecchia, Erika Dal Checco, Claudia Cariello, Luana Faita, Rubia Baldassarri, Anna M Scandroglio, Omar Saleh, Rosalba Lembo, Maria G Calabrò, Rinaldo Bellomo, Giovanni Landoni, Tiziana Boveet al.",2014 Dec 3,JAMA,https://pubmed.ncbi.nlm.nih.gov/25265449/,No keywords found,"['no', 'effective', 'pharmaceutical', 'agent', 'yet', 'identified', 'to', 'treat', 'acute', 'kidney', 'injury', 'cardiac', 'surgery', '.', 'objective', 'to', 'determine', 'whether', 'fenoldopam', 'reduces', 'need', 'renal', 'replacement', 'therapy', 'in', 'critically', 'ill', 'cardiac', 'surgery', 'patient', 'with', 'acute', 'kidney', 'injury', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'parallel-group', 'study', 'march', 'to', 'april', 'in', 'cardiovascular', 'intensive', 'care', 'unit', 'in', 'italy', '.', 'randomly', 'assigned', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', 'cardiac', 'surgery', 'with', 'early', 'acute', 'kidney', 'injury', '(', 'increase', 'of', 'serum', 'creatinine', 'level', 'baseline', 'or', 'oliguria', 'hour', ')', 'to', 'receive', 'fenoldopam', '(', 'patient', ')', 'or', 'placebo', '(', 'patient', ')', '.', 'used', 'computer-generated', 'permuted', 'block', 'randomization', 'sequence', 'treatment', 'allocation', '.', 'patient', 'completed', 'follow-up', 'day', 'surgery', ',', 'and', 'data', 'analyzed', 'according', 'to', 'intention-to-treat', 'principle', '.', 'intervention', 'continuous', 'infusion', 'of', 'fenoldopam', 'or', 'placebo', 'to', 'day', 'with', 'starting', 'dose', 'of', '.', 'gkgmin', '(', 'range', ',', '.-', '.', 'gkgmin', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', 'rate', 'of', 'renal', 'replacement', 'therapy', '.', 'secondary', 'end', 'point', 'included', 'mortality', '(', 'intensive', 'care', 'unit', 'and', '-day', 'mortality', ')', 'and', 'rate', 'of', 'hypotension', 'study', 'drug', 'infusion', '.', 'result', 'study', 'stopped', 'futility', 'recommended', 'safety', 'committee', 'planned', 'interim', 'analysis', '.', 'sixty-nine', 'of', 'patient', '(', ')', 'allocated', 'to', 'fenoldopam', 'group', 'and', 'of', 'patient', '(', ')', 'allocated', 'to', 'placebo', 'group', 'received', 'renal', 'replacement', 'therapy', '(', 'p', '.', ')', '.', 'mortality', 'day', 'of', '(', ')', 'in', 'fenoldopam', 'group', 'and', 'of', '(', ')', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'hypotension', 'occurred', 'in', '(', ')', 'patient', 'in', 'fenoldopam', 'group', 'and', 'in', '(', ')', 'patient', 'in', 'placebo', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'with', 'acute', 'kidney', 'injury', 'cardiac', 'surgery', ',', 'fenoldopam', 'infusion', ',', 'compared', 'with', 'placebo', ',', 'not', 'reduce', 'need', 'renal', 'replacement', 'therapy', 'or', 'risk', 'of', '-day', 'mortality', 'associated', 'with', 'increased', 'rate', 'of', 'hypotension', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Nephrologist Follow-Up versus Usual Care after an Acute Kidney Injury Hospitalization (FUSION): A Randomized Controlled Trial.,"Samuel A Silver, Neill K Adhikari, Chaim M Bell, Christopher T Chan, Ziv Harel, Abhijat Kitchlu, Alejandro Meraz-Muñoz, Patrick A Norman, Adic Perez, Alireza Zahirieh, Ron Wald, Samuel A Silveret al.",2021 Jul,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/34021031/,No keywords found,"['survivor', 'of', 'aki', 'higher', 'risk', 'of', 'ckd', 'and', 'death', ',', 'patient', 'see', 'nephrologist', 'hospital', 'discharge', '.', 'objective', '-year', 'vanguard', 'phase', 'trial', 'to', 'determine', 'feasibility', 'of', 'randomizing', 'survivor', 'of', 'aki', 'to', 'early', 'follow-up', 'with', 'nephrologist', 'or', 'usual', 'care', ',', 'and', 'to', 'collect', 'data', 'care', 'process', 'and', 'outcome', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'performed', 'randomized', 'controlled', 'trial', 'in', 'patient', 'hospitalized', 'with', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'stage', '-', 'aki', 'four', 'hospital', 'in', 'toronto', ',', 'canada', '.', 'randomized', 'patient', 'to', 'early', 'nephrologist', 'follow-up', '(', 'standardized', 'basket', 'of', 'care', 'emphasized', 'bp', 'control', ',', 'cardiovascular', 'risk', 'reduction', ',', 'and', 'medication', 'safety', ')', 'or', 'usual', 'care', 'july', 'to', 'june', '.', 'feasibility', 'outcome', 'included', 'proportion', 'of', 'eligible', 'patient', 'enrolled', ',', 'seen', 'nephrologist', ',', 'and', 'followed', 'to', 'year', '.', 'primary', 'clinical', 'outcome', 'major', 'adverse', 'kidney', 'event', 'year', ',', 'defined', 'death', ',', 'maintenance', 'dialysis', ',', 'or', 'incidentprogressive', 'ckd', '.', 'result', 'screened', 'participant', 'july', 'to', 'june', ',', 'of', 'eligible', '.', 'randomized', '(', ')', 'patient', '(', 'to', 'nephrology', 'follow-up', 'and', 'to', 'usual', 'care', ')', '.', 'primary', 'reason', 'stated', 'declining', 'enrollment', 'included', 'hospitalization-related', 'fatigue', '(', 'n', ')', ',', 'reluctance', 'to', 'add', 'doctor', 'to', 'health', 'care', 'team', '(', 'n', ')', ',', 'and', 'long', 'travel', 'time', '(', 'n', ')', '.', 'nephrologist', 'visit', 'occurred', 'in', 'of', '(', ')', 'intervention', 'participant', ',', 'compared', 'with', 'three', 'of', '(', ')', 'participant', 'randomized', 'to', 'usual', 'care', '.', 'primary', 'clinical', 'outcome', 'occurred', 'in', 'of', '(', ')', 'patient', 'in', 'nephrologist', 'follow-up', 'arm', ',', 'and', 'of', '(', ')', 'patient', 'in', 'usual', 'care', 'arm', '(', 'relative', 'risk', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'conclusion', 'major', 'adverse', 'kidney', 'event', 'common', 'in', 'aki', 'survivor', ',', 'found', 'in-person', 'model', 'of', 'follow-up', 'posed', 'variety', 'of', 'barrier', 'not', 'acceptable', 'to', 'many', 'patient', '.', 'clinical', 'trial', 'registry', 'name', 'and', 'registration', 'number', 'nephrologist', 'follow-up', 'versus', 'usual', 'care', 'acute', 'kidney', 'injury', 'hospitalization', '(', 'fusion', ')', ',', 'nct', 'cjasn', '-', ',', '.', 'doi', 'httpsdoi.org.cjn', '..']"
Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.,"Michael N Neely, Lauren Kato, Gilmer Youn, Lironn Kraler, David Bayard, Michael van Guilder, Alan Schumitzky, Walter Yamada, Brenda Jones, Emi Minejima, Michael N Neelyet al.",2018 Jan 25,Antimicrob Agents Chemother,https://pubmed.ncbi.nlm.nih.gov/29203493/,"Bayesian, clinical study, prospective, therapeutic drug monitoring, vancomycin.","['hypothesized', 'dosing', 'vancomycin', 'to', 'achieve', 'trough', 'concentration', 'of', 'mgliter', 'overdoses', 'many', 'adult', 'compared', 'to', 'area', 'concentration-time', 'curve', '(', 'auc', ')', '-guided', 'dosing', '.', 'conducted', '-year', ',', 'prospective', 'study', 'of', 'vancomycin', 'dosing', ',', 'plasma', 'concentration', ',', 'and', 'outcome', '.', 'in', 'year', ',', 'nonstudy', 'clinician', 'targeted', 'trough', 'concentration', 'of', 'to', 'mgliter', '(', 'infection', 'dependent', ')', 'and', 'controlled', 'dosing', '.', 'in', 'year', 'and', ',', 'study', 'team', 'controlled', 'vancomycin', 'dosing', 'with', 'bestdose', 'bayesian', 'software', 'to', 'achieve', 'daily', ',', 'steady-state', 'aucmic', 'ratio', 'of', ',', 'with', 'maximum', 'auc', 'value', 'of', 'mg', 'hliter', ',', 'regardless', 'of', 'trough', 'concentration', '.', 'bayesian', 'estimation', 'of', 'auc', ',', 'used', 'trough', 'sample', 'in', 'year', 'and', 'and', 'optimally', 'timed', 'sample', 'in', 'year', '.', 'enrolled', 'adult', 'year', 'old', 'with', 'available', 'vancomycin', 'concentration', '.', 'of', 'trough', 'concentration', 'therapeutic', 'versus', 'of', 'auc', '(', 'p', '.', ')', '.', 'enrollment', ',', 'median', 'trough', 'concentration', 'year', '.', ',', '.', ',', 'and', '.', 'mgliter', '(', 'p', '.', ')', ',', 'with', ',', ',', 'and', 'mgliter', '(', 'p', '.', ')', '.', 'bayesian', 'auc-guided', 'dosing', 'in', 'year', 'and', 'associated', 'with', 'fewer', 'additional', 'blood', 'sample', 'per', 'subject', '(', '.', ',', '.', ',', 'and', '.', 'p', '.', ')', ',', 'shorter', 'therapy', 'duration', '(', '.', ',', '.', ',', 'and', '.', 'day', 'p', '.', ')', ',', 'and', 'reduced', 'nephrotoxicity', '(', ',', ',', 'and', 'p', '.', ')', '.', 'median', 'inpatient', 'stay', 'day', 'among', 'nephrotoxic', 'patient', 'versus', 'day', '(', 'p', '.', ')', '.', 'no', 'difference', 'in', 'efficacy', 'year', ',', 'with', 'of', 'patient', 'microbiologically', 'proven', 'infection', '.', 'compared', 'to', 'trough', 'concentration', 'target', ',', 'auc-guided', ',', 'bayesian', 'estimation-assisted', 'vancomycin', 'dosing', 'associated', 'with', 'decreased', 'nephrotoxicity', ',', 'reduced', 'per-patient', 'blood', 'sampling', ',', 'and', 'shorter', 'length', 'of', 'therapy', ',', 'without', 'compromising', 'efficacy', '.', 'benefit', 'potential', 'substantial', 'cost', 'saving', '.', '(', 'study', 'registered', 'clinicaltrials.gov', 'registration', 'no', '.', 'nct', '.', ')', '.']"
Metformin-Associated Lactic Acidosis Undergoing Renal Replacement Therapy in Intensive Care Units: A Five-Million Population-Based Study in the North-West of Italy.,"Filippo Mariano, Marco Pozzato, Paola Inguaggiato, Cesare Guarena, Ernesto Turello, Massimo Manes, Paola David, Silvia Berutti, Valentina Consiglio, Alessandro Amore, Andrea Campo, Angela Marino, Mauro Berto, Paola Carpani, Giovanni Calabrese, Maurizio Gherzi, Emanuele Stramignoni, Guido Martina, Andrea Serra, Luciano Comune, Elisabetta Roscini, Antonio Marciello, Vincenzo Todini, Patrizia Vio, Oliviero Filiberti, Roberto Boero, Vincenzo Cantaluppi, Filippo Marianoet al.",2017,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/28668963/,No keywords found,"['metformin-associated', 'lactic', 'acidosis', '(', 'mala', ')', 'severe', 'complication', 'of', 'drug', 'administration', 'with', 'significant', 'morbidity', 'and', 'mortality', '.', 'far', 'no', 'study', 'in', 'large', 'population', 'area', 'examined', 'incidence', ',', 'clinical', 'profile', 'and', 'outcome', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '-mala', 'patient', 'admitted', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'and', 'treated', 'renal', 'replacement', 'therapy', '(', 'mala-rrt', ')', '.', 'method', 'retrospective', 'analysis', '-year', 'period', '(', '-', ')', 'in', 'piedmont', 'and', 'aosta', 'valley', 'region', '(', ',', ',', 'inhabitant', ',', ',', 'diabetic', 'treated', 'with', 'metformin', ')', 'of', 'mala-rrt', 'case', '.', 'result', 'one', 'hundred', 'and', 'seventeen', 'case', 'of', 'aki-mala-rrt', 'observed', '(', '.', ',', 'metformin', 'treated', 'diabetic', ',', '.', 'of', 'rrt-icu', 'patient', ')', '.', 'survival', 'rate', '..', 'average', 'duration', 'of', 'rrt', '.', 'day', 'mean', 'dialysis', 'effluent', 'of', 'mlkgday', '.', 'admission', 'patient', 'dehydrated', ',', 'and', 'experienced', 'shock', 'and', 'oliguria', '.', 'conclusion', 'data', 'showed', 'mala-rrt', 'common', 'complication', ',', 'needing', 'prevention', '.', 'adopted', 'policy', 'of', 'early', ',', 'extended', ',', 'continuous', 'and', 'high', 'efficiency', 'dialysis', 'could', 'contribute', 'to', 'observed', 'high', 'survival', 'rate', '.', 'video', 'journal', 'club', '``', 'cappuccino', 'with', 'claudio', 'ronco', ""''"", 'httpwww.karger.comdoi', '.']"
Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.,"Patrick M Wanner, Dirk U Wulff, Mirjana Djurdjevic, Wolfgang Korte, Thomas W Schnider, Miodrag Filipovic, Patrick M Wanneret al.",2021 Nov 2,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/34711333/,No keywords found,"['intraoperative', 'arterial', 'hypotension', 'strongly', 'associated', 'with', 'postoperative', 'major', 'adverse', 'cardiovascular', 'event', '(', 'mace', ')', 'however', ',', 'whether', 'targeting', 'higher', 'intraoperative', 'mean', 'arterial', 'blood', 'pressure', '(', 'map', ')', 'may', 'prevent', 'adverse', 'event', 'remains', 'unclear', '.', 'objective', 'study', 'sought', 'to', 'determine', 'whether', 'targeting', 'higher', 'intraoperative', 'map', 'lower', 'incidence', 'of', 'postoperative', 'mace', '.', 'method', 'single-center', 'randomized', 'controlled', 'trial', 'assigned', 'adult', 'patient', 'cardiovascular', 'risk', 'undergoing', 'major', 'noncardiac', 'surgery', 'to', 'intraoperative', 'map', 'target', 'of', 'mm', 'hg', '(', 'control', ')', 'or', 'mm', 'hg', '(', 'map', ')', '.', 'primary', 'outcome', 'acute', 'myocardial', 'injury', 'postoperative', 'day', '-', 'andor', '-day', 'maceacute', 'kidney', 'injury', '(', 'aki', ')', '(', 'acute', 'coronary', 'syndrome', ',', 'congestive', 'heart', 'failure', ',', 'coronary', 'revascularization', ',', 'stroke', ',', 'aki', ',', 'and', 'all-cause', 'mortality', ')', '.', 'secondary', 'outcome', '-year', 'mace', '.', 'result', 'in', 'total', ',', 'patient', 'randomized', '(', 'intention-to-treat', 'population', ')', '.', 'cumulative', 'intraoperative', 'duration', 'with', 'map', 'mm', 'hg', 'significantly', 'shorter', 'in', 'map', 'group', '(', 'median', 'minute', 'interquartile', 'range', 'to', 'minute', 'v', 'minute', 'interquartile', 'range', '-', 'minute', 'p', '.', ')', '.', 'primary', 'outcome', 'incidence', 'map', 'and', 'control', '(', 'risk', 'difference', '-', '.', 'ci', '-', 'to', ')', ',', 'primary', 'contributor', 'aki', '(', 'incidence', ')', '.', 'acute', 'myocardial', 'injury', 'occurred', 'in', '(', 'map', ')', 'and', '(', 'control', ')', 'of', 'patient', '.', 'secondary', 'outcome', 'incidence', 'map', 'and', 'control', '(', 'risk', 'difference', '.', 'ci', '-', 'to', '.', ')', '.', 'conclusion', 'finding', 'not', 'support', 'universally', 'targeting', 'higher', 'intraoperative', 'blood', 'pressure', 'to', 'reduce', 'postoperative', 'complication', '.', 'despite', 'reduction', 'in', 'hypotensive', 'time', 'with', 'map', 'mm', 'hg', ',', 'no', 'significant', 'reduction', 'in', 'acute', 'myocardial', 'injury', 'or', '-day', 'maceaki', 'could', 'found', '.', '(', 'biomarkers', ',', 'blood', 'pressure', ',', 'bi', 'risk', 'stratificationmanagement', 'of', 'patient', 'cardiac', 'risk', 'in', 'major', 'noncardiac', 'surgery', 'bbb', 'nct', ')', '.']"
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.,"Jeff D Williamson, Mark A Supiano, William B Applegate, Dan R Berlowitz, Ruth C Campbell, Glenn M Chertow, Larry J Fine, William E Haley, Amret T Hawfield, Joachim H Ix, Dalane W Kitzman, John B Kostis, Marie A Krousel-Wood, Lenore J Launer, Suzanne Oparil, Carlos J Rodriguez, Christianne L Roumie, Ronald I Shorr, Kaycee M Sink, Virginia G Wadley, Paul K Whelton, Jeffrey Whittle, Nancy F Woolard, Jackson T Wright Jr, Nicholas M Pajewski                              ;, SPRINT Research Group, Jeff D Williamsonet al.",2016 Jun 28,JAMA,https://pubmed.ncbi.nlm.nih.gov/27195814/,No keywords found,"['appropriate', 'treatment', 'target', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'in', 'older', 'patient', 'with', 'hypertension', 'remains', 'uncertain', '.', 'objective', 'to', 'evaluate', 'effect', 'of', 'intensive', '(', 'mm', 'hg', ')', 'compared', 'with', 'standard', '(', 'mm', 'hg', ')', 'sbp', 'target', 'in', 'person', 'aged', 'year', 'or', 'older', 'with', 'hypertension', 'without', 'diabetes', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'multicenter', ',', 'randomized', 'clinical', 'trial', 'of', 'patient', 'aged', 'year', 'or', 'older', 'participated', 'in', 'systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', ')', '.', 'recruitment', 'began', 'october', ',', ',', 'and', 'follow-up', 'ended', 'august', ',', '.', 'intervention', 'participant', 'randomized', 'to', 'sbp', 'target', 'of', 'less', 'mm', 'hg', '(', 'intensive', 'treatment', 'group', ',', 'n', ')', 'or', 'sbp', 'target', 'of', 'less', 'mm', 'hg', '(', 'standard', 'treatment', 'group', ',', 'n', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'cardiovascular', 'disease', 'outcome', 'composite', 'of', 'nonfatal', 'myocardial', 'infarction', ',', 'acute', 'coronary', 'syndrome', 'not', 'resulting', 'in', 'myocardial', 'infarction', ',', 'nonfatal', 'stroke', ',', 'nonfatal', 'acute', 'decompensated', 'heart', 'failure', ',', 'and', 'death', 'cardiovascular', 'cause', '.', 'all-cause', 'mortality', 'secondary', 'outcome', '.', 'result', 'among', 'participant', '(', 'mean', 'age', ',', '.', 'year', '.', 'woman', ')', ',', '(', '.', ')', 'provided', 'complete', 'follow-up', 'data', '.', 'median', 'follow-up', 'of', '.', 'year', ',', 'significantly', 'lower', 'rate', 'of', 'primary', 'composite', 'outcome', '(', 'event', 'in', 'intensive', 'treatment', 'group', 'v', 'event', 'in', 'standard', 'treatment', 'group', 'hazard', 'ratio', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', 'and', 'all-cause', 'mortality', '(', 'death', 'v', 'death', ',', 'respectively', 'hr', ',', '.', 'ci', ',', '.-.', ')', '.', 'overall', 'rate', 'of', 'serious', 'adverse', 'event', 'not', 'different', 'treatment', 'group', '(', '.', 'in', 'intensive', 'treatment', 'group', 'v', '.', 'in', 'standard', 'treatment', 'group', 'hr', ',', '.', 'ci', ',', '.-.', ')', '.', 'absolute', 'rate', 'of', 'hypotension', '.', 'in', 'intensive', 'treatment', 'group', 'v', '.', 'in', 'standard', 'treatment', 'group', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', ',', '.', 'v', '.', ',', 'respectively', ',', 'syncope', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', ',', '.', 'v', '.', 'electrolyte', 'abnormality', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', ',', '.', 'v', '.', 'acute', 'kidney', 'injury', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'and', '.', 'v', '.', 'injurious', 'fall', '(', 'hr', ',', '.', 'ci', ',', '.-.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'ambulatory', 'adult', 'aged', 'year', 'or', 'older', ',', 'treating', 'to', 'sbp', 'target', 'of', 'less', 'mm', 'hg', 'compared', 'with', 'sbp', 'target', 'of', 'less', 'mm', 'hg', 'resulted', 'in', 'significantly', 'lower', 'rate', 'of', 'fatal', 'and', 'nonfatal', 'major', 'cardiovascular', 'event', 'and', 'death', 'cause', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
"Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: a randomized, controlled clinical trial.","Glenn Van Wynsberge, Veerle Grootaert, Franky Buyle, Jens Van Praet, Roos Colman, Ine Moors, Annemie Somers, Diana Huis In 't Veld, Pieter De Cock                                                            ;, VANC-DOS Consortium, Kim Bigler, Andreas Capiau, Barbara Claus, Laure Degroote, Julie De Keulenaer, Sabine Deryckere, Lotte Deschepper, Sanne De Smet, Veronique De Smet, Astrid Heus, Liesbeth Huys, Jolien Langui, Tom Lodewyck, Sarah Mertens, Jeroen Neyt, Alexander Schauwvlieghe, Sylvia Snauwaert, Katleen Van Butsele, Stefaan Vandecasteele, Kevin Van Laethem, Karen Vermis, Barbara Verstraete, Glenn Van Wynsbergeet al.",2024 Feb 16,Trials,https://pubmed.ncbi.nlm.nih.gov/38365814/,No keywords found,"['vancomycin', 'commonly', 'prescribed', 'antibiotic', 'to', 'treat', 'gram-positive', 'infection', '.', 'efficacy', 'of', 'vancomycin', 'known', 'to', 'directly', 'related', 'to', 'pharmacokineticpharmacodynamic', '(', 'pkpd', ')', 'index', 'of', 'area', 'concentration-time', 'curve', '(', 'auc', ')', 'divided', 'minimal', 'inhibitory', 'concentration', '(', 'mic', ')', 'of', 'pathogen', '.', 'however', ',', 'in', 'country', ',', 'steady-state', 'plasma', 'concentration', 'used', 'surrogate', 'parameter', 'of', 'target', 'aucmic', ',', 'practice', 'drawback', '.', 'hence', ',', 'direct', 'auc-guided', 'monitoring', 'of', 'vancomycin', 'using', 'model-informed', 'precision', 'dosing', '(', 'mipd', ')', 'tool', 'proposed', 'earlier', 'attainment', 'of', 'target', 'concentration', 'and', 'reducing', 'vancomycin-related', 'nephrotoxicity', '.', 'however', ',', 'solid', 'scientific', 'evidence', 'benefit', 'in', 'clinical', 'practice', 'still', 'lacking', '.', 'randomized', 'controlled', 'trial', '(', 'rct', ')', 'aim', 'to', 'investigate', 'clinical', 'utility', 'of', 'mipd', 'dosing', 'of', 'vancomycin', 'administered', 'via', 'continuous', 'infusion', 'in', 'hospitalized', 'adult', '.', 'method', 'participant', 'ward', 'two', 'belgian', 'hospital', 'randomly', 'allocated', 'to', 'intervention', 'group', 'or', 'standard-of-care', 'comparator', 'group', '.', 'in', 'intervention', 'group', ',', 'clinical', 'pharmacist', 'perform', 'dose', 'calculation', 'using', 'ce-labeled', 'mipd', 'software', 'and', 'target', 'auch', 'of', 'to', 'mg', 'hl', ',', 'whereas', 'patient', 'in', 'comparator', 'group', 'receive', 'standard-of-care', 'dosing', 'and', 'monitoring', 'according', 'to', 'institutional', 'guideline', '.', 'primary', 'endpoint', 'proportion', 'of', 'patient', 'reaching', 'target', 'auchmic', 'of', '-', 'and', 'h', 'start', 'of', 'vancomycin', 'treatment', '.', 'secondary', 'endpoint', 'proportion', 'of', 'patient', 'with', '(', 'worsening', ')', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'h', 'stop', 'of', 'vancomycin', 'treatment', ',', 'proportion', 'of', 'patient', 'reaching', 'target', 'auchmic', 'of', '-', 'and', 'h', 'start', 'of', 'vancomycin', 'treatment', ',', 'and', 'proportion', 'of', 'time', 'within', 'target', 'auchmic', 'of', '-', '.', 'discussion', 'trial', 'clarify', 'propagated', 'benefit', 'and', 'provide', 'new', 'insight', 'to', 'optimally', 'monitor', 'vancomycin', 'treatment', '.', 'trial', 'registration', 'eudract', 'number', '--', '.', 'registered', 'june', ',', '.', 'clinicaltrials', 'gov', 'identifier', 'nct', '.', 'registered', 'september', ',', '.', 'protocol', 'version', ',', 'protocol', 'date', 'april', ',', '.']"
"Comparison of nephrotoxicity between two gadolinium-contrasts, gadodiamide and gadopentetate in patients with mildly diminished renal failure.","Shokichi Naito, Hiromi Tazaki, Tomoko Okamoto, Kazuhiro Takeuchi, Shinichi Kan, Yasuo Takeuchi, Kouju Kamata, Shokichi Naitoet al.",2017,J Toxicol Sci,https://pubmed.ncbi.nlm.nih.gov/28496044/,"Chronic Kidney Disease (CKD), Gadodiamide, Gadopentetate, Nephrotoxicity, Gadolinium-Contrast medium.","['although', 'gadolinium', '(', 'gd', ')', '-based', 'contrast', 'medium', 'found', 'to', 'nephrotoxic', ',', 'nephrotoxicity', ',', 'and', 'dependence', 'of', 'nephrotoxicity', 'chelate', 'type', ',', 'not', 'assessed', 'in', 'patient', 'with', 'normal', 'or', 'mildly', 'diminished', 'renal', 'failure', '.', 'prospective', ',', 'randomized', 'study', 'compared', 'nephrotoxicity', 'of', 'low', 'dos', 'of', 'nonionic', 'gd-based', 'contrast', 'medium', 'gadodiamide', '(', 'omniscan', ')', 'and', 'ionic', 'gd-based', 'contrast', 'medium', 'gadopentetate', '(', 'magnevist', ')', 'in', 'patient', 'with', 'serum', 'creatinine', '.', 'mgdl', '.', 'patient', 'aged', 'to', 'year', ',', 'weighing', 'to', 'kg', 'and', 'with', 'normal', 'or', '.', 'mgdl', 'serum-creatinine', 'in', 'month', 'prior', 'to', 'undergoing', 'magnetic', 'resonance', 'imaging', '(', 'mri', ')', 'of', 'brain', ',', 'enrolled', '.', 'patient', 'randomized', 'to', 'receive', '.', 'molkg', 'gadodiamide', 'or', 'gadopentetate', '.', 'serum-creatinine', ',', 'serum', 'cystatin-c', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'using', 'modification', 'of', 'diet', 'in', 'renal', 'disease', '(', 'mdrd', ')', 'formula', ',', 'and', 'estimated', 'creatinine', 'clearance', 'rate', '(', 'eccr', ')', 'using', 'cockcroft-gault', 'formula', 'measured', 'and', '-', 'hr', 'mri', '.', 'group', 'compared', 'statistically', 'mann-whitney', 'u-tests', 'and', 'wilcoxon', 'signed-rank', 'test', '.', 'no', 'significant', 'difference', 'in', 'clinical', 'characteristic', 'gadodiamide', '(', 'n', ')', 'and', 'gadopentetate', '(', 'n', ')', 'group', '.', 'serum-creatinine', ',', 'egfr', 'and', 'eccr', 'and', '-', 'hr', 'mri', 'not', 'differ', 'significantly', 'within', 'either', 'group', 'or', 'two', 'group', '.', 'serum', 'cystatin-c', 'significantly', 'higher', '-', 'hr', 'mri', 'in', 'gadodiamide', 'group', '(', '.', '.', 'vs.', '.', '.', 'mgl', ',', 'p', '.', ')', '.', 'ionic', 'contrast', 'medium', ',', 'gadopentetate', ',', 'not', 'affect', 'renal', 'function', 'mri', ',', 'whereas', 'nonionic', 'contrast', 'medium', ',', 'gadodiamide', ',', 'affected', 'renal', 'function', 'transiently', '.']"
Practice of Extracorporeal Therapies for Septic Acute Kidney Injury Patients in Intensive Care Units in Mainland China.,"Yu Zhou, Fachun Zhou, Xue Wang, Ping Chang, Ling Zhang, Qiang Yao, Jacques Goldstein, Xinyu Liu, Minmin Wang, Yu Zhouet al.",2019:47 Suppl 3:1-6.,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/30982039/,No keywords found,"['continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'and', 'extracorporeal', 'therapy', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'organ', 'dysfunction', 'syndrome', 'in', 'critically', 'ill', 'patient', 'common', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'many', 'study', 'focused', 'clinical', 'practice', 'managing', 'condition', '.', 'however', ',', 'study', 'describe', 'utilization', 'of', 'extracorporeal', 'therapy', ',', 'especially', 'crrt', ',', 'in', 'patient', 'with', 'sepsis-associated', 'aki', '.', 'summary', 'two', 'hundred', 'icu', 'physician', 'included', 'in', 'survey', 'february', ',', ',', 'to', 'march', ',', ',', 'current', 'status', 'of', 'septic', 'aki', 'and', 'clinical', 'practice', 'in', 'crrt', '.', 'according', 'to', 'response', ',', 'of', 'sepsis', 'patient', 'in', 'icu', 'aki', ',', 'and', 'required', 'extracorporeal', 'therapy', '.', 'however', ',', 'of', 'candidate', 'gave', 'therapy', 'medical', 'or', 'nonmedical', 'reason', '.', 'overall', 'survival', 'sepsis', 'among', 'survivor', ',', 'dialysis', 'free', 'discharge', '.', 'crrt', 'common', 'modality', 'of', 'extracorporeal', 'therapy', 'in', 'icu', ',', 'and', 'of', 'physician', 'chose', 'convection', 'major', 'clearance', 'mode', '.', 'survey', 'showed', 'of', 'physician', 'saw', 'removal', 'of', 'inflammatory', 'mediator', 'major', 'objective', 'of', 'extracorporeal', 'therapy', 'however', ',', '.', 'of', 'physician', 'considered', 'inflammation', 'measure', 'to', 'trigger', 'crrt', '.', 'median', 'treatment', 'duration', 'of', 'crrt', 'in', 'china', 'h', 'per', 'day', 'day', '.', 'key', 'message', 'similarity', 'and', 'difference', 'in', 'crrt', 'practice', 'septic', 'aki', 'patient', 'in', 'china', 'and', 'globally', '.', 'difference', 'reveal', 'insight', 'improving', 'outcome', 'of', 'patient', '.']"
"Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial.","F Perry Wilson, Melissa Martin, Yu Yamamoto, Caitlin Partridge, Erica Moreira, Tanima Arora, Aditya Biswas, Harold Feldman, Amit X Garg, Jason H Greenberg, Monique Hinchcliff, Stephen Latham, Fan Li, Haiqun Lin, Sherry G Mansour, Dennis G Moledina, Paul M Palevsky, Chirag R Parikh, Michael Simonov, Jeffrey Testani, Ugochukwu Ugwuowo, F Perry Wilsonet al.",2021 Jan 18:372:m4786.,BMJ,https://pubmed.ncbi.nlm.nih.gov/33461986/,No keywords found,"['to', 'determine', 'whether', 'electronic', 'health', 'record', 'alert', 'acute', 'kidney', 'injury', 'would', 'improve', 'patient', 'outcome', 'of', 'mortality', ',', 'dialysis', ',', 'and', 'progression', 'of', 'acute', 'kidney', 'injury', '.', 'design', 'double', 'blinded', ',', 'multicenter', ',', 'parallel', ',', 'randomized', 'controlled', 'trial', '.', 'setting', 'six', 'hospital', '(', 'four', 'teaching', 'and', 'two', 'non-teaching', ')', 'in', 'yale', 'new', 'health', 'system', 'in', 'connecticut', 'and', 'rhode', 'island', ',', 'u', ',', 'ranging', 'small', 'community', 'hospital', 'to', 'large', 'tertiary', 'care', 'center', '.', 'participant', 'adult', 'inpatient', 'with', 'acute', 'kidney', 'injury', ',', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'creatinine', 'criterion', '.', 'intervention', 'electronic', 'health', 'record', 'based', '``', 'pop-up', ""''"", 'alert', 'acute', 'kidney', 'injury', 'with', 'associated', 'acute', 'kidney', 'injury', 'order', 'set', 'upon', 'provider', 'opening', 'of', 'patient', ""'s"", 'medical', 'record', '.', 'main', 'outcome', 'measure', 'composite', 'of', 'progression', 'of', 'acute', 'kidney', 'injury', ',', 'receipt', 'of', 'dialysis', ',', 'or', 'death', 'within', 'day', 'of', 'randomization', '.', 'prespecified', 'secondary', 'outcome', 'included', 'outcome', 'hospital', 'and', 'frequency', 'of', 'various', 'care', 'practice', 'acute', 'kidney', 'injury', '.', 'result', 'patient', 'randomized', 'month', '.', 'primary', 'outcome', 'occurred', 'in', '(', '.', ')', 'of', 'patient', 'with', 'alert', 'and', 'in', '(', '.', ')', 'of', 'patient', 'receiving', 'usual', 'care', '(', 'relative', 'risk', '.', ',', 'confidence', 'interval', '.', 'to', '.', ',', 'p.', ')', '.', 'analysis', 'hospital', 'showed', 'worse', 'outcome', 'in', 'two', 'non-teaching', 'hospital', '(', 'n', ',', ')', ',', 'alert', 'associated', 'with', 'higher', 'risk', 'of', 'primary', 'outcome', '(', 'relative', 'risk', '.', ',', 'confidence', 'interval', '.', 'to', '.', ',', 'p.', ')', '.', 'death', 'occurred', 'center', '(', '.', 'in', 'alert', 'group', 'v', '.', 'in', 'usual', 'care', 'group', ',', 'p.', ')', '.', 'certain', 'acute', 'kidney', 'injury', 'care', 'practice', 'increased', 'in', 'alert', 'group', 'not', 'appear', 'to', 'mediate', 'outcome', '.', 'conclusion', 'alert', 'not', 'reduce', 'risk', 'of', 'primary', 'outcome', 'among', 'patient', 'in', 'hospital', 'with', 'acute', 'kidney', 'injury', '.', 'heterogeneity', 'of', 'effect', 'across', 'clinical', 'center', 'lead', 'to', 're-evaluation', 'of', 'existing', 'alerting', 'system', 'acute', 'kidney', 'injury', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation.,"Stefanie W Benoit, Bradley P Dixon, Stuart L Goldstein, Michael R Bennett, Adam Lane, Dana T Lounder, Seth J Rotz, Nicholas J Gloude, Kelly E Lake, Bridget Litts, Stella M Davies, Stefanie W Benoitet al.",2019 Sep,Bone Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/30700793/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'in', 'pediatric', 'hematopoietic', 'stem', 'cell', 'transplantation', '(', 'hsct', ')', '.', 'serum', 'creatinine', 'imprecise', 'biomarker', 'of', 'aki', '.', 'hypothesized', 'combining', 'creatinine', 'with', 'serum', 'cystatin', 'c', '(', 'cysc', ')', 'and', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'effectively', 'characterizes', 'aki', 'first', 'day', 'of', 'hsct', 'and', 'better', 'identifies', 'patient', 'risk', 'of', 'adverse', 'outcome', 'creatinine', 'alone', '.', 'prospectively', 'assessed', 'type', 'and', 'severity', 'of', 'aki', 'in', 'consecutive', 'allogeneic', 'hsct', 'patient', 'using', 'weekly', 'creatinine', ',', 'cysc', ',', 'and', 'ngal', '.', 'combined', 'biomarkers', 'to', 'define', 'composite', 'type', 'of', 'aki', ',', 'including', 'positive', 'aki', '(', 'simultaneously', 'detected', 'creatinine', ',', 'cysc', ',', 'and', 'ngal', 'aki', ')', '.', 'outcome', 'included', 'renal', 'replacement', 'therapy', 'and', 'transplant-related', 'mortality', '.', 'in', ',', 'of', 'patient', 'aki', 'least', 'one', 'measure', 'developed', 'type', 'of', 'aki', '.', 'mild', 'aki', 'often', 'preceded', 'severe', 'aki', '.', 'patient', 'with', 'creatinine', 'or', 'ngal', 'aki', 'severe', 'or', 'repeated', 'tended', 'to', 'worse', 'outcome', '.', 'five', 'patient', 'with', 'positive', 'aki', 'highest', 'rate', 'of', 'morbidity', 'and', 'mortality', '.', 'aki', 'evaluation', 'with', 'creatinine', ',', 'cysc', ',', 'and', 'ngal', 'provides', 'comprehensive', 'profile', 'of', 'early', 'aki', 'and', 'narrowly', 'identifies', 'patient', 'highest', 'risk', 'of', 'adverse', 'outcome', ',', 'providing', 'opportunity', 'early', ',', 'impactful', 'intervention', '.']"
A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury.,"Abdullah H Almalki, Sherine E Ismail, Mohammad A Qureshi, Zuhair Abunijem, Mohamed E Balla, Saliman Karsou, Rehan A Qureshi, Akram Ahmad, Salhah AlSulami, Maryam Khalil, Jani Hafez, Jane E H Thomson, Muhammad A Siddiqui, Oyindamola B Yusuf, Zeyad A Zahrani, Abdulhameed Gasim, K H Mujtaba Quadri, Abdullah H Almalkiet al.",2017 Nov-Dec,Saudi J Kidney Dis Transpl,https://pubmed.ncbi.nlm.nih.gov/29265039/,No keywords found,"['-day', 'readmission', ',', 'in-hospital', 'mortality', ',', 'determinant', 'of', 'los', ',', 'and', 'patient-centered', 'outcome', '.', 'eighteen', 'patient', 'randomized', 'to', 'pc', ',', 'and', 'to', 'uc', '.', 'baseline', 'characteristic', 'comparable', 'in', 'group', '.', 'using', 'intention-to-treat', 'analysis', ',', 'median', 'los', '.', 'interquartile', 'range', '(', 'iqr', ')', '.', 'and', '.', 'day', '(', 'iqr', '.', ')', 'pc', 'and', 'uc', ',', 'respectively', '(', 'p', '.', ')', '.', 'of', 'five', 'readmission', ',', 'none', 'aki', '.', 'no', 'in-hospital', 'mortality', 'reported', '.', 'champ-path', 'aki', 'pragmatic', 'trial', 'demonstrated', 'pc', 'not', 'different', 'uc', 'in', 'reducing', 'los', '.', 'no', 'difference', 'in', '-day', 're-', 'admission', ',', 'in-hospital', 'mortality', ',', 'and', 'patient-centered', 'outcome', '.']"
Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.,"Ivan Gocze, Matthias Koch, Philipp Renner, Florian Zeman, Bernhard M Graf, Marc H Dahlke, Michael Nerlich, Hans J Schlitt, John A Kellum, Thomas Bein, Ivan Goczeet al.",2015 Mar 23,PLoS One,https://pubmed.ncbi.nlm.nih.gov/25798585/,No keywords found,"['to', 'assess', 'ability', 'of', 'urinary', 'biomarkers', 'igfbp', '(', 'insulin-like', 'growth', 'factor-binding', 'protein', ')', 'and', 'timp-', '(', 'tissue', 'inhibitor', 'of', 'metalloproteinase', ')', 'to', 'early', 'predict', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'high-risk', 'surgical', 'patient', '.', 'introduction', 'postoperative', 'aki', 'associated', 'with', 'increase', 'in', 'short', 'and', 'long-term', 'mortality', '.', 'using', 'igfbp', 'and', 'timp-', 'early', 'detection', 'of', 'cellular', 'kidney', 'injury', ',', 'thus', 'allowing', 'early', 'initiation', 'of', 'renal', 'protection', 'measure', ',', 'may', 'represent', 'new', 'concept', 'of', 'evaluating', 'renal', 'function', '.', 'method', 'in', 'prospective', 'study', ',', 'urinary', 'timp-igfbp', 'measured', 'in', 'surgical', 'patient', 'high', 'risk', 'aki', '.', 'predefined', 'cut-off', 'value', 'of', 'timp-igfbp', '.', 'used', 'assessing', 'diagnostic', 'accuracy', '.', 'perioperative', 'characteristic', 'evaluated', ',', 'and', 'roc', 'analysis', 'well', 'logistic', 'regression', 'model', 'of', 'risk', 'assessment', 'calculated', 'with', 'and', 'without', 'timp-igfbp', 'test', '.', 'result', 'patient', 'included', 'in', 'study', ',', 'of', '(', ')', 'developed', 'aki', '.', 'highest', 'median', 'value', 'of', 'biomarker', 'detected', 'in', 'septic', ',', 'transplant', 'and', 'patient', 'hepatic', 'surgery', '(', '.', 'v', '.', 'v', '.', 'ngl', ')', '.', 'area', 'receiving', 'operating', 'characteristic', 'curve', '(', 'auc', ')', 'risk', 'of', 'aki', '.', ',', 'early', 'use', 'of', 'rrt', '.', 'and', '-day', 'mortality', '..', 'in', 'multivariable', 'model', 'with', 'established', 'perioperative', 'risk', 'factor', ',', 'timp-igfbp', 'test', 'strongest', 'predictor', 'of', 'aki', 'and', 'significantly', 'improved', 'risk', 'assessment', '(', 'p.', ')', '.', 'conclusion', 'urinary', 'timp-igfbp', 'test', 'sufficiently', 'detect', 'patient', 'with', 'risk', 'of', 'aki', 'major', 'non-cardiac', 'surgery', '.', 'due', 'to', 'rapid', 'responsiveness', 'extends', 'time', 'frame', 'intervention', 'to', 'prevent', 'development', 'of', 'aki', '.']"
Development and validation of a predictive model for acute kidney injury in patients with moderately severe and severe acute pancreatitis.,"Dongliang Yang#, Li Zhao#, Jian Kang, Chao Wen, Yuanhao Li, Yanbo Ren, Hui Wang, Su Zhang, Suosuo Yang, Jing Song, Dongna Gao, Yuling Li, Dongliang Yanget al.",2022 Aug,Clin Exp Nephrol,https://pubmed.ncbi.nlm.nih.gov/35430680/,No keywords found,"['acute', 'kidney', 'injury', 'serious', 'complication', 'of', 'moderately', 'severe', 'and', 'severe', 'acute', 'pancreatitis', ',', 'significantly', 'increase', 'mortality', '.', 'currently', 'no', 'reliable', 'tool', 'early', 'identification', 'of', 'aki', 'especially', 'severe', 'aki', 'in', 'patient', '.', 'aim', 'to', 'develop', 'predictive', 'model', 'physician', 'assess', 'risk', 'of', 'aki', 'and', 'severe', 'aki', ',', 'thus', 'take', 'preventive', 'measure', '.', 'method', 'patient', 'with', 'diagnosis', 'of', 'msap', 'and', 'sap', 'admitted', 'to', 'hospital', 'january', 'to', 'december', 'retrospectively', 'included', 'in', 'study', '.', 'participant', 'divided', 'training', 'and', 'validation', 'cohort', 'randomly', ',', 'in', 'ratio', '.', 'clinical', 'signature', 'built', 'based', 'reproducible', 'feature', ',', 'using', 'least', 'absolute', 'shrinkage', 'and', 'selection', 'operator', 'method', 'and', 'machine', 'learning', '.', 'multivariate', 'logistic', 'regression', 'analysis', 'used', 'to', 'develop', 'prediction', 'model', '.', 'nomogram', 'performance', 'determined', 'discrimination', ',', 'calibration', ',', 'and', 'clinical', 'usefulness', '.', 'result', 'total', 'of', 'eligible', 'patient', 'enrolled', '.', 'patient', 'allocated', 'in', 'training', 'cohort', 'and', 'in', 'validation', 'cohort', '.', 'aki', 'occurred', 'in', 'patient', '(', ')', 'in', 'training', 'cohort', 'and', '(', ')', 'in', 'validation', 'cohort', ',', 'respectively', '.', 'clinical', 'feature', ',', 'including', 'c-reactive', 'protein', ',', 'intra-abdominal', 'pressure', 'and', 'serum', 'cysc', ',', 'significantly', 'associated', 'with', 'aki', 'well', 'severe', 'aki', '.', 'nomogram', 'showed', 'favorable', 'discrimination', ',', 'calibration', 'and', 'clinical', 'usefulness', '.', 'conclusion', 'novel', 'risk', 'score', 'model', 'good', 'performance', 'predicting', 'aki', 'and', 'severe', 'aki', 'in', 'msap', 'and', 'sap', 'patient', '.', 'application', 'of', 'model', 'help', 'clinician', 'stratify', 'patient', 'primary', 'prevention', ',', 'surveillance', 'and', 'early', 'therapeutic', 'intervention', 'to', 'improve', 'care', 'and', 'prognosis', '.']"
Pre-operative proteinuria and post-operative acute kidney injury in noncardiac surgery: the NARA-Acute Kidney Injury cohort study.,"Masatoshi Nishimoto, Miho Murashima, Maiko Kokubu, Masaru Matsui, Masahiro Eriguchi, Ken-Ichi Samejima, Yasuhiro Akai, Kazuhiko Tsuruya, Masatoshi Nishimotoet al.",2020 Dec 4,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/31891400/,No keywords found,"['little', 'known', 'association', 'pre-operative', 'proteinuria', 'and', 'post-operative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'noncardiac', 'surgery', '.', 'method', 'retrospective', 'cohort', 'study', '.', 'adult', 'underwent', 'noncardiac', 'surgery', 'general', 'anesthesia', 'to', 'nara', 'medical', 'university', 'hospital', 'included', '.', 'with', 'obstetric', 'or', 'urological', 'surgery', ',', 'missing', 'data', 'analysis', 'or', 'pre-operative', 'dialysis', 'excluded', '.', 'exposure', 'of', 'interest', 'pre-operative', 'proteinuria', ',', 'defined', '(', ')', 'or', 'dipstick', 'test', '.', 'outcome', 'variable', 'post-operative', 'aki', ',', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', 'criterion', ',', 'within', 'week', 'surgery', '.', 'multivariable', 'logistic', 'regression', 'analysis', 'performed', '.', 'result', 'among', 'subject', ',', '(', '.', ')', 'developed', 'aki', '.', 'pre-operative', 'proteinuria', 'independently', 'associated', 'with', 'post-operative', 'aki', ',', 'with', 'odds', 'ratio', '(', 'or', ')', 'confidence', 'interval', '(', 'ci', ')', 'of', '.', '(', '.-.', ')', '.', 'sensitivity', 'analysis', 'restricted', 'to', 'elective', 'surgery', 'yielded', 'similar', 'result', '.', 'proteinuria', 'increased', ',', 'association', 'with', 'aki', 'became', 'stronger', 'or', '(', 'ci', ')', '.', '(', '.-', '.', ')', ',', '.', '(', '.-', '.', ')', ',', '.', '(', '.-', '.', ')', 'and', '.', '(', '.-', '.', ')', 'urinary', 'protein', '(', '-', ')', ',', '(', ')', ',', '(', ')', 'and', '(', ')', ',', 'respectively', '.', 'subgroup', 'analysis', 'showed', 'proteinuria', 'especially', 'associated', 'with', 'post-operative', 'aki', 'among', 'subject', 'with', 'renin-angiotensin', 'system', 'inhibitor', ',', 'anti-hypertensives', ',', 'hypoalbuminemia', 'or', 'impaired', 'renal', 'function', '(', 'p', 'interaction', '.', ',', '.', ',', '.', 'or', '.', ',', 'respectively', ')', '.', 'conclusion', 'in', 'noncardiac', 'surgery', ',', 'pre-operative', 'proteinuria', 'independently', 'associated', 'with', 'post-operative', 'aki', '.', 'subject', 'with', 'proteinuria', 'managed', 'with', 'caution', 'to', 'avoid', 'aki', 'peri-operatively', '.']"
Prophylactic Fibrinogen Decreases Postoperative Bleeding but Not Acute Kidney Injury in Patients Undergoing Heart Transplantation.,"Alireza Jahangirifard, Zargham Hossein Ahmadi, Farah Naghashzadeh, Babak Sharif-Kashani, Farin Rashid-Farokhi, Ali Afshar, Reyhaneh Yamini-Sharif, Yousef Rezaei, Alireza Jahangirifardet al.",2018 Sep,Clin Appl Thromb Hemost,https://pubmed.ncbi.nlm.nih.gov/29050500/,"acute kidney injury, bleeding, fibrinogen, heart transplantation, transfusion.","['present', 'study', 'premier', 'clinical', 'attempt', 'to', 'scrutinize', 'practicability', 'of', 'prophylactic', 'fibrinogen', 'infusion', 'in', 'patient', 'undergoing', 'heart', 'transplantation', '(', 'ht', ')', '.', 'total', 'of', 'consecutive', 'patient', 'undergone', 'ht', 'january', 'and', 'december', 'assessed', '.', 'exclusion', 'of', 'patient', ',', 'patient', 'given', 'preoperative', 'g', 'fibrinogen', 'concentrate', 'period', 'of', 'minute', 'termination', 'of', 'cardiopulmonary', 'bypass', 'pump', 'and', 'complete', 'reversal', 'of', 'heparin', ',', 'and', 'patient', 'not', 'given', '.', 'laboratory', 'measured', 'general', 'anesthesia', 'and', 'and', 'hour', 'surgery', '.', 'in', 'addition', ',', 'major', 'adverse', 'event', 'also', 'evaluated', 'hospitalization', '.', 'mean', 'age', 'of', 'patient', '.', '.', 'year', ',', 'with', 'predominance', 'of', 'male', 'sex', '(', '.', ')', '.', 'laboratory', 'baseline', 'comparable', 'group', '.', 'length', 'of', 'hospital', 'stay', 'longer', 'in', 'control', 'group', 'compared', 'to', 'fibrinogen', 'group', '(', '-', 'v', '-', 'day', 'p', '.', ')', '.', 'trend', 'patient', 'in', 'fibrinogen', 'group', 'to', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'surgery', '(', 'v', '.', ')', 'and', 'less', 'reoperation', 'bleeding', '(', 'v', '.', ')', '.', 'amount', 'of', 'postoperative', 'bleeding', 'significantly', 'higher', 'in', 'control', 'group', 'compared', 'to', 'fibrinogen', 'group', '(', 'p', '.', ')', '.', 'number', 'of', 'packed', 'red', 'blood', 'cell', 'transfused', 'hour', 'surgery', 'significantly', 'lower', 'in', 'fibrinogen', 'group', '(', 'p', '.', ')', '.', 'transfusion', 'of', 'fibrinogen', 'in', 'patient', 'undergoing', 'ht', 'may', 'associated', 'with', 'reduction', 'in', 'postoperative', 'bleeding', ',', 'number', 'of', 'packed', 'red', 'blood', 'cell', ',', 'and', 'hospital', 'length', 'of', 'stay', 'however', ',', 'may', 'enhance', 'postoperative', 'aki', '.']"
"CRRTnet: a prospective, multi-national, observational study of continuous renal replacement therapy practices.","Michael Heung, Sean M Bagshaw, Andrew A House, Luis A Juncos, Robin Piazza, Stuart L Goldstein, Michael Heunget al.",2017 Jul 6,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/28683729/,No keywords found,"['continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'recommended', 'modality', 'of', 'dialysis', 'critically', 'ill', 'patient', 'with', 'hemodynamic', 'instability', '.', 'yet', 'remains', 'significant', 'variability', 'in', 'crrt', 'prescribed', 'and', 'delivered', ',', 'and', 'limited', 'evidence-basis', 'to', 'guide', 'practice', '.', 'method', 'prospective', ',', 'multi-center', 'observational', 'study', 'of', 'patient', 'undergoing', 'crrt', '.', 'initial', 'enrollment', 'phase', 'occur', 'academic', 'medical', 'center', 'in', 'north', 'america', 'year', ',', 'with', 'target', 'enrollment', 'of', 'patient', '.', 'adult', 'patient', '(', '-', 'year', 'of', 'age', ')', 'receiving', 'crrt', 'eligible', 'inclusion', 'patient', 'undergo', 'crrt', 'less', 'h', 'excluded', 'analysis', '.', 'data', 'collection', 'include', 'patient', 'characteristic', 'baseline', 'and', 'time', 'of', 'crrt', 'initiation', 'detail', 'of', 'crrt', 'prescription', 'and', 'delivery', ',', 'including', 'machine-generated', 'treatment', 'data', 'and', 'patient', 'outcome', '.', 'discussion', 'goal', 'of', 'study', 'to', 'establish', 'large', 'comprehensive', 'registry', 'of', 'critically', 'ill', 'adult', 'receiving', 'crrt', '.', 'specific', 'aim', 'include', 'describing', 'variation', 'in', 'crrt', 'prescription', 'and', 'delivery', 'across', 'quality', 'domain', 'validating', 'quality', 'measure', 'crrt', 'care', 'correlating', 'process', 'and', 'outcome', 'and', 'establishing', 'large', 'registry', 'use', 'in', 'quality', 'improvement', 'and', 'benchmarking', 'effort', '.', 'initial', 'analysis', ',', 'particular', 'area', 'of', 'interest', 'anticoagulation', 'protocol', 'approach', 'to', 'fluid', 'overload', 'crrt-related', 'workload', 'and', 'patient', 'safety', '.', 'trial', 'registration', 'registered', 'clinicaltrials.gov', 'nct', '.']"
"Selenium, Vitamin C and N-Acetylcysteine do not Reduce the Risk of Acute Kidney Injury after Off-Pump CABG: a Randomized Clinical Trial.","Shahram Amini, Hojat Naghavi Robabi, Mohammad Abbasi Tashnizi, Vida Vakili, Shahram Aminiet al.",2018 Mar-Apr,Braz J Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/29898141/,No keywords found,"['aim', 'of', 'study', 'to', 'investigate', 'impact', 'of', 'perioperative', 'administration', 'of', 'n-acetylcysteine', ',', 'selenium', 'and', 'vitamin', 'c', 'incidence', 'and', 'outcome', 'of', 'acute', 'kidney', 'injury', 'off-pump', 'coronary', 'bypass', 'graft', 'surgery', '.', 'method', 'patient', 'requiring', 'elective', 'off-pump', 'coronary', 'bypass', 'graft', 'surgery', 'randomized', 'to', 'receive', 'either', 'n-acetylcysteine', ',', 'vitamin', 'c', 'and', 'selenium', 'mg', ',', 'mg', ',', '.', 'mg', ',', 'and', 'nothing', 'orally', 'twice', 'day', ',', 'respectively', ',', 'day', 'to', 'day', 'surgery', '.', 'assessed', 'development', 'of', 'acute', 'kidney', 'injury', 'using', 'acute', 'kidney', 'injury', 'network', 'criterion', ',', 'time', 'of', 'onset', ',', 'severity', 'and', 'duration', ',', 'duration', 'of', 'mechanical', 'ventilation', ',', 'intensive', 'care', 'unit', 'and', 'hospital', 'length', 'of', 'stay', ',', 'and', 'in-hospital', 'mortality', '.', 'result', 'patient', 'completed', 'study', '.', 'total', 'incidence', 'of', 'acute', 'kidney', 'injury', '.', '(', 'n', ')', 'with', '(', '.', ')', ',', '(', '.', ')', ',', '(', '.', ')', ',', 'and', '(', '.', ')', 'patient', 'in', 'vitamin', 'c', ',', 'nac', ',', 'selenium', ',', 'and', 'control', 'group', ',', 'respectively', '(', 'p.', ')', '.', 'not', 'register', 'significant', 'difference', 'in', 'incidence', ',', 'time', 'of', 'occurrence', ',', 'severity', 'and', 'duration', 'of', 'acute', 'kidney', 'injury', ',', 'well', 'duration', 'of', 'mechanical', 'ventilation', ',', 'intensive', 'care', 'unit', 'and', 'hospital', 'length', 'of', 'stay', ',', 'and', 'in-hospital', 'mortality', 'among', 'four', 'group', '.', 'conclusion', 'found', 'perioperative', 'administration', 'of', 'n-acetylcysteine', ',', 'vitamin', 'c', 'and', 'selenium', 'not', 'effective', 'in', 'preventing', 'acute', 'kidney', 'injury', 'and', 'associated', 'morbidity', 'and', 'mortality', 'off-pump', 'coronary', 'bypass', 'graft', 'surgery', '.']"
Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).,"Werner Ribitsch, Gernot Schilcher, Franz Quehenberger, Stefan Pilz, Rupert H Portugaller, Martini Truschnig-Wilders, Robert Zweiker, Marianne Brodmann, Philipp Stiegler, Alexander R Rosenkranz, John W Pickering, Joerg H Horina, Werner Ribitschet al.",2017 Jan 27:7:41300.,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/28128223/,No keywords found,"['.-', '.', ')', 'and', 'sensitivity', 'of', '.', '(', 'ci', '.-', '.', ')', 'of', 'ungal', 'diagnosis', 'of', 'ci-aki', '.', 'in', 'study', 'ungal', 'failed', 'to', 'predict', 'ci-aki', 'and', 'inadequate', 'triage', 'tool', 'to', 'guide', 'early', 'intervention', 'strategy', 'to', 'prevent', 'ci-aki', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
"Study on the application of a segmented sodium citrate solution anticoagulation strategy in critically ill patients receiving CRRT: a prospective, randomized controlled study.","Yu Chen, Fang Feng, Hong Guo, Lu Zhang, Jian Liu, Yu Chenet al.",2024 Aug 16,Trials,https://pubmed.ncbi.nlm.nih.gov/39152492/,No keywords found,"['to', 'explore', 'feasibility', 'and', 'effectiveness', 'of', 'segmented', 'sodium', 'citrate', 'solution', 'anticoagulation', 'strategy', 'in', 'patient', 'receiving', 'crrt', '.', 'method', 'prospective', ',', 'randomized', 'controlled', 'study', 'conducted', '.', 'result', 'according', 'to', 'inclusion', 'and', 'exclusion', 'criterion', ',', 'patient', 'included', 'and', 'randomly', 'divided', 'two', 'group', '.', 'moreover', ',', 'coagulation', 'index', ',', 'liver', 'function', 'index', ',', 'renal', 'function', 'index', ',', 'and', 'sofa', 'and', 'apache', 'ii', 'score', 'not', 'significantly', 'differ', 'two', 'group', '(', 'p', '.', ')', '.', 'coagulation', 'grade', 'of', 'venous', 'port', 'in', 'experimental', 'group', 'lower', 'in', 'control', 'group', 'and', 'two', 'group', 'of', 'filter', ',', 'difference', 'not', 'statistically', 'significant', '(', 'p', '.', ')', '.', 'sodium', 'citrate', 'solution', 'infusion', 'method', 'maintained', 'low', 'blood', 'calcium', 'concentration', '(', '.-', '.', 'mmoll', ')', 'in', 'peripheral', 'circulation', 'pathway', ',', 'and', 'no', 'patient', 'developed', 'hypocalcaemia', '(', '.', 'mmoll', ')', '.', 'lifespan', 'of', 'extracorporeal', 'circulation', 'tube', 'in', 'experimental', 'group', 'and', 'control', 'group', '.', '.', 'h', 'and', '.', '.', 'h', ',', 'respectively', '(', '.', ',', 'p', '.', ')', '.', 'conclusion', 'segmented', 'citrate', 'solution', 'anticoagulation', 'strategy', 'could', 'extend', 'lifespan', 'of', 'extracorporeal', 'circulation', 'tube', 'and', 'improve', 'crrt', 'efficacy', '.', 'trial', 'registration', 'chinese', 'clinical', 'trial', 'registry', 'number', 'chictr', '.', 'registered', 'march', ',', '.']"
Value of electronic alerts for acute kidney injury in high-risk wards: a pilot randomized controlled trial.,"Yanhua Wu, Yuanhan Chen, Shaowen Li, Wei Dong, Huaban Liang, Miaoyi Deng, Yingnan Chen, Shixin Chen, Xinling Liang, Yanhua Wuet al.",2018 Aug,Int Urol Nephrol,https://pubmed.ncbi.nlm.nih.gov/29556903/,No keywords found,"['to', 'investigate', 'application', 'value', 'of', '``', 'electronic', 'alert', ""''"", '(', '``', 'e-alerts', ""''"", ')', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'among', 'high-risk', 'ward', 'of', 'hospital', '.', 'method', 'prospective', ',', 'randomized', ',', 'controlled', 'study', 'conducted', '.', 'developed', 'e-alert', 'system', 'aki', 'and', 'ran', 'system', 'in', 'intensive', 'care', 'unit', 'and', 'division', 'focusing', 'cardiovascular', 'disease', '.', 'e-alert', 'system', 'diagnosed', 'aki', 'automatically', 'based', 'serum', 'creatinine', 'level', '.', 'patient', 'assigned', 'randomly', 'to', 'e-alert', 'group', '(', 'patient', ')', 'or', 'non-e-alert', 'group', '(', 'patient', ')', '.', 'e-alert', 'group', 'could', 'receive', 'pop-up', 'message', '.', 'result', 'sensitivity', ',', 'specificity', ',', 'youden', 'index', 'and', 'accuracy', 'of', 'aki', 'e-alert', 'system', '.', ',', '.', ',', '.', 'and', '.', ',', 'respectively', '.', 'prevalence', 'of', 'diagnosis', 'aki', 'and', 'expanded-aki', '(', 'aki', 'or', 'multiple-organ', 'failure', ')', 'in', 'e-alert', 'group', 'higher', 'in', 'non-e-alert', 'group', '(', 'aki', '.', 'and', '.', ',', 'p', '.', 'expanded-aki', '.', 'and', '.', ',', 'p', '.', ')', '.', 'prevalence', 'of', 'nephrology', 'consultation', 'in', 'e-alert', 'group', 'higher', 'in', 'non-e-alert', 'group', '(', '.', 'and', '.', ',', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'prevalence', 'dialysis', ',', 'rehabilitation', 'of', 'renal', 'function', 'or', 'death', 'in', 'two', 'group', '.', 'conclusion', 'e-alert', 'system', 'described', 'reliable', 'tool', 'to', 'make', 'accurate', 'diagnosis', 'of', 'aki', '.']"
Volume control strategy and patient survival in sepsis-associated acute kidney injury receiving continuous renal replacement therapy: a randomized controlled trial with secondary analysis.,"Cheol Ho Park, Hee Byung Koh, Jin Hyeog Lee, Hui-Yun Jung, Joohyung Ha, Hyung Woo Kim, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo, Cheol Ho Parket al.",2024 Jun 21,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/38902283/,"Bioelectrical impedance analysis, Continuous renal replacement therapy, Sepsis-associated acute kidney injury, Volume control.","['optimal', 'strategy', 'volume', 'control', 'and', 'clinical', 'implication', 'of', 'achieved', 'volume', 'control', 'unknown', 'in', 'patient', 'with', 'sepsis-associated', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'receiving', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '.', 'randomized', 'controlled', 'trial', 'aimed', 'to', 'compare', 'survival', 'according', 'to', 'conventional', 'or', 'bioelectrical', 'impedance', 'analysis', '(', 'bia', ')', '-guided', 'volume', 'control', 'strategy', 'in', 'patient', 'with', 'sepsis-associated', 'aki', 'receiving', 'crrt', '.', 'also', 'compared', 'patient', 'survival', 'according', 'to', 'achieved', 'volume', 'accumulation', 'rate', '(', 'cumulative', 'fluid', 'balance', 'day', 'fluid', 'overload', 'measured', 'bia', 'enrollment', ')', 'post-hoc', 'analysis', '.', 'randomly', 'assigned', 'patient', 'to', 'conventional', 'volume', 'control', 'strategy', '(', 'n', ')', 'or', 'to', 'bia-guided', 'volume', 'control', 'strategy', '(', 'n', ')', '.', 'no', 'difference', 'in', '-day', 'mortality', '(', 'hr', ',', '.', 'ci', ',', '.-', '.', ')', 'or', '-day', 'mortality', '(', 'hr', ',', '.', 'ci', '.-', '.', ')', 'conventional', 'and', 'bia-guided', 'volume', 'control', 'group', '.', 'in', 'secondary', 'analysis', ',', 'achieved', 'volume', 'accumulation', 'rate', 'significantly', 'associated', 'with', 'patient', 'survival', '.', 'compared', 'with', 'achieved', 'volume', 'accumulation', 'rate', 'of', '-', ',', 'hr', '(', 'ci', ')', 'risk', 'of', '-day', 'mortality', '.', '(', '.-', '.', ')', ',', '.', '(', '.-', '.', ')', ',', 'and', '.', '(', '.-', '.', ')', 'in', 'of', '-', '-', ',', '-', ',', 'and', ',', 'respectively', '.', 'hence', ',', 'bia-guided', 'volume', 'control', 'in', 'patient', 'with', 'sepsis-associated', 'aki', 'receiving', 'crrt', 'not', 'improve', 'patient', 'outcome', '.', 'in', 'secondary', 'analysis', ',', 'achieved', 'volume', 'accumulation', 'rate', 'associated', 'with', 'patient', 'survival', '.']"
"Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.","Jens H Westhoff, Felix S Seibert, Sina Waldherr, Frederic Bauer, Burkhard Tönshoff, Alexander Fichtner, Timm H Westhoff, Jens H Westhoffet al.",2017 Jun,Eur J Pediatr,https://pubmed.ncbi.nlm.nih.gov/28409285/,No keywords found,"['whereas', 'urinary', 'calprotectin', 'and', 'kim-', 'useful', 'prediction', 'of', 'rrt', ',', 'urinary', 'ngal', 'good', 'diagnostic', 'performance', 'in', 'predicting', 'mortality', 'in', 'pediatric', 'patient', 'with', 'aki', 'of', 'heterogeneous', 'etiology', '.', 'known', 'increasing', 'evidence', 'urinary', 'biomarkers', 'like', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'valuable', 'prediction', 'of', 'adverse', 'outcome', 'in', 'adult', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'whereas', 'data', 'pediatric', 'aki', 'scarce', '.', 'new', 'urinary', 'calprotectin', 'and', 'kim-', 'not', 'predict', 'mortality', 'in', 'heterogeneous', 'pediatric', 'aki', 'cohort', ',', 'show', 'moderate', 'performance', 'in', 'prediction', 'of', 'dialysis', '.', 'urinary', 'ngal', 'good', 'predictor', 'of', 'mortality', 'performing', 'better', 'prifle', 'stage', ',', 'egfr', ',', 'or', 'creatinine', ',', 'show', 'moderate', 'performance', 'in', 'prediction', 'of', 'dialysis', '.']"
"Remote Ischemic Preconditioning Prevents Postoperative Acute Kidney Injury After Open Total Aortic Arch Replacement: A Double-Blind, Randomized, Sham-Controlled Trial.","Hui Zhou, Lijing Yang, Guyan Wang, Congya Zhang, Zhongrong Fang, Guiyu Lei, Sheng Shi, Jun Li, Hui Zhouet al.",2019 Jul,Anesth Analg,https://pubmed.ncbi.nlm.nih.gov/30896603/,No keywords found,"['acute', 'kidney', 'injury', 'common', 'complication', 'open', 'total', 'aortic', 'arch', 'replacement', 'lack', 'effective', 'preventive', 'strategy', '.', 'remote', 'ischemic', 'preconditioning', 'controversial', 'result', 'of', 'benefit', 'to', 'kidney', 'and', 'may', 'perform', 'better', 'in', 'high-risk', 'patient', 'of', 'acute', 'kidney', 'injury', '.', 'investigated', 'whether', 'remote', 'ischemic', 'preconditioning', 'would', 'prevent', 'postoperative', 'acute', 'kidney', 'injury', 'open', 'total', 'aortic', 'arch', 'replacement', '.', 'method', 'enrolled', 'patient', 'scheduled', 'open', 'total', 'aortic', 'arch', 'replacement', 'and', 'randomized', 'to', 'receive', 'either', 'remote', 'ischemic', 'preconditioning', '(', 'cycle', 'of', '-minute', 'right', 'upper', 'limb', 'ischemia', 'and', '-minute', 'reperfusion', ')', 'or', 'sham', 'preconditioning', '(', 'cycle', 'of', '-minute', 'right', 'upper', 'limb', 'pseudo', 'ischemia', 'and', '-minute', 'reperfusion', ')', ',', 'via', 'blood', 'pressure', 'cuff', 'inflation', 'and', 'deflation', '.', 'primary', 'end', 'point', 'incidence', 'of', 'acute', 'kidney', 'injury', 'within', 'day', 'surgery', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', 'criterion', '.', 'secondary', 'end', 'point', 'included', 'short-term', 'clinical', 'outcome', '.', 'result', 'significantly', 'fewer', 'patient', 'developed', 'postoperative', 'acute', 'kidney', 'injury', 'with', 'remote', 'ischemic', 'preconditioning', 'compared', 'with', 'sham', '(', '.', 'v', '.', 'absolute', 'risk', 'reduction', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'remote', 'ischemic', 'preconditioning', 'significantly', 'reduced', 'acute', 'kidney', 'injury', 'stage', 'ii-iii', '(', '.', 'v', '.', 'p', '.', ')', '.', 'remote', 'ischemic', 'preconditioning', 'shortened', 'mechanical', 'ventilation', 'duration', '(', 'hour', 'interquartile', 'range', ',', '-', 'versus', 'hour', 'interquartile', 'range', ',', '-', 'p', '.', ')', ',', 'whereas', 'no', 'significant', 'difference', 'observed', 'group', 'in', 'secondary', 'outcome', '.', 'conclusion', 'remote', 'ischemic', 'preconditioning', 'prevented', 'acute', 'kidney', 'injury', 'open', 'total', 'aortic', 'arch', 'replacement', ',', 'especially', 'severe', 'acute', 'kidney', 'injury', 'and', 'shortened', 'mechanical', 'ventilation', 'duration', '.', 'observed', 'renoprotective', 'effect', 'of', 'remote', 'ischemic', 'preconditioning', 'require', 'investigation', 'in', 'clinical', 'research', 'and', 'underlying', 'mechanism', '.']"
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit.,"François Lamontagne, Marie-Hélène Masse, Julie Menard, Sheila Sprague, Ruxandra Pinto, Daren K Heyland, Deborah J Cook, Marie-Claude Battista, Andrew G Day, Gordon H Guyatt, Salmaan Kanji, Rachael Parke, Shay P McGuinness, Bharath-Kumar Tirupakuzhi Vijayaraghavan, Djillali Annane, Dian Cohen, Yaseen M Arabi, Brigitte Bolduc, Nicole Marinoff, Bram Rochwerg, Tina Millen, Maureen O Meade, Lori Hand, Irene Watpool, Rebecca Porteous, Paul J Young, Frederick D'Aragon, Emilie P Belley-Cote, Elaine Carbonneau, France Clarke, David M Maslove, Miranda Hunt, Michaël Chassé, Martine Lebrasseur, François Lauzier, Sangeeta Mehta, Hector Quiroz-Martinez, Oleksa G Rewa, Emmanuel Charbonney, Andrew J E Seely, Demetrios J Kutsogiannis, Remi LeBlanc, Armand Mekontso-Dessap, Tina S Mele, Alexis F Turgeon, Gordon Wood, Sandeep S Kohli, Jason Shahin, Pawel Twardowski, Neill K J Adhikari                              ;, LOVIT Investigators and the Canadian Critical Care Trials Group, François Lamontagneet al.",2022 Jun 23,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/35704292/,No keywords found,"['study', 'evaluated', 'use', 'of', 'intravenous', 'vitamin', 'c', 'in', 'adult', 'with', 'sepsis', 'receiving', 'vasopressor', 'therapy', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'shown', 'mixed', 'result', 'with', 'respect', 'to', 'risk', 'of', 'death', 'and', 'organ', 'dysfunction', '.', 'method', 'in', 'randomized', ',', 'placebo-controlled', 'trial', ',', 'assigned', 'adult', 'in', 'icu', 'no', 'longer', 'hour', ',', 'proven', 'or', 'suspected', 'infection', 'main', 'diagnosis', ',', 'and', 'receiving', 'vasopressor', 'to', 'receive', 'infusion', 'of', 'either', 'vitamin', 'c', '(', 'dose', 'of', 'mg', 'per', 'kilogram', 'of', 'body', 'weight', ')', 'or', 'matched', 'placebo', 'administered', 'every', 'hour', 'to', 'hour', '.', 'primary', 'outcome', 'composite', 'of', 'death', 'or', 'persistent', 'organ', 'dysfunction', '(', 'defined', 'use', 'of', 'vasopressor', ',', 'invasive', 'mechanical', 'ventilation', ',', 'or', 'new', 'renal-replacement', 'therapy', ')', 'day', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', '(', 'to', 'vitamin', 'c', 'group', 'and', 'to', 'control', 'group', ')', '.', 'primary', 'outcome', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'vitamin', 'c', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'control', 'group', '(', 'risk', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'day', ',', 'death', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'vitamin', 'c', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'risk', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', 'and', 'persistent', 'organ', 'dysfunction', 'in', 'of', 'patient', '(', '.', ')', 'and', 'of', 'patient', '(', '.', ')', ',', 'respectively', '(', 'risk', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'finding', 'similar', 'in', 'two', 'group', 'regarding', 'organ-dysfunction', 'score', ',', 'biomarkers', ',', '-month', 'survival', ',', 'health-related', 'quality', 'of', 'life', ',', 'stage', 'acute', 'kidney', 'injury', ',', 'and', 'hypoglycemic', 'episode', '.', 'in', 'vitamin', 'c', 'group', ',', 'one', 'patient', 'severe', 'hypoglycemic', 'episode', 'and', 'another', 'serious', 'anaphylaxis', 'event', '.', 'conclusion', 'in', 'adult', 'with', 'sepsis', 'receiving', 'vasopressor', 'therapy', 'in', 'icu', ',', 'received', 'intravenous', 'vitamin', 'c', 'higher', 'risk', 'of', 'death', 'or', 'persistent', 'organ', 'dysfunction', 'day', 'received', 'placebo', '.', '(', 'funded', 'lotte', 'and', 'john', 'hecht', 'memorial', 'foundation', 'lovit', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Development and internal validation of a prediction model for acute kidney injury following cardiac valve replacement surgery.,"Ling Pan, Yang Deng, Shichen Dai, Xu Feng, Li Feng, Zhenhua Yang, Yunhua Liao, Baoshi Zheng, Ling Panet al.",2023 Jan 1:370:345-350.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/36306946/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'cardiac', 'surgery', '.', 'study', 'aim', 'to', 'develop', 'and', 'validate', 'risk', 'model', 'predicting', 'aki', 'cardiac', 'valve', 'replacement', 'surgery', '.', 'method', 'data', 'patient', 'undergoing', 'surgical', 'valve', 'replacement', 'january', 'and', 'december', 'in', 'hospital', 'retrospectively', 'analyzed', '.', 'subject', 'randomly', 'divided', 'derivation', 'cohort', 'and', 'validation', 'cohort', 'ratio', 'of', '.', 'primary', 'outcome', 'defined', 'aki', 'within', 'day', 'surgery', '.', 'logistic', 'regression', 'analysis', 'conducted', 'to', 'select', 'risk', 'predictor', 'developing', 'prediction', 'model', '.', 'receiver', 'operator', 'characteristic', 'curve', '(', 'roc', ')', ',', 'calibration', 'plot', 'and', 'clinical', 'decision', 'curve', 'analysis', '(', 'dca', ')', 'used', 'to', 'evaluate', 'discrimination', ',', 'precision', 'and', 'clinical', 'benefit', 'of', 'prediction', 'model', '.', 'result', 'total', 'of', 'patient', 'involved', 'in', 'study', '.', 'prevalence', 'of', 'aki', 'following', 'surgery', '.', '(', ')', '.', 'logistic', 'regression', 'analysis', 'showed', 'age', ',', 'hemoglobin', ',', 'fibrinogen', ',', 'serum', 'uric', 'acid', ',', 'cystatin', 'c', ',', 'bicarbonate', ',', 'and', 'cardiopulmonary', 'bypass', 'time', 'independent', 'risk', 'factor', 'associated', 'with', 'aki', 'surgical', 'valve', 'replacement', '(', 'p', '.', ')', '.', 'area', 'roc', 'curve', '(', 'auc', ')', 'in', 'derivation', 'cohort', 'and', 'validation', 'cohort', '.', '(', 'ci', '.-', '.', ')', 'and', '.', '(', 'ci', '.-', '.', ')', ',', 'respectively', '.', 'calibration', 'plot', 'indicated', 'excellent', 'consistency', 'prediction', 'probability', 'and', 'actual', 'probability', '.', 'dca', 'demonstrated', 'great', 'clinical', 'benefit', 'of', 'prediction', 'model', '.', 'conclusion', 'developed', 'prediction', 'model', 'predicting', 'aki', 'cardiac', 'valve', 'replacement', 'surgery', 'internally', 'validated', 'to', 'good', 'discrimination', ',', 'calibration', ',', 'and', 'clinical', 'practicability', '.']"
Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome.,"Eric P Schmidt, Katherine H Overdier, Xiaojun Sun, Lei Lin, Xinyue Liu, Yimu Yang, Lee Anne Ammons, Terra D Hiller, Matt A Suflita, Yanlei Yu, Yin Chen, Fuming Zhang, Clay Cothren Burlew, Charles L Edelstein, Ivor S Douglas, Robert J Linhardt, Eric P Schmidtet al.",2016 Aug 15,Am J Respir Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/26926297/,No keywords found,"['degradation', 'of', 'endothelial', 'glycocalyx', ',', 'glycosaminoglycan', '(', 'gag', ')', '-rich', 'layer', 'lining', 'vascular', 'lumen', ',', 'associated', 'with', 'onset', 'of', 'kidney', 'injury', 'in', 'animal', 'model', 'of', 'critical', 'illness', '.', 'unclear', 'similar', 'pathogenic', 'degradation', 'occurs', 'in', 'critically', 'ill', 'patient', '.', 'objective', 'to', 'determine', 'urinary', 'index', 'of', 'gag', 'fragmentation', 'associated', 'with', 'outcome', 'in', 'patient', 'with', 'critical', 'illness', 'septic', 'shock', 'or', 'acute', 'respiratory', 'distress', 'syndrome', '(', 'ards', ')', '.', 'method', 'prospectively', 'collected', 'urine', 'patient', 'within', 'hour', 'of', 'admission', 'to', 'denver', 'health', 'medical', 'intensive', 'care', 'unit', '(', 'icu', ')', 'septic', 'shock', '.', 'nonseptic', 'icu', 'control', ',', 'collected', 'urine', 'surgical', 'icu', 'patient', 'admitted', 'trauma', '.', 'medical', 'icu', 'validation', 'cohort', ',', 'obtained', 'serially', 'collected', 'urine', 'sample', 'patient', 'with', 'ards', '.', 'performed', 'mass', 'spectrometry', 'urine', 'sample', 'to', 'determine', 'gag', '(', 'heparan', 'sulfate', ',', 'chondroitin', 'sulfate', ',', 'and', 'hyaluronic', 'acid', ')', 'concentration', 'well', 'pattern', 'of', 'heparan', 'sulfatechondroitin', 'sulfate', 'disaccharide', 'sulfation', '.', 'compared', 'index', 'to', 'measurement', 'obtained', 'using', 'dimethylmethylene', 'blue', ',', 'inexpensive', ',', 'colorimetric', 'urinary', 'assay', 'of', 'sulfated', 'gag', '.', 'measurement', 'and', 'main', 'result', 'in', 'septic', 'shock', ',', 'index', 'of', 'gag', 'fragmentation', 'correlated', 'with', 'development', 'of', 'renal', 'dysfunction', 'hour', 'urine', 'collection', 'and', 'with', 'hospital', 'mortality', '.', 'association', 'remained', 'controlling', 'severity', 'of', 'illness', 'and', 'similarly', 'observed', 'using', 'inexpensive', 'dimethylmethylene', 'blue', 'assay', '.', 'predictive', 'finding', 'corroborated', 'using', 'urine', 'sample', 'previously', 'collected', 'three', 'consecutive', 'time', 'point', 'patient', 'with', 'ards', '.', 'conclusion', 'early', 'index', 'of', 'urinary', 'gag', 'fragmentation', 'predict', 'acute', 'kidney', 'injury', 'and', 'in-hospital', 'mortality', 'in', 'patient', 'with', 'septic', 'shock', 'or', 'ards', '.', 'clinical', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', '(', 'nct', ')', '.']"
Effect of Dexmedetomidine on Postoperative Renal Function in Patients Undergoing Cardiac Valve Surgery Under Cardiopulmonary Bypass: A Randomized Clinical Trial.,"Yong-Qiang Qiu, Lv-Ping Zhuang, Pei-Yuan Wu, Li-Ying Zhong, Xiao-Hui Zhong, Bin Chen, Zhong-Kai Liu, Hui-Rong Luo, Li-Ping Yang, Yong-Qiang Qiuet al.",2023 Aug,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/37179127/,No keywords found,"['effect', 'of', 'dexmedetomidine', 'postoperative', 'renal', 'function', 'investigated', 'in', 'patient', 'undergoing', 'cardiac', 'valve', 'surgery', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'design', 'randomized', 'controlled', 'trial', '.', 'setting', 'university', 'teaching', ',', 'grade', 'tertiary', 'hospital', '.', 'participant', 'total', 'of', 'patient', 'scheduled', 'to', 'undergo', 'cardiac', 'valve', 'replacement', 'or', 'valvuloplasty', 'cpb', 'eligible', 'and', 'randomly', 'divided', 'group', '(', 'n', ')', 'and', 'c', '(', 'n', ')', 'january', 'and', 'march', '.', 'intervention', 'patient', 'in', 'group', 'administered', '.', 'gkgh', 'of', 'dexmedetomidine', 'intravenously', 'minute', 'anesthesia', 'induction', 'to', 'hour', 'surgery', 'normal', 'saline', 'used', 'instead', 'of', 'dexmedetomidine', 'in', 'group', 'c.', 'measurement', 'and', 'main', 'result', 'primary', 'outcome', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'acute', 'kidney', 'injury', 'defined', 'according', 'to', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', ')', '.', '.', 'and', '.', 'in', 'group', 'and', 'c', ',', 'respectively', '(', 'p', '.', ')', '.', 'secondary', 'outcome', 'intraoperative', 'hemodynamics', 'and', 'various', 'index', 'in', 'serum', '.', 'ten', 'minute', 'cpb', '(', ')', ',', 'minute', 'cpb', '(', ')', ',', 'and', 'minute', 'cpb', '(', ')', ',', 'mean', 'arterial', 'pressure', 'in', 'group', 'lower', 'in', 'group', 'c', ',', 'with', 'statistical', 'significance', '(', '.', '.', 'v', '.', '.', 'mmhg', ',', 'p.', '.', '.', 'v', '.', '.', 'mmhg', ',', 'p', '.', '.', '.', 'v', '.', '.', 'mmhg', ',', 'p', '.', ')', '.', ',', 'heart', 'rate', 'in', 'group', 'significantly', 'lower', 'in', 'group', 'c', '(', '.', '.', 'v', '.', '.', 'bpm', ',', 'p.', ')', '.', 'tumor', 'necrosis', 'factor', ',', 'interleukin-', ',', 'c-reactive', 'protein', ',', 'and', 'cystatin', 'c', 'level', 'in', 'group', 'lower', 'in', 'group', 'c', 'surgery', '(', ')', 'and', 'hour', 'surgery', '(', ')', ',', 'with', 'statistical', 'significance', '.', 'duration', 'of', 'mechanical', 'ventilation', ',', 'intensive-care-unit', 'stay', 'time', ',', 'and', 'hospital', 'stay', 'time', 'in', 'group', 'significantly', 'shorter', 'in', 'group', 'c.', 'incidence', 'of', 'tachycardia', ',', 'hypertension', ',', 'nausea', ',', 'and', 'vomiting', 'in', 'group', 'similar', 'to', 'in', 'group', 'c.', 'conclusion', 'dexmedetomidine', 'may', 'considered', 'way', 'to', 'reduce', 'incidence', 'and', 'severity', 'of', 'postoperative', 'aki', 'in', 'patient', 'undergoing', 'cardiac', 'valve', 'surgery', 'cardiopulmonary', 'bypass', '.']"
Efficacy of continuous renal replacement on acute renal injury developed in severe sepsis.,"Y Zhang, D R Shao, Z P He, X X Ma, C J Shi, Y Zhanget al.",2019 Mar-Apr,J Biol Regul Homeost Agents,https://pubmed.ncbi.nlm.nih.gov/30973001/,"acute kidney injury, continuous renal replacement therapy, inflammatory response, severe sepsis.","['sepsis', 'systemic', 'inflammatory', 'response', 'develop', 'severe', 'sepsis', '(', 'septic', 'shock', ')', ',', 'eventually', 'lead', 'to', 'multiple', 'organ', 'dysfunction', 'syndrome', '(', 'mod', ')', '.', 'study', 'aimed', 'to', 'assess', 'effect', 'of', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'acute', 'renal', 'injury', 'caused', 'severe', 'sepsis', 'monitoring', 'biochemical', 'parameter', '.', 'total', 'of', 'patient', 'with', 'septic', 'shock', 'and', 'acute', 'kidney', 'injury', 'included', '.', 'control', 'group', '(', 'case', ')', 'treated', 'with', 'routine', 'treatment', 'and', 'intermittent', 'renal', 'replacement', 'therapy', '(', 'irrt', ')', '.', 'experimental', 'group', '(', 'case', ')', 'treated', 'with', 'routine', 'treatment', 'and', 'continuous', 'renal', 'replacement', 'therapy', 'crrt', '.', 'change', 'in', 'inflammation', 'and', 'biochemical', 'index', 'and', 'apache-', 'ii', 'score', 'evaluated', 'treatment', 'and', ',', ',', 'and', 'day', 'treatment', '.', 'inflammatory', 'marker', '(', 'neutrophil', 'percentage', ',', 'c-reactive', 'protein', '(', 'crp', ')', 'and', 'procalcitonin', '(', 'pct', ')', 'level', ')', 'in', 'experimental', 'group', 'decreased', 'significantly', 'treatment', '.', 'in', 'control', 'group', ',', 'index', 'of', 'inflammation', 'still', 'increased', 'one', 'day', 'treatment', 'and', 'decreased', 'day', 'of', 'treatment', '.', 'treatment', ',', 'blood', 'lactate', ',', 'serum', 'creatinine', 'and', 'urea', 'nitrogen', 'level', 'decreased', ',', 'urine', 'volume', 'increased', '.', 'treatment', ',', 'vasoactive', 'dose', 'in', 'experimental', 'group', 'significantly', 'lower', 'of', 'control', 'group', '(', 'p', 'less', '.', ')', '.', 'crrt', 'good', 'treatment', 'septic', 'shock-related', 'acute', 'kidney', 'injury', ',', 'improves', 'biochemical', 'indicator', 'and', 'protects', 'kidney', 'function', '.']"
Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.,"T P Menting, T B Sterenborg, Y de Waal, R Donders, K E Wever, M S Lemson, J A van der Vliet, J F Wetzels, L J SchultzeKool, M C Warlé, T P Mentinget al.",2015 Oct,Eur J Vasc Endovasc Surg,https://pubmed.ncbi.nlm.nih.gov/26015372/,No keywords found,"['despite', 'increasing', 'use', 'of', 'pre-', 'and', 'post-hydration', 'protocol', 'and', 'low', 'osmolar', 'instead', 'of', 'high', 'osmolar', 'iodine', 'containing', 'contrast', 'medium', ',', 'incidence', 'of', 'contrast', 'induced', 'nephropathy', '(', 'cin', ')', 'still', 'significant', '.', 'evidence', 'contrast', 'medium', 'cause', 'ischemia', 'reperfusion', 'injury', 'of', 'renal', 'medulla', '.', 'remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'non-invasive', ',', 'safe', ',', 'and', 'low', 'cost', 'method', 'to', 'reduce', 'ischemia', 'reperfusion', 'injury', '.', 'aim', 'of', 'study', 'to', 'investigate', 'whether', 'ripc', ',', 'adjunct', 'to', 'standard', 'preventive', 'measure', ',', 'reduces', 'contrast', 'induced', 'acute', 'kidney', 'injury', 'in', 'patient', 'risk', 'of', 'cin', '.', 'method', 'ripcin', 'study', 'multicenter', ',', 'single', 'blinded', ',', 'randomized', 'controlled', 'trial', 'in', 'patient', 'risk', 'of', 'cin', 'received', 'standard', 'hydration', 'combined', 'with', 'ripc', 'or', 'hydration', 'with', 'sham', 'preconditioning', '.', 'ripc', 'applied', 'four', 'cycle', 'of', 'min', 'ischemia', 'and', 'min', 'reperfusion', 'of', 'forearm', '.', 'primary', 'outcome', 'measure', 'change', 'in', 'serum', 'creatinine', 'baseline', 'to', 'to', 'hour', 'contrast', 'administration', '.', 'result', 'with', 'regard', 'to', 'primary', 'endpoint', ',', 'no', 'significant', 'effect', 'of', 'ripc', 'found', '.', 'cin', 'occurred', 'in', 'four', 'patient', '(', 'sham', 'and', 'ripc', ')', '.', 'pre-defined', 'subgroup', 'analysis', 'of', 'patient', 'with', 'mehran', 'risk', 'score', ',', 'showed', 'significantly', 'reduced', 'change', 'in', 'serum', 'creatinine', 'baseline', 'to', 'to', 'hour', 'in', 'patient', 'allocated', 'to', 'ripc', 'group', '(', 'creatinine', '-', '.', '.', 'moll', ')', 'compared', 'with', 'sham', 'group', '(', 'creatinine', '.', '.', 'moll', ')', '.', 'conclusion', 'ripc', ',', 'adjunct', 'to', 'standard', 'preventive', 'measure', ',', 'not', 'improve', 'serum', 'creatinine', 'level', 'contrast', 'administration', 'in', 'patient', 'risk', 'of', 'cin', 'according', 'to', 'dutch', 'guideline', '.', 'however', ',', 'present', 'data', 'indicate', 'ripc', 'might', 'beneficial', 'effect', 'in', 'patient', 'high', 'or', 'high', 'risk', 'of', 'cin', '(', 'mehran', 'score', ')', '.', 'ripcin', 'study', 'registered', 'httpwww.controlled-trials.comisrctn', '.']"
Preoperative serum ST2 level predicts acute kidney injury after adult cardiac surgery.,"Kevin W Lobdell, Devin M Parker, Donald S Likosky, Michael Rezaee, Moritz Wyler von Ballmoos, Shama S Alam, Sherry Owens, Heather Thiessen-Philbrook, Todd MacKenzie, Jeremiah R Brown, Kevin W Lobdellet al.",2018 Sep,J Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/29759735/,No keywords found,"['purpose', 'of', 'study', 'to', 'evaluate', 'relationship', 'preoperative', 'level', 'of', 'serum', 'soluble', 'st', '(', 'st', ')', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', '.', 'previous', 'research', 'shown', 'biomarkers', 'facilitate', 'prediction', 'of', 'aki', 'and', 'complication', 'cardiac', 'surgery', '.', 'method', 'preoperative', 'st', 'protein', 'measured', 'in', 'patient', 'undergoing', 'isolated', 'coronary', 'artery', 'bypass', 'graft', 'surgery', 'hospital', 'participating', 'in', 'northern', 'new', 'england', 'biomarker', 'study', 'to', '.', 'aki', 'severity', 'defined', 'using', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'definition', '.', 'preoperative', 'st', 'level', 'measured', 'using', 'multiplex', 'assay', '.', 'ordered', 'logistic', 'regression', 'used', 'to', 'examine', 'relationship', 'st', 'level', 'and', 'level', 'of', 'aki', 'severity', '.', 'result', 'participant', 'in', 'study', 'showed', 'significant', 'association', 'elevated', 'preoperative', 'st', 'level', 'and', 'acute', 'kidney', 'risk', '.', 'adjustment', ',', 'odds', 'of', 'patient', 'developing', 'akin', 'stage', 'or', ',', 'compared', 'with', 'akin', 'stage', ',', '.', 'time', 'higher', '(', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', 'patient', 'in', 'highest', 'tercile', 'of', 'preoperative', 'st.', 'adjustment', ',', 'patient', 'in', 'highest', 'tercile', 'of', 'preoperative', 'st', 'significantly', 'greater', 'odds', 'of', 'developing', 'akin', 'stage', 'or', 'aki', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', 'compared', 'with', 'patient', 'with', 'akin', 'stage', '.', 'conclusion', 'preoperative', 'st', 'level', 'associated', 'with', 'postoperative', 'aki', 'risk', 'and', 'used', 'to', 'identify', 'patient', 'higher', 'risk', 'of', 'developing', 'aki', 'cardiac', 'surgery', '.']"
Dexmedetomidine mitigates acute kidney injury after coronary artery bypass grafting: a prospective clinical trial.,"Congli Zhang, Yang Zhang, Di Liu, Mei Mei, Nannan Song, Qin Zhuang, Yiyao Jiang, Yuanyuan Guo, Gang Liu, Xiaohong Li, Li Ren, Congli Zhanget al.",2024 Aug,Rev Esp Cardiol (Engl Ed),https://pubmed.ncbi.nlm.nih.gov/38423177/,No keywords found,"['to', 'evaluate', 'impact', 'of', 'dexmedetomidine', 'impact', 'cardiac', 'surgery-associated', 'acute', 'kidney', 'injury', '(', 'csa-aki', ')', ',', 'kidney', 'function', ',', 'and', 'metabolic', 'and', 'oxidative', 'stress', 'in', 'patient', 'undergoing', 'coronary', 'artery', 'bypass', 'grafting', 'with', 'heart-lung', 'machine', 'support', '.', 'method', 'randomized', 'double-masked', 'trial', 'with', 'participant', '(', '-', 'year', ')', 'undergoing', 'coronary', 'artery', 'bypass', 'grafting', 'conducted', 'january', 'to', 'december', '.', 'participant', 'divided', 'dex', '(', 'n', ')', 'and', 'n', '(', 'n', ')', 'group', '.', 'dex', 'administered', '.', 'mcgkg', 'minute', ',', '.', 'mcgkgh', 'end', 'of', 'surgery', 'n', 'group', 'received', 'equivalent', 'saline', '.', 'blood', 'and', 'urine', 'sampled', 'various', 'time', 'point', 'pre-', 'and', 'postsurgery', '.', 'primary', 'outcome', 'measure', 'incidence', 'of', 'csa-aki', ',', 'defined', 'occurrence', 'of', 'aki', 'within', 'hour', 'surgery', '.', 'result', 'incidence', 'of', 'csa-aki', 'significantly', 'lower', 'in', 'dex', 'group', 'in', 'n', 'group', '(', '.', 'v', '.', 'p.', ')', '.', 'substantial', 'increase', 'found', 'in', 'estimated', 'glomerular', 'filtration', 'rate', 'value', 't-t', '(', 'p.', ')', 'and', 'urine', 'volume', 'hour', 'surgery', '(', 'p.', ')', '.', 'marked', 'decrease', 'found', 'in', 'serum', 'creatinine', 'level', ',', 'blood', 'glucose', 'level', 't-t', '(', 'p.', ')', ',', 'blood', 'urea', 'nitrogen', 'level', 't-t', '(', 'p.', ')', ',', 'free', 'fatty', 'acid', 'level', 't-t', '(', 'p.', ')', ',', 'and', 'lactate', 'level', 't-t', '(', 'p.', ')', '.', 'conclusion', 'dex', 'reduces', 'csa-aki', ',', 'potentially', 'regulating', 'metabolic', 'disorder', 'and', 'reducing', 'oxidative', 'stress', '.', 'registered', 'with', 'chinese', 'clinical', 'study', 'registry', '(', 'no', '.', 'chictr', ')', '.']"
Prognostic significance of malnutrition risk in elderly patients with acute kidney injury in the intensive care unit.,"Na Wang#, Ping Wang#, Wen Li, Li Jiang, Meiping Wang, Bo Zhu, Xiuming Xi, Na Wanget al.",2022 Oct 18,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/36258183/,No keywords found,"['malnutrition', 'common', 'in', 'critically', 'ill', 'patient', ',', 'nutrition', 'status', 'in', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'poorly', 'studied', '.', 'study', 'aimed', 'to', 'investigate', 'relationship', 'malnutrition', 'risk', 'and', 'occurrence', 'and', 'prognosis', 'of', 'aki', 'in', 'elderly', 'patient', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'method', 'data', 'extracted', 'beijing', 'acute', 'kidney', 'injury', 'trial', '(', 'bakit', ')', '.', 'total', 'of', 'elderly', 'patient', 'included', 'and', 'compared', 'according', 'to', 'clinical', 'characteristic', 'of', 'aki', 'and', 'non-aki', 'group', ',', 'and', 'of', 'survivor', 'and', 'non-survivors', 'of', 'aki', 'in', 'study', '.', 'receiver', 'operating', 'characteristic', '(', 'roc', ')', 'curve', 'used', 'to', 'analyse', 'predictive', 'value', 'of', 'modified', 'nutrition', 'risk', 'in', 'critically', 'ill', '(', 'mnutric', ')', 'score', 'occurrence', 'and', '-day', 'prognosis', 'of', 'aki', '.', 'multivariate', 'cox', 'regression', 'analysis', 'used', 'to', 'evaluate', 'effect', 'of', 'mnutric', 'score', '-day', 'mortality', 'in', 'aki', 'patient', '.', 'result', 'compared', 'with', 'non-aki', 'group', ',', 'aki', 'patient', 'higher', 'mnutric', 'score', ',', 'and', 'non-survivors', 'higher', 'mnutric', 'score', 'survivor', 'in', 'aki', 'population', '.', 'moreover', ',', 'multivariate', 'cox', 'regression', 'showed', '-day', 'mortality', 'in', 'aki', 'patient', 'increased', '.', '(', 'ci', ',', '.-', '.', ')', 'every', 'point', 'increase', 'in', 'mnutric', 'score', ',', 'and', 'mnutric', 'score', 'good', 'predictive', 'ability', 'occurrence', 'of', 'aki', 'and', '-day', 'mortality', 'in', 'aki', 'patient', '.', 'mortality', 'of', 'aki', 'patient', 'with', 'mnutric', 'significantly', 'increased', '.', 'conclusion', 'elderly', 'patient', 'high', 'risk', 'of', 'malnutrition', ',', 'affect', 'occurrence', 'and', 'prognosis', 'of', 'aki', '.', 'adequate', 'attention', 'given', 'to', 'nutritional', 'status', 'of', 'elderly', 'patient', '.', 'trial', 'registration', 'study', 'registered', 'www.chictr.org.cn', '(', 'registration', 'number', 'chi', 'ctr-onc-', ')', 'december', '.']"
Early high-dose continuous veno-venous hemofiltration alleviates the alterations of CD4+ T lymphocyte subsets in septic patients combined with acute kidney injury.,"Beibei Jin, Da Cao, Ning Yang, Ling Wang, Ruifang Li, Xiumei Liu, Ping Gong, Beibei Jinet al.",2022 Jul,Artif Organs,https://pubmed.ncbi.nlm.nih.gov/35132659/,No keywords found,"['study', 'aim', 'to', 'determine', 'whether', 'early', 'high-dose', 'continuous', 'venous-venous', 'hemofiltration', '(', 'cvvh', ')', 'alleviates', 'alteration', 'in', 'cd', 'lymphocyte', 'subset', 'in', 'septic', 'patient', 'combined', 'with', 'acute', 'kidney', 'injury', '.', 'method', 'enrolled', 'septic', 'patient', 'combined', 'with', 'acute', 'kidney', 'injury', 'randomized', 'cvvh', '(', 'n', ')', 'and', 'conventional', 'treatment', '(', 'non-cvvh', ',', 'n', ')', 'group', '.', 'healthy', 'volunteer', '(', 'n', ')', 'enrolled', '.', 'cvvh', 'initiated', 'within', 'h', 'of', 'intensive', 'care', 'unit', '(', 'icu', ')', 'admission', 'with', 'dos', 'of', 'mlkgh', 'and', 'maintained', 'least', 'h.', 'th', ',', 'th', ',', 'th', ',', 'and', 'treg', 'measured', 'flow', 'cytometry', 'day', ',', ',', 'and', 'of', 'icu', 'admission', '.', 'sequential', 'organ', 'failure', 'assessment', '(', 'sofa', ')', 'score', 'calculated', '.', 'result', 'th', 'percentage', 'and', 'thth', 'ratio', 'lower', ',', 'and', 'th', ',', 'th', ',', 'and', 'treg', 'percentage', 'and', 'thtreg', 'ratio', 'higher', 'in', 'septic', 'patient', 'compared', 'to', 'healthy', 'volunteer', '.', 'cvvh', 'significantly', 'increased', 'th', 'percentage', 'and', 'thth', 'ratio', ',', 'and', 'significantly', 'decreased', 'th', ',', 'th', ',', 'and', 'treg', 'percentage', 'and', 'thtreg', 'ratio', 'compared', 'to', 'non-cvvh', '.', 'th', 'percentage', 'and', 'thth', 'ratio', 'negatively', 'correlated', 'with', 'sofa', 'score', ',', 'th', ',', 'th', ',', 'and', 'treg', 'percentage', 'and', 'thtreg', 'ratio', 'positively', 'correlated', 'with', 'sofa', 'score', '.', 'patient', 'with', 'cvvh', 'significantly', 'lower', 'sofa', 'score', 'day', 'of', 'icu', 'admission', 'and', 'shorter', 'icu', 'stay', 'compared', 'to', 'with', 'non-cvvh', '.', 'conclusion', 'septic', 'patient', 'combined', 'with', 'acute', 'kidney', 'injury', 'exhibit', 'different', 'alteration', 'of', 'cd', 'lymphocyte', 'subset', '.', 'early', 'high-dose', 'cvvh', 'alleviates', 'alteration', ',', 'may', 'one', 'of', 'factor', 'associated', 'with', 'improved', 'sepsis', 'severity', '.']"
"Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting).","Nicolas Meneveau, Geraud Souteyrand, Pascal Motreff, Christophe Caussin, Nicolas Amabile, Patrick Ohlmann, Olivier Morel, Yoann Lefrançois, Vincent Descotes-Genon, Johanne Silvain, Nassim Braik, Romain Chopard, Marion Chatot, Fiona Ecarnot, Hélène Tauzin, Eric Van Belle, Loïc Belle, François Schiele, Nicolas Meneveauet al.",2016 Sep 27,Circulation,https://pubmed.ncbi.nlm.nih.gov/27573032/,No keywords found,"['no', 'randomized', 'study', 'investigated', 'value', 'of', 'optical', 'coherence', 'tomography', '(', 'oct', ')', 'in', 'optimizing', 'result', 'of', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'non-st-segment', 'elevation', 'acute', 'coronary', 'syndrome', '.', 'method', 'conducted', 'multicenter', ',', 'randomized', 'study', 'involving', 'patient', 'with', 'non-st-segment', 'elevation', 'acute', 'coronary', 'syndrome', 'to', 'compare', 'oct-guided', 'pci', '(', 'use', 'of', 'oct', 'pre-', 'and', 'post-pci', 'oct-guided', 'group', ')', 'to', 'fluoroscopy-guided', 'pci', '(', 'angiography-guided', 'group', ')', '.', 'primary', 'end', 'point', 'functional', 'result', 'of', 'pci', 'assessed', 'measure', 'of', 'post', 'pci', 'fractional', 'flow', 'reserve', '.', 'secondary', 'end', 'point', 'included', 'procedural', 'complication', 'and', 'type', 'periprocedural', 'myocardial', 'infarction', '.', 'safety', 'assessed', 'rate', 'of', 'acute', 'kidney', 'injury', '.', 'result', 'oct', 'use', 'led', 'to', 'change', 'in', 'procedural', 'strategy', 'in', 'of', 'patient', 'in', 'oct-guided', 'group', '.', 'primary', 'end', 'point', 'improved', 'in', 'oct-guided', 'group', ',', 'with', 'significantly', 'higher', 'fractional', 'flow', 'reserve', 'value', '(', '..', 'versus', '..', ',', 'p.', ')', 'compared', 'with', 'angiography-guided', 'group', '.', 'no', 'significant', 'difference', 'in', 'rate', 'of', 'type', 'myocardial', 'infarction', '(', 'in', 'oct-group', 'versus', 'in', 'angiography-guided', 'group', ',', 'p.', ')', '.', 'rate', 'of', 'procedural', 'complication', '(', '.', ')', 'and', 'acute', 'kidney', 'injury', '(', '.', ')', 'identical', 'in', 'group', 'despite', 'longer', 'procedure', 'time', 'and', 'use', 'of', 'contrast', 'medium', 'in', 'oct-guided', 'group', '.', 'post-pci', 'oct', 'revealed', 'stent', 'underexpansion', 'in', 'of', 'patient', ',', 'stent', 'malapposition', 'in', ',', 'incomplete', 'lesion', 'coverage', 'in', ',', 'and', 'edge', 'dissection', 'in', '..', 'led', 'to', 'frequent', 'use', 'of', 'poststent', 'overdilation', 'in', 'oct-guided', 'group', 'versus', 'angiography-guided', 'group', '(', 'versus', '.', ',', 'p.', ')', 'with', 'lower', 'residual', 'stenosis', '(', '..', 'versus', '..', ',', 'p.', ')', '.', 'conclusion', 'in', 'patient', 'with', 'non-st-segment', 'elevation', 'acute', 'coronary', 'syndrome', ',', 'oct-guided', 'pci', 'associated', 'with', 'higher', 'postprocedure', 'fractional', 'flow', 'reserve', 'pci', 'guided', 'angiography', 'alone', '.', 'oct', 'not', 'increase', 'periprocedural', 'complication', ',', 'type', 'myocardial', 'infarction', ',', 'or', 'acute', 'kidney', 'injury', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Dyschloremia Is a Risk Factor for the Development of Acute Kidney Injury in Critically Ill Patients.,"Min Shao, Guangxi Li, Kumar Sarvottam, Shengyu Wang, Charat Thongprayoon, Yue Dong, Ognjen Gajic, Kianoush Kashani, Min Shaoet al.",2016 Aug 4,PLoS One,https://pubmed.ncbi.nlm.nih.gov/27490461/,No keywords found,"['dyschloremia', 'common', 'in', 'critically', 'ill', 'patient', ',', 'although', 'impact', 'not', 'well', 'studied', '.', 'investigated', 'epidemiology', 'of', 'dyschloremia', 'and', 'association', 'with', 'incidence', 'of', 'acute', 'kidney', 'injury', 'and', 'intensive', 'care', 'unit', 'outcome', '.', 'material', 'and', 'method', 'single-center', ',', 'retrospective', 'cohort', 'study', 'mayo', 'clinic', 'hospital-rochester', '.', 'adult', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', 'january', 'st', ',', ',', 'december', 'th', ',', 'included', '.', 'patient', 'with', 'known', 'acute', 'kidney', 'injury', 'and', 'chronic', 'kidney', 'disease', 'stage', 'intensive', 'care', 'unit', 'admission', 'excluded', '.', 'evaluated', 'association', 'of', 'dyschloremia', 'with', 'icu', 'outcome', ',', 'adjustment', 'effect', 'of', 'age', ',', 'gender', ',', 'charlson', 'comorbidity', 'index', 'and', 'severity', 'of', 'illness', 'score', '.', 'result', 'total', 'of', ',', 'patient', 'enrolled', 'in', 'final', 'analysis', 'following', 'implementation', 'of', 'eligibility', 'criterion', '.', 'cohort', ',', ',', 'patient', '(', ')', 'developed', 'acute', 'kidney', 'injury', '.', 'of', 'total', 'patient', 'enrolled', ',', ',', 'baseline', 'serum', 'chloride', '.', 'in', 'group', ',', ',', '(', ')', 'hypochloremia', ',', 'and', '(', ')', 'hyperchloremic', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', 'higher', 'in', 'hypochloremic', 'and', 'hyperchloremic', 'patient', 'compared', 'to', 'with', 'normal', 'serum', 'chloride', 'level', '(', 'vs.', 'and', 'vs.', ',', 'respectively', 'p', '.', ')', '.', 'baseline', 'serum', 'chloride', 'lower', 'in', 'acute', 'kidney', 'injury', 'group', 'vs.', 'non-acute', 'kidney', 'injury', 'group', 'mmoll', '(', '-', ')', 'vs.', 'mmoll', '(', '-', ')', ',', 'p', '..', 'in', 'multivariable', 'logistic', 'regression', 'model', ',', 'baseline', 'serum', 'chloride', 'of', 'mmoll', 'found', 'to', 'independently', 'associated', 'with', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'or', '.', ',', 'ci', '.-', '.', 'p', '.', ')', '.', 'discussion', 'dyschloremia', 'common', 'in', 'critically', 'ill', 'patient', ',', 'and', 'severe', 'hypochloremia', 'independently', 'associated', 'with', 'increased', 'risk', 'of', 'development', 'of', 'acute', 'kidney', 'injury', '.']"
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.,"Edouard Soum, Jean-François Timsit, Stephane Ruckly, Didier Gruson, Emmanuel Canet, Kada Klouche, Laurent Argaud, Maïté Garrouste-Orgeas, Christophe Mariat, François Vincent, Sophie Cayot, Michael Darmon, Julien Bohé, Carole Schwebel, Lila Bouadma, Claire Dupuis, Bertrand Souweine, Alexandre Lautrette, Edouard Soumet al.",2022 Nov 29,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36447221/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'serious', 'complication', 'in', 'icu', 'result', 'in', 'increased', 'mortality', 'and', 'risk', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'study', 'suggest', 'rrt', 'modality', 'may', 'impact', 'long-term', 'renal', 'recovery', 'aki', '.', 'however', ',', 'predictive', 'factor', 'of', 'severe', 'long-term', 'ckd', 'in', 'icu', 'patient', 'with', 'aki', 'requiring', 'rrt', 'unknown', '.', 'method', 'performed', 'ancillary', 'study', 'of', 'multicenter', 'elvis', 'trial', 'in', 'population', 'with', 'aki', 'requiring', 'rrt', '.', 'patient', 'alive', 'month', 'rrt', 'initiation', 'eligible', '.', 'serum', 'creatinine', 'level', 'available', ',', 'and', 'month', 'and', 'and', 'year', 'recorded', '.', 'ckd', 'stage', 'determined', 'according', 'to', 'glomerular', 'filtration', 'rate', 'estimated', 'ckd-epi', 'formula', '.', 'timepoint', ',', 'two', 'group', 'of', 'patient', 'compared', ',', 'nomild', 'ckd', 'group', 'with', 'normal', 'or', 'mildly', 'to', 'moderately', 'decreased', 'renal', 'function', '(', 'stage', ',', 'and', 'of', 'international', 'classification', ')', 'and', 'severe', 'ckd', 'group', '(', 'stage', 'and', ')', '.', 'objective', 'to', 'identify', 'predictive', 'factor', 'of', 'severe', 'long-term', 'ckd', '.', 'result', 'of', 'eligible', 'patient', ',', 'follow-up', 'month', ',', '(', '.', ')', 'nomild', 'ckd', 'group', 'and', '(', '.', ')', 'severe', 'ckd', 'group', ',', 'and', 'patient', 'year', 'comprising', '(', '.', ')', 'nomild', 'ckd', 'group', 'and', '(', '.', ')', 'severe', 'ckd', 'group', '.', 'multivariate', 'analysis', 'showed', 'long', 'rrt', 'period', 'associated', 'with', 'severe', 'ckd', 'to', 'month', '(', 'orm', '.', 'ci', '.-', '.', 'per', 'day', ')', 'and', 'high', 'sofa', 'score', 'initiation', 'of', 'rrt', 'not', 'associated', 'with', 'severe', 'ckd', 'to', 'year', '(', 'orm', '.', 'ci', '.-', '.', 'per', 'point', ')', '.', 'conclusion', 'severe', 'long-term', 'ckd', 'found', 'in', 'of', 'icu', 'survivor', 'underwent', 'rrt', 'aki', '.', 'duration', 'of', 'rrt', 'in', 'aki', 'patient', 'identified', 'new', 'predictive', 'factor', 'severe', 'long-term', 'ckd', '.', 'finding', 'taken', 'consideration', 'in', 'future', 'study', 'prognosis', 'of', 'icu', 'patient', 'with', 'aki', 'requiring', 'rrt', '.', 'trial', 'registration', 'elvis', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '(', 'june', ',', ')', ',', 'and', 'ancillary', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '(', 'october', ',', ')', '.']"
Early negative fluid balance is associated with lower mortality after cardiovascular surgery.,"Chenglong Li, Hong Wang, Nan Liu, Ming Jia, Haitao Zhang, Xiuming Xi, Xiaotong Hou                              ;, Beijing Acute Kidney Injury Trial (BAKIT) Workgroup, Chenglong Liet al.",2018 Nov,Perfusion,https://pubmed.ncbi.nlm.nih.gov/29871564/,No keywords found,"['early', 'fluid', 'expansion', 'could', 'prevent', 'postoperative', 'organ', 'hypoperfusion', '.', 'however', ',', 'excessive', 'fluid', 'resuscitation', 'adversely', 'influence', 'multiple', 'organ', 'system', '.', 'retrospective', ',', 'observational', 'study', 'aimed', 'to', 'investigate', 'relationship', 'early', 'negative', 'fluid', 'balance', 'and', 'postoperative', 'mortality', 'in', 'critically', 'ill', 'adult', 'patient', 'following', 'cardiovascular', 'surgery', '.', 'method', 'in', 'total', ',', 'critically', 'ill', 'patient', 'undergone', 'cardiovascular', 'surgery', 'and', 'whose', 'intensive', 'care', 'unit', 'length', 'of', 'stay', '(', 'los', ')', 'hour', 'enrolled', '.', 'baseline', 'characteristic', ',', 'daily', 'fluid', 'balance', 'and', 'cumulative', 'fluid', 'balance', 'obtained', '.', 'patient', 'followed', 'discharge', 'or', 'day', '.', 'multivariate', 'logistic', 'regression', 'adjusted', 'propensity', 'score', 'used', 'to', 'analyze', 'relationship', 'early', 'negative', 'fluid', 'balance', 'and', 'postoperative', 'mortality', '.', 'result', 'overall', ',', 'postoperative', 'mortality', '.', '(', ')', '.', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', 'ii', 'admission', '(', 'odd', 'ratio', 'or', '.', ')', ',', 'acute', 'kidney', 'injury', 'stage', '(', 'or', '.', ')', 'and', 'renal', 'replacement', 'therapy', 'received', '(', 'or', '.', ')', 'independent', 'risk', 'factor', 'of', 'postoperative', 'mortality', ',', 'whereas', 'negative', 'daily', 'fluid', 'balance', 'day', '(', 'or', '.', ')', 'protective', 'factor', '.', 'patient', 'with', 'negative', 'daily', 'fluid', 'balance', 'day', 'lower', 'postoperative', 'mortality', '(', '.', 'vs.', '.', 'in', 'positive', 'fluid', 'balance', 'group', ')', ',', 'lower', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'stage', ',', 'less', 'likely', 'to', 'receive', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'and', 'experienced', 'shorter', 'hospital', 'los', 'compared', 'with', 'with', 'daily', 'positive', 'fluid', 'balance', '.', 'conclusion', 'retrospective', ',', 'observational', 'study', 'indicates', 'early', 'negative', 'fluid', 'balance', 'associated', 'with', 'lower', 'postoperative', 'mortality', 'in', 'critically', 'ill', 'patient', 'following', 'cardiovascular', 'surgery', '.', 'prospective', ',', 'randomized', 'trial', 'needed', 'to', 'prove', 'benefit', 'restrictive', 'fluid', 'management', 'strategy', '.']"
The protocol of enhanced recovery after cardiac surgery in adult patients: A stepped wedge cluster randomized trial.,"Dou Dou, Su Yuan, Yuan Jia, Yang Wang, Yinan Li, Hongbai Wang, Jie Ding, Xie Wu, Dongyun Bie, Qiao Liu, Ran An, Haoqi Yan, Fuxia Yan, Dou Douet al.",2024 Jun:272:48-55.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/38437910/,No keywords found,"['enhanced', 'recovery', 'cardiac', 'surgery', 'bundle', 'of', 'measurement', 'preoperative', 'to', 'postoperative', 'phase', 'to', 'improve', 'patient', ""'"", 'recovery', '.', 'method', 'study', 'multicenter', ',', 'stepwise', 'design', ',', 'cluster', 'randomized', 'controlled', 'trial', '.', ',', 'patient', 'presenting', 'control', 'and', 'intervention', 'period', 'eligible', 'aged', 'to', 'year', 'old', 'awaiting', 'elective', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'center', 'randomly', 'assigned', 'to', 'staggered', 'start', 'date', 'one-way', 'crossover', 'control', 'phase', 'to', 'intervention', 'phase', '.', 'in', 'intervention', 'period', ',', 'patient', 'receive', 'era', 'strategy', 'including', 'preoperative', ',', 'intraoperative', ',', 'and', 'postoperative', 'approach', '.', 'control', 'phase', ',', 'patient', 'receive', 'usual', 'care', '.', 'primary', 'outcome', 'consists', 'of', 'major', 'adverse', 'cardiac', 'and', 'cerebrovascular', 'event', '(', 'macces', ')', ',', 'postoperative', 'pulmonary', 'complication', '(', 'ppcs', ')', ',', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'discussion', 'study', 'aim', 'to', 'compare', 'application', 'of', 'era', 'management', 'protocol', 'and', 'traditional', 'management', 'protocol', 'in', 'adult', 'cardiac', 'surgery', 'extracorporeal', 'circulation', '.']"
Development of a MALDI MS-based platform for early detection of acute kidney injury.,"Emma Carrick, Jill Vanmassenhove, Griet Glorieux, Jochen Metzger, Mohammed Dakna, Martin Pejchinovski, Vera Jankowski, Bahareh Mansoorian, Holger Husi, William Mullen, Harald Mischak, Raymond Vanholder, Wim Van Biesen, Emma Carricket al.",2016 Jul,Proteomics Clin Appl,https://pubmed.ncbi.nlm.nih.gov/27119821/,No keywords found,"['septic', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'associated', 'with', 'poor', 'outcome', '.', 'partly', 'attributed', 'to', 'delayed', 'diagnosis', 'and', 'incomplete', 'understanding', 'of', 'underlying', 'pathophysiology', '.', 'aim', 'to', 'develop', 'early', 'predictive', 'test', 'aki', 'based', 'analysis', 'of', 'urinary', 'peptide', 'biomarkers', 'maldi-ms.', 'experimental', 'design', 'urine', 'sample', 'patient', 'with', 'sepsis', 'analyzed', 'maldi-ms.', 'marker', 'search', 'and', 'multimarker', 'model', 'establishment', 'performed', 'using', 'peptide', 'profile', 'patient', 'with', 'existing', 'or', 'within', 'next', 'day', 'developing', 'aki', 'and', 'with', 'no', 'change', 'in', 'renal', 'function', '.', 'replicates', 'of', 'urine', 'sample', 'pool', 'aki', 'and', 'non-aki', 'patient', 'group', 'and', 'normal', 'control', 'also', 'included', 'to', 'select', 'analytically', 'robust', 'aki', 'marker', '.', 'result', 'thirty-nine', 'urinary', 'peptide', 'selected', 'cross-validated', 'variable', 'selection', 'to', 'generate', 'support', 'vector', 'machine', 'multidimensional', 'aki', 'classifier', '.', 'prognostic', 'performance', 'of', 'aki', 'classifier', 'independent', 'validation', 'set', 'including', 'remaining', 'patient', 'of', 'study', 'population', '(', 'control', 'and', 'case', ')', 'good', 'with', 'area', 'receiver', 'operating', 'characteristic', 'curve', 'of', '.', 'and', 'sensitivity', 'and', 'specificity', 'of', 'and', ',', 'respectively', '.', 'conclusion', 'and', 'clinical', 'relevance', 'urinary', 'peptide', 'marker', 'model', 'detects', 'onset', 'of', 'aki', 'with', 'acceptable', 'accuracy', 'in', 'septic', 'patient', '.', 'platform', 'eventually', 'transferred', 'to', 'clinic', 'fast', 'maldi-ms', 'test', 'format', '.']"
Role of modified hydration for preventing contrast-associated acute kidney injury in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.,"Lei Liu, Li Zhou, Weiping Li, Hui Chen, Hongwei Li, Lei Liuet al.",2023 Jan,Intern Emerg Med,https://pubmed.ncbi.nlm.nih.gov/36539602/,"Contrast-associated acute kidney injury, Hydration, Major adverse cardiovascular events, Percutaneous coronary intervention.","['to', 'assess', 'efficacy', 'of', 'modified', 'hydration', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', 'in', 'st-segment', 'elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'primary', 'percutaneous', 'coronary', 'intervention', '(', 'ppci', ')', '.', 'total', 'of', 'patient', 'randomly', 'assigned', 'to', 'group', '.', 'traditional', 'hydration', 'group', '(', 'group', ')', 'given', 'rate', 'of', 'mlkgh', 'h', ',', 'and', 'modified', 'hydration', 'group', '(', 'group', 'ii', ')', 'given', 'rate', 'of', 'mlkgh', 'in', 'first', 'h', ',', 'and', 'reduced', 'to', 'mlkgh', 'h.', '.', 'mgkg', 'of', 'furosemide', 'given', '-h', 'hydration', '.', 'primary', 'endpoint', 'incidence', 'of', 'ca-aki', ',', 'and', 'secondary', 'endpoint', 'incidence', 'of', 'major', 'adverse', 'cardiovascular', 'event', '(', 'mace', ')', 'median', 'of', '.', 'month', '(', 'iqr', '.', ',', '.', 'month', ')', 'follow-up', '.', 'incidence', 'of', 'ca-aki', '..', 'among', ',', 'group', '.', 'and', 'group', 'ii', '.', ',', 'respectively', '.', 'no', 'significant', 'difference', 'in', 'ca-aki', 'and', 'creatinine', 'level', 'two', 'hydration', 'group', '.', 'multivariable', 'logistics', 'regression', 'analysis', 'revealed', 'creatinine', ',', 'white', 'blood', 'cell', ',', 'and', 'n-terminal', 'pro-b-type', 'natriuretic', 'peptide', 'associated', 'with', 'ca-aki', '.', 'moreover', ',', 'ca-aki', 'independent', 'predictor', 'all-cause', 'death', 'and', 'cardiac', 'death', 'follow-up', 'period', '.', 'modified', 'hydration', 'may', 'reduce', 'incidence', 'of', 'ca-aki', ',', 'although', 'difference', 'not', 'statistically', 'significant', '.', 'relationship', 'ca-aki', 'and', 'mortality', 'strengthened', 'creatinine', 'time', 'baseline', 'increased', '.', 'mitigating', 'occurrence', 'of', 'ca-aki', 'may', 'reduce', 'all-cause', 'death', 'and', 'cardiac', 'death', '.']"
"Impact of ketamine versus propofol for anesthetic induction on cognitive dysfunction, delirium, and acute kidney injury following cardiac surgery in elderly, high-risk patients.","Erica D Wittwer, Jane H Cerhan, Darrell R Schroeder, Hartzell V Schaff, William J Mauermann, Erica D Wittweret al.",2023 Jul-Sep,Ann Card Anaesth,https://pubmed.ncbi.nlm.nih.gov/37470525/,No keywords found,"['evaluate', 'effect', 'of', 'ketamine', 'versus', 'propofol', 'used', 'induction', 'of', 'anesthesia', 'in', 'elderly', ',', 'high-risk', 'cardiac', 'surgical', 'patient', 'postoperative', 'complication', 'including', 'cognitive', 'dysfunction', ',', 'delirium', ',', 'and', 'acute', 'kidney', 'injury', '.', 'method', 'prospective', ',', 'randomized', 'study', 'performed', 'tertiary', 'medical', 'center', '.', 'total', 'of', 'patient', 'aged', 'and', 'older', 'presenting', 'complex', 'cardiac', 'surgery', 'randomized', 'to', 'receive', 'either', 'ketamine', 'or', 'propofol', 'induction', 'of', 'anesthesia', '.', 'patient', 'underwent', 'battery', 'of', 'cognitive', 'testing', 'preoperatively', 'and', 'postoperatively', 'and', 'incidence', 'of', 'delirium', 'and', 'acute', 'kidney', 'injury', 'measured', '.', 'norepinephrine', '(', 'nee', ')', 'equivalent', 'following', 'induction', 'assessed', 'group', '.', 'result', 'total', 'of', 'patient', 'included', ',', 'in', 'ketamine', 'group', 'and', 'in', 'propofol', 'group', 'with', 'patient', 'excluded', 'analysis', '.', 'no', 'difference', 'found', 'group', 'in', 'either', 'postoperative', 'cognitive', 'dysfunction', 'or', 'delirium', 'incidence', '.', 'acute', 'kidney', 'injury', 'occurred', 'in', '(', ')', 'patient', 'in', 'ketamine', 'group', 'in', '(', ')', 'patient', 'in', 'propofol', 'group', ',', 'difference', 'not', 'meet', 'statistical', 'significance', '(', 'p', '.', 'relative', 'risk', '.', ',', 'ci', '.-.', ')', '.', 'nee', 'equivalent', 'lower', 'in', 'ketamine', 'group', ',', '.', '.', 'versus', '.', '.', ',', 'p', '..', 'conclusion', 'use', 'of', 'ketamine', 'versus', 'propofol', 'induction', 'of', 'anesthesia', 'not', 'impact', 'incidence', 'of', 'postoperative', 'cognitive', 'dysfunction', 'or', 'delirium', '.', 'twice', 'many', 'patient', 'in', 'propofol', 'group', 'developed', 'acute', 'kidney', 'injury', ',', 'although', 'not', 'reaching', 'statistical', 'significance', 'and', 'warranting', 'investigation', '.', 'in', 'elderly', ',', 'high-risk', 'patient', ',', 'ketamine', 'associated', 'with', 'significantly', 'reduced', 'need', 'vasopressor', 'support', 'following', 'induction', '.']"
Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial).,"Pierre-Grégoire Guinot, Olivier Desebbe, Guillaume Besch, Philippe Guerci, Philippe Gaudard, Diane Lena, Paul Michel Mertes, Osama Abou-Arab, Belaid Bouhemad                              ;, NOVACC study group, Maxime Nguyen, Bastien Durand, Audrey Martin, Vivien Berthoud, Tiberiu Constandache, Sandrine Grosjean, Mohamed Radhouani, Jean-Baptiste Anciaux, Pierre Voizeux, Anouck Appriou, Valentin Kabout, Jules Marcand, Florian Nays, Maxime Guilhot, Rudy Alardin, Dejan Ilic, Thomas Senot, Beyls Christophe, Bayart Guillaume, Lagarde Clément, Leviel Florent, Lefebvre Thomas, Haye Guillaume, Huguetto Aurore, David Helene, Grelet Tommy, Pereira Lucas, Zaepffel Zoé, Guilhot Maxime, Bataillard Amélie, Alardin Rudy, Senot Thomas, Jelicic Aleksandra, Ilic Dejan, Bronnert, Tissot Michel, Fouace Charles, Pierre-Grégoire Guinotet al.",2024 Jun:272:86-95.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/38492626/,No keywords found,"['cardiac', 'surgery-associated', 'acute', 'kidney', 'injury', '(', 'cs-aki', ')', 'affect', 'to', 'of', 'patient', ',', 'increasing', 'morbidity', 'and', 'healthcare', 'cost', '.', 'condition', 'result', 'complex', 'factor', 'like', 'ischemia-reperfusion', 'injury', 'and', 'renal', 'hemodynamic', 'change', ',', 'often', 'exacerbated', 'surgical', 'procedure', '.', 'norepinephrine', ',', 'commonly', 'used', 'in', 'cardiac', 'surgery', ',', 'may', 'heighten', 'risk', 'of', 'cs-aki', '.', 'in', 'contrast', ',', 'vasopressin', ',', 'noncatecholaminergic', 'agent', ',', 'show', 'potential', 'in', 'preserving', 'renal', 'function', 'favorably', 'affecting', 'renal', 'hemodynamic', '.', 'preliminary', 'finding', ',', 'suggest', 'vasopressin', 'could', 'reduce', 'incidence', 'of', 'cs-aki', 'compared', 'to', 'norepinephrine', '.', 'additionally', ',', 'vasopressin', 'linked', 'to', 'lower', 'incidence', 'of', 'postoperative', 'atrial', 'fibrillation', ',', 'another', 'factor', 'contributing', 'to', 'longer', 'hospital', 'stay', 'and', 'higher', 'cost', '.', 'study', 'hypothesizes', 'vasopressin', 'could', 'effectively', 'reduce', 'cs-aki', 'occurrence', 'and', 'severity', 'optimizing', 'renal', 'perfusion', 'cardiac', 'surgery', '.', 'study', 'design', 'novacc', 'trial', '(', 'nct', ')', 'multicenter', ',', 'randomized', ',', 'double', 'blinded', 'superiority-controlled', 'trial', 'testing', 'superiority', 'of', 'vasopressin', 'norepinephrine', 'in', 'patient', 'scheduled', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'primary', 'composite', 'end', 'point', 'occurrence', 'of', 'acute', 'kidney', 'injury', 'and', 'death', '.', 'secondary', 'end', 'point', 'neurological', ',', 'cardiologic', ',', 'digestive', ',', 'and', 'vasopressor', 'related', 'complication', 'day', ',', 'day', ',', 'day', ',', 'hospital', 'and', 'intensive', 'care', 'unit', 'length', 'of', 'stay', ',', 'medico-economic', 'cost', 'day', '.', 'conclusion', 'novacc', 'trial', 'assess', 'effectiveness', 'of', 'vasopressin', 'in', 'cardiac', 'surgery', 'with', 'cpb', 'in', 'reducing', 'acute', 'kidney', 'injury', ',', 'mortality', ',', 'and', 'medical', 'cost', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery.,"Eva Martha Madsen Svarrer, Henrik Ørbæk Andersen, Morten Helvind, Maartje C J Slagman, Gerjan Navis, Robin P F Dullaart, Björn Dahlbäck, Lars Bo Nielsen, Eva Martha Madsen Svarreret al.",2016,Biomark Med,https://pubmed.ncbi.nlm.nih.gov/26642098/,No keywords found,"['to', 'investigate', 'whether', 'apom', 'excreted', 'in', 'urine', 'of', 'child', 'undergoing', 'heart', 'surgery', 'and', 'potential', 'of', 'apom', 'early', 'biomarker', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'material', 'method', 'urine', 'collected', 'in', 'child', 'undergoing', 'heart', 'surgery', '.', 'apom', 'measured', 'with', 'elisa', '.', 'u-apom', 'characterized', 'gel', 'filtration', 'chromatography', 'and', 'western', 'blotting', '.', 'result', 'apom', 'excreted', 'urine', '-', 'h', 'postoperatively', 'full-length', 'apom', 'in', 'particle', 'smaller', 'plasma', 'hdl', '.', 'h', ',', 'u-apom', 'predicted', 'aki', 'with', 'area', 'receiver-operating', 'characteristic', 'curve', 'of', '.', '(', 'p', '.', ')', '.', 'sensitivity', '.', 'and', 'specificity', '.', 'cutoff', 'level', '.', 'nmoll', '.', 'conclusion', 'apom', 'excreted', 'in', 'urine', 'of', 'child', 'cardiac', 'surgery', '.', 'potential', 'biomarker', 'of', 'aki', 'deserves', 'exploration', '.']"
Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary Findings of the Urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic Heart Failure Study (AKINESIS).,"Patrick T Murray, Nicholas Wettersten, Dirk J van Veldhuisen, Christian Mueller, Gerasimos Filippatos, Richard Nowak, Christopher Hogan, Michael C Kontos, Chad M Cannon, Gerhard A Müeller, Robert Birkhahn, Yu Horiuchi, Paul Clopton, Pam Taub, Gary M Vilke, Olga Barnett, Kenneth McDonald, Niall Mahon, Julio NuÑez, Carlo Briguori, Claudio Passino, Alan Maisel, Patrick T Murrayet al.",2019 Aug,J Card Fail,https://pubmed.ncbi.nlm.nih.gov/31128242/,No keywords found,"['worsening', 'renal', 'function', '(', 'wrf', ')', 'acute', 'heart', 'failure', '(', 'ahf', ')', 'occurs', 'frequently', 'and', 'associated', 'with', 'adverse', 'outcome', ',', 'though', 'association', 'questioned', '.', 'wrf', 'evaluated', 'function', 'and', 'injury', '.', 'evaluated', 'whether', 'urine', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ungal', ')', 'superior', 'to', 'creatinine', 'prediction', 'and', 'prognosis', 'of', 'wrf', 'in', 'patient', 'with', 'ahf', '.', 'method', 'and', 'result', 'performed', 'multicenter', ',', 'international', ',', 'prospective', 'cohort', 'of', 'patient', 'with', 'ahf', 'requiring', 'iv', 'diuretic', '.', 'primary', 'outcome', 'whether', 'ungal', 'predicted', 'development', 'of', 'wrf', ',', 'defined', 'sustained', 'increase', 'in', 'creatinine', 'of', '.', 'mgdl', 'or', 'first', 'value', 'or', 'initiation', 'of', 'renal', 'replacement', 'therapy', ',', 'within', 'first', 'day', '.', 'main', 'secondary', 'outcome', 'composite', 'of', 'in-hospital', 'adverse', 'event', '.', 'enrolled', 'patient', '(', 'mean', '.', 'year', 'of', 'age', ',', 'men', ')', '.', 'primary', 'outcome', 'occurred', 'in', 'patient', '(', '.', ')', '.', 'first', ',', 'peak', 'and', 'ratio', 'of', 'ungal', 'to', 'urine', 'creatinine', '(', 'area', 'curve', '(', 'auc', ')', '.', ')', 'not', 'diagnostic', 'utility', 'first', 'creatinine', '(', 'auc', '.', ')', '.', 'adverse', 'event', 'in', 'patient', '.', 'ungal', 'not', 'predict', '(', 'auc', '.', ')', 'adverse', 'clinical', 'event', 'better', 'creatinine', '(', 'auc', '.', ')', '.', 'conclusion', 'ungal', 'not', 'superior', 'to', 'creatinine', 'predicting', 'wrf', 'or', 'adverse', 'in-hospital', 'outcome', 'and', 'not', 'recommended', 'wrf', 'in', 'ahf', '.']"
Effects of delayed remote ischemic preconditioning on peri-operative myocardial injury in patients undergoing cardiac surgery - A randomized controlled trial.,"Tae Kyong Kim, Jeong Jin Min, Youn Joung Cho, Derek J Hausenloy, Hyuk Ahn, Kyung-Hwan Kim, Ho Young Hwang, Deok Man Hong, Yunseok Jeon, Tae Kyong Kimet al.",2017 Jan 15:227:511-515.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/27839807/,No keywords found,"['remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'two', 'time', 'window', 'organ', 'protection', 'acute', 'and', 'delayed', '.', 'previous', 'study', 'mainly', 'focused', 'acute', 'time', 'window', 'to', 'evaluate', 'organ', 'protection', 'ripc', '.', 'evaluated', 'myocardial', 'protection', 'delayed', 'ripc', 'in', 'adult', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'method', 'total', 'of', 'adult', 'patient', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'randomized', 'to', 'receive', 'either', 'delayed', 'ripc', '(', 'four', 'cycle', 'of', 'min', 'of', 'ischemia', 'followed', 'min', 'of', 'reperfusion', 'inflation', 'to', 'mmhg', 'and', 'deflation', 'of', 'blood', 'pressure', 'cuff', 'upper', 'arm', ')', 'or', 'control', 'treatment', '-h', 'surgery', '.', 'primary', 'endpoint', 'post-operative', 'troponin', 'level', 'serially', 'measured', 'h.', 'secondary', 'endpoint', 'included', 'post-operative', 'serum', 'creatinine', 'level', ',', 'acute', 'kidney', 'injury', ',', 'and', 'composite', 'complication', '.', 'result', 'no', 'significant', 'difference', 'in', 'post-operative', 'troponin', 'value', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'defined', 'acute', 'kidney', 'injury', 'network', 'staging', 'system', ',', 'lower', 'in', 'delayed', 'ripc', 'group', 'compared', 'to', 'control', 'group', '(', '.', 'vs.', '.', 'relative', 'risk', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p.', ')', '.', 'moreover', ',', 'occurrence', 'of', 'composite', 'complication', 'lower', 'in', 'delayed', 'ripc', 'group', 'compared', 'with', 'control', 'group', '(', '.', 'vs.', '.', 'relative', 'risk', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p.', ')', '.', 'conclusion', 'ripc', 'not', 'provide', 'cardioprotective', 'effect', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', ',', 'appeared', 'to', 'reduce', 'acute', 'kidney', 'injury', ',', 'well', 'rate', 'of', 'composite', 'complication', '.']"
Prolonged Blood Storage and Risk of Posttransfusion Acute Kidney Injury.,"Janet Adegboye, Suneeti Sapatnekar, Edward J Mascha, Karan Shah, Michael Lioudis, Hani Essber, Barak Cohen, Eva Rivas, Nancy M Heddle, John W Eikelboom, Martin H Ellis, Yehudit Sharon, Romi Sinha, Andrea Kurz, Daniel I Sessler, Janet Adegboyeet al.",2022 Jan 1,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/34793586/,No keywords found,"['erythrocyte', 'transfusion', 'independently', 'associated', 'with', 'acute', 'kidney', 'injury', '.', 'kidney', 'injury', 'may', 'consequent', 'to', 'progressive', 'hematologic', 'change', 'develop', 'storage', '.', 'study', 'therefore', 'tested', 'hypothesis', 'prolonged', 'erythrocyte', 'storage', 'increase', 'posttransfusion', 'acute', 'kidney', 'injury', '.', 'method', 'informing', 'fresh', 'versus', 'old', 'red', 'cell', 'management', '(', 'inform', ')', 'trial', 'randomized', ',', 'patient', 'to', 'receive', 'either', 'freshest', 'or', 'oldest', 'available', 'matching', 'erythrocyte', 'unit', 'and', 'showed', 'comparable', 'mortality', 'with', '.', 'priori', 'substudy', 'compared', 'incidence', 'of', 'posttransfusion', 'acute', 'kidney', 'injury', 'in', 'randomized', 'group', '.', 'acute', 'kidney', 'injury', 'defined', 'creatinine', 'component', 'of', 'kidney', 'disease', 'improving', 'global', 'outcome', 'criterion', '.', 'result', ',', 'patient', 'included', 'in', 'substudy', 'received', ',', 'erythrocyte', 'unit', '.', 'patient', 'received', 'one', 'unit', ',', 'mean', 'age', 'of', 'blood', 'unit', 'used', 'exposure', '.', 'median', 'of', 'mean', 'age', 'of', 'blood', 'unit', 'transfused', 'per', 'patient', 'day', 'interquartile', 'range', ',', ',', 'in', 'freshest', 'available', 'blood', 'group', 'and', 'day', 'interquartile', 'range', ',', ',', 'in', 'oldest', 'available', 'blood', 'group', '.', 'in', 'primary', 'analysis', ',', 'posttransfusion', 'acute', 'kidney', 'injury', 'observed', 'in', 'of', ',', '(', '.', ')', 'patient', 'given', 'freshest', 'available', 'blood', 'and', ',', 'of', ',', '(', '.', ')', 'patient', 'given', 'oldest', 'available', 'blood', ',', 'with', 'estimated', 'relative', 'risk', '(', 'ci', ')', 'of', '.', '(', '.', 'to', '.', 'p', '.', ')', '.', 'secondary', 'analysis', 'treated', 'blood', 'age', 'continuous', 'variable', '(', 'defined', 'duration', 'of', 'storage', 'in', 'day', ')', ',', 'with', 'estimated', 'relative', 'risk', '(', 'ci', ')', 'of', '.', '(', '.', 'to', '.', 'p', '.', ')', '-day', 'increase', 'in', 'mean', 'age', 'of', 'erythrocyte', 'unit', '.', 'conclusion', 'in', 'population', 'of', 'patient', 'without', 'severely', 'impaired', 'baseline', 'renal', 'function', 'receiving', 'fewer', 'erythrocyte', 'unit', ',', 'duration', 'of', 'blood', 'storage', 'no', 'effect', 'incidence', 'of', 'posttransfusion', 'acute', 'kidney', 'injury', '.']"
"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.","Jiamin Liu, Yan Li, Jinzhuo Ge, Xiaofang Yan, Haibo Zhang, Xin Zheng, Jiapeng Lu, Xi Li, Yan Gao, Lubi Lei, Jing Liu, Jing Li                              ;, ESPRIT Collaborative Group, Jiamin Liuet al.",2024 Jul 20,Lancet,https://pubmed.ncbi.nlm.nih.gov/38945140/,No keywords found,"['uncertainty', 'exists', 'whether', 'lowering', 'systolic', 'blood', 'pressure', 'to', 'less', 'mm', 'hg', 'superior', 'to', 'of', 'less', 'mm', 'hg', ',', 'particularly', 'in', 'patient', 'with', 'diabetes', 'and', 'patient', 'with', 'previous', 'stroke', '.', 'method', 'in', 'open-label', ',', 'blinded-outcome', ',', 'randomised', 'controlled', 'trial', ',', 'participant', 'with', 'high', 'cardiovascular', 'risk', 'enrolled', 'hospital', 'or', 'community', 'in', 'china', '.', 'used', 'minimised', 'randomisation', 'to', 'assign', 'participant', 'to', 'intensive', 'treatment', 'targeting', 'standard', 'office', 'systolic', 'blood', 'pressure', 'of', 'less', 'mm', 'hg', 'or', 'standard', 'treatment', 'targeting', 'less', 'mm', 'hg', '.', 'primary', 'outcome', 'composite', 'of', 'myocardial', 'infarction', ',', 'revascularisation', ',', 'hospitalisation', 'heart', 'failure', ',', 'stroke', ',', 'or', 'death', 'cardiovascular', 'cause', ',', 'assessed', 'intention-to-treat', 'principle', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'sept', ',', ',', 'and', 'july', ',', ',', 'participant', '(', 'with', 'diabetes', 'and', 'with', 'previous', 'stroke', ')', 'assigned', 'to', 'intensive', 'treatment', '(', 'n', ')', 'or', 'standard', 'treatment', '(', 'n', ')', '.', 'mean', 'age', 'year', '(', 'sd', ')', '.', 'mean', 'systolic', 'blood', 'pressure', 'throughout', 'follow-up', '(', 'except', 'first', 'month', 'of', 'titration', ')', 'mm', 'hg', '(', 'sd', ')', 'in', 'intensive', 'treatment', 'group', 'and', 'mm', 'hg', '(', ')', 'in', 'standard', 'treatment', 'group', '.', 'median', 'of', 'year', 'of', 'follow-up', ',', 'primary', 'outcome', 'event', 'occurred', 'in', '(', ')', 'participant', 'in', 'intensive', 'treatment', 'group', 'and', '(', ')', 'in', 'standard', 'treatment', 'group', '(', 'hazard', 'ratio', 'hr', ',', 'ci', '-', 'p', ')', '.', 'no', 'heterogeneity', 'of', 'effect', 'diabetes', 'status', ',', 'duration', 'of', 'diabetes', ',', 'or', 'history', 'of', 'stroke', '.', 'serious', 'adverse', 'event', 'of', 'syncope', 'occurred', 'frequently', 'in', 'intensive', 'treatment', 'group', '(', 'of', ')', 'in', 'standard', 'treatment', 'group', '(', 'eight', 'of', 'hr', ',', 'ci', '-', ')', '.', 'no', 'significant', 'between-group', 'difference', 'in', 'serious', 'adverse', 'event', 'of', 'hypotension', ',', 'electrolyte', 'abnormality', ',', 'injurious', 'fall', ',', 'or', 'acute', 'kidney', 'injury', '.', 'interpretation', 'hypertensive', 'patient', 'high', 'cardiovascular', 'risk', ',', 'regardless', 'of', 'status', 'of', 'diabetes', 'or', 'history', 'of', 'stroke', ',', 'treatment', 'strategy', 'of', 'targeting', 'systolic', 'blood', 'pressure', 'of', 'less', 'mm', 'hg', ',', 'compared', 'with', 'of', 'less', 'mm', 'hg', ',', 'prevents', 'major', 'vascular', 'event', ',', 'with', 'minor', 'excess', 'risk', '.', 'funding', 'ministry', 'of', 'science', 'and', 'technology', 'of', 'china', 'and', 'fuwai', 'hospital', '.', 'translation', 'mandarin', 'translation', 'of', 'abstract', 'see', 'supplementary', 'material', 'section', '.']"
Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery.,"Kirolos A Jacob, David E Leaf, Jan M Dieleman, Diederik van Dijk, Arno P Nierich, Peter M Rosseel, Joost M van der Maaten, Jan Hofland, Jan C Diephuis, Fellery de Lange, Christine Boer, Jolanda Kluin, Sushrut S Waikar                              ;, Dexamethasone for Cardiac Surgery (DECS) Study Group, Kirolos A Jacobet al.",2015 Dec,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/25952257/,No keywords found,"['administration', 'of', 'prophylactic', 'glucocorticoid', 'suggested', 'strategy', 'to', 'reduce', 'postoperative', 'aki', 'and', 'adverse', 'event', 'cardiac', 'surgery', 'requiring', 'cardiopulmonary', 'bypass', '.', 'in', 'post', 'hoc', 'analysis', 'of', 'large', 'placebo-controlled', 'randomized', 'trial', 'of', 'dexamethasone', 'in', 'adult', 'patient', 'undergoing', 'cardiac', 'surgery', ',', 'examined', 'severe', 'aki', ',', 'defined', 'use', 'of', 'rrt', ',', 'primary', 'outcome', '.', 'secondary', 'outcome', 'doubling', 'of', 'serum', 'creatinine', 'level', 'or', 'aki-rrt', ',', 'well', 'aki-rrt', 'or', 'in-hospital', 'mortality', '(', 'rrtdeath', ')', '.', 'primary', 'outcome', 'occurred', 'in', 'ten', 'patient', '(', '.', ')', 'in', 'dexamethasone', 'group', 'and', 'in', 'patient', '(', '.', ')', 'in', 'placebo', 'group', '(', 'relative', 'risk', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'in', 'stratified', 'analysis', ',', 'strongest', 'signal', 'potential', 'benefit', 'of', 'dexamethasone', 'in', 'patient', 'with', 'egfr', 'mlmin', 'per', '.', '(', ')', '.', 'in', 'conclusion', ',', 'compared', 'with', 'placebo', ',', 'intraoperative', 'dexamethasone', 'appeared', 'to', 'reduce', 'incidence', 'of', 'severe', 'aki', 'cardiac', 'surgery', 'in', 'with', 'advanced', 'ckd', '.']"
"A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of High-Dose, Short-Term Vitamin D Administration in the Prevention of Acute Kidney Injury after Cardiac Surgery.","Pegah Eslami, Manouchehr Hekmat, Mahmoud Beheshti, Ramin Baghaei, Seyed Mohsen Mirhosseini, Fatemeh Pourmotahari, Seyed Ali Ziai, Mahnoosh Foroughi, Pegah Eslamiet al.",2021,Cardiorenal Med,https://pubmed.ncbi.nlm.nih.gov/33498049/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', 'relatively', 'common', 'complication', 'affecting', 'short-', 'and', 'long-term', 'survival', '.', 'renoprotective', 'effect', 'of', 'vitamin', '(', 'vitd', ')', 'confirmed', 'in', 'several', 'experimental', 'model', '.', 'study', 'conducted', 'to', 'evaluate', 'effect', 'of', 'high-dose', 'vitd', 'administration', 'in', 'patient', 'with', 'vitd', 'insufficiency', 'incidence', 'of', 'postoperative', 'aki', ',', 'urinary', 'level', 'of', 'tubular', 'biomarkers', ',', 'and', 'serum', 'anti-inflammatory', 'biomarker', 'coronary', 'artery', 'bypass', 'graft', '.', 'design', 'and', 'method', 'in', 'randomized', 'double-blind', 'controlled', 'clinical', 'trial', ',', 'patient', 'randomly', 'allocated', 'to', 'either', 'vitd', 'group', '(', 'n', ')', ',', 'receiving', ',', 'iu', 'vitd', 'tablet', 'daily', 'consecutive', 'day', 'surgery', 'or', 'control', 'group', '(', 'n', ')', ',', 'receiving', 'placebo', 'tablet', '.', 'result', 'no', 'difference', 'in', 'incidence', 'of', 'postoperative', 'aki', 'group', '.', 'of', 'urinary', 'level', 'of', 'interleukin-', 'and', 'kidney', 'injury', 'molecule-', 'significantly', 'increased', 'operation', '(', 'p', '.', ',', ')', '.', 'also', ',', 'serum', 'level', 'of', 'interleukin-', 'increased', 'day', 'of', 'vitd', 'supplementation', '(', 'p', '.', ')', '.', 'in', 'comparison', 'with', 'control', 'group', ',', 'remained', 'higher', 'level', 'operation', '(', 'p', '.', ')', 'and', 'next', 'day', '(', 'p', '.', ')', '.', 'patient', 'with', 'aki', 'postoperative', 'bleeding', 'and', 'received', 'blood', 'transfusion', '.', 'conclusion', 'vitd', 'pretreatment', 'unable', 'to', 'impose', 'change', 'in', 'incidence', 'of', 'aki', 'and', 'urinary', 'level', 'of', 'renal', 'biomarkers', '.', 'however', ',', 'high-dose', 'administration', 'of', 'vitd', 'may', 'improve', 'anti-inflammatory', 'state', 'and', 'operation', '.', 'study', 'needed', 'to', 'assess', 'renoprotective', 'effect', 'of', 'vitd', 'coronary', 'surgery', 'patient', '.']"
Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial.,"Amit X Garg, P J Devereaux, Andrew Hill, Manish Sood, Bharat Aggarwal, Luc Dubois, Swapnil Hiremath, Randolph Guzman, Vikram Iyer, Matthew James, Eric McArthur, Louise Moist, George Ouellet, Chirag R Parikh, Virginia Schumann, Sumit Sharan, Heather Thiessen-Philbrook, Sheldon Tobe, Ron Wald, Michael Walsh, Matthew Weir, Neesh Pannu                              ;, Curcumin AAA AKI Investigators, Amit X Garget al.",2018 Oct 29,CMAJ,https://pubmed.ncbi.nlm.nih.gov/30373740/,No keywords found,"['curcumin', ',', 'popular', 'herbal', 'supplement', 'plant', 'turmeric', ',', 'prevented', 'ischemic', 'reperfusion', 'and', 'toxin-induced', 'injury', 'in', 'many', 'animal', 'study', 'and', 'single-centre', 'randomized', 'human', 'trial', '.', 'sought', 'to', 'test', 'whether', 'perioperative', 'oral', 'curcumin', '(', 'compared', 'with', 'placebo', ')', 'affect', 'inflammatory', 'response', 'and', 'risk', 'of', 'postrepair', 'complication', 'elective', 'abdominal', 'aortic', 'aneurysm', 'repair', 'in', 'human', '.', 'method', 'conducted', 'parallel-group', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'of', 'patient', 'hospital', 'in', 'canada', 'scheduled', 'to', 'undergo', 'elective', 'repair', 'of', 'unruptured', 'abdominal', 'aortic', 'aneurysm', '(', 'november', 'to', 'november', ')', '.', 'patient', 'in', 'treatment', 'group', 'received', 'perioperative', 'oral', 'curcumin', '(', '-mg', 'dos', 'time', ')', '.', 'patient', ',', 'health', 'care', 'provider', 'and', 'local', 'research', 'staff', 'unaware', 'of', 'treatment', 'assignment', '.', 'primary', 'outcome', 'median', 'concentration', 'of', 'bio', 'marker', 'indicating', 'injury', 'and', 'inflammation', '(', 'postoperative', 'urine', 'interleukin-', 'and', 'perioperative', 'rise', 'in', 'serum', 'creatinine', ',', 'plasma', 'n-terminal', 'pro-b-type', 'natriuretic', 'peptide', 'and', 'plasma', 'high-sensitivity', 'c-reactive', 'protein', ')', '.', 'result', 'baseline', 'characteristic', 'similar', 'in', 'group', '(', 'patient', 'overall', 'median', 'age', 'yr', ')', '.', 'of', 'patient', 'in', 'group', 'took', 'of', 'scheduled', 'capsule', '.', 'neither', 'curcumin', 'placebo', 'significantly', 'affected', 'of', 'biomarkers', '(', 'p', '.', 'comparison', ')', '.', 'regarding', 'secondary', 'outcome', ',', 'higher', 'risk', 'of', 'acute', 'kidney', 'injury', 'with', 'curcumin', 'with', 'placebo', '(', 'v.', ',', 'p', '.', ')', ',', 'no', 'between-group', 'difference', 'in', 'median', 'length', 'of', 'hospital', 'stay', '(', 'v.', 'day', ',', 'p', '.', ')', 'or', 'risk', 'of', 'clinical', 'event', '(', 'v.', ',', 'p', '.', ')', '.', 'interpretation', 'curcumin', 'no', 'beneficial', 'effect', 'used', 'in', 'elective', 'abdominal', 'aortic', 'aneurysm', 'repair', '.', 'finding', 'emphasize', 'importance', 'of', 'testing', 'turmeric', 'and', 'curcumin', 'espousing', 'health', 'benefit', ',', 'currently', 'done', 'in', 'popular', 'medium', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'no', '.', 'nct', '.']"
A randomized trial of loading vancomycin in the emergency department.,"Jamie M Rosini, Julie Laughner, Brian J Levine, Mia A Papas, John F Reinhardt, Neil B Jasani, Jamie M Rosiniet al.",2015 Jan,Ann Pharmacother,https://pubmed.ncbi.nlm.nih.gov/25358330/,No keywords found,"['optimizing', 'vancomycin', 'dosing', 'may', 'help', 'eradicate', 'bacteria', 'avoiding', 'resistance', '.', 'guideline', 'recommend', 'loading', 'dos', 'however', ',', 'no', 'data', 'to', 'demonstrate', 'may', 'result', 'in', 'rapid', 'achievement', 'of', 'therapeutic', 'trough', '.', 'objective', 'to', 'evaluate', 'percentage', 'of', 'trough', 'reaching', 'therapeutic', 'level', ',', ',', 'and', 'hour', 'following', 'initial', 'vancomycin', 'dose', 'of', 'mgkg', 'compared', 'with', 'mgkg', '.', 'method', 'prospective', ',', 'randomized', 'study', 'performed', 'in', 'community', 'academic', 'medical', 'center', '.', 'patient', 'to', 'receive', 'vancomycin', 'in', 'emergency', 'department', 'randomized', 'to', 'initial', 'traditional', 'dose', 'of', 'mgkg', 'or', '-mgkg', 'loading', 'dose', 'followed', 'mgkg', 'every', 'hour', 'dos', '.', 'patient', 'weighing', 'kg', 'or', 'with', 'creatinine', 'clearance', 'mlmin', 'excluded', '.', 'result', 'in', 'total', ',', 'patient', 'enrolled', 'hour', 'initial', 'dose', 'of', 'vancomycin', ',', 'significantly', 'greater', 'proportion', 'of', 'patient', 'reaching', 'target', 'trough', 'level', 'of', 'mgl', 'among', 'patient', 'received', 'loading', 'dose', 'compared', 'with', 'traditional', 'dose', '(', 'v', ',', 'p', '.', ')', '.', 'trend', 'continued', 'hour', 'not', 'statistically', 'significant', '.', 'hour', ',', 'no', 'difference', 'in', 'percentage', 'of', 'patient', 'reaching', 'target', 'level', 'group', '.', 'no', 'statistically', 'significant', 'difference', 'in', 'nephrotoxicity', 'or', 'adverse', 'event', 'among', 'group', 'demonstrated', '.', 'conclusion', 'loading', 'dose', 'of', 'mgkg', 'of', 'vancomycin', 'achieved', 'higher', 'percentage', 'of', 'therapeutic', 'level', 'hour', 'compared', 'with', 'traditional', 'dose', 'of', 'mgkg', ',', 'without', 'increased', 'nephrotoxicity', 'or', 'adverse', 'event', '.']"
Determinants of postoperative complications in high-risk noncardiac surgery patients optimized with hemodynamic treatment strategies: A post-hoc analysis of a randomized multicenter clinical trial.,"Stéphane Bar, Mouhamed Djahoum Moussa, Richard Descamps, Younes El Amine, Belaid Bouhemad, Marc-Olivier Fischer, Emmanuel Lorne, Hervé Dupont, Momar Diouf, Pierre Grégoire Guinot                              ;, OPHIQUE study group, Stéphane Baret al.",2024 May:93:111325.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/37992534/,No keywords found,"['post-hoc', 'analysis', 'of', 'randomized', 'controlled', 'trial', 'undertaken', 'to', 'establish', 'determinant', 'of', 'postoperative', 'complication', 'and', 'acute', 'kidney', 'injury', 'in', 'high-risk', 'noncardiac', 'surgery', 'patient', 'supported', 'with', 'hemodynamic', 'treatment', 'strategy', '.', 'design', 'conducted', 'post-hoc', 'analysis', 'of', 'patient', 'enrolled', 'in', 'optimization', 'hemodynamic', 'individualized', 'respiratory', 'quotient', '(', 'ophique', ')', 'trial', '.', 'setting', 'operating', 'room', 'in', 'four', 'university', 'medical', 'center', 'and', 'one', 'non-university', 'hospital', 'december', ',', ',', 'to', 'september', ',', '.', 'patient', 'enrolled', 'patient', 'with', 'high', 'risk', 'of', 'postoperative', 'complication', 'undergoing', 'high-risk', 'noncardiac', 'surgery', 'lasting', 'h', 'or', 'longer', 'general', 'anesthesia', '.', 'intervention', 'patient', 'treated', 'according', 'to', 'hemodynamic', 'treatment', 'strategy', 'included', 'cardiac', 'output', 'optimization', 'titration', 'of', 'fluid', 'challenge', 'and', 'targeted', 'systolic', 'blood', 'pressure', 'to', 'remain', 'within', 'of', 'reference', 'value', '.', 'measurement', 'assessed', 'association', 'pre-operative', 'and', 'intra-operative', 'exposure', 'of', 'interest', 'with', 'composite', 'primary', 'outcome', 'of', 'major', 'complication', 'or', 'death', 'within', 'seven', 'day', 'following', 'surgery', 'using', 'multivariable', 'logistic', 'regression', 'model', '.', 'also', 'assessed', 'association', 'exposure', 'of', 'interest', 'and', 'acute', 'kidney', 'injury', '.', 'main', 'result', 'data', 'of', 'patient', 'analyzed', '.', 'in', 'multivariate', 'analysis', ',', 'factor', 'independently', 'associated', 'with', 'primary', 'outcome', 'age', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', ',', 'preoperative', 'hemoglobin', 'concentration', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', ',', 'non-vascular', 'surgery', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', ',', 'and', 'intraoperative', 'surgical', 'complication', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', '.', 'factor', 'independently', 'associated', 'with', 'postoperative', 'acute', 'kidney', 'injury', 'age', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', ',', 'preoperative', 'creatinine', 'concentration', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', ',', 'non-vascular', 'surgery', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', ',', 'and', 'intraoperative', 'surgical', 'complication', '(', 'or', '.', '(', '.-', '.', ')', ',', 'p', '.', ')', '.', 'conclusion', 'surgical', 'complication', ',', 'lower', 'preoperative', 'hemoglobin', 'concentration', ',', 'age', ',', 'and', 'vascular', 'surgery', 'associated', 'with', 'postoperative', 'complication', 'in', 'high-risk', 'noncardiac', 'surgery', 'population', 'supported', 'with', 'hemodynamic', 'treatment', 'strategy', '.']"
Pulsatile cardiopulmonary bypass and renal function in elderly patients undergoing aortic valve surgery†.,"Aldo Domenico Milano, Mikhail Dodonov, Willem Van Oeveren, Francesco Onorati, Y John Gu, Maddalena Tessari, Tiziano Menon, Leonardo Gottin, Giuseppe Faggian, Aldo Domenico Milanoet al.",2015 Feb,Eur J Cardiothorac Surg,https://pubmed.ncbi.nlm.nih.gov/24740935/,No keywords found,"['to', 'evaluate', 'pulsatile', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'protective', 'influence', 'renal', 'function', 'in', 'elderly', 'patient', 'undergoing', 'aortic', 'valve', 'replacement', '(', 'avr', ')', '.', 'method', 'forty-six', 'patient', '(', 'year', 'old', ')', 'with', 'aortic', 'valve', 'stenosis', 'underwent', 'avr', 'with', 'either', 'pulsatile', 'perfusion', '(', 'pp', ')', 'or', 'non-pulsatile', 'perfusion', '(', 'np', ')', 'cpb', '.', 'haemodynamic', 'efficacy', 'of', 'blood', 'pump', 'either', 'type', 'of', 'perfusion', 'described', 'in', 'term', 'of', 'energy', 'equivalent', 'pressure', 'and', 'surplus', 'haemodynamic', 'energy', '.', 'urine', 'sample', 'collected', 'surgery', ',', 'sternum', 'closure', ',', 'and', 'and', 'h', 'of', 'intensive', 'care', 'unit', 'stay', 'to', 'detect', 'acute', 'kidney', 'injury', 'marker', '.', 'perioperative', 'urine', 'level', 'of', 'n-acetyl', '--', 'd-glucosaminidase', '(', 'nag', ')', ',', 'kidney', 'injury', 'molecule-', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'assessed', 'together', 'with', 'plasma', 'creatinine', ',', 'creatinine', 'clearance', '(', 'ccr', ')', 'and', '-h', 'haemodynamic', 'monitoring', '.', 'normally', 'distributed', 'continuous', 'variable', 'described', 'mean', 'standard', 'deviation', 'and', 'non-normally', 'distributed', 'data', 'presented', 'median', 'th-th', 'percentile', '.', 'result', 'pp', 'characterized', 'significantly', 'higher', 'amount', 'of', 'surplus', 'haemodynamic', 'energy', 'transferred', 'to', 'patient', '(', 'p', '.', ')', ',', 'with', 'lower', 'mean', 'systemic', 'vascular', 'resistance', 'cpb', '(', 'p', '.', ')', 'and', 'h', 'postoperatively', '(', 'group-p', '.', ')', '.', 'no', 'difference', 'found', 'pre-', 'and', 'postoperative', 'ccr', 'in', 'pp', 'group', '(', 'v', 'mlmin', ',', 'p', '.', ')', ',', 'statistically', 'significant', 'perioperative', 'decrement', 'observed', 'in', 'np', 'group', '(', 'v', 'mlmin', ',', 'p', '.', ')', '.', 'pp', 'group', 'showed', 'significantly', 'lower', 'urinary', 'level', 'of', 'nag', 'h', 'postoperatively', '(', 'p', '.', ')', ',', 'and', 'ngal', 'sternum', 'closure', '(', 'p', '.', ')', ',', 'h', '(', 'p', '.', ')', 'and', 'h', '(', 'p', '.', ')', 'postoperatively', '.', 'conclusion', 'short-term', 'pp', 'in', 'elderly', 'patient', 'showed', 'higher', 'safety', 'renal', 'physiology', 'np', ',', 'resulting', 'in', 'better', 'maintenance', 'of', 'glomerular', 'filtration', 'and', 'lower', 'renal', 'tissue', 'injury', '.']"
Angiopoietin/Tie2 Dysbalance Is Associated with Acute Kidney Injury after Cardiac Surgery Assisted by Cardiopulmonary Bypass.,"Rianne M Jongman, Jan van Klarenbosch, Grietje Molema, Jan G Zijlstra, Adrianus J de Vries, Matijs van Meurs, Rianne M Jongmanet al.",2015 Aug 26,PLoS One,https://pubmed.ncbi.nlm.nih.gov/26309217/,No keywords found,"['pathophysiology', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', 'not', 'completely', 'understood', '.', 'recent', 'evidence', 'suggests', 'pivotal', 'role', 'endothelium', 'in', 'aki', '.', 'in', 'experimental', 'model', 'of', 'aki', ',', 'endothelial', 'specific', 'receptor', 'tie', 'with', 'ligand', 'angiopoietin', '(', 'ang', ')', 'and', 'ang', 'deranged', '.', 'study', 'investigates', 'status', 'cardiac', 'surgery', ',', 'and', 'possible', 'relation', 'angiopoietins', 'and', 'aki', '.', 'method', 'cohort', 'of', 'patient', 'underwent', 'cardiac', 'surgery', ',', 'blood', 'and', 'urine', 'collected', 'predefined', 'time', 'point', '.', 'cohort', 'identified', 'patient', 'least', 'post-operative', 'serum', 'creatinine', 'increase', '(', 'aki', ')', '.', 'constructed', 'control', 'group', '(', 'n', ')', 'using', 'propensity', 'matching', '.', 'systemic', 'level', 'of', 'ang', ',', 'ang', ',', 'and', 'stie', 'measured', 'in', 'plasma', 'and', 'aki', 'marker', 'albumin', ',', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'and', 'n-acetyl-beta-d-glucosaminidase', '(', 'nag', ')', 'measured', 'in', 'urine', '.', 'result', 'ang', 'plasma', 'level', 'increased', 'time', 'in', 'aki', '(', '.', 'to', '.', 'ngml', ')', 'and', 'control', 'patient', '(', '.', 'to', '.', 'ngml', ')', '.', 'ang', 'level', 'increased', '.-fold', 'in', 'patient', 'developed', 'aki', 'cardiac', 'surgery', 'compared', 'to', 'matched', 'control', 'patient', '.', 'plasma', 'level', 'of', 'stie', 'decreased', '.-fold', 'and', 'ang', 'decreased', '-fold', 'time', 'in', 'group', ',', 'not', 'different', 'aki', 'and', 'control', '(', 'ang', 'p', '.', 'and', 'stie', 'p', '.', ')', '.', 'moreover', ',', 'found', 'positive', 'correlation', 'plasma', 'level', 'of', 'ang', 'and', 'urinary', 'level', 'of', 'nag', '.', 'conclusion', 'endothelial', 'angtie', 'system', 'in', 'dysbalance', 'in', 'patient', 'develop', 'aki', 'cardiac', 'surgery', 'compared', 'to', 'matched', 'control', 'patient', '.']"
Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial.,"Naser Aslanabadi, Roghayeh Afsar Gharebagh, Saba Moharramzadeh, Taher Entezari-Maleki, Naser Aslanabadiet al.",2019 Apr,Int Urol Nephrol,https://pubmed.ncbi.nlm.nih.gov/30830654/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'one', 'of', 'important', 'complication', 'of', 'contrast', 'medium', '.', 'aimed', 'to', 'evaluate', 'preventive', 'effect', 'of', 'pentoxifylline', '(', 'ptx', ')', 'cin', 'in', 'diabetic', 'patient', 'undergoing', 'angioplasty', 'using', 'cystatin', 'c.', 'material', 'and', 'method', 'present', 'study', 'randomized', 'clinical', 'trial', ',', 'investigated', 'impact', 'of', 'ptx', 'in', 'prevention', 'of', 'cin', 'among', 'diabetic', 'patient', 'undergoing', 'angioplasty', 'using', 'cystatin', 'c', 'novel', 'biomarker', 'of', 'renal', 'injury', '.', 'patient', 'randomly', 'allocated', 'intervention', 'and', 'control', 'group', '.', 'intervention', 'group', 'received', 'total', 'of', 'mg', 'ptx', 'orally', 'angioplasty', '.', 'serum', 'level', 'of', 'cystatin', 'c', 'and', 'creatinine', 'measured', 'baseline', 'and', 'h', 'procedure', '.', 'result', 'incidence', 'of', 'cin', '.', 'in', 'ptx', 'group', 'vs.', '.', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'baseline', 'level', 'of', 'cystatin', 'c', '.', '.', 'mgl', 'in', 'ptx', 'group', 'and', '.', '.', 'mgl', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'angioplasty', ',', 'level', 'of', 'cystatin', 'c', 'increased', 'to', '.', '.', 'in', 'ptx', 'group', 'and', 'to', '.', '.', 'in', 'control', 'group', 'not', 'statistically', 'significant', '.', 'similar', 'pattern', 'also', 'seen', 'in', 'level', 'of', 'serum', 'creatinine', '.', 'conclusion', 'result', 'of', 'study', 'not', 'support', 'potential', 'benefit', 'of', 'ptx', 'in', 'prevention', 'of', 'cin', 'in', 'diabetic', 'patient', 'undergoing', 'angioplasty', '.']"
Does lung ultrasound-guided ultrafiltration lead to better outcomes in acute kidney injury requiring intermittent hemodialysis: A randomized control trial.,"Vidhya K Zachariah, Vellathussery Chakkalakkoombil Sunitha, Natarajan Ramachandran, Balasubramanian Vairappan, Sreejith Parameswaran, Puthenpurackal Sivanpillai Priyamvada, Vidhya K Zachariahet al.",2024 Oct,Hemodial Int,https://pubmed.ncbi.nlm.nih.gov/38965069/,No keywords found,"['optimization', 'of', 'ultrafiltration', 'hemodialysis', 'critical', 'parameter', 'in', 'achieving', 'therapeutic', 'efficacy', 'and', 'ensuring', 'hemodynamic', 'stability', '.', 'various', 'modality', 'blood', 'volume', 'monitoring', ',', 'inferior', 'vena', 'cava', 'diameter', 'assessment', ',', 'natriuretic', 'peptide', 'level', ',', 'bioimpedance', 'assay', ',', 'and', 'lung', 'ultrasound', 'widely', 'explored', 'in', 'context', 'of', 'maintenance', 'hemodialysis', ',', 'concept', 'of', 'volume-guided', 'ultrafiltration', 'in', 'dialysis', 'patient', 'with', 'acute', 'kidney', 'injury', 'remains', 'unexplored', '.', 'method', 'adult', 'patient', 'with', 'acute', 'kidney', 'injury', 'requiring', 'dialysis', ',', 'hemodynamically', 'stable', 'and', 'not', 'ventilator', 'support', ',', 'without', 'underlying', 'lung', 'pathology', 'or', 'cardiac', 'failure', ',', 'randomized', 'two', 'group', '.', 'patient', 'underwent', '-zone', 'lung', 'ultrasound', 'dialysis', '.', 'ultrafiltration', 'decided', 'based', 'treating', 'physician', ""'s"", 'clinical', 'judgment', 'in', 'control', '.', 'in', 'intervention', 'group', ',', 'ultrafiltration', 'order', 'prescribed', 'treating', 'physician', 'modified', ',', 'based', 'kerley', 'b', 'line', 'score', 'obtained', 'lung', 'ultrasound', '.', 'rest', 'of', 'dialysis', 'prescription', 'similar', '.', 'postdialysis', 'lung', 'ultrasound', 'done', 'in', 'group', 'to', 'assess', 'postdialysis', 'volume', 'status', 'min', 'dialysis', 'session', '.', 'result', 'total', 'of', 'patient', 'undergoing', 'hemodialysis', 'acute', 'kidney', 'injury', 'randomized', '.', 'baseline', 'characteristic', 'comparable', 'except', 'higher', 'baseline', 'b', 'line', 'score', 'score', 'in', 'intervention', 'arm', '.', 'patient', 'received', 'similar', 'dialysis', 'prescription', '.', 'lung', 'ultrasound-guided', 'ultrafiltration', 'arm', 'higher', 'change', 'in', 'b', 'line', 'score', '(', 'bls', ')', 'baseline', '(', '-', '.', 'vs.', '-', 'p', 'value', '.', ')', 'first', 'dialysis', 'session', '.', 'predialysis', 'bls', 'indexed', 'to', 'ultrafiltration', '(', 'mlkbwh', ')', 'significantly', 'lower', 'in', 'control', ',', 'reflecting', 'relatively', 'higher', 'rate', 'of', 'ultrafiltration', 'in', 'control', 'compared', 'with', 'intervention', '(', 'p', '.', ')', '.', 'total', 'number', 'of', 'dialysis', 'session', 'done', 'in', 'control', 'and', 'intervention', 'arm', 'and', ',', 'respectively', '.', 'among', 'control', ',', 'session', '(', '.', ')', 'intradialytic', 'adverse', 'event', ',', 'whereas', ',', 'in', 'intervention', 'arm', ',', 'session', '(', '.', ')', 'adverse', 'intradialytic', 'event', '(', 'p', '.', ')', '.', 'conclusion', 'lung', 'ultrasound-guided', 'ultrafiltration', 'associated', 'with', 'better', 'safety', 'profile', ',', 'demonstrated', 'reduced', 'intradialytic', 'event', '.']"
"A comprehensive description of kidney disease progression after acute kidney injury from a prospective, parallel-group cohort study.","Kerry L Horne, Daniela Viramontes-Hörner, Rebecca Packington, John Monaghan, Susan Shaw, Aleli Akani, Timothy Reilly, Thomas Trimble, Grazziela Figueredo, Nicholas M Selby, Kerry L Horneet al.",2023 Dec,Kidney Int,https://pubmed.ncbi.nlm.nih.gov/37611867/,"acute kidney injury, chronic kidney disease, long-term outcomes, mortality.","['age', ',', 'baseline', 'kidney', 'function', ',', 'and', 'diabetes', '.', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'and', 'urinary', 'albumincreatinine', 'ratio', '(', 'uacr', ')', 'measured', 'three-months', ',', 'one-', ',', 'three-', 'and', 'five-years', '.', 'outcome', 'included', 'kidney', 'disease', 'progression', ',', 'heart', 'failure', 'episode', 'and', 'mortality', '.', 'in', 'matched', 'individual', ',', 'kidney', 'disease', 'progression', 'five', 'year', 'found', 'to', 'significantly', 'increased', 'in', 'of', 'exposed', 'group', 'versus', 'of', 'non-exposed', '(', 'adjusted', 'odds', 'ratio', '.', 'confidence', 'interval', '.', 'to', '.', ')', '.', 'in', 'aki', 'group', ',', 'largely', 'characterized', 'incomplete', 'recovery', 'of', 'kidney', 'function', 'three', 'month', '.', 'episode', 'of', 'aki', 'follow-up', 'significantly', 'common', 'in', 'exposed', 'group', '(', 'odds', 'ratio', '.', '.', 'to', '.', ')', 'and', 'additive', 'effect', 'risk', 'of', 'kidney', 'disease', 'progression', '.', 'mortality', 'and', 'heart', 'failure', 'episode', 'frequent', 'in', 'exposed', 'group', ',', 'association', 'with', 'aki', 'no', 'longer', 'significant', 'model', 'adjusted', 'three-month', 'egfr', 'and', 'uacr', '.', 'in', 'general', 'hospitalized', 'population', ',', 'kidney', 'disease', 'progression', 'five', 'year', 'common', 'and', 'strongly', 'associated', 'with', 'aki', '.', 'thus', ',', 'time', 'course', 'of', 'change', 'and', 'attenuation', 'of', 'association', 'with', 'adverse', 'outcome', 'adjustment', 'three-month', 'egfr', 'and', 'uacr', 'suggest', 'non-recovery', 'of', 'kidney', 'function', 'important', 'assessment', 'in', 'post-aki', 'care', 'and', 'potential', 'future', 'target', 'intervention', '.', 'study', 'registration', 'isrctn', '.']"
Development and validation of a prediction model for the early occurrence of acute kidney injury in patients with acute pancreatitis.,"Simin Wu, Qin Zhou, Yang Cai, Xiangjie Duan, Simin Wuet al.",2023 Dec,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/36999227/,No keywords found,"['acute', 'pancreatitis', '(', 'ap', ')', 'associated', 'with', 'high', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'study', 'aimed', 'to', 'develop', 'nomogram', 'predicting', 'early', 'onset', 'of', 'aki', 'in', 'ap', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', '.', 'method', 'clinical', 'data', 'patient', 'diagnosed', 'with', 'ap', 'extracted', 'medical', 'information', 'mart', 'intensive', 'care', 'iv', 'database', '.', 'eligible', 'ap', 'patient', 'randomly', 'divided', 'training', 'and', 'validation', 'cohort', '.', 'independent', 'prognostic', 'factor', 'early', 'development', 'of', 'aki', 'in', 'ap', 'patient', 'determined', 'using', 'all-subsets', 'regression', 'method', 'and', 'multivariate', 'logistic', 'regression', '.', 'nomogram', 'constructed', 'predicting', 'early', 'occurrence', 'of', 'aki', 'in', 'ap', 'patient', '.', 'performance', 'of', 'nomogram', 'evaluated', 'based', 'area', 'receiver', 'operating', 'characteristic', 'curve', '(', 'auc', ')', ',', 'calibration', 'curve', 'and', 'decision', 'curve', 'analysis', '(', 'dca', ')', '.', 'result', 'seven', 'independent', 'prognostic', 'factor', 'identified', 'predictive', 'factor', 'early', 'onset', 'aki', 'in', 'ap', 'patient', '.', 'auc', 'of', 'nomogram', 'in', 'training', 'and', 'validation', 'cohort', '.', '(', 'ci', ',', '.-', '.', ')', 'and', '.', '(', 'ci', ',', '.-', '.', ')', ',', 'respectively', '.', 'auc', 'of', 'nomogram', 'higher', 'compared', 'with', 'of', 'bisap', ',', 'ranson', ',', 'apache', 'ii', 'score', '.', ',', 'calibration', 'curve', 'revealed', 'predicted', 'outcome', 'in', 'agreement', 'with', 'actual', 'observation', '.', 'finally', ',', 'dca', 'curve', 'showed', 'nomogram', 'good', 'clinical', 'applicability', 'value', '.', 'conclusion', 'constructed', 'nomogram', 'showed', 'good', 'predictive', 'ability', 'early', 'occurrence', 'of', 'aki', 'in', 'ap', 'patient', '.']"
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America.,"Noopur Raje, Garson David Roodman, Wolfgang Willenbacher, Kazuyuki Shimizu, Ramón García-Sanz, Evangelos Terpos, Lisa Kennedy, Lorenzo Sabatelli, Michele Intorcia, Guy Hechmati, Noopur Rajeet al.",2018 May,J Med Econ,https://pubmed.ncbi.nlm.nih.gov/29480139/,No keywords found,"['large', ',', 'pivotal', ',', 'phase', 'trial', 'in', 'patient', 'with', 'newly', 'diagnosed', 'multiple', 'myeloma', '(', 'mm', ')', 'demonstrated', 'denosumab', ',', 'compared', 'with', 'zoledronic', 'acid', ',', 'non-inferior', 'prevention', 'of', 'skeletal-related', 'event', '(', 'sres', ')', ',', 'extended', 'observed', 'median', 'progression-free', 'survival', '(', 'pfs', ')', '.', 'month', ',', 'and', 'showed', 'significantly', 'less', 'renal', 'toxicity', '.', 'cost-effectiveness', 'of', 'denosumab', 'v', 'zoledronic', 'acid', 'in', 'mm', 'in', 'u', 'assessed', 'societal', 'and', 'payer', 'perspective', '.', 'method', 'xgeva', 'global', 'economic', 'model', 'developed', 'integrating', 'data', 'phase', 'trial', 'comparing', 'efficacy', 'of', 'denosumab', 'with', 'zoledronic', 'acid', 'prevention', 'of', 'sres', 'in', 'mm', '.', 'sre', 'rate', 'adjusted', 'to', 'reflect', 'real-world', 'incidence', '.', 'model', 'included', 'utility', 'decrement', 'sres', ',', 'administration', ',', 'serious', 'adverse', 'event', '(', 'saes', ')', ',', 'and', 'disease', 'progression', '.', 'drug', ',', 'administration', ',', 'sre', 'management', ',', 'saes', ',', 'and', 'anti-mm', 'treatment', 'cost', 'based', 'data', 'published', 'study', '.', 'societal', 'perspective', ',', 'model', 'additionally', 'included', 'sre-related', 'direct', 'non-medical', 'cost', 'and', 'indirect', 'cost', '.', 'net', 'monetary', 'benefit', '(', 'nmb', ')', 'calculated', 'using', 'willingness-to-pay', 'threshold', 'of', 'u', ',', '.', 'one-way', 'deterministic', 'and', 'probabilistic', 'sensitivity', 'analysis', 'conducted', '.', 'result', 'societal', 'perspective', ',', 'compared', 'with', 'zoledronic', 'acid', ',', 'use', 'of', 'denosumab', 'resulted', 'in', 'incremental', 'cost', 'of', 'u', ',', 'and', 'incremental', 'quality-adjusted', 'life-year', '(', 'qaly', ')', 'of', '.', ',', 'translating', 'cost', 'per', 'qaly', 'gained', 'of', 'u', ',', 'and', 'nmb', 'of', 'u', ',', 'in', 'favor', 'of', 'denosumab', '.', 'result', 'sensitive', 'to', 'sre', 'rate', 'and', 'pfs', 'parameter', '.', 'limitation', 'cost', 'estimated', 'multiple', 'source', ',', 'varied', 'tumor', 'type', ',', 'patient', 'population', ',', 'country', ',', 'and', 'parameter', '.', 'pfs', 'and', 'overall', 'survival', 'extrapolated', 'beyond', 'follow-up', 'of', 'primary', 'analysis', 'using', 'fitted', 'parametric', 'curve', '.', 'conclusion', 'denosumab', ""'s"", 'efficacy', 'in', 'delaying', 'or', 'preventing', 'sres', ',', 'potential', 'to', 'improve', 'pfs', ',', 'and', 'lack', 'of', 'renal', 'toxicity', 'make', 'cost-effective', 'option', 'prevention', 'of', 'sres', 'in', 'mm', 'compared', 'with', 'zoledronic', 'acid', '.']"
Acute Kidney Injury in Acute Ischemic Stroke Patients in Clinical Trials.,"Adnan I Qureshi, Hunain Aslam, Werdah Zafar, Wei Huang, Iryna Lobanova, Syed H Naqvi, Kunal Malhotra, Niraj Arora, Premkumar N Chandrasekaran, Farhan Siddiq, Brandi R French, Camilo R Gomez, Adnan I Qureshiet al.",2020 Sep,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/32618695/,No keywords found,"['acute', 'ischemic', 'stroke', 'patient', 'risk', 'of', 'acute', 'kidney', 'injury', 'due', 'to', 'volume', 'depletion', ',', 'contrast', 'exposure', ',', 'and', 'preexisting', 'comorbid', 'disease', '.', 'determined', 'occurrence', 'rate', 'and', 'identified', 'predictor', 'associated', 'with', 'acute', 'kidney', 'injury', 'in', 'acute', 'ischemic', 'stroke', 'patient', '.', 'setting', 'multiple', 'specialized', 'icu', 'within', 'academic', 'medical', 'center', '.', 'design', 'post', 'hoc', 'analysis', 'of', 'pooled', 'data', 'prospective', 'randomized', 'clinical', 'trial', '.', 'patient', 'acute', 'ischemic', 'stroke', 'patient', 'recruited', 'within', 'hour', 'or', 'within', 'hour', 'of', 'symptom', 'onset', '.', 'intervention', 'iv', 'recombinant', 'tissue', 'plasminogen', 'activator', ',', 'endovascular', 'treatment', ',', 'iv', 'albumin', ',', 'or', 'placebo', '.', 'measurement', 'and', 'main', 'result', 'serum', 'creatinine', 'level', 'baseline', 'and', 'within', 'day', 'or', 'discharge', 'used', 'to', 'classify', 'acute', 'kidney', 'injury', 'classification', 'stage', '.', 'increase', 'in', 'serum', 'creatinine', 'seen', 'in', '(', '.', ')', 'and', 'acute', 'kidney', 'injury', 'seen', 'in', '(', '.', ')', 'of', ',', 'patient', 'with', 'acute', 'ischemic', 'stroke', '.', 'severity', 'of', 'acute', 'kidney', 'injury', 'grade', ',', 'ii', ',', 'and', 'iii', 'in', '.', ',', '.', ',', 'and', '.', 'patient', ',', 'respectively', '.', 'patient', 'with', 'albumin', '(', '.', 'compared', 'with', '.', 'p', '.', ')', ',', 'preexisting', 'hypertension', '(', '.', 'compared', 'with', '.', 'p', '.', ')', ',', 'and', 'preexisting', 'renal', 'disease', '(', '.', 'compared', 'with', '.', 'p', '.', ')', 'higher', 'risk', 'of', 'acute', 'kidney', 'injury', '.', 'risk', 'of', 'acute', 'kidney', 'injury', 'lower', 'either', 'underwent', 'ct', 'angiography', '(', '.', 'compared', 'with', '.', 'p', '.', ')', 'or', 'endovascular', 'treatment', '(', '.', 'compared', 'with', '.', 'p', '.', ')', '.', 'in', 'multivariate', 'analysis', ',', 'hypertension', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', 'and', 'renal', 'disease', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', 'associated', 'with', 'acute', 'kidney', 'injury', '.', 'risk', 'of', 'death', 'significantly', 'higher', 'among', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', 'adjusting', 'age', 'and', 'national', 'institute', 'of', 'health', 'stroke', 'scale', 'score', 'stratum', '.', 'conclusion', 'occurrence', 'rate', 'of', 'acute', 'kidney', 'injury', 'in', 'acute', 'ischemic', 'stroke', 'patient', 'low', 'and', 'not', 'higher', 'in', 'patient', 'underwent', 'ct', 'angiogram', 'or', 'received', 'endovascular', 'treatment', '.', 'occurrence', 'of', 'acute', 'kidney', 'injury', 'increased', 'risk', 'of', 'death', 'within', 'month', 'among', 'acute', 'ischemic', 'stroke', 'patient', '.']"
"Electronic Alerts for Acute Kidney Injury Amelioration (ELAIA-1): a completely electronic, multicentre, randomised controlled trial: design and rationale.","Marina Mutter, Melissa Martin, Yu Yamamoto, Aditya Biswas, Boian Etropolski, Harold Feldman, Amit Garg, Noah Gourlie, Stephen Latham, Haiqun Lin, Paul M Palevsky, Chirag Parikh, Erica Moreira, Ugochukwu Ugwuowo, Francis P Wilson, Marina Mutteret al.",2019 Jun 1,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/31154298/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'among', 'hospitalised', 'patient', 'and', 'under-recognised', 'provider', 'and', 'yet', 'carry', 'significant', 'risk', 'of', 'morbidity', 'and', 'mortality', '.', 'electronic', 'alert', 'aki', 'become', 'common', 'despite', 'lack', 'of', 'strong', 'evidence', 'of', 'benefit', '.', 'designed', 'multicentre', ',', 'randomised', ',', 'controlled', 'trial', 'to', 'evaluate', 'effectiveness', 'of', 'aki', 'alert', '.', 'aim', 'to', 'highlight', 'several', 'challenge', 'faced', 'in', 'design', 'of', 'trial', ',', 'us', 'electronic', 'screening', ',', 'enrolment', ',', 'randomisation', ',', 'intervention', 'and', 'data', 'collection', '.', 'method', 'and', 'analysis', 'design', 'and', 'implementation', 'of', 'electronic', 'alert', 'system', 'aki', 'reiterative', 'process', 'involving', 'several', 'challenge', 'and', 'limitation', 'set', 'confines', 'of', 'electronic', 'medical', 'record', 'system', '.', 'trial', 'electronically', 'identify', 'and', 'randomise', 'adult', 'with', 'aki', 'six', 'hospital', '.-', 'year', 'period', 'to', 'usual', 'care', 'versus', 'electronic', 'alert', 'containing', 'aki-specific', 'order', 'set', '.', 'primary', 'outcome', 'composite', 'of', 'aki', 'progression', ',', 'inpatient', 'dialysis', 'and', 'inpatient', 'death', 'within', 'day', 'of', 'randomisation', '.', '-month', 'pilot', 'in', 'medical', 'intensive', 'care', 'unit', 'of', 'yale', 'new', 'hospital', ',', 'demonstrated', 'feasibility', 'of', 'automating', 'enrolment', 'and', 'data', 'collection', '.', 'feedback', 'provider', 'exposed', 'to', 'alert', 'used', 'to', 'continually', 'improve', 'alert', 'clarity', ',', 'user', 'friendliness', 'and', 'alert', 'specificity', 'refined', 'inclusion', 'and', 'exclusion', 'criterion', '.', 'ethic', 'and', 'dissemination', 'study', 'approved', 'appropriate', 'ethic', 'committee', 'of', 'study', 'site', '.', 'study', 'qualified', 'waiver', 'of', 'informed', 'consent', 'present', 'no', 'minimal', 'risk', 'and', 'not', 'feasibly', 'conducted', 'in', 'absence', 'of', 'waiver', '.', 'committed', 'to', 'open', 'dissemination', 'of', 'data', 'clinicaltrials.gov', 'and', 'submission', 'of', 'result', 'to', 'nih', 'data', 'sharing', 'repository', '.', 'result', 'of', 'trial', 'submitted', 'publication', 'in', 'peer-reviewed', 'journal', '.', 'trial', 'registration', 'number', 'nct', 'pre-results', '.']"
Plasma Neutrophil Gelatinase-Associated Lipocalin Is Associated With Acute Kidney Injury and Clinical Outcomes in Neonates Undergoing Cardiopulmonary Bypass.,"Luke W Schroeder, Jason R Buckley, Robert E Stroud, Renee H Martin, Elizabeth K Nadeau, Ryan Barrs, Eric M Graham, Luke W Schroederet al.",2019 Oct,Pediatr Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/31206501/,No keywords found,"['acute', 'kidney', 'injury', 'frequent', 'complication', 'following', 'neonatal', 'cardiac', 'surgery', 'and', 'associated', 'with', 'significant', 'morbidity', 'and', 'mortality', '.', 'objective', 'of', 'study', 'to', 'determine', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'associated', 'with', 'acute', 'kidney', 'injury', 'and', 'clinical', 'outcome', 'in', 'neonate', 'with', 'congenital', 'heart', 'disease', 'undergoing', 'cardiopulmonary', 'bypass', '.', 'design', 'retrospective', 'single-center', 'observational', 'study', '.', 'setting', 'pediatric', 'cardiac', 'icu', 'within', 'tertiary-care', 'academic', 'hospital', '.', 'patient', 'patient', 'age', 'less', 'day', 'undergoing', 'cardiac', 'surgery', 'requiring', 'cardiopulmonary', 'bypass', '.', 'intervention', 'none', '.', 'measurement', 'and', 'main', 'result', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'peaked', 'hour', 'postcardiopulmonary', 'bypass', 'and', 'doubled', 'compared', 'with', 'preoperative', 'level', '.', 'higher', 'preoperative', 'and', '-hour', 'postoperative', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'associated', 'with', 'acute', 'kidney', 'injury', '(', 'r', '.', ',', 'r', '.', ')', ',', 'longer', 'duration', 'of', 'mechanical', 'ventilation', '(', 'r', '.', ',', 'r', '.', ')', ',', 'icu', '(', 'r', '.', ',', 'r', '.', ')', 'and', 'hospital', 'length', 'of', 'stay', '(', 'r', '.', ',', 'r', '.', ')', ',', 'and', 'total', 'hospital', 'charge', '(', 'r', '.', ',', 'r', '.', 'p', 'value', '.', ')', '.', 'conclusion', 'preoperative', 'and', '-hour', 'postoperative', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'associated', 'with', 'acute', 'kidney', 'injury', 'and', 'worse', 'clinical', 'outcome', 'in', 'neonate', 'undergoing', 'cardiac', 'surgery', '.', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'may', 'role', 'in', 'risk', 'stratification', 'predicting', 'postoperative', 'renal', 'dysfunction', 'well', 'providing', 'potential', 'clinical', 'trajectory', 'in', 'postoperative', 'period', '.']"
Impact of a novel contrast reduction system on contrast savings in coronary angiography - The DyeVert randomised controlled trial.,"Steffen Desch, Georg Fuernau, Janine Pöss, Roza Meyer-Saraei, Mohammed Saad, Ingo Eitel, Holger Thiele, Suzanne de Waha, Steffen Deschet al.",2018 Apr 15:257:50-53.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/29373136/,No keywords found,"['prominent', 'procedure-related', 'and', 'thus', 'modifiable', 'risk', 'factor', 'contrast-induced', 'acute', 'kidney', 'injury', 'contrast', 'medium', '(', 'cm', ')', 'volume', '.', 'dyevert', 'system', 'designed', 'to', 'reduce', 'amount', 'of', 'cm', '.', 'primary', 'objective', 'of', 'randomised', 'controlled', 'trial', 'thus', 'to', 'examine', 'whether', 'novel', 'dyevert', 'contrast', 'reduction', 'system', '(', 'osprey', 'medical', 'inc.', ',', 'minnetonka', ',', 'mn', ',', 'usa', ')', 'lead', 'to', 'reduction', 'in', 'cm', 'volume', 'in', 'patient', 'undergoing', 'diagnostic', 'coronary', 'angiography', '.', 'method', 'patient', 'scheduled', 'diagnostic', 'coronary', 'angiogram', 'randomised', 'to', 'angiography', 'with', 'or', 'without', 'dyevert', 'system', '.', 'primary', 'efficacy', 'endpoint', 'mean', 'cm', 'volume', '.', 'image', 'quality', 'evaluated', 'independent', 'reviewer', 'blinded', 'to', 'treatment', 'allocation', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomisation', '.', 'baseline', 'characteristic', 'well', 'balanced', 'group', '.', 'use', 'of', 'dyevert', 'system', 'resulted', 'in', 'significant', '.', 'reduction', 'in', 'cm', 'volume', '(', '..', 'ml', 'versus', '..', 'ml', ',', 'p.', ')', '.', 'image', 'quality', 'using', 'dyevert', 'system', 'non-inferior', 'compared', 'to', 'control', '(', 'p.', ')', '.', 'no', 'device-related', 'adverse', 'event', '.', 'conclusion', 'dyevert', 'system', 'lead', 'to', 'significant', 'reduction', 'in', 'cm', 'volume', 'in', 'patient', 'undergoing', 'diagnostic', 'coronary', 'angiography', ',', 'maintaining', 'image', 'quality', '.']"
"Sports drinks do not increase acute kidney injury risk in males during industrial work in the heat when euhydration is maintained, a randomized crossover trial.","Whitley C Atkins, Zachary J McKenna, Brendon P McDermott, Whitley C Atkinset al.",2024 Jun 1,Appl Physiol Nutr Metab,https://pubmed.ncbi.nlm.nih.gov/38452351/,"acute kidney injury, fructose, hydration, sports drinks.","['ln', '.', '.', 'sport', 'drink', 'ln', '.', '.', 'pgml', 'groupwide', '.', ',', 'p', '.', ')', '.', 'data', 'provide', 'no', 'evidence', 'consumption', 'of', 'fructose', 'sweetened', 'sport', 'drink', 'increase', 'risk', 'of', 'acute', 'kidney', 'injury', 'physical', 'work', 'in', 'heat', '.']"
Nephroprotective effects of remote ischemic preconditioning in coronary angiography.,"Naufal Shamilevich Zagidullin, Alina Rinatovna Dunayeva, Valdimir Vyacheslavovich Plechev, Alexander Zhanovich Gilmanov, Shamil Zarifovich Zagidullin, Fikret Er, Valentin Nikolaevich Pavlov, Naufal Shamilevich Zagidullinet al.",2017,Clin Hemorheol Microcirc,https://pubmed.ncbi.nlm.nih.gov/27814282/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'formidable', 'side', 'effect', 'of', 'iodinated', 'contrast', 'medium', 'use', 'in', 'subject', 'undergoing', 'coronary', 'angiogram', '(', 'cag', ')', '.', 'remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'may', 'reduce', 'risk', 'of', 'cin', '.', 'aim', 'aim', 'of', 'study', 'to', 'investigate', 'nephroprotective', 'effect', 'of', 'ripc', 'in', 'coronary', 'heart', 'disease', '(', 'chd', ')', 'in', 'patient', ',', 'undergoing', 'cag', ',', 'with', 'mild', 'to', 'moderate', 'lowered', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', '.', 'material', 'in', 'randomized', ',', 'blinded', ',', 'sham', 'ripc', '(', 'sripc', ')', 'controlled', 'study', 'patient', 'with', 'chd', 'and', 'gfr', 'less', 'mlminm', ',', 'undergoing', 'cag', ',', 'investigated', '.', 'patient', 'randomized', 'ripc', '(', 'n', ',', '..', 'year', ')', 'or', 'sripc', '(', 'n', ',', '..', ')', '.', 'ripc', 'performed', 'cag', 'mean', 'of', '--', 'minute', 'cycle', 'cuff', 'pumped', 'upper', 'arm', 'mm', 'hg', 'systolic', 'blood', 'pressure', '(', 'bp', ')', ',', 'in', 'sripc', 'corresponded', 'to', 'diastolic', 'bp', '.', 'primary', 'endpoint', 'development', 'of', 'cin', 'and', 'secondary', '-', 'change', 'of', 'biomarkers', '(', 'creatinine', ',', 'urea', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'cystatin-c', ')', '.', 'result', 'in', 'ripc', 'group', ',', 'cin', 'occurred', 'in', 'of', 'case', ',', 'in', 'sripc', '-', '..', 'investigated', 'marker', 'increased', 'in', 'sripc', 'and', 'declined', 'in', 'ripc', 'difference', 'significant', 'in', 'marker', 'group', 'and', 'cag', '.', 'conclusion', 'ripc', 'proved', 'nephroprotective', 'effect', 'in', 'prevention', 'of', 'contrast-induced', 'nephropathy', 'in', 'chd', 'subject', 'with', 'mild', 'to', 'moderate', 'lowered', 'egfr', '.']"
A Clinical Nomogram Based on the Triglyceride-Glucose Index to Predict Contrast-Induced Acute Kidney Injury after Percutaneous Intervention in Patients with Acute Coronary Syndrome with Diabetes Mellitus.,"Yue Hu, Xiaotong Wang, Shengjue Xiao, Na Sun, Chunyan Huan, Huimin Wu, Minjia Guo, Tao Xu, Defeng Pan, Yue Huet al.",2022 Oct 27:2022:5443880.,Cardiovasc Ther,https://pubmed.ncbi.nlm.nih.gov/36349299/,No keywords found,"['.', 'based', 'result', 'of', 'lasso', 'regression', 'and', 'multivariate', 'analysis', ',', 'determined', 'subtypes', 'of', 'ac', ',', 'age', ',', 'multivessel', 'coronary', 'artery', 'disease', ',', 'hyperuricemia', ',', 'low-density', 'lipoprotein', 'cholesterol', ',', 'triglyceride-glucose', 'index', ',', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'independent', 'predictor', 'ci-aki', 'pci', 'in', 'patient', 'with', 'ac', 'combined', 'with', 'dm', '.', 'using', 'indicator', 'to', 'develop', 'nomogram', ',', 'auc-roc', 'of', 'training', 'and', 'validation', 'set', 'calculated', 'to', '.', '(', 'confidence', 'interval', '(', 'ci', ')', '.-', '.', ')', 'and', '.', '(', 'ci', '.-', '.', ')', ',', 'respectively', ',', 'indicating', 'high', 'prediction', 'efficiency', '.', 'verification', 'bootstrap', 'internal', 'verification', ',', 'found', 'calibration', 'curve', 'showed', 'good', 'agreement', 'nomogram', 'predicted', 'and', 'observed', 'value', '.', 'and', 'dca', 'result', 'showed', 'nomogram', 'high', 'clinical', 'application', '.', 'in', 'conclusion', ',', 'constructed', 'and', 'validated', 'nomogram', 'to', 'predict', 'ci-aki', 'risk', 'pci', 'in', 'patient', 'with', 'ac', 'and', 'dm', '.', 'model', 'provide', 'scientific', 'reference', 'predicting', 'occurrence', 'of', 'ci-aki', 'and', 'improving', 'prognosis', 'of', 'patient', '.']"
Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate >60 mL/min at 1 year.,"Sokratis Stoumpos, Patrick B Mark, Emily P McQuarrie, Jamie P Traynor, Colin C Geddes, Sokratis Stoumposet al.",2017 Jan 1,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/28391314/,No keywords found,"['severe', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'among', 'hospitalized', 'patient', 'often', 'necessitates', 'initiation', 'of', 'short-term', 'dialysis', '.', 'little', 'known', 'long-term', 'outcome', 'of', 'recover', 'to', 'normal', 'renal', 'function', '.', 'aim', 'of', 'study', 'to', 'determine', 'long-term', 'renal', 'outcome', 'of', 'patient', 'experiencing', 'aki', 'requiring', 'dialysis', 'secondary', 'to', 'hypoperfusion', 'injury', 'andor', 'sepsis', 'recovered', 'to', 'apparently', 'normal', 'renal', 'function', '.', 'method', 'adult', 'patient', 'with', 'aki', 'requiring', 'dialysis', 'in', 'centre', 'january', 'and', 'december', 'identified', '.', 'included', 'patient', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'mlmin', '.', 'month', 'or', 'later', 'episode', 'of', 'aki', '.', 'patient', 'followed', 'march', '.', 'primary', 'outcome', 'time', 'to', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '(', 'defined', 'egfr', 'persistently', 'mlmin', '.', 'month', 'episode', 'of', 'aki', '.']"
High-Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery.,"Loren E Smith, Derek K Smith, Jeffrey D Blume, MacRae F Linton, Frederic T Billings th, Loren E Smithet al.",2017 Dec 9,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/29223955/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', 'associated', 'with', 'increased', 'short-', 'and', 'long-term', 'mortality', '.', 'inflammation', ',', 'oxidative', 'stress', ',', 'and', 'endothelial', 'dysfunction', 'and', 'damage', 'play', 'important', 'role', 'in', 'development', 'of', 'aki', '.', 'high-density', 'lipoprotein', '(', 'hdl', ')', 'anti-inflammatory', 'and', 'antioxidant', 'property', 'and', 'improve', 'endothelial', 'function', 'and', 'repair', '.', 'statin', 'enhance', 'hdl', ""'s"", 'anti-inflammatory', 'and', 'antioxidant', 'capacity', '.', 'hypothesized', 'higher', 'preoperative', 'hdl', 'cholesterol', 'concentration', 'associated', 'with', 'decreased', 'aki', 'cardiac', 'surgery', 'and', 'perioperative', 'statin', 'exposure', 'potentiates', 'association', '.', 'method', 'and', 'result', 'tested', 'hypothesis', 'in', 'subject', 'randomized', 'clinical', 'trial', 'of', 'perioperative', 'atorvastatin', 'to', 'reduce', 'aki', 'cardiac', 'surgery', '.', '-component', 'latent', 'variable', 'mixture', 'model', 'used', 'to', 'assess', 'association', 'preoperative', 'hdl', 'cholesterol', 'concentration', 'and', 'postoperative', 'change', 'in', 'serum', 'creatinine', ',', 'adjusted', 'known', 'aki', 'risk', 'factor', 'and', 'suspected', 'confounders', '.', 'interaction', 'term', 'used', 'to', 'examine', 'effect', 'of', 'preoperative', 'statin', 'use', ',', 'preoperative', 'statin', 'dose', ',', 'and', 'perioperative', 'atorvastatin', 'treatment', 'association', 'preoperative', 'hdl', 'and', 'aki', '.', 'higher', 'preoperative', 'hdl', 'cholesterol', 'concentration', 'independently', 'associated', 'with', 'decreased', 'postoperative', 'serum', 'creatinine', 'change', '(', 'p.', ')', '.', 'association', 'high', 'hdl', 'concentration', 'and', 'attenuated', 'increase', 'in', 'serum', 'creatinine', 'strongest', 'in', 'long-term', 'statin-using', 'patient', '(', 'p.', ')', 'and', 'enhanced', 'with', 'perioperative', 'atorvastatin', 'treatment', '(', 'p.', ')', 'and', 'increasing', 'long-term', 'statin', 'dose', '(', 'p.', ')', '.', 'conclusion', 'higher', 'preoperative', 'hdl', 'cholesterol', 'concentration', 'associated', 'with', 'decreased', 'aki', 'cardiac', 'surgery', '.', 'preoperative', 'and', 'perioperative', 'statin', 'treatment', 'enhanced', 'association', ',', 'demonstrating', 'pharmacological', 'potentiation', 'possible', 'perioperative', 'period', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Development and validation of a nomogram to predict the risk of renal replacement therapy among acute kidney injury patients in intensive care unit.,"Jiang-Chen Peng#, Yan Wu#, Shun-Peng Xing, Ming-Li Zhu, Yuan Gao, Wen Li, Jiang-Chen Penget al.",2023 Nov,Clin Exp Nephrol,https://pubmed.ncbi.nlm.nih.gov/37498349/,No keywords found,"['no', 'universally', 'accepted', 'indication', 'to', 'initiate', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'among', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'study', 'aimed', 'to', 'develop', 'nomogram', 'to', 'predict', 'risk', 'of', 'rrt', 'among', 'aki', 'patient', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'method', 'in', 'retrospective', 'cohort', 'study', ',', 'extracted', 'aki', 'patient', 'medical', 'information', 'mart', 'intensive', 'care', 'iii', '(', 'mimic-iii', ')', 'database', '.', 'patient', 'randomly', 'divided', 'training', 'cohort', '(', ')', 'and', 'validation', 'cohort', '(', ')', '.', 'multivariable', 'logistic', 'regression', 'based', 'akaike', 'information', 'criterion', 'used', 'to', 'establish', 'nomogram', '.', 'discrimination', 'and', 'calibration', 'of', 'nomogram', 'evaluated', 'harrell', ""'s"", 'concordance', 'index', '(', 'c-index', ')', 'and', 'hosmer-lemeshow', '(', 'hl', ')', 'test', '.', 'decision', 'curve', 'analysis', '(', 'dca', ')', 'performed', 'to', 'evaluate', 'clinical', 'application', '.', 'result', 'total', 'of', 'critically', 'ill', 'patient', 'with', 'aki', 'finally', 'enrolled', '.', '(', '.', ')', 'patient', 'received', 'rrt', 'icu', 'admission', '.', '(', ')', 'patient', 'in', 'training', 'cohort', 'and', '(', ')', 'patient', 'in', 'validation', 'cohort', '.', 'nine', 'variable', ',', 'namely', ',', 'age', ',', 'hemoglobin', ',', 'creatinine', ',', 'blood', 'urea', 'nitrogen', 'and', 'lactate', 'aki', 'detection', ',', 'comorbidity', 'of', 'congestive', 'heart', 'failure', ',', 'aki', 'stage', ',', 'and', 'vasopressor', 'use', 'included', 'in', 'nomogram', '.', 'predictive', 'model', 'demonstrated', 'satisfying', 'discrimination', 'and', 'calibration', 'with', 'c-index', 'of', '.', '(', 'ci', ',', '.-', '.', 'hl', 'test', ',', 'p', '.', ')', 'in', 'training', 'set', 'and', '.', '(', 'ci', ',', '.-', '.', 'hl', 'test', ',', 'p', '.', ')', 'in', 'validation', 'set', '.', 'dca', 'showed', 'positive', 'net', 'benefit', 'of', 'nomogram', '.', 'conclusion', 'nomogram', 'developed', 'in', 'study', 'highly', 'accurate', 'rrt', 'prediction', 'with', 'potential', 'application', 'value', '.']"
Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test.,"Jennifer L J Heaney, John P Campbell, Punit Yadav, Ann E Griffin, Meena Shemar, Jennifer H Pinney, Mark T Drayson, Jennifer L J Heaneyet al.",2017 Jul 20,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/28728609/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'in', 'patient', 'with', 'multiple', 'myeloma', '(', 'mm', ')', '.', 'whether', 'serum', 'free', 'light', 'chain', '(', 'sflc', ')', 'measurement', 'distinguish', 'myeloma', 'and', 'cause', 'of', 'aki', 'requires', 'confirmation', 'to', 'guide', 'early', 'treatment', '.', 'rapid', 'and', 'portable', 'sflc', 'test', '(', 'seralite', ')', 'newly', 'available', 'and', 'could', 'reduce', 'delay', 'in', 'obtaining', 'sflc', 'result', 'and', 'accelerate', 'diagnosis', 'in', 'patient', 'with', 'unexplained', 'aki', '.', 'study', 'evaluated', 'accuracy', 'of', 'seralite', 'to', 'identify', 'mm', 'cause', 'of', 'aki', '.', 'method', 'sflcs', 'retrospectively', 'analysed', 'in', 'patient', 'with', 'aki', 'stage', 'per', 'kdigo', 'criterion', '(', 'i.e', '.', 'serum', 'creatinine', 'moll', 'or', 'dialysis', 'treatment', ')', '(', 'n', ')', 'patient', 'confirmed', 'mm', 'diagnosis', '.', 'result', 'seralite', 'flc', 'ratio', 'accurately', 'diagnosed', 'mm', 'patient', 'in', 'presence', 'of', 'aki', 'range', 'of', '.-', '.', 'returned', 'sensitivity', 'and', 'specificity', 'identifying', 'non-myeloma', 'related', 'aki', 'patient', '.', 'sflc', 'difference', '(', 'dflc', ')', 'also', 'demonstrated', 'high', 'sensitivity', '(', ')', 'and', 'specificity', '(', ')', 'optimal', 'cut-off', 'of', 'mgl', 'distinguished', 'myeloma', 'and', 'non-myeloma', 'aki', 'patient', '.', 'propose', 'pathway', 'of', 'patient', 'screening', 'and', 'stratification', 'in', 'unexplained', 'aki', 'use', 'of', 'seralite', 'in', 'clinical', 'practice', ',', 'with', 'ratio', 'range', 'of', '.-', '.', 'and', 'dflc', 'mgl', 'decision', 'point', '.', 'conclusion', 'seralite', 'accurately', 'differentiates', 'aki', 'due', 'to', 'mm', 'and', 'aki', 'due', 'to', 'cause', 'in', 'patient', 'considered', 'risk', 'of', 'myeloma', '.', 'rapid', 'test', 'sensitively', 'screen', 'mm', 'in', 'patient', 'with', 'aki', 'and', 'help', 'inform', 'early', 'treatment', 'intervention', '.']"
Predictive Capacity of Oxygen Delivery During Cardiopulmonary Bypass on Acute Kidney Injury.,"Richard F Newland, Robert A Baker, Richard J Woodman, Mary B Barnes, Timothy W Willcox                              ;, Australian and New Zealand Collaborative Perfusion Registry, Richard F Newlandet al.",2019 Dec,Ann Thorac Surg,https://pubmed.ncbi.nlm.nih.gov/31238029/,No keywords found,"['randomized', 'goal-directed', 'perfusion', 'trial', 'confirmed', 'retrospective', 'finding', 'goal-directed', 'perfusion', 'strategy', 'to', 'maintain', 'oxygen', 'delivery', 'index', '(', 'doi', ')', 'cardiopulmonary', 'bypass', 'greater', 'mlminm', 'reduces', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'developed', 'predictive', 'model', 'aki', 'using', 'data', 'australian', 'and', 'new', 'zealand', 'collaborative', 'perfusion', 'registry', 'to', 'determine', 'whether', 'finding', 'could', 'validated', 'in', 'real-world', 'clinical', 'setting', 'and', 'to', 'identify', 'optimal', 'doi', 'threshold', 'predictive', 'diagnostic', 'accuracy', '.', 'method', 'data', 'in', ',', 'cardiopulmonary', 'bypass', 'procedure', 'randomly', 'divided', 'training', '(', 'n', ')', 'and', 'validation', '(', 'n', ')', 'datasets', '.', 'multivariate', 'logistic', 'regression', 'used', 'to', 'determine', 'best', 'predictive', 'model', 'aki', '(', 'rifle', 'renal', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', 'of', 'renal', 'function', 'and', 'end-stage', 'renal', 'disease', 'classification', ')', ',', 'incremental', 'predictive', 'value', 'of', 'minimum', 'cardiopulmonary', 'bypass', 'doi', ',', 'and', 'optimal', 'threshold', '.', 'result', 'minimum', 'doi', 'significantly', 'associated', 'with', 'aki', ',', 'aki', 'risk', ',', 'and', 'aki', 'injury', 'or', 'greater', 'class', 'in', 'datasets', '(', 'validation', 'dataset', 'aki', 'odds', 'ratio', 'or', ',', '.', 'confidence', 'interval', 'ci', ',', '.-', '.', 'p', '.', 'aki', 'risk', 'or', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ',', 'aki', 'injury', 'or', 'greater', '.', 'ci', ',', '.-', '.', 'p', '.', ')', ',', 'representing', 'average', 'increase', 'in', 'likelihood', 'of', 'aki', 'every', '-mlminm', 'decrease', 'in', 'doi', '.', 'diagnostic', 'accuracy', 'similar', 'datasets', ',', 'with', 'optimal', 'doi', 'threshold', 'of', 'mlminm', '.', 'odds', 'of', 'aki', 'increased', 'in', 'threshold', '(', 'or', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'study', 'confirms', 'previous', 'finding', 'minimum', 'doi', 'cardiopulmonary', 'bypass', 'independently', 'associated', 'with', 'aki', ',', 'supporting', 'previous', 'finding', 'in', 'broader-risk', ',', 'multicenter', 'cohort', '.']"
The clinical utility of remote ischemic preconditioning in protecting against cardiac surgery-associated acute kidney injury: A pilot randomized clinical trial.,"Karolina Stokfisz, Anna Ledakowicz-Polak, Maciej Zagórski, Sławomir Jander, Katarzyna Przybylak, Marzenna Zielińska, Karolina Stokfiszet al.",2020 Feb,Adv Clin Exp Med,https://pubmed.ncbi.nlm.nih.gov/32091672/,No keywords found,"['cardiac', 'surgery-associated', 'acute', 'kidney', 'injury', '(', 'csa-aki', ')', 'well-known', ',', 'serious', 'complication', 'and', 'well-recognized', 'independent', 'risk', 'factor', 'higher', 'morbidity', 'and', 'mortality', 'among', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'objective', 'aim', 'of', 'study', 'to', 'assess', 'efficacy', 'of', 'remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'in', 'reducing', 'incidence', 'of', 'csa-aki', ',', 'measured', 'with', 'standard', 'creatinine', 'technique', 'and', 'using', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'serum', 'concentration', 'potential', 'new', 'biomarker', 'of', 'kidney', 'damage', '.', 'ethic', 'committee', 'of', 'medical', 'university', 'of', 'lodz', 'prospectively', 'approved', 'protocol', '(', 'approval', 'no', '.', 'rnnke', ')', '.', 'study', 'retrospectively', 'registered', 'with', 'u.s.', 'national', 'institute', 'of', 'health', '-', 'nih', '(', 'june', 'clinicaltrials.gov', 'identifier', 'nct', ')', '.', 'material', 'and', 'method', 'conducted', 'prospective', 'single-center', 'double-blind', 'randomized', 'and', 'controlled', 'tudy', '.', 'data', 'collected', 'patient', 'admitted', 'to', 'cardiosurgery', 'clinic', 'medical', 'university', 'of', 'lodz', '(', 'poland', ')', 'january', 'and', 'december', ',', 'scheduled', 'elective', 'cardiac', 'surgery', '(', 'off-pump', 'coronary', 'artery', 'bypass', ')', '.', 'total', 'of', 'patient', 'randomized', 'to', 'receive', 'either', 'ripc', '(', 'n', ')', 'or', 'sham', 'ripc', '(', 'n', ')', '.', 'induction', 'of', 'anesthesia', ',', 'patient', 'assigned', 'to', 'ripc', 'group', 'underwent', 'cycle', 'of', 'five-minute', 'inflation', 'to', 'mm', 'hg', 'and', 'five-minute', 'deflation', 'of', 'upper-arm', 'cuff', '.', 'control', 'group', 'deflated', 'cuff', 'placed', 'upper', 'arm', 'min', '.', 'author', 'measured', 'patient', ""'"", 'serum', 'creatinine', 'concentration', 'to', 'check', 'occurrence', 'of', 'csa-aki', 'within', 'h', 'cardiac', 'surgery', ',', 'and', 'ngal', 'serum', 'concentration', 'to', 'check', 'level', 'within', 'h', 'operation', '.', 'result', 'fewer', 'patient', 'in', 'ripc', 'group', 'developed', 'csa-aki', 'within', 'h', 'cardiac', 'surgery', 'in', 'control', 'group', '(', 'v', 'p', '.', ')', '.', 'fewer', 'patient', 'in', 'ripc', 'group', 'presented', 'increase', 'in', 'ngal', 'h', 'surgery', '(', 'median', 'v', '.', 'p', '.', ')', '.', 'conclusion', 'in', 'patient', 'undergoing', 'off-pump', 'coronary', 'artery', 'bypass', ',', 'ripc', 'significantly', 'reduces', 'occurrence', 'of', 'csa-aki', 'and', 'protects', 'increased', 'postoperative', 'ngal', 'level', '.']"
A retrospective analysis of the effect of blood transfusion on cerebral oximetry entropy and acute kidney injury.,"Milo Engoren, Russell R Brown, Anna Dubovoy, Milo Engorenet al.",2017 Jan,Perfusion,https://pubmed.ncbi.nlm.nih.gov/27440803/,No keywords found,"['acute', 'anemia', 'associated', 'with', 'cerebral', 'dysfunction', 'and', 'acute', 'kidney', 'injury', 'and', 'often', 'treated', 'with', 'red', 'blood', 'cell', 'transfusion', '.', 'sought', 'to', 'determine', 'blood', 'transfusion', 'changed', 'cerebral', 'oximetry', 'entropy', ',', 'measure', 'of', 'complexity', 'or', 'irregularity', 'of', 'oximetry', 'value', ',', 'and', 'change', 'associated', 'with', 'subsequent', 'acute', 'kidney', 'injury', '.', 'method', 'retrospective', ',', 'case-control', 'study', 'of', 'patient', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'tertiary', 'care', 'hospital', ',', 'comparing', 'received', 'red', 'blood', 'cell', 'transfusion', 'to', 'not', '.', 'acute', 'kidney', 'injury', 'defined', 'perioperative', 'increase', 'in', 'serum', 'creatinine', '.', 'moll', 'or', 'increase', '.', 'entropy', 'measured', 'using', 'approximate', 'entropy', ',', 'sample', 'entropy', ',', 'forbidden', 'word', 'entropy', 'and', 'basescale', 'entropy', 'in', '-point', 'set', '.', 'result', 'forty-four', 'transfused', 'patient', 'matched', 'to', 'randomly', 'selected', 'non-transfused', 'patient', '.', 'measure', 'of', 'entropy', 'small', 'change', 'in', 'transfused', 'group', ',', 'increased', 'in', 'non-transfused', 'group', '(', 'p.', ',', 'comparison', ')', '.', 'thirty-five', 'of', 'patient', '(', ')', 'suffered', 'acute', 'kidney', 'injury', '.', 'based', 'preoperative', 'factor', ',', 'patient', 'suffered', 'kidney', 'injury', 'similar', 'to', 'not', ',', 'including', 'baseline', 'cerebral', 'oximetry', 'level', '.', 'analysis', 'with', 'hierarchical', 'logistic', 'regression', ',', 'change', 'in', 'basescale', 'entropy', '(', 'odds', 'ratio', '.', ',', 'confidence', 'interval', '.-.', ',', 'p', '.', ')', 'and', 'interaction', 'basescale', 'entropy', 'and', 'transfusion', 'significantly', 'associated', 'with', 'subsequent', 'development', 'of', 'acute', 'kidney', 'injury', '.', 'conclusion', 'transfusion', 'of', 'red', 'blood', 'cell', 'associated', 'with', 'smaller', 'rise', 'in', 'entropy', 'value', 'compared', 'to', 'non-transfused', 'patient', ',', 'suggesting', 'change', 'in', 'regulation', 'of', 'cerebral', 'oxygenation', ',', 'and', 'change', 'in', 'cerebral', 'oxygenation', 'also', 'associated', 'with', 'acute', 'kidney', 'injury', '.']"
Neutrophil Gelatinase-Associated Lipocalin for the Early Prediction of Acute Kidney Injury in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.,"Ilan Merdler, Keren-Lee Rozenfeld, David Zahler, Moshe Shtark, Ilana Goldiner, Itamar Shimon Loewenstein, Lior Fortis, Aviram Hochstadt, Gad Keren, Shmuel Banai, Yacov Shacham, Ilan Merdleret al.",2020,Cardiorenal Med,https://pubmed.ncbi.nlm.nih.gov/32155621/,No keywords found,"['neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'glycoprotein', 'released', 'renal', 'tubular', 'cell', ',', 'used', 'marker', 'of', 'early', 'tubular', 'damage', '.', 'evaluated', 'plasma', 'ngal', 'level', 'utilization', 'identification', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'among', 'st-elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'patient', 'undergoing', 'primary', 'coronary', 'intervention', '(', 'pci', ')', '.', 'method', 'stemi', 'patient', 'treated', 'with', 'pci', 'prospectively', 'included', '.', 'plasma', 'ngal', 'level', 'drawn', 'prior', 'to', 'pci', '(', 'h', ')', 'and', 'h', 'afterwards', '.', 'aki', 'defined', 'per', 'kdigo', 'criterion', 'of', 'serum', 'creatinine', 'increase', '.', 'receiver-operating', 'characteristic', '(', 'roc', ')', 'method', 'used', 'to', 'identify', 'optimal', 'sensitivity', 'and', 'specificity', 'observed', 'ngal', 'range', '.', 'result', 'overall', 'aki', 'incidence', '.', 'ngal', 'level', 'significantly', 'higher', 'patient', 'with', 'aki', 'h', '(', 'vs.', 'p', 'ngml', ')', 'predicted', 'aki', 'with', 'sensitivity', 'and', 'specificity', '(', 'auc', '.', ',', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'in', 'multivariate', 'logistic', 'regression', 'model', ',', 'ngal', 'level', 'independently', 'associated', 'with', 'aki', 'h', '(', 'or', '.', ',', 'ci', '.-', '.', 'p', '.', ')', 'and', 'h', '(', 'or', '.', ',', 'ci', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'elevated', 'ngal', 'level', ',', 'suggesting', 'renal', 'tubular', 'damage', ',', 'independently', 'associated', 'with', 'aki', 'in', 'stemi', 'patient', 'undergoing', 'primary', 'pci', '.']"
Goal-directed perfusion to reduce acute kidney injury: A randomized trial.,"Marco Ranucci, Ian Johnson, Timothy Willcox, Robert A Baker, Christa Boer, Andreas Baumann, George A Justison, Filip de Somer, Paul Exton, Seema Agarwal, Rachael Parke, Richard F Newland, Renard G Haumann, Dirk Buchwald, Nathaen Weitzel, Rajamiyer Venkateswaran, Federico Ambrogi, Valeria Pistuddi, Marco Ranucciet al.",2018 Nov,J Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/29778331/,No keywords found,"['to', 'determine', 'whether', 'goal-directed', 'perfusion', '(', 'gdp', ')', 'strategy', 'aimed', 'maintaining', 'oxygen', 'delivery', '(', ')', 'mlmin-m-', 'reduces', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'method', 'multicenter', 'randomized', 'trial', 'enrolled', 'total', 'of', 'patient', 'undergoing', 'cardiac', 'surgery', 'in', 'institution', '.', 'patient', 'randomized', 'to', 'receive', 'either', 'gdp', 'or', 'conventional', 'perfusion', '.', 'total', 'of', 'patient', 'completed', 'study', 'and', 'analyzed', '.', 'patient', 'in', 'treatment', 'arm', 'treated', 'with', 'gdp', 'strategy', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'aimed', 'to', 'maintain', 'mlmin-m-', '.', 'perfusion', 'strategy', 'patient', 'in', 'control', 'arm', 'factored', 'body', 'surface', 'area', 'and', 'temperature', '.', 'primary', 'endpoint', 'rate', 'of', 'aki', '.', 'secondary', 'endpoint', 'intensive', 'care', 'unit', 'length', 'of', 'stay', ',', 'major', 'morbidity', ',', 'red', 'blood', 'cell', 'transfusion', ',', 'and', 'operative', 'mortality', '.', 'result', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'stage', 'reduced', 'in', 'patient', 'treated', 'with', 'gdp', '(', 'relative', 'risk', 'rr', ',', '.', 'confidence', 'interval', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'akin', 'stage', '-', 'not', 'differ', 'study', 'arm', '(', 'rr', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'secondary', 'outcome', '.', 'in', 'prespecified', 'analysis', 'of', 'patient', 'with', 'cpb', 'time', 'and', 'hour', ',', 'difference', 'in', 'favor', 'of', 'treatment', 'arm', 'pronounced', ',', 'with', 'rr', 'aki', 'of', '.', '(', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'gdp', 'strategy', 'effective', 'in', 'reducing', 'akin', 'stage', 'aki', '.', 'study', 'needed', 'to', 'define', 'perfusion', 'intervention', 'may', 'reduce', 'severe', 'level', 'of', 'renal', 'injury', '(', 'akin', 'stage', 'or', ')', '.']"
The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: A prospective randomized trial.,"Youn Yi Jo, Ji Young Kim, Ji Yeon Lee, Chang Hu Choi, Young Jin Chang, Hyun Jeong Kwak, Youn Yi Joet al.",2017 Jul,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/28700489/,No keywords found,"['dexmedetomidine', 'reported', 'to', 'renal', 'protective', 'effect', 'adult', 'open', 'heart', 'surgery', '.', 'author', 'hypothesized', 'intraoperative', 'infusion', 'of', 'dexmedetomidine', 'would', 'attenuate', 'decrease', 'in', 'renal', 'function', 'pediatric', 'open', 'heart', 'surgery', '.', 'method', 'twenty-nine', 'pediatric', 'patient', '(', '-', 'year', ')', 'scheduled', 'atrial', 'or', 'ventricular', 'septal', 'defect', 'repair', 'randomly', 'assigned', 'to', 'receive', 'either', 'continuous', 'infusion', 'of', 'normal', 'saline', '(', 'control', 'group', ',', 'n', ')', 'or', 'dexmedetomidine', '(', 'bolus', 'dose', 'of', '.', 'gkg', 'and', 'infusion', 'of', '.', 'gkgh', ')', '(', 'dexmedetomidine', 'group', ',', 'n', ')', 'anesthesia', 'induction', 'to', 'end', 'of', 'cardiopulmonary', 'bypass', '.', 'serum', 'creatinine', '(', 'scr', ')', 'measured', 'surgery', '(', ')', ',', 'minute', 'anesthesia', 'induction', '(', ')', ',', 'minute', 'cardiopulmonary', 'bypass', 'weaning', '(', ')', ',', 'hour', '(', ')', ',', 'and', 'postoperative', 'day', '(', 'pod', ')', 'and', 'postoperative', 'day', '(', 'pod', ')', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfrs', ')', 'calculated', '.', 'renal', 'biomarkers', 'measured', ',', ',', 'and', 't.', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'defined', 'absolute', 'increase', 'in', 'scr', 'of', '.', 'mgdl', 'or', 'percent', 'increase', 'in', 'scr', 'of', '.', 'result', 'incidence', 'of', 'aki', 'perioperative', 'period', 'significantly', 'higher', 'in', 'control', 'group', 'in', 'dexmedetomidine', 'group', '(', 'v', ',', 'p', '.', ')', '.', 'egfr', 'significantly', 'lower', 'in', 'control', 'group', 'in', 'dexmedetomidine', 'group', '(', '.', '.', 'v', '.', '.', ',', 'p', '.', ')', 'and', '(', '.', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'conclusion', 'intraoperative', 'infusion', 'of', 'dexmedetomidine', 'may', 'reduce', 'incidence', 'of', 'aki', 'and', 'suppress', 'post-bypass', 'egfr', 'decline', '.']"
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials.,"Josephine Warren, Roxana Mehran, Usman Baber, Ke Xu, Daniele Giacoppo, Bernard J Gersh, Giulio Guagliumi, Bernhard Witzenbichler, E Magnus Ohman, Stuart J Pocock, Gregg W Stone, Josephine Warrenet al.",2016 Jan,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/26699599/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'well-recognized', 'predictor', 'of', 'morbidity', 'and', 'mortality', 'percutaneous', 'coronary', 'intervention', '.', 'however', ',', 'impact', 'of', 'aki', 'outcome', 'of', 'patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'in', 'relation', 'to', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', 'not', 'established', '.', 'method', 'of', ',', 'patient', 'presented', 'with', 'non-st-segment', 'elevation', 'ac', 'or', 'st-segment', 'elevation', 'myocardial', 'infarction', 'enrolled', 'in', 'acuity', 'and', 'horizons-ami', 'trial', ',', ',', '(', '.', ')', 'underwent', 'cabg', 'principal', 'treatment', 'coronary', 'angiography', '.', 'end', 'point', 'measured', 'month', 'and', 'year', 'and', 'included', 'death', ',', 'myocardial', 'infarction', ',', 'and', 'ischemia-driven', 'target', 'vessel', 'revascularization', '.', 'acute', 'kidney', 'injury', 'defined', 'rise', 'in', 'creatinine', 'of', '.', 'mgdl', ',', 'or', ',', 'baseline', 'initial', 'angiography', '.', 'result', 'acute', 'kidney', 'injury', 'occurred', 'hospital', 'admission', 'in', '(', '.', ')', 'of', ',', 'patient', 'treated', 'with', 'cabg', '.', 'one-month', 'and', '-year', 'mortality', '.', 'v', '.', '(', 'p', '.', ')', 'and', '.', 'v', '.', '(', 'p', '.', ')', 'patient', 'with', 'v', 'without', 'aki', ',', 'respectively', '.', 'analogously', ',', '-month', 'and', '-year', 'incidence', 'of', 'composite', 'major', 'adverse', 'cardiac', 'event', '(', 'mace', 'death', ',', 'mi', ',', 'or', 'target', 'vessel', 'revascularization', ')', '.', 'v', '.', '(', 'p', '.', ')', 'and', '.', 'v', '.', '(', 'p', '.', ')', 'patient', 'with', 'v', 'without', 'aki', ',', 'respectively', '.', 'adjustment', 'age', ',', 'sex', ',', 'race', ',', 'diabetes', ',', 'hypertension', ',', 'and', 'baseline', 'creatinine', 'clearance', ',', 'aki', 'independent', 'predictor', 'of', 'mortality', '(', 'overall', 'and', 'cardiac-related', ')', 'and', 'mace', 'month', 'and', 'year', 'in', 'patient', 'treated', 'with', 'cabg', '.', 'conclusion', 'acute', 'kidney', 'injury', 'occurred', 'in', 'approximately', 'of', 'every', 'patient', 'with', 'ac', 'treated', 'with', 'cabg', 'and', 'powerful', 'independent', 'predictor', 'of', 'death', 'and', 'mace', '.', 'data', 'highlight', 'need', 'aki', 'prevention', 'strategy', 'in', 'patient', 'undergoing', 'cabg', '.']"
Renal Function and Urinary Biomarkers in Cardiac Bypass Surgery: A Prospective Randomized Trial Comparing Three Surgical Techniques.,"Stefanie Deininger, Markus Hoenicka, Kristina Müller-Eising, Patricia Rupp, Andreas Liebold, Wolfgang Koenig, Hagen Gorki, Stefanie Deiningeret al.",2016 Oct,Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/26636393/,No keywords found,"['background', 'cardiopulmonary', 'bypass', 'procedure', 'associated', 'with', 'increased', 'risk', 'of', 'renal', 'impairment', '.', 'to', 'extent', 'structural', 'damage', 'cause', 'functional', 'decline', 'unknown', '.', 'evaluated', 'perioperative', 'kidney', 'injury', 'and', 'function', 'in', 'patient', 'treated', 'with', 'conventional', 'extracorporeal', 'circulation', '(', 'cecc', ')', ',', 'minimized', 'extracorporeal', 'circulation', '(', 'mecc', ')', ',', 'and', 'off-pump', 'coronary', 'artery', 'bypass', 'grafting', '(', 'opcab', ')', '.', 'method', 'blood', 'and', 'urine', 'sample', ',', 'collected', 'baseline', 'and', 'to', 'hour', 'surgery', 'patient', 'of', 'hepcon', 'trial', '(', 'drks', ',', 'patient', 'randomized', 'heparin', 'management', 'and', 'surgical', 'technique', ')', ',', 'analyzed', 'difference', 'in', 'renal', 'injury', 'and', 'function', '.', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'glutathione', 's-transferase', ',', 'liver', 'fatty', 'acid-binding', 'protein', ',', 'and', 'kidney', 'injury', 'molecule-', 'measured', 'urinary', 'protein', 'marker', 'of', 'renal', 'tubular', 'injury', '.', 'serum', 'creatinine', ',', 'blood', 'urea', 'level', ',', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'determined', 'to', 'monitor', 'renal', 'function', '.', 'result', 'marker', 'of', 'tubular', 'injury', 'differed', 'significantly', 'surgical', 'technique', 'group', 'early', 'surgery', ',', 'indicating', 'detrimental', 'effect', 'in', 'cecc', '.', 'hemolysis', 'and', 'hemodilution', 'correlated', 'with', 'early', 'change', '.', 'late', 'rise', 'not', 'show', 'intergroup', 'difference', '.', 'time', 'course', 'of', 'renal', 'function', 'parameter', ',', 'well', 'development', 'of', 'acute', 'kidney', 'injury', 'in', 'patient', '(', '.', ')', ',', 'irrespective', 'of', 'surgical', 'technique', '.', 'heparin', 'management', 'not', 'influence', 'renal', 'parameter', '.', 'conclusion', 'coronary', 'artery', 'bypass', 'grafting', ',', 'cecc', 'temporarily', 'induces', 'tubular', 'injury', 'mecc', 'or', 'opcab', '.', 'however', ',', 'late', 'change', 'of', 'renal', 'function', 'parameter', 'occur', 'irrespective', 'of', 'extracorporeal', 'perfusion', 'mode', 'and', 'even', 'in', 'off-pump', 'surgery', '.']"
Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.,"Susanne Stads, Louise Schilder, S Azam Nurmohamed, Frank H Bosch, Ilse M Purmer, Sylvia S den Boer, Cynthia G Kleppe, Marc G Vervloet, Albertus Beishuizen, Armand R J Girbes, Pieter M Ter Wee, Diederik Gommers, A B Johan Groeneveld, Heleen M Oudemans-van Straaten                              ;, CASH study group, Susanne Stadset al.",2018 Jun 6,PLoS One,https://pubmed.ncbi.nlm.nih.gov/29874271/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'associated', 'with', 'high', 'mortality', '.', 'creatinine-based', 'stage', 'of', 'aki', 'considered', 'deciding', 'to', 'start', 'or', 'delay', 'rrt', '.', 'however', ',', 'creatinine', 'not', 'determined', 'renal', 'function', '(', 'excretion', ')', ',', 'also', 'dilution', '(', 'fluid', 'balance', ')', 'and', 'creatinine', 'generation', '(', 'muscle', 'mass', ')', '.', 'aim', 'of', 'study', 'to', 'explore', 'whether', 'fluid', 'balance-adjusted', 'creatinine', 'initiation', 'of', 'rrt', 'related', 'to', '-day', 'mortality', 'independent', 'of', 'marker', 'of', 'aki', ',', 'surrogate', 'of', 'muscle', 'mass', 'and', 'severity', 'of', 'disease', '.', 'method', 'performed', 'post-hoc', 'analysis', 'data', 'multicentre', 'cash', 'trial', 'comparing', 'citrate', 'to', 'heparin', 'anticoagulation', 'continuous', 'venovenous', 'hemofiltration', '(', 'cvvh', ')', '.', 'to', 'determine', 'whether', 'fluid', 'balance-adjusted', 'creatinine', 'associated', 'with', '-day', 'mortality', ',', 'performed', 'logistic', 'regression', 'analysis', 'adjusting', 'confounders', 'of', 'creatinine', 'generation', '(', 'age', ',', 'gender', ',', 'body', 'weight', ')', ',', 'marker', 'of', 'aki', '(', 'creatinine', ',', 'urine', 'output', ')', 'and', 'severity', 'of', 'disease', '.', 'result', 'of', 'patient', ',', 'patient', 'excluded', '.', 'of', 'included', 'patient', ',', 'died', 'day', '(', ')', '.', 'non-survivors', 'older', ',', 'higher', 'apache', 'ii', 'and', 'inclusion', 'sofa', 'score', ',', 'lower', 'ph', 'and', 'bicarbonate', ',', 'lower', 'creatinine', 'and', 'fluid', 'balance-adjusted', 'creatinine', 'cvvh', 'initiation', '.', 'in', 'multivariate', 'analysis', 'lower', 'fluid', 'balance-adjusted', 'creatinine', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', ',', 'not', 'unadjusted', 'creatinine', ',', 'remained', 'associated', 'with', '-day', 'mortality', 'together', 'with', 'bicarbonate', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', ',', 'apache', 'ii', 'score', 'non-significantly', 'contributed', 'to', 'model', '.', 'conclusion', 'in', 'post-hoc', 'analysis', 'of', 'multicentre', 'trial', ',', 'low', 'fluid', 'balance-adjusted', 'creatinine', 'cvvh', 'initiation', 'associated', 'with', '-day', 'mortality', ',', 'independent', 'of', 'marker', 'of', 'aki', ',', 'organ', 'failure', ',', 'and', 'surrogate', 'of', 'muscle', 'mass', ',', 'unadjusted', 'creatinine', 'not', '.', 'tool', 'needed', 'better', 'understanding', 'of', 'complex', 'determinant', 'of', '``', 'aki', 'classification', ""''"", ',', '``', 'cvvh', 'initiation', ""''"", 'and', 'relation', 'with', 'mortality', ',', 'fluid', 'balance', 'one', '.']"
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.,"Antonio Landi, Mauro Chiarito, Mattia Branca, Enrico Frigoli, Andrea Gagnor, Paolo Calabrò, Carlo Briguori, Giuseppe Andò, Alessandra Repetto, Ugo Limbruno, Paolo Sganzerla, Alessandro Lupi, Bernardo Cortese, Arturo Ausiello, Salvatore Ierna, Giovanni Esposito, Giuseppe Ferrante, Andrea Santarelli, Gennaro Sardella, Ferdinando Varbella, Dik Heg, Roxana Mehran, Marco Valgimigli, Antonio Landiet al.",2023 Aug 14,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/37587595/,No keywords found,"['simple', ',', 'contemporary', 'risk', 'score', 'prediction', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'recently', 'updated', ',', 'although', 'external', 'validation', 'lacking', '.', 'objective', 'aim', 'of', 'study', 'to', 'validate', 'updated', 'ca-aki', 'risk', 'score', 'in', 'large', 'cohort', 'of', 'acute', 'coronary', 'syndrome', 'patient', 'matrix', '(', 'minimizing', 'adverse', 'haemorrhagic', 'event', 'transradial', 'access', 'site', 'and', 'systemic', 'implementation', 'of', 'angiox', ')', 'trial', '.', 'method', 'risk', 'score', 'identifies', 'risk', 'category', 'ca-aki', '.', 'primary', 'endpoint', 'to', 'appraise', 'receiver-operating', 'characteristic', 'of', '-component', 'and', '-component', 'ca-aki', 'model', '.', 'independent', 'predictor', 'of', 'kidney', 'disease', 'improving', 'global', 'outcomes-based', 'acute', 'kidney', 'injury', 'and', 'impact', 'of', 'ca-aki', '-year', 'mortality', 'and', 'bleeding', 'also', 'investigated', '.', 'result', 'matrix', 'trial', 'included', ',', 'patient', 'with', 'complete', 'creatinine', 'value', 'and', 'no', 'end-stage', 'renal', 'disease', '.', 'ca-aki', 'occurred', 'in', '.', 'of', 'patient', ',', 'with', 'stepwise', 'increase', 'of', 'ca-aki', 'rate', 'lowest', 'to', 'highest', 'of', 'risk', 'category', '.', 'receiver-operating', 'characteristic', 'area', 'curve', '.', '(', 'ci', '.-', '.', ')', 'with', 'model', 'and', '.', '(', 'ci', '.-', '.', ')', 'with', 'model', '.', 'ca-aki', 'risk', 'systematically', 'overestimated', 'with', 'model', '(', 'hosmer-lemeshow', 'goodness-of-fit', 'test', 'p', '.', ')', '.', '-year', 'risk', 'of', 'all-cause', 'mortality', 'and', 'bleeding', 'higher', 'in', 'ca-aki', 'patient', '(', 'hr', '.', 'ci', '.-', '.', 'and', 'hr', '.', 'ci', '.-', '.', 'respectively', ')', '.', 'gradual', 'risk', 'increase', 'mortality', 'and', 'bleeding', 'function', 'of', 'ca-aki', 'risk', 'category', 'model', '.', 'conclusion', 'updated', 'ca-aki', 'risk', 'score', 'identifies', 'patient', 'incremental', 'risk', 'of', 'acute', 'kidney', 'injury', ',', 'bleeding', ',', 'and', 'mortality', '.', '(', 'minimizing', 'adverse', 'haemorrhagic', 'event', 'transradial', 'access', 'site', 'and', 'systemic', 'implementation', 'of', 'angiox', 'matrix', 'nct', ')', '.']"
The Effects of Alternative Resuscitation Strategies on Acute Kidney Injury in Patients with Septic Shock.,"John A Kellum, Lakhmir S Chawla, Christopher Keener, Kai Singbartl, Paul M Palevsky, Francis L Pike, Donald M Yealy, David T Huang, Derek C Angus                              ;, ProCESS and ProGReSS-AKI Investigators, Derek C Angus, Nicole Lucko, Francis Pike, Ali Smith, Sachin Yende, Amber E Barnato, Tammy L Eaton, Elizabeth Gimbel, Kyle Landis, Diana K Stapleton, Lisa A Weissfeld, Michael Willochell, Kourtney A Wofford, Erik Kulstad, Hannah Watts, Arvind Venkat, Peter C Hou, Anthony Massaro, Siddharth Parmar, Alexander T Limkakeng Jr, Kori Brewer, Theodore R Delbridge, Allison Mainhart, James R Miner, Todd L Allen, Colin K Grissom, Stuart Swadron, Steven A Conrad, Richard Carlson, Frank LoVecchio, Ednan K Bajwa, Michael R Filbin, Blair A Parry, Timothy J Ellender, Andrew E Sama, Jonathan Fine, Soheil Nafeei, Thomas Terndrup, Margaret Wojnar, Ronald G Pearl, Scott T Wilber, Richard Sinert, David J Orban, Jason W Wilson, Jacob W Ufberg, Timothy Albertson, Edward A Panacek, Sohan Parekh, Scott R Gunn, Jon S Rittenberger, Richard J Wadas, Andrew R Edwards, Matthew Kelly, Henry E Wang, Talmage M Holmes, Michael T McCurdy, Craig Weinert, Estelle S Harris, Wesley H Self, Diane Dubinski, Carolyn A Phillips, Ronald M Migues, John A Kellumet al.",2016 Feb 1,Am J Respir Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/26398704/,No keywords found,"['septic', 'shock', 'common', 'cause', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'and', 'fluid', 'resuscitation', 'major', 'part', 'of', 'therapy', '.', 'objective', 'to', 'determine', 'structured', 'resuscitation', 'designed', 'to', 'alter', 'fluid', ',', 'blood', ',', 'and', 'vasopressor', 'use', 'affect', 'development', 'or', 'severity', 'of', 'aki', 'or', 'outcome', '.', 'method', 'ancillary', 'study', 'to', 'process', '(', 'protocolized', 'care', 'early', 'septic', 'shock', ')', 'trial', 'of', 'alternative', 'resuscitation', 'strategy', '(', 'two', 'protocol', 'vs.', 'usual', 'care', ')', 'septic', 'shock', '.', 'measurement', 'and', 'main', 'result', 'studied', ',', 'patient', 'and', 'classified', 'aki', 'using', 'serum', 'creatinine', 'and', 'urine', 'output', '.', 'determined', 'recovery', 'status', 'hospital', 'discharge', ',', 'examined', 'rate', 'of', 'renal', 'replacement', 'therapy', 'and', 'fluid', 'overload', ',', 'and', 'measured', 'biomarkers', 'of', 'kidney', 'damage', '.', 'among', 'patient', 'without', 'evidence', 'of', 'aki', 'enrollment', ',', '.', 'of', 'protocolized', 'care', 'and', '.', 'of', 'usual', 'care', 'patient', 'developed', 'kidney', 'injury', '(', 'p', '.', ')', '.', 'aki', 'duration', '(', 'p', '.', ')', 'and', 'rate', 'of', 'renal', 'replacement', 'therapy', 'not', 'differ', 'study', 'arm', '(', '.', 'protocolized', 'care', 'and', '.', 'usual', 'care', 'p', '.', ')', '.', 'fluid', 'overload', 'occurred', 'in', '.', 'of', 'protocolized', 'care', 'and', '.', 'of', 'usual', 'care', 'patient', '(', 'p', '.', ')', '.', 'among', 'patient', 'with', 'severe', 'aki', ',', 'complete', 'and', 'partial', 'recovery', '.', 'and', '.', 'protocolized', 'patient', 'and', '.', 'and', '.', 'usual', 'care', 'patient', '(', 'p', '.', ')', '.', 'sixty-day', 'hospital', 'mortality', '.', 'patient', 'without', 'aki', ',', '.', 'with', 'stage', ',', 'and', '.', 'stage', 'to', '.', 'conclusion', 'in', 'patient', 'with', 'septic', 'shock', ',', 'aki', 'common', 'and', 'associated', 'with', 'adverse', 'outcome', ',', 'not', 'influenced', 'protocolized', 'resuscitation', 'compared', 'with', 'usual', 'care', '.']"
Impact of contrast-enhanced versus non-contrast computed tomography on acute kidney injury in acute necrotizing pancreatitis: A randomized controlled trial.,"Manoj M, Manavjit Singh Sandhu, Pankaj Gupta, Jayanta Samanta, Vishal Sharma, Vivek Kumar, Harshal Mandavdhare, Usha Dutta, Rakesh Kochhar, Manoj Met al.",2023 Dec,Indian J Gastroenterol,https://pubmed.ncbi.nlm.nih.gov/37578599/,No keywords found,"['data', 'evaluating', 'contrast-induced-acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'with', 'acute', 'pancreatitis', 'scarce', '.', 'study', 'aimed', 'to', 'compare', 'frequency', 'of', 'aki', 'in', 'patient', 'with', 'acute', 'necrotizing', 'pancreatitis', 'undergoing', 'non-contrast', 'computed', 'tomography', '(', 'ncct', ')', 'with', 'undergoing', 'contrast-enhanced', 'computed', 'tomography', '(', 'cect', ')', 'hospitalization', '.', 'method', 'prospective', 'randomized', 'controlled', 'trial', '(', 'ctri', ')', 'screened', 'consecutive', 'patient', 'with', 'acute', 'pancreatitis', 'eligibility', 'and', 'randomly', 'allocated', 'patient', 'with', 'acute', 'necrotizing', 'pancreatitis', '(', 'based', 'cect', 'in', 'first', 'week', 'of', 'illness', ')', 'and', 'normal', 'renal', 'function', 'to', 'receive', 'either', 'ncct', 'or', 'cect', 'hospitalization', '.', 'incidence', 'of', 'development', 'of', 'new', 'aki', 'and', 'clinical', 'outcome', 'compared', 'two', 'group', '.', 'post-hoc', 'analysis', 'done', 'to', 'adjust', 'disease', 'severity', '.', 'result', 'many', 'patient', 'completed', 'study', 'per', 'protocol', '(', 'ncct', 'and', 'cect', ')', '.', 'aki', 'occurred', 'in', '(', '.', ')', 'patient', ',', 'nine', '(', ')', 'in', 'ncct', 'and', '(', ')', 'in', 'cect', 'group', '.', 'contrast', 'induced-aki', 'occurred', 'in', '(', '.', ')', 'patient', ',', 'aki', 'secondary', 'to', 'acute', 'pancreatitis', '.', 'relative', 'risk', '(', 'rr', ')', 'of', 'aki', 'in', 'cect', 'group', '.', '(', 'ci', '.-.', ',', 'p', '.', ')', '.', 'frequency', 'of', 'intensive', 'care', 'unit', '(', 'icu', ')', 'admission', '(', 'rr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'need', 'drainage', 'of', 'collection', '(', 'rr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'significantly', 'higher', 'and', 'length', 'of', 'hospitalization', '(', 'p', '.', ')', 'and', 'icu', 'admission', '(', 'p', '.', ')', 'significantly', 'longer', 'in', 'cect', 'group', '.', 'however', ',', 'adjusted', 'severity', 'of', 'acute', 'pancreatitis', ',', 'no', 'difference', 'in', 'aki', 'and', 'clinical', 'outcome', 'ncct', 'and', 'cect', 'group', '.', 'duration', 'of', 'aki', 'significantly', 'longer', 'and', 'need', 'dialysis', 'significantly', 'higher', 'in', 'patient', 'aki', 'secondary', 'to', 'acute', 'pancreatitis', 'compared', 'to', 'with', 'contrast', 'induced-aki', '(', 'p', '.', ')', '.', 'conclusion', 'cect', 'not', 'significantly', 'associated', 'with', 'aki', 'in', 'acute', 'necrotizing', 'pancreatitis', '.']"
Renal Safety and Renin-Angiotensin-Aldosterone System Inhibitors in Patients With Contrast Media Exposure: A Multicenter Randomized Controlled Study.,"Yaowang Lin, Shaohong Dong, Yuanhui Liu, Yongshun Wang, Xin Sun, Jie Yuan, Danqing Yu, Huadong Liu, Yaowang Linet al.",2022 Nov 1,J Cardiovasc Pharmacol,https://pubmed.ncbi.nlm.nih.gov/35881908/,No keywords found,"['ratio', ')', 'with', 'aceiarb', 'group', '(', 'aceiarb', 'continued', 'throughout', 'study', 'period', ')', 'and', 'without', 'aceiarb', 'group', '(', 'aceiarb', 'stopped', 'hour', 'and', 'continued', 'hour', 'procedure', ')', '.', 'primary', 'endpoint', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'and', 'secondary', 'endpoint', 'major', 'adverse', 'cardiovascular', 'event', '(', 'mace', ')', ',', 'and', 'need', 'renal', 'replacement', 'therapy', 'hospitalization', 'and', '-year', 'follow-up', '.', 'occurrence', 'rate', 'of', 'ci-aki', 'not', 'comparable', 'in', 'aceiarb', 'group', 'and', 'without', 'aceiarb', 'group', '(', '.', 'and', '.', ',', 'respectively', 'p', '.', ')', '.', 'no', 'significant', 'between-group', 'difference', 'found', 'with', 'respect', 'to', 'frequency', 'of', 'mace', 'or', 'renal', 'replacement', 'therapy', 'hospitalization', 'and', '-year', 'follow-up', '.', 'subgroup', 'analysis', ',', 'among', 'patient', 'with', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'lt', 'mlmin', ',', 'incidence', 'of', 'ci-aki', 'significantly', 'higher', 'in', 'aceiarb', 'group', '.', '(', ')', 'vs.', '.', '(', ')', ',', 'p', '..', 'among', 'patient', 'with', 'egfr', 'mlmin', ',', 'incidence', 'of', 'ci-aki', 'comparable', 'in', 'group', '.', '(', ')', 'vs.', '.', '(', ')', ',', 'p', '..', 'incidence', 'of', 'mace', 'and', 'renal', 'replacement', 'therapy', 'not', 'comparable', 'in', 'group', ',', 'hospitalization', 'and', '-year', 'follow-up', '.', 'acei', 'or', 'arb', 'treatment', 'safely', 'continued', 'exposure', 'to', 'contrast', 'medium', ',', 'not', 'in', 'patient', 'with', 'egfr', 'lt', 'mlmin', '.']"
Analysis of urine biomarkers for early determination of acute kidney injury in non-septic and non-asphyxiated critically ill preterm neonates.,"A T Elmas, A Karadag, Y Tabel, R Ozdemir, G Otlu, A T Elmaset al.",2017 Feb,J Matern Fetal Neonatal Med,https://pubmed.ncbi.nlm.nih.gov/27020372/,No keywords found,"['designed', 'present', 'study', 'to', 'test', 'hypothesis', 'urinary', 'biomarkers', 'might', 'predict', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'development', 'in', 'non-septic', 'and', 'non-asphyxiated', 'critically', 'ill', 'preterm', 'infant', '.', 'evaluated', 'urine', '(', 'u', ')', 'sistatin-c', '(', 'ucys-c', ')', ',', 'kidney', 'injury', 'molecule-', '(', 'ukim-', ')', 'and', 'neutrophil', 'gelatinase', 'associate', 'lipocaline', '(', 'ungal', ')', 'marker', 'of', 'aki', '.', 'method', 'sixty-four', 'preterm', 'infant', 'with', 'gestational', 'age', 'and', 'week', 'included', 'in', 'study', '.', 'biomarkers', 'measured', 'day', 'of', 'life', '(', 'dol', ')', ',', ',', 'and', '.', 'result', 'ungal', 'level', 'in', 'aki', 'group', 'significantly', 'higher', 'in', 'no-aki', 'group', 'dol', ',', 'and', '(', 'p', '.', ',', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', '.', 'conclusion', 'ungal', 'sensitive', ',', 'early', ',', 'and', 'noninvasive', 'aki', 'biomarkers', ',', 'increasing', 'significantly', 'in', 'non-septic', 'and', 'non-asphyxiated', 'critically', 'ill', 'preterm', 'neonate', '.']"
Intermittent Online Postdilution Hemodiafiltration versus High-Flux Hemodialysis in Non-critical Acute Kidney Injury: A Pilot Randomized Controlled Trial.,"Saurabh Nayak, Arun Prabhahar, Manju Chaudhary, Pankaj Bahuguna, Ashok Kumar Yadav, Vivek Kumar, Manish Rathi, Harbir Singh Kohli, Krishan Lal Gupta, Raja Ramachandran, Saurabh Nayaket al.",2022 Sep 1,Saudi J Kidney Dis Transpl,https://pubmed.ncbi.nlm.nih.gov/37955459/,No keywords found,"['preferential', 'use', 'of', 'convective', 'mode', 'of', 'hemodialysis', '(', 'hd', ')', 'targeting', 'hyper-cytokinemia', 'state', 'in', 'sepsis-related', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'questioned', 'efficacy', '.', 'several', 'study', 'used', 'predilution', 'hemodiafiltration', '(', 'hdf', ')', 'in', 'critically', 'ill', 'aki', 'patient', 'with', 'mixed', 'result', '.', 'in', 'study', ',', 'compared', 'intermittent', 'online', 'postdilution', 'hdf', 'with', 'standard', 'high-flux', '(', 'hf', ')', 'intermittent', 'hd', 'in', 'non-critically', 'ill', 'patient', 'with', 'community-acquired', '(', 'ca', ')', 'aki', '.', 'in', 'pilot', 'study', ',', 'stable', 'patient', 'with', 'ca', 'aki', 'and', 'systemic', 'inflammatory', 'response', 'syndrome', 'included', 'and', 'given', 'either', 'postdilution', 'online-hdf', '(', 'ol-hdf', ')', 'or', 'standard', 'hf', 'hd', 'outside', 'intensive', 'care', 'unit', '.', 'primary', 'objective', 'to', 'assess', 'feasibility', 'of', 'conducting', 'study', 'larger', 'scale', 'and', 'to', 'detect', 'differential', 'impact', 'of', 'convective', 'clearance', 'rate', 'of', 'independence', 'dialysis', 'discharge', 'or', 'day', '.', 'plasma', 'cytokine', 'clearance', 'assessed', 'secondary', 'objective', '.', 'eighty', 'consecutive', 'aki', 'patient', 'randomized', 'to', 'receive', 'dialysis', 'in', 'one', 'of', 'treatment', 'arm', 'fulfilling', 'eligibility', 'criterion', '.', 'baseline', 'parameter', 'of', 'clinical', 'severity', ',', 'etiology', ',', 'and', 'indication', 'of', 'dialysis', ',', 'plus', 'baseline', 'plasma', 'cytokine', 'profile', ',', 'comparable', '.', 'moreover', ',', 'in', 'control', 'arm', 'and', '.', 'in', 'intervention', 'arm', 'became', 'independent', 'dialysis', 'discharge', 'or', 'day', '(', 'p', '.', ')', '.', 'no', 'survival', 'advantage', 'of', 'postdilution', 'ol-hdf', 'observed', '(', 'p', '.', ')', '.', 'similar', 'plasma', 'cytokine', 'clearance', 'level', 'noted', 'in', 'arm', '.', 'current', 'study', 'confirms', 'feasibility', 'however', ',', 'not', 'support', 'preferential', 'use', 'of', 'postdilution', 'ol-hdf', 'hf-hd', 'in', 'non-critical', 'patient', '.']"
A model for predicting postoperative persistent acute kidney injury (AKI) in AKI after cardiac surgery patients with normal baseline renal function.,"Yuanhan Chen, Zhiming Mo, Hong Chu, Penghua Hu, Wei Fan, Yanhua Wu, Li Song, Li Zhang, Zhilian Li, Shuangxin Liu, Zhiming Ye, Xinling Liang, Yuanhan Chenet al.",2024 Jan,Clin Cardiol,https://pubmed.ncbi.nlm.nih.gov/37805965/,No keywords found,"['persistent', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', 'not', 'uncommon', 'and', 'linked', 'to', 'poor', 'outcome', '.', 'hypothesis', 'purpose', 'to', 'develop', 'model', 'predicting', 'postoperative', 'persistent', 'aki', 'in', 'patient', 'with', 'normal', 'baseline', 'renal', 'function', 'experienced', 'aki', 'cardiac', 'surgery', '.', 'method', 'data', 'patient', 'with', 'normal', 'renal', 'function', 'baseline', 'experienced', 'aki', 'cardiopulmonary', 'bypass', 'cardiac', 'surgery', 'in', 'hospital', 'retrospectively', 'evaluated', '.', 'among', ',', 'patient', 'randomly', 'assigned', 'to', 'develop', 'model', ',', 'remaining', 'patient', 'used', 'to', 'validate', 'model', '.', 'new', 'model', 'developed', 'using', 'logistic', 'regression', 'with', 'variable', 'selected', 'using', 'least', 'absolute', 'shrinkage', 'and', 'selection', 'operator', 'regression', '.', 'result', 'incidence', 'of', 'persistent', 'aki', '.', 'in', 'development', 'group', '.', 'nine', 'variable', 'selected', 'model', ',', 'including', 'age', ',', 'hypertension', ',', 'diabetes', ',', 'coronary', 'heart', 'disease', ',', 'cardiopulmonary', 'bypass', 'time', ',', 'aki', 'stage', 'initial', 'diagnosis', 'cardiac', 'surgery', ',', 'postoperative', 'serum', 'magnesium', 'level', 'of', '.', 'mmoll', ',', 'postoperative', 'duration', 'of', 'mechanical', 'ventilation', ',', 'and', 'postoperative', 'intra-aortic', 'balloon', 'pump', 'use', '.', 'model', ""'s"", 'performance', 'good', 'in', 'validation', 'group', '.', 'area', 'receiver', 'operating', 'characteristic', 'curve', '.', '(', 'confidence', 'interval', '.-.', ')', '.', 'observation', 'and', 'prediction', 'model', 'agreed', 'well', 'in', 'calibration', 'plot', '.', 'model', 'also', 'clinically', 'useful', 'based', 'decision', 'curve', 'analysis', '.', 'conclusion', 'feasible', 'using', 'model', 'to', 'identify', 'persistent', 'aki', 'cardiac', 'surgery', 'in', 'patient', 'with', 'normal', 'baseline', 'renal', 'function', 'experienced', 'postoperative', 'aki', ',', 'may', 'aid', 'in', 'patient', 'stratification', 'and', 'individualized', 'precision', 'treatment', 'strategy', '.']"
Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.,"Carlo Briguori, Cristina Quintavalle, Enrica Mariano, Alessandro D'Agostino, Mario Scarpelli, Amelia Focaccio, Giuseppe Biondi Zoccai, Salvatore Evola, Giovanni Esposito, Giuseppe Massimo Sangiorgi, Gerolama Condorelli, Carlo Briguoriet al.",2024 Mar 19,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/38479953/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'in', 'patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'treated', 'percutaneous', 'coronary', 'intervention', '.', 'objective', 'contrast', 'medium', '(', 'cm', ')', 'volume', 'minimization', 'advocated', 'prevention', 'of', 'aki', '.', 'dyevert', 'cm', 'diversion', 'system', '(', 'osprey', 'medical', ',', 'inc', ')', 'designed', 'to', 'reduce', 'cm', 'volume', 'coronary', 'procedure', '.', 'method', 'in', 'randomized', ',', 'single-blind', ',', 'investigator-driven', 'clinical', 'trial', 'conducted', 'in', 'italian', 'center', 'february', ',', 'to', 'september', ',', ',', 'participant', 'with', 'ac', 'randomly', 'assigned', 'in', 'ratio', 'to', 'following', ')', 'contrast', 'volume', 'reduction', '(', 'cvr', ')', 'group', '(', 'n', ')', ',', 'in', 'cm', 'injection', 'handled', 'cm', 'diversion', 'system', 'and', ')', 'control', 'group', '(', 'n', ')', ',', 'in', 'conventional', 'manual', 'or', 'automatic', 'injection', 'syringe', 'used', '.', 'primary', 'endpoint', 'rate', 'of', 'aki', ',', 'defined', 'serum', 'creatinine', '(', 'scr', ')', 'increase', '.', 'mgdl', 'within', 'hour', 'cm', 'exposure', '.', 'result', 'of', '(', '.', ')', 'participant', 'with', 'st-segment', 'elevation', 'myocardial', 'infarction', '(', 'of', '.', 'in', 'cvr', 'group', 'and', 'of', '.', 'in', 'control', 'group', ')', '.', 'cm', 'volume', 'lower', 'in', 'cvr', 'group', '(', 'ml', 'v', 'ml', 'p', '.', ')', '.', 'seven', 'participant', '(', 'in', 'cvr', 'group', 'and', 'in', 'control', 'group', ')', 'not', 'postprocedural', 'scr', 'value', '.', 'aki', 'occurred', 'in', 'of', '(', ')', 'participant', 'in', 'cvr', 'group', 'and', 'in', 'of', '(', '.', ')', 'participant', 'in', 'control', 'group', '(', 'relative', 'risk', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'cm', 'volume', 'reduction', 'obtained', 'using', 'cm', 'diversion', 'system', 'effective', 'prevention', 'of', 'aki', 'in', 'patient', 'with', 'ac', 'undergoing', 'invasive', 'procedure', '.', '(', 'renal', 'insufficiency', 'following', 'contrast', 'medium', 'administration', 'trial', 'iv', 'remedialiv', 'nct', ')', '.']"
"Intraoperative Oxygen Treatment, Oxidative Stress, and Organ Injury Following Cardiac Surgery: A Randomized Clinical Trial.","Marcos G Lopez, Matthew S Shotwell, Cassandra Hennessy, Mias Pretorius, David R McIlroy, Melissa J Kimlinger, Eric H Mace, Tarek Absi, Ashish S Shah, Nancy J Brown, Frederic T Billings th                                                            ;, ROCS trial investigators, Robert Deegan, Susan S Eagle, Antonio Hernandez, Brian J Gelfand, Miklos D Kertai, Meredith Kingeter, Ryan LeFevre, Frederic W Lombard, Michael F Mantinan, Kelly K Mishra, Andrew D Shaw, Kara K Siegrist, Ban Sileshi, Robert E Freundlich, Jonathan P Wanderer, Marcos G Lopezet al.",2024 Oct 1,JAMA Surg,https://pubmed.ncbi.nlm.nih.gov/39110454/,No keywords found,"['liberal', 'oxygen', '(', 'hyperoxia', ')', 'commonly', 'administered', 'to', 'patient', 'surgery', ',', 'and', 'oxygenation', 'known', 'to', 'impact', 'mechanism', 'of', 'perioperative', 'organ', 'injury', '.', 'objective', 'to', 'evaluate', 'effect', 'of', 'intraoperative', 'hyperoxia', 'compared', 'to', 'maintaining', 'normoxia', 'oxidative', 'stress', ',', 'kidney', 'injury', ',', 'and', 'organ', 'dysfunction', 'cardiac', 'surgery', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'participant-', 'and', 'assessor-blinded', ',', 'randomized', 'clinical', 'trial', 'conducted', 'april', 'to', 'october', 'with', 'year', 'of', 'follow-up', 'single', 'tertiary', 'care', 'medical', 'center', '.', 'adult', 'patient', '(', 'year', ')', 'presenting', 'elective', 'open', 'cardiac', 'surgery', 'without', 'preoperative', 'oxygen', 'requirement', ',', 'acute', 'coronary', 'syndrome', ',', 'carotid', 'stenosis', ',', 'or', 'dialysis', 'included', '.', 'of', 'patient', 'assessed', ',', 'considered', 'eligible', 'and', 'provided', 'consent', '.', 'of', ',', 'excluded', 'prior', 'to', 'randomization', 'and', 'following', 'randomization', 'whose', 'surgery', 'cancelled', ',', 'leaving', 'participant', 'in', 'group', '.', 'intervention', 'participant', 'randomly', 'assigned', 'to', 'hyperoxia', '(', '.', 'fraction', 'of', 'inspired', 'oxygen', 'fio', ')', 'or', 'normoxia', '(', 'minimum', 'fio', 'to', 'maintain', 'oxygen', 'saturation', '-', ')', 'throughout', 'surgery', '.', 'main', 'outcome', 'and', 'measure', 'participant', 'assessed', 'oxidative', 'stress', 'measuring', 'f-isoprostanes', 'and', 'isofurans', ',', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'and', 'delirium', ',', 'myocardial', 'injury', ',', 'atrial', 'fibrillation', ',', 'and', 'additional', 'secondary', 'outcome', '.', 'participant', 'monitored', 'year', 'following', 'surgery', '.', 'result', 'two', 'hundred', 'participant', 'studied', '(', 'median', 'iqr', 'age', ',', '-', 'year', 'male', 'and', 'female', '.', 'with', 'diabetes', ')', '.', 'f-isoprostanes', 'and', 'isofurans', '(', 'primary', 'mechanistic', 'end', 'point', ')', 'increased', 'average', 'throughout', 'surgery', ',', 'median', '(', 'iqr', ')', 'of', '.', '(', '.-', '.', ')', 'pgml', 'baseline', 'to', 'peak', 'of', '.', '(', '.-', '.', ')', 'pgml', 'admission', 'to', 'intensive', 'care', 'unit', 'and', '.', 'pgml', '(', 'ci', ',', '.-', '.', 'p', '.', ')', 'higher', 'surgery', 'in', 'patient', 'assigned', 'to', 'hyperoxia', '.', 'median', '(', 'iqr', ')', 'change', 'in', 'serum', 'creatinine', '(', 'primary', 'clinical', 'end', 'point', ')', 'baseline', 'to', 'postoperative', 'day', '.', 'mgdl', '(', '-', '.', 'to', '.', ')', 'in', 'participant', 'assigned', 'hyperoxia', 'and', '-', '.', 'mgdl', '(', '-', '.', 'to', '.', ')', 'in', 'assigned', 'normoxia', '(', 'median', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'aki', 'occurred', 'in', 'participant', '(', ')', 'in', 'group', '.', 'intraoperative', 'oxygen', 'treatment', 'not', 'affect', 'additional', 'acute', 'organ', 'injury', ',', 'safety', 'event', ',', 'or', 'kidney', ',', 'neuropsychological', ',', 'and', 'functional', 'outcome', 'year', '.', 'conclusion', 'among', 'adult', 'receiving', 'cardiac', 'surgery', ',', 'intraoperative', 'hyperoxia', 'increased', 'intraoperative', 'oxidative', 'stress', 'compared', 'to', 'normoxia', 'not', 'affect', 'kidney', 'injury', 'or', 'additional', 'measurement', 'of', 'organ', 'injury', 'including', 'delirium', ',', 'myocardial', 'injury', ',', 'and', 'atrial', 'fibrillation', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol.,"Anna Wiegand, Alexander Ritter, Nicole Graf, Spyridon Arampatzis, Daniel Sidler, Karine Hadaya, Thomas F Müller, Carsten A Wagner, Rudolf P Wüthrich, Nilufar Mohebbi, Anna Wiegandet al.",2018 Jul 13,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/30001705/,No keywords found,"['graft', 'survival', 'kidney', 'transplantation', 'significantly', 'improved', 'within', 'last', 'decade', 'substantial', 'number', 'of', 'patient', 'with', 'declining', 'transplant', 'function', 'and', 'graft', 'loss', '.', 'past', 'year', 'several', 'study', 'shown', 'metabolic', 'acidosis', 'play', 'important', 'role', 'in', 'progression', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'and', 'alkalinizing', 'therapy', 'significantly', 'delayed', 'progression', 'of', 'ckd', '.', 'importantly', ',', 'metabolic', 'acidosis', 'highly', 'prevalent', 'in', 'renal', 'transplant', 'patient', 'and', 'recent', 'retrospective', 'study', 'shown', 'metabolic', 'acidosis', 'associated', 'with', 'increased', 'risk', 'of', 'graft', 'loss', 'and', 'patient', 'death', 'in', 'kidney', 'transplant', 'recipient', '.', 'however', ',', 'no', 'prospective', 'trial', 'initiated', 'yet', 'to', 'test', 'role', 'of', 'alkali', 'treatment', 'renal', 'allograft', 'function', '.', 'method', 'preserve-transplant', 'study', 'investigator-initiated', ',', 'prospective', ',', 'patient-blinded', ',', 'multi-center', ',', 'randomized', ',', 'controlled', 'phase-iv', 'trial', 'with', 'two', 'parallel-groups', 'comparing', 'sodium', 'bicarbonate', 'to', 'placebo', '.', 'primary', 'objective', 'to', 'test', 'alkali', 'treatment', 'preserve', 'kidney', 'graft', 'function', 'and', 'diminish', 'progression', 'of', 'ckd', 'in', 'renal', 'transplant', 'patient', 'assesing', 'change', 'in', 'egfr', 'year', 'baseline', '.', 'additionally', 'want', 'to', 'investigate', 'underlying', 'pathomechanisms', 'of', 'nephrotoxicity', 'of', 'metabolic', 'acidosis', '.', 'discussion', 'study', 'potential', 'to', 'provide', 'evidence', 'alkali', 'treatment', 'may', 'slow', 'or', 'reduce', 'progression', 'towards', 'graft', 'failure', 'and', 'significantly', 'decrease', 'rate', 'of', 'end', 'stage', 'renal', 'disease', '(', 'esrd', ')', ',', 'thus', 'prolonging', 'long-term', 'graft', 'survival', '.', 'implementation', 'of', 'alkali', 'therapy', 'drug', 'regimen', 'of', 'kidney', 'transplant', 'recipient', 'would', 'favorable', 'risk-benefit', 'ratio', 'since', 'alkali', 'supplement', 'routinely', 'used', 'in', 'ckd', 'patient', 'and', 'represent', 'well-tolerated', ',', 'safe', 'and', 'cost-effective', 'treatment', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'trial', 'registration', 'completed', 'april', ',', '.']"
Does Remote Ischaemic Preconditioning Protect Kidney and Cardiomyocytes After Coronary Revascularization? A Double Blind Controlled Clinical Trial.,"Seyed Mahmoud Nouraei, Afshin Gholipour Baradari, Asieh Jazayeri, Seyed Mahmoud Nouraeiet al.",2016 Oct,Med Arch,https://pubmed.ncbi.nlm.nih.gov/27994300/,No keywords found,"['to', 'investigate', 'efficacy', 'of', 'remote', 'ischaemic', 'preconditioning', 'reducing', 'kidney', 'injury', 'and', 'myocardial', 'damage', 'coronary', 'artery', 'bypass', 'grafting', 'surgery', '(', 'cabg', ')', '.', 'background', 'ischaemic', 'preconditioning', 'of', 'remote', 'organ', 'reduces', 'ischaemia-reperfusion', 'injury', 'of', 'kidney', 'and', 'myocardium', 'cabg', '.', 'method', 'to', 'reduce', 'myocardial', 'damage', 'and', 'kidney', 'injury', 'applying', 'remote', 'ischaemic', 'preconditioning', 'recruited', 'consecutive', 'patient', 'undergoing', 'elective', 'coronary', 'artery', 'bypass', 'grafting', 'surgery', '.', 'applied', 'three', 'cycle', 'of', 'lower', 'limb', 'tourniquet', ',', 'inflated', 'cuff', 'minute', 'in', 'study', 'group', 'or', 'left', 'un-inflated', '(', 'sham', 'or', 'control', 'group', ')', 'procedure', '.', 'primary', 'outcome', 'serum', 'creatinine', ',', 'creatinine', 'clearance', 'and', 'troponin-i', 'level', 'time', ',', ',', ',', 'and', 'h.', 'secondary', 'outcome', 'serum', 'c-reactive', 'protein', ',', 'inotrope', 'score', ',', 'ventilation', 'time', 'and', 'icu', 'stay', '.', 'data', ""'s"", 'analyzed', 'medcalc', '(', 'medcalc', 'software', 'bvba', ',', 'acacialaan', ',', 'belgium', ')', '.', 'compared', 'two', 'group', 'student', 'test', ',', 'chi-square', 'and', 'mann-whitney', 'test', '.', 'result', 'two', 'group', 'not', 'statistically', 'different', 'in', 'term', 'of', 'age', ',', 'gender', ',', 'smoking', 'habit', ',', 'drug', 'use', ',', 'hypertension', ',', 'hyperlipidemia', 'and', 'diabetes', 'mellitus', '.', 'study', 'showed', 'higher', 'crp', 'level', 'in', 'study', 'group', 'comparing', 'with', 'control', 'group', '(', 'p.', ')', ',', 'creatinine', 'clearance', 'slightly', 'higher', 'in', 'study', 'group', 'specially', 'h', 'procedure', 'not', 'statistically', 'significant', '(', 'p.', ')', '.', 'troponin-i', 'level', 'significantly', 'lower', 'in', 'study', 'group', '(', 'p.', ')', '.', 'conclusion', 'study', 'showed', 'lower', 'troponin-i', 'level', 'in', 'study', 'group', 'suggest', 'cardio-myocyte', 'protective', 'function', 'of', 'ripc', '.', 'also', 'showed', 'slightly', 'lower', 'creatinine', 'clearance', 'in', 'control', 'group', ',', 'gap', 'two', 'group', 'increase', 'significantly', 'hour', 'procedure', 'may', 'suggest', 'potential', 'kidney', 'protection', 'ripc', '.', 'serum', 'crp', 'level', 'higher', 'in', 'study', 'group', '.', 'multi-center', 'randomized', 'controlled', 'trial', 'with', 'longer', 'time', 'creatinine', 'clearance', 'measurement', 'may', 'show', 'potential', 'effectiveness', 'of', 'non-invasive', 'inexpensive', 'intervention', 'reducing', 'kidney', 'injury', 'cabg', '.']"
Is serum gentamicin concentration modified with autologous cell-saved blood transfusion after total knee arthroplasty using tranexamic acid? A randomised control trial.,"Panagiotis Touzopoulos, Konstantinos Arvanitidis, Eirini Filidou, Konstantinos Tilkeridis, Michael Karanikas, George Kolios, Athanasios Ververidis, Panagiotis Touzopouloset al.",2021 May,Orthop Traumatol Surg Res,https://pubmed.ncbi.nlm.nih.gov/33333277/,No keywords found,"['self-transfusion', 'proven', 'effective', 'management', 'of', 'blood', 'loss', 'total', 'knee', 'arthroplasty', '(', 'tka', ')', '.', 'considering', 'high', 'local', 'concentration', 'of', 'antibiotic', 'bone', 'cement', 'delivered', 'intravenously', 'self-transfusion', 'process', ',', 'systematic', 'toxicity', 'never', 'evaluated', '.', 'in', 'addition', ',', 'effectiveness', 'of', 'self-transfusion', 'with', 'routine', 'concomitant', 'use', 'of', 'modern', 'blood-salvage', 'strategy', ',', 'like', 'tranexamic', 'acid', ',', 'also', 'assessed', '.', 'therefore', ',', 'performed', 'randomised', 'study', 'to', 'assess', ')', 'safety', 'of', 'self-transfusion', 'in', 'tka', 'comparing', 'gentamicin', 'concentration', 'resulting', 'use', 'or', 'not', 'of', 'autologous', 'blood', 'transfusion', ')', 'efficacy', 'of', 'self-transfusion', 'in', 'tka', ',', 'with', 'concomitant', 'administration', 'of', 'tranexamic', 'acid', '.', 'hypothesis', 'self-transfusion', 'in', 'tka', 'elevates', 'serum', 'gentamicin', 'concentration', 'and', 'potential', 'risk', 'of', 'nephrotoxicity', '.', 'method', 'serum', 'concentration', 'of', 'aminoglycosides', 'measured', 'in', 'two', 'group', 'of', 'patient', ',', 'tka', ',', 'according', 'to', 'use', 'of', 'self-transfusion', '.', 'hemoglobin', ',', 'renal', 'function', 'and', 'calculated', 'blood', 'loss', 'compared', 'several', 'point', 'in', 'time', 'group', '.', 'result', 'time', 'statistically', 'significant', 'difference', 'in', 'serum', 'gentamicin', ',', 'h', 'postoperatively', 'group', '.', 'ugml.', ',', 'range', '.', 'to', '.', 'v', '.', '.ugml.', ',', 'range', 'to', '.', '(', 'p.', ')', '.', 'no', 'significant', 'difference', 'in', 'total', 'blood', 'loss', 'ml', ',', 'range', 'to', 'vs.', 'ml', 'range', 'to', '(', 'p.', ')', 'and', 'need', 'of', 'allogeneic', 'blood', 'transfusion', 'unit', 'vs.', 'unit', 'group', '.', 'conclusion', 'use', 'of', 'autologous', 'blood', 'transfusion', 'found', 'to', 'safe', ',', 'in', 'term', 'of', 'nephrotoxicity', 'of', 'aminoglycosides', 'tka', ',', 'seemed', 'to', 'ineffective', 'blood', 'salvage', 'strategy', ',', 'used', 'concomitantly', 'with', 'administration', 'of', 'tranexamic', 'acid', '.', 'level', 'of', 'evidence', 'ii', 'low-powered', 'randomised', 'study', '.', 'clinicaltrials', '.', 'gov', 'registration', 'number', 'nct', '.']"
Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial.,"Yong Liu#, Ning Tan#, Yong Huo#, Shiqun Chen, Jin Liu, Yun-Dai Chen, Keng Wu, Guifu Wu, Kaihong Chen, Jianfeng Ye, Yan Liang, Xinwu Feng, Shaohong Dong, Qiming Wu, Xianhua Ye, Hesong Zeng, Minzhou Zhang, Min Dai, Chong-Yang Duan, Guoli Sun, Yibo He, Feier Song, Zhaodong Guo, Ping-Yan Chen, Junbo Ge, Ying Xian, Jiyan Chen, Yong Liuet al.",2022 May 25,Heart,https://pubmed.ncbi.nlm.nih.gov/34509996/,No keywords found,"['to', 'evaluate', 'efficacy', 'of', 'aggressive', 'hydration', 'compared', 'with', 'general', 'hydration', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'prevention', 'among', 'patient', 'with', 'st-elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'undergoing', 'primary', 'percutaneous', 'coronary', 'intervention', '(', 'ppci', ')', '.', 'method', 'aggressive', 'hydration', 'in', 'patient', 'with', 'stemi', 'undergoing', 'ppci', 'to', 'prevent', 'contrast-induced', 'acute', 'kidney', 'injury', 'study', 'open-label', ',', 'randomised', 'controlled', 'study', 'teaching', 'hospital', 'in', 'china', '.', 'total', 'of', 'adult', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'aggressive', 'hydration', 'or', 'general', 'hydration', 'treatment', '.', 'aggressive', 'hydration', 'group', 'received', 'preprocedural', 'loading', 'dose', 'of', 'ml', 'normal', 'saline', 'within', 'min', ',', 'followed', 'postprocedural', 'hydration', 'performed', 'hour', 'left', 'ventricular', 'end-diastolic', 'pressure', 'guidance', 'and', 'additional', 'hydration', 'hour', 'ppci', '.', 'general', 'hydration', 'group', 'received', 'ml', '.', 'saline', 'mlkghour', 'hour', 'randomisation', '.', 'primary', 'end', 'point', 'ci-aki', ',', 'defined', 'or', '.', 'mgdl', 'increased', 'in', 'serum', 'creatinine', 'baseline', 'first', '-', 'hour', 'primary', 'angioplasty', '.', 'safety', 'end', 'point', 'acute', 'heart', 'failure', '.', 'result', 'july', 'to', 'may', ',', 'patient', 'enrolled', 'in', 'final', 'analysis', '.', 'ci-aki', 'occurred', 'less', 'frequently', 'in', 'aggressive', 'hydration', 'group', 'in', 'general', 'hydration', 'group', '(', '.', 'v', '.', 'risk', 'ratio', '(', 'rr', ')', '.', ',', 'ci', '.', 'to', '.', ')', '.', 'acute', 'heart', 'failure', 'not', 'significantly', 'differ', 'aggressive', 'hydration', 'group', 'and', 'general', 'hydration', 'group', '(', '.', 'v', '.', ',', 'rr', '.', ',', 'ci', '.', 'to', '.', ')', '.', 'several', 'subgroup', 'analysis', 'showed', 'better', 'effect', 'of', 'aggressive', 'hydration', 'in', 'ci-aki', 'prevention', 'in', 'male', ',', 'renal', 'insufficient', 'and', 'non-anterior', 'myocardial', 'infarction', 'participant', '.', 'conclusion', 'comparing', 'with', 'general', 'hydration', ',', 'peri-operative', 'aggressive', 'hydration', 'seems', 'to', 'safe', 'and', 'effective', 'in', 'preventing', 'ci-aki', 'among', 'patient', 'with', 'stemi', 'undergoing', 'ppci', '.']"
Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgery.,"Christian Albert, Annemarie Albert, Rinaldo Bellomo, Siegfried Kropf, Prasad Devarajan, Sabine Westphal, Hassina Baraki, Ingo Kutschka, Christian Butter, Michael Haase, Anja Haase-Fielitz, Christian Albertet al.",2018 Sep,Biomark Med,https://pubmed.ncbi.nlm.nih.gov/30088425/,No keywords found,"['to', 'assess', 'weather', 'doctor', ""'"", 'clinical', 'risk-assessment', 'major', 'adverse', 'kidney', 'event', '(', 'make', ')', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'open-heart', 'surgery', 'would', 'improve', 'informed', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'test', 'result', 'icu', 'admission', '.', 'patient', 'method', 'clinical', 'risk-assessment', 'make', 'and', 'aki', 'performed', 'with', 'and', 'without', 'providing', 'ngal', 'test', 'result', 'and', 'compared', 'in', 'exploratory-', 'and', 'validation-cohort', 'using', 'reclassification', 'metric', ',', 'exemplary', 'category-free', 'net', 'reclassification', 'improvement', '(', 'cfnri', ')', '.', 'result', 'exploratory', 'cohort', 'doctor', ""'"", 'prediction', 'of', 'make', '(', 'cfnri', '.', '.-', '.', 'p', '.', ')', 'and', 'aki', '(', 'cfnri', '.', '.-', '.', 'p', '.', ')', 'improved', 'provided', 'with', 'ngal', 'test', 'information', '.', 'finding', 'confirmed', 'in', 'validation-cohort', '(', 'make', 'cfnri', '.', '.-', '.', 'p', '.', ')', 'and', 'combined-cohort', '(', 'make', 'cfnri', '.', '.-.', ',', 'p', '.', ')', 'aki', 'cfnri', '.', '.-', '.', 'p', '.', ')', '.', 'improvement', 'mostly', 'generated', 'correctly', 'reclassifying', 'patient', 'not', 'developed', 'event', '(', 'p', '.', ')', '.', 'conclusion', 'biomarker', 'informed', 'risk-assessment', 'superior', 'in', 'predicting', 'make', 'and', 'aki', 'open-heart', 'surgery', '.']"
Impact of intraoperative fluid restriction on renal outcomes in patients undergoing robotic-assisted laparoscopic prostatectomy.,"Chie Mori, Hajime Iwasaki, Izumi Sato, Kenichi Takahoko, Yosuke Inaba, Yohei Kawasaki, Gaku Tamaki, Hidehiro Kakizaki, Chie Moriet al.",2023 Oct,J Robot Surg,https://pubmed.ncbi.nlm.nih.gov/37101057/,"Acute kidney injury, Fluid restriction, Robot-assisted laparoscopic prostatectomy.","['trial', 'registered', 'in', 'university', 'hospital', 'medical', 'information', 'network', 'registration', 'number', 'umin', '(', 'registration', 'date', 'july', ',', ')', '.']"
Prevention of post procedural acute kidney injury in the catheterization laboratory in a real-world population.,"Ehud Chorin, Eyal Ben-Assa, Maayan Konigstein, May-Tal Rofe, Aviram Hochstadt, Naama Galli, Michael Schnapper, Yaron Arbel, Ilan Rabey, Jeremy Ben Shoshan, Amir Halkin, Itzhak Herz, Ariel Finkelstein, Samuel Bazan, Gad Keren, Shmuel Banai, Ehud Chorinet al.",2017 Jan 1:226:42-47.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/27783968/,No keywords found,"['radiologist', 'and', 'cardiologist', 'remarkably', 'different', 'approach', 'to', 'clinical', 'importance', 'and', 'to', 'need', 'prophylactic', 'treatment', 'of', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', '.', 'objective', 'to', 'evaluate', 'efficacy', 'of', 'forced', 'diuresis', 'with', 'matched', 'controlled', 'hydration', '(', 'fmh', ')', 'in', 'real-world', ',', 'high', 'risk', 'population', '.', 'method', 'investigator-driven', ',', 'single-center', ',', 'retrospective', 'analysis', 'of', 'prospectively', 'collected', 'data', '.', 'total', 'of', 'consecutive', 'patient', 'undergoing', 'coronary', 'angiography', ',', 'angioplasty', 'or', 'tavr', 'treated', 'with', 'fmh', 'compared', 'to', 'matched', 'historical', 'control', 'cohort', '.', 'result', 'in', 'fmh', 'treated', 'patient', ',', 'egfr', 'improved', 'following', 'procedure', 'mlmin', 'per', '.m', 'baseline', 'to', 'mlmin', 'per', '.m', '(', 'p.', ')', 'net', 'creatinine', 'decreased', '.mgdl', 'to', '.mgdl', '(', 'p.', ')', '.', 'among', 'matched', 'control', 'group', ',', 'egfr', 'deteriorated', 'baseline', 'value', 'of', '.mlmin', 'per', '.m', 'to', '.mlmin', 'per', '.m', 'post', 'procedurally', '(', 'p.', ')', 'net', 'creatinine', 'increased', '.mgdl', 'to', '.mgdl', '(', 'p.', ')', '.', 'incidence', 'of', 'post', 'procedural', 'aki', 'substantially', 'lower', 'in', 'fmh', 'treated', 'group', '(', '.', ')', 'compared', 'to', 'control', 'group', '(', '.', ')', '.', 'multivariable', 'analysis', 'fmh', 'treatment', 'independently', 'correlated', 'with', 'reduced', 'incidence', 'of', 'post', 'procedural', 'aki', 'compared', 'with', 'control', 'group', '(', 'or', '.', ',', 'p.', ')', '.', 'contrast', 'volume', 'not', 'correlate', 'with', 'aki', 'in', 'neither', 'univariate', 'multivariate', 'analysis', '.', 'conclusion', 'in', 'patient', 'undergoing', 'coronary', 'angiography', ',', 'angioplasty', 'or', 'tavr', ',', 'considered', 'high', 'risk', 'to', 'develop', 'post', 'procedural', 'aki', ',', 'forced', 'diuresis', 'with', 'matched', 'controlled', 'hydration', 'resulted', 'in', 'significant', 'net', 'creatinine', 'decrease', ',', 'egfr', 'increase', 'and', 'decrease', 'in', 'incidence', 'of', 'aki', '.']"
Plasma Renin Concentration is Associated With Hemodynamic Deficiency and Adverse Renal Outcome in Septic Shock.,"Maxime Nguyen, Damien Denimal, Auguste Dargent, Pierre-Grégoire Guinot, Laurence Duvillard, Jean-Pierre Quenot, Bélaïd Bouhemad, Maxime Nguyenet al.",2019 Oct,Shock,https://pubmed.ncbi.nlm.nih.gov/30407370/,No keywords found,"['in', 'septic', 'shock', ',', 'systemic', 'vasodilatation', 'and', 'glomerular', 'arteriole', 'dilatation', 'responsible', 'drop', 'in', 'glomerular', 'filtration', 'observed', 'in', 'early', 'acute', 'kidney', 'injury', '.', 'angiotensin', 'ii', 'shown', 'to', 'act', 'mechanism', '.', 'objective', 'to', 'evaluate', 'impact', 'of', 'renin', 'angiotensin', 'system', 'activation', ',', 'hemodynamic', 'deficiency', 'and', 'renal', 'outcome', 'in', 'patient', 'with', 'septic', 'shock', 'and', 'to', 'assess', 'whether', 'urinary', 'sodium', 'could', 'reliable', 'test', 'high', 'plasma', 'renin', 'concentration', 'screening', '.', 'method', 'prospective', 'and', 'observational', 'study', '.', 'inclusion', 'criterion', 'early', 'septic', 'shock', '(', 'first', 'episode', ')', ',', 'dose', 'of', 'norepinephrine', '.', 'gkgmin', ',', 'start', 'of', 'substitutive', 'corticosteroid', '.', 'plasma', 'renin', 'concentration', ',', 'plasma', 'aldosterone', 'concentration', ',', 'and', 'urinary', 'sodium', 'measured', 'inclusion', '.', 'renal', 'outcome', ',', 'organ', 'deficiency', ',', 'and', '-day', 'survival', 'followed', '.', 'result', 'plasma', 'renin', 'concentration', 'associated', 'with', 'worse', 'hemodynamic', 'deficiency', 'and', 'adverse', 'renal', 'outcome', '.', 'natriuresis', 'associated', 'with', 'shock', 'severity', 'not', 'associated', 'with', 'renal', 'outcome', '.', 'low', 'natriuresis', '(', 'mm', ')', 'associated', 'with', 'higher', 'renin', 'concentration', '.', 'two', 'variable', 'weakly', 'correlated', '.', 'conclusion', 'plasma', 'renin', 'concentration', 'associated', 'with', 'adverse', 'renal', 'outcome', ',', 'probably', 'shock', 'severity', 'and', 'insufficient', 'glomerular', 'efferent', 'arteriole', 'vasoconstriction', '.', 'association', 'observed', 'low', 'natriuresis', 'and', 'high', 'plasma', 'renin', 'concentration', '.']"
Development and validation of quick Acute Kidney Injury-score (q-AKI) to predict acute kidney injury at admission to a multidisciplinary intensive care unit.,"Fiorenza Ferrari, Mariangela Valentina Puci, Ottavia Eleonora Ferraro, Gregorio Romero-González, Faeq Husain-Syed, Lilia Rizo-Topete, Mara Senzolo, Anna Lorenzin, Eva Muraro, Antonio Baracca, Mara Serrano-Soto, Alejandra Molano Triviño, Ana Coutinho Castro, Massimo De Cal, Valentina Corradi, Alessandra Brendolan, Marta Scarpa, Maria Rosa Carta, Davide Giavarina, Raffaele Bonato, Giorgio Antonio Iotti, Claudio Ronco, Fiorenza Ferrariet al.",2019 Jun 20,PLoS One,https://pubmed.ncbi.nlm.nih.gov/31220087/,No keywords found,"['patient', 'treated', 'derivation', 'group', 'and', 'validation', 'group', '.', 'candidate', 'variable', 'selected', 'based', 'literature', 'review', 'and', 'expert', 'opinion', '.', 'admission', 'egfr', 'mlmin', '.', 'mq', '(', 'or', '.', 'ci', '.-', '.', 'p.', ')', 'sofacv', '(', 'or', '.', 'ci', '.-', '.', 'p.', ')', 'lactate', 'mmoll', '(', 'or', '.', 'ci', '.-', '.', 'p', '.', ')', 'and', '(', 'timp-', ')', '(', 'igfbp', ')', '.', '(', 'or', '.', 'ci', '.-', '.', 'p', '.', ')', 'significantly', 'associated', 'with', 'aki', '.', 'q-aki', 'score', ',', 'stratified', 'patient', 'different', 'aki', 'risk', 'score', 'level', '-', '-', '-', '-', 'and', '-', '.', 'in', 'cohort', ',', 'observed', 'proportion', 'of', 'aki', 'patient', 'higher', 'in', 'higher', 'score', 'level', '.']"
Does therapeutic hypothermia reduce acute kidney injury among term neonates with perinatal asphyxia?--a randomized controlled trial.,"Vasanthan Tanigasalam, Vishnu Bhat, Bethou Adhisivam, M G Sridhar, Vasanthan Tanigasalamet al.",2016,J Matern Fetal Neonatal Med,https://pubmed.ncbi.nlm.nih.gov/26456813/,No keywords found,"['objective', 'of', 'study', 'to', 'evaluate', 'whether', 'therapeutic', 'hypothermia', 'reduces', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'among', 'term', 'neonate', 'perinatal', 'asphyxia', '.', 'method', 'randomized', 'controlled', 'trial', 'conducted', 'in', 'tertiary', 'care', 'teaching', 'hospital', ',', 'south', 'india', 'included', 'term', 'neonate', 'with', 'perinatal', 'asphyxia', 'randomized', 'to', 'receive', 'either', 'therapeutic', 'hypothermia', 'or', 'standard', 'supportive', 'care', '.', 'renal', 'parameter', 'of', 'neonate', 'in', 'group', 'monitored', 'and', 'aki', 'ascertained', 'per', 'acute', 'kidney', 'injury', 'network', 'criterion', '.', 'result', 'incidence', 'of', 'aki', 'less', 'in', 'therapeutic', 'hypothermia', 'group', 'compared', 'to', 'standard', 'treatment', 'group', '(', 'versus', ',', 'p', '.', ')', '.', 'incidence', 'of', 'stage', ',', ',', 'and', 'aki', ',', ',', 'and', 'in', 'therapeutic', 'hypothermia', 'group', 'compared', 'with', ',', ',', 'and', ',', 'respectively', ',', 'in', 'standard', 'treatment', 'group', '.', 'mortality', 'less', 'in', 'therapeutic', 'hypothermia', 'group', 'compared', 'with', 'standard', 'treatment', 'group', '(', 'versus', ',', 'p', '.', ')', '.', 'conclusion', 'therapeutic', 'hypothermia', 'reduces', 'incidence', 'and', 'severity', 'of', 'aki', 'among', 'term', 'neonate', 'with', 'perinatal', 'asphyxia', '.']"
Effect of nitric oxide delivery via cardiopulmonary bypass circuit on postoperative oxygenation in adults undergoing cardiac surgery (NOCARD trial): a randomised controlled trial.,"Karam Azem, Denis Novakovsky, Boris Krasulya, Shai Fein, Daniel Iluz-Freundlich, Julia Uhanova, Evgeniya Kornilov, Leonid A Eidelman, Shani Kaptzon, Dan Gorfil, Dan Aravot, Yaron Barac, Roussana Aranbitski, Karam Azemet al.",2024 Sep 1,Eur J Anaesthesiol,https://pubmed.ncbi.nlm.nih.gov/39037709/,No keywords found,"['cardiac', 'surgery', 'involving', 'cardiopulmonary', 'bypass', 'induces', 'significant', 'systemic', 'inflammatory', 'response', ',', 'contributing', 'to', 'various', 'postoperative', 'complication', ',', 'including', 'pulmonary', 'dysfunction', ',', 'myocardial', 'and', 'kidney', 'injury', '.', 'objective', 'to', 'investigate', 'effect', 'of', 'nitric', 'oxide', 'delivery', 'via', 'cardiopulmonary', 'bypass', 'circuit', 'various', 'postoperative', 'outcome', '.', 'design', 'prospective', ',', 'single-centre', ',', 'double-blinded', ',', 'randomised', 'controlled', 'trial', '.', 'setting', 'rabin', 'medical', 'centre', ',', 'beilinson', 'hospital', ',', 'israel', '.', 'patient', 'adult', 'patient', 'scheduled', 'elective', 'cardiac', 'surgery', 'randomly', 'allocated', 'to', 'one', 'of', 'study', 'group', '.', 'intervention', 'treatment', 'group', ',', 'ppm', 'of', 'nitric', 'oxide', 'delivered', 'via', 'cardiopulmonary', 'bypass', 'circuit', '.', 'control', 'group', ',', 'nitric', 'oxide', 'not', 'delivered', '.', 'outcome', 'measure', 'primary', 'outcome', 'incidence', 'of', 'hypoxaemia', ',', 'defined', 'p', 'fio', 'ratio', 'less', 'within', 'h', 'postoperatively', '.', 'secondary', 'outcome', 'incidence', 'of', 'low', 'cardiac', 'output', 'syndrome', 'and', 'acute', 'kidney', 'injury', 'within', 'h', 'postoperatively', '.', 'result', 'ninety-eight', 'patient', 'included', 'in', 'final', 'analysis', ',', 'with', 'patient', 'allocated', 'to', 'control', 'group', 'and', 'to', 'nitric', 'oxide', 'group', '.', 'nitric', 'oxide', 'group', 'exhibited', 'significantly', 'lower', 'hypoxaemia', 'rate', 'admission', 'to', 'cardiothoracic', 'intensive', 'care', 'unit', '(', '.', 'v', '.', '.', ')', ',', 'p', '..', 'effect', ',', 'however', ',', 'varied', 'in', 'patient', 'with', 'or', 'without', 'baseline', 'hypoxaemia', '.', 'patient', 'with', 'baseline', 'hypoxaemia', 'received', 'nitric', 'oxide', 'exhibited', 'significantly', 'lower', 'hypoxaemia', 'rate', '(', '.', 'v', '.', '.', ')', ',', 'p', '.', ',', 'and', 'higher', 'p', 'fio', 'ratio', 'time', 'point', ',', 'f', '(', ',', ')', '.', ',', 'p', '..', 'conversely', ',', 'benefit', 'not', 'observed', 'in', 'patient', 'without', 'baseline', 'hypoxaemia', '.', 'no', 'significant', 'difference', 'observed', 'in', 'incidence', 'of', 'low', 'cardiac', 'output', 'syndrome', 'or', 'acute', 'kidney', 'injury', '.', 'no', 'substantial', 'safety', 'concern', 'noted', ',', 'and', 'toxic', 'methaemoglobin', 'level', 'not', 'observed', '.', 'conclusion', 'patient', 'with', 'baseline', 'hypoxaemia', 'undergoing', 'cardiac', 'surgery', 'and', 'receiving', 'nitric', 'oxide', 'exhibited', 'lower', 'hypoxaemia', 'rate', 'and', 'higher', 'p', 'fio', 'ratio', '.', 'no', 'significant', 'difference', 'found', 'regarding', 'postoperative', 'pulmonary', 'complication', 'and', 'overall', 'outcome', '.', 'trial', 'registration', 'nct', '.']"
A New Preprocedure Risk Score for Predicting Contrast-Induced Acute Kidney Injury.,"Chongyang Duan, Yingshu Cao, Yong Liu, Lizhi Zhou, Kaike Ping, Ming T Tan, Ning Tan, Jiyan Chen, Pingyan Chen, Chongyang Duanet al.",2017 Jun,Can J Cardiol,https://pubmed.ncbi.nlm.nih.gov/28392272/,No keywords found,"['of', 'risk', 'model', 'predicting', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'available', 'postcontrast', 'exposure', 'prediction', 'however', ',', 'prediction', 'procedure', 'valuable', 'in', 'practice', '.', 'study', 'aimed', 'to', 'develop', 'risk', 'scoring', 'system', 'based', 'preprocedural', 'characteristic', 'early', 'prediction', 'of', 'ci-aki', 'in', 'patient', 'coronary', 'angiography', 'or', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', '.', 'method', 'prospectively', 'recruited', 'consecutive', 'patient', 'randomized', 'in', 'approximate', 'ratio', 'to', 'create', 'development', 'data', 'set', '(', 'n', ')', 'and', 'validation', 'data', 'set', '(', 'n', ')', '.', 'risk', 'score', 'model', 'based', 'preprocedural', 'risk', 'factor', 'developed', 'using', 'stepwise', 'logistic', 'regression', '.', 'validation', 'performed', 'bootstrap', 'and', 'split-sample', 'method', '.', 'result', 'occurrence', 'of', 'ci-aki', '.', '(', 'of', ')', ',', '.', '(', 'of', ')', ',', 'and', '.', '(', 'of', ')', 'in', 'overall', ',', 'developmental', ',', 'and', 'validation', 'data', 'set', ',', 'respectively', '.', 'risk', 'score', 'developed', 'with', 'prognostic', 'factor', '(', 'age', ',', 'serum', 'creatinine', 'level', ',', 'n-terminal', 'pro', 'b-type', 'natriuretic', 'peptide', 'level', ',', 'high-sensitivity', 'c-reactive', 'protein', ',', 'and', 'primary', 'pci', ')', ',', 'ranged', '-', ',', 'and', 'well', 'calibrated', '(', 'hosmer-lemeshow', '.', 'p', '.', ')', '.', 'good', 'discrimination', 'obtained', 'in', 'developmental', 'and', 'validation', 'data', 'set', '(', 'c-statistic', ',', '.', 'and', '.', ',', 'respectively', ')', '.', 'risk', 'score', 'highly', 'and', 'positively', 'associated', 'with', 'ci-aki', '(', 'p', 'trend', '.', ')', 'in-hospital', 'and', 'long-term', 'outcome', '.', 'conclusion', 'novel', 'risk', 'score', 'model', 'developed', 'simple', 'and', 'accurate', 'tool', 'earlypreprocedural', 'prediction', 'of', 'ci-aki', 'in', 'patient', 'undergoing', 'coronary', 'angiography', 'or', 'pci', '.', 'tool', 'allows', 'assessment', 'of', 'risk', 'of', 'ci-aki', 'contrast', 'exposure', ',', 'allowing', 'timely', 'initiation', 'of', 'appropriate', 'preventive', 'measure', '.']"
Preventing acute kidney injury and improving outcome in critically ill patients utilizing risk prediction score (PRAIOC-RISKS) study. A prospective controlled trial of AKI prevention.,"Tarek Samy Abdelaziz, Ragai Fouda, Wessam M Hussin, Mohamed S Elyamny, Yasser M Abdelhamid, Tarek Samy Abdelazizet al.",2020 Apr,J Nephrol,https://pubmed.ncbi.nlm.nih.gov/31712987/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'significant', 'impact', 'mortality', 'and', 'morbidity', 'in', 'critically', 'ill', 'patient', '.', 'method', 'prospective', 'controlled', 'interventional', 'pilot', 'study', 'composed', 'of', 'observation', 'and', 'intervention', 'arm', 'run', 'two', 'different', 'intensive', 'care', 'unit', '(', 'icu', ')', 'site', '.', 'recently', 'validated', 'risk', 'prediction', 'score', 'used', 'to', 'predict', 'aki', 'in', 'critically', 'ill', 'patient', 'high', 'risk', 'of', 'developing', 'aki', '.', 'patient', 'with', 'established', 'aki', 'time', 'of', 'recruitment', 'excluded', 'study', '.', 'package', 'of', 'early', 'preventive', 'measure', ',', 'including', 'early', 'nephrology', 'review', 'applied', 'to', 'high', 'risk', 'patient', 'in', 'intervention', 'arm', 'to', 'prevent', 'aki', 'development', '.', 'result', 'recruited', 'patient', 'intervention', 'site', 'and', 'patient', 'observation', 'site', '.', 'primary', 'outcome', 'measure', 'aki', 'incidence', '.', 'aki', 'incidence', 'significantly', 'lower', 'in', 'intervention', 'arm', 'incidence', 'in', 'observation', 'arm', '(', 'v', ',', 'p', '.', ')', '.', 'median', 'time', 'till', 'recovery', 'of', 'aki', 'episode', 'significantly', 'lower', 'in', 'intervention', 'arm', '(', '(', ')', 'vs.', '(', ')', 'day', ',', 'p', '.', ')', '.', 'day', 'mortality', 'lower', 'in', 'intervention', 'arm', ',', 'however', ',', 'not', 'statistically', 'significant', '.', 'conclusion', 'pilot', 'study', 'showed', 'feasible', 'to', 'apply', 'simple', 'risk', 'score', 'to', 'implement', 'early', 'preventive', 'measure', 'to', 'high', 'risk', 'patient', ',', 'consequently', ',', 'mitigating', 'risk', 'of', 'aki', 'development', 'and', 'reducing', 'time', 'till', 'recovery', 'of', 'aki', 'episode', '.', 'multicentre', 'study', 'needed', 'to', 'confirm', 'favourable', 'effect', '.']"
The impact of minimal invasive extracorporeal circulation on postoperative kidney function.,"Ara Shwan Media, Peter Juhl-Olsen, Nils Erik Magnusson, Ivy Susanne Modrau, Ara Shwan Mediaet al.",2021 Oct,Perfusion,https://pubmed.ncbi.nlm.nih.gov/32921252/,No keywords found,"['acute', 'kidney', 'injury', 'following', 'cardiac', 'surgery', 'frequent', 'complication', 'associated', 'with', 'increased', 'mortality', 'and', 'morbidity', '.', 'minimal', 'invasive', 'extracorporeal', 'circulation', 'suggested', 'to', 'preserve', 'postoperative', 'renal', 'function', '.', 'aim', 'of', 'study', 'to', 'assess', 'impact', 'of', 'minimal', 'invasive', 'versus', 'conventional', 'extracorporeal', 'circulation', 'early', 'postoperative', 'kidney', 'function', '.', 'method', 'randomized', 'controlled', 'trail', 'including', 'patient', 'undergoing', 'elective', 'stand-alone', 'coronary', 'artery', 'bypass', 'graft', 'surgery', 'and', 'allocated', 'in', 'ratio', 'to', 'either', 'minimal', 'invasive', '(', 'n', ')', 'or', 'conventional', 'extracorporeal', 'circulation', '(', 'n', ')', '.', 'postoperative', 'kidney', 'injury', 'assessed', 'elevation', 'of', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'sensitive', 'tubular', 'injury', 'biomarker', '.', 'in', 'addition', ',', 'assessed', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', ',', 'and', 'incidence', 'of', 'acute', 'kidney', 'injury', 'according', 'to', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'classification', '.', 'result', 'observed', 'no', 'difference', 'group', 'regarding', 'increase', 'of', 'plasma', 'ngal', '(', 'p', '.', ')', 'or', 'decline', 'of', 'egfr', '(', 'p', '.', ')', '.', 'in', 'group', ',', 'patient', 'developed', 'acute', 'kidney', 'injury', 'according', 'to', 'akin', 'classification', ',', 'regaining', 'preoperative', 'renal', 'function', 'within', 'day', '.', 'conclusion', 'finding', 'challenge', 'superiority', 'of', 'minimal', 'invasive', 'compared', 'to', 'conventional', 'extracorporeal', 'circulation', 'in', 'term', 'of', 'preservation', 'of', 'renal', 'function', 'following', 'low-risk', 'coronary', 'surgery', '.']"
Independent predictors of acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention.,"Aisulu Zhunuspekova, Jamilya Mansurova, Lyudmila Karazhanova, Aisulu Zhunuspekovaet al.",2021 Mar 4,PLoS One,https://pubmed.ncbi.nlm.nih.gov/33661913/,No keywords found,"['high', 'residual', 'platelet', 'reactivity', '(', 'rpr', ')', 'in', 'patient', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'receiving', 'antiplatelet', 'agent', 'associated', 'with', 'high', 'risk', 'of', 'developing', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'study', 'aim', 'study', 'aimed', 'identification', 'of', 'independent', 'prognostic', 'predictor', 'of', 'aki', 'risk', 'in', 'patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'pci', '.', 'study', 'design', ',', 'setting', 'and', 'patient', 'prospective', 'single-center', 'clinical', 'trial', 'included', 'patient', '(', 'n', 'without', 'aki', ',', 'n', 'with', 'aki', ',', 'mean', 'age', '..', 'year', ',', 'of', '.', 'male', ')', ',', 'underwent', 'pci', 'with', 'stenting', '.', 'prospectively', 'evaluated', 'rpr', 'using', 'optical', 'aggregometry', '.', 'development', 'of', 'aki', 'primary', 'endpoint', '.', 'result', 'acute', 'renal', 'dysfunction', 'observed', 'in', 'patient', '(', '.', ')', 'pci', ',', 'risk', 'factor', 'of', 'according', 'to', 'univariate', 'regression', 'analysis', 'age', '(', 'p', '.', ')', ',', 'low', 'diastolic', 'blood', 'pressure', '(', 'dbp', ')', '(', 'p', '.', ')', ',', 'severe', 'heart', 'failure', '(', 'hf', ')', 'according', 'to', 'killip', '(', 'p.', ')', ',', 'low', 'level', 'of', 'hemoglobin', '(', 'p', '.', ')', 'and', 'erythrocyte', '(', 'p', '.', ')', ',', 'increased', 'creatinine', '(', 'p.', ')', ',', 'low', 'baseline', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', '(', 'p.', ')', ',', 'low', 'left', 'ventricular', 'ejection', 'fraction', '(', 'lv', 'ef', ')', '(', 'p', '.', ')', ',', 'high', 'residual', 'platelet', 'reactivity', '(', 'rpr', ')', '(', 'p.', ')', 'and', 'platelet', 'aggregation', 'area', 'curve', '(', 'auc', ')', 'with', 'gml', 'adp', '(', 'p.', ')', ',', 'well', 'dose', 'of', 'x-ray', 'contrast', 'medium', '(', 'xcm', ')', '(', 'p', '.', ')', '.', 'result', 'of', 'multivariate', 'regression', 'analysis', 'following', 'independent', 'predictor', 'of', 'aki', 'established', 'with', 'inclusion', 'of', 'factor', 'baseline', 'creatinine', 'level', 'or', '.', 'ci', '.', 'to', '.', 'p.', ',', 'rpr', 'with', 'gml', 'adp', 'or', '.', 'ci', '.', 'to', '.', 'p', '.', ',', 'dose', 'of', 'xcm', 'r', '.', 'ci', '.', 'to', '.', '.', ',', 'diastolic', 'blood', 'pressure', '(', 'dbp', ')', 'or', '.', 'ci', '.', 'to', '.', 'p', '..', 'conclusion', 'adp-induced', 'high', 'residual', 'platelet', 'reactivity', ',', 'baseline', 'creatinine', 'level', ',', 'x-ray', 'contrast', 'medium', ',', 'low', 'diastolic', 'blood', 'pressure', 'independent', 'predictor', 'of', 'aki', 'in', 'patient', 'with', 'ac', 'pci', '.']"
"Possible Protective Effect of Remote Ischemic Preconditioning on Acute Kidney Injury Following Elective Percutaneous Coronary Intervention: Secondary Analysis of a Multicenter, Randomized Study.","Hiroaki Otsuka, Toru Miyoshi, Kentaro Ejiri, Kunihisa Kohno, Makoto Nakahama, Masayuki Doi, Mitsuru Munemasa, Masaaki Murakami, Kazufumi Nakamura, Hiroshi Ito, Hiroaki Otsukaet al.",2021 Feb,Acta Med Okayama,https://pubmed.ncbi.nlm.nih.gov/33649613/,"acute kidney injury, remote ischemic preconditioning, serum creatinine, stable angina.","['remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'promising', 'strategy', 'protecting', 'ischemic', 'reperfusion', 'injury', '.', 'study', 'secondary', 'analysis', 'of', 'randomized', 'study', 'aimed', 'to', 'evaluate', 'effect', 'of', 'ripc', 'early', 'increase', 'in', 'serum', 'creatinine', '(', 'scr', ')', 'following', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', ',', 'associ-ated', 'with', 'contrast-induced', 'acute', 'kidney', 'injury', '.', 'patient', 'with', 'stable', 'angina', 'undergoing', 'elective', 'pci', 'assigned', 'to', 'control', ',', 'ripc', ',', 'and', 'continuous', 'infusion', 'of', 'nicorandil', '(', 'nicorandil', ')', 'group', '.', 'endpoint', 'of', 'study', 'incidence', 'of', 'early', 'increase', 'in', 'scr', ',', 'predictor', 'of', 'contrast-induced', 'acute', 'kidney', 'injury', ',', 'defined', 'either', 'or', 'absolute', 'increase', '.', 'mgdl', 'of', 'scr', 'level', 'h', 'of', 'pci', '.', 'study', 'included', 'patient', 'dataset', 'of', 'scr', 'value', 'available', '.', 'incidence', 'of', 'early', 'increase', 'in', 'scr', 'significantly', 'lower', 'in', 'ripc', 'in', 'control', '(', '.', 'v', '.', ',', 'p', '.', ')', 'group', ',', 'not', 'significantly', 'different', 'nicorandil', 'and', 'control', 'group', '.', 'in', 'multivariate', 'analysis', ',', 'ripc', 'remained', 'significant', 'fac-tor', 'associated', 'with', 'reduction', 'in', 'incidence', 'of', 'early', 'increase', 'in', 'scr', '.', 'ripc', 'reduces', 'incidence', 'of', 'early', 'increase', 'in', 'scr', 'in', 'patient', 'with', 'stable', 'angina', 'following', 'elective', 'pci', '.']"
"Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.","Monica Gandhi, David V Glidden, Kenneth Mayer, Mauro Schechter, Susan Buchbinder, Beatriz Grinsztejn, Sybil Hosek, Martin Casapia, Juan Guanira, Linda-Gail Bekker, Alexander Louie, Howard Horng, Leslie Z Benet, Albert Liu, Robert M Grant, Monica Gandhiet al.",2016 Nov,Lancet HIV,https://pubmed.ncbi.nlm.nih.gov/27658870/,No keywords found,"['pre-exposure', 'prophylaxis', '(', 'prep', ')', 'with', 'tenofovir', 'disoproxil', 'fumarate', 'and', 'emtricitabine', 'prevention', 'of', 'hiv', 'infection', 'rolled', 'internationally', ',', 'strategy', 'to', 'maintain', 'effectiveness', 'and', 'to', 'minimise', 'adverse', 'effect', 'merit', 'consideration', '.', 'in', 'study', ',', 'aimed', 'to', 'assess', 'reduction', 'in', 'renal', 'function', 'and', 'predictor', 'of', 'renal', 'toxicity', 'in', 'large', 'open-label', 'study', 'of', 'prep', '.', 'method', 'part', 'of', 'iprex', 'open-label', 'extension', '(', 'ole', ')', 'study', ',', 'men', 'sex', 'with', 'men', 'or', 'transgender', 'woman', 'aged', '-', 'year', 'hiv', 'negative', 'and', 'participated', 'in', 'three', 'previous', 'prep', 'trial', 'brazil', ',', 'ecuador', ',', 'peru', ',', 'south', 'africa', ',', 'thailand', ',', 'and', 'usa', 'enrolled', 'open-label', 'prep', 'study', '.', 'no', 'restriction', 'current', 'renal', 'function', 'enrolment', 'iprex', 'ole', ',', 'in', 'participant', 'given', 'combination', 'tablet', 'of', 'tenofovir', 'disoproxil', 'fumarate', '(', 'mg', ')', 'and', 'emtricitabine', '(', 'mg', ')', 'and', 'advised', 'to', 'take', 'one', 'tablet', 'per', 'day', '.', 'follow-up', 'session', 'every', 'week', ',', 'participant', ""'"", 'creatinine', 'clearance', 'prep', 'estimated', 'and', 'in', 'subset', 'of', 'participant', ',', 'hair', 'sample', 'collected', 'to', 'measure', 'tenofovir', 'and', 'emtricitabine', 'concentration', '(', 'measure', 'of', 'adherence', 'and', 'exposure', ')', 'via', 'liquid-chromatography-tandem-mass-spectrometry', '.', 'reduction', 'in', 'creatinine', 'clearance', 'baseline', 'calculated', 'and', 'predictor', 'of', 'decline', 'identified', 'use', 'of', 'multivariate', 'model', '.', 'iprex', 'registered', 'with', 'clinicaltrials.com', ',', 'number', 'nct', '.', 'finding', 'baseline', 'characteristic', 'similar', 'participant', 'in', 'iprex-ole', '(', 'participant', 'with', 'person-visits', ')', 'and', 'participating', 'in', 'hair', 'substudy', '(', 'participant', 'with', 'person-visits', ')', '.', 'median', 'of', 'week', ',', 'mean', 'decline', 'in', 'creatinine', 'clearance', '-', '(', 'ci', '-', 'to', '-', 'ptrend', ')', ',', 'decline', 'greater', 'started', 'prep', 'older', 'age', 'participant', 'aged', '-', 'year', 'baseline', 'decline', 'of', '-', '(', 'ci', '-', 'to', '-', ')', 'and', 'participant', 'older', 'year', 'baseline', 'decline', 'of', '-', '(', '-', 'to', '-', ')', '.', 'in', 'multivariate', 'model', ',', 'age', 'and', 'baseline', 'creatinine', 'clearance', 'less', 'mlmin', 'predicted', 'decline', 'in', 'renal', 'function', '.', 'identified', 'monotonic', 'association', 'percentage', 'decrease', 'in', 'creatinine', 'clearance', 'and', 'number', 'of', 'dos', 'of', 'tenofovir', 'disoproxil', 'fumarate', 'and', 'emtricitabine', 'taken', 'per', 'week', ',', 'estimated', 'hair', 'concentration', 'of', 'tenofovir', 'and', 'emtricitabine', '(', 'ptrend', ')', '.', 'interpretation', 'data', 'suggest', 'frequency', 'of', 'safety', 'monitoring', 'prep', 'might', 'need', 'to', 'different', 'age', 'group', 'and', 'pharmacological', 'measure', 'monitor', 'toxic', 'effect', 'well', 'adherence', '.', 'funding', 'national', 'institute', 'of', 'health', '.']"
Endothelial glycocalyx degradation and disease severity in Plasmodium vivax and Plasmodium knowlesi malaria.,"Bridget E Barber, Matthew J Grigg, Kim A Piera, Youwei Chen, Timothy William, J Brice Weinberg, Tsin W Yeo, Nicholas M Anstey, Bridget E Barberet al.",2021 May 7,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/33963210/,No keywords found,"['degradation', 'of', 'endothelial', 'glycocalyx', 'associated', 'with', 'mortality', 'in', 'adult', 'falciparum', 'malaria', '.', 'however', ',', 'role', 'in', 'pathogenesis', 'of', 'non-falciparum', 'malaria', 'unknown', '.', 'in', 'malaysian', 'patient', 'with', 'knowlesi', '(', 'n', ')', 'and', 'vivax', '(', 'n', ')', 'malaria', ',', 'and', 'in', 'healthy', 'control', '(', 'n', ')', ',', 'measured', 'glycocalyx', 'breakdown', 'product', 'plasma', 'syndecan-', 'and', 'urinary', 'glycosaminoglycans', ',', 'and', 'evaluated', 'correlation', 'with', 'biomarkers', 'of', 'disease', 'severity', '.', 'urinary', 'glycosaminoglycans', 'increased', 'in', 'patient', 'with', 'knowlesi', 'and', 'vivax', 'malaria', 'compared', 'to', 'healthy', 'control', ',', 'and', 'in', 'knowlesi', 'malaria', 'highest', 'in', 'with', 'severe', 'disease', '.', 'in', 'knowlesi', 'malaria', ',', 'plasma', 'syndecan-', 'also', 'highest', 'in', 'with', 'severe', 'disease', ',', 'and', 'correlated', 'with', 'marker', 'of', 'endothelial', 'activation', '(', 'angiopoietin-', ',', 'osteoprotegerin', ',', 'icam-', ')', ',', 'asymmetric', 'dimethylarginine', '(', 'adma', ')', 'and', 'impaired', 'microvascular', 'reactivity', '.', 'syndecan-', 'also', 'correlated', 'with', 'endothelial', 'activation', '(', 'icam-', ',', 'angiopoietin-', ')', 'and', 'adma', 'in', 'vivax', 'malaria', '.', 'in', 'knowlesi', 'malaria', 'increased', 'syndecan-', 'associated', 'with', 'acute', 'kidney', 'injury', ',', 'controlling', 'age', 'and', 'parasitemia', '.', 'in', 'knowlesi', 'malaria', ',', 'difference', 'in', 'median', 'syndecan-', 'severe', 'and', 'non-severe', 'disease', 'marked', 'in', 'female', 'male', '.', 'endothelial', 'glycocalyx', 'degradation', 'increased', 'in', 'knowlesi', 'and', 'vivax', 'malaria', ',', 'and', 'associated', 'with', 'disease', 'severity', 'and', 'acute', 'kidney', 'injury', 'in', 'knowlesi', 'malaria', '.', 'agent', 'inhibit', 'glycocalyx', 'breakdown', 'may', 'represent', 'adjunctive', 'therapeutic', 'severe', 'non-falciparum', 'malaria', '.']"
Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD) trial: the protocol for a large pilot study.,"Tarek Samy Abdelaziz, Antje Lindenmeyer, Jyoti Baharani, Hema Mistry, Alice Sitch, R Mark Temple, Gavin Perkins, Mark Thomas, Tarek Samy Abdelazizet al.",2016 Aug 19,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/27543592/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'contributes', 'to', 'morbidity', 'and', 'mortality', ',', 'and', 'care', 'often', 'suboptimal', 'andor', 'delayed', '.', 'acute', 'kidney', 'outreach', 'to', 'reduce', 'deterioration', 'and', 'death', '(', 'akordd', ')', 'study', 'large', 'pilot', 'testing', 'provision', 'of', 'early', 'specialist', 'advice', ',', 'to', 'improve', 'outcome', 'patient', 'with', 'aki', '.', 'method', 'and', 'analysis', 'and', 'study', 'test', 'outreach', 'service', 'adult', 'patient', 'with', 'aki', ',', 'identified', 'using', 'national', 'algorithm', '.', '-month', 'phase', ',', 'aki', 'outcome', '(', '-day', 'mortality', ',', 'need', 'dialysis', 'or', 'aki', 'stage', 'deterioration', ')', 'observed', 'in', 'intervention', 'and', 'control', 'hospital', 'and', 'respective', 'community', 'area', 'no', 'intervention', 'delivered', '.', 'patient', 'receive', 'good', 'standard', 'care', '.', '-month', 'phase', ',', 'intervention', 'delivered', 'to', 'patient', 'with', 'aki', 'in', 'intervention', 'hospital', 'and', 'area', '.', 'patient', 'with', 'aki', 'in', 'control', 'hospital', 'and', 'area', 'continue', 'to', 'good', 'standard', 'care', '.', 'patient', 'already', 'dialysis', 'and', 'end', 'of', 'life', 'excluded', '.', 'intervention', 'initially', 'delivered', 'via', 'phone', 'call', ',', 'with', 'or', 'without', 'visit', 'to', 'primary', 'clinician', ',', 'aiming', 'rapidly', 'establishing', 'aetiology', ',', 'correcting', 'reversible', 'cause', 'and', 'conducting', 'appropriate', 'investigation', '.', 'surviving', 'stage', 'patient', 'followed-up', 'in', 'aki', 'clinic', '.', 'conduct', 'qualitative', 'research', 'using', 'focus', 'group-based', 'discussion', 'with', 'primary', 'and', 'secondary', 'care', 'clinician', 'early', 'and', 'late', 'phase', 'of', 'trial', '.', 'help', 'break', 'potential', 'barrier', 'and', 'improve', 'care', 'delivery', '.', 'ethic', 'and', 'dissemination', 'patient', 'contacted', 'study', 'allowing', 'to', ""'opt"", ""'"", '.', 'work', 'of', 'outreach', 'team', ',', 'guided', 'aki', 'alert', 'and', 'delivering', 'timely', 'advice', 'to', 'clinician', ',', 'may', 'improve', 'outcome', '.', 'result', 'suggest', 'benefit', 'delivered', 'aki', 'outreach', 'team', ',', 'study', 'lead', 'to', 'full', 'cluster', 'randomised', 'trial', '.', 'trial', 'registration', 'number', 'nct', 'pre-results', '.']"
Effect of intraoperative low vs. conventional tidal volume on the incidence of postoperative acute kidney injury after noncardiac surgery: a two-center randomized clinical trial.,"Xiao-Yu Jia, Xu-Ru Wang, Yan-Yu Jiang, Ming-Zi An, Da-Qing Pei, Zhen-Ping Li, Qing-He Zhou, Xiao-Yu Jiaet al.",2023 Sep,Minerva Anestesiol,https://pubmed.ncbi.nlm.nih.gov/36943711/,No keywords found,"['in', 'adult', 'undergoing', 'noncardiac', 'surgery', ',', 'correlation', 'intraoperative', 'tidal', 'volume', 'and', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'unclear', '.', 'study', 'aimed', 'to', 'investigate', 'effect', 'of', 'low', 'tidal', 'volume', 'ventilation', 'incidence', 'of', 'postoperative', 'aki', 'compared', 'with', 'conventional', 'tidal', 'volume', 'in', 'adult', 'undergoing', 'noncardiac', 'surgery', '.', 'method', 'two-center', 'prospective', 'randomized', 'controlled', 'trial', 'adult', 'patient', 'underwent', 'noncardiac', 'surgery', 'and', 'mechanical', 'ventilation', 'of', 'min', '.', 'patient', 'randomized', 'to', 'receive', 'either', 'tidal', 'volume', 'of', 'mlkg', 'pre-predicted', 'body', 'weight', '(', 'pbw', ',', 'low', 'tidal', 'volume', ')', 'or', 'tidal', 'volume', 'of', 'mlkg', 'pre-predicted', 'body', 'weight', '(', 'conventional', 'tidal', 'volume', ')', '.', 'primary', 'outcome', 'incidence', 'of', 'aki', 'non-cardiac', 'surgery', '.', 'appropriate', 'statistical', 'method', 'used', 'study', '.', 'result', 'among', 'randomized', 'patient', ',', 'with', 'low', 'tidal', 'volume', 'and', 'with', 'conventional', 'tidal', 'volume', 'evaluable', 'primary', 'outcome', '.', 'postoperative', 'aki', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'low', 'tidal', 'volume', 'group', 'and', 'patient', '(', '.', ')', 'in', 'conventional', 'tidal', 'volume', 'group', ',', 'with', 'odds', 'ratio', 'of', '.', '(', 'ci', ',', '.-', '.', ')', 'and', 'relative', 'risk', 'of', '.', '(', 'ci', ',', '.-', '.', 'p.', ')', '.', 'postoperative', 'serum', 'creatinine', 'level', 'increased', 'in', '(', '.', ')', 'patient', 'with', 'low', 'tidal', 'volume', 'compared', 'to', '(', '.', ')', 'patient', 'with', 'conventional', 'tidal', 'volume', '(', 'p.', ')', '.', 'no', 'difference', 'in', 'postoperative', 'serum', 'creatinine', 'level', 'found', 'two', 'group', '(', '.', '.-', '.', 'moll', 'vs.', '..', '-', '.', 'moll', ',', 'p.', ')', '.', 'conclusion', 'among', 'adult', 'undergoing', 'noncardiac', 'surgery', ',', 'low', 'tidal', 'volume', 'mechanical', 'ventilation', 'not', 'significantly', 'reduce', 'incidence', 'of', 'postoperative', 'aki', 'compared', 'with', 'conventional', 'tidal', 'volume', '.']"
Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI).,"Stéphane Gaudry, David Hajage, Fréderique Schortgen, Laurent Martin-Lefevre, Florence Tubach, Bertrand Pons, Eric Boulet, Alexandre Boyer, Nicolas Lerolle, Guillaume Chevrel, Dorothée Carpentier, Alexandre Lautrette, Anne Bretagnol, Julien Mayaux, Marina Thirion, Philippe Markowicz, Guillemette Thomas, Jean Dellamonica, Jack Richecoeur, Michael Darmon, Nicolas de Prost, Hodane Yonis, Bruno Megarbane, Yann Loubières, Clarisse Blayau, Julien Maizel, Benjamin Zuber, Saad Nseir, Naïke Bigé, Isabelle Hoffmann, Jean-Damien Ricard, Didier Dreyfuss, Stéphane Gaudryet al.",2015 Apr 17:16:170.,Trials,https://pubmed.ncbi.nlm.nih.gov/25902813/,No keywords found,"['currently', 'no', 'validated', 'strategy', 'timing', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'short-term', 'life-threatening', 'metabolic', 'abnormality', 'absent', '.', 'no', 'adequately', 'powered', 'prospective', 'randomized', 'study', 'addressed', 'issue', 'to', 'date', '.', 'result', ',', 'significant', 'practice', 'heterogeneity', 'exists', 'and', 'may', 'expose', 'patient', 'to', 'either', 'unnecessary', 'hazardous', 'procedure', 'or', 'undue', 'delay', 'in', 'rrt', '.', 'methodsdesign', 'multicenter', ',', 'prospective', ',', 'randomized', ',', 'open-label', 'parallel-group', 'clinical', 'trial', 'compare', 'effect', 'of', 'two', 'rrt', 'initiation', 'strategy', 'overall', 'survival', 'of', 'critically', 'ill', 'patient', 'receiving', 'intravenous', 'catecholamine', 'or', 'invasive', 'mechanical', 'ventilation', 'and', 'presenting', 'with', 'aki', 'classification', 'stage', '(', 'kdigo', ')', '.', 'in', ""'early"", ""'"", 'strategy', ',', 'rrt', 'initiated', 'immediately', '.', 'in', ""'delayed"", ""'"", 'strategy', ',', 'clinical', 'and', 'metabolic', 'condition', 'closely', 'monitored', 'and', 'rrt', 'initiated', 'one', 'or', 'event', '(', 'severity', 'criterion', ')', 'occur', ',', 'including', 'oliguria', 'or', 'anuria', 'hour', 'randomization', ',', 'serum', 'urea', 'concentration', 'mmoll', ',', 'serum', 'potassium', 'concentration', 'mmoll', ',', 'serum', 'potassium', 'concentration', '.', 'mmoll', 'persisting', 'despite', 'medical', 'treatment', ',', 'arterial', 'blood', 'ph', 'lmin', 'to', 'maintain', 'spo', 'or', 'fio', 'invasive', 'or', 'noninvasive', 'mechanical', 'ventilation', '.', 'primary', 'outcome', 'measure', 'overall', 'survival', ',', 'measured', 'randomization', '(', ')', 'death', ',', 'regardless', 'of', 'cause', '.', 'minimum', 'follow-up', 'duration', 'patient', 'day', '.', 'two', 'interim', 'analysis', 'planned', ',', 'blinded', 'to', 'group', 'allocation', '.', 'expected', 'subject', 'in', '.', 'discussion', 'akiki', 'study', 'one', 'of', 'large', 'randomized', 'controlled', 'trial', 'evaluating', 'mortality', 'according', 'to', 'timing', 'of', 'rrt', 'in', 'critically', 'ill', 'patient', 'with', 'aki', 'classification', 'stage', '(', 'kdigo', ')', '.', 'result', 'help', 'clinician', 'decide', 'to', 'initiate', 'rrt', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
C-terminal agrin fragment (CAF) reflects renal function in patients suffering from severe sepsis or septic shock.,"Michael Drey, Michael Behnes, Robert Kob, Dominic Lepiorz, Stefan Hettwer, Cornelius Bollheimer, Cornel C Sieber, Thomas Bertsch, Ursula Hoffmann, Michael Dreyet al.",2015,Clin Lab,https://pubmed.ncbi.nlm.nih.gov/25807640/,No keywords found,"['one', 'of', 'main', 'cause', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'treated', 'intensive', 'care', 'unit', '(', 'icu', ')', 'sepsis', '.', 'identification', 'of', 'new', 'biomarkers', 'indicating', 'early', 'development', 'and', 'future', 'course', 'of', 'aki', 'of', 'utmost', 'medical', 'interest', '.', 'c-terminal', 'agrin', 'fragment', '(', 'caf', ')', 'measurable', 'in', 'blood', 'serum', 'and', 'might', 'reflect', 'kidney', 'function', '.', 'therefore', ',', 'study', 'evaluates', 'caf', 'in', 'patient', 'presenting', 'to', 'internal', 'icu', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', '.', 'serum', 'level', 'of', 'caf', 'correlated', 'with', 'biomarkers', 'of', 'kidney', 'function', ',', 'marker', 'of', 'systemic', 'inflammation', ',', 'and', 'presence', 'of', 'aki', 'and', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'method', 'patient', 'suffering', 'severe', 'sepsis', 'or', 'septic', 'shock', 'included', 'first', 'hour', 'of', 'icu', 'treatment', 'and', 'blood', 'sample', 'biomarker', 'measurement', ',', 'i.e.', ',', 'caf', ',', 'creatinine', ',', 'cystatin', 'c', ',', 'procalcitonin', '(', 'pct', ')', ',', 'interleukin', ',', 'c', 'reactive', 'protein', '(', 'crp', ')', ',', 'and', 'white', 'blood', 'cell', '(', 'wbc', ')', 'collected', 'first', 'day', 'of', 'intensive', 'care', 'treatment', '.', 'number', 'of', 'rrt', 'day', 'and', 'incidence', 'of', 'aki', 'documented', '.', 'result', 'of', 'patient', '(', ')', 'suffered', 'sirssepsis', ',', '(', ')', 'severe', 'sepsis', ',', 'and', '(', ')', 'septic', 'shock', '.', 'serum', 'level', 'of', 'caf', 'significantly', 'correlated', 'with', 'creatinine', '(', 'r', '.', ',', 'p', '.', ')', 'and', 'cystatin', 'c', '(', 'r', '.', ',', 'p', '.', ')', '.', 'multiple', 'linear', 'regression', 'analysis', 'adjusting', 'caf', 'inflammatory', 'parameter', '(', 'i.e.', ',', 'wbc', ',', 'crp', ',', 'interleukin', ',', 'pct', ')', ',', 'age', ',', 'and', 'gender', 'showed', 'strong', 'correlation', 'caf', 'and', 'creatinine', '(', 'r', '.', ',', 'p', '.', ')', '.', 'serum', 'level', 'of', 'caf', 'significantly', 'associated', 'with', 'need', 'of', 'rrt', '(', 'area', 'curve', '(', 'auc', ')', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'incidence', 'of', 'aki', '(', 'auc', '.', ',', 'ci', '-.', ',', 'p', '.', ')', 'indicated', 'roc', 'analysis', '.', 'conclusion', 'in', 'patient', 'suffering', 'severe', 'sepsis', 'and', 'septic', 'shock', ',', 'serum', 'level', 'of', 'caf', 'significantly', 'associated', 'with', 'kidney', 'function', 'and', 'rrt', 'and', 'not', 'influenced', 'severe', 'septic', 'condition', '.']"
Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.,"Fei Chen, Fan Liu, Jingchao Lu, Xiuchun Yang, Bing Xiao, Yaqiong Jin, Jie Zhang, Fei Chenet al.",2018 May 18,Eur J Med Res,https://pubmed.ncbi.nlm.nih.gov/29776437/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'one', 'of', 'common', 'hospital-acquired', 'acute', 'renal', 'failure', '.', 'purpose', 'of', 'study', 'to', 'investigate', 'whether', 'coenzyme', 'q', '(', 'coq', ')', 'and', 'trimetazidine', '(', 'tmz', ')', 'prevent', 'occurrence', 'of', 'cin', 'elective', 'cardiac', 'catheterization', 'in', 'patient', 'with', 'coronary', 'artery', 'disease', 'complicated', 'with', 'renal', 'dysfunction', '.', 'method', 'consecutive', 'coronary', 'artery', 'disease', 'patient', 'with', 'renal', 'insufficiency', 'scheduled', 'coronary', 'angiography', 'enrolled', 'in', 'randomized', ',', 'paralleled', ',', 'double-blind', ',', 'controlled', 'trial', '.', 'development', 'of', 'cin', 'occurrence', 'or', 'h', 'procedure', '.', 'change', 'of', 'serum', 'creatinine', '(', 'scr', ')', ',', 'egfr', ',', 'and', 'cys-c', 'within', 'h', 'procedure', 'measured', 'and', 'compared', '.', 'in', 'vivo', 'contrast', 'medium', '(', 'cm', ')', '-induced', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'animal', 'model', 'established', ',', 'and', 'coq', 'plus', 'tmz', 'orally', 'administrated', 'to', 'evaluate', 'renal', 'protective', 'effect', '.', 'result', 'patient', 'with', 'renal', 'insufficiency', 'enrolled', 'finally', '.', 'cin', 'occurred', 'in', '(', '.', ')', 'of', 'patient', '.', 'h', 'procedure', ',', 'incidence', 'of', 'cin', 'significantly', 'lower', 'in', 'coq', 'plus', 'tmz', 'group', 'compared', 'with', 'control', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'no', 'cardiac', 'death', 'occurred', 'in', 'study', '.', 'no', 'side', 'effect', 'observed', 'administration', 'of', 'coq', 'and', 'tmz', '.', 'in', 'vivo', 'test', 'demonstrated', 'coq', 'and', 'tmz', 'could', 'significantly', 'reduce', 'concentration', 'of', 'blood', 'urea', 'nitrogen', '(', 'bun', ')', 'and', 'scr', 'induced', 'cm', 'i.v', '.', 'injection', ',', 'well', 'tubular', 'pathological', 'injury', '.', 'meanwhile', ',', 'coq', 'and', 'tmz', 'could', 'significantly', 'reduce', 'oxidation', 'stress', 'in', 'kidney', 'cm-aki', 'animal', '.', 'conclusion', 'coq', 'plus', 'tmz', 'could', 'decrease', 'incidence', 'of', 'cin', 'in', 'patient', 'with', 'renal', 'insufficiency', 'undergoing', 'elective', 'cardiac', 'catheterization', ',', 'and', 'effect', 'may', 'due', 'to', 'strong', 'anti-oxidation', 'effect', '.']"
Neutrophil Gelatinase-Associated Lipocalin for the Assessment of Reversible versus Persistent Renal Tubular Damage in ST-Segment Myocardial Infarction Patients.,"Ariel Banai, Keren-Lee Rozenfeld, Itamar Loewenstein, David Zahler, Moshe Shtark, Ilana Goldiner, Shmuel Banai, Yacov Shacham, Ariel Banaiet al.",2021,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/33756457/,No keywords found,"['study', 'investigated', 'value', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'marker', 'of', 'renal', 'tubular', 'injury', 'single', 'time', 'point', '.', 'investigated', 'possible', 'utilization', 'of', 'ngal', 'level', 'dynamic', 'identification', 'of', 'different', 'renal', 'injury', 'pattern', 'in', 'st-elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'patient', '.', 'method', 'blood', 'sample', 'plasma', 'ngal', 'in', 'stemi', 'patient', 'drawn', 'immediately', 'and', 'h', 'following', 'primary', 'coronary', 'intervention', '.', 'abnormal', 'elevation', 'of', 'ngal', 'level', 'defined', 'using', 'cardiac', 'surgery-associated', 'ngal', 'score', 'with', 'ngal', 'level', 'ngml', 'suggesting', 'renal', 'tubular', 'damage', '.', 'according', 'to', 'ngal', 'level', 'and', 'h', ',', 'patient', 'stratified', 'group', 'no', 'tubular', 'damage', '(', 'ngal', 'ngml', 'h', 'ngml', 'and', 'h', ')', '.', 'result', 'mean', 'age', 'year', ',', 'and', 'men', '.', 'of', 'patient', ',', '(', ')', 'demonstrated', 'reversible', 'tubular', 'damage', ',', 'and', '(', ')', 'persistent', 'tubular', 'damage', '.', 'patient', '(', ')', 'progressed', 'to', 'clinical', 'acute', 'kidney', 'injury', 'hospitalization', ',', 'of', 'persistent', 'tubular', 'injury', '.', 'in', 'multivariate', 'regression', 'model', ',', 'symptom', 'duration', 'independently', 'associated', 'with', 'persistent', 'tubular', 'damage', ',', 'continues', 'variable', '(', 'odds', 'ratio', 'or', '.', ',', 'confidence', 'interval', 'ci', '.-', '.', 'p', '.', ')', 'and', 'symptom', 'duration', 'min', '(', 'or', '.', ',', 'ci', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'renal', 'tubular', 'damage', 'common', 'among', 'stemi', 'patient', '.', 'dynamic', 'ngal', 'measurement', 'may', 'differentiate', 'reversible', 'and', 'persistent', 'tubular', 'damage', '.', 'trial', 'needed', 'in', 'order', 'to', 'assess', 'complex', 'cardiorenal', 'interaction', '.']"
Potential biomarkers for the early detection of acute kidney injury after percutaneous nephrolithotripsy.,"Mansur Daggülli, Mehmet M Utangaç, Onur Dede, Mehmet N Bodakci, Namık K Hatipoglu, Necmettin Penbegül, Ahmet A Sancaktutar, Yaşar Bozkurt, Haluk Söylemez, Mansur Daggülliet al.",2016,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/26481764/,"AKI, KIM-1, PNL, renal stone, urinary biomarkers.","['study', 'aim', 'to', 'investigate', 'role', 'of', 'urinary', 'biomarkers', 'in', 'determination', 'of', 'potential', 'risk', 'of', 'renal', 'parenchymal', 'tubular', 'damage', 'in', 'adult', 'patient', 'underwent', 'percutaneous', 'nephrolithotomy', '(', 'pnl', ')', 'with', 'indication', 'of', 'renal', 'stone', '.', 'randomized', 'and', 'prospective', 'controlled', 'study', 'performed', 'june', 'and', 'december', '.', 'enrolled', 'consecutive', 'patient', 'with', 'renal', 'calculus', 'cm', 'and', 'underwent', 'pnl', ',', 'well', 'healthy', 'control', 'subject', '.', 'urine', 'sample', ',', 'including', 'h', 'surgery', ',', 'and', 'h', 'surgery', 'collected', 'patient', 'group', '.', 'freshly', 'voided', 'urine', 'sample', 'collected', 'control', 'group', '.', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'n-acetyl-glucosaminidase', '(', 'nag', ')', ',', 'and', 'liver-type', 'fatty', 'acid', 'binding', 'protein', '(', 'lfabp', ')', 'level', 'measured', 'urine', 'sample', '.', 'mean', 'kim-cr', 'value', 'measured', 'h', 'operation', 'statistically', 'significant', ',', 'higher', 'preoperative', '(', 'preop', ')', 'level', '(', 'p', '.', ')', '.', 'significant', 'difference', 'detected', 'mean', 'preop', 'and', 'postoperative', '(', 'postop', ')', 'h', 'nagcr', 'value', '(', 'p', '.', ')', '.', 'also', ',', 'postop', 'h', 'ngalcr', 'level', 'statistically', 'significant', ',', 'higher', 'preop', 'level', '(', 'p', '.', ')', '.', 'according', 'to', 'comparison', 'of', 'preop', 'and', 'postop', 'level', ',', 'increase', 'in', 'lfabpcr', 'value', 'secondary', 'to', 'surgical', 'intervention', 'observed', 'without', 'statistically', 'significant', 'difference', '.', 'besides', 'lfabpcr', 'level', 'not', 'change', 'percutaneous', 'kidney', 'surgery', ',', 'kim-cr', ',', 'nagcr', ',', 'and', 'ngalcr', 'level', 'increase', 'postop', 'period', ',', 'especially', 'h.', 'study', 'with', 'larger', 'series', 'and', 'repeated', 'measurement', 'performed', 'to', 'clarify', 'used', 'to', 'demonstrate', 'renal', 'damage', 'percutaneous', 'surgery', 'or', 'not', '.']"
"Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP): A single center, open-label, three-arm, randomized, controlled intervention pilot trial.","Asieb Sekandarzad, Erika Graf, Eric Peter Prager, Hendrik Luxenburger, Dawid L Staudacher, Tobias Wengenmayer, Dominik Bettinger, Alexander Supady, Asieb Sekandarzadet al.",2024 Oct,Artif Organs,https://pubmed.ncbi.nlm.nih.gov/38770971/,No keywords found,"['to', 'investigate', 'efficacy', 'of', 'bilirubin', 'reduction', 'hemoadsorption', 'with', 'cytosorb', 'in', 'patient', 'with', 'acute-on-chronic', 'liver', 'failure', '(', 'aclf', ')', 'receiving', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '.', 'method', 'prospective', ',', 'randomized', ',', 'single-center', ',', 'open-label', ',', 'controlled', 'pilot', 'trial', '.', 'patient', 'with', 'aclf', ',', 'acute', 'kidney', 'injury', ',', 'and', 'serum', 'bilirubin', 'mgdl', 'assigned', 'to', 'one', 'of', 'three', 'study', 'group', '(', 'crrt', 'with', 'or', 'without', 'hemoadsorption', ',', 'no', 'crrt', ')', '.', 'in', 'hemoadsorption', 'group', ',', 'cytosorb', 'adsorber', 'incorporated', 'crrt', 'system', ',', 'replaced', ',', ',', 'and', 'h', ',', 'and', 'removed', 'h.', 'primary', 'endpoint', 'serum', 'bilirubin', 'level', 'h.', 'result', 'cytohep', 'terminated', 'early', 'due', 'to', 'difficulty', 'in', 'recruiting', 'patient', 'and', 'ethical', 'concern', '.', 'three', 'of', 'patient', '(', ')', 'treated', 'in', 'group', '.', 'comparing', 'three', 'group', ',', 'mean', 'bilirubin', 'level', 'h', 'lower', '-', '.', 'mgdl', 'in', '``', 'crrt', 'with', 'hemoadsorption', ""''"", 'group', 'compared', 'to', '``', 'crrt', 'without', 'hemoadsorption', ""''"", '(', 'ci', ',', '-', '.', 'to', '.', 'mgdl', 'p', '.', ')', '.', 'corresponding', 'mean', 'difference', '``', 'crrt', 'without', 'hemoadsorption', ""''"", 'and', '``', 'no', 'crrt', ""''"", '-', '.', 'mgdl', '(', 'ci', ',', '-', '.', 'to', '.', 'mgdl', 'p', '.', ')', '.', 'comparing', '``', 'crrt', 'with', 'hemoadsorption', ""''"", 'and', '``', 'no', 'crrt', ',', ""''"", '-', '.', 'mgdl', '(', 'ci', ',', '-', '.', 'to', '.', 'mgdl', 'p', '.', ')', '.', 'patient', '(', ',', '``', 'no', 'crrt', ""''"", 'group', ')', 'survived', 'day', 'study', 'inclusion', 'died', 'day', '.', 'il-', ',', 'liver', 'function', 'parameter', ',', 'and', 'clinical', 'score', 'similar', 'study', 'group', '.', 'conclusion', 'cytohep', 'failed', 'to', 'demonstrate', 'extracorporeal', 'hemoadsorption', 'combined', 'with', 'crrt', 'reduce', 'serum', 'bilirubin', 'in', 'aclf', 'patient', 'with', 'acute', 'kidney', 'failure', '.']"
Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis.,"Frederic Albrecht, Stefan Schunk, Maren Fuchs, Thomas Volk, Juergen Geisel, Danilo Fliser, Andreas Meiser, Frederic Albrechtet al.",2024,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/37918366/,No keywords found,"['rhabdomyolysis', 'characterized', 'destruction', 'of', 'muscle', 'fiber', 'various', 'cause', 'and', 'diagnosed', 'increased', 'creatine', 'kinase', 'concentration', 'in', 'blood', '.', 'myoglobin', 'released', 'blood', 'may', 'cause', 'acute', 'kidney', 'injury', '.', 'in', 'randomized', 'controlled', 'study', ',', 'hypothesized', 'myoglobin', 'elimination', 'would', 'faster', 'hemoadsorber', 'added', 'to', 'continuous', 'veno-venous', 'hemodialysis', '(', 'cvvhd', ')', '.', 'method', 'four', 'patient', 'in', 'control', 'group', 'received', 'cvvhd', 'with', 'high', 'cut-off', 'hemofilter', 'using', 'high', 'blood', 'and', 'dialysate', 'flow', 'h.', 'four', 'patient', 'in', 'cytosorb', 'group', 'received', 'treatment', ',', 'in', 'addition', ',', 'hemoadsorber', 'cytosorb', 'inserted', 'in', 'front', 'of', 'hemofilter', 'and', 'replaced', 'h.', 'blood', 'sample', 'drawn', 'simultaneously', '(', 'pre', ')', 'and', '(', 'post', ')', 'hemofilter', 'or', 'else', 'hemoadsorber', ',', 'and', 'min', ',', 'well', ',', ',', ',', 'and', 'h.', 'measurement', 'repeated', 'next', 'day', 'hemoadsorber', 'renewed', 'in', 'cytosorb', 'group', '.', 'primary', 'outcome', 'area', 'curve', '(', 'auc', ')', 'of', 'relative', 'myoglobin', 'concentration', 'percent', 'of', 'baseline', '.', 'to', 'evaluate', 'efficacy', 'of', 'myoglobin', 'removal', ',', 'relative', 'reduction', 'in', 'myoglobin', 'concentration', 'one', 'passage', 'device', 'time', 'point', 'calculated', '.', 'result', 'patient', 'in', 'cytosorb', 'group', 'significantly', 'lower', 'auc', 'first', 'h', '(', 'vs.', ',', 'p', '.', ')', 'well', 'observation', 'period', 'of', 'h', '(', 'vs.', ',', 'p', '.', ')', '.', 'relative', 'reduction', 'myoglobin', 'considerably', 'higher', 'in', 'cytosorb', 'group', 'compared', 'to', 'control', 'group', 'first', 'h.', 'conclusion', 'myoglobin', 'concentration', 'declined', 'considerably', 'faster', 'cytosorb', 'added', 'to', 'cvvhd', '.', 'compared', 'to', 'high-cut-off', 'hemofilter', ',', 'efficacy', 'of', 'cytosorb', 'in', 'myoglobin', 'elimination', 'much', 'better', '.', 'of', 'saturation', '-', 'h', 'exchange', 'may', 'necessary', '.']"
Comparing the effect of administering gelatin-low dose albumin versus albumin on renal function in liver transplantation: A randomized clinical trial.,"Samaneh Ghazanfar Tehran, Mohammad Bagher Khosravi, Mohammad Ali Sahmeddini, Mohammad Hossein Eghbal, Naeimehossadat Asmarian, Fatemeh Khalili, Pooya Vatankhah, Samaneh Ghazanfar Tehranet al.",2022 Nov,Clin Transplant,https://pubmed.ncbi.nlm.nih.gov/35950553/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'liver', 'transplantation', '(', 'lt', ')', 'independently', 'associated', 'with', 'increased', 'risk', 'of', 'morbidity', 'and', 'mortality', '.', 'study', 'aimed', 'to', 'evaluate', 'effect', 'of', 'administering', 'gelatin-low', 'dose', 'albumin', 'versus', 'albumin', 'renal', 'function', 'and', 'early', 'outcome', 'in', 'lt.', 'method', 'randomized', 'controlled', 'clinical', 'trial', 'conducted', 'patient', 'undergoing', 'lt', 'brain', 'death', 'donor', '.', 'patient', 'randomly', 'assigned', 'to', 'two', 'group', 'albumin', 'or', 'modified', 'gelatin', 'with', 'albumin', '.', 'blood', 'sample', 'collected', '(', ')', 'and', 'first', '(', ')', ',', 'second', '(', ')', ',', 'third', '(', ')', ',', 'fifth', '(', ')', ',', 'and', 'last', 'day', 'of', 'hospitalization', '(', ')', 'lt', 'detection', 'of', 'laboratory', 'parameter', ',', 'including', 'renal', 'and', 'liver', 'function', 'test', '.', 'result', 'incidence', 'of', 'akt', 'basis', 'of', 'rifle', 'criterion', '.', 'in', 'gelatin', 'group', '(', 'r', '.', ',', '.', ',', 'and', 'f', '.', ')', 'and', '.', 'in', 'albumin', 'group', '(', 'r', '.', ',', '.', ',', 'and', 'f', '.', ')', '(', 'p', '.', ')', '.', 'two', 'patient', 'in', 'gelatin', 'and', 'one', 'in', 'albumin', 'group', 'required', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'no', 'significant', 'difference', 'group', 'trend', 'of', 'change', 'in', 'renal', 'and', 'liver', 'function', 'parameter', 'assessed', 'study', 'period', '(', 't-t', ')', '.', 'furthermore', ',', 'incidence', 'of', 'complication', 'similar', 'across', 'group', '.', 'conclusion', 'study', 'showed', 'modified', 'gelatin', 'could', 'used', 'without', 'inappropriate', 'outcome', 'renal', 'function', 'in', 'patient', 'with', 'normal', 'preoperative', 'kidney', 'function', 'test', 'undergoing', 'lt', '.']"
Comparison of retrograde intrarenal stone surgery with and without a ureteral access sheath using kidney injury molecule-1 (KIM-1) levels: a prospective randomized study.,"Gökhan Ecer, Mehmet Giray Sönmez, Arif Aydın, Cemile Topçu, Haider Nihad Izaddin Alalam, Selçuk Güven, Mehmet Balasar, Gökhan Eceret al.",2022 Oct,Urolithiasis,https://pubmed.ncbi.nlm.nih.gov/35802150/,"Dual lumen ureteral access sheath, Flexible ureterorenoscopy, Kidney injury molecule-1, Retrograde intrarenal surgery, Ureteral access sheath.","['rirs', 'without', 'uas', '(', 'group', ')', ',', 'frfr', 'boston', 'scientific', 'navigator', 'uas', '(', 'group', ')', ',', 'and', 'frfr', 'dual', 'lumen', 'clearpetra', 'uas', '(', 'group', ')', '.', 'data', 'prospectively', 'collected', 'in', 'consecutive', 'patient', '.', 'urine', 'kim-cr', 'level', 'measured', 'preoperatively', ',', 'postoperative', 'h', ',', 'and', 'postoperative', 'day', '.', 'stone', 'size', ',', 'location', ',', 'number', ',', 'pre-', 'and', 'postoperative', 'stent', 'use', ',', 'operation', 'time', ',', 'stone-free', 'rate', '(', 'sfr', ')', ',', 'post-ureteroscopic', 'lesion', 'scale', '(', 'pul', ')', 'grade', ',', 'hospitalization', 'duration', ',', 'and', 'complication', 'recorded', '.', 'no', 'significant', 'difference', 'in', 'demographical', 'parameter', 'and', 'preoperative', 'kim-cr', 'level', 'among', 'group', '.', 'postoperative', 'th-hour', 'urine', 'kim-cr', 'level', 'higher', 'in', 'patient', 'without', 'uas', 'patient', 'with', 'uas', '(', '.', ',', '.', ',', '.', 'group', ',', ',', ',', 'respectively', ')', '.', 'in', 'comparing', 'group', 'with', 'group', 'and', 'separately', ',', 'group', 'statistically', 'significantly', 'higher', 'value', 'group', '(', 'p', '.', ',', 'p', '.', ',', 'respectively', ')', '.', 'according', 'to', 'uas', 'type', ',', 'no', 'significant', 'difference', 'group', 'and', '.', 'use', 'of', 'uas', 'rirs', 'shown', 'to', 'reduce', 'kidney', 'injury', 'in', 'evaluation', 'with', 'kim-', '.', 'different', 'uas', 'type', 'kidney', 'injury', 'and', 'one', 'protect', 'kidney', 'procedure', 'elucidated', 'prospective', 'randomized', 'study', 'involving', 'larger', 'patient', 'group', 'and', 'uas', 'type', '.']"
"Ionic homeostasis, acid-base balance and the risk of citrate accumulation in patients after cardiovascular surgery treated with continuous veno-venous haemofiltration with post-dilution regional citrate anticoagulation - An observational case-control study.","Agnieszka Kośka, Maciej Michał Kowalik, Anna Lango-Maziarz, Wojtek Karolak, Dariusz Jagielak, Romuald Lango, Agnieszka Kośkaet al.",2021 Oct 29,Acta Biochim Pol,https://pubmed.ncbi.nlm.nih.gov/34714613/,No keywords found,"['patient', 'cardiovascular', 'surgery', ',', 'requiring', 'renal', 'replacement', 'therapy', ',', 'benefit', 'adequate', 'non-heparin', 'circuit', 'anticoagulation', '.', 'simplified', 'regional', 'citrate', 'anticoagulation', '(', 'rca', ')', 'protocol', 'proposes', 'use', 'of', 'citric', 'acid', 'dextrose', 'formula', '(', 'acd-a', ')', 'post-dilutional', 'continuous', 'veno-venous', 'hemofiltration', '(', 'cvvh', ')', 'with', 'standard', 'bicarbonate', 'buffered', 'calcium', 'containing', 'replacement', 'solution', '.', 'citrate', 'accumulation', 'diagnosed', 'upon', 'total', 'to', 'ionized', 'calcium', 'ratio', '(', 'tcaica', ')', 'and', 'low', 'ionized', 'calcium', '(', 'ica', ')', 'considered', 'biggest', 'risk', 'related', 'to', 'regional', 'citrate', 'accumulation', '.', 'method', 'prospective', 'observational', 'case-control', 'study', 'evaluated', 'electrolyte', 'and', 'acid-base', 'homeostasis', 'in', 'cardiovascular', 'surgery', 'patient', 'treated', 'with', 'post-dilution', 'cvvh', 'with', 'simplified', 'rca', 'protocol', 'with', 'acd-a', '.', 'in', 'total', ',', 'consecutive', 'cardiovascular', 'surgery', 'patient', 'evaluated', '.', 'base', 'excess', ',', 'ph', ',', 'bicarbonate', ',', 'lactate', ',', 'na', ',', 'cl-', ',', 'mg', ',', 'and', 'inorganic', 'phosphate', 'concentration', ',', 'total', 'to', 'ionized', 'calcium', 'ratio', '(', 'tcaica', ')', ',', 'and', 'high', 'anion', 'gap', 'metabolic', 'acidosis', 'assessed', 'haemofiltration', 'treatment', 'in', 'survivor', 'and', 'non-survivors', '.', 'result', 'thirty-three', '(', ')', 'patient', 'died', '.', 'therapy', 'well', 'balanced', 'in', 'sodium', 'and', 'chloride', 'homeostasis', '.', 'lactate', 'concentration', 'and', 'anion', 'gap', 'decreased', 'cvvh', 'session', 'lasting', 'longer', 'hour', ',', 'no', 'inter-group', 'difference', 'observed', '.', 'tcaica', 'ratio', 'exceeded', '.', 'and', 'significantly', 'higher', 'in', 'non-survivors', '(', 'p.', ')', '.', 'initial', 'lactate', 'concentration', 'not', 'correlate', 'with', 'tcaica', 'ratio', 'haemofiltration', '.', 'magnesium', 'and', 'phosphate', 'concentration', 'decreased', 'and', 'additional', 'supplementation', 'with', 'magnesium', 'necessary', '.', 'magnesium', 'concentration', 'lower', 'in', 'non-survivors', '.', 'conclusion', 'incidence', 'of', 'citrate', 'accumulation', 'exceeded', 'and', 'significantly', 'higher', 'in', 'non-survivors', '.', 'supplementation', 'with', 'magnesium', 'and', 'phosphate', 'ion', 'needed', 'in', 'cvvh', 'with', 'rca', '.']"
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.,"Alexander Zarbock, Mira Küllmar, Detlef Kindgen-Milles, Carola Wempe, Joachim Gerss, Timo Brandenburger, Thomas Dimski, Bartosz Tyczynski, Michael Jahn, Nils Mülling, Martin Mehrländer, Peter Rosenberger, Gernot Marx, Tim Philipp Simon, Ulrich Jaschinski, Philipp Deetjen, Christian Putensen, Jens-Christian Schewe, Stefan Kluge, Dominik Jarczak, Torsten Slowinski, Marc Bodenstein, Patrick Meybohm, Stefan Wirtz, Onnen Moerer, Andreas Kortgen, Philipp Simon, Sean M Bagshaw, John A Kellum, Melanie Meersch                              ;, RICH Investigators and the Sepnet Trial Group, Alexander Zarbocket al.",2020 Oct 27,JAMA,https://pubmed.ncbi.nlm.nih.gov/33095849/,No keywords found,"['although', 'current', 'guideline', 'suggest', 'use', 'of', 'regional', 'citrate', 'anticoagulation', '(', 'involves', 'addition', 'of', 'citrate', 'solution', 'to', 'blood', 'filter', 'of', 'extracorporeal', 'dialysis', 'circuit', ')', 'first-line', 'treatment', 'continuous', 'kidney', 'replacement', 'therapy', 'in', 'critically', 'ill', 'patient', ',', 'evidence', 'recommendation', 'based', 'clinical', 'trial', 'and', 'meta-analyses', '.', 'objective', 'to', 'determine', 'effect', 'of', 'regional', 'citrate', 'anticoagulation', ',', 'compared', 'with', 'systemic', 'heparin', 'anticoagulation', ',', 'filter', 'life', 'span', 'and', 'mortality', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'parallel-group', ',', 'randomized', 'multicenter', 'clinical', 'trial', 'in', 'center', 'across', 'germany', 'conducted', 'march', 'and', 'december', '(', 'final', 'date', 'of', 'follow-up', ',', 'january', ',', ')', '.', 'trial', 'terminated', 'early', 'critically', 'ill', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', 'or', 'clinical', 'indication', 'initiation', 'of', 'kidney', 'replacement', 'therapy', 'enrolled', '.', 'intervention', 'patient', 'randomized', 'to', 'receive', 'either', 'regional', 'citrate', 'anticoagulation', '(', 'n', ')', ',', 'consisted', 'of', 'target', 'ionized', 'calcium', 'level', 'of', '.', 'to', '.', 'mgdl', ',', 'or', 'systemic', 'heparin', 'anticoagulation', '(', 'n', ')', ',', 'consisted', 'of', 'target', 'activated', 'partial', 'thromboplastin', 'time', 'of', 'to', 'second', ',', 'continuous', 'kidney', 'replacement', 'therapy', '.', 'main', 'outcome', 'and', 'measure', 'coprimary', 'outcome', 'filter', 'life', 'span', 'and', '-day', 'mortality', '.', 'secondary', 'end', 'point', 'included', 'bleeding', 'complication', 'and', 'new', 'infection', '.', 'result', 'among', 'patient', 'randomized', ',', '(', '.', ')', '(', 'mean', 'age', ',', '.', 'year', '.', 'woman', ')', 'completed', 'trial', '.', 'in', 'regional', 'citrate', 'group', 'v', 'systemic', 'heparin', 'group', ',', 'median', 'filter', 'life', 'span', 'hour', '(', 'interquartile', 'range', 'iqr', ',', '-', 'hour', ')', 'v', 'hour', '(', 'iqr', ',', '-', 'hour', ')', '(', 'difference', ',', 'hour', 'ci', ',', 'to', 'hour', 'p', '.', ')', '.', 'ninety-day', 'all-cause', 'mortality', 'occurred', 'in', 'of', 'patient', 'v', 'of', 'patient', '(', 'kaplan-meier', 'estimator', 'percentage', ',', '.', 'v', '.', 'unadjusted', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'unadjusted', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'unadjusted', 'p', '.', 'adjusted', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'primary', 'adjusted', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'primary', 'adjusted', 'p', '.', ')', '.', 'of', 'prespecified', 'secondary', 'end', 'point', ',', 'showed', 'no', 'significant', 'difference', '.', 'compared', 'with', 'systemic', 'heparin', 'group', ',', 'regional', 'citrate', 'group', 'significantly', 'fewer', 'bleeding', 'complication', '(', '.', 'v', '.', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'p', '.', ')', 'and', 'significantly', 'new', 'infection', '(', '.', 'v', '.', 'difference', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', 'receiving', 'continuous', 'kidney', 'replacement', 'therapy', ',', 'anticoagulation', 'with', 'regional', 'citrate', ',', 'compared', 'with', 'systemic', 'heparin', 'anticoagulation', ',', 'resulted', 'in', 'significantly', 'longer', 'filter', 'life', 'span', '.', 'trial', 'terminated', 'early', 'and', 'therefore', 'underpowered', 'to', 'reach', 'conclusion', 'effect', 'of', 'anticoagulation', 'strategy', 'mortality', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Efficacy of two hemodialyses in patients with chronic renal failure complicated by massive intracerebral hemorrhage.,"Xiangyu Zhu#, Qiu Han#, Lei Xia, Jin Shang, Xianliang Yan, Xiangyu Zhuet al.",2023 Jul,Ann Clin Transl Neurol,https://pubmed.ncbi.nlm.nih.gov/37350299/,No keywords found,"['to', 'compare', 'efficacy', 'of', 'intermittent', 'hemodialysis', '(', 'ihd', ')', 'and', 'continuous', 'veno-venous', 'hemofiltration', '(', 'cvvh', ')', 'in', 'patient', 'with', 'chronic', 'renal', 'failure', 'complicated', 'massive', 'intracerebral', 'hemorrhage', '.', 'method', 'sixty-two', 'patient', 'randomly', 'and', 'equally', 'divided', 'ihd', 'and', 'cvvh', 'group', '.', 'clinical', 'variable', 'compared', ',', 'including', 'national', 'institute', 'of', 'health', 'stroke', 'scale', '(', 'nihss', ')', 'score', 'primary', 'indicator', ',', 'cerebral', 'edema', 'volume', ',', 'hospital-acquired', 'pneumonia', '(', 'hap', ')', 'incidence', ',', 'acute', 'heart', 'failure', '(', 'ahf', ')', 'incidence', ',', 'rehemorrhage', 'incidence', ',', 'hospital', 'stay', 'length', ',', 'and', 'modified', 'rankin', 'scale', '(', 'mr', ')', 'score', '.', 'result', 'cvvh', 'group', 'lower', 'nihss', 'score', 'and', 'edema', 'volume', 'ihd', 'group', 'postoperative', 'day', 'and', '.', 'moreover', ',', 'in', 'cvvh', 'group', ',', '(', ')', 'nihss', 'score', 'postoperative', 'day', 'and', 'higher', 'postoperative', 'day', '(', 'ii', ')', 'no', 'significant', 'difference', 'in', 'nihss', 'score', 'day', 'and', 'and', '(', 'iii', ')', 'no', 'significant', 'difference', 'in', 'cerebral', 'edema', 'volume', 'found', 'postoperative', 'day', 'and', ',', ',', 'and', '.', 'in', 'ihd', 'group', ',', 'nihss', 'score', 'and', 'cerebral', 'edema', 'volume', 'postoperative', 'day', 'and', 'significantly', 'higher', 'postoperative', 'day', '.', 'cvvh', 'group', 'lower', 'incidence', 'of', 'hap', ',', 'ahf', ',', 'and', 'adverse', 'event', 'and', 'shorter', 'hospital', 'stay', 'length', 'ihd', 'group', '.', 'proportion', 'of', 'patient', 'with', 'mr', 'score', 'of', 'and', 'in', 'cvvh', 'group', 'higher', 'in', 'ihd', 'group', 'day', 'discharge', '.', 'interpretation', 'cvvh', 'effective', 'ihd', 'in', 'treatment', 'of', 'patient', 'with', 'chronic', 'renal', 'failure', 'complicated', 'massive', 'intracerebral', 'hemorrhage', '.']"
Characteristics and associated factors of acute kidney injury among adult dengue patients: A retrospective single-center study.,"Ajib Diptyanusa, Weerapong Phumratanaprapin, Benjaluck Phonrat, Kittiyod Poovorawan, Borimas Hanboonkunupakarn, Natthida Sriboonvorakul, Usa Thisyakorn, Ajib Diptyanusaet al.",2019 Jan 7,PLoS One,https://pubmed.ncbi.nlm.nih.gov/30615667/,No keywords found,"['..', 'patient', 'showed', 'significantly', '(', 'p', '.', ')', 'higher', 'proportion', 'of', 'altered', 'consciousness', ',', 'dyspnea', ',', 'low', 'mean', 'arterial', 'blood', 'pressure', ',', 'high-grade', 'fever', ',', 'major', 'bleeding', ',', 'severe', 'thrombocytopenia', ',', 'hypoalbuminemia', ',', 'severe', 'transaminitis', ',', 'coagulopathy', ',', 'metabolic', 'acidosis', ',', 'rhabdomyolysis', ',', 'proteinuria', ',', 'hematuria', ',', 'and', 'pyuria', '.', 'study', 'established', 'older', 'age', ',', 'male', 'sex', ',', 'diabetes', 'mellitus', ',', 'obesity', ',', 'severe', 'dengue', ',', 'and', 'coexisting', 'bacterial', 'infection', 'significant', 'associated', 'factor', 'aki', 'in', 'dengue', 'multivariate', 'analysis', '.', 'total', 'of', '(', '.', ')', 'patient', 'with', 'aki', 'received', 'dialysis', ',', 'among', '(', '.', ')', 'patient', 'aki', 'group', 'died', '.', 'finding', 'suggest', 'awareness', 'of', 'aki', ',', 'early', 'diagnosis', ',', 'and', 'evaluation', 'of', 'clinical', 'and', 'laboratory', 'characteristic', 'of', 'dengue', 'patient', 'help', 'clinician', 'to', 'initiate', 'appropriate', 'therapy', 'dengue-associated', 'aki', '.']"
"Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial.","Shilpa Abraham, Ramachandran Rameshkumar, Muthu Chidambaram, Rajendran Soundravally, Seenivasan Subramani, Rohit Bhowmick, Abraar Sheriff, Kaushik Maulik, Subramanian Mahadevan, Shilpa Abrahamet al.",2021 Nov,Indian J Pediatr,https://pubmed.ncbi.nlm.nih.gov/33796993/,No keywords found,"['to', 'study', 'whether', 'furosemide', 'infusion', 'in', 'early-onset', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'critically', 'ill', 'child', 'would', 'associated', 'with', 'reduced', 'proportion', 'of', 'patient', 'progressing', 'to', 'higher', 'stage', '(', 'injury', 'or', 'failure', ')', 'compared', 'to', 'placebo', '.', 'method', 'double-blind', ',', 'placebo-controlled', ',', 'randomized', 'pilot', 'trial', 'conducted', '.', 'author', 'enrolled', 'child', 'aged', '-mo', '(', 'corrected', ')', 'to', '-y', ',', 'diagnosed', 'with', 'aki', '(', '``', 'risk', ""''"", 'stage', ')', 'using', 'pediatric-risk', ',', 'injury', ',', 'failure', ',', 'loss', ',', 'end', 'stage', 'kidney', 'disease', '(', 'p-rifle', ')', 'criterion', ',', 'and', 'achieved', 'immediate', 'resuscitation', 'goal', 'within', 'h', 'of', 'admission', '.', 'participant', 'received', 'either', 'furosemide', '(', '.', 'to', '.', 'mgkgh', ')', 'or', 'placebo', '(', '-dextrose', ')', 'infusion', '.', 'primary', 'outcome', 'proportion', 'of', 'patient', 'progressing', 'to', 'higher', 'stage', '(', 'injury', 'or', 'failure', ')', '.', 'secondary', 'outcome', '(', ')', 'need', 'renal', 'replacement', 'therapy', ',', '(', 'ii', ')', 'effect', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'urine', 'and', 'blood', ')', ',', '(', 'iii', ')', 'fluid', 'balance', ',', '(', 'iv', ')', 'adverse', 'effect', ',', '(', 'v', ')', 'time', 'to', 'achieve', 'renal', 'recovery', ',', '(', 'vi', ')', 'duration', 'of', 'hospital', 'stay', 'and', 'mechanical', 'ventilation', ',', 'and', '(', 'vii', ')', 'all-cause', '-d', 'mortality', '.', 'result', 'trial', 'stopped', 'futility', ',', 'and', 'data', 'analyzed', 'intention-to-treat', 'basis', '(', 'furosemide-group', 'n', 'placebo-group', 'n', ')', '.', 'no', 'significant', 'difference', 'noted', 'in', 'progression', 'of', 'aki', 'to', 'higher', 'stage', 'furosemide', 'and', 'placebo', 'group', '(', '.', 'vs.', '.', 'relative', 'risk', '.', ',', 'ci', '.', 'to', '.', ')', '(', 'p', '.', ')', '.', 'no', 'difference', 'in', 'secondary', 'outcome', 'study', 'group', '.', 'all-cause', '-d', 'mortality', 'similar', 'group', '(', '.', 'v', '.', '.', ')', '.', 'no', 'trial-related', 'severe', 'adverse', 'event', 'occurred', '.', 'conclusion', 'furosemide', 'infusion', 'in', 'early-onset', 'aki', 'not', 'reduce', 'progression', 'to', 'higher', 'stage', 'of', 'aki', '.', 'future', 'trial', 'with', 'large', 'sample', 'size', 'warranted', '.']"
"Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.","Krittapoom Akrawinthawong, Jason Ricci, Louis Cannon, Simon Dixon, Kenneth Kupfer, David Stivers, Patrick Alexander, Shukri David, Peter A McCullough, Krittapoom Akrawinthawonget al.",2015 Mar,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/25519207/,No keywords found,"['neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'produced', 'in', 'response', 'to', 'tubular', 'injury', '.', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'associated', 'with', 'adverse', 'outcome', 'in', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'patient', '.', 'sought', 'to', 'characterize', 'blood', 'ngal', 'level', 'and', 'degree', 'of', 'kidney', 'injury', 'in', 'ckd', 'patient', 'underwent', 'coronary', 'angiography', '.', 'method', 'study', 'prospective', ',', 'blinded', 'assessment', 'of', 'blood', 'sample', 'obtained', 'patient', 'with', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfrs', ')', 'and', 'mlmin', '.', 'undergoing', 'elective', 'coronary', 'angiography', 'with', 'iodinated', 'contrast', '.', 'blood', 'ngal', 'and', 'serum', 'creatinine', 'measured', 'baseline', ',', ',', ',', ',', ',', ',', 'and', 'h', 'contrast', 'administration', '.', 'result', 'total', 'of', 'subject', 'with', 'mean', 'egfr', 'of', '..', 'mlmin', '.', 'enrolled', '.', 'graded', 'increase', 'in', 'baseline', 'ngal', 'level', 'across', 'worsening', 'stage', 'of', 'ckd', '(', 'p.', ')', '.', 'post-procedure', 'ngal', 'increased', 'baseline', 'in', 'stage', 'of', 'ckd', '.', 'eight', '(', '.', ')', 'patient', 'diagnosed', 'with', 'ci-aki', 'diagnostic', 'criterion', 'of', 'kdigo', 'definition', 'of', 'ci-aki', ',', 'and', 'seven', '(', '.', ')', 'patient', 'developed', 'subclinical', 'ci-aki', 'defined', 'twofold', 'or', 'greater', 'rise', 'in', 'ngal', '.', 'no', 'relationship', 'baseline', 'egfr', 'and', 'diabetes', 'composite', 'outcome', 'of', 'subclinical', 'and', 'clinical', 'ci-aki', '.', 'conclusion', 'baseline', 'and', 'post-procedure', 'ngal', 'progressively', 'elevated', 'according', 'to', 'baseline', 'stage', 'of', 'ckd', '.', 'using', 'twofold', 'rise', 'in', 'ngal', ',', '.', 'of', 'composite', 'ci-aki', 'detected', 'and', 'complement', '.', 'of', 'case', 'identified', 'using', 'kdigo', 'criterion', '.', 'traditional', 'risk', 'predictor', 'not', 'independently', 'associated', 'with', 'composite', 'outcome', '.']"
Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial.,"Nikolay O Kamenshchikov, Yana J Anfinogenova, Boris N Kozlov, Yulia S Svirko, Stanislav E Pekarskiy, Vladimir V Evtushenko, Vladimir A Lugovsky, Vladimir M Shipulin, Vladimir V Lomivorotov, Yuriy K Podoksenov, Nikolay O Kamenshchikovet al.",2022 Apr,J Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/32718702/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'serious', 'complication', 'of', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'effect', 'of', 'nitric', 'oxide', '(', 'no', ')', 'supplementation', 'to', 'cpb', 'circuit', 'development', 'of', 'cardiac', 'surgery-associated', 'aki', '.', 'method', 'prospective', 'randomized', 'controlled', 'study', 'included', 'patient', 'with', 'moderate', 'risk', 'of', 'renal', 'complication', 'underwent', 'elective', 'cardiac', 'surgery', 'with', 'cpb', '.', 'study', 'protocol', 'registered', 'clinicaltrials.gov', '(', 'identifier', 'nct', ')', '.', 'patient', 'randomly', 'allocated', 'to', 'either', 'no', 'supplementation', 'to', 'cpb', 'bypass', 'circuit', '(', 'no', 'treatment', 'group', 'n', ')', 'or', 'usual', 'care', '(', 'control', 'group', 'n', ')', '.', 'in', 'no', 'treatment', 'group', ',', '-ppm', 'no', 'administered', 'entire', 'cpb', 'period', '.', 'primary', 'outcome', 'incidence', 'of', 'aki', '.', 'result', 'no', 'treatment', 'associated', 'with', 'significant', 'decrease', 'in', 'aki', 'incidence', '(', 'case', '.', 'v', 'case', '.', 'in', 'control', 'group', 'relative', 'risk', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', 'and', 'higher', 'median', 'urine', 'output', 'cpb', '(', '.', 'mlkgh', 'interquartile', 'range', '(', 'iqr', ')', ',', '.-', '.', 'mlkgh', 'v', '.', 'mlkgh', 'iqr', ',', '.-', '.', 'mlkgh', 'p', '.', ')', '.', 'median', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'hour', 'surgery', 'significantly', 'lower', 'in', 'no', 'treatment', 'group', '(', '.', 'ngml', 'iqr', ',', '.-', '.', 'ngml', 'v', '.', 'ngml', 'iqr', ',', '.-', '.', 'ngml', 'p', '.', ')', '.', 'in', 'no', 'treatment', 'group', ',', 'concentration', 'of', 'no', 'metabolite', 'significantly', 'increased', 'minute', 'postclamping', ',', 'minute', 'declamping', ',', 'and', 'end', 'of', 'operation', '.', 'concentration', 'of', 'proinflammatory', 'and', 'anti-inflammatory', 'mediator', 'and', 'free', 'plasma', 'hemoglobin', 'not', 'differ', 'significantly', 'group', '.', 'conclusion', 'no', 'administration', 'in', 'patient', 'moderate', 'risk', 'of', 'renal', 'complication', 'undergoing', 'elective', 'cardiac', 'surgery', 'with', 'cpb', 'associated', 'with', 'lower', 'incidence', 'of', 'aki', '.']"
The use of urinary biomarkers to predict acute kidney injury in children after liver transplant.,"Dana Y Fuhrman, John A Kellum, Emily L Joyce, Yosuke Miyashita, George V Mazariegos, Armando Ganoza, James E Squires, Dana Y Fuhrmanet al.",2020 Feb,Pediatr Transplant,https://pubmed.ncbi.nlm.nih.gov/31652022/,No keywords found,"['aki', 'pediatric', 'liver', 'transplantation', 'associated', 'with', 'increased', 'morbidity', 'and', 'mortality', '.', 'role', 'of', 'urinary', 'biomarkers', 'prediction', 'of', 'aki', 'in', 'pediatric', 'patient', 'liver', 'transplantation', 'not', 'previously', 'reported', '.', 'primary', 'objective', 'of', 'prospective', 'pilot', 'study', 'to', 'determine', 'predictive', 'capability', 'of', 'urinary', 'kim-', ',', 'ngal', ',', 'timp-', ',', 'and', 'igfbp', 'diagnosing', 'aki', '.', 'method', 'sixteen', 'child', 'undergoing', 'liver', 'transplantation', 'enrolled', 'in', 'study', '-month', 'time', 'period', '.', 'kidney', 'disease', 'improving', 'outcome', 'criterion', 'urine', 'output', 'and', 'serum', 'creatinine', 'used', 'to', 'define', 'aki', '.', 'predictive', 'ability', 'evaluated', 'using', 'area', 'curve', 'obtained', 'roc', 'analysis', '.', 'result', 'aki', 'occurred', 'in', '(', '.', ')', 'of', 'patient', 'and', 'day', 'transplant', '.', 'no', 'difference', 'in', 'of', 'biomarkers', 'prior', 'to', 'transplant', '.', 'obtained', 'within', 'hour', 'transplant', ',', 'area', 'roc', 'curve', 'predicting', 'aki', '.', '(', 'ci', '.-', '.', ')', 'kim-', ',', '.', '(', 'ci', '.-', '.', ')', 'ngal', ',', 'and', '.', '(', 'ci', '.-', '.', ')', 'product', 'of', 'timp-', 'and', 'igfbp', '(', 'timp-igfbp', ')', '.', 'conclusion', 'result', 'show', 'ngal', 'and', 'timp-igfbp', 'provide', 'significant', 'discrimination', 'aki', 'risk', 'following', 'liver', 'transplant', 'in', 'child', '.', 'larger', 'study', 'needed', 'to', 'determine', 'optimal', 'time', 'point', 'measuring', 'biomarkers', 'and', 'to', 'validate', 'finding', '.']"
Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trial.,"Michael Walsh, Richard Whitlock, Amit X Garg, Jean-François Légaré, Andra E Duncan, Robert Zimmerman, Scott Miller, Stephen Fremes, Teresa Kieser, Ganesan Karthikeyan, Matthew Chan, Anthony Ho, Vivian Nasr, Jessica Vincent, Imtiaz Ali, Ronit Lavi, Daniel I Sessler, Robert Kramer, Jeff Gardner, Summer Syed, Tomas VanHelder, Gordon Guyatt, Purnima Rao-Melacini, Lehana Thabane, P J Devereaux                              ;, Remote IMPACT Investigators, Michael Walshet al.",2016 Mar 15,CMAJ,https://pubmed.ncbi.nlm.nih.gov/26668200/,No keywords found,"['remote', 'ischemic', 'preconditioning', 'simple', 'therapy', 'may', 'reduce', 'cardiac', 'and', 'kidney', 'injury', '.', 'undertook', 'randomized', 'controlled', 'trial', 'to', 'evaluate', 'effect', 'of', 'therapy', 'marker', 'of', 'heart', 'and', 'kidney', 'injury', 'cardiac', 'surgery', '.', 'method', 'patient', 'high', 'risk', 'of', 'death', 'within', 'day', 'cardiac', 'surgery', 'randomly', 'assigned', 'to', 'undergo', 'remote', 'ischemic', 'preconditioning', 'or', 'sham', 'procedure', 'induction', 'of', 'anesthesia', '.', 'preconditioning', 'therapy', 'three', '-minute', 'cycle', 'of', 'thigh', 'ischemia', ',', 'with', 'minute', 'of', 'reperfusion', 'cycle', '.', 'sham', 'procedure', 'identical', 'except', 'ischemia', 'not', 'induced', '.', 'primary', 'outcome', 'peak', 'creatine', 'kinase-myocardial', 'band', '(', 'ck-mb', ')', 'within', 'hour', 'surgery', '(', 'expressed', 'multiple', 'of', 'upper', 'limit', 'of', 'normal', ',', 'with', 'log', 'transformation', ')', '.', 'secondary', 'outcome', 'change', 'in', 'creatinine', 'level', 'within', 'day', 'surgery', '(', 'expressed', 'log-transformed', 'micromoles', 'per', 'litre', ')', '.', 'patient-important', 'outcome', 'assessed', 'to', 'month', 'randomization', '.', 'result', 'randomly', 'assigned', 'patient', 'to', 'remote', 'ischemic', 'preconditioning', 'and', 'to', 'sham', 'therapy', '.', 'no', 'significant', 'difference', 'in', 'postoperative', 'ck-mb', '(', 'absolute', 'mean', 'difference', '.', ',', 'confidence', 'interval', 'ci', '-', '.', 'to', '.', ')', 'or', 'creatinine', '(', 'absolute', 'mean', 'difference', '.', ',', 'ci', '-', '.', 'to', '.', ')', '.', 'outcome', 'not', 'differ', 'significantly', 'remote', 'ischemic', 'preconditioning', 'relative', 'to', 'sham', 'therapy', 'myocardial', 'infarction', ',', 'relative', 'risk', '(', 'rr', ')', '.', '(', 'ci', '.', 'to', '.', ')', 'acute', 'kidney', 'injury', ',', 'rr', '.', '(', 'ci', '.', 'to', '.', ')', 'stroke', ',', 'rr', '.', '(', 'ci', '.', 'to', '.', ')', 'and', 'death', ',', 'rr', '.', '(', 'ci', '.', 'to', '.', ')', '.', 'interpretation', 'remote', 'ischemic', 'precnditioning', 'not', 'reduce', 'myocardial', 'or', 'kidney', 'injury', 'cardiac', 'surgery', '.', 'type', 'of', 'therapy', 'unlikely', 'to', 'substantially', 'improve', 'patient-important', 'outcome', 'in', 'cardiac', 'surgery', '.', 'trial', 'registration', 'clinicaltrials.gov', ',', 'no', '.', 'nct', '.']"
Preoperative risk assessment improves biomarker detection for predicting acute kidney injury after cardiac surgery.,"Cheng-Chia Lee, Chih-Hsiang Chang, Shao-Wei Chen, Pei-Chun Fan, Su-Wei Chang, Yi-Ting Chen, Yu-Yun Nan, Pyng-Jing Lin, Feng-Chun Tsai, Cheng-Chia Leeet al.",2018 Sep 4,PLoS One,https://pubmed.ncbi.nlm.nih.gov/30180211/,No keywords found,"['although', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'emerged', 'promising', 'biomarker', 'early', 'detection', 'of', 'kidney', 'injury', ',', 'previous', 'study', 'of', 'adult', 'patient', 'underwent', 'cardiac', 'surgery', 'reported', 'moderate', 'discrimination', '.', 'age', ',', 'creatinine', ',', 'and', 'ejection', 'fraction', '(', 'acef', ')', 'score', 'preoperative', 'validated', 'risk', 'model', 'with', 'satisfactory', 'accuracy', 'predicting', 'aki', 'following', 'cardiac', 'surgery', '.', 'remains', 'unknown', 'whether', 'combining', 'preoperative', 'risk', 'assessment', 'acef', 'score', 'followed', 'urinary', 'ngal', 'test', 'in', 'population', 'of', 'high-risk', 'individual', 'optimal', 'approach', 'with', 'improved', 'predictive', 'performance', '.', 'material', 'and', 'method', 'total', 'of', 'consecutive', 'patient', 'underwent', 'cardiac', 'surgery', 'enrolled', '.', 'clinical', 'characteristic', ',', 'prognostic', 'model', 'score', ',', 'and', 'outcome', 'assessed', '.', 'urinary', 'ngal', 'examined', 'within', 'hour', 'cardiac', 'surgery', '.', 'patient', 'stratified', 'according', 'to', 'preoperative', 'acef', 'score', ',', 'and', 'comparison', 'made', 'using', 'area', 'receiver', 'operator', 'characteristic', 'curve', '(', 'auroc', ')', 'prediction', 'of', 'aki', '.', 'result', 'total', 'of', '.', '(', ')', 'of', 'patient', 'aki', '.', 'expected', ',', 'patient', 'with', 'acef', 'score', '.', 'older', 'and', 'likely', 'to', 'class', 'iii', 'or', 'iv', 'heart', 'failure', '.', 'also', 'likely', 'to', 'diabetes', 'mellitus', ',', 'myocardial', 'infarction', ',', 'and', 'peripheral', 'arterial', 'disease', '.', 'urinary', 'ngal', 'alone', 'moderately', 'predicted', 'aki', ',', 'with', 'auroc', 'of', '..', 'risk', 'stratification', 'acef', 'score', '.', 'substantially', 'improved', 'auroc', 'of', 'urinary', 'ngal', 'to', '.', '(', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'risk', 'stratification', 'preoperative', 'acef', 'score', '.', ',', 'followed', 'postoperative', 'urinary', 'ngal', ',', 'provides', 'satisfactory', 'risk', 'discrimination', 'urinary', 'ngal', 'alone', 'early', 'detection', 'of', 'aki', 'cardiac', 'surgery', '.', 'future', 'study', 'investigate', 'whether', 'strategy', 'could', 'improve', 'outcome', 'and', 'cost-effectiveness', 'of', 'care', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', '.']"
Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.,"Richard Solomon, Paul Gordon, Steven V Manoukian, J Dawn Abbott, Dean J Kereiakes, Allen Jeremias, Michael Kim, Harold L Dauerman                              ;, BOSS Trial Investigators, Richard Solomonet al.",2015 Sep 4,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/26185263/,No keywords found,"['sodium', 'bicarbonate', 'proposed', 'protection', 'of', 'kidney', 'contrast-induced', 'aki', '(', 'ciaki', ')', '.', 'however', ',', 'effect', 'of', 'bicarbonate', 'long-term', 'important', 'clinical', 'outcome', 'uncertain', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'in', 'prospective', ',', 'double-blind', ',', 'multicenter', 'randomized', 'clinical', 'trial', ',', 'patient', 'with', 'egfr', 'mlmin', 'per', '.', '(', ')', 'undergoing', 'elective', 'coronary', 'or', 'peripheral', 'angiography', 'randomized', 'to', 'infusion', 'with', 'high', 'dose', 'of', 'isotonic', 'sodium', 'bicarbonate', '(', 'target', '.', 'meqkg', ')', 'or', 'similar', 'molar', 'amount', 'of', 'isotonic', 'sodium', 'chloride', '.', 'primary', 'outcome', 'composite', 'of', 'mortality', ',', 'dialysis', ',', 'or', 'sustained', 'reduction', 'in', 'egfr', 'month', '.', 'result', 'patient', 'enrolled', 'march', 'and', 'may', '.', 'incidence', 'of', 'primary', 'outcome', '.', 'in', 'bicarbonate', 'group', 'and', '.', 'in', 'control', 'group', 'in', 'intention-to-treat', 'population', '(', 'p.', ')', '.', 'also', 'no', 'difference', 'in', 'incidence', 'of', 'ciaki', 'treatment', 'group', '(', '.', 'versus', '.', ',', 'respectively', 'p.', ')', '.', 'ciaki', 'associated', 'with', 'higher', 'incidence', 'of', 'sustained', 'loss', 'of', 'kidney', 'function', 'month', 'compared', 'with', 'without', 'ciaki', '(', '.', 'versus', '.', ',', 'respectively', 'p.', ')', '.', 'conclusion', 'high-dose', 'sodium', 'bicarbonate', 'infusion', 'in', 'patient', 'with', 'egfr', 'mlmin', 'per', '.', '(', ')', 'undergoing', 'angiography', 'not', 'demonstrate', 'difference', 'in', 'incidence', 'of', 'composite', 'of', 'death', ',', 'dialysis', ',', 'or', 'sustained', '-month', 'reduction', 'in', 'egfr', 'or', 'ciaki', 'compared', 'with', 'sodium', 'chloride', '.']"
Acute Kidney Injury Defined by Fluid-Corrected Creatinine in Premature Neonates: A Secondary Analysis of the PENUT Randomized Clinical Trial.,"Michelle C Starr, Russell L Griffin, Matthew W Harer, Danielle E Soranno, Katja M Gist, Jeffrey L Segar, Shina Menon, Lindsey Gordon, David J Askenazi, David T Selewski, Michelle C Starret al.",2023 Aug 1,JAMA Netw Open,https://pubmed.ncbi.nlm.nih.gov/37561461/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'disordered', 'fluid', 'balance', 'common', 'in', 'premature', 'neonate', 'positive', 'fluid', 'balance', 'dilutes', 'serum', 'creatinine', ',', 'and', 'negative', 'fluid', 'balance', 'concentrate', 'serum', 'creatinine', ',', 'of', 'complicate', 'aki', 'diagnosis', '.', 'correcting', 'serum', 'creatinine', 'fluid', 'balance', 'may', 'improve', 'diagnosis', 'and', 'increase', 'diagnostic', 'accuracy', 'aki', '.', 'objective', 'to', 'determine', 'whether', 'correcting', 'serum', 'creatinine', 'fluid', 'balance', 'would', 'identify', 'additional', 'neonate', 'with', 'aki', 'and', 'alter', 'association', 'of', 'aki', 'with', 'short-term', 'and', 'long-term', 'outcome', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'study', 'post', 'hoc', 'cohort', 'analysis', 'of', 'preterm', 'erythropoietin', 'neuroprotection', 'trial', '(', 'penut', ')', ',', 'phase', ',', 'randomized', 'clinical', 'trial', 'of', 'erythropoietin', ',', 'conducted', 'academic', 'center', 'and', 'neonatal', 'intensive', 'care', 'unit', 'in', 'u', 'december', 'to', 'september', '.', 'participant', 'included', 'extremely', 'premature', 'neonate', 'born', 'less', 'week', 'of', 'gestation', '.', 'data', 'analysis', 'conducted', 'in', 'december', '.', 'exposure', 'diagnosis', 'of', 'fluid-corrected', 'aki', 'first', 'postnatal', 'day', ',', 'calculated', 'using', 'fluid-corrected', 'serum', 'creatinine', '(', 'defined', 'serum', 'creatinine', 'multiplied', 'fluid', 'balance', 'calculated', 'percentage', 'change', 'birth', 'weight', 'divided', 'total', 'body', 'water', 'estimated', 'of', 'birth', 'weight', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'invasive', 'mechanical', 'ventilation', 'postnatal', 'day', '.', 'secondary', 'outcome', 'included', 'death', ',', 'hospital', 'length', 'of', 'stay', ',', 'and', 'severe', 'bronchopulmonary', 'dysplasia', '(', 'bpd', ')', '.', 'categorical', 'variable', 'analyzed', 'proportional', 'difference', 'with', 'test', 'or', 'fisher', 'exact', 'test', '.', 'test', 'and', 'wilcoxon', 'rank', 'sum', 'test', 'used', 'to', 'compare', 'continuous', 'and', 'ordinal', 'variable', ',', 'respectively', '.', 'odds', 'ratio', '(', 'or', ')', 'and', 'ci', 'association', 'of', 'exposure', 'with', 'outcome', 'of', 'interest', 'estimated', 'using', 'unconditional', 'logistic', 'regression', 'model', '.', 'result', 'total', 'of', 'premature', 'neonate', '(', 'boy', '.', 'median', 'iqr', 'birth', 'weight', ',', '-', 'g', ')', 'included', ',', 'of', '(', '.', ')', 'received', 'diagnosis', 'of', 'aki', 'using', 'uncorrected', 'serum', 'creatinine', '.', 'fluid', 'balance', 'correction', ',', 'neonate', 'with', 'aki', 'reclassified', 'not', 'fluid-corrected', 'aki', ',', 'and', 'neonate', 'previously', 'without', 'aki', 'reclassified', 'fluid-corrected', 'aki', '(', 'ie', ',', 'unveiled', 'aki', ')', '.', 'therefore', ',', 'fluid-corrected', 'aki', 'diagnosed', 'in', 'neonate', '(', '.', ')', '.', 'neonate', 'with', 'unveiled', 'aki', 'similar', 'in', 'clinical', 'characteristic', 'to', 'with', 'aki', 'whose', 'diagnosis', 'made', 'with', 'uncorrected', 'serum', 'creatinine', '.', 'compared', 'with', 'without', 'aki', ',', 'neonate', 'with', 'unveiled', 'aki', 'likely', 'to', 'require', 'ventilation', '(', 'neonate', '.', 'v', 'neonate', '.', 'and', 'longer', 'hospital', 'stay', '(', 'median', 'iqr', ',', '-', 'day', 'v', '-', 'day', ')', '.', 'in', 'multivariable', 'analysis', ',', 'diagnosis', 'of', 'fluid-corrected', 'aki', 'associated', 'with', 'increased', 'odds', 'of', 'adverse', 'clinical', 'outcome', ',', 'including', 'ventilation', '(', 'adjusted', 'or', ',', '.', 'ci', ',', '.-', '.', ')', 'and', 'severe', 'bpd', '(', 'adjusted', 'or', ',', '.', 'ci', ',', '.-.', ')', '.', 'conclusion', 'and', 'relevance', 'in', 'post', 'hoc', 'cohort', 'study', 'of', 'premature', 'neonate', ',', 'fluid', 'correction', 'increased', 'number', 'of', 'premature', 'neonate', 'with', 'diagnosis', 'of', 'aki', 'and', 'associated', 'with', 'increased', 'odds', 'of', 'adverse', 'clinical', 'outcome', ',', 'including', 'ventilation', 'and', 'bpd', '.', 'failing', 'to', 'correct', 'serum', 'creatinine', 'fluid', 'balance', 'underestimate', 'prevalence', 'and', 'impact', 'of', 'aki', 'in', 'premature', 'neonate', '.', 'future', 'study', 'consider', 'correcting', 'aki', 'fluid', 'balance', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Incidence and outcomes of acute kidney disease in patients after type A aortic dissection surgery.,"Xuelian Chen, Miao Fang, Jia Yang, Siwen Wang, Xin Wang, Linji Li, Jiaojiao Zhou, Lichuan Yang, Xuelian Chenet al.",2023 Mar,Asian J Surg,https://pubmed.ncbi.nlm.nih.gov/36050242/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'acute', 'kidney', 'disease', '(', 'akd', ')', 'and', 'ckd', '(', 'chronic', 'kidney', 'disease', ')', 'continuous', 'process', '.', 'little', 'discussion', 'of', 'risk', 'factor', 'akd', 'in', 'population', 'undergoing', 'surgery', 'acute', 'type', 'aortic', 'dissection', '(', 'aaad', ')', '.', 'objective', 'main', 'objective', 'of', 'study', 'to', 'investigate', 'risk', 'factor', 'akd', 'surgery', 'acute', 'type', 'aortic', 'dissection', 'and', 'impact', 'of', 'akd', 'early', 'and', 'late', 'mortality', '.', 'design', 'aki', 'to', 'defined', 'increase', 'in', 'serum', 'creatinine', 'to', '.', 'mgdl', 'or', '.', 'time', 'baseline', 'within', 'day', '.', 'akd', 'defined', 'kidney', 'damage', 'within', 'day', 'aki', '.', 'logistic', 'regression', 'model', 'performed', 'to', 'identify', 'risk', 'factor', 'of', 'akd', 'and', 'association', 'akd', 'and', 'early', 'mortality', 'aaad', 'surgery', '.', 'participant', 'patient', 'with', 'aki', 'aaad', 'surgery', 'admitted', 'in', 'icu', 'march', 'to', 'september', 'included', '.', 'key', 'result', 'among', 'patient', 'developed', 'aki', 'aaad', 'surgery', ',', 'patient', '(', '.', ')', 'progressed', 'to', 'akd', '.', 'multivariable', 'analysis', 'revealed', 'aki', 'stage', '(', 'or', ',', '.', ')', 'and', 'aki', 'stage', '(', 'or', ',', '.', ')', 'shown', 'to', 'independent', 'risk', 'factor', 'development', 'of', 'akd', '.', 'akd', '(', 'or', ',', '.', ')', 'proved', 'to', 'independent', 'risk', 'factor', 'early', 'mortality', ',', 'no', 'significant', 'difference', 'in', 'late', 'mortality', 'observed', 'patient', 'in', 'akd', 'and', 'non-akd', 'group', '.', 'conclusion', 'severity', 'of', 'aki', 'surgery', 'of', 'aaad', 'independently', 'associated', 'with', 'akd', '.', 'occurrence', 'of', 'akd', 'negative', 'impact', 'early', 'mortality', '.', 'clinical', 'trial', 'registration', 'chictr', ',', 'chictr', '.', 'registered', 'february', ',', 'httpwww.chictr.org.cnshowproj.aspxproj', '.']"
Improvised Field Expedient Method for Renal Replacement Therapy in a Porcine Model of Acute Kidney Injury.,"Guillaume L Hoareau, Carl A Beyer, Harris W Kashtan, Lauren E Walker, Christopher Wilson, Andrew Wishy, J Kevin Grayson, Ian J Stewart, Guillaume L Hoareauet al.",2021 Dec,Disaster Med Public Health Prep,https://pubmed.ncbi.nlm.nih.gov/32484129/,No keywords found,"['dialysis', 'patient', 'may', 'not', 'access', 'to', 'conventional', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'following', 'disaster', '.', 'hypothesized', 'improvised', 'renal', 'replacement', 'therapy', '(', 'imprrt', ')', 'would', 'comparable', 'to', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'in', 'porcine', 'acute', 'kidney', 'injury', 'model', '.', 'method', 'following', 'bilateral', 'nephrectomy', 'and', 'hour', 'of', 'caudal', 'aortic', 'occlusion', ',', 'pig', 'randomized', 'to', 'hour', 'of', 'imprrt', 'or', 'crrt', '.', 'in', 'imprrt', 'group', ',', 'blood', 'circulated', 'dialysis', 'filter', 'using', 'rapid', 'infuser', 'to', 'collect', 'ultrafiltrate', '.', 'improvised', 'replacement', 'fluid', ',', 'made', 'with', 'stock', 'solution', ',', 'infused', 'pre-pump', '.', 'in', 'crrt', 'group', ',', 'commercial', 'replacement', 'fluid', 'used', '.', 'rrt', ',', 'animal', 'received', 'isotonic', 'crystalloids', 'and', 'norepinephrine', '.', 'result', 'no', 'difference', 'in', 'serum', 'creatinine', ',', 'calcium', ',', 'magnesium', ',', 'or', 'phosphorus', 'concentration', '.', 'difference', 'group', 'in', 'serum', 'potassium', 'concentration', 'time', '(', 'p', '.', ')', ',', 'significance', 'lost', 'in', 'pairwise', 'comparison', 'specific', 'time', 'point', '.', 'replacement', 'fluid', 'or', 'ultrafiltrate', 'flow', 'not', 'differ', 'group', '.', 'no', 'difference', 'in', 'lactate', 'concentration', ',', 'isotonic', 'crystalloid', 'requirement', ',', 'or', 'norepinephrine', 'dos', '.', 'no', 'difference', 'found', 'in', 'electrolyte', 'concentration', 'commercial', 'and', 'improvised', 'replacement', 'solution', '.', 'conclusion', 'imprrt', 'system', 'achieved', 'similar', 'performance', 'to', 'crrt', 'and', 'may', 'represent', 'potential', 'option', 'temporary', 'rrt', 'following', 'disaster', '.']"
ABT-719 for the Prevention of Acute Kidney Injury in Patients Undergoing High-Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial.,"Peter A McCullough, Elliott Bennett-Guerrero, Lakhmir S Chawla, Thomas Beaver, Ravindra L Mehta, Bruce A Molitoris, Ann Eldred, Greg Ball, Ho-Jin Lee, Mark T Houser, Samina Khan, Peter A McCulloughet al.",2016 Aug 20,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/27543797/,No keywords found,"['patient', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'on-pump', ')', 'high', 'risk', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'tested', 'abt-', ',', 'novel', '-melanocyte-stimulating', 'hormone', 'analog', ',', 'prevention', 'of', 'aki', 'in', 'postoperative', 'cardiac', 'surgery', 'patient', '.', 'method', 'and', 'result', 'phase', 'b', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trial', 'included', 'adult', 'patient', 'with', 'stable', 'renal', 'function', 'undergoing', 'high-risk', 'on-pump', 'cardiac', 'surgery', 'in', 'united', 'state', 'and', 'denmark', '.', 'participant', 'received', 'placebo', '(', 'n', ')', 'or', 'cumulative', 'abt-', 'dos', 'of', '(', 'n', ')', ',', '(', 'n', ')', ',', 'or', 'gkg', '(', 'n', ')', '.', 'primary', 'outcome', 'development', 'of', 'aki', 'based', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'criterion', ',', 'measured', 'utilizing', 'preoperative', 'creatinine', 'value', 'and', 'maximum', 'value', 'within', 'hour', 'and', 'urine', 'output', 'within', 'first', 'hour', 'postsurgery', '.', 'secondary', 'outcome', 'included', 'incidence', 'of', 'aki', 'based', 'maximal', 'change', 'baseline', 'in', 'novel', 'aki', 'biomarkers', '-hour', 'period', 'clamp', 'release', 'and', 'length', 'of', 'intensive', 'care', 'unit', 'stay', 'day', 'postsurgery', '.', 'total', 'of', '.', ',', '.', ',', 'and', '.', 'of', 'patient', 'in', '-', ',', '-', ',', 'and', '-gkg', 'group', ',', 'respectively', ',', 'developed', 'aki', '(', 'stage', ',', ',', 'and', 'combined', ')', 'versus', '.', 'in', 'placebo', 'group', '(', 'pair-wise', 'comparison', 'with', 'placebo', ',', 'p.', ',', '.', ',', 'and', '.', ',', 'respectively', ')', '.', 'adverse', 'event', 'occurred', 'similar', 'rate', 'in', 'treatment', 'group', '.', 'conclusion', 'abt-', 'treatment', 'not', 'lower', 'aki', 'incidence', 'using', 'akin', 'criterion', ',', 'influence', 'elevation', 'of', 'novel', 'biomarkers', ',', 'or', 'change', '-day', 'outcome', 'in', 'patient', 'cardiac', 'surgery', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment.,"H M Wadei, D D Lee, K P Croome, M L Mai, E Golan, R Brotman, A P Keaveny, C B Taner, H M Wadeiet al.",2016 Mar,Am J Transplant,https://pubmed.ncbi.nlm.nih.gov/26663518/,"clinical research/practice, complication: medical/metabolic, delayed graft function (DGF), graft survival, kidney disease, kidney transplantation/nephrology, liver allograft function/dysfunction, liver transplantation/hepatology.","['early', 'allograft', 'dysfunction', '(', 'ead', ')', 'liver', 'transplantation', '(', 'lt', ')', 'related', 'to', 'ischemia-reperfusion', 'injury', 'and', 'may', 'lead', 'to', 'systemic', 'inflammatory', 'response', 'and', 'extrahepatic', 'organ', 'dysfunction', '.', 'evaluated', 'effect', 'of', 'ead', 'new-onset', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'requiring', 'renal', 'replacement', 'therapy', 'within', 'first', 'month', 'and', 'end-stage', 'renal', 'disease', '(', 'esrd', ')', 'within', 'first', 'year', 'post-lt', 'in', 'primary', 'lt', 'recipient', '.', 'ead', 'developed', 'in', '(', ')', 'of', 'recipient', '.', 'seventy-one', '(', '.', ')', 'recipient', 'developed', 'aki', 'and', '(', '.', ')', 'developed', 'esrd', '.', 'compared', 'with', 'without', 'ead', ',', 'recipient', 'with', 'ead', 'higher', 'risk', 'of', 'aki', 'and', 'esrd', '(', 'vs.', 'and', 'vs.', ',', 'respectively', ',', 'p', '.', ')', '.', 'multivariate', 'logistic', 'regression', 'analysis', 'showed', 'independent', 'relationship', 'ead', 'and', 'aki', 'well', 'esrd', '(', 'odds', 'ratio', '.', ',', 'confidence', 'interval', '.-.', ',', 'and', 'odds', 'ratio', '.', ',', 'confidence', 'interval', '.-.', ',', 'respectively', ')', '.', 'patient', 'experienced', 'ead', 'and', 'aki', 'inferior', '-', ',', '-', ',', '-', ',', 'and', '-year', 'patient', 'and', 'graft', 'survival', 'compared', 'with', 'with', 'either', 'ead', 'or', 'aki', 'alone', ',', 'neither', 'aki', 'ead', 'best', 'outcome', '(', 'p', '.', ')', '.', 'post-lt', 'ead', 'risk', 'factor', 'aki', 'and', 'esrd', 'and', 'considered', 'target', 'future', 'intervention', 'to', 'reduce', 'post-lt', 'short-', 'and', 'long-term', 'renal', 'dysfunction', '.']"
Intensity of Renal Replacement Therapy and Duration of Mechanical Ventilation: Secondary Analysis of the Acute Renal Failure Trial Network Study.,"Shilpa Sharma, Yvelynne P Kelly, Paul M Palevsky, Sushrut S Waikar, Shilpa Sharmaet al.",2020 Oct,Chest,https://pubmed.ncbi.nlm.nih.gov/32470389/,No keywords found,"['randomized', 'clinical', 'trial', 'failed', 'to', 'show', 'benefit', 'increasing', 'intensity', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'acute', 'kidney', 'injury', ',', 'continue', 'to', 'frequently', 'used', '.', 'in', 'addition', ',', 'intensive', 'rrt', 'associated', 'with', 'increase', 'in', 'adverse', 'event', 'potentially', 'secondary', 'to', 'small', 'solute', 'loss', ',', 'phosphate', '.', 'hypothesized', ',', 'compared', 'with', 'less-intensive', 'rrt', ',', 'intensive', 'rrt', 'would', 'lead', 'to', 'longer', 'duration', 'of', 'mechanical', 'ventilation', '.', 'research', 'question', 'more-intensive', 'renal', 'replacement', 'therapy', 'in', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', 'increase', 'time', 'to', 'extubation', 'mechanical', 'ventilation', 'compared', 'with', 'less-intensive', 'therapy', 'study', 'design', 'and', 'method', 'acute', 'renal', 'failure', 'trial', 'network', 'study', 'randomized', 'multicenter', 'trial', 'of', 'more-intensive', '(', 'hemodialysis', 'or', 'sustained', 'low-efficiency', 'dialysis', 'six', 'time', 'per', 'week', 'or', 'continuous', 'venovenous', 'hemodiafiltration', 'mlkg', 'per', 'hour', ')', 'v', 'less-intensive', '(', 'hemodialysis', 'or', 'sustained', 'low-efficiency', 'dialysis', 'three', 'time', 'per', 'week', 'or', 'continuous', 'venovenous', 'hemodiafiltration', 'mlkg', 'per', 'hour', ')', 'rrt', 'in', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', '.', 'of', 'patient', ',', 'supported', 'mechanical', 'ventilation', 'study', 'initiation', 'included', 'in', 'cox-proportional', 'hazard', 'analysis', '.', 'primary', 'outcome', 'time', 'to', 'first', 'successful', 'extubation', 'mechanical', 'ventilation', '.', 'result', 'patient', 'assigned', 'randomly', 'to', 'more-intensive', 'rrt', '.', 'lower', 'hazard', 'rate', 'of', 'successful', 'extubation', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', 'compared', 'with', 'patient', 'assigned', 'to', 'less-intensive', 'rrt', '.', 'patient', 'assigned', 'to', 'more-intensive', 'rrt', ',', 'average', ',', '.', 'ventilator-free', 'day', ',', 'compared', 'with', '.', 'day', 'in', 'assigned', 'to', 'less-intensive', 'rrt', '(', 'p', '.', ')', 'day', 'start', 'of', 'study', '.', 'interpretation', 'critically', 'ill', 'mechanically', 'ventilated', 'patient', 'assigned', 'randomly', 'to', 'more-intensive', 'rrt', 'longer', 'duration', 'of', 'mechanical', 'ventilation', 'compared', 'with', 'assigned', 'to', 'less-intensive', 'rrt', '.', 'reason', ',', 'excessive', 'phosphate', 'loss', 'more-intensive', 'rrt', ',', 'deserve', 'study', 'to', 'optimize', 'safety', 'and', 'effectiveness', 'of', 'crrt', 'delivery', '.', 'post', 'hoc', 'analysis', 'of', 'acute', 'renal', 'failure', 'trial', 'network', 'study', 'clinical', 'trial', 'registration', 'of', 'original', 'trial', 'nct', '.']"
The degree of aortic occlusion in the setting of trauma alters the extent of acute kidney injury associated with mitochondrial preservation.,"Biebele Abel, John Mares, Justin Hutzler, Babita Parajuli, Lalitha Kurada, Joseph M White, Brandon W Propper, Ian J Stewart, David M Burmeister, Biebele Abelet al.",2024 Apr 1,Am J Physiol Renal Physiol,https://pubmed.ncbi.nlm.nih.gov/38450433/,"acute kidney injury, inflammation, ischemia-reperfusion, mitochondria, swine.","['resuscitative', 'endovascular', 'balloon', 'occlusion', 'of', 'aorta', '(', 'reboa', ')', 'used', 'to', 'control', 'noncompressible', 'hemorrhage', 'not', 'addressed', 'with', 'traditional', 'tourniquet', '.', 'however', ',', 'reboa', 'associated', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'subsequent', 'mortality', 'in', 'severely', 'injured', 'trauma', 'patient', '.', ',', 'investigated', 'degree', 'of', 'aortic', 'occlusion', 'altered', 'extent', 'of', 'aki', 'in', 'porcine', 'model', '.', 'female', 'yorkshire-cross', 'swine', '(', 'n', ',', '.', '.', 'kg', ')', 'anesthetized', 'and', 'carotid', 'and', 'bilateral', 'femoral', 'artery', 'accessed', 'reboa', 'insertion', 'and', 'distal', 'and', 'proximal', 'blood', 'pressure', 'monitoring', '.', 'laparotomy', ',', '-cm', 'liver', 'laceration', 'performed', 'and', 'balloon', 'inflation', 'performed', 'in', 'zone', 'of', 'aorta', 'min', ',', 'animal', 'randomized', 'to', 'target', 'distal', 'mean', 'arterial', 'pressure', 'of', 'or', 'mmhg', 'via', 'balloon', 'volume', 'adjustment', '.', 'blood', 'draw', 'taken', 'baseline', ',', 'end', 'of', 'occlusion', ',', 'and', 'time', 'of', 'death', ',', 'point', 'renal', 'tissue', 'harvested', 'h', 'balloon', 'deflation', 'histological', 'and', 'molecular', 'analysis', '.', 'renal', 'blood', 'flow', 'lower', 'in', '-mmhg', 'group', '(', '.', '.', 'mlmin', ')', 'in', '-mmhg', 'group', '(', '.', '.', 'mlmin', ')', 'occlusion', 'phase', ',', 'recovered', 'and', 'not', 'different', 'balloon', 'deflation', '.', 'aki', 'severe', 'in', '-mmhg', 'group', ',', 'evidenced', 'circulating', 'creatinine', ',', 'blood', 'urea', 'nitrogen', ',', 'and', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '.', '-mmhg', 'group', 'increased', 'tubular', 'necrosis', ',', 'lower', 'renal', 'citrate', 'synthase', 'activity', ',', 'increased', 'tissue', 'and', 'circulating', 'syndecan-', ',', 'and', 'elevated', 'systemic', 'inflammatory', 'cytokine', '.', 'extent', 'of', 'renal', 'ischemia-induced', 'aki', 'associated', 'with', 'magnitude', 'of', 'mitochondrial', 'biomass', 'and', 'systemic', 'inflammation', ',', 'highlighting', 'potential', 'mechanistic', 'target', 'to', 'combine', 'with', 'partial', 'reboa', 'strategy', 'to', 'prevent', 'aki.new', 'noteworthy', 'large', 'animal', 'model', 'of', 'ischemia-reperfusion', 'acute', 'kidney', 'injury', '(', 'ir-aki', ')', 'lacking', '.', 'report', 'establishes', 'titratable', 'ir-aki', 'model', 'in', 'swine', 'in', 'balloon', 'catheter', 'used', 'to', 'alter', 'distal', 'pressure', 'experienced', 'kidney', ',', 'thus', 'controlling', 'renal', 'blood', 'flow', '.', 'lower', 'blood', 'flow', 'result', 'in', 'greater', 'renal', 'dysfunction', 'and', 'structural', 'damage', ',', 'well', 'lower', 'mitochondrial', 'biomass', ',', 'elevated', 'systemic', 'inflammation', ',', 'and', 'vascular', 'dysfunction', '.']"
Renal Safety of Multimodal Brain Imaging Followed by Endovascular Therapy.,"Carlo W Cereda, Michael Mlynash, Pietro E Cippà, Stephanie Kemp, Jeremy J Heit, Michael P Marks, Maarten G Lansberg, Gregory W Albers, Carlo W Ceredaet al.",2021 Jan,Stroke,https://pubmed.ncbi.nlm.nih.gov/33250038/,No keywords found,"['contrast-enhanced', 'noninvasive', 'angiography', 'and', 'perfusion', 'imaging', 'recommended', 'to', 'identify', 'eligible', 'patient', 'endovascular', 'therapy', '(', 'evt', ')', 'in', 'extended', 'time', 'window', '(', 'hour', 'or', 'wake-up', ')', '.', 'eligible', ',', 'additional', 'intraarterial', 'contrast', 'exposure', 'occur', 'evt', '.', 'aimed', 'to', 'study', 'renal', 'safety', 'in', 'defuse', '(', 'endovascular', 'therapy', 'following', 'imaging', 'evaluation', 'ischemic', 'stroke', ')', 'population', ',', 'selected', 'with', 'contrast-enhanced', 'multimodal', 'imaging', 'and', 'randomized', 'to', 'evt', 'versus', 'medical', 'management', '.', 'method', 'in', 'randomized', 'defuse', 'trial', 'population', ',', 'compared', 'change', 'in', 'serum', 'creatinine', 'baseline', '(', 'randomization', ')', 'and', 'hour', 'later', '.', 'primary', 'outcome', 'relative', 'change', 'in', 'creatinine', 'level', 'baseline', 'and', 'hour', 'in', 'evt', 'versus', 'medical', 'arm', '.', 'secondary', 'outcome', 'comparison', 'computed', 'tomography', '(', 'ct', ')', 'versus', 'magnetic', 'resonance', 'imaging', 'selection', 'in', 'evt', 'arm', '.', 'safety', 'outcome', 'comparison', 'of', 'proportion', 'of', 'patient', 'with', 'criterion', 'contrast-associated', 'kidney', 'injury', 'in', 'evt', 'versus', 'medical', 'arm', 'and', 'comparison', 'ct', 'versus', 'magnetic', 'resonance', 'imaging', 'selection', 'in', 'evt', 'arm', '.', 'result', 'in', 'defuse', 'population', '(', 'n', ',', 'age', ',', 'female', ')', ',', 'mean', 'creatinine', 'decreased', 'baseline', 'of', '..', 'mgdl', 'to', '..', 'mgdl', 'hour', '(', 'p.', ')', '.', 'no', 'difference', 'in', 'change', 'treatment', 'group', 'relative', 'to', 'baseline', ',', '.', 'reduction', 'in', 'evt', 'group', 'versus', '.', 'in', 'medical', 'group', ',', 'p', '..', 'absolute', 'decrease', '-', '..', 'in', 'evt', 'versus', '-', '..', 'in', 'medical', ',', 'p.', 'among', 'patient', 'treated', 'with', 'evt', ',', 'no', 'difference', 'in', '-hour', 'creatinine', 'level', 'change', 'patient', 'selected', 'with', 'ct', 'angiographyct', 'perfusion', '(', '-', '..', ')', 'versus', 'magnetic', 'resonance', 'imaging', '(', '-', '..', ')', ',', 'p.', 'or', '.', 'reduction', 'versus', '.', ',', 'p', '..', 'in', 'evt', 'arm', ',', 'contrast-associated', 'kidney', 'injury', 'encountered', 'in', 'of', '(', '.', ')', 'versus', '(', '.', ')', 'in', 'medical', 'arm', 'p', '..', 'in', 'evt', 'arm', ',', 'contrast-associated', 'kidney', 'injury', 'evenly', 'distributed', 'magnetic', 'resonance', 'imaging', '(', ',', '.', ')', 'versus', 'ct', 'of', '(', '.', ')', ',', 'p', '..', 'conclusion', 'perfusion', 'imaging', 'evt', 'not', 'associated', 'with', 'evidence', 'of', 'decline', 'in', 'renal', 'function', '.', 'registration', 'url', 'httpswww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.,"Giuseppe Andò, Bernardo Cortese, Enrico Frigoli, Andrea Gagnor, Stefano Garducci, Carlo Briguori, Paolo Rubartelli, Paolo Calabrò, Marco Valgimigli                              ;, MATRIX investigators, Giuseppe Andòet al.",2015 Nov,Catheter Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/25854692/,"acute coronary syndromes, acute kidney injury, contrast-induced nephropathy, percutaneous coronary intervention, transradial intervention.","['nct', ')', 'designed', 'to', 'test', 'whether', 'to', 'minimize', 'bleeding', 'event', 'using', 'radial', 'access', 'and', 'bivalirudin', ',', 'across', 'whole', 'spectrum', 'of', 'patient', 'with', 'ac', 'undergoing', 'pci', ',', 'result', 'in', 'improved', 'outcome', 'with', 'respect', 'to', 'ischemic', 'and', 'bleeding', 'complication', '.', 'aki-matrix', 'sub-study', 'provide', 'unique', 'opportunity', 'to', 'assess', 'whether', 'advantage', 'of', 'radial', 'approach', 'may', 'even', 'contribute', 'to', 'reduction', 'of', 'risk', 'of', 'aki', 'in', 'patient', 'with', 'ac', '.']"
Five-Year Follow-Up of Patients With Radio-Contrast-Induced Acute Renal Injury: Can Intravenous Sodium Bicarbonate Improve Long-Term Outcomes?,"Fernando Boccalandro, Katherine Shreyder, Laura Harmon, Mandeep Dhindsa, Tallat Fahim, Samia Sheikh, Fernando Boccalandroet al.",2021 Oct:31:61-68.,Cardiovasc Revasc Med,https://pubmed.ncbi.nlm.nih.gov/33250404/,No keywords found,"['radiocontrast-induced', 'acute', 'kidney', 'injury', '(', 'raki', ')', 'frequent', 'complication', 'angiography', 'and', 'associated', 'with', 'adverse', 'prognosis', '.', 'of', 'study', 'evaluating', 'long-term', 'outcome', 'of', 'patient', 'with', 'raki', 'based', 'institutional', 'registry', '.', 'first', 'prospective', 'study', 'to', 'evaluate', '-year', 'outcome', 'of', 'patient', 'with', 'raki', ',', 'and', 'assess', 'effect', 'of', 'sodium', 'bicarbonate', '(', 'sb', ')', 'in', 'long-term', 'outcome', 'of', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'undergoing', 'non-emergent', 'coronary', 'angiography', '.', 'materialsmethods', 'ckd', 'stage', 'iii-iv', 'patient', 'undergoing', 'elective', 'non-emergent', 'coronary', 'angiography', 'randomized', 'to', 'sb', '(', 'n', ')', 'or', 'normal', 'saline', '(', 'n', ')', 'solution', '(', 'n', ')', '.', 'incidence', 'of', 'raki', ',', 'in-hospital', ',', '-', 'and', '-year', 'mortality', 'and', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', ',', 'and', '-year', 'major', 'adverse', 'renal', 'and', 'cardiovascular', 'event', '(', 'marce', ')', 'compared', 'group', '.', 'outcome', 'of', 'patient', 'with', 'and', 'without', 'raki', 'compared', 'five-years', 'of', 'prospective', 'follow-up', '.', 'multivariate', 'predictor', 'of', 'raki', 'and', 'death', '-years', 'determined', '.', 'result', 'use', 'of', 'sb', 'not', 'improve', 'incidence', 'of', 'raki', ',', 'in-hospital', 'outcome', ',', 'survival', ',', 'and', 'freedom', 'rrt', 'or', 'marce', '-years', 'of', 'follow-up', '.', 'patient', 'developed', 'raki', 'significantly', 'higher', 'mortality', '-year', '.', 'vs.', '.', 'and', '-years', '(', 'vs.', ')', '(', 'p', '.', ')', '.', 'conclusion', 'hydration', 'with', 'sb', 'showed', 'no', 'benefit', 'compared', 'to', 'n', 'in', 'preventing', 'raki', '.', 'use', 'of', 'sb', 'not', 'superior', 'to', 'n', '-years', 'of', 'follow-up', 'regarding', 'marce', ',', 'survival', 'or', 'freedom', 'of', 'rrt', '.', 'five-year', 'mortality', 'among', 'patient', 'developed', 'raki', 'remains', 'high', ',', 'and', 'research', 'needed', 'to', 'find', 'best', 'preventive', 'strategy', 'high-risk', 'group', 'of', 'patient', '.', 'summary', 'radiocontrast-induced', 'acute-kidney-injury', '(', 'raki', ')', 'associated', 'with', 'poor', 'long-term', 'outcome', 'in', 'observational', 'and', 'short-term', 'study', '.', 'hydration', 'with', 'sodium', 'bicarbonate', '(', 'sb', ')', 'evaluated', 'in', 'prevention', 'of', 'raki', 'long-term', 'effect', 'not', 'evaluated', '.', 'randomized', 'high', 'high-risk', 'patient', 'undergoing', 'coronary', 'angiography', 'to', 'sb', 'or', 'normal', 'saline', 'following', 'five', 'year', '.', 'sb', 'showed', 'no', 'benefit', 'in', 'preventing', 'raki', ',', 'decreasing', 'major', 'adverse', 'renal', 'and', 'cardiovascular', 'event', ',', 'improving', 'survival', 'or', 'freedom', 'dialysis', '-years', '.', 'first', 'study', 'to', 'follow', 'patient', 'with', 'raki', 'period', 'of', '-years', ',', 'showing', 'significantly', 'higher', 'mortality', 'in', 'group', 'of', 'patient', '.']"
Effect of Ascorbic Acid on Cardiac Surgery-Associated Acute Kidney Injury Incidence.,"Anze Djordjevic, Stamenko Susak, Petra Kotnik, Mario Gorenjak, Zeljko Knez, Miha Antonic, Anze Djordjevicet al.",2022 Oct,Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/35643076/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'associated', 'with', 'higher', 'perioperative', 'mortality', 'and', 'morbidity', '.', 'oxidative', 'stress', 'proposed', 'cause', 'of', 'postoperative', 'aki', '.', 'ascorbic', 'acid', '(', 'aa', ')', 'supplementation', 'suggested', 'novel', 'and', 'promising', 'antioxidant', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'capability', 'of', 'aa', 'to', 'reduce', 'incidence', 'of', 'postoperative', 'aki', 'in', 'cardiac', 'surgery', 'patient', '.', 'method', 'prospective', 'randomized', 'trial', 'conducted', 'in', 'patient', 'scheduled', 'on-pump', 'cardiac', 'surgery', '.', 'subject', 'in', 'aa', 'group', 'received', 'g', 'of', 'aa', 'intravenously', 'induction', 'of', 'anesthesia', ',', 'g', 'aortic', 'cross-clamp', 'removal', 'and', 'g', 'every', 'hour', 'five', 'postoperative', 'day', '(', 'jerica', 'protocol', ')', '.', 'postoperatively', ',', 'patient', 'monitored', 'aki', 'and', 'complication', '.', 'malondialdehyde', 'level', 'monitored', 'in', 'subpopulation', 'of', 'patient', 'to', 'evaluate', 'effect', 'of', 'aa', 'oxidative', 'stress', 'level', '.', 'result', 'aa', 'and', 'control', 'group', 'consisted', 'of', 'and', 'patient', ',', 'respectively', '.', 'group', 'well', 'matched', 'baseline', 'demographic', 'and', 'similar', 'intraoperative', 'characteristic', '.', 'incidence', 'of', 'aki', 'in', 'aa', 'and', 'control', 'group', '.', 'and', '.', ',', 'respectively', '(', 'p', '.', ')', '.', 'estimated', 'glomerular', 'filtration', 'rate', 'not', 'differ', 'study', 'group', 'in', 'entire', 'postoperative', 'period', '.', 'trend', 'toward', 'higher', 'malondialdehyde', 'value', 'with', 'statistical', 'significance', 'postoperative', 'day', 'and', 'lower', 'in-hospital', 'mortality', 'in', 'aa', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'conclusion', 'result', 'not', 'support', 'effectiveness', 'of', 'aa', 'supplementation', 'in', 'reducing', 'incidence', 'of', 'postoperative', 'aki', 'in', 'on-pump', 'cardiac', 'surgery', 'patient', '.', 'clinical', 'registration', 'number', 'study', 'registered', 'with', 'isrctn', 'registry', 'trial', 'registration', 'number', 'isrctn', '.']"
Nucleosome levels and toll-like receptor expression during high cut-off haemofiltration: a pilot assessment.,"Rafidah Atan, Clive May, Simon R Bailey, Marcel Tanudji, Kumar Visvanathan, Narelle Skinner, Rinaldo Bellomo, Hermann Goehl, Markus Storr, Rafidah Atanet al.",2015 Dec,Crit Care Resusc,https://pubmed.ncbi.nlm.nih.gov/26640058/,No keywords found,"['to', 'measure', 'plasma', 'nucleosome', 'level', 'and', 'expression', 'of', 'toll-like', 'receptor', '(', 'tlrs', ')', 'in', 'pilot', 'cohort', 'of', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'within', 'randomised', 'controlled', 'trial', 'of', 'continuous', 'venovenous', 'haemofiltration', 'with', 'high', 'cut-off', 'filter', '(', 'cvvh-hco', ')', 'v', 'standard', 'filter', '(', 'cvvh-std', ')', '.', 'method', 'measured', 'plasma', 'nucleosome', 'level', 'using', 'cell', 'death', 'detection', 'elisa', 'plus', '(', 'x', ')', 'assay', 'kit', '.', 'analysed', 'plasma', 'level', 'correlation', 'with', 'disease', 'severity', 'and', 'compared', 'effect', 'of', 'cvvh-hco', 'and', 'cvvh-std', 'plasma', 'nucleosome', 'level', 'first', 'hour', '.', 'studied', 'cell', 'surface', 'tlr', 'expression', 'cd-positive', 'monocyte', 'in', 'subcohort', 'of', 'cvvh-hco', 'patient', '.', 'result', 'not', 'detect', 'nucleosomes', 'in', 'normal', 'human', 'plasma', ',', 'found', 'elevated', 'nucleosome', 'level', 'in', 'patient', 'with', 'severe', 'aki', '.', 'nucleosome', 'level', 'randomisation', 'correlated', 'weakly', 'with', 'acute', 'physiology', 'and', 'chronic', 'health', 'evaluation', 'iii', 'score', '(', 'pearson', '.', ',', 'p.', ')', '.', 'treatment', 'with', 'cvvh-hco', 'or', 'cvvh-std', 'no', 'effect', 'nucleosome', 'level', 'hour', '.', 'mean', 'fluorescence', 'intensity', '(', 'mfi', ')', 'ratio', 'of', 'tlr', 'and', 'tlr', 'expression', 'elevated', 'throughout', '-hour', 'period', '(', 'range', 'tlr', ',', '.-', '.', 'range', 'tlr', ',', '.-', '.', ')', 'and', 'not', 'appear', 'to', 'decrease', 'result', 'of', 'treatment', 'with', 'cvvh-hco', '.', 'conclusion', 'nucleosome', 'concentration', 'elevated', 'in', 'plasma', 'of', 'patient', 'with', 'severe', 'aki', 'and', 'mildly', 'correlated', 'with', 'disease', 'severity', ',', 'not', 'affected', 'treatment', 'with', 'cvvh-hco', 'or', 'cvvh-std', '.', 'similarly', ',', 'level', 'of', 'tlr', 'and', 'tlr', 'expression', 'not', 'decrease', 'time', 'cvvhcrit', 'hco', 'treatment', '.']"
Risk Factors for Long-Term Mortality and Progressive Chronic Kidney Disease Associated With Acute Kidney Injury After Cardiac Surgery.,"Jia-Rui Xu, Jia-Ming Zhu, Jun Jiang, Xiao-Qiang Ding, Yi Fang, Bo Shen, Zhong-Hua Liu, Jian-Zhou Zou, Lan Liu, Chun-Sheng Wang, Claudio Ronco, Hong Liu, Jie Teng, Jia-Rui Xuet al.",2015 Nov,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/26559305/,No keywords found,"['aim', 'of', 'study', 'to', 'evaluate', 'risk', 'factor', 'long-term', 'mortality', 'and', 'progressive', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'cardiac', 'surgery', 'in', 'patient', 'with', 'normal', 'preoperative', 'renal', 'function', 'and', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'april', 'to', 'december', ',', 'prospectively', 'enrolled', 'cardiac', 'surgery', 'patient', 'of', 'hospital', '.', 'primary', 'endpoint', 'included', 'survival', 'rate', 'and', 'secondary', 'endpoint', 'incidence', 'of', 'progressive', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'in', 'follow-up', 'period', 'of', 'year', '.', 'acute', 'kidney', 'injury', 'staged', 'kdigo', 'classification', '.', 'progressive', 'ckd', 'defined', 'gfr', 'mlmin', '.', 'or', 'end-stage', 'renal', 'disease', '(', 'esrd', ')', '(', 'starting', 'renal', 'replacement', 'therapy', 'or', 'renal', 'transplantation', ')', '.the', 'aki', 'incidence', '.', '(', 'n', ')', '.', 'and', 'year', 'overall', 'survival', '(', 'o', ')', 'rate', 'of', 'aki', 'patient', 'significantly', 'lower', 'non-aki', 'patient', '(', '.', 'and', '.', 'v', '.', 'and', '.', ',', 'p', '.', ')', ',', 'even', 'complete', 'recovery', 'of', 'renal', 'function', 'year', 'intervention', '(', 'p', '.', ')', '.', '-year', 'overall', 'survival', '(', 'o', ')', 'rate', 'of', 'patient', 'with', 'aki', 'stage', ',', ',', 'and', '.', ',', '.', ',', 'and', '.', '(', 'p', '.', ')', ',', 'respectively', '.', 'multivariate', 'cox', 'regression', 'analysis', 'of', 'factor', '-year', 'survival', 'rate', 'revealed', 'besides', 'age', '(', 'p', '.', ')', ',', 'chronic', 'cardiac', 'failure', '(', 'p', '.', ')', ',', 'diabetes', '(', 'p', '.', ')', ',', 'cardiopulmonary', 'bypass', 'time', '(', 'p', '.', ')', ',', 'and', 'length', 'of', 'intensive', 'care', 'unit', '(', 'icu', ')', 'stay', '(', 'p', '.', ')', ',', 'aki', 'significant', 'risk', 'factor', 'reducing', '-year', 'survival', 'rate', 'even', 'complete', 'recovery', 'of', 'renal', 'function', '(', 'p', '.', ')', '.', 'accumulated', 'progressive', 'ckd', 'prevalence', 'significantly', 'higher', 'in', 'aki', 'in', 'non-aki', 'patient', '(', '.', 'v', '.', ',', 'p', '.', ')', 'in', 'year', 'surgery', '.', 'even', 'with', 'complete', 'recovery', 'of', 'renal', 'function', 'discharge', ',', 'aki', 'still', 'risk', 'factor', 'accumulated', 'progressive', 'ckd', '(', 'rr', '.', ',', 'ci', '.-', '.', ')', '.the', '-year', 'mortality', 'and', 'progressive', 'ckd', 'incidence', 'even', 'complete', 'recovery', 'of', 'renal', 'function', 'significantly', 'increased', 'in', 'cardiac', 'surgery', 'patient', 'with', 'postoperative', 'aki', '.']"
Effect of Chronic Kidney Disease on Cardiovascular Events: An Epidemiological Aspect from SPRINT Trial.,"Armin Attar, Mehrab Sayadi, Armin Attaret al.",2019 Sep,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/31705750/,No keywords found,"['currently', ',', 'conflicting', 'evidence', 'exists', 'among', 'community-based', 'study', 'to', 'whether', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'cardiovascular', '(', 'cvd', ')', 'risk', 'equivalent', '.', 'aimed', 'to', 'evaluate', 'effect', 'of', 'ckd', 'cvd', 'based', 'large', 'trial', 'result', '.', 'method', 'to', 'perform', 'secondary', 'analysis', ',', 'obtained', 'data', 'of', 'sprint', 'trial', 'nhlbi', 'data', 'repository', 'center', '.', 'subject', 'with', 'baseline', 'ckd', 'and', 'without', 'ckd', 'enrolled', '.', 'composite', 'of', 'myocardial', 'infarction', ',', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'heart', 'failure', ',', 'or', 'death', 'cardiovascular', 'cause', 'considered', 'primary', 'outcome', '.', 'result', 'throughout', '.', 'year', 'of', 'follow-up', ',', 'presence', 'of', 'ckd', ',', 'compared', 'to', 'without', 'ckd', ',', 'negatively', 'affected', 'primary', 'outcome', '(', 'incidence', 'rate', ',', '.', 'per', 'year', 'vs.', '.', 'per', 'year', 'in', 'patient', 'with', 'and', 'without', 'ckd', ',', 'respectively', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'finding', 'consistent', 'across', 'secondary', 'outcome', '.', 'however', ',', 'risk', 'not', 'great', 'with', 'clinical', 'cardiovascular', 'disease', '(', 'incidence', 'rate', ',', '.', 'per', 'year', ')', '.', 'presence', 'of', 'ckd', 'strongest', 'predictor', 'of', 'developing', 'aki', 'with', 'intensive', 'blood', 'pressure', 'reduction', ',', 'increasing', 'chance', '.', 'conclusion', 'sprint', 'first', 'trial', 'revealing', 'ckd', 'independent', 'risk', 'factor', 'cvd', '.', 'however', ',', 'ckd', 'could', 'not', 'considered', 'cvd', 'risk', 'equivalent', '.', 'in', 'presence', 'of', 'ckd', ',', 'with', 'intensive', 'blood', 'pressure', 'reduction', 'chance', 'of', 'aki', 'dramatically', 'increased', '.']"
Assessment of pN-GAL as a marker of renal function in elite cyclists during professional competitions.,"A Andreazzoli, C Fossati, A Spaccamiglio, R Salvo, F Quaranta, C Minganti, L Di Luigi, P Borrione, A Andreazzoliet al.",2017 Jul-Sep,J Biol Regul Homeost Agents,https://pubmed.ncbi.nlm.nih.gov/28958144/,No keywords found,"['plasma', 'ngal', '(', 'pngal', ')', 'and', 'urinary', 'ngal', '(', 'ungal', ')', '.', 'aim', 'of', 'present', 'study', 'to', 'assess', 'acute', 'variation', 'in', 'ngal', 'plasma', 'level', 'performing', 'high', 'endurance', 'physical', 'exercise', 'in', 'group', 'of', 'professional', 'cyclist', 'two', 'major', 'european', 'professional', 'cycling', 'competition', '(', 'giro', 'ditalia', 'and', 'tour', 'de', 'france', ')', '.', 'eighteen', 'professional', 'cyclistis', 'recruited', 'study', '.', 'blood', 'sample', 'collected', 'rest', '(', 'hour', 'fasting', ')', 'and', 'immediately', 'competition', '(', 'mountain', 'stage', ')', 'in', 'order', 'to', 'assess', 'effect', 'of', 'intense', 'exercise', 'kidney', 'function', 'measuring', 'variation', 'of', 'pngal', '.', 'also', 'assessed', 'plasma', 'level', 'of', 'creatinine', ',', 'creatine-kinase', '(', 'ck', ')', ',', 'ldh', ',', 'transaminase', 'and', 'electrolyte', '.', 'result', 'showed', 'creatinine', ',', 'ck', 'and', 'electrolyte', 'level', 'remained', 'almost', 'stable', 'rest', 'and', 'post-competition', '.', 'level', 'of', 'transaminase', 'and', 'ngal', 'showed', 'mild', 'increase', 'rest', 'and', 'post-competition', ',', 'with', 'significant', 'difference', 'two', 'value', 'transaminase', '(', 'p.', ')', '.', 'however', ',', 'post-competition', 'value', 'of', 'investigated', 'variable', 'remained', 'within', 'physiological', 'range', '.', 'result', 'of', 'present', 'study', 'suggest', 'even', 'ngal', 'value', 'mildly', 'rose', 'competition', ',', 'no', 'kidney', 'injury', 'occurred', 'in', 'highly', 'trained', 'athlete', 'mountain', 'stage', 'of', 'professional', 'competition', '.', 'study', 'in', 'literature', 'confirmed', 'high', 'endurance', 'physical', 'exercise', 'seems', 'not', 'to', 'cause', 'renal', 'injury', 'in', 'elite', 'athlete', '.', 'probably', 'due', 'to', 'adaptive', 'mechanism', 'of', 'renal', 'function', 'and', 'to', 'adaptation', 'to', 'physical', 'stress', 'gained', 'with', 'training', '.']"
The furosemide stress test predicts the timing of continuous renal replacement therapy initiation in critically ill patients with acute kidney injury: a double-blind prospective intervention cohort study.,"Kun Zhang, Haohua Zhang, Chai Zhao, Zhenjie Hu, Jiuyan Shang, Yuhong Chen, Yan Huo, Congcong Zhao, Bin Li, Suzhi Guo                              ;, Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Kun Zhanget al.",2023 Apr 5,Eur J Med Res,https://pubmed.ncbi.nlm.nih.gov/37020287/,No keywords found,"['continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'remains', 'crucial', 'treatment', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'although', 'timing', 'of', 'initiation', 'still', 'matter', 'of', 'contention', '.', 'furosemide', 'stress', 'testing', '(', 'fst', ')', 'may', 'practical', 'and', 'beneficial', 'prediction', 'instrument', '.', 'research', 'meant', 'to', 'examine', 'fst', 'used', 'to', 'identify', 'high-risk', 'patient', 'crrt', '.', 'method', 'study', 'double-blind', ',', 'prospective', 'interventional', 'cohort', 'study', '.', 'patient', 'with', 'aki', 'receiving', 'intensive', 'care', 'unit', '(', 'icu', ')', 'income', ',', 'fst', 'selected', 'with', 'furosemide', 'mgkg', 'intravenous', '(', '.', 'mgkg', 'intravenous', 'loop', 'diuretic', 'received', 'within', 'day', ')', '.', 'urinary', 'volume', 'ml', 'h', 'fst', 'fst-responsive', ',', 'less', 'ml', 'fst-nonresponsive', '.', 'fst', 'result', 'kept', 'strictly', 'confidential', 'clinician', ',', 'decides', 'whether', 'to', 'initiate', 'crrt', 'based', 'laboratory', 'testing', 'and', 'clinical', 'symptom', 'fst', 'data', '.', 'fst', 'data', 'concealed', 'patient', 'and', 'clinician', '.', 'result', 'fst', 'delivered', 'to', 'of', 'patient', 'satisfied', 'inclusion', 'and', 'exclusion', 'criterion', ',', 'with', 'patient', 'responding', 'to', 'test', 'and', 'patient', 'not', 'responding', '.', '(', '.', ')', 'of', 'fst-responsive', 'patient', 'received', 'crrt', ',', '(', '.', ')', 'of', 'fst-nonresponsive', 'patient', 'received', 'crrt', '.', 'no', 'significant', 'difference', 'crrt', 'and', 'non-crrt', 'group', 'in', 'term', 'of', 'general', 'health', 'and', 'medical', 'history', '(', 'p', '.', ')', '.', 'urine', 'volume', 'h', 'of', 'fst', 'considerably', 'lower', 'in', 'crrt', 'group', 'in', 'non-crrt', 'group', '(', 'ml', ',', 'iqr-', '.', 'versus', 'ml', ',', 'iqr-', 'p', '.', ')', '.', 'fst', 'non-responders', '.', 'time', 'likely', 'to', 'initiate', 'crrt', 'fst', 'responder', '(', 'ci', '.-.', ',', 'p', '.', ')', '.', 'area', 'curve', '(', 'auc', ')', 'initiating', 'crrt', '.', '(', 'cutoff', 'of', 'ml', ',', 'sensitivity', 'of', '.', ',', 'specificity', 'of', '.', ',', 'p', '.', ')', '.', 'conclusion', 'study', 'demonstrated', 'fst', 'safe', 'and', 'practical', 'approach', 'predicting', 'initiation', 'of', 'crrt', 'in', 'critically', 'ill', 'aki', 'patient', '.', 'trial', 'registration', 'www.chictr.org.cn', ',', 'chictr', ',', 'registered', 'april', '.']"
Automated Electronic Alert for the Care and Outcomes of Adults With Acute Kidney Injury: A Randomized Clinical Trial.,"Ting Li, Buyun Wu, Li Li, Ao Bian, Juan Ni, Kang Liu, Zhongke Qin, Yudie Peng, Yining Shen, Mengru Lv, Xinyi Lu, Changying Xing, Huijuan Mao, Ting Liet al.",2024 Jan 2,JAMA Netw Open,https://pubmed.ncbi.nlm.nih.gov/38241047/,No keywords found,"['despite', 'expansion', 'of', 'published', 'electronic', 'alert', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'still', 'concern', 'regarding', 'effect', 'clinical', 'outcome', 'of', 'patient', '.', 'objective', 'to', 'evaluate', 'effect', 'of', 'aki', 'alert', 'combined', 'with', 'care', 'bundle', 'care', 'and', 'clinical', 'outcome', 'of', 'patient', 'with', 'hospital-acquired', 'aki', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'single-center', ',', 'double-blind', ',', 'parallel-group', 'randomized', 'clinical', 'trial', 'conducted', 'in', 'tertiary', 'teaching', 'hospital', 'in', 'nanjing', ',', 'china', ',', 'august', ',', ',', 'to', 'december', ',', '.', 'inclusion', 'criterion', 'inpatient', 'adult', 'aged', 'year', 'or', 'older', 'with', 'aki', ',', 'defined', 'using', 'kidney', 'disease', 'improving', 'global', 'outcome', 'creatinine', 'criterion', '.', 'participant', 'randomized', 'to', 'either', 'alert', 'group', 'or', 'usual', 'care', 'group', ',', 'stratified', 'medical', 'v', 'surgical', 'ward', 'and', 'intensive', 'care', 'unit', '(', 'icu', ')', 'v', 'non-icu', 'setting', '.', 'analysis', 'conducted', 'modified', 'intention-to-treat', 'population', '.', 'intervention', 'programmatic', 'aki', 'alert', 'system', 'generated', 'randomization', 'automatically', 'and', 'sent', 'message', 'to', 'mobile', 'telephone', 'of', 'clinician', '(', 'alert', 'group', ')', 'or', 'not', 'send', 'message', '(', 'usual', 'care', 'group', ')', '.', 'care', 'bundle', 'accompanied', 'aki', 'alert', 'and', 'consisted', 'of', 'general', ',', 'nonindividualized', ',', 'and', 'nonmandatory', 'aki', 'management', 'measure', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'maximum', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'within', 'day', 'randomization', '.', 'secondary', 'patient-centered', 'outcome', 'included', 'death', ',', 'dialysis', ',', 'aki', 'progression', ',', 'and', 'aki', 'recovery', '.', 'care-centered', 'outcome', 'included', 'diagnostic', 'and', 'therapeutic', 'intervention', 'aki', '.', 'result', 'total', 'of', 'patient', '(', 'median', 'iqr', 'age', ',', '-', 'year', 'male', '.', ')', 'randomized', 'to', 'alert', 'group', '(', 'n', ')', 'or', 'usual', 'care', 'group', '(', 'n', ')', 'and', 'analyzed', '.', 'within', 'day', 'of', 'randomization', ',', 'median', '(', 'iqr', ')', 'maximum', 'absolute', 'change', 'in', 'egfr', '.', '(', '-', '.', 'to', '.', ')', 'mlmin', '.', 'in', 'alert', 'group', 'and', '.', '(', '-', '.', 'to', '.', ')', 'mlmin', '.', 'in', 'usual', 'care', 'group', '(', 'p', '.', ')', '.', 'result', 'robust', 'in', 'subgroup', 'in', 'exploratory', 'analysis', '.', 'care-centered', 'outcome', ',', 'patient', 'in', 'alert', 'group', 'intravenous', 'fluid', '(', '.', 'v', '.', 'p', '.', ')', ',', 'less', 'exposure', 'to', 'nonsteroidal', 'anti-inflammatory', 'drug', '(', '.', 'v', '.', 'p', '.', ')', ',', 'and', 'aki', 'documentation', 'discharge', '(', '.', 'v', '.', 'p', '.', ')', 'patient', 'in', 'usual', 'care', 'group', '.', 'no', 'difference', 'observed', 'in', 'patient-centered', 'secondary', 'outcome', 'group', '.', 'conclusion', 'and', 'relevance', 'result', 'of', 'randomized', 'clinical', 'trial', 'showed', 'electronic', 'aki', 'alert', 'not', 'improve', 'kidney', 'function', 'or', 'patient-centered', 'outcome', 'changed', 'patient', 'care', 'behavior', '.', 'finding', 'warrant', 'use', 'of', 'combination', 'of', 'high-quality', 'intervention', 'and', 'aki', 'alert', 'in', 'future', 'clinical', 'practice', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
"Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial - a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial.","Pavel Suk, Jitka Rychlíčková, Lenka Součková, Vendula Kubíčková, Karel Urbánek, Pavel Suket al.",2023 Jul 30,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/37518089/,No keywords found,"['colistin', 'lipopeptide', 'antibiotic', 'administered', 'inactive', 'prodrug-colistin', 'methanesulfonate', '(', 'cm', ')', '.', 'colistin', 'drug', 'with', 'narrow', 'therapeutic', 'window', 'limiting', 'factor', 'mainly', 'nephrotoxicity', 'and', 'neurotoxicity', ',', 'dependent', 'plasma', 'concentration', '.', 'number', 'of', 'patient', 'with', 'infection', 'caused', 'multidrug-resistant', 'gram-negative', 'bacteria', 'sensitive', 'to', 'colistin', 'and', 'number', 'of', 'patient', 'requiring', 'extracorporeal', 'membrane', 'oxygenation', '(', 'ecmo', ')', 'support', 'severe', 'respiratory', 'failure', 'increased', 'significantly', 'in', 'association', 'with', 'covid', '--', 'induced', 'infection', '.', 'ecmo', 'generally', 'affect', 'pharmacokinetics', 'of', 'drug', 'creating', 'new', 'compartment', '.', 'method', 'and', 'analysis', 'col-ecmo', 'study', 'prospective', ',', 'non-randomised', ',', 'single-centre', ',', 'phase', 'iv', 'pharmacokinetic', 'clinical', 'trial', 'designed', 'to', 'assess', 'influence', 'of', 'ecmo', 'pharmacokinetics', 'of', 'colistin', 'and', 'cm', '.', 'to', 'patient', 'treated', 'with', 'colistin', 'included', 'in', 'study', 'and', 'assigned', 'to', 'one', 'of', 'two', 'arm', ',', 'depending', 'presenceabsence', 'of', 'ecmo', '.', 'study', 'participant', 'receive', 'standard', 'cm', 'dose', 'intravenously', '.', 'plasma', 'concentration', 'of', 'colistin', 'and', 'cm', 'taken', 'defined', 'interval', 'assessed', 'high-performance', 'liquid', 'chromatography-mass', 'spectrometry', '.', 'patient', 'participate', 'in', 'clinical', 'trial', 'maximum', 'of', 'three', 'monitored', 'dosing', 'interval', '.', 'population', 'pharmacokinetic', 'model', 'developed', 'to', 'assess', 'influence', 'of', 'ecmo', 'pharmacokinetics', '.', 'difference', 'greater', 'considered', 'clinically', 'significant', '.', 'ethic', 'and', 'dissemination', 'study', 'approved', 'ethic', 'committee', 'of', 'st.', 'anne', ""'s"", 'university', 'hospital', 'brno', '(', 'number', 'ml-am', ')', '.', 'related', 'manuscript', 'submitted', 'to', 'peer-review', 'journal', '.', 'trial', 'registration', 'number', 'eudract', 'number', '--', 'nct', '.']"
Miniaturized versus conventional cardiopulmonary bypass and acute kidney injury after cardiac surgery.,"S T H Chew, R R G Ng, W Liu, S G Goh, M G Caleb, L K Ti, S T H Chewet al.",2016 Jan,Perfusion,https://pubmed.ncbi.nlm.nih.gov/25910838/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'serious', 'complication', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', '.', 'conflicting', 'report', 'whether', 'miniaturized', 'cardiopulmonary', 'bypass', '(', 'mcpb', ')', 'system', 'associated', 'with', 'lower', 'aki', 'incidence', 'compared', 'with', 'conventional', 'cardiopulmonary', 'bypass', '(', 'ccpb', ')', '.', 'unknown', 'aki', 'risk', 'factor', 'differ', 'two', 'group', '.', 'assessed', 'mcpb', 'decrease', 'aki', 'cabg', 'and', 'compared', 'risk', 'factor', 'group', '.', 'method', 'sixty-eight', 'asian', 'patient', 'presenting', 'elective', 'cabg', 'tertiary', 'heart', 'centre', 'enrolled', '.', 'randomly', 'assigned', 'to', 'mcpb', '(', 'n', ')', 'or', 'ccpb', 'group', '(', 'n', ')', 'and', 'followed', 'in', 'single-blinded', ',', 'prospective', ',', 'randomized', ',', 'controlled', 'trial', '.', 'primary', 'outcome', 'acute', 'kidney', 'injury', 'network', 'stage', 'aki', '.', 'result', 'aki', 'incidence', '.', 'and', 'not', 'significantly', 'different', 'patient', 'undergoing', 'mcpb', 'versus', 'ccpb', '(', '.', 'versus', '.', ',', 'p.', ')', '.', 'first', 'cpb', 'haematocrit', 'independently', 'associated', 'with', 'aki', 'in', 'mcpb', 'group', '(', 'relative', 'risk', 'rr.', ',', 'confidence', 'interval', 'ci.-.', ',', 'p.', ')', 'post-operative', 'blood', 'loss', 'and', 'inflammation', 'independently', 'associated', 'with', 'aki', 'in', 'ccpb', 'group', '(', 'rr.', ',', 'ci.-.', ',', 'p', '.', 'rr.', ',', 'ci.-.', ',', 'p.', ')', '.', 'conclusion', 'mcpb', 'system', 'not', 'associated', 'with', 'lower', 'incidence', 'of', 'aki', 'in', 'asian', 'patient', 'undergoing', 'cabg', '.', 'risk', 'factor', 'aki', 'differed', 'patient', 'using', 'mcpb', 'and', 'ccpb', 'system', '.']"
Comparison of filter life span and solute removal during continuous renal replacement therapy: convection versus diffusion - A randomized controlled trial.,"Qiancheng Xu, Bo Jiang, Juan Li, Weihua Lu, Jianguo Li, Qiancheng Xuet al.",2022 Oct,Ther Apher Dial,https://pubmed.ncbi.nlm.nih.gov/34967496/,No keywords found,"['study', 'aimed', 'to', 'investigate', 'whether', 'continuous', 'veno-venous', 'hemodiafiltration', '(', 'cvvhdf', ')', 'different', 'filter', 'life', 'span', 'and', 'molecular', 'solute', 'clearance', 'compared', 'to', 'continuous', 'veno-venous', 'hemofiltration', '(', 'cvvh', ')', '.', 'method', 'sixty', 'patient', 'enrolled', 'in', 'study', 'and', 'randomly', 'assigned', 'to', 'cvvhdf', '(', 'n', ')', 'or', 'cvvh', '(', 'n', ')', 'group', '.', 'demographic', ',', 'laboratory', 'test', ',', 'urea', ',', 'creatinine', ',', 'il-', ',', '-microglobulin', ',', 'and', 'myoglobulin', 'clearance', 'recorded', '.', 'result', 'patient', 'in', 'cvvh', 'group', 'shorter', 'median', 'time', 'of', 'filter', 'life', 'span', 'compared', 'with', 'in', 'cvvhdf', 'group', '(', 'vs.', '.', 'h', ',', 'p', '.', ')', '.', 'urea', 'and', 'creatinine', 'clearance', 'not', 'significantly', 'different', 'group', 'time', '(', 'p', '.', ')', '.', 'il-', ',', '-microglobulin', ',', 'and', 'myoglobulin', 'clearance', 'higher', 'in', 'cvvh', 'group', '.', 'transmembrane', 'pressure', '(', 'tmp', ')', 'significantly', 'higher', 'in', 'cvvh', 'group', '.', 'conclusion', 'use', 'of', 'cvvhdf', 'may', 'lead', 'to', 'longer', 'filter', 'life', 'span', 'and', 'lower', 'clearance', 'of', 'medium', 'and', 'large', 'molecule', 'without', 'affecting', 'small', 'molecular', 'solute', 'clearance', '.', 'trial', 'registration', 'chinese', 'clinical', 'trial', 'register', '(', 'chictr', ')', ',', 'chictr', '.', 'registered', 'february', ',', 'httpwww.chictr.org.cnshowproj.aspxproj', '.']"
Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.,"Ling Sun, Xuejun Zhou, Jianguang Jiang, Xuan Zang, Xin Chen, Haiyan Li, Haitao Cao, Qingjie Wang, Ling Sunet al.",2018 Mar 12,PLoS One,https://pubmed.ncbi.nlm.nih.gov/29529072/,No keywords found,"['growth', 'differentiation', 'factor-', '(', 'gdf-', ')', 'emerging', 'biomarker', 'risk', 'stratification', 'in', 'cardiovascular', 'disease', '.', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'important', 'complication', 'in', 'patient', 'undergoing', 'coronary', 'angiography', '(', 'cag', ')', 'or', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', '.', 'in', 'retrospectively', 'observational', 'study', ',', 'aimed', 'to', 'determine', 'role', 'of', 'gdf-', 'and', 'risk', 'of', 'aki', 'in', 'acute', 'myocardial', 'infarction', '(', 'ami', ')', 'patient', '.', 'method', 'medical', 'record', 'of', 'patient', 'with', 'ami', 'reviewed', '.', 'exclusion', 'criterion', ',', 'total', 'of', 'eligible', 'patient', 'underwent', 'cag', 'or', 'pci', 'studied', '.', 'preoperative', 'clinical', 'parameter', 'including', 'gdf-', 'level', 'recorded', '.', 'multivariate', 'logistic', 'regression', 'analysis', 'used', 'to', 'identify', 'risk', 'factor', 'of', 'aki', '.', 'subsequently', ',', 'to', 'reduce', 'potential', 'selection', 'bias', 'and', 'to', 'balance', 'difference', 'two', 'group', ',', 'propensity', 'score-matched', 'analysis', 'performed', '.', 'recorded', '-day', 'all-cause', 'mortality', 'of', 'total', 'study', 'population', '.', 'kaplan-meier', 'analysis', 'performed', 'to', 'identify', 'association', 'short', 'term', 'survival', 'in', 'ami', 'patient', 'and', 'gdf-', 'level', '.', 'result', 'among', 'enrolled', 'patient', ',', 'patient', '(', '.', ')', 'developed', 'aki', '.', 'patient', 'divided', 'two', 'group', 'aki', 'group', '(', 'n', ')', 'and', 'non-aki', 'group', '(', 'n', ')', '.', 'gdf-', 'level', 'significantly', 'higher', 'in', 'aki', 'group', 'compared', 'to', 'non-aki', 'group', '(', '.', '.', 'ngl', 'vs.', '.', '.', 'ngl', ',', 'p', '.', ')', '.', 'multivariate', 'logistic', 'regression', 'analysis', 'showed', 'gdf-', 'independent', 'risk', 'factor', 'of', 'aki', '(', 'per', 'ngl', 'increase', 'of', 'gdf-', ',', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'according', 'to', 'gdf-', 'tertiles', ',', 'patient', 'divided', 'three', 'group', '.', 'patient', 'in', 'middle', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'and', 'highest', 'gdf-', 'tertile', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'higher', 'risk', 'of', 'aki', 'compared', 'to', 'patient', 'in', 'lowest', 'gdf-', 'tertile', '.', 'propensity', 'score-matched', 'group', 'set', 'comprised', 'of', 'patient', '.', 'multivariate', 'logistic', 'regression', 'revealed', 'gdf-', 'still', 'independent', 'risk', 'factor', 'aki', 'matching', '(', 'per', 'ngl', 'increase', 'of', 'gdf-', ',', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'based', 'kaplan-meier', 'analysis', ',', 'risk', 'of', '-day', 'all-cause', 'mortality', 'increased', 'in', 'higher', 'gdf-', 'tertiles', 'log', 'rank', 'chi-square', '.', ',', 'p', '.', ')', '.', 'conclusion', 'suggests', 'preoperative', 'plasma', 'gdf-', 'independent', 'risk', 'factor', 'of', 'aki', 'in', 'ami', 'patient', 'underwent', 'cag', 'or', 'pci', '.', 'gdf-', 'and', 'aki', 'associated', 'with', 'poor', 'short', 'term', 'survival', 'of', 'ami', 'patient', '.']"
High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial.,"Kevin K Chung, Elsa C Coates, David J Smith Jr, Rachel A Karlnoski, William L Hickerson, Angela L Arnold-Ross, Michael J Mosier, Marcia Halerz, Amy M Sprague, Robert F Mullins, Daniel M Caruso, Marlene Albrecht, Brett D Arnoldo, Agnes M Burris, Sandra L Taylor, Steven E Wolf                              ;, Randomized controlled Evaluation of high-volume hemofiltration in adult burn patients with Septic shoCk and acUte kidnEy injury (RESCUE) Investigators, Booker T King, Julie A Rizzo, Jeremy C Pamplin, Ian R Driscoll, Evan M Renz, Jonathan B Lundy, Leopoldo C Cancio, Carl W Cruse, Christopher A McFarren, Kimberly S Brown, Arif Showkat, Lekha George, Aneel Kumar, Barbara Birmingham, David Hill, Mary E Bruce, Arthur P Sanford, David J Leehey, Zaheed Hassan, Joseph R Shaver, Bruce Friedman, Kevin N Fosters, Michael D Peck, Herb A Phelan, Ramesh Saxena, James Howard, Dhaval Bhavsar, Satish Ponnuru, Michelle DeSouza, Sri G Yarlagadda, Kevin K Chunget al.",2017 Nov 25,Crit Care,https://pubmed.ncbi.nlm.nih.gov/29178943/,No keywords found,"['sepsis', 'and', 'septic', 'shock', 'occur', 'commonly', 'in', 'severe', 'burn', '.', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'also', 'common', 'and', 'often', 'result', 'consequence', 'of', 'sepsis', '.', 'mortality', 'unacceptably', 'high', 'in', 'burn', 'patient', 'develop', 'aki', 'requiring', 'renal', 'replacement', 'therapy', 'and', 'presumed', 'to', 'even', 'higher', 'combined', 'with', 'septic', 'shock', '.', 'hypothesized', 'high-volume', 'hemofiltration', '(', 'hvhf', ')', 'blood', 'purification', 'technique', 'would', 'beneficial', 'in', 'population', '.', 'method', 'conducted', 'multicenter', ',', 'prospective', ',', 'randomized', ',', 'controlled', 'clinical', 'trial', 'to', 'evaluate', 'impact', 'of', 'hvhf', 'hemodynamic', 'profile', 'of', 'burn', 'patient', 'with', 'septic', 'shock', 'and', 'aki', 'involving', 'seven', 'burn', 'center', 'in', 'united', 'state', '.', 'subject', 'randomized', 'to', 'hvhf', 'prescribed', 'dose', 'of', 'mlkghour', 'hour', 'control', 'subject', 'managed', 'in', 'standard', 'fashion', 'in', 'accordance', 'with', 'local', 'practice', '.', 'result', '-year', 'period', ',', 'total', 'of', 'nine', 'subject', 'enrolled', 'intervention', 'ramp-in', 'phase', 'and', 'subject', 'randomized', ',', 'control', 'and', 'hvhf', 'arm', 'respectively', '.', 'study', 'terminated', 'due', 'to', 'slow', 'enrollment', '.', 'ramp-in', 'subject', 'included', 'along', 'with', 'randomized', 'in', 'final', 'analysis', '.', 'primary', 'endpoint', ',', 'vasopressor', 'dependency', 'index', ',', 'decreased', 'significantly', 'hour', 'compared', 'to', 'baseline', 'in', 'hvhf', 'group', '(', 'p', '.', ')', 'remained', 'no', 'different', 'in', 'control', 'arm', '.', 'day', ',', 'multiple', 'organ', 'dysfunction', 'syndrome', 'score', 'decreased', 'significantly', 'in', 'hvhf', 'group', 'compared', 'to', 'day', 'of', 'treatment', 'initiation', '(', 'p', '.', ')', '.', 'no', 'change', 'in', 'inflammatory', 'marker', 'detected', '-hour', 'intervention', 'period', '.', 'no', 'significant', 'difference', 'in', 'survival', 'detected', '.', 'no', 'difference', 'in', 'adverse', 'event', 'noted', 'group', '.', 'conclusion', 'hvhf', 'effective', 'in', 'reversing', 'shock', 'and', 'improving', 'organ', 'function', 'in', 'burn', 'patient', 'with', 'septic', 'shock', 'and', 'aki', ',', 'and', 'appears', 'safe', '.', 'whether', 'reversal', 'of', 'shock', 'in', 'patient', 'improve', 'survival', 'yet', 'to', 'determined', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'registered', 'september', '.']"
Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation.,"Andreas Margraf, Chang Liu, Mira Küllmar, Melanie Meersch, Jan Rossaint, Alexander Zarbock, Andreas Margrafet al.",2022 Jun 1,Cells,https://pubmed.ncbi.nlm.nih.gov/35681510/,"CVVH, acute kidney injury, anticoagulation, citrate, heparin, inflammation, leukocytes.","['acute', 'kidney', 'injury', '(', 'aki', ')', 'frequent', 'complication', 'in', 'critically', 'ill', 'patient', '.', 'supportive', 'treatment', 'of', 'aki', 'patient', 'based', 'renal-replacement', 'therapy', ',', 'including', 'continuous', 'veno-venous', 'hemofiltration', '(', 'cvvh', ')', '.', 'to', 'limit', 'clotting', 'event', 'extracorporeal', 'surface', ',', 'anticoagulant', 'administered', ',', 'including', 'systemic', 'heparin', 'and', 'local', 'citrate', '.', 'differential', 'and', 'comparative', 'effect', 'of', 'anticoagulant', 'leukocyte', 'function', 'in', 'acute', 'kidney', 'injury', 'patient', ',', 'far', ',', 'insufficiently', 'understood', '.', 'in', 'bio-add-on-study', ',', 'aki', 'patient', 'randomized', 'part', 'of', 'parallel-group', 'trial', 'to', 'either', 'systemic', 'heparin', 'or', 'regional', 'citrate', 'anticoagulation', '.', 'patient', 'sample', 'collected', 'upon', 'inclusion', ',', 'prior', 'to', 'cvvh', 'initiation', 'day', ',', 'day', ',', 'day', 'and', 'day', ',', 'following', 'cvvh', 'initiation', ',', 'and', 'one', 'day', 'cessation', 'of', 'cvvh', ',', 'immediately', 'analyzed', '.', 'flow', 'cytometric', 'assessment', 'of', 'surface-receptor', 'molecule', 'conducted', '.', 'whole-blood-perfused', 'human', 'microfluidic', 'chamber', 'used', 'analysis', 'of', 'neutrophil', 'rolling', 'and', 'adhesion', '.', 'acute', 'kidney', 'injury', 'associated', 'with', 'significant', 'change', 'in', 'surface', 'expression', 'of', 'cd', 'and', 'cd', 'throughout', 'cvvh', 'treatment', ',', 'independent', 'of', 'anticoagulation', 'regime', '.', 'aki', 'furthermore', 'abrogated', 'selectin-induced', 'slow', 'leukocyte', 'rolling', 'and', 'diminished', 'chemokine-induced', 'leukocyte', 'arrest', '.', 'subgroup', 'analysis', 'of', 'citrate', 'vs.', 'heparin', 'treatment', 'showed', 'no', 'significant', 'difference', 'group', ',', 'independent', 'of', 'duration', 'of', 'cvvh', 'treatment', '.', 'cd', 'and', 'cd', 'expression', 'remained', 'low', 'in', 'group', 'throughout', 'cvvh', 'therapy', '.', 'data', 'confirm', 'aki', 'impairs', 'selectin-mediated', 'leukocyte', 'slow', 'rolling', 'and', 'chemokine-induced', 'leukocyte', 'arrest', 'in', 'vitro', '.', 'systemic', 'heparin', 'or', 'local', 'citrate', 'anticoagulation', 'no', 'differential', 'effect', 'leukocyte', 'recruitment', 'step', 'examined', 'in', 'study', '.']"
Construction and evaluation of a risk prediction model for pulmonary infection-associated acute kidney injury in intensive care units.,"Xinyi Cao, Yongzhi Liang, Honglin Feng, Li Chen, Shengming Liu, Xinyi Caoet al.",2023 Oct,Clin Transl Sci,https://pubmed.ncbi.nlm.nih.gov/37488744/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'one', 'of', 'common', 'complication', 'of', 'pulmonary', 'infection', '.', 'however', ',', 'nomogram', 'predicting', 'risk', 'of', 'early-onset', 'aki', 'in', 'patient', 'with', 'pulmonary', 'infection', 'not', 'comprehensively', 'researched', '.', 'in', 'study', ',', 'patient', 'with', 'pulmonary', 'infection', 'extracted', 'medical', 'information', 'mart', 'intensive', 'care', 'iii', '(', 'mimic-iii', ')', 'database', '.', 'patient', 'randomly', 'divided', 'training', 'and', 'validation', 'cohort', ',', 'with', 'training', 'cohort', 'used', 'model', 'building', 'and', 'validation', 'cohort', 'used', 'validation', '.', 'independent', 'risk', 'factor', 'patient', 'with', 'pulmonary', 'infection', 'determined', 'using', 'least', 'absolute', 'shrinkage', 'and', 'selection', 'operator', '(', 'lasso', ')', 'method', 'and', 'forward', 'stepwise', 'logistic', 'regression', ',', 'revealed', 'independent', 'risk', 'factor', 'aki', 'in', 'patient', 'with', 'pulmonary', 'infection', 'congestive', 'heart', 'failure', '(', 'chf', ')', ',', 'hypertension', ',', 'diabetes', ',', 'transcutaneous', 'oxygen', 'saturation', '(', 'spo', ')', ',', '-h', 'urine', 'output', ',', 'white', 'blood', 'cell', '(', 'wbc', ')', ',', 'serum', 'creatinine', '(', 'scr', ')', ',', 'prothrombin', 'time', '(', 'pt', ')', ',', 'potential', 'of', 'hydrogen', '(', 'ph', ')', ',', 'vasopressor', 'use', ',', 'and', 'mechanical', 'ventilation', '(', 'mv', ')', 'use', '.', 'nomogram', 'constructed', 'and', 'validated', '.', 'area', 'receiver', 'operating', 'characteristic', 'curve', '(', 'auc', ')', 'value', 'of', 'nomogram', '.', '(', 'ci', '.-', '.', ')', 'in', 'training', 'cohort', 'and', '.', '(', 'ci', '.-', '.', ')', 'in', 'validation', 'cohort', '.', 'high', 'auc', 'value', 'indicated', 'good', 'discriminative', 'ability', 'of', 'nomogram', ',', 'calibration', 'curve', 'and', 'hosmer-lemeshow', 'test', 'result', 'indicated', 'nomogram', 'well-calibrated', '.', 'improvement', 'in', 'net', 'reclassification', 'index', '(', 'nri', ')', 'and', 'integrated', 'discrimination', 'improvement', '(', 'idi', ')', 'value', 'indicate', 'nomogram', 'superior', 'to', 'simplified', 'acute', 'physiology', 'score', '(', 'sap', ')', 'ii', 'scoring', 'system', ',', 'and', 'decision-curve', 'analysis', '(', 'dca', ')', 'curve', 'indicate', 'nomogram', 'good', 'clinical', 'application', '.', 'established', 'risk-prediction', 'model', 'aki', 'in', 'patient', 'with', 'pulmonary', 'infection', ',', 'good', 'discriminative', 'power', 'and', 'superior', 'to', 'sap', 'ii', 'scoring', 'system', '.', 'model', 'provide', 'clinical', 'reference', 'information', 'patient', 'with', 'type', 'of', 'disease', 'in', 'intensive', 'care', 'unit', '.']"
Acute Kidney Injury in Mechanically Ventilated Patients: The Risk Factor Profile Depends on the Timing of Aki Onset.,"Raúl Lombardi, Nicolás Nin, Oscar Peñuelas, Alejandro Ferreiro, Fernando Rios, Maria Carmen Marin, Konstantinos Raymondos, Jose A Lorente, Younsuck Koh, Javier Hurtado, Marco Gonzalez, Fekri Abroug, Manuel Jibaja, Yaseen Arabi, Rui Moreno, Dimitros Matamis, Antonio Anzueto, Andres Esteban;, VENTILA Group, Raúl Lombardiet al.",2017 Oct,Shock,https://pubmed.ncbi.nlm.nih.gov/28379920/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'frequent', 'complication', 'in', 'patient', 'mechanical', 'ventilation', '(', 'mv', ')', '.', 'aimed', 'to', 'assess', 'risk', 'factor', 'aki', 'with', 'particular', 'emphasis', 'potentially', 'preventable', '.', 'study', 'design', ',', 'setting', ',', 'and', 'participant', 'retrospective', 'analysis', 'of', 'large', ',', 'multinational', 'database', 'of', 'mv', 'patient', 'with', 'h', 'of', 'mv', 'and', 'normal', 'renal', 'function', 'admission', '.', 'aki', 'defined', 'according', 'to', 'creatinine-based', 'kdigo', 'criterion', '.', 'risk', 'factor', 'analyzed', 'according', 'to', 'time', 'point', 'aki', 'occurred', 'early', '(', 'h', 'icu', 'admission', ',', 'akie', ')', 'and', 'late', '(', 'day', 'to', 'day', 'of', 'icu', 'stay', ',', 'akil', ')', '.', 'conditional', 'logistic', 'regression', 'model', 'used', 'to', 'identify', 'variable', 'independently', 'associated', 'with', 'aki', '.', 'result', 'three', 'thousand', 'two', 'hundred', 'six', 'patient', 'included', '.', 'seven', 'hundred', 'patient', 'aki', '(', ')', ',', 'majority', 'of', 'akie', '(', ')', '.', 'risk', 'factor', 'profile', 'highly', 'dependent', 'upon', 'timing', 'of', 'aki', 'onset', '.', 'in', 'akie', 'risk', 'factor', 'older', 'age', 'sap', 'ii', 'score', 'postoperative', 'and', 'cardiac', 'arrest', 'reason', 'mv', 'worse', 'cardiovascular', 'sofa', ',', 'ph', ',', 'serum', 'creatinine', ',', 'and', 'platelet', 'count', 'higher', 'level', 'of', 'peak', 'pressure', 'and', 'vtkg', 'and', 'fluid', 'overload', 'admission', '.', 'in', 'contrast', ',', 'akil', 'linked', 'mostly', 'to', 'event', 'occurred', 'admission', '(', 'lower', 'platelet', 'count', 'and', 'ph', 'icu-acquired', 'sepsis', 'and', 'fluid', 'overload', ')', '.', 'none', 'ventilation-associated', 'parameter', 'identify', 'risk', 'factor', 'akil', '.', 'conclusion', 'in', 'first', 'h', ',', 'risk', 'factor', 'associated', 'with', 'primary', 'disease', 'and', 'patient', ""'s"", 'condition', 'admission', '.', 'subsequently', ',', 'emergent', 'event', 'like', 'sepsis', 'and', 'organ', 'dysfunction', 'appear', 'to', 'predictive', 'factor', 'making', 'prevention', 'challenge', '.']"
"Rationale and Design of NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy.","Lenar Yessayan, H David Humes, Emily C Scribe, Sai Prasad N Iyer, Kevin K Chung, Lenar Yessayanet al.",2024,Nephron,https://pubmed.ncbi.nlm.nih.gov/37442112/,No keywords found,"['neutralize-aki', 'pivotal', 'study', 'to', 'evaluate', 'safety', 'and', 'effectiveness', 'of', 'selective', 'cytopheretic', 'device', '(', 'scd', ')', 'in', 'adult', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'requiring', 'continuous', 'kidney', 'replacement', 'therapy', '(', 'ckrt', ')', '.', 'methodsdesign', 'two-arm', ',', 'randomized', ',', 'open-label', ',', 'controlled', 'multi-center', 'pivotal', 'u', 'study', 'enroll', 'adult', 'patient', '(', 'age', '-', 'year', ')', 'in', 'intensive', 'care', 'unit', 'with', 'acute', 'kidney', 'injury', 'requiring', 'ckrt', 'and', 'least', 'one', 'additional', 'organ', 'failure', 'across', 'clinical', 'center', '.', 'eligible', 'patient', 'randomized', 'to', 'ckrt', 'plus', 'scd', 'therapy', 'versus', 'ckrt', 'alone', '.', 'therapy', 'administered', 'to', 'day', ',', 'with', 'hypothesis', 'ckrt', 'plus', 'scd', 'group', 'demonstrate', 'lower', 'mortality', 'rate', 'or', 'better', 'rate', 'of', 'renal', 'recovery', 'ckrt', 'alone', 'group', 'day', '.', 'primary', 'outcome', 'composite', 'of', 'dialysis', 'dependence', 'or', 'all-cause', 'mortality', 'day', '.', 'conclusion', 'scd', 'cell-directed', 'extracorporeal', 'therapy', 'target', 'and', 'deactivates', 'pro-inflammatory', 'neutrophil', 'and', 'monocyte', ',', 'with', 'evidence', 'of', 'efficacy', 'across', 'variety', 'of', 'critically', 'ill', 'patient', 'population', '.', 'knowledge', 'and', 'experience', 'many', 'of', 'study', 'and', 'aki', 'trial', 'incorporated', 'design', 'of', 'pivotal', 'study', ',', 'with', 'aim', 'to', 'investigate', 'role', 'of', 'effector', 'cell', 'immunomodulation', 'in', 'intervention', 'of', 'aki', '.']"
Impact of previous REnal TRansplantation on the mid-term renal Outcome after CARdiac surgery: the RETROCAR trial.,"Antoine Beurton, Antoine Fajardie, Sebastien Rubin, Pierre Belnou, Clement Aguerreche, Mathieu Pernot, Stefano Mion, Julien Imbault, Alexandre Ouattara, Antoine Beurtonet al.",2023 Feb 13,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/36099910/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'one', 'of', 'common', 'complication', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'renal', 'transplant', 'recipient', '(', 'rtrs', ')', 'higher', 'risk', 'of', 'cardiac', 'surgery-associated', 'aki', '(', 'csa-aki', ')', '.', 'relationship', 'strongly', 'suggested', 'aki', 'and', 'poor', 'long-term', 'graft', 'survival', '.', 'main', 'objective', 'to', 'evaluate', 'impact', 'of', 'on-pump', 'cardiac', 'surgery', '-year', 'renal', 'allograft', 'survival', 'rate', '.', 'method', 'study', 'population', 'consisted', 'of', 'rtrs', 'and', 'non-rtrs', 'underwent', 'cardiac', 'surgery', 'january', 'and', 'december', '.', 'matched', 'according', 'to', 'age', ',', 'sex', ',', 'preoperative', 'glomerular', 'function', ',', 'diabetes', 'and', 'type', 'of', 'surgery', '.', 'primary', 'composite', 'outcome', 'renal', 'survival', ',', 'defined', 'patient', 'survival', 'without', 'requirement', 'permanent', 'dialysis', 'or', 'new', 'kidney', 'transplantation', 'year', 'surgery', '.', 'result', 'renal', 'survival', 'rate', 'significantly', 'lower', 'in', 'rtr', 'group', 'in', 'non-rtr', 'group', 'versus', 'odds', 'ratio', '.', '(', 'confidence', 'interval', '.-', '.', ')', ',', 'p', '..', 'proportion', 'of', 'patient', 'returned', 'to', 'permanent', 'dialysis', 'higher', 'in', 'rtr', 'group', 'in', 'non-rtr', 'group', '(', 'versus', 'p', '.', ')', '.', 'proportion', 'of', 'patient', 'with', 'severe', 'aki', 'also', 'higher', 'in', 'rtr', 'group', '.', 'year', 'surgery', ',', 'serum', 'creatinine', 'level', ',', 'glomerular', 'filtration', 'rate', 'and', 'all-cause', 'mortality', 'rate', 'comparable', 'group', '.', 'conclusion', 'patient', 'with', 'functional', 'renal', 'allograft', 'low', '-year', 'renal', 'allograft', 'survival', 'rate', 'cardiac', 'surgery', 'with', 'cpb', '.', 'in', 'addition', ',', 'patient', 'significant', 'risk', 'of', 'aki', 'and', 'acute', 'kidney', 'disease', 'open-heart', 'surgery', '.']"
Prospective model for predicting renal recovery in cardiac surgery patients with acute kidney injury requiring renal replacement therapy.,"Penghua Hu, Li Song, Huaban Liang, Yuanhan Chen, Yanhua Wu, Li Zhang, Zhilian Li, Lei Fu, Yiming Tao, Shuangxin Liu, Zhiming Ye, Xia Fu, Xinling Liang, Penghua Huet al.",2021 Jul,Nephrology (Carlton),https://pubmed.ncbi.nlm.nih.gov/33742730/,No keywords found,"['to', 'develop', 'model', 'predicting', 'renal', 'recovery', 'in', 'cardiac', 'surgery', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'method', 'data', 'prospective', 'randomized', 'controlled', 'trial', ',', 'conducted', 'in', 'tertiary', 'hospital', 'to', 'compare', 'survival', 'effect', 'of', 'two', 'dosage', 'of', 'hemofiltration', 'continuous', 'rrt', 'in', 'cardiac', 'surgery', 'patient', 'march', 'and', 'august', ',', 'used', 'to', 'develop', 'model', '.', 'outcome', 'renal', 'recovery', 'defined', 'alive', 'and', 'dialysis-free', 'day', 'rrt', 'initiation', '.', 'multivariate', 'logistic', 'regression', 'with', 'stepwise', 'backward', 'selection', 'of', 'variable', 'based', 'akaike', 'information', 'criterion', 'applied', 'to', 'develop', 'model', ',', 'internally', 'validated', 'using', 'bootstrapping', '.', 'model', 'discrimination', ',', 'calibration', 'and', 'clinical', 'value', 'assessed', 'using', 'concordance', 'index', '(', 'c-index', ')', ',', 'calibration', 'plot', 'and', 'decision', 'curve', 'analysis', ',', 'respectively', '.', 'result', 'totally', ',', 'patient', 'with', 'aki', 'requiring', 'rrt', '(', '.', 'male', ')', 'with', 'median', 'age', 'of', 'year', 'included', '.', 'incidence', 'of', 'renal', 'recovery', '.', '(', 'n', ')', '.', 'model', 'included', 'six', 'variable', 'body', 'mass', 'index', 'stratification', ',', 'baseline', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'hypertension', ',', 'sepsis', ',', 'mean', 'arterial', 'pressure', 'and', 'mechanical', 'ventilation', '.', 'c-index', 'model', '.', '(', 'ci', ',', '.-.', ')', '.', 'correction', 'bootstrap', ',', 'c-index', '.', '(', 'ci', ',', '.-.', ')', '.', 'calibration', 'plot', 'indicated', 'good', 'consistency', 'actual', 'observation', 'and', 'model', 'prediction', 'of', 'renal', 'recovery', '.', 'decision', 'curve', 'analysis', 'demonstrated', 'model', 'clinical', 'usefulness', '.', 'conclusion', 'developed', 'and', 'validated', 'model', 'to', 'predict', 'chance', 'of', 'renal', 'recovery', 'in', 'cardiac', 'surgery', 'patient', 'with', 'aki', 'requiring', 'rrt', '.']"
Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy.,"Su-Young Jung, Hyunwook Kim, Seohyun Park, Jong Hyun Jhee, Hae-Ryong Yun, Hyoungnae Kim, Youn Kyung Kee, Chang-Yun Yoon, Hyung Jung Oh, Tae Ik Chang, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang, Hajeong Lee, Dong Ki Kim, Seung Hyeok Han, Su-Young Junget al.",2016 Sep,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/27603344/,No keywords found,"['electrolyte', 'and', 'mineral', 'disturbance', 'remain', 'major', 'concern', 'in', 'patient', 'undergoing', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'however', ',', 'not', 'clear', 'whether', 'imbalance', 'associated', 'with', 'adverse', 'outcome', 'in', 'patient', 'with', 'septic', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'undergoing', 'crrt', '.', 'conducted', 'post-hoc', 'analysis', 'of', 'data', 'prospective', 'randomized', 'controlled', 'trial', '.', 'total', 'of', 'patient', 'with', 'mean', 'age', 'of', '.', 'year', '(', '.', 'male', ')', 'in', 'hospital', 'enrolled', '.', 'level', 'of', 'sodium', ',', 'potassium', ',', 'calcium', ',', 'and', 'phosphate', 'measured', '(', 'hour', ')', 'and', 'hour', 'crrt', 'initiation', '.', 'starting', 'crrt', ',', 'least', 'deficiency', 'and', 'excess', 'in', 'electrolyte', 'or', 'mineral', 'observed', 'in', '(', '.', ')', 'and', '(', '.', ')', 'patient', ',', 'respectively', '.', 'excess', 'in', 'parameter', 'greatly', 'improved', ',', 'whereas', 'hypokalemia', 'and', 'hypophosphatemia', 'became', 'prevalent', 'hour', 'crrt', '.', 'however', ',', 'and', 'or', 'deficiency', 'in', 'parameter', 'time', 'point', 'not', 'associated', 'with', 'mortality', '.', 'however', ',', 'day', ',', '(', '.', ')', 'death', 'occurred', 'in', 'patient', 'with', 'phosphate', 'level', 'hour', 'of', '.', 'mgdl', 'compared', 'with', '(', '.', ')', 'in', 'patient', 'with', 'phosphate', 'level', '.', 'mgdl', '.', '-day', 'mortality', 'also', 'significantly', 'higher', 'in', 'patient', 'with', 'hyperphosphatemia', '.', 'similarly', ',', 'in', 'patient', 'survived', 'hour', 'crrt', ',', 'hyperphosphatemia', 'conferred', '.-fold', 'and', '.-fold', 'increased', 'risk', 'of', '-', 'and', '-day', 'mortality', ',', 'respectively', '.', 'result', 'remained', 'unaltered', 'serum', 'phosphate', 'level', 'analyzed', 'continuous', 'variable', '.', 'electrolyte', 'and', 'mineral', 'disturbance', 'common', ',', 'and', 'hyperphosphatemia', 'may', 'predict', 'poor', 'prognosis', 'in', 'septic', 'aki', 'patient', 'undergoing', 'crrt', '.']"
Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures.,"Judith Kooiman, Jean-Paul P M de Vries, Jan Van der Heyden, Yvo W J Sijpkens, Paul R M van Dijkman, Jan J Wever, Hans van Overhagen, Antonie C Vahl, Nico Aarts, Iris J A M Verberk-Jonkers, Harald F H Brulez, Jaap F Hamming, Aart J van der Molen, Suzanne C Cannegieter, Hein Putter, Wilbert B van den Hout, Inci Kilicsoy, Ton J Rabelink, Menno V Huisman, Judith Kooimanet al.",2018 Feb 8,PLoS One,https://pubmed.ncbi.nlm.nih.gov/29420536/,No keywords found,"['guideline', 'advise', 'periprocedural', 'saline', 'hydration', 'prevention', 'of', 'contrast', 'induced-acute', 'kidney', 'injury', '(', 'ci-aki', ')', '.', 'analysed', 'whether', '-hour', 'sodium', 'bicarbonate', 'hydration', 'administered', 'solely', 'prior', 'to', 'intra-arterial', 'contrast', 'exposure', 'non-inferior', 'to', 'standard', 'periprocedural', 'saline', 'hydration', 'in', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'patient', 'undergoing', 'elective', 'cardiovascular', 'diagnostic', 'or', 'interventional', 'contrast', 'procedure', '.', 'method', 'performed', 'open-label', 'multicentre', 'non-inferiority', 'trial', '-', '.', 'patient', 'randomized', 'to', 'hour', 'pre-procedure', 'sodium', 'bicarbonate', 'hydration', '(', 'ml', '.', ',', 'n', ')', 'or', '-', 'hour', 'saline', 'hydration', '(', 'ml', '.', ',', 'n', ')', 'prior', 'to', 'and', 'following', 'contrast', 'administration', '(', 'ml', 'of', 'saline', 'total', ')', '.', 'primary', 'outcome', 'relative', 'serum', 'creatinine', 'increase', '(', ')', '-', 'hour', 'post', 'contrast', 'exposure', '.', 'secondary', 'outcome', 'incidence', 'of', 'ci-aki', '(', 'serum', 'creatinine', 'increase', 'or', 'moll', ')', ',', 'recovery', 'of', 'renal', 'function', ',', 'need', 'dialysis', ',', 'and', 'hospital', 'cost', 'within', 'two', 'month', 'follow-up', '.', 'result', 'mean', 'relative', 'creatinine', 'increase', '.', '(', 'ci', '.', 'to', '.', ')', 'in', 'bicarbonate', 'and', '.', '(', 'ci', '-', '.', 'to', '.', ')', 'in', 'saline', 'arm', ',', 'mean', 'difference', '.', '(', 'ci', '-', '.', 'to', '.', ',', 'p-non-inferiority', '.', ')', '.', 'ci-aki', 'occurred', 'in', '(', '.', ')', 'patient', 'randomized', 'to', 'sodium', 'bicarbonate', 'and', '(', '.', ')', 'to', 'saline', '(', 'p', '.', ')', '.', 'renal', 'function', 'not', 'fully', 'recover', 'in', '.', 'and', '.', 'of', 'ci-aki', 'patient', ',', 'respectively', '(', 'p', '.', ')', '.', 'no', 'patient', 'required', 'dialysis', '.', 'mean', 'cost', 'preventive', 'hydration', 'and', 'clinical', 'preparation', 'contrast', 'procedure', 'sodium', 'bicarbonate', 'vs.', 'saline', '(', 'p', '.', ')', '.', 'conclusion', 'short', 'hydration', 'with', 'sodium', 'bicarbonate', 'prior', 'to', 'elective', 'cardiovascular', 'diagnostic', 'or', 'therapeutic', 'contrast', 'procedure', 'non-inferior', 'to', 'standard', 'periprocedural', 'saline', 'hydration', 'in', 'ckd', 'patient', 'with', 'respect', 'to', 'renal', 'safety', 'and', 'result', 'in', 'considerable', 'healthcare', 'saving', '.', 'trial', 'registration', 'netherlands', 'trial', 'register', '(', 'httpwww.trialregister.nltrialregindex.asp', ')', ',', 'nr', 'ntr', '.']"
A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.,"Anneza Panagiotou, Marten Trendelenburg, Ingmar A F M Heijnen, Stephan Moser, Leo H Bonati, Tobias Breidthardt, Gregor Fahrni, Christoph Kaiser, Raban Jeger, Michael Osthoff, Anneza Panagiotouet al.",2020 Apr 13,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/32171721/,No keywords found,"['study', 'sought', 'to', 'determine', 'efficacy', 'profile', 'and', 'safety', 'of', 'recombinant', 'human', 'c', 'esterase', 'inhibitor', '(', 'rhcinh', ')', 'in', 'prevention', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', 'elective', 'coronary', 'angiography', '.', 'background', 'contrast-associated', 'acute', 'kidney', 'injury', 'caused', 'tubular', 'cytotoxicity', 'and', 'ischemiareperfusion', 'injury', '.', 'rhcinh', 'effective', 'in', 'reducing', 'renal', 'ischemiareperfusion', 'injury', 'in', 'experimental', 'model', '.', 'method', 'in', 'placebo-controlled', ',', 'double-blind', ',', 'single-center', 'trial', 'patient', 'with', 'chronic', 'kidney', 'disease', 'randomized', 'to', 'receive', 'iukg', 'rhcinh', 'and', 'h', 'elective', 'coronary', 'angiography', 'or', 'placebo', '.', 'primary', 'outcome', 'peak', 'change', 'of', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'within', 'h', ',', 'surrogate', 'marker', 'of', 'kidney', 'injury', '.', 'result', 'median', 'peak', 'change', 'of', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'lower', 'in', 'rhcinh', 'group', '(', '.', 'ngml', 'vs.', '.', 'ngml', 'p', '.', ')', 'in', 'per-protocol', 'population', 'not', 'in', 'modified', 'intention-to-treat', 'analysis', ',', 'and', 'in', 'patient', 'with', 'percutaneous', 'coronary', 'intervention', '(', 'median', ',', '.', 'ngml', 'vs.', '.', 'ngml', 'p', '.', 'corresponding', 'to', 'median', 'proportion', 'peak', 'change', 'of', 'vs.', 'p', '.', ')', '.', 'incidence', 'of', 'cystatin', 'c', 'increase', 'within', 'h', 'lower', 'in', 'rhcinh', 'group', '(', 'vs.', 'p', '.', ')', ',', 'whereas', 'frequency', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', 'comparable', '.', 'adverse', 'event', '-month', 'follow-up', 'similarly', 'distributed', '.', 'conclusion', 'administration', 'of', 'rhcinh', 'coronary', 'angiography', 'may', 'attenuate', 'renal', 'injury', 'reflected', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'and', 'cystatin', 'c.', 'safety', 'profile', 'of', 'rhcinh', 'favorable', 'in', 'patient', 'population', 'with', 'multiple', 'comorbidities', '.', '(', 'recombinant', 'human', 'c', 'esterase', 'inhibitor', 'in', 'prevention', 'of', 'contrast-induced', 'nephropathy', 'in', 'high-risk', 'subject', 'protect', 'nct', ')', '.']"
Acute kidney injury after in-hospital cardiac arrest.,"Kenneth E Mah, Jeffrey A Alten, Timothy T Cornell, David T Selewski, David Askenazi, Julie C Fitzgerald, Alexis Topjian, Kent Page, Richard Holubkov, Beth S Slomine, James R Christensen, J Michael Dean, Frank W Moler, Kenneth E Mahet al.",2021 Mar:160:49-58.,Resuscitation,https://pubmed.ncbi.nlm.nih.gov/33450335/,No keywords found,"['determine', ')', 'frequency', 'and', 'risk', 'factor', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in-hospital', 'cardiac', 'arrest', '(', 'ihca', ')', 'in', 'therapeutic', 'hypothermia', 'pediatric', 'cardiac', 'arrest', 'in-hospital', '(', 'thapca-ih', ')', 'trial', 'and', 'associated', 'outcome', ')', 'impact', 'of', 'temperature', 'management', 'post-ihca', 'aki', '.', 'method', 'secondary', 'analysis', 'of', 'thapca-ih', 'randomized', 'controlled', 'multi-national', 'trial', 'child', ""'s"", 'hospital', '.', 'eligibility', 'serum', 'creatinine', '(', 'cr', ')', 'within', 'h', 'of', 'randomization', '.', 'outcome', 'prevalence', 'of', 'severe', 'aki', 'defined', 'stage', 'or', 'kidney', 'disease', 'improving', 'global', 'outcome', 'cr', 'criterion', '.', '-month', 'survival', 'with', 'favorable', 'neurobehavioral', 'outcome', '.', 'analysis', 'stratified', 'entire', 'cohort', 'and', 'cardiac', 'subgroup', '.', 'risk', 'factor', 'and', 'outcome', 'compared', 'among', 'cohort', 'with', 'and', 'without', 'severe', 'aki', '.', 'result', 'subject', 'randomization', 'to', 'hypothermia', ',', 'to', 'normothermia', '.', 'overall', ',', '(', ')', 'developed', 'aki', '(', 'stage', ')', ',', 'and', '(', ')', 'developed', 'severe', 'aki', '.', 'cardiac', 'patient', '(', ',', ')', 'likely', 'to', 'develop', 'severe', 'aki', '(', 'v', ',', 'p', '.', ')', '.', 'preexisting', 'cardiac', 'or', 'renal', 'condition', ',', 'baseline', 'lactate', ',', 'vasoactive', 'support', ',', 'and', 'systolic', 'blood', 'pressure', 'associated', 'with', 'severe', 'aki', '.', 'comparing', 'hypothermia', 'versus', 'normothermia', ',', 'no', 'difference', 'in', 'severe', 'aki', 'rate', '(', 'v', ',', 'p', '.', ')', ',', 'peak', 'cr', ',', 'time', 'to', 'peak', 'cr', ',', 'or', 'freedom', 'mortality', 'or', 'severe', 'aki', '(', 'p', '.', ')', '.', 'severe', 'aki', 'associated', 'with', 'decreased', 'hospital', 'survival', '(', 'v', ',', 'p', '.', ')', 'and', 'decreased', '-month', 'survival', 'with', 'favorable', 'neurobehavioral', 'outcome', '(', 'v', ',', 'p', '.', ')', '.', 'conclusion', 'severe', 'post-ihca', 'aki', 'occurred', 'frequently', 'especially', 'in', 'with', 'preexisting', 'cardiac', 'or', 'renal', 'condition', 'and', 'peri-arrest', 'hemodynamic', 'instability', '.', 'severe', 'aki', 'associated', 'with', 'decreased', 'survival', 'with', 'favorable', 'neurobehavioral', 'outcome', '.', 'hypothermia', 'not', 'decrease', 'incidence', 'of', 'severe', 'aki', 'post-ihca', '.']"
Association between mineral and bone disorder in patients with acute kidney injury following cardiac surgery and adverse outcomes.,"Tianye Yang, Wenji Wang, Xiao Tang, Peng Shi, Lulu Zhang, Wenyan Yu, Yingxin Xie, Daqiao Guo, Feng Ding, Tianye Yanget al.",2019 Oct 15,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/31615432/,No keywords found,"['numerous', 'study', 'evaluated', 'prevalence', 'and', 'importance', 'of', 'mineral', 'and', 'bone', 'disorder', 'among', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'and', 'end-stage', 'renal', 'disease', '(', 'esrd', ')', '.', 'however', ',', 'little', 'known', 'dysregulated', 'mineral', 'and', 'bone', 'metabolism', 'in', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'method', 'evaluated', 'association', 'mineral', 'and', 'bone', 'metabolite', 'and', 'clinical', 'outcome', 'in', 'patient', 'underwent', 'cardiac', 'surgery', 'and', 'developed', 'aki', 'june', 'and', 'january', '.', 'baseline', 'characteristic', 'of', 'patient', 'recorded', ',', 'and', 'level', 'of', 'mineral', 'and', 'bone', 'metabolite', ',', 'including', 'calcium', ',', 'phosphate', ',', 'intact', 'parathyroid', 'hormone', '(', 'ipth', ')', ',', '-hydroxyvitamin', '(', ')', ',', 'bone-specific', 'alkaline', 'phosphatase', '(', 'bap', ')', ',', 'tartrate-resistant', 'acid', 'phosphatase', 'b', '(', 'tracp-b', ')', 'and', 'c-terminal', 'fibroblast', 'growth', 'factor', '(', 'cfgf', ')', 'measured', 'within', 'h', 'establishing', 'clinical', 'diagnosis', '.', 'result', 'serum', 'phosphate', ',', 'ipth', 'and', 'cfgf', 'level', 'significantly', 'associated', 'with', '-day', 'mortality', '(', 'phosphate', 'hazard', 'ratio', 'hr', '.', ',', 'ci', '.', 'to', '.', ',', 'p', '.', 'ipth', 'hr', '.', ',', 'ci', '.', 'to', '.', ',', 'p', '.', 'cfgf', 'hr', '.', ',', 'ci', '.', 'to', '.', ',', 'p', '.', ')', '.', 'moreover', ',', 'higher', 'serum', 'cfgf', 'and', 'bap', 'level', 'independently', 'associated', 'with', 'increased', 'risk', 'of', 'adverse', 'outcome', '.', 'additionally', ',', 'found', 'serum', 'cfgf', 'level', 'rose', 'significantly', 'and', 'associated', 'with', 'severity', 'of', 'aki', '(', 'p', '.', ')', '.', 'conclusion', 'mineral', 'and', 'bone', 'metabolite', 'dysregulated', 'and', 'associated', 'with', 'adverse', 'clinical', 'outcome', 'among', 'patient', 'with', 'aki', '.', 'trial', 'registration', 'www.clinicaltrials.gov', 'nct', '.', 'registered', 'august', '.']"
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.,"Cristina Quintavalle, Chiara Viviani Anselmi, Francesca De Micco, Giuseppina Roscigno, Gabriella Visconti, Bruno Golia, Amelia Focaccio, Bruno Ricciardelli, Enzo Perna, Laura Papa, Elvira Donnarumma, Gerolama Condorelli, Carlo Briguori, Cristina Quintavalleet al.",2015 Sep,Circ Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/26333343/,No keywords found,"['neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'early', 'marker', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'method', 'and', 'result', 'urine', 'ngal', 'and', 'serum', 'ngal', '(', 'sngal', ')', 'assessed', ',', ',', ',', 'and', 'hour', 'contrast', 'medium', '(', 'cm', ')', 'exposure', 'in', 'high-risk', 'patient', '(', 'development', 'set', ')', '.', 'optimal', 'threshold', 'in', 'predicting', 'contrast-induced', 'aki', '(', 'serum', 'creatinine', 'scr', 'increase', '.', 'mgdl', 'hour', 'cm', 'administration', ')', 'identified', '.', 'major', 'adverse', 'event', '(', 'mae', 'death', ',', 'dialysis', ',', 'nonfatal', 'myocardial', 'infarction', ',', 'sustained', 'kidney', 'injury', ',', 'and', 'myocardial', 'revascularization', ')', 'year', 'assessed', '.', 'in', 'development', 'set', ',', 'optimal', 'threshold', 'contrast-induced', 'aki', 'occurred', 'hour', 'urine', 'ngal', '(', 'ngml', 'negative', 'predictive', 'value', 'and', 'positive', 'predictive', 'value', ')', 'and', 'sngal', '(', 'ngml', 'negative', 'predictive', 'value', 'and', 'positive', 'predictive', 'value', ')', '.', 'furthermore', ',', 'sngal', 'ngml', 'hour', 'independent', 'predictor', 'of', '-year', 'mae', '.', '-year', 'mae', 'occurred', 'in', 'patient', '(', '.', ')', 'with', 'sngal', 'ngml', 'and', 'scr', '.', 'mgdl', ',', 'in', '(', '.', ')', 'patient', 'with', 'sngal', 'ngml', ',', 'and', 'in', '(', ')', 'patient', 'with', 'scr', '.', 'mgdl', '.', 'in', 'additional', 'patient', '(', 'validation', 'set', ')', ',', 'no', 'patient', 'with', 'urine', 'ngal', 'ngml', 'or', 'sngal', 'ngml', 'hour', 'developed', 'contrast-induced', 'aki', '.', 'furthermore', ',', '(', ')', 'patient', 'with', 'sngal', 'ngml', 'and', 'scr', 'increase', '.', 'mgdl', '-year', 'mae', 'versus', '(', ')', 'patient', 'with', 'sngal', 'ngml', 'and', 'scr', 'increase', '.', 'mgdl', 'and', '(', ')', 'patient', 'with', 'scr', 'increase', '.', 'mgdl', '.', 'conclusion', 'urine', 'ngal', 'ngml', 'and', 'sngal', 'ngml', 'hour', 'reliable', 'marker', 'ruling', 'contrast-induced', 'aki', '.', 'sngal', 'ngml', 'hour', 'predicts', '-year', 'mae', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Relative contributions of anaemia and hypotension to myocardial infarction and renal injury: Post hoc analysis of the POISE-2 trial.,"Alparslan Turan, Eva Rivas, P J Devereaux, Xuan Pu, Fabio A Rodriguez-Patarroyo, Esra Kutlu Yalcin, Rod Nault, Kamal Maheshwari, Kurt Ruetzler, Daniel I Sessler, Alparslan Turanet al.",2023 May 1,Eur J Anaesthesiol,https://pubmed.ncbi.nlm.nih.gov/36891761/,No keywords found,"['hypotension', 'and', 'postoperative', 'anaemia', 'associated', 'with', 'myocardial', 'and', 'renal', 'injury', 'noncardiac', 'surgery', ',', 'interaction', 'remains', 'unknown', '.', 'objective', 'to', 'test', 'hypothesis', 'double-hit', 'of', 'postoperative', 'anaemia', 'and', 'hypotension', 'synergistically', 'worsens', '-day', 'composite', 'of', 'myocardial', 'infarction', '(', 'mi', ')', 'and', 'mortality', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'characterising', 'interaction', 'hypotension', 'and', 'anaemia', 'occur', 'time', 'myocardial', 'infarction', 'and', 'acute', 'kidney', 'injury', '.', 'design', 'post', 'hoc', 'analysis', 'of', 'poise-', 'trial', '.', 'setting', 'patient', 'enrolled', 'july', 'and', 'december', 'hospital', 'in', 'country', '.', 'patient', 'adult', 'least', 'year', 'old', 'with', 'known', 'or', 'suspected', 'cardiovascular', 'disease', '.', 'excluded', 'patient', 'without', 'available', 'postoperative', 'haemoglobin', 'measurement', 'or', 'hypotension', 'duration', 'record', '.', 'exposure', 'lowest', 'haemoglobin', 'concentration', 'and', 'average', 'daily', 'duration', 'of', 'sbp', 'less', 'mmhg', 'within', 'first', 'four', 'postoperative', 'day', '.', 'main', 'outcome', 'measure', 'primary', 'outcome', 'collapsed', 'composite', 'of', 'nonfatal', 'mi', 'and', 'all-cause', 'mortality', 'initial', 'postoperative', 'day', 'secondary', 'outcome', 'aki', '.', 'result', 'included', 'patient', '.', 'mean', 'sd', 'lowest', 'postoperative', 'haemoglobin', 'g', 'dl', '-', ',', 'and', 'of', 'patient', 'sbp', 'less', 'mmhg', 'with', 'daily', 'duration', 'ranging', 'to', 'h.', 'four', 'hundred', 'and', 'nine', '(', '.', ')', 'patient', 'infarction', 'or', 'died', 'within', 'postoperative', 'day', ',', 'and', '(', '.', ')', 'patient', 'developed', 'aki', '.', 'lowest', 'haemoglobin', 'concentration', 'less', 'g', 'dl', '-', ',', 'and', 'duration', 'of', 'sbp', 'less', 'mmhg', 'associated', 'with', 'greater', 'hazard', 'of', 'composite', 'outcome', 'of', 'nonfatal', 'mi', 'and', 'all-cause', 'mortality', ',', 'well', 'with', 'aki', '.', 'however', ',', 'not', 'find', 'significant', 'multiplicative', 'interaction', 'haemoglobin', 'spline', 'and', 'hypotension', 'duration', 'primary', 'composite', 'or', 'aki', '.', 'conclusion', 'postoperative', 'anaemia', 'and', 'hypotension', 'meaningfully', 'associated', 'with', 'primary', 'composite', 'and', 'aki', '.', 'however', ',', 'lack', 'of', 'significant', 'interaction', 'suggests', 'effect', 'of', 'hypotension', 'and', 'anaemia', 'additive', 'rather', 'multiplicative', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.']"
Effect of dexmedetomidine on the incidence of postoperative acute kidney injury in living donor liver transplantation recipients: a randomized controlled trial.,"Hye-Mee Kwon, Sa-Jin Kang, Sang-Bin Han, Jae Hwan Kim, Sung-Hoon Kim, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang, Hye-Mee Kwonet al.",2024 Jul 1,Int J Surg,https://pubmed.ncbi.nlm.nih.gov/38537086/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'one', 'of', 'common', 'complication', 'living-donor', 'liver', 'transplantation', '(', 'ldlt', ')', 'great', 'impact', 'recipient', 'and', 'graft', 'outcome', '.', 'dexmedetomidine', 'reported', 'to', 'decrease', 'incidence', 'of', 'aki', '.', 'in', 'current', 'study', ',', 'author', 'investigated', 'whether', 'intraoperative', 'dexmedetomidine', 'infusion', 'would', 'reduce', 'aki', 'following', 'ldlt', '.', 'material', 'and', 'method', 'in', 'total', ',', 'adult', 'patient', 'undergoing', 'elective', 'ldlt', 'randomly', 'assigned', 'to', 'dexmedetomidine', 'group', '(', 'n', ')', 'or', 'control', 'group', '(', 'n', ')', '.', 'dexmedetomidine', 'group', 'received', 'continuous', 'dexmedetomidine', 'infusion', 'rate', 'of', '.', 'mcgkgh', 'anesthesia', 'induction', 'h', 'graft', 'reperfusion', '.', 'primary', 'outcome', 'to', 'compare', 'incidence', 'of', 'aki', '.', 'secondary', 'outcome', 'included', 'serial', 'lactate', 'level', 'surgery', ',', 'chronic', 'kidney', 'disease', ',', 'major', 'adverse', 'cardiovascular', 'event', ',', 'early', 'allograft', 'dysfunction', ',', 'graft', 'failure', ',', 'overall', 'mortality', ',', 'duration', 'of', 'mechanical', 'ventilation', ',', 'intensive', 'care', 'unit', ',', 'and', 'hospital', 'length', 'of', 'stay', '.', 'intraoperative', 'hemodynamic', 'parameter', 'also', 'collected', '.', 'result', 'of', 'recipient', ',', '.', '(', 'n', ')', 'developed', 'aki', '.', 'incidence', 'of', 'aki', 'lower', 'in', 'dexmedetomidine', 'group', '(', '.', ',', 'n', ')', 'compared', 'with', 'control', '(', '.', ',', 'n', ')', '(', 'p', '.', ')', '.', 'significantly', 'lower', 'lactate', 'level', 'in', 'dexmedetomidine', 'group', 'reperfusion', '.', '(', '.-', '.', ')', 'v', '.', '(', '.-', '.', ')', ',', 'p', '.', 'end', 'of', 'surgery', '.', '(', '.-', '.', ')', 'v', '.', '(', '.-', '.', ')', ',', 'p', '..', 'no', 'significant', 'difference', 'in', 'secondary', 'outcome', 'besides', 'lactate', '.', 'also', ',', 'intraoperative', 'mean', 'blood', 'pressure', ',', 'cardiac', 'output', ',', 'and', 'systemic', 'vascular', 'resistance', 'not', 'show', 'difference', '.', 'conclusion', 'study', 'suggests', 'intraoperative', 'dexmedetomidine', 'administration', 'associated', 'with', 'significantly', 'decreased', 'aki', 'incidence', 'and', 'lower', 'intraoperative', 'serum', 'lactate', 'level', 'in', 'ldlt', 'recipient', ',', 'without', 'untoward', 'hemodynamic', 'effect', '.']"
Detection of acute kidney injury in premature asphyxiated neonates by serum neutrophil gelatinase-associated lipocalin (sNGAL)--sensitivity and specificity of a potential new biomarker.,"Biljana Pejović, Jelena Erić-Marinković, Marija Pejović, Jelena Kotur-Stevuljević, Amira Peco-Antić, Biljana Pejovićet al.",2015 Oct 15,Biochem Med (Zagreb),https://pubmed.ncbi.nlm.nih.gov/26525750/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'in', 'neonatal', 'intensive', 'care', 'unit', '(', 'nicu', ')', '.', 'in', 'recent', 'year', ',', 'every', 'effort', 'made', 'early', 'detection', 'of', 'aki', '.', 'hypothesis', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'sngal', ')', 'may', 'reliable', 'screening', 'test', 'early', 'diagnosis', 'of', 'aki', 'in', 'premature', 'neonate', 'perinatal', 'asphyxia', '.', 'therefore', ',', 'aim', 'to', 'assess', 'diagnostic', 'accuracy', 'of', 'sngal', 'aki', 'in', 'premature', 'asphyxiated', 'neonate', '.', 'material', 'and', 'method', 'aki', 'defined', 'in', 'third', 'day', 'of', 'life', '(', 'dol', ')', 'serum', 'creatinine', '(', 'scr', ')', 'increase', '.', 'moll', 'baseline', '(', 'lowest', 'previous', 'scr', ')', '.', 'according', 'to', 'increase', 'of', 'scr', ',', 'aki', 'patient', 'divided', 'in', 'akin', '(', 'scr', 'increase', 'to', '.', 'baseline', ')', 'and', 'akin', '(', 'scr', 'increase', '.', 'to', '.', 'baseline', ')', '.', 'sngal', 'level', 'measured', 'dol', ',', 'and', '.', 'result', 'aki', 'diagnosed', 'in', '(', '.', ')', 'of', 'enrolled', 'premature', 'asphyxiated', 'neonate', '.', 'sixty', 'one', 'patient', '(', '.', ')', 'classified', 'in', 'akin', 'and', 'patient', '(', '.', ')', 'in', 'akin', '.', 'sngal', 'reached', 'maximal', 'concentration', 'dol', 'within', 'hour', 'admission', 'to', 'nicu', ',', 'higher', 'in', 'aki', 'compared', 'with', 'no-aki', 'group', '(', '..', 'vs.', '..', 'p.', ')', 'well', 'in', 'akin', 'compared', 'with', 'akin', 'group', '(', '..', 'vs.', '..', 'p.', ')', '.', 'best', 'area', 'receiver', 'operating', 'characteristic', 'curve', '(', 'auc', ')', 'prediction', 'of', 'aki', '.', '(', '.-', '.', ')', 'p.', 'dol', 'h', 'and', '.', '(', '.-', '.', ')', 'p.', 'th', 'hour', 'admission', 'respectively', '.', 'corresponding', 'sngal', 'cutoff', 'concentration', '.', 'ngml', '(', 'sensitivity', '.', 'and', 'specificity', '.', ')', 'and', '.', 'ngml', '(', 'sensitivity', '.', 'and', 'specificity', '.', ')', '.', 'conclusion', 'in', 'premature', 'asphyxiated', 'neonate', 'sngal', 'measured', 'within', 'first', 'hour', 'of', 'dol', 'predictive', 'of', 'occurrence', 'and', 'severity', 'of', 'aki', '.', 'therefore', ',', 'plasma', 'level', 'of', 'ngal', 'may', 'used', 'early', 'diagnosis', 'of', 'aki', 'in', 'patient', '.']"
Team-Based Coaching Intervention to Improve Contrast-Associated Acute Kidney Injury: A Cluster-Randomized Trial.,"Jeremiah R Brown, Richard Solomon, Meagan E Stabler, Sharon Davis, Elizabeth Carpenter-Song, Lisa Zubkoff, Dax M Westerman, Chad Dorn, Kevin C Cox, Freneka Minter, Hani Jneid, Jesse W Currier, S Ahmed Athar, Saket Girotra, Calvin Leung, Thomas J Helton, Ajay Agarwal, Mladen I Vidovich, Mary E Plomondon, Stephen W Waldo, Kelly A Aschbrenner, A James O'Malley, Michael E Matheny, Jeremiah R Brownet al.",2023 Mar 1,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/36787125/,No keywords found,"['to', 'of', 'patient', 'in', 'united', 'state', 'undergoing', 'cardiac', 'catheterization', 'year', 'experience', 'aki', '.', 'consistent', 'use', 'of', 'risk', 'minimization', 'preventive', 'strategy', 'may', 'improve', 'outcome', '.', 'hypothesized', 'team-based', 'coaching', 'in', 'virtual', 'learning', 'collaborative', '(', 'collaborative', ')', 'would', 'reduce', 'postprocedural', 'aki', 'compared', 'with', 'technical', 'assistance', '(', 'assistance', ')', ',', 'with', 'and', 'without', 'automated', 'surveillance', 'reporting', '(', 'surveillance', ')', '.', 'method', 'improve', 'aki', 'trial', 'factorial', 'cluster-randomized', 'trial', 'across', 'veteran', 'affair', 'medical', 'center', '(', 'vamcs', ')', '.', 'participating', 'vamcs', 'received', 'assistance', ',', 'assistance', 'with', 'surveillance', ',', 'collaborative', ',', 'or', 'collaborative', 'with', 'surveillance', 'month', 'to', 'implement', 'aki', 'prevention', 'strategy', '.', 'assistance', 'and', 'collaborative', 'approach', 'promoted', 'hydration', 'and', 'limited', 'npo', 'and', 'contrast', 'dye', 'dosing', '.', 'fit', 'logistic', 'regression', 'model', 'aki', 'with', 'site-level', 'random', 'effect', 'accounting', 'clustering', 'of', 'patient', 'within', 'medical', 'center', 'with', 'prespecified', 'interest', 'in', 'exploring', 'difference', 'across', 'four', 'intervention', 'arm', '.', 'result', 'among', 'vamcs', ""'"", 'patient', ',', 'experienced', 'aki', '(', 'aki', 'event', 'among', 'patient', 'with', 'preexisting', 'ckd', ')', '.', 'aki', 'event', 'in', 'intervention', 'cluster', '(', ')', 'in', 'assistance', ',', '(', ')', 'in', 'assistance', 'with', 'surveillance', ',', '(', ')', 'in', 'collaborative', ',', 'and', '(', ')', 'in', 'collaborative', 'with', 'surveillance', '.', 'compared', 'with', 'site', 'receiving', 'assistance', 'alone', ',', 'case-mix-adjusted', 'difference', 'in', 'aki', 'event', 'proportion', '-', '(', 'confidence', 'interval', 'ci', ',', '-', 'to', '-', ')', 'assistance', 'with', 'surveillance', ',', '-', '(', 'ci', ',', '-', 'to', '-', ')', 'collaborative', ',', 'and', '-', '(', 'ci', ',', '-', 'to', '-', ')', 'collaborative', 'with', 'surveillance', '.', 'collaborative', 'with', 'surveillance', 'intervention', 'cluster', 'substantial', 'reduction', 'in', 'aki', 'compared', 'with', 'assistance', 'alone', '(', 'adjusted', 'odds', 'ratio', '.', '.-.', ')', '.', 'conclusion', 'implementation', 'trial', 'estimate', 'combination', 'of', 'collaborative', 'with', 'surveillance', 'reduced', 'odds', 'of', 'aki', 'vamcs', 'and', 'suggestive', 'of', 'reduction', 'among', 'patient', 'with', 'ckd', '.', 'clinical', 'trial', 'registry', 'name', 'and', 'registration', 'number', 'improve', 'aki', 'cluster-randomized', 'trial', '(', 'improve-aki', ')', ',', 'nct', '.']"
Off-Pump Versus On-Pump Coronary Artery Bypass Grafting In Patients With Left Main Coronary Artery Disease: A Randomized Controlled Trial.,"Karim Mohamed Mady, Amr Ahmed Abdou Ettish, Wael Mohamed Elfeky, Mohamed Mostafa Abdelaal, Karim Mohamed Madyet al.",2023 Apr,J Pak Med Assoc,https://pubmed.ncbi.nlm.nih.gov/37482823/,No keywords found,"['to', 'compare', 'outcome', 'of', 'off-pump', 'and', 'on-pump', 'coronary', 'artery', 'bypass', 'graftsurgery', 'in', 'patient', 'with', 'left', 'main', 'coronary', 'artery', 'disease', '.', 'method', 'randomised', ',', 'controlled', ',', 'prospective', ',', 'multicentric', 'study', 'conducted', 'in', 'period', 'january', 'to', 'december', 'kafrelsheikh', 'university', 'hospital', ',', 'international', 'cardiac', 'centre', 'and', 'alexandria', 'new', 'medical', 'centre', ',', 'egypt', ',', 'and', 'comprised', 'patient', 'with', 'left', 'main', 'coronary', 'artery', 'disease', 'underwent', 'coronary', 'artery', 'bypass', 'graftsurgery', '.', 'patient', 'randomised', 'to', 'on-pump', 'surgery', 'group', '(', 'control', 'group', ')', 'and', 'off-pump', 'surgery', 'group', 'ii', '(', 'interventional', 'group', ')', '.', 'patient', 'assessed', 'pre-operatively', 'presence', 'of', 'comorbid', 'condition', 'and', 'post-operatively', 'myocardial', 'infarction', ',', 'acute', 'kidney', 'injury', ',', 'pneumonia', ',', 'sternal', 'dehiscence', 'and', '-month', 'mortality', '.', 'data', 'analysed', 'using', 'spss', '.', 'result', 'of', 'patient', ',', '(', '.', ')', 'men', 'and', '(', '.', ')', 'woman', '.', 'overall', 'mean', 'age', '..', 'year', '.', '(', ')', 'patient', 'in', 'of', 'two', 'group', '.', '(', '.', ')', 'case', 'of', 'myocardial', 'infarction', 'in', 'group', 'and', '(', '.', ')', 'in', 'group', 'ii', '.', '(', '.', ')', 'case', 'of', 'acute', 'kidney', 'injury', 'in', 'group', 'and', 'none', 'in', 'group', 'ii', '.', '(', ')', 'case', 'of', 'pneumonia', 'in', 'group', 'compared', 'to', '(', '.', ')', 'in', 'group', 'ii', '.', '(', '.', ')', 'case', 'of', 'sternal', 'dehiscence', 'in', 'group', 'and', 'none', 'in', 'group', 'ii', '.', 'mortality', 'month', '(', '.', ')', 'in', 'group', 'and', '(', '.', ')', 'in', 'group', 'ii', '.', 'no', 'significant', 'difference', 'with', 'respect', 'to', 'outcome', 'group', '(', 'p.', ')', '.', 'conclusion', 'off-pump', 'coronary', 'artery', 'bypass', 'graft', 'surgery', 'found', 'to', 'efficient', 'and', 'non-inferior', 'to', 'on-pump', 'procedure', 'in', 'patient', 'with', 'left', 'main', 'coronary', 'artery', 'disease', '.', 'rct', 'registration', 'rct', 'registered', 'retrospectively', 'pan', 'african', 'clinical', 'trial', 'registry', '(', 'pactr', ')', '(', 'trial', 'pactr', 'date', 'of', 'approval', ')', '.', 'link', 'httpspactr.samrc.ac.zasearch.aspx', '.']"
Perioperative THR-184 and AKI after Cardiac Surgery.,"Jonathan Himmelfarb, Glenn M Chertow, Peter A McCullough, Thierry Mesana, Andrew D Shaw, Thoralf M Sundt, Craig Brown, David Cortville, François Dagenais, Benoit de Varennes, Manuel Fontes, Jerome Rossert, Jean-Claude Tardif, Jonathan Himmelfarbet al.",2018 Feb,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/29203473/,"acute renal failure, bone morphogenetic protein, randomized controlled trials.","['aki', 'cardiac', 'surgery', 'associated', 'with', 'mortality', ',', 'prolonged', 'hospital', 'length', 'of', 'stay', ',', 'use', 'of', 'dialysis', ',', 'and', 'subsequent', 'ckd', '.', 'evaluated', 'effect', 'of', 'thr-', ',', 'bone', 'morphogenetic', 'protein-', 'agonist', ',', 'in', 'patient', 'high', 'risk', 'aki', 'cardiac', 'surgery', '.', 'conducted', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'multidose', 'comparison', 'of', 'safety', 'and', 'efficacy', 'of', 'perioperative', 'thr-', 'using', 'two-stage', 'seamless', 'adaptive', 'design', 'in', 'patient', 'and', 'year', 'of', 'age', 'scheduled', 'nonemergent', 'cardiac', 'surgery', 'requiring', 'cardiopulmonary', 'bypass', 'and', 'recognized', 'risk', 'factor', 'aki', '.', 'primary', 'efficacy', 'end', 'point', 'proportion', 'of', 'patient', 'developed', 'aki', 'according', 'to', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'criterion', '.', 'proportion', 'of', 'patient', 'developed', 'aki', 'within', 'day', 'of', 'surgery', 'similar', 'in', 'thr-', 'treatment', 'group', 'and', 'placebo', 'group', '(', 'range', ',', '-', 'p.', ')', '.', 'prespecified', 'secondary', 'end', 'point', 'analysis', 'not', 'show', 'significant', 'difference', 'in', 'severity', 'of', 'aki', 'stage', '(', 'p.', ')', 'or', 'total', 'duration', 'of', 'aki', '(', 'p.', ')', '.', 'composite', 'of', 'death', ',', 'dialysis', ',', 'or', 'sustained', 'impaired', 'renal', 'function', 'day', 'surgery', 'not', 'differ', 'group', '(', 'range', ',', '-', 'p.', ')', '.', 'safety-related', 'outcome', 'similar', 'across', 'treatment', 'group', '.', 'in', 'conclusion', ',', 'compared', 'with', 'placebo', ',', 'administration', 'of', 'perioperative', 'thr-', 'range', 'of', 'dose', 'exposure', 'failed', 'to', 'reduce', 'incidence', ',', 'severity', ',', 'or', 'duration', 'of', 'aki', 'cardiac', 'surgery', 'in', 'high-risk', 'patient', '.']"
The impact of higher protein dosing on outcomes in critically ill patients with acute kidney injury: a post hoc analysis of the EFFORT protein trial.,"Christian Stoppe#, Jayshil J Patel#, Alex Zarbock, Zheng-Yii Lee, Todd W Rice, Bruno Mafrici, Rebecca Wehner, Man Hung Manuel Chan, Peter Chi Keung Lai, Kristen MacEachern, Pavlos Myrianthefs, Evdoxia Tsigou, Luis Ortiz-Reyes, Xuran Jiang, Andrew G Day, M Shahnaz Hasan, Patrick Meybohm, Lu Ke, Daren K Heyland, Christian Stoppeet al.",2023 Oct 18,Crit Care,https://pubmed.ncbi.nlm.nih.gov/37853490/,No keywords found,"['based', 'low-quality', 'evidence', ',', 'current', 'nutrition', 'guideline', 'recommend', 'delivery', 'of', 'high-dose', 'protein', 'in', 'critically', 'ill', 'patient', '.', 'effort', 'protein', 'trial', 'showed', 'higher', 'protein', 'dose', 'not', 'associated', 'with', 'improved', 'outcome', ',', 'whereas', 'effect', 'in', 'critically', 'ill', 'patient', 'developed', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'need', 'evaluation', '.', 'overall', 'aim', 'to', 'evaluate', 'effect', 'of', 'high-dose', 'protein', 'in', 'critically', 'ill', 'patient', 'developed', 'different', 'stage', 'of', 'aki', '.', 'method', 'in', 'post', 'hoc', 'analysis', 'of', 'effort', 'protein', 'trial', ',', 'investigated', 'effect', 'of', 'high', 'versus', 'usual', 'protein', 'dose', '(', '.', 'vs.', '.', 'gkg', 'body', 'weightday', ')', 'time-to-discharge', 'alive', 'hospital', '(', 'ttda', ')', 'and', '-day', 'mortality', 'and', 'in', 'different', 'subgroup', 'in', 'critically', 'ill', 'patient', 'with', 'aki', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'criterion', 'within', 'day', 'of', 'icu', 'admission', '.', 'association', 'of', 'protein', 'dose', 'with', 'incidence', 'and', 'duration', 'of', 'kidney', 'replacement', 'therapy', '(', 'krt', ')', 'also', 'investigated', '.', 'result', 'of', 'randomized', 'patient', ',', 'developed', 'aki', 'and', 'included', 'in', 'analysis', '(', 'in', 'high', 'and', 'in', 'usual', 'protein', 'dose', 'group', ')', '.', 'high', 'protein', 'associated', 'with', 'slower', 'time-to-discharge', 'alive', 'hospital', '(', 'ttda', ')', '(', 'hazard', 'ratio', '.', ',', 'ci', '.-', '.', ')', 'and', 'higher', '-day', 'mortality', '(', 'relative', 'risk', '.', '(', 'ci', '.-.', ')', '.', 'effect', 'modification', 'not', 'statistically', 'significant', 'subgroup', ',', 'and', 'no', 'subgroup', 'suggested', 'beneficial', 'effect', 'of', 'higher', 'protein', ',', 'although', 'harmful', 'effect', 'of', 'higher', 'protein', 'target', 'appeared', 'to', 'disappear', 'in', 'patient', 'received', 'kidney', 'replacement', 'therapy', '(', 'krt', ')', '.', 'protein', 'dose', 'not', 'significantly', 'associated', 'with', 'incidence', 'of', 'aki', 'and', 'krt', 'or', 'duration', 'of', 'krt', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'aki', ',', 'high', 'protein', 'may', 'associated', 'with', 'worse', 'outcome', 'in', 'aki', 'stage', '.', 'recommendation', 'of', 'higher', 'protein', 'dosing', 'in', 'aki', 'patient', 'carefully', 're-evaluated', 'to', 'avoid', 'potential', 'harmful', 'effect', 'especially', 'in', 'patient', 'not', 'treated', 'with', 'krt', '.', 'trial', 'registration', 'study', 'registered', 'clinicaltrials.gov', '(', 'nct', ')', 'may', 'th', '.']"
Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography.,"Steven D Weisbord, Paul M Palevsky, James S Kaufman, Hongsheng Wu, Maria Androsenko, Ryan E Ferguson, Chirag R Parikh, Deepak L Bhatt, Martin Gallagher                              ;, PRESERVE Trial Investigators, Steven D Weisbordet al.",2020 Mar 24,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/32192658/,No keywords found,"['contrast-associated', 'acute', 'kidney', 'injury', '(', 'ca-aki', ')', 'associate', 'with', 'increased', 'relative', 'risk', 'serious', 'adverse', 'outcome', '.', 'however', ',', 'magnitude', 'of', 'risk', 'and', 'incidence', 'of', 'clinically', 'significant', 'ca-aki', 'derived', 'analysis', 'of', 'large', 'cohort', 'with', 'prospective', 'assessment', 'of', 'ca-aki', 'and', 'subsequent', 'outcome', 'unknown', '.', 'objective', 'study', 'sought', 'to', 'characterize', 'relative', 'risk', 'and', 'incidence', 'of', 'serious', 'adverse', 'outcome', 'following', 'development', 'of', 'ca-aki', 'and', 'to', 'explore', 'whether', 'ca-aki', 'mediates', 'association', 'of', 'pre-angiography', 'estimated', 'glomerular', 'filtration', 'rate', 'with', 'adverse', 'outcome', '.', 'method', 'among', ',', 'participant', 'in', 'preserve', '(', 'prevention', 'of', 'serious', 'adverse', 'outcome', 'following', 'angiography', ')', 'trial', 'with', 'comprehensive', 'baseline', 'and', 'outcome', 'data', ',', 'assessed', 'whether', 'ca-aki', 'associated', 'with', '-day', 'outcome', 'comprising', 'death', ',', 'need', 'dialysis', ',', 'or', 'persistent', 'impairment', 'in', 'kidney', 'function', '.', 'calculated', 'incidence', 'of', 'clinically', 'significant', 'ca-aki', '(', 'i.e.', ',', 'proportion', 'of', 'patient', 'developed', 'ca-aki', 'and', '-day', 'outcome', ')', 'and', 'examined', 'whether', 'ca-aki', 'mediator', 'of', 'association', 'of', 'baseline', 'kidney', 'function', 'with', '-day', 'outcome', '.', 'result', 'ca-aki', 'associated', 'with', 'increased', 'relative', 'risk', '-day', 'death', ',', 'need', 'dialysis', ',', 'or', 'persistent', 'kidney', 'impairment', '(', 'odds', 'ratio', '.', 'confidence', 'interval', '.', 'to', '.', 'p', '.', ')', '.', 'incidence', 'of', 'clinically', 'significant', 'ca-aki', '.', '(', 'of', ',', 'patient', ')', '.', 'ca-aki', 'not', 'mediator', 'of', 'association', 'of', 'pre-angiography', 'estimated', 'glomerular', 'filtration', 'rate', 'with', 'primary', 'outcome', '.', 'conclusion', 'whereas', 'ca-aki', 'associated', 'with', 'increased', 'relative', 'risk', 'of', 'serious', ',', 'adverse', '-day', 'outcome', ',', 'incidence', 'of', 'clinically', 'significant', 'ca-aki', 'low', '.', 'ca-aki', 'not', 'mediate', 'association', 'of', 'pre-angiography', 'estimated', 'glomerular', 'filtration', 'rate', 'with', 'outcome', '.']"
"Preoperative Short-Term Calorie Restriction for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Open-Label, Pilot Trial.","Franziska Grundmann, Roman-Ulrich Müller, Annika Reppenhorst, Lennart Hülswitt, Martin R Späth, Torsten Kubacki, Maximilian Scherner, Michael Faust, Ingrid Becker, Thorsten Wahlers, Bernhard Schermer, Thomas Benzing, Volker Burst, Franziska Grundmannet al.",2018 Mar 13,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/29535139/,No keywords found,"['acute', 'kidney', 'injury', 'frequent', 'complication', 'cardiac', 'surgery', 'and', 'associated', 'with', 'adverse', 'outcome', '.', 'although', 'short-term', 'calorie', 'restriction', '(', 'cr', ')', 'proven', 'protective', 'in', 'rodent', 'model', 'of', 'acute', 'kidney', 'injury', ',', 'similar', 'effect', 'not', 'yet', 'demonstrated', 'in', 'human', '.', 'method', 'and', 'result', 'crkch', '(', 'effect', 'of', 'preoperative', 'calorie', 'restriction', 'renal', 'function', 'cardiac', 'surgery', ')', 'randomized', 'controlled', 'trial', 'in', 'patient', 'scheduled', 'cardiac', 'surgery', '.', 'patient', 'randomly', 'assigned', 'to', 'receive', 'either', 'formula', 'diet', 'containing', 'of', 'daily', 'energy', 'requirement', '(', 'cr', 'group', ')', 'or', 'ad', 'libitum', 'food', '(', 'control', 'group', ')', 'day', 'surgery', '.', 'in', 'total', ',', 'patient', 'enrolled', 'april', ',', ',', 'and', 'february', ',', '.', 'no', 'between-group', 'difference', 'in', 'primary', 'end', 'point', 'of', 'median', 'serum', 'creatinine', 'increment', 'hour', '(', 'control', 'group', '.', 'mgdl', '-', '.', '-', '(', '.', ')', 'mgdl', 'cr', 'group', '.', 'mgdl', '-', '.', '-', '(', '.', ')', 'mgdl', 'p.', ')', '.', 'cr', 'prevented', 'rise', 'in', 'median', 'creatinine', 'hour', '(', 'control', 'group', '.', 'mgdl', '.', '-', '.', 'mgdl', 'cr', 'group', '-', '.', 'mgdl', '-', '.', '-', '(', '.', ')', 'mgdl', 'p.', ')', ',', 'with', 'pronounced', 'effect', 'observed', 'in', 'male', 'patient', 'and', 'patient', 'with', 'body', 'mass', 'index', '.', 'benefit', 'persisted', 'discharge', 'median', 'creatinine', 'decreased', '.', 'mgdl', '(', '-', '.', '-', '.', 'mgdl', ')', 'in', 'cr', 'group', ',', 'whereas', 'increased', '.', 'mgdl', '(', '.', '-', '.', 'mgdl', 'p.', ')', 'in', 'control', 'group', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', 'reduced', '.', '(', '.', 'in', 'cr', 'group', 'compared', 'with', '.', 'in', 'control', 'group', ')', '.', 'safety-related', 'event', 'not', 'differ', 'group', '.', 'conclusion', 'despite', 'disappointing', 'result', 'with', 'respect', 'to', 'creatinine', 'rise', 'within', 'first', 'hour', ',', 'benefit', 'observed', 'later', 'time', 'point', 'and', 'subgroup', 'analysis', 'suggest', 'protective', 'potential', 'of', 'short-term', 'cr', 'in', 'patient', 'risk', 'acute', 'kidney', 'injury', ',', 'warranting', 'investigation', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.,"Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Markus Peck-Radosavljevic, Anne McCune, Victor Vargas, Macarena Simon-Talero, Juan Cordoba, Paolo Angeli, Silvia Rosi, Stewart MacDonald, Massimo Malago, Maria Stepanova, Zobair M Younossi, Claudia Trepte, Randall Watson, Oleg Borisenko, Sun Sun, Neil Inhaber, Rajiv Jalan, Christophe Bureauet al.",2017 Nov,J Hepatol,https://pubmed.ncbi.nlm.nih.gov/28645737/,No keywords found,"['patient', 'with', 'refractory', 'ascites', '(', 'ra', ')', 'require', 'repeated', 'large', 'volume', 'paracenteses', '(', 'lvp', ')', ',', 'involves', 'frequent', 'hospital', 'visit', 'and', 'associated', 'with', 'poor', 'quality-of-life', '.', 'study', 'assessed', 'safety', 'and', 'efficacy', 'of', 'automated', ',', 'low-flow', 'pump', '(', 'alfapump', 'ap', ')', 'compared', 'with', 'lvp', 'standard', 'of', 'care', 'soc', '.', 'method', 'randomized', 'controlled', 'trial', ',', 'in', 'seven', 'center', ',', 'with', 'six', 'month', 'patient', 'observation', 'conducted', '.', 'primary', 'outcome', 'time', 'to', 'first', 'lvp', '.', 'secondary', 'outcome', 'included', 'paracentesis', 'requirement', ',', 'safety', ',', 'health-related', 'quality-of-life', '(', 'hrqol', ')', ',', 'and', 'survival', '.', 'nutrition', ',', 'hemodynamics', ',', 'and', 'renal', 'injury', 'biomarkers', 'assessed', 'in', 'sub-study', 'three', 'month', '.', 'result', 'sixty', 'patient', 'randomized', 'and', 'analyzed', '(', 'ap', ',', 'soc', ',', 'mean', 'age', '.years', ',', 'mean', 'meld', '.', ')', '.', 'eighteen', 'patient', 'included', 'in', 'sub-study', '.', 'compared', 'with', 'soc', ',', 'median', 'time', 'to', 'first', 'lvp', 'not', 'reached', 'six', 'month', 'in', 'ap', 'group', ',', 'meaning', 'significant', 'reduction', 'in', 'lvp', 'requirement', 'ap', 'patient', '(', 'ap', ',', 'median', 'not', 'reached', 'soc', ',', '.days', '(', 'hr', '.', 'ci', '.-', '.', 'p.', ')', ',', 'and', 'ap', 'patient', 'also', 'showed', 'significantly', 'improved', 'chronic', 'liver', 'disease', 'questionnaire', '(', 'cldq', ')', 'score', 'compared', 'with', 'soc', 'patient', '(', 'p.', 'treatment', 'arm', ')', '.', 'improvement', 'in', 'nutritional', 'parameter', 'observed', 'hand-grip', 'strength', '(', 'p.', ')', 'and', 'body', 'mass', 'index', '(', 'p.', ')', 'in', 'sub-study', '.', 'compared', 'with', 'soc', ',', 'ap', 'patient', 'reported', 'adverse', 'event', '(', 'aes', '.', 'v', '.', '.', ',', 'p.', ')', 'and', 'serious', 'aes', '(', '.', 'v', '.', '.', ',', 'p.', ')', '.', 'aes', 'consisted', 'predominantly', 'of', 'acute', 'kidney', 'injury', 'in', 'immediate', 'post-operative', 'period', ',', 'and', 're-intervention', 'pump', 'related', 'issue', ',', 'and', 'treatable', 'in', 'case', '.', 'survival', 'similar', 'in', 'ap', 'and', 'soc', '.', 'conclusion', 'ap', 'system', 'effective', 'reducing', 'need', 'paracentesis', 'and', 'improving', 'quality', 'of', 'life', 'in', 'cirrhotic', 'patient', 'with', 'ra', '.', 'although', 'frequency', 'of', 'saes', '(', 'and', 'inference', 'hospitalization', ')', 'significantly', 'higher', 'in', 'ap', 'group', ',', 'generally', 'limited', 'and', 'not', 'impact', 'survival', '.', 'lay', 'summary', 'alfapump', 'move', 'abdominal', 'fluid', 'bladder', 'removed', 'urination', '.', 'compared', 'with', 'standard', 'treatment', ',', 'alfapump', 'reduces', 'need', 'large', 'volume', 'paracentesis', '(', 'manual', 'fluid', 'removal', 'needle', ')', 'in', 'patient', 'with', 'medically', 'untreatable', 'ascites', '.', 'improve', 'life', 'quality', 'patient', '.', 'www.clinicaltrials.govnct', '.']"
"Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study.","Guang-Hui Pan, Zheng Chen, Lu Xu, Jing-Hui Zhu, Peng Xiang, Jun-Jie Ma, Yan-Wen Peng, Guang-Hui Li, Xiao-Yong Chen, Jia-Li Fang, Yu-He Guo, Lei Zhang, Long-Shan Liu, Guang-Hui Panet al.",2016 Mar 15,Oncotarget,https://pubmed.ncbi.nlm.nih.gov/26933811/,"Pathology Section, acute rejection, calcineurin inhibitors, graft survival, mesenchymal stem cells (MSCs), nephrotoxicity.","['calcineurin', 'inhibitor', ',', 'including', 'tacrolimus', ',', 'largely', 'responsible', 'advance', 'in', 'allotransplantation', '.', 'however', ',', 'nephrotoxicity', 'associated', 'with', 'immunosuppressant', 'impairs', 'patient', ""'"", 'long-term', 'survival', 'renal', 'allograft', '.', 'therefore', ',', 'novel', 'regimen', 'minimize', 'or', 'even', 'eliminate', 'calcineurin', 'inhibitor', 'could', 'improve', 'transplantation', 'outcome', '.', 'in', 'pilot', 'study', ',', 'investigated', 'use', 'of', 'low-dose', 'tacrolimus', 'in', 'combination', 'with', 'mesenchymal', 'stem', 'cell', '(', 'msc', ')', ',', 'immunosuppressive', 'and', 'prolong', 'allograft', 'survival', 'in', 'experimental', 'organ', 'transplant', 'model', '.', 'donor-derived', ',', 'bone', 'marrow', 'msc', 'combined', 'with', 'sparing', 'dose', 'of', 'tacrolimus', '(', '.-', '.', 'mgkgday', ')', 'administered', 'to', 'de', 'novo', 'living-related', 'kidney', 'transplant', 'recipient', 'patient', 'received', 'standard', 'dose', 'of', 'tacrolimus', '(', '.-', '.', 'mgkgday', ')', '.', 'safety', 'of', 'msc', 'infusion', ',', 'acute', 'rejection', ',', 'graft', 'function', ',', 'graft', 'survival', ',', 'and', 'patient', 'survival', 'evaluated', 'month', 'following', 'kidney', 'transplantation', '.', 'patient', 'survived', 'and', 'stable', 'renal', 'function', 'month', 'follow-up', '.', 'combination', 'of', 'low-dose', 'tacrolimus', 'and', 'msc', 'effective', 'standard', 'dose', 'tacrolimus', 'in', 'maintaining', 'graft', 'survival', 'least', 'year', 'transplantation', '.', 'in', 'addition', ',', 'group', 'similar', 'urea', ',', 'urine', 'protein', ',', 'urinary', 'rbc', ',', 'urinary', 'wbc', ',', '-h', 'urine', 'protein', ',', 'and', 'creatinine', 'clearance', 'rate', 'day', 'to', 'month', 'transplantation', '.', 'furthermore', ',', 'no', 'difference', 'in', 'proportion', 'of', 'lymphocyte', ',', 'cd', ',', 'cd', ',', 'cd', ',', 'cd', ',', 'and', 'natural', 'killer', 'cell', 'detected', 'control', 'and', 'experimental', 'group', '.', 'none', 'of', 'msc', 'recipient', 'experienced', 'immediate', 'or', 'long-term', 'toxicity', 'treatment', '.', 'preliminary', 'data', 'suggests', 'addition', 'of', 'msc', 'permit', 'use', 'of', 'lower', 'dosage', 'of', 'nephrotoxic', 'calcineurin', 'inhibitor', 'following', 'renal', 'transplantation', '.']"
Early detection of acute kidney injury in the perioperative period of liver transplant with neutrophil gelatinase-associated lipocalin.,"Camila Lima, Luciana Bertocco de Paiva Haddad, Patrícia Donado Vaz de Melo, Luiz Marcelo Malbouisson, Lilian Pires Freitas do Carmo, Luiz Augusto Carneiro D'Albuquerque, Etienne Macedo, Camila Limaet al.",2019 Oct 15,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/31615452/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'in', 'patient', 'undergoing', 'liver', 'transplant', '(', 'lt', ')', 'and', 'associated', 'with', 'high', 'morbidity', 'and', 'mortality', '.', 'aim', 'to', 'evaluate', 'pattern', 'of', 'urine', 'and', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'elevation', 'perioperative', 'period', 'of', 'lt', 'and', 'to', 'assess', 'prognostic', 'marker', 'aki', 'progression', ',', 'need', 'dialysis', 'and', 'mortality', '.', 'method', 'assessed', 'ngal', 'level', 'induction', 'of', 'anesthesia', ',', 'portal', 'reperfusion', 'and', ',', ',', ',', 'and', 'h', 'surgery', '.', 'patient', 'monitored', 'daily', 'first', 'week', 'lt.', 'result', 'of', 'enrolled', 'patient', 'undergoing', 'liver', 'transplant', ',', 'developed', 'severe', 'aki', 'based', 'kdigo', 'serum', 'creatinine', '(', 'scr', ')', 'criterion', 'dialysed', ',', 'and', 'died', 'within', 'day', 'lt.', 'applying', 'cut-off', 'value', 'of', 'ngml', ',', 'ungal', 'value', 'h', 'surgery', 'good', 'predictor', 'of', 'aki', 'development', 'within', 'day', 'surgery', ',', 'positive', 'predictive', 'value', '(', 'ppv', ')', 'of', 'with', 'auc', 'of', '.', '(', 'ci', '.-.', ')', '.', 'pngal', 'h', 'lt', 'also', 'good', 'predictor', 'of', 'aki', 'in', 'first', 'week', ',', 'ppv', 'of', 'and', 'auc', 'of', '.', '(', 'ci', '.-.', ')', '.', 'based', 'pngal', 'and', 'ungal', 'cut-off', 'criterion', 'level', ',', 'time', 'to', 'aki', 'diagnosis', 'and', 'h', 'earlier', 'scr', ',', 'respectively', '.', 'best', 'time', 'to', 'assess', 'need', 'dialysis', 'h', 'lt', 'pngal', 'and', 'h', 'lt', 'ungal', '.', 'conclusion', 'in', 'conclusion', ',', 'plasma', 'and', 'urine', 'ngal', 'elevation', 'pattern', 'in', 'perioperative', 'period', 'of', 'liver', 'transplant', 'predict', 'aki', 'diagnosis', 'earlier', '.', 'ungal', 'early', 'independent', 'predictor', 'of', 'aki', 'development', 'and', 'need', 'dialysis', '.', 'study', 'needed', 'to', 'assess', 'whether', 'clinical', 'use', 'of', 'biomarkers', 'improve', 'patient', 'outcome', '.', 'trial', 'registration', 'registered', 'clinical', 'trial', '(', 'clinicaltrials.gov', ')', 'in', 'march', 'th', ',', 'title', '``', 'acute', 'kidney', 'injury', 'biomarkers', 'diagnosis', 'and', 'application', 'in', 'pre-operative', 'period', 'of', 'liver', 'transplantation', '(', 'akib', ')', ""''"", 'and', 'identifier', 'nct', ',', 'retrospectively', 'registered', '.']"
Measurement of the Concentration of Citrate in Human Biofluids in Patients Undergoing Continuous Renal Replacement Therapy Using Regional Citrate Anticoagulation: Application of a Two-Step Enzymatic Assay.,"Chris M Anstey, Fraser D Russell, Chris M Ansteyet al.",2021,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/33550280/,No keywords found,"['continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'with', 'regional', 'citrate', 'anticoagulation', '(', 'rca', ')', 'commonly', 'used', 'to', 'treat', 'acute', 'kidney', 'injury', 'in', 'critically', 'ill', 'patient', '.', 'concentration', 'of', 'citrate', 'not', 'routinely', 'measured', ',', 'with', 'citrate', 'accumulation', 'andor', 'toxicity', 'primarily', 'assessed', 'using', 'surrogate', 'measure', '.', 'objective', 'aim', 'of', 'study', 'to', 'measure', 'concentration', 'of', 'citrate', 'in', 'plasma', 'and', 'ultrafiltrate', 'in', 'patient', 'receiving', 'crrt', 'with', 'rca', 'using', 'modified', 'commercial', 'enzymatic', 'assay', '.', 'method', 'meeting', 'inclusion', 'criterion', ',', 'blood', 'sampled', 'patient', ',', ',', 'and', 'episode', 'of', 'filtration', '.', 'using', 'spectrophotometry', ',', 'sample', 'tested', 'citrate', 'concentration', '.', 'demographic', 'and', 'clinical', 'and', 'biochemical', 'data', 'also', 'collected', '.', 'throughout', ',', 'mmoll', 'solution', 'of', 'trisodium', 'citrate', 'used', 'prefilter', 'anticoagulant', '.', 'result', 'analysed', 'using', 'stata', '(', 'v.', ')', 'and', 'presented', 'mean', '(', 'sd', ')', ',', 'median', '(', 'iqr', ')', ',', 'or', 'simple', 'proportion', '.', 'comparison', 'made', 'using', 'either', 'student', 'test', 'or', 'wilcoxon', 'rank-sum', 'test', '.', 'correlation', 'assessed', 'using', 'pearson', ""'s"", 'r.', 'result', 'twenty', 'patient', '(', 'male', ')', 'enrolled', 'in', 'study', '.', 'mean', '(', 'sd', ')', 'age', '.', 'year', '(', '.', ')', '.', 'median', '(', 'iqr', ')', 'icu', 'length', 'of', 'stay', 'h', '(', ',', ')', 'with', 'undergoing', 'intermittent', 'positive', 'pressure', 'ventilation', '.', 'median', 'apache', 'score', '(', ',', ')', 'with', 'overall', 'mortality', 'rate', '.', 'median', 'filtration', 'time', 'h', '(', ',', ')', '.', 'no', 'difference', 'found', 'pre-', 'and', 'post-filtration', 'plasma', 'citrate', 'concentration', '(', 'moll', 'vs.', 'moll', ',', 'p', '.', ')', '.', 'mean', 'citrate', 'concentration', 'filtration', 'moll', '(', ')', 'with', 'maximum', 'of', ',', 'moll', '.', 'significantly', 'higher', 'prepost', 'level', '(', 'p', '.', ')', '.', 'conclusion', 'plasma', 'concentration', 'of', 'citrate', 'rose', 'significantly', 'episode', 'of', 'crrt', 'using', 'rca', 'returning', 'back', 'to', 'normal', 'cessation', 'of', 'treatment', '.']"
Health-related quality of life in survivors of acute kidney injury: The Prolonged Outcomes Study of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy study outcomes.,"Amanda Y Wang, Rinaldo Bellomo, Alan Cass, Simon Finfer, David Gattas, John Myburgh, Steve Chadban, Yoichiro Hirakawa, Toshiharu Ninomiya, Qiang Li, Serigne Lo, Federica Barzi, Louisa Sukkar, Meg Jardine, Martin P Gallagher                                                                                          ;, POST-RENAL Study Investigators and the ANZICS Clinical Trials Group, Amanda Y Wanget al.",2015 Jul,Nephrology (Carlton),https://pubmed.ncbi.nlm.nih.gov/25891297/,No keywords found,"['patient', 'with', 'chronic', 'kidney', 'disease', 'reduced', 'health-related', 'quality', 'of', 'life', '(', 'hrqol', ')', ',', 'long-term', 'hrqol', 'of', 'survivor', 'of', 'severe', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'remains', 'unclear', '.', 'method', 'analysed', 'hrqol', 'prolonged', 'outcome', 'study', 'of', 'randomized', 'evaluation', 'of', 'normal', 'versus', 'augmented', 'level', 'replacement', 'therapy', '(', 'post-renal', ')', 'study', 'and', 'compared', 'finding', 'with', 'general', 'australian', 'adult', 'population', 'enrolled', 'in', 'australian', 'diabetes', ',', 'obesity', 'and', 'lifestyle', '(', 'ausdiab', ')', 'study', '.', 'used', 'multivariate', 'analysis', 'adjusted', 'baseline', 'characteristic', 'along', 'with', 'sensitivity', 'analysis', 'using', 'age', 'and', 'sex-matched', 'case', 'control', '.', 'result', 'in', 'post-renal', 'study', ',', 'participant', 'hrqol', 'data', 'collected', 'using', 'sf-', 'questionnaire', '.', 'compared', 'with', 'participant', 'ausdiab', 'study', '.', 'unadjusted', 'analysis', 'showed', 'post-renal', 'participant', 'lower', 'physical', 'component', 'score', '(', 'pc', ',', 'mean', 'score', '.', 'v', '.', ',', 'p.', ')', 'and', 'lower', 'mental', 'component', 'score', '(', 'mc', ',', 'mean', 'score', '.', 'v', '.', ',', 'p.', ')', 'ausdiab', 'group', '.', 'age', 'and', 'sex', 'matching', ',', 'difference', 'in', 'pc', 'and', 'mc', 'remained', 'statistically', 'significant', '(', 'p.', ')', '.', 'advanced', 'age', ',', 'reduced', 'renal', 'function', 'and', 'albuminuria', '(', 'p', '.', ')', 'strongly', 'associated', 'with', 'lower', 'pc', 'value', 'not', 'mc', 'value', '.', 'matching', 'subset', 'of', 'cohort', 'basis', 'of', 'age', ',', 'sex', 'and', 'renal', 'function', ',', 'pc', 'and', 'mc', 'lower', 'in', 'post-renal', 'group', '(', 'p.', ')', '.', 'conclusion', 'survivor', 'of', 'severe', 'aki', 'in', 'post-renal', 'study', 'lower', 'physical', 'and', 'mental', 'component', 'of', 'hrqol', 'compared', 'with', 'general', 'population', ',', 'even', 'adjustment', 'reduced', 'renal', 'function', '.', 'increasing', 'age', 'and', 'reduced', 'renal', 'function', 'associated', 'with', 'poorer', 'physical', 'qol', '.']"
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.,"Jay L Koyner, Danielle L Davison, Ermira Brasha-Mitchell, Divya M Chalikonda, John M Arthur, Andrew D Shaw, James A Tumlin, Sharon A Trevino, Michael R Bennett, Paul L Kimmel, Michael G Seneff, Lakhmir S Chawla, Jay L Koyneret al.",2015 Aug,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/25655065/,"acute renal failure, clinical nephrology, diuretics.","['clinician', 'access', 'to', 'limited', 'tool', 'predict', 'patient', 'with', 'early', 'aki', 'progress', 'to', 'severe', 'stage', '.', 'in', 'early', 'aki', ',', 'urine', 'output', 'furosemide', 'stress', 'test', '(', 'fst', ')', ',', 'involves', 'intravenous', 'administration', 'of', 'furosemide', '(', '.', 'or', '.', 'mgkg', ')', ',', 'predict', 'development', 'of', 'stage', 'aki', '.', 'measured', 'several', 'aki', 'biomarkers', 'in', 'previously', 'published', 'cohort', 'of', 'patient', 'with', 'early', 'aki', 'received', 'fst', 'and', 'evaluated', 'ability', 'of', 'fst', 'urine', 'output', 'and', 'biomarkers', 'to', 'predict', 'development', 'of', 'stage', 'aki', '(', 'n', '.', ')', ',', 'receipt', 'of', 'rrt', '(', 'n', '.', ')', ',', 'or', 'inpatient', 'mortality', '(', 'n', '.', ')', '.', 'with', 'area', 'curve', '(', 'auc', ')', 'sem', 'of', '..', '(', 'p.', ')', '.', 'fst', 'urine', 'output', 'assessed', 'in', 'patient', 'with', 'increased', 'biomarker', 'level', ',', 'auc', 'progression', 'to', 'stage', 'improved', 'to', '..', 'and', 'auc', 'receipt', 'of', 'rrt', 'improved', 'to', '...', 'overall', ',', 'in', 'setting', 'of', 'early', 'aki', ',', 'fst', 'urine', 'output', 'outperformed', 'biochemical', 'biomarkers', 'prediction', 'of', 'progressive', 'aki', ',', 'need', 'rrt', ',', 'and', 'inpatient', 'mortality', '.', 'using', 'fst', 'in', 'patient', 'with', 'increased', 'biomarker', 'level', 'improves', 'risk', 'stratification', ',', 'although', 'research', 'needed', '.']"
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials.,"Daniele Giacoppo, Mahesh V Madhavan, Usman Baber, Josephine Warren, Sameer Bansilal, Bernhard Witzenbichler, George D Dangas, Ajay J Kirtane, Ke Xu, Ran Kornowski, Sorin J Brener, Philippe Généreux, Gregg W Stone, Roxana Mehran, Daniele Giacoppoet al.",2015 Aug,Circ Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/26198286/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', ',', 'defined', 'serum', 'creatinine', 'increase', '.', 'mgdl', 'or', 'within', 'hour', 'contrast', 'exposure', ',', 'common', 'complication', 'of', 'procedure', 'requiring', 'contrast', 'medium', 'and', 'associated', 'with', 'increased', 'short-', 'and', 'long-term', 'morbidity', 'and', 'mortality', '.', 'study', 'describe', 'effect', 'of', 'ci-aki', 'in', 'large-scale', 'acute', 'coronary', 'syndrome', 'population', ',', 'and', 'relationship', 'ci-aki', 'and', 'bleeding', 'event', 'not', 'extensively', 'explored', '.', 'sought', 'to', 'evaluate', 'impact', 'of', 'ci-aki', 'percutaneous', 'coronary', 'intervention', 'in', 'patient', 'presenting', 'with', 'acute', 'coronary', 'syndrome', '.', 'method', 'and', 'result', 'pooled', 'patient-level', 'data', 'patient', 'percutaneous', 'coronary', 'intervention', 'cohort', 'of', 'harmonizing', 'outcome', 'with', 'revascularization', 'and', 'stent', 'in', 'acute', 'myocardial', 'infarction', '(', 'horizons-ami', ')', 'and', 'acute', 'catheterization', 'and', 'urgent', 'intervention', 'triage', 'strategy', '(', 'acuity', ')', 'multicenter', 'randomized', 'trial', '.', 'patient', 'classified', 'according', 'to', 'ci-aki', 'development', ',', 'and', 'cardiovascular', 'outcome', 'day', 'and', 'year', 'compared', 'group', '.', 'total', 'of', 'patient', '(', '.', ')', 'developed', 'ci-aki', '.', 'patient', 'with', 'ci-aki', 'older', ',', 'with', 'extensive', 'comorbidity', 'profile', 'without', 'ci-aki', '.', 'multivariable', 'analysis', 'confirmed', 'several', 'previously', 'identified', 'predictor', 'of', 'ci-aki', ',', 'including', 'diabetes', 'mellitus', ',', 'contrast', 'volume', ',', 'age', ',', 'and', 'baseline', 'hemoglobin', '.', 'mortality', 'rate', 'significantly', 'higher', 'in', 'ci-aki', 'group', 'day', '(', '.', 'versus', '.', 'p.', ')', 'and', 'year', '(', '.', 'versus', '.', 'p.', ')', ',', 'rate', 'of', '-year', 'myocardial', 'infarction', ',', 'definiteprobable', 'stent', 'thrombosis', ',', 'target', 'lesion', 'revascularization', ',', 'and', 'major', 'adverse', 'cardiac', 'event', '.', 'major', 'bleeding', '(', '.', 'versus', '.', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p.', ')', 'also', 'higher', 'in', 'patient', 'with', 'ci-aki', '.', 'multivariable', 'adjustment', ',', 'result', 'unchanged', '.', 'conclusion', 'ci-aki', 'percutaneous', 'coronary', 'intervention', 'in', 'patient', 'presenting', 'with', 'acute', 'coronary', 'syndrome', 'independently', 'associated', 'with', 'increased', 'risk', 'of', 'short-', 'and', 'long-term', 'ischemic', 'and', 'hemorrhagic', 'event', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '(', 'horizons-ami', ')', 'and', 'acuity', '(', 'nct', ')', '.']"
"Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin.","Mustafa Erinc Sitar, Arslan Arinc Kayacelebi, Bibiana Beckmann, Jan T Kielstein, Dimitrios Tsikas, Mustafa Erinc Sitaret al.",2015 Sep,Amino Acids,https://pubmed.ncbi.nlm.nih.gov/25921952/,No keywords found,"['free', ',', 'non-protein', 'bound', 'asymmetrically', 'guanidine-dimethylated', 'arginine', '(', 'adma', ')', 'endogenous', 'inhibitor', 'of', 'nitric', 'oxide', '(', 'no', ')', 'synthesis', '.', 'human', 'erythrocytic', 'membrane', 'comprises', 'considerable', 'amount', 'of', 'large', '(', 'kda', ')', 'adma-containing', 'protein', '.', 'location', 'in', 'erythrocyte', 'membrane', 'and', 'identity', 'and', 'physiological', 'function', 'of', 'adma-containing', 'protein', 'unrevealed', '.', 'in', 'healthy', 'subject', ',', 'concentration', 'of', 'free', 'adma', 'in', 'heparinised', 'plasma', 'almost', 'identical', 'to', 'of', 'serum', '.', 'hypothesised', 'robustness', 'of', 'free', 'adma', 'concentration', 'in', 'human', 'blood', 'due', 'to', 'remarkable', 'resistance', 'of', 'erythrocytic', 'adma-containing', 'protein', 'protease', '.', 'in', 'vivo', ',', 'investigated', 'course', 'of', 'concentration', 'of', 'adma', 'in', 'serum', 'and', 'edta', 'plasma', 'of', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', 'extended', 'haemodialysis', '.', 'in', 'vitro', ',', 'studied', 'effect', 'of', 'thermolysin', ',', 'useful', 'experimental', 'proteolytic', 'enzyme', 'of', 'erythrocyte', 'membrane', 'protein', ',', 'erythrocytic', 'adma', '.', 'protein', 'binding', '(', 'pb', ')', 'of', 'adma', 'to', 'human', 'serum', 'albumin', '(', 'hsa', ')', 'also', 'determined', '.', 'in', 'study', ',', 'adma', 'measured', 'previously', 'reported', ',', 'fully', 'validated', 'gc-msms', 'method', '.', 'measured', 'almost', 'identical', 'adma', 'concentration', 'in', 'plasma', 'and', 'serum', 'sample', 'of', 'patient', '.', 'dialysis', ',', 'circulating', 'adma', 'concentration', 'decreased', 'slowly', 'and', 'moderately', 'indicating', 'removal', 'of', 'substance', ',', 'however', 'much', 'less', 'expected', 'low', 'molecular', 'weight', '(', 'da', ')', 'and', 'high', 'water', 'solubility', '.', 'dialysis', ',', 'circulating', 'adma', 'concentration', 'increased', ',', 'phenomenon', 'called', 'rebound', ',', 'and', 'adma', 'reached', 'higher', 'level', 'compared', 'to', 'baseline', '.', 'pb', 'value', 'of', 'adma', 'to', 'hsa', '.', 'surprisingly', 'high', 'pb', 'value', 'of', 'adma', 'to', 'hsa', 'may', 'explanation', 'rather', 'poor', 'dialysance', 'of', 'adma', '.', 'washed', 'human', 'erythrocyte', 'suspended', 'in', 'phosphate-buffered', 'physiological', 'saline', 'found', 'not', 'to', 'release', 'appreciable', 'amount', 'of', 'free', 'and', 'adma-containing', 'protein', '.', 'lack', 'of', 'effect', 'of', 'coagulation', 'or', 'anticoagulation', 'concentration', 'of', 'circulating', 'free', 'adma', 'in', 'human', 'likely', 'to', 'due', 'to', 'remarkable', 'resistance', 'of', 'adma-containing', 'protein', 'in', 'erythrocyte', 'membrane', 'protease', 'in', 'vivo', 'in', 'human', '.', 'study', 'suggests', 'free', 'adma', 'released', 'in', 'circulating', 'blood', 'relatively', 'high', 'rate', '.', 'considerable', 'pb', 'of', 'adma', 'to', 'hsa', 'likely', 'to', 'add', 'to', 'apparently', 'poor', 'dialysability', 'of', 'adma', '.', 'contributing', 'factor', 'could', 'redistribution', 'of', 'free', 'adma', 'plasma', 'and', 'erythrocyte', 'in', 'favour', 'of', 'plasma', 'adma', 'and', 'parallel', 'formation', 'of', 'free', 'adma', 'erythrocytic', 'adma-containing', 'protein', 'haemodialysis', '.']"
"Urine alkalinisation to prevent contrast-induced acute kidney injury: the prospective, randomised, controlled, open-label TEATE trial.","Marco Lombardi, Michela Molisana, Eugenio Genovesi, Carlo De Innocentiis, Ugo Limbruno, Leonardo Misuraca, Luciano Moretti, Luca Di Vito, Giulia Renda, Marco Zimarino, Marta Di Nicola, Raffaele De Caterina, Marco Lombardiet al.",2022 Sep 20,EuroIntervention,https://pubmed.ncbi.nlm.nih.gov/35620986/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'prognostically', 'relevant', 'in', 'invasive', 'cardiological', 'and', 'radiological', 'procedure', '.', 'administration', 'of', 'sodium', 'bicarbonate', 'controversial', 'effect', '.', 'hypothesised', 'bicarbonate', 'ineffective', 'unable', 'to', 'achieve', 'adequate', 'urine', 'alkalinisation', '.', 'aim', 'tested', 'hypothesis', 'alkaline', 'urine', 'status', 'with', 'oral', 'or', 'intravenous', '(', 'i.v', '.', ')', 'bicarbonate', 'top', 'of', 'hydration', 'alone', 'prevents', 'ci-aki', '.', 'method', 'in', 'prospective', ',', 'randomised', ',', 'parallel-group', ',', 'open-label', 'trial', ',', 'compared', ')', 'saline', 'hydration', 'alone', '(', 'n', ')', ')', 'i.v', '.', 'bicarbonate', '(', 'n', ')', 'and', ')', 'oral', 'bicarbonate', '(', 'n', ')', ',', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'scheduled', 'intra-arterial', 'administration', 'of', 'contrast', 'medium', '.', 'primary', 'endpoint', 'incidence', 'of', 'ci-aki', 'according', 'to', 'alkaline', 'urine', 'status', 'achieved', 'immediately', 'angiography', '.', 'secondary', 'endpoint', 'mean', 'change', 'of', 'urine', 'ph', 'to', 'time', 'of', 'angiography', 'and', 'incidence', 'of', 'ci-aki', 'in', 'three', 'group', '.', 'result', 'incidence', 'of', 'ci-aki', 'not', 'significantly', 'different', 'in', 'three', 'treatment', 'arm', '(', 'in', 'hydration', 'group', ',', 'in', 'oral', 'bicarbonate', 'group', 'and', 'in', 'i.v', '.', 'bicarbonate', 'group', 'p.', ')', '.', 'patient', 'achieving', 'ph', 'angiography', '(', 'n', ')', 'significantly', 'lower', 'incidence', 'of', 'ci-aki', 'compared', 'with', 'others', '(', 'n', 'odds', 'ratio', 'or', '.', ',', 'confidence', 'interval', 'ci', '.-', '.', 'p.', ',', 'primary', 'study', 'hypothesis', ')', '.', 'proportion', 'of', 'patient', 'achieving', 'ph', 'higher', 'in', 'i.v', '.', 'and', 'oral', 'bicarbonate', 'group', 'compared', 'with', 'hydration', 'alone', '.', 'conclusion', 'urinary', 'ph', 'administration', 'of', 'contrast', 'medium', 'inverse', 'correlate', 'of', 'ci-aki', 'incidence', ',', 'and', 'bicarbonate', 'superior', 'to', 'hydration', 'alone', 'in', 'achieving', 'urinary', 'alkalinisation', '.', 'since', ',', 'however', ',', 'bicarbonate', 'not', 'reduce', 'incidence', 'of', 'ci-aki', ',', 'conclude', 'urinary', 'ph', 'marker', 'and', 'not', 'mediator', 'of', 'ci-aki', '(', 'clinicaltrials.gov', 'nct', ')', '.']"
Preventive Effect of Trimetazidine on Contrast-Induced Acute Kidney Injury in CKD Patients Based on Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL): A randomized Clinical Trial.,"Amirhossein Mirhosseni, Behzad Farahani, Alireza Gandomi-Mohammadabadi, Hossein Keyvani, Maryam Biglari-Abhari, Alireza Davari, Mohammad Hossein Vazirizade-Mahabadi, Shokufeh Savaj, Amirhossein Mirhosseniet al.",2019 May,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/31209192/,No keywords found,"['contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'prevalent', 'complication', 'of', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'patient', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'effect', 'of', 'periprocedural', 'administration', 'of', 'trimetazidine', 'anti-oxidant', 'agent', 'incidence', 'of', 'ci-aki', 'in', 'ckd', 'patient', 'based', 'change', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ungal', ')', 'level', ',', 'recently', 'introduced', 'early', 'predictor', 'of', 'ci-aki', '.', 'method', 'one', 'hundred', 'ckd', 'patient', 'with', 'mean', 'gfr', 'of', 'ccmin', 'candidate', 'coronary', 'angiography', 'assigned', 'randomly', 'to', 'receive', '(', 'patient', ',', 'intervention', 'group', ')', 'or', 'not', 'receive', '(', 'patient', ',', 'control', 'group', ')', 'trimetazidine', '(', 'mgd', ')', 'hour', '.', 'ci-aki', 'defined', '.', 'mg', 'or', 'increase', 'in', 'serum', 'creatinine', '.', 'also', 'checked', 'ungal', 'and', 'h', 'angiography', '.', 'result', 'serum', 'creatinine', ',', 'showed', 'trend', 'of', 'less', 'increment', 'in', 'case', 'group', ',', 'although', 'could', 'not', 'achieve', 'significant', 'difference', ',', 'significant', 'difference', 'in', 'urinary', 'ngal', 'rise', 'two', 'group', '.', 'ci-aki', 'defined', '.', 'time', 'increase', 'in', 'ungal', 'level', '(', 'h', 'angiography', 'to', 'pre-procedurally', 'ungal', 'level', 'ratio', ')', 'according', 'to', 'roc', 'curve', '.', 'incidence', 'of', 'ci-aki', 'according', 'to', 'urinary', 'ngal', 'definition', 'in', 'trimetazidine', 'group', 'and', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'concluded', 'trimetazidine', 'treatment', 'angiography', 'may', 'effective', 'in', 'ci-aki', 'prevention', '.', 'moreover', ',', 'shown', '.', 'time', 'increase', 'in', 'urine', 'ngal', 'angiography', 'valuable', 'cut', 'point', 'clinician', 'to', 'discriminate', 'high', 'risk', 'patient', 'contrast', 'nephropathy', '.']"
One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.,"Gennaro Giustino, Usman Baber, Ioannis Mastoris, Georgios J Vlachojannis, Jennifer Yu, Paul S Teirstein, William E Downey, Wayne B Batchelor, Peter J Casterella, Eugenia Nikolsky, S Chiu Wong, Kleanthis N Theodoropoulos, George D Dangas, Roxana Mehran, Gennaro Giustinoet al.",2016 Mar,Catheter Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/26481591/,No keywords found,"['long-term', 'clinical', 'outcome', 'exposure', 'to', 'non-ionic', 'iso-osmolar', 'contrast', 'medium', '(', 'iocm', ')', 'or', 'ionic', 'low-osmolar', 'cm', '(', 'locm', ')', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'undergoing', 'coronary', 'angiography', 'unclear', '.', 'method', 'icon', 'trial', 'prospective', ',', 'double-blinded', ',', 'multicentre', 'study', 'randomly', 'assigned', 'patient', 'with', 'ckd', 'undergoing', 'coronary', 'angiography', 'with', 'or', 'without', 'percutaneous', 'coronary', 'intervention', 'to', 'non-ionic', 'iocm', 'iodixanol', 'or', 'ionic', 'locm', 'ioxaglate', '.', 'report', '-year', 'clinical', 'outcome', '.', 'result', 'randomization', ',', 'baseline', 'and', 'procedural', 'characteristic', 'well-matched', 'two', 'group', '.', 'year', ',', 'three', 'death', '(', '.', ')', 'occurred', 'in', 'ioxaglate', 'and', 'nine', 'death', 'in', 'iodixanol', 'group', '(', '.', ',', 'p', '.', ')', '.', 'cardiac', 'death', 'rate', 'year', '.', 'in', 'ioxaglate', 'group', 'and', '.', 'in', 'iodixanol', 'group', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'rate', 'of', 'myocardial', 'infarction', '(', '.', 'vs.', '.', 'p', '.', ')', 'and', 'repeated', 'revascularization', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'conclusion', 'use', 'of', 'ionic', 'locm', 'ioxaglate', 'associated', 'with', 'numerically', 'lower', 'mortality', 'year', 'compared', 'to', 'iodixanol', 'in', 'patient', 'underwent', 'cardiac', 'catheterization', '.', 'future', 'study', 'evaluating', 'long-term', 'safety', 'following', 'exposure', 'to', 'different', 'type', 'of', 'cm', 'warranted', '.']"
Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention.,"Xue Zhang, Shicheng Yang, Peng Zhang, Naikuan Fu, Xue Zhanget al.",2020 May,Coron Artery Dis,https://pubmed.ncbi.nlm.nih.gov/31658134/,No keywords found,"['purpose', 'of', 'study', 'to', 'explore', 'effect', 'of', 'nicorandil', 'incidence', 'of', 'contrast-induced', 'nephropathy', 'in', 'patient', 'with', 'coronary', 'heart', 'disease', 'undergoing', 'percutaneous', 'coronary', 'intervention', '.', 'method', 'study', 'randomized', 'patient', 'undergoing', 'percutaneous', 'coronary', 'intervention', 'to', 'receive', 'conventional', 'treatment', 'in', 'control', 'group', '(', 'hydration', 'n', ')', 'vs.', 'nicorandil', 'therapy', '(', 'nicorandil', 'mg', 'three', 'time', 'daily', 'plus', 'hydration', 'n', ')', '.', 'primary', 'endpoint', 'incidence', 'of', 'contrast-induced', 'nephropathy', ',', 'defined', 'rise', 'in', 'serum', 'creatinine', '.', 'moll', 'or', 'baseline', 'within', 'hour', 'exposure', 'to', 'contrast', 'administered', 'percutaneous', 'coronary', 'intervention', '.', 'secondary', 'endpoint', 'included', 'difference', 'in', 'post-percutaneous', 'coronary', 'intervention', 'serum', 'creatinine', ',', 'blood', 'urea', 'nitrogen', ',', 'creatinine', 'clearance', 'rate', ',', 'cystatin-c', ',', 'and', 'occurrence', 'of', 'major', 'adverse', 'event', '.', 'result', 'contrast-induced', 'nephropathy', 'incidence', '.', '(', ')', 'in', 'nicorandil', 'group', 'vs.', '.', '(', ')', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'compared', 'to', 'conventional', 'treatment', ',', 'oral', 'nicorandil', 'therapy', 'associated', 'with', 'less', 'contrast-induced', 'nephropathy', 'and', 'improved', 'renal', 'function', 'following', 'contrast', 'administration', 'percutaneous', 'coronary', 'intervention', '.']"
Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO).,"Espeed Khoshbin, Sally Spencer, Laurence Solomon, Augustine Tang, Stephen Clark, Elizabeth Stokes, Sarah Wordsworth, Lucy Dabner, Julia Edwards, Barnaby Reeves, Chris Rogers, Espeed Khoshbinet al.",2021 Mar 26,J Cardiothorac Surg,https://pubmed.ncbi.nlm.nih.gov/33771192/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'adversely', 'affect', 'outcome', 'cardiac', 'surgery', '.', 'major', 'mediator', 'of', 'aki', 'activation', 'of', 'leukocyte', 'exposure', 'to', 'cardiopulmonary', 'bypass', 'circuit', '.', 'evaluate', 'use', 'of', 'leukodepletion', 'filter', 'throughout', 'bypass', 'to', 'protect', 'post-operative', 'aki', 'removing', 'activated', 'leukocyte', 'cardiac', 'surgery', '.', 'method', 'single-centre', ',', 'double-blind', ',', 'randomized', 'controlled', 'trial', 'comparing', 'use', 'of', 'leukodepletion', 'versus', 'standard', 'arterial', 'filter', 'throughout', 'bypass', '.', 'elective', 'adult', 'patient', 'undergoing', 'heart', 'valve', 'surgery', 'with', 'or', 'without', 'concomitant', 'procedure', 'investigated', '.', 'primary', 'clinical', 'outcome', 'measured', 'development', 'of', 'aki', 'according', 'to', 'kdigo', 'criterion', '.', 'secondary', 'measure', 'included', 'biomarkers', 'of', 'renal', 'tubular', 'damage', '(', 'urinary', 'retinol', 'binding', 'protein', 'and', 'kidney', 'injury', 'molecule-', ')', ',', 'glomerular', 'kidney', 'injury', '(', 'urinary', 'micro', 'albumin', 'and', 'serum', 'cystatin', 'c', ')', 'and', 'urinary', 'neutrophil', 'gelatinase', 'associated', 'lipocalin', ',', 'well', 'length', 'of', 'hospital', 'stay', 'and', 'quality', 'of', 'life', 'measure', 'eq-d-l', 'questionnaire', '.', 'result', 'rolo', 'trial', 'randomized', 'participant', 'with', 'rate', 'of', 'recruitment', 'higher', 'anticipated', '(', 'achieved', ',', 'anticipated', ')', '.', 'incidence', 'of', 'aki', 'greater', 'in', 'leukodepletion', 'filter', 'group', '(', 'versus', ',', 'risk', 'difference', ',', 'ci', '-', 'to', ')', '.', 'clinical', 'finding', 'supported', 'biomarker', 'level', 'especially', 'tendency', 'toward', 'glomerular', 'insult', 'h', ',', 'demonstrated', 'raised', 'serum', 'cystatin', 'c', '(', 'mean', 'difference', '.', ',', 'ci', '.', 'to', '.', ',', 'p', '.', ')', 'in', 'leukodepleted', 'group', '.', 'however', 'no', 'clear', 'association', 'incidence', 'or', 'severity', 'of', 'aki', 'and', 'length', 'of', 'hospital', 'stay', '.', 'average', ',', 'health', 'related', 'quality', 'of', 'life', 'returned', 'to', 'pre-operative', 'level', 'in', 'group', 'within', 'month', 'of', 'surgery', '.', 'conclusion', 'leukocyte', 'depletion', 'cardiopulmonary', 'bypass', 'not', 'significantly', 'reduce', 'incidence', 'of', 'aki', 'valvular', 'heart', 'surgery', '.', 'method', 'to', 'ameliorate', 'renal', 'dysfunction', 'cardiac', 'surgery', 'need', 'to', 'investigated', '.', 'trial', 'registration', 'trial', 'registered', 'international', 'standard', 'randomized', 'controlled', 'trial', 'number', 'registry', 'isrctn', '.', 'registered', 'february', '.', 'trial', 'run', 'bristol', 'clinical', 'trial', 'and', 'evaluation', 'unit', '.', 'trial', 'financially', 'supported', 'national', 'institute', 'of', 'health', 'research', '(', 'research', 'patient', 'benefit', ')', ',', 'award', 'id', 'pb-pg', '--', ',', '.']"
Effect of machine learning models on clinician prediction of postoperative complications: the Perioperative ORACLE randomised clinical trial.,"Bradley A Fritz, Christopher R King, Mohamed Abdelhack, Yixin Chen, Alex Kronzer, Joanna Abraham, Sandhya Tripathi, Arbi Ben Abdallah, Thomas Kannampallil, Thaddeus P Budelier, Daniel Helsten, Arianna Montes de Oca, Divya Mehta, Pratyush Sontha, Omokhaye Higo, Paul Kerby, Stephen H Gregory, Troy S Wildes, Michael S Avidan, Bradley A Fritzet al.",2024 Nov,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/39261226/,No keywords found,"['anaesthesiologists', 'might', 'able', 'to', 'mitigate', 'risk', 'know', 'patient', 'greatest', 'risk', 'postoperative', 'complication', '.', 'trial', 'examined', 'impact', 'of', 'machine', 'learning', 'model', 'clinician', 'risk', 'assessment', '.', 'method', 'single-centre', ',', 'prospective', ',', 'randomised', 'clinical', 'trial', 'enrolled', 'surgical', 'patient', 'aged', 'yr.', 'anaesthesiologists', 'and', 'nurse', 'anaesthetist', 'providing', 'remote', 'telemedicine', 'support', 'reviewed', 'electronic', 'health', 'record', 'with', '(', 'assisted', 'group', ')', 'or', 'without', '(', 'unassisted', 'group', ')', 'reviewing', 'machine', 'learning', 'prediction', '.', 'clinician', 'predicted', 'likelihood', 'of', 'postoperative', '-day', 'all-cause', 'mortality', 'and', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'within', 'day', '.', 'primary', 'outcome', 'area', 'receiver', 'operating', 'characteristic', 'curve', '(', 'auroc', ')', 'clinician', 'prediction', 'of', 'mortality', 'and', 'aki', ',', 'comparing', 'aurocs', 'assisted', 'and', 'unassisted', 'assessment', '.', 'result', 'analysed', 'patient', '(', 'mean', 'range', 'age', '-', 'yr', 'female', ')', 'assessed', 'clinician', '.', 'of', ',', '(', '.', ')', 'patient', 'died', 'within', 'day', 'of', 'surgery', 'and', '(', '.', ')', 'patient', 'sustained', 'aki', '.', 'clinician', 'prediction', 'agreed', 'with', 'model', 'strongly', 'in', 'assisted', 'v', 'unassisted', 'group', '(', 'weighted', 'kappa', '.', 'v', '.', 'death', ',', 'mean', 'difference', '.', 'ci', '.-', '.', 'and', '.', 'v', '.', 'aki', ',', 'mean', 'difference', '.', 'ci', '.-.', ')', '.', 'clinical', 'prediction', 'of', 'death', 'similar', 'assisted', '(', 'auroc', '.', ')', 'and', 'unassisted', '(', 'auroc', '.', ')', 'group', '(', 'mean', 'difference', '.', 'ci', '-', '.', 'to', '.', 'p.', ')', '.', 'prediction', 'of', 'aki', 'auroc', 'of', '.', 'in', 'assisted', 'group', 'v', '.', 'in', 'unassisted', 'group', '(', 'difference', '.', 'ci', '-', '.', 'to', '.', 'p.', ')', '.', 'conclusion', 'clinician', 'performance', 'not', 'improved', 'machine', 'learning', 'assistance', '.', 'work', 'needed', 'to', 'clarify', 'role', 'of', 'machine', 'learning', 'in', 'real-time', 'perioperative', 'risk', 'stratification', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Acute kidney injury increases the risk of end-stage renal disease after cardiac surgery in an Asian population: a prospective cohort study.,"Sophia Tsong Huey Chew, Roderica Rui Ge Ng, Weiling Liu, Khuan Yew Chow, Lian Kah Ti, Sophia Tsong Huey Chewet al.",2017 Feb 13,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/28193259/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'cardiac', 'surgery', 'associated', 'with', 'increased', 'morbidity', 'and', 'mortality', '.', 'long-term', 'association', 'aki', 'and', 'end-stage', 'renal', 'disease', '(', 'esrd', ')', 'in', 'asian', 'population', 'unknown', '.', 'given', 'high', 'prevalence', 'of', 'diabetes', 'and', 'younger', 'age', 'of', 'presentation', 'cardiac', 'surgery', ',', 'important', 'to', 'track', 'progression', 'of', 'kidney', 'disease', '.', 'therefore', ',', 'studied', 'long-term', 'risk', 'of', 'esrd', 'and', 'mortality', 'in', 'asian', 'patient', 'developed', 'aki', 'cardiac', 'surgery', '.', 'method', 'with', 'ethic', 'approval', ',', 'prospectively', 'recruited', 'patient', 'underwent', 'cardiac', 'surgery', 'in', 'singapore', 'and', ',', 'and', 'followed', 'till', '.', 'esrd', 'and', 'mortality', 'information', 'obtained', 'singapore', 'renal', 'registry', 'and', 'singapore', 'registry', 'of', 'birth', 'and', 'death', 'respectively', '.', 'aki', 'defined', 'using', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'criterion', ',', 'and', 'esrd', 'defined', 'stage', 'chronic', 'kidney', 'disease', 'requiring', 'renal', 'replacement', 'therapy', '.', 'cox', 'proportional', 'hazard', 'regression', 'model', 'used', 'to', 'analyze', 'association', 'aki', 'and', 'primary', 'outcome', 'of', 'esrd', 'and', 'secondary', 'outcome', 'of', 'death', '.', 'result', 'aki', 'incidence', '..', 'mean', 'follow-up', 'of', '.', '.', 'year', ',', '.', 'developed', 'esrd', '.', 'hazard', 'ratio', '(', 'hr', ')', 'developing', 'esrd', '.', '(', 'c.i', '.', '.-.', ',', 'p', '.', ')', 'akin', 'stage', 'patient', ',', 'and', '.', '(', 'c.i', '.', '.-.', ',', 'p', '.', ')', 'akin', 'stage', 'and', 'patient', 'hr', 'mortality', '.', '(', 'c.i', '.', '.-.', ',', 'p', '.', ')', 'akin', 'stage', 'patient', ',', 'and', '.', '(', 'c.i', '.', '.-.', ',', 'p', '.', ')', 'akin', 'stage', 'and', 'patient', '.', 'conclusion', 'aki', 'associated', 'with', 'esrd', 'and', 'mortality', 'cardiac', 'surgery', 'in', 'asian', 'population', '.', 'trajectory', 'aki', 'to', 'esrd', 'rapid', 'within', 'year', 'of', 'cardiac', 'surgery', '.', 'concerted', 'periodic', 'follow-up', 'assessment', 'advocated', 'aki', 'patient', 'post-cardiac', 'surgery', '.']"
Effects of 20% albumin infusion therapy during liver transplantation on plasma neutrophil gelatinase-associated lipocalin level: A randomized controlled trial.,"Doyeon Kim, Jeayoun Kim, Sangbin Han, Hyunjoo Jung, Hyung-Doo Park, Justin S Ko, Mi Sook Gwak, Gaab Soo Kim, Doyeon Kimet al.",2023 Aug 1,Liver Transpl,https://pubmed.ncbi.nlm.nih.gov/36749856/,No keywords found,"['risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'liver', 'transplantation', 'lower', 'in', 'patient', 'with', 'serum', 'albumin', 'level', '.', 'mgdl', 'surgery', '.', 'tested', 'whether', 'intraoperative', 'infusion', 'of', 'albumin', 'affect', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'level', ',', 'reliable', 'indicator', 'of', 'aki', '.', 'randomly', 'assigned', 'patient', 'undergoing', 'liver', 'transplantation', 'albumin', 'group', '(', 'n', ',', 'albumin', 'ml', ')', 'and', 'control', 'group', '(', 'n', ',', 'crystalloid', 'solution', 'ml', ')', '.', 'study', 'fluid', 'infused', 'mlh', 'start', 'of', 'anhepatic', 'phase', '.', 'primary', 'outcome', 'plasma', 'ngal', 'level', 'hour', 'graft', 'reperfusion', '.', 'albumin', 'level', 'start', 'of', 'graft', 'reperfusion', 'significantly', 'greater', 'in', 'albumin', 'group', 'in', 'control', 'group', '.', '(', '.-', '.', ')', 'gdl', 'vs.', '.', '(', '.-', '.', ')', 'gdl', ',', 'p', '..', 'ngal', 'level', 'hour', 'graft', 'reperfusion', 'not', 'significantly', 'different', 'group', '.', '(', '.-', '.', ')', 'ngml', 'vs.', '.', '(', '.-', '.', ')', 'ngml', ',', 'p', '.', ',', 'and', 'aki', 'risk', 'not', 'either', '(', '.', 'v', '.', '.', ',', 'adjusted', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'group', 'regarding', 'hospital', 'readmission', 'within', 'day', 'day', 'transplantation', '(', '.', 'v', '.', '.', ',', 'adjusted', 'p', '.', 'and', '.', 'v', '.', '.', ',', 'adjusted', 'p', '.', ')', '.', 'graft', 'survival', 'probability', 'day', 'day', 'year', 'transplantation', '...', 'in', 'albumin', 'group', 'and', '...', 'in', 'control', 'group', 'hr', '.', '(', '.-', '.', ')', ',', 'adjusted', 'p', '..', 'in', 'conclusion', ',', 'intraoperative', 'infusion', 'of', 'albumin', 'ml', 'increased', 'albumin', 'level', 'failed', 'to', 'maintain', 'serum', 'albumin', '.', 'mgdl', 'surgery', '.', 'hypertonic', 'albumin', 'therapy', 'not', 'significantly', 'affect', 'plasma', 'ngal', 'level', 'and', 'clinical', 'outcome', 'including', 'aki', '.']"
Development and validation of prognostic nomogram for cirrhotic patients with acute kidney injury upon ICU admission.,"Tianbao Liao#, Yanyan Lu#, Tingting Su, Liyuan Bei, Xian Li, Yang Lu, Shuang Ren, Lina Huang, Lu-Huai Feng, Tianbao Liaoet al.",2024 Jan,Intern Emerg Med,https://pubmed.ncbi.nlm.nih.gov/37796371/,"Acute kidney injury, Intensive care unit, Model, Nomogram, Prognosis.","['ratio', '.', 'derivation', 'cohort', 'used', 'least', 'absolute', 'shrinkage', 'and', 'selection', 'operator', '(', 'lasso', ')', 'regression', 'model', 'to', 'identify', 'independent', 'predictor', 'of', 'aki', '.', 'prognostic', 'nomogram', 'constructed', 'via', 'multivariate', 'logistic', 'regression', 'analysis', 'in', 'derivation', 'cohort', 'and', 'subsequently', 'verified', 'in', 'validation', 'cohort', '.', 'nomogram', ""'s"", 'discrimination', ',', 'calibration', ',', 'and', 'clinical', 'utility', 'evaluated', 'using', 'c-index', ',', 'calibration', 'plot', ',', 'and', 'decision', 'curve', 'analysis', '(', 'dca', ')', '.', 'total', 'of', 'patient', 'enrolled', 'in', 'derivation', 'cohort', ',', 'with', 'median', 'follow-up', 'period', 'of', 'day', ',', 'median', 'survival', 'time', 'of', 'day', ',', 'and', 'death', 'rate', 'of', 'patient', '(', '.', ')', '.', 'cumulative', 'survival', 'rate', 'and', 'day', '.', 'and', '.', ',', 'respectively', '.', 'result', 'of', 'multivariate', 'analysis', 'indicated', 'advanced', 'aki', 'stage', ',', 'use', 'of', 'vasoactive', 'drug', ',', 'advanced', 'age', ',', 'lower', 'level', 'of', 'alb', ',', 'lower', 'mean', 'sbp', ',', 'longer', 'inr', ',', 'and', 'longer', 'pt', 'independent', 'risk', 'factor', 'significantly', 'influenced', 'all-cause', 'mortality', 'of', 'cirrhosis', 'patient', 'with', 'aki', '(', 'p', '.', ')', '.', 'c-indices', 'derivation', 'and', 'validation', 'cohort', '.', '(', 'ci', '.-', '.', ')', 'and', '.', '(', 'ci', '.-', '.', ')', ',', 'respectively', '.', 'model', ""'s"", 'calibration', 'plot', 'demonstrated', 'high', 'consistency', 'predicted', 'and', 'actual', 'probability', '.', 'furthermore', ',', 'dca', 'showed', 'nomogram', 'clinically', 'valuable', '.', 'therefore', ',', 'developed', 'and', 'internally', 'validated', 'prognostic', 'nomogram', 'exhibited', 'favorable', 'discrimination', ',', 'calibration', ',', 'and', 'clinical', 'utility', 'in', 'forecasting', '-day', 'and', '-day', 'survival', 'rate', 'of', 'cirrhosis', 'patient', 'with', 'aki', 'upon', 'admission', 'to', 'icu', '.']"
High dietary salt intake increases urinary NGAL excretion and creatinine clearance in healthy young adults.,"Alex M Barnett, Matthew C Babcock, Joseph C Watso, Kamila U Migdal, Orlando M Gutiérrez, William B Farquhar, Austin T Robinson, Alex M Barnettet al.",2022 Apr 1,Am J Physiol Renal Physiol,https://pubmed.ncbi.nlm.nih.gov/35157527/,"clinical trial, creatinine clearance, dietary sodium, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, sodium chloride.","['.', '.', 'mmol', 'h', 'vs.', 'salt', '.', '.', 'mmol', 'h', ',', 'p', '.', ')', '.', 'no', 'difference', 'in', 'mean', 'arterial', 'bp', '(', 'placebo', 'mmhg', 'vs.', 'salt', 'mmhg', ',', 'p', '.', ')', 'condition', '.', 'however', ',', 'salt', 'loading', 'increased', 'urinary', 'ngal', 'excretion', 'rate', '(', 'placebo', '.', '.', 'ngmin', 'vs.', 'salt', '.', '.', 'ngmin', ',', 'p', '.', ')', 'and', 'increased', 'creatinine', 'clearance', '(', 'placebo', '.', '.', 'mlmin', 'vs.', 'salt', '.', '.', 'mlmin', ',', 'p', '.', ')', '.', 'urinary', 'kim-', 'excretion', 'not', 'different', 'condition', '.', 'in', 'conclusion', ',', 'in', 'healthy', 'young', 'adult', 'day', 'of', 'dietary', 'salt', 'loading', 'increased', 'creatinine', 'clearance', 'and', 'increased', 'urinary', 'excretion', 'of', 'kidney', 'injury', 'biomarker', 'marker', 'ngal', 'not', 'kim-.new', 'noteworthy', 'in', 'healthy', 'young', 'adult', ',', 'day', 'of', 'dietary', 'salt', 'loading', 'increased', 'creatinine', 'clearance', 'and', 'increased', 'urinary', 'excretion', 'of', 'kidney', 'injury', 'biomarker', 'marker', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'despite', 'no', 'change', 'in', 'resting', 'blood', 'pressure', '.']"
"Dexmedetomidine reduces acute kidney injury after endovascular aortic repair of Stanford type B aortic dissection: A randomized, double-blind, placebo-controlled pilot study.","Xi-Sheng Shan, Hui-Rong Dai, Dan Zhao, Bi-Wen Yang, Xiao-Mei Feng, Hong Liu, Ke Peng, Fu-Hai Ji, Xi-Sheng Shanet al.",2021 Dec:75:110498.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/34488061/,No keywords found,"['to', 'determine', 'effect', 'of', 'dexmedetomidine', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'following', 'endovascular', 'aortic', 'repair', '(', 'evar', ')', 'stanford', 'type', 'b', 'aortic', 'dissection', '(', 'tbad', ')', '.', 'design', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'pilot', 'study', '.', 'setting', 'university', 'hospital', '.', 'patient', 'tbad', 'patient', 'undergoing', 'evar', 'procedure', 'enrolled', '.', 'patient', 'with', 'dissection', 'involving', 'aortic', 'arch', 'or', 'renal', 'artery', 'excluded', '.', 'intervention', 'patient', 'randomly', 'assigned', ',', 'in', 'ratio', ',', 'to', 'dexmedetomidine', 'group', '(', 'intravenous', 'dexmedetomidine', '.', 'gkgh', 'immediately', 'anesthesia', 'induction', 'and', '.', 'gkgh', 'extubation', ',', 'maintained', 'h', ')', 'or', 'normal', 'saline', 'control', 'group', '.', 'measurement', 'primary', 'outcome', 'incidence', 'of', 'aki', 'within', 'first', 'two', 'day', 'surgery', ',', 'based', 'acute', 'kidney', 'injury', 'network', '(', 'akin', ')', 'criterion', '.', 'secondary', 'outcome', 'included', 'serum', 'cystatin', 'c', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'postoperative', 'day', ',', ',', 'and', ',', 'and', 'in-hospital', 'need', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'long-term', 'outcome', 'included', 'rrt', 'and', 'all-cause', 'mortality', '.', 'main', 'result', 'ninety-eight', 'patient', 'completed', 'study', '(', 'dexmedetomidine', ',', 'n', 'control', ',', 'n', ')', '.', 'akin', 'stage', 'aki', 'occurred', 'in', '(', '.', ')', 'patient', 'receiving', 'dexmedetomidine', ',', 'compared', 'with', '(', ')', 'patient', 'receiving', 'normal', 'saline', '(', 'odds', 'ratio', '.', ',', 'ci', '.', 'to', '.', ',', 'p', '.', ')', '.', 'difference', 'remained', 'significant', 'adjusting', 'baseline', 'covariates', '(', 'adjusted', 'odds', 'ratio', '.', ',', 'ci', '.', 'to', '.', 'p', '.', ')', '.', 'dexmedetomidine', 'led', 'to', 'lower', 'serum', 'cystatin', 'c', 'postoperative', 'day', '(', 'median', 'iqr', 'mgl', '.', '.-', '.', 'vs.', '.', '.-.', ')', '.', 'no', 'between-group', 'difference', 'in', 'secondary', 'or', 'long-term', 'outcome', '.', 'follow-up', '(', 'median', '.', 'month', ')', ',', 'patient', 'in', 'dexmedetomidine', 'group', 'and', 'patient', 'in', 'control', 'group', 'required', 'rrt', '.', 'conclusion', 'dexmedetomidine', 'reduced', 'incidence', 'of', 'aki', 'in', 'tbad', 'patient', 'evar', 'procedure', '.', 'long-term', 'benefit', 'of', 'dexmedetomidine', 'in', 'patient', 'population', 'warrant', 'investigation', '.', 'trial', 'registration', 'chictr-ipr-', '.']"
Decreased renal perfusion during acute kidney injury in critical COVID-19 assessed by magnetic resonance imaging: a prospective case control study.,"Tomas Luther#, Per Eckerbom#, Eleanor Cox, Miklos Lipcsey, Sara Bülow, Michael Hultström, Francisco Martinez Torrente, Jan Weis, Fredrik Palm, Susan Francis, Robert Frithiof#, Per Liss#, Tomas Lutheret al.",2022 Sep 1,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36050748/,No keywords found,"['renal', 'hypoperfusion', 'suggested', 'to', 'contribute', 'to', 'development', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'critical', 'covid-', '.', 'however', ',', 'limited', 'data', 'exist', 'to', 'support', '.', 'aim', 'to', 'investigate', 'difference', 'in', 'renal', 'perfusion', ',', 'oxygenation', 'and', 'water', 'diffusion', 'using', 'multiparametric', 'magnetic', 'resonance', 'imaging', 'in', 'critically', 'ill', 'covid-', 'patient', 'with', 'and', 'without', 'aki', '.', 'method', 'prospective', 'case-control', 'study', 'patient', 'without', 'prior', 'kidney', 'disease', 'treated', 'in', 'intensive', 'care', 'respiratory', 'failure', 'due', 'to', 'covid-', 'examined', '.', 'kidney', 'disease', 'improving', 'global', 'outcome', 'creatinine', 'criterion', 'used', 'group', 'allocation', '.', 'main', 'comparison', 'tested', 'using', 'mann-whitney', 'u', 'test', '.', 'result', 'nineteen', 'patient', 'examined', ',', 'ten', 'with', 'aki', 'and', 'nine', 'without', 'aki', '.', 'patient', 'with', 'aki', 'examined', 'in', 'median', '-', 'day', 'criterion', 'fulfillment', '.', 'age', 'and', 'baseline', 'plasma-creatinine', 'similar', 'in', 'group', '.', 'total', 'renal', 'blood', 'flow', 'lower', 'in', 'patient', 'with', 'aki', 'compared', 'with', 'patient', 'without', '(', 'median', 'quartile', 'range', '-', 'vs.', '-', 'mlmin', ',', 'p', '.', ')', '.', 'regional', 'perfusion', 'reduced', 'in', 'cortex', '(', '-', 'vs.', '-', 'ml', 'gmin', ',', 'p', '.', ')', 'and', 'medulla', '(', '-', 'vs.', '-', 'ml', 'gmin', ',', 'p', '.', ')', '.', 'renal', 'venous', 'saturation', 'similar', 'in', 'group', '(', '-', 'vs.', '-', ',', 'n', '.', ')', ',', 'regional', 'oxygenation', '(', 'r', ')', 'in', 'cortex', '(', '-', 'vs.', '-', ',', 'n', '.', ')', 'and', 'medulla', '(', '-', 'vs.', '-', ',', 'ns.', ')', '.', 'conclusion', 'in', 'critically', 'ill', 'covid-', 'patient', 'with', 'aki', ',', 'total', ',', 'cortical', 'and', 'medullary', 'renal', 'blood', 'flow', 'reduced', 'compared', 'with', 'similar', 'patient', 'without', 'aki', ',', 'whereas', 'no', 'difference', 'in', 'renal', 'oxygenation', 'demonstrable', 'in', 'setting', '.', 'trial', 'registration', 'clinicaltrials', 'id', 'nct', ',', 'registered', 'may', 'and', 'updated', 'may', '.']"
"Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.","Stéphane Gaudry, David Hajage, Laurent Martin-Lefevre, Saïd Lebbah, Guillaume Louis, Sébastien Moschietto, Dimitri Titeca-Beauport, Béatrice La Combe, Bertrand Pons, Nicolas de Prost, Sébastien Besset, Alain Combes, Adrien Robine, Marion Beuzelin, Julio Badie, Guillaume Chevrel, Julien Bohé, Elisabeth Coupez, Nicolas Chudeau, Saber Barbar, Christophe Vinsonneau, Jean-Marie Forel, Didier Thevenin, Eric Boulet, Karim Lakhal, Nadia Aissaoui, Steven Grange, Marc Leone, Guillaume Lacave, Saad Nseir, Florent Poirson, Julien Mayaux, Karim Asehnoune, Guillaume Geri, Kada Klouche, Guillaume Thiery, Laurent Argaud, Bertrand Rozec, Cyril Cadoz, Pascal Andreu, Jean Reignier, Jean-Damien Ricard, Jean-Pierre Quenot, Didier Dreyfuss, Stéphane Gaudryet al.",2021 Apr 3,Lancet,https://pubmed.ncbi.nlm.nih.gov/33812488/,No keywords found,"['delaying', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'time', 'in', 'critically', 'ill', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', 'and', 'no', 'severe', 'complication', 'safe', 'and', 'allows', 'optimisation', 'of', 'use', 'of', 'medical', 'device', '.', 'major', 'uncertainty', 'remains', 'concerning', 'duration', 'rrt', 'postponed', 'without', 'risk', '.', 'aim', 'to', 'test', 'hypothesis', 'more-delayed', 'initiation', 'strategy', 'would', 'result', 'in', 'rrt-free', 'day', ',', 'compared', 'with', 'delayed', 'strategy', '.', 'method', 'unmasked', ',', 'multicentre', ',', 'prospective', ',', 'open-label', ',', 'randomised', ',', 'controlled', 'trial', 'done', 'in', 'intensive', 'care', 'unit', 'in', 'france', '.', 'monitored', 'critically', 'ill', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', '(', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', 'stage', ')', 'oliguria', 'h', 'or', 'blood', 'urea', 'nitrogen', 'concentration', 'higher', 'mgdl', '.', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'either', 'strategy', '(', 'delayed', 'strategy', ')', 'in', 'rrt', 'started', 'randomisation', 'or', 'to', 'more-delayed', 'strategy', '.', 'with', 'more-delayed', 'strategy', ',', 'rrt', 'initiation', 'postponed', 'mandatory', 'indication', '(', 'noticeable', 'hyperkalaemia', 'or', 'metabolic', 'acidosis', 'or', 'pulmonary', 'oedema', ')', 'or', 'blood', 'urea', 'nitrogen', 'concentration', 'reached', 'mgdl', '.', 'primary', 'outcome', 'number', 'of', 'day', 'alive', 'and', 'free', 'of', 'rrt', 'randomisation', 'and', 'day', 'and', 'done', 'in', 'intention-to-treat', 'population', '.', 'study', 'registered', 'with', 'clinicaltrial.gov', ',', 'nct', 'and', 'completed', '.', 'finding', 'may', ',', ',', 'and', 'oct', ',', ',', 'of', 'patient', 'assessed', ',', 'patient', 'underwent', 'randomisation', 'assigned', 'to', 'delayed', 'strategy', 'and', 'to', 'more-delayed', 'strategy', '.', 'number', 'of', 'complication', 'potentially', 'related', 'to', 'acute', 'kidney', 'injury', 'or', 'to', 'rrt', 'similar', 'group', '.', 'median', 'number', 'of', 'rrt-free', 'day', 'day', '(', 'iqr', '-', ')', 'in', 'delayed', 'strategy', 'and', 'day', '(', 'iqr', '-', ')', 'in', 'more-delayed', 'strategy', '(', 'p', ')', '.', 'in', 'multivariable', 'analysis', ',', 'hazard', 'ratio', 'death', 'day', '(', 'ci', '-', ',', 'p', ')', 'with', 'more-delayed', 'versus', 'delayed', 'strategy', '.', 'number', 'of', 'complication', 'potentially', 'related', 'to', 'acute', 'kidney', 'injury', 'or', 'renal', 'replacement', 'therapy', 'not', 'differ', 'group', '.', 'interpretation', 'in', 'severe', 'acute', 'kidney', 'injury', 'patient', 'with', 'oliguria', 'h', 'or', 'blood', 'urea', 'nitrogen', 'concentration', 'higher', 'mgdl', 'and', 'no', 'severe', 'complication', 'would', 'mandate', 'immediate', 'rrt', ',', 'longer', 'postponing', 'of', 'rrt', 'initiation', 'not', 'confer', 'additional', 'benefit', 'and', 'associated', 'with', 'potential', 'harm', '.', 'funding', 'programme', 'hospitalier', 'de', 'recherche', 'clinique', '.']"
A safe and effective protocol for postdilution hemofiltration with regional citrate anticoagulation.,"Thomas Dimski, Timo Brandenburger, Christian Vollmer, Detlef Kindgen-Milles, Thomas Dimskiet al.",2024 Jul 9,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/38982339/,No keywords found,"['regional', 'citrate', 'anticoagulation', '(', 'rca', ')', 'recommended', 'continuous', 'renal', 'replacement', 'therapy', '.', 'compared', 'to', 'systemic', 'anticoagulation', ',', 'rca', 'provides', 'longer', 'filter', 'lifespan', 'with', 'risk', 'of', 'metabolic', 'alkalosis', 'and', 'impaired', 'calcium', 'homeostasis', '.', 'surprisingly', ',', 'rca', 'protocol', 'designed', 'continuous', 'veno-venous', 'hemodialysis', 'or', 'hemodiafiltration', '.', 'effective', 'protocol', 'continuous', 'veno-venous', 'hemofiltration', '(', 'cvvh', ')', 'rare', ',', 'although', 'cvvh', 'standard', 'treatment', 'high-molecular-weight', 'clearance', '.', 'therefore', ',', 'evaluated', 'new', 'rca', 'protocol', 'postdilution', 'cvvh', '.', 'method', 'monocentric', 'prospective', 'interventional', 'study', 'to', 'evaluate', 'new', 'rca', 'protocol', 'postdilution', 'cvvh', '.', 'recruited', 'surgical', 'patient', 'with', 'stage', 'iii', 'acute', 'kidney', 'injury', 'needed', 'renal', 'replacement', 'therapy', '.', 'recorded', 'dialysis', 'and', 'rca', 'data', 'and', 'hemodynamic', 'and', 'laboratory', 'parameter', 'treatment', 'session', 'of', 'h.', 'primary', 'endpoint', 'filter', 'patency', 'h.', 'major', 'safety', 'parameter', 'metabolic', 'alkalosis', 'and', 'severe', 'hypocalcemia', 'time', '.', 'result', 'included', 'patient', 'underwent', 'treatment', 'session', '.', 'mean', 'filter', 'lifespan', 'h', ',', 'and', 'of', '(', ')', 'filter', 'patent', 'h.', 'censoring', 'non-cvvh-related', 'cessation', 'of', 'treatment', ',', 'of', 'filter', 'patent', 'h.', 'delivered', 'dialysis', 'dose', 'mlkgbwh', '.', 'serum', 'level', 'of', 'creatinine', ',', 'urea', 'and', 'beta-microglobulin', 'decreased', 'significantly', 'day', 'to', 'day', '.', 'metabolic', 'alkalosis', 'occurred', 'in', 'one', 'patient', '.', 'ica', '.', 'mmoll', 'occurred', 'in', 'four', 'patient', '.', 'citrate', 'accumulation', 'not', 'occur', '.', 'conclusion', 'describe', 'safe', ',', 'effective', ',', 'and', 'easy-to-use', 'rca', 'protocol', 'postdilution', 'cvvh', '.', 'protocol', 'provides', 'long', 'and', 'sustained', 'filter', 'lifespan', 'without', 'serious', 'adverse', 'effect', '.', 'risk', 'of', 'metabolic', 'alkalosis', 'and', 'hypocalcemia', 'low', '.', 'using', 'protocol', ',', 'recommended', 'dialysis', 'dose', 'safely', 'administered', 'with', 'effective', 'clearance', 'of', 'low-', 'and', 'middle-molecular-weight', 'molecule', '.', 'trial', 'registration', 'study', 'approved', 'medical', 'ethic', 'committee', 'of', 'heinrich-heine', 'university', 'duesseldorf', '(', 'no', '.', '-kfogu', ')', '.', 'trial', 'registered', 'in', 'local', 'study', 'register', 'of', 'university', '(', 'no', ')', 'and', 'retrospectively', 'registered', 'clinicaltrials.gov', '(', 'clinicaltrials.gov', 'identifier', 'nct', ')', '.']"
Deterioration of renal function at stent implantation can predict long-term outcome after stent thrombosis.,"Vojko Kanic, Meta Penko, Franjo Husam Naji, Robert Ekart, Zlatka Kanic, Dejan Dinevski, Radovan Hojs, Vojko Kanicet al.",2015 Dec:127 Suppl 5:S181-6.,Wien Klin Wochenschr,https://pubmed.ncbi.nlm.nih.gov/26377173/,No keywords found,"['aim', 'of', 'study', 'to', 'examine', 'possible', 'influence', 'of', 'minor', 'deterioration', 'of', 'renal', 'function', 'stent', 'implantation', 'not', 'fulfilling', 'criterion', 'acute', 'kidney', 'injury', 'long-term', 'outcome', 'stent', 'thrombosis', '(', 'st', ')', '.', 'background', 'decreased', 'renal', 'function', '(', 'drf', ')', 'associated', 'with', 'increased', 'risk', 'worse', 'outcome', 'percutaneous', 'coronary', 'intervention', '.', 'no', 'data', 'deterioration', 'of', 'renal', 'function', 'stent', 'implantation', 'influence', 'prognosis', 'st.', 'patient', 'with', 'higher', 'risk', 'worse', 'outcome', 'st', 'could', 'identified', 'already', 'time', 'of', 'stent', 'implantation', '.', 'method', 'data', 'consecutive', 'patient', 'treated', 'with', 'percutaneous', 'coronary', 'intervention', 'in', 'center', 'recorded', 'march', 'to', 'april', '.', 'excluded', 'patient', 'with', 'acute', 'kidney', 'injury', 'stent', 'implantation', 'and', 'of', 'with', 'st', 'without', 'acute', 'kidney', 'injury', 'stent', 'implantation', 'involved', 'in', 'study', '.', 'prospectively', 'followed', 'december', '.', '.', 'month', '.', 'patient', 'with', 'definite', 'st', 'included', 'in', 'study', '.', 'academic', 'research', 'consortium', 'definition', 'of', 'st', 'used', '.', 'data', 'death', ',', 'myocardial', 'infarction', ',', 'and', 'repeated', 'percutaneous', 'or', 'operative', 'revascularization', 'st', 'ascertained', 'hospital', 'database', ',', 'phone', 'or', 'with', 'clinical', 'examination', '.', 'outcome', 'definite', 'st', 'compared', 'in', 'patient', 'with', 'and', 'without', 'deterioration', 'of', 'renal', 'function', 'stent', 'implantation', '(', 'drfaftersi', ')', '.', 'result', 'observational', 'period', 'patient', 'with', 'drfaftersi', 'higher', 'mortality', 'rate', 'st', 'patient', 'without', 'drfaftersi', '(', '.', 'vs.', '.', 'p', 'year', '(', 'adjusted', 'hr', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'could', 'not', 'find', 'predictor', 'mace', '.', 'conclusion', 'even', 'subtle', 'drfaftersi', '(', 'not', 'fulfilling', 'criterion', 'acute', 'kidney', 'injury', ')', 'stent', 'implantation', 'associated', 'with', 'higher', 'long-term', 'mortality', 'st.', 'especially', 'risk', 'patient', 'older', 'year', 'stent', 'implantation', '.', 'drfaftersi', 'and', 'age', 'year', 'pointed', 'group', 'of', 'patient', 'with', 'high', 'risk', 'death', 'st', 'already', 'time', 'of', 'stent', 'implantation', '.', 'best', 'treatment', 'option', 'preventing', 'st', 'in', 'patient', 'still', 'to', 'determined', '.', ',', 'must', 'pay', 'special', 'attention', 'to', 'proper', 'patient', ""'"", 'preparation', 'and', 'hydration', 'to', 'avoid', 'drfaftersi', '.']"
Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial.,"Matthew T James, Bryan J Har, Benjamin D Tyrrell, Peter D Faris, Zhi Tan, John A Spertus, Stephen B Wilton, William A Ghali, Merril L Knudtson, Tolulope T Sajobi, Neesh I Pannu, Scott W Klarenbach, Michelle M Graham, Matthew T Jameset al.",2022 Sep 6,JAMA,https://pubmed.ncbi.nlm.nih.gov/36066520/,No keywords found,"['contrast-associated', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'complication', 'of', 'coronary', 'angiography', 'and', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'associated', 'with', 'high', 'cost', 'and', 'adverse', 'long-term', 'outcome', '.', 'objective', 'to', 'determine', 'whether', 'multifaceted', 'intervention', 'effective', 'prevention', 'of', 'aki', 'coronary', 'angiography', 'or', 'pci', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'stepped-wedge', ',', 'cluster', 'randomized', 'clinical', 'trial', 'conducted', 'in', 'alberta', ',', 'canada', ',', 'included', 'invasive', 'cardiologist', 'cardiac', 'catheterization', 'laboratory', 'randomized', 'to', 'various', 'start', 'date', 'intervention', 'january', 'and', 'september', '.', 'eligible', 'patient', 'aged', 'year', 'or', 'older', 'underwent', 'nonemergency', 'coronary', 'angiography', ',', 'pci', ',', 'or', 'not', 'undergoing', 'dialysis', 'and', 'predicted', 'aki', 'risk', 'of', 'greater', '.', 'thirty-four', 'physician', 'performed', 'procedure', 'among', 'patient', 'met', 'inclusion', 'criterion', '.', 'participant', 'follow-up', 'ended', 'in', 'november', '.', 'intervention', 'intervention', 'period', ',', 'cardiologist', 'received', 'educational', 'outreach', ',', 'computerized', 'clinical', 'decision', 'support', 'contrast', 'volume', 'and', 'hemodynamic-guided', 'intravenous', 'fluid', 'target', ',', 'and', 'audit', 'and', 'feedback', '.', 'control', '(', 'preintervention', ')', 'period', ',', 'cardiologist', 'provided', 'usual', 'care', 'and', 'not', 'receive', 'intervention', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'aki', '.', 'secondary', 'outcome', ',', 'including', 'contrast', 'volume', ',', 'intravenous', 'fluid', 'administration', ',', 'and', 'major', 'adverse', 'cardiovascular', 'and', 'kidney', 'event', '.', 'analysis', 'conducted', 'using', 'time-adjusted', 'model', '.', 'result', 'of', 'participating', 'cardiologist', 'divided', 'cluster', 'practice', 'group', 'and', 'center', ',', 'intervention', 'group', 'included', 'performed', 'procedure', 'among', 'patient', '(', 'mean', 'age', ',', '.', 'sd', ',', '.', 'year', 'woman', '.', ')', 'and', 'control', 'group', 'included', 'performed', 'procedure', 'among', 'patient', '(', 'mean', 'age', ',', '.', 'sd', ',', '.', 'year', 'woman', '.', ')', '.', 'incidence', 'of', 'aki', '.', '(', 'event', 'procedure', ')', 'intervention', 'period', 'and', '.', '(', 'event', 'procedure', ')', 'control', 'period', '(', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'odds', 'ratio', 'or', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'of', 'prespecified', 'secondary', 'outcome', ',', 'showed', 'no', 'significant', 'difference', '.', 'proportion', 'of', 'procedure', 'in', 'excessive', 'contrast', 'volume', 'used', 'reduced', 'to', '.', 'intervention', 'period', '.', 'control', 'period', '(', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'or', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'proportion', 'of', 'procedure', 'in', 'eligible', 'patient', 'in', 'insufficient', 'intravenous', 'fluid', 'given', 'reduced', 'to', '.', 'intervention', 'period', '.', 'control', 'period', '(', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'or', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'no', 'significant', 'between-group', 'difference', 'in', 'major', 'adverse', 'cardiovascular', 'event', 'or', 'major', 'adverse', 'kidney', 'event', '.', 'conclusion', 'and', 'relevance', 'among', 'cardiologist', 'randomized', 'to', 'intervention', 'including', 'clinical', 'decision', 'support', 'with', 'audit', 'and', 'feedback', ',', 'patient', 'undergoing', 'coronary', 'procedure', 'intervention', 'period', 'less', 'likely', 'to', 'develop', 'aki', 'compared', 'with', 'treated', 'control', 'period', ',', 'with', 'time-adjusted', 'absolute', 'risk', 'reduction', 'of', '..', 'whether', 'intervention', 'would', 'show', 'efficacy', 'outside', 'study', 'setting', 'requires', 'investigation', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
"Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial.","Yaron Arbel, Valentin Fuster, Usman Baber, Taye H Hamza, F S Siami, Michael E Farkouh, Yaron Arbelet al.",2019 Oct 15:293:197-202.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/31230933/,No keywords found,"['incidence', 'and', 'prognostic', 'significance', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'patient', 'with', 'diabetes', 'mellitus', 'and', 'multivessel', 'coronary', 'artery', 'disease', 'undergoing', 'coronary', 'revascularization', 'not', 'well', 'known', '.', 'current', 'analysis', 'included', 'patient', 'randomized', 'to', 'pci', 'vs.', 'cabg', 'part', 'of', 'freedom', 'trial', '.', 'sought', 'to', 'examine', 'impact', 'of', 'aki', 'and', 'predictor', 'in', 'diabetic', 'patient', 'with', 'multivessel', 'coronary', 'artery', 'disease', 'undergoing', 'pci', 'vs.', 'cabg', '.', 'method', 'conducted', 'pre-specified', 'subgroup', 'analysis', 'of', 'freedom', 'trial', 'to', 'examine', 'incidence', ',', 'correlate', 'and', 'impact', 'of', 'aki', 'according', 'to', 'revascularization', 'strategy', '.', 'aki', 'predictor', 'identified', 'using', 'multivariable', 'logistic', 'regression', 'and', 'association', 'aki', 'and', 'outcome', 'examined', 'using', 'cox', 'regression', '.', 'primary', 'endpoint', 'composite', 'occurrence', 'of', 'all-cause', 'death', ',', 'stroke', 'or', 'myocardial', 'infarction', 'year', 'of', 'follow-up', '.', 'result', 'ki', 'occurred', 'frequently', 'in', 'patient', 'following', 'cabg', '(', '.', ')', 'compared', 'with', 'pci', '(', '.', ')', '(', 'p', '.', ')', '.', 'aki', 'associated', 'with', 'higher', 'risk', 'major', 'cardiovascular', 'event', '(', 'mace', ')', 'year', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', ',', 'effect', 'remained', 'large', 'and', 'significant', 'irrespective', 'of', 'cabg', '(', 'hr', '.', 'ci', '.-.', ',', 'p', '.', ')', 'or', 'pci', '(', 'hr', '.', 'ci', '.-.', ',', 'p', '.', ')', '.', 'non-significant', 'interaction', '(', 'p-value', '.', ')', 'revascularization', 'method', 'and', 'aki', ',', 'supporting', 'aki', 'significant', 'risk', 'factor', 'in', 'revascularization', 'method', '.', 'conclusion', 'although', 'risk', 'aki', 'higher', 'in', 'patient', 'undergoing', 'cabg', ',', 'impact', 'of', 'aki', 'mace', 'substantial', 'irrespective', 'of', 'revascularization', 'strategy', '.', 'preventive', 'strategy', 'to', 'identify', 'patient', 'risk', 'aki', 'warranted', 'to', 'mitigate', 'long-term', 'effect', 'of', 'complication', '.']"
Risk factors for acute kidney injury at presentation among children with CNS malaria: a case control study.,"Derby Tembo, Suzanna Mwanza, Chisambo Mwaba, Ifunanya Dallah, Somwe Wa Somwe, Karl B Seydel, Gretchen L Birbeck, Derby Temboet al.",2022 Nov 1,Malar J,https://pubmed.ncbi.nlm.nih.gov/36316704/,No keywords found,"['recent', 'research', 'established', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'problem', 'in', 'severe', 'paediatric', 'malaria', '.', 'limited', 'access', 'to', 'kidney', 'diagnostic', 'study', 'in', 'low', 'resource', 'setting', 'malaria', 'common', 'constrained', 'research', 'important', 'problem', '.', 'method', 'enrolment', 'data', 'ongoing', 'clinical', 'trial', 'of', 'antipyretic', 'in', 'child', 'with', 'central', 'nervous', 'system', '(', 'cns', ')', 'malaria', ',', 'cns', 'malaria', 'malaria', 'with', 'seizure', 'or', 'coma', ',', 'used', 'to', 'identify', 'risk', 'factor', 'aki', 'presentation', '.', 'child', '-', 'year', 'old', 'with', 'cns', 'malaria', 'underwent', 'screening', 'and', 'enrollment', 'assessment', 'included', 'demographic', 'and', 'anthropomorphic', 'data', ',', 'clinical', 'detail', 'regarding', 'acute', 'illness', ',', 'and', 'laboratory', 'study', 'including', 'creatinine', '(', 'cr', ')', ',', 'quantitative', 'parasite', 'count', '(', 'qpc', ')', ',', 'quantitative', 'histidine', 'rich', 'protein', '(', 'hrp', ')', ',', 'lactate', ',', 'and', 'bilirubin', 'level', '.', 'child', 'with', 'screening', 'cr', 'moll', 'excluded', 'study', 'due', 'to', 'potential', 'nephrotoxic', 'effect', 'of', 'study', 'drug', '.', 'to', 'identify', 'risk', 'factor', 'aki', 'time', 'of', 'admission', ',', 'child', 'enrolled', 'in', 'study', 'categorized', 'aki', 'using', 'estimate', 'of', 'baseline', '(', 'i.e', '.', 'acute', 'illness', ')', 'kidney', 'function', 'and', 'creatinine', 'enrollment', 'applying', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'guideline', '.', 'logistic', 'regression', 'and', 'multivariate', 'model', 'used', 'to', 'identify', 'clinical', 'and', 'demographic', 'risk', 'factor', 'aki', 'presentation', 'among', 'child', 'enrolled', 'in', 'study', '.', 'result', 'child', 'screened', ',', 'age-appropriate', 'with', 'cns', 'malaria', ',', '(', '.', ')', 'excluded', 'due', 'to', 'cr', 'moll', ',', 'and', 'enrolled', '.', 'among', ',', 'aki', 'using', 'kdigo', 'criterion', 'observed', 'in', '(', '.', ')', '.', 'one', 'child', 'required', 'dialysis', 'recovery', '.', 'risk', 'factor', 'aki', 'in', 'logistic', 'regression', 'and', 'multivariate', 'model', 'included', 'hyperpyrexia', '(', 'or', '.', 'ci', '.-', '.', ')', 'and', 'age', 'with', 'older', 'child', 'less', 'likely', 'to', 'aki', '(', 'or', '.', 'ci', '.-.', ')', '.', 'conclusion', 'aki', 'extremely', 'common', 'among', 'child', 'presenting', 'with', 'cns', 'malaria', '.', 'hyperpyrexia', 'with', 'associated', 'dehydration', 'may', 'contribute', 'to', 'aki', 'or', 'may', 'simply', 'marker', 'inflammatory', 'systemic', 'response', 'also', 'affecting', 'kidney', '.', 'appropriate', 'fluid', 'management', 'in', 'child', 'with', 'cns', 'malaria', 'and', 'aki', 'may', 'challenging', 'since', 'generous', 'hydration', 'to', 'support', 'kidney', 'recovery', 'could', 'worsen', 'malaria-induced', 'cerebral', 'oedema', 'in', 'critically', 'ill', 'population', '.', 'trial', 'registration', 'httpsclinicaltrials.govctshownct', '.']"
Dietary restriction for prevention of contrast-induced acute kidney injury in patients undergoing percutaneous coronary angiography: a randomized controlled trial.,"Franziska Grundmann, Roman-Ulrich Müller, Karla Johanna Ruth Hoyer-Allo, Martin Richard Späth, Eva Passmann, Ingrid Becker, Roman Pfister, Stephan Baldus, Thomas Benzing, Volker Burst, Franziska Grundmannet al.",2020 Mar 23,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/32251303/,No keywords found,"['.', '(', '-.', ',', '.', ')', 'mgdl', 'vs.', 'control', '.', '(', '-.', ',', '.', ')', 'mgdlp', '.', ')', '.', 'subgroup', 'analysis', 'revealed', 'significant', 'beneficial', 'impact', 'of', 'dr', 'in', 'patient', 'received', 'ml', 'of', 'contrast', 'agent', '(', 'dr', 'n', 'creatinine', '-.', '(', '-.', ',', '.', ')', 'mgdl', 'vs.', 'control', 'n', 'creatinine', '.', '(', '-.', ',', '.', ')', 'mgdl', 'p', '.', ')', 'and', 'in', 'patient', 'with', 'risk', 'factor', 'aki', '(', 'dr', 'n', 'creatinine', '-.', '(', '-.', ',', '.', ')', 'mgdl', 'vs.', 'control', 'n', 'creatinine', '.', '(', '-.', ',', '.', ')', 'mgdl', 'p', '.', ')', '.', 'although', 'primary', 'endpoint', 'not', 'met', ',', 'result', 'of', 'trial', 'suggest', 'beneficial', 'impact', 'of', 'dr', 'in', 'low-to-moderate', 'risk', 'patient', '.']"
Clinical Assessment of Perfusion Techniques During Surgical Repair of Coarctation of Aorta With Aortic Arch Hypoplasia in Neonates: A Pilot Prospective Randomized Study.,"Y Y Kulyabin, A V Bogachev-Prokophiev, I A Soynov, A Y Omelchenko, A V Zubritskiy, Y N Gorbatykh, Y Y Kulyabinet al.",2020,Semin Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/32446921/,"Acute kidney injury, Antegrade cerebral perfusion, Aortic arch, Congenital.","['nct', ')', '.', 'patient', 'randomly', 'assigned', 'group', 'according', 'to', 'perfusion', 'strategy', '(', 'deep', 'hypothermic', 'circulatory', 'arrest', ',', 'n', 'selective', 'antegrade', 'cerebral', 'perfusion', ',', 'n', 'double', 'arterial', 'cannulation', ',', 'n', ')', '.', 'primary', 'composite', 'endpoint', 'incidence', 'of', 'adverse', 'event', 'in', 'early', 'postoperative', 'period', '(', 'acute', 'kidney', 'injury', 'kdigo', 'criterion', ',', 'new', 'brain', 'magnetic', 'resonance', 'imaging', '(', 'mri', ')', 'finding', ',', 'and', 'in-hospital', 'mortality', ')', '.', 'secondary', 'endpoint', 'intensive', 'care', 'unit', 'length', 'of', 'stay', ',', 'vasoactive-inotropic', 'score', 'index', ',', 'and', 'cardiopulmonary', 'bypass', 'duration', '.', 'patient', 'underwent', 'aortic', 'arch', 'reconstruction', 'cardiopulmonary', 'bypass', 'and', 'monitored', 'with', 'near-infrared', 'spectroscopy', 'surgery', '.', 'no', 'significant', 'difference', 'in', 'baseline', 'characteristic', 'and', 'cardiopulmonary', 'bypass', 'duration', 'observed', 'among', 'group', '.', 'incidence', 'of', 'unfavorable', 'event', 'lower', 'in', 'double', 'arterial', 'cannulation', 'group', '(', 'p', '.', ')', '.', 'acute', 'kidney', 'injury', 'observed', 'in', ',', ',', 'and', 'patient', 'deep', 'hypothermic', 'circulatory', 'arrest', ',', 'selective', 'antegrade', 'cerebral', 'perfusion', ',', 'and', 'double', 'arterial', 'cannulation', 'group', ',', 'respectively', '(', 'p', '.', ')', '.', 'twelve', 'patient', 'deep', 'hypothermic', 'circulatory', 'arrest', 'group', 'new', 'brain', 'mri', 'finding', '(', 'p', '.', ')', '.', 'in-hospital', 'death', 'with', 'no', 'significant', 'difference', 'among', 'group', '(', 'p', '.', ')', '.', '``', 'head', ""''"", 'and', '``', 'lumbar', ""''"", 'value', 'near-infrared', 'spectroscopy', 'aortic', 'arch', 'reconstruction', 'significantly', 'higher', 'in', 'selective', 'antegrade', 'cerebral', 'perfusion', 'and', 'double', 'arterial', 'cannulation', 'group', 'in', 'deep', 'hypothermic', 'circulatory', 'arrest', 'group', '.', 'patient', 'in', 'double', 'arterial', 'cannulation', 'group', 'significantly', 'lower', 'vasoactive-inotropic', 'score', 'index', 'hour', 'postoperatively', 'deep', 'hypothermic', 'circulatory', 'arrest', 'group', '(', 'p', '.', ')', '.', 'vasoactive-inotropic', 'score', 'index', 'found', 'to', 'risk', 'factor', 'acute', 'kidney', 'injury', 'and', 'early', 'mortality', '.', 'continuous', 'regional', 'perfusion', 'aortic', 'arch', 'reconstruction', 'decrease', 'risk', 'of', 'new', 'brain', 'mri', 'finding', 'in', 'infant', 'and', 'need', 'postoperative', 'inotropic', 'support', '.', 'although', 'value', 'of', 'near-infrared', 'spectroscopy', 'procedure', 'significantly', 'higher', 'with', 'continuous', 'perfusion', 'strategy', ',', 'method', 'not', 'reduce', 'acute', 'kidney', 'injury', 'incidence', 'compared', 'to', 'with', 'deep', 'hypothermic', 'circulatory', 'arrest', '.', 'double', 'arterial', 'cannulation', 'significantly', 'reduces', 'need', 'inotropic', 'support', '.']"
Distribution of Acute and Chronic Kidney Disease Across Clinical Phenotypes for Sepsis.,"Luca Molinari, Gaspar Del Rio-Pertuz, Priyanka Priyanka, Ali Smith, Joseph C Maggiore, Jason Kennedy, Hernando Gomez, Christopher W Seymour, John A Kellum                              ;, ProCESS and ProGReSS-AKI Investigators, Luca Molinariet al.",2024 Sep,Chest,https://pubmed.ncbi.nlm.nih.gov/38462074/,No keywords found,"['sepsis', 'common', 'cause', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'critically', 'ill', 'patient', '.', 'four', 'phenotype', '(', ',', ',', ',', ')', 'sepsis', ',', 'different', 'outcome', 'and', 'response', 'to', 'treatment', ',', 'described', 'using', 'routine', 'clinical', 'data', 'in', 'electronic', 'health', 'record', '.', 'research', 'question', 'frequency', 'of', 'aki', ',', 'acute', 'kidney', 'disease', '(', 'akd', ')', ',', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', ',', 'and', 'aki', 'ckd', 'differ', 'sepsis', 'phenotype', 'study', 'design', 'and', 'method', 'secondary', 'analysis', 'of', 'randomized', 'clinical', 'trial', 'of', 'early', 'resuscitation', ',', 'including', 'patient', 'with', 'septic', 'shock', 'site', '.', 'excluding', 'patient', 'with', 'end-stage', 'kidney', 'disease', 'and', 'missing', 'data', ',', 'determined', 'frequency', 'of', 'following', 'clinical', 'outcome', 'aki', '(', 'defined', 'within', 'h', 'kidney', 'disease', 'improving', 'global', 'outcome', 'stage', 'or', 'or', 'stage', 'with', 'tissue', 'inhibitor', 'of', 'metalloproteinases-', 'insulin-like', 'growth', 'factor', 'binding', 'protein', 'value', 'of', '.', ')', ',', 'ckd', ',', 'and', 'akd', '(', 'persistence', 'of', 'aki', 'stage', 'day', 'enrollment', ')', 'across', 'four', 'phenotype', '.', 'performed', 'multivariable', 'logistic', 'regression', 'to', 'assess', 'risk-adjusted', 'association', 'development', 'of', 'aki', 'and', 'akd', 'and', 'phenotype', '.', 'result', 'among', ',', 'eligible', 'patient', ',', 'patient', '(', ')', 'aki', '.', 'across', 'phenotype', ',', 'frequency', 'of', 'aki', 'varied', ',', 'highest', 'in', 'and', 'phenotype', '(', 'and', ',', 'respectively', ')', 'and', 'lowest', 'in', 'phenotype', '(', 'p', '.', ')', '.', 'akd', 'occurred', 'often', 'in', 'phenotype', '(', ')', 'and', 'least', 'often', 'in', 'phenotype', '(', 'p', '.', ')', '.', 'highest', 'frequency', 'of', 'ckd', 'and', 'of', 'aki', 'ckd', 'found', 'in', 'phenotype', '(', 'and', 'respectively', 'p', '.', ')', '.', 'in', 'multivariable', 'logistic', 'regression', 'model', '(', 'phenotype', 'reference', ')', ',', 'phenotype', 'showed', 'strongest', 'association', 'with', 'aki', '(', 'or', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', 'and', 'akd', '(', 'or', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'interpretation', 'rate', 'of', 'aki', 'and', 'akd', 'differed', 'across', 'clinical', 'sepsis', 'phenotype', 'and', 'common', 'among', 'patient', 'with', 'phenotype', 'and', '.', 'phenotype', 'showed', 'higher', 'level', 'of', 'underlying', 'ckd', 'predisposed', 'patient', 'to', 'new', 'aki', '.', 'and', 'phenotype', 'showed', 'lower', 'frequency', 'of', 'aki', 'and', 'less', 'progression', 'to', 'akd', '.']"
Pediatric reference ranges for acute kidney injury biomarkers.,"Michael R Bennett, Edward Nehus, Christopher Haffner, Qing Ma, Prasad Devarajan, Michael R Bennettet al.",2015 Apr,Pediatr Nephrol,https://pubmed.ncbi.nlm.nih.gov/25348707/,No keywords found,"['novel', 'urinary', 'biomarkers', 'useful', 'prediction', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'promising', 'urine', 'marker', 'ngal', ',', 'il-', ',', 'kim-', ',', 'and', 'lfabp', '.', 'of', 'shown', 'considerable', 'promise', 'diagnosing', 'aki', 'earlier', 'serum', 'creatinine', '(', 'scr', ')', 'using', 'disease', 'control', '.', 'set', 'to', 'determine', 'reference', 'level', 'of', 'marker', 'in', 'healthy', 'pediatric', 'population', '.', 'method', 'urine', 'collected', 'healthy', 'child', 'and', 'assayed', 'ngal', ',', 'il-', ',', 'kim-', ',', 'and', 'lfabp', 'using', 'commercially', 'available', 'kit', 'or', 'assay', 'material', '.', 'analysis', 'of', 'biomarkers', 'linear', 'regression', 'and', 'according', 'to', 'age', 'group', '(', '-', 'year', '-', '-', '-', ')', 'performed', 'to', 'determine', 'biomarker', 'level', 'differed', 'with', 'age', 'and', 'gender', '.', 'result', 'median', 'value', 'ngal', '(', '.', 'ngml', 'iqr', '.-', ')', ',', 'il-', '(', '.', 'pgml', 'iqr', '.-', '.', ')', ',', 'kim-', '(', 'pgml', 'iqr', '-', ')', ',', 'lfabp', '(', '.', 'ngml', 'iqr', '.-.', ')', '.', 'significant', 'gender', 'difference', 'found', 'with', 'ngal', 'and', 'il-', 'and', 'significant', 'age', 'difference', 'found', 'with', 'marker', '.', 'th', 'percentile', 'value', 'marker', 'varied', 'with', 'age', 'and', 'gender', 'greater', 'median', 'value', '.', 'conclusion', 'largest', 'pediatric', 'reference', 'range', 'study', 'urinary', 'measurement', 'of', 'ngal', ',', 'il-', ',', 'kim-', ',', 'and', 'lfabp', 'and', 'highlight', 'age', 'and', 'gender', 'difference', 'in', 'marker', '.', 'information', 'essential', 'rational', 'interpretation', 'of', 'study', 'and', 'clinical', 'trial', 'utilizing', 'emerging', 'aki', 'biomarkers', '.']"
Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.,"Alberto Zangrillo, Gabriele Alvaro, Alessandro Belletti, Antonio Pisano, Luca Brazzi, Maria G Calabrò, Fabio Guarracino, Tiziana Bove, Evgeny V Grigoryev, Fabrizio Monaco, Vladimir A Boboshko, Valery V Likhvantsev, Anna M Scandroglio, Gianluca Paternoster, Rosalba Lembo, Samuele Frassoni, Marco Comis, Vadim V Pasyuga, Paolo Navalesi, Vladimir V Lomivorotov                              ;, CHEETAH Study Group, Alberto Zangrilloet al.",2018 Oct,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/29580796/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'occurs', 'frequently', 'cardiac', 'surgery', '.', 'levosimendan', 'might', 'reduce', 'incidence', 'of', 'aki', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'author', 'investigated', 'whether', 'levosimendan', 'administration', 'could', 'reduce', 'aki', 'incidence', 'in', 'high-risk', 'cardiac', 'surgical', 'population', '.', 'design', 'post', 'hoc', 'analysis', 'of', 'multicenter', 'randomized', 'trial', '.', 'setting', 'cardiac', 'surgery', 'operating', 'room', 'and', 'intensive', 'care', 'unit', 'of', 'center', 'in', 'country', '.', 'participant', 'study', 'comprised', 'patient', 'underwent', 'mitral', 'valve', 'surgery', 'with', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin', '.', 'and', 'perioperative', 'myocardial', 'dysfunction', '.', 'intervention', 'patient', 'assigned', 'randomly', 'to', 'receive', 'levosimendan', '(', '.-', '.', 'gkgmin', ')', 'or', 'placebo', 'in', 'addition', 'to', 'standard', 'inotropic', 'treatment', '.', 'measurement', 'and', 'main', 'result', 'forty-six', 'patient', 'assigned', 'to', 'receive', 'levosimendan', 'and', 'to', 'receive', 'placebo', '.', 'postoperative', 'aki', 'occurred', 'in', '(', ')', 'patient', 'in', 'levosimendan', 'group', 'versus', '(', ')', 'in', 'placebo', 'group', '(', 'absolute', 'difference', '-', '.', 'confidence', 'interval', '-', '.', 'to', '-', '.', 'p', '.', ')', '.', 'incidence', 'of', 'major', 'complication', 'also', 'lower', '(', ')', 'in', 'levosimendan', 'group', 'versus', 'in', 'placebo', 'group', '(', ')', '(', 'absolute', 'difference', '-', '.', '-', '.', 'to', '-', '.', 'p', '.', ')', '.', 'trend', 'toward', 'lower', 'serum', 'creatinine', 'intensive', 'care', 'unit', 'discharge', 'observed', 'in', 'levosimendan', 'group', '(', '.', '.-', '.', 'mgdl', ')', 'versus', 'in', 'placebo', 'group', '(', '.', '.-', '.', 'mgdl', ')', '(', 'confidence', 'interval', '-', '.', '-', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'levosimendan', 'may', 'improve', 'renal', 'outcome', 'in', 'cardiac', 'surgery', 'patient', 'with', 'chronic', 'kidney', 'disease', 'undergoing', 'mitral', 'valve', 'surgery', 'develop', 'perioperative', 'myocardial', 'dysfunction', '.', 'result', 'of', 'exploratory', 'analysis', 'investigated', 'in', 'future', 'properly', 'designed', 'randomized', 'controlled', 'trial', '.']"
Free Hemoglobin Ratio as a Novel Biomarker of Acute Kidney Injury After On-Pump Cardiac Surgery: Secondary Analysis of a Randomized Controlled Trial.,"Jie Hu, Emanuele Rezoagli, Francesco Zadek, Edward A Bittner, Chong Lei, Lorenzo Berra, Jie Huet al.",2021 Jun 1,Anesth Analg,https://pubmed.ncbi.nlm.nih.gov/33481401/,No keywords found,"['cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'associated', 'with', 'high', 'risk', 'of', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'due', 'to', 'limitation', 'of', 'current', 'diagnostic', 'strategy', ',', 'sought', 'to', 'determine', 'whether', 'free', 'hemoglobin', '(', 'fhb', ')', 'ratio', '(', 'ie', ',', 'level', 'of', 'fhb', 'end', 'of', 'cpb', 'divided', 'baseline', 'fhb', ')', 'could', 'predict', 'aki', 'on-pump', 'cardiac', 'surgery', '.', 'method', 'secondary', 'analysis', 'of', 'randomized', 'controlled', 'trial', 'comparing', 'effect', 'of', 'nitric', 'oxide', '(', 'intervention', ')', 'versus', 'nitrogen', '(', 'control', ')', 'aki', 'cardiac', 'surgery', '(', 'nct', ')', '.', 'total', 'of', 'adult', 'patient', 'in', 'control', 'arm', 'included', '.', 'first', ',', 'determined', 'whether', 'fhb', 'ratio', 'associated', 'with', 'aki', 'via', 'multivariable', 'analysis', '.', 'second', ',', 'verified', 'whether', 'fhb', 'ratio', 'could', 'predict', 'aki', 'and', 'incorporation', 'of', 'fhb', 'ratio', 'could', 'improve', 'predictive', 'performance', 'early', 'stage', ',', 'compared', 'with', 'prediction', 'using', 'urinary', 'biomarkers', 'alone', '.', 'conducted', 'restricted', 'cubic', 'spline', 'in', 'logistic', 'regression', 'model', 'development', '.', 'determined', 'predictive', 'performance', ',', 'including', 'area', 'receiver-operating-characteristics', 'curve', '(', 'auc', ')', 'and', 'calibration', '(', 'calibration', 'plot', 'and', 'accuracy', ',', 'ie', ',', 'number', 'of', 'correct', 'prediction', 'divided', 'total', 'number', 'of', 'prediction', ')', '.', 'also', 'used', 'auc', 'test', ',', 'likelihood', 'ratio', 'test', ',', 'and', 'net', 'reclassification', 'index', '(', 'nri', ')', 'to', 'compare', 'predictive', 'performance', 'competing', 'model', '(', 'ie', ',', 'fhb', 'ratio', 'versus', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'ngal', ',', 'n-acetyl', '--', 'd-glucosaminidase', 'nag', ',', 'and', 'kidney', 'injury', 'molecule-', 'kim-', ',', 'respectively', ',', 'and', 'incorporation', 'of', 'fhb', 'ratio', 'with', 'ngal', ',', 'nag', ',', 'and', 'kim-', 'versus', 'urinary', 'biomarkers', 'alone', ')', ',', 'applicable', '.', 'result', 'data', 'stratified', 'median', 'fhb', 'ratio', 'showed', 'subject', 'with', 'fhb', 'ratio', '.', 'presented', 'higher', 'incidence', 'of', 'aki', '(', '.', 'v', '.', 'p', '.', ')', ',', 'need', 'of', 'renal', 'replacement', 'therapy', '(', '.', 'v', 'p', '.', ')', ',', 'and', 'higher', 'in-hospital', 'mortality', '(', '.', 'v', 'p', '.', ')', 'subject', 'with', 'fhb', 'ratio', '..', 'fhb', 'ratio', 'associated', 'with', 'aki', 'adjustment', 'preestablished', 'factor', '.', 'fhb', 'ratio', 'outperformed', 'urinary', 'biomarkers', 'with', 'highest', 'auc', 'of', '.', '(', 'confidence', 'interval', 'ci', ',', '.-', '.', ')', 'and', 'accuracy', 'of', '.', '(', 'ci', ',', '.-.', ')', '.', 'incorporation', 'of', 'fhb', 'ratio', 'achieved', 'better', 'discrimination', '(', 'auc', 'test', ',', 'p', '.', ')', ',', 'calibration', '(', 'likelihood', 'ratio', 'test', ',', 'p', '.', 'accuracy', ',', '.', 'ci', ',', '.-', '.', 'v', '.', 'ci', ',', '.-', '.', ')', ',', 'and', 'significant', 'prediction', 'increment', '(', 'nri', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', 'early', 'stage', ',', 'compared', 'with', 'prediction', 'using', 'urinary', 'biomarkers', 'alone', '.', 'conclusion', 'result', 'exploratory', ',', 'hypothesis-generating', 'retrospective', ',', 'observational', 'study', 'show', 'fhb', 'ratio', 'end', 'of', 'cpb', 'might', 'used', 'novel', ',', 'widely', 'applicable', 'biomarker', 'aki', '.', 'use', 'of', 'fhb', 'ratio', 'might', 'help', 'early', 'detection', 'of', 'aki', ',', 'compared', 'with', 'prediction', 'based', 'urinary', 'biomarkers', '.']"
Treatment Outcome of Combined Continuous Venovenous Hemofiltration and Hemoperfusion in Acute Paraquat Poisoning: A Prospective Controlled Trial.,"Changbin Li, Dayong Hu, Wen Xue, Xinhua Li, Zhen Wang, Zisheng Ai, Yaxiang Song, Xinying Liu, Jiafeng Cheng, Shuling Fan, Limin Zhao, Liya Wang, Chandra Mohan, Ai Peng, Changbin Liet al.",2018 Jan,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/29116999/,No keywords found,"['to', 'investigate', 'whether', 'combined', 'continuous', 'venovenous', 'hemofiltration', 'and', 'hemoperfusion', 'among', 'paraquat-poisoned', 'patient', 'would', 'improve', 'survival', '.', 'design', 'prospective', ',', 'controlled', 'interventional', 'study', 'year', '.', 'setting', 'single', ',', 'tertiary', ',', 'academic', 'medical', 'center', '.', 'patient', 'recruited', 'patient', 'admitted', 'to', 'shanghai', 'tenth', 'people', ""'s"", 'hospital', 'within', 'hour', 'paraquat', 'ingestion', '.', 'exclusion', 'year', 'old', ',', 'ingestion', 'of', 'paraquat', 'with', 'toxicant', ',', 'pregnant', ',', 'history', 'of', 'chronic', 'pulmonary', 'disease', ',', 'psychosis', ',', 'hyperthyroidism', ',', 'or', 'diabetes', 'with', 'impaired', 'liver', 'or', 'renal', 'function', '.', 'intervention', 'patient', 'assigned', 'to', 'receive', 'continuous', 'venovenous', 'hemofiltration', 'with', 'hemoperfusion', 'therapy', '(', 'continuous', 'venovenous', 'hemofiltration', 'group', ')', 'and', 'to', 'receive', 'conventional', 'therapy', '(', 'conventional', 'group', ')', '.', 'study', 'outcome', 'death', 'cause', 'within', 'day', 'paraquat', 'ingestion', 'and', 'frequency', 'of', 'hypoxia', ',', 'acute', 'kidney', 'injury', ',', 'or', 'adverse', 'event', '.', 'measurement', 'and', 'main', 'result', 'of', 'enrolled', 'patient', ',', 'assigned', 'to', 'continuous', 'venovenous', 'hemofiltration', 'group', 'and', 'to', 'conventional', 'group', '.', 'two', 'group', 'similar', 'baseline', 'demographic', 'and', 'clinical', 'feature', '.', 'day', 'paraquat', 'ingestion', ',', 'of', 'patient', '(', '.', ')', 'in', 'continuous', 'venovenous', 'hemofiltration', 'group', 'and', 'of', 'patient', '(', '.', ')', 'in', 'conventional', 'group', 'died', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'in', 'multivariable', 'cox', 'proportional', 'hazard', 'model', 'controlling', 'baseline', 'characteristic', ',', 'combined', 'continuous', 'venovenous', 'hemofiltration', 'and', 'hemoperfusion', 'independently', 'associated', 'with', 'reduced', 'risk', 'of', 'death', 'compared', 'with', 'conventional', 'therapy', '(', 'adjusted', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'patient', 'in', 'continuous', 'venovenous', 'hemofiltration', 'group', ',', 'compared', 'to', 'conventional', 'group', ',', 'reduced', 'occurrence', 'rate', 'of', 'hypoxia', '(', '.', 'v', '.', 'p', '.', ')', 'and', 'of', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', 'p', '.', ')', '.', 'hypophosphatemia', 'and', 'thrombocytopenia', 'common', 'in', 'continuous', 'venovenous', 'hemofiltration', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'patient', 'with', 'paraquat', 'poisoning', ',', 'treatment', 'with', 'combined', 'continuous', 'venovenous', 'hemofiltration', 'and', 'hemoperfusion', 'significantly', 'improved', '-day', 'survival', 'rate', '.']"
The efficacy of biomarkers in the diagnosis of acute kidney injury secondary to liver cirrhosis.,"Yuwei Yang, Bin Ge, Yan Liu, Jiafu Feng, Yuwei Yanget al.",2021 Apr 9,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/33832138/,No keywords found,"['study', 'to', 'investigate', 'role', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'cystatin', 'c', '(', 'cysc', ')', 'and', 'creatinine', 'in', 'diagnosis', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'secondary', 'to', 'liver', 'cirrhosis.a', 'total', 'of', 'patient', '(', 'including', 'liver', 'cirrhosis', 'patient', 'and', 'healthy', 'control', ')', 'enrolled', '.', 'liver', 'cirrhosis', 'patient', 'subdivided', 'aki', 'secondary', 'to', 'liver', 'cirrhosis', 'group', '(', 'aki', 'group', ',', 'patient', ')', 'and', 'simple', 'liver', 'cirrhosis', 'group', '(', 'lc', 'group', ',', 'patient', ')', '.', 'serum', 'ngalurine', 'ngal', '(', 'sngalungal', ')', ',', 'and', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'well', 'estimated', 'glomerular', 'filtration', 'rate', 'measured', '.', 'diagnostic', 'performance', 'of', 'indicator', 'in', 'aki', 'secondary', 'to', 'liver', 'cirrhosis', 'evaluated.the', 'level', 'of', 'sngal', ',', 'ungal', ',', 'cysc', 'and', 'scr', 'in', 'aki', 'group', 'significantly', 'higher', 'of', 'lc', 'and', 'healthy', 'control', 'group', '.', 'however', ',', 'egfr', 'and', 'c-agfr', 'of', 'aki', 'group', 'significantly', 'lower', '.', 'with', 'progression', 'of', 'aki', '(', 'aki-saki-saki-s', ')', ',', 'level', 'of', 'sngal', ',', 'ungal', ',', 'cysc', 'and', 'scr', 'increased', 'gradually', ',', 'level', 'of', 'c-agfr', 'and', 'egfr', 'decreased', 'gradually', '.', 'sngal', ',', 'ungal', 'and', 'cysc', 'positively', 'correlated', 'with', 'scr', '(', 'r', '.', ',', '.', ',', 'and', '.', ')', ',', 'negatively', 'correlated', 'with', 'c-agfr', '(', 'r', '-.', ',', '-', '.', 'and', '-.', ')', '.', 'however', ',', 'egfr', 'negative', 'correlation', 'with', 'scr', '(', 'r', '-', '.', ')', ',', 'positive', 'correlation', 'with', 'c-agfr', '(', 'r', '.', ')', '.', 'roc', 'curve', 'analysis', 'showed', 'area', 'curve', 'ungal', 'largest', '(', '.', ')', ',', 'followed', 'sngal', '(', '.', ')', '.', 'diagnostic', 'efficacy', 'of', 'ungal', 'and', 'sngal', 'in', 'aki', 'group', '.', 'and', '.', ',', 'and', 'risk', 'degree', 'or', '.', 'and', '.', ',', 'respectively.ngal', 'might', 'perform', 'better', 'scr', 'and', 'cysc', 'in', 'diagnosis', 'of', 'aki', 'secondary', 'to', 'liver', 'cirrhosis', ',', 'ungal', 'might', 'better', 'indicator', 'sngal', 'in', 'aki', 'diagnosis', '.']"
A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.,"Hang Qiu, Yinghua Zhu, Guoqi Shen, Zhen Wang, Wenhua Li, Hang Qiuet al.",2023 Mar 22:18:453-465.,Clin Interv Aging,https://pubmed.ncbi.nlm.nih.gov/36987461/,No keywords found,"['development', 'and', 'validation', 'of', 'nomogram', 'model', 'to', 'predict', 'risk', 'of', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'emergency', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'in', 'elderly', 'patient', 'with', 'acute', 'st-segment', 'elevation', 'myocardial', 'infarction', '(', 'stemi', ')', '.', 'patient', 'and', 'method', 'retrospective', 'analysis', 'of', 'elderly', '(', 'year', ')', 'stemi', 'patient', 'undergoing', 'emergency', 'pci', 'in', 'hospital', 'january', 'to', 'june', ',', 'with', 'patient', 'randomized', 'to', 'training', 'cohort', '(', 'n', ')', 'and', 'validation', 'cohort', '(', 'n', ')', '.', 'univariate', 'analysis', ',', 'lasso', 'regression', ',', 'and', 'multivariate', 'logistic', 'regression', 'analysis', 'used', 'to', 'determine', 'independent', 'risk', 'factor', 'developing', 'ci-aki', 'in', 'elderly', 'stemi', 'patient', '.', 'r', 'software', 'used', 'to', 'generate', 'nomogram', 'model', '.', 'predictive', 'power', 'of', 'nomogram', 'model', 'compared', 'with', 'mehran', 'score', '.', 'area', 'roc', 'curve', '(', 'auc', ')', ',', 'calibration', 'curve', ',', 'and', 'decision', 'curve', 'analysis', '(', 'dca', ')', 'used', 'to', 'evaluate', 'prediction', 'model', ""'s"", 'discrimination', ',', 'calibration', ',', 'and', 'clinical', 'validity', ',', 'respectively', '.', 'result', 'nomogram', 'model', 'consisted', 'of', 'five', 'variable', 'diabetes', 'mellitus', '(', 'dm', ')', ',', 'left', 'ventricular', 'ejection', 'fraction', '(', 'lvef', ')', ',', 'systemic', 'immune-inflammatory', 'index', '(', 'sii', ')', ',', 'n-terminal', 'pro-brain', 'natriuretic', 'peptide', '(', 'nt-probnp', ')', ',', 'and', 'highly', 'sensitive', 'c-reactive', 'protein', '(', 'hscrp', ')', '.', 'in', 'training', 'cohort', ',', 'auc', '.', '(', 'ci', '.-', '.', ')', ',', 'and', 'in', 'validation', 'cohort', ',', '.', '(', 'ci', '.-.', ')', '.', 'nomogram', 'model', 'better', 'predictive', 'ability', 'mehran', 'score', '.', 'based', 'calibration', 'curve', ',', 'predicted', 'and', 'observed', 'value', 'of', 'nomogram', 'model', 'in', 'good', 'agreement', 'training', 'and', 'validation', 'cohort', '.', 'decision', 'curve', 'analysis', '(', 'dca', ')', 'and', 'clinical', 'impact', 'curve', 'showed', 'nomogram', 'prediction', 'model', 'good', 'clinical', 'utility', '.', 'conclusion', 'established', 'nomogram', 'model', 'intuitively', 'and', 'specifically', 'screen', 'high-risk', 'group', 'with', 'high', 'degree', 'of', 'discrimination', 'and', 'accuracy', 'and', 'specific', 'predictive', 'value', 'ci-aki', 'occurrence', 'in', 'elderly', 'stemi', 'patient', 'pci', '.']"
Evaluation of nafamostat mesilate as an alternative anticoagulant during intermittent hemodialysis in healthy Beagle dogs.,"Joon-Hyuk Choi, Seok-Yeong Byun, Aryung Nam, Sei-Myoung Han, Kyu-Pil Lee, Kun-Ho Song, Hwa-Young Youn, Kyoung-Won Seo, Joon-Hyuk Choiet al.",2018 Mar,J Vet Emerg Crit Care (San Antonio),https://pubmed.ncbi.nlm.nih.gov/29419934/,No keywords found,"['to', 'evaluate', 'nafamostat', 'mesilate', '(', 'nm', ')', 'alternative', 'anticoagulant', 'agent', 'intermittent', 'hemodialysis', '(', 'ihd', ')', '.', 'design', 'prospective', 'randomized', 'study', '.', 'setting', 'university', 'teaching', 'hospital', '.', 'animal', 'eighteen', 'healthy', 'beagle', 'dog', '.', 'intervention', 'in', 'group', '(', 'n', ')', ',', 'nm', 'administered', 'dose', 'of', '.', 'mgkgh', 'ihd', 'hour', '.', 'in', 'group', '(', 'n', ')', ',', 'nm', 'administered', 'low', 'dose', 'of', '.', 'mgkgh', 'ihd', '.', 'in', 'group', '(', 'n', ')', ',', 'control', 'group', ',', 'unfractionated', 'heparin', '(', 'ufh', ')', 'administered', 'ihd', '.', 'evaluated', 'parameter', 'included', 'amount', 'of', 'residual', 'blood', 'clot', 'in', 'blood', 'chamber', 'and', 'arterial', 'side', 'of', 'dialyzer', 'level', 'of', 'hemoglobin', ',', 'hematocrit', ',', 'and', 'platelet', 'and', 'prothrombin', 'time', '(', 'pt', ')', ',', 'activated', 'partial', 'thromboplastin', 'time', '(', 'aptt', ')', ',', 'and', 'activated', 'clotting', 'time', '(', 'act', ')', '.', 'measurement', 'and', 'main', 'result', 'group', 'and', 'successfully', 'completed', 'ihd', 'without', 'serious', 'coagulation', 'in', 'extracorporeal', 'circulation', '.', 'residual', 'blood', 'clotting', 'in', 'blood', 'chamber', 'and', 'arterial', 'side', 'of', 'dialyzer', 'not', 'significantly', 'differ', 'in', 'group', 'and', 'compared', 'to', 'group', '(', 'group', 'v', 'group', ',', 'p', '.', 'and', 'group', 'v', 'group', ',', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'observed', 'pre-', 'and', 'posttreatment', 'pt', 'in', 'group', '(', 'p', '.', ')', 'and', '(', 'p', '.', ')', ',', 'pre-', 'and', 'posttreatment', 'aptts', 'in', 'group', '(', 'p', '.', ')', 'and', '(', 'p', '.', ')', ',', 'and', 'pre-', 'and', 'posttreatment', 'act', 'in', 'group', '(', 'p', '.', ')', 'and', '(', 'p', '.', ')', '.', 'in', 'group', ',', 'significant', 'elevation', 'of', 'act', 'observed', 'posttest', '(', 'p', '.', ')', '.', 'conclusion', 'result', 'of', 'study', 'in', 'healthy', 'beagle', 'dog', 'suggest', 'nm', '.', 'mgkgh', 'may', 'valid', 'alternative', 'to', 'ufh', 'ihd', '.', 'study', 'needed', 'in', 'patient', 'high', 'risk', 'of', 'bleeding', '.']"
Efficacy of nicorandil and ranolazine in prevention of contrast-induced nephropathy in patients with mild-to-moderate renal dysfunction: a randomized controlled trial.,"Jamal Yusuf, Gyan Prakash, Safal Safal, Vimal Mehta, Saibal Mukhopadhyay, Jamal Yusufet al.",2024 May 1,Coron Artery Dis,https://pubmed.ncbi.nlm.nih.gov/38411168/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'common', 'complication', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', '.', 'conflicting', 'evidence', 'regarding', 'efficacy', 'of', 'nicorandil', 'in', 'cin', 'prevention', '.', 'with', 'respect', 'to', 'ranolazine', ',', 'physiological', 'possibility', 'well', 'data', 'in', 'animal', 'study', 'regarding', 'protective', 'effect', 'cin', ',', 'however', ',', 'no', 'human', 'data', 'till', 'date', '.', 'aim', 'and', 'objective', 'to', 'assess', 'efficacy', 'of', 'nicorandil', 'and', 'ranolazine', 'in', 'preventing', 'cin', '.', 'secondary', 'endpoint', 'to', 'measure', 'difference', 'in', 'postprocedure', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'incidence', 'across', 'group', '.', 'also', ',', 'patient', 'followed', 'till', 'month', 'major', 'adverse', 'event', '.', 'material', 'and', 'method', 'single-center', 'randomized', 'controlled', 'study', 'included', 'patient', 'of', 'coronary', 'artery', 'disease', 'with', 'mild-to-moderate', 'renal', 'dysfunction', 'undergoing', 'elective', 'pci', '.', 'eligible', 'patient', 'assigned', 'to', 'either', 'nicorandil', '(', 'n', ')', ',', 'ranolazine', '(', 'n', ')', 'or', 'control', 'group', '(', 'n', ')', 'in', 'ratio', 'block', 'randomization', '.', 'enrolled', 'patient', 'given', 'intravenous', 'sodium', 'chloride', 'rate', 'of', '.', 'mlkgh', '(', '.', 'mlkgh', 'patient', 'with', 'left', 'ventricular', 'ejection', 'fraction', ')', 'h', 'procedure', 'till', 'h', 'procedure', '.', 'iso-osmolar', 'contrast', 'agent', '(', 'iodixanol', ')', 'used', 'patient', '.', 'in', 'addition', 'to', 'hydration', ',', 'patient', 'in', 'nicorandil', 'group', 'received', 'oral', 'nicorandil', '(', 'mg', ',', 'timesd', ')', 'and', 'in', 'ranolazine', 'group', 'received', 'oral', 'ranolazine', '(', 'mg', ',', 'timesd', ')', 'day', 'procedure', 'and', 'day', 'pci', '.', 'patient', 'in', 'control', 'group', 'received', 'hydration', '.', 'result', 'total', 'number', 'of', 'cin', '(', '.', ')', ',', 'included', '(', '.', ')', 'in', 'control', ',', '(', '.', ')', 'in', 'nicorandil', 'and', '(', '.', ')', 'in', 'ranolazine', 'group', '.', 'significant', 'association', 'of', 'cin', 'reduction', 'across', 'group', '(', 'p', '.', ')', '.', 'pairwise', 'comparison', 'also', ',', 'significant', 'benefit', 'across', 'control', 'and', 'ranolazine', 'well', 'control', 'and', 'nicorandil', '(', 'p', '.', ')', '.', 'numerically', 'higher', 'incidence', 'of', 'aki', 'in', 'control', 'difference', ',', 'however', ',', 'not', 'reach', 'statistical', 'significance', 'applying', 'bonferroni', 'correction', '(', 'p', '.', ')', '.', '-month', 'follow-up', ',', 'adverse', 'event', 'similar', 'across', 'group', '.', 'conclusion', 'study', 'add', 'to', 'existing', 'literature', 'support', 'role', 'nicorandil', 'in', 'cin', 'prevention', ',', 'efficacy', 'of', 'ranolazine', 'in', 'protecting', 'cin', 'demonstrated', 'in', 'human', 'first', 'time', '.']"
The Prevention of Contrast Induced Nephropathy by Sarpogrelate: a Prospective Randomized Controlled Clinical Trial.,"You Jeong Ki, Sun A Kwon, Hack Lyoung Kim, Jae Bin Seo, Woo Young Chung, You Jeong Kiet al.",2019 Oct 21,J Korean Med Sci,https://pubmed.ncbi.nlm.nih.gov/31625293/,No keywords found,"['although', 'strategy', 'used', 'prophylaxis', 'of', 'contrast', 'induced', 'nephropathy', ',', 'efficacy', 'not', 'fully', 'established', '.', 'sarpogrelate', 'relieve', 'vasospasm', 'and', 'anti-inflammatory', 'action', '.', 'study', 'examined', 'whether', 'sarpogrelate', 'reduces', 'incidence', 'of', 'contrast', 'induced', 'nephropathy', '(', 'cin', ')', 'or', 'subsequent', 'renal', 'impairment', 'four', 'week', 'coronary', 'angiography', 'compared', 'with', 'control', 'group', '.', 'method', 'seventy-four', 'participant', 'with', 'chronic', 'renal', 'failure', 'randomly', 'assigned', 'to', 'sarpogrelate', 'or', 'control', 'group', '.', 'patient', 'assigned', 'to', 'sarpogrelate', 'group', 'received', 'oral', 'saporogelate', 'hour', 'contrast', 'exposure', 'to', 'one', 'month', 'contrast', 'exposure', '.', 'primary', 'outcome', 'of', 'study', 'incidence', 'of', 'cin', 'within', 'hour', 'exposure', 'to', 'contrast', 'agent', '.', 'result', 'thirty-one', 'subject', 'in', 'control', 'group', 'and', 'subject', 'in', 'sarpogrelate', 'group', 'used', 'analysis', '.', 'cumulative', 'cin', 'occurred', 'numerically', 'hour', 'in', 'sarpogrelate', 'group', 'and', 'less', 'one', 'month', 'without', 'statistical', 'significance', '(', '.', 'vs.', '.', 'hour', 'and', '.', 'vs.', '.', 'one', 'month', ',', 'respectively', ')', '.', 'baseline', 'renal', 'function', 'similar', 'in', 'group', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'lower', 'in', 'sarpogrelate', 'group', 'and', 'hour', 'compared', 'with', 'control', 'group', '(', '.', 'vs.', '.', 'mlmin.m', 'p', '.', 'and', '.', 'vs.', '.', 'mlmin.m', 'p', '.', ',', 'respectively', ')', '.', 'one', 'month', ',', 'egfr', 'became', 'comparable', 'two', 'group', 'egfr', 'aggravated', 'in', 'control', 'group', 'and', 'maintained', 'in', 'sarpogrelate', 'group', '.', 'conclusion', 'study', 'failed', 'to', 'demonstrate', 'sarpogrelate', 'renoprotective', 'effect', 'contrast', 'induced', 'acute', 'kidney', 'injury', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
"The Effect of Spironolactone on Acute Kidney Injury After Cardiac Surgery: A Randomized, Placebo-Controlled Trial.","Rubén Barba-Navarro, Mirell Tapia-Silva, Carlos Garza-Garcia, Salvador López-Giacoman, Ipsae Melgoza-Toral, Armando Vázquez-Rangel, Silvana Bazúa-Valenti, Norma Bobadilla, Michael Wasung de Lay, Francisco Baranda, Lakhmir S Chawla, Gerardo Gamba, Magdalena Madero, Rubén Barba-Navarroet al.",2017 Feb,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/27522513/,No keywords found,"['cardiac', 'surgery-related', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'postoperative', 'complication', 'greatly', 'increase', 'morbidity', 'and', 'mortality', '.', 'currently', 'no', 'effective', 'intervention', 'to', 'prevent', 'aki', 'associated', 'with', 'cardiac', 'surgery', '.', 'experimental', 'data', 'shown', 'administration', 'of', 'mineralocorticoid', 'receptor', 'blocker', 'spironolactone', 'prevents', 'renal', 'injury', 'induced', 'ischemia-reperfusion', 'in', 'rat', '.', 'objective', 'of', 'study', 'to', 'test', 'whether', 'short-term', 'perioperative', 'administration', 'of', 'oral', 'spironolactone', 'could', 'reduce', 'incidence', 'of', 'aki', 'in', 'cardiac', 'surgical', 'patient', '.', 'study', 'design', 'randomized', ',', 'double-blinded', ',', 'placebo-controlled', 'trial', '.', 'setting', 'participant', 'data', 'collected', 'april', 'july', 'national', 'heart', 'institute', 'in', 'mexico', '.', 'patient', 'included', 'and', 'received', 'spironolactone', 'or', 'placebo', ',', 'respectively', '.', 'intervention', 'spironolactone', 'or', 'placebo', 'dose', 'of', 'mg', 'to', 'hour', 'surgery', 'and', 'subsequently', 'dos', 'of', 'mg', 'in', 'postoperative', 'day', ',', ',', 'and', 'administered', '.', 'outcome', 'patient', 'followed', 'day', 'or', 'discharge', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'primary', 'end', 'point', 'aki', 'incidence', 'defined', 'kdigo', 'criterion', '.', 'secondary', 'end', 'point', 'included', 'requirement', 'of', 'renal', 'replacement', 'therapy', ',', 'icu', 'length', 'of', 'stay', ',', 'and', 'icu', 'mortality', '.', 'data', 'analyzed', 'according', 'to', 'intention-to-treat', 'principle', '.', 'result', 'mean', 'age', '.', 'year', ',', 'mean', 'serum', 'creatinine', 'level', '..', 'mgdl', ',', 'median', 'thakar', 'score', 'estimation', 'of', 'aki', 'risk', '(', 'iqr', ',', '-', ')', ',', 'and', 'diabetes', '.', 'incidence', 'of', 'aki', 'higher', 'spironolactone', 'group', '(', 'v', 'p.', ')', '.', 'no', 'significant', 'difference', 'found', 'secondary', 'end', 'point', '.', 'limitation', 'single', 'center', ',', 'aki', 'mostly', 'driven', 'aki', 'stage', ',', 'planned', 'sample', 'size', 'not', 'achieved', ',', 'and', 'no', 'renin-angiotensin-aldosterone', 'system', 'washout', 'period', '.', 'conclusion', 'trial', 'demonstrated', 'spironolactone', 'not', 'protective', 'aki', 'associated', 'with', 'cardiac', 'surgery', 'and', 'may', 'trend', 'toward', 'risk', '.']"
Double-blind placebo-controlled randomized trial of N-acetylcysteine infusion following live donor liver transplantation.,"Mohammed Abdullatheef Thirunavayakalathil, Christi Titus Varghese, Viju Kumar Bharathan, Biju Chandran, Krishnanunni Nair, Shweta Mallick, Johns Shaji Mathew, Binoj Sivasankara Pillai Thankamony Amma, Ramachandran Narayana Menon, Unnikrishnan Gopalakrishnan, Dinesh Balakrishnan, Othiyil Vayoth Sudheer, Sudhindran Surendran, Mohammed Abdullatheef Thirunavayakalathilet al.",2020 Dec,Hepatol Int,https://pubmed.ncbi.nlm.nih.gov/33278022/,No keywords found,"['role', 'of', 'n-acetylcysteine', '(', 'nac', ')', 'in', 'improving', 'outcome', 'following', 'live', 'donor', 'liver', 'transplantation', '(', 'ldlt', ')', 'not', 'well', 'established', '.', 'designed', 'randomized', 'double-blind', 'placebo-controlled', 'trial', 'to', 'study', 'role', 'of', 'nac', 'infusion', 'in', 'recipient', 'undergoing', 'ldlt', '.', 'method', 'assigned', 'patient', 'underwent', 'ldlt', 'computer-generated', 'random', 'sequence', 'ratio', 'to', 'either', 'nac', 'group', 'or', 'placebo', 'group', '.', 'patient', 'in', 'nac', 'group', 'received', 'nac', 'infusion', 'started', 'beginning', 'of', 'graft', 'implantation', 'initial', 'loading', 'dose', 'of', 'mgkgh', 'h', ',', 'followed', '.', 'mgkgh', 'h', 'and', '.', 'mgkgh', 'continued', 'h.', 'placebo', 'group', 'received', 'normal', 'saline', '.', 'primary', 'endpoint', 'composite', 'occurrence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'early', 'allograft', 'dysfunction', '(', 'ead', ')', 'in', 'recipient', '.', 'secondary', 'endpoint', 'included', 'level', 'of', 'bilirubin', ',', 'aspartate', 'aminotransferase', '(', 'ast', ')', ',', 'alanine', 'aminotransferase', '(', 'alt', ')', ',', 'creatinine', ',', 'inr', ',', 'primary', 'graft', 'non-function', ',', 'intraoperative', 'bleeding', ',', 'post-transplant', 'hospital', 'stay', 'and', 'in-hospital', 'mortality', '.', 'result', 'composite', 'endpoint', 'not', 'show', 'significant', 'difference', 'nac', 'and', 'placebo', 'group', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'peak', 'ast', '(', '.', 'iul', 'v', '.', 'iul', ',', 'p', '.', ')', 'and', 'peak', 'alt', '(', '.', 'iul', 'v', '.', 'iul', ',', 'p', '.', ')', 'level', 'significantly', 'lower', 'in', 'study', 'group', '.', 'time', 'to', 'normalization', 'of', 'transaminase', 'also', 'significantly', 'low', 'in', 'study', 'group', '.', 'conclusion', 'perioperative', 'nac', 'infusion', 'following', 'ldlt', 'resulted', 'in', 'significantly', 'lower', 'postoperative', 'ast', 'and', 'alt', 'level', '.', 'rapid', 'normalization', 'of', 'transaminase', 'also', 'observed', '.', ',', 'however', ',', 'not', 'translate', 'to', 'improvement', 'in', 'aki', 'or', 'ead', '.']"
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.,"Axel Åkerblom, Robert M Clare, Yuliya Lokhnygina, Lars Wallentin, Claes Held, Frans Van de Werf, David J Moliterno, Uptal D Patel, Sergio Leonardi, Paul W Armstrong, Robert A Harrington, Harvey D White, Philip E Aylward, Kenneth W Mahaffey, Pierluigi Tricoci, Axel Åkerblomet al.",2016 Aug:178:1-8.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/27502846/,No keywords found,"['albuminuria', 'associated', 'with', 'cardiovascular', '(', 'cv', ')', 'outcome', '.', 'evaluated', 'albuminuria', ',', 'alone', 'and', 'in', 'combination', 'with', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', ',', 'predictor', 'of', 'mortality', 'and', 'cv', 'morbidity', 'in', ',', 'patient', 'with', 'non-st-segment', 'elevation', 'acute', 'coronary', 'syndrome', '.', 'method', 'baseline', 'serum', 'creatinine', 'and', 'urinary', 'dipstick', 'obtained', ',', 'with', 'albuminuria', 'stratified', 'notrace', 'albuminuria', ',', 'microalbuminuria', '(', 'mgdl', ')', ',', 'or', 'macroalbuminuria', '(', 'mgdl', ')', '.', 'kaplan-meier', 'rate', 'and', 'proportional', 'cox', 'hazard', 'model', 'of', 'cv', 'death', ',', 'overall', 'mortality', ',', 'cv', 'death', 'or', 'myocardial', 'infarction', '(', 'mi', ')', ',', 'and', 'bleeding', 'calculated', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'identified', 'adverse', 'event', 'reporting', 'and', 'creatinine', 'increase', '(', 'absolute', '.', 'mgdl', 'or', 'relative', ')', ',', 'descriptively', 'reported', '.', 'result', 'dipstick', 'albuminuria', 'and', 'creatinine', 'value', 'available', 'in', 'patient', '(', '.', ')', '.', 'patient', 'with', 'macroalbuminuria', ',', 'versus', 'notrace', 'albuminuria', ',', 'diabetes', '(', 'v', ')', 'or', 'hypertension', '(', 'v', ')', '.', 'rate', 'cv', 'death', 'and', 'overall', 'mortality', 'per', 'stratum', '.', 'and', '.', '(', 'notrace', 'albuminuria', ')', '.', 'and', '.', '(', 'microalbuminuria', ')', 'and', '.', 'and', '.', '(', 'macroalbuminuria', ')', 'year', 'of', 'follow-up', '.', 'corresponding', 'rate', 'cv', 'death', 'or', 'mi', '.', ',', '.', ',', 'and', '.', ',', 'respectively', '.', 'observed', 'acute', 'kidney', 'injury', 'rate', '.', ',', '.', ',', 'and', '.', '(', 'n', ')', ',', 'respectively', '.', 'adjusted', 'hr', 'macroalbuminuria', 'cv', 'mortality', '.', '(', 'ci', '.-', '.', ')', ',', 'and', 'adjustment', 'with', 'egfr', ',', '.', '(', 'ci', '.-.', ')', '.', 'corresponding', 'hr', 'overall', 'mortality', '.', '(', 'ci', '.-', '.', ')', 'and', '.', '(', 'ci', '.-.', ')', '.', 'conclusion', 'high-risk', 'patient', 'with', 'non-st-segment', 'elevation', 'acute', 'coronary', 'syndrome', 'and', 'albuminuria', 'increased', 'morbidity', 'and', 'increased', 'overall', 'mortality', 'independent', 'of', 'egfr', '.']"
Serum Cytokine Alterations Associated with Age of Patients with Nephropathia Epidemica.,"Venera Shakirova, Ilseyar Khaertynova, Maria Markelova, Rachael Tarlinton, Jerzy Behnke, Ekaterina Martynova, Ekaterina Garanina, Albert Rizvanov, Svetlana Khaiboullina, Venera Shakirovaet al.",2022 Jan 11:2022:4685288.,Biomed Res Int,https://pubmed.ncbi.nlm.nih.gov/35059462/,No keywords found,"['high', 'pc', 'patient', 'showed', 'reduced', 'number', 'of', 'febrile', 'day', ',', 'higher', 'maximum', 'urine', 'output', ',', 'higher', 'creatinine', 'level', ',', 'and', 'lower', 'platelet', 'level', '.', 'overall', ',', 'result', 'of', 'study', 'point', 'towards', 'stronger', 'proinflammatory', 'profile', 'occurring', 'in', 'younger', 'ne', 'patient', ',', 'associated', 'with', 'marker', 'of', 'acute', 'kidney', 'injury', 'and', 'low', 'level', 'of', 'high-density', 'cholesterol', '.', 'consistent', 'with', 'previous', 'work', 'indicating', 'pathology', 'of', 'ne', 'immune', 'driven', ',', 'with', 'inflammatory', 'immune', 'response', 'associated', 'with', 'disease', 'and', 'immune', 'response', 'extreme', 'in', 'younger', 'patient', '.']"
Renal Effects of Antisense-Mediated Inhibition of SGLT2.,"Leonie van Meer, Matthijs Moerland, Marloes van Dongen, Bas Goulouze, Marieke de Kam, Erica Klaassen, Adam Cohen, Jacobus Burggraaf, Leonie van Meeret al.",2016 Nov,J Pharmacol Exp Ther,https://pubmed.ncbi.nlm.nih.gov/27605629/,No keywords found,"['isi', 'antisense', 'sodium-glucose', 'cotransporter', '(', 'sglt', ')', 'inhibitor', 'designed', 'to', 'treat', 'type', 'diabetes', 'mellitus', 'induction', 'of', 'glucosuria', '.', 'isi', 'demonstrated', 'to', 'safe', 'and', 'effective', 'in', 'preclinical', 'trail', 'in', 'several', 'specie', '.', 'undertook', 'present', 'study', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'weekly', 'dos', 'of', ',', ',', 'and', 'mg', 'of', 'isi', 'in', 'human', '.', 'isi', 'increased', '-hour', 'urinary', 'glucose', 'excretion', 'dose', 'dependently', 'with', '.', '.', 'mgday', 'in', '-mg', 'and', '.', '.', 'mgday', 'in', '-mg', 'cohort', ',', 'versus', '.', '.', 'mgday', 'in', 'placebo', 'group', '.', 'isi', 'induced', 'reversible', 'increase', 'in', 'serum', 'creatinine', ',', 'with', 'largest', 'effect', 'eight', 'dos', 'of', 'isi', '(', 'mg', '.', '.', 'mgdl', 'increase', 'baseline', ')', '.', 'three', 'subject', 'discontinued', 'result', 'of', 'creatinine', 'increase', '.', 'renal', 'clearance', 'test', 'revealed', 'no', 'indication', 'impairment', 'of', 'glomerular', 'filtration', 'or', 'renal', 'perfusion', '.', 'creatinine', 'increase', 'accompanied', 'rise', 'in', 'level', 'of', 'urinary', 'renal', 'damage', 'marker', '--', 'microglobulin', '(', 'bm', ')', ',', 'total', 'protein', ',', 'kidney', 'injury', 'molecule', '(', 'kim', ')', ',', '-glutathione', 's-transferase', '(', 'agst', ')', ',', 'n-acetyl', '--', '(', ')', '-glucosaminidase', '(', 'nag', ')', '.', 'treatment-related', 'adverse', 'event', 'included', 'mild', 'injection', 'site', 'reaction', 'occurring', 'in', '-', 'of', 'subject', '.', 'in', 'conclusion', ',', 'isi', 'treatment', 'induced', 'glucosuria', 'dose', 'level', 'of', 'mgweek', '.', 'intended', 'pharmacological', 'effect', 'small', ',', 'amounting', 'to', 'approximately', 'of', 'total', 'amount', 'of', 'filtered', 'glucose', '.', 'change', 'in', 'serum', 'and', 'urinary', 'marker', 'indicative', 'of', 'transient', 'renal', 'dysfunction', ',', 'probably', 'of', 'tubular', 'origin', '.', 'whether', 'glucosuria', 'caused', 'specific', 'sglt', 'inhibition', 'or', 'general', 'tubular', 'dysfunction', 'or', 'combination', 'remains', 'uncertain', '.']"
Neutrophil gelatinase-associated lipocalin as a biomarker for predicting acute kidney injury during off-pump coronary artery bypass grafting.,"Muralidhar Kanchi, R Manjunath, Jos Massen, Lloyd Vincent, Kumar Belani, Muralidhar Kanchiet al.",2017 Jul-Sep,Ann Card Anaesth,https://pubmed.ncbi.nlm.nih.gov/28701593/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'following', 'cardiac', 'surgery', 'major', 'complication', 'resulting', 'in', 'increased', 'morbidity', ',', 'mortality', ',', 'and', 'economic', 'burden', '.', 'in', 'study', ',', 'assessed', 'usefulness', 'of', 'estimating', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'biomarker', 'in', 'predicting', 'aki', 'in', 'patient', 'with', 'stable', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'and', 'undergoing', 'off-pump', 'coronary', 'artery', 'bypass', 'grafting', '(', 'op-cabg', ')', '.', 'patient', 'and', 'method', 'prospectively', 'studied', 'sixty', 'nondialysis-dependent', 'ckd', 'patient', 'with', 'estimated', 'glomerular', 'filtration', 'rate', 'mlmin', '.', 'required', 'elective', 'op-cabg', '.', 'patient', 'randomized', 'two', 'group', ',', 'group', 'received', 'dopamine', 'infusion', 'gkgmin', 'following', 'anesthesia', 'induction', 'till', 'end', 'of', 'surgery', 'and', 'group', 'p', 'not', 'receive', 'intervention', '.', 'serum', 'creatinine', ',', 'ngal', ',', 'brain', 'natriuretic', 'peptide', ',', 'and', 'troponin-i', 'estimated', 'specified', 'interval', ',', ',', 'and', 'surgery', '.', 'result', 'of', 'study', 'patient', 'also', 'compared', 'to', 'simultaneous', 'matched', 'cohort', 'control', 'of', 'thirty', 'patient', '(', 'group', ')', 'without', 'renal', 'dysfunction', 'underwent', 'op-cabg', '.', 'result', 'no', 'patient', 'required', 'renal', 'replacement', 'therapy', ',', 'and', 'no', 'mortality', 'observed', 'perioperative', 'and', 'hospitalization', 'period', '.', 'six', 'patient', 'control', 'group', '(', 'n', ')', ',', 'ten', 'patient', 'placebo', 'group', '(', 'n', ')', ',', 'and', 'patient', 'dopamine', 'group', '(', 'n', ')', 'developed', 'stage', 'aki', '.', 'however', ',', 'not', 'observe', 'stage', 'and', 'stage', 'aki', 'among', 'group', '.', 'significant', 'increase', 'in', 'serum', 'ngal', 'level', 'end', 'of', 'surgery', 'and', 'h', 'postoperatively', 'in', 'placebo', 'and', 'dopamine', 'group', 'compared', 'to', 'control', '.', 'conclusion', 'measurement', 'of', 'ngal', 'appears', 'to', 'predict', 'occurrence', 'of', 'aki', 'op-cab', 'surgery', '.', 'however', ',', 'large', 'multicentric', 'study', 'may', 'required', 'to', 'confirm', 'finding', 'of', 'study', '.']"
"Evaluation of Proenkephalin A 119-159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury.","Thilo von Groote#, Felix Albert#, Melanie Meersch, Raphael Koch, Joachim Gerss, Birte Arlt, Mahan Sadjadi, Christian Porschen, Peter Pickkers, Alexander Zarbock                              ;, RICH investigators, Thilo von Grooteet al.",2023 Jul 10,Crit Care,https://pubmed.ncbi.nlm.nih.gov/37430375/,No keywords found,"['recent', 'evidence', 'suggests', 'association', 'of', 'plasma', 'proenkephalin', '-', '(', 'penkid', ')', 'with', 'early', 'and', 'successful', 'liberation', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'in', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', '.', 'however', ',', 'exploratory', 'result', 'derived', 'monocentric', 'trial', 'and', 'therefore', 'require', 'external', 'validation', 'in', 'multicenter', 'cohort', '.', 'method', 'data', 'and', 'plasma', 'sample', '``', 'effect', 'of', 'regional', 'citrate', 'anticoagulation', 'versus', 'systemic', 'heparin', 'anticoagulation', 'continuous', 'kidney', 'replacement', 'therapy', 'dialysis', 'filter', 'life', 'span', 'and', 'mortality', 'among', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury-a', 'randomized', 'clinical', 'trial', ""''"", '(', 'rich', 'trial', ')', 'used', 'validation', 'study', '.', 'penkid', 'measured', 'in', 'plasma', 'sample', 'available', 'crrt', 'initiation', 'and', 'day', 'of', 'crrt', '.', 'patient', 'categorized', 'low', 'and', 'high', 'penkid', 'group', 'with', 'cutoff', 'pmoll', '.', 'competing-risk', 'time-to-event', 'analysis', 'performed', '.', 'competing', 'risk', 'endpoint', 'successful', 'and', 'unsuccessful', 'liberation', 'crrt', ',', 'latter', 'meaning', 'death', 'or', 'initiation', 'of', 'new', 'rrt', 'within', 'one', 'week', 'of', 'discontinuation', 'of', 'primary', 'crrt', '.', 'penkid', 'compared', 'to', 'urinary', 'output', '.', 'result', 'low', 'pre-crrt', 'penkid', 'level', 'crrt', 'initiation', 'not', 'associated', 'with', 'early', 'and', 'successful', 'liberation', 'crrt', 'compared', 'to', 'patient', 'with', 'high', 'pre-crrt', 'penkid', 'level', 'subdistribution', 'hazard', 'ratio', '(', 'shr', ')', '.', ',', 'ci', '.-.', ',', 'p', '..', 'however', ',', 'landmark', 'analysis', 'day', 'of', 'ongoing', 'crrt', 'demonstrated', 'association', 'low', 'penkid', 'level', 'and', 'successful', 'liberation', 'crrt', '(', 'shr', '.', ',', 'ci', '.-.', ',', 'p', 'mld', ')', 'even', 'stronger', 'associated', 'with', 'successful', 'liberation', '(', 'shr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'compared', 'to', 'penkid', '.', 'discussion', 'study', 'suggests', 'penkid', 'may', 'competent', 'biomarker', 'to', 'monitor', 'recovery', 'of', 'kidney', 'function', 'crrt', '.', 'in', 'line', 'with', 'previous', 'finding', 'and', 'investigated', 'concept', 'in', 'multicenter', 'cohort', '.', ',', 'low', 'penkid', 'associated', 'with', 'early', 'and', 'successful', 'crrt', 'liberation', ',', 'outperformed', 'high', 'daily', 'urinary', 'output', '.', 'finding', 'of', 'study', 'warrant', 'evaluation', 'in', 'prospective', 'study', 'or', 'randomized', 'controlled', 'trial', '.', 'trial', 'registration', 'rich', 'trial', 'registered', 'clinicaltrials.gov', 'nct', '.', 'registered', 'february', '.']"
"Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.","Raj R Makkar, Wen Cheng, Ron Waksman, Lowell F Satler, Tarun Chakravarty, Mark Groh, William Abernethy, Mark J Russo, David Heimansohn, James Hermiller, Stephen Worthley, Bassem Chehab, Mark Cunningham, Ray Matthews, Ravi K Ramana, Gerald Yong, Carlos E Ruiz, Chunguang Chen, Federico M Asch, Mamoo Nakamura, Hasan Jilaihawi, Rahul Sharma, Sung-Han Yoon, Augusto D Pichard, Samir Kapadia, Michael J Reardon, Deepak L Bhatt, Gregory P Fontana, Raj R Makkaret al.",2020 Sep 5,Lancet,https://pubmed.ncbi.nlm.nih.gov/32593323/,No keywords found,"['randomised', 'trial', 'data', 'assessing', 'safety', 'and', 'efficacy', 'of', 'self-expanding', 'intra-annular', 'portico', 'transcatheter', 'aortic', 'valve', 'system', '(', 'abbott', 'structural', 'heart', ',', 'st', 'paul', ',', 'mn', ',', 'usa', ')', 'compared', 'with', 'commercially', 'available', 'valve', 'needed', 'to', 'compare', 'performance', 'among', 'design', '.', 'method', 'in', 'prospective', ',', 'multicentre', ',', 'non-inferiority', ',', 'randomised', 'controlled', 'trial', '(', 'portico', 're-sheathable', 'transcatheter', 'aortic', 'valve', 'system', 'u', 'investigational', 'device', 'exemption', 'trial', 'portico', 'ide', ')', ',', 'high', 'and', 'extreme', 'risk', 'patient', 'with', 'severe', 'symptomatic', 'aortic', 'stenosis', 'recruited', 'medical', 'centre', 'experienced', 'in', 'performing', 'transcatheter', 'aortic', 'valve', 'replacement', 'in', 'usa', 'and', 'australia', '.', 'patient', 'eligible', 'aged', 'year', 'or', 'older', ',', 'in', 'new', 'york', 'heart', 'association', 'functional', 'class', 'ii', 'or', 'higher', ',', 'and', 'severe', 'native', 'aortic', 'stenosis', '.', 'eligible', 'patient', 'randomly', 'assigned', '(', ')', 'using', 'permuted', 'block', 'randomisation', '(', 'block', 'size', 'of', 'and', ')', 'and', 'stratified', 'clinical', 'investigational', 'site', ',', 'surgical', 'risk', 'cohort', ',', 'and', 'vascular', 'access', 'method', ',', 'to', 'transcatheter', 'aortic', 'valve', 'replacement', 'with', 'first', 'generation', 'portico', 'valve', 'and', 'delivery', 'system', 'or', 'commercially', 'available', 'valve', '(', 'either', 'intra-annular', 'balloon-expandable', 'edwards-sapien', ',', 'sapien', 'xt', ',', 'or', 'sapien', 'valve', 'edward', 'lifesciences', ',', 'irvine', ',', 'ca', ',', 'usa', 'or', 'supra-annular', 'self-expanding', 'corevalve', ',', 'evolut-r', ',', 'or', 'evolut-pro', 'valve', 'medtronic', ',', 'minneapolis', ',', 'mn', ',', 'usa', ')', '.', 'investigational', 'site', 'staff', ',', 'implanting', 'physician', ',', 'and', 'study', 'participant', 'unmasked', 'to', 'treatment', 'assignment', '.', 'core', 'laboratory', 'and', 'clinical', 'event', 'assessor', 'masked', 'to', 'treatment', 'allocation', '.', 'primary', 'safety', 'endpoint', 'composite', 'of', 'all-cause', 'mortality', ',', 'disabling', 'stroke', ',', 'life-threatening', 'bleeding', 'requiring', 'transfusion', ',', 'acute', 'kidney', 'injury', 'requiring', 'dialysis', ',', 'or', 'major', 'vascular', 'complication', 'day', '.', 'primary', 'efficacy', 'endpoint', 'all-cause', 'mortality', 'or', 'disabling', 'stroke', 'year', '.', 'clinical', 'outcome', 'and', 'valve', 'performance', 'assessed', 'to', 'year', 'procedure', '.', 'primary', 'analysis', 'intention', 'to', 'treat', 'and', 'kaplan-meier', 'method', 'to', 'estimate', 'event', 'rate', '.', 'non-inferiority', 'margin', 'primary', 'safety', 'and', 'primary', 'efficacy', 'endpoint', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'ongoing', '.', 'finding', 'may', 'and', 'sept', ',', ',', 'and', 'aug', ',', ',', 'and', 'oct', ',', ',', 'with', 'recruitment', 'paused', 'month', 'funder', ',', 'recruited', 'patient', ',', 'of', 'eligible', 'and', 'randomly', 'assigned', 'to', 'portico', 'valve', 'group', '(', 'n', ')', 'or', 'commercially', 'available', 'valve', 'group', '(', 'n', ')', '.', 'mean', 'age', 'year', '(', 'sd', ')', 'and', '(', ')', 'patient', 'female', '.', 'primary', 'safety', 'endpoint', 'day', ',', 'event', 'rate', 'higher', 'in', 'portico', 'valve', 'group', 'in', 'commercial', 'valve', 'group', '(', 'v', 'absolute', 'difference', ',', 'ci', '-', 'to', 'upper', 'confidence', 'bound', 'ucb', 'pnon-inferiority', ',', 'psuperiority', ')', '.', 'year', ',', 'rate', 'of', 'primary', 'efficacy', 'endpoint', 'similar', 'group', '(', 'in', 'portico', 'group', 'v', 'in', 'commercial', 'valve', 'group', 'difference', ',', 'ci', '-', 'to', 'ucb', 'pnon-inferiority', ',', 'psuperiority', ')', '.', 'year', ',', 'rate', 'of', 'death', '(', 'v', 'p', ')', 'or', 'disabling', 'stroke', '(', 'v', 'p', ')', 'similar', 'group', '.', 'interpretation', 'portico', 'valve', 'associated', 'with', 'similar', 'rate', 'of', 'death', 'or', 'disabling', 'stroke', 'year', 'compared', 'with', 'commercial', 'valve', ',', 'associated', 'with', 'higher', 'rate', 'of', 'primary', 'composite', 'safety', 'endpoint', 'including', 'death', 'day', '.', 'first-generation', 'portico', 'valve', 'and', 'delivery', 'system', 'not', 'offer', 'advantage', 'commercially', 'available', 'valve', '.', 'funding', 'abbott', '.']"
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.,"Mauro Chiarito#, Jorge Sanz-Sanchez#, Raffaele Piccolo, Francesco Condello, Gaetano Liccardo, Matteo Maurina, Marisa Avvedimento, Damiano Regazzoli, Paolo Pagnotta, Hector M Garcia-Garcia, Roxana Mehran, Massimo Federici, Gianluigi Condorelli, Jose Luis Diez Gil, Bernhard Reimers, Giuseppe Ferrante, Giulio Stefanini, Mauro Chiaritoet al.",2023 Feb 6,Cardiovasc Diabetol,https://pubmed.ncbi.nlm.nih.gov/36747244/,No keywords found,"['despite', 'paucity', 'of', 'data', ',', 'common', 'practice', 'to', 'discontinue', 'metformin', 'invasive', 'coronary', 'angiography', 'due', 'to', 'alleged', 'risk', 'of', 'metformin-associated', 'lactic', 'acidosis', '(', 'm-ala', ')', '.', 'aimed', 'assessing', 'safety', 'of', 'metformin', 'continuation', 'in', 'diabetic', 'patient', 'undergoing', 'coronary', 'angiography', 'in', 'term', 'of', 'significant', 'increase', 'in', 'lactate', 'level', '.', 'method', 'in', 'open-label', ',', 'prospective', ',', 'multicentre', ',', 'single-arm', 'trial', ',', 'diabetic', 'patient', 'undergoing', 'coronary', 'angiography', 'with', 'or', 'without', 'percutaneous', 'coronary', 'intervention', 'european', 'center', 'screened', 'enrolment', '.', 'primary', 'endpoint', 'increase', 'in', 'lactate', 'level', 'preprocedural', 'level', '-h', 'procedure', '.', 'secondary', 'endpoint', 'included', 'contrast', 'associated-acute', 'kidney', 'injury', '(', 'ca-aki', ')', ',', 'm-ala', ',', 'and', 'all-cause', 'mortality', '.', 'result', 'diabetic', 'patient', 'metformin', 'therapy', 'included', '.', 'median', 'preprocedural', 'lactate', 'level', '.', 'mmoll', 'interquartile', 'range', '(', 'iqr', ')', '.-', '..', 'lactate', 'level', 'h', 'coronary', 'angiography', '.', 'mmoll', '(', 'iqr', '.-', '.', ')', ',', 'with', 'no', 'significant', 'difference', 'compared', 'to', 'preprocedural', 'level', '(', 'p', '.', 'median', 'difference', 'iqr', '-', '.', 'to', '.', 'mmoll', ')', '.', 'one', 'patient', '-h', 'level', 'mmoll', '(', '.', 'mmoll', ')', ',', 'no', 'case', 'of', 'm-ala', 'reported', '.', 'ca-aki', 'occurred', 'in', 'patient', '(', '.', ')', 'and', 'median', 'serum', 'creatinine', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'remained', 'similar', 'throughout', 'periprocedural', 'period', '.', 'median', 'follow-up', 'of', 'day', '(', '-', ')', ',', 'no', 'patient', 'required', 'hemodialysis', 'and', 'patient', 'died', 'due', 'to', 'non-cardiac', 'cause', '.', 'conclusion', 'in', 'diabetic', 'patient', 'undergoing', 'invasive', 'coronary', 'angiography', ',', 'metformin', 'continuation', 'throughout', 'periprocedural', 'period', 'not', 'increase', 'lactate', 'level', 'and', 'not', 'associated', 'with', 'decline', 'in', 'renal', 'function', '.', 'trial', 'registration', 'study', 'registered', 'clinicaltrials.gov', '(', 'nct', ')', '.']"
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial.,"Claudio Moretti, Enrico Cerrato, Erika Cavallero, Song Lin, Marco Luciano Rossi, Andrea Picchi, Francesca Sanguineti, Fabrizio Ugo, Alberto Palazzuoli, Maurizio Bertaina, Patrizia Presbitero, Chen Shao-Liang, Roberto Pozzi, Massimo Giammaria, Ugo Limbruno, Thierry Lefèvre, Valeria Gasparetto, Roberto Garbo, Pierluigi Omedè, Imad Sheiban, Javier Escaned, Giuseppe Biondi-Zoccai, Fiorenzo Gaita, Leor Perl, Fabrizio D'Ascenzo, Claudio Morettiet al.",2018 Apr 15:257:1-6.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/29506674/,No keywords found,"['potential', 'protective', 'effect', 'of', 'remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'remain', 'to', 'defined', '.', 'method', 'and', 'result', 'double', 'blind', ',', 'randomized', ',', 'placebo', 'controlled', 'multicenter', 'study', 'performed', '.', 'patient', 'younger', 'year', 'old', ',', 'with', 'renal', 'clearance', 'of', '-mlmin.m', ',', 'candidate', 'pci', 'clinical', 'indication', 'except', 'primary', 'pci', ',', 'allocated', 'to', 'ripc', 'or', 'to', 'standard', 'therapy', '.', 'primary', 'endpoint', 'incidence', 'of', 'cin', '.', 'secondary', 'endpoint', 'incidence', 'of', 'peri-procedural', 'myocardial', 'infarction', '(', 'pmi', ')', '.', 'february', 'to', 'april', ',', 'patient', 'scheduled', 'coronary', 'angiography', 'screened', 'study', '.', 'fulfilled', 'inclusion', 'criterion', 'and', 'received', 'pci', '.', 'patient', 'randomized', 'to', 'sham', 'ripc', '(', 'n', ')', 'or', 'treatment', 'group', '(', 'n', ')', '.', 'pre-specified', 'subgroup', 'of', 'diabetic', 'patient', 'included', '(', ')', 'case', '.', 'ripc', 'significantly', 'reduced', 'cin', 'incidence', 'in', 'overall', 'population', '(', '.', 'v', '.', '.', ',', 'p.', ',', 'with', 'nnt', ')', 'and', 'in', 'non-diabetic', 'patient', '(', '.', 'v', '.', '.', ',', 'p.', ')', ',', 'showed', 'no', 'benefit', 'in', 'diabetic', '(', '.', 'v', '.', '.', ',', 'p.', ')', '.', 'trend', 'lower', 'pmi', 'seen', 'in', 'intervention', 'arm', '(', 'creatine', 'kinase', '-', 'muscle', 'brain', 'url', '.', 'v', '.', '.', ',', 'p.', 'troponin', 'url', 'vs.', ',', 'p.', ')', '.', 'conclusion', 'remote', 'ischemic', 'preconditioning', 'significantly', 'reduces', 'incidence', 'of', 'acute', 'kidney', 'injury', 'in', 'non-diabetic', 'patient', 'undergoing', 'pci', '.', 'larger', 'sample', 'size', 'presumably', 'needed', 'to', 'assess', 'effect', 'of', 'ripc', 'patient', 'with', 'diabetes', 'mellitus', '.', 'clinical', 'trial', 'numberncthttpswww.clinicaltrial.gov', '.']"
"A Multicenter, Randomized, Controlled Phase IIb Trial of Avoidance of Hyperoxemia during Cardiopulmonary Bypass.","Shay P McGuinness, Rachael L Parke, Kate Drummond, Tim Willcox, Michael Bailey, Cornelius Kruger, Megan Baker, Keri-Anne Cowdrey, Eileen Gilder, Lianne McCarthy, Thomas Painter;, SO-COOL investigators, ShayP McGuinness, RachaelL Parke, Thomas Painter, Shay P McGuinnesset al.",2016 Sep,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/27404222/,No keywords found,"['cardiac', 'surgery', 'utilizing', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'one', 'of', 'common', 'form', 'of', 'major', 'surgery', '.', 'cardiac', 'surgery-associated', 'multiorgan', 'dysfunction', '(', 'csa-mod', ')', 'well', 'recognized', 'and', 'includes', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'hepatic', 'impairment', ',', 'myocardial', 'damage', ',', 'and', 'postoperative', 'neurologic', 'deficit', '.', 'pathophysiology', 'of', 'csa-mod', 'involves', 'numerous', 'injurious', 'pathway', 'linked', 'to', 'use', 'of', 'cpb', 'including', 'oxidative', 'stress', 'and', 'formation', 'of', 'reactive', 'iron', 'specie', '.', 'cardiac', 'surgery', 'with', 'cpb', ',', 'arterial', 'return', 'blood', 'oxygenated', 'to', 'supranormal', 'level', '.', 'study', 'aimed', 'to', 'determine', 'whether', 'avoidance', 'of', 'arterial', 'hyperoxemia', 'decreased', 'oxidative', 'stress', 'and', 'reduced', 'severity', 'of', 'multiorgan', 'dysfunction', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', 'utilizing', 'cpb', '.', 'method', 'study', 'multicenter', ',', 'open-label', ',', 'parallel-group', ',', 'randomized', 'controlled', 'study', 'of', 'avoidance', 'of', 'arterial', 'hyperoxemia', 'versus', 'usual', 'care', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', 'involving', 'cpb', '.', 'primary', 'outcome', 'incidence', 'and', 'severity', 'of', 'aki', '.', 'secondary', 'outcome', 'included', 'serum', 'biomarkers', 'csa-mod', ',', 'duration', 'of', 'mechanical', 'ventilation', ',', 'and', 'length', 'of', 'intensive', 'care', 'and', 'hospital', 'stay', '.', 'result', 'total', 'of', 'patient', 'randomized', 'and', 'analyzed', 'two', 'hospital', 'in', 'new', 'zealand', 'and', 'australia', '.', 'mean', 'pao', 'significantly', 'different', 'group', 'cpb', '.', 'no', 'difference', 'in', 'development', 'of', 'aki', '(', 'intervention', 'arm', '.', 'vs.', 'usual', 'care', '.', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', ',', 'marker', 'of', 'organ', 'damage', ',', 'or', 'intensive', 'care', 'unit', 'and', 'hospital', 'length', 'of', 'stay', '.', 'conclusion', 'avoiding', 'modest', 'hyperoxemia', 'cpb', 'failed', 'to', 'demonstrate', 'difference', 'in', 'aki', ',', 'marker', 'of', 'organ', 'damage', ',', 'or', 'length', 'of', 'stay', '.']"
Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis.,"George L Zorn rd, Stephen H Little, Peter Tadros, G Michael Deeb, Thomas G Gleason, John Heiser, Neal S Kleiman, Jae K Oh, Jeffrey J Popma, David Adams, Jian Huang, Michael J Reardon, George L Zorn rdet al.",2016 Apr,J Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/26614412/,No keywords found,"['compared', 'incidence', 'of', 'prosthesis-patient', 'mismatch', '(', 'ppm', ')', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'using', 'self-expanding', 'bioprosthesis', 'and', 'surgical', 'aortic', 'valve', 'replacement', '(', 'savr', ')', 'in', 'corevalve', 'u', 'high', 'risk', 'pivotal', 'trial', '.', 'sought', 'to', 'determine', 'influence', 'of', 'ppm', 'clinical', 'outcome', '.', 'method', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'and', 'increased', 'risk', 'surgery', 'randomized', 'to', 'tavr', 'or', 'savr', '.', 'postoperative', 'ppm', 'defined', 'effective', 'orifice', 'area', 'index', '(', 'eoai', ')', 'severe', 'ppm', '(', 'eoai', '.', 'cm', '(', ')', '(', ')', ')', 'and', 'no', 'severe', 'ppm', '(', 'eoai', '.', 'cm', '(', ')', '(', ')', ')', 'clinical', 'outcome', 'analyzed', 'in', 'tavr', 'arm', '(', 'n', ')', 'and', 'savr', 'arm', '(', 'n', ')', '.', 'left', 'ventricular', 'mass', 'index', 'and', 'regression', 'analyzed', 'baseline', 'and', 'year', '.', 'result', 'incidence', 'of', 'severe', 'ppm', 'in', 'savr', 'group', 'year', '.', 'versus', '.', 'in', 'tavr', 'group', '(', 'p', '.', ')', '.', 'left', 'ventricular', 'mass', 'index', 'regression', 'year', '.', 'tavr', 'and', '.', 'savr', 'in', 'patient', 'with', 'severe', 'ppm', '.', 'year', 'rate', 'of', 'all-cause', 'mortality', 'and', 'acute', 'kidney', 'injury', 'significantly', 'greater', 'in', 'patient', '(', 'tavr', 'savr', ')', 'with', 'severe', 'ppm', 'compared', 'with', 'no', 'severe', 'ppm', '(', '.', 'v', '.', 'p', '.', 'death', 'and', '.', 'v', '.', 'p', '.', 'acute', 'kidney', 'injury', ')', '.', 'conclusion', 'in', 'patient', 'with', 'high', 'surgical', 'risk', 'and', 'severe', 'aortic', 'stenosis', ',', 'severe', 'ppm', 'common', 'in', 'patient', 'treated', 'with', 'savr', 'treated', 'with', 'tavr', '.', 'patient', 'with', 'severe', 'ppm', 'greater', 'risk', 'death', 'and', 'acute', 'kidney', 'injury', 'patient', 'without', 'severe', 'ppm', '.']"
Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation.,"Madhav Swaminathan, Nelson Kopyt, Mohamed G Atta, Jai Radhakrishnan, Kausik Umanath, Sunny Nguyen, Brian O'Rourke, Ashley Allen, Natalie Vaninov, Arno Tilles, Elizabeth LaPointe, Andrew Blair, Chris Gemmiti, Brian Miller, Biju Parekkadan, Rita N Barcia, Madhav Swaminathanet al.",2021 Dec,Stem Cells Transl Med,https://pubmed.ncbi.nlm.nih.gov/34581517/,No keywords found,"['mesenchymal', 'stem', 'cell', '(', 'msc', ')', 'natural', 'immunoregulatory', 'function', 'explored', 'medicinal', 'use', 'cell', 'therapy', 'with', 'limited', 'success', '.', 'phase', 'ib', 'study', 'conducted', 'to', 'evaluate', 'safety', 'and', 'immunoregulatory', 'mechanism', 'of', 'action', 'of', 'msc', 'using', 'novel', 'ex', 'vivo', 'product', '(', 'sbi-', ')', 'to', 'preserve', 'cell', 'activity', 'in', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', '.', 'pharmacological', 'data', 'demonstrated', 'msc-secreted', 'factor', 'activity', 'associated', 'with', 'anti-inflammatory', 'signature', 'in', 'molecular', 'and', 'cellular', 'profiling', 'of', 'patient', 'blood', '.', 'system', 'biology', 'analysis', 'captured', 'multicompartment', 'effect', 'consistent', 'with', 'immune', 'reprogramming', 'and', 'kidney', 'tissue', 'repair', '.', 'although', 'study', 'not', 'powered', 'clinical', 'efficacy', ',', 'result', 'supportive', 'of', 'therapeutic', 'hypothesis', ',', 'namely', ',', 'treatment', 'with', 'sbi-', 'elicits', 'immunotherapeutic', 'response', 'trigger', 'accelerated', 'phenotypic', 'switch', 'tissue', 'injury', 'to', 'tissue', 'repair', '.', 'ex', 'vivo', 'administration', 'of', 'msc', ',', 'with', 'increased', 'power', 'of', 'testing', ',', 'potential', 'new', 'biological', 'delivery', 'paradigm', 'assures', 'sustained', 'msc', 'activity', 'and', 'immunomodulation', '.']"
Effect of Exogenous Albumin on the Incidence of Postoperative Acute Kidney Injury in Patients Undergoing Off-pump Coronary Artery Bypass Surgery with a Preoperative Albumin Level of Less Than 4.0 g/dl.,"Eun-Ho Lee, Wook-Jong Kim, Ji-Yeon Kim, Ji-Hyun Chin, Dae-Kee Choi, Ji-Yeon Sim, Suk-Jung Choo, Cheol-Hyun Chung, Jae-Won Lee, In-Cheol Choi, Eun-Ho Leeet al.",2016 May,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/26891150/,No keywords found,"['hypoalbuminemia', 'may', 'increase', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'author', 'investigated', 'whether', 'immediate', 'preoperative', 'administration', 'of', 'albumin', 'solution', 'affect', 'incidence', 'of', 'aki', 'off-pump', 'coronary', 'artery', 'bypass', 'surgery', '.', 'method', 'in', 'prospective', ',', 'single-center', ',', 'randomized', ',', 'parallel-arm', 'double-blind', 'trial', ',', 'patient', 'with', 'preoperative', 'serum', 'albumin', 'level', 'less', '.', 'gdl', 'administered', ',', ',', 'or', 'ml', 'of', 'human', 'albumin', 'according', 'to', 'preoperative', 'serum', 'albumin', 'level', '(', '.', 'to', '.', ',', '.', 'to', '.', ',', 'or', 'less', '.', 'gdl', ',', 'respectively', ')', 'or', 'with', 'equal', 'volume', 'of', 'saline', 'surgery', '.', 'primary', 'outcome', 'measure', 'aki', 'incidence', 'surgery', '.', 'postoperative', 'aki', 'defined', 'maximal', 'aki', 'network', 'criterion', 'based', 'creatinine', 'change', '.', 'result', 'patient', 'characteristic', 'and', 'perioperative', 'data', 'except', 'urine', 'output', 'surgery', 'similar', 'two', 'group', 'studied', ',', 'albumin', 'group', 'and', 'control', 'group', '.', 'urine', 'output', '(', 'median', 'interquartile', 'range', ')', 'surgery', 'higher', 'in', 'albumin', 'group', '(', 'ml', 'to', ')', 'in', 'control', 'group', '(', 'ml', 'to', 'p', '.', ')', '.', 'incidence', 'of', 'postoperative', 'aki', 'in', 'albumin', 'group', 'lower', 'in', 'control', 'group', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'no', 'significant', 'between-group', 'difference', 'in', 'severe', 'aki', ',', 'including', 'renal', 'replacement', 'therapy', ',', '-day', 'mortality', ',', 'and', 'clinical', 'outcome', '.', 'no', 'significant', 'adverse', 'event', '.', 'conclusion', 'administration', 'of', 'exogenous', 'albumin', 'immediately', 'surgery', 'increase', 'urine', 'output', 'surgery', 'and', 'reduces', 'risk', 'of', 'aki', 'off-pump', 'coronary', 'artery', 'bypass', 'surgery', 'in', 'patient', 'with', 'preoperative', 'serum', 'albumin', 'level', 'of', 'less', '.', 'gdl', '.']"
"Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial.","Jaya Chandrasekhar, Samantha Sartori, Roxana Mehran, Melissa Aquino, Birgit Vogel, Anita W Asgar, John G Webb, Didier Tchetche, Nicolas Dumonteil, Antonio Colombo, Stephan Windecker, Bimmer E Claessen, Jurriën M Ten Berg, David Hildick-Smith, Peter Wijngaard, Thierry Lefèvre, Efthymios N Deliargyris, Christian Hengstenberg, Prodromos Anthopoulos, George D Dangas, Jaya Chandrasekharet al.",2021 May,Clin Res Cardiol,https://pubmed.ncbi.nlm.nih.gov/33839885/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'not', 'uncommon', 'in', 'patient', 'undergoing', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', '.', 'objective', 'examined', 'incidence', ',', 'predictor', ',', 'and', 'outcome', 'of', 'aki', 'bravo', 'randomized', 'trial', '.', 'method', 'bravo-', 'trial', 'included', 'patient', 'undergoing', 'transfemoral', 'tavr', 'randomized', 'to', 'bivalirudin', 'vs.', 'unfractionated', 'heparin', '(', 'ufh', ')', '.', 'primary', 'endpoint', 'of', 'trial', 'bleeding', 'academic', 'research', 'consortium', '(', 'barc', ')', 'type', 'b', 'bleeding', 'h.', 'total', 'follow-up', 'to', 'day', '.', 'aki', 'adjudicated', 'using', 'modified', 'rifle', '(', 'valve', 'academic', 'research', 'consortium', ',', 'varc', ')', 'criterion', '-day', 'follow-up', ',', 'and', 'in', 'sensitivity', 'analysis', 'aki', 'assessed', 'day', '(', 'modified', 'varc-', 'criterion', ')', '.', 'examined', 'incidence', ',', 'predictor', ',', 'and', '-day', 'outcome', 'associated', 'with', 'diagnosis', 'of', 'aki', '.', 'also', 'examined', 'effect', 'of', 'procedural', 'anticoagulant', '(', 'bivalirudin', 'or', 'unfractionated', 'heparin', ',', 'ufh', ')', 'aki', 'within', 'h', 'tavr', '.', 'result', 'trial', 'population', 'mean', 'age', 'of', '.', '.', 'year', 'including', '.', 'woman', 'with', 'mean', 'euroscore', '.', '..', 'aki', 'occurred', 'in', '.', '-day', 'follow-up', 'and', 'associated', 'with', 'greater', 'adjusted', 'risk', 'of', '-day', 'death', '(', '.', 'v', '.', '.', ',', 'or', '.', ',', 'ci', '.-', '.', ')', 'and', 'trend', 'barc', 'b', 'bleeding', '(', '.', 'v', '.', '.', ',', 'or', '.', ',', 'ci', '.-.', ')', '.', 'predictor', 'of', '-day', 'aki', 'baseline', 'hemoglobin', ',', 'body', 'weight', ',', 'and', 'pre-existing', 'coronary', 'disease', '.', 'aki', 'occurred', 'in', '.', 'day', 'and', 'associated', 'with', 'significantly', 'greater', 'risk', 'of', '-day', 'death', '(', 'or', '.', ',', 'ci', '.-.', ')', '.', 'independent', 'predictor', 'of', 'aki', 'within', 'day', 'included', 'pre-existing', 'coronary', 'or', 'cerebrovascular', 'disease', ',', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', ',', 'and', 'transfusion', 'increased', 'risk', ',', 'whereas', 'post-dilation', 'protective', '.', 'incidence', 'of', '-h', 'aki', 'higher', 'with', 'bivalirudin', 'compared', 'to', 'ufh', 'in', 'intention', 'to', 'treat', 'cohort', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', ',', 'not', 'in', 'per-protocol', 'assessment', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'conclusion', 'in', 'bravo', 'trial', ',', 'aki', 'occurred', 'in', 'day', 'and', 'in', '.', 'day', '.', 'aki', 'associated', 'with', 'significantly', 'greater', 'adjusted', 'risk', '-day', 'death', '.', 'multivariate', 'predictor', 'of', 'aki', 'day', 'included', 'baseline', 'hemoglobin', ',', 'body', 'weight', ',', 'and', 'prior', 'coronary', 'artery', 'disease', ',', 'and', 'predictor', 'day', 'included', 'pre-existing', 'vascular', 'disease', ',', 'ckd', ',', 'transfusion', ',', 'and', 'valve', 'post-dilation', '.', 'bivalirudin', 'associated', 'with', 'greater', 'aki', 'within', 'h', 'in', 'intention', 'to', 'treat', 'not', 'in', 'per-protocol', 'analysis', '.']"
A comparison of sevoflurane versus sevoflurane-propofol combination on renal function in patients undergoing valvular heart surgery-A prospective randomized controlled pilot study.,"Reshmi L Jose, Deepa Damayanathi, Koniaparambil P Unnikrishnan, Puthuvassery R Suneel, Reshmi L Joseet al.",2021 Apr-Jun,Ann Card Anaesth,https://pubmed.ncbi.nlm.nih.gov/33884972/,No keywords found,"['objective', 'of', 'present', 'study', 'to', 'compare', 'effect', 'of', 'sevoflurane', 'with', 'sevoflurane-propofol', 'combination', 'renal', 'function', 'in', 'patient', 'undergoing', 'valvular', 'heart', 'surgery', '.', 'renal', 'protective', 'effect', 'assessed', 'using', 'novel', 'marker', 'called', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', '.', 'material', 'and', 'method', 'prospective', 'randomized', 'controlled', 'pilot', 'study', 'conducted', 'tertiary', 'care', 'center', 'in', 'india', '.', 'study', 'enrolled', 'patient', 'undergoing', 'elective', 'valvular', 'heart', 'surgery', ',', 'included', '.', 'patient', 'randomized', 'two', 'group', ',', ',', 'in', 'sevoflurane', 'group', '(', 's-group', ')', 'and', 'in', 'sevoflurane-propofol', 'group', '(', 'sp-group', ')', '.', 'baseline', 'ngal', 'level', 'and', 'test', 'ngal', 'level', 'h', 'cardiopulmonary', 'bypass', 'measured', '.', 'result', 'significant', 'rise', 'in', 'test', 'ngal', 'level', 'compared', 'to', 'baseline', 'in', 'group', '.', 'test', 'ngal', 'level', 'in', 's-group', 'significantly', 'high', 'compared', 'to', 'of', 'sp-group', '(', 'p', '.', ')', '.', 'number', 'of', 'patient', 'with', 'acute', 'kidney', 'injury', 'less', 'in', 'sp-group', 'without', 'reaching', 'statistical', 'significance', '(', 'p', '.', ')', '.', 'conclusion', 'renal', 'function', 'better', 'preserved', 'in', 'patient', 'anesthetized', 'with', 'combination', 'of', 'sevoflurane', 'and', 'propofol', '.', 'could', 'due', 'to', 'enhanced', 'protective', 'effect', 'renal', 'function', 'sevoflurane', 'and', 'propofol', '.']"
Transient vs In-Hospital Persistent Acute Kidney Injury in Patients With Acute Coronary Syndrome.,"Antonio Landi, Mattia Branca, Sergio Leonardi, Enrico Frigoli, Pascal Vranckx, Matteo Tebaldi, Ferdinando Varbella, Paolo Calabró, Giovanni Esposito, Gennaro Sardella, Stefano Garducci, Giuseppe Andò, Ugo Limbruno, Paolo Sganzerla, Andrea Santarelli, Carlo Briguori, Salvatore Colangelo, Salvatore Brugaletta, Marianna Adamo, Elmir Omerovic, Dik Heg, Stephan Windecker, Marco Valgimigli                              ;, MATRIX Investigators, Antonio Landiet al.",2023 Jan 23,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/36697156/,No keywords found,"['occurrence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'among', 'patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'undergoing', 'invasive', 'management', 'associated', 'with', 'worse', 'outcome', '.', 'however', ',', 'prognostic', 'implication', 'of', 'transient', 'or', 'in-hospital', 'persistent', 'aki', 'may', 'differ', '.', 'objective', 'aim', 'of', 'study', 'to', 'evaluate', 'prognostic', 'implication', 'of', 'transient', 'or', 'in-hospital', 'persistent', 'aki', 'in', 'patient', 'with', 'ac', '.', 'method', 'in', 'matrix', '(', 'minimizing', 'adverse', 'haemorrhagic', 'event', 'transradial', 'access', 'site', 'and', 'systemic', 'implementation', 'of', 'angiox', ')', 'trial', ',', 'subject', 'excluded', 'of', 'incomplete', 'information', 'or', 'end-stage', 'renal', 'disease', ',', 'with', 'study', 'population', 'of', ',', 'patient', '.', 'transient', 'and', 'persistent', 'aki', 'defined', 'renal', 'dysfunction', 'no', 'longer', 'or', 'still', 'fulfilling', 'aki', 'criterion', '(', '.', 'mgdl', 'or', 'relative', 'increase', 'in', 'creatinine', ')', 'discharge', ',', 'respectively', '.', 'thirty-day', 'coprimary', 'outcome', 'out-of-hospital', 'composite', 'of', 'death', ',', 'myocardial', 'infarction', ',', 'or', 'stroke', '(', 'major', 'adverse', 'cardiovascular', 'event', 'mace', ')', 'and', 'net', 'adverse', 'cardiovascular', 'event', '(', 'nace', ')', ',', 'defined', 'composite', 'of', 'mace', 'or', 'bleeding', 'academic', 'research', 'consortium', 'type', 'or', 'bleeding', '.', 'result', 'persistent', 'and', 'transient', 'aki', 'occurred', 'in', '(', '.', ')', 'and', '(', '.', ')', 'subject', ',', 'respectively', '.', 'multivariable', 'adjustment', ',', 'compared', 'with', 'patient', 'without', 'aki', ',', 'risk', '-day', 'coprimary', 'outcome', 'higher', 'in', 'patient', 'with', 'persistent', 'aki', '(', 'mace', 'adjusted', 'hr', '.', 'ci', '.-', '.', 'p', '.', 'nace', 'adjusted', 'hr', '.', 'ci', '.-', '.', 'p', '.', ')', ',', 'driven', 'mainly', 'all-cause', 'mortality', '(', 'adjusted', 'hr', '.', 'ci', '.-', '.', 'p', '.', ')', ',', 'whereas', 'transient', 'aki', 'not', 'associated', 'with', 'higher', 'rate', 'of', 'mace', 'or', 'nace', '.', 'result', 'remained', 'consistent', 'implementing', 'kdigo', '(', 'kidney', 'disease', 'improving', 'global', 'outcome', ')', 'criterion', '.', 'conclusion', 'among', 'patient', 'with', 'ac', 'undergoing', 'invasive', 'management', ',', 'in-hospital', 'persistent', 'not', 'transient', 'aki', 'associated', 'with', 'higher', 'risk', '-day', 'mace', 'and', 'nace', '.', '(', 'minimizing', 'adverse', 'haemorrhagic', 'event', 'transradial', 'access', 'site', 'and', 'systemic', 'implementation', 'of', 'angiox', 'matrix', 'nct', ')', '.']"
"Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial.","F Perry Wilson, Michael Shashaty, Jeffrey Testani, Iram Aqeel, Yuliya Borovskiy, Susan S Ellenberg, Harold I Feldman, Hilda Fernandez, Yevgeniy Gitelman, Jennie Lin, Dan Negoianu, Chirag R Parikh, Peter P Reese, Richard Urbani, Barry Fuchs, F Perry Wilsonet al.",2015 May 16,Lancet,https://pubmed.ncbi.nlm.nih.gov/25726515/,No keywords found,"['acute', 'kidney', 'injury', 'often', 'go', 'unrecognised', 'in', 'early', 'stage', 'effective', 'treatment', 'option', 'might', 'available', '.', 'aimed', 'to', 'determine', 'whether', 'automated', 'electronic', 'alert', 'acute', 'kidney', 'injury', 'would', 'reduce', 'severity', 'of', 'injury', 'and', 'improve', 'clinical', 'outcome', 'in', 'patient', 'in', 'hospital', '.', 'method', 'in', 'investigator-masked', ',', 'parallel-group', ',', 'randomised', 'controlled', 'trial', ',', 'patient', 'recruited', 'hospital', 'of', 'university', 'of', 'pennsylvania', 'in', 'philadelphia', ',', 'pa', ',', 'usa', '.', 'eligible', 'participant', 'adult', 'aged', 'year', 'or', 'older', 'in', 'hospital', 'with', 'stage', 'or', 'greater', 'acute', 'kidney', 'injury', 'defined', 'kidney', 'disease', 'improving', 'global', 'outcome', 'creatinine-based', 'criterion', '.', 'exclusion', 'criterion', 'initial', 'hospital', 'creatinine', 'mgdl', '(', 'to', 'convert', 'to', 'moll', ',', 'multiply', ')', 'or', 'greater', ',', 'fewer', 'two', 'creatinine', 'value', 'measured', ',', 'inability', 'to', 'determine', 'covering', 'provider', ',', 'admission', 'to', 'hospice', 'or', 'observation', 'unit', ',', 'previous', 'randomisation', ',', 'or', 'end-stage', 'renal', 'disease', '.', 'patient', 'randomly', 'assigned', '(', ')', 'via', 'computer-generated', 'sequence', 'to', 'receive', 'acute', 'kidney', 'injury', 'alert', '(', 'text-based', 'alert', 'sent', 'to', 'covering', 'provider', 'and', 'unit', 'pharmacist', 'indicating', 'new', 'acute', 'kidney', 'injury', ')', 'or', 'usual', 'care', ',', 'stratified', 'medical', 'versus', 'surgical', 'admission', 'and', 'intensive', 'care', 'unit', 'versus', 'non-intensive', 'care', 'unit', 'location', 'in', 'block', 'of', '-', 'participant', '.', 'primary', 'outcome', 'composite', 'of', 'relative', 'maximum', 'change', 'in', 'creatinine', ',', 'dialysis', ',', 'and', 'death', 'day', 'randomisation', '.', 'analysis', 'intention', 'to', 'treat', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'number', 'nct', '.', 'finding', 'sept', ',', ',', 'and', 'april', ',', ',', ',', 'patient', 'screened', '.', 'eligible', 'participant', 'assigned', 'to', 'acute', 'kidney', 'injury', 'alert', 'group', 'and', 'assigned', 'to', 'usual', 'care', 'group', '.', 'composite', 'relative', 'maximum', 'change', 'in', 'creatinine', ',', 'dialysis', ',', 'and', 'death', 'day', 'not', 'differ', 'alert', 'group', 'and', 'usual', 'care', 'group', '(', 'p', ')', ',', 'or', 'within', 'of', 'four', 'randomisation', 'stratum', '(', 'p', ')', '.', 'day', 'randomisation', ',', 'median', 'maximum', 'relative', 'change', 'in', 'creatinine', 'concentration', '(', 'iqr', '-', ')', 'in', 'alert', 'group', 'and', '(', '-', ')', 'in', 'usual', 'care', 'group', '(', 'p', ')', '(', ')', 'patient', 'in', 'alert', 'group', 'and', '(', ')', 'patient', 'in', 'usual', 'care', 'group', 'received', 'dialysis', '(', 'odds', 'ratio', 'ci', '-', 'p', ')', 'and', '(', ')', 'patient', 'in', 'alert', 'group', 'and', '(', ')', 'patient', 'in', 'usual', 'care', 'group', 'died', '(', '-', 'p', ')', '.', 'interpretation', 'electronic', 'alert', 'system', 'acute', 'kidney', 'injury', 'not', 'improve', 'clinical', 'outcome', 'among', 'patient', 'in', 'hospital', '.', 'funding', 'penn', 'center', 'healthcare', 'improvement', 'and', 'patient', 'safety', '.']"
Differential effect on mortality of the timing of initiation of renal replacement therapy according to the criteria used to diagnose acute kidney injury: an IDEAL-ICU substudy.,"Saber Davide Barbar, Abderrahmane Bourredjem, Rémi Trusson, Auguste Dargent, Christine Binquet, Jean-Pierre Quenot                                                                                          ;, IDEAL-ICU Study, Raphaël Clere-Jehl, Romain Hernu, Florent Montini, Rémi Bruyère, Christine Lebert, Julien Bohé, Julio Badie, Jean-Pierre Eraldi, Jean-Philippe Rigaud, Bruno Levy, Shidasp Siami, Guillaume Louis, Lila Bouadma, Jean-Michel Constantin, Emmanuelle Mercier, Kada Klouche, Damien Du Cheyron, Gaël Piton, Djillali Annane, Samir Jaber, Therry van der Linden, Gilles Blasco, Jean-Paul Mira, Carole Schwebel, Loïc Chimot, Philippe Guiot, Mai-Anh Nay, Ferhat Meziani, Julie Helms, Claire Roger, Benjamin Louart, Saber Davide Barbaret al.",2023 Aug 17,Crit Care,https://pubmed.ncbi.nlm.nih.gov/37592355/,No keywords found,"['substudy', 'of', 'randomized', 'ideal-icu', 'trial', 'assessed', 'whether', 'timing', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'initiation', 'differential', 'effect', '-day', 'mortality', ',', 'according', 'to', 'criterion', 'used', 'to', 'diagnose', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'in', 'patient', 'with', 'early-stage', 'septic', 'shock', '.', 'method', 'three', 'group', 'considered', 'according', 'to', 'criterion', 'defining', 'aki', 'creatinine', 'elevation', '(', 'group', ')', ',', 'reduced', 'urinary', 'output', '(', 'group', ')', ',', 'creatinine', 'elevation', 'plus', 'reduced', 'urinary', 'output', '(', 'group', ')', '.', 'primary', 'outcome', '-day', 'all-cause', 'death', '.', 'secondary', 'endpoint', 'rrt-free', 'day', ',', 'rrt', 'dependence', 'and', 'renal', 'function', 'discharge', '.', 'assessed', 'interaction', 'rrt', 'strategy', '(', 'early', 'vs.', 'delayed', ')', 'and', 'group', ',', 'and', 'association', 'rrt', 'strategy', 'and', 'mortality', 'in', 'group', 'logistic', 'regression', '.', 'result', 'of', 'patient', 'enrolled', ',', '(', ')', 'patient', 'in', 'group', ',', '(', ')', 'in', 'group', ',', 'and', '(', ')', 'in', 'group', '.', 'effect', 'of', 'rrt', 'initiation', 'strategy', '-day', 'mortality', 'across', 'group', 'showed', 'significant', 'heterogeneity', '(', 'adjusted', 'interaction', 'p', '.', ')', '.', 'mortality', 'vs.', 'early', 'vs.', 'late', 'rrt', 'initiation', ',', 'respectively', ',', 'in', 'group', '(', 'p', '.', ')', 'vs.', ',', 'respectively', ',', 'in', 'group', '(', 'p', '.', ')', 'and', 'vs.', ',', 'respectively', ',', 'in', 'group', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'secondary', 'outcome', '.', 'conclusion', 'timing', 'of', 'rrt', 'initiation', 'differential', 'impact', 'outcome', 'according', 'to', 'aki', 'diagnostic', 'criterion', '.', 'in', 'patient', 'with', 'elevated', 'creatinine', ',', 'early', 'rrt', 'initiation', 'associated', 'with', 'significantly', 'increased', 'mortality', '.', 'in', 'patient', 'with', 'reduced', 'urine', 'output', ',', 'late', 'rrt', 'initiation', 'associated', 'with', 'nonsignificant', ',', 'absolute', 'increase', 'in', 'mortality', '.']"
Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.,"Joerg C Schefold, Mette Krag, Søren Marker, Anders Perner, Jørn Wetterslev, Matt P Wise, Mark Borthwick, Stepani Bendel, Frederik Keus, Anne Berit Guttormsen, Theis Lange, Morten Hylander Møller                                                            ;, theSUP-ICUinvestigators, Joerg C Schefoldet al.",2019,Am J Nephrol,https://pubmed.ncbi.nlm.nih.gov/31480045/,No keywords found,"['intensive', 'care', 'unit', '(', 'icu', ')', 'patient', 'with', 'acute', 'kidney', 'injury', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'considered', 'high', 'risk', 'of', 'gastrointestinal', '(', 'gi', ')', 'bleeding', 'and', 'stress', 'ulcer', 'prophylaxis', '(', 'sup', ')', 'often', 'prescribed', '.', 'aimed', 'to', 'assess', 'incidence', 'of', 'gi', 'bleeding', 'and', 'effect', 'of', 'sup', 'in', 'patient', '.', 'method', 'assessed', 'gi', 'bleeding', 'in', 'icu', 'patient', 'receiving', 'rrt', 'baseline', '(', 'and', 'time', 'in', 'icu', ')', 'and', 'effect', 'of', 'prophylactic', 'pantoprazole', 'versus', 'placebo', 'in', 'international', 'sup', 'in', 'icu', '(', 'sup-icu', ')', 'trial', '.', 'analysis', 'conducted', 'according', 'to', 'published', 'protocol', 'and', 'statistical', 'analysis', 'plan', '.', 'result', 'data', 'of', ',', 'acutely', 'admitted', 'adult', 'icu', 'patient', 'with', 'one', 'or', 'risk', 'factor', 'gi', 'bleeding', 'randomized', 'to', 'pantoprazole', 'or', 'placebo', 'intravenously', 'daily', 'icu', 'stay', '(', 'icu', 'discharge', ',', 'death', ',', 'or', 'maximum', 'of', 'day', ')', 'analyzed', '.', 'of', '(', '.', ',', 'ci', '.-', '.', ')', 'and', 'of', '(', '.', ',', 'ci', '.-', '.', ')', 'of', 'patient', 'receiving', 'rrt', 'baseline', 'and', 'time', 'in', 'icu', ',', 'respectively', ',', 'developed', 'clinically', 'important', 'gi', 'bleeding', 'in', 'icu', '.', 'not', 'observe', 'statistically', 'significant', 'difference', 'in', 'intervention', 'effect', '(', 'pantoprazole', 'vs.', 'placebo', ')', 'in', 'proportion', 'of', 'patient', 'with', 'clinically', 'important', 'gi', 'bleeding', ',', 'clinically', 'important', 'event', ',', 'infectious', 'adverse', 'event', ',', 'use', 'of', 'intervention', 'to', 'stop', 'gi', 'bleeding', ',', 'or', '-day', 'mortality', 'in', 'patient', 'with', 'versus', 'without', 'rrt', 'baseline', '.', 'conclusion', 'in', 'adult', 'icu', 'patient', 'receiving', 'rrt', 'baseline', ',', 'observed', 'high', 'incidence', 'of', 'clinically', 'important', 'gi', 'bleeding', ',', 'not', 'observe', 'effect', 'of', 'pantoprazole', 'versus', 'placebo', 'in', 'subgroup', '.']"
"Association of Age, Frailty, and Strategy for Initiation of Renal-Replacement Therapy: A Post Hoc analysis of the STARRT-Acute Kidney Injury Trial.","Amanda Ying Wang, Ary Serpa Neto, Martin Gallagher, Ron Wald, Sean M Bagshaw, Rinaldo Bellomo                                                                                          ;, STARRT-AKI Investigators, Amanda Ying Wanget al.",2024,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/39047692/,No keywords found,"['study', 'designed', 'to', 'assess', 'association', 'of', 'age', 'and', 'frailty', 'with', 'clinical', 'outcome', 'in', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'according', 'to', 'accelerated', 'and', 'standard', 'renal-replacement', 'therapy', '(', 'rrt', ')', 'initiation', 'strategy', 'in', 'starrt-aki', 'trial', '.', 'method', 'secondary', 'analysis', 'of', 'international', 'randomized', 'trial', '.', 'older', 'age', 'defined', 'year', '.', 'frailty', 'assessed', 'using', 'clinical', 'frailty', 'scale', '(', 'cf', ')', 'score', 'and', 'defined', 'score', '.', 'primary', 'outcome', 'all-cause', 'mortality', 'day', '.', 'secondary', 'outcome', 'included', 'rrt', 'dependence', 'and', 'rrt-free', 'day', 'day', '.', 'used', 'logistic', 'and', 'linear', 'regression', 'and', 'interaction', 'testing', 'to', 'explore', 'impact', 'of', 'age', 'and', 'frailty', 'clinical', 'outcome', '.', 'result', 'of', ',', 'patient', 'randomized', 'in', 'starrt-aki', 'trial', ',', ',', '(', '.', ')', 'aged', 'year', '(', 'median', 'interquartile', 'range', '.', '.-.', ')', '.', 'older', 'patient', 'greater', 'comorbid', 'cardiovascular', 'and', 'chronic', 'kidney', 'disease', ',', 'likely', 'to', 'surgical', 'admission', 'and', 'to', 'receive', 'vasopressor', 'baseline', '.', 'older', 'patient', 'higher', '-day', 'mortality', '(', '.', 'v', '.', '.', ',', 'adjusted-odds', 'ratio', '(', 'or', ')', ',', '.', '.-.', ',', 'p', 'lt', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'rrt', 'dependence', 'day', 'older', 'and', 'younger', 'patient', '(', '.', 'v', '.', '.', ',', 'adjusted-or', ',', '.', '.-.', ',', 'p', '.', ')', '.', 'patient', 'with', 'frailty', 'higher', 'mortality', 'no', 'difference', 'in', 'rrt', 'dependence', 'day', '.', 'no', 'significant', 'interaction', 'age', 'and', 'cf', 'score', 'in', 'relation', 'to', 'mortality', ',', 'rrt', 'dependence', 'day', ',', 'and', 'secondary', 'outcome', '.', 'no', 'significant', 'difference', 'in', 'proportion', 'of', 'patient', 'received', 'rrt', 'in', 'standard-strategy', 'stratified', 'age', 'group', '(', 'adjusted-or', ',', '.', '.-.', ',', 'p', '.', ')', '.', 'conclusion', 'in', 'secondary', 'analysis', 'of', 'starrt-aki', 'trial', ',', 'older', 'and', 'frail', 'patient', 'higher', 'mortality', 'day', 'however', ',', 'no', 'difference', 'in', 'rrt', 'dependence', '.', 'mortality', 'and', 'rrt', 'dependence', 'not', 'modified', 'rrt', 'initiation', 'strategy', 'in', 'older', 'or', 'frail', 'patient', '.']"
The influence of prolonged temperature management on acute kidney injury after out-of-hospital cardiac arrest: A post hoc analysis of the TTH48 trial.,"Kristian Strand, Eldar Søreide, Hans Kirkegaard, Fabio Silvio Taccone, Anders Morten Grejs, Christophe Henri Valdemar Duez, Anni Nørgaard Jeppesen, Christian Storm, Bodil Steen Rasmussen, Timo Laitio, Christian Hassager, Valdo Toome, Johanna Hästbacka, Markus B Skrifvars, Kristian Strandet al.",2020 Jun:151:10-17.,Resuscitation,https://pubmed.ncbi.nlm.nih.gov/32087257/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'common', 'cardiac', 'arrest', 'and', 'targeted', 'temperature', 'management', '(', 'ttm', ')', '.', 'impact', 'of', 'different', 'length', 'of', 'cooling', 'development', 'of', 'aki', 'not', 'well', 'studied', '.', 'in', 'study', 'of', 'patient', 'included', 'in', 'randomised', 'controlled', 'trial', 'of', 'ttm', 'c', 'versus', 'h', 'cardiac', 'arrest', '(', 'tth', 'trial', ')', ',', 'examined', 'influence', 'of', 'prolonged', 'ttm', 'aki', 'and', 'incidence', 'and', 'factor', 'associated', 'with', 'development', 'of', 'aki', '.', 'also', 'examined', 'impact', 'of', 'aki', 'survival', '.', 'method', 'study', 'sub-study', 'of', 'tth', 'trial', ',', 'included', 'patient', 'cooled', 'to', 'c', 'out-of-hospital', 'cardiac', 'arrest', 'versus', 'h.', 'aki', 'classified', 'according', 'to', 'kdigo', 'aki', 'criterion', 'based', 'serum', 'creatinine', 'and', 'urine', 'output', 'collected', 'icu', 'discharge', 'maximum', 'of', 'seven', 'day', '.', 'survival', 'followed', 'to', 'six', 'month', '.', 'association', 'of', 'admission', 'factor', 'aki', 'analysed', 'with', 'multivariate', 'analysis', 'and', 'association', 'of', 'aki', 'mortality', 'analysed', 'with', 'cox', 'regression', 'using', 'time', 'to', 'aki', 'time-dependent', 'covariate', '.', 'result', 'of', 'patient', 'included', 'in', 'study', ',', '(', '.', ')', 'developed', 'aki', '.', 'no', 'significant', 'difference', 'in', 'incidence', ',', 'severity', 'or', 'time', 'to', 'aki', '-', 'and', '-h', 'group', '.', 'serum', 'creatinine', 'value', 'significantly', 'different', 'trajectory', 'two', 'group', 'with', 'sharp', 'rise', 'occurring', 'rewarming', '.', 'age', ',', 'time', 'to', 'return', 'of', 'spontaneous', 'circulation', ',', 'serum', 'creatinine', 'admission', 'and', 'body', 'mass', 'index', 'independent', 'predictor', 'of', 'aki', '.', 'patient', 'with', 'aki', 'higher', 'mortality', 'patient', 'without', 'aki', '(', 'hospital', 'mortality', '.', 'v', '.', ',', 'p', '.', ')', ',', 'aki', 'stage', 'and', 'independently', 'associated', 'with', 'mortality', '.', 'conclusion', 'not', 'find', 'association', 'prolonged', 'ttm', 'c', 'and', 'risk', 'of', 'aki', 'first', 'seven', 'day', 'in', 'icu', '.', 'aki', 'prevalent', 'cardiac', 'arrest', 'and', 'ttm', 'and', 'occurs', 'in', 'almost', 'half', 'of', 'icu', 'admitted', 'patient', 'and', 'commonly', 'in', 'elderly', ',', 'with', 'increasing', 'bmi', 'and', 'longer', 'arrest', 'duration', '.', 'aki', 'cardiac', 'arrest', 'independent', 'predictor', 'of', 'time', 'to', 'death', '.']"
Perioperative Metabolites Are Associated With Adverse Neonatal Congenital Heart Disease Surgical Outcomes.,"Jessica Heibel, Eric M Graham, William T Mahle, Aurelie Roux, David Graham, Cedric Manlhiot, Allen D Everett, Jessica Heibelet al.",2022 Aug 16,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/35946448/,"acute kidney injury, cardiac surgical procedures, cardiopulmonary bypass, congenital, extracorporeal membrane oxygenation, heart defects, infant, newborn, risk factors.","['base', 'clinical', 'model', 'and', 'base', 'modelmetabolites', '.', 'of', 'metabolite', 'examined', ',', 'detected', 'and', 'quantified', '.', 'first', 'principal', 'component', ',', 'principal', 'component', ',', 'composed', 'mostly', 'of', 'preoperative', 'metabolite', 'and', 'significantly', 'associated', 'with', 'composite', 'morbiditymortality', ',', 'cardiac', 'composite', ',', 'and', 'hepatic', 'injury', 'outcome', '.', 'in', 'regression', 'model', ',', 'individual', 'metabolite', 'also', 'improved', 'model', 'performance', 'composite', 'morbiditymortality', ',', 'cardiac', 'composite', ',', 'and', 'hepatic', 'injury', 'outcome', '.', 'significant', 'disease', 'pathway', 'included', 'myocardial', 'injury', '(', 'false', 'discovery', 'rate', ',', '.', ')', 'and', 'heart', 'failure', '(', 'false', 'discovery', 'rate', ',', '.', ')', '.', 'conclusion', 'in', 'neonatal', 'cardiac', 'surgery', ',', 'perioperative', 'metabolite', 'associated', 'with', 'postoperative', 'outcome', 'and', 'improved', 'clinical', 'model', 'outcome', 'association', '.', 'preoperative', 'metabolite', 'level', 'alone', 'may', 'improve', 'risk', 'model', 'and', 'provide', 'basis', 'optimizing', 'perioperative', 'care', '.']"
Comparison of double-dose vs. usual dose of nicorandil for the prevention of contrast-induced nephropathy after cardiac catheterization.,"Zhican Zeng, XiaoFeng Fu, Xue Zhang, Naikuan Fu, Zhican Zenget al.",2019 Nov,Int Urol Nephrol,https://pubmed.ncbi.nlm.nih.gov/31385178/,No keywords found,"['contrast-associated', 'nephropathy', '(', 'cin', ')', ',', 'third', 'main', 'reason', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'inpatient', ',', 'potentially', 'severe', 'side', 'effect', 'of', 'angiography', 'and', 'preventive', 'role', 'of', 'nicorandil', 'cin', 'still', 'controversal', '.', 'aim', 'of', 'clinical', 'trial', 'to', 'evaluate', 'preventive', 'role', 'of', 'different', 'dos', 'of', 'nicorandil', 'cin', 'in', 'patient', 'experiencing', 'cardiac', 'catheterization', 'compared', 'with', 'hydration', '.', 'method', 'recorded', 'outcome', 'patient', 'randomly', 'divided', 'to', 'either', 'double-dose', '(', 'mgday', ')', 'nicorandil', 'group', 'or', 'to', 'usual-dose', '(', 'mgday', ')', 'nicorandil', 'group', 'or', 'control', 'group', '(', 'hydration', ')', '.', 'primary', 'endpoint', 'of', 'current', 'research', 'occurrence', 'of', 'cin', ',', 'defined', 'relative', 'elevation', 'of', 'scr', 'level', 'of', 'baseline', 'or', 'absolute', 'increment', 'of', 'scr', 'of', '.', 'moll', '(', '.', 'mgdl', ')', 'within', 'or', 'h', 'contrast', 'medium', 'exposure', '.', 'additional', 'endpoint', 'change', 'in', 'bun', ',', 'scr', ',', 'cys-c', ',', 'egfr', ',', 'and', 'crp', 'level', 'within', 'h', 'contrast', 'agent', 'exposure', 'and', 'major', 'adverse', 'event', 'occurring', 'hospitalization', 'and', 'day', 'of', 'follow-up', '.', 'result', 'of', 'patient', '(', '.', ')', 'contrast-induced', 'nephropathy', 'in', 'double-dose', 'group', 'and', 'occured', 'of', 'patient', '(', '.', ')', 'in', 'usual-dose', 'group', ',', 'of', 'patient', '(', '.', ')', 'in', 'control', 'group', '.', 'significant', 'difference', 'in', 'occurrence', 'of', 'cin', 'double-dose', 'group', 'and', 'control', 'group', 'h', 'taking', 'radiocontrast', 'medium', '(', 'p', '.', ')', 'no', 'significant', 'difference', 'observed', 'in', 'usual-dose', 'group', 'and', 'control', 'group', '(', 'p', '.', ')', ',', 'double-dose', 'group', 'and', 'usual-dose', 'group', '(', 'p', '.', ')', 'well', '.', 'conclusion', 'daily', 'peri-procedural', 'usual-dose', 'nicorandil', 'could', 'relieve', 'contrast-induced', 'renal', 'injury', ',', 'double-dose', 'nicorandil', 'associated', 'with', 'reduced', 'incidence', 'of', 'ci-aki', 'compared', 'with', 'hydration', '.']"
Acoustic radiation force impulse (ARFI) elastography for detection of renal damage in children.,"Cemil Göya, Cihad Hamidi, Aydın Ece, Mehmet Hanifi Okur, Bekir Taşdemir, Mehmet Güli Çetinçakmak, Salih Hattapoğlu, Memik Teke, Cahit Şahin, Cemil Göyaet al.",2015 Jan,Pediatr Radiol,https://pubmed.ncbi.nlm.nih.gov/25064187/,No keywords found,"['acoustic', 'radiation', 'force', 'impulse', '(', 'arfi', ')', 'imaging', 'promising', 'method', 'noninvasive', 'evaluation', 'of', 'renal', 'parenchyma', '.', 'objective', 'to', 'investigate', 'contribution', 'of', 'arfi', 'quantitative', 'u', 'elastography', 'detection', 'of', 'renal', 'damage', 'in', 'kidney', 'with', 'and', 'without', 'vesicoureteral', 'reflux', '(', 'vur', ')', '.', 'material', 'and', 'method', 'one', 'hundred', 'seventy-six', 'kidney', 'of', 'child', '(', 'male', ',', 'female', ')', 'referred', 'voiding', 'cystourethrography', 'and', 'healthy', 'control', 'prospectively', 'investigated', '.', 'patient', 'assessed', 'according', 'to', 'severity', 'of', 'renal', 'damage', 'dimercaptosuccinic', 'acid', '(', 'dmsa', ')', 'scintigraphy', '.', 'ninety-eight', 'age-', 'and', 'gender-matched', 'healthy', 'child', 'constituted', 'control', 'group', '.', 'quantitative', 'shear', 'wave', 'velocity', '(', 'swv', ')', 'measurement', 'performed', 'in', 'upper', 'and', 'lower', 'pole', 'and', 'in', 'interpolar', 'region', 'of', 'kidney', '.', 'dmsa', 'scintigraphy', 'performed', 'in', 'child', '(', 'kidney', ')', '.', 'comparison', 'of', 'swv', 'value', 'of', 'kidney', 'with', 'and', 'without', 'renal', 'damage', 'andor', 'vur', 'done', '.', 'result', 'significantly', 'higher', 'swv', 'value', 'found', 'in', 'non-damaged', 'kidney', '.', 'severely', 'damaged', 'kidney', 'lowest', 'swv', 'value', '(', 'p', '.', ')', '.', 'high-grade', '(', 'grade', 'v-iv', ')', 'refluxing', 'kidney', 'lowest', 'swv', 'value', ',', 'non-refluxing', 'kidney', 'highest', 'value', '(', 'p', '.', ')', '.', 'significant', 'negative', 'correlation', 'found', 'mean', 'quantitative', 'u', 'elastography', 'value', 'and', 'dmsa', 'scarring', 'score', '(', 'r', '-.', ',', 'p', '.', ')', 'and', 'vur', 'grade', '(', 'r', '-.', ',', 'p', '.', ')', '.', 'swv', 'value', 'of', 'control', 'kidney', 'significantly', 'higher', 'of', 'damaged', 'kidney', '(', 'p', '.', ')', '.', 'conclusion', 'finding', 'suggest', 'decreasing', 'swv', 'of', 'renal', 'unit', 'with', 'increasing', 'grade', 'of', 'vesicoureteric', 'reflux', ',', 'increasing', 'dmsa-assessed', 'renal', 'damage', 'and', 'decreasing', 'dmsa-assessed', 'differential', 'function', '.']"
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.,"SPRINT Research Group;, Cora E Lewis, Lawrence J Fine, Srinivasan Beddhu, Alfred K Cheung, William C Cushman, Jeffrey A Cutler, Gregory W Evans, Karen C Johnson, Dalane W Kitzman, Suzanne Oparil, Mahboob Rahman, David M Reboussin, Michael V Rocco, Kaycee M Sink, Joni K Snyder, Paul K Whelton, Jeff D Williamson, Jackson T Wright Jr, Walter T Ambrosius, SPRINT Research Groupet al.",2021 May 20,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/34010531/,No keywords found,"['in', 'previously', 'reported', 'randomized', 'trial', 'of', 'standard', 'and', 'intensive', 'systolic', 'blood-pressure', 'control', ',', 'data', 'outcome', 'event', 'yet', 'to', 'adjudicated', 'and', 'post-trial', 'follow-up', 'data', 'not', 'yet', 'collected', '.', 'method', 'randomly', 'assigned', 'participant', 'increased', 'risk', 'cardiovascular', 'disease', 'not', 'diabetes', 'or', 'previous', 'stroke', 'to', 'adhere', 'to', 'intensive', 'treatment', 'target', '(', 'systolic', 'blood', 'pressure', ',', 'mm', 'hg', ')', 'or', 'standard', 'treatment', 'target', '(', 'systolic', 'blood', 'pressure', ',', 'mm', 'hg', ')', '.', 'primary', 'outcome', 'composite', 'of', 'myocardial', 'infarction', ',', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'acute', 'decompensated', 'heart', 'failure', ',', 'or', 'death', 'cardiovascular', 'cause', '.', 'additional', 'primary', 'outcome', 'event', 'occurring', 'end', 'of', 'intervention', 'period', '(', 'august', ',', ')', 'adjudicated', 'data', 'lock', 'primary', 'analysis', '.', 'also', 'analyzed', 'post-trial', 'observational', 'follow-up', 'data', 'july', ',', '.', 'result', 'median', 'of', '.', 'year', 'of', 'follow-up', ',', 'rate', 'of', 'primary', 'outcome', 'and', 'all-cause', 'mortality', 'trial', 'significantly', 'lower', 'in', 'intensive-treatment', 'group', 'in', 'standard-treatment', 'group', '(', 'rate', 'of', 'primary', 'outcome', ',', '.', 'per', 'year', 'vs.', '.', 'per', 'year', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'all-cause', 'mortality', ',', '.', 'per', 'year', 'vs.', '.', 'per', 'year', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'serious', 'adverse', 'event', 'of', 'hypotension', ',', 'electrolyte', 'abnormality', ',', 'acute', 'kidney', 'injury', 'or', 'failure', ',', 'and', 'syncope', 'significantly', 'frequent', 'in', 'intensive-treatment', 'group', '.', 'trial', 'and', 'post-trial', 'follow-up', 'data', 'combined', '(', '.', 'year', 'in', 'total', ')', ',', 'similar', 'pattern', 'found', 'treatment', 'benefit', 'and', 'adverse', 'event', 'however', ',', 'rate', 'of', 'heart', 'failure', 'no', 'longer', 'differed', 'group', '.', 'conclusion', 'among', 'patient', 'increased', 'cardiovascular', 'risk', ',', 'targeting', 'systolic', 'blood', 'pressure', 'of', 'less', 'mm', 'hg', 'resulted', 'in', 'lower', 'rate', 'of', 'major', 'adverse', 'cardiovascular', 'event', 'and', 'lower', 'all-cause', 'mortality', 'targeting', 'systolic', 'blood', 'pressure', 'of', 'less', 'mm', 'hg', ',', 'receipt', 'of', 'randomly', 'assigned', 'therapy', 'and', 'trial', '.', 'rate', 'of', 'adverse', 'event', 'higher', 'in', 'intensive-treatment', 'group', '.', '(', 'funded', 'national', 'institute', 'of', 'health', 'sprint', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Possibilities of Azilsartan Medoxomil for Preparation for Planned Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus.,"A M Kochergina, O L Barbarash, A M Kocherginaet al.",2024 Jul 31,Kardiologiia,https://pubmed.ncbi.nlm.nih.gov/39102573/,No keywords found,"['to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'azilsartan', 'medoxomil', 'preoperative', 'preparation', 'and', 'improving', 'long-term', 'prognosis', 'of', 'elective', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'in', 'patient', 'with', 'ischemic', 'heart', 'disease', '(', 'ihd', ')', ',', 'arterial', 'hypertension', '(', 'ah', ')', ',', 'and', 'type', 'diabetes', 'mellitus', '(', 'dm', ')', '.', 'material', 'and', 'method', 'study', 'sample', 'included', 'patient', 'with', 'type', 'dm', 'referred', 'elective', 'pci', 'poor', 'blood', 'pressure', '(', 'bp', ')', 'control', 'according', 'to', '-hour', 'bp', 'monitoring', '(', '-bpm', ')', '(', 'mean', 'daily', 'systolic', 'bp', 'mmhg', ',', 'mean', 'daily', 'diastolic', 'bp', 'mmhg', ')', '.', 'data', 'collected', '.', 'total', 'of', 'patient', 'included', 'and', 'distributed', 'simple', 'randomization', 'two', 'group', 'group', '(', 'main', ',', 'n', ')', 'received', 'azilsartan', 'medoxomil', 'antihypertensive', 'drug', 'dose', 'of', 'mgday', '(', 'previously', 'prescribed', 'angiotensin-converting', 'enzyme', 'inhibitor', 'or', 'angiotensin', 'ii', 'receptor', 'blocker', '(', 'arb', ')', 'discontinued', ')', 'group', '(', 'control', ',', 'n', ')', 'continued', 'previous', 'antihypertensive', 'therapy', '.', 'follow-up', 'period', 'month', '.', 'of', 'consecutive', 'follow-up', 'visit', ',', 'patient', 'examined', ',', '-bpm', 'recorded', ',', 'and', 'urinary', 'marker', 'of', 'renal', 'dysfunction', '(', 'glomerular', 'filtration', 'rate', ',', 'gfr', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'ngal', 'urine', 'albumin-creatinine', 'ratio', ',', 'uacr', 'kidney', 'injury', 'molecule', ',', 'kim-', 'and', 'interleukin-', ',', 'il-', ')', 'measured', '.', 'result', 'azilsartan', 'treatment', ',', 'gfr', 'decreased', '.', ',', 'in', 'control', 'group', ',', 'decreased', '.', '(', 'plt.', ')', '.', 'month', 'of', 'follow-up', ',', 'no', 'change', 'in', 'ngal', 'concentration', 'found', 'in', 'main', 'group', ',', 'ngal', 'concentration', 'in', 'control', 'group', 'increased', '..', 'with', 'azilsartan', ',', 'decrease', 'in', 'urinary', 'concentration', 'of', 'il-', '(', '.', ')', ',', 'in', 'patient', 'of', 'control', 'group', ',', 'il-', 'increased', '(', '.', ')', '.', 'proteinuria', 'progressed', 'in', 'group', ',', 'expectable', 'given', 'presence', 'of', 'dm', 'however', ',', 'in', 'patient', 'receiving', 'azilsartan', ',', 'uacr', 'value', 'increased', '.', ',', 'in', 'patient', 'of', 'control', 'group', ',', 'increased', '..', 'difference', 'statistically', 'significant', '.', 'no', 'statistically', 'significant', 'difference', 'found', 'in', 'concentration', 'of', 'cystatin', 'c', 'and', 'kim-', '.', 'conclusion', 'study', 'demonstrated', 'two', 'important', 'fact', 'possibility', 'diagnosing', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', 'using', 'new', ',', 'sensitive', 'marker', 'of', 'kidney', 'damage', ',', 'important', 'assessing', 'effectiveness', 'of', 'prevention', ',', 'and', 'possibility', 'of', 'using', 'arb', ',', 'in', 'particular', 'azilsartan', ',', 'prevention', 'of', 'ci-aki', 'in', 'patient', 'with', 'ihd', 'in', 'combination', 'with', 'ah', 'and', 'dm', '.']"
Perioperative Rosuvastatin in Cardiac Surgery.,"Zhe Zheng, Raja Jayaram, Lixin Jiang, Jonathan Emberson, Yan Zhao, Qi Li, Juan Du, Silvia Guarguagli, Michael Hill, Zhengming Chen, Rory Collins, Barbara Casadei, Zhe Zhenget al.",2016 May 5,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/27144849/,No keywords found,"['complication', 'cardiac', 'surgery', 'common', 'and', 'lead', 'to', 'substantial', 'increase', 'in', 'morbidity', 'and', 'mortality', '.', 'meta-analyses', 'of', 'small', 'randomized', 'trial', 'suggested', 'perioperative', 'statin', 'therapy', 'prevent', 'of', 'complication', '.', 'method', 'randomly', 'assigned', 'patient', 'in', 'sinus', 'rhythm', 'scheduled', 'elective', 'cardiac', 'surgery', 'to', 'receive', 'perioperative', 'rosuvastatin', '(', 'dose', 'of', 'mg', 'daily', ')', 'or', 'placebo', '.', 'primary', 'outcome', 'postoperative', 'atrial', 'fibrillation', 'within', 'day', 'surgery', ',', 'assessed', 'holter', 'electrocardiographic', 'monitoring', ',', 'and', 'myocardial', 'injury', 'within', 'hour', 'surgery', ',', 'assessed', 'serial', 'measurement', 'of', 'cardiac', 'troponin', 'concentration', '.', 'secondary', 'outcome', 'included', 'major', 'in-hospital', 'adverse', 'event', ',', 'duration', 'of', 'stay', 'in', 'hospital', 'and', 'intensive', 'care', 'unit', ',', 'left', 'ventricular', 'and', 'renal', 'function', ',', 'and', 'blood', 'biomarkers', '.', 'result', 'concentration', 'of', 'low-density', 'lipoprotein', 'cholesterol', 'and', 'c-reactive', 'protein', 'surgery', 'lower', 'in', 'patient', 'assigned', 'to', 'rosuvastatin', 'in', 'assigned', 'to', 'placebo', '(', 'p.', ')', '.', 'however', ',', 'rate', 'of', 'postoperative', 'atrial', 'fibrillation', 'not', 'differ', 'significantly', 'rosuvastatin', 'group', 'and', 'placebo', 'group', '(', '.', 'and', '.', ',', 'respectively', 'odds', 'ratio', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', ',', 'area', 'troponin', 'i-release', 'curve', '(', 'nghour', 'per', 'milliliter', 'and', 'nghour', 'per', 'milliliter', ',', 'respectively', 'between-group', 'difference', ',', 'ci', ',', '-', 'to', 'p.', ')', '.', 'subgroup', 'analysis', 'not', 'indicate', 'benefit', 'in', 'category', 'of', 'patient', '.', 'rosuvastatin', 'therapy', 'not', 'result', 'in', 'beneficial', 'effect', 'of', 'secondary', 'outcome', 'associated', 'with', 'significant', 'absolute', '(', 'se', ')', 'excess', 'of', '..', 'percentage', 'point', 'in', 'rate', 'of', 'postoperative', 'acute', 'kidney', 'injury', '(', 'p.', ')', '.', 'conclusion', 'in', 'trial', ',', 'perioperative', 'statin', 'therapy', 'not', 'prevent', 'postoperative', 'atrial', 'fibrillation', 'or', 'perioperative', 'myocardial', 'damage', 'in', 'patient', 'undergoing', 'elective', 'cardiac', 'surgery', '.', 'acute', 'kidney', 'injury', 'common', 'with', 'rosuvastatin', '.', '(', 'funded', 'british', 'heart', 'foundation', 'and', 'others', 'stics', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.,"Han Fu, Jing Zhang, Hong Zhang, Peng Zhang, Xiaofeng Fu, Zhican Zeng, Xue Zhang, Wenyuan Li, Shicheng Yang, Xiaogang Liu, Naikuan Fu, Han Fuet al.",2021 Sep,Perfusion,https://pubmed.ncbi.nlm.nih.gov/32909511/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'become', 'common', 'cause', 'of', 'hospital-acquired', 'acute', 'kidney', 'injury', 'in', 'elderly', 'patient', '.', 'trimetazidine', '(', 'tmz', ')', 'type', 'of', 'anti-ischemic', 'drug', 'developed', 'in', 'recent', 'year', ',', 'reduce', 'incidence', 'of', 'cin', '.', 'study', 'aimed', 'to', 'evaluate', 'efficacy', 'of', 'tmz', 'in', 'prevention', 'of', 'contrast-induced', 'nephropathy', 'in', 'elderly', 'patient', 'with', 'renal', 'insufficiency', 'undergoing', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'and', 'to', 'explore', 'mechanism', 'of', 'action', '.', 'method', 'total', 'of', 'elderly', 'patient', 'with', 'renal', 'insufficiency', 'undergoing', 'elective', 'pci', 'enrolled', 'and', 'randomly', 'assigned', 'to', 'control', 'group', '(', 'n', ',', 'hydration', ')', 'and', 'tmz', 'group', '(', 'n', ',', 'mg', 'thrice', 'daily', 'orally', 'hour', 'and', 'hour', 'pci', ')', '.', 'primary', 'endpoint', 'of', 'study', 'incidence', 'of', 'cin', ',', 'defined', 'increase', 'of', 'or', ',', 'or', 'absolute', 'increase', 'of', '.', 'mgdl', 'or', 'in', 'serum', 'creatinine', 'baseline', 'value', ',', 'to', 'hour', 'following', 'exposure', 'to', 'contrast', 'medium', '(', 'cm', ')', '.', 'result', 'incidence', 'of', 'cin', 'significantly', 'lower', 'in', 'tmz', 'group', 'in', 'control', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'no', 'difference', 'regarding', 'incidence', 'of', 'major', 'adverse', 'event', 'hospitalization', 'tmz', 'group', 'and', 'control', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'binary', 'logistic', 'regression', 'result', 'showed', 'tmz', 'protective', 'factor', 'of', 'cin', '(', 'or', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'therefore', ',', 'came', 'to', 'conclusion', 'prophylactic', 'administration', 'of', 'tmz', 'prevent', 'occurrence', 'of', 'cin', 'in', 'elderly', 'patient', 'with', 'renal', 'insufficiency', 'undergoing', 'pci', 'and', 'certain', 'protective', 'effect', 'renal', 'function', 'of', 'patient', '.', 'according', 'to', 'experimental', 'result', 'and', 'mechanism', 'of', 'tmz', 'cardiomyocytes', ',', 'speculate', 'tmz', 'increase', 'kidney', 'glucose', 'metabolism', ',', 'reduces', 'fatty', 'acid', 'oxidation', ',', 'and', 'also', 'protective', 'effect', 'kidney', 'free', 'radical', 'damage', 'and', 'ischemia-reperfusion', 'injury', '.']"
"The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial.","David J Askenazi, Patrick J Heagerty, Robert H Schmicker, Patrick Brophy, Sandra E Juul, Stuart L Goldstein, Sangeeta Hingorani                              ;, PENUT Trial Consortium, Bryan A Comstock, Rajan Wadhawan, Dennis E Mayock, Sherry E Courtney, Tonya Robinson, Kaashif A Ahmad, Ellen Bendel-Stenzel, Mariana Baserga, Edmund F LaGamma, L Corbin Downey, Raghavendra Rao, Nancy Fahim, Andrea Lampland, Ivan D Frantz rd, Janine Y Khan, Michael Weiss, Maureen M Gilmore, Robin Ohls, Nishant Srinivasan, Jorge E Perez, Victor McKay, Phuong T Vu, Billy Thomas, Nahed Elhassan, Sarah Mulkey, Philip Dydynski, Vivek K Vijayamadhavan, Neil Mulrooney, Bradley Yoder, Jordan S Kase, Jennifer Check, Semsa Gogcu, Erin Osterholm, Sara Ramel, Catherine Bendel, Cheryl Gale, Thomas George, Michael Georgieff, Tate Gisslen, Sixto Guiang rd, Anne Hall, Dana Johnson, Katie Pfister, Heather Podgorski, Kari Roberts, Erin Stepka, Melissa Engel, Heidi Kamrath, Johannah Scheurer, Angela Hanson, Katherine Satrom, Susan Pfister, Ann Simones, Erin Plummer, Elizabeth Zorn, Camilia R Martin, Deirdre O'Reilly, Nicolas Porta, Catalina Bazacliu, Jonathan Williams, Dhanashree Rajderkar, Frances Northington, Raul Chavez Valdez, Sandra Beauman, Patel Saurabhkumar, Magaly Diaz-Barbosa, Arturo Serize, Jorge Jordan, Debbie Ott, Ariana Franco Mora, Pamela Hedrick, Vicki Flynn, Amy Silvia, Bailey Clopp, John B Feltner, Isabella Esposito, Stephanie Hauge, Samantha Nikirk, Andrea Purnell, Emilie Loy, Natalie Sikes, Melanie Mason, Jana McConnell, Tiffany Brown, Henry Harrison, Denise Pearson, Tammy Drake, Jocelyn Wright, Debra Walden, Annette Guy, Jennifer Nason, Morgan Talbot, Kristen Lee, Sarah Penny, Terri Boles, Melanie Drummond, Katy Kohlleppel, Charmaine Kathen, Brian Kaletka, Shania Gonzales, Cathy Worwa, Molly Fisher, Tyler Richter, Alexander Ginder, Brixen Reich, Carrie Rau, Manndi Loertscher, Laura Bledsoe, Kandace McGrath, Kimberlee Weaver Lewis, Jill Burnett, Susan Schaefer, Karie Bird, Clare Giblin, Rita Daly, Kristi Lanier, Kelly Warden, Jenna Wassenaar, Jensina Ericksen, Bridget Davern, Mary Pat Osborne, Brittany Gregorich, Neha Talele, Evelyn Obregon, Tiglath Ziyeh, Molly Clarke, Rachel E Wegner, Palak Patel, Molly Schau, Annamarie Russow, Kelly Curry, Susan Sinnamon, Lisa Barnhart, Charlamaine Parkinson, Mary Hanson, Elizabeth Kuan, Conra Backstrom Lacy, Edshelee M Galvis, Susana Bombino, Denise Martinez, Suzi Bell, Corrie Long, Cathy Longa, Michael Westerveld, Stacy McConkey, Anne Hay, Niranjana Natarajan, Shari Gaudette, Sarah Cobb, Gregory Sharp, Elizabeth Schumacher, Leslie Schuschke, Charlotte Frey, Mario Fierro, Lois Gilmore, Pamela Lundequam, Ronald Hoekstra, Anastasia Ketko, Nina Perdue, Sean Cunningham, Kelly Stout, Becky Hall, Galina Morshedzadeh, Betsy Ostrander, Sarah Winter, Lauren Cox, Matthew A Rainaldi, Sarah Hensley, Melissa Morris, Dia Roberts, Melissa Tuttle, Christopher Boys, Solveig Hultgren, Elizabeth I Pierpont, Tom George, Kelly E King, Katherine Bataglia, Cathy Neis, Mark Bergeron, Cristina Miller, Cara Accomando, Jennifer Anne Gavin, Elizabeth Maczek, Susan Marakovitz, Aimee Knorr, Vincent C Smith, Jane E Stewart, Marie Weissbourd, Raye-Ann deRegnier, Nana Matoba, Shelly C Heaton, Erika M Cascio, Janet Brady, Suman Ghosh, Jessica Ditto, Mary Leppert, Jean Lowe, Janell Fuller, Tara DuPont, Pamela Kloska, Saurabh Patel, Lauren Carbonell, Anna Maria Patino-Fernandez, Carmen de Lerma, Kelly McDonough, Maiana De Cortada, Lacy Chavis, Jane Shannon, Mark A Konodi, Christopher Nefcy, Karl C K Kuban, Jean R Lowe, T Michael O'Shea, Manjiri Dighe, Todd Richards, Dennis W W Shaw, Colin Studholme, Christopher M Traudt, Roberta Ballard, Adam Hartman, Scott Janis, T Robin Ohls, Michael O'Shea, Ronnie Guillet, M Bethany Ball, Hannah Glass, Ben Saville, Michael Schreiber, David J Askenaziet al.",2021 May:232:65-72.e7.,J Pediatr,https://pubmed.ncbi.nlm.nih.gov/33484699/,No keywords found,"['to', 'evaluate', 'whether', 'extremely', 'low', 'gestational', 'age', 'neonate', '(', 'elgans', ')', 'randomized', 'to', 'erythropoietin', 'better', 'or', 'worse', 'kidney-related', 'outcome', 'hospitalization', 'and', '-', 'month', 'of', 'corrected', 'gestational', 'age', '(', 'cga', ')', 'compared', 'with', 'randomized', 'to', 'placebo', '.', 'study', 'design', 'performed', 'ancillary', 'study', 'to', 'multicenter', 'double-blind', ',', 'placebo-controlled', 'randomized', 'clinical', 'trial', 'of', 'erythropoietin', 'in', 'elgans', '.', 'result', 'prevalence', 'of', 'severe', '(', 'stage', 'or', ')', 'acute', 'kidney', 'injury', '(', 'aki', ')', '..', 'not', 'find', 'statistically', 'significant', 'difference', 'randomized', 'to', 'erythropoietin', 'v', 'placebo', 'in-hospital', 'primary', '(', 'severe', 'aki', ')', 'or', 'secondary', 'outcome', '(', 'aki', 'and', 'serum', 'creatininecystatin', 'c', 'value', 'day', ',', ',', ',', 'and', ')', '.', '-', 'month', 'of', 'cga', ',', 'of', 'cohort', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'mgg', ',', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'th', 'percentile', 'age', ',', 'and', 'diastolic', 'blood', 'pressure', '(', 'dbp', ')', 'th', 'percentile', 'age', '.', 'sbp', 'th', 'percentile', 'occurred', 'less', 'often', 'among', 'recipient', 'of', 'erythropoietin', '(', 'p', 'th', 'percentile', ',', 'or', 'dbp', 'th', 'or', 'th', 'percentile', 'year', 'follow-up', 'visit', '.', 'conclusion', 'elgans', 'high', 'rate', 'of', 'in-hospital', 'aki', 'and', 'kidney-related', 'problem', '-', 'month', 'of', 'cga', '.', 'recombinant', 'erythropoietin', 'may', 'protect', 'elgans', 'long-term', 'elevated', 'sbp', 'not', 'appear', 'to', 'protect', 'aki', ',', 'low', 'egfr', ',', 'albuminuria', ',', 'or', 'elevated', 'dbp', '-', 'month', 'of', 'cga', '.']"
Effect of a Single Bolus of Erythropoietin on Renoprotection in Patients Undergoing Thoracic Aortic Surgery With Moderate Hypothermic Circulatory Arrest.,"Ji Eun Kim, Suk Won Song, Jong Yeop Kim, Hyun Joo Lee, Kum-Hee Chung, Yon Hee Shim, Ji Eun Kimet al.",2016 Feb,Ann Thorac Surg,https://pubmed.ncbi.nlm.nih.gov/26576750/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'associated', 'with', 'high', 'morbidity', 'and', 'mortality', '.', 'recombinant', 'human', 'erythropoietin', 'shown', 'to', 'exert', 'cytoprotection', 'ischemia', '.', 'study', 'examined', 'effect', 'of', 'erythropoietin', 'in', 'preventing', 'aki', 'thoracic', 'aortic', 'surgery', 'with', 'moderate', 'hypothermic', 'circulatory', 'arrest', '.', 'method', 'in', 'double-blind', ',', 'randomized', 'study', ',', 'patient', 'undergoing', 'thoracic', 'aortic', 'surgery', 'with', 'moderate', 'hypothermic', 'circulatory', 'arrest', '(', 'target', 'temperature', ',', 'c', ')', 'randomly', 'received', 'either', 'erythropoietin', 'iukg', '(', '-', ')', 'or', 'amount', 'of', 'normal', 'saline', 'intravenously', 'anesthesia', 'induction', '.', 'primary', 'endpoint', 'incidence', 'of', 'aki', 'defined', 'according', 'to', 'rifle', 'criterion', 'first', 'postoperative', 'day', '.', 'result', 'aki', 'occurred', 'in', 'of', 'patient', '.', 'two', 'group', 'not', 'show', 'difference', 'in', 'incidence', 'and', 'severity', 'of', 'aki', '.', 'also', ',', 'no', 'difference', 'in', 'level', 'of', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'group', '.', 'cardiac', 'index', 'higher', 'in', 'erythropoietin', 'group', ',', 'however', ',', 'immediately', 'weaning', 'cardiopulmonary', 'bypass', '(', 'p', '.', ')', '.', 'furthermore', ',', 'postoperative', 'cardiac', 'complication', 'and', 'prolonged', 'vasopressor', 'dependence', 'reduced', 'in', 'erythropoietin', 'group', '(', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', '.', 'conclusion', 'single', 'bolus', 'administration', 'of', 'erythropoietin', 'iukg', '(', '-', ')', 'anesthesia', 'induction', 'failed', 'to', 'provide', 'renoprotection', 'in', 'patient', 'underwent', 'thoracic', 'aortic', 'surgery', 'with', 'moderate', 'hypothermic', 'circulatory', 'arrest', '.', 'however', ',', 'erythropoietin', 'significantly', 'reduced', 'cardiac', 'complication', ',', 'and', 'lowered', 'incidence', 'of', 'prolonged', 'vasopressor', 'dependence', '.']"
Roadmap fusion imaging in percutaneous coronary intervention reduces contrast medium exposure irrespective of investigator's experience level.,"Christine Quast, Raphael Phinicarides, Shazia Afzal, Verena Veulemans, Kathrin Klein, Nora Berisha, Pia Leuders, Ralf Erkens, Christian Jung, Florian Bönner, Malte Kelm, Amin Polzin, Tobias Zeus, Christine Quastet al.",2024 Jan,J Invasive Cardiol,https://pubmed.ncbi.nlm.nih.gov/38224296/,No keywords found,"['dynamic', 'coronary', 'roadmap', '(', 'dcr', ')', 'software', 'tool', 'creates', 'real-time', 'dynamic', 'coronary', 'artery', 'overlay', 'fluoroscopic', 'image', '.', 'efficacy', 'of', 'dcr', 'in', 'significantly', 'reducing', 'contrast', 'medium', 'use', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'previously', 'shown', '.', 'in', 'study', ',', 'aimed', 'to', 'determine', 'dcr', 'equally', 'effective', 'irrespective', 'of', 'performing', 'investigator', ""'s"", 'experience', 'level', '.', 'method', 'in', 'sub-analysis', 'of', 'monocentric', ',', 'open-label', ',', 'randomized', 'trial', ',', 'patient', 'with', 'hemodynamic', 'relevant', 'coronary', 'type', 'and', 'b', 'lesion', 'randomized', 'and', 'contrast', 'medium', 'use', 'conducted', 'with', '(', ')', 'or', 'without', '(', '-', ')', 'dcr', 'software', '.', 'pci', 'randomly', 'allocated', 'and', 'performed', 'investigator', 'with', 'high', '(', ')', 'or', 'medium', '(', 'b', ')', 'experience', 'level', '.', 'result', 'overall', ',', 'contrast', 'medium', 'use', 'significantly', 'reduced', 'investigator', 'in', 'dcr', 'group', ',', 'and', 'investigator', 'b', 'used', 'significantly', 'less', 'contrast', 'medium', 'with', 'software', 'investigator', 'a.', 'dcr', 'software', 'not', 'accompanied', 'increased', 'radiation', 'exposure', 'patient', 'or', 'team', '.', 'contrary', ',', 'dose', 'area', 'product', 'reduced', 'investigator', ',', 'significantly', 'reduced', 'highly', 'experienced', 'investigator', 'using', 'dcr', '.', 'fluoroscopy', 'time', 'not', 'different', 'investigator', '.', 'procedural', 'success', '.', 'serious', 'in-hospital', 'adverse', 'event', 'not', 'observed', '.', 'one', 'of', 'investigator', ""'s"", 'patient', 'suffered', 'post-procedural', 'acute', 'kidney', 'injury', 'in', '-dcr', 'group', '.', 'conclusion', 'dcr', 'significantly', 'reduces', 'contrast', 'medium', 'use', 'pci', 'irrespective', 'of', 'investigator', ""'s"", 'experience', 'level', '.']"
Proenkephalin A 119-159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial.,"Thilo von Groote#, Felix Albert#, Melanie Meersch, Raphael Koch, Christian Porschen, Oliver Hartmann, Deborah Bergmann, Peter Pickkers, Alexander Zarbock, Thilo von Grooteet al.",2022 Oct 31,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36316692/,No keywords found,"['renal', 'replacement', 'therapy', '(', 'rrt', ')', 'remains', 'key', 'rescue', 'therapy', 'critically', 'ill', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'however', ',', 'currently', 'no', 'tool', 'available', 'to', 'predict', 'successful', 'liberation', 'rrt', '.', 'biomarkers', 'may', 'allow', 'risk', 'stratification', 'and', 'individualization', 'of', 'treatment', 'strategy', '.', 'proenkephalin', '-', '(', 'penkid', ')', 'suggested', 'promising', 'marker', 'of', 'kidney', 'function', 'in', 'context', 'of', 'aki', ',', 'not', 'yet', 'evaluated', 'rrt', 'liberation', 'in', 'critically', 'ill', 'patient', 'with', 'aki', '.', 'method', 'post', 'hoc', 'analysis', 'included', 'patient', 'randomized', 'clinical', 'elain', 'trial', 'and', 'penkid', 'level', 'measured', 'in', 'blood', 'of', 'patient', '.', 'competing', 'risk', 'time-to-event', 'analysis', 'performed', 'pre-rrt', 'penkid', 'initiation', 'of', 'rrt', 'and', 'in', 'landmark', 'analysis', 'day', 'initiation', 'of', 'rrt', '.', 'competing', 'risk', 'endpoint', 'successful', 'liberation', 'rrt', 'or', 'death', 'without', 'prior', 'liberation', 'rrt', '.', 'result', 'low', 'pre-rrt', 'penkid', 'level', '(', 'penkid', 'pmoll', ')', 'rrt', 'initiation', 'associated', 'with', 'early', 'and', 'successful', 'liberation', 'rrt', 'compared', 'to', 'patient', 'with', 'high', 'pre-rrt', 'penkid', 'level', '(', 'subdistribution', 'hazard', 'ratio', '(', 'shr', ')', '.', ',', 'ci', '.-.', ',', 'p', '.', ',', 'estimated', 'd-cumulative', 'incidence', 'function', '(', 'd-cif', ')', 'of', 'successful', 'liberation', 'rrt', 'vs.', ',', 'p', '.', ')', '.', 'association', 'persisted', 'in', 'landmark', 'analysis', 'day', 'of', 'rrt', '(', 'shr', '.', ',', 'ci', '.-.', ',', 'p', '.', ',', 'd-cif', 'of', 'successful', 'liberation', 'rrt', 'vs.', ',', 'p', '.', ')', '.', 'time', 'point', ',', 'no', 'difference', 'in', 'competing', 'event', 'of', 'death', 'detected', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'rrt-dependent', 'aki', ',', 'plasma', 'penkid', 'appears', 'to', 'useful', 'biomarker', 'prediction', 'of', 'shorter', 'duration', 'and', 'successful', 'liberation', 'rrt', 'and', 'may', 'allow', 'individualized', 'approach', 'to', 'guide', 'strategy', 'of', 'rrt', 'liberation', 'in', 'critically', 'ill', 'patient', 'with', 'rrt-dependent', 'aki', '.', 'trial', 'registration', 'elain', 'trial', 'prospectively', 'registered', 'german', 'clinical', 'trial', 'registry', '(', 'identifier', 'drks', ')', 'th', 'of', 'may', '.']"
Effect of Delayed Remote Ischemic Preconditioning on Acute Kidney Injury and Outcomes in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.,"Ping Jia#, Qiang Ji#, Zhouping Zou, Qi Zeng, Ting Ren, Weize Chen, Zhixin Yan, Daoqi Shen, Yang Li, Fangyuan Peng, Ying Su, Jiarui Xu, Bo Shen, Zhe Luo, Chunsheng Wang, Xiaoqiang Ding, Ping Jiaet al.",2024 Oct 22,Circulation,https://pubmed.ncbi.nlm.nih.gov/39319450/,No keywords found,"['remote', 'ischemic', 'preconditioning', '(', 'ripc', ')', 'time', 'window', 'organ', 'protection', 'acute', 'and', 'delayed', '.', 'previous', 'study', 'mainly', 'focused', 'organoprotective', 'effect', 'of', 'acute', 'ripc', '.', 'aimed', 'to', 'determine', 'whether', 'delayed', 'ripc', 'reduce', 'occurrence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'postoperative', 'complication', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'method', 'prospective', ',', 'single-center', ',', 'double-blind', ',', 'randomized', 'controlled', 'trial', 'involved', 'patient', 'high', 'risk', 'aki', 'scheduled', 'elective', 'cardiac', 'surgery', 'requiring', 'cardiopulmonary', 'bypass', '.', 'patient', 'randomized', 'to', 'receive', 'ripc', '(', 'cycle', 'of', '-minute', 'inflation', 'and', '-minute', 'deflation', 'upper', 'arm', 'with', 'blood', 'pressure', 'cuff', ')', 'hour', 'surgery', 'or', 'sham', 'condition', '(', 'control', 'group', ')', 'induced', 'cycle', 'of', '-minute', 'inflation', 'to', 'pressure', 'of', 'mm', 'hg', 'followed', '-minute', 'cuff', 'deflation', '.', 'primary', 'end', 'point', 'incidence', 'of', 'aki', 'within', 'prior', 'day', 'cardiac', 'surgery', '.', 'secondary', 'end', 'point', 'included', 'renal', 'replacement', 'therapy', 'hospitalization', ',', 'change', 'in', 'urinary', 'biomarkers', 'of', 'aki', 'and', 'marker', 'of', 'myocardial', 'injury', ',', 'duration', 'of', 'intensive', 'care', 'unit', 'stay', 'and', 'mechanical', 'ventilation', ',', 'and', 'occurrence', 'of', 'nonfatal', 'myocardial', 'infarction', ',', 'stroke', ',', 'and', 'all-cause', 'mortality', 'day', '.', 'result', 'total', 'of', 'patient', '(', 'mean', 'age', ',', '..', 'year', 'men', '.', ')', 'randomly', 'assigned', 'to', 'ripc', 'group', '(', 'n', ')', 'or', 'control', 'group', '(', 'n', ')', '.', 'aki', 'significantly', 'reduced', 'in', 'ripc', 'group', 'compared', 'with', 'control', 'group', '(', '.', 'versus', '.', 'odds', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p.', ')', '.', 'no', 'significant', 'between-group', 'difference', 'in', 'secondary', 'end', 'point', 'of', 'perioperative', 'myocardial', 'injury', '(', 'assessed', 'concentration', 'of', 'cardiac', 'troponin', ',', 'creatine', 'kinase', 'myocardial', 'isoenzyme', ',', 'and', 'nt-probnp', 'n-terminal', 'pro-brain', 'natriuretic', 'peptide', ')', ',', 'duration', 'of', 'stay', 'in', 'intensive', 'care', 'unit', 'and', 'hospital', ',', 'and', 'occurrence', 'of', 'nonfatal', 'myocardial', 'infarction', ',', 'stroke', ',', 'and', 'all-cause', 'mortality', 'day', '.', 'conclusion', 'among', 'high-risk', 'patient', 'undergoing', 'cardiac', 'surgery', ',', 'delayed', 'ripc', 'significantly', 'reduced', 'occurrence', 'of', 'aki', '.', 'registration', 'url', 'httpswww.chictr.org.cn', 'unique', 'identifier', 'chictr', '.']"
Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR.,"Jay L Koyner, Steven G Coca, Heather Thiessen-Philbrook, Uptal D Patel, Michael G Shlipak, Amit X Garg, Chirag R Parikh                              ;, Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury (TRIBE-AKI) Consortium;, Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury TRIBE-AKI Consortium, Jai Raman, Valluvan Jeevanandam, Shahab Akhter, Prasad Devarajan, Michael Bennett, Qing Ma, Rachel Griffiths, Charles Edelstein, Cary Passik, Judy Nagy, Madhav Swaminathan, Michael Chu, Martin Goldbach, Lin Ruo Guo, Neil McKenzie, Mary Lee Myers, Richard Novick, Mac Quantz, Virginia Schumann, Laura Webster, Michael Zappitelli, Ana Palijan, Michael Dewar, Umer Darr, Sabet Hashim, John Elefteriades, Arnar Geirsson, Susan Garwood, Rowena Kemp, Isabel Butrymowicz, Jay L Koyneret al.",2015 Dec,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/26386737/,No keywords found,"['interaction', 'baseline', 'kidney', 'function', 'and', 'performance', 'of', 'biomarkers', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'development', 'of', 'aki', 'unclear', '.', 'study', 'design', 'post', 'hoc', 'analysis', 'of', 'prospective', 'cohort', 'study', '.', 'setting', 'participant', ',', 'tribe-aki', 'consortium', 'adult', 'cardiac', 'surgery', 'cohort', 'participant', '.', 'predictor', 'unadjusted', 'postoperative', 'urinary', 'biomarkers', 'of', 'aki', 'measured', 'within', 'hour', 'of', 'surgery', '.', 'outcome', 'aki', 'defined', 'aki', 'network', 'stage', '(', 'aki', ')', 'or', 'higher', ',', 'well', 'doubling', 'of', 'serum', 'creatinine', 'level', 'preoperative', 'value', 'or', 'need', 'post-operative', 'dialysis', '(', 'severe', 'aki', ')', '.', 'measurement', 'stratified', 'analysis', 'preoperative', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'versus', 'mlmin.m', '(', ')', '.', 'result', '(', ')', 'patient', 'with', 'preoperative', 'egfrsmlmin.m', '(', ')', 'developed', 'clinical', 'aki', 'compared', 'with', '(', ')', 'of', 'with', 'egfrsmlmin.m', '(', ')', '(', 'p.', ')', '.', 'log-transformed', 'biomarker', 'concentration', ',', 'significant', 'interaction', 'aki', 'and', 'baseline', 'egfr', 'interleukin', '(', 'p.', ')', 'and', 'borderline', 'significance', 'liver-type', 'fatty', 'acid', 'binding', 'protein', '(', 'p.', ')', '.', 'biomarkers', ',', 'adjusted', 'relative', 'risk', '(', 'rr', ')', 'point', 'estimate', 'risk', 'aki', 'higher', 'in', 'with', 'elevated', 'baseline', 'egfrs', 'compared', 'with', 'with', 'egfrsmlmin.m', '(', ')', '.', 'however', ',', 'difference', 'in', 'magnitude', 'of', 'risk', 'low', '(', 'adjusted', 'rrs', '.', 'ci', ',', '.-', '.', 'and', '.', 'ci', ',', '.-', '.', 'with', 'preoperative', 'egfrsmlmin.m', '(', ')', 'and', 'with', 'higher', 'egfrs', ',', 'respectively', ')', '.', 'although', 'no', 'biomarker', 'displayed', 'interaction', 'baseline', 'egfr', 'and', 'severe', 'aki', ',', 'log-transformed', 'interleukin', 'and', 'kidney', 'injury', 'molecule', 'significant', 'adjusted', 'rrs', 'severe', 'aki', 'in', 'with', 'and', 'without', 'baseline', 'egfrsmlmin.m', '(', ')', '.', 'limitation', 'limited', 'number', 'of', 'patient', 'with', 'severe', 'aki', 'and', 'post-operative', 'dialysis', '.', 'conclusion', 'association', 'early', 'postoperative', 'aki', 'urinary', 'biomarkers', 'and', 'aki', 'modified', 'preoperative', 'egfr', '.', 'degree', 'of', 'modification', 'and', 'impact', 'biomarker-aki', 'association', 'small', 'across', 'biomarkers', '.', 'finding', 'suggest', 'distinct', 'biomarker', 'cutoff', 'with', 'and', 'without', 'preoperative', 'egfrmlmin.m', '(', ')', 'not', 'necessary', '.']"
"High-sensitive troponinT, interleukin-8, and interleukin-6 link with post-surgery risk in infant heart surgery.","Elin M Thorlacius, Juho Keski-Nisula, Maria Vistnes, Tiina Ojala, Mattias Molin, Mats Synnergren, Birgitta S Romlin, Sven-Erik Ricksten, Håkan Wåhlander, Albert Gyllencreutz Castellheim, Elin M Thorlaciuset al.",2024 Jul,Acta Anaesthesiol Scand,https://pubmed.ncbi.nlm.nih.gov/38531618/,No keywords found,"['study', 'focus', 'biomarkers', 'in', 'infant', 'open', 'heart', 'surgery', ',', 'and', 'examines', 'association', 'of', 'high-sensitive', 'troponin', '(', 'hs-ctnt', ')', ',', 'interleukin-', '(', 'il-', ')', ',', 'and', 'interleukin-', '(', 'il-', ')', 'with', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'ventilatory', 'support', 'time', 'and', 'need', 'of', 'vasoactive', 'drug', '.', 'method', 'secondary', 'exploratory', 'study', 'double-blinded', 'clinical', 'randomized', 'trial', '(', 'mile-', ')', 'infant', 'undergoing', 'open', 'heart', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'in', 'sub-study', ',', 'entire', 'study', 'population', 'examined', 'without', 'considering', 'study', 'drug', '.', 'biomarkers', ""'"", 'peak', 'concentration', '(', 'highest', 'concentration', 'or', 'h', 'post-cpb', ')', 'used', 'statistical', 'analysis', '.', 'result', 'peak', 'il-', ',', 'hs-ctnt', ',', 'and', 'il-', 'occurred', 'h', 'post-cpb', ',', ',', 'and', 'of', 'patient', ',', 'respectively', '.', 'odds', 'ratio', 'of', 'developing', 'aki-', 'il-', 'pgml', '.', '(', 'ci', '..', ')', ',', 'il-', 'pgml', '.', '(', '..', ')', ',', 'and', 'hs-ctnt', 'pgml', '.', '(', '.', '.', ')', '.', 'in', 'two', 'third', 'of', 'patient', 'with', 'highest', 'peak', 'concentration', 'of', 'il-', ',', 'il-', ',', 'and', 'hs-ctnt', ',', 'need', 'ventilatory', 'support', 'h', 'and', 'use', 'of', 'vasoactive', 'drug', 'h', 'post-cpb', ',', 'in', 'less', 'one', 'third', 'of', 'patient', 'with', 'lowest', 'peak', 'concentration', 'of', 'il-', 'and', 'hs-ctnt', 'requirement', 'observed', '.', 'conclusion', 'peak', 'biomarker', 'concentration', 'and', 'cpb-time', 'strongly', 'predicted', 'aki-', ',', 'with', 'il-', 'and', 'il-', 'emerging', 'strongest', 'predictor', '.', 'furthermore', ',', 'finding', 'suggest', 'measuring', 'hs-ctnt', 'and', 'il-', 'h', 'post-cpb-weaning', 'may', 'assist', 'in', 'identifying', 'infant', 'suitable', 'early', 'extubation', 'and', 'highlight', 'risk', 'of', 'prolonged', 'ventilation', '.']"
Dexmedetomidine Attenuates Inflammation in Elderly Patients Following Major Hepatobiliary and Pancreatic Surgery: A Randomized Clinical Trial.,"Xingtong Chen#, Qian Chen#, Zhigang Qin#, Azeem Alam, Hailin Zhao, Raha West, Xianzhe Liu, Jieyu Li, Xin Li, Bin Yi, Daqing Ma, Jianteng Gu, Xingtong Chenet al.",2024 May 29:19:981-991.,Clin Interv Aging,https://pubmed.ncbi.nlm.nih.gov/38827237/,No keywords found,"['dexmedetomidine', '(', 'dex', ')', 'may', 'anti-inflammatory', 'property', 'and', 'potentially', 'reduce', 'incidence', 'of', 'postoperative', 'organ', 'injury', '.', 'objective', 'to', 'investigate', 'whether', 'dex', 'protects', 'pulmonary', 'and', 'renal', 'function', 'via', 'anti-inflammatory', 'effect', 'in', 'elderly', 'patient', 'undergoing', 'prolonged', 'major', 'hepatobiliary', 'and', 'pancreatic', 'surgery', '.', 'design', 'and', 'setting', 'october', 'and', 'december', ',', 'randomized', 'controlled', 'trial', 'carried', 'tertiary', 'hospital', 'in', 'chongqing', ',', 'china', '.', 'patient', 'patient', 'aged', '-', 'underwent', 'long-duration', '(', 'hr', ')', 'hepatobiliary', 'and', 'pancreatic', 'surgery', 'without', 'significant', 'comorbidities', 'enrolled', 'and', 'randomly', 'assigned', 'two', 'group', 'ratio', '.', 'intervention', 'patient', 'given', 'either', 'dex', 'or', 'equivalent', 'volume', 'of', '.', 'saline', '(', 'placebo', ')', 'with', 'loading', 'dose', 'of', 'g', 'kg-', 'min', ',', 'followed', '.', 'g', 'kg-', 'hr-', 'maintenance', 'end', 'of', 'surgery', '.', 'main', 'outcome', 'measure', 'change', 'in', 'serum', 'concentration', 'of', 'interleukin-', '(', 'il-', ')', 'and', 'tumour', 'necrosis', 'factor-', '(', 'tnf-', ')', 'primary', 'outcome', '.', 'result', 'one', 'hour', 'postoperatively', ',', 'serum', 'il-', 'displayed', 'nine-fold', 'increase', '(', 'p.', ')', 'in', 'placebo', 'group', '.', 'administration', 'of', 'dex', 'decreased', 'il-', 'to', '.', '.', 'pgml', '(', 'ci', '.', 'to', '.', ')', 'compared', 'to', 'placebo', 'group', '(', 'p.', '.', '.', 'pgml', ',', 'ci', '.', 'to', '.', ')', '.', 'however', ',', 'no', 'significant', 'difference', 'in', 'tnf-', 'observed', 'two', 'group', '.', 'incidence', 'of', 'postoperative', 'acute', 'kidney', 'injury', 'twice', 'high', 'in', 'placebo', 'group', '(', '.', ')', 'compared', 'to', 'dex', 'group', '(', '.', ')', ',', 'and', 'incidence', 'of', 'postoperative', 'acute', 'lung', 'injury', '.', 'in', 'dex', 'group', ',', 'lower', 'in', 'placebo', 'group', '(', '.', ')', ',', 'although', 'no', 'statistical', 'significance', 'two', 'group', '.', 'conclusion', 'dex', 'administration', 'in', 'elderly', 'patient', 'undergoing', 'major', 'hepatobiliary', 'and', 'pancreatic', 'surgery', 'reduces', 'inflammation', 'and', 'potentially', 'protects', 'kidney', 'and', 'lung', '.', 'registration', 'chinese', 'clinical', 'trial', 'registry', ',', 'identifier', 'chictr', ',', 'june', '.']"
Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials.,"Fernando G Zampieri, Ary Serpa-Neto, Ron Wald, Rinaldo Bellomo, Sean M Bagshaw                              ;, STARRT-AKI and RENAL Investigators, Fernando G Zampieriet al.",2024 Aug:82:154767.,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/38461657/,No keywords found,"['to', 'perform', 'post-hoc', 'reanalysis', 'of', 'standard', 'versus', 'accelerated', 'initiation', 'of', 'renal-replacement', 'therapy', 'in', 'acute', 'kidney', 'injury', '(', 'starrt-aki', ')', 'and', 'intensity', 'of', 'continuous', 'renal-replacement', 'therapy', 'in', 'critically', 'ill', 'patient', '(', 'renal', ')', 'trial', 'hierarchical', 'composite', 'endpoint', 'analysis', 'using', 'win', 'ratio', '(', 'wr', ')', '.', 'material', 'and', 'method', 'patient', 'with', 'complete', 'information', 'starrt-aki', '(', 'compared', 'accelerated', 'versus', 'standard', 'approach', 'renal', 'replacement', 'therapy', '-', 'rrt', 'initiation', ')', 'and', 'renal', '(', 'compared', 'two', 'different', 'rrt', 'dos', 'in', 'critically', 'ill', 'patient', ')', 'trial', 'selected', '.', 'wr', 'defined', 'hierarchical', 'composite', 'endpoint', 'using', '-day', 'mortality', ',', 'rrt', 'dependency', '-days', ',', 'intensive', 'care', 'unit', '(', 'icu', ')', 'length-of-stay', '(', 'los', ')', ',', 'and', 'hospital', 'los', '(', 'primary', 'analysis', ')', 'value', 'unit', 'represent', 'benefit', 'of', 'intervention', 'hierarchical', 'composite', 'endpoint', '.', 'secondary', 'analysis', 'replacing', 'los', 'day', 'alive', 'and', 'free', 'of', 'rrt', 'performed', '.', 'stratified', 'analysis', 'performed', 'according', 'to', 'illness', 'severity', 'score', ',', 'surgical', 'status', ',', 'and', 'presence', 'of', 'sepsis', '.', 'result', 'wr', 'analysis', 'produced', ',', ',', 'pair', 'starrt-aki', 'trial', 'and', ',', 'pair', 'renal', 'trial', ',', 'respectively', '.', 'wr', 'result', 'starrt-aki', 'and', 'renal', '.', '(', 'confidence', 'interval', 'ci', '.-', '.', 'p', '.', ')', 'and', '.', '(', 'ci', '.-', '.', 'p', '.', ')', 'primary', 'analysis', ',', 'and', '.', '(', 'ci', '.-', '.', 'p', '.', ')', 'and', '.', '(', 'ci', '.-', '.', 'p', '.', ')', 'secondary', 'analysis', ',', 'respectively', '.', 'stratified', 'analysis', 'of', 'primary', 'suggested', 'possible', 'benefit', 'of', 'accelerated-strategy', 'in', 'starrt-aki', 'trial', 'non-surgical', 'patient', 'with', 'sepsis', ',', 'secondary', 'analysis', 'suggested', 'possible', 'harm', 'of', 'accelerated-strategy', 'surgical', 'patient', 'without', 'sepsis', '.', 'no', 'evidence', 'of', 'heterogeneity', 'in', 'treatment', 'effect', 'in', 'stratified', 'analysis', 'in', 'renal', 'trial', '.', 'conclusion', 'wr', 'approach', 'using', 'hierarchical', 'composite', 'endpoint', 'feasible', 'trial', 'in', 'critical', 'care', 'nephrology', '.', 'primary', 're-analyses', 'of', 'starrt-aki', 'and', 'renal', 'trial', 'yielded', 'neutral', 'result', 'however', ',', 'suggestion', 'of', 'heterogeneity', 'in', 'treatment', 'effect', 'in', 'stratified', 'analysis', 'of', 'starrt-aki', 'trial', 'surgical', 'status', 'and', 'sepsis', '.', 'selection', 'of', 'endpoint', 'and', 'hierarchical', 'ordering', 'trial', 'design', 'using', 'wr', 'approach', 'important', 'implication', 'trial', 'interpretation', '.', 'trial', 'registry', 'clinicaltrials.gov', 'number', 'nct', '(', 'starrt-aki', ')', 'and', 'nct', '(', 'renal', ')', '.']"
High Loading Dose of Atorvastatin for the Prevention of Serum Creatinine and Cystatin C-Based Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention.,"Naikuan Fu, Min Liang, Shicheng Yang, Naikuan Fuet al.",2018 Sep,Angiology,https://pubmed.ncbi.nlm.nih.gov/29343076/,"atorvastatin, contrast-induced nephropathy, cystatin C.","['aim', 'of', 'study', 'to', 'assess', 'efficacy', 'of', 'high-dose', 'atorvastatin', 'prevention', 'of', 'contrast-induced', 'nephropathy', '(', 'cin', ')', 'in', 'patient', 'with', 'acute', 'coronary', 'syndrome', '(', 'ac', ')', 'undergoing', 'percutaneous', 'intervention', 'and', 'observe', 'incidence', 'of', 'cystatin', 'c', '(', 'cyc', ')', '-based', 'cin', '.', 'total', 'of', 'patient', 'with', 'ac', 'randomly', 'assigned', 'to', 'either', 'control', 'group', '(', 'patient', 'receiving', 'conventional', 'dose', 'atorvastatin', 'mg', 'daily', 'day', 'to', 'day', 'contrast', 'administration', ')', 'or', 'high-dose', 'atorvastatin', 'group', '(', 'patient', 'receiving', 'atorvastatin', 'mg', 'daily', 'perioperative', 'period', ')', '.', 'baseline', 'characteristic', 'of', 'group', 'similar', '.', 'primary', 'end', 'point', 'of', 'serum', 'creatinine', '(', 'scr', ')', '-based', 'cin', 'occurred', 'in', 'patient', 'in', 'control', 'group', 'and', 'patient', 'in', 'high-dose', 'atorvastatin', 'group', '(', '.', 'v', '.', 'p', '.', ')', '.', 'cystatin', 'c-based', 'cin', 'developed', 'in', 'patient', 'in', 'control', 'group', 'and', 'patient', 'in', 'high-dose', 'atorvastatin', 'group', '(', '.', 'v', '.', 'p', '.', ')', '.', 'multivariable', 'analysis', 'revealed', 'high-dose', 'atorvastatin', 'independently', 'associated', 'with', 'decreased', 'risk', 'of', 'cin', '.', 'study', 'demonstrated', 'prophylactic', 'treatment', 'with', 'high-dose', 'atorvastatin', 'reduced', 'risk', 'of', 'scr', 'and', 'cyc-based', 'cin', 'and', 'suggested', 'cyc', 'reliable', 'marker', 'early', 'diagnosis', 'of', 'cin', 'compared', 'with', 'scr', '.']"
Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis.,"Saber D Barbar, Raphaël Clere-Jehl, Abderrahmane Bourredjem, Romain Hernu, Florent Montini, Rémi Bruyère, Christine Lebert, Julien Bohé, Julio Badie, Jean-Pierre Eraldi, Jean-Philippe Rigaud, Bruno Levy, Shidasp Siami, Guillaume Louis, Lila Bouadma, Jean-Michel Constantin, Emmanuelle Mercier, Kada Klouche, Damien du Cheyron, Gaël Piton, Djillali Annane, Samir Jaber, Thierry van der Linden, Gilles Blasco, Jean-Paul Mira, Carole Schwebel, Loïc Chimot, Philippe Guiot, Mai-Anh Nay, Ferhat Meziani, Julie Helms, Claire Roger, Benjamin Louart, Remi Trusson, Auguste Dargent, Christine Binquet, Jean-Pierre Quenot                              ;, IDEAL-ICU Trial Investigators and the CRICS TRIGGERSEP Network, L Arene, L Delapierre, A-L Merel, S Moschietto, G Pradel, A Privat, M Feissel, L Barrot, N Belin, E Belle, F Belon, G Capellier, C Chaignat, M Claveau, M Grandperrin, G Labro, P Luporsi, C Manzon, J-C Navellou, C Patry, G Besch, Y Brunin, L Carteron, M Ginet, J Paillot, S Pili- Floury, E Samain, S Gaillard, A Robine, E Sauvadet, N Sedillot, X Tchenio, J Brunet, C Daubin, B Sauneuf, A Seguin, X Valette, S Cayot-Constantin, R Guerin, M Jabaudon, J Pascal, S Perbet, F Bougerol, P-L Declercq, S Gelinotte, P Andreu, P-E Charles, M Hamet, N Jacquiot, A Large, S Mortreux, A Pavon, S Prin, A Roudaut, A Toitot, J Aboab, D Friedman, V Maxime, X Ambrosi, N Heming, C Ara Somohano, A Bonadona, J-C Cartier, R Hamidfar-Roy, M Lugosi, C Minet-Binauld, L Potton, N Terzi, B Vivet, Y Aihem, G Colin, M Fiancette, M Henry-Lagarrigue, J-C Lacherade, L Martin-Lefevre, I Vinatier, C Fourdin, M Ledein, C Thomas, L Argaud, T Baudry, T Chroboczek, M Cour, S De la Salle, E Faucher, A Grateau, T Madeleine, M Simon, C Bernet, O Fontaine-Kesteloot, A Friggeri, S Ledochowski, A Lepape, N Mottard, M Rinaudo, E Rulliat-Giraud, N Sens, F Thiolliere, F Wallet, G Barberet, M Egard, F Ganster, K Kuteifan, Y Mootien, A Poidevin, T Auchet, N Ducrocq, A Kimmoun, E Novy, P Perez, C Thivilier, J-B Lascarrou, A Ayral, C Bengler, C Boutin, G Dingemans, L Elotmani, F Garnier, J-M Le Goff, S Lloret, P Massanet, B Jung, L Platon, M Cisse, M Conseil, F Belafia, G Chanques, N Clavieras, Y Coisel, J Carr, F Barbier, D Benzekri Lefevre, T Boulain, A Bretagnol, A Mathonnet, G Muller, I Runge, B Mourvillier, R Sonneville, J-F Timsit, M Arnaout, W Bougouin, A Cariou, B Champigneulle, J Charpentier, J-D Chiche, G Geri, F C Pene, J Rouche, S Spagnolo, S Bedon-Carte, P-H Dessalles, Y Monseau, M Saint-Leger, A Berger, A Boivin, X Delabranche, S Heenen, T Khouri, C Kummerien, O Martinet, A Monnier, A-R Neagu, Y Rabouël, H Rahmani, D Schnell, L Bodet-Contentin, P-F Dequin, S Ehrmann, D Garot, A Guillon, A Joret, Y Jouan, A Legras, C Lhommet, J Mankikian, E Rouve, C Salmon-Gandonniere, Saber D Barbaret al.",2018 Oct 11,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/30304656/,No keywords found,"['acute', 'kidney', 'injury', 'frequent', 'complication', 'in', 'patient', 'with', 'septic', 'shock', 'and', 'independent', 'risk', 'factor', 'death', '.', 'although', 'renal-replacement', 'therapy', 'standard', 'of', 'care', 'severe', 'acute', 'kidney', 'injury', ',', 'ideal', 'time', 'initiation', 'remains', 'controversial', '.', 'method', 'in', 'multicenter', ',', 'randomized', ',', 'controlled', 'trial', ',', 'assigned', 'patient', 'with', 'early-stage', 'septic', 'shock', 'severe', 'acute', 'kidney', 'injury', 'failure', 'stage', 'of', 'risk', ',', 'injury', ',', 'failure', ',', 'loss', ',', 'and', 'end-stage', 'kidney', 'disease', '(', 'rifle', ')', 'classification', 'system', 'without', 'life-threatening', 'complication', 'related', 'to', 'acute', 'kidney', 'injury', 'to', 'receive', 'renal-replacement', 'therapy', 'either', 'within', 'hour', 'documentation', 'of', 'failure-stage', 'acute', 'kidney', 'injury', '(', 'early', 'strategy', ')', 'or', 'delay', 'of', 'hour', 'renal', 'recovery', 'not', 'occurred', '(', 'delayed', 'strategy', ')', '.', 'failure', 'stage', 'of', 'rifle', 'classification', 'system', 'characterized', 'serum', 'creatinine', 'level', 'time', 'baseline', 'level', '(', 'or', 'mg', 'per', 'deciliter', 'with', 'rapid', 'increase', 'of', '.', 'mg', 'per', 'deciliter', ')', ',', 'urine', 'output', 'less', '.', 'ml', 'per', 'kilogram', 'of', 'body', 'weight', 'per', 'hour', 'hour', 'or', 'longer', ',', 'or', 'anuria', 'least', 'hour', '.', 'primary', 'outcome', 'death', 'day', '.', 'result', 'trial', 'stopped', 'early', 'futility', 'second', 'planned', 'interim', 'analysis', '.', 'total', 'of', 'patient', 'underwent', 'randomization', 'no', 'significant', 'between-group', 'difference', 'in', 'characteristic', 'baseline', '.', 'among', 'patient', 'follow-up', 'data', 'day', 'available', ',', 'of', 'patient', 'in', 'early-strategy', 'group', '(', 'of', 'patient', ')', 'and', 'in', 'delayed-strategy', 'group', '(', 'of', 'patient', ')', 'died', '(', 'p.', ')', '.', 'in', 'delayed-strategy', 'group', ',', '(', 'patient', ')', 'not', 'receive', 'renal-replacement', 'therapy', '.', 'criterion', 'emergency', 'renal-replacement', 'therapy', 'met', 'in', 'of', 'patient', 'in', 'delayed-strategy', 'group', '(', 'patient', ')', '.', 'conclusion', 'among', 'patient', 'with', 'septic', 'shock', 'severe', 'acute', 'kidney', 'injury', ',', 'no', 'significant', 'difference', 'in', 'overall', 'mortality', 'day', 'patient', 'assigned', 'to', 'early', 'strategy', 'initiation', 'of', 'renal-replacement', 'therapy', 'and', 'assigned', 'to', 'delayed', 'strategy', '.', '(', 'funded', 'french', 'ministry', 'of', 'health', 'ideal-icu', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial.,"Ron Wald, Brian Kirkham, Bruno R daCosta, Ehsan Ghamarian, Neill K J Adhikari, William Beaubien-Souligny, Rinaldo Bellomo, Martin P Gallagher, Stuart Goldstein, Eric A J Hoste, Kathleen D Liu, Javier A Neyra, Marlies Ostermann, Paul M Palevsky, Antoine Schneider, Suvi T Vaara, Sean M Bagshaw, Ron Waldet al.",2022 Nov 24,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36424662/,No keywords found,"['among', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'earlier', 'initiation', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'may', 'mitigate', 'fluid', 'accumulation', 'and', 'confer', 'better', 'outcome', 'among', 'individual', 'with', 'greater', 'fluid', 'overload', 'randomization', '.', 'method', 'conducted', 'pre-planned', 'post', 'hoc', 'analysis', 'of', 'standard', 'versus', 'accelerated', 'initiation', 'of', 'renal', 'replacement', 'therapy', 'in', 'acute', 'kidney', 'injury', '(', 'starrt-aki', ')', 'trial', '.', 'evaluated', 'effect', 'of', 'accelerated', 'rrt', 'initiation', 'cumulative', 'fluid', 'balance', 'course', 'of', 'day', 'following', 'randomization', 'using', 'mixed', 'model', 'censoring', 'death', 'and', 'icu', 'discharge', '.', 'assessed', 'modifying', 'effect', 'of', 'baseline', 'fluid', 'balance', 'impact', 'of', 'rrt', 'initiation', 'strategy', 'key', 'clinical', 'outcome', '.', 'patient', 'categorized', 'in', 'quartile', 'of', 'baseline', 'fluid', 'balance', ',', 'and', 'effect', 'of', 'accelerated', 'versus', 'standard', 'rrt', 'initiation', 'clinical', 'outcome', 'assessed', 'in', 'quartile', 'using', 'risk', 'ratio', '(', 'ci', ')', 'categorical', 'variable', 'and', 'mean', 'difference', '(', 'ci', ')', 'continuous', 'variable', '.', 'result', 'among', 'patient', 'in', 'modified', 'intention-to-treat', 'analysis', ',', 'available', 'data', 'baseline', 'fluid', 'balance', 'and', '(', '.', ')', 'least', 'one', 'day', 'of', 'fluid', 'balance', 'data', 'following', 'randomization', '.', 'subsequent', 'day', ',', 'participant', 'allocated', 'to', 'accelerated', 'strategy', 'lower', 'cumulative', 'fluid', 'balance', 'compared', 'to', 'in', 'standard', 'strategy', '(', '(', '-', 'to', ',', ')', 'versus', '(', 'to', ',', ')', 'ml', ',', 'p', '.', ')', '.', 'accelerated', 'rrt', 'initiation', 'not', 'confer', 'greater', '-day', 'survival', 'in', 'of', 'baseline', 'fluid', 'balance', 'quartile', '(', 'quartile', 'rr', '.', '(', 'ci', '.', 'to', '.', ')', ',', 'quartile', 'rr', '.', '(', '.', 'to', '.', ')', 'quartile', 'rr', '.', '(', 'ci', '.', 'to', '.', ')', 'and', 'quartile', 'rr', '.', '(', 'ci', '.', 'to', '.', ')', ',', 'p', 'value', 'trend', '.', ')', '.', 'conclusion', 'earlier', 'rrt', 'initiation', 'in', 'critically', 'ill', 'patient', 'with', 'aki', 'conferred', 'modest', 'attenuation', 'of', 'cumulative', 'fluid', 'balance', '.', 'nonetheless', ',', 'among', 'patient', 'with', 'greater', 'fluid', 'accumulation', 'randomization', ',', 'accelerated', 'rrt', 'initiation', 'not', 'impact', 'all-cause', 'mortality', '.', 'trial', 'registration', 'clinicaltrials.gov', 'number', ',', 'httpsclinicaltrials.govctshownct', ',', 'registered', 'october', ',', '.']"
Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study.,"Finnian R Mc Causland, Josephine Asafu-Adjei, Rebecca A Betensky, Paul M Palevsky, Sushrut S Waikar, Finnian R Mc Causlandet al.",2016 Aug 8,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/27449661/,No keywords found,"['intensive', 'rrt', 'may', 'adverse', 'effect', 'account', 'absence', 'of', 'benefit', 'observed', 'in', 'randomized', 'trial', 'of', 'intensive', 'versus', 'less', 'intensive', 'rrt', '.', 'wished', 'to', 'determine', 'association', 'of', 'intensive', 'rrt', 'with', 'change', 'in', 'urine', 'output', 'marker', 'of', 'worsening', 'residual', 'renal', 'function', 'in', 'critically', 'ill', 'patient', 'with', 'severe', 'aki', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'acute', 'renal', 'failure', 'trial', 'network', 'study', '(', 'n', ')', 'multicenter', 'trial', 'randomized', 'critically', 'ill', 'patient', 'requiring', 'initiation', 'of', 'rrt', 'to', 'intensive', '(', 'hemodialysis', 'or', 'sustained', 'low-efficiency', 'dialysis', 'six', 'time', 'per', 'week', 'or', 'continuous', 'venovenous', 'hemodiafiltration', 'mlkg', 'per', 'hour', ')', 'versus', 'less', 'intensive', '(', 'hemodialysis', 'or', 'sustained', 'low-efficiency', 'dialysis', 'three', 'time', 'per', 'week', 'or', 'continuous', 'venovenous', 'hemodiafiltration', 'mlkg', 'per', 'hour', ')', 'rrt', '.', 'mixed', 'linear', 'regression', 'model', 'fit', 'to', 'estimate', 'association', 'of', 'rrt', 'intensity', 'with', 'change', 'in', 'daily', 'urine', 'output', 'in', 'survivor', 'day', '(', 'n', ')', 'cox', 'regression', 'model', 'fit', 'to', 'determine', 'association', 'of', 'rrt', 'intensity', 'with', 'time', 'to', 'decline', 'in', 'urine', 'output', 'in', 'patient', 'day', '.', 'result', 'mean', 'age', 'of', 'participant', 'year', 'old', ',', 'men', ',', 'and', 'diabetic', '.', 'in', 'unadjusted', 'model', ',', 'among', 'patient', 'survived', 'day', ',', 'mean', 'urine', 'output', ',', 'average', ',', '.', 'mld', 'higher', '(', 'confidence', 'interval', ',', '.', 'to', '.', 'mld', ')', 'less', 'intensive', 'group', 'compared', 'with', 'intensive', 'group', '(', 'p.', ')', '.', 'intensive', 'rrt', 'associated', 'with', 'greater', 'unadjusted', 'risk', 'of', 'decline', 'in', 'urine', 'output', 'of', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'conclusion', 'intensive', 'versus', 'less', 'intensive', 'rrt', 'associated', 'with', 'greater', 'reduction', 'in', 'urine', 'output', 'first', 'day', 'of', 'therapy', 'and', 'greater', 'risk', 'of', 'developing', 'decline', 'in', 'urine', 'output', 'of', 'in', 'critically', 'ill', 'patient', 'with', 'severe', 'aki', '.']"
A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents.,"Huanhuan Zheng, Guolang Wang, Qianqian Cao, Wenkai Ren, Lingyuan Xu, Shuangshan Bu, Huanhuan Zhenget al.",2022 Dec,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/35509178/,No keywords found,"['first', 'study', 'to', 'explore', 'risk', 'factor', 'nephropathy', 'caused', 'gadolinium-based', 'contrast', 'agent', 'and', 'establish', 'prediction', 'model', 'to', 'identify', 'high-risk', 'patient', '.', 'method', 'total', 'of', 'patient', 'received', 'gadolinium-based', 'contrast', 'agent', 'in', 'hospital', 'included', '.', 'participant', 'randomly', 'assigned', 'in', 'ratio', 'to', 'modeling', 'and', 'validation', 'group', '.', 'modeling', 'group', 'divided', 'contrast-induced', 'nephropathy', 'group', 'and', 'non-contrast-induced', 'nephropathy', 'group', '.', 'clinical', 'characteristic', 'use', 'of', 'contrast', 'agent', 'compared', 'two', 'group', '.', 'risk', 'factor', 'contrast-induced', 'nephropathy', 'analyzed', 'logistic', 'regression', '.', 'nomogram', 'could', 'predict', 'incidence', 'of', 'contrast-induced', 'nephropathy', 'plotted', '.', 'validation', 'group', 'used', 'to', 'verify', 'predictive', 'model', '.', 'result', 'incidence', 'of', 'contrast-induced', 'nephropathy', 'caused', 'gadolinium-based', 'contrast', 'agent', '.', '(', ')', '.', 'logistic', 'stepwise', 'regression', 'analysis', 'showed', 'sex', ',', 'systolic', 'pressure', '(', 'sbp', ')', ',', 'absolute', 'neutrophil', 'count', ',', 'albumin', ',', 'fasting', 'blood', 'glucose', 'level', ',', 'and', 'furosemide', 'use', 'significant', 'predictor', 'of', 'contrast-induced', 'nephropathy', 'caused', 'gadolinium-based', 'contrast', 'agent', '.', 'predictor', 'included', 'in', 'nomogram', 'construction', '.', 'area', 'receiver', 'operating', 'characteristic', '(', 'roc', ')', 'curve', '.', '(', 'p', '.', ')', '.', 'specificity', 'and', 'sensitivity', 'corresponding', 'to', 'optimal', 'cutoff', 'point', '(', '.', ')', 'based', 'area', 'roc', 'curve', '.', 'and', '.', ',', 'respectively', '.', 'conclusion', 'sex', ',', 'sbp', ',', 'absolute', 'neutrophil', 'count', ',', 'albumin', ',', 'fasting', 'blood', 'glucose', 'level', ',', 'and', 'furosemide', 'use', 'significant', 'predictor', 'of', 'contrast-induced', 'nephropathy', 'caused', 'gadolinium-based', 'contrast', 'agent', '.', 'therefore', ',', 'incidence', 'of', 'contrast-induced', 'nephropathy', 'may', 'estimated', 'prediction', 'model', 'established', 'in', 'study', 'use', 'of', 'contrast', 'agent', '.']"
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.,"Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, Youssef M K Farag, Robert Toto, Sanjay Kaul, Robert Lawatscheck, Katja Rohwedder, Luis M Ruilope, Peter Rossing, Bertram Pitt, Gerasimos Filippatos, Stefan D Anker, George L Bakris                              ;, FIDELIO-DKD and FIGARO-DKD Investigators, Rajiv Agarwalet al.",2023 Dec,Ann Intern Med,https://pubmed.ncbi.nlm.nih.gov/38048573/,No keywords found,"['in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'and', 'type', 'diabetes', '(', 'td', ')', ',', 'finerenone', ',', 'nonsteroidal', 'mineralocorticoid', 'receptor', 'antagonist', ',', 'reduces', 'cardiovascular', 'and', 'kidney', 'failure', 'outcome', '.', 'finerenone', 'also', 'lower', 'urine', 'albumin-to-creatinine', 'ratio', '(', 'uacr', ')', '.', 'whether', 'finerenone-induced', 'change', 'in', 'uacr', 'mediates', 'cardiovascular', 'and', 'kidney', 'failure', 'outcome', 'unknown', '.', 'objective', 'to', 'quantify', 'proportion', 'of', 'kidney', 'and', 'cardiovascular', 'risk', 'reduction', 'seen', '-year', 'period', 'mediated', 'change', 'in', 'kidney', 'injury', ',', 'measured', 'change', 'in', 'log', 'uacr', 'baseline', 'and', 'month', '.', 'design', 'post', 'hoc', 'mediation', 'analysis', 'using', 'pooled', 'data', 'phase', ',', 'double-blind', 'trial', 'of', 'finerenone', '.', '(', 'clinicaltrials.gov', 'nct', 'and', 'nct', ')', '.', 'setting', 'several', 'clinical', 'site', 'in', 'country', '.', 'patient', 'patient', 'with', 'ckd', 'and', 'td', '.', 'intervention', 'finerenone', 'and', 'placebo', '(', ')', '.', 'measurement', 'separate', 'mediation', 'analysis', 'done', 'composite', 'kidney', '(', 'kidney', 'failure', ',', 'sustained', 'decrease', 'in', 'estimated', 'glomerular', 'filtration', 'rate', 'baseline', 'approximately', 'doubling', 'of', 'serum', 'creatinine', ',', 'or', 'kidney', 'disease', 'death', ')', 'and', 'cardiovascular', '(', 'cardiovascular', 'death', ',', 'nonfatal', 'myocardial', 'infarction', ',', 'nonfatal', 'stroke', ',', 'or', 'hospitalization', 'heart', 'failure', ')', 'outcome', '.', 'result', 'baseline', ',', 'median', 'uacr', 'mgg', '.', 'or', 'greater', 'reduction', 'in', 'uacr', 'seen', 'in', '(', '.', ')', 'patient', 'in', 'finerenone', 'group', 'and', '(', '.', ')', 'patient', 'in', 'placebo', 'group', '.', 'reduction', 'in', 'uacr', '(', 'analyzed', 'continuous', 'variable', ')', 'mediated', 'and', 'of', 'treatment', 'effect', 'kidney', 'and', 'cardiovascular', 'outcome', ',', 'respectively', '.', 'change', 'in', 'uacr', 'analyzed', 'binary', 'variable', '(', ',', 'whether', 'guideline-recommended', 'reduction', 'threshold', 'met', ')', ',', 'proportion', 'mediated', 'outcome', 'and', ',', 'respectively', '.', 'limitation', 'current', 'finding', 'not', 'readily', 'extendable', 'to', 'drug', '.', 'conclusion', 'in', 'patient', 'with', 'ckd', 'and', 'td', ',', 'early', 'albuminuria', 'reduction', 'accounted', 'large', 'proportion', 'of', 'treatment', 'effect', 'ckd', 'progression', 'and', 'modest', 'proportion', 'of', 'effect', 'cardiovascular', 'outcome', '.', 'primary', 'funding', 'source', 'bayer', 'ag', '.']"
Etiology and renal outcomes of acute tubulointerstitial nephritis: a single-center prospective cohort study in China.,"Tao Su, Yanghui Gu, Pingping Sun, Jiawei Tang, Suxia Wang, Gang Liu, Xiaomei Li, Li Yang, Tao Suet al.",2018 Jul 1,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/28992223/,No keywords found,"['aim', 'of', 'study', 'to', 'explore', 'etiology', ',', 'long-term', 'renal', 'outcome', 'and', 'affecting', 'factor', 'of', 'acute', 'tubulointerstitial', 'nephritis', '(', 'atin', ')', '.', 'method', 'patient', 'with', 'biopsy-proven', 'atin', 'january', 'to', 'december', 'peking', 'university', 'first', 'hospital', 'enrolled', 'in', 'study', 'and', 'received', 'scheduled', 'follow-up', 'least', 'month', '.', 'cause', 'of', 'atin', 'defined', 'biopsy', 'and', 'reclassified', 'follow-up', '.', 'factor', 'affecting', 'renal', 'recovery', 'month', 'post-biopsy', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'month', 'post-biopsy', 'and', 'end', 'of', 'follow-up', 'analyzed', '.', 'result', 'total', 'of', 'atin', 'patient', 'enrolled', ',', 'with', 'average', 'follow-up', 'of', 'month', '(', 'range', '-', 'month', ')', '.', 'modified', 'etiology', 'spectrum', 'identified', ',', 'with', 'decreased', 'proportion', 'of', 'drug-induced', 'atin', '(', 'd-atin', ',', 'biopsy', 'to', 'follow-up', ')', 'and', 'increase', 'in', 'autoimmune-related', 'atin', '(', '-', ')', 'with', 'late-onset', 'systemic', 'manifestation', 'in', 'patient', 'classified', 'd-atin', 'or', 'atin', 'of', 'unknown', 'cause', '.', 'recurrent', 'kidney', 'injury', 'observed', 'in', 'of', 'patient', 'with', 'tubulointerstitial', 'nephritis', 'and', 'uveitis', 'syndrome', '(', 'tinu', ')', ',', 'of', 'with', 'autoimmune', 'disease', 'and', 'of', 'with', 'd-atin', ',', 'resulting', 'in', 'prolonged', 'immunosuppressive', 'treatment', '.', 'month', ',', 'decreased', 'egfr', '(', 'mlmin', '.', ')', 'observed', 'in', 'of', 'patient', 'with', 'd-atin', ',', 'of', 'with', 'tinu', 'and', 'of', 'with', 'autoimmune', 'disease', '.', 'in', 'multivariable', 'analysis', ',', 'female', 'sex', ',', 'older', 'age', ',', 'presence', 'of', 'hypertension', 'and', 'recurrent', 'kidney', 'injury', 'independent', 'risk', 'factor', 'worse', 'renal', 'outcome', '.', 'conclusion', 'data', 'demonstrate', 'autoimmune-related', 'atin', 'may', 'present', 'with', 'systemic', 'manifestation', 'kidney', 'injury', 'and', ',', 'therefore', ',', 'commonly', 'misdiagnosed', '.', 'repeated', 'kidney', 'injury', 'not', 'uncommon', 'in', 'patient', 'with', 'atin', '.', 'scheduled', 'follow-up', ',', 'therefore', ',', 'critical', 'defining', 'exact', 'etiology', 'and', 'proper', 'management', 'of', 'atin', '.']"
"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Antithrombin Supplementation in Patients at Risk for Antithrombin Deficiency After Cardiac Surgery.","Michael George Moront, Michael K Woodward, Michael K Essandoh, Edwin G Avery, T Brett Reece, Marek Brzezinski, Bruce Spiess, Linda Shore-Lesserson, Junliang Chen, Waleska Henriquez, Miquel Barceló, George Despotis, Keyvan Karkouti, Jerrold H Levy, Marco Ranucci, Elsa Mondou                              ;, Clinical Thrombate Study Group, Robert Kramer, Kathirvel Subramaniam, Luigino Nascimben, Manuel Fontes, Vincent Scavo, Roman Sniecinski, Frederic Lombard, Ian Welsby, Jeffrey Milliken, Stephen Hazelrigg, Fred Tibayan, Yiliam Rodriguez-Blanco, Sina Moainie, Michael Moulton, Alexander Iribarne, Michael Firstenberg, Geoffrey Answini, Edward Garrett, Thomas Beaver, Hassan Reda, Wilson Szeto, Michael George Morontet al.",2022 Oct 1,Anesth Analg,https://pubmed.ncbi.nlm.nih.gov/35877927/,No keywords found,"['antithrombin', '(', ')', 'activity', 'reduced', 'cardiac', 'operation', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', ',', 'associated', 'with', 'adverse', 'outcome', '.', 'preoperative', 'supplementation', ',', 'to', 'achieve', 'and', 'activity', ',', 'may', 'potentially', 'reduce', 'postoperative', 'morbidity', 'and', 'mortality', 'in', 'cardiac', 'operation', 'with', 'cpb', '.', 'prospective', ',', 'multicenter', ',', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'study', 'designed', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'preoperative', 'treatment', 'with', 'supplementation', 'in', 'patient', 'risk', 'low', 'activity', 'undergoing', 'cardiac', 'surgery', 'with', 'cpb', '.', 'method', 'total', 'of', 'adult', 'patient', 'randomized', '(', ')', 'to', 'receive', 'either', 'single', 'dose', 'of', '(', 'n', ')', 'to', 'achieve', 'absolute', 'increase', 'of', 'pretreatment', 'activity', 'or', 'placebo', '(', 'n', ')', 'surgery', '.', 'study', 'duration', 'approximately', 'week', '.', 'primary', 'efficacy', 'end', 'point', 'percentage', 'of', 'patient', 'with', 'component', 'of', 'major', 'morbidity', 'composite', '(', 'postoperative', 'mortality', ',', 'stroke', ',', 'acute', 'kidney', 'injury', 'aki', ',', 'surgical', 'reexploration', ',', 'arterial', 'or', 'venous', 'thromboembolic', 'event', ',', 'prolonged', 'mechanical', 'ventilation', ',', 'and', 'infection', ')', 'in', 'group', '.', 'secondary', 'end', 'point', 'included', 'activity', ',', 'blood', 'loss', ',', 'transfusion', 'requirement', ',', 'duration', 'of', 'intensive', 'care', 'unit', '(', 'icu', ')', ',', 'and', 'hospital', 'stay', '.', 'safety', 'also', 'assessed', '.', 'result', 'overall', ',', 'patient', '(', 'men', ',', 'n', ',', '.', ')', 'with', 'mean', '(', 'standard', 'deviation', 'sd', ')', 'age', 'of', '.', '(', '.', ')', 'year', ',', 'with', 'majority', 'undergoing', 'complex', 'surgical', 'procedure', '(', 'n', ',', '.', ')', ',', 'analyzed', '.', 'no', 'difference', 'in', 'percentage', 'of', 'patient', 'experiencing', 'morbidity', 'composite', 'outcome', 'group', 'observed', '(', 'at-treated', '.', 'versus', 'placebo', '.', 'p', '.', 'relative', 'risk', ',', '.', ')', '.', 'infusion', ',', 'activity', 'significantly', 'higher', 'in', 'group', '(', '-', ')', 'versus', 'placebo', 'group', '(', '-', ')', ',', 'and', 'lasted', 'to', 'postoperative', 'day', '.', 'icu', ',', 'frequency', 'of', 'patient', 'with', 'activity', 'in', 'group', '(', '.', ')', 'significantly', 'higher', '(', 'p', '.', ')', 'versus', 'placebo', 'group', '(', '.', ')', '.', 'secondary', 'end', 'point', 'analysis', 'not', 'show', 'advantage', 'of', 'placebo', 'group', '.', 'significantly', 'patient', 'with', 'aki', '(', 'p', '.', ')', 'in', 'group', '(', '.', ')', 'in', 'placebo', 'group', '(', ',', '.', ')', '.', 'safety', 'result', 'showed', 'no', 'difference', 'in', 'treatment-emergent', 'adverse', 'event', 'bleeding', 'event', 'group', '.', 'conclusion', 'supplementation', 'not', 'attenuate', 'adverse', 'postoperative', 'outcome', 'in', 'cohort', 'of', 'patient', 'undergoing', 'cardiac', 'surgery', 'with', 'cpb', '.']"
The Effects of Intensive Versus Routine Treatment in Patients with Acute Kidney Injury.,"Anja Haase-Fielitz, Saban Elitok, Martin Schostak, Martin Ernst, Berend Isermann, Christian Albert, Bernt-Peter Robra, Andreas Kribben, Michael Haase, Anja Haase-Fielitzet al.",2020 Apr 24,Dtsch Arztebl Int,https://pubmed.ncbi.nlm.nih.gov/32530412/,No keywords found,"['in', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'specialized', 'treatment-initiated', 'in', 'response', 'to', 'early-warning', 'system-', 'may', 'beneficial', 'compared', 'with', 'routine', 'treatment', '.', 'method', 'to', 'explore', 'effect', 'estimator', 'in', 'pilot', 'trial', '(', 'drks', ')', ',', 'patient', 'with', 'aki', 'regular', 'ward', 'of', 'university', 'hospital', 'treated', 'either', 'in', 'usual', 'way', '(', 'control', 'group', ')', 'or', 'intensively', '(', 'intervention', 'group', ')', '.', 'subject', 'allotted', 'randomly', 'to', 'two', 'treatment', 'group', '.', 'intensive', 'treatment', 'consisted', 'of', 'early', 'warning', 'system', 'rise', 'in', 'serum', 'creatinine', 'concentration', ',', 'immediate', 'consultation', 'of', 'specialist', ',', 'and', 'issuance', 'of', 'patient', 'kidney', 'passport', '.', 'primary', 'endpoint', 'recovery', 'of', 'renal', 'function', 'aki', 'index', 'hospitalization', '.', 'renal', 'complication', 'and', 'process', 'indicator', 'secondary', 'endpoint', '.', 'result', 'proportion', 'of', 'patient', 'whose', 'renal', 'function', 'returned', 'to', 'baseline', 'aki', 'in', 'intervention', 'group', '(', 'n', ')', 'and', 'in', 'control', 'group', '(', 'n', ')', '(', 'odds', 'ratio', '.', ',', 'confidence', 'interval', '.', '.', ',', 'p', '.', ')', '.', 'calculated', 'glomerular', 'filtration', 'rate', 'went', ',', 'hospital', 'admission', 'to', 'discharge', ',', 'mlmin', '.', '(', 'st-rd', 'quartile', '-', ')', 'in', 'intervention', 'group', 'and', 'mlmin', '.', 'in', 'control', 'group', '(', 'st-rd', 'quartile', '-', 'p', '.', ')', '.', 'complication', 'of', 'aki', 'hyperkalemia', ',', 'pulmonary', 'edema', ',', 'and', 'renal', 'acidosis', 'rarer', 'in', 'intervention', 'group', '(', 'versus', 'p', '.', ')', '.', 'in', 'intervention', 'group', ',', 'compared', 'with', 'control', 'group', ',', 'cause', 'of', 'aki', 'identified', 'frequently', '(', 'versus', 'p', '.', ')', 'drug', 'with', 'relevance', 'to', 'kidney', 'discontinued', 'frequently', '(', 'versus', 'p', '.', ')', 'and', 'diagnosis', 'of', 'aki', 'frequently', 'documented', 'in', 'patient', ""'s"", 'chart', '(', 'versus', 'p', '.', ')', '.', 'conclusion', 'specialized', 'consultation', 'supported', 'early', 'warning', 'system', 'aki', 'seem', 'to', 'beneficial', 'patient', '.', 'finding', 'of', 'pilot', 'trial', 'verified', 'in', 'larger-scale', 'randomized', 'controlled', 'trial', '.']"
"Prevention of Contrast-induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Elective Coronary Angioplasty or Angiography with Sodium Potassium Citrate Solution, a Double Blind Randomized Clinical Trial.","Ali Ghorbani, Saeed Yazdankhah, Mohamad Hasan Adel, Hamed Tabesh, Ali Reza Sattari, Shahab Aldin Sattari, Habib Heybar, Shahla Madjidi, Ali Ghorbaniet al.",2019 May,Iran J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/31209191/,No keywords found,"['contrast-induced', 'nephropathy', '(', 'cin', ')', 'frequent', 'complication', 'of', 'contrast', 'exposure', '.', 'recent', 'study', 'suggested', 'nak', 'citrate', 'might', 'preventive', 'role', '.', 'investigated', 'efficacy', 'of', 'nak', 'citrate', 'to', 'prevent', 'cin', 'in', 'patient', 'with', 'renal', 'dysfunction', 'undergoing', 'coronary', 'intervention', '.', 'method', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trial', 'included', 'patient', 'with', 'estimated', 'creatinine', 'clearance', '.', ')', '.', 'post-exposure', 'cr', 'value', 'not', 'significantly', 'different', 'two', 'group', '(', '.', '.', 'mgdl', 'in', 'placebo', 'vs.', '.', '.', 'mgdl', 'in', 'treatment', 'group', ',', 'p', '.', ')', '.', 'cin-negative', 'patient', 'in', 'treatment', 'group', 'showed', 'significantly', 'higher', 'increase', 'in', 'urine', 'ph', 'of', 'cin-positive', 'patient', '(', '.', '.', 'vs.', '.', '.', ',', 'p', '.', ')', '.', 'conclusion', 'nak', 'citrate', 'solution', 'not', 'effective', 'prophylaxis', 'of', 'cin', 'in', 'patient', 'with', 'renal', 'dysfunction', '.', 'however', ',', 'probable', 'preventive', 'effect', 'might', 'exist', 'in', 'subgroup', 'of', 'patient', 'with', 'least', '.', 'unit', 'increase', 'in', 'urine', 'ph', 'value', 'following', 'nak', 'citrate', 'administration', '.']"
"Effects of intraoperative inspired oxygen fraction (FiO2 0.3 vs 0.8) on patients undergoing off-pump coronary artery bypass grafting: the CARROT multicenter, cluster-randomized trial.","Karam Nam#, Jae-Sik Nam#, Hye-Bin Kim, Jaeyeon Chung, In Eob Hwang, Jae-Woo Ju, Jinyoung Bae, Seohee Lee, Youn Joung Cho, Jae-Kwang Shim, Young-Lan Kwak, Ji-Hyun Chin, In-Cheol Choi                              ;, CARdiac suRgery and Oxygen Therapy (CARROT) Investigators;, Eun-Ho Lee#, Yunseok Jeon#, Karam Namet al.",2023 Jul 13,Crit Care,https://pubmed.ncbi.nlm.nih.gov/37443130/,No keywords found,"['to', 'maintain', 'adequate', 'oxygenation', 'of', 'utmost', 'importance', 'in', 'intraoperative', 'care', '.', 'however', ',', 'clinical', 'evidence', 'supporting', 'specific', 'oxygen', 'level', 'in', 'distinct', 'surgical', 'setting', 'lacking', '.', 'study', 'aimed', 'to', 'compare', 'effect', 'of', 'and', 'oxygen', 'in', 'off-pump', 'coronary', 'artery', 'bypass', 'grafting', '(', 'opcab', ')', '.', 'method', 'multicenter', 'trial', 'conducted', 'in', 'three', 'tertiary', 'hospital', 'august', 'to', 'august', '.', 'patient', 'undergoing', 'opcab', 'cluster-randomized', 'to', 'receive', 'either', 'or', 'oxygen', 'intraoperatively', ',', 'based', 'month', 'surgery', 'performed', '.', 'primary', 'endpoint', 'length', 'of', 'hospital', 'stay', '.', 'intraoperative', 'hemodynamic', 'data', 'also', 'compared', '.', 'result', 'total', 'of', 'patient', 'cluster-randomized', '.', 'length', 'of', 'hospital', 'stay', 'not', 'different', 'in', 'oxygen', 'group', 'compared', 'to', 'oxygen', 'group', '(', 'median', ',', '.', 'day', 'v', '.', 'day', 'sub-distribution', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', 'ci', '.-', '.', 'p', '.', ')', '.', 'incidence', 'of', 'postoperative', 'acute', 'kidney', 'injury', 'significantly', 'higher', 'in', 'oxygen', 'group', 'in', 'oxygen', 'group', '(', '.', 'v', '.', 'odds', 'ratio', ',', '.', 'ci', '.-', '.', 'p', '.', ')', '.', 'intraoperative', 'time-weighted', 'average', 'mixed', 'venous', 'oxygen', 'saturation', 'significantly', 'higher', 'in', 'oxygen', 'group', '(', 'v', 'p', '.', ')', '.', 'oxygen', 'group', 'also', 'significantly', 'greater', 'intraoperative', 'time-weighted', 'average', 'cerebral', 'regional', 'oxygen', 'saturation', 'oxygen', 'group', '(', 'v', 'p', '.', ')', '.', 'conclusion', 'in', 'patient', 'undergoing', 'opcab', ',', 'intraoperative', 'administration', 'of', 'oxygen', 'not', 'decrease', 'length', 'of', 'hospital', 'stay', ',', 'compared', 'to', 'oxygen', ',', 'may', 'reduce', 'postoperative', 'acute', 'kidney', 'injury', '.', 'moreover', ',', 'compared', 'to', 'oxygen', ',', 'intraoperative', 'use', 'of', 'oxygen', 'improved', 'oxygen', 'delivery', 'in', 'patient', 'undergoing', 'opcab', '.', 'trial', 'registration', 'clinicaltrials.gov', '(', 'nct', 'april', ',', ')', '.']"
The impact of laparoscopic adrenalectomy on renal function. Results of a prospective randomised clinical trial.,"Tomasz Kozłowski, Alicja Rydzewska-Rosolowska, Janusz Myśliwiec, Barbara Choromańska, Piotr Wojskowicz, Jacek Dadan, Marta Łukaszewicz-Zając, Barbara Mroczko, Piotr Myśliwiec, Tomasz Kozłowskiet al.",2019,Endokrynol Pol,https://pubmed.ncbi.nlm.nih.gov/31274187/,No keywords found,"['laparoscopic', 'adrenalectomy', 'gold', 'standard', 'management', 'of', 'benign', 'adrenal', 'mass', 'and', 'isolated', 'metastasis', 'to', 'adrenal', 'gland', '.', 'two', 'technique', 'of', 'endoscopic', 'adrenalectomy', 'lateral', 'transperitoneal', 'approach', '(', 'lta', ')', 'and', 'posterior', 'retroperitoneal', 'approach', '(', 'pra', ')', 'seem', 'to', 'equally', 'safe', 'and', 'effective', '.', 'recent', 'study', 'suggest', 'advantage', 'of', 'pra', 'lta', 'in', 'term', 'of', 'lower', 'intensity', 'of', 'postoperative', 'pain', ',', 'shorter', 'hospital', 'stay', ',', 'faster', 'recovery', ',', 'and', 'lower', 'early', 'morbidity', '.', 'however', ',', 'pra', 'involves', 'high', 'insufflation', 'pressure', 'of', 'co', 'within', 'limited', 'retroperitoneal', 'space', '.', 'aim', 'of', 'study', 'to', 'prospectively', 'assess', 'effect', 'of', 'lta', 'versus', 'pra', 'laparoscopic', 'adrenalectomy', 'renal', 'function', '.', 'material', 'and', 'method', 'randomly', 'assigned', 'patient', 'referred', 'unilateral', 'adrenalectomy', 'to', 'either', 'lta', '(', 'n', ')', 'or', 'pra', '(', 'n', ')', '.', 'inclusion', 'criterion', 'hormonal', 'activity', 'andor', 'tumour', 'diameter', 'cm', 'andor', 'suspicion', 'of', 'metastasis', 'to', 'adrenal', 'gland', '.', 'exclusion', 'criterion', 'comprised', 'tumour', 'cm', ',', 'result', 'of', 'imaging', 'study', 'suggesting', 'primary', 'invasive', 'malignancy', ',', 'and', 'refusal', 'to', 'undergo', 'randomisation', '.', 'patient', 'prospectively', 'followed', 'minimum', 'of', 'six', 'month', '.', 'serum', 'creatinine', ',', 'cystatin', 'c', ',', 'and', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'measured', 'preoperatively', 'and', 'postoperative', 'day', ',', ',', 'and', '.', 'result', 'found', 'increased', 'concentration', 'of', 'urinary', 'ngal', 'day', 'following', 'laparoscopic', 'adrenalectomy', 'using', 'pra', ',', 'compared', 'to', 'lta', '.', 'patient', 'undergoing', 'right-sided', 'pra', 'increased', 'creatinine', 'concentration', ',', 'compared', 'to', 'left-sided', 'pra', '.', 'patient', 'with', 'aldosterone-producing', 'adenoma', 'decreased', 'preoperative', 'egfr', 'compared', 'to', 'subject', 'with', 'non-functioning', 'incidentaloma', '.', 'ngal', 'increased', 'significantly', 'in', 'group', 'postoperatively', '.', 'disturbance', 'normalised', 'within', 'one', 'month', 'postoperatively', '.', 'conclusion', 'renal', 'function', 'impairment', 'pra', 'may', 'result', 'compression', 'of', 'inferior', 'vena', 'cava', 'high', 'retroperitoneal', 'pressure', 'right-sided', 'adrenalectomy', '.', 'despite', 'transient', 'character', 'of', 'observed', 'abnormality', ',', 'suggest', 'patient', 'with', 'high', 'risk', 'of', 'acute', 'kidney', 'injury', 'may', 'benefit', 'alternative', 'technique', 'of', 'adrenalectomy', 'using', 'lta', '.']"
Short- and long-term effects of the use of RAAS blockers immediately after renal transplantation.,"Christos Chatzikyrkou, Jenny Eichler, Annika Karch, Christian Clajus, Florian Gunnar Scurt, Wolf Ramackers, Frank Lehner, Jan Menne, Hermann Haller, Peter R Mertens, Mario Schiffer, Christos Chatzikyrkouet al.",2017 Feb,Blood Press,https://pubmed.ncbi.nlm.nih.gov/27195820/,No keywords found,"['efficacy', 'and', 'safety', 'of', 'renin', 'angiotensin', 'aldosterone', 'system', 'blocker', '(', 'raasb', ""'s"", ')', 'introduced', 'immediately', 'renal', 'transplantation', 'not', 'extensively', 'investigated', '.', 'method', 'medical', 'chart', 'of', 'kidney', 'transplant', 'recipient', 'received', 'raasb', 'in', 'early', 'postoperative', 'period', 'and', 'of', 'matched', 'control', 'analyzed', '.', 'raasb', 'given', 'primarily', 'blood', 'pressure', 'control', '.', 'result', 'patient', 'continued', 'to', 'receive', 'and', 'control', 'remained', 'continuously', 'free', 'of', 'raasb', 'in', 'first', 'year', '.', 'raasb', 'added', 'average', 'postoperative', 'day', 'and', 'mean', 'duration', 'of', 'follow-up', '.', 'year', '.', 'systolic', ',', 'blood', 'pressure', 'treatment', 'initiation', 'increased', 'in', 'raasb', 'group', '(', 'vs.', ',', 'p', '.', ')', '.', 'discharge', 'hospital', 'and', 'follow-up', 'blood', 'pressure', 'similar', 'in', 'group', ',', 'without', 'difference', 'in', 'gfr', ',', 'potassium', 'and', 'proteinuria', '.', 'endpoint', '``', 'graft', 'failure', ""''"", 'and', '``', 'graft', 'failure', 'or', 'death', 'cause', ""''"", 'significantly', 'better', 'in', 'patient', 'treated', 'with', 'raasb', ""'s"", '(', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', '.', 'treatment', 'effect', 'in', 'raasb', 'group', 'persisted', 'even', 'adjustment', 'demographic', 'parameter', ',', 'immunological', 'risk', 'factor', ',', 'peritransplant', 'risk', 'factor', ',', 'duration', 'of', 'dialysis', 'prior', 'to', 'transplantation', 'and', 'medical', 'comorbidities', '.', 'conclusion', 'thus', ',', 'raasb', ""'s"", 'used', 'effectively', 'and', 'safely', 'to', 'treat', 'hypertension', 'in', 'early', 'postoperative', 'period', 'kidney', 'transplantation', 'and', 'renoprotective', 'in', 'long', 'term', '.']"
"Effectiveness of edaravone in preventing contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A randomized, double-blind trial.","Azam Esmailnejad, Sepideh Zununi Vahed, Seyyedeh Mina Hejazian, Naser Aslanabadi, Hassanali Lotfollahhi Gharakhanlu, Majid Saraei, Ahmad Ahmadzadehpournaky, Kasra Ardalan, Mohammadreza Ardalan, Samad Ghaffari Bavil, Azam Esmailnejadet al.",2024 Aug,Pharmacol Res Perspect,https://pubmed.ncbi.nlm.nih.gov/38956898/,"antioxidants, chronic kidney injury, contrast media, contrast‐induced‐acute kidney injury, edaravone.","['.', 'of', 'patient', 'in', 'intervention', 'group', '(', 'n', ')', 'and', '.', 'of', 'control', '(', 'n', ')', '.', 'however', ',', 'difference', 'not', 'statistically', 'significant', '.', 'administration', 'of', 'single', 'dosage', 'of', 'edaravone', 'h', 'prior', 'to', 'infusion', 'of', 'contrast', 'medium', 'led', 'to', 'reduction', 'in', 'incidence', 'of', 'cin', '.', 'investigation', ',', 'employing', 'larger', 'sample', 'size', ',', 'warranted', 'to', 'gain', 'comprehensive', 'understanding', 'of', 'efficacy', '.']"
Renal function during sevoflurane or total intravenous propofol anaesthesia: a single-centre parallel randomised controlled study.,"Stephanie Franzén, Egidijus Semenas, Micael Taavo, Johan Mårtensson, Anders Larsson, Robert Frithiof, Stephanie Franzénet al.",2022 May,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/35279277/,No keywords found,"['choice', 'of', 'anaesthetic', 'may', 'influence', 'regulation', 'of', 'renal', 'perfusion', 'and', 'function', '.', 'investigated', 'renal', 'function', 'in', 'patient', 'anaesthetised', 'with', 'propofol', 'or', 'sevoflurane', 'surgery', 'and', 'postoperatively', '.', 'method', 'patient', 'with', 'asa', 'physical', 'status', '-', 'planned', 'spinal', 'surgery', 'randomised', 'to', 'propofol', 'or', 'sevoflurane', 'anaesthesia', '.', 'blood', 'and', 'urine', 'collected', 'anaesthesia', ',', 'anaesthesia', '(', 'surgery', ')', ',', 'postoperative', 'care', ',', 'and', 'day', 'surgery', '.', 'result', 'twenty-seven', 'patient', 'completed', 'study', 'protocol', '(', 'average', 'age', ',', 'yr', 'average', 'bmi', ',', 'kg', 'm-', ')', 'and', 'woman', '.', 'urine', 'output', 'and', 'sodium', 'excretion', 'lower', 'sevoflurane', 'anaesthesia', '(', 'n', ')', 'propofol', 'anaesthesia', '(', 'n', ')', '(', '.', 'v', '.', 'ml', 'kg-', 'h-', 'p.', 'and', '.', 'v', '.', 'mmol', 'h-', 'p.', ',', 'respectively', ')', '.', 'urinary', 'potassium', 'excretion', 'lower', 'anaesthesia', ',', 'without', 'intergroup', 'difference', '(', '.', 'v', '.', 'mmol', 'h-', ',', 'p.', ')', '.', 'sevoflurane', 'anaesthesia', 'increased', 'plasma', 'renin', 'compared', 'with', 'baseline', '(', 'v', 'miu', 'l-', ',', 'p.', ')', 'and', 'propofol', 'anaesthesia', '(', 'v', 'miu', 'l-', ',', 'p.', ')', '.', 'plasma', 'arginine-vasopressin', 'not', 'change', 'significantly', 'anaesthesia', ',', 'elevated', 'postoperatively', 'compared', 'with', 'baseline', 'irrespective', 'of', 'anaesthetic', '(', 'v', 'ng', 'l-', ',', 'p.', ')', '.', 'sevoflurane', 'caused', 'higher', 'postoperative', 'plasma', 'creatinine', 'propofol', '(', 'v', 'mmol', 'l-', ',', 'p.', ')', '.', 'kidney', 'injury', 'molecule-', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'not', 'change', 'significantly', 'in', 'either', 'group', '.', 'conclusion', 'sevoflurane', 'anaesthesia', 'reduced', 'urine', 'output', 'and', 'sodium', 'excretion', 'and', 'increased', 'plasma', 'renin', 'compared', 'with', 'propofol', 'anaesthesia', '.', 'impact', 'of', 'acute', 'kidney', 'injury', 'and', 'fluid', 'resuscitation', 'surgery', 'warrant', 'investigation', '.', 'clinical', 'trial', 'registration', 'eudract', '--', 'clinicaltrials.gov', 'nct', '.']"
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.,"Stéphane Gaudry, François Grolleau, Saber Barbar, Laurent Martin-Lefevre, Bertrand Pons, Éric Boulet, Alexandre Boyer, Guillaume Chevrel, Florent Montini, Julien Bohe, Julio Badie, Jean-Philippe Rigaud, Christophe Vinsonneau, Raphaël Porcher, Jean-Pierre Quenot#, Didier Dreyfuss#, Stéphane Gaudryet al.",2022 Apr 4,Crit Care,https://pubmed.ncbi.nlm.nih.gov/35379300/,No keywords found,"['intermittent', 'hemodialysis', '(', 'ihd', ')', 'and', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'two', 'main', 'rrt', 'modality', 'in', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'meta-analyses', 'conducted', 'year', 'ago', 'not', 'show', 'survival', 'difference', 'two', 'modality', '.', 'quality', 'of', 'rrt', 'delivery', 'improved', 'since', ',', 'aimed', 'to', 'reassess', 'whether', 'choice', 'of', 'ihd', 'or', 'crrt', 'first', 'modality', 'affect', 'survival', 'of', 'patient', 'with', 'severe', 'aki', '.', 'method', 'secondary', 'analysis', 'of', 'two', 'multicenter', 'randomized', 'controlled', 'trial', '(', 'akiki', 'and', 'ideal-icu', ')', 'compared', 'early', 'rrt', 'initiation', 'strategy', 'with', 'delayed', 'one', '.', 'included', 'patient', 'allocated', 'to', 'early', 'strategy', 'in', 'order', 'to', 'emulate', 'trial', 'patient', 'would', 'randomized', 'to', 'receive', 'either', 'ihd', 'or', 'crrt', 'within', 'twelve', 'hour', 'documentation', 'of', 'severe', 'aki', '.', 'determined', 'patient', ""'s"", 'modality', 'group', 'first', 'rrt', 'modality', 'received', '.', 'primary', 'outcome', '-day', 'overall', 'survival', '.', 'used', 'two', 'propensity', 'score', 'method', 'to', 'balance', 'difference', 'in', 'baseline', 'characteristic', 'group', 'and', 'primary', 'analysis', 'relied', 'inverse', 'probability', 'of', 'treatment', 'weighting', '.', 'result', 'total', 'of', 'patient', 'included', '.', 'continuous', 'rrt', 'first', 'modality', 'in', 'patient', 'and', 'ihd', 'in', '.', 'patient', 'receiving', 'crrt', 'higher', 'cardiovascular', 'and', 'total-sofa', 'score', '.', 'inverse', 'probability', 'weighting', 'allowed', 'to', 'adequately', 'balance', 'group', 'predefined', 'confounders', '.', 'weighted', 'kaplan-meier', 'death', 'rate', 'day', 'in', 'crrt', 'group', 'and', 'in', 'ihd', 'group', '(', 'weighted', 'hr', ',', 'ci', '-', ')', '.', 'in', 'complementary', 'analysis', 'of', 'less', 'severely', 'ill', 'patient', '(', 'sofa', 'score', '-', ')', ',', 'receiving', 'ihd', 'associated', 'with', 'better', 'day', 'survival', 'compared', 'to', 'crrt', '(', 'weighted', 'hr', '.', ',', 'ci', '-', 'p', '.', ')', '.', 'found', 'no', 'evidence', 'of', 'survival', 'difference', 'two', 'rrt', 'modality', 'in', 'severe', 'patient', '.', 'conclusion', 'compared', 'to', 'ihd', ',', 'crrt', 'first', 'modality', 'seemed', 'to', 'convey', 'no', 'benefit', 'in', 'term', 'of', 'survival', 'or', 'of', 'kidney', 'recovery', 'and', 'might', 'even', 'associated', 'with', 'less', 'favorable', 'outcome', 'in', 'patient', 'with', 'lesser', 'severity', 'of', 'disease', '.', 'prospective', 'randomized', 'non-inferiority', 'trial', 'implemented', 'to', 'solve', 'persistent', 'conundrum', 'of', 'optimal', 'rrt', 'technique', '.']"
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.,"Megan Rossi, David W Johnson, Mark Morrison, Elaine M Pascoe, Jeff S Coombes, Josephine M Forbes, Cheuk-Chun Szeto, Brett C McWhinney, Jacobus P J Ungerer, Katrina L Campbell, Megan Rossiet al.",2016 Feb 5,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/26772193/,No keywords found,"['generation', 'of', 'key', 'uremic', 'nephrovascular', 'toxin', ',', 'indoxyl', 'sulfate', '(', ')', ',', 'and', 'p-cresyl', 'sulfate', '(', 'pc', ')', ',', 'attributed', 'to', 'dysbiotic', 'gut', 'microbiota', 'in', 'ckd', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'whether', 'synbiotic', '(', 'pre-', 'and', 'probiotic', ')', 'therapy', 'alters', 'gut', 'microbiota', 'and', 'reduces', 'serum', 'concentration', 'of', 'microbiome-generated', 'uremic', 'toxin', ',', 'and', 'pc', ',', 'in', 'patient', 'with', 'ckd', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'predialysis', 'adult', 'participant', 'with', 'ckd', '(', 'egfr-', 'mlmin', 'per', '.', '(', ')', ')', 'recruited', 'january', ',', 'and', 'november', ',', 'to', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', ',', 'crossover', 'trial', 'of', 'synbiotic', 'therapy', 'week', '(', '-week', 'washout', ')', '.', 'primary', 'outcome', 'serum', '.', 'secondary', 'outcome', 'included', 'serum', 'pc', ',', 'stool', 'microbiota', 'profile', ',', 'egfr', ',', 'proteinuria-albuminuria', ',', 'urinary', 'kidney', 'injury', 'molecule-', ',', 'serum', 'inflammatory', 'biomarkers', '(', 'il-', ',', 'il-', ',', 'il-', ',', 'and', 'tnf-', ')', ',', 'serum', 'oxidative', 'stress', 'biomarkers', '(', 'f-isoprostanes', 'and', 'glutathione', 'peroxidase', ')', ',', 'serum', 'lp', ',', 'patient-reported', 'health', ',', 'gastrointestinal', 'symptom', 'score', ',', 'and', 'dietary', 'intake', '.', 'prespecified', 'subgroup', 'analysis', 'explored', 'effect', 'of', 'antibiotic', 'use', 'treatment', 'effect', '.', 'result', 'of', 'individual', 'randomized', '(', 'age', 'year', 'old', 'men', 'egfr', 'mlmin', 'per', '.', '(', ')', ')', ',', 'completed', 'study', '.', 'synbiotic', 'therapy', 'not', 'significantly', 'reduce', 'serum', '(', '-', 'moll', 'confidence', 'interval', 'ci', ',', '-', 'to', 'moll', ')', 'significantly', 'reduce', 'serum', 'pc', '(', '-', 'moll', 'ci', ',', '-', 'to', '-', 'moll', ')', '.', 'decrease', 'in', 'pc', 'and', 'concentration', 'pronounced', 'in', 'patient', 'not', 'receive', 'antibiotic', 'study', '(', 'n', 'serum', 'pc', ',', '-', 'moll', 'ci', ',', '-', 'to', '-', 'moll', 'serum', ',', '-', 'moll', 'ci', ',', '-', 'to', '-', 'moll', ')', '.', 'synbiotics', 'also', 'altered', 'stool', 'microbiome', ',', 'particularly', 'with', 'enrichment', 'of', 'bifidobacterium', 'and', 'depletion', 'of', 'ruminococcaceae', '.', 'except', 'increase', 'in', 'albuminuria', 'of', 'mg', 'h', '(', 'p.', ')', 'in', 'synbiotic', 'arm', ',', 'no', 'change', 'observed', 'in', 'secondary', 'outcome', '.', 'conclusion', 'in', 'patient', 'with', 'ckd', ',', 'synbiotics', 'not', 'significantly', 'reduce', 'serum', 'decrease', 'serum', 'pc', 'and', 'favorably', 'modified', 'stool', 'microbiome', '.', 'large-scale', 'clinical', 'trial', 'justified', '.']"
Acute kidney injury after out of hospital pediatric cardiac arrest.,"Timothy T Cornell, David T Selewski, Jeffrey A Alten, David Askenazi, Julie C Fitzgerald, Alexis Topjian, Richard Holubkov, Kent Page, Beth S Slomine, James R Christensen, J Michael Dean, Frank W Moler, Timothy T Cornellet al.",2018 Oct:131:63-68.,Resuscitation,https://pubmed.ncbi.nlm.nih.gov/30075198/,No keywords found,"['many', 'child', 'with', 'return', 'of', 'spontaneous', 'circulation', '(', 'rosc', ')', 'following', 'cardiac', 'arrest', '(', 'ca', ')', 'experience', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'impact', 'of', 'therapeutic', 'hypothermia', 'epidemiology', 'of', 'post-ca', 'aki', 'in', 'child', 'not', 'fully', 'investigated', '.', 'objective', 'study', 'aim', 'to', ')', 'describe', 'prevalence', 'of', 'severe', 'aki', 'in', 'comatose', 'child', 'following', 'out-of-hospital', 'ca', '(', 'ohca', ')', ',', ')', 'identify', 'risk', 'factor', 'severe', 'aki', ',', ')', 'evaluate', 'impact', 'of', 'therapeutic', 'hypothermia', 'prevalence', 'of', 'severe', 'aki', ',', 'and', ')', 'evaluate', 'association', 'of', 'severe', 'aki', 'with', 'survival', 'and', 'functional', 'outcome', '.', 'design', 'post', 'hoc', 'secondary', 'analysis', 'of', 'data', 'therapeutic', 'hypothermia', 'pediatric', 'cardiac', 'arrest', 'out-of-hospital', '(', 'thapca-oh', ')', 'trial', '.', 'setting', 'thirty-six', 'pediatric', 'intensive', 'care', 'unit', 'in', 'united', 'state', 'and', 'canada', '.', 'participant', 'of', 'eligible', 'subject', 'with', 'initial', 'creatinine', 'obtained', 'within', 'h', 'of', 'randomization', ',', 'randomized', 'to', 'therapeutic', 'hypothermia', 'and', 'randomized', 'to', 'therapeutic', 'normothermia', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'prevalence', 'of', 'severe', 'aki', ',', 'defined', 'stage', 'and', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'consensus', 'definition', 'secondary', 'outcome', 'survival', 'with', 'favorable', 'neurobehavioral', 'outcome', '.', 'study', ',', 'risk', 'factor', 'and', 'outcome', 'compared', 'withwithout', 'severe', 'aki', '.', 'result', 'of', 'subject', 'enrolled', ',', '(', ')', 'developed', 'aki', 'of', '(', 'of', 'enrolled', ')', 'developed', 'severe', 'aki', '.', 'multivariable', 'modeling', 'found', 'younger', 'age', ',', 'longer', 'duration', 'of', 'chest', 'compression', ',', 'higher', 'lactate', 'level', 'time', 'of', 'temperature', 'intervention', 'and', 'higher', 'number', 'of', 'vasoactive', 'agent', 'day', 'of', 'intervention', 'associated', 'with', 'severe', 'aki', '.', 'no', 'difference', 'in', 'severe', 'aki', 'therapeutic', 'hypothermia', '(', '.', ')', 'and', 'therapeutic', 'normothermia', '(', '.', ')', 'group', '(', 'p', '.', ')', '.', 'survival', 'lower', 'in', 'with', 'severe', 'aki', 'day', '(', 'v', 'no', 'severe', 'aki', ',', 'p', '.', ')', 'and', 'month', '(', 'v', 'no', 'severe', 'aki', ',', 'p', '.', ')', '.', 'one', 'year', 'survival', 'with', 'favorable', 'functional', 'outcome', 'lower', 'in', 'with', 'severe', 'aki', '.', 'conclusion', 'and', 'relevance', 'severe', 'aki', 'occurs', 'frequently', 'in', 'child', 'with', 'rosc', 'ohca', ',', 'especially', 'in', 'younger', 'child', 'and', 'with', 'higher', 'initial', 'lactate', 'and', 'hemodynamic', 'support', '.', 'severe', 'aki', 'associated', 'with', 'worse', 'survival', 'and', 'functional', 'outcome', '.', 'therapeutic', 'hypothermia', 'not', 'reduce', 'incidence', 'of', 'severe', 'aki', '.']"
Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis.,"Jin Seok Kim, June-Won Cheong, Yeung-Chul Mun, Jun Ho Jang, Deog-Yeon Jo, Jong Wook Lee                              ;, Aplastic Anemia Working Party of the Korean Society of Hematology, Jin Seok Kimet al.",2019 Oct,Ann Hematol,https://pubmed.ncbi.nlm.nih.gov/31256219/,"Mortality, Paroxysmal nocturnal hemoglobinuria, Renal dysfunction, Thromboembolism.","['although', 'renal', 'dysfunction', 'time', 'of', 'diagnosis', 'of', 'paroxysmal', 'nocturnal', 'hemoglobinuria', '(', 'pnh', ')', 'risk', 'factor', 'mortality', ',', 'subsequent', 'renal', 'event', 'occur', '.', 'objective', 'of', 'study', 'to', 'identify', 'clinical', 'implication', 'of', 'renal', 'dysfunction', 'occurring', 'disease', 'course', 'in', 'pnh', 'patient', '.', 'one', 'hundred', 'one', 'patient', 'with', 'granulocyte', 'clone', 'size', 'of', 'enrolled', '.', 'renal', 'event', 'observed', 'in', '(', '.', ')', 'patient', 'median', 'follow-up', 'of', '.', 'month', '.', 'median', 'time', 'to', 'first', 'renal', 'event', 'diagnosis', 'of', 'pnh', '.', 'month', '.', 'thromboembolism', '(', 'te', ')', 'event', 'and', 'recurrent', 'te', 'event', 'observed', 'in', '(', '.', ')', 'and', '(', '.', ')', 'patient', ',', 'respectively', '.', 'rate', 'of', 'recurrent', 'te', 'significantly', 'higher', 'in', 'patient', 'with', 'renal', 'event', 'compared', 'with', 'in', 'patient', 'with', 'renal', 'event', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'rate', 'of', 'recurrent', 'te', 'significantly', 'higher', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'acute', 'kidney', 'disease', '(', 'akd', ')', 'compared', 'with', 'rest', 'of', 'patient', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'ckdakd', 'independent', 'risk', 'factor', 'o', 'in', 'multivariate', 'analysis', '(', 'hazard', 'ratio', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'therefore', ',', 'close', 'monitoring', 'of', 'renal', 'event', 'in', 'pnh', 'patient', 'entire', 'clinical', 'course', 'essential', '.']"
Ultrasound dynamic monitoring of IVCD to guide application of CRRT in patients with renal failure combined with acute heart failure.,"Guang Yu, Shaoyu Tao, Yingzhi Jin, Wanxia Li, Zanqun Hu, Xiaowei Fang, Guang Yuet al.",2022 Aug 18,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/35982101/,No keywords found,"['explored', 'application', 'value', 'of', 'bedside', 'ultrasound', 'dynamic', 'monitoring', 'of', 'inferior', 'vena', 'cava', 'diameter', '(', 'ivcd', ')', 'and', 'collapse', 'with', 'sniff', '(', 'inferior', 'vena', 'cava', 'collapsibility', 'index', 'ivcci', ')', 'to', 'guide', 'dehydration', 'adjustment', 'in', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'in', 'patient', 'with', 'combined', 'renal', 'failure', 'and', 'acute', 'heart', 'failure', '.', 'selected', 'patient', 'with', 'combined', 'renal', 'and', 'acute', 'heart', 'failure', 'required', 'crrt', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'january', 'to', 'june', '.', 'according', 'to', 'different', 'blood', 'volume', 'assessment', 'method', ',', 'patient', 'randomly', 'divided', 'ultrasound', ',', 'experience', ',', 'and', 'control', 'group', '.', 'compared', 'serum', 'creatinine', ',', 'potassium', ',', 'and', 'n-terminal', 'pro-brain', 'natriuretic', 'peptide', '(', 'nt-probnp', ')', 'level', 'time', 'to', 'improved', 'heart', 'failure', 'symptom', 'crrt', 'time', 'ventilator', 'use', 'icu', 'length', 'of', 'stay', 'vasopressor', 'use', 'and', 'incidence', 'of', 'adverse', 'event', 'among', 'group', '.', 'no', 'significant', 'difference', 'in', 'serum', 'creatinine', ',', 'potassium', ',', 'and', 'nt-probnp', 'level', 'in', 'pairwise', 'comparison', 'among', 'group', 'and', 'crrt', '(', 'p', '.', ')', '.', 'time', 'to', 'improved', 'heart', 'failure', 'symptom', ',', 'crrt', 'time', ',', 'and', 'icu', 'length', 'of', 'stay', 'in', 'ultrasound', 'and', 'experience', 'group', 'lower', 'in', 'control', 'group', 'difference', 'statistically', 'significant', '(', 'p', '.', ')', '.', 'ventilator', 'use', 'duration', 'lower', 'in', 'ultrasound', 'and', 'experience', 'group', 'compared', 'with', 'control', 'group', ',', 'with', 'statistically', 'significant', 'difference', 'ultrasound', 'and', 'control', 'group', '(', 'p', '.', ')', '.', 'duration', 'of', 'vasopressor', 'use', 'in', 'ultrasound', 'and', 'control', 'group', 'lower', 'in', 'experience', 'group', 'difference', 'statistically', 'significant', '(', 'p', '.', ')', '.', 'incidence', 'of', 'adverse', 'event', 'lower', 'in', 'ultrasound', 'group', 'compared', 'with', 'experience', 'and', 'control', 'group', 'difference', 'statistically', 'significant', '(', 'p', '.', ')', '.', 'ultrasound', 'dynamic', 'monitoring', 'of', 'ivcd', 'and', 'collapse', 'with', 'sniff', 'accurately', 'assess', 'blood', 'volume', 'status', ',', 'and', 'provide', 'guidance', 'dehydration', 'adjustment', 'in', 'crrt', 'and', 'rapid', 'relief', 'of', 'heart', 'failure', 'symptom', 'in', 'patient', 'with', 'combined', 'renal', 'and', 'acute', 'heart', 'failure', '.']"
Relationship between Stroke Volume Variation and Blood Transfusion during Liver Transplantation.,"Jae Moon Choi, Yoon Kyung Lee, Hwanhee Yoo, Sukyung Lee, Hee Yeong Kim, Young-Kug Kim, Jae Moon Choiet al.",2016 Feb 20,Int J Med Sci,https://pubmed.ncbi.nlm.nih.gov/26941584/,No keywords found,"['intraoperative', 'blood', 'transfusion', 'increase', 'risk', 'perioperative', 'mortality', 'and', 'morbidity', 'in', 'liver', 'transplant', 'recipient', '.', 'high', 'stroke', 'volume', 'variation', '(', 'svv', ')', 'method', 'proposed', 'to', 'reduce', 'blood', 'loss', 'living', 'donor', 'hepatectomy', '.', 'herein', ',', 'investigated', 'whether', 'maintaining', 'high', 'svv', 'could', 'reduce', 'need', 'blood', 'transfusion', 'and', 'also', 'evaluated', 'effect', 'of', 'high', 'svv', 'method', 'postoperative', 'outcome', 'in', 'liver', 'transplant', 'recipient', '.', 'method', 'retrospectively', 'analyzed', 'patient', 'underwent', 'liver', 'transplantation', ',', 'divided', 'control', '(', 'maintaining', 'of', 'svv', 'surgery', ')', 'and', 'high', 'svv', '(', 'maintaining', '-', 'of', 'svv', 'surgery', ')', 'group', '.', 'evaluated', 'blood', 'transfusion', 'requirement', 'and', 'hemodynamic', 'parameter', ',', 'including', 'svv', ',', 'well', 'postoperative', 'outcome', ',', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'duration', 'of', 'postoperative', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', ',', 'and', 'rate', 'of', '-year', 'mortality', '.', 'result', 'mean', 'svv', 'value', '.', '.', 'in', 'control', 'group', '(', 'n', ')', 'and', '.', '.', 'in', 'high', 'svv', 'group', '(', 'n', ')', '.', 'median', 'number', 'of', 'transfused', 'packed', 'red', 'blood', 'cell', 'and', 'fresh', 'frozen', 'plasma', 'in', 'high', 'svv', 'group', 'significantly', 'lower', 'in', 'control', 'group', '(', 'vs.', 'unit', ',', 'p', '.', 'and', 'vs.', 'unit', ',', 'p', '.', ',', 'respectively', ')', '.', 'no', 'significant', 'between-group', 'difference', 'observed', 'postoperative', 'outcome', '.', 'conclusion', 'maintaining', 'high', 'svv', 'reduce', 'blood', 'transfusion', 'requirement', 'liver', 'transplantation', 'without', 'worsening', 'postoperative', 'outcome', '.', 'finding', 'provide', 'insight', 'improving', 'perioperative', 'management', 'in', 'liver', 'transplant', 'recipient', '.']"
"A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.","James A Tumlin, Claude M Galphin, Ashita J Tolwani, Micah R Chan, Anitha Vijayan, Kevin Finkel, Balazs Szamosfalvi, Devasmita Dev, J Ricardo DaSilva, Brad C Astor, Alexander S Yevzlin, H David Humes                              ;, SCD Investigator Group, Luis Juncos, Sevag Demirjian, Jorge Cerda, Ravindra Mehta, Jiuming Ye, Winfred Williams Jr, Cybele Ghossein, Bartley Griffith, Edward Ross, Ashwani Gupta, Anna Vinnikova, Robert Brown, Juan Carlos Velez, James A Tumlinet al.",2015 Aug 5,PLoS One,https://pubmed.ncbi.nlm.nih.gov/26244978/,No keywords found,"['acute', 'kidney', 'injury', '(', 'aki', ')', 'highly', 'morbid', 'condition', 'in', 'critically', 'ill', 'patient', 'associated', 'with', 'high', 'mortality', '.', 'previous', 'clinical', 'study', 'demonstrated', 'safety', 'and', 'efficacy', 'of', 'selective', 'cytopheretic', 'device', '(', 'scd', ')', 'in', 'treatment', 'of', 'aki', 'requiring', 'continuous', 'renal', 'replacement', 'therapy', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'design', ',', 'setting', ',', 'patient', 'randomized', ',', 'controlled', 'trial', 'of', 'icu', 'patient', 'with', 'aki', ',', 'received', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'alone', 'and', 'received', 'scd', 'therapy', '.', 'result', 'no', 'significant', 'difference', 'in', '-day', 'mortality', 'observed', 'treated', '(', ')', 'and', 'control', 'patient', '(', ',', 'with', 'six', 'patient', 'lost', 'to', 'follow', ')', 'in', 'intention', 'to', 'treat', '(', 'itt', ')', 'analysis', '.', 'of', 'scd', 'subject', '(', 'crrtscd', ')', 'and', 'control', 'subject', '(', 'crrt', 'alone', ')', 'maintained', 'post-filter', 'ionized', 'calcium', '(', 'ica', ')', 'level', 'in', 'protocol', ""'s"", 'recommended', 'range', '(', '.', 'mmoll', ')', 'greater', 'or', 'equal', 'to', 'of', 'therapy', 'time', ',', '-day', 'mortality', '(', ')', 'in', 'scd', 'group', 'compared', 'to', '(', ')', 'in', 'crrt', 'alone', 'group', '(', 'p', '.', ')', '.', 'dialysis', 'dependency', 'showed', 'borderline', 'statistically', 'significant', 'difference', 'scd', 'treated', 'versus', 'control', 'crrt', 'alone', 'patient', 'maintained', 'of', 'treatment', 'in', 'protocol', ""'s"", 'recommended', '(', 'r', ')', 'ica', 'target', 'range', 'of', '.', 'mmoll', 'with', 'value', 'of', ',', '(', ')', 'and', '(', ')', ',', 'respectively', '(', 'p', '.', ')', '.', 'rica', 'treated', 'and', 'control', 'subgroup', 'compared', 'composite', 'index', 'of', 'day', 'mortality', 'and', 'dialysis', 'dependency', ',', 'percentage', 'of', 'scd', 'treated', 'subject', 'versus', 'in', 'control', 'subject', '(', 'p.', ')', '.', 'incidence', 'of', 'serious', 'adverse', 'event', 'not', 'differ', 'treated', '(', ')', 'and', 'control', 'group', '(', 'p', ')', '.', 'conclusion', 'scd', 'therapy', 'may', 'improve', 'mortality', 'and', 'reduce', 'dialysis', 'dependency', 'in', 'tightly', 'controlled', 'regional', 'hypocalcaemic', 'environment', 'in', 'perfusion', 'circuit', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', 'httpclinicaltrials.govctshownct', '.']"
Applying bio-impedance vector analysis (BIVA) to adjust ultrafiltration rate in critically ill patients on continuous renal replacement therapy: A randomized controlled trial.,"Farin Rashid Farokhi, Effat Kalateh, Shadi Shafaghi, Antoine Guillaume Schneider, Seyed Mehdi Mortazavi, Hamidreza Jamaati, Seyed Mohammad Reza Hashemian, Farin Rashid Farokhiet al.",2022 Dec:72:154146.,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/36116287/,No keywords found,"['bioimpedance', 'vector', 'analysis', '(', 'biva', ')', 'suggested', 'valuable', 'tool', 'in', 'assessing', 'volume', 'status', 'in', 'critically', 'ill', 'patient', '.', 'however', ',', 'effectiveness', 'in', 'guiding', 'fluid', 'removal', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'not', 'evaluated', '.', 'method', 'in', 'randomized', 'controlled', 'trial', ',', 'critically', 'ill', 'patient', 'receiving', 'crrt', 'allocated', 'ratio', 'to', 'uf', 'prescribed', 'and', 'adjusted', 'using', 'biva', 'fluid', 'assessment', 'in', 'intervention', 'group', '(', 'patient', ')', 'or', 'conventional', 'clinical', 'parameter', '(', 'patient', ')', '.', 'primary', 'outcome', 'lean', 'body', 'mass', '(', 'lbm', ')', 'water', 'content', 'crrt', 'discontinuation', ',', 'and', 'secondary', 'outcome', 'included', 'mortality', 'rate', ',', 'urinary', 'output', ',', 'duration', 'of', 'ventilation', 'support', ',', 'and', 'icu', 'stay', '.', 'result', 'study', 'group', 'associated', 'with', 'lower', 'water', 'content', 'of', 'lbm', '(', '.', '.', 'vs.', '.', '.', 'p', '.', ')', ',', 'and', 'higher', 'mean', 'uf-rate', 'and', 'urinary', 'output', '(', '.', '.', 'vs.', '.', '.', 'mlkgh', 'and', '.', '.', 'v', '.', '.', 'mlkgh', ',', 'p', '.', ')', '.', 'mortality', 'rate', ',', 'length', 'of', 'icu', 'stay', ',', 'and', 'ventilation', 'support', 'duration', 'similar', '.', 'conclusion', 'biva', 'guided', 'uf', 'prescription', 'may', 'associated', 'with', 'lower', 'rate', 'of', 'fluid', 'overload', '.', 'larger', 'study', 'required', 'to', 'evaluate', 'impact', 'patient', ""'"", 'outcome', '.']"
Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial.,"Lorenz Weidhase, Jonathan de Fallois, Elena Haußig, Thorsten Kaiser, Meinhard Mende, Sirak Petros, Lorenz Weidhaseet al.",2020 Nov 11,Crit Care,https://pubmed.ncbi.nlm.nih.gov/33176824/,No keywords found,"['myoglobin', 'clearance', 'in', 'acute', 'kidney', 'injury', 'requiring', 'renal', 'replacement', 'therapy', 'important', 'myoglobin', 'direct', 'renal', 'toxic', 'effect', '.', 'clinical', 'data', 'comparing', 'different', 'modality', 'of', 'renal', 'replacement', 'therapy', 'addressing', 'myoglobin', 'clearance', 'limited', '.', 'study', 'aimed', 'to', 'compare', 'two', 'renal', 'replacement', 'modality', 'regarding', 'myoglobin', 'clearance', '.', 'method', 'in', 'prospective', ',', 'randomized', ',', 'single-blinded', ',', 'single-center', 'trial', ',', 'critically', 'ill', 'patient', 'requiring', 'renal', 'replacement', 'therapy', 'randomized', 'intervention', 'arm', 'using', 'continuous', 'veno-venous', 'hemodialysis', 'with', 'high', 'cutoff', 'dialyzer', 'and', 'control', 'arm', 'using', 'continuous', 'veno-venous', 'hemodiafiltration', 'postdilution', 'with', 'high-flux', 'dialyzer', '.', 'regional', 'citrate', 'anticoagulation', 'used', 'in', 'group', 'to', 'maintain', 'extracorporeal', 'circuit', '.', 'concentration', 'of', 'myoglobin', ',', 'urea', ',', 'creatinine', ',', '-microglobulin', ',', 'interleukin-', 'and', 'albumin', 'measured', 'and', 'dialyzer', 'h', ',', 'h', ',', 'h', ',', 'h', 'and', 'h', 'initiating', 'continuous', 'renal', 'replacement', 'therapy', '.', 'result', 'thirty-three', 'patient', 'allocated', 'to', 'control', 'arm', '(', 'cvvhdf', 'with', 'high-flux', 'dialyzer', ')', 'and', 'patient', 'to', 'intervention', 'arm', '(', 'cvvhd', 'with', 'high', 'cutoff', 'dialyzer', ')', '.', 'myoglobin', 'clearance', ',', 'primary', 'endpoint', ',', 'significantly', 'better', 'in', 'intervention', 'arm', 'in', 'control', 'arm', 'throughout', 'whole', 'study', 'period', '.', 'clearance', 'value', 'urea', 'and', 'creatinine', 'higher', 'in', 'control', 'arm', '.', 'no', 'measurable', 'albumin', 'clearance', 'in', 'arm', '.', 'clearance', 'data', '-microglobulin', 'and', 'interleukin-', 'non-inferior', 'in', 'intervention', 'arm', 'compared', 'to', 'control', 'arm', '.', 'dialyzer', 'lifespan', '.', '.', ',', '.', 'hour', 'in', 'control', 'arm', 'and', '.', '.', ',', '.', 'hour', 'in', 'intervention', 'arm', '(', 'p', '.', ')', '.', 'conclusion', 'myoglobin', 'clearance', 'using', 'continuous', 'veno-venous', 'hemodialysis', 'with', 'high', 'cutoff', 'dialyzer', 'and', 'regional', 'citrate', 'anticoagulation', 'better', 'with', 'continuous', 'veno-venous', 'hemodiafiltration', 'with', 'regional', 'citrate', 'anticoagulation', '.', 'trial', 'registration', 'german', 'clinical', 'trial', 'registry', '(', 'drks', ')', 'date', 'of', 'registration', '.', 'httpswww.drks.dedrkswebnavigate.donavigationidtrial.htmltrialiddrks', '.']"
A randomised controlled trial of dexmedetomidine for delirium in adults undergoing heart valve surgery.,"H-B Wang, Y Jia, C-B Zhang, L Zhang, Y-N Li, J Ding, X Wu, Z Zhang, J-H Wang, Y Wang, F-X Yan, S Yuan, D I Sessler, H-B Wanget al.",2023 May,Anaesthesia,https://pubmed.ncbi.nlm.nih.gov/36794600/,"acute kidney injury, anaesthesia, cardiac surgery, cardiopulmonary bypass, dexmedetomidine, postoperative delirium.","['dexmedetomidine', 'vs.', 'placebo', ',', 'p', '.', ',', 'adjusted', 'relative', 'risk', '(', 'ci', ')', '.', '(', '.-', '.', ')', ',', 'p', '..', 'postoperative', 'renal', 'impairment', '(', 'kidney', 'disease', 'improving', 'global', 'outcome', 'stage', ',', 'and', ')', 'detected', 'in', ',', 'and', 'participant', 'dexmedetomidine', 'and', ',', 'and', 'control', 'participant', ',', 'p', '..', 'intra-operative', 'dexmedetomidine', 'infusion', 'not', 'reduce', 'incidence', 'of', 'delirium', 'cardiac', 'valve', 'surgery', 'might', 'impair', 'renal', 'function', '.']"
The Effects of Targeted Changes in Systemic Blood Flow and Mean Arterial Pressure on Urine Oximetry During Cardiopulmonary Bypass.,"Raymond Hu, Fumitaka Yanase, Peter McCall, Roger Evans, Jaishankar Raman, Rinaldo Bellomo, Raymond Huet al.",2022 Sep,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/35718621/,No keywords found,"['poor', 'medullary', 'oxygenation', 'implicated', 'in', 'evolution', 'of', 'acute', 'kidney', 'injury', '.', 'author', 'sought', 'to', 'determine', 'increasing', 'systemic', 'flow', 'and', 'mean', 'arterial', 'pressure', 'could', 'improve', 'urine', 'oxygen', 'tension', '(', 'puo', ')', 'measured', 'in', 'bladder', ',', 'surrogate', 'of', 'kidney', 'medullary', 'oxygenation', ',', 'in', 'patient', 'undergoing', 'on-pump', 'cardiac', 'surgery', '.', 'design', 'randomized', 'crossover', 'study', '.', 'setting', 'university-affiliated', 'hospital', '.', 'participant', 'twenty', 'adult', 'patient', 'undergoing', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'with', 'expected', 'cross-clamp', 'time', 'of', 'minute', 'and', 'estimated', 'glomerular', 'filtration', 'rate', 'of', 'mlmin.m', '.', 'intervention', 'sequential', '-minute', 'period', 'of', 'intervention', 'intervention', 'h', '(', '``', 'high', ""''"", ')', 'or', 'intervention', 'n', '(', '``', 'normal', ""''"", ')', '.', 'order', 'of', 'intervention', 'determined', 'randomization', '.', 'intervention', 'h', 'targeted', 'cpb', 'flow', '.', 'lminm', 'and', 'mean', 'arterial', 'pressure', '(', 'map', ')', 'mmhg', '.', 'intervention', 'n', 'targeted', 'cpb', 'flow', '.', 'lminm', 'and', 'map', 'mmhg', '.', 'measurement', 'and', 'main', 'result', 'puo', 'measured', 'oxygen', 'sensor', 'introduced', 'bladder', 'via', 'urinary', 'catheter', '.', 'clear', 'separation', 'achieved', 'in', 'cpb', 'flow', 'and', 'map', 'intervention', 'period', '(', 'p', '.', 'group-time', 'interaction', ')', '.', 'puo', 'intervention', 'h', 'higher', 'intervention', 'n', '(', 'p', '.', 'group-time', 'interaction', ')', '.', 'minute', ',', 'puo', 'statistically', 'higher', 'in', 'intervention', 'h', 'time', 'point', '.', 'no', 'difference', 'in', 'marker', 'of', 'hemolysis', 'intervention', '.', 'conclusion', 'puo', 'higher', 'systemic', 'flow', 'and', 'map', 'increased', 'cpb', '.', 'finding', 'suggest', 'puo', 'responsive', 'to', 'change', 'in', 'hemodynamics', 'and', 'higher', 'flow', 'and', 'pressure', 'may', 'improve', 'medullary', 'oxygenation', '.']"
Intraoperative hemodynamics and risk of cardiac surgery-associated acute kidney injury: An observation study and a feasibility clinical trial.,"Khin M Noe, Andrea Don, Andrew D Cochrane, Michael Z L Zhu, Jennifer P Ngo, Julian A Smith, Amanda G Thrift, Johnny Vogiatjis, Andrew Martin, Rinaldo Bellomo, James McMillan, Roger G Evans, Khin M Noeet al.",2023 Nov,Clin Exp Pharmacol Physiol,https://pubmed.ncbi.nlm.nih.gov/37549882/,"arterial pressure, cardiopulmonary bypass, clinical perfusion, pump flow, systemic oxygen delivery.","['targeting', 'greater', 'pump', 'flow', 'and', 'mean', 'arterial', 'pressure', '(', 'map', ')', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'could', 'potentially', 'alleviate', 'renal', 'hypoxia', 'and', 'reduce', 'risk', 'of', 'postoperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'therefore', ',', 'in', 'observational', 'study', 'of', 'patient', 'undergoing', 'on-pump', 'cardiac', 'surgery', ',', 'tested', 'whether', 'intraoperative', 'hemodynamic', 'management', 'differed', 'patient', 'and', 'not', 'develop', 'aki', '.', ',', 'in', 'patient', ',', 'assessed', 'feasibility', 'of', 'larger-scale', 'trial', 'in', 'patient', 'would', 'randomized', 'to', 'greater', 'normal', 'target', 'pump', 'flow', 'and', 'map', ',', 'or', 'usual', 'care', ',', 'cpb', '.', 'in', 'observational', 'cohort', ',', 'map', 'hypothermic', 'cpb', 'averaged', '.', '.', 'mmhg', '(', 'mean', 'sd', ')', 'in', 'patient', 'developed', 'aki', 'and', '.', '.', 'mmhg', 'in', 'patient', 'not', '(', 'p', '.', ')', '.', 'pump', 'flow', 'averaged', '.', '.', 'lminm', 'in', 'group', '.', 'in', 'feasibility', 'clinical', 'trial', ',', 'compared', 'with', 'usual', 'care', ',', 'randomized', 'to', 'increased', 'target', 'pump', 'flow', 'and', 'map', 'greater', 'mean', 'pump', 'flow', '(', '.', '.', 'vs.', '.', '.', 'lminm', 'period', 'rewarming', ')', 'and', 'systemic', 'oxygen', 'delivery', '(', 'vs.', 'mlminm', ')', '.', 'target', 'map', 'mmhg', 'achieved', 'in', '.', 'of', 'patient', 'in', 'intervention', 'group', 'in', '.', 'of', 'patient', 'in', 'usual', 'care', 'group', '.', 'nevertheless', ',', 'map', 'cpb', 'not', 'differ', 'significantly', 'two', 'group', '.', 'conclude', 'little', 'insight', 'gained', 'observational', 'study', 'regarding', 'impact', 'of', 'variation', 'in', 'pump', 'flow', 'and', 'map', 'risk', 'of', 'aki', '.', 'however', ',', 'clinical', 'trial', 'to', 'assess', 'effect', 'of', 'greater', 'target', 'pump', 'flow', 'and', 'map', 'risk', 'of', 'aki', 'appears', 'feasible', '.']"
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.,"Nicolas Marincek, Piotr Radojewski, Rebecca A Dumont, Philippe Brunner, Jan Müller-Brand, Helmut R Maecke, Matthias Briel, Martin A Walter, Nicolas Marinceket al.",2015 Feb,J Nucl Med,https://pubmed.ncbi.nlm.nih.gov/25593116/,No keywords found,"['patient', 'with', 'progressive', 'unresectable', 'meningioma', 'treated', 'with', '(', ')', 'y-dotatoc', 'and', '(', ')', 'lu-dotatoc', 'tumor', 'progression', 'or', 'permanent', 'toxicity', 'occurred', '.', 'multivariable', 'cox', 'regression', 'analysis', 'used', 'to', 'study', 'predictor', 'of', 'survival', '.', 'result', 'overall', ',', 'treatment', 'cycle', 'performed', 'patient', '.', 'stable', 'disease', 'achieved', 'in', 'patient', '.', 'severe', 'hematotoxicity', 'occurred', 'in', 'patient', ',', 'and', 'severe', 'renal', 'toxicity', 'in', 'patient', '.', 'mean', 'survival', '.', 'time', 'of', 'recruitment', '.', 'stable', 'disease', 'treatment', '(', 'hazard', 'ratio', ',', '.', 'vs.', 'progressive', 'disease', 'confidence', 'interval', ',', '.-', '.', 'n', 'p', '.', ')', 'and', 'high', 'tumor', 'uptake', '(', 'hazard', 'ratio', ',', '.', 'vs.', 'intermediate', 'or', 'low', 'tumor', 'uptake', 'confidence', 'interval', ',', '.-', '.', 'n', 'p', '.', ')', 'associated', 'with', 'longer', 'survival', '.', 'conclusion', '(', ')', 'y-dotatoc', 'and', '(', ')', 'lu-dotatoc', 'promising', 'tool', 'treating', 'progressive', 'unresectable', 'meningioma', ',', 'especially', 'in', 'case', 'of', 'high', 'tracer', 'uptake', 'in', 'tumor', '.']"
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial.,"Hiddo J L Heerspink, Remo H M Furtado, Otavio Berwanger, Gary G Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Samvel B Gasparyan, Fengming Tang, Sheryl L Windsor, Vicente Cés de Souza-Dantas, Mildren Del Sueldo, Robert Frankel, Ali Javaheri, Rafael A Maldonado, Caryn Morse, Marco Mota-Gomes, Douglas Shemin, Osvaldo Lourenço Silva Jr, Alexandre Pereira Tognon, Marcel Twahirwa, Joan Buenconsejo, Russell Esterline, Jan Oscarsson, Philip Ambery, Anna Maria Langkilde, Mikhail N Kosiborod, Hiddo J L Heerspinket al.",2022 May,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/35483733/,No keywords found,"['patient', 'hospitalized', 'with', 'coronavirus', 'disease', '(', 'covid-', ')', 'infection', 'high', 'risk', 'of', 'aki', 'and', 'krt', ',', 'especially', 'in', 'presence', 'of', 'ckd', '.', 'dapagliflozin', 'in', 'respiratory', 'failure', 'in', 'patient', 'with', 'covid-', '(', 'dare-', ')', 'trial', 'showed', 'in', 'patient', 'hospitalized', 'with', 'covid-', ',', 'treatment', 'with', 'dapagliflozin', 'versus', 'placebo', 'resulted', 'in', 'numerically', 'fewer', 'participant', 'experienced', 'organ', 'failure', 'or', 'death', ',', 'although', 'difference', 'not', 'statistically', 'significant', '.', 'performed', 'secondary', 'analysis', 'of', 'dare-', 'trial', 'to', 'determine', 'efficacy', 'and', 'safety', 'of', 'dapagliflozin', 'kidney', 'outcome', 'in', 'overall', 'population', 'and', 'in', 'prespecified', 'subgroup', 'of', 'participant', 'defined', 'baseline', 'egfr', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'dare-', 'trial', 'randomized', 'patient', 'hospitalized', '(', 'egfr', 'mlmin', 'per', '.', ')', 'with', 'covid-', 'and', 'cardiometabolic', 'risk', 'factor', 'to', 'dapagliflozin', 'or', 'placebo', '.', 'dual', 'primary', 'outcome', '(', 'time', 'to', 'new', 'or', 'worsened', 'organ', 'dysfunction', 'or', 'death', ',', 'and', 'hierarchical', 'composite', 'end', 'point', 'of', 'recovery', 'change', 'in', 'clinical', 'status', 'day', ')', ',', 'and', 'key', 'secondary', 'kidney', 'outcome', '(', 'composite', 'of', 'aki', ',', 'krt', ',', 'or', 'death', ')', ',', 'and', 'safety', 'assessed', 'in', 'participant', 'with', 'baseline', 'egfr', 'and', 'mlmin', 'per', '.', 'm.', 'result', 'effect', 'of', 'dapagliflozin', 'versus', 'placebo', 'primary', 'prevention', 'outcome', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', ',', 'primary', 'recovery', 'outcome', '(', 'win', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', ',', 'and', 'composite', 'kidney', 'outcome', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', 'consistent', 'across', 'egfr', 'subgroup', '(', 'p', 'interaction', '.', ',', '.', ',', 'and', '.', ',', 'respectively', ')', '.', 'effect', 'of', 'dapagliflozin', 'aki', 'also', 'similar', 'in', 'participant', 'with', 'egfr', 'mlmin', 'per', '.', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', 'and', 'mlmin', 'per', '.', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', '.', 'dapagliflozin', 'well', 'tolerated', 'in', 'participant', 'with', 'egfr', 'and', 'mlmin', 'per', '.', 'm.', 'conclusion', 'effect', 'of', 'dapagliflozin', 'primary', 'and', 'secondary', 'outcome', 'in', 'hospitalized', 'participant', 'with', 'covid-', 'consistent', 'in', 'with', 'egfr', 'belowabove', 'mlmin', 'per', '.', 'm.', 'dapagliflozin', 'well', 'tolerated', 'and', 'not', 'increase', 'risk', 'of', 'aki', 'in', 'participant', 'with', 'egfr', 'or', 'mlmin', 'per', '.', '.']"
"Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates.","David J Askenazi, Brian A Halloran, Patrick J Heagerty, Robert H Schmicker, Patrick Brophy, Sandra E Juul, Sangeeta Hingorani, Stuart L Goldstein                              ;, PENUT Trial Consortium, Bryan A Comstock, Rajan Wadhawan, Dennis E Mayock, Sherry E Courtney, Tonya Robinson, Kaashif A Ahmad, Ellen Bendel-Stenzel, Mariana Baserga, Edmund F LaGamma, L Corbin Downey, Raghavendra Rao, Nancy Fahim, Andrea Lampland, Ivan D Frantz rd, Janine Y Khan, Michael Weiss, Maureen M Gilmore, Robin Ohls, Nishant Srinivasan, Jorge E Perez, Victor McKay, Phuong T Vu, David J Askenaziet al.",2022 Jul,Pediatr Res,https://pubmed.ncbi.nlm.nih.gov/34845352/,No keywords found,"['understanding', 'of', 'normative', 'concentration', 'of', 'urine', 'biomarkers', 'in', 'premature', 'neonate', 'limited', '.', 'method', 'evaluated', 'urine', 'extremely', 'low', 'gestational', 'age', '(', 'ga', ')', 'neonate', 'without', 'severe', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'to', 'determine', 'ga', 'affect', 'ten', 'different', 'urine', 'biomarkers', 'birth', 'and', 'first', 'postnatal', 'day', '.', ',', 'investigated', 'urine', 'biomarkers', 'changed', 'time', ',', ',', 'and', 'week', 'postmenstrual', 'age', '(', 'pma', ')', '.', 'next', ',', 'evaluated', 'impact', 'of', 'sex', 'urine', 'biomarker', 'concentration', 'birth', 'and', 'time', '.', 'finally', ',', 'evaluated', 'urine', 'biomarkers', 'impacted', 'treatment', 'with', 'erythropoietin', '(', 'epo', ')', '.', 'result', 'found', 'ten', 'biomarker', 'concentration', 'differ', 'birth', 'ga', 'and', 'urine', 'biomarker', 'concentration', 'increase', ',', 'others', 'decrease', 'time', '.', 'week', 'pma', ',', 'urine', 'biomarkers', 'differed', 'ga.', 'week', 'pma', ',', 'differed', ',', 'and', 'week', 'pma', ',', 'osteopontin', 'differed', 'ga.', 'half', 'of', 'biomarker', 'concentration', 'differed', 'sex', ',', 'and', 'showed', 'different', 'rate', 'of', 'change', 'time', 'male', 'vs.', 'female', '.', 'found', 'no', 'difference', 'in', 'urine', 'biomarkers', 'treatment', 'group', '.', 'conclusion', 'temporal', 'pattern', ',', 'ga', ',', 'and', 'sex', 'difference', 'need', 'to', 'considered', 'in', 'urine', 'aki', 'biomarker', 'analysis', '.', 'impact', 'urine', 'biomarker', 'concentration', 'differ', 'ga', 'birth', '.', 'urine', 'biomarkers', 'increase', ',', 'others', 'decrease', ',', 'first', 'postnatal', 'day', '.', 'urine', 'biomarkers', 'differ', 'ga', 'week', 'pma', ',', 'similar', 'week', 'pma', '.', 'urine', 'biomarkers', 'vary', 'sex', 'in', 'premature', 'neonate', '.', 'urine', 'biomarkers', 'not', 'differ', 'neonate', 'randomized', 'to', 'placebo', 'vs.', 'epo', '.']"
Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.,"Lee Ponsky, Simon S Lo, Yuxia Zhang, Mark Schluchter, Yiying Liu, Ravi Patel, Robert Abouassaly, Scott Welford, Vikas Gulani, John Robert Haaga, Mitchell Machtay, Rodney J Ellis, Lee Ponskyet al.",2015 Oct,Radiother Oncol,https://pubmed.ncbi.nlm.nih.gov/26362723/,No keywords found,"['to', 'evaluate', 'tolerability', 'of', 'escalating', 'dos', 'of', 'stereotactic', 'body', 'radiotherapy', '(', 'sbrt', ')', 'primary', 'treatment', 'of', 'localized', 'renal', 'cell', 'carcinoma', '(', 'rcc', ')', 'in', 'poor', 'surgical', 'candidate', '.', 'patient', 'and', 'method', 'eligible', 'patient', 'included', 'with', 'clinically', 'staged', 'radiographic', 'and', 'or', 'pathologically', 'confirmed', 'rcc', 'not', 'undergone', 'previous', 'abdominal', 'or', 'pelvic', 'radiotherapy', '.', 'patient', 'comorbid', 'medical', 'condition', 'precluded', 'surgery', '.', 'median', '(', 'range', ')', 'patient', 'age', '.years', '(', 'range', '-', ')', 'year', 'and', 'patient', 'karnofsky', 'performance', 'status', 'of', '.', 'median', 'tumor', 'volume', '.cm', '(', ')', '(', 'range', '.-.cm', '(', ')', ')', '.', 'dose-limiting', 'toxicity', '(', 'dlt', ')', 'defined', 'grade', 'or', 'worse', 'gastrointestinalgenitourinary', 'toxicity', 'common', 'terminology', 'criterion', 'of', 'adverse', 'event', '(', 'version', ')', '.', 'tumor', 'response', 'assessed', 'imaging', 'result', 'using', 'response', 'evaluation', 'criterion', 'in', 'solid', 'tumor', '(', 'recist', ')', 'measurement', 'and', 'percutaneous', 'biopsy', '.', 'result', 'total', 'of', 'patient', '(', 'men', 'and', 'woman', ')', 'treated', 'protocol', 'june', 'august', '.', 'group', 'of', '-', 'patient', 'received', ',', ',', ',', 'and', 'gy', 'in', 'fraction', '.', 'median', '(', 'range', ')', 'follow-up', '.', 'month', '(', '.-.months', ')', '.', 'possibly', 'treatment-related', 'acute', 'toxicity', ',', 'one', 'patient', 'developed', 'grade', 'fatigue', 'and', 'one', 'developed', 'grade', 'duodenal', 'ulcer', '.', 'possibly', 'treatment-related', 'late', 'toxicity', ',', 'patient', 'experienced', 'grade', 'renal', 'toxicity', '(', 'worsening', 'chronic', 'kidney', 'disease', ')', ',', 'one', 'reported', 'grade', 'urinary', 'incontinence', 'and', 'one', 'developed', 'grade', 'duodenal', 'ulcer', '.', 'among', 'patient', 'with', 'evaluable', 'response', ',', 'and', 'partial', 'response', 'and', 'stable', 'disease', ',', 'respectively', ',', 'utilizing', 'recist', 'criterion', '.', 'among', 'patient', 'post-sbrt', 'biopsy', ',', 'one', '(', ')', 'negative', 'first', 'biopsy', 'and', 'additional', 'one', '(', ')', 'turned', 'negative', 'without', 'therapy', 'second', 'biopsy', '.', 'conclusion', 'dose', 'escalation', 'to', 'gy', 'in', 'fraction', 'achieved', 'successfully', 'without', 'dose-limiting', 'toxicity', '.', 'planned', 'extension', 'of', 'phase', 'trial', 'currently', 'underway', 'treating', 'patient', 'to', 'gy', 'in', 'fraction', 'to', 'evaluate', 'experimental', 'therapy', '.']"
Hypocalcemia is associated with hypotension during CRRT: A secondary analysis of the Acute Renal Failure Trial Network Study.,"Yvelynne P Kelly, Shilpa Sharma, Suraj S Mothi, Finnian R McCausland, Mallika L Mendu, Gearoid M McMahon, Paul M Palevsky, Sushrut S Waikar, Yvelynne P Kellyet al.",2021 Oct:65:261-267.,J Crit Care,https://pubmed.ncbi.nlm.nih.gov/34274834/,No keywords found,"['investigated', 'effect', 'of', 'potentially', 'modifiable', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '-related', 'treatment', 'factor', 'risk', 'of', 'severe', 'hypotension', '.', 'material', 'and', 'method', 'carried', 'secondary', 'statistical', 'analysis', 'of', 'acute', 'renal', 'failure', 'trial', 'network', '(', 'atn', ')', 'trial', '.', 'primary', 'exposure', 'of', 'interest', 'crrt', 'treatment', 'dose', ',', 'ultrafiltration', 'rate', ',', 'blood', 'flow', 'rate', ',', 'ionized', 'calcium', 'level', 'and', 'type', 'of', 'anti-coagulation', 'used', '.', 'primary', 'outcome', 'severe', 'hypotension', ',', 'defined', 'vasopressor-inotropic', 'score', 'and', 'calculated', 'based', 'treatment', 'dos', 'of', 'vasopressor', 'and', 'inotropic', 'agent', '.', 'result', 'of', 'individual', 'enrolled', 'in', 'atn', 'trial', ',', 'managed', 'with', 'crrt', '.', '(', '.', ')', 'patient', 'experienced', 'severe', 'hypotension', 'trial', '.', 'serum', 'ionized', 'calcium', '.', 'mmoll', '(', 'hazard', 'ratio', '.', 'ci', '.-.', ')', '.', 'no', 'significant', 'difference', 'in', 'risk', 'of', 'hypotension', 'associated', 'with', 'crrt', 'treatment', 'factor', '.', 'conclusion', 'of', 'crrt', 'treatment', 'factor', 'studied', ',', 'hypocalcemia', 'with', 'serum', 'ionized', 'calcium', '.', 'mmoll', 'associated', 'with', 'significantly', 'increased', 'risk', 'of', 'treatment-associated', 'hypotension', '.', 'study', 'required', 'to', 'assess', 'whether', 'treatment', 'target', 'serum', 'calcium', 'improve', 'risk', 'of', 'hypotension', 'crrt', '.']"
Prevalence of acute kidney injury (AKI) in extremely low gestational age neonates (ELGAN).,"David J Askenazi, Patrick J Heagerty, Robert H Schmicker, Russell Griffin, Patrick Brophy, Sandra E Juul, Dennis E Mayock, Stuart L Goldstein, Sangeeta Hingorani                              ;, PENUT Trial Consortium, David J Askenaziet al.",2020 Sep,Pediatr Nephrol,https://pubmed.ncbi.nlm.nih.gov/32488672/,No keywords found,"['to', 'determine', 'prevalence', 'and', 'severity', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'different', 'time', 'frame', 'in', 'relation', 'to', 'gestational', 'age', '(', 'ga', ')', 'and', 'birthweight', '(', 'bw', ')', 'in', 'extremely', 'low', 'gestational', 'age', 'neonate', '(', 'elgan', ')', '.', 'hypothesis', 'elgan', 'with', 'lower', 'ga', 'and', 'lower', 'bw', 'higher', 'aki', 'rate', '.', 'method', 'total', 'of', 'elgan', 'enrolled', 'in', 'preterm', 'erythropoietin', 'neuroprotection', 'trial', 'evaluated', 'birth', 'death', 'or', 'hospital', 'discharge', '.', 'aki', 'defined', 'according', 'to', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'definition', 'clinically-derived', 'serum', 'creatinine', '(', 'scr', ')', 'measurement', '.', 'severe', 'aki', 'defined', 'stage', 'or', 'higher', '.', 'result', 'entire', 'cohort', ',', '(', '.', ',', 'ci', '.-', '.', ')', 'least', 'one', 'episode', 'of', 'stage', 'or', 'higher', 'aki', 'and', '(', '.', ',', 'ci', '.-', '.', ')', 'least', 'one', 'episode', 'of', 'severe', '(', 'stage', 'or', 'higher', ')', 'aki', '.', 'prevalence', 'of', 'aki', 'stage', 'or', 'higher', 'entire', 'cohort', 'early', '(', 'day', '-', ')', ',', 'middle', '(', 'day', '-', ')', ',', 'and', 'late', 'follow-up', 'period', '(', 'day', ')', '(', '.', ',', 'ci', '.-', '.', ')', ',', '(', '.', ',', 'ci', '.-', '.', ')', ',', 'and', '(', '.', ',', 'ci', '.-', '.', ')', ',', 'respectively', '.', 'rate', 'of', 'severe', 'aki', 'hospital', 'course', '.', ',', '.', ',', '.', ',', 'and', '.', '-', ',', '-', ',', '-', ',', 'and', '-week', 'ga', 'group', ',', 'respectively', '.', 'aki', 'rate', 'significantly', 'higher', 'with', 'decreasing', 'ga', 'and', 'decreasing', 'bw', 'stated', 'time', 'trend', '(', 'p', '.', 'using', 'test', 'trend', ')', '.', 'conclusion', 'aki', 'relatively', 'common', 'in', 'elgan', 'initial', 'hospital', 'course', 'and', 'associated', 'with', 'lower', 'ga', 'and', 'bw', '.']"
Molecular Regulation of Acute Tie2 Suppression in Sepsis.,"Kristina Thamm, Claudia Schrimpf, Jennifer Retzlaff, Temitayo O Idowu, Matijs van Meurs, Jan G Zijlstra, Chandra C Ghosh, Jana Zeitvogel, Thomas A Werfel, Hermann Haller, Samir M Parikh, Sascha David, Kristina Thammet al.",2018 Sep,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/29979219/,No keywords found,"['tie', 'tyrosine', 'kinase', 'receptor', 'expressed', 'endothelial', 'cell', 'maintains', 'vascular', 'barrier', 'function', '.', 'recently', 'reported', 'diverse', 'critical', 'illness', 'acutely', 'decrease', 'tie', 'expression', 'and', 'experimental', 'tie', 'reduction', 'suffices', 'to', 'recapitulate', 'cardinal', 'feature', 'of', 'septic', 'vasculature', '.', 'investigated', 'molecular', 'mechanism', 'driving', 'tie', 'suppression', 'in', 'setting', 'of', 'critical', 'illness', '.', 'design', 'laboratory', 'and', 'animal', 'research', ',', 'postmortem', 'kidney', 'biopsy', 'acute', 'kidney', 'injury', 'patient', 'and', 'serum', 'septic', 'shock', 'patient', '.', 'setting', 'research', 'laboratory', 'and', 'icu', 'of', 'hannover', 'medical', 'school', ',', 'harvard', 'medical', 'school', ',', 'and', 'university', 'of', 'groningen', '.', 'patient', 'deceased', 'septic', 'acute', 'kidney', 'injury', 'patient', '(', 'n', ')', 'and', 'control', '(', 'n', ')', 'and', 'septic', 'shock', 'patient', '(', 'n', ')', 'and', 'control', '(', 'n', ')', '.', 'intervention', 'molecular', 'biology', 'assay', '(', 'western', 'blot', ',', 'quantitative', 'polymerase', 'chain', 'reaction', ')', 'in', 'vitro', 'model', 'of', 'flow', 'and', 'transendothelial', 'electrical', 'resistance', 'experiment', 'in', 'human', 'umbilical', 'vein', 'endothelial', 'cell', 'murine', 'cecal', 'ligation', 'and', 'puncture', 'and', 'lipopolysaccharide', 'administration', '.', 'measurement', 'and', 'main', 'result', 'observed', 'rapid', 'reduction', 'of', 'tie', 'messenger', 'rna', 'and', 'protein', 'in', 'mouse', 'following', 'cecal', 'ligation', 'and', 'puncture', '.', 'in', 'cultured', 'endothelial', 'cell', 'exposed', 'to', 'tumor', 'necrosis', 'factor-', ',', 'suppression', 'of', 'tie', 'protein', 'severe', 'tie', 'messenger', 'rna', ',', 'suggesting', 'distinct', 'regulatory', 'mechanism', '.', 'evidence', 'of', 'protein-level', 'regulation', 'found', 'in', 'tumor', 'necrosis', 'factor', '--', 'treated', 'endothelial', 'cell', ',', 'septic', 'mouse', ',', 'and', 'septic', 'human', ',', 'three', 'of', 'displayed', 'elevation', 'of', 'soluble', 'n-terminal', 'fragment', 'of', 'tie', '.', 'matrix', 'metalloprotease', 'necessary', 'and', 'sufficient', 'n-terminal', 'tie', 'shedding', '.', 'since', 'clinical', 'setting', 'of', 'tie', 'suppression', 'often', 'characterized', 'shock', ',', 'next', 'investigated', 'effect', 'of', 'laminar', 'flow', 'tie', 'expression', '.', 'compared', 'with', 'absence', 'of', 'flow', ',', 'laminar', 'flow', 'induced', 'tie', 'messenger', 'rna', 'and', 'expression', 'of', 'gata', 'binding', 'protein', '.', 'conversely', ',', 'septic', 'lung', 'exhibited', 'reduced', 'gata', 'binding', 'protein', ',', 'and', 'knockdown', 'of', 'gata', 'binding', 'protein', 'in', 'flow-exposed', 'endothelial', 'cell', 'reduced', 'tie', 'messenger', 'rna', '.', 'postmortem', 'tissue', 'septic', 'patient', 'showed', 'trend', 'toward', 'reduced', 'gata', 'binding', 'protein', 'expression', 'associated', 'with', 'tie', 'messenger', 'rna', 'level', '(', 'p', '.', ')', '.', 'conclusion', 'tie', 'suppression', 'pivotal', 'event', 'in', 'sepsis', 'may', 'regulated', 'matrix', 'metalloprotease', '-driven', 'tie', 'protein', 'cleavage', 'and', 'gata', 'binding', 'protein', '-driven', 'flow', 'regulation', 'of', 'tie', 'transcript', '.']"
Comparative Analysis of Prothrombin Complex Concentrate and Fresh Frozen Plasma in Coronary Surgery.,"Fausto Biancari, Vito G Ruggieri, Andrea Perrotti, Riccardo Gherli, Till Demal, Ilaria Franzese, Magnus Dalén, Giuseppe Santarpino, Antonino S Rubino, Daniele Maselli, Antonio Salsano, Francesco Nicolini, Matteo Saccocci, Giuseppe Gatti, Stefano Rosato, Paola D'Errigo, Eeva-Maija Kinnunen, Marisa De Feo, Tuomas Tauriainen, Francesco Onorati, Giovanni Mariscalco, Fausto Biancariet al.",2019 Dec,Heart Lung Circ,https://pubmed.ncbi.nlm.nih.gov/30709591/,No keywords found,"['recent', 'study', 'suggested', 'prothrombin', 'complex', 'concentrate', '(', 'pcc', ')', 'might', 'effective', 'fresh', 'frozen', 'plasma', '(', 'ffp', ')', 'to', 'reduce', 'red', 'blood', 'cell', '(', 'rbc', ')', 'transfusion', 'requirement', 'cardiac', 'surgery', '.', 'method', 'comparative', 'analysis', 'of', 'patient', 'received', 'ffp', 'postoperatively', 'and', 'patient', 'received', 'pcc', 'with', 'or', 'without', 'ffp', 'isolated', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', '.', 'result', 'mixed-effects', 'regression', 'analysis', 'adjusted', 'multiple', 'covariates', 'and', 'participating', 'centre', 'showed', 'pcc', 'significantly', 'decreased', 'rbc', 'transfusion', '(', '.', 'v', '.', '.', ',', 'adjusted', 'or', '.', ',', 'ci', '.-', '.', ')', 'and', 'platelet', 'transfusion', 'requirement', '(', '.', 'v', '.', '.', ',', 'adjusted', 'or', '.', ',', 'ci', '.-', '.', ')', 'compared', 'with', 'ffp', '.', 'pcc', 'cohort', 'received', 'mean', 'of', '..', '(', 'median', ',', '.', ',', 'iqr', ')', 'unit', 'of', 'rbc', 'and', 'ffp', 'cohort', 'received', 'mean', 'of', '..', '(', 'median', ',', '.', ',', 'iqr', ')', 'unit', 'of', 'rbc', '(', 'adjusted', 'coefficient', ',', '-.', ',', 'ci', '-.-.', ')', '.', 'use', 'of', 'pcc', 'increased', 'risk', 'of', 'kdigo', '(', 'kidney', 'disease', 'improving', 'global', 'outcome', ')', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', '.', ',', 'adjusted', 'or', '.', ',', '.-', '.', ')', ',', 'not', 'of', 'kdigo', 'acute', 'kidney', 'injury', 'stage', '(', '.', 'v', '.', '.', ',', 'or', '.', ',', 'ci', '.-', '.', ')', 'compared', 'with', 'ffp', 'cohort', '.', 'conclusion', 'result', 'suggest', 'use', 'of', 'pcc', 'compared', 'with', 'ffp', 'may', 'reduce', 'need', 'of', 'blood', 'transfusion', 'cabg', '.']"
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.,"G Castellano, A Intini, A Stasi, C Divella, M Gigante, P Pontrelli, R Franzin, M Accetturo, A Zito, M Fiorentino, V Montinaro, G Lucarelli, P Ditonno, M Battaglia, A Crovace, F Staffieri, B Oortwijn, E van Amersfoort, G Pertosa, G Grandaliano, L Gesualdo, G Castellanoet al.",2016 Jan,Am J Transplant,https://pubmed.ncbi.nlm.nih.gov/26280899/,"basic (laboratory) research/science, complement biology, immunobiology, ischemia reperfusion injury (IRI), kidney transplantation/nephrology.","['klotho', 'anti-aging', 'factor', 'mainly', 'produced', 'renal', 'tubular', 'epithelial', 'cell', '(', 'tec', ')', 'with', 'pleiotropic', 'function', '.', 'klotho', 'down-regulated', 'in', 'acute', 'kidney', 'injury', 'in', 'native', 'kidney', 'however', ',', 'modulation', 'of', 'klotho', 'in', 'kidney', 'transplantation', 'not', 'investigated', '.', 'in', 'swine', 'model', 'of', 'ischemiareperfusion', 'injury', '(', 'iri', ')', ',', 'observed', 'remarkable', 'reduction', 'of', 'renal', 'klotho', 'h', 'iri', '.', 'complement', 'inhibition', 'c-inhibitor', 'preserved', 'klotho', 'expression', 'in', 'vivo', 'abrogating', 'nuclear', 'factor', 'kappa', 'b', '(', 'nf-kb', ')', 'signaling', '.', 'in', 'accordance', ',', 'complement', 'anaphylotoxin', 'ca', 'led', 'to', 'significant', 'down-regulation', 'of', 'klotho', 'in', 'tec', 'in', 'vitro', 'nf-kb', 'mediated', '.', 'analysis', 'of', 'klotho', 'in', 'kidney', 'cadaveric', 'donor', 'demonstrated', 'significant', 'expression', 'of', 'klotho', 'in', 'pre-implantation', 'biopsy', 'however', ',', 'patient', 'affected', 'delayed', 'graft', 'function', '(', 'dgf', ')', 'showed', 'profound', 'down-regulation', 'of', 'klotho', 'compared', 'with', 'patient', 'with', 'early', 'graft', 'function', '.', 'quantification', 'of', 'serum', 'klotho', 'year', 'transplantation', 'demonstrated', 'significant', 'lower', 'level', 'in', 'dgf', 'patient', '.', 'data', 'demonstrated', 'complement', 'might', 'pivotal', 'in', 'down-regulation', 'of', 'klotho', 'in', 'iri', 'leading', 'to', 'permanent', 'deficiency', 'year', 'transplantation', '.', 'considering', 'anti-senescence', 'and', 'anti-fibrotic', 'effect', 'of', 'klotho', 'renal', 'level', ',', 'hypothesize', 'acquired', 'deficiency', 'of', 'klotho', 'might', 'contribute', 'to', 'dgf-associated', 'chronic', 'allograft', 'dysfunction', '.']"
Remote ischaemic preconditioning versus sham procedure for abdominal aortic aneurysm repair: an external feasibility randomized controlled trial.,"Ronelle Mouton, Jon Pollock, Jasmeet Soar, David C Mitchell, Chris A Rogers, Ronelle Moutonet al.",2015 Aug 25:16:377.,Trials,https://pubmed.ncbi.nlm.nih.gov/26303818/,No keywords found,"['despite', 'advance', 'in', 'perioperative', 'care', ',', 'elective', 'abdominal', 'aorta', 'aneurysm', '(', 'aaa', ')', 'repair', 'carry', 'significant', 'morbidity', 'and', 'mortality', '.', 'remote', 'ischaemic', 'preconditioning', '(', 'ric', ')', 'physiological', 'phenomenon', 'whereby', 'brief', 'episode', 'of', 'ischaemia-reperfusion', 'protects', 'subsequent', 'longer', 'ischaemic', 'insult', '.', 'trial', 'in', 'cardiovascular', 'surgery', 'shown', 'ric', 'protect', 'patient', ""'"", 'organ', 'surgery', '.', 'aim', 'of', 'study', 'to', 'investigate', 'whether', 'ric', 'could', 'successfully', 'introduced', 'in', 'elective', 'aaa', 'repair', 'and', 'to', 'obtain', 'information', 'needed', 'to', 'design', 'multi-centre', 'rct', '.', 'method', 'consecutive', 'patient', 'presenting', 'elective', 'aaa', 'repair', ',', 'using', 'endovascular', '(', 'evar', ')', 'or', 'open', 'procedure', ',', 'in', 'single', 'large', 'city', 'hospital', 'in', 'uk', 'assessed', 'trial', 'eligibility', '.', 'patient', 'consented', 'to', 'participate', 'randomized', 'to', 'receive', 'ric', '(', 'three', 'cycle', 'of', 'min', 'ischaemia', 'followed', 'min', 'reperfusion', 'in', 'upper', 'arm', 'immediately', 'surgery', ')', 'or', 'sham', 'procedure', '.', 'patient', 'followed', 'month', '.', 'assessed', 'eligibility', 'and', 'consent', 'rate', ',', 'logistics', 'of', 'ric', 'implementation', ',', 'randomization', ',', 'blinding', ',', 'data', 'capture', ',', 'patient', 'and', 'staff', 'opinion', ',', 'and', 'variability', 'and', 'frequency', 'of', 'clinical', 'outcome', 'measure', '.', 'result', 'january', 'and', 'december', ',', 'patient', 'referred', 'aaa', 'repair', ',', 'screened', ',', '(', ')', 'eligible', ',', 'approached', 'participation', 'and', 'consented', 'to', 'participate', 'randomized', 'to', 'ric', 'and', 'to', 'sham', 'procedure', '.', 'greater', 'expected', 'variation', 'in', 'complexity', 'of', 'evar', 'impacted', 'outcome', '.', 'acute', 'kidney', 'injury', 'occurred', 'in', '(', 'akin', 'akin', 'and', 'akin', ')', 'and', '(', ')', 'perioperative', 'myocardial', 'infarction', '.', 'blinding', 'successful', ',', 'and', 'interview', 'with', 'participant', 'and', 'staff', 'indicated', 'procedure', 'acceptable', '.', 'no', 'adverse', 'event', 'secondary', 'to', 'intervention', 'in', 'month', 'following', 'intervention', '.', 'conclusion', 'study', 'provided', 'essential', 'information', 'planning', 'and', 'design', 'of', 'multi-centre', 'rct', 'to', 'assess', 'effectiveness', 'of', 'ric', 'improving', 'clinical', 'outcome', 'in', 'elective', 'aaa', 'repair', '.', 'patient', 'consent', 'high', ',', 'and', 'ric', 'intervention', 'carried', 'with', 'minimal', 'disruption', 'to', 'clinical', 'care', '.', 'allocation', 'scheme', 'definite', 'trial', 'take', 'account', 'surgical', 'procedure', 'and', 'complexity', 'to', 'avoid', 'confounding', 'effect', 'of', 'ric', ',', 'observed', 'in', 'study', '.', 'trial', 'registration', 'current', 'controlled', 'trial', 'isrctn', '(', 'date', 'of', 'registration', 'march', ')', '.', 'trial', 'protocol', 'available', 'corresponding', 'author', '.']"
Propofol-based anaesthesia versus sevoflurane-based anaesthesia for living donor kidney transplantation: results of the VAPOR-1 randomized controlled trial.,"G J Nieuwenhuijs-Moeke, V B Nieuwenhuijs, M A J Seelen, S P Berger, M C van den Heuvel, J G M Burgerhof, P J Ottens, R J Ploeg, H G D Leuvenink, M M R F Struys, G J Nieuwenhuijs-Moekeet al.",2017 May 1,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/28510740/,No keywords found,"['kidney', 'transplantation', 'associated', 'with', 'harmful', 'process', 'affecting', 'viability', 'of', 'graft', '.', 'one', 'of', 'process', 'associated', 'with', 'phenomenon', 'of', 'ischaemia-reperfusion', 'injury', '.', 'anaesthetic', 'conditioning', 'widely', 'described', 'strategy', 'to', 'attenuate', 'ischaemia-reperfusion', 'injury', '.', 'therefore', 'conducted', 'volatile', 'anaesthetic', 'protection', 'of', 'renal', 'transplants-', 'trial', ',', 'pilot', 'project', 'evaluating', 'influence', 'of', 'two', 'anaesthetic', 'regimen', ',', 'propofol-', 'v', 'sevoflurane-based', 'anaesthesia', ',', 'biochemical', 'and', 'clinical', 'outcome', 'in', 'living', 'donor', 'kidney', 'transplantation', '.', 'method', 'sixty', 'couple', 'randomly', 'assigned', 'to', 'following', 'three', 'group', 'prop', '(', 'donor', 'and', 'recipient', 'propofol', ')', ',', 'sevo', '(', 'donor', 'and', 'recipient', 'sevoflurane', ')', ',', 'and', 'prose', '(', 'donor', 'propofol', 'and', 'recipient', 'sevoflurane', ')', '.', 'primary', 'outcome', 'renal', 'injury', 'reflected', 'urinary', 'biomarkers', '.', 'follow-up', 'period', 'yr.', 'result', 'three', 'couple', 'excluded', ',', 'leaving', 'couple', 'analysis', '.', 'concentration', 'of', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', ',', 'n', '-acetyl', '--', '-glucosaminidase', '(', 'nag', ')', ',', 'and', 'heart-type', 'fatty', 'acid', 'binding', 'protein', '(', 'h-fabp', ')', 'in', 'first', 'urine', 'upon', 'reperfusion', 'showed', 'no', 'difference', '.', 'day', ',', 'kim-', 'concentration', 'higher', 'in', 'sevo', '.', '(', 'interquartile', 'range', '.-', '.', ')', 'pg', 'mmol', '-', 'compared', 'with', 'prop', '.', '(', '.-', '.', ')', 'pg', 'mmol', '-', '.', 'nag', 'sevo', ',', '.', '(', '.-', '.', ')', 'iu', 'mmol', '-', 'v', 'prop', ',', '.', '(', '.-', '.', ')', 'iu', 'mmol', '-', '.', 'concentration', 'of', 'h-fabp', 'showed', 'no', 'difference', '.', 'measured', 'glomerular', 'filtration', 'rate', ',', ',', 'and', 'month', 'showed', 'no', 'difference', '.', 'yr', ',', 'difference', 'in', 'acute', 'rejection', 'rate', '(', 'p', '.', ')', '.', 'post', 'hoc', 'testing', 'revealed', 'difference', 'prop', '(', ')', 'and', 'prose', '(', 'p', '.', ')', '.', 'difference', 'prop', 'and', 'sevo', '(', ')', 'not', 'significant', '(', 'p', '.', ')', '.', 'conclusion', 'sevo', 'group', 'showed', 'higher', 'urinary', 'kim-', 'and', 'nag', 'concentration', 'in', 'living', 'donor', 'kidney', 'transplantation', 'second', 'day', 'transplantation', '.', 'not', 'reflected', 'in', 'inferior', 'graft', 'outcome', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial.,"Yanai Ben-Gal, Rephael Mohr, Frederick Feit, E Magnus Ohman, Ajay Kirtane, Ke Xu, Roxana Mehran, Gregg W Stone, Yanai Ben-Galet al.",2015 Jun,Circ Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/26019142/,No keywords found,"['preferred', 'revascularization', 'strategy', 'diabetic', 'patient', 'with', 'acute', 'coronary', 'syndrome', 'and', 'multivessel', 'coronary', 'artery', 'disease', 'uncertain', '.', 'evaluated', 'outcome', 'of', 'diabetic', 'patient', 'with', 'moderate', 'and', 'high-risk', 'acute', 'coronary', 'syndrome', 'and', 'multivessel', 'disease', 'managed', 'with', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'versus', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', '.', 'method', 'and', 'result', 'among', 'moderate', 'and', 'high-risk', 'acute', 'coronary', 'syndrome', 'patient', 'enrolled', 'in', 'acute', 'catheterization', 'and', 'early', 'intervention', 'triage', 'strategy', '(', 'acuity', ')', 'trial', ',', 'diabetic', 'patient', 'multivessel', 'disease', 'with', 'left', 'anterior', 'descending', 'artery', 'involvement', 'and', 'managed', 'pci', '(', 'n', ')', 'or', 'cabg', '(', 'n', ')', '.', 'propensity', 'scoring', 'applied', 'to', 'adjust', 'difference', 'in', 'baseline', 'clinical', 'and', 'angiographic', 'characteristic', ',', 'yielding', 'total', 'of', 'matched', 'patient', '(', 'managed', 'pci', 'and', 'managed', 'cabg', ')', '.', 'day', ',', 'treatment', 'with', 'pci', 'compared', 'with', 'cabg', 'associated', 'with', 'lower', 'rate', 'of', 'major', 'bleeding', '(', '.', 'versus', '.', 'p.', ')', ',', 'blood', 'transfusion', '(', '.', 'versus', '.', 'p.', ')', ',', 'and', 'acute', 'kidney', 'injury', '(', '.', 'versus', '.', 'p.', ')', ',', 'unplanned', 'revascularization', 'procedure', '(', '.', 'versus', '.', 'p.', ')', '.', 'year', 'pci', 'associated', 'with', 'higher', 'rate', 'of', 'repeat', 'revascularization', 'procedure', '(', '.', 'versus', '.', 'p.', ')', ',', 'with', 'nonsignificantly', 'different', 'rate', 'of', 'myocardial', 'infarction', ',', 'stroke', ',', 'and', 'death', 'either', 'day', 'or', 'year', '.', 'conclusion', 'in', 'large-scale', 'acuity', 'trial', ',', 'diabetic', 'patient', 'with', 'acute', 'coronary', 'syndrome', 'and', 'multivessel', 'disease', 'treated', 'with', 'pci', 'rather', 'cabg', 'less', 'bleeding', 'and', 'acute', 'kidney', 'injury', ',', 'greater', 'need', 'repeat', 'revascularization', 'procedure', ',', 'and', 'comparable', 'rate', 'of', 'myocardial', 'infarction', ',', 'stroke', ',', 'and', 'death', '-year', 'follow-up', '.', 'clinical', 'trial', 'registration', 'url', 'httpwww.clinicaltrials.gov', '.', 'unique', 'identifier', 'nct', '.']"
Prospective Randomized Comparison of Fractional Flow Reserve Versus Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses: One-Month Results.,"Antonio Maria Leone, Francesco Burzotta, Cristina Aurigemma, Giovanni Luigi De Maria, Aniello Zambrano, Giuseppe Zimbardo, Manfredi Arioti, Emma Cerracchio, Rocco Vergallo, Carlo Trani, Filippo Crea, Antonio Maria Leoneet al.",2019 Aug 6,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/31331219/,"fractional flow reserve, optical coherence tomography, personalized medicine.","['httpwww.clinicaltrialsgov', '.', 'unique', 'identifier', 'nct', '.']"
The combined effects of exercise-induced muscle damage and heat stress on acute kidney stress and heat strain during subsequent endurance exercise.,"Zidong Li, Zachary McKenna, Zachary Fennel, Roberto Carlos Nava, Andrew Wells, Jeremy Ducharme, Jonathan Houck, Kylie Morana, Christine Mermier, Matthew Kuennen, Flavio de Castro Magalhaes, Fabiano Amorim, Zidong Liet al.",2022 May,Eur J Appl Physiol,https://pubmed.ncbi.nlm.nih.gov/35237867/,No keywords found,"['purpose', 'of', 'study', 'to', 'investigate', 'combined', 'effect', 'of', 'downhill', 'running', 'and', 'heat', 'stress', 'muscle', 'damage', ',', 'well', 'heat', 'strain', 'and', 'kidney', 'stress', 'subsequent', 'running', 'in', 'heat', '.', 'method', 'in', 'randomized', 'cross-over', 'study', ',', 'ten', 'non-heat-acclimated', ',', 'physically', 'active', 'male', 'completed', 'downhill', 'running', 'in', 'temperate', '(', 'eimd', 'in', 'temp', ')', 'and', 'hot', '(', 'eimd', 'in', 'hot', ')', 'condition', 'followed', 'exercise-heat', 'stress', '(', 'h', ')', 'test', '-h', 'seated', 'rest', '.', 'blood', 'and', 'urine', 'sample', 'collected', 'immediately', 'pre-', 'and', 'post-eimd', 'and', 'h', ',', 'and', 'h', 'post-eimd', '(', 'post-', 'h', ')', '.', 'core', 'temperature', 'and', 'thermal', 'sensation', 'measured', 'to', 'evaluate', 'heat', 'strain', '.', 'serum', 'creatine', 'kinase', '(', 'ck', ')', ',', 'maximal', 'voluntary', 'isometric', 'contraction', 'of', 'quadriceps', '(', 'mvc', ')', 'and', 'perceived', 'muscle', 'soreness', 'measured', 'to', 'evaluate', 'muscle', 'damage', '.', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'level', 'measured', 'to', 'indicate', 'acute', 'kidney', 'stress', '.', 'result', 'ck', ',', 'mvc', 'and', 'perceived', 'soreness', 'not', 'different', 'condition', 'timepoints', '.', 'in', 'eimd', 'in', 'hot', 'condition', ',', 'urinary', 'ngal', 'significantly', 'elevated', 'pre-', 'to', 'post-hs', '(', 'pre-hs', '.', '.-', '.', 'ngmin', ',', 'post-hs', '.', '.-', '.', 'ngmin', ',', 'p', '.', ')', '.', 'elevation', 'of', 'ngal', 'or', 'kim-', 'not', 'found', 'in', 'eimd', 'in', 'temp', 'condition', '.', 'conclusion', 'compared', 'with', 'downhill', 'running', 'in', 'temperate', 'environment', ',', 'downhill', 'running', 'in', 'hot', 'environment', 'not', 'appear', 'to', 'aggravate', 'muscle', 'damage', '.', 'however', ',', 'elevated', 'ngal', 'level', 'following', 'eimd', 'in', 'hot', 'environment', 'suggest', 'exercise', 'may', 'increase', 'risk', 'of', 'mild', 'acute', 'kidney', 'injury', 'subsequent', 'endurance', 'exercise', 'in', 'heat', '.']"
Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.,"John V Conte, James Hermiller Jr, Jon R Resar, G Michael Deeb, Thomas G Gleason, David H Adams, Jeffrey J Popma, Steven J Yakubov, Daniel Watson, Jia Guo, George L Zorn rd, Michael J Reardon, John V Conteet al.",2017,Semin Thorac Cardiovasc Surg,https://pubmed.ncbi.nlm.nih.gov/29195573/,"SAVR, TAVR, acute kidney injury, bleeding, complications.","['to', 'tavr', 'with', 'corevalve', 'bioprosthesis', 'or', 'surgical', 'bioprosthetic', 'valve', '.', 'rate', 'of', 'major', 'procedural', 'and', 'vascular', 'complication', 'occurring', '(', 'periprocedurally', '(', '-', 'day', ')', 'and', 'early', '(', '-', 'day', ')', ')', 'compared', 'tavr', 'v', 'savr', 'patient', '.', 'all-cause', 'mortality', ',', 'stroke', ',', 'myocardial', 'infarction', ',', 'and', 'major', 'infection', 'similar', 'in', 'period', 'post', 'procedure', '.', 'within', '-', 'day', ',', 'major', 'vascular', 'complication', 'rate', 'significantly', 'higher', 'with', 'tavr', '(', 'p', '.', ')', '.', 'life-threatening', 'or', 'disabling', 'bleeding', '(', 'p', '.', ')', ',', 'encephalopathy', '(', 'p', '.', ')', ',', 'atrial', 'fibrillation', '(', 'p', '.', ')', ',', 'and', 'acute', 'kidney', 'injury', '(', 'p', '.', ')', 'significantly', 'higher', 'with', 'savr', '.', 'non-iliofemoral', 'tavr', 'approach', 'higher', 'incidence', 'of', 'major', 'or', 'life-threatening', 'or', 'disabling', 'bleeding', '-days', '(', 'p', '.', ')', '.', 'procedural', 'complication', 'unique', 'to', 'tavr', 'included', 'coronary', 'occlusion', '.', '(', ')', 'and', 'tavr', 'pop', 'out', '.', '(', ')', 'with', 'no', 'valve', 'embolizations', '.', 'pop', 'out', 'similar', 'iliofemoral', '.', '(', ')', 'and', 'non-iliofemoral', 'approach', '.', '(', ')', '.', 'procedural', 'complication', 'unique', 'to', 'savr', 'included', 'aortic', 'dissection', '.', '(', ')', 'and', 'injury', 'to', 'heart', 'structure', '.', '(', ')', '.', 'procedural', 'complication', 'profile', 'of', 'tavr', 'and', 'savr', 'unique', '.', 'intraoperative', 'death', 'seen', 'in', 'tavr', '.', 'mortality', 'and', 'day', 'similar', '.', 'higher', 'incidence', 'of', 'complication', 'likely', 'reflects', 'greater', 'invasiveness', 'of', 'savr', 'in', 'aged', 'high-risk', 'population', '.']"
General anesthesia type does not influence serum levels of neutrophil gelatinase-associated lipocalin during the perioperative period in video laparoscopic bariatric surgery.,"Adriano Fernandes, João Ettinger, Fabiano Amaral, Maria José Ramalho, Rodrigo Alves, Norma Sueli Pinheiro Módolo, Adriano Fernandeset al.",2014 Dec,Clinics (Sao Paulo),https://pubmed.ncbi.nlm.nih.gov/25518015/,No keywords found,"['video', 'laparoscopic', 'bariatric', 'surgery', 'preferred', 'surgical', 'technique', 'treating', 'morbid', 'obesity', '.', 'however', ',', 'pneumoperitoneum', 'pose', 'risk', 'to', 'kidney', 'causing', 'decrease', 'in', 'renal', 'blood', 'flow', '.', 'furthermore', ',', 'in', 'surgical', 'procedure', ',', 'laparoscopic', 'bariatric', 'surgery', 'trigger', 'acute', 'inflammatory', 'response', '.', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'early', 'and', 'accurate', 'biomarker', 'of', 'renal', 'injury', ',', 'well', 'of', 'inflammatory', 'response', '.', 'anesthetic', 'drug', 'could', 'offer', 'protection', 'kidney', 'and', 'could', 'attenuate', 'acute', 'inflammatory', 'response', 'surgical', 'trauma', '.', 'objective', 'of', 'study', 'to', 'compare', 'effect', 'of', 'two', 'type', 'of', 'anesthetic', ',', 'propofol', 'and', 'sevoflurane', ',', 'serum', 'level', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'perioperative', 'period', 'in', 'laparoscopic', 'bariatric', 'surgery', '.', 'method', 'sixty-four', 'patient', 'scheduled', 'laparoscopic', 'bariatric', 'surgery', 'randomized', 'two', 'anesthesia', 'group', 'and', 'administered', 'either', 'total', 'intravenous', 'anesthesia', '(', 'propofol', ')', 'or', 'inhalation', 'anesthesia', '(', 'sevoflurane', ')', '.', 'in', 'perioperative', 'period', ',', 'blood', 'sample', 'collected', 'three', 'time', 'point', '(', 'anesthesia', ',', 'hour', 'pneumoperitoneum', 'and', 'hour', 'pneumoperitoneum', ')', 'and', 'urine', 'output', 'measured', 'hour', '.', 'acute', 'kidney', 'injury', 'evaluated', 'examining', 'clinical', 'and', 'laboratory', 'parameter', 'postoperative', 'period', '.', 'difference', 'group', 'compared', 'using', 'non-parametric', 'test', '.', 'rebec', '(', 'httpwww.ensaiosclinicos.gov.brrgrecruiting', ')', 'rbr-wtfy', 'result', 'none', 'of', 'patient', 'developed', 'acute', 'kidney', 'injury', 'study', 'and', 'no', 'significant', 'difference', 'found', 'serum', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'level', 'of', 'group', 'perioperative', 'period', '.', 'conclusion', 'choice', 'of', 'anesthetic', 'drug', ',', 'either', 'propofol', 'or', 'sevoflurane', ',', 'not', 'affect', 'serum', 'level', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', 'perioperative', 'period', 'in', 'laparoscopic', 'bariatric', 'surgery', '.']"
Urinary biomarkers after donor nephrectomy.,"Judith M Hoogendijk-van den Akker, Michiel C Warlé, Arjan D van Zuilen, Heinrich J Kloke, Kim E Wever, Frank C H d'Ancona, Denise M D Ӧzdemir, Jack F M Wetzels, Andries J Hoitsma, Judith M Hoogendijk-van den Akkeret al.",2015 May,Transpl Int,https://pubmed.ncbi.nlm.nih.gov/25581388/,"acute kidney injury, donor nephrectomy, urinary biomarkers.","['beginning', 'of', 'living-donor', 'kidney', 'transplantation', ',', 'physician', 'expressed', 'concern', 'possibility', 'unilateral', 'nephrectomy', 'harmful', 'to', 'healthy', 'individual', '.', 'to', 'investigate', 'whether', 'elevated', 'intra-abdominal', 'pressure', '(', 'iap', ')', 'laparoscopic', 'donor', 'nephrectomy', 'cause', 'early', 'damage', 'to', 'remaining', 'kidney', ',', 'evaluated', 'urine', 'biomarkers', 'laparoscopic', 'donor', 'nephrectomy', '.', 'measured', 'albumin', 'and', 'alpha', '--', 'microglobulin', '(', '--', 'mgb', ')', 'in', 'urine', 'sample', 'collected', 'and', 'open', 'and', 'laparoscopic', 'donor', 'nephrectomy', 'and', 'laparoscopic', 'cholecystectomy', 'and', 'colectomy', '.', 'additionally', ',', 'kidney', 'injury', 'molecule', '(', 'kim-', ')', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'measured', 'in', 'urine', 'sample', 'collected', 'and', 'laparoscopic', 'donor', 'nephrectomy', 'and', 'colectomy', '.', 'biomarkers', 'studied', 'in', 'patient', 'randomly', 'assigned', 'to', 'standard', 'or', 'low', 'iap', 'laparoscopic', 'donor', 'nephrectomy', '.', 'observed', 'peak', 'in', 'urinary', 'albumin', 'excretion', 'procedure', '.', 'urine', '--', 'mgb', 'rose', 'in', 'postoperative', 'period', 'with', 'peak', 'third', 'postoperative', 'day', 'donor', 'nephrectomy', '.', 'urine', '--', 'mgb', 'not', 'increase', 'laparoscopic', 'cholecystectomy', 'and', 'colectomy', '.', 'laparoscopic', 'nephrectomy', ',', 'observed', 'slight', 'increase', 'in', 'urine', 'kim-', 'surgery', 'and', 'in', 'urine', 'ngal', 'day', '-', 'procedure', '.', 'laparoscopic', 'colectomy', ',', 'kim-', 'and', 'ngal', 'increased', 'in', 'postoperative', 'period', '.', 'no', 'difference', 'high-', 'and', 'low-pressure', 'procedure', '.', 'elevated', 'urinary', '--', 'mgb', 'suggests', 'kidney', 'damage', 'donor', 'nephrectomy', ',', 'occurring', 'irrespective', 'of', 'iap', 'laparoscopic', 'procedure', '.']"
Plasma cytokine levels in spinal surgery with sevoflurane or total intravenous propofol anesthesia - A post hoc analysis of a randomized controlled trial.,"Stephanie Franzén, Egidijus Semenas, Anders Larsson, Michael Hultström, Robert Frithiof, Stephanie Franzénet al.",2023 Sep:169:156290.,Cytokine,https://pubmed.ncbi.nlm.nih.gov/37399604/,"Acute kidney injury, Interleukin-6, Propofol, Sevoflurane, Surgery.","['surgical', 'tissue', 'trauma', 'stimulates', 'inflammatory', 'response', 'resulting', 'in', 'increased', 'level', 'of', 'cytokine', 'could', 'contribute', 'to', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'not', 'clear', 'anesthetic', 'modality', 'affect', 'response', '.', 'aimed', 'to', 'investigate', 'role', 'of', 'anesthesia', 'in', 'healthy', 'surgical', 'population', 'inflammatory', 'response', 'and', 'correlation', 'to', 'plasma', 'creatinine', '.', 'study', 'post', 'hoc', 'analysis', 'of', 'published', 'randomized', 'clinical', 'trial', '.', 'analyzed', 'plasma', 'patient', 'underwent', 'elective', 'spinal', 'surgery', 'randomized', 'to', 'either', 'total', 'intravenous', 'propofol', 'anesthesia', '(', 'n', ')', 'or', 'sevoflurane', 'anesthesia', '(', 'n', ')', '.', 'plasma', 'sample', 'collected', 'anesthesia', ',', 'anesthesia', ',', 'and', 'h', 'surgery', '.', 'plasma', 'cytokine', 'level', 'surgery', 'analyzed', 'correlation', 'with', 'duration', 'of', 'surgical', 'insult', 'and', 'change', 'in', 'plasma', 'creatinine', 'concentration', '.', 'cytokine', 'interleukin-', '(', 'il-', ')', 'increased', 'surgery', 'compared', 'with', 'preoperatively', '.', 'il-', 'higher', 'in', 'sevoflurane', 'group', 'propofol', 'group', 'surgery', '.', 'no', 'patient', 'developed', 'aki', ',', 'plasma', 'creatinine', 'increased', 'postoperatively', 'in', 'sevoflurane', 'group', '.', 'significant', 'association', 'surgical', 'time', 'and', 'plasma', 'il-', 'postoperatively', '.', 'no', 'significant', 'correlation', 'change', 'in', 'plasma', 'creatinine', 'and', 'il-', 'detected', '.', 'cytokine', 'il-', ',', 'il-', ',', 'eotaxin', ',', 'interferon', '-induced', 'protein', '(', 'ip-', ')', ',', 'granulocyte', 'colony-stimulating', 'factor', '(', 'g-csf', ')', ',', 'macrophage', 'inflammatory', 'protein-', '(', 'mip-', ')', ',', 'and', 'monocyte', 'chemoattractant', 'protein', '(', 'mcp-', ')', 'lower', 'postoperatively', 'surgery', 'independent', 'of', 'anesthetic', 'modality', '.', 'post', 'hoc', 'analysis', 'revealed', 'plasma', 'il-', 'increased', 'surgery', 'and', 'in', 'sevoflurane', 'group', 'propofol', 'group', '.', 'postoperative', 'plasma', 'il-', 'concentration', 'associated', 'with', 'surgical', 'time', '.']"
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.,"SPRINT Research Group;, Jackson T Wright Jr, Jeff D Williamson, Paul K Whelton, Joni K Snyder, Kaycee M Sink, Michael V Rocco, David M Reboussin, Mahboob Rahman, Suzanne Oparil, Cora E Lewis, Paul L Kimmel, Karen C Johnson, David C Goff Jr, Lawrence J Fine, Jeffrey A Cutler, William C Cushman, Alfred K Cheung, Walter T Ambrosius, SPRINT Research Groupet al.",2015 Nov 26,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/26551272/,No keywords found,"['appropriate', 'target', 'systolic', 'blood', 'pressure', 'to', 'reduce', 'cardiovascular', 'morbidity', 'and', 'mortality', 'among', 'person', 'without', 'diabetes', 'remain', 'uncertain', '.', 'method', 'randomly', 'assigned', 'person', 'with', 'systolic', 'blood', 'pressure', 'of', 'mm', 'hg', 'or', 'higher', 'and', 'increased', 'cardiovascular', 'risk', ',', 'without', 'diabetes', ',', 'to', 'systolic', 'blood-pressure', 'target', 'of', 'less', 'mm', 'hg', '(', 'intensive', 'treatment', ')', 'or', 'target', 'of', 'less', 'mm', 'hg', '(', 'standard', 'treatment', ')', '.', 'primary', 'composite', 'outcome', 'myocardial', 'infarction', ',', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'heart', 'failure', ',', 'or', 'death', 'cardiovascular', 'cause', '.', 'result', 'year', ',', 'mean', 'systolic', 'blood', 'pressure', '.', 'mm', 'hg', 'in', 'intensive-treatment', 'group', 'and', '.', 'mm', 'hg', 'in', 'standard-treatment', 'group', '.', 'intervention', 'stopped', 'early', 'median', 'follow-up', 'of', '.', 'year', 'owing', 'to', 'significantly', 'lower', 'rate', 'of', 'primary', 'composite', 'outcome', 'in', 'intensive-treatment', 'group', 'in', 'standard-treatment', 'group', '(', '.', 'per', 'year', 'vs.', '.', 'per', 'year', 'hazard', 'ratio', 'with', 'intensive', 'treatment', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'all-cause', 'mortality', 'also', 'significantly', 'lower', 'in', 'intensive-treatment', 'group', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'rate', 'of', 'serious', 'adverse', 'event', 'of', 'hypotension', ',', 'syncope', ',', 'electrolyte', 'abnormality', ',', 'and', 'acute', 'kidney', 'injury', 'or', 'failure', ',', 'not', 'of', 'injurious', 'fall', ',', 'higher', 'in', 'intensive-treatment', 'group', 'in', 'standard-treatment', 'group', '.', 'conclusion', 'among', 'patient', 'high', 'risk', 'cardiovascular', 'event', 'without', 'diabetes', ',', 'targeting', 'systolic', 'blood', 'pressure', 'of', 'less', 'mm', 'hg', ',', 'compared', 'with', 'less', 'mm', 'hg', ',', 'resulted', 'in', 'lower', 'rate', 'of', 'fatal', 'and', 'nonfatal', 'major', 'cardiovascular', 'event', 'and', 'death', 'cause', ',', 'although', 'significantly', 'higher', 'rate', 'of', 'adverse', 'event', 'observed', 'in', 'intensive-treatment', 'group', '.', '(', 'funded', 'national', 'institute', 'of', 'health', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19).","Ranjani Somayaji, David R Luke, Arthur Lau, Rahmet Guner, Ŏ Fehmi Tabak, Mark Hepokoski, Nancy Gardetto, Steven A Conrad, Sunil D Kumar, Kalyan Ghosh, Stephen M Robbins, Donna L Senger, Daisy Sun, Rachel K S Lim, Jonathan Liu, Fatma Eser, Ridvan Karaali, Alain Tremblay, Daniel Muruve, Ranjani Somayajiet al.",2024 Mar 15,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/38490660/,No keywords found,"['dipeptidase-', '(', 'dpep-', ')', 'recently', 'discovered', 'leucocyte', 'adhesion', 'receptor', 'neutrophil', 'and', 'monocyte', 'in', 'lung', 'and', 'kidney', 'and', 'serf', 'potential', 'therapeutic', 'target', 'to', 'attenuate', 'inflammation', 'in', 'moderate-to-severe', 'covid-', '.', 'aimed', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'dpep-', 'inhibitor', ',', 'lsalt', 'peptide', ',', 'to', 'prevent', 'specific', 'organ', 'dysfunction', 'in', 'patient', 'hospitalised', 'with', 'covid-', '.', 'design', 'phase', 'randomised', ',', 'placebo-controlled', ',', 'double-blinded', ',', 'trial', '.', 'setting', 'hospital', 'in', 'canada', ',', 'turkey', 'and', 'usa', '.', 'participant', 'total', 'of', 'subject', 'with', 'moderate-to-severe', 'covid-', '.', 'intervention', 'randomisation', 'to', 'lsalt', 'peptide', 'mg', 'intravenously', 'daily', 'or', 'placebo', 'to', 'day', '.', 'primary', 'and', 'secondary', 'outcome', 'measure', 'primary', 'endpoint', 'proportion', 'of', 'subject', 'alive', 'and', 'free', 'of', 'respiratory', 'failure', 'andor', 'need', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', '.', 'numerous', 'secondary', 'and', 'exploratory', 'endpoint', 'assessed', 'including', 'ventilation-free', 'day', ',', 'and', 'change', 'in', 'kidney', 'function', 'or', 'serum', 'biomarkers', '.', 'result', 'day', ',', '(', '.', ')', 'and', '(', '.', ')', 'of', 'subject', 'in', 'placebo', 'and', 'lsalt', 'group', 'free', 'of', 'respiratory', 'failure', 'and', 'need', 'rrt', '(', 'p.', ')', '.', 'day', 'and', ',', 'number', 'of', 'patient', 'still', 'requiring', 'intensive', 'respiratory', 'support', '(', 'lminute', ',', 'non-invasive', 'or', 'invasive', 'mechanical', 'ventilation', 'or', 'extracorporeal', 'membrane', 'oxygenation', ')', '(', '.', ')', 'and', '(', '.', ')', 'in', 'placebo', 'group', 'versus', '(', '.', ')', 'and', '(', '.', ')', 'in', 'lsalt', 'group', ',', 'respectively', '(', 'p.', 'p.', ')', '.', 'unadjusted', 'analysis', 'of', 'ventilation-free', 'day', 'demonstrated', '.', 'day', 'lsalt', 'group', 'compared', 'with', '.', 'in', 'placebo', 'group', '(', 'p.', ')', '.', 'lsalt-treated', 'subject', 'significant', 'reduction', 'in', 'fold', 'expression', 'baseline', 'to', 'end', 'of', 'treatment', 'of', 'serum', 'cxcl', 'compared', 'with', 'placebo', '(', 'p.', ')', '.', 'treatment-emergent', 'adverse', 'event', 'similar', 'group', '.', 'conclusion', 'in', 'phase', 'study', ',', 'lsalt', 'peptide', 'demonstrated', 'to', 'safe', 'and', 'tolerated', 'in', 'patient', 'hospitalised', 'with', 'moderate-to-severe', 'covid-', '.', 'trial', 'registration', 'number', 'nct', '.']"
Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial.,"Michael J Mack, Michael A Acker, Annetine C Gelijns, Jessica R Overbey, Michael K Parides, Jeffrey N Browndyke, Mark A Groh, Alan J Moskowitz, Neal O Jeffries, Gorav Ailawadi, Vinod H Thourani, Ellen G Moquete, Alexander Iribarne, Pierre Voisine, Louis P Perrault, Michael E Bowdish, Michel Bilello, Christos Davatzikos, Ralph F Mangusan, Rachelle A Winkle, Peter K Smith, Robert E Michler, Marissa A Miller, Karen L O'Sullivan, Wendy C Taddei-Peters, Eric A Rose, Richard D Weisel, Karen L Furie, Emilia Bagiella, Claudia Scala Moy, Patrick T O'Gara, Steven R Messé                              ;, Cardiothoracic Surgical Trials Network (CTSN), Michael J Macket al.",2017 Aug 8,JAMA,https://pubmed.ncbi.nlm.nih.gov/28787505/,No keywords found,"['stroke', 'major', 'complication', 'of', 'surgical', 'aortic', 'valve', 'replacement', '(', 'savr', ')', '.', 'objective', 'to', 'determine', 'efficacy', 'and', 'adverse', 'effect', 'of', 'cerebral', 'embolic', 'protection', 'device', 'in', 'reducing', 'ischemic', 'central', 'nervous', 'system', '(', 'cns', ')', 'injury', 'savr', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'randomized', 'clinical', 'trial', 'of', 'patient', 'with', 'calcific', 'aortic', 'stenosis', 'undergoing', 'savr', 'north', 'american', 'center', 'march', 'and', 'july', '.', 'end', 'of', 'follow-up', 'december', '.', 'intervention', 'use', 'of', 'of', 'cerebral', 'embolic', 'protection', 'device', '(', 'n', 'suction-based', 'extraction', 'and', 'n', 'intra-aortic', 'filtration', 'device', ')', 'v', 'standard', 'aortic', 'cannula', '(', 'control', 'n', ')', 'time', 'of', 'savr', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', 'freedom', 'clinical', 'or', 'radiographic', 'cns', 'infarction', 'day', '(', 'day', ')', 'procedure', '.', 'secondary', 'end', 'point', 'included', 'composite', 'of', 'mortality', ',', 'clinical', 'ischemic', 'stroke', ',', 'and', 'acute', 'kidney', 'injury', 'within', 'day', 'surgery', 'delirium', 'mortality', 'serious', 'adverse', 'event', 'and', 'neurocognition', '.', 'result', 'among', 'randomized', 'patient', '(', 'mean', 'age', ',', '.', 'year', '.', 'woman', '.', 'completed', 'trial', ')', ',', 'rate', 'of', 'freedom', 'cns', 'infarction', 'day', '.', 'with', 'suction-based', 'extraction', 'v', '.', 'with', 'control', '(', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', ')', 'and', '.', 'with', 'intra-aortic', 'filtration', 'v', '.', 'with', 'control', '(', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', ')', '.', '-day', 'composite', 'end', 'point', 'not', 'significantly', 'different', 'suction-based', 'extraction', 'and', 'control', '(', '.', 'v', '.', ',', 'respectively', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', ')', 'intra-aortic', 'filtration', 'and', 'control', '(', '.', 'v', '.', 'between-group', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'mortality', '(', '.', 'suction-based', 'extraction', 'v', '.', 'control', 'and', '.', 'intra-aortic', 'filtration', 'v', '.', 'control', ')', 'or', 'clinical', 'stroke', '(', '.', 'suction-based', 'extraction', 'v', '.', 'control', 'and', '.', 'intra-aortic', 'filtration', 'v', '.', 'control', ')', '.', 'delirium', 'postoperative', 'day', '.', 'suction-based', 'extraction', 'v', '.', 'control', '(', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', ')', 'and', '.', 'intra-aortic', 'filtration', 'v', '.', 'control', '(', 'between-group', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', ')', '.', 'mortality', 'and', 'overall', 'serious', 'adverse', 'event', 'day', 'not', 'significantly', 'different', 'across', 'group', '.', 'patient', 'in', 'intra-aortic', 'filtration', 'group', 'v', 'patient', 'in', 'control', 'group', 'experienced', 'significantly', 'acute', 'kidney', 'injury', 'event', '(', 'v', ',', 'respectively', 'p', '.', ')', 'and', 'cardiac', 'arrhythmia', '(', 'v', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'patient', 'undergoing', 'savr', ',', 'cerebral', 'embolic', 'protection', 'device', 'compared', 'with', 'standard', 'aortic', 'cannula', 'not', 'significantly', 'reduce', 'risk', 'of', 'cns', 'infarction', 'day', '.', 'potential', 'benefit', 'reduction', 'in', 'delirium', ',', 'cognition', ',', 'and', 'symptomatic', 'stroke', 'merit', 'larger', 'trial', 'with', 'longer', 'follow-up', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial.,"Stéphane Gaudry, David Hajage, Frédérique Schortgen, Laurent Martin-Lefevre, Charles Verney, Bertrand Pons, Eric Boulet, Alexandre Boyer, Guillaume Chevrel, Nicolas Lerolle, Dorothée Carpentier, Nicolas de Prost, Alexandre Lautrette, Anne Bretagnol, Julien Mayaux, Saad Nseir, Bruno Megarbane, Marina Thirion, Jean-Marie Forel, Julien Maizel, Hodane Yonis, Philippe Markowicz, Guillaume Thiery, Florence Tubach, Jean-Damien Ricard, Didier Dreyfuss, Stéphane Gaudryet al.",2018 Jul 1,Am J Respir Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/29351007/,No keywords found,"['optimal', 'strategy', 'initiation', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'in', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', 'in', 'context', 'of', 'septic', 'shock', 'and', 'acute', 'respiratory', 'distress', 'syndrome', '(', 'ards', ')', 'unknown', '.', 'objective', 'to', 'examine', 'effect', 'of', 'early', 'compared', 'with', 'delayed', 'rrt', 'initiation', 'strategy', '-day', 'mortality', 'according', 'to', 'baseline', 'sepsis', 'status', ',', 'ards', 'status', ',', 'and', 'severity', '.', 'method', 'post', 'hoc', 'analysis', 'of', 'akiki', '(', 'artificial', 'kidney', 'initiation', 'in', 'kidney', 'injury', ')', 'trial', '.', 'measurement', 'and', 'main', 'result', 'subgroup', 'defined', 'according', 'to', 'baseline', 'characteristic', 'sepsis', 'status', '(', 'sepsis-', 'definition', ')', ',', 'ards', 'status', '(', 'berlin', 'definition', ')', ',', 'simplified', 'acute', 'physiology', 'score', '(', 'sap', ')', ',', 'and', 'sepsis-related', 'organ', 'failure', 'assessment', '(', 'sofa', ')', '.', 'of', 'patient', ',', '(', ')', 'septic', 'shock', 'and', '(', ')', 'ards', '.', 'found', 'no', 'significant', 'influence', 'of', 'baseline', 'sepsis', 'status', '(', 'p', '.', ')', ',', 'baseline', 'ards', 'status', '(', 'p', '.', ')', ',', 'and', 'baseline', 'severity', 'score', '(', 'p', '.', 'and', 'p', '.', 'sap', 'and', 'sofa', ',', 'respectively', ')', 'comparison', 'of', '-day', 'mortality', 'according', 'to', 'rrt', 'initiation', 'strategy', '.', 'delayed', 'rrt', 'initiation', 'strategy', 'allowed', 'of', 'patient', 'with', 'septic', 'shock', 'and', 'of', 'patient', 'with', 'ards', 'to', 'escape', 'rrt', '.', 'urine', 'output', 'higher', 'in', 'delayed', 'group', '.', 'renal', 'function', 'recovery', 'occurred', 'earlier', 'with', 'delayed', 'rrt', 'strategy', 'in', 'patient', 'with', 'septic', 'shock', 'or', 'ards', '(', 'p', '.', 'and', 'p', '.', ',', 'respectively', ')', '.', 'time', 'to', 'successful', 'extubation', 'in', 'patient', 'with', 'ards', 'not', 'affected', 'rrt', 'strategy', '(', 'p', '.', ')', '.', 'conclusion', 'early', 'rrt', 'initiation', 'strategy', 'not', 'associated', 'with', 'improvement', 'of', '-day', 'mortality', 'in', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', 'and', 'septic', 'shock', 'or', 'ards', '.', 'unnecessary', 'and', 'potentially', 'risky', 'procedure', 'might', 'often', 'avoided', 'in', 'fragile', 'population', '.', 'clinical', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', '(', 'nct', ')', '.']"
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.,"G Michael Deeb, Michael J Reardon, Stan Chetcuti, Himanshu J Patel, P Michael Grossman, Steven J Yakubov, Neal S Kleiman, Joseph S Coselli, Thomas G Gleason, Joon Sup Lee, James B Hermiller Jr, John Heiser, William Merhi, George L Zorn rd, Peter Tadros, Newell Robinson, George Petrossian, G Chad Hughes, J Kevin Harrison, Brijeshwar Maini, Mubashir Mumtaz, John Conte, Jon Resar, Vicken Aharonian, Thomas Pfeffer, Jae K Oh, Hongyan Qiao, David H Adams, Jeffrey J Popma                              ;, CoreValve US Clinical Investigators, G Michael Deebet al.",2016 Jun 7,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/27050187/,No keywords found,"['in', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'increased', 'risk', 'surgery', ',', 'self-expanding', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'associated', 'with', 'improved', '-year', 'survival', 'compared', 'with', 'surgery', '.', 'objective', 'study', 'sought', 'to', 'determine', 'whether', 'clinical', 'benefit', 'sustained', 'time', '.', 'method', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'deemed', 'increased', 'risk', 'surgery', 'multidisciplinary', 'heart', 'team', 'randomized', 'to', 'tavr', 'or', 'open', 'surgical', 'valve', 'replacement', '(', 'savr', ')', '.', 'three-year', 'clinical', 'and', 'echocardiographic', 'outcome', 'obtained', 'in', 'patient', 'with', 'attempted', 'procedure', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', 'u.s.', 'center', 'patient', 'underwent', 'attempted', 'procedure', '.', 'three-year', 'all-cause', 'mortality', 'or', 'stroke', 'significantly', 'lower', 'in', 'tavr', 'patient', '(', '.', 'vs.', '.', 'in', 'savr', 'p', '.', ')', '.', 'adverse', 'clinical', 'outcome', 'component', 'also', 'reduced', 'in', 'tavr', 'patient', 'compared', 'with', 'savr', 'patient', ',', 'including', 'all-cause', 'mortality', '(', '.', 'v', '.', '.', ',', 'respectively', 'p', '.', ')', ',', 'stroke', '(', '.', 'v', '.', '.', ',', 'respectively', 'p', '.', ')', ',', 'and', 'major', 'adverse', 'cardiovascular', 'or', 'cerebrovascular', 'event', '(', '.', 'v', '.', '.', ',', 'respectively', 'p', '.', ')', '.', 'year', 'aortic', 'valve', 'hemodynamics', 'better', 'with', 'tavr', 'patient', '(', 'mean', 'aortic', 'valve', 'gradient', '.', '.', 'mm', 'hg', 'vs.', '.', '.', 'mm', 'hg', 'in', 'savr', 'p', '.', ')', ',', 'although', 'moderate', 'or', 'severe', 'residual', 'aortic', 'regurgitation', 'higher', 'in', 'tavr', 'patient', '(', '.', 'vs.', '.', 'in', 'savr', 'p', '.', ')', '.', 'no', 'clinical', 'evidence', 'of', 'valve', 'thrombosis', 'in', 'either', 'group', '.', 'conclusion', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'increased', 'risk', 'surgery', 'improved', '-year', 'clinical', 'outcome', 'tavr', 'compared', 'with', 'surgery', '.', 'aortic', 'valve', 'hemodynamics', 'favorable', 'in', 'tavr', 'patient', 'without', 'difference', 'in', 'structural', 'valve', 'deterioration', '.', '(', 'safety', 'and', 'efficacy', 'study', 'of', 'medtronic', 'corevalve', '(', ')', 'system', 'in', 'treatment', 'of', 'symptomatic', 'severe', 'aortic', 'stenosis', 'in', 'high', 'risk', 'and', 'high', 'risk', 'subject', 'need', 'aortic', 'valve', 'replacement', 'nct', ')', '.']"
Remote Postdischarge Treatment of Patients With Acute Myocardial Infarction by Allied Health Care Practitioners vs Standard Care: The IMMACULATE Randomized Clinical Trial.,"Mark Y Chan, Karen W L Koh, Sock-Cheng Poh, Stephanie Marchesseau, Devinder Singh, Yiying Han, Faclin Ng, Eleanor Lim, Joseph F Prabath, Chi-Hang Lee, Hui-Wen Sim, Ruth Chen, Leonardo Carvalho, Sock-Hwee Tan, Joshua P Y Loh, Jack W C Tan, Karishma Kuwelker, R M Amanullah, Chee-Tang Chin, James W L Yip, Choy-Yee Lee, Juvena Gan, Chew-Yong Lo, Hee-Hwa Ho, Derek J Hausenloy, Bee-Choo Tai, A Mark Richards                                                                                          ;, IMMACULATE Investigators, Mark Y Chanet al.",2021 Jul 1,JAMA Cardiol,https://pubmed.ncbi.nlm.nih.gov/33377898/,No keywords found,"['data', 'remote', 'postdischarge', 'treatment', 'of', 'patient', 'with', 'acute', 'myocardial', 'infarction', '.', 'objective', 'to', 'compare', 'safety', 'and', 'efficacy', 'of', 'allied', 'health', 'care', 'practitioner-led', 'remote', 'intensive', 'management', '(', 'rim', ')', 'with', 'cardiologist-led', 'standard', 'care', '(', 'sc', ')', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'intention-to-treat', 'feasibility', 'trial', 'randomized', 'patient', 'with', 'acute', 'myocardial', 'infarction', 'undergoing', 'early', 'revascularization', 'and', 'with', 'n-terminal-pro-b-type', 'natriuretic', 'peptide', 'concentration', 'pgml', 'to', 'rim', 'or', 'sc', 'across', 'hospital', 'in', 'singapore', 'july', ',', ',', 'to', 'march', ',', '.', 'rim', 'participant', 'underwent', 'month', 'of', 'remote', 'consultation', 'included', '-blocker', 'and', 'angiotensin-converting', 'enzyme', 'inhibitorangiotensin', 'receptor', 'blocker', '(', 'ace-iarb', ')', 'dose', 'adjustment', 'centralized', 'nurse', 'practitioner', 'team', 'sc', 'participant', 'treated', 'face-to-face', 'cardiologist', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'safety', 'end', 'point', 'composite', 'of', 'hypotension', ',', 'bradycardia', ',', 'hyperkalemia', ',', 'or', 'acute', 'kidney', 'injury', 'requiring', 'hospitalization', '.', 'to', 'assess', 'efficacy', 'of', 'rim', 'in', 'dose', 'adjustment', 'of', '-blockers', 'and', 'ace-iarbs', 'compared', 'with', 'sc', ',', 'dose', 'intensity', 'score', 'derived', 'converting', 'comparable', 'dos', 'of', 'different', '-blockers', 'and', 'ace-iarbs', 'to', 'scale', 'to', '.', 'primary', 'efficacy', 'end', 'point', '-month', 'indexed', 'left', 'ventricular', 'end-systolic', 'volume', '(', 'lvesv', ')', 'adjusted', 'baseline', 'lvesv', '.', 'result', 'of', 'participant', ',', '(', '.', ')', 'randomized', 'to', 'rim', 'and', '(', '.', ')', 'to', 'sc', '.', 'rim', 'and', 'sc', 'participant', 'similar', 'mean', '(', 'sd', ')', 'age', '(', '.', '.', 'v', '.', '.', 'year', ')', ',', 'median', '(', 'interquartile', 'range', ')', 'n-terminal-pro-b-type', 'natriuretic', 'peptide', 'concentration', '(', '-', 'v', '-', 'pgml', ')', ',', 'mean', '(', 'sd', ')', 'baseline', 'left', 'ventricular', 'ejection', 'fraction', '(', '.', '.', 'v', '.', '.', ')', ',', 'and', 'mean', '(', 'sd', ')', 'indexed', 'lvesv', '(', '.', '.', 'v', '.', '.', 'mlm', ')', 'patient', '.', 'left', 'ventricular', 'ejection', 'fraction', '.', 'primary', 'safety', 'end', 'point', 'occurred', 'in', 'rim', 'v', 'sc', 'participant', '(', '.', ')', '(', 'p', '.', ')', '.', 'mean', '-blocker', 'and', 'ace-iarb', 'dose', 'intensity', 'score', 'month', '.', 'v', '.', '(', 'adjusted', 'mean', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', 'and', '.', 'v', '.', '(', 'adjusted', 'mean', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', ',', 'respectively', '.', '-month', 'indexed', 'lvesv', '.', 'v', '.', 'mlm', '(', 'adjusted', 'mean', 'difference', ',', '-', '.', 'mlm', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'low-risk', 'patient', 'with', 'revascularization', 'myocardial', 'infarction', ',', 'rim', 'allied', 'health', 'care', 'professional', 'feasible', 'and', 'safe', '.', 'no', 'difference', 'in', 'achieved', 'medication', 'dos', 'or', 'index', 'of', 'left', 'ventricular', 'remodeling', '.', 'study', 'of', 'rim', 'in', 'higher-risk', 'cohort', 'warranted', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial.,"Luis Eduardo Morales-Buenrostro, Juan Antonio Ortega-Trejo, Rosalba Pérez-Villalva, Lluvia A Marino, Yvett González-Bobadilla, Hilda Juárez, Flor M Zamora-Mejía, Norma González, Ramón Espinoza, Jonatan Barrera-Chimal, Norma A Bobadilla, Luis Eduardo Morales-Buenrostroet al.",2019 Sep 1,Am J Physiol Renal Physiol,https://pubmed.ncbi.nlm.nih.gov/31241992/,"kidney transplantation, mineralocorticoid receptor blockade, postischemic injury.","['mineralocorticoid', 'receptor', 'antagonism', 'prevents', 'acute', 'kidney', 'injury', 'induced', 'ischemia-reperfusion', 'in', 'rodent', 'and', 'pig', 'preclinical', 'model', '.', 'in', 'pilot', 'study', ',', 'showed', 'spironolactone', '(', 'mg', ')', 'reduced', 'oxidative', 'stress', 'day', 'of', 'kidney', 'transplant', '(', 'kt', ')', '.', 'in', 'present', 'study', ',', 'investigated', 'effect', 'of', 'higher', 'dos', '(', 'and', 'mg', ')', 'of', 'spironolactone', 'kidney', 'function', ',', 'tubular', 'injury', 'marker', ',', 'and', 'oxidative', 'stress', 'in', 'living', 'donor', 'kt', 'recipient', '.', 'included', 'kt', 'recipient', 'aged', 'yr', 'or', 'older', 'received', 'immunosuppression', 'therapy', 'with', 'il-', 'receptor', 'antagonist', ',', 'mycophenolate', 'mofetil', ',', 'corticosteroid', ',', 'and', 'tacrolimus', 'with', 'negative', 'cross-match', ',', 'and', 'compatible', 'blood', 'group', '.', 'patient', 'randomized', 'to', 'receive', 'placebo', '(', 'n', ')', ',', 'spironolactone', '(', 'mg', ',', 'n', ')', ',', 'or', 'spironolactone', '(', 'mg', ',', 'n', ')', '.', 'treatment', 'given', 'day', 'and', 'to', 'day', 'kt', '.', 'serum', 'creatinine', ',', 'k', ',', 'urine', 'neutrophil', 'gelatinase-associated', 'lipocalin-', ',', 'heat', 'shock', 'protein', ',', 'and', '-hydroxy', '--', 'deoxyguanosine', 'level', 'assessed', '.', 'expected', ',', 'kidney', 'function', 'improved', 'kt', '.', 'serum', 'k', 'remained', 'in', 'normal', 'range', 'along', 'study', '.', 'no', 'significant', 'effect', 'of', 'spironolactone', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin-', 'level', ',', 'whereas', 'increase', 'in', 'urinary', 'heat', 'shock', 'protein', 'level', 'tended', 'to', 'less', 'intense', 'in', 'mg', 'spironolactone-treated', 'group', '(', 'p', '.', ')', '.', 'in', 'placebo-treated', 'group', ',', 'urinary', '-hydroxylated-guanosine', 'level', 'increased', 'day', 'and', 'transplantation', '.', 'effect', 'prevented', 'in', 'patient', 'received', 'spironolactone', '.', 'in', 'conclusion', ',', 'spironolactone', 'reduces', 'acute', 'increase', 'in', 'urinary', 'oxidative', 'stress', 'in', 'living', 'donor', 'kt', 'recipient', '.']"
High Stroke Volume Variation Method by Mannitol Administration Can Decrease Blood Loss During Donor Hepatectomy.,"Hyungseok Seo, In-Gu Jun, Tae-Yong Ha, Shin Hwang, Sung-Gyu Lee, Young-Kug Kim, Hyungseok Seoet al.",2016 Jan,Medicine (Baltimore),https://pubmed.ncbi.nlm.nih.gov/26765409/,No keywords found,"['optimal', 'fluid', 'management', 'to', 'reduce', 'blood', 'loss', 'donor', 'hepatectomy', 'important', 'maximizing', 'donor', 'safety', '.', 'mannitol', 'induce', 'osmotic', 'diuresis', ',', 'helping', 'prevent', 'increased', 'intravascular', 'volume', 'status', '.', 'therefore', 'evaluated', 'effect', 'of', 'high', 'stroke', 'volume', 'variation', '(', 'svv', ')', 'method', 'mannitol', 'administration', 'and', 'fluid', 'restriction', 'blood', 'loss', 'donor', 'hepatectomy.in', 'prospective', 'study', ',', 'donor', 'scheduled', 'donor', 'right', 'hepatectomy', 'included', 'and', 'allocated', 'group', '.', 'in', 'group', ',', 'svv', 'value', 'of', 'patient', 'maintained', 'to', 'hepatic', 'resection', 'with', '.', 'gkg', 'mannitol', 'administration', 'and', 'fluid', 'restriction', 'rate', 'of', 'to', 'mlkgh', '.', 'in', 'group', 'b', ',', 'svv', 'value', 'maintained', 'fluid', 'administration', 'rate', 'of', 'to', 'mlkgh', 'without', 'diuretic', 'administration', 'surgery', '.', 'intraoperative', 'blood', 'loss', 'estimated', 'loss', 'of', 'red', 'cell', 'mass', '.', 'surgeon', 'satisfaction', 'score', 'and', 'postoperative', 'outcome', ',', 'including', 'acute', 'kidney', 'injury', ',', 'abnormal', 'chest', 'radiographic', 'finding', ',', 'and', 'hospital', 'stay', 'duration', ',', 'also', 'assessed.svv', 'hepatectomy', 'significantly', 'higher', 'in', 'group', 'in', 'group', 'b', '(', '.', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'red', 'cell', 'mass', 'loss', 'significantly', 'lower', 'in', 'group', 'in', 'group', 'b', '(', '.', '.', 'v', '.', '.', 'ml', ',', 'p', '.', ')', '.', 'surgeon', 'satisfaction', 'score', 'higher', 'in', 'group', 'in', 'group', 'b', '(', '.', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'abnormal', 'chest', 'radiographic', 'finding', ',', 'and', 'duration', 'of', 'hospital', 'stay', 'not', 'significantly', 'differ', 'groups.maintenance', 'of', 'high', 'svv', 'mannitol', 'administration', 'effective', 'and', 'safe', 'reducing', 'blood', 'loss', 'donor', 'hepatectomy', '.']"
Kidney injury molecule-1 staining in renal allograft biopsies 10 days after transplantation is inversely correlated with functioning proximal tubular epithelial cells.,"Jonna R Bank, Pieter van der Pol, Dianne Vreeken, Catherine Monge-Chaubo, Ingeborg M Bajema, Nicole Schlagwein, Daniëlle J van Gijlswijk, Sandra W van der Kooij, Marlies E J Reinders, Johan W de Fijter, Cees van Kooten, Jonna R Banket al.",2017 Dec 1,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/29045706/,No keywords found,"['kidney', 'injury', 'molecule-', '(', 'kim-', ')', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'promising', 'biomarkers', 'monitoring', 'delayed', 'graft', 'function', '(', 'dgf', ')', 'kidney', 'transplantation', '.', 'investigated', 'localization', 'and', 'distribution', 'of', 'kim-', 'and', 'ngal', 'staining', 'in', 'renal', 'allograft', 'biopsy', 'and', 'studied', 'association', 'with', 'histological', 'feature', ',', 'functional', 'dgf', '(', 'fdgf', ')', 'and', 'tubular', 'function', 'slope', '(', 'tfs', ')', ',', 'functioning', 'proximal', 'tubular', 'epithelial', 'cell', '(', 'ptec', ')', 'marker', '.', 'method', 'day', 'protocol', 'biopsy', 'of', 'donation', 'circulatory', 'death', 'recipient', 'stained', 'kim-', 'and', 'ngal', 'and', 'positive', 'area', 'quantified', 'using', 'imagej', 'software', '.', 'biopsy', 'scored', 'according', 'to', 'banff', 'and', 'acute', 'tubular', 'necrosis', '(', 'atn', ')', 'criterion', '.', 'mtechnetium-mercaptoacetyltriglycine', '(', 'mtc-mag', ')', '-renography', 'performed', 'to', 'calculate', 'tfs', '.', 'result', 'kim-', 'staining', 'located', 'brush', 'border', 'of', 'tubular', 'epithelial', 'cell', '(', 'tec', ')', 'and', 'correlated', 'with', 'denudation', ',', 'ngal', 'present', 'focally', 'in', 'cytoplasmic', 'distribution', '.', 'kim-', 'and', 'ngal', 'staining', 'not', 'correlated', 'and', 'no', 'co-localization', 'observed', '.', 'quantitative', 'staining', 'not', 'associated', 'with', 'fdgf', ',', 'kim-', 'tended', 'to', 'higher', 'in', 'patient', 'with', 'prolonged', 'fdgf', '(', 'day', 'p', '.', ')', '.', 'no', 'correlation', 'observed', 'quantitative', 'tissue', 'staining', 'and', 'urinary', 'kim-', 'or', 'ngal', '.', 'quantitative', 'kim-', 'staining', 'inversely', 'correlated', 'with', 'tfs', '(', 'spearman', ""'s"", '-', '.', 'p', '.', ')', ',', 'whereas', 'ngal', 'not', '.', 'latter', 'finding', 'might', 'cortical', 'ngal', 'staining', 'dependent', 'filtration', 'and', 'subsequent', 'reabsorption', 'functioning', 'ptecs', '.', 'staining', 'of', 'ngal', 'indeed', 'restricted', 'to', 'ptecs', ',', 'shown', 'co-localization', 'with', 'ptec-specific', 'lectin', '.', 'conclusion', 'kim-', 'and', 'ngal', 'staining', 'showed', 'different', 'localization', 'and', 'distribution', '.', 'quantitative', 'kim-', 'staining', 'inversely', 'correlated', 'with', 'functioning', 'ptecs', '.']"
Circulating endothelial cells transiently increase in peripheral blood after kidney transplantation.,"H Tejeda-Mora, J G H P Verhoeven, W Verschoor, K Boer, D A Hesselink, M W F van den Hoogen, L J W van der Laan, C C Baan, R C Minnee, M J Hoogduijn, H Tejeda-Moraet al.",2021 Apr 26,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/33903694/,No keywords found,"['diagnosis', 'of', 'kidney', 'allograft', 'rejection', 'based', 'late', 'histological', 'and', 'clinical', 'marker', '.', 'early', ',', 'specific', 'and', 'minimally-invasive', 'biomarkers', 'may', 'improve', 'rejection', 'diagnosis', '.', 'endothelial', 'cell', '(', 'ec', ')', 'one', 'of', 'earliest', 'target', 'in', 'kidney', 'transplant', 'rejection', '.', 'investigated', 'whether', 'circulating', 'ec', '(', 'cec', ')', 'could', 'serve', 'earlier', 'and', 'less', 'invasive', 'biomarker', 'allograft', 'rejection', '.', 'blood', 'collected', 'cohort', 'of', 'kidney', 'transplant', 'recipient', 'and', 'multiple', 'timepoints', 'transplantation', ',', 'including', 'cause', 'biopsy', '.', 'number', 'and', 'phenotype', 'of', 'ec', 'assessed', 'flow-cytometric', 'analysis', '.', 'unbiased', 'selection', 'of', 'ec', 'done', 'using', 'principal', 'component', '(', 'pca', ')', 'analysis', '.', 'paired', 'analysis', 'revealed', 'transient', 'cec', 'increase', 'of', '.-fold', 'third', 'day', 'post-transplant', ',', 'recovering', 'to', 'preoperative', 'level', 'seventh', 'day', 'post-transplant', 'and', 'onwards', '.', 'analysis', 'of', 'hla', 'subtype', 'demonstrated', 'cec', 'mainly', 'originate', 'recipient', '.', 'cec', 'level', 'not', 'associated', 'with', 'allograft', 'rejection', ',', 'allograft', 'function', 'or', 'allograft', 'pathology', '.', 'however', ',', 'cec', 'in', 'patient', 'with', 'allograft', 'rejection', 'and', 'increased', 'level', 'of', 'cec', 'showed', 'elevated', 'level', 'of', 'kim-', '(', 'kidney', 'injury', 'marker-', ')', '.', 'finding', 'indicate', 'cec', 'number', 'and', 'phenotype', 'affected', 'kidney', 'transplantation', 'may', 'not', 'improve', 'rejection', 'diagnosis', '.']"
Effect of using hypotension prediction index versus conventional goal-directed haemodynamic management to reduce intraoperative hypotension in non-cardiac surgery: A randomised controlled trial.,"Yusuke Yoshikawa, Makishi Maeda, Tatsuya Kunigo, Tomoe Sato, Kanako Takahashi, Sho Ohno, Tomoki Hirahata, Michiaki Yamakage, Yusuke Yoshikawaet al.",2024 May:93:111348.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/38039629/,No keywords found,"['remains', 'unclear', 'whether', 'hypotension', 'prediction', 'index', 'or', 'goal-directed', 'haemodynamic', 'therapy', 'mitigates', 'intraoperative', 'hypotension', '.', 'design', 'single', 'centre', 'randomised', 'controlled', 'trial', '.', 'setting', 'sapporo', 'medical', 'university', 'hospital', '.', 'patient', 'total', 'of', 'adult', 'patient', 'undergoing', 'major', 'non-cardiac', 'surgery', 'general', 'anaesthesia', '.', 'intervention', 'patient', 'randomly', 'assigned', 'to', 'either', 'group', 'receiving', 'conventional', 'goal-directed', 'therapy', '(', 'flotrac', 'group', ')', 'or', 'combination', 'of', 'hypotension', 'prediction', 'index', 'and', 'conventional', 'goal-directed', 'therapy', '(', 'hpi', 'group', ')', '.', 'to', 'investigate', 'independent', 'utility', 'of', 'index', ',', 'peak', 'rate', 'of', 'arterial', 'pressure', 'and', 'dynamic', 'arterial', 'elastance', 'not', 'included', 'in', 'treatment', 'algorithm', 'hpi', 'group', '.', 'measurement', 'primary', 'outcome', 'time-weighted', 'average', 'of', 'area', 'threshold', '.', 'secondary', 'outcome', 'area', 'threshold', ',', 'number', 'of', 'hypotension', 'event', ',', 'total', 'duration', 'of', 'hypotension', 'event', ',', 'mean', 'mean', 'arterial', 'pressure', 'hypotension', 'period', ',', 'number', 'of', 'hypotension', 'event', 'with', 'mean', 'arterial', 'pressure', 'mmhg', ',', 'amount', 'of', 'fluid', ',', 'blood', 'product', ',', 'blood', 'loss', ',', 'and', 'urine', 'output', ',', 'frequency', 'and', 'amount', 'of', 'vasoactive', 'agent', ',', 'concentration', 'of', 'haemoglobin', 'monitoring', 'period', ',', 'and', '-day', 'mortality', '.', 'main', 'result', 'time-weighted', 'average', 'of', 'area', 'threshold', 'lower', 'in', 'hpi', 'group', 'in', 'control', 'group', '.', 'mmhg', '(', 'interquartile', 'range', ',', '.-', '.', 'mmhg', ')', 'vs.', '.', 'mmhg', '(', '.-', '.', 'mmhg', ')', ',', 'with', 'median', 'difference', 'of', '-', '.', 'mmhg', '(', 'confidence', 'interval', ',', '-', '.', 'to', '-', '.', 'mmhg', ')', ',', 'p', '..', 'norepinephrine', 'administered', 'to', '(', ')', 'and', '(', ')', 'patient', 'in', 'hpi', 'and', 'flotrac', 'group', ',', 'respectively', '(', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'observed', 'in', 'volume', 'of', 'fluid', 'and', 'blood', 'product', 'study', 'group', '.', 'conclusion', 'current', 'randomised', 'controlled', 'trial', 'result', 'suggest', 'using', 'hypotension', 'prediction', 'index', 'independently', 'lowered', 'cumulative', 'amount', 'of', 'intraoperative', 'hypotension', 'major', 'non-cardiac', 'surgery', '.']"
"Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients.","Anna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall, Michael Ljungberg, Carl Fredrik Warfvinge, Kajsa Holgersson, Andreas Hallqvist, Peter Bernhardt, Johanna Svensson, Anna Sundlövet al.",2022 Sep,Eur J Nucl Med Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/35451612/,No keywords found,"['radionuclide', 'therapy', 'with', 'lu-dotatate', 'well', 'established', 'patient', 'with', 'advanced', 'somatostatin', 'receptor-positive', 'neuroendocrine', 'tumor', 'with', 'standard', 'schedule', 'of', '.', 'gbq', 'four', 'occasion', '.', 'however', ',', 'approach', 'not', 'consider', 'individual', 'variability', 'affecting', 'tumor', 'radiation', 'dose', 'or', 'dose', 'to', 'organ', 'risk', '.', 'therefore', ',', 'important', 'to', 'assess', 'personalized', 'strategy', '.', 'aim', 'of', 'phase', 'ii', 'trial', 'to', 'evaluate', 'individualized', 'lu-dotatate', 'number', 'of', 'cycle', 'varied', 'based', 'renal', 'dosimetry', '.', 'method', 'patient', 'eligible', 'progressive', ',', 'somatostatin', 'receptor-positive', 'neuroendocrine', 'tumor', 'with', 'ki', 'labeling', 'index', '.', 'received', 'cycle', 'of', '.', 'gbq', 'of', 'lu-dotatate', '-week', 'interval', 'predefined', 'radiation', 'dose', 'to', 'kidney', 'reached', '.', 'primary', 'endpoint', 'objective', 'tumor', 'response', '(', 'recist', 'v', '.', ')', '.', 'secondary', 'endpoint', 'included', 'progression-free', 'survival', '(', 'pfs', ')', ',', 'overall', 'survival', '(', 'o', ')', ',', 'and', 'toxicity', '(', 'ctcae', 'v', '.', '.', ')', '.', 'result', 'ninety-six', 'patient', 'received', 'median', 'of', 'cycle', '(', 'range', '-', ')', 'evaluable', 'efficacy', '.', 'objective', 'tumor', 'response', 'partial', 'response', ',', 'stable', 'disease', ',', 'and', 'progressive', 'disease', '.', 'median', 'pfs', 'and', 'o', 'month', 'and', 'month', ',', 'respectively', ',', 'and', 'significantly', 'associated', 'with', 'kidney', 'dose', ',', 'performance', 'status', ',', 'and', 'ki', 'level', 'not', 'with', 'tumor', 'origin', '.', 'overall', 'toxicity', 'mild', ',', 'and', 'common', 'event', 'grade', '-', 'anemia', ',', 'thrombocytopenia', ',', 'fatigue', ',', 'nausea', ',', 'and', 'diarrhea', '.', 'grade', '-', 'toxicity', 'occurred', 'in', 'of', 'patient', 'and', 'mostly', 'hematological', ',', 'with', 'no', 'grade', '-', 'renal', 'toxicity', '.', 'conclusion', 'individualized', 'treatment', 'with', 'lu-dotatate', 'based', 'renal', 'dosimetry', 'clearly', 'feasible', 'with', 'low', 'toxicity', 'and', 'promising', 'efficacy', ',', 'showing', 'potential', 'to', 'improve', 'outcome', 'beyond', 'standard', 'approach', ',', 'and', 'assessed', 'in', 'randomized', 'trial', '.', 'trial', 'registration', 'eudract', '-', ',', '-', '.', 'nct', '.', 'httpsclinicaltrials.govctshownct', '.']"
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.,"George D Dangas, Thierry Lefèvre, Christian Kupatt, Didier Tchetche, Ulrich Schäfer, Nicolas Dumonteil, John G Webb, Antonio Colombo, Stephan Windecker, Jurriën M Ten Berg, David Hildick-Smith, Roxana Mehran, Peter Boekstegers, Axel Linke, Christophe Tron, Eric Van Belle, Anita W Asgar, Andreas Fach, Raban Jeger, Gennaro Sardella, Hans Ulrich Hink, Oliver Husser, Eberhard Grube, Efthymios N Deliargyris, Ilknur Lechthaler, Debra Bernstein, Peter Wijngaard, Prodromos Anthopoulos, Christian Hengstenberg                              ;, BRAVO- Investigators, George D Dangaset al.",2015 Dec 29,J Am Coll Cardiol,https://pubmed.ncbi.nlm.nih.gov/26477635/,No keywords found,"['anticoagulation', 'required', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'procedure', '.', 'although', 'optimal', 'regimen', 'not', 'determined', ',', 'heparin', 'mainly', 'used', '.', 'direct', 'thrombin', 'inhibition', 'with', 'bivalirudin', 'may', 'effective', 'alternative', 'to', 'heparin', 'procedural', 'anticoagulant', 'agent', 'in', 'setting', '.', 'objective', 'goal', 'of', 'study', 'to', 'determine', 'whether', 'bivalirudin', 'offer', 'alternative', 'to', 'heparin', 'procedural', 'anticoagulant', 'agent', 'in', 'patient', 'undergoing', 'tavr', '.', 'method', 'total', 'of', 'patient', 'with', 'aortic', 'stenosis', 'randomized', 'to', 'undergo', 'transfemoral', 'tavr', 'with', 'bivalirudin', 'versus', 'unfractionated', 'heparin', 'procedure', '.', 'primary', 'endpoint', 'major', 'bleeding', 'within', 'h', 'or', 'hospital', 'discharge', '(', 'whichever', 'occurred', 'first', ')', 'and', '-day', 'net', 'adverse', 'clinical', 'event', ',', 'defined', 'combination', 'of', 'major', 'adverse', 'cardiovascular', 'event', '(', 'all-cause', 'mortality', ',', 'myocardial', 'infarction', ',', 'or', 'stroke', ')', 'and', 'major', 'bleeding', '.', 'result', 'anticoagulation', 'with', 'bivalirudin', 'versus', 'heparin', 'not', 'meet', 'superiority', 'not', 'result', 'in', 'significantly', 'lower', 'rate', 'of', 'major', 'bleeding', 'h', '(', '.', 'vs.', '.', 'relative', 'risk', '.', 'confidence', 'interval', 'ci', '.', 'to', '.', 'p', '.', ')', 'or', 'net', 'adverse', 'cardiovascular', 'event', 'day', '(', '.', 'vs.', '.', 'relative', 'risk', '.', 'ci', '.', 'to', '.', 'risk', 'difference', '-', '.', 'ci', '-', '.', 'to', '.', 'p', '.', ')', 'regarding', 'latter', ',', 'prespecified', 'noninferiority', 'hypothesis', 'met', '(', 'pnoninferiority', '.', ')', '.', 'rate', 'of', 'major', 'adverse', 'cardiovascular', 'event', 'h', 'not', 'significantly', 'different', '(', '.', 'vs.', '.', 'relative', 'risk', '.', 'ci', '.', 'to', '.', 'p', '.', ')', '.', 'h', ',', 'bivalirudin', 'group', 'significantly', 'fewer', 'myocardial', 'infarction', 'acute', 'kidney', 'injury', 'event', 'heparin', 'group', 'day', ',', 'difference', 'no', 'longer', 'significant', '.', 'conclusion', 'in', 'randomized', 'trial', 'of', 'tavr', 'procedural', 'pharmacotherapy', ',', 'bivalirudin', 'not', 'reduce', 'rate', 'of', 'major', 'bleeding', 'h', 'or', 'net', 'adverse', 'cardiovascular', 'event', 'within', 'day', 'compared', 'with', 'heparin', '.', 'although', 'superiority', 'not', 'shown', ',', 'noninferiority', 'hypothesis', 'met', 'with', 'respect', 'to', 'latter', 'factor', '.', 'given', 'lower', 'cost', ',', 'heparin', 'remain', 'standard', 'of', 'care', ',', 'and', 'bivalirudin', 'alternative', 'anticoagulant', 'option', 'in', 'patient', 'unable', 'to', 'receive', 'heparin', 'in', 'tavr', '.', '(', 'international', ',', 'multi-center', ',', 'open-label', ',', 'randomized', 'controlled', 'trial', 'in', 'patient', 'undergoing', 'tavr', 'to', 'determine', 'treatment', 'effect', 'safety', 'and', 'efficacy', 'of', 'using', 'bivalirudin', 'instead', 'of', 'ufh', 'bravo-', 'nct', ')', '.']"
Liraglutide and Renal Outcomes in Type 2 Diabetes.,"Johannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, Steven P Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B Buse                              ;, LEADER Steering Committee and Investigators, Johannes F E Mannet al.",2017 Aug 31,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/28854085/,No keywords found,"['in', 'randomized', ',', 'controlled', 'trial', 'compared', 'liraglutide', ',', 'glucagon-like', 'peptide', 'analogue', ',', 'with', 'placebo', 'in', 'patient', 'with', 'type', 'diabetes', 'and', 'high', 'cardiovascular', 'risk', 'receiving', 'usual', 'care', ',', 'found', 'liraglutide', 'resulted', 'in', 'lower', 'risk', 'of', 'primary', 'end', 'point', '(', 'nonfatal', 'myocardial', 'infarction', ',', 'nonfatal', 'stroke', ',', 'or', 'death', 'cardiovascular', 'cause', ')', 'and', 'death', '.', 'however', ',', 'long-term', 'effect', 'of', 'liraglutide', 'renal', 'outcome', 'in', 'patient', 'with', 'type', 'diabetes', 'unknown', '.', 'method', 'report', 'prespecified', 'secondary', 'renal', 'outcome', 'of', 'randomized', ',', 'controlled', 'trial', 'in', 'patient', 'assigned', 'to', 'receive', 'liraglutide', 'or', 'placebo', '.', 'secondary', 'renal', 'outcome', 'composite', 'of', 'new-onset', 'persistent', 'macroalbuminuria', ',', 'persistent', 'doubling', 'of', 'serum', 'creatinine', 'level', ',', 'end-stage', 'renal', 'disease', ',', 'or', 'death', 'due', 'to', 'renal', 'disease', '.', 'risk', 'of', 'renal', 'outcome', 'determined', 'with', 'use', 'of', 'time-to-event', 'analysis', 'with', 'intention-to-treat', 'approach', '.', 'change', 'in', 'estimated', 'glomerular', 'filtration', 'rate', 'and', 'albuminuria', 'also', 'analyzed', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', ',', 'and', 'median', 'follow-up', 'of', 'patient', '.', 'year', '.', 'renal', 'outcome', 'occurred', 'in', 'fewer', 'participant', 'in', 'liraglutide', 'group', 'in', 'placebo', 'group', '(', 'of', 'patient', 'vs.', 'of', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'result', 'driven', 'primarily', 'new', 'onset', 'of', 'persistent', 'macroalbuminuria', ',', 'occurred', 'in', 'fewer', 'participant', 'in', 'liraglutide', 'group', 'in', 'placebo', 'group', '(', 'vs.', 'patient', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'rate', 'of', 'renal', 'adverse', 'event', 'similar', 'in', 'liraglutide', 'group', 'and', 'placebo', 'group', '(', '.', 'event', 'and', '.', 'event', 'per', 'patient-years', ')', ',', 'including', 'rate', 'of', 'acute', 'kidney', 'injury', '(', '.', 'and', '.', 'event', 'per', 'patient-years', ',', 'respectively', ')', '.', 'conclusion', 'prespecified', 'secondary', 'analysis', 'show', ',', 'added', 'to', 'usual', 'care', ',', 'liraglutide', 'resulted', 'in', 'lower', 'rate', 'of', 'development', 'and', 'progression', 'of', 'diabetic', 'kidney', 'disease', 'placebo', '.', '(', 'funded', 'novo', 'nordisk', 'and', 'national', 'institute', 'of', 'health', 'leader', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease.,"Santiago Garcia, Robert J Cubeddu, Rebecca T Hahn, Julien Ternacle, Samir R Kapadia, Susheel K Kodali, Vinod H Thourani, Wael A Jaber, Craig R Asher, Sammy Elmariah, Raj Makkar, John G Webb, Howard C Herrmann, Michael Lu, Chandan M Devireddy, S Chris Malaisrie, Craig R Smith, Michael J Mack, Paul Sorajja, João L Cavalcante, Mario Goessl, Gautam R Shroff, Martin B Leon, Philippe Pibarot, Santiago Garciaet al.",2021 Sep 27,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/34556273/,No keywords found,"['aim', 'of', 'study', 'to', 'compare', '-year', 'cardiovascular', ',', 'renal', ',', 'and', 'bioprosthetic', 'valve', 'durability', 'outcome', 'in', 'patient', 'with', 'severe', 'aortic', 'stenosis', '(', ')', 'and', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'undergoing', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'or', 'surgical', 'aortic', 'valve', 'replacement', '(', 'savr', ')', '.', 'background', 'patient', 'with', 'severe', 'and', 'ckd', 'undergoing', 'tavr', 'or', 'savr', 'challenging', ',', 'understudied', 'clinical', 'subset', '.', 'method', 'intermediate-risk', 'patient', 'with', 'moderate', 'to', 'severe', 'ckd', '(', 'estimated', 'glomerular', 'filtration', 'rate', 'mlminm', ')', 'partner', '(', 'placement', 'of', 'aortic', 'transcatheter', 'valve', ')', 'trial', '(', 'patient', 'randomly', 'assigned', 'to', 'sapien', 'xt', 'tavr', 'or', 'savr', ')', 'and', 'sapien', 'intermediate', 'risk', 'registry', 'pooled', '.', 'composite', 'primary', 'outcome', 'of', 'death', ',', 'stroke', ',', 'rehospitalization', ',', 'and', 'new', 'hemodialysis', 'evaluated', 'using', 'cox', 'regression', 'analysis', '.', 'patient', 'with', 'and', 'without', 'perioperative', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'followed', 'year', '.', 'core', 'laboratory-adjudicated', 'analysis', 'of', 'structural', 'valve', 'deterioration', 'and', 'bioprosthetic', 'valve', 'failure', 'also', 'performed', '.', 'result', 'study', 'population', 'included', ',', 'tavr', 'patient', '(', 'sapien', 'xt', ',', 'sapien', ')', 'and', 'savr', 'patient', '.', 'year', ',', 'savr', 'better', 'sapien', 'xt', 'tavr', '(', '.', 'v', '.', 'p', '.', ')', 'similar', 'to', 'sapien', 'tavr', '(', '.', 'v', '.', 'p', '.', ')', '.', 'perioperative', 'aki', 'common', 'savr', 'tavr', '(', '.', 'v', '.', 'p', '.', ')', 'and', 'independently', 'associated', 'with', 'long-term', 'outcome', '.', 'compared', 'with', 'savr', ',', 'bioprosthetic', 'valve', 'failure', 'and', 'stage', 'or', 'structural', 'valve', 'deterioration', 'significantly', 'greater', 'sapien', 'xt', 'tavr', '(', 'p', '.', ')', 'not', 'sapien', 'tavr', '.', 'conclusion', 'in', 'intermediate-risk', 'patient', 'with', 'and', 'ckd', ',', 'sapien', 'tavr', 'and', 'savr', 'associated', 'with', 'similar', 'risk', 'primary', 'endpoint', 'year', '.', 'aki', 'common', 'savr', 'tavr', ',', 'and', 'sapien', 'valve', 'durability', 'comparable', 'with', 'of', 'surgical', 'bioprostheses', '.']"
Permissible Intraabdominal Hypertension following Complex Abdominal Wall Reconstruction.,"Clayton C Petro, Siavash Raigani, Mojtaba Fayezizadeh, James R Rowbottom, John C Klick, Ajita S Prabhu, Yuri W Novitsky, Michael J Rosen, Clayton C Petroet al.",2015 Oct,Plast Reconstr Surg,https://pubmed.ncbi.nlm.nih.gov/26090761/,No keywords found,"['repair', 'of', 'hernia', 'with', 'loss', 'of', 'domain', 'lead', 'to', 'elevated', 'intraabdominal', 'pressure', '.', 'author', 'aimed', 'to', 'characterize', 'effect', 'of', 'elective', 'hernia', 'repair', 'intraabdominal', 'pressure', ',', 'well', 'predictor', 'and', 'association', 'with', 'negative', 'outcome', '.', 'method', 'patient', 'undergoing', 'elective', 'hernia', 'repair', 'requiring', 'myofascial', 'release', 'intraabdominal', 'and', 'pulmonary', 'plateau', 'pressure', 'measured', 'preoperatively', ',', 'postoperatively', ',', 'and', 'morning', 'of', 'first', 'postoperative', 'day', '.', 'loss', 'of', 'domain', 'measured', 'preoperative', 'computed', 'tomography', '.', 'outcome', 'measure', 'included', 'predictor', 'of', 'increase', 'in', 'plateau', 'pressure', ',', 'respiratory', 'complication', ',', 'and', 'acute', 'kidney', 'injury', '.', 'result', 'following', 'consecutive', 'case', ',', 'diagnosis', 'of', 'intraabdominal', 'hypertension', '(', 'percent', ')', ',', 'abdominal', 'compartment', 'syndrome', '(', 'percent', ')', ',', 'and', 'abdominal', 'perfusion', 'pressure', 'less', 'mmhg', '(', 'percent', ')', 'determined', '.', 'change', 'in', 'intraabdominal', 'pressure', '(', 'preoperative', ',', '.', '.', 'mmhg', 'postoperative', ',', '.', '.', 'mmhg', 'postoperative', 'day', ',', '.', '.', 'mmhg', ')', 'and', 'abdominal', 'perfusion', 'pressure', '(', 'preoperative', ',', '.', '.', 'postoperative', ',', '.', '.', 'postoperative', 'day', ',', '.', '.', 'mmhg', ')', 'consistently', 'resolved', 'postoperative', 'day', ',', 'and', 'not', 'associated', 'with', 'respiratory', 'complication', 'or', 'acute', 'kidney', 'injury', '.', 'patient', 'remained', 'intubated', 'postoperatively', 'elevation', 'in', 'pulmonary', 'plateau', 'pressure', '(', 'mmhg', ')', 'demonstrated', 'improvement', 'in', 'plateau', 'pressure', 'postoperative', 'day', '(', 'preoperative', ',', '.', '.', 'mmhg', 'postoperative', ',', '.', '.', 'mmhg', 'postoperative', 'day', ',', '.', '.', 'mmhg', ')', ',', 'and', 'could', 'identified', 'preoperatively', 'hernia', 'volume', 'of', 'greater', 'percent', 'of', 'abdominal', 'cavity', '(', 'p', '.', ')', ',', 'still', 'likely', 'to', 'postoperative', 'respiratory', 'event', '(', 'p', '.', ')', '.', 'conclusion', 'elevated', 'intraabdominal', 'pressure', 'following', 'elective', 'hernia', 'repair', 'requiring', 'myofascial', 'release', 'common', 'transient', '.', 'change', 'in', 'plateau', 'pressure', 'mmhg', 'or', 'following', 'repair', 'expected', 'with', 'loss', 'of', 'domain', 'greater', 'percent', 'and', 'useful', 'surrogate', 'intraabdominal', 'pressure', 'measurement', 'with', 'regard', 'to', 'predicting', 'postoperative', 'pulmonary', 'complication', '.', 'perception', 'and', 'management', 'of', 'elevated', 'intraabdominal', 'pressure', 'considered', 'distinct', 'and', '``', 'permissible', ""''"", 'in', 'context', '.']"
Evaluation of urea and creatinine change during continuous renal replacement therapy: effect of blood flow rate.,"Nigel Fealy, Leanne Aitken, Eugene du Toit, Michael Bailey, Ian Baldwin, Nigel Fealyet al.",2018 Mar,Crit Care Resusc,https://pubmed.ncbi.nlm.nih.gov/29458320/,No keywords found,"['to', 'determine', 'faster', 'blood', 'flow', 'rate', '(', 'bfr', ')', 'effect', 'solute', 'maintenance', 'in', 'continuous', 'renal', 'replacement', 'therapy', '.', 'design', 'prospective', 'randomised', 'controlled', 'trial', '.', 'setting', '-bed', ',', 'single', 'centre', ',', 'tertiary', 'level', 'intensive', 'care', 'unit', '.', 'participant', 'critically', 'ill', 'adult', 'requiring', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '.', 'intervention', 'patient', 'randomised', 'to', 'receive', 'one', 'of', 'two', 'bfrs', 'mlmin', 'or', 'mlmin', '.', 'main', 'outcome', 'measure', 'change', 'in', 'urea', 'and', 'creatinine', 'concentration', '(', 'percentage', 'change', 'baseline', ')', 'and', 'delivered', 'treatment', '-hour', 'period', 'used', 'to', 'assess', 'solute', 'maintenance', '.', 'result', 'patient', 'randomised', ',', 'with', 'completing', 'study', '(', 'patient', ',', 'mlmin', 'patient', ',', 'mlmin', ')', '.', 'total', 'of', '-hour', 'period', '(', 'period', ',', 'mlmin', 'period', ',', 'ml', 'min', ')', '.', 'mean', 'hour', 'of', 'treatment', 'per', 'hour', '.', 'hour', '(', 'standard', 'deviation', 'sd', ',', '.', ')', 'in', 'mlmin', 'group', ',', 'and', '.', 'hour', '(', 'sd', ',', '.', ')', 'in', 'mlmin', 'group', '(', 'p', '.', ')', '.', 'no', 'difference', 'two', 'bfr', 'group', 'change', 'in', 'mean', 'urea', 'concentration', '(', 'mlmin', 'group', ',', '-', '.', 'sd', ',', '.', 'v', 'mlmin', 'group', ',', '-', '.', 'sd', ',', '.', 'p', '.', ')', 'or', 'change', 'in', 'mean', 'creatinine', 'concentration', '(', 'mlmin', ',', '-', '.', 'sd', ',', '.', 'v', 'mlmin', ',', '-', '.', 'sd', ',', '.', 'p', '.', ')', '.', 'independent', 'variable', 'associated', 'with', 'reduced', 'percentage', 'change', 'in', 'mean', 'serum', 'urea', 'and', 'creatinine', 'concentration', 'low', 'haemoglobin', 'level', '(', '-', '.', 'sd', ',', '.', 'p', '.', 'and', '.', 'sd', ',', '.', 'p', '.', ',', 'respectively', ')', 'and', 'less', 'hour', 'treated', '(', '-', '.', 'sd', ',', '.', 'p', '.', 'and', '-', '.', 'sd', ',', '.', 'p', '.', ',', 'respectively', ')', '.', 'no', 'effect', 'bodyweight', 'found', '.', 'conclusion', 'faster', 'bfr', 'not', 'affect', 'solute', 'control', 'in', 'patient', 'receiving', 'crrt', 'however', ',', 'difference', 'in', 'urea', 'and', 'creatinine', 'concentration', 'influenced', 'serum', 'haemoglobin', 'and', 'hour', 'of', 'treatment', '.']"
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.,"STARRT-AKI Investigators;, Canadian Critical Care Trials Group;, Australian and New Zealand Intensive Care Society Clinical Trials Group;, United Kingdom Critical Care Research Group;, Canadian Nephrology Trials Network;, Irish Critical Care Trials Group;, Sean M Bagshaw, Ron Wald, Neill K J Adhikari, Rinaldo Bellomo, Bruno R da Costa, Didier Dreyfuss, Bin Du, Martin P Gallagher, Stéphane Gaudry, Eric A Hoste, François Lamontagne, Michael Joannidis, Giovanni Landoni, Kathleen D Liu, Daniel F McAuley, Shay P McGuinness, Javier A Neyra, Alistair D Nichol, Marlies Ostermann, Paul M Palevsky, Ville Pettilä, Jean-Pierre Quenot, Haibo Qiu, Bram Rochwerg, Antoine G Schneider, Orla M Smith, Fernando Thomé, Kevin E Thorpe, Suvi Vaara, Matthew Weir, Amanda Y Wang, Paul Young, Alexander Zarbock, STARRT-AKI Investigatorset al.",2020 Jul 16,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/32668114/,No keywords found,"['acute', 'kidney', 'injury', 'common', 'in', 'critically', 'ill', 'patient', ',', 'many', 'of', 'receive', 'renal-replacement', 'therapy', '.', 'however', ',', 'effective', 'timing', 'initiation', 'of', 'therapy', 'remains', 'uncertain', '.', 'method', 'conducted', 'multinational', ',', 'randomized', ',', 'controlled', 'trial', 'involving', 'critically', 'ill', 'patient', 'with', 'severe', 'acute', 'kidney', 'injury', '.', 'patient', 'randomly', 'assigned', 'to', 'receive', 'accelerated', 'strategy', 'of', 'renal-replacement', 'therapy', '(', 'in', 'therapy', 'initiated', 'within', 'hour', 'patient', 'met', 'eligibility', 'criterion', ')', 'or', 'standard', 'strategy', '(', 'in', 'renal-replacement', 'therapy', 'discouraged', 'unless', 'conventional', 'indication', 'developed', 'or', 'acute', 'kidney', 'injury', 'persisted', 'hour', ')', '.', 'primary', 'outcome', 'death', 'cause', 'day', '.', 'result', 'of', 'patient', 'undergone', 'randomization', ',', '(', '.', ')', 'included', 'in', 'modified', 'intention-to-treat', 'analysis', '(', 'in', 'accelerated-strategy', 'group', 'and', 'in', 'standard-strategy', 'group', ')', '.', 'of', 'patient', ',', 'renal-replacement', 'therapy', 'performed', 'in', '(', '.', ')', 'in', 'accelerated-strategy', 'group', 'and', 'in', '(', '.', ')', 'in', 'standard-strategy', 'group', '.', 'day', ',', 'death', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'accelerated-strategy', 'group', 'and', 'in', '(', '.', ')', 'in', 'standard-strategy', 'group', '(', 'relative', 'risk', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'among', 'survivor', 'day', ',', 'continued', 'dependence', 'renal-replacement', 'therapy', 'confirmed', 'in', 'of', 'patient', '(', '.', ')', 'in', 'accelerated-strategy', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'standard-strategy', 'group', '(', 'relative', 'risk', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'adverse', 'event', 'occurred', 'in', 'of', 'patient', '(', '.', ')', 'in', 'accelerated-strategy', 'group', 'and', 'in', 'of', 'patient', '(', '.', ')', 'in', 'standard-strategy', 'group', '(', 'p.', ')', '.', 'conclusion', 'among', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', ',', 'accelerated', 'renal-replacement', 'strategy', 'not', 'associated', 'with', 'lower', 'risk', 'of', 'death', 'day', 'standard', 'strategy', '.', '(', 'funded', 'canadian', 'institute', 'of', 'health', 'research', 'and', 'others', 'starrt-aki', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.,"Fatima Khalifa Al-Sulaiti, Ahmed Mohamed Nader, Mohamed Omar Saad, Adila Shaukat, Rakesh Parakadavathu, Ahmed Elzubair, Daoud Al-Badriyeh, Hazem Elewa, Ahmed Awaisu, Fatima Khalifa Al-Sulaitiet al.",2019 Oct,Eur J Drug Metab Pharmacokinet,https://pubmed.ncbi.nlm.nih.gov/30919233/,No keywords found,"['vancomycin', 'therapeutic', 'drug', 'monitoring', '(', 'tdm', ')', 'based', 'achieving', '-h', 'area', 'concentration-time', 'curve', 'to', 'minimum', 'inhibitory', 'concentration', 'cure', 'breakpoints', '(', 'aucmic', ')', '.', 'approach', 'to', 'vancomycin', 'tdm', 'vary', ',', 'with', 'no', 'head-to-head', 'randomized', 'controlled', 'trial', '(', 'rct', ')', 'comparison', 'to', 'date', '.', 'objective', 'aimed', 'to', 'compare', 'clinical', 'and', 'pharmacokinetic', 'outcome', 'peak-trough-based', 'and', 'trough-only-based', 'vancomycin', 'tdm', 'approach', 'and', 'to', 'determine', 'relationship', 'vancomycin', 'aucmic', 'and', 'cure', 'rate', '.', 'method', 'multicentered', 'pragmatic', 'parallel-group', 'rct', 'conducted', 'in', 'hamad', 'medical', 'corporation', 'hospital', 'in', 'qatar', '.', 'adult', 'non-dialysis', 'patient', 'initiated', 'vancomycin', 'randomized', 'to', 'peak-trough-based', 'or', 'trough-only-based', 'vancomycin', 'tdm', '.', 'primary', 'endpoint', 'included', 'vancomycin', 'aucmic', 'ratio', 'breakpoint', 'cure', 'and', 'clinical', 'effectiveness', '(', 'therapeutic', 'cure', 'v', 'therapeutic', 'failure', ')', '.', 'descriptive', ',', 'inferential', ',', 'and', 'classification', 'and', 'regression', 'tree', '(', 'cart', ')', 'statistical', 'analysis', 'applied', '.', 'nonmem.v', '..', 'used', 'to', 'conduct', 'population', 'pharmacokinetic', 'analysis', 'and', 'auc', 'calculation', '.', 'result', 'sixty-five', 'patient', 'enrolled', 'trough-only-based-tdm', '(', 'n', ')', 'and', 'peak-trough-based-tdm', '(', 'n', ')', '.', 'peak-trough-based', 'tdm', 'significantly', 'associated', 'with', 'higher', 'therapeutic', 'cure', 'rate', 'compared', 'to', 'trough-only-based', 'tdm', '.', 'v', '.', 'p', 'value', '..', 'no', 'statistically', 'significant', 'difference', 'observed', 'all-cause', 'mortality', ',', 'neutropenia', ',', 'or', 'nephrotoxicity', 'two', 'group', '.', 'compared', 'to', 'trough-only-based', 'tdm', ',', 'peak-trough-based', 'tdm', 'associated', 'with', 'less', 'vancomycin', 'total', 'daily', 'dos', '.', 'mgkgday', '(', 'p', 'value', '.', ')', '.', 'cart', 'identified', 'creatinine', 'clearance', '(', 'clcr', ')', ',', 'aucmic', ',', 'and', 'tdm', 'approach', 'significant', 'determinant', 'of', 'therapeutic', 'outcome', '.', 'patient', 'n', ',', 'with', 'clcr', '.', 'lh', ',', 'aucmic', ',', 'received', 'peak-trough-based', 'tdm', 'achieved', 'therapeutic', 'cure', '.', 'aucmic', 'identified', 'to', 'correlated', 'with', 'cure', 'in', 'trough-only-based', 'tdm', 'recipient', 'n', ',', '..', 'no', 'minimum', 'aucmic', 'breakpoint', 'detected', 'cart', 'in', 'peak-trough-based', 'group', '.', 'conclusion', 'maintenance', 'of', 'target', 'vancomycin', 'exposure', 'and', 'implementation', 'of', 'peak-trough-based', 'vancomycin', 'tdm', 'may', 'improve', 'vancomycin-associated', 'cure', 'rate', '.', 'larger', 'scale', 'rcts', 'warranted', 'to', 'confirm', 'finding', '.']"
177 Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors : Data From the Prospective Phase 2 LUMEN Study.,"Magdalena Mileva, Camille Van Bogaert, Gwennaëlle Marin, Rachele Danieli, Carlos Artigas, Hugo Levillain, Lieveke Ameye, Loubna Taraji-Schiltz, Konstantinos Stathopoulos, Zéna Wimana, Alain Hendlisz, Patrick Flamen, Ioannis Karfis, Magdalena Milevaet al.",2024 Sep 1,Clin Nucl Med,https://pubmed.ncbi.nlm.nih.gov/38914016/,No keywords found,"['aim', 'of', 'study', 'to', 'assess', 'association', 'among', 'toxicity', ',', 'dosimetry', 'of', 'organs-at-risk', ',', 'and', 'disease', 'progression', 'in', 'patient', 'with', 'gastroenteropancreatic', 'neuroendocrine', 'tumor', '(', 'gep-nets', ')', 'treated', 'with', 'lu-dotatate', '.', 'patient', 'and', 'method', 'thirty-seven', 'patient', 'with', 'gep-nets', 'underwent', 'lu-dotatate', 'peptide', 'receptor', 'radionuclide', 'therapy', '(', 'prrt', ')', 'in', 'single-arm', ',', 'prospective', ',', 'phase', 'study', ',', 'patient', 'followed', 'with', 'blood', 'test', ',', 'isotopic', 'glomerular', 'filtration', 'rate', '(', 'igfr', ')', ',', 'and', 'imaging', 'examination', '(', 'ctmri', 'and', 'pet', ')', 'every', 'month', 'disease', 'progression', '.', 'adverse', 'event', '(', 'aes', ')', 'graded', 'per', 'ctcaev', '.', 'and', 'occurring', 'treatment', 'collected', 'and', 'followed', 'resolution', '.', 'dosimetry', ',', 'including', 'biologically', 'effective', 'dos', '(', 'bed', ')', 'to', 'kidney', ',', 'bed', 'to', 'bone', 'marrow', ',', 'and', 'absorbed', 'dose', '(', 'ad', ')', 'to', 'spleen', ',', 'performed', 'prrt', 'cycle', '.', 'statistical', 'analysis', 'explored', 'association', 'among', 'dosimetry', ',', 'toxicity', ',', 'and', 'patient', 'progression', 'free-survival', '.', 'result', 'common', 'aes', 'anemia', 'and', 'lymphopenia', '(', ')', ',', 'followed', 'thrombocytopenia', 'and', 'fatigue', '(', ')', ',', 'alopecia', '(', ')', ',', 'and', 'nausea', '(', ')', '.', 'common', 'grade', 'ae', 'lymphopenia', '(', ')', '.', 'no', 'grade', 'nephrotoxicity', '.', 'median', 'igfr', 'decrease', '(', 'p', '.', ')', ',', 'median', 'follow-up', 'of', 'month', '.', 'igfr', 'decrease', 'and', 'renal', 'bed', 'not', 'correlate', '(', 'spearman', '-.', ')', '.', 'similarly', ',', 'no', 'significant', 'association', 'found', 'bone', 'marrow', 'bed', 'or', 'spleen', 'ad', 'and', 'grade', 'of', 'hematological', 'toxicity', '.', 'observed', 'no', 'association', 'progression', 'free-survival', 'and', 'either', 'decline', 'of', 'renal', 'function', 'or', 'occurrence', 'of', 'hematological', 'toxicity', 'prrt', '.', 'conclusion', 'study', 'confirms', 'safety', 'profile', 'of', 'lu-dotatate', 'prrt', 'in', 'patient', 'with', 'gep-nets', 'irrespective', 'of', 'dosimetry', 'of', 'organ', 'risk', '.', 'kidney', ',', 'bone', 'marrow', ',', 'and', 'spleen', 'dosimetry', 'measure', 'not', 'associated', 'with', 'renal', 'or', 'hematological', 'toxicity', '.']"
Faster Blood Flow Rate Does Not Improve Circuit Life in Continuous Renal Replacement Therapy: A Randomized Controlled Trial.,"Nigel Fealy, Leanne Aitken, Eugene du Toit, Serigne Lo, Ian Baldwin, Nigel Fealyet al.",2017 Oct,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/28658026/,No keywords found,"['to', 'determine', 'whether', 'blood', 'flow', 'rate', 'influence', 'circuit', 'life', 'in', 'continuous', 'renal', 'replacement', 'therapy', '.', 'design', 'prospective', 'randomized', 'controlled', 'trial', '.', 'setting', 'single', 'center', 'tertiary', 'level', 'icu', '.', 'patient', 'critically', 'ill', 'adult', 'requiring', 'continuous', 'renal', 'replacement', 'therapy', '.', 'intervention', 'patient', 'randomized', 'to', 'receive', 'one', 'of', 'two', 'blood', 'flow', 'rate', 'or', 'mlmin', '.', 'measurement', 'and', 'main', 'result', 'primary', 'outcome', 'circuit', 'life', 'measured', 'in', 'hour', '.', 'circuit', 'and', 'patient', 'data', 'collected', 'circuit', 'clotted', 'or', 'ceased', 'electively', 'nonclotting', 'reason', '.', 'data', 'clotted', 'circuit', 'presented', 'median', '(', 'interquartile', 'range', ')', 'and', 'compared', 'using', 'mann-whitney', 'u', 'test', '.', 'survival', 'probability', 'clotted', 'circuit', 'compared', 'using', 'log-rank', 'test', '.', 'circuit', 'clotting', 'data', 'analyzed', 'repeated', 'event', 'using', 'hazard', 'ratio', '.', 'one', 'hundred', 'patient', 'randomized', 'with', 'completing', 'study', '(', 'mlmin', ',', 'n', 'mlmin', ',', 'n', ')', 'using', 'circuit', '(', 'run', 'mlmin', 'and', 'run', 'mlmin', ')', '.', 'median', 'circuit', 'life', 'first', 'circuit', '(', 'clotted', ')', 'similar', 'group', '(', 'mlmin', '.', 'hr', '.-', 'hr', 'v', 'hr', '.-', 'hr', 'p', '.', ')', '.', 'continuous', 'renal', 'replacement', 'therapy', 'using', 'blood', 'flow', 'rate', 'set', 'mlmin', 'not', 'likely', 'to', 'cause', 'clotting', 'compared', 'with', 'mlmin', '(', 'hazard', 'ratio', ',', '.', '.-', '.', 'p', '.', ')', '.', 'gender', ',', 'body', 'mass', 'index', ',', 'weight', ',', 'vascular', 'access', 'type', ',', 'length', ',', 'site', ',', 'and', 'mode', 'of', 'continuous', 'renal', 'replacement', 'therapy', 'or', 'international', 'normalized', 'ratio', 'no', 'effect', 'clotting', 'risk', '.', 'continuous', 'renal', 'replacement', 'therapy', 'without', 'anticoagulation', 'likely', 'to', 'cause', 'clotting', 'compared', 'with', 'use', 'of', 'heparin', 'strategy', '(', 'hazard', 'ratio', ',', '.', 'p', '.', ')', '.', 'longer', 'activated', 'partial', 'thromboplastin', 'time', '(', 'hazard', 'ratio', ',', '.', 'p', '.', ')', 'and', 'decreased', 'platelet', 'count', '(', 'hazard', 'ratio', ',', '.', 'p', '.', ')', 'associated', 'with', 'reduced', 'likelihood', 'of', 'circuit', 'clotting', '.', 'conclusion', 'no', 'difference', 'in', 'circuit', 'life', 'whether', 'using', 'blood', 'flow', 'rate', 'of', 'or', 'mlmin', 'continuous', 'renal', 'replacement', 'therapy', '.']"
Personalized (177)Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial.,"Michela Del Prete, François-Alexandre Buteau, Frédéric Arsenault, Nassim Saighi, Louis-Olivier Bouchard, Alexis Beaulieu, Jean-Mathieu Beauregard, Michela Del Preteet al.",2019 Mar,Eur J Nucl Med Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/30506283/,No keywords found,"['peptide', 'receptor', 'radionuclide', 'therapy', '(', 'prrt', ')', 'mostly', 'administered', 'using', 'fixed', 'injected', 'activity', '(', 'ia', ')', 'per', 'cycle', '.', 'empiric', 'regime', 'result', 'in', 'highly', 'variable', 'absorbed', 'dos', 'to', 'critical', 'organ', 'and', 'undertreatment', 'of', 'majority', 'of', 'patient', '.', 'conceived', 'personalized', 'prrt', 'protocol', 'in', 'ia', 'adjusted', 'to', 'deliver', 'prescribed', 'absorbed', 'dose', 'to', 'kidney', ',', 'with', 'aim', 'to', 'safely', 'increase', 'tumour', 'irradiation', '.', 'herein', 'report', 'initial', 'result', 'of', 'prospective', 'study', 'of', 'personalized', 'prrt', ',', 'p-prrt', 'trial', '(', 'nct', ')', '.', 'method', 'prrt-nave', 'patient', 'with', 'progressive', 'andor', 'symptomatic', 'neuroendocrine', 'tumour', '(', 'net', ')', 'scheduled', 'to', 'receive', 'four-cycle', 'induction', 'course', 'of', 'lu-octreotate', 'with', 'quantitative', 'spectct-based', 'dosimetry', '.', 'ia', 'personalized', 'according', 'to', 'glomerular', 'filtration', 'rate', 'and', 'body', 'surface', 'area', 'first', 'cycle', ',', 'and', 'according', 'to', 'prior', 'renal', 'gygbq', 'subsequent', 'cycle', '.', 'prescribed', 'renal', 'absorbed', 'dose', 'of', 'gy', 'reduced', '-', 'in', 'case', 'of', 'significant', 'renal', 'or', 'haematological', 'impairment', '.', 'responder', 'allowed', 'to', 'receive', 'consolidation', 'or', 'maintenance', 'cycle', ',', 'of', 'gy', 'to', 'kidney', 'prescribed', '.', 'simulated', 'empiric', 'prrt', 'regime', 'fixing', 'ia', '.', 'gbq', 'per', 'cycle', ',', 'with', 'percentage', 'reduction', '.', 'radiological', ',', 'molecular', 'imaging', ',', 'biochemical', ',', 'and', 'quality', 'of', 'life', 'response', ',', 'well', 'safety', ',', 'assessed', '.', 'result', 'fifty-two', 'patient', 'underwent', 'cycle', '.', 'in', 'patient', 'completed', 'induction', 'course', ',', 'median', 'cumulative', 'ia', 'of', '.', '(', 'range', ',', '.-', '.', ')', 'gbq', 'administered', ',', 'and', 'median', 'cumulative', 'kidney', 'and', 'maximum', 'tumour', 'absorbed', 'dos', '.', '(', 'range', ',', '.-', '.', ')', 'gy', 'and', '.', '(', 'range', '.-', '.', ')', 'gy', 'respectively', '.', 'compared', 'with', 'simulated', 'fixed-ia', 'induction', 'regime', ',', 'median', '.-fold', 'increase', '(', 'range', ',', '.-', '.', 'fold', ')', 'in', 'cumulative', 'maximum', 'tumour', 'absorbed', 'dose', ',', 'higher', 'in', '.', 'of', 'patient', '.', 'in', 'assessable', 'patient', ',', 'best', 'objective', 'response', 'partial', 'response', 'in', 'nine', '(', '.', ')', ',', 'minor', 'response', 'in', '(', '.', ')', ',', 'stable', 'disease', 'in', '(', '.', ')', 'and', 'progressive', 'disease', 'in', 'three', 'patient', '(', '.', ')', '.', 'in', 'particular', ',', 'of', 'patient', '(', '.', ')', 'with', 'pancreatic', 'net', 'partial', 'or', 'minor', 'response', '.', 'global', 'health', 'statusquality', 'of', 'life', 'score', 'significantly', 'increased', 'in', 'of', 'patient', '.', 'acute', 'and', 'subacute', 'side-effects', 'of', 'grade', 'or', ',', 'and', 'common', 'nausea', '(', 'in', '.', 'of', 'patient', ')', 'and', 'fatigue', '(', 'in', '.', 'of', 'patient', ')', 'respectively', '.', 'subacute', 'grade', 'or', 'toxicity', 'occurred', 'in', 'less', 'of', 'patient', ',', 'with', 'exception', 'of', 'lymphocytopenia', 'in', '.', 'of', 'patient', ',', 'without', 'clinical', 'consequence', 'however', '.', 'no', 'patient', 'experienced', 'severe', 'renal', 'toxicity', '.', 'conclusion', 'personalized', 'prrt', 'make', 'possible', 'to', 'safely', 'increase', 'tumour', 'irradiation', 'in', 'majority', 'of', 'patient', '.', 'first', 'result', 'indicate', 'favourable', 'tolerance', 'profile', ',', 'appears', 'similar', 'to', 'of', 'empiric', 'regime', '.', 'response', 'rate', 'promising', ',', 'in', 'particular', 'in', 'patient', 'with', 'net', 'of', 'pancreatic', 'origin', '.']"
Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients.,"Zaher Armaly, Suheil Artol, Adel R Jabbour, Amer Saffouri, Nayef Habashi, Amir Abd Elkadir, Naser Ghattas, Raymond Farah, Safa Kinaneh, William Nseir, Zaher Armalyet al.",2019 Nov,Ren Fail,https://pubmed.ncbi.nlm.nih.gov/31797710/,"NGAL, Radiocontrast, acute kidney injury, carnitine, phosphodiesterase 5 inhibitor.","['present', 'study', 'assesses', 'whether', 'phosphodiesterase', 'type', '(', 'pde-', ')', 'inhibitor', 'or', 'carnitine', 'exert', 'nephroprotective', 'effect', 'clinical', 'contrast-induced', 'nephropathy', '(', 'cin', ')', '.materials', 'and', 'method', 'present', 'study', 'consisted', 'of', 'three', 'group', 'of', 'ckd', 'patient', '.', 'first', 'group', 'control', 'group', ',', 'treated', 'with', 'n-acetyl-l-cysteine', 'day', 'and', 'day', 'of', 'radiocontrast', 'administration', '.', 'second', 'one', 'carnitine', 'group', ',', 'patient', 'infused', 'with', 'carnitine', 'min', 'h', 'prior', 'to', 'radiocontrast', 'administration', 'and', 'h', 'post', 'ct.', 'third', 'one', 'pde-', 'inhibitor', 'group', ',', 'patient', 'given', 'tadalafil', 'h', 'prior', 'to', 'administration', 'of', 'radiocontrast', 'and', 'in', 'subsequent', 'day', '.', 'urine', 'and', 'blood', 'sample', 'collected', 'and', 'following', 'time', 'sequence', ',', ',', ',', ',', ',', 'and', 'h', 'contrast', 'administration', ',', 'creatinine', 'and', 'ngal', 'determination.results', 'pretreated', 'with', 'n-acetyl-l-cysteine', 'prior', 'to', 'administration', 'of', 'contrast', 'medium', '(', 'cm', ')', 'to', 'ckd', 'patient', 'caused', 'significant', 'increase', 'in', 'urinary', 'not', 'of', 'plasma', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'serum', 'creatinine', '(', 'scr', ')', '.', 'in', 'contrast', ',', 'pretreatment', 'with', 'carnitine', 'prevented', 'increase', 'in', 'urinary', 'ngal', 'and', 'reduced', 'scr', 'basal', 'level', '.', 'similarly', ',', 'tadalafil', 'administration', 'diminished', 'elevation', 'of', 'cm-induced', 'urinary', 'ngal.conclusions', 'result', 'indicate', 'carnitine', 'and', 'pde-', 'inhibitor', 'may', 'comprise', 'potential', 'therapeutic', 'maneuver', 'cin', '.']"
Hemoconcentration of Creatinine Minimally Contributes to Changes in Creatinine during the Treatment of Decompensated Heart Failure.,"Christopher Maulion, Sheldon Chen, Veena S Rao, Juan B Ivey-Miranda, Zachary L Cox, Devin Mahoney, Steven G Coca, Dan Negoianu, Jennifer L Asher, Jeffrey M Turner, Lesley A Inker, F Perry Wilson, Jeffrey M Testani, Christopher Maulionet al.",2022 Apr 18,Kidney360,https://pubmed.ncbi.nlm.nih.gov/35845336/,No keywords found,"['worsening', 'serum', 'creatinine', 'common', 'treatment', 'of', 'acute', 'decompensated', 'heart', 'failure', '(', 'adhf', ')', '.', 'possible', 'contributor', 'to', 'creatinine', 'increase', 'diuresis-induced', 'change', 'in', 'volume', 'of', 'distribution', '(', 'vd', ')', 'of', 'creatinine', 'total', 'body', 'water', '(', 'tbw', ')', 'contract', 'around', 'fixed', 'mass', 'of', 'creatinine', '.', 'objective', 'to', 'better', 'understand', 'filtration', 'and', 'nonfiltration', 'factor', 'driving', 'change', 'in', 'creatinine', 'adhf', '.', 'method', 'participant', 'in', 'rose-ahf', 'trial', 'with', 'baseline', 'to', '-hour', 'serum', 'creatinine', 'net', 'fluid', 'output', 'and', 'urinary', 'kim-', ',', 'ngal', ',', 'and', 'nag', 'included', '(', 'n', ')', '.', 'change', 'in', 'vd', 'calculated', 'accounting', 'measured', 'input', 'and', 'output', 'weight-based', 'calculated', 'tbw', '.', 'change', 'in', 'observed', 'creatinine', '(', 'crobserved', ')', 'compared', 'with', 'predicted', 'change', 'in', 'creatinine', 'accounting', 'alteration', 'in', 'vd', 'and', 'non-steady', 'state', 'condition', 'using', 'kinetic', 'gfr', 'equation', '(', 'crhr', 'kinetic', ')', '.', 'result', 'considering', 'change', 'in', 'vd', ',', 'median', 'diuresis', 'to', 'elicit', '.', 'mgdl', 'rise', 'in', 'creatinine', '-', 'ml', '(', 'iqr', ',', '-', 'to', '-', ')', '.', 'accounting', 'stable', 'creatinine', 'filtration', 'diuresis', ',', 'change', 'in', 'vd', 'alone', 'insufficient', 'to', 'elicit', '.', 'mgdl', 'rise', 'in', 'creatinine', '.', 'larger', 'estimated', 'decrease', 'in', 'vd', 'paradoxically', 'associated', 'with', 'improvement', 'in', 'crobserved', '(', 'r-.', ',', 'p.', ')', '.', 'overall', ',', '-', 'of', 'change', 'in', 'ecrhr', 'kinetic', 'attributable', 'to', 'change', 'in', 'vd', '.', '.', 'mgdl', 'rise', 'in', 'ecrhr', 'kinetic', 'not', 'associated', 'with', 'worsening', 'of', 'kim-', ',', 'ngal', ',', 'nag', ',', 'or', 'postdischarge', 'survival', '(', 'p.', ')', '.', 'conclusion', 'adhf', 'therapy', ',', 'increase', 'in', 'serum', 'creatinine', 'driven', 'predominantly', 'change', 'in', 'filtration', ',', 'with', 'minimal', 'contribution', 'change', 'in', 'vd', '.']"
"Diuretics decrease fluid balance in patients on invasive mechanical ventilation: the randomized-controlled single blind, IRIHS study.","Raphaël Cinotti, Jean-Baptiste Lascarrou, Marie-Ange Azais, Gwenhaël Colin, Jean-Pierre Quenot, Pierre-Joachim Mahé, Antoine Roquilly, Aurélie Gaultier, Karim Asehnoune#, Jean Reignier#, Raphaël Cinottiet al.",2021 Mar 10,Crit Care,https://pubmed.ncbi.nlm.nih.gov/33691730/,No keywords found,"['fluid', 'overload', 'associated', 'with', 'increased', 'morbidity', 'and', 'mortality', 'in', 'critically', 'ill', 'patient', '.', 'goal', 'of', 'study', 'to', 'assess', 'efficacy', 'and', 'safety', 'of', 'diuretic', 'strategy', 'to', 'overcome', 'positive', 'fluid', 'balance', 'in', 'patient', 'invasive', 'mechanical', 'ventilation', '.', 'method', 'design', 'multicenter', ',', 'single-blind', ',', 'randomized-controlled', 'study', '.', 'patient', 'randomized', 'diuretic', '(', 'furosemide', ')', 'or', 'control', 'group', '.', 'patient', 'eligible', 'in', 'case', 'of', 'fluid', 'overload', 'defined', 'in-icu', 'weight', 'increase', ',', 'invasive', 'mechanical', 'ventilation', '(', 'fio', 'and', 'peep', 'cm', 'ho', 'inclusion', ')', 'and', 'hemodynamic', 'stabilization', '.', 'primary', 'outcome', 'fluid', 'balance', ',', 'defined', 'weight', 'variation', 'reference', 'weight', 'to', 'successful', 'extubation', '.', 'main', 'secondary', 'outcome', 'safety', 'of', 'diuretic', '.', 'result', 'patient', 'randomized', '.', 'exclusion', ',', 'patient', 'included', 'in', 'analysis', 'in', 'diuretic', 'and', 'in', 'control', 'group', '.', 'fluid', 'balance', '.', '-', '.', 'to', '.', 'kg', 'in', 'diuretic', 'and', '.', '.-', '.', 'kg', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'in', 'multiple', 'imputation', 'analysis', ',', 'fluid', 'balance', 'significantly', 'decreased', 'in', 'diuretic', 'group', '(', 'mean', 'difference', '-', '.', 'ci', '-', '.', 'to', '-', '.', ',', 'p', '.', ')', '.', 'eleven', '(', ')', 'patient', 'died', 'in', 'diuretic', 'group', 'and', '(', ')', 'patient', 'in', 'control', 'group', '(', 'p', '.', ')', '.', 'worsening', 'of', 'acute', 'kidney', 'injury', 'in', '(', '.', ')', 'patient', 'of', 'control', 'group', 'versus', '(', '.', ')', 'patient', 'in', 'diuretic', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'in', 'multicenter', 'randomized-controlled', 'study', ',', 'protocolized', 'diuretic', 'therapy', 'reduced', 'fluid', 'accumulation', 'in', 'patient', 'receiving', 'mechanical', 'ventilation', 'and', 'well', 'tolerated', 'with', 'favorable', 'safety', 'profile', '.', 'trial', 'registration', 'nct', ',', 'registered', 'january', ',', 'prospectively', 'registered', ',', 'httpsclinicaltrials.govctshowncttermdrawrank', '.']"
Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study.,"Francesco Trevisani, Federico Di Marco, Daniele Raggi, Arianna Bettiga, Riccardo Vago, Alessandro Larcher, Alessandra Cinque, Andrea Salonia, Alberto Briganti, Umberto Capitanio, Andrea Necchi, Francesco Montorsi, Francesco Trevisaniet al.",2021 Jul 1,Int J Cancer,https://pubmed.ncbi.nlm.nih.gov/33720424/,"acute kidney injury, bladder cancer, chronic kidney disease, immunotherapy, neoadjuvant therapy, renal function.","['use', 'of', 'pembrolizumab', 'largely', 'accepted', 'in', 'several', 'advanced', 'type', 'of', 'cancer', '.', 'pure', 'study', '(', 'nct', ')', 'enrolled', 'consecutively', 'patient', 'with', 'muscle-invasive', 'bladder', 'cancer', 'received', 'cycle', 'of', 'pembrolizumab', 'mg', 'every', 'week', 'planned', 'radical', 'cystectomy', '(', 'rc', ')', '.', 'clinical', ',', 'pathological', 'and', 'laboratory', 'data', 'collected', 'to', 'investigate', 'relationship', 'renal', 'function', ',', 'immunotherapy', 'and', 'cancer-related', 'outcome', '.', 'serum', 'creatinine', 'and', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'using', 'chronic', 'kidney', 'disease', 'epidemiology', 'collaboration', '(', 'ckd-epi', ')', 'creatinine-equation', 'reported', 'baseline', 'and', 'every', 'cycle', 'of', 'pembrolizumab', 'stage', 'clinical', 'classification', 'tnm', '(', 'ctnm', ')', 'stated', 'treatment', '.', 'analysis', 'not', 'demonstrate', 'significant', 'impairment', 'of', 'egfr', 'cycle', 'of', 'pembrolizumab', ',', 'neither', 'in', 'overall', 'cohort', 'in', 'subgroup', 'considering', 'stage', 'or', 'ckd', 'g-categories', 'according', 'to', 'k-digo', 'classification', '.', 'in', 'conclusion', ',', 'in', 'neoadjuvant', 'setting', 'rc', 'result', 'suggest', 'pembrolizumab', 'administration', 'safe', 'renal', 'function', 'preservation', '.']"
"Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.","C Study Collaborative Group, Richard Haynes, Lisa Blackwell, Natalie Staplin, William G Herrington, Jonathan Emberson, Parminder K Judge, Benjamin C Storey, Martin J Landray, Paul N Harden, Colin Baigent, Peter Friend, C Study Collaborative Group.",2018 Jun,Am J Transplant,https://pubmed.ncbi.nlm.nih.gov/29226570/,"clinical research/practice, immunosuppressant - calcineurin inhibitor (CNI), immunosuppressant - fusion proteins and monoclonal antibodies: alemtuzumab, immunosuppressant - fusion proteins and monoclonal antibodies: basiliximab/daclizumab, immunosuppressant - mechanistic target of rapamycin (mTOR), immunosuppression/immune modulation, kidney transplantation/nephrology.","['baseline-adjusted', 'mean', '(', 'sem', ')', 'egfr', '.', '(', '.', ')', 'mlmin', '.', 'in', 'sirolimus', 'group', 'versus', '.', '(', '.', ')', 'mlmin', '.', 'in', 'tacrolimus', 'group', '(', 'p', '.', ')', '.', 'biopsy-proven', 'acute', 'rejection', '(', '.', ')', 'v', '.', 'p', '.', ')', 'and', 'serious', 'infection', '(', 'defined', 'opportunistic', 'infection', 'or', 'requiring', 'hospitalization', '.', 'v', '.', 'p', '.', ')', 'common', 'among', 'participant', 'allocated', 'sirolimus', '.', 'compared', 'with', 'tacrolimus-based', 'therapy', ',', 'sirolimus-based', 'maintenance', 'therapy', 'not', 'improve', 'transplant', 'function', 'month', 'conversion', 'and', 'associated', 'with', 'significant', 'hazard', 'of', 'rejection', 'and', 'infection', '.', 'clinicaltrials.gov', 'identifier', 'nct', 'and', 'isrctn', '.']"
Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.,"Klemens Budde, Rohini Prashar, Hermann Haller, Maria C Rial, Nassim Kamar, Avinash Agarwal, Johan W de Fijter, Lionel Rostaing, Stefan P Berger, Arjang Djamali, Nicolae Leca, Lisa Allamassey, Sheng Gao, Martin Polinsky, Flavio Vincenti, Klemens Buddeet al.",2021 Dec 1,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/34706967/,No keywords found,"['calcineurin', 'inhibitor', '(', 'cnis', ')', 'standard', 'of', 'care', 'kidney', 'transplantation', ',', 'associated', 'with', 'nephrotoxicity', 'and', 'reduced', 'long-term', 'graft', 'survival', '.', 'belatacept', ',', 'selective', 'cell', 'costimulation', 'blocker', ',', 'approved', 'prophylaxis', 'of', 'kidney', 'transplant', 'rejection', '.', 'phase', 'trial', 'evaluated', 'efficacy', 'and', 'safety', 'of', 'conversion', 'cni-based', 'to', 'belatacept-based', 'maintenance', 'immunosuppression', 'in', 'kidney', 'transplant', 'recipient', '.', 'method', 'stable', 'adult', 'kidney', 'transplant', 'recipient', '-', 'month', 'post-transplantation', 'cni-based', 'immunosuppression', 'randomized', '(', ')', 'to', 'switch', 'to', 'belatacept', 'or', 'continue', 'treatment', 'with', 'established', 'cni', '.', 'primary', 'end', 'point', 'percentage', 'of', 'patient', 'surviving', 'with', 'functioning', 'graft', 'month', '.', 'result', 'overall', ',', 'renal', 'transplant', 'recipient', 'randomized', 'to', 'belatacept', 'conversion', '(', 'n', ')', 'or', 'cni', 'continuation', '(', 'n', ')', '.', '-month', 'rate', 'of', 'survival', 'with', 'graft', 'function', 'and', 'in', 'belatacept', 'and', 'cni', 'group', ',', 'respectively', '(', 'adjusted', 'difference', ',', '.', '.', 'ci', ',', '-', '.', 'to', '.', ')', '.', 'in', 'belatacept', 'conversion', 'versus', 'cni', 'continuation', 'group', ',', 'versus', 'of', 'patient', 'experienced', 'biopsy-proven', 'acute', 'rejection', '(', 'bpar', ')', ',', 'respectively', ',', 'and', 'versus', 'developed', 'de', 'novo', 'donor-specific', 'antibody', '(', 'dndsas', ')', ',', 'respectively', '.', '-month', 'egfr', 'higher', 'with', 'belatacept', '(', '.', 'versus', '.', 'mlmin', 'per', '.', 'with', 'cni', ')', '.', 'group', 'similar', 'rate', 'of', 'serious', 'adverse', 'event', ',', 'infection', ',', 'and', 'discontinuation', ',', 'with', 'no', 'unexpected', 'adverse', 'event', '.', 'one', 'patient', 'in', 'belatacept', 'group', 'post-transplant', 'lymphoproliferative', 'disorder', '.', 'conclusion', 'switching', 'stable', 'renal', 'transplant', 'recipient', 'cni-based', 'to', 'belatacept-based', 'immunosuppression', 'associated', 'with', 'similar', 'rate', 'of', 'death', 'or', 'graft', 'loss', ',', 'improved', 'renal', 'function', ',', 'and', 'numerically', 'higher', 'bpar', 'rate', 'lower', 'incidence', 'of', 'dndsa.clinical', 'trial', 'registry', 'name', 'and', 'registration', 'number', 'study', 'in', 'maintenance', 'kidney', 'transplant', 'recipient', 'following', 'conversion', 'to', 'nulojix', '(', 'belatacept', ')', '-based', ',', 'nct', '.']"
Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.,"Nisha Bansal, Myra A Carpenter, Daniel E Weiner, Andrew S Levey, Marc Pfeffer, John W Kusek, Jianwen Cai, Lawrence G Hunsicker, Meyeon Park, Michael Bennett, Kathleen D Liu, Chi-Yuan Hsu, Nisha Bansalet al.",2016 Jul,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/26538631/,"cardiovascular disease, kidney transplantation, mortality.","['recipient', 'of', 'kidney', 'transplant', '(', 'ktr', ')', 'increased', 'risk', 'cardiovascular', 'event', ',', 'graft', 'failure', ',', 'and', 'death', '.', 'unknown', 'whether', 'urine', 'kidney', 'injury', 'biomarkers', 'associated', 'with', 'poor', 'outcome', 'among', 'ktrs', '.', 'conducted', 'post', 'hoc', 'analysis', 'of', 'folic', 'acid', 'vascular', 'outcome', 'reduction', 'in', 'transplantation', '(', 'favorit', ')', 'trial', 'using', 'case-cohort', 'study', 'design', ',', 'selecting', 'participant', 'with', 'adjudicated', 'cardiovascular', 'event', ',', 'graft', 'failure', ',', 'or', 'death', '.', 'urine', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', ',', 'il-', ',', 'and', 'liver-type', 'fatty', 'acid', 'binding', 'protein', '(', 'l-fabp', ')', 'measured', 'in', 'spot', 'urine', 'sample', 'and', 'standardized', 'to', 'urine', 'creatinine', 'concentration', '.', 'adjusted', 'demographic', ',', 'cardiovascular', 'risk', 'factor', ',', 'egfr', ',', 'and', 'urine', 'albumin-to-creatinine', 'ratio', '.', 'patient', 'cardiovascular', 'event', ',', 'graft', 'failure', 'event', ',', 'and', 'death', '.', 'log', 'increase', 'in', 'urine', 'ngalcreatinine', 'independently', 'associated', 'with', 'greater', 'risk', 'of', 'cardiovascular', 'event', '(', 'adjusted', 'hazard', 'ratio', 'ahr', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', ',', 'greater', 'risk', 'of', 'graft', 'failure', '(', 'ahr', ',', '.', 'ci', ',', '.', 'to', '.', ')', ',', 'and', 'greater', 'risk', 'of', 'death', '(', 'ahr', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'urine', 'kim-creatinine', 'and', 'il-creatinine', 'independently', 'associated', 'with', 'greater', 'risk', 'of', 'death', '(', 'ahr', ',', '.', 'ci', ',', '.', 'to', '.', 'and', 'ahr', ',', '.', 'ci', ',', '.', 'to', '.', 'per', 'log', 'increase', ',', 'respectively', ')', 'not', 'with', 'risk', 'of', 'cardiovascular', 'event', 'or', 'graft', 'failure', '.', 'urine', 'l-fabp', 'not', 'associate', 'with', 'study', 'outcome', '.', 'in', 'conclusion', ',', 'among', 'prevalent', 'ktrs', ',', 'higher', 'urine', 'ngal', ',', 'kim-', ',', 'and', 'il-', 'level', 'independently', 'and', 'differentially', 'associated', 'with', 'greater', 'risk', 'of', 'adverse', 'outcome', '.']"
Processed electroencephalography-guided general anesthesia and norepinephrine requirements: A randomized trial in patients having vascular surgery.,"Kristen K Thomsen, Daniel I Sessler, Linda Krause, Phillip Hoppe, Benjamin Opitz, Till Kessler, Viorel Chindris, Alina Bergholz, Moritz Flick, Karim Kouz, Christian Zöllner, Leonie Schulte-Uentrop, Bernd Saugel, Kristen K Thomsenet al.",2024 Aug:95:111459.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/38599161/,No keywords found,"['processed', 'electroencephalography', '(', 'peeg', ')', 'may', 'help', 'clinician', 'optimize', 'depth', 'of', 'general', 'anesthesia', '.', 'avoiding', 'excessive', 'depth', 'of', 'anesthesia', 'may', 'reduce', 'intraoperative', 'hypotension', 'and', 'need', 'vasopressor', '.', 'tested', 'hypothesis', 'peeg-guided', '-', 'compared', 'to', 'non-peeg-guided', '-', 'general', 'anesthesia', 'reduces', 'amount', 'of', 'norepinephrine', 'needed', 'to', 'keep', 'intraoperative', 'mean', 'arterial', 'pressure', 'mmhg', 'in', 'patient', 'vascular', 'surgery', '.', 'design', 'randomized', 'controlled', 'clinical', 'trial', '.', 'setting', 'university', 'medical', 'center', 'hamburg-eppendorf', ',', 'hamburg', ',', 'germany', '.', 'patient', 'patient', 'vascular', 'surgery', '.', 'intervention', 'peeg-guided', 'general', 'anesthesia', '.', 'measurement', 'primary', 'endpoint', 'average', 'norepinephrine', 'infusion', 'rate', 'beginning', 'of', 'induction', 'of', 'anesthesia', 'end', 'of', 'surgery', '.', 'main', 'result', 'patient', 'analyzed', '.', 'mean', 'standard', 'deviation', 'average', 'norepinephrine', 'infusion', 'rate', '.', '.', 'g', 'kg-', 'min-', 'in', 'patient', 'assigned', 'to', 'peeg-guided', 'and', '.', '.', 'g', 'kg-', 'min-', 'in', 'patient', 'assigned', 'to', 'non-peeg-guided', 'general', 'anesthesia', '(', 'mean', 'difference', '.', 'g', 'kg-', 'min-', ',', 'confidence', 'interval', '.', 'to', '.', 'g', 'kg-', 'min-', ',', 'p', '.', ')', '.', 'patient', 'assigned', 'to', 'peeg-guided', 'versus', 'non-peeg-guided', 'general', 'anesthesia', ',', 'median', 'time-weighted', 'minimum', 'alveolar', 'concentration', 'of', '.', '(', '.', ',', '.', ')', 'versus', '.', '(', '.', ',', '.', ')', '(', 'p', '.', ')', 'and', 'median', 'percentage', 'of', 'time', 'patient', 'state', 'index', 'of', '(', ',', ')', 'versus', '(', ',', ')', '(', 'p', '.', ')', '.', 'conclusion', 'peeg-guided', '-', 'compared', 'to', 'non-peeg-guided', '-', 'general', 'anesthesia', 'reduced', 'amount', 'of', 'norepinephrine', 'needed', 'to', 'keep', 'mean', 'arterial', 'pressure', 'mmhg', 'third', 'in', 'patient', 'vascular', 'surgery', '.', 'whether', 'reduced', 'intraoperative', 'norepinephrine', 'requirement', 'resulting', 'peeg-guided', 'general', 'anesthesia', 'translate', 'improved', 'patient-centered', 'outcome', 'remains', 'to', 'determined', 'in', 'larger', 'trial', '.']"
"Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.","Breda Hennessey, Haim Danenberg, Frédéric De Vroey, Ajay J Kirtane, Manish Parikh, Dimitrios Karmpaliotis, John C Messenger, Aaron Strobel, Alejandro Curcio, Martijn S van Mourik, Peter Eshuis, Javier Escaned, Breda Hennesseyet al.",2024 Feb 5,EuroIntervention,https://pubmed.ncbi.nlm.nih.gov/38343370/,No keywords found,"['decreasing', 'amount', 'of', 'iodinated', 'contrast', 'important', 'safety', 'aspect', 'of', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', ',', 'particularly', 'in', 'patient', 'with', 'high', 'risk', 'of', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', ')', '.', 'dynamic', 'coronary', 'roadmap', '(', 'dcr', ')', 'pci', 'navigation', 'support', 'tool', 'projecting', 'motion-compensated', 'virtual', 'coronary', 'roadmap', 'overlay', 'fluoroscopy', ',', 'potentially', 'limiting', 'need', 'contrast', 'pci', '.', 'aim', 'study', 'investigates', 'contrast-sparing', 'potential', 'of', 'dcr', 'in', 'pci', ',', 'compared', 'to', 'standard', 'angiographic', 'guidance', '.', 'method', 'dynamic', 'coronary', 'roadmap', 'contrast', 'reduction', '(', 'dcrcontrast', ')', 'trial', 'multicentre', ',', 'international', ',', 'prospective', ',', 'unblinded', ',', 'stratified', 'randomised', 'controlled', 'trial', '.', 'patient', 'randomised', 'to', 'either', 'dcr-guided', 'pci', 'or', 'to', 'conventional', 'angiography-guided', 'pci', '.', 'primary', 'endpoint', 'total', 'volume', 'of', 'iodinated', 'contrast', 'administered', ',', 'and', 'secondary', 'endpoint', 'number', 'of', 'cineangiography', 'run', 'pci', '.', 'result', 'study', 'population', 'included', 'randomised', 'patient', '(', 'in', 'dcr', 'and', 'in', 'control', 'group', ',', 'respectively', ')', '.', 'no', 'difference', 'in', 'patient', 'demographic', ',', 'angiographic', 'characteristic', 'or', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'two', 'group', '.', 'total', 'contrast', 'volume', 'used', 'pci', 'significantly', 'lower', 'with', 'dcr', 'guidance', 'compared', 'with', 'conventional', 'angiographic', 'guidance', '(', '..', 'ml', 'v', '..', 'ml', ',', 'respectively', 'p.', ')', '.', 'total', 'number', 'of', 'cineangiography', 'run', 'also', 'significantly', 'reduced', 'in', 'dcr', 'group', '(', '..', 'v', '..', 'in', 'control', 'group', 'p.', ')', '.', 'conclusion', 'compared', 'to', 'conventional', 'angiography-guided', 'pci', ',', 'dcr', 'guidance', 'associated', 'with', 'significant', 'reduction', 'in', 'contrast', 'volume', 'and', 'number', 'of', 'cineangiography', 'run', 'pci', '.', '(', 'clinicaltrials.gov', 'nct', ')', '.']"
Perioperative glutamine supplementation restores disturbed renal arginine synthesis after open aortic surgery: a randomized controlled clinical trial.,"Saskia J H Brinkmann, Nikki Buijs, Mechteld A R Vermeulen, Efraim Oosterink, Henk Schierbeek, Albertus Beishuizen, Jean-Paul P M de Vries, Willem Wisselink, Paul A M van Leeuwen, Saskia J H Brinkmannet al.",2016 Sep 1,Am J Physiol Renal Physiol,https://pubmed.ncbi.nlm.nih.gov/27194717/,"acute kidney injury, arginine, citrulline, glutamine, ischemia-reperfusion injury.","['vs.', 'molkg', '(', '-', ')', 'h', '(', '-', ')', ',', 'citrulline', '.', '.', 'vs.', '.', '.', 'molkg', '(', '-', ')', 'h', '(', '-', ')', ',', 'and', 'arginine', 'vs.', 'molkg', '(', '-', ')', 'h', '(', '-', ')', ',', 'p', '.', ')', ',', 'synthesis', 'of', 'citrulline', 'glutamine', '(', '.', '.', 'vs.', '.', '.', 'molkg', '(', '-', ')', 'h', '(', '-', ')', ')', ',', 'citrulline', 'arginine', '(', '.', '.', 'vs.', '.', '.', 'molkg', '(', '-', ')', 'h', '(', '-', ')', ')', ',', 'and', 'arginine', 'glutamine', '(', '.', '.', 'vs.', '.', '.', 'molkg', '(', '-', ')', 'h', '(', '-', ')', ')', ',', 'respectively', '(', 'p', '.', ')', '.', 'in', 'conclusion', ',', 'production', 'of', 'citrulline', 'and', 'arginine', 'severely', 'reduced', 'clamping', 'aortic', 'surgery', '.', 'study', 'show', 'intravenous', 'supplement', 'of', 'glutamine', 'increase', 'production', 'of', 'citrulline', 'and', 'arginine', 'and', 'compensates', 'inhibitory', 'effect', 'of', 'ischemia-reperfusion', 'injury', '.']"
"The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial.","Daren K Heyland, Jayshil Patel, Charlene Compher, Todd W Rice, Danielle E Bear, Zheng-Yii Lee, Victoria C González, Kevin O'Reilly, Racquel Regala, Courtney Wedemire, Miguel Ibarra-Estrada, Christian Stoppe, Luis Ortiz-Reyes, Xuran Jiang, Andrew G Day                              ;, EFFORT Protein Trial team, Daren K Heylandet al.",2023 Feb 18,Lancet,https://pubmed.ncbi.nlm.nih.gov/36708732/,No keywords found,"['basis', 'of', 'low-quality', 'evidence', ',', 'international', 'critical', 'care', 'nutrition', 'guideline', 'recommend', 'wide', 'range', 'of', 'protein', 'dos', '.', 'effect', 'of', 'delivering', 'high-dose', 'protein', 'critical', 'illness', 'unknown', '.', 'aimed', 'to', 'test', 'hypothesis', 'higher', 'dose', 'of', 'protein', 'provided', 'to', 'critically', 'ill', 'patient', 'would', 'improve', 'clinical', 'outcome', '.', 'method', 'international', ',', 'investigator-initiated', ',', 'pragmatic', ',', 'registry-based', ',', 'single-blinded', ',', 'randomised', 'trial', 'undertaken', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', 'across', 'country', '.', 'enrolled', 'nutritionally', 'high-risk', 'adult', '(', 'year', ')', 'undergoing', 'mechanical', 'ventilation', 'to', 'compare', 'prescribing', 'high-dose', 'protein', '(', 'gkg', 'per', 'day', ')', 'with', 'usual', 'dose', 'protein', '(', 'gkg', 'per', 'day', ')', 'started', 'within', 'h', 'of', 'icu', 'admission', 'and', 'continued', 'to', 'day', 'or', 'death', 'or', 'transition', 'to', 'oral', 'feeding', '.', 'participant', 'randomly', 'allocated', '(', ')', 'to', 'high-dose', 'protein', 'or', 'usual', 'dose', 'protein', ',', 'stratified', 'site', '.', 'site', 'personnel', 'involved', 'in', 'prescribing', 'and', 'delivering', 'protein', 'dose', ',', 'not', 'possible', 'to', 'blind', 'clinician', ',', 'patient', 'not', 'made', 'aware', 'of', 'treatment', 'assignment', '.', 'primary', 'efficacy', 'outcome', 'time-to-discharge-alive', 'hospital', 'to', 'day', 'icu', 'admission', 'and', 'secondary', 'outcome', '-day', 'morality', '.', 'patient', 'analysed', 'in', 'group', 'to', 'randomly', 'assigned', 'regardless', 'of', 'study', 'compliance', ',', 'although', 'patient', 'dropped', 'of', 'study', 'receiving', 'study', 'intervention', 'excluded', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'jan', ',', ',', 'and', 'dec', ',', ',', 'patient', 'randomised', 'and', '(', ')', 'included', 'in', 'analysis', '(', 'in', 'high-dose', 'protein', 'group', 'and', 'in', 'usual', 'dose', 'group', ')', '.', 'day', 'randomisation', ',', 'cumulative', 'incidence', 'of', 'alive', 'hospital', 'discharge', '(', 'ci', '-', ')', 'in', 'high-dose', 'compared', 'with', '(', '-', ')', 'in', 'usual', 'dose', 'protein', 'group', '(', 'hazard', 'ratio', ',', 'ci', '-', 'p', ')', '.', '-day', 'mortality', 'rate', '(', 'of', ')', 'in', 'high', 'dose', 'protein', 'group', 'compared', 'with', '(', 'of', ')', 'in', 'usual', 'dose', 'protein', 'group', '(', 'relative', 'risk', ',', 'ci', '-', ')', '.', 'appeared', 'to', 'subgroup', 'effect', 'with', 'higher', 'protein', 'provision', 'particularly', 'harmful', 'in', 'patient', 'with', 'acute', 'kidney', 'injury', 'and', 'higher', 'organ', 'failure', 'score', 'baseline', '.', 'interpretation', 'delivery', 'of', 'higher', 'dos', 'of', 'protein', 'to', 'mechanically', 'ventilated', 'critically', 'ill', 'patient', 'not', 'improve', 'time-to-discharge-alive', 'hospital', 'and', 'might', 'worsened', 'outcome', 'patient', 'with', 'acute', 'kidney', 'injury', 'and', 'high', 'organ', 'failure', 'score', '.', 'funding', 'none', '.']"
"Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT.","Simon B Ascher, Rebecca Scherzer, Michelle M Estrella, Jarett D Berry, James A de Lemos, Vasantha K Jotwani, Pranav S Garimella, Rakesh Malhotra, Alexander L Bullen, Ronit Katz, Walter T Ambrosius, Alfred K Cheung, Michel Chonchol, Anthony A Killeen, Joachim H Ix, Michael G Shlipak                              ;, SPRINT Research Group, Simon B Ascheret al.",2022 Aug 22,Nephrol Dial Transplant,https://pubmed.ncbi.nlm.nih.gov/34473302/,No keywords found,"['measure', 'of', 'kidney', 'tubule', 'health', 'risk', 'marker', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'person', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'hypertension', 'treatment', ',', 'association', 'with', 'adverse', 'event', '(', 'aes', ')', 'unknown', '.', 'method', 'among', 'systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', ')', 'participant', 'with', 'ckd', ',', 'measured', 'baseline', 'eight', 'urine', 'biomarkers', 'of', 'kidney', 'tubule', 'health', 'and', 'two', 'serum', 'biomarkers', 'of', 'mineral', 'metabolism', 'pathway', 'act', 'kidney', 'tubule', '.', 'cox', 'proportional', 'hazard', 'model', 'used', 'to', 'evaluate', 'biomarker', 'association', 'with', 'risk', 'of', 'composite', 'of', 'pre-specified', 'serious', 'aes', '(', 'hypotension', ',', 'syncope', ',', 'electrolyte', 'abnormality', ',', 'aki', ',', 'bradycardia', 'and', 'injurious', 'fall', ')', 'and', 'outpatient', 'aes', '(', 'hyperkalemia', 'and', 'hypokalemia', ')', '.', 'result', 'baseline', ',', 'mean', 'age', 'year', 'and', 'mean', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'mlmin', '.', 'm.', 'median', 'follow-up', 'of', '.', 'year', ',', '(', ')', 'participant', 'experienced', 'composite', 'ae', '.', 'higher', 'urine', 'interleukin-', ',', 'kidney', 'injury', 'molecule-', ',', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'and', 'monocyte', 'chemoattractant', 'protein-', '(', 'mcp-', ')', ',', 'lower', 'urine', 'uromodulin', '(', 'umod', ')', 'and', 'higher', 'serum', 'fibroblast', 'growth', 'factor-', 'individually', 'associated', 'with', 'higher', 'risk', 'of', 'composite', 'ae', 'outcome', 'in', 'multivariable-adjusted', 'model', 'including', 'egfr', 'and', 'albuminuria', '.', 'modeling', 'biomarkers', 'in', 'combination', ',', 'higher', 'ngal', 'hazard', 'ratio', '(', 'hr', ')', '.', 'per', '-fold', 'higher', 'biomarker', 'level', ',', 'confidence', 'interval', '(', 'ci', ')', '.-.', ',', 'higher', 'mcp-', '(', 'hr', '.', ',', 'ci', '.-', '.', ')', 'and', 'lower', 'umod', '(', 'hr', '.', ',', 'ci', '.-', '.', ')', 'associated', 'with', 'higher', 'composite', 'ae', 'risk', '.', 'biomarker', 'association', 'not', 'vary', 'intervention', 'arm', '(', 'p', '.', 'interaction', ')', '.', 'conclusion', 'among', 'person', 'with', 'ckd', ',', 'several', 'kidney', 'tubule', 'biomarkers', 'associated', 'with', 'higher', 'risk', 'of', 'aes', 'hypertension', 'treatment', ',', 'independent', 'of', 'egfr', 'and', 'albuminuria', '.']"
An Educational and Administrative Intervention to Promote Rational Laboratory Test Ordering on an Academic General Medicine Service.,"Bradley M Wertheim, Andrew J Aguirre, Roby P Bhattacharyya, John Chorba, Ashutosh P Jadhav, Vanessa B Kerry, Eric A Macklin, Gabriela Motyckova, Shveta Raju, Kent Lewandrowski, Daniel P Hunt, Douglas E Wright, Bradley M Wertheimet al.",2017 Jan,Am J Med,https://pubmed.ncbi.nlm.nih.gov/27619354/,No keywords found,"['overuse', 'of', 'clinical', 'laboratory', 'testing', 'in', 'inpatient', 'setting', 'common', 'problem', '.', 'objective', 'of', 'project', 'to', 'develop', 'inexpensive', 'and', 'easily', 'implemented', 'intervention', 'to', 'promote', 'rational', 'laboratory', 'use', 'without', 'compromising', 'resident', 'education', 'or', 'patient', 'care', '.', 'method', 'study', 'comprised', 'of', 'cluster-randomized', ',', 'controlled', 'trial', 'to', 'assess', 'impact', 'of', 'multifaceted', 'intervention', 'of', 'education', ',', 'guideline', 'development', ',', 'elimination', 'of', 'recurring', 'laboratory', 'order', ',', 'unbundling', 'of', 'laboratory', 'panel', ',', 'and', 'redesign', 'of', 'daily', 'progress', 'note', 'laboratory', 'test', 'ordering', '.', 'population', 'included', 'patient', 'hospitalized', '``', 'general', 'medicine', ""''"", 'duplicated', 'consecutive', 'month', 'general', 'medicine', 'teaching', 'service', 'within', '-bed', 'tertiary', 'care', 'hospital', 'in', 'boston', ',', 'massachusetts', '.', 'primary', 'outcome', 'total', 'number', 'of', 'commonly', 'used', 'laboratory', 'test', 'per', 'patient', 'day', 'month', 'in', '.', 'secondary', 'outcome', 'included', 'subgroup', 'analysis', 'of', 'individual', 'test', 'per', 'patient', 'day', ',', 'adverse', 'event', ',', 'and', 'resident', 'and', 'nursing', 'satisfaction', '.', 'result', 'total', 'of', 'patient', 'day', 'captured', '.', 'intervention', 'produced', 'decrease', 'in', 'aggregate', 'laboratory', 'use', '(', 'rate', 'ratio', ',', '.', 'p', '.', 'confidence', 'interval', ',', '.-.', ')', '.', 'six', 'instance', 'of', 'delayed', 'diagnosis', 'of', 'acute', 'kidney', 'injury', 'and', 'near', 'miss', 'reported', 'in', 'intervention', 'arm', '.', 'conclusion', 'bundled', 'educational', 'and', 'administrative', 'intervention', 'promoting', 'rational', 'ordering', 'of', 'laboratory', 'test', 'single', 'academic', 'general', 'medicine', 'service', 'led', 'to', 'modest', 'significant', 'decrease', 'in', 'laboratory', 'use', '.', 'to', 'knowledge', ',', 'first', 'study', 'to', 'examine', 'daily', 'progress', 'note', 'tool', 'to', 'limit', 'excessive', 'test', 'ordering', '.', 'unadjudicated', 'near', 'miss', 'and', 'possible', 'harm', 'reported', 'with', 'intervention', '.', 'finding', 'warrant', 'study', '.']"
Using machine learning methods to predict 28-day mortality in patients with hepatic encephalopathy.,"Zhe Zhang#, Jian Wang#, Wei Han, Li Zhao, Zhe Zhanget al.",2023 Apr 6,BMC Gastroenterol,https://pubmed.ncbi.nlm.nih.gov/37024814/,No keywords found,"['hepatic', 'encephalopathy', '(', ')', 'associated', 'with', 'marked', 'increase', 'in', 'morbidity', 'and', 'mortality', 'cirrhosis', 'patient', '.', 'study', 'aimed', 'to', 'develop', 'and', 'validate', 'machine', 'learning', '(', 'ml', ')', 'model', 'to', 'predict', '-day', 'mortality', 'patient', 'with', '.', 'method', 'retrospective', 'cohort', 'study', 'conducted', 'in', 'medical', 'information', 'mart', 'intensive', 'care', '(', 'mimic', ')', '-iv', 'database', '.', 'patient', 'mimic-iv', 'randomized', 'training', 'and', 'validation', 'cohort', 'in', 'ratio', 'of', '.', 'training', 'cohort', 'used', 'establishing', 'model', 'validation', 'cohort', 'used', 'validation', '.', 'outcome', 'defined', '-day', 'mortality', '.', 'predictor', 'identified', 'recursive', 'feature', 'elimination', '(', 'rfe', ')', 'within', 'h', 'of', 'intensive', 'care', 'unit', '(', 'icu', ')', 'admission', '.', 'area', 'curve', '(', 'auc', ')', 'and', 'calibration', 'curve', 'used', 'to', 'determine', 'predictive', 'performance', 'of', 'different', 'ml', 'model', '.', 'result', 'in', 'mimic-iv', 'database', ',', 'patient', 'eventually', 'diagnosed', 'with', '.', 'of', ',', '(', '.', ')', 'experienced', 'death', 'within', 'day', '.', 'acute', 'physiology', 'score', 'iii', '(', 'apsiii', ')', ',', 'sepsis', 'related', 'organ', 'failure', 'assessment', '(', 'sofa', ')', ',', 'international', 'normalized', 'ratio', '(', 'inr', ')', ',', 'total', 'bilirubin', '(', 'tbil', ')', ',', 'albumin', ',', 'blood', 'urea', 'nitrogen', '(', 'bun', ')', ',', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'mechanical', 'ventilation', 'identified', 'independent', 'risk', 'factor', '.', 'validation', 'set', 'indicated', 'artificial', 'neural', 'network', '(', 'nnet', ')', 'model', 'highest', 'auc', 'of', '.', '(', 'ci.-.', ')', '.', 'furthermore', ',', 'in', 'calibration', 'curve', ',', 'nnet', 'model', 'also', 'well-calibrated', '(', 'p', '.', ')', ',', 'mean', 'better', 'predict', '-day', 'mortality', 'in', 'patient', '.', 'additionally', ',', 'performance', 'of', 'nnet', 'superior', 'to', 'existing', 'score', ',', 'including', 'model', 'end-stage', 'liver', 'disease', '(', 'meld', ')', 'and', 'model', 'end-stage', 'liver', 'disease-sodium', '(', 'meld-na', ')', '.', 'conclusion', 'in', 'study', ',', 'nnet', 'model', 'demonstrated', 'better', 'discrimination', 'in', 'predicting', '-day', 'mortality', 'compared', 'to', 'model', '.', 'developed', 'model', 'could', 'potentially', 'improve', 'early', 'detection', 'of', 'with', 'high', 'mortality', ',', 'subsequently', 'improving', 'clinical', 'outcome', 'in', 'patient', 'with', ',', 'external', 'prospective', 'validation', 'still', 'required', '.']"
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial.,"Ron Wald#, Stephane Gaudry#, Bruno R da Costa, Neill K J Adhikari, Rinaldo Bellomo, Bin Du, Martin P Gallagher, Eric A Hoste, François Lamontagne, Michael Joannidis, Kathleen D Liu, Daniel F McAuley, Shay P McGuinness, Alistair D Nichol, Marlies Ostermann, Paul M Palevsky, Haibo Qiu, Ville Pettilä, Antoine G Schneider, Orla M Smith, Suvi T Vaara, Matthew Weir, Didier Dreyfuss#, Sean M Bagshaw#                              ;, STARRT-AKI Investigators, Ron Waldet al.",2023 Nov,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/37815560/,No keywords found,"['controversy', 'regarding', 'optimal', 'renal-replacement', 'therapy', '(', 'rrt', ')', 'modality', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'method', 'conducted', 'secondary', 'analysis', 'of', 'standard', 'versus', 'accelerated', 'renal', 'replacement', 'therapy', 'in', 'acute', 'kidney', 'injury', '(', 'starrt-aki', ')', 'trial', 'to', 'compare', 'outcome', 'among', 'patient', 'initiated', 'rrt', 'with', 'either', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'or', 'intermittent', 'hemodialysis', '(', 'ihd', ')', '.', 'generated', 'propensity', 'score', 'likelihood', 'of', 'receiving', 'crrt', 'and', 'used', 'inverse', 'probability', 'of', 'treatment', 'with', 'overlap-weighting', 'to', 'address', 'baseline', 'inter-group', 'difference', '.', 'primary', 'outcome', 'composite', 'of', 'death', 'or', 'rrt', 'dependence', '-days', 'randomization', '.', 'result', 'identified', 'trial', 'participant', 'initially', 'received', 'crrt', 'and', 'initially', 'received', 'ihd', '.', 'composite', 'outcome', 'of', 'death', 'or', 'rrt', 'dependence', '-days', 'occurred', 'in', '(', '.', ')', 'patient', 'commenced', 'crrt', 'and', '(', '.', ')', 'patient', 'commenced', 'ihd', '(', 'unadjusted', 'odds', 'ratio', '(', 'or', ')', '.', 'confidence', 'interval', '(', 'ci', ')', '.-.', ')', '.', 'balancing', 'baseline', 'characteristic', 'with', 'overlap', 'weighting', ',', 'initial', 'receipt', 'of', 'crrt', 'associated', 'with', 'lower', 'risk', 'of', 'death', 'or', 'rrt', 'dependence', '-days', 'compared', 'with', 'initial', 'receipt', 'of', 'ihd', '(', 'or', '.', 'ci', '.-.', ')', '.', 'association', 'predominantly', 'driven', 'lower', 'risk', 'of', 'rrt', 'dependence', '-days', '(', 'or', '.', 'ci', '.-.', ')', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'severe', 'aki', ',', 'initiation', 'of', 'crrt', ',', 'compared', 'to', 'ihd', ',', 'associated', 'with', 'significant', 'reduction', 'in', 'composite', 'outcome', 'of', 'death', 'or', 'rrt', 'dependence', '-days', '.']"
Pilot multi-centre randomised trial of the impact of pre-operative focused cardiac ultrasound on mortality and morbidity in patients having surgery for femoral neck fractures (ECHONOF-2 pilot).,"D J Canty, J Heiberg, Y Yang, A G Royse, S Margale, N Nanjappa, D Scott, A Maier, D I Sessler, A Chuan, A Palmer, A Bucknill, C French, C F Royse, D J Cantyet al.",2018 Apr,Anaesthesia,https://pubmed.ncbi.nlm.nih.gov/29226957/,"echocardiography, hip fracture surgery, pre-operative assessment.","['recruitment', 'ratio', '.', ')', ',', 'in', 'ultrasound', 'group', 'and', 'control', '.', 'one', 'protocol', 'failure', 'among', 'recruited', '.', 'primary', 'composite', 'outcome', 'occurred', 'in', 'seven', 'of', 'ultrasound', 'group', 'patient', 'and', 'of', 'control', 'group', 'patient', '(', 'relative', 'group', 'separation', ')', '.', 'death', ',', 'acute', 'kidney', 'injury', 'and', 'cerebrovascular', 'accident', 'recorded', ',', 'no', 'case', 'of', 'myocardial', 'infarction', ',', 'pulmonary', 'embolism', 'or', 'cardiopulmonary', 'arrest', 'ocurred', '.', 'focused', 'cardiac', 'ultrasound', 'altered', 'management', 'of', 'participant', ',', 'suggesting', 'effect', 'mechanism', '.', 'pilot', 'study', 'demonstrated', 'enrolment', 'and', 'protocol', 'feasible', ',', 'primary', 'composite', 'outcome', 'appropriate', ',', 'and', 'treatment', 'effect', 'favouring', 'focused', 'cardiac', 'ultrasound', '-', 'and', 'therefore', 'support', 'large', 'randomised', 'clinical', 'trial', '.']"
A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU.,"Stijn Jonckheere, Nikolaas De Neve, Hans De Beenhouwer, Mario Berth, An Vermeulen, Jan Van Bocxlaer, Pieter Colin, Stijn Jonckheereet al.",2016 Sep,J Antimicrob Chemother,https://pubmed.ncbi.nlm.nih.gov/27246236/,No keywords found,"['several', 'population', 'pharmacokinetic', 'model', 'cefepime', 'in', 'critically', 'ill', 'patient', 'described', ',', 'indicate', 'variability', 'in', 'renal', 'clearance', 'main', 'determinant', 'of', 'observed', 'variability', 'in', 'exposure', '.', 'main', 'objective', 'of', 'study', 'to', 'determine', 'renal', 'marker', 'best', 'predicts', 'cefepime', 'clearance', '.', 'method', 'pharmacokinetic', 'model', 'developed', 'using', 'nonmem', 'based', 'plasma', 'and', 'urine', 'sample', 'icu', 'patient', 'median', 'follow-up', 'of', 'day', '.', 'four', 'serum-based', 'kidney', 'marker', '(', 'creatinine', ',', 'cystatin', 'c', ',', 'urea', 'and', 'uromodulin', ')', 'and', 'two', 'urinary', 'marker', 'measured', 'creatinine', 'clearance', '(', 'clcr', ')', 'and', 'kidney', 'injury', 'molecule-', 'evaluated', 'covariates', 'in', 'model', '.', 'result', 'two-compartment', 'model', 'incorporating', 'renal', 'and', 'non-renal', 'clearance', 'component', 'along', 'with', 'additional', 'term', 'describing', 'haemodialysis', 'clearance', 'provided', 'adequate', 'description', 'of', 'data', '.', 'cockcroft-gault', 'formula', 'best', 'predictor', 'renal', 'cefepime', 'clearance', '.', 'compared', 'with', 'base', 'model', 'without', 'covariates', ',', 'objective', 'function', 'value', 'decreased', '.', 'to', '.', ',', 'median', 'absolute', 'prediction', 'error', '.', 'to', '.', 'and', 'between-subject', 'variability', 'in', 'renal', 'cefepime', 'clearance', 'to', '.', 'creatinine-', 'and', 'cystatin', 'c-based', 'formula', 'and', 'measured', 'clcr', 'performed', 'similarly', '.', 'monte', 'carlo', 'simulation', 'using', 'sanford', 'guide', 'dose', 'recommendation', 'indicated', 'insufficient', 'dose', 'reduction', 'in', 'patient', 'with', 'decreased', 'kidney', 'function', ',', 'leading', 'to', 'potentially', 'toxic', 'level', '.', 'conclusion', 'cockcroft-gault', 'formula', 'best', 'predictor', 'cefepime', 'clearance', 'in', 'critically', 'ill', 'patient', ',', 'although', 'creatinine-', 'and', 'cystatin', 'c-based', 'formula', 'and', 'measured', 'clcr', 'performed', 'similarly', '.']"
"Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT).","Nicoline V Krogstrup, Mihai Oltean, Bo M Bibby, Gertrude J Nieuwenhuijs-Moeke, Frank J M F Dor, Henrik Birn, Bente Jespersen, Nicoline V Krogstrupet al.",2015 Aug 20,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/26297360/,No keywords found,"['delayed', 'graft', 'function', 'due', 'to', 'ischaemia-reperfusion', 'injury', 'frequent', 'complication', 'in', 'deceased', 'donor', 'renal', 'transplantation', '.', 'experimental', 'evidence', 'indicates', 'remote', 'ischaemic', 'conditioning', '(', 'ric', ')', 'provides', 'systemic', 'protection', 'ischaemia-reperfusion', 'injury', 'in', 'various', 'tissue', '.', 'method', 'and', 'analysis', ""'remote"", 'ischaemic', 'conditioning', 'in', 'renal', 'transplantation', '--', 'effect', 'immediate', 'and', 'extended', 'kidney', 'graft', 'function', ""'"", '(', 'context', 'study', ')', 'investigator', 'initiated', ',', 'multicentre', ',', 'randomised', 'controlled', 'trial', 'investigating', 'whether', 'ric', 'of', 'leg', 'of', 'recipient', 'improves', 'short', 'and', 'long-term', 'graft', 'function', 'following', 'deceased', 'donor', 'kidney', 'transplantation', '.', 'study', 'include', 'kidney', 'transplant', 'recipient', 'of', 'organ', 'donation', 'brain', 'death', 'and', 'kidney', 'transplant', 'recipient', 'of', 'organ', 'donation', 'circulatory', 'death', '.', 'participant', 'randomised', 'in', 'design', 'to', 'ric', 'or', 'sham-ric', '(', 'control', ')', '.', 'ric', 'consists', 'of', 'four', 'cycle', 'of', 'min', 'occlusion', 'of', 'thigh', 'tourniquet', 'inflated', 'to', 'mm', 'hg', ',', 'separated', 'min', 'of', 'deflation', '.', 'primary', 'end', 'point', 'time', 'to', 'reduction', 'baseline', 'plasma', 'creatinine', ',', 'estimated', 'change', 'of', 'plasma', 'creatinine', 'value', 'day', 'post-transplant', 'or', 'day', 'last', 'performed', 'dialysis', 'post-transplant', '.', 'secondary', 'end', 'point', 'need', 'of', 'dialysis', 'post-transplant', ',', 'measured', 'and', 'estimated-glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'and', 'month', 'transplantation', ',', 'patient', 'and', 'renal', 'graft', 'survival', ',', 'number', 'of', 'rejection', 'episode', 'in', 'first', 'year', ',', 'and', 'change', 'in', 'biomarkers', 'of', 'acute', 'kidney', 'injury', 'and', 'inflammation', 'in', 'plasma', ',', 'urine', 'and', 'graft', 'tissue', '.', 'ethic', 'and', 'dissemination', 'study', 'approved', 'local', 'ethical', 'committee', 'and', 'national', 'data', 'security', 'agency', '.', 'result', 'expected', 'to', 'published', 'in', '.', 'trial', 'registration', 'number', 'nct', '.']"
A predictive model for the risk of sepsis within 30 days of admission in patients with traumatic brain injury in the intensive care unit: a retrospective analysis based on MIMIC-IV database.,"Fangqi Hu#, Jiaqiu Zhu#, Sheng Zhang, Cheng Wang, Liangjia Zhang, Hui Zhou, Hui Shi, Fangqi Huet al.",2023 Aug 18,Eur J Med Res,https://pubmed.ncbi.nlm.nih.gov/37596695/,No keywords found,"['traumatic', 'brain', 'injury', '(', 'tbi', ')', 'patient', 'admitted', 'to', 'intensive', 'care', 'unit', '(', 'icu', ')', 'high', 'risk', 'of', 'infection', 'and', 'sepsis', '.', 'however', ',', 'study', 'predicting', 'secondary', 'sepsis', 'in', 'tbi', 'patient', 'in', 'icu', '.', 'study', 'aimed', 'to', 'build', 'prediction', 'model', 'risk', 'of', 'secondary', 'sepsis', 'in', 'tbi', 'patient', 'in', 'icu', ',', 'and', 'provide', 'effective', 'information', 'clinical', 'diagnosis', 'and', 'treatment', '.', 'method', 'using', 'mimic', 'iv', 'database', 'version', '.', '(', 'medical', 'information', 'mart', 'intensive', 'care', 'iv', ')', ',', 'searched', 'data', 'tbi', 'patient', 'admitted', 'to', 'icu', 'and', 'considered', 'study', 'cohort', '.', 'extracted', 'data', 'included', 'patient', 'demographic', 'information', ',', 'laboratory', 'indicator', ',', 'complication', ',', 'and', 'clinical', 'data', '.', 'study', 'cohort', 'divided', 'training', 'cohort', 'and', 'validation', 'cohort', '.', 'in', 'training', 'cohort', ',', 'variable', 'screened', 'lasso', '(', 'least', 'absolute', 'shrinkage', 'and', 'selection', 'operator', ')', 'regression', 'and', 'stepwise', 'logistic', 'regression', 'to', 'assess', 'predictive', 'ability', 'of', 'feature', 'incidence', 'of', 'patient', '.', 'screened', 'variable', 'included', 'in', 'final', 'logistic', 'regression', 'model', '.', 'finally', ',', 'decision', 'curve', ',', 'calibration', 'curve', ',', 'and', 'receiver', 'operating', 'character', '(', 'roc', ')', 'used', 'to', 'test', 'performance', 'of', 'model', '.', 'result', 'finally', ',', 'total', 'of', 'patient', 'included', 'in', 'study', ',', 'and', 'patient', 'randomly', 'divided', 'training', '(', 'n', ')', 'and', 'validation', '(', 'n', ')', 'cohort', 'ratio', 'of', '.', 'in', 'training', 'cohort', ',', 'seven', 'feature', 'identified', 'key', 'predictor', 'of', 'secondary', 'sepsis', 'in', 'tbi', 'patient', 'in', 'icu', ',', 'including', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'anemia', ',', 'invasive', 'ventilation', ',', 'gc', '(', 'glasgow', 'coma', 'scale', ')', 'score', ',', 'lactic', 'acid', ',', 'and', 'blood', 'calcium', 'level', ',', 'included', 'in', 'final', 'model', '.', 'area', 'roc', 'curve', 'in', 'training', 'cohort', 'and', 'validation', 'cohort', '.', 'and', '.', ',', 'respectively', '.', 'calibration', 'curve', 'and', 'roc', 'curve', 'show', 'model', 'favorable', 'predictive', 'accuracy', ',', 'decision', 'curve', 'show', 'model', 'favorable', 'clinical', 'benefit', 'with', 'good', 'and', 'robust', 'predictive', 'efficiency', '.', 'conclusion', 'developed', 'nomogram', 'model', 'predicting', 'secondary', 'sepsis', 'in', 'tbi', 'patient', 'admitted', 'to', 'icu', ',', 'provide', 'useful', 'predictive', 'information', 'clinical', 'decision-making', '.']"
Effect of Preoperative Beta-Blocker Use on Outcomes Following Cardiac Surgery.,"Jason B O'Neal, Frederic T Billings th, Xulei Liu, Matthew S Shotwell, Yafen Liang, Ashish S Shah, Jesse M Ehrenfeld, Jonathan P Wanderer, Andrew D Shaw, Jason B O'Nealet al.",2017 Oct 15,Am J Cardiol,https://pubmed.ncbi.nlm.nih.gov/28826895/,No keywords found,"['cardiac', 'surgery', 'perioperative', 'outcome', 'database', 'and', 'society', 'of', 'thoracic', 'surgeon', 'database', '.', 'preoperative', '-blocker', 'use', 'defined', 'society', 'of', 'thoracic', 'surgeon', 'guideline', 'patient', 'receiving', 'blocker', 'within', 'hour', 'preceding', 'surgery', '.', 'of', 'included', 'patient', ',', ',', '(', '.', ')', 'administered', 'blocker', 'within', 'hour', 'surgery', '.', 'adjusting', 'possible', 'confounders', ',', 'preoperative', '-blocker', 'use', 'associated', 'with', 'increased', 'odds', 'of', 'aki', 'stage', '(', 'odds', 'ratio', '.', ',', 'confidence', 'interval', '.', 'to', '.', ',', 'p', '.', ')', '.', 'no', 'evidence', '-blocker', 'use', 'independent', 'association', 'with', 'postoperative', 'delirium', ',', 'aki', 'stage', 'and', ',', 'stroke', ',', 'af', ',', 'mortality', ',', 'or', 'prolonged', 'length', 'of', 'stay', '.', 'secondary', 'propensity', 'score', 'analysis', 'not', 'show', 'marginal', 'association', '-blocker', 'use', 'and', 'outcome', '.', 'in', 'conclusion', ',', 'not', 'find', 'significant', 'evidence', 'preoperative', '-blocker', 'use', 'associated', 'with', 'postoperative', 'delirium', ',', 'af', ',', 'aki', ',', 'stroke', ',', 'or', 'mortality', '.']"
Coronary angiography after cardiac arrest: Rationale and design of the COACT trial.,"Jorrit S Lemkes, Gladys N Janssens, Heleen M Oudemans-van Straaten, Paul W Elbers, Nina W van der Hoeven, Jan G P Tijssen, Luuk C Otterspoor, Michiel Voskuil, Joris J van der Heijden, Martijn Meuwissen, Tom A Rijpstra, Georgios J Vlachojannis, Raoul M van der Vleugel, Koen Nieman, Lucia S D Jewbali, Gabe B Bleeker, Rémon Baak, Bert Beishuizen, Martin G Stoel, Pim van der Harst, Cyril Camaro, José P S Henriques, Maarten A Vink, Marcel T M Gosselink, Hans A Bosker, Harry J G M Crijns, Niels van Royen                              ;, COACT investigators, Jorrit S Lemkeset al.",2016 Oct:180:39-45.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/27659881/,No keywords found,"['ischemic', 'heart', 'disease', 'major', 'cause', 'of', 'out-of-hospital', 'cardiac', 'arrest', '.', 'role', 'of', 'immediate', 'coronary', 'angiography', '(', 'cag', ')', 'and', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'restoration', 'of', 'spontaneous', 'circulation', 'following', 'cardiac', 'arrest', 'in', 'absence', 'of', 'st-segment', 'elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'remains', 'debated', '.', 'hypothesis', 'hypothesize', 'immediate', 'cag', 'and', 'pci', ',', 'indicated', ',', 'improve', '-day', 'survival', 'in', 'post-cardiac', 'arrest', 'patient', 'without', 'sign', 'of', 'stemi', '.', 'design', 'in', 'prospective', ',', 'multicenter', ',', 'randomized', 'controlled', 'clinical', 'trial', ',', 'post-cardiac', 'arrest', 'patient', 'with', 'restoration', 'of', 'spontaneous', 'circulation', 'and', 'without', 'sign', 'of', 'stemi', 'randomized', 'in', 'fashion', 'to', 'immediate', 'cag', 'and', 'pci', '(', 'within', 'hour', ')', 'versus', 'initial', 'deferral', 'with', 'cag', 'and', 'pci', 'neurological', 'recovery', '.', 'primary', 'end', 'point', 'of', 'study', '-day', 'survival', '.', 'secondary', 'end', 'point', 'include', '-day', 'survival', 'with', 'good', 'cerebral', 'performance', 'or', 'minormoderate', 'disability', ',', 'myocardial', 'injury', ',', 'duration', 'of', 'inotropic', 'support', ',', 'occurrence', 'of', 'acute', 'kidney', 'injury', ',', 'need', 'renal', 'replacement', 'therapy', ',', 'time', 'to', 'targeted', 'temperature', 'control', ',', 'neurological', 'status', 'intensive', 'care', 'unit', 'discharge', ',', 'marker', 'of', 'shock', ',', 'recurrence', 'of', 'ventricular', 'tachycardia', ',', 'duration', 'of', 'mechanical', 'ventilation', ',', 'and', 'reason', 'discontinuation', 'of', 'treatment', '.', 'summary', 'coact', 'trial', 'multicenter', ',', 'randomized', ',', 'controlled', 'clinical', 'study', 'evaluate', 'effect', 'of', 'immediate', 'invasive', 'coronary', 'strategy', 'in', 'post-cardiac', 'arrest', 'patient', 'without', 'stemi', '-day', 'survival', '.']"
Single-center outcomes of combined heart and liver transplantation in the failing Fontan.,"Benjamin A D'Souza, Stephanie Fuller, Lacey P Gleason, Nicole Hornsby, Joyce Wald, Karen Krok, Abraham Shaked, Lee R Goldberg, Alberto Pochettino, Kim M Olthoff, Yuli Y Kim, Benjamin A D'Souzaet al.",2017 Mar,Clin Transplant,https://pubmed.ncbi.nlm.nih.gov/27988989/,"Fontan, combined heart and liver transplantation, congenital heart disease, liver cirrhosis, single ventricle.","['long-term', 'outcome', 'of', 'fontan', 'operation', 'include', 'fontan', 'failure', 'and', 'liver', 'disease', '.', 'combined', 'heart-liver', 'transplantation', '(', 'chlt', ')', 'option', 'select', 'patient', 'although', 'limited', 'data', 'exist', 'strategy', '.', 'retrospective', 'review', 'of', 'fontan', 'patient', 'year', 'or', 'older', 'referred', 'cardiac', 'transplant', 'evaluation', 'and', 'hospital', 'of', 'university', 'of', 'pennsylvania', 'performed', '.', 'patient', 'considered', 'potential', 'chlt', '.', 'clinical', 'variable', 'demographic', ',', 'perioperative', 'factor', ',', 'and', 'short-term', 'outcome', 'reviewed', '.', 'of', 'referral', 'cardiac', 'transplantation', ',', 'seven', 'fontan', 'patient', 'underwent', 'chlt', '.', 'patient', 'underwent', 'chlt', 'either', 'advanced', 'fibrosis', 'or', 'cirrhosis', 'liver', 'biopsy', '.', 'no', 'perioperative', 'death', '.', 'common', 'postoperative', 'morbidity', 'acute', 'kidney', 'injury', '.', 'short-term', 'complication', 'include', 'one', 'episode', 'of', 'acute', 'liver', 'rejection', 'no', 'cardiac', 'rejection', 'greater', 'r.', 'chlt', 'acceptable', 'therapeutic', 'option', 'patient', 'with', 'failing', 'fontan', 'physiology', 'exhibit', 'concomitant', 'advanced', 'liver', 'fibrosis', '.', 'however', ',', 'optimal', 'patient', 'selection', 'currently', 'undefined', ',', 'and', 'long-term', 'outcome', 'not', 'known', '.']"
"The effect of oral melatonin on renal ischemia-reperfusion injury in transplant patients: A double-blind, randomized controlled trial.","Fatemeh Panah, Amir Ghorbanihaghjo, Hassan Argani, Sanya Haiaty, Nadereh Rashtchizadeh, Leila Hosseini, Siavoush Dastmalchi, Rostam Rezaeian, Amirhesam Alirezaei, Maryam Jabarpour, Saeed Nazari Soltan Ahmad, Davoud Sanajou, Fatemeh Panahet al.",2019 Dec:57:101241.,Transpl Immunol,https://pubmed.ncbi.nlm.nih.gov/31446153/,No keywords found,"['one', 'of', 'important', 'factor', 'in', 'occurrence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'among', 'renal', 'transplant', 'patient', '(', 'rtps', ')', 'ischemia', 'reperfusion', 'injury', '(', 'iri', ')', '.', 'current', 'study', 'aimed', 'determining', 'anti-inflammatory', 'and', 'anti-oxidative', 'effect', 'of', 'melatonin', 'complication', 'of', 'iri', 'and', 'level', 'of', 'klotho', 'expression', 'in', 'patient', '.', 'method', 'total', 'of', 'renal', 'transplant', 'candidate', 'randomly', 'assigned', 'placebo', 'or', 'melatonin', 'group', 'receiving', 'dose', 'of', 'mgday', '.', 'in', 'order', 'to', 'measure', 'serum', 'melatonin', 'level', ',', 'inflammatory', 'and', 'oxidative', 'stress', 'factor', ',', 'renal', 'function', 'biomarkers', ',', 'and', 'klotho', 'geneprotein', 'expression', ',', 'venous', 'blood', 'sample', 'taken', 'patient', 'two', 'different', 'time', 'point', ',', 'e', ',', 'h', 'transplantation', 'and', 'discharge', 'hospital', '.', 'result', 'melatonin', 'associated', 'with', 'improvement', 'in', 'renal', 'transplantation', ',', 'since', 'serum', 'level', 'of', 'neutrophil', 'gelatinase-associated', 'lipocalin', ',', 'renal', 'functional', 'marker', ',', 'significantly', 'decreased', '(', 'p', '.', ')', '.', 'effect', 'of', 'melatonin', 'suppressor', 'of', 'inflammation', 'and', 'oxidative', 'stress', 'also', 'evident', 'in', 'melatonin', 'group', 'due', 'to', 'significant', 'reduction', 'in', 'serum', 'level', 'of', 'mda', ',', 'cp', ',', '-ohdg', ',', 'and', 'tnf-', 'marker', '(', 'p', '.', ')', '.', 'conclusion', 'reduction', 'in', 'serum', 'level', 'of', 'renal', 'function', 'and', 'oxidative', 'stressinflammatory', 'marker', 'in', 'melatonin', 'group', 'indicates', 'melatonin', 'inhibit', 'iri', 'outcome', 'in', 'rtps', 'anti-oxidant', 'and', 'anti-inflammatory', 'property', '.', 'however', ',', 'property', 'not', 'appear', 'result', 'of', 'influence', 'level', 'of', 'klotho', 'geneprotein', 'expression', '.']"
The Effects of Angiotensin II versus Norepinephrine on Pulmonary Vascular Resistance in Cardiac Surgery: Post Hoc Analysis of a Randomized Controlled Trial.,"Jolene Lim, Kathy Zhang, Lachlan Miles, Rinaldo Bellomo, Tim G Coulson, Jolene Limet al.",2024 Dec,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/39489662/,No keywords found,"['to', 'assess', 'whether', 'angiotensin', 'ii', 'infusion', 'increase', 'pulmonary', 'vascular', 'resistance', '(', 'pvr', ')', 'relative', 'to', 'norepinephrine', '.', 'design', 'secondary', 'analysis', 'of', 'double-blinded', 'randomized', 'feasibility', 'study', '.', 'setting', 'two', 'tertiary', 'metropolitan', 'hospital', 'in', 'melbourne', ',', 'australia', '.', 'participant', 'fifty-eight', 'adult', 'patient', 'undergoing', 'cardiac', 'surgery', 'using', 'cardiopulmonary', 'bypass', 'with', 'elevated', 'risk', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'intervention', 'angiotensin', 'ii', 'infusion', 'compared', 'with', 'norepinephrine', 'infusion', '.', 'measurement', 'and', 'main', 'result', 'no', 'significant', 'difference', 'in', 'primary', 'outcome', 'of', 'pvr', 'intraoperatively', 'and', 'postoperatively', 'angiotensin', 'ii', 'group', 'and', 'norepinephrine', 'group', '.', 'study', 'drug', '(', 'angiotensin', 'ii', 'or', 'norepinephrine', ')', 'infusion', 'rate', 'associated', 'with', 'small', 'increase', 'in', 'pvr', '(', '.', 'p', '.', ')', '.', 'strongest', 'association', 'with', 'pvr', 'random', 'effect', '(', 'ie', ',', 'patient', 'effect', ')', '(', 'p', '.', ')', '.', 'effect', 'consistent', 'across', 'secondary', 'outcome', '.', 'randomization', 'to', 'norepinephrine', 'instead', 'of', 'to', 'angiotensin', 'ii', 'associated', 'with', 'reduced', 'mean', 'systemic', 'arterial', 'to', 'mean', 'pulmonary', 'arterial', 'pressure', 'ratio', 'postoperatively', '(', '-', '.', 'p', '.', ')', '.', 'conclusion', 'result', 'of', 'study', 'suggest', 'in', 'cardiac', 'surgery', 'patient', 'and', 'dos', 'used', 'in', 'prior', 'feasibility', 'study', ',', 'angiotensin', 'ii', 'not', 'significant', 'effect', 'pulmonary', 'vasculature', 'compared', 'with', 'norepinephrine', '.', 'moreover', ',', 'dos', 'used', 'in', 'study', ',', 'neither', 'drug', 'appeared', 'to', 'substantial', 'effect', 'pulmonary', 'circulation', 'relative', 'to', 'surgical', 'and', 'patient', 'factor', '.']"
The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.,"Avital Angel-Korman, Aala Jaberi, Vaishali Sanchorawala, Andrea Havasi, Avital Angel-Kormanet al.",2020 Mar,Amyloid,https://pubmed.ncbi.nlm.nih.gov/31595786/,"AL amyloidosis, Systemic light chain amyloidosis, kidney biopsy, renal amyloidosis, repeat biopsy.","['diagnostic', 'utility', 'of', 'repeat', 'kidney', 'biopsy', 'in', 'al', 'amyloidosis', 'patient', 'in', 'complete', '(', 'cr', ')', 'or', 'good', 'partial', 'hematologic', 'response', '(', 'vgpr', ')', 'with', 'renal', 'organ', 'relapse', 'not', 'clear.methods', 'present', 'eight', 'patient', 'with', 'al', 'amyloidosis', 'repeat', 'kidney', 'biopsy', 'performed.results', 'al', 'amyloidosis', 'initially', 'diagnosed', 'kidney', 'biopsy', '.', 'patient', 'favorable', 'response', 'to', 'treatment', '(', 'crvgpr', ')', 'and', 'five', 'of', 'also', 'initially', 'renal', 'organ', 'response', '.', 'repeat', 'kidney', 'biopsy', 'done', 'due', 'to', 'gradual', 'deterioration', 'of', 'kidney', 'function', 'andor', 'proteinuria', 'maintaining', 'hematologic', 'response', '.', 'repeat', 'kidney', 'biopsy', 'showed', 'finding', 'consistent', 'with', 'amyloid', 'deposit', 'in', 'patient', '.', 'seven', 'patient', 'renal', 'progression', 'with', 'four', 'of', 'requiring', 'dialysis', 'initiation', '.', 'one', 'patient', 'favorable', 'renal', 'outcome', '.', 'patient', 'subacute', 'kidney', 'injury', 'with', 'decreasing', 'proteinuria', 'and', 'found', 'to', 'granulomatous', 'interstitial', 'nephritis', 'in', 'addition', 'to', 'amyloid', 'deposit', 'and', 'responded', 'well', 'to', 'steroid', 'treatment', 'with', 'rapid', 'improvement', 'in', 'renal', 'function.conclusions', 'in', 'al', 'amyloidosis', 'patient', 'achieve', 'favorable', 'hematologic', 'response', 'to', 'treatment', '(', 'crvgpr', ')', 'subsequently', 'develop', 'worsening', 'renal', 'insufficiency', 'or', 'proteinuria', ',', 'repeat', 'kidney', 'biopsy', 'generally', 'not', 'performed', '.', 'amyloid', 'deposit', 'persist', 'in', 'kidney', 'even', 'successful', 'hematologic', 'treatment', 'and', 'impossible', 'to', 'differentiate', 'new', 'versus', 'old', 'amyloid', 'deposit', ',', 'make', 'performing', 'repeat', 'kidney', 'biopsy', 'unnecessary', 'in', 'case', '.', 'demonstration', 'of', 'amyloid', 'deposit', 'repeat', 'kidney', 'biopsy', 'would', 'not', 'aid', 'in', 'decision', 'making', 'regarding', 're-initiation', 'of', 'hematologic', 'treatment', '.', 'kidney', 'biopsy', 'considered', 'in', 'case', 'specific', 'alternative', 'diagnosis', 'suspected', '.']"
Kidney Pathology after Hematologic Cell Transplantation-A Single-Center Observation Study of Indication Biopsies and Autopsies.,"Michael Girsberger, Jörg P Halter, Helmut Hopfer, Michael Dickenmann, Thomas Menter, Michael Girsbergeret al.",2018 Mar,Biol Blood Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/29155318/,"GVHD, Hematopoietic cell transplantation, Kidney biopsy, Thrombotic microangiopathy.","['membranous', 'glomerulonephritis', '.', 'in', 'contrast', ',', 'no', 'morphological', 'correlate', 'of', 'acute', 'gvhd', 'of', 'kidney', 'identified', '.', 'finding', 'time', 'of', 'autopsy', 'varied', 'greatly', ',', 'spanning', 'wider', 'range', 'of', 'indication', 'biopsy', '.']"
"Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)-a single center, open-label, three-arm, randomized, controlled intervention trial.","Asieb Sekandarzad, Enya Weber, Eric Peter Prager, Erika Graf, Dominik Bettinger, Tobias Wengenmayer, Alexander Supady, Asieb Sekandarzadet al.",2022 Mar 18,Trials,https://pubmed.ncbi.nlm.nih.gov/35303938/,No keywords found,"['liver', 'cirrhosis', 'major', 'healthcare', 'problem', 'and', 'mortality', 'rate', 'high', '.', 'recent', 'year', ',', 'systemic', 'inflammation', 'recognized', 'major', 'driver', 'of', 'hepatic', 'decompensation', 'and', 'progression', 'of', 'liver', 'cirrhosis', 'to', 'acute-on-chronic', 'liver', 'failure', '(', 'aclf', ')', '.', 'aim', 'of', 'cytohep', 'study', 'to', 'assess', 'impact', 'of', 'extracorporeal', 'hemoadsorption', 'with', 'cytosorb', 'adsorber', 'serum', 'bilirubin', 'concentration', ',', 'humoral', 'inflammation', 'parameter', ',', 'liver', 'function', 'parameter', ',', 'and', 'patient', 'survival', 'in', 'patient', 'with', 'aclf', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'method', 'cytohep', 'study', 'prospective', ',', 'single-center', ',', 'open-label', ',', 'three-arm', ',', 'randomized', ',', 'controlled', 'intervention', 'trial', '.', 'patient', 'with', 'aclf', 'and', 'aki', 'stage', 'according', 'to', 'kidney', 'disease', 'improving', 'global', 'outcome', '(', 'kdigo', ')', 'criterion', 'randomized', 'three', 'group', 'to', 'treated', 'with', '(', ')', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', 'and', 'cytosorb', ',', '(', ')', 'crrt', 'without', 'cytosorb', ',', 'and', '(', ')', 'without', ',', 'crrt', 'and', 'cytosorb', '.', 'in', 'hemoadsorption', 'group', ',', 'cytosorb', 'used', 'h.', 'group', 'receive', 'standard', 'of', 'care', 'with', 'early', 'or', 'late', 'initiation', 'of', 'crrt', ',', 'respectively', '.', 'primary', 'endpoint', 'of', 'study', 'serum', 'bilirubin', 'concentration', 'h', ',', 'important', 'secondary', 'endpoint', '-day', 'survival', 'and', 'panel', 'of', 'inflammatory', 'parameter', '.', 'discussion', 'cytohep', 'study', 'designed', 'to', 'evaluate', 'benefit', 'of', 'extracorporeal', 'hemoadsorption', 'in', 'patient', 'with', 'aclf', '.', 'result', 'of', 'study', 'help', 'to', 'better', 'understand', 'potential', 'role', 'of', 'hemoadsorption', 'treatment', 'of', 'aclf', 'and', 'impact', 'bilirubin', 'level', ',', 'inflammatory', 'parameter', ',', 'and', 'survival', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'registered', 'august', ',', '.', 'deutsches', 'register', 'klinischer', 'studien', '(', 'drks', ')', 'drks', '.']"
Empagliflozin to prevent post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery: Rationale and design of the EMPOAF trial.,"Maryam Aghakouchakzadeh, Kaveh Hosseini, Majid Haghjoo, Parastoo Mirzabeigi, Masih Tajdini, Azita H Talasaz, Arash Jalali, Amir Askarinejad, Erfan Kohansal, Behnam Hedayat, Ehsan Parvas, Ali Bozorgi, Jamshid Bagheri, Nader Givtaj, Naser Hadavand, Alireza Hajighasemi, Seyed Hossein Ahmadi Tafti, Saeid Hosseini, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadehet al.",2024 Aug,Pacing Clin Electrophysiol,https://pubmed.ncbi.nlm.nih.gov/38946138/,No keywords found,"['postoperative', 'atrial', 'fibrillation', '(', 'poaf', ')', 'one', 'of', 'common', 'type', 'of', 'acute', 'af', 'and', 'complicate', 'treatment', 'course', 'of', 'approximately', 'one', 'third', 'of', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'sodium-glucose', 'cotransporter-', '(', 'sglt', ')', 'inhibitor', 'among', 'newest', 'antidiabetic', 'drug', 'therapeutic', 'option', 'preventing', 'poaf', 'different', 'mechanism', '.', 'method', 'empagliflozin', 'to', 'prevent', 'poaf', '(', 'empoaf', ')', 'interventional', ',', 'investigator-initiated', ',', 'double-blind', ',', 'placebo-controlled', ',', 'multicenter', ',', 'randomized', 'controlled', 'trial', 'conducted', 'in', 'two', 'referral', 'teaching', 'cardiology', 'hospital', 'in', 'tehran', '.', 'four-hundred', 'ninety-two', 'adult', 'patient', 'scheduled', 'elective', 'isolated', 'coronary', 'artery', 'bypass', 'graft', '(', 'cabg', ')', 'surgery', 'randomly', 'assigned', 'to', 'one', 'of', 'group', 'of', 'intervention', '(', 'empagliflozin', 'mg', 'daily', ')', 'or', 'placebo', 'starting', 'least', 'day', 'surgery', 'discharge', '.', 'key', 'exclusion', 'criterion', 'history', 'of', 'diabetes', 'mellitus', ',', 'af', ',', 'ketoacidosis', ',', 'or', 'recurrent', 'urinary', 'tract', 'infection', 'along', 'with', 'severe', 'renal', 'or', 'hepatic', 'impairment', ',', 'unstable', 'hemodynamics', ',', 'and', 'patient', 'receiving', 'sglt', 'inhibitor', 'another', 'indication', '.', 'primary', 'outcome', 'incidence', 'of', 'poaf', '.', 'key', 'secondary', 'endpoint', 'composite', 'rate', 'of', 'life-threatening', 'arrhythmia', ',', 'postoperative', 'acute', 'kidney', 'injury', ',', 'hospitalization', 'length', ',', 'in-hospital', 'mortality', ',', 'stroke', ',', 'and', 'systemic', 'embolization', '.', 'key', 'safety', 'endpoint', 'rate', 'of', 'life-threatening', 'andor', 'genitourinary', 'tract', 'infection', ',', 'hypoglycemia', ',', 'and', 'ketoacidosis', '.', 'conclusion', 'empoaf', 'prospectively', 'evaluate', 'whether', 'empagliflozin', 'mg', 'daily', 'reduce', 'rate', 'of', 'poaf', 'in', 'patient', 'undergoing', 'elective', 'cabg', '.', 'enrolment', 'study', 'started', 'november', 'and', 'expected', 'to', 'ended', 'end', 'of', '.']"
Comparison of Diagnostic Value for Chronic Kidney Disease between 640-Slice Computed Tomography Kidney Scan and Conventional Computed Tomography Scan.,"Yusen Zhao, Yaoyi Wang, Yuanbo Xu, Yijie Zhao, Yingwu Qu, Hua Zhang, Zhimin Zhang, Zhenshun Hu, Xiaolong Zhu, Shujun Cui, Jin Xie, Yusen Zhaoet al.",2022 Aug 24:2022:6587617.,Contrast Media Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/36082054/,No keywords found,"['to', 'explore', 'diagnostic', 'value', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '-slice', 'computed', 'tomography', '(', 'ct', ')', 'kidney', 'scan', 'and', 'conventional', 'ct', 'scan', '.', 'method', 'total', 'of', 'ckd', 'patient', 'received', 'kidney', 'plain', 'scan', 'plus', 'enhanced', 'examination', 'in', 'ct', 'room', 'of', 'medical', 'imaging', 'department', 'of', 'hospital', 'june', 'to', 'september', 'selected', 'and', 'randomly', 'divided', 'experimental', 'group', '(', 'n', ')', 'and', 'control', 'group', '(', 'n', ')', '.', 'patient', 'in', 'control', 'group', 'received', 'conventional', 'ct', 'plain', 'scan', 'and', 'enhanced', 'scan', ',', 'and', 'patient', 'in', 'experimental', 'group', ',', 'ct', 'plain', 'scan', 'performed', 'first', ',', 'range', 'of', '-slice', 'ct', 'dynamic', 'volume', 'scan', 'determined', ',', 'and', 'bolus', 'injection', 'of', 'contrast', 'agent', ',', 'dynamic', 'volume', 'scan', 'performed', 'scanning', 'in', 'cortical', 'phase', ',', 'myeloid', 'phase', ',', 'and', 'secretory', 'phase', '.', 'imaging', 'quality', 'and', 'effective', 'scanning', 'dose', 'compared', 'two', 'modality', ',', 'and', 'relationship', 'ct', 'value', 'obtained', '-slice', 'ct', 'scan', 'and', 'conventional', 'ct', 'scan', 'and', 'renal', 'impairment', 'analyzed', '.', 'result', 'compared', 'with', 'control', 'group', ',', 'image', 'quality', 'of', '-slice', 'ct', 'scan', 'conducted', 'in', 'experimental', 'group', 'significantly', 'better', '(', 'p', '.', ')', 'effective', 'radiation', 'dos', 'of', 'experimental', 'group', 'and', 'control', 'group', ',', 'respectively', ',', '(', '.', '.', ')', 'msv', 'and', '(', '.', '.', ')', 'msv', ',', 'indicating', 'dose', 'significantly', 'lower', 'in', 'experimental', 'group', 'in', 'control', 'group', '(', '.', ',', 'p', '.', ')', ',', 'and', 'correlation', 'analysis', 'showed', 'relationship', 'sum', 'of', 'ct', 'value', 'in', 'cortical', 'phase', 'of', 'kidney', 'and', 'kidney', 'injury', 'in', 'experimental', 'group', 'r', '.', ',', 'p', '..', 'conclusion', '-slice', 'ct', 'kidney', 'scan', 'and', 'conventional', 'ct', 'scan', 'used', 'in', 'diagnosis', 'of', 'ckd', '.', '-slice', 'ct', 'lower', 'radiation', 'dose', ',', 'better', 'image', 'quality', ',', 'and', 'higher', 'application', 'value', '.']"
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial.,"Fernando G Zampieri, Bruno R da Costa, Suvi T Vaara, François Lamontagne, Bram Rochwerg, Alistair D Nichol, Shay McGuinness, Danny F McAuley, Marlies Ostermann, Ron Wald, Sean M Bagshaw                              ;, STARRT-AKI Investigators, Fernando G Zampieriet al.",2022 Aug 25,Crit Care,https://pubmed.ncbi.nlm.nih.gov/36008827/,No keywords found,"['timing', 'of', 'initiation', 'of', 'kidney-replacement', 'therapy', '(', 'krt', ')', 'in', 'critically', 'ill', 'patient', 'remains', 'controversial', '.', 'standard', 'versus', 'accelerated', 'initiation', 'of', 'renal-replacement', 'therapy', 'in', 'acute', 'kidney', 'injury', '(', 'starrt-aki', ')', 'trial', 'compared', 'two', 'strategy', 'of', 'krt', 'initiation', '(', 'accelerated', 'versus', 'standard', ')', 'in', 'critically', 'ill', 'patient', 'with', 'acute', 'kidney', 'injury', 'and', 'found', 'neutral', 'result', '-day', 'all-cause', 'mortality', '.', 'probabilistic', 'exploration', 'of', 'trial', 'endpoint', 'may', 'enable', 'greater', 'understanding', 'of', 'trial', 'finding', '.', 'aimed', 'to', 'perform', 'reanalysis', 'using', 'bayesian', 'framework', '.', 'method', 'performed', 'secondary', 'analysis', 'of', 'patient', 'randomized', 'in', 'multi-national', 'starrt-aki', 'trial', ',', 'performed', 'center', 'in', 'country', '.', 'primary', 'endpoint', ',', '-day', 'all-cause', 'mortality', ',', 'evaluated', 'using', 'hierarchical', 'bayesian', 'logistic', 'regression', '.', 'spectrum', 'of', 'prior', 'includes', 'optimistic', ',', 'neutral', ',', 'and', 'pessimistic', 'prior', ',', 'along', 'with', 'prior', 'informed', 'earlier', 'clinical', 'trial', '.', 'secondary', 'endpoint', '(', 'krt-free', 'day', 'and', 'hospital-free', 'day', ')', 'assessed', 'using', 'zero-one', 'inflated', 'beta', 'regression', '.', 'result', 'posterior', 'probability', 'of', 'benefit', 'comparing', 'accelerated', 'versus', 'standard', 'krt', 'initiation', 'strategy', 'primary', 'endpoint', 'suggested', 'no', 'important', 'difference', ',', 'regardless', 'of', 'prior', 'used', '(', 'absolute', 'difference', 'of', '.', 'credible', 'interval', 'cri', '-', '.', '.', ',', '-', '.', 'cri', '-', '.', '.', ',', 'and', '.', 'cri', '-', '.', '.', 'neutral', ',', 'optimistic', ',', 'and', 'pessimistic', 'prior', ',', 'respectively', ')', '.', 'low', 'probability', 'effect', 'size', 'equal', 'or', 'larger', 'consensus-defined', 'minimal', 'clinically', 'important', 'difference', '.', 'patient', 'allocated', 'to', 'accelerated', 'strategy', 'lower', 'number', 'of', 'krt-free', 'day', '(', 'median', 'absolute', 'difference', 'of', '-', '.', 'day', 'cri', '-', '.', '-', '.', ')', ',', 'with', 'probability', 'accelerated', 'strategy', 'associated', 'with', 'krt-free', 'day', 'of', '..', 'hospital-free', 'day', 'similar', 'strategy', ',', 'with', 'accelerated', 'strategy', 'median', 'absolute', 'difference', 'of', '.', 'hospital-free', 'day', '(', 'cri', '-', '.', '.', ')', 'compared', 'with', 'standard', 'strategy', 'and', 'probability', 'accelerated', 'strategy', 'hospital-free', 'day', '..', 'conclusion', 'in', 'bayesian', 'reanalysis', 'of', 'starrt-aki', 'trial', ',', 'found', 'low', 'probability', 'accelerated', 'strategy', 'clinically', 'important', 'benefit', 'compared', 'with', 'standard', 'strategy', '.', 'patient', 'receiving', 'accelerated', 'strategy', 'probably', 'fewer', 'day', 'alive', 'and', 'krt-free', '.', 'finding', 'not', 'support', 'adoption', 'of', 'accelerated', 'strategy', 'of', 'krt', 'initiation', '.']"
The role of cystatin C in the prognosis of adverse outcomes after the coronary artery bypass graft surgery during hospitalisation.,"Kristina S Shafranskaya, Vasiliy V Kashtalap, Olga V Gruzdeva, Anton G Kutikhin, Olga L Barbarash, Leonid S Barbarash, Kristina S Shafranskayaet al.",2015 Feb,Heart Lung Circ,https://pubmed.ncbi.nlm.nih.gov/25194959/,No keywords found,"['study', 'aimed', 'to', 'assess', 'clinical', 'significance', 'of', 'cystatin', 'c', 'in', 'prognosis', 'of', 'risk', 'of', 'hospital', 'complication', 'among', 'patient', 'with', 'coronary', 'artery', 'disease', 'cad', 'undergone', 'coronary', 'artery', 'bypass', 'surgery', '(', 'cabg', ')', '.', 'method', 'recruited', 'consecutive', 'caucasian', '(', 'russian', ')', 'patient', 'underwent', 'cabg', 'in', '-', '.', 'result', 'no', 'statistically', 'significant', 'difference', 'in', 'serum', 'creatinine', 'concentration', '(', 'scr', ')', 'and', 'glomerular', 'filtration', 'rate', 'and', 'seven', 'day', 'surgery', 'found', 'among', 'patient', 'belonging', 'to', 'different', 'euroscore', 'risk', 'group', '.', 'statistically', 'significant', 'elevation', 'of', 'serum', 'cystatin', 'c', 'concentration', '(', 'scc', ')', 'and', 'seven', 'day', 'surgery', 'demonstrated', 'in', 'euroscore', 'medium-', 'and', 'high-risk', 'group', 'in', 'comparison', 'with', 'low-risk', 'group', '.', 'in', 'addition', ',', 'revealed', 'increased', 'pre-surgical', 'level', 'of', 'scc', 'in', 'patient', 'died', 'earlier', 'seven', 'day', 'cabg', '.', 'regarding', 'cardiovascular', 'complication', ',', 'statistically', 'significant', 'elevation', 'of', 'scc', 'observed', 'in', 'patient', 'with', 'and', 'without', 'myocardial', 'infarction', '(', 'mi', ')', ',', 'stroke', ',', 'or', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'in', 'postoperative', 'period', '.', 'conclusion', 'suggest', 'determination', 'of', 'scc', 'and', 'cabg', 'surgery', 'may', 'help', 'in', 'prognosis', 'of', 'adverse', 'cardiovascular', 'and', 'renal', 'outcome', 'cabg', 'surgery', '.']"
"(177)Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment.","Madhav Prasad Yadav, Sanjana Ballal, Madhavi Tripathi, Nishikant Avinash Damle, Ranjit Kumar Sahoo, Amlesh Seth, Chandrasekhar Bal, Madhav Prasad Yadavet al.",2017 Jan,Eur J Nucl Med Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/27506431/,No keywords found,"['purpose', 'of', 'study', 'to', 'evaluate', 'efficacy', 'and', 'safety', 'of', 'novel', 'theranostic', 'agent', ',', 'lu-dkfz-psma-', 'therapy', 'in', 'metastatic', 'castration', 'resistant', 'prostate', 'cancer', '(', 'mcrpc', ')', '.', 'method', 'thirty-one', 'mcrpc', 'patient', 'with', 'progressive', 'disease', 'despite', 'second-line', 'hormonal', 'therapy', 'andor', 'docetaxel', 'chemotherapy', 'recruited', 'study', '.', 'patient', 'underwent', 'diagnosticga-psma-hbed-ccpetct', ',', 'prior', 'to', 'inclusion', 'therapy', '.', 'included', 'patient', 'underwent', 'quarterly', 'lu-dkfz-psma-', 'therapy', '.', 'hematological', ',', 'kidney', 'function', ',', 'liver', 'function', 'test', ',', 'and', 'serum', 'psa', 'level', 'recorded', 'and', 'therapy', 'week', ',', 'week', ',', 'and', 'month', 'interval', '.', 'biochemical', 'response', 'assessed', 'with', 'trend', 'in', 'serum', 'psa', 'level', '.', 'metabolic', 'response', 'assessed', 'percist', 'criterion', '.', 'clinical', 'response', 'assessed', 'visual', 'analogue', 'score', '(', 'vasmax', ')', 'analgesic', 'score', '(', ')', ',', 'karanofsky', 'performance', 'status', '(', 'kp', ')', ',', 'and', 'ttoxicity', 'and', 'response', 'criterion', 'of', 'eastern', 'cooperative', 'oncology', 'group', '(', 'ecog', ')', 'criterion', '.', 'result', 'mean', 'age', 'of', 'patient', '.', '.', 'year', '(', 'range', '-', 'year', ')', '.', 'mean', 'activity', 'administered', 'in', 'patient', 'mbq', 'ranging', 'one', 'to', 'four', 'cycle', '.', 'decline', 'in', 'mean', 'serum', 'psa', 'level', 'baseline', '(', 'baseline', 'ngml', ',', 'post', 'st', 'cycle', 'therapy', '.', 'ngml', ')', '.', 'based', 'biochemical', 'response', 'criterion', ',', ',', ',', 'and', 'complete', 'response', '(', 'cr', ')', ',', 'partial', 'response', '(', 'pr', ')', ',', 'stable', 'disease', '(', 'sd', ')', ',', 'and', 'progressive', 'disease', '(', 'pd', ')', ',', 'respectively', '.', 'metabolic', 'response', 'revealed', 'patient', 'with', 'cr', ',', 'and', 'remaining', 'patient', 'with', 'pr', 'and', 'patient', 'with', 'sd', '.', 'mean', 'vasmax', 'score', 'decreased', '.', 'to', '.', 'mean', 'analgesic', 'score', 'decreased', '.', 'to', '.', 'therapy', '.', 'mean', 'kp', 'score', 'improved', '.', 'to', '.', 'therapy', '.', 'mean', 'ecog', 'performance', 'status', 'improved', '.', 'to', '.', 'therapy', '.', 'two', 'patient', 'experienced', 'grade', 'and', 'grade', 'ii', 'hemoglobin', 'toxicity', '.', 'none', 'of', 'patient', 'experienced', 'nephrotoxicity', 'or', 'hepatotoxicity', '.', 'conclusion', 'lu-dkfz-psma-', 'radionuclide', 'therapy', 'safe', 'and', 'effective', 'approach', 'in', 'treatment', 'of', 'mcrpc', 'patient', '.']"
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.,"Samir R Kapadia, Raj Makkar, Martin Leon, Mohamed Abdel-Wahab, Thomas Waggoner, Steffen Massberg, Wolfgang Rottbauer, Samuel Horr, Lars Sondergaard, Juhana Karha, Robert Gooley, Lowell Satler, Robert C Stoler, Steven R Messé, Suzanne J Baron, Julia Seeger, Susheel Kodali, Amar Krishnaswamy, Vinod H Thourani, Katherine Harrington, Stuart Pocock, Rodrigo Modolo, Dominic J Allocco, Ian T Meredith, Axel Linke                              ;, PROTECTED TAVR Investigators, Samir R Kapadiaet al.",2022 Oct 6,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/36121045/,No keywords found,"['transcatheter', 'aortic-valve', 'replacement', '(', 'tavr', ')', 'treatment', 'of', 'aortic', 'stenosis', 'lead', 'to', 'embolization', 'of', 'debris', '.', 'capture', 'of', 'debris', 'device', 'provide', 'cerebral', 'embolic', 'protection', '(', 'cep', ')', 'may', 'reduce', 'risk', 'of', 'stroke', '.', 'method', 'randomly', 'assigned', 'patient', 'with', 'aortic', 'stenosis', 'in', 'ratio', 'to', 'undergo', 'transfemoral', 'tavr', 'with', 'cep', '(', 'cep', 'group', ')', 'or', 'without', 'cep', '(', 'control', 'group', ')', '.', 'primary', 'end', 'point', 'stroke', 'within', 'hour', 'tavr', 'or', 'discharge', '(', 'whichever', 'came', 'first', ')', 'in', 'intention-to-treat', 'population', '.', 'disabling', 'stroke', ',', 'death', ',', 'transient', 'ischemic', 'attack', ',', 'delirium', ',', 'major', 'or', 'minor', 'vascular', 'complication', 'cep', 'access', 'site', ',', 'and', 'acute', 'kidney', 'injury', 'also', 'assessed', '.', 'neurology', 'professional', 'examined', 'patient', 'baseline', 'and', 'tavr', '.', 'result', 'total', 'of', 'patient', 'across', 'north', 'america', ',', 'europe', ',', 'and', 'australia', 'underwent', 'randomization', 'assigned', 'to', 'cep', 'group', 'and', 'to', 'control', 'group', '.', 'cep', 'device', 'successfully', 'deployed', 'in', 'of', 'patient', '(', '.', ')', 'in', 'attempt', 'made', '.', 'incidence', 'of', 'stroke', 'within', 'hour', 'tavr', 'or', 'discharge', 'not', 'differ', 'significantly', 'cep', 'group', 'and', 'control', 'group', '(', '.', 'vs.', '.', 'difference', ',', '-', '.', 'percentage', 'point', 'confidence', 'interval', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'disabling', 'stroke', 'occurred', 'in', '.', 'of', 'patient', 'in', 'cep', 'group', 'and', 'in', '.', 'of', 'in', 'control', 'group', '.', 'no', 'substantial', 'difference', 'cep', 'group', 'and', 'control', 'group', 'in', 'percentage', 'of', 'patient', 'died', '(', '.', 'v', '.', '.', ')', 'stroke', ',', 'transient', 'ischemic', 'attack', ',', 'or', 'delirium', '(', '.', 'v', '.', '.', ')', 'or', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', '.', ')', '.', 'one', 'patient', '(', '.', ')', 'vascular', 'complication', 'cep', 'access', 'site', '.', 'conclusion', 'among', 'patient', 'with', 'aortic', 'stenosis', 'undergoing', 'transfemoral', 'tavr', ',', 'use', 'of', 'cep', 'not', 'significant', 'effect', 'incidence', 'of', 'periprocedural', 'stroke', ',', 'basis', 'of', 'confidence', 'interval', 'around', 'outcome', ',', 'result', 'may', 'not', 'rule', 'benefit', 'of', 'cep', 'tavr', '.', '(', 'funded', 'boston', 'scientific', 'protected', 'tavr', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Remote ischaemic preconditioning does not modulate the systemic inflammatory response or renal tubular stress biomarkers after endotoxaemia in healthy human volunteers: a single-centre, mechanistic, randomised controlled trial.","J Zwaag, R Beunders, M C Warlé, J A Kellum, N P Riksen, P Pickkers, M Kox, J Zwaaget al.",2019 Aug,Br J Anaesth,https://pubmed.ncbi.nlm.nih.gov/31084985/,No keywords found,"['remote', 'ischaemic', 'preconditioning', '(', 'ripc', ')', 'consists', 'of', 'repeated', 'cycle', 'of', 'limb', 'ischaemia', 'and', 'reperfusion', ',', 'may', 'reduce', 'perioperative', 'myocardial', 'ischaemic', 'damage', 'and', 'kidney', 'injury', '.', 'hypothesised', 'ripc', 'may', 'beneficial', 'attenuating', 'systemic', 'inflammatory', 'response', '.', 'investigated', 'whether', 'ripc', 'affect', 'response', 'in', 'human', 'to', 'bacterial', 'endotoxin', '(', 'lipopolysaccharide', 'lp', ')', 'measuring', 'plasma', 'cytokine', 'and', 'renal', 'cell-cycle', 'arrest', 'mediator', ',', 'reflect', 'renal', 'tubular', 'stress', '.', 'method', 'healthy', 'male', 'volunteer', 'randomised', 'to', 'receive', 'either', 'daily', 'ripc', 'consecutive', 'day', '(', 'ripcmultiple', ',', 'n', ')', 'plus', 'ripc', 'min', 'preceding', 'i.v', '.', 'lp', '(', 'ng', 'kg-', ')', ',', 'ripc', 'min', 'lp', '(', 'ripcsingle', ',', 'n', ')', ',', 'or', 'no', 'ripc', 'preceding', 'lp', '(', 'control', ',', 'n', ')', '.', 'surrogate', 'marker', 'of', 'renal', 'tubular', 'stress', ',', 'product', 'of', 'urinary', 'concentration', 'of', 'two', 'cell-cycle', 'arrest', 'marker', 'calculated', '(', 'tissue', 'inhibitor', 'of', 'metalloproteinases-', 'timpinsulin-like', 'growth', 'factor', 'binding', 'protein-', 'igfbp', ')', '.', 'data', 'presented', 'median', '(', 'inter-quartile', 'range', ')', '.', 'result', 'in', 'ripc', 'group', ',', 'ripc', 'alone', 'increased', 'timpigfbp', '.', 'lp', 'administration', 'resulted', 'in', 'fever', ',', 'flu-like', 'symptom', ',', 'and', 'haemodynamic', 'alteration', '.', 'plasma', 'cytokine', 'concentration', 'increased', 'profoundly', 'endotoxaemia', '(', 'control', 'group', 'tumor', 'necrosis', 'factor', 'alpha', 'tnf-', '-', 'pg', 'ml-', 'baseline', 'to', '-', 'pg', 'ml-', '.', 'h', 'lp', 'interleukin-', 'il-', '-', 'pg', 'ml-', 'baseline', 'to', '-', 'pg', 'ml-', 'h', 'lp', ')', '.', 'lp', 'administration', 'also', 'increased', 'urinary', 'timpigfbp', '.', 'ripc', 'no', 'effect', 'lps-induced', 'cytokine', 'release', 'or', 'timpigfbp', '.', 'conclusion', 'ripc', 'neither', 'modulated', 'systemic', 'cytokine', 'release', 'attenuated', 'inflammation-induced', 'tubular', 'stress', 'lp', '.', 'however', ',', 'ripc', 'alone', 'induced', 'renal', 'marker', 'of', 'cell-cycle', 'arrest', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.,"Kenechukwu Mezue, Abhinav Goyal, Gregg S Pressman, Jay C Horrow, Janani Rangaswami, Kenechukwu Mezueet al.",2017 Dec 8,Am J Hypertens,https://pubmed.ncbi.nlm.nih.gov/28985328/,No keywords found,"['visit-to-visit', 'blood', 'pressure', 'variability', 'associated', 'with', 'adverse', 'cardiovascular', 'outcome', '.', 'using', 'sprint', 'trial', 'data', 'set', ',', 'explored', 'relationship', 'blood', 'pressure', 'variability', ',', 'cardiovascular', 'outcome', ',', 'and', 'hypoperfusion-related', 'adverse', 'event', 'of', 'antihypertensive', 'therapy', 'in', 'patient', 'with', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'enrolled', 'in', 'study', '.', 'method', 'analysis', 'included', 'patient', 'with', 'ckd', 'randomized', 'in', 'sprint', 'reached', 'target', 'systolic', 'blood', 'pressure', 'respective', 'group', '(', 'intensive', 'mm', 'hg', 'standard', 'mm', 'hg', ')', '.', 'coefficient', 'of', 'variation', '(', 'cv', ')', 'diastolic', 'blood', 'pressure', '(', 'dbp', ')', 'subject', 'characterized', 'variability', '.', 'cox', 'proportional', 'hazard', 'regression', 'used', 'to', 'identify', 'independent', 'predictor', 'of', 'sprint', 'primary', 'outcome', '(', 'including', 'acute', 'coronary', 'syndrome', ',', 'stroke', ',', 'acute', 'heart', 'failure', ',', 'and', 'death', 'cardiovascular', 'cause', ')', 'and', 'major', 'side', 'effect', 'of', 'therapy-hypotension', ',', 'syncope', ',', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'p', '.', 'univariate', 'analysis', 'required', 'to', 'enter', 'model', ',', 'and', 'p', '.', 'to', 'remain', 'in', '.', 'result', 'overall', ',', ',', 'subject', '(', ',', 'standard', ',', 'intensive', ')', 'met', 'inclusion', 'criterion', '.', 'dbp', 'cv', 'predicted', 'greater', 'hazard', 'primary', 'outcome', '(', 'hazard', 'ratio', 'hr', '.', ',', 'p', '.', ')', 'in', 'overall', 'model', 'well', 'in', 'separate', 'analysis', 'treatment', 'arm', '(', 'standard', 'group', 'hr', '.', ',', 'p', '.', 'intensive', 'group', 'hr', '.', ',', 'p', '.', ')', '.', 'dbp', 'cv', 'also', 'independently', 'predicted', 'greater', 'hazard', 'aki', '(', 'hr', '.', ')', ',', 'syncope', '(', 'hr', '.', ')', ',', 'and', 'hypotensive', 'event', '(', 'hr', '.', ')', '.', 'conclusion', 'visit-to-visit', 'dbp', 'variability', 'independently', 'predicts', 'worse', 'cardiovascular', 'outcome', 'and', 'hypoperfusion-related', 'adverse', 'event', 'in', 'patient', 'with', 'ckd', 'enrolled', 'in', 'sprint', '.']"
Comparison of the Transarterial and Transthoracic Approaches in Nontransfemoral Transcatheter Aortic Valve Implantation.,"Mathurin Beve, Vincent Auffret, Reda Belhaj Soulami, Jacques Tomasi, Amedeo Anselmi, Antoine Roisne, Dominique Boulmier, Marc Bedossa, Guillaume Leurent, Erwan Donal, Hervé Le Breton, Jean-Philippe Verhoye, Mathurin Beveet al.",2019 May 1,Am J Cardiol,https://pubmed.ncbi.nlm.nih.gov/30777318/,No keywords found,"['.', ',', 'transaortic', '.', ')', 'whereas', 'patient', 'underwent', 'transarterial', 'tavi', '(', 'subclavian', '.', ',', 'transcarotid', '.', ')', '.', 'logistic', 'euroscore', 'tended', 'to', 'higher', 'in', 'transthoracic-tavi', 'recipient', '.', 'in-hospital', 'and', '-day', 'composite', 'end', 'point', 'rate', '.', 'and', '.', '(', 'p', '.', ')', ',', 'and', '.', 'and', '.', '(', 'p', '.', ')', 'transthoracic', 'and', 'transarterial', 'cohort', ',', 'respectively', '.', 'propensity', 'score-adjusted', 'logistic', 'regression', 'demonstrated', 'no', 'significant', 'detrimental', 'association', '-day', 'composite', 'end', 'point', 'and', 'transthoracic', 'access', '(', 'odds', 'ratio', '.', 'confidence', 'interval', '.', 'to', '.', 'p', '.', ')', '.', 'transarterial', 'tavi', 'associated', 'with', 'shorter', 'length', 'of', 'stay', '(', 'median', 'v', 'day', ',', 'p', '.', ')', '.', 'tavi', 'approach', 'not', 'independent', 'predictor', 'of', 'midterm', 'mortality', '.', 'in', 'conclusion', ',', 'nontransfemoral', 'transarterial-approach', 'tavi', 'safe', ',', 'feasible', ',', 'and', 'associated', 'with', 'comparable', 'rate', 'of', 'major', 'perioperative', 'complication', ',', 'and', 'midterm', 'mortality', 'compared', 'with', 'transthoracic-approach', 'tavi', '.']"
"Evaluation of Safety, Biodistribution, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177 Lu-DOTA-EB-TATE With and Without Amino Acid Infusion.","Yuanyuan Jiang, Qingxing Liu, Guochang Wang, Jingjing Zhang, Zhaohui Zhu, Xiaoyuan Chen, Yuanyuan Jianget al.",2023 Jun 1,Clin Nucl Med,https://pubmed.ncbi.nlm.nih.gov/37075254/,No keywords found,"['kidney', 'considered', 'to', 'one', 'of', 'dose-limiting', 'organ', 'in', 'peptide', 'receptor', 'radionuclide', 'therapy', '(', 'prrt', ')', '.', 'amino', 'acid', 'cocktail', 'infusion', 'applied', 'to', 'reduce', 'renal', 'absorbed', 'dose', 'inhibiting', 'proximal', 'tubular', 'reabsorption', 'of', 'radiopeptide', '.', 'evans', 'blue-modified', 'lu-labeled', 'octreotate', '(', 'lu-dota-eb-tate', ')', 'extended', 'circulation', 'in', 'blood', ',', 'may', 'make', 'amino', 'acid', 'infusion', 'unnecessary', '.', 'aim', 'of', 'study', 'to', 'evaluate', 'safety', ',', 'biodistribution', ',', 'and', 'dosimetry', 'of', 'lu-dota-eb-tate', 'with', 'and', 'without', 'amino', 'acid', 'infusion', '.', 'patient', 'and', 'method', 'ten', 'patient', 'with', 'metastatic', 'neuroendocrine', 'tumor', 'randomly', 'divided', 'group', '.', 'effect', 'of', 'amino', 'acid', 'infusion', 'renal', 'uptake', 'assessed', 'in', 'crossover', 'randomized', 'setting', '.', 'group', 'received', 'lu-dota-eb-tate', 'dose', 'of', '.', 'gbq', 'without', 'amino', 'acid', 'infusion', 'first', 'cycle', 'and', 'with', 'amino', 'acid', 'infusion', 'second', 'cycle', 'group', 'b', 'received', 'lu-dota-eb-tate', 'dose', 'of', '.', 'gbq', 'with', 'amino', 'acid', 'infusion', 'first', 'cycle', 'and', 'without', 'amino', 'acid', 'infusion', 'second', 'cycle', '.', 'patient', 'underwent', 'serial', 'whole-body', 'planar', 'imaging', ',', ',', ',', 'and', 'hour', 'and', 'spect', 'scan', 'hour', 'radioligand', 'administration', '.', 'abdominal', 'ct', 'performed', 'day', 'prrt', 'spectct', 'fusion', '.', 'dosimetry', 'calculated', 'using', 'hermes', 'software', '.', 'dosimetry', 'evaluation', 'compared', 'between-group', 'and', 'intrapatient', 'basis', '.', 'result', 'administration', 'of', 'lu-dota-eb-tate', 'with', 'or', 'without', 'amino', 'acid', 'well', 'tolerated', '.', 'no', 'grade', 'hematotoxicity', 'observed', 'in', 'of', 'patient', '.', 'grade', 'thrombocytopenia', 'reported', 'in', 'patient', '.', 'no', 'nephrotoxicity', 'of', 'grade', 'recorded', '.', 'no', 'significant', 'difference', 'observed', 'in', 'creatinine', '(', '.', '.', 'v', '.', '.', 'moll', ',', 'p', '.', ')', ',', 'blood', 'urea', 'nitrogen', '(', '.', '.', 'v', '.', '.', 'mmoll', ',', 'p', '.', ')', ',', 'or', 'gfr', '(', '.', '.', 'v', '.', '.', 'mlmin', ',', 'p', '.', ')', 'and', 'prrt', '.', 'cycle', ',', 'no', 'significant', 'difference', 'in', 'whole-body', 'effective', 'dose', ',', 'kidney', 'effective', 'dose', ',', 'well', 'residence', 'time', 'of', 'kidney', 'group', 'and', 'b', '(', 'p', '.', ')', '.', 'intrapatient', 'comparison', ',', 'without', 'and', 'with', 'amino', 'acid', 'infusion', 'also', 'not', 'show', 'significant', 'difference', 'in', 'whole-body', 'effective', 'dose', '(', '.', '.', 'v', '.', '.', 'msvmbq', ',', 'p', '.', ')', ',', 'kidney', 'effective', 'dose', '(', '.', '.', 'v', '.', '.', 'msvmbq', ',', 'p', '.', ')', ',', 'and', 'residence', 'time', 'of', 'kidney', '(', '.', '.', 'v', '.', '.', 'hour', ',', 'p', '.', ')', '.', 'conclusion', 'lu-dota-eb-tate', 'prrt', 'with', 'and', 'without', 'amino', 'acid', 'infusion', 'demonstrated', 'favorable', 'safety', 'profile', 'in', 'neuroendocrine', 'tumor', 'patient', '.', 'administration', 'of', 'lu-dota-eb-tate', 'without', 'amino', 'acid', 'infusion', 'acceptable', 'slightly', 'increased', 'kidney', 'absorbed', 'dose', 'and', 'residence', 'time', 'of', 'kidney', ',', 'and', 'not', 'affect', 'kidney', 'function', '.', 'investigation', 'in', 'larger', 'cohort', 'and', 'long-term', 'follow-up', 'warranted', '.']"
Prognostic value of intraoperative measurements of renal tissue oxygenation and microcirculation on renal function in partial nephrectomy.,"Matthias Maruschke, Katja Hagel, Oliver Hakenberg, Thomas Scheeren, Matthias Maruschkeet al.",2018 Jun,Clin Exp Nephrol,https://pubmed.ncbi.nlm.nih.gov/29197972/,No keywords found,"['partial', 'nephrectomy', '(', 'pnx', ')', 'associated', 'with', 'macrocirculatory', 'and', 'microcirculatory', 'alteration', ',', 'ultimately', 'leading', 'to', 'acute', 'kidney', 'injury', '(', 'aki', ')', '.', 'measuring', 'kidney', 'tissue', 'oxygenation', '(', 'hbo', ')', 'and', 'microcirculation', 'open', 'pnx', 'might', 'feasible', 'to', 'early', 'detect', 'alteration', 'and', 'prevent', 'postoperative', 'aki', '.', 'method', 'hbo', 'and', 'microcirculation', 'measured', 'in', 'patient', 'undergoing', 'pnx', 'reflectance', 'spectrophotometry', 'and', 'laser', 'doppler', 'flowmetry', '(', 'oc', ',', 'lea', ',', 'germany', ')', ',', 'related', 'to', 'ischemia', 'time', 'and', 'tumour', 'size', '.', 'pre-', 'and', 'postoperative', 'creatinine', 'level', 'determined', '.', 'result', 'hbo', 'lower', 'reperfusion', 'clamping', '(', 'vs.', ')', ',', 'microcirculation', 'and', 'regional', 'haemoglobin', 'not', 'differ', '.', 'ischemia', 'time', '.', 'min', 'average', '.', 'hbo', 'higher', 'without', 'ischemia', '(', 'vs.', ',', 'p', '.', ')', 'and', 'in', 'ta-', 'tb-tumours', ',', 'independent', 'of', 'ischemia', 'time', 'and', 'reperfusion', '.', 'renal', 'collecting', 'system', '(', 'rcs', ')', 'opened', 'in', 'patient', 'with', 'hbo', 'of', 'reperfusion', 'compared', 'to', 'with', 'intact', 'rcs', '.', 'postoperative', 'complication', 'occurred', 'in', 'patient', '(', ')', '.', 'hbo', 'clamping', 'vs.', 'without', 'complication', '.', 'serum', 'creatinine', 'of', 'patient', 'with', 'tb', 'higher', 'compared', 'to', 'ta', '(', 'vs.', 'moll', ')', '.', 'patient', 'with', 'larger', 'tumour', 'higher', 'postoperative', 'creatinine', 'level', '(', 'vs.', 'moll', 'p', '.', ')', '.', 'conclusion', 'showed', 'first', 'time', 'method', 'feasible', 'to', 'monitor', 'renal', 'tissue', 'oxygenation', 'level', 'of', 'microcirculation', 'non-invasively', 'and', 'reproducibly', 'pnx', '.', 'tumour', 'size', 'seems', 'to', 'decisive', 'influence', 'oxygenation', 'and', 'postoperative', 'renal', 'function', '.', 'result', 'imply', 'postoperative', 'complication', 'may', 'predicted', 'low', 'intraoperative', 'renal', 'oxygenation', 'and', 'microcirculatory', 'flow', 'measurement', '.']"
Heterogeneity of Effect of Net Ultrafiltration Rate among Critically Ill Adults Receiving Continuous Renal Replacement Therapy.,"Ary Serpa Neto, Thummaporn Naorungroj, Raghavan Murugan, John A Kellum, Martin Gallagher, Rinaldo Bellomo, Ary Serpa Netoet al.",2021,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/33027799/,No keywords found,"['in', 'continuous', 'renal', 'replacement', 'therapy', '(', 'crrt', ')', '-treated', 'patient', ',', 'net', 'ultrafiltration', '(', 'nuf', ')', 'rate', '.', 'mlkgh', 'associated', 'with', 'increased', 'mortality', '.', 'however', ',', 'may', 'heterogeneity', 'of', 'effect', 'of', 'nuf', 'rate', 'mortality', ',', 'according', 'to', 'patient', 'characteristic', '.', 'method', 'to', 'investigate', 'presence', 'and', 'impact', 'of', 'heterogeneity', 'of', 'effect', ',', 'performed', 'secondary', 'analysis', 'of', '``', 'randomized', 'evaluation', 'of', 'normal', 'versus', 'augmented', 'level', 'of', 'renal', 'replacement', 'therapy', ""''"", '(', 'renal', ')', 'trial', '.', 'exposure', 'nuf', 'rate', '(', 'weight-adjusted', 'fluid', 'volume', 'removed', 'per', 'hour', ')', 'stratified', 'tertiles', '(', '.', 'mlkgh', ')', '.', 'primary', 'outcome', '-day', 'mortality', '.', 'patient', 'clustered', 'according', 'to', 'baseline', 'characteristic', '.', 'heterogeneity', 'of', 'effect', 'assessed', 'according', 'to', 'cluster', 'and', 'baseline', 'edema', 'and', 'related', 'to', 'additional', 'impact', 'of', 'baseline', 'cardiovascular', 'sequential', 'organ', 'failure', 'assessment', '(', 'sofa', ')', 'score', '.', 'excluded', 'patient', 'with', 'missing', 'value', 'baseline', 'weight', 'andor', 'treatment', 'duration', '.', 'result', 'identified', 'cluster', '.', 'largest', '(', 'cluster', 'n', ')', 'included', 'severely', 'ill', 'patient', ',', 'with', 'sepsis', ',', 'edema', ',', 'and', 'vasopressor', 'therapy', '(', 'p', '.', ')', '.', 'compared', 'to', 'middle', 'tertile', ',', 'probability', 'of', 'harm', 'greater', 'with', 'high', 'tertile', 'of', 'nuf', 'rate', 'in', 'patient', 'in', 'cluster', 'and', 'in', 'patient', 'with', 'baseline', 'edema', '(', 'probability', 'of', 'harm', ',', 'cluster', '.', 'edema', '.', ')', '.', 'moreover', ',', 'higher', 'baseline', 'cardiovascular', 'sofa', 'score', 'also', 'increased', 'mortality', 'risk', 'with', 'high', 'and', 'low', 'compared', 'to', 'middle', 'nuf', 'rate', 'in', 'cluster', 'patient', 'and', 'in', 'patient', 'with', 'edema', '.', 'conclusion', 'in', 'crrt', 'patient', ',', 'high', 'and', 'low', 'nuf', 'rate', 'may', 'harmful', ',', 'especially', 'in', 'with', 'edema', ',', 'sepsis', ',', 'and', 'greater', 'illness', 'severity', '.', 'cardiovascular', 'sofa', 'score', 'modulate', 'association', '.', 'additional', 'study', 'needed', 'to', 'test', 'hypothesis', ',', 'and', 'targeted', 'trial', 'of', 'nuf', 'rate', 'based', 'risk', 'stratification', 'appear', 'justified', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.,"Lindsey E Roeker, Haesook T Kim, Brett Glotzbecker, Prashant Nageshwar, Sarah Nikiforow, John Koreth, Philippe Armand, Corey Cutler, Edwin P Alyea, Joseph H Antin, Paul G Richardson, Robert J Soiffer, Vincent T Ho, Lindsey E Roekeret al.",2019 Jan,Biol Blood Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/30081073/,"Defibrotide, SOS, Sinusoidal obstruction syndrome, Tacrolimus, VOD, Veno-occlusive disease.","['median', '.', 'versus', '.', ',', 'p', '.', 'day', 'of', 'onset', 'median', '.', 'versus', '.', ',', 'p', '.', ')', 'compared', 'with', 'control', 'subject', '.', 'acute', 'renal', 'dysfunction', ',', 'platelet', 'refractoriness', ',', 'and', 'elevated', 'or', 'abnormal', 'tacrolimus', 'level', 'dynamic', 'clinical', 'marker', 'alert', 'clinician', 'to', 'development', 'of', 'vodsos', 'presence', 'of', 'classical', 'diagnostic', 'criterion', '.', 'using', 'clinical', 'feature', 'to', 'recognize', 'vodsos', 'earlier', 'in', 'clinical', 'course', 'could', 'promote', 'earlier', 'treatment', 'and', 'lead', 'to', 'improved', 'outcome', 'of', 'potentially', 'serious', 'complication', '.']"
Early High-Volume Hemofiltration versus Standard Care for Post-Cardiac Surgery Shock. The HEROICS Study.,"Alain Combes, Nicolas Bréchot, Julien Amour, Nathalie Cozic, Guillaume Lebreton, Catherine Guidon, Elie Zogheib, Jean-Claude Thiranos, Jean-Christophe Rigal, Olivier Bastien, Hamina Benhaoua, Bernard Abry, Alexandre Ouattara, Jean-Louis Trouillet, Alain Mallet, Jean Chastre, Pascal Leprince, Charles-Edouard Luyt, Alain Combeset al.",2015 Nov 15,Am J Respir Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/26167637/,No keywords found,"['post-cardiac', 'surgery', 'shock', 'associated', 'with', 'high', 'morbidity', 'and', 'mortality', '.', 'removing', 'toxin', 'and', 'proinflammatory', 'mediator', 'and', 'correcting', 'metabolic', 'acidosis', ',', 'high-volume', 'hemofiltration', '(', 'hvhf', ')', 'might', 'halt', 'vicious', 'circle', 'leading', 'to', 'death', 'improving', 'myocardial', 'performance', 'and', 'reducing', 'vasopressor', 'dependence', '.', 'objective', 'to', 'determine', 'whether', 'early', 'hvhf', 'decrease', 'all-cause', 'mortality', 'day', 'randomization', '.', 'method', 'prospective', ',', 'multicenter', 'randomized', 'controlled', 'trial', 'included', 'patient', 'with', 'severe', 'shock', 'requiring', 'high-dose', 'catecholamine', '-', 'hour', 'post-cardiac', 'surgery', 'randomized', 'to', 'early', 'hvhf', '(', 'mlkgh', 'h', ')', ',', 'followed', 'standard-volume', 'continuous', 'venovenous', 'hemodiafiltration', '(', 'cvvhdf', ')', 'resolution', 'of', 'shock', 'and', 'recovery', 'of', 'renal', 'function', ',', 'or', 'conservative', 'standard', 'care', ',', 'with', 'delayed', 'cvvhdf', 'persistent', ',', 'severe', 'acute', 'kidney', 'injury', '.', 'measurement', 'and', 'main', 'result', 'day', ',', 'of', '(', ')', 'hvhf', 'and', 'of', '(', ')', 'control', 'subject', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', 'died', 'of', 'control', 'subject', 'received', 'renal-replacement', 'therapy', '.', 'between-group', 'survivor', ""'"", 'day-', ',', 'day-', ',', 'intensive', 'care', 'unit', ',', 'and', 'in-hospital', 'mortality', 'rate', ',', 'day-', 'ventilator-free', 'day', ',', 'and', 'renal', 'function', 'recovery', 'comparable', '.', 'hvhf', 'patient', 'experienced', 'faster', 'correction', 'of', 'metabolic', 'acidosis', 'and', 'tended', 'to', 'rapidly', 'weaned', 'catecholamine', 'frequent', 'hypophosphatemia', ',', 'metabolic', 'alkalosis', ',', 'and', 'thrombocytopenia', '.', 'conclusion', 'patient', 'with', 'post-cardiac', 'surgery', 'shock', 'requiring', 'high-dose', 'catecholamine', ',', 'early', 'hvhf', 'onset', 'hour', ',', 'followed', 'standard', 'volume', 'resolution', 'of', 'shock', 'and', 'recovery', 'of', 'renal', 'function', ',', 'not', 'lower', 'day-', 'mortality', 'and', 'not', 'impact', 'important', 'patient-centered', 'outcome', 'compared', 'with', 'conservative', 'strategy', 'with', 'delayed', 'cvvhdf', 'initiation', 'patient', 'with', 'persistent', ',', 'severe', 'acute', 'kidney', 'injury', '.', 'clinical', 'trial', 'registered', 'with', 'www.clinicaltrials.gov', '(', 'nct', ')', '.']"
"Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial.","Claudia Sommerer, Barbara Suwelack, Duska Dragun, Peter Schenker, Ingeborg A Hauser, Björn Nashan, Friedrich Thaiss, Claudia Sommereret al.",2016 Feb 17:17:92.,Trials,https://pubmed.ncbi.nlm.nih.gov/26888217/,No keywords found,"['immunosuppression', 'with', 'calcineurin', 'inhibitor', 'remains', 'mainstay', 'of', 'treatment', 'kidney', 'transplantation', 'however', ',', 'long-term', 'use', 'of', 'drug', 'may', 'associated', 'with', 'nephrotoxicity', '.', 'in', 'regard', ',', 'current', 'approach', 'to', 'optimise', 'available', 'immunosuppressive', 'regimen', 'to', 'reduce', 'calcineurin', 'inhibitor', 'dose', 'protecting', 'renal', 'function', 'without', 'affecting', 'efficacy', '.', 'athena', 'study', 'designed', 'to', 'evaluate', 'renal', 'function', 'in', 'two', 'regimen', 'everolimus', 'and', 'reduced', 'calcineurin', 'inhibitor-based', 'regimen', 'versus', 'standard', 'treatment', 'protocol', 'with', 'mycophenolic', 'acid', 'and', 'tacrolimus', 'in', 'de', 'novo', 'kidney', 'transplant', 'recipient', '.', 'methoddesign', 'athena', '-month', ',', 'multicentre', ',', 'open-label', ',', 'prospective', ',', 'randomised', ',', 'parallel-group', 'study', 'in', 'de', 'novo', 'kidney', 'transplant', 'recipient', '(', 'aged', 'year', 'or', 'older', ')', 'receiving', 'renal', 'allograft', 'deceased', 'or', 'living', 'donor', '.', 'eligible', 'patient', 'randomised', '(', ')', 'prior', 'to', 'transplantation', 'to', 'one', 'of', 'following', 'three', 'treatment', 'arm', 'everolimus', '(', 'starting', 'dose', '.', 'mgday', 'c', '-', 'ngml', ')', 'with', 'cyclosporine', 'or', 'everolimus', '(', 'starting', 'dose', 'mgday', 'c', '-', 'ngml', ')', 'with', 'tacrolimus', 'or', 'mycophenolic', 'acid', '(', 'enteric-coated', 'mycophenolate', 'sodium', '.', 'gday', 'or', 'mycophenolate', 'mofetil', 'gday', ')', 'with', 'tacrolimus', 'in', 'combination', 'with', 'corticosteroid', '.', 'patient', 'receive', 'induction', 'therapy', 'with', 'basiliximab', '.', 'primary', 'objective', 'to', 'demonstrate', 'non-inferiority', 'of', 'renal', 'function', '(', 'egfr', 'nankivell', 'formula', ')', 'in', 'one', 'of', 'everolimus', 'arm', 'compared', 'with', 'standard', 'group', 'month', 'post', 'transplantation', '.', 'key', 'secondary', 'objective', 'to', 'assess', 'incidence', 'of', 'treatment', 'failure', ',', 'defined', 'biopsy-proven', 'acute', 'rejection', ',', 'graft', 'loss', ',', 'or', 'death', ',', 'among', 'treatment', 'group', '.', 'objective', 'include', 'assessment', 'of', 'individual', 'component', 'of', 'treatment', 'failure', ',', 'incidence', 'and', 'severity', 'of', 'viral', 'infection', ',', 'incidence', 'and', 'duration', 'of', 'delayed', 'graft', 'function', ',', 'incidence', 'of', 'indication', 'biopsy', ',', 'slow', 'graft', 'function', 'and', 'wound', 'healing', 'complication', ',', 'and', 'overall', 'safety', 'and', 'tolerability', '.', 'exploratory', 'objective', 'include', 'evaluation', 'of', 'left', 'ventricular', 'hypertrophy', 'assessed', 'left', 'ventricular', 'mass', 'index', ',', 'evolution', 'of', 'human', 'leukocyte', 'antigen', 'and', 'non-human', 'leukocyte', 'antigen', 'antibody', ',', 'and', 'cytomegalovirus', 'substudy', '.', 'discussion', 'one', 'of', 'largest', 'european', 'multicentre', 'kidney', 'transplant', 'study', ',', 'athena', 'determine', 'whether', 'de', 'novo', 'everolimus-based', 'regimen', 'preserve', 'renal', 'function', 'versus', 'standard', 'of', 'care', '.', 'study', 'assesses', 'number', 'of', 'clinical', 'issue', 'impact', 'long-term', 'outcome', 'post', 'transplantation', 'hence', ',', 'result', 'major', 'clinical', 'impact', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', ',', 'date', 'of', 'registration', '--', 'april', 'eudract', 'number', '--', ',', 'date', 'of', 'registration', '--', 'march', '.']"
Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting.,"John V Conte, Thomas G Gleason, Jon R Resar, David H Adams, G Michael Deeb, Jeffrey J Popma, G Chad Hughes, George L Zorn, Michael J Reardon, John V Conteet al.",2016 Jan,Ann Thorac Surg,https://pubmed.ncbi.nlm.nih.gov/26433523/,No keywords found,"['transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'and', 'surgical', 'aortic', 'valve', 'replacement', '(', 'savr', ')', 'treatment', 'option', 'aortic', 'stenosis', 'in', 'patient', 'with', 'prior', 'coronary', 'artery', 'bypass', 'graft', 'surgery', '.', 'assessed', 'major', 'clinical', 'outcome', 'of', 'patient', 'enrolled', 'in', 'corevalve', 'high', 'risk', '(', 'chr', ')', 'study', '.', 'method', 'of', 'chr', 'study', 'patient', ',', 'prior', 'coronary', 'artery', 'bypass', 'graft', 'surgery', 'underwent', 'tavr', 'and', 'underwent', 'savr', '.', 'primary', 'endpoint', 'comparison', 'of', 'all-cause', 'mortality', 'year', '.', 'important', 'secondary', 'clinical', 'endpoint', 'assessed', '.', 'result', 'year', ',', 'all-cause', 'mortality', '.', 'tavr', 'versus', '.', 'savr', '(', 'p', '.', ')', 'cardiovascular', 'mortality', '.', 'tavr', 'versus', '.', 'savr', '(', 'p', '.', ')', '.', 'combination', 'of', 'society', 'of', 'thoracic', 'surgeon', 'risk', 'score', 'greater', 'and', 'age', 'greater', 'year', 'significant', 'predictor', 'of', 'mortality', ',', 'with', 'tavr', 'demonstrating', 'survival', 'advantage', '(', 'p', '.', ')', '.', 'no', 'difference', 'seen', 'stroke', '.', 'savr', 'group', 'longer', 'intensive', 'care', 'unit', 'and', 'hospital', 'stay', ',', 'increased', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'life-threatening', 'or', 'disabling', 'bleeding', ',', 'and', 'major', 'adverse', 'cardiac', 'and', 'cerebrovascular', 'event', '(', 'p', '.', ')', '.', 'pacemaker', 'implantation', 'and', 'paravalvular', 'regurgitation', 'greater', 'with', 'tavr', 'timepoints', '.', 'conclusion', 'patient', 'with', 'prior', 'coronary', 'artery', 'bypass', 'graft', 'surgery', 'and', 'aortic', 'stenosis', ',', 'tavr', 'offer', 'significant', 'morbidity', 'advantage', 'and', 'strong', 'trend', 'toward', 'improved', 'survival', 'savr', 'year', '.']"
Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients.,"Amin T Turki, Wolfgang Lamm, Christoph Schmitt, Evren Bayraktar, Ferras Alashkar, Martin Metzenmacher, Philipp Wohlfarth, Dietrich W Beelen, Tobias Liebregts, Amin T Turkiet al.",2019 Feb,Ann Hematol,https://pubmed.ncbi.nlm.nih.gov/30406350/,"Allogeneic stem cell transplantation, Anemia, Complications, Graft function, Intensive care treatment, Platelets, Thrombocytopenia.","['despite', 'significant', 'advance', 'in', 'treatment', 'of', 'complication', 'requiring', 'intensive', 'care', 'unit', '(', 'icu', ')', 'admission', ',', 'icu', 'mortality', 'remains', 'high', 'patient', 'allogeneic', 'stem', 'cell', 'transplantation', '.', 'evaluated', 'role', 'of', 'thrombocytopenia', 'and', 'poor', 'graft', 'function', 'in', 'allogeneic', 'stem', 'cell', 'recipient', 'receiving', 'icu', 'treatment', 'along', 'with', 'established', 'prognostic', 'icu', 'marker', 'in', 'order', 'to', 'identify', 'patient', 'risk', 'severe', 'complication', '.', 'icu', 'admission', ',', 'clinical', 'and', 'laboratory', 'data', 'of', 'allogeneic', 'stem', 'cell', 'transplanted', 'icu', 'patient', 'collected', 'and', 'retrospectively', 'analyzed', '.', 'platelet', 'count', '(', ',', 'l', ',', 'p', '.', ')', ',', 'hemoglobin', 'level', '(', '.', 'mgdl', ',', 'p', '.', ')', ',', 'and', 'leukocyte', 'count', '(', 'l', ',', 'p', '.', ')', 'along', 'with', 'sepsis', '(', 'p', '.', ')', 'and', 'acute', 'myeloid', 'leukemia', '(', 'p', '.', ')', 'correlated', 'significantly', 'with', 'survival', '.', 'multivariate', 'analysis', 'confirmed', 'thrombocytopenia', '(', 'hazard', 'ratio', '(', 'hr', ')', '.', '(', '.-.', ',', 'confidence', 'interval', '(', 'ci', ')', ')', 'and', 'anemia', '(', 'hr', '.', ',', '.-.', ',', 'ci', ')', 'independent', 'mortality', 'risk', 'factor', '.', 'predominant', 'icu', 'diagnosis', 'acute', 'respiratory', 'failure', '(', ')', ',', 'acute', 'kidney', 'injury', '(', ')', ',', 'and', 'septic', 'shock', '(', ')', '.', 'acute', 'graft', 'versus', 'host', 'disease', 'diagnosed', 'in', 'of', 'patient', ',', 'and', 'required', 'vasopressor', '.', 'low', 'platelet', '(', ',', 'l', ')', 'and', 'poor', 'graft', 'function', 'independent', 'prognostic', 'factor', 'impaired', 'survival', 'in', 'critically', 'ill', 'stem', 'cell', 'transplanted', 'patient', '.', 'underlying', 'pathophysiology', 'of', 'poor', 'graft', 'function', 'not', 'fully', 'understood', 'and', 'currently', 'investigation', '.', 'high-risk', 'patient', 'may', 'identified', 'and', 'icu', 'treatment', 'stratified', 'according', 'to', 'allogeneic', 'stem', 'cell', 'patient', ""'"", 'individual', 'risk', 'profile', '.', 'in', 'contrast', 'to', 'previous', 'study', 'involving', 'medical', 'or', 'surgical', 'icu', 'patient', ',', 'fraction', 'of', 'thrombocytopenic', 'patient', 'larger', 'and', 'low', 'platelet', 'better', 'differentiating', 'factor', 'in', 'multivariate', 'analysis', 'parameter', '.']"
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.,"Victor Razuk, Anton Camaj, Davide Cao, Johny Nicolas, Christian Hengstenberg, Samantha Sartori, Zhongjie Zhang, David Power, Frans Beerkens, Mauro Chiarito, Nicolas Meneveau, Christophe Tron, Nicolas Dumonteil, Julian D Widder, Markus Ferrari, Roberto Violini, Pieter R Stella, Raban Jeger, Prodromos Anthopoulos, Roxana Mehran, George D Dangas, Victor Razuket al.",2021 Nov 15,Catheter Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/33909348/,No keywords found,"['to', 'determine', 'prognostic', 'impact', 'of', 'anemia', 'in', 'patient', 'randomized', 'to', 'bivalirudin', 'or', 'unfractionated', 'heparin', '(', 'ufh', ')', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', '.', 'background', 'whether', 'periprocedural', 'use', 'of', 'bivalirudin', 'compared', 'with', 'ufh', 'in', 'anemic', 'patient', 'undergoing', 'tavr', 'impact', 'outcome', 'remains', 'unknown', '.', 'method', 'bravo-', 'trial', 'compared', 'use', 'of', 'bivalirudin', 'versus', 'ufh', 'in', 'high', 'risk', 'patient', 'undergoing', 'transfemoral', 'tavr', 'severe', 'symptomatic', 'aortic', 'stenosis', '.', 'patient', 'stratified', 'according', 'to', 'presence', '(', 'defined', 'hemoglobin', 'level', 'gdl', 'in', 'men', 'and', 'gdl', 'in', 'woman', ')', 'or', 'absence', 'of', 'anemia', '.', 'primary', 'outcome', 'net', 'adverse', 'cardiac', 'event', '(', 'nace', 'composite', 'of', 'all-cause', 'mortality', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'or', 'bleeding', ')', 'and', 'major', 'bleeding', '(', 'bleeding', 'academic', 'research', 'consortium', 'b', ')', 'day', '.', 'result', 'among', 'patient', 'with', 'available', 'baseline', 'hemoglobin', 'level', ',', '(', ')', 'anemic', 'of', '(', ')', 'received', 'bivalirudin', '.', 'no', 'significant', 'difference', 'in', 'nace', 'and', 'major', 'bleeding', 'day', 'patient', 'with', 'and', 'without', 'anemia', ',', 'irrespective', 'of', 'type', 'of', 'anticoagulant', 'used', '(', 'pinteraction', '.', 'nace', ',', 'pinteraction', '.', 'major', 'bleeding', ')', '.', 'however', ',', 'anemic', 'patient', 'higher', 'risk', 'of', 'major', 'vascular', 'complication', '(', 'adjusted', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', ',', 'and', 'acute', 'kidney', 'injury', '(', 'adjusted', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', 'compared', 'to', 'non-anemic', 'patient', 'day', '.', 'conclusion', 'anemia', 'not', 'associated', 'with', 'higher', 'risk', 'of', 'nace', 'or', 'major', 'bleeding', 'day', 'tavr', 'without', 'modification', 'of', 'treatment', 'effect', 'of', 'periprocedural', 'anticoagulation', 'with', 'bivalirudin', 'versus', 'ufh', '.']"
Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.,"Stephen Zewinger, Thomas Rauen, Michael Rudnicki, Giuseppina Federico, Martina Wagner, Sarah Triem, Stefan J Schunk, Ioannis Petrakis, David Schmit, Stefan Wagenpfeil, Gunnar H Heine, Gert Mayer, Jürgen Floege, Danilo Fliser, Hermann-Josef Gröne, Thimoteus Speer, Stephen Zewingeret al.",2018 Nov,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/30279273/,No keywords found,"['individual', 'course', 'of', 'ckd', 'may', 'vary', ',', 'and', 'improved', 'method', 'identifying', 'patient', 'experience', 'short-term', 'egfr', 'loss', 'needed', '.', 'assessing', 'urinary', 'dickkopf-', '(', 'dkk', ')', ',', 'stress-induced', 'tubular', 'epithelia-derived', 'profibrotic', 'glycoprotein', ',', 'may', 'provide', 'information', 'ongoing', 'tubulointerstitial', 'fibrosis', 'and', 'short-term', 'egfr', 'loss', '.', 'method', 'to', 'investigate', 'urinary', 'dkk', ""'s"", 'potential', 'biomarker', 'of', 'short-term', 'egfr', 'loss', '(', 'month', ')', ',', 'prospectively', 'assessed', 'egfr', 'and', 'urinary', 'dkk', 'level', 'in', 'patient', 'with', 'ckd', 'of', 'various', 'etiology', 'baseline', 'and', 'annual', 'follow-up', '.', 'also', 'measured', 'urinary', 'dkk', 'in', 'general', 'population', 'sample', 'and', 'patient', 'with', 'diagnostic', 'kidney', 'biopsy', 'or', 'iga', 'nephropathy', 'treatment', '.', 'result', 'median', 'urinary', 'dkk-to-creatinine', 'concentration', 'baseline', 'significantly', 'higher', 'in', 'patient', 'with', 'ckd', 'general', 'population', 'sample', '(', 'versus', 'pgmg', ')', '.', 'in', 'ckd', 'cohort', ',', 'urinary', 'dkk-to-creatinine', 'level', 'pgmg', 'independently', 'and', 'significantly', 'associated', 'multiple', 'adjustment', 'with', 'mean', 'annual', 'decline', 'in', 'egfr', 'of', '.', 'month', '.', 'urinary', 'dkk', 'significantly', 'improved', 'prediction', 'of', 'kidney', 'function', 'decline', 'compared', 'with', 'egfr', 'or', 'albuminuria', 'alone', '.', 'urinary', 'dkk-to-creatinine', 'level', 'related', 'to', 'extent', 'of', 'tubulointerstitial', 'fibrosis', 'in', 'kidney', 'biopsy', '.', 'in', 'patient', 'with', 'iga', 'nephropathy', ',', 'rise', 'in', 'urinary', 'dkk', 'associated', 'with', 'significant', 'egfr', 'decline', 'within', 'month', ',', 'whereas', 'stable', 'or', 'decreasing', 'urinary', 'dkk', 'indicated', 'favorable', 'course', '.', 'conclusion', 'urinary', 'dkk', 'level', 'identify', 'patient', 'high', 'risk', 'egfr', 'decline', 'next', 'month', 'regardless', 'of', 'cause', 'of', 'kidney', 'injury', 'and', 'beyond', 'established', 'biomarkers', ',', 'potentially', 'providing', 'tool', 'to', 'monitor', 'ckd', 'progression', 'and', 'assess', 'effect', 'of', 'intervention', '.']"
TAVR in Intermediate-Risk Patients: A Review of the PARTNER 2 Trial and its Future Implications.,"Sameer Arora, Cassandra J Ramm, Jacob A Misenheimer, John P Vavalle, Sameer Aroraet al.",2016 Nov,J Heart Valve Dis,https://pubmed.ncbi.nlm.nih.gov/28290162/,No keywords found,"['following', 'publication', 'of', 'result', 'of', 'partner', 'trial', ',', 'american', 'college', 'of', 'cardiologyamerican', 'heart', 'association', 'recognized', 'success', 'of', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'incorporating', 'feasible', 'option', 'in', 'high-surgical', 'risk', 'patient', ',', 'and', 'recommending', 'standard', 'of', 'care', 'patient', 'prohibitive', 'risk', 'of', 'surgery', '.', 'although', 'recognized', 'major', 'success', 'in', 'field', 'of', 'percutaneous', 'valve', 'replacement', ',', 'surgical', 'aortic', 'valve', 'replacement', '(', 'savr', ')', 'continued', 'to', 'realized', 'procedure', 'of', 'choice', 'low', 'and', 'intermediate', 'surgical', 'risk', 'patient', '.', 'meanwhile', ',', 'observational', 'study', '-', 'predominantly', 'europe', '-', 'showed', 'encouraging', 'result', 'tavr', 'in', 'lower-risk', 'population', '.', 'with', 'lack', 'of', 'large', 'randomized', 'controlled', 'clinical', 'trial', ',', 'however', ',', 'advantage', 'of', 'tavr', 'continued', 'to', 'limited', 'to', 'minority', 'of', 'patient', 'with', 'severe', ',', 'symptomatic', 'aortic', 'stenosis', '.', 'method', 'december', 'and', 'november', ',', 'partner', 'investigator', 'enrolled', 'total', 'of', ',', 'intermediate-risk', 'patient', 'with', 'severe', 'symptomatic', 'aortic', 'stenosis', 'center', 'in', 'united', 'state', 'and', 'canada', '.', 'patient', 'randomized', 'to', 'undergo', 'either', 'tavr', 'or', 'savr', '.', 'primary', 'end', 'point', 'death', 'and', 'neurological', 'event', 'two', 'year', '.', 'result', 'study', 'result', 'showed', 'similar', 'rate', 'death', 'and', 'neurological', 'event', 'in', 'tavr', 'and', 'savr', 'group', '.', 'tavr', 'group', 'found', 'to', 'larger', 'valve', 'area', 'and', 'lower', 'incidence', 'of', 'acute', 'kidney', 'injury', ',', 'bleeding', 'event', ',', 'and', 'atrial', 'fibrillation', '.', 'conversely', ',', 'savr', 'group', 'experienced', 'fewer', 'vascular', 'complication', 'and', 'lower', 'rate', 'of', 'paravalvular', 'regurgitation', '.', 'conclusion', 'result', 'of', 'partner', 'trial', 'reviewed', ',', 'and', 'implication', 'future', 'discussed', '.']"
"Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.","Jeremy Kong, Jonathan G Zaroff, Andrew P Ambrosy, Jesse K Fitzpatrick, Ivy A Ku, Jacob M Mishell, Lak N Kotinkaduwa, Björn Redfors, Nirat Beohar, Gorav Ailawadi, JoAnn Lindenfeld, William T Abraham, Michael J Mack, Saibal Kar, D Scott Lim, Brian K Whisenant, Gregg W Stone, Jeremy Konget al.",2023 Jul 18,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/37421291/,"MitraClip, acute kidney injury, heart failure, mitral valve edge‐to‐edge repair, secondary mitral regurgitation, worsening renal function.","['httpswww.clinicaltrials.gov', 'unique', 'identifier', 'nct', '.']"
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction.,"Simone Biscaglia, Vincenzo Guiducci, Javier Escaned, Raul Moreno, Valerio Lanzilotti, Andrea Santarelli, Enrico Cerrato, Giorgio Sacchetta, Alfonso Jurado-Roman, Alberto Menozzi, Ignacio Amat Santos, José Luis Díez Gil, Marco Ruozzi, Marco Barbierato, Luca Fileti, Andrea Picchi, Veronica Lodolini, Giuseppe Biondi-Zoccai, Elisa Maietti, Rita Pavasini, Paolo Cimaglia, Carlo Tumscitz, Andrea Erriquez, Carlo Penzo, Iginio Colaiori, Gianluca Pignatelli, Gianni Casella, Gianmarco Iannopollo, Mila Menozzi, Ferdinando Varbella, Giorgio Caretta, Dariusz Dudek, Emanuele Barbato, Matteo Tebaldi, Gianluca Campo                              ;, FIRE Trial Investigators, Gianluca Campo, Camilla Matese, Elisa Venturoli, Beatrice De Carolis, Daniele Maio, Martina Viola, Elisa Mosele, Chiara Manzalini, Marco Contarini, Claudia Artale, Sergio Musto D'Amore, Davide Bosi, Linda Valli, Rosa De Mola, Caterina Cavazza, Andrea Rubboli, Matteo Aquilina, Marco Balducelli, Carolina Moretti, Francesco Tomassini, Cristina Rolfo, Alfonso Franzè, Giulio Piedimonte, Greca Zanda, Luca Lo Savio, Giampiero Nobile, Alessandro Capecchi, Roberto Verardi, Barbara Coutsoumbas, Flavio Maffia, Francesco Giannini, Rossella Ruggiero, Vincenzo Argentino, Dino Bonomo, Diego Milazzo, Gerlando Pilato, Giovanni Vaccaro, Ilenia Di Liberto, Paolo Magnavacchi, Daniele Iaccarino, Pietro Landino, Alfonsina Corbisiero, Domenico Di Girolamo, Giuseppe Vadalà, Giunta Rocco, Trovato Graziano, Marco Arena, Giuseppe Andò, Francesco Costa, Giampiero Vizzari, Vittorio Virga, Francesco Saporito, Michele Pighi, Andrea Mainardi, Francesco Della Mora, Roberto Scarsini, Flavio Ribichini, Alberto Massoni, Ugo Limbruno, Andrea Berni, Stefano Rigattieri, Gianpiero D'Amico, Francesco Gallo, Maurizio D'Amico, Alfonso Gambino, Paolo Calabrò, Fabio Fimiani, Elisabetta Moscarella, Silvio Coletta, Michele De Benedictis, Marco Pavani, Umberto Barbero, Cinzia Moncalvo, Javier Escaned Barbosa, Carlos Vergará, Angela McInerney, Hernán Mejia, Oscar Vedia, Ana Gomez, Juan Caro-Codon, Virginia Fernandez-Figares, Guillermo Galeote, Santiago Jimenez-Valero, María Labrador, Guiomar Mediavilla, Sandra Rosillo, Francisco Fernandez-Aviles, Enrique Gutierrez Ibañes, Sandra Vazquez, Andres Iñiguez Romo, Guillermo Bastos Fernández, Alberto Ortiz Sáez, Jose Antonio Baz Alonso, Antonio Alejandro de Miguel Castro, Víctor Alfonso Jiménez Díaz, Saleta Fernández Barbeira, Rodrigo Estévez Loureiro, Rocío González Ferreiro, Pablo Juan Salvadores, Ana Isabel Ferrero Martínez, Sonia Soto Fernández, María José Rodríguez Pérez, María Pena Martínez, Fernando Lozano Ruiz-Poveda, Maria Lopez Lluva, Jose Abellan, Ignacio Perez, Vicente Jimenez Cruz, Bernabé López Ledesma, Raymundo Ocaranza-Sanchez, Melisa Santás Álvarez, Jeremias Bayón Lorenzo, Rubén Vila Abelleira, Alba Abellás Sequeirós, Rubén Vila, Susana Miranda, Ramiro Trillo Nouche, Diego Lopez Otero, Ana Belen Cid Alvarez, Juan Carlos Santamaria Pena, Diana Pereiro Montes, Ramón Calviño Santos, Jose Manuel Vazquez Rodriguez, Elena Paz Misiego, Ignacio J Amat Santos, Alfredo Redondo, Alberto Campo, Julio Peral, Carlos Baladron, María José Coya, Dawid Giszterowicz, Wojciech Dobrowolski, Marcin Nosal, Rafał Marosz, Piotr Wilusz, Jarosław Paździerz, Piotr Żywiec, Sławomir Szynal, Stefania Corsi, Marzia Sivieri, Andres Iniguez Romo, Ramon Calvino Santos, José Luis Diez Gil, Marco Manfrini, Stefano Volpato, Anna Zanetti, Nicola Pasenti, Greta Carraro, Giuseppe Biondi Zoccai, Filippo Maria Verardi, Serena Caglioni, Andrea Marrone, Ennio Scollo, Antonella Scala, Matteo Arzenton, Graziella Pompei, Nicola Bianchi, Roberta Campana, Marta Cocco, Assunta Di Domenico, Federico Marchini, Michele Trichilo, Federico Sanguettoli, Davide Scancarello, Claudio Farina, Sara Fernandez, Beata Chęcińska-Tokarz, Simone Biscagliaet al.",2023 Sep 7,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/37634150/,No keywords found,"['benefit', 'of', 'complete', 'revascularization', 'in', 'older', 'patient', '(', 'year', 'of', 'age', ')', 'with', 'myocardial', 'infarction', 'and', 'multivessel', 'disease', 'remains', 'unclear', '.', 'method', 'in', 'multicenter', ',', 'randomized', 'trial', ',', 'assigned', 'older', 'patient', 'with', 'myocardial', 'infarction', 'and', 'multivessel', 'disease', 'undergoing', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'of', 'culprit', 'lesion', 'to', 'receive', 'either', 'physiology-guided', 'complete', 'revascularization', 'of', 'nonculprit', 'lesion', 'or', 'to', 'receive', 'no', 'revascularization', '.', 'functionally', 'significant', 'nonculprit', 'lesion', 'identified', 'either', 'pressure', 'wire', 'or', 'angiography', '.', 'primary', 'outcome', 'composite', 'of', 'death', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'or', 'revascularization', 'year', '.', 'key', 'secondary', 'outcome', 'composite', 'of', 'cardiovascular', 'death', 'or', 'myocardial', 'infarction', '.', 'safety', 'assessed', 'composite', 'of', 'contrast-associated', 'acute', 'kidney', 'injury', ',', 'stroke', ',', 'or', 'bleeding', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', '(', 'to', 'receive', 'complete', 'revascularization', 'and', 'to', 'receive', 'culprit-only', 'revascularization', ')', '.', 'median', 'age', 'of', 'patient', 'year', '(', 'interquartile', 'range', ',', 'to', ')', 'patient', '(', '.', ')', 'woman', ',', 'and', '(', '.', ')', 'admitted', 'st-segment', 'elevation', 'myocardial', 'infarction', '.', 'primary-outcome', 'event', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'complete-revascularization', 'group', 'and', 'in', 'patient', '(', '.', ')', 'in', 'culprit-only', 'group', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'cardiovascular', 'death', 'or', 'myocardial', 'infarction', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'complete-revascularization', 'group', 'and', 'in', 'patient', '(', '.', ')', 'in', 'culprit-only', 'group', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'safety', 'outcome', 'not', 'appear', 'to', 'differ', 'group', '(', '.', 'vs.', '.', 'p', '.', ')', '.', 'conclusion', 'among', 'patient', 'year', 'of', 'age', 'or', 'older', 'with', 'myocardial', 'infarction', 'and', 'multivessel', 'disease', ',', 'underwent', 'physiology-guided', 'complete', 'revascularization', 'lower', 'risk', 'of', 'composite', 'of', 'death', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'or', 'ischemia-driven', 'revascularization', 'year', 'received', 'culprit-lesion-only', 'pci', '.', '(', 'funded', 'consorzio', 'futuro', 'in', 'ricerca', 'and', 'others', 'fire', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Impact of Aortic Atherosclerosis Burden on Outcomes of Surgical Aortic Valve Replacement.,"Alexander Iribarne, Stephanie Pan, Jock N McCullough, Joseph P Mathew, Judy Hung, Xin Zeng, Pierre Voisine, Patrick T O'Gara, Nancy M Sledz, Annetine C Gelijns, Wendy C Taddei-Peters, Steven R Messé, Alan J Moskowitz, Vinod H Thourani, Michael Argenziano, Mark A Groh, Gennaro Giustino, Jessica R Overbey, J Michael DiMaio, Peter K Smith, Alexander Iribarneet al.",2020 Feb,Ann Thorac Surg,https://pubmed.ncbi.nlm.nih.gov/31400333/,No keywords found,"['epiaortic', 'ultrasound', 'detects', 'and', 'localizes', 'ascending', 'aortic', 'atherosclerosis', '.', 'in', 'analysis', 'investigated', 'association', 'epiaortic', 'ultrasound-based', 'atheroma', 'grade', 'surgical', 'aortic', 'valve', 'replacement', '(', 'savr', ')', 'and', 'perioperative', 'adverse', 'outcome', '.', 'method', 'savr', 'patient', 'in', 'randomized', 'trial', 'of', 'embolic', 'protection', 'device', 'underwent', 'protocol-defined', '-view', 'epiaortic', 'ultrasound', 'read', 'core', 'laboratory', '.', 'aortic', 'atherosclerosis', 'quantified', 'with', 'katz', 'atheroma', 'grade', ',', 'and', 'patient', 'categorized', 'mild', '(', 'grade', 'i-ii', ')', 'or', 'moderatesevere', '(', 'grade', 'iii-v', ')', '.', 'multivariable', 'logistic', 'regression', 'used', 'to', 'estimate', 'association', 'atheroma', 'grade', 'and', 'adverse', 'outcome', ',', 'including', 'death', ',', 'clinically', 'apparent', 'stroke', ',', 'cerebral', 'infarction', 'diffusion-weighted', 'magnetic', 'resonance', 'imaging', ',', 'delirium', ',', 'and', 'acute', 'kidney', 'injury', '(', 'aki', ')', 'and', 'day', '.', 'result', 'precannulation', 'epiaortic', 'ultrasound', 'data', 'available', 'of', 'randomized', 'patient', '(', '.', ')', '.', 'of', ',', '(', '.', ')', 'moderatesevere', 'katz', 'atheroma', 'grade', 'segment', 'of', 'ascending', 'aorta', '.', 'although', 'difference', 'in', 'composite', 'of', 'death', ',', 'stroke', ',', 'or', 'cerebral', 'infarction', 'diffusion-weighted', 'magnetic', 'resonance', 'imaging', 'day', 'not', 'statistically', 'significant', ',', 'moderatesevere', 'atheroma', 'grade', 'associated', 'with', 'greater', 'risk', 'of', 'aki', 'day', '(', 'adjusted', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', '.', 'day', ',', 'patient', 'with', 'moderatesevere', 'atheroma', 'grade', 'greater', 'risk', 'of', 'death', ',', 'stroke', ',', 'or', 'aki', '(', 'adjusted', 'odds', 'ratio', ',', '.', 'confidence', 'interval', ',', '.-', '.', 'p', '.', ')', '.', 'conclusion', 'moderatesevere', 'aortic', 'atherosclerosis', 'associated', 'with', 'increased', 'risk', 'of', 'adverse', 'event', 'savr', '.', 'epiaortic', 'ultrasound', 'may', 'serve', 'useful', 'adjunct', 'identifying', 'patient', 'may', 'benefit', 'strategy', 'to', 'reduce', 'atheroembolic', 'complication', 'savr', '.']"
Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in Donation After Circulatory Death Kidney Transplant Recipients.,"Jonna R Bank, Renée Ruhaak, Darius Soonawala, Oleg Mayboroda, Fred P Romijn, Cees van Kooten, Christa M Cobbaert, Johan W de Fijter, Jonna R Banket al.",2019 May,Transplantation,https://pubmed.ncbi.nlm.nih.gov/30300282/,No keywords found,"['urinary', 'tissue', 'inhibitor', 'of', 'metalloproteinases-', '(', 'timp-', ')', 'and', 'insulin-like', 'growth', 'factor', 'binding', 'protein-', '(', 'igfbp', ')', 'validated', 'biomarkers', 'acute', 'kidney', 'injury', '.', 'investigated', 'performance', 'of', 'marker', 'in', 'predicting', 'occurrence', 'and', 'duration', 'of', 'functionally', 'defined', 'delayed', 'graft', 'function', '(', 'fdgf', ')', 'in', 'donation', 'circulatory', 'death', '(', 'dcd', ')', 'kidney', 'transplant', 'recipient', '.', 'method', 'urine', 'sample', 'of', 'dcd', 'recipient', 'analyzed', '.', 'timp-', 'and', 'igfbp', 'measured', 'with', 'elisa', 'postoperative', 'day', 'to', ',', 'day', ',', 'week', ',', 'and', 'month', ',', 'and', 'value', 'corrected', 'osmolality', '(', 'mosm', ')', '.', 'immunosuppression', 'consisted', 'of', 'anti-cd', 'antibody', 'induction', 'and', 'triple', 'maintenance', 'therapy', '(', 'steroid', ',', 'mycophenolate', 'mofetil', ',', 'and', 'calcineurin', 'inhibitor', ')', '.', 'statistical', 'analysis', 'included', 'receiver', 'operating', 'characteristic', 'curve', 'and', 'multivariate', 'logistic', 'regression', '.', 'result', 'fifty-one', '(', ')', 'renal', 'transplant', 'recipient', 'fdgf', ',', 'of', 'experienced', 'prolonged', 'fdgf', '(', 'day', ')', '.', 'timp-mosm', 'day-', 'and', 'day-', 'adequately', 'identified', 'patient', 'with', 'fdgf', '(', 'area', 'curve', 'auc', ',', '.', ')', 'and', 'prolonged', 'fdgf', '(', 'auc', ',', '.', ')', ',', 'respectively', ',', 'whereas', 'igfbpmosm', 'not', '(', 'auc', ',', '.', 'and', '.', ')', '.', 'multivariate', 'analysis', 'day', 'identified', '-hour', 'urinary', 'creatinine', 'excretion', 'and', 'timp-mosm', 'significant', 'predictor', 'of', 'fdgf', '(', 'auc', ',', '.', ',', 'confidence', 'interval', ',', '.-.', ')', '.', 'best', 'predictor', 'of', 'prolonged', 'fdgf', 'day', '-hour', 'urinary', 'creatinine', 'excretion', ',', 'timp-mosm', ',', 'and', 'total', 'warm', 'ischemia', 'time', 'with', 'auc', 'of', '.', '(', 'confidence', 'interval', ',', '.-.', ')', '.', 'consecutive', 'timp-mosm', 'value', 'showed', 'decrease', 'in', 'timp-mosm', 'increase', 'in', 'estimated', 'glomerular', 'filtration', 'rate', ',', 'enabling', 'u', 'to', 'monitor', 'fdgf', 'and', 'predict', 'resolution', 'of', 'fdgf', '.', 'conclusion', 'urinary', 'timp-', ',', 'not', 'igfbp', ',', 'promising', 'biomarker', 'to', 'predict', 'occurrence', 'and', 'duration', 'of', 'fdgf', 'in', 'dcd', 'kidney', 'transplant', 'recipient', '.']"
Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.,"Julia Neuhaus, Frederic Bauer, Christina Fitzner, Ralf-Dieter Hilgers, Felix Seibert, Nina Babel, Adrian Doevelaar, Frank Eitner, Jürgen Floege, Thomas Rauen, Timm H Westhoff, Julia Neuhauset al.",2018,Kidney Blood Press Res,https://pubmed.ncbi.nlm.nih.gov/30347407/,No keywords found,"['addition', 'of', 'immunosuppression', 'to', 'supportive', 'care', 'reduces', 'proteinuria', 'in', 'subset', 'of', 'patient', 'with', 'iga', 'nephropathy', '(', 'igan', ')', 'associated', 'with', 'increased', 'rate', 'of', 'adverse', 'event', '.', 'present', 'work', 'investigates', 'whether', 'urinary', 'biomarkers', 'able', 'to', 'identify', 'subject', 'benefit', 'immunosuppression', 'and', 'to', 'predict', 'progression', 'of', 'disease', 'in', 'sub-cohort', 'of', 'stop-igan', 'trial', '.', 'method', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', ',', 'kidney', 'injury', 'molecule-', '(', 'kim-', ')', ',', 'calprotectin', ',', 'and', 'product', 'of', 'tissue', 'inhibitor', 'of', 'metalloproteinase-', 'and', 'insulin-like', 'growth', 'factor-binding', 'protein', '(', 'timpigfbp', ')', 'measured', 'in', 'available', 'urine', 'sample', 'obtained', 'time', 'point', 'of', 'enrollment', 'in', 'stop-igan', 'trial', '(', 'n', ')', '.', 'result', 'biomarker', 'concentration', 'in', 'overall', 'study', 'population', 'and', 'subgroup', 'with', 'additional', 'immunosuppression', 'not', 'differ', 'in', 'subject', 'reaching', 'vs.', 'not', 'reaching', 'full', 'clinical', 'remission', ',', 'egfr', 'loss', ',', 'or', 'mlmin', '.', '-year', 'trial', 'phase', '(', 'p', '.', ')', '.', 'receiver-operating', 'characteristic', 'curve', 'showed', 'poor', 'predictive', 'accuracy', 'of', 'biomarker', 'above-mentioned', 'parameter', 'in', 'overall', 'study', 'population', '(', 'area', 'curve', '.', ')', '.', 'accordingly', ',', 'neither', 'significant', 'correlation', 'of', 'biomarker', 'and', 'adverse', 'outcome', 'in', 'linear', 'regression', 'analysis', ',', 'biomarker', 'concentration', 'enrollment', 'and', 'change', 'in', 'egfr', '-year', 'observation', 'period', '.', 'conclusion', 'ngal', ',', 'kim-', ',', 'calprotectin', ',', 'and', 'timp-igfbp', 'neither', 'prognostic', 'value', 'progression', 'of', 'igan', ',', 'response', 'to', 'immunosuppression', 'in', 'present', 'sub-cohort', 'of', 'stop-igan', 'trial', '.', 'search', 'appropriate', 'biomarkers', 'individualized', 'treatment', 'strategy', 'in', 'igan', 'continues', '.']"
Renal function following xenon anesthesia for partial nephrectomy-An explorative analysis of a randomized controlled study.,"Ana Stevanovic, Patrick Schaefer, Mark Coburn, Rolf Rossaint, Christian Stoppe, Peter Boor, David Pfister, Axel Heidenreich, Hildegard Christ, Martin Hellmich, Astrid V Fahlenkamp, Ana Stevanovicet al.",2017 Jul 18,PLoS One,https://pubmed.ncbi.nlm.nih.gov/28719609/,No keywords found,"['perioperative', 'preservation', 'of', 'renal', 'function', 'significant', 'impact', 'morbidity', 'and', 'mortality', 'in', 'kidney', 'surgery', '.', 'nephroprotective', 'effect', 'of', 'anesthetic', 'xenon', 'ischemia-reperfusion', 'injury', 'found', 'in', 'several', 'experimental', 'study', '.', 'objective', 'aimed', 'to', 'explore', 'whether', 'xenon', 'anesthesia', 'reduce', 'renal', 'damage', 'in', 'human', 'undergoing', 'partial', 'nephrectomy', 'and', 'to', 'gather', 'pilot', 'data', 'of', 'possible', 'nephroprotection', 'in', 'patient', '.', 'design', 'prospective', 'randomized', ',', 'single-blinded', ',', 'controlled', 'study', '.', 'setting', 'single-center', ',', 'university', 'hospital', 'of', 'aachen', ',', 'germany', 'july', '-october', '.', 'patient', 'forty-six', 'patient', 'with', 'regular', 'renal', 'function', 'undergoing', 'partial', 'nephrectomy', '.', 'intervention', 'patient', 'randomly', 'assigned', 'to', 'receive', 'xenon-', '(', 'n', ')', 'or', 'isoflurane', '(', 'n', ')', 'anesthesia', '.', 'main', 'outcome', 'measure', 'primary', 'outcome', 'maximum', 'postoperative', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'decline', 'within', 'seven', 'day', 'surgery', '.', 'secondary', 'outcome', 'included', 'intraoperative', 'and', 'tumor-related', 'data', ',', 'assessment', 'of', 'kidney', 'injury', 'marker', ',', 'adverse', 'event', 'and', 'optional', 'determination', 'of', 'renal', 'function', '-', 'month', '.', 'result', 'unexpected', 'radical', 'nephrectomy', 'performed', 'in', 'patient', ',', 'thus', 'excluded', 'per-protocol', 'analysis', ',', 'included', 'in', 'intention-to-treat', 'analysis', '.', 'maximum', 'postoperative', 'gfr', 'decline', 'attenuated', 'in', 'xenon-group', '(', '.', 'ml', 'min-', '.', 'cm-', 'versus', '.', 'ml', 'min-', '.', 'cm-', 'in', 'isoflurane', 'group', ')', ',', 'without', 'significance', '(', 'p', '.', ')', '.', 'occurrence', 'of', 'adverse', 'event', 'reduced', '(', 'p', '.', ')', 'in', 'xenon', 'group', '.', 'renal', 'function', 'similar', 'among', 'group', '-', 'month', '.', 'conclusion', 'xenon', 'anesthesia', 'feasible', 'and', 'safe', 'in', 'patient', 'undergoing', 'partial', 'nephrectomy', 'with', 'regard', 'to', 'postoperative', 'renal', 'function', '.', 'found', 'no', 'significant', 'effect', 'early', 'renal', 'function', 'less', 'adverse', 'event', 'in', 'xenon', 'group', '.', 'larger', 'randomized', 'controlled', 'study', 'in', 'heterogeneous', 'collective', 'required', ',', 'to', 'confirm', 'or', 'refute', 'possible', 'clinical', 'benefit', 'renal', 'function', 'xenon', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', 'and', 'eudract', '--', '.']"
Dose escalation of an Evans blue-modified radiolabeled somatostatin analog 177Lu-DOTA-EB-TATE in the treatment of metastatic neuroendocrine tumors.,"Qingxing Liu, Yuejuan Cheng, Jie Zang, Huimin Sui, Hao Wang, Orit Jacobson, Zhaohui Zhu, Xiaoyuan Chen, Qingxing Liuet al.",2020 Apr,Eur J Nucl Med Mol Imaging,https://pubmed.ncbi.nlm.nih.gov/31832728/,No keywords found,"['to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'lu-dota-eb-tate', ',', 'radiolabeled', 'somatostatin', 'analog', 'modified', 'evans', 'blue', ',', 'escalating', 'dos', ',', 'used', 'to', 'increase', 'tumor', 'retention', 'in', 'patient', 'with', 'progressive', 'metastatic', 'neuroendocrine', 'tumor', '(', 'net', ')', '.', 'method', 'thirty-three', 'patient', 'with', 'metastatic', 'net', 'prospectively', 'enrolled', 'four', 'group', 'group', '(', 'n', ',', 'year', ')', 'administered', 'approximately', '.', 'gbq', '(', 'mci', ')', 'lu-dotatate', 'control', 'group', 'b', '(', 'n', ',', 'year', ')', 'administered', 'approximately', '.', 'gbq', '(', 'mci', ')', 'lu-dota-eb-tate', 'group', 'c', '(', 'n', ',', 'year', ')', 'administered', 'approximately', '.', 'gbq', '(', 'mci', ')', 'lu-dota-eb-tate', 'group', '(', 'n', ',', 'year', ')', 'administered', 'approximately', '.', 'gbq', '(', 'mci', ')', 'lu-dota-eb-tate', '.', 'treatment-related', 'adverse', 'event', 'graded', 'according', 'to', 'ctcae', 'v', '...', 'ga-dotatate', 'petct', 'performed', 'baseline', 'and', '-', 'month', 'treatment', 'response', 'evaluation', '.', 'result', 'administration', 'well', 'tolerated', '.', 'no', 'ctc', 'hematotoxicity', ',', 'nephrotoxicity', ',', 'or', 'hepatotoxicity', 'observed', 'or', 'treatment', 'in', 'group', 'a-c.', 'in', 'group', ',', 'ctc-', 'hematotoxicity', 'recorded', 'in', 'patient', 'with', 'multicourse', 'chemotherapy', 'previously', '.', 'one-cycle', 'treatment', ',', 'suvmax', 'decreased', 'in', 'group', 'c', '(', '-', '.', '.', ')', 'and', 'group', '(', '-', '.', '.', ')', ',', 'greatly', 'increased', 'in', 'group', 'b', '(', '.', '.', ')', 'and', 'mildly', 'increased', 'in', 'group', '(', '.', '.', ')', '.', 'referring', 'to', 'eortc', 'criterion', ',', '.', '(', ')', ',', '(', ')', ',', '(', ')', ',', 'and', '(', ')', 'evaluated', 'partial', 'response', 'in', 'group', ',', 'b', ',', 'c', ',', 'and', ',', 'respectively', '.', 'selecting', 'lesion', 'with', 'comparable', 'baseline', 'suvmax', 'ranging', 'to', ',', 'suvmax', 'showed', 'no', 'significant', 'decrease', 'in', 'group', 'b', '(', '-', '.', '.', ')', '(', 'p', '.', ')', ',', 'significant', 'decrease', 'in', 'group', 'c', '(', '-', '.', '.', ')', '(', 'p', '.', ')', ',', 'and', 'in', 'group', '(', '-', '.', '.', ')', '(', 'p', '.', ')', 'compared', 'with', 'group', 'with', 'increased', 'suvmax', '(', '.', '.', ')', '.', 'suvmax', 'significantly', 'decreased', 'in', 'ebtate', 'group', '(', 'group', 'b-d', 'combined', ')', '(', '-', '.', '.', ')', 'compared', 'with', 'tate', 'group', '(', 'p', '.', ')', '.', 'conclusion', 'lu-dota-eb-tate', 'well', 'tolerated', 'and', 'effective', 'lu-dotatate', '.', '.', 'gbq', '(', 'mci', ')', 'and', '.', 'gbq', '(', 'mci', ')', 'dos', 'appear', 'to', 'effective', '.', 'gbq', '(', 'mci', ')', 'dose', '.', 'investigation', 'with', 'cycle', 'of', 'lu-dota-eb-tate', 'treatment', 'and', 'longer', 'follow-up', 'warranted', '.', 'trial', 'registration', 'treatment', 'using', 'lu-dota-eb-tate', 'in', 'patient', 'with', 'advanced', 'neuroendocrine', 'tumor', '(', 'nct', ')', '.', 'url', 'httpsregister.clinicaltrials.govprsappactionvieworunreleaseuidujrwtssidsrnxcxyyqv', '.']"
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease.,"Simke W Waijer, Taha Sen, Clare Arnott, Bruce Neal, Jos G W Kosterink, Kenneth W Mahaffey, Chirag R Parikh, Dick de Zeeuw, Vlado Perkovic, Brendon L Neuen, Steven G Coca, Michael K Hansen, Ron T Gansevoort, Hiddo J L Heerspink, Simke W Waijeret al.",2022 Feb,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/34876454/,No keywords found,"['clinical', 'trial', 'in', 'nephrology', 'enriched', 'patient', 'with', 'micro-', 'or', 'macroalbuminuria', 'to', 'enroll', 'patient', 'risk', 'of', 'kidney', 'failure', '.', 'however', ',', 'patient', 'with', 'normoalbuminuria', 'also', 'progress', 'to', 'kidney', 'failure', '.', 'tnf', 'receptor-', ',', 'tnf', 'receptor-', ',', 'and', 'kidney', 'injury', 'marker-', '(', 'kim-', ')', 'known', 'to', 'associated', 'with', 'kidney', 'disease', 'progression', 'in', 'patient', 'with', 'micro-', 'or', 'macroalbuminuria', '.', 'assessed', 'value', 'of', 'tnf', 'receptor-', ',', 'tnf', 'receptor-', ',', 'and', 'kim-', 'prognostic', 'biomarkers', 'ckd', 'progression', 'in', 'patient', 'with', 'type', 'diabetes', 'and', 'normoalbuminuria', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'tnf', 'receptor-', ',', 'tnf', 'receptor-', ',', 'and', 'kim-', 'measured', 'using', 'immunoassay', 'in', 'plasma', 'sample', 'patient', 'with', 'type', 'diabetes', 'high', 'cardiovascular', 'risk', 'participating', 'in', 'canagliflozin', 'cardiovascular', 'assessment', 'study', 'trial', '.', 'used', 'multivariable', 'adjusted', 'cox', 'proportional', 'hazard', 'analysis', 'to', 'estimate', 'hazard', 'ratio', 'per', 'doubling', 'of', 'biomarker', 'kidney', 'outcome', ',', 'stratified', 'population', 'fourth', 'quartile', 'of', 'biomarker', 'distribution', ',', 'and', 'assessed', 'number', 'of', 'event', 'and', 'event', 'rate', '.', 'result', 'in', 'patient', 'with', 'normoalbuminuria', '(', 'n', ')', ',', 'kidney', 'outcome', 'recorded', 'median', 'follow-up', 'of', '.', '(', 'interquartile', 'range', ',', '.-', '.', ')', 'year', '(', 'event', 'rate', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', 'per', 'patient-years', ')', '.', 'doubling', 'of', 'baseline', 'tnf', 'receptor-', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', 'and', 'tnf', 'receptor-', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', ')', 'associated', 'with', 'higher', 'risk', 'kidney', 'outcome', '.', 'baseline', 'kim-', ',', 'urinary', 'albumin-creatinine', 'ratio', ',', 'and', 'egfr', 'not', 'associated', 'with', 'kidney', 'outcome', '.', 'event', 'rate', 'in', 'highest', 'quartile', 'of', 'tnf', 'receptor-', '(', 'ngml', ')', 'and', 'tnf', 'receptor-', '(', ',', 'ngml', ')', '.', 'and', '.', 'event', 'per', 'patient-years', ',', 'respectively', ',', 'compared', 'with', '.', 'and', '.', ',', 'respectively', ',', 'in', 'lower', 'three', 'quartile', '.', 'conclusion', 'tnf', 'receptor-', 'and', 'tnf', 'receptor-', 'associated', 'with', 'kidney', 'outcome', 'in', 'patient', 'with', 'type', 'diabetes', 'and', 'normoalbuminuria', '.', 'clinical', 'trial', 'registry', 'name', 'and', 'registration', 'number', 'canagliflozin', 'cardiovascular', 'assessment', 'study', '(', 'canvas', ')', ',', 'nct', '.']"
Elevated Neutrophil Gelatinase-Associated Lipocalin for the Assessment of Structural versus Functional Renal Damage among ST-Segment Elevation Myocardial Infarction Patients.,"Keren-Lee Rozenfeld, David Zahler, Moshe Shtark, Ilana Goldiner, Gad Keren, Shmuel Banai, Yacov Shacham, Keren-Lee Rozenfeldet al.",2020,Blood Purif,https://pubmed.ncbi.nlm.nih.gov/32074603/,No keywords found,"['neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', 'early', 'marker', 'of', 'renal', 'tubular', 'damage', '.', 'investigated', 'incidence', 'and', 'possible', 'implication', 'of', 'elevated', 'ngal', 'level', '(', 'suggesting', 'renal', 'damage', ')', 'compared', 'to', 'functional', 'and', 'damage', 'marker', '(', 'manifested', 'serum', 'creatinine', 'scr', 'elevation', ')', 'and', 'no', 'ngalscr', 'change', ',', 'among', '-st-elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'patient', 'treated', 'with', 'primary', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', '.', 'method', 'included', 'patient', 'with', 'stemi', 'treated', 'with', 'pci', '.', 'blood', 'sample', 'plasma', 'ngal', 'drawn', 'h', 'following', 'pci', '.', 'used', 'term', 'ngal', '(', '-', ')', 'or', 'ngal', '(', ')', 'with', 'level', 'ngml', 'suggesting', 'renal', 'tubular', 'damage', 'and', 'term', '.', 'scr', '(', '-', ')', 'or', 'scr', '(', ')', 'to', 'consensus', 'diagnostic', 'increase', 'in', 'scr', 'defining', 'acute', 'kidney', 'injury', '.', 'patient', 'also', 'assessed', 'in', 'hospital-adverse', 'outcome', '.', 'result', 'of', 'study', 'patient', ',', '(', ')', 'ngal', '(', '-', ')', 'scr', '(', '-', ')', ',', '(', ')', 'ngal', '(', ')', 'scr', '(', '-', ')', ',', 'and', '(', ')', 'ngal', '(', ')', 'scr', '(', ')', '.', 'according', 'to', 'study', 'group', ',', 'stepwise', 'increase', 'in', 'proportion', 'of', 'left', 'ventricular', 'ejection', 'fraction', '(', 'vs.', '.', 'vs.', 'p', '.', ')', ',', 'in-hospital', 'adverse', 'outcome', '(', 'vs.', 'vs.', 'p', '.', ')', 'and', 'combination', '.', 'specifically', ',', 'ngal', '(', ')', 'scr', '(', '-', ')', 'patient', 'developed', 'composite', 'endpoint', 'compared', 'to', 'ngal', '(', '-', ')', 'scr', '(', '-', ')', 'patient', '(', 'vs.', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'similar', 'and', 'consistent', 'increase', 'observed', 'in', 'peak', 'scr', ',', 'length', 'of', 'hospital', 'stay', ',', 'and', 'c-reactive', 'protein', 'level', '.', 'conclusion', 'elevated', 'ngal', 'level', 'suggesting', 'renal', 'tubular', 'damage', ',', 'increased', 'inflammation', ',', 'or', 'common', 'among', 'stemi', 'patient', 'and', 'associated', 'with', 'adverse', 'outcome', 'even', 'in', 'absence', 'of', 'diagnostic', 'increase', 'in', 'scr', '.']"
Effect of leukoreduction on transfusion-related immunomodulation in patients undergoing cardiac surgery.,"Atif Irfan Khan, Gopal Kumar Patidar, R Lakshmy, Neeti Makhija, Sachin Talwar, Anjali Hazarika, Atif Irfan Khanet al.",2020 Dec,Transfus Med,https://pubmed.ncbi.nlm.nih.gov/32935394/,No keywords found,"['in', 'study', ',', 'aimed', 'to', 'determine', 'consequence', 'of', 'different', 'amount', 'of', 'leukocyte', 'transfusion', 'outcome', 'of', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'design', 'prospective', ',', 'single-blinded', 'cohort', 'study', 'conducted', 'year', 'july', 'to', 'june', '.', 'setting', 'study', 'setting', 'department', 'of', 'transfusion', 'medicine', ',', 'along', 'with', 'cardiac', 'anaesthesia', ',', 'cardiac', 'surgery', 'and', 'cardiac', 'biochemistry', 'department', 'in', 'tertiary', 'care', 'cardiac', 'centre', '.', 'participant', 'total', 'of', 'patient', 'undergoing', 'cardiac', 'surgery', 'study', 'period', 'divided', 'three', 'group', '(', 'in', ')', 'leukofiltered', '(', 'lr', ')', ',', 'buffy', 'coat', 'depleted', '(', 'bcd', ')', 'and', 'non-leukoreduced', '(', 'nlr', ')', '.', 'intervention', 'intervention', 'intra-', 'and', 'postoperative', 'transfusion', 'of', 'packed', 'red', 'blood', 'cell', '(', 'prbcs', ')', 'different', 'amount', 'of', 'leukocyte', '.', 'measurement', 'and', 'main', 'result', 'patient', 'detail', 'length', 'of', 'intensive', 'care', 'unit', '(', 'icu', ')', 'and', 'hospital', 'stay', ',', 'blood', 'usage', ',', 'inotropic', 'drug', 'duration', ',', 'mechanical', 'ventilation', ',', 'urine', 'output', 'and', 'infection', 'recorded', 'patient', 'data', 'sheet', ',', 'whereas', 'patient', 'followed', 'day', 'post-operation', ',', 'and', 'mortality', 'noted', '.', 'haematological', 'parameter', 'and', 'biochemical', 'parameter', 'renal', 'function', 'test', 'analysed', 'pre-', 'and', 'post-surgical', 'day', ',', ',', 'and', ',', 'whereas', 'postoperative', 'day', 'and', ',', 'cytokine-like', 'fa', 'ligand', ',', 'interleukin-', '(', 'il-', ')', 'and', 'interferon-', '(', 'inf-', ')', 'tested', '.', 'patient', 'in', 'three', 'group', 'received', 'average', 'of', 'four', ',', 'two', 'and', 'two', 'unit', 'of', 'packed', 'red', 'blood', 'cell', ',', 'platelet', 'and', 'fresh', 'frozen', 'plasma', ',', 'respectively', '.', 'statistically', 'significant', '(', 'p', '.', ')', 'rise', 'in', 'total', 'leukocyte', ',', 'neutrophil', 'and', 'lymphocyte', 'count', 'in', 'three', 'group', 'day', 'to', 'day', ',', 'reduced', 'to', 'preoperative', 'level', 'day', '.', 'shorter', 'icu', 'and', 'hospital', 'stay', 'in', 'lr', 'group', 'of', 'patient', '(', '.', 'hour', 'and', '.', '.', 'day', ')', 'compared', 'to', 'nlr', '(', '.', '.', 'hour', 'and', '.', '.', 'day', ')', 'and', 'bcd', '(', '.', '.', 'hour', 'and', '.', '.', 'day', ')', 'group', 'of', 'patient', ',', 'statistically', 'non-significant', '.', 'duration', 'of', 'mechanical', 'ventilation', 'significantly', 'lesser', 'in', 'lr', 'group', 'patient', '(', '.', '.', 'hour', ')', 'compared', 'to', 'nlr', 'group', '(', '.', '.', 'hour', ')', '.', 'risk', 'ratio', 'calculation', 'of', 'developing', 'postoperative', 'kidney', 'injury', ',', 'nlr', 'group', '.', 'and', '.', 'time', 'risk', 'compared', 'to', 'bcd', 'and', 'lr', 'group', ',', 'respectively', '.', 'postoperative', 'day', 'and', ',', 'fas-l', 'level', 'significantly', 'increased', 'in', 'three', 'group', 'of', 'patient', ',', 'whereas', 'il-', 'increased', 'in', 'nlr', 'and', 'bcd', 'group', 'and', 'decreased', 'in', 'lr', 'group', 'non-significantly', '.', 'inf-', 'level', 'decreased', 'day', 'in', 'nlr', 'and', 'bcd', 'group', 'increased', 'in', 'lr', 'group', ',', 'inversed', 'day', '.', 'conclusion', 'depletion', 'of', 'leukocyte', 'decreased', 'transfusion', 'related', 'immunomodulation', '(', 'trim', ')', 'effect', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', ',', 'also', 'depends', 'degree', 'of', 'leukoreduction', '.', 'found', 'in', 'study', ',', 'leukofiltration', 'effective', 'compared', 'to', 'buffy-coat', 'depletion', '.']"
Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial.,"Luciano Candilio, Abdul Malik, Cono Ariti, Matthew Barnard, Carmelo Di Salvo, David Lawrence, Martin Hayward, John Yap, Neil Roberts, Amir Sheikh, Shyam Kolvekar, Derek J Hausenloy, Derek M Yellon, Luciano Candilioet al.",2015 Feb,Heart,https://pubmed.ncbi.nlm.nih.gov/25252696/,No keywords found,"['remote', 'ischaemic', 'preconditioning', '(', 'ripc', ')', ',', 'using', 'brief', 'cycle', 'of', 'limb', 'ischaemiareperfusion', ',', 'non-invasive', ',', 'low-cost', 'intervention', 'may', 'reduce', 'perioperative', 'myocardial', 'injury', '(', 'pmi', ')', 'in', 'patient', 'undergoing', 'cardiac', 'surgery', '.', 'investigated', 'whether', 'ripc', 'also', 'improve', 'short-term', 'clinical', 'outcome', '.', 'method', 'one', 'hundred', 'and', 'eighty', 'patient', 'undergoing', 'elective', 'coronary', 'artery', 'bypass', 'graft', '(', 'cabg', ')', 'surgery', 'andor', 'valve', 'surgery', 'randomised', 'to', 'receive', 'either', 'ripc', '(', '-', 'min', 'cycle', 'of', 'simultaneous', 'upper', 'arm', 'and', 'thigh', 'cuff', 'inflationdeflation', 'n', ')', 'or', 'control', '(', 'uninflated', 'cuff', 'placed', 'upper', 'arm', 'and', 'thigh', 'n', ')', '.', 'study', 'primary', 'end', 'point', 'pmi', ',', 'measured', 'h', 'area', 'curve', '(', 'auc', ')', 'serum', 'high-sensitive', 'troponin-t', '(', 'hstnt', ')', 'secondary', 'end', 'point', 'included', 'short-term', 'clinical', 'outcome', '.', 'result', 'ripc', 'reduced', 'pmi', 'magnitude', '(', '-', '.', 'difference', '(', 'ci', '-', '.', 'to', '-', '.', ')', 'h', 'hstnt-auc', 'p.', ')', 'compared', 'with', 'control', '.', 'also', 'evidence', 'ripc', 'reduced', 'incidence', 'of', 'postoperative', 'atrial', 'fibrillation', '(', 'ripc', 'v', 'control', 'p.', ')', 'and', 'decreased', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', '.', 'ripc', 'v', '.', 'control', 'p.', ')', ',', 'and', 'intensive', 'care', 'unit', 'stay', 'day', '(', '.', 'day', 'ripc', '(', 'ci', '.', 'to', '.', ')', 'v', '.', 'day', 'control', '(', 'ci', '.', 'to', '.', ')', 'p.', ')', '.', 'in', 'post', 'hoc', 'analysis', ',', 'found', 'control', 'patient', 'administered', 'intravenous', 'glyceryl', 'trinitrate', '(', 'gtn', ')', 'intraoperatively', 'sustained', 'less', 'pmi', 'compared', 'with', 'not', 'receiving', 'gtn', ',', 'and', 'ripc', 'not', 'appear', 'to', 'reduce', 'pmi', 'in', 'patient', 'given', 'gtn', '.', 'conclusion', 'ripc', 'reduced', 'extent', 'of', 'pmi', 'in', 'patient', 'undergoing', 'cabg', 'andor', 'valve', 'surgery', '.', 'ripc', 'may', 'also', 'beneficial', 'effect', 'short-term', 'clinical', 'outcome', ',', 'although', 'need', 'to', 'confirmed', 'in', 'future', 'study', '.', 'trial', 'registration', 'number', 'clinicaltrials.gov', 'id', 'nct', '.']"
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial.,"Ridhima Goel, David Power, Didier Tchetche, Rishi Chandiramani, Paul Guedeney, Bimmer E Claessen, Samantha Sartori, Davide Cao, Nicolas Meneveau, Christophe Tron, Nicolas Dumonteil, Julian D Widder, Christian Hengstenberg, Markus Ferrari, Roberto Violini, Pieter R Stella, Raban Jeger, Prodromos Anthopoulos, Efthymios N Deliargyris, Roxana Mehran, George D Dangas, Ridhima Goelet al.",2019 Dec 15:297:22-29.,Int J Cardiol,https://pubmed.ncbi.nlm.nih.gov/31630816/,No keywords found,"['impact', 'of', 'diabetes', 'mellitus', '(', 'dm', ')', 'clinical', 'outcome', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'remains', 'unclear', '.', 'aim', 'of', 'study', 'to', 'investigate', 'impact', 'of', 'dm', 'short-term', 'clinical', 'outcome', 'tavr', 'in', 'large', 'randomized', 'trial', 'population', '.', 'method', 'and', 'result', 'bravo-', 'trial', 'randomized', 'patient', 'undergoing', 'trans-femoral', 'tavr', 'to', 'procedural', 'anticoagulation', 'with', 'bivalirudin', 'or', 'unfractionated', 'heparin', '.', 'study', 'population', 'divided', 'according', 'to', 'presence', 'of', 'dm', ',', 'and', 'stratified', 'according', 'to', 'use', 'of', 'insulin', '.', 'net', 'adverse', 'cardiovascular', 'outcome', '(', 'nace', '-', 'death', ',', 'myocardial', 'infarction', '(', 'mi', ')', ',', 'stroke', 'or', 'major', 'bleeding', 'bleeding', 'academic', 'research', 'consortium', '(', 'barc', ')', 'type', 'b', 'or', ')', 'primary', 'outcome', 'in-hospital', 'and', '-days', '.', 'of', 'total', 'randomized', 'patient', ',', '(', ')', 'dm', 'baseline', ',', 'with', '(', ')', 'treated', 'with', 'insulin', '.', '-days', ',', 'dm', 'patient', 'experienced', 'numerically', 'higher', 'rate', 'of', 'net', 'adverse', 'cardiovascular', 'event', '(', '.', 'v', '.', '.', ',', 'p.', ')', 'and', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', '.', ',', 'p.', ')', ',', 'non-dm', '(', 'ndm', ')', 'patient', 'numerically', 'higher', 'rate', 'of', 'cerebrovascular', 'accident', '(', '.', 'v', '.', '.', ',', 'p.', ')', '.', 'multivariable', 'adjustment', ',', 'dm', 'patient', 'higher', 'odds', 'of', 'vascular', 'complication', '-days', '(', 'or', '.', ',', 'p.', ')', 'and', 'life-threatening', 'bleeding', 'in-hospital', '(', 'or', '.', ',', 'p.', ')', 'and', '-days', '(', 'or', '.', ',', 'p.', ')', 'with', 'excess', 'overall', 'risk', 'primarily', 'attributed', 'to', 'higher', 'rate', 'observed', 'among', 'non-insulin', 'dependent', 'dm', 'patient', '.', 'conclusion', 'patient', 'with', 'dm', 'higher', 'adjusted', 'odds', 'of', 'vascular', 'and', 'bleeding', 'complication', 'to', '-days', 'post-tavr', '.', 'overall', ',', 'no', 'significant', 'association', 'dm', 'and', 'early', 'mortality', 'following', 'tavr', '.']"
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial.,"Ira R Katz, Malcolm P Rogers, Robert Lew, Soe Soe Thwin, Gheorghe Doros, Eileen Ahearn, Michael J Ostacher, Lynn E DeLisi, Eric G Smith, Robert J Ringer, Ryan Ferguson, Brian Hoffman, James S Kaufman, Julie M Paik, Chester H Conrad, Erika F Holmberg, Tamara Y Boney, Grant D Huang, Matthew H Liang                                                                                          ;, Li+ plus Investigators, Deepika Agrawal, Naheed Akhtar, Maria Androsenko, Bert Berger, Venkatesh Bhat, Lisa Brenner, Lokaranjit Chalasani, Dennis Chang, Peijun P J Chen, Brandon Cornejo, David Cory, Dena Davidson, Patrica Dickmann, Erica Duncan, Ronald Fernando, Karen C Floyd, Steven Forman, Phillip Gale, Jayant Geete, Michael Ignatowski, Kari Jones, Timothy Juergens, George Jurjus, Gauri Khatkhate, Eric P Konicki, Dean Krahn, Gunnar Larson, Susan Leckband, Joel Mack, Scott Matthews, Lorna Mayo, Erin McGlade, James Michalets, Elizabeth Miller, Emil Muly, Alexander Niculescu, Michael Ostacher, Prasad Padala, Kalpana Padala, Peggy Pazzaglia, Murray Raskind, Perry Renshaw, Geetha Shivakumar, Julia C Smith, Dennis Sullivan, Patricia Suppes, Alan Swann, Lia Thomas, Shabnam Thompson, Erick Turner, Maria Umbert, Joseph Westermeyer, Amanda Wood, Hal Wortzel, Deborah Yurgelun-Todd, Ira R Katzet al.",2022 Jan 1,JAMA Psychiatry,https://pubmed.ncbi.nlm.nih.gov/34787653/,No keywords found,"['suicide', 'and', 'suicide', 'attempt', 'persistent', 'and', 'increasing', 'public', 'health', 'problem', '.', 'observational', 'study', 'and', 'meta-analyses', 'of', 'randomized', 'clinical', 'trial', 'suggested', 'lithium', 'may', 'prevent', 'suicide', 'in', 'patient', 'with', 'bipolar', 'disorder', 'or', 'depression', '.', 'objective', 'to', 'assess', 'whether', 'lithium', 'augmentation', 'of', 'usual', 'care', 'reduces', 'rate', 'of', 'repeated', 'episode', 'of', 'suicide-related', 'event', '(', 'repeated', 'suicide', 'attempt', ',', 'interrupted', 'attempt', ',', 'hospitalization', 'to', 'prevent', 'suicide', ',', 'and', 'death', 'suicide', ')', 'in', 'participant', 'with', 'bipolar', 'disorder', 'or', 'depression', 'survived', 'recent', 'event', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'double-blind', ',', 'placebo-controlled', 'randomized', 'clinical', 'trial', 'assessed', 'lithium', 'v', 'placebo', 'augmentation', 'of', 'usual', 'care', 'in', 'veteran', 'with', 'bipolar', 'disorder', 'or', 'depression', 'survived', 'recent', 'suicide-related', 'event', '.', 'veteran', 'va', 'medical', 'center', 'episode', 'of', 'suicidal', 'behavior', 'or', 'inpatient', 'admission', 'to', 'prevent', 'suicide', 'within', 'month', 'screened', 'july', ',', ',', 'and', 'march', ',', '.', 'intervention', 'participant', 'randomized', 'to', 'receive', 'extended-release', 'lithium', 'carbonate', 'beginning', 'mgd', 'or', 'placebo', '.', 'main', 'outcome', 'and', 'measure', 'time', 'to', 'first', 'repeated', 'suicide-related', 'event', ',', 'including', 'suicide', 'attempt', ',', 'interrupted', 'attempt', ',', 'hospitalization', 'specifically', 'to', 'prevent', 'suicide', ',', 'and', 'death', 'suicide', '.', 'result', 'trial', 'stopped', 'futility', 'veteran', '(', 'mean', 'sd', 'age', ',', '.', '.', 'year', '.', 'male', ')', 'randomized', 'to', 'lithium', 'and', 'to', 'placebo', '.', 'mean', 'lithium', 'concentration', 'month', '.', 'meql', 'patient', 'with', 'bipolar', 'disorder', 'and', '.', 'meql', 'patient', 'with', 'major', 'depressive', 'disorder', '.', 'no', 'overall', 'difference', 'in', 'repeated', 'suicide-related', 'event', 'treatment', 'found', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-.', ')', '.', 'no', 'unanticipated', 'safety', 'concern', 'observed', '.', 'total', 'of', 'participant', '(', '.', ')', 'suicide-related', 'outcome', 'in', 'lithium', 'group', 'and', 'in', 'placebo', 'group', '.', 'one', 'death', 'occurred', 'in', 'lithium', 'group', 'and', 'in', 'placebo', 'group', '.', 'conclusion', 'and', 'relevance', 'in', 'randomized', 'clinical', 'trial', ',', 'addition', 'of', 'lithium', 'to', 'usual', 'veteran', 'affair', 'mental', 'health', 'care', 'not', 'reduce', 'incidence', 'of', 'suicide-related', 'event', 'in', 'veteran', 'with', 'major', 'depression', 'or', 'bipolar', 'disorder', 'experienced', 'recent', 'suicide', 'event', '.', 'therefore', ',', 'simply', 'adding', 'lithium', 'to', 'existing', 'medication', 'regimen', 'unlikely', 'to', 'effective', 'preventing', 'broad', 'range', 'of', 'suicide-related', 'event', 'in', 'patient', 'actively', 'treated', 'mood', 'disorder', 'and', 'substantial', 'comorbidities', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.,"Jonas Lanz, Won-Keun Kim, Thomas Walther, Christof Burgdorf, Helge Möllmann, Axel Linke, Simon Redwood, Christian Thilo, Michael Hilker, Michael Joner, Holger Thiele, Lars Conzelmann, Lenard Conradi, Sebastian Kerber, Gerhard Schymik, Bernard Prendergast, Oliver Husser, Stefan Stortecky, Dik Heg, Peter Jüni, Stephan Windecker, Thomas Pilgrim                              ;, SCOPE I investigators, Jonas Lanzet al.",2019 Nov 2,Lancet,https://pubmed.ncbi.nlm.nih.gov/31570258/,No keywords found,"['transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'preferred', 'treatment', 'option', 'older', 'patient', 'with', 'symptomatic', 'severe', 'aortic', 'stenosis', '.', 'difference', 'in', 'property', 'of', 'available', 'tavr', 'system', 'affect', 'clinical', 'outcome', '.', 'among', 'patient', 'undergoing', 'tavr', ',', 'compared', 'self-expanding', 'acurate', 'neo', 'tavr', 'system', 'with', 'balloon-expandable', 'sapien', 'tavr', 'system', 'with', 'regard', 'to', 'early', 'safety', 'and', 'efficacy', '.', 'method', 'in', 'randomised', 'non-inferiority', 'trial', ',', 'patient', '(', 'aged', 'year', ')', 'undergoing', 'transfemoral', 'tavr', 'treatment', 'of', 'symptomatic', 'severe', 'aortic', 'stenosis', ',', 'and', 'deemed', 'to', 'increased', 'surgical', 'risk', ',', 'recruited', 'tertiary', 'heart', 'valve', 'centre', 'in', 'germany', ',', 'netherlands', ',', 'switzerland', ',', 'and', 'uk', '.', 'participant', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'treatment', 'with', 'acurate', 'neo', 'or', 'sapien', 'with', 'computer-based', 'randomly', 'permuted', 'block', 'scheme', ',', 'stratified', 'study', 'centre', 'and', 'society', 'of', 'thoracic', 'surgeon', 'predicted', 'risk', 'of', 'mortality', '(', 'sts-prom', ')', 'category', '.', 'primary', 'composite', 'safety', 'and', 'efficacy', 'endpoint', 'comprised', 'all-cause', 'death', ',', 'stroke', ',', 'life-threatening', 'or', 'disabling', 'bleeding', ',', 'major', 'vascular', 'complication', ',', 'coronary', 'artery', 'obstruction', 'requiring', 'intervention', ',', 'acute', 'kidney', 'injury', '(', 'stage', 'or', ')', ',', 'rehospitalisation', 'valve-related', 'symptom', 'or', 'congestive', 'heart', 'failure', ',', 'valve-related', 'dysfunction', 'requiring', 'repeat', 'procedure', ',', 'moderate', 'or', 'severe', 'prosthetic', 'valve', 'regurgitation', ',', 'or', 'prosthetic', 'valve', 'stenosis', 'within', 'day', 'of', 'procedure', '.', 'endpoint', 'assessor', 'masked', 'to', 'treatment', 'allocation', '.', 'non-inferiority', 'of', 'acurate', 'neo', 'compared', 'with', 'sapien', 'assessed', 'in', 'intention-to-treat', 'population', 'basis', 'of', 'risk-difference', 'margin', 'of', 'primary', 'composite', 'endpoint', ',', 'with', 'one-sided', 'of', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', '(', 'number', 'nct', ')', 'and', 'ongoing', 'not', 'recruiting', '.', 'finding', 'feb', ',', ',', 'and', 'feb', ',', ',', 'to', 'patient', 'screened', 'and', '(', 'mean', 'age', 'year', 'sd', 'median', 'sts-prom', 'score', 'iqr', '-', ')', 'enrolled', '.', '-day', 'follow-up', 'available', '(', ')', 'of', 'patient', 'allocated', 'to', 'acurate', 'neo', 'group', ',', 'and', '(', ')', 'of', 'allocated', 'to', 'sapien', 'group', '.', 'within', 'day', ',', 'primary', 'endpoint', 'occurred', 'in', '(', ')', 'patient', 'in', 'acurate', 'neo', 'and', 'in', '(', ')', 'in', 'sapien', 'group', 'thus', ',', 'non-inferiority', 'of', 'acurate', 'neo', 'not', 'met', '(', 'absolute', 'risk', 'difference', 'upper', 'confidence', 'limit', ',', 'p', ')', '.', 'secondary', 'analysis', 'of', 'primary', 'endpoint', 'suggested', 'superiority', 'of', 'sapien', 'device', 'acurate', 'neo', 'device', '(', 'ci', 'risk', 'difference', '-', 'to', '-', ',', 'p', ')', '.', 'acurate', 'neo', 'and', 'sapien', 'group', 'not', 'differ', 'in', 'incidence', 'of', 'all-cause', 'death', '(', 'nine', 'patient', 'v', 'three', ')', 'and', 'stroke', '(', 'seven', 'v', ')', 'whereas', 'acute', 'kidney', 'injury', '(', 'v', 'three', ')', 'and', 'moderate', 'or', 'severe', 'prosthetic', 'aortic', 'regurgitation', '(', 'v', 'ten', ')', 'common', 'in', 'acurate', 'neo', 'group', '.', 'interpretation', 'tavr', 'with', 'self-expanding', 'acurate', 'neo', 'not', 'meet', 'non-inferiority', 'compared', 'to', 'balloon-expandable', 'sapien', 'device', 'in', 'term', 'of', 'early', 'safety', 'and', 'clinical', 'efficacy', 'outcome', '.', 'early', 'composite', 'safety', 'and', 'efficacy', 'endpoint', 'useful', 'in', 'discriminating', 'performance', 'of', 'different', 'tavr', 'system', '.', 'funding', 'boston', 'scientific', '(', 'usa', ')', '.']"
Safety of on- vs off-clamp robotic partial nephrectomy: per-protocol analysis from the data of the CLOCK randomized trial.,"Alessandro Antonelli, Luca Cindolo, Marco Sandri, Riccardo Bertolo, Filippo Annino, Marco Carini, Antonio Celia, Carlo D'Orta, Bernardino De Concilio, Maria Furlan, Valentina Giommoni, Manuela Ingrosso, Andrea Mari, Gianluca Muto, Roberto Nucciotti, Angelo Porreca, Giulia Primiceri, Luigi Schips, Francesco Sessa, Claudio Simeone, Alessandro Veccia, Andrea Minervini                              ;, AGILE Group (Italian Group for Advanced Laparo-Endoscopic Surgery), Alessandro Antonelliet al.",2020 May,World J Urol,https://pubmed.ncbi.nlm.nih.gov/31342246/,No keywords found,"['to', 'compare', 'safety', 'of', 'on-', 'v', 'off-clamp', 'robotic', 'partial', 'nephrectomy', '(', 'rapn', ')', '.', 'method', 'patient', 'with', 'renal', 'mass', 'randomized', 'to', 'undergo', 'on-clamp', '(', ')', 'v', 'off-clamp', '(', ')', 'rapn', '(', 'clock', 'trial-clinicaltrials.gov', 'nct', ')', 'seven', 'institution', 'one', 'experienced', 'surgeon', 'per', 'institution', '.', 'intra-operative', 'data', ',', 'complication', ',', 'and', 'positive', 'surgical', 'margin', 'compared', '.', 'result', 'due', 'to', 'relevant', 'rate', 'of', 'shift', 'assigned', 'treatment', ',', 'per-protocol', 'analysis', 'considered', 'and', 'data', 'on-clamp', 'v', 'off-clamp', 'rapns', 'analyzed', '.', 'tumor', 'size', '(', 'off-clamp', 'v', 'on-clamp', ',', '.', 'v', '.', 'cm', ',', 'p', '.', 'gdl', 'v', ',', 'p', '.', 'transfusion', 'rate', '.', 'v', '.', ',', 'p', '.', 're-intervention', 'due', 'to', 'bleeding', '.', 'v', ',', 'p', '.', ')', ',', 'acute', 'kidney', 'injury', '(', 'v', ',', 'p', '.', ')', ',', 'and', 'positive', 'surgical', 'margin', '(', '.', 'v', '.', ',', 'p', '.', ')', '.', 'multivariate', 'analysis', 'accounting', 'tumor', 'diameter', 'and', 'complexity', ',', 'considering', 'on-clamp', 'group', 'reference', 'category', ',', 'significant', 'difference', 'noted', 'in', 'off-clamp', 'group', 'exclusively', 'blood', 'loss', '(', 'or', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'conclusion', 'on-clamp', 'and', 'off-clamp', 'approach', 'rapn', 'showed', 'comparable', 'safety', 'profile', '.']"
"Incidence, Severity, and Detection of Blood Pressure Perturbations after Abdominal Surgery: A Prospective Blinded Observational Study.","Alparslan Turan, Christine Chang, Barak Cohen, Wael Saasouh, Hani Essber, Dongsheng Yang, Chao Ma, Karen Hovsepyan, Ashish K Khanna, Joseph Vitale, Ami Shah, Kurt Ruetzler, Kamal Maheshwari, Daniel I Sessler, Alparslan Turanet al.",2019 Apr,Anesthesiology,https://pubmed.ncbi.nlm.nih.gov/30875354/,No keywords found,"['intraoperative', 'and', 'postoperative', 'hypotension', 'associated', 'with', 'myocardial', 'and', 'kidney', 'injury', 'and', '-day', 'mortality', '.', 'intraoperative', 'blood', 'pressure', 'measured', 'frequently', ',', 'blood', 'pressure', 'surgical', 'ward', 'usually', 'measured', 'every', 'to', 'h', ',', 'leaving', 'long', 'interval', 'hypotension', 'and', 'hypertension', 'may', 'undetected', '.', 'study', 'evaluated', 'incidence', 'and', 'severity', 'of', 'postoperative', 'hypotension', 'and', 'hypertension', 'in', 'adult', 'recovering', 'abdominal', 'surgery', 'and', 'extent', 'to', 'serious', 'perturbation', 'missed', 'routine', 'vital-sign', 'assessment', '.', 'method', 'blood', 'pressure', 'recorded', '-min', 'interval', 'initial', 'h', 'in', 'adult', 'recovering', 'abdominal', 'surgery', 'using', 'continuous', 'noninvasive', 'monitor', '.', 'caregiver', 'blinded', 'to', 'measurement', 'and', 'depended', 'routine', 'vital-sign', 'assessment', '.', 'hypotension', 'and', 'hypertension', 'characterized', 'time', 'and', 'various', 'mean', 'arterial', 'pressure', 'threshold', '.', 'result', 'of', 'available', 'patient', ',', 'patient', 'with', 'high-quality', 'record', 'analyzed', ',', 'with', 'median', 'measurement', 'time', 'of', 'interquartile', 'range', ',', 'postoperative', 'hour', '.', 'nearly', 'quarter', 'experienced', 'episode', 'of', 'mean', 'arterial', 'pressure', 'of', 'less', 'mm', 'hg', 'lasting', 'least', 'min', '(', 'ci', ',', ',', ')', ',', 'and', 'episode', 'of', 'mean', 'arterial', 'pressure', 'of', 'less', 'mm', 'hg', 'lasting', 'least', 'min', '.', 'nearly', 'half', 'patient', 'mean', 'arterial', 'pressure', 'of', 'less', 'mm', 'hg', 'least', 'min', '(', 'ci', ',', ',', ')', 'undetected', 'routine', 'vital-sign', 'assessment', '.', 'episode', 'of', 'mean', 'arterial', 'pressure', 'greater', 'mm', 'hg', 'lasting', 'least', 'min', 'observed', 'in', '(', 'ci', ',', ',', ')', 'of', 'patient', 'mean', 'arterial', 'pressure', 'greater', 'mm', 'hg', 'least', 'min', ',', 'of', 'missed', 'routine', 'assessment', '.', 'episode', 'of', 'mean', 'arterial', 'pressure', 'less', 'mm', 'hg', 'and', 'mean', 'arterial', 'pressure', 'greater', 'mm', 'hg', 'captured', 'routine', 'vital-sign', 'assessment', 'not', 'continuous', 'monitoring', 'occurred', 'in', 'and', 'patient', ',', 'respectively', '.', 'conclusion', 'postoperative', 'hypotension', 'and', 'hypertension', 'common', ',', 'prolonged', ',', 'profound', ',', 'and', 'largely', 'undetected', 'routine', 'vital-sign', 'assessment', 'in', 'cohort', 'of', 'adult', 'recovering', 'abdominal', 'surgery', '.', 'frequent', 'or', 'continuous', 'blood', 'pressure', 'monitoring', 'may', 'detect', 'hemodynamic', 'perturbation', 'effectively', 'and', 'potentially', 'facilitate', 'treatment', '.']"
Expression of HO1 and PER2 can predict the incidence of delirium in trauma patients with concomitant brain injury.,"Matti Steimer, Sandra Kaiser, Felix Ulbrich, Johannes Kalbhenn, Hartmut Bürkle, Nils Schallner, Matti Steimeret al.",2021 Jul 28,Sci Rep,https://pubmed.ncbi.nlm.nih.gov/34321570/,No keywords found,"['p', '.', 'ho', 'p', '.', ')', ',', 'expression', 'level', 'significantly', 'correlated', 'with', 'trauma', 'severity', '(', 'per', 'p', '.', 'ho', 'p', '.', ')', 'and', 'longer', 'icu', 'length', 'of', 'stay', '(', 'per', 'p', '.', 'ho', 'p', '.', ')', '.', 'high', 'expression', 'level', 'increased', 'odds', 'of', 'delirium', 'occurrence', '(', 'per', 'or', '.', '.-', '.', 'ho', 'or', '.', '.-.', ')', '.', 'patient', 'with', 'tbi', 'showed', 'trend', 'towards', 'elevated', 'per', '(', 'or', '.', '.-.', ',', 'p', '.', ')', ',', 'not', 'towards', 'delirium', 'occurrence', '(', 'p', '.', ')', '.', 'tbi', 'patient', 'less', 'likely', 'to', 'develop', 'aki', 'compared', 'to', 'non-tbi', '(', 'p', '.', ')', '.', 'expression', 'level', 'of', 'per', 'and', 'ho', 'correlate', 'with', 'incidence', 'of', 'delirium', 'in', 'age-independent', 'manner', 'and', 'may', 'potentially', 'improve', 'diagnostic', 'algorithm', 'used', 'delirium', 'biomarkers.trial', 'registration', 'german', 'clinical', 'trial', 'register', '(', 'trial-id', 'drks', 'universal', 'trial', 'number', 'u', '--', 'jan.', ',', ')', '.']"
The efficacy and safety of quantitative flow ratio-guided complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A pilot randomized controlled trial.,"Jing Zhang, Mingyan Yao, Xinwei Jia, Huiping Feng, Jingjing Fu, Wei Tang, Hongliang Cong, Jing Zhanget al.",2023,Cardiol J,https://pubmed.ncbi.nlm.nih.gov/34581424/,No keywords found,"['in', 'patient', 'with', 'st-segment', 'elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'and', 'multivessel', 'disease', '(', 'mvd', ')', ',', 'treatment', 'strategy', 'non-infarct-related', 'artery', '(', 'non-ira', ')', 'remains', 'controversial', '.', 'quantitative', 'flow', 'ratio', '(', 'qfr', ')', 'new', 'angiography-based', 'physiological', 'assessment', 'index', '.', 'however', ',', 'little', 'evidence', 'practical', 'clinical', 'application', 'of', 'qfr', '.', 'method', 'two', 'hundred', 'and', 'twenty-nine', 'patient', 'with', 'stemi', 'and', 'mvd', 'recruited', 'study', '.', 'patient', 'randomly', 'assigned', 'to', 'either', 'receive', 'qfr-guided', 'complete', 'revascularization', '(', 'qfr-g-cr', ')', 'of', 'non-ira', 'or', 'receive', 'no', 'invasive', 'treatment', '.', 'primary', '(', ')', 'endpoint', 'analyzed', 'included', 'death', 'due', 'to', 'cause', ',', 'non-fatal', 'myocardial', 'infarction', '(', 'mi', ')', ',', 'and', 'ischemia-induced', 'revascularization', 'month', 'post-surgery', '.', 'secondary', '(', ')', 'endpoint', 'included', 'cardiovascular', 'death', ',', 'unstable', 'angina', ',', 'stent', 'thrombosis', ',', 'new', 'york', 'heart', 'association', '(', 'nyha', ')', 'class', 'iv', 'heart', 'failure', ',', 'and', 'stroke', 'year', 'post', 'surgery', '.', 'massive', 'bleeding', 'and', 'contrast-associated', 'acute', 'kidney', 'injury', '(', 'caki', ')', 'used', 'safety', 'endpoint', '.', 'result', 'around', 'month', 'follow', ',', 'outcome', 'recorded', 'in', 'patient', '(', '.', ')', 'in', 'qfr-g-cr', 'population', ',', 'relative', 'to', 'patient', '(', '.', ')', 'in', 'ira-only', 'pci', 'population', '(', 'hazard', 'ratio', 'hr', '.', 'confidence', 'interval', 'ci', '.-', '.', 'p', '.', ')', '.', 'unstable', 'angina', 'in', '(', '.', ')', 'and', '(', '.', ')', 'patient', '(', 'hr', '.', 'ci', '.-', '.', 'p', '.', ')', ',', 'respectively', '.', 'no', 'marked', 'alteration', 'found', 'in', 'massive', 'bleeding', 'and', 'caki', 'category', '.', 'conclusion', 'in', 'conclusion', ',', 'stemi', 'and', 'mvd', 'patient', 'benefit', 'qfr-g-cr', 'of', 'non-ira', 'lesion', 'in', 'initial', 'stage', 'of', 'acute', 'mi', '.', 'help', 'reduce', 'incidence', 'of', 'major', 'adverse', 'cardiovascular', 'event', 'and', 'unstable', 'angina', ',', 'relative', 'to', 'ira', 'treatment', '.', 'chinese', 'clinical', 'trial', 'registration', 'number', 'chictr', '.']"
Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease.,"Katsuaki Sakai, Yuji Ikari, Mamoru Nanasato, Hiroshi Umetsu, Masaaki Okutsu, Tomonobu Takikawa, Satoru Sumitsuji, Kenji Sadamatsu, Masanori Takada, Yasuko Kato, Nobuyuki Ogasawara, Kanichi Otowa, Katsuaki Sakaiet al.",2019 Jul,Cardiovasc Interv Ther,https://pubmed.ncbi.nlm.nih.gov/30343351/,"Coronary artery disease, Prognosis, Renal failure.","['study', 'aim', 'to', 'elucidate', '-year', 'clinical', 'outcome', 'using', 'technique', 'patient', 'with', 'stage', 'or', 'advanced', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', '.', 'research', 'proven', 'imaging-guided', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'reduces', 'contrast', 'volume', 'significantly', 'however', ',', 'short-term', 'clinical', 'benefit', 'reported', '.', 'minimum-contrast', '(', 'minicon', ')', 'study', 'based', 'registry', 'design', 'pattern', 'to', 'enroll', 'pci', 'result', 'in', 'patient', 'with', 'advanced', 'ckd', 'stage', 'or', 'comorbid', 'with', 'coronary', 'artery', 'disease', '.', 'excluded', 'case', 'of', 'emergency', 'pci', 'or', 'maintenance', 'dialysis', 'study', '.', 'in', 'study', ',', 'compared', 'intravascular', 'ultrasound', '(', 'ivus', ')', '-guided', 'minicon', 'pci', 'group', '(', 'n', ')', 'with', 'angiography-guided', 'standard', 'pci', 'group', '(', 'n', ')', '.', 'enrollment', 'of', 'minicon', 'study', 'started', 'in', '.', ',', 'ivus-guided', 'minicon', 'pci', 'performed', 'in', '(', 'stage', ')', ',', '(', 'stage', ')', '.', 'enrollment', 'finished', 'in', '.', 'ivus-guided', 'minicon', 'pci', 'group', 'exhibited', 'significantly', 'reduced', 'contrast', 'volume', '(', 'vs.', 'ml', 'p', '.', ')', 'and', 'contrast-induced', 'acute', 'kidney', 'injury', '(', 'ci-aki', 'vs.', 'p', '.', ')', '.', 'pci', 'success', 'rate', 'similarly', 'high', '(', 'vs.', 'p', '.', ')', '.', 'year', '(', 'follow-up', 'rate', ',', ')', ',', 'observed', 'less', 'induction', 'of', 'renal', 'replacement', 'therapy', '(', 'rrt', '.', 'vs.', '.', 'p', '.', ')', ',', 'all-cause', 'mortality', 'or', 'myocardial', 'infarction', 'similar', 'in', 'group', '.', 'ivus-guided', 'minicon', 'pci', 'reduces', 'ci-aki', 'significantly', 'and', 'induction', 'of', 'rrt', 'year', 'in', 'patient', 'with', 'stage', 'or', 'advanced', 'ckd', '.']"
Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis.,"J Kevin Harrison, G Chad Hughes, Michael J Reardon, Robert Stoler, Paul Grayburn, Robert Hebeler, David Liu, Yanping Chang, Jeffrey J Popma                              ;, CoreValve US Clinical Investigators, J Kevin Harrisonet al.",2017 Jan 23,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/28104211/,No keywords found,"['study', 'sought', 'to', 'explore', 'impact', 'of', 'balloon', 'post-dilation', '(', 'bpd', ')', 'outcome', 'in', 'corevalve', 'u', 'clinical', 'trial', '.', 'background', 'bpd', 'following', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'used', 'in', 'selected', 'case', 'to', 'optimize', 'hemodynamic', 'result', '.', 'method', 'procedural', 'detail', 'of', ',', 'patient', 'examined', 'to', 'determine', 'whether', 'bpd', 'performed', 'self-expanding', 'tavr', '.', '``', 'best', 'practice', ""''"", 'guideline', 'recommended', 'bpd', 'treatment', 'of', 'suboptimal', 'intraprocedural', 'valve', 'function', ',', 'primarily', 'manifested', 'moderate', 'or', 'severe', 'residual', 'aortic', 'regurgitation', '(', 'ar', ')', '.', 'result', 'procedural', 'bpd', 'performed', 'in', 'patient', '(', ')', 'patient', '.', 'common', '(', '.', ')', 'indication', 'greater', 'or', 'equal', 'to', 'moderate', 'ar', 'following', 'valve', 'deployment', '.', 'greater', 'baseline', 'aortic', 'valve', 'gradient', '(', 'p', '.', ')', ',', 'higher', 'grade', 'of', 'baseline', 'ar', '(', 'p', '.', ')', ',', 'larger', 'annular', 'diameter', '(', 'p', '.', ')', ',', 'and', 'lower', 'device', 'to', 'annular', 'ratio', '(', 'p', '.', ')', 'common', 'in', 'patient', 'underwent', 'bpd', '.', 'bpd', 'performed', 'less', 'often', 'with', '-mm', 'valve', '(', '.', ')', 'compared', 'to', 'mm', '(', '.', ')', '(', 'p', '.', ')', '.', 'bpd', 'reduced', 'moderate', 'or', 'severe', 'ar', '.', '.', 'to', '..', 'thirty-day', 'and', '-year', 'clinical', 'event', 'similar', 'in', 'group', ',', 'although', 'acute', 'kidney', 'injury', 'common', 'in', 'patient', 'undergoing', 'bpd', '(', 'p', '.', ')', '.', 'in-hospital', 'major', 'adverse', 'cardiovascular', 'and', 'cerebrovascular', 'event', 'rate', '.', 'in', 'bpd', 'group', 'versus', '.', 'others', '(', 'p', 'n', ')', '.', 'no', 'increase', 'in', 'neurological', 'event', '.', 'conclusion', 'bpd', 'of', 'self-expanding', 'bioprosthesis', 'performed', 'in', 'of', 'patient', 'in', 'corevalve', 'u', 'clinical', 'trial', 'commonly', 'to', 'reduce', 'degree', 'of', 'residual', 'ar', '.', 'bpd', 'effective', 'in', 'acutely', 'improving', 'valve', 'performance', 'without', 'associated', 'increase', 'in', 'neurologic', 'event', '.', '(', 'safety', 'and', 'efficacy', 'study', 'of', 'medtronic', 'corevalve', 'system', 'in', 'treatment', 'of', 'symptomatic', 'severe', 'aortic', 'stenosis', 'in', 'high', 'risk', 'and', 'high', 'risk', 'subject', 'need', 'aortic', 'valve', 'replacement', 'nct', 'safety', 'and', 'efficacy', 'continued', 'access', 'study', 'of', 'medtronic', 'corevalve', 'system', 'in', 'treatment', 'of', 'symptomatic', 'severe', 'aortic', 'stenosis', 'in', 'high', 'risk', 'subject', 'and', 'high', 'risk', 'subject', 'need', 'aortic', 'valve', 'replacement', 'nct', ')', '.']"
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).,"Stephen B Freedman, David Schnadower, Myka Estes, T Charles Casper, Stuart L Goldstein, Silviu Grisaru, Andrew T Pavia, Benjamin S Wilfond, Melissa Metheney, Kadyn Kimball, Phillip I Tarr                              ;, Hyperhydration to Improve Kidney Outcomes in children with Shiga Toxin-producing E. Coli infection (HIKO-STEC) Study Team, Stephen B Freedmanet al.",2023 May 27,Trials,https://pubmed.ncbi.nlm.nih.gov/37245030/,No keywords found,"['shiga', 'toxin-producing', 'e.', 'coli', '(', 'stec', ')', 'infection', 'affect', 'child', 'and', 'adult', 'worldwide', ',', 'and', 'treatment', 'remain', 'solely', 'supportive', '.', 'to', '-', 'of', 'child', 'infected', 'high-risk', 'stec', '(', 'i.e.', ',', 'e.', 'coli', 'produce', 'shiga', 'toxin', ')', 'develop', 'hemolytic', 'anemia', ',', 'thrombocytopenia', ',', 'and', 'kidney', 'failure', '(', 'i.e.', ',', 'hemolytic', 'uremic', 'syndrome', '(', 'hus', ')', ')', ',', 'half', 'of', 'require', 'acute', 'dialysis', 'and', 'die', '.', 'although', 'no', 'therapy', 'widely', 'accepted', 'able', 'to', 'prevent', 'development', 'of', 'hus', 'and', 'complication', ',', 'several', 'observational', 'study', 'suggest', 'intravascular', 'volume', 'expansion', '(', 'hyperhydration', ')', 'may', 'prevent', 'end', 'organ', 'damage', '.', 'randomized', 'trial', 'needed', 'to', 'confirm', 'or', 'refute', 'hypothesis', '.', 'method', 'conduct', 'pragmatic', ',', 'embedded', ',', 'cluster-randomized', ',', 'crossover', 'trial', 'in', 'pediatric', 'institution', 'to', 'determine', 'hyperhydration', ',', 'compared', 'to', 'conservative', 'fluid', 'management', ',', 'improves', 'outcome', 'in', 'child', 'with', 'high-risk', 'stec', 'infection', '.', 'primary', 'outcome', 'major', 'adverse', 'kidney', 'event', 'within', 'day', '(', 'make', ')', ',', 'composite', 'measure', 'includes', 'death', ',', 'initiation', 'of', 'new', 'renal', 'replacement', 'therapy', ',', 'or', 'persistent', 'kidney', 'dysfunction', '.', 'secondary', 'outcome', 'include', 'life-threatening', ',', 'extrarenal', 'complication', ',', 'and', 'development', 'of', 'hus', '.', 'pathway', 'eligible', 'child', 'treated', 'per', 'institutional', 'allocation', 'to', 'pathway', '.', 'in', 'hyperhydration', 'pathway', ',', 'eligible', 'child', 'hospitalized', 'and', 'administered', 'maintenance', 'balanced', 'crystalloid', 'fluid', 'to', 'target', 'of', 'weight', 'gain', 'and', 'reduction', 'in', 'hematocrit', '.', 'site', 'in', 'conservative', 'fluid', 'management', 'pathway', 'manage', 'child', 'in-', 'or', 'outpatient', ',', 'based', 'clinician', 'preference', ',', 'with', 'pathway', 'focused', 'close', 'laboratory', 'monitoring', ',', 'and', 'maintenance', 'of', 'euvolemia', '.', 'based', 'historical', 'data', ',', 'estimate', 'of', 'child', 'in', 'conservative', 'fluid', 'management', 'pathway', 'experience', 'primary', 'outcome', '.', 'with', 'cluster', 'enrolling', 'mean', 'of', 'patient', 'with', 'intraclass', 'correlation', 'coefficient', 'of', '.', ',', 'power', 'to', 'detect', 'absolute', 'risk', 'reduction', '.', 'discussion', 'hus', 'devastating', 'illness', 'with', 'no', 'treatment', 'option', '.', 'pragmatic', 'study', 'determine', 'hyperhydration', 'reduce', 'morbidity', 'associated', 'with', 'hus', 'in', 'child', 'with', 'high-risk', 'stec', 'infection', '.', 'trial', 'registration', 'clinicaltrials.gov', 'nct', '.', 'registered', 'february', ',', '.']"
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention.,"F Khimani, J Kim, L Chen, E Dean, V Rizk, B Betts, T Nishihori, F Locke, A Mishra, L Perez, E Ayala, M Kharfan-Dabaja, M Nieder, H Fernandez, C Anasetti, J Pidala, F Khimaniet al.",2017 Jul,Bone Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/28368376/,No keywords found,"['sirolimus', '(', 'sir', ')', 'tacrolimus', '(', 'tac', ')', 'alternative', 'to', 'methotrexate', '(', 'mtx', ')', 'tac', '.', 'however', ',', 'rational', 'selection', 'among', 'gvhd', 'prophylaxis', 'approach', 'to', 'optimize', 'survival', 'of', 'individual', 'patient', 'not', 'possible', 'based', 'current', 'evidence', '.', 'compared', 'sirtac', '(', 'n', ')', 'to', 'mtxtac', '(', 'n', ')', '.', 'primary', 'objective', 'to', 'identify', 'unique', 'predictor', 'of', 'overall', 'survival', '(', 'o', ')', '.', 'secondary', 'objective', 'to', 'compare', 'acute', 'and', 'chronic', 'gvhd', ',', 'relapse', ',', 'non-relapse', 'mortality', ',', 'thrombotic', 'microangiopathy', '(', 'tma', ')', ',', 'hepatic', 'veno-occlusive', 'disease', '(', 'vodsos', ')', ',', 'and', 'acute', 'kidney', 'injury', '.', 'day', 'grade', 'ii-iv', 'acute', 'gvhd', 'significantly', 'reduced', 'in', 'sirtac', 'v', 'mtxtac', 'group', '(', 'v', ',', 'p.', ')', '.', 'interaction', 'gvhd', 'prophylaxis', 'group', 'and', 'comorbidity', 'index', '(', 'hematopoietic', 'cell', 'transplantation', '(', 'hct', ')', '-ci', ')', 'significantly', 'impacted', 'o', '.', 'patient', 'with', 'hct-ci', 'significantly', 'worse', 'o', 'with', 'mtxtac', '(', 'hr', '.', ',', 'ci', '.-.', ',', 'p.', ')', 'no', 'effect', 'seen', 'sirtac', '(', 'hr', '.', ',', 'ci', '.-.', ',', 'p.', ')', '.', 'end', 'point', 'not', 'significantly', 'differ', 'group', 'except', 'tma', 'and', 'vodsos', 'increased', 'in', 'sirtac', 'group', ',', 'excess', 'death', 'complication', 'not', 'observed', '.', 'conclude', ',', 'gvhd', 'prophylaxis', 'approach', 'of', 'sirtac', 'associated', 'with', 'reduced', 'grade', 'ii-iv', 'acute', 'gvhd', ',', 'comparable', 'toxicity', 'profile', 'to', 'mtxtac', ',', 'and', 'improved', 'o', 'among', 'patient', 'with', 'hct-ci', '.']"
Effects of Reduced Dietary Sodium and the DASH Diet on GFR: The DASH-Sodium Trial.,"Martha Catalina Morales-Alvarez, Voravech Nissaisorakarn, Lawrence J Appel, Edgar R Miller rd, Robert H Christenson, Heather Rebuck, Sylvia E Rosas, Jeffrey H William, Stephen P Juraschek, Martha Catalina Morales-Alvarezet al.",2024 Apr 1,Kidney360,https://pubmed.ncbi.nlm.nih.gov/38326949/,No keywords found,"['sodium', 'reduction', '-week', 'period', 'decreased', 'egfr.combining', 'sodium', 'reduction', 'with', 'dietary', 'approach', 'to', 'stop', 'hypertension', 'diet', 'resulted', 'in', 'larger', 'reduction', 'in', 'egfr.changes', 'in', 'diastolic', 'bp', 'seem', 'partially', 'responsible', 'observed', 'dietary', 'effect', '.', 'background', 'potassium-rich', 'dietary', 'approach', 'to', 'stop', 'hypertension', '(', 'dash', ')', 'diet', 'combined', 'with', 'low', 'sodium', 'reduces', 'bp', '.', 'however', ',', 'effect', 'of', 'sodium', 'reduction', 'in', 'combination', 'with', 'dash', 'diet', 'kidney', 'function', 'unknown', '.', 'determined', 'effect', 'of', 'sodium', 'reduction', 'and', 'dash', 'diet', ',', 'egfr', 'using', 'cystatin', 'c.', 'method', 'dash-sodium', 'controlled', ',', 'feeding', 'study', 'in', 'adult', 'with', 'elevated', 'or', 'stage', 'hypertension', ',', 'randomly', 'assigned', 'to', 'dash', 'or', 'control', 'diet', '.', 'assigned', 'diet', ',', 'participant', 'consumed', 'of', 'three', 'sodium', 'level', 'day', '-week', 'run-in', 'period', 'of', 'high', 'sodium-control', 'diet', '.', 'three', 'sodium', 'level', 'low', '(', 'mmold', ')', ',', 'medium', '(', 'mmold', ')', ',', 'and', 'high', '(', 'mmold', ')', '.', 'primary', 'outcome', 'change', 'in', 'egfr', 'based', 'cystatin', 'c.', 'result', 'cystatin', 'c', 'measured', 'in', 'of', 'original', 'participant', ',', 'of', 'assigned', 'dash', 'diet', 'and', 'to', 'control', 'diet', '.', 'compared', 'with', 'control', ',', 'dash', 'diet', 'not', 'affect', 'egfr', '(', '.', 'mlmin', 'per', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', '.', 'contrast', ',', 'low', 'versus', 'high', 'sodium', 'intake', 'decreased', 'egfr', '(', '.', 'mlmin', 'per', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'together', ',', 'compared', 'with', 'high', 'sodium-control', 'diet', ',', 'low', 'sodium-dash', 'diet', 'decreased', 'egfr', '.', 'mlmin', 'per', '.', '(', 'ci', ',', '.', 'to', '.', ')', '.', 'effect', 'attenuated', 'with', 'adjustment', 'diastolic', 'bp', 'and', '-hour', 'urinary', 'potassium', 'excretion', '.', 'conclusion', 'combined', 'low', 'sodium-dash', 'diet', 'reduced', 'egfr', '-week', 'period', '.', 'future', 'research', 'focus', 'effect', 'of', 'dietary', 'intervention', 'subclinical', 'kidney', 'injury', 'and', 'long-term', 'effect', 'progression', 'to', 'ckd', '.', 'clinical', 'trial', 'registration', 'number', 'clinicaltrials.gov', ',', 'nct', '.']"
Perioperative individualized hemodynamic optimization according to baseline mean arterial pressure in cardiac surgery patients: Rationale and design of the OPTIPAM randomized trial.,"Richard Descamps, Julien Amour, Emmanuel Besnier, Adrien Bougle, Hélène Charbonneau, Martin Charvin, Bernard Cholley, Olivier Desebbe, Jean-Luc Fellahi, Denis Frasca, François Labaste, Diane Lena, Yazine Mahjoub, Paul-Michel Mertes, Serge Molliex, Pierre-Henri Moury, Mouhamed Djahoum Moussa, Jean-Ferreol Oilleau, Alexandre Ouattara, Sophie Provenchere, Bertand Rozec, Jean-Jacques Parienti, Marc-Olivier Fischer                              ;, OPTIPAM investigators, Richard Descampset al.",2023 Jul:261:10-20.,Am Heart J,https://pubmed.ncbi.nlm.nih.gov/36934980/,No keywords found,"['postoperative', 'morbidity', 'and', 'mortality', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', 'remain', 'high', 'despite', 'recent', 'advance', 'in', 'anesthesia', 'and', 'perioperative', 'management', '.', 'among', 'modifiable', 'risk', 'factor', 'postoperative', 'complication', ',', 'optimal', 'arterial', 'pressure', 'and', 'surgery', 'debate', 'year', '.', 'recent', 'data', 'suggest', 'optimizing', 'arterial', 'pressure', 'to', 'baseline', 'of', 'patient', 'may', 'improve', 'outcome', '.', 'hypothesize', 'optimizing', 'mean', 'arterial', 'pressure', '(', 'map', ')', 'to', 'baseline', 'map', 'of', 'patient', 'cardiac', 'surgery', 'with', 'cpb', 'and', 'first', 'hour', 'postoperatively', 'may', 'improve', 'outcome', '.', 'study', 'design', 'optipam', 'trial', '(', 'nct', ')', 'multicenter', ',', 'randomized', ',', 'open-label', 'controlled', 'trial', 'testing', 'superiority', 'of', 'optimized', 'map', 'management', 'compared', 'with', 'map', 'of', 'mm', 'hg', 'or', 'intraoperative', 'and', 'postoperative', 'period', 'in', ',', 'patient', 'scheduled', 'cardiac', 'surgery', 'with', 'cpb', '.', 'primary', 'composite', 'end', 'point', 'occurrence', 'of', 'acute', 'kidney', 'injury', ',', 'neurological', 'complication', 'including', 'stroke', 'or', 'postoperative', 'delirium', ',', 'and', 'death', '.', 'secondary', 'end', 'point', 'hospital', 'and', 'intensive', 'care', 'unit', 'length', 'of', 'stay', ',', 'day', 'and', 'day', 'mortality', ',', 'postoperative', 'cognitive', 'dysfunction', 'day', 'and', 'day', ',', 'and', 'quality', 'of', 'life', 'day', 'and', 'day', '.', 'two', 'interim', 'analysis', 'assess', 'safety', 'of', 'intervention', '.', 'conclusion', 'optipam', 'trial', 'assess', 'effectiveness', 'of', 'individualized', 'target', 'of', 'mean', 'arterial', 'pressure', 'in', 'cardiac', 'surgery', 'with', 'cpb', 'in', 'reducing', 'postoperative', 'morbidity', '.', 'clinical', 'trial', 'registration', 'nct', '.']"
Effect of Intraoperative Dexamethasone on Major Complications and Mortality Among Infants Undergoing Cardiac Surgery: The DECISION Randomized Clinical Trial.,"Vladimir Lomivorotov, Igor Kornilov, Vladimir Boboshko, Vladimir Shmyrev, Ilya Bondarenko, Ilya Soynov, Alexey Voytov, Stanislav Polyanskih, Oleg Strunin, Alexander Bogachev-Prokophiev, Giovanni Landoni, Caetano Nigro Neto, Gretel Oliveira Nicolau, Leonardo Saurith Izquierdo, Vinícius Nogueira Nascimento, Zhang Wen, Hu Renjie, Zhang Haibo, Vladlen Bazylev, Mikhail Evdokimov, Shahrijar Sulejmanov, Aleksei Chernogrivov, Dmitry Ponomarev, Vladimir Lomivorotovet al.",2020 Jun 23,JAMA,https://pubmed.ncbi.nlm.nih.gov/32573670/,No keywords found,"['corticosteroid', 'widely', 'used', 'in', 'pediatric', 'cardiac', 'surgery', 'to', 'blunt', 'systemic', 'inflammatory', 'response', 'and', 'to', 'reduce', 'complication', 'nevertheless', ',', 'clinical', 'efficacy', 'uncertain', '.', 'objective', 'to', 'determine', 'whether', 'intraoperative', 'administration', 'of', 'dexamethasone', 'effective', 'placebo', 'reducing', 'major', 'complication', 'and', 'mortality', 'pediatric', 'cardiac', 'surgery', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'intraoperative', 'dexamethasone', 'in', 'pediatric', 'cardiac', 'surgery', 'investigator-initiated', ',', 'double-blind', ',', 'multicenter', 'randomized', 'trial', 'involved', 'center', 'in', 'china', ',', 'brazil', ',', 'and', 'russia', '.', 'total', 'of', 'infant', 'younger', 'month', ',', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', 'enrolled', 'december', 'to', 'october', ',', 'with', 'follow-up', 'completed', 'in', 'november', '.', 'intervention', 'dexamethasone', 'group', '(', 'n', ')', 'received', 'mgkg', 'of', 'dexamethasone', 'control', 'group', '(', 'n', ')', 'received', 'equivolume', 'of', '.', 'sodium', 'chloride', 'intravenously', 'anesthesia', 'induction', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', 'composite', 'of', 'death', ',', 'nonfatal', 'myocardial', 'infarction', ',', 'need', 'extracorporeal', 'membrane', 'oxygenation', ',', 'need', 'cardiopulmonary', 'resuscitation', ',', 'acute', 'kidney', 'injury', ',', 'prolonged', 'mechanical', 'ventilation', ',', 'or', 'neurological', 'complication', 'within', 'day', 'surgery', '.', 'secondary', 'end', 'point', ',', 'including', 'individual', 'component', 'of', 'primary', 'end', 'point', ',', 'and', 'duration', 'of', 'mechanical', 'ventilation', ',', 'inotropic', 'index', ',', 'intensive', 'care', 'unit', 'stay', ',', 'readmission', 'to', 'intensive', 'care', 'unit', ',', 'and', 'length', 'of', 'hospitalization', '.', 'result', 'of', 'patient', 'randomized', '(', 'median', 'age', ',', 'month', '.', 'boy', ')', 'completed', 'trial', '.', 'primary', 'end', 'point', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'dexamethasone', 'group', 'v', 'patient', '(', '.', ')', 'in', 'control', 'group', '(', 'absolute', 'risk', 'reduction', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'of', 'prespecified', 'secondary', 'end', 'point', ',', 'none', 'showed', 'statistically', 'significant', 'difference', 'group', '.', 'infection', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'dexamethasone', 'group', 'v', 'patient', '(', '.', ')', 'in', 'control', 'group', '.', 'conclusion', 'and', 'relevance', 'among', 'infant', 'younger', 'month', 'undergoing', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', ',', 'intraoperative', 'administration', 'of', 'dexamethasone', ',', 'compared', 'with', 'placebo', ',', 'not', 'significantly', 'reduce', 'major', 'complication', 'and', 'mortality', 'day', '.', 'however', ',', 'study', 'may', 'underpowered', 'to', 'detect', 'clinically', 'important', 'difference', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.,"Lindsay M Miller, Dena Rifkin, Alexandra K Lee, Manjula Kurella Tamura, Nicholas M Pajewski, Daniel E Weiner, Tala Al-Rousan, Michael Shlipak, Joachim H Ix, Lindsay M Milleret al.",2021 Oct,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/33647393/,No keywords found,"['association', 'of', 'glomerular', 'marker', 'of', 'kidney', 'disease', ',', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'and', 'albuminuria', ',', 'with', 'frailty', 'and', 'cognition', 'well', 'established', '.', 'however', ',', 'relationship', 'of', 'kidney', 'tubule', 'injury', 'and', 'dysfunction', 'with', 'frailty', 'and', 'cognition', 'unknown', '.', 'study', 'design', 'observational', 'cross-sectional', 'study', '.', 'setting', 'participant', ',', 'participant', 'with', 'egfr.', ')', '.', 'cognitive', 'function', 'assessed', 'using', 'montreal', 'cognitive', 'assessment', '(', 'moca', ')', '.', 'analytical', 'approach', 'association', 'kidney', 'tubule', 'biomarkers', 'with', 'categorical', 'fi', 'evaluated', 'using', 'multinomial', 'logistic', 'regression', 'with', 'fit', 'group', 'reference', '.', 'cognitive', 'function', 'evaluated', 'using', 'linear', 'regression', '.', 'model', 'adjusted', 'demographic', ',', 'behavioral', ',', 'and', 'clinical', 'variable', 'including', 'egfr', 'and', 'urine', 'albumin', '.', 'result', 'three', 'of', 'urine', 'biomarkers', 'of', 'tubule', 'injury', 'and', 'dysfunction', 'independently', 'associated', 'with', 'fi', '.', '-fold', 'higher', 'level', 'of', 'urine', 'kim-', ',', 'marker', 'of', 'tubule', 'injury', ',', 'associated', 'with', '.', '(', 'ci', ',', '.-', '.', ')', 'greater', 'odds', 'of', 'in', 'frail', 'group', '.', 'mcp-', ',', 'marker', 'of', 'tubulointerstitial', 'fibrosis', ',', 'associated', 'with', '.', '(', 'ci', ',', '.-', '.', ')', 'greater', 'odds', 'of', 'in', 'frail', 'group', ',', 'and', ',', 'marker', 'of', 'tubule', 'reabsorptive', 'capacity', ',', 'associated', 'with', '.', '(', 'ci', ',', '.-', '.', ')', 'greater', 'odds', 'of', 'in', 'frail', 'group', '.', 'association', 'independent', 'of', 'confounders', 'including', 'egfr', 'and', 'urine', 'albumin', ',', 'and', 'stronger', 'of', 'urine', 'albumin', 'with', 'fi', '(', '.', 'ci', ',', '.-.', ')', '.', 'higher', 'urine', 'bm', ',', 'another', 'marker', 'of', 'tubule', 'reabsorptive', 'capacity', ',', 'associated', 'with', 'worse', 'cognitive', 'score', 'baseline', '(', '-', '.', 'ci', ',', '-', '.', 'to-.', ')', '.', 'urine', 'albumin', 'not', 'associated', 'with', 'cognitive', 'function', '.', 'limitation', 'cross-sectional', 'design', ',', 'and', 'fi', 'may', 'not', 'generalizable', 'in', 'population', '.', 'conclusion', 'urine', 'biomarkers', 'of', 'tubule', 'injury', ',', 'fibrosis', ',', 'and', 'proximal', 'tubule', 'reabsorptive', 'capacity', 'variably', 'associated', 'with', 'fi', 'and', 'worse', 'cognition', ',', 'independent', 'of', 'glomerular', 'marker', 'of', 'kidney', 'health', '.', 'future', 'study', 'needed', 'to', 'validate', 'result', 'among', 'patient', 'population', '.']"
Technical aspects and 30-day outcomes of the prospective early feasibility study of the GORE EXCLUDER Thoracoabdominal Branched Endoprosthesis (TAMBE) to treat pararenal and extent IV thoracoabdominal aortic aneurysms.,"Gustavo S Oderich, Mark A Farber, Pierre Galvagni Silveira, Rami Tadros, Michael Marin, Mark Fillinger, Michel Makaroun, Jason Hemmer, Meghan Madden, Gustavo S Oderichet al.",2019 Aug,J Vasc Surg,https://pubmed.ncbi.nlm.nih.gov/30612825/,No keywords found,"['study', 'report', 'technical', 'aspect', 'and', '-day', 'outcome', 'of', 'prospective', ',', 'multicenter', 'early', 'feasibility', 'study', 'designed', 'to', 'evaluate', 'gore', 'excluder', 'thoracoabdominal', 'branch', 'endoprosthesis', '(', 'tambe', 'w.', 'l.', 'gore', 'associate', ',', 'flagstaff', ',', 'ariz', ')', '.', 'method', 'thirteen', 'patient', 'with', 'pararenal', 'or', 'extent', 'iv', 'thoracoabdominal', 'aortic', 'aneurysm', 'prospectively', 'enrolled', 'five', 'u.s', 'site', 'and', 'one', 'non-u.s.', 'site', 'to', '.', 'tambe', 'included', 'four', 'portal', 'with', 'either', 'retrograde', 'or', 'antegrade', 'renal', 'portal', 'configuration', 'and', 'used', 'gore', 'viabahn', 'balloon-expandable', 'endoprosthesis', '(', 'w.', 'l.', 'gore', 'associate', ')', 'stenting', 'of', 'renal', 'and', 'mesenteric', 'artery', '.', 'primary', 'end', 'point', 'procedural', 'safety', 'day', ',', 'defined', 'absence', 'of', 'major', 'adverse', 'event', ',', 'including', 'any-cause', 'mortality', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'paraplegia', ',', 'bowel', 'ischemia', ',', 'respiratory', 'failure', ',', 'severe', 'acute', 'kidney', 'injury', '(', 'decline', 'in', 'estimated', 'glomerular', 'filtration', 'rate', ')', ',', 'dialysis', ',', 'and', 'procedural', 'blood', 'loss', 'ml', '.', 'result', 'male', 'and', 'two', 'female', 'patient', 'with', 'mean', 'age', 'of', 'year', '.', 'mean', 'aneurysm', 'diameter', 'mm', '.', 'total', 'of', 'renal', 'and', 'mesenteric', 'artery', 'incorporated', '(', 'vesselspatient', ')', '.', 'technical', 'success', 'achieved', 'in', 'patient', '(', ')', '.', 'one', 'patient', 'inadvertent', 'occlusion', 'of', 'right', 'renal', 'artery', 'due', 'to', 'dissection', '.', 'no', 'mortality', ',', 'aneurysm', 'rupture', ',', 'conversion', 'to', 'open', 'repair', ',', 'dialysis', ',', 'or', 'spinal', 'cord', 'injury', '.', 'mean', 'length', 'of', 'hospital', 'stay', 'day', '.', 'day', ',', 'four', 'patient', '(', ')', 'major', 'adverse', 'event', ',', 'due', 'to', 'procedural', 'blood', 'loss', 'ml', '.', 'one', 'patient', 'type', 'endoleak', 'distal', 'renal', 'branch', ',', 'successfully', 'treated', 'placement', 'of', 'additional', 'renal', 'stent', 'dismissal', '.', 'computed', 'tomography', 'angiography', 'day', 'showed', 'patent', 'target', 'vessel', 'and', 'no', 'type', 'or', 'type', 'iii', 'endoleak', '.', 'conclusion', 'study', 'confirms', 'early', 'feasibility', 'of', 'tambe', 'treatment', 'of', 'pararenal', 'and', 'extent', 'iv', 'thoracoabdominal', 'aortic', 'aneurysm', '.', 'high', 'technical', 'success', ',', 'no', 'mortality', ',', 'and', 'low', 'morbidity', 'rate', 'support', 'continuation', 'of', 'clinical', 'investigation', 'in', 'larger', 'population', 'of', 'patient', '.']"
Six-Month Outcomes After High-Risk Coronary Artery Bypass Graft Surgery and Preoperative Intra-aortic Balloon Counterpulsation Use: An Inception Cohort Study.,"Edward Litton, Frances Bass, Anthony Delaney, Graham Hillis, Silvana Marasco, Shay McGuinness, Paul S Myles, Christopher M Reid, Julian A Smith                              ;, PINBALL study investigators and the ANZICS CTG, Sean M Bagshaw, Heidi Buhr Keri-Anne Cowdrey, Rob Frengley, Janet Ferrier, Eileen Gilder, Seton Henderson, Marco Larobina, Jan Merthens, Matthew Morgan, Lean Navarra, Máté Rudas, Lisa Turner, Kristen Reid, Matthew Wise, Noel Young, Paul Young, D McGiffin, J Duncan, M Kaczmarek, S Seevanayagam, M Shaw, G Shardey, P Skillington, T Chorley, L Baker, B Zhang, C Bright, R Baker, N Canning, Gilfillan st, R Kruger, T Fayers, M Kyte, C Doran, J Smith, H Baxter, P Seah, S Scaybrook, A James, K Goodwin, R Dignan, N Hewitt, K Gerrard, L Curtis, R Tiruvoipati, N Broukal, H Wolfenden, Muir th, M Worthington, C Wong, J Tatoulis, R Wynne, D Marshman, D Sze, M Wilson, L Turner, J Passage, M Kolybaba, G Fermanis, P Newbon, A Newcomb, J Mack, K Duve, P Jansz, T Hunter, P Bissaker, N Dennis, N Burke, S Yadav, K Cooper, R Chard, M Halaka, L Tran, M Huq, B Billah, C M Reid, Edward Littonet al.",2018 Oct,J Cardiothorac Vasc Anesth,https://pubmed.ncbi.nlm.nih.gov/29456049/,No keywords found,"['to', 'inform', 'design', 'of', 'pivotal', 'randomized', 'controlled', 'trial', 'of', 'prophylactic', 'intra-aortic', 'balloon', 'counterpulsation', '(', 'iabc', ')', 'in', 'patient', 'undergoing', 'coronary', 'artery', 'bypass', 'graft', '(', 'cabg', ')', 'high', 'risk', 'of', 'postoperative', 'low', 'cardiac', 'output', 'syndrome', '(', 'lcos', ')', '.', 'design', 'inception', 'cohort', 'study', '.', 'setting', 'total', 'of', 'established', 'cardiac', 'center', 'in', 'australia', ',', 'canada', ',', 'new', 'zealand', ',', 'and', 'united', 'kingdom', '.', 'participant', 'adult', 'patient', 'eligible', 'inclusion', 'listed', 'cabg', 'surgery', 'and', 'or', 'lcos', 'risk', 'factor', '(', 'low', 'ejection', 'fraction', ',', 'severe', 'left', 'main', 'coronary', 'artery', 'disease', ',', 'redo', 'sternotomy', ',', 'unstable', 'angina', ')', '.', 'intervention', 'outcome', 'of', 'interest', 'composite', 'outcome', 'of', 'in-hospital', 'mortality', ',', 'postoperative', 'acute', 'myocardial', 'infarction', '(', 'ami', ')', ',', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'or', 'stroke', 'well', '-month', 'vital', 'status', 'and', 'quality', 'of', 'life', 'using', 'euroqol', '-dimensional', 'questionnaire', '(', 'eqd', ')', '.', 'measurement', 'and', 'main', 'result', 'study', 'included', 'participant', '-month', 'period', '.', 'overall', ',', 'in-hospital', 'and', '-month', 'mortality', 'occurred', 'in', '(', ')', 'and', '(', ')', 'participant', ',', 'respectively', '.', 'composite', 'outcome', 'occurred', 'in', '(', ')', '.', 'mean', 'increase', 'in', 'eqd', 'summary', 'index', 'month', '.', '(', 'standard', 'deviation', '.', ',', 'p', '.', ')', '.', 'perioperative', 'ami', ',', 'aki', ',', 'or', 'stroke', 'significantly', 'decreased', 'odds', 'of', 'clinically', 'meaningful', 'improvement', 'in', 'quality', 'of', 'life', '(', 'odds', 'ratio', '.', 'confidence', 'interval', '.-', '.', 'p', '.', ')', '.', 'preoperative', 'iabc', 'used', 'in', 'participant', 'and', 'not', 'predict', 'postoperative', 'outcome', '.', 'conclusion', 'study', 'identified', 'group', 'of', 'patient', 'risk', 'of', 'lcos', 'in', 'cabg', 'surgery', 'associated', 'with', 'substantial', 'burden', 'of', 'perioperative', 'morbidity', '.', 'preoperative', 'iabc', 'use', 'variable', ',', 'supporting', 'need', 'research', '.']"
A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.,"John G Webb, Darshan Doshi, Michael J Mack, Raj Makkar, Craig R Smith, Augusto D Pichard, Susheel Kodali, Samir Kapadia, D Craig Miller, Vasilis Babaliaros, Vinod Thourani, Howard C Herrmann, Mark Bodenhamer, Brian K Whisenant, Stephen Ramee, Hersh Maniar Jr, Dean Kereiakes, Ke Xu, Wael A Jaber, Venu Menon, E Murat Tuzcu, David Wood, Lars G Svensson, Martin B Leon, John G Webbet al.",2015 Dec 21,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/26718510/,No keywords found,"['purpose', 'of', 'study', 'to', 'determine', 'safety', 'and', 'effectiveness', 'of', 'sapien', 'xt', 'versus', 'sapien', 'system', '(', 'edward', 'lifesciences', ',', 'irvine', ',', 'california', ')', 'in', 'patient', 'with', 'symptomatic', ',', 'severe', 'aortic', 'stenosis', '(', ')', 'not', 'candidate', 'surgery', '.', 'background', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'become', 'standard', 'of', 'care', 'inoperable', 'patient', 'with', 'severe', ',', 'symptomatic', '.', 'in', 'partner', '(', 'placement', 'of', 'aortic', 'transcatheter', 'valve', ')', 'ib', 'trial', ',', 'reduction', 'in', 'all-cause', 'mortality', 'observed', 'in', 'patient', 'undergoing', 'tavr', 'with', 'balloon-expandable', 'sapien', 'transcatheter', 'heart', 'valve', 'compared', 'with', 'standard', 'therapy', ',', 'sapien', 'valve', 'associated', 'with', 'adverse', 'periprocedural', 'complication', ',', 'including', 'vascular', 'complication', ',', 'major', 'bleeding', ',', 'and', 'paravalvular', 'regurgitation', '.', 'newer', ',', 'low-profile', 'sapien', 'xt', 'system', 'developed', 'to', 'reduce', 'adverse', 'event', '.', 'method', 'total', 'of', 'patient', 'enrolled', 'site', 'in', 'united', 'state', 'april', 'to', 'february', '.', 'patient', 'randomized', 'to', 'receive', 'sapien', 'or', 'sapien', 'xt', 'system', '.', 'primary', 'endpoint', 'nonhierarchical', 'composite', 'of', 'all-cause', 'mortality', ',', 'major', 'stroke', ',', 'and', 'rehospitalization', 'year', 'in', 'intention-to-treat', 'population', ',', 'assessed', 'noninferiority', 'testing', '.', 'pre-specified', 'secondary', 'endpoint', 'included', 'cardiovascular', 'death', ',', 'new', 'york', 'heart', 'association', 'functional', 'class', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'acute', 'kidney', 'injury', ',', 'vascular', 'complication', ',', 'bleeding', ',', '-min', 'walk', 'distance', ',', 'and', 'valve', 'performance', '(', 'echocardiography', ')', '.', 'result', 'overall', 'and', 'major', 'vascular', 'complication', 'higher', 'day', 'in', 'patient', 'undergoing', 'tavr', 'with', 'sapien', 'compared', 'with', 'sapien', 'xt', '(', 'overall', '.', 'vs.', '.', 'p', '.', 'major', '.', 'vs.', '.', 'p', '.', ')', '.', 'bleeding', 'requiring', 'blood', 'transfusion', 'also', 'frequent', 'with', 'sapien', 'compared', 'with', 'sapien', 'xt', '(', '.', 'vs.', '.', 'p', '.', ')', '.', '-year', 'follow-up', ',', 'nonhierarchical', 'composite', 'of', 'all-cause', 'mortality', ',', 'major', 'stroke', ',', 'or', 'rehospitalization', 'similar', '(', '.', 'sapien', 'vs.', '.', 'sapien', 'xt', 'noninferiority', 'p', 'value', '.', ')', 'no', 'difference', 'in', 'major', 'pre-specified', 'endpoint', 'found', '.', 'conclusion', 'in', 'inoperable', 'patient', 'with', 'severe', ',', 'symptomatic', ',', 'lower-profile', 'sapien', 'xt', 'noninferior', 'to', 'sapien', 'with', 'fewer', 'vascular', 'complication', 'and', 'lesser', 'need', 'blood', 'transfusion', '.', '(', 'partner', 'ii', 'trial', 'placement', 'of', 'aortic', 'transcatheter', 'valve', 'nct', ')', '.']"
Association of fibrinolysis phenotype with patient outcomes following traumatic brain injury.,"Samantha Durbin, Alexandra Brito, Alicia Johnson, Bryan Cotton, Susan Rowell, Martin A Schreiber, Samantha Durbinet al.",2024 Mar 1,J Trauma Acute Care Surg,https://pubmed.ncbi.nlm.nih.gov/37700441/,No keywords found,"['impaired', 'coagulation', 'associated', 'with', 'elevated', 'risk', 'of', 'mortality', 'in', 'trauma', 'patient', '.', 'prior', 'study', 'demonstrated', 'increased', 'mortality', 'in', 'patient', 'with', 'hyperfibrinolysis', '(', 'hf', ')', 'and', 'fibrinolysis', 'shutdown', '(', 'sd', ')', '.', 'in', 'addition', ',', 'prior', 'study', 'demonstrated', 'no', 'effect', 'of', 'tranexamic', 'acid', '(', 'txa', ')', 'fibrinolysis', 'phenotype', '.', 'examined', 'association', 'of', 'admission', 'fibrinolysis', 'phenotype', 'with', 'traumatic', 'brain', 'injury', '(', 'tbi', ')', 'patient', 'outcome', '.', 'method', 'data', 'extracted', 'placebo-controlled', 'multicenter', 'clinical', 'trial', '.', 'patient', 'year', 'with', 'tbi', '(', 'glasgow', 'coma', 'scale', 'score', ',', '-', ')', 'and', 'systolic', 'blood', 'pressure', 'mm', 'hg', 'randomized', 'in', 'out-of-hospital', 'setting', 'to', 'receive', 'placebo', 'bolusplacebo', 'infusion', '(', 'placebo', ')', ',', 'gram', '(', 'g', ')', 'txa', 'bolus', 'g', 'txa', 'infusion', '(', 'bolus', 'maintenance', 'bm', ')', 'or', 'g', 'txa', 'bolusplacebo', 'infusion', '(', 'bolus', 'bo', ')', '.', 'fibrinolysis', 'phenotype', 'admission', 'determined', 'clot', 'lysis', 'minute', '(', 'ly', ')', 'sd', ',', '.', 'physiologic', ',', '.', 'to', '.', 'hf', ',', '.', 'logistic', 'regression', 'used', 'to', 'control', 'age', ',', 'sex', ',', 'penetrating', 'injury', ',', 'injury', 'severity', 'score', ',', 'maximum', 'head', 'ai', ',', 'and', 'txa', 'treatment', 'group', '.', 'result', 'seven', 'hundred', 'forty-seven', 'patient', 'met', 'inclusion', 'criterion', '.', 'fibrinolysis', 'shutdown', 'common', 'phenotype', 'in', 'treatment', 'group', 'and', 'associated', 'with', 'increased', 'age', ',', 'injury', 'severity', 'score', ',', 'and', 'presence', 'of', 'intracranial', 'hemorrhage', '(', 'ich', ')', '.', 'inpatient', 'mortality', '.', 'sd', 'and', 'hf', ',', 'and', '.', 'physiologic', '(', 'p', '.', ')', '.', 'no', 'difference', 'in', 'mortality', ',', 'disability', 'rating', 'scale', 'month', ',', 'acute', 'kidney', 'injury', ',', 'acute', 'respiratory', 'distress', 'syndrome', ',', 'or', 'multi-organ', 'failure', 'noted', 'fibrinolysis', 'phenotype', '.', 'conclusion', 'sd', 'common', 'phenotype', 'expressed', 'in', 'moderate', 'to', 'severe', 'tbi', '.', 'in', 'tbi', ',', 'no', 'association', 'fibrinolysis', 'phenotype', 'and', 'mortality', 'or', 'major', 'complication', '.', 'level', 'of', 'evidence', 'prognostic', 'and', 'epidemiological', 'level', 'iv', '.']"
Incidence and prognostic impact of bleeding and transfusion after coronary surgery in low-risk patients.,"Eeva-Maija Kinnunen, Marisa De Feo, Daniel Reichart, Tuomas Tauriainen, Giuseppe Gatti, Francesco Onorati, Luca Maschietto, Ciro Bancone, Francesca Fiorentino, Sidney Chocron, Karl Bounader, Magnus Dalén, Peter Svenarud, Giuseppe Faggian, Ilaria Franzese, Giuseppe Santarpino, Theodor Fischlein, Daniele Maselli, Carmelo Dominici, Saverio Nardella, Riccardo Gherli, Francesco Musumeci, Antonino S Rubino, Carmelo Mignosa, Giovanni Mariscalco, Filiberto G Serraino, Francesco Santini, Antonio Salsano, Francesco Nicolini, Tiziano Gherli, Marco Zanobini, Matteo Saccocci, Vito G Ruggieri, Jean Philippe Verhoye, Andrea Perrotti, Fausto Biancari, Eeva-Maija Kinnunenet al.",2017 Jan,Transfusion,https://pubmed.ncbi.nlm.nih.gov/27774615/,No keywords found,"['excessive', 'bleeding', 'and', 'blood', 'transfusion', 'associated', 'with', 'adverse', 'outcome', 'cardiac', 'surgery', ',', 'mechanistic', 'effect', 'difficult', 'to', 'disentangle', 'in', 'patient', 'with', 'increased', 'operative', 'risk', '.', 'study', 'aimed', 'to', 'evaluate', 'incidence', 'and', 'prognostic', 'impact', 'of', 'bleeding', 'and', 'transfusion', 'of', 'blood', 'product', 'in', 'low-risk', 'patient', 'undergoing', 'coronary', 'artery', 'bypass', 'grafting', '(', 'cabg', ')', '.', 'study', 'design', 'and', 'method', 'sixteen', 'tertiary', 'european', 'center', 'of', 'cardiac', 'surgery', 'contributed', 'to', 'prospective', 'european', 'registry', 'of', 'cabg', '(', 'e-cabg', ')', '.', 'severity', 'of', 'bleeding', 'defined', 'e-cabg', 'bleeding', 'severity', 'classification', 'and', 'universal', 'definition', 'of', 'perioperative', 'bleeding', '(', 'udpb', ')', 'classification', '.', 'result', 'of', 'patient', 'with', 'euroscore', 'ii', 'of', 'less', '(', 'mean', ',', '.', '.', ')', ',', '.', 'suffered', 'mild', 'bleeding', '(', 'e-cabg', 'bleeding', 'grade', ')', 'and', '.', 'experienced', 'severe', 'bleeding', '(', 'e-cabg', 'bleeding', 'grade', '-', ')', '.', 'similarly', ',', '.', 'udpb', 'class', 'and', '.', 'udpb', 'class', 'and', '.', 'mild', 'and', 'severe', 'bleeding', 'defined', 'e-cabg', 'and', 'udpb', 'classification', 'associated', 'with', 'increased', 'risk', 'of', 'several', 'adverse', 'event', 'adjusted', 'multiple', 'covariates', '.', 'risk', 'of', 'death', ',', 'stroke', ',', 'and', 'acute', 'kidney', 'injury', 'particularly', 'increased', 'in', 'patient', 'with', 'severe', 'bleeding', '.', 'conclusion', 'severe', 'bleeding', 'rather', 'uncommon', 'in', 'low-risk', 'patient', 'undergoing', 'cabg', ',', 'associated', 'with', 'increased', 'risk', 'of', 'major', 'adverse', 'event', '.', 'prevention', 'of', 'excessive', 'perioperative', 'bleeding', 'and', 'patient', 'blood', 'management', 'may', 'improve', 'outcome', 'of', 'cardiac', 'surgery', 'also', 'in', 'low-risk', 'patient', '.']"
Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial.,"Naglaa Hamdi Eltahan#, Neamat Hamdy Elsawy#, Kholoud M Abdelaaty#, Amal Salah Elhamaky, Ahmed H Hassan, Moataz Maher Emara, Naglaa Hamdi Eltahanet al.",2024 Feb 22,Respir Res,https://pubmed.ncbi.nlm.nih.gov/38389078/,No keywords found,"['covid-', 'abnormal', 'host', 'response', 'to', 'sars-cov-', 'infection', ',', 'associated', 'with', 'endothelial', 'dysfunction', 'and', 'multi-organ', 'failure', '.', 'atorvastatin', 'proposed', 'to', 'reduce', 'covid-', 'severity', 'and', 'mortality', 'in', 'chronic', 'and', 'de-novo', 'user', '.', 'method', 'randomized', 'double-blind', 'trial', 'included', 'covid-', 'patient', 'admitted', 'to', 'mansoura', 'university', ""'s"", 'isolation', 'hospital', 'in', 'egypt', '.', 'one', 'hundred', 'and', 'ten', 'case', 'given', 'mg', 'of', 'atorvastatin', 'daily', 'day', '(', 'group', ')', ',', 'received', 'placebo', '(', 'group', 'b', ')', '.', 'patient', 'received', 'treatment', 'per', 'hospital', 'protocol', '.', 'primary', 'outcome', 'all-cause', 'mortality', 'day', '.', 'also', 'tracked', '-month', 'mortality', ',', 'time', 'to', 'clinical', 'improvement', ',', 'risk', 'of', 'invasive', 'mechanical', 'ventilation', ',', 'acute', 'kidney', 'injury', ',', 'potential', 'adverse', 'event', ',', 'and', 'hospital', 'and', 'intensive', 'care', 'length', 'of', 'stay', '.', 'result', '-day', 'all-cause', 'mortality', '(', ')', 'in', 'group', 'v', '.', '(', '.', ')', 'in', 'group', 'b', ',', 'odds', 'ratio', '(', 'or', ')', '.', '(', '.', ',', '.', ')', ',', 'p', '.', 'adjusted', 'or', '.', '(', '.', ',', '.', ')', ',', 'p', '..', 'six-month', 'mortality', 'occurred', 'in', '(', ')', 'and', '(', '.', ')', 'in', 'group', 'vs.', 'b', ',', 'respectively', ',', 'p', '..', 'among', 'hospital', 'survivor', 'in', 'group', 'vs.', 'group', 'b', ',', 'median', 'time', 'to', 'clinical', 'improvement', 'day', '(', '-', ')', 'vs.', '(', '-', ')', ',', 'p', '.', 'duration', 'of', 'hospital', 'stay', 'day', '(', '-', ')', 'vs.', '(', '-', ')', ',', 'p', '..', 'discontinuation', 'higher', 'in', 'group', 'b', '(', 'four', 'vs.', 'one', ')', ',', 'statistically', 'insignificant', ',', 'p', '..', 'conclusion', 'in', 'adult', 'with', 'severe', 'or', 'critical', 'covid-', ',', 'atorvastatin', 'not', 'reduce', 'risk', 'of', '-day', 'or', '-month', 'mortality', 'and', 'not', 'shorten', 'length', 'of', 'hospital', 'stay', 'or', 'time', 'to', 'clinical', 'improvement', '.', 'trial', 'registration', 'clinical', 'trial', 'registry', '(', 'nct', ')', 'july', 'st', ',', '.', 'httpsclinicaltrials.govctshownct', '.']"
Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin.,"Ethan M Weinberg, Florence Wong, Hugo E Vargas, Michael P Curry, Khurram Jamil, S Chris Pappas, Pratima Sharma, K Rajender Reddy, Ethan M Weinberget al.",2024 Apr 1,Liver Transpl,https://pubmed.ncbi.nlm.nih.gov/37801553/,No keywords found,"['hepatorenal', 'syndrome-acute', 'kidney', 'injury', '(', 'hrs-aki', ')', ',', 'serious', 'complication', 'of', 'decompensated', 'cirrhosis', ',', 'limited', 'therapeutic', 'option', 'and', 'significant', 'morbidity', 'and', 'mortality', '.', 'terlipressin', 'improves', 'renal', 'function', 'in', 'patient', 'with', 'hrs-', ',', 'liver', 'transplantation', '(', 'lt', ')', 'curative', 'treatment', 'advanced', 'chronic', 'liver', 'disease', '.', 'renal', 'failure', 'post-lt', 'requiring', 'renal', 'replacement', 'therapy', '(', 'rrt', ')', 'major', 'risk', 'factor', 'graft', 'and', 'patient', 'survival', '.', 'post', 'hoc', 'analysis', 'with', '-month', 'follow-up', 'of', 'lt', 'recipient', 'placebo-controlled', 'trial', 'of', 'terlipressin', '(', 'confirm', 'nct', ')', 'conducted', 'to', 'evaluate', 'need', 'rrt', 'and', 'overall', 'survival', '.', 'patient', 'with', 'hrs-', 'treated', 'with', 'terlipressin', 'plus', 'albumin', 'or', 'placebo', 'plus', 'albumin', 'to', 'day', '.', 'rrt', 'defined', 'type', 'of', 'procedure', 'replaced', 'kidney', 'function', '.', 'outcome', 'compared', 'group', 'included', 'incidence', 'of', 'hrs-', 'reversal', ',', 'need', 'rrt', '(', 'pretransplant', 'and', 'posttransplant', ')', ',', 'and', 'overall', 'survival', '.', 'of', 'patient', 'in', 'confirm', '(', 'terlipressin', 'n', 'placebo', ',', 'n', ')', ',', '(', ')', 'underwent', 'lt', 'alone', '(', 'terlipressin', ',', 'n', 'placebo', ',', 'n', ')', 'and', 'simultaneous', 'liver-kidney', 'transplant', '(', 'terlipressin', ',', 'n', ',', 'placebo', ',', 'n', ')', '.', 'rate', 'of', 'hr', 'reversal', 'significantly', 'higher', 'in', 'terlipressin', 'group', 'compared', 'with', 'placebo', 'group', '(', ',', 'n', 'vs.', ',', 'n', 'p', '.', ')', '.', 'pretransplant', 'need', 'rrt', 'significantly', 'lower', 'among', 'received', 'terlipressin', '(', 'p', '.', ')', '.', 'posttransplant', 'need', 'rrt', ',', 'month', ',', 'significantly', 'lower', 'among', 'patient', 'received', 'terlipressin', 'and', 'alive', 'day', ',', 'compared', 'to', 'placebo', '(', 'p', '.', ')', '.', 'pretransplant', 'treatment', 'with', 'terlipressin', 'plus', 'albumin', 'in', 'patient', 'with', 'hrs-', 'decreased', 'need', 'rrt', 'pretransplant', 'and', 'posttransplant', '.']"
"Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.","Dixon B Kaufman, E Steve Woodle, Adele Rike Shields, John Leone, Arthur Matas, Alexander Wiseman, Patricia West-Thielke, Ting Sa, Eileen C King, Rita R Alloway                              ;, BEST Study Group, Paul Brailey, Tonya Dorst, Alin Girnita, Amanda Naciff-Stahl, Jessica Thomas, Simon Tremblay, Kristi Schneider, Alyssa Stucke, Deborah A Fernandez, Mary Farnsworth, Janis Cicerchi, Ann Cline, Kelly Bruno, Jessi Lipscombe, Jennifer Rohan, Dixon B Kaufmanet al.",2021 Sep,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/34233921/,No keywords found,"['immunosuppressive', 'therapy', 'in', 'kidney', 'transplantation', 'associated', 'with', 'numerous', 'toxicity', '.', 'cd-mediated', 't-cell', 'costimulation', 'blockade', 'using', 'belatacept', 'may', 'reduce', 'long-term', 'nephrotoxicity', ',', 'compared', 'with', 'calcineurin', 'inhibitor-based', 'immunosuppression', '.', 'efficacy', 'and', 'safety', 'of', 'simultaneous', 'calcineurin', 'inhibitor', 'avoidance', 'and', 'rapid', 'steroid', 'withdrawal', 'tested', 'in', 'randomized', ',', 'prospective', ',', 'multicenter', 'study', '.', 'design', ',', 'setting', ',', 'participant', ',', 'measurement', 'study', 'report', '-year', 'result', 'of', 'randomized', 'clinical', 'trial', 'of', 'recipient', 'of', 'new', 'kidney', 'transplant', '.', 'kidney', 'transplant', 'performed', 'using', 'rapid', 'steroid', 'withdrawal', 'immunosuppression', '.', 'recipient', 'randomized', 'in', 'ratio', 'to', 'receive', 'belatacept', 'with', 'alemtuzumab', 'induction', ',', 'belatacept', 'with', 'rabbit', 'anti-thymocyte', 'globulin', '(', 'ratg', ')', 'induction', ',', 'or', 'tacrolimus', 'with', 'ratg', 'induction', '.', 'composite', 'end', 'point', 'consisted', 'of', 'death', ',', 'kidney', 'allograft', 'loss', ',', 'or', 'egfr', 'of', 'mlmin', 'per', '.', 'year', '.', 'result', 'composite', 'end', 'point', 'observed', 'of', '(', ')', 'participant', 'assigned', 'to', 'belataceptalemtuzumab', ',', 'of', '(', ')', 'participant', 'assigned', 'to', 'belataceptratg', ',', 'and', 'of', '(', ')', 'participant', 'assigned', 'to', 'tacrolimusratg', '(', 'belataceptalemtuzumab', 'versus', 'tacrolimusratg', ',', 'p.', 'belataceptratg', 'versus', 'tacrolimusratg', ',', 'p.', ')', '.', 'patient', 'and', 'graft', 'survival', 'rate', 'similar', 'group', '.', 'egfr', 'of', 'mlmin', 'per', '.', 'observed', 'nine', 'of', '(', ')', 'participant', 'assigned', 'to', 'belataceptalemtuzuab', ',', 'eight', 'of', '(', ')', 'participant', 'assigned', 'to', 'belataceptratg', ',', 'and', 'of', '(', ')', 'participant', 'assigned', 'to', 'tacrolimusratg', '(', 'p.', 'belatacept', 'group', 'versus', 'tacrolimusratg', ')', '.', 'biopsy', 'sample-proven', 'acute', 'rejection', 'observed', 'of', '(', ')', 'participant', 'assigned', 'to', 'belataceptalemtuzuab', ',', 'of', '(', ')', 'participant', 'assigned', 'to', 'belataceptratg', ',', 'and', 'seven', 'of', '(', ')', 'participant', 'assigned', 'to', 'tacrolimusratg', '(', 'belataceptalemtuzumab', 'versus', 'tacrolimusratg', ',', 'p.', 'belataceptratg', 'versus', 'tacrolimusratg', ',', 'p.', ')', '.', 'gastrointestinal', 'and', 'neurologic', 'adverse', 'event', 'less', 'frequent', 'with', 'belatacept', 'versus', 'calcineurin-based', 'immunosuppression', '.', 'conclusion', 'overall', '-year', 'outcome', 'similar', 'comparing', 'maintenance', 'immunosuppression', 'using', 'belatacept', 'versus', 'tacrolimus', ',', 'and', 'protocol', 'involved', 'rapid', 'steroid', 'withdrawal', '.', 'incidence', 'of', 'egfr', 'of', 'mlmin', 'per', '.', 'significantly', 'lower', 'with', 'belatacept', 'compared', 'with', 'tacrolimus', ',', 'incidence', 'of', 'biopsy', 'sample-proven', 'acute', 'rejection', 'significantly', 'higher', '.', 'clinical', 'trial', 'registry', 'name', 'and', 'registration', 'number', 'belatacept', 'early', 'steroid', 'withdrawal', 'trial', ',', 'nct', '.']"
Acute normovolemic hemodilution in cardiac surgery: Rationale and design of a multicenter randomized trial.,"Fabrizio Monaco, Fabio Guarracino, Igor Vendramin, Chong Lei, Hui Zhang, Vladimir Lomivorotov, Roman Osinsky, Sergey Efremov, Mustafa Emre Gürcü, Michael Mazzeffi, Vadim Pasyuga, Yuki Kotani, Giuseppe Biondi-Zoccai, Fabrizio D'Ascenzo, Enrico Romagnoli, Caetano Nigro Neto, Vinicius Tadeu Nogueira Da Silva Do Nascimento, Lian Kah Ti, Suraphong Lorsomradee, Ahmed Farag, Nazar Bukamal, Giulia Brizzi, Rosetta Lobreglio, Alessandro Belletti, Cristina Arangino, Gianluca Paternoster, Matteo Aldo Bonizzoni, Maria Teresa Tucciariello, Daniel Kroeller, Ambra Licia Di Prima, Lorenzo Filippo Mantovani, Valentina Ajello, Chiara Gerli, Sabrina Porta, Federica Ferrod, Giuseppe Giardina, Cristina Santonocito, Marco Ranucci, Rosalba Lembo, Antonio Pisano, Federica Morselli, Cristina Nakhnoukh, Alessandro Oriani, Marina Pieri, Anna Mara Scandroglio, Kaan Kırali, Valery Likhvantsev, Federico Longhini, Andrey Yavorovskiy, Rinaldo Bellomo, Giovanni Landoni, Alberto Zangrillo, Fabrizio Monacoet al.",2024 Aug:143:107605.,Contemp Clin Trials,https://pubmed.ncbi.nlm.nih.gov/38866095/,No keywords found,"['minimizing', 'use', 'of', 'blood', 'component', 'reduce', 'known', 'and', 'unknown', 'blood', 'transfusion', 'risk', ',', 'preserve', 'blood', 'bank', 'resource', ',', 'and', 'decrease', 'healthcare', 'cost', '.', 'red', 'blood', 'cell', '(', 'rbc', ')', 'transfusion', 'common', 'cardiac', 'surgery', 'and', 'associated', 'with', 'adverse', 'perioperative', 'outcome', ',', 'including', 'mortality', '.', 'acute', 'normovolemic', 'hemodilution', '(', 'anh', ')', 'may', 'reduce', 'bleeding', 'and', 'need', 'blood', 'product', 'transfusion', 'cardiac', 'surgery', '.', 'however', ',', 'blood-saving', 'effect', 'and', 'impact', 'major', 'outcome', 'remain', 'uncertain', '.', 'method', 'single-blinded', ',', 'multinational', ',', 'pragmatic', ',', 'randomized', 'controlled', 'trial', 'with', 'allocation', 'ratio', 'conducted', 'in', 'tertiary', 'and', 'university', 'hospital', '.', 'study', 'designed', 'to', 'enroll', 'patient', 'scheduled', 'elective', 'cardiac', 'surgery', 'with', 'planned', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'patient', 'randomized', 'to', 'receive', 'anh', 'cpb', 'or', 'best', 'available', 'treatment', 'without', 'anh', '.', 'identified', 'anh', 'volume', 'of', 'least', 'ml', 'critical', 'threshold', 'clinically', 'relevant', 'benefit', '.', 'larger', 'anh', 'volume', ',', 'however', ',', 'allowed', 'and', 'tailored', 'to', 'patient', ""'s"", 'characteristic', 'and', 'clinical', 'condition', '.', 'result', 'primary', 'outcome', 'percentage', 'of', 'patient', 'receiving', 'rbc', 'transfusion', 'randomization', 'hospital', 'discharge', ',', 'hypothesize', 'reduced', 'to', 'with', 'anh', '.', 'secondary', 'outcome', 'all-cause', '-day', 'mortality', ',', 'acute', 'kidney', 'injury', ',', 'bleeding', 'complication', ',', 'and', 'ischemic', 'complication', '.', 'conclusion', 'trial', 'designed', 'to', 'determine', 'whether', 'anh', 'safely', 'reduce', 'rbc', 'transfusion', 'elective', 'cardiac', 'surgery', 'with', 'cpb', '.', 'study', 'registration', 'trial', 'registered', 'clinicaltrials.gov', 'in', 'april', 'with', 'trial', 'identification', 'number', 'nct', '.']"
Peritoneal Dialysis vs Furosemide for Prevention of Fluid Overload in Infants After Cardiac Surgery: A Randomized Clinical Trial.,"David M Kwiatkowski, Stuart L Goldstein, David S Cooper, David P Nelson, David L S Morales, Catherine D Krawczeski, David M Kwiatkowskiet al.",2017 Apr 1,JAMA Pediatr,https://pubmed.ncbi.nlm.nih.gov/28241247/,No keywords found,"['fluid', 'overload', 'congenital', 'heart', 'surgery', 'frequent', 'and', 'major', 'cause', 'of', 'morbidity', 'and', 'mortality', 'among', 'infant', '.', 'many', 'program', 'adopted', 'use', 'of', 'peritoneal', 'dialysis', '(', 'pd', ')', 'fluid', 'management', 'however', ',', 'benefit', 'compared', 'with', 'of', 'traditional', 'diuretic', 'administration', 'unknown', '.', 'objective', 'to', 'determine', 'whether', 'infant', 'randomized', 'to', 'pd', 'v', 'furosemide', 'treatment', 'of', 'oliguria', 'higher', 'incidence', 'of', 'negative', 'fluid', 'balance', 'postoperative', 'day', ',', 'well', 'avoidance', 'of', 'fluid', 'overload', 'shorter', 'duration', 'of', 'mechanical', 'ventilation', ',', 'intensive', 'care', 'unit', 'stay', ',', 'and', 'inotrope', 'use', 'and', 'fewer', 'electrolyte', 'abnormality', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'single-center', ',', 'unblinded', ',', 'randomized', 'clinical', 'trial', 'compared', 'method', 'of', 'fluid', 'removal', 'cardiac', 'surgery', 'october', ',', ',', 'march', ',', ',', 'in', 'large', 'tertiary', 'pediatric', 'hospital', 'in', 'ohio', '.', 'parent', 'or', 'guardian', 'of', 'eligible', 'infant', '(', 'aged', 'month', ')', 'undergoing', 'cardiac', 'surgery', 'with', 'catheter', 'placement', 'pd', 'approached', 'inclusion', '.', 'no', 'patient', 'withdrawn', 'adverse', 'effect', '.', 'recruitment', 'powered', 'primary', 'outcome', ',', 'and', 'analysis', 'based', 'intention', 'to', 'treat', '.', 'patient', 'randomized', 'to', 'pd', 'hypothesized', 'to', 'superior', 'outcome', '.', 'intervention', 'infant', 'received', 'intravenous', 'furosemide', '(', 'mgkg', 'every', 'hour', ')', 'or', 'standardized', 'pd', 'regimen', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'end', 'point', 'incidence', 'of', 'negative', 'fluid', 'balance', 'postoperative', 'day', '.', 'secondary', 'end', 'point', 'included', 'incidence', 'of', 'fluid', 'overload', ',', 'duration', 'of', 'mechanical', 'ventilation', 'and', 'intensive', 'care', 'unit', 'stay', ',', 'electrolyte', 'abnormality', 'and', 'repletion', 'dos', ',', 'duration', 'of', 'inotropic', 'administration', ',', 'and', 'mortality', '.', 'result', 'seventy-three', 'patient', '(', 'boy', 'and', 'girl', 'median', 'age', ',', 'interquartile', 'range', '(', 'iqr', ')', ',', '-', 'day', ')', 'received', 'treatment', 'and', 'completed', 'trial', '.', 'no', 'difference', 'found', 'pd', 'and', 'furosemide', 'group', 'in', 'incidence', 'of', 'negative', 'fluid', 'balance', 'first', 'postoperative', 'day', '.', 'furosemide', 'group', 'time', 'likely', 'to', 'fluid', 'overload', '(', 'odds', 'ratio', 'or', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'likely', 'to', 'prolonged', 'ventilator', 'use', '(', 'or', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'and', 'longer', 'duration', 'of', 'inotrope', 'use', '(', 'median', ',', '.', 'iqr', ',', '-', 'v', '.', 'iqr', ',', '-', 'day', ')', 'and', 'higher', 'electrolyte', 'abnormality', 'score', '(', 'median', ',', 'iqr', ',', '-', 'v', 'iqr', ',', '-', ')', 'compared', 'with', 'pd', 'group', '.', 'no', 'statistically', 'significant', 'difference', 'in', 'mortality', '(', 'patient', '.', 'in', 'furosemide', 'group', 'v', 'patient', '.', 'in', 'pd', 'group', ')', 'or', 'length', 'of', 'cardiac', 'intensive', 'care', 'unit', '(', 'median', ',', 'iqr', ',', '-', 'v', 'iqr', ',', '-', 'day', ')', 'or', 'hospital', '(', 'iqr', ',', '-', 'v', 'iqr', ',', '-', 'day', ')', 'stay', 'observed', '.', 'no', 'serious', 'complication', 'observed', '.', 'dialysis', 'discontinued', 'early', 'in', 'of', 'patient', 'in', 'pd', 'group', 'pleural-peritoneal', 'communication', '.', 'conclusion', 'and', 'relevance', 'use', 'of', 'pd', 'safe', 'and', 'allows', 'superior', 'fluid', 'management', 'with', 'improved', 'clinical', 'outcome', 'compared', 'with', 'diuretic', 'administration', '.', 'use', 'of', 'pd', 'strongly', 'considered', 'among', 'infant', 'high', 'risk', 'postoperative', 'acute', 'kidney', 'injury', 'and', 'fluid', 'overload', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifer', 'nct', '.']"
Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.,"Sean M Bagshaw, Ary Serpa Neto, Orla Smith, Matthew Weir, Haibo Qiu, Bin Du, Amanda Y Wang, Martin Gallagher, Rinaldo Bellomo, Ron Wald                                                            ;, STARRT-AKI Investigators, Sean M Bagshawet al.",2022 Dec,Intensive Care Med,https://pubmed.ncbi.nlm.nih.gov/36331570/,No keywords found,"['to', 'assess', 'whether', 'pre-existing', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'modified', 'relationship', 'strategy', 'renal-replacement', 'theraphy', '(', 'rrt', ')', 'initiation', 'and', 'clinical', 'outcome', 'in', 'starrt-aki', 'trial', '.', 'method', 'secondary', 'analysis', 'of', 'multi-national', 'randomized', 'trial', '.', 'included', 'patient', 'documented', 'pre-existing', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'data', 'prior', 'to', 'hospitalization', ',', 'and', 'defined', 'ckd', 'egfr', 'mlmin', '.', 'm.', 'primary', 'outcome', 'all-cause', 'mortality', 'day', '.', 'secondary', 'outcome', 'included', 'rrt', 'dependence', 'and', 'rrt-free', 'day', 'day', '.', 'used', 'logistic', 'and', 'linear', 'regression', 'and', 'interaction', 'testing', 'to', 'explore', 'effect', 'of', 'rrt', 'initiation', 'strategy', 'outcome', 'ckd', 'status', '.', 'result', 'studied', 'patient', 'pre-hospital', 'measure', 'of', 'kidney', 'function', '.', 'of', ',', 'patient', '(', '.', ')', 'ckd', '.', 'median', '(', 'iqr', ')', 'baseline', 'serum', 'creatinine', '(', '-', ')', 'and', '(', '-', ')', 'moll', 'with', 'and', 'without', 'ckd', ',', 'respectively', '.', 'patient', 'with', 'ckd', 'older', 'and', 'likely', 'to', 'cardiovascular', 'comorbidities', 'and', 'diabetes', 'mellitus', '.', 'patient', 'with', 'ckd', 'higher', '-day', 'mortality', '(', 'vs.', ',', 'p', '.', ')', 'compared', 'to', 'without', 'ckd', ',', 'though', 'not', 'significant', 'covariate', 'adjustment', '(', 'adjusted', 'odds', 'ratio', 'aor', ',', '.', 'ci', ',', '.-.', ')', '.', 'patient', 'with', 'ckd', 'likely', 'to', 'remain', 'rrt', 'dependent', 'day', '(', 'vs.', 'aor', ',', '.', 'ci', ',', '.-.', ')', '.', 'ckd', 'status', 'not', 'modify', 'effect', 'of', 'rrt', 'initiation', 'strategy', '-day', 'mortality', '.', 'among', 'patient', 'with', 'ckd', ',', 'allocation', 'to', 'accelerated', 'strategy', 'conferred', 'threefold', 'greater', 'odds', 'of', 'rrt', 'dependence', 'day', '(', 'aor', '.', 'ci', ',', '.-', '.', ')', 'compared', 'with', 'standard', 'strategy', ',', 'whereas', 'rrt', 'initiation', 'strategy', 'no', 'effect', 'outcome', 'among', 'without', 'ckd', '(', 'aor', '.', 'ci', ',', '.-.', ',', 'p', 'value', 'interaction', ',', '.', ')', '.', 'conclusion', 'in', 'secondary', 'analysis', 'of', 'starrt-aki', 'trial', ',', 'accelerated', 'strategy', 'of', 'rrt', 'initiation', 'conferred', 'higher', 'risk', 'of', '-day', 'rrt', 'dependence', 'among', 'patient', 'with', 'pre-existing', 'ckd', 'however', ',', 'no', 'effect', 'observed', 'in', 'absence', 'of', 'ckd', '.']"
Performance and Safety of Transfemoral TAVI With SAPIEN XT in Australian Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: SOLACE-AU Trial.,"Gerald Yong, Tony Walton, Martin Ng, Ronen Gurvitch, Stephen Worthley, Robert Whitbourn, Nigel Jepson, Ravinay Bhindi, Kan Shang, Ajay Sinhal, Gerald Yonget al.",2020 Dec,Heart Lung Circ,https://pubmed.ncbi.nlm.nih.gov/32712017/,No keywords found,"['to', 'determine', 'safety', 'and', 'performance', 'of', 'sapien', 'xt', 'transcatheter', 'heart', 'valve', '(', 'thv', ')', 'in', 'australian', 'patient', 'with', 'severe', 'aortic', 'stenosis', '(', ')', 'and', 'intermediate', 'surgical', 'risk', '.', 'method', 'eligible', 'patient', 'in', 'multi-centre', ',', 'prospective', ',', 'consecutively', 'enrolled', ',', 'non-randomised', ',', 'clinical', 'trial', ',', 'received', 'transcatheter', 'aortic', 'valve', 'replacement', 'via', 'femoral', 'artery', 'access', '.', 'follow-up', 'visit', 'discharge', ',', 'day', ',', 'and', ',', ',', 'and', 'month', '.', 'primary', 'endpoint', 'valve', 'academic', 'research', 'consortium-', 'composite', 'safety', 'day', 'all-cause', 'mortality', ',', 'stroke', ',', 'life-threatening', 'bleeding', ',', 'acute', 'kidney', 'injury-stage', ',', 'coronary', 'artery', 'obstruction', 'requiring', 'intervention', ',', 'major', 'vascular', 'complication', ',', 'and', 'valve-related', 'dysfunction', 'requiring', 'repeat', 'procedure', '.', 'endpoint', 'device', 'success', '(', 'successful', 'vascular', 'access', ',', 'delivery', ',', 'and', 'deployment', 'correct', 'position', 'intended', 'performance', 'mean', 'aortic', 'valve', 'gradient', 'mmhg', ',', 'mild', 'or', 'less', 'paravalvular', 'aortic', 'regurgitation', 'par', 'and', 'one', 'valve', 'implanted', ')', 'and', 'new', 'york', 'heart', 'association', 'functional', 'class', '(', 'nyha', ')', '.', 'kaplan-meier', '(', 'km', ')', 'estimate', 'calculated', 'primary', 'endpoint', '.', 'result', 'baseline', ',', 'mean', 'patient', '(', 'n', ')', 'age', '.', 'year', ',', 'mean', 'society', 'of', 'thoracic', 'surgeon', 'score', '.', ',', 'and', '.', 'in', 'nyha', 'class', 'iiiiv', '.', 'primary', 'composite', 'endpoint', 'km', 'estimate', '..', 'device', 'success', '..', 'sapien', 'xt', 'implanted', 'in', 'proper', 'location', 'in', '.', '(', 'n', 'valve-in-valve', 'procedure', ',', 'n', 'no', 'implant', 'due', 'to', 'left', 'main', 'coronary', 'artery', 'occlusion', ')', '.', 'no', 'device', 'malfunction', 'reported', '.', 'post', 'procedure', 'par', 'mild', 'or', 'less', 'in', '.', 'of', 'patient', '.', 'mean', 'aortic', 'gradient', 'decreased', 'baseline', '(', '.', 'mmhg', ')', 'to', 'year', '(', '.', 'mmhg', ')', '.', 'patient', '(', '.', ')', 'in', 'nyha', 'class', 'iii', 'day', '.', 'new', 'permanent', 'pacemaker', 'rate', '..', 'stroke', 'day', '.', '(', '.', 'disabling', ')', '.', 'conclusion', 'sapien', 'xt', 'safe', 'and', 'improved', 'heart', 'failure', 'symptom', 'and', 'valve', 'haemodynamics', 'in', 'cohort', 'of', 'australian', 'patient', '.']"
"The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device.","Heather Lambert, Shaun Hiu, Malcolm G Coulthard, John N S Matthews, Eva-Maria Holstein, Jean Crosier, Rachel Agbeko, Thomas Brick, Heather Duncan, David Grant, Quen Mok, Andrew Gustaf Nyman, John Pappachan, Chris Boucher, Joe Bulmer, Denise Chisholm, Kirsten Cromie, Victoria Emmet, Richard G Feltbower, Arunoday Ghose, Michael Grayling, Rebecca Harrison, Ciara A Kennedy, Elaine McColl, Kevin Morris, Lee Norman, Julie Office, Roger Parslow, Christine Pattinson, Shriya Sharma, Jonathan Smith, Alison Steel, Rachel Steel, Jayne Straker, Lamprini Vrana, Jenn Walker, Paul Wellman, Mike Whitaker, Jim Wightman, Nina Wilson, Lucy Wirz, Ruth Wood, Heather Lambertet al.",2023 Jul 1,Pediatr Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/36892305/,No keywords found,"['renal', 'replacement', 'therapy', '(', 'rrt', ')', 'option', 'limited', 'small', 'baby', 'of', 'lack', 'of', 'available', 'technology', '.', 'investigated', 'precision', 'of', 'ultrafiltration', ',', 'biochemical', 'clearance', ',', 'clinical', 'efficacy', ',', 'outcome', ',', 'and', 'safety', 'profile', 'novel', 'non-conformit', 'europenne-marked', 'hemodialysis', 'device', 'baby', 'kg', ',', 'newcastle', 'infant', 'dialysis', 'ultrafiltration', 'system', '(', 'nidus', ')', ',', 'compared', 'with', 'current', 'option', 'of', 'peritoneal', 'dialysis', '(', 'pd', ')', 'or', 'continuous', 'venovenous', 'hemofiltration', '(', 'cvvh', ')', '.', 'design', 'nonblinded', 'cluster-randomized', 'cross-sectional', 'stepped-wedge', 'design', 'with', 'four', 'period', ',', 'three', 'sequence', ',', 'and', 'two', 'cluster', 'per', 'sequence', '.', 'setting', 'cluster', 'six', 'u.k.', 'picus', '.', 'patient', 'baby', 'less', 'kg', 'requiring', 'rrt', 'fluid', 'overload', 'or', 'biochemical', 'disturbance', '.', 'intervention', 'in', 'control', ',', 'rrt', 'delivered', 'pd', 'or', 'cvvh', ',', 'and', 'in', 'intervention', ',', 'nidus', 'used', '.', 'primary', 'outcome', 'precision', 'of', 'ultrafiltration', 'compared', 'with', 'prescription', 'secondary', 'outcome', 'included', 'biochemical', 'clearance', '.', 'measurement', 'and', 'main', 'result', 'closure', ',', 'participant', 'recruited', 'six', 'picus', '(', 'control', 'and', 'intervention', ')', '.', 'primary', 'outcome', ',', 'obtained', 'control', 'and', 'intervention', 'patient', ',', 'showed', 'ultrafiltration', 'with', 'nidus', 'closer', 'to', 'prescribed', 'with', 'control', 'sd', 'control', ',', '.', ',', 'intervention', ',', '.', '(', 'mlhr', ')', 'adjusted', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '..', 'creatinine', 'clearance', 'smallest', 'and', 'least', 'variable', 'pd', '(', 'mean', ',', 'sd', ')', '(', '.', ',', '.', ')', 'mlminkg', ',', 'larger', 'nidus', '(', '.', ',', '.', ')', ',', 'and', 'largest', 'cvvh', '(', '.', ',', '.', ')', '.', 'adverse', 'event', 'reported', 'in', 'group', '.', 'in', 'critically', 'ill', 'population', 'with', 'multiple', 'organ', 'failure', ',', 'mortality', 'lowest', 'pd', 'and', 'highest', 'cvvh', ',', 'with', 'nidus', 'in', '.', 'conclusion', 'nidus', 'delivers', 'accurate', ',', 'controllable', 'fluid', 'removal', 'and', 'adequate', 'clearance', ',', 'indicating', 'important', 'potential', 'alongside', 'modality', 'infant', 'rrt', '.']"
"The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device.","Heather Lambert, Shaun Hiu, Malcolm G Coulthard, John N S Matthews, Eva-Maria Holstein, Jean Crosier, Rachel Agbeko, Thomas Brick, Heather Duncan, David Grant, Quen Mok, Andrew Gustaf Nyman, John Pappachan, Chris Boucher, Joe Bulmer, Denise Chisholm, Kirsten Cromie, Victoria Emmet, Richard G Feltbower, Arunoday Ghose, Michael Grayling, Rebecca Harrison, Ciara A Kennedy, Elaine McColl, Kevin Morris, Lee Norman, Julie Office, Roger Parslow, Christine Pattinson, Shriya Sharma, Jonathan Smith, Alison Steel, Rachel Steel, Jayne Straker, Lamprini Vrana, Jenn Walker, Paul Wellman, Mike Whitaker, Jim Wightman, Nina Wilson, Lucy Wirz, Ruth Wood, Heather Lambertet al.",2023 Jul 1,Pediatr Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/36892305/,No keywords found,"['renal', 'replacement', 'therapy', '(', 'rrt', ')', 'option', 'limited', 'small', 'baby', 'of', 'lack', 'of', 'available', 'technology', '.', 'investigated', 'precision', 'of', 'ultrafiltration', ',', 'biochemical', 'clearance', ',', 'clinical', 'efficacy', ',', 'outcome', ',', 'and', 'safety', 'profile', 'novel', 'non-conformit', 'europenne-marked', 'hemodialysis', 'device', 'baby', 'kg', ',', 'newcastle', 'infant', 'dialysis', 'ultrafiltration', 'system', '(', 'nidus', ')', ',', 'compared', 'with', 'current', 'option', 'of', 'peritoneal', 'dialysis', '(', 'pd', ')', 'or', 'continuous', 'venovenous', 'hemofiltration', '(', 'cvvh', ')', '.', 'design', 'nonblinded', 'cluster-randomized', 'cross-sectional', 'stepped-wedge', 'design', 'with', 'four', 'period', ',', 'three', 'sequence', ',', 'and', 'two', 'cluster', 'per', 'sequence', '.', 'setting', 'cluster', 'six', 'u.k.', 'picus', '.', 'patient', 'baby', 'less', 'kg', 'requiring', 'rrt', 'fluid', 'overload', 'or', 'biochemical', 'disturbance', '.', 'intervention', 'in', 'control', ',', 'rrt', 'delivered', 'pd', 'or', 'cvvh', ',', 'and', 'in', 'intervention', ',', 'nidus', 'used', '.', 'primary', 'outcome', 'precision', 'of', 'ultrafiltration', 'compared', 'with', 'prescription', 'secondary', 'outcome', 'included', 'biochemical', 'clearance', '.', 'measurement', 'and', 'main', 'result', 'closure', ',', 'participant', 'recruited', 'six', 'picus', '(', 'control', 'and', 'intervention', ')', '.', 'primary', 'outcome', ',', 'obtained', 'control', 'and', 'intervention', 'patient', ',', 'showed', 'ultrafiltration', 'with', 'nidus', 'closer', 'to', 'prescribed', 'with', 'control', 'sd', 'control', ',', '.', ',', 'intervention', ',', '.', '(', 'mlhr', ')', 'adjusted', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '..', 'creatinine', 'clearance', 'smallest', 'and', 'least', 'variable', 'pd', '(', 'mean', ',', 'sd', ')', '(', '.', ',', '.', ')', 'mlminkg', ',', 'larger', 'nidus', '(', '.', ',', '.', ')', ',', 'and', 'largest', 'cvvh', '(', '.', ',', '.', ')', '.', 'adverse', 'event', 'reported', 'in', 'group', '.', 'in', 'critically', 'ill', 'population', 'with', 'multiple', 'organ', 'failure', ',', 'mortality', 'lowest', 'pd', 'and', 'highest', 'cvvh', ',', 'with', 'nidus', 'in', '.', 'conclusion', 'nidus', 'delivers', 'accurate', ',', 'controllable', 'fluid', 'removal', 'and', 'adequate', 'clearance', ',', 'indicating', 'important', 'potential', 'alongside', 'modality', 'infant', 'rrt', '.']"
MicroRNA-21 in glomerular injury.,"Jennifer Y Lai, Jinghui Luo, Christopher O'Connor, Xiaohong Jing, Viji Nair, Wenjun Ju, Ann Randolph, Iddo Z Ben-Dov, Regina N Matar, Daniel Briskin, Jiri Zavadil, Robert G Nelson, Thomas Tuschl, Frank C Brosius rd, Matthias Kretzler, Markus Bitzer, Jennifer Y Laiet al.",2015 Apr,J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/25145934/,"TGF-β, cell survival, diabetic glomerulopathy, molecular biology, podocyte.","['tgf-', '(', ')', 'pleotropic', 'growth', 'factor', 'mediates', 'glomerulosclerosis', 'and', 'podocyte', 'apoptosis', ',', 'hallmark', 'of', 'glomerular', 'disease', '.', 'expression', 'of', 'microrna-', '(', 'mir-', ')', 'regulated', 'tgf-', '(', ')', ',', 'and', 'mir-', 'inhibits', 'apoptosis', 'in', 'cancer', 'cell', '.', 'tgf-', '(', ')', '-transgenic', 'mouse', 'exhibit', 'accelerated', 'podocyte', 'loss', 'and', 'glomerulosclerosis', '.', 'determined', 'mir-', 'expression', 'increase', 'rapidly', 'in', 'cultured', 'murine', 'podocytes', 'exposure', 'to', 'tgf-', '(', ')', 'and', 'higher', 'in', 'kidney', 'of', 'tgf-', '(', ')', '-transgenic', 'mouse', 'wild-type', 'mouse', '.', 'mir', '--', 'deficient', 'tgf-', '(', ')', '-transgenic', 'mouse', 'showed', 'increased', 'proteinuria', 'and', 'glomerular', 'extracellular', 'matrix', 'deposition', 'and', 'fewer', 'podocytes', 'per', 'glomerular', 'tuft', 'compared', 'with', 'mir-', 'wild-type', 'tgf-', '(', ')', '-transgenic', 'littermates', '.', 'similarly', ',', 'mir-', 'expression', 'increased', 'in', 'streptozotocin-induced', 'diabetic', 'mouse', ',', 'and', 'loss', 'of', 'mir-', 'in', 'mouse', 'associated', 'with', 'increased', 'albuminuria', ',', 'podocyte', 'depletion', ',', 'and', 'mesangial', 'expansion', '.', 'in', 'cultured', 'podocytes', ',', 'inhibition', 'of', 'mir-', 'accompanied', 'increase', 'in', 'rate', 'of', 'cell', 'death', ',', 'tgf-smad-signaling', 'activity', ',', 'and', 'expression', 'of', 'known', 'proapoptotic', 'mir-', 'target', 'gene', 'p', ',', 'pdcd', ',', 'smad', ',', 'tgfbr', ',', 'and', 'timp', '.', 'in', 'american-indian', 'patient', 'with', 'diabetic', 'nephropathy', '(', 'n', ')', ',', 'albumin-to-creatinine', 'ratio', 'positively', 'associated', 'with', 'mir-', 'expression', 'in', 'glomerular', 'fraction', '(', 'r.', 'p.', ')', 'not', 'tubulointerstitial', 'fraction', '(', 'p.', ')', '.', 'finding', 'suggest', 'mir-', 'ameliorates', 'tgf-', '(', ')', 'and', 'hyperglycemia-induced', 'glomerular', 'injury', 'repression', 'of', 'proapoptotic', 'signal', ',', 'thereby', 'inhibiting', 'podocyte', 'loss', '.', 'finding', 'in', 'contrast', 'to', 'observation', 'in', 'murine', 'model', 'of', 'tubulointerstitial', 'kidney', 'injury', 'consistent', 'with', 'finding', 'in', 'cancer', 'model', '.', 'aggravation', 'of', 'glomerular', 'disease', 'in', 'mir', '--', 'deficient', 'mouse', 'and', 'positive', 'association', 'with', 'albumin-to-creatinine', 'ratio', 'in', 'patient', 'with', 'diabetic', 'nephropathy', 'support', 'mir-', 'feedback', 'inhibitor', 'of', 'tgf-', 'signaling', 'and', 'function', '.']"
Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation.,"Benjamin L Laskin, Edward Nehus, Jens Goebel, Susan Furth, Stella M Davies, Sonata Jodele, Benjamin L Laskinet al.",2014 Dec,Biol Blood Marrow Transplant,https://pubmed.ncbi.nlm.nih.gov/25038395/,"Cystatin C, Kidney function, Pediatrics, Transplant.","['accurate', 'assessment', 'of', 'kidney', 'function', 'hematopoietic', 'cell', 'transplantation', '(', 'hct', ')', 'help', 'to', 'properly', 'dose', 'conditioning', 'chemotherapy', 'and', 'follow', 'patient', 'development', 'of', 'chronic', 'kidney', 'disease', '.', 'cross-sectionally', 'examined', 'child', 'and', 'young', 'adult', 'hct', 'to', 'compare', 'formal', 'nuclear', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'testing', 'with', 'estimated', 'gfr', 'using', 'creatinine', 'and', 'cystatin', 'c-based', 'equation', ',', 'including', 'original', 'schwartz', 'formula', 'and', 'recent', 'formula', 'developed', 'in', 'chronic', 'kidney', 'disease', 'in', 'child', '(', 'ckid', ')', 'cohort', '.', 'median', 'age', 'of', 'cohort', '.', 'year', '(', 'range', ',', '.', 'to', '.', 'year', ')', '.', 'mean', 'cohort', 'nuclear', 'gfr', '.', '.', 'mlmin', '.', '(', ')', ',', 'with', 'of', 'subject', '(', '.', ')', 'abnormal', 'kidney', 'function', '(', 'gfr', 'mlmin', '.', '(', ')', ')', 'hct', '.', 'creatinine-based', 'original', 'schwartz', 'and', 'bedside', 'ckid', 'formula', 'showed', 'significant', 'bias', ',', 'overestimating', 'nuclear', 'gfr', '.', '(', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', 'and', '.', '(', 'ci', ',', '.', 'to', '.', ')', 'mlmin', '.', '(', ')', ',', 'respectively', '.', 'cystatin', 'c', 'formula', 'less', 'mean', 'bias', 'and', 'improved', 'accuracy', 'also', 'decreased', 'sensitivity', 'to', 'detect', 'abnormal', 'kidney', 'function', 'hct', '.', 'full', 'ckid', 'equation', 'showed', 'best', 'performance', ',', 'with', 'mean', 'bias', 'of', '-', '.', 'mlmin', '.', '(', ')', '(', 'ci', ',', '-', '.', 'to', '.', ')', 'not', 'significantly', 'different', 'measured', 'value', 'and', '.', 'of', 'estimate', 'within', 'of', 'nuclear', 'gfr', '.', 'although', 'recent', 'bedside', 'ckid', 'formula', 'performed', 'better', 'original', 'schwartz', 'formula', ',', 'formula', 'poor', 'sensitivity', 'detecting', 'low', 'gfr', '.', 'abnormal', 'pretransplant', 'nuclear', 'gfr', 'not', 'associated', 'with', 'post-hct', 'acute', 'kidney', 'injury', ',', 'need', 'dialysis', ',', 'or', 'death', 'in', 'first', 'day', '.', 'in', 'conclusion', ',', 'observed', 'cystatin', 'c-based', 'equation', 'outperformed', 'creatinine-based', 'equation', 'in', 'estimating', 'gfr', 'in', 'child', 'hct', '.', 'however', ',', 'formula', 'decreased', 'sensitivity', 'to', 'detect', 'impaired', 'gfr', '.', 'formal', 'measurement', 'of', 'kidney', 'function', 'considered', 'in', 'child', 'and', 'young', 'adult', 'need', 'accurate', 'assessment', 'of', 'kidney', 'function', 'hct', '.']"
Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.,"Carlo Briguori, Roy O Mathew, Zhen Huang, Kreton Mavromatis, LaTonya J Hickson, Wei Ling Lau, Anoop Mathew, Sandeep Mahajan, David C Wheeler, Kathleen J Claes, Gang Chen, Fernando E B Nolasco, Gregg W Stone, Jerome L Fleg, Mandeep S Sidhu, Frank W Rockhold, Glenn M Chertow, Judith S Hochman, David J Maron, Sripal Bangalore, Carlo Briguoriet al.",2022 Mar 15,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/35261290/,"chronic coronary disease, chronic kidney disease, dialysis, guideline‐directed medical therapy.","['httpswww.clinicaltrials.gov', 'unique', 'identifier', 'nct', '.']"
Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock--a biomarker substudy of the IABP-SHOCK II-Trial.,"Janine Pöss, Georg Fuernau, Daniel Denks, Steffen Desch, Ingo Eitel, Suzanne de Waha, Andreas Link, Gerhard Schuler, Volker Adams, Michael Böhm, Holger Thiele, Janine Pösset al.",2015 Nov,Eur J Heart Fail,https://pubmed.ncbi.nlm.nih.gov/26333723/,No keywords found,"['angiopoietin-', '(', 'ang-', ')', 'mediator', 'of', 'capillary', 'leakage', ',', 'and', 'increased', 'ang-', 'level', 'associated', 'with', 'poor', 'in-hospital', 'outcome', 'in', 'pilot', 'study', 'in', 'cardiogenic', 'shock', '(', 'c', ')', '.', 'in', 'larger', 'study', ',', 'followed', 'hypothesis', 'and', 'aimed', 'assessing', 'predictive', 'role', 'of', 'ang-', 'short-', 'and', 'long-term', 'mortality', ',', 'investigating', 'effect', 'of', 'intra-aortic', 'balloon', 'pump', '(', 'iabp', ')', 'treatment', 'ang-', 'level', ',', 'and', 'identifying', 'clinical', 'and', 'procedural', 'predictor', 'of', 'increased', 'ang-', '.', 'method', 'and', 'result', 'in', 'iabp-shock', 'ii-trial', ',', 'patient', 'with', 'c', 'complicating', 'acute', 'myocardial', 'infarction', 'assigned', 'to', 'therapy', 'with', 'or', 'without', 'iabp', '.', 'substudy', 'included', 'randomized', 'patient', 'with', 'serial', 'blood', 'sampling', 'performed', 'day', ',', ',', 'and', '.', 'no', 'significant', 'difference', 'in', 'ang-', 'level', 'found', 'patient', 'with', 'or', 'without', 'iabp', '.', 'ang-', 'level', 'median', 'day', 'associated', 'with', '-day', 'hazard', 'ratio', '(', 'hr', ')', '.', ',', 'confidence', 'interval', '(', 'ci', ')', '.-.', ',', 'p', '.', ')', 'and', '-year', 'mortality', '(', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'stratification', 'of', 'patient', 'according', 'to', 'ang-', 'level', 'day', 'increased', 'association', '(', 'day', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', 'year', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'ang-', 'concentration', 'independent', 'predictor', 'mortality', 'in', 'multivariate', 'analysis', '(', 'day', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', 'year', 'hr', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'predictor', 'of', 'increased', 'ang-', 'level', 'day', 'baseline', 'ang-', ',', 'development', 'of', 'acute', 'kidney', 'injury', ',', 'bleeding', 'event', 'or', 'transfusion', ',', 'and', 'impaired', 'reperfusion', '.', 'conclusion', 'in', 'c', ',', 'high', 'level', 'of', 'ang-', 'independently', 'associated', 'with', 'poor', 'short-', 'and', 'long-term', 'outcome', 'and', 'associated', 'with', 'reperfusion', 'success', 'well', 'complication', '.', 'clinical', 'trial', 'registration', 'url', 'www.clinicaltrials.gov', 'unique', 'identifier', 'nct', '.']"
Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial.,"Kamel Mohammedi, Sibylle Hess, Matthew McQueen, Marie Pigeyre, Shun Fu Lee, Guillaume Pare, Hertzel C Gerstein, Kamel Mohammediet al.",2024 Aug,Diabetes Obes Metab,https://pubmed.ncbi.nlm.nih.gov/38747213/,No keywords found,"['to', 'assess', 'clinical', 'and', 'biochemical', 'measurement', 'identify', 'people', 'with', 'dysglycaemia', '(', 'i.e', '.', 'diabetes', 'or', 'pre-diabetes', ')', 'remain', 'free', 'of', 'serious', 'outcome', 'follow-up', '.', 'material', 'and', 'method', 'conducted', 'exploratory', 'analysis', 'using', 'data', 'outcome', 'reduction', 'with', 'initial', 'glargine', 'intervention', '(', 'origin', ')', 'study', 'to', 'identify', 'independent', 'determinant', 'of', 'outcome-free', 'status', 'in', 'middle-aged', 'and', 'older', 'adult', 'with', 'prediabetes', 'and', 'early', 'type', 'diabetes', 'country', '.', 'serious', 'outcome-free', 'status', 'defined', 'absence', 'of', 'major', 'cardiovascular', 'outcome', ',', 'kidney', 'or', 'retinal', 'outcome', ',', 'peripheral', 'artery', 'disease', ',', 'dementia', ',', 'cancer', ',', 'hospitalization', ',', 'or', 'death', 'follow-up', '.', 'result', 'in', 'total', ',', '(', '.', ')', 'participant', 'remained', 'free', 'of', 'serious', 'outcome', 'median', 'follow-up', 'of', '.', 'year', '(', 'iqr', '.', ',', '.', ')', '.', 'independent', 'clinical', 'determinant', 'of', 'outcome-free', 'status', 'included', 'younger', 'age', ',', 'female', 'sex', ',', 'non-white', 'ethnicity', ',', 'shorter', 'diabetes', 'duration', ',', 'absence', 'of', 'previous', 'cardiovascular', 'disease', ',', 'current', 'or', 'former', 'smoker', ',', 'higher', 'grip', 'strength', ',', 'mini-mental', 'state', 'examination', 'score', ',', 'and', 'ankle-brachial', 'index', ',', 'lower', 'body', 'mass', 'index', 'and', 'kidney', 'disease', 'index', ',', 'and', 'non-use', 'of', 'renin-angiotensin', 'system', 'drug', 'and', 'beta-blockers', '.', 'in', 'subset', 'of', 'people', 'with', 'baseline', 'measurement', 'of', 'biomarkers', ',', 'growth', 'differentiation', 'factor', ',', 'kidney', 'injury', 'molecule-', ',', 'n-terminal', 'pro-brain', 'natriuretic', 'peptide', ',', 'uromodulin', ',', 'c-reactive', 'protein', ',', 'factor', 'vii', 'and', 'ferritin', 'independent', 'determinant', '.', 'combination', 'of', 'clinical', 'determinant', 'and', 'biomarkers', 'best', 'identified', 'participant', 'remained', 'outcome-free', '(', 'c-statistics', '.', ',', 'confidence', 'interval', '.-', '.', 'net', 'reclassification', 'improvement', '.', ',', 'confidence', 'interval', '.-.', ')', '.', 'conclusion', 'set', 'of', 'routinely', 'measured', 'clinical', 'characteristic', 'and', 'seven', 'protein', 'biomarkers', 'identify', 'middle-aged', 'and', 'older', 'people', 'with', 'prediabetes', 'or', 'early', 'type', 'diabetes', 'least', 'likely', 'to', 'experience', 'serious', 'outcome', 'follow-up', '.']"
"A Comparison of High and Usual Protein Dosing in Critically Ill Patients With Obesity: A Post Hoc Analysis of an International, Pragmatic, Single-Blinded, Randomized Clinical Trial.","Lauren E Tweel, Charlene Compher, Danielle E Bear, Pedro Gutierrez-Castrellon, Susannah K Leaver, Kristen MacEachern, Luis Ortiz-Reyes, Lakhani Pooja, Angélica León, Courtney Wedemire, Zheng Yii Lee, Andrew G Day, Daren K Heyland, Lauren E Tweelet al.",2024 Apr 1,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/37930244/,No keywords found,"['across', 'guideline', ',', 'protein', 'dosing', 'critically', 'ill', 'patient', 'with', 'obesity', 'varies', 'considerably', '.', 'objective', 'of', 'analysis', 'to', 'evaluate', 'whether', 'population', 'would', 'benefit', 'higher', 'dos', 'of', 'protein', '.', 'design', 'post', 'hoc', 'subgroup', 'analysis', 'of', 'effect', 'of', 'higher', 'protein', 'dosing', 'in', 'critically', 'ill', 'patient', 'with', 'high', 'nutritional', 'risk', '(', 'effort', 'protein', ')', 'international', ',', 'multicenter', ',', 'pragmatic', ',', 'registry-based', 'randomized', 'trial', '.', 'setting', 'eighty-five', 'adult', 'icu', 'across', 'country', '.', 'patient', 'patient', 'with', 'obesity', 'defined', 'body', 'mass', 'index', '(', 'bmi', ')', 'greater', 'or', 'equal', 'to', 'kgm', '(', 'n', ')', '.', 'intervention', 'in', 'primary', 'study', ',', 'patient', 'randomized', 'high-dose', '(', '.', 'gkgd', ')', 'or', 'usual-dose', 'protein', 'group', '(', '.', 'gkgd', ')', '.', 'measurement', 'and', 'main', 'result', 'protein', 'intake', 'monitored', 'to', 'day', ',', 'and', 'outcome', '(', 'time', 'to', 'discharge', 'alive', 'ttda', ',', '-d', 'mortality', ',', 'day', 'of', 'mechanical', 'ventilation', 'mv', ',', 'hospital', ',', 'and', 'icu', 'length', 'of', 'stay', 'los', ')', 'recorded', 'day', 'post-randomization', '.', 'of', 'patient', 'in', 'primary', 'study', ',', 'bmi', 'greater', 'or', 'equal', 'to', 'kgm', '.', 'adjusting', 'site', 'and', 'covariates', ',', 'observed', 'nonsignificant', 'slower', 'rate', 'of', 'ttda', 'with', 'higher', 'protein', 'ruled', 'clinically', 'important', 'benefit', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'found', 'no', 'evidence', 'of', 'difference', 'in', 'ttda', 'protein', 'group', 'subgroup', 'with', 'different', 'class', 'of', 'obesity', 'or', 'patient', 'with', 'and', 'without', 'various', 'nutritional', 'and', 'frailty', 'risk', 'variable', 'examined', ',', 'even', 'removal', 'of', 'patient', 'with', 'baseline', 'acute', 'kidney', 'injury', '.', 'overall', ',', '-day', 'mortality', 'rate', '.', 'and', '.', 'in', 'high', 'protein', 'and', 'usual', 'protein', 'group', ',', 'respectively', '(', 'risk', 'difference', ',', '.', 'ci', ',', '-', '.', 'to', '.', 'p', '.', ')', '.', 'duration', 'of', 'mv', 'and', 'los', 'in', 'hospital', 'and', 'icu', 'not', 'significantly', 'different', 'group', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'with', 'obesity', ',', 'higher', 'protein', 'dos', 'not', 'improve', 'clinical', 'outcome', ',', 'including', 'with', 'higher', 'nutritional', 'and', 'frailty', 'risk', '.']"
Cohort profile of PLUTO: a perioperative biobank focusing on prediction and early diagnosis of postoperative complications.,"Nikki de Mul, Diede Verlaan, Jelle P Ruurda, Wilhelmina M U van Grevenstein, Jeroen Hagendoorn, Gert-Jan de Borst, Menno R Vriens, Remco de Bree, Ronald P Zweemer, Charles Vogely, Jelle L G Haitsma Mulier, Lisette M Vernooij, Johannes B Reitsma, Marcel R de Zoete, Janetta Top, Jan A J Kluijtmans, Imo E Hoefer, Peter Noordzij, Thijs Rettig, Marije Marsman, Anne Marie G A de Smet, Lennie Derde, Judith van Waes, Mienke Rijsdijk, Willem Jan M Schellekens, Marc J M Bonten, Arjen J C Slooter, Olaf L Cremer, Nikki de Mulet al.",2023 Apr 19,BMJ Open,https://pubmed.ncbi.nlm.nih.gov/37076142/,No keywords found,"['although', 'elective', 'surgery', 'generally', 'safe', ',', 'procedure', 'remain', 'associated', 'with', 'increased', 'risk', 'of', 'complication', '.', 'improved', 'preoperative', 'risk', 'stratification', 'and', 'earlier', 'recognition', 'of', 'complication', 'may', 'ameliorate', 'postoperative', 'recovery', 'and', 'improve', 'long-term', 'outcome', '.', 'perioperative', 'longitudinal', 'study', 'of', 'complication', 'and', 'long-term', 'outcome', '(', 'pluto', ')', 'cohort', 'aim', 'to', 'establish', 'comprehensive', 'biorepository', 'facilitate', 'research', 'in', 'field', '.', 'in', 'profile', 'paper', ',', 'discus', 'design', 'rationale', 'and', 'opportunity', 'future', 'study', '.', 'participant', 'patient', 'undergoing', 'elective', 'intermediate', 'to', 'high-risk', 'non-cardiac', 'surgery', 'eligible', 'enrolment', '.', 'first', 'seven', 'postoperative', 'day', ',', 'participant', 'subjected', 'to', 'daily', 'bedside', 'visit', 'dedicated', 'observer', ',', 'adjudicate', 'clinical', 'event', 'and', 'perform', 'non-invasive', 'physiological', 'measurement', '(', 'including', 'handheld', 'spirometry', 'and', 'single-channel', 'electroencephalography', ')', '.', 'blood', 'sample', 'and', 'microbiome', 'specimen', 'collected', 'preselected', 'time', 'point', '.', 'primary', 'study', 'outcome', 'postoperative', 'occurrence', 'of', 'nosocomial', 'infection', ',', 'major', 'adverse', 'cardiac', 'event', ',', 'pulmonary', 'complication', ',', 'acute', 'kidney', 'injury', 'and', 'deliriumacute', 'encephalopathy', '.', 'secondary', 'outcome', 'include', 'mortality', 'and', 'quality', 'of', 'life', ',', 'well', 'long-term', 'occurrence', 'of', 'psychopathology', ',', 'cognitive', 'dysfunction', 'and', 'chronic', 'pain', '.', 'finding', 'to', 'date', 'enrolment', 'of', 'first', 'participant', 'occurred', 'early', '.', 'inception', 'phase', 'of', 'project', '(', 'first', 'year', ')', ',', 'patient', 'eligible', 'of', 'patient', 'consented', 'to', 'participate', '(', ')', '.', 'observed', 'event', 'rate', 'overall', ',', 'with', 'frequent', 'complication', 'infection', '.', 'future', 'plan', 'main', 'purpose', 'of', 'pluto', 'biorepository', 'to', 'provide', 'framework', 'research', 'in', 'field', 'of', 'perioperative', 'medicine', 'and', 'anaesthesiology', ',', 'storing', 'high-quality', 'clinical', 'data', 'and', 'biomaterials', 'future', 'study', '.', 'in', 'addition', ',', 'pluto', 'aim', 'to', 'establish', 'logistical', 'platform', 'conducting', 'embedded', 'clinical', 'trial', '.', 'trial', 'registration', 'number', 'nct', '.']"
Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial.,"Xijun Yang, Mao Chai, Lingfang Xia, Zhiyong He, Xiaohua Wu, Jun Zhang, Xijun Yanget al.",2023 Jul,Acta Obstet Gynecol Scand,https://pubmed.ncbi.nlm.nih.gov/37029431/,No keywords found,"['tranexamic', 'acid', 'reduces', 'blood', 'loss', 'and', 'allogeneic', 'transfusion', 'requirement', 'in', 'various', 'surgical', 'procedure', '.', 'role', 'of', 'tranexamic', 'acid', 'cytoreductive', 'procedure', 'in', 'advanced', 'ovarian', 'cancer', 'not', 'clear', '.', 'material', 'and', 'method', 'single', 'center', 'randomized', ',', 'controlled', ',', 'three-armed', 'clinical', 'trial', '.', 'total', 'of', 'ovarian', 'cancer', 'patient', 'undergoing', 'cytoreductive', 'surgery', 'recruited', 'and', 'assigned', 'to', 'three', 'group', '(', 'n', 'group', ')', 'control', 'group', '(', 'normal', 'saline', ')', ',', 'low-dose', 'group', '(', 'mgkg', 'bolus', 'mgkg', 'continuous', 'infusion', 'of', 'tranexamic', 'acid', ')', ',', 'and', 'high-dose', 'group', '(', 'mgkg', 'bolus', 'mgkg', 'continuous', 'infusion', 'of', 'tranexamic', 'acid', ')', '.', 'primary', 'endpoint', 'intraoperative', 'blood', 'loss', 'volume', 'and', 'total', 'blood', 'loss', 'volume', ',', 'and', 'secondary', 'endpoint', 'included', 'intraoperative', 'blood', 'transfusion', 'volume', ',', 'vasoactive', 'agent', 'consumption', ',', 'admission', 'intensive', 'care', 'unit', ',', 'and', 'incidence', 'of', 'postoperative', 'complication', 'within', 'postoperative', 'day', '.', 'study', 'registered', 'clinicaltrials.gov', 'id', 'nct', '.', 'result', 'patient', 'in', 'high-dose', 'group', 'less', 'intraoperative', '(', 'median', 'iqr', '.', 'ml', '.-', '.', ')', 'and', 'total', 'blood', 'loss', 'volume', '(', '.', 'ml', '.-', '.', ')', 'in', 'control', 'group', '(', '.', 'ml', '.-.', ',', 'p', '.', 'and', '.', 'ml', '.-.', ',', 'p', '.', ',', 'respectively', ')', '.', 'in', 'contrast', ',', 'intraoperative', '(', '.', 'ml', '.-.', ',', 'p', '.', ')', 'and', 'total', 'blood', 'loss', 'volume', '(', '.', 'ml', '.-.', ',', 'p', '.', ')', 'not', 'significantly', 'reduced', 'in', 'low-dose', 'group', 'compared', 'with', 'control', 'group', '.', 'correspondingly', ',', 'relative', 'risk', 'of', 'blood', 'transfusion', '(', 'rr', 'ci', ',', '.', '.-.', ',', 'p', '.', ')', 'reduced', 'in', 'high-dose', 'group', 'and', 'required', 'less', 'intraoperative', 'noradrenaline', '(', '.', '.', 'mg', ')', 'to', 'maintain', 'stable', 'hemodynamics', 'control', 'group', '(', '.', '.', 'mg', ',', 'p', '.', ')', '.', 'furthermore', ',', 'compared', 'with', 'control', 'group', ',', 'two', 'tranexamic', 'acid', 'group', 'decreased', 'intensive', 'care', 'unit', 'admission', 'rate', '(', 'p', '.', ')', 'without', 'increasing', 'incidence', 'of', 'postoperative', 'seizure', ',', 'acute', 'kidney', 'injury', ',', 'and', 'thromboembolism', '.', 'conclusion', 'high-dose', 'tranexamic', 'acid', 'effective', 'in', 'reducing', 'blood', 'loss', 'and', 'blood', 'transfusion', 'without', 'increasing', 'risk', 'of', 'postoperative', 'complication', '.', 'high-dose', 'regime', 'tended', 'to', 'better', 'risk-benefit', 'profile', '.']"
Impact of propofol versus desflurane anesthesia on postoperative hepatic and renal functions in infants with living-related liver transplantation: a randomized controlled trial.,"Wei Liu#, Min Du#, Mingman Zhang, Xiaoke Dai, Haoming Wang, Ying Le, Shenshen Zhi, Lin Bo, Junjun Quan, Wei Liuet al.",2024 Sep 16,BMC Med,https://pubmed.ncbi.nlm.nih.gov/39285414/,No keywords found,"['effect', 'of', 'anesthetic', 'liver', 'and', 'kidney', 'function', 'infantile', 'living-related', 'liver', 'transplantation', '(', 'lrlt', ')', 'unclear', '.', 'study', 'aimed', 'to', 'investigate', 'effect', 'of', 'propofol-based', 'total', 'intravenous', 'anesthesia', '(', 'tiva', ')', 'or', 'desflurane-based', 'inhalation', 'anesthesia', 'postoperative', 'liver', 'and', 'kidney', 'function', 'in', 'infant', 'recipient', 'lrlt', 'and', 'to', 'evaluate', 'hepatic', 'ischemia-reperfusion', 'injury', '(', 'hiri', ')', '.', 'method', 'seventy-six', 'infant', 'with', 'congenital', 'biliary', 'atresia', 'scheduled', 'lrlt', 'randomly', 'divided', 'two', 'anesthesia', 'maintenance', 'group', 'group', 'with', 'continuous', 'inhalation', 'of', 'desflurane', 'and', 'group', 'p', 'with', 'infusion', 'of', 'propofol', '.', 'primary', 'focus', 'to', 'assess', 'alteration', 'of', 'liver', 'transaminase', 'and', 'serum', 'creatinine', '(', 'scr', ')', 'level', 'within', 'first', 'day', 'surgery', '.', 'and', 'peak', 'aminotransferase', 'level', 'within', 'h', 'post-surgery', 'used', 'surrogate', 'marker', 'hiri', '.', 'result', 'no', 'difference', 'in', 'preoperative', 'hepatic', 'and', 'renal', 'function', 'two', 'group', '.', 'upon', 'intensive', 'care', 'unit', '(', 'icu', ')', 'arrival', ',', 'level', 'of', 'aspartate', 'aminotransferase', '(', 'ast', ',', 'p', '.', ')', 'and', 'alanine', 'aminotransferase', '(', 'alt', ',', 'p', '.', ')', 'in', 'group', 'p', 'significantly', 'lower', 'in', 'group', 'd.', 'change', 'persisted', 'fourth', 'and', 'sixth', 'day', 'surgery', '.', 'peak', 'ast', 'and', 'alt', 'level', 'within', 'h', 'surgery', 'also', 'lower', 'in', 'group', 'p', 'in', 'group', '(', '(', ',', ')', 'vs.', '(', ',', ')', 'ul', ',', 'p', '.', '(', 'ci', '-', ')', 'and', '(', ',', ')', 'vs.', '(', ',', ')', 'ul', ',', 'p', '.', ',', '(', 'ci', '-', ')', ',', 'respectively', ')', '.', 'patient', 'in', 'group', 'p', 'lower', 'level', 'of', 'scr', 'upon', 'icu', 'arrival', 'and', 'first', 'day', 'surgery', ',', 'compared', 'to', 'group', '(', '.', '(', '.', ',', '.', ')', 'vs.', '.', '(', '.', ',', '.', ')', 'moll', ',', 'p', '.', '(', 'ci', '.-', '.', ')', 'and', '.', '(', '.', ',', '.', ')', 'vs.', '.', '(', '.', ',', '.', ')', 'moll', ',', 'p', '.', '(', 'ci', '.-', '.', ')', 'respectively', ')', '.', 'moreover', ',', 'incidence', 'of', 'severe', 'acute', 'kidney', 'injury', 'significantly', 'lower', 'in', 'group', 'p', 'compared', 'to', 'in', 'group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'conclusion', 'propofol-based', 'tiva', 'might', 'improve', 'liver', 'and', 'kidney', 'function', 'lrlt', 'in', 'infant', 'and', 'reduce', 'incidence', 'of', 'serious', 'complication', ',', 'may', 'related', 'to', 'reduction', 'of', 'hiri', '.', 'however', ',', 'biomarkers', 'necessary', 'to', 'prove', 'association', '.']"
Effect of glycemic index and carbohydrate intake on kidney function in healthy adults.,"Stephen P Juraschek, Alex R Chang, Lawrence J Appel, Cheryl A M Anderson, Deidra C Crews, Letitia Thomas, Jeanne Charleston, Edgar R Miller rd, Stephen P Jurascheket al.",2016 Jul 8,BMC Nephrol,https://pubmed.ncbi.nlm.nih.gov/27391484/,No keywords found,"['replacing', 'carbohydrate', 'with', 'protein', 'acutely', 'increase', 'glomerular', 'filtration', 'rate', '(', 'gfr', ')', 'associated', 'with', 'faster', ',', 'long-term', 'kidney', 'disease', 'progression', '.', 'effect', 'of', 'carbohydrate', 'type', '(', 'i.e', '.', 'glycemic', 'index', ',', 'gi', ')', 'kidney', 'function', 'unknown', '.', 'method', 'conducted', 'ancillary', 'study', 'of', 'randomized', ',', 'crossover', 'feeding', 'trial', 'in', 'overweightobese', 'adult', 'without', 'diabetes', 'or', 'kidney', 'disease', '(', 'n', ')', '.', 'participant', 'fed', 'of', 'four', 'healthy', ',', 'dash-like', 'diet', 'week', ',', 'separated', '-week', 'washout', 'period', '.', 'weight', 'kept', 'constant', '.', 'four', 'diet', 'high', 'gi', '(', 'gi', ')', 'with', 'high', 'carb', '(', 'kcal', ')', '(', 'reference', 'diet', ')', ',', 'low', 'gi', '(', ')', 'with', 'low', 'carb', '(', 'kcal', ')', ',', 'low', 'gi', 'with', 'high', 'carb', 'and', 'high', 'gi', 'with', 'low', 'carb', '.', 'plasma', 'collected', 'baseline', 'and', 'feeding', 'period', '.', 'study', 'outcome', 'cystatin', 'c', ',', '-microglobulin', '(', ')', ',', 'and', 'estimated', 'gfr', 'based', 'cystatin', 'c', '(', 'egfrcys', ')', '.', 'result', 'mean', '(', 'sd', ')', 'age', '(', ')', 'year', 'woman', 'black', '.', 'baseline', ',', 'mean', '(', 'sd', ')', 'cystatin', 'c', ',', ',', 'and', 'egfrcys', '.', '(', '.', ')', 'mgl', ',', '.', '(', '.', ')', 'mgl', ',', 'and', '(', ')', 'mlmin', '.', '(', ')', '.', 'compared', 'to', 'high', 'gihigh', 'carb', 'diet', ',', 'reducing', 'gi', ',', 'carb', ',', 'or', 'increased', 'egfrcys', '.', 'mlmin', '.', '(', ')', '(', 'ci', '.', ',', '.', 'p', '.', ')', ',', '.', 'mlmin', '.', '(', ')', '(', '.', ',', '.', 'p', '.', ')', ',', 'and', '.', 'mlmin', '.', '(', ')', '(', '.', ',', '.', 'p', '.', ')', ',', 'respectively', '.', 'increase', 'in', 'egfrcys', 'reducing', 'gi', 'significantly', 'associated', 'with', 'increase', 'in', 'egfrcys', 'reducing', 'carb', '(', 'p', '.', ')', '.', 'result', 'cystatin', 'c', 'and', 'reflected', 'egfrcys', '.', 'conclusion', 'reducing', 'gi', 'increased', 'gfr', '.', 'reducing', 'carb', 'increasing', 'calorie', 'protein', 'and', 'fat', ',', 'also', 'increased', 'gfr', '.', 'future', 'study', 'gi', 'examine', 'long-term', 'effect', 'of', 'increase', 'in', 'gfr', 'kidney', 'injury', 'marker', 'and', 'clinical', 'outcome', '.', 'trial', 'registration', 'clinical', 'trials.gov', ',', 'number', 'nct', '(', 'first', 'registered', 'january', ',', ')', '.']"
Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.,"Jorrit S Lemkes, Gladys N Janssens, Nina W van der Hoeven, Lucia S D Jewbali, Eric A Dubois, Martijn Meuwissen, Tom A Rijpstra, Hans A Bosker, Michiel J Blans, Gabe B Bleeker, Rémon Baak, Georgios J Vlachojannis, Bob J W Eikemans, Pim van der Harst, Iwan C C van der Horst, Michiel Voskuil, Joris J van der Heijden, Albertus Beishuizen, Martin Stoel, Cyril Camaro, Hans van der Hoeven, José P Henriques, Alexander P J Vlaar, Maarten A Vink, Bas van den Bogaard, Ton A C M Heestermans, Wouter de Ruijter, Thijs S R Delnoij, Harry J G M Crijns, Gillian A J Jessurun, Pranobe V Oemrawsingh, Marcel T M Gosselink, Koos Plomp, Michael Magro, Paul W G Elbers, Peter M van de Ven, Heleen M Oudemans-van Straaten, Niels van Royen, Jorrit S Lemkeset al.",2019 Apr 11,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/30883057/,No keywords found,"['ischemic', 'heart', 'disease', 'major', 'cause', 'of', 'out-of-hospital', 'cardiac', 'arrest', '.', 'role', 'of', 'immediate', 'coronary', 'angiography', 'and', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'in', 'treatment', 'of', 'patient', 'successfully', 'resuscitated', 'cardiac', 'arrest', 'in', 'absence', 'of', 'st-segment', 'elevation', 'myocardial', 'infarction', '(', 'stemi', ')', 'remains', 'uncertain', '.', 'method', 'in', 'multicenter', 'trial', ',', 'randomly', 'assigned', 'patient', 'cardiac', 'arrest', 'without', 'sign', 'of', 'stemi', 'to', 'undergo', 'immediate', 'coronary', 'angiography', 'or', 'coronary', 'angiography', 'delayed', 'neurologic', 'recovery', '.', 'patient', 'underwent', 'pci', 'indicated', '.', 'primary', 'end', 'point', 'survival', 'day', '.', 'secondary', 'end', 'point', 'included', 'survival', 'day', 'with', 'good', 'cerebral', 'performance', 'or', 'mild', 'or', 'moderate', 'disability', ',', 'myocardial', 'injury', ',', 'duration', 'of', 'catecholamine', 'support', ',', 'marker', 'of', 'shock', ',', 'recurrence', 'of', 'ventricular', 'tachycardia', ',', 'duration', 'of', 'mechanical', 'ventilation', ',', 'major', 'bleeding', ',', 'occurrence', 'of', 'acute', 'kidney', 'injury', ',', 'need', 'renal-replacement', 'therapy', ',', 'time', 'to', 'target', 'temperature', ',', 'and', 'neurologic', 'status', 'discharge', 'intensive', 'care', 'unit', '.', 'result', 'day', ',', 'of', 'patient', '(', '.', ')', 'in', 'immediate', 'angiography', 'group', 'and', 'of', 'patient', '(', '.', ')', 'in', 'delayed', 'angiography', 'group', 'alive', '(', 'odds', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p', '.', ')', '.', 'median', 'time', 'to', 'target', 'temperature', '.', 'hour', 'in', 'immediate', 'angiography', 'group', 'and', '.', 'hour', 'in', 'delayed', 'angiography', 'group', '(', 'ratio', 'of', 'geometric', 'mean', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'no', 'significant', 'difference', 'group', 'found', 'in', 'remaining', 'secondary', 'end', 'point', '.', 'conclusion', 'among', 'patient', 'successfully', 'resuscitated', 'out-of-hospital', 'cardiac', 'arrest', 'and', 'no', 'sign', 'of', 'stemi', ',', 'strategy', 'of', 'immediate', 'angiography', 'not', 'found', 'to', 'better', 'strategy', 'of', 'delayed', 'angiography', 'with', 'respect', 'to', 'overall', 'survival', 'day', '.', '(', 'funded', 'netherlands', 'heart', 'institute', 'and', 'others', 'coact', 'netherlands', 'trial', 'register', 'number', ',', 'ntr', '.', ')', '.']"
Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.,"Rakesh Malhotra, Timothy Craven, Walter T Ambrosius, Anthony A Killeen, William E Haley, Alfred K Cheung, Michel Chonchol, Mark Sarnak, Chirag R Parikh, Michael G Shlipak, Joachim H Ix                              ;, SPRINT Research Group, Rakesh Malhotraet al.",2019 Jan,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/30291012/,No keywords found,"['random', 'assignment', 'to', 'intensive', 'systolic', 'blood', 'pressure', '(', 'sbp', ')', 'arm', '(', 'mmhg', ')', 'in', 'systolic', 'blood', 'pressure', 'intervention', 'trial', '(', 'sprint', ')', 'resulted', 'in', 'rapid', 'decline', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfrs', ')', 'in', 'standard', 'arm', '(', 'sbpmmhg', ')', '.', 'whether', 'change', 'reflects', 'hemodynamic', 'effect', 'or', 'accelerated', 'intrinsic', 'kidney', 'damage', 'unknown', '.', 'study', 'design', 'longitudinal', 'subgroup', 'analysis', 'of', 'clinical', 'trial', 'participant', '.', 'setting', 'participant', 'random', 'sample', 'of', 'sprint', 'participant', 'with', 'prevalent', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'defined', 'egfrmlmin.m', 'ckd-epi', '(', 'ckd', 'epidemiology', 'collaboration', ')', 'creatinine-cystatin', 'c', 'equation', 'baseline', '.', 'outcome', 'measurement', 'urine', 'biomarkers', 'of', 'tubule', 'function', '(', '-microglobulin', 'bm', ',', '-microglobulin', ')', ',', 'and', 'uromodulin', ')', ',', 'injury', '(', 'interleukin', ',', 'kidney', 'injury', 'molecule', ',', 'and', 'neutrophil', 'gelatinase-associated', 'lipocalin', ')', ',', 'inflammation', '(', 'monocyte', 'chemoattractant', 'protein', ')', ',', 'and', 'repair', '(', 'human', 'cartilage', 'glycoprotein', ')', 'baseline', ',', 'year', ',', 'and', 'year', '.', 'biomarkers', 'indexed', 'to', 'urine', 'creatinine', 'concentration', 'and', 'change', 'arm', 'evaluated', 'using', 'mixed-effects', 'linear', 'model', 'and', 'intention-to-treat', 'approach', '.', 'result', 'sprint', 'participant', '(', 'in', 'intensive', 'and', 'in', 'standard', 'arm', ')', 'with', 'prevalent', 'ckd', 'included', '.', 'mean', 'age', 'year', 'and', 'egfr', '..', 'mlmin.m', 'baseline', '.', 'clinical', 'characteristic', ',', 'egfr', ',', 'urinary', 'albumin-creatinine', 'ratio', ',', 'and', 'biomarker', 'value', 'similar', 'across', 'arm', 'baseline', '.', 'compared', 'to', 'standard', 'arm', ',', 'egfr', 'lower', '.', 'and', '.mlmin.m', 'in', 'intensive', 'arm', 'year', 'and', 'year', '.', 'none', 'of', 'tubule', 'marker', 'level', 'higher', 'in', 'intensive', 'arm', 'compared', 'to', 'standard', 'arm', 'year', 'or', 'year', '.', 'two', 'tubule', 'function', 'marker', '(', 'bm', 'and', ')', '(', 'ci', ',', '-', ')', 'and', '(', 'ci', ',', '-', ')', 'lower', 'year', 'in', 'intensive', 'versus', 'standard', 'arm', ',', 'respectively', '.', 'limitation', 'exclusion', 'of', 'person', 'with', 'diabetes', ',', 'and', 'participant', 'advanced', 'ckd', '.', 'conclusion', 'among', 'participant', 'with', 'ckd', 'in', 'sprint', ',', 'random', 'assignment', 'to', 'intensive', 'sbp', 'arm', 'not', 'increase', 'level', 'of', 'urine', 'biomarkers', 'of', 'tubule', 'cell', 'damage', 'despite', 'loss', 'of', 'egfr', '.', 'finding', 'support', 'hypothesis', 'egfr', 'decline', 'in', 'intensive', 'arm', 'of', 'sprint', 'predominantly', 'reflect', 'hemodynamic', 'change', 'rather', 'intrinsic', 'damage', 'to', 'kidney', 'tubule', 'cell', '.']"
Effect of Intraoperative Low Tidal Volume vs Conventional Tidal Volume on Postoperative Pulmonary Complications in Patients Undergoing Major Surgery: A Randomized Clinical Trial.,"Dharshi Karalapillai, Laurence Weinberg, Philip Peyton, Louise Ellard, Raymond Hu, Brett Pearce, Chong O Tan, David Story, Mark O'Donnell, Patrick Hamilton, Chad Oughton, Jonathan Galtieri, Anthony Wilson, Ary Serpa Neto, Glenn Eastwood, Rinaldo Bellomo, Daryl A Jones, Dharshi Karalapillaiet al.",2020 Sep 1,JAMA,https://pubmed.ncbi.nlm.nih.gov/32870298/,No keywords found,"['in', 'patient', 'undergo', 'mechanical', 'ventilation', 'surgery', ',', 'ideal', 'tidal', 'volume', 'unclear', '.', 'objective', 'to', 'determine', 'whether', 'low-tidal-volume', 'ventilation', 'compared', 'with', 'conventional', 'ventilation', 'major', 'surgery', 'decrease', 'postoperative', 'pulmonary', 'complication', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'single-center', ',', 'assessor-blinded', ',', 'randomized', 'clinical', 'trial', 'of', 'patient', 'older', 'year', 'undergoing', 'major', 'noncardiothoracic', ',', 'nonintracranial', 'surgery', 'general', 'anesthesia', 'lasting', 'hour', 'in', 'tertiary', 'hospital', 'in', 'melbourne', ',', 'australia', ',', 'february', 'to', 'february', '.', 'last', 'date', 'of', 'follow-up', 'february', ',', '.', 'intervention', 'patient', 'randomized', 'to', 'receive', 'tidal', 'volume', 'of', 'mlkg', 'predicted', 'body', 'weight', '(', 'n', 'low', 'tidal', 'volume', 'group', ')', 'or', 'tidal', 'volume', 'of', 'mlkg', 'predicted', 'body', 'weight', '(', 'n', 'conventional', 'tidal', 'volume', 'group', ')', '.', 'patient', 'received', 'positive', 'end-expiratory', 'pressure', '(', 'peep', ')', 'cm', 'ho', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'outcome', 'composite', 'of', 'postoperative', 'pulmonary', 'complication', 'within', 'first', 'postoperative', 'day', ',', 'including', 'pneumonia', ',', 'bronchospasm', ',', 'atelectasis', ',', 'pulmonary', 'congestion', ',', 'respiratory', 'failure', ',', 'pleural', 'effusion', ',', 'pneumothorax', ',', 'or', 'unplanned', 'requirement', 'postoperative', 'invasive', 'or', 'noninvasive', 'ventilation', '.', 'secondary', 'outcome', 'postoperative', 'pulmonary', 'complication', 'including', 'development', 'of', 'pulmonary', 'embolism', ',', 'acute', 'respiratory', 'distress', 'syndrome', ',', 'systemic', 'inflammatory', 'response', 'syndrome', ',', 'sepsis', ',', 'acute', 'kidney', 'injury', ',', 'wound', 'infection', '(', 'superficial', 'and', 'deep', ')', ',', 'rate', 'of', 'intraoperative', 'need', 'vasopressor', ',', 'incidence', 'of', 'unplanned', 'intensive', 'care', 'unit', 'admission', ',', 'rate', 'of', 'need', 'rapid', 'response', 'team', 'call', ',', 'intensive', 'care', 'unit', 'length', 'of', 'stay', ',', 'hospital', 'length', 'of', 'stay', ',', 'and', 'in-hospital', 'mortality', '.', 'result', 'among', 'patient', 'randomized', ',', '(', '.', ')', 'completed', 'trial', '(', 'mean', 'age', ',', '.', 'year', '.', 'woman', '.', 'undergoing', 'abdominal', 'surgery', ')', '.', 'primary', 'outcome', 'occurred', 'in', 'of', 'patient', '(', ')', 'in', 'low', 'tidal', 'volume', 'group', 'compared', 'with', 'of', 'patient', '(', ')', 'in', 'conventional', 'tidal', 'volume', 'group', '(', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '.', 'risk', 'ratio', ',', '.', 'ci', ',', '.-', '.', 'p', '.', ')', '.', 'no', 'significant', 'difference', 'in', 'of', 'secondary', 'outcome', '.', 'conclusion', 'and', 'relevance', 'among', 'adult', 'patient', 'undergoing', 'major', 'surgery', ',', 'intraoperative', 'ventilation', 'with', 'low', 'tidal', 'volume', 'compared', 'with', 'conventional', 'tidal', 'volume', ',', 'with', 'peep', 'applied', 'equally', 'group', ',', 'not', 'significantly', 'reduce', 'pulmonary', 'complication', 'within', 'first', 'postoperative', 'day', '.', 'trial', 'registration', 'anzctr', 'identifier', 'actrn', '.']"
Large volume acute normovolemic hemodilution in patients undergoing cardiac surgery with intermediate-high risk of transfusion: A randomized controlled trial.,"Yue Ming, Fengjiang Zhang, Yuanyuan Yao, Zhenzhen Cheng, Lina Yu, Dawei Sun, Kai Sun, Yang Yu, Mingxia Liu, Longfei Ma, Yuxin HuangYang, Min Yan, Yue Minget al.",2023 Aug:87:111082.,J Clin Anesth,https://pubmed.ncbi.nlm.nih.gov/36848777/,No keywords found,"['to', 'investigate', 'whether', 'large', 'volume', 'acute', 'normovolemic', 'hemodilution', '(', 'l-anh', ')', ',', 'compared', 'with', 'moderate', 'acute', 'normovolemic', 'hemodilution', '(', 'm-anh', ')', ',', 'reduce', 'perioperative', 'allogeneic', 'blood', 'transfusion', 'in', 'patient', 'with', 'intermediate-high', 'risk', 'of', 'transfusion', 'cardiac', 'surgery', 'with', 'cardiopulmonary', 'bypass', '(', 'cpb', ')', '.', 'design', 'prospective', 'randomized', 'controlled', 'trial', '.', 'setting', 'university', 'hospital', '.', 'patient', 'patient', 'with', 'transfusion', 'risk', 'understanding', 'scoring', 'tool', '(', '``', 'trust', ""''"", ')', 'point', 'undergoing', 'cardiac', 'surgery', 'with', 'cpb', 'in', 'second', 'affiliated', 'hospital', 'of', 'zhejiang', 'university', 'may', 'to', 'january', 'included', '.', 'intervention', 'patient', 'randomly', 'assigned', 'with', 'ratio', 'to', 'm-anh', '(', 'to', 'mlkg', ')', 'or', 'l-anh', '(', 'to', 'mlkg', ')', '.', 'measurement', 'primary', 'outcome', 'perioperative', 'red', 'blood', 'cell', '(', 'rbc', ')', 'transfusion', 'unit', '.', 'composite', 'outcome', 'included', 'new-onset', 'atrial', 'fibrillation', ',', 'pulmonary', 'infection', ',', 'cardiac', 'surgery', 'associated', 'acute', 'kidney', 'injury', '(', 'csa-aki', ')', 'class', ',', 'surgical', 'incision', 'infection', ',', 'postoperative', 'excessive', 'bleeding', ',', 'and', 'resternotomy', '.', 'main', 'result', 'total', 'patient', 'screened', 'and', '(', 'l-anh', 'and', 'm-anh', ')', 'included', 'final', 'analysis', '.', 'removed', 'blood', 'volume', 'of', 'l-anh', 'significantly', 'higher', 'm-anh', '(', 'vs.', 'ml', ',', 'p', '.', ')', '.', 'perioperative', 'rbc', 'transfusion', 'median', 'unit', '(', 'th', ',', 'th', 'percentile', '-', '.', ')', 'in', 'm-anh', 'group', 'vs.', 'unit', '(', 'th', ',', 'th', 'percentile', '-', '.', ')', 'in', 'l-anh', 'group', '(', 'p', '.', ')', 'and', 'l-anh', 'associated', 'with', 'lower', 'incidence', 'of', 'transfusion', '(', '.', 'v', '.', '.', ',', 'p', '.', ',', 'rate', 'difference', '.', ',', 'confidence', 'interval', '.-.', ')', '.', 'incidence', 'of', 'postoperative', 'excessive', 'bleeding', 'significantly', 'lower', 'in', 'l-anh', 'vs.', 'm-anh', '(', '.', 'v', '.', '.', ',', 'p', '.', ',', 'rate', 'difference', '.', ',', 'confidence', 'interval', '.-', '.', ')', 'without', 'significant', 'difference', 'second', 'outcome', '.', 'volume', 'of', 'anh', 'inversely', 'related', 'to', 'perioperative', 'rbc', 'transfusion', 'unit', '(', 'spearman', 'r', '-.', ',', 'confidence', 'interval', '-', '.', 'to', '-.', ',', 'p', '.', ')', ',', 'and', 'l-anh', 'in', 'cardiac', 'surgery', 'associated', 'with', 'significantly', 'reduced', 'risk', 'of', 'perioperative', 'rbc', 'transfusion', '(', 'odds', 'ratio', '.', ',', 'confidence', 'interval', '.-.', ',', 'p', '.', ')', '.', 'conclusion', 'compared', 'with', 'm-anh', ',', 'l-anh', 'cardiac', 'surgery', 'inclined', 'to', 'associated', 'with', 'reduced', 'perioperative', 'rbc', 'transfusion', 'and', 'volume', 'of', 'rbc', 'transfusion', 'inversely', 'proportional', 'to', 'volume', 'of', 'anh', '.', 'in', 'addition', ',', 'lanh', 'cardiac', 'surgery', 'associated', 'with', 'lower', 'incidence', 'of', 'postoperative', 'excessive', 'bleeding', '.']"
Ankle-brachial pressure index as a predictor of the 2-year outcome after transcatheter aortic valve replacement: data from the Japanese OCEAN-TAVI Registry.,"Masahiro Yamawaki, Motoharu Araki, Tsutomu Ito, Yosuke Honda, Takahiro Tokuda, Yoshiaki Ito, Hiroshi Ueno, Kazuki Mizutani, Minoru Tabata, Akihiro Higashimori, Norio Tada, Kensuke Takagi, Futoshi Yamanaka, Toru Naganuma, Yusuke Watanabe, Masanori Yamamoto, Shinichi Shirai, Kentaro Hayashida                              ;, OCEAN-TAVI Registry, Masahiro Yamawakiet al.",2018 Jun,Heart Vessels,https://pubmed.ncbi.nlm.nih.gov/29230568/,"Ankle–brachial index, Long-term outcome, Peripheral artery disease, Transcatheter aortic valve replacement.","['patient', 'with', '(', ')', 'abi', '.', 'in', 'leg', 'and', '(', ')', 'abi', '.', 'in', 'either', 'leg', '.', 'primary', 'endpoint', 'all-cause', 'death', 'within', 'year', '.', 'abi', '.', 'noted', 'in', 'patient', '(', '.', ')', '.', 'abi', '.-group', 'frequent', 'and', 'severe', 'comorbidities', '.', 'primary', 'endpoint', 'in', 'abi', '.-group', 'significantly', 'higher', 'in', 'abi', '.-group', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'trend', 'continued', 'in', 'transfemoral', '(', 'tf', ')', '-approach', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', ',', 'not', 'in', 'alternative', 'approach', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'within', 'day', ',', 'abi', '.-group', 'higher', 'cardiac', 'death', 'rate', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', ',', 'whereas', 'day', 'and', 'year', ',', 'non-cardiovascular', 'death', 'frequently', 'observed', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', '.', 'in', 'abi', '.-group', ',', 'in-hospital', 'vascular', 'complication', '(', '.', 'v', '.', '.', ',', 'p', '.', ')', 'and', 'acute', 'kidney', 'injury', '(', '.', 'v', ',', '.', ',', 'p', '.', ')', 'frequently', 'found', 'using', 'transfemoral-approach', '.', 'in', 'multivariate', 'analysis', ',', 'abi', '.', 'independent', 'predictor', 'of', '-year', 'mortality', '(', 'adjusted', 'hazard', 'ratio', '.', ',', 'ci', '.-.', ',', 'p', '.', ')', '.', 'pre-procedure', 'abi', '.', 'useful', 'prognostic', 'marker', 'all-cause', 'mortality', ',', 'even', 'in', 'high-risk', 'tavr', 'population', '.']"
Myocardial Injury After Balloon Predilatation Versus Direct Transcatheter Aortic Valve Replacement: Insights From the DIRECTAVI Trial.,"Mariama Akodad, François Roubille, Gregory Marin, Benoit Lattuca, Jean-Christophe Macia, Delphine Delseny, Thomas Gandet, Pierre Robert, Laurent Schmutz, Christophe Piot, Eric Maupas, Gabriel Robert, Frederic Targosz, Bernard Albat, Guillaume Cayla, Florence Leclercq, Mariama Akodadet al.",2020 Dec 15,J Am Heart Assoc,https://pubmed.ncbi.nlm.nih.gov/33297821/,"balloon aortic valvuloplasty, direct implantation, myocardial injury, transcatheter aortic valve replacement, troponin.","['httpswww.clinicaltrials.gov', 'unique', 'identifier', 'nct', '.']"
Final 3-Year Outcomes of a Randomized Trial Comparing a Self-Expanding to a Balloon-Expandable Transcatheter Aortic Valve.,"Jonas Lanz, Helge Möllmann, Won-Keun Kim, Christof Burgdorf, Axel Linke, Simon Redwood, Michael Hilker, Michael Joner, Holger Thiele, Lars Conzelmann, Lenard Conradi, Sebastian Kerber, Christian Thilo, Stefan Toggweiler, Bernard Prendergast, Oliver Husser, Stefan Stortecky, Sarah Deckarm, Arnaud Künzi, Dik Heg, Thomas Walther, Stephan Windecker, Thomas Pilgrim                              ;, SCOPE I Investigators, Jonas Lanzet al.",2023 Jul,Circ Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/37417229/,No keywords found,"['in', 'scope', 'trial', '(', 'safety', 'and', 'efficacy', 'of', 'symetis', 'acurate', 'neotf', 'compared', 'to', 'edward', 'sapien', 'bioprosthesis', ')', ',', 'transcatheter', 'aortic', 'valve', 'implantation', 'with', 'self-expanding', 'acurate', 'neo', '(', 'neo', ')', 'not', 'meet', 'noninferiority', 'compared', 'with', 'balloon-expandable', 'sapien', '(', ')', 'device', 'regarding', 'composite', 'end', 'point', 'day', 'due', 'to', 'higher', 'rate', 'of', 'prosthetic', 'valve', 'regurgitation', 'and', 'acute', 'kidney', 'injury', '.', 'data', 'long-term', 'durability', 'of', 'neo', 'scarce', '.', ',', 'report', 'whether', 'early', 'difference', 'neo', 'and', 'translate', 'difference', 'in', 'clinical', 'outcome', 'or', 'bioprosthetic', 'valve', 'failure', 'year', 'transcatheter', 'aortic', 'valve', 'implantation', '.', 'method', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'randomized', 'to', 'transfemoral', 'transcatheter', 'aortic', 'valve', 'implantation', 'with', 'neo', 'or', 'european', 'center', '.', 'clinical', 'outcome', 'year', 'compared', 'using', 'cox', 'proportional', 'or', 'fine-gray', 'subdistribution', 'hazard', 'model', 'intention-to-treat', '.', 'bioprosthetic', 'valve', 'failure', 'reported', 'valve-implant', 'cohort', '.', 'result', 'among', 'patient', ',', 'of', 'patient', '(', '.', ')', 'died', 'in', 'neo', 'and', 'of', '(', ')', 'in', 'group', 'year', '.', 'comparing', 'neo', 'with', ',', '-year', 'rate', 'of', 'all-cause', 'death', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'stroke', '(', 'subhazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'and', 'hospitalization', 'congestive', 'heart', 'failure', '(', 'subhazard', 'ratio', ',', '.', 'ci', ',', '.-', '.', ')', 'similar', 'group', '.', 'aortic', 'valve', 'reinterventions', 'required', 'in', 'neo', 'and', 'patient', '(', 'subhazard', 'ratio', ',', '.', 'ci', ',', '.-.', ')', '.', 'new', 'york', 'heart', 'association', 'functional', 'class', 'ii', 'observed', 'in', '(', 'neo', ')', 'and', '(', ')', ',', 'respectively', '.', 'mean', 'gradient', 'remained', 'lower', 'neo', 'year', '(', 'versus', 'mm', 'hg', 'p.', ')', '.', 'conclusion', 'early', 'difference', 'neo', 'and', 'not', 'translate', 'significant', 'difference', 'in', 'clinical', 'outcome', 'or', 'bioprosthetic', 'valve', 'failure', 'throughout', 'year', '.', 'registration', 'url', 'httpsclinicaltrials.gov', ',', 'unique', 'identifier', 'nct', '.']"
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.,"Ted E Feldman, Michael J Reardon, Vivek Rajagopal, Raj R Makkar, Tanvir K Bajwa, Neal S Kleiman, Axel Linke, Dean J Kereiakes, Ron Waksman, Vinod H Thourani, Robert C Stoler, Gregory J Mishkel, David G Rizik, Vijay S Iyer, Thomas G Gleason, Didier Tchétché, Joshua D Rovin, Maurice Buchbinder, Ian T Meredith, Matthias Götberg, Henrik Bjursten, Christopher Meduri, Michael H Salinger, Dominic J Allocco, Keith D Dawkins, Ted E Feldmanet al.",2018 Jan 2,JAMA,https://pubmed.ncbi.nlm.nih.gov/29297076/,No keywords found,"['transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'established', 'selected', 'patient', 'with', 'severe', 'aortic', 'stenosis', '.', 'however', ',', 'limitation', 'suboptimal', 'deployment', ',', 'conduction', 'disturbance', ',', 'and', 'paravalvular', 'leak', 'occur', '.', 'objective', 'to', 'evaluate', 'mechanically', 'expanded', 'valve', '(', 'mev', ')', 'noninferior', 'to', 'approved', 'self-expanding', 'valve', '(', 'sev', ')', 'in', 'high-risk', 'patient', 'with', 'aortic', 'stenosis', 'undergoing', 'tavr', '.', 'design', ',', 'setting', ',', 'and', 'participant', 'reprise', 'iii', 'trial', 'conducted', 'in', 'patient', 'with', 'high', 'or', 'extreme', 'risk', 'and', 'severe', ',', 'symptomatic', 'aortic', 'stenosis', 'center', 'in', 'north', 'america', ',', 'europe', ',', 'and', 'australia', 'september', ',', ',', 'and', 'december', ',', ',', 'with', 'final', 'follow-up', 'march', ',', '.', 'intervention', 'participant', 'randomized', 'in', 'ratio', 'to', 'receive', 'either', 'mev', '(', 'n', ')', 'or', 'sev', '(', 'n', ')', '.', 'main', 'outcome', 'and', 'measure', 'primary', 'safety', 'end', 'point', '-day', 'composite', 'of', 'all-cause', 'mortality', ',', 'stroke', ',', 'life-threatening', 'or', 'major', 'bleeding', ',', 'stage', 'acute', 'kidney', 'injury', ',', 'and', 'major', 'vascular', 'complication', 'tested', 'noninferiority', '(', 'margin', ',', '.', ')', '.', 'primary', 'effectiveness', 'end', 'point', '-year', 'composite', 'of', 'all-cause', 'mortality', ',', 'disabling', 'stroke', ',', 'and', 'moderate', 'or', 'greater', 'paravalvular', 'leak', 'tested', 'noninferiority', '(', 'margin', ',', '.', ')', '.', 'noninferiority', 'criterion', 'met', ',', 'secondary', 'end', 'point', 'of', '-year', 'moderate', 'or', 'greater', 'paravalvular', 'leak', 'tested', 'superiority', 'in', 'full', 'analysis', 'data', 'set', '.', 'result', 'among', 'randomized', 'patient', '(', 'mean', 'age', ',', '.', 'sd', ',', '.', 'year', 'woman', 'predicted', 'risk', 'of', 'mortality', ',', '.', ')', ',', '(', ')', 'evaluable', 'year', '.', 'primary', 'safety', 'composite', 'end', 'point', 'day', 'occurred', 'in', '.', 'of', 'mev', 'patient', 'and', '.', 'of', 'sev', 'patient', '(', 'difference', ',', '.', 'farrington-manning', '.', 'ci', ',', '-', 'to', '.', 'p', '.', 'noninferiority', ')', '.', 'year', ',', 'primary', 'effectiveness', 'composite', 'end', 'point', 'occurred', 'in', '.', 'with', 'mev', 'and', '.', 'with', 'sev', '(', 'difference', ',', '-', '.', 'farrington-manning', '.', 'ci', ',', '-', 'to', '-', '.', 'p.', 'noninferiority', ')', '.', '-year', 'rate', 'of', 'moderate', 'or', 'severe', 'paravalvular', 'leak', '.', 'mev', 'and', '.', 'sev', '(', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'p', '.', ')', '.', 'superiority', 'analysis', 'primary', 'effectiveness', 'statistically', 'significant', '(', 'difference', ',', '-', '.', 'ci', ',', '-', '.', 'to', '-', '.', 'p', '.', ')', '.', 'mev', 'higher', 'rate', 'of', 'new', 'pacemaker', 'implant', '(', '.', 'v', '.', 'p', '.', ')', 'and', 'valve', 'thrombosis', '(', '.', 'v', ')', 'lower', 'rate', 'of', 'repeat', 'procedure', '(', '.', 'v', '.', ')', ',', 'valve-in-valve', 'deployment', '(', 'v', '.', ')', ',', 'and', 'valve', 'malpositioning', '(', 'v', '.', ')', '.', 'conclusion', 'and', 'relevance', 'among', 'high-risk', 'patient', 'with', 'aortic', 'stenosis', ',', 'use', 'of', 'mev', 'compared', 'with', 'sev', 'not', 'result', 'in', 'inferior', 'outcome', 'primary', 'safety', 'end', 'point', 'or', 'primary', 'effectiveness', 'end', 'point', '.', 'finding', 'suggest', 'mev', 'may', 'useful', 'addition', 'tavr', 'in', 'high-risk', 'patient', '.', 'trial', 'registration', 'clinicaltrials.gov', 'identifier', 'nct', '.']"
Earlier time to hemostasis is associated with decreased mortality and rate of complications: Results from the Pragmatic Randomized Optimal Platelet and Plasma Ratio trial.,"Ronald Chang, Jeffrey D Kerby, Kyle J Kalkwarf, Gerald Van Belle, Erin E Fox, Bryan A Cotton, Mitchell J Cohen, Martin A Schreiber, Karen Brasel, Eileen M Bulger, Kenji Inaba, Sandro Rizoli, Jeanette M Podbielski, Charles E Wade, John B Holcomb;, PROPPR Study Group, Ronald Changet al.",2019 Aug,J Trauma Acute Care Surg,https://pubmed.ncbi.nlm.nih.gov/31349348/,No keywords found,"['clinician', 'intuitively', 'recognize', 'faster', 'time', 'to', 'hemostasis', 'important', 'in', 'bleeding', 'trauma', 'patient', ',', 'time', 'rarely', 'reported', '.', 'method', 'prospectively', 'collected', 'data', 'pragmatic', 'randomized', 'optimal', 'platelet', 'and', 'plasma', 'ratio', 'trial', 'analyzed', '.', 'hemostasis', 'predefined', 'no', 'intraoperative', 'bleeding', 'requiring', 'intervention', 'in', 'surgical', 'field', 'or', 'resolution', 'of', 'contrast', 'blush', 'interventional', 'radiology', '(', 'ir', ')', '.', 'patient', 'underwent', 'emergent', '(', 'within', 'minute', ')', 'operating', 'room', '(', 'or', ')', 'or', 'ir', 'procedure', 'included', '.', 'mixed-effects', 'poisson', 'regression', 'with', 'robust', 'error', 'variance', '(', 'controlling', 'age', ',', 'injury', 'severity', 'score', ',', 'treatment', 'arm', ',', 'injury', 'mechanism', ',', 'base', 'excess', 'admission', 'missing', 'value', 'estimated', 'multiple', 'imputation', ',', 'and', 'time', 'to', 'orir', 'fixed', 'effect', 'and', 'study', 'site', 'random', 'effect', ')', 'with', 'modified', 'bonferroni', 'correction', 'tested', 'hypothesis', 'decreased', 'time', 'to', 'hemostasis', 'associated', 'with', 'decreased', 'mortality', 'and', 'decreased', 'incidence', 'of', 'acute', 'kidney', 'injury', '(', 'aki', ')', ',', 'acute', 'respiratory', 'distress', 'syndrome', '(', 'ards', ')', ',', 'multiple-organ', 'failure', '(', 'mof', ')', ',', 'sepsis', ',', 'and', 'venous', 'thromboembolism', '.', 'result', 'of', 'enrolled', 'patient', ',', '(', ')', 'underwent', 'emergent', 'procedure', '.', 'patient', 'with', 'decreased', 'time', 'to', 'hemostasis', 'less', 'severely', 'injured', ',', 'less', 'deranged', 'base', 'excess', 'admission', ',', 'and', 'lower', 'incidence', 'of', 'blunt', 'trauma', '(', 'p', '.', ')', '.', 'in', '(', ')', 'patient', 'in', 'hemostasis', 'achieved', ',', 'every', '-minute', 'decrease', 'in', 'time', 'to', 'hemostasis', 'associated', 'with', 'decreased', '-day', 'mortality', '(', 'rr', ',', '.', 'confidence', 'interval', 'ci', ',', '.-', '.', ')', ',', 'aki', '(', 'rr', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'ards', '(', 'rr', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'mof', '(', 'rr', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'and', 'sepsis', '(', 'rr', ',', '.', 'ci', ',', '.-', '.', ')', ',', 'not', 'venous', 'thromboembolism', '(', 'rr', ',', '.', 'ci', ',', '.-.', ')', '.', 'conclusion', 'earlier', 'time', 'to', 'hemostasis', 'independently', 'associated', 'with', 'decreased', 'incidence', 'of', '-day', 'mortality', ',', 'aki', ',', 'ards', ',', 'mof', ',', 'and', 'sepsis', 'in', 'bleeding', 'trauma', 'patient', '.', 'time', 'to', 'hemostasis', 'considered', 'endpoint', 'in', 'trauma', 'study', 'and', 'potential', 'quality', 'indicator', '.', 'level', 'of', 'evidence', 'therapeuticcare', 'management', ',', 'level', 'iii', '.']"
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial.,"Tiffany Patterson, Tim Clayton, Matthew Dodd, Zeeshan Khawaja, Marie Claude Morice, Karen Wilson, Won-Keun Kim, Nicolas Meneveau, Rainer Hambrecht, Jonathan Byrne, Didier Carrié, Doug Fraser, David H Roberts, Sagar N Doshi, Azfar Zaman, Adrian P Banning, Hélène Eltchaninoff, Hervé Le Breton, David Smith, Ian Cox, Derk Frank, Anthony Gershlick, Mark de Belder, Martyn Thomas, David Hildick-Smith, Bernard Prendergast, Simon Redwood                              ;, ACTIVATION Trial Investigators, Stuart Pocock, Duolao Wang, Florian Irague, Tiffany Pattersonet al.",2021 Sep 27,JACC Cardiovasc Interv,https://pubmed.ncbi.nlm.nih.gov/34556269/,No keywords found,"['study', 'sought', 'to', 'determine', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', 'prior', 'to', 'transcatheter', 'aortic', 'valve', 'replacement', '(', 'tavr', ')', 'in', 'patient', 'with', 'significant', 'coronary', 'artery', 'disease', 'would', 'produce', 'noninferior', 'clinical', 'result', 'compared', 'with', 'no', 'pci', '(', 'control', 'arm', ')', '.', 'background', 'pci', 'in', 'patient', 'undergoing', 'tavr', 'not', 'without', 'risk', ',', 'and', 'no', 'randomized', 'data', 'to', 'inform', 'clinical', 'practice', '.', 'method', 'patient', 'with', 'severe', 'symptomatic', 'aortic', 'stenosis', 'and', 'significant', 'coronary', 'artery', 'disease', 'with', 'canadian', 'cardiovascular', 'society', 'class', 'angina', 'randomly', 'assigned', 'to', 'receive', 'pci', 'or', 'no', 'pci', 'prior', 'to', 'tavr', '.', 'primary', 'endpoint', 'composite', 'of', 'all-cause', 'death', 'or', 'rehospitalization', 'year', '.', 'noninferiority', 'testing', '(', 'prespecified', 'margin', 'of', '.', ')', 'performed', 'in', 'intention-to-treat', 'population', '.', 'result', 'center', ',', 'patient', 'underwent', 'randomization', '.', 'year', ',', 'primary', 'composite', 'endpoint', 'occurred', 'in', '(', '.', ')', 'of', 'pci', 'arm', 'and', '(', '.', ')', 'of', 'no-pci', 'arm', '.', 'requirement', 'noninferiority', 'not', 'met', '(', 'difference', '-', '.', '-sided', 'upper', 'confidence', 'limit', '.', '-sided', 'noninferiority', 'test', 'p', '.', ')', '.', 'analysis', 'of', 'as-treated', 'population', ',', 'difference', '-', '.', '(', '-sided', 'upper', 'confidence', 'limit', '.', 'p', '.', ')', '.', 'mortality', '(', '.', ')', 'in', 'pci', 'arm', 'and', '(', '.', ')', 'in', 'no-pci', 'arm', '.', 'year', ',', 'no', 'evidence', 'of', 'difference', 'in', 'rate', 'of', 'stroke', ',', 'myocardial', 'infarction', ',', 'or', 'acute', 'kidney', 'injury', ',', 'with', 'higher', 'rate', 'of', 'bleed', 'in', 'pci', 'arm', '(', 'p', '.', ')', '.', 'conclusion', 'observed', 'rate', 'of', 'death', 'and', 'rehospitalization', 'year', 'similar', 'pci', 'and', 'no', 'pci', 'prior', 'to', 'tavr', 'however', ',', 'noninferiority', 'margin', 'not', 'met', ',', 'and', 'pci', 'resulted', 'in', 'higher', 'incidence', 'of', 'bleeding', '.', '(', 'assessing', 'effect', 'of', 'stenting', 'in', 'significant', 'coronary', 'artery', 'disease', 'prior', 'to', 'transcatheter', 'aortic', 'valve', 'implantation', 'isrctn', ')', '.']"
Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome.,"Angela J Rogers, Jiazhen Guan, Anna Trtchounian, Gary M Hunninghake, Rajani Kaimal, Manisha Desai, Lori-Ann Kozikowski, Lesley DeSouza, Susan Mogan, Kathleen D Liu, Michael A Matthay, Jay Steingrub, Art Wheeler, Joo Heon Yoon, Kiichi Nakahira, Augustine M Choi, Rebecca M Baron, Angela J Rogerset al.",2019 Aug,Crit Care Med,https://pubmed.ncbi.nlm.nih.gov/31206358/,No keywords found,"['high', 'plasma', 'level', 'of', 'inflammasome', 'mediator', 'interleukin-', 'associated', 'with', 'mortality', 'in', 'observational', 'acute', 'respiratory', 'distress', 'syndrome', 'cohort', '.', 'statin', 'exposure', 'increase', 'inflammasome', 'activation', 'and', 'lung', 'injury', 'in', 'mouse', 'model', '.', 'tested', 'whether', 'randomization', 'to', 'statin', 'therapy', 'correlated', 'with', 'increased', 'interleukin-', 'in', 'ards', 'network', 'statin', 'acutely', 'injured', 'lung', 'sepsis', 'trial', '.', 'design', 'retrospective', 'analysis', 'of', 'randomized', 'controlled', 'clinical', 'trial', '.', 'setting', 'multicenter', 'north', 'american', 'clinical', 'trial', ',', 'ards', 'network', 'statin', 'acutely', 'injured', 'lung', 'sepsis', '.', 'patient', 'six', 'hundred', 'eighty-three', 'subject', 'with', 'infection-related', 'acute', 'respiratory', 'distress', 'syndrome', ',', 'representing', 'of', 'original', 'trial', 'population', '.', 'intervention', 'random', 'assignment', 'of', 'rosuvastatin', 'or', 'placebo', 'to', 'day', 'or', 'day', 'icu', 'discharge', '.', 'measurement', 'and', 'main', 'result', 'measured', 'plasma', 'interleukin-', 'level', 'in', 'statin', 'acutely', 'injured', 'lung', 'sepsis', 'patient', 'with', 'sample', 'available', 'day', '(', 'baseline', ',', 'n', ')', 'and', 'day', '(', 'randomization', ',', 'n', ')', '.', 'tested', 'association', 'among', 'interleukin-', 'level', 'baseline', ',', 'rising', 'interleukin-', ',', 'and', 'impact', 'of', 'statin', 'therapy', '-day', 'mortality', ',', 'adjusting', 'severity', 'of', 'illness', '.', 'baseline', 'plasma', 'interleukin-', 'level', 'greater', 'or', 'equal', 'to', 'pgml', 'highly', 'associated', 'with', '-day', 'mortality', ',', 'with', 'hazard', 'of', 'death', 'of', '.', '(', 'ci', ',', '.-.', ')', '.', 'rising', 'plasma', 'interleukin-', 'also', 'associated', 'with', 'increased', 'mortality', '.', 'unit', 'increase', 'in', 'log', '(', 'interleukin-', ')', 'day', 'compared', 'with', 'baseline', ',', 'hazard', 'of', 'death', 'increased', '.', '(', 'ci', ',', '.-.', ')', '.', 'subject', 'randomized', 'to', 'statin', 'significantly', 'likely', 'to', 'experience', 'rise', 'in', 'plasma', 'interleukin-', 'level', '.', 'subject', 'with', 'acute', 'kidney', 'injury', ',', 'shock', ',', 'low', 'baseline', 'interleukin-', ',', 'and', 'not', 'receiving', 'systemic', 'corticosteroid', 'likely', 'to', 'experience', 'rising', 'interleukin-', '.', 'randomization', 'to', 'statin', 'therapy', 'associated', 'with', 'rising', 'in', 'interleukin-', 'in', 'of', 'subset', ',', 'however', '.', 'conclusion', 'elevated', 'baseline', 'plasma', 'interleukin-', 'associated', 'with', 'higher', 'mortality', 'in', 'sepsis-induced', 'acute', 'respiratory', 'distress', 'syndrome', '.', 'rise', 'in', 'plasma', 'interleukin-', 'also', 'associated', 'with', 'increased', 'mortality', 'and', 'common', 'in', 'subject', 'randomized', 'to', 'statin', 'therapy', 'in', 'clinical', 'trial', '.']"
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.,"Andreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, Martin Hudec, Matjaz Bunc, Alexander Ijsselmuiden, Peep Laanmets, Daniel Unic, Bela Merkely, Renicus S Hermanides, Vlasis Ninios, Marcin Protasiewicz, Benno J W M Rensing, Pedro L Martin, Fausto Feres, Manuel De Sousa Almeida, Eric van Belle, Axel Linke, Alfonso Ielasi, Matteo Montorfano, Mark Webster, Konstantinos Toutouzas, Emmanuel Teiger, Francesco Bedogni, Michiel Voskuil, Manuel Pan, Oskar Angerås, Won-Keun Kim, Jürgen Rothe, Ivica Kristić, Vicente Peral, Scot Garg, Hesham Elzomor, Akihiro Tobe, Marie-Claude Morice, Yoshinobu Onuma, Osama Soliman, Patrick W Serruys                              ;, LANDMARK trial investigators, Dimytri Siqueira, Ibraim Pinto, Alberto Cervone, Jorge Assef, Andrea Vilela, Antonio Paladino, Auristela Ramos, Mariana Rezende, Samira Ghorayeb, Tacianne Rolemberg Braga Silva, Savica Gjorgjievska, Irzal Hadzibegovic, Ivana Jurin, Tomislav Sipic, Nikola Pavlovic, Igor Rudez, Sime Manola, Romain Gallet DE Saint-Aurin, Madjid Boukantar, Eroan Nicolas, Pierre Valdimir Ennezat, Jean Marie Urien, Flavien Vincent, Cedric Delhaye, Tom Denimal, Alessandro Cosenza, Thibault Pamart, Sina Porouchani, Francois Pontana, David Montaigne, Vincent Balmette, Mohamed Bechiri, Elisabeth Chen, Dany Janah, Matthias Renker, Dirk Westermann, Christian Valina, Miroslaw Ferenc, Nikolaus Löffelhardt, Faridun Rahimi, Philipp Breitbart, Kilian Franke, Martin Czerny, Nawras Diab, Peter Sick, Medea Adeishvili, Norman Mangner, Stephan Haussig, Krunuslav Sveric, Lisa Crusius, Marie Roehlig, Leonidas Koliastasis, Maria Drakopoulou, Odysseas Katsaros, Nikolaos Ktenopoulos, Andreas Ioanniadis, Sotirios Evangelou, Ilias Ninios, Levente Molnar, Roland Papp, Ferencz Arnold-Béla, Orsolya Demeterné Kiss, Andrea Nagy, Csilla Czimbalmos, Dario Pellegrinni, Carolina Montonati, Mariano Pellicano, Giulio Guagliumi, Maurizio Tespili, Bellini Barbara, Russo Filippo, Ancona Marco, Vella Ciro, Ferri Luca, Agricola Eustachio, Ingallina Giacomo, Gaspare Cannone, Nedy Brambilla, Luca Testa, Stefano Avondo, Roberto Valvo, Robin Clarke, Mandy Fish, Michal Kosowski, Magdalena Krawczyk, Piotr Kubler, Tomasz Kotwica, Rui Teles, Pedro Gonçalves, Luis Raposo, Joã Brito, Silvio Leal, Pedro Freitas, Regina Ribeiras, Petra Poliacikova, Peter Marko Mihailovic, Simon Terseglav, Klemen Steblovnik, Miha Cercek, Luka Vitez, Miha Sustersic, Ana Kovac, Polonca Kogoj, Ljupka Dimitrovska, J Raul Delgado Arana, Sandra Santos Martinez, Alfredo Redondo Dieguez, Alejandro Barrero, Esther Gonzalez-Bartol, Cristhian Aristizabal, Ana Serrador Frutos, Juan Pablo Sanchez Luna, Mario Garcia Gomez, Tania Rodriguez Gabella, Verónica Quevedo Nelson, Jose Novoa Medina, Soledad Ojeda, Javier Suarez de Lezo, Miguel Romero, Rafael Gonzalez-Manzanares, Marco Alvarado, Dolores Mesa, Jorge Perea, Petur Petursson, Monér Alchay, Sofie Andréen, Menno Van Gameren, Peter den Heijer, Martijn Meuwissen, Jin M Cheng, Jeroen Vos, B E Schölzel, C Simsek, S Hubbers, Ben J L Van den Branden, N A Stens, Gaa Versteeg, Mjp Rooijakkers, H R Gehlmann, Mwa Verkroost, Gsc Geuzebroek, M H Van Wely, R J Van Geuns, L X van Nunen, Lafm van Garsse, L Timmers, Jurrien Ten Berg, A O Kraaijeveld, M G Dickinson, T C Dessing, M M Mokhles, Andreas Baumbachet al.",2024 Jun 22,Lancet,https://pubmed.ncbi.nlm.nih.gov/38795719/,No keywords found,"['transcatheter', 'aortic', 'valve', 'implantation', 'established', ',', 'guideline-endorsed', 'treatment', 'severe', 'aortic', 'stenosis', '.', 'precise', 'sizing', 'of', 'balloon-expandable', 'myval', 'transcatheter', 'heart', 'valve', '(', 'thv', ')', 'series', 'with', 'aortic', 'annulus', 'facilitated', 'increasing', 'diameter', 'in', 'mm', 'increment', ',', 'compared', 'with', 'usual', 'mm', 'increment', 'in', 'valve', 'size', '.', 'landmark', 'trial', 'aimed', 'to', 'show', 'non-inferiority', 'of', 'myval', 'thv', 'series', 'compared', 'with', 'contemporary', 'thvs', 'sapien', 'series', '(', 'edward', 'lifesciences', ',', 'irvine', ',', 'ca', ',', 'usa', ')', 'or', 'evolut', 'series', '(', 'medtronic', ',', 'minneapolis', ',', 'mn', ',', 'usa', ')', '.', 'method', 'in', 'prospective', ',', 'multinational', ',', 'randomised', ',', 'open-label', ',', 'non-inferiority', 'trial', 'across', 'hospital', 'in', 'country', '(', 'germany', ',', 'france', ',', 'sweden', ',', 'netherlands', ',', 'italy', ',', 'spain', ',', 'new', 'zealand', ',', 'portugal', ',', 'greece', ',', 'hungary', ',', 'poland', ',', 'slovakia', ',', 'slovenia', ',', 'croatia', ',', 'estonia', ',', 'and', 'brazil', ')', ',', 'participant', 'with', 'severe', 'symptomatic', 'native', 'aortic', 'stenosis', 'randomly', 'assigned', '(', ')', 'to', 'myval', 'thv', 'or', 'contemporary', 'thv', '.', 'eligibility', 'primarily', 'decided', 'heart', 'team', 'in', 'accordance', 'with', 'european', 'society', 'of', 'cardiology', 'guideline', '.', 'per', 'criterion', 'of', 'third', 'valve', 'academic', 'research', 'consortium', ',', 'primary', 'endpoint', 'day', 'composite', 'of', 'all-cause', 'mortality', ',', 'stroke', ',', 'bleeding', '(', 'type', 'and', ')', ',', 'acute', 'kidney', 'injury', '(', 'stage', '-', ')', ',', 'major', 'vascular', 'complication', ',', 'moderate', 'or', 'severe', 'prosthetic', 'valve', 'regurgitation', ',', 'and', 'conduction', 'system', 'disturbance', 'resulting', 'in', 'permanent', 'pacemaker', 'implantation', '.', 'non-inferiority', 'of', 'study', 'device', 'tested', 'in', 'intention-to-treat', 'population', 'using', 'non-inferiority', 'margin', 'of', 'and', 'assuming', 'event', 'rate', 'of', '.', 'trial', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', ',', 'and', 'eudract', ',', '--', ',', 'and', 'closed', 'to', 'new', 'participant', '.', 'finding', 'jan', ',', ',', 'and', 'dec', ',', ',', 'participant', 'with', 'severe', 'symptomatic', 'native', 'aortic', 'stenosis', 'randomly', 'assigned', ',', 'to', 'myval', 'thv', 'and', 'to', 'contemporary', 'thv', '.', '(', ')', 'participant', 'sex', 'recorded', 'female', ',', 'and', '(', ')', 'male', '.', 'mean', 'age', 'of', 'participant', 'year', '(', 'sd', ')', 'treated', 'with', 'myval', 'thv', 'and', 'year', '(', ')', 'treated', 'with', 'contemporary', 'thv', '.', 'median', 'society', 'of', 'thoracic', 'surgeon', 'score', 'in', 'group', '(', 'myval', 'iqr', '-', 'v', 'contemporary', '-', ')', '.', 'primary', 'endpoint', 'showed', 'non-inferiority', 'of', 'myval', '(', ')', 'compared', 'with', 'contemporary', 'thv', '(', ')', ',', 'with', 'risk', 'difference', 'of', '-', '(', 'one-sided', 'upper', 'ci', ',', 'pnon-inferiority', ')', '.', 'no', 'significant', 'difference', 'seen', 'in', 'individual', 'component', 'of', 'primary', 'composite', 'endpoint', '.', 'interpretation', 'in', 'individual', 'with', 'severe', 'symptomatic', 'native', 'aortic', 'stenosis', ',', 'myval', 'thv', 'met', 'primary', 'endpoint', 'day', '.', 'funding', 'meril', 'life', 'science', '.']"
Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.,"Miguel A Vazquez, George Oliver, Ruben Amarasingham, Venkatraghavan Sundaram, Kevin Chan, Chul Ahn, Song Zhang, Perry Bickel, Samir M Parikh, Barbara Wells, R Tyler Miller, Susan Hedayati, Jeffrey Hastings, Adeola Jaiyeola, Tuan-Minh Nguyen, Brett Moran, Noel Santini, Blake Barker, Ferdinand Velasco, Lynn Myers, Thomas P Meehan, Chester Fox, Robert D Toto                              ;, ICD-Pieces Study Group, Miguel Vazquez, Robert Toto, Susan Mendley, Andrew Narva, Janet Holden, Maryam Sajjad, Tony Keller, Miguel A Vazquezet al.",2024 Apr 4,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/38598574/,No keywords found,"['despite', 'availability', 'of', 'effective', 'therapy', 'patient', 'with', 'chronic', 'kidney', 'disease', ',', 'type', 'diabetes', ',', 'and', 'hypertension', '(', 'kidney-dysfunction', 'triad', ')', ',', 'result', 'of', 'large-scale', 'trial', 'examining', 'implementation', 'of', 'guideline-directed', 'therapy', 'to', 'reduce', 'risk', 'of', 'death', 'and', 'complication', 'in', 'population', 'lacking', '.', 'method', 'in', 'open-label', ',', 'cluster-randomized', 'trial', ',', 'assigned', ',', 'patient', 'with', 'kidney-dysfunction', 'triad', 'treated', 'primary', 'care', 'clinic', 'either', 'to', 'receive', 'intervention', 'used', 'personalized', 'algorithm', '(', 'based', 'patient', ""'s"", 'electronic', 'health', 'record', 'ehr', ')', 'to', 'identify', 'patient', 'and', 'practice', 'facilitator', 'to', 'assist', 'provider', 'in', 'delivering', 'guideline-based', 'intervention', 'or', 'to', 'receive', 'usual', 'care', '.', 'primary', 'outcome', 'hospitalization', 'cause', 'year', '.', 'secondary', 'outcome', 'included', 'emergency', 'department', 'visit', ',', 'readmission', ',', 'cardiovascular', 'event', ',', 'dialysis', ',', 'and', 'death', '.', 'result', 'assigned', 'practice', '(', 'enrolling', 'patient', ')', 'to', 'intervention', 'group', 'and', 'practice', '(', 'enrolling', 'patient', ')', 'to', 'usual-care', 'group', '.', 'hospitalization', 'rate', 'year', '.', '(', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', 'in', 'intervention', 'group', 'and', '.', '(', 'ci', ',', '.', 'to', '.', ')', 'in', 'usual-care', 'group', '(', 'between-group', 'difference', ',', '.', 'percentage', 'point', 'p', '.', ')', '.', 'risk', 'of', 'emergency', 'department', 'visit', ',', 'readmission', ',', 'cardiovascular', 'event', ',', 'dialysis', ',', 'or', 'death', 'cause', 'similar', 'in', 'two', 'group', '.', 'risk', 'of', 'adverse', 'event', 'also', 'similar', 'in', 'trial', 'group', ',', 'except', 'acute', 'kidney', 'injury', ',', 'observed', 'in', 'patient', 'in', 'intervention', 'group', '(', '.', 'v', '.', '.', ')', '.', 'conclusion', 'in', 'pragmatic', 'trial', 'involving', 'patient', 'with', 'triad', 'of', 'chronic', 'kidney', 'disease', ',', 'type', 'diabetes', ',', 'and', 'hypertension', ',', 'use', 'of', 'ehr-based', 'algorithm', 'and', 'practice', 'facilitator', 'embedded', 'in', 'primary', 'care', 'clinic', 'not', 'translate', 'reduced', 'hospitalization', 'year', '.', '(', 'funded', 'national', 'institute', 'of', 'health', 'and', 'others', 'icd-pieces', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants.,"Girish N Nadkarni, Kinsuk Chauhan, Veena Rao, Joachim H Ix, Michael G Shlipak, Chirag R Parikh, Steven G Coca, Girish N Nadkarniet al.",2019 Jan,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/30291011/,No keywords found,"['random', 'assignment', 'to', 'intensive', 'blood', 'pressure', '(', 'bp', ')', 'lowering', '(', 'systolic', 'bpmmhg', ')', 'compared', 'to', 'less', 'intensive', 'bp', 'target', '(', 'systolic', 'bpmmhg', ')', 'in', 'action', 'to', 'control', 'cardiovascular', 'risk', 'in', 'diabetes', 'bp', '(', 'accord-bp', ')', 'trial', 'resulted', 'in', 'rapid', 'decline', 'in', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', '.', 'whether', 'reflects', 'hemodynamic', 'effect', 'or', 'intrinsic', 'kidney', 'damage', 'unknown', '.', 'study', 'design', 'longitudinal', 'analysis', 'of', 'subgroup', 'of', 'clinical', 'trial', 'participant', '.', 'setting', 'participant', 'subgroup', 'of', 'participant', 'in', 'accord-bp', '.', 'exposure', 'urine', 'biomarkers', 'of', 'tubular', 'injury', '(', 'kidney', 'injury', 'molecule', ',', 'interleukin', 'il-', ')', ',', 'repair', '(', 'human', 'cartilage', 'glycoprotein', 'ykl-', ')', ',', 'and', 'inflammation', '(', 'monocyte', 'chemoattractant', 'protein', ')', 'baseline', 'and', 'year', '.', 'outcome', 'change', 'in', 'egfr', 'baseline', 'to', 'year', '.', 'analytical', 'approach', 'compared', 'change', 'in', 'biomarker', 'level', 'and', 'egfrs', 'across', 'participant', 'treated', 'to', 'intensive', 'versus', 'less', 'intensive', 'bp', 'goal', 'using', 'analysis', 'of', 'covariance', '.', 'result', 'of', 'participant', ',', 'randomly', 'assigned', 'to', 'intensive', 'and', 'to', 'standard', 'bp', 'arm', '.', 'mean', 'age', '.', 'year', 'and', 'egfr', 'mlmin.m', '.', 'baseline', 'clinical', 'characteristic', ',', 'egfrs', ',', 'urinary', 'albumin-creatinine', 'ratio', '(', 'acrs', ')', ',', 'and', 'urinary', 'biomarker', 'level', 'similar', 'across', 'bp', 'treatment', 'group', '.', 'compared', 'to', 'less', 'intensive', 'bp', 'treatment', ',', 'egfr', '.mlmin.m', 'lower', 'in', 'intensive', 'bp', 'treatment', 'group', 'year', '.', 'despite', 'egfr', 'reduction', ',', 'within', 'treatment', 'group', ',', 'acr', 'lower', 'and', 'urinary', 'biomarker', 'level', 'unchanged', 'or', 'lower', 'year', '.', 'also', 'within', 'group', ',', 'participant', 'with', 'largest', 'decline', 'in', 'egfrs', 'greater', 'reduction', 'in', 'urinary', 'il-', 'and', 'ykl-', 'level', '.', 'in', 'subgroup', 'analysis', 'of', 'participant', 'developing', 'incident', 'chronic', 'kidney', 'disease', '(', 'sustained', 'decline', 'and', 'egfrmlmin.m', 'n', ')', ',', 'neither', 'acr', 'biomarker', 'level', 'increased', 'in', 'intensive', 'treatment', 'group', ',', 'whereas', 'level', 'of', 'biomarker', ',', 'il-', ',', 'increased', 'in', 'less', 'intensive', 'treatment', 'group', '.', 'limitation', 'participant', 'with', 'advanced', 'baseline', 'chronic', 'kidney', 'disease', '.', 'comparison', 'across', 'treatment', 'group', 'not', 'represent', 'comparison', 'of', 'treatment', 'arm', 'created', 'solely', 'randomization', '.', 'conclusion', 'among', 'subset', 'of', 'accord-bp', 'trial', 'participant', ',', 'intensive', 'bp', 'control', 'associated', 'with', 'reduction', 'in', 'egfrs', ',', 'not', 'with', 'increase', 'in', 'injury', 'marker', 'level', '.', 'finding', 'support', 'egfr', 'decline', 'observed', 'with', 'intensive', 'bp', 'goal', 'in', 'accord', 'participant', 'may', 'predominantly', 'reflect', 'hemodynamic', 'alteration', '.']"
Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes.,"Christine P Limonte, David K Prince, Andrew N Hoofnagle, Andrzej Galecki, Irl B Hirsch, Frances Tian, Sushrut S Waikar, Helen C Looker, Robert G Nelson, Alessandro Doria, Michael Mauer, Bryan R Kestenbaum, Ian H de Boer, Christine P Limonteet al.",2024 Jan 1,Clin J Am Soc Nephrol,https://pubmed.ncbi.nlm.nih.gov/37871959/,No keywords found,"['whether', 'biomarkers', 'of', 'tubular', 'injury', 'and', 'inflammation', 'indicate', 'subclinical', 'structural', 'kidney', 'pathology', 'early', 'in', 'type', 'diabetes', 'remains', 'unknown', '.', 'method', 'investigated', 'association', 'of', 'biomarkers', 'of', 'tubular', 'injury', 'and', 'inflammation', 'with', 'kidney', 'structural', 'feature', 'in', 'adult', 'with', 'type', 'diabetes', 'renin-angiotensin', 'system', 'study', ',', 'randomized', ',', 'placebo-controlled', 'trial', 'testing', 'effect', 'of', 'enalapril', 'or', 'losartan', 'change', 'in', 'glomerular', ',', 'tubulointerstitial', ',', 'and', 'vascular', 'parameter', 'baseline', 'to', '-year', 'kidney', 'biopsy', '.', 'biosamples', 'biopsy', 'assessed', 'kidney', 'injury', 'molecule', '(', 'kim-', ')', ',', 'soluble', 'tnf', 'receptor', '(', 'stnfr', ')', ',', 'arginine-to-citrulline', 'ratio', 'in', 'plasma', ',', 'and', 'uromodulin', 'and', 'epidermal', 'growth', 'factor', '(', 'egf', ')', 'in', 'urine', '.', 'examined', 'cross-sectional', 'correlation', 'biomarkers', 'and', 'biopsy', 'feature', 'and', 'baseline', 'biomarker', 'association', 'with', '-year', 'change', 'in', 'biopsy', 'feature', '.', 'result', 'participant', ""'"", 'mean', 'age', 'year', '(', 'sd', ')', 'and', 'diabetes', 'duration', 'year', '(', 'sd', ')', 'woman', '.', 'mean', 'gfr', 'measured', 'iohexol', 'disappearance', 'mlmin', 'per', '.', '(', 'sd', ')', 'and', 'median', 'urinary', 'albumin', 'excretion', 'gmin', '(', 'interquartile', 'range', ',', '-', ')', '.', 'kim-', 'associated', 'with', 'biopsy', 'feature', 'higher', 'mesangial', 'fractional', 'volume', '(', '.', 'confidence', 'interval', '(', 'ci', ')', ',', '.', 'to', '.', 'greater', 'per', 'sd', 'kim-', ')', ',', 'glomerular', 'basement', 'membrane', '(', 'gbm', ')', 'width', '(', '.', 'nm', 'ci', ',', '.', 'to', '.', 'thicker', ')', ',', 'cortical', 'interstitial', 'fractional', 'volume', '(', '.', 'ci', ',', '.', 'to', '.', 'greater', ')', ',', 'fractional', 'volume', 'of', 'cortical', 'atrophic', 'tubule', '(', '.', 'ci', ',', '.', 'to', '.', 'greater', ')', ',', 'and', 'arteriolar', 'hyalinosis', 'index', '(', '.', 'ci', ',', '.', 'to', '.', 'higher', ')', '.', 'stnfr', 'associated', 'with', 'higher', 'mesangial', 'fractional', 'volume', '(', '.', 'ci', ',', '.', 'to', '.', 'greater', ')', 'and', 'gbm', 'width', '(', '.', 'nm', 'ci', ',', '.', 'to', '.', 'thicker', ')', 'and', 'lower', 'gbm', 'surface', 'density', '(', '.', 'ci', ',', '.', 'to', '.', 'lesser', ')', '.', 'egf', 'and', 'arginine-to-citrulline', 'ratio', 'correlated', 'with', 'severity', 'of', 'glomerular', 'and', 'tubulointerstitial', 'feature', '.', 'baseline', 'stnfr', ',', 'uromodulin', ',', 'and', 'egf', 'concentration', 'associated', 'with', '-year', 'glomerular', 'and', 'tubulointerstitial', 'feature', 'progression', '.', 'conclusion', 'biomarkers', 'of', 'tubular', 'injury', 'and', 'inflammation', 'associated', 'with', 'kidney', 'structural', 'parameter', 'in', 'early', 'type', 'diabetes', 'and', 'may', 'indicator', 'of', 'kidney', 'disease', 'risk', '.', 'clinical', 'trial', 'registry', 'name', 'and', 'registration', 'number', 'renin', 'angiotensin', 'system', 'study', '(', 'rassb-rass', ')', ',', 'nct', '.', 'podcast', 'article', 'contains', 'podcast', 'httpsdts.podtrac.comredirect.mpwww.asn-online.orgmediapodcastcjasncjn.mp', '.']"
Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.,"Derek J Hausenloy, Luciano Candilio, Richard Evans, Cono Ariti, David P Jenkins, Shyam Kolvekar, Rosemary Knight, Gudrun Kunst, Christopher Laing, Jennifer Nicholas, John Pepper, Steven Robertson, Maria Xenou, Tim Clayton, Derek M Yellon;, ERICCA Trial Investigators, Derek J Hausenloyet al.",2015 Oct 8,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/26436207/,No keywords found,"['whether', 'remote', 'ischemic', 'preconditioning', '(', 'transient', 'ischemia', 'and', 'reperfusion', 'of', 'arm', ')', 'improve', 'clinical', 'outcome', 'in', 'patient', 'undergoing', 'coronary-artery', 'bypass', 'graft', '(', 'cabg', ')', 'surgery', 'not', 'known', '.', 'investigated', 'question', 'in', 'randomized', 'trial', '.', 'method', 'conducted', 'multicenter', ',', 'sham-controlled', 'trial', 'involving', 'adult', 'increased', 'surgical', 'risk', 'undergoing', 'on-pump', 'cabg', '(', 'with', 'or', 'without', 'valve', 'surgery', ')', 'with', 'blood', 'cardioplegia', '.', 'anesthesia', 'induction', 'and', 'surgical', 'incision', ',', 'patient', 'randomly', 'assigned', 'to', 'remote', 'ischemic', 'preconditioning', '(', 'four', '-minute', 'inflation', 'and', 'deflation', 'of', 'standard', 'blood-pressure', 'cuff', 'upper', 'arm', ')', 'or', 'sham', 'conditioning', '(', 'control', 'group', ')', '.', 'anesthetic', 'management', 'and', 'perioperative', 'care', 'not', 'standardized', '.', 'combined', 'primary', 'end', 'point', 'death', 'cardiovascular', 'cause', ',', 'nonfatal', 'myocardial', 'infarction', ',', 'coronary', 'revascularization', ',', 'or', 'stroke', ',', 'assessed', 'month', 'randomization', '.', 'result', 'enrolled', 'total', 'of', 'patient', '(', 'in', 'control', 'group', 'and', 'in', 'ischemic-preconditioning', 'group', ')', 'cardiac', 'surgery', 'center', 'in', 'united', 'kingdom', '.', 'no', 'significant', 'difference', 'in', 'cumulative', 'incidence', 'of', 'primary', 'end', 'point', 'month', 'patient', 'in', 'remote', 'ischemic', 'preconditioning', 'group', 'and', 'in', 'control', 'group', '(', 'patient', '.', 'and', 'patient', '.', ',', 'respectively', 'hazard', 'ratio', 'with', 'ischemic', 'preconditioning', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', 'p.', ')', '.', 'furthermore', ',', 'no', 'significant', 'between-group', 'difference', 'in', 'either', 'adverse', 'event', 'or', 'secondary', 'end', 'point', 'of', 'perioperative', 'myocardial', 'injury', '(', 'assessed', 'basis', 'of', 'area', 'curve', 'high-sensitivity', 'assay', 'of', 'serum', 'troponin', 'hour', ')', ',', 'inotrope', 'score', '(', 'calculated', 'maximum', 'dose', 'of', 'individual', 'inotropic', 'agent', 'administered', 'in', 'first', 'day', 'surgery', ')', ',', 'acute', 'kidney', 'injury', ',', 'duration', 'of', 'stay', 'in', 'intensive', 'care', 'unit', 'and', 'hospital', ',', 'distance', '-minute', 'walk', 'test', ',', 'and', 'quality', 'of', 'life', '.', 'conclusion', 'remote', 'ischemic', 'preconditioning', 'not', 'improve', 'clinical', 'outcome', 'in', 'patient', 'undergoing', 'elective', 'on-pump', 'cabg', 'with', 'or', 'without', 'valve', 'surgery', '.', '(', 'funded', 'efficacy', 'and', 'mechanism', 'evaluation', 'program', 'medical', 'research', 'council', 'and', 'national', 'institute', 'of', 'health', 'research', 'partnership', 'and', 'british', 'heart', 'foundation', 'ericca', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.,"William F Fearon, Frederik M Zimmermann, Bernard De Bruyne, Zsolt Piroth, Albert H M van Straten, Laszlo Szekely, Giedrius Davidavičius, Gintaras Kalinauskas, Samer Mansour, Rajesh Kharbanda, Nikolaos Östlund-Papadogeorgos, Adel Aminian, Keith G Oldroyd, Nawwar Al-Attar, Nikola Jagic, Jan-Henk E Dambrink, Petr Kala, Oskar Angerås, Philip MacCarthy, Olaf Wendler, Filip Casselman, Nils Witt, Kreton Mavromatis, Steven E S Miner, Jaydeep Sarma, Thomas Engstrøm, Evald H Christiansen, Pim A L Tonino, Michael J Reardon, Di Lu, Victoria Y Ding, Yuhei Kobayashi, Mark A Hlatky, Kenneth W Mahaffey, Manisha Desai, Y Joseph Woo, Alan C Yeung, Nico H J Pijls                              ;, FAME  Investigators, Ravinay Bhindi, Peter Brady, Andy Yong, Tristan Yan, Martin Ng, Brian Plunkett, Jamie Layland, Andrew Newcomb, James Sapontis, Julian Smith, Kaleab Asrress, Badih El Nakadi, Nicolas Noiseux, Steve Miner, Charles Peniston, Aun-Yeong Chong, David Glineur, Kunal Minhas, Michael Raab, Petr Nemec, Thomas Engstroem, Gustav Thyregod, Evald Christiansen, Ivy Modrau, Gilles Rioufol, Fadi Farhat, Lazlo Szekely, Seung-Jung Park, Suk Jung Choo, Giedrius Davidavicius, Nico H J Pijls, Bart Van Straten, Henk Jan Dambrik, Brandon Bruinsma, G J W Bech, G J W Hoohenkerk, Alf Inge Larsen, Rune Haaverstad, Madhav Menon, Adam El Gamel, Miodrag Sreckovic, Milenko Rosic, Branko Beleslin, Svetozar Putnik, Matthias Corbascio, Nikolaos Ostlund-Papadogeorgos, Oskar Angeras, Anders Jeppsson, Keith Oldroyd, Colin Berry, Stuart Watkins, Nawar Al-Attar, Nick Curzen, Szaboles Miskolczi, Ohri Sunil, James Barnard, Luke Tapp, Thomas Baker, Simon Redwood, Christopher Young, Rana Sayeed, Duc Nguyen, William H Matthai, Pavan Atluri, Mladen Vidovich, Michael Eng, Anthony Perez-Tamayo, Celina Yong, William Fearon, John Giacomini, Thomas Burdon, Peter Tadros, George Zorn, Alpesh Shah, Michael Reardon, Paul Myers, Seenu Reddy, Michael Ragosta, Gorav Ailawadi, Talhat Azemi, Mohiuddin Cheema, David Underhill, Robert Hagberg, David Booth, Amir Lotfi, Sotiris Stamou, Joseph Woo, Victoria Ding, Jaden Yang, Kristopher Kapphahn, Morton Kern, James Min, Peyman Benharash, Kenneth Mahaffey, Waimei Amy Tai, Mun Hong, Shu Lin, William Jones, Manesh Patel, Yasuhiro Honda, Mark Hlatky, William F Fearonet al.",2022 Jan 13,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/34735046/,No keywords found,"['patient', 'with', 'three-vessel', 'coronary', 'artery', 'disease', 'found', 'to', 'better', 'outcome', 'with', 'coronary-artery', 'bypass', 'grafting', '(', 'cabg', ')', 'with', 'percutaneous', 'coronary', 'intervention', '(', 'pci', ')', ',', 'study', 'in', 'pci', 'guided', 'measurement', 'of', 'fractional', 'flow', 'reserve', '(', 'ffr', ')', 'lacking', '.', 'method', 'in', 'multicenter', ',', 'international', ',', 'noninferiority', 'trial', ',', 'patient', 'with', 'three-vessel', 'coronary', 'artery', 'disease', 'randomly', 'assigned', 'to', 'undergo', 'cabg', 'or', 'ffr-guided', 'pci', 'with', 'current-generation', 'zotarolimus-eluting', 'stent', '.', 'primary', 'end', 'point', 'occurrence', 'within', 'year', 'of', 'major', 'adverse', 'cardiac', 'or', 'cerebrovascular', 'event', ',', 'defined', 'death', 'cause', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'or', 'repeat', 'revascularization', '.', 'noninferiority', 'of', 'ffr-guided', 'pci', 'to', 'cabg', 'prespecified', 'upper', 'boundary', 'of', 'less', '.', 'confidence', 'interval', 'of', 'hazard', 'ratio', '.', 'secondary', 'end', 'point', 'included', 'composite', 'of', 'death', ',', 'myocardial', 'infarction', ',', 'or', 'stroke', 'safety', 'also', 'assessed', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', 'center', '.', 'patient', 'assigned', 'to', 'undergo', 'pci', 'received', 'mean', '(', 'sd', ')', 'of', '..', 'stent', ',', 'and', 'assigned', 'to', 'undergo', 'cabg', 'received', '..', 'distal', 'anastomosis', '.', '-year', 'incidence', 'of', 'composite', 'primary', 'end', 'point', '.', 'among', 'patient', 'randomly', 'assigned', 'to', 'undergo', 'ffr-guided', 'pci', 'and', '.', 'among', 'assigned', 'to', 'undergo', 'cabg', '(', 'hazard', 'ratio', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', ')', ',', 'finding', 'not', 'consistent', 'with', 'noninferiority', 'of', 'ffr-guided', 'pci', '(', 'p', '.', 'noninferiority', ')', '.', 'incidence', 'of', 'death', ',', 'myocardial', 'infarction', ',', 'or', 'stroke', '.', 'in', 'ffr-guided', 'pci', 'group', 'and', '.', 'in', 'cabg', 'group', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', ')', '.', 'incidence', 'of', 'major', 'bleeding', ',', 'arrhythmia', ',', 'and', 'acute', 'kidney', 'injury', 'higher', 'in', 'cabg', 'group', 'in', 'ffr-guided', 'pci', 'group', '.', 'conclusion', 'in', 'patient', 'with', 'three-vessel', 'coronary', 'artery', 'disease', ',', 'ffr-guided', 'pci', 'not', 'found', 'to', 'noninferior', 'to', 'cabg', 'with', 'respect', 'to', 'incidence', 'of', 'composite', 'of', 'death', ',', 'myocardial', 'infarction', ',', 'stroke', ',', 'or', 'repeat', 'revascularization', 'year', '.', '(', 'funded', 'medtronic', 'and', 'abbott', 'vascular', 'fame', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.","Simon P Bach, Alexandra Gilbert, Kristian Brock, Stephan Korsgen, Ian Geh, James Hill, Talvinder Gill, Paul Hainsworth, Matthew G Tutton, Jim Khan, Jonathan Robinson, Mark Steward, Christopher Cunningham, Bruce Levy, Alan Beveridge, Kelly Handley, Manjinder Kaur, Natalie Marchevsky, Laura Magill, Ann Russell, Philip Quirke, Nicholas P West, David Sebag-Montefiore                              ;, TREC collaborators, Gina Brown, Peter Antonio, Alex Vince, Nick Hilken, Chakanaka Sidile, Adrian Wilcockson, Richard Peto, Tom Crosby, Brendan Moran, Julie Olliff, Katti Ashok, Simone Slawik, Andrew Smethurst, Rajaram Sripadam, Veena Tagore, Monica Terlizzo, Bearn Philip, Robert Davies, Susan Dodd, Sharadah Essapen, Pasha Nisar, Alexandra Stewart, Jonathan Trickett, Bansal Ashish, Peter Billings, Palanichamy Chandran, Conor Corr, Edward Favill, Simon Gollins, Peter Marsh, Andrew Maw, Rakha Neupane, Ramesh Rajagopal, Rachel Cooper, John Griffith, Paul Hatfield, Andy Lowe, Julian Ostrowski, Rhian Simpson, Richard Adams, Robert Bleehen, Michael Davies, Meleri Morgan, Darren Boone, Nicola Lacey, Ian Seddon, Bruce Sizer, Helen Stunell, Shaobin Wu, Maher Hadaki, Dominic Blunt, Susan Cleator, Ara Darzi, Robert Goldin, Paul Ziprin, Mike Dobson, Mark Pitt, Shabbir Susnerwala, Deborah Williamson, Georgina Howarth, Stephen Lee, Paul Wright, Tim Hoare, Alan Horgan, Fiona McDonald, Stephanie Needham, John Scott, Timothy Simmons, Debashis Biswas, James Hernon, Gaurav Kapur, Sandeep Kapur, James Sington, Christopher Speakman, William Stebbings, Stuart Williams, Madhavi Adusumalli, Anil Agarwal, David Borowski, Dharmendra Garg, Mohammed Hegab, Catherine Hobday, Veena Rao, Jyotsna Shrimankar, Mohamed Tabaqchali, David Wilson, Oliver Jones, Neil Mortensen, Andrew Slater, Aron Szuts, Lai Wang, Bryan Warren, Andrew Weaver, Mukhtar Ahmad, Julian Alexander, Maxine Flubacher, David Tarver, Suhail Baluch, Richard Beable, David Cowlishaw, Antony Higginson, Prokopios Vogiatzis, Neil Cruickshank, Howard Joy, David Peake, Ulises Zanetto, Mark Saunders, Arthur Sun-Myint, Mark Teo, Arthur Allan, John Glaholm, Mark Goldstein, Rahul Hejmadi, Gerald Langman, Dion Morton, Cyril Nelson, Deborah Tattersall, Stephen Falk, Robert Longman, Huw Roach, Jamshed Shabbir, Golda Shelley-Fraser, Michael Thomas, Neil Cripps, Yasser Haba, Guy Harris, Max Hookway, Jay Simson, Angela Skull, Tijani Umar, Simon P Bachet al.",2021 Feb,Lancet Gastroenterol Hepatol,https://pubmed.ncbi.nlm.nih.gov/33308452/,No keywords found,"['radical', 'surgery', 'via', 'total', 'mesorectal', 'excision', 'might', 'not', 'optimal', 'first-line', 'treatment', 'early-stage', 'rectal', 'cancer', '.', 'organ-preserving', 'strategy', 'with', 'selective', 'total', 'mesorectal', 'excision', 'could', 'reduce', 'adverse', 'effect', 'of', 'treatment', 'without', 'substantially', 'compromising', 'oncological', 'outcome', '.', 'investigated', 'feasibility', 'of', 'recruiting', 'patient', 'to', 'randomised', 'trial', 'comparing', 'organ-preserving', 'strategy', 'with', 'total', 'mesorectal', 'excision', '.', 'method', 'trec', 'randomised', ',', 'open-label', 'feasibility', 'study', 'done', 'tertiary', 'referral', 'centre', 'in', 'uk', '.', 'eligible', 'participant', 'aged', 'year', 'or', 'older', 'with', 'rectal', 'adenocarcinoma', ',', 'staged', 'or', 'lower', ',', 'with', 'maximum', 'diameter', 'of', 'mm', 'or', 'less', 'patient', 'with', 'lymph', 'node', 'involvement', 'or', 'metastasis', 'excluded', '.', 'patient', 'randomly', 'allocated', '(', ')', 'use', 'of', 'computer-based', 'randomisation', 'service', 'to', 'undergo', 'organ', 'preservation', 'with', 'short-course', 'radiotherapy', 'followed', 'transanal', 'endoscopic', 'microsurgery', '-', 'week', ',', 'or', 'total', 'mesorectal', 'excision', '.', 'transanal', 'endoscopic', 'microsurgery', 'specimen', 'showed', 'histopathological', 'feature', 'associated', 'with', 'increased', 'risk', 'of', 'local', 'recurrence', ',', 'patient', 'considered', 'planned', 'early', 'conversion', 'to', 'total', 'mesorectal', 'excision', '.', 'non-randomised', 'prospective', 'registry', 'captured', 'patient', 'randomisation', 'considered', 'inappropriate', ',', 'of', 'strong', 'clinical', 'indication', 'one', 'treatment', 'group', '.', 'primary', 'endpoint', 'cumulative', 'randomisation', ',', ',', 'and', 'month', '.', 'secondary', 'outcome', 'evaluated', 'safety', ',', 'efficacy', ',', 'and', 'health-related', 'quality', 'of', 'life', 'assessed', 'with', 'european', 'organisation', 'research', 'and', 'treatment', 'of', 'cancer', '(', 'eortc', ')', 'qlq', 'c', 'and', 'cr', 'in', 'intention-to-treat', 'population', '.', 'trial', 'registered', 'with', 'isrctn', 'registry', ',', 'isrctn', '.', 'finding', 'feb', ',', ',', 'and', 'dec', ',', ',', 'patient', 'randomly', 'assigned', 'site', 'to', 'organ', 'preservation', 'and', 'to', 'radical', 'surgery', '.', 'cumulatively', ',', 'patient', 'randomly', 'assigned', 'month', ',', 'month', ',', 'and', 'month', '.', 'no', 'patient', 'died', 'within', 'day', 'of', 'initial', 'treatment', ',', 'one', 'patient', 'randomly', 'assigned', 'to', 'organ', 'preservation', 'died', 'within', 'month', 'following', 'conversion', 'to', 'total', 'mesorectal', 'excision', 'with', 'anastomotic', 'leakage', '.', 'eight', '(', ')', 'of', 'patient', 'randomly', 'assigned', 'to', 'organ', 'preservation', 'converted', 'to', 'total', 'mesorectal', 'excision', '.', 'serious', 'adverse', 'event', 'reported', 'in', 'four', '(', ')', 'of', 'patient', 'randomly', 'assigned', 'to', 'organ', 'preservation', 'versus', '(', ')', 'of', 'randomly', 'assigned', 'to', 'total', 'mesorectal', 'excision', '(', 'p', ',', 'test', ')', '.', 'serious', 'adverse', 'event', 'associated', 'with', 'organ', 'preservation', 'commonly', 'due', 'to', 'rectal', 'bleeding', 'or', 'pain', 'following', 'transanal', 'endoscopic', 'microsurgery', '(', 'reported', 'in', 'three', 'case', ')', '.', 'radical', 'total', 'mesorectal', 'excision', 'associated', 'with', 'medical', 'and', 'surgical', 'complication', 'including', 'anastomotic', 'leakage', '(', 'two', 'patient', ')', ',', 'kidney', 'injury', '(', 'two', 'patient', ')', ',', 'cardiac', 'arrest', '(', 'one', 'patient', ')', ',', 'and', 'pneumonia', '(', 'two', 'patient', ')', '.', 'histopathological', 'feature', 'would', 'considered', 'to', 'associated', 'with', 'increased', 'risk', 'of', 'tumour', 'recurrence', 'observed', 'transanal', 'endoscopic', 'microsurgery', 'alone', 'present', 'in', '(', ')', 'of', 'patient', 'randomly', 'assigned', 'to', 'organ', 'preservation', ',', 'versus', '(', ')', 'of', 'randomly', 'assigned', 'to', 'total', 'mesorectal', 'excision', '(', 'p', ',', 'test', ')', '.', 'eight', '(', ')', 'of', 'patient', 'assigned', 'to', 'organ', 'preservation', 'achieved', 'complete', 'response', 'to', 'radiotherapy', '.', 'patient', 'randomly', 'assigned', 'to', 'organ', 'preservation', 'showed', 'improvement', 'in', 'patient-reported', 'bowel', 'toxicity', 'and', 'quality', 'of', 'life', 'and', 'function', 'score', 'in', 'multiple', 'item', 'compared', 'to', 'randomly', 'assigned', 'to', 'total', 'mesorectal', 'excision', ',', 'sustained', 'month', ""'"", 'follow-up', '.', 'non-randomised', 'registry', 'comprised', 'patient', 'underwent', 'organ', 'preservation', 'and', 'seven', 'underwent', 'radical', 'surgery', '.', 'non-randomised', 'patient', 'underwent', 'organ', 'preservation', 'older', 'randomised', 'patient', 'and', 'likely', 'to', 'life-limiting', 'comorbidities', '.', 'serious', 'adverse', 'event', 'occurred', 'in', 'ten', '(', ')', 'of', 'non-randomised', 'patient', 'underwent', 'organ', 'preservation', 'versus', 'one', '(', ')', 'of', 'seven', 'underwent', 'total', 'mesorectal', 'excision', '.', '(', ')', 'of', 'non-randomised', 'patient', 'underwent', 'organ', 'preservation', 'high-risk', 'histopathological', 'feature', ',', '(', ')', 'of', 'achieved', 'complete', 'response', '.', 'overall', ',', 'organ', 'preservation', 'achieved', 'in', '(', ')', 'of', 'randomised', 'patient', 'and', '(', ')', 'of', 'non-randomised', 'patient', '.', 'interpretation', 'short-course', 'radiotherapy', 'followed', 'transanal', 'endoscopic', 'microsurgery', 'achieves', 'high', 'level', 'of', 'organ', 'preservation', ',', 'with', 'relatively', 'low', 'morbidity', 'and', 'indication', 'of', 'improved', 'quality', 'of', 'life', '.', 'data', 'support', 'use', 'of', 'organ', 'preservation', 'patient', 'considered', 'unsuitable', 'primary', 'total', 'mesorectal', 'excision', 'due', 'to', 'short-term', 'risk', 'associated', 'with', 'surgery', ',', 'and', 'support', 'evaluation', 'of', 'short-course', 'radiotherapy', 'to', 'achieve', 'organ', 'preservation', 'in', 'patient', 'considered', 'fit', 'total', 'mesorectal', 'excision', '.', 'larger', 'randomised', 'study', ',', 'ongoing', 'star-trec', 'study', ',', 'needed', 'to', 'precisely', 'determine', 'oncological', 'outcome', 'following', 'different', 'organ', 'preservation', 'treatment', 'schedule', '.', 'funding', 'cancer', 'research', 'uk', '.']"
Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU.,"Jan Gunst, Yves Debaveye, Fabian Güiza, Jasperina Dubois, Astrid De Bruyn, Dieter Dauwe, Erwin De Troy, Michael P Casaer, Greet De Vlieger, Renata Haghedooren, Bart Jacobs, Geert Meyfroidt, Catherine Ingels, Jan Muller, Dirk Vlasselaers, Lars Desmet, Liese Mebis, Pieter J Wouters, Björn Stessel, Laurien Geebelen, Jeroen Vandenbrande, Michiel Brands, Ine Gruyters, Ester Geerts, Ilse De Pauw, Joris Vermassen, Harlinde Peperstraete, Eric Hoste, Jan J De Waele, Ingrid Herck, Pieter Depuydt, Alexander Wilmer, Greet Hermans, Dominique D Benoit, Greet Van den Berghe                              ;, TGC-Fast Collaborators, Greet Van den Berghe, Philippe Huynen, Colin Coucke, Alexander Dehouwer, Simon De Ridder, Melanie Dekeyser, Annelies Dionys, Maarten Hendrickx, Mieke Maeckelberghe, Jolien Schildermans, Walter Staelens, Alexandra Hendrickx, Heidi Utens, Hanna Van Cleemput, Sylvia Van Hulle, Katleen Witpas, Philippe Meersseman, Joost Wauters, Marijke Peetermans, Ina Callebaut, Greetje Coninckx, Philippe Jamaer, Marijke Nulens, Vital Swinnen, Jeroen Herbots, Liesbeth Heremans, Johan Hermans, Noor Berends, Michiel Van Tornout, Dirk Vranken, Hassanin Jalil, Jan Fierens, Patrick Druwé, Sandra Oeyen, Liesbet De Bus, Kirsten Colpaert, Lander Vanhulle, Carl Roosens, Johan Decruyenaere, Klaas Vanderbiest, Wim Vandenberghe, Lien Van Laethem, Hannah Schaubroeck, Julie Dillemans, Thomas Couck, Daisy Vermeiren, Jolien Van Hecke, Anouska De Smeytere, Lesley Decoster, Bram Gadeyne, Veerle Brams, Jan Gunstet al.",2023 Sep 28,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/37754283/,No keywords found,"['randomized', ',', 'controlled', 'trial', 'shown', 'benefit', 'and', 'harm', 'tight', 'blood-glucose', 'control', 'in', 'patient', 'in', 'intensive', 'care', 'unit', '(', 'icu', ')', '.', 'variation', 'in', 'use', 'of', 'early', 'parenteral', 'nutrition', 'and', 'in', 'insulin-induced', 'severe', 'hypoglycemia', 'might', 'explain', 'inconsistency', '.', 'method', 'randomly', 'assigned', 'patient', ',', 'icu', 'admission', ',', 'to', 'liberal', 'glucose', 'control', '(', 'insulin', 'initiated', 'blood-glucose', 'level', 'mg', 'per', 'deciliter', '.', 'mmol', 'per', 'liter', ')', 'or', 'to', 'tight', 'glucose', 'control', '(', 'blood-glucose', 'level', 'targeted', 'with', 'use', 'of', 'logic-insulin', 'algorithm', 'to', 'mg', 'per', 'deciliter', '.', 'to', '.', 'mmol', 'per', 'liter', ')', 'parenteral', 'nutrition', 'withheld', 'in', 'group', 'week', '.', 'protocol', 'adherence', 'determined', 'according', 'to', 'glucose', 'metric', '.', 'primary', 'outcome', 'length', 'of', 'time', 'icu', 'care', 'needed', ',', 'calculated', 'basis', 'of', 'time', 'to', 'discharge', 'alive', 'icu', ',', 'with', 'death', 'accounted', 'competing', 'risk', '-day', 'mortality', 'safety', 'outcome', '.', 'result', 'of', 'patient', 'underwent', 'randomization', ',', 'assigned', 'to', 'liberal', 'glucose', 'control', 'and', 'to', 'tight', 'glucose', 'control', '.', 'median', 'morning', 'blood-glucose', 'level', 'mg', 'per', 'deciliter', '(', 'interquartile', 'range', ',', 'to', ')', 'with', 'liberal', 'glucose', 'control', 'and', 'mg', 'per', 'deciliter', '(', 'interquartile', 'range', ',', 'to', ')', 'with', 'tight', 'glucose', 'control', '.', 'severe', 'hypoglycemia', 'occurred', 'in', 'patient', '(', '.', ')', 'in', 'liberal-control', 'group', 'and', 'patient', '(', '.', ')', 'in', 'tight-control', 'group', '.', 'length', 'of', 'time', 'icu', 'care', 'needed', 'similar', 'in', 'two', 'group', '(', 'hazard', 'ratio', 'earlier', 'discharge', 'alive', 'with', 'tight', 'glucose', 'control', ',', '.', 'confidence', 'interval', ',', '.', 'to', '.', 'p', '.', ')', '.', 'mortality', 'day', 'also', 'similar', '(', '.', 'with', 'liberal', 'glucose', 'control', 'and', '.', 'with', 'tight', 'glucose', 'control', ',', 'p', '.', ')', '.', 'analysis', 'of', 'eight', 'prespecified', 'secondary', 'outcome', 'suggested', 'incidence', 'of', 'new', 'infection', ',', 'duration', 'of', 'respiratory', 'and', 'hemodynamic', 'support', ',', 'time', 'to', 'discharge', 'alive', 'hospital', ',', 'and', 'mortality', 'in', 'icu', 'and', 'hospital', 'similar', 'in', 'two', 'group', ',', 'whereas', 'severe', 'acute', 'kidney', 'injury', 'and', 'cholestatic', 'liver', 'dysfunction', 'appeared', 'less', 'prevalent', 'with', 'tight', 'glucose', 'control', '.', 'conclusion', 'in', 'critically', 'ill', 'patient', 'not', 'receiving', 'early', 'parenteral', 'nutrition', ',', 'tight', 'glucose', 'control', 'not', 'affect', 'length', 'of', 'time', 'icu', 'care', 'needed', 'or', 'mortality', '.', '(', 'funded', 'research', 'foundation-flanders', 'and', 'others', 'tgc-fast', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
"Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.","Alexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, Leo M A Heunks, Bruno Mourvillier, Sanne de Bruin, Endry H T Lim, Matthijs C Brouwer, Pieter R Tuinman, José F K Saraiva, Gernot Marx, Suzana M Lobo, Rodrigo Boldo, Jesus A Simon-Campos, Alexander D Cornet, Anastasia Grebenyuk, Johannes M Engelbrecht, Murimisi Mukansi, Philippe G Jorens, Robert Zerbib, Simon Rückinger, Korinna Pilz, Renfeng Guo, Diederik van de Beek, Niels C Riedemann                              ;, PANAMO study group, José Francisco K Saraiva, Suzana Lobo, Jesus Simon-Campos, Johannes Engelbrecht, Niels C Riedemann, Pierre Bulpa, Fabio S Taccone, Greet Hermans, Marc Diltoer, Michael Piagnerelli, Nikolaas De Neve, Antonio T Freire, Felipe D Pizzol, Anna Karolina Marinho, Victor H Sato, Clovis Arns da Cunha, Mathilde Neuville, Jean Dellamonica, Djillali Annane, Antoine Roquilly, Jean Luc Diehl, Francis Schneider, Jean Paul Mira, Jean Baptiste Lascarrou, Luc Desmedt, Claire Dupuis, Carole Schwebel, Guillaume Thiéry, Matthias Gründling, Marc Berger, Tobias Welte, Michael Bauer, Ulrich Jaschinski, Klaus Matschke, Roberto Mercado-Longoria, Belinda Gomez Quintana, Jorge Alberto Zamudio-Lerma, Juan Moreno Hoyos Abril, Angel Aleman Marquez, Peter Pickkers, Luuk Otterspoor, Luis Hercilla Vásquez, Carlos Rafael Seas Ramos, Alejandro Peña Villalobos, Gonzalo Gianella Malca, Victoria Chávez, Victor Filimonov, Vladimir Kulabukhov, Pinak Acharya, Sjoerd A M E G Timmermans, Matthias H Busch, Floor L F van Baarle, Rutger Koning, Liora Ter Horst, Nora Chekrouni, Thijs M van Soest, Marleen A Slim, Lonneke A van Vught, Rombout B E van Amstel, Sabine E Olie, Ingeborg E van Zeggeren, Marcel C G van de Poll, Claus Thielert, Dorothee Neukirchen, Alexander P J Vlaaret al.",2022 Dec,Lancet Respir Med,https://pubmed.ncbi.nlm.nih.gov/36087611/,No keywords found,"['vilobelimab', ',', 'anti-ca', 'monoclonal', 'antibody', ',', 'shown', 'to', 'safe', 'in', 'phase', 'trial', 'of', 'invasively', 'mechanically', 'ventilated', 'patient', 'with', 'covid-', '.', ',', 'aimed', 'to', 'determine', 'whether', 'vilobelimab', 'in', 'addition', 'to', 'standard', 'of', 'care', 'improves', 'survival', 'outcome', 'in', 'patient', 'population', '.', 'method', 'randomised', ',', 'double-blind', ',', 'placebo-controlled', ',', 'multicentre', 'phase', 'trial', 'performed', 'hospital', 'in', 'netherlands', ',', 'germany', ',', 'france', ',', 'belgium', ',', 'russia', ',', 'brazil', ',', 'peru', ',', 'mexico', ',', 'and', 'south', 'africa', '.', 'participant', 'aged', 'year', 'or', 'older', 'receiving', 'invasive', 'mechanical', 'ventilation', ',', 'not', 'h', 'intubation', 'time', 'of', 'first', 'infusion', ',', 'paofio', 'ratio', 'of', '-', 'mm', 'hg', ',', 'and', 'confirmed', 'sars-cov-', 'infection', 'with', 'variant', 'in', 'past', 'day', 'eligible', 'study', '.', 'eligible', 'patient', 'randomly', 'assigned', '(', ')', 'to', 'receive', 'standard', 'of', 'care', 'and', 'vilobelimab', 'dose', 'of', 'mg', 'intravenously', 'maximum', 'of', 'six', 'dos', '(', 'day', ',', ',', ',', ',', ',', 'and', ')', 'or', 'standard', 'of', 'care', 'and', 'matching', 'placebo', 'using', 'permuted', 'block', 'randomisation', '.', 'treatment', 'not', 'continued', 'hospital', 'discharge', '.', 'participant', ',', 'caregiver', ',', 'and', 'assessor', 'masked', 'to', 'group', 'assignment', '.', 'primary', 'outcome', 'defined', 'all-cause', 'mortality', 'day', 'in', 'full', 'analysis', 'set', '(', 'defined', 'randomly', 'assigned', 'participant', 'regardless', 'of', 'whether', 'patient', 'started', 'treatment', ',', 'excluding', 'patient', 'randomly', 'assigned', 'in', 'error', ')', 'and', 'measured', 'using', 'kaplan-meier', 'analysis', '.', 'safety', 'analysis', 'included', 'patient', 'received', 'least', 'one', 'infusion', 'of', 'either', 'vilobelimab', 'or', 'placebo', '.', 'study', 'registered', 'with', 'clinicaltrials.gov', ',', 'nct', '.', 'finding', 'oct', ',', ',', 'to', 'oct', ',', ',', 'included', 'patient', 'in', 'itt', 'analysis', '(', 'full', 'analysis', 'set', 'in', 'vilobelimab', 'group', 'and', 'in', 'placebo', 'group', ')', '.', 'one', 'patient', 'in', 'vilobelimab', 'group', 'excluded', 'primary', 'analysis', 'due', 'to', 'random', 'assignment', 'in', 'error', 'without', 'treatment', '.', 'least', 'one', 'dose', 'of', 'study', 'treatment', 'given', 'to', '(', ')', 'patient', '(', 'safety', 'analysis', 'set', ')', '.', 'patient', '(', ')', 'of', 'in', 'vilobelimab', 'group', 'and', 'patient', '(', ')', 'of', 'in', 'placebo', 'group', 'died', 'in', 'first', 'day', '.', 'all-cause', 'mortality', 'rate', 'day', '(', 'ci', '-', ')', 'in', 'vilobelimab', 'group', 'and', '(', '-', ')', 'in', 'placebo', 'group', '(', 'hazard', 'ratio', ',', 'ci', '-', 'p', ')', '.', 'in', 'predefined', 'analysis', 'without', 'site-stratification', ',', 'vilobelimab', 'significantly', 'reduced', 'all-cause', 'mortality', 'day', '(', 'hr', ',', 'ci', '-', 'p', ')', '.', 'common', 'teaes', 'acute', 'kidney', 'injury', '(', 'of', 'in', 'vilobelimab', 'group', 'v', 'of', 'in', 'placebo', ')', ',', 'pneumonia', '(', 'v', ')', ',', 'and', 'septic', 'shock', '(', 'v', ')', '.', 'serious', 'treatment-emergent', 'adverse', 'event', 'reported', 'in', '(', ')', 'of', 'patient', 'in', 'vilobelimab', 'group', 'versus', '(', ')', 'of', 'in', 'placebo', 'group', '.', 'interpretation', 'in', 'addition', 'to', 'standard', 'of', 'care', ',', 'vilobelimab', 'improves', 'survival', 'of', 'invasive', 'mechanically', 'ventilated', 'patient', 'with', 'covid-', 'and', 'lead', 'to', 'significant', 'decrease', 'in', 'mortality', '.', 'vilobelimab', 'could', 'considered', 'additional', 'therapy', 'patient', 'in', 'setting', 'and', 'research', 'needed', 'role', 'of', 'vilobelimab', 'and', 'ca', 'in', 'acute', 'respiratory', 'distress', 'syndrome-causing', 'viral', 'infection', '.', 'funding', 'inflarx', 'and', 'german', 'federal', 'government', '.']"
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.,"Martin B Leon, Craig R Smith, Michael J Mack, Raj R Makkar, Lars G Svensson, Susheel K Kodali, Vinod H Thourani, E Murat Tuzcu, D Craig Miller, Howard C Herrmann, Darshan Doshi, David J Cohen, Augusto D Pichard, Samir Kapadia, Todd Dewey, Vasilis Babaliaros, Wilson Y Szeto, Mathew R Williams, Dean Kereiakes, Alan Zajarias, Kevin L Greason, Brian K Whisenant, Robert W Hodson, Jeffrey W Moses, Alfredo Trento, David L Brown, William F Fearon, Philippe Pibarot, Rebecca T Hahn, Wael A Jaber, William N Anderson, Maria C Alu, John G Webb                              ;, PARTNER  Investigators, Martin B Leonet al.",2016 Apr 28,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/27040324/,No keywords found,"['previous', 'trial', 'shown', 'among', 'high-risk', 'patient', 'with', 'aortic', 'stenosis', ',', 'survival', 'rate', 'similar', 'with', 'transcatheter', 'aortic-valve', 'replacement', '(', 'tavr', ')', 'and', 'surgical', 'aortic-valve', 'replacement', '.', 'evaluated', 'two', 'procedure', 'in', 'randomized', 'trial', 'involving', 'intermediate-risk', 'patient', '.', 'method', 'randomly', 'assigned', 'intermediate-risk', 'patient', 'with', 'severe', 'aortic', 'stenosis', ',', 'center', ',', 'to', 'undergo', 'either', 'tavr', 'or', 'surgical', 'replacement', '.', 'primary', 'end', 'point', 'death', 'cause', 'or', 'disabling', 'stroke', 'year', '.', 'primary', 'hypothesis', 'tavr', 'would', 'not', 'inferior', 'to', 'surgical', 'replacement', '.', 'randomization', ',', 'patient', 'entered', 'one', 'of', 'two', 'cohort', 'basis', 'of', 'clinical', 'and', 'imaging', 'finding', '.', 'of', 'patient', 'included', 'in', 'transfemoral-access', 'cohort', 'and', '.', 'in', 'transthoracic-access', 'cohort', '.', 'result', 'rate', 'of', 'death', 'cause', 'or', 'disabling', 'stroke', 'similar', 'in', 'tavr', 'group', 'and', 'surgery', 'group', '(', 'p.', 'noninferiority', ')', '.', 'year', ',', 'kaplan-meier', 'event', 'rate', '.', 'in', 'tavr', 'group', 'and', '.', 'in', 'surgery', 'group', '(', 'hazard', 'ratio', 'in', 'tavr', 'group', ',', '.', 'confidence', 'interval', 'ci', ',', '.', 'to', '.', 'p.', ')', '.', 'in', 'transfemoral-access', 'cohort', ',', 'tavr', 'resulted', 'in', 'lower', 'rate', 'of', 'death', 'or', 'disabling', 'stroke', 'surgery', '(', 'hazard', 'ratio', ',', '.', 'ci', ',', '.', 'to', '.', 'p.', ')', ',', 'whereas', 'in', 'transthoracic-access', 'cohort', ',', 'outcome', 'similar', 'in', 'two', 'group', '.', 'tavr', 'resulted', 'in', 'larger', 'aortic-valve', 'area', 'surgery', 'and', 'also', 'resulted', 'in', 'lower', 'rate', 'of', 'acute', 'kidney', 'injury', ',', 'severe', 'bleeding', ',', 'and', 'new-onset', 'atrial', 'fibrillation', 'surgery', 'resulted', 'in', 'fewer', 'major', 'vascular', 'complication', 'and', 'less', 'paravalvular', 'aortic', 'regurgitation', '.', 'conclusion', 'in', 'intermediate-risk', 'patient', ',', 'tavr', 'similar', 'to', 'surgical', 'aortic-valve', 'replacement', 'with', 'respect', 'to', 'primary', 'end', 'point', 'of', 'death', 'or', 'disabling', 'stroke', '.', '(', 'funded', 'edward', 'lifesciences', 'partner', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.,"Amanda H Anderson, Dawei Xie, Xue Wang, Robin L Baudier, Paula Orlandi, Lawrence J Appel, Laura M Dember, Jiang He, John W Kusek, James P Lash, Sankar D Navaneethan, Akinlolu Ojo, Mahboob Rahman, Jason Roy, Julia J Scialla, James H Sondheimer, Susan P Steigerwalt, F Perry Wilson, Myles Wolf, Harold I Feldman                              ;, CRIC Study Investigators, Alan S Go, Raymond R Townsend, Amanda H Andersonet al.",2021 Jan,Am J Kidney Dis,https://pubmed.ncbi.nlm.nih.gov/32866540/,No keywords found,"['identification', 'of', 'novel', 'risk', 'factor', 'chronic', 'kidney', 'disease', '(', 'ckd', ')', 'progression', 'may', 'inform', 'mechanistic', 'investigation', 'and', 'improve', 'identification', 'of', 'high-risk', 'subgroup', '.', 'current', 'study', 'aimed', 'to', 'characterize', 'ckd', 'progression', 'across', 'level', 'of', 'numerous', 'risk', 'factor', 'and', 'identify', 'independent', 'risk', 'factor', 'ckd', 'progression', 'among', 'with', 'and', 'without', 'diabetes', '.', 'study', 'design', 'chronic', 'renal', 'insufficiency', 'cohort', '(', 'cric', ')', 'study', 'prospective', 'cohort', 'study', 'of', 'adult', 'with', 'ckd', 'conducted', 'u', 'clinical', 'center', '.', 'setting', 'participant', 'participant', '(', 'n', ',', ')', 'to', '.', 'year', 'of', 'follow-up', 'diabetes', '.', 'predictor', 'risk', 'factor', 'ckd', 'progression', 'across', 'sociodemographic', ',', 'behavioral', ',', 'clinical', ',', 'and', 'biochemical', 'domain', 'baseline', '.', 'outcome', 'study', 'outcome', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'egfr', ')', 'slope', 'and', 'composite', 'of', 'halving', 'of', 'egfr', 'or', 'initiation', 'of', 'kidney', 'replacement', 'therapy', '.', 'analytical', 'approach', 'stepwise', 'selection', 'of', 'independent', 'risk', 'factor', 'performed', 'stratified', 'diabetes', 'status', 'using', 'linear', 'mixed-effects', 'and', 'cox', 'proportional', 'hazard', 'model', '.', 'result', 'among', 'without', 'and', 'with', 'diabetes', ',', 'respectively', ',', 'mean', 'egfr', 'slope', 'was-', '..', 'and-', '..', 'mlmin.m', 'per', 'year', '.', 'among', 'participant', 'with', 'diabetes', ',', 'multivariable-adjusted', 'hazard', 'of', 'composite', 'outcome', 'approximately', '-fold', 'or', 'greater', 'with', 'higher', 'level', 'of', 'inflammatory', 'chemokine', 'cxcl', ',', 'cardiac', 'marker', 'n-terminal', 'pro-b-type', 'natriuretic', 'peptide', '(', 'nt-probnp', ')', ',', 'and', 'kidney', 'injury', 'marker', 'urinary', 'neutrophil', 'gelatinase-associated', 'lipocalin', '(', 'ngal', ')', '.', 'among', 'without', 'diabetes', ',', 'low', 'serum', 'bicarbonate', 'and', 'higher', 'high-sensitivity', 'troponin', ',', 'nt-probnp', ',', 'and', 'urinary', 'ngal', 'level', 'significantly', 'associated', 'with', '.-fold', 'or', 'greater', 'rate', 'of', 'composite', 'outcome', '.', 'limitation', 'observational', 'study', 'design', 'precludes', 'causal', 'inference', '.', 'conclusion', 'strong', 'association', 'cardiac', 'marker', ',', 'plasma', 'cxcl', ',', 'and', 'urinary', 'ngal', 'comparable', 'to', 'of', 'systolic', 'blood', 'pressuremm', 'hg', ',', 'well-established', 'risk', 'factor', 'ckd', 'progression', '.', 'warrant', 'investigation', 'potential', 'mechanism', 'marker', 'indicate', 'and', 'opportunity', 'to', 'use', 'to', 'improve', 'risk', 'stratification', '.']"
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.,"Michael J Reardon, Nicolas M Van Mieghem, Jeffrey J Popma, Neal S Kleiman, Lars Søndergaard, Mubashir Mumtaz, David H Adams, G Michael Deeb, Brijeshwar Maini, Hemal Gada, Stanley Chetcuti, Thomas Gleason, John Heiser, Rüdiger Lange, William Merhi, Jae K Oh, Peter S Olsen, Nicolo Piazza, Mathew Williams, Stephan Windecker, Steven J Yakubov, Eberhard Grube, Raj Makkar, Joon S Lee, John Conte, Eric Vang, Hang Nguyen, Yanping Chang, Andrew S Mugglin, Patrick W J C Serruys, Arie P Kappetein                              ;, SURTAVI Investigators, Michael J Reardonet al.",2017 Apr 6,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/28304219/,No keywords found,"['although', 'transcatheter', 'aortic-valve', 'replacement', '(', 'tavr', ')', 'accepted', 'alternative', 'to', 'surgery', 'in', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'high', 'surgical', 'risk', ',', 'less', 'known', 'comparative', 'outcome', 'among', 'patient', 'with', 'aortic', 'stenosis', 'intermediate', 'surgical', 'risk', '.', 'method', 'evaluated', 'clinical', 'outcome', 'in', 'intermediate-risk', 'patient', 'with', 'severe', ',', 'symptomatic', 'aortic', 'stenosis', 'in', 'randomized', 'trial', 'comparing', 'tavr', '(', 'performed', 'with', 'use', 'of', 'self-expanding', 'prosthesis', ')', 'with', 'surgical', 'aortic-valve', 'replacement', '.', 'primary', 'end', 'point', 'composite', 'of', 'death', 'cause', 'or', 'disabling', 'stroke', 'month', 'in', 'patient', 'undergoing', 'attempted', 'aortic-valve', 'replacement', '.', 'used', 'bayesian', 'analytical', 'method', '(', 'with', 'margin', 'of', '.', ')', 'to', 'evaluate', 'noninferiority', 'of', 'tavr', 'compared', 'with', 'surgical', 'valve', 'replacement', '.', 'result', 'total', 'of', 'patient', 'underwent', 'randomization', 'center', '.', 'of', 'patient', ',', 'underwent', 'attempted', 'tavr', 'or', 'surgical', 'procedure', '.', 'mean', '(', 'sd', ')', 'age', 'of', 'patient', '..', 'year', ',', 'and', 'intermediate', 'risk', 'surgery', '(', 'society', 'of', 'thoracic', 'surgeon', 'predicted', 'risk', 'of', 'mortality', ',', '..', ')', '.', 'month', ',', 'estimated', 'incidence', 'of', 'primary', 'end', 'point', '.', 'in', 'tavr', 'group', 'and', '.', 'in', 'surgery', 'group', '(', 'credible', 'interval', 'bayesian', 'analysis', 'difference', ',', '-', '.', 'to', '.', 'posterior', 'probability', 'of', 'noninferiority', ',', '.', ')', '.', 'surgery', 'associated', 'with', 'higher', 'rate', 'of', 'acute', 'kidney', 'injury', ',', 'atrial', 'fibrillation', ',', 'and', 'transfusion', 'requirement', ',', 'whereas', 'tavr', 'higher', 'rate', 'of', 'residual', 'aortic', 'regurgitation', 'and', 'need', 'pacemaker', 'implantation', '.', 'tavr', 'resulted', 'in', 'lower', 'mean', 'gradient', 'and', 'larger', 'aortic-valve', 'area', 'surgery', '.', 'structural', 'valve', 'deterioration', 'month', 'not', 'occur', 'in', 'either', 'group', '.', 'conclusion', 'tavr', 'noninferior', 'alternative', 'to', 'surgery', 'in', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'intermediate', 'surgical', 'risk', ',', 'with', 'different', 'pattern', 'of', 'adverse', 'event', 'associated', 'with', 'procedure', '.', '(', 'funded', 'medtronic', 'surtavi', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.,"Jeffrey J Popma, G Michael Deeb, Steven J Yakubov, Mubashir Mumtaz, Hemal Gada, Daniel O'Hair, Tanvir Bajwa, John C Heiser, William Merhi, Neal S Kleiman, Judah Askew, Paul Sorajja, Joshua Rovin, Stanley J Chetcuti, David H Adams, Paul S Teirstein, George L Zorn rd, John K Forrest, Didier Tchétché, Jon Resar, Antony Walton, Nicolo Piazza, Basel Ramlawi, Newell Robinson, George Petrossian, Thomas G Gleason, Jae K Oh, Michael J Boulware, Hongyan Qiao, Andrew S Mugglin, Michael J Reardon                              ;, Evolut Low Risk Trial Investigators, Jeffrey J Popmaet al.",2019 May 2,N Engl J Med,https://pubmed.ncbi.nlm.nih.gov/30883053/,No keywords found,"['transcatheter', 'aortic-valve', 'replacement', '(', 'tavr', ')', 'alternative', 'to', 'surgery', 'in', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'increased', 'risk', 'death', 'surgery', 'less', 'known', 'tavr', 'in', 'low-risk', 'patient', '.', 'method', 'performed', 'randomized', 'noninferiority', 'trial', 'in', 'tavr', 'with', 'self-expanding', 'supraannular', 'bioprosthesis', 'compared', 'with', 'surgical', 'aortic-valve', 'replacement', 'in', 'patient', 'severe', 'aortic', 'stenosis', 'and', 'low', 'surgical', 'risk', '.', 'patient', 'reached', '-month', 'follow-up', ',', 'analyzed', 'data', 'regarding', 'primary', 'end', 'point', ',', 'composite', 'of', 'death', 'or', 'disabling', 'stroke', 'month', ',', 'using', 'bayesian', 'method', '.', 'result', 'of', 'patient', 'underwent', 'randomization', ',', 'attempted', 'tavr', 'or', 'surgical', 'procedure', 'performed', 'in', '.', 'patient', ""'"", 'mean', 'age', 'year', '.', '-month', 'estimated', 'incidence', 'of', 'primary', 'end', 'point', '.', 'in', 'tavr', 'group', 'and', '.', 'in', 'surgery', 'group', '(', 'difference', ',', '-', '.', 'percentage', 'point', 'bayesian', 'credible', 'interval', 'difference', ',', '-', '.', 'to', '.', 'posterior', 'probability', 'of', 'noninferiority', '.', ')', '.', 'day', ',', 'patient', 'undergone', 'tavr', ',', 'compared', 'with', 'surgery', ',', 'lower', 'incidence', 'of', 'disabling', 'stroke', '(', '.', 'v', '.', '.', ')', ',', 'bleeding', 'complication', '(', '.', 'v', '.', '.', ')', ',', 'acute', 'kidney', 'injury', '(', '.', 'v', '.', '.', ')', ',', 'and', 'atrial', 'fibrillation', '(', '.', 'v', '.', '.', ')', 'and', 'higher', 'incidence', 'of', 'moderate', 'or', 'severe', 'aortic', 'regurgitation', '(', '.', 'v', '.', '.', ')', 'and', 'pacemaker', 'implantation', '(', '.', 'v', '.', '.', ')', '.', 'month', ',', 'patient', 'in', 'tavr', 'group', 'lower', 'aortic-valve', 'gradient', 'in', 'surgery', 'group', '(', '.', 'mm', 'hg', 'vs.', '.', 'mm', 'hg', ')', 'and', 'larger', 'effective', 'orifice', 'area', '(', '.', 'cm', 'vs.', '.', 'cm', ')', '.', 'conclusion', 'in', 'patient', 'with', 'severe', 'aortic', 'stenosis', 'low', 'surgical', 'risk', ',', 'tavr', 'with', 'self-expanding', 'supraannular', 'bioprosthesis', 'noninferior', 'to', 'surgery', 'with', 'respect', 'to', 'composite', 'end', 'point', 'of', 'death', 'or', 'disabling', 'stroke', 'month', '.', '(', 'funded', 'medtronic', 'clinicaltrials.gov', 'number', ',', 'nct', '.', ')', '.']"
